<SEC-DOCUMENT>0001193125-20-247166.txt : 20200916
<SEC-HEADER>0001193125-20-247166.hdr.sgml : 20200916
<ACCEPTANCE-DATETIME>20200916160625
ACCESSION NUMBER:		0001193125-20-247166
CONFORMED SUBMISSION TYPE:	40FR12B
PUBLIC DOCUMENT COUNT:		169
FILED AS OF DATE:		20200916

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ImmunoPrecise Antibodies Ltd.
		CENTRAL INDEX KEY:			0001715925
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		40FR12B
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39530
		FILM NUMBER:		201178917

	BUSINESS ADDRESS:	
		STREET 1:		880 - 580 HORNBY STREET
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6C3B6
		BUSINESS PHONE:		6048060626

	MAIL ADDRESS:	
		STREET 1:		880 - 580 HORNBY STREET
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6C3B6
</SEC-HEADER>
<DOCUMENT>
<TYPE>40FR12B
<SEQUENCE>1
<FILENAME>d20922d40fr12b.htm
<DESCRIPTION>40FR12B
<TEXT>
<HTML><HEAD>
<TITLE>40FR12B</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">40-F</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>&#9746;<B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>Registration statement pursuant to Section&nbsp;12 of the Securities Exchange Act of 1934
</B></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>or </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>&#9744;<B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>Annual report pursuant to Section&nbsp;13(a) or 15(d) of the Securities Exchange Act of 1934
</B></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the fiscal year ended <U></U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission File Number <U></U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of Registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>British Columbia</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>8731</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>N/A</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Province or other jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>incorporation or organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Primary Standard Industrial</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Classification Code Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification Number)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>3204 - 4464 Markham Street </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Victoria, British Columbia V8Z 7X8 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(250) <FONT STYLE="white-space:nowrap">483-0308</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address and telephone number of Registrant&#146;s principal executive offices) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ImmunoPrecise Antibodies (USA), Ltd. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>4837 Amber Valley Parkway Suite 11 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Fargo, ND 58104 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(701)
353-0022 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name, address (including zip code) and telephone number (including area code) of agent for service in the United States)
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Securities registered or to be registered pursuant to Section&nbsp;12(b) of the Act: </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="33%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="31%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title of each class</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Trading</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Symbol(s)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Name of each exchange</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>on which registered</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Common Shares, no par value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>IPA</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>The Nasdaq Stock Market LLC</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Securities registered pursuant to Section&nbsp;12(g) of the Act: None. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Securities for which there is a reporting obligation pursuant to Section&nbsp;15(d) of the Act: None </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For annual reports, indicate by check mark the information filed with this Form: </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B></B>&#9744;<B></B><B>&nbsp;&nbsp;Annual information form</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B></B>&#9744;<B></B><B>&nbsp;&nbsp;Audited annual financial statements</B></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate the number of outstanding shares of each of the issuer&#146;s classes of capital or common stock as of the close of the period covered by the annual
report: <B>N/A</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the Registrant: (1)&nbsp;has filed all reports required to be filed by Section&nbsp;13 or 15(d) of the
Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2)&nbsp;has been subject to such filing requirements for the past 90 days. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#9744;&nbsp;&nbsp;Yes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9746;&nbsp;&nbsp;No </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of
Regulation <FONT STYLE="white-space:nowrap">S-T</FONT> (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#9744;&nbsp;&nbsp;Yes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9744;&nbsp;&nbsp;No </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Exchange
Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Emerging growth company&nbsp;&nbsp;&#9746; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to
use the extended transition period for complying with any new or revised financial accounting standards&#134; provided pursuant to Section&nbsp;13(a) of the Exchange Act.&nbsp;&nbsp;&#9744; </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#134;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The term &#147;new or revised financial accounting standard&#148; refers to any update issued by the Financial
Accounting Standards Board to its Accounting Standards Codification after April 5, 2012. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant
has filed a report on and attestation to its management&#146;s assessment of the effectiveness of its internal control over financial reporting under Section&nbsp;404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public
accounting firm that prepared or issued its audit report.&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXPLANATORY NOTE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd. (the &#147;Company&#148;, the &#147;Registrant&#148;) is a Canadian issuer eligible to file its registration statement pursuant
to Section&nbsp;12 of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), on Form <FONT STYLE="white-space:nowrap">40-F</FONT> pursuant to the multi-jurisdictional disclosure system of the Exchange Act. The Company is a
&#147;foreign private issuer&#148; as defined in Rule <FONT STYLE="white-space:nowrap">3b-4</FONT> under the Exchange Act. Equity securities of the Company are accordingly exempt from Sections 14(a), 14(b), 14(c), 14(f) and 16 of the Exchange Act
pursuant to Rule <FONT STYLE="white-space:nowrap">3a12-3.</FONT> </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORWARD LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Exhibits incorporated by reference into this Registration Statement of the Registrant contain forward-looking statements that reflect our
management&#146;s expectations with respect to future events, our financial performance and business prospects. All statements other than statements of historical fact are forward-looking statements. The use of the words such as &#147;plan&#148;,
&#147;expect&#148;, &#147;project&#148;, &#147;intend&#148;, &#147;believe&#148;, &#147;anticipate&#148;, &#147;estimate&#148;, &#147;may&#148;, &#147;will&#148;, &#147;would&#148;, &#147;could&#148;, &#147;likely&#148;, &#147;potential&#148;,
&#147;proposed&#148; and other similar words (including negative and grammatical variations), or statements that certain events or conditions &#147;may&#148; or &#147;will&#148; occur, and similar expressions may identify forward-looking statements,
but the absence of these words does not mean that a statement is not forward-looking. These statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that may cause actual results or
events to differ materially from those anticipated in the forward-looking statements. Applicable risks and uncertainties include, but are not limited to, those identified under the heading &#147;Risk Factors&#148; on page 14 of the Annual
Information Form for the year ended April&nbsp;30, 2020, attached as Exhibit 99.40 to this Registration Statement and incorporated herein by reference, and under the heading &#147;Risks and Uncertainties&#148; on page 21 of the Registrant&#146;s
Management&#146;s Discussion&nbsp;&amp; Analysis for the year ended April&nbsp;30, 2020, attached as Exhibit 99.83 to this Registration Statement and incorporated herein by reference, and in other filings that the Registrant has made and may make
with applicable securities authorities in the future. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, that contribute to the possibility that the
predictions, forecasts, projections and other forward-looking statements will not occur, including, without limitation, the Company&#146;s beliefs with respect to the potential for its antibodies to be further developed or approved to treat <FONT
STYLE="white-space:nowrap">COVID-19</FONT> (or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2)</FONT></FONT> or to complete any transactions with respect to those antibodies. No assurance can be given that these
expectations will prove to be correct and such forward-looking statements in the Exhibits incorporated by reference into this Registration Statement should not be unduly relied upon. The Registrant&#146;s forward-looking statements contained in the
Exhibits incorporated by reference into this Registration Statement are made as of the respective dates set forth in such Exhibits. Such forward-looking statements are based on the beliefs, expectations and opinions of management on the date the
statements are made. In preparing this Registration Statement, the Registrant has not updated such forward-looking statements to reflect any change in circumstances or in management&#146;s beliefs, expectations or opinions that may have occurred
prior to the date hereof. Nor does the Registrant assume any obligation to update such forward-looking statements in the future. For the reasons set forth above, investors should not place undue reliance on forward-looking statements. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DIFFERENCES IN UNITED STATES AND CANADIAN REPORTING PRACTICES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Registrant is permitted, under a multijurisdictional disclosure system adopted by the United States, to prepare this Registration Statement in accordance
with Canadian disclosure requirements, which are different from those of the United States. The Registrant has historically prepared its consolidated financial statements in accordance with International Financial Reporting Standards, as issued by
the International Accounting Standards Board, which differ in certain respects from United States generally accepted accounting principles (&#147;US GAAP&#148;) and from practices prescribed by the SEC. Therefore, the Registrant&#146;s financial
statements filed with this Registration Statement may not be comparable to financial statements prepared in accordance with U.S. GAAP. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PRINCIPAL DOCUMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with General Instruction B.(1) of Form <FONT STYLE="white-space:nowrap">40-F,</FONT> the Registrant hereby incorporates by reference
Exhibits&nbsp;99.1 through 99.91, inclusive, as set forth in the Exhibit Index attached hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with General Instruction D.(9) of Form <FONT
STYLE="white-space:nowrap">40-F,</FONT> the Registrant has filed the written consent of the experts named in the foregoing Exhibits as Exhibit&nbsp;99.91, as set forth in the Exhibit Index attached hereto. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TAX MATTERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Purchasing, holding, or
disposing of securities of the Registrant may have tax consequences under the laws of the United States and Canada that are not described in this registration statement on Form <FONT STYLE="white-space:nowrap">40-F.</FONT> </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DESCRIPTION OF COMMON SHARES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
required disclosure is included under the heading &#147;Description of Capital Structure&#148; in the Registrant&#146;s Annual Information Form for the fiscal year ended April 30, 2020, attached hereto as Exhibit 99.40. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">OFF-BALANCE</FONT> SHEET ARRANGEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Registrant has no <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet arrangements. (as that term is defined in paragraph 11(ii) of General
Instruction B to Form <FONT STYLE="white-space:nowrap">40-F)</FONT> that have or are reasonably likely to have a current or future effect on its financial condition, changes in financial condition, revenues or expenses, results of operations,
liquidity, capital expenditures or capital resources that is material to investors. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CURRENCY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated, all dollar amounts in this Registration Statement are in Canadian dollars. The exchange rate of Canadian dollars into
United&nbsp;States dollars, on April&nbsp;30, 2020, based upon the daily average closing rate as quoted by the Bank of Canada, was U.S.$1.00 = Cdn$1.3943. The exchange rate of Canadian dollars into United States dollars, on September&nbsp;15, 2020,
based upon the daily average closing rate as quoted by the Bank of Canada, was US$1.00 = Cdn$1.3176. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONTRACTUAL OBLIGATIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the contractual obligations of the Registrant as of April 30, 2020: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center"><B>Payments due by period (in Cdn$)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Contractual Obligations</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Less than 1<BR>year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B><FONT STYLE="white-space:nowrap">1-3</FONT> years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B><FONT STYLE="white-space:nowrap">3-5&nbsp;years</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>More&nbsp;than&nbsp;5<BR>years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and Accrued Liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,766,058</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,766,058</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans Payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">312,139</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">121,833</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">190,306</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred Acquisition Payments (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,052,626</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,546,088</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">506,538</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,082,978</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">849,255</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,233,723</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>8,213,801</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,283,234</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,930,567</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Cdn$1,016,112 aggregate payments not included in this table are to be settled with issuance of shares.
</P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NASDAQ CORPORATE GOVERNANCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A foreign private issuer that follows home country practices in lieu of certain provisions of the listing rules of the Nasdaq Stock Market LLC (the
&#147;<B>Nasdaq Stock Market Rules</B>&#148;) must disclose the ways in which its corporate </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
governance practices differ from those followed by domestic companies. As required by Nasdaq Rule 5615(a)(3), the Registrant will disclose on its website, https://www.immunoprecise.com/, as of
the listing date, each requirement of the Nasdaq Stock Market Rules that it does not follow and describe the home country practice followed in lieu of such requirements. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNDERTAKING </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Registrant undertakes to
make available, in person or by telephone, representatives to respond to inquiries made by the Commission staff, and to furnish promptly, when requested to do so by the Commission staff, information relating to the securities registered pursuant to
Form <FONT STYLE="white-space:nowrap">40-F</FONT> or transactions in said securities. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSENT TO SERVICE OF PROCESS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Registrant has concurrently filed a Form <FONT STYLE="white-space:nowrap">F-X</FONT> in connection with the class of securities to which this Registration
Statement relates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any change to the name or address of the Registrant&#146;s agent for service shall be communicated promptly to the Commission by
amendment to the Form <FONT STYLE="white-space:nowrap">F-X</FONT> referencing the file number of the Registrant. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following documents are being filed with the Commission as Exhibits to this Registration Statement: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Exhibit&nbsp;No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex991.htm">News Release dated May 30, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex992.htm">News Release dated June 26, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex993.htm">News Release dated July 15, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex994.htm">News Release dated August 1, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex995.htm">Consolidated Financial Statements of ImmunoPrecise Antibodies Ltd. for the year ended April 30, 2019 and 2018 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex996.htm">Management Certification of Form 13-501F1 dated August 28, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex997.htm">Certification of Annual Filings by CFO dated August 28, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex998.htm">Certification of Annual Filings by CEO dated August 28, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.9</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex999.htm">Management&#146;s Discussion and Analysis of ImmunoPrecise Antibodies Ltd. for year ended April 30, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9910.htm">News Release dated August 28, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.11</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9911.htm">Notice of Annual General Meeting of Shareholders of ImmunoPrecise Antibodies Ltd. dated August 29, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.12</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9912.htm">News Release dated September 23, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.13</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9913.htm">News Release dated September 24, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.14</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9914.htm">Condensed Interim Consolidated Financial Statements (Unaudited) of ImmunoPrecise Antibodies Ltd. dated July 31, 2019 and 2018 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.15</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9915.htm">Management&#146;s Discussion and Analysis of ImmunoPrecise Antibodies Ltd. for three months ended July 31, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.16</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9916.htm">Certification of Interim Filings by CFO dated September 30, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.17</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9917.htm">Certification of Interim Filings by CEO dated September 30, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.18</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9918.htm">News Release dated September 30, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.19</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9919.htm">Notice of Annual General Meeting of Shareholders of ImmunoPrecise Antibodies Ltd. amended dated September 30, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.20</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9920.htm">News Release dated October 1, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.21</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9921.htm">News Release dated October 3, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.22</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9922.htm">News Release dated October 18, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.23</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9923.htm">Voting Instruction Form for Annual General Meeting to be held on November 22, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.24</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9924.htm">Notice of Annual General Meeting of Shareholders of ImmunoPrecise Antibodies Ltd. dated October 22, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.25</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9925.htm">Notice of Meeting and Management Information Circular dated October 22, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.26</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9926.htm">Form of Proxy for Annual General Meeting of ImmunoPrecise Antibodies Ltd. to be held on November 22, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.27</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9927.htm">Shareholder Rights Plan Agreement between ImmunoPrecise Antibodies Ltd. and Computershare Trust Company dated October 17, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.28</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9928.htm">News Release dated November 5, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.29</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9929.htm">News Release dated December 2, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.30</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9930.htm">Management&#146;s Discussion and Analysis of ImmunoPrecise Antibodies Ltd. for six months ended October 31, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.31</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9931.htm">Condensed Interim Consolidated Financial Statements (Unaudited) of ImmunoPrecise Antibodies Ltd. dated October&nbsp;31, 2019 and 2018 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.32</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9932.htm">Certification of Interim Filings by CFO dated December 17, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.33</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9933.htm">Certification of Interim Filings by CEO dated December 17, 2019 </A></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.34</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9934.htm">News Release dated December 17, 2019<BR></A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.35</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9935.htm">News Release dated January 6, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.36</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9936.htm">News Release dated January 9, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.37</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9937.htm">News Release dated January 20, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.38</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9938.htm">Certification of Annual Filings by CFO dated February 14, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.39</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9939.htm">Certification of Annual Filings by CEO dated February 14, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.40</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9940.htm">Annual Information Form of ImmunoPrecise Antibodies Ltd. for the year ended April 30, 2020 dated February 14, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.41</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9941.htm">Form NI 44-101 Notice of intent to qualify dated February 19, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.42</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9942.htm">News Release dated February 20, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.43</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9943.htm">News Release dated March 2, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.44</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9944.htm">News Release dated March 6, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.45</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9945.htm">Management&#146;s Discussion and Analysis of ImmunoPrecise Antibodies Ltd. for the three and nine month period ended January 31, 2020 and 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.46</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9946.htm">Condensed Interim Consolidated Financial Statements (Unaudited) of ImmunoPrecise Antibodies Ltd. dated January 31, 2020 and 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.47</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9947.htm">Certification of Interim Filings by CFO dated March 10, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.48</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9948.htm">Certification of Interim Filings by CEO dated March 10, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.49</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9949.htm">News Release dated March 10, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.50</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9950.htm">News Release dated March 12, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.51</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9951.htm">News Release dated March 30, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.52</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9952.htm">News Release dated March 31, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.53</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9953.htm">News Release dated April 2, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.54</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9954.htm">Material Change Report of ImmunoPrecise Antibodies Ltd. dated March 30, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.55</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9955.htm">Material Change Report of ImmunoPrecise Antibodies Ltd. dated March 31, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.56</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9956.htm">News Release dated April 14, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.57</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9957.htm">News Release dated April 15, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.58</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9958.htm">News Release dated April 17, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.59</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9959.htm">News Release dated April 24, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.60</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9960.htm">Material Change Report of ImmunoPrecise Antibodies Ltd. dated April 24, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.61</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9961.htm">News Release dated May 6, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.62</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9962.htm">News Release dated May 8, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.63</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9963.htm">Share Purchase Agreement, dated March 15, 2018, by and among ImmunoPrecise Antibodies Ltd., ImmunoPrecise Netherlands B.V., Modiquest Research B.V., Immulease B.V., Immusys B.V. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.64</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9964.htm">Share Exchange Agreement for U-Protein Express B.V., dated August 10, 2017, by and among ImmunoPrecise Antibodies Ltd., U-Protein Express B.V., and the sellers and principals signatory thereto
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.65</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9965.htm">News Release dated May 15, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.66</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9966.htm">News Release dated May 15, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.67</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9967.htm">Material Change Report of ImmunoPrecise Antibodies Ltd. dated May 15, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.68</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9968.htm">Amendment, Termination, and Settlement Agreement dated March 14, 2019 between ImmunoPrecise Antibodies Ltd., ImmunoPrecise Netherlands B.V., Immusys B.V., Modiquest Research, Immulease B.V., and Mr Jozef Maria
 Raats </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.69</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9969.htm">Form 45-106F1 Report of Exempt Distribution dated May 25, 2020 </A></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.70</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9970.htm">News Release dated May 27, 2020</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.71</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9971.htm">News Release dated June 4, 2020</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.72</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9972.htm">News Release dated June 11, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.73</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9973.htm">News Release dated June 22, 2020</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.74</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9974.htm">News Release dated June 29, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.75</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9975.htm">Material Change Report of ImmunoPrecise Antibodies Ltd. dated June 29, 2020</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.76</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9976.htm">News Release dated July 13, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.77</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9977.htm">News Release dated July 20, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.78</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9978.htm">News Release dated July 28, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.79</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9979.htm">News Release dated July 31, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.80</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9980.htm">News Release dated August 13, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.81</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9981.htm">Consolidated Financial Statements of ImmunoPrecise Antibodies Ltd. for the years ended April 30, 2020 and 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.82</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9982.htm">Management Certification of Form 13-501F1 dated August 28, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.83</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9983.htm">Management&#146;s Discussion and Analysis of ImmunoPrecise Antibodies Ltd. for year ended April 30, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.84</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9984.htm">Certification of Annual Filings by CFO dated August 28, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.85</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9985.htm">Certification of Annual Filings by CEO dated August 28, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.86</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9986.htm">News Release dated August 31, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.87</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9987.htm">News Release dated September 1, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.88</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9988.htm">News Release dated September 8, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.89</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9989.htm">News Release dated September 9, 2020</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.90</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9990.htm">News Release dated September 10, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.91</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d20922dex9991.htm">Consent of Crowe MacKay LLP dated September 16, 2020 </A></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Exchange Act, the Registrant certifies that it meets all of the requirements for filing on Form <FONT
STYLE="white-space:nowrap">40-F</FONT> and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>IMMUNOPRECISE ANTIBODIES LTD.</B></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-bottom:1pt; margin-top:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jennifer Bath</P></TD></TR></TABLE></DIV> <DIV ALIGN="right">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Jennifer Bath</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: September 16, 2020 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d20922dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g83a33.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Antibodies Announces an Unprecedented Onboarding of Pharma and Biotech Clients Using IPA&#146;s
Proprietary High-Throughput <FONT STYLE="white-space:nowrap">B-Cell</FONT> Select<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> and DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Diversified Offerings of 9 Transgenic Animal Strains Platforms supports Solid Growth in Drug Discovery Services </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, May 30, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTC PINK: IPATF) announces that
its proprietary, high-throughput <FONT STYLE="white-space:nowrap">B-cell</FONT> and phage display platforms have garnered a lot of attention as of late, and for a good reason. These species-independent platforms allow for high-throughput and more
efficient antibody discovery than traditional hybridoma-based counterparts and are readily adapted for use with fully-human transgenic animals, compounding the benefits for the Company&#146;s clients. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In recent weeks and months, IPA has been engaged by several large pharmaceutical companies to conduct work using transgenic animals from Ligand Pharmaceutics
(distributors of OmniRat<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP>, OmniMouse<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP>, OmniFlic<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP>, and OmniChicken<SUP
STYLE="font-size:85%; vertical-align:top">&#153;</SUP>), Ablexis (distributors of AlivaMab<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>), Harbour BioMed (distributors of Harbour
Mice<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, an undisclosed transgenic <FONT STYLE="white-space:nowrap">knock-out</FONT> animal, Alloy Therapeutics (Distributors of Alloy
Mice<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>) and Trianni (distributors of Trianni Mice<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA announced today that <FONT STYLE="white-space:nowrap">B-cell</FONT> and phage display programs have launched in seven of the above nine platforms, and
three of these programs are being trialed by a single client in two different discovery platforms simultaneously. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;This unprecedented growth in the
demand and use of alternative transgenic species and strains is a client solicitation that IPA has been anticipating, and is fully prepared to respond to,&#148; stated Dr. Jennifer Bath, President and CEO of IPA. &#147;The requests have been well
distributed across our locations worldwide and continue to engage all three of our global, antibody manufacturing sites.&#148; It is widely believed that fully human antibodies manufactured through transgenic animal use will witness a continually
growing demand, and Dr.&nbsp;Bath confirms this, furthering the belief that the Company&#146;s unique ability to handle the variety of transgenic species, at a global, high-capacity, uniquely positions the Company at the forefront of this industry
trend. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Extension of Warrant Expiry Dates </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company also announces that it will apply to the TSX Venture Exchange to extend the expiry date of 875,000 share purchase warrants issued in a private placement financing on June 18, 2019 (see news release dated June 19, 2018). The share purchase
warrants are exercisable at a price of $1.00 per share and the expiry date is being extended from June 18, 2019 to June 18, 2020. The extension of the expiry date is subject to the acceptance of the TSX Venture Exchange. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA is a
full-service, therapeutic antibody discovery company focused on the next generation of antibody discovery, to deliver the most therapeutically-relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical
trials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA operates from
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">state-of-the-art</FONT></FONT></FONT> laboratory facilities located at the Vancouver Island Technology Park in Victoria, British Columbia, in
collaboration with its wholly-owned subsidiary operations at </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
U-Protein Express B.V., in the Life Science Incubator, Utrecht, and ModiQuest Research, Oss, both in the Netherlands. The Company operates globally to offer antibody services from target analysis
to <FONT STYLE="white-space:nowrap">pre-clinical</FONT> studies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The services offered to clients include antibody discovery against a broad spectrum of
antigens, including challenging targets. Amongst these services, the Company offers hybridoma production, <FONT STYLE="white-space:nowrap">B-cell</FONT> services, and a variety of phage display platforms. The Company also provides a broad range of
supporting services including immunologically-based assays, recombinant protein manufacturing, humanization, optimization, stable cell line development, and advanced solutions to challenges faced by clients in antibody-related research and
development. The antibodies produced by IPA target a wide variety of therapeutic, diagnostic and research applications. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward Looking Information </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148;
within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and
similar expressions to identify forward-looking statements. Any such forward-looking statements are based on assumptions and analyses made by IPA in light of its experience and its perception of historical trends, current conditions and expected
future developments. However, whether actual results and developments will conform to IPA&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause IPA&#146;s actual results to
differ materially from those expressed or implied by the forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and
uncertainties described in IPA&#146;s annual management discussion and analysis for the fiscal year ended April 30, 2018 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the
date of this press release and, unless required by applicable law, IPA undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View original content to download multimedia: <U> </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.newswire.ca/en/releases/archive/May2019/30/c3394.htm</U><U>l</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-</FONT></FONT> <FONT STYLE="white-space:nowrap">863-7071,</FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 08:30e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">30-MAY-19</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>d20922dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.2 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g78m49.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Guarantees Success for Customers of Their Well-Established B cell Select<SUP
STYLE="font-size:85%; vertical-align:top">&#153;</SUP> Antibody Discovery Platform </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, June&nbsp;26, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD.
(the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTC PINK: IPATF), the industry leader in the discovery of novel, therapeutic monoclonal antibodies, announces that from this point forward it will guarantee the success of campaigns
powered by its proprietary B cell Select<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> Antibody Discovery platform. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pioneering innovative
antibody discovery, ImmunoPrecise harnesses its species agnostic platform, driven by scientific experts with over a decade of experience in single B cell services, to leverage its already industry-wide, unprecedented success rates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">B cell technologies is a space where IPA has spent years differentiating itself from competitors. The Company understands the importance to ensure clients can
readily ascertain who has the depth of experience and proven success to partner with pharma, without jeopardizing outcomes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">It can be to the detriment of
pharmaceutical partners and patients when therapeutic programs are continually repeated due to low success rates, oftentimes a result of contract organizations&#146; lack of experience in modern technologies, which can take years to master, or their
use of outdated platforms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We believe that backing our expertise with a success guarantee, in a royalty-free service offering, aligns our B Cell
Select<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> platform with the goals of our clients worldwide&#148;, stated IPA President and CEO, Dr.&nbsp;Jennifer Bath. &#147;Ultimately, our optimized platform, exhibiting a minimum 94%
success rate, along with our success guarantee, decreases turnaround time, attenuates risk, and reduces the overall cost for our clients in getting antibody therapeutics to the clinic. We are both humbled and honored to be servicing this
niche.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For more information about ImmunoPrecise&#146;s proprietary B cell Select<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> &#9744;
platform visit <U><FONT STYLE="white-space:nowrap">https://www.immunoprecise.com/services/b-cell-select/</FONT></U> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies
Ltd. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a full-service, therapeutic antibody discovery company focused on the next generation of antibody discovery, to deliver the most
therapeutically-relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise operates
from <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">state-of-the-art</FONT></FONT></FONT> laboratory facilities located in Victoria, British Columbia, in collaboration with its wholly-owned
subsidiary operations at ImmunoPrecise Antibodies Europe (formerly ModiQuest Research), in Oss, and <FONT STYLE="white-space:nowrap">U-Protein</FONT> Express, in Utrecht, both in the Netherlands. The Company operates globally to offer a continuum of
superior antibody services, from target analysis to <FONT STYLE="white-space:nowrap">pre-clinical</FONT> studies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward Looking Information </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148;
within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and
similar expressions to identify forward-looking statements. Any such forward-looking </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and expected future developments.
However, whether actual results and developments will conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to
differ materially from those expressed or implied by the forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and
uncertainties described in ImmunoPrecise&#146;s annual management discussion and analysis for the fiscal year ended April&nbsp;30, 2018 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak
only as of the date of this press release and, unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View original content to download multimedia: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.newswire.ca/en/releases/archive/June2019/26/c7762.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 08:15e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">26-JUN-19</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>d20922dex993.htm
<DESCRIPTION>EX-99.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.3 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g78m49.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Antibodies Announces Immuno-oncology Discovery Collaboration with Entos Pharmaceuticals </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, July&nbsp;15, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTC PINK: IPATF), an
industry leader in the discovery of novel, therapeutic monoclonal antibodies, announces that it has entered into a new antibody discovery collaboration with Entos Pharmaceuticals Inc., to develop a therapeutic candidate against an undisclosed,
immuno-oncology target, by leveraging ImmunoPrecise&#146;s proprietary B cell Select<B><SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP></B> platform. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise&#146;s well-established B cell Select<B><SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP></B> platform is capable of screening tens of
millions of cells, to identify a greater diversity of antibodies, with very little manipulation. This proprietary platform is species and tissue independent, allowing for the generation of antibodies from samples not possible using other methods.
The B cell Select<B><SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP></B> platform takes advantage of the diversity of the animal&#146;s immune repertoire, and allows for screening of any protein class, complex therapeutic targets,
post-translational modifications, and small molecules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Our B cell Select<B><SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP></B> platform
has a proven track record of discovering large panels of high-affinity antibodies against a broad range of antibody targets, including difficult membrane proteins. Our North American B cell laboratory boasts over one decade of experience with a 94%
success rate. This is, in part, why we are very confident in these collaborations, and continue to field requests from such reputable groups,&#148; said Dr.&nbsp;Jennifer Bath, IPA President and CEO. &#147;We are pleased that Entos Pharmaceuticals
Inc., a global leader in next generation nucleic acid-based therapies, considers us to be a trusted partner in antibody discovery.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The team
at Entos is committed to developing breakthrough medicines to address pressing clinical unmet needs,&#148; said Dr.&nbsp;John Lewis, CEO of Entos. &#147;We have been extremely impressed with IPA&#146;s B cell Select<B><SUP
STYLE="font-size:85%; vertical-align:top">&#153;</SUP></B> platform, which provides an ideal approach to develop therapeutic candidates.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Andy
Nixon stepping down from ImmunoPrecise&#146;s Board. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company also announces that board director Andy Nixon has stepped down from his duties due to
an arisen conflict of interest. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise&#146;s Chair, James Kuo, stated they &#147;regretfully&#148; accepted Andy&#146;s resignation &#147;We will
miss Andy&#146;s contribution on the ImmunoPrecise board. He is a highly qualified Director and we wish him every success in the future&#148;, Kuo said. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Erratum </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In May 30th news Release Extension of Warrant
Expiry Dates, the actual placement date should&#146;ve read June&nbsp;18, 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The Company also announces that it will apply to the TSX Venture
Exchange to extend the expiry date of 875,000 share purchase warrants issued in a private placement financing on June&nbsp;18, 2018 (see news release dated June&nbsp;19, 2018). The share purchase warrants are exercisable at a price of $1.00 per
share and the expiry date is being extended from June&nbsp;18, 2019 to June&nbsp;18, 2020. The extension of the expiry date is subject to the acceptance of the TSX Venture Exchange.&#148; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Entos Pharmaceuticals </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Entos Pharmaceuticals is focused on the development of next generation nucleic acid-based therapies using their proprietary Fusogenix drug delivery system.
Fusogenix uses a novel mechanism of action to deliver molecules, intact and unmodified, directly into the cytosol of target cells. The technology is applicable to a wide range of therapeutic types including gene therapy, mRNA, miRNA, RNAi and
CRISPR. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a full-service, therapeutic antibody discovery company focused on the next generation of antibody discovery, to deliver the most
therapeutically-relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise operates
from <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">state-of-the-art</FONT></FONT></FONT> laboratory facilities located in Victoria, British Columbia and Oss, the Netherlands, in collaboration with
it&#146;s wholly owned subsidiary <FONT STYLE="white-space:nowrap">U-Protein</FONT> Express B.V., in Utrecht, the Netherlands. The Company operates globally to offer a continuum of superior antibody services, from target analysis to <FONT
STYLE="white-space:nowrap">pre-clinical</FONT> studies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward Looking Information </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148;
within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and
similar expressions to identify forward-looking statements. Any such forward-looking statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and
expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause
ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower
than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and analysis for the fiscal year ended April&nbsp;30, 2018 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking
statements&#148; contained herein speak only as of the date of this press release and, unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information,
future events or otherwise. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View original content to download multimedia: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.newswire.ca/en/releases/archive/July2019/15/c3293.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 08:30e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">15-JUL-19</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>5
<FILENAME>d20922dex994.htm
<DESCRIPTION>EX-99.4
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.4</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.4 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g78m49.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise&#146;s Wholly Owned Talem Therapeutics Announces the Creation of its Scientific Committee </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, Aug. 1, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTCQB PINK: IPATF) announces the
launch of its High Value Target Scientific Committee which will strengthen the scientific oversight and methodological practice within Talem. The Committee consists of a selection of internationally recognized visionary scientists and experts from a
broad range of disciplines. Their task is to assist in the planning of Talem&#146;s partnerships, in particular, they are charged with overseeing the development of the scientific pipeline including reviewing and selecting potential targets for
discovery, evaluating partnerships with Biotech and Pharma companies, and ensuring scientific rigor and best practices are adhered to. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The composition of
the committee, and supporting processes, reflects a management-staff collaboration that ensures experience and agreement on a common direction that will lead to a high level of commitment and partnerships. The strategic plan will span three years,
from 2019&#150;2022, with the aim of developing a robust pipeline and established partnerships. Talem management, Dr.&nbsp;Jennifer Bath, will work closely with newly elected Chairwoman, Dr.&nbsp;Ilse Roodink. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Initial electees to the committee include Dr.&nbsp;Ilse Roodink (IPA Europe), Dr.&nbsp;Zalan Szabo <FONT STYLE="white-space:nowrap">(U-Protein</FONT> Express,
an IPA Company), Dr.&nbsp;Andra Li (IPA Canada), and Dr.&nbsp;Jennifer Bath (Talem, IPA Ltd). Future nominations are to be expected as Talem continues to grow it&#146;s IP Estate. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Talem Therapeutics </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Talem Therapeutics
(<U>www.talemtherapeutics.com</U>) is an international biopharmaceutical company focused on the discovery and development of new antibodies originating from IPA&#146;s innovative and proprietary technologies and Structure-Based Drug Design platform
capabilities. Talem will focus on a broad pipeline of partnered and <FONT STYLE="white-space:nowrap">in-house</FONT> drug candidates in multiple therapeutic areas including, but not limited to, neurology, immuno-oncology, gastroenterology,
inflammation, and rare/specialty diseases. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a full-service, therapeutic antibody discovery company focused on the next generation of antibody discovery, to deliver the most
therapeutically-relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise operates
from <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">state-of-the-art</FONT></FONT></FONT> laboratory facilities located in Victoria, British Columbia, in collaboration with its wholly-owned
subsidiary operations at ImmunoPrecise Antibodies Europe (formerly ModiQuest Research), in Oss, and <FONT STYLE="white-space:nowrap">U-Protein</FONT> Express, in Utrecht, both in the Netherlands. The Company operates globally to offer a continuum of
superior antibody services, from target analysis to <FONT STYLE="white-space:nowrap">pre-clinical</FONT> studies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward Looking Information </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148;
within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and
similar expressions to identify forward-looking statements. Any such forward-looking </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and expected future developments.
However, whether actual results and developments will conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to
differ materially from those expressed or implied by the forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and
uncertainties described in ImmunoPrecise&#146;s annual management discussion and analysis for the fiscal year ended April&nbsp;30, 2018 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak
only as of the date of this press release and, unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View original content to download multimedia: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.newswire.ca/en/releases/archive/August2019/01/c9196.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 08:00e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">01-AUG-19</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.5
<SEQUENCE>6
<FILENAME>d20922dex995.htm
<DESCRIPTION>EX-99.5
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.5</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.5 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g20922g68y41.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR THE YEARS ENDED APRIL&nbsp;30, 2019 AND 2018 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Expressed in Canadian Dollars) </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="23%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g20922g55v98.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Crowe MacKay LLP</B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">1100&nbsp;-&nbsp;1177&nbsp;West&nbsp;Hastings&nbsp;St.</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vancouver, BC V6E 4T5</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Main +1 (604) <FONT
STYLE="white-space:nowrap">687-4511</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fax&nbsp;&nbsp;&nbsp;&nbsp;+1 (604) <FONT STYLE="white-space:nowrap">687-5805</FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">www.crowemackay.ca</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Independent Auditor&#146;s Report </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the Shareholders of ImmunoPrecise Antibodies Ltd. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Opinion
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have audited the consolidated financial statements of ImmunoPrecise Antibodies Ltd. (&#147;the Group&#148;), which comprise the consolidated
statements of financial position as at April&nbsp;30, 2019 and April&nbsp;30, 2018 and the consolidated statements of loss and comprehensive loss, changes in equity and cash flows for the years then ended, and notes to the consolidated financial
statements, including a summary of significant accounting policies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In our opinion, the accompanying consolidated financial statements present fairly, in
all material respects, the consolidated financial position of the Group as at April&nbsp;30, 2019 and April&nbsp;30, 2018, and its consolidated financial performance and its consolidated cash flows for the years then ended in accordance with
International Financial Reporting Standards. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Basis for Opinion </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We conducted our audit in accordance with Canadian generally accepted auditing standards. Our responsibilities under those standards are further described in
the <I>Auditor&#146;s Responsibilities for the Audit of the Consolidated Financial Statements</I> section of our report. We are independent of the Group in accordance with the ethical requirements that are relevant to our audit of the consolidated
financial statements in Canada, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Material Uncertainty Related to Going Concern </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We
draw attention to Note 1 to the consolidated financial statements which describes the material uncertainty that may cast significant doubt on the Group&#146;s ability to continue as a going concern. Our opinion is not modified in respect of this
matter. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Management is responsible
for the other information. The other information comprises: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Management&#146;s Discussion and Analysis </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our opinion on the consolidated financial statements does not cover the other information and we do not express any form of assurance conclusion thereon. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with our audit of the consolidated financial statements, our responsibility is to read the other information identified above and, in doing so,
consider whether the other information is materially inconsistent with the consolidated financial statements or our knowledge obtained in the audit, or otherwise appears to be materially misstated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We obtained the other information prior to the date of this auditor&#146;s report. If, based on the work we have performed on this other information, we
conclude that there is a material misstatement of this other information, we are required to report that fact in this auditor&#146;s report. We have nothing to report in this regard. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Responsibilities of Management and Those Charged with Governance for the Consolidated Financial
Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with
International Financial Reporting Standards, and for such internal control as management determines is necessary to enable the preparation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In preparing the consolidated financial statements, management is responsible for assessing the Company&#146;s ability to continue as a going concern,
disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Those charged with governance are responsible for overseeing the Company&#146;s financial reporting process. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Auditor&#146;s Responsibilities for the Audit of the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether
due to fraud or error, and to issue an auditor&#146;s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with Canadian generally accepted auditing
standards will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions
of users taken on the basis of these consolidated financial statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As part of an audit in accordance with Canadian generally accepted auditing
standards, we exercise professional judgment and maintain professional skepticism throughout the audit. We also: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Identify and assess the risks of material misstatement of the consolidated financial statements, whether due to
fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is
higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are
appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Group&#146;s internal control. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and
related disclosures made by management. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Conclude on the appropriateness of management&#146;s use of the going concern basis of accounting and, based on
the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Group&#146;s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are
required to draw attention in our auditor&#146;s report to the related disclosures in the consolidated financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to
the date of our auditor&#146;s report. However, future events or conditions may cause the Group to cease to continue as a going concern. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Evaluate the overall presentation, structure and content of the consolidated financial statements, including the
disclosures, and whether the consolidated financial statements represent the underlying transactions and events in a manner that achieves fair presentation. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Obtain sufficient appropriate audit evidence regarding the financial information of the entities or business
activities within the Group to express an opinion on the consolidated financial statements. We are responsible for the direction, supervision and performance of the group audit. We remain solely responsible for our audit opinion.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 2 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We communicate with those charged with governance regarding, among other matters, the planned scope and
timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also
provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our
independence, and where applicable, related safeguards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The engagement partner on the audit resulting in this independent auditor&#146;s report is Keith
L. Gagnon. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>&#147;Crowe MacKay LLP&#148; </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Chartered Professional Accountants </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vancouver, Canada
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>August&nbsp;28, 2019 </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 3 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSOLIDATED STATEMENTS OF FINANCIAL POSITION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Note</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ASSETS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,471,650</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,806,133</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,558,354</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,660,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,120,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">412,690</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">393,451</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">560,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">333,702</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">342,636</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,877,971</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,782,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,450</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>8</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment and leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>9</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,638,549</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,581,369</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>6,&nbsp;7,&nbsp;10</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,417,231</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,042,483</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>6, 7</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,254,114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,892,157</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unallocated purchase price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>7</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,186,330</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,345,719</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,575,440</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>LIABILITIES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>15</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,594,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,034,156</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">724,693</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">317,539</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>11</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,708,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>12</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82,953</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">187,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>13</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,757</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,474</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>6, 7</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,031,237</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,737,337</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,204,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,284,320</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>11</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,489,397</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>12</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,717</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102,631</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>13</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,320</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38,984</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>6, 7</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,032,744</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,074,822</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>21</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,939,559</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">882,336</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,276,644</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,872,490</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>SHAREHOLDERS&#146; EQUITY</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>14</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,699,425</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,455,112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contributed surplus</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>14</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,074,192</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,707,738</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated other comprehensive (loss) income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(228,060</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">277,090</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,476,482</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,736,990</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,069,075</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,702,950</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities and equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,345,719</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,575,440</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nature of operations (Note 1)&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Commitments (Note 18)&nbsp;&nbsp;&nbsp;&nbsp; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Approved and
authorized on behalf of the Board of Directors on August&nbsp;27, 2019&nbsp;&nbsp;&nbsp;&nbsp; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<I>James Kuo&#148;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</I></U>Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<I>Greg Smith</I>&#148;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes
are an integral part of these consolidated financial statements </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5
</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Note</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>REVENUE</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,926,268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,441,349</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>COST OF SALES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,631,634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,990,323</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>GROSS PROFIT</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,294,634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,451,026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>EXPENSES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Advertising</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">819,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">134,680</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization and depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>9,&nbsp;10</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,875,907</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">233,534</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bad debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,837</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Consulting fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>15</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">452,196</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">864,549</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange (gain) loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(117,506</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">101,543</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Insurance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">185,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39,845</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest and bank charges</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">413,590</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,591</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Management fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>15</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">650,574</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">429,184</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Office and general</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">716,601</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">563,996</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Professional fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>15</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">985,557</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,030,178</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">324,396</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65,093</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repairs and maintenance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38,803</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,985</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">485,845</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">509,248</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Salaries and benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>15</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,503,259</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,852,322</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>14, 15</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,114,112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,221,511</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Telephone and utilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,775</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,395</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Travel</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">320,293</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">218,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,817,588</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,380,233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Loss before other income (expense) and income taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,522,954</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,929,207</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>OTHER INCOME (EXPENSE)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>6,&nbsp;7,&nbsp;11</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(904,925</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(205,185</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest and other income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,085</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73,004</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss on settlement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>11, 14</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(214,885</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,089,725</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(132,181</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Loss before income taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,612,679</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,061,388</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>21</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,788</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(109,715</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>NET LOSS FOR THE YEAR</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,617,467</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,171,103</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ITEMS THAT MAY BE RECLASSIFIED SUBSEQUENTLY TO LOSS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange difference on translating foreign operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(505,150</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">277,090</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>COMPREHENSIVE LOSS FOR THE YEAR</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,122,617</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,894,013</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>LOSS PER SHARE &#150; BASIC AND DILUTED</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.12</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.11</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>62,710,530</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>45,532,568</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes
are an integral part of these consolidated financial statements </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6
</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian dollars, except for share figures) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Share<BR>Capital</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Contributed<BR>Surplus</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated<BR>Other<BR>Comprehensive<BR>(Loss)&nbsp;Income</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Deficit</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>38,578,522</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,459,909</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>198,032</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(4,565,887</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,092,054</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to private placements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash issue costs and finders&#146; fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">281,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29,669</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29,669</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to acquisition of <FONT STYLE="white-space:nowrap">U-Protein</FONT> (Note
6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,030,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,022,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,022,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to acquisition of IPA Europe and Immulease (Note 7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,600,399</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,909,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,909,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants attached to Debentures offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">214,872</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">214,872</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finder&#146;s shares and finder&#146;s warrants issued pursuant to Debentures offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">580,320</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">383,010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">187,627</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">570,637</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to warrant exercise</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">650,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">195,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">195,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to option exercise</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">503,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">265,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(114,304</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">151,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,221,511</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,221,511</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss for the year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">277,090</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,171,103</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,894,013</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>55,474,178</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20,455,112</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,707,738</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>277,090</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(9,736,990</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>12,702,950</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adoption of IFRS 15 (Note 4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(122,025</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(122,025</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, May&nbsp;1, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>55,474,178</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20,455,112</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,707,738</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>277,090</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(9,859,015</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>12,580,925</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to private placements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,977,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,802,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,802,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash issue costs and finders&#146; fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">182,460</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(288,504</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(288,504</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustment to value of shares issued pursuant to acquisition of IPA Europe and Immulease</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">975,045</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">975,045</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to settlement of Debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,377,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,115,370</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">283,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,398,370</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to Crossbeta settlement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78,514</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to deferred acquisition payment to IPA Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">714,793</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">507,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">507,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to option exercise</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">135,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,158</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,658</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,114,112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,114,112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss for the year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(505,150</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,617,467</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,122,617</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>67,939,445</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>32,699,425</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,074,192</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(228,060</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(17,476,482</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>18,069,075</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes
are an integral part of these consolidated financial statements </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7
</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSOLIDATED STATEMENTS OF CASH FLOWS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss for the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,617,467</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,171,103</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Items not affecting cash:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization and depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,263,284</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">458,079</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(578,969</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,389</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion and accrued interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">922,575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">205,185</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(105,656</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss on settlement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">214,885</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,114,112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,221,511</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,787,236</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,222,938</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in <FONT STYLE="white-space:nowrap">non-cash</FONT> working capital related to
operations:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102,114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(284,952</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">289,524</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(27,944</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">167,319</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(320,974</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment tax credits recoverable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,151</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,934</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(225,828</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(421,673</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">482,990</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">407,154</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">122,174</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,206,596</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,416,322</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Investing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(645,058</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(345,487</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash paid to acquire <FONT STYLE="white-space:nowrap">U-Protein</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,265,331</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash paid to acquire IPA Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,561,423</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,556,754</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,201,812</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,172,241</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Financing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds on share issuance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,843,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,596,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(288,504</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29,669</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repayment of leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(23,912</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net proceeds from debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,241,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from loans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loan repayments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(378,775</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,124</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,351,809</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,801,907</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase (decrease) in cash during the year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,943,401</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(772,312</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(210,434</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,344</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash &#150; beginning of the year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,806,133</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,578,445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash &#150; end of the year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,539,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,806,133</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash paid for interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">371,262</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">533</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash paid for income tax</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">415,144</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">152,168</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Supplemental cash flow information (Note 20) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes
are an integral part of these consolidated financial statements </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8
</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>NATURE OF OPERATIONS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd. (the &#147;Company&#148; or &#147;IPA&#148;) was incorporated under the laws of Alberta on November&nbsp;22,
1983. The Company is listed on the TSX Venture Exchange (the &#147;Exchange&#148;) as a Tier 2 life science issuer under the trading symbol &#147;IPA&#148;. The Company&#146;s OTC symbol is &#147;IPATF&#148;. The Company is a supplier of custom
hybridoma development services. The address of the Company&#146;s corporate office is 3204 &#150; 4464 Markham Street, Victoria, BC, Canada V8Z 7X8. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements have been prepared on the basis of accounting principles applicable to a going concern. This assumes the
Company will continue in operation for the foreseeable future and will be able to realize its assets and discharge its obligations in the normal course of operations. The Company has incurred operating losses since inception, including $7,617,467
for the year ended April&nbsp;30, 2019 and has accumulated a deficit of $17,476,482 as at April&nbsp;30, 2019. The Company may need to raise additional funds in order to continue on as a going concern and there can be no assurances that sufficient
funding, including adequate financing, will be available. The ability of the Company to arrange additional financing in the future depends in part, on the prevailing capital market conditions and profitability of its operations. These material
uncertainties may cast significant doubt on the Company&#146;s ability to continue as a going concern. Accordingly, the consolidated financial statements do not give effect to adjustments that would be necessary should the Company be unable to
continue as a going concern and therefore be required to realize its assets and liquidate its liabilities, contingent obligations and commitments other than in the normal course of business and at amounts different from those in the consolidated
financial statements. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>BASIS OF PRESENTATION </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(a)&nbsp;Statement of compliance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (&#147;IFRS&#148;),
as issued by the International Accounting Standards Board (&#147;IASB&#148;), and include the significant accounting policies as described in Note 3. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">These consolidated financial statements were approved by the Board of Directors for issue on August&nbsp;27, 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(b) Basis of measurement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">These consolidated financial statements have been prepared on the historical cost basis. In addition, these consolidated financial statements
have been prepared using the accrual basis of accounting, except for cash flow information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(c) Basis of consolidation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">These consolidated financial statements include the financial statements of the Company and the following subsidiaries which are wholly owned
and subject to control by the Company: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Name of Subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">%&nbsp;Equity<BR><FONT STYLE="white-space:nowrap">Interest&nbsp;-&nbsp;2019</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">% Equity<BR><FONT STYLE="white-space:nowrap">Interest&nbsp;-&nbsp;2018</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Country of<BR>Incorporation</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (Canada) Ltd. (formerly 0496106 B.C. Ltd.)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Canada</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (USA) Ltd.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">USA</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (N.D.) Ltd.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">USA</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (MA) LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">USA</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Talem Therapeutics LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">USA</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">U-Protein</FONT> Express B.V.
<FONT STYLE="white-space:nowrap">(&#147;U-Protein&#148;)</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Netherlands</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Netherlands B.V.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Netherlands</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (Europe) B.V. (&#147;IPA Europe&#148;, formerly ModiQuest Research
B.V.)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Netherlands</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Immulease B.V. (&#147;Immulease&#148;)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Netherlands</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Control is achieved when the Company has the power to, directly or indirectly, govern the financial and
operating policies of an entity so as to obtain benefits from its activities. Subsidiaries are fully consolidated from the date on which control is obtained and continue to be consolidated until the date that such control ceases. Intercompany
balances, transactions and unrealized intercompany gains and losses are eliminated upon consolidation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(d) Functional and presentation
currency </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The functional currency of a company is the currency of the primary economic environment in which the company operates. The
presentation currency for a company is the currency in which the company chooses to present its financial statements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The functional
currency of the Company and ImmunoPrecise Antibodies (Canada) Ltd. is the Canadian dollar. The functional currency of ImmunoPrecise Antibodies (USA) Ltd., ImmunoPrecise Antibodies (N.D.) Ltd., ImmunoPrecise Antibodies (MA) LLC and Talem Therapeutics
LLC is the US dollar. The functional currency of <FONT STYLE="white-space:nowrap">U-Protein,</FONT> ImmunoPrecise Netherlands BV, IPA Europe and Immulease is the Euro. The presentation currency of the Company is the Canadian dollar. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Entities whose functional currencies differ from the presentation currency are translated into Canadian dollars as follows: assets and
liabilities &#150; at the closing rate as at the reporting date, and income and expenses &#150; at the average rate of the period. All resulting changes are recognized in other comprehensive income as cumulative translation differences. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Transactions in foreign currencies are translated into the functional currency at exchange rates at the date of the transactions. Foreign
currency monetary assets and liabilities are translated at the functional currency exchange rate at the reporting date. <FONT STYLE="white-space:nowrap">Non-monetary</FONT> items that are measured in terms of historical cost in a foreign currency
are translated using exchange rates as at the dates of the initial transactions. <FONT STYLE="white-space:nowrap">Non-monetary</FONT> items measured at fair value in a foreign currency are translated using the exchange rates at the date when the
fair value is determined. All gains and losses on translation of these foreign currency transactions are included in profit or loss. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">When
the Company disposes of its entire interest in a foreign operation, or loses control, joint control, or significant influence over a foreign operation, the foreign currency gains or losses accumulated in other comprehensive income related to the
foreign operation are recognized in profit or loss. If an entity disposes of part of an interest in a foreign operation which remains a subsidiary, a proportionate amount of foreign currency gains or losses accumulated in other comprehensive income
related to the subsidiary are reallocated between controlling and <FONT STYLE="white-space:nowrap">non-controlling</FONT> interests. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SIGNIFICANT ACCOUNTING POLICIES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Business combination</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Acquisitions of businesses are accounted for using the acquisition method. The consideration transferred in a business combination is measured
at fair value, which is calculated as the sum of the acquisition-date fair values of the assets transferred by the Company, liabilities incurred by the Company to the former owners of the acquiree and the equity interests issued by the Company in
exchange for control of the acquiree. Acquisition-related costs are generally recognized in profit or loss as incurred. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">At the acquisition
date, the identifiable assets acquired and the liabilities assumed are recognized at their fair value at the acquisition date. Goodwill is measured as the excess of the sum of the consideration transferred, the amount of any <FONT
STYLE="white-space:nowrap">non-controlling</FONT> interests in the acquiree, and the fair value of the acquirer&#146;s previously held equity interest in the acquiree (if any) over the net of the acquisition-date amounts of the identifiable assets
acquired and the liabilities assumed. If, after reassessment, the net of the acquisition-date amounts of the identifiable assets acquired and liabilities assumed exceeds the sum of the consideration transferred, the amount of any <FONT
STYLE="white-space:nowrap">non-controlling</FONT> interests in the acquiree and the fair value of the acquirer&#146;s previously held interest in the acquiree (if any), the excess is recognized immediately in profit or loss as a bargain purchase
gain. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">When the consideration transferred by the Company in a business combination includes assets or liabilities resulting from a
contingent consideration arrangement, the contingent consideration is measured at its acquisition-date fair value and included as part of the consideration transferred in a business combination. Changes in the fair value of the contingent
consideration that qualify as measurement period adjustments are adjusted retrospectively, with corresponding adjustments against goodwill. Measurement period adjustments are adjustments that arise from additional information obtained during the
&#145;measurement period&#146; (which cannot exceed one year from the acquisition date) about facts and circumstances that existed at the acquisition date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The subsequent accounting for changes in the fair value of the contingent consideration that do not qualify as measurement period adjustments
depends on how the contingent consideration is classified. Contingent consideration that is classified as equity is not remeasured at subsequent reporting dates and its subsequent settlement is accounted for within equity. Contingent consideration
that is classified as an asset or a liability is remeasured at subsequent reporting dates in accordance with IAS 39, <I>Financial Instruments: Recognition and Measurement </I>or IAS 37, <I>Provisions, Contingent Liabilities and Contingent
Assets,</I> as appropriate, with the corresponding gain or loss being recognized in profit or loss. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Revenue recognition</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company recognizes revenue from sale of antibodies and service agreements. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Sale of antibodies: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Revenue from
sale of antibodies is recognized when the terms of a contract with a customer have been satisfied. This occurs when: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The control over the product has been transferred to the customer; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The product is received by the customer or transfer of title to the customer occurs upon shipment.
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Following delivery, the customer bears the risks of obsolescence and loss in relation to the goods. Revenue is
recognized based on the price specified in the contract, net of estimated sales discounts and returns. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Contract revenue: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Revenues from contracted services are generally recognized as the performance obligations are satisfied over time, and the related expenditures
are incurred pursuant to the terms of the agreement. Contract revenue is recognized on a percentage of completion basis when the key milestones contained within the contract are </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">satisfied and there is an enforceable right to payment for performance completed to date. For
contracts with no enforceable right to payment when the contract is incomplete, contract revenue is recognized on a completed contract basis when the customers are satisfied with the service at the end of the contract. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Unbilled revenue and deferred revenue: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Amounts recognized as revenue in excess of billings are classified as unbilled revenue. Amounts received in advance of the performance of
services are classified as deferred revenue. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Cost of sales: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Cost of sales includes materials, direct labour, and allocation of overhead including depreciation of lab equipment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Financial instruments</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Recognition and Classification</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company recognizes a financial asset or financial liability on the statement of financial position when it becomes party to the contractual
provisions of the financial instrument. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company classifies its financial instruments in the following categories: at fair value
through profit and loss (&#147;FVTPL&#148;), at fair value through other comprehensive income (loss) (&#147;FVTOCI&#148;) or at amortized cost. The Company determines the classification of financial assets at initial recognition. The classification
of debt instruments is driven by the Company&#146;s business model for managing the financial assets and their contractual cash flow characteristics. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Equity instruments that are held for trading are classified as FVTPL. For other equity instruments, on the day of acquisition the Company can
make an irrevocable election (on an <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">instrument-by-instrument</FONT></FONT> basis) to designate them as at FVTOCI. Financial liabilities are measured at amortized cost, unless they are
required to be measured at FVTPL (such as instruments held for trading or derivatives) or if the Company has opted to measure them at FVTPL. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Measurement</I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Financial
assets and liabilities at FVTPL: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Financial assets and liabilities carried at FVTPL are initially recorded at fair value and transaction
costs are expensed in profit or loss. Realized and unrealized gains and losses arising from changes in the fair value of the financial assets and liabilities held at FVTPL are included in profit or loss in the period in which they arise. Where
management has opted to recognize a financial liability at FVTPL, any changes associated with the Company&#146;s own credit risk will be recognized in other comprehensive income (loss). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Financial assets at FVTOCI: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Elected investments in equity instruments at FVTOCI are initially recognized at fair value plus transaction costs. Subsequently they are
measured at fair value, with gains and losses recognized in other comprehensive income (loss). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Financial assets and liabilities at
amortized cost: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Financial assets and liabilities at amortized cost are initially recognized at fair value plus or minus transaction costs,
respectively, and subsequently carried at amortized cost less any impairment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Impairment of financial assets at amortized cost: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company recognizes a loss allowance for expected credit losses on financial assets that are measured at amortized cost. At each reporting
date, the Company measures the loss allowance for the financial asset at an amount equal to the lifetime expected credit losses if the credit risk on the financial asset has increased </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
significantly since initial recognition. If at the reporting date, the financial asset has not increased significantly since initial recognition, the Company measures the loss allowance for the
financial asset at an amount equal to the twelve month expected credit losses. The Company shall recognize in profit or loss, as an impairment gain or loss, the amount of expected credit losses (or reversal) that is required to adjust the loss
allowance at the reporting date to the amount that is required to be recognized. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Derecognition</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Financial assets: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company
derecognizes financial assets only when the contractual rights to cash flows from the financial assets expire, or when it transfers the financial assets and substantially all of the associated risks and rewards of ownership to another entity. Gains
and losses on derecognition are generally recognized in profit or loss. However, gains and losses on derecognition of financial assets classified as FVTOCI remain within accumulated other comprehensive income (loss). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Financial liabilities: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The
Company derecognizes financial liabilities only when its obligations under the financial liabilities are discharged, cancelled or expired. Generally, the difference between the carrying amount of the financial liability derecognized and the
consideration paid and payable, including any <FONT STYLE="white-space:nowrap">non-cash</FONT> assets, is recognized in profit or loss. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Government assistance</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company periodically applies for financial assistance under available government incentive programs. Government assistance relating to
capital expenditures is reflected as a reduction of the cost of such assets. Government assistance relating to research and development expenditures is recorded as a reduction of current year&#146;s expenses when the related expenditures are
incurred. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Inventory</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Inventory consists of supplies, parts and antibodies and is valued at the lower of average cost and net realizable value. Costs include
acquisition, freight and other directly attributable costs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Equipment and leasehold improvements</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Equipment and leasehold improvements are stated at cost, less accumulated depreciation. Depreciation is provided using the straight-line method
over the following terms: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="38%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Asset</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Basis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Term</P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Lab equipment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Straight line</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5 years</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Furniture and equipment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Straight line</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5 years</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Computer hardware</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Straight line</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">2 years</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Computer software</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Straight line</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">1 year</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Leasehold improvements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Straight line</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Remaining term of the lease plus the first renewal option</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2018, the Company changed its depreciation method and rates to better
estimate the assets&#146; useful lives. This change has been applied prospectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Intangible assets</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Intangible assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business
combination is their fair value at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and accumulated impairment losses. Internally generated intangibles, excluding
capitalized development costs, are not capitalized and the related expenditure is reflected in profit or loss in the period in which the expenditure is incurred. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The useful lives of intangible assets are assessed as either finite or indefinite. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment whenever there is an indication
that the intangible asset may be impaired. The amortization period and the amortization method for an intangible asset with a finite useful life are reviewed at least at the end of each reporting period. Changes in the expected useful life or the
expected pattern of consumption of future economic benefits embodied in the asset are considered to modify the amortization period or method, as appropriate, and are treated as changes in accounting estimates. The amortization expense on intangible
assets with finite lives is recognized in profit or loss in the expense category that is consistent with the function of the intangible assets. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Intangible assets with indefinite useful lives are not amortized, but are tested for impairment annually, either individually or at the
cash-generating unit level. The assessment of indefinite life is reviewed annually to determine whether the indefinite life continues to be supportable. If not, the change in useful life from indefinite to finite is made on a prospective basis. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Gains or losses arising from derecognition of an intangible asset are measured as the difference between the net disposal proceeds and the
carrying amount of the asset and are recognized in profit or loss when the asset is derecognised. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Goodwill</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Goodwill represents the excess of the purchase price in a business combination over the fair value of net tangible and intangible assets
acquired. Goodwill is not subject to amortization and an impairment test is performed annually or as events occur that could indicate impairment. Goodwill is reported at cost less any impairment. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the purposes of assessing impairment, assets are grouped at the lowest levels for which there are separately identifiable cash flows
(&#147;cash generating units&#148; or &#147;CGU&#148;s). To test for impairment, goodwill is allocated to each of the Company&#146;s CGUs, groups of CGUs, or an operating segment expected to benefit from the acquisition. Goodwill is tested by
combining the carrying amounts of equipment and leasehold improvements, intangible assets and goodwill and comparing this to the recoverable amount. Fair value less costs of disposal, is price to be received in an orderly transaction between market
participants. Value in use is assessed using the present value of the expected future cash flows. Any excess of the carrying amount over the recoverable amount is recorded as impairment. Impairment charges, which are not tax affected, are recognized
in in profit or loss and are not reversed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Impairment of long-lived assets</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset
may not be recoverable. Recoverability of assets to be held and used is measured by comparison of their carrying amount to the recoverable amount. The recoverable amount is the higher of the fair value less selling costs or the value in use. Value
in use is determined by the present value of the future cash flows from the asset. If the recoverable amount is less than the carrying amount, then there is impairment. Where an impairment loss exists, the portion of the carrying amount exceeding
the recoverable amount is recorded as an expense immediately. Assets that have been impaired in prior periods are tested for possible reversal of impairment whenever events or changes in circumstance indicate that the impairment has reversed. If the
impairment has reversed, the carrying amount of the asset is increased to its recoverable amount but not beyond the carrying amount that would have been determined had no impairment loss been recognized for the asset in prior periods. The reversal
is recognized in profit or loss immediately. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Income taxes</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Income taxes are recognized in the statement of comprehensive income, except where they relate to items recognized directly in equity, in which
case the related taxes are recognized in equity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Deferred tax assets and liabilities are recognized based on the difference between the tax
and accounting values of assets and liabilities and are calculated using enacted or substantively enacted tax rates for the periods in which the differences are expected to reverse. The effect of tax rate changes is recognized in profit or loss or
equity, as applicable, in the period of substantive enactment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Current taxes receivable or payable are estimated on taxable income for the
current year at the statutory tax rates enacted or substantively enacted. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Deferred tax assets are recognized only to the extent that it is
probable that future taxable profits of the relevant entity or group of entities, in a particular jurisdiction, will be available against which the assets can be utilized. As an exception, deferred tax assets and liabilities are not recognized if
the temporary differences arise from the initial recognition of goodwill or an asset or liability in a transaction (other than in a business combination) that affects neither accounting profit nor taxable profit. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Investment tax credits (&#147;ITCs&#148;) are accounted for as a reduction in the cost of the expense when there is reasonable assurance that
such credits will be realized. These ITCs are used to reduce current income taxes payable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Leases</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Leases meeting certain criteria are accounted for as finance leases. The imputed interest is charged against operations. If the lease contains
a term that allows ownership to pass to the Company, or there is a bargain purchase option, the capitalized value is amortized over the lesser of the lease term and its estimated useful life. All other leases are accounted for as operating leases
and the leased assets are not recognized on the Company&#146;s statement of financial position. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Share capital</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Equity instruments are contracts that give a residual interest in the net assets of the Company. The Company&#146;s common shares are
classified as equity instruments. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Proceeds from unit placements are allocated between common shares and warrants issued based on the
residual value method, with the common shares being valued first. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Share issuance costs</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Costs directly identifiable with the raising of share capital financing are charged against share capital. Share issuance costs incurred in
advance of share subscriptions are recorded as deferred assets. Share issuance costs related to uncompleted share subscriptions are charged to operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Share-based payments</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Where equity-settled share options are awarded to employees, the fair value of the options at the date of grant is charged to profit or loss
over the vesting period. Performance vesting conditions are taken into account by adjusting the number of equity instruments expected to vest at each reporting date so that, ultimately, the cumulative amount recognized over the vesting period is
based on the number of options that eventually vest. <FONT STYLE="white-space:nowrap">Non-vesting</FONT> conditions and market vesting conditions are factored into the fair value of the options granted. As long as all other vesting conditions are
satisfied, a charge is made irrespective of whether these vesting conditions are satisfied. The cumulative expense is not adjusted for failure to achieve a market vesting condition or where a <FONT STYLE="white-space:nowrap">non-vesting</FONT>
condition is not satisfied. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Where the terms and conditions of options are modified before they vest, the increase in the fair value of the
options, measured immediately before and after the modification, is also charged to profit or loss over the remaining vesting period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Where equity instruments are granted to
<FONT STYLE="white-space:nowrap">non-employees,</FONT> they are recorded at the fair value of the goods or services received in profit or loss, unless they are related to the issuance of shares. Amounts related to the issuance of shares are recorded
as a reduction of share capital. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">When the value of goods or services received in exchange for the share-based payment cannot be reliably
estimated, the fair value is measured by use of a valuation model. The expected life used in the model is adjusted, based on management&#146;s best estimate, for the effects of <FONT STYLE="white-space:nowrap">non-transferability,</FONT> exercise
restrictions, and behavioural considerations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">All equity-settled share-based payments are reflected in contributed surplus, until
exercised. Upon exercise, shares are issued from treasury and the amount reflected in contributed surplus is credited to share capital, adjusted for any consideration paid. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Where a grant of options is cancelled or settled during the vesting period, excluding forfeitures when vesting conditions are not satisfied,
the Company immediately accounts for the cancellation as an acceleration of vesting and recognizes the amount that otherwise would have been recognized for services received over the remainder of the vesting period. Any payment made to the employee
on the cancellation is accounted for as the repurchase of an equity interest except to the extent the payment exceeds the fair value of the equity instrument granted, measured at the repurchase date. Any such excess is recognized as an expense. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Earnings (loss) per share</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Basic earnings (loss) per share is calculated by dividing the net income (loss) available to common shareholders by the weighted average number
of common shares outstanding during the period. Dilutive earnings per share reflect the potential dilution of securities that could share in the earnings of an entity. In periods where a net loss is incurred, potentially dilutive common shares are
excluded from the loss per share calculation as the effect would be anti-dilutive and basic and diluted loss per common share is the same. In a profit year, under the treasury stock method, the weighted average number of common shares outstanding
used for the calculation of diluted earnings per share assumes that the proceeds to be received on the exercise of dilutive stock options and warrants are used to repurchase common shares at the average price during the year. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ADOPTION OF NEW ACCOUNTING STANDARDS AND ACCOUNTING STANDARDS ISSUED BUT NOT YET EFFECTIVE
</B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(a) Adoption of New Accounting Standards </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Financial instruments</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On
May&nbsp;1, 2018, the Company adopted IFRS 9, <I>Financial Instruments </I>(&#147;IFRS 9&#148;), which replaces IAS 39, <I>Financial Instruments: Recognition and Measurement </I>(&#147;IAS 39&#148;) and all previous versions of IFRS 9. The new
standard provides guidance on the classification and measurement of financial assets and financial liabilities, <FONT STYLE="white-space:nowrap">de-recognition</FONT> of financial instruments, impairment of financial assets and hedge accounting.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The adoption of IFRS 9 on May&nbsp;1, 2018 resulted in changes in accounting policies; however there were no adjustments to the amounts
recognized in these consolidated financial statements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Classification and measurement of financial assets and financial liabilities
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">IFRS9 requires financial assets to be classified into three measurement categories on initial recognition: fair value through profit
and loss (&#147;FVTPL&#148;), fair value through other comprehensive income (&#147;FVOCI&#148;), and amortized cost. Investments in equity instruments are required to be measured by default at FVTPL. IFRS 9 permits entities to elect into an
irrevocable option for equity instruments to report changes in fair value in other comprehensive income. Classification and measurement of financial assets is dependent on the entity&#146;s business model for managing the financial assets and
related contractual cash flows. IFRS 9 retains most of the requirements of IAS 39 related to classification and measurement of financial liabilities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Impairment </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">IFRS 9 introduces a three stage expected credit loss (&#147;ECL&#148;) model for determining impairment of financial assets. The expected
credit loss model does not require the occurrence of a triggering event before an entity recognizes credit losses. IFRS 9 requires an entity to recognize expected credit losses upon initial recognition of a financial asset and to update the quantum
of expected credit losses at the end of each reporting period to reflect changes to credit risk of the financial asset. The adoption of the ECL model did not have a material impact on the Company&#146;s consolidated financial statements. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s financial assets at adoption date mainly comprised of cash, amounts receivable and investment. Cash and amounts receivable
are classified and accounted for under IFRS 9 at amortized cost, and investment is classified and accounted for at FVTPL. Financial liabilities are mainly comprised of accounts payable and accrued liabilities, debentures, loans payable and deferred
acquisition payments, which are accounted for at amortized cost. The Company completed a detailed assessment of its financial assets and liabilities as at May&nbsp;1, 2018. The following table shows the original classification under IAS 39 and the
new classification under IFRS 9: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="21%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Original classification (measurement)</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>IAS 39</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>New classification and<BR>measurement IFRS 9</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Loans and receivables (amortized cost)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Amortized cost</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Loans and receivables (amortized cost)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Amortized cost</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Available for sale (FVTOCI)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">FVTPL</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Other financial liabilities (amortized cost)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Amortized cost</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Other financial liabilities (amortized cost)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Amortized cost</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Other financial liabilities (amortized cost)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Amortized cost</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Other financial liabilities (amortized cost)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Amortized cost</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Revenue recognition</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">IFRS 15, <I>Revenue from Contracts with Customers </I>(&#147;IFRS 15&#146;) establishes a comprehensive framework for revenue recognition. The
standard replaces IAS 18, <I>Revenue </I>and IAS 11, <I>Construction Contracts </I>and related interpretations and represents a new single model for recognition of revenue from contracts with customers. The model features a five-step analysis of
transactions to determine the nature of an entity&#146;s obligation to perform and whether, how much, and when revenue is recognized. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The
Company adopted IFRS 15 as of May&nbsp;1, 2018 and the new standard has been applied retrospectively using the modified retrospective approach, where prior periods are not restated and the cumulative effect of initially applying this standard is
recognised in the opening deficit balance on May&nbsp;1, 2018. The Company applied IFRS 15 using the practical expedient under which the Company elected to apply IFRS 15 retrospectively only to contracts that were not completed at the date of
initial application. The impact was determined to be an increase of $122,025 to the opening deficit balance on May&nbsp;1, 2018 and an increase of $207,667 to revenue and an increase of $85,642 to cost of sales in the current year. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company recognizes revenue from sale of antibodies and service agreements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Sale of antibodies </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Revenue from sale of antibodies is recognized when the terms of a contract with a customer have been satisfied. This occurs when: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The control over the product has been transferred to the customer; and </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The product is received by the customer or transfer of title to the customer occurs upon shipment.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Following delivery, the customer bears the risks of obsolescence and loss in relation to the
goods. Revenue is recognized based on the price specified in the contract, net of estimated sales discounts and returns. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Contract
revenue </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Revenues from contracted services are generally recognized as the performance obligations are satisfied over time, and the
related expenditures are incurred pursuant to the terms of the agreement. Under IFRS 15, the Company has determined that revenue should be recognized on a percentage of completion basis when the key milestones contained within the contract are
satisfied and there is an enforceable right to payment for performance completed to date. For contracts with no enforceable right to payment when the contract is incomplete, contract revenue is recognized on a completed contract basis when the
customers are satisfied with the service at the end of the contract. The Company has determined that the percentage of completion as the time expended as a proportion of total time expected at the end of the reporting period is an appropriate
measure of progress towards the completion of these performance obligations under IFRS 15. Previously, revenue was recognized as the performance obligations were satisfied regardless of whether there was an enforceable right to payment if a contract
was terminated. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Unbilled revenue and deferred revenue </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Amounts recognized as revenue in excess of billings are classified as unbilled revenue. Amounts received in advance of the performance of
services are classified as deferred revenue. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(b) Accounting Standards Issued But Not Yet Effective </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following revised standards are effective for the annual periods noted with earlier application permitted. The Company also has not early
adopted any amendment, standard or interpretation that has been issued but is not yet effective. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Leases</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In January 2016, the IASB issued IFRS 16, <I>Leases,</I> which supersedes IAS 17, <I>Leases.</I> IFRS 16 establishes principles for the
recognition, measurement, presentation and disclosure of leases. The standard establishes a single model for lessees to bring leases <FONT STYLE="white-space:nowrap">on-balance</FONT> sheet while lessor accounting remains largely unchanged and
retains the finance and operating lease distinctions. The standard is applicable to the Company effective May&nbsp;1, 2019. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Upon adoption
of IFRS 16, the Company will record a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset, with an associated lease liability, on the consolidated statement of financial position as at May&nbsp;1, 2019.
The <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset and liability will be unwound over the term of the lease giving rise to an interest expense and depreciation charge, respectively. Currently the
Company&#146;s operating leases relate to the rental of office and lab spaces (Note 18 &#150;Commitments). The <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset capitalized is expected to be
$1,396,513 and the liability recorded is expected to be $1,442,954. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CRITICAL ACCOUNTING ESTIMATES AND JUDGMENTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The preparation of the consolidated financial statements in conformity with IFRS required estimates and judgments that affect the amounts
reported in the financial statements. Actual results could differ from these estimates and judgments. Estimates are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the year in which the estimate is revised.
Significant areas requiring the use of estimates and judgments are as follows: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Functional currency</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has used judgment in determining the currency of the primary economic environment in which the entity operates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Amounts receivable</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company monitors the financial stability of its customers and the environment in which they operate to make estimates regarding the
likelihood that the individual trade receivable balances will be paid. Credit risks for outstanding customer receivables are regularly assessed and allowances are recorded for estimated losses, if required. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Equipment</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company
has used estimates in the determination of the expected useful lives of equipment and leasehold improvements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Revenue recognition</U>
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">percentage-of-completion</FONT></FONT> method requires the use of
estimates to determine the stage of completion which is used to determine the recorded amount of revenue, unbilled revenue and deferred revenue on uncompleted contracts. The determination of anticipated revenues includes the contractually agreed
revenue and may also involve estimates of future revenues if such additional revenues can be reliably estimated and it is considered probable that they will be recovered. The determination of anticipated costs for completing a contract is based on
estimates that can be affected by a variety of factors, including the cost of materials, labour, and <FONT STYLE="white-space:nowrap">sub-contractors.</FONT> The determination of estimates is based on the Company&#146;s business practices as well as
its historical experience. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Impairments</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the purposes of assessing impairment, assets are grouped at the lowest levels for which there are separately identifiable cash flows
(&#147;cash generating units&#148; or &#147;CGU&#148;s). Each asset or CGU is evaluated every reporting period to determine whether there are any indicators of impairment. If any such indicators exist, which is often judgment-based, a formal
estimate of recoverable amount is performed and an impairment charge is recognized to the extent that the carrying amount exceeds the recoverable amount. The recoverable amount of an asset or CGU of assets is measured at the higher of fair value
less costs of disposal or value in use. These determinations and their individual assumptions require that management make a decision based on the best available information at each reporting period. The estimates and assumptions are subject to risk
and uncertainty; hence, there is the possibility that changes in circumstances will alter these projections, which may impact the recoverable amount of the assets. In such circumstances, some or all of the carrying value of the assets may be further
impaired or the impairment charge reversed with the impact recorded in profit or loss. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company performs a goodwill impairment test
annually and when circumstances indicate that the carrying value may not be recoverable. For the purposes of impairment testing, goodwill acquired through business combinations has been allocated to two different CGUs. The recoverable amount of each
CGU was based on value in use, determined by discounting the future cash flows to be generated from the continuing use of the CGU. The cash flows were projected over a five-year period based on past experience and actual operating results. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company performed its annual goodwill impairment test in April 2019 and no impairment was indicated for the period tested. The values
assigned to the key assumptions represented management&#146;s assessment of future trends in the industry and were based on historical data from both internal and external sources. Weighted average costs of capital of 17.5% and 10.2%, respectively,
was used in the assessments of the two CGUs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Determination of segments</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">An operating segment is a component of the Company that engages in business activities from which it may earn revenues and incur expenses. All
operating segments&#146; results are reviewed by the Company&#146;s management in order to make decisions regarding the allocation of resources to the segment. Segment results include items directly attributable to a segment as those that can be
allocated on a reasonable basis. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As the Company provides antibody production and related services in one distinct category,
there is only one category to report revenues by production site. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Life of intangible assets</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Intangible assets are amortized based on estimated useful life less their estimated residual value. Significant assumptions are involved in the
determination of useful life and residual values and no assurance can be given that actual useful lives and residual values will not differ significantly from current assumptions. Actual useful life and residual values may vary depending on a number
of factors including internal technical evaluation, attributes of the assets and experience with similar assets. Changes to these estimates may affect the carrying value of assets, net income (loss) and comprehensive income (loss) in future periods.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Purchase price allocation</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The acquisition of <FONT STYLE="white-space:nowrap">U-Protein</FONT> on August&nbsp;22, 2017 and the acquisition of IPA Europe and Immulease on
April&nbsp;5, 2018 were accounted for as business combinations at fair value in accordance with IFRS 3, <I>Business Combinations</I>. The acquired assets and assumed liabilities were adjusted to their fair values assigned through completion of a
purchase price allocation, as described below. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The purchase price allocation process resulting from a business combination requires
management to estimate the fair value of identifiable assets acquired including intangible assets and liabilities assumed including the deferred acquisition payment obligations. The Company uses valuation techniques, which are generally based on
forecasted future net cash flows discounted to present value, and also relies on work performed by third-party valuation specialists. These valuations are closely linked to the assumptions used by management on the future performance of the related
assets and the discount rates applied. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ACQUISITION OF <FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On August&nbsp;22, 2017, the Company completed the acquisition of <FONT STYLE="white-space:nowrap">U-Protein</FONT> whereby the Company has
acquired all of the issued and outstanding shares of <FONT STYLE="white-space:nowrap">U-Protein</FONT> for &#128;6,830,000 on terms as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,734,732 (CAD$4,062,607) was paid in cash on closing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3,030,503 common shares of the Company were issued on closing; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,047,634 in deferred payments over a three-year period. The deferred payments can be made in cash or
common shares of the Company at the election of <FONT STYLE="white-space:nowrap">U-Protein</FONT> shareholders. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The
transaction was accounted for as a business combination, as the operations of <FONT STYLE="white-space:nowrap">U-Protein</FONT> meet the definition of a business. As the transaction was accounted for as a business combination, transaction costs of
$17,717 were expensed. The goodwill resulting from the allocation of the purchase price to the total fair value of net assets represented the sales and growth potential of <FONT STYLE="white-space:nowrap">U-Protein.</FONT> Goodwill recorded is
allocated in its entirety to <FONT STYLE="white-space:nowrap">U-Protein.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The fair value of the 3,030,503 common shares issued ($3,022,308) was determined based on the
Canadian dollar equivalent of the consideration required of &#128;2,047,634 pursuant to the share purchase agreement. The Company has allocated the purchase price as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,062,607</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3,030,503 common shares of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,022,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of deferred payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,134,410</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,219,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">797,276</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">370,530</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,815</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment, net of accumulated amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">216,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intellectual property (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,064,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,655,893</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(269,657</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income taxes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,197</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(810,800</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,219,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The deferred payments of &#128;2,047,634 over a three-year period was
fair valued on the date of acquisition using a discounted cash flow model. A&nbsp;discount rate of 16.3% was used. The changes in the value of the deferred payments during the years ended April&nbsp;30, 2019 and 2018 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amount at date of acquisition</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,134,410</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">157,491</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">116,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,408,205</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">244,915</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,049,754</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(40,670</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,562,696</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ACQUISITION OF IPA EUROPE AND IMMULEASE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company acquired all of the issued and outstanding shares of IPA Europe and its sister entity, Immulease, for an
aggregate purchase price of &#128;7,000,000 on terms as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,500,000 (CAD$3,988,132) was paid in cash on closing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">6,600,399 common shares of the Company were issued on closing; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,000,000 in deferred payments over a three-year period. The deferred payments will be made in three equal
installments of cash and equity totaling &#128;666,666 and will be prorated if the EBITDA of IPA Europe for the fiscal year preceding the date of payment is less than its average EBITDA over the previous two fiscal years. During the year ended
April&nbsp;30, 2019, the Company and the seller entered into an Amendment, Termination and Settlement Agreement whereby the deferred payments shall no longer be subject to an adjustment and will be paid in equal installments of cash and equity
totaling &#128;666,666. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The transaction was accounted for as a business combination, as the operations of IPA Europe
and Immulease meet the definition of a business. As the transaction was accounted for as a business combination, transaction costs of $36,821 were expensed. The goodwill resulting from the allocation of the purchase price to the total fair value of
net assets represented the sales and growth potential of IPA Europe. Goodwill recorded is allocated in its entirety to IPA Europe. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The
fair value of the 6,600,399 common shares issued ($4,884,295) was determined to be $0.74 per share based on the fair value of the Company&#146;s shares immediately prior to the completion of the acquisition. The Company has allocated the purchase
price as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,988,132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6,600,399 common shares of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,884,295</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of deferred payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,353,708</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,226,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">270,339</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">572,427</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,286,995</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment, net of accumulated amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">568,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Software</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible assets (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,304,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,640,671</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(580,339</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(22,897</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(298,979</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,636,192</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,226,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The deferred payments of &#128;2,000,000 over a three-year period was
fair valued on the date of acquisition using a discounted cash flow model. A discount rate of 10.1% was used. The changes in the value of the deferred payments during the years ended April&nbsp;30, 2019 and 2018 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amount at date of acquisition as determined on a preliminary basis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,409,307</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,488</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19,841</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,403,954</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in estimate of fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(34,258</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">232,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,014,503</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(86,326</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,501,285</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">IPA Europe changed its name from ModiQuest Research B.V. in April 2019. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INVESTMENT </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Investment consists of a 29% (2018 &#150; 37%) interest in QVQ Holding B.V. (&#147;QVQ&#148;), which is recorded at cost, being the best
approximation of the investment&#146;s fair value. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Judgment is required as to the extent of influence that the Company has over QVQ. The
Company considered the extent of voting power over the entity, the power to participate in financial and operating policy decisions of the entity, representation on the board of directors, material transactions between the entities, interchange of
management personnel, and provision of essential technical information. The Company has determined that the Company is not considered to have significant influence over QVQ, as the Company does not have the power to participate in financial and
operating policy decisions, does not have representation on the Board of Directors of QVQ, and the majority of the common shares are held by QVQ management. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>EQUIPMENT AND LEASEHOLD IMPROVEMENTS </B></P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="54%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Computer<BR>Hardware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Furniture&nbsp;&amp;<BR>Equipment</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Computer<BR>Software</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Leasehold<BR>Improvements</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Lab<BR>Equipment</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66,712</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,337</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,754</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">287,586</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">940,406</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,381,795</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquired on acquisitions of</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,603,504</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,603,504</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,190</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,619</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">105,835</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">227,726</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">384,471</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,469</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,469</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93,813</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98,527</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,373</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">393,421</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,787,105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,385,239</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquired on acquisition of</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IPA Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,184</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,538</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87,821</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">612,046</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">729,589</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,153</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,141</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(31,294</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>110,997</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>111,065</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>130,015</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>393,421</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,369,010</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,114,508</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated Depreciation:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,420</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,423</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,754</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42,438</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">561,182</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">737,217</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquired on acquisition of</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">819,122</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">819,122</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,463</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,795</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,545</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,614</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">164,176</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">239,593</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,938</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,938</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,883</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,218</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,299</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,552,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,803,870</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,252</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,533</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103,764</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500,194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">677,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(43</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,029</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,072</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>88,135</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>85,636</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>48,789</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>205,816</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,047,583</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,475,959</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Book Value:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,930</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,309</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,074</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">291,369</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,234,687</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,581,369</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>April&nbsp;30, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>22,862</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>25,429</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>81,226</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>187,605</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,321,427</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,638,549</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INTANGIBLE ASSETS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The intangible assets were acquired as a result of the acquisition of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe and are
amortized using the straight-line method over their useful lives. The intellectual property has a useful life of 10 years, and the proprietary processes and certifications have a useful life of 5 years. The changes in the value of the intangible
assets during the years ended April&nbsp;30, 2019 and 2018 are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Intellectual<BR>Property</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Proprietary<BR>Processes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Certifications</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquired on acquisition of <FONT STYLE="white-space:nowrap">U-Protein</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,064,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,064,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">206,229</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">206,229</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,270,229</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,270,229</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquired on acquisition of IPA Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,159,755</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">145,108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,304,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(125,004</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(229,263</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,401</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(359,668</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,145,225</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,930,492</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>139,707</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>10,215,424</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated Amortization:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">218,487</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">218,487</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,259</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,259</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">227,746</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">227,746</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">416,890</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,169,233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,586,123</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,035</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,641</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(15,676</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>635,601</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,162,592</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,798,193</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Book Value:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,042,483</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,042,483</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>April&nbsp;30, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,509,624</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,767,900</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>139,707</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>8,417,231</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DEBENTURES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company completed a nonconvertible debenture (the &#147;Debentures&#148;) financing in the principal amount of
$4,252,000 (the &#147;Offering&#148;). The Debentures are unsecured, bear interest at a rate of 10% per annum, payable semi-annually, and are due eighteen months from the date of issue. Under the Offering, a holder of a Debenture received 37,500
detachable share purchase warrants (the &#147;Warrants&#148;) for every $25,000 of Debentures subscribed for by the holder. The Warrants are exercisable at $0.70 per share for a period of four years from the date of issue. The fair value of the
Debentures at the time of issue was calculated as the discounted cash flows assuming a 15% effective interest rate. The fair value of the Warrants was determined at the time of issue as the difference between the face value and the fair value of the
Debentures. On initial recognition, the Company bifurcated $4,003,125 to the carrying value of the Debentures and $248,875 to the Warrants. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Under the Offering, the Company paid the following finder&#146;s fees: $10,300 in cash, 580,320 shares of the Company with a fair value of
$383,010, and 415,942 finder&#146;s warrants valued at $187,627. The fair value of the finder&#146;s warrants was estimated on the date of issue using the Black-Scholes option valuation model with the following weighted average assumptions: dividend
yield of $nil, risk free interest rate of 1.60%, expected life of 4 years and expected volatility based on the historical volatility of similar companies of 100%. The total fair value of the finder&#146;s fees was allocated <FONT
STYLE="white-space:nowrap">pro-rata</FONT> based on the carrying values of the Debentures and Warrants, with $546,934 allocated to the Debentures and $34,003 allocated to the Warrants. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;25, 2018, the Company settled $1,377,000 of the Debentures by issuing
1,377,000 units at a price of $1.00 per unit. Each unit consists of one common share of the Company and one share purchase warrant, with each warrant entitling the holder to purchase an additional share at $1.25 for two years. The fair value of the
1,377,000 common shares issued was determined to be $1,115,370. The fair value of the warrants issued was determined to be $283,000 and estimated on the date of issue using the Black-Scholes option valuation model with the following weighted average
assumptions: dividend yield of $nil, risk free interest rate of 1.58%, expected life of 2 years and expected volatility based on the historical volatility of similar companies of 68.7%. The settlement resulted in a loss of $189,715. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2019, the Company recorded accretion expense of $427,592 (2018 &#150; $33,206). The changes in the value
of the Debentures during the years ended April&nbsp;30, 2019 and 2018 are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amount at date of issue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,003,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transaction costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(546,934</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,206</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,489,397</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">427,592</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Settlement of debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,208,655</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,708,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>LOANS PAYABLE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company assumed loans payable of &#128;60,750 (CAD$94,995) as a result of the acquisition of IPA Europe. On
July&nbsp;7, 2015, IPA Europe entered into a loan agreement in the principal amount of &#128;165,000, maturing on July&nbsp;31, 2020. The loan is secured by certain equipment, bears an interest rate of 4% per annum and is repayable in monthly
installments of &#128;2,250. The interest is owed per month in arrears. The principal outstanding at April&nbsp;30, 2019 is &#128;31,500 (CAD$47,423) (2018 &#150; &#128;58,500 (CAD$90,728)). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company assumed loans payable of &#128;56,450 (CAD$88,271) as a result of the acquisition of IPA Europe. On
February&nbsp;1, 2016, IPA Europe entered into a loan agreement in the principal amount of &#128;100,000, maturing on February&nbsp;28, 2021. The loan is secured by certain equipment, bears an interest rate of 3% per annum and is repayable in
monthly installments of &#128;1,675. The interest is owed per month in arrears. The principal outstanding at April&nbsp;30, 2019 is &#128;34,675 (CAD$52,203) (2018 &#150; &#128;54,775 (CAD$84,950)). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company assumed loans payable of &#128;74,000 (CAD$115,713) as a result of the acquisition of Immulease. On
May&nbsp;18, 2016, Immulease entered into a credit facility agreement pursuant to which the lender provides a facility amount of up to &#128;200,000. The credit facility is unsecured, bears an interest rate of 3% per annum and is repayable on
demand. The interest is owed per month in arrears. The principal outstanding at April&nbsp;30, 2019 is &#128;8,000 (CAD$12,044) (2018 &#150; &#128;74,000 (CAD$114,767)). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On May&nbsp;23, 2018, the Company entered into a loan agreement with a Director of the Company and his spouse and issued a promissory note in
the principal amount of $200,000. The note was unsecured and bore an interest rate of 5.45% per annum. The principal of the note plus accrued interest of $3,972 was repaid in full during the year ended April&nbsp;30, 2019. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans payable assumed</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">298,979</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loan repayments and foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,534</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">290,445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loan proceeds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loan repayments and foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(378,775</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,670</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82,953</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-current</FONT> portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,717</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>LEASES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company entered into certain equipment leases expiring between 2021 and 2023 with interest rates of between 13% and 17% per annum. The
Company&#146;s obligations under these finance leases are secured by the lessor&#146;s title to the leased assets. The terms and the outstanding balances as at April&nbsp;30, 2019 and 2018 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment under finance lease repayable in monthly instalments of $1,228 with interests of between
13% and 17% per annum. Due dates are between May 2021 and March 2023.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,077</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46,458</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(35,757</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,474</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-current</FONT> portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,320</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38,984</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As at April&nbsp;30, 2019, the Company&#146;s equipment includes a net carrying amount of $104,014 (2018
&#150; $48,762) for the leased equipment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following is a schedule of the Company&#146;s future minimum lease payments related to the
equipment under finance lease: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,003</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,003</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,641</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,923</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total minimum lease payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">131,570</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: imputed interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,493</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total present value of minimum lease payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,077</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Current portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(35,757</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-current</FONT> portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,320</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SHARE CAPITAL </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>a) Authorized: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Unlimited
common shares without par value. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>b) Share capital transactions: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>2018 Transactions </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On
August&nbsp;16, 2017, the Company completed a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement, issuing 5,250,000 common shares at $1.00 per share for gross proceeds of $5,250,000. The Company issued 281,100 common shares
valued at $328,887 and paid a total of $24,000 as finders&#146; fees. The Company also incurred $5,669 of cash issue costs. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On
August&nbsp;22, 2017, the Company issued 3,030,503 common shares pursuant to the acquisition of <FONT STYLE="white-space:nowrap">U-Protein.</FONT> The shares were valued at $3,022,308, which was the Canadian dollar equivalent of the consideration
required of &#128;2,047,634 pursuant to the share purchase agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;1, 2018, the Company issued 650,000 common shares
pursuant to exercise of warrants for gross proceeds of $195,000. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company issued 6,600,399 common shares
pursuant to the acquisition of IPA Europe and Immulease. The shares were valued at $4,884,295, which was estimated based on the fair value of $0.74 per share immediately prior to the completion of the acquisition. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company issued 580,320 common shares of the Company and 415,942 finder&#146;s warrants pursuant to the Debentures
Offering (Note 11). The fair value of the 580,320 common shares issued ($383,010) was estimated using a fair value of $0.66 per share. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2018, the Company issued 503,334 common shares pursuant to exercise of stock options for total gross
proceeds of $151,000. A value of $114,304 was transferred from contributed surplus to share capital as a result. The weighted average share price at dates the stock options were exercised was $0.68. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>2019 Transactions </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On
June&nbsp;19, 2018, the Company closed a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement financing by issuing a total of 875,000 units of the Company at a price of $0.80 per unit for gross proceeds of $700,000. Each unit
consists of one common share of the Company and one share purchase warrant, with each warrant entitling the holder to purchase an additional share at a price of $1.00 for a period of one year from the date of issue. The Company will have the right
to accelerate the expiry date of the warrants provided that the volume weighted average price trades at a price equal to or greater than $1.50 for a period of 20 consecutive days. In the event of acceleration, the expiry date will be accelerated to
a date that is 30 days after the Company issues a news release announcing that it has elected to exercise this acceleration right. All of the proceeds have been allocated to the common shares issued with a $nil value assigned to the warrants issued.
The Company paid finders cash fees totaling $3,000 and incurred $7,926 of cash issue costs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;24, 2018, the Company closed a
<FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement financing by issuing a total of 9,102,500 units of the Company at a price of $1.00 per unit for gross proceeds of $9,102,500. Each unit consists of one common share of the
Company and one share purchase warrant, with each warrant entitling the holder to purchase an additional share at a price of $1.25 for a period of two years from the date of issue. The Company will have the right to accelerate the expiry date of the
warrants provided that the volume weighted average price trades at a price equal to or greater than $1.75 for a period of 20 consecutive days. In the event of acceleration, the expiry date will be accelerated to a date that is 30 days after the
Company issues a news release announcing that it has elected to exercise this acceleration right. All of the proceeds have been allocated to the common shares issued with a $nil value assigned to the warrants issued. The Company paid finders cash
fees totaling $201,540 and issued 182,460 finder&#146;s shares. The Company also incurred $76,038 of cash issue costs. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On
December&nbsp;22, 2017, the Company announced that it had signed a binding letter of intent with Crossbeta Biosciences B.V. (&#147;Crossbeta&#148;) whereby the Company had agreed to acquire all of the issued and outstanding shares of Crossbeta. The
proposed transaction was terminated and settled on October&nbsp;23, 2018. In consideration of the settlement, the Company paid &#128;37,000 ($55,969) and issued 78,514 shares valued at $61,241. The Company accrued a settlement liability of $92,040
as at April&nbsp;30, 2018. As such, the remaining loss on settlement of $25,170 was recognized in the current year. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;25,
2018, the Company settled $1,377,000 of the Debentures by issuing 1,377,000 units at a price of $1.00 per unit (Note 11). Each unit consists of one common share of the Company and one share purchase warrant, with each warrant entitling the holder to
purchase an additional share at $1.25 for two years. The fair value of the 1,377,000 common shares issued was determined to be $1,115,370. The fair value of the warrants issued was determined to be $283,000 and estimated on the date of issue using
the Black-Scholes option valuation model with the following weighted average assumptions: dividend yield of $nil, risk free interest rate of 1.58%, expected life of 2 years and expected volatility based on the historical volatility of similar
companies of 68.7%. The settlement resulted in a loss of $189,715. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;27, 2019, the Company issued 714,793 common shares
pursuant to the second deferred payment to IPA Europe (Note 7). The common shares are valued at $507,503. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the year ended
April&nbsp;30, 2019, the Company issued 135,000 common shares pursuant to exercise of stock options for total gross proceeds of $40,500. A value of $30,658 was transferred from contributed surplus to share capital as a result. The weighted average
share price at dates the stock options were exercised was $1.05. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>c) Escrow </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">There are 3,255,890 common shares of the Company held in escrow as at April&nbsp;30, 2019. Under the Escrow Agreement, the common shares held
in escrow will be released from escrow as to 1,627,945 common shares on each of June&nbsp;29, 2019 and December&nbsp;29, 2019. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>d)
Options </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has an incentive Stock Option Plan (&#147;the Plan&#148;) under which
<FONT STYLE="white-space:nowrap">non-transferable</FONT> options to purchase common shares of the Company may be granted to directors, officers, employees or service providers of the Company. The terms of the plan provide that the Directors have the
right to grant options to acquire common shares of the Company at not less than the closing market price of the shares on the day preceding the grant at terms of up to ten years. The maximum number of options outstanding under the Plan shall not
result, at any time, in more than 10% of the issued and outstanding common shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;18, 2017, the Company granted 2,140,000 stock options, exercisable at $1.01
per option, to officers and employees of the Company. The options are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date; <FONT STYLE="white-space:nowrap">one-third</FONT> 12 months
after grant date and <FONT STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $1,614,486 using the Black-Scholes option pricing model and the following assumptions: dividend
yield of 0%, expected volatility of 100%, a risk-free interest rate of 1.60%, and an expected life of 5 years. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On January&nbsp;3, 2018,
the Company granted 1,250,000 stock options, exercisable at $0.65 per option, to officers and directors of the Company. The options are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant
date; <FONT STYLE="white-space:nowrap">one-third</FONT> 12 months after grant date and <FONT STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $606,907 using the Black-Scholes
option pricing model and the following assumptions: dividend yield of 0%, expected volatility of 100%, a risk-free interest rate of 1.60%, and an expected life of 5 years. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;8, 2018, the Company granted 700,000 stock options, exercisable at $0.47 per option, to an officer of the Company. The options
are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date; <FONT STYLE="white-space:nowrap">one-third</FONT> 12 months after grant date and
<FONT STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $245,751 using the Black-Scholes option pricing model and the following assumptions: dividend yield of 0%, expected
volatility of 100%, a risk-free interest rate of 1.60%, and an expected life of 5 years. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;24, 2018, the Company granted
95,000 stock options, exercisable at $0.95 per option, to employees of the Company. The options are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date;
<FONT STYLE="white-space:nowrap">one-third</FONT> 12 months after grant date and <FONT STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $67,402 using the Black-Scholes option
pricing model and the following assumptions: dividend yield of 0%, expected volatility of 100%, a risk-free interest rate of 1.60%, and an expected life of 5 years. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On November&nbsp;7, 2018, the Company granted 300,000 stock options, exercisable at $0.82 per option, to employees of the Company. The options
are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date; <FONT STYLE="white-space:nowrap">one-third</FONT> 12 months after grant date and
<FONT STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $184,658 using the Black-Scholes option pricing model and the following assumptions: dividend yield of 0%, expected
volatility of 100%, a risk-free interest rate of 2.20%, and an expected life of 5 years. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;31, 2018, the Company granted
1,250,000 stock options, exercisable at $1.00 per option, to officers and directors of the Company. The options are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date; <FONT
STYLE="white-space:nowrap">one-third</FONT> 12 months after grant date and <FONT STYLE="white-space:nowrap">one-third</FONT> 18&nbsp;months after grant date. The fair value of these options was estimated to be $625,485 using the Black-Scholes option
pricing model and the following assumptions: dividend yield of 0%, expected volatility of 100%, a risk-free interest rate of 2.20%, and an expected life of 5 years. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On January&nbsp;11, 2019, the Company granted 415,000 stock options, exercisable at $1.00 per option, to officers and an employee of the
Company. The options are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date; <FONT STYLE="white-space:nowrap">one-third</FONT> 12 months after grant date and <FONT
STYLE="white-space:nowrap">one-third</FONT> 18&nbsp;months after grant date. The fair value of these options was estimated to be $228,801 using the Black-Scholes option pricing model and the following assumptions: dividend yield of 0%, expected
volatility of 100%, a risk-free interest rate of 2.20%, and an expected life of 5 years. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Expected volatility was based on the historical
volatility of similar companies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2019 the Company has recorded $1,114,112 (2018 -
$1,221,511) of share-based payments expense. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The changes in the stock options for the years ended April&nbsp;30, 2019 and 2018 are as
follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>options </B><br><B>#</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted<BR>average<BR>exercise&nbsp;price<BR>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted<BR>average&nbsp;life<BR>remaining<BR>(years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,960,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.45</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4.38</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,090,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(503,334</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(675,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.04</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,871,666</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.68</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4.20</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,060,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(135,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expired</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(200,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,293,333</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,303,333</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.78</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3.87</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,511,666</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Exercisable, April&nbsp;30 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,791,667</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.67</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3.28</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Details of the options outstanding as at April&nbsp;30, 2019 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Expiry Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exercise&nbsp;price</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Remaining&nbsp;life<BR>(year)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Options<BR>outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unvested</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Vested</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December&nbsp;20, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">708,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">708,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;18, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,085,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,085,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January&nbsp;3, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February&nbsp;7, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">700,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">233,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">466,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;24, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November&nbsp;7, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January&nbsp;11, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">415,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">415,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.78</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3.87</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,303,333</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,511,666</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,791,667</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>e) Warrants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The changes in the warrants for the years ended April&nbsp;30, 2019 and 2018 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>warrants</B><br><B>#</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;average<BR>exercise&nbsp;price</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;average&nbsp;life<BR>remaining (years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>650,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.30</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.88</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issued</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,378,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(650,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,378,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.70</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3.93</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issued</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,354,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>17,732,500</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1.04</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1.90</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Details of the warrants outstanding as at April&nbsp;30, 2019 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Expiry Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exercise&nbsp;price</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Remaining&nbsp;life</B><br><B>(year)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Warrants<BR>outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March&nbsp;26, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,378,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;18, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">875,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;24, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,102,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October&nbsp;25, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,377,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1.04</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1.89</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>17,732,500</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subsequent to April&nbsp;30, 2019, the expiry date of these warrants has been extended to June&nbsp;18, 2020.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>f) Finder&#146;s Warrants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As at April&nbsp;30, 2019 the Company has 415,942 finder&#146;s warrants outstanding. The warrants have an exercise price of $0.70 per share
and expire on March&nbsp;26, 2022. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>15.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>RELATED PARTY TRANSACTIONS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Key management personnel are those persons having authority and responsibility for planning, directing and controlling the activities of the
Company. Key management consists of Thomas D&#146;Orazio, former President and CEO; Robert Beecroft, former Interim CEO; Dr.&nbsp;Jennifer Bath, President and CEO; Lisa Helbling, CFO; Natasha Tsai, former CFO; Reginald Beniac, former Chief Operating
Officer; Charles Wheelock, Chief Technology Officer; Oren Beske, former President of ImmunoPrecise Antibodies (USA) Ltd.; Martin Hessing, a Director of <FONT STYLE="white-space:nowrap">U-Protein;</FONT> Jos Raats, former President and CEO of IPA
Europe; and Directors of the Company. During the years ended April&nbsp;30, 2019 and 2018, the compensation for key management is as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Consulting fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,292</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Management fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">394,126</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">131,614</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Professional fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,263</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58,569</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Salaries and other short-term benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">995,855</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">662,997</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Severance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">169,346</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">770,928</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">474,824</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,314,964</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,552,350</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">At April&nbsp;30, 2019, included in accounts payable and accrued liabilities is $nil (2018 - $3,501) due to
related parties. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the years ended April&nbsp;30, 2019, the spouse of a Director provided administrative services for $54,225 (2018
&#150; $60,520). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>16.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CAPITAL MANAGEMENT</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s objectives when managing capital are to ensure sufficient liquidity for operations and adequate funding for growth and
capital expenditures while maintaining an efficient balance between debt and equity. The capital structure of the Company consists of credit facilities and shareholders&#146; equity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company makes adjustments to its capital structure upon approval from its Board of
Directors, in light of economic conditions and the Company&#146;s working capital requirements. There were no changes in the Company&#146;s approach to capital management during the year. The Company is not subject to any externally imposed capital
requirements. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>17.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>FINANCIAL INSTRUMENTS</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s financial instruments include cash, amounts receivable, restricted cash, investment, accounts payable and accrued
liabilities, debentures, loans payable, and deferred acquisition payments. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Fair value is the price that would be received to sell an asset
or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy establishes three levels to classify the inputs to valuation techniques used to measure fair value, by reference
to the reliability of the inputs used to estimate the fair values. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Level 1 - applies to assets or liabilities for which there are quoted
prices in active markets for identical assets or liabilities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Level 2 - applies to assets or liabilities for which there are inputs other
than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent
transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Level 3 - applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the
measurement of the fair value of the assets or liabilities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The fair value of investment is determined based on &#147;Level&nbsp;2&#148;
inputs as its cost was the best approximation of its fair value. As at April&nbsp;30, 2019, the Company believes that the carrying values of cash, amounts receivable, restricted cash, accounts payable and accrued liabilities, debentures, loans
payable, and deferred acquisition payments approximate their fair values because of their nature and relatively short maturity dates or durations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Concentration of risk: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Industry </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company
operates in the contract research organization sector and is affected by general economic trends. A decline in economic conditions, research spending or other adverse conditions could lead to reduced revenue. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Concentrations of credit risk </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Credit risk relates to cash, restricted cash and amounts receivable and arises from the possibility that counterparty to an instrument may fail
to perform. At April&nbsp;30, 2019, all of the Company&#146;s cash was held with tier one banks. The Company has evaluated amounts receivable and determined that there were no allowances for doubtful accounts at April&nbsp;30, 2019 and 2018. During
the year ended April&nbsp;30, 2019 the Company incurred bad debt expense of $1,837 (2018 - $16,454). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Currency risk </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company operates in the US and Europe which gives rise to exposure to market risks from changes in foreign currency values. Most
significantly, the Company is exposed to potential currency fluctuations between US and Canadian dollars, which was translated at 1.3423 at April&nbsp;30, 2019, and the Euro and Canadian dollar, which was translated at 1.5055 at April&nbsp;30, 2019.
Fluctuations in the exchange rate could impact profitability. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">At April&nbsp;30, 2019, the Company is exposed to currency risk through the following assets
and liabilities denominated in US dollars and Euros: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Euros</B><br><B>(&#128;)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>US&nbsp;Dollars<BR>(US $)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,752,749</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">183,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">344,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">568,190</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,158,696</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">751,565</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(461,416</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(83,624</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(74,175</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,063,981</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,599,572</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(83,624</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,440,876</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">667,941</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the year ended April&nbsp;30, 2019, a 5% increase in foreign exchange rates by the Canadian dollar relative
to the US dollar would have decreased net income (loss) by approximately $45,000. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the year ended April&nbsp;30, 2019, a 5% increase in
foreign exchange rates by the Canadian dollar relative to the Euro would have decreased other comprehensive income (loss) by approximately $109,000. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Liquidity risk: </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The
Company&#146;s approach to managing its obligations is to maintain sufficient resources to meet its obligations when due without undue risk to the Company. The Company monitors its cash requirements on an ongoing basis to ensure that there are
sufficient resources for operations as well as to fund anticipated leasing, capital and development expenditures. In addition, the Company manages its cash to meet its debt obligations and to fund general and administrative costs. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Contractual cash flow requirements as at April&nbsp;30, 2019 were as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&lt; 1</B><br><B>year</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>1 &#150; 2</B><br><B>years</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2 &#150; 5<BR>years</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&gt;5<BR>years</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,594,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,594,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loan payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82,953</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,717</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,670</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,529,403</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,529,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,058,807</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,003</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,003</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,564</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">131,570</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Minimum lease payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">649,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">516,318</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">966,166</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,131,925</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,875,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,875,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,807,130</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,123,442</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">999,730</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,930,302</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>18.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>COMMITMENTS</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2018, the Company extended its existing operation lease agreements for rental of office and laboratory
space in Victoria, BC, Canada to include one additional office space and for an additional term of 5 years. The new lease agreement commenced May&nbsp;1, 2018 and terminates on April&nbsp;30, 2023. The new lease is in the amount of $21,015 per month
for all four spaces from May&nbsp;1, 2018 to April&nbsp;30, 2021 and $21,914 per month from May&nbsp;1, 2021 to April&nbsp;30, 2023. The minimum annual payments under these leases are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">252,186</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">252,186</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">262,968</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">262,968</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,030,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the Company&#146;s rental of office and laboratory space in Utrecht, Netherlands, the current lease commenced on
January&nbsp;1, 2017 and terminates on December&nbsp;31, 2019. Annual minimum lease payments are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="92%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&#128;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,415</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the Company&#146;s rental of office and laboratory space in Oss, Netherlands, the current lease commenced on
January&nbsp;1, 2018 and terminates on December&nbsp;31, 2019. Effective December&nbsp;31, 2018, the lease automatically rolls into a 3 year term through December&nbsp;31, 2022. Annual minimum lease payments are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&#128;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">116,970</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">643,332</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>19.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SEGMENTED INFORMATION AND ECONOMIC DEPENDENCE</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">At April&nbsp;30, 2019 and 2018, the Company has one reportable segment, being antibody production and related services. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the years ended April&nbsp;30, 2019, the Company had sales to nil (2018 - one) customer who in aggregate accounted for more than 10%
(2018 &#150; 10%) of revenue. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s revenues are allocated to geographic segments for the years ended
April&nbsp;30, 2019 and 2018 as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">United States of America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,849,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,356,111</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Canada</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">859,445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">351,741</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,796,501</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,733,497</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">420,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>10,926,268</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>5,441,349</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s revenues are allocated according to revenue types for the years ended April&nbsp;30, 2019
and 2018 as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Project revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,497,257</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,200,733</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Product sales revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">204,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,680</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cryo storage revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">224,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">219,936</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>10,926,268</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>5,441,349</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s <FONT STYLE="white-space:nowrap">non-current</FONT> assets are allocated to geographic
segments as at April&nbsp;30, 2019 and 2018 as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">986,323</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">681,312</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Netherlands</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,481,425</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,111,431</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>18,467,748</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>19,792,743</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Geographic segmentation of the Company&#146;s (loss) income is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America - Corporate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,524,410</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,656,705</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(293,351</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,955,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Netherlands</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(799,706</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">440,602</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(7,617,467)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(5,171,103)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Geographic segmentation of the interest and accretion, and amortization and depreciation is
as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Interest and accretion</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America - Corporate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,278,144</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">238,457</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,565</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,888</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Netherlands</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,806</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,431</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,318,515</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">255,776</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Amortization and depreciation</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America - Corporate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,385</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">330,408</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">192,044</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Netherlands</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,904,491</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">266,035</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,263,284</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">458,079</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>20.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SUPPLEMENTAL CASH FLOW INFORMATION </B></P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B><FONT STYLE="white-space:nowrap">Non-cash</FONT> investing and
financing transactions:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,</B><br><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,</B><br><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt settlement by issuance of shares and warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,398,370</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Crossbeta settlement by issuance of shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquisition of equipment by capital lease</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84,531</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38,984</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of shares and warrants issued pursuant to debenture offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">785,509</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of shares issued pursuant to acquisition of
<FONT STYLE="white-space:nowrap">U-Protein</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,022,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of shares issued pursuant to acquisition of IPA Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">975,045</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,909,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of shares issued pursuant to deferred acquisition payment to IPA Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">507,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following changes in liabilities arose from financing activities: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-cash</FONT> changes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Cash Flows</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Settlement<BR>by issuance<BR>of shares</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Acquisition</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accretion</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Foreign<BR>exchange<BR>movements<BR>and&nbsp;change<BR>in&nbsp;estimates</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,812,159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,556,754</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(507,503</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">477,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(161,254</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,063,981</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,489,397</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,208,655</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">427,592</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,708,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">290,445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(178,775</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,670</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46,458</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(23,912</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84,531</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,077</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,638,459</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,759,441</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,716,158</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84,531</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">904,925</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(161,254</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,991,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-cash</FONT> changes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2017</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Cash Flows</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Allocation&nbsp;of<BR>transaction<BR>costs and<BR>bifurcation</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Acquisition</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accretion</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Foreign<BR>exchange<BR>movements</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,543,717</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">171,979</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96,463</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,812,159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,241,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(785,509</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,206</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,489,397</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,124</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">298,979</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,410</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">290,445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38,984</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38,984</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,274,560</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(785,509</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,842,696</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">205,185</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94,053</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,630,985</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>21.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INCOME TAXES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Income tax expense differs from the amount that would be computed by applying the federal and provincial statutory tax rates of 27% (2018 -
26%) to the earnings before income taxes. The reasons for the differences and related tax effects are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Earnings (loss) before income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,612,679</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,061,388</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income taxes (recovery) on earnings before income taxes, at above basic rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,055,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,391,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase (decrease) in taxes resulting from:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nondeductible expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">414,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">371,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effects of tax rate change</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(131,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax rate difference by jurisdiction</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(35,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax benefits not recognized (recognized)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,634,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,296,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income taxes (recovery)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">110,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">476,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">164,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income taxes (recovery)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(471,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(54,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income taxes (recovery)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">110,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April 30, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Temporary differences give rise to the following deferred income tax assets and liabilities:
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-capital</FONT> losses carried forward (expire from 2026 to
2039)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,668,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,390,030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other tax pools</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,896,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,279,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capital losses carried forward</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">129,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">104,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment and leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory and intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,940,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financing costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">231,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: unrecognized deferred income tax asset</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,849,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,210,030</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,940,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(882,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>22.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SUBSEQUENT EVENT </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Subsequent to the <FONT STYLE="white-space:nowrap">year-end,</FONT> the Company issued 55,000 common shares pursuant to the exercise of stock
options for total gross proceeds of $16,500. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.6
<SEQUENCE>7
<FILENAME>d20922dex996.htm
<DESCRIPTION>EX-99.6
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.6</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.6 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT STYLE="white-space:nowrap">13-501F1</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS &#150; </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>PARTICIPATION FEE </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MANAGEMENT CERTIFICATION </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="42%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt; padding-right:2pt">I, <U>Lisa
Helbling&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, an officer of the reporting issuer noted below have examined this Form
<FONT STYLE="white-space:nowrap">13-501F1</FONT> (the <B>Form)</B> being submitted hereunder to the Alberta Securities Commission and certify that to my knowledge, having exercised reasonable diligence, the information provided in the Form is
complete and accurate.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&#147;Lisa Helbling, Chief Financial
Officer&#148;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">August 28, 2019</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:2pt">Date:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title:</P>
<P STYLE="font-size:10pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Reporting Issuer Name:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ImmunoPrecise Antibodies
Ltd.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>End date of previous financial year:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;April&nbsp;30,
2019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Type of Reporting Issuer:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>[X ]&nbsp;Class&nbsp;1&nbsp;reporting&nbsp;issuer</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>[&nbsp;&nbsp;&nbsp;&nbsp; ]&nbsp;Class&nbsp;3B&nbsp;reporting&nbsp;issuer</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Highest Trading Marketplace:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;TSX Venture
Exchange&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Market value of listed or quoted equity securities</U>: </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Equity Symbol</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" ALIGN="center">IPA</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>1st Specified Trading Period </B>(dd/mm/yy)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><U></U><U></U>&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5"><U>&nbsp;&nbsp;&nbsp;&nbsp;01/05/18&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;to&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;31/07/18&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="3">Closing price of the security in the class or series on the last trading day of the specified trading period in which such security was listed or quoted on the highest trading marketplace</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.0800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">(i)</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="3">Number of securities in the class or series of such security outstanding at the end of the last trading day of the specified trading period</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;56,459,178</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">(ii)</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ROWSPAN="3">Market value of class or series</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(i) x (ii)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;60,975,912.24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">(A)</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>2nd Specified Trading Period </B>(dd/mm/yy)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="4"><U>&nbsp;&nbsp;&nbsp;&nbsp;01/08/18&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;to&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;31/10/18&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="3">Closing price of the security in the class or series on the last trading day of the specified trading period in which such security was listed or quoted on the highest trading marketplace</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.9300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">(iii)</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="3">Number of securities in the class or series of such security outstanding at the end of the last trading day of the specified trading period</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;67,121,138</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">(iv)</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(iii)&nbsp;x&nbsp;(iv)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;62,422,658.34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Market value of class or series</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">(B)</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3rd Specified Trading Period </B>(dd/mm/yy)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="4"><U>&nbsp;&nbsp;&nbsp;&nbsp;01/11/18&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;to&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;31/01/19&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="3">Closing price of the security in the class or series on the last trading day of the specified trading period in which such security was listed or quoted on the highest trading marketplace</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.7000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">(v)</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="3">Number of securities in the class or series of such security outstanding at the end of the last trading day of the specified trading period</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;67,199,652</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">(vi)</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(v)&nbsp;x&nbsp;(vi)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;47,039,756.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Market value of class or series</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(C)</TD>
<TD VALIGN="top" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4th Specified Trading Period </B>(dd/mm/yy)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="4" ALIGN="center"><U>&nbsp;&nbsp;&nbsp;&nbsp;01/02/19&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;to&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;30/04/19&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="3">Closing price of the security in the class or series on the last trading day of the specified trading period in which such security was listed or quoted on the highest trading marketplace</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.7800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">(vii)</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="3">Number of securities in the class or series of such security outstanding at the end of the last trading day of the specified trading period</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;67,939,445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">(viii)</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(vii)&nbsp;x&nbsp;(viii)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;52,992,767.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Market value of class or series</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">(D)</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>5th Specified Trading Period </B>(dd/mm/yy)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="4"><U>&nbsp;&nbsp;&nbsp;&nbsp;Not&nbsp;applicable&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;to&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="3">Closing price of the security in the class or series on the last trading day of the specified trading period in which such security was listed or quoted on the highest trading marketplace</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">(ix)</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="3">Number of securities in the class or series of such security outstanding at the end of the last trading day of the specified trading period</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(x)</TD>
<TD VALIGN="top" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(ix)&nbsp;x&nbsp;(x)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Market value of class or series</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">(E)</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="3"><B>Average Market Value of Class</B><B></B><B>&nbsp;or Series </B>(Calculate the simple average of the market value of the class or series of security for each applicable specified trading period (i.e. A through E
above))</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;55,857,773.52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">(<B>1</B>)</TD>
<TD VALIGN="bottom" ALIGN="right"><B></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B></B>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(Repeat the above calculation for each other class or series of equity securities of the reporting issuer (and a subsidiary,
if applicable) that was listed or quoted on a marketplace at the end of the previous financial year) </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Fair value of outstanding debt securities:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(Provide details of how value was determined)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">$&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(<B>2</B>)</TD>
<TD VALIGN="top" ALIGN="right"><B></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top"><B></B>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Capitalization for the previous financial year</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(1)&nbsp;+&nbsp;(2)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;55,857,773.52</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Participation Fee</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3,000.0000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Late Fee</B>, if applicable</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">$&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Total Fee Payable</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3,000.0000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(Participation Fee plus Late Fee)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.7
<SEQUENCE>8
<FILENAME>d20922dex997.htm
<DESCRIPTION>EX-99.7
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.7</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.7 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Form <FONT STYLE="white-space:nowrap">52-109FV1</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Certification of Annual Filings </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Venture Issuer Basic Certificate </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I, <B>Lisa Helbling, </B>the <B>Chief Financial Officer</B> of <B>ImmunoPrecise Antibodies Ltd.,</B> certify the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.<B><I></I></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Review:</I></B><B> </B>I have reviewed the AIF, if any, annual financial statements and annual MD&amp;A,
including, for greater certainty, all documents and information that are incorporated by reference in the AIF (together, the &#147;annual filings&#148;) of <B>ImmunoPrecise Antibodies Ltd. </B>(the &#147;issuer&#148;) for the financial year ended
<B>April</B><B></B><B>&nbsp;30, 2019.</B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>No misrepresentations:</I></B><B> </B>Based on my knowledge, having exercised reasonable diligence, the
annual filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, for the
period covered by the annual filings. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Fair presentation:</I></B><B> </B>Based on my knowledge, having exercised reasonable diligence, the
annual financial statements together with the other financial information included in the annual filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for
the periods presented in the annual filings. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: <B>August</B><B></B><B>&nbsp;28, 2019</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>&#147;Lisa Helbling&#148; </I></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lisa Helbling </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Financial
Officer </P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8pt; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>NOTE TO READER</U></B></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In contrast to the certificate required for
<FONT STYLE="white-space:nowrap">non-venture</FONT> issuers under National Instrument <FONT STYLE="white-space:nowrap">52-109</FONT> <I>Certification of Disclosure in Issuers&#146; Annual and Interim Filings</I> (NI
<FONT STYLE="white-space:nowrap">52-109),</FONT> this Venture Issuer Basic Certificate does not include representations relating to the establishment and maintenance of disclosure controls and procedures (DC&amp;P) and internal control over
financial reporting (ICFR), as defined in NI <FONT STYLE="white-space:nowrap">52-109.</FONT> In particular, the certifying officers filing this certificate are not making any representations relating to the establishment and maintenance of</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">i)&#8195;&#8201;&#8202;controls and other
procedures designed to provide reasonable assurance that information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted under securities legislation is recorded, processed, summarized
and reported within the time periods specified in securities legislation; and</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">ii)&#8195;&#8202;a process to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with the issuer&#146;s GAAP.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The issuer&#146;s certifying officers are responsible for ensuring that processes are in place to provide them with sufficient knowledge to support the
representations they are making in this certificate. Investors should be aware that inherent limitations on the ability of certifying officers of a venture issuer to design and implement on a cost effective basis DC&amp;P and ICFR as defined in NI <FONT
STYLE="white-space:nowrap">52-109</FONT> may result in additional risks to the quality, reliability, transparency and timeliness of interim and annual filings and other reports provided under securities legislation.</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.8
<SEQUENCE>9
<FILENAME>d20922dex998.htm
<DESCRIPTION>EX-99.8
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.8</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.8 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Form <FONT STYLE="white-space:nowrap">52-109FV1</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Certification of Annual Filings </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Venture Issuer Basic Certificate </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I, <B>Jennifer Bath, Chief Executive Officer </B>of <B>ImmunoPrecise Antibodies Ltd., </B>certify the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Review:</I></B><B> </B>I have reviewed the AIF, if any, annual financial statements and annual MD&amp;A,
including, for greater certainty, all documents and information that are incorporated by reference in the AIF (together, the &#147;annual filings&#148;) of <B>ImmunoPrecise Antibodies Ltd.</B> (the &#147;issuer&#148;) for the financial year ended
<B>April&nbsp;30, 2020.</B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>No misrepresentations:</I></B><B> </B>Based on my knowledge, having exercised reasonable diligence, the
annual filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, for the
period covered by the annual filings. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Fair presentation:</I></B><B> </B>Based on my knowledge, having exercised reasonable diligence, the
annual financial statements together with the other financial information included in the annual filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for
the periods presented in the annual filings. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: <B>August</B><B></B><B>&nbsp;28, 2020</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>&#147;Jennifer Bath&#148; </I></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jennifer Bath </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Executive
Officer </P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8pt; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>NOTE TO READER</U></B></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In contrast to the certificate required for
<FONT STYLE="white-space:nowrap">non-venture</FONT> issuers under National Instrument <FONT STYLE="white-space:nowrap">52-109</FONT> <I>Certification of Disclosure in Issuers&#146; Annual and Interim Filings</I> (NI
<FONT STYLE="white-space:nowrap">52-109),</FONT> this Venture Issuer Basic Certificate does not include representations relating to the establishment and maintenance of disclosure controls and procedures (DC&amp;P) and internal control over
financial reporting (ICFR), as defined in NI <FONT STYLE="white-space:nowrap">52-109.</FONT> In particular, the certifying officers filing this certificate are not making any representations relating to the establishment and maintenance of</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">i)&#8195;&#8201;&#8202;controls and other
procedures designed to provide reasonable assurance that information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted under securities legislation is recorded, processed, summarized
and reported within the time periods specified in securities legislation; and</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">ii)&#8195;&#8202;a process to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with the issuer&#146;s GAAP.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The issuer&#146;s certifying officers are responsible for ensuring that processes are in place to provide them with sufficient knowledge to support the
representations they are making in this certificate. Investors should be aware that inherent limitations on the ability of certifying officers of a venture issuer to design and implement on a cost effective basis DC&amp;P and ICFR as defined in NI <FONT
STYLE="white-space:nowrap">52-109</FONT> may result in additional risks to the quality, reliability, transparency and timeliness of interim and annual filings and other reports provided under securities legislation.</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.9
<SEQUENCE>10
<FILENAME>d20922dex999.htm
<DESCRIPTION>EX-99.9
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.9</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.9 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED APRIL 30,
2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following Management&#146;s Discussion and Analysis (&#147;MD&amp;A&#148;), prepared as of August 28th,
2019, should be read in conjunction with the audited, consolidated financial statements of ImmunoPrecise Antibodies Ltd. (&#147;the Company&#148;, &#147;ImmunoPrecise&#148; or &#147;IPA&#148;) for the year ended April&nbsp;30, 2019. This MD&amp;A is
the responsibility of management and has been reviewed and approved by the Board of Directors of IPA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The referenced, consolidated financial statements
have been prepared in accordance with International Financial Reporting Standards (&#147;IFRS&#148;) and related IFRS Interpretations Committee (&#147;IFRIC&#146;s&#148;) as issued by the International Accounting Standards Board (&#147;IASB&#148;).
All financial amounts are stated in Canadian dollars unless stated otherwise. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This MD&amp;A may contain certain statements that constitute &#147;forward-looking statements&#148; within the meaning of National Instrument <FONT
STYLE="white-space:nowrap">51-102,</FONT> Continuous Disclosure Obligations of the Canadian Securities Administrators. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward-looking statements often,
but not always, are identified by the use of words such as &#147;seek&#148;, &#147;anticipate&#148;, &#147;believe&#148;, &#147;plan&#148;, &#147;estimate&#148;, &#147;expect&#148;, &#147;targeting&#148; and &#147;intend&#148; and statements that an
event or result &#147;may&#148;, &#147;will&#148;, &#147;should&#148;, &#147;could&#148;, or &#147;might&#148; occur or be achieved and other similar expressions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In this MD&amp;A, forward-looking statements include the Company&#146;s future plans and expenditures, the satisfaction of rights and performance of
obligations under agreements to which the Company is a part, the ability of the Company to hire and retain employees and consultants and estimated administrative assessment and other expenses. The forward-looking statements that are contained in
this MD&amp;A involve a number of risks and uncertainties. As a consequence, actual results might differ materially from results forecast or suggested in these forward-looking statements. Some of these risks and uncertainties are identified under
the heading &#147;RISKS AND UNCERTAINTIES&#148; in this MD&amp;A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Furthermore, forward-looking statements contained herein are made as of the date of
this MD&amp;A and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results or otherwise. There can be no assurance that forward-looking statements will prove to
be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>GENERAL </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company was incorporated under the laws of
Alberta on November&nbsp;22, 1983 and is listed on the TSX Venture Exchange (the &#147;Exchange&#148;) as a Tier 2 life science issuer under the trading symbol &#147;IPA&#148;. The Company&#146;s OTC symbol is &#147;IPATF&#148;. The address of the
Company&#146;s corporate office is 3204 &#150; 4464 Markham Street, Victoria, BC V8Z 7X8.<B> </B> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CORPORATE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&nbsp;20, 2018, the Company announced that Mr.&nbsp;Guy Champagne resigned from his position as a Director of the Company and thereupon joined the
Company&#146;s Advisory Board. <B></B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Henceforth, on November&nbsp;21, 2018, the Company announced that Paul Andreola was appointed as a Director of the
Company at its annual general meeting held in Vancouver, BC on November&nbsp;20, 2018. Mr.&nbsp;Andreola has over 20 years of business development and financial markets experience including senior management, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED APRIL 30,
2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
marketing, and communications roles for early stage companies. Previously in his career, Mr.&nbsp;Andreola was a licensed investment advisor for over 10 years and has facilitated multiple early
stage private and public companies in the resource and technology sectors. Mr.&nbsp;Andreola is currently the CEO and Director of NameSilo Technologies Corp. (CSE: URL) and Ironwood Capital Corp. (TSXV: IRN.P). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>OVERVIEW </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has emerged as a recognized,
full-service, biologics Contract Research Organization (CRO) with global operations. The Company is innovation-driven and is strategically positioned - both geographically and scientifically - to provide customized and
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">end-to-end</FONT></FONT> biologics services. They offer a cohesive and extensive portfolio in the protein and antibody research, manufacturing and validation continuum. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s services include, but are not limited to, proprietary B cell sorting, screening and sequencing; custom, immune and na&iuml;ve phage display
production and screening; expertise with transgenic animals and multi-species antibody discovery; <FONT STYLE="white-space:nowrap">bi-specific,</FONT> <FONT STYLE="white-space:nowrap">tri-specific,</FONT> and VNAR (shark) antibody manufacturing; DNA
cloning, protein and antibody downstream processing, purification in gram scale levels, characterization and validation; antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production
with multiplexed, high-throughput screening and clone-picking; cryopreservation; and custom antigen modeling, design and manufacturing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moreover, in the
past 12 months, the Company has gained increasing recognition as a rising leader in the biologics, CRO space. They have focused on organic growth through market penetration and service diversification, as well as strategic expansion with platform
and process integration. Furthermore, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">end-to-end</FONT></FONT> services have been leveraged through acquisition, enabling a steady foundation for future growth. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA Canada and IPA Europe have both been designated as approved CROs for the world&#146;s leading, transgenic animal platform producing human antibodies, and
exercised an advantage in optimizing services for various transgenic animal vendors. The Company made strategic investments in R&amp;D activities to develop proprietary technologies enabling the application of their B cell Select<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP> and DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> platforms to a broad range of transgenic animal species and strains. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This past year, the Company announced a full-service B cell facility in Victoria, British Columbia, offering B cell screening, sorting and sequencing on a
broad range of therapeutically relevant protein families, including GPCRs and other multi-membrane spanning proteins. The Company&#146;s proprietary B cell Select<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> platform enables antibody
screening directly from B cells, allowing for the analysis of a more diverse set of antibodies, and for faster, deeper screening compared to traditional technologies. In July 2018, IPA Europe expanded the Company&#146;s B cell technologies to the
EU, increasing its global capacity, and further differentiating ImmunoPrecise from its competitors. Months later, the Company went on to announce that, due to the platform&#146;s greater than 90% success rate, it now offers a guarantee on the
success of campaigns powered by its proprietary B cell </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Select<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> Antibody Discovery platform. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">U-Protein</FONT> Express, situated in the Dutch biotechnology hub of Utrecht, The Netherlands, has been a staple in the
recombinant protein community, operating for over 15 years, and specializing in the manufacture of complex proteins and antibodies in a variety of formats, and from a range of mammalian cell types. Their streamlined and efficient operations have
enabled them to successfully support over 5,000 different programs, with over a 90% success rate, for pharmaceutical and biotechnology industries as well as leading, academic institutions. In a seamless coordination, their operations also support
the downstream expression and purification of the antibodies originating from the B cell Select<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> programs, enabling validation of the platform&#146;s outputs and comprehensive deliverables for
clients. Recently, this site announced the obtainment of an exclusive license from Stanford University for <FONT STYLE="white-space:nowrap">one-year</FONT> of exclusively on the marketing and sale of the novel protein, Wnt surrogate Fc, to the
global research market. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED APRIL 30,
2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA Europe&#146;s contribution in services and intellectual property to the Company after its acquisition
have been substantial. The integration of IPA Europe significantly expanded the Company&#146;s services portfolio including affinity maturation, humanization, functional assay design and development, na&iuml;ve and diseased scFv libraries, and
proprietary methods of immunization against conformational targets (e.g. ModiVacc<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> lymphoid tumor immunization and DNA immunization technologies). Adding to their proprietary services, this year,
IPA Europe developed and <FONT STYLE="white-space:nowrap">rolled-out</FONT> the aforementioned, novel service offering for the discovery of fully human antibodies, DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP>, a combination of
transgenic animal immunization and custom phage display antibody selections. While CRO services are the mainstay of the Company, ImmunoPrecise has worked continuously on building an intellectual property estate and portfolio of proprietary methods
and physical assets through collaborations, joint ventures, acquisitions and <FONT STYLE="white-space:nowrap">in-licensing.</FONT> The Company has strategically invested in the development and licensing of antibody discovery platforms and related
intellectual property assets. The onboarding of existing assets with regard to equipment, technologies, IP and licenses within the Company&#146;s EU operations has been compounded by active research and development at all operational sites this
year, including the <FONT STYLE="white-space:nowrap">on-going</FONT> development of new service offerings to be rolled out in the fiscal year 2020, but more notably, internal discovery programs focused on novel, therapeutic antibodies, primarily in
the field of immuno-oncology. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Recently, the Company formed Talem Therapeutics (Talem), based in Cambridge, Massachusetts, to support its internal,
therapeutic, discovery programs. Talem is structured to secure assets during their discovery and development stage and seek out strategic partnerships with clinical-stage pharma and biotech companies where it will aid in the <FONT
STYLE="white-space:nowrap">out-licensing</FONT> or sale of the therapeutics for clinical trials. The ability for investors to support individual assets or portfolios generates an asymmetrical opportunity for investments, while avoiding
ImmunoPrecise&#146;s shareholders dilution. The depth and speed of IPA&#146;s offerings enables Talem to customize each program and leverages the Company&#146;s expertise and technologies in the antibody discovery. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s management placed a critical emphasis this past year on building, integrating and securing the business infrastructure to facilitate
scalable, strategic growth, recognize cost synergies and reduce its carbon footprint. These activities included, but were not limited to, globalizing and standardizing core information technology (IT) infrastructure such as server and client
operating systems, databases, security tools, computing platforms and cloud computing, communication tools and content management platforms, to protect both the Company&#146;s, and its client&#146;s, IP. This move allows for cost effective and quick
reaction to market demands. The Company integrated IT services including the global service desk has decreased costs and risk while removing collaboration barriers including tools that allow for communicating in different languages. They have also
begun to capture synergies after the global integration of sales, marketing, R&amp;D, management, and legal services. They have prepared for the integration of fundamental business services such as payroll, financial controls, and an Oracle suite of
enterprise software. They will continue to enhance these integrations, as well as create synergies in additional areas such as M&amp;A communications and tax integration. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>STRATEGY AND OUTLOOK </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our newly formed management team
has a passionate emphasis on initiatives designed to drive revenue, bolster internal assets and maximize shareholder value. We aim to continue to build on revenue and asset generation through internal development and well-informed, strategic
acquisitions and joint ventures. Our strategy also includes growth through alliances and partnerships, within both our research (Talem) and service sectors, as well as potential new market sectors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED APRIL 30,
2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our objective is to aggressively expand our position as the preferred, global partner for researchers across
the globe. Therefore, our strategy is to deliver the leading, comprehensive and integrated continuum of protein and antibody services and enable our clients and partners to bring new and enhanced therapies to the clinic faster, by offering a
progression of services with excellence and continued innovation. We believe we possess a competitive advantage which allows us to execute this strategy, as we continue to focus on our integrated <U><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">end-to-end</FONT></FONT> platform</U>, coupled with a <U>strong, scientific <FONT STYLE="white-space:nowrap">know-how</FONT></U>, enabling us to navigate our clients through the process of discovery through lead
candidates. Our ability to customize programs, yet maintain scientific rigor, enables our clients to access our global portfolio of services with confidence. Our personable and responsible <U>global project management team</U> ensures that our
clients have program details at their fingertips, at any minute, in any time zone, with the <U>security measures</U> needed to ensure our clients&#146; peace of mind. In addition to the aforementioned strengths, our global footprint and streamlined
processes enable us to leverage our competitive advantages to mature as the global, preferred therapeutic antibody provider. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our strategy is supported by
growing trends in pharma and finance. Global pharmaceutical companies are continuing to increase their share of reliance on CRO&#146;s to improve the efficiency and cost of development, increase turnaround time, and access advanced and integrated
expertise. When analyzing pharmaceutical outsourcing trends, in July, 2019, several major drivers of the CRO industry growth were identified, including robust biopharmaceutical funding, accelerated drug approval rates, the growing number of clinical
trials, and proliferation of biopharmaceutical companies without internal research and clinical capabilities<SUP STYLE="font-size:85%; vertical-align:top">1</SUP>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In an attempt to streamline, many large pharmaceutical companies are limiting the number of external CRO vendors that can be contracted. This is particularly
good for those CROs that fulfill multiple niches in the discovery and manufacturing pipeline. In a recent estimate, the CRO industry alone was estimated to be $30&nbsp;billion USD, and &#147;<I>highly</I><I> fragmented</I><I>&#133;</I><I> though
relatively few of full scale and breadth of service&#148;</I><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The key players serving the
monoclonal antibodies market are Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck&nbsp;&amp; Co., Inc, Amgen, Inc., Abbott Laboratories, AstraZeneca, Eli Lilly and Company, Mylan N.V., Daiichi Sankyo Company, Ltd., Bayer AG, Bristol Myers
Squibb Co., Johnson&nbsp;&amp; Johnson Services, Inc., Biogen Inc., Thermo Fisher Scientific, Inc., Sanofi Genzyme, F. <FONT STYLE="white-space:nowrap">Hoffmann-La</FONT> Roche Ltd., and Novo Nordisk
A/S<SUP STYLE="font-size:85%; vertical-align:top">2</SUP>. In 2016 alone, Novartis invested 9&nbsp;billion USD and Pfizer invested 7.9&nbsp;billion USD in R&amp;D<SUP STYLE="font-size:85%; vertical-align:top">3</SUP>. This is of little surprise
given the global monoclonal antibody market was valued at USD 85.4&nbsp;billion in 2015 and is expected to reach a value of USD 138.6&nbsp;billion by 2024<SUP STYLE="font-size:85%; vertical-align:top">2</SUP>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ongoing, growing investments in R&amp;D are expected to continue to ramp up for antibodies given the rising prevalence of cancer and other chronic diseases<SUP
STYLE="font-size:85%; vertical-align:top">4</SUP>. <B></B>In oncology, in particular, antibodies are viewed as the mainstay, as people move away from other types of therapies such as small
molecules<SUP STYLE="font-size:85%; vertical-align:top">5</SUP>. In recent years, the success of key pipeline drugs in the immuno-oncology space have been a key component of the record high capital market funding for the biotechnology sector<SUP
STYLE="font-size:85%; vertical-align:top">1</SUP>. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Healthcare Insights Life Sciences, CRO Sector Fundamentals Remain Hot for M&amp;A Consolidation, July&nbsp;3,
2019.<B> </B> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">2</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Monoclonal Antibodies (mAbs) Market Size Worth $138.6 Billion By 2024, Nov. 2016<B> </B> </P></TD></TR></TABLE>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">3</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Monoclonal Antibody Market 2019-2025 Growth, Key Players, Size, Demands and Forecasts, April, 2019
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">4</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Research Antibodies Market Size, Share&nbsp;&amp; Trends Analysis Report By Product, By Type (Monoclonal,
Polyclonal), By Technology, By Source, By Application (Oncology, Neurobiology), By <FONT STYLE="white-space:nowrap">End-use,</FONT> And Segment Forecasts, 2018 &#150; 2025, March, 2018 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">5</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">GEN, Antibody Discovery Looks Over the Horizon, Feb. 7, 2019. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ACQUISITION OF <FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> EXPRESS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&nbsp;22, 2017, the Company completed the acquisition of <FONT STYLE="white-space:nowrap">U-Protein</FONT> Express BV
<FONT STYLE="white-space:nowrap">(&#147;U-Protein&#148;)</FONT> whereby the Company has acquired all the issued and outstanding shares of <FONT STYLE="white-space:nowrap">U-Protein</FONT> for &#128;6,830,000 on terms as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,734,732 (CAD$4,062,607) was paid in cash on closing; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED APRIL 30,
2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3,030,503 common shares of the Company were issued on closing; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,047,634 in deferred payments over a three-year period. The deferred payments can be made in cash or
common shares of the Company at the election of <FONT STYLE="white-space:nowrap">U-Protein</FONT> shareholders. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transaction was
accounted for as a business combination, as the operations of <FONT STYLE="white-space:nowrap">U-Protein</FONT> meet the definition of a business. As a result, transaction costs of $17,717 were expensed. The goodwill resulting from the allocation of
the purchase price to the total fair value of net assets represented the sales and growth potential of <FONT STYLE="white-space:nowrap">U-Protein.</FONT> Goodwill recorded is allocated in its entirety to
<FONT STYLE="white-space:nowrap">U-Protein.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The first deferred payment of &#128;682,545 (CAD$1,049,754) has been made in cash during the year
ended April&nbsp;30, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the 3,030,503 common shares issued ($3,022,308) was determined based on the Canadian dollar equivalent of
the consideration required of &#128;2,047,634 pursuant to the share purchase agreement. The Company has allocated the purchase price as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,062,607</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3,030,503 common shares of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,022,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of deferred payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,134,410</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,219,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">797,276</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">370,530</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,815</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment, net of accumulated amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">216,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intellectual property (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,064,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,655,893</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(269,657</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income taxes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,197</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(810,800</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,219,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ACQUISITION OF IPA EUROPE AND IMMULEASE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company acquired all of the issued and outstanding shares of ImmunoPrecise Antibodies (Europe) B.V. (&#147;IPA Europe&#148;) and its
sister entity, Immulease B.V. (&#147;Immulease&#148;), for an aggregate purchase price of &#128;7,000,000 on terms as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,500,000 (CAD$3,988,132) was paid in cash on closing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">6,600,399 common shares of the Company were issued on closing; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,000,000 in deferred payments over a three-year period. The deferred payments will be made in three equal
installments of cash and equity totaling &#128;666,666 and will be prorated if the EBITDA of IPA Europe for the fiscal year preceding the date of payment is less than its average EBITDA over the previous two fiscal years. During the year ended
April&nbsp;30, 2019, the Company and the seller entered into an Amendment, Termination and Settlement Agreement whereby the deferred payments shall no longer be subject to an adjustment and will be paid in equal installments of cash and equity
totaling &#128;666,666. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED APRIL 30,
2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA Europe changed its name from ModiQuest Research B.V. in April 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA Europe is a privately held company based in Oss, The Netherlands, and specializes in the generation of monoclonal antibodies against difficult target
antigens. IPA Europe applies proprietary technologies to all aspects of the antibody discovery process in research and development, diagnostic and therapeutic applications. Using its proprietary
ModiFuse<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> (hybridoma electrofusion), ModiSelect<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> <FONT STYLE="white-space:nowrap">(B-cell</FONT> selection) and ModiPhage<SUP
STYLE="font-size:85%; vertical-align:top">&#153;</SUP> (phage display) technologies, IPA Europe can generate very large panels of monoclonal antibodies from various backgrounds including mouse, rat, rabbit, chicken, llama and human, as well as
transgenic animals harboring the human antibody gene repertoire. IPA Europe serves clients in Europe, the US, Asia and Russia. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transaction was
accounted for as a business combination, as the operations of IPA Europe and Immulease meet the definition of a business. As a result, transaction costs of $36,821 were expensed. The goodwill resulting from the allocation of the purchase price to
the total fair value of net assets represented the sales and growth potential of IPA Europe. Goodwill recorded is allocated in its entirety to IPA Europe. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The first deferred payment of &#128;666,666 (CAD$1,014,503), consisting of cash of &#128;333,333 (CAD$507,000) and common shares of the Company with a fair
value of $507,503, has been made during the year ended April&nbsp;30, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the 6,600,399 common shares issued ($4,884,295) was
determined to be $0.74 per share based on the fair value of the Company&#146;s shares immediately prior to the completion of the acquisition. The Company has allocated the purchase price as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,988,132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6,600,399 common shares of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,884,295</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of deferred payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,353,708</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,226,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">270,339</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">572,427</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,286,995</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment, net of accumulated amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">568,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Software</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible assets (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,304,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,640,671</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(580,339</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(22,897</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(298,979</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,636,192</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,226,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED APRIL 30,
2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SELECTED ANNUAL INFORMATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a summary of certain selected financial information of the Company for the years ended April&nbsp;30, 2019, 2018 and 2017. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2017</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,926,268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,441,349</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,630,515</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,449,222</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,370,556</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,016,989</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net (loss) earnings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,617,467</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,171,103</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,383,820</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,345,719</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,575,440</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,928,969</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,276,644</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,872,490</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(836,915</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividends declared</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Nil</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Nil</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Earnings (loss) per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.12</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.11</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.27</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>OVERALL PERFORMANCE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2019 the Company achieved growth in revenues to $10,926,268 from $5,441,349 in 2018. The increased revenue was due to the
acquisitions of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe, the Company&#146;s growth in higher revenue service offerings such as our <FONT STYLE="white-space:nowrap">B-cell</FONT> services and transgenic animals, as well as
new client onboarding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s new laboratory in Victoria is now a fully operational antibody production facility that effectively doubles its
revenue generating capacity. To drive the execution of its strategic and growth initiatives, the Company continues to focus on the recruitment of scientific and technical staff, development of new technical training programs and a commitment to
integrate continuous improvement and quality management methodologies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To support management and the Board of Directors in exercising oversight, the
Company is implementing information systems for marketing and sales automation and customer relationship management, as well as accounting and financial reporting, resource planning and project management. Comprehensive operational and management
reporting capabilities are being implemented with a view to effectively support a geographically dispersed organization allowing managers access to company data globally. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With the aid of a third-party HR consulting firm, significant effort was applied to strengthening and aligning the Company&#146;s human resources by: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Stabilizing staffing for sales growth going forward:</I> Remuneration and incentive systems have been aligned
with targeted revenue and gross profit performance, and operational roles and responsibilities have been focused on managing demand. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Leadership and operational alignment:</I> The Company has made changes and updates job descriptions,
compensation plans, and other reward and recognition systems, and is implementing career planning and development mechanisms and job performance and quality measures. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Future growth will provide opportunities for company personnel to develop new skills and abilities to tackle eventual challenges in a growing company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the 2019 fiscal year, the goal of the organization was to grow sales revenue and expand our brand awareness. This focus is consistent with the
&#145;leading with our scientists&#146; philosophy, which is resonating with our </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED APRIL 30,
2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
customers from both diagnostic and, in particular, the therapeutic market segment. The Company is also expanding its commitment to research and development initiatives aimed at introducing new
services through both development as well as through partnerships. To achieve the best results from its investments, the Company continued to add key scientific and management personnel to its team. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RESULTS OF OPERATIONS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended
April&nbsp;30, 2019, the Company increased revenues to $10,926,268 from $5,441,349 in 2018. This represents a 101% increase in revenue and stems from the acquisitions of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe, the
Company&#146;s ability to grow its core business and expand its market share in Europe, and an increase in projects for the <FONT STYLE="white-space:nowrap">B-cell</FONT> lab. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2019, the Company increased its gross margin to $5,294,634 from $2,451,026 in 2018. In percentage terms, the
Company&#146;s gross margin increased to 48% from 45% in 2018. The higher gross margin in 2019 was mostly attributable to the fact that the Company focused on higher margin projects at its new <FONT STYLE="white-space:nowrap">B-cell</FONT> lab and
introduced additional efficiencies into its operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recorded a net loss of $7,617,467 during the year ended April&nbsp;30, 2019, compared
to net loss of $5,171,103 for the year ended April&nbsp;30, 2018. The net loss increased in 2019, primarily as a result of the acquisitions of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe, which required higher expenses in all
facets of the business in order to manage a global landscape. The Company continues to invest in research and development in pursuit of its goal of broadening the breadth and value of its intellectual property assets in techniques inherent in the
production of human antibodies through new working partnerships with several companies with leading transgenic platforms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">$1,312,403 of the costs
incurred during the year ended April&nbsp;30, 2019 were <FONT STYLE="white-space:nowrap">one-time</FONT> costs which are not expected to be incurred again. These <FONT STYLE="white-space:nowrap">one-time</FONT> costs included costs incurred to
improve operational efficiency across all the divisions, to integrate <FONT STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe into IPA&#146;s global network, to continue to establish a global structure for reporting and oversight, and also
included severances paid to departed executive officers and paying out contracts from consultants. The Company also made investments that would enable its future growth, such as new management hires, more training programs, and additional space.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Variances of note in the Company&#146;s expenses include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Advertising and promotion fees of $819,250 in 2019 (2018 - $134,680) were incurred to support the Company&#146;s
initiatives focused on business development, marketing and branding programs. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Amortization expense increased to $1,875,907 from $233,534 in 2018 due to the amortization of intangible assets
which were acquired as a result of the acquisitions of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Consulting fees of $452,196 in 2019 (2018 - $864,549) were lower compared to 2018, because most of the consulting
fees incurred in 2018 were <FONT STYLE="white-space:nowrap">one-time</FONT> costs to support initiatives focused on operational efficiency training programs, and systems implementation. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Interest expense of $413,590 in 2019 (2018 - $50,591) was primarily incurred on the nonconvertible debentures
(&#147;Debentures&#148;) which were completed in April 2018. The Debentures bear interest at a rate of 10% per annum, payable semi-annually, and are due eighteen months from the date of issue. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The insurance expense of $185,099 (2018 - $39,845), management fees of $650,574 (2018 - $429,184), office and
general expense of $716,601 (2018 - $563,996), and rent expense of $324,396 (2018 - $65,093), were all higher compared to 2018 due to the expansion of the Company&#146;s laboratory facilities, an increase in commercial activities and the
acquisitions of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe (e.g., auditing, third-party business valuation, etc.). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED APRIL 30,
2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Salaries and benefits expense increased to $3,503,259 from $1,852,322 in 2018, primarily as a result of the
acquisitions of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe. $443,245 of the salaries were attributed to the profit-sharing payout made to the former shareholders of <FONT STYLE="white-space:nowrap">U-Protein,</FONT> as part of
the acquisition agreement. This is an annual payout that is made once per year. After 2020, the profit-sharing payout for <FONT STYLE="white-space:nowrap">U-Protein</FONT> will cease and the Company will be under no further obligations to share
profits with the former shareholders of <FONT STYLE="white-space:nowrap">U-Protein.</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Company recorded a share-based payments expense of $1,114,112 (2018 - $1,221,511) as a result of the vesting
of the 2,060,000 stock options granted during the current fiscal year versus 4,090,000 stock options granted during the April&nbsp;30, 2018 fiscal year. The option plan is aimed to align staff to the future company growth plans.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The travel expense increased to $320,293 from $218,125 in 2018 due to an increase in marketing activities and
business-related travel required in connection with managing a global organization. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SUMMARY OF QUARTERLY RESULTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets out financial information for the past eight quarters: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" STYLE="border-bottom:1.00pt solid #000000" ALIGN="center"><FONT STYLE="font-size:8pt"><B>Three Months Ended ($) </B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>January&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>October&nbsp;31,<BR>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>July&nbsp;31,<BR>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,641,109</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,695,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,716,791</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,872,785</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,842,317</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,187,056</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,485,732</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,102,362</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted loss per share*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.06</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended ($) </B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>January&nbsp;31,<BR>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>October&nbsp;31,<BR>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>July&nbsp;31,<BR>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,810,722</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,723,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,316,261</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">591,058</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income (loss)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,198,428</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,211,591</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(903,252</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(857,832</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted loss per share*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.04</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.03</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The basic and fully diluted calculations result in the same value due to the anti-dilutive effect of
outstanding stock options and warrants. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The losses for the quarters ended April&nbsp;30, 2019 and April&nbsp;30, 2018 are greater than
other quarters, as the Company invested heavily in growth enabling initiatives and also due to the <FONT STYLE="white-space:nowrap">catch-up</FONT> amortization recorded of intangible assets which were acquired as a result of the acquisitions of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">NON-IFRS</FONT> MEASURES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following are <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures and investors are cautioned not to place undue reliance on them and are urged to
read all IFRS accounting disclosures present in the audited consolidated financial statements and accompanying notes for the years ended April&nbsp;30, 2019 and 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company uses certain <FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial measures as supplemental indicators of its financial and operating
performance. These <FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial measures include adjusted operating EBITDA and adjusted operating expenses. The Company believes these supplementary financial measures reflect the Company&#146;s ongoing
business in a manner that allows for meaningful <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">period-to-period</FONT></FONT> comparisons and analysis of trends in its business. These
<FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures do not have any standardized meaning prescribed under IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED APRIL 30,
2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company defines adjusted operating EBITDA as operating earnings before interest, taxes, depreciation,
amortization, share-based compensation, and asset impairment charges. Adjusted operating EBITDA is presented on a basis consistent with the Company&#146;s internal management reports. The Company discloses adjusted operating EBITDA to capture the
profitability of its business before the impact of items not considered in management&#146;s evaluation of operating unit performance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the year ended
April&nbsp;30, 2019, excluding the <FONT STYLE="white-space:nowrap">one-time</FONT> costs of $1,312,403, EBITDA would have been ($1,537,071). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company
defines adjusted operating expenses as operating expenses before share-based compensation, depreciation, amortization and asset impairment charges. Adjusted operating expenses are presented on a basis consistent with the Company&#146;s internal
management reports. The <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures are reconciled to reported IFRS figures in the tables below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2019<BR>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2018<BR>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,617,467</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,171,103</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income taxes (recovery)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,788</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">109,715</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization and depreciation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,263,284</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">458,079</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">904,925</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">205,185</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange loss (gain)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(117,506</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">101,543</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">413,590</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,591</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest and other income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,085</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(73,004</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss on settlement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">214,885</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,114,112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,221,511</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Adjusted EBITDA</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,849,474</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,097,483</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2019<BR>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2018<BR>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,817,588</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,380,233</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization and depreciation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,263,284</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">458,079</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange loss (gain)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(117,506</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">101,543</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">413,590</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,591</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,114,112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,221,511</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Adjusted Operating Expenses</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,144,108</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,548,509</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FINANCING ACTIVITIES </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On
August&nbsp;16, 2017, the Company completed a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement, issuing 5,250,000 common shares at $1.00 per share for gross proceeds of $5,250,000. The Company issued 281,100 common shares and
paid a total of $24,000 as finders&#146; fees. The Company also incurred $5,669 of cash issue costs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED APRIL 30,
2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&nbsp;22, 2017, the Company issued 3,030,503 common shares pursuant to the acquisition of <FONT
STYLE="white-space:nowrap">U-Protein.</FONT> The shares were valued at $3,022,308, which was the Canadian dollar equivalent of the consideration required of &#128;2,047,634 pursuant to the share purchase agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;1, 2018, the Company issued 650,000 common shares pursuant to exercise of warrants for gross proceeds of $195,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company completed a nonconvertible debenture (the &#147;Debentures&#148;) financing in the principal amount of $4,252,000 (the
&#147;Offering&#148;). The Debentures are unsecured, bear interest at a rate of 10% per annum, payable semi-annually, and are due eighteen months from the date of issue. Under the Offering, a holder of a Debenture will receive 37,500 detachable
share purchase warrants (the &#147;Warrants&#148;) for every $25,000 of Debentures subscribed for by the holder. The Warrants are exercisable at $0.70 per share for a period of four years from the date of issue. Under the Offering, the Company paid
the following finder&#146;s fees: $10,300 in cash, 580,320 shares of the Company with a fair value of $383,010, and 415,942 finder&#146;s warrants valued at $187,627. On October&nbsp;25, 2018, the Company settled $1,377,000 of the Debentures by
issuing 1,377,000 units at a price of $1.00 per unit. Each unit consists of one common share of the Company and one share purchase warrant, with each warrant entitling the holder to purchase an additional share at a price of $1.25 for a period of
two years from the date of issue. This partial Debenture Settlement had the effect of strengthening the Company&#146;s balance sheet and reducing the ongoing interest obligations of the Company. A total of $2,875,000 of Debentures remains
outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company issued 6,600,399 common shares pursuant to the acquisition of IPA Europe and Immulease. The shares were
valued at $4,884,295, which was estimated based on the fair value of $0.74 per share immediately prior to the completion of the acquisition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the
year ended April&nbsp;30, 2018, the Company issued 503,334 common shares pursuant to exercise of stock options for total gross proceeds of $151,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On
May&nbsp;23, 2018, the Company entered into a loan agreement with a Director of the Company and his spouse and issued a promissory note in the principal amount of $200,000. The note was unsecured and bore an interest rate of 5.45% per annum. The
principal of the note plus accrued interest of $3,972 was repaid in full during the year ended April&nbsp;30, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&nbsp;19, 2018, the Company
closed a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement financing by issuing a total of 875,000 units of the Company at a price of $0.80 per unit for gross proceeds of $700,000. Each unit consists of one common share of the
Company and one share purchase warrant, with each warrant entitling the holder to purchase an additional Share at a price of $1.00 for a period of one year from the date of issue. The Company will have the right to accelerate the expiry date of the
warrants provided that the volume weighted average price trades at a price equal to or greater than $1.50 for a period of 20 consecutive days. In the event of acceleration, the expiry date will be accelerated to a date that is 30 days after the
Company issues a news release announcing that it has elected to exercise this acceleration right. The Company paid finders cash fees totaling $3,000 and incurred $7,926 of cash issue costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&nbsp;24, 2018, the Company closed a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement financing by issuing a total of
9,102,500 units of the Company at a price of $1.00 per unit for gross proceeds of $9,102,500. Each unit consists of one common share of the Company and one share purchase warrant, with each warrant entitling the holder to purchase an additional
share at a price of $1.25 for a period of two years from the date of issue. The Company will have the right to accelerate the expiry date of the warrants provided that the volume weighted average price trades at a price equal to or greater than
$1.75 for a period of 20 consecutive days. In the event of acceleration, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED APRIL 30,
2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the expiry date will be accelerated to a date that is 30 days after the Company issues a news release announcing that it has elected to exercise this acceleration right. The Company paid finders
cash fees totaling $201,540 and issued 182,460 finder&#146;s shares. The Company also incurred $76,038 of cash issue costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&nbsp;22, 2017,
the Company announced that it had signed a binding letter of intent with Crossbeta Biosciences B.V. (&#147;Crossbeta&#148;) whereby the Company had agreed to acquire all of the issued and outstanding shares of Crossbeta. The proposed transaction was
terminated and settled on October&nbsp;23, 2018. In consideration of the settlement, the Company paid &#128;37,000 ($55,969) and issued 78,514 shares valued at $61,241. The Company accrued a settlement liability of $92,040 as at April&nbsp;30, 2018.
As such, the remaining loss on settlement of $25,170 was recognized in the current year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;27, 2019, the Company issued 714,793 common shares
pursuant to the second deferred acquisition payment to IPA Europe. The common shares are valued at $507,503. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2019,
the Company issued 135,000 common shares pursuant to exercise of stock options for total gross proceeds of $40,500. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>LIQUIDITY AND CAPITAL RESOURCES
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s objectives when managing capital are to ensure sufficient liquidity for operations and adequate funding for growth and capital
expenditures while maintaining an efficient balance between debt and equity. The capital structure of the Company consists of shareholders&#146; equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company makes adjustments to its capital structure upon approval from its Board of Directors, in light of economic conditions and the Company&#146;s
working capital requirements. There were no changes in the Company&#146;s approach to capital management during the year. The Company is not subject to any externally imposed capital requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As at April&nbsp;30, 2019, the Company held cash of $5,471,650 (2018 &#150; $1,806,133) and had working capital of $2,673,667 (2018 &#150; $498,377). As part
of the investing activities, the Company made equipment purchases of $645,058 and made deferred acquisition payments of $1,556,754. As part of the financing activities, the Company issued 9,977,500 units for gross proceeds of $9,802,500, received
$40,500 from exercise of stock options, received loans of $200,000, offset by lease repayments of $23,912 and loan repayments of $378,775. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company&#146;s consolidated financial statements have been prepared on the basis of accounting principles applicable to a going concern. This assumes the Company will continue in operation for the foreseeable future and will be able to realize its
assets and discharge its obligations in the normal course of operations. The Company has incurred operating losses since inception, including $7,617,467 for the year ended April&nbsp;30, 2019 and has accumulated a deficit of $17,476,482<B> </B>as at
April&nbsp;30, 2019. The Company may need to raise additional funds in order to continue on as a going concern and there can be no assurances that sufficient funding, including adequate financing, will be available. The ability of the Company to
arrange additional financing in the future depends in part, on the prevailing capital market conditions and profitability of its operations. These material uncertainties may cast significant doubt on the Company&#146;s ability to continue as a going
concern. Accordingly, the consolidated financial statements do not give effect to adjustments that would be necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets and liquidate its
liabilities, contingent obligations and commitments other than in the normal course of business and at amounts different from those in the consolidated financial statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As at April&nbsp;30, 2019, the Company does not have any commitments for capital expenditures. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED APRIL 30,
2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CAPITAL EXPENDITURES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company made equipment purchases of $645,058 during the year ended April&nbsp;30, 2019 (2018 - $345,487). During the year ended April&nbsp;30, 2018, the
Company also paid net cash of $3,265,331 to acquire <FONT STYLE="white-space:nowrap">U-Protein</FONT> and paid net cash of $3,561,423 to acquire IPA Europe during the year ended April&nbsp;30, 2018. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RELATED PARTY TRANSACTIONS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Key management personnel are
those persons having authority and responsibility for planning, directing and controlling the activities of the Company. Key management consists of Dr.&nbsp;Jennifer Bath, President and CEO; Lisa Helbling, CFO; Natasha Tsai, former CFO; Reginald
Beniac, former Chief Operating Officer; Charles Wheelock, Chief Technology Officer; Oren Beske, former President of ImmunoPrecise Antibodies (USA) Ltd.; Martin&nbsp;Hessing, a Director of <FONT STYLE="white-space:nowrap">U-Protein;</FONT> Jos Raats,
former President and CEO of IPA Europe; and Directors of the Company. During the year ended April&nbsp;30, 2019 and 2018, the compensation for key management is as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Consulting fees<SUP STYLE="font-size:85%; vertical-align:top">(1) </SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,292</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Management fees<SUP STYLE="font-size:85%; vertical-align:top">(2) </SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">394,126</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">131,614</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Professional fees<SUP STYLE="font-size:85%; vertical-align:top">(3) </SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,263</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58,569</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Salaries and other short-term benefits<SUP STYLE="font-size:85%; vertical-align:top">(4)
</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">995,855</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">662,997</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Severance<SUP STYLE="font-size:85%; vertical-align:top">(5) </SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">169,346</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">770,928</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">474,824</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,314,964</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,552,350</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The charge includes consulting fees paid to Guy Champagne, a former Director. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The charge includes management fees paid to Dr.&nbsp;Martin Hessing, a Director of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> and Dr.&nbsp;Jos Raats, former President and CEO of IPA Europe. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The charge includes professional fees paid to Malaspina Consultants Inc. in which Natasha Tsai was an associate
until July&nbsp;31, 2018 and an owner thereafter. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The charge includes salaries and benefits paid to Dr.&nbsp;Jennifer Bath and former management that includes
Thomas D&#146;Orazio, Robert Beecroft Dr.&nbsp;Oren Beske and Reginald Beniac. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The charge includes severance paid to Thomas D&#146;Orazio, Dr.&nbsp;Oren Beske and Reginald Beniac.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At April&nbsp;30, 2019, included in accounts payable and accrued liabilities is $nil (2018 - $3,501) due to related parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the years ended April&nbsp;30, 2019, the spouse of a Director provided administrative services for $54,225 (2018 &#150; $60,520). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>OUTSTANDING SHARE DATA </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s outstanding
share information as at August&nbsp;28, 2019 is as follows: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED APRIL 30,
2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Security</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Exercise<BR>Price</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Expiry date</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issued and outstanding common shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,994,445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">NA</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">NA</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">653,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">December&nbsp;20,&nbsp;2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,085,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">September&nbsp;18,&nbsp;2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">January&nbsp;3, 2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">700,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">February&nbsp;7, 2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">September 24, 2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">November&nbsp;7, 2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">December 31, 2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">415,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">January&nbsp;11, 2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">875,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">June 18, 2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,102,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">September 24, 2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,377,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">October 25, 2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,793,942</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">March 26, 2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">91,391,220</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">OFF-BALANCE</FONT> SHEET ARRANGEMENTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company does not utilize <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet transactions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>COMMITMENTS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2018,
the Company extended its existing operation lease agreements for rental of office and laboratory space in Victoria, BC, Canada to include one additional office space and for an additional term of 5 years. The new lease agreement commenced
May&nbsp;1, 2018 and terminates on April&nbsp;30, 2023. The new lease is in the amount of $21,015 per month for all four spaces from May&nbsp;1, 2018 to April&nbsp;30, 2021 and $21,914 per month from May&nbsp;1, 2021 to April&nbsp;30, 2023. The
minimum annual payments under these leases are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">252,186</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">252,186</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">262,968</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">262,968</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,030,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the Company&#146;s rental of office and laboratory space in Utrecht, Netherlands,
the current lease commenced on January&nbsp;1, 2017 and terminates on December&nbsp;31, 2019. Annual minimum lease payments are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&#128;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,415</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED APRIL 30,
2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the Company&#146;s rental of office and laboratory space in Oss, Netherlands, the current lease commenced
on January&nbsp;1, 2018 and terminates on December&nbsp;31, 2019. Effective December&nbsp;31, 2018, the lease automatically rolls into a <FONT STYLE="white-space:nowrap">3-year</FONT> term through December&nbsp;31, 2022. Annual minimum lease
payments are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&#128;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">116,970</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">643,332</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CRITICAL ACCOUNTING ESTIMATES AND JUDGMENTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of the consolidated financial statements in conformity with IFRS required estimates and judgments that affect the amounts reported in the
financial statements. Actual results could differ from these estimates and judgments. Estimates are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the year in which the estimate is revised. Significant areas
requiring the use of estimates and judgments are as follows: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Functional currency </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has used judgment in determining the currency of the primary economic environment in which the entity operates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Amounts receivable </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company monitors the financial
stability of its customers and the environment in which they operate to make estimates regarding the likelihood that the individual trade receivable balances will be paid. Credit risks for outstanding customer receivables are regularly assessed and
allowances are recorded for estimated losses, if required. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Equipment </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has used estimates in the determination of the expected useful lives of equipment and leasehold improvements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Revenue recognition </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">percentage-of-completion</FONT></FONT> method requires the use of estimates to determine the stage of completion which is used to determine the recorded amount of revenue, unbilled
revenue and deferred revenue on uncompleted contracts. The determination of anticipated revenues includes the contractually agreed revenue and may also involve estimates of future revenues if such additional revenues can be reliably estimated and it
is considered probable that they will be recovered. The determination of anticipated costs for completing a contract is based on estimates that can be affected by a variety of factors, including the cost of materials, labour, and subcontractors. The
determination of estimates is based on the Company&#146;s business practices as well as its historical experience. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Impairments </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the purposes of assessing impairment, assets are grouped at the lowest levels for which there are separately identifiable cash flows (&#147;cash generating
units&#148; or &#147;CGU&#148;s). Each asset or CGU is evaluated every reporting period to determine whether there are any indicators of impairment. If any such indicators exist, which is often judgment-based, a formal estimate of recoverable amount
is performed and an impairment charge is recognized to the extent that the carrying amount exceeds the recoverable amount. The recoverable amount of an asset or CGU of assets is measured at the higher of fair value less costs of disposal or value in
use. These determinations and their individual assumptions require that management make a decision based on the best available information at each reporting period. The estimates and assumptions are subject to risk and uncertainty; hence, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED APRIL 30,
2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
there is the possibility that changes in circumstances will alter these projections, which may impact the recoverable amount of the assets. In such circumstances, some or all of the carrying
value of the assets may be further impaired or the impairment charge reversed with the impact recorded in profit or loss. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company performs a goodwill
impairment test annually and when circumstances indicate that the carrying value may not be recoverable. For the purposes of impairment testing, goodwill acquired through business combinations has been allocated to two different CGUs. The
recoverable amount of each CGU was based on value in use, determined by discounting the future cash flows to be generated from the continuing use of the CGU. The cash flows were projected over a five-year period based on past experience and actual
operating results. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company performed its annual goodwill impairment test in April 2019 and no impairment was indicated for the period tested. The
values assigned to the key assumptions represented management&#146;s assessment of future trends in the industry and were based on historical data from both internal and external sources. Weighted average costs of capital of 17.5% and 10.2%,
respectively, was used in the assessments of the two CGUs . </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Determination of segments</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An operating segment is a component of the Company that engages in business activities from which it may earn revenues and incur expenses. All operating
segments&#146; results are reviewed by the Company&#146;s management in order to make decisions regarding the allocation of resources to the segment. Segment results include items directly attributable to a segment as those that can be allocated on
a reasonable basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As the Company provides antibody production and related services in one distinct category, there is only one category to report
revenues by production site. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Life of intangible assets</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Intangible assets are amortized based on estimated useful life less their estimated residual value. Significant assumptions are involved in the determination
of useful life and residual values and no assurance can be given that actual useful lives and residual values will not differ significantly from current assumptions. Actual useful life and residual values may vary depending on a number of factors
including internal technical evaluation, attributes of the assets and experience with similar assets. Changes to these estimates may affect the carrying value of assets, net income (loss) and comprehensive income (loss) in future periods. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Purchase price allocation</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The acquisition of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> on August&nbsp;22, 2017 and the acquisition of IPA Europe and Immulease on April&nbsp;5, 2018 were accounted for as business combinations at fair value in accordance with IFRS 3, <I>Business
Combinations.</I> The acquired assets and assumed liabilities were adjusted to their fair values assigned through completion of a purchase price allocation, as described below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The purchase price allocation process resulting from a business combination requires management to estimate the fair value of identifiable assets acquired
including intangible assets and liabilities assumed including the deferred acquisition payment obligations. The Company uses valuation techniques, which are generally based on forecasted future net cash flows discounted to present value, and also
relies on work performed by third-party valuation specialists. These valuations are closely linked to the assumptions used by management on the future performance of the related assets and the discount rates applied. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED APRIL 30,
2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ADOPTION OF NEW ACCOUNTING STANDARDS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Financial instruments</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On May&nbsp;1, 2018, the Company
adopted IFRS 9, <I>Financial Instruments </I>(&#147;IFRS 9&#148;), which replaces IAS 39, <I>Financial Instruments: Recognition and Measurement </I>(&#147;IAS 39&#148;) and all previous versions of IFRS 9. The new standard provides guidance on the
classification and measurement of financial assets and financial liabilities, <FONT STYLE="white-space:nowrap">de-recognition</FONT> of financial instruments, impairment of financial assets and hedge accounting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The adoption of IFRS 9 on May&nbsp;1, 2018 resulted in changes in accounting policies; however there were no adjustments to the amounts recognized in these
consolidated financial statements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Classification and measurement of financial assets and financial liabilities </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IFRS9 requires financial assets to be classified into three measurement categories on initial recognition: fair value through profit and loss
(&#147;FVTPL&#148;), fair value through other comprehensive income (&#147;FVOCI&#148;), and amortized cost. Investments in equity instruments are required to be measured by default at FVTPL. IFRS 9 permits entities to elect into an irrevocable
option for equity instruments to report changes in fair value in other comprehensive income. Classification and measurement of financial assets is dependent on the entity&#146;s business model for managing the financial assets and related
contractual cash flows. IFRS 9 retains most of the requirements of IAS 39 related to classification and measurement of financial liabilities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Impairment </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IFRS 9 introduces a three-stage expected
credit loss (&#147;ECL&#148;) model for determining impairment of financial assets. The expected credit loss model does not require the occurrence of a triggering event before an entity recognizes credit losses. IFRS 9 requires an entity to
recognize expected credit losses upon initial recognition of a financial asset and to update the quantum of expected credit losses at the end of each reporting period to reflect changes to credit risk of the financial asset. The adoption of the ECL
model did not have a material impact on the Company&#146;s consolidated financial statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s financial assets are mainly comprised of
cash, amounts receivable and investment. Cash and amounts receivable are classified and accounted for under IFRS 9 at amortized cost, and investment is classified and accounted for at FVTPL. Financial liabilities are mainly comprised of accounts
payable and accrued liabilities, debentures, loans payable and deferred acquisition payments, which are accounted for at amortized cost. The Company completed a detailed assessment of its financial assets and liabilities as at May&nbsp;1, 2018. The
following table shows the original classification under IAS 39 and the new classification under IFRS 9: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="28%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Original classification<BR>IAS 39</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>New classification<BR>IFRS 9</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Cash</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Loans and receivables (amortized cost)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Amortized cost</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Amounts receivable</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Loans and receivables (amortized cost)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Amortized cost</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Investment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Available for sale (FVOCI)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">FVTPL</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Accounts payable and accrued liabilities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Other financial liabilities (amortized cost)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Amortized cost</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Debentures</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Other financial liabilities (amortized cost)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Amortized cost</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Loans payable</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Other financial liabilities (amortized cost)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Amortized cost</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Deferred acquisition payments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Other financial liabilities (amortized cost)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Amortized cost</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Revenue recognition</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IFRS
15, <I>Revenue from Contracts with Customers </I>(&#147;IFRS 15&#146;) establishes a comprehensive framework for revenue recognition. The standard replaces IAS 18, <I>Revenue </I>and IAS 11, <I>Construction Contracts </I>and related interpretations
and represents a new single model for recognition of revenue from contracts with customers. The model features a five-step analysis of transactions to determine the nature of an entity&#146;s obligation to perform and whether, how much, and when
revenue is recognized. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED APRIL 30,
2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company adopted IFRS 15 as of May&nbsp;1, 2018 and the new standard has been applied retrospectively
using the modified retrospective approach, where prior periods are not restated and the cumulative effect of initially applying this standard is recognised in the opening deficit balance on May&nbsp;1, 2018. The Company applied IFRS 15 using the
practical expedient under which the Company elected to apply IFRS 15 retrospectively only to contracts that were not completed at the date of initial application. The impact was determined to be an increase of $122,025 to the opening deficit balance
on May&nbsp;1, 2018 and an increase of $207,667 to revenue and an increase of $85,642 to cost of sales in the current year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recognizes
revenue from sale of antibodies and service agreements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Sale of antibodies </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Revenue from sale of antibodies is recognized when the terms of a contract with a customer have been satisfied. This occurs when: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The control over the product has been transferred to the customer; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The product is received by the customer or transfer of title to the customer occurs upon shipment.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following delivery, the customer bears the risks of obsolescence and loss in relation to the goods. Revenue is recognized based on the
price specified in the contract, net of estimated sales discounts and returns. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Contract revenue </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Revenues from contracted services are generally recognized as the performance obligations are satisfied over time, and the related expenditures are incurred
pursuant to the terms of the agreement. Under IFRS 15, the Company has determined that revenue should be recognized on a percentage of completion basis when the key milestones contained within the contract are satisfied and there is an enforceable
right to payment for performance completed to date. For contracts with no enforceable right to payment when the contract is incomplete, contract revenue is recognized on a completed contract basis when the customers are satisfied with the service at
the end of the contract. The Company has determined that the percentage of completion as the time expended as a proportion of total time expected at the end of the reporting period is an appropriate measure of progress towards the completion of
these performance obligations under IFRS 15. Previously, revenue was recognized as the performance obligations were satisfied regardless of whether there was an enforceable right to payment if a contract was terminated. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Unbilled revenue and deferred revenue </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amounts recognized
as revenue in excess of billings are classified as unbilled revenue. Amounts received in advance of the performance of services are classified as deferred revenue. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ACCOUNTING STANDARDS ISSUED BUT NOT YET EFFECTIVE </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
following revised standards are effective for the annual periods noted with earlier application permitted. The Company also has not early adopted any amendment, standard or interpretation that has been issued but is not yet effective. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Leases</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In January 2016, the IASB issued IFRS 16, Leases,
which supersedes IAS 17, Leases. IFRS 16 establishes principles for the recognition, measurement, presentation and disclosure of leases. The standard establishes a single model for lessees to bring leases
<FONT STYLE="white-space:nowrap">on-balance</FONT> sheet while lessor accounting remains largely unchanged and retains the finance and operating lease distinctions. The standard is applicable to the Company effective May&nbsp;1, 2019. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED APRIL 30,
2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon adoption of IFRS 16, the Company will record a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset, with an associated lease liability, on the consolidated statement of financial position as at May&nbsp;1, 2019. The
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset and liability will be unwound over the term of the lease giving rise to an interest expense and depreciation charge, respectively. Currently the
Company&#146;s operating leases relate to the rental of office and lab spaces. The <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset capitalized is expected to be $1,396,513 and the liability recorded
is expected to be $1,442,954. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DISCLOSURE CONTROLS AND PROCEDURES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Disclosure controls and procedures are intended to provide reasonable assurance that information required to be disclosed is recorded, processed, summarized,
and reported within the time periods specified by securities regulations and that the information required to be disclosed is accumulated and communicated to management. Internal controls over financial reporting are intended to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with IFRS. In connection with National Instrument <FONT STYLE="white-space:nowrap">52-109</FONT> (Certificate
of Disclosure in Issuer&#146;s Annual and Interim Filings) (&#147;NI <FONT STYLE="white-space:nowrap">52-109&#148;),</FONT> the Chief Executive Officer and Chief Financial Officer of the Company have filed a Venture Issuer Basic Certificate with
respect to the financial information contained in the consolidated financial statements for the year ended April&nbsp;30, 2019 and this accompanying MD&amp;A (together, the &#147;Annual Filings&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In contrast to the full certificate under NI <FONT STYLE="white-space:nowrap">52-109,</FONT> the Venture Issuer Basic Certificate does not include
representations relating to the establishment and maintenance of disclosure controls and procedures and internal control over financial reporting, as defined in NI <FONT STYLE="white-space:nowrap">52-109.</FONT> For further information the reader
should refer to the Venture Issuer Basic Certificates filed by the Company with the Annual Filings on SEDAR at www.sedar.com. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FINANCIAL INSTRUMENTS
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s financial instruments include cash, amounts receivable, restricted cash, investment, accounts payable and accrued liabilities,
debentures, loans payable, and deferred acquisition payments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fair value is the price that would be received to sell an asset or paid to transfer a
liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy establishes three levels to classify the inputs to valuation techniques used to measure fair value, by reference to the reliability of
the inputs used to estimate the fair values. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Level&nbsp;1 - applies to assets or liabilities for which there are quoted prices in active markets for
identical assets or liabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Level&nbsp;2 - applies to assets or liabilities for which there are inputs other than quoted prices that are observable
for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or
model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Level&nbsp;3 - applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement
of the fair value of the assets or liabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of investment is determined based on &#147;Level&nbsp;2&#148; inputs as its cost was the
best approximation of its fair value. As at April&nbsp;30, 2019, the Company believes that the carrying values of cash, amounts receivable, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED APRIL 30,
2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
restricted cash, accounts payable and accrued liabilities, debentures, loans payable, and deferred acquisition payments approximate their fair values because of their nature and relatively short
maturity dates or durations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Concentration of risk: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Industry </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company operates in the contract research
organization sector and is affected by general economic trends. A decline in economic conditions, research spending or other adverse conditions could lead to reduced revenue. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Concentrations of credit risk </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Credit risk relates to
cash, restricted cash and amounts receivable and arises from the possibility that counterparty to an instrument may fail to perform. At April&nbsp;30, 2019, all of the Company&#146;s cash was held with tier one banks. The Company has evaluated
amounts receivable and determined that there were no allowances for doubtful accounts at April&nbsp;30, 2019 and 2018. During the year ended April&nbsp;30, 2019 the Company incurred bad debt expense of $1,837 (2018 - $16,454). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Currency risk </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company operates in the US and Europe
which gives rise to exposure to market risks from changes in foreign currency values. Most significantly, the Company is exposed to potential currency fluctuations between US and Canadian dollars, which was translated at 1.3423 at April&nbsp;30,
2019, and the Euro and Canadian dollar, which was translated at 1.5055 at April&nbsp;30, 2019. Fluctuations in the exchange rate could impact profitability. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At April&nbsp;30, 2019, the Company is exposed to currency risk through the following assets and liabilities denominated in US dollars and Euros: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Euros<BR>(&#128;)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>US&nbsp;Dollars<BR>(US $)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,752,749</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">183,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">344,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">568,190</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,158,696</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">751,565</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(461,416</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(83,624</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(74,175</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,063,981</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,599,572</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(83,624</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,440,876</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">667,941</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the year ended April&nbsp;30, 2019, a 5% increase in foreign exchange rates by the Canadian dollar relative to the US
dollar would have decreased net income (loss) by approximately $45,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the year ended April&nbsp;30, 2019, a 5% increase in foreign exchange rates
by the Canadian dollar relative to the Euro would have decreased other comprehensive income (loss) by approximately $109,000. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Liquidity risk: </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s approach to managing its obligations is to maintain sufficient resources to meet its obligations when due without undue risk to the Company.
The Company monitors its cash requirements on an ongoing basis </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED APRIL 30,
2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to ensure that there are sufficient resources for operations as well as to fund anticipated leasing, capital and development expenditures. In addition, the Company manages its cash to meet its
debt obligations and to fund general and administrative costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Contractual cash flow requirements as at April&nbsp;30, 2019 were as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&lt; 1<BR>year<BR>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>1 &#150; 2<BR>years<BR>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2 &#150; 5<BR>years<BR>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&gt;5<BR>years<BR>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,594,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,594,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loan payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82,953</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,717</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,670</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,529,403</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,529,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,058,807</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,003</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,003</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,564</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">131,570</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Minimum lease payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">649,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">516,318</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">966,166</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,131,925</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,875,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,875,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,807,130</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,123,442</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">999,730</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,930,302</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RISKS AND UNCERTAINTIES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Research and Development and Product Development </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA is a
life science company that makes customized antibodies and is engaged in the research and product development of new processes, procedures and innovative approaches to the antibody production and new antibodies. The Company has been engaged in such
research and development activities for over 20 years and has had significant success. Continued investment in retaining key scientific staff as well as an ongoing commitment in research and development activities will continue to be a cornerstone
in the Company&#146;s development of new services, processes, and competitive advantages such as Rapid Prime and its methods for the production of human antibodies. The Company realizes that such research and product development activities
endeavour, but cannot assure, the production of new and innovative processes, procedures or innovative approaches to antibody production or new antibodies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Custom Products </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is reliant on the
development, marketing and sale of its current custom monoclonal and polyclonal antibodies. If it does not achieve sufficient market acceptance of its expansion of its commercialization of its products and services, it will be difficult for the
Company to achieve consistent profitability. The Company&#146;s marketing and sales approach and external sales personnel continues to introduce a steady stream of new customers. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Obsolescence </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Maintaining a competitive position requires
constant growth, development and strategic marketing and planning. If the Company is unable to maintain a technological advantage, its ability to grow its business will be adversely affected and its products may become obsolete compared with other
technologies. To mitigate this, the Company is making investments in new methods, technology and facilities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Competition </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA may face significant competition in selling its products and services. Many competitors may have substantial marketing, financial, development and
personnel resources. To remain competitive, the Company believes that </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED APRIL 30,
2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
it must effectively and economically provide: (i)&nbsp;products and services that satisfy customer demands, (ii)&nbsp;superior customer service, (iii)&nbsp;high levels of quality and reliability,
and (iv)&nbsp;dependable and efficient distribution networks. Increased competition may require the Company to reduce prices or increase spending on sales and marketing and customer support, which may have a material adverse effect on its financial
condition and results of operations. Any decrease in the quality of IPA&#146;s products or level of service to customers or any occurrence of a price war among the Company&#146;s competitors may adversely affect the business and results of
operations. Customer reach, service and <FONT STYLE="white-space:nowrap">on-time</FONT> delivery will continue to be a hallmark of the Company&#146;s ability to compete with other market players. Further, the recent acquisitions translate to
spreading the IPA footprint on two continents. In addition, the Company has deployed a sales team tasked with continually sourcing and providing market intelligence as part of its activities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Intellectual Property Protection </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although IPA is
developing its patent portfolio, IPA&#146;s intellectual property is still protected primarily through trade secrets and copyright protection. The Company takes steps to document and protect its trade secrets and authorship of works protectable by
copyright. However, there is no guarantee that such steps protect against the disclosure of confidential information, rights of employees, or that legal actions would provide sufficient remedy for any breach. Additionally, IPA&#146;s trade secrets
might otherwise become known or be independently developed by competitors. If the Company&#146;s internal information and knowledge cannot be protected, the business might be adversely affected. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Failure of Laboratory Facilities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s
operations could suffer as a result of a failure of its laboratory facilities. The Company&#146;s business is dependent upon a laboratory infrastructure to produce products and services. These systems and operations are vulnerable to damage and
interruption from fires, earthquakes, telecommunications failures, and other events. Any such errors or inadequacies in the software that may be encountered could adversely affect operations, and such errors may be expensive or difficult to correct
in a timely manner. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The production of monoclonal and polyclonal antibodies requires state of the art laboratory facilities and animal care standards and
the success of these laboratory services depends on the recruitment and retention of highly qualified technical staff to maintain the level and quality standards that customers expect of the Company&#146;s products and services. There is no
assurance that the Company will be able to expand and operate such <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">state-of-the-art</FONT></FONT></FONT> laboratory services and recruit and retain
qualified staff. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Financial and Regulatory Risks </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company is currently subject to financial and regulatory risks. The financial risk is derived from the uncertainty pertaining to the Company&#146;s ability to raise capital to continue operations. Regulatory risks include the possible delays in
getting regulatory approval for the transactions that the Board of Directors believe to be in the best interest of the Company and include increased fees for filings and the introduction of ever more complex reporting requirements, the cost of which
the Company must meet in order to maintain its exchange listing. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FURTHER INFORMATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additional information relating to the Company can be found on SEDAR at <U>www.sedar.com</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.10
<SEQUENCE>11
<FILENAME>d20922dex9910.htm
<DESCRIPTION>EX-99.10
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.10</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.10 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g0910042201519.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Antibodies&#146; Annual Revenues Increase 100% to $10,926,268 Million </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, Aug. 28, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTC PINK: IPATF) today reports
its financial results for the year ended April 30, 2019. The financial statements and related Management&#146;s Discussion and Analysis (&#147;MD&amp;A&#148;) can be viewed on SEDAR at <U>www.sedar.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Financial Highlights: </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Revenue </I></B>ImmunoPrecise achieved record annual revenue of $10,926,268 in fiscal 2019 compared to $5,441,349 in fiscal 2018. This
represents a 100% increase in revenue as a result of its completed acquisitions of IPA Europe (formerly ModiQuest Research), and IPA&#146;s ability to grow its core business and expand into higher revenue service offerings in therapeutic discovery.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Gross Margin </I></B>ImmunoPrecise increased its gross margin to $5,294,634 from $2,451,026 in 2019. In percentage terms, the
Company&#146;s gross margin increased to 48% from 45% in 2018. The higher margin in 2019 was mostly attributable to the Company&#146;s increased focus on larger programs with higher margins at its new <FONT STYLE="white-space:nowrap">B-cell</FONT>
lab, as well as increased efficiencies in operations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Net Loss </I></B>ImmunoPrecise recorded a net loss of $7,617,467 during the
year ended April 30, 2019, compared to net loss of $5,171,103 for the year ended April 30, 2018. The net loss increased in 2019, primarily as a result of the acquisitions of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe, which
required higher expenses in all facets of the business in order to manage a global landscape. $1,312,403 of the costs incurred during the year ended April 30, 2019, were <FONT STYLE="white-space:nowrap">one-time</FONT> costs which are not expected
to be incurred again. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Growth Initiatives in Fiscal 2020: </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Asset Building </I></B>While CRO services remain the mainstay of the Company, ImmunoPrecise has worked continuously on building an
intellectual property estate and portfolio of proprietary methods and physical assets through collaborations, joint ventures, acquisitions and <FONT STYLE="white-space:nowrap">in-licensing.</FONT> The onboarding of existing assets with regard to
equipment, technologies, IP and licenses within the Company&#146;s EU operations has been compounded by active research and development at all operational sites this year. This includes the <FONT STYLE="white-space:nowrap">on-going</FONT>
development of new service offerings to be rolled out in the fiscal year 2020, but more notably, internal, discovery programs focused on novel, therapeutic antibodies, primarily in the field of immuno-oncology. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Talem Therapeutics </I></B>Recently, the Company formed Talem Therapeutics (Talem), based in Cambridge, Massachusetts, to support its
internal, therapeutic, discovery programs. Talem is structured to secure assets during their discovery and development stage and seek out strategic partnerships with clinical-stage pharma and biotech companies, where it will aid in the <FONT
STYLE="white-space:nowrap">out-licensing</FONT> or sale of the therapeutics for clinical trials. The ability for investors to support individual assets or portfolios in Talem generates an asymmetrical opportunity for investments, while avoiding
ImmunoPrecise&#146;s shareholders dilution. The depth and speed of IPA&#146;s offerings enables Talem to customize each program and leverages the Company&#146;s expertise and technologies in antibody discovery. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Global Integration and Cost Synergies </I></B>ImmunoPrecise integrated IT services,
including the global service desk, and decreased cost and risk while removing collaboration barriers, including tools that allow for communicating in different languages. They have also begun to capture synergies after the global integration of
sales, marketing, R&amp;D, management, and legal services. IPA has prepared for the integration of fundamental business services such as payroll, financial controls, and an Oracle suite of enterprise software. They will continue to enhance these
integrations, as well as create synergies in additional areas such as M&amp;A communications and tax integration. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>B cell Select<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP> and DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> </I></B>IPA Canada and IPA Europe have both been designated as approved CROs for the world&#146;s leading, transgenic animal
platform producing human antibodies, and exercised an advantage in optimizing services for various transgenic animal vendors. The Company made strategic investments in R&amp;D activities to develop proprietary technologies enabling the application
of their B cell Select<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> and DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> platforms to a broad range of transgenic animal species and strains. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The Market: </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>CRO Services
and Therapeutic Development </I></B>In an attempt to streamline, many large pharmaceutical companies are limiting the number of external CRO vendors that can be contracted. This is particularly promising for those CROs that fill multiple niches in
the discovery and manufacturing pipeline. The key players serving the monoclonal antibodies market are Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck&nbsp;&amp; Co., Inc, Amgen, Inc., Abbott Laboratories, AstraZeneca, Eli Lilly and Company,
Mylan N.V., Daiichi Sankyo Company, Ltd., Bayer AG, Bristol Myers Squibb Co., Johnson&nbsp;&amp; Johnson Services, Inc., Biogen Inc., Thermo Fisher Scientific, Inc., Sanofi Genzyme, F. <FONT STYLE="white-space:nowrap">Hoffmann-La</FONT> Roche Ltd.,
and Novo Nordisk A/S<SUP STYLE="font-size:85%; vertical-align:top">2</SUP>. In 2016 alone, Novartis invested 9&nbsp;billion USD and Pfizer invested 7.9&nbsp;billion USD in R&amp;D<SUP STYLE="font-size:85%; vertical-align:top">3</SUP>. This is of
little surprise given the global monoclonal antibody market was valued at USD 85.4&nbsp;billion in 2015 and is expected to reach a value of USD 138.6&nbsp;billion by 2024<SUP STYLE="font-size:85%; vertical-align:top">2</SUP>. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Monoclonal Antibodies (mAbs) Market Size Worth $138.6 Billion By 2024, Nov. 2016 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Monoclonal Antibody Market 2019-2025 Growth, Key Players, Size, Demands and Forecasts, April, 2019
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We continue to expand our therapeutic offerings as a global, full-service antibody provider to pharmaceutical and biotech
companies internationally, and to accelerate our volume of large-scale, therapeutic programs. Simultaneously, IPA sets itself on a path of Antibody Discovery and IP estate-building through Talem Therapeutics, which will expand our clinical
partnerships and continue to build our IP estate&#148; commented Jennifer Bath, CEO of the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a full-service, biologics Contract Research Organization (CRO) with global operations. They are innovation-driven and strategically positioned
- both geographically and scientifically - to provide customized and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">end-to-end</FONT></FONT> biologics services. IPA offers a cohesive and extensive portfolio in the protein and
antibody research, manufacturing and validation continuum. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise operates from laboratory facilities located Oss and Utrecht, The Netherlands,
and Victoria, British Columbia, with the headquarters situated in the U.S. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward Looking Information </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking
statements&#148; within the meaning of applicable Canadian securities </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and
similar expressions to identify forward-looking statements. Any such forward-looking statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and
expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause
ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower
than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and analysis for the fiscal year ended April 30, 2018 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking
statements&#148; contained herein speak only as of the date of this press release and, unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information,
future events or otherwise. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View original content to download multimedia: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.newswire.ca/en/releases/archive/August2019/28/c5390.htm</U><U>l</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-</FONT></FONT> <FONT STYLE="white-space:nowrap">863-7071,</FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 18:33e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">28-AUG-19</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.11
<SEQUENCE>12
<FILENAME>d20922dex9911.htm
<DESCRIPTION>EX-99.11
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.11</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.11 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Date: August&nbsp;29, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g0910042434445.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">510&nbsp;Burrard&nbsp;St,&nbsp;3rd&nbsp;Floor<BR>Vancouver&nbsp;BC,V6C&nbsp;3B9<BR><U>www.computershare.com</U></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To: All Canadian Securities Regulatory Authorities </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Subject: IMMUNOPRECISE ANTIBODIES LTD. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Sir/Madam:
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Meeting Type :</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Annual General Meeting</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Record Date for Notice of Meeting :</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">September&nbsp;25, 2019</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Record Date for Voting (if applicable) :</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">September&nbsp;25, 2019</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Beneficial Ownership Determination Date :</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">September&nbsp;25, 2019</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Meeting Date :</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">November 06, 2019</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Meeting Location (if available) :</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Vancouver, BC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Issuer sending proxy related materials directly to NOBO:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Yes</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Issuer paying for delivery to OBO:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Notice and Access (NAA) Requirements:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NAA for Beneficial Holders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NAA for Registered Holders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting Security Details: </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Description</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>CUSIP Number</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>ISIN</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">COMMON SHARES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">45257F101</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">CA45257F1018</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sincerely, </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Computershare
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Agent for IMMUNOPRECISE ANTIBODIES LTD. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.12
<SEQUENCE>13
<FILENAME>d20922dex9912.htm
<DESCRIPTION>EX-99.12
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.12</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.12 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g0910042554707.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Launches Abthena<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> Bispecific Platform And Artemis<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP> Intelligence Metadata (AIM) </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, Sept. 23, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the
&#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTCQB: IPATF), an industry leader in the discovery of novel, therapeutic antibodies, announces its Abthena<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> bispecific antibody
platform and the complementary Artemis<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> Intelligence Metadata (AIM)<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> suite. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Bispecific antibodies are a class of engineered antibodies and antibody-like proteins that, in contrast to traditional, monospecific antibodies, do not occur
naturally. Abthena<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> bispecifics have the ability to bind two different molecules with a single antibody, increasing the therapeutic effectiveness of targeting infectious diseases, payload
delivery and functional activity toward challenging targets. Alternatively, Abthena<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> products can be used to &#145;dual target&#146;, allowing detection or binding of a target cell type with much
higher specificity than traditional, monospecific antibodies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At ImmunoPrecise, we have designed an advanced discovery platform for wild-type and fully
human bispecific antibody components, which allows for the generation of heterodimer, optimized, IgG backbones with validated binding attributes. Abthena<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> produces yields comparable to its
monospecific equivalents, with a high degree of dimer formation, a platform which blends seamlessly with Artemis Intelligence Metadata (AIM)<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> capabilities to enable rapid turnaround on additional
algorithmic outputs in therapeutic optimization, stability, affinity and manufacturability. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is an international, full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell Select<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP> single-cell interrogation technology; DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP>, for custom, synthetic DNA libraries, and the Abthena<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP> bispecific program. IPA is focused on the next generation of antibody discovery, to deliver the most therapeutically relevant antibodies, in a shorter period of time, with the highest probability of
succeeding to clinical trials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise discovery and development are conducted in Utrecht and Oss, the Netherlands
<FONT STYLE="white-space:nowrap">(U-Protein</FONT> Express and IPA Europe, respectively), and in Victoria, British Columbia (IPA Canada). The Company operates globally to offer a continuum of superior antibody services, transforming the face of
therapeutic discovery, by decreasing turnaround time and risk, and promoting clinical success. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward Looking Information </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148;
within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and
similar expressions to identify forward-looking statements. Any such forward-looking statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and
expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause
ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower
than </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and analysis for the fiscal year ended April&nbsp;30, 2018 which can be accessed at
<U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such
information, whether as a result of new information, future events or otherwise. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View original content to
download multimedia: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.newswire.ca/en/releases/archive/September2019/23/c7987.htm</U><U>l</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 08:53e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">23-SEP-19</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.13
<SEQUENCE>14
<FILENAME>d20922dex9913.htm
<DESCRIPTION>EX-99.13
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.13</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.13 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g0910042554707.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise&#146;s Talem Therapeutics Enters into an LOI with AgonOx Pharma in the Advancement of Novel,
Immuno-Oncology Therapeutics </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, Sept. 24, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE:
IPA) (OTCQB: IPATF), an industry leader in the discovery of novel, therapeutic antibodies, announces that Talem Therapeutics, its wholly-owned subsidiary, has entered into an LOI to form a Joint Venture as it partners in the continued development of
antibody therapeutics to target T cell mediated anti-tumor activity, with AgonOx, a clinical-stage biopharma company. AgonOx specializes in identifying and developing immuno-oncology therapeutics. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AgonOx&#146;s approach to target discovery begins with genomic and proteomic analyses of tumor-infiltrating lymphocytes isolated from human tumor biopsies.
Candidates are further validated in the laboratory by utilizing an array of <I>in vitro </I>and <I>in vivo </I>systems. The partnership with Talem is addressing targets involved in T cell mediated anti-cancer activity, with therapeutics that, in
preliminary, in vivo-validated animal models of established tumors, have demonstrated significant tumor reduction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This partnership will advance two of
AgonOx&#146;s top 10 candidates to emerge from its translational science platform focused on modulation of the tumor microenvironment and, if commercialized, may result in approximately $720&nbsp;million USD comprised of licensing fees, as well as
development and commercial milestones in addition to royalties on worldwide sales. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Andrew Weinberg, President and CSO of AgonOx, stated
&#147;Collaborating with Talem strengthens our efforts to develop immuno-oncology drug candidates by leveraging IPA&#146;s ability to address challenging targets, with the deep mining of the immune repertoire in a species agnostic manner. This LOI
supports AgonOx&#146;s mission of discovering and delivering science that can change the standard of care for patients with cancer. ImmunoPrecise has first-rate scientists that we hope to work with for years to come.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Talem will leverage the internal development capabilities of ImmunoPrecise, including high throughput, rapid identification of candidates through single cell
interrogation, as well as accessing synthetic and natural immune phage libraries, and its bispecific platform, Abthena<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP>. All of these technologies integrate seamlessly with IPA&#146;s integrated
Artemis<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> Intelligence Metadata (AIM)<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> capabilities to enable rapid turnaround on additional outputs in therapeutic optimization, stability,
affinity, and manufacturability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Both companies will aid in the functional analyses of the candidates, while AgonOx also pulls from its experience in <FONT
STYLE="white-space:nowrap">pre-clinical</FONT> and clinical development, built, in part, on access to physicians and relevant samples through their alignment with the Earl A. Chiles Research Institute at the Providence Cancer Institute. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We look forward to advancing the development of these candidates toward an Investigational New Drug filing. AgonOx has extensive expertise in validating
the expression and function of biologically relevant immuno-oncology targets&#148; said Jennifer Bath, CEO of ImmunoPrecise. &#147;We see significant advantages from Talem and AgonOx leadership sharing knowledge across antibody discovery,
development, <FONT STYLE="white-space:nowrap">pre-clinical</FONT> and clinical trials. This partnership will enhance the companies&#146; pipelines of novel, monoclonal antibodies that could transform the standard of care for patients with advanced
cancers.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About AgonOx </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AgonOx, Inc. is a <FONT
STYLE="white-space:nowrap">spin-off</FONT> company from the Providence Cancer Institute located in Portland, Oregon, developing immune system modulators for use in cancer therapy. <FONT STYLE="white-space:nowrap">T-cell</FONT> modulation has
improved outcomes in several indications and AgonOx works to expand this benefit with novel agents and combination therapies. The founders of AgonOx were the first to identify and develop anti-OX40 as a cancer therapy and, along with the Providence
Cancer Institute, brought the first OX40 agent into clinical trials. Utilizing bioinformatics and <I>in vitro </I>and <I>in vivo </I>assay systems, AgonOx has identified novel immune-related pathways and develops new targets to generate future
therapies for cancer patients. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is an international, full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell Select
progressive, single-cell interrogation technology and the DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> custom phage libraries, as well as the Abthena<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> bispecific program.
IPA is focused on the next generation of antibody discovery, to deliver the most therapeutically relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise discovery and development are conducted in Utrecht and Oss, the Netherlands <FONT STYLE="white-space:nowrap">(U-Protein</FONT> Express and IPA
Europe, respectively), and in Victoria, British Columbia (IPA Canada). The Company operates globally to offer a continuum of superior antibody services, transforming the face of therapeutic discovery, by decreasing turnaround time and risk, and
promoting clinical success. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward Looking Information </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148;
within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and
similar expressions to identify forward-looking statements. Any such forward-looking statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and
expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause
ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower
than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and analysis for the fiscal year ended April 30, 2018 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking
statements&#148; contained herein speak only as of the date of this press release and, unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information,
future events or otherwise. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922g24r30.jpg" ALT="LOGO">
 View original content to download multimedia: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">http://www.prnewswire.com/news-releases/immunoprecises-talem-therapeutics-enters-into-an-loi-with-agonox-pharma-in-the-advancement-of-novel-
</FONT></FONT></FONT></FONT></FONT></FONT></FONT></FONT><BR>immuno-oncolo</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View original content to download multimedia: <U>http://www.newswire.ca/en/releases/archive/September2019/24/c6164.htm</U>l </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 08:45e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">24-SEP-19</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.14
<SEQUENCE>15
<FILENAME>d20922dex9914.htm
<DESCRIPTION>EX-99.14
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.14</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.14 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g20922g0910043934869.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR THE THREE MONTHS ENDED JULY&nbsp;31, 2019 AND 2018 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited &#150; Expressed in Canadian Dollars) </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF NO AUDITOR REVIEW OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying unaudited condensed interim consolidated financial statements of the Company and all information contained in the first quarter 2020 report
have been prepared by and are the responsibility of the Company&#146;s management. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit Committee of the Board of Directors has reviewed the
condensed interim consolidated financial statements and related financial reporting matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s independent auditor has not performed a
review of these condensed interim consolidated financial statements in accordance with standards established by the Chartered Professional Accountants of Canada for a review of condensed interim consolidated financial statements by an entity&#146;s
auditor. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDENSED INTERIM CONSOLIDATED STATEMENTS OF FINANCIAL POSITION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Note</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>July 31,</B><br><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April 30,</B><br><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ASSETS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,951,871</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,471,650</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,341,193</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,558,354</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,019,068</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,120,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">237,481</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">393,451</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">318,530</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">333,702</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,868,143</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,877,971</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,916</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,450</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>7</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>8</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,075,172</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,638,549</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>6,&nbsp;7,&nbsp;9</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,776,735</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,417,231</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>5, 6</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,019,458</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,254,114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,866,828</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,345,719</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>LIABILITIES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>14</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,274,988</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,594,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">168,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">813,821</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">724,693</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>10</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,804,090</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,708,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>11</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">77,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82,953</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>12</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">341,597</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,757</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>5, 6</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,973,491</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,031,237</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,454,091</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,204,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>11</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,968</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,717</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>12</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,383,682</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,320</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>5, 6</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,428,644</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,032,744</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,884,419</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,939,559</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,164,804</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,276,644</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>SHAREHOLDERS&#146; EQUITY</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>13</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,725,780</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,699,425</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subscriptions received</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>13</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contributed surplus</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>13</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,348,832</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,074,192</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(830,664</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(228,060</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19,543,424</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,476,482</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,702,024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,069,075</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities and equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,866,828</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,345,719</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nature of operations (Note 1) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Commitments (Note 15) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Approved and authorized on behalf of the
Board of Directors on September&nbsp;26, 2019 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<I>James
Kuo&#148;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</I>
</U>Director&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;</U><I><U>Greg Smith</U></I><U>&#148;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</U>Director </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes
are an integral part of these condensed interim consolidated financial statements </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDENSED INTERIM CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three months ended July 31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Note</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>REVENUE</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,716,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,872,785</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>COST OF SALES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,339,693</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,304,959</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>GROSS PROFIT</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,376,406</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,567,826</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>EXPENSES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Advertising</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">117,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53,769</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization and depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>8,&nbsp;9</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">547,841</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,562</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Consulting fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,340</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">163,320</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange gain</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(112,976</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82,490</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Insurance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,531</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,055</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest and bank charges</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">118,960</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">118,431</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Management fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>14</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,148</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46,298</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Office and general</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">223,335</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">143,540</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Professional fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>14</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">149,720</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">277,803</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,165</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103,362</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repairs and maintenance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72,743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">167,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,788</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Salaries and benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>14</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,096,244</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">927,039</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>13, 14</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">285,995</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">311,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Telephone and utilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,764</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Travel</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">119,305</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73,028</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,852,168</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,438,712</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Loss before other income (expense) and income taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,475,762</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(870,886</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>OTHER INCOME (EXPENSE)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>5,&nbsp;6,&nbsp;9</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(552,893</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(237,539</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest and other income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,402</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,515</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(540,491</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(194,024</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Loss before income taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,016,253</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,064,910</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,055</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(37,452</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>NET LOSS FOR THE PERIOD</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,012,198</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,102,362</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ITEMS THAT MAY BE RECLASSIFIED SUBSEQUENTLY TO LOSS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange difference on translating foreign operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(602,604</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(384,967</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>COMPREHENSIVE LOSS FOR THE PERIOD</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,614,802</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,487,329</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>LOSS PER SHARE &#150; BASIC AND DILUTED</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.03</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,982,923</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,941,298</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes
are an integral part of these condensed interim consolidated financial statements </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian dollars, except for share figures) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Share<BR>Capital</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Subscriptions</B><br><B>Received</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Contributed</B><br><B>Surplus</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated</B><br><B>Other<BR>Comprehensive<BR>(Loss) Income</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Deficit</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>55,474,178</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20,455,112</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,707,738</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>277,090</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(9,859,015</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>12,580,925</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to private placements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">875,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">700,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">700,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash issue costs and finders&#146; fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,926</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,926</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to option exercise</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">110,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,980</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,980</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">311,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">311,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss for the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(384,967</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,102,362</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,487,329</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, July&nbsp;31, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>56,459,178</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>21,202,166</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,994,458</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(107,877</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(10,961,377</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>12,127,370</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to private placements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,102,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,102,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,102,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash issue costs and finders&#146; fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">182,460</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(277,578</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(277,578</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustment to value of shares issued pursuant to acquisition of IPA Europe and Immulease</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">975,045</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">975,045</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to settlement of Debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,377,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,115,370</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">283,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,398,370</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to Crossbeta settlement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78,514</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to deferred acquisition payment to IPA Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">714,793</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">507,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">507,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to option exercise</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,178</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,678</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">802,412</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">802,412</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss for the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(120,183</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,515,105</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,635,288</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>67,939,445</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>32,699,425</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,074,192</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(228,060</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(17,476,482</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>18,069,075</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adoption of IFRS 16 (Note 3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(54,744</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(54,744</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, May&nbsp;1, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>67,939,445</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>32,699,425</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,074,192</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(228,060</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(17,531,226</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>18,014,331</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to option exercise</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,355</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,355</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subscriptions received</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">285,995</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">285,995</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss for the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(602,604</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,012,198</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,614,802</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, July&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>67,989,445</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>32,725,780</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,500</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,348,832</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(830,664</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(19,543,424</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>15,702,024</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes
are an integral part of these condensed interim consolidated financial statements </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three months ended July 31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss for the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,012,198</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,102,362</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Items not affecting cash:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization and depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">702,284</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">220,007</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(55,140</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(273,555</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">552,893</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">237,539</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(118,983</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">285,995</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">311,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(645,149</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(606,671</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in <FONT STYLE="white-space:nowrap">non-cash</FONT> working capital related to
operations:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">217,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">398,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">101,746</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">487</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">155,970</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">259,246</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,172</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54,605</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(319,074</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(290,719</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">141,532</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89,128</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,663</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(243,514</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(160,168</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Investing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(70,894</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,099</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Internally generated development costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,621</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividend received</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,460</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(81,515</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(18,639</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Financing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds on share issuance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">733,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,926</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subscriptions received</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repayment of leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(105,075</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from loans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loan repayments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(20,398</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(50,431</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash (used in) provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(108,973</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">871,643</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(Decrease) increase in cash during the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(434,002</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">692,836</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(116,311</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(137,945</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash &#150; beginning of the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,539,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,806,133</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash &#150; end of the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,988,787</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,361,024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash paid for interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,196</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,218</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash paid for income tax</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,315</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Supplemental cash flow information (Note 17) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes
are an integral part of these condensed interim consolidated financial statements </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three months ended July 31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>NATURE OF OPERATIONS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd. (the &#147;Company&#148; or &#147;IPA&#148;) was incorporated under the laws of Alberta on November&nbsp;22,
1983. The Company is listed on the TSX Venture Exchange (the &#147;Exchange&#148;) as a Tier 2 life science issuer under the trading symbol &#147;IPA&#148;. The Company&#146;s OTC symbol is &#147;IPATF&#148;. The Company is a supplier of custom
hybridoma development services. The address of the Company&#146;s corporate office is 3204 &#150; 4464 Markham Street, Victoria, BC, Canada V8Z 7X8. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The condensed interim consolidated financial statements have been prepared on the basis of accounting principles applicable to a going concern.
This assumes the Company will continue in operation for the foreseeable future and will be able to realize its assets and discharge its obligations in the normal course of operations. The Company has incurred operating losses since inception,
including $2,012,198 for the three months ended July 31, 2019 and has accumulated a deficit of $19,543,424 as at July 31, 2019. The Company may need to raise additional funds in order to continue on as a going concern and there can be no assurances
that sufficient funding, including adequate financing, will be available. The ability of the Company to arrange additional financing in the future depends in part, on the prevailing capital market conditions and profitability of its operations.
These material uncertainties may cast significant doubt on the Company&#146;s ability to continue as a going concern. Accordingly, the condensed interim consolidated financial statements do not give effect to adjustments that would be necessary
should the Company be unable to continue as a going concern and therefore be required to realize its assets and liquidate its liabilities, contingent obligations and commitments other than in the normal course of business and at amounts different
from those in the condensed interim consolidated financial statements. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>BASIS OF PRESENTATION </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(a) Statement of compliance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">These condensed interim consolidated financial statements have been prepared in conformity with International Accounting Standard
(&#147;IAS&#148;) 34, <I>Interim Financial Reporting</I>, using the same accounting policies as detailed in the Company&#146;s audited annual financial statements for the year ended April&nbsp;30, 2019. They do not include all the information
required for complete annual financial statements in accordance with International Financial Reporting Standards (&#147;IFRS&#148;), as issued by the International Accounting Standards Board (&#147;IASB&#148;) and interpretations of the
International Financial Reporting Interpretations Committee (&#147;IFRIC&#148;) and therefore should be read together with the audited annual financial statements for the year ended April&nbsp;30, 2019. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">These condensed interim consolidated financial statements were approved by the Board of Directors for issue on September&nbsp;26, 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(b) Basis of measurement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">These condensed interim consolidated financial statements have been prepared on the historical cost basis. In addition, these condensed interim
consolidated financial statements have been prepared using the accrual basis of accounting, except for cashflow information. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(c) Basis
of consolidation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">These condensed interim consolidated financial statements include the financial statements of the Company and the
following subsidiaries which are wholly owned and subject to control by the Company: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three months ended July 31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Name of Subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">%&nbsp;Equity<br><FONT STYLE="white-space:nowrap">Interest&nbsp;-&nbsp;2020</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">%&nbsp;Equity<BR><FONT STYLE="white-space:nowrap">Interest&nbsp;-&nbsp;2019</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Country of<BR>Incorporation</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (Canada) Ltd. (formerly 0496106 B.C. Ltd.)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Canada</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (USA) Ltd.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">USA</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (N.D.) Ltd.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">USA</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (MA) LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">USA</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Talem Therapeutics LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">USA</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">U-Protein</FONT> Express B.V.
<FONT STYLE="white-space:nowrap">(&#147;U-Protein&#148;)</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Netherlands</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Netherlands B.V.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Netherlands</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (Europe) B.V. (&#147;IPA Europe&#148;, formerly ModiQuest Research
B.V.)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Netherlands</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Immulease B.V. (&#147;Immulease&#148;)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Netherlands</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Control is achieved when the Company has the power to, directly or indirectly, govern the financial and
operating policies of an entity so as to obtain benefits from its activities. Subsidiaries are fully consolidated from the date on which control is obtained and continue to be consolidated until the date that such control ceases. Intercompany
balances, transactions and unrealized intercompany gains and losses are eliminated upon consolidation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(d) Functional and presentation
currency </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The functional currency of a company is the currency of the primary economic environment in which the company operates. The
presentation currency for a company is the currency in which the company chooses to present its financial statements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The functional
currency of the Company and ImmunoPrecise Antibodies (Canada) Ltd. is the Canadian dollar. The functional currency of ImmunoPrecise Antibodies (USA) Ltd., ImmunoPrecise Antibodies (N.D.) Ltd., ImmunoPrecise Antibodies (MA) LLC and Talem Therapeutics
LLC is the US dollar. The functional currency of <FONT STYLE="white-space:nowrap">U-Protein,</FONT> ImmunoPrecise Netherlands BV, IPA Europe and Immulease is the Euro. The presentation currency of the Company is the Canadian dollar. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Entities whose functional currencies differ from the presentation currency are translated into Canadian dollars as follows: assets and
liabilities &#150; at the closing rate as at the reporting date, and income and expenses &#150; at the average rate of the period. All resulting changes are recognized in other comprehensive income as cumulative translation differences. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Transactions in foreign currencies are translated into the functional currency at exchange rates at the date of the transactions. Foreign
currency monetary assets and liabilities are translated at the functional currency exchange rate at the reporting date. <FONT STYLE="white-space:nowrap">Non-monetary</FONT> items that are measured in terms of historical cost in a foreign currency
are translated using exchange rates as at the dates of the initial transactions. <FONT STYLE="white-space:nowrap">Non-monetary</FONT> items measured at fair value in a foreign currency are translated using the exchange rates at the date when the
fair value is determined. All gains and losses on translation of these foreign currency transactions are included in profit or loss. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">When
the Company disposes of its entire interest in a foreign operation, or loses control, joint control, or significant influence over a foreign operation, the foreign currency gains or losses accumulated in other comprehensive income related to the
foreign operation are recognized in profit or loss. If an entity disposes of part of an interest in a foreign operation which remains a subsidiary, a proportionate amount of foreign currency gains or losses accumulated in other comprehensive income
related to the subsidiary are reallocated between controlling and <FONT STYLE="white-space:nowrap">non-controlling</FONT> interests. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three months ended July 31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ADOPTION OF NEW ACCOUNTING STANDARDS AND ACCOUNTING STANDARDS ISSUED BUT NOT YET EFFECTIVE
</B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(a) Adoption of New Accounting Standards </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has adopted the following new standards, along with any consequential amendments, effective May&nbsp;1, 2019. These changes were
made in accordance with the applicable transitional provisions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company adopted all of the requirements of IFRS 16, <I>Leases
</I>(&#147;IFRS 16&#148;) as of May&nbsp;1, 2019. IFRS 16 replaces IAS 17, <I>Leases </I>(&#147;IAS 17&#148;). IFRS 16 provides a single lessee accounting model, requiring lessees to recognize assets and liabilities for all leases unless the lease
term is 12 months or less or the underlying asset has a low value. The Company has adopted IFRS 16 using the modified retrospective application method, where the 2019 comparatives are not restated and a cumulative catch up adjustment is recorded on
May&nbsp;1, 2019 for any differences identified, including adjustments to opening deficit balance. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company analyzed its contracts to
identify whether they contain a lease arrangement for the application of IFRS 16. The following is the Company&#146;s new accounting policy for leases under IFRS 16: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">At inception of a contract, the Company assesses whether the contract is, or contains, a lease. A contract is, or contains, a lease if the
contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Leases of <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets are recognized at the lease commencement date at the present value of the lease payments that are not paid at that date. The lease payments are discounted
using the interest rate implicit in the lease, if that rate can be readily determined, and otherwise at the Company&#146;s incremental borrowing rate. At the commencement date, a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset is measured at cost, which is comprised of the initial amount of the lease liability adjusted for any lease payments made at or before the
commencement date, plus any decommissioning and restoration costs, less any lease incentives received. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Each lease payment is allocated
between repayment of the lease principal and interest. Interest on the lease liability in each period during the lease term is allocated to produce a constant periodic rate of interest on the remaining balance of the lease liability. Except where
the costs are included in the carrying amount of another asset, the Company recognizes in profit or loss (a)&nbsp;the interest on a lease liability and (b)&nbsp;variable lease payments not included in the measurement of a lease liability in the
period in which the event or condition that triggers those payments occurs. The Company subsequently measures a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset at cost less any accumulated
depreciation and any accumulated impairment losses; and adjusted for any remeasurement of the lease liability. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> assets are depreciated over the shorter of
the asset&#146;s useful life and the lease term, except where the lease contains a bargain purchase option a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset is depreciated over the asset&#146;s
useful life. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On the date of transition, the Company recorded a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset of $1,668,533 related to the office rent in property and equipment, and the lease obligation of $1,723,277 was recorded as at May&nbsp;1, 2019,
discounted using the Company&#146;s incremental borrowing rate of 8%, and measured at an amount equal to the lease obligation as if IFRS 16 had been applied since the commencement date. The net difference between
<FONT STYLE="white-space:nowrap">right-of-use</FONT> assets and lease liabilities on the date of transition was recognized as a deficit adjustment of $54,744 on May&nbsp;1, 2019. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three months ended July 31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(b) Accounting Standards Issued But Not Yet Effective </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In October 2018, the IASB issued amendments to IFRS 3, Business Combinations. The amendments narrowed and clarified the definition of a
business. The amendments will help companies determine whether an acquisition is a business or a group of assets. They also permit a simplified assessment of whether an acquired set of activities and assets is a group of assets rather than a
business. Distinguishing between a business and a group of assets is important because an acquirer recognizes goodwill only when acquiring a business. This amendment will be effective for annual periods beginning on or after January&nbsp;1, 2020.
Early adoption is permitted. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CRITICAL ACCOUNTING ESTIMATES AND JUDGMENTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The preparation of the condensed interim consolidated financial statements in conformity with IFRS required estimates and judgments that affect
the amounts reported in the financial statements. Actual results could differ from these estimates and judgments. Estimates are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the year in which the estimate is
revised. Significant areas requiring the use of estimates and judgments are as follows: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Functional currency </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has used judgment in determining the currency of the primary economic environment in which the entity operates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Amounts receivable </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The
Company monitors the financial stability of its customers and the environment in which they operate to make estimates regarding the likelihood that the individual trade receivable balances will be paid. Credit risks for outstanding customer
receivables are regularly assessed and allowances are recorded for estimated losses, if required. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Property and equipment </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has used estimates in the determination of the expected useful lives of property and equipment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Revenue recognition </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">percentage-of-completion</FONT></FONT> method requires the use of estimates to determine the stage of completion which is used to determine the recorded amount of revenue, unbilled revenue
and deferred revenue on uncompleted contracts. The determination of anticipated revenues includes the contractually agreed revenue and may also involve estimates of future revenues if such additional revenues can be reliably estimated and it is
considered probable that they will be recovered. The determination of anticipated costs for completing a contract is based on estimates that can be affected by a variety of factors, including the cost of materials, labour, and <FONT
STYLE="white-space:nowrap">sub-contractors.</FONT> The determination of estimates is based on the Company&#146;s business practices as well as its historical experience. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Impairments </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the
purposes of assessing impairment, assets are grouped at the lowest levels for which there are separately identifiable cash flows (&#147;cash generating units&#148; or &#147;CGU&#148;s). Each asset or CGU is evaluated every reporting period to
determine whether there are any indicators of impairment. If any such indicators exist, which is often judgment-based, a formal estimate of recoverable amount is performed and an impairment charge is recognized to the extent that the carrying amount
exceeds the recoverable amount. The recoverable amount of an asset or CGU of assets is measured at the higher of fair value less costs of disposal or value in use. These determinations and their individual assumptions require that management make a
decision based on the best available information at each reporting period. The estimates and assumptions are subject to risk and uncertainty; hence, there is the possibility that changes in circumstances will alter these projections, which may
impact the recoverable amount of the assets. In such circumstances, some or all of the carrying value of the assets may be further impaired or the impairment charge reversed with the impact recorded in profit or loss. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three months ended July 31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company performs a goodwill impairment test annually and when circumstances indicate that
the carrying value may not be recoverable. For the purposes of impairment testing, goodwill acquired through business combinations has been allocated to two different CGUs. The recoverable amount of each CGU was based on value in use, determined by
discounting the future cash flows to be generated from the continuing use of the CGU. The cash flows were projected over a five-year period based on past experience and actual operating results. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company performed its annual goodwill impairment test in April 2019 and no impairment was indicated for the period tested. The values
assigned to the key assumptions represented management&#146;s assessment of future trends in the industry and were based on historical data from both internal and external sources. Weighted average costs of capital of 17.5% and 10.2%, respectively,
was used in the assessments of the two CGUs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Determination of segments </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">An operating segment is a component of the Company that engages in business activities from which it may earn revenues and incur expenses. All
operating segments&#146; results are reviewed by the Company&#146;s management in order to make decisions regarding the allocation of resources to the segment. Segment results include items directly attributable to a segment as those that can be
allocated on a reasonable basis. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As the Company provides antibody production and related services in one distinct category, there is only
one category to report revenues by production site. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Life of intangible assets </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Intangible assets are amortized based on estimated useful life less their estimated residual value. Significant assumptions are involved in the
determination of useful life and residual values and no assurance can be given that actual useful lives and residual values will not differ significantly from current assumptions. Actual useful life and residual values may vary depending on a number
of factors including internal technical evaluation, attributes of the assets and experience with similar assets. Changes to these estimates may affect the carrying value of assets, net income (loss) and comprehensive income (loss) in future periods.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Purchase price allocation </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The acquisition of <FONT STYLE="white-space:nowrap">U-Protein</FONT> on August 22, 2017 and the acquisition of IPA Europe and Immulease on
April 5, 2018 were accounted for as business combinations at fair value in accordance with IFRS 3, <I>Business Combinations</I>. The acquired assets and assumed liabilities were adjusted to their fair values assigned through completion of a purchase
price allocation, as described below. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The purchase price allocation process resulting from a business combination requires management to
estimate the fair value of identifiable assets acquired including intangible assets and liabilities assumed including the deferred acquisition payment obligations. The Company uses valuation techniques, which are generally based on forecasted future
net cash flows discounted to present value, and also relies on work performed by third-party valuation specialists. These valuations are closely linked to the assumptions used by management on the future performance of the related assets and the
discount rates applied. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ACQUISITION OF <FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On August 22, 2017, the Company completed the acquisition of <FONT STYLE="white-space:nowrap">U-Protein</FONT> whereby the Company has acquired
all of the issued and outstanding shares of <FONT STYLE="white-space:nowrap">U-Protein</FONT> for &#128;6,830,000 on terms as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,734,732 (CAD$4,062,607) was paid in cash on closing; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three months ended July 31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3,030,503 common shares of the Company were issued on closing; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,047,634 in deferred payments over a three-year period. The deferred payments can be made in cash or
common shares of the Company at the election of <FONT STYLE="white-space:nowrap">U-Protein</FONT> shareholders. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The
transaction was accounted for as a business combination, as the operations of <FONT STYLE="white-space:nowrap">U-Protein</FONT> meet the definition of a business. As the transaction was accounted for as a business combination, transaction costs of
$17,717 were expensed. The goodwill resulting from the allocation of the purchase price to the total fair value of net assets represented the sales and growth potential of <FONT STYLE="white-space:nowrap">U-Protein.</FONT> Goodwill recorded is
allocated in its entirety to <FONT STYLE="white-space:nowrap">U-Protein.</FONT> The fair value of the 3,030,503 common shares issued ($3,022,308) was determined based on the Canadian dollar equivalent of the consideration required of &#128;2,047,634
pursuant to the share purchase agreement. The Company has allocated the purchase price as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,062,607</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3,030,503 common shares of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,022,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of deferred payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,134,410</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,219,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">797,276</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">370,530</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,815</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment, net of accumulated amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">216,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intellectual property (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,064,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,655,893</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(269,657</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income taxes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,197</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(810,800</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,219,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The deferred payments of &#128;2,047,634 over a three-year period was fair valued on the date of acquisition
using a discounted cash flow model. A discount rate of 16.3% was used. The changes in the value of the deferred payments during the three months ended July&nbsp;31, 2019 and the year ended April&nbsp;30, 2019 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,408,205</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">244,915</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,049,754</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(40,670</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,562,696</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">284,166</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(91,596</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, July&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,755,266</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ACQUISITION OF IPA EUROPE AND IMMULEASE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company acquired all of the issued and outstanding shares of IPA Europe and its sister entity, Immulease, for an
aggregate purchase price of &#128;7,000,000 on terms as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,500,000 (CAD$3,988,132) was paid in cash on closing; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three months ended July 31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">6,600,399 common shares of the Company were issued on closing; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,000,000 in deferred payments over a three-year period. The deferred payments will be made in three equal
installments of cash and equity totaling &#128;666,666 and will be prorated if the EBITDA of IPA Europe for the fiscal year preceding the date of payment is less than its average EBITDA over the previous two fiscal years. During the year ended
April&nbsp;30, 2019, the Company and the seller entered into an Amendment, Termination and Settlement Agreement whereby the deferred payments shall no longer be subject to an adjustment and will be paid in equal installments of cash and equity
totaling &#128;666,666. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The transaction was accounted for as a business combination, as the operations of IPA Europe and
Immulease meet the definition of a business. As the transaction was accounted for as a business combination, transaction costs of $36,821 were expensed. The goodwill resulting from the allocation of the purchase price to the total fair value of net
assets represented the sales and growth potential of IPA Europe. Goodwill recorded is allocated in its entirety to IPA Europe. The fair value of the 6,600,399 common shares issued ($4,884,295) was determined to be $0.74 per share based on the fair
value of the Company&#146;s shares immediately prior to the completion of the acquisition. The Company has allocated the purchase price as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,988,132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6,600,399 common shares of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,884,295</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of deferred payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,353,708</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,226,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">270,339</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">572,427</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,286,995</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment, net of accumulated amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">568,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Software</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible assets (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,304,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,640,671</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(580,339</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(22,897</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(298,979</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,636,192</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,226,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The deferred payments of &#128;2,000,000 over a three-year period was fair valued on the date of acquisition
using a discounted cash flow model. A discount rate of 10.1% was used. The changes in the value of the deferred payments during the three months ended July&nbsp;31, 2019 and the year ended April&nbsp;30, 2019 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,403,954</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in estimate of fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(34,258</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">232,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,014,503</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(86,326</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,501,285</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">172,971</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(27,387</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, July&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,646,869</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three months ended July 31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INVESTMENT </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Investment consists of a 29% (2019 &#150; 29%) interest in QVQ Holding B.V. (&#147;QVQ&#148;), which is recorded at cost, being the best
approximation of the investment&#146;s fair value. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Judgment is required as to the extent of influence that the Company has over QVQ. The
Company considered the extent of voting power over the entity, the power to participate in financial and operating policy decisions of the entity, representation on the board of directors, material transactions between the entities, interchange of
management personnel, and provision of essential technical information. The Company has determined that the Company is not considered to have significant influence over QVQ, as the Company does not have the power to participate in financial and
operating policy decisions, does not have representation on the Board of Directors of QVQ, and the majority of the common shares are held by QVQ management. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>PROPERTY AND EQUIPMENT </B></P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Computer</B><br><B>Hardware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Furniture&nbsp;&amp;</B><br><B>Equipment</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Computer</B><br><B>Software</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Building</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Leasehold</B><br><B>Improvements</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Lab</B><br><B>Equipment</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93,813</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98,527</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,373</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">393,421</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,787,105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,385,239</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquired on acquisition of IPA Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,184</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,538</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87,821</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">612,046</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">729,589</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,153</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,141</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(31,294</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">110,997</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,065</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">130,015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">393,421</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,369,010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,114,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,952</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,668,533</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66,942</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,739,427</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(848</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(54,746</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(55,594</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, July&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>114,949</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>111,065</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>129,167</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,668,533</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>393,421</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,381,206</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,798,341</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated Depreciation:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,883</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,218</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,299</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,552,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,803,870</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,252</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,533</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103,764</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500,194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">677,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(43</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,029</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,072</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,636</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,789</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">205,816</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,047,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,475,959</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,905</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,803</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,938</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">108,920</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,588</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">125,408</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">282,562</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(248</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(35,104</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(35,352</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, July&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>93,040</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>87,439</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>72,479</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>108,920</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>223,404</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,137,887</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,723,169</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Book Value:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,429</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81,226</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">187,605</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,321,427</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,638,549</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>July&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>21,909</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>23,626</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>56,688</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,559,613</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>170,017</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,243,319</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,075,172</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three months ended July 31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INTANGIBLE ASSETS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The intangible assets were acquired as a result of the acquisitions of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe and are
amortized using the straight-line method over their useful lives. The intellectual property has a useful life of 10 years, and the proprietary processes and certifications have a useful life of 5 years. The changes in the value of the intangible
assets during the three months ended July 31, 2019 and the year ended April 30, 2019 are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Internally<BR>Generated<BR>Development</B><br><B>Costs</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Intellectual<BR>Property</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Proprietary<BR>Processes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Certifications</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,270,229</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,270,229</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquired on acquisition of IPA Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,159,755</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">145,108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,304,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(125,004</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(229,263</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,401</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(359,668</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,145,225</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,930,492</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">139,707</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,215,424</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,621</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,621</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(205</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(117,845</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(168,598</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,972</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(290,620</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, July&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>10,416</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,027,380</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,761,894</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>135,735</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>9,935,425</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated Amortization:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">227,746</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">227,746</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">416,890</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,169,233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,586,123</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,035</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,641</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(15,676</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">635,601</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,162,592</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,798,193</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">317,055</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">419,722</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(20,052</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(39,173</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(59,225</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, July&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>718,216</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,440,474</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,158,690</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Book Value:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,509,624</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,767,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">139,707</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,417,231</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>July&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>10,416</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,309,164</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,321,420</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>135,735</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,776,735</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DEBENTURES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company completed a nonconvertible debenture (the &#147;Debentures&#148;) financing in the principal amount of
$4,252,000 (the &#147;Offering&#148;). The Debentures are unsecured, bear interest at a rate of 10% per annum, payable semi-annually, and are due eighteen months from the date of issue. Under the Offering, a holder of a Debenture received 37,500
detachable share purchase warrants (the &#147;Warrants&#148;) for every $25,000 of Debentures subscribed for by the holder. The Warrants are exercisable at $0.70 per share for a period of four years from the date of issue. The fair value of the
Debentures at the time of issue was calculated as the discounted cash flows assuming a 15% effective interest rate. The fair value of the Warrants was determined at the time of issue as the difference between the face value and the fair value of the
Debentures. On initial recognition, the Company bifurcated $4,003,125 to the carrying value of the Debentures and $248,875 to the Warrants. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three months ended July 31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Under the Offering, the Company paid the following finder&#146;s fees: $10,300 in cash,
580,320 shares of the Company with a fair value of $383,010, and 415,942 finder&#146;s warrants valued at $187,627. The fair value of the finder&#146;s warrants was estimated on the date of issue using the Black-Scholes option valuation model with
the following weighted average assumptions: dividend yield of $nil, risk free interest rate of 1.60%, expected life of 4 years and expected volatility based on the historical volatility of similar companies of 100%. The total fair value of the
finder&#146;s fees was allocated <FONT STYLE="white-space:nowrap">pro-rata</FONT> based on the carrying values of the Debentures and Warrants, with $546,934 allocated to the Debentures and $34,003 allocated to the Warrants. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On October 25, 2018, the Company settled $1,377,000 of the Debentures by issuing 1,377,000 units at a price of $1.00 per unit. Each unit
consists of one common share of the Company and one share purchase warrant, with each warrant entitling the holder to purchase an additional share at $1.25 for two years. The fair value of the 1,377,000 common shares issued was determined to be
$1,115,370. The fair value of the warrants issued was determined to be $283,000 and estimated on the date of issue using the Black-Scholes option valuation model with the following weighted average assumptions: dividend yield of $nil, risk free
interest rate of 1.58%, expected life of 2 years and expected volatility based on the historical volatility of similar companies of 68.7%. The settlement resulted in a loss of $189,715. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the three months ended July&nbsp;31, 2019, the Company recorded accretion expense of $95,756 (2018 &#150; $123,372). The changes in the
value of the Debentures during the three months ended July&nbsp;31, 2019 and the year ended April&nbsp;30, 2019 are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,489,397</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">427,592</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Settlement of debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,208,655</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,708,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,756</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, July&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,804,090</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>LOANS PAYABLE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April 5, 2018, the Company assumed loans payable of &#128;60,750 (CAD$94,995) as a result of the acquisition of IPA Europe. On July 7, 2015,
IPA Europe entered into a loan agreement in the principal amount of &#128;165,000, maturing on July 31, 2020. The loan is secured by certain equipment, bears an interest rate of 4% per annum and is repayable in monthly installments of &#128;2,250.
The interest is owed per month in arrears. The principal outstanding at July&nbsp;31, 2019 is &#128;24,750 (CAD$36,202) (April 30, 2019 &#150; &#128;31,500 (CAD$47,423)). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April 5, 2018, the Company assumed loans payable of &#128;56,450 (CAD$88,271) as a result of the acquisition of IPA Europe. On February 1,
2016, IPA Europe entered into a loan agreement in the principal amount of &#128;100,000, maturing on February&nbsp;28, 2021. The loan is secured by certain equipment, bears an interest rate of 3% per annum and is repayable in monthly installments of
&#128;1,675. The interest is owed per month in arrears. The principal outstanding at July 31, 2019 is &#128;29,650 (CAD$43,369) (April 30, 2019 &#150; &#128;34,675 (CAD$52,203)). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company assumed loans payable of &#128;74,000 (CAD$115,713) as a result of the acquisition of Immulease. On
May&nbsp;18, 2016, Immulease entered into a credit facility agreement pursuant to which the lender provides a facility amount of up to &#128;200,000. The credit facility is unsecured, bears an interest rate of 3% per annum and is repayable on
demand. The interest is owed per month in arrears. The principal outstanding at July&nbsp;31, 2019 is &#128;8,000 (CAD$11,701) (April 30, 2019 &#150; &#128;8,000 (CAD$12,044)). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three months ended July 31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On May 23, 2018, the Company entered into a loan agreement with a Director of the Company and
his spouse and issued a promissory note in the principal amount of $200,000. The note was unsecured and bore an interest rate of 5.45% per annum. The principal of the note plus accrued interest of $3,972 was repaid in full during the year ended
April&nbsp;30, 2019. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">290,445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loan proceeds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loan repayments and foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(378,775</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,670</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loan repayments and foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(20,398</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, July&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">91,272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(77,304</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-current</FONT> portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,968</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>LEASES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company entered into certain equipment leases expiring between 2021 and 2023 with interest rates of between 13% and 17% per annum. The
Company&#146;s obligations under these finance leases are secured by the lessor&#146;s title to the leased assets. The Company also entered into office leases in January 2018 and May 2018. With the adoption of IFRS 16, <I>Leases </I>(see Note 3),
the Company recognized a lease obligation with regard to the office leases. The terms and the outstanding balances as at July&nbsp;31, 2019 and April&nbsp;30, 2019 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>July 31,</B><br><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April 30,</B><br><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment under finance lease repayable in monthly instalments of $1,228 with interests of between
13% and 17% per annum. Due dates are between May 2021 and March 2023.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98,527</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,077</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> asset
from office lease repayable in monthly instalments of $21,015 and an interest rate of 8% per annum and an end date of April&nbsp;2023.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">835,958</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> asset
from office lease repayable in monthly instalments of $22,012 and an interest rate of 8% per annum and an end date of December&nbsp;2022.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">790,794</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(341,597</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(35,757</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-current</FONT> portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,383,682</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,320</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As at July&nbsp;31, 2019, the Company&#146;s equipment includes a net carrying amount of $94,478 (April 30,
2019 &#150; $104,014) for the leased equipment. The net carrying amount of the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets from office lease obligation is $1,559,613 (April 30, 2019 &#150;
$nil). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following is a schedule of the Company&#146;s future minimum lease payments related to the equipment under finance lease and
the office lease obligation: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three months ended July 31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">423,840</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">565,122</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">552,739</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">446,989</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total minimum lease payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,988,690</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: imputed interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(263,411</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total present value of minimum lease payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,725,279</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Current portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(341,597</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-current</FONT> portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,383,682</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SHARE CAPITAL </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>a) Authorized: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Unlimited
common shares without par value. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>b) Share capital transactions: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>2019 Transactions </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On
June&nbsp;19, 2018, the Company closed a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement financing by issuing a total of 875,000 units of the Company at a price of $0.80 per unit for gross proceeds of $700,000. Each unit
consists of one common share of the Company and one share purchase warrant, with each warrant entitling the holder to purchase an additional share at a price of $1.00 for a period of one year from the date of issue. The Company will have the right
to accelerate the expiry date of the warrants provided that the volume weighted average price trades at a price equal to or greater than $1.50 for a period of 20 consecutive days. In the event of acceleration, the expiry date will be accelerated to
a date that is 30 days after the Company issues a news release announcing that it has elected to exercise this acceleration right. All of the proceeds have been allocated to the common shares issued with a $nil value assigned to the warrants issued.
The Company paid finders cash fees totaling $3,000 and incurred $7,926 of cash issue costs. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;24, 2018, the Company closed
a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement financing by issuing a total of 9,102,500 units of the Company at a price of $1.00 per unit for gross proceeds of $9,102,500. Each unit consists of one common share of the
Company and one share purchase warrant, with each warrant entitling the holder to purchase an additional share at a price of $1.25 for a period of two years from the date of issue. The Company will have the right to accelerate the expiry date of the
warrants provided that the volume weighted average price trades at a price equal to or greater than $1.75 for a period of 20 consecutive days. In the event of acceleration, the expiry date will be accelerated to a date that is 30 days after the
Company issues a news release announcing that it has elected to exercise this acceleration right. All of the proceeds have been allocated to the common shares issued with a $nil value assigned to the warrants issued. The Company paid finders cash
fees totaling $201,540 and issued 182,460 finder&#146;s shares. The Company also incurred $76,038 of cash issue costs. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On
December&nbsp;22, 2017, the Company announced that it had signed a binding letter of intent with Crossbeta Biosciences B.V. (&#147;Crossbeta&#148;) whereby the Company had agreed to acquire all of the issued and outstanding shares of Crossbeta. The
proposed transaction was terminated and settled on October&nbsp;23, 2018. In consideration of the settlement, the Company paid &#128;37,000 ($55,969) and issued 78,514 shares valued at $61,241. The Company accrued a settlement liability of $92,040
as at April&nbsp;30, 2018. As such, the remaining loss on settlement of $25,170 was recognized in the year ended April&nbsp;30, 2019. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three months ended July 31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On October 25, 2018, the Company settled $1,377,000 of the Debentures by issuing 1,377,000
units at a price of $1.00 per unit (Note 10). Each unit consists of one common share of the Company and one share purchase warrant, with each warrant entitling the holder to purchase an additional share at $1.25 for two years. The fair value of the
1,377,000 common shares issued was determined to be $1,115,370. The fair value of the warrants issued was determined to be $283,000 and estimated on the date of issue using the Black-Scholes option valuation model with the following weighted average
assumptions: dividend yield of $nil, risk free interest rate of 1.58%, expected life of 2 years and expected volatility based on the historical volatility of similar companies of 68.7%. The settlement resulted in a loss of $189,715. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;27, 2019, the Company issued 714,793 common shares pursuant to the second deferred payment to IPA Europe (Note 6). The common
shares are valued at $507,503. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2019, the Company issued 135,000 common shares pursuant to exercise of
stock options for total gross proceeds of $40,500. A value of $30,658 was transferred from contributed surplus to share capital as a result. The weighted average share price at dates the stock options were exercised was $1.05. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>2020 Transactions </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During
the three months ended July&nbsp;31, 2019, the Company issued 50,000 common shares pursuant to exercise of stock options for total gross proceeds of $15,000. A value of $11,355 was transferred from contributed surplus to share capital as a result.
The weighted average share price at dates the stock options were exercised was $0.69. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>c) Escrow </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">There are 1,627,945 common shares of the Company held in escrow as at July&nbsp;31, 2019. Under the Escrow Agreement, the common shares held in
escrow will be released from escrow on December&nbsp;29, 2019. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>d) Options </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has an incentive Stock Option Plan (&#147;the Plan&#148;) under which <FONT STYLE="white-space:nowrap">non-transferable</FONT>
options to purchase common shares of the Company may be granted to directors, officers, employees or service providers of the Company. The terms of the plan provide that the Directors have the right to grant options to acquire common shares of the
Company at not less than the closing market price of the shares on the day preceding the grant at terms of up to ten years. The maximum number of options outstanding under the Plan shall not result, at any time, in more than 10% of the issued and
outstanding common shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;24, 2018, the Company granted 95,000 stock options, exercisable at $0.95 per option, to
employees of the Company. The options are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date; <FONT STYLE="white-space:nowrap">one-third</FONT> 12 months after grant date and <FONT
STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $67,402 using the Black-Scholes option pricing model and the following assumptions: dividend yield of 0%, expected volatility
of 100%, a risk-free interest rate of 1.60%, and an expected life of 5 years. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On November&nbsp;7, 2018, the Company granted 300,000 stock
options, exercisable at $0.82 per option, to employees of the Company. The options are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date;
<FONT STYLE="white-space:nowrap">one-third</FONT> 12 months after grant date and <FONT STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $184,658 using the Black-Scholes
option pricing model and the following assumptions: dividend yield of 0%, expected volatility of 100%, a risk-free interest rate of 2.20%, and an expected life of 5 years. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three months ended July 31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;31, 2018, the Company granted 1,250,000 stock options, exercisable at $1.00
per option, to officers and directors of the Company. The options are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date; <FONT STYLE="white-space:nowrap">one-third</FONT> 12 months
after grant date and <FONT STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $625,485 using the Black-Scholes option pricing model and the following assumptions: dividend
yield of 0%, expected volatility of 100%, a risk-free interest rate of 2.20%, and an expected life of 5 years. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On January 11, 2019, the
Company granted 415,000 stock options, exercisable at $1.00 per option, to officers and an employee of the Company. The options are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant
date; <FONT STYLE="white-space:nowrap">one-third</FONT> 12 months after grant date and <FONT STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $228,801 using the Black-Scholes
option pricing model and the following assumptions: dividend yield of 0%, expected volatility of 100%, a risk-free interest rate of 2.20%, and an expected life of 5 years. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Expected volatility was based on the historical volatility of similar companies. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the three months ended July&nbsp;31, 2019 the Company has recorded $285,995 (2018 - $311,700) of share-based payments expense. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The changes in the stock options for the three months ended July 31, 2019 and the year ended April 30, 2019 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>options</B><br><B>#</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted<BR>average<BR>exercise&nbsp;price</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted<BR>average&nbsp;life<BR>remaining</B><br><B>(years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,871,666</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.68</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4.20</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,060,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(135,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expired</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(200,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,293,333</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,303,333</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.78</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3.87</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(50,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(50,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, July&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,203,333</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.78</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3.64</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,606,667</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Exercisable, July&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,596,666</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.73</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3.35</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Details of the options outstanding as at July&nbsp;31, 2019 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Expiry Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exercise&nbsp;price</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Remaining&nbsp;life</B><br><B>(year)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Options<BR>outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unvested</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Vested</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December&nbsp;20, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">658,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">658,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;18, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,035,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,035,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January&nbsp;3, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February&nbsp;7, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">700,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">233,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">466,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;24, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November&nbsp;7, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">833,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">416,666</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January&nbsp;11, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">415,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">276,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">138,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.78</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3.64</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,203,333</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,606,667</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,596,666</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three months ended July 31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>e) Warrants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The changes in the warrants for the three months ended July&nbsp;31, 2019 and the year ended April&nbsp;30, 2019 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="55%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>warrants</B><br><B>#</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;average<BR>exercise price</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;average&nbsp;life<BR>remaining (years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,378,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.70</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3.93</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issued</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,354,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2019 and July 31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>17,732,500</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1.04</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1.70</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Details of the warrants outstanding as at July&nbsp;31, 2019 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Expiry Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exercise&nbsp;price</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Remaining&nbsp;life</B><br><B>(year)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Warrants<BR>outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March&nbsp;26, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,378,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;18, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">875,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;24, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,102,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October&nbsp;25, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,377,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.04</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,732,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">During the three months ended July&nbsp;31, 2019, the expiry date of these warrants was extended from
June&nbsp;18, 2019 to June&nbsp;18, 2020. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>f) Finder&#146;s Warrants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As at July&nbsp;31, 2019 the Company has 415,942 finder&#146;s warrants outstanding. The warrants have an exercise price of $0.70 per share and
expire on March&nbsp;26, 2022. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>RELATED PARTY TRANSACTIONS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Key management personnel are those persons having authority and responsibility for planning, directing and controlling the activities of the
Company. Key management consists of Thomas D&#146;Orazio, former President and CEO; Robert Beecroft, former Interim CEO; Dr.&nbsp;Jennifer Bath, President and CEO; Lisa Helbling, CFO; Natasha Tsai, former CFO; Reginald Beniac, former Chief Operating
Officer; Charles Wheelock, Chief Technology Officer; Oren Beske, former President of ImmunoPrecise Antibodies (USA) Ltd.; Martin Hessing, a Director of <FONT STYLE="white-space:nowrap">U-Protein;</FONT> Jos Raats, former President and CEO of IPA
Europe; and Directors of the Company. During the three months ended July 31, 2019 and 2018, the compensation for key management is as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019<BR>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018<BR>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Management fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,148</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103,980</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Professional fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,075</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Salaries and other short-term benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">485,845</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">101,830</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">264,882</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,092</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">795,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">393,977</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three months ended July 31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the three months ended July 31, 2019, the spouse of a Director provided administrative
services for $nil (2018 &#150; $15,625). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>15.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>COMMITMENTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the Company&#146;s rental of office and laboratory space in Victoria, BC, Canada, the current lease commenced on May 1, 2018 and terminates
on April 30, 2023. The lease is in the amount of $21,015 per month for all four spaces from May&nbsp;1, 2018 to April&nbsp;30, 2021 and $21,914 per month from May&nbsp;1, 2021 to April&nbsp;30, 2023. The minimum annual payments under these leases
are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">252,186</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">252,186</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">262,968</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">262,968</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,030,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the Company&#146;s rental of office and laboratory space in Utrecht, Netherlands, the current lease
commenced on January&nbsp;1, 2017 and terminates on December&nbsp;31, 2019. Annual minimum lease payments are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&#128;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,415</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the Company&#146;s rental of office and laboratory space in Oss, Netherlands, the current lease commenced
on January&nbsp;1, 2018 and terminates on December&nbsp;31, 2019. Effective December&nbsp;31, 2018, the lease automatically rolls into a 3 year term through December&nbsp;31, 2022. Annual minimum lease payments are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&#128;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">116,970</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">643,332</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>16.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SEGMENTED INFORMATION AND ECONOMIC DEPENDENCE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">At July 31, 2019 and April 30, 2019, the Company has one reportable segment, being antibody production and related services. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the three months ended July&nbsp;31, 2019, the Company had sales to nil (2018 - nil) customer who in aggregate accounted for more than
10% (2018 &#150; 10%) of revenue. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s revenues are allocated to geographic segments for the three months ended July 31,
2019 and 2018 as follows: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three months ended July 31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019<BR>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018<BR>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">United States of America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">904,377</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">601,011</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Canada</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">206,823</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">140,632</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,505,926</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,057,779</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98,973</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73,363</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,716,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,872,785</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s revenues are allocated according to revenue types for the three months ended July&nbsp;31,
2019 and 2018 as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019<BR>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018<BR>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Project revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,611,868</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,760,773</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Product sales revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,234</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,941</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cryo storage revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,997</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81,071</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,716,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,872,785</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s <FONT STYLE="white-space:nowrap">non-current</FONT> assets are allocated to geographic
segments as at July&nbsp;31, 2019 and April&nbsp;30, 2019 as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>July 31,</B><br><B>2019<BR>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April 30,</B><br><B>2019<BR>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,674,974</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">986,323</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Netherlands</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">17,323,711</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">17,481,425</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,998,685</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,467,748</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Geographic segmentation of the Company&#146;s (loss) income is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019<BR>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018<BR>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America - Corporate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,974,763</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(600,917</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(112,064</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,057,389</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Netherlands</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74,629</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">555,944</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,012,198</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,102,362</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Geographic segmentation of the interest and accretion, and amortization and depreciation is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Interest and accretion</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019<BR>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018<BR>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America - Corporate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">630,675</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">345,959</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,918</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Netherlands</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,203</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,093</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">671,853</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">355,970</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three months ended July 31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Amortization and depreciation</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019<BR>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018<BR>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America - Corporate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,640</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">126,771</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,559</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Netherlands</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">554,873</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">183,448</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">702,284</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">220,007</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>17.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SUPPLEMENTAL CASH FLOW INFORMATION </B></P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B><FONT STYLE="white-space:nowrap">Non-cash</FONT> investing and
financing transactions:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>July 31,</B><br><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>July&nbsp;31,</B><br><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquisition of equipment by capital lease</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,668,533</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following changes in liabilities arose from financing activities: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="53%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-cash</FONT> changes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April 30,</B><br><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Cash<BR>Flows</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Acquisition</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accretion</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Foreign<BR>exchange<BR>movements<BR>and&nbsp;change<BR>in&nbsp;estimates</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>July 31,</B><br><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,063,981</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">457,137</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(118,983</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,402,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,708,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,756</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,804,090</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,670</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(20,398</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">91,272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,077</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(105,075</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,723,277</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,725,279</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,991,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(125,473</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,723,277</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">552,893</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(118,983</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,022,776</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>18.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SUBSEQUENT EVENTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>a) Exercise of Stock Options </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Subsequent to the three months ended July&nbsp;31, 2019, the Company issued 5,000 common shares pursuant to the exercise of stock options for
total gross proceeds of $1,500. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>b) Debentures </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;26, 2019, the company modified the terms of $2,750,000 debentures to extend the due date 6 months to March&nbsp;26, 2020,
with the ability to pay earlier with no penalty, and increase the interest rate to 12.5%. The remaining debentures of $125,000 were paid on maturity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.15
<SEQUENCE>16
<FILENAME>d20922dex9915.htm
<DESCRIPTION>EX-99.15
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.15</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.15 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE THREE MONTHS ENDED
JULY 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following Management&#146;s Discussion and Analysis (&#147;MD&amp;A&#148;), prepared as of September 30,
2019, should be read in conjunction with the unaudited condensed interim consolidated financial statements of ImmunoPrecise Antibodies Ltd. (&#147;the Company&#148;, &#147;ImmunoPrecise&#148; or &#147;IPA&#148;) for the three months ended
July&nbsp;31, 2019, together with the audited financial statements and accompanying MD&amp;A of the Company for the year ended April&nbsp;30, 2019. This MD&amp;A is the responsibility of management and has been reviewed and approved by the Board of
Directors of IPA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The referenced financial statements have been prepared in accordance with International Financial Reporting Standards
(&#147;IFRS&#148;), as issued by the International Accounting Standards Board and as applicable to the preparation of interim financial statements, including IAS 34, <I>Interim Financial Reporting</I>. Except as otherwise noted, all dollar figures
in this MD&amp;A are stated in Canadian dollars which is the Company&#146;s reporting currency. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This MD&amp;A may contain certain statements that constitute &#147;forward-looking statements&#148; within the meaning of National Instrument <FONT
STYLE="white-space:nowrap">51-102,</FONT> Continuous Disclosure Obligations of the Canadian Securities Administrators. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward-looking statements often,
but not always, are identified by the use of words such as &#147;seek&#148;, &#147;anticipate&#148;, &#147;believe&#148;, &#147;plan&#148;, &#147;estimate&#148;, &#147;expect&#148;, &#147;targeting&#148; and &#147;intend&#148; and statements that an
event or result &#147;may&#148;, &#147;will&#148;, &#147;should&#148;, &#147;could&#148;, or &#147;might&#148; occur or be achieved and other similar expressions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In this MD&amp;A, forward-looking statements include the Company&#146;s future plans and expenditures, the satisfaction of rights and performance of
obligations under agreements to which the Company is a part, the ability of the Company to hire and retain employees and consultants and estimated administrative assessment and other expenses. The forward-looking statements that are contained in
this MD&amp;A involve a number of risks and uncertainties. As a consequence, actual results might differ materially from results forecast or suggested in these forward-looking statements. Some of these risks and uncertainties are identified under
the heading &#147;RISKS AND UNCERTAINTIES&#148; in this MD&amp;A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Furthermore, forward-looking statements contained herein are made as of the date of
this MD&amp;A and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results or otherwise. There can be no assurance that forward-looking statements will prove to
be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>GENERAL </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company was incorporated under the laws of
Alberta on November 22, 1983 and is listed on the TSX Venture Exchange (the &#147;Exchange&#148;) as a Tier 2 life science issuer under the trading symbol &#147;IPA&#148;. The Company&#146;s OTC symbol is &#147;IPATF&#148;. The address of the
Company&#146;s corporate office is 3204 &#150; 4464 Markham Street, Victoria, BC V8Z 7X8. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>OVERVIEW </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has emerged as a recognized, full-service, biologics Contract Research Organization (CRO) with global operations. The Company is innovation-driven
and is strategically positioned - both geographically and scientifically - to provide customized and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">end-to-end</FONT></FONT> biologics services. They offer a cohesive and extensive
portfolio in the protein and antibody research, manufacturing and validation continuum. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE THREE MONTHS ENDED
JULY 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s services include, but are not limited to, proprietary B cell sorting, screening and
sequencing; custom, immune and na&iuml;ve phage display production and screening; expertise with transgenic animals and multi- species antibody discovery; <FONT STYLE="white-space:nowrap">bi-specific,</FONT>
<FONT STYLE="white-space:nowrap">tri-specific,</FONT> and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing, purification in gram scale levels, characterization and validation; antibody engineering;
transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening and clone-picking; cryopreservation; and custom antigen modeling, design and manufacturing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moreover, in the past 12 months, the Company has gained increasing recognition as a rising leader in the biologics, CRO space. They have focused on organic
growth through market penetration and service diversification, as well as strategic expansion with platform and process integration. Furthermore, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">end-to-end</FONT></FONT> services
have been leveraged through acquisition, enabling a steady foundation for future growth. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA Canada and IPA Europe have both been designated as approved
CROs for the world&#146;s leading, transgenic animal platform producing human antibodies, and exercised an advantage in optimizing services for various transgenic animal vendors. The Company made strategic investments in R&amp;D activities to
develop proprietary technologies enabling the application of their B cell Select<SUP STYLE="font-size:85%; vertical-align:top">TM </SUP>and DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> platforms to a broad range of transgenic
animal species and strains. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This past year, the Company announced a full-service B cell facility in Victoria, British Columbia, offering B cell
screening, sorting and sequencing on a broad range of therapeutically relevant protein families, including GPCRs and other multi-membrane spanning proteins. The Company&#146;s proprietary B cell
Select<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> platform enables antibody screening directly from B cells, allowing for the analysis of a more diverse set of antibodies, and for faster, deeper screening compared to traditional
technologies. In July 2018, IPA Europe expanded the Company&#146;s B cell technologies to the EU, increasing its global capacity, and further differentiating ImmunoPrecise from its competitors. Months later, the Company went on to announce that, due
to the platform&#146;s greater than 90% success rate, it now offers a guarantee on the success of campaigns powered by its proprietary B cell Select<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> Antibody Discovery platform. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">U-Protein</FONT> Express, situated in the Dutch biotechnology hub of Utrecht, The Netherlands, has been a staple in the
recombinant protein community, operating for over 15 years, and specializing in the manufacture of complex proteins and antibodies in a variety of formats, and from a range of mammalian cell types. Their streamlined and efficient operations have
enabled them to successfully support over 5,000 different programs, with over a 90% success rate, for pharmaceutical and biotechnology industries as well as leading, academic institutions. In a seamless coordination, their operations also support
the downstream expression and purification of the antibodies originating from the B cell Select<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> programs, enabling validation of the platform&#146;s outputs and comprehensive deliverables for
clients. Recently, this site announced the obtainment of an exclusive license from Stanford University for <FONT STYLE="white-space:nowrap">one-year</FONT> of exclusively on the marketing and sale of the novel protein, Wnt surrogate Fc, to the
global research market. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA Europe&#146;s contribution in services and intellectual property to the Company after its acquisition have been substantial.
The integration of IPA Europe significantly expanded the Company&#146;s services portfolio including affinity maturation, humanization, functional assay design and development, na&iuml;ve and diseased scFv libraries, and proprietary methods of
immunization against conformational targets (e.g. ModiVacc<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> lymphoid tumor immunization and DNA immunization technologies). Adding to their proprietary services, this year, IPA Europe developed
and <FONT STYLE="white-space:nowrap">rolled-out</FONT> the aforementioned, novel service offering for the discovery of fully human antibodies, DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP>, a combination of transgenic animal
immunization and custom phage display antibody selections. While CRO services are the mainstay of the Company, ImmunoPrecise has worked continuously on building an intellectual property estate and portfolio of proprietary methods and physical assets
through collaborations, joint </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE THREE MONTHS ENDED
JULY 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ventures, acquisitions and <FONT STYLE="white-space:nowrap">in-licensing.</FONT> The Company has
strategically invested in the development and licensing of antibody discovery platforms and related intellectual property assets. The onboarding of existing assets with regard to equipment, technologies, IP and licenses within the Company&#146;s EU
operations has been compounded by active research and development at all operational sites this year, including the <FONT STYLE="white-space:nowrap">on-going</FONT> development of new service offerings to be rolled out in the fiscal year 2020, but
more notably, internal discovery programs focused on novel, therapeutic antibodies, primarily in the field of immuno-oncology. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Recently, the Company
formed Talem Therapeutics (&#147;Talem&#148;), based in Cambridge, Massachusetts, to support its internal, therapeutic, discovery programs. Talem is structured to secure assets during their discovery and development stage and seek out strategic
partnerships with clinical-stage pharma and biotech companies where it will aid in the <FONT STYLE="white-space:nowrap">out-licensing</FONT> or sale of the therapeutics for clinical trials. The ability for investors to support individual assets or
portfolios generates an asymmetrical opportunity for investments, while avoiding ImmunoPrecise&#146;s shareholders dilution. The depth and speed of IPA&#146;s offerings enables Talem to customize each program and leverages the Company&#146;s
expertise and technologies in the antibody discovery. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s management placed a critical emphasis this past year on building, integrating
and securing the business infrastructure to facilitate scalable, strategic growth, recognize cost synergies and reduce its carbon footprint. These activities included, but were not limited to, globalizing and standardizing core information
technology (IT) infrastructure such as server and client operating systems, databases, security tools, computing platforms and cloud computing, communication tools and content management platforms, to protect both the Company&#146;s, and its
client&#146;s, IP. This move allows for cost effective and quick reaction to market demands. The Company integrated IT services including the global service desk has decreased costs and risk while removing collaboration barriers including tools that
allow for communicating in different languages. They have also begun to capture synergies after the global integration of sales, marketing, R&amp;D, management, and legal services. They have prepared for the integration of fundamental business
services such as payroll, financial controls, and an Oracle suite of enterprise software. They will continue to enhance these integrations, as well as create synergies in additional areas such as M&amp;A communications and tax integration. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>STRATEGY AND OUTLOOK </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our newly formed management team
has a passionate emphasis on initiatives designed to drive revenue, bolster internal assets and maximize shareholder value. We aim to continue to build on revenue and asset generation through internal development and well-informed, strategic
acquisitions and joint ventures. Our strategy also includes growth through alliances and partnerships, within both our research (Talem) and service sectors, as well as potential new market sectors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our objective is to aggressively expand our position as the preferred, global partner for researchers across the globe. Therefore, our strategy is to deliver
the leading, comprehensive and integrated continuum of protein and antibody services and enable our clients and partners to bring new and enhanced therapies to the clinic faster, by offering a progression of services with excellence and continued
innovation. We believe we possess a competitive advantage which allows us to execute this strategy, as we continue to focus on our integrated <U>end- <FONT STYLE="white-space:nowrap">to-end</FONT> platform</U>, coupled with a <U>strong, scientific <FONT
STYLE="white-space:nowrap">know-how</FONT></U>, enabling us to navigate our clients through the process of discovery through lead candidates. Our ability to customize programs, yet maintain scientific rigor, enables our clients to access our global
portfolio of services with confidence. Our personable and responsible <U>global project management team</U> ensures that our clients have program details at their fingertips, at any minute, in any time zone, with the <U>security measures</U> needed
to ensure our clients&#146; peace of mind. In addition to the aforementioned strengths, our global footprint and streamlined processes enable us to leverage our competitive advantages to mature as the global, preferred therapeutic antibody provider.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE THREE MONTHS ENDED
JULY 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our strategy is supported by growing trends in pharma and finance. Global pharmaceutical companies are
continuing to increase their share of reliance on CRO&#146;s to improve the efficiency and cost of development, increase turnaround time, and access advanced and integrated expertise. When analyzing pharmaceutical outsourcing trends, in July, 2019,
several major drivers of the CRO industry growth were identified, including robust biopharmaceutical funding, accelerated drug approval rates, the growing number of clinical trials, and proliferation of biopharmaceutical companies without internal
research and clinical capabilities<SUP STYLE="font-size:85%; vertical-align:top">1</SUP>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In an attempt to streamline, many large pharmaceutical
companies are limiting the number of external CRO vendors that can be contracted. This is particularly good for those CROs that fulfill multiple niches in the discovery and manufacturing pipeline. In a recent estimate, the CRO industry alone was
estimated to be $30&nbsp;billion USD, and &#147;<I>highly fragmented</I><I>&#133;</I><I> though relatively few of full scale and breadth of service</I>&#148;<SUP STYLE="font-size:85%; vertical-align:top">1</SUP>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The key players serving the monoclonal antibodies market are Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck&nbsp;&amp; Co., Inc, Amgen, Inc., Abbott
Laboratories, AstraZeneca, Eli Lilly and Company, Mylan N.V., Daiichi Sankyo Company, Ltd., Bayer AG, Bristol Myers Squibb Co., Johnson&nbsp;&amp; Johnson Services, Inc., Biogen Inc., Thermo Fisher Scientific, Inc., Sanofi Genzyme, F. <FONT
STYLE="white-space:nowrap">Hoffmann-La</FONT> Roche Ltd., and Novo Nordisk A/S<SUP STYLE="font-size:85%; vertical-align:top">2</SUP>. In 2016 alone, Novartis invested 9&nbsp;billion USD and Pfizer invested 7.9&nbsp;billion USD in R&amp;D<SUP
STYLE="font-size:85%; vertical-align:top">3</SUP>. This is of little surprise given the global monoclonal antibody market was valued at USD 85.4&nbsp;billion in 2015 and is expected to reach a value of USD 138.6&nbsp;billion by 2024<SUP
STYLE="font-size:85%; vertical-align:top">2</SUP>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ongoing, growing investments in R&amp;D are expected to continue to ramp up for antibodies given the
rising prevalence of cancer and other chronic diseases<SUP STYLE="font-size:85%; vertical-align:top">4</SUP>. In oncology, in particular, antibodies are viewed as the mainstay, as people move away from other types of therapies such as small
molecules<SUP STYLE="font-size:85%; vertical-align:top">5</SUP>. In recent years, the success of key pipeline drugs in the immuno-oncology space have been a key component of the record high capital market funding for the biotechnology sector<SUP
STYLE="font-size:85%; vertical-align:top">1</SUP>. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Healthcare Insights Life Sciences, CRO Sector Fundamentals Remain Hot for M&amp;A Consolidation, July&nbsp;3,
2019. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">2</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Monoclonal Antibodies (mAbs) Market Size Worth $138.6 Billion By 2024, Nov. 2016 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">3</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Monoclonal Antibody Market 2019-2025 Growth, Key Players, Size, Demands and Forecasts, April, 2019
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">4</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Research Antibodies Market Size, Share&nbsp;&amp; Trends Analysis Report By Product, By Type (Monoclonal,
Polyclonal), By Technology, By Source, By Application (Oncology, Neurobiology), By <FONT STYLE="white-space:nowrap">End-use,</FONT> And Segment Forecasts, 2018 &#150; 2025, March, 2018 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">5</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">GEN, Antibody Discovery Looks Over the Horizon, Feb. 7, 2019. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ACQUISITION OF <FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> EXPRESS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&nbsp;22, 2017, the Company completed the acquisition of <FONT STYLE="white-space:nowrap">U-Protein</FONT> Express BV
<FONT STYLE="white-space:nowrap">(&#147;U-Protein&#148;)</FONT> whereby the Company has acquired all the issued and outstanding shares of <FONT STYLE="white-space:nowrap">U-Protein</FONT> for &#128;6,830,000 on terms as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,734,732 (CAD$4,062,607) was paid in cash on closing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3,030,503 common shares of the Company were issued on closing; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,047,634 in deferred payments over a three-year period. The deferred payments can be made in cash or
common shares of the Company at the election of <FONT STYLE="white-space:nowrap">U-Protein</FONT> shareholders. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transaction was
accounted for as a business combination, as the operations of <FONT STYLE="white-space:nowrap">U-Protein</FONT> meet the definition of a business. As a result, transaction costs of $17,717 were expensed. The goodwill resulting from the allocation of
the purchase price to the total fair value of net assets represented the sales and growth potential of <FONT STYLE="white-space:nowrap">U-Protein.</FONT> Goodwill recorded is allocated in its entirety to
<FONT STYLE="white-space:nowrap">U-Protein.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The first deferred payment of &#128;682,545 (CAD$1,049,754) has been made in cash during the year
ended April&nbsp;30, 2019. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE THREE MONTHS ENDED
JULY 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the 3,030,503 common shares issued ($3,022,308) was determined based on the Canadian dollar
equivalent of the consideration required of &#128;2,047,634 pursuant to the share purchase agreement. The Company has allocated the purchase price as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B></B>$<B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,062,607</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3,030,503 common shares of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,022,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of deferred payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,134,410</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,219,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">797,276</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">370,530</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,815</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment, net of accumulated amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">216,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intellectual property (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,064,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,655,893</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(269,657</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income taxes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,197</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(810,800</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,219,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ACQUISITION OF IPA EUROPE AND IMMULEASE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company acquired all of the issued and outstanding shares of ImmunoPrecise Antibodies (Europe) B.V. (&#147;IPA Europe&#148;) and its
sister entity, Immulease B.V. (&#147;Immulease&#148;), for an aggregate purchase price of &#128;7,000,000 on terms as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,500,000 (CAD$3,988,132) was paid in cash on closing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">6,600,399 common shares of the Company were issued on closing; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,000,000 in deferred payments over a three-year period. The deferred payments will be made in three equal
installments of cash and equity totaling &#128;666,666 and will be prorated if the EBITDA of IPA Europe for the fiscal year preceding the date of payment is less than its average EBITDA over the previous two fiscal years. During the year ended
April&nbsp;30, 2019, the Company and the seller entered into an Amendment, Termination and Settlement Agreement whereby the deferred payments shall no longer be subject to an adjustment and will be paid in equal installments of cash and equity
totaling &#128;666,666. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA Europe changed its name from ModiQuest Research B.V. in April 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA Europe is a privately held company based in Oss, The Netherlands, and specializes in the generation of monoclonal antibodies against difficult target
antigens. IPA Europe applies proprietary technologies to all aspects of the antibody discovery process in research and development, diagnostic and therapeutic applications. Using its proprietary
ModiFuse<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> (hybridoma electrofusion), ModiSelect<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> <FONT STYLE="white-space:nowrap">(B-cell</FONT> selection) and ModiPhage<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP> (phage display) technologies, IPA Europe can generate very large panels of monoclonal antibodies from various backgrounds including mouse, rat, rabbit, chicken, llama and human, as well as
transgenic animals harboring the human antibody gene repertoire. IPA Europe serves clients in Europe, the US, Asia and Russia. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE THREE MONTHS ENDED
JULY 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transaction was accounted for as a business combination, as the operations of IPA Europe and Immulease
meet the definition of a business. As a result, transaction costs of $36,821 were expensed. The goodwill resulting from the allocation of the purchase price to the total fair value of net assets represented the sales and growth potential of IPA
Europe. Goodwill recorded is allocated in its entirety to IPA Europe. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The first deferred payment of &#128;666,666 (CAD$1,014,503), consisting of cash of
&#128;333,333 (CAD$507,000) and common shares of the Company with a fair value of $507,503, has been made during the year ended April&nbsp;30, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
fair value of the 6,600,399 common shares issued ($4,884,295) was determined to be $0.74 per share based on the fair value of the Company&#146;s shares immediately prior to the completion of the acquisition. The Company has allocated the purchase
price as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,988,132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6,600,399 common shares of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,884,295</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of deferred payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,353,708</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,226,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">270,339</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">572,427</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,286,995</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment, net of accumulated amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">568,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Software</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible assets (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,304,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,640,671</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(580,339</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(22,897</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(298,979</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,636,192</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,226,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>OVERALL PERFORMANCE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the three months ended July&nbsp;31, 2019 the Company achieved revenues of $2,716,099, compared to revenues of $2,872,785 in the 2018 fiscal period. The
decrease in revenue was due to project volume being down and significant time spent on R&amp;D projects. Outlook is positive for second quarter customer project volume. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s new laboratory in Victoria is now a fully operational antibody production facility that effectively doubles its revenue generating
capacity. To drive the execution of its strategic and growth initiatives, the Company continues to focus on the recruitment of scientific and technical staff, development of new technical training programs and a commitment to integrate continuous
improvement and quality management methodologies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE THREE MONTHS ENDED
JULY 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To support management and the Board of Directors in exercising oversight, the Company is implementing
information systems for marketing and sales automation and customer relationship management, as well as accounting and financial reporting, resource planning and project management. Comprehensive operational and management reporting capabilities are
being implemented with a view to effectively support a geographically dispersed organization allowing managers access to company data globally. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With the
aid of a third-party HR consulting firm, significant effort was applied to strengthening and aligning the Company&#146;s human resources by: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Stabilizing staffing for sales growth going forward: </I>Remuneration and incentive systems have been aligned
with targeted revenue and gross profit performance, and operational roles and responsibilities have been focused on managing demand. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Leadership and operational alignment</I>: The Company has made changes and updates job descriptions,
compensation plans, and other reward and recognition systems, and is implementing career planning and development mechanisms and job performance and quality measures. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Future growth will provide opportunities for company personnel to develop new skills and abilities to tackle eventual challenges in a growing company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the 2020 fiscal year, the goal of the organization is to grow sales revenue and expand our brand awareness. This focus is consistent with the &#145;leading
with our scientists&#146; philosophy, which is resonating with our customers from both diagnostic and, in particular, the therapeutic market segment. The Company is also expanding its commitment to research and development initiatives aimed at
introducing new services through both development as well as through partnerships. To achieve the best results from its investments, the Company continued to add key scientific and management personnel to its team. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RESULTS OF OPERATIONS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the three months ended
July&nbsp;31, 2019, the Company generated revenues of $2,716,099, compared to revenues of $2,872,785 in the 2018 fiscal period. This represents a 5% decrease in revenue and is due to project volume being down and significant time spent on R&amp;D
projects. Outlook is positive for second quarter customer project volume. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the three months ended July&nbsp;31, 2019, the Company achieved a gross
profit of $1,376,406, compared to $1,567,826 in the 2018 fiscal period. In percentage terms, the Company&#146;s gross profit decreased to 51% from 54% in 2018. The lower gross profit in 2019 was mostly attributable to the fact that the Company did
an analysis of its costs during 2019 and has allocated a higher percentage of expenses to its cost of sales, as more expenses are considered to be directly attributable to generating revenues. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recorded a net loss of $2,012,198 during the three months ended July&nbsp;31, 2019, compared to net loss of $1,102,362 for the three months ended
July&nbsp;31, 2018. The net loss increased in 2019 due to $191,420 lower gross profit and higher expenses, primarily <FONT STYLE="white-space:nowrap">non-cash</FONT> expenses: amortization of acquired companies&#146; intangible assets, depreciation
of leased assets as a result of implementing IFRS 16, <I>Leases</I>, and the accretion expense on deferred acquisition payments. In addition, the Company continues to invest in research and development in pursuit of its goal of broadening the
breadth and value of its intellectual property assets in techniques inherent in the production of human antibodies through new working partnerships with several companies with leading transgenic platforms. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE THREE MONTHS ENDED
JULY 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Variances of note in the Company&#146;s expenses include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Advertising and promotion fees of $117,200 in 2019 (2018 - $53,769) were incurred to support the Company&#146;s
initiatives focused on business development, marketing and branding programs. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Amortization expense increased to $547,841 from $175,562 in 2018 due to the amortization of intangible assets
which were acquired as a result of the acquisitions of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Consulting fees of $22,340 in 2019 (2018 - $163,320) and professional fees of $149,720 (2018 - $277,803) were
lower compared to 2018, because much of the consulting and professional fees incurred in 2018 were <FONT STYLE="white-space:nowrap">one-time</FONT> costs to support initiatives focused on operational efficiency training programs, and systems
implementation. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The office and general expense of $223,335 (2018 - $143,540) was higher compared to 2018 due to the expansion of
the Company&#146;s laboratory facilities, an increase in commercial activities and the acquisitions of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe (e.g., auditing, third-party business valuation, etc.). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Research and development of $167,260 (2018 - $31,788) increased, primarily as a result of the fact that the
Company focused more efforts on the investment in research and development as well as the increase in the number of R&amp;D related projects. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Salaries and benefits expense increased to $1,096,244 from $927,039 in 2018, primarily because the Company has
continued to add key scientific and management personnel to its team. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Company recorded a share-based payments expense of $285,995 (2018 - $311,700) as a result of the vesting of
the 2,060,000 stock options granted during the April 30, 2019 fiscal year versus 4,090,000 stock options granted during the April&nbsp;30, 2018 fiscal year. The option plan is aimed to align staff to the future company growth plans.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The travel expense increased to $119,305 from $73,028 in 2018 due to an increase in marketing activities and
business-related travel required in connection with managing a global organization. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SUMMARY OF QUARTERLY RESULTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets out financial information for the past eight quarters: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>July&nbsp;31,</B><br><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,</B><br><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>January&nbsp;31,</B><br><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>October&nbsp;31,</B><br><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,716,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,641,109</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,695,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,716,791</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,012,198</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,842,317</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,187,056</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,485,732</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted loss per share*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.03</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.06</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>July&nbsp;31,</B><br><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,</B><br><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>January&nbsp;31,</B><br><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>October&nbsp;31,</B><br><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,872,785</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,810,722</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,723,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,316,261</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income (loss)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,102,362</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,198,428</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,211,591</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(903,252</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted loss per share*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.04</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.03</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The basic and fully diluted calculations result in the same value due to the anti-dilutive effect of
outstanding stock options and warrants. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The losses for the quarters ended April&nbsp;30, 2019 and April&nbsp;30, 2018 are greater than
other quarters, as the Company invested heavily in growth enabling initiatives and also due to the <FONT STYLE="white-space:nowrap">catch-up</FONT> amortization recorded of intangible assets which were acquired as a result of the acquisitions of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE THREE MONTHS ENDED
JULY 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">NON-IFRS</FONT> MEASURES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following are <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures and investors are cautioned not to place undue reliance on them and are urged to
read all IFRS accounting disclosures present in the condensed consolidated interim financial statements and accompanying notes for the condensed consolidated interim financial statements for the three months ended July&nbsp;31, 2019 and the
consolidated financial statements and accompanying notes to the financial statements for the year ended April&nbsp;30, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company uses certain <FONT
STYLE="white-space:nowrap">non-IFRS</FONT> financial measures as supplemental indicators of its financial and operating performance. These <FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial measures include adjusted operating EBITDA and
adjusted operating expenses. The Company believes these supplementary financial measures reflect the Company&#146;s ongoing business in a manner that allows for meaningful
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">period-to-period</FONT></FONT> comparisons and analysis of trends in its business. These <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures do not have any standardized meaning
prescribed under IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company defines adjusted
operating EBITDA as operating earnings before interest, taxes, depreciation, amortization, share-based compensation, and asset impairment charges. Adjusted operating EBITDA is presented on a basis consistent with the Company&#146;s internal
management reports. The Company discloses adjusted operating EBITDA to capture the profitability of its business before the impact of items not considered in management&#146;s evaluation of operating unit performance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company defines adjusted operating expenses as operating expenses before share-based compensation, depreciation, amortization and asset impairment
charges. Adjusted operating expenses are presented on a basis consistent with the Company&#146;s internal management reports. The <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures are reconciled to reported IFRS figures in the tables below:
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>July 31,</B><br><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>July 31,</B><br><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,012,198</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,102,362</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income taxes (recovery)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,055</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,452</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization and depreciation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">547,841</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,562</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">552,893</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">237,539</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange gain</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(112,976</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82,490</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">118,960</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">118,431</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest and other income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12,402</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(43,515</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">285,995</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">311,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Adjusted EBITDA</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(635,942</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(347,683</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>July 31,</B><br><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>July 31</B><br><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,852,168</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,438,712</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization and depreciation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">547,841</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,562</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange gain</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(112,976</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82,490</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">118,960</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">118,431</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">285,995</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">311,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Adjusted Operating Expenses</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,012,348</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,915,509</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE THREE MONTHS ENDED
JULY 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FINANCING ACTIVITIES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On May&nbsp;23, 2018, the Company entered into a loan agreement with a Director of the Company and his spouse and issued a promissory note in the principal
amount of $200,000. The note was unsecured and bore an interest rate of 5.45% per annum. The principal of the note plus accrued interest of $3,972 was repaid in full during the year ended April&nbsp;30, 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June 19, 2018, the Company closed a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement financing by issuing a total of 875,000 units of
the Company at a price of $0.80 per unit for gross proceeds of $700,000. Each unit consists of one common share of the Company and one share purchase warrant, with each warrant entitling the holder to purchase an additional Share at a price of $1.00
for a period of one year from the date of issue. The Company will have the right to accelerate the expiry date of the warrants provided that the volume weighted average price trades at a price equal to or greater than $1.50 for a period of 20
consecutive days. In the event of acceleration, the expiry date will be accelerated to a date that is 30 days after the Company issues a news release announcing that it has elected to exercise this acceleration right. The Company paid finders cash
fees totaling $3,000 and incurred $7,926 of cash issue costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&nbsp;24, 2018, the Company closed a
<FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement financing by issuing a total of 9,102,500 units of the Company at a price of $1.00 per unit for gross proceeds of $9,102,500. Each unit consists of one common share of the
Company and one share purchase warrant, with each warrant entitling the holder to purchase an additional share at a price of $1.25 for a period of two years from the date of issue. The Company will have the right to accelerate the expiry date of the
warrants provided that the volume weighted average price trades at a price equal to or greater than $1.75 for a period of 20 consecutive days. In the event of acceleration, the expiry date will be accelerated to a date that is 30 days after the
Company issues a news release announcing that it has elected to exercise this acceleration right. The Company paid finders cash fees totaling $201,540 and issued 182,460 finder&#146;s shares. The Company also incurred $76,038 of cash issue costs.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&nbsp;22, 2017, the Company announced that it had signed a binding letter of intent with Crossbeta Biosciences B.V. (&#147;Crossbeta&#148;)
whereby the Company had agreed to acquire all of the issued and outstanding shares of Crossbeta. The proposed transaction was terminated and settled on October 23, 2018. In consideration of the settlement, the Company paid &#128;37,000 ($55,969) and
issued 78,514 shares valued at $61,241. The Company accrued a settlement liability of $92,040 as at April 30, 2018. As such, the remaining loss on settlement of $25,170 was recognized in fiscal year 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;27, 2019, the Company issued 714,793 common shares pursuant to the second deferred acquisition payment to IPA Europe. The common shares are
valued at $507,503. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2019, the Company issued 135,000 common shares pursuant to exercise of stock options for total
gross proceeds of $40,500. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the three months ended July 31, 2019, the Company issued 50,000 common shares pursuant to exercise of stock options for
total gross proceeds of $15,000. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>LIQUIDITY AND CAPITAL RESOURCES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s objectives when managing capital are to ensure sufficient liquidity for operations and adequate funding for growth and capital expenditures
while maintaining an efficient balance between debt and equity. The capital structure of the Company consists of shareholders&#146; equity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE THREE MONTHS ENDED
JULY 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company makes adjustments to its capital structure upon approval from its Board of Directors, in light of
economic conditions and the Company&#146;s working capital requirements. There were no changes in the Company&#146;s approach to capital management during the year. The Company is not subject to any externally imposed capital requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As at July 31, 2019, the Company held cash of $4,951,871 (April 30, 2019 &#150; $5,471,650) and had working capital of $1,414,052 (2018 &#150; $2,673,667).
During the three months ended July&nbsp;31, 2019, the Company used $243,514 in its operating activities. As part of the investing activities, the Company made equipment purchases of $70,894 and made incurred internally generated development costs of
$10,621. As part of the financing activities, the Company received $15,000 from exercise of stock options, received $1,500 from subscriptions received, offset by lease repayments of $105,075 and loan repayments of $20,398. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&nbsp;26, 2019, the company modified the terms of $2,750,000 debentures to extend the due date 6 months to March 26, 2020, with the ability to pay
earlier with no penalty, and increase the interest rate to 12.5%. The remaining debentures of $125,000 were paid on maturity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s
consolidated financial statements have been prepared on the basis of accounting principles applicable to a going concern. This assumes the Company will continue in operation for the foreseeable future and will be able to realize its assets and
discharge its obligations in the normal course of operations. The Company has incurred operating losses since inception, including $2,012,198 for the three months ended July&nbsp;31, 2019 and has accumulated a deficit of $19,543,424 as at July 31,
2019. The Company may need to raise additional funds in order to continue on as a going concern and there can be no assurances that sufficient funding, including adequate financing, will be available. The ability of the Company to arrange additional
financing in the future depends in part, on the prevailing capital market conditions and profitability of its operations. These material uncertainties may cast significant doubt on the Company&#146;s ability to continue as a going concern.
Accordingly, the consolidated financial statements do not give effect to adjustments that would be necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets and liquidate its liabilities,
contingent obligations and commitments other than in the normal course of business and at amounts different from those in the consolidated financial statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As at July&nbsp;31, 2019, the Company does not have any commitments for capital expenditures. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CAPITAL EXPENDITURES </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company made equipment
purchases of $70,894 during the three months ended July&nbsp;31, 2019 (2018 - </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">$24,099). During the three months ended July&nbsp;31, 2019, the Company also
incurred internally generated development costs of $10,621. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RELATED PARTY TRANSACTIONS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Key management personnel are those persons having authority and responsibility for planning, directing and controlling the activities of the Company. Key
management consists of Dr.&nbsp;Jennifer Bath, President and CEO; Lisa Helbling, CFO; Natasha Tsai, former CFO; Reginald Beniac, former Chief Operating Officer; Charles Wheelock, Chief Technology Officer; Oren Beske, former President of
ImmunoPrecise Antibodies (USA) Ltd.; Martin Hessing, a Director of <FONT STYLE="white-space:nowrap">U-Protein;</FONT> Jos Raats, former President and CEO of IPA Europe; and Directors of the Company. During the three months ended July 31, 2019 and
2018, the compensation for key management is as follows: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE THREE MONTHS ENDED
JULY 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Management fees<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,148</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103,980</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Professional fees<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,075</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Salaries and other short-term
benefits<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">485,845</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">101,830</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">264,882</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,092</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">795,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">393,977</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The charge includes management fees paid to Dr.&nbsp;Martin Hessing, a Director of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> and Dr.&nbsp;Jos Raats, former President and CEO of IPA Europe. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The charge includes professional fees paid to Malaspina Consultants Inc. in which Natasha Tsai was an associate
until July&nbsp;31, 2018 and an owner thereafter. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The charge includes salaries and benefits paid to Dr.&nbsp;Jennifer Bath and former management that includes
Thomas D&#146;Orazio, Robert Beecroft Dr.&nbsp;Oren Beske and Reginald Beniac. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the three months ended July&nbsp;31, 2019, the
spouse of a Director provided administrative services for $nil (2018 &#150; $15,625). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>OUTSTANDING SHARE DATA </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s outstanding share information as at September&nbsp;30, 2019 is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Security</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Exercise&nbsp;Price</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Expiry date</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issued and outstanding common shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,994,445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">NA</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">NA</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">653,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">December&nbsp;20, 2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,035,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">September&nbsp;18,&nbsp;2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">January&nbsp;3, 2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">700,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">February&nbsp;7, 2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">September&nbsp;24, 2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">November&nbsp;7, 2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">December&nbsp;31, 2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">415,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">January&nbsp;11, 2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">875,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">June&nbsp;18, 2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,102,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">September&nbsp;24, 2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,377,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">October&nbsp;25, 2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,793,942</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">March&nbsp;26, 2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">91,341,220</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">OFF-BALANCE</FONT> SHEET ARRANGEMENTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company does not utilize <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE THREE MONTHS ENDED
JULY 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>COMMITMENTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the Company&#146;s rental of office and laboratory space in Victoria, BC, Canada, the current lease commenced on May&nbsp;1, 2018 and terminates on
April&nbsp;30, 2023. The lease is in the amount of $21,015 per month for all four spaces from May&nbsp;1, 2018 to April&nbsp;30, 2021 and $21,914 per month from May&nbsp;1, 2021 to April&nbsp;30, 2023. The minimum annual payments under these leases
are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">252,186</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">252,186</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">262,968</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">262,968</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,030,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the Company&#146;s rental of office and laboratory space in Utrecht, Netherlands, the current lease commenced on
January&nbsp;1, 2017 and terminates on December&nbsp;31, 2019. Annual minimum lease payments are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&#128;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,415</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the Company&#146;s rental of office and laboratory space in Oss, Netherlands, the current lease commenced on
January&nbsp;1, 2018 and terminates on December&nbsp;31, 2019. Effective December&nbsp;31, 2018, the lease automatically rolls into a <FONT STYLE="white-space:nowrap">3-year</FONT> term through December&nbsp;31, 2022. Annual minimum lease payments
are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&#128;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">116,970</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">643,332</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SUBSEQUENT EVENTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Exercise of Stock Options </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subsequent to the three months
ended July&nbsp;31, 2019, the Company issued 5,000 common shares pursuant to the exercise of stock options for total gross proceeds of $1,500. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Debentures </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&nbsp;26, 2019, the company
modified the terms of $2,750,000 debentures to extend the due date 6 months to March 26, 2020, with the ability to pay earlier with no penalty, and increase the interest rate to 12.5%. The remaining debentures of $125,000 were paid on maturity. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE THREE MONTHS ENDED
JULY 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CRITICAL ACCOUNTING ESTIMATES AND JUDGMENTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of the consolidated financial statements in conformity with IFRS required estimates and judgments that affect the amounts reported in the
financial statements. Actual results could differ from these estimates and judgments. Estimates are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the year in which the estimate is revised. Significant areas
requiring the use of estimates and judgments are as follows: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Functional currency </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has used judgment in determining the currency of the primary economic environment in which the entity operates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Amounts receivable </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company monitors the financial
stability of its customers and the environment in which they operate to make estimates regarding the likelihood that the individual trade receivable balances will be paid. Credit risks for outstanding customer receivables are regularly assessed and
allowances are recorded for estimated losses, if required. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Equipment </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has used estimates in the determination of the expected useful lives of equipment and leasehold improvements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Revenue recognition </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">percentage-of-completion</FONT></FONT> method requires the use of estimates to determine the stage of completion which is used to determine the recorded amount of revenue, unbilled
revenue and deferred revenue on uncompleted contracts. The determination of anticipated revenues includes the contractually agreed revenue and may also involve estimates of future revenues if such additional revenues can be reliably estimated and it
is considered probable that they will be recovered. The determination of anticipated costs for completing a contract is based on estimates that can be affected by a variety of factors, including the cost of materials, labour, and <FONT
STYLE="white-space:nowrap">sub-contractors.</FONT> The determination of estimates is based on the Company&#146;s business practices as well as its historical experience. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Impairments </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the purposes of assessing impairment,
assets are grouped at the lowest levels for which there are separately identifiable cash flows (&#147;cash generating units&#148; or &#147;CGU&#148;s). Each asset or CGU is evaluated every reporting period to determine whether there are any
indicators of impairment. If any such indicators exist, which is often judgment-based, a formal estimate of recoverable amount is performed and an impairment charge is recognized to the extent that the carrying amount exceeds the recoverable amount.
The recoverable amount of an asset or CGU of assets is measured at the higher of fair value less costs of disposal or value in use. These determinations and their individual assumptions require that management make a decision based on the best
available information at each reporting period. The estimates and assumptions are subject to risk and uncertainty; hence, there is the possibility that changes in circumstances will alter these projections, which may impact the recoverable amount of
the assets. In such circumstances, some or all of the carrying value of the assets may be further impaired or the impairment charge reversed with the impact recorded in profit or loss. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company performs a goodwill impairment test annually and when circumstances indicate that the carrying value may not be recoverable. For the purposes of
impairment testing, goodwill acquired through business combinations has been allocated to two different CGUs. The recoverable amount of each CGU was based on value in use, determined by discounting the future cash flows to be generated from the
continuing use of the CGU. The cash flows were projected over a five-year period based on past experience and actual operating results. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE THREE MONTHS ENDED
JULY 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company performed its annual goodwill impairment test in April 2019 and no impairment was indicated for
the period tested. The values assigned to the key assumptions represented management&#146;s assessment of future trends in the industry and were based on historical data from both internal and external sources. Weighted average costs of capital of
17.5% and 10.2%, respectively, was used in the assessments of the two CGUs . </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Determination of segments </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An operating segment is a component of the Company that engages in business activities from which it may earn revenues and incur expenses. All operating
segments&#146; results are reviewed by the Company&#146;s management in order to make decisions regarding the allocation of resources to the segment. Segment results include items directly attributable to a segment as those that can be allocated on
a reasonable basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As the Company provides antibody production and related services in one distinct category, there is only one category to report
revenues by production site. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Life of intangible assets </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Intangible assets are amortized based on estimated useful life less their estimated residual value. Significant assumptions are involved in the determination
of useful life and residual values and no assurance can be given that actual useful lives and residual values will not differ significantly from current assumptions. Actual useful life and residual values may vary depending on a number of factors
including internal technical evaluation, attributes of the assets and experience with similar assets. Changes to these estimates may affect the carrying value of assets, net income (loss) and comprehensive income (loss) in future periods. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Purchase price allocation </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The acquisition of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> on August&nbsp;22, 2017 and the acquisition of IPA Europe and Immulease on April&nbsp;5, 2018 were accounted for as business combinations at fair value in accordance with IFRS 3, <I>Business
Combinations</I>. The acquired assets and assumed liabilities were adjusted to their fair values assigned through completion of a purchase price allocation, as described below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The purchase price allocation process resulting from a business combination requires management to estimate the fair value of identifiable assets acquired
including intangible assets and liabilities assumed including the deferred acquisition payment obligations. The Company uses valuation techniques, which are generally based on forecasted future net cash flows discounted to present value, and also
relies on work performed by third-party valuation specialists. These valuations are closely linked to the assumptions used by management on the future performance of the related assets and the discount rates applied. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ADOPTION OF NEW ACCOUNTING STANDARDS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has
adopted the following new standards, along with any consequential amendments, effective May&nbsp;1, 2019. These changes were made in accordance with the applicable transitional provisions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company adopted all of the requirements of IFRS 16, <I>Leases </I>(&#147;IFRS 16&#148;) as of May&nbsp;1, 2019. IFRS 16 replaces IAS 17, <I>Leases
</I>(&#147;IAS 17&#148;). IFRS 16 provides a single lessee accounting model, requiring lessees to recognize assets and liabilities for all leases unless the lease term is 12 months or less or the underlying asset has a low value. The Company has
adopted IFRS 16 using the modified retrospective application method, where the 2019 comparatives are not restated and a cumulative catch up adjustment is recorded on May&nbsp;1, 2019 for any differences identified, including adjustments to opening
deficit balance. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE THREE MONTHS ENDED
JULY 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company analyzed its contracts to identify whether they contain a lease arrangement for the application
of IFRS 16. The following is the Company&#146;s new accounting policy for leases under IFRS 16: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At inception of a contract, the Company assesses whether
the contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Leases of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets are recognized at the lease commencement date at
the present value of the lease payments that are not paid at that date. The lease payments are discounted using the interest rate implicit in the lease, if that rate can be readily determined, and otherwise at the Company&#146;s incremental
borrowing rate. At the commencement date, a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset is measured at cost, which is comprised of the initial amount of the lease liability adjusted for any
lease payments made at or before the commencement date, plus any decommissioning and restoration costs, less any lease incentives received. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each lease
payment is allocated between repayment of the lease principal and interest. Interest on the lease liability in each period during the lease term is allocated to produce a constant periodic rate of interest on the remaining balance of the lease
liability. Except where the costs are included in the carrying amount of another asset, the Company recognizes in profit or loss (a)&nbsp;the interest on a lease liability and (b)&nbsp;variable lease payments not included in the measurement of a
lease liability in the period in which the event or condition that triggers those payments occurs. The Company subsequently measures a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset at cost less
any accumulated depreciation and any accumulated impairment losses; and adjusted for any remeasurement of the lease liability. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> assets are depreciated over
the shorter of the asset&#146;s useful life and the lease term, except where the lease contains a bargain purchase option a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset is depreciated over the
asset&#146;s useful life. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On the date of transition, the Company recorded a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset of $1,668,533 related to the office rent in property and equipment, and the lease obligation of $1,723,277 was recorded as at May&nbsp;1, 2019,
discounted using the Company&#146;s incremental borrowing rate of 8%, and measured at an amount equal to the lease obligation as if IFRS 16 had been applied since the commencement date. The net difference between <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets and lease liabilities on the date of transition was recognized as a deficit adjustment of $54,744 on May&nbsp;1, 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ACCOUNTING STANDARDS ISSUED BUT NOT YET EFFECTIVE </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
October 2018, the IASB issued amendments to IFRS 3, Business Combinations. The amendments narrowed and clarified the definition of a business. The amendments will help companies determine whether an acquisition is a business or a group of assets.
They also permit a simplified assessment of whether an acquired set of activities and assets is a group of assets rather than a business. Distinguishing between a business and a group of assets is important because an acquirer recognizes goodwill
only when acquiring a business. This amendment will be effective for annual periods beginning on or after January&nbsp;1, 2020. Early adoption is permitted. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DISCLOSURE CONTROLS AND PROCEDURES </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with
National Instrument <FONT STYLE="white-space:nowrap">52-109</FONT> (Certificate of Disclosure in Issuer&#146;s Annual and Interim Filings) (&#147;NI <FONT STYLE="white-space:nowrap">52-109&#148;),</FONT> the Chief Executive Officer and Chief
Financial Officer of the Company have filed a Venture Issuer Basic Certificate with respect to the financial information contained in the unaudited condensed interim consolidated financial statements for the three months ended July 31, 2019 and this
accompanying MD&amp;A. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE THREE MONTHS ENDED
JULY 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In contrast to the full certificate under NI <FONT STYLE="white-space:nowrap">52-109,</FONT> the Venture
Issuer Basic Certificate does not include representations relating to the establishment and maintenance of disclosure controls and procedures and internal control over financial reporting, as defined in NI
<FONT STYLE="white-space:nowrap">52-109.</FONT> For further information the reader should refer to the Venture Issuer Basic Certificates filed by the Company with the Annual Filings on SEDAR at <U>www.sedar.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FINANCIAL INSTRUMENTS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s financial
instruments include cash, amounts receivable, investment, accounts payable and accrued liabilities, loans payable, deferred acquisition payments and debentures. The fair value of investment is determined based on &#147;Level&nbsp;1&#148; inputs
which consist of quoted prices in active markets for identical assets. As at July&nbsp;31, 2019, the Company believes that the carrying values of cash, amounts receivable, accounts payable and accrued liabilities, deferred payments, debentures, and
loans payable approximate their fair values because of their nature and relatively short maturity dates or durations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RISKS AND UNCERTAINTIES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Research and Development and Product Development </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA is a
life science company that makes customized antibodies and is engaged in the research and product development of new processes, procedures and innovative approaches to the antibody production and new antibodies. The Company has been engaged in such
research and development activities for over 20 years and has had significant success. Continued investment in retaining key scientific staff as well as an ongoing commitment in research and development activities will continue to be a cornerstone
in the Company&#146;s development of new services, processes, and competitive advantages such as Rapid Prime and its methods for the production of human antibodies. The Company realizes that such research and product development activities
endeavour, but cannot assure, the production of new and innovative processes, procedures or innovative approaches to antibody production or new antibodies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Custom Products </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is reliant on the
development, marketing and sale of its current custom monoclonal and polyclonal antibodies. If it does not achieve sufficient market acceptance of its expansion of its commercialization of its products and services, it will be difficult for the
Company to achieve consistent profitability. The Company&#146;s marketing and sales approach and external sales personnel continues to introduce a steady stream of new customers. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Obsolescence </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Maintaining a competitive position requires
constant growth, development and strategic marketing and planning. If the Company is unable to maintain a technological advantage, its ability to grow its business will be adversely affected and its products may become obsolete compared with other
technologies. To mitigate this, the Company is making investments in new methods, technology and facilities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Competition </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA may face significant competition in selling its products and services. Many competitors may have substantial marketing, financial, development and
personnel resources. To remain competitive, the Company believes that it must effectively and economically provide: (i)&nbsp;products and services that satisfy customer demands, (ii)&nbsp;superior customer service, (iii)&nbsp;high levels of quality
and reliability, and (iv)&nbsp;dependable and efficient distribution networks. Increased competition may require the Company to reduce prices or increase spending on sales and marketing and customer support, which may have a material adverse effect
on its financial condition and results of operations. Any decrease in the quality of IPA&#146;s products or level of service to customers or any occurrence of a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE THREE MONTHS ENDED
JULY 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
price war among the Company&#146;s competitors may adversely affect the business and results of operations. Customer reach, service and <FONT STYLE="white-space:nowrap">on-time</FONT> delivery
will continue to be a hallmark of the Company&#146;s ability to compete with other market players. Further, the recent acquisitions translate to spreading the IPA footprint on two continents. In addition, the Company has deployed a sales team tasked
with continually sourcing and providing market intelligence as part of its activities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Intellectual Property Protection </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although IPA is developing its patent portfolio, IPA&#146;s intellectual property is still protected primarily through trade secrets and copyright protection.
The Company takes steps to document and protect its trade secrets and authorship of works protectable by copyright. However, there is no guarantee that such steps protect against the disclosure of confidential information, rights of employees, or
that legal actions would provide sufficient remedy for any breach. Additionally, IPA&#146;s trade secrets might otherwise become known or be independently developed by competitors. If the Company&#146;s internal information and knowledge cannot be
protected, the business might be adversely affected. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Failure of Laboratory Facilities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s operations could suffer as a result of a failure of its laboratory facilities. The Company&#146;s business is dependent upon a laboratory
infrastructure to produce products and services. These systems and operations are vulnerable to damage and interruption from fires, earthquakes, telecommunications failures, and other events. Any such errors or inadequacies in the software that may
be encountered could adversely affect operations, and such errors may be expensive or difficult to correct in a timely manner. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The production of
monoclonal and polyclonal antibodies requires state of the art laboratory facilities and animal care standards and the success of these laboratory services depends on the recruitment and retention of highly qualified technical staff to maintain the
level and quality standards that customers expect of the Company&#146;s products and services. There is no assurance that the Company will be able to expand and operate such
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">state-of-the-art</FONT></FONT> laboratory services and recruit and retain qualified staff. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Financial and Regulatory Risks </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is currently
subject to financial and regulatory risks. The financial risk is derived from the uncertainty pertaining to the Company&#146;s ability to raise capital to continue operations. Regulatory risks include the possible delays in getting regulatory
approval for the transactions that the Board of Directors believe to be in the best interest of the Company and include increased fees for filings and the introduction of ever more complex reporting requirements, the cost of which the Company must
meet in order to maintain its exchange listing. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FURTHER INFORMATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additional information relating to the Company can be found on SEDAR at <U>www.sedar.com</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.16
<SEQUENCE>17
<FILENAME>d20922dex9916.htm
<DESCRIPTION>EX-99.16
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.16</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.16 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Form <FONT STYLE="white-space:nowrap">52-109FV2</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Certification of Interim Filings </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Venture Issuer Basic Certificate </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I, <B>Lisa Helbling</B>, the <B>Chief Financial Officer </B>of <B>ImmunoPrecise Antibodies Ltd.</B>, certify the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Review: </I></B>I have reviewed the interim financial report and interim MD&amp;A (together, the
&#147;interim filings&#148;) of <B>ImmunoPrecise Antibodies Ltd.</B> (the &#147;issuer&#148;) for the interim period ended <B>July&nbsp;31, 2019.</B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>No misrepresentations: </I></B>Based on my knowledge, having exercised reasonable diligence, the interim
filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the
period covered by the interim filings. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Fair presentation: </I></B>Based on my knowledge, having exercised reasonable diligence, the interim
financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods
presented in the interim filings. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B></B>Date:<B> September&nbsp;30, 2019</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><I>&#147;Lisa Helbling&#148;</I></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Lisa Helbling</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chief Financial Officer</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8pt; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>NOTE TO READER</U></B></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In contrast to the certificate required for non-venture issuers under
National Instrument 52-109 <I>Certification of Disclosure in Issuers&#146; Annual and Interim Filings</I> (NI 52-109), this Venture Issuer Basic Certificate does not include representations relating to the establishment and maintenance of disclosure
controls and procedures (DC&amp;P) and internal control over financial reporting (ICFR), as defined in NI 52-109. In particular, the certifying officers filing this certificate are not making any representations relating to the establishment and
maintenance of</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">i)&#8195;&#8201;&#8202;controls and other procedures designed to provide reasonable assurance that information
required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities
legislation; and</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">ii)&#8195;&#8202;a process
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer&#146;s GAAP.</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The issuer&#146;s certifying officers are responsible for ensuring that processes are
in place to provide them with sufficient knowledge to support the representations they are making in this certificate. Investors should be aware that inherent limitations on the ability of certifying officers of a venture issuer to design and
implement on a cost effective basis DC&amp;P and ICFR as defined in NI 52109 may result in additional risks to the quality, reliability, transparency and timeliness of interim and annual filings and other reports provided under securities
legislation.</P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.17
<SEQUENCE>18
<FILENAME>d20922dex9917.htm
<DESCRIPTION>EX-99.17
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.17</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.17 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Form <FONT STYLE="white-space:nowrap">52-109FV2</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Certification of Interim Filings </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Venture Issuer Basic Certificate </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I, <B>Jennifer Bath</B>, the <B>Chief Executive Officer </B>of <B>ImmunoPrecise Antibodies Ltd.</B>, certify the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Review: </I></B>I have reviewed the interim financial report and interim MD&amp;A (together, the
&#147;interim filings&#148;) of <B>ImmunoPrecise Antibodies Ltd.</B> (the &#147;issuer&#148;) for the interim period ended <B>July&nbsp;31, 2019.</B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>No misrepresentations: </I></B>Based on my knowledge, having exercised reasonable diligence, the interim
filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the
period covered by the interim filings. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Fair presentation: </I></B>Based on my knowledge, having exercised reasonable diligence, the interim
financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods
presented in the interim filings. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B></B>Date:<B> September 30, 2019</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><I>&#147;Jennifer Bath&#148;</I></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jennifer Bath</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chief Executive Officer</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8pt; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>NOTE TO READER</U></B></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In contrast to the certificate required for non-venture issuers under
National Instrument 52-109 <I>Certification of Disclosure in </I><I>Issuers&#146; Annual and Interim Filings</I> (NI 52-109), this Venture Issuer Basic Certificate does not include representations relating to the establishment and maintenance of
disclosure controls and procedures (DC&amp;P) and internal control over financial reporting (ICFR), as defined in NI 52-109. In particular, the certifying officers filing this certificate are not making any representations relating to the
establishment and maintenance of</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">i)&#8195;&#8201;&#8202;controls and other procedures designed to provide reasonable assurance that information
required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities
legislation; and</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">ii)&#8195;&#8202;a process
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer&#146;s GAAP.</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The issuer&#146;s certifying officers are responsible for ensuring that processes are
in place to provide them with sufficient knowledge to support the representations they are making in this certificate. Investors should be aware that inherent limitations on the ability of certifying officers of a venture issuer to design and
implement on a cost effective basis DC&amp;P and ICFR as defined in NI 52109 may result in additional risks to the quality, reliability, transparency and timeliness of interim and annual filings and other reports provided under securities
legislation.</P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.18
<SEQUENCE>19
<FILENAME>d20922dex9918.htm
<DESCRIPTION>EX-99.18
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.18</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.18 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g20922g72h92.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Antibodies Announces 95.7% Investors Favored Debenture Extension and Q1 2020 Financial Results </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, Sept. 30, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTCQB: IPATF) an industry
leader in the discovery of novel, therapeutic monoclonal antibodies, announces today that it has signed extension agreements with its Debenture Holders of the amended terms and conditions on its $2,750,000 debenture that was originally issued
September 26, 2018. The Company has also released its financial results for the first quarter ended July 31<SUP STYLE="font-size:85%; vertical-align:top">st</SUP>, 2019. The financial statements and related management&#146;s discussion and analysis
(&#147;MD&amp;A&#148;) can be viewed on SEDAR at <U>www.sedar.com</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Debenture: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The debenture, which originally matured on September 26, 2019, has been amended to extend the maturity date until March 26, 2020. The terms of the amendment
will also include an additional 2.5% interest payment on the ongoing 10% rate. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Financial Highlights: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Revenue. </B>During the three months ended July&nbsp;31, 2019, the Company generated revenues of $2,716,099, compared to revenues of $2,872,785 in the 2018
fiscal period. This represents a 5% decrease in revenue and is due to project volume being down and significant time spent on R&amp;D projects. Outlook is positive for second quarter customer project volume. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gross Margin. </B>During the three months ended July 31, 2019, the Company achieved a gross profit of $1,376,406, compared to $1,567,826 in the 2018 fiscal
period. In percentage terms, the Company&#146;s gross profit decreased to 51% from 54% in 2018. The lower gross profit in 2019 was mostly attributable to the fact that the Company did an analysis of its costs during 2019 and has allocated a higher
percentage of expenses to its cost of sales, as more expenses are considered to be directly attributable to generating revenues. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Net Loss. </B>The
Company recorded a net loss of $2,012,198 during the three months ended July 31, 2019, compared to net loss of $1,102,362 for the three months ended July 31, 2018. The net loss increased in 2019 due to $191,420 lower gross profit and higher
expenses, primarily <FONT STYLE="white-space:nowrap">non-cash</FONT> expenses: amortization of acquired companies&#146; intangible assets, depreciation of leased assets as a result of implementing IFRS 16, <I>Leases</I>, and the accretion expense on
deferred acquisition payments. In addition, the Company continues to invest in research and development in pursuit of its goal of broadening the breadth and value of its intellectual property assets in techniques inherent in the production of human
antibodies through new working partnerships with several companies with leading transgenic platforms. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is an international, full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell Select<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP> progressive, single-cell interrogation technology and the DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> custom phage libraries, as well as the Abthena<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP> bispecific program. IPA is focused on the next generation of antibody discovery, to deliver the most therapeutically relevant antibodies, in a shorter period of time, with the highest probability of
succeeding to clinical trials. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
ImmunoPrecise discovery and development are conducted in Utrecht and Oss, the Netherlands <FONT STYLE="white-space:nowrap">(U-Protein</FONT> Express and IPA Europe, respectively), and in
Victoria, British Columbia (IPA Canada). The Company operates globally to offer a continuum of superior antibody services, transforming the face of therapeutic discovery, by decreasing turnaround time and risk, and promoting clinical success. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward Looking Information </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains
statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148; within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;,
&#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and similar expressions to identify forward-looking statements. Any such forward-looking statements are based on
assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and expected future developments. However, whether actual results and developments will conform to
ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the
forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual
management discussion and analysis for the fiscal year ended April 30, 2018 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless
required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View original content to download multimedia: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.newswire.ca/en/releases/archive/September2019/30/c1633.htm</U><U>l</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 08:45e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">30-SEP-19</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.19
<SEQUENCE>20
<FILENAME>d20922dex9919.htm
<DESCRIPTION>EX-99.19
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.19</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.19 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle">Date: September&nbsp;30,&nbsp;2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g38v66.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">510&nbsp;Burrard&nbsp;St,&nbsp;3rd&nbsp;Floor</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vancouver&nbsp;BC,&nbsp;V6C&nbsp;3B9</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><U>www.computershare.com</U></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To: All Canadian Securities Regulatory Authorities </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Subject: IMMUNOPRECISE ANTIBODIES LTD. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Sir/Madam:
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Meeting Type :</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Annual General Meeting</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Record Date for Notice of Meeting :</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">September&nbsp;25, 2019</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Record Date for Voting (if applicable) :</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">September&nbsp;25, 2019</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Beneficial Ownership Determination Date :</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">September&nbsp;25, 2019</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Meeting Date :</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>November&nbsp;22, 2019 (AMENDED)</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Meeting Location (if available) :</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Vancouver, BC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Issuer sending proxy related materials directly to NOBO:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Yes</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Issuer paying for delivery to OBO:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Notice and Access (NAA) Requirements:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">NAA for Beneficial Holders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">NAA for Registered Holders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting Security Details: </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><B>Description</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>CUSIP Number</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>ISIN</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">COMMON SHARES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">45257F101</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">CA45257F1018</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sincerely, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Computershare
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Agent for IMMUNOPRECISE ANTIBODIES LTD. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.20
<SEQUENCE>21
<FILENAME>d20922dex9920.htm
<DESCRIPTION>EX-99.20
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.20</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.20 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g20922g72h92.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Antibodies Appoints Biotech Industry Executive Dr.&nbsp;Stefan Lang as Chief Business Officer </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, Oct. 1, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTCQB: IPATF) a provider of <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">best-in-class</FONT></FONT> therapeutic antibody discovery capabilities for the global industry, today announced the appointment of industry professional and leader, Dr.&nbsp;Stefan Lang,
as Chief Business Officer. In this newly created role, Dr.&nbsp;Lang, who has more than 20 years of experience as a senior executive in the biotechnology industry, will be responsible for corporate and business development initiatives, as well as
corporate and product strategic planning. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We are excited to welcome Dr.&nbsp;Lang to ImmunoPrecise. He brings an impressive breadth of leadership
expertise in the biotech industry, including experience working at the organizational level and as a globally-recognized and respected leader in antibody business development&#148; said Dr.&nbsp;Jennifer Bath, Chief Executive Officer of
ImmunoPrecise. &#147;We look forward to Dr.&nbsp;Lang&#146;s insightful contributions as we pursue our mission of transforming next generation antibody therapeutics and diagnostics.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Lang joins ImmunoPrecise from Aldevron LLC, where he served as the Vice President of Business Development. He brings extensive background knowledge
in the therapeutic antibody sector including corporate strategy, R&amp;D innovation, sales and business development. He holds a Dr.&nbsp;rer. nat. in biology from the technical university of Karlsruhe, Germany. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;I am thrilled to join ImmunoPrecise Antibodies at such an exciting time in the Company&#146;s development,&#148; said Dr.&nbsp;Lang. &#147;In only a few
years, ImmunoPrecise has established itself as a leader in the antibody discovery space, with a clear vision and the technical capabilities to become the preferred partner of choice for this industry. I see tremendous opportunity to build on this
progress and I am eager to lend my expertise to ImmunoPrecise as the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">partner-of-choice</FONT></FONT> for biopharmaceutical companies pursuing antibody discovery in immunotherapies and
diagnostics. I look forward to leveraging my extensive business development and commercial experience to support the Company&#146;s strategic plan.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is an
international, full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell Select<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> single-cell technology and the DeepDisplay<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP> custom phage libraries, as well as the Abthena<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> bispecific program. All of these technologies integrate seamlessly with IPA&#146;s integrated
Artemis<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> Intelligence Metadata (AIM)<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> capabilities to enable rapid turnaround on additional outputs in therapeutic optimization, stability,
affinity, and manufacturability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise discovery and development are conducted in Utrecht and Oss, the Netherlands
<FONT STYLE="white-space:nowrap">(U-Protein</FONT> Express and IPA Europe, respectively), and in Victoria, British Columbia (IPA Canada). The Company operates globally to offer a continuum of superior antibody services, transforming the face of
therapeutic discovery, by decreasing turnaround time and risk, and promoting clinical success. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward Looking Information </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact,</I>
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<I>may constitute &#147;forward-looking statements&#148; within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;,
&#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and similar expressions to identify forward-looking statements. Any such forward-looking statements are based on assumptions and
analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s
expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements
contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and
analysis for the fiscal year ended April 30, 2018 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless required by applicable law,
ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise.</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View original content to download multimedia: <U> </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.newswire.ca/en/releases/archive/October2019/01/c5469.htm</U><U>l</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 08:00e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">01-OCT-19</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.21
<SEQUENCE>22
<FILENAME>d20922dex9921.htm
<DESCRIPTION>EX-99.21
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.21</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.21 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g20922g72h92.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Strengthens Board of Directors with Antibody Business Leader, Brian Lundstrom </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, Oct. 3, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTC QB: IPATF) a provider of <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">best-in-class</FONT></FONT> therapeutic antibody discovery capabilities for the global industry, today announced the appointment of Brian Lundstrom to the company&#146;s Board of Directors.
Dr.&nbsp;James Kuo, ImmunoPrecise Chairman, noted: &#147;With the addition of Mr.&nbsp;Lundstrom, ImmunoPrecise further strengthens its strategic and operational commitment to industry-leading therapeutic antibody discovery for both its clients and
the company&#146;s emerging internal pipeline.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Trained in immunology and international business, Mr.&nbsp;Lundstrom has over 30 years&#146;
experience from mostly publicly traded companies with a focus on antibody therapeutics. He started his career with product and clinical development for Novo Nordisk, in Europe, in 1987 and moved to the US in 1993 to form a dedicated business
development function. He subsequently served as business development and financing lead for publicly traded companies such as OGS (now UCB), SangStat (now a Division of Sanofi Genzyme), ACADIA and ISCO. This included SangStat&#146;s $600M sale and
integration into Genzyme in 2003. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since 2011, Mr.&nbsp;Lundstrom has established global business leadership in transgenic animals for discovery of human
therapeutic antibodies, first with OMT, and then with Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), after their $178M acquisition of OMT. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We
welcome Brian Lundstrom to our board and consider his immense experience in developing and closing pharma partnerships as a tremendous benefit to the company, as ImmunoPrecise continues to take stage as a leader in data-driven, therapeutic antibody
discovery,&#148; said Dr.&nbsp;Jennifer Bath, President and CEO of ImmunoPrecise. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is an international, full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell Select<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP> progressive single-cell interrogation technology and the DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> custom, OmniAb-based phage libraries, as well as the Abthena<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP> bispecific program. IPA is focused on the next generation of antibody discovery, to deliver the most therapeutically-relevant antibodies, in a shorter period of time, with the highest probability of
succeeding to clinical trials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise discovery and development are conducted in Utrecht and Oss, the Netherlands
<FONT STYLE="white-space:nowrap">(U-Protein</FONT> Express and IPA Europe, respectively), and in Victoria, British Columbia (IPA Canada). The Company operates globally to offer a continuum of superior antibody services, transforming the face of
therapeutic discovery, by decreasing turnaround time and risk, and promoting clinical success. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward Looking Information </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148;
within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and
similar expressions to identify forward-looking statements. Any such forward-looking statements are based on assumptions and analyses made by ImmunoPrecise in light of its</I> </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<I>experience and its perception of historical trends, current conditions and expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s
expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements
contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and
analysis for the fiscal year ended April 30, 2018 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless required by applicable law,
ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise.</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View original content to download multimedia: <U> </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.newswire.ca/en/releases/archive/October2019/03/c9898.htm</U><U>l</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 08:00e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">03-OCT-19</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.22
<SEQUENCE>23
<FILENAME>d20922dex9922.htm
<DESCRIPTION>EX-99.22
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.22</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.22 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g20922g72h92.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Adopts Shareholder Rights Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, Oct. 18, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTCQB: IPATF), an industry
leader in the discovery of novel, therapeutic antibodies, announces that its Board of Directors has adopted a shareholder rights plan (the &#147;Shareholder Rights Plan&#148;) effective October 17, 2019. The Shareholder Rights Plan has been accepted
for filing by the TSX Venture Exchange (&#147;TSXV&#148;), subject to certain conditions, including ratification by the Company&#146;s shareholders at its upcoming annual general meeting of shareholders scheduled to be held on November 22, 2019 (the
&#147;AGM&#148;). The Shareholder Rights Plan is similar to rights plans adopted by other Canadian companies and ratified by their shareholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
purpose of the Rights Plan is to ensure that all shareholders are treated fairly in connection with any offer to acquire the outstanding common shares of the Company and that the board of directors of the Company has the opportunity to identify,
solicit, develop and negotiate value-enhancing alternatives to any unsolicited take-over bid. The Shareholder Rights Plan has not been adopted in response to, or in anticipation of, any known or anticipated take-over bid. If ratified by shareholders
of the Company at the AGM, the Shareholder Rights Plan will be in effect for a term of three years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A summary of the principal terms and conditions of
the Shareholder Rights Plan will be set out in the Company&#146;s Management Information Circular to be mailed to shareholders prior to the AGM. A copy of the complete Shareholder Rights Plan will be filed on SEDAR. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is an
international, full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell Select<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> progressive, single-cell interrogation technology and the
DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> custom phage libraries, as well as the Abthena<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> bispecific program. IPA is focused on the next generation of antibody discovery,
to deliver the most therapeutically relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise discovery and development are conducted in Utrecht and Oss, the Netherlands <FONT STYLE="white-space:nowrap">(U-Protein</FONT> Express and IPA
Europe, respectively), and in Victoria, British Columbia (IPA Canada). The Company operates globally to offer a continuum of superior antibody services, transforming the face of therapeutic discovery, by decreasing turnaround time and risk, and
promoting clinical success. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward Looking Information </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148;
within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and
similar expressions to identify forward-looking statements. Any such forward-looking statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and
expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause
ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower
than </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and analysis for the fiscal year ended April&nbsp;30, 2018 which can be accessed at
<U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such
information, whether as a result of new information, future events or otherwise. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View original content to
download multimedia: <U> </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.newswire.ca/en/releases/archive/October2019/18/c6691.htm</U><U>l</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 08:32e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">18-OCT-19</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.23
<SEQUENCE>24
<FILENAME>d20922dex9923.htm
<DESCRIPTION>EX-99.23
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.23</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IMMUNOPRECISE ANTIBODIES LTD.</B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.23</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="right">


<IMG SRC="g20922g96c86.jpg" ALT="LOGO">
</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Security Class</B></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Holder Account Number</B></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="2%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="94%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px dashed #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px dashed #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fold</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24" COLSPAN="3"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Voting Instruction Form (&#147;VIF&#148;) - Annual General Meeting to be held on Friday, November&nbsp;22, 2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><FONT STYLE="white-space:nowrap">NON-REGISTERED</FONT> (BENEFICIAL) SECURITYHOLDERS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">We are sending to you the enclosed proxy-related materials that relate to a meeting of the holders of the series or class of securities that are held on your behalf by the intermediary identified above. Unless you attend the meeting
and vote in person, your securities can be voted only by management, as proxy holder of the registered holder, in accordance with your instructions.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">2.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>We are prohibited from voting these securities on any of the matters to be acted upon at the meeting without your specific voting instructions. </I>In order for these securities to be voted at the meeting, <I>it will be necessary
for us to have your specific voting instructions. </I>Please complete and return the information requested in this VIF to provide your voting instructions to us promptly.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">3.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">If you want to attend the meeting and vote in person, please write your name in the place provided for that purpose in this form. You can also write the name of someone else whom you wish to attend the meeting and vote on your
behalf. Unless prohibited by law, the person whose name is written in the space provided will have full authority to present matters to the meeting and vote on all matters that are presented at the meeting, even if those matters are not set out in
this form or the information circular. Consult a legal advisor if you wish to modify the authority of that person in any way. If you require help, please contact the Registered Representative who services your account.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>This VIF should be signed by you in the exact manner as your name appears on the VIF. If these voting instructions are given on behalf of a body corporate set out the full legal name of the body corporate, the name and position
of the person giving voting instructions on behalf of the body corporate and the address for service of the body corporate.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">5.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">If this VIF is not dated, it will be deemed to bear the date on which it is mailed by management to you.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">6.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>When properly signed and delivered, securities represented by this VIF will be voted as directed by you, however, if such a direction is not made in respect of any matter, the VIF will direct the voting of the securities to be
made as recommended in the documentation provided by Management for the meeting.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">7.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">This VIF confers discretionary authority on the appointee to vote as the appointee sees fit in respect of amendments or variations to matters identified in the notice of meeting or other matters as may properly come before the
meeting or any adjournment thereof.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">8.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Your voting instructions will be recorded on receipt of the VIF.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">9.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">By providing voting instructions as requested, you are acknowledging that you are the beneficial owner of, and are entitled to instruct us with respect to the voting of, these securities.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">10.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">If you have any questions regarding the enclosed documents, please contact the Registered Representative who services your account.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">11.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">This VIF should be read in conjunction with the information circular and other proxy materials provided by Management.</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px dashed #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px dashed #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fold</P></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>VIFs submitted must be received by 10:00 am, Pacific Time, on Wednesday, November&nbsp;20, 2019 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>VOTE USING THE TELEPHONE OR INTERNET 24 HOURS A DAY 7 DAYS A WEEK! </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g70b71.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>If you vote by telephone or the Internet, DO NOT mail back this VIF. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting by mail </B>may be the only method for securities held in the name of a corporation or securities being voted on behalf of another individual. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting by mail or by Internet </B>are the only methods by which a holder may choose an appointee other than the Management appointees named on the reverse
of this VIF. Instead of mailing this VIF, you may choose one of the two voting methods outlined above to vote this VIF. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>To vote by telephone or the
Internet, you will need to provide your CONTROL NUMBER listed below. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CONTROL NUMBER </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g20922g93z86.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">Appointee(s) </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Management Appointees are: Jennifer
Bath, an officer and director of </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">OR </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If you wish to attend in person or
appoint </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">the Company, or failing her, James Kuo, a director of the Company, or
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">someone else to attend on your behalf, </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">failing him, Lisa Helbling, an officer
of the Company, or failing her, Paul </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">print your name or the name of your
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Andreola, a director of the Company </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">appointee in this space (see Note #3 on
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">reverse). </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">as my/our proxyholder with full power of substitution and to
attend, act and to vote for and on behalf of the securityholder in accordance with the following direction (or if no directions have </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">been given, as the proxyholder
sees fit) and all other matters that may properly come before the Annual General Meeting of securityholders of Immunoprecise Antibodies Ltd. to be held at
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Northwest Law Group Barrister and Solicitors, Suite 704, 595 Howe Street, Vancouver, BC on Friday, November&nbsp;22, 2019 at 10:00 am, Pacific Time and at any
adjournment or postponement </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">thereof. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">VOTING RECOMMENDATIONS ARE INDICATED BY
HIGHLIGHTED TEXT OVER THE BOXES. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">For </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Against </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">1. Number of Directors </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">To Set the Number of Directors at seven (7). </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">&#151;&#151;&#151;&#151;&nbsp;&nbsp; </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">2. Election of Directors </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Fold </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">For
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Withhold </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">For </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Withhold </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">For </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Withhold </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">01. Jennifer Bath </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">02. James Kuo </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">03. Greg Smith </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">04. Robert Beecroft </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">05. Robert Burke </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">06. Paul Andreola </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">07. Brian Lundstrom </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">For </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Withhold </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">3. Appointment of Auditors </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Appointment of Crowe MacKay LLP as Auditors of the Company for the
ensuing year and authorizing the Directors to fix their remuneration. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">For
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Against </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">4. Stock Option Plan </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">To consider and, if thought fit, to pass an ordinary resolution approving and ratifying the Company&#146;s currently implemented Stock Option Plan, as </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">more fully set out in the accompanying Information Circular. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">For </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Against </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">5. Shareholder Rights Plan </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">&#151;&#151;&#151;&#151;&nbsp;&nbsp; </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Fold </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">To consider, and if thought fit, to pass an ordinary resolution, the full text of which is set forth in the accompanying Information Circular, approving </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">and ratifying the Company&#146;s Shareholder Rights Plan, as more particularly described in the accompanying Information Circular. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Authorized Signature(s)&#151;This section must be completed for your </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Signature(s) </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Date </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">instructions to be executed. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If you are voting on behalf of a corporation or another individual you may be required to provide </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">documentation evidencing your power to sign this VIF with signing capacity stated. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Interim
Financial Statements - Mark this box if you would </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Annual Financial Statements - Mark this box if you would </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">like to receive Interim Financial Statements and </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">like to receive the Annual Financial
Statements and </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">accompanying Management&#146;s Discussion and Analysis by
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">accompanying Management&#146;s Discussion and Analysis by </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">mail. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">mail. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If you are not mailing back your VIF, you may register online to receive the above
financial report(s) by mail at www.computershare.com/mailinglist. </FONT></P> <P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">T L R Q 3 0 1 0 5 6 A R 1 </FONT></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.24
<SEQUENCE>25
<FILENAME>d20922dex9924.htm
<DESCRIPTION>EX-99.24
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.24</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.24 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Unit 3204 &#150; 4464 Markham Street, Victoria, BC V8Z 7X8 </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOTICE IS HEREBY GIVEN </B>that the Annual General Meeting (the &#147;Meeting&#148;) of the shareholders of ImmunoPrecise Antibodies Ltd. (the
&#147;Company&#148;) will be held at Suite 704, 595 Howe Street, Vancouver, BC, V6C 2T5 on Friday, November 22, 2019 at 10:00 a.m. (PST) for the following purposes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to set the number of directors at seven (7)&nbsp;persons; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to elect Jennifer Bath, James Kuo, Greg Smith, Robert Beecroft, Robert Burke, Paul Andreola and Brian Lundstrom
as directors of the Company for the ensuing year; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to appoint Crowe MacKay LLP as the auditors of the Company for the ensuing year and to authorize the directors
to fix the remuneration to be paid to the auditors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to consider, and if thought fit, to pass an ordinary resolution approving and ratifying the Company&#146;s 10%
rolling stock option plan as more particularly described in the accompanying Information Circular; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to consider, and if thought fit, to pass an ordinary resolution approving and ratifying the Company&#146;s
shareholder rights plan, as more particularly described in the accompanying Information Circular; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to transact such other business as may be properly brought before the Meeting or any adjournment thereof.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All registered shareholders are entitled to attend and vote at the Meeting in person or by proxy. The Board of Directors (the
&#147;<B>Board</B>&#148;) requests that all registered shareholders who will not be attending the Meeting in person read, date and sign the accompanying proxy and deliver it to Computershare Investor Services Inc. (&#147;<B>Computershare</B>&#148;).
If a registered shareholder does not deliver a proxy to Computershare, Attention: Proxy Department, 100 University Avenue, 8th Floor, Toronto, Ontario, M5J 2Y1, by 10:00 a.m. (Vancouver, British Columbia time) on <B>Wednesday,
November</B><B></B><B>&nbsp;20, 2019 </B>(or before 48 hours, excluding Saturdays, Sundays and holidays before any adjournment of the meeting at which the proxy is to be used) then the shareholder will not be entitled to vote at the Meeting by
proxy. Only shareholders of record at the close of business on <B>September</B><B></B><B>&nbsp;25, 2019 </B>will be entitled to vote at the Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If
you are a <FONT STYLE="white-space:nowrap">non-registered</FONT> Shareholder of the Company, please complete and return the materials in accordance with the instructions set forth in the accompanying Information Circular. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An Information Circular and a form of proxy accompany this notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DATED at Vancouver, British Columbia, the 22<SUP STYLE="font-size:85%; vertical-align:top">rd</SUP> day of October, 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ON BEHALF OF THE BOARD </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IMMUNOPRECISE ANTIBODIES LTD.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>&#147;Jennifer Bath&#148; </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jennifer Bath </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Executive Officer, President and Director </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.25
<SEQUENCE>26
<FILENAME>d20922dex9925.htm
<DESCRIPTION>EX-99.25
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.25</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.25 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Unit 3204 &#150; 4464 Markham Street, Victoria, BC V8Z 7X8 </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOTICE IS HEREBY GIVEN </B>that the Annual General Meeting (the &#147;Meeting&#148;) of the shareholders of ImmunoPrecise Antibodies Ltd. (the
&#147;Company&#148;) will be held at Suite 704, 595 Howe Street, Vancouver, BC, V6C 2T5 on Friday, November 22, 2019 at 10:00 a.m. (PST) for the following purposes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to set the number of directors at seven (7)&nbsp;persons; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to elect Jennifer Bath, James Kuo, Greg Smith, Robert Beecroft, Robert Burke, Paul Andreola and Brian Lundstrom
as directors of the Company for the ensuing year; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to appoint Crowe MacKay LLP as the auditors of the Company for the ensuing year and to authorize the directors
to fix the remuneration to be paid to the auditors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to consider, and if thought fit, to pass an ordinary resolution approving and ratifying the Company&#146;s 10%
rolling stock option plan as more particularly described in the accompanying Information Circular; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to consider, and if thought fit, to pass an ordinary resolution approving and ratifying the Company&#146;s
shareholder rights plan, as more particularly described in the accompanying Information Circular; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to transact such other business as may be properly brought before the Meeting or any adjournment thereof.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All registered shareholders are entitled to attend and vote at the Meeting in person or by proxy. The Board of Directors (the
&#147;<B>Board</B>&#148;) requests that all registered shareholders who will not be attending the Meeting in person read, date and sign the accompanying proxy and deliver it to Computershare Investor Services Inc. (&#147;<B>Computershare</B>&#148;).
If a registered shareholder does not deliver a proxy to Computershare, Attention: Proxy Department, 100 University Avenue, 8th Floor, Toronto, Ontario, M5J 2Y1, by 10:00 a.m. (Vancouver, British Columbia time) on <B>Wednesday,
November</B><B></B><B>&nbsp;20, 2019 </B>(or before 48 hours, excluding Saturdays, Sundays and holidays before any adjournment of the meeting at which the proxy is to be used) then the shareholder will not be entitled to vote at the Meeting by
proxy. Only shareholders of record at the close of business on <B>September</B><B></B><B>&nbsp;25, 2019 </B>will be entitled to vote at the Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If
you are a <FONT STYLE="white-space:nowrap">non-registered</FONT> Shareholder of the Company, please complete and return the materials in accordance with the instructions set forth in the accompanying Information Circular. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An Information Circular and a form of proxy accompany this notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DATED at Vancouver, British Columbia, the 22<SUP STYLE="font-size:85%; vertical-align:top">rd</SUP> day of October, 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ON BEHALF OF THE BOARD </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IMMUNOPRECISE ANTIBODIES LTD.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>&#147;Jennifer Bath&#148; </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jennifer Bath </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Executive Officer, President and Director </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.26
<SEQUENCE>27
<FILENAME>d20922dex9926.htm
<DESCRIPTION>EX-99.26
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.26</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IMMUNOPRECISE ANTIBODIES LTD.</B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.26</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="right">


<IMG SRC="g20922g32c30.jpg" ALT="LOGO">
</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Security Class</B></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Holder Account Number</B></P></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px dashed #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px dashed #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fold</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13" COLSPAN="3"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Form of Proxy - Annual General Meeting to be held on Friday, November&nbsp;22, 2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>This Form of Proxy is solicited by and on behalf of Management.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Notes to proxy</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Every holder has the right to appoint some other person or company of their choice, who need not be a holder, to attend and act on their behalf at the meeting or any adjournment or postponement thereof. If you wish to appoint a
person or company other than the persons whose names are printed herein, please insert the name of your chosen proxyholder in the space provided (see reverse).</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">2.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top">If the securities are registered in the name of more than one owner (for example, joint ownership, trustees, executors, etc.), then all those registered should sign this proxy. If you are voting on behalf of a corporation or another
individual you must sign this proxy with signing capacity stated, and you may be required to provide documentation evidencing your power to sign this proxy.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">3.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top">This proxy should be signed in the exact manner as the name(s) appear(s) on the proxy.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top">If this proxy is not dated, it will be deemed to bear the date on which it is mailed by Management to the holder.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">5.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>The securities represented by this proxy will be voted as directed by the holder, however, if such a direction is not made in respect of any matter, this proxy will be voted as </B><B>recommended by Management.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">6.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top">The securities represented by this proxy will be voted in favour or withheld from voting or voted against each of the matters described herein, as applicable, in accordance with the instructions of the holder, on any ballot that may
be called for and, if the holder has specified a choice with respect to any matter to be acted on, the securities will be voted accordingly. </TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">7.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top">This proxy confers discretionary authority in respect of amendments or variations to matters identified in the Notice of Meeting or other matters that may properly come before the meeting or any adjournment or postponement
thereof.</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px dashed #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px dashed #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;<U></U></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:6pt">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">8.</P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">This proxy should be read in conjunction with the
accompanying documentation provided by Management.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Fold</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Proxies submitted must be received by 10:00 am, Pacific Time, on Wednesday, November&nbsp;20, 2019 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>VOTE USING THE TELEPHONE OR INTERNET 24 HOURS A DAY 7 DAYS A WEEK! </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g39h15.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>If you vote by telephone or the Internet, DO NOT mail back this proxy. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting by mail </B>may be the only method for securities held in the name of a corporation or securities being voted on behalf of another individual. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting by mail or by Internet </B>are the only methods by which a holder may appoint a person as proxyholder other than the Management nominees named on
the reverse of this proxy. Instead of mailing this proxy, you may choose one of the two voting methods outlined above to vote this proxy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>To vote by
telephone or the Internet, you will need to provide your CONTROL NUMBER listed below. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CONTROL NUMBER </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g20922g21a59.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">Appointment of Proxyholder </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">I/We being holder(s) of
Immunoprecise Antibodies Ltd. hereby appoint (s): Jennifer Bath, an officer and director of the Company, or failing her, James Kuo, a director of the Company, or failing him, Lisa Helbling, an officer of the Company, or failing her, Paul Andreola, a
director of the Company </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">OR </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Print the name of the person you are appointing if
this person is someone other than the Chairman of the Meeting. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">as my/our proxyholder with full power of substitution and to attend, act and to vote for and on
behalf of the shareholder in accordance with the following direction (or if no directions have been given, as the proxyholder sees fit) and all other matters that may properly come before the Annual General Meeting of shareholders of Immunoprecise
Antibodies Ltd. to be held at Northwest Law Group Barrister and Solicitors, Suite 704, 595 Howe Street, Vancouver, BC on Friday, November&nbsp;22, 2019 at 10:00 am, Pacific Time and at any adjournment or postponement thereof. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">VOTING RECOMMENDATIONS ARE INDICATED BY HIGHLIGHTED TEXT OVER THE BOXES. </FONT></P> <P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">For </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Against </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">1. Number of Directors </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">To Set the Number of Directors at seven (7). </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">&#151;&#151;&#151;&#151;&nbsp;&nbsp; </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">2. Election of Directors </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Fold </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">For
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Withhold </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">For </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Withhold </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">For </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Withhold </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">01. Jennifer Bath </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">02. James Kuo </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">03. Greg Smith </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">04. Robert Beecroft </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">05. Robert Burke </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">06. Paul Andreola </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">07. Brian Lundstrom </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">For </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Withhold </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">3. Appointment of Auditors </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Appointment of Crowe MacKay LLP as Auditors of the Company for the
ensuing year and authorizing the Directors to fix their remuneration. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">For
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Against </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">4. Stock Option Plan </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">To consider and, if thought fit, to pass an ordinary resolution approving and ratifying the Company&#146;s currently implemented Stock Option Plan, as </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">more fully set out in the accompanying Information Circular. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">For </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Against </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">5. Shareholder Rights Plan </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">&#151;&#151;&#151;&#151;&nbsp;&nbsp; </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Fold </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">To consider, and if thought fit, to pass an ordinary resolution, the full text of which is set forth in the accompanying Information Circular, approving </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">and ratifying the Company&#146;s Shareholder Rights Plan, as more particularly described in the accompanying Information Circular. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Authorized Signature(s)&#151;This section must be completed for your </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Signature(s) </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Date </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">instructions to be executed. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">I/We authorize you to act in accordance with my/our instructions set out above. I/We hereby
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">revoke any proxy previously given with respect to the Meeting. If no voting instructions are </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">indicated above, this Proxy will be voted as recommended by Management. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Interim Financial
Statements - Mark this box if you would </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Annual Financial Statements - Mark this box if you would </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">like to receive Interim Financial Statements and </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">like to receive the Annual Financial
Statements and </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">accompanying Management&#146;s Discussion and Analysis by
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">accompanying Management&#146;s Discussion and Analysis by </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">mail. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">mail. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If you are not mailing back your proxy, you may register online to receive the above
financial report(s) by mail at www.computershare.com/mailinglist. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">T L R Q 3 0 1 0 5 7 A R 1 </FONT></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.27
<SEQUENCE>28
<FILENAME>d20922dex9927.htm
<DESCRIPTION>EX-99.27
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.27</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.27 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SHAREHOLDER RIGHTS PLAN AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BETWEEN </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE
ANTIBODIES LTD. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMPUTERSHARE TRUST COMPANY OF CANADA </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Made as of October&nbsp;17, 2019 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 1 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INTERPRETATION </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Certain Definitions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Currency</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Number and Gender</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Sections</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Statutory References</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Calculation of Voting Shares Beneficially Owned</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Acting Jointly or in Concert</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Generally Accepted Accounting Principles</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>ARTICLE 2</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>THE RIGHTS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Issuance of Rights; Legend on Share Certificates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Initial Exercise Price; Exercise of Rights; Detachment of Rights</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Adjustments to Exercise Price; Number of Rights</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Date on Which Exercise is Effective</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Execution, Authentication, Delivery and Dating of Rights Certificates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Registration, Transfer and Exchange</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Mutilated, Lost, Stolen and Destroyed Rights Certificates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Persons Deemed Owners</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Delivery and Cancellation of Certificates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Agreement of Rights Holders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Exclusion of Warranty by Rights Agent</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>ARTICLE 3</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>ADJUSTMENTS TO THE RIGHTS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Flip-in Event</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Fiduciary Duties of the Board of Directors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>ARTICLE 4</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>THE RIGHTS AGENT</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">General</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Merger, Amalgamation, Consolidation or Change of Name of Rights Agent</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Duties of Rights Agent</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Change of Rights Agent</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Compliance with Anti-Money Laundering Legislation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Privacy Legislation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>ARTICLE 5</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>MISCELLANEOUS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Redemption, Waiver, Extension and Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Expiration</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Issuance of New Rights Certificates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Supplements and Amendments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Fractional Rights and Fractional Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Rights of Action</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Holder of Rights Not Deemed a Shareholder</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Notice of Proposed Actions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Notices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Costs of Enforcement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Regulatory Approvals</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Declaration as to Non-Canadian and Non-United States Holders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Successors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Benefits of this Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Shareholder Reconfirmation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Determinations and Actions by the Board of Directors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.17</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Force Majeure</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.18</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Governing Law</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.19</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Language</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.20</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Severability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.21</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Effective Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.22</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Time of the Essence</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.23</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Counterparts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 2 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SHAREHOLDER RIGHTS PLAN AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THIS AGREEMENT </B>is made as of the 17th day of October, 2019 between: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IMMUNOPRECISE ANTIBODIES LTD.</B>, a corporation subsisting under the laws of British Columbia (the &#147;<B>Corporation</B>&#148;) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>COMPUTERSHARE TRUST
COMPANY OF CANADA</B>, a trust company incorporated under the laws of Canada (the &#147;<B>Rights Agent</B>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B> the
board of directors of the Corporation has determined that it is in the best interests of the Corporation to adopt a shareholder rights plan in order to ensure, to the extent possible, that: (i)&nbsp;all shareholders of the Corporation are treated
fairly in connection with any Offer to Acquire the outstanding Voting Shares, and (ii)&nbsp;the board of directors of the Corporation has the opportunity to identify, solicit, develop and negotiate value-enhancing alternatives, as appropriate, to
any unsolicited Offer to Acquire the outstanding Voting Shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>AND WHEREAS</B> each Right (as defined herein) issued pursuant to this
Agreement entitles the holder thereof, from and after the Separation Time (as defined herein), to purchase securities of the Corporation pursuant to the terms and subject to the conditions set forth herein; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>AND WHEREAS</B> the Corporation desires to appoint the Rights Agent to act on behalf of the Corporation and the holders of Rights, and the
Rights Agent is willing to so act, in connection with the issuance, transfer, exchange and replacement of Rights Certificates (as defined herein), the exercise of Rights and other matters referred to herein; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW THEREFORE</B>, in consideration of the premises and the respective covenants and agreements set forth herein, the Corporation and the
Rights Agent hereby agree as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 1 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INTERPRETATION </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.1</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Certain Definitions</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the purposes of this Agreement, including the recitals hereto, the following terms have the meanings indicated: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Acquiring Person</B>&#148; means any Person who is the Beneficial Owner of 20% or more of the then
outstanding Voting Shares, but does not include: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Corporation or any Subsidiary of the Corporation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any Person who becomes the Beneficial Owner of 20% or more of the then outstanding Voting Shares as a result of
one or any combination of: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a Voting Share Reduction, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a Permitted Bid Acquisition, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">an Exempt Acquisition, </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;2&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(D)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a Convertible Security Acquisition, or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(E)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a Pro Rata Acquisition, </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">provided, however, that if a Person becomes the Beneficial Owner of 20% or more of the then outstanding Voting Shares by reason of one or any
combination of a Voting Share Reduction, a Permitted Bid Acquisition, an Exempt Acquisition, a Convertible Security Acquisition or a Pro Rata Acquisition, and thereafter becomes the Beneficial Owner of an additional 1% or more of the then
outstanding Voting Shares (other than pursuant to a Voting Share Reduction, a Permitted Bid Acquisition, an Exempt Acquisition, a Convertible Security Acquisition or a Pro Rata Acquisition or any combination thereof), then, as of the date that such
Person becomes the Beneficial Owner of such additional Voting Shares, such Person shall become an &#147;<B>Acquiring Person</B>&#148;; </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">for the period of 10 days after the Disqualification Date, any Person who becomes the Beneficial Owner of 20%
or more of the outstanding Voting Shares as a result of such Person becoming disqualified from relying on subsection 1.1(f)(ii)(B) where such disqualification results solely because such Person is making or has announced a current intention to make
a Take-over Bid, either alone or by acting jointly or in concert with any other Person, unless such disqualified Person during such 10 day period acquires an additional 1% or more of the then outstanding Voting Shares. For the purposes of this
definition, &#147;<B>Disqualification Date</B>&#148; means the first date of public announcement that such Person is making or intends to make a Take-over Bid, either alone or by acting jointly or in concert with another Person;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">an underwriter or a member of a banking or selling group that becomes the Beneficial Owner of 20% or more of
the Voting Shares in connection with a distribution of securities pursuant to an underwriting agreement with the Corporation; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a Person (a &#147;<B>Grandfathered Person</B>&#148;) who is the Beneficial Owner of more than 20% of the
outstanding Voting Shares determined as at the Record Time, provided, however, that this exception shall not be, and shall cease to be, applicable to a Grandfathered Person in the event that such Grandfathered Person shall, after the Record Time:
(1)&nbsp;cease to own more than 20% of the outstanding Voting Shares, or (2)&nbsp;become the Beneficial Owner of any additional Voting Shares that increases its Beneficial Ownership of Voting Shares by more than 1.0% of the number of Voting Shares
outstanding as at the Record Time (other than pursuant to one or any combination of a Voting Share Reduction, a Permitted Bid Acquisition, an Exempt Acquisition, a Convertible Security Acquisition or a Pro Rata Acquisition). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Affiliate</B>&#148;, when used to indicate a relationship with a specified Person, means a Person that
directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, such specified Person. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Agreement</B>&#148; means this shareholder rights plan agreement between the Corporation and the
Rights Agent, as amended, supplemented or restated from time to time. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;3&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Associate</B>&#148;, when used to indicate a relationship with a specified Person, means any relative
of such specified Person who has the same home as such specified Person, or any person to whom such specified Person is married, or any person with whom such specified Person is living in a conjugal relationship outside marriage, or any relative of
such spouse or other Person who has the same home as such specified Person. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>BCBCA</B>&#148; means the<I> Business Corporations Act</I>, S.B.C. 2002, c. 57, as amended, and the
regulations thereunder, and any comparable or successor laws or regulations thereto. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(i) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A Person shall be deemed the &#147;<B>Beneficial Owner</B>&#148; of, and to
have &#147;<B>Beneficial</B> <B>Ownership</B>&#148; of, and to &#147;<B>Beneficially Own</B>&#148;: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any securities as to which such Person or any of such Person&#146;s Affiliates or Associates is the owner at
law or in equity; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any securities as to which such Person or any of such Person&#146;s Affiliates or Associates has the right to
become the owner at law or in equity, whether such right is exercisable immediately or within a period of 60 days thereafter and whether or not on the condition or occurrence of a contingency or the making of one or more payments, upon the
conversion, exchange or exercise of any Convertible Security or pursuant to any agreement, arrangement, pledge or understanding, whether or not in writing, other than: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">customary agreements with and between underwriters and banking group or selling group members with respect to a
distribution of securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">pledges of securities in the ordinary course of the pledgee&#146;s business; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">agreements between the Corporation and any Person pursuant to an amalgamation, merger, arrangement, business
combination or other similar transaction (statutory or otherwise, but for greater certainty not including a Take-over Bid) that is conditional upon the approval of the shareholders of the Corporation to be obtained prior to such Person acquiring
such securities; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any securities that are Beneficially Owned within the meaning of subsections 1.1(f)(i)(A) or 1.1(f)(i)(B) by
any other Person with which such Person is acting jointly or in concert. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding the provisions of subsection 1.1(f)(i), a Person shall not be deemed the &#147;<B>Beneficial
Owner</B>&#148; of, or to have &#147;<B>Beneficial Ownership</B>&#148; of, or to &#147;<B>Beneficially Own</B>&#148;, any security solely by reason of any one or more of the following circumstances: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">(A)&nbsp;&nbsp;&nbsp;&nbsp;(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the holder of such security having agreed to deposit or tender such security to a Take-over Bid made by such
Person or any of such Person&#146;s Affiliates or Associates or any other Person with which such Person is acting jointly or in concert pursuant to a Permitted Lock-Up Agreement, or </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;4&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such security having been deposited or tendered pursuant to a Take-over Bid made by such Person or any of such
Person&#146;s Affiliates or Associates or made by any other Person acting jointly or in concert with such Person until such deposited or tendered security has been taken up or paid for, whichever shall first occur; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such Person, any Affiliate or Associate of such Person or any other Person acting jointly or in concert with
such Person holding such security; provided that: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the ordinary business of such Person (the &#147;<B>Portfolio Manager</B>&#148;) includes the management or
administration of investment funds for other Persons (which, for greater certainty, may include or be limited to one or more employee benefit plans or pension plans) and such security is held by the Portfolio Manager in the ordinary course of such
business in the performance of the Portfolio Manager&#146;s duties for the account of any other Person (a &#147;<B>Client</B>&#148;), including non-discretionary accounts held on behalf of a Client by a registered broker or dealer,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the ordinary business of such Person (the &#147;<B>Fund Manager</B>&#148;) is manager or trustee of one or more
mutual funds registered or qualified to issue its securities under the laws of Canada or the United States of America or any province or state thereof (each, a &#147;<B>Mutual Fund</B>&#148;), or such Person is a Mutual Fund, and holds such security
for the purposes of its activity as such Fund Manager or Mutual Fund, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such Person (the &#147;<B>Trust Company</B>&#148;) is licensed to carry on the business of a trust company
under applicable laws and, as such, acts as trustee or administrator or in a similar capacity in relation to the estates of deceased or incompetent Persons (each, an &#147;<B>Estate Account</B>&#148;) or in relation to other accounts (each, an
&#147;<B>Other Account</B>&#148;) and holds such security in the ordinary course of such duties for such Estate Accounts or for such Other Accounts, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such Person (the &#147;<B>Crown Agent</B>&#148;) is established by statute for purposes that include, and the
ordinary business or activity of such Person includes, the management of investment funds for employee benefit plans, pension plans and insurance plans of various public bodies, or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such Person (the &#147;<B>Plan Administrator</B>&#148;) is the administrator or the trustee of one or more
pension funds or plans registered under the laws of Canada, the United States of America, the European Union or any province, state or other political subdivision thereof (each, a &#147;<B>Plan</B>&#148;), or is a Plan, and holds such security for
the purposes of its activity as such Plan Administrator or Plan, </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;5&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
provided; however, that in any of the foregoing cases, the Portfolio Manager, the Fund Manager, the Mutual Fund, the Trust Company, the Crown Agent, the Plan Administrator or the Plan, as the
case may be, is not then making or has not then announced an intention to make, a Take-over Bid, other than an Offer to Acquire Voting Shares or other securities pursuant to a distribution by the Corporation, a Permitted Bid or by means of ordinary
market transactions (including pre-arranged trades entered into in the ordinary course of business of such Person) executed through the facilities of the Exchange, alone or by acting jointly or in concert with any other Person; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such Person is a Client of the same Portfolio Manager as another Person on whose account the Portfolio Manager
holds such security, or because such Person is an Estate Account or an Other Account of the same Trust Company as another Person on whose account the Trust Company holds such security or because such Person is a Plan with the same Plan Administrator
as another Plan on whose account the Plan Administrator holds such security; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(D)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such Person is a Client of a Portfolio Manager and such security is owned at law or in equity by the Portfolio
Manager or because such Person is an Estate Account or an Other Account of a Trust Company and such security is owned at law or in equity by the Trust Company or such Person is a Plan and such security is owned at law or in equity by the Plan
Administrator of such Plan; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(E)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such Person is the registered holder of securities as a result of carrying on the business, or acting as a
nominee, of a securities depositary. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Board of Directors</B>&#148; means the board of directors of the Corporation or any duly constituted
and empowered committee thereof. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Book Entry Form</B>&#148; means, in reference to securities, securities that have been issued and
registered in uncertificated form and includes securities evidenced by an advice or other statement and securities which are maintained electronically on the records of the Corporation&#146;s transfer agent but for which no certificate has been
issued. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Book Entry Rights Exercise Procedures</B>&#148; has the meaning ascribed thereto in subsection 2.2(c).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Business Day</B>&#148; means any day, other than a Saturday or Sunday or a day on which banking
institutions in Vancouver, British Columbia are authorized or obligated by law to close. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Canadian Dollar Equivalent</B>&#148; of any amount which is expressed in United States dollars means
on any date the Canadian dollar equivalent of such amount determined by reference to the U.S. - Canadian Exchange Rate in effect on such date. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>certificate</B>&#148; means either a physical paper certificate or a Direct Registration System (DRS)
form evidencing the ownership of Shares or Rights. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;6&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(m)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Close of Business</B>&#148; on any given date means the time on such date (or, if such date is not a
Business Day, the time on the next succeeding Business Day) at which the principal office of the transfer agent for the Common Shares in Vancouver, British Columbia (or after the Separation Time, the principal office of the Rights Agent in
Vancouver, British Columbia) is closed to the public;<I> provided, however</I>, that for the purposes of the definitions of &#147;Competing Permitted Bid&#148; and &#147;Permitted Bid&#148;, &#147;Close of Business&#148; on any date means 11:59 p.m.
(local time at the place of deposit) on such date (or, if such date is not a Business Day, 11:59 p.m. (local time at the place of deposit) on the next succeeding Business Day). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(n)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Closing Price</B>&#148; per security of any securities on any date of determination means:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the closing board lot sale price or, if such price is not available, the average of the closing bid and asked
prices, for each of such securities as reported by the principal stock exchange or national securities quotation system on which such securities are listed or admitted to trading (provided that, if at the date of determination such securities are
listed or admitted to trading on more than one stock exchange or national securities quotation system, then such price or prices shall be determined based upon the stock exchange or quotation system on which such securities are then listed or
admitted to trading on which the largest number of such securities were traded during the most recently completed calendar year); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if for any reason none of such prices is available on such day or the securities are not listed or admitted to
trading on a stock exchange or a national securities quotation system, then the last sale price, or in case no sale takes place on such date, the average of the high bid and low asked prices for each of such securities in the over-the-counter
market, as quoted by any reporting system then in use; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if for any reason none of such prices is available on such day or the securities are not listed or admitted to
trading on a stock exchange or a national securities quotation system or quoted by any such reporting system, then the average of the closing bid and asked prices as furnished by a professional market maker making a market in the securities selected
in good faith by the Board of Directors; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if for any reason none of such prices are available on such date, then the &#147;<B>Closing Price</B>&#148; per
security of such securities on such date shall mean the fair value per security of the securities on such date as determined by a nationally or internationally recognized investment dealer or investment banker with respect to the fair value per
security of such securities and, if the Closing Price so determined is expressed in United States dollars, then such amount shall be converted to the Canadian Dollar Equivalent. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(o)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Common Shares</B>&#148; means the common shares in the share capital of the Corporation as presently
constituted, as such shares may be subdivided, consolidated, reclassified or otherwise changed from time to time. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(p)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Competing Permitted Bid</B>&#148; means a Take-over Bid that: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">is made after a Permitted Bid or another Competing Bid has been made and prior to the expiry, termination or
withdrawal of such Permitted Bid or Competing Permitted Bid; </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;7&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">satisfies all components of the definition of a Permitted Bid other than the requirement set forth in
subsection 1.1(oo)(ii)(A) of the definition of a Permitted Bid; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">contains, and the take-up and payment for securities tendered or deposited thereunder is subject to, an
irrevocable and unqualified condition that no Voting Shares and/or Convertible Securities will be taken up or paid for pursuant to such Take-over Bid prior to the Close of Business on the last day of the minimum initial deposit period that such
Take-over Bid must remain open for deposits of securities thereunder pursuant to NI 62-104 after the date of the Take-over Bid constituting the Competing Permitted Bid; </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">provided, however, that a Take-over Bid that qualified as a Competing Permitted Bid shall cease to be a Competing Permitted Bid at any time and
as soon as such time as when such Take-over Bid ceases to meet any or all of the provisions of this definition. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(q)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Controlled</B>&#148; means as follows: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a body corporate is &#147;controlled&#148; by another Person or two or more other Persons acting jointly or in
concert if: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">securities entitled to vote in the election of directors of such body corporate carrying more than 50% of the
votes for the election of directors are held, directly or indirectly, by or for the benefit of the other Person or Persons, and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the votes carried by such securities are entitled, if exercised, to elect a majority of the board of directors
of such body corporate; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a Person which is not a body corporate is &#147;controlled&#148; by another Person or two or more other Persons
acting jointly or in concert if more than 50% of the voting or equity interests of such Person are held, directly or indirectly, by or for the benefit of the other Person or Persons; </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">and &#147;<B>controls</B>&#148;, &#147;<B>controlling</B>&#148; and &#147;<B>under common control with</B>&#148; shall be interpreted
accordingly. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(r)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Convertible Security</B>&#148; means a security issued by the Corporation from time to time (other
than the Rights) carrying any purchase, exercise, conversion or exchange right pursuant to which the holder thereof may acquire Voting Shares or other securities carrying any purchase, exercise, conversion or exchange right pursuant to which the
holder thereof may acquire Voting Shares, directly or indirectly, (in each case, whether such right is exercisable immediately or within or after a specified period and whether or not on condition or the happening of any contingency).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(s)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Convertible Security Acquisition</B>&#148; means the acquisition of Voting Shares by a Person upon the
purchase, exercise, conversion or exchange of Convertible Securities acquired or received by such Person pursuant to a Permitted Bid Acquisition, an Exempt Acquisition or a Pro Rata Acquisition. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(t)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Co-Rights Agent</B>&#148; has the meaning ascribed thereto in subsection 4.1(a).
</P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;8&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(u)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Disposition Date</B>&#148; has the meaning ascribed thereto in subsection 5.1(b).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Dividend Reinvestment Acquisition</B>&#148; means an acquisition of Voting Shares and/or Convertible
Securities of any class or series pursuant to a Dividend Reinvestment Plan. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(w)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Dividend Reinvestment Plan</B>&#148; means a regular dividend reinvestment or other plan of the
Corporation made available by the Corporation to holders of its securities where such plan permits the holder to direct that some or all of: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">dividends paid in respect of shares of any class of the Corporation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">proceeds of redemption of shares of the Corporation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">interest paid on evidences of indebtedness of the Corporation; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">optional cash payments; </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">be applied to the purchase from the Corporation of Voting Shares and/or Convertible Securities. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(x)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Effective Date</B>&#148; means October&nbsp;17, 2019. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(y)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Election to Exercise</B>&#148; has the meaning ascribed thereto in subsection 2.2(e)(ii).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(z)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Exchange</B>&#148; means the TSX Venture Exchange and any other exchange on which the Common Shares
may, from time to time, be listed for trading. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(aa)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Exempt Acquisition</B>&#148; means an acquisition by a Person of Voting Shares and/or Convertible
Securities: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in respect of which the Board of Directors has waived the application of Section&nbsp;3.1 pursuant to the
provisions of Section&nbsp;5.1; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">made as an intermediate step in a series of related transactions in connection with an acquisition by the
Corporation or its Subsidiaries of a Person or assets, provided that the Person who acquires such Voting Shares distributes or is deemed to distribute such Voting Shares to its securityholders within 10 Business Days of the completion of such
acquisition, and following such distribution no Person has become the Beneficial Owner of 20% or more of the Corporation&#146;s then outstanding Voting Shares; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">pursuant to an amalgamation, merger, arrangement, business combination or other similar transaction (statutory
or otherwise, but for greater certainty not including a Take-over Bid) that is conditional upon the approval of the shareholders of the Corporation to be obtained prior to such Person acquiring such securities. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(bb)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Exercise Price</B>&#148; means, as of any date, the price at which a holder of a Right may purchase
the securities issuable upon exercise of one whole Right in accordance with the terms hereof. Subject to adjustment in accordance with the terms hereof, the Exercise Price shall be: </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;9&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">until the Separation Time, an amount equal to three times the Market Price, from time to time, per Common
Share; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">from and after the Separation Time, an amount equal to three times the Market Price, as at the Separation Time,
per Common Share. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(cc)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Expansion Factor</B>&#148; has the meaning ascribed thereto in subsection 2.3(b)(v)(A).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(dd)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Expiration Time</B>&#148; means the earlier of: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Termination Time; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Close of Business on that date on which a Reconfirmation Meeting occurs and at which this Agreement is not
reconfirmed or presented for reconfirmation as contemplated in Section&nbsp;5.15. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ee)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Fiduciary</B>&#148; means a trust company registered under the trust company legislation of Canada or
any province thereof, a trust company organized under the laws of any state of the United States, a portfolio manager registered under the securities legislation of one or more provinces of Canada or an investment adviser registered under the<I>
United States Investment Advisers Act of 1940</I>, as amended, or any other securities legislation of the United States or any state of the United States. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ff)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Flip-in Event</B>&#148; means a transaction or event in or pursuant to which any Person becomes an
Acquiring Person. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(gg)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>holder</B>&#148; has the meaning ascribed thereto in Section&nbsp;2.8. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(hh)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Independent Shareholders</B>&#148; means holders of outstanding Voting Shares, other than any:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Acquiring Person; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Offeror other than a Person who at the relevant time is deemed not to Beneficially Own such Voting Shares by
reason of subsection 1.1(f)(ii)(B); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Affiliate or Associate of such Acquiring Person or Offeror; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Person acting jointly or in concert with such Acquiring Person or Offeror; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">employee benefit plan, stock purchase plan, deferred profit sharing plan or any similar plan or trust for the
benefit of employees of the Corporation or a Subsidiary of the Corporation, unless the beneficiaries of such plan or trust direct the manner in which the Voting Shares are to be voted or withheld from voting or direct whether or not the Voting
Shares are to be deposited or tendered to a Take-over Bid. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Market Price</B>&#148; per security of any securities on any date of determination means the average
of the daily Closing Prices per security of such securities on each of the 20 consecutive Trading Days through to and including the Trading Day immediately preceding such date of determination; provided, however, that if an event of a type analogous
to any of the events described in Section&nbsp;2.3 shall have caused any Closing Price used to determine the Market Price on any Trading Day not to be fully comparable </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;10&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
with the Closing Price on the Trading Day immediately preceding such date of determination, each such Closing Price so used shall be appropriately adjusted in a manner analogous to the applicable
adjustment provided for in Section&nbsp;2.3 in order to make it fully comparable with the Closing Price on the Trading Day immediately preceding such date of determination. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(jj)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>NI 62-104</B>&#148; means National Instrument 62-104 - <I>Take-Over Bids and Issuer Bids </I>adopted
by the Canadian securities regulatory authorities, as now in effect or as the same may from time to time be amended, re-enacted or replaced. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(kk)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Nominee</B>&#148; has the meaning ascribed thereto in Section&nbsp;2.2(c). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ll)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Offer to Acquire</B>&#148; shall include: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">an offer to purchase or a solicitation of an offer to sell Voting Shares, or a public announcement of an
intention to make such an offer or solicitation; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">an acceptance of an offer to sell Voting Shares, whether or not such offer to sell has been solicited,
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">or any combination thereof, and the Person accepting an offer to sell shall be deemed to be making an Offer to Acquire
to the Person that made the offer to sell. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(mm)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Offeror</B>&#148; means a Person who has made a public announcement of a current intention to make, or
who is making, a Take-over Bid (including a Permitted Bid or a Competing Permitted Bid). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(nn)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Offeror&#146;s Securities</B>&#148; means the aggregate of the Voting Shares Beneficially Owned by an
Offeror on the date of an Offer to Acquire. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(oo)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Permitted Bid</B>&#148; means a Take-over Bid made by an Offeror by way of take-over bid circular
which also complies with the following additional provisions: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Take-over Bid is made to all holders of record of Voting Shares, other than the Offeror;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Take-over Bid contains, and the take-up and payment for securities tendered or deposited is subject to, an
irrevocable and unqualified provision that no Voting Shares and/or Convertible Securities will be taken up or paid for pursuant to the Take-over Bid: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">prior to the Close of Business on a date that is not less than 105 days following the date of the Take-over Bid
or such shorter minimum period that a take-over bid that is not exempt from any of the requirements of Division 5 (Bid Mechanics) of NI 62-104 must remain open for deposits of securities thereunder, in the applicable circumstances at such time,
pursuant to NI 62-104; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">then only if, at the Close of Business on the date Voting Shares and/or Convertible Securities are first taken
up or paid for under such Take-over Bid, more than 50% of the then Voting Shares held by Independent Shareholders have been deposited or tendered pursuant to the Take-over Bid and not withdrawn; </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;11&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Take-over Bid contains an irrevocable and unqualified provision that Voting Shares and/or Convertible
Securities may be deposited or tendered pursuant to such Take-over Bid, unless such Take-over Bid is withdrawn, at any time prior to the Close of Business on the date Voting Shares and/or Convertible Securities are first taken up or paid for under
the Take-over Bid; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Take-over Bid contains an irrevocable and unqualified provision that any Voting Shares and/or Convertible
Securities deposited or tendered pursuant to the Take-over Bid may be withdrawn until taken up and paid for; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Take-over Bid contains an irrevocable and unqualified provision that in the event that the deposit
condition set forth in subsection 1.1(oo)(ii)(B) is satisfied, the Offeror will make a public announcement of that fact and the Take-over Bid will remain open for deposits and tenders of Voting Shares and/or Convertible Securities for not less than
10 days from the date of such public announcement; </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">provided, however, that a Take-over Bid that qualified as a Permitted
Bid shall cease to be a Permitted Bid at any time and as soon as such time as when such Take-over Bid ceases to meet any or all of the provisions of this definition. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(pp)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Permitted Bid Acquisition</B>&#148; means an acquisition of Voting Shares and/or Convertible
Securities made pursuant to a Permitted Bid or a Competing Permitted Bid;<I> provided that </I>for greater certainty, any acquisition of Voting Shares and/or Convertible Securities made pursuant to a Competing Permitted Bid or a Permitted Bid that
ceased to be a Competing Permitted Bid or a Permitted Bid by reason of such acquisition ceasing to meet any or all of the provisions of the definition of &#147;Competing Permitted Bid&#148; or &#147;Permitted Bid&#148;, as applicable, including
before such acquisition ceased to be a Competing Permitted Bid or Permitted Bid, as applicable, will not be a Permitted Bid Acquisition. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(qq)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Permitted Lock-Up Agreement</B>&#148; means an agreement between a Person and one or more holders of
Voting Shares and/or Convertible Securities (each a &#147;<B>Locked-Up Person</B>&#148;) pursuant to which such Locked-Up Person agrees to deposit or tender Voting Shares and/or Convertible Securities to a Take-over Bid (the &#147;<B>Lock-Up
Bid</B>&#148;) made or to be made by such Person, any of such Person&#146;s Affiliates or Associates or any other Person with which, and in respect of which security, such Person is acting jointly or in concert; provided that: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the terms of such agreement are publicly disclosed and a copy is made available to the public (including the
Corporation) not later than the date of the Lock-Up Bid or, if the Lock-Up Bid has been made prior to the date on which such agreement is entered into, not later than the date of such agreement (or, if such date is not a Business Day, on the
Business Day next following such date); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the agreement permits such Locked-Up Person to terminate its obligation to deposit or tender to or not to
withdraw Voting Shares and/or Convertible Securities from the Lock-Up Bid, and to terminate any obligation with respect to the voting of such securities, in order to deposit or tender such securities to another Take-over Bid or to support another
transaction: </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;12&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">where the price or value of the consideration per Voting Share or Convertible Security offered under such other
Take-over Bid or transaction: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">exceeds the price or value of the consideration per Voting Share and/or Convertible Security offered under
the<BR> Lock-Up Bid; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">exceeds by as much as or more than a specified amount (the &#147;<B>Specified Amount</B>&#148;) the price or
value of the consideration per Voting Share or Convertible Security at which the Locked-Up Person has agreed to deposit or tender Voting Shares and/or Convertible Securities to the Lock-Up Bid, provided that such Specified Amount is not greater than
7% of the price or value of the consideration per Voting Share or Convertible Security offered under the Lock-Up Bid; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the number of Voting Shares or Convertible Securities offered to be purchased under the Lock-Up Bid is less
than 100% of the Voting Shares or Convertible Securities held by Independent Shareholders, where the price or value of the consideration per Voting Share or Convertible Security offered under such other Take-over Bid or transaction is not less than
the price or value of the consideration per Voting Share or Convertible Security offered under the Lock-Up Bid and the number of Voting Shares and/or Convertible Securities to be purchased under such other Take-over Bid or transaction:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">exceeds the number of Voting Shares and/or Convertible Securities that the Offeror has offered to purchase
under the Lock-Up Bid; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">exceeds by as much as or more than a specified number (the &#147;<B>Specified Number</B>&#148;) the number of
Voting Shares or Convertible Securities that the Offeror has offered to purchase under the Lock-Up Bid, provided that the Specified Number is not greater than 7% of the number of Voting Shares or Convertible Securities offered to be purchased under
the Lock-Up Bid; </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">and for greater certainty, such agreement may contain a right of first refusal or require a period of
delay to give the Offeror under the Lock-Up Bid an opportunity to match the higher price, value or number in such other Take-over Bid or transaction, or other similar limitation on a Locked-Up Person&#146;s right to withdraw Voting Shares from the
agreement, so long as the limitation does not preclude the exercise by the Locked-Up Person of the right to withdraw Voting Shares and/or Convertible Securities in sufficient time to deposit or tender to the other Take-over Bid or support the other
transaction; and </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">no &#147;break-up&#148; fees, &#147;top-up&#148; fees, penalties, expenses or other amounts that exceed in the
aggregate the greater of: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the cash equivalent of 2.5% of the price or value of the consideration payable under the Lock-Up Bid to a
Locked-Up Person; and </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;13&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">50% of the amount by which the price or value of the consideration payable under another Take-over Bid or other
transaction to a Locked- Up Person exceeds the price or value of the consideration that such Locked-Up Person would have received under the Lock-Up Bid, </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">shall be payable by a Locked-Up Person pursuant to the agreement in the event that the Locked-Up Bid is not successfully concluded or if any
Locked-Up Person fails to deposit or tender Voting Shares and/or Convertible Securities to the Lock-Up Bid or withdraws Voting Shares and/or Convertible Securities previously deposited or tendered thereto in order to deposit or tender to another
Take-over Bid or support another transaction. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(rr)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Person</B>&#148; includes any individual, firm, partnership, association, trust, trustee, executor,
administrator, legal personal representative, government, governmental body or authority, corporation, or other incorporated or unincorporated organization, syndicate or other entity. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ss)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Privacy Laws</B>&#148; has the meaning set forth in Section&nbsp;4.6. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(tt)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Pro Rata Acquisition</B>&#148; means an acquisition by a Person of Voting Shares and/or Convertible
Securities pursuant to: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a Dividend Reinvestment Acquisition; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a stock dividend, a stock split or other event pursuant to which such Person becomes the Beneficial Owner of
Voting Shares and/or Convertible Securities on the same pro rata basis as all other holders of Voting Shares of the same class or series; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the acquisition or exercise by the Person of only those rights to purchase Voting Shares and/or Convertible
Securities distributed directly by the Corporation to that Person (and not acquired from any other person) in the course of a distribution to all holders of securities of the Corporation of one or more particular classes or series pursuant to a
rights offering; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a distribution of Voting Shares and/or Convertible Securities made pursuant to a prospectus or by way of a
private placement or a conversion or exchange of any Convertible Security, </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">provided, however, that such Person does not
thereby acquire a greater percentage of Voting Shares or of Convertible Securities so offered than such Person&#146;s percentage of Voting Shares Beneficially Owned immediately prior to such acquisition. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(uu)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Reconfirmation Meeting</B>&#148; has the meaning set forth in Section&nbsp;5.15.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(vv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Record Time</B>&#148; means 11:59 p.m. on the Effective Date. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ww)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Redemption Price</B>&#148; has the meaning set forth in subsection 5.1(a). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(xx)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Regular Periodic Cash Dividend</B>&#148; means cash dividends paid on the Common Shares at regular
intervals in any fiscal year of the Corporation. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;14&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(yy)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Right</B>&#148; means a right to purchase securities upon the terms and subject to the conditions set
forth in this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(zz)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Rights Certificates</B>&#148; means the certificates representing the Rights after the Separation
Time, which shall be substantially in the form attached hereto as Schedule &#147;A&#148; or such other form as the Corporation and the Rights Agent may agree. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(aaa)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Rights Register</B>&#148; and &#147;<B>Rights Registrar</B>&#148; have the respective meanings
ascribed thereto in subsection 2.6(a). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(bbb)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B><I>Securities Act</I></B><B> (British Columbia)</B>&#148; means the<I> Securities Act</I>, R.S.A.
2000, c. S-4, as amended, and the rules and regulations made thereunder, as now in effect or as the same may from time to time be amended, re-enacted or replaced. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ccc)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Separation Time</B>&#148; means the Close of Business on the tenth Trading Day after the earlier of:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Share Acquisition Date; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the date of the commencement of, or first public announcement or disclosure of the intent of any Person (other
than the Corporation or any Subsidiary of the Corporation) to commence, a Take-over Bid (other than a Permitted Bid or Competing Permitted Bid, so long as such Take-over Bid continues to satisfy the requirements of a Permitted Bid or Competing
Permitted Bid); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the date on which a Permitted Bid or Competing Permitted Bid ceases to qualify as a Permitted Bid or Competing
Permitted Bid, as applicable, </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">or such later date as may be determined by the Board of Directors in good faith, provided,
however, that if any Take-over Bid referred to in subsection 1.1(ccc)(ii) above expires, is not made or is cancelled, terminated or otherwise withdrawn prior to the Separation Time, such Take-over Bid shall be deemed, for the purposes of this
definition, never to have been commenced, made or announced and further provided that if the Board of Directors determines, pursuant to Section&nbsp;5.1, to waive the application of Section&nbsp;3.1 to a Flip-In Event, then the Separation Time in
respect of such Flip-In Event shall be deemed never to have occurred. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ddd)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Share Acquisition Date</B>&#148; means the first date of public announcement or disclosure by the
Corporation or an Acquiring Person of facts indicating that a Person has become an Acquiring Person, which, for the purposes of this definition, shall include, without limitation, a report filed pursuant to Section&nbsp;5.2 of NI 62-104 or
subsection 13(d) of the <I>U.S. Exchange Act</I>, announcing or disclosing such information. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(eee)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Subsidiary</B>&#148; of a Person means any other Person that is controlled by such first Person.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(fff)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Take-over Bid</B>&#148; means an Offer to Acquire Voting Shares and/or Convertible Securities if,
assuming that the Voting Shares and/or Convertible Securities subject to the Offer to Acquire are acquired and assuming they are Beneficially Owned at the date of such Offer to Acquire by the Person making such Offer to Acquire, such Voting Shares
(including Voting Shares that may be acquired upon conversion of the Convertible Securities), together with the Offeror&#146;s Securities, constitute in the aggregate 20% or more of the then outstanding Voting Shares at the date of the Offer to
Acquire. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;15&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ggg)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Termination Time</B>&#148; means the time at which the right to exercise Rights shall terminate
pursuant to Section&nbsp;5.1. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(hhh)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Trading Day</B>&#148;, when used with respect to any securities, means a day on which the principal
Canadian or United States securities exchange (as determined by the Board of Directors) on which such securities are listed or admitted to trading is open for the transaction of business or, if the securities are not listed or admitted to trading on
any Canadian or United States securities exchange, a Business Day. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>U.S. - Canadian Exchange Rate</B>&#148; on any date means: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if on such date the Bank of Canada sets a daily average rate of exchange for the conversion of one United
States dollar into Canadian dollars, such rate; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in any other case, the rate on such date for the conversion of one United States dollar into Canadian dollars
which is calculated in the manner which shall be determined by the Board of Directors from time to time acting in good faith. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(jjj)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B><I>U.S. Exchange Act</I></B>&#148; means the<I> United States Securities Exchange Act of 1934</I>, as
amended, and the rules and regulations thereunder as from time to time in effect, and any comparable or successor laws, rules or regulations thereto. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(kkk)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B><I>U.S. Securities Act</I></B>&#148; means the<I> United States Securities Act of 1933</I>, as
amended, and the rules and regulations thereunder, and any comparable or successor laws, rules or regulations thereto. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(lll)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Voting Share Reduction</B>&#148; means an acquisition or a redemption by the Corporation of Voting
Shares and/or Convertible Securities which, by reducing the number of then outstanding Voting Shares and/or Convertible Securities of a class or series, increases the percentage of Voting Shares Beneficially Owned by any Person.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(mmm)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Voting Shares</B>&#148; means, collectively, the Common Shares and any other securities in the capital
of the Corporation, the holders of which are entitled to vote generally in the election of directors of the Board of Directors and &#147;<B>Voting Shares</B>&#148;, when used with reference to any Person other than the Corporation, means common
shares (or equivalent) of such other Person and any other securities the holders of which are entitled to vote generally in the election of the directors or to otherwise affect control of such other Person. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.2</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Currency</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All sums of money which are referred to in this Agreement are expressed in lawful money of Canada, unless otherwise specified. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.3</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Number and Gender</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Wherever the context requires, terms (including defined terms) used herein importing the singular number only include the plural and <I>vice
versa</I> and words importing any one gender include all others. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.4</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Sections</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The division of this Agreement into Articles, Sections, subsections and Schedules are for convenience of reference only and shall not affect the construction
or interpretation of this Agreement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;16&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
The terms this &#147;<B>Agreement</B>&#148;, &#147;<B>hereunder</B>&#148;, &#147;<B>hereof</B>&#148;, and similar expressions refer to this Agreement as amended or supplemented from time to time
and not to any particular Article, Section, subsection or Schedule or other portion hereof and include any agreement or instrument supplemental or ancillary hereto. Unless something in the subject matter or context is inconsistent therewith,
references herein to Articles, Sections, subsections and Schedules are to Articles, Sections, subsections and Schedules of or to this Agreement. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.5</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Statutory References</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the context otherwise requires, any reference to a specific section, subsection, clause or rule of any act or regulation shall be deemed
to refer to the same as it may be amended, re-enacted or replaced or, if repealed and there shall be no replacement therefor, to the same as it is in effect on the date of this Agreement. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.6</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Calculation of Voting Shares Beneficially Owned</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the purposes of this Agreement, the percentage of Voting Shares Beneficially Owned by any Person, shall be and be deemed to be the product
determined by the formula: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle" ROWSPAN="2" ALIGN="right">100</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="2">x</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><U>&nbsp;&nbsp;A&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">B</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">where: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A&nbsp;=</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">the number of votes for the election of all directors generally attaching to the Voting Shares Beneficially Owned by such Person; and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">B&nbsp;=</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">the number of votes for the election of all directors generally attaching to all outstanding Voting Shares.</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Where any Person is deemed to Beneficially Own unissued Voting Shares pursuant to subsection 1.1(f), such Voting Shares shall
be deemed to be outstanding for the purpose of both A and B in the formula above. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.7</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Acting Jointly or in Concert</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the purposes of this Agreement, a Person is acting jointly or in concert with its Affiliates and Associates, and with every Person who is a
party to an agreement, commitment or understanding, whether formal or informal and whether or not in writing, with the first Person to acquire, or make an Offer to Acquire, Voting Shares and/or Convertible Securities (other than customary agreements
with and between underwriters and banking or selling group members with respect to a distribution of securities and pledges of securities in the ordinary course of business to secure indebtedness). </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.8</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Generally Accepted Accounting Principles</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Wherever in this Agreement reference is made to generally accepted accounting principles, such reference shall be deemed to be the
recommendations at the relevant time of the Canadian Institute of Chartered Accountants, or any successor institute, applicable on a consolidated basis (unless otherwise specifically provided herein to be applicable on an unconsolidated basis) as at
the date on which a calculation is made or required to be made in accordance with generally accepted accounting principles. Where the character or amount of any asset or liability or item of revenue or expense is required to be determined, or any
consolidation or other accounting computation is required to be made for the purpose </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;17&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of this Agreement or any document, such determination or calculation shall, to the extent applicable and except as otherwise specified herein or as otherwise agreed in writing by the parties, be
made in accordance with generally accepted accounting principles applied on a consistent basis. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 2 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE RIGHTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.1</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Issuance of Rights; Legend on Share Certificates</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">One Right shall be issued at the Record Time in respect of each Voting Share issued and outstanding at the
Record Time and one Right shall be issued in respect of each Voting Share issued after the Record Time and prior to the earlier of the Separation Time and the Expiration Time. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Certificates representing Voting Shares which are issued prior to the earlier of the Separation Time and the
Expiration Time shall also evidence one Right for each Voting Share represented thereby and shall have impressed on, printed on, written on or otherwise affixed to them a legend in a form substantially to the following effect: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#147;Until the earlier of the Separation Time and the Expiration Time (as both such terms are defined in the Shareholder Rights Agreement
referred to below), this certificate also evidences certain rights of the holder as set forth in a Shareholder Rights Plan Agreement dated as of October&nbsp;17, 2019 between ImmunoPrecise Antibodies Ltd. (the &#147;Corporation&#148;) and
Computershare Trust Company of Canada, as such may be supplemented and amended from time to time (the &#147;Shareholder Rights Agreement&#148;), the terms of which are incorporated herein by reference, and a copy of which is on file at the principal
executive offices of the Corporation, is available for viewing at www.sedar.com and is available to the holder upon demand without charge. Under certain circumstances, as set forth in the Shareholder Rights Agreement, the rights may be amended, may
be redeemed, may expire, may become null and void or may be evidenced by separate certificates and no longer evidenced by this certificate.&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, until the earlier of the Separation Time and the Expiration Time, certificates representing Voting Shares shall
also evidence one Right for each Voting Share evidenced thereby, notwithstanding the absence of the foregoing legend. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any Voting Shares issued and registered in Book Entry Form prior to the earlier of the Separation Time and the
Expiration Time shall evidence, in addition to the Voting Shares, one Right for each Voting Share represented thereby and the registration record of such Voting Shares shall include the foregoing legend, adapted accordingly as the Rights Agent may
reasonably require. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.2</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Initial Exercise Price; Exercise of Rights; Detachment of Rights</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to adjustment as herein set forth, including without limitation as set forth in Article 3, each Right
will entitle the holder thereof, from and after the Separation Time and prior to the Expiration Time, to purchase one Common Share for the Exercise Price (which Exercise Price and number of Common Shares are subject to adjustment as set forth
below). Notwithstanding any other provision of this Agreement, any Rights held by the Corporation or any of its Subsidiaries shall be null and void. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;18&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Until the Separation Time: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Rights shall not be exercisable and no Right may be exercised; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">for administrative purposes, each Right will be evidenced by the certificate for the associated Voting Share
registered in the name of the holder thereof (which certificate shall be deemed to represent a Rights Certificate) or by Book Entry Form registration for the associated Voting Share and will be transferable only together with, and will be
transferred by a transfer of, such associated Voting Share. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">From and after the Separation Time and prior to the Expiration Time, the Rights may be exercised, and the
registration and transfer of the Rights shall be separate from and independent of Voting Shares. Promptly following the Separation Time, the Corporation will determine whether it wishes to issue Rights Certificates or whether it will maintain the
Rights in Book Entry Form. In the event that the Corporation determines to maintain Rights in Book Entry Form, it will put in place such alternative procedures as are determined necessary in consultation with the Rights Agent for the Rights to be
maintained in Book Entry Form (the &#147;<B>Book Entry Rights Exercise Procedures</B>&#148;), it being hereby acknowledged that such procedures shall, to the greatest extent possible, replicate in all substantive respects the procedures set out in
this Agreement with respect to the exercise of the Rights Certificates and that the procedures set out in this Agreement shall be modified only to the extent necessary, as reasonably determined by the Rights Agent, to permit the Corporation to
maintain the Rights in Book Entry Form. In such event, the Book Entry Rights Exercise Procedures shall be deemed to replace the procedures set out in this Agreement with respect to the exercise of Rights and all provisions of this Agreement
referring to the Rights Certificates shall be applicable to Rights registered in Book Entry Form in like manner as the Rights in certificated form. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event that the Corporation determines to issue Rights Certificates, then promptly following the
Separation Time, the Corporation will prepare or cause to be prepared and the Rights Agent will mail to each holder of record of Voting Shares as of the Separation Time and, in respect of each Convertible Security converted into Voting Shares after
the Separation Time and prior to the Expiration Time, promptly after such conversion, the Corporation will prepare or cause to be prepared and the Rights Agent will mail to the holder so converting (other than a Person indicated by the Corporation
in writing to be an Acquiring Person and, in respect of any Rights Beneficially Owned by such Acquiring Person which are not held of record by such Acquiring Person, the holder of record of such rights as indicated by the Corporation in writing (a
&#147;<B>Nominee</B>&#148;)) at such holder&#146;s address as shown by the records of the Corporation (the Corporation hereby agreeing to furnish copies of such records to the Rights Agent for this purpose): </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a Rights Certificate in substantially the form of Schedule &#147;A&#148; appropriately completed, representing
the number of Rights held by such holder at the Separation Time and having such marks of identification or designation and such legends, summaries or endorsements printed thereon as the Corporation may deem appropriate and as are not inconsistent
with the provisions of this Agreement, or as may be required to comply with any law, rule or regulation or judicial or administrative order, or with any article or regulation of any self-regulatory organization, stock exchange or securities
quotation system on which the Rights may from time to time be listed or traded, or to conform to usage; and </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;19&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a disclosure statement prepared by the Corporation describing the Rights, </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">provided that a Nominee shall be sent the materials provided for in subsections 2.2(d)(i) and 2.2(d)(ii) only in respect of all Voting Shares
held of record by it which are not Beneficially Owned by an Acquiring Person as indicated to the Rights Agent by the Corporation in writing, and the Corporation may require any Nominee or suspected Nominee to provide such information and
documentation as the Corporation deems necessary or appropriate for such purpose. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event that the Corporation determines to issue Rights Certificates, Rights may be exercised in whole or
in part on any Business Day after the Separation Time and prior to the Expiration Time by submitting to the Rights Agent, at its principal office in Vancouver, British Columbia or Toronto, Ontario: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Rights Certificate evidencing such Rights; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">an election to exercise (an &#147;<B>Election to Exercise</B>&#148;), substantially in the form attached to the
Rights Certificate duly completed, and executed in a manner acceptable to the Rights Agent; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">payment by certified cheque, banker&#146;s draft, money order or wire transfer payable to the order of the
Corporation, of a sum equal to the Exercise Price multiplied by the number of Rights being exercised and a sum sufficient to cover any transfer tax or charge which may be payable in respect of any transfer involved in the transfer or delivery of
Rights Certificates or the issuance or delivery of certificates for Common Shares in a name other than that of the holder of the Rights being exercised. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event that the Corporation determines to issue Rights Certificates, then upon receipt of a Rights
Certificate, together with an appropriately completed and duly executed Election to Exercise (which does not indicate that such Right is null and void as provided by subsection 3.1(b)) and payment as set forth in subsection 2.2(e), the Rights Agent
(unless otherwise instructed in writing by the Corporation) will thereupon promptly: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">requisition from the transfer agent of the Common Shares certificates representing the number of Common Shares
to be purchased (the Corporation hereby irrevocably authorizing its transfer agent to comply with all such requisitions); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">after receipt of such Common Share certificates, deliver such certificates to, or to the order of, the
registered holder of such Rights Certificate, registered in such name or names as may be designated by such holder in the Election to Exercise, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">when appropriate, under Section 5.5, requisition from the Corporation the amount of cash, if any, to be paid in
lieu of issuing fractional Common Shares; </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;20&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">when appropriate, under Section&nbsp;5.5, after receipt of the cash referred to in subsection 2.2(f)(iii),
deliver such cash to, or to the order of, the registered holder of the Rights Certificate; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">tender to the Corporation all payments received on exercise of the Rights. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the holder of any Rights shall exercise less than all the Rights evidenced by such holder&#146;s Rights
Certificate, a new Rights Certificate evidencing the Rights remaining unexercised will be issued by the Rights Agent to such holder or to such holder&#146;s duly authorized assigns. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Corporation covenants and agrees that it will: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">take all such action as may be necessary and within its power to ensure that all Common Shares delivered upon
the exercise of Rights shall, at the time of delivery of the certificates for such Common Shares (subject to payment of the Exercise Price), be duly and validly authorized, executed, issued and delivered as fully paid and non-assessable;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">take all such action as may reasonably be considered to be necessary and within its power to comply with any
applicable requirements of the BCBCA, the <I>Securities Act</I> (British Columbia), the<I> U.S. Exchange Act</I>, the<I> U.S. Securities Act </I>and comparable legislation of each of the other provinces and territories of Canada and states of the
United States of America, or the rules and regulations thereunder or any other applicable law, rule or regulation, in connection with the issuance and delivery of the Rights, the Rights Certificates and the issuance of any Common Shares upon
exercise of the Rights; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">use reasonable efforts to cause all Common Shares issued upon exercise of the Rights to be listed on each
Exchange; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">cause to be reserved and kept available out of its authorized and unissued Common Shares, the number of Common
Shares that, as provided in this Agreement, will from time to time be sufficient to permit the exercise in full of all outstanding Rights; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">pay when due and payable, if applicable, any and all federal, provincial, state and municipal taxes (not in the
nature of income, capital gains or withholding taxes) and charges which may be payable in respect of the original issuance or delivery of the Rights Certificates or certificates for Common Shares issued upon the exercise of Rights, provided that the
Corporation shall not be required to pay any transfer tax or charge which may be payable in respect of any transfer of Rights or the issuance or delivery of certificates for Common Shares issued upon the exercise of Rights, in a name other than that
of the holder of the Rights being transferred or exercised; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">after the Separation Time, except as permitted by Section&nbsp;5.1 or Section&nbsp;5.4, not take (or permit any
Subsidiary to take) any action if at the time such action is taken it is reasonably foreseeable that such action will diminish substantially or otherwise eliminate the benefits intended to be afforded by the Rights. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;21&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.3</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Adjustments to Exercise Price; Number of Rights</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Exercise Price, the number and kind of securities subject to purchase upon exercise of each Right and the
number of Rights outstanding are subject to adjustment from time to time as provided in this Section&nbsp;2.3 and in Article 3. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event that the Corporation shall at any time after the Record Time and prior to the Expiration Time:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">subdivide or change the then-outstanding Common Shares into a greater number of Common Shares;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">consolidate or change the then-outstanding Common Shares into a smaller number of Common Shares;
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">or, in the event that the Corporation shall at any time after the Separation Time and prior to the Expiration Time: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">declare or pay a distribution on the Voting Shares payable in Voting Shares or Convertible Securities other
than pursuant to any Dividend Reinvestment Plan; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">issue any Voting Shares (or Convertible Securities in respect thereof) in respect of, in lieu of or in exchange
for existing Common Shares, whether in a reclassification, amalgamation, statutory arrangement, consolidation or otherwise, </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">then the Exercise Price and the number of Rights outstanding (or, if the payment or effective date therefor shall occur after the Separation
Time, the securities purchasable upon the exercise of Rights) shall be adjusted as follows (without duplication with respect to Section&nbsp;2.1): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the Exercise Price and number of Rights outstanding are to be adjusted: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Exercise Price in effect after such adjustment will be equal to the Exercise Price in effect immediately
prior to such adjustment divided by the number of Common Shares (or other securities of the Corporation) (the &#147;<B>Expansion Factor</B>&#148;) that a holder of one Common Share immediately prior to such dividend, subdivision, change,
consolidation or issuance would hold thereafter as a result thereof, and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">each Right held prior to such adjustment will become that number of Rights equal to the Expansion Factor, and
the adjusted number of Rights will be deemed to be allocated among the Common Shares with respect to which the original Rights were associated (if they remain outstanding) and the securities of the Corporation issued in respect of such dividend,
subdivision, change, consolidation or issuance, so that each such Common Share (or other security of the Corporation) will have exactly one Right associated with it, and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">for greater certainty, if the securities purchasable upon exercise of Rights are to be adjusted, the securities
purchasable upon exercise of each Right after such adjustment will be the securities that a holder of the securities purchasable upon exercise of one Right immediately prior to such dividend, subdivision, change, consolidation or issuance would hold
thereafter as a result thereof. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;22&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Adjustments made pursuant to this subsection 2.3(b) shall be made successively, whenever an
event referred to in this subsection 2.3(b) occurs. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If, after the Record Time and prior to the Expiration Time, the Corporation shall issue any of its securities
other than Common Shares in a transaction of a type described in subsections 2.3(b)(iii) or 2.3(b)(iv), such securities shall be treated herein as nearly equivalent to Common Shares as may be practicable and appropriate under the circumstances and
the Corporation and the Rights Agent agree to amend, supplement or restate this Agreement in order to effect such treatment. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If an event occurs which would require an adjustment under both this Section&nbsp;2.3 and Section&nbsp;3.1, the
adjustment provided for in this Section&nbsp;2.3 shall be in addition to, and shall be made prior to, any adjustment required pursuant to Section&nbsp;3.1. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event the Corporation shall at any time after the Record Time and prior to the Separation Time issue any
Common Shares otherwise than in a transaction referred to in subsection 2.3(b), each such Common Share so issued shall automatically have one new Right associated with it, which Right shall be evidenced by the certificate representing such
associated Common Share (as provided in Section&nbsp;2.1). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event the Corporation shall, at any time after the Record Time and prior to the Separation Time, fix a
record date for the making of a distribution to all holders of Common Shares of rights or warrants entitling them (for a period expiring within 45 calendar days after such record date) to subscribe for or purchase Common Shares (or Convertible
Securities in respect of Common Shares) at a price per Common Share (or, in the case of such a Convertible Security, having a conversion, exchange or exercise price per security (including the price required to be paid to purchase such Convertible
Security)) less than 90% of the Market Price per Common Share on such record date, the Exercise Price in effect after such record date will equal the Exercise Price in effect immediately prior to such record date multiplied by a fraction of which:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the numerator shall be the number of Common Shares outstanding on such record date plus the number of Common
Shares which the aggregate offering price of the total number of Common Shares so to be offered (and/or the aggregate initial conversion, exchange or exercise price of the Convertible Securities so to be offered (including the price required to be
paid to purchase such Convertible Securities)) would purchase at such Market Price per Common Share; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the denominator shall be the number of Common Shares outstanding on such record date plus the number of
additional Common Shares to be offered for subscription or purchase (or into which the Convertible Securities so to be offered are initially convertible, exchangeable or exercisable). </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">In case such subscription price is satisfied, in whole or in part, by consideration other than cash, the value of such consideration shall be
as determined in good faith by the Board of Directors. Such adjustment shall be made successively whenever such a record date is fixed. To the extent that such rights or warrants are not exercised prior to the expiration thereof, the Exercise Price
shall be readjusted in the manner contemplated above based on the number of Common Shares (or securities convertible into or exchangeable for Common Shares) actually issued upon the exercise of such rights or warrants. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;23&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For purposes of this Agreement, the granting of the right to purchase Common Shares (whether from treasury or
otherwise) pursuant to any Dividend Reinvestment Plan or any share purchase plan providing for the reinvestment of dividends or interest payable on securities of the Corporation or the investment of periodic optional payments or employee benefit or
stock option or similar plans (so long as such right to purchase is in no case evidenced by the delivery of rights or warrants by the Corporation) shall not be deemed to constitute an issue of rights or warrants by the Corporation; provided,
however, that in the case of any Dividend Reinvestment Plan or share purchase plan, the right to purchase Common Shares is at a price per security of not less than 90% of the current market price per share (determined as provided in such plans) of
the Common Shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event the Corporation shall at any time after the Record Time and prior to the Separation Time fix a
record date for the making of a distribution to all holders of Common Shares of: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">evidences of indebtedness or assets (other than a Regular Periodic Cash Dividend or a dividend paid in Common
Shares, but including any dividend payable in securities other than Common Shares); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">rights or warrants entitling them to subscribe for or purchase Voting Shares other than Common Shares (or
Convertible Securities in respect of the Voting Shares other than Common Shares), at a price per Voting Share (or, in the case of a Convertible Security in respect of Voting Shares, having a conversion, exchange or exercise price per security
(including the price required to be paid to purchase such Convertible Security)) less than 90% of the Market Price per Common Share on such record date (excluding rights or warrants referred to in subsection 2.3(f)), </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">the Exercise Price in effect after such record date shall be equal to the Exercise Price in effect immediately prior to such record date less
the fair market value (as determined in good faith by the Board of Directors) of the portion of the assets, evidences of indebtedness, rights, warrants or other securities so to be distributed applicable to each of the securities purchasable upon
exercise of one Right. Such adjustment shall be made successively whenever such a record date is fixed. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each adjustment made pursuant to this Section&nbsp;2.3 shall be made as of: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the payment or effective date for the applicable dividend, subdivision, change, consolidation or issuance, in
the case of an adjustment made pursuant to subsection 2.3(b); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the record date for the applicable dividend or distribution, in the case of an adjustment made pursuant to
subsections 2.3(f) or 2.3(h), subject to readjustment to reverse the same if such distribution shall not be made. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event the Corporation shall at any time after the Record Time and prior to the Separation Time issue any
securities (other than Common Shares), or rights or warrants to subscribe for or purchase any such securities, or Convertible Securities in respect of </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;24&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
any such securities, in a transaction referred to in any of subsections 2.3(b), 2.3(f) and 2.3(h), inclusive, if the Board of Directors acting in good faith determines that the adjustments
contemplated by subsections 2.3(b), 2.3(f) and 2.3(h) in connection with such transaction will not appropriately protect the interests of the holders of Rights, then the Board of Directors may from time to time, but subject to obtaining the prior
approval of the holders of the Rights obtained as set forth in subsection 5.4(b), determine what other adjustments to the Exercise Price, number of Rights or securities purchasable upon exercise of Rights would be appropriate and, notwithstanding
subsections 2.3(b), 2.3(f) and 2.3(h), such adjustments, rather than the adjustments contemplated by subsections 2.3(b), 2.3(f) and 2.3(h), shall be made upon the Board of Directors providing written certification thereof to the Rights Agent as set
forth in subsection 2.3(r). The Corporation and the Rights Agent shall amend, supplement or restate this Agreement as appropriate to provide for such adjustments. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding anything herein to the contrary, no adjustment of the Exercise Price shall be required unless
such adjustment would require an increase or decrease of at least 1% in such Exercise Price; provided, however, that any adjustments which by reason of this subsection 2.3(k) are not required to be made shall be carried forward and taken into
account in any subsequent adjustment. All adjustments to the Exercise Price made pursuant to this subsection 2.3 shall be calculated to the nearest cent. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All Rights originally issued by the Corporation subsequent to any adjustment made to an Exercise Price
hereunder shall evidence the right to purchase, at the adjusted Exercise Price, the number of Common Shares purchasable from time to time hereunder upon exercise of the Rights, all subject to further adjustment as provided herein.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(m)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unless the Corporation shall have exercised its election, as provided in subsection 2.3(n), upon each
adjustment of an Exercise Price as a result of the calculations made in subsections 2.3(f) and 2.3(h), each Right outstanding immediately prior to the making of such adjustment shall thereafter evidence the right to purchase, at the adjusted
Exercise Price, that number of Common Shares obtained by: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">multiplying (A)&nbsp;the number of Common Shares covered by a Right immediately prior to such adjustment, by
(B)&nbsp;the Exercise Price in effect immediately prior to such adjustment; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">dividing the product so obtained by the Exercise Price in effect immediately after such adjustment.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(n)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Corporation may elect on or after the date of any adjustment of an Exercise Price to adjust the number of
Rights, in lieu of any adjustment in the number of Common Shares purchasable upon the exercise of a Right. Each of the Rights outstanding after the adjustment in the number of Rights shall be exercisable for the number of Common Shares for which a
Right was exercisable immediately prior to such adjustment. Each Right held of record prior to such adjustment of the number of Rights shall become the number of Rights obtained by dividing the relevant Exercise Price in effect immediately prior to
adjustment of the relevant Exercise Price by the relevant Exercise Price in effect immediately after adjustment of the relevant Exercise Price. The Corporation shall make a public announcement of its election to adjust the number of Rights,
indicating the record date for the adjustment, and, if known at the time, the amount of the adjustment to be made. This record date may be the date on which the relevant Exercise Price is adjusted or any day thereafter, but, if the Rights
Certificates have been issued, shall be at </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;25&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
least 10 calendar days later than the date of the public announcement. If Rights Certificates have been issued, upon each adjustment of the number of Rights pursuant to this subsection 2.3(n),
the Corporation shall, as promptly as practicable, cause to be distributed to holders of record of Rights Certificates on such record date, Rights Certificates evidencing, subject to Section&nbsp;5.5, the additional Rights to which such holders
shall be entitled as a result of such adjustment, or, at the option of the Corporation, shall cause to be distributed to such holders of record in substitution and replacement for the Rights Certificates held by such holders prior to the date of
adjustment, and upon surrender thereof, if required by the Corporation, new Rights Certificates evidencing all the Rights to which such holders shall be entitled after such adjustment. Rights Certificates so to be distributed shall be issued,
executed and countersigned in the manner provided for herein and may bear, at the option of the Corporation, the relevant adjusted Exercise Price and shall be registered in the names of holders of record of Rights Certificates on the record date
specified in the public announcement. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(o)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In any case in which this Section&nbsp;2.3 shall require that an adjustment in an Exercise Price be made
effective as of a record date for a specified event, the Corporation may elect to defer until the occurrence of such event the issuance to the holder of any Right exercised after such record date of the number of Common Shares and other securities
of the Corporation, if any, issuable upon such exercise over and above the number of Common Shares and other securities of the Corporation, if any, issuable upon such exercise on the basis of the relevant Exercise Price in effect prior to such
adjustment; provided, however, that the Corporation shall deliver to such holder an appropriate instrument evidencing such holder&#146;s right to receive such additional Common Shares (fractional or otherwise) or other securities upon the occurrence
of the event requiring such adjustment. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(p)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding anything in this Section&nbsp;2.3 to the contrary, the Corporation shall be entitled to make
such adjustments in the Exercise Price, in addition to those adjustments expressly required by this Section&nbsp;2.3, as and to the extent that in its good faith judgment the Board of Directors shall determine to be advisable in order that any:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">subdivision or consolidation of the Common Shares; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">issuance wholly for cash of any Common Shares at less than the applicable Market Price; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">issuance wholly for cash of any Common Shares or securities that by their terms are exchangeable for or
convertible into or give a right to acquire Common Shares; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">stock dividends; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">issuance of rights or warrants referred to in this Section&nbsp;2.3, hereafter made by the Corporation to
holders of its Common Shares, </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">shall not be taxable to such shareholders. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(q)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Irrespective of any adjustment or change in the securities purchasable upon exercise of the Rights, the Rights
Certificates theretofore and thereafter issued may continue to represent the securities so purchasable which were represented in the initial Rights Certificates issued hereunder. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;26&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(r)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Whenever an adjustment to the Exercise Price is made pursuant to this Section&nbsp;2.3, the Corporation shall:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">promptly prepare a certificate setting forth such adjustment and a brief statement of the facts accounting for
such adjustment; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">promptly file with the Rights Agent and with each transfer agent for the Common Shares a copy of such
certificate and mail a brief summary thereof to each holder of Rights who requests a copy. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Failure to file such
certificate or to cause such notice to be given as aforesaid, or any defect therein, shall not affect the validity of any such adjustment or change. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.4</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Date on Which Exercise is Effective</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Person in whose name any certificate for Common Shares or confirmation in Book Entry Form is issued upon the exercise of Rights shall for
all purposes be deemed to have become the holder of record of the Common Shares represented thereby on, and such certificate or entry shall be dated, the date upon which the Rights Certificate evidencing such Rights was duly surrendered (together
with a duly completed Election to Exercise) and payment of the Exercise Price for such Rights (and any applicable transfer taxes and other governmental charges payable by the exercising Person hereunder) was made; provided, however, that if the date
of such surrender and payment is a date upon which the Common Share transfer books of the Corporation are closed, such Person shall be deemed to have become the record holder of such shares on, and such certificate or entry shall be dated, the next
Business Day on which the Common Share transfer books of the Corporation are open. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.5</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Execution, Authentication, Delivery and Dating of Rights Certificates</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Rights will be evidenced, in the case of Rights in Book Entry Form, by a statement issued under the Rights Agent&#146;s direct registration
system or, alternatively, if the Corporation determines to issue Rights Certificates, by the following procedures: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Rights Certificates shall be executed on behalf of the Corporation by the Chief Executive Officer,
President or Chief Financial Officer or Secretary of the Corporation. The signature of any of these officers on the Rights Certificates may be manual or facsimile. Rights Certificates bearing the manual or facsimile signatures of individuals who
were at any time the proper officers of the Corporation shall bind the Corporation, notwithstanding that such individuals or any of them have ceased to hold such offices prior to the countersignature and delivery of such Rights Certificates.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Promptly following the Separation Time, the Corporation will notify the Rights Agent of such Separation Time
and will deliver Rights Certificates executed by or on behalf of the Corporation to the Rights Agent for countersignature, and the Rights Agent shall countersign (manually or by facsimile signature in a manner satisfactory to the Corporation) and
deliver such Rights Certificates to the holders of the Rights pursuant to Section&nbsp;2.2. No Rights Certificate shall be valid for any purpose until countersigned by the Rights Agent as aforesaid. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each Rights Certificate shall be dated the date of countersignature thereof. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;27&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.6</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Registration, Transfer and Exchange</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">After the Separation Time, the Corporation will cause to be kept a register (the &#147;<B>Rights
Register</B>&#148;) in which, subject to such reasonable regulations as it may prescribe, the Corporation will provide for the registration and transfer of Rights. The Rights Agent is hereby appointed registrar for the Rights (the &#147;<B>Rights
Registrar</B>&#148;) for the purpose of maintaining the Rights Register for the Corporation and registering Rights and transfers of Rights as herein provided and the Rights Agent hereby accepts such appointment. In the event that the Rights Agent
shall cease to be the Rights Registrar, the Rights Agent will have the right to examine the Rights Register at all reasonable times. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">After the Separation Time and prior to the Expiration Time, upon surrender for registration of transfer or
exchange of any Rights Certificate, and subject to the provisions of subsections 2.6(d) and 3.1(b), the Corporation will execute, and the Rights Agent will countersign, deliver and register, in the name of the holder or the designated transferee or
transferees, as required pursuant to the holder&#146;s instructions, one or more new Rights Certificates evidencing the same aggregate number of Rights as did the Rights Certificates so surrendered. Alternatively, in the case of the exercise of
Rights in Book Entry Form, the Rights Agent shall provide the holder or the designated transferee or transferees with one or more statements issued under the Rights Agent&#146;s direct registration system evidencing the same aggregate number of
Rights as did the direct registration system&#146;s records for the Rights transferred or exchanged. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All Rights issued upon any registration of transfer or exchange of Rights Certificates shall be valid
obligations of the Corporation, and such Rights shall be entitled to the same benefits under this Agreement as the Rights surrendered upon such registration of transfer or exchange. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Every Rights Certificate surrendered for registration of transfer or exchange shall be duly endorsed, or be
accompanied by a written instrument of transfer in form satisfactory to the Corporation or the Rights Agent, as the case may be, duly executed by the holder thereof or such holder&#146;s attorney duly authorized, in writing. As a condition to the
issuance of any new Rights Certificate under this Section&nbsp;2.6, the Corporation may require the payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in relation thereto and any other expenses (including
the fees and expenses of the Rights Agent) in connection therewith. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.7</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Mutilated, Lost, Stolen and Destroyed Rights Certificates</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If any mutilated Rights Certificate is surrendered to the Rights Agent prior to the Expiration Time, the
Corporation shall execute and the Rights Agent shall countersign and deliver in exchange therefor a new Rights Certificate evidencing the same number of Rights as did the Rights Certificate so surrendered. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If there shall be delivered to the Corporation and the Rights Agent prior to the Expiration Time:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">evidence to their reasonable satisfaction of the destruction, loss or theft of any Rights Certificate; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such security and indemnity as may be reasonably required by them to save each of them and any of their agents
harmless, </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;28&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
then, in the absence of notice to the Corporation or the Rights Agent that such Rights Certificate has been acquired by a bona fide purchaser, the Corporation shall execute and, upon the
Corporation&#146;s request the Rights Agent shall countersign and deliver, in lieu of any such destroyed, lost or stolen Rights Certificate, a new Rights Certificate evidencing the same number of Rights as did the Rights Certificate so destroyed,
lost or stolen. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As a condition to the issuance of any new Rights Certificate under this Section&nbsp;2.7, the Corporation may
require the payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in relation thereto and any other expenses (including the fees and expenses of the Rights Agent) connected therewith. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Every new Rights Certificate issued pursuant to this Section&nbsp;2.7 in lieu of any destroyed, lost or stolen
Rights Certificate shall evidence a contractual obligation of the Corporation, whether or not the destroyed, lost or stolen Rights Certificate shall be at any time enforceable by anyone, and shall be entitled to all the benefits of this Agreement
equally and proportionately with any and all other Rights duly issued hereunder. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.8</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Persons Deemed Owners</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation, the Rights Agent and any agent of the Corporation or the Rights Agent may deem and treat the Person in whose name a Rights
Certificate (or, prior to the Separation Time, the associated Voting Share certificate) is registered as the absolute owner thereof and of the Rights evidenced thereby for all purposes whatsoever. As used in this Agreement, unless the context
otherwise requires, the term &#147;<B>holder</B>&#148; of any Rights shall mean the registered holder of such Rights (or, prior to the Separation Time, the associated Voting Shares). </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.9</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Delivery and Cancellation of Certificates</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All Rights Certificates surrendered upon exercise or for redemption, for registration of transfer or exchange shall, if surrendered to any
Person other than the Rights Agent, be delivered to the Rights Agent and, in any case, shall be promptly cancelled by the Rights Agent. The Corporation may at any time deliver to the Rights Agent for cancellation any Rights Certificates previously
countersigned and delivered hereunder which the Corporation may have acquired in any manner whatsoever, and all Rights Certificates so delivered shall be promptly cancelled by the Rights Agent. No Rights Certificate shall be countersigned in lieu of
or in exchange for any Rights Certificates cancelled as provided in this Section&nbsp;2.9 except as expressly permitted by this Agreement. The Rights Agent shall, subject to applicable law, destroy all cancelled Rights Certificates and deliver a
certificate of destruction to the Corporation on request. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.10</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Agreement of Rights Holders</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Every holder of Rights, by accepting such Rights, consents and agrees with the Corporation and the Rights Agent and with every other holder of
Rights: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to be bound by and subject to the provisions of this Agreement, as amended from time to time in accordance with
the terms hereof, in respect of all Rights held; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that, prior to the Separation Time, each Right will be transferable only together with, and will be transferred
by a transfer of, the associated Voting Share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that, after the Separation Time, the Rights will be transferable only on the Rights Register as provided
herein; </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;29&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that, prior to due presentment of a Rights Certificate (or, prior to the Separation Time, the associated Voting
Share certificate) for registration of transfer, the Corporation, the Rights Agent and any agent of the Corporation or the Rights Agent may deem and treat the Person in whose name the Rights Certificate (or, prior to the Separation Time, the
associated Voting Share certificate) is registered as the absolute owner thereof and of the Rights evidenced thereby (notwithstanding any notations of ownership or writing on such Rights Certificate or the associated Voting Share certificate made by
anyone other than the Corporation or the Rights Agent) for all purposes whatsoever, and neither the Corporation nor the Rights Agent shall be affected by any notice to the contrary; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that such holder of Rights is not entitled to receive any fractional Rights or any fractional Common Shares or
other securities upon exercise of a Right (except as provided herein); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that, without the approval of any holder of Rights or Voting Shares and upon the sole authority of the Board of
Directors acting in good faith, this Agreement may be supplemented, amended or restated from time to time as provided herein; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that notwithstanding anything in this Agreement to the contrary, neither the Corporation nor the Rights Agent
shall have any liability to any holder of a Right or any other Person as a result of its inability to perform any of its obligations under this Agreement by reason of any preliminary or permanent injunction or other order, decree or ruling issued by
a court of competent jurisdiction or by a governmental, regulatory or administrative agency or commission, or any statute, rule, regulation or executive order promulgated or enacted by any governmental authority, prohibiting or otherwise restraining
performance of such obligation. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.11</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Exclusion of Warranty by Rights Agent</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Rights Agent shall have no obligation under this Agreement to ensure or verify compliance with any
applicable laws or regulatory requirements on the issue, exercise or transfer of any Rights or Common Shares issuable upon the exercise thereof. The Rights Agent shall be entitled to process all proffered transfers and exercises of Rights upon the
presumption that such transfers or exercises are permissible pursuant to all applicable laws and regulatory requirements. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Rights Agent may assume for the purposes of this Agreement that any address on the Register is the
holder&#146;s actual address and is determinative as to residency and that the address of any transferee to whom any Rights are to be registered, as shown on the transfer document, is the transferee&#146;s residency. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Rights Agent shall have no obligation to ensure that the legends appearing on the Rights Certificates or
Common Shares comply with the regulatory requirements or securities laws of any applicable jurisdiction. </P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 3
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADJUSTMENTS TO THE RIGHTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.1</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Flip-in Event</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to subsection 3.1(b) and Section&nbsp;5.1, in the event that prior to the Expiration Time a Flip-in
Event occurs, each Right shall thereafter constitute, effective from and </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;30&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
after the Close of Business on the tenth Trading Day following the Share Acquisition Date, the right to purchase from the Corporation, upon exercise thereof in accordance with the terms hereof,
that number of Common Shares as have an aggregate Market Price on the date of the consummation or occurrence of such Flip-in Event equal to twice the Exercise Price for an amount in cash equal to the Exercise Price (such right to be appropriately
adjusted in a manner analogous to the applicable adjustment provided for in Section&nbsp;2.3 if, after such date of consummation or occurrence, an event of a type analogous to any of the events described in Section&nbsp;2.3 shall have occurred with
respect to such Common Shares). </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding anything in this Agreement to the contrary but subject to Section&nbsp;5.1, upon the occurrence
of any Flip-in Event, any Rights that are or were Beneficially Owned on or after the earlier of the Separation Time and the Share Acquisition Date, or which may thereafter be Beneficially Owned, by: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">an Acquiring Person, any Affiliate or Associate of an Acquiring Person, any other Person acting jointly or in
concert with an Acquiring Person or any Associate or Affiliate of an Acquiring Person (or any Affiliate or Associate of any such Person so acting jointly and in concert); or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a transferee, direct or indirect, of an Acquiring Person, any Affiliate or Associate of an Acquiring Person,
any other Person acting jointly or in concert with an Acquiring Person or any Associate or Affiliate of an Acquiring Person (or any Affiliate or Associate of any such Person so acting jointly and in concert), in a transfer of Rights occurring
subsequent to the Acquiring Person becoming such, </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">shall become null and void without any further action and any holder
of such Rights (including any transferee of, or other successor entitled to, such Rights, whether directly or indirectly) shall thereafter have no right to exercise such Rights under any provisions of this Agreement and, further, shall thereafter
not have any rights whatsoever with respect to such Rights, whether under any provision of this Agreement or otherwise. The holder of any Rights represented by a Rights Certificate which is submitted to the Rights Agent upon exercise or for
registration of transfer or exchange which does not contain the necessary certifications set forth in the Rights Certificate establishing that such Rights are not void under this subsection 3.1(b) shall be deemed to be an Acquiring Person for the
purposes of this subsection 3.1(b) and such Rights shall become null and void. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any Rights Certificate that represents Rights Beneficially Owned by a Person described in either of subsections
3.1(b)(i) or 3.1(b)(ii) or transferred to any Nominee of any such Person, and any Rights Certificate issued upon transfer, exchange, replacement or adjustment of any other Rights Certificate referred to in this sentence, shall contain or will be
deemed to contain the following legend: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#147;The Rights represented by this Rights Certificate were issued to a Person
who was an Acquiring Person or an Affiliate or an Associate of an Acquiring Person (as such terms are defined in the Rights Agreement) or acting jointly or in concert with any of them. This Rights Certificate and the Rights represented hereby shall
be void in the circumstances specified in subsection 3.1(b) of the Rights Agreement.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The Rights Agent shall not be under any
responsibility to ascertain the existence of facts that would require the imposition of such legend but shall be required to impose such </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;31&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
legend only if instructed to do so in writing by the Corporation or if a holder fails to certify upon transfer or exchange in the space provided to do so. The issuance of a Rights Certificate
without the legend referred to in this subsection 3.1(c) shall have no effect on the provisions of subsection 3.1(b). </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">After the Separation Time, the Corporation shall do all such acts and things necessary and within its power to
ensure compliance with the provisions of this Section&nbsp;3.1 including, without limitation, all such acts and things as may be required to satisfy the requirements of the BCBCA, the<I> Securities Act</I> (British Columbia) and the securities laws
or comparable legislation in each of the provinces of Canada and in any other jurisdiction where the Corporation is subject to such laws and the rules of each Exchange in respect of the issue of Common Shares upon the exercise of Rights in
accordance with this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.2</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Fiduciary Duties of the Board of Directors</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For clarification it is understood that nothing contained in this Article 3 shall be considered to affect the obligations of the Board of
Directors to exercise its fiduciary duties. Without limiting the generality of the foregoing, nothing contained herein shall be construed to suggest or imply that the Board of Directors shall not be entitled to recommend that holders of the Voting
Shares reject or accept any Take-over Bid or take any other action including, without limitation, the commencement, prosecution, defence or settlement of any litigation and the submission of additional or alternative Take-over Bids or other
proposals to the shareholders of the Corporation with respect to any Take-over Bid or otherwise that the Board of Directors believes is necessary or appropriate in the exercise of its fiduciary duties. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 4 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE RIGHTS
AGENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.1</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>General</B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Corporation hereby appoints the Rights Agent to act as agent for the Corporation and the holders of the
Rights in accordance with the terms and conditions hereof, and the Rights Agent hereby accepts such appointment. The Corporation may from time to time appoint one or more co-rights agents (each, a &#147;Co-Rights Agent&#148;) as it may deem
necessary or desirable. In the event the Corporation appoints one or more Co-Rights Agents, the respective duties of the Rights Agent and Co-Rights Agents shall be as the Corporation may determine. The Corporation covenants that it will pay to the
Rights Agent from time to time reasonable remuneration for its services hereunder and will pay to or reimburse the Rights Agent upon its request for all reasonable expenses, disbursements and advances made or incurred by the Rights Agent in the
administration or execution of this Agreement and the exercise and performance of its duties hereunder (including reasonable compensation and disbursements of its legal counsel and all other advisers and assistants not regularly in its employ
pursuant to subsection 4.3(a)). The Corporation also agrees to indemnify the Rights Agent and each of its directors, officers, employees, agents and shareholders for, and to hold each of them harmless against, any loss, liability, or expense,
incurred without gross negligence, bad faith or wilful misconduct on the part of the Rights Agent, for anything done or omitted by the Rights Agent in connection with the acceptance and administration of this Agreement, including without limitation
the costs and expenses of defending against any claim of liability, which right to indemnification will survive the termination of this Agreement or the resignation or removal of the Rights Agent. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;32&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Rights Agent shall be protected and shall incur no liability for or in respect of any action taken,
suffered or omitted by it in connection with its administration of this Agreement in reliance upon any certificate for Common Shares, Rights Certificate, certificate for other securities of the Corporation, instrument of assignment or transfer,
power of attorney, endorsement, affidavit, letter, notice, direction, consent, certificate, statement, or other paper or document believed by it to be genuine and to be signed, executed and, where necessary, verified or acknowledged, by the proper
Person or Persons. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding any other provision of this Agreement, and whether such losses or damages are foreseeable or
unforeseeable, the Rights Agent shall not be liable under any circumstances whatsoever for any (i)&nbsp;breach by any other party of securities law or other rule of any securities regulatory authority, (ii)&nbsp;lost profits or (iii)&nbsp;special,
indirect, incidental, consequential, exemplary, aggravated or punitive losses or damages. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Corporation shall inform the Rights Agent in a reasonably timely manner of events which may materially
affect the administration of this Agreement by the Rights Agent and, at any time upon request, shall provide to the Rights Agent an incumbency certificate certifying the then current officers of the Corporation. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No provision contained in this Agreement shall require the Rights Agent to expend or risk its own funds or
otherwise incur financial liability in the performance of any of its duties or in the exercise of any of its rights or powers under this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.2</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Merger, Amalgamation, Consolidation or Change of Name of Rights Agent</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any corporation into which the Rights Agent or any successor Rights Agent may be merged or amalgamated or with
which it may be consolidated, or any corporation resulting from any merger, amalgamation or consolidation to which the Rights Agent or any successor Rights Agent is a party, or any corporation succeeding to the shareholder or stockholder services
business of the Rights Agent or any successor Rights Agent, will be the successor to the Rights Agent under this Agreement without the execution or filing of any document or any further act on the part of any of the parties hereto, provided that
such corporation would be eligible for appointment as a successor Rights Agent under the provisions of Section&nbsp;4.4. In case at the time such successor Rights Agent succeeds to the agency created by this Agreement any of the Rights Certificates
have been countersigned but not delivered any such successor Rights Agent may adopt the countersignature of the predecessor Rights Agent and deliver such Rights Certificates so countersigned; and in case at that time any of the Rights Certificates
have not been countersigned, any successor Rights Agent may countersign such Rights Certificates either in the name of the predecessor Rights Agent or in the name of the successor Rights Agent; and in all such cases such Rights Certificates will
have the full force provided in the Rights Certificates and in this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In case at any time the name of the Rights Agent is changed and at such time any of the Rights Certificates
shall have been countersigned but not delivered, the Rights Agent may adopt the countersignature under its prior name and deliver Rights Certificates so countersigned; and in case at that time any of the Rights Certificates shall not have been
countersigned, the Rights Agent may countersign such Rights Certificates either in its prior name or in its changed name; and in all such cases such Rights Certificates shall have the full force provided in the Rights Certificates and in this
Agreement. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;33&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.3</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Duties of Rights Agent</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Rights Agent undertakes the duties and obligations imposed by this Agreement upon the following terms and conditions, by all of which the
Corporation and the holders of Rights Certificates, by their acceptance thereof, shall be bound: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Rights Agent may retain and consult with legal counsel (who may be legal counsel for the Corporation) and
the opinion of such counsel will be full and complete authorization and protection to the Rights Agent as to any action taken or omitted by it in good faith and in accordance with such opinion; the Rights Agent may also, with the prior written
consent of the Corporation (such consent not to be unreasonably withheld), consult with such other experts as the Rights Agent shall consider necessary or appropriate to properly carry out the duties and obligations imposed under this Agreement and
the Rights Agent shall be entitled to rely in good faith on the advice of any such expert; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">whenever in the performance of its duties under this Agreement the Rights Agent deems it necessary or desirable
that any fact or matter be proved or established by the Corporation prior to taking, refraining from taking or suffering any action hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be
deemed to be conclusively proved and established by a certificate signed by a person believed by the Rights Agent to be the Chief Executive Officer, President, Chief Financial Officer or the Secretary or Assistant Secretary of the Corporation and
delivered to the Rights Agent; and such certificate will be full authorization to the Rights Agent for any action taken or suffered in good faith by it under the provisions of this Agreement in reliance upon such certificate; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Rights Agent will be liable hereunder for its own gross negligence, bad faith or wilful misconduct and that
of its officers, directors and employees; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Rights Agent will not be liable for or by reason of any of the statements of fact or recitals contained in
this Agreement or in the certificates for Common Shares, or the Rights Certificates (except its countersignature thereof which countersignature shall not be construed as a representation or warranty by the Rights Agent as to the validity of this
Agreement or the Rights Certificate(s), except the due certification thereof) or be required to verify the same, and all such statements and recitals are and will be deemed to have been made by the Corporation only; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Rights Agent will not be under any responsibility in respect of the validity of this Agreement or the
execution and delivery hereof (except the due authorization, execution and delivery hereof by the Rights Agent) or in respect of the validity or execution of any Common Share certificate, or Rights Certificate (except its countersignature thereof);
nor will it be responsible for any breach by the Corporation of any covenant or condition contained in this Agreement or in any Rights Certificate; nor will it be responsible for any change in the exercisability of the Rights (including the Rights
becoming void pursuant to subsection 3.1(b) or any adjustment required under the provisions of Section&nbsp;2.3 or responsible for the manner, method or amount of any such adjustment, nor will it be responsible for the ascertaining of the existence
of facts that would require any such adjustment (except with respect to the exercise of Rights after receipt of the certificate contemplated by Section&nbsp;2.3 describing any such adjustment or any written notice from the Corporation or any holder
that a Person has become an Acquiring Person); nor will it by any act hereunder be deemed to make any representation or </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;34&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
warranty as to the authorization of any Common Shares to be issued pursuant to this Agreement or any Rights or as to any Common Shares, when issued, being duly and validly authorized, issued and
delivered as fully paid and non-assessable; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Corporation agrees that it will perform, execute, acknowledge and deliver or cause to be performed,
executed, acknowledged and delivered all such further and other acts, instruments and assurances as may reasonably be required by the Rights Agent for the carrying out or performing by the Rights Agent of the provisions of this Agreement;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Rights Agent is hereby authorized and directed to accept instructions with respect to the performance of
its duties hereunder from any individual designated in writing by the Corporation and believed by the Rights Agent to be the Chief Executive Officer, President, Chief Financial Officer, or the Secretary of the Corporation, and to apply to such
individuals for advice or instructions in connection with its duties, and it shall not be liable for any action taken or suffered by it in good faith in accordance with instructions of any such individual; it is understood that instructions to the
Rights Agent shall, except where circumstances make it impractical or the Rights Agent otherwise agrees, be given in writing and, where not in writing, such instructions shall be confirmed in writing as soon as reasonably practicable after the
giving of such instructions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Rights Agent and any shareholder or director, officer or employee of the Rights Agent may buy, sell or deal
in Common Shares, Rights or other securities of the Corporation or become pecuniarily interested in any transaction in which the Corporation may be interested, or contract with or lend money to the Corporation or otherwise act as fully and freely as
though it were not the Rights Agent under this Agreement; nothing herein shall preclude the Rights Agent from acting in any other capacity for the Corporation or for any other legal entity; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Rights Agent may execute and exercise any of the rights or powers hereby vested in it or perform any duty
hereunder either itself or by or through its attorneys or agents, and the Rights Agent will not be answerable or accountable for any act, default, neglect or misconduct of any such attorneys or agents or for any loss to the Corporation resulting
from any such act, default, neglect or misconduct, provided reasonable care was exercised in the selection and continued employment thereof. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.4</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Change of Rights Agent</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Rights Agent may resign and be discharged from its duties under this Agreement by giving 60 days prior written notice (or such lesser
notice as is acceptable to the Corporation) to the Corporation, to each transfer agent of Voting Shares and to the holders of the Rights, all in accordance with Section&nbsp;5.9 and at the expense of the Corporation. The Corporation may remove the
Rights Agent by giving 30 days prior written notice to the Rights Agent, to the transfer agent of the Voting Shares and to the holders of the Rights in accordance with Section&nbsp;5.9. If the Rights Agent should resign or be removed or otherwise
become incapable of acting, the Corporation will appoint a successor to the Rights Agent. If the Corporation fails to make such appointment within a period of 30 days after such removal or after it has been notified in writing of such resignation or
incapacity by the resigning or incapacitated Rights Agent or by the holder of any Rights (which holder shall, with such notice, submit such holder&#146;s Rights Certificate for inspection of the Corporation), then the holder of any Rights may apply
to any court of competent jurisdiction for the appointment of a new Rights Agent. Any successor Rights Agent, whether appointed by the Corporation or by such a court, must be a corporation incorporated under the laws of Canada or a province thereof
and authorized to carry on the business of a trust company in the Province of British Columbia. After appointment, the successor Rights Agent will be vested with the same powers, </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;35&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
rights, duties and responsibilities as if it had been originally named as Rights Agent without further act or deed; but the predecessor Rights Agent, upon receiving all amounts owing to it
hereunder (unless otherwise agreed by the Rights Agent), shall deliver and transfer to the successor Rights Agent any property at the time held by it hereunder, and execute and deliver any further assurance, conveyance, act or deed necessary for the
purpose. Not later than the effective date of any such appointment, the Corporation will file notice thereof in writing with the predecessor Rights Agent and each transfer agent of the Voting Shares and mail a notice thereof in writing to the
holders of the Rights in accordance with Section&nbsp;5.9. Failure to give any notice provided for in this Section&nbsp;4.4, however, or any defect therein, shall not affect the legality or validity of the resignation or removal of the Rights Agent
or the appointment of the successor Rights Agent, as the case may be. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.5</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Compliance with Anti-Money Laundering Legislation</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Rights Agent shall retain the right not to act and shall not be liable for refusing to act if, due to a lack of information or for any
other reason whatsoever, the Rights Agent reasonably determines that such an act might cause it to be in non-compliance with any applicable anti-money laundering or anti-terrorist legislation, regulation or guidelines. Further, should the Rights
Agent reasonably determine at any time that its acting under this Agreement has resulted in it being in non-compliance with any applicable anti-money laundering or anti-terrorist legislation, regulation or guidelines, then it shall have the right to
resign on ten days&#146; written notice to the Corporation, provided: (i)&nbsp;that the Rights Agent&#146;s written notice shall describe the circumstances of such non-compliance; and (ii)&nbsp;that if such circumstances are rectified to the Rights
Agent&#146;s satisfaction within such ten day period, then such resignation shall not be effective. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.6</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Privacy Legislation</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of the parties hereto acknowledges that federal and/or provincial legislation that addresses the protection of individual&#146;s personal
information (collectively, &#147;<B>Privacy Laws</B>&#148;) applies to obligations and activities under this Agreement. Despite any other provision of this Agreement, neither party will take or direct any action that would contravene, or cause the
other to contravene, applicable Privacy Laws. The Corporation will, prior to transferring or causing to be transferred personal information to the Rights Agent, obtain and retain required consents of the relevant individuals to the collection, use
and disclosure of their personal information, or will have determined that such consents either have previously been given upon which the parties can rely or are not required under the Privacy Laws. The Rights Agent will use commercially reasonable
efforts to ensure that its services hereunder comply with Privacy Laws. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 5 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MISCELLANEOUS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.1</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Redemption, Waiver, Extension and Termination</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the prior consent of the holders of Voting Shares or Rights obtained as set forth in subsections
5.4(a) or 5.4(b), as applicable, the Board of Directors acting in good faith may, at any time prior to the later of the Share Acquisition Date and the Separation Time, elect to redeem all but not less than all of the then outstanding Rights at a
redemption price of $0.00001 per Right, appropriately adjusted in a manner analogous to the applicable adjustment provided for in Section&nbsp;2.3 if an event of the type analogous to any of the events described in Section&nbsp;2.3 shall have
occurred (such redemption price being herein referred to as the &#147;<B>Redemption Price</B>&#148;). </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;36&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Board of Directors may waive the application of Section&nbsp;3.1 in respect of the occurrence of any
Flip-in Event if the Board of Directors has determined in good faith, following the Share Acquisition Date and prior to the Separation Time, that a Person became an Acquiring Person by inadvertence and without any intention to become, or knowledge
that it would become, an Acquiring Person under this Agreement and, in the event that such a waiver is granted by the Board of Directors, such Share Acquisition Date shall be deemed not to have occurred. Any such waiver pursuant to this subsection
5.1(b) may only be given on the condition that such Person, within 14 days after the foregoing determination by the Board of Directors or such later date as the Board of Directors may determine (the &#147;<B>Disposition Date</B>&#148;), has reduced
its Beneficial Ownership of Voting Shares such that the Person is no longer an Acquiring Person. If the Person remains an Acquiring Person at the Close of Business on the Disposition Date, then the Disposition Date shall be deemed to be the date of
occurrence of a further Share Acquisition Date and Section&nbsp;3.1 shall apply thereto. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event that a Person acquires Voting Shares and/or Convertible Securities pursuant to a Permitted Bid or
an Exempt Acquisition referred to in subsection 5.1(d), then the Board of Directors shall, notwithstanding the provisions of subsection 5.1(a), immediately upon the consummation of such acquisition and without further formality, be deemed to have
elected to redeem the Rights at the Redemption Price. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Board of Directors acting in good faith may, prior to the occurrence of the relevant Flip-in Event, upon
prior written notice delivered to the Rights Agent, determine to waive the application of Section&nbsp;3.1 to a Flip-in Event that may occur by reason of a Take-over Bid made by means of a Take-over Bid circular to all holders of record of Voting
Shares; provided that, if the Board of Directors waives the application of Section&nbsp;3.1 to a particular Take-over Bid pursuant to this subsection 5.1(d), then the Board of Directors shall be deemed to have waived the application of
Section&nbsp;3.1 to any other Take-over Bid made by means of a Take-over Bid circular to all holders of record of Voting Shares prior to the expiry of any Take-over Bid in respect of which a waiver is, or is deemed to have been, granted under this
subsection 5.1(d). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the prior consent of the holders of Voting Shares obtained as set forth in subsection 5.4(b)(i), the
Board of Directors may, at any time prior to the occurrence of a Flip-in Event as to which the application of Section&nbsp;3.1 has not been waived pursuant to this Section&nbsp;5.1, if such Flip-in Event would occur by reason of an acquisition of
Voting Shares and/or Convertible Securities otherwise than pursuant to a Take-over Bid made by means of a Take-over Bid circular to all registered holders of Voting Shares and otherwise than in the circumstances set forth in subsection 5.1(b), waive
the application of Section&nbsp;3.1 to such Flip-in Event. In such event, the Board of Directors shall extend the Separation Time to a date at least 10 Business Days subsequent to the meeting of shareholders called to approve such waiver.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Board of Directors may, prior to the Close of Business on the tenth Business Day following a Share
Acquisition Date or such later Business Day as it may from time to time determine, upon prior written notice delivered to the Rights Agent, waive the application of Section&nbsp;3.1 to the related Flip-in Event; provided that the Acquiring Person
has reduced its Beneficial Ownership of Voting Shares (or has entered into a contractual arrangement with the Corporation, acceptable to the Board of Directors, to do so within 10 days of the date on which such contractual arrangement is entered
into or such later date as the Board of Directors may determine) such that, at the time the waiver becomes effective pursuant to this subsection 5.1(f), such Person is no longer an Acquiring Person. In the event of such a waiver becoming effective
prior to the Separation Time, for the purposes of this Agreement, such Flip-in Event shall be deemed not to have occurred. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;37&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Where a Take-over Bid that is not a Permitted Bid or Competing Permitted Bid is withdrawn or otherwise
terminated after the Separation Time has occurred and prior to the occurrence of a Flip-in Event, or if the Board of Directors grants a waiver under subsection 5.1(f) after the Separation Time, then the Board of Directors may elect to redeem all the
outstanding Rights at the Redemption Price. Upon the Rights being redeemed pursuant to this subsection 5.1(g), all of the provisions of this Agreement shall continue to apply as if the Separation Time had not occurred and Rights Certificates
representing the number of Rights held by each holder of record of Voting Shares at the Separation Time had not been mailed to each such holder and for all purposes of this Agreement the Separation Time shall be deemed not to have occurred and the
Corporation shall be deemed to have issued replacement Rights to the holders of its then outstanding Voting Shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the Board of Directors is deemed under subsection 5.1(c) to have elected or elects under subsections 5.1(a)
or 5.1(g) to redeem the Rights, then the right to exercise the Rights will thereupon, without further action and without notice, terminate and the only right thereafter of the holders of Rights shall be to receive the Redemption Price.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Within 10 Business Days after the Board of Directors is deemed under subsection 5.1(c) to have elected or
elects under subsection 5.1(a) or 5.1(g) to redeem the Rights, the Corporation shall give notice of redemption to the holders of the then outstanding Rights by mailing such notice to each such holder at his last address as it appears upon the Rights
Register or, prior to the Separation Time, on the registry books of the transfer agent for the Voting Shares. Any notice which is mailed in the manner herein provided shall be deemed given, whether or not the holder receives the notice. Each such
notice of redemption will state the method by which the payment of the Redemption Price will be made. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Corporation shall not be obligated to make a payment of the Redemption Price to any holder of Rights unless
the holder is entitled to receive at least $10.00 in respect of all Rights held by such holder. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.2</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Expiration</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No Person will have any rights pursuant to this Agreement or in respect of any Right after the Expiration Time, except in respect of any right
to receive cash, securities or other property which has accrued at the Expiration Time and except as specified in subsections 4.1(a) and 4.1(b). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.3</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Issuance of New Rights Certificates</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding any of the provisions of this Agreement or of the Rights to the contrary, the Corporation may, at its option, issue new Rights
Certificates evidencing Rights in such form as may be approved by its Board of Directors to reflect any adjustment or change in the number or kind or class of securities purchasable upon exercise of Rights made in accordance with the provisions of
this Agreement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;38&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.4</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Supplements and Amendments</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to subsections 5.4(b) and 5.4(c), the Corporation may from time to time amend, supplement, restate or
delete any of the provisions of this Agreement and the Rights provided that no amendment, supplement, restatement or deletion shall be made without the prior consent of the shareholders of the Corporation or holders of the Rights, given as provided
in subsection 5.4(b), except that amendments, supplements, restatements or deletions made for any of the following purposes shall not require such prior approval but shall be subject to subsequent ratification in accordance with subsection 5.4(b):
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in order to make such changes as are necessary in order to maintain the validity of this Agreement and the
Rights as a result of any change in any applicable legislation, regulations or rules; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in order to make such changes as are necessary in order to cure any clerical or typographical error.
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything in this Section&nbsp;5.4 to the contrary, no amendment, supplement, restatement or deletion
shall be made to the provisions of Article 4 or any other provision specifically relating to the rights or duties of the Rights Agent except with the written concurrence of the Rights Agent thereto. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any amendment, supplement, restatement or deletion made by the Board of Directors pursuant to subsection 5.4(a)
shall if made: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">prior to the Separation Time, be submitted to the shareholders of the Corporation at the next meeting of
shareholders and the shareholders may, by resolution passed by a majority of the votes cast by Independent Shareholders who vote in respect of such amendment, supplement, restatement or deletion, confirm or reject such amendment, supplement,
restatement or deletion; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">after the Separation Time, be submitted to the holders of Rights at a meeting to be held on a date not later
than the date of the next meeting of shareholders of the Corporation and the holders of Rights may, by resolution passed by a majority of the votes cast by the holders of Rights which have not become void pursuant to subsection 3.1(b) who vote in
respect of such amendment, supplement, restatement or deletion, confirm or reject such amendment, supplement, restatement or deletion. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Any amendment, supplement, restatement or deletion pursuant to subsection 5.4(a) shall be effective from the later of the date of the consent
of the holders of Voting Shares or Rights, as applicable, adopting such amendment, supplement, restatement or deletion and the date of approval thereof by the Exchange (except in the case of an amendment, supplement, restatement or deletion referred
to in subsections 5.4(a)(i) or (ii), which shall be effective from the later of the date of the resolution of the Board of Directors adopting such amendment, supplement, restatement or deletion and the date or approval thereof by the Exchange and
shall continue in effect until it ceases to be effective (as in this subsection 5.4(b) described) and, where such amendment, supplement, restatement or deletion is confirmed, it shall continue in effect in the form so confirmed). If an amendment,
supplement, restatement or deletion pursuant to subsections 5.4(a)(i) or (ii)&nbsp;is rejected by the shareholders or the holders of Rights or is not submitted to the shareholders or holders of Rights as required, then such amendment, supplement,
restatement or deletion shall cease to be effective, as applicable: </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;39&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">from and after the termination of the meeting at which it was rejected or to which it should have been but was
not submitted; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">from and after the date of the meeting of holders of Rights that should have been (but was not) held prior to
or concurrently with the time of the next meeting of shareholders of the Corporation; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">from and after the date a meeting of shareholders should have been held pursuant to applicable law but was not
held, </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">and no subsequent resolution of the Board of Directors to amend, supplement, restate or delete any provision of
this Agreement to substantially the same effect shall be effective until confirmed by the shareholders or holders of Rights, as the case may be. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For greater certainty, neither the exercise by the Board of Directors of any power or discretion conferred on
it hereunder nor the making by the Board of Directors of any determination or the granting of any waiver it is permitted to make or give hereunder shall constitute an amendment, supplement, restatement or deletion of the provisions of this Agreement
or the Rights, for purposes of this Section&nbsp;5.4 or otherwise. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unless otherwise provided herein, the approval, confirmation or consent of the holders of Rights with respect
to any matter arising hereunder shall be deemed to have been given if the action requiring such approval, confirmation or consent is authorized by the affirmative votes of the holders of Rights present or represented at and entitled to be voted at a
meeting of the holders of Rights and representing a majority of the votes cast in respect thereof. For the purposes hereof, each outstanding Right (other than Rights which are void pursuant to the provisions hereof or which, prior to the Separation
Time, are held otherwise than by Independent Shareholders) shall be entitled to one vote, and the procedures for the calling, holding and conduct of the meeting shall be those, as nearly as may be, which are provided in the Corporation&#146;s bylaws
and under applicable laws with respect to meetings of shareholders of the Corporation. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.5</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Fractional Rights and Fractional Shares</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Corporation shall not be required to issue fractions of Rights or to distribute Rights Certificates which
evidence fractional Rights. Any such fractional Right shall be null and void and the Corporation will not have any obligation or liability in respect thereof. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Corporation shall not be required to issue fractional Common Shares upon exercise of the Rights or to
distribute certificates that evidence fractional Common Shares. In lieu of issuing fractional Common Shares, the Corporation shall pay to the registered holder of Rights Certificates at the time such Rights are exercised as herein provided, an
amount in cash equal to the same fraction of the Market Price of one Common Share at the date of such exercise. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.6</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Rights of Action</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the terms of this Agreement, rights of action in respect of this Agreement, other than rights of action vested solely in the Rights
Agent, are vested in the respective holders of the Rights; and </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;40&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any holder of any Rights, without the consent of the Rights Agent or of the holder of any other Rights may, on such holder&#146;s own behalf and for such holder&#146;s own benefit and the benefit
of other holders of Rights, enforce, and may institute and maintain any suit, action or proceeding against the Corporation to enforce, or otherwise act in respect of, such holder&#146;s right to exercise such holder&#146;s Rights in the manner
provided in this Agreement and in such holder&#146;s Rights Certificate. Without limiting the foregoing or any remedies available to the holders of Rights, it is specifically acknowledged that the holders of Rights would not have an adequate remedy
at law for any breach of this Agreement and will be entitled to specific performance of the obligations under, and injunctive relief against actual or threatened violations of, the obligations of any Person subject to this Agreement. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.7</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Holder of Rights Not Deemed a Shareholder</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No holder, as such, of any Rights shall be entitled to vote, receive dividends or be deemed for any purpose the holder of Common Shares or any
other securities which may at any time be issuable on the exercise of Rights, nor shall anything contained herein or in any Rights Certificate be construed to confer upon the holder of any Rights, as such, any of the rights of a shareholder of the
Corporation or any right to vote for the election of directors or upon any matter submitted to shareholders at any meeting thereof, or to give or withhold consent to any action, or to receive notice of meetings or other actions affecting
shareholders (except as provided in Section&nbsp;5.8) or to receive dividends or subscription rights or otherwise, until such Rights shall have been exercised in accordance with the provisions hereof. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.8</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Notice of Proposed Actions</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Corporation proposes after the Separation Time and prior to the Expiration Time to effect the liquidation, dissolution or winding up of
the Corporation or the sale of all or substantially all of the Corporation&#146;s assets, then, in each such case, the Corporation shall give to each holder of a Right, in accordance with Section&nbsp;5.9, a notice of such proposed action, which
shall specify the date on which such liquidation, dissolution, or winding up is to take place, and such notice shall be so given at least 20 Business Days prior to the date of the taking of such proposed action by the Corporation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5.9 Notices </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notices or demands
authorized or required by this Agreement to be given or made to or by the Rights Agent, the holder of any Rights or the Corporation will be sufficiently given or made and shall be deemed to be received if delivered or sent by first-class mail,
postage prepaid, or by facsimile machine or other means of printed telecommunication, charges prepaid and confirmed in writing by mail or delivery, addressed (until another address is filed in writing with the Rights Agent or the Corporation, as
applicable), as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if to the Corporation: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">880-580 Hornby Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Vancouver,
British Columbia </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">V6C 3B6 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Jennifer Bath, CEO and President
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email:
<I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Redacted: email address] </I> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Facsimile No.:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(604) 684-0642; </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if to the Rights Agent: </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;41&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">COMPUTERSHARE TRUST COMPANY OF CANADA </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">510 Burrard Street, Third Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Vancouver VC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">V6C 3B9 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General Manager, Emerging Issuer
Solutions (EIS) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Facsimile No.:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(604) 661-9401; and </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if to the holder of any Rights, to the address of such holder as it appears on the Rights Register or, prior to
the Separation Time, on the registry books of the Corporation for the Common Shares. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any notice which is mailed or sent
or delivered in the manner provided for herein shall be deemed given and received whether or not the holder receives the notice. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.10</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Costs of Enforcement</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation agrees that if the Corporation, or any other Person the securities of which are purchasable upon exercise of Rights, fails to
fulfil any of its obligations pursuant to this Agreement, then the Corporation or such Person will reimburse the holder of any Rights for the reasonable costs and expenses (including legal fees) incurred by such holder in actions to enforce such
holder&#146;s rights pursuant to any Rights or this Agreement. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.11</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Regulatory Approvals</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any obligation of the Corporation or action or event contemplated by this Agreement, shall be subject to applicable law and to the receipt of
any requisite approval or consent from any governmental or regulatory authority. Without limiting the generality of the foregoing, any issuance or delivery of debt or equity securities (other than non-convertible debt security) of the Corporation
upon the exercise of Rights and any amendment to this Agreement shall be subject to the applicable prior consent of each Exchange. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless
provided with written notice to the contrary, the Rights Agent is entitled to assume that all such necessary consents and approvals have been obtained. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.12</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Declaration as to Non-Canadian and Non-United States Holders</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, upon the advice of outside counsel, any action or event contemplated by this Agreement would require compliance with the securities laws or
comparable legislation of a jurisdiction outside Canada and the United States of America, the Board of Directors acting in good faith may take such actions as it may deem appropriate to ensure that such compliance is not required, including without
limitation establishing procedures for the issuance to a Canadian resident Fiduciary of Rights or securities issuable on exercise of Rights, the holding thereof in trust for the Persons entitled thereto (but reserving to the Fiduciary or to the
Fiduciary and the Corporation, as the Corporation may determine, absolute discretion with respect thereto) and the sale thereof and remittance of the proceeds of such sale, if any, to the Persons entitled thereto. In no event shall the Corporation
or the Rights Agent be required to issue or deliver Rights or securities issuable on exercise of Rights to Persons who are citizens, residents or nationals of any jurisdiction other than Canada and any province or territory thereof and of the United
States of America and any state thereof in which such issue or delivery would be unlawful without registration of the relevant Persons or securities for such purposes. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;42&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.13</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Successors</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All the covenants and provisions of this Agreement by or for the benefit of the Corporation or the Rights Agent shall bind and enure to the
benefit of their respective successors and assigns hereunder. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.14</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Benefits of this Agreement</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nothing in this Agreement shall be construed to give to any Person other than the Corporation, the Rights Agent and the holders of the Rights
any legal or equitable right, remedy or claim under this Agreement; this Agreement shall be for the sole and exclusive benefit of the Corporation, the Rights Agent and the holders of the Rights. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.15</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Shareholder Reconfirmation</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Agreement must be reconfirmed by a resolution passed by a majority of the votes cast by Independent Shareholders who vote in respect of
such resolution at the annual meeting of the Corporation to be held in 2019 and at every third annual meeting of the Confirmation thereafter (each such annual meeting being a &#147;<B>Reconfirmation Meeting</B>&#148;). If this Agreement is not so
reconfirmed or is not presented for reconfirmation at any such Reconfirmation Meeting, this Agreement and all outstanding Rights shall terminate and be void and of no further force and effect on and from the Close of Business on the date of the
applicable Reconfirmation Meeting; provided that termination shall not occur if a Flip-in Event has occurred (other than a Flip-in Event which has been waived pursuant to subsections 5.1(b), 5.1(d) or 5.1(f) hereof), prior to the date upon which
this Agreement would otherwise terminate pursuant to this Section&nbsp;5.15. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.16</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Determinations and Actions by the Board of Directors</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All actions, calculations, interpretations and determinations (including all omissions with respect to the foregoing) which are done or made by
the Board of Directors, in good faith: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">may be relied upon by the Rights Agent (and in the case of reliance by the Rights Agent, the good faith of the
Board of Directors shall be presumed); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">shall not subject the Board of Directors to any liability to the holders of the Rights or to any other parties.
</P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.17</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Force Majeure</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No party shall be liable to the other, or held in breach of this Agreement, if prevented, hindered, or delayed in the performance or observance
of any provision contained herein by reason of act of God, riots, terrorism, acts of war, epidemics, governmental action or judicial order, earthquakes, or any other similar causes (including, but not limited to, mechanical, electronic or
communication interruptions, disruptions or failures). Performance times under this Agreement shall be extended for a period of time equivalent to the time lost because of any delay that is excusable under this Section. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.18</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Governing Law</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Agreement and the Rights issued hereunder shall be deemed to be a contract made under the laws of the Province of British Columbia and for
all purposes will be governed by and construed in accordance with the laws of such province applicable to contracts to be made and performed entirely within such province. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;43&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.19</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Language</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Les parties aux pr&eacute;sentes ont exig&eacute; que la pr&eacute;sente convention ainsi que tous les documents et avis qui s&#146;y
rattachent ou qui en coulent soient r&eacute;dig&eacute;s en langue anglaise. The parties hereto have required that this Agreement and all documents and notices related thereto or resulting therefrom be drawn up in English. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.20</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Severability</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any term or provision hereof or the application thereof to any circumstance is, in any jurisdiction and to any extent, invalid or
unenforceable, such term or provision will be ineffective only to the extent of such invalidity or unenforceability without invalidating or rendering unenforceable the remaining terms and provisions hereof or the application of such term or
provision to circumstances other than those as to which it is held invalid or unenforceable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.21</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Effective Date</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Agreement is effective as of and from the Effective Date. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.22</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Time of the Essence</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Time shall be of the essence hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(remainder of page intentionally blank) </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder
Rights Plan Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page&nbsp;44&nbsp;of&nbsp;44</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.23</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Counterparts</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Agreement may be executed in any number of counterparts and each of such counterparts will for all purposes be deemed to be an original,
and all such counterparts shall together constitute one and the same instrument. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties hereto have caused
this Agreement to be duly executed effective the 17<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> day of October, 2019. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>IMMUNOPRECISE ANTIBODIES LTD.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"><B>COMPUTERSHARE TRUST COMPANY OF CANADA</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><I>(signed) &#147;Jennifer Bath&#148;</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><I>(signed) &#147;Evelyn Hsu&#148;</I></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Jennifer Bath</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Evelyn Hsu</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">President &amp; CEO</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Account Manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><I>(signed) &#147;Charles Wheelock&#148;</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><I>(signed) &#147;Vanessa Lee&#148;</I></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Charles Wheelock</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vanessa Lee</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Technology Officer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Relationship Manager</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE &#147;A&#148; </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">to a Shareholder Rights Plan Agreement made as of October&nbsp;17, 2019, between ImmunoPrecise Antibodies Ltd. and Computershare Trust Company
of Canada. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>[Form of Rights Certificate] </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Certificate No.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Rights</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE RIGHTS ARE SUBJECT TO REDEMPTION, AT THE OPTION OF THE CORPORATION, ON THE TERMS SET FORTH IN THE SHAREHOLDER RIGHTS PLAN
AGREEMENT. UNDER CERTAIN CIRCUMSTANCES (SPECIFIED IN SUBSECTION 3.1(b) OF SUCH AGREEMENT), RIGHTS BENEFICIALLY OWNED BY AN ACQUIRING PERSON, CERTAIN RELATED PARTIES OF AN ACQUIRING PERSON OR A TRANSFEREE OF AN ACQUIRING PERSON OR ANY SUCH RELATED
PARTIES WILL BECOME VOID WITHOUT FURTHER ACTION. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Rights Certificate </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This certifies that
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> is the registered holder of the number of Rights set forth above, each of which entitles the registered holder thereof, subject to the terms, provisions
and conditions of the Shareholder Rights Plan Agreement made as of October&nbsp;17, 2019, as such agreement may from time to time be amended, restated, varied or replaced (the &#147;<B>Rights Agreement</B>&#148;) between ImmunoPrecise Antibodies
Ltd., a corporation established pursuant to the laws of British Columbia, (the &#147;<B>Corporation</B>&#148;) and Computershare Trust Company of Canada, a trust company incorporated under the laws of Canada, as Rights Agent (the &#147;<B>Rights
Agent</B>&#148;) (which term shall include any successor Rights Agent under the Rights Agreement), to purchase from the Corporation, at any time after the Separation Time and prior to the Expiration Time (as such terms are defined in the Rights
Agreement), one fully paid common share of the Corporation (a &#147;<B>Common Share</B>&#148;) at the Exercise Price referred to below, upon presentation and surrender of this Rights Certificate, together with the Form of Election to Exercise
appropriately completed and duly executed, to the Rights Agent at its principal office in Vancouver, British Columbia or Toronto, Ontario. Until adjustment thereof in certain events as provided in the Rights Agreement, the Exercise Price shall be
equal to three times the Market Price per Common Share (payable in cash, certified cheque or money order payable to the order of the Corporation). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of Common Shares which may be purchased for the Exercise Price is subject to adjustment as set forth in the Rights Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Rights Certificate is subject to all of the terms, provisions and conditions of the Rights Agreement, which terms, provisions and
conditions are hereby incorporated by reference and made a part hereof and to which Rights Agreement reference is hereby made for a full description of the rights, limitations of rights, obligations, duties and immunities thereunder of the Rights
Agent, the Corporation and the holder of the Rights Certificates. By acceptance hereof, the holder is deemed to accept, and agrees to be bound by the terms of the Rights Agreement. Copies of the Rights Agreement are on file at the principal
executive offices of the Corporation and are available upon written request. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Rights Certificate, with or without other Rights
Certificates, upon surrender at the principal office of the Rights Agent in Vancouver, British Columbia or Toronto, Ontario may be exchanged for another Rights Certificate or Rights Certificates of like tenor evidencing an aggregate number of Rights
equal to the aggregate number of Rights evidenced by the Rights Certificate or Rights Certificates surrendered. If this Rights Certificate shall be exercised in part, the registered holder shall be entitled to receive, upon surrender hereof, another
Rights Certificate or Rights Certificates for the number of whole Rights not exercised. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In certain circumstances described in the Rights Agreement, each Right evidenced hereby may
be adjusted so as to entitle the registered holder thereof to purchase or receive securities or shares in the capital of the Corporation other than Common Shares or more or less than one Common Share (or a combination thereof), all as provided in
the Rights Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the provisions of the Rights Agreement, the Rights evidenced by this Certificate may be redeemed by the
Corporation at a redemption price of $0.00001 per Right subject to adjustment in certain events. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No fractional Common Shares will be
issued upon the exercise of any Right or Rights evidenced hereby, but in lieu thereof a cash payment will be made, as provided in the Rights Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No holder of this Rights Certificate, as such, shall be entitled to vote or receive dividends or be deemed for any purpose the holder of Common
Shares or any other securities which may at any time be issuable upon the exercise hereof, nor shall anything contained in the Rights Agreement or herein be construed to confer upon the holder hereof, as such, any of the rights of a shareholder of
the Corporation or any right to vote for the election of directors or upon any matter submitted to shareholders at any meeting thereof, or to give or withhold consent to any action, or to receive notice of any meeting or other actions affecting
shareholders (except as provided in the Rights Agreement), or to receive dividends or subscription rights or otherwise, until the Rights evidenced by this Rights Certificate shall have been exercised as provided in the Rights Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Rights Certificate shall not be valid for any purpose until it shall have been countersigned by the Rights Agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WITNESS the facsimile signature of the proper officers of the Corporation. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="57%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"><B>IMMUNOPRECISE ANTIBODIES LTD.</B></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-bottom:1pt; margin-top:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-bottom:1pt; margin-top:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"><B>Countersigned:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"><B>COMPUTERSHARE TRUST COMPANY OF CANADA</B></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-bottom:1pt; margin-top:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A - 2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM OF ELECTION TO EXERCISE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
undersigned hereby irrevocably elects to exercise <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
whole Rights represented by this Rights Certificate to purchase the Common Shares issuable upon the exercise of such Rights and requests that certificates for such Common Shares be issued in the name of and delivered to: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="26%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Rights&nbsp;Certificate&nbsp;No.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-bottom:1pt; margin-top:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">City and Province</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Social Insurance No. or other taxpayer identification numbers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If such number of Rights shall not be all the Rights
evidenced by this Rights Certificate, a new Rights Certificate for the balance of such Rights shall be registered in the name of and delivered to: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="26%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">City and Province</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Social Insurance No. or other taxpayer identification numbers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Signature</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">(Signature must correspond to name as written upon the face of this Rights Certificate in every particular, without alteration or enlargement or any change whatsoever)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Written Signature Guaranteed</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Signature must be Medallion guaranteed by a Canadian Schedule I chartered bank, a member of the Securities
Transfer Agent Medallion Program (STAMP), a member of the Stock Exchanges Medallion </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Program (SEMP) or a member of the New York Stock Exchange, Inc. Medallion Signature Program (MSP). Members of these programs are usually members of a recognized stock exchange in Canada or the
United States, members of the Investment Industry Regulatory Organization of Canada, members of the Financial Industry Regulatory Authority in the United States or banks and trust companies in the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(To be completed by the holder if true) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned hereby represents, for the benefit of the Corporation and all holders of Rights and Common Shares, that the Rights evidenced
by this Rights Certificate are not and, to the knowledge of the undersigned, have never been, Beneficially Owned by an Acquiring Person or by an Affiliate or Associate of an Acquiring Person, any other Person acting jointly or in concert with an
Acquiring Person or any Affiliate or Associate of any such other Person (as such terms are defined in the Rights Agreement). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000">Signature</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">NOTICE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>In the event that the certifications set forth above in the Form of Election to Exercise and Assignment are not completed, the Corporation
shall deem the Beneficial Owner of the Rights represented by this Rights Certificate to be an Acquiring Person (as defined in the Rights Agreement) and, accordingly, such Rights shall be null and void. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM OF ASSIGNMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="26%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(Please print name and address of transferee)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">the Rights represented by this Rights Certificate, together with all right,
title and interest therein. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Signature:</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Written Signature Guaranteed</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" COLSPAN="4">(Signature must correspond to name as written upon the face of this<BR>Rights Certificate in every particular, without alteration or<BR>enlargement or any change whatsoever)</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Signature must be Medallion guaranteed by a Canadian Schedule I chartered bank, a member of the Securities
Transfer Agent Medallion Program (STAMP), a member of the Stock Exchanges Medallion Program (SEMP) or a member of the New York Stock Exchange, Inc. Medallion Signature Program (MSP). Members of these programs are usually members of a recognized
stock exchange in Canada or the United States, members of the Investment Industry Regulatory Organization of Canada, members of the Financial Industry Regulatory Authority in the United States or banks and trust companies in the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(To be completed by the assignor if true) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned hereby represents, for the benefit of the Corporation and all holders of Rights and Common Shares, that the Rights evidenced
by this Rights Certificate are not and, to the knowledge of the undersigned have never been, Beneficially Owned by an Acquiring Person or by an Affiliate or Associate of an Acquiring Person, any other Person acting jointly or in concert with an
Acquiring Person or any Affiliate or Associate of any such other Person (as such terms are defined in the Rights Agreement). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000">Signature</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(Please print name below signature)</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>In the event that the certifications set forth above in the Form of Election to Exercise and Assignment are not completed, the Corporation
shall deem the Beneficial Owner of the Rights represented by this Rights Certificate to be an Acquiring Person (as defined in the Rights Agreement) and, accordingly, such Rights shall be null and void. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.28
<SEQUENCE>29
<FILENAME>d20922dex9928.htm
<DESCRIPTION>EX-99.28
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.28</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.28 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g20922g54g94.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Talem Therapeutics accesses the OmniAb<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> platform from Ligand
Pharmaceuticals </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, Nov. 5, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTCQB:
IPATF), an industry leader in the discovery of novel, therapeutic antibodies, announces that Talem Therapeutics, a wholly-owned subsidiary, has entered into a worldwide OmniAb<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> platform
license agreement with Ligand Pharmaceuticals (NASDAQ:LGND). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This license enables Talem to access Ligand&#146;s unique OmniAb platform for use with
Talem&#146;s leading antibody discovery capabilities. OmniAb is a genetically engineered platform for the generation of diverse mono- and bispecific, fully human antibodies, and the industry&#146;s only platform comprised of the three species rats,
mice, and chickens. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the license, Talem has the right to develop and partner fully human antibodies in OmniRat<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, OmniFlic<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, OmniMouse<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>,
OmniChicken<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, and OmniClic<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP>. Talem will leverage OmniAb with ImmunoPrecise&#146;s leading, high-throughput technologies, allowing programs
to leapfrog risky and time-consuming early discovery and accelerate generation of <FONT STYLE="white-space:nowrap">de-risked</FONT> lead candidates for partners worldwide. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ligand is eligible to receive clinical milestone payments as well as <FONT STYLE="white-space:nowrap">mid-single-digit</FONT> royalties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Talem will leverage the multiple technology tracks for antibody discovery within ImmunoPrecise, including high throughput, rapid identification of candidates
through high performance, single B cell interrogation; electrofusion-based, single step cloning hybridoma generation; and accessing ImmunoPrecise&#146;s DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> custom, immune phage
libraries. All of these technologies cohere seamlessly with IPA&#146;s integrated Artemis<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> Intelligence Metadata (AIM)<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> capabilities to
enable rapid turnaround on additional outputs in therapeutic optimization, stability, affinity, and manufacturability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;ImmunoPrecise has years of
experience successfully employing OmniAb animals in antibody discovery. Combining ImmunoPrecise&#146;s <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">end-to-end</FONT></FONT> antibody discovery technologies with Ligand&#146;s
leading OmniAb platform is a natural progression, supporting both companies&#146; overall mission of getting the best therapeutic antibodies to the clinic faster, in this case, all under one roof,&#148; said Jennifer Bath, CEO of ImmunoPrecise.
&#147;Enabling Talem&#146;s internal discovery for the development of therapeutic antibodies in OmniAb animals provides Talem, and its future partners, a distinctively streamlined path to the clinic.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise also announces that, effective November&nbsp;30, 2019, Jason Orloske will no longer be Vice President of Operations. We would like to thank
Jason for his support and contributions while we wish him the best for his next endeavors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About
OmniAb<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">OmniAb is a three-species transgenic-animal platform consisting of five different
technologies used for producing mono- and bispecific human therapeutic antibodies. OmniRat<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> is the industry&#146;s first human monoclonal antibody technology based on rats. It has a complete
immune system with a diverse antibody repertoire and generates antibodies with human idiotypes as effectively as wild-type animals make rat antibodies. OmniMouse<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> is a transgenic mouse that
complements OmniRat and expands epitope coverage. OmniFlic<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> is an engineered rat with a fixed light chain for development of bispecific, fully human antibodies. OmniChicken<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> is the industry&#146;s first human monoclonal antibody technology based on chickens. OmniClic<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> is a transgenic chicken that has been
engineered to focus sequence diversity in the CDRs of the VH domain while leaving the VL domain germline in sequence. The five technologies use patented technology, have broad freedom to operate and deliver fully human antibodies with high affinity,
specificity, expression, solubility and stability. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Ligand Pharmaceuticals </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines.
Ligand&#146;s business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Ligand&#146;s goal is to
offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified and lower-risk business than a typical biotech company. Ligand&#146;s business model is based on doing what they do best: drug
discovery, early-stage drug development, product reformulation and partnering. Ligand partners with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management and commercialization) to ultimately
generate our revenue. Ligand&#146;s Captisol<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> platform technology is a patent-protected, chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of
drugs. OmniAb<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> is a patent-protected transgenic animal platform used in the discovery of fully human <FONT STYLE="white-space:nowrap">mono-and</FONT> bispecific therapeutic antibodies. Ligand
has established multiple alliances, licenses and other business relationships with the world&#146;s leading pharmaceutical companies including Amgen, Merck, Pfizer, Gilead, Janssen, Baxter International and Eli Lilly. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Talem Therapeutics LLC </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Talem Therapeutics (Talem)
is a wholly owned subsidiary of ImmunoPrecise Antibodies USA and is focused on the discovery and development of next-generation, human, monoclonal, therapeutic antibodies targeting neurology, immuno-oncology, gastroenterology, inflammation, and
rare/specialty diseases. Using the proprietary antibody discovery platforms and innovative technologies housed at ImmunoPrecise Antibodies and <FONT STYLE="white-space:nowrap">U-Protein</FONT> Express (an IPA company), Talem aims to accelerate
novel, therapeutic antibody treatments to the clinic through strategic alliances and partners. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is an international, full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell Select<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP> progressive, single-cell interrogation technology and the DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> custom phage libraries, as well as the Abthena<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP> bispecific program. IPA is focused on the next generation of antibody discovery, to deliver the most therapeutically relevant antibodies, in a shorter period of time, with the highest probability of
succeeding to clinical trials. ImmunoPrecise discovery and </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
development are conducted in Utrecht and Oss, the Netherlands <FONT STYLE="white-space:nowrap">(U-Protein</FONT> Express and IPA Europe, respectively), and in Victoria, British Columbia (IPA
Canada). The Company operates globally to offer a continuum of superior antibody services, transforming the face of therapeutic discovery, by decreasing turnaround time and risk, and promoting clinical success. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release
contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148; within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;,
&#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and similar expressions to identify forward-looking statements. Any such forward-looking statements are based on
assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and expected future developments. However, whether actual results and developments will conform to
ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the
forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual
management discussion and analysis for the fiscal year ended April&nbsp;30, 2018 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless
required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922g24r30.jpg" ALT="LOGO">
 View original content to download multimedia: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">http://www.prnewswire.com/news-releases/talem-therapeutics-accesses-the-omniab-platform-from-ligand-pharmaceuticals-300952237.html
</FONT></FONT></U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View original content to download multimedia: <U>http://www.newswire.ca/en/releases/archive/November2019/05/c8822.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 16:02e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">05-NOV-19</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.29
<SEQUENCE>30
<FILENAME>d20922dex9929.htm
<DESCRIPTION>EX-99.29
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.29</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.29 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g20922g72h92.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Announces Annual General Meeting Results </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, Dec. 2, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTC QB: IPATF) announces that all
resolutions were passed by the shareholders at its annual general meeting (&#147;AGM&#148;) held in Vancouver, British Columbia, on November&nbsp;22, 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shareholders, represented in person or by proxy, at the AGM voted in favour of setting the number of directors at 7, appointed incumbent directors
Dr.&nbsp;Jennifer Bath, Dr.&nbsp;James Kuo, Robert Beecroft, Dr.&nbsp;Robert Burke, Greg Smith, Paul Andreola and Brian Lundstrom as directors of the Company for the ensuing year. Shareholders also appointed Crowe Mackay LLP as the Company&#146;s
external auditor, approved the Company&#146;s rolling 10% stock option plan and approved the newly adopted shareholder rights plan (the &#147;Shareholder Rights Plan&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The purpose of the Shareholder Rights Plan is to ensure that all shareholders are treated fairly in connection with any offer to acquire the outstanding
common shares of the Company and that the board of directors of the Company has the opportunity to identify, solicit, develop and negotiate value-enhancing alternatives to any unsolicited take-over bid. The Shareholder Rights Plan has not been
adopted in response to, or in anticipation of, any known or anticipated take-over bid. The Shareholder Rights Plan will now be in effect for a term of three years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A summary of the principal terms and conditions of the Shareholder Rights Plan is set out in the Company&#146;s Management Information Circular and a copy of
the Shareholder Rights Plan is filed on SEDAR. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is an international, full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell Select<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP> progressive, single-cell interrogation technology and the DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> custom phage libraries, as well as the Abthena<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP> bispecific program. IPA is focused on the next generation of antibody discovery, to deliver the most therapeutically relevant antibodies, in a shorter period of time, with the highest probability of
succeeding to clinical trials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise discovery and development are conducted in Utrecht and Oss, the Netherlands
<FONT STYLE="white-space:nowrap">(U-Protein</FONT> Express and IPA Europe, respectively), and in Victoria, British Columbia (IPA Canada). The Company operates globally to offer a continuum of superior antibody services, transforming the face of
therapeutic discovery, by decreasing turnaround time and risk, and promoting clinical success. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward Looking Information </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148;
within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and
similar expressions to identify forward-looking statements. Any such forward-looking statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and
expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause
ImmunoPrecise&#146;s actual results to differ materially from </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
those expressed or implied by the forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower than
anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and analysis for the fiscal year ended April&nbsp;30, 2018 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking
statements&#148; contained herein speak only as of the date of this press release and, unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information,
future events or otherwise. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View original content to download multimedia: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.newswire.ca/en/releases/archive/December2019/02/c2791.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 08:00e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">02-DEC-19</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.30
<SEQUENCE>31
<FILENAME>d20922dex9930.htm
<DESCRIPTION>EX-99.30
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.30</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.30 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE SIX MONTHS ENDED
OCTOBER 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following Management&#146;s Discussion and Analysis (&#147;MD&amp;A&#148;), prepared as of
December&nbsp;17, 2019, should be read in conjunction with the unaudited condensed interim consolidated financial statements of ImmunoPrecise Antibodies Ltd. (&#147;the Company&#148;, &#147;ImmunoPrecise&#148; or &#147;IPA&#148;) for the three and
six months ended October&nbsp;31, 2019, together with the audited financial statements and accompanying MD&amp;A of the Company for the year ended April&nbsp;30, 2019. This MD&amp;A is the responsibility of management and has been reviewed and
approved by the Board of Directors of IPA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The referenced financial statements have been prepared in accordance with International Financial Reporting
Standards (&#147;IFRS&#148;), as issued by the International Accounting Standards Board and as applicable to the preparation of interim financial statements, including IAS 34, <I>Interim Financial Reporting</I>. Except as otherwise noted, all dollar
figures in this MD&amp;A are stated in Canadian dollars which is the Company&#146;s reporting currency. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This MD&amp;A may contain certain statements that constitute &#147;forward-looking statements&#148; within the meaning of National Instrument <FONT
STYLE="white-space:nowrap">51-102,</FONT> Continuous Disclosure Obligations of the Canadian Securities Administrators. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward-looking statements often,
but not always, are identified by the use of words such as &#147;seek&#148;, &#147;anticipate&#148;, &#147;believe&#148;, &#147;plan&#148;, &#147;estimate&#148;, &#147;expect&#148;, &#147;targeting&#148; and &#147;intend&#148; and statements that an
event or result &#147;may&#148;, &#147;will&#148;, &#147;should&#148;, &#147;could&#148;, or &#147;might&#148; occur or be achieved and other similar expressions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In this MD&amp;A, forward-looking statements include the Company&#146;s future plans and expenditures, the satisfaction of rights and performance of
obligations under agreements to which the Company is a part, the ability of the Company to hire and retain employees and consultants and estimated administrative assessment and other expenses. The forward-looking statements that are contained in
this MD&amp;A involve a number of risks and uncertainties. As a consequence, actual results might differ materially from results forecast or suggested in these forward-looking statements. Some of these risks and uncertainties are identified under
the heading &#147;RISKS AND UNCERTAINTIES&#148; in this MD&amp;A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Furthermore, forward-looking statements contained herein are made as of the date of
this MD&amp;A and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results or otherwise. There can be no assurance that forward-looking statements will prove to
be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>GENERAL </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company was incorporated under the laws of
Alberta on November&nbsp;22, 1983 and is listed on the TSX Venture Exchange (the &#147;Exchange&#148;) as a Tier&nbsp;2 life science issuer under the trading symbol &#147;IPA&#148;. The Company&#146;s OTC symbol is &#147;IPATF&#148;. The address of
the Company&#146;s corporate office is 3204&nbsp;&#150;&nbsp;4464 Markham Street, Victoria, BC V8Z 7X8.<B> </B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE SIX MONTHS ENDED
OCTOBER 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>OVERVIEW </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has emerged as a recognized, full-service, biologics Contract Research and Organization (CRO) with global operations. The Company is
innovation-driven and is strategically positioned - both geographically and scientifically - to provide highly customized, human, therapeutic antibodies. IPA offers a cohesive and extensive portfolio in the protein and antibody research,
manufacturing and validation continuum. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s services include, but are not limited to, proprietary B cell sorting, screening and
sequencing; custom, immune and na&iuml;ve phage display production and screening; expertise with transgenic animals and multi-species antibody discovery; <FONT STYLE="white-space:nowrap">bi-specific,</FONT>
<FONT STYLE="white-space:nowrap">tri-specific,</FONT> VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing, purification in gram scale levels, characterization and validation; antibody engineering;
transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening and clone-picking; cryopreservation; and custom antigen modeling, design and manufacturing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moreover, in the past 18 months, the Company has gained increasing recognition as a rising leader in the biologics, CRO space, with a focus on organic growth
through market penetration and service diversification, as well as strategic expansion with platform and process integration. Furthermore, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">end-to-end</FONT></FONT> services have been
leveraged through acquisition, enabling a steady foundation for future growth. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA Canada and IPA Europe have both been designated as approved CROs for
the world&#146;s leading, transgenic animal platform producing human antibodies, and exercised an advantage in optimizing services for various transgenic animal vendors. The Company made strategic investments in R&amp;D activities to develop
proprietary technologies enabling the application of their B cell Select<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> and DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> platforms to a broad range of transgenic animal
species and strains. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2018, the Company built on its ten years of experience in single B cell interrogation to offer full-service B cell screening,
sorting and sequencing in both N America and Europe on a species agnostic platform, including transgenic, humanized animals. This service is offered against a broad range of therapeutically relevant protein families, including GPCRs and other
challenging, multi-membrane spanning proteins. The Company&#146;s platforms enable antibody screening directly from B cells, allowing for the analysis of a more diverse set of antibodies, and for faster, deeper screening compared to traditional
technologies. The Company announced over a 90% success rate on its B cell technology, which is now offered with a success guarantee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">U-Protein</FONT> Express, situated in the Dutch biotechnology hub of Utrecht, The Netherlands, has been a staple in the recombinant protein community, operating for over 15 years, and specializing in the manufacture of
complex proteins and antibodies in a variety of formats, and from a range of mammalian cell types. Their streamlined and efficient operations have enabled them to successfully support over 5,000 different programs, with over a 90% success rate, for
pharmaceutical and biotechnology industries as well as leading, academic institutions. In a seamless coordination, their operations also support the downstream expression and purification of the antibodies originating from the B cell Select
programs, enabling validation of the platform&#146;s outputs and comprehensive deliverables for clients. The site also has a global, exclusive license from Stanford University for the marketing and sales of the novel protein, Wnt surrogate Fc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA Europe&#146;s contribution in services and intellectual property to the Company after its acquisition have been substantial. The integration of IPA Europe
significantly expanded the Company&#146;s services portfolio including affinity maturation, humanization, functional assay design and development, na&iuml;ve and diseased scFv libraries, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE SIX MONTHS ENDED
OCTOBER 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">and proprietary methods of immunization against conformational targets (e.g. ModiVacc<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP> lymphoid tumor immunization and DNA immunization technologies). Adding to their proprietary services, IPA Europe developed and <FONT STYLE="white-space:nowrap">rolled-out</FONT> the aforementioned
DeepDisplay service for the discovery of fully human antibodies using transgenic animal immunization and custom phage display. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While CRO services are the
mainstay of the Company, ImmunoPrecise has worked continuously on building an intellectual property estate and portfolio of proprietary methods and physical assets through collaborations, joint ventures, acquisitions and <FONT
STYLE="white-space:nowrap">in-licensing.</FONT> The Company has strategically invested in the development and licensing of antibody discovery platforms and related intellectual property assets. The onboarding of existing assets with regard to
equipment, technologies, IP and licenses within the Company&#146;s EU operations has been compounded by active research and development at all operational sites this year, including the <FONT STYLE="white-space:nowrap">on-going</FONT> development of
new service offerings to be rolled out in the fiscal year 2020, but more notably, internal discovery programs focused on novel, therapeutic antibodies, primarily in the field of immuno-oncology. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company formed Talem Therapeutics (&#147;Talem&#148;), based in Cambridge, Massachusetts, to support its internal and partnered therapeutic, discovery
programs. Talem offers strategic partnerships with pharma and biotech companies and is the only company to offer these services as a partnership in OmniAb transgenic animals using their own license. The ability for investors to support individual
assets or portfolios generates an asymmetrical opportunity for investments, while avoiding ImmunoPrecise shareholder dilution. The depth and speed of IPA&#146;s offerings enables Talem to customize each program and leverages the Company&#146;s
expertise and technologies in the antibody discovery. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s management placed a critical emphasis this past year on building, integrating
and securing the business infrastructure to facilitate scalable, strategic growth and recognizing cost synergies. These activities included, but were not limited to, globalizing and standardizing core information technology (IT) infrastructure such
as server and client operating systems, databases, security tools, computing platforms and cloud computing, communication tools and content management platforms, to protect both the Company&#146;s, and its client&#146;s IP. The Company integrated IT
services, including the global service desk, has decreased costs and risks while removing collaboration barriers including tools that allow for communicating in different languages. The Company has also begun to capture synergies after the global
integration of sales, marketing, R&amp;D, management, and legal services. The Company has significantly integrated fundamental business services such as payroll, financial controls, and Oracle&#146;s Netsuite CRM and ERP. They will continue to
enhance these integrations, as well as create synergies in additional areas such as M&amp;A communications and tax integration. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>STRATEGY AND OUTLOOK
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our management team has a passionate emphasis on initiatives designed to drive revenue, bolster internal assets and maximize shareholder value. We aim
to continue to build on revenue and asset generation through internal development and well-informed, strategic acquisitions and joint ventures. Our strategy also includes growth through alliances and partnerships, within both our research (Talem)
and service sectors, as well as potential new market sectors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our objective is to aggressively expand our position as the preferred, global partner for
researchers across the globe. Therefore, our strategy is to deliver the leading, comprehensive and integrated continuum of protein and antibody services and enable our clients and partners to bring new and enhanced therapies to the clinic faster, by
offering a progression of services with excellence and continued innovation. We believe we possess a competitive advantage which allows us to execute this strategy, as we continue to focus on our integrated <U>end-</U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE SIX MONTHS ENDED
OCTOBER 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT STYLE="white-space:nowrap">to-end</FONT> platform</U>, coupled with a <U>strong, scientific <FONT
STYLE="white-space:nowrap">know-how,</FONT></U> enabling us to navigate our clients through the process of discovery through lead candidates. Our ability to customize programs, yet maintain scientific rigor, enables our clients to access our global
portfolio of services with confidence. Our personable and responsible <U>global project management team</U> ensures that our clients have program details at their fingertips, at any minute, in any time zone, with the <U>security measures</U> needed
to ensure our clients&#146; peace of mind. In addition to the aforementioned strengths, our global footprint and streamlined processes enable us to leverage our competitive advantages to mature as the global, preferred therapeutic antibody provider.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our strategy is supported by growing trends in pharma and finance. Global pharmaceutical companies are continuing to increase their share of reliance on
CRO&#146;s to improve the efficiency and cost of development, increase turnaround time, and access advanced and integrated expertise. When analyzing pharmaceutical outsourcing trends, from October 2019, several major drivers of the CRO industry
growth were identified, including robust biopharmaceutical funding, accelerated drug approval rates, the growing number of clinical trials, and proliferation of biopharmaceutical companies without own internal research and clinical capabilities<SUP
STYLE="font-size:85%; vertical-align:top">1</SUP>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In an attempt to streamline, many large pharmaceutical companies are limiting the number of external
CRO vendors that can be contracted. This is particularly good for those CROs that fulfill multiple niches in the discovery and manufacturing pipeline. In a recent estimate, the CRO industry alone was estimated to be $30&nbsp;billion USD, and
<I>&#147;highly fragmented</I><I>&#133;</I><I> though relatively few of full scale and breadth of service</I>&#148;<SUP STYLE="font-size:85%; vertical-align:top">1</SUP>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The key players serving the monoclonal antibodies market are Pfizer, GlaxoSmithKline Novartis, Merck&nbsp;&amp; Co., Amgen, Abbott Laboratories, AstraZeneca,
Eli Lilly and Company, Mylan, Daiichi Sankyo Company, Bayer, Bristol Myers Squibb Co., Johnson&nbsp;&amp; Johnson Services, Biogen, Thermo Fisher Scientific, Sanofi Genzyme, F. <FONT STYLE="white-space:nowrap">Hoffmann-La</FONT> Roche, and Novo
Nordisk<SUP STYLE="font-size:85%; vertical-align:top">2</SUP>. In 2016 alone, Novartis invested 9&nbsp;billion USD and Pfizer invested 7.9&nbsp;billion USD in R&amp;D<SUP STYLE="font-size:85%; vertical-align:top">3</SUP>. This is of little surprise
given the global monoclonal antibody market was valued at USD 85.4&nbsp;billion in 2015 and is expected to reach a value of USD 138.6&nbsp;billion by 2024<SUP STYLE="font-size:85%; vertical-align:top">2</SUP>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ongoing, growing investments by pharma in R&amp;D are expected to ramp up for antibodies given the rising prevalence of cancer and other chronic diseases<SUP
STYLE="font-size:85%; vertical-align:top">4</SUP>. <B></B>In oncology, antibodies are viewed as the mainstay, as people move away from other types of therapies such as small molecules<SUP STYLE="font-size:85%; vertical-align:top">5</SUP>. In recent
years, the success of key pipeline drugs in the immuno-oncology space have been a key component of the record high capital market funding for the biotechnology sector<SUP STYLE="font-size:85%; vertical-align:top">1</SUP>. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Healthcare Insights Life Sciences, CRO Sector Fundamentals Remain Hot for M&amp;A Consolidation,
October&nbsp;3, 2019.<B> </B> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">2</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Monoclonal Antibodies (mAbs) Market Size Worth $138.6 Billion By 2024, Nov. 2016<B> </B> </P></TD></TR></TABLE>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">3</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Monoclonal Antibody Market 2019-2025 Growth, Key Players, Size, Demands and Forecasts, April, 2019
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">4</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Research Antibodies Market Size, Share&nbsp;&amp; Trends Analysis Report By Product, By Type (Monoclonal,
Polyclonal), By Technology, By Source, By Application (Oncology, Neurobiology), By <FONT STYLE="white-space:nowrap">End-use,</FONT> And Segment Forecasts, 2018 &#150; 2025, March, 2018 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">5</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">GEN, Antibody Discovery Looks Over the Horizon, Feb. 7, 2019. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ACQUISITION OF <FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> EXPRESS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&nbsp;22, 2017, the Company completed the acquisition of <FONT STYLE="white-space:nowrap">U-Protein</FONT> Express BV
<FONT STYLE="white-space:nowrap">(&#147;U-Protein&#148;)</FONT> whereby the Company has acquired all the issued and outstanding shares of <FONT STYLE="white-space:nowrap">U-Protein</FONT> for &#128;6,830,000 on terms as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,734,732 (CAD$4,062,607) was paid in cash on closing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3,030,503 common shares of the Company were issued on closing; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,047,634 in deferred payments over a <FONT STYLE="white-space:nowrap">six-year</FONT> period. The deferred
payments can be made in cash or common shares of the Company at the election of <FONT STYLE="white-space:nowrap">U-Protein</FONT> shareholders. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE SIX MONTHS ENDED
OCTOBER 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transaction was accounted for as a business combination, as the operations of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> meet the definition of a business. As a result, transaction costs of $17,717 were expensed. The goodwill resulting from the allocation of the purchase price to the total fair value of net assets
represented the sales and growth potential of <FONT STYLE="white-space:nowrap">U-Protein.</FONT> Goodwill recorded is allocated in its entirety to <FONT STYLE="white-space:nowrap">U-Protein.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The first deferred payment of &#128;682,545 (CAD$1,049,754) has been made in cash during the year ended April&nbsp;30, 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the 3,030,503 common shares issued ($3,022,308) was determined based on the Canadian dollar equivalent of the consideration required of
&#128;2,047,634 pursuant to the share purchase agreement. The Company has allocated the purchase price as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,062,607</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3,030,503 common shares of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,022,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of deferred payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,134,410</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,219,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">797,276</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">370,530</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,815</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment, net of accumulated amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">216,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intellectual property (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,064,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,655,893</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(269,657</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income taxes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,197</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(810,800</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,219,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ACQUISITION OF IPA EUROPE AND IMMULEASE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company acquired all of the issued and outstanding shares of ImmunoPrecise Antibodies (Europe) B.V. (&#147;IPA Europe&#148;) and its
sister entity, Immulease B.V. (&#147;Immulease&#148;), for an aggregate purchase price of &#128;7,000,000 on terms as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,500,000 (CAD$3,988,132) was paid in cash on closing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">6,600,399 common shares of the Company were issued on closing; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,000,000 in deferred payments over a <FONT STYLE="white-space:nowrap">six-year</FONT> period. The deferred
payments will be made in six equal installments of cash and equity totaling &#128;666,666 and will be prorated if the EBITDA of IPA Europe for the fiscal year preceding the date of payment is less than its average EBITDA over the previous two fiscal
years. During the year ended April&nbsp;30, 2019, the Company and the seller entered into an Amendment, Termination and Settlement Agreement whereby the deferred payments shall no longer be subject to an adjustment and will be paid in equal
installments of cash and equity totaling &#128;666,666. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE SIX MONTHS ENDED
OCTOBER 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA Europe changed its name from ModiQuest Research B.V. in April 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA Europe is a privately held company based in Oss, The Netherlands, and specializes in the generation of monoclonal antibodies against difficult target
antigens. IPA Europe applies proprietary technologies to all aspects of the antibody discovery process in research and development, diagnostic and therapeutic applications. Using its proprietary
ModiFuse<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> (hybridoma electrofusion), ModiSelect<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> <FONT STYLE="white-space:nowrap">(B-cell</FONT> selection) and ModiPhage<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP> (phage display) technologies, IPA Europe can generate very large panels of monoclonal antibodies from various backgrounds including mouse, rat, rabbit, chicken, llama and human, as well as
transgenic animals harboring the human antibody gene repertoire. IPA Europe serves clients in Europe, the US, Asia and Russia. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transaction was
accounted for as a business combination, as the operations of IPA Europe and Immulease meet the definition of a business. As a result, transaction costs of $36,821 were expensed. The goodwill resulting from the allocation of the purchase price to
the total fair value of net assets represented the sales and growth potential of IPA Europe. Goodwill recorded is allocated in its entirety to IPA Europe. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The first deferred payment of &#128;666,666 (CAD$1,014,503), consisting of cash of &#128;333,333 (CAD$507,000) and common shares of the Company with a fair
value of $507,503, has been made during the year ended April&nbsp;30, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the 6,600,399 common shares issued ($4,884,295) was
determined to be $0.74 per share based on the fair value of the Company&#146;s shares immediately prior to the completion of the acquisition. The Company has allocated the purchase price as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,988,132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6,600,399 common shares of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,884,295</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of deferred payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,353,708</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,226,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">270,339</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">572,427</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,286,995</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment, net of accumulated amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">568,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Software</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible assets (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,304,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,640,671</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(580,339</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(22,897</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(298,979</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,636,192</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,226,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE SIX MONTHS ENDED
OCTOBER 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>OVERALL PERFORMANCE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the six months ended October&nbsp;31, 2019 the Company achieved revenues of $5,878,464, compared to revenues of $5,589,576 in the 2018 fiscal period.
The increase in revenue was due to an increase in the volume and contract size of client projects. Outlook continues to be positive for third quarter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s new laboratory in Victoria is now a fully operational antibody production facility that effectively doubles its revenue generating
capacity. To drive the execution of its strategic and growth initiatives, the Company continues to focus on the recruitment of scientific and technical staff, development of new technical training programs and a commitment to integrate continuous
improvement and quality management methodologies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To support management and the Board of Directors in exercising oversight, the Company is implementing
information systems for marketing and sales automation and customer relationship management, as well as accounting and financial reporting, resource planning and project management. Comprehensive operational and management reporting capabilities are
being implemented with a view to effectively support a geographically dispersed organization allowing managers access to company data globally. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With the
aid of a third-party HR consulting firm, significant effort was applied to strengthening and aligning the Company&#146;s human resources by: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Stabilizing staffing for sales growth going forward:</I> Remuneration and incentive systems have been aligned
with targeted revenue and gross profit performance, and operational roles and responsibilities have been focused on managing demand. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Leadership and operational alignment:</I> The Company has made changes and updates job descriptions,
compensation plans, and other reward and recognition systems, and is implementing career planning and development mechanisms and job performance and quality measures. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Future growth will provide opportunities for company personnel to develop new skills and abilities to tackle eventual challenges in a growing company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the 2020 fiscal year, the goal of the organization is to grow sales revenue and expand our brand awareness. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This focus is consistent with the &#145;leading with our scientists&#146; philosophy, which is resonating with our customers from both diagnostic and, in
particular, the therapeutic market segment. The Company is also expanding its commitment to research and development initiatives aimed at introducing new services through both internal development as well as through partnerships. To achieve the best
results from its investments, the Company continued to add key scientific and management personnel to its team. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RESULTS OF OPERATIONS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Three months ended October&nbsp;31, 2019 </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the three
months ended October&nbsp;31, 2019, the Company generated revenues of $3,162,365, compared to revenues of $2,716,791 in the 2018 fiscal period. This represents a 16% increase in revenue due to an increase in the volume and contract size of client
projects. Outlook continues to be positive for third quarter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the three months ended October&nbsp;31, 2019, the Company achieved a gross profit of
$2,490,015, compared to $1,401,725 in the 2018 fiscal period. In percentage terms, the Company&#146;s gross profit increased to 79% from 52% in 2018. The higher gross profit in 2019 was mostly attributable to IPA Europe&#146;s research project costs
being </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE SIX MONTHS ENDED
OCTOBER 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">classified as Research and development (R&amp;D) expense. No such allocation was done in Q1 2020 and as such,
the Company&#146;s allocation of R&amp;D expenses from cost of sales during Q2 2020 also included the R&amp;D expenses incurred in Q1 2020. This resulted in higher R&amp;D expenses reported and lower cost of sales reported for Q2 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recorded a net loss of $1,363,545 during the three months ended October&nbsp;31, 2019, compared to net loss of $1,485,732 for the three months
ended October&nbsp;31, 2018. The net loss decreased in 2019 due to $1,088,290 higher gross profit and lower advertising and consulting expenses offset by higher <FONT STYLE="white-space:nowrap">non-cash</FONT> amortization of acquired
companies&#146; intangible assets, depreciation of leased assets as a result of implementing IFRS 16, <I>Leases,</I> higher office and general expense, and higher research and development costs. The Company continues to invest in research and
development in pursuit of its goal of broadening the breadth and value of its intellectual property assets in techniques inherent in the production of human antibodies through new working partnerships with several companies with leading transgenic
platforms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Variances of note in the Company&#146;s expenses include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Advertising and promotion fees of $60,950 in 2019 (2018 - $268,877) were incurred to support the Company&#146;s
initiatives focused on business development, marketing and branding programs. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Amortization expense increased to $746,543 from $209,221 in 2018 due to the amortization of intangible assets
which were acquired as a result of the acquisitions of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Consulting fees of $43,005 in 2019 (2018 - $149,487) were lower because in 2018 consultants were engaged to
support <FONT STYLE="white-space:nowrap">one-time</FONT> initiatives focused on operational efficiency training programs, and systems implementation. The company evaluated the use of consulting services vs employees and where appropriate added
employees to the team. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The office and general expense of $386,172 (2018 - $170,816) was higher compared to 2018 primarily due to
increased information technology expenses related to integrating the acquisitions of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe and implementation of the new ERP system. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Research and development of $445,842 (2018 - $19,266) increased as a result of the investment in R&amp;D to
broaden the breadth and value of its intellectual property assets in techniques inherent in the production of antibodies. The R&amp;D expense also increased as a result of reallocation from cost of sales to R&amp;D expenses incurred in Q1 2020.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Salaries and benefits expense increased to $997,473 from $864,559 in 2018, primarily due to periodic salary
adjustments and additions to key scientific and management personnel. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Six months ended October&nbsp;31, 2019 </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the six months ended October&nbsp;31, 2019, the Company generated revenues of $5,878,464, compared to revenues of $5,589,576 in the 2018 fiscal period.
This represents a 5% increase in revenue due to an increase in the volume and contract size of client projects. Outlook continues to be positive for third quarter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the six months ended October&nbsp;31, 2019, the Company achieved a gross profit of $3,866,421, compared to $2,969,551 in the 2018 fiscal period. In
percentage terms, the Company&#146;s gross profit increased to 66% from 53% in 2018. The higher gross profit in 2019 was primarily a result of the Company implementing a new ERP system that tracks project costs in more detail than historical
methods. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recorded a net loss of $3,375,743 during the six months ended October&nbsp;31, 2019, compared to net loss of $2,588,094 for the six
months ended October&nbsp;31, 2018. The net loss increased in 2019 due to $896,870 higher gross profit and lower advertising, consulting and professional fees offset by higher expenses, primarily <FONT STYLE="white-space:nowrap">non-cash</FONT>
amortization of acquired companies&#146; intangible assets, depreciation of leased assets as a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE SIX MONTHS ENDED
OCTOBER 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">result of implementing IFRS 16, <I>Leases</I>, higher office and general expense, and higher research and
development costs. The Company continues to invest in research and development in pursuit of its goal of broadening the breadth and value of its intellectual property assets in techniques inherent in the production of human antibodies through new
working partnerships with several companies with leading transgenic platforms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Variances of note in the Company&#146;s expenses include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Advertising and promotion fees of $178,150 in 2019 (2018 - $322,646) were incurred to support the Company&#146;s
initiatives focused on business development, marketing and branding programs. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Amortization expense increased to $1,294,384 from $384,783 in 2018 due to the amortization of intangible assets
which were acquired as a result of the acquisitions of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Consulting fees of $65,345 in 2019 (2018 - $312,807) and professional fees of $515,280 (2018 - $277,803) were
lower because 2018 consultant and professional services were engaged to support one-time initiatives focused on operational efficiency training programs, systems implementation and integration of acquisitions. The company evaluated the use of
consulting services vs employees and where appropriate added employees to the team. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The office and general expense of $609,507 (2018 - $314,356) was higher compared to 2018 primarily due to
increased information technology expenses related to integrating the acquisitions of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe and implementation of the new ERP system. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Research and development of $613,102 (2018 - $51,054) increased as a result of the investment in R&amp;D to
broaden the breadth and value of its intellectual property assets in techniques inherent in the production of antibodies. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Salaries and benefits expense increased to $2,093,717 from $1,791,598 in 2018, primarily due to periodic salary
adjustments and additions to key scientific and management personnel. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SUMMARY OF QUARTERLY RESULTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets out financial information for the past eight quarters: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>October&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>July&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>January&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,162,365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,716,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,641,109</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,695,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,363,545</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,012,198</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,842,317</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,187,056</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted loss per share*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.03</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.06</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>October&nbsp;31,<BR>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>July&nbsp;31,<BR>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>January&nbsp;31,<BR>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,716,791</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,872,785</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,810,722</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,723,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income (loss)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,485,732</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,102,362</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,198,428</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,211,591</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted loss per share*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.04</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.03</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The basic and fully diluted calculations result in the same value due to the anti-dilutive effect of
outstanding stock options and warrants. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE SIX MONTHS ENDED
OCTOBER 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The losses for the quarters ended April&nbsp;30, 2019 and April&nbsp;30, 2018 are greater than other
quarters, as the Company invested heavily in growth enabling initiatives and <FONT STYLE="white-space:nowrap">catch-up</FONT> amortization recorded of intangible assets which were acquired as a result of the acquisitions of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">NON-IFRS</FONT> MEASURES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following are <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures and investors are cautioned not to place undue reliance on them and are urged to
read all IFRS accounting disclosures present in the condensed consolidated interim financial statements and accompanying notes for the condensed consolidated interim financial statements for the six months ended October&nbsp;31, 2019 and the
consolidated financial statements and accompanying notes to the financial statements for the year ended April&nbsp;30, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company uses certain <FONT
STYLE="white-space:nowrap">non-IFRS</FONT> financial measures as supplemental indicators of its financial and operating performance. These <FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial measures include adjusted operating EBITDA and
adjusted operating expenses. The Company believes these supplementary financial measures reflect the Company&#146;s ongoing business in a manner that allows for meaningful
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">period-to-period</FONT></FONT> comparisons and analysis of trends in its business. These <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures do not have any standardized meaning
prescribed under IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company defines adjusted
operating EBITDA as operating earnings before interest, taxes, depreciation, amortization, share-based compensation, and asset impairment charges. Adjusted operating EBITDA is presented on a basis consistent with the Company&#146;s internal
management reports. The Company discloses adjusted operating EBITDA to capture the profitability of its business before the impact of items not considered in management&#146;s evaluation of operating unit performance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company defines adjusted operating expenses as operating expenses before share-based compensation, depreciation, amortization and asset impairment
charges. Adjusted operating expenses are presented on a basis consistent with the Company&#146;s internal management reports. The <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures are reconciled to reported IFRS figures in the tables below:
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Three months ended<BR>October&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Six months ended<BR>October&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,363,545</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,485,732</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,375,743</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,588,094</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58,339</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">152,898</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54,284</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">190,350</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">746,543</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">209,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,294,384</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">384,783</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">212,967</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">240,998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">765,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">478,537</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange loss (gain)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,331</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(122,248</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(117,307</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(204,738</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114,788</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">115,230</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">233,748</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">233,661</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest and other income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(42,299</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(37,544</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(54,701</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(81,059</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">214,120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">183,123</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">494,823</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Adjusted EBITDA</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(63,418</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(744,054</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(699,360</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,091,737</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE SIX MONTHS ENDED
OCTOBER 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Three months ended<BR>October&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Six months ended<BR>October&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,624,553</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,531,105</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,476,721</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,969,817</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">746,543</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">209,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,294,384</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">384,783</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange loss (gain)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,331</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(122,248</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(117,307</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(204,738</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114,788</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">115,230</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">233,748</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">233,661</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">214,120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">183,123</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">494,823</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Adjusted Operating Expenses</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,553,433</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,145,779</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,565,781</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,061,288</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FINANCING ACTIVITIES </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On
May&nbsp;23, 2018, the Company entered into a loan agreement with a Director of the Company and his spouse and issued a promissory note in the principal amount of $200,000. The note was unsecured and bore an interest rate of 5.45% per annum. The
principal of the note plus accrued interest of $3,972 was repaid in full during the year ended April&nbsp;30, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&nbsp;19, 2018, the Company
closed a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement financing by issuing a total of 875,000 units of the Company at a price of $0.80 per unit for gross proceeds of $700,000. Each unit consists of one common share of the
Company and one share purchase warrant, with each warrant entitling the holder to purchase an additional Share at a price of $1.00 for a period of one year from the date of issue. The Company will have the right to accelerate the expiry date of the
warrants provided that the volume weighted average price trades at a price equal to or greater than $1.50 for a period of 20 consecutive days. In the event of acceleration, the expiry date will be accelerated to a date that is 30 days after the
Company issues a news release announcing that it has elected to exercise this acceleration right. The Company paid finders cash fees totaling $3,000 and incurred $7,926 of cash issue costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&nbsp;24, 2018, the Company closed a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement financing by issuing a total of
9,102,500 units of the Company at a price of $1.00 per unit for gross proceeds of $9,102,500. Each unit consists of one common share of the Company and one share purchase warrant, with each warrant entitling the holder to purchase an additional
share at a price of $1.25 for a period of two years from the date of issue. The Company will have the right to accelerate the expiry date of the warrants provided that the volume weighted average price trades at a price equal to or greater than
$1.75 for a period of 20 consecutive days. In the event of acceleration, the expiry date will be accelerated to a date that is 30 days after the Company issues a news release announcing that it has elected to exercise this acceleration right. The
Company paid finders cash fees totaling $201,540 and issued 182,460 finder&#146;s shares. The Company also incurred $76,038 of cash issue costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On
December&nbsp;22, 2017, the Company announced that it had signed a binding letter of intent with Crossbeta Biosciences B.V. (&#147;Crossbeta&#148;) whereby the Company had agreed to acquire all the issued and outstanding shares of Crossbeta. The
proposed transaction was terminated and settled on October&nbsp;23, 2018. In consideration of the settlement, the Company paid &#128;37,000 ($55,969) and issued 78,514 shares valued at $61,241. The Company accrued a settlement liability of $92,040
as at April&nbsp;30, 2018. As such, the remaining loss on settlement of $25,170 was recognized in fiscal year 2019. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE SIX MONTHS ENDED
OCTOBER 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;27, 2019, the Company issued 714,793 common shares pursuant to the second deferred acquisition
payment to IPA Europe. The common shares are valued at $507,503. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2019, the Company issued 135,000 common shares
pursuant to exercise of stock options for total gross proceeds of $40,500. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&nbsp;26, 2019, the Company modified the terms of $2,750,000
debentures to extend the due date 6 months to March&nbsp;26, 2020, with the ability to pay earlier with no penalty, and increase the interest rate to 12.5%. The remaining debentures of $125,000 were paid on maturity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the six months ended October&nbsp;31, 2019, the Company issued 55,000 common shares pursuant to exercise of stock options for total gross proceeds of
$16,500. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>LIQUIDITY AND CAPITAL RESOURCES </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company&#146;s objectives when managing capital are to ensure sufficient liquidity for operations and adequate funding for growth and capital expenditures while maintaining an efficient balance between debt and equity. The capital structure of the
Company consists of shareholders&#146; equity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company adjusts to its capital structure upon approval from its Board of Directors, considering
economic conditions and the Company&#146;s working capital requirements. There were no changes in the Company&#146;s approach to capital management during the year. The Company is not subject to any externally imposed capital requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As at October&nbsp;31, 2019, the Company held cash of $2,964,271 (April 30, 2019 &#150; $5,471,650) and had working capital of $803,364 (2018 &#150;
$2,673,667). During the six months ended October&nbsp;31, 2019, the Company used $1,812,590 in its operating activities. As part of the investing activities, the Company made equipment purchases of $190,043 and made incurred internally generated
development costs of $71,817. As part of the financing activities, the Company received $16,500 from exercise of stock options, offset by lease repayments of $203,123, loan repayments of $49,135 and debenture repayments of $125,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s consolidated financial statements have been prepared based on accounting principles applicable to a going concern. This assumes the Company
will continue in operation for the foreseeable future and will be able to realize its assets and discharge its obligations in the normal course of operations. The Company has incurred operating losses since inception, including $3,375,743 for the
six months ended October&nbsp;31, 2019 and has accumulated a deficit of $20,906,969 as at October&nbsp;31, 2019. The Company may need to raise additional funds in order to continue as a going concern and there can be no assurances that sufficient
funding, including adequate financing, will be available. The ability of the Company to arrange additional financing in the future depends in part, on the prevailing capital market conditions and profitability of its operations. These material
uncertainties may cast significant doubt on the Company&#146;s ability to continue as a going concern. Accordingly, the consolidated financial statements do not give effect to adjustments that would be necessary should the Company be unable to
continue as a going concern and therefore be required to realize its assets and liquidate its liabilities, contingent obligations and commitments other than in the normal course of business and at amounts different from those in the consolidated
financial statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As at October&nbsp;31, 2019, the Company does not have any commitments for capital expenditures. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE SIX MONTHS ENDED
OCTOBER 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CAPITAL EXPENDITURES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company made equipment purchases of $190,043 during the six months ended October&nbsp;31, 2019 (2018 - $409,662). During the six months ended
October&nbsp;31, 2019, the Company also incurred internally generated development costs of $71,817. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RELATED PARTY TRANSACTIONS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Key management personnel are those persons having authority and responsibility for planning, directing and controlling the activities of the Company. Key
management consists of Dr.&nbsp;Jennifer Bath, President and CEO; Lisa Helbling, CFO; Natasha Tsai, former CFO; Reginald Beniac, former Chief Operating Officer; Charles Wheelock, Chief Technology Officer; Oren Beske, former President of
ImmunoPrecise Antibodies (USA) Ltd.; Martin Hessing, a Director of <FONT STYLE="white-space:nowrap">U-Protein;</FONT> Jos Raats, former President and CEO of IPA Europe; and Directors of the Company. During the three and six months ended
October&nbsp;31, 2019 and 2018, the compensation for key management is as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Three months ended<BR>October&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Six months ended<BR>October&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Management fees<SUP STYLE="font-size:85%; vertical-align:top"> (1) </SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,331</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102,403</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89,479</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">206,383</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Professional fees<SUP STYLE="font-size:85%; vertical-align:top"> (2) </SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,655</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Salaries and other short-term benefits<SUP STYLE="font-size:85%; vertical-align:top"> (3)
</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">285,531</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,911</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">771,376</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">182,741</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,988</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,666</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">269,870</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">263,758</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">334,850</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">293,560</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,130,725</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">687,537</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The charge includes management fees paid to Dr.&nbsp;Martin Hessing, a Director of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> and Dr.&nbsp;Jos Raats, former President and CEO of IPA Europe. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The charge includes professional fees paid to Malaspina Consultants Inc. in which Natasha Tsai was an associate
until October&nbsp;31, 2018 and an owner thereafter. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The charge includes salaries and benefits paid to Dr.&nbsp;Jennifer Bath and former management that includes
Thomas D&#146;Orazio, Robert Beecroft, Dr.&nbsp;Oren Beske and Reginald Beniac. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the three and six months ended October&nbsp;31,
2019, the spouse of a Director provided administrative services for $nil and $nil (2018 &#150; $15,625 and $31,250). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE SIX MONTHS ENDED
OCTOBER 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>OUTSTANDING SHARE DATA </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s outstanding share information as at December&nbsp;17, 2019 is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Security</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Exercise&nbsp;Price</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Expiry date</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issued and outstanding common shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,994,445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">NA</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">NA</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">October&nbsp;1, 2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">550,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">December 20, 2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">950,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">September 18, 2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">January&nbsp;3,2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">700,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">February&nbsp;7,2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">September 24, 2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">November&nbsp;7,2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">December 31, 2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">415,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">January 11, 2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">October&nbsp;1, 2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">October&nbsp;3, 2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">875,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">June 18, 2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,102,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">September&nbsp;24,&nbsp;2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,377,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">October 25, 2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,793,942</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">March 26, 2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">91,252,887</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">OFF-BALANCE</FONT> SHEET ARRANGEMENTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company does not utilize <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet transactions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>COMMITMENTS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the Company&#146;s rental of office and
laboratory space in Victoria, BC, Canada, the current lease commenced on May&nbsp;1, 2018 and terminates on April&nbsp;30, 2023. The lease is in the amount of $21,015 per month for all four spaces from May&nbsp;1, 2018 to April&nbsp;30, 2021 and
$21,914 per month from May&nbsp;1, 2021 to April&nbsp;30, 2023. The minimum annual payments under these leases are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">252,186</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">252,186</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">262,968</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">262,968</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,030,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the Company&#146;s rental of office and laboratory space in Utrecht, Netherlands, the current lease commenced on
January&nbsp;1, 2017 and terminates on December&nbsp;31, 2019. Annual minimum lease payments are as follows: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE SIX MONTHS ENDED
OCTOBER 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&#128;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,415</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the Company&#146;s rental of office and laboratory space in Oss, Netherlands, the current lease commenced on
January&nbsp;1, 2018 and terminates on December&nbsp;31, 2019. Effective December&nbsp;31, 2018, the lease automatically rolls into a <FONT STYLE="white-space:nowrap">3-year</FONT> term through December&nbsp;31, 2022. Annual minimum lease payments
are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&#128;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">116,970</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">643,332</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CRITICAL ACCOUNTING ESTIMATES AND JUDGMENTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of the consolidated financial statements in conformity with IFRS required estimates and judgments that affect the amounts reported in the
financial statements. Actual results could differ from these estimates and judgments. Estimates are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the year in which the estimate is revised. Significant areas
requiring the use of estimates and judgments are as follows: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Functional currency </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has used judgment in determining the currency of the primary economic environment in which the entity operates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Amounts receivable </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company monitors the financial
stability of its customers and the environment in which they operate to make estimates regarding the likelihood that the individual trade receivable balances will be paid. Credit risks for outstanding customer receivables are regularly assessed and
allowances are recorded for estimated losses, if required. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Equipment </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has used estimates in the determination of the expected useful lives of equipment and leasehold improvements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Revenue recognition </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">percentage-of-completion</FONT></FONT> method requires the use of estimates to determine the stage of completion which is used to determine the recorded amount of revenue, unbilled
revenue and deferred revenue on uncompleted contracts. The determination of anticipated revenues includes the contractually agreed revenue and may also involve estimates of future revenues if such additional revenues can be reliably estimated and it
is considered probable that they will be recovered. The determination of anticipated costs for completing a contract is based on estimates that can be affected by a variety of factors, including the cost of materials, labor, and sub-contractors. The
determination of estimates is based on the Company&#146;s business practices as well as its historical experience. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE SIX MONTHS ENDED
OCTOBER 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Impairments </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the purposes of assessing impairment, assets are grouped at the lowest levels for which there are separately identifiable cash flows (&#147;cash generating
units&#148; or &#147;CGU&#148;s). Each asset or CGU is evaluated every reporting period to determine whether there are any indicators of impairment. If any such indicators exist, which is often judgment-based, a formal estimate of recoverable amount
is performed, and an impairment charge is recognized to the extent that the carrying amount exceeds the recoverable amount. The recoverable amount of an asset or CGU of assets is measured at the higher of fair value less costs of disposal or value
in use. These determinations and their individual assumptions require that management make a decision based on the best available information at each reporting period. The estimates and assumptions are subject to risk and uncertainty; hence, there
is the possibility that changes in circumstances will alter these projections, which may impact the recoverable amount of the assets. In such circumstances, some or all the carrying value of the assets may be further impaired or the impairment
charge reversed with the impact recorded in profit or loss. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company performs a goodwill impairment test annually and when circumstances indicate that
the carrying value may not be recoverable. For the purposes of impairment testing, goodwill acquired through business combinations has been allocated to two different CGUs. The recoverable amount of each CGU was based on value in use, determined by
discounting the future cash flows to be generated from the continuing use of the CGU. The cash flows were projected over a five-year period based on past experience and actual operating results. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company performed its annual goodwill impairment test in April 2019 and no impairment was indicated for the period tested. The values assigned to the key
assumptions represented management&#146;s assessment of future trends in the industry and were based on historical data from both internal and external sources. Weighted average costs of capital of 17.5% and 10.2%, respectively, was used in the
assessments of the two CGUs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Determination of segments </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An operating segment is a component of the Company that engages in business activities from which it may earn revenues and incur expenses. All operating
segments&#146; results are reviewed by the Company&#146;s management in order to make decisions regarding the allocation of resources to the segment. Segment results include items directly attributable to a segment as those that can be allocated on
a reasonable basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As the Company provides antibody production and related services in one distinct category, there is only one category to report
revenues by production site. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Life of intangible assets </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Intangible assets are amortized based on estimated useful life less their estimated residual value. Significant assumptions are involved in the determination
of useful life and residual values and no assurance can be given that actual useful lives and residual values will not differ significantly from current assumptions. Actual useful life and residual values may vary depending on a number of factors
including internal technical evaluation, attributes of the assets and experience with similar assets. Changes to these estimates may affect the carrying value of assets, net income (loss) and comprehensive income (loss) in future periods. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Purchase price allocation </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The acquisition of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> on August&nbsp;22, 2017 and the acquisition of IPA Europe and Immulease on April&nbsp;5, 2018 were accounted for as business combinations at fair value in accordance with IFRS 3, <I>Business
Combinations.</I> The acquired assets and assumed liabilities were adjusted to their fair values assigned through completion of a purchase price allocation, as described below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE SIX MONTHS ENDED
OCTOBER 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The purchase price allocation process resulting from a business combination requires management to estimate
the fair value of identifiable assets acquired including intangible assets and liabilities assumed including the deferred acquisition payment obligations. The Company uses valuation techniques, which are generally based on forecasted future net cash
flows discounted to present value and relies on work performed by third-party valuation specialists. These valuations are closely linked to the assumptions used by management on the future performance of the related assets and the discount rates
applied. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ADOPTION OF NEW ACCOUNTING STANDARDS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company has adopted the following new standards, along with any consequential amendments, effective May&nbsp;1, 2019. These changes were made in accordance with the applicable transitional provisions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company adopted all the requirements of IFRS 16, <I>Leases</I> (&#147;IFRS 16&#148;) as of May&nbsp;1, 2019. IFRS 16 replaces IAS 17, <I>Leases</I>
(&#147;IAS 17&#148;). IFRS 16 provides a single lessee accounting model, requiring lessees to recognize assets and liabilities for all leases unless the lease term is 12 months or less or the underlying asset has a low value. The Company has adopted
IFRS 16 using the modified retrospective application method, where the 2019 comparatives are not restated and a cumulative catch up adjustment is recorded on May&nbsp;1, 2019 for any differences identified, including adjustments to opening deficit
balance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company analyzed its contracts to identify whether they contain a lease arrangement for the application of IFRS 16. The following is the
Company&#146;s new accounting policy for leases under IFRS 16: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At inception of a contract, the Company assesses whether the contract is, or contains, a
lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Leases of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets are recognized at the lease commencement date at
the present value of the lease payments that are not paid at that date. The lease payments are discounted using the interest rate implicit in the lease, if that rate can be readily determined, and otherwise at the Company&#146;s incremental
borrowing rate. At the commencement date, a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset is measured at cost, which is comprised of the initial amount of the lease liability adjusted for any
lease payments made at or before the commencement date, plus any decommissioning and restoration costs, less any lease incentives received. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each lease
payment is allocated between repayment of the lease principal and interest. Interest on the lease liability in each period during the lease term is allocated to produce a constant periodic rate of interest on the remaining balance of the lease
liability. Except where the costs are included in the carrying amount of another asset, the Company recognizes in profit or loss (a)&nbsp;the interest on a lease liability and (b)&nbsp;variable lease payments not included in the measurement of a
lease liability in the period in which the event or condition that triggers those payments occurs. The Company subsequently measures a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset at cost less
any accumulated depreciation and any accumulated impairment losses; and adjusted for any remeasurement of the lease liability. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> assets are depreciated over
the shorter of the asset&#146;s useful life and the lease term, except where the lease contains a bargain purchase option a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset is depreciated over the
asset&#146;s useful life. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On the date of transition, the Company recorded a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset of $1,668,533 related to the office rent in property and equipment, and the lease obligation of $1,723,277 was recorded as at May&nbsp;1, 2019,
discounted using the Company&#146;s incremental borrowing rate of 8%, and measured at an amount equal to the lease obligation as if IFRS 16 had been applied since the commencement date. The net difference between <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets and lease liabilities on the date of transition was recognized as a deficit adjustment of $54,744 on May&nbsp;1, 2019. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE SIX MONTHS ENDED
OCTOBER 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ACCOUNTING STANDARDS ISSUED BUT NOT YET EFFECTIVE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In October 2018, the IASB issued amendments to IFRS 3, Business Combinations. The amendments narrowed and clarified the definition of a business. The
amendments will help companies determine whether an acquisition is a business or a group of assets. They also permit a simplified assessment of whether an acquired set of activities and assets is a group of assets rather than a business.
Distinguishing between a business and a group of assets is important because an acquirer recognizes goodwill only when acquiring a business. This amendment will be effective for annual periods beginning on or after January&nbsp;1, 2020. Early
adoption is permitted. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DISCLOSURE CONTROLS AND PROCEDURES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with National Instrument <FONT STYLE="white-space:nowrap">52-109</FONT> (Certificate of Disclosure in Issuer&#146;s Annual and Interim Filings)
(&#147;NI <FONT STYLE="white-space:nowrap">52-109&#148;),</FONT> the Chief Executive Officer and Chief Financial Officer of the Company have filed a Venture Issuer Basic Certificate with respect to the financial information contained in the
unaudited condensed interim consolidated financial statements for the six months ended October&nbsp;31, 2019 and this accompanying MD&amp;A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In contrast
to the full certificate under NI <FONT STYLE="white-space:nowrap">52-109,</FONT> the Venture Issuer Basic Certificate does not include representations relating to the establishment and maintenance of disclosure controls and procedures and internal
control over financial reporting, as defined in NI <FONT STYLE="white-space:nowrap">52-109.</FONT> For further information the reader should refer to the Venture Issuer Basic Certificates filed by the Company with the Annual Filings on SEDAR at
<U>www.sedar.com</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FINANCIAL INSTRUMENTS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company&#146;s financial instruments include cash, amounts receivable, investment, accounts payable and accrued liabilities, loans payable, deferred acquisition payments and debentures. The fair value of investment is determined based on
&#147;Level&nbsp;1&#148; inputs which consist of quoted prices in active markets for identical assets. As at October&nbsp;31, 2019, the Company believes that the carrying values of cash, amounts receivable, accounts payable and accrued liabilities,
deferred payments, debentures, and loans payable approximate their fair values because of their nature and relatively short maturity dates or durations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RISKS AND UNCERTAINTIES </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Research and Development and
Product Development </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA is a life science company that makes customized antibodies and is engaged in the research and product development of new
processes, procedures and innovative approaches to the antibody production and new antibodies. The Company has been engaged in such research and development activities for over 20 years and has had significant success. Continued investment in
retaining key scientific staff as well as an ongoing commitment in research and development activities will continue to be a cornerstone in the Company&#146;s development of new services, processes, and competitive advantages such as Rapid Prime, B
cell Select, DeepDisplay and its methods for the production of human antibodies. The Company realizes that such research and product development activities endeavour, but cannot assure, the production of new and innovative processes, procedures or
innovative approaches to antibody production or new antibodies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE SIX MONTHS ENDED
OCTOBER 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Custom Products </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is reliant on the development, marketing and sale of its current custom monoclonal and polyclonal antibodies. If it does not achieve sufficient
market acceptance of its expansion of its commercialization of its products and services, it will be difficult for the Company to achieve consistent profitability. The Company&#146;s marketing and sales approach and external sales personnel
continues to introduce a steady stream of new customers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Obsolescence </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Maintaining a competitive position requires constant growth, development and strategic marketing and planning. If the Company is unable to maintain a
technological advantage, its ability to grow its business will be adversely affected and its products may become obsolete compared with other technologies. To mitigate this, the Company is making investments in new methods, technology and
facilities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Competition </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA may face significant
competition in selling its products and services. Many competitors may have substantial marketing, financial, development and personnel resources. To remain competitive, the Company believes that it must effectively and economically provide:
(i)&nbsp;products and services that satisfy customer demands, (ii)&nbsp;superior customer service, (iii)&nbsp;high levels of quality and reliability, and (iv)&nbsp;dependable and efficient distribution networks. Increased competition may require the
Company to reduce prices or increase spending on sales and marketing and customer support, which may have a material adverse effect on its financial condition and results of operations. Any decrease in the quality of IPA&#146;s products or level of
service to customers or any occurrence of a price war among the Company&#146;s competitors may adversely affect the business and results of operations. Customer reach, service and <FONT STYLE="white-space:nowrap">on-time</FONT> delivery will
continue to be a hallmark of the Company&#146;s ability to compete with other market players. Further, the recent acquisitions translate to spreading the IPA footprint on two continents. In addition, the Company has deployed a sales team tasked with
continually sourcing and providing market intelligence as part of its activities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Intellectual Property Protection </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although IPA is developing its patent portfolio, IPA&#146;s intellectual property is still protected primarily through trade secrets and copyright protection.
The Company takes steps to document and protect its trade secrets and authorship of works protectable by copyright. However, there is no guarantee that such steps protect against the disclosure of confidential information, rights of employees, or
that legal actions would provide sufficient remedy for any breach. Additionally, IPA&#146;s trade secrets might otherwise become known or be independently developed by competitors. If the Company&#146;s internal information and knowledge cannot be
protected, the business might be adversely affected. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Failure of Laboratory Facilities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s operations could suffer as a result of a failure of its laboratory facilities. The Company&#146;s business is dependent upon a laboratory
infrastructure to produce products and services. These systems and operations are vulnerable to damage and interruption from fires, earthquakes, telecommunications failures, and other events. Any such errors or inadequacies in the software that may
be encountered could adversely affect operations, and such errors may be expensive or difficult to correct in a timely manner. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The production of
monoclonal and polyclonal antibodies requires state of the art laboratory facilities and animal care standards and the success of these laboratory services depends on the recruitment and retention of highly qualified technical staff to maintain the
level and quality standards that customers expect of the Company&#146;s products and services. There is no assurance that the Company will be able to expand and operate such <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">state-of-the-art</FONT></FONT></FONT> laboratory services and recruit and retain qualified staff. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE SIX MONTHS ENDED
OCTOBER 31, 2019 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Financial and Regulatory Risks </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is currently subject to financial and regulatory risks. The financial risk is derived from the uncertainty pertaining to the Company&#146;s ability
to raise capital to continue operations. Regulatory risks include the possible delays in getting regulatory approval for the transactions that the Board of Directors believe to be in the best interest of the Company and include increased fees for
filings and the introduction of ever more complex reporting requirements, the cost of which the Company must meet in order to maintain its exchange listing. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FURTHER INFORMATION </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additional information relating to
the Company can be found on SEDAR at <U>www.sedar.com</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.31
<SEQUENCE>32
<FILENAME>d20922dex9931.htm
<DESCRIPTION>EX-99.31
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.31</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.31 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g20922g23q22.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD.
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR THE THREE AND SIX MONTHS ENDED OCTOBER&nbsp;31, 2019 AND 2018 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited &#150; Expressed in Canadian Dollars) </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF NO AUDITOR REVIEW OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying unaudited condensed interim consolidated financial statements of the Company and all information contained in the second quarter 2020 report
have been prepared by and are the responsibility of the Company&#146;s management. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit Committee of the Board of Directors has reviewed the
condensed interim consolidated financial statements and related financial reporting matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s independent auditor has not performed a
review of these condensed interim consolidated financial statements in accordance with standards established by the Chartered Professional Accountants of Canada for a review of condensed interim consolidated financial statements by an entity&#146;s
auditor. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDENSED INTERIM CONSOLIDATED STATEMENTS OF FINANCIAL POSITION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Note</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>October&nbsp;31,<BR>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,</B><br><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ASSETS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,964,271</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,471,650</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,845,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,558,354</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,080,071</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,120,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">454,539</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">393,451</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">472,180</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">333,702</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,816,361</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,877,971</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,341</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,450</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>7</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>8</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,921,415</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,638,549</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>6,&nbsp;7,&nbsp;9</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,471,021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,417,231</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>5, 6</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,043,581</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,254,114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,369,123</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,345,719</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>LIABILITIES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>14</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,083,411</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,594,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">802,665</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">724,693</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>10</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,708,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>11</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,897</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82,953</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>12</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">341,597</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,757</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>5, 6</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,979,427</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,031,237</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,012,997</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,204,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>11</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,638</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,717</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>12</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,285,634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,320</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>5, 6</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,570,255</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,032,744</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,890,088</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,939,559</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,765,612</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,276,644</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>SHAREHOLDERS&#146; EQUITY</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>13</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,728,415</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,699,425</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contributed surplus</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>13</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,561,817</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,074,192</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(779,752</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(228,060</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(20,906,969</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,476,482</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,603,511</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,069,075</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities and equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,369,123</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,345,719</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nature of operations (Note 1)&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Commitments (Note 15)&nbsp;&nbsp;&nbsp;&nbsp; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Approved and
authorized on behalf of the Board of Directors on December&nbsp;11, 2019&nbsp;&nbsp;&nbsp;&nbsp; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="23%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="23%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<I>James&nbsp;Kuo&#148;</I>&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<I>Greg&nbsp;Smith</I>&#148;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these condensed interim consolidated financial statements </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDENSED INTERIM CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and six months ended October&nbsp;31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="54%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Three months ended<BR>October&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Six months ended<BR>October&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Note</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>REVENUE</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,162,365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,716,791</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,878,464</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,589,576</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>COST OF SALES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">672,350</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,315,066</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,012,043</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,620,025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>GROSS PROFIT</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,490,015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,401,725</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,866,421</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,969,551</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>EXPENSES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Advertising</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,950</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">268,877</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">178,150</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">322,646</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization and depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>8,&nbsp;9</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">746,543</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">209,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,294,384</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">384,783</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bad debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,249</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,249</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Consulting fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,005</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">149,487</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65,345</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">312,807</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange gain</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,331</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(122,248</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(117,307</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(204,738</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Insurance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,584</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,699</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,754</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest and bank charges</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114,788</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">115,230</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">233,748</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">233,661</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Management fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>14</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,287</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,599</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,435</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">91,897</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Office and general</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">386,172</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">170,816</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">609,507</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">314,356</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Professional fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>14</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">365,560</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">335,980</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">515,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">613,783</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68,548</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98,779</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">109,713</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">202,141</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repairs and maintenance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,133</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,077</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,133</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">117,820</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">445,842</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,266</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">613,102</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51,054</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Salaries and benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>14</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">997,473</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">864,559</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,093,717</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,791,598</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>13,&nbsp;14</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">214,120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">183,123</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">494,823</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Telephone and utilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,434</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,609</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,534</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,373</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Travel</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,196</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">178,501</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">153,059</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,624,553</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,531,105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,476,721</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,969,817</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Loss before other income (expenses) and income taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,134,538</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,129,380</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,610,300</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,000,266</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>OTHER INCOME (EXPENSES)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>5,&nbsp;6,&nbsp;9</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(212,967</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(240,998</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(765,860</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(478,537</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest and other income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42,299</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,544</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54,701</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81,059</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(170,668</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(203,454</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(711,159</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(397,478</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Loss before income taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,305,206</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,332,834</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,321,459</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,397,744</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(58,339</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(152,898</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(54,284</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(190,350</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>NET LOSS FOR THE PERIOD</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,363,545</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,485,732</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,375,743</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,588,094</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ITEMS THAT MAY BE RECLASSIFIED SUBSEQUENTLY TO LOSS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange difference on translating foreign operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,912</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(214,474</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(551,692</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(599,441</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>COMPREHENSIVE LOSS FOR THE PERIOD</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,312,633</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,700,206</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,927,435</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,187,535</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>LOSS PER SHARE &#150; BASIC AND DILUTED</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.05</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.04</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,993,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,399,042</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,988,113</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58,170,170</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these condensed interim consolidated financial statements </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian dollars, except for share figures) </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Share<BR>Capital</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Contributed<BR>Surplus</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated<BR>Other<BR>Comprehensive<BR>(Loss) Income</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Deficit</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>55,474,178</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20,455,112</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,707,738</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>277,090</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(9,859,015</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>12,580,925</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to private placements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,977,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,802,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,802,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash issue costs and finders&#146; fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">182,460</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(288,504</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(288,504</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to settlement of Debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,377,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,115,370</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">283,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,398,370</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to option exercise</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">110,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,980</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,980</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">494,823</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">494,823</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss for the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(599,441</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,588,094</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,187,535</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, October&nbsp;31, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>67,121,138</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>31,142,458</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,460,581</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(322,351</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(12,447,109</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20,833,579</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustment to value of shares issued pursuant to acquisition of IPA Europe and Immulease</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">975,045</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">975,045</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to Crossbeta settlement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78,514</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to deferred acquisition payment to IPA Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">714,793</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">507,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">507,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to option exercise</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,178</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,678</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">619,289</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">619,289</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss for the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94,291</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,029,373</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,935,082</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>67,939,445</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>32,699,425</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,074,192</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(228,060</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(17,476,482</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>18,069,075</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adoption of IFRS 16 (Note 3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(54,744</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(54,744</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, May&nbsp;1, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>67,939,445</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>32,699,425</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,074,192</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(228,060</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(17,531,226</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>18,014,331</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to option exercise</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,990</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12,490</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss for the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(551,692</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,375,743</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,927,435</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, October&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>67,994,445</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>32,728,415</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,561,817</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(779,752</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(20,906,969</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>14,603,511</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these condensed interim consolidated financial statements </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the six months ended October&nbsp;31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss for the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,375,743</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,588,094</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Items not affecting cash:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization and depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,365,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">446,689</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(76,739</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(175,460</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">765,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">478,537</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(113,493</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">494,823</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(934,142</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,343,505</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in <FONT STYLE="white-space:nowrap">non-cash</FONT> working capital related to
operations:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(286,946</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(522,726</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(36,781</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(61,088</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300,520</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(138,478</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">148,156</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(510,651</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(513,012</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">77,972</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">251,313</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,812,590</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,716,035</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Investing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(190,043</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(409,662</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Internally generated development costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(71,817</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividend received</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,460</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(261,860</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(404,202</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Financing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds on share issuance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,835,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(288,504</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repayment of leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(203,123</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from loans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loan repayments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(49,135</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(300,441</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repayment of debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(125,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash (used in) provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(360,758</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,446,555</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(Decrease) increase in cash during the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,435,208</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,326,318</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(113,280</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(301,399</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash &#150; beginning of the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,539,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,806,133</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash &#150; end of the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,990,612</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,831,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash paid for interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">143,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">216,572</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash paid for income tax</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,433</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Supplemental cash flow information (Note 17) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these condensed interim consolidated financial statements </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and six months ended October&nbsp;31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>NATURE OF OPERATIONS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd. (the &#147;Company&#148; or &#147;IPA&#148;) was incorporated under the laws of Alberta on November&nbsp;22,
1983. The Company is listed on the TSX Venture Exchange (the &#147;Exchange&#148;) as a Tier 2 life science issuer under the trading symbol &#147;IPA&#148;. The Company&#146;s OTC symbol is &#147;IPATF&#148;. The Company is a supplier of custom
hybridoma development services. The address of the Company&#146;s corporate office is 3204 &#150; 4464 Markham Street, Victoria, BC, Canada V8Z 7X8. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The condensed interim consolidated financial statements have been prepared on the basis of accounting principles applicable to a going concern.
This assumes the Company will continue in operation for the foreseeable future and will be able to realize its assets and discharge its obligations in the normal course of operations. The Company has incurred operating losses since inception,
including $3,375,743 for the six months ended October&nbsp;31, 2019 and has accumulated a deficit of $20,906,969 as at October&nbsp;31, 2019. The Company may need to raise additional funds in order to continue on as a going concern and there can be
no assurances that sufficient funding, including adequate financing, will be available. The ability of the Company to arrange additional financing in the future depends in part, on the prevailing capital market conditions and profitability of its
operations. These material uncertainties may cast significant doubt on the Company&#146;s ability to continue as a going concern. Accordingly, the condensed interim consolidated financial statements do not give effect to adjustments that would be
necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets and liquidate its liabilities, contingent obligations and commitments other than in the normal course of business and at amounts
different from those in the condensed interim consolidated financial statements. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>BASIS OF PRESENTATION </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(a) Statement of compliance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">These condensed interim consolidated financial statements have been prepared in conformity with International Accounting Standard
(&#147;IAS&#148;) 34, <I>Interim Financial Reporting</I>, using the same accounting policies as detailed in the Company&#146;s audited annual financial statements for the year ended April&nbsp;30, 2019. They do not include all the information
required for complete annual financial statements in accordance with International Financial Reporting Standards (&#147;IFRS&#148;), as issued by the International Accounting Standards Board (&#147;IASB&#148;) and interpretations of the
International Financial Reporting Interpretations Committee (&#147;IFRIC&#148;) and therefore should be read together with the audited annual financial statements for the year ended April&nbsp;30, 2019. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">These condensed interim consolidated financial statements were approved by the Board of Directors for issue on December&nbsp;11, 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(b) Basis of measurement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">These condensed interim consolidated financial statements have been prepared on the historical cost basis. In addition, these condensed interim
consolidated financial statements have been prepared using the accrual basis of accounting, except for cashflow information. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(c) Basis
of consolidation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">These condensed interim consolidated financial statements include the financial statements of the Company and the
following subsidiaries which are wholly owned and subject to control by the Company: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and six months ended October&nbsp;31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Name of Subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">% Equity<BR><FONT STYLE="white-space:nowrap">Interest&nbsp;-&nbsp;2020</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">% Equity<BR><FONT STYLE="white-space:nowrap">Interest&nbsp;-&nbsp;2019</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Country of<BR>Incorporation</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (Canada) Ltd.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Canada</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (USA) Ltd., incorporated in Nevada, USA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">USA</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (USA) Ltd., incorporated in Delaware, USA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">USA</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (N.D.) Ltd.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">USA</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (MA) LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">USA</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Talem Therapeutics LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">USA</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">U-Protein</FONT> Express B.V.
<FONT STYLE="white-space:nowrap">(&#147;U-Protein&#148;)</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Netherlands</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Netherlands B.V.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Netherlands</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (Europe) B.V. (&#147;IPA Europe&#148;, formerly ModiQuest Research
B.V.)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Netherlands</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Immulease B.V. (&#147;Immulease&#148;)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Netherlands</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Control is achieved when the Company has the power to, directly or indirectly, govern the financial and
operating policies of an entity so as to obtain benefits from its activities. Subsidiaries are fully consolidated from the date on which control is obtained and continue to be consolidated until the date that such control ceases. Intercompany
balances, transactions and unrealized intercompany gains and losses are eliminated upon consolidation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company incorporated a new
subsidiary, ImmunoPrecise Antibodies (USA) Ltd. in Delaware, USA on September&nbsp;11, 2019. ImmunoPrecise Antibodies (USA) Ltd., incorporated in Nevada, USA, was dissolved on November&nbsp;4, 2019.&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(d) Functional and presentation currency </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The functional currency of a company is the currency of the primary economic environment in which the company operates. The presentation
currency for a company is the currency in which the company chooses to present its financial statements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The functional currency of the
Company and ImmunoPrecise Antibodies (Canada) Ltd. is the Canadian dollar. The functional currency of ImmunoPrecise Antibodies (USA) Ltd., ImmunoPrecise Antibodies (N.D.) Ltd., ImmunoPrecise Antibodies (MA) LLC and Talem Therapeutics LLC is the US
dollar. The functional currency of <FONT STYLE="white-space:nowrap">U-Protein,</FONT> ImmunoPrecise Netherlands BV, IPA Europe and Immulease is the Euro. The presentation currency of the Company is the Canadian dollar. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Entities whose functional currencies differ from the presentation currency are translated into Canadian dollars as follows: assets and
liabilities &#150; at the closing rate as at the reporting date, and income and expenses &#150; at the average rate of the period. All resulting changes are recognized in other comprehensive income as cumulative translation differences. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Transactions in foreign currencies are translated into the functional currency at exchange rates at the date of the transactions. Foreign
currency monetary assets and liabilities are translated at the functional currency exchange rate at the reporting date. <FONT STYLE="white-space:nowrap">Non-monetary</FONT> items that are measured in terms of historical cost in a foreign currency
are translated using exchange rates as at the dates of the initial transactions. <FONT STYLE="white-space:nowrap">Non-monetary</FONT> items measured at fair value in a foreign currency are translated using the exchange rates at the date when the
fair value is determined. All gains and losses on translation of these foreign currency transactions are included in profit or loss. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and six months ended October&nbsp;31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">When the Company disposes of its entire interest in a foreign operation, or loses control,
joint control, or significant influence over a foreign operation, the foreign currency gains or losses accumulated in other comprehensive income related to the foreign operation are recognized in profit or loss. If an entity disposes of part of an
interest in a foreign operation which remains a subsidiary, a proportionate amount of foreign currency gains or losses accumulated in other comprehensive income related to the subsidiary are reallocated between controlling and <FONT
STYLE="white-space:nowrap">non-controlling</FONT> interests. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ADOPTION OF NEW ACCOUNTING STANDARDS AND ACCOUNTING STANDARDS ISSUED BUT NOT YET EFFECTIVE
</B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(a) Adoption of New Accounting Standards </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has adopted the following new standards, along with any consequential amendments, effective May&nbsp;1, 2019. These changes were
made in accordance with the applicable transitional provisions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company adopted all of the requirements of IFRS 16, <I>Leases</I>
(&#147;IFRS 16&#148;) as of May&nbsp;1, 2019. IFRS 16 replaces IAS 17, <I>Leases</I> (&#147;IAS 17&#148;). IFRS 16 provides a single lessee accounting model, requiring lessees to recognize assets and liabilities for all leases unless the lease term
is 12 months or less or the underlying asset has a low value. The Company has adopted IFRS 16 using the modified retrospective application method, where the 2019 comparatives are not restated and a cumulative catch up adjustment is recorded on
May&nbsp;1, 2019 for any differences identified, including adjustments to opening deficit balance. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company analyzed its contracts to
identify whether they contain a lease arrangement for the application of IFRS 16. The following is the Company&#146;s new accounting policy for leases under IFRS 16: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">At inception of a contract, the Company assesses whether the contract is, or contains, a lease. A contract is, or contains, a lease if the
contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Leases of <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets are recognized at the lease commencement date at the present value of the lease payments that are not paid at that date. The lease payments are discounted
using the interest rate implicit in the lease, if that rate can be readily determined, and otherwise at the Company&#146;s incremental borrowing rate. At the commencement date, a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset is measured at cost, which is comprised of the initial amount of the lease liability adjusted for any lease payments made at or before the
commencement date, plus any decommissioning and restoration costs, less any lease incentives received. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Each lease payment is allocated
between repayment of the lease principal and interest. Interest on the lease liability in each period during the lease term is allocated to produce a constant periodic rate of interest on the remaining balance of the lease liability. Except where
the costs are included in the carrying amount of another asset, the Company recognizes in profit or loss (a)&nbsp;the interest on a lease liability and (b)&nbsp;variable lease payments not included in the measurement of a lease liability in the
period in which the event or condition that triggers those payments occurs. The Company subsequently measures a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset at cost less any accumulated
depreciation and any accumulated impairment losses; and adjusted for any remeasurement of the lease liability. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> assets are depreciated over the shorter of
the asset&#146;s useful life and the lease term, except where the lease contains a bargain purchase option a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset is depreciated over the asset&#146;s
useful life. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and six months ended October&nbsp;31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On the date of transition, the Company recorded a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset of $1,668,533 related to the office rent in property and equipment, and the lease obligation of $1,723,277 was recorded as at May&nbsp;1, 2019, discounted using the Company&#146;s
incremental borrowing rate of 8%, and measured at an amount equal to the lease obligation as if IFRS 16 had been applied since the commencement date. The net difference between
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets and lease liabilities on the date of transition was recognized as a deficit adjustment of $54,744 on May&nbsp;1, 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(b) Accounting Standards Issued But Not Yet Effective </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In October 2018, the IASB issued amendments to IFRS 3, Business Combinations. The amendments narrowed and clarified the definition of a
business. The amendments will help companies determine whether an acquisition is a business or a group of assets. They also permit a simplified assessment of whether an acquired set of activities and assets is a group of assets rather than a
business. Distinguishing between a business and a group of assets is important because an acquirer recognizes goodwill only when acquiring a business. This amendment will be effective for annual periods beginning on or after January&nbsp;1, 2020.
Early adoption is permitted. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CRITICAL ACCOUNTING ESTIMATES AND JUDGMENTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The preparation of the condensed interim consolidated financial statements in conformity with IFRS required estimates and judgments that affect
the amounts reported in the financial statements. Actual results could differ from these estimates and judgments. Estimates are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the year in which the estimate is
revised. Significant areas requiring the use of estimates and judgments are as follows: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Functional currency</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has used judgment in determining the currency of the primary economic environment in which the entity operates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Amounts receivable</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The
Company monitors the financial stability of its customers and the environment in which they operate to make estimates regarding the likelihood that the individual trade receivable balances will be paid. Credit risks for outstanding customer
receivables are regularly assessed and allowances are recorded for estimated losses, if required. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Property and equipment</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has used estimates in the determination of the expected useful lives of property and equipment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Revenue recognition</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">percentage-of-completion</FONT></FONT> method requires the use of estimates to determine the stage of completion which is used to determine the recorded amount of revenue, unbilled revenue
and deferred revenue on uncompleted contracts. The determination of anticipated revenues includes the contractually agreed revenue and may also involve estimates of future revenues if such additional revenues can be reliably estimated and it is
considered probable that they will be recovered. The determination of anticipated costs for completing a contract is based on estimates that can be affected by a variety of factors, including the cost of materials, labour, and <FONT
STYLE="white-space:nowrap">sub-contractors.</FONT> The determination of estimates is based on the Company&#146;s business practices as well as its historical experience. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Impairments</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the
purposes of assessing impairment, assets are grouped at the lowest levels for which there are separately identifiable cash flows (&#147;cash generating units&#148; or &#147;CGU&#148;s). Each asset or CGU is evaluated every reporting period to
determine whether there are any indicators of impairment. If any such indicators exist, which </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and six months ended October&nbsp;31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
is often judgment-based, a formal estimate of recoverable amount is performed and an impairment charge is recognized to the extent that the carrying amount exceeds the recoverable amount. The
recoverable amount of an asset or CGU of assets is measured at the higher of fair value less costs of disposal or value in use. These determinations and their individual assumptions require that management make a decision based on the best available
information at each reporting period. The estimates and assumptions are subject to risk and uncertainty; hence, there is the possibility that changes in circumstances will alter these projections, which may impact the recoverable amount of the
assets. In such circumstances, some or all of the carrying value of the assets may be further impaired or the impairment charge reversed with the impact recorded in profit or loss. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company performs a goodwill impairment test annually and when circumstances indicate that the carrying value may not be recoverable. For
the purposes of impairment testing, goodwill acquired through business combinations has been allocated to two different CGUs. The recoverable amount of each CGU was based on value in use, determined by discounting the future cash flows to be
generated from the continuing use of the CGU. The cash flows were projected over a five-year period based on past experience and actual operating results. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company performed its annual goodwill impairment test in April 2019 and no impairment was indicated for the period tested. The values
assigned to the key assumptions represented management&#146;s assessment of future trends in the industry and were based on historical data from both internal and external sources. Weighted average costs of capital of 17.5% and 10.2%, respectively,
was used in the assessments of the two CGUs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Determination of segments</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">An operating segment is a component of the Company that engages in business activities from which it may earn revenues and incur expenses. All
operating segments&#146; results are reviewed by the Company&#146;s management in order to make decisions regarding the allocation of resources to the segment. Segment results include items directly attributable to a segment as those that can be
allocated on a reasonable basis. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As the Company provides antibody production and related services in one distinct category, there is only
one category to report revenues by production site. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Life of intangible assets</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Intangible assets are amortized based on estimated useful life less their estimated residual value. Significant assumptions are involved in the
determination of useful life and residual values and no assurance can be given that actual useful lives and residual values will not differ significantly from current assumptions. Actual useful life and residual values may vary depending on a number
of factors including internal technical evaluation, attributes of the assets and experience with similar assets. Changes to these estimates may affect the carrying value of assets, net income (loss) and comprehensive income (loss) in future periods.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Purchase price allocation</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The acquisition of <FONT STYLE="white-space:nowrap">U-Protein</FONT> on August&nbsp;22, 2017 and the acquisition of IPA Europe and Immulease on
April&nbsp;5, 2018 were accounted for as business combinations at fair value in accordance with IFRS 3, <I>Business Combinations.</I> The acquired assets and assumed liabilities were adjusted to their fair values assigned through completion of a
purchase price allocation, as described below. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The purchase price allocation process resulting from a business combination requires
management to estimate the fair value of identifiable assets acquired including intangible assets and liabilities assumed including the deferred acquisition payment obligations. The Company uses valuation techniques, which are generally based on
forecasted future net cash flows discounted to present value, and also relies on work performed by third-party valuation specialists. These valuations are closely linked to the assumptions used by management on the future performance of the related
assets and the discount rates applied. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and six months ended October&nbsp;31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ACQUISITION OF <FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On August&nbsp;22, 2017, the Company completed the acquisition of <FONT STYLE="white-space:nowrap">U-Protein</FONT> whereby the Company has
acquired all of the issued and outstanding shares of <FONT STYLE="white-space:nowrap">U-Protein</FONT> for &#128;6,830,000 on terms as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,734,732 (CAD$4,062,607) was paid in cash on closing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3,030,503 common shares of the Company were issued on closing; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,047,634 in deferred payments over a three-year period. The deferred payments can be made in cash or
common shares of the Company at the election of <FONT STYLE="white-space:nowrap">U-Protein</FONT> shareholders. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The
transaction was accounted for as a business combination, as the operations of <FONT STYLE="white-space:nowrap">U-Protein</FONT> meet the definition of a business. As the transaction was accounted for as a business combination, transaction costs of
$17,717 were expensed. The goodwill resulting from the allocation of the purchase price to the total fair value of net assets represented the sales and growth potential of <FONT STYLE="white-space:nowrap">U-Protein.</FONT> Goodwill recorded is
allocated in its entirety to <FONT STYLE="white-space:nowrap">U-Protein.</FONT> The fair value of the 3,030,503 common shares issued ($3,022,308) was determined based on the Canadian dollar equivalent of the consideration required of &#128;2,047,634
pursuant to the share purchase agreement. The Company has allocated the purchase price as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,062,607</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3,030,503 common shares of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,022,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of deferred payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,134,410</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,219,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">797,276</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">370,530</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,815</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment, net of accumulated amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">216,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intellectual property (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,064,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,655,893</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(269,657</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income taxes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,197</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(810,800</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,219,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The deferred payments of &#128;2,047,634 over a three-year period was fair valued on the date of acquisition
using a discounted cash flow model. A discount rate of 16.3% was used. The changes in the value of the deferred payments during the six months ended October&nbsp;31, 2019 and the year ended April&nbsp;30, 2019 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,408,205</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">244,915</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,049,754</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(40,670</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,562,696</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">356,516</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(86,753</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, October&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,832,459</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and six months ended October&nbsp;31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ACQUISITION OF IPA EUROPE AND IMMULEASE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company acquired all of the issued and outstanding shares of IPA Europe and its sister entity, Immulease, for an
aggregate purchase price of &#128;7,000,000 on terms as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,500,000 (CAD$3,988,132) was paid in cash on closing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">6,600,399 common shares of the Company were issued on closing; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,000,000 in deferred payments over a three-year period. The deferred payments will be made in three equal
installments of cash and equity totaling &#128;666,666 and will be prorated if the EBITDA of IPA Europe for the fiscal year preceding the date of payment is less than its average EBITDA over the previous two fiscal years. During the year ended
April&nbsp;30, 2019, the Company and the seller entered into an Amendment, Termination and Settlement Agreement whereby the deferred payments shall no longer be subject to an adjustment and will be paid in equal installments of cash and equity
totaling &#128;666,666. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The transaction was accounted for as a business combination, as the operations of IPA Europe and
Immulease meet the definition of a business. As the transaction was accounted for as a business combination, transaction costs of $36,821 were expensed. The goodwill resulting from the allocation of the purchase price to the total fair value of net
assets represented the sales and growth potential of IPA Europe. Goodwill recorded is allocated in its entirety to IPA Europe. The fair value of the 6,600,399 common shares issued ($4,884,295) was determined to be $0.74 per share based on the fair
value of the Company&#146;s shares immediately prior to the completion of the acquisition. The Company has allocated the purchase price as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,988,132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6,600,399 common shares of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,884,295</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of deferred payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,353,708</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,226,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">270,339</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">572,427</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,286,995</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment, net of accumulated amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">568,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Software</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible assets (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,304,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,640,671</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(580,339</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(22,897</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(298,979</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,636,192</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,226,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and six months ended October&nbsp;31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The deferred payments of &#128;2,000,000 over a three-year period was fair valued on the date
of acquisition using a discounted cash flow model. A discount rate of 10.1% was used. The changes in the value of the deferred payments during the six months ended October&nbsp;31, 2019 and the year ended April&nbsp;30, 2019 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,403,954</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in estimate of fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(34,258</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">232,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,014,503</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(86,326</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,501,285</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">242,678</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(26,740</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, October&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,717,223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INVESTMENT </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Investment consists of a 29% (2019 &#150; 29%) interest in QVQ Holding B.V. (&#147;QVQ&#148;), which is recorded at cost, being the best
approximation of the investment&#146;s fair value. Judgment is required as to the extent of influence that the Company has over QVQ. The Company considered the extent of voting power over the entity, the power to participate in financial and
operating policy decisions of the entity, representation on the board of directors, material transactions between the entities, interchange of management personnel, and provision of essential technical information. The Company has determined that
the Company is not considered to have significant influence over QVQ, as the Company does not have the power to participate in financial and operating policy decisions, does not have representation on the Board of Directors of QVQ, and the majority
of the common shares are held by QVQ management. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>PROPERTY AND EQUIPMENT </B></P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Computer<BR>Hardware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Furniture&nbsp;&amp;<BR>Equipment</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Computer<BR>Software</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Building</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Leasehold<BR>Improvements</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Lab<BR>Equipment</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93,813</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98,527</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,373</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">393,421</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,787,105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,385,239</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquired on acquisition of IPA Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,184</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,538</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87,821</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">612,046</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">729,589</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,153</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,141</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(31,294</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">110,997</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,065</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">130,015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">393,421</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,369,010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,114,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,952</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,668,533</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">186,091</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,858,576</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(760</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(49,382</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(50,142</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, October&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>114,949</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>111,065</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>129,255</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,668,533</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>393,421</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,505,719</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,922,942</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated Depreciation:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,883</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,218</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,299</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,552,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,803,870</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,252</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,533</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103,764</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500,194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">677,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(43</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,029</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,072</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,636</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,789</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">205,816</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,047,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,475,959</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,071</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">217,840</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,588</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">268,562</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">557,089</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(217</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(31,304</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(31,521</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, October&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>95,206</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>87,666</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>92,570</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>217,840</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>223,404</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,284,841</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,001,527</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Book Value:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,429</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81,226</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">187,605</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,321,427</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,638,549</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>October&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>19,743</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>23,399</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>36,685</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,450,693</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>170,017</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,220,878</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,921,415</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and six months ended October&nbsp;31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INTANGIBLE ASSETS&nbsp;&nbsp;&nbsp;&nbsp; </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The intangible assets were acquired as a result of the acquisitions of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe and are
amortized using the straight-line method over their useful lives. The intellectual property has a useful life of 10 years, and the proprietary processes and certifications have a useful life of 5 years. The changes in the value of the intangible
assets during the six months ended October&nbsp;31, 2019 and the year ended April&nbsp;30, 2019 are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Internally<BR>Generated<BR>Development<BR>Costs</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Intellectual<BR>Property</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Proprietary<BR>Processes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Certifications</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,270,229</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,270,229</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquired on acquisition of IPA Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,159,755</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">145,108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,304,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(125,004</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(229,263</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,401</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(359,668</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,145,225</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,930,492</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">139,707</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,215,424</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,817</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,817</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(529</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(105,730</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(151,265</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,563</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(261,087</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, October&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>71,288</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,039,495</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,779,227</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>136,144</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>10,026,154</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated Amortization:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">227,746</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">227,746</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">416,890</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,169,233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,586,123</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,035</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,641</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(15,676</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">635,601</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,162,592</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,798,193</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">203,475</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">605,294</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">808,769</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,712</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(34,117</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(51,829</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, October&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>821,364</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,733,769</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,555,133</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Book Value:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,509,624</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,767,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">139,707</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,417,231</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>October&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>71,288</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,218,131</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,045,458</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>136,144</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,471,021</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DEBENTURES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company completed a nonconvertible debenture (the &#147;Debentures&#148;) financing in the principal amount of
$4,252,000 (the &#147;Offering&#148;). The Debentures are unsecured, bear interest at a rate of 10% per annum, payable semi-annually, and are due eighteen months from the date of issue. Under the Offering, a holder of a Debenture received 37,500
detachable share purchase warrants (the &#147;Warrants&#148;) for every $25,000 of Debentures subscribed for by the holder. The Warrants are exercisable at $0.70 per share for a period of four years from the date of issue. The fair value of the
Debentures at the time of issue was calculated as the discounted cash flows assuming a 15% effective interest rate. The fair value of the Warrants was determined at the time of issue as the difference between the face value and the fair value of the
Debentures. On initial recognition, the Company bifurcated $4,003,125 to the carrying value of the Debentures and $248,875 to the Warrants.&nbsp;&nbsp;&nbsp;&nbsp; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and six months ended October&nbsp;31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Under the Offering, the Company paid the following finder&#146;s fees: $10,300 in cash,
580,320 shares of the Company with a fair value of $383,010, and 415,942 finder&#146;s warrants valued at $187,627. The fair value of the finder&#146;s warrants was estimated on the date of issue using the Black-Scholes option valuation model with
the following weighted average assumptions: dividend yield of $nil, risk free interest rate of 1.60%, expected life of 4 years and expected volatility based on the historical volatility of similar companies of 100%. The total fair value of the
finder&#146;s fees was allocated <FONT STYLE="white-space:nowrap">pro-rata</FONT> based on the carrying values of the Debentures and Warrants, with $546,934 allocated to the Debentures and $34,003 allocated to the Warrants. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;25, 2018, the Company settled $1,377,000 of the Debentures by issuing 1,377,000 units at a price of $1.00 per unit. Each unit
consists of one common share of the Company and one share purchase warrant, with each warrant entitling the holder to purchase an additional share at $1.25 for two years. The fair value of the 1,377,000 common shares issued was determined to be
$1,115,370. The fair value of the warrants issued was determined to be $283,000 and estimated on the date of issue using the Black-Scholes option valuation model with the following weighted average assumptions: dividend yield of $nil, risk free
interest rate of 1.58%, expected life of 2 years and expected volatility based on the historical volatility of similar companies of 68.7%. The settlement resulted in a loss of $189,715. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;26, 2019, the Company modified the terms of $2,750,000 debentures to extend the due date 6 months to March&nbsp;26, 2020,
with the ability to pay earlier with no penalty, and increase the interest rate to 12.5%. The remaining debentures of $125,000 were paid on maturity. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the three and six months ended October&nbsp;31, 2019, the Company recorded accretion expense of $70,910 and $166,666 (2018 &#150;
$124,045 and $247,417). The changes in the value of the Debentures during the six months ended October&nbsp;31, 2019 and the year ended April&nbsp;30, 2019 are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,489,397</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">427,592</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Settlement of debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,208,655</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,708,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">166,666</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repayment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(125,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, October&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>LOANS PAYABLE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company assumed loans payable of &#128;60,750 (CAD$94,995) as a result of the acquisition of IPA Europe. On
July&nbsp;7, 2015, IPA Europe entered into a loan agreement in the principal amount of &#128;165,000, maturing on July&nbsp;31, 2020. The loan is secured by certain equipment, bears an interest rate of 4% per annum and is repayable in monthly
installments of &#128;2,250. The interest is owed per month in arrears. The principal outstanding at October&nbsp;31, 2019 is &#128;18,000 (CAD$26,408) (April 30, 2019 &#150; &#128;31,500 (CAD$47,423)). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company assumed loans payable of &#128;56,450 (CAD$88,271) as a result of the acquisition of IPA Europe. On
February&nbsp;1, 2016, IPA Europe entered into a loan agreement in the principal amount of &#128;100,000, maturing on February&nbsp;28, 2021. The loan is secured by certain equipment, bears an interest rate of 3% per annum and is repayable in
monthly installments of &#128;1,675. The interest is owed per month in arrears. The principal outstanding at October&nbsp;31, 2019 is &#128;24,625 (CAD$36,127) (April 30, 2019 &#150; &#128;34,675 (CAD$52,203)). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and six months ended October&nbsp;31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company assumed loans payable of &#128;74,000 (CAD$115,713) as a
result of the acquisition of Immulease. On May&nbsp;18, 2016, Immulease entered into a credit facility agreement pursuant to which the lender provides a facility amount of up to &#128;200,000. The credit facility is unsecured, bears an interest rate
of 3% per annum and is repayable on demand. The interest is owed per month in arrears. The principal outstanding at October&nbsp;31, 2019 is &#128;nil (CAD$nil) (April 30, 2019 &#150; &#128;8,000 (CAD$12,044)).&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On May&nbsp;23, 2018, the Company entered into a loan agreement with a Director of the Company and his spouse and issued a promissory note in
the principal amount of $200,000. The note was unsecured and bore an interest rate of 5.45% per annum. The principal of the note plus accrued interest of $3,972 was repaid in full during the year ended April&nbsp;30, 2019. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">290,445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loan proceeds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loan repayments and foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(378,775</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,670</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loan repayments and foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(49,135</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, October&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,535</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(55,897</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-current</FONT> portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,638</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>LEASES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company entered into certain equipment leases expiring between 2021 and 2023 with interest rates of between 13% and 17% per annum. The
Company&#146;s obligations under these finance leases are secured by the lessor&#146;s title to the leased assets. The Company also entered into office leases in January 2018 and May 2018. With the adoption of IFRS 16, <I>Leases</I> (see Note 3),
the Company recognized a lease obligation with regard to the office leases. The terms and the outstanding balances as at October&nbsp;31, 2019 and April&nbsp;30, 2019 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>October&nbsp;31,<BR>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment under finance lease repayable in monthly instalments of $1,228 with interests of between
13% and 17% per annum. Due dates are between May&nbsp;2021 and March&nbsp;2023.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98,527</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,077</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> asset
from office lease repayable in monthly instalments of $21,015 and an interest rate of 8% per annum and an end date of April 2023.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">788,881</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> asset
from office lease repayable in monthly instalments of $22,012 and an interest rate of 8% per annum and an end date of December 2022.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">739,823</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(341,597</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(35,757</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-current</FONT> portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,285,634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,320</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As at October&nbsp;31, 2019, the Company&#146;s equipment includes a net carrying amount of $94,478 (April 30,
2019 &#150; $104,014) for the leased equipment. The net carrying amount of the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets from office lease obligation is $1,450,693 (April 30, 2019 &#150;
$nil). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and six months ended October&nbsp;31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following is a schedule of the Company&#146;s future minimum lease payments related to
the equipment under finance lease and the office lease obligation: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">294,759</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">565,122</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">552,739</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">446,989</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total minimum lease payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,859,609</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: imputed interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(232,378</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total present value of minimum lease payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,627,231</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Current portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(341,597</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-current</FONT> portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,285,634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SHARE CAPITAL </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>a) Authorized: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Unlimited
common shares without par value. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>b) Share capital transactions: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>2019 Transactions </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On
June&nbsp;19, 2018, the Company closed a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement financing by issuing a total of 875,000 units of the Company at a price of $0.80 per unit for gross proceeds of $700,000. Each unit
consists of one common share of the Company and one share purchase warrant, with each warrant entitling the holder to purchase an additional share at a price of $1.00 for a period of one year from the date of issue. The Company will have the right
to accelerate the expiry date of the warrants provided that the volume weighted average price trades at a price equal to or greater than $1.50 for a period of 20 consecutive days. In the event of acceleration, the expiry date will be accelerated to
a date that is 30 days after the Company issues a news release announcing that it has elected to exercise this acceleration right. All of the proceeds have been allocated to the common shares issued with a $nil value assigned to the warrants issued.
The Company paid finders cash fees totaling $3,000 and incurred $7,926 of cash issue costs. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;24, 2018, the Company closed
a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement financing by issuing a total of 9,102,500 units of the Company at a price of $1.00 per unit for gross proceeds of $9,102,500. Each unit consists of one common share of the
Company and one share purchase warrant, with each warrant entitling the holder to purchase an additional share at a price of $1.25 for a period of two years from the date of issue. The Company will have the right to accelerate the expiry date of the
warrants provided that the volume weighted average price trades at a price equal to or greater than $1.75 for a period of 20 consecutive days. In the event of acceleration, the expiry date will be accelerated to a date that is 30 days after the
Company issues a news release announcing that it has elected to exercise this acceleration right. All of the proceeds have been allocated to the common shares issued with a $nil value assigned to the warrants issued. The Company paid finders cash
fees totaling $201,540 and issued 182,460 finder&#146;s shares. The Company also incurred $76,038 of cash issue costs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and six months ended October&nbsp;31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;22, 2017, the Company announced that it had signed a binding letter of
intent with Crossbeta Biosciences B.V. (&#147;Crossbeta&#148;) whereby the Company had agreed to acquire all of the issued and outstanding shares of Crossbeta. The proposed transaction was terminated and settled on October&nbsp;23, 2018. In
consideration of the settlement, the Company paid &#128;37,000 ($55,969) and issued 78,514 shares valued at $61,241. The Company accrued a settlement liability of $92,040 as at April&nbsp;30, 2018. As such, the remaining loss on settlement of
$25,170 was recognized in the year ended April&nbsp;30, 2019. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;25, 2018, the Company settled $1,377,000 of the Debentures
by issuing 1,377,000 units at a price of $1.00 per unit (Note 10). Each unit consists of one common share of the Company and one share purchase warrant, with each warrant entitling the holder to purchase an additional share at $1.25 for two years.
The fair value of the 1,377,000 common shares issued was determined to be $1,115,370. The fair value of the warrants issued was determined to be $283,000 and estimated on the date of issue using the Black-Scholes option valuation model with the
following weighted average assumptions: dividend yield of $nil, risk free interest rate of 1.58%, expected life of 2 years and expected volatility based on the historical volatility of similar companies of 68.7%. The settlement resulted in a loss of
$189,715. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;27, 2019, the Company issued 714,793 common shares pursuant to the second deferred payment to IPA Europe (Note 6).
The common shares are valued at $507,503. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2019, the Company issued 135,000 common shares pursuant to
exercise of stock options for total gross proceeds of $40,500. A value of $30,658 was transferred from contributed surplus to share capital as a result. The weighted average share price at dates the stock options were exercised was $1.05. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>2020 Transactions</I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During
the six months ended October&nbsp;31, 2019, the Company issued 55,000 common shares pursuant to exercise of stock options for total gross proceeds of $16,500. A value of $12,490 was transferred from contributed surplus to share capital as a result.
The weighted average share price at dates the stock options were exercised was $0.69. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>c) Escrow </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">There are 1,627,945 common shares of the Company held in escrow as at October&nbsp;31, 2019. Under the Escrow Agreement, the common shares held
in escrow will be released from escrow on December&nbsp;29, 2019. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>d) Options </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has an incentive Stock Option Plan (&#147;the Plan&#148;) under which <FONT STYLE="white-space:nowrap">non-transferable</FONT>
options to purchase common shares of the Company may be granted to directors, officers, employees or service providers of the Company. The terms of the plan provide that the Directors have the right to grant options to acquire common shares of the
Company at not less than the closing market price of the shares on the day preceding the grant at terms of up to ten years. The maximum number of options outstanding under the Plan shall not result, at any time, in more than 10% of the issued and
outstanding common shares.&nbsp;&nbsp;&nbsp;&nbsp; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;24, 2018, the Company granted 95,000 stock options, exercisable at
$0.95 per option, to employees of the Company. The options are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date; <FONT STYLE="white-space:nowrap">one-third</FONT> 12 months after
grant date and <FONT STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $67,402 using the Black-Scholes option pricing model and the following assumptions: dividend yield of
0%, expected volatility of 100%, a risk-free interest rate of 1.60%, and an expected life of 5 years. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and six months ended October&nbsp;31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On November&nbsp;7, 2018, the Company granted 300,000 stock options, exercisable at $0.82 per
option, to employees of the Company. The options are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date; <FONT STYLE="white-space:nowrap">one-third</FONT> 12 months after grant date
and <FONT STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $184,658 using the Black-Scholes option pricing model and the following assumptions: dividend yield of 0%, expected
volatility of 100%, a risk-free interest rate of 2.20%, and an expected life of 5 years. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;31, 2018, the Company granted
1,250,000 stock options, exercisable at $1.00 per option, to officers and directors of the Company. The options are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date; <FONT
STYLE="white-space:nowrap">one-third</FONT> 12 months after grant date and <FONT STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $625,485 using the Black-Scholes option
pricing model and the following assumptions: dividend yield of 0%, expected volatility of 100%, a risk-free interest rate of 2.20%, and an expected life of 5 years. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On January&nbsp;11, 2019, the Company granted 415,000 stock options, exercisable at $1.00 per option, to officers and an employee of the
Company. The options are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date; <FONT STYLE="white-space:nowrap">one-third</FONT> 12 months after grant date and <FONT
STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $228,801 using the Black-Scholes option pricing model and the following assumptions: dividend yield of 0%, expected
volatility of 100%, a risk-free interest rate of 2.20%, and an expected life of 5 years. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;1, 2019, the Company granted
250,000 stock options, exercisable at $0.475 per option, to an officer of the Company. The options are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date; <FONT
STYLE="white-space:nowrap">one-third</FONT> 12 months after grant date and <FONT STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $86,395 using the Black-Scholes option
pricing model and the following assumptions: dividend yield of 0%, expected volatility of 100%, a risk-free interest rate of 1.46%, and an expected life of 5 years. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;1, 2019, the Company granted 200,000 stock options, exercisable at $1.00 per option, to a consultant of the Company. The
options vested immediately upon grant. The fair value of these options was estimated to be $32,096 using the Black-Scholes option pricing model and the following assumptions: dividend yield of 0%, expected volatility of 100%, a risk-free interest
rate of 1.56%, and an expected life of 2 years. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;3, 2019, the Company granted 150,000 stock options, exercisable at $0.50
per option, to a director of the Company. The options are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date; <FONT STYLE="white-space:nowrap">one-third</FONT> 12 months after grant
date and <FONT STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $53,326 using the Black-Scholes option pricing model and the following assumptions: dividend yield of 0%,
expected volatility of 100%, a risk-free interest rate of 1.46%, and an expected life of 5 years. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;3, 2019, the Company
granted 65,000 stock options, exercisable at $1.01 per option, to employees of the Company. The options vested immediately upon grant. The fair value of these options was estimated to be $14,627 using the Black-Scholes option pricing model and the
following assumptions: dividend yield of 0%, expected volatility of 100%, a risk-free interest rate of 1.54%, and an expected life of 2.96 years. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Expected volatility was based on the historical volatility of similar companies. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the three and six months ended October&nbsp;31, 2019 the Company has recorded $214,120 and $500,115 (2018 - $183,123 and $494,823) of
share-based payments expense. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and six months ended October&nbsp;31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The changes in the stock options for the six months ended October&nbsp;31, 2019 and the year
ended April&nbsp;30, 2019 are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>options</B><br><B>#</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted<BR>average<BR>exercise<BR>price</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted<BR>average&nbsp;life<BR>remaining</B><br><B>(years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,871,666</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.68</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4.20</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,060,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(135,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expired</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(200,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,293,333</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,303,333</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.78</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3.87</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">665,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(55,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(803,333</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, October&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,110,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.78</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3.50</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,741,667</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Exercisable, October&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,368,333</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.75</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3.07</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Details of the options outstanding as at October&nbsp;31, 2019 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Expiry Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exercise<BR>price</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Remaining<BR>life</B><br><B>(year)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Options<BR>outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unvested</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Vested</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October 1, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.92</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December&nbsp;20, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">550,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">550,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;18, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">950,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">950,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January 3, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February&nbsp;7, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">700,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">700,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;24, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,666</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November&nbsp;7, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.02</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">833,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">416,666</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January 11, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">415,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">276,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">138,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October 1, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.92</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October 3, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.78</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3.50</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,110,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,741,667</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,368,333</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>e) Warrants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The changes in the warrants for the six months ended October&nbsp;31, 2019 and the year ended April&nbsp;30, 2019 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>warrants</B><br><B>#</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted<BR>average<BR>exercise<BR>price</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted<BR>average&nbsp;life<BR>remaining</B><br><B>(years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,378,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.70</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3.93</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issued</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,354,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2019 and October&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>17,732,500</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1.04</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1.44</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Details of the warrants outstanding as at October&nbsp;31, 2019 are as follows: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and six months ended October&nbsp;31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Expiry Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exercise<BR>price</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Remaining<BR>life</B><br><B>(year)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Warrants<BR>outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March&nbsp;26, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,378,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;18, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">875,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;24, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,102,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October&nbsp;25, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,377,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.04</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,732,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">During the six months ended October&nbsp;31, 2019, the expiry date of these warrants was extended from
June&nbsp;18, 2019 to June&nbsp;18, 2020. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>f) Finder&#146;s Warrants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As at October&nbsp;31, 2019 the Company has 415,942 finder&#146;s warrants outstanding. The warrants have an exercise price of $0.70 per share
and expire on March&nbsp;26, 2022. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>RELATED PARTY TRANSACTIONS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Key management personnel are those persons having authority and responsibility for planning, directing and controlling the activities of the
Company. Key management consists of Thomas D&#146;Orazio, former President and CEO; Robert Beecroft, former Interim CEO; Dr.&nbsp;Jennifer Bath, President and CEO; Lisa Helbling, CFO; Natasha Tsai, former CFO; Reginald Beniac, former Chief Operating
Officer; Charles Wheelock, Chief Technology Officer; Oren Beske, former President of ImmunoPrecise Antibodies (USA) Ltd.; Martin Hessing, a Director of <FONT STYLE="white-space:nowrap">U-Protein;</FONT> Jos Raats, former President and CEO of IPA
Europe; and Directors of the Company. During the three and six months ended October&nbsp;31, 2019 and 2018, the compensation for key management is as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Three months ended<BR>October&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Six months ended<BR>October&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Management fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,331</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102,403</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89,479</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">206,383</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Professional fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,655</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Salaries and other short-term benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">285,531</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,911</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">771,376</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">182,741</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,988</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,666</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">269,870</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">263,758</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">334,850</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">293,560</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,130,725</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">687,537</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the three and six months ended October&nbsp;31, 2019, the spouse of a Director provided administrative
services for $nil and $nil (2018 &#150; $15,625 and $31,250). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and six months ended October&nbsp;31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>15.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>COMMITMENTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the Company&#146;s rental of office and laboratory space in Victoria, BC, Canada, the current lease commenced on May&nbsp;1, 2018 and
terminates on April&nbsp;30, 2023. The lease is in the amount of $21,015 per month for all four spaces from May&nbsp;1, 2018 to April&nbsp;30, 2021 and $21,914 per month from May&nbsp;1, 2021 to April&nbsp;30, 2023. The minimum annual payments under
these leases are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">252,186</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">252,186</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">262,968</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">262,968</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,030,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the Company&#146;s rental of office and laboratory space in Utrecht, Netherlands, the current lease
commenced on January&nbsp;1, 2017 and terminates on December&nbsp;31, 2019. Annual minimum lease payments are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&#128;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,415</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the Company&#146;s rental of office and laboratory space in Oss, Netherlands, the current lease commenced
on January&nbsp;1, 2018 and terminates on December&nbsp;31, 2019. Effective December&nbsp;31, 2018, the lease automatically rolls into a 3 year term through December&nbsp;31, 2022. Annual minimum lease payments are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&#128;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">116,970</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">643,332</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>16.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SEGMENTED INFORMATION AND ECONOMIC DEPENDENCE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">At October&nbsp;31, 2019 and April&nbsp;30, 2019, the Company has one reportable segment, being antibody production and related services. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the six months ended October&nbsp;31, 2019, the Company had sales to nil (2018 - nil) customer who in aggregate accounted for more than
10% (2018 &#150; 10%) of revenue. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s revenues are allocated to geographic segments for the three and six months ended
October 31, 2019 and 2018 as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Three months ended<BR>October&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Six months ended<BR>October&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">United States of America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,379,352</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">723,593</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,283,729</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,324,604</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Canada</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">474,654</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">159,191</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">681,477</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">299,823</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,303,393</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,832,655</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,809,319</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,890,434</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,966</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,352</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103,939</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74,715</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,162,365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,716,791</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,878,464</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,589,576</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and six months ended October&nbsp;31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s revenues are allocated according to revenue types for the three and six
months ended October&nbsp;31, 2019 and 2018 as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Three months ended<BR>October&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Six months ended<BR>October&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Project revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,964,969</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,648,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,576,837</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,409,368</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Product sales revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">187,010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,614</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">247,244</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,555</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cryo storage revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,386</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,582</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54,383</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">117,653</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,162,365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,716,791</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,878,464</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,589,576</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s <FONT STYLE="white-space:nowrap">non-current</FONT> assets are allocated to geographic
segments as at October&nbsp;31, 2019 and April&nbsp;30, 2019 as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>October&nbsp;31,<BR>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,536,209</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">986,323</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Netherlands</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,016,553</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,481,425</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,552,762</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,467,748</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Geographic segmentation of the Company&#146;s (loss) income is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Three months ended<BR>October&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Six months ended<BR>October&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America - Corporate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,683,246</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,499,126</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,658,009</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,100,043</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">317,850</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">940,674</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">205,786</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(116,715</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Netherlands</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,851</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72,720</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76,480</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">628,664</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,363,545</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,485,732</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,375,743</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,588,094</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Geographic segmentation of the interest and accretion, and amortization and depreciation is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Three months ended<BR>October&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Six months ended<BR>October&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Interest and accretion</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America - Corporate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">294,569</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">349,576</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">925,244</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">695,535</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,645</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,207</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42,620</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Netherlands</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,541</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,744</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,538</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">327,755</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">356,228</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">999,608</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">712,198</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and six months ended October&nbsp;31, 2019 and 2018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Three months ended<BR>October&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Six months ended<BR>October&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Amortization and depreciation</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America - Corporate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,639</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,279</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">117,780</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46,433</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">244,551</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82,992</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Netherlands</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">525,155</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">180,249</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,080,028</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">363,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">663,574</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">226,682</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,365,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">446,689</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>17.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SUPPLEMENTAL CASH FLOW INFORMATION </B></P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B><FONT STYLE="white-space:nowrap">Non-cash</FONT> investing and
financing transactions:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>October&nbsp;31,<BR>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>July&nbsp;31,<BR>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquisition of equipment by capital lease</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,668,533</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following changes in liabilities arose from financing activities: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="53%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-cash</FONT> changes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Cash<BR>Flows</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Acquisition</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accretion</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Foreign<BR>exchange<BR>movements<BR>and&nbsp;change<BR>in&nbsp;estimates</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>October 31,<BR>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,063,981</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">599,194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(113,493</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,549,682</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,708,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(125,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">166,666</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,670</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(49,135</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,535</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,077</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(203,123</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,723,277</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,627,231</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,991,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(377,258</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,723,277</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">765,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(113,493</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,989,448</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.32
<SEQUENCE>33
<FILENAME>d20922dex9932.htm
<DESCRIPTION>EX-99.32
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.32</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.32 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Form <FONT STYLE="white-space:nowrap">52-109FV2</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B><B><I>Certification of Interim Filings</I></B><B> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B><B><I>Venture Issuer Basic Certificate</I></B><B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I, <B>Lisa</B> <B>Helbling</B>, the <B>Chief Financial Officer</B> of <B>ImmunoPrecise Antibodies Ltd.</B>, certify the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Review: </I></B>I have reviewed the interim financial report and interim MD&amp;A (together, the
&#147;interim<B><I> </I></B>filings&#148;) of <B>ImmunoPrecise Antibodies Ltd.</B> (the &#147;issuer&#148;) for the interim period ended <B>October 31, 2019.</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>No misrepresentations: </I></B>Based on my knowledge, having exercised reasonable diligence, the<B><I>
</I></B>interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with
respect to the period covered by the interim filings. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Fair presentation: </I></B>Based on my knowledge, having exercised reasonable diligence, the
interim<B><I> </I></B>financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date
of and for the periods presented in the interim filings. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: <B>December</B><B></B><B>&nbsp;17, 2019</B> </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><I>&#147;Lisa Helbling&#148;</I></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Lisa Helbling</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chief Financial Officer</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8pt; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>NOTE TO READER</U></B></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In contrast to the certificate required for
<FONT STYLE="white-space:nowrap">non-venture</FONT> issuers under National Instrument <FONT STYLE="white-space:nowrap">52-109</FONT> <I>Certification of Disclosure in</I> <I>Issuers&#146; Annual and Interim Filings </I>(NI <FONT
STYLE="white-space:nowrap">52-109),</FONT> this Venture Issuer Basic Certificate does not include representations relating to<I> </I>the establishment and maintenance of disclosure controls and procedures (DC&amp;P) and internal control over
financial reporting (ICFR), as defined in NI <FONT STYLE="white-space:nowrap">52-109.</FONT> In particular, the certifying officers filing this certificate are not making any representations relating to the establishment and maintenance of</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">i)&#8195;&#8201;&#8202;controls and other
procedures designed to provide reasonable assurance that information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted under securities legislation is recorded, processed, summarized
and reported within the time periods specified in securities legislation; and</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">ii)&#8195;&#8202;a process to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with the issuer&#146;s GAAP.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The issuer&#146;s certifying officers are responsible for ensuring that processes are in place to provide them with sufficient knowledge to support the
representations they are making in this certificate. Investors should be aware that inherent limitations on the ability of certifying officers of a venture issuer to design and implement on a cost effective basis DC&amp;P and ICFR as defined in NI
52109 may result in additional risks to the quality, reliability, transparency and timeliness of interim and annual filings and other reports provided under securities legislation.</P></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.33
<SEQUENCE>34
<FILENAME>d20922dex9933.htm
<DESCRIPTION>EX-99.33
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.33</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.33 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Form <FONT STYLE="white-space:nowrap">52-109FV2</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Certification of Interim Filings </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Venture Issuer Basic Certificate </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I, <B>Jennifer Bath</B>, the <B>Chief Executive Officer</B> of <B>ImmunoPrecise Antibodies Ltd.</B>, certify the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Review: </I></B>I have reviewed the interim financial report and interim MD&amp;A (together, the
&#147;interim filings&#148;) of <B>ImmunoPrecise Antibodies Ltd. </B>(the &#147;issuer&#148;) for the interim period ended <B>October 31, 2019.</B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>No misrepresentations: </I></B>Based on my knowledge, having exercised reasonable diligence, the interim
filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the
period covered by the interim filings. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Fair presentation: </I></B>Based on my knowledge, having exercised reasonable diligence, the interim
financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods
presented in the interim filings. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: <B>December</B><B></B><B>&nbsp;17, 2019</B> </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><I>&#147;Jennifer Bath&#148;</I></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jennifer Bath</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chief Executive Officer</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8pt; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>NOTE TO READER</U></B></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In contrast to the certificate required for
<FONT STYLE="white-space:nowrap">non-venture</FONT> issuers under National Instrument <FONT STYLE="white-space:nowrap">52-109</FONT> <I>Certification of Disclosure in </I><I>Issuers&#146; Annual and Interim Filings</I> (NI <FONT
STYLE="white-space:nowrap">52-109),</FONT> this Venture Issuer Basic Certificate does not include representations relating to the establishment and maintenance of disclosure controls and procedures (DC&amp;P) and internal control over financial
reporting (ICFR), as defined in NI <FONT STYLE="white-space:nowrap">52-109.</FONT> In particular, the certifying officers filing this certificate are not making any representations relating to the establishment and maintenance of</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">i)&#8195;&#8201;&#8202;controls and other
procedures designed to provide reasonable assurance that information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted under securities legislation is recorded, processed, summarized
and reported within the time periods specified in securities legislation; and</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">ii)&#8195;&#8202;a process to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with the issuer&#146;s GAAP.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The issuer&#146;s certifying officers are responsible for ensuring that processes are in place to provide them with sufficient knowledge to support the
representations they are making in this certificate. Investors should be aware that inherent limitations on the ability of certifying officers of a venture issuer to design and implement on a cost effective basis DC&amp;P and ICFR as defined in NI
52109 may result in additional risks to the quality, reliability, transparency and timeliness of interim and annual filings and other reports provided under securities legislation.&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.34
<SEQUENCE>35
<FILENAME>d20922dex9934.htm
<DESCRIPTION>EX-99.34
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.34</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.34 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g0910042201519.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Announces Record Quarterly Revenue and Significantly Expands Gross Margins </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, Dec. 17, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTCQB: IPATF) announces today
that it has released its financial results for the second quarter ended October&nbsp;31, 2019. The financial statements and related management&#146;s discussion and analysis (&#147;MD&amp;A&#148;) can be viewed on SEDAR at <U>www.sedar.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Financial Highlights: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Revenue. </B>During the three
months ended October&nbsp;31, 2019, the company generated revenues of $3,162,365, compared to revenues of $2,716,791 in the 2018 fiscal period. This represents a 16% rise in revenue for the three-month period. The increasing revenue trend is due to
growth in both the volume of contracts as well as an increase in the financial value of individual client programs resulting in a larger average value per program. Revenue outlook is positive for third quarter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gross Margin.</B> During the three months ended October&nbsp;31, 2019, the Company achieved a gross profit of $2,490,015 compared to $1,401,725 in the 2018
fiscal period. Gross profit increased by 78% over the same period last year. In percentage terms, the Company&#146;s gross profit increased to 79% from 52% in 2018. The higher gross profit in 2019 was mostly attributable to the Company investing
heavily in research and development initiatives, broadening the breadth and value of its intellectual property in both therapeutic oncology assets as well as advanced technologies in the discovery and analysis of human antibody sequences. Gross
profit was positivity affected by an increase in the average value per program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Net Loss.</B> During the three months ended October&nbsp;31, 2019, the
Company recorded a net loss of $1,363,545 compared to net loss of $1,485,732 for the three months ended October&nbsp;31, 2018. The net loss decreased in 2019 due to $1,088,290 higher gross profit and lower advertising and consulting expense, offset
by higher <FONT STYLE="white-space:nowrap">non-cash</FONT> expenses including amortization of acquired companies&#146; intangible assets, depreciation of leased assets as a result of implementing IFRS 16, <I>Leases,</I> and higher office expenses.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-IFRS</FONT> Measures*. </B><FONT STYLE="white-space:nowrap">Non-IFRS</FONT> Adjusted EBITDA was ($63,418) in the
second quarter of 2019 compared to ($744,054) in the second quarter of 2018. The reduction in loss is due primarily to <FONT STYLE="white-space:nowrap">non-cash</FONT> expenses reconciling IFRS Net Loss to Adjusted EBITDA. The reduction in EBITDA
Loss for the quarter is due to higher gross profit ($1,088,290) offset by higher Adjusted Operating Expenses ($407,654) primarily due to the Company&#146;s investment in research and development and information technology. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Reflecting on the calendar year of 2019, Dr.&nbsp;Jennifer Bath, CEO and President, added, &#147;During 2019 we won an increased number of large pharma
clients requiring more comprehensive therapeutic discovery and development outsourcing. These wins have been a core priority for ImmunoPrecise as we grow, which required substantive, strategic investments in our global infrastructure to attract, win
and retain large pharma. Onboarding of these programs differs from our pipeline to date in terms of timing and workflow management. While it is a significant positive that we are winning larger programs, we have been cognizant that short-term
revenue recognition can be affected by the timing of project activity. We have worked diligently to ensure that these are coupled with renewing, smaller projects to attain business continuity, thoughtful space and equipment utilization and therefore
greater profitability going into 2020.&#148; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is an international, full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell Select<SUP
STYLE="font-size:85%; vertical-align:top">&#153;</SUP> progressive, single-cell interrogation technology and the DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> custom phage libraries, as well as the Abthena<SUP
STYLE="font-size:85%; vertical-align:top">&#153;</SUP> bispecific program. IPA is focused on the next generation of antibody discovery, to deliver the most therapeutically relevant antibodies, in a shorter timeframe, with the highest probability of
succeeding to clinical trials. ImmunoPrecise&#146;s discovery and development are conducted in Utrecht and Oss, the Netherlands <FONT STYLE="white-space:nowrap">(U-Protein</FONT> Express and IPA Europe, respectively), and in Victoria, British
Columbia (IPA Canada). The Company operates globally to offer a continuum of superior antibody services, transforming the face of therapeutic discovery, by decreasing turnaround time and risk, and promoting clinical success. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward Looking Information </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains
statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148; within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;,
&#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and similar expressions to identify forward-looking statements. Any such forward-looking statements are based on
assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and expected future developments. However, whether actual results and developments will conform to
ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the
forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual
management discussion and analysis for the fiscal period ended October&nbsp;31, 2019 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and,
unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">*Non-IFRS</FONT> Financial Measure </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Readers are cautioned that &#147;Adjusted EBITDA&#148; is a measure not recognized under IFRS. Adjusted EBITDA is defined as earnings before interest
income, taxes, depreciation and amortization, share-based compensation, restructuring costs, impairment charges and other <FONT STYLE="white-space:nowrap">non-recurring</FONT> gains or losses. Management believes Adjusted EBITDA is a useful measure
that facilitates <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">period-to-period</FONT></FONT> operating comparisons. Readers are cautioned that &#147;Adjusted EBITDA&#148; is not an alternative to measures determined in
accordance with IFRS and should not, on its own, be construed as indicator of performance, cash flow or profitability. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture
Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View original content to
download multimedia: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.newswire.ca/en/releases/archive/December2019/17/c6142.html </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor relations please contact: Frederick Chabot, Phone: <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 09:08e <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">17-DEC-19</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.35
<SEQUENCE>36
<FILENAME>d20922dex9935.htm
<DESCRIPTION>EX-99.35
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.35</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.35 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g0910042201519.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Antibodies Will Be in San Francisco During J.P. Morgan Healthcare Conference Week January <FONT
STYLE="white-space:nowrap">13-16,</FONT> 2020 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, Jan. 6, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or
&#147;IPA&#148;) (TSX VENTURE: IPA) (OTCQB: IPATF) announced today IPA will be in San Francisco during the J.P. Morgan 38th Annual Healthcare Conference events running from January <FONT STYLE="white-space:nowrap">13-16,</FONT> 2020 in San
Francisco, California. The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology
creators, and members of the investment community. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Thirty-eight years ago, this meeting launched as a boutique event with only 20 companies focused on
biotechnology. Now it attracts more than 450 companies, both public and private, to deliver presentations to more than 9,000 attendees. Global thought leaders and biotech industry experts share their ideas and strategies with investors to reshape
the industry. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jennifer Bath, ImmunoPrecise President and CEO, Frederic Chabot, Investor Relations, and Brian Lundstrum, Director, will be taking investor
and business development meetings throughout the conference. To request a meeting please email <U>Sue LeGare</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd.
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is an international, full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell
Select<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> progressive, single-cell interrogation technology and the DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> custom phage libraries, as well as the Abthena<SUP
STYLE="font-size:85%; vertical-align:top">&#153;</SUP> bispecific program. IPA is focused on the next generation of antibody discovery, to deliver the most therapeutically relevant antibodies, in a shorter timeframe, with the highest probability of
succeeding to clinical trials. ImmunoPrecise&#146;s discovery and development are conducted in Utrecht and Oss, the Netherlands <FONT STYLE="white-space:nowrap">(U-Protein</FONT> Express and IPA Europe, respectively), and in Victoria, British
Columbia (IPA Canada). The Company operates globally to offer a continuum of superior antibody services, transforming the face of therapeutic discovery, by decreasing turnaround time and risk, and promoting clinical success. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward Looking Information </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains
statements that, to the extent they are not recitations of historical facts, may constitute &#147;forward-looking statements&#148; within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;,
&#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and similar expressions to identify forward-looking statements. Any such forward-looking statements are based on
assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and expected future developments. However, whether actual results and developments will conform to
ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the
forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for ImmunoPrecise being lower than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s
annual management discussion and analysis for the fiscal period ended October&nbsp;31, 2019 which can be </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless required by applicable law, ImmunoPrecise
undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE
ImmunoPrecise Antibodies Ltd. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View original content to download multimedia: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.newswire.ca/en/releases/archive/January2020/06/c4036.html </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 09:30e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">06-JAN-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.36
<SEQUENCE>37
<FILENAME>d20922dex9936.htm
<DESCRIPTION>EX-99.36
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.36</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.36 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g0910042201519.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Subsidiary Joins Genmab and Merus in Expansion to new Biotech Accelerator at the Center of Europe&#146;s
Most Competitive Science Region </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA and UTRECHT, The Netherlands, Jan. 9, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or
&#147;IPA&#148;) (TSX VENTURE: IPA) (OTC QB: IPATF) a provider of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">best-in-class</FONT></FONT> therapeutic antibody discovery capabilities for the global industry, today announced that
its wholly owned subsidiary <FONT STYLE="white-space:nowrap">U-Protein</FONT> Express BV signed a long-term lease contract for the new multi-tenant building for life sciences &#147;Accelerator&#148; at the Utrecht Science Park (Utrecht, The
Netherlands). In addition to accommodating large biotechnology companies, the new building will offer space to companies that want to accelerate their development. The design is based on the vision of listed biotechnology companies Genmab
(NASDAQ:GMAB) and Merus (NASDAQ:MRUS): Improving lives of patients by developing innovative therapies for cancer treatment, partly by entering into valuable collaborations. Accelerator endorses this ambition by creating a unique hub within the
innovation ecosystem. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accelerator offers Utrecht Science Park a welcome addition to accommodate more innovative companies in the Life Sciences sector.
The building will be developed aiming for high sustainability requirements (BREEAM Excellent) and will have a prominent place at the entrance of Utrecht Science Park. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We are happy to welcome <FONT STYLE="white-space:nowrap">U-Protein</FONT> Express to Accelerator. Accelerator is designed to facilitate and connect Life
Sciences companies, creating a tight international community within Utrecht Science Park. <FONT STYLE="white-space:nowrap">U-Protein</FONT> Express is a great addition to the ecosystem and Accelerator will stimulate their growth ambitions,&#148;
said Chiel van Dijen, Commercial Director of Kadans Science Partner. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Martin Hessing, General Manager of
<FONT STYLE="white-space:nowrap">U-Protein</FONT> Express, stated: &#147;We are delighted to move our continuously expanding service activities towards the new building alongside important stakeholders such as Genmab and Merus. This will enable us
to keep in pace with our growing contract research business as Accelerator will give us over <FONT STYLE="white-space:nowrap">3-4</FONT> times current capacity&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The investments we are making in our European operations are a strong reflection of ImunoPrecise&#146;s position in the marketplace and positive outlook
for the future,&#148; said Dr.&nbsp;Jennifer Bath, President and CEO. &#147;The Accelerator provides <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">state-of-the-art</FONT></FONT></FONT> facilities
that enable our talented team to respond to the increasing demand for our services and innovative technologies.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies
Ltd. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is an international, full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell
Select<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> progressive single-cell interrogation technology and the DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> custom, OmniAb<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>-based phage libraries, as well as the Abthena<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> bispecific program. IPA is focused on the next generation of antibody discovery, to
deliver the most therapeutically relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise discovery and development are conducted in Utrecht and Oss, the Netherlands <FONT STYLE="white-space:nowrap">(U-Protein</FONT> Express and IPA
Europe, respectively), and in Victoria, British Columbia (IPA Canada). The Company operates globally to offer a continuum of superior antibody services, transforming the face of therapeutic discovery, by decreasing turnaround time and risk, and
promoting clinical success. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward Looking Information </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148;
within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and
similar expressions to identify forward-looking statements. Any such forward-looking statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and
expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause
ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower
than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and analysis for the fiscal year ended April&nbsp;30, 2019 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking
statements&#148; contained herein speak only as of the date of this press release and, unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information,
future events or otherwise. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View original content to download multimedia: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.newswire.ca/en/releases/archive/January2020/09/c3850.html </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 08:59e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">09-JAN-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.37
<SEQUENCE>38
<FILENAME>d20922dex9937.htm
<DESCRIPTION>EX-99.37
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.37</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.37 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g0910042201519.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise integrates <FONT STYLE="white-space:nowrap">SGI-DNA&#146;s</FONT> benchtop automated DNA printer to
accelerate antibody discovery and manufacturing services </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, SAN DIEGO, and UTRECHT, Netherlands, Jan. 20, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES
LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTC QB: IPATF) a provider of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">best-in-class</FONT></FONT> therapeutic antibody discovery capabilities for the
global industry, and <FONT STYLE="white-space:nowrap">SGI-DNA,</FONT> INC., a company dedicated to developing transformative synthetic biology technologies and revolutionary DNA data storage solutions, today announced that IPA is integrating <FONT
STYLE="white-space:nowrap">SGI-DNA&#146;s</FONT> benchtop automated DNA printer to accelerate antibody discovery and manufacturing services at its European facilities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies will become the first CRO in Europe to integrate the BioXp<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> 3200 System in
its workflows as part of its vision for adopting breakthrough technologies in the discovery and manufacturing of antibodies. The BioXp 3200 System&nbsp;is the world&#146;s first benchtop automated system that rapidly synthesizes and clones
high-quality, double-stranded DNA fragments into any vector in an overnight run. Placing the BioXp 3200 System at IPA&#146;s Utrecht laboratories <FONT STYLE="white-space:nowrap">(U-Protein</FONT> Express BV), IPA will be accelerating turnaround
time for generating custom DNA for the discovery and manufacturing of antibodies and proteins. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The BioXp 3200 System will greatly reduce our
turnaround time for cloning activities in our discovery and manufacturing projects, positively impacting our manufacturing capacity. Moreover, the BioXp 3200 enables additional avenues of synthetic biology, enhancing our ability to generate, analyze
and screen large numbers of gene sequences for a variety of applications,&#148; said Dr.&nbsp;Jennifer Bath, President and CEO of ImmunoPrecise. &#147;It fits perfectly into our continuous implementation of new, emerging, and disruptive
technologies&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Martin Hessing, General Manager of <FONT STYLE="white-space:nowrap">U-Protein</FONT> Express, added, &#147;by automating
rapid DNA synthesis, we will put IPA in a competitive position, allowing faster delivery of our antibodies.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dan Gibson, CTO and <FONT
STYLE="white-space:nowrap">Co-Founder</FONT> of <FONT STYLE="white-space:nowrap">SGI-DNA,</FONT> commented, &#147;we are pleased to partner with ImmunoPrecise to further develop ground-breaking solutions on the BioXp platform that will enable them
to rapidly design, assemble and optimize antibody functionality with iterative speeds not available with any other workflow. Together, we will continue to refine solutions that shorten the antibody design-synthesis-screening timeline from weeks and
months down to days, providing clear advantages to their customers.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is an international, full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell Select<SUP
STYLE="font-size:85%; vertical-align:top">&#153;</SUP> progressive single-cell interrogation technology and the DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> custom,
OmniAb<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>-based phage libraries, as well as the Abthena<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> bispecific program. IPA is focused on the next generation of antibody
discovery, to deliver the most therapeutically relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise discovery and development are conducted in Utrecht and Oss, the Netherlands <FONT STYLE="white-space:nowrap">(U-Protein</FONT> Express and IPA
Europe, respectively), and in Victoria, British Columbia (IPA Canada). The Company operates globally to offer a continuum of superior antibody services, transforming the face of therapeutic discovery, by decreasing turnaround time and risk, and
promoting clinical success. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148;
within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and
similar expressions to identify forward-looking statements. Any such forward-looking statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and
expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause
ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower
than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and analysis for the fiscal year ended October&nbsp;31, 2019 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking
statements&#148; contained herein speak only as of the date of this press release and, unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information,
future events or otherwise. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View original content to download multimedia: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.newswire.ca/en/releases/archive/January2020/20/c7663.html </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 08:00e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">20-JAN-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.38
<SEQUENCE>39
<FILENAME>d20922dex9938.htm
<DESCRIPTION>EX-99.38
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.38</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.38 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Form <FONT STYLE="white-space:nowrap">52-109FV1</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B><B><I>Certification of Annual Filings in Connection</I></B><B> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B><B><I>With Voluntarily Filed AIF</I></B><B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This certificate is being filed on the same date that <B>IMMUNOPRECISE ANTIBODIES LTD.</B> has filed an AIF. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I, <B>Lisa Helbling,</B> Chief Financial Officer of <B>IMMUNOPRECISE ANTIBODIES LTD., </B>certify the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Review:</I></B><B> </B>I have reviewed the AIF, annual financial statements and annual MD&amp;A,
including, for greater certainty, all documents and information that are incorporated by reference in the AIF (together, the &#147;annual filings&#148;) of <B>IMMUNOPRECISE ANTIBODIES LTD., </B>(the &#147;Issuer&#148;) for the financial year ended
<B>April</B><B></B><B>&nbsp;30, 2019.</B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>No misrepresentations:</I></B><B> </B>Based on my knowledge, having exercised reasonable diligence, the
annual filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, for the
period covered by the annual filings. <B></B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Fair presentation:</I></B><B> </B>Based on my knowledge, having exercised reasonable diligence, the
annual financial statements together with the other financial information included in the annual filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for
the periods presented in the annual filings. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: <B></B>February&nbsp;14, 2020 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&#147;<I>Lisa Helbling</I>&#148;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>LISA HELBLING</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Chief Financial Officer</B></TD></TR>
</TABLE> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>NOTE TO READER </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman">In contrast to the certificate required for <FONT STYLE="white-space:nowrap">non-venture</FONT> issuers under National
Instrument <FONT STYLE="white-space:nowrap">52-109</FONT> <I>Certification of Disclosure in Issuers&#146; Annual and Interim Filings</I> (NI <FONT STYLE="white-space:nowrap">52-109),</FONT> this Venture Issuer Basic Certificate does not include
representations relating to the establishment and maintenance of disclosure controls and procedures (DC&amp;P) and internal control over financial reporting (ICFR), as defined in NI <FONT STYLE="white-space:nowrap">52-109.</FONT> In particular, the
certifying officers filing this certificate are not making any representations relating to the establishment and maintenance of </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">controls and other procedures designed to provide reasonable assurance that information required to be
disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and
</P></TD>
<TD WIDTH="1%">&nbsp;</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a process to provide reasonable assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with the issuer&#146;s GAAP. </P></TD>
<TD WIDTH="1%">&nbsp;</TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; padding-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman">The issuer&#146;s certifying officers are responsible for
ensuring that processes are in place to provide them with sufficient knowledge to support the representations they are making in this certificate. Investors should be aware that inherent limitations on the ability of certifying officers of a venture
issuer to design and implement on a cost effective basis DC&amp;P and ICFR as defined in NI <FONT STYLE="white-space:nowrap">52-109</FONT> may result in additional risks to the quality, reliability, transparency and timeliness of interim and annual
filings and other reports provided under securities legislation. </P></div>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.39
<SEQUENCE>40
<FILENAME>d20922dex9939.htm
<DESCRIPTION>EX-99.39
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.39</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.39 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Form <FONT STYLE="white-space:nowrap">52-109FV1</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B><B><I>Certification of Annual Filings in Connection</I></B><B> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B><B><I>With Voluntarily Filed AIF</I></B><B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This certificate is being filed on the same date that <B>IMMUNOPRECISE ANTIBODIES LTD.</B> has filed an AIF. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I, <B>Jennifer Bath,</B> Chief Executive Officer of <B>IMMUNOPRECISE ANTIBODIES LTD., </B>certify the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Review:</I></B><B> </B>I have reviewed the AIF, annual financial statements and annual MD&amp;A,
including, for greater certainty, all documents and information that are incorporated by reference in the AIF (together, the &#147;annual filings&#148;) of <B>IMMUNOPRECISE ANTIBODIES LTD., </B>(the &#147;Issuer&#148;) for the financial year ended
<B>April</B><B></B><B>&nbsp;30, 2019.</B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>No misrepresentations:</I></B><B> </B>Based on my knowledge, having exercised reasonable diligence, the
annual filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, for the
period covered by the annual filings. <B></B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Fair presentation:</I></B><B> </B>Based on my knowledge, having exercised reasonable diligence, the
annual financial statements together with the other financial information included in the annual filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for
the periods presented in the annual filings. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: <B></B>February&nbsp;14, 2020 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&#147;<I>Jennifer Bath</I>&#148;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>JENNIFER BATH</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Chief Executive Officer</B></TD></TR>
</TABLE> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>NOTE TO READER </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; font-size:10pt; font-family:Times New Roman">In contrast to the certificate required for <FONT STYLE="white-space:nowrap">non-venture</FONT> issuers under National Instrument <FONT
STYLE="white-space:nowrap">52-109</FONT> <I>Certification of Disclosure in Issuers&#146; Annual and Interim Filings</I> (NI <FONT STYLE="white-space:nowrap">52-109),</FONT> this Venture Issuer Basic Certificate does not include representations
relating to the establishment and maintenance of disclosure controls and procedures (DC&amp;P) and internal control over financial reporting (ICFR), as defined in NI <FONT STYLE="white-space:nowrap">52-109.</FONT> In particular, the certifying
officers filing this certificate are not making any representations relating to the establishment and maintenance of </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">controls and other procedures designed to provide reasonable assurance that information required to be
disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and
</P></TD>
<TD WIDTH="1%">&nbsp;</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a process to provide reasonable assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with the issuer&#146;s GAAP. </P></TD>
<TD WIDTH="1%">&nbsp;</TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; padding-bottom:0pt; margin-left:1%; font-size:10pt; font-family:Times New Roman">The issuer&#146;s certifying officers are responsible for ensuring that processes
are in place to provide them with sufficient knowledge to support the representations they are making in this certificate. Investors should be aware that inherent limitations on the ability of certifying officers of a venture issuer to design and
implement on a cost effective basis DC&amp;P and ICFR as defined in NI <FONT STYLE="white-space:nowrap">52-109</FONT> may result in additional risks to the quality, reliability, transparency and timeliness of interim and annual filings and other
reports provided under securities legislation. </P></div>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.40
<SEQUENCE>41
<FILENAME>d20922dex9940.htm
<DESCRIPTION>EX-99.40
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.40</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.40 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g20922sp331.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ANNUAL INFORMATION FORM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">of </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES
LTD. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">February&nbsp;14, 2020 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>INTRODUCTORY&nbsp;NOTES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>CORPORATE STRUCTURE</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>GENERAL DEVELOPMENT OF THE BUSINESS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>BUSINESS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>RISK FACTORS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>DIVIDENDS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>DESCRIPTION OF CAPITAL STRUCTURE</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>MARKET FOR SECURITIES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ESCROWED SECURITIES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>DIRECTORS AND EXECUTIVE OFFICERS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>LEGAL PROCEEDINGS AND REGULATORY ACTIONS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>INTEREST OF MANAGEMENT AND OTHERS IN MATERIAL TRANSACTIONS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>TRANSFER AGENT AND REGISTRAR</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>MATERIAL CONTRACTS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>INTERESTS OF EXPERTS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ADDITIONAL INFORMATION</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ANNUAL INFORMATION FORM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INTRODUCTORY NOTES </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Date of
Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In this annual information form (&#147;<B>Annual Information Form</B>&#148;), ImmunoPrecise Antibodies Ltd., together with its
subsidiaries, as the context requires, is referred to as &#147;<B>IPA</B>&#148; or the &#147;<B>Company</B>&#148;. All information contained in this Annual Information Form is as at February&nbsp;14, 2020, unless otherwise stated, being the date of
the most recently completed financial year of the Company, and the use of the present tense and of the words &#147;is&#148;, &#147;are&#148;, &#147;current&#148;, &#147;currently&#148;, &#147;presently&#148;, &#147;now&#148; and similar expressions
in this Annual Information Form is to be construed as referring to information given as of that date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cautionary Statement Regarding Forward-Looking
Statements and Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Annual Information Form contains forward -looking statements and information about the Company which reflect
management&#146;s expectations regarding the Company&#146;s future growth, results of operations, operational and financial performance and business prospects and opportunities. In addition, the Company may make or approve certain statements or
information in future filings with Canadian securities regulatory authorities, in news releases, or in oral or written presentations by representatives of the Company that are not statements of historical fact and may also constitute forward-looking
statements or forward-looking information. All statements and information, other than statements or information of historical fact, made by the Company that address activities, events or developments that the Company expects or anticipates will or
may occur in the future are forward-looking statements and information, including, but not limited to statements and information preceded by, followed by, or that include words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;,
&#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;anticipate&#148;, &#147;believe&#148;, &#147;intends&#148;, &#147;plan&#148;, &#147;forecast&#148;, &#147;budget&#148;, &#147;schedule&#148;, &#147;project&#148;, &#147;estimate&#148;,
&#147;outlook&#148;, or the negative of those words or other similar or comparable words. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward-looking statements and information involve significant
risks, assumptions, uncertainties and other factors that may cause actual future performance, achievement or other realities to differ materiality from those expressed or implied in any forward-looking statements or information and, accordingly,
should not be read as guarantees of future performance, achievement or realities. Although the forward looking statements and information contained in this Annual Information Form reflect management&#146;s current beliefs based upon information
currently available to management and based upon what management believes to be reasonable assumptions, the Company cannot be certain that actual results will be consistent with these forward- looking statements and information. A number of risks
and factors could cause actual results, performance, or achievements to differ materially from the results expressed or implied in the forward&#151;looking statements and information. Such risks and factors include, but are not limited to, the
following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company may continue to operate at a net loss; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an investment in the Company is speculative; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company may require additional financing in order to continue the development and growth of its business;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company will continue to be a going concern. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company does not plan to pay dividends in the near future; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the success of the Company&#146;s business development and marketing strategy; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company may be subject to growth-related risks including pressure on its internal systems;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company may lose customers which may have a significant impact on revenues; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s ability to meet customer performance requirements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the trend towards of the concentration of the pharma market; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s current products are custom products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">brand awareness of the Company&#146;s products and services; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company may face significant competition from larger businesses; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company will be dependent on the experience and skill of its management and key personnel;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company not infringing a third party&#146;s intellectual property rights; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company may need to take active steps to protect its intellectual property; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the pharma industry is subject to patent and other intellectual property litigation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s products and services may become obsolete without innovation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company needs to continually develop its services; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s customers may restrict the use of certain scientific information; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s services could expose it to potential liability; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company does not suffer any failures to its laboratory systems; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company uses a limited number of suppliers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">government regulation of the Company&#146;s products and services; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">uninsured or uninsurable risks of the business; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the directors and officers may engage in business that is in conflict with the Company. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Common Shares of the Company are speculative and may experience high volatility on the TSX Venture Exchange
(&#147;TSXV&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">global economic conditions may adversely affect the Company&#146;s business; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">foreign exchange rates; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">market percent of smaller companies. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For further details, see the &#147;Risk Factors&#148; section of this Annual Information Form.&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although the Company has attempted to identify important risks and factors that could cause actual actions, events or results to differ materially from those
described in forward -looking statements or information, there may be other factors and risks that cause actions, events or results not to be as anticipated, estimated or intended. Further, any forward&#151;looking statements and information
contained herein are made as of the date of this Annual Information Form and, other than as required by applicable securities laws, the Company assumes no obligation to update or revise them to reflect new events or circumstances. New factors emerge
from time to time, and it is not possible for management to predict all of such factors and to assess in advance the impact of each such factor on the Company&#146;s business or the extent to which any factor, or combination of factors, may cause
actual realities to differ materially from those contained in any forward-looking statement or information. Accordingly, readers should not place undue reliance on forward looking statements and information contained in this Annual Information Form
and the documents incorporated by reference herein. All forward-looking statements and information disclosed in this Annual Information Form are qualified by this cautionary statement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Currency and Exchange Rate Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The financial
statements included herein are reported in Canadian dollars. References in this Annual Information Form to &#147;<B>C$</B>&#148; or &#147;<B>$</B>&#148; are to the lawful currency of Canada, references to &#147;<B>euros</B>&#148; are to the lawful
currency of the European Union, and references to &#147;<B>US$</B>&#148; are to the lawful currency of the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&nbsp;13, 2020, the
Bank of Canada noon rate of exchange for one Canadian dollar in United States dollars was C$1.00 = US $0.7544 and for one Canadian dollar in euros was C$1.00 = euros 0.6955. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CORPORATE STRUCTURE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company was continued on September&nbsp;2, 2016 under the <I>Business Corporations Act</I> (British Columbia). On December&nbsp;21, 2016, the Company
changed its name to &#147;ImmunoPrecise Antibodies Ltd.&#148; The address of the Company&#146;s corporate office is 3204 &#150; 4464 Markham Street, Victoria, BC V8Z 7X8. The registered and records office of the Company is located at Suite 704, 595
Howe Street, Vancouver, BC V6C 2T5. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following sets out the Company&#146;s intercorporate relationship with its subsidiaries: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g20922sp333.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GENERAL DEVELOPMENT OF THE BUSINESS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has emerged as a recognized,
full-service, biologics Contract Research and Organization (&#147;CRO&#148;) with a presence in Canada, the US and the Netherlands. The Company is innovation-driven and positioned geographically and scientifically to provide industry-leading human
therapeutic antibody discovery and development services for its customers and partners. The Company offers a cohesive and extensive portfolio in the protein and antibody research, manufacturing and validation continuum. The Company is listed on the
TSX Venture Exchange (the &#147;Exchange&#148;) as a Tier 2 life science issuer under the trading symbol &#147;IPA&#148;. The Company&#146;s OTC Market symbol is &#147;IPATF&#148;. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Three Year History </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Over the last three years, the
Company has focused on growing its product offering and revenues through organic growth and mergers and acquisition as set out below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Fiscal Year Ended 2017 </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Revenue Growth </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2017,
the Company achieved growth in revenues to $2,630,515 from $1,896,118 in 2016. The Company recorded a net loss of $5,269,420 during the year ended April&nbsp;30, 2017, compared to net income of $151,035 for the year ended April&nbsp;30, 2016. The
net loss comprised of the $3,887,160 listing expenses recorded on completion of its reverse takeover and an operating loss of $1,382,260, which was mostly attributable to <FONT STYLE="white-space:nowrap">non-recurring</FONT> costs in foundational
growth-enabling investments made to pursue strategic initiatives which attracted consulting fees and other <FONT STYLE="white-space:nowrap">one-tie</FONT> costs such as systems development, business development and operational efficiency aimed at
configuring the Company for significant future growth. At the same time, the Company increased staffing and incurred higher lab operating costs to accommodate greater levels of activity. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Reverse Takeover Transaction </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&nbsp;21, 2016,
the Company completed its acquisition of IPA pursuant to the terms of a share exchange agreement dated October&nbsp;20, 2016 (the &#147;Agreement&#148;) among the Company, ImmunoPrecise Antibodies Ltd. (&#147;IPAL&#148;) and the shareholders of
IPAL. Under the terms of the Agreement, the Company (A)&nbsp;paid the principal shareholders $1,000,000 and (B)&nbsp;issued a total of 9,602,966 common shares of the Company to the shareholders of IPAL (the &#147;Consideration Shares&#148;). The
Consideration Shares represented twenty five percent (25%) of the issued and outstanding shares of the Company on closing of the transaction (&#147;Transaction&#148;) and Financing (as defined below). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Concurrent with closing the Transaction, the Company issued 14,377,500 common shares of the Company at a price of $0.30 per share for gross proceeds of
$4,313,250 (the &#147;Financing&#148;). In connection with the Financing, the Company paid finders a cash fee of $42,291 and issued finders share totalling of 505,750 common shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As part of the Transaction, the Company changed its name to &#147;ImmunoPrecise Antibodies Ltd.&#148; The Company became listed on the TSX Venture Exchange as
a Tier 2 Life Sciences Issuer under the symbol &#147;IPA&#148;. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Exchangeable Note Financing </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&nbsp;12, 2016 and prior to closing of the Transaction set forth above, IPAL entered into an exchangeable note for an aggregate sum of $97,500. The
exchangeable note bore interest at a rate of 5% per annum and was due and payable on September&nbsp;12, 2017. The terms of the exchangeable note allowed the holder to exchange the principal amount of the note for 650,000 units of the Company. Each
unit is comprised of one common share of the Company and one share purchase warrant with each share purchase warrant exercisable into one additional common share at a price of $0.30 per share for a period of one year from the date of issuance of the
warrants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;17, 2017 the exchangeable note was converted into 650,000 units of the Company. On conversion date, the Company had recorded
interest and accretion of $6,715. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Fiscal Year Ended 2018 </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Revenue Growth </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company achieved record annual revenue
of $5,441,349 in fiscal 2018 compared to $2,630,515 in fiscal 2017. This represents a 106% increase in revenue as a result of its acquisitions of <FONT STYLE="white-space:nowrap">U-Protein</FONT> Express B.V.
<FONT STYLE="white-space:nowrap">(&#147;U-Protein&#148;)</FONT> and ImmunoPrecise Europe BV (&#147;IPA Europe&#148;), and its ability to grow its core business and expand into higher revenue service offerings in therapeutic antibody discovery. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Acquisition of IPA Europe (formerly, ModiQuest Research B.V.) </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company acquired all of the issued and outstanding shares of IPA Europe (formerly called ModiQuest Research BV) located in Oss, The
Netherlands. IPA Europe specializes in the generation of monoclonal antibodies (&#147;mAbs&#148;) against difficult target antigens. IPA Europe applies proprietary technologies to all aspects of the antibody discovery process in research and
development, diagnostic and therapeutic applications. Using its proprietary ModiFuse<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> (hybridoma electrofusion), ModiSelect<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> (B cell
selection) and ModiPhage<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> (phage display) technologies, IPA Europe can generate very large panels of monoclonal antibodies from various backgrounds including mouse, rat, rabbit, chicken,
llama and human, as well as transgenic animals harboring the human antibody gene repertoire. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of the transaction, the Company acquired IPA
Europe and its sister entity, Immulease B.V. (&#147;Immulease&#148;), for an aggregate purchase price of &#128;7,000,000 (C$11,200,000) (the &#147;Purchase Price&#148;). Immulease is a holding company owning research equipment used in IPA
Europe&#146;s operations. &#128;5,000,000 (C$8,000,000) of the Purchase Price was paid on closing, consisting of &#128;2,500,000 (C$4,000,000) in cash and 6,600,399 common shares of the Company (valued at a price of &#128;0.38 (C$0.57) per share).
The remaining &#128;2,000,000 (C$3,200,000) of the Purchase Price will be paid in three annual installments of consisting of equal parts cash and equity. The first deferred payment of &#128;666,666 (C$1,014,503), consisting of cash of &#128;333,333
(C$507,000) and 714,793 shares of the Company was made during the financial year ended April&nbsp;30, 2019. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Acquisition of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&nbsp;22, 2017, the Company acquired all the issued and outstanding shares in <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Express B.V. <FONT STYLE="white-space:nowrap">(&#147;U-Protein&#148;)</FONT> pursuant to the terms and conditions of a securities purchase agreement among the Company,
<FONT STYLE="white-space:nowrap">U-Protein</FONT> and the shareholders of <FONT STYLE="white-space:nowrap">U-Protein</FONT> (the <FONT STYLE="white-space:nowrap">&#147;U-Protein</FONT> Agreement&#148;).
<FONT STYLE="white-space:nowrap">U-Protein</FONT> is a company based in Utrecht, The Netherlands and holds the rights to proprietary expression technology used in antibody production. <FONT STYLE="white-space:nowrap">U-Protein</FONT> is a CRO that
offers fast and large-scale production of (mammalian) recombinant proteins and antibodies for research and <FONT STYLE="white-space:nowrap">pre-clinical</FONT> applications. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Agreement, the Company acquired all of the issued and outstanding shares of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> for &#128;6,830,000 (CAD$10,108,400) (the &#147;Purchase Price&#148;), of which (A) &#128;2,734,732 (CAD$4,047,390) was paid in cash on closing, (B)&nbsp;a total of 3,030,503 common shares of the Company
were issued on closing, and (C) &#128;2,047,634 (CAD$3,030,498) in deferred payments over a three (3)&nbsp;year period (the &#147;Deferred Payments&#148;). The Deferred Payments may be made, at the election of the
<FONT STYLE="white-space:nowrap">U-Protein</FONT> shareholder, in cash or by the issuance of up to 3,030,498 common shares over a three-year period. As of the date of this Annual Report, the Company has satisfied the Deferred Payments in 2018 and
2019. The final Deferred Payment is due in December 2020. If the final Deferred Payment is not satisfied by the Company, the shareholders of <FONT STYLE="white-space:nowrap">U-Protein</FONT> will be permitted to repurchase the shares of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> from the Company at a fair market price.&nbsp;&nbsp;&nbsp;&nbsp; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As part of the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Agreement, the shareholders of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> were issued a dividend of any cash in <FONT STYLE="white-space:nowrap">U-Protein</FONT> above &#128;500,000. In accordance with the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Agreement, the three
principal shareholders of <FONT STYLE="white-space:nowrap">U-Protein</FONT> executed <FONT STYLE="white-space:nowrap">on-going</FONT> management and employment contracts, which include <FONT STYLE="white-space:nowrap">non-solicitation</FONT> and <FONT
STYLE="white-space:nowrap">non-competition</FONT> clauses as well as performance incentives based on the net profits of <FONT STYLE="white-space:nowrap">U-Protein.</FONT> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Establishes a New Full-Service B Cell Facility </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In April
2018, the Company launched its new, innovative full-service B cell offering, located in Victoria, British Columbia, offering B cell screening, sorting and sequencing on a broad range of therapeutic-relevant protein families including GPCRs <FONT
STYLE="white-space:nowrap">(G-protein</FONT> coupled receptors) and other multi-membrane spanning proteins. A B cell facility permits the Company to increase the speed of antibody discovery platforms, maintains native antibody paring and provides
antibodies of higher sensitivity and specificity. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Strengthened Management Team </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In February 2018, the Company announced the appointment of Jennifer L. Bath as the new Chief Executive Officer and President. Dr.&nbsp;Bath&#146;s appointment
added significant senior leadership and scientific depth to the Company&#146;s leadership team. Previously, Dr.&nbsp;Bath served in an executive role at Aldevron, LLC, as the Global Director, where she held both strategic and technical roles. She
headed the global sales and client relations teams, and defined business strategies by applying knowledge based on science, technology and the market. In addition, Dr.&nbsp;bath served as a key technical specialist, particularly for therapeutic
antibody discovery, and was responsible for growth and retention of clients. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As part of the expansion of the Company&#146;s senior leadership team, the
Company also appointed Charles (Chip) Wheelock as the global Chief Technology Officer and Kari Graber as the Director of Global Client Services and Project Management. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Private Placement Financings </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&nbsp;22, 2017, as
part of the acquisition of <FONT STYLE="white-space:nowrap">U-Protein,</FONT> the Company completed a private placement, issuing 5,250,000 common shares at $1.00 per share for gross proceeds of $5,250,000. The Company also issued 281,100 common
shares as finders&#146; fees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;26, 2018, the Company completed a <FONT STYLE="white-space:nowrap">non-convertible</FONT> debenture (the
&#147;Debentures&#148;) financing in the principal amount of C$4,002,000 (the &#147;Offering&#148;). The Debentures are unsecured, bear interest at a rate of 10% per annum, payable semi-annually, and were original due on September&nbsp;26, 2019
(which have now been extended to March&nbsp;26, 2020). Under the Offering, a holder of a Debenture received 37,500 detachable share purchase warrants (the &#147;Warrants&#148;) for every $25,000 of Debentures subscribed for by the holder. The
Warrants are exercisable at $0.70 per share for a period of four years from the date of issue. The proceeds of the Offering were used to satisfy the closing cash payment to acquire IPA Europe and Immulease. In fiscal 2019, the Company settled
$1,377,000 of previously issued debentures by issuing 1,377,000 Units at a price of $1.00 per Unit. Each Unit consisted of one common share and one share purchase warrant, with each warrant entitling the holder to purchase an additional share at a
price of $1.25 for a period of two years from the date of issue. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Fiscal Year Ended 2019 </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Revenue Growth </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company achieved record annual revenue
of $10,926,268 in fiscal 2019 compared to $5,441,349 in fiscal 2018. This represents a 100% increase in revenue as a result of its completed acquisitions of IPA Europe and the Company&#146;s ability to grow its core business and expand into higher
revenue service offerings in therapeutic discovery. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Asset Building and New Service Offerings </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While CRO services remain the mainstay of the Company, the Company has worked continuously on building an intellectual property estate and portfolio of
proprietary methods and physical assets through collaborations, joint ventures, acquisitions and <FONT STYLE="white-space:nowrap">in-licensing.</FONT> The onboarding of existing assets with regard to equipment, technologies, IP and licenses within
the Company&#146;s European operations has been compounded by active research and development at all operational sites this year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company also added
the following key new service offerings in fiscal 2019: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Phage-Display Antibody Platforms.</B> Allows the Company to generate monoclonal antibodies in a diverse range
of species against complex protein structures. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Genetic Immunization Platform</B>. The Company&#146;s advanced genetic immunization strategies are applicable
in multiple species, including transgenics, and across all discovery platforms. Through the Company&#146;s <FONT STYLE="white-space:nowrap">in-house</FONT> developed vectors, its protocol produces native protein with appropriate post-transcriptional
modifications <I>in vivo</I>. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP>. </B>DeepDisplay is a service offering in
therapeutic discovery to select rare, fully human antibodies. The combination of transgenic animal immunization with phage display antibody selection delivers the most therapeutically relevant antibodies in a shorter time period with the highest
probability of success compared to conventional technologies. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Talem Therapeutics </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company formed Talem Therapeutics, LLC (&#147;Talem&#148;), based in Cambridge, Massachusetts, to create, advance and partner therapeutic antibodies,
discovery programs. Talem is structured to secure assets during their discovery and development stage and seek out strategic partnerships with pharmaceutical and biotech companies, where it will aid in the
<FONT STYLE="white-space:nowrap">out-licensing</FONT> or sale of the therapeutics. The ability for investors to support individual assets or portfolios in Talem generates an asymmetrical opportunity for investments, while avoiding the Company
shareholders dilution. The depth and speed of the Company&#146;s offerings enables Talem to customize each program and leverages the Company&#146;s expertise and technologies in antibody discovery. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>New Headquarters and Species Agnostic B Cell Offerings </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In May 2018, the Company opened its U.S. headquarters in Fargo, North Dakota. The opening of a U.S. headquarters in Fargo, North Dakota allows the Company to
take advantage of a U.S. location that has a significant and diverse economy with a strong history of supporting global life science companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In July
2018, the Company launched its European B cell expansion at IPA Europe. Similar to the Company&#146;s existing B cell facility in Victoria, British Columbia, a European B cell service allows the Company to accelerate international growth and meet
the international demand of its CRO services. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Key Additions to the Management Team </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In February 2019, the Company appointed Lisa Helbling as Chief Financial Officer. Ms.&nbsp;Helbing has brought over 30 years of experience in accounting,
financing, and business development within the public markets and has a demonstrated ability to manage financial and operational challenges while governing a dynamic and growing business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Private Placement Financings </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&nbsp;18, 2018, the Company completed a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement financing of 875,000 units at a price of
$0.80 per unit for gross proceeds of $700,000. Each unit consisted of one share and one share purchase warrant, with each warrant exercisable at $1.00 per share for a period of one year from the date of issue. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&nbsp;27, 2018, the Company completed a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement financing by issuing a total of
9,102,500 units (&#147;Units&#148;) of the Company at a price of $1.00 per Unit for gross proceeds of $9,102,500. Each Unit sold in the financing consisted of one common share and one share purchase warrant, with each warrant entitling the holder to
purchase an additional share at a price of $1.25 for a period of two years from the date of issue. The Company will have the right to accelerate the expiry date of the warrants provided that the Company&#146;s volume weighted average price trades at
a price equal to or greater than $1.75 for a period of 20 consecutive days. In the event of acceleration, the expiry date will be accelerated to a date that is 30 days after the Company issues a news release announcing that it has elected to
exercise this acceleration right. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Subsequent to Fiscal Year Ended 2019 </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Revenue Growth </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the six months ended
October&nbsp;31, 2019 the Company achieved revenues of $5,878,464, compared to revenues of $5,589,576 in the 2018 fiscal period. The increase in revenue was due to an increase in number of large pharma customers requiring more comprehensive
therapeutic discovery and development outsourcing.&nbsp;&nbsp;&nbsp;&nbsp; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>New Service Offerings </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subsequent to the fiscal year ended April&nbsp;30, 2019, the Company has continued to focus advanced service offerings for therapeutic discovery as set out
below: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Abthena</B><B><SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP></B><B> bispecific antibody platform.
</B>Abthena bispecifics have the ability to bind two different molecules with a single antibody, increasing the therapeutic effectiveness of targeting infectious diseases, payload delivery and functional activity toward challenging targets.<B> </B>
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Integrating <FONT STYLE="white-space:nowrap">SGI-DNA&#146;s</FONT> benchtop automated DNA printer. </B>The
Company has integrated <FONT STYLE="white-space:nowrap">SGI-DNA&#146;s</FONT> benchtop automated DNA printer, BioXp 3200, to accelerate antibody discovery and manufacturing services at its European facilities.<B> </B> </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Key Additions to the Board and Management Team </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
October 2019, the Company appointed Dr.&nbsp;Stefan Lang as Chief Business Officer. In this newly created role, Dr.&nbsp;Lang, who has more than 20 years of experience as a senior executive in the biotechnology industry, will be responsible for
corporate and business development initiatives, as well as corporate and product strategic planning. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Also in October 2019, the Company appointed Brian
Lundstrom as a member of the Board of Directors. Mr.&nbsp;Lundstrom has over 30 years&#146; protein and antibody therapeutic business experience and was appointed </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to work actively with management to further strengthen the Company&#146;s strategic and commercial growthcommitment to industry-leading therapeutic antibody discovery for both its clients and the
company&#146;s emerging internal pipeline.<B> </B> </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BUSINESS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has emerged as a recognized,
full-service, biologics contract research organisation (&#147;CRO&#148;) with global operations. A CRO is a company that provides support to the pharmaceutical, biotechnology and medical device industries in the form of research services outsourced
to them on a contract basis. The Company is innovation-driven and is strategically positioned - both geographically and scientifically - to provide highly customized, human, therapeutic antibodies. The Company offers a cohesive and extensive
portfolio in the protein and antibody research, manufacturing and validation continuum. The Company&#146;s full-service package allows it to assist clients from the moment they identify a therapeutic target to the time they are preparing to apply
for investigational review of the clinical product. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Products and Services </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>CRO Services </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s CRO services include, but
are not limited to, proprietary B cell sorting, screening and sequencing; custom, immune and na&iuml;ve phage display production and screening; expertise with transgenic animals and multi-species antibody discovery;
<FONT STYLE="white-space:nowrap">bi-specific,</FONT> <FONT STYLE="white-space:nowrap">tri-specific,</FONT> VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing, purification in gram scale levels,
characterization and validation; antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening and clone-picking; cryopreservation; and
custom antigen modeling, design and manufacturing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moreover, in the past 18 months, the Company has gained increasing recognition as a rising leader in
the biologics, CRO space, with a focus on organic growth through market penetration and service diversification, as well as strategic expansion with platform and process integration. Furthermore, <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">end-to-end</FONT></FONT> services have been leveraged through acquisition, enabling a steady foundation for future growth. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA
Canada and IPA Europe have both been designated as approved CROs for the world&#146;s leading, transgenic animal platform producing human antibodies, and exercised an advantage in optimizing services for various transgenic animal vendors. The
Company made strategic investments in R&amp;D activities to develop proprietary technologies enabling the application of their B cell Select<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> and DeepDisplay<SUP
STYLE="font-size:85%; vertical-align:top">&#153;</SUP> platforms to address a range of transgenic animal species and strains.&nbsp;&nbsp;&nbsp;&nbsp; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s key CRO services are set forth in detail below: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="77%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Service</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Details</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>B cell Select<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP><SUP STYLE="font-size:85%; vertical-align:top"> </SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">In 2018, the Company built on its ten years of experience in single B cell interrogation to offer full-service B cell screening, sorting and sequencing in both North America and Europe on a species agnostic platform, including
transgenic, humanized animals. This service is offered against a broad range of therapeutically relevant protein families, including GPCRs and other challenging, multi-membrane spanning proteins. The Company&#146;s platforms enable antibody
screening directly from B cells, allowing for the analysis of a more diverse set of antibodies, and for faster, deeper screening compared to traditional technologies. The Company announced over a 90% success rate on its B cell technology, which is
now offered&nbsp;with&nbsp;a success guarantee.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Phage Display</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">The Company&#146;s phage display services are based on building custom immune libraries from multiple species, including transgenic animals, or the selection of antigen-specific recombinant antibody fragments from our proprietary
human or llama phage libraries. The proprietary libraries have been made from human patient and na&iuml;ve (scFv) repertoires, as well as from na&iuml;ve llama (VHH) repertoires. Custom immune libraries are prepared from blood, spleen, lymph nodes,
and bone marrow of immunized animals or humans and capture the entire immune repertoire for panning, rescue, and identification of unique antibodies with <FONT STYLE="white-space:nowrap">pre-specified</FONT> characteristics.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>DeepDisplay</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">A powerful new technology utilizing a combination of Ligand&#146;s OmniAb&reg; transgenic animal platform and ImmunoPrecise Antibodies&#146; custom phage display antibody selection.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Abthena<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> Bispecifics</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">The Company&#146;s proprietary bispecific Abthena<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> technology complements its diverse discovery process, integrating seamlessly with the Artemis<SUP
STYLE="font-size:85%; vertical-align:top">&#153;</SUP> Intelligence Metadata (AIM)<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> capabilities, to enable rapid turnaround on additional algorithmic outputs in therapeutic antibody
optimization, stability, affinity, and manufacturability.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>LucinaTech<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> Humanization</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">The Company provides a robust and efficient antibody humanization service, which consistently retains affinity and specificity levels. The approach is based on <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">state-of-the-art</FONT></FONT></FONT> in silico antibody modeling to identify essential framework and CDR residues for grafting onto a human antibody framework.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Affinity Maturation</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Antibody affinity is important in therapeutic and diagnostic applications. ImmunoPrecise&#146;s antibody affinity maturation service can improve antibody affinities by several fold. The Company applies different strategies to
increase the affinity of the antibody, including gene shuffling and random mutagenesis</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Immunization, hybridoma, sequencing</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">The Company offers cutting edge antibody development services including a variety of immunization methods: Rapid Prime immunization, DNA immunization (NonaVac<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP>),
cell-based immunization (ModiVacc<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP>), electro- fusion and hybridoma generation using semi-solid media and clone picking, as well as high throughput, multiplexed screening methods. With
ImmunoProtect<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP>, the DNA sequence of the antibody will be determined and can be used to express the antibody recombinantly.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>rPEx protein manufacturing</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">The Company provides fast and large-scale production of recombinant mammalian proteins and antibodies for research and preclinical applications. With over 90% success rate with difficult to express proteins and antibodies (e.g. <FONT
STYLE="white-space:nowrap">Fc-fusion</FONT> proteins, bispecific antibodies), the Company offers gram scale production with low endotoxin levels.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Cell line development</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Using its proprietary vectors, the Company offers stable cell line development services (non GMP) of target proteins or antibodies adapted to specific growth conditions and media.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In fiscal 2019, the Company&#146;s CRO services accounted for 95% (2018: 96%) of the revenue of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Therapeutic Discovery Program </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While CRO services are the mainstay of the Company, ImmunoPrecise has worked continuously on building an intellectual property estate and portfolio of
proprietary methods and physical assets through collaborations, joint ventures, acquisitions and <FONT STYLE="white-space:nowrap">in-licensing.</FONT> The Company has invested strategically invested in the development and licensing of antibody
discovery platforms and related intellectual property assets. The onboarding of existing assets with regard to equipment, technologies, IP and licenses within the Company&#146;s EU operations has been compounded by active research and development at
all operational sites this year, including the <FONT STYLE="white-space:nowrap">on-going</FONT> development of new service offerings to be rolled out in the fiscal year 2020, but more notably, internal discovery programs focused on novel,
therapeutic antibodies, primarily in the field of immuno-oncology. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company formed Talem Therapeutics (&#147;Talem&#148;), based in Cambridge,
Massachusetts, to support its internal and partnered therapeutic, discovery programs. Talem offers strategic partnerships with pharma and biotech companies and is the only company to offer these services as a partnership in OmniAb transgenic animals
using their own license. The ability for investors to support individual assets or portfolios generates an asymmetrical opportunity for investments, while avoiding ImmunoPrecise shareholder dilution. The depth and speed of IPA&#146;s offerings
enables Talem to customize each program and leverages the Company&#146;s expertise and technologies in the antibody discovery. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Production of Services
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s operations are carried out globally in three separate facilities: Victoria British, Columbia (IPA Canada) and Utrecht and Oss, the
Netherlands <FONT STYLE="white-space:nowrap">(U-Protein</FONT> Express and IPA Europe). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA Canada&#146;s new laboratory in Victoria is located at a
fully operational antibody production facility that effectively doubles its revenue generating capacity. To drive the execution of its strategic and growth initiatives, the Company continues to focus on the recruitment of scientific and technical
staff, development of new technical training programs and a commitment to integrate continuous improvement and quality management methodologies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">U-Protein</FONT> Express, situated in the Dutch biotechnology hub of Utrecht, The Netherlands, has been a staple in the recombinant protein community, operating for over 17 years, and specializing in the manufacture of
complex proteins and antibodies in a variety of formats, and from a range of mammalian cell types. Their streamlined and efficient operations have enabled them to successfully support over 6,000 different programs, with over a 90% success rate, for
pharmaceutical and biotechnology industries as well as leading, academic institutions. In a seamless coordination, their operations also support the downstream expression and purification of the antibodies originating from the B cell Select
programs, enabling validation of the platform&#146;s outputs and comprehensive deliverables for clients. The site also has a global, exclusive license from Stanford University for the marketing and sales of the novel protein, Wnt surrogate Fc, which
they <FONT STYLE="white-space:nowrap">co-developed.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA Europe&#146;s contribution in services and intellectual property to the Company after its
acquisition have been substantial. The integration of IPA Europe significantly expanded the Company&#146;s services portfolio including affinity maturation, humanization, functional assay design and development, na&iuml;ve and disease human scFv
libraries, na&iuml;ve llama scFv libraries, and proprietary methods of immunization against conformational targets (e.g. ModiVacc<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> mouse lymphoid tumor immunization and DNA immunization
technologies). Adding to their proprietary services, IPA Europe developed and <FONT STYLE="white-space:nowrap">rolled-out</FONT> the aforementioned DeepDisplay service for the discovery of fully human antibodies using transgenic animal immunization
and custom phage display. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Intellectual Property </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has initiated the protection of new innovation in its product pipeline and has trademarked its ImmunoProtect technology. Currently, the Company has
applied for one patent application and is in the process of applying for additional patent applications relating to its proprietary technology. Its intellectual property strategy has been to protect its intellectual property primarily through a
combination of trade secrets and copyright. See also &#147;Risk Factors&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company continues to develop new products such as synthetic estrogen
receptor modulator tracker; quantitative self, biomarkers and screening methodologies, production of specific antibodies; screening services and data mining methodologies which will provide expansion and new commercial opportunities for the Company.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Specialized Skill and Knowledge </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s
qualified staff of research and development scientists with experience in biotechnology and pharmaceutical sector, academic research and government. The Company brings 30 years of experience in the production of antibodies and has a strong
reputation for the delivery of a high standard of quality and professional antibody services and products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, the Company has an <FONT
STYLE="white-space:nowrap">in-house</FONT> research staff, including a number of research scientists with MSc and cadre technical staff, innovating proprietary Rapid Prime immunization, single step cloning using semi-solid media for HAT selection of
hybridomas, and B cell selection and screening. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Competitive Conditions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company competes primarily against other full-service CROs as well as services provided by <FONT STYLE="white-space:nowrap">in-house</FONT> research and
development, or R&amp;D, departments of biopharmaceutical companies. The Company&#146;s major CRO competitors include Abveris Inc., Aldevron LLC, Antibody Solutions, Genscript Biotech Corp, Lake Pharma Inc., and several specialty and regional CROs.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company generally competes on the basis of a number of factors, including experience within specific therapeutic areas, quality of staff and
services, reliability, range of provided services, ability to recruit principal investigators and patients into studies expeditiously, ability to organize and manage large-scale, global clinical trials, global presence with strategically located
facilities, speed to completion, price and overall value. The Company believes it competes effectively with its competitors across these factors, particularly due to its full-service operating model, its therapeutic expertise, its global platform
and its experienced and committed management team. However, some of the Company&#146;s competitors have greater financial resources and a wider range of service offerings over a greater geographic area than we do, which could put us at a competitive
disadvantage with respect to these competitors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Many competitors offer custom antibody production services in addition to large catalogues of antibodies
available for sale through their websites. Over the years a number of competitors have been acquired and merged into larger companies, particularly larger laboratory facilities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The R&amp;D Antibodies market is highly fragmented and served by numerous small suppliers of a similar size and scale to the Company, and no single company
appears to dominate the field. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Regulatory Environment </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The development, testing, manufacturing, labeling, storage and approval of antibody and therapeutic products are subject to regulation by various government
authorities in Canada and Europe. Companies in the pharmaceutical and biotechnology industries, such as the Company&#146;s clients, that carry out clinical trials are subject to stringent regulations. These regulations apply to the Company&#146;s
clients and are generally applicable to us when we are providing services to our clients. Consequently, the Company must comply with relevant laws and regulations in the conduct of its business. The Company is in compliance with all Canadian and
European regulations regarding the <FONT STYLE="white-space:nowrap">on-going</FONT> operation of its laboratory facilities and delivery of all its products and services. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Seasonality </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sales of the Company&#146;s products and
services are not subject to seasonality fluctuations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Changes to Contracts </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company uses a standard Master Services Agreement (&#147;MSA&#148;) with all customers for custom monoclonal and polyclonal antibodies and peptide
protection and does not anticipate any changes in its MSA. The Company has a standard form of contract for its other services and anticipates development of a standard license agreement to take advantage of new licensing opportunities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Foreign Operations </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company currently conducts
operations in Canada and Europe and distributes and offers its products and services globally. As such, it does not anticipate any risks associated with foreign operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Market for Products </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Market Segment and Geographic
Areas </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Therapeutic antibodies dominate markets worth was US$115&nbsp;billion in 2018. It is estimated that the human therapeutic antibody market will
grow to US$300&nbsp;billion in 2025. Growth drivers in the antibodies market are as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Increasing research and development expenditures in the life science sector and in therapeutics industry
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Emergence of innovative facilitating platforms </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Growing demand for revolutionary therapies for major diseases as populations age and life expectancies increase
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Growing emphasis on antibody development at CRO&#146;s </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Increasing applications in the environmental sectors </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Biopharmaceuticals is the fastest growing pharma sector. This market is mainly dominated by large pharmaceutical companies, like Abbvie, Novartis, Roche and
Johnson&nbsp;&amp; Johnson. The world&#146;s best-selling drug in 2018 was Humira (&#147;Adalimumab&#148;) by Abbvie, with global revenues of US$19.9&nbsp;billion. Companies are currently sponsoring clinical studies for more than 570 mAbs. Of these,
approximately 90% are early-stage studies designed to assess safety (Phase I) or safety and preliminary efficacy (Phase I/II or Phase II) in patient populations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Diagnostics market was estimated at about US$20&nbsp;billion in 2017. This market is driven by strong
growth in the immunoassay market and has a CAGR of 5.3%. The value of this market reached an estimated US$35&nbsp;billion in 2026. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In recent years, the
number of monoclonal antibody drugs approved for launch proliferated, with 79 approved and available on the market as December 2019. For 2022, it is expected that 9 of 15 best-selling drugs worldwide will be monoclonal antibody drugs, the fastest
growing and most important segment in global <FONT STYLE="white-space:nowrap">bio-pharmaceutical</FONT> market. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The R&amp;D market is highly fragmented
and served by numerous small suppliers. The global research-based protein- and antibody-related service and product market is expected to grow with a CAGR of 6.1% from 2018 to 2025 from an estimated US$2.5&nbsp;billion in 2016 to
US$3.1&nbsp;billion, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Previously, the Company has focused on the diversified and relatively small R&amp;D Antibody market delivering
products and services to academic, biotechnology and pharmaceutical customers located primarily in North America. With the acquisition of <FONT STYLE="white-space:nowrap">U-Protein</FONT> Express and Modiquest Research, the Company is expanding to
the therapeutic antibody market and delivering an expanded portfolio of products and services to customers in Europe and ROW. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Marketing Plan and
Strategies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Market Acceptance </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has a
long-standing acceptance of its customized antibodies and peptide production services in the market. The Company believes that the market acceptance of its products will continue as it organically grows its business, optimizes its laboratory, new
sales and marketing capacity and production process to support long-term growth. Further, the Company is one of the few approved CROs for multiple transgenic animal providers on the market, enabling the faster development of therapeutic antibodies.
Among 28 human antibodies approved by the FDA between 2002 and 2019, 19 were animal derived and only 9 generated by phage display. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Bankruptcy and
Similar Procedures </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company does not have any bankruptcy, receivership or similar proceedings or any voluntary bankruptcy, receivership or similar
proceedings within the three most recently completed financial years or completed during or proposed for the current financial year. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RISK FACTORS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are numerous and
varied risks, known and unknown, that may prevent the Company from achieving its goals. The risks described below are not the only ones the Company will face. If any of these risks actually occurs, the Company business, financial condition or
results of operations may be materially and adversely affected. In that case, the trading price of the Company&#146;s securities could decline and investors in such securities could lose all or part of their investment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Company Operates at a Net Loss </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although the Company
earns revenues and operates at a significant margin, the Company&#146;s operates, on a consolidated basis, at a net loss. The Company&#146;s business operations will be largely dependent upon its ability to increase sales in order to cover its
ongoing operating expenses. There is no assurance that the Company will increase its sales resulting in it to operate at a profit. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Speculative Nature of Investment Risk </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An investment in the Company&#146;s common shares carries a high degree of risk and should be considered as a speculative investment by purchasers. The Company
has limited cash reserves. The Company&#146;s revenue from operations may not mitigate the risks associated with the Company&#146;s planned activities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liquidity and Future Financing Risk </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although the Company
is a going concern, the Company does not have cash reserves for funding future growth and expansion and therefore may require additional financing in order to fund future growth in operations and expansion plans. The Company&#146;s ability to secure
any required financing to sustain its operations will depend in part upon prevailing capital market conditions, as well as the Company&#146;s business success. There can be no assurance that the company will be successful in its efforts to secure
any additional financing or additional financing on terms satisfactory to the Company&#146;s management. If additional financing is raised by issuing shares of the Company, control may change, and shareholders may suffer additional dilution. If
adequate funds are not available, or are not available on acceptable terms, the Company may be required to scale back its business plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Going-Concern
Risk </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The financial statements of the Company have been prepared on a going concern basis under which an entity is considered to be able to realize its
assets and satisfy its liabilities in the ordinary course of business. The Company&#146;s future operations are dependent upon the achievement of <FONT STYLE="white-space:nowrap">on-going</FONT> profitable operations. There can be no assurances that
the Company will be successful in continuing to achieve profitability. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Absence of Cash Dividends </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To date, the Company has not paid any cash dividends on its Common Shares and it does not anticipate the payment of any dividends on its Common Shares in the
foreseeable future. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Business Development and Marketing Strategy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s future growth and profitability will depend on the effectiveness and efficiency of its national and international business development and
marketing and sales strategy, including the Company&#146;s ability to (i)&nbsp;grow brand recognition for its services internationally; (ii)&nbsp;determine appropriate business development, marketing and sales strategies and (iii)&nbsp;maintain
acceptable operating margins on such costs. There can be no assurance that business development, marketing and sales costs will result in revenues for the Company&#146;s business in the future, or will generate awareness of the Company&#146;s
products and services. In addition, no assurance can be given that the Company will be able to manage the Company&#146;s business development, marketing and sales costs on a cost-effective basis. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Management of Growth </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company may be subject to
growth-related risks including pressure on its internal systems and controls. The Company ability to manage its growth effectively will require it to continue to implement and improve its operational and financial systems and to expand, train and
manage its employee base. The inability of the Company to deal with this growth could have a material adverse impact on its business, operations and prospects. The Company may experience growth in the number of its employees and the scope of its
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
operating and financial systems, resulting in increased responsibilities for the Company&#146;s personnel, the hiring of additional personnel and, in general, higher levels of operating expenses.
In order to manage its current operations and any future growth effectively, the Company will also need to continue to implement and improve its operational, financial and management information systems and to hire, train, motivate, manage and
retain its employees. There can be no assurance that the Company will be able to manage such growth effectively, that its management, personnel or systems will be adequate to support the Company&#146;s operations or that the Company will be able to
achieve the increased levels of revenue commensurate with the increased levels of operating expenses associated with this growth. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>May Lose One or More
of its Customers </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s customers may terminate their contracts with it upon 30 to 90 days&#146; notice for a number of reasons or, in
some cases, for no reason. Although the Company&#146;s customers are currently comprised of a number of pharma entities, the Company is making a strategic shift to increase the number of larger pharma and biotech customers, including the size of
each service contract. If any one of the Company&#146;s major customers cancels its contract with the Company, its revenue may decrease. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Failure to
Meet the Delivery and Performance Requirements set forth in Customer Contracts </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to maintain its current customer relationships and to meet the
performance and delivery requirements in its customer contracts, the Company must be able to provide products and services at appropriate levels and with acceptable quality and at an acceptable cost. The Company&#146;s ability to deliver the
products and provide the services it offers to its customers is limited by many factors, including the difficulty of the processes associated with its products and services, the lack of predictability in the scientific process and the shortage of
qualified scientific personnel. In particular, a large portion of the Company&#146;s revenue depends on producing biologics and the current rate at which the Company is producing them. Some of the Company&#146;s customers can influence when it will
deliver products and perform services under their contracts. If the Company is unable to meet its contractual commitments, it may delay or lose revenue, lose customers or fail to expand its existing relationships.<B> </B> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Custom Products </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is reliant on the
development, marketing and sale of its custom antibodies. If the Company does not achieve sufficient market acceptance of its products and services, it will be difficult for the Company to achieve consistent profitability. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Brand Awareness </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s expansion of its
products and services depends on increasing brand awareness with respect to its products and services. There is no assurance that the Company will be able to achieve brand awareness. In addition, the Company must successfully develop a larger market
for its services in order to increase the sales of its services. If the Company is not able to successfully develop a market for its services, then such failure will have a material adverse effect on the business, financial condition and operating
results of the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Competition </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although the
Company believes that there are only a limited number of full-service, biologics, CRO firms, the Company may face significant competition in selling its products and services. Competitors may have substantial marketing, financial, development and
personnel resources. To remain competitive, the Company believes that it must effectively and economically provide: (i)&nbsp;products and services that satisfy </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
customer demands, (ii)&nbsp;superior customer service, and (iii)&nbsp;high levels of quality and reliability. Increased competition may require the Company to reduce prices or increase spending
on sales and marketing and customer support, which may have a material adverse effect on its financial condition and results of operations. Any decrease in the quality of the Company&#146;s products or level of service to customers or any occurrence
of a price war among the Company&#146;s competitors and the Company may adversely affect the business and results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Key Personnel Risk
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s success will depend on its directors&#146; and officers&#146; ability to develop the Company&#146;s business and manage its
operations, and on the Company&#146;s ability to attract and retain the Chief Executive Officer, management team and other key technical, sales, public relations and marketing staff or consultants to operate and grow the business. The loss of any
key person or the inability to find and retain new key persons could have a material adverse effect on the Company&#146;s business. Competition for experienced scientists is intense. The Company competes with pharmaceutical and biotechnology
companies, including its customers and collaborators, medicinal chemistry outsourcing companies, contract research companies, and academic and research institutions to recruit scientists. The Company&#146;s inability to hire additional qualified
personnel may also require an increase in the workload for both existing and new personnel. The Company may not be successful in attracting new scientists or management or in retaining or motivating its existing personnel. The shortage of
experienced scientists, and other factors, may lead to increased recruiting, relocation and compensation costs for such scientists, which may exceed the Company&#146;s expectations. These increased costs may reduce the Company&#146;s profit margins
or make hiring new scientists impracticable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Patent Infringement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While the Company believes that its products and operations will not violate the intellectual property rights of third parties, other parties could bring legal
actions against the Company claiming damages and seeking to enjoin the marketing and sale of the Company&#146;s products for allegedly conflicting with patents held by them. Any such litigation could result in substantial cost to the Company and
diversion of effort by its management and technical personnel. If any such actions are successful, in addition to any potential liability for damages, the Company could be required to obtain a license in order to continue to market the affected
products. There can be no assurance that the Company would prevail in such action or that any license required under any such patent would be available on acceptable terms, if at all. Failure to obtain needed patents, licenses or proprietary
information held by others may have material adverse effect on the Company&#146;s business. In addition, if the Company were to become involved in such litigation, it could consume a substantial portion of the Company&#146;s time and resources. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Intellectual Property Protection </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s
success will depend on its ability to obtain, protect and enforce patents on their technology. Any patents that the Company&#146;s may own or license in the future may not afford meaningful protection for their technology and products. The
Company&#146;s efforts to enforce and maintain our intellectual property rights may not be successful and may result in substantial costs and diversion of management time. In addition, others may challenge patents the Company may obtain in the
future and, as a result, these patents could be narrowed, invalidated or rendered unenforceable or it may be forced to stop using the technology covered by these patents or to license the technology from third parties. In addition, current and
future patent applications on which the Company depend may not result in the issuance of patents. Even if the Company&#146;s rights are valid, enforceable and broad in scope, competitors may develop products based on similar technology that is not
covered by the Company&#146;s patents. Further, since there is a substantial backlog of patent applications at the various patent offices, the approval or rejection of the Company and its competitors&#146; patent applications may take several years.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to patent protection, the Company also relies on copyright and trademark protection, trade
secrets, <FONT STYLE="white-space:nowrap">know-how,</FONT> continuing technological innovation and licensing opportunities. In an effort to maintain the confidentiality and ownership of the Company&#146;s trade secrets and proprietary information,
the Company requires its employees, consultants and advisors to execute confidentiality and proprietary information agreements. However, these agreements may not provide the Company with adequate protection against improper use or disclosure of
confidential information and there may not be adequate remedies in the event of unauthorized use or disclosure. Furthermore, like many companies in the Company&#146;s industry, we may from time to time hire scientific personnel formerly employed by
other companies involved in one or more areas similar to the activities we conduct. In some situations, our confidentiality and proprietary information agreements may conflict with, or be subject to, the rights of third parties with whom our
employees, consultants or advisors have prior employment or consulting relationships. Although the Company&#146;s require its employees and consultants to maintain the confidentiality of all confidential information of previous employers, the
Company or these individuals may be subject to allegations of trade secret misappropriation or other similar claims as a result of their prior affiliations. Finally, others may independently develop substantially equivalent proprietary information
and techniques, or otherwise gain access to its trade secrets. The Company&#146;s failure to protect its proprietary information and techniques may inhibit or limit its ability to exclude certain competitors from the market and execute its business
strategies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Patent and Other Intellectual Property Litigation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The drug research and development industry has a history of patent and other intellectual property litigation and these lawsuits will likely continue. Because
the Company produces and provides many different products and services in this industry, it faces potential patent infringement suits by companies that control patents for similar products and services. In order to protect or enforce the
Company&#146;s intellectual property rights, it may have to initiate legal proceedings against third parties. In addition, others may sue the Company for infringing their intellectual property rights or the Company may initiate a lawsuit seeking a
declaration from a court that it does not infringe the proprietary rights of others. The patent positions of pharmaceutical, biotechnology and drug discovery companies are generally uncertain and involve complex legal and factual questions. No
consistent policy has emerged from the U.S. Patent and Trademark Office or the courts regarding the breadth of claims allowed or the degree of protection afforded under patents like those for which the Company has applied. Legal proceedings relating
to intellectual property would be expensive, take significant time and divert management&#146;s attention from other business concerns, whether the Company wins or loses. The cost of such litigation could affect the Company&#146;s profitability.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, if the Company does not prevail in an infringement lawsuit brought against it, the Company might have to pay substantial damages, including
treble damages, and it could be required to stop the infringing activity or obtain a license to use the patented technology. Any required license may not be available to the Company on acceptable terms, or at all. In addition, some licenses may be
nonexclusive, and therefore, the Company&#146;s competitors may have access to the same technology licensed to the Company. If the Company fails to obtain a required license or are unable to design around a patent, it may be unable to sell some of
its products or services. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Obsolescence </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
pharmaceutical and biotechnology industries are characterized by rapid and continuous technological innovation. The Company competes with companies around the world that are engaged in the development and production of products and services,
including pharmaceutical companies, biotechnology companies, and contract research companies. Academic institutions, governmental agencies and other research organizations also are conducting research and developing technologies in areas in which
the Company </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
provides services, either on their own or through collaborative efforts. The Company&#146;s pharmaceutical and biotechnology company customers have internal departments that provide products and
services that directly compete with the Company&#146;s products and services. Many of the Company&#146;s competitors offer a broader range of products and services and have greater access to financial, technical, scientific, business development,
recruiting and other resources than the Company does, and some of their competitors may also operate with a lower cost structure. The Company anticipates that it will face increased competition in the future as new companies enter the market and
advanced technologies become available. The Company&#146;s products, services and expertise may become obsolete or uneconomical due to technological advances or entirely different approaches developed by the Company, its customers or one or more of
its competitors. For example, advances in databases and molecular modeling tools that predict how effectively compounds will treat a targeted disease may render some of their technologies obsolete. While the Company plans to develop technologies
that will give them a competitive advantage, they may not be able to develop the technologies necessary for them to successfully compete in the future. Additionally, the existing approaches of the Company&#146;s competitors or new approaches or
technologies developed by their competitors may be more effective than those they develop. The Company may not be able to compete successfully with existing or future competitors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Research and Development and Product Development </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company is a life science company providing custom antibody engineering and production services for a wide variety of environmental, diagnostic and research applications and to support their research and development efforts for research and <FONT
STYLE="white-space:nowrap">pre-clinical</FONT> applications. The Company is engaged development of new process, procedures and innovative approaches to antibody production. The Company has been engaged in such research and development activities for
over 30 years. However, there is an <FONT STYLE="white-space:nowrap">on-going</FONT> expense associated with research and development activities and no assurance that such research and product development activities will produce new and innovative
processes, procedures or innovative approaches to antibody production. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Customers May Restrict the Company&#146;s Use of Scientific Information
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s ability to improve the efficiency of the CRO services it provides by, among other things, developing an effective database designed
to predict how chemical compounds interact with a targeted disease-related protein, depends in part on the Company&#146;s generation and use of information that is not proprietary to their customers and that they derive from performing these
services. However, the Company&#146;s customers may not allow them to use this information with other customers, such as the general interaction between types of chemistries and types of drug targets that the Company generates when performing drug
discovery services for their customers. Without the ability to use this information, the Company may not be able to develop a database, which may limit their ability to improve the efficiency of the drug discovery services they provide. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Failure of Laboratory Facilities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s
operations could suffer as a result of a failure of its laboratory facilities. The Company&#146;s business will be dependent upon a laboratory infrastructure to produce products and services. These systems and operations are vulnerable to damage and
interruption from fires, earthquakes, telecommunications failures, and other events. Any such errors or inadequacies in the software that may be encountered could adversely affect operations, and such errors may be expensive or difficult to correct
in a timely manner. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The production of antibodies requires state of the art laboratory facilities and the success of these laboratory services depends on
the recruitment and retention of highly qualified technical staff to maintain the level and quality of standard of the Company&#146;s products and services expected from customers. There is no assurance that the Company will be able to expand and
operate such state of the art laboratory services and recruit and retain qualified staff. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company produces and supplies antibodies and there is no guarantee that such production will be
successful and produce the desired results. As a result, the Company continues to be exposed to potential liability that may exceed any insurance coverage that the Company may obtain in the future. As a result, the Company may incur significant
liability exposure, which may exceed any insurance coverage that the Company may obtain in the future. Even if the Company elects to purchase such insurance in the future, the Company may not be able to maintain adequate levels of insurance at
reasonable cost and/or reasonable terms. Excessive insurance costs or uninsured claims may increase the Company&#146;s operating loss and affect its financial condition. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limited Number of Suppliers </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company currently
purchases certain key components of biological and chemical materials that it uses in its products and services from a limited number of outside sources. The Company&#146;s reliance on its suppliers exposes it to risks, including: (i)&nbsp;the
possibility that one or more of its suppliers could terminate their services at any time without penalty; (ii)&nbsp;the potential inability of its suppliers to obtain required materials; (iii)&nbsp;the potential delays and expenses of seeking
alternative sources of supply; and (iv)&nbsp;reduced control over pricing, quality and timely delivery due to the difficulties in switching to alternative suppliers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Consequently, if materials from the Company&#146;s suppliers are delayed or interrupted for any reason, the Company may not be able to deliver their products
and perform their services on a timely basis or in a cost-efficient manner. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Change in Law, Regulations and Guidelines </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s businesses are subject to particular laws, regulations, and guidelines. Although the Company intends to comply with all laws and
regulations, there is no guarantee that the governing laws and regulations will not change which will be outside of the Company&#146;s control. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Uninsured or Uninsurable Risk </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company may become
subject to liability for risks against which it cannot insure or against which the Company may elect not to insure due to the high cost of insurance premiums or other factors. The payment of any such liabilities would reduce the funds available for
the Company&#146;s usual business activities. Payment of liabilities for which the Company does not carry insurance may have a material adverse effect on the Company&#146;s financial position and operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Conflicts of Interest Risk </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain of the Company&#146;s
directors and officers are also involved as advisors for other companies. Situations may arise in connection with potential acquisitions or opportunities where the other interests of these directors and officers conflict with or diverge from the
Company&#146;s interests. In accordance with the British Columbia <I>Business Corporations Act </I>(&#147;BCBCA&#148;), directors who have a material interest in any person who is a party to a material contract or a proposed material contract are
required, subject to certain exceptions, to disclose that interest and generally abstain from voting on any resolution to approve the contract. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
addition, the directors and the officers are required to act honestly and in good faith with a view to our best interests. However, in conflict of interest situations, the Company&#146;s directors and officers may owe the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
same duty to another company and will need to balance their competing interests with their duties to the Company. Circumstances (including with respect to future corporate opportunities) may
arise that may be resolved in a manner that is unfavourable to the Company.<B> </B> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Market Risk for Securities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The market price for the Company&#146;s shares could be subject to wide fluctuations. Factors such as commodity prices, government regulation, interest rates,
share price movements of peer companies and competitors, as well as overall market movements, may have a significant impact on the market price of the Company&#146;s shares. The stock market has from time to time experienced extreme price and volume
fluctuations, which have often been unrelated to the operating performance of particular companies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Global Economic Conditions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Current global economic conditions could have a negative effect on the Company&#146;s business and results of operations. Market disruptions have included
extreme volatility in securities prices, as well as severely diminished liquidity and credit availability. The economic crisis may adversely affect the Company in a variety of ways. Access to lines of credit or the capital markets may be severely
restricted, which may preclude the Company from raising funds required for operations and to fund continued development. It may be more difficult for the Company to complete strategic transactions with third parties. The financial and credit market
turmoil could also negatively impact suppliers, customers and banks with whom the Company does business. Such developments could decrease the Company&#146;s ability to source, produce and distribute its products or obtain financing and could expose
it to risk that one of its suppliers, customers or banks will be unable to meet their obligations under agreements with them. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Foreign Exchange Rates
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company may conduct business with customers, distributors, suppliers, or other service providers in currencies other than Canadian Dollars and
Euros. Therefore, the Company&#146;s business could be adversely affected by fluctuations in domestic or foreign currencies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Smaller Companies
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Market perception of smaller companies may change, potentially affecting the value of investors&#146; holdings and the ability of the Company to raise
further funds through the issue of further Common Shares or otherwise. The share price of publicly traded smaller companies can be highly volatile. The value of the Common Shares may go down as well as up and, in particular, the share price may be
subject to sudden and large falls in value given the restricted marketability of the Common Shares, results of operations, changes in earnings estimates or changes in general market, economic and political conditions. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DIVIDENDS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has not paid any
dividends. The Company intends to retain its earnings, if any, to finance the future growth and development of its business and does not expect to pay dividends or to make any other distributions in the foreseeable future. Payment of dividends in
the future is dependent upon the earnings and financial condition of the Company and other factors which the Board may deem appropriate at the time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are no restrictions in the constating documents of the Company, and it is not currently expected that there will exist such restriction elsewhere, which
could prevent the Company from paying dividends. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DESCRIPTION OF CAPITAL STRUCTURE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Shares </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s authorized share
capital consists of an unlimited number of Common Shares. As at the date of this Annual Information Form, 67,994,445 Common Shares are issued and outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Registered holders of Common Shares are entitled to receive notice of and attend all meetings of shareholders of the Company, and are entitled to one vote for
each Common Share held at a meeting of shareholders other than meetings at which only the holders of any other class or series of shares of the Company may be issued or outstanding from time to time or are entitled to vote as a separate class or
series. In addition, holders of Common Shares are entitled to receive on a <I>pro rata</I> basis dividends if, as and when declared by the board of directors and, upon liquidation, dissolution or <FONT STYLE="white-space:nowrap">winding-up</FONT> of
the Company, are entitled to receive on a <I>pro rata</I> basis the net assets of the Company after payment of debts and other liabilities, in each case subject to the rights, privileges, restrictions and conditions attaching to any other series or
class of shares, including preferred shares, ranking in priority to, or equal with, the holders of the Common Shares. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MARKET FOR
SECURITIES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Trading Price and Volume </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Common
Shares of the Company are listed for trading on the TSXV under the symbol &#147;IPA&#148;. The following table sets out the market price range and trading volumes of the Common Shares on the TSXV for the periods indicated. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="69%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>TSXV&nbsp;Price&nbsp;Range&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Month&nbsp;and&nbsp;Year</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>High<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Low<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Volume<BR>(number&nbsp;of&nbsp;shares)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">May 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.130</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.830</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,840,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.320</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,820,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.210</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,050,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">August 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.130</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.950</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,520,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.910</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.970</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.720</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,660,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.910</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.690</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,980,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.650</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,020,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.710</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.690</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">671,030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.830</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,430,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.840</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.680</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,930,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.850</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.660</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,310,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">May 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.670</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,360,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.670</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,010,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.720</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.530</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,020,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">August 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.670</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.550</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,070,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.630</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.470</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,410,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.620</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,870,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.650</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.520</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.650</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,030,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.670</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.510</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,096,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Prior Sales </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since May&nbsp;1, 2018, the Company issued the following securities. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="25%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="24%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Date&nbsp;Issued</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Security</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Issue&nbsp;Price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Aggregate&nbsp;Issue<BR>Price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Consideration</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Received</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;18, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Common Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">875,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">0.80</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$</TD>
<TD VALIGN="top" ALIGN="right">700,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Cash</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;23, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Common Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">9,102,500</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$</TD>
<TD VALIGN="top" ALIGN="right">&nbsp;1.00</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$</TD>
<TD VALIGN="top" ALIGN="right">9,102,500</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Cash</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October&nbsp;25, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Common Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,377,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$</TD>
<TD VALIGN="top" ALIGN="right"> 1.00</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$</TD>
<TD VALIGN="top" ALIGN="right">1,377,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Debenture Conversion</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December&nbsp;13, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Common Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">78,514</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$</TD>
<TD VALIGN="top" ALIGN="right"> 0.78</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$</TD>
<TD VALIGN="top" ALIGN="right">55,673.90</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Settlement Agreement</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March&nbsp;27, 2019<SUP STYLE="font-size:85%; vertical-align:top">(2) </SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Common Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">714,793</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$</TD>
<TD VALIGN="top" ALIGN="right"> 0.71</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="top" ALIGN="right">507,503<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">(Deemed</P></TD>
<TD NOWRAP VALIGN="top">&nbsp;<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">)&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Deferred Payment for IPA Europe</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Notes</U>: </P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On October&nbsp;25, 2018, 1,377,000 common shares were issued in exchange for debentures converted.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On March&nbsp;17, 2019, 714,793 common shares were issued pursuant to a deferred payment to IPA Europe.
</P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ESCROWED SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No securities of the Company are currently held in escrow or are subject to contractual restrictions on transfer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DIRECTORS AND EXECUTIVE OFFICERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Directors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The directors of the Company are set forth
below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="24%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Name&nbsp;and</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Municipality</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>of&nbsp;Residence</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Principal</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Occupation&nbsp;During</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Past&nbsp;Five&nbsp;Years</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Director&nbsp;Since</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number&nbsp;of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Voting</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Securities<SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent&nbsp;of&nbsp;Voting<BR>Securities<SUP STYLE="font-size:85%; vertical-align:top">(1) </SUP></B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Jennifer Bath</B><SUP STYLE="font-size:85%; vertical-align:top">(3)(4)</SUP></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">North Dakota, USA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">CEO, President of the Company since February 2018; Global Director of Aldevron, LLC from July 2015 to February 2018; Associate Professor at Concordia College from May 2005 to August 2015</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">May 2018</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">41,669 (Direct)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">*</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>James Kuo</B><SUP STYLE="font-size:85%; vertical-align:top">(2)(4)</SUP></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">California, USA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Managing Director at Athena Bioventures, Chairman of the Company since December 2016.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">December&nbsp;2016</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Nil</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Nil</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Robert</B> <B>Beecroft</B><SUP STYLE="font-size:85%; vertical-align:top">(2)(5)</SUP></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">British Columbia, Canada</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Retired; President and CEO of the Company from May&nbsp;9, 1995 to August 13, 2016</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">December 2016</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">4,330,433<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP> (Direct&nbsp;and&nbsp;Indirect)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">6.37%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Greg Smith</B><SUP STYLE="font-size:85%; vertical-align:top">(2)(3)(4)</SUP></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">British Columbia, Canada</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">President&nbsp;&amp; Owner of Broadway Refrigeration; Chairman of Lite Access Technologies (TSXV:LTE); Director of Atlas Engineered Products Inc. (TSXV: AEP)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">September&nbsp;2016</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">55,000 (Direct&nbsp;and&nbsp;Indirect)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">*</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Robert Burke</B><SUP STYLE="font-size:85%; vertical-align:top">(4)(5)</SUP></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">British Columbia, Canada</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Professor at the University of Victoria.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">December 2017</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">83,000<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP> (Direct&nbsp;and Indirect)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">*</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Paul Andreola</B><SUP STYLE="font-size:85%; vertical-align:top"> (3)(4)</SUP></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Vancouver, Canada</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">CEO and Director of NameSilo Technologies Corp. (TSXV: URL); Director of Ironwood Capital Corp. (TSXV: IRN.P)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">November 2018</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">5,413,400<SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP> (Direct&nbsp;and Indirect)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">7.96%</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Brian</B> <B>Lundstrom</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Nevada,
USA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">CBO and VP of Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">October 2019</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Nil</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Nil</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Notes</U>: </P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Denotes less than 1% of the issued and outstanding Common Shares.<B> </B> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The information as to the nature of Common Shares beneficially owned, or controlled or directed, directly or
indirectly, by the directors, not being within the knowledge of the Company, has been furnished by such directors. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the Audit Committee. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the Compensation Committee. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the Finance Committee. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the Nomination Committee. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Of the 4,330,433 shares, 4,001,113 shares are held by Mr.&nbsp;Beecroft and 329,320 are held by a trust for
which Mr.&nbsp;Beecroft is a trustee. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Of the 55,000 shares, 50,000 shares are held by Mr. Smith and 5,000 shares are held by the spouse of Mr. Smith.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Of the 83,000 shares, 40,000 shares are held by Mr. Burke and 43,000 shares are held by the spouse of Mr.
Burke. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Of the 2,678,400 shares, 1,694,800 shares are held by Mr.&nbsp;Andreola, 1,159,600 shares are held by the
spouse of Mr.&nbsp;Andreola and 2,550,000 shares are held by NameSilo Technologies Corp., a company controlled by Mr. Andreola. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Officers </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The executive officers of the Company are set forth below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="24%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Name&nbsp;and</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Municipality</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>of&nbsp;Residence</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Principal</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Occupation&nbsp;During</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Past&nbsp;Five&nbsp;Years</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Officer&nbsp;Since</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number&nbsp;of<BR>Voting<BR>Securities<SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent&nbsp;of&nbsp;Voting<BR>Securities</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Jennifer Bath</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">North Dakota, USA</P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">As Above.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">February&nbsp;2018</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">As&nbsp;Above</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">As&nbsp;Above</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Lisa Helbling</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">North Dakota, USA</P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Financial Officer of the Company since January 2019; CFO of Anchor Ingredients from January to August 2018; and CFO and Treasurer of TMI Hospitality from December 2011 to December 2017</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">January 2019</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">10,000 (Direct)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">*</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stefan Lang</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Freiburg, Germany</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Business Officer of the Company since October 2019; Vice President of Business Development of Aldevron LLC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">October 2019</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">7,000 (Direct)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">*</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Charles</B> <B>Wheelock</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">North Dakota,
USA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Technology Officer of the Company since April 2018; Vice President of Implementation Specialist from 2016 to 2017; Vice President of Summit Group Software from 2015 to 2016; Senior Global Technical Account Manager of Microsoft
from 2002 to 2015</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">April 2018</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">5,000 (Direct)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">*</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Note</U>:<B> </B> </P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Denotes less than 1% of the issued and outstanding Common Shares. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The information as to the nature of Common Shares beneficially owned, or controlled or directed, directly or
indirectly, by the executive officers, not being within the knowledge of the Company, has been furnished by such officers. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Shareholdings of Directors and Executive Officers </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As at
the date of this Annual Information Form, the directors and executive officers of the Company, as a group, beneficially owned, or controlled or directed, directly or indirectly, 9,945,502 Common Shares, representing approximately 14.6% of the issued
and outstanding Common Shares of the Company.&nbsp;&nbsp;&nbsp;&nbsp; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Biographical Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a brief description of each of the executive officers and directors of the Company (including details with regard to their principal
occupations for the last five years).<I> </I> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Jennifer Bath, Chief Executive Officer, President and Director </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Jennifer Bath has twenty years&#146; experience in biopharma industry, previously serving on the executive team at Aldevron, LLC. Prior, she was the
executive director of the Global Vaccine Institute and has served as an international advisor with an experienced and proven leader in strategic planning and corporate growth as well as converting pharma companies&#146; scientific challenges into
operational solutions. Dr.&nbsp;Bath specializes in strategic growth, business operations alignment, and value creation. She holds a Ph.D. in Cellular and Molecular biology from North Dakota State University. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>James Kuo, Chairman and Director </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;James Kuo, MD,
MBA currently serves as Chief Executive Officer of OncoTracker, Inc. in West Hollywood, CA. James Kuo is an experienced biotech industry executive and investor, who brings business and management experience to the company. During his career, he has
held executive positions in private as well as listed biotech companies in the US. He previously served as CEO of BioMicro Systems, Inc. and Synthetic Biologics, Inc. Prior to that, he was CEO of Discovery Laboratories, Inc. after having worked as
Associate Director in Corporate Licensing and Development at Pfizer Inc. Dr.&nbsp;Kuo is presently Managing Director at Athena Bioventures in La Jolla, CA.A physician by training, James Kuo obtained his MBA at the Wharton School of the University of
Pennsylvania. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Robert Beecroft, Director </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Robert
Beecroft is a director of the Company. has served as founder, CTO and director of the Company since 1999 and has over 25 year&#146;s experience in the development of innovative and proprietary methods for the production of monoclonal and polyclonal
antibodies and peptides. Mr.&nbsp;Beecroft has a B.Sc. in Microbiology from University of Victoria and has been involved in over 15 Research Projects over the course of the last 25 years and been an instructor for graduate students at the University
of Victoria on the use and production of monoclonal antibodies for over 13 years. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Greg Smith, Director </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.<B></B>&nbsp;Greg Smith is a seasoned capital markets veteran who held senior positions in investment banking before recently transitioning to private
equity with the acquisition of one of the largest HVAC companies in Western Canada. Mr.&nbsp;Smith also held the position of Portfolio Manager for Phillips, Hagar&nbsp;&amp; North&nbsp;&amp; Executive Director, Canadian Securitization Group, CIBC
World Markets in Toronto for close to ten years. Mr.&nbsp;Smith currently serves as President&nbsp;&amp; Director of Broadway Refrigeration&nbsp;&amp; Air Conditioning Co. Ltd. and Omega Mechanical Ltd., who collectively have over 150 employees.
Mr.&nbsp;Smith earned an MBA from Dalhousie University, is a Chartered Financial Analyst and has served in advisory and board positions to multiple private and public ventures. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Robert Burke, Director </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Robert&nbsp;D. Burke is
an Emeritus Professor at the University of Victoria, where he was a faculty member for over 35 years. He has a longstanding research interest in the molecular basis of cellular signaling in early embryonic development. His research involves
production and characterization of antibodies and he employs them extensively with high-resolution optical imaging methods. Dr.&nbsp;Burke has published over 100 peer-reviewed publications and has supervised numerous trainees. He was Chair of the
Department of Biochemistry and Microbiology for 8 years, was on the University of Victoria Senate for 12 years, and served on numerous advisory and management committees nationally and internationally. Dr.&nbsp;Burke completed a BSc (Honours) and a
PhD at the University of Alberta. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Paul Andreola, Director </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Andreola has over 20 years of business development and financial markets experience including senior management, marketing, and communications roles
for early stage companies. Mr.&nbsp;Andreola is the President, Chief Executive Officer and Director of NameSilo Technologies Corp. Previously in his career, Mr.&nbsp;Andreola was a licensed investment advisor for over 10 years and has facilitated
multiple early stage private and public companies in the resource and technology sectors. Mr.&nbsp;Andreola has served on the board of, and in advisory positions to, several public and private companies </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Brian Lundstrom, Director </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Lundstrom is trained
in immunology and international business and has over 30 years&#146; experience. Mr. Lundstrom started his career with product and clinical development for Novo Nordisk and subsequently held increasingly executive roles, including with SangStat, now
a division of Sanofi Genzyme. During the past eight years, Mr.&nbsp;Lundstrom established the global business for the industry&#146;s most diverse and partnered transgenic animal platforms for antibody discovery, which was sold to Ligand
Pharmaceuticals Incorporated in 2016. Mr.&nbsp;Lundstrom is presently an executive with Ligand and CEO of Abvivo LLC. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Lisa Helbling, Chief Financial
Officer </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ms.&nbsp;Lisa Helbling has over 30 years experience in finance and accounting gained from diverse industries and roles. For the past 8 years,
she served in the role of CFO, most recently for the Company. Prior to being a CFO, she was the VP of Internal Audit and Business Risk Management for Otter Tail Corporation (NASDQ: OTTR) a diversified electric utility and Controller for Clarica Life
iInsurance <FONT STYLE="white-space:nowrap">Company-U.S.,</FONT> a subsidiary of a Clarica Life Insurance Co., then listed on the Toronto Stock Exchange. She began her career in public accounting. As the Company&#146;s CFO Ms.&nbsp;Helbling provides
strategic vision and leadership to create and execute finance strategy to support the Company&#146;s global sites, management of debt and equity, financial planning, budgeting and cash management. Ms.&nbsp;Helbling also develops and oversees the
accounting, financial reporting, financial internal controls, risk management and compliance activities. Ms Helbling currently serves on the Board of Directors for Healthy Dakota Mutual Holdings and is Chair of the Audit and Compliance Committee.
She is a Certified Public Accountant and has a Bachelor of Science in Accounting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Stefan Lang, Chief Business Officer </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Lang previously served as the Vice President of Business Development at Aldevron LLC. Dr.&nbsp;Lang brings extensive background knowledge in the
therapeutic antibody sector including corporate strategy, R&amp;D innovation, sales and business development. He has an impressive breadth of leadership within the biotech industry, including experience working at the organizational level and as a
globally recognized and respected leader in antibody business development. Dr.&nbsp;Lang holds a Dr.&nbsp;rer. nat. in biology from the Technical University of Karlsruhe, Germany a diploma in biology from the University of Kassel, Germany. He
started his career as a technical consultant and moved into the biotech industry in 2000. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Charles Wheelock, Chief Technology Officer </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Wheelock brings a diverse background to IPA, he has held leadership positions within the software development and services industries over the past 25
years encompassing global ERP deployments, cloud transformations and building strategic line of business applications. Mr.&nbsp;Wheelock has served as a Vice </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
President at Implementation Specialists and Summit Group Software, leading software services, development, and sales. Prior to Implementation Specialists Mr.&nbsp;Wheelock spent 16 years at
Microsoft in various roles, where he drove both strategic and technical initiatives from within the customer services organization. Mr.&nbsp;Wheelock holds a Bachelor&#146;s degree from the University of Kansas along with several industry and
project management certifications. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cease Trade Orders or Bankruptcies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the knowledge of the Company: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">no director or executive officer of the Company is, as at the date of this Annual Information Form, or was
within 10 years before the date of this Annual Information Form, a director, chief executive officer or chief financial officer of any company (including IPA), that: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">was subject to an order that was issued while the director or executive officer was acting in the capacity as
director, chief executive officer or chief financial officer; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">was subject to an order that was issued after the director or executive officer ceased to be a director, chief
executive officer or chief financial officer and which resulted from an event that occurred while that person was acting in the capacity as director, chief executive officer or chief financial officer. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the purposes of this subsection (a), &#147;order&#148; means a cease trade order, an order similar to a cease trade order or an order that
denied the relevant company access to any exemption under securities legislation, and in each case that was in effect for a period of more than 30 consecutive days. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">no director or executive officer of the Company, or a shareholder holding a sufficient number of securities of
the Company to affect materially control of the Company: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">is, as at the date of this Annual Information Form, or has been within the 10 years before the date of this
Annual Information Form, a director, chief executive officer or chief financial officer of any company (including IPA) that, while that person was acting in that capacity, or within a year of that person ceasing to act in that capacity, become
bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency or was subject to or instituted any proceedings, arrangement or compromise with creditors or had a receiver, receiver manager or trustee appointed to hold its
assets; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">has, within the 10 years before the date of this Annual Information Form, become bankrupt, made a proposal
under any legislation relating to bankruptcy or insolvency, or was subject to or instituted any proceedings, arrangement or compromise with creditors, or had a receiver, receiver manager or trustee appointed to hold the assets of the director,
executive officer or shareholder. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing information, not being within the knowledge of the Company, has been furnished by the
respective directors, officers and shareholders holding a sufficient number of securities of the Company to affect materially control of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Penalties or Sanctions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No director or executive officer of the Company, or a shareholder holding a sufficient number of securities of the Company to affect materially the control of
the Company, has been subject to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any penalties or sanctions imposed by a court relating to securities legislation or by a securities regulatory
authority or has entered into a settlement agreement with a securities regulatory authority; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any other penalties or sanctions imposed by a court or regulatory body that would likely be considered
important to a reasonable investor in making an investment decision regarding the Company. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing information, not being within
the knowledge of the Company, has been furnished by the respective directors, officers and shareholders holding a sufficient number of securities of the Company to affect materially control of the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Conflicts of Interest </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s directors and
officers may serve as directors or officers of other companies or have significant shareholdings in other resource companies and, to the extent that such other companies may participate in ventures in which the Company may participate, the directors
of the Company may have a conflict of interest in negotiating and concluding terms respecting the extent of such participation. In the event that such conflict of interest arises at a meeting of the Company&#146;s board of directors, a director who
has such a conflict will abstain from voting for or against the approval of such participation or such terms. In accordance with the BCBCA, the directors of the Company are required to act honestly, in good faith and in the best interests of the
Company. In determining whether or not the Company will participate in a particular program and the interest therein to be acquired by it, the directors will primarily consider the degree of risk to which the Company may be exposed and its financial
position at that time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The directors and officers of the Company are aware of the existence of laws governing the accountability of directors and
officers for corporate opportunity and requiring disclosures by the directors of conflicts of interest and the Company will rely upon such laws in respect of any directors&#146; and officers&#146; conflicts of interest or in respect of any breaches
of duty by any of its directors and officers. All such conflicts will be disclosed by such directors or officers in accordance with the BCBCA and they will govern themselves in respect thereof to the best of their ability in accordance with the
obligations imposed upon them by law. See &#147;<I>Risk Factors &#150; Conflicts of Interest</I>&#148;. The directors and officers of the Company are not aware of any such conflicts of interests. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>LEGAL PROCEEDINGS AND REGULATORY ACTIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is not aware of: (a)&nbsp;any legal proceedings to which it is a party, or by which any of its property is subject, which would be material to it
and are not aware of any such proceedings being contemplated, (b)&nbsp;any penalties or sanctions imposed by a court relating to securities legislation, or other penalties or sanctions imposed by a court or regulatory body against it that would
likely be considered important to a reasonable investor making an investment decision and (c)&nbsp;any settlement agreements that we have entered into before a court relating to securities legislation or with a securities regulatory authority. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INTEREST OF MANAGEMENT AND OTHERS IN MATERIAL TRANSACTIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No director, executive officer or shareholder holding on record or beneficially, directly or indirectly, more than 10% of the issued shares of the Company, or
any of their respective associates or affiliates has any material interest, direct or indirect, in any transaction in which the Company has participated prior to the date of this Annual Information Form, which has materially affected or is
reasonably expected to materially affect the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TRANSFER AGENT AND REGISTRAR </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transfer agent and registrar for the Common Shares is Computershare Investor Services Inc. at 3rd Floor, 510 Burrard Street, Vancouver, British Columbia.
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MATERIAL CONTRACTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except for
contracts entered into in the ordinary course of business, the only material contracts that the Company has entered in the financial year ended April&nbsp;30, 2019, or before the last financial year but still in effect, are as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Securities Purchase Agreement dated August&nbsp;22, 2017 among the Company,
<FONT STYLE="white-space:nowrap">U-Protein</FONT> and the shareholders of <FONT STYLE="white-space:nowrap">U-Protein.</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Share Purchase Agreement dated March&nbsp;15, 2018 among the Company, ImmunoPrecise Netherlands B.V., Modiquest
Research B.V., Immulease B.V. and Immusys B.V. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Copies of the above material contracts are available for inspection at the registered
office of the Company located at c/o Northwest Law Group, Suite 704, 595 Howe Street, Vancouver, BC V6C 2T5. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INTERESTS OF EXPERTS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Crowe MacKay LLP, Chartered Accountants, provided an auditor&#146;s report in respect to the Company&#146;s financial statements for the year ended
April&nbsp;30, 2019. Crowe MacKay LLP is independent with respect to the Company in accordance with the Rules of Professional Conduct of the Institute of Chartered Accountants of British Columbia. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADDITIONAL INFORMATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additional
financial information is provided in the Company&#146;s comparative financial statements and management&#146;s discussion and analysis for the year ended April&nbsp;30, 2019, which will be available under the Company&#146;s profile on the SEDAR
website at www.sedar.com. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Copies of all materials incorporated by reference herein and additional information relating to the Company are available under
the Company&#146;s profile on the SEDAR website at www.sedar.com. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated February&nbsp;14, 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BY ORDER OF THE BOARD OF DIRECTORS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>&#147;Jennifer
Bath&#148; </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jennifer Bath </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">President and Chief Executive
Officer </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.41
<SEQUENCE>42
<FILENAME>d20922dex9941.htm
<DESCRIPTION>EX-99.41
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.41</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.41 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">APPENDIX A - NOTICE DECLARING INTENTION TO BE QUALIFIED UNDER NATIONAL </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INSTRUMENT <FONT STYLE="white-space:nowrap">44-101</FONT> SHORT FORM PROSPECTUS DISTRIBUTIONS </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(&#147;NI <FONT STYLE="white-space:nowrap">44-101&#148;)</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">February&nbsp;19, 2020 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TO:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BRITISH COLUMBIA SECURITIES COMMISSION</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">AND&nbsp;TO:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ALBERTA SECURITIES COMMISSION</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Issuer&#148;) intends to be qualified to file a short form prospectus under NI <FONT
STYLE="white-space:nowrap">44-101.</FONT> The Issuer acknowledges that it must satisfy all applicable qualification criteria prior to filing a preliminary short form prospectus. This notice does not evidence the Issuer&#146;s intent to file a short
form prospectus, to enter into any particular financing or transaction or to become a reporting issuer in any jurisdiction. This notice will remain in effect until withdrawn by the Issuer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&#147;<I>Jennifer Bath</I>&#148;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jennifer Bath</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chief Executive Officer</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.42
<SEQUENCE>43
<FILENAME>d20922dex9942.htm
<DESCRIPTION>EX-99.42
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.42</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.42 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g72h92.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Launches Coronavirus Vaccine and Therapeutic Antibody Program </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, Feb. 20, 2020 /CNW/ - ImmunoPrecise Antibodies Ltd (the &#147;Company&#148;), a provider of <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">best-in-class</FONT></FONT> therapeutic antibody discovery capabilities for the global industry, announces its commitment to the development of innovative vaccines against the new coronavirus originating in Wuhan, China <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">(SARS-CoV-2)</FONT></FONT> as well as coronavirus-neutralizing antibodies, addressing both prophylactic and therapeutic measures to fight the virus and its associated disease, <FONT
STYLE="white-space:nowrap">COVID-19.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA&#146;s Rapid Research and Development (RR&amp;D) Team is leveraging its unique ability to address global,
pandemic crises in an abbreviated timeframe. To date, the virus has caused approximately 1,875 deaths and over 74,000 known infections and is rapidly expanding worldwide. ImmunoPrecise has designated Dr.&nbsp;Ilse Roodink, the chairwoman of
IPA&#146;s subsidiary Talem Therapeutic&#146;s scientific committee, as the Coronavirus Global Project Leader. Under her supervision, the Company has embarked on a global response and properly designed campaign. The sophisticated infrastructure of
IPA significantly contributed to a quick, but sensible, response initiated by the design and production of relevant <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> target antigens to facilitate the upcoming
identification of prophylactic and therapeutic compounds using IPA&#146;s proprietary discovery platforms (including B Cell Select<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> and DeepDisplay<SUP
STYLE="font-size:85%; vertical-align:top">&#153;</SUP>) and Talem&#146;s access to the leading transgenic animal platform OmniAb<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> for direct generation of human antibodies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We believe that ImmunoPrecise will make an impressive contribution to the global fight against <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">SARS-CoV-2,&#148;</FONT></FONT> stated Dr.&nbsp;Jennifer Bath, President and CEO of ImmunoPrecise Antibodies. &#147;With the aid of iterative advancements rapidly compiling from across the globe, including data such as the
February 19th release of the prefusion form of the new coronavirus spike glycoprotein, research teams are advancing the collective effort toward the development of efficacious vaccines, therapeutic antibodies, and diagnostics. We grow more
determined each day about contributing to this endeavor, as we monitor the rapid, global spread of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2.&#148;</FONT></FONT> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is an
international, full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell Select<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> progressive single-cell interrogation technology and the
DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> custom, OmniAb<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>-based phage libraries, as well as the Abthena<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP>
bispecific program. IPA is focused on the next generation of antibody discovery, to deliver the most therapeutically relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise&#146;s discovery and development are conducted in Utrecht and Oss, the Netherlands <FONT STYLE="white-space:nowrap">(U-Protein</FONT> Express
and IPA Europe, respectively), and in Victoria, British Columbia (IPA Canada). The Company operates globally to offer a continuum of superior antibody services, transforming the face of therapeutic discovery, by decreasing turnaround time and risk,
and promoting clinical success. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is no assurance that the Company will be successful in the development of a vaccine and/or therapeutic against the
new coronavirus. In particular, the development of a vaccine and/or therapeutic requires significant capital, which will require additional financing by the Company, successful clinical trials and extensive regulatory approvals. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release
contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148; within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;,
&#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and similar expressions to identify forward-looking statements. Any such forward-looking statements are based on
assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and expected future developments. However, whether actual results and developments will conform to
ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the
forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual
management discussion and analysis for the fiscal year ended October&nbsp;31, 2019 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless
required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View original content to download multimedia: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">http://www.prnewswire.com/news-releases/immunoprecise-launches-coronavirus-vaccine-and-therapeutic-antibody-program-301008684.html
</FONT></FONT></U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View original content to download multimedia: <U>http://www.newswire.ca/en/releases/archive/February2020/20/c1932.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 14:39e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">20-FEB-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.43
<SEQUENCE>44
<FILENAME>d20922dex9943.htm
<DESCRIPTION>EX-99.43
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.43</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.43 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g78m49.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Announces Artificial Intelligence Collaboration with EVQLV to Accelerate Vaccine and Antibody Discovery
for <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> Coronavirus </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The partnership with the
New York-based artificial intelligence company will focus on high-throughput computational antibody design to derive novel leads from ImmunoPrecise&#146;s platforms and accelerate Coronavirus therapeutic antibody discovery and development. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NEW YORK and VICTORIA, March&nbsp;2, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148; (TSX VENTURE: IPA) (OTC QB:
IPATF), through its subsidiary, Talem Therapeutics (talemtherapeutics.com), and the New York-based company EVQLV, Inc. (evqlv.com), announces a new collaboration aimed at accelerating the global effort to develop lead therapeutic and vaccine
candidates against the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> virus. IPA&#146;s announcement discloses they have teamed up with EVQLV, an artificial intelligence (AI) company focused on
accelerating the discovery and optimization of antibody therapies, as the companies work together to augment and accelerate Talem&#146;s Coronavirus discovery program. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922gra001.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As part of the collaboration, EVQLV will perform <I>in silico</I> antibody design and discovery to generate novel,
optimized antibody sequences leveraging lead candidate data from IPA&#146;s discovery technologies, as well as previously published sequences. EVQLV plans to utilize its high-speed, evolutionary algorithms with IPA&#146;s expedited B cell Select<SUP
STYLE="font-size:85%; vertical-align:top">&#153;</SUP> and custom DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> antibody outputs to intelligently discover context-dependent representations that comprise the mutational space
of therapeutic candidates for the treatment of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> Coronavirus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We have been working diligently with EVQLV&#146;s executive team on strategic and operational alignments for the past nine months, an astonishingly
fateful advantage under these circumstances, and are able, consequently, to leverage the benefits of this collaboration immediately,&#148; said Dr.&nbsp;Jennifer Bath, President and CEO of IPA. &#147;Our time spent with EVQLV&#146;s management has
demonstrated their immense capacity for creativity and thinking outside the box, while absorbing the complexities of IPA&#146;s technologies and outputs. We believe the two teams will create significant therapeutic value together.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EVQLV will build on IPA&#146;s vast sequence outputs as well as published data to identify and screen hundreds of millions of potential treatments in only
days, a feat that would be impossible in a laboratory. Using a wide range of machine learning algorithms, EVQLV can filter candidates with a higher probability of success by computationally measuring and leveraging biological rules and unseen
patterns. IPA will narrow the most promising, yet diverse, candidates and demonstrate their unique attributes by synthesizing and wet lab testing specific subsets of selected leads. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We aim to dramatically reduce the time it takes to identify robust lead candidates with clinical relevance,&#148; added Dr.&nbsp;Bath. &#147;It was
clear to us that EVQLV and ImmunoPrecise were a textbook fit. Harnessing the most innovative technologies to more quickly and effectively tackle this global health crisis reflects the core of both company&#146;s philosophies, pushing the frontlines
of innovation to improve human health and patient outcomes.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EVQLV&#146;s algorithms work by initially exploring approximately 10150 therapeutic
possibilities against each Coronavirus target the team pursues. Based on the learning the AI gains from this process, EVQLV&#146;s computational engine is able to generate millions of potentially relevant therapeutic antibodies against the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> Coronavirus. Using high-performance cloud computing, EVQLV runs a massively parallel process to screen these candidates down to the optimal leads by considering
critical antibody characteristics. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to collaborating to produce novel, computationally generated therapies for
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2,</FONT></FONT> EVQLV&#146;s cutting edge AI can be applied to candidates generated from IPA&#146;s rapid discovery programs to quickly expand libraries of therapeutics for
other disease indications. Further to the Coronavirus collaboration, the companies plan to continue to work together to leverage EVQLV&#146;s continuously improving AI, along with IPA&#146;s expertise in the design and discovery of biologics, to
develop a wide range of novel therapies for patients in need. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We are excited to be working with the incredible team at IPA&#148; stated
EVQLV&#146;s CEO, Andrew Satz. &#147;ImmunoPrecise&#146;s <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">end-to-end</FONT></FONT> antibody discovery capabilities and their highly sophisticated platforms are ideally optimized to
leverage our computational technology to rapidly discover treatments for the Coronavirus. By working together, we are supporting our shared commitment of using cutting edge technology to accelerate the identification and validation of novel
therapies for those in need.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Therapeutic candidates developed through this collaboration will remain the ownership of IPA, with commercial
royalties issued to EVQLV upon completion of pre-defined, commercial milestones. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About EVQLV </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EVQLV develops artificial intelligence, engineered with life science data and biological knowledge, to deliver an innovative paradigm that accelerates the
speed at which biologic therapies reach patients. Comprised of experts in machine learning, molecular biology, computational biology, pharmacology, software engineering, antibody design, cloud computing, and preclinical/clinical development, EVQLV
is on a mission to transform how healing reaches those in need. For further information, visit <U>www.evqlv.com</U> or contact Daniel Gigante at <U>dgigante@evqlv.com.</U> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a
full-service, therapeutic antibody discovery Contract Research Organization offering species agnostic, multi-format, characterized and engineered, human monoclonal antibodies, on an abbreviated timeframe, for its pharmaceutical clients. For further
information, visit <U>www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Talem Therapeutics LLC </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Talem Therapeutics is focused on the discovery and development of therapeutic antibodies targeting emerging, infectious diseases, neurology, immuno-oncology,
inflammation, and rare/specialty diseases. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With direct access to world-class, expedited and <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">end-to-end</FONT></FONT> technologies in the antibody discovery and development process, Talem accelerates novel, therapeutic antibody treatments to the clinic through strategic alliances and partnerships. For further
information, visit <U>www.talemtherapeutics.com</U> or contact <U>bd@talemtherapeutics.com.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is no assurance that ImmunoPrecise will be
successful in the development of a vaccine and/or therapeutic against the new coronavirus. In particular, the development of a vaccine and/or therapeutic requires significant capital, which will require additional financing by ImmunoPrecise,
successful clinical trials and extensive regulatory approvals. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148;
within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and
similar expressions to identify forward-looking statements. Any such forward-looking statements are based on assumptions and analyses made by </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and expected future developments. However, whether actual results and developments will
conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the
forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual
management discussion and analysis for the fiscal year ended October&nbsp;31, 2019 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless
required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. SOURCE ImmunoPrecise Antibodies </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View original content to download multimedia: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.prnewswire.com/news-releases/immunoprecise-announces-artificial-intelligence-collaboration-with-evqlv-to-accelerate-
vaccine-and-antibody-discovery-for-sars-cov-2-coronavirus-301014196.html</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View original content to download multimedia: <U>http://www.newswire.ca/en/releases/archive/March2020/02/c0350.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial Corp.,
1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 07:00e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">02-MAR-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.44
<SEQUENCE>45
<FILENAME>d20922dex9944.htm
<DESCRIPTION>EX-99.44
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.44</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.44 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922gra002.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Announces Debt Settlement of Previously Issued Debentures </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, March&nbsp;6, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTC QB: IPATF) announces
that it wishes to settle up to $796,875 of previously issued debentures including interest by issuing up to 1,328,125 Shares at a price of $0.60 per Share (the &#147;Debt Settlement&#148;). The purpose of the Debt Settlement is to reduce the ongoing
debt obligations of the debentures and is subject to the approval of the TSX Venture Exchange. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a full-service, therapeutic antibody discovery Contract Research Organization offering species agnostic, multi-format, characterized and
engineered, human monoclonal antibodies, on an abbreviated timeframe, for its pharmaceutical clients. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148;
within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and
similar expressions to identify forward-looking statements. Any such forward-looking statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and
expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s expectations and predictions is subject to any </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements
contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and
analysis for the fiscal year ended October&nbsp;31, 2019 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless required by applicable
law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View original content to download multimedia: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.newswire.ca/en/releases/archive/March2020/06/c1853.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information:</B> For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 17:44e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">06-MAR-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.45
<SEQUENCE>46
<FILENAME>d20922dex9945.htm
<DESCRIPTION>EX-99.45
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.45</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.45 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE NINE MONTHS ENDED
JANUARY&nbsp;31, 2020 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following
Management&#146;s Discussion and Analysis (&#147;MD&amp;A&#148;), prepared as of March 09, 2020, should be read in conjunction with the unaudited condensed interim consolidated financial statements of ImmunoPrecise Antibodies Ltd. (&#147;the
Company&#148;, &#147;ImmunoPrecise&#148; or &#147;IPA&#148;) for the three and nine months ended January&nbsp;31, 2020, together with the audited financial statements and accompanying MD&amp;A of the Company for the year ended April&nbsp;30, 2019.
This MD&amp;A is the responsibility of management and has been reviewed and approved by the Board of Directors of IPA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The referenced financial
statements have been prepared in accordance with International Financial Reporting Standards (&#147;IFRS&#148;), as issued by the International Accounting Standards Board and as applicable to the preparation of interim financial statements,
including IAS 34, <I>Interim Financial Reporting</I>. Except as otherwise noted, all dollar figures in this MD&amp;A are stated in Canadian dollars, which is the Company&#146;s reporting currency. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FORWARD-LOOKING STATEMENTS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This MD&amp;A may contain
certain statements that constitute &#147;forward-looking statements&#148; within the meaning of National Instrument <FONT STYLE="white-space:nowrap">51-102,</FONT> Continuous Disclosure Obligations of the Canadian Securities Administrators. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward-looking statements often, but not always, are identified by the use of words such as &#147;seek&#148;, &#147;anticipate&#148;, &#147;believe&#148;,
&#147;plan&#148;, &#147;estimate&#148;, &#147;expect&#148;, &#147;targeting&#148; and &#147;intend&#148; and statements that an event or result &#147;may&#148;, &#147;will&#148;, &#147;should&#148;, &#147;could&#148;, or &#147;might&#148; occur or
be achieved and other similar expressions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In this MD&amp;A, forward-looking statements include the Company&#146;s future plans and expenditures, the
satisfaction of rights and performance of obligations under agreements to which the Company is a part, the ability of the Company to hire and retain employees and consultants and estimated administrative assessment and other expenses. The
forward-looking statements that are contained in this MD&amp;A involve a number of risks and uncertainties. As a consequence, actual results might differ materially from results forecast or suggested in these forward-looking statements. Some of
these risks and uncertainties are identified under the heading &#147;RISKS AND UNCERTAINTIES&#148; in this MD&amp;A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Furthermore, forward-looking
statements contained herein are made as of the date of this MD&amp;A and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results or otherwise. There can be no
assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking
statements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>GENERAL </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company was incorporated
under the laws of Alberta on November&nbsp;22, 1983, and is listed on the TSX Venture Exchange (the &#147;Exchange&#148;) as a Tier 2 life science issuer under the trading symbol &#147;IPA&#148;. The Company&#146;s OTC symbol is &#147;IPATF&#148;.
The address of the Company&#146;s corporate office is 3204 &#150; 4464 Markham Street, Victoria, BC V8Z 7X8. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE NINE MONTHS ENDED
JANUARY 31, 2020 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>OVERVIEW </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has emerged as a recognized, full-service, biologics Contract Research and Organization (CRO) with global operations. The Company is
innovation-driven and is strategically positioned - both geographically and scientifically - to provide highly customized, human, therapeutic and diagnostic antibodies. IPA offers a cohesive and extensive portfolio in the protein and antibody
research, manufacturing and validation continuum. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s services include, but are not limited to, proprietary B cell sorting, screening and
sequencing; custom, immune and na&iuml;ve phage display production and screening; expertise with transgenic animals and multi-species antibody discovery; <FONT STYLE="white-space:nowrap">bi-specific,</FONT>
<FONT STYLE="white-space:nowrap">tri-specific,</FONT> VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing, purification in gram scale levels, characterization and validation; antibody engineering;
transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening and clone-picking; cryopreservation; and custom antigen modeling, design and manufacturing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moreover, in the past 18 months, the Company has gained increasing recognition as a rising leader in the biologics, CRO space, with a focus on organic growth
through market penetration and service diversification, as well as strategic expansion with platform and process integration. Furthermore, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">end-to-end</FONT></FONT> services have been
leveraged through acquisition, enabling a steady foundation for future growth. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA Canada and IPA Europe have both been designated as approved CROs for
the world&#146;s leading, transgenic animal platform producing human antibodies, and exercised an advantage in optimizing services for various transgenic animal vendors. The Company made strategic investments in R&amp;D activities to develop
proprietary technologies enabling the application of their B cell Select<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> and DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> platforms to a broad range of transgenic animal
species and strains. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2018, the Company built on its ten years of experience in single B cell interrogation to offer full-service B cell screening,
sorting and sequencing in both North America and Europe on a species agnostic platform, including transgenic, humanized animals. This service is offered against a broad range of commercially relevant targets, including complex proteins, small
molecules and chemical groups. The Company&#146;s platforms enable antibody screening directly from B cells, enabling the analysis of a more diverse set of antibodies, and for faster, deeper screening compared to traditional technologies. The
Company announced an over 90% success rate on its B cell technology, which is now offered with a success guarantee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">U-Protein</FONT> Express, situated in the Dutch biotechnology hub of Utrecht, The Netherlands, has been a staple in the
recombinant protein community, operating for over 15 years, and specializing in the manufacture of complex proteins and antibodies in a variety of formats, and from a range of mammalian cell types. Their streamlined and efficient operations have
enabled them to successfully support over 5,000 different programs, with an over 90% success rate, for pharmaceutical and biotechnology industries as well as leading, academic institutions. In a seamless coordination, their operations also support
the downstream expression and purification of antibodies originating from the B cell Select programs, enabling validation of the platform&#146;s outputs and comprehensive deliverables for clients. The site also has a global, exclusive license from
Stanford University for the marketing and sales of the novel protein, Wnt surrogate Fc, used as a growth factor for organoid culture. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE NINE MONTHS ENDED
JANUARY 31, 2020 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA Europe&#146;s contribution in services and intellectual property to the Company after its acquisition
have been substantial. The integration of IPA Europe significantly expanded the Company&#146;s services portfolio including affinity maturation, humanization, functional assay design and development, na&iuml;ve and diseased scFv libraries, and
proprietary methods of immunization against conformational targets (e.g. ModiVaccTM lymphoid tumor immunization and DNA immunization technologies). Using the discovery technologies of
ModiFuse<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> (hybridoma electrofusion), ModiSelect<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> <FONT STYLE="white-space:nowrap">(B-cell</FONT> selection) and ModiPhage<SUP
STYLE="font-size:85%; vertical-align:top">&#153;</SUP> (phage display) technologies, IPA Europe can generate very large panels of monoclonal antibodies from various backgrounds including mouse, rat, rabbit, chicken, llama and human, as well as
transgenic animals harboring the human antibody gene repertoire. Adding to their proprietary services, IPA Europe developed and <FONT STYLE="white-space:nowrap">rolled-out</FONT> the aforementioned DeepDisplay service for the discovery of fully
human antibodies using transgenic animal immunization and custom phage display. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While CRO services are the mainstay of the Company, ImmunoPrecise has
worked continuously on building an intellectual property estate and portfolio of proprietary methods and physical assets through collaborations, joint ventures, acquisitions and <FONT STYLE="white-space:nowrap">in-licensing.</FONT> The Company has
strategically invested in the development and licensing of antibody discovery platforms and related intellectual property assets. The onboarding of existing assets with regard to equipment, technologies, IP and licenses within the Company&#146;s EU
operations has been compounded by active research and development at all operational sites, including the <FONT STYLE="white-space:nowrap">on-going</FONT> development of new service offerings to be rolled out in the fiscal year 2020, but more
notably, internal discovery programs focused on novel, therapeutic antibodies, primarily in the field of immuno-oncology and infectious diseases.&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company formed Talem Therapeutics (&#147;Talem&#148;), based in Cambridge, Massachusetts, to support its internal and partnered therapeutic, discovery
programs. Talem offers strategic partnerships with pharma and biotech companies and is the only company to offer these services as a partnership in OmniAb<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> transgenic animals using their own
license. The ability for investors to support individual assets or portfolios generates an asymmetrical opportunity for investments, while avoiding ImmunoPrecise shareholder dilution. The depth and speed of IPA&#146;s offerings enables Talem to
customize each program and leverages the Company&#146;s expertise and technologies in antibody discovery. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s management placed a critical
emphasis this past year on building, integrating and securing the business infrastructure to facilitate scalable, strategic growth and recognizing cost synergies. These activities included, but were not limited to, globalizing and standardizing core
information technology (IT) infrastructure such as server and client operating systems, databases, security tools, computing platforms and cloud computing, communication tools and content management platforms, to protect both the Company&#146;s and
its client&#146;s IP. The Company has also begun to capture synergies after the global integration of sales, marketing, R&amp;D, management, and legal services. The Company has significantly integrated fundamental business services such as payroll,
financial controls, and Oracle&#146;s Netsuite CRM and ERP. They will continue to enhance these integrations, as well as create additional synergies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>STRATEGY AND OUTLOOK </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our management team has a
passionate emphasis on initiatives designed to drive revenue, bolster internal assets and maximize shareholder value. We aim to continue to build on revenue and asset generation through internal development and well-informed, strategic acquisitions
and joint ventures. Our strategy also includes growth through alliances and partnerships, within both our research (Talem) and service sectors, as well as potential new market sectors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE NINE MONTHS ENDED
JANUARY 31, 2020 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our objective is to aggressively expand our position as the preferred, global partner for researchers across
the globe. Therefore, our strategy is to deliver the leading, comprehensive and integrated continuum of protein and antibody services and to enable our clients and partners to bring new and enhanced therapies to the clinic faster, by offering a
progression of services with excellence and continued innovation. We believe we possess a competitive advantage which allows us to execute this strategy, as we continue to focus on our integrated <U><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">end-to-end</FONT></FONT> platform</U>, coupled with a <U>strong, scientific <FONT STYLE="white-space:nowrap">know-how</FONT></U>, enabling us to navigate our clients through the process of discovery through lead candidate
selection. Our ability to customize programs, yet maintain scientific rigor, enables our clients to access our global portfolio of services with confidence. Our personable and responsible <U>global project management team</U> ensures that our
clients have program details at their fingertips, at any minute, in any time zone, with the <U>security measures</U> needed to ensure our clients&#146; peace of mind. In addition to the aforementioned strengths, our global footprint and streamlined
processes enable us to leverage our competitive advantages to mature as the global, preferred therapeutic antibody provider. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our strategy is supported by
growing trends in pharma and finance. Global pharmaceutical companies are continuing to increase their share of reliance on CRO&#146;s to improve the efficiency and cost of development, increase turnaround time, and access advanced and integrated
expertise. When analyzing pharmaceutical outsourcing trends, from October 2019, several major drivers of the CRO industry growth were identified, including robust biopharmaceutical funding, accelerated drug approval rates, the growing number of
clinical trials, and proliferation of biopharmaceutical companies without own internal research and clinical capabilities<SUP STYLE="font-size:85%; vertical-align:top">1</SUP>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In an attempt to streamline, many large pharmaceutical companies are limiting the number of external CRO vendors that can be contracted. This is particularly
promising for those CROs that fill multiple niches in the discovery and manufacturing pipeline. In a recent estimate, the CRO industry alone was estimated to be $30&nbsp;billion USD, and &#147;<I>highly fragmented&#133; relatively few of full scale
and breadth of service</I>&#148;<SUP STYLE="font-size:85%; vertical-align:top">1</SUP>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The key players serving the monoclonal antibodies market are
Pfizer, GlaxoSmithKline, Novartis, Merck&nbsp;&amp; Co., Amgen, Abbott Laboratories, AstraZeneca, Eli Lilly and Company, Mylan, Daiichi Sankyo Company, Bayer, Bristol Myers Squibb Co., Johnson&nbsp;&amp; Johnson Services, Biogen, Thermo Fisher
Scientific, Sanofi Genzyme, F. <FONT STYLE="white-space:nowrap">Hoffmann-La</FONT> Roche, and Novo Nordisk<SUP STYLE="font-size:85%; vertical-align:top">2</SUP>. In 2016 alone, Novartis invested 9&nbsp;billion USD and Pfizer invested
7.9&nbsp;billion USD in R&amp;D<SUP STYLE="font-size:85%; vertical-align:top">3</SUP>. This is of little surprise given the global monoclonal antibody market was valued at USD 85.4&nbsp;billion in 2015 and is expected to reach a value of USD
138.6&nbsp;billion by 2024<SUP STYLE="font-size:85%; vertical-align:top">2</SUP>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ongoing, growing investments by pharma in R&amp;D are expected to ramp
up for antibodies given the rising prevalence of cancer and other chronic diseases<SUP STYLE="font-size:85%; vertical-align:top">4</SUP>. In oncology, antibodies are viewed as the mainstay, as people move away from other types of therapies such as
small molecules<SUP STYLE="font-size:85%; vertical-align:top">5</SUP>. In recent years, the success of key pipeline drugs in the immuno-oncology space have been a key component of the record high capital market funding for the biotechnology sector<SUP
STYLE="font-size:85%; vertical-align:top">1</SUP>. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Healthcare Insights Life Sciences, CRO Sector Fundamentals Remain Hot for M&amp;A Consolidation,
October&nbsp;3, 2019. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">2</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Monoclonal Antibodies (mAbs) Market Size Worth $138.6 Billion By 2024, Nov. 2016 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">3</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Monoclonal Antibody Market 2019-2025 Growth, Key Players, Size, Demands and Forecasts, April, 2019
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">4</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Research Antibodies Market Size, Share&nbsp;&amp; Trends Analysis Report By Product, By Type (Monoclonal,
Polyclonal), By Technology, By Source, By Application (Oncology, Neurobiology), By <FONT STYLE="white-space:nowrap">End-use,</FONT> And Segment Forecasts, 2018 &#150; 2025, March, 2018 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">5</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">GEN, Antibody Discovery Looks Over the Horizon, Feb. 7, 2019. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE NINE MONTHS ENDED
JANUARY 31, 2020 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ACQUISITION OF <FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> EXPRESS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&nbsp;22, 2017, the Company completed the acquisition of <FONT STYLE="white-space:nowrap">U-Protein</FONT> Express BV
<FONT STYLE="white-space:nowrap">(&#147;U-Protein&#148;)</FONT> whereby the Company has acquired all the issued and outstanding shares of <FONT STYLE="white-space:nowrap">U-Protein</FONT> for &#128;6,830,000 on terms as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,734,732 (CAD$4,062,607) was paid in cash on closing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3,030,503 common shares of the Company were issued on closing; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,047,634 in deferred payments over a <FONT STYLE="white-space:nowrap">six-year</FONT> period. The deferred
payments can be made in cash or common shares of the Company at the election of <FONT STYLE="white-space:nowrap">U-Protein</FONT> shareholders. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transaction was accounted for as a business combination, as the operations of <FONT STYLE="white-space:nowrap">U-Protein</FONT> meet the definition of a
business. As a result, transaction costs of $17,717 were expensed. The goodwill resulting from the allocation of the purchase price to the total fair value of net assets represented the sales and growth potential of
<FONT STYLE="white-space:nowrap">U-Protein.</FONT> Goodwill recorded is allocated in its entirety to <FONT STYLE="white-space:nowrap">U-Protein.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The first deferred payment of &#128;682,545 (CAD$1,049,754) has been made in cash during the year ended April&nbsp;30, 2019, and the second deferred payment
of &#128;682,545 (CAD$1,007,435) has been made in cash during the nine months ended January&nbsp;31, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the 3,030,503 common shares
issued ($3,022,308) was determined based on the Canadian dollar equivalent of the consideration required of &#128;2,047,634 pursuant to the share purchase agreement. The Company has allocated the purchase price as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B></B>$<B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,062,607</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3,030,503 common shares of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,022,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of deferred payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,134,410</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,219,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">797,276</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">370,530</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,815</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment, net of accumulated amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">216,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intellectual property (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,064,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,655,893</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(269,657</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income taxes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,197</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(810,800</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,219,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ACQUISITION OF IPA EUROPE AND IMMULEASE </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company acquired all of the issued and outstanding shares of ImmunoPrecise Antibodies (Europe) B.V. (&#147;IPA Europe&#148;) and its
sister entity, Immulease B.V. (&#147;Immulease&#148;), for an aggregate purchase price of &#128;7,000,000 on terms as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,500,000 (CAD$3,988,132) was paid in cash on closing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE NINE MONTHS ENDED
JANUARY 31, 2020 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">6,600,399 common shares of the Company were issued on closing; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,000,000 in deferred payments over a <FONT STYLE="white-space:nowrap">six-year</FONT> period. The deferred
payments were to be made in six equal installments of cash and equity totaling &#128;666,666 and prorated if the EBITDA of IPA Europe for the fiscal year preceding the date of payment is less than its average EBITDA over the previous two fiscal
years. During the year ended April&nbsp;30, 2019, the Company and the seller entered into an Amendment, a Termination and Settlement Agreement whereby the deferred payments shall no longer be subject to an adjustment and will be paid in equal
installments of cash and equity totaling &#128;666,666. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA Europe changed its name from ModiQuest Research B.V. in April 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transaction was accounted for as a business combination, as the operations of IPA Europe and Immulease meet the definition of a business. As a result,
transaction costs of $36,821 were expensed. The goodwill resulting from the allocation of the purchase price to the total fair value of net assets represented the sales and growth potential of IPA Europe. Goodwill recorded is allocated in its
entirety to IPA Europe. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The first deferred payment of &#128;666,666 (CAD$1,014,503), consisting of cash of &#128;333,333 (CAD$507,000) and common shares
of the Company with a fair value of $507,503, has been made during the year ended April&nbsp;30, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the 6,600,399 common shares
issued ($4,884,295) was determined to be $0.74 per share based on the fair value of the Company&#146;s shares immediately prior to the completion of the acquisition. The Company has allocated the purchase price as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B></B>$<B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,988,132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6,600,399 common shares of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,884,295</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of deferred payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,353,708</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,226,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">270,339</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">572,427</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,286,995</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment, net of accumulated amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">568,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Software</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible assets (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,304,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,640,671</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(580,339</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(22,897</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(298,979</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,636,192</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,226,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE NINE MONTHS ENDED
JANUARY 31, 2020 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>OVERALL PERFORMANCE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the nine months ended January&nbsp;31, 2020 the Company achieved revenues of $9,912,904, compared to revenues of $8,285,159 in the 2019 fiscal period.
This represents a 20% increase in revenue for the nine-month period. The increasing revenue trend is due to growth in both the volume and financial value of the client contracts, resulting in a larger average value per program. Revenue outlook is
positive for the fourth quarter.&nbsp;&nbsp;&nbsp;&nbsp; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the first time in the Company&#146;s history, Adjusted EBITDA for the quarter and nine-month
period ending January&nbsp;31, 2020 was positive, at $717,716 and $18,356 respectively. This is a result of third quarter&#146;s 50% increase in revenue and lower adjusted operating expenses compared to the prior year&#146;s quarter and nine-month
periods. Adjusted EBITDA is a <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measure which is fully defined on page ten of this document. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To drive the
execution of its strategic and growth initiatives, the Company continues to focus on the recruitment of scientific and technical staff, development of new technical training programs and a commitment to integrate continuous improvement and quality
management methodologies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To support management and the Board of Directors in exercising oversight, the Company is implementing information systems for
marketing and sales automation and customer relationship management, as well as accounting and financial reporting, resource planning and project management. Comprehensive operational and management reporting capabilities are being implemented with
a view to effectively support a geographically dispersed organization allowing managers access to company data globally. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With the aid of a third-party HR
consulting firm, significant effort was applied to strengthening and aligning the Company&#146;s human resources by: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Stabilizing staffing for sales growth going forward:</I> Remuneration and incentive systems have been aligned
with targeted revenue and gross profit performance, and operational roles and responsibilities have been focused on managing demand. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Leadership and operational alignment:</I> The Company has made changes and updates job descriptions,
compensation plans, and other reward and recognition systems, and is implementing career planning and development mechanisms and job performance and quality measures. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Future growth will provide opportunities for company personnel to develop new skills and abilities to tackle eventual challenges in a growing company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the 2020 fiscal year, the goal of the organization is to grow sales revenue and expand our brand awareness. This focus is consistent with the &#145;leading
with our scientists&#146; philosophy, which is resonating with our clients from both diagnostic and, in particular, the therapeutic market segment. The Company is also expanding its commitment to research and development initiatives aimed at
introducing new services through both internal development as well as through partnerships. To achieve the best results from its investments, the Company continues to add key scientific and management personnel to its team. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RESULTS OF OPERATIONS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Three months ended
January&nbsp;31, 2020</I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the three months ended January&nbsp;31, 2020, the Company generated revenues of $4,034,440, compared to revenues of
$2,695,583 in the 2019 fiscal period.&nbsp;This represents a 50% increase in revenue for the three-month </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE NINE MONTHS ENDED
JANUARY 31, 2020 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">period. The increasing revenue trend is due to growth in both the volume of contracts as well as an increase
in the financial value of individual client programs resulting in a larger average value per program. Revenue outlook is positive for the fourth quarter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the three months ended January&nbsp;31, 2020, the Company achieved a gross profit of $2,223,669, compared to $1,568,055 in the 2019 fiscal period. In
percentage terms, the Company&#146;s gross profit has decreased slightly to 55% from 58% in 2019. The lower gross profit % in 2020 was mostly due to the reclassification of certain overhead expenses to cost of sales for Q3 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recorded a net loss of $625,837 during the three months ended January&nbsp;31, 2020, compared to net loss of $1,187,056 for the three months ended
January&nbsp;31, 2019. The net loss decreased in 2020 due to $655,614 higher gross profit as well as cost synergies resulting in lower spend, offset by higher <FONT STYLE="white-space:nowrap">non-cash</FONT> amortization of acquired companies&#146;
intangible assets, depreciation of leased assets as a result of implementing IFRS 16, Leases. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Variances of note in the Company&#146;s expenses include:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Advertising and promotion fees of $48,117 in 2020 (2019 - $357,286) were higher in 2019 due to certain <FONT
STYLE="white-space:nowrap">one-time</FONT> expenses incurred to support the Company&#146;s initiatives focused on business development, marketing and branding programs. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Amortization expense increased to $783,076 from $137,499 in 2019 due to the amortization of intangible assets
which were acquired as a result of the acquisitions of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Management fees increased to $419,045 from $45,881 in 2019. $373,927 of the management fees were attributed to
the profit-sharing payout made to the former shareholders of <FONT STYLE="white-space:nowrap">U-Protein,</FONT> as part of the acquisition agreement. The profit-sharing payout is a three-year, annual obligation with declining percentage of profit
sharing each year. After fiscal year 2021, the profit-sharing payout for <FONT STYLE="white-space:nowrap">U-Protein</FONT> will cease and the Company will be under no further obligations to share profits with the former shareholders of <FONT
STYLE="white-space:nowrap">U-Protein.</FONT> The profit-sharing expense was recorded as Salaries and benefits in the second quarter and was reclassified as Management fees for consistency with the prior year. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Office and general expenses of ($57,268) in 2020 is negative as a result of implementing IFRS <FONT
STYLE="white-space:nowrap">16-</FONT> Leases. The leased asset is capitalized and depreciated with lease expense being eliminated and the lease obligation being recorded as a liability of the company. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Salaries and benefits expense decreased to $601,826 from $865,938 in 2019, primarily due to reclassifying
profit-sharing expense to management fees. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Nine months ended January&nbsp;31, 2020</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the nine months ended January&nbsp;31, 2020, the Company generated revenues of $9,912,904, compared to revenues of $8,285,159 in the 2019 fiscal
period.&nbsp;This represents a 20% increase in revenue for the nine month-period. The increasing revenue trend is due to growth in both the volume and financial value of client contracts, resulting in a larger average value per program. Revenue
outlook is positive for fourth quarter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the nine months ended January&nbsp;31, 2020, the Company achieved a gross profit of $6,090,090, compared
to $4,723,701 in the 2019 fiscal period. In percentage terms, the Company&#146;s gross profit increased to 61% from 57% in 2019. The higher gross profit in 2020 was primarily a result of the Company implementing a new ERP system that tracks project
costs in more detail than historical methods. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE NINE MONTHS ENDED
JANUARY 31, 2020 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recorded a net loss of $4,001,580 during the nine months ended January&nbsp;31, 2020, compared to
net loss of $3,775,150 for the nine months ended January&nbsp;31, 2019. Despite $1,366,389 higher gross profit as well as cost synergies resulting in lower spend, the net loss increased in 2020 primarily due to increase in investments in research
and development and <FONT STYLE="white-space:nowrap">non-cash</FONT> amortization of acquired companies&#146; intangible assets, depreciation of leased assets as a result of implementing IFRS 16, <I>Leases</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Variances of note in the Company&#146;s expenses include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Advertising and promotion fees of $226,267 in 2020 (2019 - $679,932) were incurred to support the Company&#146;s
initiatives focused on business development, marketing and branding programs. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Amortization expense increased to $2,077,460 from $522,282 in 2019 due to the amortization of intangible assets
which were acquired as a result of the acquisitions of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Consulting fees of $134,343 in 2020 (2019 - $405,770) and professional fees of $688,939 (2019 - $743,722) were
lower because 2019 consultant and professional services were engaged to support <FONT STYLE="white-space:nowrap">one-</FONT> time initiatives focused on operational efficiency training programs, systems implementation and integration of
acquisitions. The company evaluated the use of consulting services vs employees and where appropriate added employees to the team. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Management fees increased to $489,480 from $137,778 in 2019. $373,927 of the management fees were attributed to
the profit-sharing payout made to the former shareholders of <FONT STYLE="white-space:nowrap">U-Protein,</FONT> as part of the acquisition agreement. The profit-sharing payout is a three-year, annual obligation, with declining percentage of profit
sharing. After fiscal year 2021, the profit-sharing payout for <FONT STYLE="white-space:nowrap">U-Protein</FONT> will cease and the Company will be under no further obligations to share profits with the former shareholders of <FONT
STYLE="white-space:nowrap">U-</FONT> Protein. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Research and development of $667,292 (2019 - $297,198) increased as a result of the investment in R&amp;D to
broaden the breadth and value of its intellectual property assets in techniques inherent in the production of antibodies. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SUMMARY OF
QUARTERLY RESULTS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets out financial information for the past eight quarters: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three&nbsp;Months&nbsp;Ended&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>January&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>October&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>July&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,034,440</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,162,365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,716,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,641,109</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(625,837</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,363,545</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,012,198</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,842,317</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted loss per share*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.01</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.03</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.06</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="12"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>January&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>October&nbsp;31,<BR>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>July&nbsp;31,<BR>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,695,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,716,791</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,872,785</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,810,722</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net (loss)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,187,056</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,485,732</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,102,362</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,198,428</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted loss per share*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.04</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The basic and fully diluted calculations result in the same value due to the anti-dilutive effect of
outstanding stock options and warrants. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE NINE MONTHS ENDED
JANUARY 31, 2020 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The losses for the quarters ended April&nbsp;30, 2019 and April&nbsp;30, 2018 are greater than other
quarters, as the Company invested heavily in growth enabling initiatives and <FONT STYLE="white-space:nowrap">catch-up</FONT> amortization recorded of intangible assets which were acquired as a result of the acquisitions of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">NON-IFRS</FONT> MEASURES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following are <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures and investors are cautioned not to place undue reliance on them and are urged to
read all IFRS accounting disclosures present in the condensed consolidated interim financial statements and accompanying notes for the condensed consolidated interim financial statements for the nine months ended January&nbsp;31, 2020 and the
consolidated financial statements and accompanying notes to the financial statements for the year ended April&nbsp;30, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company uses certain <FONT
STYLE="white-space:nowrap">non-IFRS</FONT> financial measures as supplemental indicators of its financial and operating performance. These <FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial measures include adjusted operating EBITDA and
adjusted operating expenses. The Company believes these supplementary financial measures reflect the Company&#146;s ongoing business in a manner that allows for meaningful
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">period-to-period</FONT></FONT> comparisons and analysis of trends in its business. These <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures do not have any standardized meaning
prescribed under IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company defines adjusted
operating EBITDA as operating earnings before interest, taxes, depreciation, amortization, share-based compensation, and asset impairment charges. Adjusted operating EBITDA is presented on a basis consistent with the Company&#146;s internal
management reports. The Company discloses adjusted operating EBITDA to capture the profitability of its business before the impact of items not considered in management&#146;s evaluation of operating unit performance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company defines adjusted operating expenses as operating expenses before share-based compensation, depreciation, amortization and asset impairment
charges. Adjusted operating expenses are presented on a basis consistent with the Company&#146;s internal management reports. The <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures are reconciled to reported IFRS figures in the tables below:
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Three&nbsp;months&nbsp;ended</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Nine&nbsp;months&nbsp;ended</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>January&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>January&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(625,837</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,187,056</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,001,580</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,775,150</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">138,887</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58,405</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">193,171</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">248,755</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">783,076</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">137,499</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,077,460</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">522,282</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">109,893</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">189,652</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">875,753</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">668,189</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange loss (gain)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,978</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(88,329</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(142,875</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">139,388</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87,306</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">373,136</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">320,967</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest and other income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">231</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(43,946</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(54,470</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(125,005</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">143,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">234,924</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">643,215</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">729,747</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Adjusted EBITDA</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">717,716</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(461,353</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,356</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,553,090</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE NINE MONTHS ENDED
JANUARY 31, 2020 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Three&nbsp;months&nbsp;ended</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Nine&nbsp;months&nbsp;ended</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD ROWSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>January&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>January&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,600,495</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,551,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,077,216</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,706,912</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">783,076</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">137,499</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,077,460</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">522,282</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange loss (gain)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,978</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(88,329</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(142,875</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">139,388</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87,306</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">373,136</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">320,967</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">143,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">234,924</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">643,215</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">729,747</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Adjusted Operating Expenses</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,505,953</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,029,408</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,071,734</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,276,791</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FINANCING ACTIVITIES </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On
May&nbsp;23, 2018, the Company entered into a loan agreement with a Director of the Company and his spouse and issued a promissory note in the principal amount of $200,000. The note was unsecured and bore an interest rate of 5.45% per annum. The
principal of the note plus accrued interest of $3,972 was repaid in full during the year ended April&nbsp;30, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&nbsp;19, 2018, the Company
closed a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement financing by issuing a total of 875,000 units of the Company at a price of $0.80 per unit for gross proceeds of $700,000. Each unit consists of one common share of the
Company and one share purchase warrant, with each warrant entitling the holder to purchase an additional Share at a price of $1.00 for a period of one year from the date of issue. The Company will have the right to accelerate the expiry date of the
warrants provided that the volume weighted average price trades at a price equal to or greater than $1.50 for a period of 20 consecutive days. In the event of acceleration, the expiry date will be accelerated to a date that is 30 days after the
Company issues a news release announcing that it has elected to exercise this acceleration right. The Company paid finders cash fees totaling $3,000 and incurred $7,926 of cash issue costs. The Company extended the warrants for an additional twelve
months from the original expiry. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&nbsp;24, 2018, the Company closed a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement
financing by issuing a total of 9,102,500 units of the Company at a price of $1.00 per unit for gross proceeds of $9,102,500. Each unit consists of one common share of the Company and one share purchase warrant, with each warrant entitling the
holder to purchase an additional share at a price of $1.25 for a period of two years from the date of issue. The Company will have the right to accelerate the expiry date of the warrants provided that the volume weighted average price trades at a
price equal to or greater than $1.75 for a period of 20 consecutive days. In the event of acceleration, the expiry date will be accelerated to a date that is 30 days after the Company issues a news release announcing that it has elected to exercise
this acceleration right. The Company also proceeded with a Debenture Settlement of $1,377,000 by issuing up to 1,377,000 Units at a price of $1.00 per Unit (the &#147;Debt Settlement&#148;). Each Unit is on the same terms as the Financing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company paid finders cash fees totaling $201,540 and issued 182,460 finder&#146;s shares. The Company also incurred $76,038 of cash issue costs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE NINE MONTHS ENDED
JANUARY 31, 2020 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&nbsp;22, 2017, the Company announced that it had signed a binding letter of intent with Crossbeta
Biosciences B.V. (&#147;Crossbeta&#148;) whereby the Company had agreed to acquire all the issued and outstanding shares of Crossbeta. The proposed transaction was terminated and settled on October&nbsp;23, 2018. In consideration of the settlement,
the Company paid &#128;37,000 ($55,969) and issued 78,514 shares valued at $61,241. The Company accrued a settlement liability of $92,040 as at April&nbsp;30, 2018. As such, the remaining loss on settlement of $25,170 was recognized in fiscal year
2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;27, 2019, the Company issued 714,793 common shares pursuant to the second deferred acquisition payment to IPA Europe. The common
shares are valued at $507,503. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2019, the Company issued 135,000 common shares pursuant to exercise of stock options
for total gross proceeds of $40,500. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&nbsp;26, 2019, the Company modified the terms of $2,750,000 debentures to extend the due date 6 months
to March&nbsp;26, 2020, with the ability to pay earlier with no penalty, and increase the interest rate to 12.5%. The remaining debentures of $125,000 were paid on maturity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the nine months ended January&nbsp;31, 2020, the Company issued 55,000 common shares pursuant to exercise of stock options for total gross proceeds of
$16,500. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;6, 2020, the Company announced that it wishes to settle up to $796,875 of previously issued debentures including interest by
issuing up to 1,328,125 Shares at a price of $0.60 per Share (the &#147;Debt Settlement&#148;). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>LIQUIDITY AND CAPITAL RESOURCES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s objectives when managing capital are to ensure sufficient liquidity for operations and adequate funding for growth and capital expenditures
while maintaining an efficient balance between debt and equity. The capital structure of the Company consists of shareholders&#146; equity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company
adjusts to its capital structure upon approval from its Board of Directors, considering economic conditions and the Company&#146;s working capital requirements. There were no changes in the Company&#146;s approach to capital management during the
year. The Company is not subject to any externally imposed capital requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As at January&nbsp;31, 2020, the Company held cash of $2,004,593 (April
30, 2019 &#150; $5,471,650) and had working capital of $1,140,179 (April 30, 2019 &#150; $2,673,667). During the nine months ended January&nbsp;31, 2020, the Company used $1,854,898 in its operating activities. As part of the investing activities,
the Company made equipment purchases of $368,143, incurred internally generated development costs of $169,716, and made a deferred acquisition payment of $1,007,435. As part of the financing activities, the Company received $16,500 from exercise of
stock options, offset by lease repayments of $229,423, loan repayments of $66,654 and debenture repayments of $125,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s consolidated
financial statements have been prepared based on accounting principles applicable to a going concern. This assumes the Company will continue in operation for the foreseeable future and will be able to realize its assets and discharge its obligations
in the normal course of operations. The Company has </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE NINE MONTHS ENDED
JANUARY 31, 2020 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">incurred operating losses since inception, including $4,001,580 for the nine months ended January&nbsp;31,
2020 and has accumulated a deficit of $21,532,806 as at January&nbsp;31, 2020. The Company may need to raise additional funds in order to continue as a going concern and there can be no assurances that sufficient funding, including adequate
financing, will be available. The ability of the Company to arrange additional financing in the future depends in part, on the prevailing capital market conditions and profitability of its operations. These material uncertainties may cast
significant doubt on the Company&#146;s ability to continue as a going concern. Accordingly, the consolidated financial statements do not give effect to adjustments that would be necessary should the Company be unable to continue as a going concern
and therefore be required to realize its assets and liquidate its liabilities, contingent obligations and commitments other than in the normal course of business and at amounts different from those in the consolidated financial statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As at January&nbsp;31, 2020, the Company does not have any commitments for capital expenditures. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CAPITAL EXPENDITURES </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company made equipment
purchases of $368,143 during the nine months ended January&nbsp;31, 2020 (2019 -&nbsp;$542,975).&nbsp;During the nine months ended January&nbsp;31, 2020, the Company also incurred internally generated development costs of $169,716. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RELATED PARTY TRANSACTIONS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Key management personnel are
those persons having authority and responsibility for planning, directing and controlling the activities of the Company. Key management consists of Dr.&nbsp;Jennifer Bath, President and CEO; Lisa Helbling, CFO; Dr.&nbsp;Stefan Lang, CBO; Charles
Wheelock, CTO, and Former Employees: Natasha Tsai, CFO; Reginald Beniac, Chief Operating Officer; Oren Beske, President of ImmunoPrecise Antibodies (USA) Ltd.; Martin Hessing, Director of <FONT STYLE="white-space:nowrap">U-Protein;</FONT> Jos Raats,
President and CEO of IPA Europe; and Directors of the Company. During the three and nine months ended January&nbsp;31, 2020 and 2019, the compensation for key management is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Three&nbsp;months&nbsp;ended</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Nine&nbsp;months&nbsp;ended</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>January&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>January&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Management fees <SUP STYLE="font-size:85%; vertical-align:top">(1) </SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103,524</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89,479</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">309,907</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Professional fees <SUP STYLE="font-size:85%; vertical-align:top">(2) </SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,185</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,840</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Salaries and other short-term benefits <SUP STYLE="font-size:85%; vertical-align:top">(3)
</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">365,563</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76,446</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,136,939</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">259,187</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,388</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">156,257</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">305,348</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">420,015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">381,951</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">352,412</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,531,766</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,039,949</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The charge includes management fees paid to Dr.&nbsp;Martin Hessing, a former Director of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> and Dr.&nbsp;Jos Raats, former President and CEO of IPA Europe. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The charge includes professional fees paid to Malaspina Consultants Inc. in which Natasha Tsai was an associate
until October&nbsp;31, 2018 and an owner thereafter. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The charge includes salaries and benefits paid to current key management and former management that includes
Robert Beecroft, Dr.&nbsp;Oren Beske and Reginald Beniac. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE NINE MONTHS ENDED
JANUARY 31, 2020 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the three and nine months ended January&nbsp;31, 2020, the spouse of a Director provided
administrative services for $nil and $nil (2019 &#150; $15,625 and $46,875). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>OUTSTANDING SHARE DATA </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s outstanding share information as at March 01, 2020 is as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Security</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Exercise&nbsp;Price</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Expiry&nbsp;date</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issued and outstanding common shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,994,445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">NA</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">NA</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">October&nbsp;1,&nbsp;2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">550,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">December&nbsp;20,&nbsp;2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">950,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">September&nbsp;18,&nbsp;2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">January&nbsp;3, 2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">700,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">February&nbsp;7, 2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">September&nbsp;24, 2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">November&nbsp;7, 2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">December&nbsp;31, 2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">415,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">January&nbsp;11, 2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">October&nbsp;1, 2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">October&nbsp;3, 2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">875,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">June&nbsp;18, 2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,102,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">September&nbsp;24, 2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,377,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">October&nbsp;25, 2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,793,942</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">March&nbsp;26, 2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">91,252,887</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">OFF-BALANCE</FONT> SHEET ARRANGEMENTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company does not utilize <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE NINE MONTHS ENDED
JANUARY 31, 2020 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>COMMITMENTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the Company&#146;s rental of office and laboratory space in Victoria, BC, Canada, the current lease commenced on May&nbsp;1, 2018 and terminates on
April&nbsp;30, 2023. The lease is in the amount of $21,015 per month for all four spaces from May&nbsp;1, 2018 to August&nbsp;31, 2020. The lease agreement was amended effective December&nbsp;1, 2019 so that it now only covers three spaces, and the
lease is in the amount of $13,891 per month from December&nbsp;1, 2019 to April&nbsp;30, 2021 and $14,485 per month from May&nbsp;1, 2021 to April&nbsp;30, 2023. The minimum annual payments under these leases are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">105,075</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">195,186</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">173,820</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">173,820</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">647,901</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the Company&#146;s rental of office and laboratory space in Oss, Netherlands, the current lease commenced on
January&nbsp;1, 2018 and terminated on December&nbsp;31, 2019. Effective December&nbsp;31, 2018, the lease automatically rolls into a <FONT STYLE="white-space:nowrap">3-year</FONT> term through December&nbsp;31, 2022. The Company rented a new
additional space and the lease commenced on August&nbsp;1, 2019. Annual minimum lease payments are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&#128;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">182,989</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">185,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">185,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">123,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">677,656</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CRITICAL ACCOUNTING ESTIMATES AND JUDGMENTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of the consolidated financial statements in conformity with IFRS required estimates and judgments that affect the amounts reported in the
financial statements. Actual results could differ from these estimates and judgments. Estimates are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the year in which the estimate is revised. Significant areas
requiring the use of estimates and judgments are as follows: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Functional currency </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has used judgment in determining the currency of the primary economic environment in which the entity operates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE NINE MONTHS ENDED
JANUARY 31, 2020 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Amounts receivable </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company monitors the financial stability of its customers and the environment in which they operate to make estimates regarding the likelihood that the
individual trade receivable balances will be paid. Credit risks for outstanding customer receivables are regularly assessed and allowances are recorded for estimated losses, if required. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Equipment </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has used estimates in the
determination of the expected useful lives of equipment and leasehold improvements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Revenue recognition </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">percentage-of-completion</FONT></FONT> method requires the use of estimates to determine
the stage of completion which is used to determine the recorded amount of revenue, unbilled revenue and deferred revenue on uncompleted contracts. The determination of anticipated revenues includes the contractually agreed revenue and may also
involve estimates of future revenues if such additional revenues can be reliably estimated and it is considered probable that they will be recovered. The determination of anticipated costs for completing a contract is based on estimates that can be
affected by a variety of factors, including the cost of materials, labor, and subcontractors. The determination of estimates is based on the Company&#146;s business practices as well as its historical experience. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Impairments </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the purposes of assessing impairment,
assets are grouped at the lowest levels for which there are separately identifiable cash flows (&#147;cash generating units&#148; or &#147;CGU&#148;s). Each asset or CGU is evaluated every reporting period to determine whether there are any
indicators of impairment. If any such indicators exist, which is often judgment-based, a formal estimate of recoverable amount is performed, and an impairment charge is recognized to the extent that the carrying amount exceeds the recoverable
amount. The recoverable amount of an asset or CGU of assets is measured at the higher of fair value less costs of disposal or value in use. These determinations and their individual assumptions require that management make a decision based on the
best available information at each reporting period. The estimates and assumptions are subject to risk and uncertainty; hence, there is the possibility that changes in circumstances will alter these projections, which may impact the recoverable
amount of the assets. In such circumstances, some or all the carrying value of the assets may be further impaired or the impairment charge reversed with the impact recorded in profit or loss. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company performs a goodwill impairment test annually and when circumstances indicate that the carrying value may not be recoverable. For the purposes of
impairment testing, goodwill acquired through business combinations has been allocated to two different CGUs. The recoverable amount of each CGU was based on value in use, determined by discounting the future cash flows to be generated from the
continuing use of the CGU. The cash flows were projected over a five-year period based on past experience and actual operating results. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company
performed its annual goodwill impairment test in April 2019 and no impairment was indicated for the period tested. The values assigned to the key assumptions represented management&#146;s assessment of future trends in the industry and were based on
historical data from both internal and external sources. Weighted average costs of capital of 17.5% and 10.2%, respectively, was used in the assessments of the two CGUs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE NINE MONTHS ENDED
JANUARY 31, 2020 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Determination of segments </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An operating segment is a component of the Company that engages in business activities from which it may earn revenues and incur expenses. All operating
segments&#146; results are reviewed by the Company&#146;s management in order to make decisions regarding the allocation of resources to the segment. Segment results include items directly attributable to a segment as those that can be allocated on
a reasonable basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As the Company provides antibody production and related services in one distinct category, there is only one category to report
revenues by production site. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Life of intangible assets </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Intangible assets are amortized based on estimated useful life less their estimated residual value. Significant assumptions are involved in the determination
of useful life and residual values and no assurance can be given that actual useful lives and residual values will not differ significantly from current assumptions. Actual useful life and residual values may vary depending on a number of factors
including internal technical evaluation, attributes of the assets and experience with similar assets. Changes to these estimates may affect the carrying value of assets, net income (loss) and comprehensive income (loss) in future periods. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Purchase price allocation </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The acquisition of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> on August&nbsp;22, 2017 and the acquisition of IPA Europe and Immulease on April&nbsp;5, 2018 were accounted for as business combinations at fair value in accordance with IFRS 3, <I>Business
Combinations</I>. The acquired assets and assumed liabilities were adjusted to their fair values assigned through completion of a purchase price allocation, as described below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The purchase price allocation process resulting from a business combination requires management to estimate the fair value of identifiable assets acquired
including intangible assets and liabilities assumed including the deferred acquisition payment obligations. The Company uses valuation techniques, which are generally based on forecasted future net cash flows discounted to present value and relies
on work performed by third-party valuation specialists. These valuations are closely linked to the assumptions used by management on the future performance of the related assets and the discount rates applied. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ADOPTION OF NEW ACCOUNTING STANDARDS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has
adopted the following new standards, along with any consequential amendments, effective May&nbsp;1, 2019. These changes were made in accordance with the applicable transitional provisions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company adopted all the requirements of IFRS 16, Leases (&#147;IFRS 16&#148;) as of May&nbsp;1, 2019. IFRS 16 replaces IAS 17, Leases (&#147;IAS
17&#148;). IFRS 16 provides a single lessee accounting model, requiring lessees to recognize assets and liabilities for all leases unless the lease term is 12 months or less or the underlying asset has a low value. The Company has adopted IFRS 16
using the modified retrospective application method, where the 2019 comparatives are not restated and a cumulative catch up adjustment is recorded on May&nbsp;1, 2019 for any differences identified, including adjustments to opening deficit balance.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company analyzed its contracts to identify whether they contain a lease arrangement for the application of IFRS 16. The following is the
Company&#146;s new accounting policy for leases under IFRS 16: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At inception of a contract, the Company assesses whether the contract is, or contains, a
lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE NINE MONTHS ENDED
JANUARY 31, 2020 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Leases of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets
are recognized at the lease commencement date at the present value of the lease payments that are not paid at that date. The lease payments are discounted using the interest rate implicit in the lease, if that rate can be readily determined, and
otherwise at the Company&#146;s incremental borrowing rate. At the commencement date, a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset is measured at cost, which is comprised of the initial amount
of the lease liability adjusted for any lease payments made at or before the commencement date, plus any decommissioning and restoration costs, less any lease incentives received. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each lease payment is allocated between repayment of the lease principal and interest. Interest on the lease liability in each period during the lease term is
allocated to produce a constant periodic rate of interest on the remaining balance of the lease liability. Except where the costs are included in the carrying amount of another asset, the Company recognizes in profit or loss (a)&nbsp;the interest on
a lease liability and (b)&nbsp;variable lease payments not included in the measurement of a lease liability in the period in which the event or condition that triggers those payments occurs. The Company subsequently measures a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset at cost less any accumulated depreciation and any accumulated impairment losses; and adjusted for any remeasurement of the lease liability. <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> assets are depreciated over the shorter of the asset&#146;s useful life and the lease term, except where the lease contains a bargain purchase option a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset is depreciated over the asset&#146;s useful life. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On the
date of transition, the Company recorded a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset of $1,668,533 related to the office rent in property and equipment, and the lease obligation of $1,723,277
was recorded as at May&nbsp;1, 2019, discounted using the Company&#146;s incremental borrowing rate of 8%, and measured at an amount equal to the lease obligation as if IFRS 16 had been applied since the commencement date. The net difference between
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets and lease liabilities on the date of transition was recognized as a deficit adjustment of $54,744 on May&nbsp;1, 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ACCOUNTING STANDARDS ISSUED BUT NOT YET EFFECTIVE </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
October 2018, the IASB issued amendments to IFRS 3, Business Combinations. The amendments narrowed and clarified the definition of a business. The amendments will help companies determine whether an acquisition is a business or a group of assets.
They also permit a simplified assessment of whether an acquired set of activities and assets is a group of assets rather than a business. Distinguishing between a business and a group of assets is important because an acquirer recognizes goodwill
only when acquiring a business. This amendment will be effective for annual periods beginning on or after January&nbsp;1, 2020. Early adoption is permitted. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DISCLOSURE CONTROLS AND PROCEDURES </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with
National Instrument <FONT STYLE="white-space:nowrap">52-109</FONT> (Certificate of Disclosure in Issuer&#146;s Annual and Interim Filings) (&#147;NI <FONT STYLE="white-space:nowrap">52-109&#148;),</FONT> the Chief Executive Officer and Chief
Financial Officer of the Company have filed a Venture Issuer Basic Certificate with respect to the financial information contained in the unaudited condensed interim consolidated financial statements for the nine months ended January&nbsp;31, 2020
and this accompanying MD&amp;A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In contrast to the full certificate under NI <FONT STYLE="white-space:nowrap">52-109,</FONT> the Venture Issuer Basic
Certificate does not include representations relating to the establishment and maintenance of disclosure controls and procedures and internal control over financial reporting, as defined in NI <FONT STYLE="white-space:nowrap">52-109.</FONT> For
further information the reader should refer to the Venture Issuer Basic Certificates filed by the Company with the Annual Filings on SEDAR at <U>www.sedar.com</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE NINE MONTHS ENDED
JANUARY 31, 2020 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FINANCIAL INSTRUMENTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s financial instruments include cash, amounts receivable, investment, accounts payable and accrued liabilities, loans payable, deferred
acquisition payments and debentures. The fair value of investment is determined based on &#147;Level&nbsp;1&#148; inputs which consist of quoted prices in active markets for identical assets. As at January&nbsp;31, 2020, the Company believes that
the carrying values of cash, amounts receivable, accounts payable and accrued liabilities, deferred payments, debentures, and loans payable approximate their fair values because of their nature and relatively short maturity dates or durations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RISKS AND UNCERTAINTIES </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Research and Development and
Product Development </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA is a life science company that makes customized antibodies and is engaged in the research and product development of new
processes, procedures and innovative approaches to the antibody production and new antibodies. The Company has been engaged in such research and development activities for over 20 years and has had significant success. Continued investment in
retaining key scientific staff as well as an ongoing commitment in research and development activities will continue to be a cornerstone in the Company&#146;s development of new services, processes, and competitive advantages such as Rapid Prime, B
cell Select, DeepDisplay and its methods for the production of human antibodies. The Company realizes that such research and product development activities endeavour, but cannot assure, the production of new and innovative processes, procedures or
innovative approaches to antibody production or new antibodies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Custom Products </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is reliant on the development, marketing and sale of its current custom monoclonal and polyclonal antibodies. If it does not achieve sufficient
market acceptance of its expansion of its commercialization of its products and services, it will be difficult for the Company to achieve consistent profitability. The Company&#146;s marketing and sales approach and external sales personnel
continues to introduce a steady stream of new customers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Obsolescence </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Maintaining a competitive position requires constant growth, development and strategic marketing and planning. If the Company is unable to maintain a
technological advantage, its ability to grow its business will be adversely affected and its products may become obsolete compared with other technologies. To mitigate this, the Company is making investments in new methods, technology and
facilities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Competition </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA may face significant
competition in selling its products and services. Many competitors may have substantial marketing, financial, development and personnel resources. To remain competitive, the Company believes that it must effectively and economically provide:
(i)&nbsp;products and services that satisfy customer demands, (ii)&nbsp;superior customer service, (iii)&nbsp;high levels of quality and reliability, and (iv)&nbsp;dependable and efficient distribution networks. Increased competition may require the
Company to reduce prices or increase spending on sales and marketing and customer support, which may have a material adverse effect on its financial condition and results of operations. Any decrease in the quality of IPA&#146;s products or level of
service to customers or any occurrence of a price war among the Company&#146;s competitors may adversely affect the business and results of operations. Customer reach, service and <FONT STYLE="white-space:nowrap">on-time</FONT> delivery will
continue to be a hallmark of the Company&#146;s ability to compete </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE NINE MONTHS ENDED
JANUARY 31, 2020 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">with other market players. Further, the recent acquisitions translate to spreading the IPA footprint on two
continents. In addition, the Company has deployed a sales team tasked with continually sourcing and providing market intelligence as part of its activities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Intellectual Property Protection </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although IPA is
developing its patent portfolio, IPA&#146;s intellectual property is still protected primarily through trade secrets and copyright protection. The Company takes steps to document and protect its trade secrets and authorship of works protectable by
copyright. However, there is no guarantee that such steps protect against the disclosure of confidential information, rights of employees, or that legal actions would provide sufficient remedy for any breach. Additionally, IPA&#146;s trade secrets
might otherwise become known or be independently developed by competitors. If the Company&#146;s internal information and knowledge cannot be protected, the business might be adversely affected. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Failure of Laboratory Facilities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s
operations could suffer as a result of a failure of its laboratory facilities. The Company&#146;s business is dependent upon a laboratory infrastructure to produce products and services. These systems and operations are vulnerable to damage and
interruption from fires, earthquakes, telecommunications failures, and other events. Any such errors or inadequacies in the software that may be encountered could adversely affect operations, and such errors may be expensive or difficult to correct
in a timely manner. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The production of monoclonal and polyclonal antibodies requires state of the art laboratory facilities and animal care standards and
the success of these laboratory services depends on the recruitment and retention of highly qualified technical staff to maintain the level and quality standards that customers expect of the Company&#146;s products and services. There is no
assurance that the Company will be able to expand and operate such <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">state-of-the-art</FONT></FONT></FONT> laboratory services and recruit and retain
qualified staff. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Financial and Regulatory Risks </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company is currently subject to financial and regulatory risks. The financial risk is derived from the uncertainty pertaining to the Company&#146;s ability to raise capital to continue operations.&nbsp;Regulatory risks include the possible delays in
getting regulatory approval for the transactions that the Board of Directors believe to be in the best interest of the Company and include increased fees for filings and the introduction of ever more complex reporting requirements, the cost of which
the Company must meet in order to maintain its exchange listing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g29h61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE NINE MONTHS ENDED
JANUARY 31, 2020 </P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Pandemic Risk </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A new Coronavirus, known as <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> and causing a disease called <FONT
STYLE="white-space:nowrap">COVID-19,</FONT> which has proved to be highly contagious, emerged in Wuhan, China at the end of 2019. Since the future course and duration of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> outbreak are unknown, the
Company is currently unable to determine whether the outbreak will have a negative effect on the Company&#146;s results in the fourth quarter of 2020 and beyond. There has been no impact on results through January&nbsp;31, 2020, and the Company has
not experienced negative impact on client sales or the supply chain. The Company&#146;s sales, operations and financial performance could suffer given a potential rapidly spreading virus. Internally, the virus may infect its employees resulting in
operating at lower productivity levels or even a complete laboratory shutdown. The company&#146;s business is dependent on its laboratories to produce its products and services which if not operating will impact the financial performance of the
company and its ability to meet its obligations. The Company has diversified geographic locations with the ability to perform similar services at other sites. In addition, certain roles have the ability to work remotely and the Company has business
interruption insurance which may aid in the recovery of lost profits. External factors may also contribute to this risk, such as the impact of a pandemic on the Company&#146;s clients and suppliers. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FURTHER INFORMATION </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additional information relating to
the Company can be found on SEDAR at <U>www.sedar.com</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Canada | Europe | United
States </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.immunoprecise.com </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.46
<SEQUENCE>47
<FILENAME>d20922dex9946.htm
<DESCRIPTION>EX-99.46
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.46</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.46 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g20922snap0001.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR THE THREE AND NINE MONTHS ENDED JANUARY&nbsp;31, 2020 AND 2019 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited &#150; Expressed in Canadian Dollars) </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF NO AUDITOR REVIEW OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying unaudited condensed interim consolidated financial statements of the Company and all information contained in the third quarter 2020 report
have been prepared by and are the responsibility of the Company&#146;s management. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit Committee of the Board of Directors has reviewed the
condensed interim consolidated financial statements and related financial reporting matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s independent auditor has not performed a
review of these condensed interim consolidated financial statements in accordance with standards established by the Chartered Professional Accountants of Canada for a review of condensed interim consolidated financial statements by an entity&#146;s
auditor. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDENSED INTERIM CONSOLIDATED STATEMENTS OF FINANCIAL POSITION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Note</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>January&nbsp;31,</B><br><B>2020</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,</B><br><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ASSETS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,938,836</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,471,650</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,186,009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,558,354</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,274,527</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,120,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">714,932</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">393,451</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">480,722</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">333,702</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,595,026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,877,971</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65,757</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,450</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>7</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>8</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,648,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,638,549</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>6,&nbsp;7,&nbsp;9</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,148,415</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,417,231</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>5, 6</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,012,714</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,254,114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,560,378</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,345,719</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>LIABILITIES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>14</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">969,877</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,594,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,252,213</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">724,693</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>10</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,708,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>11</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82,953</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>12</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">464,949</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,757</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>5, 6</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">972,792</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,031,237</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,454,847</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,204,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>11</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,717</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>12</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">895,953</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,320</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>5, 6</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,755,964</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,032,744</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,004,256</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,939,559</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,111,020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,276,644</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>SHAREHOLDERS&#146; EQUITY</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>13</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,728,415</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,699,425</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contributed surplus</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>13</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,704,917</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,074,192</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(451,168</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(228,060</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(21,532,806</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,476,482</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,449,358</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,069,075</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities and equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,560,378</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,345,719</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nature of operations (Note 1) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Commitments (Note 15) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Approved and authorized on behalf of the
Board of Directors on March 09, 2020 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<I>James Kuo&#148;
</I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<I>Greg
Smith</I>&#148;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these condensed interim consolidated financial statements </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDENSED INTERIM CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and nine months ended January&nbsp;31, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="54%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Three&nbsp;months&nbsp;ended</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Nine&nbsp;months&nbsp;ended</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>January&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>January&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Note</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>REVENUE</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,034,440</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,695,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,912,904</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,285,159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>COST OF SALES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,810,771</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,127,528</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,822,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,561,458</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>GROSS PROFIT</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,223,669</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,568,055</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,090,090</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,723,701</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>EXPENSES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Advertising</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,117</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">357,286</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">226,267</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">679,932</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization and depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>8,&nbsp;9</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">783,076</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">137,499</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,077,460</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">522,282</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bad debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,943</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,192</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Consulting fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68,998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">92,963</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">134,343</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">405,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange gain</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,978</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(88,329</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(142,875</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Insurance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39,350</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,734</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">83,465</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,488</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest and bank charges</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">139,388</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87,306</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">373,136</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">320,967</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Management fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>14</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">419,045</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,881</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">489,480</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">137,778</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Office and general</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(57,268</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">211,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">552,239</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">525,491</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Professional fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>14</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">173,659</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">129,939</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">688,939</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">743,722</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,234</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">99,883</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">134,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">302,024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repairs and maintenance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,243</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,887</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,376</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">161,707</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54,190</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,049</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">667,292</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">297,198</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Salaries and benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>14</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">601,826</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">865,938</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,695,543</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,657,536</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>13,&nbsp;14</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">143,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">234,924</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">643,215</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">729,747</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Telephone and utilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,298</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,994</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39,832</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,367</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Travel</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78,318</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,719</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">256,819</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">220,778</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,600,495</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,551,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,077,216</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,706,912</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Loss before other income (expenses) and income taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(376,826</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(982,945</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,987,126</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,983,211</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>OTHER INCOME (EXPENSES)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>5, 6, 9</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(109,893</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(189,652</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(875,753</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(668,189</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest and other income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(231</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,946</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54,470</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">125,005</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(110,124</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(145,706</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(821,283</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(543,184</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Loss before income taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(486,950</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,128,651</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,808,409</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,526,395</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(138,887</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(58,405</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(193,171</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(248,755</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>NET LOSS FOR THE PERIOD</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(625,837</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,187,056</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,001,580</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,775,150</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ITEMS THAT MAY BE RECLASSIFIED SUBSEQUENTLY TO </B>LOSS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange difference on translating foreign operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">328,584</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">133,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(223,108</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(465,671</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>COMPREHENSIVE LOSS FOR THE PERIOD</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(297,253</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,053,286</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,224,688</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,240,821</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>LOSS PER SHARE &#150; BASIC AND DILUTED</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.01</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.06</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.06</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>WEIGHTED AVERAGE NUMBER OF SHARES </B><B>OUTSTANDING</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,994,445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,163,809</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,990,224</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,168,049</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these condensed interim consolidated financial statements </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian dollars, except for share figures) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Share</B><br><B>Capital</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Contributed</B><br><B>Surplus</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated</B><br><B>Other</B><br><B>Comprehensive</B><br><B>(Loss) Income</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Deficit</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>55,474,178</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20,455,112</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,707,738</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>277,090</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(9,859,015</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>12,580,925</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to private placements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,977,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,802,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,802,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash issue costs and finders&#146; fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">182,460</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(288,504</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(288,504</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to settlement of Debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,377,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,115,370</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">283,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,398,370</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to Crossbeta settlement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78,514</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to option exercise</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">110,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,980</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,980</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">729,747</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">729,747</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss for the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(465,671</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,775,150</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,240,821</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, January&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>67,199,652</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>31,203,699</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,695,505</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(188,581</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(13,634,165</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20,076,458</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustment to value of shares issued pursuant to acquisition of IPA Europe and Immulease</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">975,045</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">975,045</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to deferred acquisition payment to IPA Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">714,793</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">507,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">507,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to option exercise</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,178</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,678</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">384,365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">384,365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss for the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(39,479</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,842,317</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,881,796</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>67,939,445</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>32,699,425</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,074,192</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(228,060</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(17,476,482</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>18,069,075</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adoption of IFRS 16 (Note 3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(54,744</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(54,744</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, May&nbsp;1, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>67,939,445</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>32,699,425</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,074,192</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(228,060</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(17,531,226</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>18,014,331</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to option exercise</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,990</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12,490</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">643,215</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">643,215</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss for the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(223,108</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,001,580</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,224,688</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, January&nbsp;31, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>67,994,445</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>32,728,415</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,704,917</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(451,168</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(21,532,806</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>14,449,358</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these condensed interim consolidated financial statements </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the nine months ended January&nbsp;31, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss for the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,001,580</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,775,150</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Items not affecting cash:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization and depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,973,696</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">685,258</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,429</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(166,432</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">883,485</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">668,189</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,609</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(142,875</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">643,215</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">729,747</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(508,364</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,001,263</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in <FONT STYLE="white-space:nowrap">non-cash</FONT> working capital related to
operations:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(627,655</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">509,726</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(153,713</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(255,372</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(321,481</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">130,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(147,020</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">92,949</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(624,185</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,110,676</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">527,520</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">306,493</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,854,898</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,327,446</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Investing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(368,143</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(542,975</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Internally generated development costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(169,716</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,007,435</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,049,754</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividend received</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,460</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,545,294</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,587,269</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Financing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds on share issuance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,835,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(288,504</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repayment of leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(229,423</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from loans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loan repayments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(66,654</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(342,874</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repayment of debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(125,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash (used in) provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(404,577</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,404,122</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(Decrease) increase in cash during the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,804,769</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,489,407</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">270,262</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(172,994</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash &#150; beginning of the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,539,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,806,133</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash &#150; end of the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,004,593</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,122,546</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash paid for interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">143,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">216,572</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash paid for income tax</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">140,861</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Supplemental cash flow information (Note 17) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these condensed interim consolidated financial statements </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and nine months ended January 31, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>NATURE OF OPERATIONS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd. (the &#147;Company&#148; or &#147;IPA&#148;) was incorporated under the laws of Alberta on November&nbsp;22,
1983. The Company is listed on the TSX Venture Exchange (the &#147;Exchange&#148;) as a Tier 2 life science issuer under the trading symbol &#147;IPA&#148;. The Company&#146;s OTC symbol is &#147;IPATF&#148;. The Company is a supplier of custom
hybridoma development services. The address of the Company&#146;s corporate office is 3204 &#150; 4464 Markham Street, Victoria, BC, Canada V8Z 7X8. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The condensed interim consolidated financial statements have been prepared on the basis of accounting principles applicable to a going concern.
This assumes the Company will continue in operation for the foreseeable future and will be able to realize its assets and discharge its obligations in the normal course of operations. The Company has incurred operating losses since inception,
including $4,001,580 for the nine months ended January&nbsp;31, 2020 and has accumulated a deficit of $21,532,806 as at January&nbsp;31, 2020. The Company may need to raise additional funds in order to continue on as a going concern and there can be
no assurances that sufficient funding, including adequate financing, will be available. The ability of the Company to arrange additional financing in the future depends in part, on the prevailing capital market conditions and profitability of its
operations. These material uncertainties may cast significant doubt on the Company&#146;s ability to continue as a going concern. Accordingly, the condensed interim consolidated financial statements do not give effect to adjustments that would be
necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets and liquidate its liabilities, contingent obligations and commitments other than in the normal course of business and at amounts
different from those in the condensed interim consolidated financial statements. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>BASIS OF PRESENTATION </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(a) Statement of compliance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">These condensed interim consolidated financial statements have been prepared in conformity with International Accounting Standard
(&#147;IAS&#148;) 34, <I>Interim Financial Reporting</I>, using the same accounting policies as detailed in the Company&#146;s audited annual financial statements for the year ended April&nbsp;30, 2019. They do not include all the information
required for complete annual financial statements in accordance with International Financial Reporting Standards (&#147;IFRS&#148;), as issued by the International Accounting Standards Board (&#147;IASB&#148;) and interpretations of the
International Financial Reporting Interpretations Committee (&#147;IFRIC&#148;) and therefore should be read together with the audited annual financial statements for the year ended April&nbsp;30, 2019. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">These condensed interim consolidated financial statements were approved by the Board of Directors for issue on March 09, 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(b) Basis of measurement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">These condensed interim consolidated financial statements have been prepared on the historical cost basis. In addition, these condensed interim
consolidated financial statements have been prepared using the accrual basis of accounting, except for cashflow information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and nine months ended January 31, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(c) Basis of consolidation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">These condensed interim consolidated financial statements include the financial statements of the Company and the following subsidiaries which
are wholly owned and subject to control by the Company: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Name&nbsp;of&nbsp;Subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">%&nbsp;Equity<br><FONT STYLE="white-space:nowrap">Interest&nbsp;-&nbsp;2020</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">%&nbsp;Equity<br><FONT STYLE="white-space:nowrap">Interest&nbsp;-&nbsp;2019</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Country&nbsp;of<BR>Incorporation</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (Canada) Ltd.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Canada</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (USA) Ltd., incorporated in Nevada, USA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">USA</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (USA) Ltd., incorporated in Delaware, USA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">USA</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (N.D.) Ltd.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">USA</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (MA) LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">USA</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Talem Therapeutics LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">USA</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">U-Protein</FONT> Express B.V.
<FONT STYLE="white-space:nowrap">(&#147;U-Protein&#148;)</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Netherlands</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Netherlands B.V.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Netherlands</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (Europe) B.V. (&#147;IPA Europe&#148;, formerly ModiQuest Research
B.V.)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Netherlands</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Immulease B.V. (&#147;Immulease&#148;)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Netherlands</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Control is achieved when the Company has the power to, directly or indirectly, govern the financial and
operating policies of an entity so as to obtain benefits from its activities. Subsidiaries are fully consolidated from the date on which control is obtained and continue to be consolidated until the date that such control ceases. Intercompany
balances, transactions and unrealized intercompany gains and losses are eliminated upon consolidation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company incorporated a new
subsidiary, ImmunoPrecise Antibodies (USA) Ltd. in Delaware, USA on September&nbsp;11, 2019. ImmunoPrecise Antibodies (USA) Ltd., incorporated in Nevada, USA, was dissolved on November&nbsp;4, 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(d) Functional and presentation currency </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The functional currency of a company is the currency of the primary economic environment in which the company operates. The presentation
currency for a company is the currency in which the company chooses to present its financial statements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The functional currency of the
Company and ImmunoPrecise Antibodies (Canada) Ltd. is the Canadian dollar. The functional currency of ImmunoPrecise Antibodies (USA) Ltd., ImmunoPrecise Antibodies (N.D.) Ltd., ImmunoPrecise Antibodies (MA) LLC and Talem Therapeutics LLC is the US
dollar. The functional currency of <FONT STYLE="white-space:nowrap">U-Protein,</FONT> ImmunoPrecise Netherlands BV, IPA Europe and Immulease is the Euro. The presentation currency of the Company is the Canadian dollar. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Entities whose functional currencies differ from the presentation currency are translated into Canadian dollars as follows: assets and
liabilities &#150; at the closing rate as at the reporting date, and income and expenses &#150; at the average rate of the period. All resulting changes are recognized in other comprehensive income as cumulative translation differences. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Transactions in foreign currencies are translated into the functional currency at exchange rates at the date of the transactions. Foreign
currency monetary assets and liabilities are translated at the functional currency exchange rate at the reporting date. <FONT STYLE="white-space:nowrap">Non-monetary</FONT> items that are measured in terms of historical cost in a foreign currency
are translated using exchange rates as at the dates of the initial transactions. <FONT STYLE="white-space:nowrap">Non-monetary</FONT> items measured at fair value in a foreign currency are translated using the exchange rates at the date when the
fair value is determined. All gains and losses on translation of these foreign currency transactions are included in profit or loss. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and nine months ended January 31, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">When the Company disposes of its entire interest in a foreign operation, or loses control,
joint control, or significant influence over a foreign operation, the foreign currency gains or losses accumulated in other comprehensive income related to the foreign operation are recognized in profit or loss. If an entity disposes of part of an
interest in a foreign operation which remains a subsidiary, a proportionate amount of foreign currency gains or losses accumulated in other comprehensive income related to the subsidiary are reallocated between controlling and <FONT
STYLE="white-space:nowrap">non-controlling</FONT> interests. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ADOPTION OF NEW ACCOUNTING STANDARDS AND ACCOUNTING STANDARDS ISSUED BUT NOT YET EFFECTIVE
</B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(a) Adoption of New Accounting Standards </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has adopted the following new standards, along with any consequential amendments, effective May&nbsp;1, 2019. These changes were
made in accordance with the applicable transitional provisions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company adopted all of the requirements of IFRS 16, <I>Leases</I>
(&#147;IFRS 16&#148;) as of May&nbsp;1, 2019. IFRS 16 replaces IAS 17, <I>Leases</I> (&#147;IAS 17&#148;). IFRS 16 provides a single lessee accounting model, requiring lessees to recognize assets and liabilities for all leases unless the lease term
is 12 months or less or the underlying asset has a low value. The Company has adopted IFRS 16 using the modified retrospective application method, where the 2019 comparatives are not restated and a cumulative catch up adjustment is recorded on
May&nbsp;1, 2019 for any differences identified, including adjustments to opening deficit balance. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company analyzed its contracts to
identify whether they contain a lease arrangement for the application of IFRS 16. The following is the Company&#146;s new accounting policy for leases under IFRS 16: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">At inception of a contract, the Company assesses whether the contract is, or contains, a lease. A contract is, or contains, a lease if the
contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Leases of <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets are recognized at the lease commencement date at the present value of the lease payments that are not paid at that date. The lease payments are discounted
using the interest rate implicit in the lease, if that rate can be readily determined, and otherwise at the Company&#146;s incremental borrowing rate. At the commencement date, a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset is measured at cost, which is comprised of the initial amount of the lease liability adjusted for any lease payments made at or before the
commencement date, plus any decommissioning and restoration costs, less any lease incentives received. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Each lease payment is allocated
between repayment of the lease principal and interest. Interest on the lease liability in each period during the lease term is allocated to produce a constant periodic rate of interest on the remaining balance of the lease liability. Except where
the costs are included in the carrying amount of another asset, the Company recognizes in profit or loss (a)&nbsp;the interest on a lease liability and (b)&nbsp;variable lease payments not included in the measurement of a lease liability in the
period in which the event or condition that triggers those payments occurs. The Company subsequently measures a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset at cost less any accumulated
depreciation and any accumulated impairment losses; and adjusted for any remeasurement of the lease liability. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> assets are depreciated over the shorter of
the asset&#146;s useful life and the lease term, except where the lease contains a bargain purchase option a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset is depreciated over the asset&#146;s
useful life. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and nine months ended January 31, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On the date of transition, the Company recorded a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset of $1,668,533 related to the office rent in property and equipment, and the lease obligation of $1,723,277 was recorded as at May&nbsp;1, 2019, discounted using the Company&#146;s
incremental borrowing rate of 8%, and measured at an amount equal to the lease obligation as if IFRS 16 had been applied since the commencement date. The net difference between
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets and lease liabilities on the date of transition was recognized as a deficit adjustment of $54,744 on May&nbsp;1, 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(b) Accounting Standards Issued But Not Yet Effective </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In October 2018, the IASB issued amendments to IFRS 3, Business Combinations. The amendments narrowed and clarified the definition of a
business. The amendments will help companies determine whether an acquisition is a business or a group of assets. They also permit a simplified assessment of whether an acquired set of activities and assets is a group of assets rather than a
business. Distinguishing between a business and a group of assets is important because an acquirer recognizes goodwill only when acquiring a business. This amendment will be effective for annual periods beginning on or after January&nbsp;1, 2020.
Early adoption is permitted. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CRITICAL ACCOUNTING ESTIMATES AND JUDGMENTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The preparation of the condensed interim consolidated financial statements in conformity with IFRS required estimates and judgments that affect
the amounts reported in the financial statements. Actual results could differ from these estimates and judgments. Estimates are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the year in which the estimate is
revised. Significant areas requiring the use of estimates and judgments are as follows: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Functional currency</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has used judgment in determining the currency of the primary economic environment in which the entity operates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Amounts receivable</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The
Company monitors the financial stability of its customers and the environment in which they operate to make estimates regarding the likelihood that the individual trade receivable balances will be paid. Credit risks for outstanding customer
receivables are regularly assessed and allowances are recorded for estimated losses, if required. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Property and equipment</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has used estimates in the determination of the expected useful lives of property and equipment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Revenue recognition</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">percentage-of-completion</FONT></FONT> method requires the use of estimates to determine the stage of completion which is used to determine the recorded amount of revenue, unbilled revenue
and deferred revenue on uncompleted contracts. The determination of anticipated revenues includes the contractually agreed revenue and may also involve estimates of future revenues if such additional revenues can be reliably estimated and it is
considered probable that they will be recovered. The determination of anticipated costs for completing a contract is based on estimates that can be affected by a variety of factors, including the cost of materials, labour, and <FONT
STYLE="white-space:nowrap">sub-contractors.</FONT> The determination of estimates is based on the Company&#146;s business practices as well as its historical experience. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and nine months ended January 31, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Impairments</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the purposes of assessing impairment, assets are grouped at the lowest levels for which there are separately identifiable cash flows
(&#147;cash generating units&#148; or &#147;CGU&#148;s). Each asset or CGU is evaluated every reporting period to determine whether there are any indicators of impairment. If any such indicators exist, which is often judgment-based, a formal
estimate of recoverable amount is performed and an impairment charge is recognized to the extent that the carrying amount exceeds the recoverable amount. The recoverable amount of an asset or CGU of assets is measured at the higher of fair value
less costs of disposal or value in use. These determinations and their individual assumptions require that management make a decision based on the best available information at each reporting period. The estimates and assumptions are subject to risk
and uncertainty; hence, there is the possibility that changes in circumstances will alter these projections, which may impact the recoverable amount of the assets. In such circumstances, some or all of the carrying value of the assets may be further
impaired or the impairment charge reversed with the impact recorded in profit or loss. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company performs a goodwill impairment test
annually and when circumstances indicate that the carrying value may not be recoverable. For the purposes of impairment testing, goodwill acquired through business combinations has been allocated to two different CGUs. The recoverable amount of each
CGU was based on value in use, determined by discounting the future cash flows to be generated from the continuing use of the CGU. The cash flows were projected over a five-year period based on past experience and actual operating results. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company performed its annual goodwill impairment test in April 2019 and no impairment was indicated for the period tested. The values
assigned to the key assumptions represented management&#146;s assessment of future trends in the industry and were based on historical data from both internal and external sources. Weighted average costs of capital of 17.5% and 10.2%, respectively,
was used in the assessments of the two CGUs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Determination of segments</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">An operating segment is a component of the Company that engages in business activities from which it may earn revenues and incur expenses. All
operating segments&#146; results are reviewed by the Company&#146;s management in order to make decisions regarding the allocation of resources to the segment. Segment results include items directly attributable to a segment as those that can be
allocated on a reasonable basis. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As the Company provides antibody production and related services in one distinct category, there is only
one category to report revenues by production site. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Life of intangible assets</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Intangible assets are amortized based on estimated useful life less their estimated residual value. Significant assumptions are involved in the
determination of useful life and residual values and no assurance can be given that actual useful lives and residual values will not differ significantly from current assumptions. Actual useful life and residual values may vary depending on a number
of factors including internal technical evaluation, attributes of the assets and experience with similar assets. Changes to these estimates may affect the carrying value of assets, net income (loss) and comprehensive income (loss) in future periods.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Purchase price allocation</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The acquisition of <FONT STYLE="white-space:nowrap">U-Protein</FONT> on August&nbsp;22, 2017 and the acquisition of IPA Europe and Immulease on
April&nbsp;5, 2018 were accounted for as business combinations at fair value in accordance with IFRS 3, <I>Business Combinations</I>. The acquired assets and assumed liabilities were adjusted to their fair values assigned through completion of a
purchase price allocation, as described below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and nine months ended January 31, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The purchase price allocation process resulting from a business combination requires
management to estimate the fair value of identifiable assets acquired including intangible assets and liabilities assumed including the deferred acquisition payment obligations. The Company uses valuation techniques, which are generally based on
forecasted future net cash flows discounted to present value, and also relies on work performed by third-party valuation specialists. These valuations are closely linked to the assumptions used by management on the future performance of the related
assets and the discount rates applied. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ACQUISITION OF <FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On August&nbsp;22, 2017, the Company completed the acquisition of <FONT STYLE="white-space:nowrap">U-Protein</FONT> whereby the Company has
acquired all of the issued and outstanding shares of <FONT STYLE="white-space:nowrap">U-Protein</FONT> for &#128;6,830,000 on terms as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,734,732 (CAD$4,062,607) was paid in cash on closing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3,030,503 common shares of the Company were issued on closing; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,047,634 in deferred payments over a three-year period. The deferred payments can be made in cash or
common shares of the Company at the election of <FONT STYLE="white-space:nowrap">U-Protein</FONT> shareholders. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The
transaction was accounted for as a business combination, as the operations of <FONT STYLE="white-space:nowrap">U-Protein</FONT> meet the definition of a business. As the transaction was accounted for as a business combination, transaction costs of
$17,717 were expensed. The goodwill resulting from the allocation of the purchase price to the total fair value of net assets represented the sales and growth potential of <FONT STYLE="white-space:nowrap">U-Protein.</FONT> Goodwill recorded is
allocated in its entirety to <FONT STYLE="white-space:nowrap">U-Protein.</FONT> The fair value of the 3,030,503 common shares issued ($3,022,308) was determined based on the Canadian dollar equivalent of the consideration required of &#128;2,047,634
pursuant to the share purchase agreement. The Company has allocated the purchase price as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,062,607</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3,030,503 common shares of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,022,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of deferred payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,134,410</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,219,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">797,276</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">370,530</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,815</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment, net of accumulated amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">216,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intellectual property (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,064,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,655,893</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(269,657</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income taxes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,197</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(810,800</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,219,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and nine months ended January 31, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The deferred payments of &#128;2,047,634 over a three-year period was fair valued on the date
of acquisition using a discounted cash flow model. A discount rate of 16.3% was used. The changes in the value of the deferred payments during the nine months ended January&nbsp;31, 2020 and the year ended April&nbsp;30, 2019 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,408,205</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">244,915</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,049,754</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(40,670</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,562,696</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">315,348</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,007,435</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,473</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, January&nbsp;31, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">885,082</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ACQUISITION OF IPA EUROPE AND IMMULEASE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company acquired all of the issued and outstanding shares of IPA Europe and its sister entity, Immulease, for an
aggregate purchase price of &#128;7,000,000 on terms as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,500,000 (CAD$3,988,132) was paid in cash on closing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">6,600,399 common shares of the Company were issued on closing; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,000,000 in deferred payments over a three-year period. The deferred payments are made in three equal
installments of cash and equity totaling &#128;666,666 and prorated if the EBITDA of IPA Europe for the fiscal year preceding the date of payment is less than its average EBITDA over the previous two fiscal years. During the year ended
April&nbsp;30, 2019, the Company and the seller entered into an Amendment, Termination and Settlement Agreement whereby the deferred payments shall no longer be subject to an adjustment and will be paid in equal installments of cash and equity
totaling &#128;666,666. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The transaction was accounted for as a business combination, as the operations of IPA Europe and
Immulease meet the definition of a business. As the transaction was accounted for as a business combination, transaction costs of $36,821 were expensed. The goodwill resulting from the allocation of the purchase price to the total fair value of net
assets represented the sales and growth potential of IPA Europe. Goodwill recorded is allocated in its entirety to IPA Europe. The fair value of the 6,600,399 common shares issued ($4,884,295) was determined to be $0.74 per share based on the fair
value of the Company&#146;s shares immediately prior to the completion of the acquisition. The Company has allocated the purchase price as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,988,132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6,600,399 common shares of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,884,295</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of deferred payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,353,708</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,226,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">270,339</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">572,427</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,286,995</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment, net of accumulated amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">568,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Software</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible assets (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,304,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,640,671</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(580,339</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(22,897</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(298,979</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,636,192</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,226,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and nine months ended January 31, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The deferred payments of &#128;2,000,000 over a three-year period was fair valued on the date
of acquisition using a discounted cash flow model. A discount rate of 10.1% was used. The changes in the value of the deferred payments during the nine months ended January&nbsp;31, 2020 and the year ended April&nbsp;30, 2019 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,403,954</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in estimate of fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(34,258</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">232,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,014,503</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(86,326</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,501,285</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">401,471</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(59,082</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, January&nbsp;31, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,843,674</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INVESTMENT </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Investment consists of a 29% (2019 &#150; 29%) interest in QVQ Holding B.V. (&#147;QVQ&#148;), which is recorded at cost, being the best
approximation of the investment&#146;s fair value. Judgment is required as to the extent of influence that the Company has over QVQ. The Company considered the extent of voting power over the entity, the power to participate in financial and
operating policy decisions of the entity, representation on the board of directors, material transactions between the entities, interchange of management personnel, and provision of essential technical information. The Company has determined that
the Company is not considered to have significant influence over QVQ, as the Company does not have the power to participate in financial and operating policy decisions, does not have representation on the Board of Directors of QVQ, and the majority
of the common shares are held by QVQ management. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and nine months ended January 31, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>PROPERTY AND EQUIPMENT </B></P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Computer</B><br><B>Hardware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Furniture&nbsp;&amp;</B><br><B>Equipment</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Computer</B><br><B>Software</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Building</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Automobile</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Leasehold</B><br><B>Improvements</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Lab</B><br><B>Equipment</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><U>Cost:</U></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93,813</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98,527</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,373</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">393,421</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,787,105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,385,239</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquired on acquisition of IPA Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,184</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,538</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87,821</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">612,046</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">729,589</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,153</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,141</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(31,294</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">110,997</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,065</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">130,015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">393,421</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,369,010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,114,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IFRS 16 transition adjustment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,668,533</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,668,533</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,182</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,263</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,205</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,495</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">254,998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">368,143</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Disposals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(73,697</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(75,052</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,804</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(320,645</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(49,221</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(632,290</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,158,709</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(871</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(935</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(26,107</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(27,767</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, January 31, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>51,482</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>36,013</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>121,340</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,391,216</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>48,351</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>350,695</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,965,611</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,964,708</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><U>Accumulated Depreciation:</U></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,883</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,218</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,299</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,552,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,803,870</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,252</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,533</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103,764</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500,194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">677,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(43</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,029</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,072</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,636</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,789</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">205,816</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,047,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,475,959</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,519</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,408</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,005</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">280,182</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51,738</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">355,197</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">777,066</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Disposals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(73,697</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(75,052</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,804</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(80,616</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(49,221</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(632,290</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(918,680</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(218</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,493</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,699</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, January 31, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>31,957</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>15,992</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>103,772</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>199,566</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,029</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>208,333</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,752,997</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,316,646</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Book Value:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,429</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81,226</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">187,605</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,321,427</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,638,549</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>January&nbsp;31, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>19,525</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20,021</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>17,568</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,191,650</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>44,322</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>142,362</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,212,614</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,648,062</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and nine months ended January 31, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INTANGIBLE ASSETS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The intangible assets were acquired as a result of the acquisitions of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe and are
amortized using the straight-line method over their useful lives. The intellectual property has a useful life of 10 years, and the proprietary processes and certifications have a useful life of 5 years. The changes in the value of the intangible
assets during the nine months ended January&nbsp;31, 2020 and the year ended April&nbsp;30, 2019 are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Internally</B><br><B>Generated</B><br><B>Development</B><br><B>Costs</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Intellectual<BR>Property </B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Proprietary<BR>Processes </B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Certifications</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total </B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><U>Cost:</U></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,270,229</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,270,229</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquired on acquisition of IPA Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,159,755</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">145,108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,304,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(125,004</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(229,263</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,401</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(359,668</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,145,225</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,930,492</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">139,707</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,215,424</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">169,716</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">169,716</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,184</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(121,232</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(173,443</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,086</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(302,945</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, January&nbsp;31, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>165,532</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,023,993</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,757,049</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>135,621</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>10,082,195</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><U>Accumulated Amortization:</U></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">227,746</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">227,746</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">416,890</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,169,233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,586,123</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,035</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,641</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(15,676</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">635,601</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,162,592</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,798,193</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">303,867</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">892,763</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,196,630</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(20,656</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(40,387</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(61,043</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, January&nbsp;31, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>918,812</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,014,968</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,933,780</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Book Value:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,509,624</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,767,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">139,707</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,417,231</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>January&nbsp;31, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>165,532</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,105,181</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,742,081</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>135,621</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,148,415</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DEBENTURES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company completed a nonconvertible debenture (the &#147;Debentures&#148;) financing in the principal amount of
$4,252,000 (the &#147;Offering&#148;). The Debentures were unsecured, bore interest at a rate of 10% per annum, payable semi-annually, and were due eighteen months from the date of issue. Under the Offering, a holder of a Debenture received 37,500
detachable share purchase warrants (the &#147;Warrants&#148;) for every $25,000 of Debentures subscribed for by the holder. The Warrants are exercisable at $0.70 per share for a period of four years from the date of issue. The fair value of the
Debentures at the time of issue was calculated as the discounted cash flows assuming a 15% effective interest rate. The fair value of the Warrants was determined at the time of issue as the difference between the face value and the fair value of the
Debentures. On initial recognition, the Company bifurcated $4,003,125 to the carrying value of the Debentures and $248,875 to the Warrants. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and nine months ended January 31, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Under the Offering, the Company paid the following finder&#146;s fees: $10,300 in cash,
580,320 shares of the Company with a fair value of $383,010, and 415,942 finder&#146;s warrants valued at $187,627. The fair value of the finder&#146;s warrants was estimated on the date of issue using the Black-Scholes option valuation model with
the following weighted average assumptions: dividend yield of $nil, risk free interest rate of 1.60%, expected life of 4 years and expected volatility based on the historical volatility of similar companies of 100%. The total fair value of the
finder&#146;s fees was allocated <FONT STYLE="white-space:nowrap">pro-rata</FONT> based on the carrying values of the Debentures and Warrants, with $546,934 allocated to the Debentures and $34,003 allocated to the Warrants. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;25, 2018, the Company settled $1,377,000 of the Debentures by issuing 1,377,000 units at a price of $1.00 per unit. Each unit
consists of one common share of the Company and one share purchase warrant, with each warrant entitling the holder to purchase an additional share at $1.25 for two years. The fair value of the 1,377,000 common shares issued was determined to be
$1,115,370. The fair value of the warrants issued was determined to be $283,000 and estimated on the date of issue using the Black-Scholes option valuation model with the following weighted average assumptions: dividend yield of $nil, risk free
interest rate of 1.58%, expected life of 2 years and expected volatility based on the historical volatility of similar companies of 68.7%. The settlement resulted in a loss of $189,715. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;26, 2019, the Company modified the terms of $2,750,000 debentures to extend the due date 6 months to March&nbsp;26, 2020,
with the ability to pay earlier with no penalty, and increase the interest rate to 12.5%. The remaining debentures of $125,000 were paid on maturity. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the three and nine months ended January&nbsp;31, 2020, the Company recorded accretion expense of $70,910 and $166,666 (2018 &#150;
$71,309 and $318,726). The changes in the value of the Debentures during the nine months ended January&nbsp;31, 2020 and the year ended April&nbsp;30, 2019 are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,489,397</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">427,592</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Settlement of debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,208,655</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,708,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">166,666</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repayment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(125,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, January&nbsp;31, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>LOANS PAYABLE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company assumed loans payable of &#128;60,750 (CAD$94,995) as a result of the acquisition of IPA Europe. On
July&nbsp;7, 2015, IPA Europe entered into a loan agreement in the principal amount of &#128;165,000, maturing on July&nbsp;31, 2020. The loan is secured by certain equipment, bears an interest rate of 4% per annum and is repayable in monthly
installments of &#128;2,250. The interest is owed per month in arrears. The principal outstanding at January&nbsp;31, 2020 is &#128;11,250 (CAD$16,416) (April 30, 2019 &#150; &#128;31,500 (CAD$47,423)). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company assumed loans payable of &#128;56,450 (CAD$88,271) as a result of the acquisition of IPA Europe. On
February&nbsp;1, 2016, IPA Europe entered into a loan agreement in the principal amount of &#128;100,000, maturing on February&nbsp;28, 2021. The loan is secured by certain equipment, bears an interest rate of 3% per annum and is repayable in
monthly installments of &#128;1,675. The interest is owed per month in arrears. The principal outstanding at January&nbsp;31, 2020 is &#128;19,600 (CAD$28,600) (April 30, 2019 &#150; &#128;34,675 (CAD$52,203)). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and nine months ended January 31, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April 5, 2018, the Company assumed loans payable of &#128;74,000 (CAD$115,713) as a result
of the acquisition of Immulease. On May 18, 2016, Immulease entered into a credit facility agreement pursuant to which the lender provides a facility amount of up to &#128;200,000. The credit facility is unsecured, bears an interest rate of 3% per
annum and is repayable on demand. The interest is owed per month in arrears. The principal outstanding at January 31, 2020 is &#128;nil (CAD$nil) (April 30, 2019 &#150; &#128;8,000 (CAD$12,044)). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On May&nbsp;23, 2018, the Company entered into a loan agreement with a Director of the Company and his spouse and issued a promissory note in
the principal amount of $200,000. The note was unsecured and bore an interest rate of 5.45% per annum. The principal of the note plus accrued interest of $3,972 was repaid in full during the year ended April&nbsp;30, 2019. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">290,445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loan proceeds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loan repayments and foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(378,775</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,670</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loan repayments and foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(66,654</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, January&nbsp;31, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>LEASES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company entered into certain equipment and automobile leases expiring between 2021 and 2023 with interest rates of between 8% and 17% per
annum. The Company&#146;s obligations under these finance leases are secured by the lessor&#146;s title to the leased assets. The Company also entered into office leases in January 2018 and May 2018. With the adoption of IFRS 16, <I>Leases</I> (see
Note 3), the Company recognized a lease obligation with regard to the office leases. The terms and the outstanding balances as at January&nbsp;31, 2020 and April&nbsp;30, 2019 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>January&nbsp;31,</B><br><B>2020</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,</B><br><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment under lease in monthly instalments of $1,228 with interests of between 13% and 17% per
annum. Due dates are between May 2021 and March 2023.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98,527</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,077</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Automobile under lease in monthly instalments of $1,155 with an interest rate of 8% per annum and
an end date of September 2023.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,351</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> asset
from office lease repayable in monthly instalments of $14,485 and an interest rate of 8% per annum and an end date of April 2023.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">538,328</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> asset
from office lease repayable in monthly instalments of $22,012 and an interest rate of 8% per annum and an end date of December 2022.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">637,252</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> asset
from office lease repayable in monthly instalments of $1,224 and an interest rate of 8% per annum and an end date of December 2022.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38,444</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(464,949</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(35,757</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-current</FONT> portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">895,953</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,320</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and nine months ended January 31, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As at January&nbsp;31, 2020, the Company&#146;s equipment and automobile include a net
carrying amount of $98,527 (April 30, 2019 &#150; $104,014) for the leased equipment and $44,322 (April 30, 2019 &#150; $nil) for the leased automobile. The net carrying amount of the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets from office lease obligation is $1,191,650 (April 30, 2019 &#150; $nil). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following is a schedule of the Company&#146;s future minimum lease payments related to the equipment under finance lease and the office
lease obligation: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">172,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">536,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">492,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">381,490</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,774</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total minimum lease payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,588,885</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: imputed interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(227,983</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total present value of minimum lease payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,360,902</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Current portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(464,949</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-current</FONT> portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">895,953</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SHARE CAPITAL </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>a)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Authorized: </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Unlimited common shares without par value. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>b)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Share capital transactions: </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>2019 Transactions</I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On
June&nbsp;19, 2018, the Company closed a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement financing by issuing a total of 875,000 units of the Company at a price of $0.80 per unit for gross proceeds of $700,000. Each unit
consists of one common share of the Company and one share purchase warrant, with each warrant entitling the holder to purchase an additional share at a price of $1.00 for a period of one year from the date of issue. The Company will have the right
to accelerate the expiry date of the warrants provided that the volume weighted average price trades at a price equal to or greater than $1.50 for a period of 20 consecutive days. All of the proceeds have been allocated to the common shares issued
with a $nil value assigned to the warrants issued. The Company paid finders cash fees totaling $3,000 and incurred $7,926 of cash issue costs. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;24, 2018, the Company closed a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement financing by issuing a
total of 9,102,500 units of the Company at a price of $1.00 per unit for gross proceeds of $9,102,500. Each unit consists of one common share of the Company and one share purchase warrant, with each warrant entitling the holder to purchase an
additional share at a price of $1.25 for a period of two years from the date of issue. The Company will have the right to accelerate the expiry date of the warrants provided that the volume weighted average price trades at a price equal to or
greater than $1.75 for a period of 20 consecutive days. All of the proceeds have been allocated to the common shares issued with a $nil value assigned to the warrants issued. The Company paid finders cash fees totaling $201,540 and issued 182,460
finder&#146;s shares. The Company also incurred $76,038 of cash issue costs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and nine months ended January 31, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;22, 2017, the Company announced that it had signed a binding letter of
intent with Crossbeta Biosciences B.V. (&#147;Crossbeta&#148;) whereby the Company had agreed to acquire all of the issued and outstanding shares of Crossbeta. The proposed transaction was terminated and settled on October&nbsp;23, 2018. In
consideration of the settlement, the Company paid &#128;37,000 ($55,969) and issued 78,514 shares valued at $61,241. The Company accrued a settlement liability of $92,040 as at April&nbsp;30, 2018. As such, the remaining loss on settlement of
$25,170 was recognized in the year ended April&nbsp;30, 2019. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;25, 2018, the Company settled $1,377,000 of the Debentures
by issuing 1,377,000 units at a price of $1.00 per unit (Note 10). Each unit consists of one common share of the Company and one share purchase warrant, with each warrant entitling the holder to purchase an additional share at $1.25 for two years.
The fair value of the 1,377,000 common shares issued was determined to be $1,115,370. The fair value of the warrants issued was determined to be $283,000 and estimated on the date of issue using the Black-Scholes option valuation model with the
following weighted average assumptions: dividend yield of $nil, risk free interest rate of 1.58%, expected life of 2 years and expected volatility based on the historical volatility of similar companies of 68.7%. The settlement resulted in a loss of
$189,715. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;27, 2019, the Company issued 714,793 common shares pursuant to the second deferred payment to IPA Europe (Note 6).
The common shares are valued at $507,503. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2019, the Company issued 135,000 common shares pursuant to
exercise of stock options for total gross proceeds of $40,500. A value of $30,658 was transferred from contributed surplus to share capital as a result. The weighted average share price at dates the stock options were exercised was $1.05. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>2020 Transactions </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During
the nine months ended January&nbsp;31, 2020, the Company issued 55,000 common shares pursuant to exercise of stock options for total gross proceeds of $16,500. A value of $12,490 was transferred from contributed surplus to share capital as a result.
The weighted average share price at dates the stock options were exercised was $0.69. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>c)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Options </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has an incentive Stock Option Plan (&#147;the Plan&#148;) under which <FONT STYLE="white-space:nowrap">non-transferable</FONT>
options to purchase common shares of the Company may be granted to directors, officers, employees or service providers of the Company. The terms of the plan provide that the Directors have the right to grant options to acquire common shares of the
Company at not less than the closing market price of the shares on the day preceding the grant at terms of up to ten years. The maximum number of options outstanding under the Plan shall not result, at any time, in more than 10% of the issued and
outstanding common shares.&nbsp;&nbsp;&nbsp;&nbsp; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;24, 2018, the Company granted 95,000 stock options, exercisable at
$0.95 per option, to employees of the Company. The options are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date; <FONT STYLE="white-space:nowrap">one-third</FONT> 12 months after
grant date and <FONT STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $67,402 using the Black-Scholes option pricing model and the following assumptions: dividend yield of
0%, expected volatility of 100%, a risk-free interest rate of 1.60%, and an expected life of 5 years. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On November&nbsp;7, 2018, the
Company granted 300,000 stock options, exercisable at $0.82 per option, to employees of the Company. The options are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date; <FONT
STYLE="white-space:nowrap">one-third</FONT> 12 months after grant date and <FONT STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $184,658 using the Black-Scholes option
pricing model and the following assumptions: dividend yield of 0%, expected volatility of 100%, a risk-free interest rate of 2.20%, and an expected life of 5 years. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and nine months ended January 31, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;31, 2018, the Company granted 1,250,000 stock options, exercisable at $1.00
per option, to officers and directors of the Company. The options are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date; <FONT STYLE="white-space:nowrap">one-third</FONT> 12 months
after grant date and <FONT STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $625,485 using the Black-Scholes option pricing model and the following assumptions: dividend
yield of 0%, expected volatility of 100%, a risk-free interest rate of 2.20%, and an expected life of 5 years. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On January&nbsp;11, 2019,
the Company granted 415,000 stock options, exercisable at $1.00 per option, to officers and an employee of the Company. The options are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant
date; <FONT STYLE="white-space:nowrap">one-third</FONT> 12 months after grant date and <FONT STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $228,801 using the Black-Scholes
option pricing model and the following assumptions: dividend yield of 0%, expected volatility of 100%, a risk-free interest rate of 2.20%, and an expected life of 5 years. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;1, 2019, the Company granted 250,000 stock options, exercisable at $0.475 per option, to an officer of the Company. The options
are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date; <FONT STYLE="white-space:nowrap">one-third</FONT> 12 months after grant date and
<FONT STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $86,395 using the Black-Scholes option pricing model and the following assumptions: dividend yield of 0%, expected
volatility of 100%, a risk-free interest rate of 1.46%, and an expected life of 5 years. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;1, 2019, the Company granted
200,000 stock options, exercisable at $1.00 per option, to a consultant of the Company. The options vested immediately upon grant. The fair value of these options was estimated to be $32,096 using the Black-Scholes option pricing model and the
following assumptions: dividend yield of 0%, expected volatility of 100%, a risk-free interest rate of 1.56%, and an expected life of 2 years. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;3, 2019, the Company granted 150,000 stock options, exercisable at $0.50 per option, to a director of the Company. The options
are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date; <FONT STYLE="white-space:nowrap">one-third</FONT> 12 months after grant date and
<FONT STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $53,326 using the Black-Scholes option pricing model and the following assumptions: dividend yield of 0%, expected
volatility of 100%, a risk-free interest rate of 1.46%, and an expected life of 5 years. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;3, 2019, the Company granted
65,000 stock options, exercisable at $1.01 per option, to employees of the Company. The options vested immediately upon grant. The fair value of these options was estimated to be $14,627 using the Black-Scholes option pricing model and the following
assumptions: dividend yield of 0%, expected volatility of 100%, a risk-free interest rate of 1.54%, and an expected life of 2.96 years. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Expected volatility was based on the historical volatility of similar companies. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the three and nine months ended January&nbsp;31, 2020 the Company has recorded $143,100 and $643,215 (2018 - $234,924 and $729,747) of
share-based payments expense. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and nine months ended January 31, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The changes in the stock options for the nine months ended January&nbsp;31, 2020 and the year
ended April&nbsp;30, 2019 are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of</B><br><B>options</B><br><B>#</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted</B><br><B>average</B><br><B>exercise&nbsp;price</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted</B><br><B>average&nbsp;life</B><br><B>remaining</B><br><B>(years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance,&nbsp;April&nbsp;30,&nbsp;2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,871,666</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.68</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4.20</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,060,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(135,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expired</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(200,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,293,333</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,303,333</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.78</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3.87</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">665,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(55,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(903,333</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, January&nbsp;31, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,010,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.78</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3.24</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,153,333</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Exercisable, January&nbsp;31, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,856,667</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.78</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2.96</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Details of the options outstanding as at January&nbsp;31, 2020 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Exercise&nbsp;price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Remaining&nbsp;life</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Expiry Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(year)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unvested</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Vested</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October 1, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December&nbsp;20, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">550,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">550,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;18, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">950,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">950,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January 3, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February&nbsp;7, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.02</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">700,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">700,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;24, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,666</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November&nbsp;7, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.92</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">416,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">833,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January 11, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">315,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">105,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">210,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October 1, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October 3, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.78</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3.24</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,010,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,153,333</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,856,667</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>d)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Warrants </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The changes in the warrants for the nine months ended January&nbsp;31, 2020 and the year ended April&nbsp;30, 2019 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="55%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of</B><br><B>warrants</B><br><B>#</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;average</B><br><B>exercise&nbsp;price</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;average&nbsp;life</B><br><B>remaining&nbsp;(years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,378,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.70</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3.93</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issued</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,354,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2019 and January&nbsp;31, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>17,732,500</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1.04</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1.19</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and nine months ended January 31, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Details of the warrants outstanding as at January&nbsp;31, 2020 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Expiry&nbsp;Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exercise&nbsp;price</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Remaining&nbsp;life</B><br><B>(year)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Warrants</B><br><B>outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March&nbsp;26, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,378,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;18, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">875,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1) </SUP>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;24, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,102,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October&nbsp;25, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,377,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.04</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,732,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">During the nine months ended January&nbsp;31, 2020, the expiry date of these warrants was extended from
June&nbsp;18, 2019 to June&nbsp;18, 2020. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>e)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Finder&#146;s Warrants </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As at January&nbsp;31, 2020, the Company has 415,942 finder&#146;s warrants outstanding. The warrants have an exercise price of $0.70 per share
and expire on March&nbsp;26, 2022. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>RELATED PARTY TRANSACTIONS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Key management personnel are those persons having authority and responsibility for planning, directing and controlling the activities of the
Company. Key management consists of Dr.&nbsp;Jennifer Bath, President and CEO; Lisa Helbling, CFO; Dr.&nbsp;Stefan Lang, Chief Business Officer; Charles Wheelock, Chief Technology Officer; Natasha Tsai, former CFO; Reginald Beniac, former Chief
Operating Officer; Oren Beske, former President of ImmunoPrecise Antibodies (USA) Ltd.; Martin Hessing, a former Director of <FONT STYLE="white-space:nowrap">U-Protein;</FONT> Jos Raats, former President and CEO of IPA Europe; and Directors of the
Company. During the three and nine months ended January&nbsp;31, 2020 and 2018, the compensation for key management is as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Three&nbsp;months&nbsp;ended</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Nine&nbsp;months&nbsp;ended</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>January&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>January&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Management fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103,524</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89,479</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">309,907</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Professional fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,185</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,840</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Salaries and other short-term benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">365,563</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76,446</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,136,939</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">259,187</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,388</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">156,257</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">305,348</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">420,015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">381,951</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">352,412</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,531,766</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,039,949</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the three and nine months ended January&nbsp;31, 2020, the spouse of a Director provided administrative
services for $nil and $nil (2019 &#150; $15,625 and $46,875). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>15.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>COMMITMENTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the Company&#146;s rental of office and laboratory space in Victoria, BC, Canada, the current lease commenced on May&nbsp;1, 2018 and
terminates on April&nbsp;30, 2023. The lease is in the amount of $21,015 per month for all four spaces from May&nbsp;1, 2018 to August&nbsp;31, 2020. The lease agreement was amended effective December&nbsp;1, 2019 so that it now only covers three
spaces, and the lease is in the amount of $13,891 per month from </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and nine months ended January 31, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">December&nbsp;1, 2019 to April&nbsp;30, 2021 and $14,485 per month from May&nbsp;1, 2021 to
April&nbsp;30, 2023. The minimum annual payments under these leases are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">105,075</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">195,186</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">173,820</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">173,820</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">647,901</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the Company&#146;s rental of office and laboratory space in Oss, Netherlands, the current lease commenced
on January&nbsp;1, 2018 and terminated on December&nbsp;31, 2019. Effective December&nbsp;31, 2018, the lease automatically rolls into a 3 year term through December&nbsp;31, 2022. The Company rented a new additional space and the lease commenced on
August&nbsp;1, 2019. Annual minimum lease payments are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&#128;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">182,989</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">185,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">185,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">123,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">677,656</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>16.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SEGMENTED INFORMATION AND ECONOMIC DEPENDENCE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">At January&nbsp;31, 2020 and April&nbsp;30, 2019, the Company has one reportable segment, being antibody production and related services. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the nine months ended January&nbsp;31, 2020, the Company had sales to nil (2019 - nil) customer who in aggregate accounted for more than
10% (2019 &#150; 10%) of revenue. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s revenues are allocated to geographic segments for the three and nine months ended
January&nbsp;31, 2020 and 2019 as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Three&nbsp;months&nbsp;ended</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Nine&nbsp;months&nbsp;ended</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>January&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>January&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">United States of America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,527,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">716,370</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,811,675</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,040,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Canada</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">311,967</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">217,210</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">993,444</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">517,033</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,715,950</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,762,003</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,525,269</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,652,437</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">478,576</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">582,516</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74,715</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,034,440</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,695,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,912,904</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,285,159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s <FONT STYLE="white-space:nowrap">non-current</FONT> assets are allocated to geographic
segments as at January&nbsp;31, 2020 and April&nbsp;30, 2019 as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>January&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>April&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,228,396</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">986,323</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Netherlands</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,736,956</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,481,425</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,965,352</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,467,748</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and nine months ended January 31, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Geographic segmentation of the Company&#146;s (loss) income is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Three&nbsp;months&nbsp;ended</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Nine&nbsp;months&nbsp;ended</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>January&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>January&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America - Corporate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,592</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,587,360</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,595,417</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,687,403</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72,873</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(95,649</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">278,659</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(212,364</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Netherlands</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(761,302</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">495,953</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(684,822</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,124,617</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(625,837</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,187,056</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,001,580</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,775,150</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Geographic segmentation of the interest and accretion, and amortization and depreciation is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Three&nbsp;months&nbsp;ended</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Nine&nbsp;months&nbsp;ended</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>January&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>January&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Interest&nbsp;and&nbsp;accretion</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America - Corporate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">198,635</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">263,571</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,123,879</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">959,106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,755</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,809</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,934</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Netherlands</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,891</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,578</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64,635</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,116</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">249,281</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">276,958</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,248,889</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">989,156</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="8"></TD>
<TD HEIGHT="16" COLSPAN="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Three months ended</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Nine months ended</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>January&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>January&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Amortization and depreciation</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America - Corporate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,909</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54,188</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,927</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,647</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">275,478</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,439</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Netherlands</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">909,895</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">143,146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,918,449</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">506,843</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">953,731</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">137,499</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,248,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">522,282</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>17.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SUPPLEMENTAL CASH FLOW INFORMATION </B></P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>January&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>January&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP>
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B><FONT STYLE="white-space:nowrap">Non-cash&nbsp;investing&nbsp;and&nbsp;financing&nbsp;
transactions:</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquisition of equipment by capital lease</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,668,533</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the three and nine months ended January 31, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited &#150; Expressed in Canadian Dollars) </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following changes in liabilities arose from financing activities: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-cash&nbsp;changes</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,</B><br><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Cash&nbsp;Flows</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Acquisition</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Disposal</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accretion</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Foreign</B><br><B>exchange</B><br><B>movements</B><br><B>and&nbsp;change</B><br><B>in&nbsp;estimates</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>January</B><br><B>31, 2020 $</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,063,981</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,007,435</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">716,819</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,609</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,728,756</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,708,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(125,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">166,666</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,670</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(66,654</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,077</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(229,423</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,723,277</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(240,029</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,360,902</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,991,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,428,512</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,723,277</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(240,029</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">883,485</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,609</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,884,674</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.47
<SEQUENCE>48
<FILENAME>d20922dex9947.htm
<DESCRIPTION>EX-99.47
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.47</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.47 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Form <FONT STYLE="white-space:nowrap">52-109FV2</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Certification of Interim Filings </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Venture Issuer Basic Certificate </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I, <B>Lisa</B> <B>Helbling</B>, the <B>Chief Financial Officer</B> of <B>ImmunoPrecise Antibodies Ltd.</B>, certify the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Review: </I></B>I have reviewed the interim financial report and interim MD&amp;A (together, the
&#147;interim<B><I> </I></B>filings&#148;) of <B>ImmunoPrecise Antibodies Ltd.</B> (the &#147;issuer&#148;) for the interim period ended <B>January 31, 2020.</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>No misrepresentations: </I></B>Based on my knowledge, having exercised reasonable diligence, the<B><I>
</I></B>interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with
respect to the period covered by the interim filings. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Fair presentation: </I></B>Based on my knowledge, having exercised reasonable diligence, the
interim<B><I> </I></B>financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date
of and for the periods presented in the interim filings. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: <B>March</B><B></B><B>&nbsp;10, 2020</B> </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><I>&#147;Lisa Helbling&#148;</I></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Lisa Helbling</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chief Financial Officer</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8pt; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>NOTE TO READER</U></B></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In contrast to the certificate required for
<FONT STYLE="white-space:nowrap">non-venture</FONT> issuers under National Instrument <FONT STYLE="white-space:nowrap">52-109</FONT> <I>Certification of Disclosure in</I> <I>Issuers&#146; Annual and Interim Filings </I>(NI <FONT
STYLE="white-space:nowrap">52-109),</FONT> this Venture Issuer Basic Certificate does not include representations relating to<I> </I>the establishment and maintenance of disclosure controls and procedures (DC&amp;P) and internal control over
financial reporting (ICFR), as defined in NI <FONT STYLE="white-space:nowrap">52-109.</FONT> In particular, the certifying officers filing this certificate are not making any representations relating to the establishment and maintenance of</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">i)&#8195;&#8201;&#8202;controls and other
procedures designed to provide reasonable assurance that information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted under securities legislation is recorded, processed, summarized
and reported within the time periods specified in securities legislation; and</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">ii)&#8195;&#8202;a process to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with the issuer&#146;s GAAP.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The issuer&#146;s certifying officers are responsible for ensuring that processes are in place to provide them with sufficient knowledge to support the
representations they are making in this certificate. Investors should be aware that inherent limitations on the ability of certifying officers of a venture issuer to design and implement on a cost effective basis DC&amp;P and ICFR as defined in NI
52109 may result in additional risks to the quality, reliability, transparency and timeliness of interim and annual filings and other reports provided under securities legislation.</P></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.48
<SEQUENCE>49
<FILENAME>d20922dex9948.htm
<DESCRIPTION>EX-99.48
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.48</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.48 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Form <FONT STYLE="white-space:nowrap">52-109FV2</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Certification of Interim Filings </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Venture Issuer Basic Certificate </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I, <B>Jennifer Bath</B>, the <B>Chief Executive Officer</B> of <B>ImmunoPrecise Antibodies Ltd.</B>, certify the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Review: </I></B>I have reviewed the interim financial report and interim MD&amp;A (together, the
&#147;interim<B><I> </I></B>filings&#148;) of <B>ImmunoPrecise Antibodies Ltd.</B> (the &#147;issuer&#148;) for the interim period ended <B>January 31, 2020.</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>No misrepresentations: </I></B>Based on my knowledge, having exercised reasonable diligence, the<B><I>
</I></B>interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with
respect to the period covered by the interim filings. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Fair presentation: </I></B>Based on my knowledge, having exercised reasonable diligence, the interim
financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods
presented in the interim filings. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: <B>March</B> <B>10, 2020</B> </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><I>&#147;Jennifer Bath&#148;</I></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jennifer Bath</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chief Executive Officer</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8pt; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>NOTE TO READER</U></B></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In contrast to the certificate required for
<FONT STYLE="white-space:nowrap">non-venture</FONT> issuers under National Instrument <FONT STYLE="white-space:nowrap">52-109</FONT> <I>Certification of Disclosure in</I> <I>Issuers&#146; Annual and Interim Filings </I>(NI <FONT
STYLE="white-space:nowrap">52-109),</FONT> this Venture Issuer Basic Certificate does not include representations relating to<I> </I>the establishment and maintenance of disclosure controls and procedures (DC&amp;P) and internal control over
financial reporting (ICFR), as defined in NI <FONT STYLE="white-space:nowrap">52-109.</FONT> In particular, the certifying officers filing this certificate are not making any representations relating to the establishment and maintenance of</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">i)&#8195;&#8201;&#8202;controls and other
procedures designed to provide reasonable assurance that information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted under securities legislation is recorded, processed, summarized
and reported within the time periods specified in securities legislation; and</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">ii)&#8195;&#8202;a process to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with the issuer&#146;s GAAP.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The issuer&#146;s certifying officers are responsible for ensuring that processes are in place to provide them with sufficient knowledge to support the
representations they are making in this certificate. Investors should be aware that inherent limitations on the ability of certifying officers of a venture issuer to design and implement on a cost effective basis DC&amp;P and ICFR as defined in NI
52109 may result in additional risks to the quality, reliability, transparency and timeliness of interim and annual filings and other reports provided under securities legislation.</P></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.49
<SEQUENCE>50
<FILENAME>d20922dex9949.htm
<DESCRIPTION>EX-99.49
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.49</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.49 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922sp365p.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Reports Record Quarterly and Nine Month Revenue and Positive Adjusted EBITDA </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, March&nbsp;10, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTCQB: IPATF) today
announced financial results for its fiscal year 2020 third quarter ended January&nbsp;31, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Revenue. </B>The Company posted a quarterly revenue of
$4,034,440, an increase of 50%<B> </B>from the <FONT STYLE="white-space:nowrap">year-ago</FONT> quarter and an <FONT STYLE="white-space:nowrap">all-time</FONT> record. The increasing revenue trend is due to growth in both the volume and financial
value of client contracts. Revenue outlook is positive for the fourth quarter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gross Margin. </B>During the three months ended January&nbsp;31, 2020,
the Company<B> </B>achieved a gross profit of $2,223,669. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Net Loss. </B>The Company reported a record low for net loss of $625,837, during the<B>
</B>three months ended January&nbsp;31, 2020, representing a decrease of 47% in net loss from the <FONT STYLE="white-space:nowrap">year-ago</FONT> quarter. The decrease in net loss is due to a $655,614 increase in gross profit, as well as recognized
cost synergies resulting in lower spend, offset by higher <FONT STYLE="white-space:nowrap">non-cash</FONT> amortization of intangible assets, depreciation of leased assets as a result of implementing IFRS 16, <I>Leases</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-IFRS</FONT> Measures*. </B>For the first time in the Company&#146;s history, Adjusted EBITDA for<B> </B>the quarter
and the nine-month period ending January&nbsp;31, 2020, was positive, at $717,716 and $18,356, respectively, compared to ($461,353) and ($1,553,090) for the same periods last year. The positive Adjusted EBITDA is a result of the third quarter&#146;s
50% increase in revenue and lower adjusted operating expenses compared to the prior year&#146;s quarter and nine-month period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We are pleased to
report IPA&#146;s record quarterly revenue and earnings, which was fueled by strong demand for a wide variety of our products and services in tool, research and therapeutic antibody discovery and manufacturing,&#148; said Jennifer Bath, IPA&#146;s
President and CEO. &#147;Careful attention to operational prioritization, site efficiencies and brand recognition in 2019 led to new vendor qualifications from pharmaceutical and biotech companies, enabling larger allocations of corporate budgets in
the 2020 calendar year. This past quarter is a powerful testament to the satisfaction and engagement of our clients, and the realization of leveraged synergies globally.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent ImmunoPrecise Highlights: </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">IPA Launched Coronavirus Vaccine and Therapeutic Programs </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">As IPA Directs R&amp;D Efforts Toward Coronavirus, Company is Added to WHO Draft Landscape of Companies Combating
<FONT STYLE="white-space:nowrap">COVID-19</FONT> </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Company Announced AI Collaboration with EVQLV, Inc., to Accelerate the Efforts in the Development of a
Coronavirus Therapeutic </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">IPA Integrated SGI&#146;s DNA Automated DNA Printer at Utrecht Site </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">IPA Subsidiary, UPE, Joining Genmab and Merus in Expansion to New Biotech Accelerator in the Center of European
Science Industry </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA periodically provides information for investors on its corporate website, <U>ImmunoPrecise.com</U>. This includes
press releases and other information on financial performance, reports filed or furnished with the TSX, information on corporate governance and details related to its annual meeting of shareholders. Reports filed or furnished with the TSX can be
found at <U>sedar.com</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a full-service, therapeutic antibody discovery Contract Research Organization offering species agnostic, multi-format, characterized and
engineered, human monoclonal antibodies, on an abbreviated timeframe, for its pharmaceutical clients. For further information, visit <U>www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com</U>. There is no assurance that ImmunoPrecise
will be successful in the development of a vaccine and/or therapeutic against the new coronavirus. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148;
within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and
similar expressions to identify forward-looking statements. Any such forward-looking statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and
expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause
ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower
than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and analysis for the fiscal period ended January&nbsp;31, 2020 which can be accessed at <U>www.sedar.com</U>. The
&#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result
of new information, future events or otherwise. </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Non-IFRS</FONT> Financial Measure </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Readers are cautioned that &#147;Adjusted EBITDA&#148; is a measure not recognized under IFRS. Adjusted EBITDA is defined as earnings before interest
income, taxes, </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
depreciation and amortization, share-based compensation, restructuring costs, impairment charges and other <FONT STYLE="white-space:nowrap">non-recurring</FONT> gains or losses. Management
believes Adjusted EBITDA is a useful measure that facilitates <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">period-to-period</FONT></FONT> operating comparisons. Readers are cautioned that &#147;Adjusted EBITDA&#148; is not an
alternative to measures determined in accordance with IFRS and should not, on its own, be construed as indicator of performance, cash flow or profitability. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922g24r30.jpg" ALT="LOGO">
 View original content to download multimedia: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.newswire.ca/en/releases/archive/March2020/10/c8130.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot,<B> </B>Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact
Financial Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 09:22e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">10-MAR-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.50
<SEQUENCE>51
<FILENAME>d20922dex9950.htm
<DESCRIPTION>EX-99.50
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.50</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.50 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g0910043129628.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Announces the Launch of PolyTope mAb Therapy<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> to
Tackle Coronavirus Pandemic </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>New Approach Entails a Defined Antibody Combination Targeting Multiple Epitopes and Mechanisms of Viral
Evasion </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, March&nbsp;12, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTC QB:
IPATF), following its announcement to develop innovative treatments against the new coronavirus, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2,</FONT></FONT> unveils its unique approach utilizing PolyTope mAb Therapy<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP>, enabled by IPA&#146;s diverse discovery platforms and artificial intelligence capabilities with their partner, EVQLV, Inc., in the development of a universal
<FONT STYLE="white-space:nowrap">COVID-19</FONT> therapy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Current vaccine strategies under development for <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> are being designed to protect uninfected individuals, however, this does not address the patients with active disease. Antibody therapies represent a potentially powerful treatment option for <FONT
STYLE="white-space:nowrap">COVID-19</FONT> patients, however, the current, proposed curative options (including polyclonal, sensitized serum or individual monoclonal antibody therapies) are potentially susceptible to escape by viral mutation and are
likely not broadly effective against multiple strains, leaving segments of the population untreatable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Given the continuous increase in information
on <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> transmission, and seemingly higher than predicted mutation rates, we believe that traditional treatments and diagnostics targeting limited epitopes may
present a significant liability for long-term efficacy of a therapeutic, vaccine or diagnostic&#148;, stated ImmunoPrecise CEO and president, Dr.&nbsp;Jennifer Bath. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The emerging <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> virus, and other new (related) pathogens, requires the
rapid development of broadly effective treatments and vaccines. Given its biology, developing an effective therapeutic workplan for treating <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> infection
required a sophisticated approach that considered multiple mechanisms of immune system involvement, the predictability of mutations within the virus genome, and other attributes with the potential to provide maximum clinical benefit for both current
and future variants of the virus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ilse Roodink, Chairwoman of Talem&#146;s Scientific Advisory Committee and Coronavirus Global Project Leader
emphasized, &#147;Our PolyTope mAb Therapy<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> perfectly combines the benefits of using well-defined and fully characterized monoclonal antibodies with the essential need for a multi-targeting
strategy to tackle this quickly emerging virus, thereby significantly accelerating effective clinical application&#148;. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise
Antibodies Ltd. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a full-service, therapeutic antibody discovery Contract Research Organization offering species agnostic,
multi-format, characterized and engineered, human monoclonal antibodies, on an abbreviated timeframe, for its pharmaceutical clients. For further information, visit <U>www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com</U>. There is
no assurance that ImmunoPrecise will be successful in the development of a vaccine and/or therapeutic against the new coronavirus. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking
Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact, may constitute
&#147;forward-looking statements&#148; within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;,
&#147;believe&#148;, &#147;intend&#148; and similar expressions to identify forward-looking statements. Any such forward-looking statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of
historical trends, current conditions and expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and
uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements contained in this news release. Such factors include, among other things, actual
revenues and earnings for IPA being lower than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and analysis for the fiscal year ended January&nbsp;31, 2020 which can be accessed at
<U>www.sedar</U><U>.</U>com. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such
information, whether as a result of new information, future events or otherwise. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922g24r30.jpg" ALT="LOGO">
 View original content to download multimedia: <U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">http://www.prnewswire.com/news-releases/immunoprecise-announces-the-launch-of-polytope-mab-therapy-to-tackle-coronavirus-pandemic-301022138.html
</FONT></FONT></FONT></FONT></FONT></FONT></FONT></FONT></FONT></FONT></U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922g24r30.jpg" ALT="LOGO">
 View original content to download multimedia: <U>http://www.newswire.ca/en/releases/archive/March2020/12/c1265.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com,<B> </B>Contact
Financial Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 07:00e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">12-MAR-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.51
<SEQUENCE>52
<FILENAME>d20922dex9951.htm
<DESCRIPTION>EX-99.51
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.51</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.51 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g0910043129628.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise&#146;s Artificial Intelligence Partner, EVQLV, Submits First Panel of Optimized Antibody Sequences to
Coronavirus for PolyTope(TM) mAb Therapy Program </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>We caution that this is still early stage research and development and is not
making any express or implied claims that it has the ability to eliminate the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> virus at this time. We further caution that we have not undertaken any clinical
trials. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, March&nbsp;30, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTC QB:
IPATF) announces that its collaborator, EVQLV, has submitted their first panel of candidate therapeutic antibody sequences, comprised of DNA sequences encoding for potentially therapeutic antibodies against the new coronavirus, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2.</FONT></FONT> These DNA sequences were generated using computational antibody design, a method which combines mathematics, statistics, and computer science to identify
high-affinity antibodies. The submitted antibody sequences were <FONT STYLE="white-space:nowrap">pre-screened</FONT> by EVQLV&#146;s artificial intelligence-driven algorithms, which work to maximize the resulting antibodies&#146; therapeutic
potential while minimizing safety and manufacturing risks. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA believes treatments for the new coronavirus are ideally generated using data from the
newly emerged strain, in part as the spike protein from the 2019 virus has been shown to have a unique sequence that sets it apart from the 2002 <FONT STYLE="white-space:nowrap">SARS-CoV</FONT> and SARS-related CoVs<SUP
STYLE="font-size:85%; vertical-align:top">1</SUP>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;As new insights into
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> are captured by researchers around the world, we are applying these insights in an attempt to generate an efficacious and sustainable therapy. The submission
of the first panel of antibody sequences by EVQLV is an important milestone,&#148; stated Dr.&nbsp;Jennifer Bath, CEO of IPA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The next step in this
process for IPA is to review the antibody candidates from EVQLV&#146;s artificial intelligence. IPA will select approximately 1,200 ideal candidates that were characterized and screened by EVQLV&#146;s artificial intelligence and validate the
antibody candidates <I>in vitro</I> (i.e. at IPA&#146;s lab facilities) for the purpose of producing and testing these antibodies. IPA has sufficient financial resources to carry out this testing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While computational analyses are routine practice in antibody optimization, it is uncommon to run millions of computational antibody designs and breadth of
screening calculations performed by EVQLV&#146;s artificial intelligence. The use of EVQLV&#146;s technology, in conjunction with IPA&#146;s research insights and parameters, generated this first panel of optimized antibody sequences against <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> in less than one week. Given the early stage nature of discovered antibody sequences in the development chain, IPA and EVQLV will continue to work on additional
panels of computationally generated sequence candidates against <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2.</FONT></FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;EVQLV&#146;s approach simulates antibody discovery and characterization that occurs in the laboratory and generates candidate sequences which are
screened using algorithms seeking desirable attributes,&#148; said Dr.&nbsp;Bath. &#147;By computationally generating and screening millions of antibody sequences, the algorithms provide our laboratory teams prospective panels of <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">anti-SARS-CoV-2</FONT></FONT> antibody sequences for further validation.&#148; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Walls et al., 2020, Cell 180, 1&#150;12 </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About EVQLV </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EVQLV develops artificial intelligence,
engineered with life science data and biological knowledge, that accelerates the speed at which biologic therapies reach patients. Comprised of experts in machine learning, molecular biology, computational biology, pharmacology, software
engineering, antibody design, cloud computing, and preclinical/clinical development, EVQLV is on a mission to transform how healing reaches those in need. For further information, visit <U>www.evqlv.com</U> or contact Daniel Gigante at
<U>dgigante@evqlv.com</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a full-service, therapeutic antibody discovery Contract Research Organization offering species agnostic, multi-format, characterized and
engineered, human monoclonal antibodies, on an abbreviated timeframe, for its pharmaceutical clients. For further information, <U>visit www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release
contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148; within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;,
&#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and similar expressions to identify forward-looking statements. Any such forward-looking statements are based on
assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and expected future developments. However, whether actual results and developments will conform to
ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the
forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual
management discussion and analysis for the fiscal year ended April 30th, 2019, which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless
required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922g24r30.jpg" ALT="LOGO">
 View original content to download multimedia: <U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">http://www.prnewswire.com/news-releases/immunoprecises-artificial-intelligence-partner-evqlv-submits-first-panel-of-optimized-antibody-sequences-to-coronavirus</FONT></FONT></FONT></FONT></FONT></FONT></U><U>-</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922g24r30.jpg" ALT="LOGO">
 View original content to download multimedia: <U>http://www.newswire.ca/en/releases/archive/March2020/30/c7938.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact<B>
</B>Financial Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 16:12e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">30-MAR-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.52
<SEQUENCE>53
<FILENAME>d20922dex9952.htm
<DESCRIPTION>EX-99.52
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.52</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.52 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g0910042554707.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Announces Extension of Debentures and Completion of Debt Settlement of Previously Issued Debentures
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, March&nbsp;31, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTC QB: IPATF)
announces that it has extended maturity date for $2,000,000 of previously issued debentures from March&nbsp;26, 2020 to September&nbsp;26, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company is also pleased to announced that it has completed its settlement of $700,00 of previously issued debentures and interest of $46,875 accrued thereon by issuing 1,244,792 common shares at a price of $0.60 per share (the &#147;Debt
Settlement&#148;). The purpose of the Debt Settlement is to reduce the ongoing debt obligations of the debentures. The shares will be subject to a four month hold period expiring on July&nbsp;27, 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is an
international, full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell Select<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> progressive single-cell interrogation technology and the
DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> custom, transgenic animal phage libraries, as well as the Abthena<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> bispecific program. IPA is focused on the next generation of
antibody discovery, to deliver the most therapeutically-relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s antibody discovery and development are conducted in Utrecht and Oss, the Netherlands <FONT STYLE="white-space:nowrap">(U-Protein</FONT>
Express and IPA Europe, respectively), and in Victoria, British Columbia (IPA Canada). The Company operates globally to offer a continuum of superior antibody services, transforming the face of therapeutic discovery, by decreasing turnaround time
and risk, and promoting clinical success. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Forward Looking Information </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148;
within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and
similar expressions to identify forward-looking statements. Any such forward-looking statements are based on assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and
expected future developments. However, whether actual results and developments will conform to the Company&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause the
Company&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements contained in this news release. The forward-looking statements contained herein speak only as of the date of this press release and,
unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. </I></B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922g24r30.jpg" ALT="LOGO">
 View original content to download multimedia: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.newswire.ca/en/releases/archive/March2020/31/c6774.htm</U><U>l</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 09:40e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">31-MAR-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.53
<SEQUENCE>54
<FILENAME>d20922dex9953.htm
<DESCRIPTION>EX-99.53
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.53</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.53 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g0910042554707.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Announces Appointment of Yasmina Noubia Abdiche, Ph.D., as Chief Scientific Officer </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, April&nbsp;2, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTC QB: IPATF), a provider
of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">best-in-class</FONT></FONT> therapeutic antibody discovery capabilities for the global industry, today announced the appointment of Yasmina Noubia Abdiche, Ph.D., as Chief
Scientific Officer, effective April 2020. Dr.&nbsp;Abdiche will, among other responsibilities, lead the Company&#146;s global research and development teams. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We are excited to have Dr.&nbsp;Abdiche join the ImmunoPrecise team,&#148; said Dr.&nbsp;Jennifer Bath, IPA&#146;s President and CEO. &#147;She has a
distinguished background in therapeutic antibody discovery and a strong track record of advancing drugs to the clinic. With over 15 years of industry experience Dr.&nbsp;Abdiche is a highly respected, strategic and skilled thought leader with solid
scientific and business acumen.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Most recently, Dr.&nbsp;Abdiche was CSO at Carterra, where she helped transition their LSA analytical antibody
screening platform from concept through prototype to global commercialization. Dr.&nbsp;Abdiche previously served as a Research Fellow on the leadership team at Rinat-Pfizer where she led a team of scientists providing core support for biomolecular
interaction analysis and played an active role on the governing committee for Pfizer&#146;s Postdoctoral Program. She is <FONT STYLE="white-space:nowrap">co-inventor</FONT> of several therapeutic antibodies that entered clinical trials including a
current, market-approved drug, Ajovy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;I am thrilled to lead ImmunoPrecise&#146;s research and development programs and accelerate their <FONT
STYLE="white-space:nowrap">pre-clinical</FONT> pipeline,&#148; stated Dr.&nbsp;Yasmina Abdiche. &#147;I am honored to work with the team of incredibly talented and experienced scientists at IPA.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Abdiche graduated from Oxford University with a Ph.D. in Biological Chemistry and a Master&#146;s degree in Chemistry. She completed postdoctoral
research in Dr.&nbsp;David Myszka&#146;s laboratory at the University of Utah in Salt Lake City, where she optimized biosensor methods for characterizing small molecule interactions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a
full-service, therapeutic antibody discovery Contract Research Organization offering species agnostic, multi-format, characterized and engineered, human monoclonal antibodies, on an abbreviated timeframe, for its pharmaceutical clients. For further
information, visit <U>www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148;
within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and
similar expressions to identify forward-looking statements. Any such forward-looking statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and
expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause
ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements contained in this news release. Such </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management
discussion and analysis for the last quarter ended January&nbsp;31, 2020 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless required
by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922g24r30.jpg" ALT="LOGO">
 View original content to download multimedia: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.newswire.ca/en/releases/archive/April2020/02/c8868.htm</U><U>l</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>on investor
relations, please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 08:35e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">02-APR-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.54
<SEQUENCE>55
<FILENAME>d20922dex9954.htm
<DESCRIPTION>EX-99.54
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.54</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.54 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT STYLE="white-space:nowrap">51-102F3</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MATERIAL CHANGE REPORT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>Item 1</B>.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Name and Address of Company</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>IMMUNOPRECISE ANTIBODIES LTD.</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3204-4464 Markham Street</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Victoria, BC V8Z 7X8</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">(the &#147;Company&#148;)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>Item 2</B>.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Date of Material Change</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">March&nbsp;30, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>Item 3</B>.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>News Release</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">The news release was issued on March&nbsp;30, 2020 and was disseminated by Newswire.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>Item 4</B>.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Summary of Material Change</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">The Company announced that its artificial intelligence partner, EVQLV, submitted their first panel of candidate therapeutic optimized antibody sequences to Coronavirus, <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">SARS-CoV-2,</FONT></FONT> for PolyTope<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> mAb Therapy Program.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>Item 5</B>.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Full Description of Material Change</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Please refer to the Company&#146;s news release disseminated on March&nbsp;30, 2020, a copy of which is attached hereto.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>Item 6</B>.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Reliance on Subsection 7.1(2) of National Instrument <FONT STYLE="white-space:nowrap">51-102</FONT></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Not applicable.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>Item 7</B>.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Omitted Information</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">None.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>Item 8</B>.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Executive Officer</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">For further information, please contact:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Jennifer Bath</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">(250) <FONT STYLE="white-space:nowrap">483-0308</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>Item 9</B>.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Date of Report</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">April&nbsp;7, 2020</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise&#146;s Artificial Intelligence Partner, EVQLV, Submits First Panel of Optimized Antibody
Sequences to Coronavirus for PolyTope(TM) mAb Therapy Program </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt; text-indent:4%">


<IMG SRC="g20922g78m49.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NEWS PROVIDED BY </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Antibodies Ltd.</B><FONT
STYLE="FONT-FAMILY:SYMBOL">&#174;</FONT><B></B><B> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mar 30, 2020, 16:12 ET </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>We caution that this is still early
stage research and development and is not making any express or implied claims that it has the ability to eliminate the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> virus at this time. We further caution
that we have not undertaken any clinical trials. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, March&nbsp;30, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or
&#147;IPA&#148;) (TSX VENTURE: IPA) (OTC QB: IPATF) announces that its collaborator, EVQLV, has submitted their first panel of candidate therapeutic antibody sequences, comprised of DNA sequences encoding for potentially therapeutic antibodies
against the new coronavirus, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2.</FONT></FONT> These DNA sequences were generated using computational antibody design, a method which combines mathematics, statistics, and
computer science to identify <FONT STYLE="white-space:nowrap">high-affinity</FONT> antibodies. The submitted antibody sequences were <FONT STYLE="white-space:nowrap">pre-screened</FONT> by EVQLV&#146;s artificial intelligence-driven algorithms,
which work to maximize the resulting antibodies&#146; therapeutic potential while minimizing safety and manufacturing risks. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA believes treatments for
the new coronavirus are ideally generated using data from the newly emerged strain, in part as the spike protein from the 2019 virus has been shown to have a unique sequence that sets it apart from the 2002
<FONT STYLE="white-space:nowrap">SARS-CoV</FONT> and SARS-related CoVs<SUP STYLE="font-size:85%; vertical-align:top">1</SUP>. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;As new insights into
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> are captured by researchers around the world, we are applying these insights in an attempt to generate an efficacious and sustainable therapy. The submission
of the first panel of antibody sequences by EVQLV is an important milestone,&#148; stated Dr.&nbsp;Jennifer Bath, CEO of IPA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The next step in this
process for IPA is to review the antibody candidates from EVQLV&#146;s artificial intelligence. IPA will select approximately 1,200 ideal candidates that were characterized and screened by EVQLV&#146;s artificial intelligence and validate the
antibody candidates <I>in vitro</I> (i.e. at IPA&#146;s lab facilities) for the purpose of producing and testing these antibodies. IPA has sufficient financial resources to carry out this testing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While computational analyses are routine practice in antibody optimization, it is uncommon to run millions of computational antibody designs and breadth of
screening calculations performed by EVQLV&#146;s artificial intelligence. The use of EVQLV&#146;s technology, in conjunction with IPA&#146;s research insights and parameters, generated this first panel of optimized antibody sequences against <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> in less than one week. Given the early stage nature of discovered antibody sequences in the development chain, IPA and EVQLV will continue to work on additional
panels of computationally generated sequence candidates against <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2.</FONT></FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;EVQLV&#146;s approach simulates antibody discovery and characterization that occurs in the laboratory and generates candidate sequences which are
screened using algorithms seeking desirable attributes,&#148; said Dr.&nbsp;Bath. &#147;By computationally generating and screening millions of antibody sequences, the algorithms provide our laboratory teams prospective panels of <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">anti-SARS-CoV-2</FONT></FONT> antibody sequences for further validation.&#148; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Walls et al., 2020, Cell 180, 1&#150;12 </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About EVQLV </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EVQLV develops artificial intelligence,
engineered with life science data and biological knowledge, that accelerates the speed at which biologic therapies reach patients. Comprised of experts in machine learning, molecular biology, computational biology, pharmacology, </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">software engineering, antibody design, cloud computing, and preclinical/clinical development, EVQLV is on a
mission to transform how healing reaches those in need. For further information, visit www.evqlv.com or contact Daniel Gigante at dgigante@evqlv.com. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a
full-service, therapeutic antibody discovery Contract Research Organization offering species agnostic, multi-format, characterized and engineered, human monoclonal antibodies, on an abbreviated timeframe, for its pharmaceutical clients. For further
information, visit <U>www.immunoprecise.com</U> or contact solutions@immunoprecise.com. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148;
within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and
similar expressions to identify forward-looking statements. Any such forward-looking statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and
expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause
ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower
than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and analysis for the fiscal year ended April 30th, 2019, which can be accessed at www.sedar.com. The &#147;forward-looking
statements&#148; contained herein speak only as of the date of this press release and, unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information,
future events or otherwise. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For further information: For investor relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Related Links </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">www.immunoprecise.com </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.55
<SEQUENCE>56
<FILENAME>d20922dex9955.htm
<DESCRIPTION>EX-99.55
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.55</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.55 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT STYLE="white-space:nowrap">51-102F3</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MATERIAL CHANGE REPORT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>Item 1</B>.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Name and Address of Company</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>IMMUNOPRECISE ANTIBODIES LTD.</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3204-4464 Markham Street</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Victoria, BC V8Z 7X8</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">(the &#147;Company&#148;)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>Item 2</B>.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Date of Material Change</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">March&nbsp;31, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>Item 3</B>.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>News Release</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">The news release was issued on March&nbsp;31, 2020 and was disseminated by Newswire.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>Item 4</B>.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Summary of Material Change</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">The Company announced that it has extended the maturity date for $2,000,000 of previously issued debentures from March&nbsp;26, 2020 to September&nbsp;26, 2020. The Company completed its settlement of $700,000 of previously
issued debentures and interest of $46,875 accrued thereon by issuing 1,244,792 common shares at a price of $0.60 per share.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>Item 5</B>.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Full Description of Material Change</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Please refer to the Company&#146;s news release disseminated on March&nbsp;31, 2020, a copy of which is attached hereto.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>Item 6</B>.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Reliance on Subsection 7.1(2) of National Instrument <FONT STYLE="white-space:nowrap">51-102</FONT></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Not applicable.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>Item 7</B>.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Omitted Information</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">None.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>Item 8</B>.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Executive Officer</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">For further information, please contact:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Jennifer Bath</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">(250) <FONT STYLE="white-space:nowrap">483-0308</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>Item 9</B>.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Date of Report</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">April&nbsp;7, 2020</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Announces Extension of Debentures and Completion of Debt Settlement of Previously Issued
Debentures </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt; margin-left:4%">


<IMG SRC="g20922g50a04.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NEWS PROVIDED BY </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Antibodies Ltd.</B><FONT
STYLE="FONT-FAMILY:SYMBOL">&#174;</FONT><B></B><B> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mar 31, 2020, 09:40 ET </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, March&nbsp;31, 2020 /CNW/ - IMMUNOPRECISE
ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTC QB: IPATF) announces that it has extended maturity date for $2,000,000 of previously issued debentures from March&nbsp;26, 2020 to September&nbsp;26, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is also pleased to announced that it has completed its settlement of $700,00 of previously issued debentures and interest of $46,875 accrued
thereon by issuing 1,244,792 common shares at a price of $0.60 per share (the &#147;Debt Settlement&#148;). The purpose of the Debt Settlement is to reduce the ongoing debt obligations of the debentures. The shares will be subject to a four month
hold period expiring on July&nbsp;27, 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is an international, full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell Select<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP> progressive single-cell interrogation technology and the DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> custom, transgenic animal phage libraries, as well as the Abthena<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP> bispecific program. IPA is focused on the next generation of antibody discovery, to deliver the most therapeutically-relevant antibodies, in a shorter period of time, with the highest probability of
succeeding to clinical trials. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s antibody discovery and development are conducted in Utrecht and Oss, the Netherlands <FONT
STYLE="white-space:nowrap">(U-Protein</FONT> Express and IPA Europe, respectively), and in Victoria, British Columbia (IPA Canada). The Company operates globally to offer a continuum of superior antibody services, transforming the face of
therapeutic discovery, by decreasing turnaround time and risk, and promoting clinical success. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Forward Looking Information </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148;
within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and
similar expressions to identify forward-looking statements. Any such forward-looking statements are based on assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and
expected future developments. However, whether actual results and developments will conform to the Company&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause the
Company&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements contained in this news release. The forward-looking statements contained herein speak only as of the date of this press release and,
unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For further information: For investor relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Related Links </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">www.immunoprecise.com </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.56
<SEQUENCE>57
<FILENAME>d20922dex9956.htm
<DESCRIPTION>EX-99.56
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.56</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.56 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g0910042201519.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Announces Agreement with Janssen </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA and CAMBRIDGE, MA, April&nbsp;14, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTC QB:
IPATF), a global leader in therapeutic antibody discovery and development, announced that it, through its subsidiary Talem Therapeutics, has entered into a research license agreement (the &#147;Agreement&#148;) with Janssen Research&nbsp;&amp;
Development, LLC (&#147;Janssen&#148;), providing Janssen exclusive access to a panel of novel, monoclonal antibodies against an undisclosed target. Pursuant to the Agreement, Janssen holds an option to acquire all commercial rights to the
antibodies. The financial details of the transaction have not been disclosed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;This Agreement validates Talem&#146;s business concept in early
antibody discovery and development,&#148; said Ilse Roodink, Chairwoman of Talem&#146;s Scientific Advisory Committee and Scientific Director at IPA Europe. &#147;It is a significant milestone to see this exclusive agreement through Talem finalized
with Janssen, a company so well positioned to further develop and maximize the potential of these lead candidates for clinical applications.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Talem continues to build a therapeutic program pipeline for commercial partnering, thus optimizing shareholder value creation based on IPA&#146;s
infrastructure across Europe and North America,&#148; added Jennifer Bath, President and CEO of IPA. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a full-service, therapeutic antibody discovery Contract Research Organization offering species agnostic, multi-format, characterized and
engineered, human monoclonal antibodies, on an abbreviated timeframe, for its pharmaceutical clients. For further information, visit <U>www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Talem Therapeutics LLC </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Talem Therapeutics is
focused on the discovery and development of therapeutic antibodies targeting emerging, infectious diseases, neurology, immuno-oncology, inflammation, and rare/ specialty diseases. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With direct access to world-class, expedited and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">end-to-end</FONT></FONT> technologies in
the antibody discovery and development process, Talem accelerates novel, therapeutic antibody treatments to the clinic through strategic alliances and partnerships. For further information, visit <U>www.talemtherapeutics.com</U> or contact
<U>bd@talemtherapeutics.com</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148;
within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and
similar expressions to identify forward-looking statements. Any such forward-looking statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and
expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause
ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower
than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and analysis for the last quarter ended January&nbsp;31, 2020 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking
statements&#148; contained herein speak only as of the date of this press release and, unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information,
future events or otherwise. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922g24r30.jpg" ALT="LOGO">
 View original content to download multimedia:
<U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">http://www.prnewswire.com/news-releases/immunoprecise-announces-agreement-with-janssen-301039878.html</FONT></FONT></U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922g24r30.jpg" ALT="LOGO">
 View original content to download multimedia: <U>http://www.newswire.ca/en/releases/archive/April2020/14/c0272.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 07:00e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">14-APR-20</FONT></FONT> </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.57
<SEQUENCE>58
<FILENAME>d20922dex9957.htm
<DESCRIPTION>EX-99.57
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.57</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.57 </B></P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g0910042201519.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Participates in Public Consensus Statement, from the WHO, on Collaboration for Developing a <FONT
STYLE="white-space:nowrap">COVID-19</FONT> Vaccine </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, April&nbsp;15, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or
&#147;IPA&#148;) (TSX VENTURE: IPA) (OTC QB: IPATF) provides an update on its participation and support of global solidarity in the fight against coronavirus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Our scientific team is honored to play its part on WHO working groups dedicated to scientific transparency and teamwork towards stopping the spread of <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2,&#148;</FONT></FONT> stated Dr.&nbsp;Jennifer Bath, CEO of ImmunoPrecise. &#147;Together, we work to strengthen our common goal of a safe and effective vaccine for all, and we
echo the WHO&#146;s gratitude to the public for putting their trust in the scientific community. It was our pleasure to sign the public statement showing our support, and we humbly thank the WHO for their leadership in these efforts.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">https://www.who.int/news-room/detail/13-04-2020-public-statement-for-collaboration-on-covid-19-vaccine-development
</FONT></FONT></FONT></FONT></FONT></FONT></FONT></FONT></FONT></FONT></FONT></U> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a full-service, therapeutic antibody discovery Contract Research Organization offering species agnostic, multi-format, characterized and
engineered, human monoclonal antibodies, on an abbreviated timeframe, for its pharmaceutical clients. For further information, visit <U>www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com</U>. There is no assurance that ImmunoPrecise
will be successful in the development of a vaccine and/or therapeutic against the new coronavirus. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148;
within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and
similar expressions to identify forward-looking statements. Any such forward-looking statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and
expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause
ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower
than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and analysis for the last quarter of the fiscal year ended January&nbsp;31, 2020 which can be accessed at <U>www.sedar.com</U>. The
&#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result
of new information, future events or otherwise. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in
the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922g24r30.jpg" ALT="LOGO">
 View original content to download multimedia: <U>http://www.newswire.ca/en/releases/archive/April2020/15/c7604.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 09:07e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">15-APR-20</FONT></FONT> </P>
<P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.58
<SEQUENCE>59
<FILENAME>d20922dex9958.htm
<DESCRIPTION>EX-99.58
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.58</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.58 </B></P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g0910042201519.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Provides Updates on B Cell Select<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> and Deep
Display<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> Programs for <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> Antibody Discovery </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>We caution that this news release is not making any express or implied claims that we have the ability to eliminate the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> virus at this time. We further caution that we have not undertaken any clinical trials.</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, April&nbsp;17, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTC QB: IPATF) is pleased
to provide an update on its research activities for the novel coronavirus <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">(SARS-CoV-2)</FONT></FONT> which outlines the Company&#146;s workflows for their experimental vaccines and
therapeutics for the research community. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA&#146;s multitargeting approach combines various <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> spike protein forms with the Company&#146;s diverse technologies. Hence, IPA anticipates that it can accelerate
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">anti-SARS-CoV-2</FONT></FONT> human antibody discovery, targeting multiple viral epitopes and mechanisms of viral evasion, by immunizing Ligand&#146;s (NASDAQ:LGND) OmniRat<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> animals using the Company&#146;s Rapid Prime<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> protocol followed by IPA&#146;s B cell
Select<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> and hybridoma generation in parallel with human, naive phage library screening. Subsequent high-throughput binding assays, computational Artemis<SUP
STYLE="font-size:85%; vertical-align:top">&#153;</SUP> optimization, and protein interaction analyses permit faster preclinical lead selection. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>&#147;In addition to</U> using our antibody discovery platforms for <U>the potentially</U> rapid identification of a diverse panel of fully <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2-specific</FONT></FONT></FONT> antibodies, we aim targeting additional novel epitopes which are likely inaccessible to conventional antibody
formats by screening our <FONT STYLE="white-space:nowrap">in-house,</FONT> highly complex, VHH repertoire (collection of variable regions of heavy chain antibodies, a region which binds to the target immunogen),&#148; stated Ilse Roodink, Chairwoman
of Talem&#146;s Scientific Advisory Committee and Coronavirus Global Project Leader. &#147;Due to the relative high sequence homology of VHHs with human antibodies, extensive humanization is not required and therefore, our discovery strategy mixture
will significantly contribute to the fast generation of a monoclonal antibody cocktail with broad epitope coverage and diverse functionalities, which is key to successful development of an effective, long-lasting therapy with a high safety
profile.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Apart from the various <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> spike protein forms
which IPA has been producing for use in the therapeutic development, data obtained during the discovery and characterization of lead antibody candidates may be of significant value in the reverse-engineering of vaccine candidates used in the
formulation of an effective, but <FONT STYLE="white-space:nowrap">low-risk,</FONT> vaccine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jennifer Bath, Ph. D., has reviewed and approved the
scientific disclosure contained in this news release. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a full-service, therapeutic antibody discovery Contract Research Organization offering species agnostic, multi-format, characterized and
engineered, human monoclonal antibodies, on an abbreviated timeframe, for its pharmaceutical clients. For further information, visit <U>www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com</U>. There is no assurance that ImmunoPrecise
will be successful in the development of a vaccine and/or therapeutic against the new coronavirus. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148;
within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and
similar expressions to identify forward-looking statements. Any such forward-looking statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and
expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause
ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower
than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and analysis for the last quarter of the fiscal year ended January&nbsp;31, 2020 which can be accessed at <U>www.sedar.com</U>. The
&#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result
of new information, future events or otherwise. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in
the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922g24r30.jpg" ALT="LOGO">
 View original content to download multimedia: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">http://www.prnewswire.com/news-releases/immunoprecise-provides-updates-on-b-cell-select-and-deep-display-programs-for-sars-cov-2-antibody
</FONT></FONT></FONT></FONT></FONT></FONT></FONT></FONT></FONT></FONT></FONT></FONT></FONT></FONT></FONT></FONT><BR>-discovery-30104</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE
ImmunoPrecise Antibodies Ltd. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922g24r30.jpg" ALT="LOGO">
 View original content to download multimedia: <U>http://www.newswire.ca/en/releases/archive/April2020/17/c3531.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 08:00e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">17-APR-20</FONT></FONT> </P>
<P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.59
<SEQUENCE>60
<FILENAME>d20922dex9959.htm
<DESCRIPTION>EX-99.59
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.59</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.59 </B></P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g0910042201519.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Updates on State and Federal Funding </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IPA Awarded Grant Focused on Coronavirus and Other Emerging Pathogens </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FARGO, ND, April&nbsp;24, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTC QB: IPATF), is
pleased to announce that the state of North Dakota has awarded a Bioscience Innovation Grant totalling US$75,000 for the enhancement of a novel platform for rapidly developing treatments for <FONT STYLE="white-space:nowrap">COVID-19</FONT> and other
emerging pathogens. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Advances in bioscience have already transformed many sectors including agriculture and medicine,&#148; state Agriculture
Commissioner Doug Goehring said. &#147;These grants will help North Dakota stay on the forefront of bioscience innovation.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company reports that
this grant was the first application of many to be submitted by IPA over the next several months. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;ImmunoPrecise is in the process of applying for
both state and federal grants to support the development of a treatment for <FONT STYLE="white-space:nowrap">COVID-19</FONT> using our PolyTopeTM mAb Therapy,&#148; stated Jennifer Bath, IPA President and CEO. &#147;We turned first to the State of
North Dakota, given their strong history of support for Biotechnology and Innovation. It is with gratitude we accept the ND Bioscience Innovation Grant and we are confident we can leverage this funding, along with our research advances, to continue
to build on our current successes.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Furthermore, the company is also pleased to announce that that it has been approved for a US$209,000 loan under
the Payroll Protection Program (&#147;PPP&#148;) administered by the U.S. Small Business Administration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The PPP is a US$349&nbsp;billion loan program
that originated from the U.S. Coronavirus Aid, Relief and Economic Security (CARES) Act. As a U.S. Small Business, ImmunoPrecise qualified for the PPP which allows businesses with fewer than 500 employees to obtain loans of up to US$10&nbsp;million
to assist companies in maintaining their workers through the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The PPP loan has a term of two
years, is unsecured, and is guaranteed by the U.S. Small Business Administration. The loan will be forgiven if the proceeds are used by ImmunoPrecise to cover payroll costs (including benefits), with up to twenty-five percent (25%) allowed for rent
and utilities, during the eight-week period following the loan origination date. ImmunoPrecise firmly expects to meet the requirements for full loan forgiveness. The forgiven amount is not included in taxable income. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company further announces that it plans to complete a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement offering of 10% convertible
debentures (&#147;Debentures&#148;) in the principal amount of CAD$2,000,000 (the &#147;Offering&#148;). The debentures are unsecured, bear interest at a rate of 10% per annum, payable annually and due two years from the date of issue (which may be
repaid early at the option of the Company). The principal amount of the Debentures may be convertible at the option of the holder into units of the Company at a conversion price of CAD$0.85 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company may force convert the principal amount of the Debentures at $0.85 per share if the average closing price is equal to or greater than CAD$1.50 for
twenty (20)&nbsp;trading days (the &#147;20 Day Period&#148;). In order to exercise this right, the Company must issue a new release announcing its intention to exercise this right within 10 business days after the end of the particular 20 Day
Period. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company may pay a finder&#146;s fee in cash and/or share purchase warrants under the Offering. Closing
of the Offering is subject to acceptance of the TSX Venture Exchange. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a full-service, therapeutic antibody discovery Contract Research Organization offering species agnostic, multi-format, characterized and
engineered, human monoclonal antibodies, on an abbreviated timeframe, for its pharmaceutical clients. For further information, visit <U>www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com.</U> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This news release contains
statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148; within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;,
&#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and similar expressions to identify forward-looking statements. Any such forward-looking statements are based on
assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and expected future developments. However, whether actual results and developments will conform to
ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the
forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual
management discussion and analysis for the last quarter of the fiscal year ended January&nbsp;31, 2020 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press
release and, unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. SOURCE ImmunoPrecise Antibodies </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922g24r30.jpg" ALT="LOGO">
 View original content to download multimedia: <U>http://www.newswire.ca/en/releases/archive/April2020/24/c5915.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 13:26e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">24-APR-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.60
<SEQUENCE>61
<FILENAME>d20922dex9960.htm
<DESCRIPTION>EX-99.60
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.60</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.60 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT STYLE="white-space:nowrap">51-102F3</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MATERIAL CHANGE REPORT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Item&nbsp;1</B>.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Name and Address of Company</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>IMMUNOPRECISE ANTIBODIES LTD.</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3204-4464 Markham Street</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Victoria, BC V8Z
7X8</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">(the &#147;Company&#148;)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Item&nbsp;2.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Date of Material Change</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">April&nbsp;24, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Item&nbsp;3.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>News Release</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">The news release was issued on April&nbsp;24, 2020 and was disseminated by Newswire.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Item&nbsp;4.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Summary of Material Change</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">The Company announced that it plans to complete a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement offering of 10% convertible debentures (the &#147;Debentures&#148;) in the principal amount of CAD$2,000,000
(the &#147;Offering&#148;).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Item&nbsp;5.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Full Description of Material Change</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">The Company announces that it plans to complete a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement offering of 10% convertible debentures (&#147;Debentures&#148;) in the principal amount of CAD$2,000,000
(the &#147;Offering&#148;). The debentures are unsecured, bear interest at a rate of 10% per annum, payable annually and due two years from the date of issue (which may be repaid early at the option of the Company). The principal amount of the
Debentures may be convertible at the option of the holder into units of the Company at a conversion price of CAD$0.85 per share.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">The Company may force convert the principal amount of the Debentures at $0.85 per share if the average closing price is equal to or greater than CAD$1.50 for twenty (20)&nbsp;trading days (the &#147;20 Day Period&#148;). In order
to exercise this right, the Company must issue a new release announcing its intention to exercise this right within 10 business days after the end of the particular 20 Day Period. The Company may pay a finder&#146;s fee in cash and/or share purchase
warrants under the Offering. Closing of the Offering is subject to acceptance of the TSX Venture Exchange.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Please refer to the Company&#146;s news release disseminated on April&nbsp;24, 2020.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Item&nbsp;6.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Reliance on Subsection 7.1(2) of National Instrument <FONT STYLE="white-space:nowrap">51-102</FONT></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Not applicable.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Item&nbsp;7.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Omitted Information</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">None.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Item&nbsp;8.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Executive Officer</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">For further information, please contact:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Jennifer Bath</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">(250) <FONT STYLE="white-space:nowrap">483-0308</FONT></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Item&nbsp;9</B>.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Date of Report</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">April&nbsp;27, 2020</TD></TR>
</TABLE> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.61
<SEQUENCE>62
<FILENAME>d20922dex9961.htm
<DESCRIPTION>EX-99.61
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.61</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.61 </B></P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g0910042201519.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Antibodies Increases Discovery Capabilities to Help Pinpoint Lead Drug Candidates with Addition of Octet
HTX </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, May&nbsp;6, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTC QB: IPATF),
a provider of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">best-in-class</FONT></FONT> therapeutic antibody discovery capabilities for the global industry, today announced its laboratory in Victoria, BC, has leased a high
throughput, label-free Octet HTX biosensor from Fort&eacute;Bio. This analytical tool addresses ImmunoPrecise&#146;s need for increased speed and sample throughput when characterizing large panels of therapeutic antibody candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Octet HTX offers dramatic time savings for researchers studying the binding interactions of hundreds of drug candidates by producing high quality data
supported with analysis tools allowing data-driven decisions to be made with confidence. It is especially useful in early-stage screening to guide the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">library-to-leads</FONT></FONT>
triage and cut time and costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The need for higher analytical throughput is a central theme within our pharma and biopharmaceutical
customers,&#148; noted Yasmina Abdiche, Chief Scientific Officer at ImmunoPrecise. &#147;We believe that the HTX system&#146;s throughput, versatility, reliability and ease of use will accelerate our discovery efforts towards identifying
clinically-ready leads.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a full-service, therapeutic antibody discovery Contract Research Organization offering species agnostic, multi-format, characterized and
engineered, human monoclonal antibodies, on an abbreviated timeframe, for its pharmaceutical clients. For further information, visit <U>www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release
contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148; within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;,
&#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and similar expressions to identify forward-looking statements. Any such forward-looking statements are based on
assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and expected future developments. However, whether actual results and developments will conform to
ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the
forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual
management discussion and analysis for the previous quarter ended January&nbsp;31, 2020 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and,
unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922g24r30.jpg" ALT="LOGO">
 View original content to download multimedia: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.newswire.ca/en/releases/archive/May2020/06/c8003.htm</U><U>l</U>
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For
investor relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact
Financial Corp., Suite 810, 609 Granville Street, P.O. Box 10322, Vancouver, B.C., V7Y 1G5, Canada </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 07:24e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">06-MAY-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.62
<SEQUENCE>63
<FILENAME>d20922dex9962.htm
<DESCRIPTION>EX-99.62
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.62</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.62 </B></P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g0910042201519.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Increases Financing to $2.3 Million and Makes Payment in Respect of Deferred Purchase Price for IPA Europe
and Immulease </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, May&nbsp;8, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTC
QB: IPATF) is pleased to announce that it has increased its previously announced (see news release dated April&nbsp;24, 2020) <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement financing of 10% convertible debentures from
CAD$2,000,000 to CAD$2,300,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The debentures will continue to be unsecured, bear interest at a rate of ten percent (10%) per year, payable annually,
and are due two years from the date of issue (which may be repaid early at the option of the Company). The principal amount of the debentures may be convertible, at the option of the holder, into units of the Company at a conversion price of $0.85
per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company may force convert the principal amount of the debentures at CAD$0.85 per share if the average closing price is equal to or greater
than CAD$1.50 for 20 trading days. In order to exercise this right, the Company must issue a news release announcing its intention to exercise this right within 10 business days after the end of the particular
<FONT STYLE="white-space:nowrap">20-day</FONT> period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Closing of the offering is subject to acceptance of the TSX Venture Exchange. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Deferred Purchase Price for IPA Europe and Immulease </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company also announces that it has issued shares and made payment in respect of the deferred purchase price for its wholly owned subsidiary ImmunoPrecise Antibodies (Europe) B.V. (&#147;IPA Europe&#148;) and its sister entity Immulease B.V.
(&#147;Immulease&#148;), acquired in 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The share issuance and cash payments were made in respect of the second deferred payment due for IPA Europe
and Immulease. The Company paid &#128;335,555 in cash, and issued 664,153 common shares also valued at &#128;335,555 based on a price of C$0.77 per share, being the closing price for the Company&#146;s shares on April&nbsp;30, 2020 and converted to
euros based on the daily exchange rate quoted by the Bank of Canada for the 10 prior business days. The shares issued are subject to a four month and one day hold period under applicable Canadian securities laws </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a
full-service, therapeutic antibody discovery Contract Research Organization offering species agnostic, multi-format, characterized and engineered, human monoclonal antibodies, on an abbreviated timeframe, for its pharmaceutical clients. For further
information, visit <U>www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com</U>. There is no assurance that ImmunoPrecise will be successful in the development of a vaccine and/or therapeutic against the new coronavirus. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release
contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148; within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;,
&#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>&#147;intend&#148; and similar expressions to identify forward-looking statements. Any such
forward-looking statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and expected future developments. However, whether actual results and
developments will conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed
or implied by the forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and uncertainties described in
ImmunoPrecise&#146;s annual management discussion and analysis for the quarter ended January&nbsp;31, 2020 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this
press release and, unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922g24r30.jpg" ALT="LOGO">
 View original content to download multimedia: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.newswire.ca/en/releases/archive/May2020/08/c1654.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 07:51e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">08-MAY-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.63
<SEQUENCE>64
<FILENAME>d20922dex9963.htm
<DESCRIPTION>EX-99.63
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.63</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.63 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SHARE PURCHASE AGREEMENT </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THIS
SHARE PURCHASE AGREEMENT</B> (this &#147;Agreement&#148;) is made as of the 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> day of March, 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AMONG: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>IMMUNOPRECISE NETHERLANDS
B.V.,</B> a company duly formed under the laws of the Netherlands, with its registered office located in Haarlemmermeer, Netherlands, registered with the trade register of the Chamber of Commerce under number 71010149 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(the &#147;Purchaser&#148;) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>OF
THE FIRST PART </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AND: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>IMMUNOPRECISE ANTIBODIES LTD.,</B> a company duly formed under the laws of the Province of British Columbia, with its principal office
located at Unit 3204, 4464 Markham Street, Victoria, BC V8Z 7X8 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(the &#147;Parent&#148;) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>OF THE SECOND PART </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AND: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>MODIQUEST RESEARCH B.V.,</B> a company duly formed under the laws of the Netherlands, with its principal office located at Kloosterstraat 9
RE2, 5349 AB, Oss, the Netherlands, registered with the trade register of the Chamber of Commerce under number 09148575. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(&#147;ModiQuest
Research&#148;) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>OF THE THIRD PARTY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AND: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>IMMULEASE B.V.,</B> a company
duly formed under the laws of the Netherlands, with its principal office located at Schoutstraat 58, 6525XV Nijmegen, the Netherlands, registered with the trade register of the Chamber of Commerce under number 09213199. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(&#147;Immulease&#148;) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>OF THE
FOURTH PART </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>IMMUSYS B.V.</B>, a company duly formed under the laws of the Netherlands, with its
principal office located at Schoutstraat 58, 6525XV Nijmegen, the Netherlands, registered with the trade register of the Chamber of Commerce under number 09140672. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(the &#147;Seller&#148;) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>OF
THE FIFTH PART </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>WHEREAS: </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A.
&nbsp;&nbsp;&nbsp;&nbsp;The Seller is the sole owner of all of the issued and outstanding shares of ModiQuest Research and Immulease; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">B.
&nbsp;&nbsp;&nbsp;&nbsp;The Seller has agreed to sell to the Purchaser, and the Purchaser has agreed to purchase from the Seller, all of the outstanding shares of ModiQuest Research and lmmulease in exchange for shares of the Parent and certain
payments made by the Purchaser as set forth herein (the &#147;Transaction&#148;); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">C. &nbsp;&nbsp;&nbsp;&nbsp;The Parties agree that these recitals
shall form part of this Agreement, </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOW THEREFORE THE PARTIES AGREE AS FOLLOWS: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>INTERPRETATION</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.1.&nbsp;&nbsp;&nbsp;&nbsp;Where used herein or Schedules hereto, the following terms shall have the following meanings: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Action&#148; has the meaning set forth in Section&nbsp;4.15. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Additional Dividend&#148; has the meaning set forth in Schedule 6.1. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Affiliate&#148; means any and all Persons with respect to which the ultimate parent of a Party, at present or
in the future, either directly or indirectly, holds more than fifty percent (50%) of the nominal value of the share capital issued, or more than fifty percent (50%) of the voting power at general meetings, or has the power to appoint and to dismiss
a majority of the managing directors or otherwise to direct the activities of such Person, or any other Person qualifying as a &#145;subsidiary&#146;, as part of a &#145;group&#146; or as a &#145;participation&#146; as referred to in sections 2:24a,
2:24b and 2:24c of the NCC; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(d) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Agreement&#148; means this agreement including all schedules and appendices
referred to herein or attached hereto, any and all as amended from time to time; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(e) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Breach&#148; means a
breach of any of the warranties as referred to in Section 9.1. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(f) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Business&#148; means the business in which respectively
ModiQuest Research and lmmulease are engaged, namely, respectively technology used for antibody generation, expression and optimisation, and the leasing of certain equipment by lmmulease to ModiQuest Research. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(g) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Business Day&#148; means a day (other than a Saturday or Sunday) on which banks are generally open for normal
business in Amsterdam, the Netherlands and Victoria, Canada. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(h) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Cap&#148; means the cap on the aggregate of
liabilities as defined in Section 9.4. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(i) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Cash Payment&#148; means the payment set forth in
Section&nbsp;2.3(a). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(j) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Closing&#148; means closing of the sale and transfer of the ModiQuest Research
Shares and the lmmulease Shares by the Seller to the Purchaser as set forth herein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(k) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Closing Date&#148;
means the date of closing of the Transaction as agreed to by the Parties but in any event no later than March 31, 2018. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(l)
&nbsp;&nbsp;&nbsp;&nbsp;&#147;Closing Price&#148; means the closing price of the Parent Shares as quoted on the TSXV. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(m)
&nbsp;&nbsp;&nbsp;&nbsp;&#147;Companies&#148; means ModiQuest Research and lmmulease collectively and &#147;Company&#148; means any one of them, as the context requires. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(n) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Company Director&#148; means lmmusys B.V., the sole statutory director (<I>statutair bestuurder</I>) of each
of the Companies on the Signing Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(o) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Data Room&#148; means the data room at
<U>https://cp.sync.com/files/625350499</U> made available to the Purchaser, its Parent and their representatives and advisers from December 6, 2017 to February 28, 2018. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(p) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Deed of Transfer&#148; means the notarial deed of transfer for the ModiQuest Research Shares and lmmulease
Shares, to be executed in the agreed form on the Closing Date before the Notary. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(q) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Deferred Cash
Payment&#148; and &#147;Deferred Cash Payments&#148; have the meanings set forth in Section&nbsp;2.3(b). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(r)
&nbsp;&nbsp;&nbsp;&nbsp;&#147;Deferred Share Payment&#148; and &#147;Deferred Share Payments&#148; have the meanings set forth in Section&nbsp;2.3(b) </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(s) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Disentanglement Agreement&#148; has the meaning set forth in Section 4.12(iii). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(t) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Dividend&#148; has the meaning set forth in Schedule 6.1.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(u) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Dutch GAAP&#148; means generally accepted accounting principles applicable in the Netherlands to private
companies like each of the Companies. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(v) &nbsp;&nbsp;&nbsp;&nbsp;&#147;EBITDA&#148; means earnings before interest, taxes, depreciation
and amortization attributable to ModiQuest Research as a separate business unit, determined in accordance with IFRS. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(w)
&nbsp;&nbsp;&nbsp;&nbsp;&#147;Exchange Rate&#148; means the Bank of Canada noon rate for European Euros in Canadian dollars on the date immediately preceding the Closing Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(x) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Financing&#148; means debt or equity financing to the Parent for not less than &#128;2,500,000. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(y) &nbsp;&nbsp;&nbsp;&nbsp;&#147;First Additional Payment Date&#148; means the date which is 60 days after the First ModiQuest Fiscal Year
End. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(z) &nbsp;&nbsp;&nbsp;&nbsp;&#147;First ModiQuest Fiscal Year End&#148; means the first ModiQuest Research Fiscal Year End ending on
or after December 31, 2018. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(aa) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Fundamental Warranties&#148; has the meaning as defined in
Section&nbsp;9.1. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(bb) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Governmental Body&#148; means any government, parliament, legislature, regulatory
authority, agency, commission, board or court or other law, rule or regulation making entity having or purporting to have jurisdiction on behalf of any nation, state, province or subdivision thereof, including any municipality or district. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(cc) &nbsp;&nbsp;&nbsp;&nbsp;&#147;IFRS&#148; means International Financial Reporting Standards applicable to Canadian publically traded
companies. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(dd) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Intellectual Property Rights&#148; has the meaning set forth in Section&nbsp;4.20. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(ee) &nbsp;&nbsp;&nbsp;&nbsp;&#147;lmmulease Shares&#148; means the 18,000 common shares in the capital of lmmulease B.V. held by lmmusys B.V.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(ff) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Law&#148; means with respect to the relevant subject matter or Person, all applicable legislation,
regulations, rules, directives, decrees, and other legislative measures or decisions having the force of law, as well as treaties, conventions and other agreements between states, or between states and the European Union or other supranational
bodies, rules of common law, customary law and equity, and all other laws of, or having effect in, any jurisdiction from time to time. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(gg) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Lien&#148; means any lien, charge, pledge, security interest, encumbrance, right of first refusal, <FONT
STYLE="white-space:nowrap">pre-emptive</FONT> right or other restriction of any sort whatsoever. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(hh) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Losses&#148; means all damages and losses assessed in
accordance with sections 6:95 et seq. of the NCC, including without limitation all claims, liabilities, obligations, costs, damages, losses and expenses (including reasonable attorneys&#146; and expert fees and costs of investigation) of any nature,
whether or not involving a third party, however excluding loss of (anticipated) share value, loss of profit, loss of goodwill, revenue or dividends, loss of anticipated savings or return on investment, or indirect or consequential losses of any
kind. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(ii) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Management Agreement&#148; means the form of agreement set forth in Appendix A. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(jj) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Material Permits&#148; has the meaning set forth in Section&nbsp;4.18. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(kk) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Material Adverse Effect&#148; or &#147;Material Adverse Change&#148; means any effect, event, occurrence or
change that is materially adverse to (i)&nbsp;the legality, validity or enforceability of any Transaction Documents, (ii)&nbsp;the results of operations, assets, business, prospects or condition (financial or otherwise) of the particular Party,
taken as a whole, or (iii)&nbsp;a Party&#146;s ability to perform, in any material respect, its obligations under any Transaction Documents, but not including any effect, event, asset, occurrence or change that results or arises from or relates to
any change (iv)&nbsp;in applicable Law, generally accepted accounting principles applicable to the particular Party, or interpretations thereof or (v)&nbsp;to economies in general or the industry in which the particular Party operates. For greater
clarity, a Material Adverse Effect or Material Adverse Change with respect the Companies, includes an adverse effect or change (A)&nbsp;to the turnover of each Company relative to the turnover in the period 12 months preceding such effect, event,
occurrence or change, and/or (B)&nbsp;on the value of the Companies taken as a whole of at least EUR 250,000; and a Material Adverse Effect or Material Adverse Change with respect to the Purchaser and the Parent includes (C)&nbsp;a change in the
affairs, assets, liabilities or financial condition of the Parent, taken as a whole, resulting in the closing price of the Parent Shares as quoted by the TSXV on the trading day immediately prior to the Closing Date being less than 20% of the price
of the Parent Shares on the Signing Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(ll) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Material Contract&#148; has the meaning set forth in
Section&nbsp;4.14. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(mm) &nbsp;&nbsp;&nbsp;&nbsp;&#147;ModiQuest Research Fiscal Year End&#148; means the fiscal year end of ModiQuest
Research, being December 31 as of the Signing Date, and as such fiscal year end may be amended after Closing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(nn)
&nbsp;&nbsp;&nbsp;&nbsp;&#147;ModiQuest Research Shares&#148; means the 180 common shares in the capital of ModiQuest Research B.V. held by lmmusys B.V. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(oo) &nbsp;&nbsp;&nbsp;&nbsp;&#147;NCC&#148; means the Netherlands Civil Code (&#147;<I>Burgerlijk Wetboek</I>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(pp) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Notary&#148; means civil law notary Mr.&nbsp;R.M. Rieter or another civil law notary of Bird&nbsp;&amp; Bird
LLP in The Hague, or such civil law notary&#146;s substitute. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(qq) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Notary Account&#148; means the trust account
(<I>kwaliteitsrekening</I>) of the office of the Notary, bank account number NL66ABNA0240486331 in the name of &#145;<I>Kwaliteitsrekening Notariaat Bird&nbsp;&amp; Bird</I>&#148; with ABN AMRO Bank (BlC: ABNANL2A). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(rr) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Party&#148; or &#147;Parties&#148; means respectively each party and more than one party, or as the context
requires, all five Parties to this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(ss) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Person&#148; means an individual or corporation,
partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or agency or subdivision thereof) or other entity of any kind. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(tt) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Premises&#148; means the premises set forth in Schedule 4.19. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(uu) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Proceeding&#148; means an action, claim, suit, investigation or proceeding (including, without limitation,
an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(vv)
&nbsp;&nbsp;&nbsp;&nbsp;&#147;Parent Financial Statements&#148; means the audited and unaudited financial statements of the Parent in the Parent Public Filings. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(ww) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Parent Public Filings&#148; means the Parent&#146;s filings on the SEDAR filing system. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(xx) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Parent Shares&#148; means common shares in the capital of the Parent. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(yy) &#147;Parent Share Equivalents&#148; means any securities of the Parent that would entitle the holder thereof to acquire at any time
Parent Shares, including, without limitation, any debt, preferred shares, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Parent
Shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(zz) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Purchaser&#146;s Group&#148; means the Purchaser, the Parent, any holding company or ultimate
beneficial owner of the Parent, any subsidiary of the Parent and any subsidiary of any such holding company or ultimate beneficial owner as well as all their Affiliates; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(aaa) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Registrar&#148; means the British Columbia Registrar of Companies. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(bbb) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Required Approvals&#148; has the meaning set out in Section&nbsp;7.1. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(ccc) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Second Additional Payment Date&#148; means the date which is 60 days after the Second ModiQuest Fiscal Year
End. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(ddd) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Second ModiQuest Fiscal Year End&#148; means the ModiQuest Research Fiscal Year End ending on or
after December&nbsp;31, 2019. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(eee) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Securities Authorities&#148; has the meaning set out in
Section&nbsp;7.4. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(fff) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Seller Principal&#148; means Mr Jos Raats, being the statutory director and the sole
shareholder of the Seller. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(ggg) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Share Payment&#148; means the payments set forth in 2.3(a). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(hhh) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Shares&#148; means the ModiQuest Research Shares and the lmmulease Shares collectively and
&#147;Share&#148; means any one of them, as the context requires. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(iii) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Signing Date&#148; the date all
Parties hereto have signed this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(jjj) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Tax Act&#148; means the <I>Income Tax Act</I> (Canada).
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(kkk) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Taxes&#148; means means all forms of taxation, impositions, duties, contributions and levies in the
nature of taxation including (without prejudice to the generality of the foregoing) income tax, tax on capital gains, corporation tax, value added tax, stamp duties, transfer taxes, land taxes (other than rates), sales tax or use taxes, social
security contributions, wage taxes, secondary tax liabilities and any amounts withheld on account of any of the foregoing together with all penalties, charges, surcharges, fines, costs and interest relating thereto (in all cases, regardless of
whether such taxes, penalties, charges, surcharges, fines, costs and interest are directly or primarily chargeable against or attributable to the relevant Party or any other Person and regardless of whether the relevant Person has, or may have, any
right of reimbursement against any other Person) and including any contractual obligation to pay any of the above. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(lll)
&nbsp;&nbsp;&nbsp;&nbsp;&#147;Third Additional Payment Date&#148; means the date which is 60 days after the Third ModiQuest Fiscal Year End. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(mmm) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Third ModiQuest Fiscal Year End&#148; means the ModiQuest Research Fiscal Year End ending on or after
December&nbsp;31, 2020. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(nnn) &nbsp;&nbsp;&nbsp;&nbsp;&#147;Transaction Documents&#148; means this Agreement, all exhibits and schedules
hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder and any documents required by the TSXV, applicable securities legislation relating to this Agreement and other regulatory bodies having
jurisdiction to carry out the terms and objectives of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(ooo) &nbsp;&nbsp;&nbsp;&nbsp;&#147;TSXV&#148; means the TSX Venture
Exchange. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.2. &nbsp;&nbsp;&nbsp;&nbsp;All dollar amounts referred to in this Agreement are in lawful currency of Canada, unless expressly stated
othenrwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.3. &nbsp;&nbsp;&nbsp;&nbsp;Any representations or warranties by the Seller or the Purchaser and qualified by the expression &#145;to the
Seller&#146;s knowledge&#146;, &#145;to the Purchaser&#146;s knowledge&#146; or &#145;so far as the Seller is aware&#146; or any similar expression shall be deemed to comprise such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">knowledge, information, awareness or knowledge that the named Party actually (<I>feitelijk</I>) has or is
deemed to have on the basis of due and careful consideration and diligent enquiry, enquiry in his capacity as a manager/employer and/or, as the case may be, shareholder, of all senior employees of such Party and its Affiliates that have knowledge of
the relevant matters, said enquiry made as a result of one Party&#146;s due diligence investigation relative to the transactions contemplated in this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.4. &nbsp;&nbsp;&nbsp;&nbsp;Where in this Agreement a Dutch term is given in italics or in italics and in brackets after an English term and there is any
inconsistency or difference in interpretation between the meaning of the Dutch and the English term, the meaning of the Dutch term shall prevail. English language words used in this Agreement intend to describe Dutch legal concepts, and the
interpretation or consequences of the use of those words according to Canadian law or any other foreign Law shall be disregarded. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.5.
&nbsp;&nbsp;&nbsp;&nbsp;The following schedules are attached to and form part of this Agreement: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="82%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Seller</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">each of the Companies Share Capitalization</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.14</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">each of the Companies Material Contracts</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.19</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">each of the Companies Premises</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.20</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Intellectual Property</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Appendix&nbsp;&nbsp;&nbsp;&nbsp;A</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Management Agreement</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Appendix&nbsp;&nbsp;&nbsp;&nbsp;B</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Disentanglement Agreement</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>PURCHASE AND SALE OF SHARES</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.1. &nbsp;&nbsp;&nbsp;&nbsp;<U>Purchase and Sale of Shares.</U> Subject to the terms and conditions of this Agreement, the Seller hereby sells, and the
Purchaser hereby purchases, the Shares free from any Lien with effect from the Closing Date and with all rights attaching to them including the right to receive all distributions and dividends declared, paid or made in respect of the Shares after
the Closing Date relative to the period thereafter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.2. &nbsp;&nbsp;&nbsp;&nbsp;<U>Transfer of the Shares.</U> On the Closing Date and subject to the
terms and conditions set forth herein, the Purchaser agrees to acquire and accept and the Seller agrees to transfer (<I>leveren</I>) to the Purchaser all of its Shares as set forth in Schedule 2.2 hereto, free and clear from any Lien and with all
rights attaching to the Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.3. &nbsp;&nbsp;&nbsp;&nbsp;<U>Consideration.</U> In consideration of the sale and transfer of the Shares, the Purchaser
shall pay a total purchase price of &#128;7,000,000 (in words: seven million euro) as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) &nbsp;&nbsp;&nbsp;&nbsp;On the Closing
Date the Purchaser will pay to the Seller an aggregate of &#128;5,000,000 payable in cash and Parent Shares as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#128;2,500,000, to be paid to the Seller in cash (the &#147;Cash Payment&#148;). The Purchaser shall ensure
that the Cash Payment shall be credited to the Notary Account no later than 14.00 pm CET (Central European Time) on the Closing Date. The Notary shall hold the </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Cash Payment in escrow for the Purchaser until execution of the Deed of Transfer, where after the Notary shall hold the Cash Payments in escrow for the Seller, and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#128;2,500,000, to be paid by the issuance by the Parent to the Seller of 6,600,399 Parent Shares (the
&#147;Share Payment&#148;) having an agreed upon value of C$0.57 per Parent Share, converted at an agreed upon rate of C$1 = &#128;0.6645 (being the daily exchange rate for December 6, 2017 as quoted by the Bank of Canada); and
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) &nbsp;&nbsp;&nbsp;&nbsp;After the Closing Date, the Purchaser will pay to the Seller an aggregate of &#128;2,000,000
payable in cash and Parent Shares as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On or before the First Additional Payment Date, the Purchaser shall: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(A) &nbsp;&nbsp;&nbsp;&nbsp;Pay to the Seller &#128;333,333, in cash, and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(B) &nbsp;&nbsp;&nbsp;&nbsp;Ensure that the Parent shall issue Parent Shares to the Seller having a value of &#128;333,333 based on the
greater of (1) $0.57 per Parent Share, and (2)&nbsp;the Closing Price on the First ModiQuest Fiscal Year End, converted to euros based on average the daily exchange rate as quoted by the Bank of Canada for the 10 Business Days immediately prior to
the date such Parent Shares are issued, </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On or before the Second Additional Payment Date, the Purchaser shall: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(A) &nbsp;&nbsp;&nbsp;&nbsp;Pay to the Seller &#128;333,333, in cash, and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(B) &nbsp;&nbsp;&nbsp;&nbsp;Ensure that the Parent shall issue Purchaser Shares to the Seller having a value of &#128;333,333 based on the
greater of (1) $0.57 per Parent Share, and (2)&nbsp;the Closing Price on the Second ModiQuest Fiscal Year End, converted to euros based on the average daily exchange rate as quoted by the Bank of Canada for the 10 Business Days immediately prior to
the date such Parent Shares are issued, </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On or before the Third Additional Payment Date, the Purchaser shall: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(A) &nbsp;&nbsp;&nbsp;&nbsp;Pay to the Seller &#128;333,334, in cash, and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(B) &nbsp;&nbsp;&nbsp;&nbsp;Ensure that the Parent shall issue Parent Shares to the Seller having a value of &#128;333,334 based on the
greater of (1) $0.57 per Parent Share, and (2)&nbsp;the Closing Price on the Third ModiQuest Fiscal Year End, converted to euros based on the average daily </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">
exchange rate as quoted by the Bank of Canada for the 10 Business Days immediately prior to the date such Parent Shares are issued, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The deferred cash payments under this Section&nbsp;2.3(b) are hereinafter referred to individually as a &#147;Deferred Cash Payment&#148; and
collectively as the &#147;Deferred Cash Payments&#148; the deferred share issuances be made under this Section&nbsp;2.3(b) are hereinafter referred to individually as a &#147;Deferred Share Payment&#148; and collectively as the &#147;Deferred Share
Payments&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding that the Parent has designated the Purchaser to perform certain obligations under this Section&nbsp;2.3, as between the
Purchaser, Parent and Seller, the Parent shall be jointly and severally liable with the Purchaser to pay each portion of the purchase price in cash and equity to Seller as provided in this Section&nbsp;2.3. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.4. &nbsp;&nbsp;&nbsp;&nbsp;<U>Extension of Deferred Payments</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) &nbsp;&nbsp;&nbsp;&nbsp;lf the ModiQuest Research Fiscal Year End for the particular fiscal year for which a Deferred Cash Payment or
Deferred Share Payment is to be made, is the same as the Parent&#146;s fiscal year end for the same period, then the Purchaser and the Parent may elect to delay payment of such Deferred Cash Payment or issuance of such Deferred Share Payment, or
both, until the date that is 10 business days after the date that the Parent&#146;s audited financial statements for the particular fiscal year are filed and posted on the SEDAR filing system, provided that the Parent provides written notice of such
election to the Seller by no later than the First Additional Payment Date, the Second Additional Payment Date or the Third Additional Payment Date, as applicable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) &nbsp;&nbsp;&nbsp;&nbsp;lf the Purchaser and the Parent elect to defer payment of the Deferred Cash Payment or issuance of the Deferred
Share Payment, or both, as set forth in Section&nbsp;2.4(a), then the Deferred Cash Payment or the Deferred Share Payment, or both, as applicable and as adjusted as set forth in Section&nbsp;2.5, shall bear simple interest at a rate of 4% per annum,
beginning on the date of the First Additional Payment Date, Second Additional Payment Date or Third Additional Payment Date, as applicable, until the date that such Deferred Cash Payment or Deferred Share Payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.5. &nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustment to Deferred Payments.</U> For Section&nbsp;2.3(b), the Deferred Cash Payments and the value of the Deferred Share
Payments to be made by the Purchaser to the Seller shall be adjusted downwards (but not upwards) if the EBITDA for the ModiQuest Research fiscal year ending on the particular ModiQuest Research fiscal year end date set forth in
Section&nbsp;2.3(b)(i), 2.3(b)(ii), or 2.3(b)(iii) (the &#147;Particular ModiQuest Fiscal Year&#148;), as applicable, is less than the average annual EBITDA over the two (2)&nbsp;comparable ModiQuest Research fiscal years immediately preceding the
Particular ModiQuest Fiscal Year. Such adjustment shall be made pro rata based on the ratio that the annual EBITDA for the Particular ModiQuest Fiscal Year bears to the average annual EBITDA over the two (2)&nbsp;comparable ModiQuest fiscal years
immediately preceding the Particular ModiQuest Fiscal Year. <U>For example</U>, if the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
EBITDA for the ModiQuest Research fiscal year ending December 31, 2018 is &#128;1,000,000 and the average of the annual EBITDA for ModiQuest Research&#146;s fiscal years ending December 31, 2017
and December 31, 2016 is &#128;3,000,000, then the Deferred Cash Payment to be made pursuant to Section&nbsp;2.3(b)(i)(A) shall be &#128;111,111 and the value of the Parent Shares to be issued pursuant to the Deferred Share Payment under
Section&nbsp;2.3(b)(i)(B) shall be &#128;111,111. Alternatively, if the EBITDA for ModiQuest Research&#146;s fiscal year ending December 31, 2018 is &#128;1,000,000 and the average of the annual EBITDA for ModiQuest Research&#146;s fiscal years
ending December 31, 2017 and December&nbsp;31, 2016 is &#128;1,000,000, then the Deferred Cash Payment to be made pursuant to Section&nbsp;2.3(b)(i)(A) shall be &#128;333,333 and the value of the Parent Shares to be issued pursuant to the Deferred
Share Payment under Section&nbsp;2.3(b)(i)(B) shall be &#128;333,333. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.6. &nbsp;&nbsp;&nbsp;&nbsp;<U>Examination of Books and Records</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) &nbsp;&nbsp;&nbsp;&nbsp;The Seller may, within 10 days of the payment of any Deferred Cash Payment or Deferred Share Payment (the
&#147;Initial Review Period&#148;), make written request to the Purchaser and the Parent that they make available to the Seller copies of all supporting documentation, working papers, invoices and other information as may be reasonably required to
verify the calculation of the applicable Deferred Cash Payment or Deferred Share Payment (a &#147;Records Request&#148;). Within 10 business days after the receipt of a Records Request, the Purchaser and the Parent shall make such information
available to the Seller, and upon receipt of such material, the Seller shall have a further 10 business days to review such information (the &#147;Records Review Period&#148;). During the Records Review Period, the Seller and their authorized
representatives shall have access to all books and records of ModiQuest Research, the Purchaser and the Parent to the extent required to complete their review of the calculation of the Deferred Cash Payment or Deferred Share Payment, including but
not limited to the working papers used in the preparation thereof. The Purchaser and Parent shall cooperate with the Seller and its authorized representatives with respect to such review. Within the Records Review Period, the Seller shall be
entitled, by written notice to the Purchaser and the Parent, to dispute the calculation of the applicable Deferred Cash Payment or Deferred Share Payment, which notice will set out the reasons for the amount in dispute and reasonable details of the
calculation of such disputed amount (a &#147;Dispute Notice&#148;). The Purchaser shall have 10 business days after the receipt of a Dispute Notice (the &#147;Negotiation Period&#148;) to review the disputed amount and, if necessary, revise the
applicable Deferred Cash Payment or Deferred Share Payment by mutual agreement of the Parent and Seller. lf the Parent and Seller are unable to agree on the adjustments to be made to the Deferred Cash Payment or the Deferred Share Payment within the
Negotiation Period, then such disputed items will be referred immediately thereafter to the Parent&#146;s principal independent auditors or, if the Seller and the Parent mutually elect, a Canadian nationally recognized independent firm of chartered
accountants that is independent of and has no business dealings with any of the Purchaser, the Parent, ModiQuest Research or the Seller (the &#147;Auditor&#148;). The fees and expenses of the Auditor for reviewing and revising the Deferred Cash
Payment or Deferred Share Payment will be paid </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
by the Seller, unless the Auditor determines that the Deferred Cash Payment or Deferred Share Payment is increased by an amount equal to or more than the greater of (A) 3% of the amount
originally calculated by the Purchaser and the Parent and (B) &#128;10,000, in which case the Purchaser shall bear the Auditors&#146; fees. The determination of the Auditor shall be final and binding on the parties. lf the Seller does not dispute in
writing the original calculation of the Deferred Cash Payment or Deferred Share Payment within the Initial Review Period or the Records Review Period, if applicable, or if the Seller and Parent mutually agree to settle such dispute within the
Negotiation Period, such calculation of the Deferred Cash Payment or Deferred Share Payment shall be final and binding on the parties. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b)
Except as may be required by law, the Seller agrees not to (i)&nbsp;disclose, disseminate or otherwise make public any information provided by the Purchaser and the Parent under this Section&nbsp;2.6, or (ii)&nbsp;use the information provided by the
Purchaser and the Parent under Section&nbsp;2.6 for any purpose other than disputing the amount of the Deferred Cash Payment or Deferred Share Payment, without the prior written consent of the Purchaser and the Parent, to be obtained in each
instance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.7. &nbsp;&nbsp;&nbsp;&nbsp;<U>Closing</U>. Closing shall take place on the Closing Date at the offices of the Notary at Zuid-Hollandplein 22,
2596 AW The Hague, the Netherlands and at such time as agreed to by the Parties or on such other date or at such other time or place as the Parties may mutually agree. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.8. &nbsp;&nbsp;&nbsp;&nbsp;<U>Closing Deliveries</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) &nbsp;&nbsp;&nbsp;&nbsp;<U>Companies and the Seller Deliveries</U>. On or prior to the Closing Date, each of the Companies and the Seller
shall deliver or cause to be delivered the following documents to the Purchaser: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(i) &nbsp;&nbsp;&nbsp;&nbsp;The original shareholders
register of each of the Companies; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(ii) &nbsp;&nbsp;&nbsp;&nbsp;The Amendment Agreement to Management Agreement duly signed by Jos
Raats. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) &nbsp;&nbsp;&nbsp;&nbsp;<U>Purchaser Deliveries</U>. On or prior to the Closing Date, the Purchaser shall deliver or cause to
be delivered the following documents to the Seller; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(i) &nbsp;&nbsp;&nbsp;&nbsp;Payment by wire transfer, bank draft or certified cheque
of the Cash Payment to the Notary Account. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(ii) &nbsp;&nbsp;&nbsp;&nbsp;A share certificate registered in the name of the Seller
representing the Share Payment or a direct registration advice issued by the transfer agent for the Parent Shares advising that the Share Payment has been issued to the Seller and registered in the name of the Seller. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(iii) &nbsp;&nbsp;&nbsp;&nbsp;A certificate, or the equivalent, as to the corporate
existence and good standing of the Parent, issued by the Registrar, dated not more than five business days prior to the Closing Date; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(iv) &nbsp;&nbsp;&nbsp;&nbsp;The Amendment Agreement to Management Agreement duly signed by the Purchaser and the Parent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.9. &nbsp;&nbsp;&nbsp;&nbsp;<U>Further Actions.</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) &nbsp;&nbsp;&nbsp;&nbsp;The Seller, the Purchaser and each of the Companies shall sign the Deed of Transfer before the Notary who shall
execute the Deed of Transfer, thus effectuating the transfer of the Shares from the Seller to the Purchaser. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b)
&nbsp;&nbsp;&nbsp;&nbsp;On the first Business Day following the Closing Date, the Notary shall pay the Cash Payment to the Seller in the amounts as specified in Section&nbsp;2.3(a)(i) above, to such bank accounts as shall be designated in writing by
the Seller to the Notary. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c) &nbsp;&nbsp;&nbsp;&nbsp;Each Party to this Agreement covenants and agrees that, from time to time prior to
and subsequent to Closing, it will execute and deliver all such documents, including all such additional conveyances, transfers, consents and other assurances and do all such other acts and things as may be necessary or desirable in order to carry
out the purposes of this Agreement, including, but not limited to, such documents, instruments or agreements as may reasonably be requested by the TSXV in connection with the transactions contemplated in this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.10. &nbsp;&nbsp;&nbsp;&nbsp;The Notary is a partner of Bird&nbsp;&amp; Bird LLP, the firm of the external legal advisors to the Purchaser. The Seller
acknowledges that it is aware of the relevant provisions of the Ordinance lnterdisciplinary Cooperat&iacute;on (<I>Verordening Interdisciplinaire Samenwerking</I>) and the articles 19 through 22 of the Professional Code of Conduct (<I>Verordening
Beroeps- en Gedragsregels</I>) of the Royal Professional Organisation of Civil Law Notaries (<I>Koninklijke Notari&euml;le Beroepsorganisatie</I>). The Seller hereby acknowledges and agrees that the Notary may advise and act on behalf of the
Purchaser and the Parent with respect to this Agreement, and any agreements and/or any disputes related to or resulting from this Agreement but not in respect of the Deed of Transfer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.11. &nbsp;&nbsp;&nbsp;&nbsp;<U>Post-Closing Changes to Company Articles and Directors</U>. The Seller acknowledges, agrees and accepts that post-Closing,
the Purchaser intends to (a)&nbsp;appoint an additional member (to be designated by the Purchaser) to the board of managing directors for each of the Companies, and to replace the Seller with Jos Raats as a managing director for each of the
Companies; and (b)&nbsp;to amend the articles of association for each of the Companies to provide for a Managing Director A (to be authorized to act alone on behalf of the particular Company) and a Managing Director B (to be authorized to act only
in cooperation or jointly with the Managing Director A). The person designated by the Purchaser will be appointed as the Managing Director A, and Mr.&nbsp;Raats will be appointed as the Managing Director B. The Seller covenants and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
agrees to cooperate with the Purchaser, and to sign and deliver such documents, and to take such actions, as the Purchaser may reasonably request to give effect to the above changes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>REPRESENTATIONS AND WARRANTIES OF THE SELLER</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Seller hereby warrants to the Purchaser and the Parent that each of the following representations is true and accurate on the Signing Date
and will be true and accurate on the Closing Date and acknowledges that the Purchaser is relying on such representations and warranties in connection with the purchase of the Shares: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.1. &nbsp;&nbsp;&nbsp;&nbsp;The Seller owns the Shares as the sole legal, beneficial and recorded owner thereof, with good and marketable title thereto, free
and clear of all Liens, and demands whatsoever, with full right, power and authority to sell, transfer and deliver the same to the Purchaser upon Closing, and such Shares are not subject to any shareholders&#146; agreement, voting trust agreement or
similar agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.2. &nbsp;&nbsp;&nbsp;&nbsp;The Seller is an entity duly incorporated or formed, validly existing under the laws of the jurisdiction
of its incorporation or formation with full right, corporate, partnership, limited liability company or similar power and authority to enter into and to consummate the transactions contemplated in this Agreement and otherwise to carry out its
obligations hereunder. The execution and delivery of this Agreement and performance by the Seller of the transactions contemplated herein have been duly authorized by all necessary corporate, partnership, limited liability company or similar action,
as applicable, on the part of the Seller. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.3. &nbsp;&nbsp;&nbsp;&nbsp;No Person has any agreement or option or any right or privilege (whether by Law, <FONT
STYLE="white-space:nowrap">pre-emptive</FONT> or contractual) capable of becoming an agreement or option for the purchase any of the Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.4.
&nbsp;&nbsp;&nbsp;&nbsp;This Agreement has been duly executed by the Seller, and when delivered by the Seller in accordance with the terms hereof, will constitute the valid and legally binding obligation of the Seller, enforceable against it in
accordance with its terms, except: (i)&nbsp;as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#146; rights generally,
(ii)&nbsp;as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii)&nbsp;insofar as indemnification and contribution provisions may be limited by applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.5. &nbsp;&nbsp;&nbsp;&nbsp;The Seller represents that it (or any other Person) has no right or claims whatsoever to any shares in the capital of, or any
other equity or ownership interest in, each of the Companies other than the Shares, and it (or any other Person) does not have any options, warrants, or any other instruments or rights entitling the Seller to exercise, purchase, convert or otherwise
acquire any shares in the capital of, or any other equity or ownership interest in, each or both of the Companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.6. &nbsp;&nbsp;&nbsp;&nbsp;The
execution and delivery of the Transaction Documents and the consummation of the transactions contemplated hereby or thereby will not, in any material respect: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) &nbsp;&nbsp;&nbsp;&nbsp;Violate, be in conflict with, result in any breach of,
constitute a default, or cause the acceleration of any obligation of the Seller, under: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(i) &nbsp;&nbsp;&nbsp;&nbsp;Any agreement,
instrument, license, permit or authority to which such Seller is, or is entitled to be, a party or to which the Shares are subject, </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(ii)
&nbsp;&nbsp;&nbsp;&nbsp;Any judgment, decree, order, statute, rule or regulation applicable to the Seller, </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(iii)
&nbsp;&nbsp;&nbsp;&nbsp;Any provision of Law or any judicial or administrative order, award, judgment or decree applicable to the Seller, or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(iv) &nbsp;&nbsp;&nbsp;&nbsp;Any provision of the constituting documents, articles, <FONT STYLE="white-space:nowrap">by-laws,</FONT>
partnership agreement, resolutions, or other governing documents of the Seller, </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) &nbsp;&nbsp;&nbsp;&nbsp;Result in the creation of any
Lien upon any or all of the Shares under any agreement or instrument whatsoever; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c) &nbsp;&nbsp;&nbsp;&nbsp;Give to any Person any
material interest or rights that have not been waived prior to the date hereof, including <FONT STYLE="white-space:nowrap">pre-emptive</FONT> or preferential rights of purchase of any part or all of the Shares, or any right of termination,
cancellation or acceleration under any agreement, instrument, license, permit or authority referred to in Section&nbsp;3.6(a)(i); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.7.
&nbsp;&nbsp;&nbsp;&nbsp;No permits, licenses, certifications, approvals, consents, or other action of a Governmental Body is required for the execution, delivery or performance by the Seller of the Transaction Documents or the transactions
contemplated hereby or thereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.8. &nbsp;&nbsp;&nbsp;&nbsp;The Seller is not a &#147;U.S. person&#148; as that term is defined in Rule 901(k) of
Regulation S promulgated under the United States Securities Act of 1933; the Seller was not in the United States at the time it received the offer to acquire the Parent Shares; and the Seller was not in the United States at the time such Seller
decided to acquire the Parent Shares or at the time the Seller executed this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.9. &nbsp;&nbsp;&nbsp;&nbsp;The Seller acknowledges and agrees
that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) &nbsp;&nbsp;&nbsp;&nbsp;no securities commission or similar regulatory authority or other Governmental Body has reviewed or
passed on the merits of the Parent Shares; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) &nbsp;&nbsp;&nbsp;&nbsp;there is no government or other insurance covering the Parent
Shares; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c) &nbsp;&nbsp;&nbsp;&nbsp;there are risks associated with the purchase of the Parent Shares; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(d) &nbsp;&nbsp;&nbsp;&nbsp;there are restrictions on the Seller&#146;s ability to resell
the Parent Shares and it is the responsibility of the Seller to find out what those restrictions are and to comply with them before selling the Parent Shares; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(e) &nbsp;&nbsp;&nbsp;&nbsp;the Parent has advised the Seller that the Parent is relying on an exemption from the requirements to provide the
Seller with a prospectus and to sell securities through a Person registered to sell securities under the <I>Securities Act</I> (British Columbia) and, as a consequence of acquiring securities pursuant to this exemption, certain protections, rights
and remedies provided by the <I>Securities Act</I> (British Columbia), including statutory rights of rescission or damages, will not be available to the Seller. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.10. &nbsp;&nbsp;&nbsp;&nbsp;The Seller is acquiring the Parent Shares for its own account, for investment purposes only and not with a view to resale or
distribution or other disposition of the Parent Shares in violation to applicable securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.11. &nbsp;&nbsp;&nbsp;&nbsp;The Seller has been
advised to consult with its own legal, tax and other advisors with respect to the merits of the acquisition of the Parent Shares and applicable resale restrictions, and the Seller is solely responsible for compliance with applicable resale
restrictions with respect to the Parent Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>REPRESENTATIONS AND WARRANTIES OF EACH OF THE COMPANIES</U>
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Seller (in its capacity of Seller of the Shares and its capacity as managing director of each of the Companies) hereby warrants
to the Purchaser and the Parent that each of the following representations is true and accurate on the Signing Date and will be true and accurate on the Closing Date, and acknowledges that the Purchaser and the Parent are relying on such
representations and warranties in connection with the purchase of the respective Shares of each of the Companies: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.1.
&nbsp;&nbsp;&nbsp;&nbsp;<U>Organization and Qualification</U>. Each Company is an entity duly incorporated or otherwise organized, validly existing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and
authority to own and use its properties and assets and to carry on its business as currently conducted. Each Company is neither in violation nor in default of any of the provisions of its articles of incorporation. Each Company is duly qualified to
conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so
qualified or in good standing, as the case may be, could not have or reasonably be expected to result in a Material Adverse Effect and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke,
limit or curtail such power and authority or qualification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.2. &nbsp;&nbsp;&nbsp;&nbsp;<U>Subsidiaries, Partnerships and Joint Ventures</U>. The
Companies do not have any subsidiaries or agreements of any nature to acquire any subsidiary or to acquire or lease any other business operations and will not prior to the Closing Date acquire, or agree to acquire, any subsidiary or business without
the prior written consent of the Purchaser. The Companies are not a partner or a participant in any partnership, joint </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
venture, profit sharing arrangement or other association of any kind, including as a beneficiary or trustee in any trust arrangement and is not party to any agreement under which any Company
agrees to carry on any part of its business or any other activity in such manner or by which any Company agrees to any revenue or profit sharing arrangement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.3. &nbsp;&nbsp;&nbsp;&nbsp;<U>Capitalization</U>. The capitalization of each Company is as set forth on Schedule 4.3, and the Shares are registered and
recorded in the name of the Seller. The Shares represent all of the issued and outstanding share capital of the relevant Company and, except as set forth on Schedule 4.3, no Company has issued any capital stock. No Person has any right of first
refusal, preemptive right, right of participation, or any similar right granted by any Company to participate in the transactions contemplated by the Transaction Documents. Except as set out in Schedule 4.3, there are no outstanding options,
warrants, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire any
shares in the capital stock, or contracts, commitments, understandings or arrangements by which any Company is or may become bound to issue additional shares in the capital stock of any Company. The consummation of the transactions contemplated
under the Transaction Documents will not obligate any Company to issue interests in the share capital of such Company or other securities to any Person (other than the Purchaser) and will not result in a right of any holder of any shares, options,
warrant or similar securities in any Company to adjust the exercise, conversion, exchange or reset price under any of such securities. All of the outstanding shares of each Company&#146;s share capital are duly authorized, validly issued, fully paid
and <FONT STYLE="white-space:nowrap">non-assessable,</FONT> have been issued in compliance with all applicable laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase
securities. On the Closing Date no further approval or authorization of any shareholder, the Company Director or others will be required to complete the transactions contemplated under the Transaction Documents. There are no shareholders agreements,
voting agreements or other similar agreements with respect to Company&#146;s share capital to which any Company is a party or, to the knowledge of the Seller, between or among any of the Companies and the Seller. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.4. &nbsp;&nbsp;&nbsp;&nbsp;<U>Ownership of Shares</U>. The Seller is the sole registered legal and beneficial owner of the Shares, and the Shares represent
all of the issued and outstanding shares in the capital of the relevant Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.5. &nbsp;&nbsp;&nbsp;&nbsp;<U>Authorization: Enforcement</U>. Each
Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
On the Closing Date, the execution and delivery of each of this Agreement and the other Transaction Documents by each Company and the consummation by it of the transactions contemplated hereby and thereby will be duly authorized by all necessary
action on the part of each Company and no further action will be required by any Company, the Company Director or the Seller in connection herewith or therewith other than in connection with the Required Approvals. This Agreement, and each other
Transaction Document to which a Company is a party, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
has been (or upon delivery will have been) duly executed by such Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of
such Company enforceable against such Company in accordance with its terms, except: (i)&nbsp;as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting
enforcement of creditors&#146; rights generally, (ii)&nbsp;as limited by Laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii)&nbsp;insofar as indemnification and contribution provisions
may be limited by applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.6. &nbsp;&nbsp;&nbsp;&nbsp;<U>No Conflicts</U>. The execution , delivery and performance by each Company of this
Agreement and the other Transaction Documents to which it is a party and the consummation by it of the transactions contemplated hereby and thereby do not and will not: (i)&nbsp;conflict with or violate any provision of any Company&#146;s
certificate or articles of incorporation, or other organizational or charter documents, (ii)&nbsp;conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of
any Lien upon any of the properties or assets of any Company, or to Seller&#146;s knowledge give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit
facility, debt or other instrument (evidencing a Company debt or Lien) or other written agreement (evidencing a Company debt or Lien) to which Company is a party or by which any property or asset of any Company shall become bound or affected, or
(iii)&nbsp;subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which Company is subject (including
federal and state securities laws and regulations), or by which any property or asset of any Company is bound or affected; except in the case of each of clauses (ii)&nbsp;and (iii), such as could not have or reasonably be expected to result in a
Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.7. &nbsp;&nbsp;&nbsp;&nbsp;<U>Filings, Consents and Approvals</U>. The Companies are not required to obtain any consent,
waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by
the Companies of the Transaction Documents, other than consents, waivers, authorizations, orders, notices, filings or registrations necessary in connection with the Required Approvals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.8. &nbsp;&nbsp;&nbsp;&nbsp;<U>Books and Records</U>. The books and records of each Company fairly and correctly set out and disclose in all material
respects, in accordance with Dutch GAAP, the financial position of each Company as at the date hereof, and all material financial transactions of each Company relating to the Business have been accurately recorded in such books and records in all
material respects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.9. &nbsp;&nbsp;&nbsp;&nbsp;<U>Corporate Records</U>. The corporate records and minute books of each Company contain complete and
accurate copies of their respective constituting documents, minutes of all meetings and resolutions of the directors or managers (including any committees thereof) and shareholders of such Company, respectively, and the register of shareholders
(including register of transfers) and register of directors or managers of Company are complete and accurate in all material respects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.10. &nbsp;&nbsp;&nbsp;&nbsp;<U>Officers and Directors</U>. The officers and directors of each of the
Companies are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="83%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Position</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">lmmusys&nbsp;B.V</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer of ModiQuest Research</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">lmmusys B.V</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer of lmmulease</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.11. &nbsp;&nbsp;&nbsp;&nbsp;<U>Financial Statements</U>. At the Closing Date, the Financial Statements will have been
prepared in accordance with Dutch GAAP as applied by the Companies for the book years 2015, 2016 and 2017, and will present fairly the assets, liabilities and the financial position of Company as at the dates indicated and the results of operation
of each Company for the periods indicated as required pursuant to article 2: 391 NCC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.12. &nbsp;&nbsp;&nbsp;&nbsp;<U>No Material Changes</U>. Since
December 31, 2016, no Material Adverse Change has occurred. Without prejudice to the foregoing, since December 31, 2016, each Company&#146;s Business has been carried on in the normal course and: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">except in accordance with terms of this Transaction and except for dividend authorised and paid to the Seller
relative to book year 2016 of Modiquest Research and the dividend set forth in Schedule 6.1 (which dividend relates to the book year 2017 of ModiQuest Research) no dividend or other distribution on any shares in the capital of any Company has been
made, declared or authorized and no Company has either purchased or redeemed or agreed to purchase or redeem any of the shares in its capital; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">no payment of any kind has been made or authorized to or on behalf of the Seller or to or on behalf of
officers, directors or shareholders of any Company; and no Company has paid or agreed to pay any compensation, pension, bonus, share of profits or other benefit to, or for the benefit of, any employee, director or officer of any Company except in
the ordinary course of business and has not increased or agreed to increase the compensation of any director, officer or management employee except in the ordinary course of business, which may include a 1.5% increase in the salary of ModiQuest
Research&#146;s employees and any increases in management fees set forth under the Management Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">no Company has transferred, assigned, sold or otherwise disposed of any of its assets except (A)&nbsp;assets
transferred, assigned, sold or otherwise disposed of in the ordinary course of business which has been disclosed to Purchaser and (B)&nbsp;assets transferred, assigned, sold or otherwise disposed of to disentangle assets held beneficially or jointly
with ModiQuest BV, ModiQuest Therapeutics BV or the Seller as set forth in that lntra-Group Disentanglement Agreement among ModiQuest BV, ModiQuest </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Therapeutics BV, ModiQuest Research and the Seller attached as Appendix B to this Agreement (the &#147;Disentanglement Agreement&#148;) provided that, with respect to this
Section&nbsp;4.12(iii)(B), the Seller has, prior to the Signing Date, provided the Purchaser and the Parent with a written list of all such assets transferred, assigned or sold to pursuant to the Disentanglement Agreement; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">no Company has discharged or satisfied any Lien or subjected any of its assets to any Lien;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to Seller&#146;s knowledge no Company has incurred or assumed any liability (fixed or contingent) other than
liabilities included in the relevant Company Financial Statements (ending December 31, 2016) and liabilities incurred or assumed, or resulting from contracts entered into since December&nbsp;31, 2016 in the ordinary course of business;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">no Company has suffered an extraordinary loss, or waived any rights of material value (each in excess of euro
50,000); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(vii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">no Company has incurred or assumed any material obligation, except for material obligations incurred or
assumed, or resulting from contracts entered into, since December 31, 2016 in the ordinary course of business. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.13.
&nbsp;&nbsp;&nbsp;&nbsp;<U>Sole Business</U>. The Business is the only business which has been or is currently conducted by the Companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.14.
&nbsp;&nbsp;&nbsp;&nbsp;<U>Material Contracts and Capital Commitments</U>. Schedule 4.14 sets forth the material agreements, contracts, mortgages, indentures and leases to which any Company is a Party or to which it is bound (each, an &#147;Material
Contract&#148; and collectively, the &#147;Material Contracts&#148;) which when absent or terminated would cause a Material Adverse Effect. Each Material Contract to the Seller&#146;s knowledge is valid and binding and is in full force and effect,
and the Companies have not, nor to the Seller&#146;s knowledge has any third party, breached any material provision of, or is in default under the terms of, any such Material Contract. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.15. &nbsp;&nbsp;&nbsp;&nbsp;<U>Litigation</U>. There is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the
knowledge of the Seller, threatened against or affecting any Company or any of its properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively,
an &#147;<U>Action</U>&#148;) which (i)&nbsp;adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the transactions contemplated therein or (ii)&nbsp;to Seller&#146;s knowledge could, if
there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither Company nor any director or officer thereof is or has been the subject of any Action involving a claim of violation of or liability
under applicable securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Seller, there is not pending or contemplated, any investigation by any Governmental Body involving any Company, or any current
or former director or officer of any Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.16.&nbsp;&nbsp;&nbsp;&nbsp;<U>Labour Relations</U>.&nbsp;&nbsp;No labor dispute exists or, to the
knowledge of the Seller, is imminent with respect to any of the employees of any Company, which could reasonably be expected to result in a Material Adverse Effect. None of Companies&#146; employees to Seller&#146;s knowledge is a member of a union
that relates to such employee&#146;s relationship with the relevant Company, and no Company is a party to a collective bargaining agreement, and the Seller believes that their relationships with their employees are good. To the knowledge of the
Seller, no executive officer of any Company is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement or
<FONT STYLE="white-space:nowrap">non-competition</FONT> agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject any Company
to any liability with respect to any of the foregoing matters. Each Company is in compliance with all applicable Laws relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the failure
to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.17.&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance</U>.&nbsp;&nbsp;To the Seller&#146;s knowledge, no Company: (i)&nbsp;is in default under or in violation of (and no
event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by a Company under), nor has any Company received notice of a claim that it is in default under or that it is in violation of, any
indenture, loan or credit agreement or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree, or order of any court, arbitrator or other governmental
authority or (iii)&nbsp;is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection,
occupational health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.18.&nbsp;&nbsp;&nbsp;&nbsp;<U>Regulatory Permits</U>.&nbsp;&nbsp;Each Company possesses all certificates, authorizations and permits issued by the
appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as currently conducted by them, except where the failure to possess such permits could not reasonably be expected to result in a
Material Adverse Effect (&#147;<U>Material Permits</U>&#148;), and each Company has not received any notice of proceedings relating to the revocation or modification of any Material Permit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.19.&nbsp;&nbsp;&nbsp;&nbsp;<U>Title to Assets</U>.&nbsp;&nbsp;Each Company has good and marketable title to all real property owned and leased by it as set
forth in Schedule 4.19 and good and marketable title in all personal property owned by it that is material to the Business, in each case free and clear of all Liens, except for (i)&nbsp;Liens as do not materially affect the value of such property
and do not materially interfere with the use made and proposed to be made of such property by any Company, and (ii)&nbsp;Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance
with Dutch GAAP and the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by each Company are held by it under valid, subsisting and enforceable leases with which each Company are in
material compliance. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.20.&nbsp;&nbsp;&nbsp;&nbsp;<U>lntellectual Property</U>.&nbsp;&nbsp;To the Seller&#146;s knowledge, each
Company has, or has rights to use, all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights as
necessary or required for use in connection with its Businesses as presently conducted and which the failure to so have could have a Material Adverse Effect as such rights are set forth in Schedule 4.20 (collectively, the &#147;<U>lntellectual
Property Rights</U>&#148;), except with respect to the HEK293 cell lines, which ModiQuest Research uses without a license. No Company has received a notice (written) that any of the lntellectual Property Rights has expired, terminated or been
abandoned, or is expected to expire or terminate or be abandoned within seven (7)&nbsp;years from the Signing Date. Except with respect to the <FONT STYLE="white-space:nowrap">co-existence</FONT> agreement dated July&nbsp;17, 2017 among the Seller
and Quest Diagnostic lnvestments LLC (a copy of which has been provided by the Seller to the Parent) concerning the restricted registration and use of the ModiQuest trademark, inclusive of its logo and the caption &#147;research&#148;, no Company
has received a written notice of a claim that the lntellectual Property Rights violate or infringe upon the rights of any Person. Except as set forth in Schedule 4.20, no Company has licensed any of its lntellectual Property Rights. To the knowledge
of the Seller, all such lntellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the lntellectual Property Rights. Each Company has taken reasonable security measures to protect the secrecy,
confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.21.&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax Status</U>.&nbsp;&nbsp;Except for matters that would not, individually or in the aggregate, have or reasonably be expected
to result in a Material Adverse Effect, each Company (i) has made or filed all federal, state and local income and franchise Tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii)&nbsp;has paid all Taxes and
other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material Taxes
for periods subsequent to the periods to which such returns, reports or declarations apply according to Dutch GAAP as applied by each of the Companies. To the knowledge of the Seller there are no unpaid Taxes in any material amount claimed to be due
by the taxing authority of any jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.22.&nbsp;&nbsp;&nbsp;&nbsp;<U>Related Party lndebtedness</U>.&nbsp;&nbsp;Except as disclosed in Financial
Statements and salaries incurred in the ordinary course of business since the date thereof, no Company has loans or indebtedness outstanding which have been made to or from directors, former directors, officers, shareholders and employees of such
Company or to any person or corporate body not dealing at arm&#146;s length with any of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.23.&nbsp;&nbsp;&nbsp;&nbsp;<U>Guarantees of
lndebtedness</U>.&nbsp;&nbsp;No Company has guaranteed any dividend, obligation or indebtedness of any other Person, nor has any other Person guaranteed any dividend, obligation or indebtedness of any Company, except as provided under section 4.12
(i). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.24.&nbsp;&nbsp;&nbsp;&nbsp;<U>Insurance</U>.&nbsp;&nbsp; Each Company is insured by insurers of recognized
financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which such Company is engaged. No Company has any reason to believe that it will not be able to renew its existing insurance
coverage as and when such coverage expires (or terminates at Closing, if applicable) or to obtain similar coverage from similar insurers as may be necessary to continue its business after Closing without a significant increase in cost. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>REPRESENTATIONS AND WARRANTIES OF THE PURCHASER AND THE PARENT</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Purchaser and the Parent warrant to each of the Companies and the Seller that each of the following representations is true and accurate on
the Signing Date and will be true and accurate on the Closing Date and acknowledge that each of the Companies and the Seller are relying upon such covenants, representations and warranties in entering into this Agreement: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Organization and Qualification</U>.&nbsp;&nbsp;The Purchaser is a company duly incorporated, and validly existing under the
laws of the Netherlands, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. The Parent is a company duly incorporated, validly existing and in good standing under the
laws of the Province of British Columbia, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Purchaser nor the Parent is in violation or default of any of
the provisions of its respective certificate or notice of articles, articles or other organizational or charter documents. The Parent is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each
jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to
result in a Material Adverse Effect and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Capitalization</U>.&nbsp;&nbsp;The authorized capital of the Parent consists of an unlimited number of common shares without
par value, of which, as of the Signing Date, 47,643,459 common shares are issued and outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Authorization;
Enforcement</U>.&nbsp;&nbsp;Each of the Purchaser and the Parent have the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction Documents and
otherwise to carry out its obligations hereunder and thereunder. On the Closing Date, the execution and delivery of each of this Agreement and the other Transaction Documents by the Purchaser and the Parent and the consummation by it of the
transactions contemplated hereby and thereby will be duly authorized by all </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
necessary action on the part of the Purchaser and the Parent and no further action will be required by the Purchaser, the Parent, their respective board of directors or their shareholders in
connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been (or upon delivery will have been) duly executed by each of the Purchaser and
the Parent and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Purchaser and the Parent enforceable against the Purchaser and the Parent in accordance with its terms, except:
(i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#146; rights generally, (ii)&nbsp;as limited by laws relating
to the availability of specific performance, injunctive relief or other equitable remedies and (iii)&nbsp;insofar as indemnification and contribution provisions may be limited by applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.4.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Conflicts</U>.&nbsp;&nbsp;The execution, delivery and performance by each of the Purchaser and the Parent of this Agreement
and the other Transaction Documents to which it is a party and the consummation by it of the transactions contemplated hereby and thereby do not and will not: (i)&nbsp;conflict with or violate any provision of the Purchaser&#146;s or the
Parent&#146;s articles of incorporation or other organizational or charter documents, (ii)&nbsp;conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of
any Lien upon any of the properties or assets of the Purchaser or the Parent or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility,
debt or other instrument (evidencing a Purchaser debt, a Parent debt or otherwise) or other understanding to which the Purchaser or the Parent is a party or by which any property or asset of the Purchaser or the Parent is bound or affected, or
(iii)&nbsp;subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Purchaser or the Parent
is subject (including federal and state securities laws and regulations), or by which any property or asset of the Purchaser and the Parent is bound or affected; except in the case of each of clauses (ii)&nbsp;and (iii), such as could not have or
reasonably be expected to result in a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Filings, Consents and Approvals</U>.&nbsp;&nbsp;Neither the
Purchaser nor the Parent is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person
in connection with the execution, delivery and performance by the Purchaser and the Parent of the Transaction Documents to which it is a party, other than consents, waivers, authorizations, orders, notices, filings or registrations necessary in
connection with the Required Approvals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.6.&nbsp;&nbsp;&nbsp;&nbsp;<U>lssuance of the Securities</U>.&nbsp;&nbsp;Upon Closing, all of the Parent Shares
issued to the Seller will be duly and validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> shares in the capital of the Parent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.7.&nbsp;&nbsp;&nbsp;&nbsp;<U>Reporting lssuer</U>.&nbsp;&nbsp;The Parent is a reporting issuer in good standing in the province of British Columbia and
Alberta, and is not in default of any applicable securities, taxation and corporate legislation, regulations, orders, notices or policies in force therein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.8.&nbsp;&nbsp;&nbsp;&nbsp;<U>Disclosure Record</U>.&nbsp;&nbsp;The Parent has timely filed with the
relevant authorities all documents required to have been filed by it under the securities laws applicable to it. As of their respective dates, each of the Parent Public Filings complied in all material respects with the requirements of the
applicable securities laws pertaining to such filings, and none of the Parent Public Filings contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements
therein not misleading in light of the circumstances in which they were made. There have been no confidential material change reports filed by the Parent with any securities regulatory authority having jurisdiction. No material adverse change in the
Parent&#146;s financial position has taken place since the date of the latest balance sheet contained in its most recent audited financial statements, except as publicly disclosed in the Parent Public Filings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.9.&nbsp;&nbsp;&nbsp;&nbsp;<U>Exchange Listing and Filings</U>.&nbsp;&nbsp;The Parent Shares are listed on the TSXV and, on the Closing Date, the Parent
Shares to be issued to the Seller as set out in Section&nbsp;2.2 hereto will have been, or will prior to the Closing Date, be approved for issuance, listing and, upon expiry of all resale restrictions, trading through the TSXV. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Parent Financial Statements</U>.&nbsp;&nbsp;The Parent Financial Statements have been prepared in accordance with applicable
securities laws and in accordance with IFRS applicable to Canadian public enterprises and present fairly the assets, liabilities and the financial position of the Parent as at the dates indicated and the results of operation of the Parent for the
periods indicated and no Material Adverse Effect in such financial position or such results of operation has occurred since the dates thereof. The Parent has not received any advice or notification from its independent certified public accountants
that the Parent has used any improper accounting practice that would have the effect of not reflecting or incorrectly reflecting in the Parent Financial Statements or the books and records of the Parent, any properties, assets, liabilities, revenues
or expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.11.&nbsp;&nbsp;&nbsp;&nbsp;<U>Litigation</U>.&nbsp;&nbsp;There is no Action pending or, to the knowledge of the Parent, threatened against
or affecting the Purchaser, the Parent or any of their properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) which (i)&nbsp;adversely affects or
challenges the legality, validity or enforceability of any of the Transaction Documents or the transactions contemplated therein or (ii)&nbsp;could, if there were an unfavorable decision, have or reasonably be expected to result in a Material
Adverse Effect. Neither the Purchaser, the Parent, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under applicable securities laws or a claim of breach of fiduciary duty.
There has not been, and to the knowledge of the Parent, there is not pending or contemplated, any investigation by any Governmental Body involving the Parent or any current or former director or officer of the Parent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.12.&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance</U>.&nbsp;&nbsp; To the Purchaser&#146;s knowledge, after reasonable investigation, neither the Purchaser nor the
Parent: (i)&nbsp;is in default under or in violation of (and no </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Purchaser or the Parent thereunder), nor has the Purchaser or the Parent
received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or
not such default or violation has been waived), (ii) is not in violation of any judgment, decree, or order of any court, arbitrator or other governmental authority or (iii)&nbsp;is not and has not been in violation of any statute, rule, ordinance or
regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor
matters, except in each case as could not have or reasonably be expected to result in a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.13.&nbsp;&nbsp;&nbsp;&nbsp;<U>Taxes</U>.&nbsp;&nbsp;Except for matters that would not, individually or in the aggregate, have or reasonably be expected to
result in a Material Adverse Effect, the Parent (i)&nbsp;has made or filed all federal, state and local income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii)&nbsp;has paid all taxes and
other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii)&nbsp;has set aside on its books provision reasonably adequate for the payment of all material
taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Parent know of
no basis for any such claim. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>ADDITIONAL COVENANTS OF PARTIES</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Covenants of the Seller and the Companies</U>.&nbsp;&nbsp;Each of the Companies hereby covenant and agree with the Purchaser and
the Parent as follows, and the Seller, jointly and severally, covenants and agrees to do such things as may be necessary or desirable to cause or permit each of the Companies to comply with the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Conduct of Business</U>.&nbsp;&nbsp;Between the Signing Date and the Closing of the transactions contemplated
hereby, unless otherwise expressly contemplated or permitted in this Agreement or consented to in writing by the Purchaser, each Company will: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">(i) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Conduct the Business substantially as presently operated and only in the ordinary course and in
compliance with all applicable Laws; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">(ii) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Maintain the books, records and accounts of each Company in the
ordinary course of business and record all transactions on a basis consistent with past practices; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">(iii) &nbsp;&nbsp;&nbsp;&nbsp;Not
amend the articles, <FONT STYLE="white-space:nowrap">by-laws</FONT> or other constitutional documents of any Company or the terms of the outstanding securities of any Company, including any outstanding indebtedness and credit facilities of any
Company; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not amalgamate, merge or otherwise
consolidate itself with any other Person or adopt or enter into a plan of liquidation or dissolution with respect to itself; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not issue, sell, pledge, lease, dispose of or otherwise encumber any securities or
any options, warrants or other rights to acquire securities, or redeem or purchase any of the outstanding securities of or ownership interests in any Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not incur or commit to incur any indebtedness for borrowed money nor pay any indebtedness
(other than trade payables incurred in the ordinary course of business or as disclosed in Financial Statements); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not guarantee, endorse or otherwise become responsible for any material liability, obligation
or indemnity of any other Person, or make any loans or advances, any and all other than those incurred or assumed in the ordinary course of business or appearing in the Disentanglement Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not split, consolidate or reclassify any of the shares nor undertake any other capital
reorganization; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not sell, lease, encumber or otherwise dispose of, directly or
indirectly, any properties or assets of Company, other than in the ordinary course of their respective businesses; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not enter into any partnership, joint venture, memorandum of understanding, strategic
alliance or similar agreement, arrangement or relationship, or any new material contract (other than contracts in the ordinary course of business); and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">(xi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not declare, set aside or pay any dividend or other distribution to its shareholders or
other owners, with the exception of a dividend payment as set forth in Schedule 6.1(a). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the generality of the forgoing, the Parties
acknowledge and agree that ModiQuest Research, the Seller, ModiQuest BV and ModiQuest Therapeutics BV are in the process of reorganizing their affairs, which reorganization includes the transfer of assets and list other actions being taken as part
of <FONT STYLE="white-space:nowrap">re-organization</FONT> among ModiQuest Research, the Seller, ModiQuest BV and ModiQuest Therapeutics BV and that such actions will not constitute a breach of this Section&nbsp;6.1(a) to the extent that the Seller
has, prior to the Signing Date, provided the Purchaser and the Parent with a written list of such transfers and other actions to be taken, including a reasonable description of the assets to be transferred or otherwise assigned to the Seller,
ModiQuest BV and ModiQuest Therapeutics and the Seller and the Purchaser have consented to such transfers and other actions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Financial Statements</U>.&nbsp;&nbsp;Each of the Companies
shall provide the Purchaser with its Financial Statements as soon as practicable after the date hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions of Closing</U>.&nbsp;&nbsp;The Seller shall use commercially reasonable efforts to cause each of the
terms and conditions precedent for the benefit of the Purchaser to be fulfilled on or before the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Covenants
of the Purchaser</U>.&nbsp;&nbsp;The Purchaser and the Parent hereby covenant and agree with each of the Companies and the Seller as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions of Closing</U>.&nbsp;&nbsp;The Purchaser and the Parent shall use commercially reasonable efforts to
cause each of the conditions to closing for the benefit of each of the Companies and the Seller to be fulfilled on or before the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Mutual Covenants</U>.&nbsp;&nbsp;Each of the Purchaser, the Parent, each of the Companies and the Seller hereby covenant and
agree each with the other as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Confidentiality</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All information regarding each of the Companies and the Seller and their respective
affiliates, provided to the Purchaser and the Parent under this Agreement or in furtherance of the transactions contemplated hereunder, will be kept in strict confidence by the Purchaser, the Parent and their Affiliates and agents and will not be
used, dealt with, exploited or commercialized or disclosed to any third party (other than the Purchaser&#146;s and the Parent&#146;s professional advisors with a need to know such information for the purposes contemplated in this Agreement) by the
Purchaser, the Parent or any of their Affiliates or agents without the prior written consent of the Seller unless (A)&nbsp;such disclosure is required by law, by regulatory authorities having jurisdiction with respect to the Parent or the
transactions contemplated herein or by the TSXV, or (B)&nbsp;such disclosure is reasonably necessary for the completion of the transactions contemplated herein. lf the transactions contemplated in this Agreement do not proceed for any reason, then
upon receipt of a written request from the Seller, the Parent will immediately return to the Seller or destroy all information regarding each of the Companies, the Seller and their respective Affiliates provided in connection with the transactions
contemplated in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All information regarding the Purchaser, the Parent
and their Affiliates, provided to the Seller under this Agreement or in furtherance of the transactions contemplated hereunder, will be kept in strict confidence by the Seller and its Affiliates and agents and will not be used, dealt with, exploited
or commercialized or disclosed to any third party (other than the Seller&#146;s professional advisors with a need to know such information for the purposes contemplated in this Agreement) by the Seller or any Affiliate or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
their agents without the prior written consent of the Purchaser or the Parent unless (A)&nbsp;such disclosure is required by law, by regulatory authorities having jurisdiction with respect to
each of the Companies or the transactions contemplated herein or by the TSXV, or (B)&nbsp;such disclosure is reasonably necessary for the completion of the transactions contemplated herein. lf the transactions contemplated in this Agreement do not
proceed for any reason, then upon receipt of a written request from the Purchaser (or the Parent), the Seller will immediately return to the Purchaser (or the Parent) or destroy all information regarding the Purchaser, the Parent and their
Affiliates provided in connection with the transactions contemplated in this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(iii) &nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the
generality of the forgoing, the provisions of Section&nbsp;6.3(a)(i) and 6.3(a)(ii) shall not apply to any information that the Purchaser or the Parent (in the case of Section&nbsp;6.3(a)(i)) or the Seller (in the case of Sect&iacute;on 6.3(a)(ii))
can demonstrate: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(A) &nbsp;&nbsp;&nbsp;&nbsp;is or becomes available to the public other than as a direct or indirect result of any
violation by the Purchaser or the Parent of Section&nbsp;6.3(a)(i) or the Seller of Section&nbsp;6.3(a)(ii); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(B)
&nbsp;&nbsp;&nbsp;&nbsp;is or becomes available to the Purchaser or the Parent (in the case of Section&nbsp;6.3(a)(i)) or the Seller (in the case of 6.3(a)(ii)) on a <FONT STYLE="white-space:nowrap">non-confidential</FONT> basis from a source other
than the Purchaser, the Parent or the Seller, provided that such source does not owe a duty of confidentiality to the Seller (in the case of Section&nbsp;6.3(a)(i)) or the Purchaser or the Parent (in the case of Section&nbsp;6.3(a)(ii)); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(C) &nbsp;&nbsp;&nbsp;&nbsp;is or was demonstrably independently developed by the Purchaser or the Parent (in the case of
Section&nbsp;6.3(a)(i)) or the Seller or any of the Companies (in the case of 6.3(a)(ii)) without the use of any information disclosed pursuant to Section&nbsp;6.3(a)(i)) or Section&nbsp;6.3(a)(ii)); or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(D) &nbsp;&nbsp;&nbsp;&nbsp;was lawfully and demonstrably in the possession of the Purchaser or the Parent (in the case of
Section&nbsp;6.3(a)(i)) or the Seller or any of the Companies (in the case of Section&nbsp;6.3(a)(ii)) prior to its disclosure by Seller or any of the Companies, the Purchaser or the Parent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) &nbsp;&nbsp;&nbsp;&nbsp;<U><FONT STYLE="white-space:nowrap">Non-Solicitation</FONT></U>. Until such time, if any, as this Agreement is
terminated pursuant to the terms set out herein, except in accordance with the terms and conditions of this Agreement, the Companies and the Seller will not directly or indirectly solicit, initiate, entertain or accept any inquiries or proposals
from, discuss or negotiate with, provide any <FONT STYLE="white-space:nowrap">non-public</FONT> information to, or otherwise consider the merits of any unsolicited inquiries or proposals from, any Person or entity (other than the Purchaser or the
Parent) relating to any transaction involving (i)&nbsp;the sale of any of businesses or assets (other than sales made in the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
ordinary course of business) of any of the Companies; (ii)&nbsp;any sale of the capital stock or other ownership interests of any of the Companies; or (iii)&nbsp;any merger, consolidation,
business combination or similar transaction. Each of the Companies and the Seller agrees to promptly notify the Purchaser if it receives an unsolicited offer for any such transaction, or obtains information that such an offer is reasonably likely to
be made, which notice shall include the identity of the prospective offeror and, if known, the consideration to be paid and terms of the prospective offer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.4. &nbsp;&nbsp;&nbsp;&nbsp;<U>Additional Dividend</U>. The Parties agree that, after Closing, the Seller shall be entitled to the Additional Dividend on the
terms and subject to the conditions set forth in Schedule 6.1 and each of the Parties agrees to comply with the provisions of Schedule 6.1 in respect of the Additional Dividend. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>SECURITIES REGULATORY APPROVALS</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.1. &nbsp;&nbsp;&nbsp;&nbsp;The terms of this Agreement are subject to the approval of all securities regulatory authorities having jurisdiction with respect
to this Agreement and the transactions contemplated herein, including, but not limited to, the TSXV (the &#147;Required Approvals&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.2.
&nbsp;&nbsp;&nbsp;&nbsp;The Parent will with reasonable diligence do all such things and provide all such reasonable assurances as may be required to obtain the approval of all applicable regulatory authorities, including the TSXV, to the
transactions and within the time contemplated in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.3. &nbsp;&nbsp;&nbsp;&nbsp;The Seller and each of the Companies shall promptly comply
with all reasonable conditions and requirements of the TSXV to the completion of the transactions contemplated herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.4. &nbsp;&nbsp;&nbsp;&nbsp;lf
the TSXV or any other securities regulatory authority having jurisdiction with respect to this Agreement and the transactions contemplated herein (collectively the &#147;Securities Authorities&#148;), shall prevent the consummation of the
transactions contemplated herein, neither of the Parties nor their respective directors, officers, legal counsel, servants, or agents shall in any way be liable to the other Parties to this Agreement in respect of any damages or losses suffered by
them as a result of such failure of the Securities Authorities to give their approval, provided that such Party has, with all due diligence and in good faith, used and demonstrates its commercially reasonable efforts to obtain the approval of such
Securities Authorities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.5. &nbsp;&nbsp;&nbsp;&nbsp;The Seller and the Parent shall provide each other with reasonable opportunity to review and comment
on all filings, applications, submissions and other material communications to Securities Authorities. The Seller and the Parent shall use its commercially reasonable efforts to cooperate with and assist each other in the preparation and making of
all filings, applications and submissions to such Securities Authorities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.6. &nbsp;&nbsp;&nbsp;&nbsp;The Seller and the Parent shall promptly notify
each other of any material </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
communication to such party from any Securities Authorities in respect of the transactions contemplated herein and shall provide the other Party with a copy thereof if such communication is in
writing. The Seller and the Parent shall consult with each other prior to participating in any substantive meeting or discussion with any Securities Authorities in respect of the transactions contemplated herein and shall give each other the
opportunity to attend and participate thereat. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.7. &nbsp;&nbsp;&nbsp;&nbsp;The Seller understands, acknowledges and agrees that, if required under
applicable securities laws and the policies of the TSXV, the Parent Shares issued as part of the Share Payment or the Deferred Share Payment may be subject to restrictions on resale and the certificates or electronic records representing the Share
Payment or the Deferred Share Payments, and any certificates or electronic records issued in exchange therefor, may be endorsed with restrictive legends substantially similar to the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY [<I>insert the date that is four
months and a day after the distribution date</I>]. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">WITHOUT PRIOR WRITTEN APPROVAL OF TSX VENTURE EXCHANGE AND COMPLIANCE WITH ALL
APPLICABLE SECURITIES LEGISLATION, THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD, TRANSFERRED, HYPOTHECATED OR OTHERWISE TRADED ON OR THROUGH THE FACILITIES OF TSX VENTURE EXCHANGE OR OTHERWISE IN CANADA OR TO OR FOR THE BENEFIT OF
A CANADIAN RESIDENT UNTIL [<I>insert the date that is four months and a day after the distribution date</I>].&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8.
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>CONDITIONS PRECEDENT TO CLOSING</U> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8.1. &nbsp;&nbsp;&nbsp;&nbsp;<U>Mutual Conditions Precedent</U>. The
respective obligations of the Purchaser, the Parent, each of the Companies and the Seller to complete the transactions contemplated in this Agreement are subject to the fulfilment, at or prior to Closing, of the following conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) &nbsp;&nbsp;&nbsp;&nbsp;The TSXV shall have approved such Agreement and such transactions; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) &nbsp;&nbsp;&nbsp;&nbsp;lf required by any applicable Law or securities regulatory authority having jurisdiction with respect to this
Agreement and the transactions contemplated herein, including, but not limited to, the TSXV, the shareholders of the Seller shall have approved the transactions contemplated in this Agreement; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c) &nbsp;&nbsp;&nbsp;&nbsp;There shall have been no action taken under any applicable Law by any Governmental Body which makes it illegal or
otherwise directly or indirectly restrains, enjoins or prohibits or would otherwise have a Material Adverse Effect on one Party&#146;s ability to perform in any material respect on a timely basis its obligations under any Transaction Document as a
result of which the other Party or Parties cannot reasonably require from such Party the completion of the transactions contemplated in this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8.2. &nbsp;&nbsp;&nbsp;&nbsp;The conditions precedent in Section&nbsp;8.1 are for the mutual benefit of the
Parties and may be waived, in whole or in part, at any time by each of the Parties, such waiver being without prejudice to any other right that any Party may have. In the event any of the foregoing conditions contained in Section&nbsp;8.1 are not
fulfilled or performed at or before the Closing Date to the reasonable satisfaction of the Parties, any of the Purchaser, the Parent or the Seller may terminate this Agreement by written notice to the other and in such event each of the Purchaser,
the Parent, each of the Companies and the Seller shall be released from all further obligations hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8.3. &nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions
Precedent to Purchaser&#146;s and Parent&#146;s Obligations</U>. All of the obligations of the Purchaser and/or the Parent to complete the transactions contemplated in this Agreement are subject to the fulfilment, at or prior to Closing, of the
following conditions: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) &nbsp;&nbsp;&nbsp;&nbsp;The Parent shall have completed the Financing on terms satisfactory to the Parent, in
its sole discretion; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) &nbsp;&nbsp;&nbsp;&nbsp;The respective representations and warranties of the Seller including those set forth in
Section&nbsp;4 concerning each of the Companies contained in this Agreement shall be, in all material respects, true and correct when made and as of the Closing Date, with the same force and effect as though such representations and warranties had
been made on and as of such date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c) &nbsp;&nbsp;&nbsp;&nbsp;Each of the Companies and the Seller shall have performed and complied in
all material respects with all of their respective covenants and obligations required to be performed prior to Closing; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(d)
&nbsp;&nbsp;&nbsp;&nbsp;The Seller obtaining all required directors&#146;, shareholders&#146;, regulatory, and third party consents required for the Transaction </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(e) &nbsp;&nbsp;&nbsp;&nbsp;Between Signing Date and Closing, there shall have been no Material Adverse Change in the Business, taken as a
whole; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(f) &nbsp;&nbsp;&nbsp;&nbsp;At Closing, each of the Companies and the Seller shall have delivered those items set forth in
Section&nbsp;2.8(a) of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8.4. &nbsp;&nbsp;&nbsp;&nbsp;The conditions precedent in Section&nbsp;8.3 are for the benefit of the Purchaser and
the Parent and may be waived, in whole or in part, at any time by each of them, such waiver being without prejudice to any other right that any Party may have. In the event any of the foregoing conditions contained in Section&nbsp;8.3 are not
fulfilled or performed at or before the Closing Date to the reasonable satisfaction of the Purchaser or the Parent, each of the Purchaser and the Parent may terminate this Agreement by written notice to the Seller and the Seller and in such event
each of the Parties shall be released from all further obligations hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8.5. &nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions Precedent to each of the
Companies and Seller Obligations</U>. All of the obligations of each of the Companies and the Seller to complete the transactions contemplated in this Agreement are subject to fulfilment, at or prior to Closing, of the following conditions: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) &nbsp;&nbsp;&nbsp;&nbsp;The representations and warranties of the Purchaser and the
Parent contained in this Agreement shall be, in all material respects, true and correct when made and as of the Closing Date, with the same force and effect as though such representations and warranties had been made on and as of such date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) &nbsp;&nbsp;&nbsp;&nbsp;The Purchaser and the Parent shall have performed and complied in all material respects with all of its covenants
and obligations required to be performed prior to Closing; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c) &nbsp;&nbsp;&nbsp;&nbsp;The Purchaser and the Parent obtaining all required
directors&#146;, shareholders&#146;, regulatory, and third Party consents required for the Transaction; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(d)
&nbsp;&nbsp;&nbsp;&nbsp;Between Signing Date and Closing, there shall have been no Material Adverse Change with respect to the Parent; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(e) &nbsp;&nbsp;&nbsp;&nbsp;At Closing, the Purchaser or the Parent shall have delivered those items set forth in Section&nbsp;2.8(b) of this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8.6. &nbsp;&nbsp;&nbsp;&nbsp;The conditions precedent in Section&nbsp;8.5 are for the benefit of each of the Companies and the Seller and may
be waived, in whole or in part, at any time by each of the Companies and the Seller, such waiver being without prejudice to any other right that any Party may have. In the event any of the foregoing conditions contained in Section&nbsp;8.5 are not
fulfilled or performed at or before the Closing Date to the reasonable satisfaction of each of the Companies or the Seller, any of each of the Companies or the Seller may terminate this Agreement by written notice to the other and in such event each
of the Parties shall be released from all further obligations hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>LIMITATIONS OF LIABILITY; SURVIVAL
OF REPRESENTATIONS AND WARRANTIES</U> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.1. &nbsp;&nbsp;&nbsp;&nbsp;In the event of a breach by the relevant Party or Parties (such Party the
&#147;Breaching Party&#148;) of any of the representations and warranties listed in Section&nbsp;3, 4 and 5 and the Schedules referred to herein (a &#147;Breach&#148;), the Party or Parties suffering Losses (such Party the <FONT
STYLE="white-space:nowrap">&#147;non-Breaching</FONT> Party&#148;) shall upon obtaining knowledge thereof notify the Breaching Party promptly in writing of such Breach, setting out in reasonable detail the events or facts giving rise to the Breach,
and to the extent possible indicating the amount of Losses involved. The failure of a <FONT STYLE="white-space:nowrap">non-Breaching</FONT> Party to make a claim shall, however, not be considered a waiver of the right to make this claim as long as
the claim is made in writing and is received by the Breaching Party within eighteen (18)&nbsp;months from the Closing Date, or, in the event of a claim resulting from a Breach of the following representations and warranties (the &#147;Fundamental
Warranties&#148;), is made in writing and is received by the Breaching Party within the periods specified below: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a)
&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3, Section&nbsp;4.1 &#150; 4.6(i), 4.7, Section&nbsp;4.12 (v) and Sections <FONT STYLE="white-space:nowrap">5.1-5.7</FONT> within the period set by the relevant state of limitations relating to claims; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) &nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.21 and Section&nbsp;5.13 (Taxation) within six
(6)&nbsp;months after the period set by the relevant statute of limitations relating to Taxes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.2. &nbsp;&nbsp;&nbsp;&nbsp;In the event of a Breach, as
sole and exclusive remedy to the <FONT STYLE="white-space:nowrap">non-Breaching</FONT> Party, the Breaching Party shall compensate the <FONT STYLE="white-space:nowrap">non-Breaching</FONT> Party for any Losses suffered by the <FONT
STYLE="white-space:nowrap">Non-Breaching</FONT> Party as a result of such Breach, provided that the maximum liability shall not exceed the amount referred to in Section&nbsp;9.4. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.3. &nbsp;&nbsp;&nbsp;&nbsp;A claim against the Breaching Party for Losses in connection with a Breach shall: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;not be permitted for any individual claims or series of related claims in an amount equal to or below
&#128;&nbsp;25,000 (twenty five thousand Euro); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) &nbsp;&nbsp;&nbsp;&nbsp;in any event, not be permitted unless the aggregate of either
all of the <FONT STYLE="white-space:nowrap">non-Breaching</FONT> Party&#146;s claims in excess of the limit under (a)&nbsp;above exceeds the sum of &#128;&nbsp;100,000 (hundred thousand Euro), in which case the full amount of Losses shall be payable
and not only the excess; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c) &nbsp;&nbsp;&nbsp;&nbsp;in the event of a claim resulting from a Breach of any of the Fundamental Warranties,
not be permitted upon the elapse of the relevant limitation period as specified in Section&nbsp;9.1; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(d) &nbsp;&nbsp;&nbsp;&nbsp;in any
other event, not be permitted after eighteen (18)&nbsp;months after the Closing Date, </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">provided that the thresholds referred to in
Section&nbsp;9.3.(a) and (b)&nbsp;shall not apply to claims relating to the Fundamental Warranties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.4. &nbsp;&nbsp;&nbsp;&nbsp;The Breaching Party
shall not be liable for Losses as a result of any Breaches in excess of 20% of the Cash Payment (the &#147;Cap&#148;), provided that the Cap shall not apply to any claim in relation to any of the Fundamental Warranties, which are subject to a cap
equal to 100% of the Cash Payment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.5. &nbsp;&nbsp;&nbsp;&nbsp;Any Losses payable by the relevant Breaching Party under this Agreement shall take into
consideration any negative or positive effects to the <FONT STYLE="white-space:nowrap">non-Breaching</FONT> (including but not limited to Tax effects). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.6. &nbsp;&nbsp;&nbsp;&nbsp;The Parties agree that if a claim notified to the Breaching Party is a result of or connected with a claim by a third party (each
such claim a &#147;Third Party Claim&#148;) against or owed by the <FONT STYLE="white-space:nowrap">non-Breaching</FONT> Party (or the relevant Company), then: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) &nbsp;&nbsp;&nbsp;&nbsp;no admissions in relation to such Third Party Claim shall be made by or on behalf of the <FONT
STYLE="white-space:nowrap">non-Breaching</FONT> Party or any of its Affiliates (including the Companies) and the claim shall not be compromised, disposed of or settled without first consulting with the Breaching Party including a description in
reasonable detail of the events or facts giving rise to said Third Party Claim, the interests at stake (as referred to hereinafter), and actions to be taken and making a fair attempt to agree with the Breaching Party on how to settle the Third Party
Claim (a &#147;Mutual Settlement Attempt&#148;), unless circumstances reasonably require immediate action from the <FONT STYLE="white-space:nowrap">non-Breaching</FONT> Party or the relevant Company and the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
<FONT STYLE="white-space:nowrap">non-Breaching</FONT> Party is not reasonably able to timely consult with the Breaching Party and to make a Mutual Settlement Attempt, in which case the
non-Breaching Party shall immediately (if reasonably possible by email prior to any action, and otherwise as soon as reasonably practicable thereafter) inform the Breaching Party of any such situation, setting out in reasonable detail the actions to
be taken in relation to such Third Party Claim and the interests at stake (as referred to hereinafter). For the avoidance of misunderstanding; the non-Breaching Party shall have the right, following such consultation and a Mutual Settlement Attempt,
to settle with its own professional advisors, any such Third Party Claim by way of a written settlement agreement allowing its disclosure to the Breaching Party, provided (a)&nbsp;such settlement shall at all times strike a fair balance between the
interests of the Breaching Party in keeping the Losses as low as possible on one hand and the interests of the <FONT STYLE="white-space:nowrap">non-Breaching</FONT> Party in maintaining existing business relationships with such third Parties on the
other hand; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) &nbsp;&nbsp;&nbsp;&nbsp;the Parties will cooperate in dealing with any Third Party Claim and will allow each other access
to all relevant books and records during normal business hours, with the right to make copies thereof and/or take extracts therefrom; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c)
&nbsp;&nbsp;&nbsp;&nbsp;without prejudice to the generality of the foregoing, the Breaching Party shall make available to the <FONT STYLE="white-space:nowrap">non-Breaching</FONT> Party such persons as the non-Breaching Party may reasonably request
for assessing, contesting, disputing, defending, compromising or appealing the Third Party Claim, and shall attend any relevant proceedings as a witness to give evidence and prepare appropriately for such attendance; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(d) &nbsp;&nbsp;&nbsp;&nbsp;the <FONT STYLE="white-space:nowrap">non-Breaching</FONT> Party shall provide the Breaching Party a true and
complete copy of any written settlement agreement signed by the Third Party and the <FONT STYLE="white-space:nowrap">non-Breaching</FONT> Party, or as the case may be, a true and complete copy of any arbitration decisions, verdict or court judgments
relative to any Third Party Claim. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.7. &nbsp;&nbsp;&nbsp;&nbsp;The <FONT STYLE="white-space:nowrap">non-Breaching</FONT> Party shall procure that all
reasonable steps are taken and all reasonable assistance is given to avoid or mitigate any claims or Losses in the absence of mitigation might give rise to a liability in respect of any claims. Nothing in this Agreement shall be deemed to relieve <FONT
STYLE="white-space:nowrap">non-Breaching</FONT> Party from any duty under applicable law to mitigate any loss or damage incurred by it as a result of any Breach. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.8. &nbsp;&nbsp;&nbsp;&nbsp;No claims for Losses may be made for and neither the Purchaser nor the Parent shall be indemnified or reimbursed for any Losses
resulting from a Breach which was, is or could have become known to the Purchaser or the Parent by reviewing the documents fairly disclosed to it in the Data Room or otherwise provided by the Seller or by any of the Companies, or their advisors or
representatives, in the period as from October [20], 2017 to the Signing Date of this Agreement or for which provision was made in the 31 December 2017 Financial Statements. For the purpose hereof, &#145;fairly disclosed&#146; means all facts,
matters or other information which could have been reasonably discovered from records which are in the public domain, all facts, matters or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other information that appear clearly on the face of it, and facts, matters or other information disclosed in the Data Room or otherwise in such a manner and with such detail that a prudent
individual who is knowledgeable in the relevant field, and who may or could have been assisted by professional advisors, reviewing the relevant information should have reasonably assessed the financial, legal, commercial or other relevance and
consequences of such disclosure, provided (and without prejudice to the Purchaser&#146;s right to terminate this Agreement pursuant to Section&nbsp;8.3(b) and Section 8.4) that if the Seller has knowledge of a Breach prior to the Closing Date, the
limitations set forth in this Section&nbsp;9.8 shall not apply unless the Seller has provided express notice to the Purchaser and the Parent of such Breach prior to the Closing Date, including a description in reasonable detail of the circumstances
relating to such Breach. Notwithstanding anything in this Agreement to the contrary, neither the Purchaser nor the Parent shall be indemnified or reimbursed for any Losses resulting from a Breach or inaccuracy of any representation, warranty if the
Party seeking indemnification for such Losses had actual knowledge of such Breach or of any facts or circumstances rendering such representation or warranty inaccurate prior to the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.9. &nbsp;&nbsp;&nbsp;&nbsp;The Breaching Party shall not be liable for a warranty Breach to the extent it relates to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) &nbsp;&nbsp;&nbsp;&nbsp;Any act, omission, transaction, or arrangement performed at the request of the
<FONT STYLE="white-space:nowrap">non-Breaching</FONT> Party before the Closing Date or in respect of which the <FONT STYLE="white-space:nowrap">non-Breaching</FONT> Party has given its prior written consent or performed by the non-Breaching Party
after the Closing Date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) &nbsp;&nbsp;&nbsp;&nbsp;Any change in applicable Law or generally accepted published interpretation of
applicable Law after the Closing Date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Any change in the accounting or taxation policies and practice of the
non-Breaching Party after the Closing Date in comparison to the accounting or taxation policies prior to the Closing; and/or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(d)
&nbsp;&nbsp;&nbsp;&nbsp;A contingent liability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.10. &nbsp;&nbsp;&nbsp;&nbsp;Any Losses for which the
<FONT STYLE="white-space:nowrap">non-Breaching</FONT> Party can claim indemnification shall take into account any amount actually received by the <FONT STYLE="white-space:nowrap">non-Breaching</FONT> Party or the relevant Company under any insurance
policy, less any increase in Purchaser&#146;s insurance premium as a consequence of recovering any such Losses under any such policy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.11.
&nbsp;&nbsp;&nbsp;&nbsp;Neither the Purchaser nor the Parent shall be entitled to deduct any amount or set off any claim for Losses or other (alleged) indebtedness of the Seller to the Purchaser or the Parent against any portion of the purchase
price set forth in Section 2.3 due (or to become due) by the Purchaser to the Seller nor delay payment of any portion of the purchase price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.12.
&nbsp;&nbsp;&nbsp;&nbsp;The Purchaser and the Parent confirm that when entering into this Agreement it did not rely on any other warranty or statement than the Seller&#146;s representations and warranties set out in Sections 3 and 4. The
applicability of sections 7:17 and 7:20 up to and including 7:23 of the Dutch Civil Code is hereby excluded. The Purchaser and the Parent acknowledge and agree that neither the Seller, the Companies nor any of their
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
advisers make any representation or warranty as to the accuracy of forecasts, estimates, projections, statements of intent or statements of opinion given to the Purchaser, the Parent or other
member of the Purchaser&#146;s Group or their advisers or as may be included in any information in the Data Room, provided that the Seller represents and warrants to the Purchaser and the Parent that the Seller believes any forecasts, estimates,
projections, statements of intent or statements of opinion given to the Purchaser, the Parent or other member of the Purchaser&#146;s Group or their advisors or as may be included in any information in the Data Room are reasonable in the
circumstances. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.13. &nbsp;&nbsp;&nbsp;&nbsp;None of the limitations of liability as set out in this Section&nbsp;9 shall apply to any claim arising from
fraud and/or deliberately misleading statements (&#147;<I>bedrog</I>&#148;) by the Breaching Party, including any claim in relation to Tax, where any relevant Governmental Authorities alleges fraud, default, negligent conduct or conduct involving
dishonesty on the part of the Breaching Party and/or any Company or in relation to the matter giving rise to such claim. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.14.
&nbsp;&nbsp;&nbsp;&nbsp;None of the limitations of liability as set out in this Section&nbsp;9 or other contractual provisions herein such as under Section&nbsp;5 shall prejudice in any manner any right the Seller may have as a shareholder of the
Parent under the <I>Securities Act</I> (British Columbia) or other Laws protecting shareholders in a public company in Canada, and in the event of any conflict between any contractual provisions herein and said rights under Canadian or other foreign
Law, the latter shall supersede and set aside the conflicting contractual provisions herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>COLLECTION OF
PERSONAL INFORMATION</U> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10.1. &nbsp;&nbsp;&nbsp;&nbsp;The Seller acknowledges and consents to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the fact that the Purchaser and/or the Parent is collecting the Seller&#146;s and the Seller Principal&#146;s
personal information (as that term is defined under applicable privacy legislation, including, without limitation, the <I>Personal Information Protection and Electronic Documents Act</I> (Canada) and any other applicable similar, replacement or
supplemental provincial or federal legislation or laws in effect from time to time) (&#147;Seller Personal Information&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Purchaser and/or the Parent will retain such personal information for as long as permitted or required by
Law or commercially reasonable business practices for publicly traded entities; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the fact that the Parent may be required by the applicable securities laws of the applicable province, the
rules and policies of any stock exchange or the rules of the Investment Industry Regulatory Organization of Canada to provide regulatory authorities with any personal information provided under this Agreement or any of the Transaction Documents.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10.2. &nbsp;&nbsp;&nbsp;&nbsp;The Seller agrees, acknowledges and consents that the Purchaser and the
Parent, as the case may be, may use and disclose the Seller Personal Information as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">for internal use with respect to managing the relationships between and contractual obligations of the
Purchaser, the Parent and the Seller; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">for use and disclosure for income tax related purposes, including without limitation, where required by law,
disclosure to Canada Revenue Agency; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">for disclosure to securities regulatory authorities, the Exchange and other regulatory bodies with jurisdiction
with respect to reports of trades and similar regulatory filings; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">for disclosure to a governmental or other authority to which the disclosure is required by court order or
subpoena compelling such disclosure and where there is no reasonable alternative to such disclosure; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">for disclosure to professional advisers of the Purchaser and the Parent in connection with the performance of
their professional services provided each such advisor is bound by confidentiality obligations no less stringent than confidentiality obligations set out in this Agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">for disclosure to any Person where such disclosure is necessary for legitimate business reasons and is made
with the Seller&#146;s prior written consent; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">for disclosure to a court determining the rights of the Parties under this Agreement or any of the Transaction
Documents; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">for use and disclosure as otherwise required or permitted by Law. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10.3. &nbsp;&nbsp;&nbsp;&nbsp;The Seller authorizes the indirect collection of personal information (as defined in the applicable securities laws of the
Province of Ontario) by the Ontario Securities Commission and confirms that the Seller has been notified by the Parent: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that the Parent will be delivering such personal information to the Ontario Securities Commission;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that such personal information is being collected indirectly by the Ontario Securities Commission under the
authority granted to it in the securities laws of the Province of Ontario; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that such personal information is being collected for the purpose of the administration and enforcement of the
securities laws of the Province of Ontario; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that the title, business address and business telephone number of the public official in the Province of
Ontario who can answer questions about the Ontario Securities Commission&#146;s indirect collection of personal information is as follows: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Administrative Support Clerk </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Ontario Securities Commission </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Suite 1903, Box 55, 20 Queen Street West </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Toronto, Ontario &nbsp;&nbsp;&nbsp;&nbsp;M5H 3S8 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Telephone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">416-593-3684</FONT></FONT>
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>11. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>MISCELLANEOUS</U>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11.1. &nbsp;&nbsp;&nbsp;&nbsp;Time shall be of the essence of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11.2. &nbsp;&nbsp;&nbsp;&nbsp;This Agreement contains the whole agreement between the Parties hereto in respect of the purchase and sale of the Shares and
there are no warranties, representations, liabilities, remedies, or other terms, conditions or collateral agreements expressed, implied or statutory, other than as expressly set forth in this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11.3. &nbsp;&nbsp;&nbsp;&nbsp;This Agreement may be amended or modified only by written instrument executed by each of the Parties affected thereby or by
their respective successors and permitted assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11.4. &nbsp;&nbsp;&nbsp;&nbsp;This Agreement shall enure to the benefit of and be binding upon the
Parties hereto and their respective successors and permitted assigns. Neither Party may assign this Agreement without the prior written consent of each of the other Parties hereto, which consent may be withheld for any reason whatsoever. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11.5. &nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise specifically provided for herein, each of the Companies, the Seller, the Parent and the Purchaser shall be
responsible for the expenses (including fees and expenses of legal advisors, accountants and other advisors) incurred by them, respectively, in connection with the negotiation and settlement of this Agreement and the completion of the transactions
contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11.6. &nbsp;&nbsp;&nbsp;&nbsp;The Parties waive their rights to wholly or partially rescind (&#147;<I>ontbinden</I>&#148;) this
Agreement, to demand the rescission of this Agreement in legal proceedings pursuant to article 6:265 NCC or to nullify (&#147;<I>vernietigen</I>&#148;) or to otherwise reverse the transfer of Shares and other transactions contemplated hereby
following Closing pursuant to article 6:228 NCC or to alter this Agreement pursuant to article 6:230 NCC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11.7. &nbsp;&nbsp;&nbsp;&nbsp;Any notice to be
given under this Agreement shall be duly and properly given if made in writing and delivered or facsimiled to the addressee at the address as set out on page one of this Agreement for each of the Seller, the Purchaser and the Parent, and for each of
the Seller, at the address set forth on such Seller&#146;s signature page to this Agreement. Any notice given as aforesaid shall be deemed to have been given or made on, if delivered, the date on which it was delivered or, if facsimiled, on the next
business day after it was facsimiled. Any Party hereto may change its address for notice from time to time by providing notice of such change to the other Parties hereto in accordance with the foregoing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11.8. &nbsp;&nbsp;&nbsp;&nbsp;This Agreement contains the entire agreement between the Parties relating to
the subject matter of this Agreement, to the exclusion of any terms implied by Law which may be excluded by contract, and supersedes any previous written or oral agreement between the Parties to this Agreement in relation to the matters dealt with
in this Agreement. As regards, the mutual confidentiality provisions under Section&nbsp;6.3(a), such provisions shall be considered to replace and cancel said Confidentiality Agreement by an between Parent and ModiQuest Research retroactively as of
the date [20 October] 2017 in order to become binding by and between all Parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11.9. &nbsp;&nbsp;&nbsp;&nbsp;lf any provision in this Agreement is
held to be illegal, invalid or unenforceable, in whole or in part, under any applicable Law, then: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) &nbsp;&nbsp;&nbsp;&nbsp;such
provision or part shall to that extent be deemed not to form part of this Agreement but the legality, validity or enforceability of the remainder of this Agreement shall not be affected; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) &nbsp;&nbsp;&nbsp;&nbsp;the Parties shall use reasonable efforts to agree a replacement provision that is legal, valid and enforceable to
achieve so far as possible the intended effect of the illegal, invalid or unenforceable provision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11.10. &nbsp;&nbsp;&nbsp;&nbsp;This Agreement may be
executed in one or more counter-parts, each of which so executed shall constitute an original and all of which together shall constitute one and the same agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11.11. &nbsp;&nbsp;&nbsp;&nbsp;No waiver of any provision of this Agreement shall be effective unless such waiver is in writing and signed by or on behalf of
the Party entitled to make such waiver. In addition, no failure to exercise, nor any delay in exercising, on the part of a Party, any right or remedy under this Agreement shall operate as a waiver, nor shall any single or partial exercise of any
right or remedy prevent any further or other exercise or the exercise of any other right or remedy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11.12. &nbsp;&nbsp;&nbsp;&nbsp;This Agreement and any
dispute, controversy or claim arising hereunder or in connection herewith, its subject matter or formation (including any dispute or claim relating to <FONT STYLE="white-space:nowrap">non-contractual</FONT> obligations) shall be governed by and
construed in accordance with the laws of the Netherlands. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11.13. &nbsp;&nbsp;&nbsp;&nbsp;The Parties irrevocably agree that all disputes which may arise
under or otherwise in connection with this Agreement and the documents to be entered into pursuant to it, including disputes concerning the existence and validity thereof, shall be finally and exclusively resolved by arbitration in the Netherlands
in accordance with the arbitration rules of the Netherlands Arbitration Institute (<I>Nederlands Arbitrage Instituut</I>) taking into account the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the arbitral tribunal shall be composed of three (3)&nbsp;arbitrators of which at least one (1)&nbsp;shall be a
lawyer with a Netherlands law degree or admitted or licensed to practise Netherlands law, each of them appointed in accordance with the applicable arbitration rules; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the place of arbitration shall be Amsterdam, the Netherlands; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the arbitration shall be conducted in accordance with the NAI Arbitration Rules then in effect, as modified
herein; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the proceedings shall be conducted in the Dutch language; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the arbitral tribunal shall decide in accordance with the rules of law (<I>naar de regelen des rechts</I>);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Parties shall not be precluded from applying for injunctive relief in summary proceedings (<I>kort
geding</I>) before any competent court instead of an arbitration tribunal; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the right, if any, to discovery is excluded; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">neither the Parties nor the arbitration institute may have the arbitral award published; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">consolidation of the arbitral proceedings with other arbitral proceedings pending in the Netherlands, as
provided for in section 1046 of the Dutch Code of Civil Procedure, is excluded. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The award of the arbitrators shall be final and binding on the Parties and may be presented by any of the
Parties for enforcement in any court of competent jurisdiction and the Parties hereby consent to the jurisdiction of such court solely for purposes of enforcement of this arbitration agreement and any award rendered hereunder. In any such
enforcement action, irrespective of where it is brought, none of the Parties will seek to invalidate or modify the decision of the arbitrators or otherwise to invalidate or circumvent the procedures set forth in this Section&nbsp;11.13 as the sole
and exclusive means of settling or resolving such dispute. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The fees of the arbitrators and the other costs of such arbitration shall be borne by the Parties in such
proportions as shall be specified in the arbitration award. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#151; EXECUTION PAGES FOLLOW &#151; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>lN WITNESS WHEREOF</B> the Parties hereto have executed this Agreement as of the day and year first above
written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>IMMUNOPRECISE ANTIBODIES LTD.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>IMMUNOPRECISE NETHERLANDS B.V.</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">by its authorized signatory:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">by its authorized signatory:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">


<IMG SRC="g20922g03a10.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Jennifer Bath</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Guy J&eacute;r&ocirc;me Champagne</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">President and CEO</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Managing director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>IMMUSYS B.V.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By its authorized signatory:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">


<IMG SRC="g20922g03b10.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Jos Raats</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Managing director</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>MODIQUEST RESEARCH B.V.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>IMMULEASE B.V</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By its authorized signatory:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By its authorized signatory:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">


<IMG SRC="g20922g03c10.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">


<IMG SRC="g20922g03d10.jpg" ALT="LOGO">
</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">lmmusys B.V., on its behalf</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Immusys B.V., on its behalf</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Jos Raats</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jos Raats</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">[Signature page &#150; Share Purchase Agreement] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B> the Parties hereto have executed this Agreement as of the day and year first above
written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>IMMUNOPRECISE ANTIBODIES LTD.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>IMMUNOPRECISE NETHERLANDS B.V.</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">by its authorized signatory:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">by its authorized signatory:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">


<IMG SRC="g20922g82f51.jpg" ALT="LOGO">
</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Jennifer Bath</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Guy J&eacute;r&ocirc;me Champagne</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">President and CEO</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Managing director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>IMMUSYS B.V.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By its authorized signatory:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Jos Raats</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Managing director</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>MODIQUEST RESEARCH B.V.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>IMMULEASE B.V</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By its authorized signatory:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By its authorized signatory:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">lmmusys B.V., on its behalf</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">lmmusys B.V., on its behalf</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Jos Raats</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jos Raats</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">[Signature page &#150; Share Purchase Agreement] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE 2.2 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">to Share Purchase Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">dated
the 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> day of March, 2018 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Seller </U></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="21%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="21%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Seller</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>No.&nbsp;of&nbsp;Shares</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Class of ModiQuest&nbsp;Research&nbsp;Shares</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">lmmusys B.V.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">180&nbsp;(each&nbsp;one hundred&nbsp;euro)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Ordinary&nbsp;shares</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>180</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="20%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="20%"></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Seller</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>No.&nbsp;of&nbsp;Shares</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Class&nbsp;of&nbsp;lmmulease&nbsp;Shares</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">lmmusys B.V.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">18,000&nbsp;(each&nbsp;one euro)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Ordinary&nbsp;shares</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>18,000</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE 4.3 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">to Share Purchase Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">dated
the 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> day of March, 2018 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Share Capitalization of ModiQuest Research </U></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Designation of Security</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount&nbsp;Authorized</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount&nbsp;Outstanding</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">900</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">180</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Share Purchase Warrants</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Not Applicable</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Nil</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Stock Options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Not&nbsp;Applicable</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Nil</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Share Capitalization of lmmulease </U></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Designation of Security</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount&nbsp;Authorized</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount&nbsp;Outstanding</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">90,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">18,000</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Share Purchase Warrants</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Not Applicable</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Nil</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Stock Options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Not&nbsp;Applicable</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Nil</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE 4.14 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">to Share Purchase Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">dated
the 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> day of March, 2018 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Material Contracts of ModiQuest Research and lmmulease
</U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each of those agreements and contracts set forth in the Data Room under the heading &#147;Material Contracts.&#148; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE 4.19 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">to Share Purchase Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">dated
the 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> day of March, 2018 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Premises of ModiQuest Research and lmmulease </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>ModiQuest Research &#150; Leasehold Premises </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kloosterstraat 9, 5349 AB (postal address: lndustrielaan 63, 5349 AE) Oss, RE 2120, 2140/01, 2142, 2142/01, 2122, 2132, 2134, 2140, 2144, 2201, 2302, 3214,
3214/01, 0328, 0328/01, 0330, 0330/01, 3216, forming part of Pivot Park (OLSP Exploitatie BV), more particularly described in that lease agreement dated January 22, 2018 among OLSP Exploitatie BV and ModiQuest Research. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE 4.20 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">to Share Purchase Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">dated
the 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> day of March, 2018 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>lntellectual Propertv </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None other than: </P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">(non-registered)</FONT> copyrights regarding the documentation and know how
owned by Modiquest Research; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">tradenames: Modiquest Research B.V. and lmmulease B.V. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">trademark: Modiquest logo </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">trademark: Modiquest product/service mark is in process of registration by lmmusys. EUTM registration number
014916506 (Nice classes 1, 5, 42, 45) </P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Licenses Granted on the lntellectual Property </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Those licenses granted to ModiQuest BV and ModiQuest Therapeutics BV set forth in the Disentanglement Agreement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE 6.1 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">to Share Purchase Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">dated
the 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> day of March, 2018 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Permitted Dividend </U></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Parties acknowledge and agree that prior to Closing, the Seller (as shareholder of ModiQuest Research) has
resolved to make a dividend payment in the total amount of &#128;54,605 (the &#147;Dividend&#148;), which Dividend has been approved by the management board of ModiQuest Research as required in accordance with section 2:216 of the Dutch Civil Code.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Parties further acknowledge and agree that after Closing, the Purchaser shall resolve to make additional
dividend distributions of up to &#128;160,000 in the aggregate (the &#147;Additional Dividend Distribution&#148;), subject to the following conditions: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On or before December 31, 2018, and subject to paragraph (c), the Additional Dividend Distribution shall not be
payable unless after payment of the Additional Dividend Distribution, ModiQuest Research will have net working capital equal to or greater than &#128;250,000; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">After December 31, 2018, and subject to paragraph (c), the Additional Dividend Distribution shall be payable
regardless of the amount of net working capital left in ModiQuest Research after payment of the Additional Dividend Distribution; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Additional Dividend Distribution is permitted under applicable law (including the management board of
ModiQuest Research having approved such Additional Dividend Distribution in accordance with section 2:216 of the Dutch Civil Code). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">lf sufficient funds are not available for the payment of the entire Additional Dividend Distribution at one
instance without violating the conditions set forth in Section&nbsp;2, the Purchaser shall make partial dividend distributions (a &#147;Partial Additional Dividend Distribution&#148;) to the extent that such Partial Additional Dividend Distributions
may be made without violating the conditions set forth in Section&nbsp;2 until the entire aggregate amount of the Additional Dividend Distribution has been paid, and further provided that the Purchaser shall not be required to make Partial
Additional Dividend Distributions unless the Partial Additional Dividend Distribution that may be made without violating the conditions set forth in Section&nbsp;2 is greater than or equal to (i) &#128;25,000 or (ii)&nbsp;the total amount of the
Additional Dividend Distribution remaining to be distributed, whichever is less. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Upon payment of the Additional Dividend Distribution or a Partial Additional Dividend Distribution, the
Purchaser shall pay to the Seller, as additional purchase price for the ModiQuest Research Shares, an amount equal to the Additional Dividend Distribution or Partial Additional Dividend Distribution so paid. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>APPENDIX A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">to Share Purchase Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">dated
the 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> day of March, 2018 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Amendment Agreement to Management Agreement </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(See Attached) </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>APPENDIX B </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">to Share Purchase Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">dated
the 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> day of March, 2018 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Disentanglement Agreement </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(See Attached) </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.64
<SEQUENCE>65
<FILENAME>d20922dex9964.htm
<DESCRIPTION>EX-99.64
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.64</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.64 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SHARE EXCHANGE AGREEMENT </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THIS
SHARE EXCHANGE AGREEMENT </B>(this &#147;Agreement&#148;) is made as of the 10<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> day of August, 2017. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AMONG: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>IMMUNOPRECISE ANTIBODIES LTD.,
</B>a company duly formed under the laws of the Province of British Columbia, with its principal office located at Unit 3204, 4464 Markham Street, Victoria, BC V8Z 7X8 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(the &#147;Purchaser&#148;) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>OF
THE FIRST PART </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AND: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B><FONT
STYLE="white-space:nowrap">U-PROTEIN</FONT> EXPRESS B.V., </B>a company duly formed under the laws of the Netherlands, with its principal office located at Life Sciences Incubator, Utrecht, Science Park, Yalelaan, 62, 3584 CM, Utrecht, The
Netherlands, registered with the trade register of the Chamber of Commerce under number 30230407. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">(&#147;U-Protein&#148;</FONT> or the &#147;Company&#148;) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>OF THE SECOND PARTY </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AND: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>THE UNDERSIGNED SHAREHOLDERS OF <FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> EXPRESS B.V.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(collectively referred to as the <FONT STYLE="white-space:nowrap">&#147;U-Protein</FONT> Shareholders&#148; or &#147;Sellers&#148;) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>OF THE THIRD PART </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>WHEREAS: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A. &nbsp;&nbsp;&nbsp;&nbsp;The U-Protein Shareholders are the owners of all of the issued and outstanding shares of
<FONT STYLE="white-space:nowrap">U-Protein,</FONT> such that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">i.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Universiteit Utrecht Holding B.V. (&#147;Utrecht University&#148;) has forty percent (40%) ownership of
U-Protein; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">ii.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Bionomics B.V. (&#147;Bionomics&#148;) has twenty percent (20%) ownership of
<FONT STYLE="white-space:nowrap">U-Protein;</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">iii.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Wieger Hemrika (&#147;Hemrika&#148;) has twenty percent (20%) ownership of
<FONT STYLE="white-space:nowrap">U-Protein;</FONT> and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">iv.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Roland Romijn (&#147;Romijn&#148;) has twenty percent (20%) ownership of
<FONT STYLE="white-space:nowrap">U-Protein.</FONT> </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">B. &nbsp;&nbsp;&nbsp;&nbsp;The <FONT STYLE="white-space:nowrap">U-Protein</FONT>
Shareholders have agreed to sell to the Purchaser, and the Purchaser has agreed to purchase from the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders, all of their respective shares of <FONT STYLE="white-space:nowrap">U-Protein</FONT>
in exchange for shares of the Purchaser and certain cash payments made by the Purchaser as set forth herein (the &#147;Transaction&#148;). </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">C. &nbsp;&nbsp;&nbsp;&nbsp;The Purchaser, <FONT STYLE="white-space:nowrap">U-Protein</FONT> and the <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Shareholders agree that these Recitals shall form part of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOW THEREFORE THIS AGREEMENT
WITNESSES </B>that for good and valuable consideration including the sum of $10 now paid by each of the parties to the other, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree each with the other as follows: </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>INTERPRETATION</U> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.1. &nbsp;&nbsp;&nbsp;&nbsp;Where used herein or in any amendments or Schedules hereto, the following terms shall have the following meanings: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Bionomics <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares&#148; means the 3,600 <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Shares held by Bionomics. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Business&#148; means the business
in which <FONT STYLE="white-space:nowrap">U-Protein</FONT> is engaged, namely, holding rights to proprietary expression technology used in antibody and protein production. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Closing&#148; means closing of the purchase, sale and transfer of the
<FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares by the Purchaser as set forth herein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Closing
Date&#148; means the date of closing of the Transaction as agreed to by the parties but in any event no later than August 31, 2017. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Deed of Transfer&#148; means the notarial deed of transfer for the
<FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares, to be executed in the agreed form on the Closing Date before the Notary. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Exchange Rate&#148; means the Bank of Canada noon rate for European Euros in Canadian dollars on the date
immediately preceding the Closing Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Financing&#148; means the
<FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement financing of a minimum of 5,100,000 Purchaser Shares at a price of $1.00 per share for minimum gross proceeds of $5,100,000. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Governmental Body&#148; means any government, parliament, legislature, regulatory authority, agency,
commission, board or court or other law, rule or regulation making entity having or purporting to have jurisdiction on behalf of any nation, state, province or subdivision thereof, including any municipality or district. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Hemrika <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares&#148; means the 3,600 <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Shares held by Hemrika. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp; &#147;IFRS&#148; means International
Financial Reporting Standards. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Lien&#148; means any lien, charge, pledge, security interest,
encumbrance, right of first refusal, <FONT STYLE="white-space:nowrap">pre-emptive</FONT> right or other restriction of any sort whatsoever. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(I)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Material Adverse Effect&#148; means (i)&nbsp;a material adverse effect on the legality, validity or
enforceability of any Transaction Document, (ii)&nbsp;a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of <FONT STYLE="white-space:nowrap">U-Protein,</FONT> taken as a whole,
or (iii)&nbsp;a material adverse effect on <FONT STYLE="white-space:nowrap">U-Protein&#146;s</FONT> ability to perform in any material respect on a timely basis its obligations under any Transaction Document. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Management Agreement&#148; means the form of management agreement (or, should the parties so agree,
employment agreement) set forth in Schedule 2.4. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(n)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Notary&#148; means civil law notary Mr.&nbsp;R.M.
Rieter or another civil law notary of Bird&nbsp;&amp; Bird LLP in The Hague, or such civil law notary&#146;s substitute. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(o)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Notary Account&#148; means the trust account
<I>(kwaliteitsrekening) </I>of the office of the Notary, bank account number NL66ABNA0240486331 in the name of <I>&#145;Kwaliteitsrekening Notariaat Bird</I><I></I>&nbsp;&amp; <I>Bird&#146; </I>with ABN AMRO Bank (BIC: ABNANL2A) </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(p)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Person&#148; means an individual or corporation, partnership, trust, incorporated or unincorporated
association, joint venture, limited liability company, joint stock company, government (or agency or subdivision thereof) or other entity of any kind. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(q)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Premises&#148; means the premises set forth in Schedule 4.19. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(r)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Proceeding&#148; means an action, claim, suit, investigation or proceeding (including, without limitation, an
informal investigation or partial proceeding, such as a deposition), whether commenced or threatened. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(s)&nbsp;&nbsp;&nbsp;&nbsp;
&#147;Purchaser Financial Statements&#148; means the audited and unaudited financial statements of the Purchaser in the Purchaser Public Filings. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(t)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Purchaser Public Filings&#148; means the Purchaser&#146;s filings on the SEDAR filing system. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(u)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Purchaser Shares&#148; means common shares in the capital of the Purchaser. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Purchaser Share Equivalents&#148; means any securities of the Purchaser that would entitle the holder thereof
to acquire at any time Purchaser Shares, including, without limitation, any debt, preferred shares, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder
thereof to receive, Purchaser Shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(w)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Registrar&#148; means the British Columbia Registrar of Companies.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(x)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Required Approvals&#148; has the meaning set out in Section&nbsp;7.1. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(y)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Romijn <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares&#148; means the 3,600 <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Shares held by Romijn. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(z)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Securities Authorities&#148; has the
meaning set out in Section&nbsp;7.4. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(aa)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Tax Act&#148; means the <I>Income Tax Act </I>(Canada). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(bb)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Transaction Documents&#148; means this Agreement, all exhibits and schedules hereto and any other documents
or agreements executed in connection with the transactions contemplated hereunder and any documents required by the TSXV, applicable securities legislation relating to this Agreement and other regulatory bodies having jurisdiction to carry out the
terms and objectives of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(cc)&nbsp;&nbsp;&nbsp;&nbsp; &#147;TSXV&#148; means the TSX Venture Exchange. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(dd)&nbsp;&nbsp;&nbsp;&nbsp; &#147;Utrecht <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares&#148; means the 7,200 <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Shares held by Utrecht University. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(ee)&nbsp;&nbsp;&nbsp;&nbsp;
<FONT STYLE="white-space:nowrap">&#147;U-Protein</FONT> Directors&#148; means PodiCeps B.V., the statutory director of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and any other managers or other persons performing similar functions or duties,
of <FONT STYLE="white-space:nowrap">U-Protein.</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(ff)&nbsp;&nbsp;&nbsp;&nbsp; <FONT STYLE="white-space:nowrap">&#147;U-Protein</FONT>
Financial Statements&#148; means the financial statements for the financial year ended December 31, 2016. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(gg)&nbsp;&nbsp;&nbsp;&nbsp; <FONT
STYLE="white-space:nowrap">&#147;U-Protein</FONT> Material Contract&#148; means the contracts referred to in Schedule 4.14. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(hh)&nbsp;&nbsp;&nbsp;&nbsp; <FONT STYLE="white-space:nowrap">&#147;U-Protein</FONT> Shares&#148;
means the Utrecht <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares, the Bionomics <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares, the Hemrika Utrecht <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares and the Romijn <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Shares, representing all of the issued and outstanding shares in the capital of <FONT STYLE="white-space:nowrap">U-Protein.</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp; <FONT STYLE="white-space:nowrap">&#147;U-Protein</FONT> Share Equivalents&#148; means any securities of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> that would entitle the holder thereof to acquire at any time shares in the share capital of <FONT STYLE="white-space:nowrap">U-Protein,</FONT> including, without limitation, any debt, preferred shares,
right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or that otherwise entitles the holder thereof, to receive shares in the share capital of
<FONT STYLE="white-space:nowrap">U-Protein.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.2. &nbsp;&nbsp;&nbsp;&nbsp;All dollar amounts referred to in this Agreement are in lawful currency
of Canada, unless expressly stated otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.3. &nbsp;&nbsp;&nbsp;&nbsp;The following schedules are attached to and form part of this Agreement: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="85%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top">4.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">U-Protein</FONT> Share Capitalization</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top">4.14</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">U-Protein</FONT> Material Contracts</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top">4.19</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">U-Protein</FONT> Premises</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top">4.20</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Intellectual Property</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Purchaser Subsidiaries</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Purchaser Share Capitalization</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top">6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Warranty Deed</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top">7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Transfer Deed</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top">8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Management Agreements</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>PURCHASE AND SALE OF SHARES</U> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.1.&nbsp;&nbsp;&nbsp;&nbsp; <U>Purchase and Sale of <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares</U>. Subject to the terms and conditions of this
Agreement, the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders hereby sell, and the Purchaser hereby purchases, the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares free from any Lien with effect from the Closing Date and with
all rights attaching to them including the right to receive all distributions and dividends declared, paid or made in respect of the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares after the Closing Date. More specifically: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp; Utrecht University hereby sells the Utrecht <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares to the
Purchaser and the Purchaser hereby purchases the Utrecht <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares from Utrecht University; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp; Bionomics hereby sells the Bionomics <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares to the Purchaser and
the Purchaser hereby purchases the Bionomics <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares from Bionomics; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp; Hemrika hereby sells the Hemrika <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares to the Purchaser and the
Purchaser hereby purchases the Hemrika Shares from Hemrika; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp; Romijn hereby sells the Romijn <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Shares to the Purchaser and the Purchaser hereby purchases the Romijn <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares from Romijn. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.2.&nbsp;&nbsp;&nbsp;&nbsp; Transfer of the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares. On the Closing Date and subject to the terms and
conditions set forth herein, the Purchaser agrees to acquire and accept and the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders severally, and not jointly, agree to transfer <I>(leveren) </I>to the Purchaser each of their <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Shares as set forth in Schedule 2.1 hereto, free and clear from any Lien and with all rights attaching to the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.3.&nbsp;&nbsp;&nbsp;&nbsp; <U>Consideration</U>. In consideration of the
<FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares, the Purchaser shall pay a total purchase price of &#128;6,830,000 as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp; pay &#128;2,734,732 to the U-Protein Shareholders on the Closing Date as follows </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#128;912,488 in cash to Utrecht University; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#128;456,244 in cash to Bionomics BV; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#128;683,000 in cash to Wieger Hemrika; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#128;683,000 in cash to Roland Romijn; </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(the &#147;Cash Payments&#148;). The Purchaser shall ensure that the Cash Payments shall be credited to the Notary Account no later than 14.00
pm CET (Central European Time) on the Closing Date. The Notary shall hold the Cash payments in escrow for the Purchaser until execution of the Deed of Transfer, whereafter the Notary shall hold the Cash Payments in escrow for the <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Shareholders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp; issue Purchaser Shares having a cash value of
&#128;2,047,634 to the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders on the Closing Date as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Purchaser Shares having a cash value of &#128;909,756 to Utrecht University; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Purchaser Shares having a cash value of &#128;454,878 to Bionomics; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Purchaser Shares having a cash value of &#128;341,500 to Wieger Hemrika; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Purchaser Shares having a cash value of &#128;341,500 to Roland Romijn; </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">which Purchaser Shares are not subject to a lock up but trading shall only take place in accordance with the applicable TXSV rules regarding
insider knowledge </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">In the event that the Purchase Shares are not issued to the Sellers within 4 weeks after the Closing Date, the Purchaser
shall pay the cash equivalent to the Sellers </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp; pay in cash or, at the sole election of each U Protein
Shareholders, issue Purchaser Shares having a cash value of, &#128;2,047,634 to the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#128;909,756 to Utrecht University as follows: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp; &#128;303,252 on December 31, 2018; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp; &#128;303,252 on December 31, 2019; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(C)&nbsp;&nbsp;&nbsp;&nbsp; &#128;303,252 on December 31, 2020. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#128;454,878 to the Bionomics as follows: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp; &#128;151,626 on December 31, 2018; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp; &#128;151,626 on December 31, 2019; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(C) &nbsp;&nbsp;&nbsp;&nbsp;&#128;151,626 on December 31, 2020. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#128;341,500 to Hemrika as follows: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp; &#128;113,833 on December 31, 2018; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp; &#128;113,833 on December 31, 2019; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(C)&nbsp;&nbsp;&nbsp;&nbsp; &#128;113,833 on December 31, 2020. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#128;341,500 to Romijn as follows: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp; &#128;113,833 on December 31, 2018; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp; &#128;113,833 on December 31, 2019; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(C)&nbsp;&nbsp;&nbsp;&nbsp; &#128;113,833 on December 31, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the purposes of sections 2.1(b) and 2.1(c), the number of Purchaser Shares will be determined by the following formula: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Cash Value <I>I </I>(CAD $1.00 <I>I </I>Exchange Rate) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.4.&nbsp;&nbsp;&nbsp;&nbsp; <U>Closing</U>. Closing shall take place on the Closing Date at the offices of the Notary at the Zuid-Hollandplein 22, 2596 AW
The Hague, the Netherlands and at such time as agreed to by the <FONT STYLE="white-space:nowrap">U-Protein,</FONT> U-Protein Shareholders and the Purchaser or on such other date or at such other time or place as the U-Protein, <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Shareholders and the Purchaser may mutually agree. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Closing Deliveries.</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp; <U><FONT STYLE="white-space:nowrap">U-Protein</FONT> and the Shareholders Deliveries</U>. On or prior to the
Closing Date, <FONT STYLE="white-space:nowrap">U-Protein</FONT> and the Shareholders shall deliver or cause to be delivered the following documents to the Purchaser: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp; The original shareholders register of <FONT STYLE="white-space:nowrap">U-Protein;</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp; A copy of the duly executed board resolution in connection with the execution, delivery and performance of this
Agreement by <FONT STYLE="white-space:nowrap">U-Protein</FONT> and the transactions contemplated hereby, including, if necessary, the approval of the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders of this Agreement and the
transactions contemplated hereby; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp; A certificate executed by a duly authorized officer of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> dated as of the Closing Date to the effect that the representations and warranties made by <FONT STYLE="white-space:nowrap">U-Protein</FONT> in this Agreement are true and correct in all material respects;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp; A copy of the Management Agreements duly signed by Martin Hessing, Wieger Hemrika and Roland Romijn. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp; A copy of the Warranty Deed duly signed by the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders and
the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp; <U>Purchaser Deliveries</U>. On or prior to the Closing Date, the Purchaser shall deliver or
cause to be delivered the following documents to <FONT STYLE="white-space:nowrap">U-Protein</FONT> and the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp; Payment by wire transfer, bank draft of the Cash Payments to the Notary Account; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp; Electronic Shares representing the total number of Purchaser Shares issuable to such <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Shareholder pursuant to Section&nbsp;2.2(b) hereof and as set out in Schedule 2.1; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp; A certificate, or the equivalent, as to the corporate existence and good standing of the Purchaser, issued by the
Registrar, dated not more than five business days prior to the Closing Date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp; A copy, certified by a duly
authorized officer of the Purchaser to be true and complete as of the Closing Date, of the records of all corporate action taken to authorize the execution, delivery and performance of this Agreement by the Purchaser and the transactions
contemplated hereby, including, if necessary, the approval of the Purchaser Shareholders of this Agreement and the transactions contemplated hereby; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp; A certificate executed by a duly authorized officer of the Purchaser dated as of the Closing Date to the effect
that the representations and warranties made by the Purchaser in this Agreement are true and correct in all material respects; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(vi)&nbsp;&nbsp;&nbsp;&nbsp;A copy of the Management Agreements duly signed by the Purchaser; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(vii)&nbsp;A copy of the Warranty Deed duly signed by the Purchaser. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Further Actions.</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp; The <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders, the Purchaser and <FONT
STYLE="white-space:nowrap">U-Protein</FONT> shall sign the Deed of Transfer before the Notary who shall execute the Deed of Transfer, thus effectuating the transfer of the U-Protein Shares from the <FONT STYLE="white-space:nowrap">U-Protein</FONT>
Shareholders to the Purchaser; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp; On the first business day following the Closing Date, the Notary
shall pay the Cash Payments to the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders in the amounts as specified in Section&nbsp;2.3.(a) above, to such bank accounts as shall be designated in writing by the <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Shareholders to the Notary; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp; The Purchaser shall pass a resolution
of the general meeting of shareholders of <FONT STYLE="white-space:nowrap">U-Protein</FONT> resolving to [(a) amend the articles of association of <FONT STYLE="white-space:nowrap">U-Protein]</FONT> and (b)&nbsp;appoint Podiceps BV for 2 years as
managing director of <FONT STYLE="white-space:nowrap">U-Protein,</FONT> effective as per the moment of execution of the Deed of Transfer; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp; The Notary shall amend the articles of association of <FONT STYLE="white-space:nowrap">U-Protein;</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp; Each party to this Agreement covenants and agrees that, from time to time prior to and subsequent to Closing, he,
she or it will execute and deliver all such documents, including all such additional conveyances, transfers, consents and other assurances and do all such other acts and things as may be necessary or desirable in order to carry out the purposes of
this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.7.&nbsp;&nbsp;&nbsp;&nbsp; The Notary is a partner of Bird&nbsp;&amp; Bird LLP, the firm of the external legal advisors to the
Purchaser. Each <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder acknowledges that it is aware of the relevant provisions of the Ordinance Interdisciplinary Cooperation (<I>Verordening lnterdisciplinaire Samenwerking) </I>and the
articles 19 through 22 of the Professional Code of Conduct ( <I>Verordening Beroeps- en Gedragsregels) </I>of the Royal Professional Organisation of Civil Law Notaries <I>(Koninklijke Notariele Beroepsorganisatie). </I>Each <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Shareholder hereby acknowledges and agrees that the Notary may advise and act on behalf of the Purchaser with respect to this Agreement, and any agreements and/or any disputes related to or resulting from
this Agreement. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>COVENANTS, REPRESENTATIONS AND WARRANTIES OF THE <FONT STYLE="white-space:nowrap">U-PROTEIN</FONT>
SHAREHOLDERS</U> </B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The covenants, representations and warranties provided by each
<FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder to the Purchaser in connection with the purchase of the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares are set out in schedule 1 to the Warranty Deed attached hereto as Schedule
6 D. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>COVENANTS, REPRESENTATIONS AND WARRANTIES OF <FONT STYLE="white-space:nowrap">U-PROTEIN</FONT></U>
</B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The covenants, representations and warranties provided by <FONT STYLE="white-space:nowrap">U-Protein</FONT> to the
in connection with the purchase of the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares are set out in schedule 2 to the Warranty Deed attached hereto as Schedule 6 is true and accurate at the date of this Agreement and the Closing Date.
</P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>COVENANTS, REPRESENTATIONS AND WARRANTIES OF THE PURCHASER</U> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Purchaser covenants, represents and warrants with and to <FONT STYLE="white-space:nowrap">U-Protein</FONT> and the <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Shareholders as follows and acknowledges that <FONT STYLE="white-space:nowrap">U-protein</FONT> and the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders are relying upon such covenants,
representations and warranties in entering into this Agreement: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.1.&nbsp;&nbsp;&nbsp;&nbsp; <U>Organization and Qualification</U>. The Purchaser is a
company duly incorporated, validly existing and in good standing under the laws of the Province of British Columbia, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted.
The Purchaser is not in violation or default of any of the provisions of its respective certificate or notice of articles, articles or other organizational or charter documents. The Purchaser is duly qualified to conduct business and is in good
standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the
case may be, could not have or reasonably be expected to result in a Material Adverse Effect and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and
authority or qualification. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.2.&nbsp;&nbsp;&nbsp;&nbsp; <U>Subsidiaries. Partnerships and Joint Ventures</U>. Except as set forth in
Schedule 5.2, the Purchaser does not have any subsidiaries or agreements of any nature to acquire any subsidiary or to acquire or lease any other business operations and will not prior to the Closing Date acquire, or agree to acquire, any subsidiary
or business without the prior written consent of <FONT STYLE="white-space:nowrap">U-Protein.</FONT> The Purchaser is not a partner or a participant in any partnership, joint venture, profit sharing arrangement or other association of any kind,
including as a beneficiary or trustee in any trust arrangement and is not party to any agreement under which the Purchaser agrees to carry on any part of its business or any other activity in such manner or by which the Purchaser agrees to any
revenue or profit sharing arrangement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.3.&nbsp;&nbsp;&nbsp;&nbsp; <U>Capitalization</U>. The capitalization of the Purchaser will be as set forth on
Schedule 5.3. Except as set forth on Schedule 5.3, the Purchaser has not issued any shares of its capital stock. No Person has any right of first refusal, preemptive right, right of participation, or any similar right granted by the Purchaser to
participate in the transactions contemplated by the Transaction Documents. Except as set out in Schedule 5.3, there are no outstanding options, warrants, calls or commitments of any character whatsoever relating to, or securities, rights or
obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire any shares in the capital stock, or contracts, commitments, understandings or arrangements by which the Purchaser is or may
become bound to issue additional shares in the capital stock of the Purchaser or Purchaser Share Equivalents. Except as set out in Schedule 5.3, the consummation of the transactions contemplated under the Transaction Documents will not obligate the
Purchaser to issue shares of its capital stock or other securities to any Person (other than the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders in accordance with this Agreement) and will not result in a right of any holder of the
Purchaser&#146;s securities to adjust the exercise, conversion, exchange or reset price under any of such securities. All of the outstanding shares of the Purchaser&#146;s capital stock are duly authorized, validly issued, fully paid and <FONT
STYLE="white-space:nowrap">non-assessable,</FONT> have been issued in compliance with all applicable laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase
securities. On the Closing Date no further approval or authorization of the Purchaser&#146;s board of directors or shareholders or others will be required to complete the transactions contemplated under the Transaction Documents. There are no
stockholders agreements, voting agreements or other similar agreements with respect to the Purchaser&#146;s capital stock to which the Purchaser is a party or, to the knowledge of the Purchaser, between or among any of the Purchaser&#146;s
shareholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.4.&nbsp;&nbsp;&nbsp;&nbsp; <U>Authorization; Enforcement</U>. The Purchaser has the requisite corporate power and authority to enter into
and to consummate the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. On the Closing Date, the execution and delivery of each of this
Agreement and the other Transaction Documents by the Purchaser and the consummation by it of the transactions contemplated hereby and thereby will be duly authorized by all necessary action on the part of the Purchaser and no further action will be
required by the Purchaser, its board of directors or its shareholders in connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been (or
upon delivery will have been) duly executed by the Purchaser and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Purchaser enforceable against the Purchaser in accordance with
its terms, except: (i)&nbsp;as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#146; rights generally, (ii)&nbsp;as
limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii)&nbsp;insofar as indemnification and contribution provisions may be limited by applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.5.&nbsp;&nbsp;&nbsp;&nbsp; <U>No Conflicts</U>. The execution, delivery and performance by the Purchaser of this Agreement and the other Transaction
Documents to which it is a party and the consummation by it of the transactions contemplated hereby and thereby do not and will not: (i)&nbsp;conflict with or violate any provision of the Purchaser&#146;s articles of incorporation or other
organizational or charter documents, (ii)&nbsp;conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of
the Purchaser, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Purchaser debt or
otherwise) or other understanding to which the Purchaser is a party or by which any property or asset of the Purchaser </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">is bound or affected, or (iii)&nbsp;subject to the Required Approvals, conflict with or result in a violation of
any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Purchaser is subject (including federal and state securities laws and regulations), or by which any property or
asset of the Purchaser is bound or affected; except in the case of each of clauses (ii)&nbsp;and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.6.&nbsp;&nbsp;&nbsp;&nbsp; <U>Filings. Consents and Approvals.</U> The Purchaser is not required to obtain any consent, waiver, authorization or order of,
give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by the Purchaser of the Transaction
Documents, other than consents, waivers, authorizations, orders, notices, filings or registrations necessary in connection with the Required Approvals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.7.&nbsp;&nbsp;&nbsp;&nbsp; <U>Issuance of the Securities.</U> Upon Closing, all of the Purchaser Shares issued to the
<FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders will be duly and validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> shares in the capital of the Purchaser. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.8.&nbsp;&nbsp;&nbsp;&nbsp; <U>Books and Records.</U> The books and records of the Purchaser fairly and correctly set out and disclose in all material
respects, in accordance with IFRS, the financial position of Purchaser as at the date hereof, and all material financial transactions of the Purchaser have been accurately recorded in such books and records. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.9.&nbsp;&nbsp;&nbsp;&nbsp; <U>Corporate Records</U>. The corporate records and minute books of the Purchaser contain complete and accurate copies of the
constating documents of the Purchaser, minutes of all meetings and resolutions of the directors (including any committees thereof) and shareholders of the Purchaser, and the share certificate books, register of shareholders, register of transfers
and register of directors of the Purchaser are complete and accurate in all material respects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.10.&nbsp;&nbsp;&nbsp;&nbsp; Officers and Directors. The
officers and directors of the Purchaser are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="78%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Position</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Thomas D&#146;Orazio</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">CEO, President and Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Natasha Tsai</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">CFO</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Robert Beecroft</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">CTO and Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dawn Wattie</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Corporate Secretary</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Guy Champagne</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">James Kuo</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Greg Smith</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.11. &nbsp;&nbsp;&nbsp;&nbsp;<U>Reporting Issuer</U>. The Purchaser is a reporting issuer in good standing in the
province of British Columbia and Alberta, and is not in default of any applicable securities, taxation and corporate legislation, regulations, orders, notices or policies in force therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.12. &nbsp;&nbsp;&nbsp;&nbsp;<U>Disclosure Record</U>. The Purchaser has timely filed with the relevant authorities all documents required to have been filed
by it under the securities laws applicable to it. As of their respective dates, each of the Purchaser Public Filings complied in all material respects with the requirements of the applicable securities laws pertaining to such filings, and none of
the Purchaser Public Filings contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances in which they
were made. There have been no confidential material change reports filed by the Purchaser with any securities regulatory authority having jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.13. &nbsp;&nbsp;&nbsp;&nbsp;<U>Exchange Listing and Filings</U>. The Purchaser Shares are listed on the TSXV and, on the Closing Date, the Purchaser Shares
to be issued to the U-Protein Shareholders as set out in Section 2.2 hereto will have been approved for issuance, listing and, upon expiry of all resale restrictions, trading through the TSXV. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.14.&nbsp;&nbsp;&nbsp;&nbsp; <U>Purchaser Financial Statements.</U> The Purchaser Financial Statements have been
prepared in accordance with applicable securities laws and in accordance with IFRS and present fairly the assets, liabilities and the financial position of the Purchaser as at the dates indicated and the results of operation of the Purchaser for the
periods indicated and no Material Adverse Effect in such financial position or such results of operation has occurred since the dates thereof. The Purchaser has not received any advice or notification from its independent certified public
accountants that the Purchaser has used any improper accounting practice that would have the effect of not reflecting or incorrectly reflecting in the Purchaser Financial Statements or the books and records of the Purchaser, any properties, assets,
liabilities, revenues or expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.15.&nbsp;&nbsp;&nbsp;&nbsp; <U>Litigation</U>. There is no Action pending or, to the knowledge of the Purchaser,
threatened against or affecting the Purchaser or any of its properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) which (i)&nbsp;adversely affects or
challenges the legality, validity or enforceability of any of the Transaction Documents or the transactions contemplated therein or (ii)&nbsp;could, if there were an unfavorable decision, have or reasonably be expected to result in a Material
Adverse Effect. Neither the Purchaser, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under applicable securities laws or a claim of breach of fiduciary duty. There has
not been, and to the knowledge of the Purchaser, there is not pending or contemplated, any investigation by any Governmental Body involving the Purchaser or any current or former director or officer of the Purchaser. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.16.&nbsp;&nbsp;&nbsp;&nbsp; <U>Compliance</U>. To the Purchaser&#146;s knowledge, after reasonable investigation, the Purchaser: (i)&nbsp;is not in default
under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Purchaser under), nor has the Purchaser received notice of a claim that it is in default under
or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is
not in violation of any judgment, decree, or order of any court, arbitrator or other governmental authority or (iii)&nbsp;is not and has not been in violation of any statute, rule, ordinance or regulation of any governmental authority, including
without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as could not have or
reasonably be expected to result in a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.17.&nbsp;&nbsp;&nbsp;&nbsp; <U>Taxes.</U> Except for matters that would not,
individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect, the Purchaser (i)&nbsp;has made or filed all federal, state and local income and franchise tax returns, reports and declarations required by any
jurisdiction to which it is subject, (ii)&nbsp;has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii)&nbsp;has set aside on its
books provision reasonably adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing
authority of any jurisdiction, and the officers of the Purchaser know of no basis for any such claim. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>ADDITIONAL COVENANTS OF PARTIES</U> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Covenants of <FONT STYLE="white-space:nowrap">U-Protein</FONT></U>. <FONT STYLE="white-space:nowrap">U-Protein</FONT> hereby
covenants and agrees with the Purchaser as follows, and the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders severally, but not jointly, covenant and agree to do such things as may be necessary or desirable to cause or permit <FONT
STYLE="white-space:nowrap">U-Protein</FONT> to comply with the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp; <U>Conduct of Business</U>. Between
the date of this Agreement and the Closing of the transactions contemplated hereby, unless otherwise expressly contemplated or permitted in this Agreement or consented to in writing by the Purchaser, <FONT STYLE="white-space:nowrap">U-Protein</FONT>
will: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;Conduct the Business substantially as presently operated and only in the ordinary course and in
compliance with all applicable laws; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp; Maintain the books, records and accounts of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> in the ordinary course of business and record all transactions on a basis consistent with Dutch GAAP </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp; Not amend the articles, <FONT STYLE="white-space:nowrap">by-laws</FONT> or other constating documents of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> or the terms of the outstanding securities of <FONT STYLE="white-space:nowrap">U-Protein,</FONT> including any outstanding indebtedness and credit facilities of
<FONT STYLE="white-space:nowrap">U-Protein;</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp; Not amalgamate, merge or otherwise consolidate itself with
any other person or adopt or enter into a plan of liquidation or dissolution with respect to itself; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp; Not
issue, sell, pledge, lease, dispose of or otherwise encumber any securities or any options, warrants or other rights to acquire securities, or redeem or purchase any of the outstanding securities of or ownership interests in <FONT
STYLE="white-space:nowrap">U-Protein;</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(vi)&nbsp;&nbsp;&nbsp;&nbsp; Not incur or commit to incur any indebtedness for borrowed money
(other than trade payables incurred in the ordinary course of business); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(vii)&nbsp;&nbsp;&nbsp;&nbsp; Not guarantee, endorse or otherwise
become responsible for any material liability, obligation or indemnity of any other person, or make any loans or advances; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(viii)&nbsp;&nbsp;&nbsp;&nbsp; Not split, consolidate or reclassify any of the shares nor undertake any other capital reorganization; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(ix)&nbsp;&nbsp;&nbsp;&nbsp; Not sell, lease, encumber or otherwise dispose of, directly or indirectly, any business, properties or assets of <FONT
STYLE="white-space:nowrap">U-Protein,</FONT> other than in the ordinary course of their respective businesses; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(x)&nbsp;&nbsp;&nbsp;&nbsp;
Not enter into any partnership, joint venture, memorandum of understanding, strategic alliance or similar agreement, arrangement or relationship, or any new material contract (other than contracts in the ordinary course of business); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(xi)&nbsp;&nbsp;&nbsp;&nbsp; Not declare, set aside or pay any dividend or other distribution to its shareholders or other owners. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp; <U><FONT STYLE="white-space:nowrap">U-Protein</FONT> Financial Statements</U>.
<FONT STYLE="white-space:nowrap">U-Protein</FONT> shall provide the Purchaser with the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Financial Statements as soon as practicable after the date hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp; <U>Conditions of Closing.</U> <FONT STYLE="white-space:nowrap">U-Protein</FONT> shall use commercially reasonable
efforts to cause each of the terms and conditions precedent for the benefit of the Purchaser to be fulfilled on or before the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.2.&nbsp;&nbsp;&nbsp;&nbsp; <U>Covenants of the Purchaser</U>. The Purchaser hereby covenants and agrees with U-Protein and the <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Shareholders as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp; <U>Conditions to Closing</U>. The
Purchaser shall use commercially reasonable efforts to cause each of the conditions to closing for the benefit of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders to be
fulfilled on or before the Closing Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp; <U>Purchaser Financing.</U> The Parties agree that the Purchaser will
complete a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement of a minimum 5,100,000 Purchaser Shares at a price of $1.00 per Purchaser Share for minimum gross proceeds of $5,100,000 conjunction with closing of the Transaction
(the &#147;Financing&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.3.&nbsp;&nbsp;&nbsp;&nbsp; <U>Mutual Covenants.</U> Each of the Purchaser,
<FONT STYLE="white-space:nowrap">U-Protein</FONT> and the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders hereby covenant and agree each with the other as follows: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp; <U>Confidentiality</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp; All information regarding <FONT STYLE="white-space:nowrap">U-Protein</FONT> and the
<FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders and their respective affiliates, provided to the Purchaser under this Agreement or in furtherance of the transactions contemplated hereunder, will be kept in strict confidence by the
Purchaser and its affiliates or agents and will not be used, dealt with, exploited or commercialized or disclosed to any third party (other than the Purchaser&#146;s professional advisors with a need to know such information for the purposes
contemplated in this Agreement) by the Purchaser or any affiliate or agent of the Purchaser without the prior written consent of U-Protein unless (A)&nbsp;such disclosure is required by law, by regulatory authorities having jurisdiction with respect
to the Purchaser or the transactions contemplated herein or by the TSXV, or (B)&nbsp;such disclosure is reasonably necessary for the completion of the transactions contemplated herein. If the transactions contemplated in this Agreement do not
proceed for any reason, then upon receipt of a written request from <FONT STYLE="white-space:nowrap">U-Protein,</FONT> the Purchaser will immediately return to <FONT STYLE="white-space:nowrap">U-protein</FONT> or destroy all information regarding
U-Protein, the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders and their respective affiliates provided in connection with the transactions contemplated in this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp; All information regarding the Purchaser and its affiliates, provided to
<FONT STYLE="white-space:nowrap">U-Protein</FONT> under this Agreement or in furtherance of the transactions contemplated hereunder, will be kept in strict confidence by <FONT STYLE="white-space:nowrap">U-Protein</FONT> and its affiliates or agents
and will not be used, dealt with, exploited or commercialized or disclosed to any third party (other than the <FONT STYLE="white-space:nowrap">U-Protein&#146;s</FONT> professional advisors with a need to know such information for the purposes
contemplated in this Agreement) by <FONT STYLE="white-space:nowrap">U-Protein</FONT> or any affiliate or agent of U-Protein without the prior written consent of the Purchaser unless (A)&nbsp;such disclosure is required by law, by regulatory
authorities having jurisdiction with respect to <FONT STYLE="white-space:nowrap">U-Protein</FONT> or the transactions contemplated herein or by the TSXV, or (B)&nbsp;such disclosure is reasonably necessary for the completion of the transactions
contemplated herein. If the transactions contemplated in this Agreement do not proceed for any reason, then upon receipt of a written request from the Purchaser, <FONT STYLE="white-space:nowrap">U-Protein</FONT> will immediately return to the
Purchaser or destroy all information regarding the Purchaser and its affiliates provided in connection with the transactions contemplated in this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp; Notwithstanding the generality of the forgoing, the provisions of Section&nbsp;6.3(a)(i) and 6.3(a)(ii) shall not
apply to any information that the Purchaser (in the case of Section 6.3(a)(i)) or <FONT STYLE="white-space:nowrap">U-Protein</FONT> (in the case of Section&nbsp;6.3(a)(ii)) can demonstrate: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp; is or becomes available to the public other than as a direct or indirect result of any violation by the Purchaser
of Section&nbsp;6.3(a)(i) or <FONT STYLE="white-space:nowrap">U-Protein</FONT> of Section 6.3(a)(ii); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp; is or
becomes available to the Purchaser (in the case of Section&nbsp;6.3(a)(i)) or <FONT STYLE="white-space:nowrap">U-Protein</FONT> (in the case of 6.3(a)(ii)) on a <FONT STYLE="white-space:nowrap">non-confidential</FONT> basis from a source other than
the Purchaser or <FONT STYLE="white-space:nowrap">U-Protein,</FONT> provided that such source does not owe a duty of confidentiality to <FONT STYLE="white-space:nowrap">U-Protein</FONT> (in the case of Section&nbsp;6.3(a)(i)) or the Purchaser (in
the case of Section&nbsp;6.3(a)(ii)); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(C)&nbsp;&nbsp;&nbsp;&nbsp; is or was demonstrably independently developed by the Purchaser (in the
case of Section&nbsp;6.3(a)(i)) or <FONT STYLE="white-space:nowrap">U-Protein</FONT> (in the case of 6.3(a)(ii)) without the use of any information disclosed pursuant to Section&nbsp;6.3(a)(i)) or Section&nbsp;6.3(a)(ii)); or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(D)&nbsp;&nbsp;&nbsp;&nbsp; was lawfully and demonstrably in the possession of the Purchaser (in the case of Section&nbsp;6.3(a)(i)) or <FONT
STYLE="white-space:nowrap">U-Protein</FONT> (in the case of Section&nbsp;6.3(a)(ii)) prior to its disclosure by <FONT STYLE="white-space:nowrap">U-Protein</FONT> or the Purchaser. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp; <U><FONT STYLE="white-space:nowrap">Non-Solicitation.</FONT></U> Until such time, if any, as this Agreement is
terminated pursuant to the terms set out herein, except in accordance with the terms and conditions of this Agreement, U-Protein </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">and the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders will not directly or
indirectly solicit, initiate, entertain or accept any inquiries or proposals from, discuss or negotiate with, provide any <FONT STYLE="white-space:nowrap">non-public</FONT> information to, or otherwise consider the merits of any unsolicited
inquiries or proposals from, any person or entity (other than the Purchaser) relating to any transaction involving (i)&nbsp;the sale of any of businesses or assets (other than sales made in the ordinary course of business) of <FONT
STYLE="white-space:nowrap">U-Protein;</FONT> (ii)&nbsp;any sale of the capital stock or other ownership interests of <FONT STYLE="white-space:nowrap">U-Protein;</FONT> or (iii)&nbsp;any merger, consolidation, business combination or similar
transaction. <FONT STYLE="white-space:nowrap">U-Protein</FONT> and the <FONT STYLE="white-space:nowrap">U-Protein</FONT> shareholders agrees to promptly notify the Purchaser if it receives an unsolicited offer for any such transaction, or obtains
information that such an offer is reasonably likely to be made, which notice shall include the identity of the prospective offeror and the consideration to be paid and terms of the prospective offer. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>SECURITIES REGULATORY APPROVALS</U> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.1.&nbsp;&nbsp;&nbsp;&nbsp; The terms of this Agreement are subject to the approval of all securities regulatory authorities having jurisdiction with respect
to this Agreement and the transactions contemplated herein, including, but not limited to, the TSXV (the &#147;Required Approvals&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.2.&nbsp;&nbsp;&nbsp;&nbsp; The Purchaser will with reasonable diligence do all such things and provide all such reasonable assurances as may be required to
obtain the approval of all applicable regulatory authorities, including the TSXV, to the transactions contemplated in this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.3.&nbsp;&nbsp;&nbsp;&nbsp; The <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders and <FONT STYLE="white-space:nowrap">U-Protein</FONT> shall
promptly comply with all reasonable conditions and requirements of the TSXV to the completion of the transactions contemplated herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.4.&nbsp;&nbsp;&nbsp;&nbsp; If the TSXV or any other securities regulatory authority having jurisdiction with respect to this Agreement and the transactions
contemplated herein (collectively the &#147;Securities Authorities&#148;), shall prevent the consummation of the transactions contemplated herein, neither of the parties nor their respective directors, officers, legal counsel, servants, or agents
shall in any way be liable to the other parties to this Agreement in respect of any damages or losses suffered by them as a result of such failure of the Securities Authorities to give their approval, provided that such party has, with all due
diligence and in good faith, used its commercially reasonable efforts to obtain the approval of such Securities Authorities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.5.&nbsp;&nbsp;&nbsp;&nbsp;
<FONT STYLE="white-space:nowrap">U-Protein</FONT> and the Purchaser shall provide each other with reasonable opportunity to review and comment on all filings, applications, submissions and other material communications to Securities Authorities. <FONT
STYLE="white-space:nowrap">U-Protein</FONT> and the Purchaser shall use its commercially reasonable efforts to cooperate with and assist each other in the preparation and making of all filings, applications and submissions to such Securities
Authorities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.6.&nbsp;&nbsp;&nbsp;&nbsp; <FONT STYLE="white-space:nowrap">U-Protein</FONT> and the Purchaser shall promptly notify each other of any
material communication to such party from any Securities Authorities in respect of the transactions contemplated herein and shall provide the other party with a copy thereof if such communication is in writing.
<FONT STYLE="white-space:nowrap">U-Protein</FONT> and the Purchaser shall consult with each other prior to participating in any substantive meeting or discussion with any Securities Authorities in respect of the transactions contemplated herein and
shall give each other the opportunity to attend and participate thereat. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>CONDITIONS PRECEDENT TO CLOSING</U> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8.1.&nbsp;&nbsp;&nbsp;&nbsp; <U>Mutual Conditions Precedent</U>. The respective obligations of the Purchaser, <FONT STYLE="white-space:nowrap">U-Protein</FONT>
and the U-Protein Shareholders to complete the transactions contemplated in this Agreement are subject to the fulfilment, at or prior to Closing, of the following conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp; All securities regulatory authorities having jurisdiction with respect to this Agreement and the transactions
contemplated herein, including, but not limited to, the TSXV, shall have approved such Agreement and such transactions; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp; If required by any applicable law or securities regulatory authority
having jurisdiction with respect to this Agreement and the transactions contemplated herein, including, but not limited to, the TSXV, the shareholders of the Purchaser shall have approved the transactions contemplated in this Agreement; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp; There shall have been no action taken under any applicable law or by any Governmental Body which makes it illegal
or otherwise directly or indirectly restrains, enjoins or prohibits or would otherwise have a Material Adverse Effect on the completion of the transactions contemplated in this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8.2.&nbsp;&nbsp;&nbsp;&nbsp; The conditions precedent in Section&nbsp;8.1 are for the mutual benefit of the Purchaser and
<FONT STYLE="white-space:nowrap">U-Protein</FONT> and may be waived, in whole or in part, at any time by both <FONT STYLE="white-space:nowrap">U-Protein</FONT> and the Purchaser, such waiver being without prejudice to any other right that any party
may have. In the event any of the foregoing conditions contained in Section&nbsp;8.1 are not fulfilled or performed at or before the Closing Date to the reasonable satisfaction of both the Purchaser and
<FONT STYLE="white-space:nowrap">U-Protein,</FONT> any of the Purchaser or <FONT STYLE="white-space:nowrap">U-Protein</FONT> may terminate this Agreement by written notice to the other and in such event each of the Purchaser, <FONT
STYLE="white-space:nowrap">U-Protein</FONT> and the U-Protein Shareholders shall be released from all further obligations hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8.3.&nbsp;&nbsp;&nbsp;&nbsp; <U>Conditions Precedent to Purchaser Obligations</U>. All of the obligations of the Purchaser to complete the transactions
contemplated in this Agreement are subject to the fulfilment, at or prior to Closing, of the following conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp; The respective representations and warranties of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and the <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Shareholders contained in this Agreement shall be, in all material respects, true and correct when made and as of the Closing Date, with the same force and effect as though such representations and
warranties had been made on and as of such date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp; <FONT STYLE="white-space:nowrap">U-Protein</FONT> and each of
the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders shall have performed and complied in all material respects with all of their respective covenants and obligations required to be performed prior to Closing; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp; <FONT STYLE="white-space:nowrap">U-Protein</FONT> obtaining all required directors&#146;, shareholders&#146;,
regulatory, and third party consents, including without limitation, approval of the TSXV, required for the Transaction; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp; At Closing, there shall have been no materially adverse change in the affairs, assets, liabilities or financial
condition of <FONT STYLE="white-space:nowrap">U-Protein</FONT> or the Business, taken as a whole; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp; At Closing,
each of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders shall have delivered those items set forth in Section&nbsp;2.4(a) of this Agreement; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp; Completion of the Financing concurrently with closing of the Transaction. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8.4.&nbsp;&nbsp;&nbsp;&nbsp; The conditions precedent in Section&nbsp;8.3 are for the benefit of the Purchaser and may be waived, in whole or in part, at any
time by the Purchaser, such waiver being without prejudice to any other right that any party may have. In the event any of the foregoing conditions contained in Section&nbsp;8.3 are not fulfilled or performed at or before the Closing Date to the
reasonable satisfaction of the Purchaser, the Purchaser may terminate this Agreement by written notice to <FONT STYLE="white-space:nowrap">U-Protein</FONT> and the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders and in such event each
of the Purchaser, <FONT STYLE="white-space:nowrap">U-Protein</FONT> and the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders shall be released from all further obligations hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8.5.&nbsp;&nbsp;&nbsp;&nbsp; <U>Conditions Precedent to <FONT STYLE="white-space:nowrap">U-Protein</FONT> and
<FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders Obligations</U>. All of the obligations of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders to complete the
transactions contemplated in this Agreement are subject to fulfilment, at or prior to Closing, of the following conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp; The representations and warranties of the Purchaser contained in this Agreement shall be, in all material respects,
true and correct when made and as of the Closing Date, with the same force and effect as though such representations and warranties had been made on and as of such date; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp; The Purchaser shall have performed and complied in all material
respects with all of its covenants and obligations required to be performed prior to Closing; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp; The Purchaser
obtaining all required directors&#146;, shareholders&#146;, regulatory, and thirdparty consents, including without limitation, approval of the TSXV, required for the Transaction; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp; At Closing, there shall have been no materially adverse change in the affairs, assets, liabilities or financial
condition of the Purchaser, taken as a whole; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp; At Closing, the Purchaser shall have delivered those items
set forth in Section&nbsp;2.4(b) of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8.6.&nbsp;&nbsp;&nbsp;&nbsp; The conditions precedent in Section&nbsp;8.5 are for the benefit of <FONT
STYLE="white-space:nowrap">U-protein</FONT> and the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders and may be waived, in whole or in part, at any time by <FONT STYLE="white-space:nowrap">U-Protein</FONT> and the <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Shareholders, such waiver being without prejudice to any other right that any party may have. In the event any of the foregoing conditions contained in Section&nbsp;8.5 are not fulfilled or performed at or
before the Closing Date to the reasonable satisfaction of <FONT STYLE="white-space:nowrap">U-Protein</FONT> or the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders, any of <FONT STYLE="white-space:nowrap">U-Protein</FONT> or the
U-Protein Shareholders may terminate this Agreement by written notice to the other and in such event each of the Purchaser, <FONT STYLE="white-space:nowrap">U-Protein</FONT> and the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders
shall be released from all further obligations hereunder. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>SURVIVAL OF REPRESENTATIONS AND WARRANTIES</U>. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.1.&nbsp;&nbsp;&nbsp;&nbsp; The covenants, agreements, representations, warranties, and indemnities of the parties contained in this Agreement shall survive
Closing of the transactions contemplated herein and, notwithstanding Closing or any documents delivered or investigations made in connection therewith, shall continue in full force and effect for a period after Closing, provided that a claim for a
breach of any such representation or warranty, to be effective, must be asserted in writing on or prior to the applicable expiration time set out in this Section&nbsp;9.1, provided that a claim for any breach of any representations or warranties
contained in this Agreement or in any of the Transaction Documents involving fraud or fraudulent misrepresentations may be made at any time following the Closing Date, subject only to applicable limitation periods imposed by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.2.&nbsp;&nbsp;&nbsp;&nbsp; No investigations made by or on behalf of any or all of the parties to this Agreement at any time shall have the effect of
waiving, diminishing the scope of, or otherwise affecting any representation or warranty made by any other party herein or pursuant hereto. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>COVENANTS</U> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10.1.&nbsp;&nbsp;&nbsp;&nbsp; <U>U-Protein Financial Statements</U>. As soon as commercially reasonable following the Closing, the parties shall prepare and
deliver, the following financial statements of <FONT STYLE="white-space:nowrap">U-Protein</FONT> (collectively, the <FONT STYLE="white-space:nowrap">&#147;U-Protein</FONT> Financial Statements&#148;) or such further or lesser financial statements of
<FONT STYLE="white-space:nowrap">U-Protein</FONT> as the Purchaser is required to include in a business acquisition report pursuant to the provisions of Part 8 of National Instrument <FONT STYLE="white-space:nowrap">51-102-</FONT> <I>Continuous
Disclosure Obligations </I>of the Canadian Securities Administrators (&#147;NI 51-102&#148;): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Audited (i)&nbsp;statements of comprehensive income, (ii)&nbsp;statement of changes in equity and
(iii)&nbsp;statement of cash flows for each of <FONT STYLE="white-space:nowrap">U-Protein&#146;s</FONT> two most recently completed fiscal years ended prior to the Closing Date; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Audited statements of financial position as of the end of each of
<FONT STYLE="white-space:nowrap">U-Protein&#146;s</FONT> two most recently completed fiscal years ended prior to the Closing Date; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unaudited (i)&nbsp;statements of comprehensive income, (ii)&nbsp;statement of changes in equity and
(iii)&nbsp;statement of cash flows for <FONT STYLE="white-space:nowrap">U-Protein&#146;s</FONT> most recently completed three, six or nine month interim fiscal period (as applicable) ended prior to the Closing Date (if any); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unaudited statements of financial position as of the end of
<FONT STYLE="white-space:nowrap">U-Protein&#146;s</FONT> most recently completed three, six or nine month interim fiscal period (as applicable) ended prior to the Closing Date (if any); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The <FONT STYLE="white-space:nowrap">U-Protein</FONT> Financial Statements shall be prepared in accordance with
the requirements set forth in Part 8 of Nl <FONT STYLE="white-space:nowrap">51-102</FONT> and the provisions of National Instrument <FONT STYLE="white-space:nowrap">52-107</FONT> - <I>Acceptable Accounting Principles and Auditing Standards
</I>applicable thereto. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders covenant and agree to use
commercially reasonable efforts to co-operate with the auditors of the Purchaser in connection with the preparation of the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Financial Statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10.2.&nbsp;&nbsp;&nbsp;&nbsp; <U>Distribution of Excess Capital</U>. On or before the Closing Date, <FONT STYLE="white-space:nowrap">U-Protein</FONT> may
declare a dividend to distribute any cash in excess of &#128;500,000. <FONT STYLE="white-space:nowrap">U-Protein</FONT> and the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders will ensure that &#128;500,000 in cash will remain in <FONT
STYLE="white-space:nowrap">U-Protein</FONT> on the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10.3.&nbsp;&nbsp;&nbsp;&nbsp; <U>Default of Payment</U>. If the Purchaser fails to pay
or issue any payment under section 2.2(c) of this Agreement, <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders, who collectively held all of the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares prior to the Closing Date, may:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp; provide notice to the Purchaser that the Purchaser is in default of its obligations under section 2.2(c) of
this Agreement (the &#147;Event of Default&#148;); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp; require the Purchaser to remedy the Event of Default
(the &#147;Notice of Default&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Purchaser will have 90 days after receipt of the Notice of Default to remedy the Event of
Default or to commence and to thereafter diligently continue to remedy the Event of Default. If the Event of Default is not remedied or being diligently remedied by the Purchaser within 90 days of receipt of the Notice of Default, then the U-Protein
Shareholder may require the Purchaser to sell all of the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares to the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders at their fair market value provided that the fair market value
will be determined by an independent valuator selected by the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders and the Purchaser on mutual approval. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>COLLECTION OF PERSONAL INFORMATION</U> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11.1.&nbsp;&nbsp;&nbsp;&nbsp; The <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders acknowledge and consent to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the fact that the Purchaser is collecting the <FONT STYLE="white-space:nowrap">U-Protein</FONT>
Shareholders&#146; personal information (as that term is defined under applicable privacy legislation, including, without limitation, the <I>Persona/Information Protection and Electronic Documents Act </I>(Canada) and any other applicable similar,
replacement or supplemental provincial or federal legislation or laws in effect from time to time); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Purchaser will retain such personal information for as long as permitted or required by law or commercially
reasonable business practices for publicly traded entities; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the fact that the Purchaser may be required by the applicable securities laws of the applicable province, the
rules and policies of any stock exchange or the rules of the Investment Industry Regulatory Organization of Canada to provide regulatory authorities with any personal information provided under this Agreement or any of the Transaction Documents.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11.2.&nbsp;&nbsp;&nbsp;&nbsp; The <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders agree,
acknowledge and consent that the Purchaser, as the case may be, may use and disclose the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders&#146; personal information as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">for internal use with respect to managing the relationships between and contractual obligations of the
Purchaser and the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">for use and disclosure for income tax related purposes, including without limitation, where required by law,
disclosure to Canada Revenue Agency; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">for disclosure to securities regulatory authorities, the Exchange and other regulatory bodies with jurisdiction
with respect to reports of trades and similar regulatory filings; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">for disclosure to a governmental or other authority to which the disclosure is required by court order or
subpoena compelling such disclosure and where there is no reasonable alternative to such disclosure; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">for disclosure to professional advisers of the Purchaser in connection with the performance of their
professional services; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">for disclosure to any person where such disclosure is necessary for legitimate business reasons and is made
with the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders&#146; prior written consent; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">for disclosure to a court determining the rights of the parties under this Agreement or any of the Transaction
Documents; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">for use and disclosure as otherwise required or permitted by law. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11.3.&nbsp;&nbsp;&nbsp;&nbsp; The <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders authorize the indirect collection of personal information (as
defined in the applicable securities laws of the Province of Ontario) by the Ontario Securities Commission and confirms that the Seller has been notified by the Purchaser: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that the Purchaser will be delivering such personal information to the Ontario Securities Commission;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that such personal information is being collected indirectly by the Ontario Securities Commission under the
authority granted to it in the securities laws of the Province of Ontario; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that such personal information is being collected for the purpose of the administration and enforcement of the
securities laws of the Province of Ontario; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that the title, business address and business telephone number of the public official in the Province of
Ontario who can answer questions about the Ontario Securities Commission&#146;s indirect collection of personal information is as follows: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Administrative Support Clerk </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Ontario Securities Commission </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Suite 1903, Box 55, 20 Queen Street West </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Toronto, Ontario M5H 3S8 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Telephone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">416-593-3684</FONT></FONT> </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>MISCELLANEOUS</U>. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12.1.&nbsp;&nbsp;&nbsp;&nbsp; Time shall be of the essence of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12.2.&nbsp;&nbsp;&nbsp;&nbsp; This Agreement contains the whole agreement between the parties hereto in respect
of the purchase and sale of <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares and there are no warranties, representations, terms, conditions or collateral agreements expressed, implied or statutory, other than as expressly set forth in this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12.3.&nbsp;&nbsp;&nbsp;&nbsp; This Agreement may be amended or modified only by written instrument executed by each of the parties affected
thereby or by their respective successors and permitted assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12.4.&nbsp;&nbsp;&nbsp;&nbsp; This Agreement shall ensure to the benefit of and be
binding upon the parties hereto and their respective successors and permitted assigns. Neither party may assign this Agreement without the consent of the other party which consent may be withheld for any reason whatsoever. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12.5.&nbsp;&nbsp;&nbsp;&nbsp; Unless otherwise specifically provided for herein, each of <FONT STYLE="white-space:nowrap">U-Protein,</FONT> the <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Shareholders and the Purchaser shall be responsible for the expenses (including fees and expenses of legal advisors, accountants and other advisors) incurred by them, respectively, in connection with the
negotiation and settlement of this Agreement and the completion of the transactions contemplated hereby. In the event of a termination of this Agreement prior to consummation of the transactions contemplated hereby, the obligation of each party to
pay its own expenses will be subject to any rights that such party may have arising from a breach of this Agreement by another party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12.6.&nbsp;&nbsp;&nbsp;&nbsp; Neither this Agreement nor any right or obligation hereunder shall be assignable by any of the parties hereto without the prior
written consent of each of the other parties hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12.7.&nbsp;&nbsp;&nbsp;&nbsp; Any notice to be given under this Agreement shall be duly and properly
given if made in writing and delivered or facsimiled to the addressee at the address as set out on page one of this Agreement for each of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and the Purchaser, and for each of the <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Shareholders, at the address set forth on such <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder&#146;s signature page to this Agreement. Any notice given as aforesaid shall be deemed to have
been given or made on, if delivered, the date on which it was delivered or, if facsimiled, on the next business day after it was facsimiled. Any party hereto may change its address for notice from time to time by providing notice of such change to
the other parties hereto in accordance with the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12.8.&nbsp;&nbsp;&nbsp;&nbsp; This Agreement may be executed in one or more counter-parts,
each of which so executed shall constitute an original and all of which together shall constitute one and the same agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12.9.&nbsp;&nbsp;&nbsp;&nbsp; With the exception of the provisions of the Deed of Warranty, this Agreement shall be construed and enforced in accordance with,
and the rights of the parties shall be governed by, the laws of the Province of British Columbia, and each of the parties hereto irrevocably attorns to the jurisdiction of the courts of the Province of British Columbia. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>13.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13.1.&nbsp;&nbsp;&nbsp;&nbsp; No claim shall be
made by <FONT STYLE="white-space:nowrap">U-Protein</FONT> or any of the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders against the Purchaser, or by the Purchaser against <FONT STYLE="white-space:nowrap">U-Protein</FONT> or any of the
<FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders, as a result of any misrepresentation or as a result of the breach of any covenant or warranty herein contained unless the aggregate loss or damage to such party exceeds $5,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13.2.&nbsp;&nbsp;&nbsp;&nbsp; <FONT STYLE="white-space:nowrap">U-Protein</FONT> managers may take one Board of Director position after closing to be
determined by <FONT STYLE="white-space:nowrap">U-Protein</FONT> when appropriate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF </B>the parties hereto have executed this Agreement as of the day and year first above
written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>IMMUNOPRECISE ANTIBODIES LTD.</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">by its authorized signatory:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g20o84.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Thomas D&#146;Orazio</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CEO and Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B><FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> EXPRESS B.V.</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">On its behalf PodiCeps B.V., on its behalf</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Bionomics B.V. by its authorized signatory:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">*</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Martin Hessing</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF </B>the parties hereto have executed this Agreement as of the day and year first above
written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>IMMUNOPRECISE ANTIBODIES LTD.</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">by its authorized signatory:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Thomas D&#146;Orazio</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CEO and Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B><FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> EXPRESS B.V.</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">On its behalf PodiCeps B.V., on its behalf</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Bionomics B.V. by its authorized signatory:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g12b66.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">*</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Martin Hessing</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> SHAREHOLDER SIGNATURE PAGE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">to that Share Exchange Agreement </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">dated the 10 day of August, 2017 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">in the presence of:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>BIONOMICS B.V.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g37l23.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g66d01.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signature of Witness</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Martin Hessing</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g46r96.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="67%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of Shares:</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Address of Shareholder:</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder&#146;s Jurisdiction of Residence:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">


<IMG SRC="g20922sp1659.jpg" ALT="LOGO">
</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>U-PROTEIN SHAREHOLDER SIGNATURE PAGE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">to that Share Exchange Agreement </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">dated the 10 day of August, 2017 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">in the presence of:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>UNIVERSITEIT UTRECHT HOLDING BV</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g96r61.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g75f04.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signature of Witnesss</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Name: </B>O. Schoots, Director<B></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g53s83.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="65%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Number of Shares:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">7,200</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address of Shareholder:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Yalelaan 40, 3584 CM Utrecht</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Shareholder&#146;s Jurisdiction of Residence:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">The Netherlands</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> SHAREHOLDER SIGNATURE PAGE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">to that Share Exchange Agreement </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">dated the 10 day of August, 2017 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">in the presence of:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><B>Wieger Hemrika</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signature of Witness</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>WEIGER HEMRIKA</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">


<IMG SRC="g20922g04e69.jpg" ALT="LOGO">
</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="65%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Number of Shares:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3,600</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address of Shareholder:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Kattenburgerhof 52 1018KD </TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Shareholder&#146;s Jurisdiction of Residence:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Amsterdam</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> SHAREHOLDER SIGNATURE PAGE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">to that Share Exchange Agreement </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">dated the 10 day of August, 2017 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">*</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">in the Presence of:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g89x17.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g10u33.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signature of Witness</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">ROLAND ROMIJN</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Monique Kuipers</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="69%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of shares:</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Address of Shareholder:</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shareholder&#146;s&nbsp;Jurisdiction&nbsp;of&nbsp;Residence:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">


<IMG SRC="g20922gra0439.jpg" ALT="LOGO">
</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE 2.1</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">to that Share Exchange Agreement </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">dated the 10 day of August, 2017 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U><FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders </U></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B><FONT STYLE="white-space:nowrap">U-Protein</FONT>
Shareholder</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>No.&nbsp;of&nbsp;Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Class&nbsp;of&nbsp;U-Protein</FONT><BR>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Universiteit Utrecht Holding BV</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Ordinary&nbsp;shares</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bionomics BV</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Ordinary shares</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Wieger Hemrika</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Ordinary shares</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Roland Romijn</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Ordinary shares</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>18,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE 4.3 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">to that Share Exchange Agreement </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">dated the 10 day of August, 2017 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Share Capitalization of <FONT STYLE="white-space:nowrap">U-Protein</FONT> </U></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Designation of Security</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount&nbsp;Authorized</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount&nbsp;Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Unlimited</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share Purchase Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Not&nbsp;Applicable</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Nil</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock Options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Not Applicable</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Nil</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE 4.14 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">to that Share Exchange Agreement </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">dated the 10 day of August, 2017 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Material Contracts of <FONT STYLE="white-space:nowrap">U-Protein</FONT> </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="white-space:nowrap">U-Protein</FONT> has committed in cash and in kind contribution in a number of subsidy projects for a total
obligation of 31.000 euro. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="white-space:nowrap">U-protein</FONT> has a number of distributor arrangements in place </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="white-space:nowrap">U-protein</FONT> has a rent agreement within the Life Science Building that comprises of a part of the
infrastructure to be paid in the rent during a 10 year period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE 4.19 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">to that Share Exchange Agreement </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">dated the 10<I> </I>day of August, 2017 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Premises of <FONT STYLE="white-space:nowrap">U-Protein</FONT> </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">U-Protein</FONT> has hired laboratories and offices in the Life Science Building at the Utrecht Science Park at the Yalelaan
62, 3584 CM, Utrecht, The Netherlands for a period of 3 years and can be prolonged each year. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE 4.20 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">to that Share Exchange Agreement </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">dated the 10 day of August<I></I>, 2017 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Intellectual Property </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">U-Protein</FONT> has no patents, patent applications, registered trademarks active. <FONT STYLE="white-space:nowrap">U-protein</FONT> therefore believes that it has no Intellectual Property rights with the exception of
trade secrets, copyright and other proprietary rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="white-space:nowrap">U-protein</FONT> has constructed prior to the
inception of the company and in the course of running <FONT STYLE="white-space:nowrap">U-protein</FONT> a large number of expression vectors for particular cell lines that <FONT STYLE="white-space:nowrap">U-protein</FONT> considers as her
proprietary tools. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Licenses Granted on the Intellectual Property </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">U-Protein</FONT> has 2 license agreement with lmmunoprecise Antibodies (Victoria, Canada) and Argenix (Gent, Belgium) in
place that enables these customers to make use of the <FONT STYLE="white-space:nowrap">U-protein</FONT> vectors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE 5.2 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">to that Share Exchange Agreement </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">dated the 10 day of August, 2017 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Subsidiaries of Purchaser </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">0496106 B.C. Ltd. (private company formerly lmmunoPrecise Antibodies Ltd.) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE 5.3 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">to that Share Exchange Agreement </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">dated the 10 day of August, 2017 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Share Capitalization of the Purchaser </U></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Designation of Security</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount&nbsp;Authorized</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount&nbsp;Outstanding</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Unlimited</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">38,578,522</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share Purchase Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Not&nbsp;Applicable</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Nil</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock Options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Not Applicable</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">1,955,000</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 6 - WARRANTY DEED </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">to that Share Exchange Agreement </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">dated the 10 day of August, 2017 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(See Attached) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DATED <U></U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2017 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>as the Purchaser </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNIVERSITEIT UTRECHT HOLDING B.V. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BIONOMICS B.V. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WIEGER
HEMRIKA </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ROLAND A.P. ROMIJN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>as the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> EXPRESS B.V. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>as the Company </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WARRANTY DEED
RELATING TO THE SHARE EXCHANGE AGREEMENT FOR THE </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SALE AND PURCHASE OF THE ENTIRE SHARE CAPITAL OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> EXPRESS B.V. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CONTENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">DEFINITIONS AND INTERPRETATION</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">WARRANTIES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3&middot;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">LIABILITY</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4&middot;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">MISCELLANEOUS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5&middot;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">GOVERNING LAW AND JURISDICTION</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SCHEDULE 1: <FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> SHAREHOLDERS&#146;
WARRANTIES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SCHEDULE 2: COMPANY&#146;S WARRANTIES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SCHEDULE 3: LIMITATIONS ON LIABILITY</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SCHEDULE 4: DATA ROOM DVD</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THIS WARRANTY DEED </B>is made on
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2017, </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BETWEEN: </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>IMMUNOPRECISE ANTIBODIES LTD.,</B> a company duly formed under the laws of the Province of British Columbia,
with its principal office located at Unit 3204, 4464 Markham Street, Victoria, BC V8Z 7X8 (the <B>Purchaser);</B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>UNIVERSITEIT UTRECHT HOLDING B.V.,</B><B></B><B> a </B>private company with limited liability <I>(besloten
vennootschap met beperkte aansprakelijkheid) </I>incorporated under the laws of the Netherlands, having its corporate seat in Utrecht, the Netherlands and its registered address at Yalelaan 40, 3584 CM, Utrecht the Netherlands, registered with the
trade register <I>(handelsregister) </I>of the Chamber of Commerce <I>(Kamer van Koophandel) </I>under number 30147272 <B>(University Utrecht);</B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>BIONOMICS B.V., </B>a private company with limited liability <I>(besloten vennootschap met beperkte
aansprakelijkheid) </I>incorporated under the laws of, the Netherlands, having its corporate seat in Houten, the Netherlands and its registered address at Hazenakker 18, 3994 EJ, Houten, the Netherlands, registered with the trade register
(handelsregister) of the Chamber of Commerce <I>(Kamer van Koophandel) </I>under number 30166792 <B>(Bionomics);</B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>WIEGER HEMRIKA., </B>a private individual residing at Kattenbruggerhof 52, 1018 KD Amsterdam, holder of a
passport with number NT35F36B9 <B>(Hemrika);</B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ROLAND A.P. ROMIJN., </B>a private individual residing at Meester Tydemanstraat 234001 CR Tiel married with
Mrs.&nbsp;MJHM Kuipers, born on <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-06-1969</FONT></FONT> te Idaarderadeel, holder of a passport with number NUJ33LHJ7 <B>(Romijn); </B>and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> EXPRESS B.V.,</B><B></B><B> </B>a private company with
limited liability <I>(besloten vennootschap met beperkte aansprakelijkheid) </I>incorporated under the laws of the Netherlands, having its corporate seat in Utrecht, the Netherlands and its registered address at Life Sciences Incubator, Utrecht
Science Park, Yalelaan, 62, 3584 CM, Utrecht, The Netherlands, registered with the trade register of the Chamber of Commerce under number 30230407 <B>(the Company).</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">University Utrecht, Bionomics, Hemrika and Romijn are hereinafter jointly also referred to as the U-<B>Protein Shareholders </B>and each as <B>a <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Shareholder. </B>The <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders and the Company are hereinafter jointly also referred to as the <B>Warrantors </B>and each as a Warrantor. The Purchaser
and the Warrantors are hereinafter jointly also referred to as the <B>Parties </B>and each as a <B>Party.</B> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>WHEREAS: </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On the date of this Deed, the Purchaser, the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders and
the Company entered into the SEA (as defined below). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In connection with entering into the SEA, the Warrantors agreed to give the Warranties on the terms set out in
this Deed. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IT IS AGREED AS FOLLOWS: </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DEFINITIONS AND INTERPRETATION </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Schedules form part of this Deed and have the same force and effect as if set out in the body of this Deed.
Any reference to this Deed includes the Schedules. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In this Deed, words and expressions defined and interpretations included in clause 1 of the SEA have the same
meanings and interpretations, unless otherwise defined in this Deed or the context requires otherwise. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In this Deed, unless the context otherwise requires: </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="60%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Breach:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">has the meaning as defined in clause 3.1.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Claim:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">has the meaning as defined in clause 3.2.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Company&#146;s Warranties:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">has the meaning as defined in clause 2.2.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Losses:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">means any damages (including Taxes) suffered by the Purchaser or the Company arising out of or in connection with this Deed, as determined on the basis of sections 6:95 and 6:96 of the Dutch Civil Code.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>SEA:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">means the share exchange agreement between the Warrantors, the Purchaser and the Company dated on the date of this Deed.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B><FONT STYLE="white-space:nowrap">U-Protein&nbsp;Shareholders&#146;&nbsp;Warranties:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">has the meaning as defined in clause 2.1.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Warranties:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">means the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders&#146; Warranties and the Company&#146;s Warranties.</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any Warranty qualified by the expression &#145;to the U-Protein Shareholders&#146; knowledge&#146; or &#145;to
the Warrantors&#146; knowledge&#146; or &#145;so far as the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders are aware&#146; or &#145;so far as the Warrantors are aware&#146; or any similar expression shall be deemed to comprise such
knowledge, information, belief, awareness or knowledge that each Warrantor actually <I>(jeitelijk) </I>has or is deemed to have on the basis of due and careful consideration and diligent enquiry, enquiry in his/its capacity as a manager/employee
and/or, as the case may be, shareholder of the Company, of all employees within the Company that reasonably would be expected to have knowledge of the relevant matters. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>WARRANTIES</B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder, for itself and no other <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Shareholder, hereby covenants, represents and warrants with and to the Purchaser that each of the statements and representation set forth in <B>Schedule 1 </B>to this Deed (the <B><FONT
STYLE="white-space:nowrap">U-Protein</FONT> Shareholders&#146;</B> <B>Warranties) </B>are true and accurate as per the date of signing of this Deed and Closing. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company hereby covenants, represents and warrants with and to the Purchaser that each of the statements and
representation set forth in <B>Schedule 2 </B>to this Deed (the <B>Company&#146;s Warranties) </B>are true and accurate as per the date of signing of this Deed and Closing. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>LIABILITY</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the limitations as set out in <B>Schedule 3, </B>the
<FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders shall be liable towards the Purchaser in the event the Warranties are not true and accurate at the signing date and the Completion Date (a <B>Breach).</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders are liable towards the Purchaser:
(a)&nbsp;pursuant to a claim in relation to a Warranty Breach <B>(Claim); </B>or (b)&nbsp;for a breach (before or after Completion) of this Deed, the Purchaser shall have the right to claim the Losses suffered as a result. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>MISCELLANEOUS</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The applicability of sections 7:17 and 7:20 up to and including 7=23 DCC is hereby excluded
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">None of the rights or obligations under this Deed may be assigned or transferred without the prior written
consent of all of the Parties. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="white-space:nowrap">4-3</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Deed may be entered into in any number of counterparts, all of which taken together shall constitute one
and the same instrument. The Parties may enter into this Deed by signing any such counterpart. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="white-space:nowrap">4-4</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No waiver of any provision of this Deed shall be effective unless such waiver is in writing and signed by or on
behalf of the Party entitled to make such waiver. In addition, no failure to exercise, nor any delay in exercising, on the part of a Party, any right or remedy under this Deed shall operate as a waiver, nor shall any single or partial exercise of
any right or remedy prevent any further or other exercise or the exercise of any other right or remedy. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="white-space:nowrap">4-5</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No amendment of this Deed shall be effective unless such amendment is in writing and signed by or on behalf of
each of the Parties. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each Party waives its right to rescind <I>(ontbinden) </I>this Deed, in whole or in part, on the basis of
section 6:265 of the Dutch Civil Code or to request a competent court to amend this Deed on the basis of section 6:230(2) of the Dutch Civil Code. Furthermore, a Party in error <I>(dwaling) </I>shall bear the risk of that error in making this Deed.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="white-space:nowrap">4-7</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any notice in connection with this Deed shall be in writing in English and delivered by hand, registered post
or courier using an internationally recognised courier company, to the addresses specified on the first page or such other address as a Party may inform the other Parties in writing, or by email. A notice shall be effective upon receipt and shall be
deemed to have been received: (i)&nbsp;at the time of delivery, if delivered by hand, registered post or courier; or (ii)&nbsp;if delivered by email at the time of sending. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>GOVERNING LAW AND JURISDICTION</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Governing law</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">This Deed and any dispute, controversy or claim arising hereunder or in connection herewith, its subject matter or formation (including any
dispute or claim relating to <FONT STYLE="white-space:nowrap">non-contractual</FONT> obligations) shall be governed by and construed in accordance with the laws of the Netherlands. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Jurisdiction and forum</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">Any dispute, controversy or claim arising from or connected with this Deed, including one regarding the existence, validity or termination of
this Deed or the consequences of its nullity and any <FONT STYLE="white-space:nowrap">non-contractual</FONT> or other dispute (a <B>Dispute) </B>shall be referred to and finally resolved by arbitration in the Netherlands in accordance with the
arbitration rules of the Netherlands Arbitration Institute <I>(Nederlands Arbitrage Instituut) </I>taking into account the following (the <B>Rules), </B>taking into account the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the arbitral tribunal shall consist of three arbitrators of which at least one (1)&nbsp;shall be a lawyer with
a Netherlands law degree or admitted to practise Netherlands law, each of them appointed in accordance with the Rules. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the arbitral tribunal shall decide in accordance with the rules of law <I>(naar de regelen des rechts).</I>
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.2.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the seat of the arbitration shall be Amsterdam, the Netherlands and the language of the arbitration shall be
English. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.2.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Parties waive any right to refer points of law to appeal to the courts, to the extent that such waiver can
validly be made. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.2.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Parties agree that the arbitral tribunal shall have the power to order on a provisional basis any relief
which it would have power to grant in a final award. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[signature page follows] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS</B> whereof the Parties have executed this Deed on the date which appears first on the first
page. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">On&nbsp;behalf&nbsp;of&nbsp;<B>IMMUNOPRECISE&nbsp;ANTIBODIES </B><B>LTD</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">On&nbsp;behalf&nbsp;of&nbsp;<B>UNIVERSITEIT&nbsp;UTRECHT&nbsp;HOLDING&nbsp;B.V.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">On behalf of <B>BIONOMICS B.V.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>WIEGER HEMRIKA</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>ROLAND ROMIJN</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Signature page Warranty Deed </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>The undersigned: </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mrs.&nbsp;MJHM Kuipers,, residing at the Meester Tydemanstraat 23 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4001 CR in Tiel, born in te Idaarderadeel, the Netherlands, on <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-06-1969,</FONT></FONT>
married to Mr.&nbsp;R. Romijn, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>herewith declares</U> to grant her unconditional consent as referred to in article 88 paragraph 1, Book 1 of the Dutch
Civil Code to the obligations of her husband, Mr.&nbsp;R. Romijn, pursuant to this Warranty Deed </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Signed in
<U></U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>2017 </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SCHEDULE 1: <FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> SHAREHOLDERS&#146; WARRANTIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder, for itself and no other <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder,
hereby covenants, represents and warrants with and to the Purchaser as follows, and acknowledges that the Purchaser is relying on such covenants, representations and warranties in connection with the purchase of the U-Protein Shares: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Such <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder owns that number of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Shares set forth next to its name in Schedule 2.1 to the SEA hereto, as the beneficial and recorded owner thereof, with good and marketable title thereto, free and clear of all mortgages, liens, charges,
security interests, adverse claims, pledges, encumbrances and demands whatsoever, with full right, power and authority to sell, transfer and deliver the same to the Purchaser upon Closing, and such U-Protein Shares are not subject to any
shareholders&#146; agreement, voting trust agreement or similar agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If an individual, such <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder is of legal capacity and
age, and has all necessary power and authority to enter into the Transaction Documents and to carry out its, his or her obligations under the Transaction Documents. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If an entity other than an individual, such U-Protein Shareholder is an entity duly incorporated or formed,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company or similar power and authority to enter into and to consummate the
transactions contemplated by the Transaction Documents otherwise to carry out its obligations thereunder. The execution and delivery of each of the Transaction Documents and performance by such <FONT STYLE="white-space:nowrap">U-Protein</FONT>
Shareholder of the transactions contemplated therein have been duly authorized by all necessary corporate, partnership, limited liability company or similar action, as applicable, on the part of such U-Protein Shareholder. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">14</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No Person has any agreement or option or any right or privilege (whether by law,
<FONT STYLE="white-space:nowrap">pre-emptive</FONT> or contractual) capable of becoming an agreement or option for the purchase from such U-Protein Shareholder of any of the U-Protein Shares held by it. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each of the Transaction Documents has been duly executed by such
<FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder, and when delivered by such <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder in accordance with the terms thereof, will constitute the valid and legally binding obligation of
such <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder, enforceable against it in accordance with its terms, except: (i)&nbsp;as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors&#146; rights generally, (ii)&nbsp;as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii)&nbsp;insofar
as indemnification and contribution provisions may be limited by applicable law. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Such <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder represents that it has no right or claims
whatsoever to any shares in the capital of, or any other equity or ownership interest in, <FONT STYLE="white-space:nowrap">U-Protein</FONT> other than those U- Protein Shares set forth next to its name in Schedule 2.1 to the SEA, and does not have
any </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
options, warrants, or any other instruments or rights entitling such <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder to exercise, purchase, convert or otherwise acquire any shares
in the capital of, or any other equity or ownership interest in, <FONT STYLE="white-space:nowrap">U-Protein.</FONT> </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The execution and delivery of the Transaction Documents and the consummation of the transactions contemplated
hereby or thereby will not, in any material respect: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Violate, be in conflict with, result in any breach of, constitute a default, or cause the acceleration of any
obligation of such <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder, under: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any agreement, instrument, license, permit or authority to which such U-Protein Shareholder is, or is entitled
to be, a party or to which the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares are subject, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any judgment, decree, order, statute, rule or regulation applicable to such U-Protein Shareholder,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any provision of law or regulation of any Governmental Body or any judicial or administrative order, award,
judgment or decree applicable to such U-Protein Shareholder, or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any provision of the constating documents, articles, <FONT STYLE="white-space:nowrap">by-laws,</FONT>
partnership agreement, resolutions, or other governing documents of such <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder, if not an individual, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Result in the creation of any Lien upon any or all of the <FONT STYLE="white-space:nowrap">U-Protein</FONT>
Shares under any agreement or instrument whatsoever; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Give to any person any material interest or rights that have not been waived prior to the date hereof,
including <FONT STYLE="white-space:nowrap">pre-emptive</FONT> or preferential rights of purchase of any part or all of the U-Protein Shares, or any right of termination, cancellation or acceleration under any agreement, instrument, license, permit
or authority referred to in Section&nbsp;1.7(a)(i); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No permits, licenses, certifications, approvals, consents, or other action of a Governmental Body is required
for the execution, delivery or performance by such <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder of the Transaction Documents or the transactions contemplated hereby or thereby. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Such <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder is not a &#147;U.S. person&#148; as that
term is defined in Rule 901(k) of Regulation S promulgated under the United States Securities Act of 1933; such <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder was not in the United States at the time it received the offer to acquire
the Purchaser Shares; and such <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder was not in the United States at the time such <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder decided to acquire the Purchaser Shares or at
the time such <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder executed this Deed. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Such <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder acknowledges and agrees that:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">no securities commission or similar regulatory authority or other Governmental Body has reviewed or passed on
the merits of the Purchaser Shares; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">there is no government or other insurance covering the Purchaser Shares; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">there are risks associated with the purchase of the Purchaser Shares; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">there are restrictions on such <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder&#146;s ability to
resell the Purchaser Shares and it is the responsibility of such U-Protein Shareholder to find out what those restrictions are and to comply with them before selling the Purchaser Shares; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Purchaser has advised such <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder that the Purchaser
is relying on an exemption from the requirements to provide such <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder with a prospectus and to sell securities through a person registered to sell securities under the <I>Securities Act
</I>(British Columbia) and, as a consequence of acquiring securities pursuant to this exemption, certain protections, rights and remedies provided by the <I>Securities Act </I>(British Columbia), including statutory rights of rescission or damages,
will not be available to such <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each U-Protein Shareholder is acquiring the Purchaser Shares for its own account, &middot;for investment
purposes only and not with a view to resale or distribution or other disposition of the Purchaser Shares in violation to applicable securities laws. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder has been advised to consult with its own
legal, tax and other advisors with respect to the merits of the acquisition of the Purchaser Shares and applicable resale restrictions, and each <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder is solely responsible for compliance with
applicable resale restrictions with respect to the Purchaser Shares. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SCHEDULE 2: COMPANY&#146;S WARRANTIES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">U-Protein</FONT> hereby covenants, represents and warrants with and to the Purchaser as follows, and acknowledges that the
Purchaser is relying on such covenants, .representations and warranties in connection with the purchase of the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Organization and Qualification</U>. <FONT STYLE="white-space:nowrap">U-Protein</FONT> is an entity duly
incorporated or otherwise organized, validly existing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently
conducted. <FONT STYLE="white-space:nowrap">U-Protein</FONT> is neither in violation nor in default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents. <FONT
STYLE="white-space:nowrap">U-Protein</FONT> is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such
qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in: (i)&nbsp;a material adverse effect on the legality, validity or enforceability of
any Transaction Document, (ii)&nbsp;a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of <FONT STYLE="white-space:nowrap">U-Protein,</FONT> taken as a whole, or (iii)&nbsp;a
material adverse effect on <FONT STYLE="white-space:nowrap">U-Protein&#146;s</FONT> ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), being a &#147;Material
Adverse Effect&#148;) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Subsidiaries, Partnerships and Joint Ventures</U>. <FONT STYLE="white-space:nowrap">U-Protein</FONT> does
not have any subsidiaries or agreements of any nature to acquire any subsidiary or to acquire or lease any other business operations and will not prior to the Closing Date acquire, or agree to acquire, any subsidiary or business without the prior
written consent of the Purchaser. <FONT STYLE="white-space:nowrap">U-</FONT> Protein is not a partner or a participant in any partnership, joint venture, profit sharing arrangement or other association of any kind, including as a beneficiary or
trustee in any trust arrangement and is not party to any agreement under which <FONT STYLE="white-space:nowrap">U-Protein</FONT> agrees to carry on any part of its business or any other activity in such manner or by which <FONT
STYLE="white-space:nowrap">U-Protein</FONT> agrees to any revenue or profit sharing arrangement </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Capitalization</U>. The capitalization of <FONT STYLE="white-space:nowrap">U-Protein</FONT> is as set forth
on Schedule <FONT STYLE="white-space:nowrap">4-3</FONT> to the SEA, and Schedule 2.1 to the SEA sets forth the number of <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares owned beneficially, and of record, by the <FONT
STYLE="white-space:nowrap">U-</FONT> Protein Shareholders as of the date hereof. Except as set forth on Schedule <FONT STYLE="white-space:nowrap">4-3</FONT> to the SEA, <FONT STYLE="white-space:nowrap">U-Protein</FONT> has not issued any capital
stock. No Person has any right of first refusal, <FONT STYLE="white-space:nowrap">pre-emptive</FONT> right, right of participation, or any similar right granted by <FONT STYLE="white-space:nowrap">U-</FONT> Protein to participate in the transactions
contemplated by the Transaction Documents. Except as set out in Schedule <FONT STYLE="white-space:nowrap">4-3</FONT> to the SEA, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character
whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire any shares in the capital stock, or contracts, commitments, understandings
or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
arrangements by which <FONT STYLE="white-space:nowrap">U-Protein</FONT> is or may become bound to issue additional shares in the capital stock of <FONT STYLE="white-space:nowrap">U-Protein</FONT>
or <FONT STYLE="white-space:nowrap">U-Protein</FONT> Share Equivalents. The consummation of the transactions contemplated under the Transaction Documents will not obligate <FONT STYLE="white-space:nowrap">U-Protein</FONT> to issue interests in the
share capital of <FONT STYLE="white-space:nowrap">U-Protein</FONT> or other securities to any Person (other than the Purchaser) and will not result in a right of any holder of <FONT STYLE="white-space:nowrap">U-Protein</FONT> securities to adjust
the exercise, conversion, exchange or reset price under any of such securities. All of the outstanding shares of <FONT STYLE="white-space:nowrap">U-Protein&#146;s</FONT> share capital are duly authorized, validly issued, fully paid and <FONT
STYLE="white-space:nowrap">non-assessable,</FONT> have been issued in compliance with all applicable laws, and none of such outstanding shares was issued in violation of any <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights or similar
rights to subscribe for or purchase securities. On the Closing Date no further approval or authorization of any shareholder, the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Directors or others will be required to complete the transactions
contemplated under the Transaction Documents. There are no shareholders agreements, voting agreements or other similar agreements with respect to <FONT STYLE="white-space:nowrap">U-Protein&#146;s</FONT> share capital to which <FONT
STYLE="white-space:nowrap">U-Protein</FONT> is a party or, to the knowledge of <FONT STYLE="white-space:nowrap">U-Protein,</FONT> between or among any of the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Ownership of <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shares</U>. The <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Shareholders are the sole registered owners, and to the knowledge of <FONT STYLE="white-space:nowrap">U-Protein,</FONT> the sole legal and beneficial owners, of all of the issued and outstanding <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Shares, in the amounts set forth next to their respective names as set out on Schedule 2.1 to the SEA. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Authorization; Enforcement</U>. <FONT STYLE="white-space:nowrap">U-Protein</FONT> has the requisite
corporate power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents Agreement and each of the other Transaction Documents and otherwise to carry out its obligations thereunder. On the Closing
Date, the execution and delivery of the Transaction Documents by <FONT STYLE="white-space:nowrap">U-Protein</FONT> and the consummation by it of the transactions contemplated thereby will be duly authorized by all necessary action on the part of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> and no further action will be required by <FONT STYLE="white-space:nowrap">U-Protein,</FONT> the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Directors or the
<FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders in connection herewith or therewith other than in connection with the Required Approvals. Each of the Transaction Documents to which <FONT STYLE="white-space:nowrap">U-Protein</FONT> is
a party, has been (or upon delivery will have been) duly executed by <FONT STYLE="white-space:nowrap">U-Protein</FONT> and, when delivered in accordance with the terms thereof, will constitute the valid and binding obligation of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> enforceable against <FONT STYLE="white-space:nowrap">U-Protein</FONT> in accordance with its terms, except: (i)&nbsp;as limited by general equitable principles and applicable bankruptcy, insolvency,
reorganization, moratorium and other laws of general application affecting enforcement of creditors&#146; rights generally, (ii)&nbsp;as limited by laws relating to the availability of specific performance, injunctive relief or other equitable
remedies and (iii)&nbsp;insofar as indemnification and contribution provisions may be limited by applicable law. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>No Conflicts</U>. The execution, delivery and performance by
<FONT STYLE="white-space:nowrap">U-Protein</FONT> of the Transaction Documents to which it is a party and the consummation by it of the transactions contemplated thereby do not and will not: (i)&nbsp;conflict with or violate any provision of <FONT
STYLE="white-space:nowrap">U-Protein&#146;s</FONT> certificate or articles of incorporation, bylaws or other organizational or charter documents, (ii)&nbsp;could result in the creation of any Lien upon any of the properties or assets of <FONT
STYLE="white-space:nowrap">U-Protein,</FONT> or (iii) </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental
authority to which <FONT STYLE="white-space:nowrap">U-Protein</FONT> is subject (including federal and state securities laws and regulations), or by which any property or asset of <FONT STYLE="white-space:nowrap">U-Protein</FONT> is bound or
affected; except in the case of each of clauses (ii)&nbsp;and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Filings. Consents and Approvals</U>. <FONT STYLE="white-space:nowrap">U-Protein</FONT> is not required to
obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery
and performance by <FONT STYLE="white-space:nowrap">U-Protein</FONT> of the Transaction Documents, other than consents, waivers, authorizations, orders, notices, filings or registrations necessary in connection with the Required Approvals.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Books and Records</U>. The books and records of <FONT STYLE="white-space:nowrap">U-Protein</FONT> fairly and
correctly set out and disclose in all material respects, in accordance with Dutch GAAP, the financial position of <FONT STYLE="white-space:nowrap">U-Protein</FONT> as at the date hereof, and all material financial transactions of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> relating to the Business have been accurately recorded in such books and records. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Corporate Records</U>. The corporate records and minute books of
<FONT STYLE="white-space:nowrap">U-Protein</FONT> contain complete and accurate copies of their respective constating documents, minutes of all meetings and resolutions of the directors or managers (including any committees thereof) and shareholders
of <FONT STYLE="white-space:nowrap">U-Protein,</FONT> respectively, and the share certificate books, register of shareholders, register of transfers and register of directors or managers of <FONT STYLE="white-space:nowrap">U-Protein</FONT> are
complete and accurate in all material respects. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Officers and Directors</U>. The officers and directors of <FONT STYLE="white-space:nowrap">U-Protein</FONT>
are as follows: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Position</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PodiCeps&nbsp;B.V.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director&nbsp;<I>(bestuurder)<BR></I></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U><FONT STYLE="white-space:nowrap">U-Protein</FONT> Financial Statements</U>. At the Closing Date, the <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Financial Statements will have been prepared in accordance with local GAAP and will present fairly the assets, liabilities and the financial position of <FONT STYLE="white-space:nowrap">U-Protein</FONT> as
at the dates indicated and the results of operation of <FONT STYLE="white-space:nowrap">U-Protein</FONT> for the periods indicated and no Material Adverse Effect in such financial position or such results of operation has occurred since the dates
thereof. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>No Material Changes</U>. Since December 31, 2016, <FONT STYLE="white-space:nowrap">U-Protein&#146;s</FONT>
Business has been carried on in the normal course and: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">except in accordance with terms of this Transaction, no dividend or other distribution on any shares in the
capital of <FONT STYLE="white-space:nowrap">U-Protein</FONT> has been made, declared or authorized and <FONT STYLE="white-space:nowrap">U-Protein</FONT> has neither purchased nor redeemed nor agreed to purchase or redeem any of the shares in its
capital; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">no payment of any kind has been made or authorized to or on behalf of any of the
<FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders or to or on behalf of officers, directors or shareholders of <FONT STYLE="white-space:nowrap">U-Protein;</FONT> and <FONT STYLE="white-space:nowrap">U-Protein</FONT> has not paid or
agreed to pay any compensation, pension, bonus, share of profits or other benefit to, or for the benefit of, any employee, director or officer of <FONT STYLE="white-space:nowrap">U-Protein</FONT> except in the ordinary course of business and has not
increased or agreed to increase the compensation of any director, officer or management employee except in the ordinary course of business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">there has to the Warrantors&#146; knowledge riot been any material adverse change in the financial position or
condition of <FONT STYLE="white-space:nowrap">U-Protein</FONT> or any damage, loss or other material adverse change in circumstances affecting <FONT STYLE="white-space:nowrap">U-Protein&#146;s</FONT> Business or its right or capacity to carry on
business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">U-Protein</FONT> has not transferred, assigned, sold or otherwise disposed of
any of its assets except in the ordinary course of business and has not mortgaged, pledged, subjected to lien, granted a security interest in or otherwise encumbered any of its assets; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">has not discharged or satisfied any Lien or paid any obligation or liability (fixed or contingent) other than
liabilities included in the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Financial Statements and liabilities incurred since December 31, 2016 in the ordinary course of business; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">U-</FONT> Protein has not suffered an extraordinary loss, or waived any rights
of material value, or entered into any material commitment or transaction not in the ordinary course of business; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">U-Protein</FONT> has not incurred or assumed any obligation or liability
(fixed or contingent), except secured and unsecured current obligations and liabilities incurred in the ordinary course of business. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Sole Business</U>. The Business is the only business which has been or is currently conducted by <FONT
STYLE="white-space:nowrap">U-Protein.</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.14.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Material Contracts and Capital Commitments</U>. Schedule 1.13 to the SEA sets forth the material agreements,
contracts, mortgages, indentures and leases to which <FONT STYLE="white-space:nowrap">U-Protein</FONT> is a party or to which it is bound (each, an <FONT STYLE="white-space:nowrap">&#147;U-Protein</FONT> Material Contract&#148; and collectively, the
<FONT STYLE="white-space:nowrap">&#147;U-Protein</FONT> Material Contracts&#148;). Each <FONT STYLE="white-space:nowrap">U-Protein</FONT> Material Contract is valid and binding and is in full force and effect, and
<FONT STYLE="white-space:nowrap">U-Protein</FONT> has not, nor to <FONT STYLE="white-space:nowrap">U-Protein&#146;s</FONT> knowledge has any third party, breached any material provision of, or is in default under the terms of, any such <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Material Contract. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.15.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Litigation</U>. There is no action, suit, inquiry, notice of violation, proceeding or investigation pending
or, to the knowledge of <FONT STYLE="white-space:nowrap">U-Protein,</FONT> threatened against or affecting <FONT STYLE="white-space:nowrap">U-Protein</FONT> or any of its properties before or by any court, arbitrator, governmental or administrative
agency or regulatory authority (federal, state, county, local or foreign) (collectively, an &#147;<U>Action</U>&#148;) which (i)&nbsp;adversely affects or challenges the legality, validity or enforceability of any of the Transaction
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Documents or the transactions contemplated therein or (ii)&nbsp;could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither <FONT
STYLE="white-space:nowrap">U-Protein</FONT> nor any director or officer thereof is or has been the subject of any Action involving a claim of violation of or liability under applicable securities laws or a claim of breach of fiduciary duty. There
has not been, and to the knowledge of <FONT STYLE="white-space:nowrap">U-Protein,</FONT> there is not pending or contemplated, any investigation by any Governmental Body involving <FONT STYLE="white-space:nowrap">U-</FONT> Protein, or any current or
former director or officer of <FONT STYLE="white-space:nowrap">U-Protein.</FONT> </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.16.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Labour Relations</U>. No labor dispute exists or, to the knowledge of
<FONT STYLE="white-space:nowrap">U-Protein,</FONT> is imminent with respect to any of the employees of <FONT STYLE="white-space:nowrap">U-Protein,</FONT> which could reasonably be expected to result in a Material Adverse Effect. None of <FONT
STYLE="white-space:nowrap">U-Protein&#146;s</FONT> employees is a member of a union that relates to such employee&#146;s relationship with <FONT STYLE="white-space:nowrap">U-Protein,</FONT> and <FONT STYLE="white-space:nowrap">U-Protein</FONT> is
not a party to a collective bargaining agreement, and <FONT STYLE="white-space:nowrap">U-Protein</FONT> believes that their relationships with their employees are good. To the knowledge of <FONT STYLE="white-space:nowrap">U-Protein,</FONT> no
executive officer of <FONT STYLE="white-space:nowrap">U-Protein</FONT> is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement or <FONT
STYLE="white-space:nowrap">non-competition</FONT> agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject <FONT
STYLE="white-space:nowrap">U-Protein</FONT> to any liability with respect to any of the foregoing matters. <FONT STYLE="white-space:nowrap">U-Protein</FONT> is to its knowledge in compliance with all applicable laws and regulations relating to
employment and employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.17.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Compliance</U>. To <FONT STYLE="white-space:nowrap">U-Protein&#146;s</FONT> knowledge, after reasonable
investigation, <FONT STYLE="white-space:nowrap">U-Protein:</FONT> (i)&nbsp;is not in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by <FONT
STYLE="white-space:nowrap">U-Protein</FONT> under), nor has <FONT STYLE="white-space:nowrap">U-Protein</FONT> received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other
agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is not in violation of any judgment, decree, or order of any court, arbitrator or other
governmental authority or (iii)&nbsp;is not or has not been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes,
environmental protection, occupational health and safety, product quality and safety and employment and labour matters, except in each case as could not have or reasonably be expected to result in a Material Adverse Effect. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.18.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Regulatory Permits</U>. <FONT STYLE="white-space:nowrap">U-Protein</FONT> possesses to its knowledge all
certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as currently conducted by them, except where the failure to possess such
permits could not reasonably be expected to result in a Material Adverse Effect (&#147;<U>Material Permits</U>&#148;), and <FONT STYLE="white-space:nowrap">U-Protein</FONT> has not received any notice of proceedings relating to the revocation or
modification of any Material Permit. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.19.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Title to Assets</U>. <FONT STYLE="white-space:nowrap">U-Protein</FONT> has good and marketable title in fee
simple to all real property owned and leased by it as set forth in Schedule 4.19 to the SEA and good and marketable title in all personal property owned by it that is material to the Business, in each case free and clear of all Liens, except for
(i)&nbsp;Liens as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by <FONT STYLE="white-space:nowrap">U-Protein</FONT> and (ii)&nbsp;Liens for the payment
of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with Dutch GAAP and the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by <FONT
STYLE="white-space:nowrap">U-Protein</FONT> are held by it under valid, subsisting and enforceable leases with which <FONT STYLE="white-space:nowrap">U-Protein</FONT> are in material compliance. <FONT STYLE="white-space:nowrap">U-Protein</FONT> has
not granted or entered into any agreement, option, understanding or commitment to sell or otherwise dispose of or grant any Liens upon any of their respective real or personal property or assets, or any part thereof, or any right or privilege
capable of becoming an agreement, option, understanding or commitment to sell or otherwise dispose of or grant any Liens upon any of their respective real or personal property or asset or any part thereof, other than sales or other dispositions made
in the ordinary course of business. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.20.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Intellectual Property</U>. <FONT STYLE="white-space:nowrap">U-Protein</FONT> has no inventions or running
patents, patent applications, trademarks or trademark applications. The trade names of <FONT STYLE="white-space:nowrap">U-Protein</FONT> are exhaustively listed in the chamber of commerce excerpt of <FONT STYLE="white-space:nowrap">U-Protein.</FONT>
In addition thereto, <FONT STYLE="white-space:nowrap">U-Protein</FONT> has trade secrets, copyrights and licenses. As set forth in Schedule 4.20 to the SEA, <FONT STYLE="white-space:nowrap">U-Protein</FONT> has constructed a large number of
expression vectors that the Company considers as a proprietary trade secret. However, the Company can not guarantee that these vectors are not or in part infringing on patent or other positions of third parties.
<FONT STYLE="white-space:nowrap">U-Protein</FONT> has not received a written notice of a claim or otherwise has any knowledge that the Company violates or infringes upon the rights of any Person. Except as set forth in Schedule 4.20 to the SEA, <FONT
STYLE="white-space:nowrap">U-Protein</FONT> has not licensed any of its Intellectual Property Rights. To the knowledge of <FONT STYLE="white-space:nowrap">U-Protein,</FONT> there is no existing infringement by another Person of any of the
Intellectual Property Rights. <FONT STYLE="white-space:nowrap">U-</FONT> Protein has taken reasonable security measures to protect the secrecy, confidentiality and value of all of their constructed vectors, except where failure to do so could not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.21.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Tax Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be
expected to result in a Material Adverse Effect, <FONT STYLE="white-space:nowrap">U-Protein</FONT> (i)&nbsp;has made or filed all federal, state and local income and franchise tax returns, reports and declarations required by any jurisdiction to
which it is subject, (ii)&nbsp;has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii)&nbsp;has set aside on its books provision
reasonably adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any
jurisdiction, and the officers and managers of <FONT STYLE="white-space:nowrap">U-Protein</FONT> know of no basis for any such claim. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.22.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Related Party Indebtedness</U>. Except as disclosed in <FONT STYLE="white-space:nowrap">U-Protein</FONT>
Financial Statements and salaries incurred in the ordinary course of business since the date thereof, <FONT STYLE="white-space:nowrap">U-</FONT> Protein has no loans or indebtedness outstanding which have been made to or from directors, former
directors, officers, shareholders and employees of <FONT STYLE="white-space:nowrap">U-Protein</FONT> or to any person or corporate body not dealing at arm&#146;s length with any of the foregoing, and will not, prior to closing, pay any such
indebtedness unless in accordance with budgets agreed in writing by the Purchaser. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.23.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Guarantees of Indebtedness</U>. <FONT STYLE="white-space:nowrap">U-Protein</FONT> has not guaranteed any
dividend, obligation or indebtedness of any other Person, nor has any other Person guaranteed any dividend, obligation or indebtedness of <FONT STYLE="white-space:nowrap">U-Protein.</FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.24.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Insurance</U>. <FONT STYLE="white-space:nowrap">U-Protein</FONT> is insured by insurers of recognized
financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which <FONT STYLE="white-space:nowrap">U-Protein</FONT> is engaged. <FONT STYLE="white-space:nowrap">U-Protein</FONT> does
not have any reason to believe that <FONT STYLE="white-space:nowrap">U-Protein</FONT> will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary
to continue its business without a significant increase in cost. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SCHEDULE 3: LIMITATIONS ON LIABILITY </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Claims and Compensation</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event of a Breach, the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders shall be severally
but not jointly be liable to pay to the Purchaser, or to any other person designated by the Purchaser, at the Purchaser&#146;s election an amount equal to the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholder&#146;s proportion to the
Shares as reflected in Recital A of the SEA (i.e. 40/20/20/20) of (i)&nbsp;the amount necessary to place the Company in the position in which it would have been if the relevant Breach had not occurred or (ii)&nbsp;the actual amount of Losses
suffered or incurred by the Purchaser in respect of such Breach. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event of a Breach, the Purchaser shall within [20] Business Days after discovery of the circumstances
relating to such Breach, submit to the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders a Claim for compensation of Losses which shall set out: (a)&nbsp;reasonable particulars of the facts relating to such Claim; (b)&nbsp;an estimate
of the likely amount of the Claim; and (b)&nbsp;the election of the Purchaser as referred to in clause 1.1 provided, however, that any failure or delay on the part of the Purchaser to notify the <FONT STYLE="white-space:nowrap">U-Protein</FONT>
Shareholders in accordance with this Clause shall not prejudice the Purchaser&#146;s right to make a Claim, provided however that any additional damages that are caused by the Purchaser informing the <FONT STYLE="white-space:nowrap">U-Protein</FONT>
Shareholders after said 20 Business Days, will remain for the expense of Purchaser. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Defence against Third Party Claims</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Where a Claim of the Purchaser for Losses is based upon or relates to a Third Party Claim, the Purchaser shall notify the <FONT
STYLE="white-space:nowrap">U-Protein</FONT> Shareholders of such Third Party Claim promptly after becoming aware thereof but in any event within 20 Business Days after having received a written notice of such Third Party Claim. Within 10 Business
Days after the date of that notification the Parties shall consult each other on the course of action to be taken. The <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders shall, however, at their sole reasonable discretion, be entitled at
their own cost to take, or require the Purchaser to procure that the Company will take, any action necessary to defend or settle the Third Party Claim, whereby it is agreed that any course of action taken, irrespective by which Party, shall be
consistent with past practice. The <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders shall use reasonable endeavours to strike a fair balance between the interests of the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders in
keeping the Compensation as low as possible and the interests of the Purchaser and the Company to maintain good business relations with the third party concerned. The Parties shall cooperate with each other in dealing with any Third Party Claim and
shall allow each other and their representatives, upon reasonable written notice, access during normal business hours to such books, records and other information, including the right to inspect and take copies, as may be reasonably required. Such
books and records will be subject to a duty of confidentiality except for disclosure necessary for resolving such Third Party Claim or otherwise required by Applicable Law or stock exchange rules. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Effect of Tax, provisions and insurance</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In determining the amount of any Losses or whether the thresholds referred to in clause 5 have been reached, the following factors shall be
taken into account: (a)&nbsp;any actual reduction in Tax </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
payable by the Company, to the extent that such refund or reduction is attributable to the facts giving rise to the Claim and (b)&nbsp;any amount actually received by the Company under an
insurance policy or from a third party, to the extent that such amount is attributable to the facts giving rise to the Claim. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Limitations</U></B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Limitations in time</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">A notice of a Claim can be given by the Purchaser to the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Until expiry of the applicable statute of limitations with respect to the Warranties set out in paragraphs 1.1,
1.2, 1.3, 1.4 and 1.5 of Schedule 2; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">until six (6)&nbsp;months after the expiry of the applicable statute of limitations, being the period during
which any competent Tax Authority is authorised to impose a Tax Claim on the Company, with respect to the Warranties set out in paragraph 1.21 of Schedule 2; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">within 18 (eighteen) months from the Closing Date in respect of all other Warranties in this Deed.
</P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Maximum liability</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The aggregate liability of each of the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders in respect of any Claims in respect of
the Warranties, shall not exceed 30% (thirty percent) of such <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders&#146;s proportion of the purchase price that has been paid at the date that any such Claim is finally settled, except for
Claims with respect to the Warranties set out in paragraphs 1.1, 1.2, 1.3, 1.4 and 1.5 of Schedule 2 for which the liability of the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders shall be unlimited and not restricted by the terms of
this clause 4.2. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Minimum claims</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Subject to any other limitations set out in this Deed, the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders shall not be liable
for a Breach unless: (a)&nbsp;the amount of an individual Claim, or a series of Claims arising from similar or related matters or circumstances, exceeds EUR 10,000; and (b)&nbsp;the aggregate amount of all Claims exceeds EUR 50,000, in which case
the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders&#146; liability shall extend to the full amount of all Claims and shall not be limited to the excess only. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>No double recovery</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Purchaser shall not be entitled to recover from the <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders more than once in
respect of any Damages if such Damages are caused by more than one Breach of the Warranties. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>No fraud </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The limitations of the liability of <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders pursuant to this Schedule 3 shall not apply
in the event of fraud <I>(fraude), </I>wilful misconduct <I>(opzet) </I>or, intentional misrepresentation <I>(bedrog) </I>on the part of <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders or the Company as a result of which one or more
Warranties is inaccurate or misleading. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>No liability for Disclosed Information. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In connection with the due diligence investigation, the <FONT STYLE="white-space:nowrap">U-Protein</FONT>
Shareholders have provided the written information regarding the Shares, the Company and the business of the Company as stored on the DVD an index of which is attached hereto as <B>Schedule 4</B> and/or the Disclosure Letter <B>(Disclosed
Information) </B>to the Purchaser. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The <FONT STYLE="white-space:nowrap">U-Protein</FONT> Shareholders shall not be liable for a breach of the
Warranties if and to the extent the relevant fact, circumstance or matter resulting in such breach has been Fairly Disclosed in the Disclosed Information. <B>Fairly Disclosed </B>means: fairly and unambiguously disclosed in such a manner that a
purchaser reviewing the relevant information could have reasonably assessed the financial, legal, commercial or other relevance and consequence thereof, provided however that where reference is made to a document or a particular part of a document,
but the document itself is not included in the Disclosed Information, then such reference and document or particular part of a document shall not be deemed to have been Fairly Disclosed. On the basis of the Disclosed Information, the Purchaser is
not aware of any Breach. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SCHEDULE&nbsp;4: DATA ROOM DVD </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 7 &#150; TRANSFER DEED </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">to that Share Exchange Agreement </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">dated the <U></U>10<U></U><U></U><U></U><U></U> day of August<U></U><U></U><U></U><U></U>, 2017 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(See Attached) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">RRI/ALDE/IMMAD </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">9&nbsp;August 2017 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TRANSFER OF
EIGHTEEN THOUSAND (18,000) ORDINARY SHARES </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IN THE SHARE CAPITAL OF <FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> EXPRESS B.V.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">This day, the &nbsp;&nbsp;&nbsp;&nbsp; day of August, two thousand and seventeen, appeared before me, Renatus Martinus Rieter, civil
law notary officiating in The Hague, the Netherlands: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, for the purposes hereof acting as a written attorney of: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Universiteit Utrecht Holding B.V.</U>, </B>a private company with limited liability <I>(besloten
vennootschap met beperkte aansprakelijkheid) </I>organised under the laws of the Netherlands, having its corporate seat in Utrecht, and with business address: Yalelaan 40, 3584 CM Utrecht, registered in the trade register under number 30147272,
hereinafter referred to as <B>&#147;Universiteit Utrecht Holding&#148;; </B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U><B>Bionomics B.V.</B></U>, a private company with limited liability <I>(besloten vennootschap met beperkte
aansprakelijkheid) </I>organised under the laws of the Netherlands, having its corporate seat in Houten, and with business address: Hazenakker 18, 3994 EJ Houten, registered in the trade register under number 30166792, hereinafter referred to as:
<B>&#147;Bionomics&#148;; </B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Wieger Hemrika</U>, </B>born in Amsterdam, the Netherlands on the thirteenth day of August nineteen
hundred sixty, residing at Kattenburgerhof 52, 1018 KD Amsterdam, not married, holder of a passport of the Netherlands with number NT35FF36B9, hereinafter referred to as: the <B>&#147;Mr. Hemrika&#148;; </B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Roland Antonius Paulus Romijn</U>, </B>born in Tiel, the Netherlands on the twelfth day of February
nineteen hundred <FONT STYLE="white-space:nowrap">seventy-one,</FONT> residing at Mr. Tydemanstraat 23, 4001 CR Tiel, married, holder of a passport of the Netherlands with number NUJ33LHJ7, hereinafter referred to as: the <B>&#147;Mr. Romijn&#148;;
</B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>lmmunoprecise Antibodies Ltd.</U>, </B>a company organised under the laws of the Province of British
Columbia, Canada, having its principal office at Unit 3204, 4464 Markham Street, Victoria BC V8Z7X8, registered under the laws of the Province of British Columbia, under number C1088362, hereinafter referred to as: the <B>&#147;Buyer&#146;&#146;;
</B>and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>U-Protein Express B.V.</U>, </B>a private company with limited liability <I>(besloten vennootschap met
beperkte aansprakelijkheid) </I>organised under the laws of the Netherlands, having its corporate seat in Utrecht, and with business address: Yalelaan 62, 3584 CM Utrecht, registered in the trade register under number 30230407, hereinafter referred
to as: the <B>&#147;Company&#148;</B>.<B> </B> </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The appearing person, acting as aforementioned, declared: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>WHEREAS:</U> </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The total share capital of the Company amounts to eighteen thousand euro (EUR 18,000, consisting of (18,000)
ordinary shares, numbered 1 up to and including 18,000, each share having a nominal value of one euro (EUR 1) . </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Sellers hold the Shares as follows: </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Universiteit Utrecht Holding, seven thousand two hundred (7,200) ordinary shares, numbered 1 up to and including
7,200 (the <B>&#147;UU Shares&#148;</B>);<B></B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B></B>Bionomics, three thousand six hundred (3,600) ordinary shares, numbered 7,201 up to and including 10,800
(the <B>&#147;Bionomics Shares&#148;</B>); <B></B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Mr.&nbsp;Hemrika, three thousand six hundred (3,600) ordinary shares, numbered 10,801 up to and including 14,400
(the <B>&#147;Hemrika Shares&#148;</B>); and<B></B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Mr.&nbsp;Romijn, three thousand six hundred (3,600) ordinary shares, numbered 14,401 up to and including 18,001
(the <B>&#147;Romijn Shares&#148;</B>), <B></B> </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">the UU Shares, Bionomics Shares, Hemrika Shares, and the Romijn Shares,
hereinafter referred to as: the <B>&#147;Shares&#148;</B>.<B> </B> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On the &nbsp;&nbsp;&nbsp;&nbsp; day of August, two thousand and seventeen the parties to this deed entered into
a share exchange agreement, this agreement hereinafter referred to as: the <B>&#147;Agreement&#148;</B>.<B> </B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Agreement the Sellers are obliged, among other things, to transfer their Shares to the Buyer, which transfer the Sellers and
the Buyer wish to effectuate by this deed. A copy of the Agreement is attached to this deed <B>(<U>Annex</U>)</B>.<B></B> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(D)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Sellers and the Buyer now wish to give effect to the above. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>IT IS HEREBY AGREED AS FOLLOWS:</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Transfer</U> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Article 1</U> </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Pursuant to the Agreement, the Sellers hereby transfer the Shares to the Buyer as follows:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Universiteit Utrecht Holding transfers the UU Shares to the Buyer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Bionomics transfers the Bionomics Shares to the Buyer; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Hemrika transfers the Hemrika Shares to the Buyer; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Romijn transfers the Romijn Shares to the Buyer, </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">who hereby accepts the Shares from the Sellers, such subject to the provisions laid down in the Agreement and the agreement embodied in this
deed. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Shares are for the account and risk of the Buyer as per the date hereof. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Purchase price</U> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Article 2</U> </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The purchase price for the Shares and the method of payment appears from the Agreement and is sufficiently
known to the Sellers and the Buyer. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Prior to the execution of this deed, the Buyer has paid part of the purchase price, being an amount of two
million seven hundred thirty-four thousand seven hundred <FONT STYLE="white-space:nowrap">thirty-two</FONT> euro (EUR 2,734,732) (the <B>&#147;Cash Payment&#148;) </B>into the trust account <I>(kwaliteitsrekening) </I>of R.M. Rieter, civil law
notary, being NL66ABNA0240486331 in the name of <I>&#145;Kwaliteitsrekening Notariaat Bird</I><I></I>&nbsp;&amp; <I>Bird&#146; </I>with ABN AMRO Bank (BIC: ABNANL2A) (the <B>&#147;Notary&#146;s Account&#148;). </B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Cash Payment paid to the Notary&#146;s Account is allocated to the Shares as follows:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Buyer has paid an amount of nine hundred twelve thousand four hundred eighty-eight euro (EUR 912,488) for
the UU Shares (the<B> &#147;UU Consideration&#148;); </B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Buyer has paid an amount of four hundred <FONT STYLE="white-space:nowrap">fifty-six</FONT> thousand two
hundred forty-four euro (EUR 456,244) for the Bionomics Shares (the <B>&#147;Bionomics Consideration&#148;); </B>and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Buyer has paid an amount of six hundred eighty-three thousand euro (EUR 683,000) for the Hemrika Shares
(the <B>&#147;Hemrika Consideration&#148;); </B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Buyer has paid an amount of six hundred eighty-three thousand (EUR 683,000) for the Romijn Shares (the
<B>&#147;Romijn Consideration&#148;). </B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Sellers hereby instruct the civil law notary to transfer the Cash Payment to the following bank accounts:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Universiteit Utrecht Holding hereby instructs the civil law notary to transfer the UU Consideration to bank
account number NL34 RABO 0379 8590 09 at Rabobank Bank in Utrecht (BIC: RABONL2U) in the name of Universiteit Utrecht Holding. Universiteit Utrecht Holding hereby grants discharge to the Buyer for its obligation to pay the UU Consideration;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Bionomics hereby instructs the civil law notary to transfer the Bionomics Consideration to bank account number
NL83RABO0379851725 at Rabobank Rijn en Heuvelrug in Houten, The Netherlands (BIC: RABONL2U) in the name of Bionomics. Bionomics hereby grants discharge to the Buyer for its obligation to pay the Bionomics Consideration;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Hemrika hereby instructs the civil law notary to transfer the Hemrika Consideration to bank account number NL67
INGB 0003 6074 08 at ING Bank in Amsterdam in the name of Hemrika. Hemrika hereby grants discharge to the Buyer for its obligation to pay the Hemrika Consideration; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Romijn hereby instructs the civil law notary to transfer the Romijn Consideration to bank account number NL
191NGB0005689698 at ING Bank in Tiel, the Netherlands (BIC: INGBNL2A), in the name of Romijn. Romijn hereby grants discharge to the Buyer for its obligation to pay the Romijn Consideration. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Warranties</U> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Article 3</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Sellers warrant <I>(garanderen) </I>to the Buyer that at this time the following is correct: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Sellers are fully entitled to the Shares; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Sellers have validly acquired the Shares in the manner stated in article 4 to this deed;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Sellers&#146; right on the Shares is unconditional and not subject to a restriction, dissolution or
nullification whatsoever; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Sellers have the legal authority to transfer the Shares; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Sellers have not been deprived of the authority to alienate the Shares by virtue of section 2:22a,
paragraph 1, of the Dutch Civil Code, hereinafter referred to as: &#147;<B>DCC</B>&#148;; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Shares are fully <FONT STYLE="white-space:nowrap">paid-up;</FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Shares are not encumbered with any pledge or usufruct; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">no depositary receipts in respect to the Shares have been issued. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Acquisition by Seller</U> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Article 4</U>
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Sellers acquired the Shares upon issue by the notarial deed of incorporation of the Company, executed before a deputy of Kees Hendrikus Josef
Flink, at that time civil law notary officiating in Utrecht, on the twenty-fourth day of September, two thousand and seven. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Restrictions on
transfer of Shares</U> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Article 5</U> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
restrictions on the transfer of shares, as laid down in article 17 of the articles of association of the Company (the obligation to offer for sale) need not to be complied with in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
connection with the transfer of the Shares, since all shareholders of the Company are party to this deed and hereby waive one another&#146;s rights under the share transfer restriction clause and
unanimously grant their consent to the transfer of the Shares to the Buyer. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Prior agreements</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Article 6</U> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise provided for in this
deed, all that has been agreed between the Sellers and the Buyer relating to the transfer of the Shares prior to the execution of this deed shall remain in full force and effect, provided, however, that a condition subsequent, if any, may no longer
be invoked, and a condition precedent, if any, is deemed to have been fulfilled. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Dissolution</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Article 7</U> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Sellers and the Buyer waive the
right to dissolve the agreement contained in this deed under the provisions of section 6:265 DCC. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Acknowledgement</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Article 8</U> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company hereby acknowledges the
transfer of the Shares and shall cause the required notes to be entered into its shareholders&#146; register. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Concentration</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Article 9</U> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The present transfer of shares will not
effect a concentration for which an official notification is required within the meaning of the Competitive Trading Act (<I>Mededingingswet</I>). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Governing law</U> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Article 10</U> </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The agreement contained in this deed is governed by and construed in accordance with Dutch law.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The District Court of The Hague, the Netherlands, shall have exclusive jurisdiction in relation to any matters
arising out of, or in connection with, the agreement contained in this deed. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Civil law notary</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Article 11</U> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Sellers declare to have knowledge
of the fact that the civil law notary, Renatus Martinus Rieter, is associated with Bird&nbsp;&amp; Bird LLP, the firm that has acted as legal counsel of the Buyer with regard to this transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With reference to the Regulation on Professional Rules of Conduct ( <I>Verordening beroeps- en gedragsregels) </I>established by the Royal Professional
Organisation of Civil Law Notaries <I>(Koninklijke Notariele Beroepsorganisatie) </I>the Sellers hereby explicitly </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
declare to consent to the fact that the Buyer is assisted and represented by Bird&nbsp;&amp; Bird LLP in relation to the agreement embodied in this deed and any agreements that may be concluded
and any disputes that may arise in connection therewith. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Interpretation</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Article 12</U> </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">12.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In this deed Dutch legal concepts are expressed in English terms, with the original Dutch term occasionally in
brackets. Although an attempt has been made to translate them as literally as possible, the Dutch concepts concerned may not be exactly identical to the concepts described by the English terms. In case of a dispute on the interpretation of these
concepts, the Dutch interpretation shall prevail. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">12.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Headings are inserted for convenience only and shall not affect the interpretation of this deed.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>POWERS OF ATTORNEY/ATTACHMENTS</U> </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The powers of attorney to the appearing person are evidenced by written documents, which are attached to this
deed. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Furthermore to this deed is attached a copies of the Agreement. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CLOSE </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The appearing person is known to me, civil law
notary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS DEED, drawn up to be kept in the civil law notary&#146;s custody, was executed in The Hague, the Netherlands, on the date mentioned in its
heading. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to the execution of this deed, I, civil law notary, informed the appearing person of the substance of the deed and gave the appearing
person an explanation thereon, and furthermore pointed out the consequences which will result for the parties, or one or more of them, from the contents of this deed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The appearing person then declared to have taken notice of the contents of this deed after timely being given the opportunity thereto and not to require this
deed to be read out in full. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Immediately after a limited reading, this deed was signed by the appearing person and me, civil law notary. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 8 &#150; MANAGEMENT AGREEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">to that Share Exchange Agreement </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">dated <U></U>the 10 day of August, 2017 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(See Attached) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Exchange Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EMPLOYMENTAGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS EMPLOYMENT AGREEMENT (the &#147;Agreement&#148;) dated this &nbsp;&nbsp;&nbsp;&nbsp; day of August 2017 (the &#147;Effective Date&#148;) is: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="85%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">BETWEEN:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B><FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> EXPRESS BV. </B>having its business address at Life Sciences Incubator, Utrecht, Science Park, Yalelaan, 62, 3584, CM, Utrecht, The Netherlands</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">(&#147;Company&#148;)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">AND:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>IMMUNOPRECISE ANTIBODIES LTD. </B>having its business address at U.Vic Vancouver Island Technology Park, #3204-4464 Markham Street, Victoria, BC, Canada, V8Z 7X8</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">(&#147;IPA&#148;)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">AND:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>WIEGER HEMRIKA, </B>having an address at Kattenburgerhof 52, 1018 KD Amsterdam, The Netherlands</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">(&#147;Wieger&#148;)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(Hereinafter collectively referred to as the &#147;Parties&#148;) </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>WHEREAS </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Company shareholders have entered into a definitive agreement in which each of shareholders of Company has
exchanged their shares for IP A shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Company and IP A wishes Wieger to continue to on a full-time basis with the Company as Chief Scientist and
Wieger accepts this continuing appointment in accordance with the terms and conditions of this Employment Agreement. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOW THEREFORE
</B>with the consideration and mutual covenants contained herein, the parties agree that the following terms and conditions shall apply to the relationship: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ROLES AND RESPONSIBILITIES </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As of the Effective Date, Company, IPA and Wieger agree that Wieger shall continue to as Chief Scientist of the
Company, on a full-time employment basis, based on a forty-hour work week, as further described in Schedule A for the term of the Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Wieger shall report to President and CEO of the Company in the performance of his full-time roles and
responsibilities as Chief Scientist. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Wieger shall adhere to all corporate policies and procedures as amended from time to time in the performance of
his roles and responsibilities for the term of the Agreement including the protection of confidential information of Company and will execute any and all instruments to protect such confidential information. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Wieger agrees: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">not to engage in any other projects or business activities that would conflict or compete with Company&#146;s
business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to disclose in writing to Company any conflict of interest circumstances and any
<FONT STYLE="white-space:nowrap">non-arms</FONT> length transactions and or projects to Company during the term of the Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">not engage to in any other projects or work without prior disclosure, consultation and written approval of the
Company; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to disclose in writing to the Company all current business and consulting services and activities that he is
currently engaged in. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>COMPENSATION AND EQUITY </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Company will continue to pay Wieger a monthly base salary of Euro 6669,75 gross, including the statutory
holiday allowance, each month for the term of the Agreement commencing on the Effective Date. The monthly base salary will be reviewed annually by the Board and may be increased at the sole discretion of the Board of Directors of IPA.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Company will also pay Wieger a portion of the profits achieved by the Company as further described in Schedule
B attached hereto and as determined by the Company and thereafter Wieger will be entitled to receive annual bonuses upon achievement of performance targets based on key profitability metrics as set by the Board of Directors of IPA and at the sole
discretion of the Board of Directors of IPA. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Upon completion of the transaction with IPA in accordance with the Definitive Agreement, IPA will issue Wieger
initial options (&#147;Options&#148;) in accordance with formulae agreed with the Board of Directors of IPA. These Options will be issued in accordance with IPA Stock Option Plan at exercise price set upon the completion of the transaction with IPA.
Wieger will be entitled to exercise these Options as per the vesting terms set by the Board of Directors of IPA pursuant to IPA&#146;s Stock Option Plan. Thereafter, Wieger will be entitled to the grant of additional options pursuant to the
IPA&#146;s Stock Option Plan at the sole discretion of the Board of Directors. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Company will pay Wieger Euro 200 gross for travel costs and any other
<FONT STYLE="white-space:nowrap">pre-approved</FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses in accordance with corporate policies and Wieger shall provide a monthly summary of expenses
with receipts to Company of any other <FONT STYLE="white-space:nowrap">pre-approved</FONT> expenses other than travel costs. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Wieger will participate in any Company and IPA benefits plans implemented from time to time where applicable.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Wieger will be entitled to 30 days of vacation scheduled in consultation with the Chief Executive Officer of
Company, eight percent (8%) vacation compensation payable in May annually, and 3% percent compensation payable in December annually to any other Dutch employment statutory rights and or benefits. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company is not bound by any collective bargaining agreement and no collective bargaining agreement applies
to the subject employment. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>INTELLECTUAL PROPERTY, <FONT STYLE="white-space:nowrap">NON-COMPETITION</FONT> AND CONFIDENTIALITY
</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Wieger agrees that all right, title, and interest in and to intellectual property, including but not limited to
all technical reports, business processes, procedures, techniques, routines, designs, drawings, and financial, commercial or technical information in any form, written materials, data bases, plans, diagrams, drawings, models, and other things which
Wieger may conceive, develop or contribute to or reduce to practice arising from the performance of the roles and responsibilities as Chief Scientist which: (a)&nbsp;relates directly to Company&#146;s present business or development; or (b)&nbsp;is
created or made using any equipment, supplies, facilities, resources, or confidential information of Company, whether or not made during or after office hours, or on, or off Company&#146;s premises, or alone or with others is hereinafter referred to
as the &#147;Developments&#148;. These Developments shall be the sole property of Company, its assigns, and Company and its assigns shall be the sole owner of all intellectual property rights, including but not limited to copyrights, trade marks
(word marks, design marks, certification or service marks), trade secrets, and other rights in connection therewith the Developments. Wieger agrees to assign, grant and convey to Company rights he may have or acquire in the intellectual property and
intellectual property rights of the Developments and will execute any and all assignments to give effect to this transfer of rights to Company. Wieger irrevocably and unconditionally waives any moral rights he may have now or in the future in any
Developments in favour of Company. Wieger further agrees, as to all such intellectual property and intellectual property rights, to assist Company in every proper way (at Company&#146;s expense) to obtain and from time to time enforce copyrights,
trade marks, trade secrets, or other protection, on said intellectual property, and to that end he will execute all documents for use in applying for and obtaining such protection and enforcing same, as Company may desire, together with any
assignments thereof to Company or persons designated by it. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Wieger agrees during the term of this Agreement not to engage in any other business activity that would
directly or indirectly compete with the business of Company during the term of this Agreement and for a period of two (2)&nbsp;years following termination of this Agreement. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Wieger agrees not to solicit directly or indirectly through a partnership or any business structures with any
customer/client of Company for any other business or business activity or to solicit or induce any employee of Company to join any other business or business activity for a period of two (2)&nbsp;years following termination of this Agreement.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">15.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Wieger agrees to be bound by the confidentiality policies and procedures of Company to protect and not to
disclose without prior written consent of Company any confidential information of Company including but not limited to customer/client information, all Company data, Company information including the terms of this Agreement and that Wieger will
execute any and all instruments to protect such confidential information of Company. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>TERMINATION </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">16.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to any Dutch statutory laws and prior permission of Employment Tribunal (<I>UWV), </I>Company may
terminate the Agreement for any reason with one hundred and twenty (120)&nbsp;days written notice (&#147;Notice&#148;) as per any day of a calendar month, for any reason or in lieu of such written notice the payment of the equivalent of salary and
benefits for such Notice. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">17.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Company may terminate the Agreement immediately for just cause. Just cause for the purposes of this Agreement
means the basis under Dutch law in which an employee may be terminated immediately without notice including but not limited to inappropriate, fraudulent and illicit actions. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">18.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Wieger may terminate this Agreement with sixty (60)&nbsp;days written notice to Company and Board of Directors
of IP A as per any day of a calendar month. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">19.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event of termination for any reason, Wieger agrees to return all Company and project materials,
documents and documentation including electronic documents (&#147;Materials&#148;) in useable form relating to Company&#146;s business, work or investigations prepared, used or possessed by his under his control arising from the performance of
Services which will be and remain the sole and exclusive property of Company. All such Materials, including Company books and records are to be delivered to Company&#146;s address first referenced above or such address as provided by Company from
time to time. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">20.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event of termination, Wieger agrees to cooperate with Company to transition any such current, pending or
potential transactions and projects and provide all necessary information and or documentation. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">21.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event of termination, Wieger agrees not to make disparaging and damaging comments or statements in
writing or verbally concerning Company in public or to any vendors or suppliers or take any actions that are intended to damage the reputation and goodwill of Company. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>GENERAL TERMS </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">22.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Agreement and the schedules attached hereto contain all the terms and conditions relating to the
employment of Wieger by Company and supersede all previous agreements relating thereto. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">23.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any further amendment, modification or variation hereof shall be valid only if it is in writing signed by all
the parties hereto. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">24.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Formal notices required or permitted by this Agreement shall be in writing and shall be delivered by email,
hand, by facsimile, or by registered mail to the addresses provided hereinunder or as provided by the parties from time to time. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">25.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Agreement and all matters arising hereunder shall be interpreted and construed in accordance with the laws
of the Netherlands. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">26.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Agreement and the rights and obligations herein shall not be assigned by Wieger to any other party without
the express written consent of Company and any attempted assignment shall be considered to be void and of no force and effect. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">27.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Agreement shall enure to the benefit of and be binding upon the parties and their respective permitted
assigns. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">28.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The obligations hereinunder respecting the payments, ownership and use of intellectual property and
confidentiality survive the termination of this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">29.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A waiver of a provision of this Agreement shall not constitute a subsequent waiver of the provision nor any
other provision of this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">30.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event that a provision of this Agreement is deemed unenforceable by a court of competent jurisdiction,
the remaining provisions shall remain in full force and effect. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">31.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Agreement may be executed in counterparts by the parties, each of which shall constitute an original
instrument for the purposes of this Agreement. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF </B>the Parties have executed this Employment Agreement the day
and year first before written above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ACCEPTED AND AGREED TO BY: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> EXPRESS B.V. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AUTHORIZED SIGNATORY </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ACCEPTED AND AGREED TO BY: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ACCEPTED AND AGREED TO BY: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AUTHORIZED SIGNATORY </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="27%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">In the presence of:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Witness</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>WIEGER&nbsp;HEMRIKA&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Occupation</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE A &#150; CHIEF SCIENTIST </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[to be attached] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE B &#150; PROFIT SHARING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with the terms of the Letter of Intent executed by the parties on June&nbsp;30, 2017, Wieger is entitled to share in the net profits earned by <FONT
STYLE="white-space:nowrap">U-Protein</FONT> as a shareholder over the next three years as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">50% of the net profits, less subsidies, grants or other government funding for the first year;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">33% of the net profits, less subsidies, grants or other government funding for the second year;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">20% of the net profits, less subsidies, grants or other government funding for third year.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>MANAGEMENT AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS MANAGEMENT SERVICES AGREEMENT (the &#147;Agreement&#148;) dated this &nbsp;&nbsp;&nbsp;&nbsp; day of August 2017 (the &#147;Effective Date&#148;) is:
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="84%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">BETWEEN:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B><FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> EXPRESS BV. </B>having its business address at Life Sciences Incubator, Utrecht, Science Park, Yalelaan, 62, 3584, CM, Utrecht, The Netherlands</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-right:2.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(&#147;Company&#148;)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">AND:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>IMMUNOPRESICE ANTIBODIES LTD. </B>having its business address at U.Vic Vancouver Island Technology Park, #3204-4464 Markham Street, Victoria, BC, Canada, V8Z 7X8</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-right:2.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(&#147;IPA&#148;)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">AND:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>PODICEPS B.V, </B>having a business address at Hazenakker 18, 3994 EJ Houten, The Netherlands</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-right:2.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(&#147;Podiceps&#148;)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">AND:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>MARTIN HESSING, </B>having a residential address at Hazenakker 18, 3994 EJ Houten, The Netherlands</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-right:2.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(&#147;Martin&#148;)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(Hereinafter collectively referred to as the &#147;Parties&#148;) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>WHEREAS </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Company shareholders have entered into a definitive agreement in which each of shareholders of Company has
exchanged their shares for IPA shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Company and IPA wishes Podiceps to continue to provide management services to Company and to designate Martin
Hessing as the President and Chief Executive Officer of the Company and Podiceps accepts this continuing appointment in accordance with the terms and conditions of this Management Agreement (the &#147;Agreement&#148;). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOW THEREFORE </B>with the consideration and mutual covenants contained herein, the parties agree that
the following terms and conditions shall apply to the relationship: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ROLES AND RESPONSIBILITIES </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As of the Effective Date, Company, IPA and Podiceps agree that Podiceps shall continue to act as board member
of the Company, to provide management services and to designate Martin to continue as President and Chief Executive Officer for no less than a <FONT STYLE="white-space:nowrap">two-year</FONT> period to perform the roles and responsibilities of
President and Chief Executive Officer for Company, 3 days per week, as further described in Schedule A for the term of the Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Podiceps shall report to the Board of Directors of IP A. in the performance of its roles and responsibilities
as board member and President and Chief Executive Officer of the Company and the performance of these roles and responsibilities will be reviewed with the Board of Directors of IPA regularly. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Podiceps shall adhere to all corporate policies and procedures as amended from time to time in the performance
of his roles and responsibilities for the term of the Agreement including the protection of confidential information of Company and will execute any and all instruments to protect such confidential information. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Podiceps agrees: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">not to engage in any other projects or business activities that would conflict or compete with Company&#146;s
business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to disclose in writing to Board of Directors of IP A any conflict of interest circumstances and any <FONT
STYLE="white-space:nowrap">non-arms</FONT> length transactions and or projects to Company during the term .of the Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">not engage to in any other projects or work without prior disclosure, consultation and written approval of the
Board of Directors of IP A; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to disclose in writing to Board of Directors of IP A all current business and consulting services and
activities that he is currently engaged in. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Company, IPA and Board of Directors of IPA are aware and allow Martin to continue his management activities
(Dutch; bestuurder) for <FONT STYLE="white-space:nowrap">U-PACT</FONT> BV (<U><FONT STYLE="white-space:nowrap">www.u-pact.com</FONT></U>) and SERPINx BV (<U>www.serpinx.com</U>) as long as its <FONT STYLE="white-space:nowrap">non-competing</FONT>
with Company or IPA&#146;s business and creates no conflict of interest. When such a situation might occur, Martin will disclose and consult with the Board of Directors of IPA on the situation and parties will negotiate a solution in good faith.
Prior to the closing or as soon as reasonably can be expected parties agree that the mouse antibody and hybridoma business of Podiceps and the license agreements with the Utrecht University and University Medical Center Utrecht as well as the
existing distributor arrangements of Podiceps BV will be acquired by IP A as asset arrangement or alternatively be divested by Podiceps or sold to third parties. Further Martin hereby discloses that he and/or his holding company Bionomics BV is
shareholder of <FONT STYLE="white-space:nowrap">AM-Pharma</FONT> BV (<U>www.AM-Pharma.com</U>), BiOrion BV (<U>www.biorion.com</U>), Microdish BV, (<U>www.microdish.nl</U>) and Hoekmine BV (<U>www.hoekmine.com</U>), but has no active roles here.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>COMPENSATION AND EQUITY </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Company will continue to pay Podiceps a monthly fee of Euro 10.000 (ex VAT), each month for the term of the
Agreement commencing on the Effective Date. The monthly fee will be reviewed annually by the Board and may be increased at the sole discretion of the Board of Directors of IPA. Podiceps is responsible for any and all applicable taxes arising from
the payment of monthly fee or for any liabilities arising from any and all decisions from any Dutch taxing authorities including the Payroll Authority regarding the payment of the monthly fee. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Company will also pay Podiceps a portion of the profits achieved by the Company as further described in
Schedule A attached hereto and thereafter Podiceps will be entitled to receive annual bonuses upon achievement of performance targets based on key profitability metrics as set by the Board of Directors of IP A and at the sole discretion of the Board
of Directors of IP A. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Upon completion of the transaction with IPA in accordance with the Definitive Agreement, IP A will issue
Podiceps initial options (&#147;Options&#148;) in accordance with formulae agreed with the Board of Directors of IP A. These Options will be issued in accordance with IP A Stock Option Plan at exercise price set upon the completion of the
transaction with IP A. Podiceps will be entitled to exercise these Options as per the vesting terms set by the Board of Directors of IPA pursuant to IPA&#146;s Stock Option Plan. Thereafter, Podiceps will be entitled to the grant of additional
options pursuant to the IPA&#146;s Stock Option Plan at the sole discretion of the Board of Directors. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Company will pay Podiceps Euro 90,10 (ex VAT) for telephone and travel costs and any other <FONT
STYLE="white-space:nowrap">pre-approved</FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses in accordance with corporate policies and Podiceps shall provide a monthly summary of expenses with
receipts to Company of any other <FONT STYLE="white-space:nowrap">pre-approved</FONT> expenses other than telephone and travel costs. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>INTELLECTUAL PROPERTY, <FONT STYLE="white-space:nowrap">NON-COMPETITION</FONT> AND CONFIDENTIALITY </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Podiceps and Martin agree that all right, title, and interest in and to intellectual property, including but
not limited to all technical reports, business processes, procedures, techniques, routines, designs, drawings, and financial, commercial or technical information in any form, written materials, data bases, plans, diagrams, drawings, models, and
other things which Martin may conceive, develop or contribute to or reduce to practice arising from the performance of the roles and responsibilities as President and Chief Executive Officer which: (a)&nbsp;relates directly to Company&#146;s present
business or development; or (b)&nbsp;is created or made using any equipment, supplies, facilities, resources, or confidential information of Company, whether or not made during or after office hours, or on, or off Company&#146;s premises, or alone
or with others is hereinafter referred to as the &#147;Developments&#148;. These Developments shall be the sole property of Company, its assigns, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
and Company and its assigns shall be the sole owner of all intellectual prope1iy rights, including but not limited to copyrights, trade marks (word marks, design marks, certification or service
marks), trade secrets, and other rights in connection therewith the Developments. Martin agrees to assign, grant and convey to Company rights he may have or acquire in the intellectual property and intellectual property rights of the Developments
and will execute any and all assignments to give effect to this transfer of rights to Company. Martin irrevocably and unconditionally waives any moral rights he may have now or in the future in any Developments in favour of Company. Martin further
agrees, as to all such intellectual property and intellectual property rights, to assist Company in every proper way (at Company&#146;s expense) to obtain and from time to time enforce copyrights, trade marks, trade secrets, or other protection, on
said intellectual property, and to that end he will execute all documents for use in applying for and obtaining such protection and enforcing same, as Company may desire, together with any assignments thereof to Company or persons designated by it.
Parties realize that the IPR that are property of U-PACT BV and SERPINx BV are not included here and do not form part of the IPR and business of either the company or IP A. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Martin agrees during the term of this Agreement not to engage in any other business activity that would
directly or indirectly compete with the business of Company during the term of this Agreement and for a period of two (2)&nbsp;years following termination of this Agreement. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Martin agrees not to solicit directly or indirectly through a partnership or any business structures with any
customer/client of Company for any other business or business activity or to solicit or induce any employee of Company to join any other business or business activity for a period of two (2)&nbsp;years following termination of this Agreement.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Martin agrees to be bound by the confidentiality policies and procedures of Company to protect and not to
disclose without prior written consent of Company any confidential information of Company including but not limited to customer/client information, all Company data, Company information including the terms of this Agreement and that Martin will
execute any and all instruments to protect such confidential information of Company. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>TERMINATION</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to any Dutch statutory laws and or requirements, with one hundred and twenty days (120)&nbsp;written
notice to Podiceps (or Martin) for any reason as determined by the Board of Directors of IPA, without Podiceps (or Martin) being entitled to any damages in respect. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Podiceps may terminate the Agreement with one hundred and twenty days (120)&nbsp;written notice to the Company
and IP A Board of Directors following the expiry of the <FONT STYLE="white-space:nowrap">two-year</FONT> period as set out in Section&nbsp;1 above. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">15.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Agreement will terminate immediately in the event of insufficient funding, cessation of business,
bankruptcy or insolvency of Company, without Podiceps (or Martin) being entitled to any damages in that respect. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">16.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event of termination for any reason, Podiceps and Martin agrees to return all Company and project
materials, documents and documentation including electronic documents (&#147;Materials&#148;) in useable form relating to Company&#146;s business, work or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
investigations prepared, used or possessed by either of them or being under their control arising from the performance of Services which will be and remain the sole and exclusive property of
Company. All such Materials, including Company books and records are to be delivered to Company&#146;s address first referenced above or such address as provided by Company from time to time. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">17.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event of termination, Podiceps and Martin agrees to cooperate with Company to transition any such
current, pending or potential transactions and projects and provide all necessary information and or documentation. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">18.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event of termination, Podiceps and Martin agrees not to make disparaging and damaging comments or
statements in writing or verbally concerning Company in public or to any vendors or suppliers or take any actions that are intended to damage the reputation and goodwill of Company. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>GENERAL TERMS </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">19.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Agreement and the schedules attached hereto contain all the terms and conditions relating to the Services
to be performed by Podiceps for the benefit of the Company and replace all previous agreements relating thereto. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">20.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any further amendment, modification or variation hereof shall be valid only if it is in writing signed by all
the parties hereto. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">21.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Formal notices required or permitted by this Agreement shall be in writing and shall be delivered by email,
hand, by facsimile, or by registered mail to the addresses provided hereinunder or as provided by the parties from time to time. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">22.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Agreement and all matters arising hereunder shall be interpreted and construed in accordance with the laws
of the Netherlands. The parties will take all steps to resolve all disputes privately amongst themselves. In the event that such efforts are unsuccessful, such dispute including one regarding the existence, validity or termination of this Agreement
or the consequences of its nullity and any <FONT STYLE="white-space:nowrap">non-contractual</FONT> or other dispute (a <B>Dispute) </B>shall be referred to and finally resolved by arbitration in the Netherlands in accordance with the arbitration
rules of the Netherlands Arbitration Institute <I>(Nederlands Arbitrage Instituut) </I>taking into account the following (the <B>Rules), </B>taking into account the following: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the arbitral tribunal shall consist of three arbitrators of which at least one (1)&nbsp;shall be a lawyer with
a Netherlands law degree or admitted to practise Netherlands law, each of them appointed in accordance with the Rules. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the arbitral tribunal shall decide in accordance with the rules of law <I>(naar de regelen des rechts). </I>
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.1.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the seat of the arbitration shall be Amsterdam, the Netherlands and the language of the arbitration shall be
English. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.1.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Parties waive any right to refer points of law to appeal to the courts, to the extent that such waiver can
validly be made. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.1.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Parties agree that the arbitral tribunal shall have the power to order on a provisional basis any relief
which it would have power to grant in a final award. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">23.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Agreement and the rights and obligations herein shall not be assigned by Podiceps to any other party
without the express written consent of Company and any attempted assignment shall be considered to be void and of no force and effect. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">24.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Agreement shall enure to the benefit of and be binding upon the parties and their respective permitted
assigns. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">25.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The obligations hereinunder respecting the payments, ownership and use of intellectual property and
confidentiality survive the termination of this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">26.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A waiver of a provision of this Agreement shall not constitute a subsequent waiver of the provision nor any
other provision of this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">27.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event that a provision of this Agreement is deemed unenforceable by a court of competent jurisdiction,
the remaining provisions shall remain in full force and effect.29. This Agreement may be executed in counterparts by the parties, each of which shall constitute an original instrument for the purposes of this Agreement. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF </B>the Parties have executed this Management Agreement the day and year first before written above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ACCEPTED AND AGREED TO BY: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> EXPRESS B.V. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AUTHORIZED SIGNATORY </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ACCEPTED AND AGREED TO BY: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PODICEPS B.V. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AUTHORIZED SIGNATORY </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ACCEPTED AND AGREED TO BY: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IMMUNOPRESICE ANTIBODIES LTD. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AUTHORIZED SIGNATORY </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">In the presence of:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Witness</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-bottom:1pt; margin-top:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>MARTIN&nbsp;HESSING</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Occupation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE A &#150; CEO ROLES AND RESPONSIBILITIES </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In consultation with Board of Directors of IP A and its senior management team, CEO will be responsible for the overall leadership and management of the
Company and for the conduct of its business .. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The roles and responsibilities of CEO and/or the CEO&#146;s delegates shall include but not be limited to
the following items: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Vision&nbsp;&amp; Entrepreneurship </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">CEO shall lead strategic thinking on short and long-term direction for the Company. <B>
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B></B>CEO will create and communicate a vision for the development of the business. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Develop, implement and assess effectiveness of the corporate strategy and business plans. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Acquire and use knowledge of the marketplace to anticipate changes in the market to make strategic changes for
the Company. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Business Development </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">CEO shall represent the Company in developing relationships with stakeholders including shareholders, licensees,
suppliers, partners, employees, governments, industry community and others. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Expand and invest in the Company&#146;s R&amp;D program for its technology. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Lead corporate development activities. <B> </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B></B>Develop a strategic map of the European industry, determine Company&#146;s current and desired position
and develop and implement a plan to achieve the desired position </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Understand barriers to expansion and the strategies to overcome them </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>General Management </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Provide executive leadership to the Company and deliver the results targeted in the corporate strategy and
business plans. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Establish and maintain internal processes, procedures, and culture, and set a high standard of integrity
throughout the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Ensure the planning and management of the operating budget is within the means of the Company.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Assess the talent of potential personnel and identify the right people to become the senior management team at
the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Implement strategies and structures to recruit and retain highly productive employees </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Coach, mentor and encourage team development. <B> </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B></B>ensure effective communications between Management and the BOD </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Corporate Governance&nbsp;&amp; Compliance </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Ensure that financial statements are accurate, up to date and submitted to the BOD on a timely basis.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Approval of all expenditures and all contractual agreements and business arrangements. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Corporate Development&nbsp;&amp; Finance </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Define a clear vision and strategy for building corporate value. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Implement a 2017 Budget and thereafter prepare an annual budget (&#147;Budget&#148;) and review Budget regularly
with BOD. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Identify, prioritize and promote key value drivers for the Company, including the assessment of new market
opportunities. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Build financial models with internal and external resources to align the financial strategy with the corporate
vision. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Position the Company strategically and structurally to achieve maximum valuation and be attractive to
institutional investors and the broader investment community. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Ensure that transparent financial reporting structures are developed and implemented. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Build an external-facing communications strategy to articulate the right message to the right stakeholders that
will result in awareness of Company&#146;s technology, market opportunities, corporate recognition and enhanced valuation. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Marketing&nbsp;&amp; Investor Communication </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Assume management responsibility for all aspects of marketing strategy, marketing communications, marketing and
promotions for Company </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Attend various industry and financial conferences to actively promote the Company to potential and existing
investors. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE B &#150; PROFIT SHARING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with the terms of the Letter of lntent executed by the parties on June&nbsp;30, 2017, Podiceps B.V. is entitled to share in the net profits
earned by <FONT STYLE="white-space:nowrap">U-Protein</FONT> as a shareholder over the next three years as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">50% of the net profits, less subsidies, grants or other government funding for the first year;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">33% of the net profits, less subsidies, grants or other government funding for the second year;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">20% of the net profits, less subsidies, grants or other government funding for third year.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EMPLOYMENT AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS EMPLOYMENT AGREEMENT (the &#147;Agreement&#148;) dated this&nbsp;&nbsp;&nbsp;&nbsp; day of August 2017 (the &#147;Effective Date&#148;) is: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">BETWEEN:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B><FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> EXPRESS BV. </B>having its business address at Life Sciences Incubator, Utrecht, Science Park, Yalelaan, 62, 3584, CM, Utrecht, The Netherlands</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">(&#147;Company&#148;)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">AND:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>IMMUNOPRECISE ANTIBODIES LTD. </B>having its business address at U.Vic Vancouver Island Technology Park, #3204-4464 Markham Street, Victoria, BC, Canada, V8Z 7X8</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">(&#147;IPA&#148;)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">AND:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>ROLAND ROMIJN, </B>having an address at Mr.&nbsp;Tydemanstraat 23, 4001 CR Tiel, The Netherlands</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">(&#147;Roland&#148;)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(Hereinafter collectively referred to as the &#147;Parties&#148;) </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>WHEREAS </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Company shareholders have entered into a definitive agreement in which each of shareholders of Company has
exchanged their shares for IPA shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Company and IPA wishes Roland to continue on a full-time basis with the Company as Chief Scientist and Roland
accepts this continuing appointment in accordance with the terms and conditions of this Employment Agreement. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOW THEREFORE </B>with the consideration and mutual covenants contained herein, the parties agree that
the following terms and conditions shall apply to the relationship: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ROLES AND RESPONSIBILITIES </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As of the Effective Date, Company, IPA and Roland agree that Roland shall continue to as Chief Scientist of the
Company, on a full-time employment basis, based on a forty-hour work week, as further described in Schedule A for the term of the Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Roland shall report to President and CEO of the Company. in the performance of his full-time roles and
responsibilities as Chief Scientist. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Roland shall adhere to all corporate policies and procedures as amended from time to time in the performance of
his roles and responsibilities for the term of the Agreement including the protection of confidential information of Company and will execute any and all instruments to protect such confidential information. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Roland agrees: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">not to engage in any other projects or business activities that would conflict or compete with Company&#146;s
business; &middot; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to disclose in writing to Company any conflict of interest circumstances and any
<FONT STYLE="white-space:nowrap">non-arms</FONT> length transactions and or projects to Company during the term of the Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">not engage to in any other projects or work without prior disclosure, consultation and written approval of the
Company; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to disclose in writing to the Company all current business and consulting services and activities that he is
currently engaged in. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>COMPENSATION AND EQUITY </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Company will continue to pay Roland a monthly base salary of Euro 6669,75 gross including the statutory holiday
allowance, each month for the term of the Agreement commencing on the Effective Date. The monthly base salary will be reviewed annually by the Board and may be increased at the sole discretion of the Board of Directors of IP A.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Company will also pay Roland a portion of the profits achieved by the Company as further described in Schedule
B attached hereto and as determined by the Company and thereafter Roland will be entitled to receive annual bonuses upon achievement of performance targets based on key profitability metrics as set by the Board of Directors of IPA and at the sole
discretion of the Board of Directors of IPA. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Upon completion of the transaction with IPA in accordance with the Definitive Agreement, IP A will issue Roland
initial options (&#147;Options&#148;) in accordance with formulae agreed with the Board of Directors of IP A. These Options will be issued in accordance with IP A Stock Option Plan at exercise price set upon the completion of the transaction with
IPA. Roland will be entitled to exercise these Options as per the vesting terms set by the Board of Directors of IP A pursuant to IP A&#146;s Stock Option Plan. Thereafter, Roland will be entitled to the grant of additional options pursuant to the
IPA&#146;s Stock Option Plan at the sole discretion of the Board of Directors. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Company will pay Roland Euro 189 gross for travel costs and any other
<FONT STYLE="white-space:nowrap">pre-approved</FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses in accordance with corporate policies and Roland shall provide a monthly summary of expenses
with receipts to Company of any other <FONT STYLE="white-space:nowrap">pre-approved</FONT> expenses other than travel costs. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Roland will participate in any Company and IPA benefits plans implemented from time to time where applicable.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Roland will be entitled to thirty (30)&nbsp;days of vacation scheduled in consultation with the Chief Executive
Officer of Company, eight percent (8%) vacation compensation payable in May annually and three percent (3%) compensation payable in December annually, and to any other Dutch employment statutory rights and or benefits. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company is not bound by any collective bargaining agreement and no collective bargaining agreement applies
to the subject employment. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>INTELLECTUAL PROPERTY, <FONT STYLE="white-space:nowrap">NON-COMPETITION</FONT> AND CONFIDENTIALITY
</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Roland agrees that all right, title, and interest in and to intellectual property, including but not limited to
all technical reports, business processes, procedures, techniques, routines, designs, drawings, and financial, commercial or technical information in any form, written materials, data bases, plans, diagrams, drawings, models, and other things which
Roland may conceive, develop or contribute to or reduce to practice arising from the performance of the roles and responsibilities as Chief Scientist which: (a)&nbsp;relates directly to Company&#146;s present business or development; or (b)&nbsp;is
created or made using any equipment, supplies, facilities, resources, or confidential information of Company, whether or not made during or after office hours, or on, or off Company&#146;s premises, or alone or with others is hereinafter referred to
as the &#147;Developments&#148;. These Developments shall be the sole property of Company, its assigns, and Company and its assigns shall be the sole owner of all intellectual property rights, including but not limited to copyrights, trade marks
(word marks, design marks, certification or service marks), trade secrets, and other rights in connection therewith the Developments. Roland agrees to assign, grant and convey to Company rights he may have or acquire in the intellectual property and
intellectual property rights of the Developments and will execute any and all assignments to give effect to this transfer of rights to Company. Roland irrevocably and unconditionally waives any moral rights he may have now or in the future in any
Developments in favour of Company. Roland further agrees, as to all such intellectual property and intellectual property rights, to assist Company in every proper way (at Company&#146;s expense) to obtain and from time to time enforce copyrights,
trade marks, trade secrets, or other protection, on said intellectual property, and to that end he will execute all documents for use in applying for and obtaining such protection and enforcing same, as Company may desire, together with any
assignments thereof to Company or persons designated by it. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Roland agrees during the term of this Agreement not to engage in any other business activity that would
directly or indirectly compete with the business of Company during the term of this Agreement and for a period of two (2)&nbsp;years following termination of this Agreement. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Roland agrees not to solicit directly or indirectly through a partnership or any business structures with any
customer/client of Company for any other business or business activity or to solicit or induce any employee of Company to join any other business or business activity for a period of two (2)&nbsp;years following termination of this Agreement.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">15.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Roland agrees to be bound by the confidentiality policies and procedures of Company to protect and not to
disclose without prior written consent of Company any confidential information of Company including but not limited to customer/client information, all Company data, Company information including the terms of this Agreement and that Roland will
execute any and all instruments to protect such confidential information of Company. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>TERMINATION </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">16.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to any Dutch statutory laws and prior permission of Employment Tribunal <I>(UWV), </I>Company may
terminate the Agreement for any reason with one hundred and twenty (120)&nbsp;days written notice (&#147;Notice&#148;) as per any day of a calendar month, for any reason or in lieu of such written notice the payment of the equivalent of salary and
benefits for such Notice. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">17.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Company may terminate the Agreement immediately for just cause. Just cause for the purposes of this Agreement
means the basis under Dutch law in which an employee may be terminated immediately without notice including but not limited to inappropriate, fraudulent and illicit actions. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">18.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Roland may terminate this Agreement with sixty (60)&nbsp;days written notice to Company and Board of Directors
of IP A as per any day of a calendar month. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">19.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event of termination for any reason, Roland agrees to return all Company and project materials,
documents and documentation including electronic documents (&#147;Materials&#148;) in useable form relating to Company&#146;s business, work or investigations prepared, used or possessed by his under his control arising from the performance of
Services which will be and remain the sole and exclusive property of Company. All such Materials, including Company books and records are to be delivered to Company&#146;s address first referenced above or such address as provided by Company from
time to time. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">20.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event of termination, Roland agrees to cooperate with Company to transition any such current, pending or
potential transactions and projects and provide all necessary information and or documentation. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">21.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event of termination, Roland agrees not to make disparaging and damaging comments or statements in
writing or verbally concerning Company in public or to any vendors or suppliers or take any actions that are intended to damage the reputation and goodwill of Company. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>GENERAL TERMS </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">22.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Agreement and the schedules attached hereto contain all the terms and conditions relating to the
employment of Roland by the Company and replace all previous agreements relating thereto. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">23.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any further amendment, modification or variation hereof shall be valid only if it is in writing signed by all
the parties hereto. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">24.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Formal notices required or permitted by this Agreement shall be in writing and shall be delivered by email,
hand, by facsimile, or by registered mail to the addresses provided hereinunder or as provided by the parties from time to time. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">25.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Agreement and all matters arising hereunder shall be interpreted and construed in accordance with the laws
of the Netherlands. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">26.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Agreement and the rights and obligations herein shall not be assigned by Roland to any other party without
the express written consent of Company and any attempted assignment shall be considered to be void and of no force and effect. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">27.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Agreement shall enure to the benefit of and be binding upon the parties and their respective permitted
assigns. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">28.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The obligations hereinunder respecting the payments, ownership and use of intellectual property and
confidentiality survive the termination of this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">29.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A waiver of a provision of this Agreement shall not constitute a subsequent waiver of the provision nor any
other provision of this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">30.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event that a provision of this Agreement is deemed unenforceable by a court of competent jurisdiction,
the remaining provisions shall remain in full force and effect. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">31.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Agreement may be executed in counterparts by the parties, each of which shall constitute an original
instrument for the purposes of this Agreement. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF </B>the Parties have executed this Employment Agreement the day
and year first before written above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ACCEPTED AND AGREED TO BY: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> EXPRESS B.V. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AUTHORIZED SIGNATORY </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ACCEPTED AND AGREED TO BY: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ACCEPTED AND AGREED TO BY: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AUTHORIZED SIGNATORY </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">In the presence of:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Witness</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-bottom:1pt; margin-top:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>ROLAND ROMIJN</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Occupation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE A &#150; CHIEF SCIENTIST </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[to be attached] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE B &#150; PROFIT SHARING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with the terms of the Letter of lntent executed by the parties on June&nbsp;30, 2017, Roland is entitled to share in the net profits earned by <FONT
STYLE="white-space:nowrap">U-Protein</FONT> as a shareholder over the next three years as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">50% of the net profits, less subsidies, grants or other government funding for the first year;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">33% of the net profits, less subsidies, grants or other government funding for the second year;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">20% of the net profits, less subsidies, grants or other government funding for third year.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.65
<SEQUENCE>66
<FILENAME>d20922dex9965.htm
<DESCRIPTION>EX-99.65
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.65</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.65 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g50a04.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Increases Financing to $2.592 Million </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, May&nbsp;15, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTC QB: IPATF) is pleased to
announce that it has increased its previously announced (see news release dated April&nbsp;24, 2020 and May&nbsp;8, 2020) <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement financing of 10% convertible debentures from
CAD$2,300,000 to CAD$2,592,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The debentures will continue to be unsecured, bear interest at a rate of ten percent (10%) per year, payable annually,
and are due two years from the date of issue (which may be repaid early at the option of the Company). The principal amount of the debentures may be convertible, at the option of the holder, into units of the Company at a conversion price of $0.85
per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company may force convert the principal amount of the debentures at CAD$0.85 per share if the average closing price is equal to or greater
than CAD$1.50 for 20 trading days. In order to exercise this right, the Company must issue a news release announcing its intention to exercise this right within 10 business days after the end of the particular
<FONT STYLE="white-space:nowrap">20-day</FONT> period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Closing of the offering is subject to acceptance of the TSX Venture Exchange. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a
full-service, therapeutic antibody discovery Contract Research Organization offering species agnostic, multi-format, characterized and engineered, human monoclonal antibodies, on an abbreviated timeframe, for its pharmaceutical clients. For further
information, visit <U>www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com</U>. There is no assurance that ImmunoPrecise will be successful in the development of a vaccine and/or therapeutic against the new coronavirus. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release
contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148; within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;,
&#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and similar expressions to identify forward-looking statements. Any such forward-looking statements are based on
assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and expected future developments. However, whether actual results and developments will conform to
ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the
forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual
management discussion and analysis for the quarter ended January&nbsp;31, 2020 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless
required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise. </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922ccc1.jpg" ALT="LOGO">
 View original content to download multimedia: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.newswire.ca/en/releases/archive/May2020/15/c2707.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 12:00e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">15-MAY-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.66
<SEQUENCE>67
<FILENAME>d20922dex9966.htm
<DESCRIPTION>EX-99.66
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.66</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.66 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g50a06.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Closes Oversubscribed Debenture Financing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, May&nbsp;15, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTC QB: IPATF) is pleased to
announce that it has closed its previously announced <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement financing by issuing a total of CAD$2,592,000 10% convertible debentures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The debentures are unsecured, bear interest at a rate of ten percent (10%) per year, payable annually, and are due May&nbsp;15, 2022 (which may be repaid
early at the option of the Company). The principal amount of the debentures may be convertible, at the option of the holder, into units of the Company at a conversion price of CAD $0.85 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company may force convert the principal amount of the debentures at CAD$0.85 per share if the average closing price is equal to or greater than CAD$1.50
for 20 trading days. In order to exercise this right, the Company must issue a news release announcing its intention to exercise this right within 10 business days after the end of the particular <FONT STYLE="white-space:nowrap">20-day</FONT>
period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jennifer Bath, CEO of the Company, subscribed for $175,000 of debentures and Paul Andreola, a director of the Company, subscribed, directly and
indirectly, for a total of $229,000 debentures. Participation by these insiders in the private placement is considered a related party transaction pursuant to Multilateral Instrument <FONT STYLE="white-space:nowrap">61-101</FONT> &#151; Protection
of Minority Security Holders in Special Transactions. The Company is exempt from the requirements to obtain a formal valuation or minority shareholder approval in connection with the insider&#146;s participation in the private placement in reliance
of sections 5.5(a) and 5.7(a) of MI <FONT STYLE="white-space:nowrap">61-101.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The securities are subject to restrictions on resale expiring on
September&nbsp;16, 2020. The Company paid finders cash commissions totalling $43,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Proceeds of the offering will be used to expand operations and
sales in the United States, Canada and Europe and working capital purposes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Resignation of Chief Technical Officer</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chip Wilson has announced he is resigning as Chief Technical Officer effective immediately. The Board of Directors would like to thank Mr.&nbsp;Wilson for all
of his efforts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On behalf of the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About
ImmunoPrecise Antibodies Ltd. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a full-service, therapeutic antibody discovery Contract Research Organization offering species
agnostic, multi-format, characterized and engineered, human monoclonal antibodies, on an abbreviated timeframe, for its pharmaceutical clients. For further information, visit <U>www.immunoprecise.com</U> or contact
<U>solutions@immunoprecise.com</U>. There is no assurance that ImmunoPrecise will be successful in the development of a vaccine and/or therapeutic against the new coronavirus. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release
contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148; within the meaning of applicable Canadian securities</I> </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<I>laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148;
and similar expressions to identify forward-looking statements. Any such forward-looking statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions
and expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause
ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower
than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and analysis for the quarter ended January&nbsp;31, 2020 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking
statements&#148; contained herein speak only as of the date of this press release and, unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information,
future events or otherwise.</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922ccc1.jpg" ALT="LOGO">
 View original content to download multimedia: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.newswire.ca/en/releases/archive/May2020/15/c9403.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 18:06e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">15-MAY-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.67
<SEQUENCE>68
<FILENAME>d20922dex9967.htm
<DESCRIPTION>EX-99.67
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.67</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.67 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT STYLE="white-space:nowrap">51-102F3</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MATERIAL CHANGE REPORT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Name and Address of Company </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman"><B>IMMUNOPRECISE ANTIBODIES LTD.</B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">3204-4464 Markham Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">Victoria, BC V8Z 7X8 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">(the
&#147;Company&#148;) </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Date of Material Change </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">May&nbsp;15, 2020 </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>News Release </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">The news release was issued on May&nbsp;15, 2020 and was disseminated by Cision. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Summary of Material Change </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">On May&nbsp;15, 2020, the Company closed a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement financing of 10% convertible
debentures in the principal amount of CAD$2,592,000. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">Also on May&nbsp;15, 2020, the Company announced the resignation of its Chief
Technology Officer, Chip Wheelock. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Full Description of Material Change </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman"><U>Convertible Debenture Financing</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">On May&nbsp;15, 2020, the Company closed its previously announced <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement
financing by issuing 10% convertible debentures in the principal amount of CAD$2,592,000. The debentures are unsecured, bear interest at a rate of 10% per annum, payable annually and are due May&nbsp;15, 2022 (which may be repaid early at the option
of the Company). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">The principal amount of the debentures may be convertible, at the option of the holder, into shares of the Company at a
conversion price of CAD$0.85 per share. The Company may force convert the principal amount of the debentures at $0.85 per share if the average closing price is equal to or greater than CAD$1.50 for twenty (20)&nbsp;trading days (the &#147;20 Day
Period&#148;). In order to exercise this right, the Company must issue a new release announcing its intention to exercise this right within 10 business days after the end of the particular 20 Day Period. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">Jennifer Bath, CEO of the Company, subscribed for $175,000 of debentures and Paul Andreola, a director of the Company, subscribed, directly
and indirectly, for a total of $229,000 debentures. Participation by these insiders in the private placement is considered a related party transaction pursuant to Multilateral Instrument <FONT STYLE="white-space:nowrap">61-101</FONT> &#150;
Protection of Minority Security Holders in Special Transactions. The Company is exempt from the requirements to obtain a formal valuation or minority shareholder approval in connection with the insider&#146;s participation in the private placement
in reliance of sections 5.5(a) and 5.7(a) of MI <FONT STYLE="white-space:nowrap">61-101.</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">The securities are subject to
restrictions on resale expiring on September&nbsp;16, 2020. The Company paid finders cash commissions totalling $43,000. Proceeds of the offering will be used to expand operations and sales in the United States, Canada and Europe and working capital
purposes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman"><U>Resignation of Chief Technology Officer</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">Also on May&nbsp;15, 2020, the Company announced the resignation of its Chief Technology Officer, Chip Wheelock. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;&nbsp;6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Reliance on Subsection 7.1(2) of National Instrument <FONT STYLE="white-space:nowrap">51-102</FONT>
</B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Omitted Information </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">None. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Executive Officer </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">For further information, please contact: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman"><B>Jennifer Bath</B> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">Chief
Executive Officer </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">(250) <FONT STYLE="white-space:nowrap">483-0308</FONT> </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Date of Report </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:10%; font-size:10pt; font-family:Times New Roman">May&nbsp;21, 2020 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.68
<SEQUENCE>69
<FILENAME>d20922dex9968.htm
<DESCRIPTION>EX-99.68
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.68</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.68 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DATED 14th MARCH 2019 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUSYS B.V.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MODIQUEST
RESEARCH B.V. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMULEASE B.V. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MR JOS RAATS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE NETHERLANDS B.V. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES
LTD. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT, TERMINATION AND SETTLEMENT AGREEMENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THIS AMENDMENT, TERMINATION AND SETTLEMENT AGREEMENT</B> is dated 14th March 2019 and is made<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BETWEEN: </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>IMMUSYS B.V. </B>a private company with limited liability (<I>besloten vennootschap met beperkte
aansprakelijkheid</I>) incorporated under the laws of the Netherlands, having its corporate seat in Haarlemmermeer, the Netherlands and its registered address at Schoutstraat 58, 6525XV Nijmegen, the Netherlands, the Netherlands, registered with the
trade register (<I>handelsregister</I>) of the Chamber of Commerce (<I>Kamer van Koophandel</I>) with registration number 09140672 (<B>Immusys</B>); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>MODIQUEST RESEARCH B.V.</B>, a private company with limited liability (<I>besloten vennootschap met beperkte
aansprakelijkheid</I>) incorporated under the laws of the Netherlands, having its corporate seat in Nijmegen, the Netherlands and its registered address at Kloosterstraat 9, RE21, 5349 AB Oss, the Netherlands, registered with the trade register
(<I>handelsregister</I>) of the Chamber of Commerce (<I>Kamer van Koophandel</I>) with registration number 09148575 (<B>ModiQuest Research</B>); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>IMMULEASE B.V.</B>, a private company with limited liability (<I>besloten vennootschap met beperkte
aansprakelijkheid</I>) incorporated under the laws of the Netherlands, having its corporate seat in Haarlemmermeer, the Netherlands and its registered address at Schoutstraat 58, 6525XV Nijmegen, the Netherlands, the Netherlands, registered with the
trade register (<I>handelsregister</I>) of the Chamber of Commerce (<I>Kamer van Koophandel</I>) with registration number 09213199 (<B>Immulease</B>); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>MR JOZEF MARIA RAATS</B>, a private individual born in Brunssum, the Netherlands on 22&nbsp;February 1962,
currently residing at Schoutstraat 58, 6525XV Nijmegen, the Netherlands, the Netherlands (<B>Raats</B>); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>IMMUNOPRECISE NETHERLANDS B.V.</B> a private company with limited liability (<I>besloten vennootschap met
beperkte aansprakelijkheid</I>) incorporated under the laws of the Netherlands, having its corporate seat in Haarlemmermeer, the Netherlands and its registered address at Kloosterstraat 9, RE21, 5349AB Oss, the Netherlands, the Netherlands,
registered with the trade register (<I>handelsregister</I>) of the Chamber of Commerce (<I>Kamer van Koophandel</I>) with registration number 71010149 (<B>ImmunoPrecise Netherlands</B>); and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>IMMUNOPRECISE ANTIBODIES LTD.</B>, a limited liability company, having its business address at U.Vic
Vancouver Island Technology Park, #3204-4464 Markham Street, Victoria, BC, Canada, V8Z 7X8 (<B>ImmunoPrecise Antibodies</B>). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ModiQuest
Research, Immulease, ImmunoPrecise Netherlands and ImmunoPrecise Antibodies are hereinafter jointly also referred to as the <B>IPA Group Companies </B>and each also an <B>IPA Group Company</B>. The IPA Group Companies, Immusys and Raats are
hereinafter jointly referred to as the <B>Parties </B>and each as a <B>Party</B>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>WHEREAS: </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On 15&nbsp;March 2018, the IPA Group Companies and Immusys entered into a share purchase agreement in relation
to the sale by Immusys of all of the shares in ModiQuest Research and Immulease (the <B>Shares</B>) to ImmunoPrecise Netherlands (a 100% subsidiary of ImmunoPrecise Antibodies) (the <B>SPA</B>). Transfer of the Shares was completed on 6&nbsp;April
2018. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On the date hereof, Immusys is a managing director of ImmunoPrecise Netherlands and Raats (the 100% shareholder
of Immusys) is a managing director of Immusys, ImmunoPrecise Netherlands and <FONT STYLE="white-space:nowrap">U-Protein</FONT> Express B.V. (a 100% subsidiary of ImmunoPrecise Antibodies (<B><FONT STYLE="white-space:nowrap">U-Protein</FONT>
Express</B>)). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On 1&nbsp;February 2005, ModiQuest Research and Immusys entered into a management agreement in connection with
the provision of certain services by Immusys to ModiQuest Research, which management agreement was amended on 15&nbsp;March 2018 (the <B>Management Agreement</B>). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(D)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Parties agreed to prematurely terminate the Management Agreement, effective as per 1&nbsp;March 2019 (the
<B>Effective Date</B>). The Parties furthermore agreed that: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">effective as per the Effective Date, Immusys shall resign as managing director B of ModiQuest Research;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">effective as per the Effective Date, Raats shall resign as managing director of
<FONT STYLE="white-space:nowrap">U-Protein</FONT> and ImmunoPrecise Netherlands; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">ImmunoPrecise Antibodies shall pay the Settlement Amount (as defined below in, and in accordance with, Clause
2) to Immusys. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(E)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In this amendment, termination and settlement agreement (the <B>Settlement Agreement</B>), the Parties wish to
lay down the terms and conditions under which (i)&nbsp;the Management Agreement shall be terminated, (ii)&nbsp;Immusys shall resign as managing director B of ModiQuest Research and Raats shall resign as managing director of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> and ImmunoPrecise Netherlands, (iii)&nbsp;the Deferred Cash Payment and Deferred Share Payment as referred to in section 2.3 (b) of the SPA shall no longer be subject to an adjustment in accordance with
section 2.5 of the SPA, and (a)&nbsp;to fully and finally settle all claims a Party has or may have in respect of, as a consequence of or in connection with the termination of the Management Agreement and the various relationships (including the
directorship of Immusys with ModiQuest Research and the directorship of Raats with <FONT STYLE="white-space:nowrap">U-Protein</FONT> and ImmunoPrecise Netherlands) in respect of the Management Agreement and the SPA (including all claims any IPA
Group Company has or may have in respect of, as a consequence of or in connection with any representation and warranty relative to the Deferred Cash Payment and Deferred Share Payment provisions in the SPA). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(F)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In this Settlement Agreement, the Parties furthermore wish to clarify that section 2.1 of the Trademark and
Domain name Assignment and License Agreement dated 12&nbsp;March 2018 (the <B>Trademark License Agreement</B>) pursuant to which Licensee 1 (as defined in the Trademark License Agreement) is licensed to use the trademark &#147;Modiquest&#148; in
communications with and to certain parties, also includes the right to use the email domains the email domains &#145;@modiquest.com&#146; and &#145;@modiquest.nl&#146; (the <B>Email Domains</B>). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IT IS HEREBY AGREED AS FOLLOWS: </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>TERMINATION OF THE MANAGEMENT AGREEMENT; RESIGNATIONS </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Immusys, Raats and ModiQuest Research hereby agree that the Management Agreement, in deviation of section 8 of
the Management Agreement, shall terminate effective as per the Effective Date without any termination fee or any other amount being payable by any Party (either pursuant to the Management Agreement, the SPA or otherwise) in relation with such
termination and/or the resignations referred to below in Clause 1.2), except for the payment by ImmunoPrecise Antibodies to Immusys of the Settlement Amount in accordance with Clause 2. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Immusys shall resign as managing director B of ModiQuest Research and Raats shall resign as managing director
of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and ImmunoPrecise Netherlands, all effective as per the Effective Date. Immusys and Raats shall each sign, as soon as possible after the date hereof and in any event no later than 15<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP> March 2019, resignation letters substantially in the form attached hereto as <B>Annex 1 </B>(the <B>Resignation Letters</B>). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Parties acknowledge and confirm that termination of the Management Agreement shall not affect in any way
whatsoever any of the obligations under clause 5 (<I>Confidentiality</I>), clause 6 (<I>Return of documents</I>), clause 7 (<I>Violation/penalties</I>) and/or clause 9 (<I>Non-competition and
<FONT STYLE="white-space:nowrap">non-solicitation</FONT></I>) which shall remain in full force and effect. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Without prejudice to Clause 1.3, neither Immusys nor Raats shall have or keep in its/his possession documents
and/or correspondence and/or data carriers and/or copies thereof, containing confidential information in relation to any IPA Group Company and in general information on (the operations of) any IPA Group Company, which have been made available to any
of them or created by them (either alone or with others) in respect of the services under the Management Agreement (the <B>Data Carriers</B>). Raats shall, unless otherwise agreed with ImmunoPrecise Antibodies, on or before 15<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP> March 2019, return to ImmunoPrecise Antibodies (or such other IPA Group Company as ImmunoPrecise Antibodies shall designate) all Data Carriers and no copies, other than electronic copies made
pursuant to automatic archiving, computer <FONT STYLE="white-space:nowrap">back-up</FONT> procedures and/or disaster recovery systems shall be kept and it being understood that nothing herein shall derogate any rights granted or given to Immusys and
its affiliates under the Disentanglement Agreement (as defined in the SPA). </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>TRADEMARK LICENSE: EMAIL DOMAINS </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Without prejudice to the rights granted to the Licensee 1 and the Licensee 2 under the Trademark License
Agreement, the Parties acknowledge and agree that the right to use the trademark &#147;Modiquest&#148; when used in communications as referred to in section 2.1 of Trademark License Agreement, also include the right for Immusys and Raats (and their
affiliates) to use the Email Domains in such communications and Immusys and Raats agree that they (as well as their affiliates) shall only use the Email Domains for the sole purpose of communications with
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
the competent authorities, patent agents and other experts to maintain the current patent registrations of Modiquest B.V. as well as the licensees of such patents. With a view to the foregoing
and for the purposes set out in sections 2.1 through 2.1.3 of the Trademark License Agree, section 2.1.7 of the Trade Mark Licence Agreement shall be revised to read as follows: &#147;<I>Communications with Assignor when addressed by Assignee or its
affiliates, or when useful to inform Assignee or its affiliates about the (performance or termination) license granted herein, or communications with Assignee or its affiliates, shareholders of Modiquest B.V., third party licensees of said patents
and patent applications and their advisors or other third parties which Modiquest B.V. is obliged to inform according current contracts or when useful to inform such parties&#148;.</I> </TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SETTLEMENT AMOUNT </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the terms and conditions of this Settlement Agreement and provided that ImmunoPrecise Antibodies has
received the duly signed Resignation Letters, ImmunoPrecise Antibodies hereby agrees to pay to Immusys a cash amount of EUR 1,000,000, being an amount equal to three times the Deferred Cash Payment (the <B>Cash Settlement Amount</B>) in the
following three instalments: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="56%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Instalment</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Payment Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EUR 333,333</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">20<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> March 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EUR 335,555</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1&nbsp;May 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EUR 333,556</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1&nbsp;May 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the terms and conditions of this Settlement Agreement and provided that ImmunoPrecise Antibodies has
received the duly signed Resignation Letters, ImmunoPrecise Antibodies hereby furthermore agrees to pay to Immusys an amount of EUR 1,000,000 (the <B>Share Settlement Amount</B>), payable in three instalments in kind by means of issuance of such
number of common shares in its capital (such common shares the <B>IPA Shares</B>) as shall be calculated as follows: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="56%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Instalment</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Issue Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B># of IPA Shares</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EUR 335,555</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">31&nbsp;March 2019 (the <B>First</B> <B>Issue Date</B>).</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">such # of IPA Shares having a value of EUR 333,555 based on the greater of (1) $0.57 per IPA Share, and (2)&nbsp;the closing price of the IPA Shares as quoted on the TSXV (the <B>Closing Price</B>) on 31&nbsp;December 2018,
converted to euros based on average the daily exchange rate as quoted by the Bank of Canada for the 10 Business Days immediately prior to the First Issue Date</TD></TR></TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
<DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="95%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="56%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EUR 335,555</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">As soon as reasonably possible after 30&nbsp;April 2020 but no later than 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> May 2020 (the <B>Second Issue</B> <B>Date</B>)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">such # of IPA Shares having a value of EUR 335,555 based on the greater of (1) $0.57 per IPA Share, and (2)&nbsp;the Closing Price of the IPA Shares as quoted on 30&nbsp;April 2020, converted to euros based on average the daily
exchange rate as quoted by the Bank of Canada for the 10 Business Days immediately prior to the Second Issue Date</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EUR 335,556</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">As soon as reasonably possible after 30&nbsp;April 2021 but no later than 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> May 2021 (the <B>Second Issue</B> <B>Date</B>)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">such # of IPA Shares having a value of EUR 335,556 based on the greater of (1) $0.57 per IPA Share, and (2)&nbsp;the Closing Price of the IPA Shares as quoted on 30&nbsp;April 2021, converted to euros based on average the daily
exchange rate as quoted by the Bank of Canada for the 10 Business Days immediately prior to the Third Issue Date</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to Immusys and Raats each having been discharged by the general meeting of shareholders of the
companies referred to in Recital (B)&nbsp;above at or prior to the date of this Settlement Agreement (<B>Discharge</B>), Immusys and Raats declare and confirm that payment of the Cash Settlement Amount and the Share Settlement Amount (jointly the
<B>Settlement Amount</B>) to Immusys constitutes full and final settlement and discharge (<I>volledige kwijting</I>) of any and all claims they, or any company or person affiliated with any of them, have or may have against any IPA Group Company
pursuant to, in respect of, as a consequence of or in connection with the SPA, the Management Agreement and the termination thereof, and their resignation as managing director of ModiQuest Research, <FONT STYLE="white-space:nowrap">U-Protein</FONT>
and ImmunoPrecise Netherlands. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to Immusys and Raats each having been granted Discharge and except for payment of the Settlement
Amount, each of Immusys and Raats hereby irrevocably and unconditionally waives any rights or claims it/he has or may have against any IPA Group Company, in respect of, as a consequence of or in connection with section 2.3, 2.4, 2.5 and 2.6 of the
SPA (as applicable unto the signing of this Settlement Agreement), the Management Agreement, the termination of the Management Agreement and their resignation as managing director of ModiQuest Research,
<FONT STYLE="white-space:nowrap">U-Protein</FONT> and ImmunoPrecise Netherlands. Likewise, each IPA Group Company hereby irrevocably and unconditionally waives any rights or claims it/he has or may have against Raats or Immusys pursuant to, in
respect of, as a consequence of or in connection with section 2.3, 2.4, 2.5 and 2.6 of the SPA (as applicable unto the signing of this Settlement Agreement), the Management Agreement, the termination of the Management Agreement and their resignation
as managing director of ModiQuest Research, <FONT STYLE="white-space:nowrap">U-Protein</FONT> and ImmunoPrecise Netherlands, and any covenant, representation and warranty by Immusys or Raats relative thereto. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">ImmunoPrecise Netherlands and ImmunoPrecise Antibodies each represent that it has no claim under any warranty
given by Immusys in the SPA or other Transaction Documents (as defined in the SPA) at the date of signing this Settlement Agreement nor it is aware, having heard senior staff, their officers and directors, of any facts or circumstances that may
cause such claim. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Neither ImmunoPrecise Netherlands nor ImmunoPrecise Antibodies shall be entitled to deduct any amount or set
off any claim for Losses (as defined in the SPA) to ImmunoPrecise Netherlands or ImmunoPrecise Antibodies against any portion of the Settlement Amount set forth in Section&nbsp;3.1 and 3.2 due (or to become due) by ImmunoPrecise Antibodies to
Immusys nor delay payment of any portion of the Settlement Amount. Each IPA Group Company accepts and agrees with Immusys and Raats that in the event of any controversy or inconsistency between (A)&nbsp;the provisions of the Transaction Documents
and (B)<B></B>&nbsp;the provisions of Clause 3.1 through this Clause 3.6, the latter shall supersede and that nothing therein is intended or shall be construed to release ImmunoPrecise Antibodies from its duty to pay any and all portions of the
Settlement Amount by ImmunoPrecise Antibodies on respectively the First Issue Date, the Second Issue Date and Third Issue Date. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>MISCELLANEOUS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Costs</B> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each Party shall bear its own fees and expenses in connection with the negotiation, preparation and completion
of this Settlement Agreement, and in fulfilling any obligations in connection with this Settlement Agreement </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Further
assurance</B> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each Party shall at its own costs and expenses from time to time execute such documents, perform such acts and
do things as the other Part(y)(ies) may reasonably require to give the fullest possible effect to the transactions contemplated by this Settlement Agreement. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Confidentiality</B> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each Party will keep the existence and contents of this Settlement Agreement confidential, unless disclosure is
required by any court or other competent authority. Each IPA Group Company undertakes to Immusys and Raats that it shall refrain from making negative comments or statements to third parties about Immusys and Raats which would adversely affect the
business carried on by them. Each of Immusys and Raats undertakes to each IPA Group Company that it shall refrain from making negative comments or statements to third parties about any IPA Group Company which would adversely affect the business
carried on by them. <B> </B></P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Entire Agreement</B> </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Settlement Agreement and the agreements referred to herein concerning Sections 2.3, 2.4 and 2.5 of the
SPA, the Management Agreement and the clarification of the License Agreement referred to herein constitute the entire agreement between the Parties relating to the subject matter hereof and set aside and cancel any earlier agreements, either
verbally or in writing, between the Parties with respect to Sections 2.3, 2.4 and 2.5 of the SPA and the Management Agreement. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding the aforesaid, the Trademark Licence Agreement (as amended), the Disentanglement Agreement and
any other Transaction Documents all rights and duties thereunder shall remain in full force and effect as provided in each of such documents including but not limited to the current loan agreements between Immusys and Immulease in the amount of euro
8,000, and between Modiquest B.V. and ModiQuest Research in the amount of respectively euro 38,025 and euro 38, 000. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Amendments</B> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Settlement Agreement may not be amended, supplemented or changed, nor may any provision of this Settlement
Agreement be waived, except by a written instrument making specific reference to this Settlement Agreement signed by the Party against whom enforcement of any such amendment, supplement, change or waiver is sought. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Severability</B> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.7</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The invalidity or unenforceability of any provision of this Settlement Agreement shall not affect the validity
or enforceability of any other provision of this Settlement Agreement. Any such invalid or unenforceable provision shall be replaced or be deemed to be replaced by a provision that is considered to be valid and enforceable and which interpretation
shall be as close as possible to the intent of the invalid or unenforceable provision. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>No rescission</B> </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.8</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each Party waives its right to rescind (<I>ontbinden</I>) this Settlement Agreement, in whole or in part, on
the basis of section 6:265 Dutch Civil Code or to request a competent court to amend this Settlement Agreement on the basis of section 6:230(2) Dutch Civil Code. Furthermore, a Party in error (<I>dwaling</I>) shall bear the risk of that error in
making this Settlement Agreement. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Counterparts</B> </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.9</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Settlement Agreement may be signed in any number of counterparts, each of which shall be deemed an
original and all of which together shall form one instrument. Each Party may enter into this Settlement Agreement by executing any such counterpart. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Settlement agreement</B> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.10</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Settlement Agreement constitutes a settlement agreement (<I>vaststellingsovereenkomst</I>) in accordance
with article 7:900 of the Dutch Civil Code. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>APPLICABLE LAW AND COMPETENT COURT </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Settlement Agreement and any dispute, controversy or claim arising hereunder or in connection herewith,
its subject matter or formation (including any dispute or claim relating to <FONT STYLE="white-space:nowrap">non-contractual</FONT> obligations) shall be exclusively governed by and construed in accordance with the laws of the Netherlands.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any and all disputes between the Parties hereto arising under or in connection with this Settlement Agreement
or further agreements resulting from this Settlement Agreement, including all disputed claims for breach by any party of any undertaking or covenant under this Settlement Agreement, shall be finally resolved by the Amsterdam District Court following
proceedings in English before the Chamber for International Commercial Matters (<B>Netherlands Commercial Court</B> or <B>NCC</B>). An action for interim measures, including protective measures, available under Dutch law may be brought in the
NCC&#146;s Court in Summary Proceedings in proceedings in English. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I></I>[<I>signature page follows</I>]<I> </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS </B>whereof the Parties have executed this Settlement Agreement on the date which appears
first on the first page. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For and on behalf of <B>IMMUSYS B.V.</B> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g05a19.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name: Jos Raats</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title: managing director</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For and on behalf of <B>MODIQUEST RESEARCH B.V.</B> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g05b19.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name: Ms.&nbsp;Jennifer Lynne Bath</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title: managing director</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For and on behalf of <B>IMMULEASE B.V.</B> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g05c19.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name: Ms.&nbsp;Jennifer Lynne Bath</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title: managing director</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For and on behalf of <B>IMMUNOPRECISE NETHERLANDS B.V.</B> </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g05d19.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name: Ms.&nbsp;Jennifer Lynne Bath</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title: managing director</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For and on behalf of <B>IMMUNOPRECISE ANTIBODIES LTD.</B> </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g05e19.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name: Ms.&nbsp;Jennifer Lynne Bath</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title: managing director</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>JOS RAATS</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g05f19.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ANNEX 1: FORM RESIGNATION LETTER </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">To:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">[relevant company] </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[&#9679;] 2019 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Re: Resignation as managing director of
[</B>&#9679;<B></B><B>] </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Sirs, </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I hereby inform you
that I tender my resignation from my position as managing director (<I>bestuurder</I>) on the management board (<I>bestuur</I>) of [&#9679;], a private company with limited liability (<I>besloten vennootschap met beperkte aansprakelijkheid</I>)
incorporated under the laws of the Netherlands, having its corporate seat in [&#9679;], the Netherlands and its registered address at [&#9679;], the Netherlands, registered with the trade register (<I>handelsregister</I>) of the Chamber of Commerce
(<I>Kamer van Koophandel</I>) with registration number [&#9679;] (the <B>Company</B>), effective as per 1&nbsp;March 2019 (the <B>Effective Time</B>). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
hereby request the general meeting of shareholders of the Company to discharge me (<I>finale kwijting verlenen</I>) for my duties and activities as managing director of the Company in the period up to and including the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I declare that, as per the Effective Time, I have no outstanding claims whatsoever against the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I furthermore agree to cooperate with anything reasonably required or reasonably advisable in connection with my resignation as managing director of the
Company. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Yours sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="49"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> &nbsp;<P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:3pt">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.69
<SEQUENCE>70
<FILENAME>d20922dex9969.htm
<DESCRIPTION>EX-99.69
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.69</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.69 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g20922dsp1_2.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">Form <FONT STYLE="white-space:nowrap">45-106F1</FONT> Report of Exempt Distribution </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">BCSC EDER Reference Number 9130385 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">ITEM&nbsp;1&#151;REPORT TYPE </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">&uuml; New report </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Amended report If amended, provide filing date of report that is being
amended <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">(YYYY-MM-DD)</FONT></FONT> </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">ITEM&nbsp;2&#151;PARTY CERTIFYING THE REPORT </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Indicate the party certifying the report (select only one). For guidance regarding whether an issuer is an investment fund, refer to section 1.1 of National Instrument <FONT
STYLE="white-space:nowrap">81-106</FONT> Investment Fund Continuous Disclosure and the companion policy to NI <FONT STYLE="white-space:nowrap">81-106.</FONT>
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Investment fund issuer </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">&uuml; Issuer (other than an investment fund)
Underwriter </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">ITEM&nbsp;3&#151;ISSUER NAME AND OTHER IDENTIFIERS </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Provide the
following information about the issuer, or if the issuer is an investment fund, about the fund. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Full legal name ImmunoPrecise Antibodies Ltd. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Previous full legal name </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If the issuer&#146;s name changed in the last 12 months, provide most
recent previous legal name. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Website (if applicable) </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If the issuer has a legal
entity identifier, provide below. Refer to Part B of the Instructions for the definition of &#147;legal entity identifier&#148;. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Legal entity identifier
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If two or more issuers distributed a single security, provide the full legal name(s) of the <FONT STYLE="white-space:nowrap">co-issuer(s)</FONT> other than the
issuer named above. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Full legal name(s) of <FONT STYLE="white-space:nowrap">co-issuer(s)</FONT> (if applicable) </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">ITEM&nbsp;4&#151;UNDERWRITER INFORMATION </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If an underwriter is completing the report, provide
the underwriter&#146;s full legal name and firm NRD number. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Full legal name
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Firm NRD number (if applicable) </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If the underwriter does not have a firm NRD
number, provide the head office contact information of the underwriter. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Street address </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Municipality Province/State </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Country Postal code/Zip code </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Telephone number Website (if applicable) </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g20922dsp2_1.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">ITEM&nbsp;5&#151;ISSUER INFORMATION </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If the issuer
is an investment fund, do not complete Item 5. Proceed to Item 6. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">a)&nbsp;&nbsp;&nbsp;&nbsp;Primary industry </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Provide the issuer&#146;s North American Industry Classification Standard (NAICS) code (6 digits only) that in your reasonable judgment most closely corresponds to the
issuer&#146;s primary business activity. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">NAICS industry code 3 2 5 4 1 2 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If
the issuer is in the mining industry, indicate the stage of operations. This does not apply to issuers that provide services to issuers operating in the mining industry. Select the category that best describes the issuer&#146;s stage of operations.
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Exploration Development Production </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Is the issuer&#146;s primary business to
invest all or substantially all of its assets in any of the following? If yes, select all that apply. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Mortgages Real estate Commercial/business debt Consumer debt
Private companies Cryptoassets&nbsp;&nbsp;&nbsp;&nbsp;b)&nbsp;&nbsp;&nbsp;&nbsp;Number of employees </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Number of employees: &uuml; 0&#151;49 50&#151;99 100&#151;499
500 or more </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">c)&nbsp;&nbsp;&nbsp;&nbsp;SEDAR profile number </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Does the issuer
have a SEDAR profile? </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">No &uuml; Yes If yes, provide SEDAR profile number 0 0 0 0 5 5 4 2 </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If the issuer does not have SEDAR profile complete item 5(d)&#151;(h).
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">d)&nbsp;&nbsp;&nbsp;&nbsp;Head office address </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Street address Province/State
Municipality Postal code/Zip code Country Telephone number&nbsp;&nbsp;&nbsp;&nbsp;e)&nbsp;&nbsp;&nbsp;&nbsp;Date of formation and financial <FONT STYLE="white-space:nowrap">year-end</FONT> </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Date of formation Financial <FONT STYLE="white-space:nowrap">year-end</FONT> </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">YYYY MM DD MM DD
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">f)&nbsp;&nbsp;&nbsp;&nbsp;Reporting issuer status </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Is the issuer a reporting
issuer in any jurisdication of Canada? No Yes </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If yes, select the jurisdictions of Canada in which the issuer is a reporting issuer. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">All AB BC MB NB NL NT NS NU ON PE QC SK YT&nbsp;&nbsp;&nbsp;&nbsp;g)&nbsp;&nbsp;&nbsp;&nbsp;Public listing status </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If the issuer has a CUSIP number, provide below (first 6 digits only) </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">CUSIP number </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If the issuer is publicly listed, provide the name of the exchange on which the issuer&#146;s equity securities primarily trade. Provide only the name of an exchange and not a
trading facility such as, for example, an automated trading system.</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Exchange name </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">h)&nbsp;&nbsp;&nbsp;&nbsp;Size of issuer&#146;s assets </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Select the size of the issuer&#146;s
assets based on its most recently available annual financial statements (Canadian $). If the issuer has not prepared annual financial statements for its first financial year, provide the size of the issuer&#146;s assets at the distribution end date.
</FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g20922ndsp3.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">$0 to under $5M $5M to under $25M $25M to under $100M </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">$100M to under $500M $500M to under $1B $1B or over </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g20922dsp4_2.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">ITEM&nbsp;6&#151;INVESTMENT FUND ISSUER INFORMATION
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If the issuer is an investment fund, provide the following information. &nbsp;&nbsp;&nbsp;&nbsp;a)&nbsp;&nbsp;&nbsp;&nbsp;Investment fund manager information Full
legal name </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Firm NRD number (if applicable) </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If the investment fund manager
does not have a firm NRD number, provide the head office contact information of the investment fund manager. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Street address </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Municipality Province/State Country Postal code/Zip code Telephone number Website (if applicable)&nbsp;&nbsp;&nbsp;&nbsp;b)&nbsp;&nbsp;&nbsp;&nbsp;Type of investment fund
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Type of investment fund that most accurately identifies the issuer (select only one) . </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Money market Equity Fixed income Balanced </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Alternative strategies Cryptoasset Other (describe)
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Indicate whether one or both of the following apply to the investment fund .
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Invests primarily in other investment fund issuers </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Is a UCITs Fund&sup1;
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">&sup1;Undertaking for the Collective Investment of Transferable Securities funds (UCITs Funds) are investment funds regulated by the European Union (EU) directives
that allow collective investment schemes to operate throughout the EU on a passport basis on authorization from one member state. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">c)&nbsp;&nbsp;&nbsp;&nbsp;Date of
formation and financial <FONT STYLE="white-space:nowrap">year-end</FONT> of the investment fund </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Date of formation Financial
<FONT STYLE="white-space:nowrap">year-end</FONT> </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">YYYY MM DD MM DD
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">d)&nbsp;&nbsp;&nbsp;&nbsp;Reporting issuer status of the investment fund </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Is
the investment fund a reporting issuer in any jurisdication of Canada? No Yes </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If yes, select the jurisdictions of Canada in which the investment fund is a
reporting issuer. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">All AB BC MB NB NL NT NS NU ON PE QC SK YT&nbsp;&nbsp;&nbsp;&nbsp;e)&nbsp;&nbsp;&nbsp;&nbsp;Public listing status of the investment fund
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If the investment fund has a CUSIP number, provide below (first 6 digits only)
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">CUSIP number </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If the investment fund is publicly listed, provide the name of
the exchange on which the investment fund&#146;s securities primarily trade. Provide only the name of an exchange and not a trading facility such as, for example, an automated trading system.</FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Exchange name </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">f)&nbsp;&nbsp;&nbsp;&nbsp;Net asset value (NAV) of the investment fund
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Select the NAV range of the investment fund as of the date of the most recent NAV calculation (Canadian $). $0 to under $5M $5M to under $25M $25M to under $100M
$100M to under $500M $500M to under $1B $1B or over Date of NAV calculation: </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">YYYY MM DD </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g20922ndsp5_2.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">ITEM&nbsp;7&#151;INFORMATION ABOUT THE DISTRIBUTION
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If an issuer located outside of Canada completes a distribution in a jurisdiction of Canada, include in Item 7 and Schedule 1 information about </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">purchasers resident in that jurisdiction of Canada only. Do not include in Item 7 securities issued as payment of commissions or finder&#146;s fees in </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">connection with the distribution, which must be disclosed in Item 8. The information provided in Item 7 must reconcile with the information provided in </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Schedule 1 of the report.</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">a)&nbsp;&nbsp;&nbsp;&nbsp;Currency </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Select the currency or currencies in which the distribution was made. All dollar amounts provided in the report must be in Canadian dollars. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">&uuml; Canadian dollar US dollar Euro Other (describe) </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">b)&nbsp;&nbsp;&nbsp;&nbsp;Distribution
date(s) </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">State the distribution start and end dates. If the report is being filed for securities distributed on only one distribution date, provide the distribution
date </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">as both the start and end dates. If the report is being filed for securities distributed on a continuous basis, include the start and end dates for the
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">distribution period covered by the report.</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Start date 2020 05 15 End date 2020
05 25 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">YYYY MM DD YYYY MM DD </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">c)&nbsp;&nbsp;&nbsp;&nbsp;Detailed purchaser
information </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Complete Schedule 1 of this form for each purchaser and attach the schedule to the completed report. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">d)&nbsp;&nbsp;&nbsp;&nbsp;Types of securities distributed </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Provide the following information
for all distributions reported on a per security basis. Refer to Part A(12) of the Instructions for how to indicate the </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">security code. If providing the CUSIP
number, indicate the full <FONT STYLE="white-space:nowrap">9-digit</FONT> CUSIP number assigned to the security being distributed. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Canadian $ </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Single or </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Security CUSIP number Number of </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Description of security lowest Highest price Total amount </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">code (if applicable) securities
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">price </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">C V D 875907 2,627,000.00 1.0000 2,627,000.00 </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">e)&nbsp;&nbsp;&nbsp;&nbsp;Details of rights and convertible/exchangeable securities </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If any
rights (e.g. warrants, options) were distributed, provide the exercise price and expiry date for each right. If any convertible/exchangeable securities </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">were
distributed, provide the conversion ratio and describe any other terms for each convertible/exchangeable security.</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Convertible / </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Exercise price </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">exchangeable Underlying Expiry date Conversion </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">(Canadian $) </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">security code security code (YYYY- <FONT STYLE="white-space:nowrap">MM-DD)</FONT>
ratio Describe other items (if applicable) </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Lowest Highest </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">C V D C M S 0.8500
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">f)&nbsp;&nbsp;&nbsp;&nbsp;Summary of the distribution by jurisdiction and exemption </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">State the total dollar amount of securities distributed and the number of purchasers for each jurisdiction of Canada and foreign jurisdiction where a </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">purchaser resides and for each exemption relied on in Canada for that distribution. However, if an issuer located outside of Canada completes a </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">distribution in a jurisdiction of Canada, include distributions to purchasers resident in that jurisdiction of Canada only. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">This table requires a separate line item for: (i)&nbsp;each jurisdiction where a purchaser resides, (ii)&nbsp;each exemption relied on in the jurisdiction where a </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">purchaser resides, if a purchaser resides in a jurisdiction of Canada, and (iii)&nbsp;each exemption relied on in Canada, if a purchaser resides in a foreign </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">jurisdiction. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">For jurisdictions within Canada, state the province or territory, otherwise
state the country. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Province or Number of unique&sup2;&ordf; </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Exemption relied
on Total amount (Canadian $) </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">country purchasers </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Alberta NI <FONT
STYLE="white-space:nowrap">45-106</FONT> 2.3 [Accredited investor] 3 110,000.00 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">British Columbia NI <FONT STYLE="white-space:nowrap">45-106</FONT> 2.3 [Accredited
investor] 17 1,344,000.00 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Ontario NI <FONT STYLE="white-space:nowrap">45-106</FONT> 2.3 [Accredited investor] 15 500,000.00 </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Qu&eacute;bec NI <FONT STYLE="white-space:nowrap">45-106</FONT> 2.3 [Accredited investor] 9 305,000.00 </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">United Kingdom NI <FONT STYLE="white-space:nowrap">45-106</FONT> 2.3 [Accredited investor] 1 68,000.00 </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">United States NI <FONT STYLE="white-space:nowrap">45-106</FONT> 2.3 [Accredited investor] 2 225,000.00 </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g20922ndsp6.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">NI <FONT STYLE="white-space:nowrap">45-106</FONT> 2.5 [Family, friends and business 1 75,000.00 Ontario associates] </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Total dollar amount of securities distributed 2,627,000.00 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Total number of unique
purchasers&sup2;&aacute;&micro;&#135; 48 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">2a In calculating the number of unique purchasers per row, count each purchaser only once. Joint purchasers may be counted
as one purchaser. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">2b In calculating the total number of unique purchasers to which the issuer distributed securities, count each purchaser only once, regardless of
whether the issuer distributed multiple types of securities to, and relied on multiple exemptions for, that purchaser. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">g)&nbsp;&nbsp;&nbsp;&nbsp;Net proceeds to
the investment fund by jurisdiction </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If the issuer is an investment fund, provide the net proceeds to the investment fund for each jurisdiction of Canada and
foreign jurisdiction where a purchaser resides.&sup3; If an issuer located outside of Canada completes a distribution in a jurisdiction of Canada, include net proceeds for that jurisdiction of Canada only. For jurisdictions within Canada, state the
province or territory, otherwise state the country. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Net proceeds Province or country (Canadian $) </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Total net proceeds to the investment fund </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">&sup3;&#147;Net proceeds&#148; means the gross
proceeds realized in the jurisdiction from the distributions for which the report is being filed, less the gross redemptions that occurred during the distribution period covered by the report. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">h)&nbsp;&nbsp;&nbsp;&nbsp;Offering materials&#151;This section applies only in Saskatchewan, Ontario, Qu&eacute;bec, New Brunswick and Nova Scotia. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If a distribution has occurred in Saskatchewan, Ontario, Qu&eacute;bec, New Brunswick or Nova Scotia, complete the table below by listing the offering materials that are required
under the prospectus exemption relied on to be filed with or delivered to the securities regulatory authority or regulator in those jurisdictions. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">In Ontario, if
the offering materials listed in the table are required to be filed with or delivered to the Ontario Securities Commission (OSC), attach an electronic version of the offering materials that have not been previously filed with or delivered to the
OSC. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Previously filed </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Date of document or Date previously filed or with or
delivered to Description other material delivered regulator? </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">(YYYY-MM-DD)</FONT></FONT> <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">(YYYY-MM-DD)</FONT></FONT> (Y/N) </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g20922ndsp7_2.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">ITEM&nbsp;8&#151;COMPENSATION INFORMATION </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Provide
information for each person (as defined in NI <FONT STYLE="white-space:nowrap">45-106)</FONT> to whom the issuer directly provides, or will provide, any compensation in connection with the distribution. Complete additional copies of this page if
more than one person was, or will be, compensated. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Indicate whether any compensation was paid, or will be paid, in connection with the distribution. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">No &uuml; Yes If yes, indicate number of persons compensated. 3&nbsp;&nbsp;&nbsp;&nbsp;a)&nbsp;&nbsp;&nbsp;&nbsp;Name of person compensated and registration status </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Indicate whether the person compensated is a registrant. No &uuml; Yes If the person compensated is an individual, provide the name of the individual. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Full legal name of individual </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Family name First given name Secondary given names </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If the person compensated is not an individual, provide the following information. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Full legal
name of <FONT STYLE="white-space:nowrap">non-individual</FONT> Canaccord Genuity Corp. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Firm NRD number 9 0 0 (if applicable) </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Indicate whether the person compensated facilitated the distribution through a funding portal or an internet-based portal. &uuml; No Yes </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">b)&nbsp;&nbsp;&nbsp;&nbsp;Business contact information </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If a firm NRD number is not provided in
Item 8 (a), provide the business contact information of the person being compensated. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Street address </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Municipality Province/State Country Postal code/Zip code Email address Telephone number
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">c)&nbsp;&nbsp;&nbsp;&nbsp;Relationship to issuer or investment fund manager
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Indicate the person&#146;s relationship with the issuer or investment fund manager (select all that apply). Refer to the meaning of &#147;connected&#148; in Part
B(2) of the Instructions and the meaning of &#147;control&#148; in section 1.4 of NI <FONT STYLE="white-space:nowrap">45-106</FONT> for the purposes of completing this section. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Connect with the issuer or investment fund manager Insider of the issuer (other than an investment fund) </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Director or officer of the investment fund or investment fund manager Employee of the issuer or investment fund manager </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">&uuml; None of the above&nbsp;&nbsp;&nbsp;&nbsp;d)&nbsp;&nbsp;&nbsp;&nbsp;Compensation details
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Provide details of all compensation paid, or to be paid, to the person identified in Item 8(a) in connection with the distribution. Provide all amounts in Canadian
dollars. Include cash commissions, securities-based compensation, gifts, discounts or other compensation. Do not report payments for services incidental to the distribution, such as clerical, printing, legal or accounting services. An issuer is not
required to ask for details about, or report on, internal allocation arrangements with the directors, officers or employees of a <FONT STYLE="white-space:nowrap">non-individual</FONT> compensated by the issuer. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Cash commissions paid 40,500.00 Security code 1 Security code 2 Security code 3 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Value of all
securities </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Security codes distributed as compensation&acirc;&acute; </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Describe
terms of warrants, options or other rights </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Other compensation&acirc;&micro; Describe </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Total compensation paid 40,500.00 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Check box if the person will or may receive any deferred
compensation (describe the terms below) </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">&acirc;&acute;Provide the aggregate value of all securities distributed as compensation, excluding options, warrants or
other rights exercisable to acquire additional securities of the issuer. Indicate the security codes for all securities distributed as compensation, including options, warrants or other rights exercisable to acquire additional securities of the
issuer. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">&acirc;&micro;Do not include deferred compensation. </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g20922ndsp8.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">a)&nbsp;&nbsp;&nbsp;&nbsp;Name of person compensated and registration status </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Indicate whether the person compensated is a registrant. No &uuml; Yes If the person compensated is an individual, provide the name of the individual. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Full legal name of individual </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Family name First given name Secondary given names </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If the person compensated is not an individual, provide the following information. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Full legal
name of <FONT STYLE="white-space:nowrap">non-individual</FONT> Echelon Wealth Partners </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Firm NRD number 3 2 4 2 0 (if applicable) </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Indicate whether the person compensated facilitated the distribution through a funding portal or an internet-based portal. &uuml; No Yes </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">b)&nbsp;&nbsp;&nbsp;&nbsp;Business contact information </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If a firm NRD number is not provided in
Item 8 (a), provide the business contact information of the person being compensated. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Street address </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Municipality Province/State Country Postal code/Zip code Email address Telephone number
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">c)&nbsp;&nbsp;&nbsp;&nbsp;Relationship to issuer or investment fund manager
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Indicate the person&#146;s relationship with the issuer or investment fund manager (select all that apply). Refer to the meaning of &#147;connected&#148; in Part
B(2) of the Instructions and the meaning of &#147;control&#148; in section 1.4 of NI <FONT STYLE="white-space:nowrap">45-106</FONT> for the purposes of completing this section. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Connect with the issuer or investment fund manager Insider of the issuer (other than an investment fund) </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Director or officer of the investment fund or investment fund manager Employee of the issuer or investment fund manager </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">&uuml; None of the above&nbsp;&nbsp;&nbsp;&nbsp;d)&nbsp;&nbsp;&nbsp;&nbsp;Compensation details
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Provide details of all compensation paid, or to be paid, to the person identified in Item 8(a) in connection with the distribution. Provide all amounts in Canadian
dollars. Include cash commissions, securities-based compensation, gifts, discounts or other compensation. Do not report payments for services incidental to the distribution, such as clerical, printing, legal or accounting services. An issuer is not
required to ask for details about, or report on, internal allocation arrangements with the directors, officers or employees of a <FONT STYLE="white-space:nowrap">non-individual</FONT> compensated by the issuer. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Cash commissions paid 2,500.00 Security code 1 Security code 2 Security code 3 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Value of all
securities </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Security codes distributed as compensation&acirc;&acute; </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Describe
terms of warrants, options or other rights </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Other compensation&acirc;&micro; Describe </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Total compensation paid 2,500.00 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Check box if the person will or may receive any deferred
compensation (describe the terms below) </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">&acirc;&acute;Provide the aggregate value of all securities distributed as compensation, excluding options, warrants or
other rights exercisable to acquire additional securities of the issuer. Indicate the security codes for all securities distributed as compensation, including options, warrants or other rights exercisable to acquire additional securities of the
issuer. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">&acirc;&micro;Do not include deferred compensation. </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g20922ndsp9.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">a)&nbsp;&nbsp;&nbsp;&nbsp;Name of person compensated and registration status </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Indicate whether the person compensated is a registrant. No &uuml; Yes If the person compensated is an individual, provide the name of the individual. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Full legal name of individual </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Family name First given name Secondary given names </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If the person compensated is not an individual, provide the following information. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Full legal
name of <FONT STYLE="white-space:nowrap">non-individual</FONT> Raymond James Ltd. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Firm NRD number 8 2 4 0 (if applicable) </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Indicate whether the person compensated facilitated the distribution through a funding portal or an internet-based portal. &uuml; No Yes </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">b)&nbsp;&nbsp;&nbsp;&nbsp;Business contact information </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If a firm NRD number is not provided in
Item 8 (a), provide the business contact information of the person being compensated. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Street address </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Municipality Province/State Country Postal code/Zip code Email address Telephone number
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">c)&nbsp;&nbsp;&nbsp;&nbsp;Relationship to issuer or investment fund manager
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Indicate the person&#146;s relationship with the issuer or investment fund manager (select all that apply). Refer to the meaning of &#147;connected&#148; in Part
B(2) of the Instructions and the meaning of &#147;control&#148; in section 1.4 of NI <FONT STYLE="white-space:nowrap">45-106</FONT> for the purposes of completing this section. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Connect with the issuer or investment fund manager Insider of the issuer (other than an investment fund) </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Director or officer of the investment fund or investment fund manager Employee of the issuer or investment fund manager </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">&uuml; None of the above&nbsp;&nbsp;&nbsp;&nbsp;d)&nbsp;&nbsp;&nbsp;&nbsp;Compensation details
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Provide details of all compensation paid, or to be paid, to the person identified in Item 8(a) in connection with the distribution. Provide all amounts in Canadian
dollars. Include cash commissions, securities-based compensation, gifts, discounts or other compensation. Do not report payments for services incidental to the distribution, such as clerical, printing, legal or accounting services. An issuer is not
required to ask for details about, or report on, internal allocation arrangements with the directors, officers or employees of a <FONT STYLE="white-space:nowrap">non-individual</FONT> compensated by the issuer. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Cash commissions paid 1,750.00 Security code 1 Security code 2 Security code 3 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Value of all
securities </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Security codes distributed as compensation&acirc;&acute; </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Describe
terms of warrants, options or other rights </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Other compensation&acirc;&micro; Describe </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Total compensation paid 1,750.00 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Check box if the person will or may receive any deferred
compensation (describe the terms below) </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">&acirc;&acute;Provide the aggregate value of all securities distributed as compensation, excluding options, warrants or
other rights exercisable to acquire additional securities of the issuer. Indicate the security codes for all securities distributed as compensation, including options, warrants or other rights exercisable to acquire additional securities of the
issuer. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">&acirc;&micro;Do not include deferred compensation. </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g20922ndsp10.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">ITEM&nbsp;9&#151;DIRECTORS, EXECUTIVE OFFICERS AND PROMOTERS OF THE ISSUER </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If the issuer is an investment fund, do not complete Item 9. Procced to Item 10.&nbsp;
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Indicate whether the issuer is any of the following (select the one that applies&#151;if more than one applies, select only one). </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">&uuml; Reporting issuer in any jurisdiction of Canada Foreign public issuer </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Wholly owned
subsidiary of a reporting issuer in any jurisdiction of Canada&acirc;&para; </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Provide name of reporting issuer </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Wholly owned subsidiary of a foreign public issuer&acirc;&para; </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Provide name of foreign public
issuer </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Issuer distributing only eligible foreign securities and the distribution is to permitted clients only&acirc;&middot; </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If the issuer is at least one of the above, do not complete Item 9(a) &#150; (c). Proceed to Item 10.</FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">&acirc;&para;An issuer is a wholly owned subsidiary of a reporting issuer or a foreign public issuer if all of the issuer&#146;s outstanding voting securities, other than
securities that are required by law to be owned by its directors, are beneficially owned by the reporting issuer or the foreign public issuer, respectively.
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">&acirc;&middot;Check this box if it applies to the current distribution even if the issuer made previous distributions of other types of securities to <FONT
STYLE="white-space:nowrap">non-permitted</FONT> clients. Refer to the definitions of &#147;eligible foreign security&#148; and &#147;permitted client&#148; in Part B(1) of the Instructions. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If the issuer is none of the above, check this box and complete Item 9(a)&#151;(c).
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">a)&nbsp;&nbsp;&nbsp;&nbsp;Directors, executive officers and promoters of the issuer </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Provide the following information for each director, executive officer and promoter of the issuer. For locations within Canada, state the province or territory; otherwise state the
country. For &#147;Relationship to issuer&#148;, &#147;D&#148; &#150; Director, &#147;O&#148; &#150; Executive Officer, &#147;P&#148; &#150; Promoter. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Business
location of non-individual or </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Relationship to issuer residentail Secondary given (select all that apply) jurisdiction of Organization or company name Family name
First given name names individual </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Province or country D O P
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">b)&nbsp;&nbsp;&nbsp;&nbsp;Promoter information </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If the promoter listed above
is not an individual, provide the following information for each director and executive officer of the promoter. For locations within Canada, state the province or territory; otherwise state the country. For &#147;Relationship to promoter&#148;,
&#147;D&#148; &#150; Director, &#147;O&#148; &#150; Executive Officer. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Residential </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Relationship to promoter jurisdiction of Secondary given individual (select one or both if applicable) Organization or company name Family name First given name names Province or D
O country </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">c)&nbsp;&nbsp;&nbsp;&nbsp;Residential address of each individual
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Complete Schedule 2 of this form providing the full residential address for each individual listed in Item 9(a) and (b)&nbsp;and attach to the completed report.
Schedule 2 also requires information to be provided about control persons. </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g20922ndsp11.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">ITEM&nbsp;10&#151;CERTIFICATION </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Provide the
following certification and business contact information of an officer, director or agent of the issuer or underwriter. If the issuer or underwriter is not a company, an individual who performs functions similar to that of a director or officer may
certify the report. For example, if the issuer is a trust, the report may be certified by the issuer&#146;s trustee. If the issuer is an investment fund, a director or officer of the investment fund manager (or, if the investment fund manager is not
a company, an individual who performs similar functions) may certify the report if the director or officer has been authorized to do so by the investment fund. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">The
certification may be delegated, but only to an agent that has been authorized by an officer or director of the issuer or underwriter to prepare and certify the report on behalf of the issuer or underwriter. If the report is being certified by an
agent on behalf of the issuer or underwriter, provide the applicable information for the agent in the boxes below. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If the individual completing and filing the
report is different from the individual certifying the report, provide the name and contact details for the individual completing and filing the report in Item 11.
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">The signature on the report must be in typed form rather than handwritten form. The report may include an electronic signature provided the name of the signatory
is also in typed form. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Securities legislation requires an issuer or underwriter that makes a distribution of securities under certain prospectus exemptions to file
a completed report of exemt distribution. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">By completing the information below, I certify, on behalf of the issuer/underwriter/investment fund manager, to the
securities regulatory authority or regulator, as applicable, that I have reviewed this report and to my knowledge, having exercised reasonable diligence, the information provided in this report is true and, to the extent required, complete.
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Name of issuer/underwriter/ Immunoprecise Antibodies Ltd.&nbsp;&nbsp;&nbsp;&nbsp;investment fund manager/agent </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Full legal name Bath Jennifer </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Family
name&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;First given name Secondary given names </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Title CEO </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Telephone number 7789661252 Email address jennifer@immunoprecise.com </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Signature Jennifer Bath
Date 2020 05 25 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">YYYY MM DD
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF"><FONT STYLE="white-space:nowrap">ITEM&nbsp;11-</FONT> CONTACT PERSON </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Provide
the following business contact information for the individual that the securities regulatory authority or regulator may contact with any questions regarding the contents of this report, if different than the individual certifying the report in Item
10. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Same as individual certifying the report </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Full legal name Hethey Charles
Title Attorney </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Family name First given name Secondary given names </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Name of
company O&#146;Neill Law LLP </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Telephone number 6046875792 Email address cch@stockslaw.com </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g20922ndsp12.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">Notice&#151;Collection and use of personal information </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">The personal information required under this form is collected on behalf of and used by the securities regulatory authority or regulator under the authority granted in securities
legislation for the purposes of the administration and enforcement of the securities legislation. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">If you have any questions about the collection and use of this
information, contact the securities regulatory authority or regulator in the local jurisdiction(s) where the report is filed, at the address(es) listed at the end of this form. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">The attached Schedules 1 and 2&nbsp;may contain personal information of individuals and details of the distribution(s). The information in Schedules 1 and 2 will not be placed on
the public file of any securities regulatory authority or regulator. However, freedom of information legislation may require the securities regulatory authority or regulator to make this information available if requested. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">By signing this report, the issuer/underwriter confirms that each individual listed in Schedule 1 or 2 of the report who is resident in a jurisdiction of Canada:
a)&nbsp;&nbsp;&nbsp;&nbsp;has been notified by the issuer/underwriter of the delivery to the securities regulatory authority or regulator of the information pertaining to the individual as set out in Schedules 1 or 2, that this information is being
collected by the securities regulatory authority or regulator under the authority granted in securities legislation, that this information is being collected for the purposes of the administration and enforcement of the securities legislation of the
local jurisdiction, and of the title, business address and business telephone number of the public official in the local jurisdiction, as set out in this form, who can answer questions about the security regulatory authority&#146;s or
regulator&#146;s indirect collection of the information, and&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;has authorized the indirect collection of the information by the securities regulatory authority or regulator. </FONT></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.70
<SEQUENCE>71
<FILENAME>d20922dex9970.htm
<DESCRIPTION>EX-99.70
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.70</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.70 </B></P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g0910042201519.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NSERC Awards Grant to Fund Collaboration Between ImmunoPrecise and the University of Victoria for the Generation of a
Potential <FONT STYLE="white-space:nowrap">COVID-19</FONT> Antibody-Based Test in Canada that can Provide Real-Time Responses </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, May&nbsp;27,
2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTCQB: IPATF), specialists in custom antibody discovery and development, today announced a collaboration between University of Victoria
(&#147;UVic&#148;)-based laboratory of Dr.&nbsp;Alexandre Brolo, experts in the development of novel diagnostic tools, and ImmunoPrecise Antibodies. The objective of this partnership is to develop a colorimetric antibody-based test for the detection
and screening of <FONT STYLE="white-space:nowrap">COVID-19.</FONT> Although most immunoassays are developed for blood or serum, this team is aiming to use patient saliva. The goal is to enable the test to be realized with an easily obtainable
sample, which should be suitable for a home-test kit. The color change readout will be measured using a cell phone camera and analyzed by a custom cell phone application. The results, including the general location (by zone rather than by specific
household, to comply with privacy rights) of the test, can be uploaded to a cloud-hosted database. This will provide immediate information about the number of infections and the general locations to the health authorities. The program builds on
successful technology previously developed by Dr.&nbsp;Brolo&#146;s laboratory for the detection of the Zika virus. This previous technology demonstrated positive results in a pilot field study performed in Brazil, which verified the
technology&#146;s ability to detect Dengue/Zika proteins using patient saliva samples. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;While the diagnostic testing is only one portion of
IPA&#146;s overall Coronavirus program, the need for a highly reliable, quick and easy to administer diagnostic is an unmet need, and the laboratory of Dr.&nbsp;Brolo has the expertise and game plan we are honored to contribute to&#148;, stated
Dr.&nbsp;Jennifer Bath, President and CEO of IPA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Monoclonal, highly specific antibodies are the main component required for the development of
immunoassays. The antibodies for this project will be generated using IPA&#146;s unique proprietary B cell Select<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> platform. The high affinity and selectivity of the resulting antibodies will
enable tests with <FONT STYLE="white-space:nowrap">no-cross-reactivity,</FONT> low background, and enhanced detection. IPA and Dr.&nbsp;Brolo&#146;s group will work together to establish the most appropriate targets for the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> detection and to secure patient samples for validating the tests. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We are interested in partnering with
the Brolo group to speed up the application of these antibodies in a colorimetric antibody-based test for the detection and screening of <FONT STYLE="white-space:nowrap">COVID-19&#148;,</FONT> explains Dr.&nbsp;Barry Duplantis, Canada project lead
for diagnostics. &#147;We have the expertise and networks to support the commercialization of the detection technology that incorporates our monoclonal antibodies&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">one-year</FONT> NSERC award consists of a $50,000 grant to the Brolo laboratory. ImmunoPrecise will provide the
antibodies to be used in the kit and will retain an exclusive option on the commercialization rights. Reasonable commercial terms will enable IPA to efficiently bring the technology to market and reach those in need quickly. All agreements will
align with NSERC and UVic intellectual property and research policies and ensure utilization of results of this research for the benefit of Canada and Canadians, with the submission of research results in open access, peer-reviewed literature. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA and UVic are already working within their respective roles on the <FONT STYLE="white-space:nowrap">COVID-19</FONT> diagnostic platform. IPA is actively
engaged in the process of screening antibody panels already under development, to determine which antibodies best meet the profile for those required in the diagnostic kit. The antibodies will then be tested against <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> spike protein and validated using both convalescent and na&iuml;ve, human patient samples. Validation of the portable diagnostic will then require approval by Health Canada prior to field tests and
/ or commercialization. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Debenture Issuance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company also announces that further to its <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement (see news release dated May&nbsp;15,
2020) it has issued an additional CAD $35,000 of 10% convertible debentures. In total, the Company issued CAD $2,627,000 of convertible debentures on the financing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The debentures issued under this tranche are unsecured, bear interest at a rate of ten percent (10%) per year, payable annually, and are due May&nbsp;22, 2022
(which may be repaid early at the option of the Company). The principal amount of the debentures may be convertible, at the option of the holder, into shares of the Company at a conversion price of CAD $0.85 per share. The Company may force convert
the principal amount of the debentures at CAD$0.85 per share if the average closing price is equal to or greater than CAD $1.50 for 20 trading days. In order to exercise this right, the Company must issue a news release announcing its intention to
exercise this right within 10 business days after the end of the particular <FONT STYLE="white-space:nowrap">20-day</FONT> period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The securities under
this tranche are subject to restrictions on resale expiring on September&nbsp;16, 2020. The Company paid a finder&#146;s fee totaling $1,750 under this final tranche. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Brolo Group </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Alexandre&nbsp;G. Brolo is a
professor at the University of Victoria in Canada where he directs an innovative, multidisciplinary, and high-impact research program that spans the areas of nanotechnology, surface spectroscopy, electrochemistry and bioanalytical chemistry.
Dr.&nbsp;Brolo&#146;s research is centered on the optical and spectroscopic properties of metallic nanostructures that support a physical phenomenon called &#147;surface plasmon excitation&#148;. His work explores the fabrication, characterization,
and application of these metallic nanostructures in biosensing and in enhanced spectroscopy, particularly in their use for remote chemical sensing and in combination with microfluidics. Dr.&nbsp;Brolo has published more than 150 research papers in
top international journals and conference proceedings and presented on numerous occasions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a full-service, antibody discovery Contract Research Organization offering species agnostic, multi-format, characterized and engineered,
human monoclonal antibodies, on an abbreviated timeframe. For further information, visit <U>www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com</U>. There is no assurance that ImmunoPrecise will be successful in the development of a
diagnostic for the new Coronavirus. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This news release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148;
within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and
similar expressions to identify forward-looking statements. Any such forward-looking statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and
expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause
ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower
than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and analysis for the last quarter of the fiscal year ended January&nbsp;31, 2020 which can be accessed at <U>www.sedar.com</U>. The
&#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result
of new information, future events or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. SOURCE ImmunoPrecise Antibodies </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922g0910043129893.jpg" ALT="LOGO">
 View original content to download multimedia: </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">http://www.prnewswire.com/news-releases/nserc-awards-grant-to-fund-collaboration-between-immunoprecise-and-the-university-of-victoria-for-the-generation-of-</FONT></FONT></FONT></FONT></FONT></FONT></FONT></FONT></FONT></FONT>
</FONT></U><U>a</U> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922g0910043129893.jpg" ALT="LOGO">
 View original content to download multimedia: <U>http://www.newswire.ca/en/releases/archive/May2020/27/c7311.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact<B>
</B>Financial Corp., Suite 810, 609 Granville Street, P.O. Box 10322, Vancouver, B.C., V7Y 1G5, Canada. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 07:30e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">27-MAY-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.71
<SEQUENCE>72
<FILENAME>d20922dex9971.htm
<DESCRIPTION>EX-99.71
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.71</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.71 </B></P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g0910042201519.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Collaborates with the NIH and Integrated Biotherapeutics to Study the Structural Details of Antibodies
with Therapeutic Potential to Treat or Prevent Coronavirus Disease 2019 <FONT STYLE="white-space:nowrap">(COVID-19)</FONT> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, BC, June&nbsp;4,
2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSXV: IPA) (OTCQB: IPATF), a provider of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">best-in-class</FONT></FONT> therapeutic antibody
discovery capabilities for the global industry, today announced it is collaborating, pursuant to an agreement dated May&nbsp;14, 2020, in a multi-company effort with the laboratory of Dr.&nbsp;Frederick Dyda at the National Institute of Diabetes and
Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health (NIH), and Dr.&nbsp;M. Javad Aman at Integrated Biotherapeutics (IBT), to better understand the molecular binding interactions of potential therapeutic antibody candidates
resulting from IPA&#146;s <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> programs aimed at treating or preventing <FONT STYLE="white-space:nowrap">COVID-19.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This research consortium unites three reputable teams for lead antibody characterization, using Cryogenic Electron Microscopy (Cryo-EM) to determine the
structural details of antibodies bound to the spike protein from the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> virus. IBT will provide the well-characterized trimeric spike protein ectodomain and the
receptor binding domain (RBD) against which IPA&#146;s antibodies will be characterized using Cryo-EM performed in Dr.&nbsp;Dyda&#146;s laboratory. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cryo-EM is a microscopy technique that uses an electron beam as its primary energy source (instead of a light beam), which allows for much greater resolution
and magnification than with a traditional microscope and is emerging as a mainstream technique in structural biology. An initial cooling of the sample to cryogenic temperatures enables determination of the macromolecular structures under analysis,
in this case, the atomic resolution that can be used to elucidate the precise epitopes targeted by IPA&#146;s antibodies in their molecular binding interactions with the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> spike protein. The data will shed light on the Company&#146;s understanding of how their lead candidate antibodies neutralize the virus that is causing <FONT
STYLE="white-space:nowrap">COVID-19.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The tripartite collaboration will deliver detailed, molecular-level understanding of how our lead
antibodies interact with and neutralize the pathogenic <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> spike protein&#148;, stated Yasmina Abdiche, CSO of ImmunoPrecise. &#147;This information is critical
in elucidating their mechanism of action and informing their combination into therapeutic cocktails that aim to provide potent and long-lasting protection against <FONT STYLE="white-space:nowrap">COVID-19</FONT> and emerging virus variants.&#148;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We welcome this synergistic collaboration with ImmunoPrecise and the NIH towards delineation of critical sites of vulnerability in the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> that can lead to development of safe and effective immunotherapies for <FONT STYLE="white-space:nowrap">COVID-19&#148;,</FONT> added M. Javad Aman, President and
CSO of IBT. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Dyda has a PhD from the University of Pittsburgh. He is a senior investigator at the Laboratory of Molecular Biology of the NIDDK
and studies molecular details of macromolecules by producing high resolution images (Cryo-EM) to look at changes in protein structure using high-resolution images, as these usually relate to the function of the protein. He is an avid publisher in <FONT
STYLE="white-space:nowrap">top-tier</FONT> peer-reviewed journals such as <I>Cell</I> and <I>Nature.</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Aman has a PhD from Johannes
Gutenberg-Universitat Mainz and did his <FONT STYLE="white-space:nowrap">Post-doc</FONT> at NIH and the University of Virginia. He leads Integrated Biotherapeutics, a well-respected technology company in Maryland, and serves there as President and
CSO. He leads their scientific programs and specializes in viral and bacterial diseases, with over 110 peer-reviewed publications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is not
making any express or implied claims that its product has the ability to eliminate, cure or contain <FONT STYLE="white-space:nowrap">COVID-19</FONT> (or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2)</FONT></FONT> at
this time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Dyda Lab </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Dyda&#146;s
laboratory applies experimental structural biology to provide atomic-level mechanistic understanding of how protein-protein and <FONT STYLE="white-space:nowrap">protein-DNA</FONT> complexes are regulated, using
<FONT STYLE="white-space:nowrap">X-ray</FONT> crystallography and cryo-EM as complementary tools. In particular, the researchers are investigating how the movement of mobile genetic elements, such as transposons, is controlled. This happens in
several contexts which interests the laboratory, such as DNA transposition and the integration of viral DNA into host cell chromosomes. For more information visit
<U><FONT STYLE="white-space:nowrap">https://www-mslmb.niddk.nih.gov/dyda/people.html</FONT></U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The research described here is conducted in part by
the Division of Intramural Research at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health. The content in this release is the sole responsibility of the authors and does not necessarily
represent the official views or imply endorsement of the National Institutes of Health. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Integrated Biotherapeutics </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IBT is a biotechnology company focused on the discovery of novel vaccines and therapies for emerging infectious diseases with a pipeline that includes
promising product candidates for bacterial and viral infections including vaccines for Staphylococcal infections, unique <FONT STYLE="white-space:nowrap">pan-filovirus</FONT> immunotherapeutics and vaccines, and a variety of other product candidates
for emerging pathogens. Located in Rockville, MD, IBT has a close working relationship with United States Government agencies including the National Institute of Allergy and Infectious Diseases (NIAID/NIH). National Cancer Research Institute (NCI),
Department of Defense (DOD), United States Army Medical Research Institute of Infection Diseases (USAMRIID) as well as many biotechnology and pharmaceutical companies and academic laboratories. For more information, visit
<U>www.integratedbiotherapeutics.com</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a full-service, therapeutic antibody discovery Contract Research Organization offering species agnostic, multi-format, characterized and
engineered, human monoclonal antibodies, on an abbreviated timeframe, for its pharmaceutical clients. For further information, visit <U>www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release
contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148; within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;,
&#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and similar expressions to identify forward-looking statements. Any such forward-looking statements are based on
assumptions and analyses made by ImmunoPrecise considering its experience and its perception of historical trends, current conditions and expected future developments. However, whether actual results and developments will conform to
ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the
forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual
management discussion and analysis for the previous quarter ended January&nbsp;31, 2020 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and,
unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922g0910043129893.jpg" ALT="LOGO">
 View original content to download multimedia:<U> </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">http://www.prnewswire.com/news-releases/immunoprecise-collaborates-with-the-nih-and-integrated-biotherapeutics-to-study-the-structural-details-of-antibodies-wi</FONT></FONT></FONT></FONT></FONT>
</FONT></FONT></FONT></FONT></FONT></FONT></U><U>t</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922g0910043129893.jpg" ALT="LOGO">
 View original content to download multimedia: <U>http://www.newswire.ca/en/releases/archive/June2020/04/c3849.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact<B>
</B>Financial Corp., Suite 810, 609 Granville Street, P.O. Box 10322, Vancouver, B.C., V7Y 1G5, Canada. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 07:30e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">04-JUN-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.72
<SEQUENCE>73
<FILENAME>d20922dex9972.htm
<DESCRIPTION>EX-99.72
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.72</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.72 </B></P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g0910042201519.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recombinant <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> Proteins Now
Available For Research From ImmunoPrecise&#146;s European Subsidiary, UPE </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">UTRECHT, Netherlands, June&nbsp;11, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES
LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTC QB: IPATF) (Germany: TQB2) subsidiary <FONT STYLE="white-space:nowrap">U-Protein</FONT> Express BV (&#147;UPE&#148;) today announced the availability of its new recombinant <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> proteins, and other proteins associated with <FONT STYLE="white-space:nowrap">COVID-19,</FONT> for use by researchers globally in the design and discovery of novel
therapeutics, vaccines and diagnostic test kits for coronavirus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;UPE&#146;s management stepped up immediately in early January, soon after the
emergence of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2,</FONT></FONT> and began the construct design and manufacturing of proteins that play a central role in the infection of human lung tissue by the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> virus,&#148; said Dr.&nbsp;Roland Romijn, Head of General Operations at UPE. &#147;By using ImmunoPrecise&#146;s proprietary rPEx<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP> protein production platform, we have produced high quality, high yield, batches of multiple subunits of the viral Spike protein, and other <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2-related</FONT></FONT></FONT> proteins, which we believe are useful reagents for the analysis of, and generation of, antibody therapeutics, vaccines and diagnostics. We continue
to focus on the development of new, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2-related</FONT></FONT></FONT> recombinant proteins to support the scientific community in this crucial,
global effort. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These proteins are now available to the scientific community to help combat the current <FONT STYLE="white-space:nowrap">COVID-19</FONT>
pandemic crisis. The recombinant coronavirus proteins (and other proteins related to <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> infection) are produced using ImmunoPrecise&#146;s proprietary rPEx
protein production platform, utilizing transient transfection of HEK293 cells. In contrast to more basic recombinant protein expression platforms like <I>E. coli</I> cells or insect cells, the rPEx platform generates superior recombinant proteins
that more closely resemble the native conformations of the proteins. This is especially important for retaining the functions of the heavily glycosylated, viral Spike protein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The success of this program at UPE is an exemplary demonstration of the selfless efforts, unity and determination that have arisen within ImmunoPrecise
as part of our larger, global efforts in fighting coronavirus,&#148; stated Dr.&nbsp;Jennifer Bath, President and CEO of ImmunoPrecise. &#147;The substantive time and energy dedicated by this team have not only enabled this much needed support to
the broader scientific community but have also served as a cornerstone in our own efforts at IPA, as we continue to rapidly advance our coronavirus therapeutic, vaccine and diagnostic programs.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">COVID-19</FONT> related proteins are available online at
<U><FONT STYLE="white-space:nowrap">www.u-proteinexpress.com</FONT></U>. For academic and commercial institutions seeking more information about these proteins and potentially other reagents related to
<FONT STYLE="white-space:nowrap">COVID-19,</FONT> please contact us on the UPE website or email: <U><FONT STYLE="white-space:nowrap">info@u-proteinexpress.com</FONT></U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jennifer Bath, Ph.D., Chief Executive Officer of ImmunoPrecise, has reviewed and approved the scientific disclosure of this news release. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain
<FONT STYLE="white-space:nowrap">COVID-19</FONT> (or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2)</FONT></FONT> at this time. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About <FONT STYLE="white-space:nowrap">U-Protein</FONT> Express BV </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">U-protein</FONT> Express is a Dutch biotechnology service provider company based in Utrecht, The Netherlands. UPE was founded
in 2007 as a <FONT STYLE="white-space:nowrap">spin-off</FONT> company of the Utrecht University and has established the rPEx<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> technology. The rPEx technology is based on transient transfection of
HEK293 cells and yields high quality, high amounts of recombinant proteins and antibodies in a short time span. Dr.&nbsp;Roland Romijn is one of the founders of UPE and holds a PhD from the Utrecht University. His work at UPE involves overall
project management and exploration of new technologies to improve the rPEx technology. Since the acquisition of UPE by ImmunoPrecise Antibodies in 2017, Dr.&nbsp;Romijn has worked closely with other members of the global team to synergistically
improve the company&#146;s goods, services and IP assets. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a full-service, therapeutic antibody discovery Contract Research Organization offering species agnostic, multi-format, characterized and
engineered, human monoclonal antibodies, on an abbreviated timeframe, for its pharmaceutical clients. For further information, visit <U>www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release
contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148; within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;,
&#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and similar expressions to identify forward-looking statements. Any such forward-looking statements are based on
assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and expected future developments. However, whether actual results and developments will conform to
ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the
forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s management
discussion and analysis for the previous quarter ended January&nbsp;31, 2020 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless
required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922g0910043129893.jpg" ALT="LOGO">
 View original content to download multimedia: <U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">http://www.prnewswire.com/news-releases/recombinant-sars-cov-2-proteins-now-available-for-research-from-immunoprecises-european-subsidiary-upe-301074408.html
</FONT></FONT></FONT></FONT></FONT></FONT></FONT></FONT></FONT></U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922g0910043129893.jpg" ALT="LOGO">
 View original content to download multimedia: <U>http://www.newswire.ca/en/releases/archive/June2020/11/c3230.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact<B>
</B>Financial Corp., Suite 810, 609 Granville Street, P.O. Box 10322, Vancouver, B.C., V7Y 1G5, Canada. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 08:12e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">11-JUN-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.73
<SEQUENCE>74
<FILENAME>d20922dex9973.htm
<DESCRIPTION>EX-99.73
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.73</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.73 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g0910042201519.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Collaborative <FONT STYLE="white-space:nowrap">COVID-19</FONT> Vaccine Project Between ImmunoPrecise Antibodies Europe
and LiteVax BV, Funded Through TRANSVAC2 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">OSS, Netherlands, June&nbsp;22, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or
&#147;IPA&#148;) (TSX VENTURE: IPA) (OTCQB: IPATF) (FSE: TQB2), and LiteVax BV (&#147;LiteVax&#148;) (the Netherlands), today announced that a preclinical study to analyze the immunogenicity, safety and potency of IPA&#146;s novel <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> vaccine candidates, when formulated with LiteVax&#146;s Adjuvant (LVA), has been granted funding by TRANSVAC2, which is expected to cover the complete costs of a
preclinical vaccine study. TRANSVAC2 is a network of leading European groups working in the field of vaccine development, which itself is funded by the European Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">That effort is one of a number of preclinical programs currently being undertaken by IPA to assist in the efforts against <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">SARS-CoV-2.</FONT></FONT> On March 12th, 2020, IPA first announced details of its research on <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> to develop a PolyTope<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP> monoclonal antibody (mAb) therapy for the treatment of patients with <FONT STYLE="white-space:nowrap">COVID-19,</FONT> which could also be used prophylactically in high risk patients who may have
been exposed to the virus. The Company also disclosed its intent to develop a PolyTope vaccine, to be rationally designed based on large subsets of data obtained during the development of the PolyTope mAb Therapy. IPA then announced its intent to
begin development of a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> diagnostic and then, on May 27<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, 2020, IPA announced that, in collaboration with
the University of Victoria, the Company had sought and received a grant from NSERC towards the costs to develop a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> diagnostic kit. Today&#146;s announcement
aims to provide an update to the Company&#146;s progress on the first <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> program announced by IPA, namely the efforts toward the development of a PolyTope
vaccine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The purpose of the collaboration announced today between IPA and LiteVax is to conduct a <FONT STYLE="white-space:nowrap">pre-clinical</FONT>
study to determine whether IPA&#146;s protein-based vaccine candidates, formulated with LVA (adjuvant), results in potent, neutralizing antibody responses that confer protection against
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> infection in a swine animal model. IPA will supply protein-based vaccine candidates and LiteVax will supply its LVA. Both parties will retain full rights to
their respective proprietary assets and <FONT STYLE="white-space:nowrap">know-how</FONT> used for the study. It is anticipated that <FONT STYLE="white-space:nowrap">pre-clinical</FONT> vaccine trials will begin in August, 2020, and that data will be
compiled by <FONT STYLE="white-space:nowrap">mid-November,</FONT> 2020. Should the preclinical study prove successful, IPA and LiteVax may then negotiate the terms for a preclinical study in a second animal model, as well as details the around the
potential commercialization of any resulting vaccine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA&#146;s extensive therapeutic programs targeting the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> are providing the Company with unique and comprehensive data points which are expected to be useful in the formulation of IPA&#146;s
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">anti-SARS-CoV-2</FONT></FONT> potential vaccine candidates. In addition, this data is intended to inform the development by IPA of future therapies and vaccines against novel
coronavirus strains and variants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is no assurance that ImmunoPrecise and LiteVax will be successful in the development of a vaccine and/or
therapeutic against the new coronavirus, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2.</FONT></FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jennifer Bath,
Ph.D., Chief Executive Officer of ImmunoPrecise, has reviewed and approved the scientific disclosure of this news release. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Director Retires
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Robert Beecroft has announced his resignation from the Company&#146;s Board of Directors. Mr.&nbsp;Beecroft was the founder of ImmunoPrecise
Antibodies and led the company for over two decades, </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">building quality services and products for customers across the globe. He has served on the board since the
Company went public in 2016, assisting in the Company transition and continuing to offer his expertise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;None of what ImmunoPrecise has become today
would be possible without Rob Beecroft&#146;s vision, perseverance and hard work,&#148; stated Dr.&nbsp;James Kuo, Chairman of IPA&#146;s board of directors. His commitment to excellence is only matched by his sense of camaraderie, which we were all
privileged to experience. On behalf of the entire board, we owe him our profound gratitude and wish him well. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About TRANSVAC </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRANSVAC2 is a European vaccine research and development (R&amp;D) infrastructure that aims to accelerate the development of safe, effective and affordable
vaccines that shall be one of the most successful and cost-effective public health tools for disease prevention. However, vaccine development is time-consuming and complex, requiring a combination of specialized skills and technical capacities not
readily available at a single organization. In order to facilitate access to these skills and capacities, and to promote collaborations in the European vaccine landscape, TRANSVAC2 offers high quality technical services across four different service
platforms: Technology (for process development and GMP production), Immunocorrelates&nbsp;&amp; Systems Biology, Animal models, and support for Clinical Trials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRANSVAC2 has received funding from the European Union&#146;s Horizon 2020 research and innovation program under grant agreement N&deg; 730964. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About LiteVax </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LiteVax BV is a Dutch biopharmaceutical
SME with the mission to impact global health by developing and exploiting novel immunoadjuvants to increase vaccine efficacy. New and more effective vaccines against a wide range of infectious diseases are needed as evidenced by the recent
outbreaks. For further information, please contact <U>luuk.hilgers@litevax.com</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a full-service, therapeutic antibody discovery Contract Research Organization offering species agnostic, multi-format, characterized and
engineered, human monoclonal antibodies, on an abbreviated timeframe, for its pharmaceutical clients. For further information, visit <U>www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com.</U> There is no assurance that ImmunoPrecise
will be successful in the development of a vaccine and/or therapeutic against the new coronavirus. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148;
within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and
similar expressions to identify forward-looking statements. Any such forward-looking statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and
expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause
ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements contained in this news release. Such factors include, among other things, ImmunoPrecise may not be successful in the
development of any vaccine, therapy or diagnostic kits to be used in the prevention, treatment or diagnosis of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2.</FONT></FONT> LiteVax and ImmunoPrecise may not be able to
negotiate the terms for further </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>development or commercialization of any product resulting from the collaboration. actual revenues and
earnings for IPA being lower than anticipated, potential adverse impacts due to the global <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic such as delays in regulatory review, manufacturing and clinical trials, supply chain interruptions
and disruption of the global economy, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and analysis for the previous quarter ended January&nbsp;31, 2020 which can be accessed at <U>www.sedar.com</U>.
The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a
result of new information, future events or otherwise. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is
defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. </I></P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922dsp540.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Logo : LiteVax (CNW Group/ImmunoPrecise Antibodies Ltd.) </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922adsp540_1.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Logo: European Commission (CNW Group/ImmunoPrecise Antibodies Ltd.) </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922adsp541.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Logo : TRANSVAC (CNW Group/ImmunoPrecise Antibodies Ltd.) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922g0910043129893.jpg" ALT="LOGO">
 View original content to download multimedia: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.newswire.ca/en/releases/archive/June2020/22/c7964.htm</U><U>l</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>Frederick
Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email:<B> </B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">frederick@contactfinancial.com, Contact Financial Corp., Suite 810, 609 Granville Street, P.O. Box 10322, Vancouver, B.C., V7Y 1G5, Canada. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 07:30e <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-JUN-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.74
<SEQUENCE>75
<FILENAME>d20922dex9974.htm
<DESCRIPTION>EX-99.74
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.74</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.74 </B></P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922g0910042201519.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IPA Confirms Discovery of Fully Human, Potent, Neutralizing Antibodies Targeting <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>IPA Announces Discovery of Functional Antibodies from Humans and Llama
(VHH), Identified Using IPA Phage Display Technology </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, BC, June&nbsp;29, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the
&#147;Company&#148; or &#147;IPA&#148;) (TSXV: IPA) (OTCQB: IPATF) (FSE: TQB2), an experienced leader in full-service, therapeutic antibody discovery and development, today announced the identification of numerous lead candidate antibodies with
highly-potent neutralizing activity <I>in vitro</I>, which are being manufactured for further testing and possible inclusion in the Company&#146;s PolyTope<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> mAb Therapy to combat the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March 12<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, 2020, ImmunoPrecise announced
several preclinical programs currently being undertaken to assist in the efforts against <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2.</FONT></FONT> Today&#146;s announcement updates the Company&#146;s progress on the
development of a PolyTope<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> mAb therapy designed to treat severely ill patients, as well as protect high-risk individuals such as those exposed to the virus, front-line workers, the elderly,
and the immunocompromised. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise deployed several proprietary discovery platforms that leveraged the immune systems of humans, llama, rabbits and
Ligand Pharmaceutical&#146;s (NASDAQ:LGND) OmniAb&Ograve; genetically engineered rats producing human antibodies. The neutralizing antibodies announced today are the result of functional screenings from the top 300 <I>lead</I> antibodies analyzed
from the human and llama campaigns. The Company has stated that functional analysis of the remaining 1,300 <I>lead</I> antibodies from the rabbit and OmniAb&Ograve; rat campaigns were performed independently, and they anticipate the release of the
preliminary functional data screens from these additional programs in the near future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Arriving at this critical point in our preliminary research
with many lead, functional therapeutic candidates is indicative of the broad scientific scope of IPA&#146;s <FONT STYLE="white-space:nowrap">anti-COVID-19</FONT> programs,&#148; stated Dr.&nbsp;Jennifer Bath, CEO and President of IPA. &#147;An
effective cocktail therapy for <FONT STYLE="white-space:nowrap">COVID-19,</FONT> targeting multiple epitopes on the virus, could prove fundamental in combating this pandemic in an effective and enduring way.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s scientific approach has led to a diverse set of lead antibody candidates, and thus far has generated many potently neutralizing antibodies
to multiple epitopes, supporting the Company&#146;s aim of generating a therapeutic that retains efficacy, even as <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> continues to evolve. To further support the
Company&#146;s robust scientific approach, IPA is preparing to test these lead antibodies against additional, documented, mutated strains of the virus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company anticipates <FONT STYLE="white-space:nowrap">pre-clinical</FONT> studies will begin summer 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jennifer Bath, Ph.D., Chief Executive Officer of ImmunoPrecise, has reviewed and approved the scientific disclosure of this news release. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The use of therapeutics for humans in clinical trials will require approval of the applicable government regulation agency, e.g. The Company is not making any
express or implied claims that its product has the ability to eliminate, cure or contain <FONT STYLE="white-space:nowrap">COVID-19</FONT> (or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2)</FONT></FONT> at this time.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise
is a full-service, therapeutic antibody discovery Contract Research Organization offering species agnostic, multi-format, characterized and engineered, human monoclonal antibodies, on an abbreviated timeframe, for its pharmaceutical clients. For
further information, visit <U>www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com.</U> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148;
within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and
similar expressions to identify forward-looking statements. Any such forward-looking statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and
expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause
ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements contained in this news release. Such factors include, among other things, ImmunoPrecise may not be successful in the
development of any vaccine, therapy or diagnostic kits to be used in the prevention, treatment or diagnosis of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2,</FONT></FONT> actual revenues and earnings for IPA being
lower than anticipated, potential adverse impacts due to the global <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic such as delays in regulatory review, manufacturing and clinical trials, supply chain interruptions and disruption of the
global economy, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and analysis for the previous quarter ended January&nbsp;31, 2020 which can be accessed at <U>www.sedar.com</U>. The
&#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result
of new information, future events or otherwise. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in
the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. </I>SOURCE ImmunoPrecise Antibodies </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922g0910043129893.jpg" ALT="LOGO">
 View original content to download multimedia: <U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">http://www.prnewswire.com/news-releases/ipa-confirms-discovery-of-fully-human-potent-neutralizing-antibodies-targeting-sars-cov-2-301085161.html</FONT></FONT></FONT></FONT></FONT></FONT></FONT>
</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922g0910043129893.jpg" ALT="LOGO">
 View original content to download multimedia: <U>http://www.newswire.ca/en/releases/archive/June2020/29/c2047.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information:
</B>ImmunoPrecise Antibodies Ltd., Jennifer Bath, CEO, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-250-483-0308,</FONT></FONT></FONT> 3204-4464 Markham Street, Victoria, BC<B> </B>V8Z
7X8, www.immunoprecise.com; For investor relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email:
frederick@contactfinancial.com, Contact Financial Corp., Suite 810, 609 Granville Street, P.O. Box 10322, Vancouver, B.C., V7Y 1G5, Canada. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO:
ImmunoPrecise Antibodies Ltd. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 12:48e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">29-JUN-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.75
<SEQUENCE>76
<FILENAME>d20922dex9975.htm
<DESCRIPTION>EX-99.75
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.75</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.75 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT STYLE="white-space:nowrap">51-102F3</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MATERIAL CHANGE REPORT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Item 1</B>.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Name and Address of Company</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>IMMUNOPRECISE ANTIBODIES LTD.</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3204-4464 Markham Street</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Victoria, BC V8Z 7X8</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(the &#147;Company&#148;)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Item 2</B>.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Date of Material Change</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">June&nbsp;29, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Item 3</B>.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>News Release</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">The news release was issued on June&nbsp;29, 2020 and was disseminated by Newswire.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Item 4</B>.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Summary of Material Change</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">The Company announced the identification of numerous lead candidate antibodies with highly- potent neutralizing activity <I>in vitro</I>, which are being manufactured for further testing and possible inclusion in the
Company&#146;s PolyTope<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> mAb Therapy to combat the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Item 5</B>.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Full Description of Material Change</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Please refer to the Company&#146;s news release disseminated on June&nbsp;29, 2020, a copy of which is attached hereto.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Item 6</B>.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Reliance on Subsection 7.1(2) of National Instrument <FONT STYLE="white-space:nowrap">51-102</FONT></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Not applicable.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Item 7</B>.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Omitted Information</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">None.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Item 8</B>.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Executive Officer</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">For further information, please contact:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Jennifer Bath</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(250) <FONT STYLE="white-space:nowrap">483-0308</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Item 9</B>.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Date of Report</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">June&nbsp;30, 2020</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Schedule A </B></P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g20922immu.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IPA Confirms Discovery of Fully Human, Potent, Neutralizing Antibodies Targeting <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>IPA Announces Discovery of Functional
Antibodies from Humans and Llama (VHH), Identified Using IPA Phage Display Technology </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, June&nbsp;29, 2020 / - IMMUNOPRECISE ANTIBODIES
LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTCQB: IPATF) (FSE:TQB2), an experienced leader in full-service, therapeutic antibody discovery and development, today announced the identification of numerous lead candidate
antibodies with highly-potent neutralizing activity <I>in vitro</I>, which are being manufactured for further testing and possible inclusion in the Company&#146;s PolyTope<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> mAb Therapy to combat
the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March 12<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, 2020, ImmunoPrecise
announced several preclinical programs currently being undertaken to assist in the efforts against <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2.</FONT></FONT> Today&#146;s announcement updates the Company&#146;s
progress on the development of a PolyTope<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> mAb therapy designed to treat severely ill patients, as well as protect high-risk individuals such as those exposed to the virus, front-line
workers, the elderly, and the immunocompromised. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise deployed several proprietary discovery platforms that leveraged the immune systems of
humans, llama, rabbits and Ligand Pharmaceutical&#146;s (NASDAQ:LGND) OmniAb&reg; genetically engineered rats producing human antibodies. The neutralizing antibodies announced today are the result of functional screenings from the top 300
<I>lead</I> antibodies analyzed from the human and llama campaigns. The Company has stated that functional analysis of the remaining 1,300 <I>lead</I> antibodies from the rabbit and OmniAb&reg; rat campaigns were performed independently, and they
anticipate the release of the preliminary functional data screens from these additional programs in the near future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Arriving at this critical
point in our preliminary research with many lead, functional therapeutic candidates is indicative of the broad scientific scope of IPA&#146;s <FONT STYLE="white-space:nowrap">anti-COVID-19</FONT> programs,&#148; stated Dr.
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jennifer Bath, CEO and President of IPA. &#147;An effective cocktail therapy for <FONT
STYLE="white-space:nowrap">COVID-19,</FONT> targeting multiple epitopes on the virus, could prove fundamental in combating this pandemic in an effective and enduring way.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s scientific approach has led to a diverse set of lead antibody candidates, and thus far has generated many potently neutralizing antibodies
to multiple epitopes, supporting the Company&#146;s aim of generating a therapeutic that retains efficacy, even as <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> continues to evolve. To further support the
Company&#146;s robust scientific approach, IPA is preparing to test these lead antibodies against additional, documented, mutated strains of the virus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company anticipates <FONT STYLE="white-space:nowrap">pre-clinical</FONT> studies will begin summer 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jennifer Bath, Ph.D., Chief Executive Officer of ImmunoPrecise, has reviewed and approved the scientific disclosure of this news release. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The use of therapeutics for humans in clinical trials will require approval of the applicable government regulation agency, e.g. The Company is not making any
express or implied claims that its product has the ability to eliminate, cure or contain <FONT STYLE="white-space:nowrap">COVID-19</FONT> (or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2)</FONT></FONT> at this time.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise
is a full-service, therapeutic antibody discovery Contract Research Organization offering species agnostic, multi-format, characterized and engineered, human monoclonal antibodies, on an abbreviated timeframe, for its pharmaceutical clients. For
further information, visit <U>www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com</U><U>.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For further information: ImmunoPrecise
Antibodies Ltd., Jennifer Bath, CEO, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-250-483-0308,</FONT></FONT></FONT> 3204-4464 Markham Street, Victoria, BC V8Z 7X8,
<U>www.immunoprecise.co</U><U>m</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For investor relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: <U>frederick@contactfinancial.co</U><U>m</U>, Contact Financial Corp., Suite 810, 609 Granville Street, P.O. Box 10322, Vancouver, B.C., V7Y 1G5,
Canada. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news
release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148; within the meaning of applicable Canadian securities laws. The Company uses words such as
&#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and similar expressions to identify forward-looking statements. Any such forward-looking
statements are based on assumptions and analyses made by </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and expected future developments. However, whether actual results and developments will
conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the
forward-looking statements contained in this news release. Such factors include, among other things, ImmunoPrecise may not be successful in the development of any vaccine, therapy or diagnostic kits to be used in the prevention, treatment or
diagnosis of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2,</FONT></FONT> actual revenues and earnings for IPA being lower than anticipated, potential adverse impacts due to the global
<FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic such as delays in regulatory review, manufacturing and clinical trials, supply chain interruptions and disruption of the global economy, and those risks and uncertainties described in
ImmunoPrecise&#146;s annual management discussion and analysis for the previous quarter ended January&nbsp;31, 2020 which can be accessed at <U>www.sedar.com.</U><U> </U>The &#147;forward-looking statements&#148; contained herein speak only as of
the date of this press release and, unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. </I>SOURCE ImmunoPrecise Antibodies </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.76
<SEQUENCE>77
<FILENAME>d20922dex9976.htm
<DESCRIPTION>EX-99.76
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.76</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.76 </B></P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922pre.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Functional, Human Antibodies Targeting
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> Discovered Using IPA&#146;s Proprietary B cell Select<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> and Single Step Cloning Hybridoma
Technologies </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>IPA announces discovery of additional, neutralizing antibodies, developed against <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT></I></B>, <I>discovered using Ligand Pharmaceuticals&#146;</I><B><I> </I></B><I>genetically engineered
OmniRat</I><I><SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP></I><I> strains producing human antibodies</I> </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA,
July&nbsp;13, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX.V: IPA) (OTCQB: IPATF) (FSE:TQB2), a leader in full-service, therapeutic antibody discovery and development, today announced the
identification of additional, human lead candidate antibodies generated against <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2,</FONT></FONT> also demonstrating potent <I>in vitro</I> neutralizing activity, discovered
using the Company&#146;s B cell Select<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> and Single Step Cloning Hybridoma Platforms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On
June&nbsp;29, IPA confirmed the identification of a series of lead candidate antibodies demonstrating potent, <I>in vitro</I> neutralizing activity. These functional antibodies were derived from human and llama (VHH) samples using IPA&#146;s
DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> phage technology. The Company has now added to this lead candidate pool with additional, potent neutralizing antibodies from Ligand Pharmaceuticals&#146; (NASDAQ:LGND) OmniRat<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> therapeutic human antibody platform as well as wild-type rabbits. The lead neutralizing antibodies announced in the Company&#146;s June&nbsp;29 release, as well as those announced today, are
comprised primarily of fully human antibodies (from humans and OmniRat transgenic animals), which are expected to both accelerate timelines to the clinic and to increase the safety and tolerability profiles of the therapeutic candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These lead neutralizing antibodies have been moved into manufacturing at the Company for further <FONT STYLE="white-space:nowrap">pre-clinical</FONT> testing
and possible inclusion in the Company&#146;s PolyTope<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> mAb Therapy to combat the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. The Company is currently exploring business
development opportunities with respect to is <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> antibody programs. The broad range of antibodies being produced at IPA have potential for further use in areas
such as additional combination therapies, control antibodies, diagnostics, singular antibody therapies, <FONT STYLE="white-space:nowrap">pre-clinical</FONT> and clinical batch release assays, and laboratory research. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;IPA continues to advance the development of its PolyTope Therapy directed toward
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> as part of an exceptionally comprehensive <FONT STYLE="white-space:nowrap">pre-clinical</FONT> therapeutic program ongoing at the Company&#148;, said
Dr.&nbsp;Jennifer Bath, CEO and president of IPA, referencing the number of in vitro human samples, species, antibody formats and discovery platforms used in IPA&#146;s study. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company believes that the large amount of data obtained during the development of the first PolyTope therapy should also be foundational in addressing
future strains and seasonal variations of the virus, enabling IPA to rapidly formulate more effective vaccines and therapeutics to Coronavirus should the virus continue to evolve. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The high throughput technologies at IPA enable large-scale screening and analysis of natural immune systems coupled with substantial characterization data, to
find antibodies that have the potential to be used to prevent and treat diseases, and aim to bring forward solutions with greater efficacy in the clinic. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The current coronavirus program has enabled IPA to showcase the breadth and agility of the Company&#146;s customized platforms, especially as they pertain to
managing complicated viral outbreaks, a serious threat to public health that most would agree the world is not prepared to manage. &#147;The accumulating data, stemming from our commitment to scientific rigor, and the cohesive nature of our global
response teams, has highlighted the value of our platforms in responding during a global pandemic&#148;, said Dr.&nbsp;Jennifer Bath, CEO and President of IPA. &#147;More than ever, innovation and experience are key. Our ability screen human samples
in parallel from a multitude of sources, highlights IPA&#146;s unique capabilities. The quality of a potential therapeutic or vaccine coming out of any program is directly related to the amount of, and quality of, data entering the program, making
IPA&#146;s approach and streamlined technologies ideally suited for undertaking research to address complicated, viral pandemics&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company
anticipates <FONT STYLE="white-space:nowrap">pre-clinical</FONT> studies will begin summer 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jennifer Bath, Ph.D., Chief Executive Officer of
ImmunoPrecise, has reviewed and approved the scientific disclosure of this news release. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s lead antibodies against <FONT
STYLE="white-space:nowrap">COVID-19</FONT> (or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2)</FONT></FONT> have not yet been studied in human clinical trials and, as a result, IPA is not making any express or implied
claims that its products have been proven to have the ability to eliminate, cure or contain <FONT STYLE="white-space:nowrap">COVID-19</FONT> (or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2)</FONT></FONT> at this
time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a full-service, therapeutic antibody discovery Contract Research Organization offering species agnostic, multi-format, characterized and
engineered, human monoclonal antibodies, on an abbreviated timeframe, for its pharmaceutical clients. For further information, visit <U>www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com.</U> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release
contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148; within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;,
&#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148;, &#147;should&#148; and similar expressions to identify forward-looking statements and include the Company&#146;s
beliefs with respect to the potential for its antibodies to be further developed or approved to treat </I><FONT STYLE="white-space:nowrap">COVID-19</FONT> (or
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2)</FONT></FONT> or to complete any transactions with respect to those antibodies<I>. Any such forward-looking statements are based on assumptions and analyses made by
ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s expectations and predictions
is subject to any number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements contained in this news release.
Such factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and analysis for the previous quarter ended
January</I><I></I><I>&nbsp;31, 2020 which can be accessed at </I><I><U>www.sedar.com</U></I><I>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless required by applicable law,
ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise.</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922ccc1.jpg" ALT="LOGO">
 View original content to download multimedia: <U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">http://www.prnewswire.com/news-releases/functional-human-antibodies-targeting-sars-cov-2-discovered-using-ipas-proprietary-b-cell-select-and-single-step-clonin</FONT></FONT></FONT></FONT></FONT>
</FONT></FONT></U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922ccc1.jpg" ALT="LOGO">
 View original content to download multimedia: <U>http://www.newswire.ca/en/releases/archive/July2020/13/c1518.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact<B>
</B>Financial Corp., Suite 810, 609 Granville Street, P.O. Box 10322, Vancouver, B.C., V7Y 1G5, Canada </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 07:51e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">13-JUL-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.77
<SEQUENCE>78
<FILENAME>d20922dex9977.htm
<DESCRIPTION>EX-99.77
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.77</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.77 </B></P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922pre.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IPA Announces Repayment of Remaining 2018 Debentures and $3,811,205 in Warrant Exercises </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, BC, July&nbsp;20, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTCQB: IPATF) (FSE:
TQB2), a leader in full-service, therapeutic antibody discovery and development, today announces that it has repaid the remaining 12.5% debentures issued in April 2018. In addition, IPA has received CAD$3,811,205 in connection with the exercise of
previously issued warrants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>&#147;Over the last two months we have strengthened our balance sheet with the oversubscribed convertible debenture
financing and the receipt of approximately $3.8&nbsp;million from warrant exercises,&#148; states Jennifer Bath, Chief Executive Officer of ImmunoPrecise. &#147;The early repayment of the 2018 debentures removed a significant short-term debt
obligation.&#148; </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Of the CAD$3.8&nbsp;million in warrants exercised, warrant holders exercised 875,000 warrants at CAD$1.00; 1,357,971 warrants at
CAD$0.70 per share and 1,588,500 warrants were exercised at CAD$1.25 per share. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a full-service, therapeutic antibody discovery Contract Research Organization offering species agnostic, multi-format, characterized and
engineered, human monoclonal antibodies, on an abbreviated timeframe, for its pharmaceutical clients. For further information, visit <U>www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com.</U> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release
contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148; within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;,
&#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148;, &#147;should&#148; and similar expressions to identify forward-looking statements. Any such forward-looking
statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and expected future developments. However, whether actual results and developments will
conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the
forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual
management discussion and analysis for the previous quarter ended January&nbsp;31, 2020 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and,
unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. </I>SOURCE ImmunoPrecise Antibodies<I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922ccc1.jpg" ALT="LOGO">
 View original content to download multimedia: <U>http://www.newswire.ca/en/releases/archive/July2020/20/c9245.htm</U><U>l</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., Suite 810, 609 Granville Street, P.O. Box 10322, Vancouver, B.C., V7Y 1G5, Canada. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 08:00e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">20-JUL-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.78
<SEQUENCE>79
<FILENAME>d20922dex9978.htm
<DESCRIPTION>EX-99.78
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.78</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.78 </B></P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922pre.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IPA Awarded US$1.5M Bioscience Innovation Grant for Coronavirus Research from the North Dakota Department of Agriculture
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, BC, July&nbsp;28, 2020 /CNW/ -IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSXV: IPA) (OTCQB: IPATF)
(FSE:TQB2), a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">best-in-class</FONT></FONT> therapeutic antibody discovery company for the global industry, is pleased to announce that the Agriculture Commissioner Doug Goehring
announced grants totaling $4.4&nbsp;million have been awarded to foster the growth of bioscience industry in North Dakota in the area of coronavirus research. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (USA) Ltd. and its subsidiary Talem Therapeutics, LLC, received US$1.5&nbsp;million for the development of antibody therapeutics
against <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2.</FONT></FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The grants will help companies&#146; partner,
assist and develop technologies to benefit coronavirus research, virus screening technologies, antibody therapies, immunotherapies and sanitation technologies,&#148; Goehring said. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The state Emergency Commission approved $5&nbsp;million in funding from the coronavirus relief bill for coronavirus research. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company reports that it has also applied for federal funding to support the clinical manufacturing of the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">anti-SARS-CoV-2</FONT></FONT> therapeutics and that it continues to seek funds for clinical trials as well as for long-term monitoring and rapid protection against coronavirus and other emerging and infectious diseases.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We are honored to receive this important grant from the North Dakota Department of Agriculture as our scientists work tirelessly to advance
efficacious solutions for this public-health emergency,&#148; stated Dr.&nbsp;Jennifer Bath, CEO of ImmunoPrecise Antibodies. &#147;This grant will be a tremendous support to our North Dakota teams and our scientists in the discovery and development
of the most promising neutralizing candidates to treat COVID.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a full-service, therapeutic antibody discovery and development organization specializing in species agnostic, multi-format, characterized and
engineered, human monoclonal antibodies, on an abbreviated timeframe. For further information, visit <U>www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This news release contains
statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148; within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;,
&#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148;, &#147;should&#148; and similar expressions to identify forward-looking statements and include the Company&#146;s
beliefs with respect to the potential for its antibodies to be further developed or approved to treat <FONT STYLE="white-space:nowrap">COVID-19</FONT> (or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2)</FONT></FONT> or
to complete any transactions with respect to those antibodies. Any such forward-looking statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and
expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements contained in
this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and analysis for the
previous quarter ended January&nbsp;31, 2020 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless required by applicable law,
ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922ccc1.jpg" ALT="LOGO">
 View original content to download multimedia: <U>http://www.newswire.ca/en/releases/archive/July2020/28/c0109.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., Suite 810, 609 Granville Street, P.O. Box 10322, Vancouver, B.C., V7Y 1G5, Canada. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 08:23e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">28-JUL-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.79
<SEQUENCE>80
<FILENAME>d20922dex9979.htm
<DESCRIPTION>EX-99.79
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.79</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.79 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922pre.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IPA&#146;s Human <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Anti-SARS-CoV-2</FONT></FONT>
Therapeutic Antibodies Demonstrate Synergistic Neutralization </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, BC, July&nbsp;31, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the
&#147;Company&#148; or &#147;IPA&#148;) (TSXV: IPA) (OTCQB: IPATF) (FSE:TQB2), a provider of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">best-in-class</FONT></FONT> therapeutic antibody capabilities, is pleased to announce that
additional characterization of a subset of fully human, therapeutic antibodies, already shown to have potent neutralizing activity, are exhibiting enhanced neutralization upon combinatorial (dual antibody) testing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Previously, IPA confirmed the identification of numerous therapeutic antibodies derived from multiple species (human, llama, Ligand&#146;s humanized OmniRat,
and wild-type rabbits) demonstrating potent, <I>in vitro</I> neutralizing activity. These functional antibodies were discovered using the Company&#146;s DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> phage technology, B Cell
Select<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> and Single Step Hybridoma platforms. The functional antibodies discovered to date bind to multiple regions of the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> spike protein. The purpose of this update is to announce the Company&#146;s most recent advancements regarding further characterization of the first subset of
antibodies, namely, those discovered using the Company&#146;s DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> phage technology that demonstrate binding to the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> spike Receptor Binding Domain. The Company has confirmed that a subset of six of these antibodies, falling into three different epitope bins, were analyzed in
combination, and resulted in clear synergistic effects, meaning their activities are in fact enhanced in combination studies resulting in near complete neutralization of
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> pseudovirus infection. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;As we characterize IPA&#146;s
approximately seventy-five functional lead candidates it is clear that our extensive program has generated therapeutics with broadly diverse profiles, providing substantial opportunities for multi-epitope targeted strategies,&#148; stated Jennifer
Bath, CEO of IPA. &#147;After selecting approximately sixteen hundred antibodies with the most desirable binding profiles to various spike protein formats, we down-selected our leads based on very specific criteria, all of which are key in our
ongoing determination of ideal candidates.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As the Company continues to screen its repository of functional antibodies, it advances the
identification of synergistic neutralizing antibody pairs, which they believe will set a new precedent in the <FONT STYLE="white-space:nowrap">on-going</FONT> fight against <FONT STYLE="white-space:nowrap">COVID-19.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company continues to further analyze multiple, additional, subsets of antibodies, including neutralizing antibodies demonstrated to bind to the S1 and S2
domains of the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> spike protein. Furthermore, the Company has begun steps for the expression of the lead antibodies for
<FONT STYLE="white-space:nowrap">pre-clinical</FONT> and clinical manufacturing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jennifer Bath, Ph.D., Chief Executive Officer of ImmunoPrecise, has
reviewed and approved the scientific disclosure of this news release. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s lead antibodies against
<FONT STYLE="white-space:nowrap">COVID-19</FONT> (or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2)</FONT></FONT> have not yet been studied in human clinical trials and, as a result, IPA is not making any express or
implied claims that its products have been proven to have the ability to eliminate, cure or contain <FONT STYLE="white-space:nowrap">COVID-19</FONT> (or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2)</FONT></FONT> at
this time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a full-service, therapeutic antibody discovery company utilizing species agnostic, multi-format, characterized and engineered, human
monoclonal antibodies, on an abbreviated timeframe. For further information, visit <U>www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This news release contains
statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148; within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;,
&#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148;, &#147;should&#148; and similar expressions to identify forward-looking statements and include the Company&#146;s
beliefs with respect to the potential for its antibodies to be further developed or approved to treat <FONT STYLE="white-space:nowrap">COVID-19</FONT> (or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2)</FONT></FONT> or
to complete any transactions with respect to those antibodies. Any such forward-looking statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and
expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause
ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower
than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and analysis for the previous quarter ended January&nbsp;31, 2020 which can be accessed at <U>www.sedar.com</U>. The
&#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result
of new information, future events or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922ccc1.jpg" ALT="LOGO">
 View original content to download multimedia:
<U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">http://www.prnewswire.com/news-releases/ipas-human-anti-sars-cov-2-therapeutic-antibodies-demonstrate-synergistic-neutralization-301103841.html</FONT>
</FONT></FONT></U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922ccc1.jpg" ALT="LOGO">
 View original content to download multimedia: <U>http://www.newswire.ca/en/releases/archive/July2020/31/c6232.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., Suite 810, 609 Granville Street, P.O. Box 10322, Vancouver, B.C., V7Y 1G5, Canada </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 08:13e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">31-JUL-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.80
<SEQUENCE>81
<FILENAME>d20922dex9980.htm
<DESCRIPTION>EX-99.80
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.80</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.80 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922pre.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IPA Appoints New York Based Crescendo Communications as Investor Relations and Corporate Communications Advisor </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, BC, Aug. 13, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTCQB: IPATF) (FSE:TQB2), a
provider of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">best-in-class</FONT></FONT> therapeutic antibody capabilities announces that it has retained Crescendo Communications, LLC (&#147;Crescendo&#148;) as its investor
relations firm to help broaden awareness of the Company within the North American financial markets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Waldman, President and CEO of Crescendo,
commented, &#147;ImmunoPrecise has developed a broad portfolio of therapeutic antibodies that bind to multiple regions of the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> spike protein. We are excited
about the potential of these antibodies, which have already achieved nearly complete neutralization of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> in combination studies. We are honored to support the
company in combatting this global pandemic and look forward to helping increase awareness within the investment community, especially in the U.S.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The investor relations agreement is for a renewable three-month term and may be terminated by either party by giving 30 days written notice of such
termination. The Company has granted Crescendo 250,000 incentive options to purchase common shares of the Company at a price of $1.50 per share for a period of 3 years. The options are subject to following vesting period: 25% at three months after
the date of grant and 25% every three months thereafter. The options will be granted in accordance with the Company&#146;s stock option plan and as set forth by TSX Venture Exchange policy. Both the options and the investor relations consulting
agreement are subject to the approval of the TSX Venture Exchange </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Crescendo Communications, LLC </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Crescendo Communications, LLC, headquartered in New York City with offices and affiliates in Europe and Asia, is an emerging leader within the investor
relations industry. The principals of Crescendo have represented hundreds of companies across all market caps and industries. The firm was founded on a strategic and professional approach to investor relations that builds awareness of public
companies through tailored outreach programs that target institutional investors, analysts, and the financial media. Our approach is centered around properly educating investors and cultivating trust in order to uphold and protect our clients&#146;
long-term credibility and reputation on Wall Street. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a full-service, therapeutic antibody discovery company utilizing species agnostic, multi-format, characterized and engineered, human
monoclonal antibodies, on an abbreviated timeframe. For further information, visit <U>www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This news release contains
statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148; within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;,
&#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148;, &#147;should&#148; and similar expressions to identify forward-looking statements. Any such forward-looking
statements are based on assumptions and analyses made by ImmunoPrecise in light of its </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
experience and its perception of historical trends, current conditions and expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s
expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements
contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and
analysis for the previous quarter ended January&nbsp;31, 2020 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless required by
applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922ccc1.jpg" ALT="LOGO">
 View original content to download multimedia: <U>http://www.newswire.ca/en/releases/archive/August2020/13/c1254.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., Suite 810, 609 Granville Street, P.O. Box 10322, Vancouver, B.C., V7Y 1G5, Canada. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 08:00e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">13-AUG-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.81
<SEQUENCE>82
<FILENAME>d20922dex9981.htm
<DESCRIPTION>EX-99.81
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.81</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.81 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g20922g23q22.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR THE YEARS ENDED APRIL&nbsp;30, 2020 AND 2019 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Expressed in Canadian Dollars) </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="18%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">


<IMG SRC="g20922g76p10.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Crowe MacKay LLP</B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">1100&nbsp;-1177&nbsp;West&nbsp;Hastings&nbsp;St.</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Vancouver,&nbsp;BC&nbsp;V6E&nbsp;4T5</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Main +1 (604) <FONT STYLE="white-space:nowrap">687-4511</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Fax&nbsp;&nbsp;&nbsp;+1 (604) <FONT STYLE="white-space:nowrap">687-5805</FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">www.crowemackay.ca</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Independent Auditor&#146;s Report </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the Shareholders of ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Opinion </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have audited the consolidated financial
statements of ImmunoPrecise Antibodies Ltd. (&#147;the Group&#148;), which comprise the consolidated statements of financial position as at April&nbsp;30, 2020 and April&nbsp;30, 2019 and the consolidated statements of loss and comprehensive loss,
changes in shareholders&#146; equity and cash flows for the years then ended, and notes to the consolidated financial statements, including a summary of significant accounting policies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In our opinion, the accompanying consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Group
as at April&nbsp;30, 2020 and April&nbsp;30, 2019, and its consolidated financial performance and its consolidated cash flows for the years then ended in accordance with International Financial Reporting Standards. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Basis for Opinion </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We conducted our audit in accordance
with Canadian generally accepted auditing standards. Our responsibilities under those standards are further described in the <I>Auditor&#146;s Responsibilities for the Audit of the Consolidated Financial Statements</I> section of our report. We are
independent of the Group in accordance with the ethical requirements that are relevant to our audit of the consolidated financial statements in Canada, and we have fulfilled our other ethical responsibilities in accordance with these requirements.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Material Uncertainty Related to
Going Concern </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We draw attention to Note 1 to the consolidated financial statements which describes the material uncertainty that may cast significant
doubt on the Group&#146;s ability to continue as a going concern. Our opinion is not modified in respect of this matter. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Management is responsible for the other information. The other information comprises: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Management&#146;s Discussion and Analysis </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our opinion on the consolidated financial statements does not cover the other information and we do not express any form of assurance conclusion thereon. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with our audit of the consolidated financial statements, our responsibility is to read the other information identified above and, in doing so,
consider whether the other information is materially inconsistent with the consolidated financial statements or our knowledge obtained in the audit, or otherwise appears to be materially misstated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We obtained the other information prior to the date of this auditor&#146;s report. If, based on the work we have performed on this other information, we
conclude that there is a material misstatement of this other information, we are required to report that fact in this auditor&#146;s report. We have nothing to report in this regard. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Responsibilities of Management and Those Charged with Governance for the Consolidated Financial
Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with
International Financial Reporting Standards, and for such internal control as management determines is necessary to enable the preparation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In preparing the consolidated financial statements, management is responsible for assessing the Group&#146;s ability to continue as a going concern,
disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate the Group or to cease operations, or has no realistic alternative but to do so. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Those charged with governance are responsible for overseeing the Group&#146;s financial reporting process. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Auditor&#146;s Responsibilities for the Audit of the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether
due to fraud or error, and to issue an auditor&#146;s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with Canadian generally accepted auditing
standards will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions
of users taken on the basis of these consolidated financial statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As part of an audit in accordance with Canadian generally accepted auditing
standards, we exercise professional judgment and maintain professional skepticism throughout the audit. We also: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Identify and assess the risks of material misstatement of the consolidated financial statements, whether due to
fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is
higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are
appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Group&#146;s internal control. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and
related disclosures made by management. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Conclude on the appropriateness of management&#146;s use of the going concern basis of accounting and, based on
the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Group&#146;s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are
required to draw attention in our auditor&#146;s report to the related disclosures in the consolidated financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to
the date of our auditor&#146;s report. However, future events or conditions may cause the Group to cease to continue as a going concern. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Evaluate the overall presentation, structure and content of the consolidated financial statements, including the
disclosures, and whether the consolidated financial statements represent the underlying transactions and events in a manner that achieves fair presentation. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Obtain sufficient appropriate audit evidence regarding the financial information of the entities or business
activities within the Group to express an opinion on the consolidated financial statements. We are responsible for the direction, supervision and performance of the group audit. We remain solely responsible for our audit opinion.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 2 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We communicate with those charged with governance regarding, among other matters, the planned scope and
timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also
provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our
independence, and where applicable, related safeguards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The engagement partner on the audit resulting in this independent auditor&#146;s report is Keith
L. Gagnon. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>&#147;Crowe MacKay LLP&#148; </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Chartered Professional Accountants </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vancouver, Canada
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>August&nbsp;28, 2020 </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 3 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSOLIDATED STATEMENTS OF FINANCIAL POSITION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Note</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,</B><br><B>2020</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,</B><br><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ASSETS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,605,706</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,471,650</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,491,636</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,558,354</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxes receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,549</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">818,643</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">799,542</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,168,317</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">393,451</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">526,591</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">333,702</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,699,442</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,556,699</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,129</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,450</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deposit on equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87,847</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>8</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">118,896</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>9</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,077,762</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,638,549</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>6,&nbsp;7,&nbsp;10</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,285,392</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,226,749</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>6, 7</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,908,653</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,883,047</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,263,121</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,462,898</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>LIABILITIES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,766,058</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,594,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,474,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">724,693</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>11</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,708,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>12</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">121,833</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82,953</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>13</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">752,306</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,757</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>6, 7</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,814,820</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,031,237</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,929,767</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,204,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debenture subscriptions received</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>22</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">313,268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>12</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">190,306</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,717</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>13</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,131,744</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,320</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>6, 7</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,010,620</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,032,744</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>21</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,601,577</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,056,738</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,177,282</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,393,823</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>SHAREHOLDERS&#146; EQUITY</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>14</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,086,942</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,699,425</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contributed surplus</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>14</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,777,771</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,074,192</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated other comprehensive income (loss)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(300,222</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(228,060</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(22,478,652</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,476,482</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,085,839</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,069,075</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities and shareholders&#146; equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,263,121</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,462,898</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nature of operations (Note 1) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Commitments (Note 18) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subsequent events (Notes 14 and 22) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Approved and authorized on behalf of the Board of Directors on August&nbsp;26, 2020 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="23%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="23%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<I>James&nbsp;Kuo&#148;</I>&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<I>Greg&nbsp;Smith</I>&#148;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these consolidated financial statements </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Note</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>REVENUE</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,057,927</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,926,268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>COST OF SALES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,023,943</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,631,634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>GROSS PROFIT</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,033,984</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,294,634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>EXPENSES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Advertising</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">377,728</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">819,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization and depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>9,&nbsp;10</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,573,009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,875,907</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bad debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,433</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,837</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Consulting fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>15</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">227,036</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">452,196</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange gain</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(78,148</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(117,506</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Insurance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">135,444</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">185,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest and bank charges</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">536,499</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">413,590</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Management fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>15</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">653,154</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">650,574</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Office and general</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">871,436</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">716,601</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Professional fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>15</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">883,623</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">985,557</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">127,633</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">324,396</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repairs and maintenance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,303</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38,803</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">446,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">485,845</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Salaries and benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>15</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,619,189</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,503,259</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>14,&nbsp;15</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">739,011</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,114,112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Telephone and utilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,410</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,775</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Travel</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">296,342</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">320,293</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,587,382</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,817,588</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Loss before other income (expense) and income taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,553,398</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,522,954</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>OTHER INCOME (EXPENSE)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>6,&nbsp;7,&nbsp;11</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(899,731</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(904,925</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest and other income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>22</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">272,006</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,085</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss on settlement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>11, 14</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(112,031</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(214,885</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(739,756</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,089,725</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Loss before income taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,293,154</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,612,679</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Income taxes recovery (expense)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="center"><B>21</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">345,728</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,788</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>NET LOSS FOR THE YEAR</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,947,426</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,617,467</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ITEMS THAT MAY BE RECLASSIFIED SUBSEQUENTLY TO LOSS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange difference on translating foreign operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(72,162</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(505,150</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>COMPREHENSIVE LOSS FOR THE YEAR</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,019,588</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,122,617</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>LOSS PER SHARE &#150; BASIC AND DILUTED</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.07</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.12</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68,144,478</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,710,530</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these consolidated financial statements </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS&#146; EQUITY </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian dollars, except for share figures) </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Share<BR>Capital</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Contributed<BR>Surplus</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated<BR>Other<BR>Comprehensive<BR>(Loss)&nbsp;Income</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Deficit</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>55,474,178</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20,455,112</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,707,738</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>277,090</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(9,859,015</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>12,580,925</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to private placements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,977,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,802,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,802,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash issue costs and finders&#146; fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">182,460</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(288,504</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(288,504</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustment to value of shares issued pursuant to acquisition of IPA Europe and Immulease</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">975,045</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">975,045</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to settlement of Debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,377,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,115,370</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">283,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,398,370</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to Crossbeta settlement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78,514</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to deferred acquisition payment to IPA Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">714,793</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">507,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">507,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to option exercise</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">135,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,158</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,658</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,114,112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,114,112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss for the year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(505,150</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,617,467</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,122,617</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>67,939,445</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>32,699,425</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,074,192</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(228,060</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(17,476,482</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>18,069,075</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adoption of IFRS 16 (Note 4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(54,744</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(54,744</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, May&nbsp;1, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>67,939,445</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>32,699,425</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,074,192</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(228,060</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(17,531,226</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>18,014,331</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to settlement of Debentures and accrued interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,244,792</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">858,906</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">858,906</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to option exercise</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,990</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12,490</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares issued pursuant to warrant exercise</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">680,971</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">499,621</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(22,942</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">476,679</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">739,011</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">739,011</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss for the year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(72,162</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,947,426</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,019,588</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>69,920,208</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>34,086,942</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,777,771</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(300,222</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(22,478,652</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>15,085,839</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these consolidated financial statements </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSOLIDATED STATEMENTS OF CASH FLOWS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss for the year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,947,426</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,617,467</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Items not affecting cash:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization and depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,408,347</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,263,284</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(455,161</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(578,969</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">899,731</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">922,575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense settled in shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(48,018</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(105,656</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(28,492</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss on settlement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">214,885</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">739,011</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,114,112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(273,102</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,787,236</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in <FONT STYLE="white-space:nowrap">non-cash</FONT> working capital related to
operations:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(933,282</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102,114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(23,392</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">289,524</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(774,866</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">167,319</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(192,889</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,934</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">171,996</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(421,673</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxes payable and receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(115,817</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">750,057</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">407,154</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,391,295</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,206,596</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Investing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(373,753</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(645,058</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deposit on equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(87,847</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Internally generated development costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(114,042</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,007,435</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,556,754</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,583,077</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,201,812</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Financing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds on share issuance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">493,179</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,843,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(288,504</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debenture subscriptions received</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">313,268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repayment of leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(657,215</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(23,912</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from loans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">283,328</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loan repayments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82,859</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(378,775</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repayment of debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(175,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">174,701</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,351,809</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(Decrease) increase in cash during the year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,799,671</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,943,401</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(48,594</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(210,434</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash &#150; beginning of the year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,539,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,806,133</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash &#150; end of the year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,690,835</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,539,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash is comprised of:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,605,706</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,471,650</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,129</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,450</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,690,835</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,539,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash paid for interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300,868</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">371,262</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash paid for income tax</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">238,426</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">415,144</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Supplemental cash flow information (Note 20)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these consolidated financial statements </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>NATURE OF OPERATIONS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies Ltd. (the &#147;Company&#148; or &#147;IPA&#148;) was incorporated under the laws of Alberta on November&nbsp;22,
1983. The Company is listed on the TSX Venture Exchange (the &#147;Exchange&#148;) as a Tier 2 life science issuer under the trading symbol &#147;IPA&#148;. The Company&#146;s OTC symbol is &#147;IPATF&#148;. The Company is a supplier of custom
hybridoma development services. The address of the Company&#146;s corporate office is 3204 &#150; 4464 Markham Street, Victoria, BC, Canada V8Z 7X8. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements have been prepared on the basis of accounting principles applicable to a going concern. This assumes the
Company will continue in operation for the foreseeable future and will be able to realize its assets and discharge its obligations in the normal course of operations. The Company has incurred operating losses since inception, including $4,947,426
for the year ended April&nbsp;30, 2020 and has accumulated a deficit of $22,478,652 as at April&nbsp;30, 2020. The Company may need to raise additional funds in order to continue on as a going concern and there can be no assurances that sufficient
funding, including adequate financing, will be available. The ability of the Company to arrange additional financing in the future depends in part, on the prevailing capital market conditions and profitability of its operations. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In March 2020, there was a global pandemic outbreak of <FONT STYLE="white-space:nowrap">COVID-19.</FONT> The actual and threatened spread of
the virus globally has had a material adverse effect on the global economy and specifically, the regional economies in which the Company operates. The pandemic could result in delays in the course of business and could have a negative impact on the
Company&#146;s ability to raise new capital. It is not possible for the Company to predict the duration or magnitude of the adverse results of the outbreak and its effects on the Company&#146;s business or results of operations at this time. These
material uncertainties may cast significant doubt on the Company&#146;s ability to continue as a going concern. Accordingly, the consolidated financial statements do not give effect to adjustments that would be necessary should the Company be unable
to continue as a going concern and therefore be required to realize its assets and liquidate its liabilities, contingent obligations and commitments other than in the normal course of business and at amounts different from those in the consolidated
financial statements. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>BASIS OF PRESENTATION </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(a) Statement of compliance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (&#147;IFRS&#148;),
as issued by the International Accounting Standards Board (&#147;IASB&#148;), and include the significant accounting policies as described in Note 3. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">These consolidated financial statements were approved by the Board of Directors for issue on August&nbsp;26, 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(b) Basis of measurement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">These consolidated financial statements have been prepared on the historical cost basis. In addition, these consolidated financial statements
have been prepared using the accrual basis of accounting, except for cashflow information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(c) Basis of consolidation</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">These consolidated financial statements include the financial statements of the Company and the following subsidiaries which are wholly owned
and subject to control by the Company: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Name of Subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">%&nbsp;Equity<BR><FONT STYLE="white-space:nowrap">Interest&nbsp;-&nbsp;2020</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">%&nbsp;Equity<BR><FONT STYLE="white-space:nowrap">Interest&nbsp;-&nbsp;2019</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Country of<BR>Incorporation</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (Canada) Ltd.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Canada</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (USA) Ltd., incorporated in Nevada, USA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">USA</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (USA) Ltd., incorporated in Delaware, USA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">USA</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (N.D.) Ltd.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">USA</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (MA) LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">USA</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Talem Therapeutics LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">USA</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">U-Protein</FONT> Express B.V.
<FONT STYLE="white-space:nowrap">(&#147;U-Protein&#148;)</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Netherlands</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Netherlands B.V.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Netherlands</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ImmunoPrecise Antibodies (Europe) B.V. (&#147;IPA Europe&#148;, formerly ModiQuest Research
B.V.)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Netherlands</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Immulease B.V. (&#147;Immulease&#148;)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Netherlands</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Control is achieved when the Company has the power to, directly or indirectly, govern the financial and
operating policies of an entity so as to obtain benefits from its activities. Subsidiaries are fully consolidated from the date on which control is obtained and continue to be consolidated until the date that such control ceases. Intercompany
balances, transactions and unrealized intercompany gains and losses are eliminated upon consolidation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company incorporated a new
subsidiary, ImmunoPrecise Antibodies (USA) Ltd. in Delaware, USA on September&nbsp;11, 2019. ImmunoPrecise Antibodies (USA) Ltd., incorporated in Nevada, USA, was dissolved on November&nbsp;4, 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(d) Functional and presentation currency</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The functional currency of a company is the currency of the primary economic environment in which the company operates. The presentation
currency for a company is the currency in which the company chooses to present its financial statements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The functional currency of the
Company and ImmunoPrecise Antibodies (Canada) Ltd. is the Canadian dollar. The functional currency of ImmunoPrecise Antibodies (USA) Ltd., ImmunoPrecise Antibodies (N.D.) Ltd., ImmunoPrecise Antibodies (MA) LLC and Talem Therapeutics LLC is the US
dollar. The functional currency of <FONT STYLE="white-space:nowrap">U-Protein,</FONT> ImmunoPrecise Netherlands BV, IPA Europe and Immulease is the Euro. The presentation currency of the Company is the Canadian dollar. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Entities whose functional currencies differ from the presentation currency are translated into Canadian dollars as follows: assets and
liabilities &#150; at the closing rate as at the reporting date, and income and expenses &#150; at the average rate of the period. All resulting changes are recognized in other comprehensive income as cumulative translation differences. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Transactions in foreign currencies are translated into the functional currency at exchange rates at the date of the transactions. Foreign
currency monetary assets and liabilities are translated at the functional currency exchange rate at the reporting date. <FONT STYLE="white-space:nowrap">Non-monetary</FONT> items that are measured in terms of historical cost in a foreign currency
are translated using exchange rates as at the dates of the initial transactions. <FONT STYLE="white-space:nowrap">Non-monetary</FONT> items measured at fair value in a foreign currency are translated using the exchange rates at the date when the
fair value is determined. All gains and losses on translation of these foreign currency transactions are included in profit or loss. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">When the Company disposes of its entire interest in a foreign operation, or loses control,
joint control, or significant influence over a foreign operation, the foreign currency gains or losses accumulated in other comprehensive income related to the foreign operation are recognized in profit or loss. If an entity disposes of part of an
interest in a foreign operation which remains a subsidiary, a proportionate amount of foreign currency gains or losses accumulated in other comprehensive income related to the subsidiary are reallocated between controlling and <FONT
STYLE="white-space:nowrap">non-controlling</FONT> interests. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SIGNIFICANT ACCOUNTING POLICIES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Business combination</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Acquisitions of businesses are accounted for using the acquisition method. The consideration transferred in a business combination is measured
at fair value, which is calculated as the sum of the acquisition-date fair values of the assets transferred by the Company, liabilities incurred by the Company to the former owners of the acquiree and the equity interests issued by the Company in
exchange for control of the acquiree. Acquisition-related costs are generally recognized in profit or loss as incurred. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">At the acquisition
date, the identifiable assets acquired and the liabilities assumed are recognized at their fair value at the acquisition date. Goodwill is measured as the excess of the sum of the consideration transferred, the amount of any <FONT
STYLE="white-space:nowrap">non-controlling</FONT> interests in the acquiree, and the fair value of the acquirer&#146;s previously held equity interest in the acquiree (if any) over the net of the acquisition-date amounts of the identifiable assets
acquired and the liabilities assumed. If, after reassessment, the net of the acquisition-date amounts of the identifiable assets acquired and liabilities assumed exceeds the sum of the consideration transferred, the amount of any <FONT
STYLE="white-space:nowrap">non-controlling</FONT> interests in the acquiree and the fair value of the acquirer&#146;s previously held interest in the acquiree (if any), the excess is recognized immediately in profit or loss as a bargain purchase
gain. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">When the consideration transferred by the Company in a business combination includes assets or liabilities resulting from a
contingent consideration arrangement, the contingent consideration is measured at its acquisition-date fair value and included as part of the consideration transferred in a business combination. Changes in the fair value of the contingent
consideration that qualify as measurement period adjustments are adjusted retrospectively, with corresponding adjustments against goodwill. Measurement period adjustments are adjustments that arise from additional information obtained during the
&#145;measurement period&#146; (which cannot exceed one year from the acquisition date) about facts and circumstances that existed at the acquisition date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The subsequent accounting for changes in the fair value of the contingent consideration that do not qualify as measurement period adjustments
depends on how the contingent consideration is classified. Contingent consideration that is classified as equity is not remeasured at subsequent reporting dates and its subsequent settlement is accounted for within equity. Contingent consideration
that is classified as an asset or a liability is remeasured at subsequent reporting dates in accordance with IAS 39, <I>Financial Instruments: Recognition and Measurement </I>or IAS 37, <I>Provisions, Contingent Liabilities and Contingent
Assets</I>, as appropriate, with the corresponding gain or loss being recognized in profit or loss. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Revenue recognition</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company recognizes revenue from sale of antibodies and service agreements. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Sale of antibodies: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Revenue from
sale of antibodies is recognized when the terms of a contract with a customer have been satisfied. This occurs when: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The control over the product has been transferred to the customer; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The product is received by the customer or transfer of title to the customer occurs upon shipment.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Following delivery, the customer bears the risks of obsolescence and loss in relation to the
goods. Revenue is recognized based on the price specified in the contract, net of estimated sales discounts and returns. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Contract
revenue: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Revenues from contracted services are generally recognized as the performance obligations are satisfied over time, and the
related expenditures are incurred pursuant to the terms of the agreement. Contract revenue is recognized on a percentage of completion basis when the key milestones contained within the contract are satisfied and there is an enforceable right to
payment for performance completed to date. For contracts with no enforceable right to payment when the contract is incomplete, contract revenue is recognized on a completed contract basis when the customers are satisfied with the service at the end
of the contract. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Unbilled revenue and deferred revenue: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Amounts recognized as revenue in excess of billings are classified as unbilled revenue. Amounts received in advance of the performance of
services are classified as deferred revenue. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Cost of sales: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Cost of sales includes materials, direct labour, and allocation of overhead including depreciation of lab equipment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Financial instruments</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Recognition and Classification</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company recognizes a financial asset or financial liability on the statement of financial position when it becomes party to the contractual
provisions of the financial instrument. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company classifies its financial instruments in the following categories: at fair value
through profit and loss (&#147;FVTPL&#148;), at fair value through other comprehensive income (loss) (&#147;FVTOCI&#148;) or at amortized cost. The Company determines the classification of financial assets at initial recognition. The classification
of debt instruments is driven by the Company&#146;s business model for managing the financial assets and their contractual cash flow characteristics. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Equity instruments that are held for trading are classified as FVTPL. For other equity instruments, on the day of acquisition the Company can
make an irrevocable election (on an <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">instrument-by-instrument</FONT></FONT> basis) to designate them as at FVTOCI. Financial liabilities are measured at amortized cost, unless they are
required to be measured at FVTPL (such as instruments held for trading or derivatives) or if the Company has opted to measure them at FVTPL. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Measurement</I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Financial
assets and liabilities at FVTPL: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Financial assets and liabilities carried at FVTPL are initially recorded at fair value and transaction
costs are expensed in profit or loss. Realized and unrealized gains and losses arising from changes in the fair value of the financial assets and liabilities held at FVTPL are included in profit or loss in the period in which they arise. Where
management has opted to recognize a financial liability at FVTPL, any changes associated with the Company&#146;s own credit risk will be recognized in other comprehensive income (loss). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Financial assets at FVTOCI: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Elected investments in equity instruments at FVTOCI are initially recognized at fair value plus transaction costs. Subsequently they are
measured at fair value, with gains and losses recognized in other comprehensive income (loss). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Financial assets and liabilities at amortized cost: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Financial assets and liabilities at amortized cost are initially recognized at fair value plus or minus transaction costs, respectively, and
subsequently carried at amortized cost less any impairment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Impairment of financial assets at amortized cost: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company recognizes a loss allowance for expected credit losses on financial assets that are measured at amortized cost. At each reporting
date, the Company measures the loss allowance for the financial asset at an amount equal to the lifetime expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition. If at the reporting
date, the financial asset has not increased significantly since initial recognition, the Company measures the loss allowance for the financial asset at an amount equal to the twelve month expected credit losses. The Company shall recognize in profit
or loss, as an impairment gain or loss, the amount of expected credit losses (or reversal) that is required to adjust the loss allowance at the reporting date to the amount that is required to be recognized. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Derecognition</I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Financial
assets: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company derecognizes financial assets only when the contractual rights to cash flows from the financial assets expire, or when
it transfers the financial assets and substantially all of the associated risks and rewards of ownership to another entity. Gains and losses on derecognition are generally recognized in profit or loss. However, gains and losses on derecognition of
financial assets classified as FVTOCI remain within accumulated other comprehensive income (loss). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Financial liabilities: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company derecognizes financial liabilities only when its obligations under the financial liabilities are discharged, cancelled or expired.
Generally, the difference between the carrying amount of the financial liability derecognized and the consideration paid and payable, including any <FONT STYLE="white-space:nowrap">non-cash</FONT> assets, is recognized in profit or loss. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Government assistance</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company periodically applies for financial assistance under available government incentive programs. Government assistance relating to
capital expenditures is reflected as a reduction of the cost of such assets. Government assistance relating to research and development expenditures is recorded as a reduction of current year&#146;s expenses when the related expenditures are
incurred. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Inventory</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Inventory consists of supplies, parts and antibodies and is valued at the lower of average cost and net realizable value. Costs include
acquisition, freight and other directly attributable costs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Equipment and leasehold improvements</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Equipment and leasehold improvements are stated at cost, less accumulated depreciation. Depreciation is provided using the straight-line method
over the following terms: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Asset</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Basis</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Term</P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lab equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Straight&nbsp;line</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5 years</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Furniture and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Straight line</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5 years</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Computer hardware</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Straight line</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">2 years</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Computer software</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Straight line</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">1 year</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Building</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Straight line</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Remaining term of the property lease</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Automobile</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Straight line</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4 years</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Straight line</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Remaining term of the lease plus the first renewal option</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Intangible assets</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Intangible assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business
combination is their fair value at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and accumulated impairment losses. Internally generated intangibles, excluding
capitalized development costs, are not capitalized and the related expenditure is reflected in profit or loss in the period in which the expenditure is incurred. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The useful lives of intangible assets are assessed as either finite or indefinite. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment whenever there is an indication
that the intangible asset may be impaired. The amortization period and the amortization method for an intangible asset with a finite useful life are reviewed at least at the end of each reporting period. Changes in the expected useful life or the
expected pattern of consumption of future economic benefits embodied in the asset are considered to modify the amortization period or method, as appropriate, and are treated as changes in accounting estimates. The amortization expense on intangible
assets with finite lives is recognized in profit or loss in the expense category that is consistent with the function of the intangible assets. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Intangible assets with indefinite useful lives are not amortized, but are tested for impairment annually, either individually or at the
cash-generating unit level. The assessment of indefinite life is reviewed annually to determine whether the indefinite life continues to be supportable. If not, the change in useful life from indefinite to finite is made on a prospective basis. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Gains or losses arising from derecognition of an intangible asset are measured as the difference between the net disposal proceeds and the
carrying amount of the asset and are recognized in profit or loss when the asset is derecognised. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Goodwill</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Goodwill represents the excess of the purchase price in a business combination over the fair value of net tangible and intangible assets
acquired. Goodwill is not subject to amortization and an impairment test is performed annually or as events occur that could indicate impairment. Goodwill is reported at cost less any impairment. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the purposes of assessing impairment, assets are grouped at the lowest levels for which there are separately identifiable cash flows
(&#147;CGU&#148;s). To test for impairment, goodwill is allocated to each of the Company&#146;s CGUs, groups of CGUs, or an operating segment expected to benefit from the acquisition. Goodwill is tested by combining the carrying amounts of equipment
and leasehold improvements, intangible assets and goodwill and comparing this to the recoverable amount. Fair value less costs of disposal is price to be received in an orderly transaction between market participants. Value in use is assessed using
the present value of the expected future cash flows. Any excess of the carrying amount over the recoverable amount is recorded as impairment. Impairment charges, which are not tax affected, are recognized in in profit or loss and are not reversed.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Impairment of long-lived assets</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset
may not be recoverable. Recoverability of assets to be held and used is measured by comparison of their carrying amount to the recoverable amount. The recoverable amount is the higher of the fair value less selling costs or the value in use. Value
in use is determined by the present value of the future cash flows from the asset. If the recoverable amount is less than the carrying amount, then there is impairment. Where an impairment loss exists, the portion of the carrying amount exceeding
the recoverable amount is recorded as an expense immediately. Assets that have been impaired in prior periods are tested for possible reversal of impairment whenever events or changes in circumstance indicate that the impairment has
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
reversed. If the impairment has reversed, the carrying amount of the asset is increased to its recoverable amount but not beyond the carrying amount that would have been determined had no
impairment loss been recognized for the asset in prior periods. The reversal is recognized in profit or loss immediately. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Income
taxes</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Income taxes are recognized in the statement of comprehensive income (loss), except where they relate to items recognized
directly in equity, in which case the related taxes are recognized in equity. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Deferred tax assets and liabilities are recognized based on
the difference between the tax and accounting values of assets and liabilities and are calculated using enacted or substantively enacted tax rates for the periods in which the differences are expected to reverse. The effect of tax rate changes is
recognized in profit or loss or equity, as applicable, in the period of substantive enactment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Current taxes receivable or payable are
estimated on taxable income for the current year at the statutory tax rates enacted or substantively enacted. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Deferred tax assets are
recognized only to the extent that it is probable that future taxable profits of the relevant entity or group of entities, in a particular jurisdiction, will be available against which the assets can be utilized. As an exception, deferred tax assets
and liabilities are not recognized if the temporary differences arise from the initial recognition of goodwill or an asset or liability in a transaction (other than in a business combination) that affects neither accounting profit nor taxable
profit. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Investment tax credits (&#147;ITCs&#148;) are accounted for as a reduction in the cost of the expense when there is reasonable
assurance that such credits will be realized. These ITCs are used to reduce current income taxes payable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Leases</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">At inception of a contract, the Company assesses whether the contract is, or contains, a lease. A contract is, or contains, a lease if the
contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Leases of <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets are recognized at the lease commencement date at the present value of the lease payments that are not paid at that date. The lease payments are discounted
using the interest rate implicit in the lease, if that rate can be readily determined, and otherwise at the Company&#146;s incremental borrowing rate. At the commencement date, a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset is measured at cost, which is comprised of the initial amount of the lease liability adjusted for any lease payments made at or before the
commencement date, plus any decommissioning and restoration costs, less any lease incentives received. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Each lease payment is allocated
between repayment of the lease principal and interest. Interest on the lease liability in each period during the lease term is allocated to produce a constant periodic rate of interest on the remaining balance of the lease liability. Except where
the costs are included in the carrying amount of another asset, the Company recognizes in profit or loss (a)&nbsp;the interest on a lease liability and (b)&nbsp;variable lease payments not included in the measurement of a lease liability in the
period in which the event or condition that triggers those payments occurs. The Company subsequently measures the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset at cost less any accumulated
depreciation and any accumulated impairment losses; and adjusted for any remeasurement of the lease liability. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> assets are depreciated over the shorter of
the asset&#146;s useful life and the lease term, except where the lease contains a bargain purchase option a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset is depreciated over the asset&#146;s
useful life. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Share capital</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Equity instruments are contracts that give a residual interest in the net assets of the Company. The Company&#146;s common shares are
classified as equity instruments. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Proceeds from unit placements are allocated between common shares and warrants issued based
on the residual value method, with the common shares being valued first. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Share issuance costs</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Costs directly identifiable with the raising of share capital financing are charged against share capital. Share issuance costs incurred in
advance of share subscriptions are recorded as deferred assets. Share issuance costs related to uncompleted share subscriptions are charged to operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Share-based payments</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Where equity-settled share options are awarded to employees, the fair value of the options at the date of grant is charged to profit or loss
over the vesting period. Performance vesting conditions are taken into account by adjusting the number of equity instruments expected to vest at each reporting date so that, ultimately, the cumulative amount recognized over the vesting period is
based on the number of options that eventually vest. <FONT STYLE="white-space:nowrap">Non-vesting</FONT> conditions and market vesting conditions are factored into the fair value of the options granted. As long as all other vesting conditions are
satisfied, a charge is made irrespective of whether these vesting conditions are satisfied. The cumulative expense is not adjusted for failure to achieve a market vesting condition or where a <FONT STYLE="white-space:nowrap">non-vesting</FONT>
condition is not satisfied. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Where the terms and conditions of options are modified before they vest, the increase in the fair value of the
options, measured immediately before and after the modification, is also charged to profit or loss over the remaining vesting period. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Where equity instruments are granted to <FONT STYLE="white-space:nowrap">non-employees,</FONT> they are recorded at the fair value of the goods
or services received in profit or loss, unless they are related to the issuance of shares. Amounts related to the issuance of shares are recorded as a reduction of share capital. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">When the value of goods or services received in exchange for the share-based payment cannot be reliably estimated, the fair value is measured
by use of a valuation model. The expected life used in the model is adjusted, based on management&#146;s best estimate, for the effects of <FONT STYLE="white-space:nowrap">non-transferability,</FONT> exercise restrictions, and behavioural
considerations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">All equity-settled share-based payments are reflected in contributed surplus, until exercised. Upon exercise, shares are
issued from treasury and the amount reflected in contributed surplus is credited to share capital, adjusted for any consideration paid. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Where a grant of options is cancelled or settled during the vesting period, excluding forfeitures when vesting conditions are not satisfied,
the Company immediately accounts for the cancellation as an acceleration of vesting and recognizes the amount that otherwise would have been recognized for services received over the remainder of the vesting period. Any payment made to the employee
on the cancellation is accounted for as the repurchase of an equity interest except to the extent the payment exceeds the fair value of the equity instrument granted, measured at the repurchase date. Any such excess is recognized as an expense. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Earnings (loss) per share</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Basic earnings (loss) per share is calculated by dividing the net income (loss) available to common shareholders by the weighted average number
of common shares outstanding during the period. Dilutive earnings per share reflect the potential dilution of securities that could share in the earnings of an entity. In periods where a net loss is incurred, potentially dilutive common shares are
excluded from the loss per share calculation as the effect would be anti-dilutive and basic and diluted loss per common share is the same. In a profit year, under the treasury stock method, the weighted average number of common shares outstanding
used for the calculation of diluted earnings per share assumes that the proceeds to be received on the exercise of dilutive stock options and warrants are used to repurchase common shares at the average price during the year. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ADOPTION OF NEW ACCOUNTING STANDARDS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has adopted the following new standards, along with any consequential amendments, effective May&nbsp;1, 2019. These changes were
made in accordance with the applicable transitional provisions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company adopted all of the requirements of IFRS 16, <I>Leases
</I>(&#147;IFRS 16&#148;) as of May&nbsp;1, 2019. IFRS 16 replaces IAS 17, <I>Leases </I>(&#147;IAS 17&#148;). IFRS 16 provides a single lessee accounting model, requiring lessees to recognize assets and liabilities for all leases unless the lease
term is 12 months or less or the underlying asset has a low value. The Company has adopted IFRS 16 using the modified retrospective application method, where the 2019 comparatives are not restated and a cumulative catch up adjustment is recorded on
May&nbsp;1, 2019 for any differences identified, including adjustments to opening deficit balance. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company analyzed its contracts to
identify whether they contain a lease arrangement for the application of IFRS 16. The following is the Company&#146;s new accounting policy for leases under IFRS 16: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">At inception of a contract, the Company assesses whether the contract is, or contains, a lease. A contract is, or contains, a lease if the
contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Leases of <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets are recognized at the lease commencement date at the present value of the lease payments that are not paid at that date. The lease payments are discounted
using the interest rate implicit in the lease, if that rate can be readily determined, and otherwise at the Company&#146;s incremental borrowing rate. At the commencement date, a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset is measured at cost, which is comprised of the initial amount of the lease liability adjusted for any lease payments made at or before the
commencement date, plus any decommissioning and restoration costs, less any lease incentives received. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Each lease payment is allocated
between repayment of the lease principal and interest. Interest on the lease liability in each period during the lease term is allocated to produce a constant periodic rate of interest on the remaining balance of the lease liability. Except where
the costs are included in the carrying amount of another asset, the Company recognizes in profit or loss (a)&nbsp;the interest on a lease liability and (b)&nbsp;variable lease payments not included in the measurement of a lease liability in the
period in which the event or condition that triggers those payments occurs. The Company subsequently measures a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset at cost less any accumulated
depreciation and any accumulated impairment losses; and adjusted for any remeasurement of the lease liability. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> assets are depreciated over the shorter of
the asset&#146;s useful life and the lease term, except where the lease contains a bargain purchase option a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset is depreciated over the asset&#146;s
useful life. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On the date of transition, the Company recorded a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset of $1,668,533 related to the office rent in property and equipment, and the lease obligation of $1,723,277 was recorded as at May&nbsp;1, 2019,
discounted using the Company&#146;s incremental borrowing rate of 8%, and measured at an amount equal to the lease obligation as if IFRS 16 had been applied since the commencement date. The net difference between
<FONT STYLE="white-space:nowrap">right-of-use</FONT> assets and lease liabilities on the date of transition was recognized as a deficit adjustment of $54,744 on May&nbsp;1, 2019. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CRITICAL ACCOUNTING ESTIMATES AND JUDGMENTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The preparation of the consolidated financial statements in conformity with IFRS required estimates and judgments that affect the amounts
reported in the financial statements. Actual results could differ from these estimates and judgments. Estimates are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the year in which the estimate is revised.
Significant areas requiring the use of estimates and judgments are as follows: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Functional currency</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has used judgment in determining the currency of the primary economic environment in which the entity operates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Amounts receivable</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company monitors the financial stability of its customers and the environment in which they operate to make estimates regarding the
likelihood that the individual trade receivable balances will be paid. Credit risks for outstanding customer receivables are regularly assessed and allowances are recorded for estimated losses, if required. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Property and equipment</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has used estimates in the determination of the expected useful lives of property and equipment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Revenue recognition</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">percentage-of-completion</FONT></FONT> method requires the use of estimates to determine the stage of completion which is used to determine the recorded amount of revenue, unbilled revenue
and deferred revenue on uncompleted contracts. The determination of anticipated revenues includes the contractually agreed revenue and may also involve estimates of future revenues if such additional revenues can be reliably estimated and it is
considered probable that they will be recovered. The determination of anticipated costs for completing a contract is based on estimates that can be affected by a variety of factors, including the cost of materials, labour, and <FONT
STYLE="white-space:nowrap">sub-contractors.</FONT> The determination of estimates is based on the Company&#146;s business practices as well as its historical experience. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Impairments</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the
purposes of assessing impairment, assets are grouped at the lowest levels for which there are separately identifiable cash flows (&#147;CGU&#148;s). Each asset or CGU is evaluated every reporting period to determine whether there are any indicators
of impairment. If any such indicators exist, which is often judgment-based, a formal estimate of recoverable amount is performed and an impairment charge is recognized to the extent that the carrying amount exceeds the recoverable amount. The
recoverable amount of an asset or CGU of assets is measured at the higher of fair value less costs of disposal or value in use. These determinations and their individual assumptions require that management make a decision based on the best available
information at each reporting period. The estimates and assumptions are subject to risk and uncertainty; hence, there is the possibility that changes in circumstances will alter these projections, which may impact the recoverable amount of the
assets. In such circumstances, some or all of the carrying value of the assets may be further impaired or the impairment charge reversed with the impact recorded in profit or loss. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company performs a goodwill impairment test annually and when circumstances indicate that the carrying value may not be recoverable. For
the purposes of impairment testing, goodwill acquired through business combinations has been allocated to two different CGUs. The recoverable amount of each CGU was based on value in use, determined by discounting the future cash flows to be
generated from the continuing use of the CGU. The cash flows were projected over a five-year period based on past experience and actual operating results. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company performed its annual goodwill impairment test in April 2020 and no impairment was indicated for the period tested. The values
assigned to the key assumptions represented management&#146;s assessment of future trends in the industry and were based on hgarristorical data from both internal and external sources. Weighted average costs of capital of 16.33% and 12.26%,
respectively, was used in the assessments of the two CGUs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Determination of segments</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">An operating segment is a component of the Company that engages in business activities from which it may earn revenues and incur expenses. All
operating segments&#146; results are reviewed by the Company&#146;s management in order to make decisions regarding the allocation of resources to the segment. Segment results include items directly attributable to a segment as those that can be
allocated on a reasonable basis. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As the Company provides antibody production and related services in one distinct category,
there is only one category to report revenues by production site. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Life of intangible assets</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Intangible assets are amortized based on estimated useful life less their estimated residual value. Significant assumptions are involved in the
determination of useful life and residual values and no assurance can be given that actual useful lives and residual values will not differ significantly from current assumptions. Actual useful life and residual values may vary depending on a number
of factors including internal technical evaluation, attributes of the assets and experience with similar assets. Changes to these estimates may affect the carrying value of assets, net income (loss) and comprehensive income (loss) in future periods.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Purchase price allocation</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The acquisition of <FONT STYLE="white-space:nowrap">U-Protein</FONT> on August&nbsp;22, 2017 and the acquisition of IPA Europe and Immulease on
April&nbsp;5, 2018 were accounted for as business combinations at fair value in accordance with IFRS 3, <I>Business Combinations</I>. The acquired assets and assumed liabilities were adjusted to their fair values assigned through completion of a
purchase price allocation, as described below. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The purchase price allocation process resulting from a business combination required
management to estimate the fair value of identifiable assets acquired including intangible assets and liabilities assumed including the deferred acquisition payment obligations. The Company used valuation techniques, which were based on forecasted
future net cash flows discounted to present value, and also relied on work performed by third-party valuation specialists. These valuations were closely linked to the assumptions used by management on the future performance of the related assets and
the discount rates applied. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ACQUISITION OF <FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On August&nbsp;22, 2017, the Company completed the acquisition of <FONT STYLE="white-space:nowrap">U-Protein</FONT> whereby the Company
acquired all of the issued and outstanding shares of <FONT STYLE="white-space:nowrap">U-Protein</FONT> for &#128;6,830,000 on terms as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,734,732 (CAD$4,062,607) was paid in cash on closing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3,030,503 common shares of the Company were issued on closing; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,047,634 in deferred payments over a three-year period. The deferred payments can be made in cash or
common shares of the Company at the election of <FONT STYLE="white-space:nowrap">U-Protein</FONT> shareholders. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The
transaction was accounted for as a business combination, as the operations of <FONT STYLE="white-space:nowrap">U-Protein</FONT> meet the definition of a business. As the transaction was accounted for as a business combination, transaction costs of
$17,717 were expensed. The goodwill resulting from the allocation of the purchase price to the total fair value of net assets represented the sales and growth potential of <FONT STYLE="white-space:nowrap">U-Protein.</FONT> Goodwill recorded is
allocated in its entirety to <FONT STYLE="white-space:nowrap">U-Protein.</FONT> The fair value of the 3,030,503 common shares issued ($3,022,308) was determined based on the Canadian dollar equivalent of the consideration required of &#128;2,047,634
pursuant to the share purchase agreement. The Company has allocated the purchase price as follows: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,062,607</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3,030,503 common shares of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,022,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of deferred payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,134,410</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,219,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">797,276</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">370,530</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,815</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment, net of accumulated amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">216,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intellectual property (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,064,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,655,893</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(269,657</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income taxes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,197</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(810,800</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,219,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The deferred payments of &#128;2,047,634 over a three-year period was
fair valued on the date of acquisition using a discounted cash flow model. A discount rate of 16.2% was used. The changes in the value of the deferred payments during the years ended April&nbsp;30, 2020 and 2019 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,408,205</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">244,915</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,049,754</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(40,670</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,562,696</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">350,137</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,007,435</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,130</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">931,528</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ACQUISITION OF IPA EUROPE AND IMMULEASE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company acquired all of the issued and outstanding shares of IPA Europe and its sister entity, Immulease, for an
aggregate purchase price of &#128;7,000,000 on terms as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,500,000 (CAD$3,988,132) was paid in cash on closing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">6,600,399 common shares of the Company were issued on closing; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,000,000 in deferred payments over a three-year period. The deferred payments are made in three equal
installments of cash and equity totaling &#128;666,666 and prorated if the EBITDA of IPA Europe for the fiscal year preceding the date of payment is less than its average EBITDA over the previous two fiscal years. During the year ended
April&nbsp;30, 2019, the Company and the seller entered into an Amendment, Termination and Settlement Agreement whereby the deferred payments shall no longer be subject to an adjustment and will be paid in equal installments of cash and equity
totaling &#128;666,666. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The transaction was accounted for as a business combination, as the operations of IPA Europe and
Immulease meet the definition of a business. As the transaction was accounted for as a business combination, transaction costs of $36,821 were expensed. The goodwill resulting from the allocation of the purchase price to the total
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
fair value of net assets represented the sales and growth potential of IPA Europe. Goodwill recorded is allocated in its entirety to IPA Europe. The fair value of the 6,600,399 common shares
issued ($4,884,295) was determined to be $0.74 per share based on the fair value of the Company&#146;s shares immediately prior to the completion of the acquisition. The Company has allocated the purchase price as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">$</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,988,132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6,600,399 common shares of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,884,295</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of deferred payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,353,708</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,226,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">270,339</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">572,427</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,286,995</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment, net of accumulated amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">568,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Software</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible assets (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,304,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,640,671</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(580,339</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(22,897</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(298,979</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,636,192</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,226,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The deferred payments of &#128;2,000,000 over a three-year period was fair valued on the date of acquisition
using a discounted cash flow model. A discount rate of 14% was used. The changes in the value of the deferred payments during the years ended April&nbsp;30, 2020 and 2019 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,403,954</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in estimate of fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(34,258</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">232,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,014,503</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(86,326</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,501,285</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">382,928</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,699</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,893,912</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INVESTMENT </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Investment consists of a 29% (2019 &#150; 29%) interest in QVQ Holding B.V. (&#147;QVQ&#148;), which is recorded using the equity method, being
the best approximation of the investment&#146;s fair value, resulting in a change in fair value of $28,492 recognized in other income. Judgment is required as to the extent of influence that the Company has over QVQ. The Company considered the
extent of voting power over the entity, the power to participate in financial and operating policy decisions of the entity, representation on the board of directors, material transactions between the entities, interchange of management personnel,
and provision of essential technical information. The Company has determined that the Company is not considered to have significant influence over QVQ, as the Company does not have the power to participate in financial and operating policy
decisions, does not have representation on the Board of Directors of QVQ, and the majority of the common shares are held by QVQ management. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>PROPERTY AND EQUIPMENT </B></P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Computer<BR>Hardware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Furniture&nbsp;&amp;<BR>Equipment</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Computer<BR>Software</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Building</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Automobile</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Leasehold<BR>Improvements</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Lab</B><br><B>Equipment</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93,813</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98,527</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,373</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">393,421</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,787,105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,385,239</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquired on acquisition of IPA Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,184</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,538</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87,821</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">612,046</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">729,589</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,153</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,141</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(31,294</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">110,997</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,065</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">130,015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">393,421</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,369,010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,114,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IFRS 16 transition adjustment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,668,533</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,668,533</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,999</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">905,225</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,997</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,495</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">350,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,327,976</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Disposals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(73,697</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(75,052</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(80,193</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(196,325</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(49,221</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(633,152</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,107,640</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,166</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">972</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,367</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,602</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>54,299</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>36,013</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>49,919</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,383,599</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>49,969</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>350,695</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,098,485</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,022,979</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated Depreciation:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,883</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,218</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,299</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,552,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,803,870</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,252</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,533</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103,764</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500,194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">677,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(43</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,029</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,072</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,636</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,789</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">205,816</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,047,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,475,959</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66,198</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">696,948</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,145</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69,273</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">497,409</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,367,183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Disposals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(73,697</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(75,052</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(80,193</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(49,221</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(633,152</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(911,315</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">170</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,366</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">142</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,712</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,390</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>37,454</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>17,778</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>34,964</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>700,314</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,287</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>225,868</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,921,552</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,945,217</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Book Value:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,429</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81,226</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">187,605</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,321,427</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,638,549</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>April&nbsp;30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>16,845</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>18,235</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>14,955</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,683,285</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>42,682</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>124,827</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,176,933</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,077,762</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INTANGIBLE ASSETS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The intangible assets were acquired as a result of the acquisitions of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe and are
amortized using the straight-line method over their useful lives. The intellectual property has a useful life of 10 years, and the proprietary processes have a useful life of 5 years. The internally generated development costs will commence
amortizing once the development process is ready to be used. The changes in the value of the intangible assets during the years ended April&nbsp;30, 2020 and 2019 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Internally<BR>Generated<BR>Development<BR>Costs</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Intellectual<BR>Property</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Proprietary<BR>Processes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Certifications</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,270,229</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,270,229</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquired on acquisition of</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IPA Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,159,755</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">145,108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,304,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reclassification adjustment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,809,518</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,809,518</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(125,004</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(229,263</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,401</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(359,668</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,145,225</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,740,010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">139,707</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,024,942</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114,042</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114,042</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">533</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,464</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,140</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39,591</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>114,575</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,158,689</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,765,150</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>140,161</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>12,178,575</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated Amortization:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">227,746</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">227,746</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">416,890</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,169,233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,586,123</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,035</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,641</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(15,676</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">635,601</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,162,592</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,798,193</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">406,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,634,830</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,041,164</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42,226</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53,826</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,053,535</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,839,648</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,893,183</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Book Value:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,509,624</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,577,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">139,707</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,226,749</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>April&nbsp;30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>114,575</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,105,154</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,925,502</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>140,161</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>8,285,392</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During fiscal year 2020, the Company reviewed the cost of the acquired phage libraries and identified the need
to create an additional human phage library. This resulted in bifurcating the cost of the phage library into the costs to develop the proprietary process to create a phage library and the cost of the phage library acquired (Inventory). Accordingly,
a reclassification was made between Inventory and Proprietary Processes resulting in an increase in the cost of the Proprietary Processes by $1,809,518. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DEBENTURES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company completed a nonconvertible debenture (the &#147;Debentures&#148;) financing in the principal amount of
$4,252,000 (the &#147;Offering&#148;). The Debentures were unsecured, bore interest at a rate of 10% per annum, payable semi-annually, and were due eighteen months from the date of issue. Under the Offering, a holder of a Debenture received 37,500
detachable share purchase warrants (the &#147;Warrants&#148;) for every $25,000 of Debentures subscribed for by the holder. The Warrants are exercisable at $0.70 per share for a period of four years from the date of issue. The fair value of the
Debentures at the time of issue was calculated as the discounted cash flows assuming a 15% effective interest rate. The fair value of the Warrants was determined at the time of issue as the difference between the face value and the fair value of the
Debentures. On initial recognition, the Company bifurcated $4,003,125 to the carrying value of the Debentures and $248,875 to the Warrants. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Under the Offering, the Company paid the following finder&#146;s fees: $10,300 in cash, 580,320 shares of the Company with a fair value of
$383,010, and 415,942 finder&#146;s warrants valued at $187,627. The fair value of the finder&#146;s warrants was estimated on the date of issue using the Black-Scholes option valuation model with the following weighted average assumptions: dividend
yield of $nil, risk free interest rate of 1.60%, expected life of 4 years and expected volatility based on the historical volatility of similar companies of 100%. The total fair value of the finder&#146;s fees was allocated <FONT
STYLE="white-space:nowrap">pro-rata</FONT> based on the carrying values of the Debentures and Warrants, with $546,934 allocated to the Debentures and $34,003 allocated to the Warrants. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;25, 2018, the Company settled $1,377,000 of the Debentures by issuing 1,377,000 units at a price of $1.00 per unit. Each unit
consisted of one common share of the Company and one share purchase warrant, with each warrant entitling the holder to purchase an additional share at $1.25 for two years. The fair value of the 1,377,000 common shares issued was determined to be
$1,115,370. The fair value of the warrants issued was determined to be $283,000 and estimated on the date of issue using the Black-Scholes option valuation model with the following weighted average assumptions: dividend yield of $nil, risk free
interest rate of 1.58%, expected life of 2 years and expected volatility based on the historical volatility of similar companies of 68.7%. The settlement resulted in a loss of $189,715. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;26, 2019, the Company modified the terms of $2,750,000 Debentures to extend
the due date by 6 months to March&nbsp;26, 2020, with the ability to pay earlier with no penalty, and increased the interest rate to 12.5%. The remaining debentures of $125,000 were paid on maturity. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;26, 2020, the Company settled $700,000 of the Debentures plus accrued interest of $46,875 by issuing 1,244,792 common shares. The
fair value of the 1,244,792 common shares issued was determined to be $858,906. The settlement resulted in a loss of $112,031. $50,000 of the Debentures were paid on maturity. The maturity date of the remaining Debentures of $2,000,000 was extended
to September&nbsp;26, 2020. The Company repaid the remaining balance of $2,000,000 plus interest subsequent to <FONT STYLE="white-space:nowrap">year-end.</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2020, the Company recorded accretion expense of $166,666 (2019 &#150; $427,592). The changes in the value
of the Debentures during the years ended April&nbsp;30, 2020 and 2019 are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April 30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,489,397</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">427,592</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Settlement of debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,208,655</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April 30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,708,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">166,666</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repayment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(175,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Settlement of debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(700,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April 30, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>LOANS PAYABLE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company assumed loans payable of &#128;60,750 (CAD$94,995) as a result of the acquisition of IPA Europe. On
July&nbsp;7, 2015, IPA Europe entered into a loan agreement in the principal amount of &#128;165,000, maturing on July&nbsp;31, 2020. The loan is secured by certain equipment, bears an interest rate of 4% per annum and is repayable in monthly
installments of &#128;2,250. The interest is owed per month in arrears. The principal outstanding at April&nbsp;30, 2020 is &#128;4,500 (CAD$6,797) (2019 &#150; &#128;31,500 (CAD$47,423)). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company assumed loans payable of &#128;56,450 (CAD$88,271) as a result of the acquisition of IPA Europe. On
February&nbsp;1, 2016, IPA Europe entered into a loan agreement in the principal amount of &#128;100,000, maturing on February&nbsp;28, 2021. The loan is secured by certain equipment, bears an interest rate of 3% per annum and is repayable in
monthly installments of &#128;1,675. The interest is owed per month in arrears. The principal outstanding at April&nbsp;30, 2020 is &#128;14,575 (CAD$22,014) (2019 &#150; &#128;34,675 (CAD$52,203)). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company assumed loans payable of &#128;74,000 (CAD$115,713) as a result of the acquisition of Immulease. On
May&nbsp;18, 2016, Immulease entered into a credit facility agreement pursuant to which the lender provided a facility amount of up to &#128;200,000. The credit facility was unsecured, bore an interest rate of 3% per annum and was repayable on
demand. The interest was owed per month in arrears. The principal outstanding at April&nbsp;30, 2020 is &#128;nil (CAD$nil) (2019 &#150; &#128;8,000 (CAD$12,044)). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On May&nbsp;23, 2018, the Company entered into a loan agreement with a Director of the Company and his spouse and issued a promissory note in
the principal amount of $200,000. The note was unsecured and bore an interest rate of 5.45% per annum. The principal of the note plus accrued interest of $3,972 was repaid in full during the year ended April&nbsp;30, 2019. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;15, 2020, the Company was approved for a US$209,000 loan under the Payroll
Protection Program (&#147;PPP&#148;) administered by the U.S. Small Business Administration. The PPP is a US$349&nbsp;billion loan program that originated from the U.S. Coronavirus Aid, Relief and Economic Security (CARES) Act. The PPP loan has a
term of two years, is unsecured, and is guaranteed by the U.S. Small Business Administration. The loan will be forgiven if the proceeds are used by the Company to cover payroll costs (including benefits), with up to 25% allowed for rent and
utilities, during the eight-week period following the loan origination date. The Company expects to meet the requirements for full loan forgiveness. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">290,445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loan proceeds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loan repayments and foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(378,775</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,670</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loan proceeds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">283,328</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loan repayments and foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82,859</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, April&nbsp;30, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">312,139</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(121,833</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-current</FONT> portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">190,306</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>LEASES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company entered into certain equipment and automobile leases expiring between 2021 and 2023 with interest rates of between 8% and 17% per
annum. The Company&#146;s obligations under these finance leases are secured by the lessor&#146;s title to the leased assets. The Company also entered into office leases in January 2018 and May 2018. With the adoption of IFRS 16, <I>Leases</I> (see
Note 4), the Company recognized a lease obligation with regard to the office leases. The terms and the outstanding balances as at April&nbsp;30, 2020 and 2019 are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2020</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment under lease in monthly instalments of $1,228 with interests of between 13% and 17% per
annum. Due dates are between May 2021 and March 2023.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,222</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,077</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Automobile under lease in monthly instalments of $1,155 with an interest rate of 8% per annum and
an end date of September 2023.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,330</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> asset
from office lease repayable in monthly instalments of $9,602 and an interest rate of 8% per annum and an end date of May 2021. The obligation includes an early termination fee of $15,981.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">135,230</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> asset
from office lease repayable in monthly instalments of $16,445 and an interest rate of 8% per annum and an end date of December 2022.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">475,727</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> asset
from office lease repayable in monthly instalments of $23,236 and an interest rate of 8% per annum and an end date of December 2022.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">673,235</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> asset
from office lease repayable in monthly instalments of $13,891 to $21,015 and an interest rate of 8% per annum and an end date of April 2023.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">485,307</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(752,306</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(35,757</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-current</FONT> portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,131,744</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,320</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As at April&nbsp;30, 2020, the Company&#146;s lab equipment and automobile include a net
carrying amount of $77,285 (2019 &#150; $104,014) for the leased equipment and $42,682 (2019 &#150; $nil) for the leased automobile. The net carrying amount of the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets from office lease obligation is $1,683,285 (2019 &#150; $nil). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following is a schedule of the Company&#146;s future minimum lease payments related to the equipment under finance lease and the office
lease obligation: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">849,255</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">714,898</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">513,051</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,774</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total minimum lease payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,082,978</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: imputed interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(198,928</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total present value of minimum lease payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,884,050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Current portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(752,306</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-current</FONT> portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,131,744</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SHARE CAPITAL </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>a) Authorized: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Unlimited
common shares without par value. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>b) Share capital transactions: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>2019 Transactions </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On
June&nbsp;19, 2018, the Company closed a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement financing by issuing a total of 875,000 units of the Company at a price of $0.80 per unit for gross proceeds of $700,000. Each unit
consisted of one common share of the Company and one share purchase warrant, with each warrant entitling the holder to purchase an additional share at a price of $1.00 for a period of one year from the date of issue. The Company has the right to
accelerate the expiry date of the warrants provided that the volume weighted average price trades at a price equal to or greater than $1.50 for a period of 20 consecutive days. All of the proceeds have been allocated to the common shares issued with
a $nil value assigned to the warrants issued. The Company paid finders cash fees totaling $3,000 and incurred $7,926 of cash issue costs. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;24, 2018, the Company closed a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement financing by issuing a
total of 9,102,500 units of the Company at a price of $1.00 per unit for gross proceeds of $9,102,500. Each unit consisted of one common share of the Company and one share purchase warrant, with each warrant entitling the holder to purchase an
additional share at a price of $1.25 for a period of two years from the date of issue. The Company has the right to accelerate the expiry date of the warrants provided that the volume weighted average price trades at a price equal to or greater than
$1.75 for a period of 20 consecutive days. All of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
proceeds have been allocated to the common shares issued with a $nil value assigned to the warrants issued. The Company paid finders cash fees totaling $201,540 and issued 182,460 finder&#146;s
shares. The Company also incurred $76,038 of cash issue costs. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;22, 2017, the Company announced that it had signed a
binding letter of intent with Crossbeta Biosciences B.V. (&#147;Crossbeta&#148;) whereby the Company had agreed to acquire all of the issued and outstanding shares of Crossbeta. The proposed transaction was terminated and settled on October&nbsp;23,
2018. In consideration of the settlement, the Company paid &#128;37,000 ($55,969) and issued 78,514 shares valued at $61,241. The Company accrued a settlement liability of $92,040 as at April&nbsp;30, 2018. As such, the remaining loss on settlement
of $25,170 was recognized in the year ended April&nbsp;30, 2019. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;25, 2018, the Company settled $1,377,000 of the
Debentures by issuing 1,377,000 units at a price of $1.00 per unit (Note 11). Each unit consisted of one common share of the Company and one share purchase warrant, with each warrant entitling the holder to purchase an additional share at $1.25 for
two years. The fair value of the 1,377,000 common shares issued was determined to be $1,115,370. The fair value of the warrants issued was determined to be $283,000 and estimated on the date of issue using the Black-Scholes option valuation model
with the following weighted average assumptions: dividend yield of $nil, risk free interest rate of 1.58%, expected life of 2 years and expected volatility based on the historical volatility of similar companies of 68.7%. The settlement resulted in
a loss of $189,715. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;27, 2019, the Company issued 714,793 common shares pursuant to the second deferred payment to IPA Europe
(Note 7). The common shares were valued at $507,503. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2019, the Company issued 135,000 common shares
pursuant to exercise of stock options for total gross proceeds of $40,500. A value of $30,658 was transferred from contributed surplus to share capital as a result. The weighted average share price at dates the stock options were exercised was
$1.05. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>2020 Transactions</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;26, 2020, the Company settled $700,000 of the Debentures plus accrued interest of $46,875 by issuing 1,244,792 common shares
(Note&nbsp;11). The fair value of the 1,244,792 common shares issued was determined to be $858,906. The settlement resulted in a loss of $112,031. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2020, the Company issued 55,000 common shares pursuant to exercise of stock options for total gross
proceeds of $16,500. A value of $12,490 was transferred from contributed surplus to share capital as a result. The weighted average share price at dates the stock options were exercised was $0.69. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2020, the Company issued 680,971 common shares pursuant to exercise of warrants and finder&#146;s warrants
for total gross proceeds of $476,679. A value of $22,942 was transferred from contributed surplus to share capital as a result. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>c)
Options </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has an incentive Stock Option Plan (&#147;the Plan&#148;) under which
<FONT STYLE="white-space:nowrap">non-transferable</FONT> options to purchase common shares of the Company may be granted to directors, officers, employees or service providers of the Company. The terms of the plan provide that the Directors have the
right to grant options to acquire common shares of the Company at not less than the closing market price of the shares on the day preceding the grant at terms of up to five years. The maximum number of options outstanding under the Plan shall not
result, at any time, in more than 10% of the issued and outstanding common shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;24, 2018, the Company granted 95,000 stock options, exercisable at $0.95
per option, to employees of the Company. The options are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date; <FONT STYLE="white-space:nowrap">one-third</FONT> 12 months after grant
date and <FONT STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $67,402 using the Black-Scholes option pricing model and the following assumptions: dividend yield of 0%,
expected volatility of 100%, a risk-free interest rate of 1.60%, and an expected life of 5 years. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On November&nbsp;7, 2018, the Company
granted 300,000 stock options, exercisable at $0.82 per option, to employees of the Company. The options are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date; <FONT
STYLE="white-space:nowrap">one-third</FONT> 12 months after grant date and <FONT STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $184,658 using the Black-Scholes option
pricing model and the following assumptions: dividend yield of 0%, expected volatility of 100%, a risk-free interest rate of 2.20%, and an expected life of 5 years. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;31, 2018, the Company granted 1,250,000 stock options, exercisable at $1.00 per option, to officers and directors of the
Company. The options are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date; <FONT STYLE="white-space:nowrap">one-third</FONT> 12 months after grant date and <FONT
STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $625,485 using the Black-Scholes option pricing model and the following assumptions: dividend yield of 0%, expected
volatility of 100%, a risk-free interest rate of 2.20%, and an expected life of 5 years. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On January&nbsp;11, 2019, the Company granted
415,000 stock options, exercisable at $1.00 per option, to officers and an employee of the Company. The options are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date; <FONT
STYLE="white-space:nowrap">one-third</FONT> 12 months after grant date and <FONT STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $228,801 using the Black-Scholes option
pricing model and the following assumptions: dividend yield of 0%, expected volatility of 100%, a risk-free interest rate of 2.20%, and an expected life of 5 years. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;3 2019, the Company granted 250,000 stock options, exercisable at $0.475 per option, to an officer of the Company. The options
are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date; <FONT STYLE="white-space:nowrap">one-third</FONT> 12 months after grant date and
<FONT STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $86,395 using the Black-Scholes option pricing model and the following assumptions: share price on grant date of $0.48,
dividend yield of 0%, expected volatility of 100%, a risk-free interest rate of 1.46%, and an expected life of 5 years. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;3,
2019, the Company granted 200,000 stock options, exercisable at $1.00 per option, to a consultant of the Company. The options vested immediately upon grant. The fair value of these options was estimated to be $32,096 using the Black-Scholes option
pricing model and the following assumptions: share price on grant date of $0.48, dividend yield of 0%, expected volatility of 100%, a risk-free interest rate of 1.56%, and an expected life of 2 years. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;3, 2019, the Company granted 150,000 stock options, exercisable at $0.50 per option, to a director of the Company. The options
are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date; <FONT STYLE="white-space:nowrap">one-third</FONT> 12 months after grant date and
<FONT STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $53,326 using the Black-Scholes option pricing model and the following assumptions: share price on grant date of $0.48,
dividend yield of 0%, expected volatility of 100%, a risk-free interest rate of 1.46%, and an expected life of 5 years. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;3,
2019, the Company granted 65,000 stock options, exercisable at $1.01 per option, to employees of the Company. The options vested immediately upon grant. The fair value of these options was estimated to be $14,627 using the Black-Scholes option
pricing model and the following assumptions: share price on grant date of $0.48, dividend yield of 0%, expected volatility of 100%, a risk-free interest rate of 1.54%, and an expected life of 2.96 years. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;3, 2020, the Company granted 55,000 stock options, exercisable at $1.01 per
option, to employees of the Company. The options are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after grant date; <FONT STYLE="white-space:nowrap">one-third</FONT> 12 months after grant date
and <FONT STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $20,582 using the Black-Scholes option pricing model and the following assumptions: share price on grant date of
$0.69, dividend yield of 0%, expected volatility of 100%, a risk-free interest rate of 0.75%, and an expected life of 3 years. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On
April&nbsp;29, 2020, the Company granted 250,000 stock options, exercisable at $0.76 per option, to an officer of the Company. The options are subject to vesting conditions as follows: <FONT STYLE="white-space:nowrap">one-third</FONT> 6 months after
grant date; <FONT STYLE="white-space:nowrap">one-third</FONT> 12 months after grant date and <FONT STYLE="white-space:nowrap">one-third</FONT> 18 months after grant date. The fair value of these options was estimated to be $129,340 using the
Black-Scholes option pricing model and the following assumptions: share price on grant date of $0.76, dividend yield of 0%, expected volatility of 100%, a risk-free interest rate of 0.38%, and an expected life of 3.93 years. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Expected volatility was based on the historical volatility of similar companies. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2020 the Company has recorded $739,011 (2019 - $1,114,112) of share-based payments expense. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The changes in the stock options for the years ended April&nbsp;30, 2020 and 2019 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>options</B><br><B>#</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted<BR>average<BR>exercise&nbsp;price</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted<BR>average&nbsp;life<BR>remaining<BR>(years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2018 (outstanding)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,871,666</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.68</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4.20</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,060,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(135,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expired</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(200,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,293,333</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2019 (outstanding)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,303,333</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.78</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3.87</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">970,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(55,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(903,333</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2020 (outstanding)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,315,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.77</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3.03</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,193,333</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Exercisable, April&nbsp;30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,121,667</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.80</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2.79</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Details of the options outstanding as at April&nbsp;30, 2020 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Expiry Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exercise<BR>price</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Remaining<BR>life</B><br><B>(year)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Options<BR>outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unvested</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Vested</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October&nbsp;1, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December&nbsp;20, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">550,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">550,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;18, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">950,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">950,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January&nbsp;3, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February&nbsp;7, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">700,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">700,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April&nbsp;3, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;24, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November&nbsp;7, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">416,666</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">833,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January&nbsp;7, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January&nbsp;11, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April&nbsp;1, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.92</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October&nbsp;1, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.475</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">166,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">83,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October&nbsp;3, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.77</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3.03</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,315,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,193,333</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,121,667</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">65,000 of these stock options have been exercised subsequent to April&nbsp;30, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">62,500 of these stock options have been exercised subsequent to April&nbsp;30, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">200,000 of these stock options have been exercised subsequent to April&nbsp;30, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These options were amended during the year from an exercise price of $1.00 to $0.76. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>d) Warrants </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The changes
in the warrants for the years ended April&nbsp;30, 2020 and 2019 are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>warrants</B><br><B>#</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;average<BR>exercise price</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;average<BR>life remaining<BR>(years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April 30, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,378,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.70</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3.93</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issued</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,354,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April 30, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>17,732,500</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1.04</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1.90</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(675,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April 30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>17,057,500</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1.05</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.91</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Details of the warrants outstanding as at April&nbsp;30, 2020 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Expiry Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exercise&nbsp;price</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Remaining<BR>life</B><br><B>(year)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Warrants<BR>outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March&nbsp;26, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,703,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;18, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">875,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;24, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,102,500</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October&nbsp;25, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,377,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.04</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,057,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">705,000 of these warrants have been exercised subsequent to April&nbsp;30, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">During the year ended April&nbsp;30, 2020, the expiry date of these warrants was extended from June&nbsp;18,
2019 to June&nbsp;18, 2020. All of these warrants have been exercised subsequent to April&nbsp;30, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">1,721,000 of these warrants have been exercised subsequent to April&nbsp;30, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">115,000 of these warrants have been exercised subsequent to April&nbsp;30, 2020. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>e)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Finder&#146;s Warrants </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The changes in the finder&#146;s warrants for the years ended April&nbsp;30, 2020 and 2019 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>warrants</B><br><B>#</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;average<BR>exercise price</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;average<BR>life remaining<BR>(years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2018 and 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>415,942</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.70</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2.91</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,971</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance, April&nbsp;30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B></B>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B>409,971</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.70</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1.90</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">22,000 of these warrants have been exercised subsequent to April&nbsp;30, 2020. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As at April&nbsp;30, 2020, the Company has 409,971 finder&#146;s warrants outstanding. The warrants have an exercise price of $0.70 per share
and expire on March&nbsp;26, 2022. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>15.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>RELATED PARTY TRANSACTIONS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Key management personnel are those persons having authority and responsibility for planning, directing and controlling the activities of the
Company. Key management consists of Dr.&nbsp;Jennifer Bath, President and CEO; Lisa Helbling, CFO; Dr.&nbsp;Stefan Lang, Chief Business Officer; Dr.&nbsp;Yasmina Abdiche, Chief Scientific Officer; Charles Wheelock, former Chief Technology Officer;
Natasha Tsai, former CFO; Reginald Beniac, former Chief Operating Officer; Oren Beske, former President of ImmunoPrecise Antibodies (USA) Ltd.; Martin Hessing, a former Director of <FONT STYLE="white-space:nowrap">U-Protein;</FONT> Jos Raats, former
President and CEO of IPA Europe; and Directors of the Company. During the years ended April&nbsp;30, 2020 and 2019, the compensation for key management is as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Consulting fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,292</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Management fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">178,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">394,126</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Professional fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,263</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Salaries and other short-term benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,052,465</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">995,855</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Severance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">632,279</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">770,928</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,863,607</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,314,964</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">At April&nbsp;30, 2020, included in accounts payable and accrued liabilities is $412,188 (2019 - $nil) due to
related parties. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2020, the spouse of a former Director provided administrative services for $nil
(2019 &#150; $54,225). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the year ended April, 30, 2020, a company controlled by Martin Hessing, a former Director of <FONT
STYLE="white-space:nowrap">U-Protein,</FONT> sold certain equipment to <FONT STYLE="white-space:nowrap">U-Protein</FONT> for a cash consideration of &#128;25,000. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">These transactions are in the normal course of operations and are measured at the exchange amount, which is the amount of consideration
established and agreed to by the related parties, unless otherwise noted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>16.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CAPITAL MANAGEMENT </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s objectives when managing capital are to ensure sufficient liquidity for operations and adequate funding for growth and
capital expenditures while maintaining an efficient balance between debt and equity. The capital structure of the Company consists of credit facilities and shareholders&#146; equity. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company makes adjustments to its capital structure upon approval from its Board of Directors, in light of economic conditions and the
Company&#146;s working capital requirements. There were no changes in the Company&#146;s approach to capital management during the year. The Company is not subject to any externally imposed capital requirements. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>17.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>FINANCIAL INSTRUMENTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s financial instruments include cash, amounts receivable, restricted cash, investment, accounts payable and accrued
liabilities, debentures, loans payable, leases and deferred acquisition payments. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Fair value is the price that would be received to sell
an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy establishes three levels to classify the inputs to valuation techniques used to measure fair value, by
reference to the reliability of the inputs used to estimate the fair values. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Level 1 - applies to assets or liabilities for which there
are quoted prices in active markets for identical assets or liabilities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Level 2 - applies to assets or liabilities for which there are
inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or
infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Level 3 - applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the
measurement of the fair value of the assets or liabilities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The fair value of investment is determined based on &#147;Level&nbsp;2&#148;
inputs as its value under the equity method was the best approximation of its fair value. As at April&nbsp;30, 2020, the Company believes that the carrying values of cash, amounts receivable, restricted cash, accounts payable and accrued
liabilities, debentures, loans payable, leases and deferred acquisition payments approximate their fair values because of their nature and relatively short maturity dates or durations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Concentration of risk: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Industry </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company
operates in the contract research organization sector and is affected by general economic trends. A decline in economic conditions, research spending or other adverse conditions could lead to reduced revenue. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Concentrations of credit risk </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Credit risk relates to cash, restricted cash and amounts receivable and arises from the possibility that counterparty to an instrument may fail
to perform. At April&nbsp;30, 2020, all of the Company&#146;s cash was held with tier one banks. The Company has evaluated amounts receivable and determined that there were no material allowances for doubtful accounts at April&nbsp;30, 2020 and
2019. During the year ended April&nbsp;30, 2020 the Company incurred bad debt expense of $48,433 (2019 - $1,837). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Currency risk</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company operates in the US and Europe which gives rise to exposure to market risks from changes in foreign currency values. Most
significantly, the Company is exposed to potential currency fluctuations between US and Canadian dollars, which was translated at 1.3556 at April&nbsp;30, 2020, and the Euro and Canadian dollar, which was translated at 1.51039 at April&nbsp;30,
2020. Fluctuations in the exchange rate could impact profitability. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">At April&nbsp;30, 2020, the Company is exposed to currency risk
through the following assets and liabilities denominated in US dollars and Euros: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Euros</B><br><B>(&#128;)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>US&nbsp;Dollars</B><br><B>(US $)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,246,018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">452,226</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">752,224</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">906,428</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78,719</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,076,961</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,358,654</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(642,781</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(570,253</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19,075</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(209,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,870,669</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,532,525</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(779,253</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(455,564</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">579,401</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the year ended April&nbsp;30, 2020, a 5% increase in foreign exchange rates by the Canadian dollar relative
to the US dollar would have decreased other comprehensive income (loss) by approximately $39,000. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the year ended April&nbsp;30, 2020,
a 5% increase in foreign exchange rates by the Canadian dollar relative to the Euro would have decreased other comprehensive income (loss) by approximately $34,000. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Liquidity risk:</I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The
Company&#146;s approach to managing its obligations is to maintain sufficient resources to meet its obligations when due without undue risk to the Company. The Company monitors its cash requirements on an ongoing basis to ensure that there are
sufficient resources for operations as well as to fund anticipated leasing, capital and development expenditures. In addition, the Company manages its cash to meet its debt obligations and to fund general and administrative costs. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Contractual cash flow requirements as at April&nbsp;30, 2020 were as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&lt; 1</B><br><B>year</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>1 &#150; 2</B><br><B>years</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2 &#150; 5</B><br><B>years</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&gt;5</B><br><B>years</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,766,058</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,766,058</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">121,833</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">190,306</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">312,139</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payments<SUP STYLE="font-size:85%; vertical-align:top">(1) </SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,546,088</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">506,538</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,052,626</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">849,255</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">714,898</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">518,825</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,082,978</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,283,234</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,411,742</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">518,825</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,213,801</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">$1,016,112 aggregate payments not included in this table are to be settled by issuance of
shares.&nbsp;&nbsp;&nbsp;&nbsp; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>18.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>COMMITMENTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company entered into a lease for a piece of equipment for its Victoria, BC, Canada laboratory space on April&nbsp;29, 2020. The lease
commenced on May&nbsp;15, 2020 with a 36 month term. The monthly lease payment is USD$15,829. The Company has a right to purchase the equipment at fair market value at the end of the lease term. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>19.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SEGMENTED INFORMATION AND ECONOMIC DEPENDENCE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">At April&nbsp;30, 2020 and 2019, the Company has one reportable segment, being antibody production and related services. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2020, the Company had sales to nil (2019 - nil) customer who in aggregate accounted for more than 10%
(2019&nbsp;&#150;&nbsp;10%) of revenue. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s revenues are allocated to geographic segments for the years ended
April&nbsp;30, 2020 and 2019 as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">United States of America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,949,014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,849,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Canada</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">714,764</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">859,445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,114,674</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,796,501</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,279,475</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">420,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,057,927</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,926,268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s revenues are allocated according to revenue types for the years ended April&nbsp;30, 2020
and 2019 as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Project revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,195,074</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,497,257</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Product sales revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">739,283</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">204,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cryo storage revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">123,570</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">224,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,057,927</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,926,268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s <FONT STYLE="white-space:nowrap">non-current</FONT> assets are allocated to geographic
segments as at April&nbsp;30, 2020 and 2019 as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2020</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,429,210</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">986,323</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Netherlands</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,134,469</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,919,876</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,563,679</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,906,199</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Geographic segmentation of the Company&#146;s net loss is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America - Corporate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,226,844</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,524,410</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(683,039</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(293,351</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Netherlands</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(37,543</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(799,706</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,947,426</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,617,467</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Geographic segmentation of the interest and accretion, and amortization and depreciation is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Interest and accretion</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America - Corporate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">856,872</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,278,144</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,942</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,565</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Netherlands</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">493,416</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,806</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,436,230</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,318,515</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Amortization and depreciation</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America - Corporate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">125,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,385</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">498,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">330,408</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Netherlands</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,784,452</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,904,491</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,408,347</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,263,284</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>20.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SUPPLEMENTAL CASH FLOW INFORMATION </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B><FONT STYLE="white-space:nowrap">Non-cash</FONT> investing and
financing transactions:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2020</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt settlement by issuance of shares and warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">858,906</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,398,370</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Crossbeta settlement by issuance of shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquisition of building and equipment by capital lease</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,622,756</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84,531</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of shares issued pursuant to acquisition of IPA Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">975,045</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of shares issued pursuant to deferred acquisition payment to IPA Europe</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">507,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following changes in liabilities arose from financing activities: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-cash</FONT> changes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Cash Flows</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Acquisition</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Settlement<BR>/ Disposal</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accretion</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Foreign<BR>exchange<BR>movements<BR>and<BR>change in<BR>estimates</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2020</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,063,981</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,007,435</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">733,065</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,829</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,825,440</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,708,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(175,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(700,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">166,666</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debenture subscriptions received</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">313,268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">313,268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,670</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,469</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">312,139</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,077</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(657,215</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,677,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(196,325</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(46,987</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,884,050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,991,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,325,913</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,677,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(896,325</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">899,731</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,158</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,334,897</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-cash</FONT> changes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2018</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Cash Flows</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Settlement<BR>by issuance<BR>of shares</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Acquisition</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accretion</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Foreign<BR>exchange<BR>movements<BR>and<BR>change in<BR>estimates</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,812,159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,556,754</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(507,503</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">477,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(161,254</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,063,981</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,489,397</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,208,655</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">427,592</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,708,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">290,445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(178,775</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,670</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46,458</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(23,912</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84,531</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,077</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,638,459</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,759,441</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,716,158</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84,531</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">904,925</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(161,254</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,991,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>21.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INCOME TAXES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Income tax expense differs from the amount that would be computed by applying the federal and provincial statutory tax rates of 27% (2019 -
27%) to the earnings before income taxes. The reasons for the differences and related tax effects are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Earnings (loss) before income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,293,154</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,612,679</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income taxes (recovery) on earnings before income taxes, at above basic rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,429,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,055,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase (decrease) in taxes resulting from:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nondeductible expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">383,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">414,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effects of tax rate change and foreign exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(64,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax rate difference by jurisdiction</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax benefits not recognized</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">709,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,634,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income taxes (recovery)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(346,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMUNOPRECISE ANTIBODIES LTD. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended April&nbsp;30, 2020 and 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Expressed in Canadian Dollars) </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">109,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">476,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income taxes (recovery)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(455,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(471,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income taxes (recovery)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(346,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Temporary differences give rise to the following deferred income tax assets and liabilities: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-capital</FONT> losses carried forward (expire from 2026 to
2039)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,721,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,668,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other tax pools</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,468,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,896,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capital losses carried forward</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">148,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">129,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment and leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory and intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,608,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,057,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financing costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">152,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: unrecognized deferred income tax asset</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,549,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,849,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,602,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,057,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>22.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SUBSEQUENT EVENTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On May&nbsp;15, 2020, the Company closed a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement financing by issuing 10%
convertible debentures (&#147;New Debentures&#148;) for total proceeds of $2,592,000. On May&nbsp;27, 2020, the Company issued an additional $35,000 of the 10% New Debentures. In total, the Company issued $2,627,000 of the New Debentures. The New
Debentures are unsecured, bear interest at a rate of 10% per year and payable annually. The maturity date is May&nbsp;15, 2022 for $2,592,000 of the New Debentures and May&nbsp;22, 2022 for $35,000 of the New Debentures. The principal amount of the
New Debentures may be convertible, at the option of the holder, into units of the Company at a conversion price of $0.85 per share. The Company may force convert the principal amount of the New Debentures at $0.85 per share if the average closing
price is equal to or greater than $1.50 for 20 trading days. The Company paid finders cash commissions totalling $44,750. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In advance of
the closing of the New Debentures, the Company has received $313,268 of the proceeds as at April&nbsp;30, 2020. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Subsequent to
April&nbsp;30, 2020, ImmunoPrecise Antibodies (USA) Ltd. and its subsidiary Talem Therapeutics, LLC (Subgrantee), was awarded a grant of USD$1.5&nbsp;million by the ND Department of Agriculture through the CARES Act ND Bioscience Group Program for
the development of antibody therapeutics against <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-</FONT></FONT> 2. The total grant project cost is USD$2M for which the Subgrantee&#146;s must contribute an amount not less
than 25% of the grant project cost or USD$500,000. The amount earned for the year ended April&nbsp;30, 2020 of approximately USD$158,000 has been accrued and recorded in other income. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Subsequent to April&nbsp;30, 2020, the Company made the second deferred payment pursuant to the acquisition of IPA Europe and Immulease, by
making a cash payment of &#128;335,555 (CAD$518,533) and issuing 664,163 common shares of the Company with a fair value of $511,406. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Subsequent to April&nbsp;30, 2020, the Company granted 250,000 stock options at a price of $1.50 per share for a period of 3 years. The options
are subject to following vesting period: 25% at three months after the date of grant and 25% every three months thereafter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.82
<SEQUENCE>83
<FILENAME>d20922dex9982.htm
<DESCRIPTION>EX-99.82
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.82</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.82 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT STYLE="white-space:nowrap">13-501F1</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS &#150; </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>PARTICIPATION FEE </I></B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MANAGEMENT CERTIFICATION </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt; padding-right:2pt">I, <U>Lisa
Helbling&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><B></B>, an officer of the reporting issuer noted below have examined this Form
<FONT STYLE="white-space:nowrap">13-501F1</FONT> (the <B>Form</B>) being submitted hereunder to the Alberta Securities Commission and certify that to my knowledge, having exercised reasonable diligence, the information provided in the Form is
complete and accurate.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><U>Lisa Helbling, Chief Financial
Officer&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:2pt">August 28, 2020</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-RIGHT:1px solid #000000; padding-right:2pt;border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:2pt">Date:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="22%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Reporting Issuer Name:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><U>&nbsp;&nbsp;&nbsp;&nbsp;ImmunoPrecise Antibodies Ltd.&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>End date of previous financial year:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;April 30, 2020&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Type of Reporting Issuer:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>[x] Class&nbsp;1 reporting</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>[&nbsp;&nbsp;&nbsp;&nbsp;]&nbsp;Class&nbsp;3B&nbsp;reporting</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>issuer</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>issuer</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Highest Trading Marketplace:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;TSX Venture&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><U>Market value of listed or quoted equity securities:</U></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Equity Symbol</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IPA&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="69%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>1st Specified Trading Period </B>(dd/mm/yy)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><U>&nbsp;&nbsp;&nbsp;&nbsp;05/01/19&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;31/07/19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing price of the security in the class or series on the</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">last trading day of the specified trading period in which</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">such security was listed or quoted on the highest trading</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">$<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.5900</U></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">marketplace</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(i)</P></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of securities in the class or series of such</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">security outstanding at the end of the last trading day of</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U></U>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;67,989,445</U></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">the specified trading period</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U></U>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(i) x (ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;40,113,772.55</U></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Market value of class or series</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(A)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>2nd Specified Trading Period </B>(dd/mm/yy)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="right"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;01/08/19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;to&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;31/10/19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"><U></U>&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Closing price of the security in the class or series on the</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">last trading day of the specified trading period in which</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">such
security was listed or quoted on the highest trading marketplace</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U></U>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.6000</U></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of securities in the class or series of such</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">security outstanding at the end of the last trading day of</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U></U>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;67,994,445</U></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">the specified trading period</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U></U>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(iii) x (iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;40,796,667</U></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Market value of class or series</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>3rd Specified Trading Period </B>(dd/mm/yy)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="right"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;01/11/19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;to&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;31/01/20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"><U></U><U></U>&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Closing price of the security in the class or series on the</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">last trading day of the specified trading period in which</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">such
security was listed or quoted on the highest trading marketplace</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U></U>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.5700</U></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of securities in the class or series of such</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">security outstanding at the end of the last trading day of</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">the
specified trading period</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U></U>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;67,994,445</U></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U></U>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(v) x (vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;38,756,833.65</U></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Market value of class or series</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(C)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4th Specified Trading Period </B>(dd/mm/yy)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;01/02/20&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;to&nbsp;&nbsp;&nbsp;&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;30/04/20&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing price of the security in the class or series on the</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">last trading day of the specified trading period in which</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">such security was listed or quoted on the highest trading</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">$<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.7700</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">marketplace</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Number of securities in the class or series of such</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">security outstanding at the end of the last trading day of</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;67,994,445</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">the specified trading period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(vii)&nbsp;x&nbsp;(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
$<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;52,355,722.65</U></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Market value of class or series</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">(D)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>5th Specified Trading Period </B>(dd/mm/yy)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right"><U>&nbsp;&nbsp;&nbsp;&nbsp;Not
applicable&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;&nbsp;&nbsp;to&nbsp;&nbsp;&nbsp;&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing price of the security in the class or series on the</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">last trading day of the specified trading period in which</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">such security was listed or quoted on the highest trading</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">$<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">marketplace</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Number of securities in the class or series of such</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">security outstanding at the end of the last trading day of</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">the specified trading period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(ix) x
(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Market value of class or series</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">(E)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Average Market Value of Class</B><B></B><B>&nbsp;or Series </B>(Calculate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">the simple average of the market value of the class or</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">series of security for each applicable specified trading</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">$<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;43,005,748.96</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">period (i.e. A through E above))</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">(<B>1</B>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">(Repeat the above calculation for each other class or series of equity securities of the reporting issuer (and a subsidiary, if applicable) that was listed or quoted on a marketplace at the end of the previous financial
year)</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Fair value of outstanding debt securities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(Provide details of how value was determined)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$<U></U></TD>
<TD VALIGN="bottom" ALIGN="right"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2"><B>(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Capitalization for the previous financial year</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;+&nbsp;(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$<U></U></TD>
<TD VALIGN="bottom" ALIGN="right"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;43,005,748.96</U></TD>
<TD NOWRAP VALIGN="bottom"><U></U>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Participation Fee</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$<U></U></TD>
<TD VALIGN="bottom" ALIGN="right"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,200.0000</U></TD>
<TD NOWRAP VALIGN="bottom"><U></U>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Late Fee</B>, if applicable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$<U></U></TD>
<TD VALIGN="bottom" ALIGN="right"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Fee Payable</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$<U></U></TD>
<TD VALIGN="bottom" ALIGN="right"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,200.0000</U></TD>
<TD NOWRAP VALIGN="bottom"><U></U>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(Participation Fee plus Late Fee)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.83
<SEQUENCE>84
<FILENAME>d20922dex9983.htm
<DESCRIPTION>EX-99.83
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.83</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.83 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922dsp597.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED
APRIL&nbsp;30, 2020 </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following
Management&#146;s Discussion and Analysis (&#147;MD&amp;A&#148;), prepared as of August&nbsp;28, 2020, should be read in conjunction with the audited consolidated financial statements of ImmunoPrecise Antibodies Ltd. (&#147;the Company&#148;,
&#147;ImmunoPrecise&#148; or &#147;IPA&#148;) for the year ended April&nbsp;30, 2020. This MD&amp;A is the responsibility of management and has been reviewed and approved by the Board of Directors of IPA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The referenced, consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (&#147;IFRS&#148;) and
related IFRS Interpretations Committee (&#147;IFRIC&#146;s&#148;) as issued by the International Accounting Standards Board (&#147;IASB&#148;). All financial amounts are stated in Canadian dollars unless stated otherwise. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FORWARD-LOOKING STATEMENTS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This MD&amp;A may contain
certain statements that constitute &#147;forward-looking statements&#148; within the meaning of National Instrument <FONT STYLE="white-space:nowrap">51-102,</FONT> Continuous Disclosure Obligations of the Canadian Securities Administrators. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward-looking statements often, but not always, are identified by the use of words such as &#147;seek&#148;, &#147;anticipate&#148;, &#147;believe&#148;,
&#147;plan&#148;, &#147;estimate&#148;, &#147;expect&#148;, &#147;targeting&#148; and &#147;intend&#148; and statements that an event or result &#147;may&#148;, &#147;will&#148;, &#147;should&#148;, &#147;could&#148;, or &#147;might&#148; occur or
be achieved and other similar expressions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In this MD&amp;A, forward-looking statements include the Company&#146;s future plans and expenditures, the
satisfaction of rights and performance of obligations under agreements to which the Company is a part, the ability of the Company to hire and retain employees and consultants and estimated administrative assessment and other expenses. The
forward-looking statements that are contained in this MD&amp;A involve a number of risks and uncertainties. As a consequence, actual results might differ materially from results forecast or suggested in these forward-looking statements. Some of
these risks and uncertainties are identified under the heading &#147;RISKS AND UNCERTAINTIES&#148; in this MD&amp;A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Furthermore, forward-looking
statements contained herein are made as of the date of this MD&amp;A and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results or otherwise. There can be no
assurance that forward- looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking
statements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>GENERAL </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company was incorporated
under the laws of Alberta on November&nbsp;22, 1983, and is listed on the TSX Venture Exchange (the &#147;Exchange&#148;) as a Tier 2 life science issuer under the trading symbol &#147;IPA&#148;. The Company&#146;s OTC symbol is &#147;IPATF&#148;.
The address of the Company&#146;s corporate office is 3204 &#150; 4464 Markham Street, Victoria, BC V8Z 7X8. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>OVERVIEW </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a leading, global, technology platform company with full service,
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">end-to-end</FONT></FONT> solutions that empower pharmaceutical companies across the globe to discover, develop, optimize, engineer and manufacture treatments against any disease. The
Company&#146;s experience, cutting-edge technologies and focus on intense scientific rigor enables unparalleled support of its partners in their quest to bring innovative treatments to the clinic. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922dsp597.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED
APRIL&nbsp;30, 2020 </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
With ImmunoPrecise&#146;s industry-leading technologies, fully integrated project management team and software, and <FONT STYLE="white-space:nowrap">one-stop</FONT> service offerings, the Company
dramatically reduces the time required for, and the inherent risk associated with, conventional multi-vendor product development. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has gained
global recognition as a leader in antibody discovery and development. They have achieved organic growth through market penetration and service diversification, as well as accretive growth through strategic expansion, acquiring and integrating the
most innovative technologies from across the globe. ImmunoPrecise houses a streamlined and exceptionally comprehensive capabilities platform in biologics discovery, development and manufacturing to enable an unparalleled single-vendor approach. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise boasts a highly experienced executive team which was further expanded this fiscal year, adding Dr.&nbsp;Stefan Lang (formerly of Aldevron and
Genovac) and Dr.&nbsp;Yasmina Abdiche (formerly of Carterra and Pfizer-Renat). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has standardized and unified global activities, recognizing
cost synergies and centralizing oversight to maximize transparency and financial gains. The departments of marketing, sales, project management, business development, finance and IT are now centralized and uniformly serve all of the subsidiaries to
ensure consistent messaging, quality and accuracy of information. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><U>Operations </U></I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA&#146;s services include, but are not limited to, custom antigen modeling, design and manufacturing; proprietary B cell sorting, screening and sequencing;
custom, immune and na&iuml;ve phage display production and screening; hybridoma production with multiplexed, high-throughput screening and clone-picking; expertise with transgenic animals and multi-species antibody discovery; antibody
characterization studies such as affinity measurements, functional assays and epitope mapping and binning; <FONT STYLE="white-space:nowrap">bi-specific,</FONT> <FONT STYLE="white-space:nowrap">tri-specific,</FONT> VHH, and VNAR (shark) antibody
manufacturing; DNA synthesis and cloning, protein and antibody downstream processing with purification of protein in gram scale levels including characterization and validation; antibody engineering; transient and stable cell line generation;
antibody optimization and humanization; and cryopreservation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company continues to expand on its approximate twelve years of expertise in single B
cell interrogation, offering full-service B cell screening, sorting and sequencing at IPA Canada. This service is available against all classes of targets including complex proteins, small molecules and various chemical groups. The Company&#146;s
platforms enable antibody screening directly from B cells, facilitating the analysis of a more diverse set of antibodies, and for faster, deeper screening compared to traditional technologies. The Company announced an over 90% success rate on its B
cell technology, which is offered with a success guarantee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA Canada and IPA Europe have both been designated as approved CROs for the world&#146;s
leading, transgenic animal platforms producing human antibodies. Leveraging this opportunity, the Company made strategic investments in R&amp;D activities to develop proprietary technologies enabling the application of their B cell Select<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP> and DeepDisplay<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> platforms to a broad range of transgenic animal species and strains. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA Europe&#146;s contribution in services and intellectual property to the Company are substantial. The integration of IPA Europe significantly expanded the
Company&#146;s services portfolio including affinity maturation, humanization, functional assay design and development, na&iuml;ve and diseased scFv libraries, and proprietary methods of immunization against conformational targets (e.g. ModiVacc<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP> lymphoid tumor immunization and DNA immunization technologies). Using the discovery technologies of ModiFuse<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> (hybridoma electrofusion),
ModiSelect<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> <FONT STYLE="white-space:nowrap">(B-cell</FONT> selection) and ModiPhage<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> (phage display) technologies, IPA Europe can
generate very large panels of monoclonal antibodies from various backgrounds including mouse, rat, rabbit, chicken, llama and human, as well as transgenic animals harboring the human antibody gene repertoire. Adding to their proprietary </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922dsp597.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED
APRIL&nbsp;30, 2020 </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
services, IPA Europe developed and <FONT STYLE="white-space:nowrap">rolled-out</FONT> the aforementioned DeepDisplay service for the discovery of fully human antibodies using transgenic animal
immunization and custom phage display. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">U-Protein</FONT> Express (UPE) has been a staple in the recombinant protein
community, operating for close to 20 years, and specializing in the manufacture of complex proteins and antibodies in a variety of formats and from a range of mammalian cell types. Their streamlined and efficient operations have enabled them to
successfully support over 5,000 different programs, with an over 90% success rate, for pharmaceutical and biotechnology industries as well as leading, academic institutions. In a seamless coordination, their operations also support the downstream
expression and purification of antibodies originating from the Company&#146;s B cell Select programs, enabling validation of the platform&#146;s outputs and comprehensive deliverables for clients. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">UPE holds a global, exclusive license from Stanford University for the marketing and sales of the novel protein, Wnt surrogate Fc, used as a growth factor for
organoid culture. In addition, they hold a <FONT STYLE="white-space:nowrap">non-exclusive</FONT> distributor agreement for this protein with major players in the study of organoid biology. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While the Company has strategically reduced overhead by eliminating much of its <FONT STYLE="white-space:nowrap">non-wet</FONT> lab footprint, eliminating
substantial square footage dedicated to offices and gathering spaces, it has continued to invest significantly in <FONT STYLE="white-space:nowrap">ROI-generating</FONT> capacity, committing to new laboratory build outs and equipment purchases to
support its continued, aggressive growth. In January 2020, UPE signed a long-term lease contract for a new multi-tenant building for life sciences at the Utrecht Science Park (Utrecht, The Netherlands) alongside important stakeholders such as Genmab
and Merus. Furthermore, along with <FONT STYLE="white-space:nowrap">SGI-</FONT> DNA, Inc., IPA announced that UPE integrated <FONT STYLE="white-space:nowrap">SGI-DNA&#146;s</FONT> benchtop automated DNA printer, making IPA the first CRO in Europe to
integrate the BioXp<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> 3200 System in its workflow as a part of the Company&#146;s vision for adopting breakthrough technologies in the discovery and manufacturing of antibodies. IPA aims to
positively impact their manufacturing capacities by converting the antibody design-synthesis-screening timeline from weeks and months down to days, providing clear advantages to their partners. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><U>Talem Therapeutics </U></I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Talem Therapeutics
(&#147;Talem&#148;) oversees and houses the internal and partnered therapeutic pipeline for the Company. Talem offers strategic partnerships with pharma and biotech companies and is the only company to offer these services as a partnership in OmniAb<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> transgenic animals using their own license. The Company has leveraged several of its progressive technologies to discover novel therapeutics for its pipeline using Ligand&#146;s OmniRat strains.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Talem&#146;s pipeline is indication agnostic and has expanded to include single monoclonal antibody therapeutics, combination antibody therapies and
vaccines. Their therapies target a variety of diseases within the areas of immuno-oncology, cancer, autoimmunity, inflammation and COVID. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is
in a unique position to access the highly effective discovery platforms and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">end-to-end</FONT></FONT> services that are used to successfully generate therapeutic pipelines for leading
biotech and pharmaceutical companies, at a fraction of the cost to the Company. Talem also has a distinct advantage in accessing the decades of experience in antibody therapeutic design, discovery and development at each of IPA&#146;s subsidiaries,
while also drawing on the clinical and commercial experience of the executive management team, in a consolidated and focused effort. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Talem Therapeutics
entered into a research license agreement with Janssen Research&nbsp;&amp; Development. The agreement, which provided Janssen exclusive access to a panel of novel, monoclonal antibodies, is anticipated to be the first of many <FONT
STYLE="white-space:nowrap">out-licensing</FONT> deals. The financial details of the transaction were not disclosed at the request of Janssen. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922dsp597.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED
APRIL&nbsp;30, 2020 </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In February 2020, IPA announced its commitment to developing innovative vaccines and therapeutics against the
SARS- <FONT STYLE="white-space:nowrap">CoV-2</FONT> spike protein, using their proprietary discovery platforms in an exceptionally broad, global campaign. The Company&#146;s objective was further clarified in March, when IPA defined their PolyTope<SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP> approach, utilizing highly characterized protein and antibody combinations targeting multiple epitopes and mechanisms of virus evasion. This approach is designed to provide maximum clinical benefit
against both current and future variants and strains of the virus by combining well-defined and fully characterized, protective antibodies (for therapeutics) and epitopes (for vaccines). The Company&#146;s use of high- throughput binding assays,
computational optimization (Artemis<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP>), and protein interaction analyses has yielded valuable data sets for informed preclinical lead selection. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The aggressive advancement of Talem&#146;s pipeline is a key priority for IPA, and the Company expects to complete multiple commercial deals in Talem
Therapeutics fiscal year 2021. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>STRATEGY AND OUTLOOK </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our management team has a passionate emphasis on initiatives designed to drive revenue, bolster internal assets and maximize shareholder value. We aim to
continue to build on revenue and asset generation through internal development and well-informed, strategic acquisitions and joint ventures. Our strategy also includes growth through alliances and partnerships, within both our research (Talem) and
service sectors, as well as potential new market sectors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><U>Operations </U></I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our objective is to continue to aggressively expand our market share as we assist our partners with building their pipelines, expanding the volume and size of
projects with our partners, and <FONT STYLE="white-space:nowrap">on-boarding</FONT> new clients by actively introducing them to the benefits of extensive vendor consolidation, the routinely high success rates of our programs and fast turnaround
times. We continue to possess a competitive advantage with our integrated <U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">end-to-end</FONT></FONT> platform</U>, coupled with a <U>strong, scientific
<FONT STYLE="white-space:nowrap">know-how</FONT></U>, enabling us to navigate our partners through the process of discovery, development and manufacturing. Our ability to customize programs, yet maintain scientific rigor, enables our clients to
access our global portfolio of services with confidence. Our personable and responsible <U>global project management team</U> and unified software ensures that our clients have program details at their fingertips, at any minute, in any time zone,
with the <U>security measures</U> needed to ensure our clients&#146; peace of mind. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><U>Talem Therapeutics </U></I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our strategy is supported by growing trends in pharma and finance. Global pharmaceutical companies are continuing to increase their share of reliance on
CRO&#146;s to improve the efficiency and cost of development, increase turnaround time, and access advanced and integrated expertise. When analyzing pharmaceutical outsourcing trends, from October 2019, several major drivers of the CRO industry
growth were identified, including robust biopharmaceutical funding, accelerated drug approval rates, the growing number of clinical trials, and proliferation of biopharmaceutical companies without internal research and clinical capabilities<SUP
STYLE="font-size:85%; vertical-align:top">1</SUP>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In an attempt to streamline, many large pharmaceutical companies are limiting the number of external
CRO vendors that can be contracted. This is particularly promising for those CROs that fill multiple niches in the discovery and manufacturing pipeline. In a recent estimate, the CRO industry alone was estimated to be $30&nbsp;billion USD, and
<I>&#147;highly fragmented</I><I>&#133;</I><I> relatively few of full scale and breadth of service</I>&#148;<SUP STYLE="font-size:85%; vertical-align:top">1</SUP>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The key players serving the monoclonal antibodies market are Pfizer, GlaxoSmithKline, Novartis, Merck&nbsp;&amp; Co., Amgen, Abbott Laboratories, AstraZeneca,
Eli Lilly and Company, Mylan, Daiichi Sankyo Company, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922dsp597.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED
APRIL&nbsp;30, 2020 </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Bayer, Bristol Myers Squibb Co., Johnson&nbsp;&amp; Johnson Services, Biogen, Thermo Fisher Scientific, Sanofi Genzyme, F. <FONT STYLE="white-space:nowrap">Hoffmann-La</FONT> Roche, and Novo
Nordisk<SUP STYLE="font-size:85%; vertical-align:top">2</SUP>. In 2016 alone, Novartis invested 9&nbsp;billion USD and Pfizer invested 7.9&nbsp;billion USD in R&amp;D<SUP STYLE="font-size:85%; vertical-align:top">3</SUP>. This is of little surprise
given the global monoclonal antibody market was valued at USD 85.4&nbsp;billion in 2015 and is expected to reach a value of USD 138.6&nbsp;billion by 2024<SUP STYLE="font-size:85%; vertical-align:top">2</SUP>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ongoing, growing investments by pharma in R&amp;D are expected to ramp up for antibodies given the rising prevalence of cancer and other chronic diseases<SUP
STYLE="font-size:85%; vertical-align:top">4</SUP>. In oncology, antibodies are viewed as the mainstay, as people move away from other types of therapies such as small molecules<SUP STYLE="font-size:85%; vertical-align:top">5</SUP>. In recent years,
the success of key pipeline drugs in the immuno-oncology space have been a key component of the record high capital market funding for the biotechnology sector<SUP STYLE="font-size:85%; vertical-align:top">1</SUP>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ACQUISITION OF <FONT STYLE="white-space:nowrap">U-PROTEIN</FONT> EXPRESS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&nbsp;22, 2017, the Company completed the acquisition of <FONT STYLE="white-space:nowrap">U-Protein</FONT> Express BV (&#147;U-Protein&#148;) whereby
the Company has acquired all the issued and outstanding shares of <FONT STYLE="white-space:nowrap">U-Protein</FONT> for &#128;6,830,000 on terms as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,734,732 (CAD$4,062,607) was paid in cash on closing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3,030,503 common shares of the Company were issued on closing; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,047,634 in deferred payments over a three-year period. The deferred payments can be made in cash or
common shares of the Company at the election of <FONT STYLE="white-space:nowrap">U-Protein</FONT> shareholders. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transaction was
accounted for as a business combination, as the operations of <FONT STYLE="white-space:nowrap">U-Protein</FONT> meet the definition of a business. As a result, transaction costs of $17,717 were expensed. The goodwill resulting from the allocation of
the purchase price to the total fair value of net assets represented the sales and growth potential of <FONT STYLE="white-space:nowrap">U-Protein.</FONT> Goodwill recorded is allocated in its entirety to
<FONT STYLE="white-space:nowrap">U-Protein.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The first deferred payment of &#128;682,545 (CAD$1,049,754) has been made in cash during the year
ended April&nbsp;30, 2019, and the second deferred payment of &#128;682,545 (CAD$1,007,435) has been made in cash during the year ended April&nbsp;30, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the 3,030,503 common shares issued ($3,022,308) was determined based on the Canadian dollar equivalent of the consideration required of
&#128;2,047,634 pursuant to the share purchase agreement. The Company has allocated the purchase price as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Healthcare Insights Life Sciences, CRO Sector Fundamentals Remain Hot for M&amp;A Consolidation,
October&nbsp;3, 2019. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">2</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Monoclonal Antibodies (mAbs) Market Size Worth $138.6 Billion By 2024, Nov. 2016 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">3</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Monoclonal Antibody Market 2019-2025 Growth, Key Players, Size, Demands and Forecasts, April, 2019
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">4</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Research Antibodies Market Size, Share&nbsp;&amp; Trends Analysis Report By Product, By Type (Monoclonal,
Polyclonal), By Technology, By Source, By Application (Oncology, Neurobiology), By <FONT STYLE="white-space:nowrap">End-use,</FONT> And Segment Forecasts, 2018 &#150; 2025, March, 2018 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">5</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">GEN, Antibody Discovery Looks Over the Horizon, Feb. 7, 2019. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922dsp597.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED
APRIL&nbsp;30, 2020 </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="border-bottom:1.00pt solid #000000">$</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,062,607</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3,030,503 common shares of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,022,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of deferred payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,134,410</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,219,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">797,276</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">370,530</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,815</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment, net of accumulated amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">216,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intellectual property (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,064,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,655,893</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(269,657</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income taxes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,197</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(810,800</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,219,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ACQUISITION OF IPA EUROPE AND IMMULEASE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&nbsp;5, 2018, the Company acquired all of the issued and outstanding shares of ImmunoPrecise Antibodies (Europe) B.V. (&#147;IPA Europe&#148;) and its
sister entity, Immulease B.V. (&#147;Immulease&#148;), for an aggregate purchase price of &#128;7,000,000 on terms as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,500,000 (CAD$3,988,132) was paid in cash on closing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">6,600,399 common shares of the Company were issued on closing; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#128;2,000,000 in deferred payments over a three-year period. The deferred payments were to be made in three
equal installments of cash and equity totaling &#128;666,666 and prorated if the EBITDA of IPA Europe for the fiscal year preceding the date of payment is less than its average EBITDA over the previous two fiscal years. During the year ended
April&nbsp;30, 2019, the Company and the seller entered into an Amendment, a Termination and Settlement Agreement whereby the deferred payments shall no longer be subject to an adjustment and will be paid in equal installments of cash and equity
totaling &#128;666,666. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA Europe changed its name from ModiQuest Research B.V. in April 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transaction was accounted for as a business combination, as the operations of IPA Europe and Immulease meet the definition of a business. As a result,
transaction costs of $36,821 were expensed. The goodwill resulting from the allocation of the purchase price to the total fair value of net assets represented the sales and growth potential of IPA Europe. Goodwill recorded is allocated in its
entirety to IPA Europe. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The first deferred payment of &#128;666,666 (CAD$1,014,503), consisting of cash of &#128;333,333 (CAD$507,000) and common shares
of the Company with a fair value of $507,503, has been made during the year ended April&nbsp;30, 2019. The second deferred payment, consisting of cash of &#128;335,555 (CAD$518,533) and common shares of the Company with a fair value of $511,406, has
been made subsequent to the year ended April&nbsp;30, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the 6,600,399 common shares issued ($4,884,295) was determined to be $0.74
per share based on the fair value of the Company&#146;s shares immediately prior to the completion of the acquisition. The Company has allocated the purchase price as follows: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922dsp597.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED
APRIL&nbsp;30, 2020 </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="border-bottom:1.00pt solid #000000">$</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,988,132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6,600,399 common shares of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,884,295</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of deferred payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,353,708</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,226,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">270,339</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">572,427</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unbilled revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,286,995</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment, net of accumulated amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">568,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Software</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible assets (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,304,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill (not deductible for tax purposes)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,640,671</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(580,339</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(22,897</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(298,979</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,636,192</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,226,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During fiscal year 2020, the Company reviewed the cost of the acquired phage libraries and identified the need to create an
additional human phage library. This resulted in bifurcating the cost of the phage library into the costs to develop the proprietary process to create a phage library and the cost of the phage library acquired (Inventory). Accordingly, a
reclassification was made between Inventory and Proprietary Processes of $1,815,395. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SELECTED ANNUAL INFORMATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a summary of certain selected financial information of the Company for the years ended April&nbsp;30, 2020, 2019 and 2018. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2018</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,057,927</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,926,268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,441,349</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(18,611,325</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,449,222</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,370,556</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net (loss) earnings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,947,426</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,617,467</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,171,103</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,263,121</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,462,898</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,575,440</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12,177,282</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,393,823</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,872,490</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividends declared</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Nil</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Nil</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Nil</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Earnings (loss) per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.07</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.12</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.11</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During fiscal year 2020, the Company reviewed the cost of the acquired phage libraries and identified the need to create an
additional human phage library. This resulted in bifurcating the cost of the phage library into the costs to develop the proprietary process to create a phage library and the cost of the phage library acquired (Inventory). Accordingly, a
reclassification was made between Inventory and Proprietary Processes resulting in an increase in the cost of the Proprietary Processes by $1,809,518 as at April&nbsp;30, 2019. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922dsp597.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED
APRIL&nbsp;30, 2020 </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>OVERALL PERFORMANCE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s continued focus on identifying and onboarding new clients seeking the breadth and depth of the <FONT STYLE="white-space:nowrap">end-</FONT> <FONT
STYLE="white-space:nowrap">to-end</FONT> services offered, combined with continued growth to core existing client business, led to increases in both volume and financial value of contracts during the year ended April&nbsp;30, 2020. As a result,
revenues of $14,057,927 were achieved compared to revenues of $10,926,268 in the 2019 fiscal year, a 29% increase in revenue for the year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Revenue
outlook remains positive for the first quarter of the 2021 fiscal year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Adjusted EBITDA for the year ending April&nbsp;30, 2020 was $52,311. This is a
significant improvement from the adjusted EBITDA of ($ 2,849,474) for the 2019 fiscal year. The improvement is a result of the increase in revenue and higher gross profit compared to the prior year. Adjusted EBITDA is a <FONT
STYLE="white-space:nowrap">non-IFRS</FONT> measure which is fully defined on page ten of this document. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To drive the execution of its strategic and
growth initiatives, the Company continues to focus on the recruitment of scientific and technical staff, development of new technical training programs and a commitment to integrate continuous improvement and quality management methodologies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To support management and the Board of Directors in exercising oversight, the Company is implementing information systems for marketing and sales automation
and customer relationship management, as well as accounting and financial reporting, resource planning and project management. Comprehensive operational and management reporting capabilities are being implemented with a view to effectively support a
geographically dispersed organization allowing managers access to company data globally. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With the aid of a third-party HR consulting firm, significant
effort was applied to strengthening and aligning the Company&#146;s human resources by: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Stabilizing staffing for sales growth going forward: </I>Remuneration and incentive systems have been<I>
</I>aligned with targeted revenue and gross profit performance, and operational roles and responsibilities have been focused on managing demand. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Leadership and operational alignment</I>: The Company has made changes and updated job descriptions,<I>
</I>compensation plans, and other reward and recognition systems, and is implementing career planning and development mechanisms and job performance and quality measures. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Future growth will provide opportunities for company personnel to develop new skills and abilities to tackle eventual challenges in a growing company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the 2021 fiscal year, the goal of the organization is to grow sales revenue and expand our brand awareness. This focus is consistent with the &#145;leading
with our scientists&#146; philosophy, which is resonating with our clients from both diagnostic and, in particular, the therapeutic market segment. The Company is also expanding its commitment to research and development initiatives aimed at
introducing new services through both internal development as well as through partnerships. To achieve the best results from its investments, the Company continues to add key scientific and management personnel to its team. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RESULTS OF OPERATIONS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company achieved revenues of
$14,057,927 during the year ended April&nbsp;30, 2020, compared to revenues of $10,926,268 in the 2019 fiscal year. This represents a 29% increase in revenue for the year. The increasing revenue trend is due to increases in both volume and financial
values of client contracts as a result of continued </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922dsp597.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED
APRIL&nbsp;30, 2020 </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
focus on expanding the breadth and depth of services offered, new client onboarding including top pharma companies, and growing its core existing client business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2020, the Company achieved a gross profit of $8,033,984, compared to $5,294,634 in the 2019 fiscal year. In percentage
terms, the Company&#146;s gross profit increased to 57% from 48% in 2019. The higher gross profit in 2020 was primarily a result of the Company implementing a new ERP system that tracks project costs in more detail than historical methods. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recorded a net loss of $4,947,426 during the year ended April&nbsp;30, 2020, compared to net loss of $7,617,467 for the year ended April&nbsp;30,
2019. Despite $2,739,350 higher gross profit as well as cost synergies resulting in lower spend, there was still a net loss in 2020 primarily due to increase in investments in research and development and
<FONT STYLE="white-space:nowrap">non-cash</FONT> amortization of acquired companies&#146; intangible assets, depreciation of leased assets as a result of implementing IFRS 16, <I>Leases.</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Variances of note in the Company&#146;s expenses include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Advertising and promotion fees of $377,728 in 2020 (2019 - $819,250) were incurred to support the Company&#146;s
initiatives focused on business development, marketing and branding programs. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Amortization expense increased to $2,573,009 from $1,875,907 in 2019 due to the amortization of intangible assets
which were acquired as a result of the acquisitions of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Consulting fees of $227,036 in 2020 (2019 - $452,196) and professional fees of $883,623 (2019 - $985,557) were
lower because 2019 consultant and professional services were engaged to support <FONT STYLE="white-space:nowrap">one-time</FONT> initiatives focused on operational efficiency training programs, systems implementation and integration of acquisitions.
The Company evaluated the use of consulting services vs employees and where appropriate added employees to the team. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">$493,278 of the management fees were attributed to the profit-sharing payout made to the former shareholders of <FONT
STYLE="white-space:nowrap">U-Protein,</FONT> as part of the acquisition agreement. The profit-sharing payout is a three-year, annual obligation, with declining percentage of profit sharing. After fiscal year 2021, the profit-sharing payout for <FONT
STYLE="white-space:nowrap">U-Protein</FONT> will cease and the Company will be under no further obligations to share profits with the former shareholders of <FONT STYLE="white-space:nowrap">U-Protein.</FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Salaries and benefits expense increased to $4,619,189 from $3,503,259 in 2019, primarily due to the additions of
key employees to the team instead of utilizing consultants. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Company recorded a share-based payments expense of $739,011 (2019 - $1,114,112) as a result of the vesting of
the stock options granted during the current and previous fiscal years versus more stock options vested during the April&nbsp;30, 2019 fiscal year. The option plan is aimed to align staff to the future company growth plans. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FOURTH QUARTER </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Three-month period ended April&nbsp;30,
2020 compared to the three-month period ended April&nbsp;30, 2019: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company had a net loss for the three-month period ended April&nbsp;30, 2020 of
$954,016 compared to a net loss of $3,842,317 for the same period in 2019. The higher loss in the quarter ended April&nbsp;30, 2019 resulted from the Company&#146;s investment in growth enabling initiatives and
<FONT STYLE="white-space:nowrap">catch-up</FONT> amortization recorded of intangible assets which were acquired as a result of the acquisitions of <FONT STYLE="white-space:nowrap">U-Protein</FONT> and IPA Europe. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922dsp597.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED
APRIL&nbsp;30, 2020 </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SUMMARY OF QUARTERLY RESULTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets out financial information for the past eight quarters: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>January&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>October&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>July&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,145,023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,034,440</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,162,365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,716,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(945,846</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(625,837</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,363,545</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,012,198</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted loss per share*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.01</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.01</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.03</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>January&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>October&nbsp;31,<BR>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>July&nbsp;31,<BR>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,641,109</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,695,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,716,791</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,872,785</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net (loss)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,842,317</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,187,056</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,485,732</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,102,362</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted loss per share*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.06</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The basic and fully diluted calculations result in the same value due to the anti-dilutive effect of
outstanding stock options and warrants. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">NON-IFRS</FONT> MEASURES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following are <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures and investors are cautioned not to place undue reliance on them and are urged to
read all IFRS accounting disclosures present in the consolidated financial statements and accompanying notes for the consolidated financial statements for the year ended April&nbsp;30, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company uses certain <FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial measures as supplemental indicators of its financial and operating
performance. These <FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial measures include adjusted operating EBITDA and adjusted operating expenses. The Company believes these supplementary financial measures reflect the Company&#146;s ongoing
business in a manner that allows for meaningful <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">period-to-period</FONT></FONT> comparisons and analysis of trends in its business. These
<FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures do not have any standardized meaning prescribed under IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company defines adjusted operating EBITDA as operating earnings before interest, taxes, depreciation, amortization, share-based compensation, and asset
impairment charges. Adjusted operating EBITDA is presented on a basis consistent with the Company&#146;s internal management reports. The Company discloses adjusted operating EBITDA to capture the profitability of its business before the impact of
items not considered in management&#146;s evaluation of operating unit performance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company defines adjusted operating expenses as operating expenses
before share-based compensation, depreciation, amortization and asset impairment charges. Adjusted operating expenses are presented on a basis consistent with the Company&#146;s internal management reports. The
<FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures are reconciled to reported IFRS figures in the tables below: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922dsp597.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED
APRIL&nbsp;30, 2020 </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,</B><br><B>2020</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,</B><br><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,947,426</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,617,467</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income taxes (recovery)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(345,728</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,788</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization and depreciation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,408,347</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,263,284</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">899,731</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">904,925</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange loss (gain)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(78,148</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(117,506</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">536,499</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">413,590</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest and other income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(272,006</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,085</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss on settlement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">214,885</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">739,011</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,114,112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Adjusted EBITDA</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,311</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,849,474</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,</B><br><B>2020</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>April&nbsp;30,</B><br><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12,587,382</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,817,588</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization and depreciation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,573,009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,263,284</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange loss (gain)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(78,148</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(117,506</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">536,499</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">413,590</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">739,011</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,114,112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Adjusted Operating Expenses</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,817,011</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,144,108</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FINANCING ACTIVITIES </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On
May&nbsp;23, 2018, the Company entered into a loan agreement with a Director of the Company and his spouse and issued a promissory note in the principal amount of $200,000. The note was unsecured and bore an interest rate of 5.45% per annum. The
principal of the note plus accrued interest of $3,972 was repaid in full during the year ended April&nbsp;30, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&nbsp;19, 2018, the Company
closed a <FONT STYLE="white-space:nowrap">non-</FONT> brokered private placement financing by issuing a total of 875,000 units of the Company at a price of $0.80 per unit for gross proceeds of $700,000. Each unit consists of one common share of the
Company and one share purchase warrant, with each warrant entitling the holder to purchase an additional Share at a price of $1.00 for a period of one year from the date of issue. The Company will have the right to accelerate the expiry date of the
warrants provided that the volume weighted average price trades at a price equal to or greater than $1.50 for a period of 20 consecutive days. In the event of acceleration, the expiry date will be accelerated to a date that is 30 days after the
Company issues a news release announcing that it has elected to exercise this acceleration right. The Company paid finders cash fees totaling $3,000 and incurred $7,926 of cash issue costs. The Company extended the warrants for an additional twelve
months from the original expiry. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&nbsp;24, 2018, the Company closed a <FONT STYLE="white-space:nowrap">non-brokered</FONT> private placement
financing by issuing a total of 9,102,500 units of the Company at a price of $1.00 per unit for gross proceeds of $9,102,500. Each unit consists of one common share of the Company and one share purchase warrant, with each warrant entitling the
holder to purchase an additional share at a price of $1.25 for a period of two years from the date of issue. The Company will have the right to accelerate the expiry date of the warrants provided that the volume weighted average price trades at a
price equal to or greater than $1.75 for a period of 20 consecutive days. In the event of acceleration, the expiry date will be accelerated to a date that is 30 days after the Company issues a news release announcing
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922dsp597.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED
APRIL&nbsp;30, 2020 </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
that it has elected to exercise this acceleration right. The Company also proceeded with a Debenture Settlement of $1,377,000 by issuing up to 1,377,000 Units at a price of $1.00 per Unit (the
&#147;Debt Settlement&#148;). Each Unit is on the same terms as the Financing. The Company paid finders cash fees totaling $201,540 and issued 182,460 finder&#146;s shares. The Company also incurred $76,038 of cash issue costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&nbsp;22, 2017, the Company announced that it had signed a binding letter of intent with Crossbeta Biosciences B.V. (&#147;Crossbeta&#148;) whereby
the Company had agreed to acquire all the issued and outstanding shares of Crossbeta. The proposed transaction was terminated and settled on October&nbsp;23, 2018. In consideration of the settlement, the Company paid &#128;37,000 ($55,969) and
issued 78,514 shares valued at $61,241. The Company accrued a settlement liability of $92,040 as at April&nbsp;30, 2018. As such, the remaining loss on settlement of $25,170 was recognized in fiscal year 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;27, 2019, the Company issued 714,793 common shares pursuant to the second deferred acquisition payment to IPA Europe. The common shares are
valued at $507,503. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2019, the Company issued 135,000 common shares pursuant to exercise of stock options for total
gross proceeds of $40,500. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&nbsp;26, 2019, the Company modified the terms of $2,750,000 debentures to extend the due date by 6 months to
March&nbsp;26, 2020, with the ability to pay earlier with no penalty, and increased the interest rate to 12.5%. The remaining debentures of $125,000 were paid on maturity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;26, 2020, the Company settled $700,000 of the $2,750,000 debentures plus accrued interest of $46,875 by issuing 1,244,792 common shares. The
fair value of the 1,244,792 common shares issued was determined to be $858,906. The settlement resulted in a loss of $112,031. $50,000 of the Debentures were paid on maturity. The maturity date of the remaining debentures of $2,000,000 was extended
to September&nbsp;26, 2020. The Company repaid the remaining balance of $2,000,000 plus interest subsequent to <FONT STYLE="white-space:nowrap">year-end.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&nbsp;15, 2020, the Company was approved for a US$209,000 loan under the Payroll Protection Program (&#147;PPP&#148;) administered by the U.S. Small
Business Administration. The PPP is a US$349&nbsp;billion loan program that originated from the U.S. Coronavirus Aid, Relief and Economic Security (CARES) Act. The PPP loan has a term of two years, is unsecured, and is guaranteed by the U.S. Small
Business Administration. The loan will be forgiven if the proceeds are used by the Company to cover payroll costs (including benefits), with up to 25% allowed for rent and utilities, during the eight-week period following the loan origination date.
The Company expects to meet the requirements for full loan forgiveness. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2020, the Company issued 55,000 common
shares pursuant to exercise of stock options for total gross proceeds of $16,500. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2020, the Company issued 680,971
common shares pursuant to exercise of warrants for total gross proceeds of $476,679. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On May&nbsp;15, 2020, the Company closed a <FONT
STYLE="white-space:nowrap">non-brokered</FONT> private placement financing by issuing 10% convertible debentures (&#147;New Debentures&#148;) for total proceeds of $2,592,000. On May&nbsp;27, 2020, the Company issued an additional $35,000 of the 10%
New Debentures. In total, the Company issued $2,627,000 of the New Debentures. The New Debentures are unsecured, bear interest at a rate of 10% per year and payable annually. The maturity date is May&nbsp;15, 2022 for $2,592,000 of the New
Debentures and May&nbsp;22, 2022 for $35,000 of the New Debentures. The principal amount of the New Debentures may be convertible, at the option of the holder, into units of the Company at a conversion price of $0.85 per share. The Company may force
convert the principal amount of the New Debentures at $0.85 per share if the average closing price is equal to or greater than $1.50 for 20 trading days. The Company paid finders cash commissions totaling $44,750.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922dsp597.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED
APRIL&nbsp;30, 2020 </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Subsequent to April&nbsp;30, 2020, the Company issued 332,500 common shares pursuant to exercise of stock options for total gross proceeds of $252,725. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subsequent to April&nbsp;30, 2020, the Company issued 3,428,000 common shares pursuant to exercise of warrants and finder&#146;s warrants for total gross
proceeds of $3,666,400. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>LIQUIDITY AND CAPITAL RESOURCES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s objectives when managing capital are to ensure sufficient liquidity for operations and adequate funding for growth and capital expenditures
while maintaining an efficient balance between debt and equity. The capital structure of the Company consists of shareholders&#146; equity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company
adjusts to its capital structure upon approval from its Board of Directors, considering economic conditions and the Company&#146;s working capital requirements. There were no changes in the Company&#146;s approach to capital management during the
year. The Company is not subject to any externally imposed capital requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As at April&nbsp;30, 2020, the Company held cash of $2,605,706 (2019
&#150; $5,471,650) and had working capital deficiency of $230,325 (2019 &#150; $2,673,667). During the year ended April&nbsp;30, 2020, the Company used $1,391,295 in its operating activities. As part of the investing activities, the Company made
equipment purchases of $373,753, made a deposit of $87,847 towards equipment, incurred internally generated development costs of $114,042, and made a deferred acquisition payment of $1,007,435. As part of the financing activities, the Company
received $493,179 from exercise of stock options and warrants, received debenture subscriptions of $313,268 and loan proceeds of $283,328, offset by lease repayments of $657,215, loan repayments of $82,859 and debenture repayments of $175,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s consolidated financial statements have been prepared based on accounting principles applicable to a going concern. This assumes the Company
will continue in operation for the foreseeable future and will be able to realize its assets and discharge its obligations in the normal course of operations. The Company has incurred operating losses since inception, including $4,947,426 for the
year ended April&nbsp;30, 2020 and has accumulated a deficit of $22,478,652 as at April&nbsp;30, 2020. The Company may need to raise additional funds in order to continue as a going concern and there can be no assurances that sufficient funding,
including adequate financing, will be available. The ability of the Company to arrange additional financing in the future depends in part, on the prevailing capital market conditions and profitability of its operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In March 2020, there was a global pandemic outbreak of <FONT STYLE="white-space:nowrap">COVID-19.</FONT> The actual and threatened spread of the virus
globally has had a material adverse effect on the global economy and specifically, the regional economies in which the Company operates. The pandemic could result in delays in the course of business and could have a negative impact on the
Company&#146;s ability to raise new capital. It is not possible for the Company to predict the duration or magnitude of the adverse results of the outbreak and its effects on the Company&#146;s business or results of operations at this time. These
material uncertainties may cast significant doubt on the Company&#146;s ability to continue as a going concern. Accordingly, the consolidated financial statements do not give effect to adjustments that would be necessary should the Company be unable
to continue as a going concern and therefore be required to realize its assets and liquidate its liabilities, contingent obligations and commitments other than in the normal course of business and at amounts different from those in the consolidated
financial statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As at April&nbsp;30, 2020, the Company does not have any commitments for capital expenditures. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922dsp597.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED
APRIL&nbsp;30, 2020 </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CAPITAL EXPENDITURES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company made equipment purchases of $373,753 during the year ended April&nbsp;30, 2020 (2019 - $645,058). During the year ended April&nbsp;30, 2020, the
Company also incurred internally generated development costs of $114,042. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RELATED PARTY TRANSACTIONS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Key management personnel are those persons having authority and responsibility for planning, directing and controlling the activities of the Company. Key
management consists of Dr.&nbsp;Jennifer Bath, President and CEO; Lisa Helbling, CFO; Dr.&nbsp;Stefan Lang, CBO; Dr.&nbsp;Yasmina Abdiche, CSO; and Former Employees: Natasha Tsai, CFO; Charles Wheelock, CTO; Reginald Beniac, Chief Operating Officer;
Oren Beske, President of ImmunoPrecise Antibodies (USA) Ltd.; Martin Hessing, Director of <FONT STYLE="white-space:nowrap">U-Protein;</FONT> Jos Raats, President and CEO of IPA Europe; and Directors of the Company. During the years ended
April&nbsp;30, 2020 and 2019, the compensation for key management is as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Consulting fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,292</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Management fees<SUP STYLE="font-size:85%; vertical-align:top">(1) </SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">178,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">394,126</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Professional fees<SUP STYLE="font-size:85%; vertical-align:top">(2) </SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,263</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Salaries and other short-term benefits<SUP STYLE="font-size:85%; vertical-align:top">(3)
</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,052,465</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">995,855</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Severance<SUP STYLE="font-size:85%; vertical-align:top">(5) </SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">632,279</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">770,928</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,863,607</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,314,964</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The charge includes management fees paid to Dr.&nbsp;Martin Hessing, a former Director of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> and Dr.&nbsp;Jos Raats, former President and CEO of IPA Europe. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The charge includes professional fees paid to Malaspina Consultants Inc. in which Natasha Tsai was an associate
until October&nbsp;31, 2018 and an owner thereafter. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The charge includes salaries and benefits paid to current key management and former management that includes
Robert Beecroft, Dr.&nbsp;Oren Beske and Reginald Beniac. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The charge includes severance paid to Dr.&nbsp;Oren Beske and Reginald Beniac. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At April&nbsp;30, 2020, included in accounts payable and accrued liabilities is $412,188 (2019 - $nil) due to related parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended April&nbsp;30, 2020, the spouse of a former Director provided administrative services for $nil (2019 &#150; $54,225). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended April, 30, 2020, a company controlled by Martin Hessing, a former Director of <FONT STYLE="white-space:nowrap">U-Protein,</FONT> sold
certain equipment to <FONT STYLE="white-space:nowrap">U-Protein</FONT> for a cash consideration of &#128;25,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These transactions are in the normal
course of operations and are measured at the exchange amount, which is the amount of consideration established and agreed to by the related parties, unless otherwise noted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922dsp597.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED
APRIL&nbsp;30, 2020 </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>OUTSTANDING SHARE DATA </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s outstanding share information as at August&nbsp;28, 2020 is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Security</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Exercise&nbsp;Price</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Expiry date</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issued and outstanding common shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74,349,871</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">NA</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">NA</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">October&nbsp;1,&nbsp;2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">485,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">December&nbsp;20,&nbsp;2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">887,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">September&nbsp;18,&nbsp;2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">January&nbsp;3, 2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">700,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">February&nbsp;7, 2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">March&nbsp;3, 2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock Options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">August&nbsp;13, 2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">September&nbsp;24, 2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">November&nbsp;7, 2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">December&nbsp;31, 2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">January&nbsp;7, 2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">January&nbsp;11, 2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">April&nbsp;1, 2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.475</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">October&nbsp;1, 2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">October&nbsp;3, 2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,381,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">September&nbsp;24, 2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,262,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">October&nbsp;25, 2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,385,971</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">March&nbsp;26, 2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93,616,842</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">OFF-BALANCE</FONT> SHEET ARRANGEMENTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company does not utilize <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet transactions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>COMMITMENTS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company entered into an operating lease
for a piece of equipment for its Victoria, BC, Canada laboratory space on April&nbsp;29, 2020. The lease commenced on May&nbsp;15, 2020 with a <FONT STYLE="white-space:nowrap">36-month</FONT> term. The monthly lease payment is USD$15,829. The
Company has a right to purchase the equipment at fair market value at the end of the lease term. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SUBSEQUENT EVENTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subsequent to April&nbsp;30, 2020, ImmunoPrecise Antibodies (USA) Ltd. and its subsidiary Talem Therapeutics, LLC (Subgrantee), was awarded a grant of
USD$1.5&nbsp;million by the ND Department of Agriculture through the CARES Act ND Bioscience Group Program for the development of antibody therapeutics against SARS-CoV- 2. The total grant project cost is USD$2M for which the Subgrantee&#146;s must
contribute an amount not less than 25% of the grant project cost or USD$500,000. The amount earned for the year ended April&nbsp;30, 2020 of approximately USD$158,000 has been accrued and recorded in other income. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922dsp597.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED
APRIL&nbsp;30, 2020 </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subsequent to April&nbsp;30, 2020, the Company made the second deferred payment pursuant to the acquisition
of IPA Europe and Immulease, by making a cash payment of &#128;335,555 (CAD$518,533) and issuing 664,163 common shares of the Company with a fair value of $511,406. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subsequent to April&nbsp;30, 2020 and on August&nbsp;31, 2020, the Company issued 250,000 with an exercise price of $1.50 that vest 25% every three months
with an expiration date of August&nbsp;13, 2023. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CRITICAL ACCOUNTING ESTIMATES AND JUDGMENTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of the consolidated financial statements in conformity with IFRS required estimates and judgments that affect the amounts reported in the
financial statements. Actual results could differ from these estimates and judgments. Estimates are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the year in which the estimate is revised. Significant areas
requiring the use of estimates and judgments are as follows: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Functional currency </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has used judgment in determining the currency of the primary economic environment in which the entity operates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Amounts receivable </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company monitors the financial
stability of its customers and the environment in which they operate to make estimates regarding the likelihood that the individual trade receivable balances will be paid. Credit risks for outstanding customer receivables are regularly assessed and
allowances are recorded for estimated losses, if required. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Equipment </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has used estimates in the determination of the expected useful lives of equipment and leasehold improvements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Revenue recognition </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">percentage-of-completion</FONT></FONT> method requires the use of estimates to determine the stage of completion which is used to determine the recorded amount of revenue, unbilled
revenue and deferred revenue on uncompleted contracts. The determination of anticipated revenues includes the contractually agreed revenue and may also involve estimates of future revenues if such additional revenues can be reliably estimated and it
is considered probable that they will be recovered. The determination of anticipated costs for completing a contract is based on estimates that can be affected by a variety of factors, including the cost of materials, labor, and <FONT
STYLE="white-space:nowrap">sub-contractors.</FONT> The determination of estimates is based on the Company&#146;s business practices as well as its historical experience. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Impairments </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the purposes of assessing impairment,
assets are grouped at the lowest levels for which there are separately identifiable cash flows (&#147;cash generating units&#148; or &#147;CGU&#148;s). Each asset or CGU is evaluated every reporting period to determine whether there are any
indicators of impairment. If any such indicators exist, which is often judgment-based, a formal estimate of recoverable amount is performed, and an impairment charge is recognized to the extent that the carrying amount exceeds the recoverable
amount. The recoverable amount of an asset or CGU of assets is measured at the higher of fair value less costs of disposal or value in use. These determinations and their individual assumptions require that management make a decision based on the
best available information at each reporting period. The estimates and assumptions are subject to risk and uncertainty; hence, there is the possibility that changes in circumstances will alter these projections, which may impact the recoverable
amount of the assets. In such circumstances, some or all the carrying value of the assets may be further impaired or the impairment charge reversed with the impact recorded in profit or loss. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922dsp597.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED
APRIL&nbsp;30, 2020 </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company performs a goodwill impairment test annually and when circumstances indicate that the carrying
value may not be recoverable. For the purposes of impairment testing, goodwill acquired through business combinations has been allocated to two different CGUs. The recoverable amount of each CGU was based on value in use, determined by discounting
the future cash flows to be generated from the continuing use of the CGU. The cash flows were projected over a five-year period based on past experience and actual operating results. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company performed its annual goodwill impairment test in April 2020 and no impairment was indicated for the period tested. The values assigned to the key
assumptions represented management&#146;s assessment of future trends in the industry and were based on historical data from both internal and external sources. Weighted average costs of capital of 16.33% and 12.26%, respectively, was used in the
assessments of the two CGUs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Determination of segments </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An operating segment is a component of the Company that engages in business activities from which it may earn revenues and incur expenses. All operating
segments&#146; results are reviewed by the Company&#146;s management in order to make decisions regarding the allocation of resources to the segment. Segment results include items directly attributable to a segment as those that can be allocated on
a reasonable basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As the Company provides antibody production and related services in one distinct category, there is only one category to report
revenues by production site. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Life of intangible assets </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Intangible assets are amortized based on estimated useful life less their estimated residual value. Significant assumptions are involved in the determination
of useful life and residual values and no assurance can be given that actual useful lives and residual values will not differ significantly from current assumptions. Actual useful life and residual values may vary depending on a number of factors
including internal technical evaluation, attributes of the assets and experience with similar assets. Changes to these estimates may affect the carrying value of assets, net income (loss) and comprehensive income (loss) in future periods. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Purchase price allocation </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The acquisition of <FONT
STYLE="white-space:nowrap">U-Protein</FONT> on August&nbsp;22, 2017 and the acquisition of IPA Europe and Immulease on April&nbsp;5, 2018 were accounted for as business combinations at fair value in accordance with IFRS 3, <I>Business</I>
<I>Combinations</I>. The acquired assets and assumed liabilities were adjusted to their fair values assigned through<I> </I>completion of a purchase price allocation, as described below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The purchase price allocation process resulting from a business combination requires management to estimate the fair value of identifiable assets acquired
including intangible assets and liabilities assumed including the deferred acquisition payment obligations. The Company uses valuation techniques, which are generally based on forecasted future net cash flows discounted to present value and relies
on work performed by third-party valuation specialists. These valuations are closely linked to the assumptions used by management on the future performance of the related assets and the discount rates applied. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ADOPTION OF NEW ACCOUNTING STANDARDS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has
adopted the following new standards, along with any consequential amendments, effective May&nbsp;1, 2019. These changes were made in accordance with the applicable transitional provisions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company adopted all the requirements of IFRS 16, <I>Leases</I> (&#147;IFRS 16&#148;) as of May&nbsp;1, 2019. IFRS 16 replaces IAS 17, <I>Leases</I>
(&#147;IAS 17&#148;). IFRS 16 provides a single lessee accounting model, requiring lessees to recognize assets and liabilities for all leases unless the lease term is 12 months or less or the underlying asset has a low
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922dsp597.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED
APRIL&nbsp;30, 2020 </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
value. The Company has adopted IFRS 16 using the modified retrospective application method, where the 2019 comparatives are not restated and a cumulative catch up adjustment is recorded on
May&nbsp;1, 2019 for any differences identified, including adjustments to opening deficit balance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company analyzed its contracts to identify whether
they contain a lease arrangement for the application of IFRS 16. The following is the Company&#146;s new accounting policy for leases under IFRS 16: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At
inception of a contract, the Company assesses whether the contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for
consideration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Leases of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-</FONT></FONT> use assets are recognized at the lease
commencement date at the present value of the lease payments that are not paid at that date. The lease payments are discounted using the interest rate implicit in the lease, if that rate can be readily determined, and otherwise at the Company&#146;s
incremental borrowing rate. At the commencement date, a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset is measured at cost, which is comprised of the initial amount of the lease liability adjusted
for any lease payments made at or before the commencement date, plus any decommissioning and restoration costs, less any lease incentives received. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each
lease payment is allocated between repayment of the lease principal and interest. Interest on the lease liability in each period during the lease term is allocated to produce a constant periodic rate of interest on the remaining balance of the lease
liability. Except where the costs are included in the carrying amount of another asset, the Company recognizes in profit or loss (a)&nbsp;the interest on a lease liability and (b)&nbsp;variable lease payments not included in the measurement of a
lease liability in the period in which the event or condition that triggers those payments occurs. The Company subsequently measures the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset at cost less
any accumulated depreciation and any accumulated impairment losses; and adjusted for any remeasurement of the lease liability. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> assets are depreciated over
the shorter of the asset&#146;s useful life and the lease term, except where the lease contains a bargain purchase option a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset is depreciated over the
asset&#146;s useful life. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On the date of transition, the Company recorded a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset of $1,668,533 related to the office rent in property and equipment, and the lease obligation of $1,723,277 was recorded as at May&nbsp;1, 2019,
discounted using the Company&#146;s incremental borrowing rate of 8%, and measured at an amount equal to the lease obligation as if IFRS 16 had been applied since the commencement date. The net difference between <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets and lease liabilities on the date of transition was recognized as a deficit adjustment of $54,744 on May&nbsp;1, 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ACCOUNTING STANDARDS ISSUED BUT NOT YET EFFECTIVE </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
October 2018, the IASB issued amendments to IFRS 3, Business Combinations. The amendments narrowed and clarified the definition of a business. The amendments will help companies determine whether an acquisition is a business or a group of assets.
They also permit a simplified assessment of whether an acquired set of activities and assets is a group of assets rather than a business. Distinguishing between a business and a group of assets is important because an acquirer recognizes goodwill
only when acquiring a business. This amendment will be effective for annual periods beginning on or after January&nbsp;1, 2020. Early adoption is permitted. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DISCLOSURE CONTROLS AND PROCEDURES </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Disclosure controls
and procedures are intended to provide reasonable assurance that information required to be disclosed is recorded, processed, summarized, and reported within the time periods specified by securities regulations and that the information required to
be disclosed is accumulated and communicated to management. Internal controls over financial reporting are intended to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with IFRS. In connection with National Instrument <FONT STYLE="white-space:nowrap">52-109</FONT> (Certificate of Disclosure in Issuer&#146;s Annual and Interim Filings)
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922dsp597.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED
APRIL&nbsp;30, 2020 </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(&#147;NI <FONT STYLE="white-space:nowrap">52-109&#148;),</FONT> the Chief Executive Officer and Chief Financial Officer of the Company have filed a Venture Issuer Basic Certificate with respect
to the financial information contained in the consolidated financial statements for the year ended April&nbsp;30, 2020 and this accompanying MD&amp;A (together, the &#147;Annual Filings&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In contrast to the full certificate under NI <FONT STYLE="white-space:nowrap">52-109,</FONT> the Venture Issuer Basic Certificate does not include
representations relating to the establishment and maintenance of disclosure controls and procedures and internal control over financial reporting, as defined in NI <FONT STYLE="white-space:nowrap">52-109.</FONT> For further information the reader
should refer to the Venture Issuer Basic Certificates filed by the Company with the Annual Filings on SEDAR at www.sedar.com. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FINANCIAL INSTRUMENTS
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s financial instruments include cash, amounts receivable, restricted cash, investment, accounts payable and accrued liabilities,
debentures, loans payable, leases and deferred acquisition payments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fair value is the price that would be received to sell an asset or paid to transfer
a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy establishes three levels to classify the inputs to valuation techniques used to measure fair value, by reference to the reliability
of the inputs used to estimate the fair values. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Level 1 - applies to assets or liabilities for which there are quoted prices in active markets for
identical assets or liabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Level 2 - applies to assets or liabilities for which there are inputs other than quoted prices that are observable for
the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or
model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Level
3 - applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of investment is determined based on &#147;Level&nbsp;2&#148; inputs as its value under the equity method was the best approximation of its
fair value. As at April&nbsp;30, 2020, the Company believes that the carrying values of cash, amounts receivable, restricted cash, accounts payable and accrued liabilities, debentures, loans payable, leases and deferred acquisition payments
approximate their fair values because of their nature and relatively short maturity dates or durations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Concentration of risk: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Industry </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company operates in the contract research
organization sector and is affected by general economic trends. A decline in economic conditions, research spending or other adverse conditions could lead to reduced revenue. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Concentrations of credit risk </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Credit risk relates to
cash, restricted cash and amounts receivable and arises from the possibility that counterparty to an instrument may fail to perform. At April&nbsp;30, 2020, all of the Company&#146;s cash was held with tier one banks. The Company has evaluated
amounts receivable and determined that there were no allowances for doubtful accounts at April&nbsp;30, 2020 and 2019. During the year ended April&nbsp;30, 2020 the Company incurred bad debt expense of $48,433 (2019 - $1,837). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922dsp597.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED
APRIL&nbsp;30, 2020 </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Currency risk </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company operates in the US and Europe which gives rise to exposure to market risks from changes in foreign currency values. Most significantly, the Company
is exposed to potential currency fluctuations between US and Canadian dollars, which was translated at 1.3556 at April&nbsp;30, 2020, and the Euro and Canadian dollar, which was translated at 1.51039 at April&nbsp;30, 2020. Fluctuations in the
exchange rate could impact profitability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At April&nbsp;30, 2020, the Company is exposed to currency risk through the following assets and liabilities
denominated in US dollars and Euros: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Euros</B><br><B>(&#128;)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>US&nbsp;Dollars<BR>(US $)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,246,018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">452,226</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">752,224</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">906,428</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78,719</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,076,961</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,358,654</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(642,781</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(570,253</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19,075</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(209,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,870,669</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,532,525</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(779,253</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(455,564</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">579,401</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the year ended April&nbsp;30, 2020, a 5% increase in foreign exchange rates by the Canadian dollar relative to the US
dollar would have decreased other comprehensive income (loss) by approximately $39,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the year ended April&nbsp;30, 2020, a 5% increase in foreign
exchange rates by the Canadian dollar relative to the Euro would have decreased other comprehensive income (loss) by approximately $34,000. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Liquidity
risk: </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s approach to managing its obligations is to maintain sufficient resources to meet its obligations when due without undue risk
to the Company. The Company monitors its cash requirements on an ongoing basis to ensure that there are sufficient resources for operations as well as to fund anticipated leasing, capital and development expenditures. In addition, the Company
manages its cash to meet its debt obligations and to fund general and administrative costs. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Contractual cash flow requirements as at April&nbsp;30, 2020
were as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&lt; 1</B><br><B>year</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>1 &#150; 2</B><br><B>years</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2 &#150; 5<BR>years</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&gt;5<BR>years<BR>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,766,058</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,766,058</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loan payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">121,833</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">190,306</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">312,139</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred acquisition payments<SUP STYLE="font-size:85%; vertical-align:top">(1) </SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,546,088</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">506,538</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,052,626</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">849,255</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">714,898</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">518,825</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,082,978</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,283,234</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,411,742</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">518,825</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,213,801</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">$1,016,112 aggregate payments not included in this table are to be settled by issuance of shares.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922dsp597.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED
APRIL&nbsp;30, 2020 </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RISKS AND UNCERTAINTIES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Research and Development and Product Development </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA is a
life science company that makes customized antibodies and is engaged in the research and product development of new processes, procedures and innovative approaches to the antibody production and new antibodies. The Company has been engaged in such
research and development activities for over 20 years and has had significant success. Continued investment in retaining key scientific staff as well as an ongoing commitment in research and development activities will continue to be a cornerstone
in the Company&#146;s development of new services, processes, and competitive advantages such as Rapid Prime, B cell Select, DeepDisplay and its methods for the production of human antibodies. The Company realizes that such research and product
development activities endeavour, but cannot assure, the production of new and innovative processes, procedures or innovative approaches to antibody production or new antibodies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Custom Products </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is reliant on the
development, marketing and sale of its current custom monoclonal and polyclonal antibodies. If it does not achieve sufficient market acceptance of its expansion of its commercialization of its products and services, it will be difficult for the
Company to achieve consistent profitability. The Company&#146;s marketing and sales approach and external sales personnel continues to introduce a steady stream of new customers. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Obsolescence </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Maintaining a competitive position requires
constant growth, development and strategic marketing and planning. If the Company is unable to maintain a technological advantage, its ability to grow its business will be adversely affected and its products may become obsolete compared with other
technologies. To mitigate this, the Company is making investments in new methods, technology and facilities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Competition </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA may face significant competition in selling its products and services. Many competitors may have substantial marketing, financial, development and
personnel resources. To remain competitive, the Company believes that it must effectively and economically provide: (i)&nbsp;products and services that satisfy customer demands, (ii)&nbsp;superior customer service, (iii)&nbsp;high levels of quality
and reliability, and (iv)&nbsp;dependable and efficient distribution networks. Increased competition may require the Company to reduce prices or increase spending on sales and marketing and customer support, which may have a material adverse effect
on its financial condition and results of operations. Any decrease in the quality of IPA&#146;s products or level of service to customers or any occurrence of a price war among the Company&#146;s competitors may adversely affect the business and
results of operations. Customer reach, service and <FONT STYLE="white-space:nowrap">on-time</FONT> delivery will continue to be a hallmark of the Company&#146;s ability to compete with other market players. Further, the recent acquisitions translate
to spreading the IPA footprint on two continents. In addition, the Company has deployed a sales team tasked with continually sourcing and providing market intelligence as part of its activities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Intellectual Property Protection </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although IPA is
developing its patent portfolio, IPA&#146;s intellectual property is still protected primarily through trade secrets and copyright protection. The Company takes steps to document and protect its trade secrets and authorship of works protectable by
copyright. However, there is no guarantee that such steps protect against the disclosure of confidential information, rights of employees, or that legal actions would provide sufficient remedy for any breach. Additionally, IPA&#146;s trade secrets
might otherwise become known or be independently developed by competitors. If the Company&#146;s internal information and knowledge cannot be protected, the business might be adversely affected. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922dsp597.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IMMUNOPRECISE ANTIBODIES LTD. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MANAGEMENT DISCUSSION AND ANALYSIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR THE YEAR ENDED
APRIL&nbsp;30, 2020 </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Failure of Laboratory Facilities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s operations could suffer as a result of a failure of its laboratory facilities. The Company&#146;s business is dependent upon a laboratory
infrastructure to produce products and services. These systems and operations are vulnerable to damage and interruption from fires, earthquakes, telecommunications failures, and other events. Any such errors or inadequacies in the software that may
be encountered could adversely affect operations, and such errors may be expensive or difficult to correct in a timely manner. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The production of
monoclonal and polyclonal antibodies requires state of the art laboratory facilities and animal care standards and the success of these laboratory services depends on the recruitment and retention of highly qualified technical staff to maintain the
level and quality standards that customers expect of the Company&#146;s products and services. There is no assurance that the Company will be able to expand and operate such <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">state-of-the-art</FONT></FONT></FONT> laboratory services and recruit and retain qualified staff. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Financial and Regulatory
Risks </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is currently subject to financial and regulatory risks. The financial risk is derived from the uncertainty pertaining to the
Company&#146;s ability to raise capital to continue operations. Regulatory risks include the possible delays in getting regulatory approval for the transactions that the Board of Directors believe to be in the best interest of the Company and
include increased fees for filings and the introduction of ever more complex reporting requirements, the cost of which the Company must meet in order to maintain its exchange listing. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Pandemic Risk </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A new Coronavirus, known as <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> and causing a disease called COVID- 19, which has proved to be highly contagious, emerged in Wuhan, China at the end of 2019. Since the future course and duration
of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> outbreak are unknown, the Company is currently unable to determine whether the outbreak will have a negative effect on the Company&#146;s results in the fourth quarter of 2020 and beyond. There
has been no impact on results through April&nbsp;30, 2020, and the Company has not experienced negative impact on client sales or the supply chain. The Company&#146;s sales, operations and financial performance could suffer given a potential rapidly
spreading virus. Internally, the virus may infect its employees resulting in operating at lower productivity levels or even a complete laboratory shutdown. The Company&#146;s business is dependent on its laboratories to produce its products and
services which if not operating will impact the financial performance of the company and its ability to meet its obligations. The Company has diversified geographic locations with the ability to perform similar services at other sites. In addition,
certain roles have the ability to work remotely and the Company has business interruption insurance which may aid in the recovery of lost profits. External factors may also contribute to this risk, such as the impact of a pandemic on the
Company&#146;s clients and suppliers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FURTHER INFORMATION : </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additional information relating to the Company can be found on SEDAR at <U>www.sedar.co</U><U>m</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.84
<SEQUENCE>85
<FILENAME>d20922dex9984.htm
<DESCRIPTION>EX-99.84
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.84</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.84 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Form <FONT STYLE="white-space:nowrap">52-109FV1</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Certification of Annual Filings </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Venture Issuer Basic Certificate </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I, <B>Lisa Helbling,</B> <B>Chief Financial Officer</B> of <B>ImmunoPrecise Antibodies Ltd., </B>certify the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Review:</I></B><B> </B>I have reviewed the AIF, if any, annual financial statements and annual MD&amp;A,
including, for greater certainty, all documents and information that are incorporated by reference in the AIF (together, the &#147;annual filings&#148;) of <B>ImmunoPrecise Antibodies Ltd. </B>(the &#147;issuer&#148;) for the financial year ended
<B>April&nbsp;30, 2020.</B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>No misrepresentations:</I></B><B> </B>Based on my knowledge, having exercised reasonable diligence, the
annual filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, for the
period covered by the annual filings. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Fair presentation:</I></B><B> </B>Based on my knowledge, having exercised reasonable diligence, the
annual financial statements together with the other financial information included in the annual filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for
the periods presented in the annual filings. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: <B>August</B><B></B><B>&nbsp;28, 2020 </B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><I>&#147;Lisa Helbling&#148;</I></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Lisa Helbling</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chief Financial Officer</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1.00pt;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>NOTE TO READER </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; font-size:10pt; font-family:Times New Roman">In contrast to the certificate required for <FONT STYLE="white-space:nowrap">non-venture</FONT> issuers under National Instrument <FONT
STYLE="white-space:nowrap">52-109</FONT> <I>Certification of Disclosure in Issuers&#146; Annual and Interim Filings</I> (NI <FONT STYLE="white-space:nowrap">52-109),</FONT> this Venture Issuer Basic Certificate does not include representations
relating to the establishment and maintenance of disclosure controls and procedures (DC&amp;P) and internal control over financial reporting (ICFR), as defined in NI <FONT STYLE="white-space:nowrap">52-109.</FONT> In particular, the certifying
officers filing this certificate are not making any representations relating to the establishment and maintenance of </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">controls and other procedures designed to provide reasonable assurance that information required to be
disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a process to provide reasonable assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with the issuer&#146;s GAAP. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; padding-bottom:0pt; margin-left:1%; font-size:10pt; font-family:Times New Roman">The
issuer&#146;s certifying officers are responsible for ensuring that processes are in place to provide them with sufficient knowledge to support the representations they are making in this certificate. Investors should be aware that inherent
limitations on the ability of certifying officers of a venture issuer to design and implement on a cost effective basis DC&amp;P and ICFR as defined in NI <FONT STYLE="white-space:nowrap">52-109</FONT> may result in additional risks to the quality,
reliability, transparency and timeliness of interim and annual filings and other reports provided under securities legislation. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P></div>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.85
<SEQUENCE>86
<FILENAME>d20922dex9985.htm
<DESCRIPTION>EX-99.85
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.85</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.85 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Form <FONT STYLE="white-space:nowrap">52-109FV1</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Certification of Annual Filings </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Venture Issuer Basic Certificate </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I, <B>Jennifer Bath, Chief Executive Officer </B>of <B>ImmunoPrecise Antibodies Ltd., </B>certify the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Review:</I></B><B> </B>I have reviewed the AIF, if any, annual financial statements and annual MD&amp;A,
including, for greater certainty, all documents and information that are incorporated by reference in the AIF (together, the &#147;annual filings&#148;) of <B>ImmunoPrecise Antibodies Ltd.</B> (the &#147;issuer&#148;) for the financial year ended
<B>April&nbsp;30, 2020.</B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>No misrepresentations:</I></B><B> </B>Based on my knowledge, having exercised reasonable diligence, the
annual filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, for the
period covered by the annual filings. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Fair presentation:</I></B><B> </B>Based on my knowledge, having exercised reasonable diligence, the
annual financial statements together with the other financial information included in the annual filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for
the periods presented in the annual filings. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: <B>August</B><B></B><B>&nbsp;28, 2020 </B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><I>&#147;Jennifer Bath&#148;</I></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jennifer Bath</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chief Executive Officer</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1.00pt;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>NOTE TO READER </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; font-size:10pt; font-family:Times New Roman">In contrast to the certificate required for <FONT STYLE="white-space:nowrap">non-venture</FONT> issuers under National Instrument <FONT
STYLE="white-space:nowrap">52-109</FONT> <I>Certification of Disclosure in Issuers&#146; Annual and Interim Filings</I> (NI <FONT STYLE="white-space:nowrap">52-109),</FONT> this Venture Issuer Basic Certificate does not include representations
relating to the establishment and maintenance of disclosure controls and procedures (DC&amp;P) and internal control over financial reporting (ICFR), as defined in NI <FONT STYLE="white-space:nowrap">52-109.</FONT> In particular, the certifying
officers filing this certificate are not making any representations relating to the establishment and maintenance of </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">controls and other procedures designed to provide reasonable assurance that information required to be
disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a process to provide reasonable assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with the issuer&#146;s GAAP. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; padding-bottom:0pt; margin-left:1%; font-size:10pt; font-family:Times New Roman">The
issuer&#146;s certifying officers are responsible for ensuring that processes are in place to provide them with sufficient knowledge to support the representations they are making in this certificate. Investors should be aware that inherent
limitations on the ability of certifying officers of a venture issuer to design and implement on a cost effective basis DC&amp;P and ICFR as defined in NI <FONT STYLE="white-space:nowrap">52-109</FONT> may result in additional risks to the quality,
reliability, transparency and timeliness of interim and annual filings and other reports provided under securities legislation. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P></div>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.86
<SEQUENCE>87
<FILENAME>d20922dex9986.htm
<DESCRIPTION>EX-99.86
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.86</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.86 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922dsp86.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Reports Record Revenues and Positive Adjusted EBITDA Fiscal 2020 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Reports rapid advancement of <FONT STYLE="white-space:nowrap">COVID-19</FONT> antibody programs; </I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>combination studies achieve nearly complete neutralization of
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, BC, Aug. 31, 2020 /CNW/ - IMMUNOPRECISE
ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSXV: IPA) (OTCQB: IPATF) today announced financial results and provided a business update for its fiscal year 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Highlights: </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Characterized a subset of fully human, therapeutic antibodies shown to have potent neutralizing activity and
exhibiting enhanced neutralization upon combinatorial (dual antibody) testing </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Awarded multiple grants for the development of antibody therapeutics against <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Announced TRANSVAC2 funding collaborative <FONT STYLE="white-space:nowrap">COVID-19</FONT> vaccine project
between ImmunoPrecise Antibodies Europe and LiteVax BV </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">IPA subsidiary, UPE, joining Genmab and Merus in expansion to new biotech accelerator in the Center of European
Science Industry </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Collaborating with the NIH and Integrated Biotherapeutics to study the structural details of antibodies with
therapeutic potential to treat or prevent <FONT STYLE="white-space:nowrap">COVID-19</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Awarded grant by SERC to fund collaboration with the University of Victoria to develop a potential saliva-based <FONT
STYLE="white-space:nowrap">COVID-19</FONT> antibody test designed to provide real-time results </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Added to WHO draft landscape of companies combating <FONT STYLE="white-space:nowrap">COVID-19</FONT>
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Integrated SGI&#146;s automated DNA Printer at Utrecht Site, first in Europe </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Financial Results </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Revenue.</B> The Company posted
record revenue of $14,057,927 compared to revenues of $10,926,268 in the 2019 fiscal year, a 29% increase in revenue for the year. Revenue in Q4 was up 57% over Q4 2019. The Company&#146;s continued focus on identifying and onboarding new clients
seeking the breadth and depth of the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">end-to-end</FONT></FONT> services offered, combined with continued growth to core existing client business, led to increases in both volume and
financial value of contracts during the year ended April&nbsp;30, 2020. Revenue outlook is positive for the first quarter of fiscal 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gross
Margin.</B> Gross profit increased 52% to 8,033,984, compared to 5,294,634 for the for the same period last year an increase of $2,739,350 over <FONT STYLE="white-space:nowrap">year-end</FONT> April&nbsp;30, 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Net Loss. </B>The Company reported a net loss of $4,947,426 for year ended April&nbsp;30, 2020 compared to a net loss of $7,617,467 for the same periods
last year, a $2,670.041 improvement over prior year. The decrease in net loss is primarily attributable to the increase in gross profit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT
STYLE="white-space:nowrap">Non-IFRS</FONT> Measures*</B> Adjusted EBITDA for the year was $52,311 compared to ($2,849,474) for fiscal year ending April&nbsp;30, 2019. This significant improvement in Adjusted EBITDA is primarily a result of the
increase in gross profit compared to the prior year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;It was a record fiscal year for ImmunoPrecise, a result of our ongoing partnerships with
pharma and biotech companies from across the globe, coupled with the continued addition of new clients for research, diagnostic and therapeutic programs,&#148; said Jennifer Bath, chief executive officer of ImmunoPrecise. &#147;We work diligently
alongside our clients to help them build pipelines and research programs, serving as an innovative extension of their laboratories and building lasting relationships. We are rapidly gaining traction in the market, and I am pleased to report our
customer base has grown to include over 400 of the leading pharma and biotech companies worldwide, as well as more than half of the top twenty global pharma companies. We anticipate the continuance of this trend in larger, multi-year agreements to
be further bolstered by a robust <FONT STYLE="white-space:nowrap">out-licensing</FONT> strategy.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;In addition to our strong financial
performance, I am pleased to report rapid development of our <FONT STYLE="white-space:nowrap">COVID-19</FONT> program. As we have shared previously, current vaccine strategies under development for <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> are designed to protect uninfected individuals. However, these approaches do not address patients with active disease and will likely not be effective in a number of critical populations including
the elderly and immunocompromised. Moreover, given the high potential for continued virus mutation, alternative treatments targeting limited epitopes may not provide long-term efficacy. In contrast, our antibody discovery platforms represent a
powerful treatment option for <FONT STYLE="white-space:nowrap">COVID-19</FONT> patients generating unparalleled diversity of novel human antibodies, which is being designed to provide maximum clinical benefit for both current and future variants of
the virus.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;I am pleased to report that our lead antibodies have produced clear synergistic effects, confirming their activities are enhanced
in combination studies and resulting in near complete neutralization of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> pseudovirus infection. We are now accelerating
<FONT STYLE="white-space:nowrap">pre-clinical</FONT> testing with plans to submit an IND to the FDA as soon as practical. In the meantime, we are actively pursuing additional collaboration and partnership opportunities. We have also been awarded
multiple grants, which further validate our platform, and we will continue to actively explore other <FONT STYLE="white-space:nowrap">non-dilutive</FONT> funding opportunities.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Lastly, we are excited to partner with Dr.&nbsp;Alexandre Brolo&#146;s lab at the University of Victoria (&#147;UVic&#148;), to develop a saliva-based
antibody-based test for the detection and screening of <FONT STYLE="white-space:nowrap">COVID-19.</FONT> Unlike current immunoassays that are developed for blood or serum, our goal is to develop a test kit that will provide rapid results, and can be
easily administered anywhere, including at home. Overall, we are highly encouraged by the progress of our programs, all leveraging our core antibody expertise, and we look forward to providing further updates.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IPA periodically provides information for investors on its corporate website, <U>ImmunoPrecise.com</U>. This includes press releases and other information on
financial performance, reports filed or furnished with the TSX, information on corporate governance and details related to its annual meeting of shareholders. Reports filed or furnished with the TSX can be found at <U>sedar.com</U>. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a leading, global, technology platform company with full service, end-to-end solutions that empower pharmaceutical companies across the globe
to discover, develop, optimize, engineer and manufacture treatments against any disease. The Company&#146;s experience, cutting-edge technologies and focus on intense scientific rigor enables unparalleled support of its partners in their quest to
bring innovative treatments to the clinic. With ImmunoPrecise&#146;s industry-leading technologies, fully integrated project management platform, and one-stop service offerings, the Company dramatically reduces the time required for, and the
inherent risk associated with, conventional multi-vendor product development. For further information, visit <U>www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release
contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148; within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;,
&#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and similar expressions to identify forward-looking statements. Any such forward-looking statements are based on
assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and expected future developments. However, whether actual results and developments will conform to
ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the
forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual
management discussion and analysis for the fiscal period ended January 31, 2020 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless
required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise.</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">*Non-IFRS Financial Measure </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Readers are cautioned that
&#147;Adjusted EBITDA&#148; is a measure not recognized under IFRS.</I><I> </I><I>Adjusted EBITDA is defined as earnings before interest income, taxes, depreciation and amortization, share-based compensation, restructuring costs, impairment charges
and other non-recurring gains or losses. Management believes Adjusted EBITDA is a useful measure that facilitates period-to-period operating comparisons.</I><I> </I><I>Readers are cautioned that &#147;Adjusted EBITDA&#148; is not an alternative to
measures determined in accordance with IFRS and should not, on its own, be construed as indicator of performance, cash flow or profitability.</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922ccc1.jpg" ALT="LOGO">
 View original content to download multimedia: <U> </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">http://www.prnewswire.com/news-releases/immunoprecise-reports-record-revenues-and-positive-adjusted-ebitda-fiscal-2020-301120834.html</FONT></FONT></FONT></FONT></FONT></FONT></FONT></FONT></FONT>
</FONT></FONT></U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922ccc1.jpg" ALT="LOGO">
 View original content to download multimedia: <U>http://www.newswire.ca/en/releases/archive/August2020/31/c0095.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: 1-438-863-7071, Email: frederick@contactfinancial.com, Contact Financial Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 07:30e 31-AUG-20 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.87
<SEQUENCE>88
<FILENAME>d20922dex9987.htm
<DESCRIPTION>EX-99.87
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.87</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.87 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922dsp88.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImmunoPrecise Antibodies Grants Stock Options </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, BC, Sept. 1, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSXV: IPA) (OTCQB: IPATF) (FSE: TQB2), a
leader in full-service, therapeutic antibody discovery and development, today reports that, pursuant to the Company&#146;s Stock Option Plan, the Board of Directors has authorized the granting of incentive stock options to executive management of
the Company to acquire an aggregate of 1,350,000 common shares of the Company. The options have an exercise price of $1.70 per share, expire five years from the date of grant and are subject to certain vesting requirements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a
global technology platform company with <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">end-to-end</FONT></FONT> solutions empowering companies to discover and develop therapies against any disease. The Company&#146;s experience
and cutting-edge technologies enable unparalleled support of its partners in their quest to bring innovative treatments to the clinic. ImmunoPrecise&#146;s full-service capabilities dramatically reduce the time required for, and the inherent risk
associated with, conventional multi-vendor product development. For further information, visit <U>www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release
contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148; within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;,
&#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148;, &#147;should&#148; and similar expressions to identify forward-looking statements. Any such forward-looking
statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and expected future developments. However, whether actual results and developments will
conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the
forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual
management discussion and analysis for the previous quarter ended January&nbsp;31, 2020 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and,
unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise.</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922ccc1.jpg" ALT="LOGO">
 View original content to download multimedia: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.newswire.ca/en/releases/archive/September2020/01/c7410.html</U>
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor relations please contact: Frederick Chabot, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> frederick@contactfinancial.com, Contact Financial Corp., 1450 - 701 West Georgia St., Vancouver, BC V7Y 1G5 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 08:00e <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">01-SEP-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.88
<SEQUENCE>89
<FILENAME>d20922dex9988.htm
<DESCRIPTION>EX-99.88
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.88</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.88 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g20922dsp88.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IPA CEO to Participate in Virtual Panel: &#147;New Approaches to <FONT STYLE="white-space:nowrap">COVID-19:</FONT>
Hidden Breakthroughs,&#148; on Thursday, September 10th </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, BC, Sept. 8, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or
&#147;IPA&#148;) (TSXV: IPA) (OTCQB: IPATF) (FSE:TQB2), a leader in full-service, therapeutic antibody discovery and development, today announced that Dr.&nbsp;Jennifer Bath, CEO of IPA, will participate on a virtual panel, entitled, &#147;New
Approaches to <FONT STYLE="white-space:nowrap">COVID-19:</FONT> Hidden Breakthroughs,&#148; being held on Thursday, September&nbsp;10, 2020 at 1:00&nbsp;p.m. ET. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The virtual panel discussion will also include: Tom Equels, CEO of <U>AIM ImmunoTech Inc.</U> (NYSE American: AIM); Dr.&nbsp;David Jin, CEO of <U>Avalon
GlobloCare Corp.</U> (NASDAQ:AVCO); Jeff Wolf, CEO of <U>Heat Biologics, Inc.</U> (NASDAQ: HTBX) and Vered Caplan, CEO of <U>Orgenesis Inc.</U> (NASDAQ: ORGS). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The event brings together executives from leading biopharmaceutical companies to discuss how their companies are helping address the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic. The panel will be moderated by broadcast journalist Christine Corrado of Proactive Investors. Investors interested in attending the event can register at: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT STYLE="white-space:nowrap">https://zoom.us/webinar/register/8215990551540/WN_YFe8n6dQSm6mpgG3iWfF-w</FONT></U> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a
global technology platform company with <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">end-to-end</FONT></FONT> solutions empowering companies to discover and develop therapies against any disease. The Company&#146;s experience
and cutting-edge technologies enable unparalleled support of its partners in their quest to bring innovative treatments to the clinic. ImmunoPrecise&#146;s full-service capabilities dramatically reduce the time required for, and the inherent risk
associated with, conventional multi-vendor product development. For further information, visit <U>www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release
contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148; within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;,
&#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148;, &#147;should&#148; and similar expressions to identify forward-looking statements and include the Company&#146;s
beliefs with respect to the potential for its antibodies to be further developed or approved to treat </I><FONT STYLE="white-space:nowrap">COVID-19</FONT> (or
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2)</FONT></FONT> or to complete any transactions with respect to those antibodies.<I> Any such forward-looking statements are based on assumptions and analyses made by
ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s expectations and predictions
is subject to any number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements contained in this news release.
Such factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and analysis for the previous quarter ended
January</I><I></I><I>&nbsp;31, 2020 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of this press release and, unless required by applicable law, ImmunoPrecise
undertakes no obligation to publicly update or revise such information, whether as</I> <I>a result of new information, future events or otherwise.</I> </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">


<IMG SRC="g20922ccc1.jpg" ALT="LOGO">
 View original content to download multimedia: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>http://www.newswire.ca/en/releases/archive/September2020/08/c1782.html</U>
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For
investor relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact
Financial Corp., Suite 810, 609 Granville Street, P.O. Box 10322, Vancouver, B.C., V7Y 1G5 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 08:00e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">08-SEP-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.89
<SEQUENCE>90
<FILENAME>d20922dex9989.htm
<DESCRIPTION>EX-99.89
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.89</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.89 </B></P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g20922g26f32.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman"><B>ImmunoPrecise Announces Participation at the H.C. Wainwright 22nd Annual Global Investment Conference on September <FONT
STYLE="white-space:nowrap">14-16,</FONT> 2020 (Virtual Conference) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, BC, Sept. 9, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the
&#147;Company&#148; or &#147;IPA&#148;) (TSXV: IPA) (OTCQB: IPATF) (FSE:TQB2), a leader in full-service, therapeutic antibody discovery and development, today announced that it will be presenting at the H.C. Wainwright Annual Global Investment
Conference being held virtually on September <FONT STYLE="white-space:nowrap">14-16,</FONT> 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jennifer Bath, CEO of ImmunoPrecise, will provide an
overview of the Company&#146;s business during the live presentation and will be available to participate in <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-on-one</FONT></FONT> meetings with investors who are registered to
attend the conference. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you are an institutional investor, and would like to attend the Company&#146;s presentation, please click on the following link
(<U>www.hcwevents.com</U>) to register for the conference. Once your registration is confirmed, you will be prompted to log into the conference website to request a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-on-one</FONT></FONT> meeting with the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Event:</B> H.C. Wainwright 22<SUP
STYLE="font-size:85%; vertical-align:top">nd</SUP> Annual Global Investment Conference (Virtual Conference) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Date: </B>September <FONT
STYLE="white-space:nowrap">14-16,</FONT> 2020 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Presentation Day</B><B></B><B>&nbsp;&amp; Time:</B> September&nbsp;15, 12:30 PM (EDT) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Location: </B><U>https://wsw.com/webcast/hcw7/ipa.v/1665422</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">H.C. Wainwright is a full-service investment bank dedicated to providing corporate finance, strategic advisory and related services to public and private
companies across multiple sectors and regions. H.C. Wainwright&nbsp;&amp; Co. also provides research and sales and trading services to institutional investors. According to Sagient Research Systems, H.C. Wainwright&#146;s team is ranked as the #1
Placement Agent in terms of aggregate CMPO (confidentially marketed public offering), RD (registered direct offering) and PIPE (private investment in public equity) executed cumulatively since 1998. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a
global technology platform company with <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">end-to-end</FONT></FONT> solutions empowering companies to discover and develop therapies against any disease. The Company&#146;s experience
and cutting-edge technologies enable unparalleled support of its partners in their quest to bring innovative treatments to the clinic. ImmunoPrecise&#146;s full-service capabilities dramatically reduce the time required for, and the inherent risk
associated with, conventional multi-vendor product development. For further information, visit <U>www.immunoprecise.com</U> or contact <U>solutions@immunoprecise.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release
contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148; within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;,
&#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148;, &#147;should&#148; and similar expressions to identify forward-looking statements. Any such forward-looking
statements are based on assumptions and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and expected future developments. However, whether actual results and developments will
conform to ImmunoPrecise&#146;s expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the
forward-looking statements contained in this news release. Such factors include, among other things, actual revenues and earnings for IPA being lower than anticipated, and those risks and uncertainties described in ImmunoPrecise&#146;s annual
management discussion and analysis for the previous quarter and audited fiscal year ended April&nbsp;30, 2020, which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148; contained herein speak only as of the date of
this press release and, unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View original content to download multimedia: <U> </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">http://www.prnewswire.com/news-releases/immunoprecise-announces-participation-at-the-hc-wainwright-22nd-annual-global-investment-conference-on-september-</FONT></FONT></FONT></FONT></FONT></FONT>
</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View original
content to download multimedia: <U>http://www.newswire.ca/en/releases/archive/September2020/09/c5168.html</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor relations please contact: Frederick Chabot, Phone:
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial Corp., Suite 810, 609 Granville Street, P.O. Box 10322,
Vancouver, B.C., V7Y 1G5, Canada. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">CNW 17:37e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">09-SEP-20</FONT></FONT> </P>
<P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.90
<SEQUENCE>91
<FILENAME>d20922dex9990.htm
<DESCRIPTION>EX-99.90
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.90</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.90 </B></P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g20922g26f32.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman"><B>ImmunoPrecise Commences Application Process to Dual List on NASDAQ </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VICTORIA, BC, Sept. 10, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the &#147;Company&#148; or &#147;IPA&#148;) (TSX VENTURE: IPA) (OTCQB: IPATF) ( FSE:TQB2),
a provider of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">best-in-class</FONT></FONT> therapeutic antibody discovery capabilities for the global pharmaceutical and biotech industries, is pleased to announce that it has
commenced the application process to dual list its stock on the NASDAQ Capital Market (&#147;NASDAQ&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By listing on NASDAQ, the Company believes
that it will gain greater exposure and access to a larger base of retail and institutional investors in the United States and internationally. NASDAQ is the world&#146;s <FONT STYLE="white-space:nowrap">pre-eminent</FONT> exchange for biotech and
pharma companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The listing of the Company&#146;s common shares on NASDAQ remains subject to the approval of the exchange and satisfaction of all
applicable listing requirements. The Company plans to provide updates on its progress as it advances toward this goal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Jennifer Bath, CEO of
ImmunoPrecise, comments, &#147;We have worked very hard to meet the requirements for Nasdaq and believe that we meet substantially all the requirements. Our plan to move to a senior U.S. exchange reflects our success and momentum in growing our CRO
business, as well as advancement of our robust therapeutic pipeline. Moreover, we believe that listing on Nasdaq will provide a broader platform as we execute on upcoming catalysts, including near-term milestones related to our <FONT
STYLE="white-space:nowrap">COVID-19</FONT> therapeutic and diagnostic programs. We believe that listing on Nasdaq will also help broaden our shareholder base, increase appeal to institutional investors, allow for inclusion in key indexes and ETFs,
as well as provide shareholders with enhanced liquidity.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImmunoPrecise Antibodies Ltd. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImmunoPrecise is a global technology platform company with <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">end-to-end</FONT></FONT> solutions
empowering companies to discover and develop therapies against any disease. The Company&#146;s experience and cutting-edge technologies enable unparalleled support of its partners in their quest to bring innovative treatments to the clinic.
ImmunoPrecise&#146;s full-service capabilities dramatically reduce the time required for, and the inherent risk associated with, conventional multi-vendor product development. For further information, visit <U>www.immunoprecise.com</U> or contact
<U>solutions@immunoprecise.com</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains statements that, to the extent they are not recitations of historical fact, may constitute &#147;forward-looking statements&#148;
within the meaning of applicable Canadian securities laws. The Company uses words such as &#147;may&#148;, &#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;believe&#148;, &#147;intend&#148; and
similar expressions to identify forward-looking statements. These statements include, but are not limited to, statements regarding the Company&#146;s plan and ability to list on NASDAQ. Any such forward-looking statements are based on assumptions
and analyses made by ImmunoPrecise in light of its experience and its perception of historical trends, current conditions and expected future developments. However, whether actual results and developments will conform to ImmunoPrecise&#146;s
expectations and predictions is subject to any number of risks, assumptions and uncertainties. Many factors could cause ImmunoPrecise&#146;s actual results to differ materially from those expressed or implied by the forward-looking statements
contained in this news release. Such factors include, among other things, the Company&#146;s ability to complete the NASDAQ listing process in a timely manner or at all, actual revenues and earnings for IPA being lower than anticipated, and those
risks and uncertainties described in ImmunoPrecise&#146;s annual management discussion and analysis for the previous quarter ended January&nbsp;31, 2020 which can be accessed at <U>www.sedar.com</U>. The &#147;forward-looking statements&#148;
contained herein speak only as of the date of this press release and, unless required by applicable law, ImmunoPrecise undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or
otherwise. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of this release. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View original content to download multimedia: <U> </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">http://www.prnewswire.com/news-releases/immunoprecise-commences-application-process-to-dual-list-on-nasdaq-301127342.html
</FONT></FONT></FONT></FONT></U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE ImmunoPrecise Antibodies Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">View original content to download multimedia: <U>http://www.newswire.ca/en/releases/archive/September2020/10/c9655.html</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">%SEDAR: 00005542E </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B>For investor
relations please contact: Frederick Chabot, Phone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-438-863-7071,</FONT></FONT></FONT> Email: frederick@contactfinancial.com, Contact Financial
Corp., Suite 810, 609 Granville Street, P.O. Box 10322, Vancouver, B.C., V7Y 1G5, Canada. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CO: ImmunoPrecise Antibodies Ltd. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CNW 07:30e <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">10-SEP-20</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.91
<SEQUENCE>92
<FILENAME>d20922dex9991.htm
<DESCRIPTION>EX-99.91
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.91</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.91 </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the incorporation by reference in the Registration Statement on Form <FONT STYLE="white-space:nowrap">40-F</FONT> of ImmunoPrecise
Antibodies Ltd. (&#147;the Company&#148;) of our report dated August&nbsp;28, 2020 relating to the Company&#146;s consolidated financial statements for the years ended April&nbsp;30, 2020 and 2019, and of our report dated August&nbsp;28, 2019
relating to the Company&#146;s consolidated financial statements for the years ended April&nbsp;30, 2019 and 2018, which appears in this Form <FONT STYLE="white-space:nowrap">40-F.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Crowe MacKay LLP </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chartered Professional Accountants </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vancouver, British Columbia, Canada </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 16, 2020 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>93
<FILENAME>g20922adsp540_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922adsp540_1.jpg
M_]C_X  02D9)1@ !  $ 8 !@  #__@ ?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$  @&!@<&!0@'!P<*"0@*#18.#0P,#1L3%! 6(!PB(1\<
M'QXC*#,K(R8P)AX?+#TM,#4V.3HY(BL_0SXX0S,X.3<!"0H*#0L-&@X.&C<D
M'R0W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W
M-S<W-S<W-__$ :(   $% 0$! 0$!           ! @,$!08'" D*"P$  P$!
M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M *#-]_X$/_C1[*'8+L/^$EUW_H,WW_@0_P#C1[*'8+L/^$EUW_H,WW_@2_\
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MY2NDD* "F 4 % !0 4 % !0 4 % !0 4K@%, H *0!3>CL""E< I@% !0 4
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MY"%M_P!=5_F*RJ_ RH[G1_$K_DH&J?6/_P!%K6>'_AH)[G*5T$A0 4 % !0
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M?Q'.6_)0?S%>5B<QIT*T:;>YLH-K8Q,UZ:E%Z19ERM!5V$% !0 4 % !0 4
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M Z7Q+-;JPP<+CMUR<,/QKY;$9U".)44]/3S.N-%\IQCV-Y%&7DLYT0#)9HF
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M>GWD[);P/A(48A"O4,?4X(Z^]?I618:$,.IK<\ZO)\UCDZ^CV.8* "@ H *
M"@ H * "@ H * "F!I:+J^IZ1?*^F7#Q2.P4J#\LG/ (KS,PPU.K2:EY_D:4
MW9GO+7]O%>PV<US&+R1-ZQEN2!U(K\FE@ZLY\Z7NGK*<;'BGBW6-9O\ 6+BU
MU2=P()2H@!(1<="!ZX[^]?I^3T*=/#*47W/+K.\CGZ]LR84Q!0 4 % !0 4P
M+%C_ ,A"V_ZZK_,5E5^!E1W.C^)7_)0-4^L?_HM:SP_\-!/<Y2N@D* "@ H
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M;F9+O[3#.%EBD#9&PC@ ^QR*^SR:DJ=%)QL]3CK2UT9SU>WUL8!0 4 % !0
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MY\)DW]GXCFI[%3K<R./SGFOJEM<Y H#8,4U=!:X4O,-@H * "@ H * "@ H
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M.LVI".&P(6YP<^OM2EBKJU@4+'LM<1H% "4 % "T % "8H 6@!,4 +0 4 %
M!0 F* %H 3% "T % !0 4 )B@!: $Q0 M !0 4 % "8H 6@!,4 +0 4 )B@8
MM(050PH * "D E "T )0 M !0 4 )F@!: "@ H 2@!: "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * /+?$OQ(US2?%MUHNGZ;;W7E%1&-CM(^4#'
M@'WKLIX:,X\S9FYV=BI_PL?QQ_T*H_\  :;_ !I_5H=PYCM/!.NZSKUG=3:Q
MIHL7CD"QKY;)N&,D_-]17/4@HO0M.YU%9;#//K;QYJ,WQ+;PTUK;"T$SQ^8
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M<V\HV@G!-93HJ*O<%*YZL.E<EC06CH(X+X@>.[KPE<V5O900323*SN)L\ '
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M;CV(Q7.G9W135S@?!O@77_">LM*NI6LEA*<318;+ 9P1Z&MZM536PDK'HZC
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M_M?P?IMT2"_E"-R/[R_*?Y5S5H\DVBEJCQ&;3'UCQQKUA%&7G=[IX@.I96+
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B@;SX5Z==>(GU5;Z>%GF$YB15V@YR>WJ*W5>3CRD\MF?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>94
<FILENAME>g20922adsp541.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922adsp541.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MD.XB)5[H%SPI''KWZ\T ?5]A>1:AI]M>0G,5Q$LJ<YX89'\Z!%B@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@#Y5\<^/?$VOWMUIFI2?9+>"5HWLX"0H*MT8]6P1WXST H&CBJ!A
M0!])? [6)=1\$/9SON;3[@Q)Z^60&7)[\EA] *"3TV@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M#YX^/.C167B:PU6*,)]OA*R$?Q/'@9_[Y91^% T>3T#"@#V?]GS4$34-;TUF
M/F2QQSHO;"DJQ_\ 'UH$SWB@04 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MZ!G T#"@#Z%^ FFR6WA:_OWC*B[N=J$C[RH,9'J,EA]0:!,]:H$% !0 4 %
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M'TY /KGT% CW?M0(* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MQGWH$?4?A_0K3PYH=II5DN(+= H)ZL>['W)R:!&I0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!7OK.WO[*
M:SNXEEMYT,<B-T92,$4 ?('BK1#X;\4:AI&YV6VE*HSC!*'E2?P(H&8] PH
M* /J'X2>%X- \%VUT4/VW45%Q,S 9 (^1?H!S]6/TH).^QB@ H * "@ H *
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M2_!IU1U_TC4Y"^3D$1H2JC!]]QSZ,* /+?B-KB^+OB2;4S)!9VTPL8Y'8!5
M?#N3G &23GT STH ZGXP6_AC4="TZ^T/5],DGTY1;>1!<HS&'@*  <G:>WHQ
M/:@#L_@YXA36? L-F6)NM-/D2 GG;R4/TQQ_P$T"/)/@RUNOQ*L?.4F0Q2^2
M1V;8<_\ CNZ@9]/GI0(R[[Q%HFE7'V?4=9L;2<C=Y<]PD;8]<$T 5O\ A-O"
MG_0S:3_X'1?_ !5 [&]0(* "@ H * "@"O=WMM80-<7EQ%;P)RTDKA5'XF@#
MQCQA\= K2V7A:(.-N/MLR$8;U1#Z>K?EZ@['+_"C6[R[^*EG/J-W-<W%S%)$
M99I"Q^X6 R>WR]* /I8=*!"T % &7XF_Y%76/^O.;_T T >#_ /_ )'N]_[!
MS_\ HR.@9]&4"/D_P#_R5+2?^OT_UH'T/J[% CY4TY#I?QD@AA<Q+#K8ARIV
MX7SMI'TQD'V- SH?C;J_]L^-K31[/?,UE&(]B#),KD$@#OQL'UR.U '56_P
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MMH*!B<D+/*J_@ V!^5 '4Z;IECI%FEGI]I%:VZ?=CB0*/KQU/O0!<H * "@
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M(;'((/(/(X- C3H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H "<"@#@?B;\0H_!NF+;V31OK-P,PQN-PC3/+L/P('OZX- 'S-
M?7USJ=_/?7LQFN;AS)(Y &YCR>.@_I0,KT#"@#2T#0=0\2ZQ#IFF0B2XER1N
M.%4#DDGL!_GF@1]5^$/!^F^#M'6RL8_WKX:>8G+2OC&?8>@Z#ZDT".A(R,4
M>&?&'X<.DD_BG2(5,1&^]@1>0>\H ZCNWY\Y) ,\4H&% !0!UG@/QQ>>"M96
M9=\NG2D"YMP?O#^\.VX=ORH$?4ND:M::UI-KJ5C(7MKA Z$C!^A]P>*!%Z@
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M('&?U!'H- @H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M',4 % 'T]\(O"1\->$DN9_\ C]U(+/(,8V+CY%_(Y^K$4$GH- !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M4 % 'U;\,O$</B/P18R*3]HM$6UG#')WHH&?Q&#^..U CLJ!!0 4 % !0 4
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C * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>95
<FILENAME>g20922ccc1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922ccc1.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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5YJD*<_W.&G2I*+A%0Y.2*Y8IG__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>96
<FILENAME>g20922dsp1_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922dsp1_2.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /W\H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H ^+/VJ/V[/A'^R'K7A+0OB3X=^(VMW?C+3-1U;2Y
M/ ^D>&=2MK>WTNZ@LYTOWU[Q?HSQ3-)<(4$,<ZE0Q9E( /+3Q=.>,Q.!C&2J
MX6E0K2;2Y''$2Q$(*+3NY)X>?,G%))PLY7:CO+#SAA:.*;C[.O5K4HJ[YE*A
M&A.3:M91:KPY;-MM2NE9-WOV5/VV_A3^U]/XUM_AIX?^(.AOX#BT*;5SXYTK
MPYIBW"^(7U5+(::= \6:R9F0Z/<^;YPM]N^+87W-L]>6 K1RVEF?-#ZO5Q-7
M"QC>7M%4I4J563:Y>50<:T5%J;ES*2<4DF^%XB$<3#"6E[2=*=5.RY>6G.G!
MIN]^:]2-E:UD[M:)_8M<1N% !0 4 '3VQ^&,4;>5@/GCX6_M._#'XQ?%'XM_
M"CP)+J^I:Q\&)]*L_%6NM;:</"UY?ZE)>V\MCH&H6^JS75]/87NG7EK=--96
ML:RPLL,DR@L*P<7C<I6<T5RX*6*EA:;GI.JXPYU7A%73P]2*O2G*493C::AR
M2C)O&1^I8ZCEU5IXJKAY8B48W:HJ$J472JMJ/+62K4W*$%-0O*$Y1JPG37CM
MC^WEX3USQ[KG@7PC\ /VJ/'-MX<^(5_\--6^('@OX2V?B#X;V>OZ3JR:1JEQ
M/XFM/%F;;2[2619YY)[6*:.W(E: !E#++(RS*EEU=+ZAA\TC[3#U<7^YI2H\
M\Z:K<ZYX^R<J<ES1<K-.,E&<91B9E;+*F-HN4<9B,OIPG6HX1^UJQG/#PQ"P
M_L_=?UA1FJ;@[)U$U"4H.,W]TTA'SQ_PU!\))_C[I7[-VD:Q-XA^)%]H.M>(
M-2303IFH:+X4AT2&*X?3?%%^NIK-I^M74$OF064-K<NJ)ON?LZRPF8P/_"A_
M:<L-K1RNA3KU*K5J513Q-+"NG0FKJI4I5*U-U=J<8MKVCJ1E34XZ2R[^RUB?
M=J9MB:F&HTE;VL)4\+6Q?M:T&XNG1G"A4A3EK*=1:0Y%*:X[XT?MH?"KX(>+
MY_!.L:!\4/&>KZ)I%EXD\>3_  T\"7WB_2_A=X6OVD^R^)OB'J$%S FB:2T4
M,TW[D7EP(H]Y@VR1^9EAZ]*O4K)S^KX3#55AZN-K)PPE/%3A&=/".JE*3KU%
M."C&,'!.24YQ:E;JGA:\*>%<8>VQ&.4YX;"TVI8JO2I2=.K6ITKJ]*G43A*4
MI1O)-04N65O0/B-^TA\*_AI\.?#/Q-U/5-2U_1/'1T>'X>:5X-T:^\2^*/B#
MJ/B"R_M#0](\(:!9H)]1U&\M/WB)(8(T',TD0YK;&0Q&"S!Y3/"UJV9QE7C]
M5HQ52K;"IRQ$WJH1ITDKRJ2FH:QM)N4;\V#G0QF#_M!8BGA<OBJ7/B,0W2IT
MG5FJ5.$URNHJCJ/D]E&$JJE&?N>Y)KS#P]^V_P#"7Q!\+?BW\33X?^)OAZZ^
M!MH;OXF_"_Q;X2@\-?%7PTKQ/<6,5UX<U/6([+S;VVCDE@/]J!"$99'C=2@C
M'2A@LOP>:*I'%X'&8JG@H5<.U-1Q<JU##U*%3G]GRSP]3$4U6M=*T_9NHXV*
MPT98C'5LN<)8;%4<-/&*-:+@JF'A1J5U4IN/-S*=.G>*T?OTG-0A4C)_.7@3
M_@KW^S7\0?&WA#P'HO@CXXVNK^-/$VA>%-*N-3\-> H--M]1\0:G;:593:A-
M:?$NYFALDN+J-I7AMYW5%8I&[ *>_+L!6S+%1PE"4(5)4Z]1.HY*/+AZ%3$3
M5XQD[N%*2C[MG)I-Q5Y+GQ6(A@\/6Q-12=.A!SDHI<UHJ[LFXJ_:[7J?9GQ7
M_:B^$GP=\;_#;X;>)=8FU#QY\4?%VA^$= \*>'3IFH:UI[:_="SM/$/B&RN=
M4M7TKPTERT<;W1\V5VDQ;6\Y23R^3+X/,LR_LO"6E7CA\7B:D_\ ES1AA,/5
MQ,H59J[C5JPHSC1IJ,I2DKS]G33J+?%KZCEM7-,1^[PU.480C9^TKR<X0DJ,
M;*,O9<\9592E"$8VCS.I*$)?1%2!\6?%+]M[P?\ #3XK:[\&]-^#/[1GQ>\8
M>%]$T37O$"_!7X<:?X\LM&L]?B,^G+J/E^*K2\LYFB\MB9;-(CYR!)')(7#"
MU_KD<;4HT:OL<!B?JE2JX?N_;>QA648S3:^&324N63E2JVBXQYGMB*+PGU!5
M:D(SS'#SQ5"GS>_*C3Q%3"SERM)M1JT[2<>:,5.G>2E+E7H'P$_:D\ ?M WW
MB_P]H?A_XB> /'/@)M./B[X<_%CPE+X+\<:';:NLLFDWUWI)O+R(VEU%"9$,
M=T[HLL)E2/SX]_>L,Y8*&/HUJ5?#.M/#3E2GS.CB*:O*C5C9.,[7LU>$G"I%
M2<Z52,>255TL5'"5J-3#UJE'ZQ1]I#EC7H)PC*K1=WS0C.<82OROF::3BU)_
M2=<YJ% !0 4 5KV\M-.L[O4+^YAL[&PMI[R]N[F18;>UM+6)IKBYGE<A8H8H
M4=V=B JJ23@5E6K4L-1JUZ]14J-",ISG)VC&,5=MOLDC2E2J5JE.C1@ZE6K*
M,(0BKN4I-1C%+NVTD<OX!\>>&?B9X2TGQQX-OFU3POKR74^B:H8);:/5+&VO
M;FQ34;6*=5D-C</:O+!(Z(9(7CD"@.*ZJM"KA_91K4W1G5HT*ZA)6G&&(HPK
MTE4CO"?LZD'*G*TZ;;A-1G&45S4JU*O[;V,U4A0K5:#G&_(ZF'J2HUE!M+FC
M3K0J4N>-Z<W!SI2J4I0J3[&LC4\4^/7Q[\#?LZ>!X_'/CJ+Q!?V][K>F^&=
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M-9\?>)#?V]OX=T>YCNU^S3+]I>?R9?+B.P;L:5.<\?6R^I!X2>'H5JTZM?\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /R
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MH]Y3GD=:7*OY:<.9JG3C:$$VTN:4G*EX6O\ 2/#WQO\ ^"H__"92Q67F^$?
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M^UEIWP1U+7+3X1>!/V7-6^(7Q,T"Y\6:[XNTG1_C5/<3W.D327GB/4M0O?\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M>_"OP%\3IO!=QXXT'^VYOAYXRTKX@>#W_M36=,_L?Q=HBSII>K;=(U&U6_\
M)6YG'V6]%S:OO_>0OM&,\/.6$QE+,,._9XRA0Q6&A4LG:CC:2HXF')*\'[2F
MN7F<7.&].4):G157M\'B,!5]["8MTG5I[<SHRYZ?O*TX\LG?W9*^TKK0]"J
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MFA%MR4:V+I3H8F4^?F]LJM*<XRIUO:4US-Q@I:FE\/\ ]F7X#?"WX>Z_\*O
MOPR\/:+X#\507MKXHT.07VKMXDM]0@EM;F+7]6UR\O-2UA?LTTD,?VN\F,,;
M!(3&J@ QLGC\-3P>*]_#4.7V=.*5*,)1<&JL52Y.6MS4J<G77[Z4Z<)RJ.44
MT\+%8+%2QF&]S%2M>HVYR<5S6IOVG,O8KGFO8V]E:=1<EIROPO@[]AS]E/P
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MT279''0H4L+0HX:A#V='#PA3IQNWRPIQ481NVV^6*2NVWIJVRU69J% !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M511IU*="&(Q%7V\J-&E0]C0HX:CS_(WQ-_9:^,>I_LW:U%\/]+M],^.$5_\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M7_Y_]'_$/_\ J;?^6O\ ]\!_K]_U*?\ RZ_^]P_X;5_:G_Y_?@!_X:/XB_\
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M_B+_ //_ */^(?\ _4V_\M?_ +X#_7[_ *E/_EU_][A_PVK^U/\ \_OP _\
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M_AH_B+_\_P#H_P"(?_\ 4V_\M?\ [X#_ %^_ZE/_ )=?_>X?\-J_M3_\_OP
M_P##1_$7_P"?_1_Q#_\ ZFW_ ):__? ?Z_?]2G_RZ_\ O</^&U?VI_\ G]^
M'_AH_B+_ //_ */^(?\ _4V_\M?_ +X#_7[_ *E/_EU_][A_PVK^U/\ \_OP
M _\ #1_$7_Y_]'_$/_\ J;?^6O\ ]\!_K]_U*?\ RZ_^]P_X;5_:G_Y_?@!_
MX:/XB_\ S_Z/^(?_ /4V_P#+7_[X#_7[_J4_^77_ -[A_P -J_M3_P#/[\ /
M_#1_$7_Y_P#1_P 0_P#^IM_Y:_\ WP'^OW_4I_\ +K_[W#_AM7]J?_G]^ '_
M (:/XB__ #_Z/^(?_P#4V_\ +7_[X#_7[_J4_P#EU_\ >X?\-J_M3_\ /[\
M/_#1_$7_ .?_ $?\0_\ ^IM_Y:__ 'P'^OW_ %*?_+K_ .]P_P"&U?VI_P#G
M]^ '_AH_B+_\_P#H_P"(?_\ 4V_\M?\ [X#_ %^_ZE/_ )=?_>X?\-J_M3_\
M_OP _P##1_$7_P"?_1_Q#_\ ZFW_ ):__? ?Z_?]2G_RZ_\ O</^&U?VI_\
MG]^ '_AH_B+_ //_ */^(?\ _4V_\M?_ +X#_7[_ *E/_EU_][A_PVK^U/\
M\_OP _\ #1_$7_Y_]'_$/_\ J;?^6O\ ]\!_K]_U*?\ RZ_^]P_X;5_:G_Y_
M?@!_X:/XB_\ S_Z/^(?_ /4V_P#+7_[X#_7[_J4_^77_ -[A_P -J_M3_P#/
M[\ /_#1_$7_Y_P#1_P 0_P#^IM_Y:_\ WP'^OW_4I_\ +K_[W#_AM7]J?_G]
M^ '_ (:/XB__ #_Z/^(?_P#4V_\ +7_[X#_7[_J4_P#EU_\ >X?\-J_M3_\
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M_>X?\-J_M3_\_OP _P##1_$7_P"?_1_Q#_\ ZFW_ ):__? ?Z_?]2G_RZ_\
MO</^&U?VI_\ G]^ '_AH_B+_ //_ */^(?\ _4V_\M?_ +X#_7[_ *E/_EU_
M][A_PVK^U/\ \_OP _\ #1_$7_Y_]'_$/_\ J;?^6O\ ]\!_K]_U*?\ RZ_^
M]P_X;5_:G_Y_?@!_X:/XB_\ S_Z/^(?_ /4V_P#+7_[X#_7[_J4_^77_ -[A
M_P -J_M3_P#/[\ /_#1_$7_Y_P#1_P 0_P#^IM_Y:_\ WP'^OW_4I_\ +K_[
MW#_AM7]J?_G]^ '_ (:/XB__ #_Z/^(?_P#4V_\ +7_[X#_7[_J4_P#EU_\
M>X?\-J_M3_\ /[\ /_#1_$7_ .?_ $?\0_\ ^IM_Y:__ 'P'^OW_ %*?_+K_
M .]P_P"&U?VI_P#G]^ '_AH_B+_\_P#H_P"(?_\ 4V_\M?\ [X#_ %^_ZE/_
M )=?_>X?\-J_M3_\_OP _P##1_$7_P"?_1_Q#_\ ZFW_ ):__? ?Z_?]2G_R
MZ_\ O</^&U?VI_\ G]^ '_AH_B+_ //_ */^(?\ _4V_\M?_ +X#_7[_ *E/
M_EU_][A_PVK^U/\ \_OP _\ #1_$7_Y_]'_$/_\ J;?^6O\ ]\!_K]_U*?\
MRZ_^]P_X;5_:G_Y_?@!_X:/XB_\ S_Z/^(?_ /4V_P#+7_[X#_7[_J4_^77_
M -[A_P -J_M3_P#/[\ /_#1_$7_Y_P#1_P 0_P#^IM_Y:_\ WP'^OW_4I_\
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MTJUU7Q5X4TG7=0M],@O+NZGAT^.[OYDA2>YN)%C5 \LC NWYR?HAZA0 4 %
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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MZ!L9_P""Z/\ \T!_J-FW_01A/_!E;_YG#_AGW]I__HW#QW_X7/[/W_SZ*/\
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M ?ZC9M_T$83_ ,&5O_F</^&??VG_ /HW#QW_ .%S^S]_\^BC_7O*/^@;&?\
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M^%S^S]_\^BC_ %[RC_H&QG_@NC_\T!_J-FW_ $$83_P96_\ F</^&??VG_\
MHW#QW_X7/[/W_P ^BC_7O*/^@;&?^"Z/_P T!_J-FW_01A/_  96_P#F</\
MAGW]I_\ Z-P\=_\ A<_L_?\ SZ*/]>\H_P"@;&?^"Z/_ ,T!_J-FW_01A/\
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MZ!L9_P""Z/\ \T!_J-FW_01A/_!E;_YG#_AGW]I__HW#QW_X7/[/W_SZ*/\
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M ?ZC9M_T$83_ ,&5O_F</^&??VG_ /HW#QW_ .%S^S]_\^BC_7O*/^@;&?\
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M^%S^S]_\^BC_ %[RC_H&QG_@NC_\T!_J-FW_ $$83_P96_\ F</^&??VG_\
MHW#QW_X7/[/W_P ^BC_7O*/^@;&?^"Z/_P T!_J-FW_01A/_  96_P#F</\
MAGW]I_\ Z-P\=_\ A<_L_?\ SZ*/]>\H_P"@;&?^"Z/_ ,T!_J-FW_01A/\
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MZ!L9_P""Z/\ \T!_J-FW_01A/_!E;_YG#_AGW]I__HW#QW_X7/[/W_SZ*/\
M7O*/^@;&?^"Z/_S0'^HV;?\ 01A/_!E;_P"9P_X9]_:?_P"C</'?_A<_L_?_
M #Z*/]>\H_Z!L9_X+H__ #0'^HV;?]!&$_\ !E;_ .9P_P"&??VG_P#HW#QW
M_P"%S^S]_P#/HH_U[RC_ *!L9_X+H_\ S0'^HV;?]!&$_P#!E;_YG#_AGW]I
M_P#Z-P\=_P#A<_L_?_/HH_U[RC_H&QG_ (+H_P#S0'^HV;?]!&$_\&5O_F<_
M5?\ 9._Y-8_9I_[(!\&__5=>'*_)S]5/H"@ H * /G_XR?\ )1?V3O\ LX#Q
M'_ZRQ^TM0!] 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MFU6@I4Y?1M>>=P4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 ?/\ ^R=_R:Q^S3_V0#X-_P#JNO#E 'T!0 4 % 'S_P#&3_DHO[)W_9P'
MB/\ ]98_:6H ^@* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M4NI='5D!B9HY 64D HZ,K#/!4@\@TFU&/,VHQY5*[T7*US*5]N5Q:DGLT[[
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M[_D@_P %O^R4_#W_ -1/2:^LXI_Y*7B#_L8XW_U(J'Q_"7_),Y#_ -@.'_\
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M-*$:U>CA76]^-)TK4XM.M6C2=.3HTYJ#B[->#V&OZKX$^*W[0FA77QRUV_\
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M\YC4E"/[VDHSQ6!P\)2J16(R_#8F$Z?M:D#W?P9X@O\ PUX>T+0/&LGC2_\
M'?BVSU#Q3J%Q;^%?'GB+PYHE_P"(;B^U,Z!_PF-AH=SH?A[3](##3[>"\U"Q
MV0V4,OE(+E"_/FT8X?!X_!86LYSRG U*3Q3O1>(JT,/.=7%1J5)+FG7K*I5I
MTX5*DJ2E3PU-OV=.(\%5^L3H9C4I\F'S+%P=*@E&<J-"4Z-+#4JE"GSRARX=
MT?K%5Q5*K7^LXB4W^^E'Y1\!_%#XA+\ (OAY>^*]6OOBSXFT31+SPCXMOKV^
MNM=;P=X[T'4?%%YXK?4)3/<27?ANSTGQG9)<22+^_P!"TY3)&UU$:US^+CAJ
MT:#=">44L3_:$Z:]FU2RO#4L53JKEE%Q_M.E7R_ NJI*?UW$XBHN9TI'5A(Q
MH9MBG-*IA\7C:L,OIS2</K%7,:N7/"I5+PJK UJ<LSJT(J:AEDH0]E[./*;'
MP^^)?BKPUX]\*^)?%GB_6+SX=WGP:^"VB^)X=:U2]O;#1_$WBSPWKVL:=XTE
M:\NG6&ZOM3T)]*NYPAEN9M<LFE=O*&/0Q[H8/&\7PJP4:7]KYHL&HQUHO*<N
MR[&3P=&,4U&G7PF*QF(C3CRQ]K@HQBG.LD_"P3KXC!\.RI2<JU/+L+/$*4_X
M\,?FF-P/MIN6DJM#$0P,54G)<F&J8AM\L-.^^#?Q,UZRU/XK^(OB+<>.M2@U
M[Q-X3U?PUX=T;PEX\\<R^#]"\2^%%UC1=$70/"FAZI<:&L6CK9->S-:6L+7\
MD_F,9I5\SCP]*=' T,!B+2S'#YACZ&(JMIP]O&AE=:M1^L.U*-'"XC%U:&&Y
MYQBZ--U(JWM''T*LX5\PGB<+)?V?5R_!SP\4[*=...SC!PQ<:<E";ECJ>"AB
MZC]FY4U5IT9RE[.FY6-7TJXU"U_:#\>1^//'OAO7O WB359_#%\GCSQ?!X7T
M6UT;X;>$M=MK.^\ 7VLGPS=:8]]=WCW,-UI'F/\ :Y2)(Y@DD?)6JU,NR? X
MZA36)Q7/F$YTI_OXXQT<^S'#4\+&[FXJM1HTL+2>%E3G'W'1DI/WNG"PAF&<
M5,OJ\]/"U8993BZ:="K06(R_"U:E9>[%JI"=2=:2Q$)QO=5H2C>)!I.GZAX[
MC^+OC/5_&/C_ ,%^(-!B\+WVC2Z9X^\7:9X>\'RR_!_P7XFNHYO!$NM-X9OK
M2+6-0OYKB+4])NO,\V7S&W!63?-K9-@L?B\'-5ZF!QF;\CK_ +^G7A@\54IT
M:,XRNE3J0A&G^X]E-<W-2G"I:2G+?^%-\,TL52Y(YCE.6U:L:-Z%15L5CLPA
M4J1G3Y9NI&-.FH^T=2%J<83A.GS0EVOP(\9^)/$.K>(;+Q%+>O-JO@?X3?%&
M.SO9KF7^P+SX@:#J5MKGA^Q2[EDDM-+AU?PM<7D%KN*P'598TP@54]+%X2GA
M5F5"D^:&5YUF. I2;;J2P\:6"Q])59O6I4HSQ]:@INUJ%*A32M3/-P]:I4_L
MNM.49?VAEE*M*4+QA.MAL37PD\13A\-.GBL/#"55&G:,JBK5I+GJRE+Z4KS3
MN/G_ /9._P"36/V:?^R ?!O_ -5UX<H ^@* "@ H ^?_ (R?\E%_9._[. \1
M_P#K+'[2U 'T!0 4 % 'S^_[,WPN%YJ]Y97GQ@T+^W/$'B/Q3J&G^%OVCOVB
M?".A?V[XMUW4?$_B2^L?#?ACXIV&E:1]O\0:MJ=_+#86=M#YU[*RQKN(HV\@
MV\@3]F;X7?;-(O+R\^,&N?V%X@\.>*=/T_Q3^T=^T3XMT+^W?".NZ=XG\-WU
M]X;\3_%._P!*U?[!X@TC3+^*&_L[F'SK&)FC;8!1M\@V^1[M?6-EJ=E>:9J5
MG:ZAIVH6MQ8W^GWUO%=V5]97<3V]U9WEI<(\5S:S0221R12*R.CLK @D%2C&
M47"45*,DTXM733T::>C36C3+IU*E&I"K2G*E5I2C.$X-QE"46G&491:<91:3
MBTTTTFG<S]3\-^'=:TA?#^L:!HNK:"AT\IHFIZ58W^D(=)N+>\TLKIMU ]NI
ML[NTM)[<B/\ <R6L3Q[6C4BY2E.M#$SDY8BG55>%63;J1K)MJM&;]Z-5-MJH
MFIIMN^IE"$:5&6'I15/#SHSP\J44HTY8>I3=*I0E!6BZ,Z3=*=)KDE3;@XN+
M:*EGX,\'Z?\ V-]@\*>&K'_A'+K5+[P]]CT+2[;^P;W7/M7]M7FC>3:K_9=U
MJ'VZ^^U2VWE/<?;)_-+^:^Y1;AR\KY>7#0P4;:6P=/V'L\(K;8:'U7#<E!?N
MH_5Z'+!>QI\J=*G+FYJ<9<V)EC'>*=\7/VW/BG=:XF7UC$<U=_O9>WK7D_:S
MYN?UWX/_  E\3Z+I_AKQ-\+OAUXA\.:1J%UJVE:!KO@GPUJVBZ9JM[/<75[J
M>GZ5J&F2VMEJ$]U=W<TMQ#$DDDES*[L6D8E0_=U<+6I^Y6P-.E1P]2.D\/2H
M0A3H4J,E:5*G1ITZ<*4*;C&G"G",$E&*6D6X0Q5*+<:>.G.KB8+2.(J5*DJM
M2I7BM*LZE64JDYU%*4JDI3DW)MF[<^!_!=[!KMK>>$/"]W:^*-*M="\36USX
M?TF>#Q%H=C;7%G9:-KL,MHR:OI5O:7=U!%:70EACCN941 LC TISBTU)Q:Q*
MQJ:;3^N+V%L7_P!A*^K8:U?^*OJ]#W_W5/EFE&-"=.I1BJ-2C06&IR@N24,-
M%U91P\)1LXT(RKUI*DFJ:=:JU&]2=\?6OA/\+/$FM6OB7Q%\-/A_KWB.PL[7
M3[+7]:\&^'=4UJSL+"[BO[&QM=5OM-ENK>SM[Z"&YBACE5(YH4D10Z!@J;=&
MM4Q-)NEB*LX59U8>[4G4IN].I*<;2E.F]83;<HO6+0-*6'IX62YL+0A5ITZ+
MUI4Z=>DZ%:$*;]R,*U&4J-6,4HU*3=.:<&T6G^&GPXD\91_$63X?^"7^(4%M
M]BA\=OX4T)O&4-F$>+[)'XG:P.I1VWER2)Y2W(3:[#&"<JC_ +-[98?]PL3?
MVRI^Y[6[BW[3EMSW<(-\U[N$;_"K%6*K^Q]NE6^K-.ESKG]DTI).GS7Y&E.:
M3C:RE)+XG>#3OA5\+]'\2W7C32/AOX"TOQC>WL^I7GBS3O!_AZQ\2W>HW-I+
M87-_=:[;:<E[/>RV,\]L\[SM(\4SQLQ1RI=%O#4G0P[]A1<:D'3I^Y#EJU*5
M:K%PC:/+4JT*%6I&UIU*-*<DY4X-36IT\15C7Q$(UZ\73E&I42G-2I0J4Z4E
M.2<DZ5.M6ITVG>$*M2,;1G)/JET71DU>7Q NDZ8NOSZ;!HT^MK86JZO-I%M<
MSWEMI4NI"+[1)IL5Y=7,Z6S2&))+B615#2,3*2C&M"*485W"56*T525.,H4Y
M5$M)N$)SA!RNXQG**LI-/23<E24FY+#^U]DF[^R]M[+VWL[_  >U]A0]KRVY
M_8TN:_LX6\6\;?LZ?#?7?A]\7?!O@OPIX(^&6K_&+PMKWAWQ)XN\+^!=!M-2
MO+C6[.]M_P"UM<CTE-,F\230SWT]QLNKU&=Y)/WJ&0M5TI>Q_LZE'3!Y?C\#
MCEAEI1D\%B\/B7!4U[D'6CAU1=3DDXQDGRS4>1]-#$NECO[0K1^LXI4JM'VD
MY7J\E2E*DH^UDI3Y8WC+EO9\D5I9-=MX=^$?PQ\+>&]6\)Z+\// >EZ!XC24
M^+-(TOP=X?TS2/%=S=6ZV^H7GB+2K2P6WUB>[0,)FO$N&D#%79AU>+E'%P]A
M5IJ6#A*3I8:5IT:,74=10ITVN2,8RU2C&*YES63.# TYX'V-2G5DL92ITX2Q
M,;PK5)4XJ//*HFYW>KUG)J[U>YH:+\-/AQX:TG1= \._#_P3H&A>&M5.N^'-
M%T7PIH6E:3H&ME+J(ZQHNG6-A%;Z5JICO;U/M=K'%-MNYAOQ*^YRJU9U*5:=
M6<JU"G*C3G*3<Z=&4'2E2A)OFA3E2;IRIQ:BX-P:Y="XPA3A7I0A&%/$N$JT
M(I*-65.K3KTY58JRFZ=:C2K0<DW&K2IU(VG"+6O8^%/"VF:]K/BG3?#6@:?X
MG\1PV%OXA\1V.C:=::]KUOI22QZ7!K.KV]LEWJD-FD\RVZ7,LJPB9Q&%#',0
M;I4I8>FW3H2JRKRIQ]VFZ\XQC.LX*T75E&,8RJ-<[C&*;:2*FW4G3J5/?G0I
MNE3E+65.DY<SIP;NXTW)*3A&T>97M<WZ0!0!R[^!_!<ES>WDGA#PN]YJ.OZ;
MXJU&Z?P_I+7-_P"*-%M[2TT?Q)>SM:%[K7[&UL+&&VU"5FN(([*!(I$6% KA
M*5+V"IMTUA7B)45%\OL98N-6GBI4K6]F\3"M6AB'"SK1JU8U.95))JK&-=5%
M6BJRJPHTYJ:YU.GAJL:V&IR4K\T,/6C&K1B[QI58QJ4U&23(/%OP^\ ^/X]+
MB\=^"/"'C6+0[]-5T6+Q;X:T;Q''H^J1C;'J6EIK%E<#3[]5X6X@$<@'1JF"
M5.M#$TUR8BDG&%6.E2$6TVHS5I13:3:32;2[(J3<J-7#R;EAZ]O:4F[TZEDT
MN>#]V5E*27,G92:ZL;IGP[^'^BKY>C^!?!VDI_9^KZ3LTSPQHE@O]E>(-1;6
M-?TS;:V*#^S]2U=WO;RW_P!7<W+M/,KRDM142K4:N&JI5</7I8?#U*4_>IU*
M&$IU:6%HSA*\94L-2K5J>'IR3A1IU:L*<8QJ23F*4*]/%07+B:-2K6IU5I5A
M6KNDZ]6%1>]&I6>'H.K--2J.C2YV_9PY;L'@WPA:FT:V\*^&[=K#P\?"-@T&
MAZ9$;+PHQMRWABT,=J/LWAXFTM2=.CVVW^C1?NOW:XNM*6(>,EB).O+,)0EB
MG4;F\3*DZSIRQ#E?VTJ;Q&(<'4YG!UZSC;VL^:*-&EAEA(X>E"@LO4UA53BH
M+#*I[)5%AU%+V*FJ%!35/EYO8TN:_LX6Y_P]\(?A-X2TT:/X4^%_P[\,Z0NN
MV?BA=*\/>"O#6BZ:OB73VC>P\1"QTW3(81KML\430WX3[1$8U*2*5&*56JOJ
MUJDE]256.']Y_N(UZ=2C7C1U_=*M2K5:550Y54IU:D)WC.2;J4Z=:6)E5A&K
M+&.F\0YQ4G7=*K&O2=9R3=5TJ\(5J;GS<E6$:D;3BFM#6/AO\._$6G^(=(\0
M> O!>NZ3XNU"WU;Q7I>L>%M#U/3_ !/JEI;6-E::EXALKVQDAUK4(;/3--@C
MN+Q)I$BT^VC5@D$83*48RAAJ4HJ5/!SE5H0:O&A4G4G6G4HQ>E*<ZM2I5E."
MC*52<YMN4I-[QJU85)58U)QJ3I*A*:DU*5"*E&-&4D[NE&,I15-OD2E))6;,
MC4/@O\'=6\.)X.U7X3_#34_",6I2ZS'X5U#P)X7O?#D>KSN9)]530[G2GLDU
M*20EGN1 )6))+$FG)\]3#U9^]5PG-[";UG1YI2G+V4GK3YISG.7(XWE*4GK)
MMQ!NE&K"D_9PKJG&I&/NJI&C3ITJ,9I64E2I4:5.FI74*=*G"-HPBEH^(/A?
M\-/%D&A6OBKX=^!?$UKX6(/AFV\0>$M UF#PX5@6U4Z%#J.GS)I!%LJPC[((
ML(H3[HQ2J)5:U7$55[3$5J=2E4JR]ZI.E6356G.;O*5.JFU4A)N,TVI)W)C%
M4Z,,-!*&'I3IU(4HJU.%2DU*E4C!6C&=.23IR24H-)Q:8FA_#?PGX;\5W_B_
M1-,M],U"]\'^%O D=G86FG6&E:=X9\'W>N7>BZ=IUI8V4+0PQ2:]=H(Y))8X
MHX8([>.!5<2[>WK..,52K.K/'XMXVO4J2E.=2O["GAU*3;LVHTW)S:=:<JDE
M4J3A"A"E*I4X0P-*G3A1H991JT,/2IPC"%*G7G3J5(Q44FHMT:2C335*GR.5
M.G&=6M.IPW@CX ^!_"7C7QK\1+_1/"GB/QKXG\<ZUXNTCQ9>>#M(B\4^$[#6
M=)T/3)?#>G>(YC=7YLPVCO,TD,UFDAO"IMQL+29X6V"P&$P=!>RJ4*>-IUJT
M/W<L5#%YMC\TC&JHZN-'ZZJ"C.=12]BJJY.=4X9U:'ML=C,96E[6%>>"J4:,
MUS1PU3"97@\M<Z3DVE.LL(ZKE",)157V3<^7GEZ+=_#[P%?^'-2\'7_@CPA>
M^$=9N=1O=8\*W?AK1KGPYJMYJ^H3:OJUWJ6AS6365]<WNJW-Q>W,L\#M/<3R
M32EI'9C%2$:T,/3JQ56GA(TH4(S2E&C##Q4:$*4975.-&,5&E&"BJ<4E!121
MU*I4C4K58U)1JXCF]K-2:G5YHJ$O:23O/FA&,)<S=XQ47HDB>S\$>"].\,V_
M@K3_  AX7L/!UG#!;6GA*ST#2;7PS:V]M,EQ;06^@P6BV,$,5Q%%*B) JH\:
MLH#*"-:E6I6JTJ]6I*K6H3I5:=2<G*=.I0E&=&I"<FY1G1G&,J4XM2IRC&4&
MFDS&-.G"%:E"G&-.O&K"K!12C4A7A*G7A4BE:<:T)SA5C)-5(2E&::DTY-0\
M&^#]6EUR;5?"GAO4YO$VCVWAWQ)+J&A:7>R^(/#]D]^]GH6N27-J[:MH\#ZI
MJ;165T98(SJ-T50&XDWY3A"I0GA:D5/#5*OMYT9).E*MR4Z?MI4W>$JOLZ-*
M'M&G/DI4XWM"*6\*M6G4H5J=6<*V%4HT9QDU.C&<E.<:4DU*FI22E)0:4I)-
MW:.=LO@]\(]-\.:MX.T[X6?#FP\(Z[#;V^N>%K+P1X9M?#FLV]I;1V5I!JVA
MP:8MEJ,,-G%%!&EQ#(J11)&H"J *J_OXPA7_ 'T*=3VT(S]]1JV@O:Q4KJ-2
MU.FN=6E:$%?W8VSI_N9.5+]U)TW2;C[K]DZE6JZ3:L_9NK7KU'#X74K59VYJ
MDV^I\-^%O#/@W1;/PUX0\.:%X5\.:;&\6G:!X;TC3]#T6PB=VD>.STK2[>"U
MM8VD=V*Q1*"6)(R355I2Q"Y:\G7BH*E:HW->SC'DC3M*_N1BN50^%1T2MH13
MITZ/-[*G&ES3E-\D5&\YOFE-\J5YRDW*4GJWJVV8I^&?PW-M961^'W@@V>F:
M=#I&G6A\*:";;3])MM6M-?M]+LH/L&RTTZ+7=/L-12VB58DN[*WN5430HZD9
M2A-5(2<:D7A9*2;4E+ QJ0P4DUJG@X5JL,*UKAXU:D:/(IR3N:]I*<ZGOSJ?
M75.4M92696_M'F;NY?7[+Z[>_P!:LO;^TL:5IX+\':?J$.JV'A/PU8ZI;7>N
MZA;ZE::%I=MJ%O?^*)8+CQ->PWD-JLT5WJ\]M;27\RN'NWMXVN&D**1$$J45
M3IKV<(T?JZC'W8JA[9XCV%E9*C[=NM[/X/;-U.7G?,5.4JG-[23FY5*59\S;
MO5H89X.A5=[WJ4<(WA:4W[U/#-T(-4FXGSU\7/V:1\0I-,L/#^H_#'PUX3LM
M.U&RC\.>(O@1X0\<2>%M2UB]O[O5_&GPNUE=3T2X\#^.;M=3NQ)?7B^(++SE
MAN1IHF^T->8/#4ZOM*6)YGAIX:&#@Z$OJ^,H8.%!898'#XE<\*>!E1C&G*@\
M-*<::]G0K48*,8[PKTZ,*3I8:G*O2QE3'355.KAL3B9U(UU7Q>&;BZN(IXB+
MK1K4ZU&4Y5:SQ'MY2ISI?0&A>#- T'P5HWP^CLH]1\,:+X9T[PE%8:Q'#J,=
M[HNF:9#I,=MJ<5Q$8KT2V<"K*KQ[)-S97!Q7?F==YKBL=BL;2IU'CZU6M5IN
M"=-RJS=22Y)<RY5)Z)WM9:MZGFY7A8Y1@\#@\)4G". I4Z5.?,U4M3BH*7-&
MUI.UWRV5V[)+0Y:W^!GP3L_#VI>$;7X._"RU\)ZQ'80ZOX8M_A]X2@\/:K#I
M4T]QI<6I:+'I"V=]'9W%S<RVZS0N(7N)&C"L[$X5?W\:=.M^^A1JJM3C/WXP
MK*E2H*K!2NHU50H4:*J*TE2HTJ=^2G!+>C".&J3JX>*H5:E.5&<Z:4)RHSG5
MJSI2E&SE3E4K5JDH-N,IU:LVG*I)N[#\'OA);6L-C;_"WX<P6-MK.C>(K>SA
M\$>&8K6W\0>'+6WL?#VNPVZ:8(XM9TNRL[2WLKU5$]K%:PQP.B1J%U]O75:E
MB/;35>A.O4IU.>7M*<\4FL5.$[\T)XE-JO*+3K)M5'*X*$(T98=0C'#SHPPT
MJ225.6'I2G.E0E#X71ISJ3G"DUR0E.<HQ3DV]#1_AI\./#OB?6/&N@?#_P $
MZ%XR\0KLU_Q;H_A30M,\3ZXA,9*:QKUE81WVI+F*(XN9Y!F-?[HQE2_V>C+#
M4/W&'E)2E2I^Y3<DY24G"-HN2E.;3:NG.3WD[NI%5JT,152JUZ:<85)KFJ1B
MU&+C&<KRBFH032:34(IZ15I/%GPY^'OCV31YO'/@3P;XSF\/7JZEH$OBSPQH
MGB*30]10HRW^COK%C<-IEZK1QD3VQC<%%^;@8*?[G$1Q5+]UBJ<7"-:'NU8P
M;NXQJ1M.,6U=Q32;Z%2;G1EAYMRH3=Y4I:TY.SC>4'[K?*W&[6S:V;-ZUT31
M;'4=0UBRTC2[/5M6AL+;5=4M;"TM]1U.WTI)X]+@U"]BB6:\ALX[JY6W29W6
M$7$HC"B1LM-QA*G%N-.=6=>45I&5><*5*=:45HZLZ5"A3G4:YY0HTH-N-."4
M>SASQJ<D?:4Z4:$967-&A"=2I"C&6\:4:E:K4C334(SJU))*4Y-TF\)>%'LM
M>TQ_#'AYM.\4W-U>>)]/;1=-:R\1WE];P6E[=Z]:&V\K5[FXM+:VAEENUE:2
M.WC1R5C4#.=*G4P\,+4IQGA:7.H4913I0]I6J8BIRTVG"//B*M6O.R7-6J5*
MLKSG*3NG*5&O/%4FZ6)FX.5:#Y:LG2I0H4G*HK3;IT:=.C!M^Y2IPIQM",4O
M&_%W[-7PR\0:!X!\&:'X1\">$? ?@WXAP>.M0\":5X!\/KX1\31#0_$6BW^B
MWGAZT2STZ&.]_M[SIKB2UNP_V78\#^;OCMWJ8W!XK%/ZW3P6&QF'IT:OOQ2Q
M6'G0@X.?,H+#SG[:,5'62LG!OF6E*J\/A<QHX:^&KX]X%NO2?)4@\%F6 S"[
M<.64W4A@OJU^>/)&KS^\H>SGZ%J'PB^$^K>$;#X?ZK\,/AYJ?@/2F@;2_!&H
M>"O#=[X1TUK4DVK6'ANYTQ].LVA+,8S%;)LW';C-55E*M7I8JM)U<30=Z56;
M<JM-VY;TZDKS@^7W;Q:TTV,J:]A"K2H_N:==WJ0A[D:CYN:\XQLI/F2E>2?O
M*^YT]KX9\-V-Y9:C8^']#L]0TW1SX=TZ_M=)L+>\L/#[307#:%974-NLEKHY
MN+6VE-E$RP;[:)MFZ-2"4YS>)<Y.3QCIO$-MMUW1]LJ+K-_Q726(KJFY\W)[
M>MRV]I/FS5&E%8=1I0BL(JBH)125%5O9>V5))?NU5]C1]IR6Y_94N:_LXVJZ
M/X*\&^'='OO#OA_PEX9T+P_JEQJ=YJ>AZ/H.E:9H^HW>MO)+K-U?:996D=M=
MW%_)+*]U)+&[7#2,92Y8YSJ0A5P]/"58JIA:%)4*=&:4J5.BFVJ,*;O"-).4
MFJ<4H)R=EJS:$I4\14Q=.3ABJU7V]2M%M59UTHI5IU%:<JJ4(+VC;G:$5>T5
M;*L/A;\,M)T74?#6E_#KP)IGAW6-&MO#FKZ!8>$?#]EHNJ>'K**ZM[/0=1TJ
MWT]+:]T:""_OHXK*:)X(TO)U5 )7#;.M5;C)U9N4*]/%1;D[QQ-*.'ITL0G?
M2O3AA,)"G67[R$<+AXQDE0IJ.=&G##U%5H0C0JQA*DITTH35.=6O6G3YHV:A
M.MB<35E"_+*KB*]1ISJU'*CJ?P:^$&MZW=>)=9^%/PVU?Q'>V%MI=[K^I^!O
M#%_K=WIEE+;SV>G76JW>ER74]A!/:6DD5O)*T<;VL3*H,:D32E*A*4Z,G1G/
M$4\7*4&X2EBJ4N>EB9.-F\13DE*G6?[R$E>,D]0G"%2E&A4@IT*=&6'C3DDX
M1P\Z<Z4Z$8.\8T9TJE2G*DDH2ISG!Q<9-/J=,\)>%=$U;7]>T;PSX?TC7?%4
MMG-XHUK3-%TVPU;Q)-IUNUII\NOZC:VT=QK$MK:LT,+7<DQBC8HA53BH22P[
MPB5L(ZE6JZ/_ "Z]K7457J.G\'M*RA%59\O-448\[=E:I>]5A6E[U:E2A0A4
M>LX4:<I2IT8R?O1I0E.<H4TU",I2:2<G?E-3^"WP=UE?#"ZQ\)OAIJJ^"<?\
M(8NI^!/"U\OA';<1W8_X1@76E.-!Q=0Q3?Z#Y'[R)'^\H(NG.="O'%49.CB8
MTX48UH-PJJC3A[*G252-IJG3I_NX03Y8P]R*4="JDYU:=:C5G*I1Q%:IB*L)
M-RA5KUI3G6KU(N\9UJLYSE4J23G.4YRE)N3;Z?Q-X-\(>-=/BTCQEX5\-^+=
M*@G^U0Z9XFT/3->T^&Y^RW-C]IBLM5M9X8Y_L5[>6_F*@;RKN:/.R5@V,Z5*
MHU*I3C.45.*<HIM1J1Y:B3:=E./NS6THZ2NBJ56KATXT*DJ"?L[J$G!?NJM.
MM2NHM?PJU*E5I_R5:=.I&TX1:Q;KX4?"V]\&P?#F]^&W@&[^'MH(5M? =UX.
M\.W'@VV6VF^T6ZP>%Y=.;381%/\ O$"6PVO\RX;FM*[>)G3JXG]_4HVY)U/?
ME#ECR1Y)2NX\L?=5FK1T6FA%!O"JHL,WAU6YU45+]VIJIK44U"W-SO6?-?F^
MU<F?X8_#66PT[2I?A[X'DTO1]"N?"VDZ:_A/07L-+\,7DVGW-YX<TZS;3S#9
M:%/<:3I4LEA"B6[OIEHS1EK>,IM+$5Y5IXB5:I+$5*N&K3JN<G4E6P525;!U
M93;YI5<)5E*KAJC;E0J2E.DX2;9DJ5)8?ZHJ<5A?WR]CRKV5L33G1Q"]G;D_
M?T:E2E6T_>TYSISYHRDGB?$CX9P>,]!\26V@R^&?#/BGQ+I^D:1J?B35O 'A
MKQQ:ZYH6B7US>VWA3QCHFM11'Q+X0E%_JL$FGB_L9HH]7O6L;NRN)C..6I!S
MC"DU3JX7ZP\16PU:#J8?$5'15!SJ0A.E+VT80HN%:$XS4L-0A4]K0C*A/II5
M72<7&=6E4H4I4L-6HU%3K83FG&HWAY2A4A!2E!*<'3E"2;=HU%"I#F?@5\#K
M'X+67BQDN_#MQJWC36M/U?5;;P5X*L_ASX#T>+1]"T_PYI&C>#? ]IJFJ'0=
M(M].TV-V2XU74II;BYN)6G".D4/9.LOJF'PD54E"C4KUIU*U5UJM6OB7#VLG
M+EA&-*,*5*C0HP@E2HTH*4JM1SJSY5"3KO$35*+C0IX6G"C2]E"-"C7Q6)BY
M)SJ2J5YUL;B*M>LY)5)S]RG2A&,%U]E\&?@]INL7/B'3OA1\-;#7[S6'\0WF
MN67@7PO:ZQ=:_);WMG)KESJ4&EK<3ZPUIJ6HP->/(TQCO[E"^V>0-RPA&EA_
MJM**IX7DK4O8Q2C2]GB8QAB*?LU:')7C"$:T+<M6,8J:DHI+><YSK2Q$YRE7
ME[!2J2;=1K"SC5PR<W[S^KU8QJ4+O]S.,9T^623.BL?!'@O2_P"Q?[,\(>%]
M._X1O0;GPMX=^PZ!I5I_8/AB\^P?:_#FB_9[1/[+T&?^R],\S3[;RK=_[.M=
MT9^SQ[-:U2IB?KGUBI*O_:"A'%>TDY_68T_:>S6(YF_;*'MJW(JG,H^UJ<MN
M>5U%NG[+D;A["M+$4^73V=>=^>O"UN6M/F?-4C:<KN\G=G/W_P &_A#JA\)-
MJ?PJ^&^HMX!AMK?P*U_X&\,79\%6]DT#6<'A(W&EO_PCD,#6UL8DT_[.L9MX
MR@'EKBE7K+%U,>JTUCZJ:GB>:7UB::<6I5K^TDG&4HM.3TDULV3-*>'G@YKF
MPE2<JLZ$M:,JDFW*I*F_<E.3E)RFXN3<FV[MG13^"O!MU%K4%UX2\,W$/B35
M;#7?$4,^@Z5+%KVMZ6FFQZ9K.M1R6A75-5M(]%T=8+NY$LT(TFS$;J+6+9"E
M**PL8R<5@:DJV'2;2P]656=>56BE_"J2K3G6E.GRR=6<ZC?/)MU*4I.JY-R=
M>@\+4;=W4PSISHRP\V_BH.E4J4G1E>FZ=2<''EE)/(O/A5\+[_Q3_P )Q?\
MPW\!7OC4/IT@\87G@_P]<^*1)I$R7.DO_P )!-IS7^^RN(XY;=O/S Z*T6UE
M!"H-X5S>&?U=U)SJ3=+]VY3J4:F'G.7);FG/#UJM"<G=RHU:E)MPG*+SKTZ>
M*4%B81Q"I1C""JI5%"$*M.O&$5-/EC&O2I5HQ5DJM.G424X1:FTCX9_#CP]X
MFUCQKH'P_P#!&A^,O$*E-?\ %ND>%-!TSQ-KB$H2FL:]96$=]J:YBB.+F>0?
MNU_NC"II4*$\+17L<-4:<Z,/<I2:<FG*G&T)-.<VFTW><G]IWJHE6K0Q%5*K
MB*:<859^]4C%J*<8SE>44U"":32:A%;15J_AOX3_  L\&ZQ=>(?"'PT\ >%=
M?OI-4EO=<\-^#?#NAZQ>2ZW-97&M276IZ9IT%S<27]QING2W322,;A["V:7>
MT$96Z=2I1PZPE*I*EA8QIP5&,G&DH4I5)4H>S34%&G*K5E3C:T)5:CBDYRO5
M5NO4]K6;K5>?GYY^_/GY7!SYI7?/R2E'FO?EDXWLVCS[X-_\E%_:Q_[. \.?
M^LL?LTU CZ H * "@ H ^?\ PY_R=/\ &3_L@'[-/_JQ?VL: /H"@ H ^?\
M]D[_ )-8_9I_[(!\&_\ U77AR@#Z H ^?_C)_P E%_9._P"S@/$?_K+'[2U
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M .R=_P FL?LT_P#9 /@W_P"JZ\.4 ?0% !0 4 ?/_P 9/^2B_LG?]G >(_\
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M ,,T_#K_ *&/]H#_ ,2Q_:G_ /GR4 '_  S3\.O^AC_: _\ $L?VI_\ Y\E
M%#2?V4_A+H&E:9H6A:A\<-%T31=/LM)T;1M)_:D_:>T[2M)TK3K:.ST_3-,T
M^S^,$=O8:?:VD,,$-O!&D<4<2(BJJ@ V\K!MY6+_ /PS3\.O^AC_ &@/_$L?
MVI__ )\E &AH?[/'PVT#Q-X:\70W'Q0UK6_!^H7VK>&F\:_'CXZ?$+2M(U74
M?#VM^%+O4[?P[X\^(^L:0VH-X=\1Z[8I<2V+R11ZI/Y3(S;@;!L>X4 % !0
M4 % !0 4 % !0 4 % !0!\__ +)W_)K'[-/_ &0#X-_^JZ\.4 ?0% !0 4 >
M/_&O_A07_"*Z?_PT7_PI_P#X0G_A(+7^R_\ A=?_  A?_"*_\)5_9VJ_8?[/
M_P"$Z_T#_A(/[(_MSRO)_P!)^S?;MG[KSJ /F#_C5E_U8!_YKK0 ?\:LO^K
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MUUH /^-67_5@'_FNM !_QJR_ZL _\UUH /\ C5E_U8!_YKK0 ?\ &K+_ *L
M_P#-=: #_C5E_P!6 ?\ FNM !_QJR_ZL _\ -=: #_C5E_U8!_YKK0 ?\:LO
M^K /_-=: #_C5E_U8!_YKK0 ?\:LO^K /_-=: #_ (U9?]6 ?^:ZT '_ !JR
M_P"K /\ S76@ _XU9?\ 5@'_ )KK0 ?\:LO^K /_ #76@ _XU9?]6 ?^:ZT
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M@ _XU9?]6 ?^:ZT '_&K+_JP#_S76@ _XU9?]6 ?^:ZT '_&K+_JP#_S76@
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M_P"AKC/_  IK?_)A_8^4_P#0KPG_ (34?_D _P"&"OV8/^A1\=_^'[_:!_\
MGHT?VQF__0UQG_A36_\ DP_L?*?^A7A/_":C_P#(!_PP5^S!_P!"CX[_ /#]
M_M __/1H_MC-_P#H:XS_ ,*:W_R8?V/E/_0KPG_A-1_^0#_A@K]F#_H4?'?_
M (?O]H'_ .>C1_;&;_\ 0UQG_A36_P#DP_L?*?\ H5X3_P )J/\ \@'_  P5
M^S!_T*/CO_P_?[0/_P ]&C^V,W_Z&N,_\*:W_P F']CY3_T*\)_X34?_ ) /
M^&"OV8/^A1\=_P#A^_V@?_GHT?VQF_\ T-<9_P"%-;_Y,/['RG_H5X3_ ,)J
M/_R ?\,%?LP?]"CX[_\ #]_M _\ ST:/[8S?_H:XS_PIK?\ R8?V/E/_ $*\
M)_X34?\ Y /^&"OV8/\ H4?'?_A^_P!H'_YZ-']L9O\ ]#7&?^%-;_Y,/['R
MG_H5X3_PFH__ " ?\,%?LP?]"CX[_P##]_M _P#ST:/[8S?_ *&N,_\ "FM_
M\F']CY3_ -"O"?\ A-1_^0#_ (8*_9@_Z%'QW_X?O]H'_P">C1_;&;_]#7&?
M^%-;_P"3#^Q\I_Z%>$_\)J/_ ,@'_#!7[,'_ $*/CO\ \/W^T#_\]&C^V,W_
M .AKC/\ PIK?_)A_8^4_]"O"?^$U'_Y /^&"OV8/^A1\=_\ A^_V@?\ YZ-'
M]L9O_P!#7&?^%-;_ .3#^Q\I_P"A7A/_  FH_P#R ?\ #!7[,'_0H^.__#]_
MM __ #T:/[8S?_H:XS_PIK?_ "8?V/E/_0KPG_A-1_\ D _X8*_9@_Z%'QW_
M .'[_:!_^>C1_;&;_P#0UQG_ (4UO_DP_L?*?^A7A/\ PFH__(!_PP5^S!_T
M*/CO_P /W^T#_P#/1H_MC-_^AKC/_"FM_P#)A_8^4_\ 0KPG_A-1_P#D _X8
M*_9@_P"A1\=_^'[_ &@?_GHT?VQF_P#T-<9_X4UO_DP_L?*?^A7A/_":C_\
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M-1_^0#_A@K]F#_H4?'?_ (?O]H'_ .>C1_;&;_\ 0UQG_A36_P#DP_L?*?\
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M_P#0KPG_ (34?_D _P"&"OV8/^A1\=_^'[_:!_\ GHT?VQF__0UQG_A36_\
MDP_L?*?^A7A/_":C_P#(!_PP5^S!_P!"CX[_ /#]_M __/1H_MC-_P#H:XS_
M ,*:W_R8?V/E/_0KPG_A-1_^0#_A@K]F#_H4?'?_ (?O]H'_ .>C1_;&;_\
M0UQG_A36_P#DP_L?*?\ H5X3_P )J/\ \@'_  P5^S!_T*/CO_P_?[0/_P ]
M&C^V,W_Z&N,_\*:W_P F']CY3_T*\)_X34?_ ) /^&"OV8/^A1\=_P#A^_V@
M?_GHT?VQF_\ T-<9_P"%-;_Y,/['RG_H5X3_ ,)J/_R ?\,%?LP?]"CX[_\
M#]_M _\ ST:/[8S?_H:XS_PIK?\ R8?V/E/_ $*\)_X34?\ Y /^&"OV8/\
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MX8*_9@_Z%'QW_P"'[_:!_P#GHT?VQF__ $-<9_X4UO\ Y,/['RG_ *%>$_\
M":C_ /(!_P ,%?LP?]"CX[_\/W^T#_\ /1H_MC-_^AKC/_"FM_\ )A_8^4_]
M"O"?^$U'_P"0#_A@K]F#_H4?'?\ X?O]H'_YZ-']L9O_ -#7&?\ A36_^3#^
MQ\I_Z%>$_P#":C_\@'_#!7[,'_0H^.__  _?[0/_ ,]&C^V,W_Z&N,_\*:W_
M ,F']CY3_P!"O"?^$U'_ .0#_A@K]F#_ *%'QW_X?O\ :!_^>C1_;&;_ /0U
MQG_A36_^3#^Q\I_Z%>$_\)J/_P @'_#!7[,'_0H^._\ P_?[0/\ \]&C^V,W
M_P"AKC/_  IK?_)A_8^4_P#0KPG_ (34?_D _P"&"OV8/^A1\=_^'[_:!_\
MGHT?VQF__0UQG_A36_\ DP_L?*?^A7A/_":C_P#(!_PP5^S!_P!"CX[_ /#]
M_M __/1H_MC-_P#H:XS_ ,*:W_R8?V/E/_0KPG_A-1_^0#_A@K]F#_H4?'?_
M (?O]H'_ .>C1_;&;_\ 0UQG_A36_P#DP_L?*?\ H5X3_P )J/\ \@'_  P5
M^S!_T*/CO_P_?[0/_P ]&C^V,W_Z&N,_\*:W_P F']CY3_T*\)_X34?_ ) /
M^&"OV8/^A1\=_P#A^_V@?_GHT?VQF_\ T-<9_P"%-;_Y,/['RG_H5X3_ ,)J
M/_R ?\,%?LP?]"CX[_\ #]_M _\ ST:/[8S?_H:XS_PIK?\ R8?V/E/_ $*\
M)_X34?\ Y /^&"OV8/\ H4?'?_A^_P!H'_YZ-']L9O\ ]#7&?^%-;_Y,/['R
MG_H5X3_PFH__ " ?\,%?LP?]"CX[_P##]_M _P#ST:/[8S?_ *&N,_\ "FM_
M\F']CY3_ -"O"?\ A-1_^0#_ (8*_9@_Z%'QW_X?O]H'_P">C1_;&;_]#7&?
M^%-;_P"3#^Q\I_Z%>$_\)J/_ ,@'_#!7[,'_ $*/CO\ \/W^T#_\]&C^V,W_
M .AKC/\ PIK?_)A_8^4_]"O"?^$U'_Y /^&"OV8/^A1\=_\ A^_V@?\ YZ-'
M]L9O_P!#7&?^%-;_ .3#^Q\I_P"A7A/_  FH_P#R ?\ #!7[,'_0H^.__#]_
MM __ #T:/[8S?_H:XS_PIK?_ "8?V/E/_0KPG_A-1_\ D _X8*_9@_Z%'QW_
M .'[_:!_^>C1_;&;_P#0UQG_ (4UO_DP_L?*?^A7A/\ PFH__(!_PP5^S!_T
M*/CO_P /W^T#_P#/1H_MC-_^AKC/_"FM_P#)A_8^4_\ 0KPG_A-1_P#D#T3]
MD[_DUC]FG_L@'P;_ /5=>'*\T]$^@* "@ H ^?\ XR?\E%_9._[. \1_^LL?
MM+4 ?0% 'D7BSXQ^&O _BC4-&\2O%I>A:)X5T+Q%KGB:6:YN%TV[\6^+D\'>
M$-'_ +(L=/N+B>35-1AU/;<!U$1L #&R2/)!-*2J?6ERS3I5\'A<.HPE4>*Q
M&(HXRO6HTE!.7M<+2H8:3A%3E46-I)*#C%5=)4,0OJ;ITE*E7H9KB*DW*,%0
MI953P-6I-\VDHSIXNI*]X\OU:22J2FE'C?%?[4OPL\-^"9O&%E+XJ\0W#V/B
M.?3/"NF_#_XBCQ2]YX:N[K2KVV\1Z ?"#ZGX!L$UZV&FRZMXEL=,L;>:9/-F
M 9=VD:=:KB,)@\*J=;$8YX&-%NK%8=/,:ZP^#5?%14Z5!U:O/!4IOZPYT:]*
M-&5:E.FI3P]'VU3'5_J.%PDJWUBK*$I2A2PU&&*Q->C0C^]Q=&CA*M+%>UPT
M:E*>'K4*T:GLJU.I+J(OC;X6M;Z/3-8:X.IW_B:[\,Z-I/@[0?'_ (^U>:;2
M(]+LO$-]K6G:!X%,N@:1I?B2]N=-N=8D$^C1+#:RSZI!-=/:6E4XTJ\J4<+4
M=535:;J3BJ5"%*&,Q>%H5*M:I)4Z"Q*P=65)8AT?:2A56&>)HTXXFKCSRITO
M:5X?5ZE*A0J5:,FO;>UJX7#XR='#4E>IC?8X?&82<I8:$ZD?;J-:C1E&SYCQ
M'^U5\(O#BZXJ2>/O$=SH26[_ &?PE\)OB=X@@UT7'B/3/"('A#6[/PG_ &+X
MP,?B/6+"PF.CZE>"&>5HI"LB,HRH7Q,<-.C&4J>(K8*BFXRBX0Q\,16PV)G3
MDE5^J3P^$Q6)AB(4YPK4:#^K^VJ5*-.K=9_5ZE:A*TJ]"ACJ[IPE&3?]FQIO
M&4>9/V5.O0E6HTZU.M4I?5Y5%+$NA2A5J4^_TCXQ_#W7/&4?@'3-6U.3Q-)8
M7E_%;W'A/Q?I^EN=-2S?5=*C\2ZAH,&C/XFTY+^T:^T%=0.J60F!N[.':VW2
MG!U5B72E":PCESN-2FU*%.N\+.MA[2_VK#0Q*^KSQ6&]MAH5[4I554DHN)5(
MTUAG-2I_6O9*$90G&4)UL//%T:5>#BI86O5PM.>(IT,2J5:=&+J1@X69YAK7
M[5?@32-2N-._L#XA8TWXF7WPVU*YOOAYX\LQ>7&D>$->\6ZQK'@FR@\,7=Y\
M0K6U3P_=V)MM$MKBX:;9,$%G/:W-YE1E"MA\+B_:1IX6OA\PQ4Y3YE5HTLOQ
M%/!SG5H\O-3I2Q->@IUZCA0P])UY5ZL*^#Q6&I=-6E*E5QF&NI8G"?V<HQB^
M:E6JYC.C*GAX5X\U+ZS'"3J8J-!OGK<E*E24I8FA*7H<7QS^%T^N>$?#MKXC
MN;O4/&]MI=UX>FLO#7BN]T5AKFDOKFA6NL^);70Y-(\+:GJ>DQ275EI^MWVG
M7=XB'[-#*1BNCZO56+QN <5'%9?.O3K0E*,?WN%@JF)HTIRDH8FMAZ35:O1P
M\JM6E0:KSA&BU,XXXBB\)AL=&=\+BX4:E.2C+F]E7KK"T*M2G;VE&C5Q+^K4
MZM:%.G+$*5%2=2$HJQJ'QJ^&VE>-5^'M]K]S#XH%_9Z7<0)X<\47&CZ;J.HZ
M/)K^F66M>*K;19-#T*YOM)AFFM8]0U&V-R89(H!),C1CEI5:5:-><*D8PPWU
ME3G-JE#FP5&EB<5"G.KR1K5,/AZL,15IT7.I&@JE9Q]G1K2I]-6$Z$:3J1:]
MM'#3A&/OS<,7BZN!P\W"'-.-.IC*,\,JDHJ$:TJ4)RC*O053E8OVG?@Q+!K5
MRGB'Q +;0I/"D<MQ)\-OB=%!JZ^.=6N]#\'W/@^:7P<J>/+#6-5L+R"TO/#9
MU6WF\AG67R\.=U2J^SI3]C5C*M7KX:%%TYK$^WPV#GCZ]*6$<5B82A@X2K^_
M2BI0Y5!RE.$9*JEA[NK.$:48\[K>T@\/R^WPV%?^TQDZ'-#$8S#TJD/:<]*=
M2U2,>2IRR>%?VC_AGXJU#Q%IR?\ ":^%SX<NM<@EO?'_ ,./'?@'3-2M_#&D
M6>L^(;_2M0\6>'["&:WTVWNY([F&=K>ZC>RG<VWV<PSSYRE3AA?K;JPY(TL5
M6E",E.K&EA,;'+ZE14X<SJQEB:E&%-T/:\TZJHZ8BG7HTB*E+%TL#3ISG7KS
MP5&FE"7+*OC\)4QN'P[;2Y*[PU*=6=*HH2A'E;TJ4W+M/$/Q5\%>%]$\/Z[J
MEUKLMOXJCMY?#NEZ'X+\:^*/%>K17%M#=F2T\$>&?#U_XB9+>UGBENV;2U%D
MC[KSR #C:5&=/'K+))+&*4XRCS1=.FJ=2-*=2M73="C0C4G"G+$5:L*"G.$?
M:7G%/.G4A5PGUZG)/"ODY9OW>=U%*5.%*,K3JU*D(3G"G3C*I*G"=2,7"$I+
MC[[]I7X,:;<Z]:WOBN^MW\.&Q6\G;P;XZ:POWO\ Q-I_@R.+POJ<?AIK/QI-
M!XLU73](NX_#\^IM8WERMO>BWD#*N=*,JU.%6C"56,YT:<(PC*56I]9HXC$X
M:=.C%.K4H8JAA,36PN)A"6'Q-.C.5"K45KZQC>I&ES0C-X?&XF7-.$(TJ671
MC/'1KRE)1P]?"1G!U\+7=/%4W)1E14G8H:3^T=X/\27.M6'A_1_&]K>Z%XK\
M,^%9/^$Z^&_Q2\!6NK76NZ9!XAO8?#QU3P%->ZEK-AX<&H7#:7)86LWGV<,=
MTUE:7]O?N/EI4*6*K2Y</4EF,;4^6M6<<LH8FI7K4J-.3]K0]KAJE!55-1<X
M5:=/VF*C2PM=+E<JE.+;G"AAZC?*X4Z57%XFCA<+0Q,ZG)[!U*F*PDY3<9QA
MA\3"O[T:6)]AB_"3]J'PE\2]$UWQ!J-C=^#+*S\2:)I/A^PU?1_B)9^(-:T7
MQ=?3:;X*UVXT;Q1\./#[H=:N[+4'C30Y/$=C!!9R2SZHCP745E3A[+ X#%5F
MJ=;%*M&K23C*-"MA\#3S2M1<U)3E+#Y=5IXFO4E1I4$N>6&JXJA&.(GE.K&&
M/S#!)3BLN@IRE5A*E*<?K>(P#<8N\&YXW#RPU"A&K+&RK2IX>OA,-BJE/#RZ
M;2_VB_AE<3^&=,U'74M];\56OA?4M-M=)T/QUK.F0:1X]OM2M/ .I:SK<O@R
MQA\,P:W_ &<8HVUN/3(TO9DL1)))-;-=Z?5JRJ3H.')7POM*>)4G&%.CB\+E
M]',<=AE5DXPG+#X>JZM-/DK5Z%.I56'ISI8BC0=:3PWMO;VBJ=6M&'LW[9SH
M4\?5P$,1:FI7A[6G%5ZE)U<-AYSC_M56A.CB*W5>#/C%\/\ Q_KVK>'/"6IZ
MMJ=_HUA#JLUU+X0\9:5X>U'2[B[FL(-3\->+=8T"UT/Q?ISWEO<0BYT+4=1B
MW02#?\C8QIIU*$\1%.-.E*E&49KV=6/MXU9T)/#U.6NJ=:%&I.E5]G[.<8J4
M9-2BY76_V?$1PM7W:TOK"2BG.'/A)488FFZL.:E&MAYXBC"K1E-5:<I\LH)Q
MFH^4ZE^UG\/K"XM_^))X^BTZ#QWXS\%:S>ZE\//B!8W21> ] UG5/$'B'PGH
M=OX3N]1\>:7;ZII<6FR?V3;N8#+<W,[1Q69$T8>I1JTJ%:K56%I8C+Z^80]K
M[DJ=*CC\#@8/%1DXK!T:L<?3Q:Q6(E"A2H1<:\J=>%>E0NI"I2KU\)[*<L51
MQ6"PD(Q4?9UJN-PE;'05*JYJ-1K#X:O&%*DJE?$5EAU0I3PV,PV+J>HZ?\:O
MAKJGC'3O >F^(+B\\0ZK:M<Z=Y'AWQ.^@7$J:1'X@?25\8_V-_PC\?B5-!FB
MU)]"?4UU-+.1;EK00D/71'#UI3QE-4VIX#VKJJ5H^[A\5' XB=+F:^L4\/C)
MQPM>IA_:PHXA^QJRA-.)S?6</[#!XA5HRI8^5*-%IIRYJ^&EC,/&K!7GAW7P
ML95Z"Q$:7MJ:YJ7.BCK/QZ^%^@ZUXG\.WVLZU+K'@Z:TL]>L](\"^/?$'DZK
MJ&GZ3JVG>'M/N- \,7D&N^*KS2];L+NVT+2Y;S4KB'[3)#:NMC=&WYU).@L2
MK^QE5G0@[/FJ5*7MW7]E3M[2K3PL<-6GBZU.,J6$IQ53$SI0G3E+JJT9X=T8
MU4J?M\.L5%N4>6.'E7GAJ=2K*_+0]MB*<J&'C6=.>)K<M.A&I.<%+.T_]I'X
M-:GJ'A_3-/\ %=Y<77B:'PQ-IS)X0\;+9VB^,WU"'PNGB+4G\.+:>$+C4;O2
M[ZSB@UV?39?MD*V;HMU+'#)NJ,G.K"+A)4/;WJ*I3="7U? 4,TJ^RQ"DZ%:V
M6XBEC8>QJ5/:X;VE6ESQH5G3Y)XBE14G4;IN'(I0E"<:L.?,*V5+VE%Q56FH
MYAAZN$JN<(JC54%5<%5I.;4_:3^#+Z;KNL+XKO%TKP_)H"7%^_@_QO%:ZM#X
MIUR+PSX>U#P?+)X;5?'NC7^OSQ6,.I^&O[6LVF;:9Q@XR@I3C2<*=1SJU51C
M1]G/ZS[25&IB*:EA>7ZS35:A2JU:$ZE*,,1"E4=&53DE;L=&I'$8C"M*-3"4
M<77JRE*,:,*>7J^.3Q#:H>TP6D<7155UL/.=.G5IPJ5*<9:_@+XV>#OB'>>-
M[71M/\=Z/#X FL8=;U+QS\.?&_P^TV7[;HUKKC-I]QXTT+36FDM+2Z07=M+'
M#=6QV22P+;W%M/<E;EPV7SS.O.%+"4YXJ#;J0<N7!SG3K5HQA*3G052G5IQJ
MPYH.I1J4VU./*90_>8JC@Z*E6KU:=.:C&$_=E5?N4)\T8\M>5.5&M&#TG2KT
MW3E.4:T:65I'Q^\%7*QC7?[3\.O/X?G\:H\F@^+-2TG2/ LD=Y=:%KWC3Q1:
M>&AH7@>_U;3K"XN;72-5U**ZEV^3!Y]PKQQZ2I5*/MJ=6G*&)P<J='$TDG+D
MQM2="*R[#R2MCL?#ZWA(U<+@E6K1J5E[.%6@Z>(JY.O1]I!4ZL*E"NYRP]6$
MXSC4PU.-7GS"I[-SCA<NG/#8IX?'8B5/#UJ%%5)5*564\/2J6_[1GP^U"32Y
M]*N;X:,W_"8/XGO?$>A^*_!6K^$8_!T&A+=1:AX1\5>&K+6FU*ZU+Q7X7MK6
MREL[62Y36H9[4W :))Y<907M*D7]7EAH5:-2DO;NMB:N8++L/@H4J+E4>(JU
M:681]FHRK0K8">'E0YZEX:M.\X4G"4\/C*>&Q"E4C3A1I3RS%YF\9[67[J>&
MA0H492KJ:P_LL2JWUA1I\L]+2_VA/A;K2Z&ND:AXLU"]U[4KW2;?1+3X7_%*
M;Q-I%UIVHMI-_+XP\*IX,.L> M-@U%#!)J/B6QTFS5BI,^UE)%&[M"4*D5AG
MBG4ISA4HJE^_LG6IRE1C7E+#8BE3PKFL54KT*V'IT95J<Z:ES48R<KP<:JH\
MDXRA4E4=&AB/W=*252I!4,3AJTJM.,J4:6(H5)34:M-RO>$?C=X'\6_#[4_B
M<%\3^%?".D7VL6=W=>/O"'B/P5>M'I%^]@NH6>EZ_IUO=:AIU^P@>RDM8I6F
M-TEL42^CGM()JVH8?+\1*2E',J.%JT(4OWM:3Q?*J%#V-)3J2Q$YSC"G3A&?
MM^:%7#.O0JT:M2XIRQ>/P<?CRVK7HUJC:A03PRD\146(FXT?8T/9U/;U'-1H
M.E45;V;A)+G[O]ISX,6&CVNLWWB+7[2*['B(C2;GX<?$R#Q;9KX2.D'Q*VK>
M!Y/!X\1:(NFVNNZ3>W!U#2[41V-X-0/^A(]PFGLY>THTE*$O;PIU(S52FZ,:
M=3$SP:G5KJ3H4(PQ=*IA:SK5*:P^(A*C7]G4BXA14J\*\Z,92^KUZ>&E!1DJ
MLL16PD\=0HT:+2JUZF(PL'6P\:$*CQ"=.-%3G5IQGT,/QD\*)XH\3>']3N[;
M2;+P_;^=;ZY<S71LM2.G^%=.\9^)2T@T];73;?2O#NN:#=&2:]9KA;VX\N-1
M8R%L925*CB:E=2H5,-/%R=-Q<I2PF#JX/"3Q4.6\I/\ M+$U<!["$)5/:4(R
MCSJLHP(0J5:N7PP\57I9I2P7U:<9+FJ8G&SS5TL-[.UXMX;*Y8E5)-1<:L8R
M4&J;K6O%?QG^'7@K1] UOQ%J^IV]KXFT]]7T:SL/"7C'7=>GT>WMK6\O]:N?
M"^@Z!>ZSIFC:=;7UG)J%_?6%M;:<+J+[?+;[QG2M%X?%U,%5<:=:A+EK2<H^
MPH?O/9*>(Q*?U;#TI5$X1K5JM.E*2:C-M,5"^)PL<;AXRK8>;A&DX1E*=:I4
MA.I3I8>BDZV(K5*=.I4IT*%.I5G3A.<8.$6U6/QT^%@\7Q>!E\3O+X@DNXK!
MA!H'B6XT.TO;CPO%XTLK34O%L&C/H6DW%WX7E_M"UCO=2@:ZC@N5MA+):SI$
MK<L<7*=J,, L2ZTJK5*,?J4U#%Q3J."J5,,Y*5:E3<ZE.E>M**I)S3Y9>RP=
M:,75IX^GAJM#V2=64Z6+KU,-AJSA3YYPHUL32EAX5:D84_;2HTG)3Q%"-3%L
M?V@_ 6OSV*>$[FZUF#_A,O#'A/69=0T?Q1X4DLX/&<.HIX6\1Z%%XE\.6B>,
M/#NIZC9PPVNJ:9*^G74,EQ<6M].;4PS:4Z%:57"TY4ITEBYX^C%2CRU:6*R[
M+YYG7P^)P\^2OAIK!P<W&M"-1.I0_=.G5=2&%?$8;#TL3-UX3G0IY?6@J4HU
M:5:CF.9T,KI5*6(IRG1J1C7JSYG2E4M.C.E/V<VBU\=OC%9?!3PEIGB&X?P3
M'=:WXITCPKIC_$;X@6_PO\&076HI=W<]WKOC6XT+61I%K;Z;IU_, FF7<DTD
M44"(&F#+R.K_ +9@<''D4\6Z^LZG)RQP^&JUWRQ492JU*DX4\/3IQ2O4KQE*
M481DUV0HREAL;BE"I.&!A1G*-*"G+]_C,-@XMWG!0ITWB?;59W;C2IS<83E:
M+CTSX\>"H[[1O#/BG5])L/&=[86L^JV_A$>+O&_@#2=1N]&;Q%:Z0?BC'X*T
MS1EU"[T!1J-E9ZFND7]]:NEQ;6+Q2(S[XF5'#/'/FJ4Z67TZ\ZLL12>'E?!P
MY\="E"4I?6*F#M-XBEAI5JU&G3E4K4J7+.,,**JU*>!GRPE_:+I/#NC/V\)T
M<3B'AL%7G.,8^QH8NJHT:5>LH8:>);PU&O6FDY='I/Q@^'VL^ O^%G6FM7EO
MX&:*">VUO6/#GBCP]_:$%V+7^SIM(TS7M&L]0UF*^DOK2*R:QM;@7LUPD-H9
MI3LJL52J8*4:6)I3A7E.5.-&,)5,0ZD:M2C[)8>FIUO:.5.3A3]GSU*7)7IQ
ME1J4ZDHP=6GCE.6$FJE*G%U)56^2BJ:HQQ$ZOMZG+1=*G2E>M54W3HSA5I59
M0JT:L(9&C?'SX6ZWILVJ6VMZOIUK::1XVUV]B\3>"/'?@[4M.TGX=7&F6OC*
M[U/1O%OAG3=0TT:=<:QIZ&.ZMH9)S,WV9)A#*8U*+AAY8I6J4(0H3;I2C6?^
MTU\5A:$%"DYSE5J8C!8JE&C&+K<])IP7-#FZ,/2J8FO3PM&$GB*N)I8.G3DG
M3E.O6PU/%TXP53EYJ<L/6HU/;QO0BJM.,JBG.,7E:_\ M#_#[PK9:_J>MWM[
M-9:5>7-GIUEX9\,^/_%OBO4SI?A[1_$&NS2^$=$\%2W]M::;#KE@+J^M1J%C
M:).C7UW9S+-;6_/BJD\)0J5'352M%8R4(0G%TN3!XFM@93K8EM4L*I8_#8G"
MJIB'3H.5.G.E7K1K1M.$4,;.FL//]U+ZC"4Y1E&2KX^BL9AZ-*E9U*\YX"IA
M\7&G24L3:=:$\-3]ASU$T/\ :'\!7MWX0\/ZY)JVB>,O$^EZ?/=Z-9>&/&WB
M+P]X<UZY\(OXVO?">L_$+3/"@\.Z;K]IX?M[N\-EJ-[I]V]O LXM52:,-W8R
MC3PE?.(1K>UPV2QQE2KB'%TJ52A@*_U;$UJ#GIB%1K6IU(8>5:<*C5.45/W3
M+"REC,-@\71I3C3Q_P!7=&G)1>(A#&5*<,%+%4*<ZCPKQ'MJ*3J/V//*4:=>
MK"#J!I_[3/P8U32+C6M,\3:O?VD*^'WLK>R\!?$.YUGQ''XIT^^U3P_+X*\.
M0^%&U7QY!>6.E:O*DGARRU1%_L;45=D?3[E8(K4*^'TJ4:BG&O7PTH1A*=2G
M5PRHRK^UI4U*I2I0AB,/5]O4C&A*C7HUH5)4JD)NJ4HU>?V<ER4J,:\IMJ%+
MV<ZSP\4JT^6E*K]87U>5",W7CB'&A*G&K*,'TUA\:/AUJ7C'3_ -IJ^J?\)1
MJ=LT]K:77A#QE8:>MU%I,>O7&@7GB"_\/PZ3IOC&WT26._G\-7E]!K$%LWG3
M6*1@L"%&I4>+5+EFL$JDIRC.#A.G0Q,,%6JX>HI.&+HT<7.&&JU\)*M2I5Y*
MG.<9Z&<J]*%+"U9R]FL7.G3A"2E"K"I5P\L51IXBA)*MA)UL-"5:C#%4Z,JL
M(MTU(HZS\>OA?H.M>)_#M]K.M2ZQX.FM+/7K/2/ OCWQ!Y.JZAI^DZMIWA[3
M[C0/#%Y!KOBJ\TO6["[MM"TN6\U*XA^TR0VKK8W1M\%).@L2K^QE5G0@[/FJ
M5*7MW7]E3M[2K3PL<-6GBZU.,J6$IQ53$SI0G3E+IJT9X=T8U4J?M\.L5%N4
M>6.'E7GAJ=2K*_+0]MB*<J&'C6=.>)K<M.A&I.<%+/B_:.^$%Q<>$+:R\1:O
MJ#^-QH?]C2:7X$^(&J6EB_B6Y6ST&W\87VG>%IK;X>W=[=%HHK?Q3+HTI:&8
M% 8)?+VC2<L14PT)4Y2I1J3]HJM-X:2I8&69U/98OG^JUI1R^/USDHUIS>'E
M3JJ+C5IN7-5K4Z%!XBJY4XQJ>QE3E":Q$9_7?[-M/"\OUF$?[0O@U.5)4WB8
MSHJ7/":C7;]ICX,HFNS/XDUI++P]%H,]UJC_  _^(R:+J=OXG\06_A7P_<>$
MM;;PF+#QS;7OB&YAL8IO#ESJJ>86W,%C=DSI7JPA*E"<I3J4Z4:7)-8ESK4<
M1B*-L*XK$N%6AA:]6E4]E[.I"'-"34H<W4Z-2->IAFE&="CCJ]23E%4:=/+(
MTY9ASXB_L(5,)[6"K495%6A-^SY.=2BL+Q-^U+\/-$U'2=*TZ'Q'J=Q=Q:I?
M:Y>WW@KXC:%H/A#2M$\%ZUXVU8^(M<NO \UO9^)[.PTJWAG\)'_B?P/J<7FZ
M<A1EJX4:]:MB*&&5&K.A"NXR]M'V5>K3QF'RRE2PE6E&K'%PJ9IB\-@ZF(PO
MMJ%#FJRE.52G&C4BG[)O#0G4=*MBZ^%P]&BX\M1SQ#]LU651TXX/DRZGBLQI
MO&RP\*]##WC4C3JQK1[/3_CM\.9O$:^"K_7X['QA:F>RURTATGQ7-X9T;7=/
M\+6?C+5-$N/'%]X9L='AO8?#MW_:,,%[/875Q:6US.EJOV2Z2V=2-.,,9B*5
M1O X.&)K.M54*-\/A,;++Z]5+VDX2=#%*-*O&C4K^Q=2E.4G2JT:M3GHSJ2A
M@HU*7+BL8L*E2H^TK<M3&4%7P\;^RIU(PKQNL/4K4:'MIQE2457C.E'1\&?&
M7X?^/AXG;PQJ&NSQ^$+:SOM9EU;P/XZ\,0-INH1:A/IVK:'/XH\-Z?'XJT>[
M@TN^DM]0T1M0MITA#Q2NLL9?+$/ZI@:N8XE.AA</.O3J\\7&M1J8:A0Q->G6
MPS7UFE4IT,30J.%2C&352*2;NEK1E&OCJ>78><:^*JPI5*:IRC.E4IUZU7#T
MIT\1!O#SA.M0K4XRC5:YJ4[M*+9':?&_X6W]U]AL?%MK=WH;PZGV6"QU=YM_
MBKP[?>+=#4J-/^4S>&M-OM1ESC[);V[27GD C)BU4P5/'5*M-K^SIYE2K)6M
M"IE-*E5Q\7-7@H4?;T:7MN;V-3$U882E4GB7[$C"UJ>,CAI8=NI'%T,!B:+Y
M9KGHYEB983!22<4^:M6C*]*WM:5)?6*T*>':JO@?!O[5'PN\3^";7Q=>7.MZ
M/=2:=X:OI_#$/A'QUKFO7#>+=*OM<T2#PGIVF^$S>_$5)M+TO5IOM/A:SU:W
M']BZF/,_XE]P8M\91G@8MUT_W4ZM&MRQG+V-?"TL/5QBJ0Y55I8?#K%49_6Z
M]*C1J8>M0Q*<:=:!I#EJXG%X>A.-:.%<ZD*J?+3JX5XVM@L+7C.?+!3Q56C[
M-852EB*6)E]4G!UURO.U;]K?X;6T.IRZ#I_C'7K>PM_A7=VFN/X+\8:1X/UR
M#XL:YI&E:)!H7BJ[\/M;:IK%M9:U9:A-I<$;W4B2FWMHYKFVO8K!K#U56="<
M>2I2S&MEU6GK.LIX;!2S#$5:%&DJD\7&.%IU94EA^?VDE1;=/#XS!XBN-PA&
M7-+V<EE^)QZ4U*G&G["I6PM+#XR4U%X"I7QU)X1O%1IJA-5752>'KPAV\O[1
M7PBM],\,:M+XBU9;/Q;<BUTY1X'\?->Z8QUY_"SS^,M+3PP;WX>V$7B2*32Y
M;SQ3;Z/;PWD;6\LJ2J4$1I2EBJ."@X2K5Z>%JTVJE/V,XXZE[; J.(YOJ[JX
MVG=X.C[7VV)<91H4ZDXRBLG6IPPV(Q4N:-'"3Q=.JG":JQEE]_KS]@X^VE#!
MI*6)JQING0A*G.I.,*E.4NDT/XN_#WQ#HOBKQ)INNS)X;\%76KV?B'Q%JFA^
M(M T&VGT"[O[#6OL.LZ[I-G9ZY!8WNEWT$\^F37D4;PA6<&1-^5[87"XNTE1
MQL:$L.N67M:T<33P]7#2I4+>WFL1'$T8T'&FU6JRE0I\U:E5IPT@U/%8C!4_
M>KX24X5DO@I3I5*U*K"5;^"IT98>HZT.?FI4^2M44:56C.?&I^TS\'FTR;4W
MU?Q;:+#XDN?""Z3J/PI^+.F>*;OQ):>%O^$UDTK2_!NH^"(->U>9O"I7487L
M=-N(YXI(_(>1Y%5KE%TZ5&K)<M.M0KXI=X8?"8JE@L55KP^/#QPV)K0IU_;Q
MINBO:5*BC2I59PMPE&;AIHZ,8S33I5'B7B(X?V-9-TJZKRPM:%%T9U%5J1C3
M@Y3J4HS[O4_B+H5OX;\)^)]*O],OM,\:7OAV+P]=7T^KZ?::CIVMPC59;V"2
MRT'49XIXO#,&I:C%#=6MK"[6:PW5U8QN]S 8J*P&+GA,>_JTL.L8Z[TFZ2P6
M%Q&)K2NI*DXQ]ARRDZL(\LKTG6K.CAZ\89K%X>6)PZG./+24%[.2DZN(Q-'!
MX>G4A)1JTN?%8BC1J/V<IT7)RG2Y83<>:L/C[\-=2B\+RV$_C2X_X3/4KG3O
M#-NGPG^*XO=4ALFTQ+GQ''I[>"1<V_@2,ZSI)/BZXAAT#;J$##4ML@)OV%6,
M_93A["<:,Z]55FJ/U:$)5HN&,]JX+!8B4L/65/"XOV.)K.#]E1G>-XA5IU,/
M7Q5*7M<-0JTZ/M::<Z=:I4I2KTUA)P4HXZ,J4)S4\&Z\+0FG).,DK]W\;_AA
M9:78ZQ+XDD>QU/0$\3:6+/0/$NH7VJZ3/JUMH5C_ &7I5AH\U[J6IW^KW=O:
MV&EVUO+?Z@[G[%;7 1RN'-O&,92J1C@YNG&$YUN7'X?%8K#-48Q=5WPV"Q=>
MLE!O"TJ%2>*5%(UE'V5;V%5QH357&T'*K*-*E"KEV)P^$Q<:E>HXT::IXG%8
M>A"4ZD85ZE:G'#RJ\Q%H'QS^&?BC4/"FD^']9U?4]2\9Z9=ZQHUE!X*\<+<6
MVFV%_?Z3?77B:.7PVA\$+;:OI=]I\R^(_P"RFBO(1:2*MQ(D3[1I3E5KT8<L
MGA</A,5.<9P='V&.HSKX.<*ZDZ%5XFC3G4HPI5)U)PC=1U5\_:05)56^6,J^
M*PJC).-7V^"KT,/BZ?L9)5;X>KB:*JODM&$I5F_8TZE2"7'QG\(Z?XGD\+7T
MU]<:C<>*'\*:+9^&?#/C_P 7ZG<7UCI_AZ[UN\URST'P5-#X<T+3;CQ/I$%S
MKDMW<:/;_;H!=ZC:W#26T"PM.>+C3=))^U6)J1DY*-!4</B,1A'*K7J.G3HU
M9XK!XVC2H57"5=X?FPLL0IVC=6U)8B>KIX+ZM3KZ>_'$XG#RQM*A2IQYI5^;
M .AB4Z7-47M*D*E&FJ49U;WCCXQ_#_X=:CI^D>)]3U=-2U Z<4L] \'^,_&4
MVGV^K:C_ &1I>HZ^/!OA_5!X8T>ZU3-I%J6KFQM'F1XUG+HP$4+8C$PPE+6K
M.I2HIR]RDJU=J-&C.O/EH0K56_W5*=2-2<4Y1BXIM%9/#X:>+JIQH4Z>(J^Z
MG.HZ6$IJMBJD*,.:M4AAZ<HRK2ITY1I\\%-IS@FWP[\9OASXK\77G@;0-=N[
M_P 16#>(XKB+_A&_%-KI!NO"&L1Z#XFT^U\37NBPZ+?:MIFIS6Z7%A;:A-=1
MQ75O<F+[-<132.A%XC#O%4?>H1A2JIMJ#E2JRG"%6G"?+.K2]I3E3G5IQE3I
M54J524*DHQ=XF$\'5A1KQ<*DI0A9>^H3JX6&-I0JRAS1HSK86?MJ,*KA*K"%
M;V:D\/75/'\0?'CP#X/NM;B\4:H]K#IVMZAH&G0Z%H/CGQ9KNJW^A>'=,\1^
M(X(_#V@^#9[B:73K+4XY'.EMJ\)AC=WFBFAN+:URA5IN%*4IQC[:&*Q$97_=
M0P>#QT,LK8JO5ERQPU.ECW.C6E7]G2I4X+$^VGAY2J4URMUG0I^].%3"X>2=
MHR^NXO"ULPH86FKM595<!3IUZ/)+VDZE1X;V,:JI>WU;OXV_"VPMY[N\\76=
MI:VM];Z?+<3V6JQ0">Y\'6_C^*5)7L LU@/"-U!J#WT9:UC5_)DF2X5HAO5I
M5*%3V,Z<O;*6(I^SA%U*GM,+B:>"JT_9TU*?/]<JT,+1AR\V(Q&(PU+#JK/$
MT(U,HU*<L/AL4JL(X;%X>ABJ-24XPA.AB98A4JB<W&RY<)BZU5.TL/AL+B<7
M7C2PU"K5ACZ+^T+\+?$-SI%CHU_XOO-4UC5=2T:+1%^%GQ4AU_2KS2#IXU"7
MQ7H%QX+CU'P3I<(U?26_M/Q!;:99,NJ6CI<,MS$7.2?+S)<U-8:>*<XVE3C2
MA/%TG"52-X0Q,JN QM&E@Y26,K5\+6H4J$ZM.4%-2M2HSG2E4C[6%:%#DB^>
M<ISAAJJG2A#FE6PT:6,PM6IBZ2GA*5*O3J5:T(2YCDK+]KGX*2Z';:]K&H^,
MO"-K=CQ+=P6OB[X9?$31-2_X1_PIKNGZ!JWC*>QE\,O)9>"HKC5]*N)-;N?)
ML[:VO'DOI+5K&^CL:ITG5CA'2E"?UNCEU9)3C^Z_M55_J-.O)M0HU*]3#5J-
M'FER5ZGL?J\ZT,9@IXBZDO95\5AW&<IX2MC*'N0G45:IEZIRQD<+R1D\1*@J
MB<Z=%2JQY*UX+ZO6]GT%[^TQ\&-.T.Y\0W?B;5XM/LM2U?3+V!? 7Q#EUNQ_
ML"#3;S6M7O?#4'A1]7L_"EE8:SHU[-XCFL4TA+36+&[-]]FO(99%&C5E/ TE
M3<99ARJES+DC"4\55P,88J<K0P51XVC6PGL\9*A-8BE.BXJI%Q50_>K%>Q3K
M_4YTZ<E13JNK.KAUBZ,<(J7.\<ZV%_VBBL$J_M:*E4I\T(R:NZK^T/\ "72-
M9UKP]-K^JWFK^'TU@:G:Z-X,\;Z[!%>:'X5A\;WNC0ZIH_AVYT^Z\0MX4G74
MK;28;I[V\ABN#:03&UG$.%6;HX3%8UTYRHX.E7K3TY6X8;&O+L0X*HX*7U?&
M\M'$-/EPZG3K8B5+#U(5970A[>O@\-3G'GQT\-"DV_=_VNC[?"RJ25U2IXBE
M=T9U.6-:I&5&DYUXNF8GB[]H?1O#OP2TKXRZ?X/\=WZ^)?\ A'[+PSX,U7P3
MXZTKQ3-KWBC4(-)T?2M?T32O".M:QH<'V^=5DO8='U))$V-IR:@]W91WO3C,
M-B,+F6%RFFJ=?%XNLJ4)*<HT(15.6(K5:U14Y2PZH8:G5JU:=>G3JTG2G3KP
MHRIU?9YX"IA\;A\3C?:2HX/"4JM:<W&//.--J%/ZO&I4I0K_ %BI*E"A.-54
M91JQK3JPH1J5(;\'QX^'EIX8T?Q%XEU^RT3[?X:UCQ)>K!9^*KW3K*V\,:WI
M7A?Q-+#>W_A;3+N6QM/$VL65C!->Z9IL]ZLRSP6OEK+Y*K1I0G_L]25?#U'E
M?L)\L%.K#.W+^R'[.E4KQ4\;&+<:<*E3V7++VLHJ+9C0JRGAIUJRA0G0ECZ=
M:GS2O3GE4*T\QY8U:="M.&#C0FJU7V,81FZ5._/7H1J4-5_:1^$VD>%9/%DN
MJ^)9[5;KQ#9)HEG\.OB/=^-'NO"RQMKQ?P';^$W\1VMA91SVDT^HW&E1645O
M?6MV]PMK<Q3/R8JJ\-0C5A#VSJ8:>)IQC**AR0G4H-8BLW[+!-8FE/"5/KDJ
M+HXJ$\/54*T)07;AZ+KUZE",E'V&)H82<OB7ML32AB*,**A>6*=7#5(XFDL*
MJSJT+U:?-!-KNK;Q[867PRM_B;XTA7P?IMMX)A\;>*+>66YU4>&K)-$76]6@
MDEMK".XU V, F0F&R624P'9#N8)7=F-&GE^-Q.$]M[=8?$O"QJ1B_P![/VRP
M]/DBN9_O*CBH+7XE<PRKGSA8)X&C-O,>26'IU.2G4<*NM'VJ<W3I5'!Q=6/M
M90I2<H^UG&/M'Q+?M'_"5+G2;-M6\4+=:S'=/8PM\,OB@C));VFHW]M9:F7\
M&A=#U34[#2[RZTBPU(VEUK5NL4^D0WL5Q"\O+B)?58XQU+<V HSK58*47+]U
MAX8JO1@K_O,7AL/.-;&8.GS8K!4[SQ=&A&$W$HN.(6&=)IPQ<Z,*4G[L6L1B
M8X/#UW*5E#"5\5..'HXV;CA*M;FITZTI0FH\/\,?VL?!/C?3- O?$=I?^";O
MQC=W<OA;3IO#_P 3+Y$T)K.YU/0)_&^L:M\,]$TSP+XCUC2;&]OK/2+N\N(;
MZWBCGTC4-5AG62ML1!8.E/ZS4C2Q."PM3$8ZGS1Y,/4H4?K6)PM&HW&>*Q.#
MPCA7QF&A1AB\,G-U,,J,85ZC^+$U*5"]7#2Q%/#X:K:2G757$0P-+$3I6?U?
M"XC'2^K86O4J.G4J+V525#%PKX6AZ'??'KP#;?">_P#C/IT/C7Q#X+M+6WN[
M)=#^'GC>7Q#X@CO6LX]-;PYX:O\ 0K34-6M;V74+-8;^.$6)$K2/=)%#-)$8
MBE4P>(PF%Q,)4:V+Q-/"1@XRE.E5J8F6%7MJ=-3J4DJD92C&4/:5H.D\-3KO
M$8:-:,'5HXZGB*V&K0=#"T*F(G5E)4Z3I4L,L5.5.K/EA54:3M)TY2C3J1J4
MJKA4H5XT]#0/C=\./$WBBU\&Z3JNL?\ "07=M)-#;ZAX,\;:+IXO+>PCU.^\
M.RZ_K'AVUTF#QI8Z?*+B]\,27RZS91I(UW8PB*0HX493^M>RE"K'!NIS2A4I
MRA.%'$+"5:^&DI-8O#4L4XX:IBL*ZV'IUY1HSJQJ247F\13A'"^U4Z$L7[)0
MIU(2A4A.M0GBJ5*O!J^&K5<-3G7I4J_LYU:,?:TXSIN,G-?_ !F^'FEZEXKT
MR^U35H)/!*6:^(K\>#O&DN@6^H:A+IT%AX>L/$\'AY]'U[Q?<S:OI4</AS2[
MZ]U:1M1ME2R)F0-A"7/A_K-.,YTW5="G&-.;JUZD)5X3^JT%%UL7"E/#8BG6
MJX6G6I4*E&I3JSA.+B="7^TK")IUHT95ZEI+V>'I0I0KRGBZU_8X/_9ZD,1&
M.*J493H25:"E2O-<_9_M&_";4;;3+C2M4\5:Q)JD&IW']F:+\,/BCK&OZ+#H
MVHZKH^H/XQ\-Z9X,GU7P&(]7T/6+!?\ A)+/2O,NM-N+>+?-$R Q$OJE*I6J
M)RH4L+'%NK"TZ'L98=8J"6(BWA_;3H-5(X?VJKNZ7L^;0J-.I)TX>SG3J5<2
ML)"G4A*G5E6<J,;JC44:KHQ^LX>=3$J'U:G1KTJ\ZL:-2$WC:%^TW\/=;T.Q
M\5E/$6A:#=^%]$\0_P!F>(?!?Q!T_P"(AN/%.K:II?A72M,^'T7@V>[\27.J
MG0->DM8]'N;^ZN$L89K6SN;.\BNZZ<1AZF#G*E77[UU:6'ITZ5ZU3VZPL\;C
M*-:G#]Y1J8'#O#U:ZY*D:4)UY8F6%CAXNODGS*-6E*G+"+ZXY5Y35.FZ>&JX
M.C1KT7-)3H8N>+4:,ZKH2E5=+#4:=?$RQ-'![MW^T9\'[*V\/74WB>^*>)K"
M'5--BM_!_C>\O;;39=;'AJ:_\0:?9^');KPE:66O'[!?RZY#IRZ;,KI?FV*-
MMB%*4\8L#3<)UW]1Y7&I3E0E_:<*L\N<,4I/#36.C1FL(XUFL1-TJ=)SJ5Z$
M:F<J]*&&J8J<O9T:*S!S4E*%2/\ 93IQS%.A)*MS8/VL)5X>SYX052IRNG2J
MRAUGQ*\=7'P^T"UUFW\-WOB1[S7_  _X=BM[74-,TR"UO/$NL66A:7-?W-]/
MYPMI-4U"SM@+&TOYO,N8RT*PB6:&*,76QN"PB3BL754)5-U3@FI5IJ"O*4J.
M'5;%.+Y*;I8:JI5H3=*-3>49_5L;7IQ]I/!X7$XE4TTG-8;#5L0US2M&*E[)
M4K^]/GJ0Y:<US<I\2O'5Q\/M M=9M_#=[XD>\U_P_P"'8K>UU#3-,@M;SQ+K
M%EH6ES7]Q?3^<+:35-0L[8"QM+^;S+F,M"L(EFA*,76QN"PB3BL754)5-U3@
MFI5IJ*O*4J.'5;%<KY*;I8:JI5H3=*-0E&:PV-KTX^TG@\+B<2J::3FL-AJV
M(:YI6C%2]DJ5_>GSU(<M.:YN5OC[XJ^!OAC%82>,-5O;234EO9K*QT?P[XF\
M6ZM)8Z6L#ZOJ[Z+X1T?4[^WT#38[JU>^U::VCL;%+F)KNXA652V:G#VJH\RB
MTHN<Y>Y1HPG+V<*F)KRM0PM*4_<C5Q%2E3E).*DVFE:HU71E6C3E.$9QI14(
MN=2K6G&<X4*%**=7$8B4*=2<:%"%2M*%.<E!QA)KD/#GQJA\5_%#QMX'T7P_
M<'PM\/?#^F:AXC\=ZG!XPTFTGUK6+*VUBPTKPV+SP*N@>(=/70;JVO;B_@\4
MI-&+NV\FPN(7DN("4U0RW-LRQ498:GEF(K8>%.22JU982FY8N<Z=1TYT:=*<
M94:<H1KN<X2E56'I5,)4Q6=^?$95A<*GB*F9X>GBX3BKT?85YSI8?V=6'.JE
M6I.*O":HP2<XTZM:OAL90P_'^ /VF+?QIH'@74]0\&7'A'5?%7BS5M$UG0=8
M\064LGA'P[9>"=8^(NE^,KW4+>S\B\T[4?!MMX>OTB M_);Q(()9O-L9E;KK
M4%A/]ZJPP_U7+<3C<>I-?[%B,!B,)@,?@9VTG/#9CBX4%63C&MAO9XZE%T:]
M).%4IRJ8FG1J*NI8[#X3*YTHU)4\WIXN=2>&Q6%DX*U*I@L-C\1>TX1KX'$8
M'VCK1<EJWG[5/PHM[5[G3K?XG>(&C\2^$_#)L]#^"_Q:N+V:3QG-?+HNN:;!
M=>#;?^W?"CV>E:I?#6=*-[:306)^RR7$]S:PW4T:%2K7P6'M[">-Q&*PD?;_
M +GV.(P>$IXVO2Q<:G+4PDHT*U"3^L0IJ$:OMJCAAZ&*K4)G7HTZ>-J*K"HL
M!A:&,DJ4HU55H8G%2P6'EAITW*GB76Q,)T:<:,YN52#@KS<8RW%_:#^'%K<:
M=9:QK0M[O6-7O;+34T70_''B"VM-,C\47_A#2];\77MOX-@A\":=J&NZ;=V4
M-[K;6NF37,$D5CJ5\@$KY4(NN\'3A9U<71P]:+37L']<HK%8*E#$2Y*<L3BL
M).C6I82;IXN<JGL88><E%SNK.-*EB,2U)8;#U<31;<)*KSX!0AF4G02E4]CE
M^(<Z>)Q$/:4*-&-.OB*E#VCIT[=A^T)\(-1N]?M+7Q<5_P"$9L=>U#5;Z\\/
M^*-.T46_A?Q ?"OB*/3-?U'1(-,UZ]TWQ#Y-C<V>F7=Y<Q27MEOB"WULTZC>
M6%AC(1E*A4^H>S48R=6K_:E-U,O=&@DZ]98M1E"BZ5.:E6A4P^E>G.G&Y+V>
M(>%FU&K%XF,[M*G2>#2GB8UJS?L:#HTW[:2K3@_J_P#M"3H?O!GA_P".'AKQ
MGJ7ABP\&:?X@U :QXF\0^'=<7Q-X7\9_#K5O#"^&?#(U_4+VZ\-^._"VF:G<
MC[1J'AFS13;6\3_\)"DR7#?9S%)K3I<S7-*,:53 8G'4IQE"HI_5LRP^5SH-
M0DW2J?6*F(O&IRSC]3JKV;336$J]**K*//.K0QF%P4HQ@^2-7%8.KF,)3JR:
MC[)X&C*M"=+VW/.KAX6C"JZM/VJLC8* /G_]D[_DUC]FG_L@'P;_ /5=>'*
M/H"@ H * /G_ .,G_)1?V3O^S@/$?_K+'[2U 'T!0!Y;K'PC\,ZYXEO/%.I7
M6L3WM[K7@'6IK4S:>=/#?#:;4K[PQIRPOIC2?V;%K.J7.J.C3-*;P1R1RQHG
MEEX>4\+*E*E.470Q6.Q<5?3VN8913R6LG:SY(X2GS4HW]VO.<Y.49*"SQ%*&
M)C4A4ORU,+A<(TI2LJ>$S-YJI1BVXQJ5ZSC0Q3MRUL)3I4G%2@JAY]??LO\
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M'JJK[2,*;M1H_5E<)VA0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % 'S_^R=_R:Q^S3_V0#X-_^JZ\.4 ?0% !
M0 4 ?/\ \9/^2B_LG?\ 9P'B/_UEC]I:@#Z H Q)/#7AR:^?4Y= T274I+ZQ
MU.34)-*L7OGU+2[62QTS4'NV@,K7UI9336\$Y8R0Q2O'&RHQ!44H-."Y7&=2
MHFM&JE:A'#5IIK:=7#0AAZDEK.A&-*3=.*BB7OIJ?O*4*5)IZWIT*[Q5&F[[
MPHXJ4L32A\-.O)UHI5&Y'.?\*J^%_P#;0\1_\*W\ _\ "1+HU[X=77O^$/\
M#W]M+X?U.>[NM1T(:I_9WVD:-=7-_?RSV0E\B5[V=Y$9IG++D@J%?"\D5AL5
M3I4:U&R]E6HT*5.A0I5:?P5*=&C2I4:4)IQITJ=.G!*$(I5S24Z-3F:J8>M4
MQ%*5WS4L15JSK5:].6\*U2M4G5J58M3G5G.I*3E)MVK3X;?#NP\.W_@^Q\ ^
M"[+PEJFG0Z1J?A:T\+:';>'=1TFWL8],M]+O]$AL5L[S3HM-BBM$MI87C6"-
M8E41J%%5_P#:5*.)_?J5159*K[Z=5*FE4:E>]1*C22F_>2I4U?W(V5&4L+.%
M7#2>'J4HN,)TW[.4(NI6K.,91LXQ=;$5ZK2:3J5ZTW[U2;DMI\./AY869TZQ
M\!^#++3SIFJZ(;&T\+Z';69T;74L(]<T@VT-BL?]F:C'I>F+=VNWRK@:=:B9
M'%O'LT=:J^:]6;YIPJ2O)ZSIUJV)IS>NLZ>(Q&(Q$)/6-:O6JQ:G5G*2H?[+
M[/ZM_L_L)TZM/V7[OV=2E1CAZ52');EG2P\(4*<XVE"C"-*+4(J*77_AS\/?
M%>F:MHOBGP)X-\2Z-KUS8WFN:3K_ (7T36=,UJ[TN"VMM,NM6L-1L9H-1N;2
MVLK.*"6X21H4M(4C*K$H7)I.5*32<J%65>F^M.O/XZT'O&K+[52-IRZMETZD
MZ*4:4Y4E&@L*E!N*6&4IR6'2C:U!2JU)*E_#4JDWRWG*]^V\'^$K(J;3PMX<
MM"E_:ZHAMM$TR IJ=CH\7AZRU%3%:KMO[?0((=,BN!^\CLX4MD80J$%U92K7
M]M)U;^WOSMR_WESEB?BO_O#J5'7_ .?KG-U.9RE>(^Y"-*'NTX4Z5&,%I&-*
MA5^L4*48K14Z-=>VI02Y:=7]Y!*?O&?!\./A[:^$)_A];> _!EOX"NH;RWNO
M!$'A?1(O"%Q;ZC<RWFH03^&H[$:=-#=7<\\\R/;%99)G=PS.28K)8B-&%=>W
MAAXT84HU/?5*&'C&-"%-2NH1HQA&-&,;*G&,5!125KC4J4ZU;$PJ2AB,1.I4
MJU8R:J5:E5-5:E2::E.=5-JI*3<IIM2;N7=*\%>#="T/2?#&B>$O#.C^&]!G
MM+G0_#VE:#I6GZ'HMS87 N[&XTG2;2TCM=.GMKL":)[>*-HY '0JPS6LZM6=
M6G7G5G*O2C*,*DI-SA&5&>&E&,V^:,98>I4H22:3HSG2?N2E%X*C15.I25*"
MI59QJ3ARQY)SA5AB(SE&UI3C7ITZT9--JK"%1-3C%K>NK2UOK6YL;ZVM[RRN
MX)K6[L[J&.XM;JUN(VBGMKFWF5HYH)(G='C=65E8J002*QG"%2$J=2$9TY*T
MHR2<6NSB[IKR:-X3G2G"I2G*G4IR4H2BW&491=XRC)6<91:333335T<WJ'@+
MP+JVL>&_$.J^"_">IZ_X,69?!^N:AX<T>]UCPHMQ$D%POAO4KFS>YT)988XX
MW%E)!N5%5L@ #6-2I3KU\3"<H8G%0=*M5C)JI6IN3FZ=6::E4@Y-R<)MQ<FW
M:[;,^6*PT,%RI8.G*$X4+?N8SII*G*-+X(RII)0DHIQ22BU8?HG@;P5X9U;Q
M!KWAOP?X6\/:[XLNHKWQ3K6B>'])TG5O$MY '6&[\0:C86D5QK-U&LD@66[D
MF=0[8(R<Q3_<X>.%I?NL+"<ZD:,/=I1J5+>TJ*FK04YV7/)+FE97;L$TJE=X
MFHE/$NG"DZLE>I[*GI"GSN\O9P6D(7Y8]$@/@;P3Y=Y%_P (?X6\K4;?7+/4
M(SX?TGR[^T\3W_\ :OB6UO$^R8NK?5M4_P!,OHY RW=Q^^N!))\U5"4J:@J<
MG!4_JO(HMKE^HRJ2P7*E;E^IRJU986UOJ\JE1TN1SE>I2E.M'$3;E7@I*-23
MO4BITZ-&:4W[R4Z.&P]*23]ZGAZ,'>-*"C8NO"/A2]DUN6]\,>'KN7Q+IEMH
MGB.2ZT73;B37]&LENTL](UMY;9CJNF0)J%^L5K=&6*,7MP%0"9]V<X0J4:F&
MJ04\/5JNM.E))TYUG"E3=6<'>,JKIT*,'4:<W"C2BWRTX)*G^YJTJ]+]U7P]
M-4:52'NSI4HSG4C2ISC:4*<9U)S4(M14YSDE>3;YK3_@[\(])G\+76E?"SX<
MZ9=>!;:\L_!-QI_@CPS93^#K34&=]0M?"TUMIB/X>MKEY9&FBL#;K*9&+ABQ
MSHYS<Z\W)N>*P\,)6DV^:MA:::IX:J]ZF'IIM0HSO3BFU&*3(5*FJ<*2IQ5*
MG6EB80Y5RQQ$Y1E.O&-K1K2E",I54E-RC%N3<5:]H_PQ^&OARQ_LSP_\/? ^
MA:;G36_L_1_">@:78[M&UN[\2Z0?LEEI\46;'Q'?W^JVQV?N+V]GNXML\SR-
M2K5HJC%59QCA^7V24I)4N7#PPD?9J]H<N%IT\-'EM;#TX45^[C&*UE.<IUJD
MIN52O]8]K)MN53ZVK8KVC>L_K*26(YK^V2M4Y@UKX9?#;Q)!8VOB+X?>"->M
M=,U^;Q9IMMK7A/0=4@T_Q3<7$EW/XEL8;ZPE2TU^2[FFF?4(@MPTDKN9"S$F
M*3="KAZU%^QK82+A0J0]R=&$GS2A2E&TJ<9-MN,'%-ZM7"<YU*>)I5).=+&1
MA#$0DVXUXTH0I4XUHNZJQITJ=.G!34E"$(0BE&*2T)_ _@JZM+BPN?!_A>XL
M;N+Q%!=64_A_29;2Y@\7SM=>+(;BVDM#'-%K5RS2ZBCJ1>NQ>Y$K'-9U*<*M
M/V56$:E+V4*')-*4?84I1E2H\KNO94Y0A*%.W)"4(N*3BK7&O7IU(UH5IPK0
MJTJT9QG)3C6H4GAZ-6,DU)5:-"4J-*HGS4Z3=.+4&XEFV\)^%K*R\.Z;9^&M
M M-.\'FW;PE86VC:=;V7A8VFG7&CVI\.VL5LL6B&'2+N[L8S9K#LMKJ:!<12
M,K=$Z]>K7J8JK6G4Q-93C4JRG*56<:CC*I&=1MRDIRA!S4FU)QBY7<5;"G&-
M&C+#THJEAY\O-2@E&G+DJQK0YH*T7RUHQJQNO=JQC45I),SKCX>> +OQ%+XP
MNO W@^Y\6SPV]M/XHN/#.BS>(IK>SMKVRM+>76Y+(WDD,%GJ>I01HTQ5(M0N
M8U 6>0-@H1C2KT%%1H8KG]M322A6]I"-*I[6'PU/:4XQISYT^:$8PE>*2-7.
M;E2DYR<J"C&D[N].,*T<3%0>\%'$0C7BHV2K1C55IQ4DW4?AU\/M7TB\\/ZM
MX%\&ZIH.HZ1I/A_4-$U'PQHE[I%_H.@232Z'HEYIMS8O;W6D:=+<7#VEG)&T
M-LT\C0HA=B=:E2I5J>UJSE4JK$_7.>;<I_7+07UOF;;^LVI4U[>_M;4X>][D
M;112PL*=+#+ZO3HTIT*<*?[N,*$URSHPC&RC2G'W9TTE"2T::-K3_#OA_2-'
M'A[2M"T?2] 6.ZA70]/TRRLM'$5]+-/>Q#3+:!+81W$UQ<22KY>)&GD9P2[$
MQ6_VB/)B/W\%"%+EJ>_'V=.$:=.G:5UR4Z<8PA#X8PC&,4HI(FC&.&=\/%4&
MIRJ)TTH/VDYNI.I[MO?E-N<I?$YMR;;;9P%O\!O@;:>')_!UK\&?A1;>$;G6
M(?$-SX6M_AWX0A\.7&OVRHEOKD^AQZ.+*76(ECC"7C0F90BA7&T8KGGS8.7/
M+FRYN6$=W?"MMN3P[WHMMMMT^5MMM[CDE-XQS7,\?'DQ3EJ\3%/F4<1?^-%2
M;=JG,KZVN=T/"_AD2-*/#NA"5KK2[YI1I&GB1K[1(DM]%O&?[/DW5A!''':R
MD[[=(U6(H% $[2YMI>TK5;]?:XBC]6Q%2^_M*^'?U>M/XJM']U-RI^Z)P@X*
MFX1=.-.C246ERJEAZ[Q5"FH[*G0Q+>(HPMRTJ[=6"C4?,<W;_"3X568L1:_#
M+X?6HTN;6+G31;^#/#D TZX\0ZA;:MX@GL1'IJ_9)M3U6SM+R\>+8US<6L,T
MY>2)65P;I*DJ3=-8>GAZ-)1]WV5'"556PM*G:W)3PU9*KAX1M&C52J4U&2N5
M4_>^V57]XL35JUJRG[WM:U;#SPE:K4O?GJU<+4J8:K4E>4\/4G1DW3E*+MZW
M\-/AQXF:%O$?@#P3X@:WU&^UBW;6_"NA:JT&K:I8?V5J6J0F_L)3%J-WI?\
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M,:=*-"$5"A"E2H1IQ24(T:%7V]"C&"M%4J-=>VI4TN2G5_>02GJ5?#/P_P#
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M%&E1BVKJE0A3HQ;?)"-V=/6)N% !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MXIW^E:O]@\0:1IE_%#?V=S#YUC$S1ML HV^0;?(^@* "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#Y_P#V
M3O\ DUC]FG_L@'P;_P#5=>'* /H"@ H * /G_P",G_)1?V3O^S@/$?\ ZRQ^
MTM0!] 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 ?/_[)W_)K'[-/_9 /@W_ZKKPY0!]
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M$RVU2\\-ZIJ_Q+\1>$]"/AC2[2VT+6I-6DN- G>U73F^Q)J;30K+Y\*E.K#
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MLK"RU[PY\++7P_>1:IX;M[K4;=Y_M?B?3-42VM;Z[.E>1;Q-=3E5'^T<9AL
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^?_V3O^36/V:?^R ?!O\
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MW_)K'[-/_9 /@W_ZKKPY0!] 4 % !0!\_P#QD_Y*+^R=_P!G >(__66/VEJ
M/H"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@#Y_\ V3O^36/V:?\ L@'P;_\ 5=>'* /H
M"@ H * /G_XR?\E%_9._[. \1_\ K+'[2U 'T!0 4 % 'R!\-_#OQ1^*&D^*
M?%MY^TG\8/"__%X/CWX6T_P]X6\-_L[?V%H^A?#_ ../Q#\ >&[&Q?Q/\!M:
MU6;RO#_AC3!+-?ZI>S2S>;*TG[P*H ?$?P[\4?A=I/A;Q;9?M)_&#Q1CXP?
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MX&.&<9O$T?[0RB&91J3A&"J5*E13HU*>&5"E5IX?%5/:<SRC,:IVEO\ M1_
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M2J6Y*U-QG&U2E*=/FYH<W/"<8]561L% !0 4 % !0 4 % !0 4 % !0 4 %
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M<=(9Y@,'A,*FW>G+#95EF!E[;?E@ZV#K3BX.HW3G"3BIRG"/&7/[-_Q:N(/
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M,DQ%"M.+FZ'-.=?$49PIXCGC2I4YPI.M.=#R2+]B7QXWP[U/P!.WA=KGP_\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % 'S_\ LG?\FL?LT_\ 9 /@W_ZKKPY0!] 4 % !
M0!\X?M 7\F@:_P#LY>+I=#\8:UHG@_XX:KJWB1O!7@;QE\0M5TC2M1_9Y^/?
MA2TU.X\.^ ]"UC5FT]O$7B/0K%[B*Q>.*35(/-9%;<#8-B__ ,-+?#K_ *%S
M]H#_ ,1._:G_ /G-T '_  TM\.O^A<_: _\ $3OVI_\ YS= !_PTM\.O^A<_
M: _\1._:G_\ G-T '_#2WPZ_Z%S]H#_Q$[]J?_YS= !_PTM\.O\ H7/V@/\
MQ$[]J?\ ^<W0 ?\ #2WPZ_Z%S]H#_P 1._:G_P#G-T '_#2WPZ_Z%S]H#_Q$
M[]J?_P"<W0 ?\-+?#K_H7/V@/_$3OVI__G-T '_#2WPZ_P"A<_: _P#$3OVI
M_P#YS= !_P -+?#K_H7/V@/_ !$[]J?_ .<W0 ?\-+?#K_H7/V@/_$3OVI__
M )S= !_PTM\.O^A<_: _\1._:G_^<W0 ?\-+?#K_ *%S]H#_ ,1._:G_ /G-
MT '_  TM\.O^A<_: _\ $3OVI_\ YS= !_PTM\.O^A<_: _\1._:G_\ G-T
M'_#2WPZ_Z%S]H#_Q$[]J?_YS= !_PTM\.O\ H7/V@/\ Q$[]J?\ ^<W0 ?\
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M .<W0 ?\-+?#K_H7/V@/_$3OVI__ )S= !_PTM\.O^A<_: _\1._:G_^<W0
M?\-+?#K_ *%S]H#_ ,1._:G_ /G-T '_  TM\.O^A<_: _\ $3OVI_\ YS=
M!_PTM\.O^A<_: _\1._:G_\ G-T '_#2WPZ_Z%S]H#_Q$[]J?_YS= !_PTM\
M.O\ H7/V@/\ Q$[]J?\ ^<W0 ?\ #2WPZ_Z%S]H#_P 1._:G_P#G-T '_#2W
MPZ_Z%S]H#_Q$[]J?_P"<W0 ?\-+?#K_H7/V@/_$3OVI__G-T '_#2WPZ_P"A
M<_: _P#$3OVI_P#YS= !_P -+?#K_H7/V@/_ !$[]J?_ .<W0 ?\-+?#K_H7
M/V@/_$3OVI__ )S= !_PTM\.O^A<_: _\1._:G_^<W0 ?\-+?#K_ *%S]H#_
M ,1._:G_ /G-T '_  TM\.O^A<_: _\ $3OVI_\ YS= !_PTM\.O^A<_: _\
M1._:G_\ G-T '_#2WPZ_Z%S]H#_Q$[]J?_YS= !_PTM\.O\ H7/V@/\ Q$[]
MJ?\ ^<W0 ?\ #2WPZ_Z%S]H#_P 1._:G_P#G-T '_#2WPZ_Z%S]H#_Q$[]J?
M_P"<W0 ?\-+?#K_H7/V@/_$3OVI__G-T '_#2WPZ_P"A<_: _P#$3OVI_P#Y
MS= !_P -+?#K_H7/V@/_ !$[]J?_ .<W0 ?\-+?#K_H7/V@/_$3OVI__ )S=
M !_PTM\.O^A<_: _\1._:G_^<W0 ?\-+?#K_ *%S]H#_ ,1._:G_ /G-T '_
M  TM\.O^A<_: _\ $3OVI_\ YS= !_PTM\.O^A<_: _\1._:G_\ G-T '_#2
MWPZ_Z%S]H#_Q$[]J?_YS= !_PTM\.O\ H7/V@/\ Q$[]J?\ ^<W0 ?\ #2WP
MZ_Z%S]H#_P 1._:G_P#G-T '_#2WPZ_Z%S]H#_Q$[]J?_P"<W0 ?\-+?#K_H
M7/V@/_$3OVI__G-T '_#2WPZ_P"A<_: _P#$3OVI_P#YS= !_P -+?#K_H7/
MV@/_ !$[]J?_ .<W0 ?\-+?#K_H7/V@/_$3OVI__ )S= !_PTM\.O^A<_: _
M\1._:G_^<W0 ?\-+?#K_ *%S]H#_ ,1._:G_ /G-T '_  TM\.O^A<_: _\
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M.'_^@_\ \H8G_P"4A_P\4\"_]$,^/_\ WY^!O_S\Z/\ 5+B#_H7_ /E?#?\
MRX/];.'_ /H/_P#*&)_^4A_P\4\"_P#1#/C_ /\ ?GX&_P#S\Z/]4N(/^A?_
M .5\-_\ +@_ULX?_ .@__P H8G_Y2'_#Q3P+_P!$,^/_ /WY^!O_ ,_.C_5+
MB#_H7_\ E?#?_+@_ULX?_P"@_P#\H8G_ .4A_P /%/ O_1#/C_\ ]^?@;_\
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MAB?_ )2'_#Q3P+_T0SX__P#?GX&__/SH_P!4N(/^A?\ ^5\-_P#+@_ULX?\
M^@__ ,H8G_Y2'_#Q3P+_ -$,^/\ _P!^?@;_ //SH_U2X@_Z%_\ Y7PW_P N
M#_6SA_\ Z#__ "AB?_E(?\/%/ O_ $0SX_\ _?GX&_\ S\Z/]4N(/^A?_P"5
M\-_\N#_6SA__ *#_ /RAB?\ Y2'_  \4\"_]$,^/_P#WY^!O_P _.C_5+B#_
M *%__E?#?_+@_P!;.'_^@_\ \H8G_P"4A_P\4\"_]$,^/_\ WY^!O_S\Z/\
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M\N#_ %LX?_Z#_P#RAB?_ )2'_#Q3P+_T0SX__P#?GX&__/SH_P!4N(/^A?\
M^5\-_P#+@_ULX?\ ^@__ ,H8G_Y2'_#Q3P+_ -$,^/\ _P!^?@;_ //SH_U2
MX@_Z%_\ Y7PW_P N#_6SA_\ Z#__ "AB?_E(?\/%/ O_ $0SX_\ _?GX&_\
MS\Z/]4N(/^A?_P"5\-_\N#_6SA__ *#_ /RAB?\ Y2'_  \4\"_]$,^/_P#W
MY^!O_P _.C_5+B#_ *%__E?#?_+@_P!;.'_^@_\ \H8G_P"4A_P\4\"_]$,^
M/_\ WY^!O_S\Z/\ 5+B#_H7_ /E?#?\ RX/];.'_ /H/_P#*&)_^4A_P\4\"
M_P#1#/C_ /\ ?GX&_P#S\Z/]4N(/^A?_ .5\-_\ +@_ULX?_ .@__P H8G_Y
M2'_#Q3P+_P!$,^/_ /WY^!O_ ,_.C_5+B#_H7_\ E?#?_+@_ULX?_P"@_P#\
MH8G_ .4A_P /%/ O_1#/C_\ ]^?@;_\ /SH_U2X@_P"A?_Y7PW_RX/\ 6SA_
M_H/_ /*&)_\ E(?\/%/ O_1#/C__ -^?@;_\_.C_ %2X@_Z%_P#Y7PW_ ,N#
M_6SA_P#Z#_\ RAB?_E(?\/%/ O\ T0SX_P#_ 'Y^!O\ \_.C_5+B#_H7_P#E
M?#?_ "X/];.'_P#H/_\ *&)_^4A_P\4\"_\ 1#/C_P#]^?@;_P#/SH_U2X@_
MZ%__ )7PW_RX/];.'_\ H/\ _*&)_P#E(?\ #Q3P+_T0SX__ /?GX&__ #\Z
M/]4N(/\ H7_^5\-_\N#_ %LX?_Z#_P#RAB?_ )2'_#Q3P+_T0SX__P#?GX&_
M_/SH_P!4N(/^A?\ ^5\-_P#+@_ULX?\ ^@__ ,H8G_Y2'_#Q3P+_ -$,^/\
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M@_Z%_P#Y7PW_ ,N#_6SA_P#Z#_\ RAB?_E(?\/%/ O\ T0SX_P#_ 'Y^!O\
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M -^?@;_\_.C_ %2X@_Z%_P#Y7PW_ ,N#_6SA_P#Z#_\ RAB?_E(?\/%/ O\
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MZ/\ 5+B#_H7_ /E?#?\ RX/];.'_ /H/_P#*&)_^4A_P\4\"_P#1#/C_ /\
M?GX&_P#S\Z/]4N(/^A?_ .5\-_\ +@_ULX?_ .@__P H8G_Y2'_#Q3P+_P!$
M,^/_ /WY^!O_ ,_.C_5+B#_H7_\ E?#?_+@_ULX?_P"@_P#\H8G_ .4A_P /
M%/ O_1#/C_\ ]^?@;_\ /SH_U2X@_P"A?_Y7PW_RX/\ 6SA__H/_ /*&)_\
ME(?\/%/ O_1#/C__ -^?@;_\_.C_ %2X@_Z%_P#Y7PW_ ,N#_6SA_P#Z#_\
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M_P#\H8G_ .4A_P /%/ O_1#/C_\ ]^?@;_\ /SH_U2X@_P"A?_Y7PW_RX/\
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M/ O_ $0SX_\ _?GX&_\ S\Z/]4N(/^A?_P"5\-_\N#_6SA__ *#_ /RAB?\
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M3E>I*,7R\\?=3YG?1.SMRM=AR!0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!^TO[)W_ ":Q^S3_ -D
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MAU3X(K8CZCAJ#JX#+[8FE*^)KWQ6%;=>/U>GRMZ2?[^M[S>KMS2]ZM7YN/\
M*L)]<Q%7DS2H_J<U;!T[99C4G"7MYW:YG%?[+#W9SU^S/QOX^W,][X6^#]U'
MJ-_XRTR;P]JTUM\2=9R-=\0W<^I!KW1=7B::YELKC19$%NL$U]?-B9F69AFO
M?R*G&CG&?TY4*>6UH_5(_4:/\!4XTI<F+IR4::G]9YO>M1I2AR)5(WE$\#.:
MDJW#^1U85ZN94I5L8Y8RNFJ]*JY13P4XN=5TU!1<X\U:I&JW*5%J%-W]>\'>
M/=/\$? 'X26WB.T34?!'B[Q%XX\,>,]/="Y;1KZ^OO\ 3K<*-RW=C.L=PA3Y
MBJ2*F'=67S,VRUYGQ3CL-2JNABZ.6X;$82JFE[+%494'2;;TY9<TH2O[JYE.
M2DH<K]#)\Q>4\+PQOLE7H_VNJ&(I27,JV$K8.NJ]+EZMJ,9):<SBJ;E&,Y,Z
M#QU\);1-/_9S^';:G!?^&[#6/'VKW6MQD26\W@NWN[?Q.U]))$=JF302B,R_
M+YLORY4KGER_/*E/,^)<YQ%'V&*PF6X",Z335L91C]44%%IR<7BDK1LY^S=F
MN9-';C,DIU,ARK)LOK^WPV:9U?#58R][ZMBX8O$<W-HG.CAY3;E[BG*DY+DC
M)6D^UZ?\1_B+\'/BII&JZ)K,^E?$&Z\$:]-X=M-=M+*UL))=0UKP:L\/B#1=
M,N5GBTN>:TEE$#PO)$NR5FW*BPU*ODV%SC+,11JT%F&4U<7!UI49<^,H894,
M<X.C5JKEJOV=6$).,XPC*\.6TI9XZIA<W>68W!5*5;^Q<ZP>'BJ,*L90RS$X
MR$L'[=5:=/EE1J4Y4G[/GI.I7NI)OE.AT72/#0^+&G_'M$M&M_$-[I7@RSTL
M.D;Q?$W4/$$O@W7YHXHV)V0:)8WNH8D&9/MHDR"<CEHUL52R:?#<>9.O3ECZ
M=3=1RM8-YG*+=OB6*4<->+M%_N]4K/OQU#"5<X_UAE;ERFM6R^O3^U+,*&-A
MEF!G**=G&I0Q%.OR[QA0C4^)IKS3Q7KY\/?#3Q).OC;QOX(,_P"T/\28%O/!
M%K]JO+\^6[BQU #Q;H/EV)*[]WG7/S(O[D_>7JP6'^LXGANE]2PV8?\ &+89
M^QQ<N6CI74>>_P!7Q/OKFY$O9?!.?O*W+/AQ=98:GQC5^N8C+TN+ZD?;X2/-
M75\#?D4?;X;W)<O/+]\O?ITURN_-#YB^"WABT\5_$;1(=7E6'0-&:Y\5>)KN
M='DA@T+PY$VJWYN0@9O*F\B.V) =LW8(5CP?N,VQKRS*\7BZ22KTZ:IX>*NK
MXFM*-'#J-DW>-2<9\J5W&#21\/E^!EF^9X3 2;DL;6M6E+7]RE*KB)3E*22;
MHPJ)2E*RG*-V[Z_85I/:^//BM\$_B[IVJ:+K4\_B+6?!?BFZ\.VVN6^E6^IZ
M98ZGJGA\"/Q!HVF7@FDT&]2)V>U"%K$!'<#-?#1A5R7+>(LHJ4JM"-;*WC\.
MJ[HN<YPI0PV-:]A5JP4'7IQJ0AS*2523<4K-_<XNK0SG$9-FN&JTZSR_.*>"
MFJ4:T.3"5\4\5@%*-6E2=Z,95:-2JE*$ZC@E-R3A#-^Q:!XA\ ?&[XK^&!;6
M4?BCP/<:3XPT")D5M%\;Z;K%I)?S01 Y_L[5;=A?Q$ X9Y0Q#-M0FZ^!J\/9
M-7YJE"&:9?B<!5>O-A)N:E0D_P"?"5)*ETO3E#ECRQ3EV>SP^+QW$>9T+4\3
MALLSS+\?3VYJ]."^KXN*_EQ5&C-U+:*K3E>4ZDJC6IJ.L>)-1_: TOP=?7=[
MJGPTE\!:'+XOT#5));[PE8:*?!IN+S4[FTNF:TTB9;A(W2]C$$GFE5#DR%62
MH8./#_$..J1C2Q]#'XSZKB(6ABE7C7BJ%.C4C:I)N3:]DN9.+D^7W>:/$JV.
M69<&8/".52ABLJP*Q&&?OX:K1E4JQKRKT97I.*I12=2:TY8QYK/EEX)^S3+I
ML/Q)\6V>F7$<&LZAX)\9Z;\/9[AT1VUZ9(_[,6&28*%O7L([D*6*9^=>K 'Z
M#BB&)J<,?O*;E*-3!5,=""=WAHMO%12C=M*?LW:-VDN9:1;7C\/2R[#\:4?9
M3C' 1Q.*A@YSNXIMRCAFY3Z2H\\%SV<YSA&[E)1E8_9FT[5M"^(?B?5?$%I=
MZ9X;\.>$_%=MX^DU2":VM+>WDLFB&EZF;B,+]LEOQ RVSD2/Y#E0=A!7%6(P
M];ANI#"U8U:^-EAEERI23E/$>U@Z<Z'*[WC#G2G'2#FDVG)$<,8;'X?BW!2K
MQG0^H5:]3,)U;VI4/J]?FE7G).*@ZOLZC<G:2@YW<8MEW6_B!XYF_9OT'43X
MT\7->7_Q0\0:/=WDGB367O+O11X=B9-(N[EKTR7.FC>W^C2,T66)V\FH66X!
M<683#RP.'=+^QW6E#V%+V;KK,%'VW)R\OM$M%.W,HZ)V+HYGC%PSFV)P^,Q-
M%T>(*%'#R5>K[2CAGE;J1H0GS\T::E:7(I<O.N:W-J>V"V\*']J7P%<3:UXA
MC\3+X;T#R=(B\,:;+H3J/ EPJ&7Q$WBZ.ZA)MR[D+HDF'41@E6,B^(Y8N/"_
M%T:5"E+#?6,PYZDJTX58_OX7Y:*P\X2L[)7KPNFW962?J5(X5YCP0ZM:K3KQ
MR_+/9PA1A.G)>VJ\O/4E7IRIMRYDU&E4M%*2<G)QCY1XJ\0-HGP(^&-NGC?Q
MQX4;49_BM"NG^$[8SZ?X@9?%%P@L_$,H\7:0;>S!F\L,+74_DNISY7R[)O1I
M8=8GB+'1>!PN/5/ 9*VL5*RHIX;6='_9\1S5&HZJU+6$%SZWAKF&(^J9?BJG
MU[$Y=?/\T2JX2/-5=JC:C)?6,-:,?B3]I+WOLK<]5\47T\OA;Q7I]CK.K^);
MVV_9\\%$_#*_4Q^'[.QN])L5O/'&C[[VZ6^U73%5)7ABLM/E4R!A-,,;?-JP
MBL?B*M2C3H4?]::T99BOX]&4)\U/"M*,7&ABFW#VGM90BW/GHI+FD\MG+^S<
MCHTZU2K6?"-*=/+K/ZOC+PJ4Y5&^9J5>BDFJ*I*K4C3I1HU[N48>$_LW?\BW
M^T!_V236/_1=S7O\7_[MDG_8YR__ -.,\/@C_D<XO_L4X_\ ]*PQ['-K7BVY
M^+_PD\'6]U?:GX&O_A7X$?Q=X8OWEO\ PF-!DT>8ZUJ6I:7<LUE:-';Q(PO6
M2-U>.)1)\VU_*E0P'U+C7&8N,*=?"YKF7U?$*T,12K1IPEAX4:T;5(MUI:4X
M2UYINV[771Q&94UX>X3+I3E'%91E'ML,KSI5J4L34IXF56AK3J<N'CK*<7RJ
M$-?=1P_C?7=/T#X*?#RST/QSXX\+:5>:A\7K;1[+PG USI_B/3H_%MW%86WB
M&X/B[2&AL_LTL2"0VNIDI=SGRLC9-KA:&(Q>?8KZ[@,-C<5'+<CE7CBVH*C5
MEA4ZLZ45A\0G4YE*\;4E>G!<]G>'9BJN&P655OJ..KY?@XYYF4,/5P/[R4J,
M)?NHW^L8>]-0Y90E[6=WK;[3]DBLM \=>-/A#X?(MM/\=?#WP_\ "KQ=H=T[
M+$/$?A1K+2[CQ%HDCG&Z^T]H7U"W!)+)).JJ!YC5QRJ8C+ZW%68T[SP&+QN;
MX#%TUJZ56<*BPF*BNSJ5OJ];9*+IMN3]G%9T:>&QV4\&Y35M2QD,KRC,<#5;
MMS2I5$L7A):;5,/A8U:6[]K3E>4(*?/Y9H_C/QA:6?[5L-KXK\2VT/ARXO9?
M#T5OKNJ0Q:#+<>/+\7$NC1QW072Y)0[AVMA$6WMN)R:N6$PDLKX%JRPM*53$
MSR^G6FZ<'*K36!BE3J2:O."48I1DW%**5M$=-+$XB'$/&U"&(J1H4,/GM:E3
M4Y*%.M[:=3VL()\L*G/*4^>*4N>4I7NVSL_A-?W=YIW[/&IW^H7TU]<:1^T%
M>7FIR32W6I/<R2WDTU\T\TZR7%X9"TF]YE9GY+@G<(XAITL/4XUI481H4:.5
MY!&$*<5&-.,:E-14(QY8Q44K12LE:RL3P]5K8G_4VK7F\36J\09AS2K2E-U'
M_9>)7OSESR:>S;4M.CV/)/"FNMK_ (*^/MV?&/C+QNL7@/PK;KJWCBW-KJT.
MWQ1*YLH8?^$IUX"Q0R>8C"]7+SR_N5QND]K%8987%\+Q^H87+W+/:$N3"2YH
M3_<\JG-_5\-:>G);DE[D8/GUY8^;E6*>)J9W_P *&+Q\:?#^:)/%QY94VXIN
M%-?6<2N1KEDY<T&Y.2Y/=4I>I^./$#2_M,^$M 7QOXXNA!XU\ S/X*NK8IX)
ML%&E:=*+NPN1XNF\V\W2K)M.@VWSW4_[WY=TWD9)AU_J]F>*^HX9\N&SM+%N
M7^V)I8J/)R_5]())P3^M?!&/N*_+'?/<1R8W(,-]>Q-+G?#S^JPC_LE3_;,'
M+FJ2^L1M+W54M]6G^\C'WOMQI^)/$DMEIO@KQ%%9:W\;M,TOXQ>*;W5)]=M'
MGUWPY<:;:WB?\(7;:<TVJR1Z?%9JVKV\S7DMNYT^-C! HVIGE]&'M8TJDZ>0
MRK</4XTJU&24<4JTH<V-JU&J48UJ,VJ,X2BY_O9.%::7,_1S2I4E3S+V,*F<
MO#\1VJ8:I&4OJ7L:D^3#8>"=24J.)_APJQY*-E"G/#*K-P7B/QQ76-9\.>$_
M'5OX[\0>,? WB75_$4N@6?C"U2V\2>&M2W6RZII3.'E2ZTU!;PI&]C*MFC0,
ML<,9):7W<AC2P6/KY76P%'"YGAL)0<Z^&DW2Q5!2ER5)IVG"MS3;?ME*K.,N
M;GY?=CX>>5*F/RZ6:X7&U:F55\>XO"8B"4L'B71DU3H25XO#JG&<;4O9PBXQ
MC.$ZL7-?--?6GQP4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 ?M+^R=_R:Q^S3_V0#X-_P#JNO#E?SD?T0?0% !0 4 ?G1_P4GU3
M3-$^''P3U/6-1L-(TVU^/]I]HU#4[NWL+&W\[X)_&^WA\^[NI(XH=\\L4:[F
M&YY$499@#[_"]:CAL\P-6O5A0I0]MS3J2C"$;X>K%7E)I*[:2N]6TMV>#Q-1
MK5\CQM&A2G6JR]CRPIQE.;MB*4G:,4V[)-NRT2;V1^:=Q\>O#%W<:/=77QGT
M&YNO#T5K!H%S<?$73YKC0X+%UDLH='FDU@OID5O(B-$EL8Q&R H 0*_588_(
M*<L1*GC<OA+%N3KN-;#)UG--2=9J2=1R4I*3GS74FG=-GY9+ 9].GAZ,\%CY
M4<)I0INCB'"BO=TI1<>6G\$/@4?AC_*K6--_:$T+1M3O]:TCXX:3I6L:H93J
M>K:;\2[.QU/43/,+F8W]_:ZTD]X9+@"5O-=]S@,<L,U$L7PY/#T\)/$Y;+"T
M>7V=&53"NE#DBXPY*;?)'EC)QC9+EBVE9-EK"<11Q,\9'#9C'&34HRKJGB56
ME&3BY1E52YVI.$').5FX1;^%6??_ +1.C:IYG]I_'33-1\W4+75I?M_Q.M;O
MS-5L($M;'4Y/M&MOOU"WMHXX8K@YDCCC5$8*H 5+%<-8=TW0Q&64'2C.,'3J
M86#A&I+FJ1BXM<L:DO>FE92EK*[*K8?B7$0J4Z]',Z\*L8PG&I#%3C.-.3G"
M,U)-2C"3<HIW49-M)-ME2[^/7AB_AU.WO_C1H-[!K-[%J6L07?Q%T^YAU74;
M<;8+_4XIM89;Z]C4D)/.'=1P&%5#&<.4O8>RQ66T_JG.J'+4PL?8JI_$5*TE
M[/G^WR6YNMR9X7B.H\0ZF&S*;Q:IQKN5/%-UHT;>QC5NG[14K+V:G=0LN6UB
M?0?V@] \*K<IX8^-^D>&UNS&UVN@_$JRT=;HQ!A$;E=/UJ$3% S!2^[;N.,9
M-/$8WAW%J,<5B\NQ,87Y55JX:HHWLGRJ<G:]E>V]E?8G#X'B#!RE+"X3,,+*
M22DZ5+$TVTKM)N$8MI-MI/:[,2[^+OP]O[F:]OOB?X-O;RX<RW%W=^-=$N;F
M>1OO233S:FSRN<#+,Q-:TLTR2A"-*CF.!HTX*T80KX>$8K>RC&:27HB*V6YY
MB*DJM? 8ZO5E\4ZE#$3F[))7E*+;LDEJ]DD5O^%H_#+_ **+X$_\*[P__P#+
M"K_MC*/^AK@__"FC_P#)F?\ 8^;?]"O%_P#A-6_^0-FT^.OA.PTZ31['XQ^'
M;+2)KV#4Y=*M/B%IMMITNI6K1-;:A)8PZNL+WL+00&.<H9$,*%6&P8QGF&0U
M*M*O4QV7SKT%*-.I*MAW.G&:E&2A-R<H*2E)246DU*2=TV:PR_/:5*M0IX''
MTZ&(Y55IQHXB,*JA)2@JD%%1GRR2E'F3Y9)-6:-F]_:7L]1N=/O-0_: MK^[
MTF<W6E75[\5HKJYTRY*&,W&GSSZ\SV<_ELR^9"R-@D9P:PIUN%Z'M/8U<KH^
MV@Z=3DEA(<\&[N$^5KF@WJXNZOT-ZE'B>M&G"K2S2K&C-5(1G'%R4*D?AG!2
M349QZ25FNC*>H_M#Z)J^HV.KZM\<M*U35M+(;3=3U'XF6E[J.G,K!P;&]N=;
M>:T(=0V8G3D ]15T<5PWAHU88?$Y;0A65JD:=3"P4U9JTU%I25FU[U]&UL37
MPO$>)=)XG#YE7=!WINK3Q4_9NZE>',GR.Z3O&VJ3W0NI_M$:+K5]I^IZQ\<]
M+U;4](D2;2=1U/XFVE_?:9-'*D\<NGW=UK;RV4BSQI(K0NA#HK Y -%#%<-X
M558X;$Y;AXUXN-14JF%IJI%IQ<9J#2E%QE*+4KJS:V;"OAN),4J:Q.'S+$*B
M^:"JPQ510EI[T5-/E>BU5GHNQ?O/VG8=0>"6_P#VA8KZ2U6Z2VDO/BRER]NE
M[;O:7BP/-K[&%9[622&4(0)(W9'RI(K*,^%(*I&$\IC&K%0FD\&E."E&:C-+
M245.$)J+NE*,96O%-:N/%3E2DXYJY4*BJTFUC+TZJA.FJD'O"HJ=2I34XVDH
M5)QORSDGSC_&SP6^DQ: _P 6_"[:%!>/J$&BOX]TEM)AOY(S%)?1:<=5^SQW
MC1$H9EC#E3@MBNIYCD/MUB?K^ ^LQA[)5?;X?VBI\W,Z:GS<RAS>]R7Y>;6U
MSECEV>PH3PT<#CXX:I-59TE1Q"IRJ**@JDH*/+*:@E%3:<E%**=E86;XV^#+
MG2K/0KCXN>&)]$TV::YT[1YO'VE2Z587%R6:XGL]/?5C!:S2L[EWBC5F+$L3
MDT?VCD*KO%?7L L3*"INK[;#^U<%:T'4YN9P7*K1;LK+31!_9^>JA]5^HX]8
M;G57V/L<1[+VBBXJI[/EY.=1;BIVYN5M7LV:T?[1FDPVEMI\7QWTZ*PLM.NM
M(L[*/XGVR6EII-\L2WNEVULNN".#3KA8(!+;(JQ2"&,.IV#&,\3PS4G4J5*^
M63J5I0E4E*>%<IRI-NG*;;;E*FVW!N[@V^6US>E0XFP\*5.A1S.A3H2<J<:<
M,5"-.3YDY0C%)0D^>=W%)OFE?XG>GI'Q[\,^'HY8=!^-&A:'#-<VMY-%I'Q&
MT_3(Y;RQ9FLKN6.RUB-7N;=F8Q2L"T98E",FM*V/X?Q')]8QF7UW2510]I6P
MT^158>SJJ/-)\JJ0]RHE;GA[LKK0PHY?GN&]I]7P./H>V]E[3V='$0Y_85/:
MT>?EBN;V-7]Y2O?V=3WX6EJ+%\?/#4"6\</QIT.&.TUAO$-HD7Q&L(TM=?;&
M[7+=4UD"'6#@9O4"SG ^>DL;P\G%K%Y<G&@\+%^UPUUAGOAU[VE!]:2_=OK$
MJ6"X@DJBEA,PDJU=8JHG2Q+Y\5'X<3.\?>KQZ5I7J+I(U=._::MM'CN8M)_:
M"@TN*\O;G4;R+3OBO'8QW6H7C!KN_N4MM?03WL[*#).X9W(!9CBL:E7A:M&E
M"K4RJK"A3C1IQG+"25.E&_+2@I-J-.-WRPC:*N[+4VIT>)Z,ZU2E2S2E/$5'
M6JRA'%QE5JR24JM1I)SJ248ISE>344F]$<_8_&WP9I?]H?V9\7/#&G?VM9SZ
M?JOV'Q]I5I_:=A<L&N+'4/L^K)]LLY652\,V]&(!93BNBIF&0U84Z=7'8"I3
MHSA4IQG6P\HPJ4[^SG"+DU&=.[Y))*4;OE:,8X'/Z=:IB88/,(8BM&I&I5C2
MQ*J3C5:=6,YJ*E*-5I.HFVIM+FN7-)^/OAO0(!;:%\:M$T6V%['J0M])^(]A
MIT U&*)H(K\16>LQK]M2%FC6?&]58J& .*FOC>'L2T\3B\NKN,)TTZE7#3M"
MHK5(+FD[0FM)QVDM&F%' \0893CA\'F%"-1TY35.EB8*3I352DY*,5S.G-*=
M-N[A-*4;-7*UG\<?"&GVNJ6-A\8/#=C8ZXB1:W9V?Q TRVM=8CC9VCCU2WAU
M=8]016DD(6=9 #(Q'WCFIX_(*OL/:XW+ZGU62G1YJV&E[&:Y;2I7D_9R7+&T
MH6:Y8ZZ(<<%Q#3GB*D,)F,*F+C.->4:6)4JT9\W/&K)13J1GS2YU-M2YI7O=
MFQJ7[26GZQIW]CZO\?+/5-("QI_9>I?%."^TX)"-L*_8;K77AVHH 4;,*!@8
MK"-?ABG6^L0K97#$)N7M8SPBJ<S=W+G34KMZMWNWN:>QXG]C]6]EFGU?D5/V
M7+B_9^S2Y5#DMR\B6BC:R6EK'*1?%?X;V\L<\'Q*\$0302)+#-%XQT&.6&6-
M@\<D<B:B&CD5E!#*000"#D5VO.,GLU_:F#LTTU]9H[/1JW/LUHSC_LC-U_S*
M\6K;?[-6_P#D#I]8_:-TKQ%9IIWB#X[Z?KNGQLC1V&L?%"VU.S1H\>6R6M[K
MDD:LNU<$*,8&.E<=+$<,8>K[>A6RNA65_P!Y">$A/7?WXM2UOKKKU.RI0XFJ
MT7AZM',ZE!\MZ4X8J5/W-8W@TX^ZTG'32VEC%;XT^"'TN'0W^+/A5M%M[R34
M(-(;QWI#:7!J$L0AEOH=/.J^1%>/"HC:98PY4!2V!BNC^T\B]LL3_:& ^L1A
M[)5?;X?VBI<W/[-3YN90Y_?Y$^7F]ZU]3G66YW&C/#1R_'1P\ZBK2I*A75.5
M:,/9QJR@H\KJ1I_NU-KF4/=3Y="__P +^\.?VQ;^(O\ A=>B?\)!:11P6FN?
M\+'L/[8M88;<VD4-OJ?]L_:88DM&:%5210L9* !3BL_KO#JHUL/];RY8?$.3
MJTO:X;V=5S:<W4AS<LW)I.3DFY-)N[+>"X@<Z%1X3,'/"1C"A)TL3S484VW"
M-)\MZ<8-MQC"RBVVDFS1L?VE;'2]-_L;3/C]:Z=H^VY7^R;'XJ0VFF[;R266
M\7[#;Z\D&V>6:9Y!L^=I7+9+'.5:MPOB)^TKU<KKS2C'FJ2PDY<L(J,(WDV[
M1BE&*VC%)*R2-Z5/BF@Y.C#-:+E.563@L7!NI)\TJC<;7G*6LIOWF]6[E"+]
MH#P];ZC!J\'QMT:#5K73TTFVU2+XDV,>HV^EQP?98]-@O4UH30Z>MK^Y6W1Q
M&(_D"[>*TEC.')TZ]&>*RV5'%3=2M3E5PKA6J2:E*=6+ERU)RE&+<IIR;BFW
M=(QA@N(*4\+4IX3,:=3 0C3PTHTL3&6'IQ4HQIT)**=&$8SFHQIN,4IR25I.
M]/3?C?X.T:/48M(^+_AK2HM7M'L-6BTWQ_I=C'J=C)GS++44M=607MHVYMT,
MP=#DY7FKJYAD%=4XU\=E]:-&<:D%4K8>:A4A\$XJ4FHSA]F2M*/1HFC@,_PU
M25;#X/,*%:<90E.G1Q$)RA-ISA*48J3C)I.46[2:5T[(V;O]I+3[[2AH5]\?
M+.\T-;>*T71KOXIP7&E+:P1B*&V&G3:ZUN+>.)518Q'M50   *Q]OPQ[?ZU[
M;*_K/.ZGM>?">U]HWS.?M+\W.V[N5^9O6]S6-#B6GAUA(4<SAA8TU25&,,4J
M2I)**I*FDH*FHI14+<J22M8-._:2T_2-+70M)^/EGI>B*D\2Z/IWQ3@LM+6*
MZ>22ZC73[;74@"3/-*TBB/#F5RV2QR5Z_#&*J.KB:V5XBJU%.=6>$J3M%*,4
MY3;=HQ245?1)):(>'H<38.*AA*.9X6$9<RC2ABJ:4MW)*"BE*ZWW,U?CUX83
M4['6U^-&@KK.EP6]KIFKK\1=/74].M;2$VUI;6-^-8\^S@AMR8HXXI$5$)50
M%.*U^O\ #ZA7I_7<O5/%2E.M'VV&Y:TYVYY58\UJDIV7-*:;E97;L8?V?GW^
MS?[%C[X*$*>'_<XC]Q3I-RIPH^[^ZA3DVX1ARJ#;<4F1+\<_"*#60GQA\.*/
M$1)\0!?B#IBC72;AKLG60-7_ .)F3=,TW^D^;^\8O]XYI?7N'N3#TOKF7>SP
MCBZ$/:X;EHN$>6#I1YK4W&/NQ<%'ECHK(OZGQ"JM>M]5S%5L5&I&M4]EB>>M
M&KK5C5ER\U2-1_Q%-M3^U<LV?[0'AW3X].AL/C9HMC#H\>H0Z1%9_$BQMH]*
MAU;/]JQ:='#K*K8QWNYOM"PA!-N/F!LTJN,X=KNNZV*RVL\5&G"LYU<+/VT*
M33I0J\TG[2--I.G&=U!I<J04L'Q#A_8>PPN8T/JM25:CR4\3#V-647"56ERQ
M7LZDH-PE.%I.+<6[-HH6?QJ\$Z=;:A9:?\6O"UA9ZM#%;ZK:6?CS2;6VU.W@
MD\Z&#4((-55+R&.8;U29756^8 'FM9YGD=25&53,,#.6'FJE)RKX=NE46BJ4
MVYMPFEHI1M)=S.EEV>4/:>QP&.H^UIRI3Y*&(ASTIJTZ<^6*YJ<UI*#O&2W3
M.GN?VH5O4MH[S]HA;M+.YM[VT2Y^+8G2UO+1M]I=VRR^(&$%S"XW1RIM9#RI
M!KDC4X5IR<X3RJ$Y1G%RC+!IN-2+A4BVFFXSA*4)K:49.,KIM'3*CQ/*FJ,J
M6:2HQ=-JFXXMP3HSA4I-1:Y4Z52G3J4VE[DX0E&THIK*TW]H/0=&^U?V1\;]
M(TK[=>Q:E>_V;\2K.Q^V:C!(TL%_=?9=:3[1>QRN[I/)ND5F)# DUK/%\.5(
MT85,3ELX8:,H4HRJ85JE"4%3E"FFVH1E!*$HQLG!*+5M#..$XBA/$588;,HU
M,7*,J\U3Q*E6E";JQE5DE>I*-1NI%S;:FW-6D[D&N_'KPQXHFAN?$WQGT'Q%
M<6T;16\^N_$73]7FMXF(9HX9=0UB5HHRP!*J0"0.*>'QG#N#Y_JF*RW"\]G+
MV57"T^9K1<W)*-[+17VZ!B,)Q%BU!8K#9CB52OR*K3Q-3DO9RY>=/EO97M:]
ME<PO^%H_#+_HHO@3_P *[P__ /+"NG^V,H_Z&N#_ /"FC_\ )G-_8^;?]"O%
M_P#A-6_^0#_A:/PR_P"BB^!/_"N\/_\ RPH_MC*/^AK@_P#PIH__ "8?V/FW
M_0KQ?_A-6_\ D _X6C\,O^BB^!/_  KO#_\ \L*/[8RC_H:X/_PIH_\ R8?V
M/FW_ $*\7_X35O\ Y /^%H_#+_HHO@3_ ,*[P_\ _+"C^V,H_P"AK@__  IH
M_P#R8?V/FW_0KQ?_ (35O_D _P"%H_#+_HHO@3_PKO#_ /\ +"C^V,H_Z&N#
M_P#"FC_\F']CYM_T*\7_ .$U;_Y /^%H_#+_ **+X$_\*[P__P#+"C^V,H_Z
M&N#_ /"FC_\ )A_8^;?]"O%_^$U;_P"0#_A:/PR_Z*+X$_\ "N\/_P#RPH_M
MC*/^AK@__"FC_P#)A_8^;?\ 0KQ?_A-6_P#D _X6C\,O^BB^!/\ PKO#_P#\
ML*/[8RC_ *&N#_\ "FC_ /)A_8^;?]"O%_\ A-6_^0#_ (6C\,O^BB^!/_"N
M\/\ _P L*/[8RC_H:X/_ ,*:/_R8?V/FW_0KQ?\ X35O_D _X6C\,O\ HHO@
M3_PKO#__ ,L*/[8RC_H:X/\ \*:/_P F']CYM_T*\7_X35O_ ) /^%H_#+_H
MHO@3_P *[P__ /+"C^V,H_Z&N#_\*:/_ ,F']CYM_P!"O%_^$U;_ .0#_A:/
MPR_Z*+X$_P#"N\/_ /RPH_MC*/\ H:X/_P *:/\ \F']CYM_T*\7_P"$U;_Y
M /\ A:/PR_Z*+X$_\*[P_P#_ "PH_MC*/^AK@_\ PIH__)A_8^;?]"O%_P#A
M-6_^0#_A:/PR_P"BB^!/_"N\/_\ RPH_MC*/^AK@_P#PIH__ "8?V/FW_0KQ
M?_A-6_\ D _X6C\,O^BB^!/_  KO#_\ \L*/[8RC_H:X/_PIH_\ R8?V/FW_
M $*\7_X35O\ Y /^%H_#+_HHO@3_ ,*[P_\ _+"C^V,H_P"AK@__  IH_P#R
M8?V/FW_0KQ?_ (35O_D _P"%H_#+_HHO@3_PKO#_ /\ +"C^V,H_Z&N#_P#"
MFC_\F']CYM_T*\7_ .$U;_Y /^%H_#+_ **+X$_\*[P__P#+"C^V,H_Z&N#_
M /"FC_\ )A_8^;?]"O%_^$U;_P"0#_A:/PR_Z*+X$_\ "N\/_P#RPH_MC*/^
MAK@__"FC_P#)A_8^;?\ 0KQ?_A-6_P#D _X6C\,O^BB^!/\ PKO#_P#\L*/[
M8RC_ *&N#_\ "FC_ /)A_8^;?]"O%_\ A-6_^0#_ (6C\,O^BB^!/_"N\/\
M_P L*/[8RC_H:X/_ ,*:/_R8?V/FW_0KQ?\ X35O_D _X6C\,O\ HHO@3_PK
MO#__ ,L*/[8RC_H:X/\ \*:/_P F']CYM_T*\7_X35O_ ) /^%H_#+_HHO@3
M_P *[P__ /+"C^V,H_Z&N#_\*:/_ ,F']CYM_P!"O%_^$U;_ .0#_A:/PR_Z
M*+X$_P#"N\/_ /RPH_MC*/\ H:X/_P *:/\ \F']CYM_T*\7_P"$U;_Y /\
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M:/PR_P"BB^!/_"N\/_\ RPH_MC*/^AK@_P#PIH__ "8?V/FW_0KQ?_A-6_\
MD _X6C\,O^BB^!/_  KO#_\ \L*/[8RC_H:X/_PIH_\ R8?V/FW_ $*\7_X3
M5O\ Y /^%H_#+_HHO@3_ ,*[P_\ _+"C^V,H_P"AK@__  IH_P#R8?V/FW_0
MKQ?_ (35O_D _P"%H_#+_HHO@3_PKO#_ /\ +"C^V,H_Z&N#_P#"FC_\F']C
MYM_T*\7_ .$U;_Y /^%H_#+_ **+X$_\*[P__P#+"C^V,H_Z&N#_ /"FC_\
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MLL?M+4 ?0% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'S_P#LG?\ )K'[-/\ V0#X-_\
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M6WB6:*^M)KG5864<9@<#5DHU:\,2ZWLW&I:6'C3J1AA$I1=:5:E.K5C2QO\
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MR-*N<Z@H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M7Q4E15>LJ2@X^S5:JH6]I.^)<? [X*WFE3:#=_!_X776AW.FZ'HUQHUQ\/\
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MI22G).2YI:ZL)1C.5"4XJ4L)3=*@Y)-T:3LW3I-ZTZ;:5X0M%V6FAB77P?\
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M9=50Y?=K4</4BXNG9U=%^&/PU\-6_P!C\._#WP/H%I]LL=1^RZ+X3T#2K?\
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M #_A'/VI_P#HLGP _P#$:?B+_P#18T '_".?M3_]%D^ '_B-/Q%_^BQH /\
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M /18T '_  CG[4__ $63X ?^(T_$7_Z+&@ _X1S]J?\ Z+)\ /\ Q&GXB_\
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M/@!_XC3\1?\ Z+&@ _X1S]J?_HLGP _\1I^(O_T6- !_PCG[4_\ T63X ?\
MB-/Q%_\ HL: #_A'/VI_^BR? #_Q&GXB_P#T6- !_P (Y^U/_P!%D^ '_B-/
MQ%_^BQH /^$<_:G_ .BR? #_ ,1I^(O_ -%C0 ?\(Y^U/_T63X ?^(T_$7_Z
M+&@ _P"$<_:G_P"BR? #_P 1I^(O_P!%C0 ?\(Y^U/\ ]%D^ '_B-/Q%_P#H
ML: #_A'/VI_^BR? #_Q&GXB__18T '_".?M3_P#19/@!_P"(T_$7_P"BQH /
M^$<_:G_Z+)\ /_$:?B+_ /18T '_  CG[4__ $63X ?^(T_$7_Z+&@ _X1S]
MJ?\ Z+)\ /\ Q&GXB_\ T6- !_PCG[4__19/@!_XC3\1?_HL: #_ (1S]J?_
M *+)\ /_ !&GXB__ $6- !_PCG[4_P#T63X ?^(T_$7_ .BQH /^$<_:G_Z+
M)\ /_$:?B+_]%C0 ?\(Y^U/_ -%D^ '_ (C3\1?_ *+&@ _X1S]J?_HLGP _
M\1I^(O\ ]%C0 ?\ ".?M3_\ 19/@!_XC3\1?_HL: #_A'/VI_P#HLGP _P#$
M:?B+_P#18T '_".?M3_]%D^ '_B-/Q%_^BQH /\ A'/VI_\ HLGP _\ $:?B
M+_\ 18T '_".?M3_ /19/@!_XC3\1?\ Z+&@ _X1S]J?_HLGP _\1I^(O_T6
M- !_PCG[4_\ T63X ?\ B-/Q%_\ HL: .0\:ZW^TE\-;'PWXEUWXA_ _Q3HE
MW\4/@UX*UC1-)^!/CSPKJMSI7Q,^+G@CX;:A<:9X@O/VC]=M]-U"SM/%DU["
M\^D7\;26:1O$5D+*;?(-OD?5] !0 4 ?/_[)W_)K'[-/_9 /@W_ZKKPY0!]
M4 % !0!\_P#QD_Y*+^R=_P!G >(__66/VEJ /H"@ H * "@ H * "@ H * "
M@ H * "@ H ^:/VP5N6_9T^(B64T%O>,GAA;2>ZMI+NV@N3XR\/"":XM(KJV
M>Z@278SPI<V[.JE5EC+!UP:J/->%51E&G5?$60J$IQ<X1G_:F%Y92A&=-SC%
MV<HJI!R2:4XM\RG$.E'*N)76A*=&/#_$+J0A-4YR@LDQ_-&%24*L82<;J,W3
MJ*+LW":7*^7^*FJ_%3X>^%O!7BCXE_$_P>='T;XS_#N\\4>(? O@_P 4_"C0
M])\!2W%WIVN)XR.K_%+Q@MYH)N[RPENKBYN]/L88(B]RC+'YB[4JE"GFV2>V
ME[*C-YQ3K2JU81PTYU,BS!9?"4)QC%5%CXTU1E.I+GQ4\+&C"%:"E4QQ-/%2
MRS-GATZDXPRB=&%&E-XF"I9_EE3,*BG";E*F\M5=584Z491P\<5[2=6E5<*?
MQMXU\:KX^\1?$O7;77;WQ!HRZ%^T+IWAR]NKNYN[9="L/B9^S+%9QZ*]Q(ZI
MH+R&>XM/L^+>2*Z$\(*3AFZ\BIU(8#)95Z<J>)JY_P %RJJI%QK7CX@<94J4
M:RE::J4</3HT.2I[]&%*%"T5348\6>U8SP?$\:5:-;#4\%GOL73FIT5&IX99
M77J>Q<6X<M2O5JUI.G[M2K4J5;RE.4G]5?MCZKXUT-? 6K?#E;H^-K#0/C-/
MX<:Q@:YO;>^7X=70^UV=NFG:@TUU;0F6>-4L+YR\*[+:=L12>52ERYQ54FHX
M>>5TZ>*DZLL/&&"J<6\(0QDYXB$*D\/".%E5<\1"$YT(*56,6X(].NO]FRKD
MIQK5H9PIX>E.*G"KBH<+<6SPE*4)5\-&:J8F-*#IRQ.'C/FY)5J2DYQ^=/#G
MC[Q4=+OTD^*FCGX"S^+_ (:V?Q%\6>!?VD/BW\9-1\ Z1?6/C=O%U_<_'KQ1
MX!\*W/@ZTU+6+'P1:ZEI^FZVUSX:BN+NY)T:WU" Q^K&&%Y<NCC6Z.%EBLT^
MJU5*-'#UO9Y=3J8'!RQBKQK8RA'&JM4P^,E.K'%XET\LJ8G$<KPZ6JH9C4I2
MJ/-J>$P_MZ/)&I5C5>;9=3Q-9Y8L-*.6UXY76QSKX?DH4X4J4<9AL+0J8:O7
MJXU[\4?#TN@^)] 3XK?%C7[4>+_C2WPFU74/V@_%GPUT+Q"NC1>$K?POIMIX
M\T/[3XT^(FLV8O)GTC0],.N0:C97$VH76G:G/<6]R/)J5L9')Z6)]FZ>=X7
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MZ[\I\=_#3XL7OP-^$OQ?^'?PUTO4[B;X6^(_AQJ/POM?BWX$^*'P_EU7P?\
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M7$NE>(DU2SFFN)Y987>XE:10J2IXMXZ'+&O_ +.^7EC[!2P:Y<%-85IX:-3
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MG5G.<E]NK/K6JU:TE]E3K5)59J$5[M*E&4VJ5"FH4:%-1HT*=.C"$(ZM( H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H ^?_ -I;_DG7AS_LX#]D[_UJ?X-T ?0% !0 4 ?/_P"R
M=_R:Q^S3_P!D ^#?_JNO#E 'T!0 4 % 'S_\9/\ DHO[)W_9P'B/_P!98_:6
MH ^@* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M _XR*_ZO_P#_ #EE0 ?\9%?]7_\ _G+*@ _XR*_ZO_\ _.65 !_QD5_U?_\
M^<LJ #_C(K_J_P#_ /.65 !_QD5_U?\ _P#G+*@ _P",BO\ J_\ _P#.65 !
M_P 9%?\ 5_\ _P"<LJ #_C(K_J__ /\ .65 !_QD5_U?_P#^<LJ #_C(K_J_
M_P#\Y94 '_&17_5__P#YRRH /^,BO^K_ /\ \Y94 '_&17_5_P#_ .<LJ #_
M (R*_P"K_P#_ ,Y94 '_ !D5_P!7_P#_ )RRH /^,BO^K_\ _P Y94 '_&17
M_5__ /YRRH /^,BO^K__ /SEE0 ?\9%?]7__ /G+*@ _XR*_ZO\ _P#SEE0
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M#_PH_P!EC_Z):@ _X7)\1?\ HT[]H#_PH_V6/_HEJ #_ (7)\1?^C3OV@/\
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M4:Q!:Z)\0KC2)OB+X=NM)DT3Q[I_A;PK-X*L?"VC6.H1ZE?Z+\3=&\3Z*O\
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MNN3:OJ_Q7U"ZU2QU-[/1+3PIJWBS0;'XMZGI=I#>63>)+272_#+ZOIP,J_\
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M,JU:OA\/)4L+AG[*C"='"TJL(XD]-^&W@37O#OCO6O%7C.+Q1=:C:?#;X?\
MAN+Q;>^,+B]\/:RVBZ3+)XG>7P^/%DRQ:K_;4DTS33Z'!" )+BVN7GU"],N^
M+Q>&PU/B/$TH*AAZF9XG%0BU?FP,,-0>&=)>]&BJ,X8KFC>A-*NJ<:<J,5R\
MN'I8NM'(:%6]6I0P,8N$6[T<?5Q-=8BG.;ESXCVM%X*,)REB.?ZM%UJGM*5
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0!\__ +)W_)K'[-/_ &0#X-_^JZ\.4 ?0% !0 4 ?/_QD_P"2
MB_LG?]G >(__ %EC]I:@#Z H * "@ H * "@ H * "@ H * "@ H * "@ H
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M?CW\:5B'B;4?'=[>> ?AU=:Y8>)/$?PWTWX/ZYJ&I:=X8^*WC+P=)\0?BO\
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M .R=_P FL?LT_P#9 /@W_P"JZ\.4 ?0% !0 4 ?/_P 9/^2B_LG?]G >(_\
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MCA?K,DI2G-RJ8N=*523<Y/W81H4X4(**]BI5U&3IU(4Z7=5!84 % !0 4 %
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M_P#HLGP _P#$:?B+_P#18T '_".?M3_]%D^ '_B-/Q%_^BQH /\ A'/VI_\
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MW-2C2G[LZ\)S@E[WNT_9.2FXW5.:C7H3]G4Y:CI5J-51=.K3E+JZ0!0 4 %
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M]E&$6N:%2-"E"ARTX>RG4J>UBZ,*-?8J#4* "@ H * "@ H * "@ H * "@
MH ^?_P!D[_DUC]FG_L@'P;_]5UX<H ^@* "@ H ^?_C)_P E%_9._P"S@/$?
M_K+'[2U 'T!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0!Y?X^^,/@CX::KX>T+Q*?&%WK?BG3_$&K:'HW@KX9_$OXFZK<Z5X
M5N?#MGX@U.XT_P"&WA'79]-T^SN_%GAR![B]CMXVDU>!(V=BP4 X_P#X:6^'
M7_0N?M ?^(G?M3__ #FZ #_AI;X=?]"Y^T!_XB=^U/\ _.;H /\ AI;X=?\
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M #FZ #_AI;X=?]"Y^T!_XB=^U/\ _.;H /\ AI;X=?\ 0N?M ?\ B)W[4_\
M\YN@ _X:6^'7_0N?M ?^(G?M3_\ SFZ #_AI;X=?]"Y^T!_XB=^U/_\ .;H
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M % !0 4 % !0 4 % !0 4 ?/_P"R=_R:Q^S3_P!D ^#?_JNO#E 'T!0 4 %
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M$\VK2C2I^TJO#Y=+%U7"C23A[2K[##\E*+E'VE3E4YKF<SA_"'[9L7C[48_
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MT_P;_P"R ?M+?^K%_9.KE.L^@* "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@#Y_\.?\G3_&3_L@'[-/_JQ?VL: /H"@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H ^?\ ]D[_ )-8_9I_[(!\&_\ U77AR@#Z H * "@#Y_\
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MX:G3I1<K<W+3BH1<FDE>R5[)*^R6QX7XC_Y.G^#?_9 /VEO_ %8O[)U8FY]
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M'S_X<_Y.G^,G_9 /V:?_ %8O[6- 'T!0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?/\ ^R=_
MR:Q^S3_V0#X-_P#JNO#E 'T!0 4 % 'S_P#&3_DHO[)W_9P'B/\ ]98_:6H
M^@* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M/G#XH)XWT#XT?"SXB^&OA=XP^)NB:+\+_C7X*UNU\%:O\--.U72=5\:>*_@+
MKOA^XN(/B3\0/"EO=:?-:?#[Q&CO97-U)%)% )(E6=7!L&Q?_P"%R?$7_HT[
M]H#_ ,*/]EC_ .B6H /^%R?$7_HT[]H#_P */]EC_P"B6H /^%R?$7_HT[]H
M#_PH_P!EC_Z):@ _X7)\1?\ HT[]H#_PH_V6/_HEJ #_ (7)\1?^C3OV@/\
MPH_V6/\ Z):@ _X7)\1?^C3OV@/_  H_V6/_ *):@ _X7)\1?^C3OV@/_"C_
M &6/_HEJ #_A<GQ%_P"C3OV@/_"C_98_^B6H /\ A<GQ%_Z-._: _P#"C_98
M_P#HEJ #_A<GQ%_Z-._: _\ "C_98_\ HEJ #_A<GQ%_Z-._: _\*/\ 98_^
MB6H /^%R?$7_ *-._: _\*/]EC_Z):@ _P"%R?$7_HT[]H#_ ,*/]EC_ .B6
MH /^%R?$7_HT[]H#_P */]EC_P"B6H /^%R?$7_HT[]H#_PH_P!EC_Z):@ _
MX7)\1?\ HT[]H#_PH_V6/_HEJ #_ (7)\1?^C3OV@/\ PH_V6/\ Z):@ _X7
M)\1?^C3OV@/_  H_V6/_ *):@ _X7)\1?^C3OV@/_"C_ &6/_HEJ #_A<GQ%
M_P"C3OV@/_"C_98_^B6H /\ A<GQ%_Z-._: _P#"C_98_P#HEJ #_A<GQ%_Z
M-._: _\ "C_98_\ HEJ #_A<GQ%_Z-._: _\*/\ 98_^B6H /^%R?$7_ *-.
M_: _\*/]EC_Z):@ _P"%R?$7_HT[]H#_ ,*/]EC_ .B6H /^%R?$7_HT[]H#
M_P */]EC_P"B6H H?"]/&^O?&CXI_$7Q+\+O&'PQT36?A?\ !3P5H=KXUU?X
M::CJNK:KX+\5_'K7?$%Q;P?#;X@>*[>UT^&T^(/AQ$>]N;62626<1Q,L#.38
M-CZ/H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * /G_ /9._P"36/V:?^R ?!O_ -5UX<H ^@*
M"@ H ^?_ (R?\E%_9._[. \1_P#K+'[2U 'T!0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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ME*=.=:4<7B8X2%3#X7"X;#=%7#X;&YQ'%2QU.CALOS/+\J=."YE1P4,NQ/\
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M"C%RQ4?J=..*4Z-)5N7$?VC6O2A"6$J0PV'G%X'$1E+&Q^T:P*"@ H * "@
MH * "@ H * "@ H ^?\ ]D[_ )-8_9I_[(!\&_\ U77AR@#Z H * "@#Y_\
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M-I^ '_AF_AU_\SE !_PR=^RQ_P!&T_ #_P ,W\.O_F<H /\ AD[]EC_HVGX
M?^&;^'7_ ,SE !_PR=^RQ_T;3\ /_#-_#K_YG* #_AD[]EC_ *-I^ '_ (9O
MX=?_ #.4 '_#)W[+'_1M/P _\,W\.O\ YG* #_AD[]EC_HVGX ?^&;^'7_S.
M4 '_  R=^RQ_T;3\ /\ PS?PZ_\ F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\
M,G?LL?\ 1M/P _\ #-_#K_YG* #_ (9._98_Z-I^ '_AF_AU_P#,Y0 ?\,G?
MLL?]&T_ #_PS?PZ_^9R@ _X9._98_P"C:?@!_P"&;^'7_P SE !_PR=^RQ_T
M;3\ /_#-_#K_ .9R@ _X9._98_Z-I^ '_AF_AU_\SE !_P ,G?LL?]&T_ #_
M ,,W\.O_ )G* #_AD[]EC_HVGX ?^&;^'7_S.4 '_#)W[+'_ $;3\ /_  S?
MPZ_^9R@ _P"&3OV6/^C:?@!_X9OX=?\ S.4 <A\)OA[X!^&O[27QLT+X<^!_
M!_@#1+OX'_LW:M=:-X*\,Z+X5TJYU6?QY^U-9SZG<:?H5E:V\VH26EA8P/</
M&9&CLX$+%84"@'U?0!S=UXR\(6*:G)>^*O#=G'HEK=WVLO=:YIENFD65A.;:
M^O-3:6Z46%K;W(,4LLYC2-QL<AN*AU*:@ZOM(JG%TTY\RY4ZM2K2I)RO9.K5
MH5J=-7O.I1JPC>5.:5*$W4C146ZTE)QII/G:A3HUIM1^)J%+$8>K*R]VG7HS
M=HU8.6U8WMEJ5G::CIMW:W^GW]M!>6-]8W$5U9WEG<QK-;75I<P.T=Q;2PNC
MI+&S*ZN&4D$&MJE.I1J3I582I5*4G&<)Q<90E%V<91:3C*+5FFDT]&94ZD*L
M(U*4XU*<E>,HM2BUT::NFO-%JH+*=YJ&GZ?]F^WWUG8B\NX;"S^V7,-M]JOK
M@,8+*V\YU\^[D$;[(4W.VQMJG!J7*,6HN2BVIR2;2=J5.=:HTNU.C3J59O:%
M.$YRM&,FAZ1E/:$.12ETBZE2%&FF]ESU:E.E"_Q5)PA&\I13-/U"PU6QM-3T
MJ^L]2TV_@CNK'4-/N8;RQO+690\-S:7=L[Q7$#H0RR1LRL"""16DH2IOEG%P
MDK:--/576CMNFFO)W&TXRG!KEE2G.G.+T<)TY.$X26\9PG&4)Q=G&47%I--!
M<:CI]G<6%I=WUG:W6J3RVNEVMQ<P07&HW,%K/?36]A#*ZO>3QV5K<W#1Q*[+
M%;RR$!(V(44Y2E"*YI0A*K**U<:<9TZ<JC2U4(U*M*$IOW5.K3BW><4YDU"*
ME)\L7.---Z+GDI2C!-Z<\HPFXQW:A)I6B[$6HZ?-?76F0WUG+J5A!:75[IT5
MS ]]9VU^UREC<75HKF6W@N&LKP122(JR&TF"$^4VT2;BYQ5X1FZ3DOA52,*=
M25-M:*<:=6E-P^)0J4Y-<LXMC:C*,&^6<H>TC%Z-PYI04TMW#GA.',M.:,HW
MO%I.AO;.XN+NTM[NVGNK!H4OK6&>*2XLFN(A/;K=PHY>V:2!ED02*I9"&7(.
M:2UBY1UC&3@VME.*C*4+K12C&<&X[I3BVK25V_=DHOW9."J)/1\CE.$9I;\C
MG2J04MG*G.*=X22M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % 'S_^R=_R:Q^S3_V0#X-_^JZ\.4 ?0% !0 4 ?/\ \9/^
M2B_LG?\ 9P'B/_UEC]I:@#Z H * "@#Y?^+7P9O/B7\;OA!KU_%XLM_!7A7P
M1\5[#6]:\&_$GQ7\-=6LM;\0WWP\D\/V3:EX"\6Z%K]Y:74&C:RSPPR368-F
MANE5_L^7@X4Z=;.JM64X.O@\!2PZ4ZBC4J4L7B*E:,X0ER2Y*<X2BZT;)O\
M=/GN==:NGE&'PE-QE6CFU'$SBX)N.'AEN9474C.47RM5ZU"FU3DJKC-JSI>T
M/&?C-\(OB=ILGQQT+X9?#_Q#X_TSXO? +PC\-]"US4/B#HUY/X>UKP:WC^"X
MC\9ZO\2/%\7B'5Y+_3/%ED;348Y-=EFN[>9=2ELXF%R>[+L5^^P5+%*&&IX7
MBO+,]J5E3A"E+"4WP_1Q-.E2PT+QQ%"&45*S@Z,*=6G4;A5GB$J-3FG"E2GA
M<;1J2G7IY5FF7.C)SDXU:\L5B,+5YZDK.A.KC*E*I%5%.@J=.-.DZ<KT_0?
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M5E24HPJPKT8<C-'^"^I^%K2?P!XET/7_ !#;_$3X :OX.T'PWKOCG0M.O_\
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M>&O"OQ!U#XA?#?6?C;X US6?A]XD^$]MK-@/&?BQ/%-K'XL\$?&>UC\(^,O
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MV.&K+ X3#4HJ$(4E3Q-3"8CF5-QIJIEONTE!TG'J/$?_ "=/\&_^R ?M+?\
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M!] 4 % !0!\__&3_ )*+^R=_V<!XC_\ 66/VEJ /H"@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@#Y_\ $?\ R=/\&_\ L@'[
M2W_JQ?V3J /H"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H ^?_  Y_R=/\9/\ L@'[-/\ ZL7]K&@#Z H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * /G_\ 9._Y-8_9I_[(!\&__5=>'* /H"@ H * /G_XR?\ )1?V3O\
MLX#Q'_ZRQ^TM0!] 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MT '_  IOXB_]'8_M ?\ A.?LL?\ T-- !_PIOXB_]'8_M ?^$Y^RQ_\ 0TT
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M 4 ?/W[1OB3]GOPSX.T&7]I#0/#WB7P?J7C"TTSP]I/B/X8ZG\68)O&0\/\
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MK_Q"#QY_\XNC^Q\W_P"A5C/_  FK?_(!_;&4_P#0TPG_ (4T?_DP_P"%B?\
M!+K_ *(O\.O_ !"#QY_\XNC^Q\W_ .A5C/\ PFK?_(!_;&4_]#3"?^%-'_Y,
M/^%B?\$NO^B+_#K_ ,0@\>?_ #BZ/['S?_H58S_PFK?_ " ?VQE/_0TPG_A3
M1_\ DP_X6)_P2Z_Z(O\ #K_Q"#QY_P#.+H_L?-_^A5C/_":M_P#(!_;&4_\
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M'S?_ *%6,_\ ":M_\@']L93_ -#3"?\ A31_^3#_ (6)_P $NO\ HB_PZ_\
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M\>?_ #BZ/['S?_H58S_PFK?_ " ?VQE/_0TPG_A31_\ DP_X6)_P2Z_Z(O\
M#K_Q"#QY_P#.+H_L?-_^A5C/_":M_P#(!_;&4_\ 0TPG_A31_P#DP_X6)_P2
MZ_Z(O\.O_$(/'G_SBZ/['S?_ *%6,_\ ":M_\@']L93_ -#3"?\ A31_^3#_
M (6)_P $NO\ HB_PZ_\ $(/'G_SBZ/['S?\ Z%6,_P#":M_\@']L93_T-,)_
MX4T?_DP_X6)_P2Z_Z(O\.O\ Q"#QY_\ .+H_L?-_^A5C/_":M_\ (!_;&4_]
M#3"?^%-'_P"3#_A8G_!+K_HB_P .O_$(/'G_ ,XNC^Q\W_Z%6,_\)JW_ ,@'
M]L93_P!#3"?^%-'_ .3#_A8G_!+K_HB_PZ_\0@\>?_.+H_L?-_\ H58S_P )
MJW_R ?VQE/\ T-,)_P"%-'_Y,/\ A8G_  2Z_P"B+_#K_P 0@\>?_.+H_L?-
M_P#H58S_ ,)JW_R ?VQE/_0TPG_A31_^3#_A8G_!+K_HB_PZ_P#$(/'G_P X
MNC^Q\W_Z%6,_\)JW_P @']L93_T-,)_X4T?_ ),/^%B?\$NO^B+_  Z_\0@\
M>?\ SBZ/['S?_H58S_PFK?\ R ?VQE/_ $-,)_X4T?\ Y,/^%B?\$NO^B+_#
MK_Q"#QY_\XNC^Q\W_P"A5C/_  FK?_(!_;&4_P#0TPG_ (4T?_DP_P"%B?\
M!+K_ *(O\.O_ !"#QY_\XNC^Q\W_ .A5C/\ PFK?_(!_;&4_]#3"?^%-'_Y,
M/^%B?\$NO^B+_#K_ ,0@\>?_ #BZ/['S?_H58S_PFK?_ " ?VQE/_0TPG_A3
M1_\ DP_X6)_P2Z_Z(O\ #K_Q"#QY_P#.+H_L?-_^A5C/_":M_P#(!_;&4_\
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M'S?_ *%6,_\ ":M_\@']L93_ -#3"?\ A31_^3#_ (6)_P $NO\ HB_PZ_\
M$(/'G_SBZ/['S?\ Z%6,_P#":M_\@']L93_T-,)_X4T?_DP_X6)_P2Z_Z(O\
M.O\ Q"#QY_\ .+H_L?-_^A5C/_":M_\ (!_;&4_]#3"?^%-'_P"3#_A8G_!+
MK_HB_P .O_$(/'G_ ,XNC^Q\W_Z%6,_\)JW_ ,@']L93_P!#3"?^%-'_ .3#
M_A8G_!+K_HB_PZ_\0@\>?_.+H_L?-_\ H58S_P )JW_R ?VQE/\ T-,)_P"%
M-'_Y,/\ A8G_  2Z_P"B+_#K_P 0@\>?_.+H_L?-_P#H58S_ ,)JW_R ?VQE
M/_0TPG_A31_^3#_A8G_!+K_HB_PZ_P#$(/'G_P XNC^Q\W_Z%6,_\)JW_P @
M']L93_T-,)_X4T?_ ),/^%B?\$NO^B+_  Z_\0@\>?\ SBZ/['S?_H58S_PF
MK?\ R ?VQE/_ $-,)_X4T?\ Y,/^%B?\$NO^B+_#K_Q"#QY_\XNC^Q\W_P"A
M5C/_  FK?_(!_;&4_P#0TPG_ (4T?_DP_P"%B?\ !+K_ *(O\.O_ !"#QY_\
MXNC^Q\W_ .A5C/\ PFK?_(!_;&4_]#3"?^%-'_Y,/^%B?\$NO^B+_#K_ ,0@
M\>?_ #BZ/['S?_H58S_PFK?_ " ?VQE/_0TPG_A31_\ DP_X6)_P2Z_Z(O\
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MK_Q"#QY_\XNC^Q\W_P"A5C/_  FK?_(!_;&4_P#0TPG_ (4T?_DP_P"%B?\
M!+K_ *(O\.O_ !"#QY_\XNC^Q\W_ .A5C/\ PFK?_(!_;&4_]#3"?^%-'_Y,
M/^%B?\$NO^B+_#K_ ,0@\>?_ #BZ/['S?_H58S_PFK?_ " ?VQE/_0TPG_A3
M1_\ DP_X6)_P2Z_Z(O\ #K_Q"#QY_P#.+H_L?-_^A5C/_":M_P#(!_;&4_\
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M:)K5GIEAK5UI&J6NC:I)<1:7JUQ87<&F:C+:.8KJ.POY(E@O)(9%9)%B=RC
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MR<HJ-I-6/G^OI#YP* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M\'*I3_>34JC<RIK/Q'\:>(=.UG2M8UM[ZP\0>)3XPU>%[+38VN_$1MC9B_\
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M%RC%.;YIR;G4<IMO63T.2KN.(* "@ H * "@ H * "@ H * "@ H * "@ H
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M&T_ #_PS?PZ_^9R@ _X9._98_P"C:?@!_P"&;^'7_P SE !_PR=^RQ_T;3\
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M-I^ '_AF_AU_\SE !_PR=^RQ_P!&T_ #_P ,W\.O_F<H /\ AD[]EC_HVGX
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M\0=(C\.^#]1\(?#RY\=V&N:UX<^)T>O>,_#]WX T*YU;4+OQ[X!B\'P0>!]
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MWK82<J=9)-PIU*=6K0J4G42=-U:=2A-5*2FZD(NG4E%4ZU&=3MZ184 % !0
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M6,P\$W&M1JPIU+SBO8*"A"51OZU6C:"YIXC$5JSN_P![:UN8US]F7P-<^+/
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M4?%GC/QCK?A:]\-W%OK7B$^#[26[T_P;H?B31/"7AJ;2_"7@_1=)L_#NC_\
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M$C_:G_Z(W\ /_$EOB+_]"=0 ?\)'^U/_ -$;^ '_ (DM\1?_ *$Z@ _X2/\
M:G_Z(W\ /_$EOB+_ /0G4 '_  D?[4__ $1OX ?^)+?$7_Z$Z@ _X2/]J?\
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M $)U !_PD?[4_P#T1OX ?^)+?$7_ .A.H /^$C_:G_Z(W\ /_$EOB+_]"=0
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M$C_:G_Z(W\ /_$EOB+_]"=0 ?\)'^U/_ -$;^ '_ (DM\1?_ *$Z@ _X2/\
M:G_Z(W\ /_$EOB+_ /0G4 '_  D?[4__ $1OX ?^)+?$7_Z$Z@ _X2/]J?\
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M@ H * "@ H * "@ H * "@ H ^?_ -K'_DUC]I;_ +(!\9/_ %77B.@#Z H
M* "@ H * "@ H * "@ H * "@#Y__9._Y-8_9I_[(!\&_P#U77AR@#Z H *
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M-/W.N<L^?_V:?^2=>(_^S@/VL?\ UJ?XR4 ?0% !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!\_\ [6/_ ":Q
M^TM_V0#XR?\ JNO$= 'T!0 4 % !0 4 % !0 4 % !0 4 % 'S_^R=_R:Q^S
M3_V0#X-_^JZ\.4 ?0% !0 4 ?/\ \9/^2B_LG?\ 9P'B/_UEC]I:@#Z H *
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ME^P!_P")]?\ Y.- !_PVI_U.7[ '_B?7_P"3C0 ?\-J?]3E^P!_XGU_^3C0
M?\-J?]3E^P!_XGU_^3C0 ?\ #:G_ %.7[ '_ (GU_P#DXT '_#:G_4Y?L ?^
M)]?_ ).- !_PVI_U.7[ '_B?7_Y.- !_PVI_U.7[ '_B?7_Y.- !_P -J?\
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M-_ #_P 26^(O_P!"=0 ?\)'^U/\ ]$;^ '_B2WQ%_P#H3J #_A(_VI_^B-_
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ML?M+4 ?0% !0 4 % 'S_ /LG?\FL?LT_]D ^#?\ ZKKPY0!] 4 % !0!\_\
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MY2I484YRYW5G6Q,^:G"E]K5PG0?/_P"R=_R:Q^S3_P!D ^#?_JNO#E 'T!0
M4 % 'S_XC_Y.G^#?_9 /VEO_ %8O[)U 'T!0 4 % 'S_ /M8_P#)K'[2W_9
M/C)_ZKKQ'0!] 4 % !0 4 ?/_P &_P#DHO[6/_9P'AS_ -98_9IH ^@* "@
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M.I&<Z52GF3DE4G:55UOAQ,92]PKD-@H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * /G_ /9._P"36/V:?^R ?!O_
M -5UX<H ^@* "@ H ^?_ (R?\E%_9._[. \1_P#K+'[2U 'T!0 4 % !0 4
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ML>W_ /#6/[+'_1RWP _\/)\.O_FCH /^&L?V6/\ HY;X ?\ AY/AU_\ -'0
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MNZE\J)_+AM997PD;, #[?H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#Y_\ V3O^
M36/V:?\ L@'P;_\ 5=>'* /H"@ H * /G_XR?\E%_9._[. \1_\ K+'[2U '
MT!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0!\_P#[)W_)K'[-/_9 /@W_ .JZ\.4 ?0%
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M%!QI4G^ZC+$Q<Y^RXW_AHSQNJ7&@?\*L\-S_ !#T_P 4^+/#VK:38_%*XN/
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MT;Q!X'\'Z[I&I)I$6HZ5K/AK1=3TV_C\/2"70([VQO;*2&Z33955[-9486S
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M^AIH /\ A3?Q%_Z.Q_: _P#"<_98_P#H:: #_A3?Q%_Z.Q_: _\ "<_98_\
MH:: #_A3?Q%_Z.Q_: _\)S]EC_Z&F@ _X4W\1?\ H[']H#_PG/V6/_H:: #_
M (4W\1?^CL?V@/\ PG/V6/\ Z&F@ _X4W\1?^CL?V@/_  G/V6/_ *&F@ _X
M4W\1?^CL?V@/_"<_98_^AIH /^%-_$7_ *.Q_: _\)S]EC_Z&F@ _P"%-_$7
M_H[']H#_ ,)S]EC_ .AIH /^%-_$7_H[']H#_P )S]EC_P"AIH /^%-_$7_H
M[']H#_PG/V6/_H:: #_A3?Q%_P"CL?V@/_"<_98_^AIH /\ A3?Q%_Z.Q_:
M_P#"<_98_P#H:: #_A3?Q%_Z.Q_: _\ "<_98_\ H:: #_A3?Q%_Z.Q_: _\
M)S]EC_Z&F@ _X4W\1?\ H[']H#_PG/V6/_H:: #_ (4W\1?^CL?V@/\ PG/V
M6/\ Z&F@ _X4W\1?^CL?V@/_  G/V6/_ *&F@ _X4W\1?^CL?V@/_"<_98_^
MAIH /^%-_$7_ *.Q_: _\)S]EC_Z&F@ _P"%-_$7_H[']H#_ ,)S]EC_ .AI
MH /^%-_$7_H[']H#_P )S]EC_P"AIH /^%-_$7_H[']H#_PG/V6/_H:: #_A
M3?Q%_P"CL?V@/_"<_98_^AIH /\ A3?Q%_Z.Q_: _P#"<_98_P#H:: #_A3?
MQ%_Z.Q_: _\ "<_98_\ H:: #_A3?Q%_Z.Q_: _\)S]EC_Z&F@ _X4W\1?\
MH[']H#_PG/V6/_H:: #_ (4W\1?^CL?V@/\ PG/V6/\ Z&F@ _X4W\1?^CL?
MV@/_  G/V6/_ *&F@ _X4W\1?^CL?V@/_"<_98_^AIH /^%-_$7_ *.Q_: _
M\)S]EC_Z&F@ _P"%-_$7_H[']H#_ ,)S]EC_ .AIH /^%-_$7_H[']H#_P )
MS]EC_P"AIH /^%-_$7_H[']H#_PG/V6/_H:: #_A3?Q%_P"CL?V@/_"<_98_
M^AIH /\ A3?Q%_Z.Q_: _P#"<_98_P#H:: #_A3?Q%_Z.Q_: _\ "<_98_\
MH:: #_A3?Q%_Z.Q_: _\)S]EC_Z&F@ _X4W\1?\ H[']H#_PG/V6/_H:: #_
M (4W\1?^CL?V@/\ PG/V6/\ Z&F@ _X4W\1?^CL?V@/_  G/V6/_ *&F@ _X
M4W\1?^CL?V@/_"<_98_^AIH /^%-_$7_ *.Q_: _\)S]EC_Z&F@ _P"%-_$7
M_H[']H#_ ,)S]EC_ .AIH /^%-_$7_H[']H#_P )S]EC_P"AIH /^%-_$7_H
M[']H#_PG/V6/_H:: #_A3?Q%_P"CL?V@/_"<_98_^AIH /\ A3?Q%_Z.Q_:
M_P#"<_98_P#H:: #_A3?Q%_Z.Q_: _\ "<_98_\ H:: #_A3?Q%_Z.Q_: _\
M)S]EC_Z&F@ _X4W\1?\ H[']H#_PG/V6/_H:: /,/C=X0^+7PU^"_P 7?B+H
M7[5/QPN];\ ?"_Q]XUT:UU;PO^S#/I5SJOA7PIJVNZ?;ZG!9_LZ6L\VGR7=A
M"DR07-O(T;.$EC8AU /L^@ H * "@ H * "@ H * "@ H * /G_]D[_DUC]F
MG_L@'P;_ /5=>'* /H"@ H * /G_ .,G_)1?V3O^S@/$?_K+'[2U 'T!0 4
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M?C8>VRW.(M5,5B9PIX>GE6!QBK1QE!8.KB(0_M&=2O\ JY7GGH'S_P#LT_\
M).O$?_9P'[6/_K4_QDH ^@* "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@#Y__ &L?^36/VEO^R ?&3_U77B.@
M#Z H * "@ H * "@ H * "@ H * "@#Y_P#V3O\ DUC]FG_L@'P;_P#5=>'*
M /H"@ H * /G_P",G_)1?V3O^S@/$?\ ZRQ^TM0!] 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0!\_\ [-/_ "3KQ'_V<!^UC_ZU/\9* /H"@ H
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MC_Z&F@ _X4W\1?\ H[']H#_PG/V6/_H:: #_ (4W\1?^CL?V@/\ PG/V6/\
MZ&F@ _X4W\1?^CL?V@/_  G/V6/_ *&F@ _X4W\1?^CL?V@/_"<_98_^AIH
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MMV?]%-_\SG\'?_I7% !_PK[]NS_HIO\ YG/X._\ TKB@ _X5]^W9_P!%-_\
M,Y_!W_Z5Q0!Y_P#$[P-^U)_PB$N@_%[XA^(+OX9?$3Q!X)^#GC6#PM\9/@QJ
M>NC0OC=XV\/?"&[FL;"7_@G#X;^T^3_PFR32I'KVDS>3#*8+J*<1F@#]/Z "
M@ H * "@ H * "@ H * "@ H ^?_ -D[_DUC]FG_ +(!\&__ %77AR@#Z H
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M0/!WAG5YIEB,4EUJ[^=%,P0COR_#SIY;DN78RFUC:^9Y]]=J5(<F)HU:?"&
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MM]3N=1ATK3(5F2'6I$31RLB1*8UN'A:<W@LRK4HNCBXYG["CBZ\E4PM.*RW
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MHCUW]I;_ ))UX<_[. _9._\ 6I_@W7&:GT!0 4 % !0 4 % !0 4 % !0 4
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!\__LT_\DZ\1_\
M9P'[6/\ ZU/\9* /H"@ H * "@ H * "@#G+?PEX?L_%>J^-[?3_ "_%&MZ%
MHGAK5-3^UWK_ &K1/#M[K>HZ-9?8GN3:0_9[SQ%K,GG0P1S2?;-LLCI%$L5P
MJ3IT*F&@^6C5KO$SC9:UW1I8=SN_>7[FA2ARIJ'N\W+S2E)W4J3JPPM.H^:.
M"5=459+D6)=&5?5).7.\/1?O<W+R>YRJ4N;)U/X:^!]9;QH=6\/VVH#XA:?I
MFE^,(KN>^F@UBQT:WN+72XFMWNC%8O;PW4VR6S2WDWE9"YDC1TP]E!4)8=<T
M*;QCQZ<)SA.&-]G@Z2Q-.K"4:M*I&& PGLW3G#V4Z*J4U&I*<I0K+$?6N6,J
MSPD<"^>,9PGA(U,95^KU*4U*E4IRGC\7[15(2]K"M*E4YZ<80CP4_P"S1\%;
MWP+XG^'&K^$+CQ#X5\:7&F77BU/%7BWQKXL\0>(9]%GM;C1GU;QIXD\1WWB*
M\&GO96JVJR:J5MXH1#"$AS&>CVLE4P%6*C"IEF+CC\.X0A!1QD7&7UF<81C&
MM5GR0C6G751UX15.O[2G[H4[T98B5*<XRQ.$E@9RYYW6$G"K3>'IMMNC3BJU
M65-4?9^RJSE6I.%;]X=9J7P@^'6K^([?Q9?^'%FU^TN/!EU;7J:GK5LD,_P]
ME\03^#V2QM=1CM NGR>*=>(3R-DXOMMRLRP0"$A5J4ZD:L9-5(8C&8I2>K^L
M9AE\,KQE1\U[NM@(1H.+O&%O:TXPK-U'E.A2J8>GA)07U>C1H8>$%>*C1PV.
MH9E0@G%IVIXW#4*U[\TN3V4G*C*=.6#XE_9[^$GBWSWUGPU?"XN=>UWQ)<7^
MC^+O&GAK59M1\3V=CI_B6WDU?PWXBL+UM!U:RTS3X;[0S/\ V7=I9Q">SDV"
MN:%&E3A0I*FI4<-3K4E2G[]&I2KXVMF-6EB:,^:EBZ4L;B*V(5+%0K4X2GRT
MXQA&,5NISB\6XSE">-JX:O4G%N%2.(P>#I9?AL1AZD6IX7$4<'1A0A7PLJ-;
MDY[S<JM5SK:C^S?\&=3U+^TI_",]L&BTM)]%TCQ3XQT'PC>7&A65MIV@ZKJ/
M@?0_$%IX>U+7]+L['3X[#6+O2YK^R_LVR-K<Q-9P&+6JY5_K?MJDZWUQ8KVG
M/.<W%XWVBQD\.Y2;PM7%*M66(JX7V-6LJU95)R56?,J7^SPP5.@E0A@(TJ=%
M4XJ'[FA_"P];E2^LX6E]C"8GVV&C=VI*[OK>(?@9\,_$MAX6L+O1M6TG_A"=
M(7P]X6U3P;XS\;_#[Q+HOA];>UM6T&V\6^!/$>CZVVB2Q6%CYUA+J$EO.]G!
M)-&\D2,MXBI4Q.+Q6-KU)2Q&.ES8EJ3C3Q+4ZDX_6*,'&C6C"=6K*G"K3E&D
MZD_9J/-*^>&IT\'A*&!H4XQPN$450C**J2HN,8PYZ-2HIU:524(1A4JTYQJ5
M8+EJ3G%M/)U+]F_X,ZI9Z?I]QX0E@LM,\-WGA.VMM)\3^+]"B?1KW5X_$#_;
MET37[3^U-7@\11+K%IK%[]HU&QU%I-0L[N"\E>9YDVZM6NFZ=6I' QO3;I*D
MLL;> >'C2Y(X66%C*=&C/#*E..&G4PO-]6J3I2JDE05&,%S*A/'3_>?O75>9
MTO89C'$NKSO%TL=34?K5'%.M1KU(4ZU2$JM*G.,%K^S1\'+*/4Q!X?U[[7K&
ML^$_$6JZU/\ $7XE77B?4/$'@=9X?#>NW?BNZ\7R:S-K,%I<S6DUZU\9[VT*
MVE\]S:HD2M2Y?JJC3IQA@\3B<72A&E35-5\9A88/%N=)05.K2Q6&IJGB</5C
M/#UW*I4JTIU*U6<\ZE&-7ZS[24YO%82E@:DI5:CG]6H8N>.P\(3Y^>C+"XNI
M*OA:U*4*V%FH?5ZE.-.FH]%X1^"7PU\":_)XD\,:%?66HBWN[33H+OQ3XNUK
M0_#5GJ$J3ZC9^"O"^N:[>:-X$L[R6*)KF#P[8:9'<&&/SE?RUVE*4J%#ZO3?
MN<D:;G+]Y6=&FXNG0>(GS5WAZ3A!TL.ZCH4G&/LZ<>56UK?[15]M5]Z?M98A
MI>Y!XB<90GB)4X<M.6(G&=13KR@ZLO:5;S;J3YN5_:6_Y)UX<_[. _9._P#6
MI_@W4@?0% !0 4 % !0 4 % !0 4 % !0 4 % !0!\__ +2W_).O#G_9P'[)
MW_K4_P &Z /H"@ H * "@ H * "@ H * "@ H * /G_]D[_DUC]FG_L@'P;_
M /5=>'* /H"@ H * /G_ .,G_)1?V3O^S@/$?_K+'[2U 'T!0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % 'YX6?Q&TKX3ZAXS\%Z/^W%^QAX=M(/B
MA\6_$DWAKQ_X9MK_ ,9>&-5\>?%#Q=X\UWPQXAN[7]J_P\DVH:/K?B74--);
M1-,D"V"+-;I,KY-@V-#_ (:-_P"K^OV /_"-_P#RU* #_AHW_J_K]@#_ ,(W
M_P#+4H /^&C?^K^OV /_  C?_P M2@ _X:-_ZOZ_8 _\(W_\M2@ _P"&C?\
MJ_K]@#_PC?\ \M2@ _X:-_ZOZ_8 _P#"-_\ RU* #_AHW_J_K]@#_P (W_\
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M[;4I2=?%X:C4^K1Q"H5:T:=9TY\T8XOB7]KCX<^%_"?P^\87GA_Q[>:?\2?
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M3JP4URR4:D5.*E'[,DFN9='='BO[-/\ R3KQ'_V<!^UC_P"M3_&2N<W/H"@
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M /G_ /:6_P"2=>'/^S@/V3O_ %J?X-T ?0% !0 4 % !0 4 % !0 4 % !0
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M<YN<I5GZKXN_9WU#7O%NI>--'\<VFCZO=?%30/B39PZCX2EUO3K6#3OA//\
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MA?M+?\DZ\.?]G ?LG?\ K4_P;K(9] 4 % !0 4 % !0 4 % !0 4 % !0 4
M% 'S_P#M+?\ ).O#G_9P'[)W_K4_P;H ^@* "@ H * "@ H * "@ H * "@
MH ^?_P!D[_DUC]FG_L@'P;_]5UX<H ^@* "@ H ^?_C)_P E%_9._P"S@/$?
M_K+'[2U 'T!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'QA\)/BU
MH'PTT#Q;X0\7>$OCA::W:?'#]I'5F72?V;OVA?%.E7&E>*OVA?B?XK\.ZGIG
MB+PI\+]2TC5]/O\ P[K>E7T-Q8WUQ&T=XGS!@RJ;!L>G_P##2WPZ_P"A<_:
M_P#$3OVI_P#YS= !_P -+?#K_H7/V@/_ !$[]J?_ .<W0 ?\-+?#K_H7/V@/
M_$3OVI__ )S= !_PTM\.O^A<_: _\1._:G_^<W0 ?\-+?#K_ *%S]H#_ ,1.
M_:G_ /G-T '_  TM\.O^A<_: _\ $3OVI_\ YS= !_PTM\.O^A<_: _\1._:
MG_\ G-T '_#2WPZ_Z%S]H#_Q$[]J?_YS= !_PTM\.O\ H7/V@/\ Q$[]J?\
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M^(G?M3__ #FZ #_AI;X=?]"Y^T!_XB=^U/\ _.;H /\ AI;X=?\ 0N?M ?\
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MNE6NE>%?VA?B?X4\.Z9IGAWPI\4--TC1]/T_P[HFE6,-O8V-O&L=FGREBS,
M>G_\,T_#K_H8_P!H#_Q+']J?_P"?)0 ?\,T_#K_H8_V@/_$L?VI__GR4 '_#
M-/PZ_P"AC_: _P#$L?VI_P#Y\E !_P ,T_#K_H8_V@/_ !+']J?_ .?)0 ?\
M,T_#K_H8_P!H#_Q+']J?_P"?)0 ?\,T_#K_H8_V@/_$L?VI__GR4 '_#-/PZ
M_P"AC_: _P#$L?VI_P#Y\E !_P ,T_#K_H8_V@/_ !+']J?_ .?)0 ?\,T_#
MK_H8_P!H#_Q+']J?_P"?)0 ?\,T_#K_H8_V@/_$L?VI__GR4 '_#-/PZ_P"A
MC_: _P#$L?VI_P#Y\E !_P ,T_#K_H8_V@/_ !+']J?_ .?)0 ?\,T_#K_H8
M_P!H#_Q+']J?_P"?)0 ?\,T_#K_H8_V@/_$L?VI__GR4 '_#-/PZ_P"AC_:
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M\,>&[&^\2>)]1O\ 5=7^P>'](TRPBFO[RYF\FQB5I&V T ?0% !0 4 % !0
M4 % !0 4 % !0!@ZQXFT3P_>^'-/U:[>TNO%FLMX?T%197]Q%>:NFDZGK?V.
M6YM+:2'3]VFZ/J,B2WDEO$[P+"CM--%'(Z<74JNC"WM(TJM?E;4;TZ+IJHXN
M32E*/M(R]G%NHX*I4C!TZ564*<7&C5Q%K4:#I1G+^7V]:&'I-Q7O<LJU2G3Y
MDN6,IP4G'F5^$M_CE\*KN#XE7%IXNMKB+X0:XOAKXB>1IVLRR>']>>VL[N/3
M!"FFF36+ETO[6-!I:7H>=WME)N(I(D**^L4,NQ-%J5#-<9]0PD[I*KBUBX8'
MV.K3A_M-2$.>HH4^24:W/[!^T(KM86KBZ%?]W5P&"CF->+3;IX*6&JXN-=VN
MI1>'H5:G+'FG:#CR\[47Z!X@\0:1X5\/ZUXHUZ[^P:%X=TC4-=UB]-O=7/V/
M2M*M);^_NOLMG!+<3^5:02OY4,,DK;-J(S$*<ZE2%&/-4?+'FC"]F_>G-0BM
M+[RDE?97NVE=F^$P];&U\/A<+#VE?%3A3I0;4'*=1J,(WFXJ-VTO?<4NK1HV
MEW;WUI:WUI)YMK>6\-W;2['C\RWN(UFADV2*KINC=3M9589P0",5O5I5,/5J
M4*L>6I0G*$XW3M*#<9*Z;3LTU=-I]&T<M&M3Q%&E7HRYJ->$:D)6:O"<5*+M
M))J\6G9I-=4F<SXE\=>&?!S0_P#"1WEYI<,\VBVL5_)HFN3Z4U[XA\0Z;X5T
M73O[8M--EL5U.[UW5M/MTLC<"XVSFX:-;:.29)HQEB*\<-2BY5I2A"$+<KG*
M=+$UOW?-95%3I82O.O*#E'#Q5/V[I^WH>TUY9*,Y*+E&E0Q>)FXIR5.A@J=.
MIB)U'%-4^6%12I1GRSQ'+56'C5="LJ?75(CY_P#VF7O!\+K.RLM7\0:%_;GQ
M@_9Q\+:AJ'A;Q'KOA'7?["\6_M$_"SPQXCL;'Q)X8U&PU72/M_A_5M3L)9K"
M\MIO)O9561=Q- !_PS3\.O\ H8_V@/\ Q+']J?\ ^?)0 ?\ #-/PZ_Z&/]H#
M_P 2Q_:G_P#GR4 '_#-/PZ_Z&/\ : _\2Q_:G_\ GR4 '_#-/PZ_Z&/]H#_Q
M+']J?_Y\E !_PS3\.O\ H8_V@/\ Q+']J?\ ^?)0 ?\ #-/PZ_Z&/]H#_P 2
MQ_:G_P#GR4 '_#-/PZ_Z&/\ : _\2Q_:G_\ GR4 '_#-/PZ_Z&/]H#_Q+']J
M?_Y\E !_PS3\.O\ H8_V@/\ Q+']J?\ ^?)0 ?\ #-/PZ_Z&/]H#_P 2Q_:G
M_P#GR4 '_#-/PZ_Z&/\ : _\2Q_:G_\ GR4 '_#-/PZ_Z&/]H#_Q+']J?_Y\
ME !_PS3\.O\ H8_V@/\ Q+']J?\ ^?)0 ?\ #-/PZ_Z&/]H#_P 2Q_:G_P#G
MR4 >8?%KX2Z!\-= \)>+O"'BWXX6FMVGQP_9NTE6U;]I']H7Q5I5SI7BK]H7
MX7^%/$6F:GX=\5_%#4M(UC3[_P .ZWJMC-;WUC<1M'>/\H8*RFWR#;Y'V?0
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MQEX<T8UTL<\OJ8W#4XU9UJD%B*M&4J563\KTKX">,=1\,?M#:[XR^&GBV_\
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M\,5_]2;^P!_X@+_^4=0 ?\,5_P#4F_L ?^("_P#Y1U !_P ,5_\ 4F_L ?\
MB O_ .4=0 ?\,5_]2;^P!_X@+_\ E'4 '_#%?_4F_L ?^("__E'4 '_#%?\
MU)O[ '_B O\ ^4=0 ?\ #%?_ %)O[ '_ (@+_P#E'4 '_#%?_4F_L ?^("__
M )1U !_PQ7_U)O[ '_B O_Y1U !_PQ7_ -2;^P!_X@+_ /E'4 '_  Q7_P!2
M;^P!_P"("_\ Y1U !_PQ7_U)O[ '_B O_P"4=0 ?\,5_]2;^P!_X@+_^4=0
M?\,5_P#4F_L ?^("_P#Y1U !_P ,5_\ 4F_L ?\ B O_ .4=0 ?\,5_]2;^P
M!_X@+_\ E'4 '_#%?_4F_L ?^("__E'4 '_#%?\ U)O[ '_B O\ ^4=0 ?\
M#%?_ %)O[ '_ (@+_P#E'4 '_#%?_4F_L ?^("__ )1U !_PQ7_U)O[ '_B
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M?M3_ /19/@!_XC3\1?\ Z+&@ _X1S]J?_HLGP _\1I^(O_T6- !_PCG[4_\
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MR? #_P 1I^(O_P!%C0 ?\(Y^U/\ ]%D^ '_B-/Q%_P#HL: #_A'/VI_^BR?
M#_Q&GXB__18T '_".?M3_P#19/@!_P"(T_$7_P"BQH /^$<_:G_Z+)\ /_$:
M?B+_ /18T '_  CG[4__ $63X ?^(T_$7_Z+&@ _X1S]J?\ Z+)\ /\ Q&GX
MB_\ T6- !_PCG[4__19/@!_XC3\1?_HL: #_ (1S]J?_ *+)\ /_ !&GXB__
M $6- !_PCG[4_P#T63X ?^(T_$7_ .BQH ] ^$_@7_A5WPL^&GPS_M3^W/\
MA77P_P#!O@7^V_L/]F?VQ_PB/AW3= _M3^S?M=W_ &?]J_L_S_LWVJY\KSO+
M\Z39O8V^0;?(] H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
CH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>97
<FILENAME>g20922dsp2_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922dsp2_1.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /W\H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M*:W_ ,F'_"K?AE_T3KP)_P"$CX?_ /E?1_8^4?\ 0JP?_A-1_P#D _MC-O\
MH:8O_P *:W_R8?\ "K?AE_T3KP)_X2/A_P#^5]']CY1_T*L'_P"$U'_Y /[8
MS;_H:8O_ ,*:W_R8?\*M^&7_ $3KP)_X2/A__P"5]']CY1_T*L'_ .$U'_Y
M/[8S;_H:8O\ \*:W_P F'_"K?AE_T3KP)_X2/A__ .5]']CY1_T*L'_X34?_
M ) /[8S;_H:8O_PIK?\ R8?\*M^&7_1.O G_ (2/A_\ ^5]']CY1_P!"K!_^
M$U'_ .0#^V,V_P"AIB__  IK?_)A_P *M^&7_1.O G_A(^'_ /Y7T?V/E'_0
MJP?_ (34?_D _MC-O^AIB_\ PIK?_)A_PJWX9?\ 1.O G_A(^'__ )7T?V/E
M'_0JP?\ X34?_D _MC-O^AIB_P#PIK?_ "8?\*M^&7_1.O G_A(^'_\ Y7T?
MV/E'_0JP?_A-1_\ D _MC-O^AIB__"FM_P#)A_PJWX9?]$Z\"?\ A(^'_P#Y
M7T?V/E'_ $*L'_X34?\ Y /[8S;_ *&F+_\ "FM_\F'_  JWX9?]$Z\"?^$C
MX?\ _E?1_8^4?]"K!_\ A-1_^0#^V,V_Z&F+_P#"FM_\F'_"K?AE_P!$Z\"?
M^$CX?_\ E?1_8^4?]"K!_P#A-1_^0#^V,V_Z&F+_ /"FM_\ )A_PJWX9?]$Z
M\"?^$CX?_P#E?1_8^4?]"K!_^$U'_P"0#^V,V_Z&F+_\*:W_ ,F'_"K?AE_T
M3KP)_P"$CX?_ /E?1_8^4?\ 0JP?_A-1_P#D _MC-O\ H:8O_P *:W_R8?\
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MMC-O^AIB_P#PIK?_ "8?\*M^&7_1.O G_A(^'_\ Y7T?V/E'_0JP?_A-1_\
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MK?AE_P!$Z\"?^$CX?_\ E?1_8^4?]"K!_P#A-1_^0#^V,V_Z&F+_ /"FM_\
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M/E'_ $*L'_X34?\ Y /[8S;_ *&F+_\ "FM_\F'_  JWX9?]$Z\"?^$CX?\
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M'_"K?AE_T3KP)_X2/A__ .5]']CY1_T*L'_X34?_ ) /[8S;_H:8O_PIK?\
MR8?\*M^&7_1.O G_ (2/A_\ ^5]']CY1_P!"K!_^$U'_ .0#^V,V_P"AIB__
M  IK?_)A_P *M^&7_1.O G_A(^'_ /Y7T?V/E'_0JP?_ (34?_D _MC-O^AI
MB_\ PIK?_)A_PJWX9?\ 1.O G_A(^'__ )7T?V/E'_0JP?\ X34?_D _MC-O
M^AIB_P#PIK?_ "8?\*M^&7_1.O G_A(^'_\ Y7T?V/E'_0JP?_A-1_\ D _M
MC-O^AIB__"FM_P#)A_PJWX9?]$Z\"?\ A(^'_P#Y7T?V/E'_ $*L'_X34?\
MY /[8S;_ *&F+_\ "FM_\F'_  JWX9?]$Z\"?^$CX?\ _E?1_8^4?]"K!_\
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M6FG8^>;NV]KNXE,04 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MV8/^A1\=_P#A^_V@?_GHT?VQF_\ T-<9_P"%-;_Y,/['RG_H5X3_ ,)J/_R
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MY3_T*\)_X34?_D _X8*_9@_Z%'QW_P"'[_:!_P#GHT?VQF__ $-<9_X4UO\
MY,/['RG_ *%>$_\ ":C_ /(!_P ,%?LP?]"CX[_\/W^T#_\ /1H_MC-_^AKC
M/_"FM_\ )A_8^4_]"O"?^$U'_P"0#_A@K]F#_H4?'?\ X?O]H'_YZ-']L9O_
M -#7&?\ A36_^3#^Q\I_Z%>$_P#":C_\@'_#!7[,'_0H^.__  _?[0/_ ,]&
MC^V,W_Z&N,_\*:W_ ,F']CY3_P!"O"?^$U'_ .0#_A@K]F#_ *%'QW_X?O\
M:!_^>C1_;&;_ /0UQG_A36_^3#^Q\I_Z%>$_\)J/_P @'_#!7[,'_0H^._\
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MK?\ R8?V/E/_ $*\)_X34?\ Y /^&"OV8/\ H4?'?_A^_P!H'_YZ-']L9O\
M]#7&?^%-;_Y,/['RG_H5X3_PFH__ " ?\,%?LP?]"CX[_P##]_M _P#ST:/[
M8S?_ *&N,_\ "FM_\F']CY3_ -"O"?\ A-1_^0#_ (8*_9@_Z%'QW_X?O]H'
M_P">C1_;&;_]#7&?^%-;_P"3#^Q\I_Z%>$_\)J/_ ,@'_#!7[,'_ $*/CO\
M\/W^T#_\]&C^V,W_ .AKC/\ PIK?_)A_8^4_]"O"?^$U'_Y /^&"OV8/^A1\
M=_\ A^_V@?\ YZ-']L9O_P!#7&?^%-;_ .3#^Q\I_P"A7A/_  FH_P#R ?\
M#!7[,'_0H^.__#]_M __ #T:/[8S?_H:XS_PIK?_ "8?V/E/_0KPG_A-1_\
MD _X8*_9@_Z%'QW_ .'[_:!_^>C1_;&;_P#0UQG_ (4UO_DP_L?*?^A7A/\
MPFH__(!_PP5^S!_T*/CO_P /W^T#_P#/1H_MC-_^AKC/_"FM_P#)A_8^4_\
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M_A^_V@?_ )Z-']L9O_T-<9_X4UO_ ),/['RG_H5X3_PFH_\ R ?\,%?LP?\
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MV8/^A1\=_P#A^_V@?_GHT?VQF_\ T-<9_P"%-;_Y,/['RG_H5X3_ ,)J/_R
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M.I-03LK7M>]M+GR#X(_:[O\ Q[XK^"/@/2/A5JEIXN^*'PZTSXL>+H-2O/&
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M*,95$N1/GO)QCW%<YN% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MG_DG7B/_ +. _:Q_]:G^,E 'T!0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M@6E_X+A_\B'UC$?\_P"I_P"!R_S#_AGGX _]$.^#_P#X;/P7_P#*2CZIA/\
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M_@N'_P B'UC$?\_ZG_@<O\P_X9Y^ /\ T0[X/_\ AL_!?_RDH^J83_H%I?\
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M "(?6,1_S_J?^!R_S#_AGGX _P#1#O@__P"&S\%__*2CZIA/^@6E_P""X?\
MR(?6,1_S_J?^!R_S#_AGGX _]$.^#_\ X;/P7_\ *2CZIA/^@6E_X+A_\B'U
MC$?\_P"I_P"!R_S#_AGGX _]$.^#_P#X;/P7_P#*2CZIA/\ H%I?^"X?_(A]
M8Q'_ #_J?^!R_P P_P"&>?@#_P!$.^#_ /X;/P7_ /*2CZIA/^@6E_X+A_\
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M *G_ ('+_,/^&>?@#_T0[X/_ /AL_!?_ ,I*/JF$_P"@6E_X+A_\B'UC$?\
M/^I_X'+_ ##_ (9Y^ /_ $0[X/\ _AL_!?\ \I*/JF$_Z!:7_@N'_P B'UC$
M?\_ZG_@<O\SF/V;_  ;X0\#?\%%=5TGP5X4\-^#]*N/V*[[4;C3/"^AZ7X?T
M^?4)?CGH5M+?366DVMO#+>/;6EI$TS(79+6)"Q6-0/F\XITZ6)IQI4XTX^RB
M[1BHJ_/-7LDE>R2OY'M9;.<Z$G.;DU-I.3;=N6.EWT/V KRCT H _,7X<?\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M^BX_!_\ \.9X+_\ EW1];PG_ $%4O_!D/\P^KXC_ )\5/_ )?Y!_PT-\ ?\
MHN/P?_\ #F>"_P#Y=T?6\)_T%4O_  9#_,/J^(_Y\5/_  "7^0?\-#? '_HN
M/P?_ /#F>"__ )=T?6\)_P!!5+_P9#_,/J^(_P"?%3_P"7^0?\-#? '_ *+C
M\'__  YG@O\ ^7='UO"?]!5+_P &0_S#ZOB/^?%3_P  E_D'_#0WP!_Z+C\'
M_P#PYG@O_P"7='UO"?\ 052_\&0_S#ZOB/\ GQ4_\ E_D'_#0WP!_P"BX_!_
M_P .9X+_ /EW1];PG_052_\ !D/\P^KXC_GQ4_\  )?Y!_PT-\ ?^BX_!_\
M\.9X+_\ EW1];PG_ $%4O_!D/\P^KXC_ )\5/_ )?Y!_PT-\ ?\ HN/P?_\
M#F>"_P#Y=T?6\)_T%4O_  9#_,/J^(_Y\5/_  "7^0?\-#? '_HN/P?_ /#F
M>"__ )=T?6\)_P!!5+_P9#_,/J^(_P"?%3_P"7^0?\-#? '_ *+C\'__  YG
M@O\ ^7='UO"?]!5+_P &0_S#ZOB/^?%3_P  E_D'_#0WP!_Z+C\'_P#PYG@O
M_P"7='UO"?\ 052_\&0_S#ZOB/\ GQ4_\ E_D'_#0WP!_P"BX_!__P .9X+_
M /EW1];PG_052_\ !D/\P^KXC_GQ4_\  )?Y!_PT-\ ?^BX_!_\ \.9X+_\
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M\&0_S#ZOB/\ GQ4_\ E_D'_#0WP!_P"BX_!__P .9X+_ /EW1];PG_052_\
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M\ E_D'_#0WP!_P"BX_!__P .9X+_ /EW1];PG_052_\ !D/\P^KXC_GQ4_\
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M ?\ HN/P?_\ #F>"_P#Y=T?6\)_T%4O_  9#_,/J^(_Y\5/_  "7^0?\-#?
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M )=T?6\)_P!!5+_P9#_,/J^(_P"?%3_P"7^0?\-#? '_ *+C\'__  YG@O\
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M]!5+_P &0_S#ZOB/^?%3_P  E_D'_#0WP!_Z+C\'_P#PYG@O_P"7='UO"?\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MZ5IOP@TC48O VFWNAZ':V,ESX--_-+KT_ESW\,,#/ZV*J8&A'$^TMA\/E_\
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MIJO1=+V<%&E5PE;'8;%T,1+-*J\2L+&ES3K5L%AL*HOF>*JXM8VJZM-Q3IK
M_5LNQE:AB?:.K4JT)X3$X7!8JG6ITN(T?]KR_P!?U>S@TKX2Z[)X>TOPC8^+
MOB+XBN9_%=O8^"[/5O!4/CS3H[365^'4GA7798=%U#13?V=QXJT?5(6U56L=
M,U**"20;8J%?!4<XJ8FBXRRI8BA&,6OW^882DO;8:FJGLIU,/+&JIEU#%82&
M+F\33YL3A,)0G&J=-.C'$5\LH8*M'%PS:M3>&J4[N%7 5\TK9?A\9!1YIPE4
MH4*F8RHXF.'I+#\M*EBJ^)?LEV.M_%3XLZ%X"\,_%+5? V@Z.=7M].M+_P !
M7WC:\/ACPG::\EKJ,?C/XA?$+2_AAJ>JZ.FFQP-IDEMI7AV_L+:75/M-_>_8
MU>\TCLEA8X?-X93.M&M]9Q$,-[:,9*-*K2Q&)H^QPB;C'%8C,8U<)[&GBI8.
MG]8HO"4*\JM:C+%^=A,3'&9;4S2:>#HX7#2Q:IZ5*N(HSIX.5ZD?=CAH8%?7
M:]7V<J\ZF%C&LXPG&>&C/\;_ (@>/O"WBCX?1>#+R&#3O#^E^)?B?\4]'32[
M;5W\0_#WPS+H&AZKH.GWLT(N=-U)3XIN=;LKBUBCDNIO" LG,<-[*5Y,-*A#
M'8NKBZD8Y1@Z6'PU>4VJ4J&(S6O5IX#'SESJ,*&"6 Q=3&QE.4%AIU9QC4J4
MJ9V.,JN7T:5!Q_MK'U7+!TJ;]JZ\,%AJF(Q6'I*;HPDL3B*F79?"O/E]C/'4
MJW+HX/S[3OVGO$*:9K.M:9X>TWQOI5OJNK^+;J\O/%-IX533?A9J'Q#\0^ /
M ,7@F#3_  MJ3^//%6M_\(IJ&HVFG73:9'*+N.*75XY)K6*37"X:?_"/0Q;]
M@L7++<-5KV3J?7L[:QN&H_5N:"C1RW!8[!4L=7<Z35.FZU&CBZT<7&GAC*M.
ME0S',,#.6,PM.&/J4(<OLX*&0Y=@EFZ=1IU+U,S>)IX2]*I&M.3O.AAU0YK\
M_P"T9\4KO7]%NM,^''P^TKX;O=_%C5M6U[Q'\1_$C>+KSX>_"74[W0=9\5:3
MX:TGX9S:?IOVF[G\/WMG'>:Y<-<)=2V;QVWF)J,7#*I*GE^(QU6,N59)2S.E
M'#KVTHXC,*5&KE6&GS*FIU,4I5$Z---JDIU_;>UP[P6([GAI5\13PN6OZQ*6
M;X7*'4JIT(+$NG7GCXJ%JE1PPE;"XG"*MHIXBC"U-T*\:U/O/@;\4_&^N^'=
M1M_C!H6G>%M9\)>"? WBO7->&NV]S;W$'BK1-0U;4!KME#H.G67A35-,?3+D
MSV%K=ZQ!':SV4QOC)++%#Z.8PPF H8ZM]93AE6.Q675W\:E+ X3 5WB8S2A[
M1XB&-@YPA0IPAB%5I8?VM%4IR\["UY8_'4Z.#PU3V&9T89A@HRO[2.'QN/Q]
M#"X647%-NE#"J%.I*7MJU/EGB*5"LYTUXQX6_:H\23:Y\3M8OM!\6ZMI5U9>
M ;WX3?#_ %GX>>+?AC?R#7_'5Q\/4L[#Q%XW\)Z<OBY]4DU+PCK4NHV3W^GV
M/]MBT$Z1P_:+G+"4*]7"87#.@Y9M4S+#4\0JLHT'@\/C\+/$NC5P^M:FLGHY
M;FE3$U*M)2QE:CB%AZDX1A2P^V)GAX8FI.ABHRPM/+LVKTHQY)TL3_8]/"S6
M)HXJ-2=&K_:N)Q\,-A84JEJ>&CE]2I0CB<36C4ZJ?]J[Q!H%MJNJ^,/A/'8:
M'HX^*-A)<^$O&E[XUU;6-?\ AGKMCH$UMX9T"#P)87&J:+>ZGJ=GIGVVX>QN
MXM4\VTBTR[M?)U"YYU.+HX9J,XU\=A\#5PU-TJCCSXS,:&61C7E2C4J4Z=6I
M7CC,%.C1Q-;%Y="K7J8;"XB,<'/:M2J4*F(4Z;C1P==1KU)2I0Y:$\BQ&?TZ
MD>>I&FZT<+A:E#$4JM6C0HXF4(PQ=:E[2K3?8_M-_$&;3;Z[UCX)IX=.@>"?
M$WQ"\5R:EXQ\3:3_ &;X3TJ2*+P_=:+H_BGX1:3XCO=8UMXM;BATW6_#?AV2
M&?PY=K(7@DMI[G6K1G*G6IX>IS8A1P6'C",J;F\QS&KF.'PF&I37M\.TZF&P
M-:=6I+FHX;,:<ZV%6(H2P53.@Y5<9@Z*I.&%Q>*KTX8C$7H48X3!+*JF-Q.(
MNU.G["GF%:/)3<Z56KA/W6+^K5OK='J;;XU>,M.T^:5?!=MXAT30]4T/X:?V
M_K/CJTT_QGXG^+-]>:+HCV+^'-(^'=MHEEX:75]49;O7FO=)D4V5U)9^'F@:
MV6>ZCA7J)X54HK,*^/CET%*I"C*AEU3,%BJ^*G4=:>%I0H99C,12A3>8UJE.
M%.#2K5.181Q%.-"5?$J>&>%IX6MC8<JFJ+S+#X/$8'"X-J2GBJLJN98+!7Q,
M<%3I2J.K6Q$J=.K5.)@_:L\:7&A76HVGPG\+:Q>Z)I_C+6?$;>'OBS?:CX9M
M=)\)>/!X#MO[!UZ[^%UC?>(-4U[4+#Q0-*MCH=C!--X>,<MY!!<B\AO"TJ>(
MJY?&52>&HXV>0T^>I37.GQ!B,52PCI1C4E"K&%&G@L;4YZU!QPF.BYJG6IPH
MUZQ<IX..-YU3E/"1S22<)RG22RC+\!CL:L14C3;HSP\\9/!5J-.GB*\,5AY1
MC2G'VTL/Z;\9_BQK?P\U[P\NCV=QJL-AX/\ &?C+6/#-L=.@N?%-S:77AGPC
MX,\(Q:G>VT_]D76J>+O&-GY,\03<^F%'8Q&1),,*I5,;7I>[4HQ>5X",;M2A
MB\XS.%.AB]+7I87 Y?FLZT)M0<)*<K.FJE*ZJC]2H5O;?5J\9XO%SIN+J3GE
M^691CL5CX\L8S:5/$U,KC*=.,JBE4A"',JDHS\\\5_M1>+_#N@^-U/PV\+67
MC'P2OC?4-2@UGXFWMGX(M_#?@ZS\+3MJ@\5P?#JXO]0UZYO/%^F:7'HEEX>N
M(VU.TO+4:B;=(KVXRG3KXK"8>66U(SK8I4L.W%)SAC\7F>:9/@J&$I5'36,=
M?%Y5B:M)XB6!A["*==T9SA3GIAIT/K_U3%OV#YXRC&I+V<5A:>!P698VOC*[
M3H8.G@L+C\*\1.G/&*/MX3I.M"GBI8;=\-_'[78-&\,>';G0$\<_$227QMHE
MU8Z=X@T>PUGQ*WPI\(-)XR\4VNDPZ3;VUD;CXCPQ>&8[%5@@CEU2"X%P$Q;G
MMQ;P]2KC*V7TY4\+#"XO'PA)5:BI8:.=_P!EY?&I.G"M5E]=PK_M*+A2G6]E
M2Q%*C0Q%6E:6. 6(E'#?VI%8&IB\5E6&4X1?L(U<SRBCG=;2<^>EA\#AIUZ,
M'.I7JU94L.JLX?695J?*M^TQ\4-HURV^'GPQU7P]IGPW_P"$EU[2= ^)OC2Z
M\2'QEXA\::KX*\ ^$M+F\1?!W0(K:XNM;T&^T[4;?5[+3[JRNYKE'1?['V:P
M*A%5ITFY3A7Q.283!5X*#HUJN9*G5Q57GA.HJN$PV#Q%+&PQ%*7O8?V$W3?U
MZ7]GE64UA*>)HTY.5..?5L33J:3I4LBPM*K6I.,>9QQ<J]1T'3?-2_=U7&LW
M"*J>L^"/C/XD\1^+[SX=ZYX#TW1_&V@^(]0LO%MCH?C*Z\2Z)X?\)1>&=%\0
M:-XK;6KSP=HLMU/JESXBTK3(-+:PMRT]OJSPW4\.DS2-G0IQK8>EB(U%RPH5
MGB6K.-#&T\=7PE'!4VW&=9XFCAYX^%65.BZ>$Y77I4ZM7#TZQ5=?#S<*]#V?
MUF5">7I5(2EB<'.FGB,56BFOJRP>(AB,%5IP>)YL2L+R3='%.M0S=)U7Q;X\
M\2>.O$LOQ5USP#X5^%OCC5?#TG@?PGI/P_N6U:P\,V>FWU_=?$+4/&/@W7]4
M@35%>>XM(= G\/R)I=[;2BXFFG2:#BCB8X+*(Y[B8/$QJTLQK>PFG"A2A@\5
MC<'&FG2<*]3$+ZLL15DZRA&K.-#V#A2E/$=$Z4\3F%3)\,HT*M)8"$:T)<]>
MK4QV$PN,4U&I%T*-*'UKZI&#I57*>'JUG77M/84>"\._M&^-_+^'^E#PCHOB
MB_U[7?"WAWQ1>:YXTC\%^(;?Q'XV\-0?$I= \%>$;/P-?0^*O^$<\!ZI:SWD
MM_J'AY=EJJK/=7'VEXO0K86MAJ\L)5INK/"8;'T^>@E5J8K$9%@90QV+E2YH
MT\+A<;FU"6!HS=;W,5B()8>&&EAI5L)-?5I8["SE7PF*JT,9AYU8^QIT\JS;
M/:F79;S2M*K[:CAFJ]2E*@ZCP]%RE6J8AU(QZ32?VA_%]S!X,O-9^'OA/P]8
M>(=?\2:3K]Y>?$+Q88O!_P#PCJ12R^'M16;X.6[K\3I(5U)QX?OETS3)!I<G
MV/Q%>F>W$W'7K8?#4JE>=>-2C2RS$8^,Z-Y1Q4\.L:ZE+ >U5)UH8=81/'?6
M(X/,,)SUO^$NL\!C51F'UFI.5*EA7&M]?PV"5.K.,'06)>#5*>.=+VZHRQ$L
M7%8*6&>-P&)OA[YA16.P?MO*X/C!\8]5\;^#Y;B]OO#O@#^P/AO<ZC:Z?XD\
M(W7BG4/%'Q+CU/QIJ>C^(K/4_@!<0S67A7P'H^HR+%HU]H-S)##:/<S7%QJC
M2Z1U5(T,LK9O_:%;VT,JQ&,P/[J'M(-9#DT,SQ^-KJ,J$XU,PKSPV!7LJBPT
M:F)K?5Z&'E"BHN<XXS#8;^Q_:UY8M0Q\:M2'U>7U+.,[GDN40I*<:M*%.AS2
MQDH5H5L4E1HTL37G&E4GF?HVK?M)^,-,\)V?BA_AUX)L8O$GA'5_B9X/C\0_
M%R^TBQ3X8^'=/TC4=;\1?$+5K3X8:C%X1UE$\0:%!;Z/HJ>+Q/-J0#WEO%!-
M-'GC:.*P#QM"M0Y\;E4N7&4:$G47M:M98?!83!2Y(5,9C<77CB*<:3H4,/#Z
MN[8NI.M0A4ZL#3CF3H5<#-U\OQV(H83!U^5PG5K5:>+K2K5J$W&6&P4*&$=5
M593GBN6I&-;!4)0J*'-3?M)^/K6#7=:\:>$=&\(>#M,USPW96D_@WQ9>>(?&
M4-QHOPP3XS?$?3M8LO$/PS32;O2H-#MKC1A-92V\\DOGQPW%E<20W=KT5,.\
M-6E3@O[0J+%9NJ$:;A3I8C!X+$U<CPTYNI5IRIUZV>>PIQ_?4Z-/ZQ"564Z&
M"JK,>;+'6S1894(T:4L7@LI4Z=6K+VV%Q^;5Z#C2C*$7"I/#Y9B5F/L^2I:E
MAXSDJD<9.GE_51_M&>//[3'A*7X2:$WCR[US3['3M'L/BBU_X<L]&U7P5XE\
M9P:GXM\5)X 1M!U+38- M8=7TVQTS6EM5U_3YK&[U3[3#%/RU>6E1Q52-6G*
M661S-XUN3A1I_P!EK*_:SP\W'VV(HU9YMAL/2G/#8>JL3&M"K0I4J4Z\50KT
M:DZ?M%6HTL71RVK@4J2G7Q+S'%8VE3H2I*HJ5&O3PN78W'M?6:E*5&E&*K*<
MTEW>K^+?'WCKX"Z+XX\ 6EWX6\3^*/#_ (3\2R65A)H>JZ[I&AZE)INH>)(?
M"L_B_38]%O?$T?A^74/[+EUW3H[*2Z^S&]M8XV>--,THT\MQKI8FO6IX#!U9
M_6ZD*=-8BG2A0JM<U)O$P7L<3['Z["DZ]7ZO#$QP<JF(]@WMA.>K'$4U'#U,
M7%UZ%"U6I5P56O2KRHQG&M!8>I.A6C"4\-5M23<Z%2M%4O:0/'M&^/WCJQU7
M3-'\/6VA?%;P;J_AKP5;^!_'?C+Q8/!?C3Q3XU\7>'O$/CTMXXMO#OPEL?#?
MA?PY8^!]&N+R[GTS3GNK:.VM#%8:A<ZF;:QNK"=-YK#$4J.$K97B:]%J%6?U
M>&%RS X&MCL9B*M1SJ<U:KC\+3H0P\*M.6)J58R6&PM*=:C,*?+"DH_6JTZ=
M%8G%QJ4J2K0EC<WK93@\'AJ=-TH3GAL7AZU/$>UFINBU)2G5H+Z_H67[5'B>
M^\/Z#K5E\+]!O_/\->%_%WB:73?B9=76A:9HGC+Q_J'@GPHOA?5G^'<5SXNU
M76[739M6TZVFTS18Y8RL-W<6/F12RS*$:-6F\3&MAL$Y951J3J46L32Q688&
M.-Q>'EA%-V>3QK85YA*5:#C0K3K4H3J4EAZD26)A1Q?[A3Q>&_UB<:-.K"2G
M#A^I&'M)3?+*%/,.7$K"R5*:]IA_9R;3JSP^=;?M->,-8\9:;=:?X7T*+P/>
M^#='UGPMH=GXR@OO&/B[4/B;XMT+PM\*[KQK8W/A&&V^&>EW2Q>)M006NKZ[
M,]K SW,4-S;"PG*.'Q"^N4:U-0S.$\-AJ="4[8.A5>"S#-\P=?&PIR<L1EV7
MY?!XBC0IUZ45BH^Q>,E6PU2.F82A@)0A5A4IX:CB,P5;%63G)Y;B,/E7U3#X
M5.2J1Q^:9GA88;$U*V'4'A9?6/JU%UY1OZ1^U3XGO=/NM2N_AIX7EL?#>D>.
M_$7C;5/#'Q2O_$&C:=HG@WQA>>"K)_"MY??#/2)_%>I:[JVC>(Q917-GHEJH
MT.1I;Y8IDEI4X.K&@Z49WQ4,GC0A.,85*V)SV6,AEM&G[[I*E45/+J]6O4JT
MW1PN91J2H^UH>PK98B4L)5J4ZSI1IT*F.]M7C4E.CA\/E6%RK%YG4K^SI3JJ
MO@X8_$4982C1K598S RP_-'VLJE#JO!GQB\:7$/Q]\9^/-+T'2]"^%$%MI=M
MX1\&>)1XU$6J:!X8N/&?B(W7B"Y\'^'Y3XEN++7_  ]IUQID0O[&RN-+:.WN
MYG>XD>7"HLJPM2A".)S#,L?7H81W<,/5C[3"Y9AX4JC:E.A+-88Z,L16P^'K
M6NO8*%.G*IOAX?6<VPV!<Z6$POU7#5JLYR3KT98NMB)MXV$:DZ6'=' 4L-BJ
M=&G.7-2Q3KSKU85:"H^8ZM\:OB;\-M>\9>*/'7BFQU;X>>%?#-MX2\0:7;Z!
MI5LOASXQZKX5O/B587%GK5K#'<W/A][/5/#WA"VLKE+B=KF[TJ:1Y9[R>1LZ
ME*M+#YA@L%>MF&8UZ^$R"O-*F\37P%/#X:5Z5I4F\?BZN88B\Y1I859/4P\?
M:.LVKPT?K&)R2M6IPP&"G3PF-S"E.KS>RPF:YA7P5*+JS]FXO*_JF&]I-1B\
M5'-<3BI1H4L)AZ4;B?'OQ=9_%+X1>";C5]=N]&TB?1O!/Q6UY?A?XDE\+^+O
M'NN>$-2>[V_$FQ\*CPAX8ET+Q3:Z)!+I=MJ]M<W%YXAGM/(0::(;KK]K@:N8
M9[6I1E#*W#-(Y9"4O9Q4,LOC:N.C4K2C4QD)8?"X[ TZ=%U/9SPV+Q%:$H*G
M6H>:I5J64995Q-54\Q<<LQ&*5.$:BY\SQ.$P>'RZ4(3G+"7ACUCY3Q$(3G3_
M +)A0K3^M8F$[_P[\7_$[XT7[Z#_ ,+6U7X=6EOX8T_XEVNJ^$-!^'UQXR\0
M>'_B)XM\;3>"[&VB\<>#M?TBS\+:+X1TC1+.6[31KF]OKRY9GOH3;L;Z88:<
M,-#$8E5*.*P#R_ XK"-1BECHY/EV.S&KBFTZBC6Q>.JX;#4:+POLGE^);G6Y
MG3H=F(JRH9AB,%]6A&G.KF?LZMJLJ?L<#F=3+</'"5?:QC4Q+A@Y8W,E5A6A
M2CFF"C0A2A*G(O\ B[Q3\2?!VI_%^?4_B)XO&M^&? >K^+?AOX.@T3X8R^"?
M$WA[28M+M[;5Y[M/!3>(CXQ;7R=/U&UFU>PL"-;A?3K(+MEM8R^V(EAX581]
MM/.\JPN,IOFC##X?,\YJ4L'#!24KRH8G+J-2A.6(G7QE+%T<5)NE3EA*E3.J
MHTJL*-7%+"X667XRK1Q;2E-RP&64_K^(QL.7E53!XO$PQL(X:E1PU7#?5:?[
MR<<;07MGC#XC>(-'\3Z5X2\*^%=(UW45T+_A,?%MUXB\5W?A/3?#G@Z&^&GW
M%W8-IOA3Q#=^(?$+SI=&WTQ;2RMG6RD^TZE:&2 7'+/$4*']J5Z\G#+\FITJ
MF*JPC[2M:O#&3I1P]!\D*KY,#6E5=2O045*FJ?M92FJ>M&%6K2R^$:;689JJ
MT<+1?+&E[7#?4E6AB:SDYT(J6/H1A.G1Q+;Y^:$(Q4I>,V'[4FNWLUCIH^&N
MC0:YXSTCPQX@^%^G2?$F)[>_T?Q7IOBC6].F^*&IP>#G@^&ES'H/A'6=3EAL
M/^$N5K>UD6UENKE#;5U5</B,-+'X>O&%'%Y/4J+,)2J-8+#TJ-+VE:5/%\G/
MB*V'DZ5#$4(89>SJ8K!U%5GA*T\52*;IUZ5/'85SQ65XFG.6&JTZ;6(KRAC<
M!@8..$JNG[.CB*N8T*F'E4K1KNE3Q*KX;#XBBL/4Y7X=?M1>/]?U#P1X9'PY
MF\<^(/%TMOXQ\0:EX7N?$\O@OP?\//&?C;Q)I?@]_#OC.S^%_P#8GB!['PIH
MJZM*?%5_X)GO[7$EB;J]F.G0;X?"JI.E2FZF&HX7#4%C*^*I^PKPS&KEF&S2
MIAWAI<M*V'GC\-@)T\/7K8RC[M2IA:T8U<1+'%57A_K+Y80Q3Q.+HT,%"I*O
M^XRVM++:E>5>E1E4I_VEBL%C<1@_;4(X92<L/7Q>%A&BY]_\<_BE\2=!U*_T
M3X76^D'6=,D\ ^'[)?$=S;:;H&L>,/BOK]UH&C)JVL2:9J,^FZ/H&E6%[JTR
MVEG)<W=W>Z3!&)(UGM;W@P\*N*JPI4IQBL3C*^ A>3C*DLORO^WLRQ"M1K?O
M98%4,)E[E&I0C7K8JIB</45*BXZXBOAL'2G.MSN6'PL,;-1AS)K%XY9/EE%\
MU6A&5*MF#K5<<XU:=6CA<)#V56$L1S1E\ _%/Q/I7P6T/7=:&N>//B!JWC;7
M? -E9>(]?\%V]MJ'BS3?%&M^'9XE\9>#/AUX7TH>![=M U*]AU@>$XKU]/@5
MFLKF^=;:3HQDJ47E$,'[-1S+ 4L93J5Y3H)47EU3-:E7%N+Q485(8:$H_P"S
M1E1J-4I4XQA.51%.#A6S=XJ:4,!B84ZD<)RXB,)5:^$P=*AA(S=&<I?6<52I
M5:6*K>UPV)>(HUJ]J&G ^ OVB?'.K13:EJ^EV>KZ[JES>0^&/"GAOQ9I4WP]
MNIO%/CGQ)X3\#0?\)O?_  XT[5)]&ATCX8^)-?;7C'%*;/7IP=$OIVTR"V5E
M#"8-4W"I4Q='#5(XC$N6&BI3R[&<1XM5(TG7]@L#E.*RS"R;IUWB:D:4N3"5
M/K=2LY*,*V*E.I?"T<35A..'7ML12^J3RC)'1A3JK#^VCC,]Q6.Y93E2C3JX
M6K&CBZ^#BFFC]I+XF>)/#L>L^$/!_@^+Q>D6@Z39^'9_B'J.L_#'6;[QW\8=
M2^&WAG6X_%-G\(;?7]2@&G>#]8UFVDMH-+B%CJ[&[M)W%M-;ZTJ$JE3+_8I3
MPV92RV3E6_<U:=/^QJ_$.9TJ,(RG&-:EEU3!Q=2O[6//5C.%&$L-5P^-FO.G
M1H8SGK4H3PG]IQC4BYS_ -HP=7!Y;AZ-6E-4I2IXC-L5B,)35-4WB,5EWLJ.
M,^K8F6)P_N_A+XM:WJ%W\4T\;>%-&\&VOPQC%Q<6MEXIUGQ!XFO-.AM=2NY=
M=N=$O? FBV=MX>OH=,FFTB^TW5]:%]&D\=TFF7]E=6%OR8JMA\)D]3-^:I4A
M2J8F+IQA%."P\*=14:KE4BZ6.Y*M*57#N#H1IU:->AC,5AJU.M+6C1J5LSP>
M54Y4GB<31PDV^>7)SXOE@O8MP4JN'IUUB,-*O*-&I[7#33PT;JWFMC^TMXPN
M=1M_#<WPFTU?%^OWG@=_"&AV'Q)CU.UGT7QWI'C+7[&X\9:S'X,CA\*:]I>B
M>"=1U#4]-L8_$$$5M<VKV6H:A)/'%)U5L+6H^UI)TI5\#7S*ACI<\UA<,\MP
M>'Q$ZL*[I>UKTI8C&X+ R;PM*K3KXF$O93IV<L(UL/4PU+'TIRE@\3A\)B*$
M'[*.-G#$X_#8)<V%=;D@IPK5\3A&L3-8FG@,=&7U>6&K.G7TS]I'4)'T?QGX
M@TVT\/>!XO#OP_@\76J:Q'>Z3H&M_$37?$EI;ZY;>(;GPU:7>NZ=9V^@:(+=
M!!I1N+7QG'<W%M%-%'"N2]G%RE'VM>ECJD:6&@Z/)BZ%7"<.SX@Q&'J8:G4J
M<^(Q<<;@L"J,:E9T\7AN2A*;JU(S*T:D*DJ%I4\=E]3&4\3AXKFI5:<^(<)D
M.#Q/UB48JG2I2PN<8N;M#DP\+XE1A[.K3]3^''CWQ9XI\5>+[?7-$N= T^#P
M;X#\5:3HFI36C7.AS^);SQQ ^E:E=VNG0RPW\FC^'_#^HW5I,MVUC<:M<6Z3
MSQQ(2ZT%@\KQN(J5(5,7@\=B*%1<Z]E3='*,GQ=7#JK2C.-2EA\5BL3!8J,)
M.M"2J1@XJ$$1J4JN+PD:%3FP^(P\IQ4:<U4E1CC\71PV/=.JJ<X?VA1@U3PT
MW"5)8-JI&G6G5O\ .6@?M(?&Z]NM U[5_ W@:;1E\*Z;XEUW1O#'C36!I4OA
M[XH_$C3?#GPKU.VU?7?ALFI7?C-=#TW7_+T.""TL;\SFYNK[3C/9VMOO1I1@
MX4L92JT'5JY)@:LG%.>%S'$8?%5\SITZ$9KVM+"PKY36QOMJD'@*4ZT*$L?.
MDYU[Q\:^&GCH4*4)QP4N(Z]-<UZU;#9#&E",:MI.&'ABZBQSH5:=/$.O/#4(
MIX:'UE+?\5?M1?$4OJ=KX ^'/P_N1JGAQM6^'^H^*_B;K<&H7ES>_$3PY\-/
M#4_B_P %^'_AQ>MH>FZYK&NW5UIJ6^OW5Q<0Z+/%=IIDK2&TYL#&>,A0<5%U
M)ULCDZ4)2E;"9O0Q..;J57!*CB,/@,'6KXB,:6)I8>G)5E+$<L:%;>M&AAYU
MZ<IU)2PU//'**IJ,I5,AI5/KCH7FZ=2A3Q7U?"J56IAZM:K7M1HRIPG6CZ[\
M3_BOJOP]M=!N-1TJ>36[#P%XX^(WB#P]X:UFVNM+U&3PAI&EZ<OA*+5=7\&/
M=W]KJ'BOQ9I$%E=6\.@WC2V<,KH\'VG3YZT>,Q5+!TY8JA&6"PE!U7"A.6*S
M7,J&#RZ+@JKA3JU*=+&2<I8BIAZ<:<X5(3=2EB,/GAH6P>&JYE6H8'GKI8JK
M%SJ+"X7"X/%8_'XRE!QC.M1P\,-2I5H.BI\N+AR5*=54_:6-$^+GBZ]\(_&#
M6M6^'-IIWB3X5SZG#!X8T_QB^KV_B"2V\$Z1XVL+!]?E\+6*:7J[VNM6EE>0
MP6FIVMK=+(L-[?1KOI8F6'P>"PN/K5[8656M'$5(Q;A2H87'5,'B<51NXU*]
M&G&E6J152GAJLZE&I1<(14*T[P%"6-S'!X";6&6-I8*I&4GSU*,L6YP5+%4H
MZ4:L)P]IRQJ57+"5L-B'R3JRP]/@-?\ VHKN.VU"_P#!7@72_$.CVF@>(_&=
MKXA\2>/8O!GA_4_!7@F'1(O%FMV%[%X8UF>6==<UM=(TN 6I@U"?3+V6>\TZ
MT^RW%ZZE.K0]O*K3DZ>$JX>-:G2C*IBW2QN(Q.'RUX;#-06(Q..>!Q>(H8=U
M:4'A/J=18F5?&1PU/GP<HXUY?1P\X?6\TA3CAH2<E1^LJC3KXR%?$1A-4L/E
M]/$X&GB:T85<0L7B*U"."<<#BZU.YJG[5&C:;IKZB/#L<C+>?$Z9=+E\10P:
MR/"WPH\*76I^)?$4^F1Z5-+!+'XTBM?"QL@'V3WT5S]H;(MW52G64:E/#4_K
M>,CA:U>G2@[0JUI9[')<JP\:[]R/]K<\,90JS45"DJT.2HZ,YFF"B\1/#+$0
MG@J.+Q.58>E4FH\L5F&34<\KUJ]Y05&G@<%+$>TM*HZE2E135*&)YZ7::U\4
M/B#H7A3P%<77PUT(_$;XB>)H_#ND>!D^(5V=(TU9=&UOQ$U[KOC%? 1DM?L6
MAZ)<37\5IHE\L4H>&TEOB(GN-*U*-/,(8*A45>C1I8FOC,19PIT*&$7+.K2C
M[T\1&IB*F$PU%-492J8J,IQIPA*1EA:D*V J9A54Z%&*P+IT[0=>I+%UL+1E
M34'4A!5*2JXBLHJI+GH85SDZ3G.%'R[PW^U3XE\42ZK+I?P:U5-$N=8C\*^
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MFY<CL3RQ]G&CRKV4*$L+&%ER1PTJD:TL/&.RH2K0C5E12]FZD8S<>9)K;M?
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MA^6IAL/3HSG[1\"_!'QNT_XH?$+Q/\7/$'C*XACGUK2_#=LM];1_#G7= O\
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MXYMB*Z5J_MX4</1@W5G-P='$T:,?K>/G#Z8KSCH"@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /G_ ,1_\G3_  ;_
M .R ?M+?^K%_9.H ^@* "@#Y_P#V:?\ DG7B/_LX#]K'_P!:G^,E 'T!0 4
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M'+ZU9.,<SQ-3"X=6=Y3HX>KB:M3915*G&FJ;ES<TJM2$80E&-:5+U6D(^?\
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MZ%/$3<H4HMRY9RI5IPG3HXJE3J8.I.,5'$-5\.ZWO-04?/\ XC_Y.G^#?_9
M/VEO_5B_LG4 ?0% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % 'S_XC_P"3I_@W_P!D _:6_P#5B_LG4 ?0% !0!\__
M +-/_).O$?\ V<!^UC_ZU/\ &2@#Z H * "@ H * "@ H * "@ H * "@ H
M*4ES1E';F37WJP;?(^3;[]EFWN-'^$EK:>.;S3-9^%OCA/%%QJMKHB&R\9:(
MGCB?QXOA/7-'?5OD@AUD:?+:WZ7;S6LMG.T:^3J-U;3/"2J8*KEU7#RC&6 R
M:CE4E*"<:M7#</8C(<+CK73IU*"Q6)KJCS2C*EB*N&G*4O98FES8K"PQ>!S7
M U?AS'.*V:PJ))5,.L1GT,ZKX2,G=RI5E3I8>JUR*I5P^$Q<J=\/&@[7A7]E
M7PYX.U/P;XNTGQ?XV?X@^'O$>I^)M>U[4_&'CW5_"WB>^\7O>R?$=;?X8:IX
MUN/#'A)?$$VI7=PCZ18PR64\5HX:X6"2.YJ*IT+4<+"4,"LOJY9[*M*.(K/"
M.E%T(_6JD/:PE2QU#"8ZK[%4J=>5&I0]G2I5E[+?&>TQSKU<1)?6JF,HXRE.
M"G3IT*E&HJ<(QHPJ1C5C3RJ5?**/MY594L-652\ZM--IHW[/OC+P%;>'+SX7
M?$_1?#_BK3O"$7@;Q)?^+?AW>>,/#'B?0[#6]=U_0[D>&=.^('AZ\T;7M+OO
M$6KK!=1:[-!)%J$Z75G<$0-:JC*I1H4\%SWP2P^6TJD4DJL:^7Y?0RZ6*PU2
M7/"C/%T,/256G6HXJG'V-#DCS0JRK[U9QKU:E:JI\\<?G&-H1C*,:<5G./CC
MJU#$+V;J5H47"$*,Z57"R4O:U'>-3V4>T\2_#CXHZAHVD:5I'Q4\-:F$TP:?
MXKMOBO\ "73OB!H'B2X:XGNY]:MM'\,^*_!<^BZHTDRP+"VH7VG16UO#''IX
MF#7$F=:C1KSJTJM/FP%6G3I^ST^L04*;HU)4\0TZ:J8B$I2K2J86K%5FI48T
M://AYQ3G4I4X.,W#%PJU:GM(7A2E&I*,J5&5*\IJGA90BJ$H5X591<WB:N(J
MN%6%>[^ ^GCX-^"?@YI7B&ZLM.\$:O\ #/4K+5KS3XK^>>W^''C7P_XPCTX6
M-O=645I!=+H7]GQ>6^RRBGC*QS+;B*3MGBIU,PPN/J.52>%A4@_:3<ZM;GRS
M$9:JE:M+WIUVJZQ%>JXWKU8S;4/:<T#"26$H9M15.$?[4H9I2<:452HT)9G[
M=R]A17,H4,/*NU0P_/[M&$*7M=.<X2\_93M=0T#P5H%WXXNEC\&_#;X@> HK
MRRT"""ZN;WQGXI\&>*].\1PK<ZI<PVK:3?\ @VV!L)HKR.\%T=\L*QE)<*-2
M>&HTXTN58C#TN&%0G--PC7X9;E2J5*2E!U*>*J<KJ48U:<J<%*$:TI-5([5:
MU.OALRP=:DY8?-,TS;'UE&?++V&;T<WP]?"PERRY:E.EFTU3Q+BUST8R>'M-
MQC#-^SG\1[W4I?&NH?&#PQ/\3H?B%X6^(&D:W!\);JU\&6$WA[P)K'PZN]&N
M_!B_$U]0U*ROM U[4Y/./B>">WNI8Y%DDAA6W#PLE@FEADX4Z]7,98M-IRK4
M<RH9;3JTZ,G&V'J4*N68>KAJKA62C%4\12Q#=6K6Q=2I.GBZ562E"O@<OP5-
MQ7)*']FYQB<WH5:C;DJCJSQ'L<3"$:"DE.=!X?GA"CSEU^Q]J\EIX3M[7XHZ
M;;7^A1^)K:_\6#X;06?CVUB\3?$'5?']W>_#_P :^'/&&D:GX-U1KG4TM9H=
M2E\3Z+-_9UO.NB0R-.MQ6%JQPN+R^JH/ZO@,)D>&E3C)TYXB.1X2AA:5+$35
MZ5?!8IT.;$8:OAZM6-.K6HX?%T8U)2.6=&4\%F&&YH^WQV/SG&JI*+E2HRSJ
MI.=9TZ+G[2EB,+&I*.$Q-#$4/>:GBJ6*=.@J/HO@/]G_ %#P#XOT[Q7-XOC\
M2:?X9/QV.@^'K?PLNEZI-8_&GQMX<^(%Q8:CK5UXKFM=0O\ 3=8T;4K:*Y6R
MTV*Y@U6U66.W>QDGOCZU[/*:V#JX7ZW4EE>59;)4W&$:E+)H8NCA^2E5ERQJ
M5L+7I4:JGB%3=>E.LI4J=94:'?*:JNI2C/V$*^:T<S=2I*4W3JK 5\%74I4X
M*3IRG7^L0<:;J4HP=*U>4E43/V7?A3KGPX\,>*=0\466I:1K'C#Q7J-YI'AC
M6;_0=5U/P%\.=*FGT[X=_#Z?4O#,]QIMR-(T3?*4L[N_BAFU:XA2\NQ%]IF<
MU&GEF79=+$?7*].BJF.Q*]K?%8ZK2HT9U9.M:<ZE'!X;!8&I7<*?UF>#EBG3
MC*NT<M9K$YMF.9*DZ%.NXTZ$)J'M(TU5KXS$SDX5*VF)S7'9EC*,'5E[##8B
MAA^6FJ*I0PH_V:/%T?AVX\&CXQM%X1\/:_8^+/A3I-O\/M*6Y\+^)=+\?I\1
M--U#QMJEQKD\WCZ&UU./^S$M; >$XWTRXN$G\[43#J5KGAJM3!TLKG35.>8Y
M/0PV#P]:I&;PZP>&RC$9(Z<L-"I3J2K8K 8AK%5GBN7V]&C5PE'"1]M3KJKA
M\/6J9C3JQF\NS>MCL3BJ$9I5I8K&X^EF?M*6)<)1I0PF/IRQ&$I.A47[QTL9
M+&48Q@IX/V</%UEK<_Q$L/BCH]O\8-7UOQ%J'B7Q-+\.9KGP1?:9XI\.>"O"
MNI:+H_@%_'8O-'6VTKX?^&9;&ZN/$VIRQW=M-)=B^@N'M:SK+FP7]F4I2IX&
MM@\3A,2I<E2M5EB<;B,P>(IU%"$*-2EB,35I4H.C5I/"2]G5A5Q"CBUU?6L3
M44'BJD:T\+7P57!QA#V5*C# TL;1I4*D4Y5:T*JS'%U<1/V].K+$5%*A/#X>
MG3PT?/;/]A?P_9S>!9;C4?A?XFG\/>"_AYX.\2:SX\^ '@WQSXHNA\.[5+.S
MU3X=:OXAU>>W^'$NHVZE+NUNM.\3VZ[8Y;1+:Y1IY>]XR*S?&9G2HO#1Q&8Q
MS.$:524,3"O&AA:"HSQMG4GA;8.C-*G"ABZ<Y5Y4<93E5C*GS8^,L?2Q4:U1
MU*N*ACJ,O;*-7#JEC<=CL<Y_5.6%)XJG/,*\74;>%KQC0C7P52G2]E+[V "@
M # 48 '  '   KA*244HI<JBK)+1)+1));6/ /VL?^36/VEO^R ?&3_U77B.
M@9] 4 8_B#59]"T/5=8MM$UCQ)/I=C<7L6@^'TTZ37-6:WC:3[#I4>K:C86<
MM]*%*QI/>6Z,Q"[P2*B<U347)2Y'.G&3C&4_9QG.,)57""E4E"E%NI.-*%2L
MX1DJ5*K4Y:<KIP]I-0YXP;3LYOEC=1;C'F>D7)I04IN,(MIU)P@I37RS\%].
MCN_C9\0_'7@C1/B1I7@#Q?X3TJ7Q9=?%GPW\1= \07_Q*MM;OI+.T\,Q?%RQ
MMO$MMX8TWPY=7,;6%FJ^&[9[RU31HXY/MXKJPL)8;+,7A:DZ;PWUK#U<NC"4
M76=Z->GF=?%V_?2=65++84*F/OC6J-:.F%CAT\,;*5?,,LQ"IQCB:.&QN'Q]
MH>["G"I@IY;1HRIWP?NU)YK.J\#*5*<IJI6E.I.$W]?5@:'S_P"'/^3I_C)_
MV0#]FG_U8O[6- 'T!0!\2_'SXD#Q)XOO?@5KO@?XP:?\+WT[3[OXD>.?#_P0
M^,/Q TWQOI=\!<2?#3P;>?#[P#KUJL5Y $AUW5[JXM3;6LTMA81S7EU+=:,\
MOE2JXE8NLG'^RL92EAL-4A.G]9Q>'=.O0Q56I)0IQP.%Q"IU(14Y2QF(H\E6
M-/!QF\5T5U+"X90H3OBLRP]6/MZ56*^HT*CJ8>L_<G[99A4IJ:P\.2$,/"I'
M&2JRJ0I8:K]H6+6[V5FUI%);VK6MNUK!+:SV$L%NT2&&*2QNHHIK.1(RJF":
M*.2,J4=%92!=95%6J^UDIU%.7/)3C44I<SYI*I!RC--W:G&4HRW3::9PX=4E
M0H*C!TZ*IP]G!PE3<8<JY8NG-1G!QC9.$XQE%KEDDTT>$_M+?\DZ\.?]G ?L
MG?\ K4_P;K,V/H"@#PO]H/P_H'B'P/IL7B?3?BAJ>A:/XU\'^);Z+X1V]Q>>
M*[;_ (1S5X=7M+]['24DU^\TFVO;6VFGC\+0SZX/+C?34\Y-R9*4:6.R^O)U
M8^Q>,C&<'65.+Q.6XS!/VSPK6*BIT\3.G2G2M3IXB=*>*G#"JM)5.,JF"Q]"
M'*_:TZ'-&])5)QI8["8AQI*O_L\OX*=:E6NJV%5>E3A4KSI4Y97[/D7B6*W\
M?FXD\<-\-Y/%5@_PBC^)TGCJ7Q_%X9/A70?[;.NM\4%'C!(&\8'7?LL7B0M>
MI&K;2+1K54[I<WU# _6?9?7U+%<_L5226$]NU@%6]@_92Q/L%S5&DJOLY48X
MJ^+CB&\/W'UF7U/VRPJP]%5?;>VUS!5L4\7*A]8;J+#>R>$C!1M0]K&M+#+V
M$H-_1-<QJ?/_ .S3_P DZ\1_]G ?M8_^M3_&2@#W\Y .,9 XSP,CID@' J9\
MZA+V:3FD^52;4>:VBDTFTK[M)M+9/8%:ZZ(_.[PUX#_:#T+]I#X6^)O&'P^\
M!:A_:ES\:=3\9>/_  U\1?&NO00Z?KD?A"TT.PO+:]^"6E6OA[^RM TO3=-T
M;19-4F2_^QZA-)?0W"SRWEY1R4?K5"LOJ_+DD*=:44I1KX^>/PV)Q%>-23I.
MM6Q&)A&/LI*,L)ED*:IRJT\#2P\]<U?M*,JF$4:T'GV >'A.4J52CE^&RS/,
M+2C*BGBE2IQI8JKB<35IU'1JYSB>14Z,,R=7"_HE2,CY_P#C)_R47]D[_LX#
MQ'_ZRQ^TM0!] 4 >=?%S3)]5^%WQ$L;+3Y=2U*?P+XP@TJSM;1[R^FU"Z\-Z
MI9V\.GV\4;RR7DWVAH$2%2[^>8U!WX/C<0TJM;),UI4*<JM:IAJD(PIQ<IRN
MD^2,8IRE=QB^5)W:6FB/5R.I3HYSE-2K.-*C3QF%G.4Y*,(QA7A)RE*348QB
MES.3:4;7NK$_PJL[O3OA?\-]/U"UN;"_L/ 7A"SO;&\@EM;NSN[7P_I\%S:W
M5M.JR6]S#,CQO%(JLC(RL 017U^?U*=;/<ZJT:D:M&KCL7.$X24H3A+$5)1E
M&46XRC)-.,DVFFFG8^0X;I5</P]D5"M3E0K4,OP<*E.<7"=.<,/3C*$X22E&
M49)J46DTTTTFCOJ\D]H^ /\ @EQ_R8G\#/\ NIO_ *N+X@T ??Q.T$X.%!.%
M!8\#. J@DGV S4SDJ<)S:E)0BY-1BY2=E>T8Q3<I.VD4FV]$KC2NTM%?35I+
MYMZ)>;T1\.^"_B3;_&7XQ:'K?C?P%\8_!5CX%US7+'X2^$O$_P !_C/IUM-K
MD]E?Z+?_ !0\9>-KKX>)X8T(W&B3ZC9:-8'76BM[35;BYO9S?W\-GI'3ERY*
M$\9":689A@G3G"<O8K X*<Z6)K83]\Z?ML=B*F'P[Q3A&2A[&.#P;K1GB*V(
M>9\M.2RY*4L+A,73G5JTW[6.-Q5)RHX=THX>51/+L-*K*M&K5LZU9PQ-2GAJ
M.#ISK?<=8$GS_P"(_P#DZ?X-_P#9 /VEO_5B_LG4 ?0% !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'S_XC_Y.G^#?
M_9 /VEO_ %8O[)U 'T!0 4 ?/_[-/_).O$?_ &<!^UC_ .M3_&2@#Z H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M\X4&P;'T_0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MFRO/ L4J> OV</",VI-)JS7UQK/PX^(%SXQ^)OC>YE30T^U>)KBSG-CX>O9
M;BW0O%Y^FPN5/K1Q>#HYK'%86G5PV#H9_1S'#TH63HY=E^44\'@,/&//R1Q&
M+Q,/9YM*$E&O@HP52KBFEAX\=7ZUC,OK4<PC2K8[%Y3GU#$5(SGR5,SS_%.M
M5E[T>9X++],3@(RYI0QDI3C1HR7MY;>J?LA?$SQ%IM_I_B:Y^&VN?8W_ &K?
M$.B_VGK?B+4K'7/''QMU'R/A_J?B?2[OP7Y=KI6C>%KW4[*\M1)JWDR0VAMA
M=IGR/#>'A+*J6%BWA<=3R++,FA.E9PHS69?7\ZQU*;4)_6,15P^%Q>#FH0G#
M$U<1"<H.C2Q5;V(8F@LW6*K4G4P+S_"YK-1M"K+!X#)7EF$P+IW<'_%G1K-U
ME"IA\/2FT_;U<+2T;;]D;Q_+XLTB#Q!J?@[7OA_8>)_@EK-[)>>(O$LGB/4-
M#^#/PHU?PYI?A6XTF;PL]M/:2?$B[AUM[E]9Q<VM_>++;1S1A+OTL57IXFOF
MN,=/]_6QO%6886G)1G0EBL\PF#RW!2Q$&K0IX;+H8FC6IPC72J0H3@ZD*U6G
M1\3#X.&'RS+\#9NK3RC(<KQ%:,W"5/\ LS.ZV<XRMAFE><L3.5*E1O\ 5I4X
M)QO'V<)/P+7/V9?&DT7@#X!Z]X8T?XB6L'A/P#I%V[^"OB-+X!^$,S_%'5?%
MOQ*\4> /%>N>!++P9+<WG@[5_P"QK1K+7--U[3HM&M+&VTM[:[F:STRZM0EF
MF"Q4Y5HRR3$9+-YA5:ABJU#(\EI*&"Y:TU4E#'YOA:,\17P7UN&+CC*D,?[%
M8"$SJS%1I8',88:EIFE7B:I1PU.5XQJY]CY4\!B:GL^:G3ED^#G4J*CB%0]C
M.E.OA*E:IBX4ZOVS\??@S\3?'_B;3M9\ :EX3M+33O@I\9OAWIUMXCUK7-(.
MC>+OB+9^';'1/$]O#I7AK5H]1MK6RTB]M9E9K.:%+S?";C>T0\IX>CBO[;H8
M].5#.J.586=6FTZ]/"4<SEB<VHQC)*-\7AG2G2G[2SQ&#HTJL%3J.O0[<)B(
M8%9!["C&4<ES)X]T9>["JZ&78C#8%*JN>4?8UJTX3@Z;3H8FK5C/VE&-&OXV
M?V.O%WA^ZUFR\)0_#:]\!ZAXL^%(U+X<>(-3U^R\/^/? ?@#X5WO@N[MO'\E
MGX5ODU'5Y?%6H1ZQ+9SV>I6^K6WAS3+*]N[9#_HG;B:\L5]:=>G"M+$8WB/'
MTH3C>C@L3F=+!4LMK4:/PUOJOU2K.K3G[)4\5CJN/HU*F*H0E5\[!X:C@\+A
MZ-.=6-:EDV39;4K1DU4JSP6:8O&Y@E-.+IPQ6'KT<)2K)3E"A2J8=X>-"JXK
MB-/_ &)OBUI?A2Q\%6D_PAM]$U+X.^%_AMXBCL=7\4Z=#H4^H?%^Z^(7QBA\
M(Z=!X):"YTCQ!I5ZMO8RW361M9-)M;8V0MY&FBZ*.(I4L=AZDZF(JX;"9APK
MB85)R4\37PO#&7NEA:&(4FH*HLRY\3.I&4GB:6)K*;HU(4V5B*-*I2Q,J%*.
M'Q->EQBJ<8-QIT*_$;A3P=6$E=J&$P="AAO9*E%4/9*=*5=.5.72>*?V-/%_
MB^[^)M]K'A7X)7UOXS^,7PP\>6^B>(=0G\5ZMJOAWP9XG34_$NBZU\3+OX06
M>L6.BZKH]O9V]EX4N]/\4VFE+]NL;?5?[.ODAL>3+'2PD>'OK-&-:6 Q^/Q6
M+BDFN3&Y?C*%.5VHQS+%8+'8VKBJ6(Q%+!U:U"%+#5:G-3C65XYU:D,SA@:C
MH.KE%++<+*3=HO#XG R@H07,\NHU\+@81Q$</5Q%-8Z2Q\,.ZT:GMXO&/P#\
M2^$M"T6P\&>%]&D_:"\3_M#:C\4-#\5:#X3\1:SX)\'^%#XGFTN"'6?&5QH%
MCIOAW3M"^&5YIRIH,ESI[7]YICQZ9;7;*\XSP]-5<1P]A/K-;#4L%@,9#.L6
MY*%2J\SP6</'U</5J7>,Q/\ :>95G@(M5:M+VE.OB:.'P\ZTDL9["E3SK$TL
M%!PQ4\IHY;@Z=I+DR>MP_.C0JQC%1P-#$T\EA+%U^54HQ7LJ4\37I8>C/[=^
M%_A:X\"^$IO >F>'O["T;PD3I'AC5=0UBVU34O&#/90W^J^,]<ALH3]@O=2\
M2WNJ33":XN+FXD\ZZF2!K@1!YE5JXW"UIX>%/ 5YTJV'PV&C?V."H8=2PN7T
ME-<W[N%"E2E"$%4]EA_8QG.5?VM*E.$I1P]=+$3GB^><<3C,5R4Z4\7B\3.6
M(QU2%*G:,;SJ6;<:,?;^UIT:*PM*A7K_ #5HW[*^OWUAX5OO&R^#)?%OA>T^
M!^G:7?V>IZEKUOH'_"N?%%]XM\:^(]!GU#PGIGV?Q7K^H:MJ]NE['96LR6NH
M2P_:(5EG6XW52EAZ[JX"G]3C&OB/8RC=U,-@8<.TLLRW PDY>_1P^.A)XJ*=
M*&,P;C[:$W&&%IZ8BI7Q$<;2JQI5L-B(YA-4'%PHRQF:YS6Q..QLHISE&<,!
M' U\!3E.O]3S/#+EJ22^NSY[P[^RQ\0K'7%\4:MH?P:_X2;SOAG:Z]XDTS5M
M=;Q7\1!X8^)4/C3QAXM\;^*+OX?"YN-5OT\/^#[K3M :&]M;!K&ZTB'4H;-H
M[T+#U(86$(X1RRZE5GS3P]*U:C@U1R+-L!@ZE%S=*IC<7#,<UGBL3C,1]7JX
MFG1HU*B>(IR]J\R4,56Q6(H<\:Z>;4Z$ZDW>6$S''Y75>"DK36%P_P#9>%QN
M5\E)5EAX8EU**<:TZ5*W<?LR^.9_"-IIMU\//V?M<\3W&HZG%\0=1\1ZUKNI
MZ;\9IET*ZLO#'Q*^*$;_  K^T^)M=TO5[N\O(O!6J2:KIEO]N!M=;B?3[7;Q
M8NDJV'AA<+&. PO]GXFE3PJ7MZ.6YA4G@W3QN$E4Y7B<34I86=*KF-:G0QE.
M5>5>2Q4U.-7J]O3688S%VJ253,85X24W3K5LLG/%^VRJI.+D\-A:5.MA73I4
M9U:.(6"AAIT\-2K.=/D=9_8J\30>'=<T3PAHOPFT>Y=?A3I$6LV$F@:3K/CO
MP'X.^'FG^%]?^'OC:Y\1_ 3QGI]IH+>*=-MM<1;S1_%]OJD=O;6ES8Z:;6&X
MC]'%UZ6*QM3$3IS>&Q&;YCCZ^%<TZ%:%=*GE]>HN7FE6P6'E5IPPT94I4<54
MJ9CA\TIXBM*,.;#\L<-AUBG[3,(Y-1PDL5"/(Z&/_M.MC\=+"4Z4Z$:.&Q].
MK]6JNG[&$:"CAYX&OAX>SE]#^*_@!:WOAOX!>%M)\$?#OQ#X?^$6OP:I+H'C
MV];4+32XK7P?KVB:9/X=O9_ FIB^N=+UK4[&ZM[;[#H,3)IT!BELQ;16]88J
MMB)YCB\?0J_[2LLQN%P>+FYK%4,9)X)X+$RE*=:K+FCA)4L55GB:M93K?6V\
M77I<L^>C2C'+7@*M.'LL7C</6QN'482H5<-*O7K8ZE2Y:=*G1ESUDZ$886-&
M>'C6R[DPN'Q4IT_%=<_8Z\5IX,O-(\)ZIX8TSQ!J_@OX>Z3XUU""]L]/N?BE
MKNE>(_$'B7QY;>,M7\0?##Q=9/X<OKS4;*"RBU'POXDM_L3W^GR:5!:3JE9X
MB%"G5C2P%-_V/A\9AU0P%;D]C]1P.4U\MP=6K&5/$1GCW*O"KBI.+G5>7X&<
M,;"O3IU<-TTZM2I;%5_]DS2HLSK3KX>K7?U?$9GFF7YE/#82:J8:O'"T5A,5
MAZ51U(66/K3GA*D76I8GUSQK\!=1N?@)X0^#?@WPGX"NX-+N](EO-'\;^))+
MSP9HHMI[G5;@C13\*M2TWX@Z%;ZK/Y4?ABXT+PI8R6A1;*?0WL[,VG1BITL5
MG&78JJW5P>7SI<LYP=2LZ6'H0PE)2I5:U252O+#<_P#M=3'/%4,3&GBE5KUN
M:1EEJ^I8+&4YJ<:^,55U84*JI7GB*[Q%=TL3"C".&3JVM"&7SPM2G*IAZV$G
MAIU*%3Q_Q?\ LD^*=1O/'MQH7PY_9OND\9:OXVFN+7Q##=0:%K)U#P_H5E\.
M/%/BOPUI_P ,)HM9OO"%YINL16WAN\O+^S$GB.YUN'4X;^-;5^6G3A4P5/ 8
MN=2%.4L8ZE6E+GJX=XK-\3C*V)PJDJ=.68XK 5Z>$^OSA3KX#ZG"C2>*P^)Q
M".O#5:6'Q%&K4INM&A5R9J,7[*/U3!Y5' XS+E!<_+@7BJ5'&TL/S2IXE1C1
MJQPSH4:JY"X^"/B7Q7\67\&>'?#=II=K\-=+O4\)?&[7/ _CJRUOP(-.^$X\
M ^#?!/@2_P#&O@;2](CT.T\632>)'OO OB#78[][,-J,=E(L9O=ZE2>90SO,
MYN6%Q.._M:#J0K?5\3CJN/S12C[=RB\52I8?)JN+RZE">$KX&E.-''X:I6Q%
M:=*GQ8*C#*8</Y?7ITLSPF%GDWM,-.'/2P>'RZE2QF(GAYTVZ%?$X[,\-AZE
M7$8BI3QJI8K$8"IAY4<+"K1^@/A9^SSXE^'_ ,"?B!X'L+C3/"OQ(\=VVN/?
M:_HWB:UU"QN-=NM-_LNQ\0S:GX.^$_PXAL=8N;:.'[9J-CX6BU%I%%U<7VI7
MJ?:9*Q]6G6H8"A0H1EA<)6H5YX*<IT</*"Q%"IB\!3G&5=4,)BJ-&5)QPV'P
M^&HRQ%>I1P%/GG&H\'">&QF(Q,L1+V\J7L:6,=*G7JJ4*==X?&UL-7<HXC$4
M<3B)UW3QF*QDJ\*=+#UL7.C&$:?&>#OV:[&S^(O@#_A+?A1\,]+TC2]<\5_%
M:U\-^#M(?Q+\/_ GB72?#_A/P;H$.G^)->\)Z.VI>+-7OM0U;Q+<WPTC29Y[
MO0;6Y:*6XTP7EQI@YQPM7$8BA6DJF$P52A1E*$*$Z,\UQE"M+#Y;&FVJ."P.
M'RJM2E"E-153-:U1TL/#&PH0RKTW5PM&C-NG+%8G"QQ5*,IXA8^CE^'SCVF-
MS"K4I)O$UZN99?2M6E.O5HX3V4<1B:-'$I'QD^"_Q)E\3?$'XEZ-H/@[7=:M
M!JFM> /%D-[XDU/XJ1BZ\ /X.TGX3:=H\7AA[;PIX$;Q+<_VUJ-[8:U=QWBR
M7#7.D1S@W\?E1P\)X7ZE53I5<?4K9=B)T9^SAC</F^/=%XC,L1[*<Z%#*,#B
M(JA25'%TJ-7!4<PC.DXUL/6]*.(A3Q='%8B,L5@LOCA<93I*--5\'/*I4L=7
MHY=2^'%8S-YX:OAWB*E7"XCDQ_U!O$8:EAXPX34_V,/&>H^&M+L;72_AUX8T
M^ZU;PNGC/X1:#XLAU+P1XHTGPGH%UX>T_6O$_C#QY\ O$8\:^+98KMKNXGO/
M MA<L]AI*V^JVMQH]OJ#>G6JQKYA"I6DZ^!K8C,<5.FJ:H?4:V8RRMS> A2J
M>T4J"P%><*]#%Y;B9U\PQ5=5:/M:].OY.%H5<%A;86K.AC<-@LOP=*I[24GB
MH8*.9\\<5)IPC3K3Q]&'L*U#,L+"A@*5%T*D9P>&]%US]D^X4W>K:5X8^&GB
M_6-2\8M%JFD_$;5=<OM'U3X7Z?X#TWP)X7\,ZWK$GA;5;[7K.P?P]X=\07OA
MVYM5L-7U#3HQ=WBR007L?-B*N)Q-&I"I['VV+IYM6KU/9KV:S7%YG7QN7X_Z
MNDJ>(E@<+5J9?0C4E36"^M5\9A4ZU-0K]=*G&FL-2]M5A@\MIY9AL'2BH^TC
MEV&PJ^OX".(?OX;ZWF5;$8N>,IQJU<1AZ=' 5Z?U2M4HT<;2/V2=<T"_\$W%
MGX.^"MW<^%O"'P!\/OXF21] U^UD^''C&[\4^.[#1(;3X87AL]%U&\N;6\M5
M348%N1I%OILUI80L+V#NGB(1QV.JX.=7!T*F.Q<J-5WKXF> EPX\HRU8KFJ0
M]IBLOQM+#XJ\ZM55XOVDJ\*F%I4ZW+*&*GA*4)PPU.N\/BY3IT(.E0HXW,,U
M>*S&CAI356HL!C<MKXS+H-QA5P,:^(G"GB'CJSI6/#O[*7B^9B/%<'P_T>74
M+_PA8_$'6?"&O^)+KQ'\9K#PUXRTSQK>^.?'NL77A32KF/Q=>7>B6>GVND";
M4HM*L=6U2WMM:>%X(8>>A*A1^JTUAHQP$9TJTLN]ZIAL)5PV69KA*3HSG)/&
MSQ6,QV$Q.8XC$T:-3%QP-..*AC)\TI]>/<ZN,QV+P565"M6CF-&E7G9U?JN:
M8_ .KA91]]4*>!RC#XO!X!4ZE2-*MB54HPPL8W6YH'[.?BOP;XK\":KX=\"_
M!>[TOX?R?$O6-"AU36+B"WTFZ\8>)?%&NZ'X6\$^'4^$-W'\-8;!-0T*!O%6
MB:L)VMXM0LY]!OD-K<6[P554ZD:N*E4C6_LO*\MG5IR=6L_84Z,,;5A5G*E.
M%"+JX^%' 7E0QM".!IU98'V470K%>SQ$*]-4U&-7,*F-4(^[23IJE2HU<12D
MZD<7B\33PM'%5\1+V5?"9GB,5B</B,13GB*..^G/B3X1U+QOHNB:%:SV=I9I
MXT\$Z[XA^T37"--HGA7Q'I_B>ZT^S$-LXN9KNZTBSM&CF\F-H+B<LV5$<F5%
MJCF& Q+BJE#!SQ-5QDO>]H\#BZ.#G&.L5*AC:N&Q-W*\/8W@W-1(E*K]1QM&
M#C2Q.+PZPS;7M*:I8BK1I9A"[47>>72QE&C/DTK3I2E!1YK?-'Q%_9A\1^*]
M5\6^-M*E\(1?$?6O$WC[5](\1ZC>W\=SH^A:E\(-0^%WA#PO8:DGAF[FTC3I
MY9--U;6!;6\JF>RC)34C:VX3+"QCA\-##5</3K4J]#%T\P@IRA]=>+S["8R5
M&I/EE)T(9-1J8.FG'EIXN-.M"BG5K5CNCBY1QE.K-QJ4,-5RKZG&I153ZE3R
M^C/%SK4J2J4U/%U,YJ5XRFZU.=3*L9B</[>BN6@>D?"KX2ZYX5^(OC[QQK'A
M/X<>'&\0Z-H>A:/>>']6D\:^+#::/:VUD(I_$^I_#CPO?Z%X<^SV&GLGA@76
MNV4=S ]W;36K3RQ2[3J5I8'-:,:[I8G,,;B,5&48)+FJ2Q,XUL3-27UNLIXA
MRH>VHNK@:;JX2.+Q6%>&IX3QJ6%A2K93+V<9T\NRZAA9.<G)QG"EA83I86,H
MOZK0C["4*LZ-2%/,&J&+J8'!XI8F6*^=[3]D[XAK-JVOZMX8^"&L>)+O1O"^
MA^(5/B#Q18W?QSAM/%%_J_C67XO^.$^'<VH1:=KUO9>$9HM$&E^(K*R33[S1
M#]ITN<R2J+I4*5*G0P\*>&J8C#SJY=)JI@:-/#99C\)AZD74@YX_&4<;F-7&
MU,3BJ5&>,E0PLZDJ.)I>W/2Q;I8G&5<53JU\+7ISS-X7%1G)XBC2Q>8Y5C,/
MAZ2C4IO"TH8/ XC+.6C6DL-1Q-2K1]I&K/"QO3_LA>+WU[X6F]N/"NN^!/!,
M6IZE'\/[;7;/PAX=\">)9_&7B+QEIDGP]6Y^#?BK5K6PL%U/0M"LKC0=<\ 7
MEGI_AL(9+NUO7TZ"_:N&(Q6*YJF+Q<<OP>%PV*K5ITZTZF#P:P\E5=%^VHT\
M=6]I/%N6*QU&K0J4Z&)P6,>%IU9Y5E2Q6!6&E0I8%U\7BIXFAAX*6'^K8J&%
MH*454:I3Q>&HT*U6-1X2E.KCL7B<5A:^6.K**]5\&? ;Q+H/P$^(7PQ72_A_
MX-\0?$"Z\1173^$KR6^2#3/$T5MI=]?>(O'4/@3PY?\ CSQDFC_;L>(-0\.V
MM[.5L8KZ:[GMYM2O*Q,J5>GD.%DY5<+E]3 _6J:C]6I2H4<?'$XJEA,/0J.G
MAG6PT?92]A+#TJN)E5Q-.E@H58T*+I8K&TLPS;-H2ITL?7>(K8&;7MG1Q?U:
M<L+*NZD5ST*693=:%!QJ1P^&:H1==1M+A/%'[)^IK<:O8^%O"OPDUWP)KOBW
MQ#JUQ\-O&MYK%EX/L9M4\)>!O#VC_$6]TVQ\'ZK'XS\>:7?^'/$>J-9:FEM]
MLO/%)O6URWO;2.>L&Y5Z-*C5J2PE>%#&PHXS#W=7*ZM?,L5B83RO#J5"E1<L
M++"4U5I5,+/ UJ>)^KJM2Q>)5?2E*A1CIAU4]A/+$XRDT\RP^!PF)C4HYG5?
M.Y*6*Q,813IXFG/!8# 4YTX2HTXT?4OA;\"=0^'DWQ?NXK/P;9>*_&5MHVF^
M'OBKIT<=UXZU>RTGX?>'_"UK-XV#^%;&2*YM=>T6;5!&NL:XEU)J,T[O;R$Q
M&LTJU,;E6.PN#C'+,3C<5FV(E2HMPPW-B\=B\3@ZW-!1E&K2H8KZK-1H?NG2
ME7IU:LL1.,./*Z,<%C<JGC5',<+E>"RS"1G.*6(<,-3I1QM&7-S\\*U6ESPK
M.M&4J'U;"3H0A@:52I\OR?LS>/-)\2Z#'%\'/@IJ5[XJU#0M4\9:1:>)?&%M
MX*UG2_ASX3\3Z7)??%#XAM\(KF^\<>*]=\7?$4ZH]IJVD))J]OH[VEQ<O#8W
M$\EWHUYXG"_5Z5# 1GF>,HP]G!8? U,RHY3E]"CA<"I4Z6,GA<-2SER3EAHR
ME7AC)3PU:=*C'64L=3PZK?6GBL1%8# ^UE/DQM>5'%8W-*V,EB(7KX*G6GE>
M1T$H_7J&7_O,)AZ;]O'$SZ/PW^S3XLOO&4.FW7AGPE;Z%\+_ /A3?A[PW\2M
M8NO$%CX@M9?A=L\>W"_"SP#+X7ET_2/#VHZSXNU?PX=?A\5":WTZVO=,2SN8
MXG,UPKXB-*OC85FL74J9C+"SK3]OC:\5E%/AW#K-:\HPE2]K6P<\VQ/)3Q"S
M%5J<YPC&I1JTW7]FW'!0A">!J4JTJV$]E;!X"MFF:8K,,3+!6C!8O$X7!2P%
M# U&Z-++<3AZ56FU5I8K!R[#X2_"[Q7?^,M.TSQ+I]W8>&?!GA#X=6'Q'=M.
M\16&B^._B_\ #[6/%>HV%SX9O_$OACP_<>*O"@N=?@UV\U2UTJ"QGOM/TBVM
M;F\C@OT36C4PU.G5Q&%I?5\%3K\^48:=U7P\WEF#R?%5*\'-RC3PF%RZAA,M
M=>,*F(<ZV8JA0]E@:D\\;#FK.*A3CC<=/,'F->C*I&$\OQ.82S7 86G9RI*=
M>MCLPEC:-.OB'AZ%;$9;BJE;VW,M3XK?LXZ]XP^)7BKQ_IWP^^"GBDZJ_@>V
MEMO&.J7^A7GCKPIHNC:]8ZY\/_&^HZ7\+];N+;PVVN7^B:V1YVNV^KCPW8:7
M?Z=;6ULD]>?@8+#4\11JTX2IXG,,3B912YJ:57 X'#8;%U:7[N&*Q& JX;$S
MP^%K?NXU,;/&TL9A\52I<O96G"KRIU*RY,NH8:G+F:EAJ]+-JV+K_5VI7IT\
M?@,1/!XBK&4)0BI4_88BCB*R?H-Y\'_%FD?!3P3\.?#,?A36-1\+^*_"'B"\
MTC5-7U3PAX3DTW0/&T'C-O#>B7^G^&?$-UH^BZ;+;V=GIEO_ &7,%M-+MK8M
M;@^;%T8BM4J8S+J_//%1P>&GAJU6M.4<3B9K(L3E=/&5)Q]I+ZU5Q=2ECJT_
M:.4:G/-5*DXI5.'"TGA\)FM*G/ZG4Q]7$SA&C&,Z5"CC,R6)Q."BI*FOJ\LO
MGB<O35->Y4NJ45I'QCPS^R[XNTQOAQ'=?#[X#6">&?'_ (@\<ZC='4CXODTZ
M;4#I8L[JZL;[X):,GQ.^(JC2H'M_B'>7'A'7].,<"33:T/[1;7'*K.,%&A7E
M0GA\FQ&!H5:=.-'DQ5=8M0^JTJ4HQRNA!U</+%O"3GA\SMBXSRS"*IA'@MJ]
M6OB7F#K1ISCF698;%5:<FW_LU+E]O2J5'&^)IU57S%8?!5(0IX+GPLH8FHZ+
M1FZO^S%\<?$?@$>'M5U_P%IE]H_@CP%X(TC2?#NO74MEX@T[1->U36/B'#XE
M\0^-?A/XBL8K+QA<P>%KJYL[GP1X@M52QN-,N;>]A/VRXSQ*H2J1K8?#\M.I
MB\/*K@IRA+"T\OP.55\%EF#BZE*M[>678K'XVK"M*C0GB(4\)5@\%B8QE0I3
MJ.M.I*:I5X+,JM/&454I8AXS,\UP>/Q5>,*->C]5A6P^!AAO9TZ]7V,L1B)2
MEBJ#^K2UY?V0DLO!7C#3[+P+\.];\1:CI7@_PEX*L=<\8W5OI?A'P?I%K%JF
MLZ?!K4OP>U:S6SE\7ZMXJWZ!;^#(]'U/2&LM+NK:UT]SI]GIB9\\J2I3C4=3
M&RK5ZV(H*JUAJ.'P6"P=&=&I6JU<?%8?*L!6Q%/$8ZC5>,E4Q5/'?6\-A\8\
ML'2IX>I1Q$XR]K2P%2FZ<:B4?KV+Q6;5<;B,/4A3HPP4Y4,VJTJ&)P^%4Z/+
M*G##4Z-6<#V#QQ\$)?$>A_ 311X(^#WB&P^%.MV&J:GH.KZ1!X?\*:=)8>!]
M9\/6-YX&T./PCX@BT^+3]<O[*]M-* TY$CL8 +Z-K5%D6-KU:N;9CF>%G.->
MK@<RI8+$UZLJF,PV,KU<)6P5:=6W--)8:=#$5%-2I^UCB84Z\Z,:4L\/2E'*
M:678I4JGM\1@I8^E"DE0Q&'A*I+'1IIZ4ZLY5%4C)TI+$4_K&#J.A2QE2K#R
M:#]E'Q#X?TB%="L/A_K.IWGA3X=:7\0;'6-8UK0;/XOZKIWB/Q#X@^($'CK7
M]-\(:C>2>'IKO5+%M.M7L;^*:VBO-)GM;/3[QEJ:L,+"J\-@Z=LEAB:5.C@L
M1"-6C2P6#R?$99@<54H.3AB,P52O2K8J%2:6(_L_!.6,]I"#H[JI6J1^MU&\
M)F\EF>(=7#5:EJ6)S+-,OS*I@\-6DHUJ.$C'"XO"TL5%>UH+,*N(AA'4C.-;
MI?@=^S%'\*_&N@^)-2\!?!53HW@#4].L-=\(:1#I>M>$_%NN^/?&?BKQ#IWA
M#2V\$QFT\&W6E^*K>RMVCUNRDLX],DM5T^:*^DFCUCBW0PF,YIUWB98/)\+*
M<6YRQ5'+LNI4<1"M%<LHRGC:4L2N55_K:>&4X8:6!HQG&(@L3]2YX0DZ&89Q
MB>1J,*5&EBIX2&6NC&,>26(PV#PJP]6HX4I\U2O6=>O.O5<O+- _9N\=?$:T
MUSQ9XC\*^"O ]YXYO?&HU*^EUGQ5/\1O$_@/XG?$'3-7U?0_%XOO!&D3^!H]
M(\ 6EU:67A:WGU>)M4NXKJ:^T^:.=Y\L!0HX*CE%.M>DZ%+*IXS"T)0K8:IB
M<'6IYU5K5:CDEB\35S>,L.G*,89?@<1CZ5"MBX5:=-;9A*6*Q&=49)-1JYC1
MP>)A-IQY,IQO#>%]E33JPAAZV&^J8^OBZ5>3QU7#4*BPM**IJEZ2_P"RU*_Q
M'N[Z#PU\,M*\%VFI75YX;\2:;+J2>/-'\*WG@>7PQ<?"31?#J>&H=,\)^"KC
M6KJ]UJ_N;#7+A-3EO)S<Z2MW*;]>2I1E6RW'8><O8XRK@\PP:E2=H8V.*]M#
M O'2Y8RIX?*,++#8; X&G"O2I5,#A<51J8?EJ8>H4Y+#XK"3I053#4*V!Q-)
M2483R^OA<90QN,JX=*,_K6)S:M#%2QF/K5,/BG3QU7"U98FA2HJ.1%^SG\8X
MM"\/W5WXA\&ZOX_E^'/B70_&FM0>(O$_AJR/B2>T\$:/X;TKPK<VWA;4-0TS
MPJGA3PYKVC27\4EC=V4WBK4=8@LKJ[O)($]'&5:5;$XRK3H1J4Z];!XB4:EH
M?6I5,TAF&=X?$1BIQCA\9"A@L-AFWBIT\'EF#P-=58N>)66'H4L-A\/@X59*
M&!G4P^#KNA3EB,)@L-EN:X'*,0K3IPK8VA6S&KCL;2E[.G6Q6)JO#XG#X;#8
M?"3\_O/V)?$%_+HT+Z)\+]"\&ZIX[\1^(_''PG\":GI_AGP7;6NKV7@S1]'U
MK2+O6/@;X@GUCQ?H^C>%+A8]1L;+P3JIOM9O-0L]?TR2ZFCD>!K1PN(RQUZD
MJ]/*J4WAJJIQIO"XA9GF>.A4PN&ISA.C"I3Q.7T)0HX^C3HT\"\/6I9C0J64
MXB>+K4<9R^RA5Q4\-STYJ&(>(H4L%1A*AC,37HS6*@\=4S.O4^N8'&/$QQ="
M;EAJF"P\8?37Q;^$7B;Q]X\^'^KZ/I7@6+3O!6EZW]B\7>*K^7Q%KWA_6M0M
M)8+&]\->!]1\"W=M;Z]97=KI%Y;>*[7Q=I%_;E;NW:UNK>=UE\NI3Q,ZF<U:
M598*MCLOK82C7HK]^IU:=>"]G5BJ,\!34L1-8A498FCC:'[JMA55IX3$X3:,
M,+##Y10G1>,HX''4*]7#UFWAY8>A4PTVJD)NM#&U:D:,HTO;4J%7 UE#$T,7
M*%3%X3$^*_"/]C8>'KCPNWQ*T7PCX@M=-U+Q!XB\617&NZ?XJC\;>,(]-MM!
M\'^*]:TG2_@YX"T>^U7^R]6\83:A=ZEIFI:E+<MI+WFJ:Q-;K=6?J3JT)TYJ
M%)89+#5J>'P].G#V6#K8O%X.OB:E"HN2%'V,,JRY8;ZGA,%1C6J8NM##8>K>
MKB.*IAI5H36*KU,76>(PD9UJE2?^TX'"X',Z#HXBG.56I/VE?,IN5/$XK'/Z
MO!4)8F=%0H0TK/\ 9F^)]EH7AF&+Q-X37Q3H+^+]"TG7;2]UFPA\#>#;'P1X
MZ\&?" >&+1M NGU76-*3Q4-1U5)9M)$U]J-U-!=F'3;*TDP]I-TW[9_6*^+R
ME4\QG*4J<\9FDJN2O$15:G:KA\#4PN7XS!4JL'*MA_KM?%PPSKXO$1CZD<1S
M9E5QE6/^RO.5B5A8N].KED\=C,QKTZT9WIQQE3&U<!B9JG35.M3RK 8*K5<,
M.L1/%U;]D?5O$>H?"Z2Z\#?"_P '^%-&N+Z^\>_#KP1XMLDT6;Q5<7]G)_PM
M*S\2:U^SO<:SXG^(<MAIUDG]JVS^!M;M7$RIXCGCN)?-WHXAX7-?KM*3E0P]
M##2R^DXQI0RVOAIXO$/"X6E1<.3!8C$5Z,<1[*M0H5Z-&V+RS%P<*,/+JT*E
M7*ZF"<W+$UY5Z.-K.I/GS/#5X86G[3%SG[5>VHJGBIT:=2CBYTZF)]IA<=@Z
MD95)^T_#GX.>(/#GA?XU6^J>%OAAH>O_ !0O_$5Y!!I5R?& O_[5TZ^AMD\?
M>-;_ .'GAK4/&-H+Z_N?*MM3TC49;"RG:Q2\OH$B6/R,9AJE?AFGDM)P5:-'
M$04+*GAH3JTZ=.$GR1G&MB4J:=?,?JM"MBN6C/$4*N*I5L5BO3PDZ.%XDEFW
M[R6&C6PTHU7)O&3IT*U2I)IRDYX:FU-.A@%B\31PE3VOU:O3PU2EA<+Y'X:_
M9/U?2=6^'<4?@KX.^&-&\'VWPUOM.UCP[J^K7?B'X::CX/U"#5?&6@_#;3%^
M'>C6#P^-M1AN)-9\4_:-!OKV+5KJWO\ 2[V.*!H_?CCK9MC\>Y2]E/$8NI02
M@E4G@\1ED<%A\IJ^^UA\ORZO[3$T:%.>(HUG*ZH82M)U5YD*%6GE=#!\T:]6
M6%AA<2JO,Z+Q-/$5I/.XQBX^US2KA)T:-&4X4G@*N&HSAB<70@\//N?C9\$O
M'OQ$USQK)IWASX8>(M(\46/PQTS3G\=>)K^.TTRV\%7OC#5;Y=?\!S_"?Q)I
M7C;2AJOB&&8:/=ZA:)J"3R@7>CW6GVM[+YN$C3A/#+%I.&'SBKF%XP57_9Y9
M=E^"ITO9RE27MHRHXZ=*I&I"6$J5J.)HU95%*G#TW7E&RC5K.A'+YX;V$)_5
MY1Q%;&2K8FM1Q,55E3^L4*674:O/0K4IPP;H5\-B,-6JPGS$?P ^*6F^/M1\
M>>'/"OP+T:Y;X@:5KMK;/J^L7.J:EH^E>%O%GAJRO-3\6Z?\+=-U.#3M/N-8
MT'5=/\!W!UJSLI=)NK2U\1V]K<P"P*3G1PM2-.4HXNO'-JGM)2=3ZOC,?&#I
M8B<OW?\ :=9*>88.>)KPPM:EA,=I[?ZM3HSQFJ,H4:3IJ5.A1R[#22C&G"IA
ML%B<)B'A\+2:J_V3&4\%0JS="KB:->K1@Y82E5J8K$U^?TO]DWXA6OC/P3XI
MU[5_#7BN?PCX&L7TJXDU^WT.'PK\5[>WU'5M9USP[9/\']7\0?V5X@\::G=W
M6I3V'CCPXEU93+;:EH^K);1QTJT(TJ>?8?+7*A"MAIX'*JU9JI6HX#^RL-DU
M#"8KD]ES4Z&%I5:Z52ICJ'UNJJ]'"X;$IXMPDJT\O^N17U:KCWC<SPU!SIT9
MU99OB\VEB,.JDZB=;FKT,-"T<)B%1P_LZF/JX>H\/'NOAS^RW8_#?XC_  VU
MK0O OPNM=#\#>!+?1=4\87,BZYX[U[Q2-%.EW>N:;I5_X BD\)ZY,VV*Z\36
MGC&>?4]-BBTR_P!*DCM-.FTKTWCH_6,^G3C+"83%_NL!AZ-E[+#^VIUN2K5B
MZ;IT'^]]M@.7%4:^+E#,(U\/B)8N.+PJ_7<3A\M^N5H8O,)8BIC,SQ$X**KX
MFNISJ\E.,;5.7$1H5<'5E]7^HT_;8>C1=*<;<S\9/@O\29?$WQ!^)>C:#X.U
MW6K0:IK7@#Q9#>^)-3^*D8NO #^#M)^$VG:/%X8>V\*>!&\2W/\ ;6HWMAK5
MW'>+)<-<Z1'.#?Q^''#PGA?J55.E5Q]2MEV(G1G[.&-P^;X]T7B,RQ'LISH4
M,HP.(BJ%)4<72HU<%1S",Z3C6P];THXB%/%T<5B(RQ6"R^.%QE.DHTU7P<\J
ME2QU>CEU+X<5C,WGAJ^'>(J5<+B.3'_4&\1AJ6'C#A-3_8P\9ZCX:TNQM=+^
M'7AC3[K5O"Z>,_A%H/BR'4O!'BC2?">@77A[3]:\3^,/'GP"\1CQKXMEBNVN
M[B>\\"V%RSV&DK;ZK:W&CV^H-Z=:K&OF$*E:3KX&MB,QQ4Z:IJA]1K9C+*W-
MX"%*I[12H+ 5YPKT,7EN)G7S#%5U5H^UKTZ_DX6A5P6%MA:LZ&-PV"R_!TJG
MM)2>*A@HYGSQQ4FG"-.M/'T8>PK4,RPL*& I470J1G!X;T77/V3[A3=ZMI7A
MCX:>+]8U+QBT6J:3\1M5UR^T?5/A?I_@/3? GA?PSK>L2>%M5OM>L[!_#WAW
MQ!>^';FU6PU?4-.C%W>+)!!>Q\V(JXG$T:D*GL?;8NGFU:O4]FO9K-<7F=?&
MY?C_ *NDJ>(E@<+5J9?0C4E36"^M5\9A4ZU-0K]=*G&FL-2]M5A@\MIY9AL'
M2BH^TCEV&PJ^OX".(?OX;ZWF5;$8N>,IQJU<1AZ=' 5Z?U2M4HT<CPK^R5K/
MA%M&DL?!7P3GU32M._9\TV7Q19RR>'=:NM-^&^L:?K_CG0X%L?AA</IVE7/B
M"P@U&S6.^D2_2RL-/N+?2H[*&Z3N^M>PQF*J8*52AA99EC\12C-NI5J8.7#O
M]D95];GSQE5Q.!Q=.EB&ISJ_Q*^)CB'5E[&?-*&(J8;WY4Z&*K8"I3G3H)QP
MF&Q>+SK%X_,J6"A44Y4\'C\NS#%9=*;2JT862HU?:3G''\:? G4_AEX1/C./
M3+75_%5_H%G8>/K+PGI7Q5\37_Q0U[Q)\3;;Q_XT\,Z[??#GX<>)/%%IX!:"
MUO\ 3-.N?[&N[>RM_$&HPRV-K!>3?:>",J>'>'RR%!8[+9?V/AX8>M3A"%;^
MRLHS/ ?6\8W_ +(\1.MB<#BY0Q=6GAL3_9U+!5L52H3@J??6HO$XG$XS#XV>
M!K1KYU6A7<:4JU##X_,,OJ83#X=.4*D.7"4\9A:_U3]YAJN*_M6C#$XO#^U7
MJ/@#X->*-._9OT7P;I/A+P1X(\0Z]XYTSQ_XA\#6<$?@SPGI.E7WQ.LO&>K>
M#K2'0M U--/,'A*WCT=0NFMYLD&)C TKS1=M5PI8OAV$ZCQ=#)887VTY5)5)
M?6J6&JUYUZ#YI1E&AG=7ZW0HJK&C[*E&C3JPI\C7%1:J4N(ZJPU+#SS>EC\/
MAZ<835-T9X597AI5_:>SJQJXG+Z4)XBO*C[2GB:TJTL%+D>%?5?#+]G]_!/C
M[3?B)?KH#>);C2/BC_PF&L:?)=7.K:WK/Q#\?Z=XNL=.%_=Z9!,WA/0[2VOX
M;.R:2**.?4IIEM1+++/+SX.:PF G@E'E4L#DE!\C?)4Q6#HXK^TL353?OU*V
M)J4GA*D^>=/#RK4(K#TE&E+IQDZN,Q'M:O)5Y<?C*]*<HVJ8?!PI0P.682@H
MWC",L H?VDDU[;%8+!U7/$.+G3\R_P"&4'U+4_$UQKW@'X+_ &/4O&/QJ\;S
MP6 D\KXB:YXKM[O2OAA+\1M/C^'UG'-::5H'B;Q9:W]G<3>(8UN#!>Q->27L
MR6?(J#ADT<#0K2PV(IY75P-*G%*>'PV,Q>/I8K%YC1E[DE7IQP.!^I<M&E/#
MQ_V6-2,<#AL34[:E;#5<U^N3565*KCLGK5YNSKU,%E^5SPF(P3YI2;I5<9)8
MGV:KQI5TZOMHP5>K1E?^&G[+OB'PE\:M-\?>*]6MO%VC^%?#.AZ9X#UB?Q%8
M1:_X7ETOP-I/@F[\/V^CI\*(]8E\.W26^KZC.DGQ'?3+B\U)+F3PVM]"+ZO8
M^NP=;/L5[/V6,S;$XR3J*,9.MA<5CZF,A2K./L5#ZK36%H48UHYA.#P[J8;$
M82%:=!>%#"UH8/(L#*<*F&RO"86E*FH1BJ6(P]-.IB*,IPJSE4KXCVCE5H/+
MYRPE;ZEB(XFA0IJ7V]7G'>% !0!\_P#B/_DZ?X-_]D _:6_]6+^R=0!] 4 %
M 'S_ /LT_P#).O$?_9P'[6/_ *U/\9* /9?$OB/1/!WAW7?%GB2_32_#WAG2
M-1U[7-2EBGFCL-)TFTEOM0NWAM8I9IA#:P2OY<,4DC;=J(S$ Q.<*2CSR45*
M=.FK_P ]6<:5./ES3G&-WHKW;2NS?"X:OC,11PF&I^TKUYQITX7C&\I.R7-)
MQC%=Y2:BEJVDKGDND_M*?!K6M9@\/Z?XGU,ZK/J-_I7D7G@?Q]I=O;7UAH$O
MBI(M1U#4_"]O::7%J'AFWN=4TJ>\G@BUFSM9[C27O8H)&2ZBE2P^+Q,H\E/
MX?$XBLYWA[..#J*CBJ<XM.:Q.&FX.OA%"6+I4JE*O/#JC5ISGE3C*JZ'LHNH
ML0\)[)P3FIPQTHT\+7C*-X_5:M:2PJQ=UA88V^"J5H8M.BIM)_: ^'5W?>&M
M U#6?LOB?Q%:>'KA;#2]"\<ZKHVG-XLTJ76O#<>J^)+CP;I]MH U+3H7-K_;
ML>CR33*;58OM.(C=6#HU<=0J6A5RN6*I8I2<5"GB<!A*6,Q^'I5+\F)GAJ%3
MVZC0<ZM7#0J5XTE&C7C1YXXBA.C1Q-*IS8;%1P];#2LU4JX3&XVK@,!B)4=9
MTUB*]-4I7YJ=&O.%)UI1J4*M:II_[1WPODD\-V&J^((K35_$]GX9U6P@TS1?
M'.K:3:Z+X[O=3M? >J:YKL_@RQ@\+VVM+IICC?7$TR..\E2R$DDDML]W;H5(
M3JTJD?95<(JL,4IN,*='%83+Z.8X[#JM.483>'P]656G=PK5Z%.I56'ISI8B
MC0TJ\U"56-5+W:U:%-4FZ\JE&GCZN IUU&E&3<'5IQC7G2]MAJ$YQ2Q-6A.C
MB*W5^!/C'\/_ (DZKKFC>#M3U?4+OP]9:9J=[->^#O&GA_2;S2=:N-4M=(UG
MPYKWB+P_8:9XNT2]FT75!!J.A7>HVLHLW9)BI4M/LJD<++&3IRH4859T)JJG
M1K4ZM.G"M*%3#U>3$4VJ56G4O4I13C.+3?,BJB]E4ITFU)UHU)4Y4VJM*?LG
M3C54:]-SHRG2E5IQJ4U/GA)N,HJ49)<M!^T5\-;>;1;#6M<2UU7Q#)I]SI%M
MH6B>.O$=G_PC_B7Q5J_A;P9X@UC4H?!5K'X;L-4O=+6&2YU1+6QM;NZBMA?7
M$5Q9W5^J$?K+H0H7=2I1PTYJ:5*$*N(P4<="A[2HXQ4YT6WAZ=7V.)K\KA]6
MIXA3P\-,33EA88FM.,E0P]7'4;\MZKEEDZ5',7["#G4<,'5J7JU*?M:*PT98
MMU%0A5E2H']ICX=2^/++P5ISZU>VC17"ZAXN;POXSM/"R:E)XK\+>"-#TKPY
MKL_A?^S/'$U_XH\4164L^A7]W;Z<VGW)OY8=N \#2GCXSJ4$E34,/*DI/DJU
MI8FCC<71E"E44)+#2P.6X[%1Q<K4JD:5-4/;*HY4\\2Z>$?LZE2/UF,L2ZE)
M.ZI4,%3;QM2=6/-3C7PN(JX'"SP3DL5*MC(1C3YX^SGOZW^T!\,-"FN[:34/
M$VL7-A_PE)OK?PE\.OB+XT:P'@NYO+#Q#)J4GA/PIJ,6EVT.I:??6,5S>R6\
M%U=6DUM:R331,B\<\33IX>KB;2E2H898J3Y>1>QE.O"D^>K[.G&5=X:M*A&I
M.#JT8/$POAOWIU1P==XBEA&HTJ]:M1H0A.45*4Z]#"8F#C!-SG2A0QV#G6JT
MXRIT/K%*%:4*DE Q-#_:=^$^LQ>'EEG\:Z!J6OZ;X.U-M$\1_#+XB:9J/AR/
MQYJ\GA_PK!XPE/AF2Q\+37^MQ2VD#ZA>0P3;5G@FEM)HKB7U)8&LL96P5-PK
M5*%6IAW.,N6DZ]+"T,;.@IU532Q,<+B*51X6:CBDW.E*BJU&M3I^;1Q5*O35
M2GS6>'K8M+E;D\)0^M>TQ<8QYG+"I8+$2CB(WI248<LVZU)3]GT+Q)HOB:UO
MKS0;T:E::=JVJZ'<7$,-PD!U70[N73]5M;::>&-+P6U_!/;/-;M+%YUO-$)"
M\3A>&<G##4\4J<I4ZU%UZ22M.K2]Y0E"$K2M64>>A)I1K4I4Z])RHU:=271\
M-:MAW[M3#SC"HND)RITZJBY+W6XPJP511;=.ISTJG+5IU(1\#\-_M%0MX5O/
M'7Q#T32/"'AFYU.72_"VE^%-8\8_%3XEW=[8?VA)KFC^*_AOX6^&<=[X<\2Z
M3:61N+_3=*N?$PLXXKR2ZN((+,S2TY4J6&PM2K6C[>O1>*;I7J8.G@U&C?%2
MQDE3Y*5*K55#$U:]"AA\/6Y*<L1*=116]6A..88O!4'&<,)7GA>>I*-"I6Q,
M7/V<*%&4G[:.+ITYXG *%1XC%X5TZU/#)3:AH7W[3?PPT=];OM8U26#PQIUO
MHMUIFNZ/I/B?Q7<ZO97_ (:TCQ;J^M/H'ACPY?7NE>%-&T/Q-X5GO==N1]AM
MO[<07LMGL4S[K#5XUOJE:E*AC'CZN!C3DE[->SJ4<+"K5Q%_88>-;,7C,!35
M><(3JX.3IU:GM.6GS4W.O2H8K"P>)P6(P6&Q=*I34I5:E3$5<PBL+2PRBZ]7
M$+#X'ZTJ-*,\1*E5DW0C&BYSL^*?VEOACX7@U.9(OB#XK32-<T?PY=3> OA3
M\2?&>F3:SJ^N0>'QINF>(M"\+SZ+K.IV.H3,E[8:?J5S>6SP/ UN;MHK>7*C
M"=>OA,/"$H3Q=?V%-U(RI1THUJ\J]ZBCS82G1P]:I4Q5-3H0C!MSL5+EA&I*
M4XQ5/"?6_B3]R:H?5Z3:O&EB,4\5AEAJ%:5*=2->%>T<-&I6AJ?$/X\>#OAM
MJ]KH6MZ;XRGO+OP)XO\ B$M_8>"_$]WX:TS0_!ME'>7P\2>)K?2I+'PW/,)!
M%&M\\827RXKCR9;RR2]YJ]6=.EF[I4U5JY/1I5)1E4C2IUJF(J5*6&P]'$2O
M2G5KSI5.10<[PIU)QYO9R1U8/#?6ZF4PC/E_M;%T\)1@HR=>/,J;J5YX?W:D
M*-!UJ$:KFH2C*M'3V=/$5*&%8_M/_"IO!Q\5ZQJ.N:7+831Z?KV@6O@;XC:S
MK^F:K%H.F>)-4%EH-EX,&LZ]X<LM'U:ROV\26.E/I3V-Q%?BY6VE#COQE&GA
M,2J*KJ5&I/$JG6JI8=1I87%/!U*V,525LMC&OR4ZGUZ5%4YU:4)2_>4W/S\%
M*OBL-AJL\,Z-:O1P=54H2]JJD\;3G.C2P=6,5',)R='$TXK!JK)SPN*BX1GA
MZ\:?HVO?%+P5X<G\+6EY?ZI?WOC,0R^';#POX5\6>--0N["8VJ_VW=6'@_1-
M3N-(\-1->V2SZUJ$=KIUL;N$7%U$9%SG[&HL96P+CR8C#:5E.T*>'?-4C%8B
MO/EH4'.5&M&E[:I#VKI552YW3G9PK4IX.&.A4C+#5:?M:5FO:5X*-.<GAZ'\
M?$2A&K2E.%"G4G3C4@YQBIQOYGXC_:J^$7AQ=<5)/'WB.YT)+=_L_A+X3?$[
MQ!!KHN/$>F>$0/"&MV?A/^Q?&!C\1ZQ86$QT?4KP0SRM%(5D1E&5!O$1P\Z,
M92IXBM@J2DXRBX0Q\,16PV*G3DE5^J3P^$Q6)AB(4YPK4:#^K^VJ5*-.KI6?
ML*E:A*TJ]"ACJ[IPE&3?]FQIO&4>9/V5.O0E6HTZU.M4I?5Y5%+$NA2A5J4]
MR+]I#X.23ZU;?\)/J$$NA6"ZA.+OP7X[L4U2,ZG;Z%):>$YKSPS%'XWUF#Q!
M=VND3Z5X=;5+ZWU*XCTZ>WCO6$!KEE[*56$76C&I1IJ-%.M4J?6*=>MAJM&C
M24ZM?#8BAA<3B,/BZ$*F%KX>A5KTJTZ4)31&4'/#T^>%*5>G6J+VLXT8TEAI
M4:>(IXF=5PA@Z^'G7HPQ&&Q<J.(H2J1C5I0;L5[']IGX-7Z:(]OXAUY&UV]F
MT^.VO?AU\2M-OM#FM_$E[X/:;QMI^H^$(+GX>:>_BG3;_2HK_P 40Z/:SW=G
M-##-(\; :*C4=:A0CRREB:="I2DIP=&7UFDJV&I+$*7L%B<12:G0PCJ+%5E*
M'LZ,G.*96OAJ-6M6ISI0H.HI*5.:J<M&C1Q%>K&ER^UGA\/0Q%"MB,3"$L/A
MZ=6$ZU6G%W-'3OVA?A%J=QJ\%KXHNH8]"L/&6J7VI:EX4\9:-H3V'P]U*WT?
MQI/I?B+5_#]MI>N#2=2NK>"==-O+M]T@**R@D903J818VG"4J$H8*I!*$O;5
M:>8PC/ SHX:WUBM'%<\8472I3YJS5#^-^[-(TY3K3H12E.CB98.H[KV=+%0^
MM.="K6O[*G.G'!8FI44YQ5.E2]K-QISIRG;\8?&SP?X(UGPEH6JV/C*>Y\9:
M%XA\2:?>:7X'\5:CH^E:+X9T^VU#4;_Q7JUMI+0>%8!]ML8,ZDT#1S7D*SK"
MK;AABZSP<<XYX+FR3!5L96<IQC1E[*4HQH4\1=TIUJWLZTJ2@Y1E&C*/-[6K
MA:6(,-!XJGEE:BI3HYIC,-@J3C";G&>*A*=.I5I656G32BE+FBJB3G4Y/88;
M&5<-Q7AS]J?X8:KX*T_Q7JTWB'2-2DL]%?4_".G>!OB/XG\0V]_JWAVU\2RQ
M>'=(T?P2=5\<Z';:9<M.WB#0M,N],:"VFG-PD<4GE]N84Z67U\52]NJM'"5<
M93G4Y)0=*. G2AB*N*I.]3 TX?6,-+FQ:HIPQ6&G%RCB*+GAA*JQL:4Z*Y8X
MB&'JT%.5-2JTL9+$+!J#C.=*KB*RPF(4L-AZM>I2JX?$TGS.A-G;^"?C7X-^
M('BK5?"GAFS\:ROI/A?POXM/B'4_ /C#0?"-_IOBVR74],M=-\1ZWHUK:SZN
MFFSV%S-8NT4RK?!4626ROX[!U,/4H4\QG7<*$LJQU;+\13G."G&O0IPJ5'!7
M:JTH\W+*I3E-1M"I-1H8G!U<1$,30J++949^WIYIA(XZA.G&4H_5YU)TJ<JN
MEZ+JRIU'2C44?:*$U&\H3C'AO"'[4_PR\2Z+J^J7T^LZ+=:7>ZDEOI,7A;QO
MK=[XCTE/%&O>'?#VI^"%T[PF3\0[C58M#:Y-CX337);22<VDK-)%N?F4Z3PF
M!Q4).7UO#X&M*ER2]O1GC<OCF2A.A;VZHTJ"KMXQTHX6<<)BJD:G)AZSI]-2
M/LL5B\-)>S6$JXRE[2HX0A)Y?BJ> Q5Y<\J=.2QM6E2HT)U%B:L,3@I^PA+&
M4J1-J'[5?PAMO#FM^)M'D\?>,+#0?#]AX@O$\&_";XG:ZQ&J_P!F#3?#_P!M
MA\)IIUEXRF_MG2V?P]?WUGJ5K%=BXO;:VMHY9H]I4I0=&]O9U\5A<)3JQDJE
M.K/%S4*=7#2IN?US#*_O5\$L3#FY:,'/$U:-&HXTW9\[5#DHXNO-5G[*5.G@
M7BH8EUH5.6=!PJ8/$TE[>-.\Z,TG:+:[CQM\:? ?P^\-:;XF\23^(X(M8TFX
MUG2M"L/ _C?6O&5U86=E#?7\\W@C1?#MWK^FQ6,%S;F_EO=-MTTXS*+]K?G'
M-CJCP4L5148U\1A(5)N-*I"5']VW&,IXN+EA:-&I42IT\35JQH2E)*,VVDS
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M6F]*LB@H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M2_AQH?BS5/&7@N_U3P1K&I^"['P0)M)\,?"/7;S3M/TS0],\-Z?=Z;X@\?\
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M*-"G4G*E3A2A",Y*;A&E0I47:;7/)U94Y5ZCJ2G:K6J1I>SPZHT*715B= 4
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M]N^+==T[PQX;L;[Q)XG^%EAI6D?;_$&K:98137]Y;0^=>Q*TB[@: /H"@ H
M* "@ H * "@ H * /'_&/QT^'_@7Q5+X*U=/B!JGB:V\/Z/XIO-,\"_!WXO_
M !-_L[0O$&H^(=)T2^U2]^&_@77;32OMVH>%/$<4$-W/#-)_9%PZQE%#$ Y_
M_AI;X=?]"Y^T!_XB=^U/_P#.;H ]@\)^*="\<>%?#7C7PM??VIX8\7^']&\4
M^'-3^RWEC_:.A>(-.MM6TB^^Q:C;V]W9^?I]W;R^3=00S1^9LEC1U90 =!0
M4 % !0 4 % !0 4 % 'C_C'XZ?#_ ,"^*I?!6KI\0-4\36WA_1_%-YIG@7X.
M_%_XF_V=H7B#4?$.DZ)?:I>_#?P+KMII7V[4/"GB.*"&[GAFD_LBX=8RBAB
M<_\ \-+?#K_H7/V@/_$3OVI__G-T >H> _'?AGXD^&;7Q=X0NM0N]$N]0\0:
M2K:MX?\ $/A75;75?"OB'5?"GB+3-3\.^*]*TW5]'U#3_$6B:K8S6]]8V\BR
M6;_*5*LP!V% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % 'S_P"(_P#DZ?X-_P#9 /VEO_5B_LG4 ?0% !0!\_\
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M.+G5E4J8;!8F&-4Z66RA5E1J8>-7$X?#0].\;:UXWL?'GA;PWXN^-/B?^PO
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MXKV.%K81UTI5J\Y5,35A2>'@\1]<LW_Q5^)GA7XC:AX/N/B[JVM^-/#GQ/\
MAUX)\*?![7?#7P]MM7^+'PRU\>$#XL^+%^=%\&Z;JEU/9)K7BJ4ZSX9DTCP_
MIH\)BTO["6Y$TDI@W3Q/U:I3A&O6KTLY^O8:,G;*_J%+,EEU727M:,L<\)E]
M>4\9.K0QDLQ>%P%.A-T%3[<9!X:%:-:L\!1HT*-? XMQ5?\ M7%U^6I5R^-*
M"24*%2<L!3H4>7'8*%&.;9AB,1@Y24O$M1^+?C6]\2P^/+/XIW&O?%CP]^SE
M^T%KFN_#^'PWX4EN_@AXFMO$WPDN+CPE#I.F^&4O)$M;2UXM?$[ZQJ%P+87T
M4K6E["B].5RPF'PU>K/$1Q645<5P0L9F4_W-.KA:^9XE9M&JTX4\/"A1JXF,
MXPC#$Y=!3IXRL\3"-4[,WI8F>"S/ 8&\<=2S3.*>6X6,-:E3#9+GT,EQ4'5<
MI.>*G'#U(NI*6$Q\ZJ>%I0HTJU-^Z^*?VCK[6YO%VH>$/BWIFC?"A?B7\,?#
M=S\8=%M/".IZ/X \&:]\.]0U[7/$>FZ]KNC7^@W%O<^*[73=,.K:S#JMA9R:
MI+&55H=D7DP4Z:I_7J_U"$LPSN%.I*$?WT<'E>78G+L'9Z<F)KUJU2FX\N(Q
MU)PI82LI8C"U5ST9TZM&K/#I8NO1R3*<2Z,>:3^LXGB''9?F%64:;4XU,+E]
M+VE2DVJ>%GAI5<11Y:6*A/RT^-]:A\9>(-;A^*+_ !.UGQ!JO[(NIZ!H>O\
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M_P"3I_@W_P!D _:6_P#5B_LG4 ?0% !0!\__ +-/_).O$?\ V<!^UC_ZU/\
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M+W^SM"\/Z=;:3I%C]MU&XN+N[^SZ?:6\7G74\TTGE[Y9'=F8FWR#;Y'04 %
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M]?7$C27C_,%"JIL&QV% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % 'S_P"(_P#DZ?X-_P#9 /VEO_5B_LG4 ?0%
M !0!\_\ [-/_ "3KQ'_V<!^UC_ZU/\9* /H"@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MJI&6&PN)G5C"JZ=&.,C*6'C6A&FZ\%)Q<9XGV+P-%2I5:V*IX>O0K59QD:F
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MK\U_K=3#X>I+#TIXOV\H4%3HIJG2I1ABWW[./AV[\2Z%<Q:A)'X(TOQ!X?\
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MT/B_2],U:TURVU/6]6@E3Q?XR?3H;OQ%I.CZ+K4::#+K[:6-.N;/0-(<Z?\
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MC1Y;E7N6L3/-)))5"I+#3H3HVB\-&,:<7&,H?NJ^(Q.'E.G).G5J82MBL1+
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MJ>D^';CQ/#I.IVQMVL+[Q=XCU0VKS7&I7VIZI;ZIJ&I2ZI-XDU/5-7U"^O\
M7KN^NM5N[B:-Y;TK;6ZP77E+$X>6&JO]V_=BZ:6'E1I*A1P\*%"6'5)X>C2A
M1YJ<:/(XU:E6KS.I/F41E*.(AB;N56*C?VC]LJDX2TJ5E6]I[5QI1HX:$*CE
M1I8;#TJ-*E3C[7VG-:=^SW\+](ET6ZTVQ\7VFJ:%JMWK,'B"/XI_%3_A*M6O
M+]]->]B\7^+&\:'6?'>ES_V/I"2:9XCOM5L6CTJSB-N8[6)8](5ZE*I3G3Y8
M*E15!4E3IK#N"J8FK%U,-R_5ZM6-;&8NM&O4I3KQK8K$UE456O5E+">'I355
M3BY3K3]HZCE+V\9>QI8>U+$<WMZ,'1P]"DZ=&I"FX4**<6J4.6]:_ SX<6&J
MZ?K6G6/B;3=2TW6=<UV&?3?B+\1]/2YN?$>M7/B+6-/U:ULO%D4&N^&9=<O+
MR]3P]J45UI-O+=3&WLHO,8'GIQC2C"FHJ5.&#I8'DFE4ISPU"G5HX>%:G4YH
M5YX>E7JTL/7K1J5\/2E[.C5A",%':M^_=253W9U*[Q+E3_=3A6E'#QJ2I3I<
MDJ$:_P!5P\L53HNG2Q52FJN(A5JN4VFC_ KX<>'T\.Q:39>*;2#PCXFE\6>%
M[5OB3\2KFST#49M.N-(?3M*L[OQ=+#9>$?[,NI[9?"T4:Z$B/A-.7:N-X5JM
M.=&KSN56AA:^#52I^]J5,/B)4IU(8B=3GEBI<]"A4IU<2ZM:A4HTJE"I3G3A
M)3B81Q<J\JZYI8C$T\9-QO3MBJ;K-5Z2I\JH3J?6,1'$.A[-8FG6JT\2JM.I
M*+N:W\%_AQXB\8VWCS6-#O;OQ':2Z==0N/$WBNVT7^T-(M[NSTW6)?"EIKD6
MAW&NV]C?7-JFJ3:<]X+=U@,YABC1.6-"E&.)@H+EQ7UCVE[M_P"UX-Y?BO9M
MMNC]8PC5*M[%T_:<E*I.]6C2G#6I.514%-Z8;V*A:T=,/C(9AAXU.6WMHX?&
M4U7H1K<\:,YUU348XBO&I<\$_"CP/\._-'A.QUBR2?P_H'A>6+4/%_C'Q% =
M%\+Q7EOH4 @\1Z_?QI=6UK?SV_VY5%W+ EO#-/)%:6Z0]&(G+%T<70Q%JE/'
MUIXC$7C%3JUJF%P^#J5)5$E44JM#"T%5M)>TJ0=>?-7G4JRRC"$*M*M"*A4H
M1G3AR^[&-.>*K8SV:@K0]G3Q&(KRH0<>3#0J2HX=4J+]F8^B? CX7^'='.@Z
M;H>IMI9T;P]X=$&J>,?&VNS)X?\ "NO:AXET#1([[7?$5Y=1:3::KJEYBT29
M8GM3#82H]A;06T-RQ%6<J52<E*I1Q&'Q2FXQ=26)PE.E2P]>K4:YZ]6DJ,*B
MG6E4;K^TQ,KXFK5JSUK3E7>(]M:2Q2S)5(M)0MF\8PS%1@DH4UB8QBFJ<8>S
MY4Z/LVKF5+^S=\'9KCQ'=MX<U=;KQ1;:M9:C<0^//B#;S6%GK>OZ=XKU*U\*
MR0>*D;P/;R^)M+L]46/PX=*6*[66>$1R7,[38TKT,/1PM)N-+#U,NJ0U;GS9
M3*M++5*JVZLZ>#6(JTZ%*<Y4HX?DPW(\/2I4H9S4:F(^LSA!U/9XZFUR15)K
M,Z4*.82E025&5;&0IQ^L5Y4W7JSYJLJCJSG.70^/_@Q\.OBA8Z=IWCC1M1U>
MUTS3-6T2(0>*_%^B3W>B:]9V]CK6C:U>:!KUE<>(=(OHK.RDN++5);R"6XL+
M6Z>,W-K#-'<9RIXKZY"T:W-3FTHQ5'GHUEB*$WAK?5W/#UESX>3I<V'YIJBX
M1J5%+6A6JX6E1HT:LX0P]6E6IMSE*I&K0A4I0G[63E5DW3JU:=52FU7A.<*Z
MJ1DT>177[)GA"]T#QA87FNZ_=Z_XTUO7[O4-=NM?\;W&GZ+H/B;Q&UUJ^B^"
M/"<GC<Z9X"U*;P0Q\,'7- 33[UT O)S,Q:W=4FJ,<OA%SBL+/"5L1.%24<1B
M:^'Q4,SKN.*UQ&%P^+S>FL?4PM&I[*$E&,/WM.GB(8SIT:CQ7M*%/V<\-6PV
M&I1@O8X=?V3+)L'5JTJGM*>,Q&%P;49UJ\'.MS5Z<'AZ-9TH]5KO[//AP>'+
M'2_ =Y-X6U^PU?4-4C\6^)=3\??$+6+M_$&CGPQXEN/$%UJWQ"M+WQOJMQX7
M86-I+XLO]?LK-K/3Y6TZZ33H(%RQ$%BE["M:.#JX/$9=7ITH4J<I8'%3IUZ]
M.BW3G0H5ZN+H4,14QDL/6Q$I0J-2C5K2K+6A/ZLXSBG5K8>OA\7AI5JE6HJ.
M)PLJOU?7G5=8:G#$XJFL)0KX>CR8B<?X;E3GZ9X(^'?AKX>Z+X<T#PS'J=KI
MOA;PW;^%]-M9M;UBXM'L8)(YWO;[39+TV-[KL]RC33:K+;->N9YE,_ERNC=F
M*Q53%XG%XJHHQEBW2;A%>Y2CAU5A1IT(N_L*<(57"4:7+[6,*'M_:/#T'3XL
M-A*>$HX:C&4I?5E6]Z_)[2==TI5JE6$.6$Y2G2C*FI1<<-S58X9485JT9]S7
M,=04 % !0 4 % !0 4 % !0 4 % !0 4 % 'S_XC_P"3I_@W_P!D _:6_P#5
MB_LG4 ?0% !0!\__ +-/_).O$?\ V<!^UC_ZU/\ &2@#Z H * "@#P_5OVF_
MV;= U74]"UW]H/X'Z+K>BZA>:3K&C:M\6/ >G:KI.JZ=<R6>H:9J>GWFOQSV
M&H6MW#-!-;SQI)%)$Z.JLI  #2?VF_V;=>U73-"T+]H/X'ZSK>LZA9:3HVC:
M3\6/ >HZKJNJZC<QV>GZ9IFGV>OR3WVH75W-#!#;P1O)+)*B(K,P! /<* "@
M H * "@ H * "@ H \O\:_&[X+_#75;?0OB+\7OA?X UN[T^+5K71O&OC_PI
MX5U6YTJ>YN[.#4[?3]=U:UGFT^2[L+Z!+A(S&TEG.@8M"X4 X_\ X:Q_98_Z
M.6^ '_AY/AU_\T= 'N&DZMI6O:5IFNZ%J>GZSHFLZ?9:MHVL:3>6VHZ5JNE:
MC;1WFGZGIFH6<DEO?:?=6DT,\-Q!(\<L<J.C,K D T* "@ H * "@ H * "@
M H \O\:_&[X+_#75;?0OB+\7OA?X UN[T^+5K71O&OC_ ,*>%=5N=*GN;NS@
MU.WT_7=6M9YM/DN["^@2X2,QM)9SH&+0N% ./_X:Q_98_P"CEO@!_P"'D^'7
M_P T= 'L'A;Q9X5\<:%8^*?!7B7P_P"+_#&J?:O[,\1^%M9T[Q!H6H_8;RXT
MZ\^PZOI-S/:7?V?4+2[M9?*E?RYK66)\/&R@ Z"@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * ./\ &OQ"\ _#72K?7?B+XX\'^ -$N]0BTFUUCQKX
MFT7PKI5SJL]M=WD&F6^H:[>VMO-J$EI87TZ6Z2&1H[.=PI6%RH!Y?_PUC^RQ
M_P!'+? #_P /)\.O_FCH ]0\%?$+P#\2=*N-=^'/CCP?X^T2TU"72;K6/!7B
M;1?%.E6NJV]M:7D^F7&H:%>W5O#J$=I?V,[V[R+(L=Y Y4+*A8 ["@ H * "
M@ H * "@ H * "@ H * /G__ (:Q_98_Z.6^ '_AY/AU_P#-'0!T'A;]H3X!
M>.-=L?"W@KXX?!_Q?XFU3[5_9GASPM\2_!?B#7=1^PV=QJ-Y]ATC2=:GN[O[
M/I]I=W4OE1/Y<-K+*^$C9@ >P4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M1\=O^$7_ +'O/#W@WP]\5[3Q#XULI-.N-"T/Q?=ZKH?@SP[X=UZ[O/\ A O
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M56E=6<\/#&.5>-2K]6<:DIX/FC@:=#$REAZL\13Q52CAG4K_ &Q4FH4 ?/\
MX<_Y.G^,G_9 /V:?_5B_M8T ?0% 'Q=X6\2:_P"#OV7?C3XH\+E4U_0/BE^V
M5J>FW#6;:@ME-:_M.?&>1M1-BJM]L^QPB2Z\DJ5?[-M<;2:QK>SYL'2K8EX'
M"XC&Y?A\3B5*$'AL)B<=A\/B\2IU(RI4WA\-4JUE5JQE3I.'M*D7",D]:2J+
MV\L/A?K^*HX?%5<-A?>_VO%4<-5JX7"6@XU)?6L1"EA^6G*-27M.6G*,W%JU
MX@U+PQ\!/#'B#XF>&?BAXP\>7\?PL\4>.6\">,/BGK7C6R\?1Z5;6>H1>-=+
M7Q%J&K/X'T:TGF6.XE\+6NGZ*D.M)&UB7CLEC[I1K0KU<KI4*=#VF-RS")UH
MSG_94\=CZ> A6Q&(G)XFI1:J.<Z.*KR=186I4H3I26)G+#!0CBZ6$QU25?$.
M4*LW/"P3GCE0P6(Q4L'A<%!T\)]:J>SYJ*HTZ=;G4*52<J<E%<AJGQW^.NG>
M/_#7P;@U/X,:IXO\1ZSX)(\?Z?X-\82>#=.T+QMX'^+_ (GBLI?""?$U[VXU
MW3[CX96LL<W_  DL,.IV.L(X@TUI%>*J>%=6CF$XR]G+)_[6A7YXV=:IEU+)
MJ\)4Z:=\.YK-70Q&'G4KRPSC3Q"KUN;ZL]:2A++ZF9.5.4,5A<'BL+AZ==.M
MAUB,UPN72^M2]DUB,/*.(E4PF+IT\*L16P^*H.A36&=6IDR?M/\ QCTSP/-X
MIU/2_AK/?ZW\!?&WQ.\+:=9:1XGM[32_$7P\\3>&_"VH0:_>3>*IY-8T/6I?
M$MM?P6UI!IMQI:6\EI+=:HQ%U3PM"&-^KJAS4)8O&\&*"G)35+"<6U9P=";C
M"'M,3@(TI)8R/LZ6)E.,OJ-!4W&KR8VI/ 4<95JM3AEKXKPU64(-2JXCARCB
M:M+$TZ3J-4Z.)^K253!RK5*D/=Y<:^9^SZRT^.?QHT7Q'J]AXJ3X:ZQI7@SX
MR>'OA7XA_P"$9\*^*M(U3Q+'XW\#^'O&&C:CX?&H^.]3B\.W&C2^(+>QN8KI
M-9&KA&GA_L<J()..M4IX;"8+%3ISK+&X;B'DA!J$E7R##YIBW7=XU/W6-IY9
M.@L&OWF%J35;Z[BH/V*Z<12J4:>'ESP@\33R'%Q<DW&G0SG.*>22PLG>'-5P
MU:I]<6-7)"I1C]6>!IS?UB/F_AS]J_X_ZIX3O_%>I_#KPAH=EXE\$:-XX^'D
MFL7?@NWCM8M6\:>$O#<6FWNF^$_C]XK\1^-M+%GXG<R^(#X=\$+9W5A';W.F
M+->K!#U3P<Z,Z> JUX1S".;9)@)S5-SINCFU>K1E5]C1J5J-%THTO:82<LRJ
MT\QBZCI*E'#RE/*M7IPGB\32ISE@,/@\^JQI5'['$>VR7!5\3:4ZT(2;G5I1
MI8S"+!JM@'.$95L1S.I#V!_BU\5+?Q9XP\,ZWXA^#,.E_#Z;2O"/B5;VS\5>
M!?$7C?Q'XC^'=QXTLM8^'@;QQJITN-)I+:P@\/ROJ%W>BPU:[BUNS>Q2WE\C
M&UZ:R;-\=&+LJ6;TL+0IU9?6*=;*<%1KU:E9TO8U)PK<]6M*&'EAJN7X3V.(
M^L8IR?+Z-##NGCLHPTZD%.O'+\95J.$94%1S#.\5EE+#-5.:-.K2CAXJ.(JQ
MKTL?C*D,)]3PL:G/'ROPU^U#\1!)\(_L5GX5U+P3JFK?!7X<^++=-+\6:CK.
MF^(?B-X)\*ZW/=7?Q'\:?$6UF&HVDOBC3Y(M+M=!\?7=[;[)[[6;:2:\ETOZ
M3,L&HYYFV!G)QH8BKQ+# U81I8>SR2EF57FC"C"U9U*N75\/4IT\+EV'PLHR
ME3K55]5HXKY;#8Z5'A7*<QA3<\9'!9-B<73E.K62AFF/HX->]4J5*E*%.C5A
M7C7KXK$XBO.HH2PM.G3J8E^=^)/BGX]?X;?#O6K7XA^(-'C^'^E?"K6/&6L:
MEXHU;1M+UC4?B1^T=X;\/Z='XO\ $WVLRW&E6GA'PIXLBNXIO.C2SUX^<"CJ
MAX\EC&>+R.O65.5/%X?(\MI.M)2I5,56X5JYEF526'NEB,7[7$9+4P[FX3KX
MBO4HPK0G6J5(?3U>2#XFPL8TI2H/CO'M)VKX:AEN(S'!95"FU=8?#3G/'.F^
M27LZF4T)48Q6&2?TYX5_:"\6S?$#_A ?$[>!YX]*\5?$OPUJ/C#1K/5-)T/Q
M OA7X?\ @[X@Z+=Z#;ZEXCOAIEQ#9>*+RRU.VDOM5'FZ#<RPS0IN2'SZ]5TL
MNJXU)0J4<BS3'RIR=TL7E>>TLFG*_N/ZI6O.JJ;2JT:LEAWB*JHNK7YW#DQ.
M%HJM2KQQF9950I^QES3I87-,LS7'0H5E9I8ZG+ X=TYP;I8C!XFAB5AZ,L5&
MC0\U\+_M5?%+6)?A/KVIZ?\ #VP\#>)?"/P5U+QG>V.E:QK;1Z_\7)4L19)J
M'A[QSJ6K?#9H;Z]TUM+@\0>#=5L-625PWB#3PDL]MZV)P4*&:YSETN?V=#%8
MO!8-749RJX?)UF2<JZ_<U:_M4Z&(P,Y9=7P]"IAL71JXN=>EAI99E+ZN\6L!
MRXB&#EC:\IN7M/\ 8L)G5?+W.5&$8U52^I4)8J&88=8RA5KTL50GA\+##RJ2
MJ>%?VA_B^V@W.K:;!\/X_"O@C0OA'K&N:;K-GX^\1>*?$*?$;QSXJ\,:K8:?
MXJU?X@3R:/)9V^F65W;WNHP:^2PFMG@$;Q2VW'@5&IAL@KXF[IYGCLJRCDI6
MA.$L9D/#>,AB74GS^T='%9O/VD)QE5Q=&,?:8JGB54Q&(PQ]:5',.(L'A[1G
ME>$S_-.:I%RA*.69SQ'06'4(3IJ"Q.'RA1BZ:IT<#4E>CAJN&=/"X?5T[]J+
MXT7GBGQ'?/\ #GPO8?#6#5_C%X:T"^\3>)?AIX,6'5/A59^*6COKWQ5J7QWN
MM8U6*]OO#&;[3F^&FA'1[/47OI;^YM-/:>[YJ3J/**N+J<L,;7RFAFN$IZ62
MKUL'2AAYTX5*L*D5];Y)8NIB\!&&+IT\#5H4JV)7L/3G0I_VQAL!2E4>&HYC
MALNQ;]E.56;KP525;#1E&DXSC"]7#86-/%RQV%3Q5"NKQHRHVO[2OQWN/#]G
MH0TWX?CXJ7?BOP=;3V$G@R_L[_2_"/BWPCK7B*/4;#X:7OQMCMOB-/!?:!J%
MOY_@OXF:T\FG6E[JZZ?_ * UA<==:FH-NESRHX.6:PQ,_9U;^TR^E@*].%:@
MZ4<9EOM*>8488BI]4S.CA:\L-3=2K]<F\#PT:L)*K.HXP5>A@<1A(*K3<7'$
MXW$X2HJ>,3>$QUH8657".4\LJ8MSE#V-#V-)XSW:_P#C7K][\$_AGXZ\.-X0
MM?$_Q,U7P/X7AU35;3Q/<^!_#&N>*+Y=,U'4;[2M43PUKM_865_%=V\&FW3Z
M'<W-T]K:R7%L93*M8JC%9Q@<NP-1_5LP]M6HUIQA7<L+3RK$YM2<51JPA4GB
MJ%"%*C-32C[95W2DX/#R2J^PP6:8G$Q]I4RFI+#U(1?L/WZS6EE$G4YOK"HQ
MPU:JZ^*C&6(C&%"K3I8BI%QQ)\S6GQ^^/?A_SO!OAC3M(^)'C;4?'_QZU;5/
M$<$>A:QX9L=!^''B'0-,?1] T;X@?'WP$FCZ;G7%=TC\6:P^B1VLD9T_4$$D
M\'!AZJEEF#Q<*;AA,#E[Q>(>(K4U.LL5G6>4::ECG:5.C2IX*-.&._L_%4W0
MGA5*E04J-.IUU:#IXO'T:M1RQ6(QN7X+#JCAZBI4:G^K>48NI+ZKS34JU:I4
MJ5(X'ZYAIUZOURO'$2=*HI;FG?M"_$2VU[QOXFCU/P+ BO\ LWZGJOPOU;Q0
M_C75X+'XIZ%HFAWUK\/+[PMXD.DVMO#X@U:.[M=4M(M:L=?EM;BU4V32+J*]
M\<(J5;'8"%2MB(2XDS3*J%?ZO4C6PS_L[*ZV%KXFG6=.:PV%:Q-;%8%K#3IT
M/K>+IXB+I3HUN/VKE2H8NI"-)T>&GF4E2J1EA\3++\RS]XFG0<='6Q=&EA:$
M,5SU)X>4L#1K8:OS0C3^F/V8-6\:ZY\'-"U;Q_XEL/%GB&[UKQF)-7T_2+_1
MD-M:>,=<L;>UFMM0\1ZU(\D'V5XT9;J-$@$$"PK]G+RYIP> R&I&$HSKY+DV
M(J2E)-SGB<LPN(YY6A"]5PJP6(J?\O\ $JMB8QH0K1PU'.C*I+%Y[&4DZ>'S
MG.,-1A:SI4L+F6)PT87O9P4J4I4%RQ=+#2HT)RKU*4\57^@:S.H^?_C)_P E
M%_9._P"S@/$?_K+'[2U 'T!0!\]?"-Y(_'O[6[PH))D^/6@/%&<@/(O[*O[-
M91"0"<,P X!ZUSXNI5HX3%5:$/:5Z5&I.G"S?-.,&X1LM7S225EJ[Z:FE&,)
M5:4*DN2G*<5*7\L6TF]=-%J>8_"..QUOPI\,/C1X@^,/C.T^(?B^[@3Q'H5S
MX^UJ?PAJWB*Y6Y77OA-I?PEU+5F\.Z-?:1=V]Q8H^F:/;:[;'0I);R\E<WKS
M]V-=#*92IX%O,L'+ SQ5/FM6JYE2A@'7CF%&K)3J4%+3&.&"E1P:3]E.BZ7N
MJ*R^LULSI2G##QR_-,1A*=2$HPA@XT<TGAJ.'K2IQIPQ/M8<N&<\7&K7K2K0
MG1G&JL/R>?77[5/Q;M/"?A3QC':_"F^C^+/A.^\5>!?#,-AXFM]8\ ?V9XM\
M':!-I?CV]7Q3<CQ:AA\5-;W5]I]AX:_LS4[6.S-I?";?'*H3CBL'E;J1K8JK
M5R.53&T(N> >'S?&8;"N%)<RG[2,,0ZV Q$JTH9C2H8BK]7PBHN,],=".$AG
M>)A=T,IQ&>X*-)K]Y.OE&69SC88B556C&G4J90HUL*J+G1ABZ*6*G)\SWO$'
MQ[^/.DRZ_P""M/M?AKK/CKPS\5KKP5?:_IGA749[._\ #R?"_0/B3!JFD_"3
M4?C%INOZI-;'Q%;:;J$FC>)-<GM8;5]472IHI&M;;*<XT\-EV-M^X>!S?%8N
M+<G>>59BL O?HTZU7 X7%1O+ZS+"9A'"XF6'PE15?K$*RUQ.&^K5*4.92^O_
M -F3PT>:,)4:>85,QI3I\U7V5''XG#RRZ56-)5<MEB<-.M6IJ,L'*E6UH/VJ
M-8U#PQJ/B'3!X(E_XJ;]F#2]$C5/$+0WFE_'#4?"-GX@GCCU>31]2N9(4U?7
M?[,EGTS3'4Z:#=V4C03PUZ5#!1GFJP$G/V3SK.,NC)>SYWAL!D=+-L/4_=SK
M4O;3=5.LX3J4G0<>11?[Q\6&DW0Q3Q=J&(P?#=?-*L/?@H9C0QF=8*>'DJT*
M=2-%5\NP])TY1C6]K4G!56YTN7F;#]H#]H+5)E6V;X.VL7B#PU\?O%/AWSO!
M_C2Y?0;+X$?$&S\+FUUPI\18!XCN?$6FZA;('M!HRZ5/')<D:I&19CRJM3ZG
MD=?.,1'V_P#9^3</YW7ITW[)5H9O@)XJM@:+DJKHS@Z<ITL9-5HPC_L\\'5?
M^U'7A,/]=Q%2G1J>RHOB+'\.4W./-.%6E4QT</CIJ,HQJ4Z7U*=.M@XNG+%<
MT:T,7@[NA&32OVI?C#XE\>Z</#_PTTM/AI:^(_AAX3\0WFIZC\/M-G-[\1/#
M/A3Q')J%IXG\1_'/0]4LKJTC\5QI9:%:_#?Q!)K)TTQVFHQSW9BLO2G@OJ^,
MQU#$5.6C&OGV&PTN5\ZGDDL?#G=.B\34Q/MI8'GK472P,L)A:WUR52K0I*5?
MQXXWV^49=CL/#EQ-7+<LS/$1J*2I.&8JGRT:=2HJ,*,8.;I0QCJXJG5QD98*
M5&C.$JA[3X#^*OC^;X$>)/C5XWM_"^L26_AKQ+XNT'PIX*T+6M'F@T[PW;:H
MRZ5?ZEJ_B75SK.I7TFF"43V]EIJ6XNOL_DW1A^TS>5BJWU;*<OQ"<%C,5@\O
MQ-2I5E[+"4Y9CA<)7BI*TYTZ&$EB)^VKNI)SHPYU3HN+4O<P6$6-S_$99&?L
M,'#-<7EM-R]^K;!YEBL%*M.:]G!NK"E3<:,:4>2:E>K-5(QI?+FK?'GX[>$/
MB)K5O'>^%?B9XF\;^#/@%IW@[2? MH8O!7AJ\\<WWQFUJ75)?"/C?XT:/8:A
MJ\FGZ#86 NG\9^&?[;$>E-&;9A#9UZDJ$Z5.OEE*FYXJAG>84:V)G"%W1R_)
ML#B9TZ%&=:E.DZDG.I+"1Q&*GA(.OBVL2E*+Q52CB,GRO-I>QPU&6!Q>*C0]
MHU6;Q.99'@*$*]:-"2Q$,-+%5'2Q'L*$9U/K&&Y<*E.N:\/QX^,-[XH\+WVJ
MZK\//A_XIMO@[\<+W5?#?B?Q)I^K>#M;U;X9_$#PG#-=1>&? 'Q1UVQTWQ#-
MH=MJL-S$/%FNW7AAKB]2;^U4MY8KCEK5L/A,#Q!F%&#Q='#X/AS,%AE*52NJ
M=67$5/%4L'BGAZ<>2O*&%_VRGA*E&M46!P\Z7/*,Z/-]7JU<XR#+ZCKX?ZQB
M\WP*J^RC3IN=;"9!B,'4Q5!5ZCG4P\J]58?"5*M&IB<.\5BZ5;"1DJ=3WC]G
M;QSX\\?^,/C'K?B75K=?#<EQ\+KWPKX,ET74+'5_!<7B7X4>$O%E[IMWJ%QX
MBN8+H"XUMTD2/2K%VNH;F9I#'+';6?75P<<#AL9A9U5B\1A,[SG"K$Q]V$Z.
M$K4J5*/(W4:2A[-Q4:JA%NI/D;K-QQI8EXVGD&.A2^J4\QX>P&-J4'S.4:U?
M'9K2E)RO%.7-AZB=3V<7/#O"46E+"SJXGZMKA.D* /G_ /9._P"36/V:?^R
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MA<'/VKQE2GBJRKT/JZH5<35/CO\ '73O'_AKX-P:G\&-4\7^(]9\$D>/]/\
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M.E4P[="I0G7J4I4WR2IU,5.%3$U(.-G">(J4Z<Z\HVE6G3A*HY.,6K6@^ /
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M[74(;OX@^(T=[*YM8Y8Y8!)$S0*Y-OD&WR,__A3?Q%_Z.Q_: _\ "<_98_\
MH:: ._\ AE\.['X8^#H_!]KKFO\ BI6U_P ;^)]2U_Q7_8)US6M<^(/C7Q%X
M^\2WNH1>&=!T;281+K_B?4S'!8Z59PQ0^5$L?R%F3C&47&24HR3335TT]&FG
MHTUHT--Q:<6XN+NFM&FMFFMFB7PM\+/ACX&GURY\%?#GP'X/N?$TCS>)+CPM
MX0\/^'Y_$$LCRR22ZY+I.G6[:M(TD\S,UT923,Y)RQRVE]56!M_L4;VP_P#R
MX5X*F[4OX:O",8/W?@2CLDB>5?6'C++ZVU9U[?OK*3FDZGQV4VYVYOB;EN[B
M>'_A7\,/"5M8V?A3X<> O#-GI>LW'B/3;7P_X/\ #VBVVG>(;JRO--NM=L8-
M-TZ%+369M.U"_M9+V)4G>&^N(F<I,ZM49SA3A2C.4:5.C/#P@FU&.'J2C.I0
MC%:1HU)PA.=))0E*$92BW%-4VW+%3;O/'3A4Q,NN(J4IQJ4YUWO5G3G"$X2J
M<TH3A&46G%-79?A[X GM(;";P/X/FL;;1]0\/6]E+X9T62TM] U>ZM+[5M#A
MMGLC'%H][>V%C<7%DJB":6R@DD1GA0J4YSH\GLI.E[-X*4.5N/+++FWE[C:W
M*\ Y2>":L\*VW0Y+LFI&-:-6%6*JPK2Q4JD9I24Y8U3CC934KJ4L7&I..*<K
MO$*<U5YU)WOMX1\)M<7-VWACP\UU>:W8>);RY;1=--Q=>(]*L[33]+\07,QM
MM\^MV=A86-M;WSEIX8;."*.14A152E*/L+-Q^J^W=&SM[%XJ-6&)]E_S[^L0
MKUXU^6WMHUJL:G,JDTW42JP5.JO:4U"C249^]'V>&KK$X>GRNZY*&)2Q%&%N
M6E72JP4:BYC T_X3_"S2)?$4^E?#3P!I<WB^]@U+Q;-I_@WP[92^*-1M;L:A
M:W_B*2VTU&UN]AOP+F.>\,TB3 2*P?YJ5)*A1P^'HKV-#"5HXBA2A[E.CB(.
M,HUZ4(VC3K1E&+C5@HS3C%J2:05?WU6K7K?O:]>A+"U:D_>J5,-*$J4L/4G*
M\IT)4Y2IRHR;IN$I0<>5M&EJ'P_\!ZKXDM/&.J>"?".I>+[#3KK1['Q5J'AO
M1KSQ)9:1?))%>Z7::Y<63WMMIUQ'+*DMM'.L4BRN'4ACF%3IQCBX*G&,<?3]
MCB8J*2Q%+3]U75K5J?NKW*G-'1::(IRE)X;FDY/!5/;8>[;]A5V]K1O_  JE
MM.>'++S,+_A2WP<_M>T\0?\ "IOAI_;]A9Z)I]AK?_"">%O[7LK#PS-9W/AR
MQM-2_LK[1;6>E7&GV$ME#'(J6CV-NT"QM"A7H5:M&IB*T:LXUL75G7KS4I*=
M:M4I5*-2M5DGS5*M2C6JTIU)N4Y4JM2G)N,Y)X^QHJA1POLH+#8>E["E2Y8^
MSI4+\WL:=.W+"ES>][.*4+ZVN;,?PY^'L-C/I<7@3P;%IEU<:1=W6G1^&-$2
MQN+KP]=1WV@7,]HMB(IKC3;Z**XLY'0M;2Q))"4=01C!*G&G"FN2%)MPC'2,
M&\-#!2<4K*+>#IT\(VK7PU.%!_NH1@ME.:J5JRDU6Q$*E.K.[YZM.M5KUZU.
MI+XIPJU\5B:U2,FXSJXBO4DG.M4<J-W\)_A9?:%I/A>^^&GP_O/#6@:HFN:%
MX=N_!OAVXT+1=:CFFN(]7TG2)M-:UTW5%GN)Y!=6\4<H>:1@^YR2VDYX>HU>
MIA*7L:$G\5&C[-4O94I;TZ7LDJ?LX-1]FE"W*K$I\L,53C[M/&RE/$16D:\Y
MS]I.5:*TJRE4_>2E44G*?O-N6H?\*G^%G]J^%]=_X5I\/_[;\$62:9X+UG_A
M#?#O]J^$-.CC:&/3_"^H?V;]HT"R6%F006,D$85BH7!Q5JI457%5U.2KXV'L
ML14YGSUZ25E3K3OS58):<DW*-M+!4_?05.K^]IQJ3K*,_>BJTZGM9U5&5TJD
MZJ]I.=N:53WVW+4T8/A]X"M+6[L;7P1X0MK*_@TNUOK.#PUHT-K>6VB7D^H:
M+;W=O'9".X@L+^ZN;FUCD5EMYKB66((\C,9BW"-"G%\L,+5I5Z,5I&C7H4L/
M0HUJ26E.K1HX3"T:52-ITZ6&P].+4*--1F4(2J5ZLHJ57%4ZU&M-I.=:CB)X
MBKB*563UJ4Z]7%XJI6A-N-6>)Q$YJ4JU1RCM_AQ\/+/Q1JOCBT\!>#+7QIKM
MG_9VN>+[?POH<'BC6=/V1Q?8-5\016*WVHV?EPPIY-Q/(FV)!MPHQ$(0IT,1
MA:<%##8N7/7HQ25*M+7WJM-6A4E[TM9J3]YZZLN;=2KAJU1N=;!Q<,/4EK.A
M!N[C1D[RI1;U<8.*;UL<^GP,^"<7A>^\#Q_![X61^"M4U)=9U+P>GP^\))X7
MU'6(V1TU6^\/KI L+O4E>.-A<RP/*"BD/D#%/6.$@]88"_U:+VPU[W]@MJ-^
M:5_9\M[ONPC*4*N*KQDXU\=_O-1.T\1L_P!_->]5^%?Q'+9=D=G?^$O"NJ>&
MYO!NI^&?#^H^$)].71Y_"E_HVFW?AN;24C6)-+FT.XMGLI-.6)$06S0&(*H4
M+@ 45U]:DYXK_:)RFJCE5_>-U$^93;G=N:DE)2^)-73N*A_LBC'"_P"S*$7&
M*I?NU&+3C**4+6BXMQ:6C3:>C.3N_@M\'+_P[8^$+[X3?#.]\)Z7J0UG3?"]
MWX#\+7/AW3M8"[1JMCHLVE-9VFI!>/M,4*2XXW53E)U\/BG)O$X1RE0JMOVM
M&4ZDJLW2J?%3<ZLI5).#BY5)2F[R;9$*=.E0Q&%IPC3PV+A"G7I12C3K0IPA
M2IPJTTE&I"%.E3IPC--1A3A!)1A%+>E^'_@.?6K+Q'-X)\(S>(M-NH;W3M>E
M\-Z-)K5A>V^FG1H+NRU1[(W-K=1:.S6*2Q2JZVQ,"D1'92IRE1G6G2;I3K^U
M]K*#Y95/;^R]M[1JSG[;V%#VO-?VGL:7/?V<+.4(3ITZ4XJ5*@J2IPDDX4U0
ME5G04(O2*HSKUYTE%)4Y5JLH6=2;>EH7AGPWX7AOK;PSX>T/P[;ZIJM_KNIP
M:%I-AI$.HZYJLOGZIK-]%I]O$MWJMY.!)<7<H>:9_FD=CS2C[E*AAX^[0PD/
M9T::TIT:?-*?LZ4%[M.'/.<^6"4>:<I6O)MU+WJM:O+WJ^(E&56H]:E64*<*
M4)5)OWIRC2ITZ47)MQIPA!6C&*6Y0!Y?\3OAA'\28_!<L/C3QAX UOX?^,)/
M&OAKQ)X*C\&SZK:ZK/X-\8> [NWN+3QYX/\ $VD7>GS^'?'&NQ.DFF&19&@E
MBEC:'YC;Y!M\CC_^%-_$7_H[']H#_P )S]EC_P"AIH [#X8?#"/X:1^-)9?&
MGC#Q_K?C[QA'XU\2>)/&L?@V#5;G5;?P;X/\!VEO;VG@/P?X9TBTT^W\.^!]
M"B1(M,61I%GEEED:;Y38-C5LOA;\,M-\8WOQ$T[X=>!+#X@:E%)#J/CFR\(^
M'[7QC?PRI%'+%>^)H-/74KJ)XX(%99;E@5AC!&$&'1;PU*K0P[="A7:E4ITW
MR0J23<DYPC:,FFVTY)M-M[MCK2>(=%UVZ[PZ4:3J/G=)1ORJGS7Y%'FE91LE
M=VW8RV^%/PNLK[Q'J=G\-O -IJ7C"XM+OQ;J-MX.\/07WBFZL+E+RQN?$=W%
MIRRZW<6UY%%/%)>O,T<D:R(5900J?[BE1P]']S0PU=8FC3A[E.EB8R4XXBG"
M-HPKQG%256*5122DI728JB5:I4JU5[6K5HSP\YS]Z4\/4INE4H3E*[E1J4FZ
M<Z3;A*FW"47%V'>(_A9\,?&%GJFG>+?ASX#\4Z?KFJVNNZW8>(_"'A_6[/6-
M<L+*UTRQUG5+74]/FCU#5;?3;&RM(KN=9)HX+.")'$<2*HO=EA91]V6!G4J8
M9K1X>=6<JE6=!K6E.I4E*=25/E<YRE*3;;9HZM62:E5G)2IPHM.3:=&G.=2G
M2:;UIPJ5)SA#X8SG.44I2;:7_P *_AAJFM:=XCU/X<> M1\1:/8V&F:1KU_X
M/\/7>M:5INE7T&IZ7I^G:I<:<]S8V-GJ5K;7=O!#*D<,]O%+&JR1JPN%2I2K
M5\12G*GB,3)3K58MQJ59J,H*52::E.2A.45*3;492C>S:>=DJ%+"VMAJ$:D*
M=+_EU3A6@Z5:,*?PPC5IMTZD8I*<&X23B[&K#X'\%6_D>1X0\+P?9;/Q!I]M
MY/A_28_L]AXLO8M2\4V,&RT'DV>LZC!#=:A"N$O)X4EN5DD0,,YQ52A4PM1*
M>&JT*&&G1DKTIX;"TW2PV'G3=X2H8>E*5.A2:=.C3;A3C&+:*ISG1=Z4G2?U
MF6-O!N+^N3=1SQ=XV_VF3JU7*O\ Q9.I4;F^>5\[_A6'PT'B'1?%W_"O/ P\
M6>&M,BT3P[XG_P"$2T >(= T:"%[>#2=%UK^S_MFE:9';R21):VTT42H[*$"
MD@WSS]KC*_._;YBFL74N^?%*33DL1/XJRDTF_:.5VDWL8^RI+#X3">R@L+E[
M3PM'E7LL,U%13P].W)1:BE%.FHM126R.HTW2-)T;3H-'T?3-/TK2;2-X;72]
M-LK:QTZVB=WD>*"RM8DAAC9Y)&*H@!+L2,DYB24H1I22E3C3A1C!J\52IP5*
MG247HJ<*<8TX02Y8PBH12BDC5-QG.HFXU)U)UI26DI5:M256I5E+=U*E64JD
MYM\TZDI3DW)MG VWP1^"]EIFOZ+9_"+X86FC>*XE@\4Z3;> ?"D&F>)88[R\
MU%(=?L(M)6#6(EU#4+^Z"W:3 37UQ*!OF=F))2P]'"27-A<-.-2C1>M*E4IQ
MC"$Z=-^Y"<(0A&,HI.,8QBFE%)5[2HJDJO/)59^UYI\SYI>W4%6YI7N_;*E3
M56[_ 'BIP4[\D;7I?A+\*I].T?1YOAG\/IM(\/65MIN@:7+X,\.2:=H>G66H
M66JV>GZ/8OIIATRR@U33=/O(X+9(XX[BPMYE420(R[.O7>(>+=:;Q4I4INLY
MR]JYT(UH4)NI?G<J,,1B(4I-WIQKUHP:56:EC&G3A'DA3C&/+B(<JBDN3%^S
M^MPLE;EQ7LJ7UB.U;V=/VBER1MTMMX8\-V6O:AXIL_#VAVGB?5["QTO5O$=M
MI-A!KVIZ9I;SR:9IVH:O%;K=WMA:/<W+06\TKQPFXE,:J9&SG!NG"K2IMPIU
MJOMZD(Z1G64%35:<592JJG&-/VDDY\D5&_*DBG%2=&4DI2P].5&DVKNE2E/V
MDJ5-OX*<IKGE"-HN?O-7U-RD,* /F#PG^SEXH\#>%?#7@KPM^U%^T!I?ACP?
MX?T;PMX<TS^Q?V9;W^SM"\/Z=;:3I%C]MU']G&XN[O[/I]I;Q>==3S32>7OE
MD=V9B;?(-OD;^G_ O5AXO\">+?%OQV^,'Q$_X5UX@U+Q3X>\/>*=.^!VF:%_
M;NI^"?%W@![Z^?P!\%_#>JW/D^'_ !MKPBA&J1P^=-%++')Y*K1L&Q[@FD:5
M'JLVNQZ9IZ:W<V%MI5QK"65LNJW&EV5Q=7=GILVH+&)Y;""ZO;V:.W:0QQR7
M<[JH:5RQ'W%4C#W8U91G-+13G"+A"4DM)2C!N,9.[C%N*:3L.4I25*,FY1H>
MT]FF[JG[;V7M>1/2/M?84?:<MN?V-+FO[.%J%UX4\+WO]K?;?#>@7?\ ;TVG
M7&N?:M'TZX_MJXTCR/[)GU;S;=O[1FLOLUM]G>X\QH/L\?E%?+7"C&-/V?(E
M#V5=8J'*K<F*7L[8F-K<M=>QHVK*U1>RI^]^[C92][FYO>YZ$L+*^O-A9^VY
M\-*^]"7UG$<U%_NY>WK7B_:SYJE_X%\$:I!XHM=3\&^%=1MO&\<,7C2WO_#V
MD7<'B^*VLH]-MX_%$-Q9NFOQQ:=#%:HM\)PL,21* BA1+I4Y4EAY4XRH1JRQ
M"IN*=-5Y.$I5E!KE564J5.4JB7.W3@V[PC;15:D:L:\:DHUH4EAXU%)J<:"E
M6DJ*FGS*DI8BO)4T^12K5G:]2?-AV'P>^$FE6%II>F?"WX<Z;IFGZOH^OV&G
M6'@CPS9V%CKOAVWBM/#^M6EG;Z8D5MJ^F6L$,-G>1HLUK'"B0.BH -W5J^TI
MU?:3]K1]NX3YGSP>)I^QQ+C*]X_6*/[JO9KVM/W*G-'0R<8^SJTN5>RK4XTJ
MD++EG2A6GB84YQVE3CB*DZ\823C&M.=5)3DY/6\*_#WP!X%EUF?P3X'\'^#I
M_$5^^J>(9O"OAG1?#TNNZF[.SZCK,FD65NVIW[-)(3<7)ED)=B6^8YB,I4Z%
M+"P;AAJ%_9T8NU*G=)/DIJT(748I\J6D4NB'/]Y7GBJGOXFHDIU9:U9)-M*5
M1WE))MM)MJ[;W8[_ (0#P&/%-WXY_P"$)\(CQM?Z5_8-_P",/^$;T8>*;W0\
MJ?[&N_$'V+[?<Z5E5/V22X:'Y1\G%3&,84<3AHQ4</C)*6(I)6IUY)<JE6@O
M=JR479.:DTM-AR;G/#U9OFJ82ZH3EK*C?F;]E)ZT[\TK\CC\4N[*'A_X5_##
MPE;6-GX4^''@+PS9Z7K-QXCTVU\/^#_#VBVVG>(;JRO--NM=L8--TZ%+369M
M.U"_M9+V)4G>&^N(F<I,ZM<9SA3A2C.4:5.C/#P@FU&.'J2C.I0C%:1HU)PA
M.=))0E*$92BW%-#;<L5-N\\=.%3$RZXBI2G&I3G7>]6=.<(3A*IS2A.$91:<
M4UE>,/@S\._&7AG_ (12\\.:5I6GI91:59SZ%H^AV-[INC#Q!H_B:]T339)=
M+GBL]&U#5=!TR2\LTA\JX^S(SKYD<<D>3A%RPMUS4\+7RZM[%V=&JLJFY8&A
M6I[3P]",ITJ=+3V5*I4A1=-38W*3ABH<S4L72S&$IW?M(5,TH5L/C,53E]G%
M5%7G4=9WE.K:=55%>+FE^"OP<F\,Z9X+F^$OPSE\':)JG]MZ-X3E\!^%G\,Z
M1K/F2R_VOIF@MI1L;#5/-GG?[5!!'+NF=M^7).LI2G5PU><G*O@HJ&'J2;=2
MA"*2C"C-^]2C%1BE&#BDDDE9(EZPQE-ZT\P<GBHOX<2Y-.3Q$=JSDTG)U%)M
MI-[&O;_#7X=65E?:9:> ?!5IIVJ:5%H6I:?;^%="@LM1T2"^U+4X='OK2*P6
M*[TJ/4M8U>[6TE5X5GU6\E""2YE9W&K4@J,8U)1CAJF'K44I-*E6PD*-/"U:
M:3M"IA:>&P\,/.-I488>C&FXQI049E",J<Z,HJ5*HL6IP:3A)8]WQRE%Z26-
M>N+NG]9?\;G*NN_"CX6^)X;6V\3?#7P!XAM['7I_%-E!KO@[P[JT-GXGN6#W
M/B.UBU#3I5M]>E<!GU",+<.1EI":BDEAZF'JT%["KA%.-"</<G1C4JRKU(TI
M1LZ:G6G*M-0:4JLI5'>;;=2]ZG7I2]ZEBE35:#UA65&C'#TE5B]*BI4(0H4U
M-/DHPC2C:$5%7F^'?P_;Q?#\06\"^#F\>V]@-)M_&[>&-$/B^#2U5D738?$I
ML?[1BL CNHMUN1'AB-N":=)NA]8]BW1^MN]?D?)[9^[K5Y;>T?NQUG?X8]D*
M:52.'IU$IPPG\",M8T?B_A)W5/XI?!;XI=V=C2&% !0 4 % !0 4 % 'S_XC
M_P"3I_@W_P!D _:6_P#5B_LG4 ?0% !0!\__ +-/_).O$?\ V<!^UC_ZU/\
M&2@#Z H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MJT(5:"Q$JOL:E.E.GRRI4W'-MOV8_@M::3JNB1>&=8:QU0Z(JFX\?_$6[O\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 ?/\ XC_Y.G^#?_9 /VEO_5B_LG4 ?0% !0!\_P#[-/\
MR3KQ'_V<!^UC_P"M3_&2@#Z H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MG_Z'WX ?^&#^(O\ ]$U1_8/_ %%?^4O_ +H']K?]0_\ Y/\ _:!_PLW]J?\
MZ'WX ?\ A@_B+_\ 1-4?V#_U%?\ E+_[H']K?]0__D__ -H'_"S?VI_^A]^
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M )2_^Z!_:W_4/_Y/_P#:!_PLW]J?_H??@!_X8/XB_P#T35']@_\ 45_Y2_\
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MG_Z'WX ?^&#^(O\ ]$U1_8/_ %%?^4O_ +H']K?]0_\ Y/\ _:!_PLW]J?\
MZ'WX ?\ A@_B+_\ 1-4?V#_U%?\ E+_[H']K?]0__D__ -H'_"S?VI_^A]^
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M )2_^Z!_:W_4/_Y/_P#:!_PLW]J?_H??@!_X8/XB_P#T35']@_\ 45_Y2_\
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MG_Z'WX ?^&#^(O\ ]$U1_8/_ %%?^4O_ +H']K?]0_\ Y/\ _:!_PLW]J?\
MZ'WX ?\ A@_B+_\ 1-4?V#_U%?\ E+_[H']K?]0__D__ -H'_"S?VI_^A]^
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M )2_^Z!_:W_4/_Y/_P#:!_PLW]J?_H??@!_X8/XB_P#T35']@_\ 45_Y2_\
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MG_Z'WX ?^&#^(O\ ]$U1_8/_ %%?^4O_ +H']K?]0_\ Y/\ _:!_PLW]J?\
MZ'WX ?\ A@_B+_\ 1-4?V#_U%?\ E+_[H']K?]0__D__ -H'_"S?VI_^A]^
M'_A@_B+_ /1-4?V#_P!17_E+_P"Z!_:W_4/_ .3_ /V@?\+-_:G_ .A]^ '_
M (8/XB__ $35']@_]17_ )2_^Z!_:W_4/_Y/_P#:!_PLW]J?_H??@!_X8/XB
M_P#T35']@_\ 45_Y2_\ N@?VM_U#_P#D_P#]H'_"S?VI_P#H??@!_P"&#^(O
M_P!$U1_8/_45_P"4O_N@?VM_U#_^3_\ V@?\+-_:G_Z'WX ?^&#^(O\ ]$U1
M_8/_ %%?^4O_ +H']K?]0_\ Y/\ _:!_PLW]J?\ Z'WX ?\ A@_B+_\ 1-4?
MV#_U%?\ E+_[H']K?]0__D__ -H'_"S?VI_^A]^ '_A@_B+_ /1-4?V#_P!1
M7_E+_P"Z!_:W_4/_ .3_ /V@?\+-_:G_ .A]^ '_ (8/XB__ $35']@_]17_
M )2_^Z!_:W_4/_Y/_P#:!_PLW]J?_H??@!_X8/XB_P#T35']@_\ 45_Y2_\
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MG_Z'WX ?^&#^(O\ ]$U1_8/_ %%?^4O_ +H']K?]0_\ Y/\ _:!_PLW]J?\
MZ'WX ?\ A@_B+_\ 1-4?V#_U%?\ E+_[H']K?]0__D__ -H'_"S?VI_^A]^
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M )2_^Z!_:W_4/_Y/_P#:!_PLW]J?_H??@!_X8/XB_P#T35']@_\ 45_Y2_\
MN@?VM_U#_P#D_P#]H<;\(_BE\4_%W[<VD^!OB7?_  _U?_A$/V3_ (A>+-$U
M3P+X+\1>"MW_  G?Q?\ A1H^I6&J66O_ !%\6_;/L_\ PKNPF@G@N+/']H7"
M21OM1AY6.PGU*K&E[3VG-!2OR\N[DK6O+^7>_4[\+B/K--U.3DY9.-KWV2=[
MV7<_2ZN,Z0H _,7X<?\ 'GX__P"R_P#[3W_K1_Q4K['*O]PH?]O_ /IR9\WC
M_P#>ZO\ V[_Z1$]"KT3C/BWP7XNU.R^(E[X<T?Q--=S:E\<?B)IVO?#U_#L"
MVLGA&>WNKZ[\8+JUS9"]E_LW5(+*!M0M+XZ8#J8TRXM3J$D4R>7DB5?+\!A9
M16*PLL/G"Q*DXQ6#Y,US66&ERI*4EC:C6&]G5]I[>\ZN&=..$Q,9=^8Q5*MC
MZUO85XK))8:49:XB4LOR>AB*33<E>AAG5Q7+35*M15*-6LYT:])/WWX.7$\G
MA&[LWD:6RT/QEX\\.Z)(R2)C0- \7ZQI>CVR>827AM+*VCLHW!PR62D5Z-"=
M2K@,JK5KNO6P="524I.4ZG*G3IXB<I-RE/%484L5.4FY2E6<FW<YL9"G1S#'
M4J6E.,Z-1)--0J8C"8;%8BG'ELHQI8JO7IQII)48P5*RY+'J,O\ JI/]Q_\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#QOX+_ /*26_\
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M_(/^&/O@CZ?&#_Q)C]I;_P">Y1];Q?\ T%5?_!D__D@^KX?_ )\4_P#P"/\
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MO_GN4?6\7_T%5?\ P9/_ .2#ZOA_^?%/_P  C_D'_#'WP1]/C!_XDQ^TM_\
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M $%5?_!D_P#Y(/J^'_Y\4_\ P"/^0?\ #'WP1]/C!_XDQ^TM_P#/<H^MXO\
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M?_GQ3_\  (_Y!_PQ]\$?3XP?^),?M+?_ #W*/K>+_P"@JK_X,G_\D'U?#_\
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M'[2W_P ]RCZWB_\ H*J_^#)__)!]7P__ #XI_P#@$?\ (/\ AC[X(^GQ@_\
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M7DE"HX4X2E/V=.5.=5Q5)5J"FZT/GCXG_$GXI6T_C[7?#_C[5_#5E\&?@)X
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M /XD]^T?_P#/4JO[*P'_ #X_\GJ?_)B^OXO_ )^_^2P_^1#_ (5Q9_\ 0_\
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M)/?M'_\ SU*S_LK ?\^/_)ZG_P F:?7\7_S]_P#)8?\ R(?\*XL_^A_^/_\
MXD]^T?\ _/4H_LK ?\^/_)ZG_P F'U_%_P#/W_R6'_R(?\*XL_\ H?\ X_\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H \;^"_\ RDEO_P#LQ^Z_]7SI5?+9W_O=/_KU'_TNH>]E?^[S_P"O
MC_\ 28'ZN5XQZ04 ?F+\./\ CS\?_P#9?_VGO_6C_BI7V.5?[A0_[?\ _3DS
MYO'_ .]U?^W?_2(GH5>B<84 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M]&T_ #_PS?PZ_P#F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\ #)W[+'_1M/P
M_P##-_#K_P"9R@ _X9._98_Z-I^ '_AF_AU_\SE !_PR=^RQ_P!&T_ #_P ,
MW\.O_F<H /\ AD[]EC_HVGX ?^&;^'7_ ,SE !_PR=^RQ_T;3\ /_#-_#K_Y
MG* #_AD[]EC_ *-I^ '_ (9OX=?_ #.4 '_#)W[+'_1M/P _\,W\.O\ YG*
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M.4 '_#)W[+'_ $;3\ /_  S?PZ_^9R@ _P"&3OV6/^C:?@!_X9OX=?\ S.4
M'_#)W[+'_1M/P _\,W\.O_F<H /^&3OV6/\ HVGX ?\ AF_AU_\ ,Y0 ?\,G
M?LL?]&T_ #_PS?PZ_P#F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\ #)W[+'_1
MM/P _P##-_#K_P"9R@ _X9._98_Z-I^ '_AF_AU_\SE !_PR=^RQ_P!&T_ #
M_P ,W\.O_F<H /\ AD[]EC_HVGX ?^&;^'7_ ,SE !_PR=^RQ_T;3\ /_#-_
M#K_YG* #_AD[]EC_ *-I^ '_ (9OX=?_ #.4 '_#)W[+'_1M/P _\,W\.O\
MYG* #_AD[]EC_HVGX ?^&;^'7_S.4 '_  R=^RQ_T;3\ /\ PS?PZ_\ F<H
M/^&3OV6/^C:?@!_X9OX=?_,Y0 ?\,G?LL?\ 1M/P _\ #-_#K_YG* #_ (9.
M_98_Z-I^ '_AF_AU_P#,Y0 ?\,G?LL?]&T_ #_PS?PZ_^9R@ _X9._98_P"C
M:?@!_P"&;^'7_P SE !_PR=^RQ_T;3\ /_#-_#K_ .9R@ _X9._98_Z-I^ '
M_AF_AU_\SE !_P ,G?LL?]&T_ #_ ,,W\.O_ )G* #_AD[]EC_HVGX ?^&;^
M'7_S.4 '_#)W[+'_ $;3\ /_  S?PZ_^9R@ _P"&3OV6/^C:?@!_X9OX=?\
MS.4 '_#)W[+'_1M/P _\,W\.O_F<H /^&3OV6/\ HVGX ?\ AF_AU_\ ,Y0
M?\,G?LL?]&T_ #_PS?PZ_P#F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\ #)W[
M+'_1M/P _P##-_#K_P"9R@ _X9._98_Z-I^ '_AF_AU_\SE !_PR=^RQ_P!&
MT_ #_P ,W\.O_F<H /\ AD[]EC_HVGX ?^&;^'7_ ,SE !_PR=^RQ_T;3\ /
M_#-_#K_YG* #_AD[]EC_ *-I^ '_ (9OX=?_ #.4 '_#)W[+'_1M/P _\,W\
M.O\ YG* #_AD[]EC_HVGX ?^&;^'7_S.4 '_  R=^RQ_T;3\ /\ PS?PZ_\
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M;#P3X2\5:IJWA*#X@>-;G0?$OA.;Q';^-[V'QSXMT'1["\:Y73M TEK;4/\
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M:D</4Q<J=6O2PE3#PI0^OU>BU+X[^*+KX^Z1\+/#^K^ +*V@\=#PIKW@W4M
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@#Y_P#$?_)T_P &_P#L@'[2W_JQ?V3J /H"
M@ H ^?\ ]FG_ ))UXC_[. _:Q_\ 6I_C)0!] 4 % !0!\X/\4/C1KWC?XH^&
MOAS\+/A?K.B?#'QAI'@JZUOQK\:_%?@O5=6U74?AI\/_ (DSW%OX?T+X"^*[
M>UT^"T^(-C9([ZN\DLFGSR&*)612 <_\0OBQ^TE\-? /CCXBZ[\$_@?=Z)X
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M!=,O/%/Q^\:>']=U'_A6/Q'\5?#>\U2^T32?V;]=M-*^W:AX4N[N*VBU>_\
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M*-.I4DNO+2A*I)0BO>J5'&+5.E34JM6?+3I0G4E&#S=5\5:#H>L>&-!U._\
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MT_QSXIB\F&>.&;^U-\\<KVUNUOF6>O\ _#-/PZ_Z&/\ : _\2Q_:G_\ GR4
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MV*.(RVLI1HJ*ITOJ>*Q?U=^UIT:=;@OBSX OO'_[0'Q9T[PY\,%\0>-T\&_
M_P#X1#XLOJ_AVQ7X-ZHFI^/+H^),:IJEOK%F1;VTV&\,V6IW-^0-.OHX;"9Y
ME\[)U[*$<5;ZO##<53K8BMM]8P6'RSA>KC,M3I\U63Q>'YZ/L*L(8*K[;FKU
MH2H4T^C-OWU;$8.$_:5:_"TZ5"CR+]UB\1CN(:."QMYVIOZMB.2M[7F^LX/V
M7/@Z=6=>JHO3]F^\T/PGX0OM9^!NE?$F-OB1\4_$/Q=^&MO/X ?6/B+;ZUXE
M\72_#37M7E\6Z]8>'/&,7AVRU2UN;72==UJ&.PBU R6D:7NGQVQPI\M&.34(
M4U'#X;AO X.$(VA# YXL'D=/%XYM6E&LXX#%X&IF.%C6Q<8RIK#^UP\G*&M.
M&*G+-*M2O[/%5,_Q>)55RE"6)R5XG-YTL%!48RY:5:MC<)F/U*M[+#U*U&K/
M$N.)D^?DM/\ V5OB!97]SK]UX!T*Z\4W&E_LUP0:_'J/AF\UNQL?!O[1VM>.
M/%/AE_$NH74.I:DOAWX9VW@>QENIV"ZE'X7L(+5KJ2RBBB]7!UZ6$I8:DZW[
M[ZU&>.K04TL;4I\&0RNICJGNQG4^LYS+$U(JK%5U+$5,14IP52I,].%2F\!6
MI3]UO"\:T\+0E"*>$HYK7]IDN!BH<U&FJ=*MB:4(T9RP^%=2O!3C3J<U3!\0
M?LL_%?5QX"&N:#X_U#^R_ 6CZ!X9@\$^(?V>+-?A?XOM/%WBC4]9\0:AXC^*
M7@_Q/K/@XWNGZIH,L?B#X9K>ZL?[):"XM'^SVC+P9-*."Q655*O[O$X2.1.>
M(FDZ-/"X+*,KPV+R]O#J..JVQ6%QG/@_:?V;F$,0J=2OAZ<JU:?/FDEB*.9P
MC".(PE?,.(:WU-1:J8B>/S;&8G 8V]6:PO+]6JTDJE54\?ECBZN$A6K5:E*E
M]J_%_P"#UI\4?&?PK7Q/X0TKQOX*\/:1\1HO$=GXB32=0TIM0U?1=&M- .H:
M-J#(FL&2\M;B1,6<T4,T$<[+"\<+KYF(HU)8C.<31IJ%6IDN)H8*4;1E2QTL
MQR[$4/8R<G*A5A3H59T\1S1]DX6593E'FO#SE0P>5X?VT^:AFN"K8CWFW/"4
MLKSG#5W4DHP56$JN*H4ZM+E_?1JRO1=)5%'Y:TWX2?'S1_!UOX6O?ASJOB/5
M?%_PB_9HT+6O$#>-O!30^&/$GPG\075WXQT_Q+-J?B87VIW<EA>I+97.D1:M
M;W4D$T<]S:_NY)OI,9B<-B<XYH/V6$H<78;/E7Y+0JX66'R*A5C3IJU55Z57
M*ZM6K&I3IQE0J<]&=:NEAY\..PM*EB,YQ& BI4,7DO$&2X7#4XJG[&-3$<05
MLKDN>4(1PM:AFM"A3A%^TPTZ485:,*,I5*._H7[*$=QX@BU7Q3\+/#]V?$/B
MW]J6Y\?3WK^&[[_A)_#OC+QMJ6N?"FP\31B_E.OZ/Y<UMJ5GIMPL\6F7F+F6
M"TO SUX.(C6I9;]5P+E3G3X5PM&G&$N3DXBPU7 NEB(R;7+CL-36,IX;,%)>
MPHRE1H8B%.4(/W,;7P^(SJGCE/GA'-\I;J-2YEE-+AZMA,PH:KG6%J9@L/'$
M81+EQ4X0JRI5:<.=<MX>^ OQF<Z.GB+X:I+XOGLOV:)]+^+%[X]T.[U/X<^(
M_AYX6T*S^(^I/86^J/=(T]K9ZSHS76B2WTNN2:E]AU"$:*#>U[M2M0_MK-<5
MA*ZP6'GQ%FN8*I&BI+&93B<+EM+ZCRM*<5C:N'E!4*\(T*"ISQTI4\9A\'3K
M^![%TLOIX90==+(IY93HMKEPN,689]4R_%QYY.$OJ%/&X7$>VB_K%%*G1PJK
M.MBUAN3N_P!E/XJRM\6G?0OB)J/C/Q#H'Q-L-4\63^)?V>-$\(?$G_A)[V9O
M#-G:ZAX:\'VGQ)\2_9+*6U\J'Q[KVF0Z%+IX33KF]A6,/YN31I8>CD5'%1C]
M5P]7AN..HUDY<]7 9ME.)S/'1H87EPE12I83&55C:WM<SK4J\L//"SK8JO5A
MIG:Q&)_M6IA9<]>K'/9X%TW%QI4<7E6:X?+\!4GC8U:L5&IBL)AYX*CRY9ST
M8XKZQ2I87#T)?J7X7\+^'?!FA:=X:\*:#H_AC0-+B>.PT30=.L])TNS\Z62Y
MN/L]C8Q1PQ-+=33S2,J R2S22.6=V8U5JSJS3G)R4(PIP72%*E%4Z5*$=H4Z
M5.,:=*G%*%.G&,(1C&*2>'I>RIJZM5FW4JR;YIU*T_>JU:LVW*I5J3;G4JSE
M*=2;<Y2E)MO?K(W/G_Q'_P G3_!O_L@'[2W_ *L7]DZ@#$_:<>2/3_@LT[6B
M>'_^&B/A2OBAKXE;/^S6U*\33!<%B(=I\5-X>"B?Y#(8P/WA2C JI_K)D'+>
MWL\]Y;;^W_U<S;V%O[WQ\EO>]IR<NIEF"B^'\^NI-QCD[=ME1CQ)DDL4Y]J4
M<(J[JO94E-S]Q2&_ 1D/Q(_:M6P$8T5?C?I8M?LZHMH=8/PA^&A\2^4R ![C
M^U-WVC!(%QYH/[SS*Z*&G#F17MR^WSOV%K6^K?VUC.7E2^Q]9^M\M];\UO<4
M#IQZPZSA^PY?;O*<I>-Y7[WUNV+5/VO:I_9BRVRT_<^Q;5VV]WQ'_P G3_!O
M_L@'[2W_ *L7]DZN<S,#]K-I$^'?@YI#$NBK\=?@(?%#7)*VB^'A\5_"OVLW
MI/[L60N/LGF^?^ZV;MW:M\KLN(^'>?E4'5S-1YO^@A\/YPL$H]/:/&O#J@OB
M==TE#W^46)]LLDXC^K<RKK+I6Y/B]@L3A?KVVO(LO^M>WM_S#^UYO<YBQ\'S
M;?\ "[_VI5TKR/[*7Q9\-C=_9%C%O_PE9^&ND#7/,9!SJ']F+X;\X9P/W6<2
M%\XX#VG]A+VG,J:SO.5A;[?5?998Y^SZ.G_:3S*[_P"?_MUTT>.]M_:V"YOX
M2X>RSE^'XO[6XCM>WO7^KK#<O-_RY]ER^YRGB_[0_P#R?9_P3J_[NY_]4[HE
M(#W3]KG^TQ^S%\=?['\P7H^&GBC/E>:)!9#3I?[3V>3\^?[-^U^W][Y<TJ;H
MQS#('B7".#CGF0O$NK94EA5G&!^L.JW[JI*CS^TYO=]GS<WNW.W ?6/:UOJ?
M/]>^J8[ZI[/^+]<^I8CZI[*VOMOK'LO9<OO>TY>7WK'/>$7T<_M1:A_PC!T]
MM/;]FCP(^KMI0MVMB@\:^(/^$*,SP#;M.EMX@-J%/,.X\H(L=5)8E2XQ5=3C
M3CFN5\BG=+ZY]4S/^T-_^7RHK*_;WU4?8;7U\6FZG]G\#<EOJSP6>VMR_#_Q
MC'L=?BY.?ZUR?8Y_;6][G/+/VA_^3[/^"=7_ '=S_P"J=T2N8[3VS]KUKR/]
MG/XE/:-$D:6.BMJ[3F18$\-+XGT0^*FN&BQMMQX;&J&0O^["!_-_=[JSA_R-
M^%;_ ,'_ %BR'VM]N3^U<+;FOIR^T]GS<VG+<*L92RSB*-)3EB)9#Q J"I*]
M1XAY+CE04$M7-U>114?>YK<NMC.\$/9_\-7?%]=#^R_V5_PI'X'OJ9T]8?LG
M]L'Q!\51IGFR0C;]J_X1T6>P Y^S?9B1L\JN_"JHLHSCVMTEQ#4Y.;?V_P#9
M&6_7M/BYKK">UOM.UO?]H+$_4K<,/#NG]9EEN/Y^1Z_4%C,+_9VVBH^V>:>P
M:W?M]TE;R3]H?_D^S_@G5_W=S_ZIW1*Y!GT;^TCH<_B;X,>,?"UOX@\(>&7\
M3KHOAV35O'6K/HGAI+36/$.DV%_8W5]%#*YN[ZQGN+&TMD53<W5Y;VX>/SMZ
MS#VJS'(IT)J-3#9MEN*C'D=2=5X+%4\9&E2HJ5-UZDY8>*]BJE)SAS_O(6N7
M:+P>;QDZL%/*LTI*I2E[-T)5LOQ-".(G6:E["E0E456I7Y)^QA!U.2?+RN/X
M8^-?'-UXY\??"_QV?#NMZGX$T;P7KD7C3P;X8UCP?X:U&W\8MXB6+0&T#6_%
MOB:>SUK3(= BEF==:N$GAU6UE$5MN\L]--4\3@*F-3Y:M#,:^7U(N:G[65+!
M9?C7B()0BZ<7]?\ 8RI2=7EE2YE6G[1PI\TTL)B\-A*2C]6KX)8NC!<WM,-3
MCBL1@XT:TK*%7G^KN=&M"-+GY:T)8>"HQJ5JOB/_ ).G^#?_ &0#]I;_ -6+
M^R=6!L3_ +2.AZAXG^%\WAG3/$O@KPK<ZYXQ^'-DVI>/M1ET[0;FU3Q[X=O;
MW1%^S@2:EJVJVEI-IUGIL<ENUY<7L5N)X/-\U"A!RS3))1UEA<:L7"$8.I4E
M5P6'Q&+P[I4(SI.LZ&)HT<35@JM.V'H5I\ZY-=+T%@,ZAB*3JTJ^68["RO)4
MZ<(XW#RP4YUJKC45&G&&(DE4=.HE4=-<DKV+?PI\:^-=7\2?$CP#X\;P]J^N
M?#B]\-0R^,?!_AW5O"?AG7D\4:+_ &Y%8P>'=:\4^)+G2M6TR PI<Q_VY?I(
MEY:7"F#[0;>'2FZ6(P2QE*$Z#AC<3@90G-5/:2PM#!598JE)4Z5J-66+E15-
MJ;IU<-6A[6K:ZYZOM,/C:>$DN:%; 8?'0FH<B@JV+S#".A)\\^>47@/;*:4+
MPK1BZ:Y5.IF^(_\ DZ?X-_\ 9 /VEO\ U8O[)U9FAM?'CQOKO@7X?W-[X9TK
MQ/J&N:UJ>F>&;*]\+>"/%_Q!N_"\>LSF&_\ %]WX:\$:'J^J7EIH^F)>7B1Q
MV3I-=0V=K(\2W7F)S5E"M6PF!K3K4,-C)SCB*]&$G.CAZ=*=6JH349QHU\0H
M+"86K43A2Q%>G6G&=.E.+Z*"]G3Q>*C"G6J8*BZM&A4E!1KUW.%&A"<)5:,J
MM"-:K"MC(49JO]2I8F5%2JQA%^$?L(2^&+/X:?$#PQX3M_&D.D^&OC?\5+>U
MD\;^&?'F@:Q<6M[XIO;JVFO;KQ[HUA>:EK#IN>_1O,N;6YD>&^CMYSY0])3G
M5R3ANK*-*G&G@JF'C3I2AR4XT,=B_9PI1C)\U"G0G2ITZRYJ<Y0J4_:SKT,1
M&''64*>>9Y!2J3JUI99BJM2I2G3=6OB<CRMXFK).$*<*E;%PQ%;V,%!1HU*%
M:E2C@\1A)U/7?$?_ "=/\&_^R ?M+?\ JQ?V3JYC0[GXHZ]\-?"GAJ+Q3\44
MT)M%\/:QI>HZ.VL:3%KEVGBP3&V\/)X6TK[)<W=[XPFO+C[/I\&F027TLUR(
M[92\F#*<HXG"_5Z4JN8SE4I82%%+ZQ.=2C4A5IT7=."GA_:JO-RA2AAO:SQ$
MX4(U)+2%+VU+$4IRA3PCA&6)E6G&GAH4J56G4C/$SJ-4HTZ=>%&I%U-%6C2<
M/WJ@<5\!_!>M:!!\1/&_B'3I?#FK_&'Q[/\ $*7P6\\,X\'V;Z!H7AS2],NV
MMLP?\)#<Z=H%MJ.J^0TD2:AJ5S!'+<);K<3]<HK"9=EF5*I"M/+EBY5:E.[I
M>VQN-Q&.JT:$G\6&PLL1]7I32BJSA4Q,84U7]G'GJ2CB,QQF/IQY:-:G@\/1
MO3E2JU:6"P\:$,37A+WXUJ[4G",U"K2PD<+0K0C5HSBH_$?_ "=/\&_^R ?M
M+?\ JQ?V3JYC0^@* "@ H * "@ H * "@ H * "@#Y_\1_\ )T_P;_[(!^TM
M_P"K%_9.H ^@* "@#Y__ &:?^2=>(_\ LX#]K'_UJ?XR4 ?0% !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M5=:\>?LR7FC:9>:@NOFWM=0OK30-=GMK>219)X]%OWB5ULYC'GMY%[>1[?\
M\-8_LL?]'+? #_P\GPZ_^:.@#-TO]I?]D#0X[N+1?V@/V;='BO\ 4K[6+^+2
M_BM\,-/CO=7U2=KK4M5NTM->C%SJ5W<LTL]S(&EF=B\C,QS1'W*=*E'W:5"+
MA3@M(4X.<JCC"*TA%SG.;C%)<\Y2M>3;<FYU)U9MRJU.3GF]92]E2IT*?-)Z
MR]G0I4J,+M\E*E3IQM"$4O(M?_:;_9MF_:2^$^NP_M!_ ^71--^!_P"T'I.H
M:Q%\6/ ;Z58:KK7CS]F2\T;3+S4%U\V]KJ%]::!KL]M;R2+)/'HM^\2NMG,8
MS;R%MY'H7C/XX_L._$;2H]"^(?Q@_92\>:'!>1:A#HWC/X@?"'Q1I4-_!'-#
M#?1Z=KFKW-O'>1Q7$Z+,L8=5FD4, Y!SE2I2G3JRIQE4H\WLYN*<H<RM+DDU
M>/,M)6:NM&:0JU:<*M.G4E"%>*C4C&34:D8RC.,9I-*48SC&:4KI2C&2U297
M\$?&;]A+X965YIOPW^*_[)7P^T[4+E;W4+#P1XZ^#OA.ROKQ(E@2[O+70=4M
M8KFY6%5C$LBLX50H.!BNAU:LJ=.E*I*5*DY.$')N$'.W.XQ;M%RY8\S27-RJ
M][(P5.G&I*JJ<8U9QC&4U%*4HP<G",I6NXP<YN*;M%SDU;F=ZND?%CX6?%#]
MJ?X7_P#"L_B7\/\ XB?V%\ /VB/[;_X07QEX=\6_V/\ VG\1?V6O[-_M3^P-
M2N_[/^U?V??^1Y_E^;]AN/+W>2^W,L^OZ "@ H * "@ H * "@ H * "@#Y_
M\1_\G3_!O_L@'[2W_JQ?V3J /H"@ H ^?_V:?^2=>(_^S@/VL?\ UJ?XR4 ?
M0% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M.6%I5*M#(H5JD*&*S3)JV>UJEKT</@Z%*OBX4H4W.,ZU;%82ME?O.K2CA/\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * /G_Q'_P G3_!O_L@'[2W_ *L7]DZ@#Z H * /G_\ 9I_Y)UXC
M_P"S@/VL?_6I_C)0![9K6B:+XDTF_P!!\1:1I>O:'JEL]GJFC:UI]IJFDZC:
M2<26M_IU]%+;WELP W12QNIQR*$^6=*I'W9T*E.M3DM)4ZM&I&K1JP:UC4I5
M80J4YQM*%2,9Q:E%---QYDFXJ49PDEI>%2+A.#[QG"4H3B])1DXM--HXKPG\
M+?#W@[QQ\2?'^FW6K7.N?%"Y\+S:W%J$UC)I^F6_A#0DT#1M,T""UT^WDL].
M6W\^X>.XFNV-Q>3NKHC+&E49.A@G@8MRIRQN+S"<Y-NI/$8R.'IU')WY>6%/
M"T:=-**:C%\\IR;D15A"IB,/B>2--X3 4,NI0@N6G##X?$8O%1:CJU4G5QM7
MVC347&-*,804-=*[^&?PWO\ 5M3UZ_\ A]X(O==UF?0;K6-:N_"F@W.K:K<^
M%;N/4/"]QJ>HS6#7%]/H]_#%<V$D\CM9S1));F-U# HREA>7ZM)X?EK3Q$?9
MMT[8BI2GAYUURVM6G0J5*,ZJ]^5*<Z;DX2DG=1NJK57[1>PEAK3][_9ISC4G
MA];_ +B4X0G*E_#E.,9.+<4U%K/PL^&/B+2-1\/^(/ASX#UW0=8UQ_$^K:)K
M/A#P_J>D:IXEDDCED\0ZCIM[I\EO>ZXTL43M?S1O<%HU)DRH(B"5)X-TDJ;R
MYR>%<?=>%<ZE2K-X>UO8N56K5J2=/E<JE2I-WE.38VV\2VVWC(TXXAO>O&E3
MI4:4:S_Y>QI4J-&E34^90ITJ4(VC3BEM:_X/\)>*M#/ACQ1X7\.^)/#3&R+>
M'M?T33-8T,G3)X;G3B=)U&VFM2;6XM[>6 ^5^Z>"-X]K(I%N4O;TL5S/ZSAZ
MJKTJMW[6E75[5J=3XH55S.U2+4U=V>K)A%4J,\/32IX>I2EAYTHKEIRH3CR2
MHR@K1E2E#W94VG!Q]UIK0XM_@1\#WTK7]"?X-?"EM#\5ZK%KGBG1G^'GA%M*
M\2ZW!.UU#K&OZ<='^SZQJL=TS3+=W<<TRR,7#ACFH45&GA:*2C1P$G/#4TK0
MP\W#V3E0C\-&3IMTW*FHOD?)?ET&M*E6JM*M>"IU9_:J4U-5%"I+><%42J*,
MFTII2MS*YIZI\(OA1K=QI]WK/PQ^'FKW6DZ/#X=TJYU3P7X;O[C3/#]O<PWE
MOH6GS7>FR/9Z/%=V]O.EE"4@62"-U0,BD:*I4CB*F*C.4<55JT:TZR;56=;#
MS]IAZLZB?/*K0G[]&HVY4I^]!Q>I#ITWAH8)PB\'3C6A"@TO8QAB*;HXB,:5
MN2,:]%NE6BHI5:;<)J478NW7PT^'%[X@U+Q9>_#_ ,$W?BG6-#E\,ZOXENO"
MFA7'B#5?#<\9BG\/ZEK,M@UW?:')$2CV,TSP,I(,9!Q67LX>PQ6%Y(_5L;)3
MQ%&R]E7G'X95J?P591Z2J*371FJG.-7"5U)QKX"SPU1-J>':;:]A/XJ-G*37
MLW'5ONSI;+2-)TW2K70=.TO3K#0[&PATJRT:RLK:UTJSTNWMUM(--M=.@B6W
MM["*U584MXXUC6-0BJ%&*O$REC)5Y8MO%2Q+DZSK/VCJN=^=U'/F<W.[YN:_
M-=WO<SH0AA(TH86"PT*%O9QI)4U3Y7>/(H64>5ZKEM9['#Z5\&OA!H6DZUH.
MB?"GX;:/H7B/38=&\0Z+I7@;PQI^DZ]I%LUX]OI6M:=::7';ZIIL3ZAJ#);7
M,<L2F^N"J@S/N*C=:BL-5?M</&<:JI3]ZFJD*=*C"HH2O%3A2P]"E&=N:-.C
M2@FHTX):4Y2HXA8NE)TL6O:6K0;C5_>U)5:O[Q6G^]JSG5J>][]2<IRO*3;L
M7GPE^%5_X9T?P5?_  S^'U[X-\/3VMUH'A*\\&>'+GPSH=S8L6LKG1]!FTUK
M'39[=B3%);P1M&22A&:J=2I4Q-'&5)RGC,,TZ->3;K4FDDG3JMN<&DDDXR5D
MDNAFH0C1Q&&C!1P^+35>DDE3K*3O)58+W:BD]6IIW>KU+]A\.?A[I7BO4?'F
ME^!/!NF^.-7M(;#5O&=AX7T2S\5ZG8V\-O;P66H^(K>Q34+VTBM[2TB2&:X=
M%2UB55"QJ J<I4:=:E2DZ5+$3]K5A%N,:M3FE/VE2*LISYISESR3ES2D[WD[
MNI&-66&G52J3P=-TJ$IKF="D]Z=%N[I4WUA#ECY$L_@#P)=7.HWMUX*\)7%Y
MJ^MZ+XEU:[G\-Z-+<ZGXC\-+;+X=\0:C/)9%[W6]*6RLQ97TS//:BTA$$D?E
M)M*4I4/8^QDZ/U:=>K2Y&X>RJXJG*CBJE/EMR3Q-*<Z5><;2K4YRA4<HR:;J
MKVWM%6_>JK1IX::G[W/AZ-25:E0GS7YJ-*K*56G2=X0J2E.,5)MC++X>> --
M\0:_XKT[P/X/L/%/BJ".V\4>);+PSHMKX@\26T4?DQ6^OZS!9+=ZQ D0"+'=
MS3*JC: !Q6:A".&JX)14<'7E*=2@DE1J2G?GE.E\$I2N^9RBW*[NW<N4YSJT
M*TYRE6PD5"C4DVYT8)W4:4G[U.*>JC!I)ZV&6?PX^'NG>$3\/]/\!^#+#P&4
MFB/@BS\+Z):^$3'<W;:A<1GPW!8KIVR6_=[EU^S8:9VD;+DM6TZM2=3#59U)
M2JX-X>6'G*3<J$L(X/"RHR;O2>&=.F\.X.+HN$'3Y>56SLKXEV5\9[;ZP[?Q
M_K$'3K^V_P"?OMJ<I0K<_-[2$G&?,FT.U+X=_#_6+/Q'IVK^!?!VJ:?XPN;2
M\\76.I>&-$OK/Q3=Z?;6EG877B.VNK%X];N;:TT^P@AEO5F:*.RMT0JL*!<U
M[JH)>ZL)7EB:*6BHXF4_:2Q%)?\ +NO*I^\E5A:HY^\Y<VI:E)7M)IN@L*]7
M_NL>=1PW_7B*JU$J/\->TG:/ORO57X7?#)--T[14^'7@1='T?Q)_PF6D:2OA
M'P^NFZ5XO^U3WW_"5:=8#3_(L?$GVVZN;C^TX42Z\VXED\W?(Q-QJ5(5,+6C
M.4:V!IRHX>:;4\/1G"5.=*C)/FI4Y0E*$H4W&,H2E%IIM$<J]GBJ5E[+'**Q
M,+>YB%#V?(J\=JJC[&ER^T4N7V5.UN2-M&Z\">"+[Q3I_CJ^\&^%;SQMI%G+
MIVD^,;KP]I%QXITS3Y]WGV.G^(9K-K^RLY-[[X8;A$;<<J<FHI?N)5YT?W,\
M5%0K2A[DJT(M.,*KC9U(Q<4U&=TFE9:(=1*M&A"JO:PPLW4HQG[T:-1KEE.F
MI75.;3:<HVDUHW8J:]\-?ASXH\0:'XK\3^ /!7B+Q3X8;=X:\2Z]X5T+5_$'
MAYO,$V[0]9U"PEN]);SE5\VLT7S*&ZC-%'_9ZTL10_<5YQY95*?N5)1Y90Y9
M3C:3CR3G&S=N6<H[2::JI5Z4</72K4(RYXTYKGIJ5X2YE"5XJ7-3A*Z5[P@[
MWBK8J?!'X,1^)-7\8Q_"+X8)XOU^'4[?7O%2> ?"B^)-:M];MWM-9@U?7%TD
M7NI0W]K))#=)<3R+<1R,DH=6(.<*5*GAZV#ITXPPF(BX5:$8I4JL'4C6<*E-
M)0G%UHQJN,HM.I&,VN9)FDJE2=?#8J<Y2Q6#E3GAZTFW5H3I4_8TIT:C]^E*
ME2;I4Y0<7"G[D6HZ">'O@A\%_"6E:[H7A3X0_"_PSHGBBTFT_P 3:-X>\ >%
M-%TKQ%87$)MY['7=/TW28;?5[22!FC>&[CE1D)4J5.*UFW4I+#U&YT(U%55.
M3O356+BXU%!WBJD7"#4TN9.$6G[JM%+]QB%BJ/[G%12BJT/<JJ*YK152-II+
MGG9)V7/*WQ._5WO@SP?J/]A_VAX4\-7_ /PC$5S!X:^VZ%I=U_PCT-YIDFBW
MD.A^?:M_9,4^C32V$BVOE![:5X&!B8H55_?SQ52M^^J8VE5H8B4_?E7H5IPJ
MUJ-:4KNK2JU*5.I5IS<H3G3A.2<H1:5**P]*C0H)4*.&G1J4:<%R0I5,.FL/
M4IPC:,)T%*2HRBE*DI-0<;L9IG@CP7HMUH]]H_A#POI-[X>\/CPEH%YIF@:3
M876A^%1):RCPSH]Q:VB2:;X?$ME9/_9UNT=MNM(6\O,2%=9UZTZF*JSK3E5Q
MTJ<L3.4Y.>(E1]JZ,J\F[U94G6K.FZCDX>UJ\MO:2O*I4XPH4HTXQIX652=&
M"BE&C.LDJLZ<4K4Y55&*J2BDYJ*4F[(\Y\"_L]?"[P#XQ\8_$6Q\.V&M?$/Q
MMXIUOQ1J?C[Q'I'AV_\ &=FNMQV=NWAK2/$EMHEM?67A.SM;"U@M=.,TNQ$/
MF22LQ8Y8=?5,OHY91]W#TX5H56DE/%NOB\1C)SQCCRQKU/:8F4(N44E2A3A;
MW7)UB$L3C*N,J^].?U7V=-ZTL/\ 5,'0P5/ZO&7,Z3G"A[6JU)RE7JUIIQC*
M,(]I>_"[X9ZEX2_X0#4?AUX%O_ GG-<_\(5>^$?#]UX2^T-?2:HT_P#PC<^G
MMI_G'4I9;LO]GW&>5YL^8Q8DES2PTI>]+!1I1P[>KH1H4U1H1HMZTHT:48TJ
M2ARJG3BH0M%)&D*DZ4\34I3E3J8R56>(E%N,J\Z\G.O*LU9U95IMRJRGS.I)
MMS;;N8I^#WA#_A96B?$Y$NX=3\.?#O5?ACHOAZ!=,@\):?X<UG5]+U?4'M])
MBTP317TCZ/I]K\MV+<6T C%ON.^JC.2AG,*K^LK/?J2Q3K?O&X8'Z[[.FKZ.
M%1XZM*NJBJ.<HT[."C)2RE!<F5TZ:^KPR>MB:]"-*U->UQ5.A2<I66GL84/W
M/L_9\KJU7/GO#DUM*^%'PNT(Z,VB?#;P#H[>'-*U;0O#S:5X.\.Z>=!T/79S
M=:YHVC&TTZ/^R]*U&Y9I;NTMO*AN'8O,CL<TIMU%751N:Q5"CA:RD[JMAL,D
ML/AZJ=_:4*"25&C.].DDN2,;#22G3J))3I8BKC(2^U#%UTU6Q47O'$5DVJM=
M6JU$VIR=S7\)>"?!O@#2%\/^!/"7ACP5H*7$]VFB>$M!TKPYI"75T_F7-RNF
MZ/:6]NMQ-)\TD@CW.>6)-5.I4J1ITZDY3A1@J=.,FW&%-7M"";:C!7=HJT5=
MZ:@TG4JUFKUJ\N>K/[=2>W/4E\4Y?WI-OS.8?X)_!F31O$'AV3X1_#%_#_BS
M5QX@\5:$_@+PJVC>)=>643KK?B#2VTDVVLZN)E607EY%--N ;?D9K-)1IX.C
M%*-'+Y<V%@M(8:5DG+#Q7NT9625Z:B[)+9&JJU%7Q&)522Q.+A[*O5YG[2M3
M]Y^SJSOS5(7G/W)MQ]Z6GO.^W??#CX>:FDT>I> _!FH)/X8E\$3I?>%]#NTF
M\%SRK--X1F6XL7$GAB29$D;2FS:,R!C$2 :J4I2E6G*3E/$U</7K2;NZM;"2
ME/"UJC>LZN&E.<L/4E>=&4Y.FXN3OE32HK#JDO9+"*LJ"A[JHK$1A#$*DE;V
M:KPITX5E#E]K&G",^91BEP'Q(_9T^%/Q1M;&P\1^&=,@T]/%/@WQ/XAT_3-%
M\-PV?CY/ 45S%X8\,^/HKS0[K_A)/"5FMR-FG2E @MXHXI(XM\<BBK8NABIK
MV_U>KCL0J-5*=">+Q^#E@:V-J4W\6+C1E%T\1=352G2E-S5.,4.*6$K82FO8
M*KA\-@XU:7[NM0PF%QU+,(8;#SC_  J$ZU*4*E)1Y/95\0H*$ZKJ+NX_AE\-
MX=+\+Z'%\/O!$6B^"-1M-7\%Z/'X3T%-+\(:M8+(ECJ?A?3UL!!H&HVR33+%
M<V,<$D8E<(RACG25:K+$1Q<JLY8J-.I1C6<I.JJ5:'LJM)5&^=4ZM/\ =U()
M\LX>Y)..A/LZ:H5L+R16&Q$HSJTN5>SJSA456$ZE.W+.4*L8U(RDFXU(J::D
MDRG!\(OA1::7XJT.U^&'P\MM%\=7,U[XWTB#P5X;ATOQC>7)+7%WXJT^/31!
MXAN96)+RW\=P['EB:Q<(/#T,(XIX7"24Z%%I>RHR34E*E3^"G)2C&2<(IIQ3
MO=(W=6H\1/%.I)XJI#V4ZSD_:RI<KA[.52_/*'))PY&W'E;C:S:+Z?#;X=Q:
M[H?B>+P#X+C\2^&-)70?#?B%/"VAIKOA[0TB\A-&T/5EL1=:3I*PCRQ:6LL4
M(7Y0F.*U]I45?%XGVDEB<?\ [S5YG[3$>\I?OYWYJWO)2_>.7O)/<YU1HJAA
M<*J4%AL [X:ERQ]EAWR\EZ%.W+1?+[MZ:B^73;0LZIX$\#ZYJLVNZUX-\*:Q
MK<_A^]\)SZSJGAW2-0U6;PMJ,HFU#PU-J%W9R7$GA^ZF59)M.:0VTK*&>-B,
MUBZ=-T\31<(NCC?9?6(67)7]@VZ/MHVY:OL7*3I<ZE[-R?):[.A5:L7AVJDH
MO"3G4H-2:=&I4BH3J4G?]W.<$H3E#EE**46VE8RD^$WPKCE\(3Q_#/X?I/\
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M(DDZ6#CAL/'#J?-.,J%.M.<\1SUI>EU !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % 'S_XC_P"3I_@W_P!D _:6_P#5B_LG4 ?0% !0!^&MM^R+^SS\3_$/Q5\<
M^.?A]_;GBG6_C_\ M(?VIJG_  EGC?3/M7]F?'SXD:/8_P"A:/XEM;2'R].T
M^TA_<V\>[R=[[I&9F^ER_+\)7PE&K5H\TY<UWS36TY):*26B26QXF+QF(HXB
MI3IU.6$>6RY8O>,6]7%O=FC_ ,,$?LF_]$H_\OKXE?\ S8UV?V5@/^?'_D]3
M_P"3.;Z_B_\ G[_Y+#_Y$P]7_8K_ &,]!NM!L=4^&AMKKQ-JDNBZ'"OC#XK7
M+7VIPZ5J6MR6H-KXID6 C2](U&;?.8D/V?RPQDDC1Y_LS+U*<%0;E2H5<1**
ME5;]C0=-5))*3<G%U::4(WG+F]R,K.VD,3CY4JU:-1>RP_LO:2:I)1]M6IX>
ME>Z3:E5J0A=74>;FERP3DK>D_L._L>:YIMGJ^D_#%;O3K^!;BUN%\<?$Z/?&
MV1AX9O%R2P3(P9)(9422-T9)%5T91;RG +EM14HRC&<91JSG"4)Q4X3A.-1Q
MG"<'&<)Q;C.+4HMQ:9G]?Q:E.'M>65*<Z<XN$$XSIS=.<))QNI0G&49)ZJ2:
M>QH']@G]DQ02?A3@*"3_ ,5U\2C@#D\?\)C6=3+<MI4YU)T>6%.+E)\]5VC%
M7;LI-NR6R3?8%C\8VDJNKT7NP_\ D3D;7]D3]B&]T?PMKUK\/?,TGQI=V-CX
M9NO^$L^+B?VE=:E;W%U91>1)XE6:S\R"TN&W7<<"KY>'*EE!;RS+HUL+0=&U
M7&0E4HQYZOOPAA98R3OS6C;#0E4M)Q>G(E[1J+TJXK'T'C54GRO+JKHXCW:;
M]G4CBX8!QT3YK8N<*5X<T=>>_LTYKK_^&"/V3?\ HE'_ )?7Q*_^;&J_LK ?
M\^/_ ">I_P#)F?U_%_\ /W_R6'_R(?\ #!'[)@_YI1C'_4]?$KC'_<XTI99E
MT(RE*ARQBFV^>KHDKO13OH@6/Q?_ #]_\EA_\B9&@_L2_L;^)M(L==T/X9?;
M=*U&)IK*Z_X3/XIVWG1I(\+-Y%WXKBFCQ)&XQ)&I^7.,$$D,LR^=.A5A0O3Q
M%*C7IOGJKFI5Z4*U*5G.ZYJ<XRY9)2C>TDI)I.6.QE.I6HRJ\M3#5:U"HN6'
MNU:%6=&K&ZC9\M2$H\T6XRM>+<6F\OQ1^Q]^Q3X,.C)K_P ,[NWDU[43I6E0
MV/B'XRZW<7%VEK/?3M);Z%X@O)+.QM[*UN+BXOKE(;6VAA>6XFC12U95,%E5
M&3A4I<O)0KXF;<JW)3P^&4'6JU:G-R4H0=2G!2J2BIU:E*C#FJU(0E<,5CIQ
M<H5593A3BG[%2G5J<WLZ5*#2G6JR4)RC2I1G4<83GR\L)--\(_L??L7>.=/C
MU7P[\*-;DTZ>UMKVUO-6O_CIX8AO+2\:X6UN;!O$VKZ?]OAD6U>17MQ*/*EM
MYL^5=P/-TO)L'!>_A72<9<KA.56G5A+V=.HXSI3E&K3<8U8QDIPCR58U:$K5
MJ-:G3Q_M+$<[IPQ$:EHJ2G25*K1E%RE%.%>FI4:FL6_<J2]UQG\$X2EUO_#!
M'[)O_1*/_+Z^)7_S8U']E8#_ )\?^3U/_DROK^+_ .?O_DL/_D0_X8(_9-_Z
M)1_Y?7Q*_P#FQH_LK ?\^/\ R>I_\F'U_%_\_?\ R6'_ ,B8NO\ [%/[&GAB
MQBU+7/AI]ALIM3T;1HI_^$R^*ESNU+Q!JUGH>D6WEV?BJ60>?JFH6D/F%1''
MYV^5DC5G4CE. G5H4(X>]7$2E"G'GJ>]*%.I6DKN=E:G2G*\FE[MD^9I/2&+
MQ]2->4*EXX:C5Q%1\M-<M*A"52K/5*_+"+?+&\I6M&+=D/N_V)?V-['5](T&
MZ^&?E:MKL6I3:3:?\)G\4W^U1:1';RZBWGQ^*VA@\F.Z@.)I(R_F8C#%2!$<
MNRV5:6&C1O6A1EB''GJZ485:-"4[N7+I5KTH\J?,^;F47&,FH>-QL:2K.K:G
M*M"@GRP_BU*5>M"%N6^M/#5I<UN5<EFU*4%+7_X8(_9-_P"B4?\ E]?$K_YL
M:O\ LK ?\^/_ ">I_P#)B^OXO_G[_P"2P_\ D0_X8(_9-_Z)1_Y?7Q*_^;&C
M^RL!_P ^/_)ZG_R8?7\7_P _?_)8?_(A_P ,$?LF_P#1*/\ R^OB5_\ -C1_
M96 _Y\?^3U/_ ),/K^+_ .?O_DL/_D0_X8(_9-_Z)1_Y?7Q*_P#FQH_LK ?\
M^/\ R>I_\F'U_%_\_?\ R6'_ ,B'_#!'[)O_ $2C_P OKXE?_-C1_96 _P"?
M'_D]3_Y,/K^+_P"?O_DL/_D0_P"&"/V3?^B4?^7U\2O_ )L:/[*P'_/C_P G
MJ?\ R8?7\7_S]_\ )8?_ "(?\,$?LF_]$H_\OKXE?_-C1_96 _Y\?^3U/_DP
M^OXO_G[_ .2P_P#D0_X8(_9-_P"B4?\ E]?$K_YL:/[*P'_/C_R>I_\ )A]?
MQ?\ S]_\EA_\B'_#!'[)O_1*/_+Z^)7_ ,V-']E8#_GQ_P"3U/\ Y,/K^+_Y
M^_\ DL/_ )$/^&"/V3?^B4?^7U\2O_FQH_LK ?\ /C_R>I_\F'U_%_\ /W_R
M6'_R(?\ #!'[)O\ T2C_ ,OKXE?_ #8T?V5@/^?'_D]3_P"3#Z_B_P#G[_Y+
M#_Y$/^&"/V3?^B4?^7U\2O\ YL:/[*P'_/C_ ,GJ?_)A]?Q?_/W_ ,EA_P#(
MA_PP1^R;_P!$H_\ +Z^)7_S8T?V5@/\ GQ_Y/4_^3#Z_B_\ G[_Y+#_Y$/\
MA@C]DW_HE'_E]?$K_P";&C^RL!_SX_\ )ZG_ ,F'U_%_\_?_ "6'_P B'_#!
M'[)O_1*/_+Z^)7_S8T?V5@/^?'_D]3_Y,/K^+_Y^_P#DL/\ Y$/^&"/V3?\
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M .?O_DL/_D0_X8(_9-_Z)1_Y?7Q*_P#FQH_LK ?\^/\ R>I_\F'U_%_\_?\
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MSX_\GJ?_ "8?7\7_ ,_?_)8?_(A_PP1^R;_T2C_R^OB5_P#-C1_96 _Y\?\
MD]3_ .3#Z_B_^?O_ )+#_P"1#_A@C]DW_HE'_E]?$K_YL:/[*P'_ #X_\GJ?
M_)A]?Q?_ #]_\EA_\B'_  P1^R;_ -$H_P#+Z^)7_P V-']E8#_GQ_Y/4_\
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M#_GQ_P"3U/\ Y,/K^+_Y^_\ DL/_ )$/^&"/V3?^B4?^7U\2O_FQH_LK ?\
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MA*4XSIX?GE)13E7ITE2JR7)R1E&484Y.I*C1JSJ.JZD)6C5J>[5!04 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M\ E_D'_#0WP!_P"BX_!__P .9X+_ /EW1];PG_052_\ !D/\P^KXC_GQ4_\
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M ?\ HN/P?_\ #F>"_P#Y=T?6\)_T%4O_  9#_,/J^(_Y\5/_  "7^0?\-#?
M'_HN/P?_ /#F>"__ )=T?6\)_P!!5+_P9#_,/J^(_P"?%3_P"7^0?\-#? '_
M *+C\'__  YG@O\ ^7='UO"?]!5+_P &0_S#ZOB/^?%3_P  E_D'_#0WP!_Z
M+C\'_P#PYG@O_P"7='UO"?\ 052_\&0_S#ZOB/\ GQ4_\ E_D'_#0WP!_P"B
MX_!__P .9X+_ /EW1];PG_052_\ !D/\P^KXC_GQ4_\  )?Y!_PT-\ ?^BX_
M!_\ \.9X+_\ EW1];PG_ $%4O_!D/\P^KXC_ )\5/_ )?Y!_PT-\ ?\ HN/P
M?_\ #F>"_P#Y=T?6\)_T%4O_  9#_,/J^(_Y\5/_  "7^0?\-#? '_HN/P?_
M /#F>"__ )=T?6\)_P!!5+_P9#_,/J^(_P"?%3_P"7^0?\-#? '_ *+C\'__
M  YG@O\ ^7='UO"?]!5+_P &0_S#ZOB/^?%3_P  E_D'_#0WP!_Z+C\'_P#P
MYG@O_P"7='UO"?\ 052_\&0_S#ZOB/\ GQ4_\ E_D'_#0WP!_P"BX_!__P .
M9X+_ /EW1];PG_052_\ !D/\P^KXC_GQ4_\  )?Y!_PT-\ ?^BX_!_\ \.9X
M+_\ EW1];PG_ $%4O_!D/\P^KXC_ )\5/_ )?Y!_PT-\ ?\ HN/P?_\ #F>"
M_P#Y=T?6\)_T%4O_  9#_,/J^(_Y\5/_  "7^0?\-#? '_HN/P?_ /#F>"__
M )=T?6\)_P!!5+_P9#_,/J^(_P"?%3_P"7^0?\-#? '_ *+C\'__  YG@O\
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M]!5+_P &0_S#ZOB/^?%3_P  E_D'_#0WP!_Z+C\'_P#PYG@O_P"7='UO"?\
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M^?%3_P  E_D'_#0WP!_Z+C\'_P#PYG@O_P"7='UO"?\ 052_\&0_S#ZOB/\
MGQ4_\ E_D'_#0WP!_P"BX_!__P .9X+_ /EW1];PG_052_\ !D/\P^KXC_GQ
M4_\  )?Y!_PT-\ ?^BX_!_\ \.9X+_\ EW1];PG_ $%4O_!D/\P^KXC_ )\5
M/_ )?Y!_PT-\ ?\ HN/P?_\ #F>"_P#Y=T?6\)_T%4O_  9#_,/J^(_Y\5/_
M  "7^0?\-#? '_HN/P?_ /#F>"__ )=T?6\)_P!!5+_P9#_,/J^(_P"?%3_P
M"7^0?\-#? '_ *+C\'__  YG@O\ ^7='UO"?]!5+_P &0_S#ZOB/^?%3_P
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M^BX_!_\ \.9X+_\ EW1];PG_ $%4O_!D/\P^KXC_ )\5/_ )?Y!_PT-\ ?\
MHN/P?_\ #F>"_P#Y=T?6\)_T%4O_  9#_,/J^(_Y\5/_  "7^0?\-#? '_HN
M/P?_ /#F>"__ )=T?6\)_P!!5+_P9#_,/J^(_P"?%3_P"7^0?\-#? '_ *+C
M\'__  YG@O\ ^7='UO"?]!5+_P &0_S#ZOB/^?%3_P  E_D'_#0WP!_Z+C\'
M_P#PYG@O_P"7='UO"?\ 052_\&0_S#ZOB/\ GQ4_\ E_D'_#0WP!_P"BX_!_
M_P .9X+_ /EW1];PG_052_\ !D/\P^KXC_GQ4_\  )?Y!_PT-\ ?^BX_!_\
M\.9X+_\ EW1];PG_ $%4O_!D/\P^KXC_ )\5/_ )?Y!_PT-\ ?\ HN/P?_\
M#F>"_P#Y=T?6\)_T%4O_  9#_,/J^(_Y\5/_  "7^0?\-#? '_HN/P?_ /#F
M>"__ )=T?6\)_P!!5+_P9#_,/J^(_P"?%3_P"7^0?\-#? '_ *+C\'__  YG
M@O\ ^7='UO"?]!5+_P &0_S#ZOB/^?%3_P  E_D'_#0WP!_Z+C\'_P#PYG@O
M_P"7='UO"?\ 052_\&0_S#ZOB/\ GQ4_\ E_D'_#0WP!_P"BX_!__P .9X+_
M /EW1];PG_052_\ !D/\P^KXC_GQ4_\  )?Y!_PT-\ ?^BX_!_\ \.9X+_\
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M/_"<_98_^AIH /\ A3?Q%_Z.Q_: _P#"<_98_P#H:: #_A3?Q%_Z.Q_: _\
M"<_98_\ H:: #_A3?Q%_Z.Q_: _\)S]EC_Z&F@ _X4W\1?\ H[']H#_PG/V6
M/_H:: #_ (4W\1?^CL?V@/\ PG/V6/\ Z&F@ _X4W\1?^CL?V@/_  G/V6/_
M *&F@ _X4W\1?^CL?V@/_"<_98_^AIH /^%-_$7_ *.Q_: _\)S]EC_Z&F@
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MW).$K<LDW4HR@J3E%QC7]I[-M-*I[)P57D;^+V;J4U4Y;\CJ04K<T;Z-(D*
M/.-<^,7PB\,S:7;>)/BG\./#UQK>IWVBZ+!KGCCPSI,VKZSI>HMH^IZ3I<5_
MJD37^IVFK(]E/:P"26&X1H)$64%:=-.M6I8>BO:UZ].-:G2A[U2I1FN:%6$(
MWE*G..L9Q3C):IM%U*=2A3JU:L)4:5!QC4G.+A"G*=)5H1G*22@Y46JL5)IR
MI-5%>#3.[AU#3[BZN;&WOK.>]LXK6>[LX;F&2ZM8+X3&QFN;=',D$5P+>X,3
MNJB3R)-A.QL%G:4K/EC.5)OHJD(PG*FWLIQA5I3E!^]&-2$FDIQ;S4H^ZDU[
MT5.*OO"3E&,UWC*4)Q4EHW&23O%V5[^QBO8-,DO;2/4;JVN;RUT][F%+VXM+
M.2VBN[J"T9Q+-;02WEHDDJ(51KJ%6(,BADE?GY=?9J+E;[*FY*#E;X5)QDHW
MM=QDE>S&URQC)KEC*7)%O1.?*Y\B>SER1E+E6O+%NUDV6Z /G_XZ:AXO&K?
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M/_"<_98_^AIH /\ A3?Q%_Z.Q_: _P#"<_98_P#H:: #_A3?Q%_Z.Q_: _\
M"<_98_\ H:: #_A3?Q%_Z.Q_: _\)S]EC_Z&F@ _X4W\1?\ H[']H#_PG/V6
M/_H:: #_ (4W\1?^CL?V@/\ PG/V6/\ Z&F@ _X4W\1?^CL?V@/_  G/V6/_
M *&F@ _X4W\1?^CL?V@/_"<_98_^AIH /^%-_$7_ *.Q_: _\)S]EC_Z&F@
M_P"%-_$7_H[']H#_ ,)S]EC_ .AIH /@7J'B_P#M;X[>$O%OCKQ!\1/^%=?&
M#3O"WA[Q#XITWP3IFN_V%J?P.^"_C][&^3P!X1\-Z5<^3X@\;:\8IAI<<WDS
M112R2>2K4 ?0% !0 4 % 'S_ .(_^3I_@W_V0#]I;_U8O[)U 'T!0 4 ?/\
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M^59-3J5W2C3CS8?#QPV)^LT,-4G2I8F%2FW4INHZLDW4HSG2J>TE\K^%+_\
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MZF(I8V&8XB/Z;UYQV'S_ /LG?\FL?LT_]D ^#?\ ZKKPY0!] 4 % !0 4 %
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M%TG"4:ZK1?I'QD_Y*+^R=_V<!XC_ /66/VEJX3M/H"@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@#Y_^#?_ "47]K'_ +. \.?^LL?LTT ?0% !
M0 4 % 'S_P"(_P#DZ?X-_P#9 /VEO_5B_LG4 ?0% !0!\_\ [-/_ "3KQ'_V
M<!^UC_ZU/\9* /H"@ H * "@ H * "@ H * "@ H * "@ H ^?\ ]D[_ )-8
M_9I_[(!\&_\ U77AR@#Z H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * /G_ ,1_\G3_  ;_ .R ?M+?^K%_9.H ^@* "@ H
M * "@ H * "@ H * "@ H * "@ H * "@#Y_^,G_ "47]D[_ +. \1_^LL?M
M+4 ?0% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'S_ /!O_DHO
M[6/_ &<!X<_]98_9IH ^@* "@ H * /G_P 1_P#)T_P;_P"R ?M+?^K%_9.H
M ^@* "@#Y_\ V:?^2=>(_P#LX#]K'_UJ?XR4 ?0% !0 4 % !0 4 % !0 4
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M94 '_"C/C%_T3[_SJ/\ MU__ #LJ #_A1GQB_P"B??\ G4?]NO\ ^=E0 ?\
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MP?!?PW;^#/\ A+_$WB3XP3Z=X+?_ (73\1_@)_PBVNV/P:^,'B&_\1_\)_\
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M (49\8O^B??^=1_VZ_\ YV5 !_PHSXQ?]$^_\ZC_ +=?_P [*@ _X49\8O\
MHGW_ )U'_;K_ /G94 '_  HSXQ?]$^_\ZC_MU_\ SLJ #_A1GQB_Z)]_YU'_
M &Z__G94 '_"C/C%_P!$^_\ .H_[=?\ \[*@ _X49\8O^B??^=1_VZ__ )V5
M !_PHSXQ?]$^_P#.H_[=?_SLJ #_ (49\8O^B??^=1_VZ_\ YV5 'L'[,5G%
MH\'QH\-W'@S_ (0_Q-X:^,$&G>,W_P"%T_$?X]_\)3KM[\&O@_XAT_Q'_P )
M_P#%72--\02[/!^M^%M%^P36B0VW_"-8@9DDR0#Z?H * "@ H ^?_$?_ "=/
M\&_^R ?M+?\ JQ?V3J /H"@ H ^?_P!FG_DG7B/_ +. _:Q_]:G^,E 'T!0
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MP'AS_P!98_9IH ^@* "@ H * /G_ ,1_\G3_  ;_ .R ?M+?^K%_9.H ^@*
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M_P FL?LT_P#9 /@W_P"JZ\.4 ?0% !0 4 % !0 4 % !0 4 % !0 4 % !0
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M * "@ H * "@ H ^?_@W_P E%_:Q_P"S@/#G_K+'[-- 'T!0 4 % !0!\_\
MB/\ Y.G^#?\ V0#]I;_U8O[)U 'T!0 4 ?/_ .S3_P DZ\1_]G ?M8_^M3_&
M2@#Z H * "@ H * "@ H * "@ H * "@ H * /S ^$_Q3\<>$_A9\-/"W@7X
MM_\ "2^"?#/P_P#!N@>#O$?_  [*_;:UG^W_  KHWAW3=.\/:U_:^C_$:&PU
M7[=I%M9W7VRQBBMI_/\ -@18G50;?(-OD>@?\+S^,7_10?\ SEQ^W7_\\V@
M_P"%Y_&+_HH/_G+C]NO_ .>;0 ?\+S^,7_10?_.7'[=?_P \V@ _X7G\8O\
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MNO\ ^>;0 ?\ "\_C%_T4'_SEQ^W7_P#/-H /^%Y_&+_HH/\ YRX_;K_^>;0
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MIJG7Y(X14Y87VTZ#DYU.7$8BKA\36I^RO#!976QN*P]XO%T*F!S'-\)F?/\
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M_P"2B_LG?]G >(__ %EC]I:J ^@* "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * /G_X-_P#)1?VL?^S@/#G_ *RQ^S30!] 4 % !0 4 ?/\ XC_Y
M.G^#?_9 /VEO_5B_LG4 ?0% !0!\_P#[-/\ R3KQ'_V<!^UC_P"M3_&2@#Z
MH * "@ H * "@ H * V\K'@\'P$TVQUR:ZTCXB?$_0O!MUXCN/%M[\*M&UGP
M]8>!KS7[W5)=:U*X:]C\+'Q;9Z9?:O-)=7>B67BBUTBY:6:.:P>&YN(IWAG]
M6IT*4TL73P=-T<+'$?O(X:ER\E*G%+E5:&&@W#"PQ?UF.&C[-45!8?#>Q6(7
MMYUZD7]6GB[?6948Q3Q#Y/9SG+GC/V-:LE&5?$87ZOB*M1.M.JZM6M.ISP_9
M6\ 31ZEI6K:_XYUWP;+IGC;2O#?@#5=5T;_A%_ 5O\0['4--\6/X4ET_P]:Z
MU+-<V6JZE# =<UC6ETZ*]F@TU;2!S$<X1E2PL:%.K.%>CA,-@:.+C+EQ-#"8
M.M@Z^$HTW%*C>A5R_ SC7J4)XFH\+25>M57,I;TZSHX_#8^E",*F'S&6;NG9
MSIU<QG'$QJ8FI[1SJ1=3Z[BY2HT:E+#*>(G*-&,HTW"WX=_9J\/:)JUGXAU3
MQ[\2?&GB"TU?P)K#:SXKO_"+75U+\.;+Q1IWARUGM_#O@S2;.*S%EXKOH[A;
M:UMY)VM;>=I!</=37G4Z[]K3K1IPA.GBLQQLK*5JF(S3*Z&4XJ<DY-1BZ&'A
M5I4Z7LZ=*NY*$5AU##P\Y8*E&-2G%RC3E@\!@(1NK4L+EN:K.,+"#:<Y26)O
M3J5*TJM2I0DXN7M;55FZA^RCX%OHM8MD\4^/M/M?$5A\4=+U^VLK[PLT6JV/
MQ5\;7'C_ %:"=K[PC<R6ITOQ%<ROILEF]M(D1\J^:_7DK#5I82K@ZL(QE]0C
MP\J<)WY7/AC$RQ.6UI<KC)U)>TKT<3%2C2JT:\^6E3K0H5J/5FT8YN\3/$+V
M57$T<=AI5*5U*.'S'*,+D^+HQ4_:04:E' X/$J4H2JPQ6'BX5%AZE?#5=C4?
M@U>>(?VC?#?QAUBWT6ST3X?^"+[0?#*:?K.K76M>)=?U=I81JWBG19=(M=-T
MV'PYI=_XEL]*>&\U6>3_ (3359"UDN8;E8"H\''/*K;6(S18?#PA%MT:>&I3
M]MB*[<FFL5BZD,)0E&%-1AAL%'GKUW6C3PJQ2E6PV2X&G-_5,NJU\35YG.,Y
M59PI4:.'C&$_9U,-%4HXNK*M'F^MTL*Z-.E["56O]$5D4?/_ .R=_P FL?LT
M_P#9 /@W_P"JZ\.4 ?0% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0!\_\ B/\ Y.G^#?\ V0#]I;_U8O[)U 'T!0 4 % !
M0 4I*Z<=DTU^@;?(\3N/@5X:;P)X=\#:?KWBS0Y/!WB&[\5^$/&.F76AGQ;X
M<\17E]K=Y)J5B^I>'[O1[O\ =>(=6LC;:AH][:RVEV\5Q!-DL9C&=/\ LSV-
M6=">58'#9=3E'E;J83#8&CEWLZ\9QG3J>VH4*<JK4(\M=1KX?V%2G2=,IJ-.
M&:TG'VE+.,5BL97A)R25;$YE+-KTW3E"<8T,8XSH)RD^2G&G6=:+J<_/:I^S
M/X5UZ'2I=?\ &GQ,USQ!HVAWNEV7C#4_$6FW'B6'5KGQKH'Q MO%L,PT%;*S
MUO3_ !-X:TR6RL;2QM]#M[='L5T@V16!.A5ITIUJF#2P%2I]0Y)4ESRHK+Z&
M:X:*3Q/UAUOK.'SC&T<8\9]9E6A*"YH<KYLYTH5ZU&KBXK%PI1Q].5&I&,*-
M2GCUE\:D'"@J/LO8_P!F86>&J85T*U.NIXEU)XF7MEB:]^SUXJU#6_A]>V'Q
MK^)T<_ANX\>W_B'QY>:SX6G\?7EUXJTS0M-M+/1](F^'UQX+L-#6#27CETZT
M\.Z;;0EA>6T/]HN]T,(Q@\5.<Z<8X/\ LJK@'1@ZG-B)U<RPF-J/$U93>(Y9
MQI5TJM#$4J^'O1H81X?#0C"GIK'#J',Z]=YEAL8I5;*%&GA\MS3!05"G15.D
MZE.IC,/)1K4JE/$1C7GC'B*DK5>DM/V:/AWIVBZ[X>TRX\36&E:]H'PW\.W$
M":K;W<UM9?"_5[[6]$N(+W4].NKF?4;R_P!0N7U"YO9KMKC=N3R9"SMT2K2;
MPMH0IPP>;4<XHTX0C3ITZV'P^5X6AAHTX*,8X*E0RC"PA2BHU(IU$JMG!4^>
M6'C.MCL34J3G7S'+,9E>(F^5.=/'U<TKXK$VC%1CBJE;-\74YHI4(R5)+#J,
M91GFR_LM^"+BZOX[CQ/X]G\+R7OCG6/#_@.75- ;PKX*\1_$?3?$.F>+?$?A
MIO\ A&?[9DU"Y@\5^(W@MM9U?5].L7U><V-C;KM1.25+GP%? 5*DYPJ9?#*:
M=5\JJX?+:<L.X82BXQ5-QBL)AJ:K5Z=;%*C1C15=4I5(3]"&)G1QU''45&A*
M.,HX_$4:5X4,;C*%15:=?%PBU*7[V*K5*-&='#UL2HXNM1J8N,:\='7/V;O!
M^L:K;>(;?Q%XUT#Q/I?AOX?^'O#GB31;WP\-2\,2?#<^+TT+7=)AU;PU?6-Q
MJ]Q:>.-?L[Z+4[/4=/N;>X6(V"#>9.ZMB\15K8G$0J?5ZV+Q^)Q]25-*SEC,
M+2PF(PSA452$L+4I4(-1G&56G54:U.M"K3I2IX4+4,JP&3<OM,%E^&GAH*3D
MISBZV7XB%2I.G*F_:T:^686I3=/V<+JI&I"I3FX+L+SX3:;JOPH\1_"77_%7
MC?Q'I_BWP_XD\/Z_XKUW6+.^\97J>*H;V'5;^.[.E+I>G7"B_F-K9V6DVVFV
M:I%!:V$5M"D"YSJQ=;!5:=&%!8"K@ZU*G#G<>;!5Z6(I*I.K.I6K<]2E'VLZ
MM65::<E[5/E<>C 8NM@,;3Q].2K5Z=554JD8JG=14(P5.BJ,(0C&,5:FHN4N
M:I4<ZLZE2?)>+?V=/#'BC7SXMM_%?CGPIXL@N? U[H_B/PU=^&/MWA^\\!:9
MXMT2PN--M?$/A35M/G-_HOC?Q#8W\6I65_#)%=(8([:6,24X5ZE.I4G"3BJ^
M,QV+K03:C6CF.$R_!XG"U+-26&<,KPE6FZ<J>)I8B+JT\3%J"AY]'#PH4Y4H
MMR@\MP.66D]J679C5S3"UURJ-\1'%57S7O0J4HQISH.+J<^7:_LL> +3PUKO
MA8:YXWGLO$/@O6_ VH7EUJND7&IG3-?\:ZYX\OKU+I] PVK_ -LZ_>QK/-'*
MGD)$KQ/*'FDFA5>&K8.M2C&+P-3AJI2C9\G_ !BL5#+HM7NXU8I+%VDG4_Y<
MRPY%7"0K8?%X>I.;6-7$7M9>ZIM\3JBLQDK14(NFZ,985*'+2<I>TC6CRQCH
M>*/V;_"WB7Q3<>-8?%_Q#\+^)G\71^-K/5/"VMZ1I\FEZ]!\.8_AE;O;07?A
MZ[AO=/30XUN6L-3CO[6>[R;F*>T)M*SH.6&4E2DTIT\?2DF])4\QQ67XO$QD
MOA?O9=1A2;7-1C.I5IN.*AAL1A^NOR8F&74J]*-2GE<<'&G%IKF6!GFU2CSS
MBU5A*4LXQ/M98>="4X4Z-)M498FGB*T'[,OA72'TT^#?&OQ,^'\<>B6'AWQ0
MG@_Q#I-I<?$#3-/U?5=>B/BC5M3\/7^J:?JSZOK_ (@N9-8\,WWA[4I&UNZ4
MW>P1+!M2KRHUJ;C&+P5">&J4L#)-X2G/!X7#8+#-*_MY0IX3!X3#SH5*\\/B
M:6&I0QE'$+GY\9THSHU(Z0Q=6>,G/&QA3CBG]?Q%3%8R+M#ZO:KB*M6M3E]7
MY\'4J5)8&>%<Y-^P>#_!>E^"8=?@TJXU"=/$?BS7_&-Z=1F@G>'4_$5T+N]@
MM6@M8=MBDB@1)+YLH'WY9#S6%**HX3"8./\ "P4:T8-VYFJ^+Q.-GS62C=5<
M54C'EC%*G&":<DY2TDE+$8C$:\^)^K<RNVE]4P.$R^G9R;E>5'!TI3<I2<JL
MJDDXQ<81\N^,G_)1?V3O^S@/$?\ ZRQ^TM3&?0% !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % 'S_P#!O_DHO[6/_9P'AS_UEC]FF@#Z H * "@
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ML?V6/^CEO@!_X>3X=?\ S1T '_#6/[+'_1RWP _\/)\.O_FCH /^&L?V6/\
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M !_PVI_U.7[ '_B?7_Y.- !_PVI_U.7[ '_B?7_Y.- !_P -J?\ 4Y?L ?\
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MZ.%FD\3'(ZN42BHIT7)SQE6G7YFU.2Y\59P=.+ISIPQ$95&O8/[$K(D* "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MT/\ Y(/^%C6?_0@?'_\ \1A_:/\ _G5T?VK@/^?_ /Y)4_\ D _L_%_\^O\
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MGXO_ )]?^30_^2#_ (6-9_\ 0@?'_P#\1A_:/_\ G5T?VK@/^?\ _P"25/\
MY /[/Q?_ #Z_\FA_\D'_  L:S_Z$#X__ /B,/[1__P ZNC^U<!_S_P#_ "2I
M_P#(!_9^+_Y]?^30_P#D@_X6-9_]"!\?_P#Q&']H_P#^=71_:N _Y_\ _DE3
M_P"0#^S\7_SZ_P#)H?\ R0?\+&L_^A ^/_\ XC#^T?\ _.KH_M7 ?\__ /R2
MI_\ (!_9^+_Y]?\ DT/_ )(/^%C6?_0@?'__ ,1A_:/_ /G5T?VK@/\ G_\
M^25/_D _L_%_\^O_ ":'_P D'_"QK/\ Z$#X_P#_ (C#^T?_ /.KH_M7 ?\
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MZNC^U<!_S_\ _)*G_P @']GXO_GU_P"30_\ D@_X6-9_]"!\?_\ Q&']H_\
M^=71_:N _P"?_P#Y)4_^0#^S\7_SZ_\ )H?_ "0?\+&L_P#H0/C_ /\ B,/[
M1_\ \ZNC^U<!_P __P#R2I_\@']GXO\ Y]?^30_^2#_A8UG_ -"!\?\ _P 1
MA_:/_P#G5T?VK@/^?_\ Y)4_^0#^S\7_ ,^O_)H?_)!_PL:S_P"A ^/_ /XC
M#^T?_P#.KH_M7 ?\_P#_ ,DJ?_(!_9^+_P"?7_DT/_D@_P"%C6?_ $('Q_\
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MH?\ R0?\+&L_^A ^/_\ XC#^T?\ _.KH_M7 ?\__ /R2I_\ (!_9^+_Y]?\
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M?'__ ,1A_:/_ /G5T?VK@/\ G_\ ^25/_D _L_%_\^O_ ":'_P D'_"QK/\
MZ$#X_P#_ (C#^T?_ /.KH_M7 ?\ /_\ \DJ?_(!_9^+_ .?7_DT/_D@_X6-9
M_P#0@?'_ /\ $8?VC_\ YU=']JX#_G__ .25/_D _L_%_P#/K_R:'_R0?\+&
ML_\ H0/C_P#^(P_M'_\ SJZ/[5P'_/\ _P#)*G_R ?V?B_\ GU_Y-#_Y(/\
MA8UG_P!"!\?_ /Q&']H__P"=71_:N _Y_P#_ ))4_P#D _L_%_\ /K_R:'_R
M0?\ "QK/_H0/C_\ ^(P_M'__ #JZ/[5P'_/_ /\ )*G_ ,@']GXO_GU_Y-#_
M .2#_A8UG_T('Q__ /$8?VC_ /YU=']JX#_G_P#^25/_ ) /[/Q?_/K_ ,FA
M_P#)!_PL:S_Z$#X__P#B,/[1_P#\ZNC^U<!_S_\ _)*G_P @']GXO_GU_P"3
M0_\ D@_X6-9_]"!\?_\ Q&']H_\ ^=71_:N _P"?_P#Y)4_^0#^S\7_SZ_\
M)H?_ "0?\+&L_P#H0/C_ /\ B,/[1_\ \ZNC^U<!_P __P#R2I_\@']GXO\
MY]?^30_^2#_A8UG_ -"!\?\ _P 1A_:/_P#G5T?VK@/^?_\ Y)4_^0#^S\7_
M ,^O_)H?_)!_PL:S_P"A ^/_ /XC#^T?_P#.KH_M7 ?\_P#_ ,DJ?_(!_9^+
M_P"?7_DT/_D@_P"%C6?_ $('Q_\ _$8?VC__ )U=']JX#_G_ /\ DE3_ .0#
M^S\7_P ^O_)H?_)!_P +&L_^A ^/_P#XC#^T?_\ .KH_M7 ?\_\ _P DJ?\
MR ?V?B_^?7_DT/\ Y(/^%C6?_0@?'_\ \1A_:/\ _G5T?VK@/^?_ /Y)4_\
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M?_9 /VEO_5B_LG4 ?0% !0!\_P#[-/\ R3KQ'_V<!^UC_P"M3_&2@#Z H *
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MT/P_^T')I0\8>*-1^-Z^/?#WBW]F:TTO28M=\31Z)-H>KZEX2TWXHSZQX/\
M#5P/#'B>;_A';W5#KLTEG?V6GW5K=WEM]DFA>X.N6JC#,:+Q7L']8S+,Z.,L
MZCP<:*X<P<U]46)=Z."_MF-9X#$)0J\]Z4*OOU*<O3G&C6_M6E3E*."HY+CL
M1E[NZ==XJAF_$E3*XU*CMB)XR6 CE<*^%K2E/$4YT(8JC4?L>7ZN_:Q_Y-8_
M:6_[(!\9/_5=>(ZX"#Z H * "@ H * "@ H * "@#X _X)<?\F)_ S_NIO\
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MR4^WB!I4\X6$C.[RO%_V8\-S>T4EPM5Y_:>R?LU6_MSF]C[?_A5>-^J_V?\
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M?_$?_)T_P;_[(!^TM_ZL7]DZ@#Z H * /G_]FG_DG7B/_LX#]K'_ -:G^,E
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M3NB4 ??] !0 4 % 'S_\9/\ DHO[)W_9P'B/_P!98_:6H ^@* "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@#Y_P#$?_)T_P &_P#L@'[2W_JQ
M?V3J /H"@ H ^?\ ]FG_ ))UXC_[. _:Q_\ 6I_C)0!] 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 9^K:3I6O:5J>A:[IFGZSHFLZ?>:3K&C:M96VHZ
M5JNE:C;26>H:9J>GWD<EO?:?=6DTT$UO/&\<L<KHZLK$$ \/_P"&3OV6/^C:
M?@!_X9OX=?\ S.4 '_#)W[+'_1M/P _\,W\.O_F<H /^&3OV6/\ HVGX ?\
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M']"T[[;>7&HWGV'2-)MK>TL_/U"[N[J7RHD\R:YEE?+R,Q-O(-O(Z"@ H *
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M +-/_).O$?\ V<!^UC_ZU/\ &2@#Z H * "@ H * "@ H * "@ H * "@ H
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M56HG3Q'M8232DFHQ4?;*P*"@ H * "@ H * "@ H * "@ H * "@ H * "@
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MX_\ )Z?_ ,F'U_"?\_?_ "6?_P B'_#6=Y_T;5\?_P#P8?LX?_1#4?V5C_\
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M^RL?_P ^/_)Z?_R8?7\)_P _?_)9_P#R(?\ #6=Y_P!&U?'_ /\ !A^SA_\
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M</\ Z(:C^RL?_P ^/_)Z?_R8?7\)_P _?_)9_P#R(?\ #6=Y_P!&U?'_ /\
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MP_9P_P#HAJ/[*Q__ #X_\GI__)A]?PG_ #]_\EG_ /(A_P -9WG_ $;5\?\
M_P &'[.'_P!$-1_96/\ ^?'_ )/3_P#DP^OX3_G[_P"2S_\ D0_X:SO/^C:O
MC_\ ^##]G#_Z(:C^RL?_ ,^/_)Z?_P F'U_"?\_?_)9__(A_PUG>?]&U?'__
M ,&'[.'_ -$-1_96/_Y\?^3T_P#Y,/K^$_Y^_P#DL_\ Y$/^&L[S_HVKX_\
M_@P_9P_^B&H_LK'_ //C_P GI_\ R8?7\)_S]_\ )9__ "(?\-9WG_1M7Q__
M /!A^SA_]$-1_96/_P"?'_D]/_Y,/K^$_P"?O_DL_P#Y$/\ AK.\_P"C:OC_
M /\ @P_9P_\ HAJ/[*Q__/C_ ,GI_P#R8?7\)_S]_P#)9_\ R(?\-9WG_1M7
MQ_\ _!A^SA_]$-1_96/_ .?'_D]/_P"3#Z_A/^?O_DL__D0_X:SO/^C:OC__
M .##]G#_ .B&H_LK'_\ /C_R>G_\F'U_"?\ /W_R6?\ \B'_  UG>?\ 1M7Q
M_P#_  8?LX?_ $0U']E8_P#Y\?\ D]/_ .3#Z_A/^?O_ )+/_P"1#_AK.\_Z
M-J^/_P#X,/V</_HAJ/[*Q_\ SX_\GI__ "8?7\)_S]_\EG_\B'_#6=Y_T;5\
M?_\ P8?LX?\ T0U']E8__GQ_Y/3_ /DP^OX3_G[_ .2S_P#D0_X:SO/^C:OC
M_P#^##]G#_Z(:C^RL?\ \^/_ ">G_P#)A]?PG_/W_P EG_\ (A_PUG>?]&U?
M'_\ \&'[.'_T0U']E8__ )\?^3T__DP^OX3_ )^_^2S_ /D0_P"&L[S_ *-J
M^/\ _P"##]G#_P"B&H_LK'_\^/\ R>G_ /)A]?PG_/W_ ,EG_P#(A_PUG>?]
M&U?'_P#\&'[.'_T0U']E8_\ Y\?^3T__ ),/K^$_Y^_^2S_^1#_AK.\_Z-J^
M/_\ X,/V</\ Z(:C^RL?_P ^/_)Z?_R8?7\)_P _?_)9_P#R(?\ #6=Y_P!&
MU?'_ /\ !A^SA_\ 1#4?V5C_ /GQ_P"3T_\ Y,/K^$_Y^_\ DL__ )$/^&L[
MS_HVKX__ /@P_9P_^B&H_LK'_P#/C_R>G_\ )A]?PG_/W_R6?_R(?\-9WG_1
MM7Q__P#!A^SA_P#1#4?V5C_^?'_D]/\ ^3#Z_A/^?O\ Y+/_ .1#_AK.\_Z-
MJ^/_ /X,/V</_HAJ/[*Q_P#SX_\ )Z?_ ,F'U_"?\_?_ "6?_P B'_#6=Y_T
M;5\?_P#P8?LX?_1#4?V5C_\ GQ_Y/3_^3#Z_A/\ G[_Y+/\ ^1#_ (:SO/\
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M;I^9O2K4ZT7*E+FC%V;LUJDGLTGLT?>U8FH4 ?F+\./^//Q__P!E_P#VGO\
MUH_XJ5]CE7^X4/\ M_\ ].3/F\?_ +W5_P"W?_2(GH5>B<9\IZ?X[^)EGJGQ
M+\2Z]?V_]@>%_C)X7\$Z9X8T^[TC4+ >&-0.@Z5>S&67P1I.IVNI[O%EAJSO
M+K&I*TUC]CACA@B>34N7 3J/#9+4Q<DZF;8W,</.WO*ERXK%X+!JE*$:-HT\
M9@XTI>TI593H5:N)G4C.K2P^ VK*%3%9KAL,HTX95@*6)C-J<959PP5+,\0J
ML7.M%N>%=2G1E3E0C3JSA"=.:HRKXCZLKJ,3Y_\ COXA\9Z-)\,],\&7?C.W
MN/$WC._TK5(/A_;?#2?Q5?:=9^"_%&MK;Z;)\6()/#]NJ7NEVDTKS-%*T,$B
M0L9'5'XZCJRQ?LX?6)4Z>!Q>)E'#+#-\]+$Y?2A.I]87-*G&.(J1Y*%ZLJDZ
M;Y7",G'KI1I1P>)JS5)5(5L)3A*LZ_*E5G.,U%4/MR45RNHN2-G=H\T\/?';
MQ3X?\!PZSJ>F>*O&^H>(OB#JOA'P1I?B/3+<>.;6/1=,N;K78?B-I_P,\%>(
MHM,O+'4-'UQ(X]%\-WLRVYL/MD4;-<3Q*6+E]6ROV5*.(KXS#5<9S4UB72^I
MPJTJ=.=1TZ&(<<5>O2I5X*%/#1Q'-2]I2G%P=RPM&.(QJG5EAJ>"6'HU(3]E
MS2QM7GDH895*M'FPLZ/LJ\*E2I*I.FJU6BJU.6'C/KC\>_%]S8)?Z9\([U!I
MO@J\\<>*]/\ %6NZKX)UG3-.TO6]7TB^M=%T;7_!,=YJMY<1:/-?:=_:<.@1
MW5O-&;E]/=E5G5QE/#SQ56LO99=@J.75ZU6\9UZ4<PIXBHXSPU-SBJF#^KM8
MJ"Q$I?%[#VTXQA4G#X.5>>$PWM%'&8VOB\-023>&E4PWU'DFZ_NS5&O]>BHS
MCAY2ISARSIJ\W3T)OCW<@W&NVG@Q)_AY!XCA\&)XDD\2?9O$$WB:Y@A-OCPE
M_84D:>'#J%S;V#7YUC[6LKF0::ULOGG/$8R>%H5:U2@FG'-GAHQG_$ED\,PG
M75=N$?8*M_9>*^KRIK$W2INK&DY\L<*,:-94^6K*+7]ERK<T-(0S5X'V#I.,
MY.K.E#,<-.M&<:$5^]C3G4E!<_G&N?'3XJ*F@Z[-X5T'PUX6UWX-^*/B,MKI
M'CE=3\4P1VUUX.&D7'F:M\+)]-MM4A77T@>S(OK5EOKB9IG>QAAN_1C1KT<S
MQ>!Q?)'ZKCLAP:=*;G'VF89OB,'-34J5*4Z4Z-%NMR3I5*;@Z6'J.5=8S#<\
MJU&IDU/,,+=NK#'U$Y+D;AA<JJ8I\FLE!JJI2HRJ4Y\_)1E7HPC*MACN8OVA
MKVS:YU3Q#X'ATSP:FI_%71;+6K#Q2=7URXOOA0_B.;49;GPXWANR@M-/OM-\
M,WLD,J:M/,ERP@>V\G;=OQ_6*BPZJSP[5:MEL,RP]&$XR]I">)P>$]C.I+DC
M2J2K8_#ND_WE.5)SG5G0G#V3]&>!Y<;@L!1JNK4Q.+R_!RE.*IJ%3,,N_M"G
M-*,I\\*<8SIU6U3?,HRA&2DU#T#P'\0?$OB3Q'K'ACQ3X,T_PK?:9X7\,>++
M>73/%A\46MY8>*;WQ#:VUL[R>'=)>TOK5=!/VA?+EC\VX9(99HXEGF[(PFJ6
M+]KRPKX'%?5*D(-S@YJA3K.I2J2C3E*D^?DCSTJ=1N,G*G!<O-R2C#V&7XJB
MY2PV91Q,Z3G%0G&.'^JZ5(1G44:DEB5)QA.=.,5"U6<I3A2\K7]H/5M(C\-_
M:?"5U?:1J=]XB&J^*_$GB*#1+.UAT_XAZGX06PTO5[/P-;>'+O5;:"WBNS8Z
MUJ/AEOL;P+#=:G=">2N/"XEUJF4T9T_90QN!R6JJDI)5*E7,\)2J)TX25.EB
M/9UITXXE8:<:SG5OA<NY94J#J5%0P^9UX5.>I@\=FU%4DKQA2RZ<Y7G*/-4H
MQK4XSCA/:PJT[T9K&8VFH^WG:O/VC[[3-0\>6FJ> 5TM/"ECXJOM&MM2\33Z
M3X@UZ/PG?Z?9S33Z#K/A>S*:9J%KJ5M?V6I>';GQ7:?9F'VV6RG=(&O U_K<
M,+S15&MB,5EE!TDY.=&&8YA'+W*M"<*56E6PLY*52G.DL/5;C'#XRK&<*DJQ
MU!8.E7K0J*O2H4*]532M"K*CEU7'QC1JQ=2C*$_85:+O4CBJ<HN<L(XPJ^RW
M/'OQ[;P;J6K:%9>#K_7];M_$>A^&]%M;,>*-1BU&?5/"=QXON[R_MO!?@CQ)
MK-A9V=A:7$1-CHNKN[^6SK!"9)(.98Z<W5IT<.Y5:&)QE&2_?.*HX.EELYUG
M*AAZ\H2G/,Z5*$)PC3YH^]B(N<8FE/#4_9TZM6LJ5.I@\-B%_#YG5Q6+QV%I
MT(*K5HQERK SK3GSJ7LW)0I3G",:EOP#\8_$GCWQ-::#!\.+KPW!;>&=+\1^
M)Y_%NHZ[X<UG2EU36?&&@V]MI7A?5_!-O?:HDMYX4%S!-J/]AF6QU))WCAFC
M%K-Z5*+J1K5O@PU/V,8MN#K>VK83#XM4:M*$I0I2HJM*EB?WT_9U(05)5XSG
M*CE6H2P^'PM234JV)JXNFHQNZ/)@Y853JPK/EE.-2&*C*DO8Q?-"=.HZ;5RK
MX@^-FN:3\0-5\"1>"[6TAB26PT'7O$7B.[\.G7M:D\+7OB+3Y]*L]0\*G3M:
M\.M<64^FS2Z/K>JZM!<V\K2:']FC,Y\FMC*WU'-ZM*,*.)P>'QU6C";ESMX)
M0<I5:4J<9J%2G-XBA4H+%8>=./+7K8>?M(TNRE@J2JY?[2I*>'KU,(J\H1NH
M1Q&)6'E"$XR<%6I.5/FIXJ6$YO:)4)5I.DJO :-^T?XJTWPG\-K[Q/X3T35;
MS6?#/P_U/Q=>Z-XIU"ZO[9_'%Q':6%[IOA_2/ EPL $+Q7MX->N?#-E;FY%O
M9WNH>7YK>MBI0HYR\LC!1A]=I9=S*;J>SQ52E1E:<W3IT50C5KTJ2G4JT<74
M4E4AEZ=7#4J_G\G^RXS$J2<J%/&XJ--I03PV%J5[QBN:=:53DP]94^2E5HM4
MG*MBJ?)B98?NOA]\5_%VHZK+HOBW1-'$FH^-OC!I>CWND:Y/<+:Z/\.]42TM
M(;NTF\,V/^D2;VAWB:4D0"=FW3?9X/*H8Z:RZA5K4T\5')\7FE7EE[DG0S"G
MA8T8ODCRIJO93Y%:-&+<9SJS<.W&X2%#&5*=&3]A+%95A8*2]Z/UW)YYA*H]
M7?\ @J;I\SY:F)J4HS=/#0J5\KPI^T9?^(]:\#6=WX"3P]HGC/2/"-[#K&K>
M);FRD>^\7:))JUO!X<_M'PK::-XKLK2Y0:=.+?7[?5OM&?+T5XC')-Z2;698
MK+YQY'0G6ITFW:K4='"QQ7M'0ERR="I!5HTZN%EB^6=&3Q$*%-5:E&,PPL<#
M&LX5E7>&KUZ55J/+",:.93RU)S4IJ%=M4\3*C75&G["M!4<1B*[5&7U%5'&%
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0!XW\%_^4DM_P#]F/W7_J^=*KY;._\
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M $(7P _\/W\1?_H9:/[>_P"H7_RK_P#<P_LG_J(_\D_^W#_A67[4_P#T(7P
M_P##]_$7_P"AEH_M[_J%_P#*O_W,/[)_ZB/_ "3_ .W#_A67[4__ $(7P _\
M/W\1?_H9:/[>_P"H7_RK_P#<P_LG_J(_\D_^W#_A67[4_P#T(7P _P##]_$7
M_P"AEH_M[_J%_P#*O_W,/[)_ZB/_ "3_ .W#_A67[4__ $(7P _\/W\1?_H9
M:/[>_P"H7_RK_P#<P_LG_J(_\D_^W#_A67[4_P#T(7P _P##]_$7_P"AEH_M
M[_J%_P#*O_W,/[)_ZB/_ "3_ .W#_A67[4__ $(7P _\/W\1?_H9:/[>_P"H
M7_RK_P#<P_LG_J(_\D_^W#_A67[4_P#T(7P _P##]_$7_P"AEH_M[_J%_P#*
MO_W,/[)_ZB/_ "3_ .W#_A67[4__ $(7P _\/W\1?_H9:/[>_P"H7_RK_P#<
MP_LG_J(_\D_^W#_A67[4_P#T(7P _P##]_$7_P"AEH_M[_J%_P#*O_W,/[)_
MZB/_ "3_ .W#_A67[4__ $(7P _\/W\1?_H9:/[>_P"H7_RK_P#<P_LG_J(_
M\D_^W#_A67[4_P#T(7P _P##]_$7_P"AEH_M[_J%_P#*O_W,/[)_ZB/_ "3_
M .W#_A67[4__ $(7P _\/W\1?_H9:/[>_P"H7_RK_P#<P_LG_J(_\D_^W#_A
M67[4_P#T(7P _P##]_$7_P"AEH_M[_J%_P#*O_W,/[)_ZB/_ "3_ .W#_A67
M[4__ $(7P _\/W\1?_H9:/[>_P"H7_RK_P#<P_LG_J(_\D_^W#_A67[4_P#T
M(7P _P##]_$7_P"AEH_M[_J%_P#*O_W,/[)_ZB/_ "3_ .W#_A67[4__ $(7
MP _\/W\1?_H9:/[>_P"H7_RK_P#<P_LG_J(_\D_^W#_A67[4_P#T(7P _P##
M]_$7_P"AEH_M[_J%_P#*O_W,/[)_ZB/_ "3_ .W#_A67[4__ $(7P _\/W\1
M?_H9:/[>_P"H7_RK_P#<P_LG_J(_\D_^W#_A67[4_P#T(7P _P##]_$7_P"A
MEH_M[_J%_P#*O_W,/[)_ZB/_ "3_ .W#_A67[4__ $(7P _\/W\1?_H9:/[>
M_P"H7_RK_P#<P_LG_J(_\D_^W#_A67[4_P#T(7P _P##]_$7_P"AEH_M[_J%
M_P#*O_W,/[)_ZB/_ "3_ .W#_A67[4__ $(7P _\/W\1?_H9:/[>_P"H7_RK
M_P#<P_LG_J(_\D_^W#_A67[4_P#T(7P _P##]_$7_P"AEH_M[_J%_P#*O_W,
M/[)_ZB/_ "3_ .W#_A67[4__ $(7P _\/W\1?_H9:/[>_P"H7_RK_P#<P_LG
M_J(_\D_^W#_A67[4_P#T(7P _P##]_$7_P"AEH_M[_J%_P#*O_W,/[)_ZB/_
M "3_ .W#_A67[4__ $(7P _\/W\1?_H9:/[>_P"H7_RK_P#<P_LG_J(_\D_^
MW#_A67[4_P#T(7P _P##]_$7_P"AEH_M[_J%_P#*O_W,/[)_ZB/_ "3_ .W#
M_A67[4__ $(7P _\/W\1?_H9:/[>_P"H7_RK_P#<P_LG_J(_\D_^W#_A67[4
M_P#T(7P _P##]_$7_P"AEH_M[_J%_P#*O_W,/[)_ZB/_ "3_ .W#_A67[4__
M $(7P _\/W\1?_H9:/[>_P"H7_RK_P#<P_LG_J(_\D_^W#_A67[4_P#T(7P
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M>+<(X:*BD\3*I6^K4XX=S<(U93Q%Z$%&3YJR=*-ZGND4Y49U:M)XBG2>%O\
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M+Z=*MBU"49RPU5PHUZ=6C3HXBI6QT9/^SZ6*E&45]=5S;?(V"@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^?\
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M9.H ^@* "@#Y_P#V:?\ DG7B/_LX#]K'_P!:G^,E 'T!0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MOKTY.5+-,/\ 6L,U&5Y8?F<(UIQMS4(5)1G&BZZI>VE2K1H\[HU5#OZP-@H
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MC2JU(7:"BE8W\%^EP]O'>QBUO;NPD%]INHZ8[3V4S03/;QZE:P-=V3.I,5Y
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M3DN22B[7<(S5FFK2<DDY1O%37*^:FVIP7*Y1BIQ;OTA!0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % 'S_ .(_^3I_@W_V0#]I;_U8O[)U 'T!0 4 ?/\
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M'EN!PM"LZ>)R_+\LPJG3<Z*Q7U6&;_6\#B)PGS1P=;$YE'%PJJ%135&GA:F
MC[-8FIZ!\/?V>V\(_$/2/B)>6GA1=>%U\7+[7]9TP3-J\L/C'7M(7P3X3TR:
M31[?R?!^C^$=,BAELUDMHA?V5O.EM,\DMS7/A9K#4'3YZBE4R[#4*ZYG*.)Q
M];%RS/-,9B)2:E4E#,)UHY=.:E.&%QF*ARX9/V=3:O"%9WC0A05+,:5>A"$I
M>SH8+!Y54R;"TJ<'&T:F*PRPM?&QAR4X5\/&$98B$*4Z?(3_ ++<&M>,_%&M
M>(/ WPF;2M=^)WBKX@:N]F"]_P#$FWD\$W?A?P/H?Q!LAX#M4DTNQN-;UR>]
ML)M0URWFD+71\]M3N;:'@A2JTLHC@H*E[:A@<ZI4*5FL-#,,QS18G#X]J*2=
M2EE\JN#YGAY5*#]C[*525&G6AV3K3>.G7AB:T*->ODRJU$U]9A@,!@J2Q6#P
M\[\U*,LTP.7XRE*%6/MJ2JT:GL814*N)\-_V4?$WA7XK> O%?BW5-+\6^'?A
MYX'\):-X.N!K>F6>I^"=8\/^#M/\-:CI^@:6WPCDUN70M2O8]8O+AH/B)I%A
M<IJD45[X<N9;&*X/M_6Z:QF?XR/M57S+$XB=.M.3G4K8:LE2AA\4H2HQ4:5"
M,9JGB'F<%C8O&X=X6O5G-<6)A'$X7*Z2PU#"*E[^)PN'C[/"4*_U_$9CSX%2
M4U""J5*&$C&E1P-7ZEAH8>K7K8=_5H]#XM^!/CWQ+XX?5KKPI\)->TE_C5%\
M2%U3Q;XBO]:,.BZ?X7\'>'-/MI?ASJ/PDO=/N?$26.@7MO:7\'B73[G2)X[7
M4K6^N%N;O26\_!/ZLLMJU%_M.68?-X1=-N#G6QV8XW&8>5.NK5,'4A2E@*<\
M92C.I&%*OAO88BC+FGTXJ7UBGF&'G5J5<-BZ6 H4Z<N6$:%+#8;EJTIP7/#&
M866.KX[&3P=>*AB7B5:K@\11P^*H<MH_[/\ \:O#-M_:OA'1/@5X9\37.N?%
M+6O*&LZ[J+:5K'C+PS:Z1X<\5ZWXTTKX7:!?_%77M.N6\0V[?VQI.DW(T_Q!
M#'+JM]<:5YNIY/#TE@*>5PK5:6&EE-3+*DZ:C!PA6Q^#Q&(5+#J3HNM7P^"P
M\*F/O3G+%4%B*F$JNM51O*KA:V81Q^*PSKU*>:8#'>]4YW4IX;#9KAZM/FE!
MSHT8_P!HQGAL"YXBC14*]&A7PU"K0I83EK[]BOQ1=^(O$/VK5M(U;0V\ Z?X
M'\!:Q=>)X=,U;P-I$_@G2/AUXC\/Z?I=A\(9-=.C3Z"?$VH^6?B*^F76I:E;
MW$WA^&]C_M-/16)ISQ6-Q56C'GQV:TZ^(]V,OK.5_P!LQS*>#FH?5XP]EAJ.
M&P.'A66.=+V+JX;%8.%65 \^E4S&A3RZ=/%J6,R[ R=&K.$*DJ.=0PU6=/,W
M.O'$2K5JV:S>*Q6(I_4JE7"UIX3$TL;2HTX3^I?&7PJNK+1/AMX?^%7AGP78
M>'?!'BZ]\17OA.ZU:\\#Z7>Q2>%_%]K;-;:AH'A'79(]2;Q=KMAJEQ<&S262
M6.XO&G>X'EW/!BI5<77JU<1'V_\ PG8W"4/WLZ+P]2O1IX2C[%TX25*C# /%
MX*,::BL/2KP=&G-4E3>^#IX?"866&A[GM,1ETYSE2C7E*GA<?A<96JRYZL/:
M8GFPM*K%U>=8B5.5"K.C[;ZU1X;P[\$/&7AG]GK4OAOH6F_#WPSXKO\ 65U:
MYTKPWJ5UI'A_6[ ^(M-OM4T#Q/X^T#P#I&HZIJVM^&[&?1M0\8+X2AU"07OV
MJ6TN;B)I+G?$SA6_L>%6G#&8? *DJV'E".%PDXQG6J.%'"4O;4*5"E5J0Q$\
M'"-/!8VM2JTWA\'A,7+#4,L!".%J9M5DI4*F.ABU0K0JSKXJE5J8+ZOA\15Q
M53V5>O6HU4ITZU6I/$T*2I0EBL77P_UJM!X<_9UO]'^!GC3X66VB?#3P?/\
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M:6_]6+^R=0!] 4 % 'S_ /LT_P#).O$?_9P'[6/_ *U/\9* /H"@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MS1E%J4;K2]UK1JNA-R4(S4J=6G*,N;E<*U*=&:]R49+W)RLU)-.S/*HOV<=
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M^#G>-/,,'C,#4:TE&EC<+6PE64&TTJD:=:4J;E&45-1<H3BG%^(Z+^R=\--
M\3ZOXKT_4O&2ZCK'Q3U7XLRV\^KZ=<:?9:UJ_A/Q;X4NM#TRWDT4M8^%%7QQ
MXGU6.R23S5U+5)9C<M"S6[%->RRF63IMX:6"S+ 2G)N59T<RE@U.3F[KGPN'
MR_!X+!^[[.CA,/3I2IU''G.UXJ?UW%X_DA]8QE+)Z51\MH\N2XJ&+PS237OU
MJ\'/%R;;K.I4E'V<Y*2U?AK^SMIWP\G\$F[^)7Q*^(=A\,]%_L+X=:-XX'PX
MATWP?:G2%\/FXL/^$#^'/AFZU34?[!5K 76M76J.D,TWEE9)Y9).RKC:U?$X
M_'5K5,?F,)TJ^(?-&<J53$4,55I*G"4</"-7$8;#U9N-%3O1A&,XT^:$O-GA
M:+CAZ27)A\+B98RG15G!8ET\32C5<IJ59^SIXO$QA'VO)^^<I1E.%.4/H>N0
MZ H * /F#7[GX@>!OC[XW\:Z/\&/B!\3/#'B_P"#_P '/"UGJ7@76_A!9?V=
MKO@3QI\>=6UNQU2R^)'Q3\)W:YT_XA>')8)K2"\AD\RX1I$> J38-C?_ .%R
M?$7_ *-._: _\*/]EC_Z):@#H/V>O"VN^!O@%\#_  5XIL?[+\3>#_@_\-/"
MWB/3/M5G>_V=KOA_P7HNDZO8_;=.N+BTN_L^H6EQ%YUK/-#)Y>^*1T96)M\@
MV^1[!0!\^^-?V:OAWX^\'^,?!>OS^(_L/C'QW/\ $6;4K#4K2RUO0O$=S#96
MD[>'KZ/32EK8RZ?:36,MO=0W@GM-3OK:X,L-R4#P;E@:F0U<.W&?#N)EB<.W
M_P O7/-L1G$Z.)2M&K0EBL0UR)0<84L/.$HXFC#$+*M2C7I\0T9M^RXFPL<)
MBX)V2IPRS"973E1TO&I3I8*A7C*;J1^LJ3E&5"3H%.X_9OTV[UW7;RY^)_Q/
ME\'>)?&]M\0-<^%F[X;P^"=1U^TFTF[A6?4;?X;Q^,/[+^WZ'IET]DOBI8I6
MMC%*'MI98)#!-8*.#ARQQ7]F5,16P;K*_P!6K8C&XK,/:P5+V4:DZ.*QE>IA
MWB(UE3;IRM*I2I3@YTH-8[V:]@\RH4\-BG"TG6HT\NP^52B_:JHJ?ML#AJ="
MLZ*I.SG*FZ<YN1]'4C0* "@ H ^0/AOXB^*/PNTGQ3X2O/V;/C!XGQ\8/CWX
MIT_Q#X6\2?L[#0M8T+X@?''XA^/_  W?6*>)_CSHNJP>9X?\3:898;_2[*:*
M;S8FC_=AF-@V#XC^(OBC\4-)\+>$K+]FSXP>%_\ B\'P$\4ZAXA\4^)/V=O[
M"T?0OA_\<?AYX_\ $=]?)X8^/.M:K-Y7A_PQJ9BAL-+O9I9O*B6/]X64 ^OZ
M .0UOP5I.O\ B?P9XKO9K]-0\#RZ]-I5O!);+871\1:/)HE\NI12VDDDR):2
M,T0AF@Q)@N77Y#$*<(5L35<5/ZW@:V75(32</85L7@<9-\NGO^TR^C!-MP]G
M.K%P<I0E"*T%6AA:;;BL'C:>.IN+L_;4L)C\%%2;O^[]EF%:32Y9>TA2:FHQ
MG"?@MA^R9X1\,QVH^'OC[XF?#:YT[Q[XK\?Z5>^&[CP#K$NDW/B_0++PUJ/A
MO3[3X@_#_P 26,/A2WTG3[:&QLVM'ELTC2*"Y6"**&+2$JU.. C]8J2^H9?B
MLL4IN,YU\-B\UAG%1XB<HN<Z\<73I\M:,H5)TX?OW6J3J59JM1HXC%8_&U::
MEB,PS##9G.5Y)0QF&RVKE2J4XQDE:MAZ]:=:%15(>VJ.=)4HQIPA])Z%IUYI
M&CZ=IE_KVK>*+VQMHX+GQ#KL.A6^L:O*F=U[J,'AG1=(TJ*Y?^);#3+*'CY8
M5JZDXSFY0I1H*T5R0<W%6BHMWJ3G*\FG*5Y64I/E48VBG3C*G'EE4E5?-)\T
ME!-*4G)1]R,(\L$U".G,XQ3G*<^:<M:LRPH * /D#X;^(OBC\+M)\4^$KS]F
MSXP>)\?&#X]^*=/\0^%O$G[.PT+6-"^('QQ^(?C_ ,-WUBGB?X\Z+JL'F>'_
M !-IAEAO]+LIHIO-B:/]V&8V#8/B/XB^*/Q0TGPMX2LOV;/C!X7_ .+P? 3Q
M3J'B'Q3XD_9V_L+1]"^'_P <?AYX_P#$=]?)X8^/.M:K-Y7A_P ,:F8H;#2[
MV:6;RHEC_>%E /K^@#D-;\%:3K_B?P9XKO9K]-0\#RZ]-I5O!);+871\1:/)
MHE\NI12VDDDR):2,T0AF@Q)@N77Y#$*<(5L35<5/ZW@:V75(32</85L7@<9-
M\NGO^TR^C!-MP]G.K%P<I0E"*T%6AA:;;BL'C:>.IN+L_;4L)C\%%2;O^[]E
MF%:32Y9>TA2:FHQG"?EFA_LU?#SPU\/_ !]\,]$N/$MCX6^(/BJ^\5W]N-3M
M+BXT.>].C!-'\-376FRK8>'[2'0K&"TLIX[O[- OV>)UACA2#>-6HJ?#].<Y
M57PWB,/B</.HW*I6J8;-JF<4_K4WK6YL34=.K-<E:K15YU'B'.O+/$8>&)K<
M1UZC<:G%%&O1QCC9)?6<K655JM%-/DJ3HIUO>YZ:Q,I2C35'EHKZ"''X?TK/
M\#=*VG8* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#Y_\1_\
MG3_!O_L@'[2W_JQ?V3J /H"@ H ^?_V:?^2=>(_^S@/VL?\ UJ?XR4 ?0% !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 ?/_ (C_ .3I_@W_ -D _:6_]6+^R=0!] 4 % 'S_P#LT_\
M).O$?_9P'[6/_K4_QDH ^@* "@#Y_P#B7XH^*?\ PM/X<_#/X9Z]\/\ PO\
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M%XS!S?1U<%BJV$JRAU=.52A*5-M1DX.+E&$FXKK:0!0 4 ?,%MK_ ,??''Q
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M047:Z3M=:72=NB)J@W"@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@#Y_P#$?_)T_P &_P#L@'[2W_JQ?V3J /H"@ H ^?\ ]FG_ ))UXC_[. _:
MQ_\ 6I_C)0!] 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0!\_^(_\ DZ?X-_\ 9 /VEO\ U8O[)U '
MT!0 4 ?FU\,/C1\7O"6F^//#_A;X4?#?Q+H5A\?_ -J#[#K>O_&GQ/X2U:\^
MU?M(_%:]N?M?A_3O@5XAM]/\F\N;B"/R]8O/-B@CG;R6F:"#TL/E6(Q%&%:G
M.G&$KV4G)/23B[I0:W7?8X:V/HT*DJ4HS<HVO91MJDUO)='V/2/^&B_C]_T0
MSX/_ /B1GC3_ .ACK?\ L/%_\_*7_@4__E9G_:F'_DJ?='_Y,/\ AHOX_?\
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M/_\ B1GC3_Z&.C^P\7_S\I?^!3_^5A_:F'_DJ?='_P"3#_AHOX_?]$,^#_\
MXD9XT_\ H8Z/[#Q?_/RE_P"!3_\ E8?VIA_Y*GW1_P#DP_X:+^/W_1#/@_\
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M3_Z&.C^P\7_S\I?^!3_^5A_:F'_DJ?='_P"3#_AHOX_?]$,^#_\ XD9XT_\
MH8Z/[#Q?_/RE_P"!3_\ E8?VIA_Y*GW1_P#DP_X:+^/W_1#/@_\ ^)&>-/\
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MI?\ @4__ )6']J8?^2I]T?\ Y,/^&B_C]_T0SX/_ /B1GC3_ .ACH_L/%_\
M/RE_X%/_ .5A_:F'_DJ?='_Y,/\ AHOX_?\ 1#/@_P#^)&>-/_H8Z/[#Q?\
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MGW1_^3#_ (:+^/W_ $0SX/\ _B1GC3_Z&.C^P\7_ ,_*7_@4_P#Y6']J8?\
MDJ?='_Y,/^&B_C]_T0SX/_\ B1GC3_Z&.C^P\7_S\I?^!3_^5A_:F'_DJ?='
M_P"3#_AHOX_?]$,^#_\ XD9XT_\ H8Z/[#Q?_/RE_P"!3_\ E8?VIA_Y*GW1
M_P#DP_X:+^/W_1#/@_\ ^)&>-/\ Z&.C^P\7_P _*7_@4_\ Y6']J8?^2I]T
M?_DP_P"&B_C]_P!$,^#_ /XD9XT_^ACH_L/%_P#/RE_X%/\ ^5A_:F'_ )*G
MW1_^3#_AHOX_?]$,^#__ (D9XT_^ACH_L/%_\_*7_@4__E8?VIA_Y*GW1_\
MDP_X:+^/W_1#/@__ .)&>-/_ *&.C^P\7_S\I?\ @4__ )6']J8?^2I]T?\
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M]EC\GI3A'[-6=>ECZE&'.J4(3Y92G!/VM+E/%'QU\3V^H7<36L_AV?PSX/\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * /&_@O_P I);__ +,?NO\
MU?.E5\MG?^]T_P#KU'_TNH>]E?\ N\_^OC_])@?JY7C'I!0!^8OPX_X\_'__
M &7_ /:>_P#6C_BI7V.5?[A0_P"W_P#TY,^;Q_\ O=7_ +=_](B>A5Z)QGSX
M/@8\GQ7M?B/<:]IL&GZ5K6H>)-(\.:/I/BRQQKVH:#?>'I]1U8ZC\1=1T"::
M6UU*[DN)](\+Z%=W<J6QN;J18&6;EP-">!6+=.<?:UJ.)H4;1E[*A#%5X8BK
M:G4JU9).K3C-TZ%7#4)5)UJLZ4JDXRI]6(Q*KTE04.6$_JOMY2<74J?5)4Y4
MK3A3IKFC[*%.$Z\<14IX>/U>G.,&SUOP=X8M_"&A0Z/%/]KG:[U/5=4OS"ML
M=2UO7-2NM8UG4#;K(XMUGU*]N9$A\R3RD9(P[",,>I*-.EAZ%).-'"4:6'IJ
M33ER481@I3E&,(RJ3LZE64804ZLIS48\UESU)SJUJ]>I+FJ5ZCF][1BDH4J4
M;MOV="C"G0IIMM4Z<$VW=OIR 00>A!!'3@\&HJ4X5*<Z4US0G%QDKM7BU9JZ
MLU=/=-/L2GRM-:..WR,#2O"V@:)X:M?!^G:='#X;LM,_L:WTJ:6XO(AI9A:W
M:SEEO9I9KB-H69&,LCLP8Y)J<11I8NA+"XB"JT)T8X>4'LZ4::HJ#M9Z4XJ-
M[\SM=OFU-OK%98J>-51QQ53$5,5*HK)^WJU95YU$DE&+=64II12C&]HQ44DO
M.+?]GOX16]C/IK>%KB_L[E/#,4Z:SXG\7Z](\'@S4;O5?"MK]IUK7KJ9;/2[
MV^N&MK=9!%'&8X0GD0Q1QMTXM0NY2E3KRQ,:CG-U?K,\++!RQ,JSE[66(^KR
M<%7E.56,U"M&:K4Z=2,RK3E#V7NPI*,X*G"$*=.-*I5H5YT84Z<8PA0E5PU*
M4J$8JBU[2#AR5Z\:FJWP7^&KV$.FR>''FMH=(\0Z(7GUOQ%/>W5AXKO=+U'Q
M$=1U.;5FO-4U"^O=%TR674+R>>\W6WRSJ)) ]P2I.FZ453]E/!S@HQ48QG@,
M3+&X62@DHIT\5.=>>G[^I.;K^UYI7*M:I6HXFA4ES4L7.<ZL;)<SGA*N :32
M3A".#KU,/3IP<:=&GR*E&'LJ3AJZ;\,?!&C^*[KQKIVBO!XAN_MS/.=5UJ?3
MK>XU7R/[6OM.\/W&HOI6DZGJ'V6W^V7UE96]S=^2HN)9,5EAZ%+"*JL/#D]L
MG%ZN7+"59XB=*DYN7L:,\1)UZE"CR49UK59PE4C&2FK.59455?,J')RK17E2
MH_5Z4ZG+;VU2EAVZ%*K5YZE*@W2IRC3;BZVI_"3X>:Q-J4^I^&X;V35[K6;W
M4//O]69)[O7]/TG2]5N!$+\)#))9Z%I*H8E3R'LEFM_*F9Y'AX2@XTH\CC["
M%2%*49SA.DJN8+-92IU(R4Z=19A&.)IUH2C5I2BHTIPII0'&K.,ZDU9NM.E4
MJ*48RC.5#!5,NIJ<))PE#ZE6JX>=)Q=.K&;=6$Y^\4K;X+_#NTAL(H]*U>6;
M3]7NM<CU2\\9>-=0\07>HWVE-H=V^L^);_Q#-JNOVTFC%+$VFIWEW;?9X((A
M$$MXA&ZN%H5H>SJ4TX?5L5A)1BW",Z&,Y'BH55!Q565:=.G5E5J<U55Z=.O&
M<:U.$XTJ]5.+YM83PU2FVD_8SPDISP_L+I^P5-U*JY*/)"4*^(ISC*%>M&=[
M3OA/X TFQ&F:?H'V>R76O#'B%8#JFM3 :QX-TW1=(\-WF^?4G<BST_P]H\7D
M[_*F^Q[KA)7EE:3JJU*E6I3K3:E6HU<;6A)Q32JYA#$T\7)P5HR5:.+Q"<'[
ML%4_=*#C!QP<(O#4\&U_LU'#X?"0A=JV'PN)^N4*?-\3Y,1^\YVW.7P3E*'N
MG!^ ?@:?!_Q O/'=[KNG7?EZ;K^C^'=!T+3/%>E:3HNG>(]6TW5M0B^R^)OB
M'XGMX,3:39^7;Z#;>';%7ENY39,]POD\^7TG@,)6PW-[2=>&%I.2YE&%'!JK
M["E356=:LHP]M*,(RQ$Z5*E&G2H4J24W/KQN)>*E%1A[.E&O+%-/E=25>5.=
M*524J<*--NHJLYUI^P5:O5Y:E6K)P2.YD^$GP_E\17?B>70YI=2O9KR[N;:7
M7/$,GAYM1U#3WTJ^UJ/PB^JG0H/$%QIDLMK)JT6FI?/#-)&UP5D8-FL'AEA\
M3A?9<V'Q4*]*=.4I2C&GB92GB:='F;>&A7G.=2M##^RC5J2E.:E-MN?K5=3I
MU(U.2=.5"7-%1A*;PW*\/[9Q2=?V'LZ?LE6]HJ?LJ7*E[*GRX$G[/WPKFAM;
M:71=<EM;33='TE;23Q]\0GM+JS\/7)N] .J6C>*3%K%[IDQ'V.]OTN;FU2..
M*":.*-$754H+$K%^]+$1KT,4I2G.:^M8=4(PQ7)*3@\3*.&HPKXAQ]MBH0<,
M3.M&<U+%R_<RP\8QIT94L10<:<(4W]7Q*K*KAE*FHRCA5]8K.CAHM4,-*;EA
MZ=*235V\^!OPRO0JSZ'J**FM>(->1;3Q=XST]8[SQ8R2>)[.);#Q!"(_#^JS
MH)KS0EQI=Q,7FELVE=G;*6"PTJ-.A.FY4:6%G@E"4YM/"3ESJA4O)^UITI6^
MK*KS_5%&FL+[&-."CT+&8E3G453EG.I0K.2C%-5\-3E2I5XM1]RNJ<YPG6AR
MU:T925:<^9WLVGP7^&]CJFE:M9Z!<6T^CPZ'%:6D7B'Q.NAS2>&+2"P\.W^K
M>&_[9_LG7M9TVTM;2.VU/4[*[O81:0%)P8(RG4KK%U\==O$XBI6JR;;<(UL1
M!T\16I4FW2H5JU-RIU:M"%.I4IRE"<G"4D^6R^J4,#9+#86$:5.*5I>QA4=6
M%"=16J5*$*LI584*LYT85)2J1@IMM^HT#"@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M _X9T^/W_1<_@_\ ^(Y^-/\ Z)RC^V\7_P ^Z7_@,_\ Y8']EX?^>I]\?_D
M_P"&=/C]_P!%S^#_ /XCGXT_^B<H_MO%_P#/NE_X#/\ ^6!_9>'_ )ZGWQ_^
M0#_AG3X_?]%S^#__ (CGXT_^B<H_MO%_\^Z7_@,__E@?V7A_YZGWQ_\ D _X
M9T^/W_1<_@__ .(Y^-/_ *)RC^V\7_S[I?\ @,__ )8']EX?^>I]\?\ Y /^
M&=/C]_T7/X/_ /B.?C3_ .B<H_MO%_\ /NE_X#/_ .6!_9>'_GJ??'_Y /\
MAG3X_?\ 1<_@_P#^(Y^-/_HG*/[;Q?\ S[I?^ S_ /E@?V7A_P">I]\?_D _
MX9T^/W_1<_@__P"(Y^-/_HG*/[;Q?_/NE_X#/_Y8']EX?^>I]\?_ ) /^&=/
MC]_T7/X/_P#B.?C3_P"B<H_MO%_\^Z7_ (#/_P"6!_9>'_GJ??'_ .0#_AG3
MX_?]%S^#_P#XCGXT_P#HG*/[;Q?_ #[I?^ S_P#E@?V7A_YZGWQ_^0#_ (9T
M^/W_ $7/X/\ _B.?C3_Z)RC^V\7_ ,^Z7_@,_P#Y8']EX?\ GJ??'_Y /^&=
M/C]_T7/X/_\ B.?C3_Z)RC^V\7_S[I?^ S_^6!_9>'_GJ??'_P"0#_AG3X_?
M]%S^#_\ XCGXT_\ HG*/[;Q?_/NE_P" S_\ E@?V7A_YZGWQ_P#D _X9T^/W
M_1<_@_\ ^(Y^-/\ Z)RC^V\7_P ^Z7_@,_\ Y8']EX?^>I]\?_D _P"&=/C]
M_P!%S^#_ /XCGXT_^B<H_MO%_P#/NE_X#/\ ^6!_9>'_ )ZGWQ_^0#_AG3X_
M?]%S^#__ (CGXT_^B<H_MO%_\^Z7_@,__E@?V7A_YZGWQ_\ D _X9T^/W_1<
M_@__ .(Y^-/_ *)RC^V\7_S[I?\ @,__ )8']EX?^>I]\?\ Y /^&=/C]_T7
M/X/_ /B.?C3_ .B<H_MO%_\ /NE_X#/_ .6!_9>'_GJ??'_Y /\ AG3X_?\
M1<_@_P#^(Y^-/_HG*/[;Q?\ S[I?^ S_ /E@?V7A_P">I]\?_D _X9T^/W_1
M<_@__P"(Y^-/_HG*/[;Q?_/NE_X#/_Y8']EX?^>I]\?_ ) /^&=/C]_T7/X/
M_P#B.?C3_P"B<H_MO%_\^Z7_ (#/_P"6!_9>'_GJ??'_ .0#_AG3X_?]%S^#
M_P#XCGXT_P#HG*/[;Q?_ #[I?^ S_P#E@?V7A_YZGWQ_^0#_ (9T^/W_ $7/
MX/\ _B.?C3_Z)RC^V\7_ ,^Z7_@,_P#Y8']EX?\ GJ??'_Y /^&=/C]_T7/X
M/_\ B.?C3_Z)RC^V\7_S[I?^ S_^6!_9>'_GJ??'_P"0#_AG3X_?]%S^#_\
MXCGXT_\ HG*/[;Q?_/NE_P" S_\ E@?V7A_YZGWQ_P#D _X9T^/W_1<_@_\
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M3_Z)RC^V\7_S[I?^ S_^6!_9>'_GJ??'_P"0#_AG3X_?]%S^#_\ XCGXT_\
MHG*/[;Q?_/NE_P" S_\ E@?V7A_YZGWQ_P#D _X9T^/W_1<_@_\ ^(Y^-/\
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MI?\ @,__ )8']EX?^>I]\?\ Y /^&=/C]_T7/X/_ /B.?C3_ .B<H_MO%_\
M/NE_X#/_ .6!_9>'_GJ??'_Y /\ AG3X_?\ 1<_@_P#^(Y^-/_HG*/[;Q?\
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M S_^6!_9>'_GJ??'_P"0#_AG3X_?]%S^#_\ XCGXT_\ HG*/[;Q?_/NE_P"
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M:G^,E 'T!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MF?( >_\ _".?M3_]%D^ '_B-/Q%_^BQH /\ A'/VI_\ HLGP _\ $:?B+_\
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MH%  /8* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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MES5)5)4H0]K*4W&4H\T(4TW$]^KRR3Y__9._Y-8_9I_[(!\&_P#U77AR@#Z
MH * /@#_ ()<?\F)_ S_ +J;_P"KB^(- 'W_ $ % 'S_ /LT_P#).O$?_9P'
M[6/_ *U/\9* /H"@ H ^ /V!?^;U/^S_ /\ :._]TV@#[_H * /G_P#9I_Y)
MUXC_ .S@/VL?_6I_C)0!] 4 % 'P!_P2X_Y,3^!G_=3?_5Q?$&@#[_H * /G
M_P#9I_Y)UXC_ .S@/VL?_6I_C)0!] 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'S
M_P"(_P#DZ?X-_P#9 /VEO_5B_LG4 ?0% !0!\_\ [-/_ "3KQ'_V<!^UC_ZU
M/\9* /H"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * /G_P#9._Y-8_9I_P"R ?!O_P!5UX<H ^@* "@#X _X)<?\F)_
MS_NIO_JXOB#0!]_T % 'S_\ LT_\DZ\1_P#9P'[6/_K4_P 9* /H"@ H ^ /
MV!?^;U/^S_\ ]H[_ -TV@#[_ * "@#Y__9I_Y)UXC_[. _:Q_P#6I_C)0!]
M4 % 'P!_P2X_Y,3^!G_=3?\ U<7Q!H ^_P"@ H ^?_V:?^2=>(_^S@/VL?\
MUJ?XR4 ?0% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!\_^(_^3I_@W_V0#]I;_P!6
M+^R=0!] 4 % 'S_^S3_R3KQ'_P!G ?M8_P#K4_QDH ^@* "@ H * "@ H *
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M8:790Q0^5$L?[LLQL&QZ!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M,8?5ZF)SW_;)\(>&1XJOOB/HVL>%_#=CK'C>#PEXKF'AG3_#FNVW@KQEX?\
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M!PF7SI045B8TZ^)J8VBZU7#+#57156CB/J^'Q56/M=U\:M*@\$>"/%]IX/\
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M?$8=*498;V+;:Y>:-?#TL32ER-JI3YJ-:$O95Z=&O%-.=*,90<O0*R-0H *
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MVEC\SJ0GC:\8QIQJJASK#TZ5""4:$(QESXE\]2IC,2E6K5.6EAJ.'RG1I\N
MP]*+I8#*_;3PM!SG-PKXJG0AB:LI2ER.*5!4\'3A2I1P>&G/#Q=52<S7\0?
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MI4J5:66XRIA,KHTH2;]OB,QJX+,*%2A1Q#JT6J&+=-4K4:^5X:_:?\9R^,O
MOA30=3\$RZ+XSGU?XCZGXJ^(GBGPO';ZAX3U/QYXO?6O"7A(WGQ3T?5M*O\
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M_:47*C2=2*E[369N% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M6)KPY;\KY[N+E&+CL_\ #6/[+'_1RWP _P##R?#K_P":.@0?\-8_LL?]'+?
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M.AC'_<QT DEHM$MD'_#6/[+'_1RWP _\/)\.O_FCH /^&L?V6/\ HY;X ?\
MAY/AU_\ -'0 ?\-8_LL?]'+? #_P\GPZ_P#FCH /^&L?V6/^CEO@!_X>3X=?
M_-'0 ?\ #6/[+'_1RWP _P##R?#K_P":.@ _X:Q_98_Z.6^ '_AY/AU_\T=
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M9XBI&-6O*I47,==_PUC^RQ_T<M\ /_#R?#K_ .:.D(/^&L?V6/\ HY;X ?\
MAY/AU_\ -'0 ?\-8_LL?]'+? #_P\GPZ_P#FCH /^&L?V6/^CEO@!_X>3X=?
M_-'0 ?\ #6/[+'_1RWP _P##R?#K_P":.@ _X:Q_98_Z.6^ '_AY/AU_\T=
M!_PUC^RQ_P!'+? #_P /)\.O_FCH /\ AK']EC_HY;X ?^'D^'7_ ,T= !_P
MUC^RQ_T<M\ /_#R?#K_YHZ #_AK']EC_ *.6^ '_ (>3X=?_ #1T '_#6/[+
M'_1RWP _\/)\.O\ YHZ #_AK']EC_HY;X ?^'D^'7_S1T '_  UC^RQ_T<M\
M /\ P\GPZ_\ FCH /^&L?V6/^CEO@!_X>3X=?_-'0 ?\-8_LL?\ 1RWP _\
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M 'S_ /LT_P#).O$?_9P'[6/_ *U/\9* /H"@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@#XP^"'B_XM?#7X+_"'X<Z[^RM\<+O6_ 'PO\ >"M8N
MM)\4?LPSZ5<ZKX5\*:3H6H7&F3WG[1=K/-I\EW83/"\]M;R-&R%XHV)13;Y!
MM\CT_P#X7)\1?^C3OV@/_"C_ &6/_HEJ #_A<GQ%_P"C3OV@/_"C_98_^B6H
M /\ A<GQ%_Z-._: _P#"C_98_P#HEJ #_A<GQ%_Z-._: _\ "C_98_\ HEJ
M#_A<GQ%_Z-._: _\*/\ 98_^B6H /^%R?$7_ *-._: _\*/]EC_Z):@ _P"%
MR?$7_HT[]H#_ ,*/]EC_ .B6H /^%R?$7_HT[]H#_P */]EC_P"B6H /^%R?
M$7_HT[]H#_PH_P!EC_Z):@ _X7)\1?\ HT[]H#_PH_V6/_HEJ #_ (7)\1?^
MC3OV@/\ PH_V6/\ Z):@ _X7)\1?^C3OV@/_  H_V6/_ *):@ _X7)\1?^C3
MOV@/_"C_ &6/_HEJ #_A<GQ%_P"C3OV@/_"C_98_^B6H /\ A<GQ%_Z-._:
M_P#"C_98_P#HEJ #_A<GQ%_Z-._: _\ "C_98_\ HEJ #_A<GQ%_Z-._: _\
M*/\ 98_^B6H /^%R?$7_ *-._: _\*/]EC_Z):@ _P"%R?$7_HT[]H#_ ,*/
M]EC_ .B6H /^%R?$7_HT[]H#_P */]EC_P"B6H /^%R?$7_HT[]H#_PH_P!E
MC_Z):@ _X7)\1?\ HT[]H#_PH_V6/_HEJ #_ (7)\1?^C3OV@/\ PH_V6/\
MZ):@ _X7)\1?^C3OV@/_  H_V6/_ *):@ _X7)\1?^C3OV@/_"C_ &6/_HEJ
M #_A<GQ%_P"C3OV@/_"C_98_^B6H /\ A<GQ%_Z-._: _P#"C_98_P#HEJ #
M_A<GQ%_Z-._: _\ "C_98_\ HEJ #_A<GQ%_Z-._: _\*/\ 98_^B6H /^%R
M?$7_ *-._: _\*/]EC_Z):@ _P"%R?$7_HT[]H#_ ,*/]EC_ .B6H /^%R?$
M7_HT[]H#_P */]EC_P"B6H /^%R?$7_HT[]H#_PH_P!EC_Z):@ _X7)\1?\
MHT[]H#_PH_V6/_HEJ #_ (7)\1?^C3OV@/\ PH_V6/\ Z):@ _X7)\1?^C3O
MV@/_  H_V6/_ *):@ _X7)\1?^C3OV@/_"C_ &6/_HEJ #_A<GQ%_P"C3OV@
M/_"C_98_^B6H /\ A<GQ%_Z-._: _P#"C_98_P#HEJ #_A<GQ%_Z-._: _\
M"C_98_\ HEJ #_A<GQ%_Z-._: _\*/\ 98_^B6H /^%R?$7_ *-._: _\*/]
MEC_Z):@ _P"%R?$7_HT[]H#_ ,*/]EC_ .B6H /^%R?$7_HT[]H#_P */]EC
M_P"B6H /@7I_B\:M\=O%OBWP)X@^'7_"Q/C!IWBGP]X>\4ZEX)U/7?["TSX'
M?!?P ]]?/X \7>)-*MO.\0>"->$4(U22;R88I98X_.5:-@V/H"@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@#Y_\1_\G3_!O_L@'[2W_JQ?V3J
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M=W*2Z**M:*Z'IX*O/$4I3FHQ<9.*44TK)1?5ON?J37 =84 ?F+\./^//Q_\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M?_GQ3_\  (_Y!_PQ]\$?3XP?^),?M+?_ #W*/K>+_P"@JK_X,G_\D'U?#_\
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M'[2W_P ]RCZWB_\ H*J_^#)__)!]7P__ #XI_P#@$?\ (/\ AC[X(^GQ@_\
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M_(/^&/O@CZ?&#_Q)C]I;_P">Y1];Q?\ T%5?_!D__D@^KX?_ )\4_P#P"/\
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MO_GN4?6\7_T%5?\ P9/_ .2#ZOA_^?%/_P  C_D'_#'WP1]/C!_XDQ^TM_\
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M $%5?_!D_P#Y(/J^'_Y\4_\ P"/^0?\ #'WP1]/C!_XDQ^TM_P#/<H^MXO\
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M?_GQ3_\  (_Y!_PQ]\$?3XP?^),?M+?_ #W*/K>+_P"@JK_X,G_\D'U?#_\
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M1J5X0JY;]4GB*[ISPN'K5'/$XC#4:U!&]>G4H?6JT?W^&C6=#"QA%JK5K87
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M&? WA^/Q#\*;[7?B!I?@'5X_#_B3Q'X:LW^(EK'>2VVML]JGA^&>?7+U@O\
M96GZBPF6WC!4Y8UY51@N7%9A2HXBK1UF\'A<74G]2Q5504JE6A6P\57J3PE.
MO]64,1*LEA:=+%XBZT*F'>/E44(8?!U:&'I59UJ-..(Q-7#0KSPRE5G"EAZM
M&3]G.6*JT:"=3#4JE:GC:T\%0ZO5OVK/"VGW^J6-A\._BMXC33IO'MG;W^BZ
M/X2CT_6-0^&;VH\966GSZ[XUTUK:.PAN'=]1U*/3]-\ZTET\WHU1H;&?"-6"
MPTL55?U:A3H/%RE45[8&&-JX&IC+4_:.5*-2$*U*E&^+QF&KTJV PV*4:ZHZ
M1HU)5Z&'C"7M:]?!X6,7"I&V)S#+(9I@J$N:"<9UL/*=.4K>SP]:C4CBYT*;
MI5:F5!^VC\([[5?&6G:-:^*/$-OX#\-W^N^(=3\/+X2UD65_IR6IE\(W7AZR
M\7/XETGQ+/-=K;61U70]/T[4+F">VL-0N9X6C'3"C*?-RV47CZ6749VDZ>(K
M5<QIY7>C5A&5)<F*JP<J%:=+&3PS^MT,-5PW[TY75C&GA:DTZ2KX-8V4:G+2
ME0H/+*F;QG651P]SZE3YIUZ/M<-0K5*6'Q%>E7G[-:\O[2\CZYHFAZ9\&_B7
M=SS>)?%^B>+H+B[^'EIJG@W2_!_A[1_$%UXC?2(?'%S-XCM;BU\3>&WCLM*:
M>]B2_FAN8(=4@CTN[R<H4Z4L16ER8:.68O,'4@O;<L\'CZF75,'-4N;]Z\30
MKTHU:;JT)S5*5*I4PWUO$X/57FI1HQ=2NL?@,#"D[4N?^T,)/'4JSG5Y(T(Q
MPD)5I4L5]7KJ,7S4H.=#VW;VOQFM-0^$Z_%*W\+ZSID6IO9V?ACP_K&I^#[Z
M^UW4]<U>T\/^%(4U'P-XG\2:5!;:KK6H:?"KF_::V6=C=P021/&NE;#XBG5P
M>$I<CQF-=.$8OFE"@ZG-.=2M*"Y*E'#X>$\95J8:I6I3PT'*A5J2:0\/*G4E
MC9M5'ALNABJM648*-2I1P5&5>O[*C6=*I3K6ISH0P^,AA:RQ,?95J=)>\<5X
M;^(7Q0\06>K>.[_Q+\+O"/PQ\!:UXIT?Q=+?>"?%6MZ[XGA^'MY=:/XVUO2M
M0C^(NEVWP^L4US1]>ALH;NP\6R26MK;W4K(\YM4F3IX>CA\;6A6J4,?AU7P^
M%I1OB>3$<ZR]\\/;*O6Q<98;$?5*6'A.'M?J:JSK-U:>DL+BZF+658:$8YA"
M>%A4E)^TI>UQ-+#XIT*<$Z+<:%'$*A+%3JP52O&=98:%&$55<G[3^F?;)M*N
M/A)\8+/7)-;TG0O#^@SV/P\?5?%-QKGA;Q-XPTVXT^*T^(\T6A6[:'X8GFN$
M\3S:!<6 U.P;4(+2*662W4DX4JT[)U,)+'1Q-*,X2EA5EU++ZN)J5:L9/"NE
M%9GA:=.I1Q%6%6LW0IN55TX5,*4Z-2;M64,,\/@L31Q$XU8T\1#'XRO@L/##
MTW3^M5*W/A<36G1^KJI'#8>K6LXQ2;4_:K\&7-MX5U/3/"'C[5/#_B ^%(];
M\26T7@FVT?X?W?C#2;;7]+L/%K:KXXL[J\O(= NDU2\7PQ:^(UM+("ZF989H
M'GNO".$KUJ6)JQH4*2QOL\1.-6-*N\OP-;'XF-&FZ?UKW:5&=)2JX:E!XQ2P
M;FL32KTJ55(8BE!1EA*SQBJ4:4\'%1G7INOFW]B4W*<9O"2B\Q4J5Z>)F^2+
MKI.@X5)8B_M,W=_X@U.V'A#7_ GA:PTWP%/8ZYXWT;0+J\UX^/O$&IKI^MV>
MCZ1\2(KK1O#EOX1\+^(]1NH==BTK5[=&@NFTUUM_LFH2X_5J=:KF$X81T<96
MPSHN7/5I?V7E>*SC-H5YT56HJI/"_4*>"E0GB'#$5I0Q-%\\?9S4ES/"_4)+
M'PKX>4TZ.O-/&8[+<JRBI2A4=*JZ$L?BL4J\JM.C1Q5+#3^I8M>SJU#H+?\
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MQG8>-[F]UO4?$.JSZEXAO=4U6TG-[>W^H374S7\TSSF8AJZ5B*JQ> Q3Y/\
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M^$-=^)%WX@^-#Q_%+1O%.G_"3P1X@M_'VHZMXKUR'1/!7Q6^(6E?"Q;3PEX
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MM-QQCM0Q;I8?)LRQ>*J2PTX>SP=#&9A/+,)@Z6*HSQF'G3KTZKKV=2MTX_\
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M0 4 % !0 4 % !0 4 % !0 4 ?/_ (C_ .3I_@W_ -D _:6_]6+^R=0!] 4
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MRE.<W>4IR<I-MMEVD,* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@#Y_\ $?\ R=/\&_\ L@'[2W_JQ?V3J /H"@ H \?^!WA;7?!W@O6M
M)\16/]G:A=_&#]H7Q3;V_P!JL[O?H7CGX^_$OQKX6OO-L;B:-/MOACQ!I%YY
M+.LT'VOR;B.&XBEBC-@V/8* "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H \?UKPMKMW\??AIXUM['S/#
M'A[X/_'#PMJ^I?:K-/L>N^,/&G[/6K>'+'[$]PMW/]KT_P #>*9?.A@DAA_L
MO9/)$]S;K<&P;'L% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
C 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>98
<FILENAME>g20922dsp4_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922dsp4_2.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /W\H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M'RC_ *%6#_\ ":C_ /(!_;&;?]#3%_\ A36_^3#_ (5;\,O^B=>!/_"1\/\
M_P KZ/['RC_H58/_ ,)J/_R ?VQFW_0TQ?\ X4UO_DP_X5;\,O\ HG7@3_PD
M?#__ ,KZ/['RC_H58/\ \)J/_P @']L9M_T-,7_X4UO_ ),/^%6_#+_HG7@3
M_P )'P__ /*^C^Q\H_Z%6#_\)J/_ ,@']L9M_P!#3%_^%-;_ .3#_A5OPR_Z
M)UX$_P#"1\/_ /ROH_L?*/\ H58/_P )J/\ \@']L9M_T-,7_P"%-;_Y,/\
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M5OPR_P"B=>!/_"1\/_\ ROH_L?*/^A5@_P#PFH__ " ?VQFW_0TQ?_A36_\
MDP_X5;\,O^B=>!/_  D?#_\ \KZ/['RC_H58/_PFH_\ R ?VQFW_ $-,7_X4
MUO\ Y,/^%6_#+_HG7@3_ ,)'P_\ _*^C^Q\H_P"A5@__  FH_P#R ?VQFW_0
MTQ?_ (4UO_DP_P"%6_#+_HG7@3_PD?#_ /\ *^C^Q\H_Z%6#_P#":C_\@']L
M9M_T-,7_ .%-;_Y,/^%6_#+_ *)UX$_\)'P__P#*^C^Q\H_Z%6#_ /":C_\
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M5;\,O^B=>!/_  D?#_\ \KZ/['RC_H58/_PFH_\ R ?VQFW_ $-,7_X4UO\
MY,/^%6_#+_HG7@3_ ,)'P_\ _*^C^Q\H_P"A5@__  FH_P#R ?VQFW_0TQ?_
M (4UO_DP_P"%6_#+_HG7@3_PD?#_ /\ *^C^Q\H_Z%6#_P#":C_\@']L9M_T
M-,7_ .%-;_Y,/^%6_#+_ *)UX$_\)'P__P#*^C^Q\H_Z%6#_ /":C_\ (!_;
M&;?]#3%_^%-;_P"3#_A5OPR_Z)UX$_\ "1\/_P#ROH_L?*/^A5@__":C_P#(
M!_;&;?\ 0TQ?_A36_P#DP_X5;\,O^B=>!/\ PD?#_P#\KZ/['RC_ *%6#_\
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M^%-;_P"3#_A5OPR_Z)UX$_\ "1\/_P#ROH_L?*/^A5@__":C_P#(!_;&;?\
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M_P""9'_);?VU_P#NV_\ ]1+Q]7XKQ;_R4&8?]P/_ %&HG[-PG_R3^ _[C_\
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MY[6VBGJ?,U,95JY-6R.48K"5\0\3*:3]JI^PEA[*3DX*'))NSIM\UGS6]T]
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MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M_P#0KPG_ (34?_D _P"&"OV8/^A1\=_^'[_:!_\ GHT?VQF__0UQG_A36_\
MDP_L?*?^A7A/_":C_P#(!_PP5^S!_P!"CX[_ /#]_M __/1H_MC-_P#H:XS_
M ,*:W_R8?V/E/_0KPG_A-1_^0#_A@K]F#_H4?'?_ (?O]H'_ .>C1_;&;_\
M0UQG_A36_P#DP_L?*?\ H5X3_P )J/\ \@'_  P5^S!_T*/CO_P_?[0/_P ]
M&C^V,W_Z&N,_\*:W_P F']CY3_T*\)_X34?_ ) /^&"OV8/^A1\=_P#A^_V@
M?_GHT?VQF_\ T-<9_P"%-;_Y,/['RG_H5X3_ ,)J/_R ?\,%?LP?]"CX[_\
M#]_M _\ ST:/[8S?_H:XS_PIK?\ R8?V/E/_ $*\)_X34?\ Y /^&"OV8/\
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MX8*_9@_Z%'QW_P"'[_:!_P#GHT?VQF__ $-<9_X4UO\ Y,/['RG_ *%>$_\
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M_P"AKC/_  IK?_)A_8^4_P#0KPG_ (34?_D _P"&"OV8/^A1\=_^'[_:!_\
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M*_9@_P"A1\=_^'[_ &@?_GHT?VQF_P#T-<9_X4UO_DP_L?*?^A7A/_":C_\
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M-1_^0#_A@K]F#_H4?'?_ (?O]H'_ .>C1_;&;_\ 0UQG_A36_P#DP_L?*?\
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M,92E3P>286A-1J0]_GAB*M6JJ?L84JT)X:3<Z\)>P.#^(_[4WQ<G\#_%/1_
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M"FE>RNK/1N,6U9N,7>*Z6N,[0H * "@ H * "@ H * "@ H * "@ H * "@
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M^T>7U/:X*53DY?:2PTDE3E4YI*FE2;=)*"O>&_@7\+/"-]X0U+0/"WV2_P#
M2^-QX4N9];\1:G+I4GQ'U1-9\;71.JZO<B_O]4U%?,>[O1<3Q+)+%;R1132(
M]4ZDZ7\-J-LOP>5+W8W67X#V7U7#1;5XPINC1<I*TZTJ<)5YU)13152J^U]J
ME+V^8U,VG?KCZM/$49XC2UK4L57IPI*U&E&HU2IP2CRUO$/P!^$_BGQ#KWBG
M7?#-S=ZSXGNO =[XADA\3^+M/L-8O/AEJT>N>![J_P!%TW7K?39[C3-2BB<2
M&TW7$<:V]T9[<"*C"3E@94Y85^S=#&U,QIII35/&U<&\!4KPC44HQE/"M0E&
M*4'.%*NX^WHTJL"LOK"DJK;YL!5RR3BW!RP-:N\34P\G!Q<HNM.HU)MSC&K6
MI0G&E6JPG5U_]G/X+^)](US0=>\$6^I:5XE^(2?%37K6;6/$2-JGCN..W@&L
MW=S!JZ3R0&TM8;5M-\T:>]JIM6M3;NT31A_]DEDTZ'N2X?G7J8!OWOJ]3$5L
M1B*T[3YE5E.OBJ]6]95.6<HN/+[*ER.JW6_M-5&W_;&'H87%V;BZN'PU/#TJ
M%*+BTZ,:<,+1LZ/LY.<9U9-U*M6<^AO_ (/_  ]U'QY9?$R;1;NV\9V5A8:6
M^I:5XC\3Z'9ZMI^DS3W.C6GB?P_HNLVND>+HM,N;JYFL!K=AJ'V&69Y+0PNQ
M:JHRE06+5*3C''-SK1;<HNJZ2H2KPC*\:.*E0C&C+%453Q#I15-U7!**FK"-
M6GA:4XI1P47"CR^Y*%-SC4='GARSEAW4A&;P\I2H.5VZ=Y2OQMY^S#\&-2M=
M;M]5T#Q'K%UX@UGPWKVH>(-:^)GQ0UCQE#J7@_4IM7\*'1_'.I^,Y_$/AVQT
MC4[F[N;*PTG4[*TMY+VY,4"_:9?,K#U:F$_L_P"KR]D\KKSQ-!I+F=>IAW@Z
ME3$R:<L;*KA&\+5^N.NJN&_<5%*E[IK5FZ\L5*LHU%BZ%3#5*<HQ=%4*E98B
M=.C0M['#Q=>,*R^KTZ3C4ITIQ<94J;CT47P)^%D.J1:ROAN=M3B^),WQ=%U-
MXC\57#2?$.;0#X6_X2&YCN-;>.[,6@XM(+&=)+*W"))!;1RQHZS3DZ,,+"D^
M6."P^/PM!+_EU1S2O5Q./47NIUZM>LW6O[:G&I*E2J4Z3Y#*<546*C.\EC/[
M/5>\I7J+*E0^H1D[WY:,L-1J.*:C6JTU6Q"JU7*;QG_9K^#)T[PGID/A:_L(
M_!&I^)=6\-WVD^-/'>C:]9W/C+4[C6/%UO=^)M)\36^KZQI&M:C<RS:AI>I7
MUW8WF(TN+>1(8U1TZDZ-3#5:;47A<%A<NA!I.E+!8*%.GA</6HR3HXB%"-*F
MZ?UB%64:B=7F]K*4Y:2E*2QB;O\ 7L94S"K+[<<;5<^?$X>?QX2KRU)TXRPL
MJ/)2DZ,.6E[AL)\"/A3'J$>J?\(J'OXOB9_PN%9Y];\17(/Q&70_^$;A\1/#
M<:N\4OV?1 EM;V#HUA;"&&2WM8Y88W0HU)X?ZG[)\KR^CCZ&';2E*E3S2M6K
MX^TI\SE/$U,17<ZLG*K&%6=*$X4GR&<X0G#&4Y13ACXY?"O&UE.&5/#O 025
ME"-"6$P\^6GRJK4I^TK*I.4Y2U_#'PN\*^ ],\8:=X#M;GPV/&>LZ]XFU!'U
M;7]:TVU\3^(C+-J>KZ9HVK:Q-:Z+'<:A,][/9:4NG6\T\DLS()IGD;CQ="=?
M)UD]*M["A0PM7"X:3C[26'IU(R48J4I*K.G1<KTJ4JO)2C[E+V<78Z:56,<R
M>9UJ?MZM6K0J5XW]FJ[H<L4Y1BG352=.*IU*WLW4J*,/:.?)!+QKPM^R#\*K
M#X:_"SP%XUL9O&NH?"_P3K?@BW\46NH^)O!5QK6G^+K/[+XWBU#3_#7B:/[3
MI.MN6FFTR_NM2A1Q&ZDS1++7?F+PV-Q&+J4\+]7PV+P6%RZ5#VCG#ZE@HTEA
M:4K*$)2H2HPJ4:JIPJ49W=*4+N^&&J8G#OG=?GKK-,5G$:O)&,Z>.Q6(Q%>I
M5IR]Z<.98FI1JQC)0KTO<JPE"T%WEW^SA\%[W3]8TF[\&+/IFO>!O!WPUU6Q
M;7_%(MKCP+X!NKB]\*^'(XEUL"SLK6YN[EI6M_*EO1,RWTERGRBZF+Q%7$SQ
M=2IS8FIFM'.YS:C>69X?V7L,2TE9JDZ%-PP]OJJDI2]C>=1RRHT*>&PN&P5%
M2I8;!X'%Y;1@ISO3P>.AR8N$9\W/[2M&REB7+ZTN6#A6BZ<'&#5?V<?A3>^*
MY/B!:>'39>.8/$$7C72=2?7_ !E/X=TWQY9^&KGPG8>+SX$MO%%KH-QJJ:+<
M):W$BV<$MY%:6PGF,EI;2V_&WB:.'K4L#B7A*\J.8T:-:4?;RPRS1\^-5%5)
M<U.%:M>O*E3G3A[:56K%1J5JTI[VP]3V-/%4%6PM.6 ]I1A:A[:&6U(U,'&<
MZ<;REA^50HU*BJ2ITTJ:O27LS!\?_L\S_$3X(>&?@IKOQ$\17EK9:KX"O?&O
MBO4FU6^\1^.;+PGXATWQ'KED^I1>(K:_\/7&MWNG[$O+2_EDTV.55ME801@=
M-66&GFV78Z&&='!Y77=:CA8UJD:BE2PE;#X&3QD'"LZV%K3H8RIB&G5Q-:@W
M4<9595(Q2GB*>"S6A*I3EB\VP^*HU*OL8^PI_7JO-BHTL'5=6FL-*A.OA*.%
M<W"C0J1@I35.TNQTGX _"?1'\,SV/AFY:]\)>+KGQ[I6J:EXG\7:UK5UXTN]
M!NO"\WB;Q/K>LZ]=7_C76!X?O9[%+CQ#<ZHT40B\HHT$1C*=>K1G2G2<:7L,
M+B<%3C"$(TZ>'QE6%?%1A2C%4XU,16IJI6KQBL14G*K*55NM6YX]E'V6(HMR
ME#%5<-5JN4YSG.6"ESX2$JDI.I['#24?8X=26'IJ%.,:2C3@HSI\"?A3%\0)
M_B<OA./_ (3"?4X]=EN'UCQ!)H?_  DL6EKHB>+H_!LFJMX=A\:#1573_P#A
M(H]*35#:#[,;OR?DK/#SE@Z4Z.'?)3E[=)/WW2CB9NIBJ>'E/FEAJ6*J-U,5
M1P\J5+$5&ZE:$YZFE?\ VEQ=9N7+&A"23<55CA9<^%5>,.58CZM*TL.ZZJ.@
MXQ]DX<D;8J?LT?!&'P;XR\ 0>"$M_"WC_P 62>.O%=E;>(/%5M?:AXL?5;/6
MX]:MM>@UQ-5T>XMM4L+.>U33;VTBLS;HMK'"@VE47+#T\EI49.G#AV5*67I-
MWP\J+;IOF^*LTG[.7MW5YZ*C0GS48Q@JYG[?,L0U&53-Z=:CBU*,94ZU+$*H
MJ]-TI)TH0JNM6J3C3A"+K5JM>WMJDZDK$O[.GP>G\;VWQ$F\+7<GBJS\4V7C
M>WN7\6^-&TI/&-AX>F\*0^*#X7/B+^Q)->?P_-]CN+Y].::Z6"V>Z>:2TMWA
MJC4EATU2Y8QY,?3C%PC.-.EF<U4Q]&C&:DJ%'$U$ZDZ-%0I1J3JU(0C.M5E/
M.K"->DJ-5<\$L$G=OGJ?V=.,\%*M4352M4PTHQ5.I6E.HH+V;DZ?NG3> OA)
MX!^&$FK/X'T>\T2#6+JYNYM,/B/Q/JFA:=)>WDNH7L/AKP]K.LW>F>$+&XU"
M>6YFL]"M-.MY9G,LD32?-4TY2I8:EA(R;HT(TX0YVZE2-.C#V5"E[:IS5G1P
M].]/#T74=+#P<HT804FFZD55Q5;&S7^T5W.=1Q]R,ZE22G5K2I0Y:7MZTTI5
MZ_)[:O*,95IS<4UAK\ /A.GB74?%B^&KM=8U3Q[H_P 4+Y?^$J\8_P!C/X_T
M'2YM%TWQ1%X9_M_^QK34AIT_ESF"PB2[:WM9;M)YK.WDA,.WA(82G0]V. >8
M/#W]]T5FD:L,?&G*?-*-.NJU=^S3]G2G7K5*,:=2K4E)XC_:O;^W2E]9HX.A
M6M%0]K3R_$T,7@U4<%'GEAZ^%H.%25ZGLZ4:$I2H7ING<?LX?!N?2M&T=/"E
MWI\/A[Q5XF\:Z+J&B>+O&OA_Q'IWB3QIJ%]J?BV^@\6:'XCM-;\C5[G4;M;R
MR;4&M)X)%M9(&MHHX44/W;P+A[JR[!4LNHP_Y=O 4?9\F$KTOX>*H<U&G4G3
MQ4:RJUH^WJ\]9N;*C=58[VC<GF.)6,KR^W];C!TX8FC-6GAJ]*G*5*E4PTJ,
MZ-*4J=)PA)Q=OXJ?"*+XEQ?"ZP&MKH6B_#KXF^$?B)=:6NE?VBOB"+P9%>R:
M1H'G-J5M_9<2ZK+IUY]J,=YC^S!'Y),OF1Z4*DZ.;X7-YR=2IA*691C#2-ZV
M88&O@?;N5G;V-/$UI*"BN>4E[\$GS14IPEE./RJ$?9QQT<%2YTV_9T<+C\)C
M:E-1T<OK$,(L.Y.:Y(5)2M-^Z[%E\!_A/I_C:^^(=KX1B7Q1?ZE?ZW++-JVO
MW6B6WB#5=._LC5_$VE^$KK59-!T7Q3J&E9L[S6M/TRUU"[@)BN+F1&*G"E"-
M'"U\#37+AL11K8>4&W+EPV(K/$8C"T92;GA\+7Q#=>MAJ$J="K7M6G3E42DK
MJ_OZ]+$U-:U%T)*2]U3J86"I86K6C&T:];"THJEAJU>-2KAZ2]E1G"'NG/:+
M^R]\"_#T&G6FF>"&%EI?@OQ-\.;73K_Q1XRUG3'\!^+M1DU;7/"5_IFL>(;J
MUU70FOY7DMK2]AN$T\'R]/%K& @TJ-U:>*I56Y0QE# 8>M?XIPRM267S<_C6
M)PL92C3QD9+%N,G&5>478M5)QQ5#&1DZ>)PN,QF84IP_=^SQ6/4%C9QC#E@H
M8ETX3K4.7ZO*K%5G2]K[Y*G[,GP37P/X@^'<OA"ZOO#'BI]#?Q&-5\7^.-7\
M0ZROABYM;KPW;7_C75?$EQXCFL=*>RM8[*T.J^1:P1?9H(TMV:(W4J2JRPTZ
MEI/"8IXV%XQM/%R48U,1B(VY<75K1C&&(GBE6>)A&,*_M()(FB_JTZU3#_N)
M5L)4P'[M*"I8.I"K3>%PT8VCA*$8UZSI4\*J,:,ZDJE%0J/F+5]^SA\%=1L_
MB78W?@>V>V^+\.C6_P 05CUCQ%;2ZS!X=L[:QT.&SN;;6(YO#<5C!:6[0IHL
MFG!)D-P!]H=I6ESG[/#TO:3C'"9A/-:34Y1J0S">)6+EBE5BU4<_K"]I%.;A
M"\HPC&$Y1<4X0I2YH0C'_8GEW*XIT_J3PWU.5'V33IVJ851H59\GM*M.G252
M<O8TN2X?@#\*#->7,OAB6\NK_P =^&/B;>7&J>(_%FK2WGCGP7I.G:)X6UR\
M?4=>E>Z_L_3])TY4LY&-HTMJMQ) ]RS3-7MJU.6&J4)1H5L#/,ZN&:IQ4*57
M-X8B&.G[.'(I^VCBJT%%M>PIR5/#.A&G2Y)=*G.C4PU3GJ4*V%P.!J1=2;<L
M'EU:&(PM#GDY248UJ:G4DGS8ARJ?676C6JJ?F_PD_9BM?A[\0+OXEZ[KNC:Q
MK\4'C*T\.Z3X0T'Q=X3\'>'8/'^MZ9XB\775GX>\6_$WQL]KJFI:MI<,THTJ
M]TG3%::YEBTJ.YN[FXN*PM7ZGE[P5/FE*IAL#A*E2;C+EPV73Q4\-A\/>#KP
MP\'B;*G7Q&*=*%##T</.CAZ:HEXU+&8U8C^%0AB<1BXTM'*IB:]*&'^L8B<5
M"G.O'#PE3E4HT,/[>=:K6Q*K5/8NCZ-XJ_9_^$OC7Q5>^-/$OABYOO$.I0>#
M+;4[B#Q1XOTNQU2+X>>)1XN\%C5-#TC7[73-2DTKQ!NN8I+FSE=EDDMY6DMI
M7A:<)5G@9^TPLO9RCBUCU=*I&.,6#GE_MX1J*<83>$J.E+E24G"C5DG6H4*E
M-U[XFFJ-5MPCA<3@?=;IR>$Q<X5,10E.GRSE3J3IIVE)\BE4C!QC5JJ?,>)O
MV;_"NJ^)O VO:!<)X8M?#WQNN_CQXNT[[)?:U-X\\8R^%-4\-6LMQJ.H:V#H
MHMI+RPND$4%S B:3%;P6T"MYD:P,E@J^#FEST,LR_-<%@Z-[>PGF]9UL1B/:
M/FE.7[_&IQE[TOK>E6%.E&G(Q2^M8;,*,O=K9G6RB=>J]>:AD]3#SP^'5/2,
M(-X/"ZPY4I4IU9PJ5:U2;Z&U_9V^#MEKWB'Q):^$&@U7Q,?$<E\R^(_%9T_3
MKOQA;/:>+=4\*:*VN'3O VMZW#(_]HZGX<M-*O+UV,ES/))\]<[H4G@*N6./
M^QUZ$L+*%Y<_U257V\L'"M?VU/!NLE5^J4ZD<,JB4U24DF;RQ%66+PV.DT\3
MA*U'$PDX0Y98G#TO84,36I\OL\1B:5!>PIXC$0JUHT/W*G[+W2V_P$^%#6OA
MRQ'AB:"U\(?#?6?A)X9BM?$?BJS&C> /$%GI5AK&BV;6NN1LEU<6>B:7%_:I
M+:E&+0>5>(7<OT8^I/,I9S/'/V\L_5*./;2A[>%&K5KTX>YR^RA[6M4E.%'V
M<*J<8U5.%.G&.&";RZ&6TL&W2IY1B7C,+%OVBIXEPE3]M/VO/[::A*:C[?VJ
MCSU'%*4YMTY_V=?@W<V&M:9/X-5[#7_ 7A3X8ZC;G7O$Z@>"/ \MW/X3T?37
M76@^B3:;=7UQ<1:AIK6E\9_+GDN7F@B>.\17K8JIB:M:K)UL5F4,WJ58/V=7
M^T:2I1I8J%6ER5*,J:HP]G"E*%*#YY1IIU*CG&&I4\%1P6&H0BL-E^$Q& HT
M:B5:DL)BTEBJ-6E6]I"O'$Q2A7>(C5G5@E3G*4$HJBO[,GP533KS3$\*ZDJW
MWQ"TWXK76I+XY^("^)'^(FD:?9Z58^*E\6CQ3_;<.HKIUC!!((M02*=&G$\<
MOVJ<S*%:=*IEE6ERTGD\L9+"1A"$*=+Z_4KU<9!THQ5.K1Q,L3656A6A4HRI
MS]C[-48PA%3I0J4<;AZKG4IX_#83"5^>I4E.=# .E+!I5)2=2G4PTZ%*I2KT
MY0KQJP57VGM+R':M^S/\%]8DUN:[\+:E;W>O^-YOB/>:AI'CCQ_X?U2S\;76
MD_V%J.O^'M4T'Q19W?A.XU#1MUG?Q:)-I\%_#+*E[%.)7WXTHJA2PF'II*A@
MHXNE2IR]^#H8^O\ 6<7A*L9\RQ&"K8C]]+!8A5<(JGOQHQ>IK-N=7$UI.]7%
MQP4:DMFWET%2P-6-OX>)PU.,:<,53Y,3R1C&5648I*W>_LY?!:^T_5-)E\#6
MD&DZO\-X?A%>:5INJZ_I&F)\.H;VYU >&M/T_2M6M[?2(9+R[GDFNK".VN[C
M*K/<2+&@35U9RJ5JLGSU*^+R_'5'-*?/B,J=\O;4DU['"W:AA;?56I2C.C)2
MDF0;IO#.#<9X2&80I3N_:+^U?9/,*DJE^>I7Q3HTI3Q%24JZE#GA4C)R;[[P
MMX"\)>";KQ+>>&-'CTFX\7:M::WXA:.ZO[A+[4K#0M)\-6<R0WEU+'81PZ)H
M>EVJV]HD$(%J'\OS))'=RKU9TJ=&<W*G2J8FK%.S?M,9B*F+Q,W+XI.IB*LY
MOF;Y;J$.6G&,5G&G"#IN*Y?88?#X2FKNT,/A(RAAZ48WM&--3EJES3E*4YN4
MVY/KZR+"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * /G_PY_P G3_&3_L@'[-/_ *L7]K&@
M#Z H * "@#\]?V:OVJ?@_P"'?V<O@!X?U,_%0:EH7P3^%6CZA_9W[/7[0>M:
M>+[3/ N@V5W]AUG1?A?=Z?JUGY\$GE7MA=7-M.FV6":2)T=MXX7$M)QPU646
MDTU3FTUT::5FFMFC)UZ$6XNM3BXZ-.<4TUHTU?2Q[7_PV#\$?7XP?^(S?M+?
M_.CI_5,7_P! M7_P7/\ ^1%]8P__ #_I_P#@<?\ ,/\ AL'X(^OQ@_\ $9OV
MEO\ YT='U3%_] M7_P %S_\ D0^L8?\ Y_T__ X_YA_PV#\$?7XP?^(S?M+?
M_.CH^J8O_H%J_P#@N?\ \B'UC#_\_P"G_P"!Q_S#_AL'X(^OQ@_\1F_:6_\
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M_P#@<?\ ,/\ AL'X(^OQ@_\ $9OVEO\ YT='U3%_] M7_P %S_\ D0^L8?\
MY_T__ X_YA_PV#\$?7XP?^(S?M+?_.CH^J8O_H%J_P#@N?\ \B'UC#_\_P"G
M_P"!Q_S#_AL'X(^OQ@_\1F_:6_\ G1T?5,7_ - M7_P7/_Y$/K&'_P"?]/\
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M.CZIB_\ H%J_^"Y__(A]8P__ #_I_P#@<?\ ,/\ AL'X(^OQ@_\ $9OVEO\
MYT='U3%_] M7_P %S_\ D0^L8?\ Y_T__ X_YA_PV#\$?7XP?^(S?M+?_.CH
M^J8O_H%J_P#@N?\ \B'UC#_\_P"G_P"!Q_S#_AL'X(^OQ@_\1F_:6_\ G1T?
M5,7_ - M7_P7/_Y$/K&'_P"?]/\ \#C_ )A_PV#\$?7XP?\ B,W[2W_SHZ/J
MF+_Z!:O_ (+G_P#(A]8P_P#S_I_^!Q_S#_AL'X(^OQ@_\1F_:6_^='1]4Q?_
M $"U?_!<_P#Y$/K&'_Y_T_\ P./^8?\ #8/P1]?C!_XC-^TM_P#.CH^J8O\
MZ!:O_@N?_P B'UC#_P#/^G_X''_,/^&P?@CZ_&#_ ,1F_:6_^='1]4Q?_0+5
M_P#!<_\ Y$/K&'_Y_P!/_P #C_F'_#8/P1]?C!_XC-^TM_\ .CH^J8O_ *!:
MO_@N?_R(?6,/_P _Z?\ X''_ ##_ (;!^"/K\8/_ !&;]I;_ .='1]4Q?_0+
M5_\ !<__ )$/K&'_ .?]/_P./^8?\-@_!'U^,'_B,W[2W_SHZ/JF+_Z!:O\
MX+G_ /(A]8P__/\ I_\ @<?\P_X;!^"/K\8/_$9OVEO_ )T='U3%_P#0+5_\
M%S_^1#ZQA_\ G_3_ / X_P"8?\-@_!'U^,'_ (C-^TM_\Z.CZIB_^@6K_P""
MY_\ R(?6,/\ \_Z?_@<?\P_X;!^"/K\8/_$9OVEO_G1T?5,7_P! M7_P7/\
M^1#ZQA_^?]/_ ,#C_F'_  V#\$?7XP?^(S?M+?\ SHZ/JF+_ .@6K_X+G_\
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M#_AL'X(^OQ@_\1F_:6_^='1]4Q?_ $"U?_!<_P#Y$/K&'_Y_T_\ P./^8?\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M]-RE7G5G4]WV7PU\/M+\,ZW=>(;?5/$.J:I>^%_#WA2[N->U0:K+<6?AN_\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 >=?L4?\G9?M\_\ =K/_ *K7Q77QN:_[_7_[<_\ 3<#Z3+_]TI?]O?\
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M.O\ YG* #_AD[]EC_HVGX ?^&;^'7_S.4 '_  R=^RQ_T;3\ /\ PS?PZ_\
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M=?\ S.4 '_#)W[+'_1M/P _\,W\.O_F<H /^&3OV6/\ HVGX ?\ AF_AU_\
M,Y0 ?\,G?LL?]&T_ #_PS?PZ_P#F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\
M#)W[+'_1M/P _P##-_#K_P"9R@ _X9._98_Z-I^ '_AF_AU_\SE !_PR=^RQ
M_P!&T_ #_P ,W\.O_F<H /\ AD[]EC_HVGX ?^&;^'7_ ,SE !_PR=^RQ_T;
M3\ /_#-_#K_YG* #_AD[]EC_ *-I^ '_ (9OX=?_ #.4 '_#)W[+'_1M/P _
M\,W\.O\ YG* #_AD[]EC_HVGX ?^&;^'7_S.4 '_  R=^RQ_T;3\ /\ PS?P
MZ_\ F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\,G?LL?\ 1M/P _\ #-_#K_YG
M* #_ (9._98_Z-I^ '_AF_AU_P#,Y0 ?\,G?LL?]&T_ #_PS?PZ_^9R@ _X9
M._98_P"C:?@!_P"&;^'7_P SE !_PR=^RQ_T;3\ /_#-_#K_ .9R@ _X9._9
M8_Z-I^ '_AF_AU_\SE !_P ,G?LL?]&T_ #_ ,,W\.O_ )G* #_AD[]EC_HV
MGX ?^&;^'7_S.4 '_#)W[+'_ $;3\ /_  S?PZ_^9R@ _P"&3OV6/^C:?@!_
MX9OX=?\ S.4 '_#)W[+'_1M/P _\,W\.O_F<H /^&3OV6/\ HVGX ?\ AF_A
MU_\ ,Y0 ?\,G?LL?]&T_ #_PS?PZ_P#F<H /^&3OV6/^C:?@!_X9OX=?_,Y0
M ?\ #)W[+'_1M/P _P##-_#K_P"9R@ _X9._98_Z-I^ '_AF_AU_\SE !_PR
M=^RQ_P!&T_ #_P ,W\.O_F<H /\ AD[]EC_HVGX ?^&;^'7_ ,SE !_PR=^R
MQ_T;3\ /_#-_#K_YG* #_AD[]EC_ *-I^ '_ (9OX=?_ #.4 '_#)W[+'_1M
M/P _\,W\.O\ YG* #_AD[]EC_HVGX ?^&;^'7_S.4 '_  R=^RQ_T;3\ /\
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M&_\ L@'[2W_JQ?V3J\\ZCZ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^?_  Y_R=/\9/\
ML@'[-/\ ZL7]K&@#Z H * "@ H * "@#Y_\ #G_)T_QD_P"R ?LT_P#JQ?VL
M: /H"@ H * /G_\ 9._Y-8_9I_[(!\&__5=>'* /H"@ H * "@ H * "@ H
M* "@ H * "@ H * /E#XL?$+P#\-?VDO@GKOQ%\<>#_ &B7?P/\ VD=)M=8\
M:^)M%\*Z5<ZK/X\_99O(-,M]0UV]M;>;4)+2POITMTD,C1V<[A2L+E3;R#;R
M.O\ ^&L?V6/^CEO@!_X>3X=?_-'0 ?\ #6/[+'_1RWP _P##R?#K_P":.@ _
MX:Q_98_Z.6^ '_AY/AU_\T= !_PUC^RQ_P!'+? #_P /)\.O_FCH /\ AK']
MEC_HY;X ?^'D^'7_ ,T= !_PUC^RQ_T<M\ /_#R?#K_YHZ #_AK']EC_ *.6
M^ '_ (>3X=?_ #1T '_#6/[+'_1RWP _\/)\.O\ YHZ #_AK']EC_HY;X ?^
M'D^'7_S1T '_  UC^RQ_T<M\ /\ P\GPZ_\ FCH /^&L?V6/^CEO@!_X>3X=
M?_-'0 ?\-8_LL?\ 1RWP _\ #R?#K_YHZ #_ (:Q_98_Z.6^ '_AY/AU_P#-
M'0 ?\-8_LL?]'+? #_P\GPZ_^:.@ _X:Q_98_P"CEO@!_P"'D^'7_P T= !_
MPUC^RQ_T<M\ /_#R?#K_ .:.@ _X:Q_98_Z.6^ '_AY/AU_\T= !_P -8_LL
M?]'+? #_ ,/)\.O_ )HZ #_AK']EC_HY;X ?^'D^'7_S1T '_#6/[+'_ $<M
M\ /_  \GPZ_^:.@ _P"&L?V6/^CEO@!_X>3X=?\ S1T '_#6/[+'_1RWP _\
M/)\.O_FCH /^&L?V6/\ HY;X ?\ AY/AU_\ -'0 ?\-8_LL?]'+? #_P\GPZ
M_P#FCH /^&L?V6/^CEO@!_X>3X=?_-'0 ?\ #6/[+'_1RWP _P##R?#K_P":
M.@ _X:Q_98_Z.6^ '_AY/AU_\T= !_PUC^RQ_P!'+? #_P /)\.O_FCH /\
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M2K75;?QY^U->3Z9<:AH5[=6\.H1VE_8SO;O(LBQWD#E0LJ%@#ZOH * "@ H
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M /\ A3?Q%_Z.Q_: _P#"<_98_P#H:: #_A3?Q%_Z.Q_: _\ "<_98_\ H::
M/,/B]X0^+7@#PII.NZ/^U3\<+F[O_BA\$/!4T>I^%_V89K9-*^)7QH\ ?#G7
M;B-+7]G2W==0@T3Q5J$]H[2-''=0V[S13PH\$P!Z?_PIOXB_]'8_M ?^$Y^R
MQ_\ 0TT '_"F_B+_ -'8_M ?^$Y^RQ_]#30 ?\*;^(O_ $=C^T!_X3G[+'_T
M-- 'F'QN\(?%KX:_!?XN_$70OVJ?CA=ZWX ^%_C[QKHUKJWA?]F&?2KG5?"O
MA35M=T^WU."S_9TM9YM/DN["%)D@N;>1HV<)+&Q#J 'P0\(?%KXE?!?X0_$7
M7?VJ?CA::WX_^%_@#QKK%KI/A?\ 9AM]*M=5\5>%-)UW4+?3(+S]G2ZGAT^.
M[OYDA2>YN)%C5 \LC NP!Z?_ ,*;^(O_ $=C^T!_X3G[+'_T-- !_P *;^(O
M_1V/[0'_ (3G[+'_ -#30 ?\*;^(O_1V/[0'_A.?LL?_ $-- &A^SQKGB;7O
MAM/+XN\2:AXOUO1?BA\>/!3>)-6L?#VG:KJNE?#SXZ?$?P'X=N-3M/"FB:/I
M":@OAWPWI44SV.F64<LD3R^4K2-D ]PH * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /
MG_PY_P G3_&3_L@'[-/_ *L7]K&@#Z H * "@#Y__9._Y-8_9I_[(!\&_P#U
M77AR@#Z H * "@#\[;+X)6WQ'_:G^/7B>\T#X ZQ:>&?&7PE6Y;XH? 6/XF^
M-4@M_AQX6OY8O!WC:7X@:.G@XE 3"7T?5EANB+HI*!Y!61*.$P4L:URO^VLU
M<)8;_9L5&I2HX!TIRQ5JO,J564)TXJE"4$JD8S4JBJ4]\\4<2\MP,ESPEP[A
MU*%?]]A7&MG/$<))X9J"?,H.->]1JM#V<&H*G>? /\2_BO;>'_CE?>%OB#+X
M&M/AKX1_:9^(.G:7X6\#?#""TUCQ+X>^-'Q7T/1I=<&I>";P36RVNE6<]X]N
MMO>ZA=VZ75U>O)->&_VPL95J>6*4W+FPO ^&IPE=TJ:SF&(IXN:A%PFN54:?
MU>C3J4J%!*48T^5Q4/:GA,/5XLRS+94[T,?BZOUB;G4E6G3P>4\)5:='VDIN
MT9/,,3"4Y*56-&4*5&=*-&C[/TT^-_C/X5US4Q?_ !>UGQ3I_A/XM_L_>'FL
MM4\)?#FP_P"$BTGXU3>%M,\2:3K4^A^#[.2#3=(DUV2ZT5],>POHGCV:K?:M
M$0HZLNIT<1F%/"SI?N_[1XBRO64N9T\LR.6<87%S<7%/&JO;#U7!0P4\*K+!
M1Q#>(/CY5*_]F5,4JO+5ED669U?E34*U;-<9@:^%IQZ82KA\*I/VCJXJ->I*
M=/$PI1C1.T^-FA>(M2_:0^$NM>#;N>#Q?X,^#?Q@\2Z#8BZD@T[Q&UMXP^$%
MKJ7A368ED6.:PU?2KJ\LTDE#"TNI;.^0&2R4'ER^I]3CQ-CW3J5Z-"'#U'$T
M*:4YUL'6J<12KJC"3C'ZY1E0I8G!RYH-UJ*PTZD<-B<3&?HXVFL1@\DP;J_5
MW6S#'2HUFW&-'$T\#1^KU*KC&;EAFYRI8NFHRE+"U:WLN7$1HU*?QMX6\&R_
M'?6? ,^@>&OA)J]Q<0_MO>+-)T#]HKX/77Q&T-+B7]HSPZ+6QNO#4OBC0;CP
MKX@6:]6VEU%FO7M8S>0_8Y3+E-ZN'J4,KJXC#PP^,GA.'."8TGRVJ5E5PN>3
MA]7Q4G^XI58TTYPG1E[67L'-T?8M2[<UQ-.KF4:5:5?"1J9NZ->,9)JC4PW#
MN34J\:E*/NXET:L)QA*G6C3;C[2E.I"<6^JT%/V?;6U_9GTWX]3?"J+PKH^F
M?M':9XA\._&33?!>A^!_ WQ)MO$G@8ZCX#\/^'_&&H7^F:!INA7#ZE8Z%8PW
MUXR:1#;O;7$UO*)'BM5P%;,*^(A66+A6X?R^67XK$SA5Q^*HK&PC5JUJEHSE
MC8\LJ&/A"*E1K49X>I>5)MX-8NGE>8TI4886M2XFP,<90PD90PE**R3.O8SI
MK[6'Q<?JV.A6FH_6*N*6(=.E4J^RA]7?#/5KKP]\!/C'K_@FYFM/!NCW_P 4
MM9^"%U+'/<PVO@VPT=KW1I](MM9CD1_"T7B:'6WT:$1M9'2%TY;5#9&$'S<_
MKYAA.':%?$3JTL\H8+$RKSQ$83Q$6LPQO]GO%*2<I8E96\![=8B^)]I=8O\
MVGVI.14,-BN))8:G##SR6OCLJI8>&$<8X:5.6799#'1H/#N-)4WCOK:<L.U#
MVSJR@[-,\D'QK^(_PX\3:-:^/?BTVJ>"VT[]G;QSXQ\6>*?#_@70+'POI/Q0
ME^)>A^)=+FO]$\.Z=::/X*&K^&O#3P7FHF>^M)+V43ZN\$@$?MXBAAL/F$L+
M\%##YYGF5QE.=I5XTLB>.RZE4E[L/;K'2C3PZHQHO$?N</.%>K-NKQT(XBOP
MUE.;TU.IC<RRVAB)T:5-SC3>$S3AZGC,12II3J/VF79ACJF,4W4I48TI8BA#
M"QIVAQVL_'CXRZYX<\6>)_#7Q6OM'LO"7@3]K'XBZ8+#PAX%N8?$J?"?XP_V
M%\/=+U%M<\*7,D7AS_A&0EG<M9+:7UW!,)EOHKLBZK/#X5J."J58_OG1X$C4
MHU%)0=?/IYI2S*5>,'"M&3^K4W[&G4HNA6II)0BJU&KZ=2EA<7Q3E>182I*C
M@LTK8ZE[>C*,YTX8?*>&J\:F&E5C5ISE]:S'$U:=::K8>I2J22A5IRPU2AH?
M$KQOXITKXA> ='\=?$[45T_PS\;/!>O6OCB3PMX=:]\'V/C_ . /QBN-7L[.
MST;PXM@NA:3<6TSV>I:[8ZH;"WF-SK5S?P64TCY8-TJ=;-8/$/"?4H<2Y5]:
MER<]6CA:7"^/P];$U9Q^I4*WM,?*E4J*A1P]:%*EAZ5*GB\1"J^/"8JO7RW,
MFL.J_P!;R?A/,WAH0K5(1KXCB:MA*U*A3I2^MSIRAEU.JH.O5JQK5*LHS5%0
MHT^8\6_M#_M#V^F^$4C\?>"/ =C)H7B74/"OCCQUJVG>"E^-E]IGQ#\4^'?"
MBV?AN#X#_$&7QA/JW@[2O"VM2^%_!P\):Q?#Q0LND7*0R)'9E&$YYE1A/#1C
MB987))U,H2Q#JPJXW"1JYDUAWRXSEPM=RHIO'/\ LJ47'-854XU'HJ>#AAZ?
ML,?+'X.6-S*D\Q_<X>*H8:E@IX>^,G?+X?O*^,IPQ<L(\-F4<%]:PBHTN:E4
M^UO@GK/CWQ5XN^+NK^+?&E_=Z;X9\;GP5HG@:ST?PY8^&M(AC\'>!O$-QJ O
MW\,6_B74-3&I:SJD,;7NI10K;3(DMC]HC$J5[*C2RW"5H<U>>/JYG)5*KAS4
MJ6"S[.<NH4Z<:#5%\^&PV']O*3K\TZ,)49PYJTJ_D8?$5Z^.Q-"=J"P%++'.
M--2Y:M7&Y)E>-K.7MX*K"G3KUJLJ$.6E5BZM55G.'L*.%O>(_P#DZ?X-_P#9
M /VEO_5B_LG5R'I'T!0 4 % 'S_^TM_R3KPY_P!G ?LG?^M3_!N@#Z H * "
M@ H ^?\ ]D[_ )-8_9I_[(!\&_\ U77AR@#Z H * "@#Y_\ @W_R47]K'_LX
M#PY_ZRQ^S30!] 4 % !0!\_^(_\ DZ?X-_\ 9 /VEO\ U8O[)U 'T!0 4 %
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M%E[:GAJF#E1J.G&I5C3GAW6K4<1>7M'4K0A.3A2HQA]%5R'2% !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!\_\
MAS_DZ?XR?]D _9I_]6+^UC0!] 4 % !0!\__ +)W_)K'[-/_ &0#X-_^JZ\.
M4 ?0% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?/_B/_DZ?X-_]D _:6_\
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M'M)VYYQI4HRDXT:2AJ4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0!\_\ AS_DZ?XR?]D _9I_]6+^UC0!] 4
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MM(88(;>"-(XHXD1%55 !MY6#;RL7_P#AFGX=?]#'^T!_XEC^U/\ _/DH /\
MAFGX=?\ 0Q_M ?\ B6/[4_\ \^2@ _X9I^'7_0Q_M ?^)8_M3_\ SY* *%E^
MRG\)=-N=6O-.U#XX6%WKVH1ZMKMU9?M2?M/6MSK6JP:5IFA0ZGJT\'Q@5]1U
M"/1-%T;3UN+AI)%M=)LK<,(;6)$-O(-O(O\ _#-/PZ_Z&/\ : _\2Q_:G_\
MGR4 '_#-/PZ_Z&/]H#_Q+']J?_Y\E !_PS3\.O\ H8_V@/\ Q+']J?\ ^?)0
M!0D_93^$LVJV6NRZA\<)=;TW3]3TG3M8D_:D_:>?5;#2M:N=)O-8TRRU!OC
M9[73[Z[T#0I[FWBD6.>31;!Y5=K.$QFWD&WD7_\ AFGX=?\ 0Q_M ?\ B6/[
M4_\ \^2@ _X9I^'7_0Q_M ?^)8_M3_\ SY* #_AFGX=?]#'^T!_XEC^U/_\
M/DH H:G^RG\)=:MH[/6-0^.&K6D&H:3JT-KJ?[4G[3U_;0ZKH&JV6NZ%J<<%
MU\8'2/4--UO3M/U"TN%426UU86]Q"R30(Z@%_P#X9I^'7_0Q_M ?^)8_M3__
M #Y* #_AFGX=?]#'^T!_XEC^U/\ _/DH /\ AFGX=?\ 0Q_M ?\ B6/[4_\
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M^OKB1I+Q_F"A54V#8["@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M+%X59SI3PE+V4N>K6S*A7@W",\+/+<4\'-SCS/VE*I7IUH*I3<HM^Q]C[?\
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M(>%=#3XJ>$?$WAKXI7:Z)83?#W[1\/-"U3Q'JM[X:TCQ!>WO@I/$WQ-@L9[
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M6LFY3G4=E*?)=12C']W2A2CRPBE"-XTXN?+%>TJN=:IS5JM2I/0H$% !0 4
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MIH /^%-_$7_H[']H#_PG/V6/_H:: #_A3?Q%_P"CL?V@/_"<_98_^AIH /\
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MIH /^%-_$7_H[']H#_PG/V6/_H:: #_A3?Q%_P"CL?V@/_"<_98_^AIH /\
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M3I_C)_V0#]FG_P!6+^UC0!] 4 % !0!\_P#[)W_)K'[-/_9 /@W_ .JZ\.4
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M$T/H"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@#Y_\1_\ )T_P;_[(!^TM_P"K%_9.H ^@* /G_P .?\G3_&3_ +(!^S3_
M .K%_:QH ^@* "@ H ^?_P!D[_DUC]FG_L@'P;_]5UX<H ^@* "@ H * "@
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MW["?_P _.@ _X5E\'?\ I%Q_YC[]A/\ ^?G0 ?\ "LO@[_TBX_\ ,??L)_\
MS\Z #_A67P=_Z1<?^8^_83_^?G0 ?\*R^#O_ $BX_P#,??L)_P#S\Z #_A67
MP=_Z1<?^8^_83_\ GYT '_"LO@[_ -(N/_,??L)__/SH /\ A67P=_Z1<?\
MF/OV$_\ Y^= !_PK+X._](N/_,??L)__ #\Z #_A67P=_P"D7'_F/OV$_P#Y
M^= !_P *R^#O_2+C_P Q]^PG_P#/SH /^%9?!W_I%Q_YC[]A/_Y^= !_PK+X
M._\ 2+C_ ,Q]^PG_ //SH /^%9?!W_I%Q_YC[]A/_P"?G0 ?\*R^#O\ TBX_
M\Q]^PG_\_.@ _P"%9?!W_I%Q_P"8^_83_P#GYT '_"LO@[_TBX_\Q]^PG_\
M/SH /^%9?!W_ *1<?^8^_83_ /GYT '_  K+X._](N/_ #'W["?_ ,_.@#U#
MX>_ /]D3XE> ? _Q%T+]F'X'VFB>/_!_AGQKHUKJWP6^&-OJMKI7BK1;+7=/
MM]3@L]&NK>'4([2_A29(+FXC617"2R* [ '7_P##)W[+'_1M/P _\,W\.O\
MYG* #_AD[]EC_HVGX ?^&;^'7_S.4 '_  R=^RQ_T;3\ /\ PS?PZ_\ F<H
M/^&3OV6/^C:?@!_X9OX=?_,Y0 ?\,G?LL?\ 1M/P _\ #-_#K_YG* #_ (9.
M_98_Z-I^ '_AF_AU_P#,Y0 ?\,G?LL?]&T_ #_PS?PZ_^9R@ _X9._98_P"C
M:?@!_P"&;^'7_P SE !_PR=^RQ_T;3\ /_#-_#K_ .9R@ _X9._98_Z-I^ '
M_AF_AU_\SE !_P ,G?LL?]&T_ #_ ,,W\.O_ )G* #_AD[]EC_HVGX ?^&;^
M'7_S.4 '_#)W[+'_ $;3\ /_  S?PZ_^9R@ _P"&3OV6/^C:?@!_X9OX=?\
MS.4 '_#)W[+'_1M/P _\,W\.O_F<H /^&3OV6/\ HVGX ?\ AF_AU_\ ,Y0!
MX!J'@+]F_P#X2_QUX2\(_P#!//P_\1/^%=>(--\+>(?$/A;X6?LDZ9H7]NZG
MX)\(^/TL;%/'_P 1?#>JW/D^'_&V@F68Z7'#YTTL44DGDLU !_PK+X._](N/
M_,??L)__ #\Z #_A67P=_P"D7'_F/OV$_P#Y^= !_P *R^#O_2+C_P Q]^PG
M_P#/SH /^%9?!W_I%Q_YC[]A/_Y^= !_PK+X._\ 2+C_ ,Q]^PG_ //SH /^
M%9?!W_I%Q_YC[]A/_P"?G0 ?\*R^#O\ TBX_\Q]^PG_\_.@ _P"%9?!W_I%Q
M_P"8^_83_P#GYT '_"LO@[_TBX_\Q]^PG_\ /SH /^%9?!W_ *1<?^8^_83_
M /GYT '_  K+X._](N/_ #'W["?_ ,_.@ _X5E\'?^D7'_F/OV$__GYT '_"
MLO@[_P!(N/\ S'W["?\ \_.@ _X5E\'?^D7'_F/OV$__ )^= !_PK+X._P#2
M+C_S'W["?_S\Z #_ (5E\'?^D7'_ )C[]A/_ .?G0 ?\*R^#O_2+C_S'W["?
M_P _.@ _X5E\'?\ I%Q_YC[]A/\ ^?G0 ?\ "LO@[_TBX_\ ,??L)_\ S\Z
M#_A67P=_Z1<?^8^_83_^?G0 ?\*R^#O_ $BX_P#,??L)_P#S\Z #_A67P=_Z
M1<?^8^_83_\ GYT '_"LO@[_ -(N/_,??L)__/SH [#X=2_"WX:?$/P9I^C?
ML5ZA^SYK?Q.U#5_ &D>.K/PC^S'I%M<W-GX2\1_$NY\/:M>_"/XI:UKJ:?=:
M5\.M0N%5M/EM6NM-LA,T;>4Z@'V?0!\_^'/^3I_C)_V0#]FG_P!6+^UC0!]
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M14L_J4922A3PSKYE2KT8UDN:I7I4\NE5HIT:=.LYNG.IAW",JM_P+^T'XO\
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M@ H * "@ H * "@#Y_\ V3O^36/V:?\ L@'P;_\ 5=>'* /H"@ H * "@ H
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M 'T!0!\_^'/^3I_C)_V0#]FG_P!6+^UC0!] 4 % !0!\_P#[)W_)K'[-/_9
M/@W_ .JZ\.4 ?0% !0 4 % !0 4 % 'D'CWX"?"3XGOK3^//!UMXB/B(>"%U
ME;K4]<MXKT?#G6=3U_P<##8ZI!'"+'5=9U.5A"L?VI+QX+S[1 %B6Z%2>%JX
M*M0?)5R_,)9IAY63=+'RPM'!/$+F3N_JU"E35.7-23A[14U4<IM5TL11K8>M
M[U&O@ZN7U(_#S82M65>I2O&S7-62FJD6JL6DH3BE8K:_^SW\(_$K0/JGAF]6
M6#7O$WB-;C2O%OC3P_=37_C,0KXMM+VZT#Q#93:AX>U=;:V6\T&Y>;2IQ;0B
M2R(B0+S+#T8TOJ_)S4/JU?!RIR;G">'Q.)JXRI3JPDW&JUBJU3$4:E12J8>K
M)3P\Z3C'EVC6J0<W"7)*5?"8E.*47"O@,'#+\+5I.*3HSI8*"PUZ+A[2FYJK
MS^TJ.5^V^!OPML](?0;;POY6DO=?#N\>T&M>(6!N?A0VC-X D$SZL95_LIO#
M^D?*) MU]D_TT7/FR^9W_6\1];GCO:?[5/&XO,)5.6.N,Q^&6$Q=;EMR?O<.
ME3]FH^RA\=.$)^\<V&I4\%AUA<-%4J$<N>4*"NTLO<L5)X=.5VES8W$OVM_;
M+VME4M"FH9%Y^SA\&;Z30Y;GP?)_Q3][>WUG%!XF\76EM?-?^*;GQO<67B6S
MM->B@\8:*OBV\N-5ATK7H]2L;:Y<26]M%L7;ST7]7K8:O2]VI@Z&"PU&Z4H0
MIY;AOJF7S]G*].6)P6'O##8R498NBW*I"NJDI39.C3J4,5AIK]UC,1CL362;
MC*53,ZBJYC%5(M5(4,=)16+PL)1PU>G&%*K1E2A&"Y34?V4?A=JWBN'6+^SO
MV\,6_A?4/#Z^#+77_&.F6-]+KGC36O&WB-O$-[IOBN ^*_#FJZCK=RMUX9UB
MWO=+E"H)(7BCCAB6#<L%5JU8OFDJ634,/&24J>'HY'AL1A<'%TI\]*O4I0JT
M94,15@Z^'JX=5H5)5JCJ1TDK*DJ+>'G'$9QBZM2FW&M/$9Q6P%>O5HUXN-;!
MM5,'5YEAJD(U(8F5*U.E3Y)]?<?L[?"*Z\4_\)A+X<U0:NOB.P\806T7C;QY
M;>&K/Q5IUDFF0>(=.\%V_B9/#VF:N^G1K:W%U::7#)=P[HKIID=E,1IQA&4-
M9*4<=#WY2J2C3S*&*ACZ=.51RE2I8IXW$U:M*FX4WB*GUI16)A3JPF<(32CR
MJE%+"*4:25"-3ZA5PM;!2K1H\BK3PLL%A84:E93J0H48X:,EAG*DTLOV=OA%
MI6E:9H^D>%[C2[;0K_P9JNBR67BGQG:WVF:C\/M''A_PE<6VJVWB.*_1;71-
M]A/$MVJ7]M<7,-^+E+J82;SQ&(>)EC85(QQOM\5BE4G!3@\1C,+2P>(E5HIQ
MA6I5:%"C">'E^Y?LU.,85?WAK6F\3+&/$.4UF%-4<3ROV<ITUF5?-THRBOW,
MXYCB:V*IU::C4I5)14)*G2IPA9^#?PC@^%5GXSN[J_TK6?%_Q'\;ZOX_\<:]
MHGAUO">E:CK>I1VUE;Q:9X>DUK5Y-,L+32;"PMU274[Z6:5+BZFF>:[D-$)1
MHY?EN64(RCALMIU5%2<7*=;$XBKB\35?)"G&*G6K2C1IJ+]CAJ="@YU'2]I/
M.LG6S#'9A-WGBO84J<=6Z.%PE"&'PM!R;?M)QA&52M5M!5<16K3A2H4G3H4L
M/Q'_ ,G3_!O_ +(!^TM_ZL7]DZLQGT!0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0!\__ +)W_)K'[-/_ &0#X-_^JZ\.4 ?0
M% !0 4 % !0 4 8!\+Z$?%">,S8_\5+%H,OAA-2^TW@VZ'-J$.JRV/V/[1]E
M.Z_MX9?.,!F&S:) A*DIKV/UOV?N_77A77Z\_P!26+6&WOR^R6.Q7P<O/[7]
MYS<E/DF<(U)X6I-<T\$L3&B]5R+&/"/$JRLI>T>!POQJ3A[+]WR\]3GPM9^&
M/@/Q#?\ BK4M=\.6>JW7C;PKI?@GQ2M_+>7-IJ_AC1;K7+[3-+FTZ6Y-I"(+
MOQ'K,HN(((KAFNUWRMY$/DC_ -WEA4Y0HRQ4,<N24H3ABZ<*%.GB*=6#C5I5
M:2PU!TY4IP]G.G&K#EJ7F]W7J2CAH3<90PD,33IPE"$H>SQBI+%4ZD)1<*U.
MO&C3A4IUE4A*"E#EY)U(RXUOV<_@[<>!O%/PXU/PI=>(/"OC=[)_%T7BOQ9X
MS\6Z[XB;3'MFTK^U?&/B;Q#?^(+M; 6=K':*^J$6L=ND5N(XE"5;J2Y\#4M"
M,\NQ=/'T'&$(<N-I3IU(XJ:C%*M6E*C25:==5'B(05*O[2G[AE3O1G7G2G.G
M/$86>!DXSE%QPDZ=>F\-1LU]7I*.)Q#IPH>S5*I6J5:7)5DYG37/PC^'EWXN
MT_QU/X=5O%.E76B7NGZDFIZS EK<^'-#\5>&M%=-.@U%+$K;:)XU\36PC:V9
M'&I>9(KRVUN\%TL16H?6?95''ZW/%3K-VDYSQM/+Z6*DW)-IU897@4[-<OL+
MPY95:SJ9PI4Z<)4X1482PN$P3BMOJV QE3,,+2794<75G54E:<^;V=24Z2C!
M<MK'[-WP8UVTT6QU/P?))::#=:[<V<%OXF\7Z>EY#XF\1/XL\0:-XA_L[7X#
MXK\+7_B)Q?3Z!K9U#2GDBAS9[8(U2</5GA:V$KT)<E3 T,OPU%-*4(T\II*C
MEDI4IJ5.I7R^"O@\54A/$X>I*=:E6C6J3G*9X>C4I8JC.FG#&5\=B*KNU-U<
MS<Y9AR54U4HT\;SN.)HT9PHU8*%.5-TZ<(Q;??LV_!K4M1U_4KWPK>RMXDA\
M01ZCI@\8>.(?#5O-XLM)[#Q3J>@^$H/$B:)X5UW5[.ZO8;[5M%T_3[^Z6_NQ
M/</]JF\V<+.>"4%0DX^RE0E!S?M94XX;%4L;1P].57GE3P:Q5"C6G@H..#JR
MI4U5H3C%)=%24JE6C6<G"K02Y)4VZ3YX4'AJ5>7LN15,50P\G1PV+J<V)PL%
M%8>K2Y8VUO$_P+^&GB[69-=U?2]>@O;N"WM-9M_#WCSQ_P"#]%\4VEI;QV=O
M:>-_#?A'Q/IND^.K1+");,0>(;'4X_LI>U*FW=HVFFHTYU9\L9JO4E5G3JQC
M6H.K.*C*K]6K*=!59*,'*JJ:J.5.E)R<J5-QE.4:>%ITY2H_4:<:.'J4I2I5
MZ-*$W4A3IXBFXUXPA4E.<(JI:,YU)12=2;EG^(OV=OA)XFUBZU^_T'6[#6;J
MYT*^^W^%?'WQ"\#S6=_X<T:[\.:3J.DCP9XJTM=$U)?#E]<:1/=Z>MK/>:<4
ML;R2>TACACJG.=*<YQG)NI6KUZG/)U%5GB516)A5C4<HU</B)8:A5KX6HI86
MM7HT\14HRKP51#LZ-'#V4:.&P]+"TH**C&E0H5ZF)H1@HI<L\/6JUIX>JK5J
M"K5H4JD*=:I&56']F?X)VUAIVEP^#98]-TO2_%>BVM@OBGQE]D;2_&FO'Q1K
MMG?6Y\0[-3C_ .$CQJ5D;U;AM*ND2;2S9O&A52;E?5Q?U?+<+%P;IRIT\G_Y
M%DJ4J?+*CB,"G*-#%TG#%PA4JT_;.%6I&<J,(RY^2+G[?%XF3E%2<ZF8450Q
MZJ<R?M:&-IJ/UO#5.;#8FI"G6K4IUJ=.I'O_  )\.?"7PVTZ^TWPI9ZG$NJ:
M@VK:OJ6O^)?$_C/Q'K6HM;P6:WFM>*_&>L:KK6L316-I:6L)O;^?R+>T@@AV
M0PHBZ3K3G3I4GRQI4%)0A"$*<4YR<YS<:<8J52I-N=6K).I5F^:I.4M04$IN
M=Y2ER0IIRG*?+3I\WLZ5-2;5.E!RG*-*GRTXRG4FHJ4YM^;_  ;_ .2B_M8_
M]G >'/\ UEC]FFLBCZ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * /G_XR?\ )1?V3O\ LX#Q'_ZRQ^TM0!] 4 ?/_AS_ ).G^,G_
M &0#]FG_ -6+^UC0!] 4 % !0!\__LG?\FL?LT_]D ^#?_JNO#E 'T!0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % 'A_Q'^''C[7O'W@7XB_#GQUX/\ !^M^
M#_!_Q&\%75KXU^'.M?$+2M6TKXA:U\,==GN+>#0OB=X+GTO4+&[^&5BB.]S>
MQRQZI.#$C1HY-@V,_P#X1S]J?_HLGP _\1I^(O\ ]%C0 ?\ ".?M3_\ 19/@
M!_XC3\1?_HL: #_A'/VI_P#HLGP _P#$:?B+_P#18T '_".?M3_]%D^ '_B-
M/Q%_^BQH /\ A'/VI_\ HLGP _\ $:?B+_\ 18T '_".?M3_ /19/@!_XC3\
M1?\ Z+&@ _X1S]J?_HLGP _\1I^(O_T6- !_PCG[4_\ T63X ?\ B-/Q%_\
MHL: #_A'/VI_^BR? #_Q&GXB_P#T6- !_P (Y^U/_P!%D^ '_B-/Q%_^BQH
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MB+_]%C0 ?\(Y^U/_ -%D^ '_ (C3\1?_ *+&@ _X1S]J?_HLGP _\1I^(O\
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M_P#HLGP _P#$:?B+_P#18T '_".?M3_]%D^ '_B-/Q%_^BQH /\ A'/VI_\
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M4>:]2">/MZ"M^^@E[98=>_'_ 'B4*E6-#?\ C2ITJM14OC<*52:CRPDUF/\
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M/_:1U:UT;QKX9T7Q3I5KJMOX\_99LX-3M]/UVRNK>'4([2_OH$N$C618[R=
MP65PV9L=?_PR=^RQ_P!&T_ #_P ,W\.O_F<H /\ AD[]EC_HVGX ?^&;^'7_
M ,SE !_PR=^RQ_T;3\ /_#-_#K_YG* #_AD[]EC_ *-I^ '_ (9OX=?_ #.4
M '_#)W[+'_1M/P _\,W\.O\ YG* #_AD[]EC_HVGX ?^&;^'7_S.4 '_  R=
M^RQ_T;3\ /\ PS?PZ_\ F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\,G?LL?\
M1M/P _\ #-_#K_YG* #_ (9._98_Z-I^ '_AF_AU_P#,Y0 ?\,G?LL?]&T_
M#_PS?PZ_^9R@ _X9._98_P"C:?@!_P"&;^'7_P SE !_PR=^RQ_T;3\ /_#-
M_#K_ .9R@ _X9._98_Z-I^ '_AF_AU_\SE !_P ,G?LL?]&T_ #_ ,,W\.O_
M )G* #_AD[]EC_HVGX ?^&;^'7_S.4 '_#)W[+'_ $;3\ /_  S?PZ_^9R@
M_P"&3OV6/^C:?@!_X9OX=?\ S.4 '_#)W[+'_1M/P _\,W\.O_F<H /^&3OV
M6/\ HVGX ?\ AF_AU_\ ,Y0 ?\,G?LL?]&T_ #_PS?PZ_P#F<H /^&3OV6/^
MC:?@!_X9OX=?_,Y0 ?\ #)W[+'_1M/P _P##-_#K_P"9R@ _X9._98_Z-I^
M'_AF_AU_\SE !_PR=^RQ_P!&T_ #_P ,W\.O_F<H /V3O^36/V:?^R ?!O\
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M0UW2;J>'3X[N_OITMTD6-9+R=PH:5RT%'I__  R=^RQ_T;3\ /\ PS?PZ_\
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M=?\ S.4 '_#)W[+'_1M/P _\,W\.O_F<H /^&3OV6/\ HVGX ?\ AF_AU_\
M,Y0 ?\,G?LL?]&T_ #_PS?PZ_P#F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\
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M:5/)O;Z=5F92MMG,BY8:E"C4SFI57/\ 7UE,:4&W*ERX)9Q]86(H2?L:G/\
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M5G&3JU)XFHJL*5"U\&_^2B_M8_\ 9P'AS_UEC]FFN<Z3Z H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * /G_XR?\E%_9._[. \1_\
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M\1._:G_^<W0 ?\-+?#K_ *%S]H#_ ,1._:G_ /G-T '_  TM\.O^A<_: _\
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M- !_PIOXB_\ 1V/[0'_A.?LL?_0TT '_  IOXB_]'8_M ?\ A.?LL?\ T--
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M^AIH /\ A3?Q%_Z.Q_: _P#"<_98_P#H:: #_A3?Q%_Z.Q_: _\ "<_98_\
MH:: #_A3?Q%_Z.Q_: _\)S]EC_Z&F@ _X4W\1?\ H[']H#_PG/V6/_H:: #_
M (4W\1?^CL?V@/\ PG/V6/\ Z&F@ _X4W\1?^CL?V@/_  G/V6/_ *&F@ _X
M4W\1?^CL?V@/_"<_98_^AIH /^%-_$7_ *.Q_: _\)S]EC_Z&F@ _P"%-_$7
M_H[']H#_ ,)S]EC_ .AIH /^%-_$7_H[']H#_P )S]EC_P"AIH /^%-_$7_H
M[']H#_PG/V6/_H:: #_A3?Q%_P"CL?V@/_"<_98_^AIH /\ A3?Q%_Z.Q_:
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M7Q?\1/$_A^9?#G]C1>/_ (:?&#X?2Z?KRP:HWB7^R9/CU\7?&WC+5D??I:7
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MKTDZF)I+$0G&EZIXC_Y.G^#?_9 /VEO_ %8O[)U><,^@* "@ H * "@ H *
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MK*$G2]DRI\&_^2B_M8_]G >'/_66/V::DW/H"@ H * "@ H * "@ H * "@
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MLG4 ?0% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'S_P#M+?\
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M[-- CZ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M/G_XR?\ )1?V3O\ LX#Q'_ZRQ^TM0!] 4 ?/_AS_ ).G^,G_ &0#]FG_ -6+
M^UC0!] 4 % !0!^;7[-_[3MUX?\ V=_@+H2_L^_'#65T3X+_  MTA=8TF^^
M2:5JHTWP/H5F-3TQ-9^.NGZ@FGW0A\^$7UA97(CE03V\$NZ).Z&6XV<(3A1O
M"24HOGIK1JZ=G)-:=]3DECL+3E*$JMI0;37+/=.SVC;H>S_\-9WG_1M7Q_\
M_!A^SA_]$-5?V5C_ /GQ_P"3T_\ Y,7U_"?\_?\ R6?_ ,B'_#6=Y_T;5\?_
M /P8?LX?_1#4?V5C_P#GQ_Y/3_\ DP^OX3_G[_Y+/_Y$/^&L[S_HVKX__P#@
MP_9P_P#HAJ/[*Q__ #X_\GI__)A]?PG_ #]_\EG_ /(A_P -9WG_ $;5\?\
M_P &'[.'_P!$-1_96/\ ^?'_ )/3_P#DP^OX3_G[_P"2S_\ D0_X:SO/^C:O
MC_\ ^##]G#_Z(:C^RL?_ ,^/_)Z?_P F'U_"?\_?_)9__(A_PUG>?]&U?'__
M ,&'[.'_ -$-1_96/_Y\?^3T_P#Y,/K^$_Y^_P#DL_\ Y$/^&L[S_HVKX_\
M_@P_9P_^B&H_LK'_ //C_P GI_\ R8?7\)_S]_\ )9__ "(?\-9WG_1M7Q__
M /!A^SA_]$-1_96/_P"?'_D]/_Y,/K^$_P"?O_DL_P#Y$/\ AK.\_P"C:OC_
M /\ @P_9P_\ HAJ/[*Q__/C_ ,GI_P#R8?7\)_S]_P#)9_\ R(?\-9WG_1M7
MQ_\ _!A^SA_]$-1_96/_ .?'_D]/_P"3#Z_A/^?O_DL__D0_X:SO/^C:OC__
M .##]G#_ .B&H_LK'_\ /C_R>G_\F'U_"?\ /W_R6?\ \B'_  UG>?\ 1M7Q
M_P#_  8?LX?_ $0U']E8_P#Y\?\ D]/_ .3#Z_A/^?O_ )+/_P"1#_AK.\_Z
M-J^/_P#X,/V</_HAJ/[*Q_\ SX_\GI__ "8?7\)_S]_\EG_\B'_#6=Y_T;5\
M?_\ P8?LX?\ T0U']E8__GQ_Y/3_ /DP^OX3_G[_ .2S_P#D0_X:SO/^C:OC
M_P#^##]G#_Z(:C^RL?\ \^/_ ">G_P#)A]?PG_/W_P EG_\ (G >.OBW\-_B
MA_9?_"R_V'_B!\1/["^W?V)_PG7AW]D[Q;_8_P#:?V/^TO[+_M_XZ7?]G_:O
M[/L//\CR_-^PV_F;O)3:?V5C_P#GQ_Y/3_\ DP^OX3_G[_Y+/_Y$\_W_ +,G
M_2-3_P Q7^Q7_P#/CH_LK'_\^/\ R>G_ /)A]?PG_/W_ ,EG_P#(AO\ V9/^
MD:G_ )BO]BO_ .?'1_96/_Y\?^3T_P#Y,/K^$_Y^_P#DL_\ Y$-_[,G_ $C4
M_P#,5_L5_P#SXZ/[*Q__ #X_\GI__)A]?PG_ #]_\EG_ /(AO_9D_P"D:G_F
M*_V*_P#Y\=']E8__ )\?^3T__DP^OX3_ )^_^2S_ /D0W_LR?](U/_,5_L5_
M_/CH_LK'_P#/C_R>G_\ )A]?PG_/W_R6?_R(;_V9/^D:G_F*_P!BO_Y\=']E
M8_\ Y\?^3T__ ),/K^$_Y^_^2S_^1#?^S)_TC4_\Q7^Q7_\ /CH_LK'_ //C
M_P GI_\ R8?7\)_S]_\ )9__ "(;_P!F3_I&I_YBO]BO_P"?'1_96/\ ^?'_
M )/3_P#DP^OX3_G[_P"2S_\ D0W_ +,G_2-3_P Q7^Q7_P#/CH_LK'_\^/\
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M +,G_2-3_P Q7^Q7_P#/CH_LK'_\^/\ R>G_ /)A]?PG_/W_ ,EG_P#(AO\
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M_(A_PUG>?]&U?'__ ,&'[.'_ -$-1_96/_Y\?^3T_P#Y,/K^$_Y^_P#DL_\
MY$/^&L[S_HVKX_\ _@P_9P_^B&H_LK'_ //C_P GI_\ R8?7\)_S]_\ )9__
M "(?\-9WG_1M7Q__ /!A^SA_]$-1_96/_P"?'_D]/_Y,/K^$_P"?O_DL_P#Y
M$/\ AK.\_P"C:OC_ /\ @P_9P_\ HAJ/[*Q__/C_ ,GI_P#R8?7\)_S]_P#)
M9_\ R(?\-9WG_1M7Q_\ _!A^SA_]$-1_96/_ .?'_D]/_P"3#Z_A/^?O_DL_
M_D0_X:SO/^C:OC__ .##]G#_ .B&H_LK'_\ /C_R>G_\F'U_"?\ /W_R6?\
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MW_R6?_R(?\-9WG_1M7Q__P#!A^SA_P#1#4?V5C_^?'_D]/\ ^3#Z_A/^?O\
MY+/_ .1/(/%/B_X'>.-=OO%/C7_@GUX@\7^)M4^R_P!I>(_%/@3]CSQ!KNH_
M8;.WTZR^W:OJWQLGN[O[/I]I:6L7FROY<-K%$F$C50?V5C_^?'_D]/\ ^3#Z
M_A/^?O\ Y+/_ .1.?W_LR?\ 2-3_ ,Q7^Q7_ //CH_LK'_\ /C_R>G_\F'U_
M"?\ /W_R6?\ \B&_]F3_ *1J?^8K_8K_ /GQT?V5C_\ GQ_Y/3_^3#Z_A/\
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M ">G_P#)A]?PG_/W_P EG_\ (AO_ &9/^D:G_F*_V*__ )\=']E8_P#Y\?\
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M &9/^D:G_F*_V*__ )\=']E8_P#Y\?\ D]/_ .3#Z_A/^?O_ )+/_P"1#?\
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M=)K5-K9KJ=-.I"K!5*;YH2O9V:V;3T:3W1]OUF6% !0!^4W[//\ R0'X'?\
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M--RYZ<:U*G"59JC/VE)JE&5&:J3^D:V$% !0 4 % !0 4 % !0 4 % !0 4
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MZ<96;C[2,/:<DI)-0G*"G.G&;BZL:59TU)4:O)L4@"@ H * "@ H * "@ H
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0!\_^'/^3I_C)_V0#]FG_P!6+^UC0!] 4 % !0!\_P#[)W_)K'[-
M/_9 /@W_ .JZ\.4 ?0% !0!\0?L]?!+POXX^ 7P/\:^*?&7[0&J>)O%_P?\
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MU9-/7Q%X;T*^>WBODCEDTN#S5=5VD_0/T+__  S3\.O^AC_: _\ $L?VI_\
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M4],U"SDCGL-0M;N&&>&X@D22*2)'1E900 9__#-/PZ_Z&/\ : _\2Q_:G_\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 <?X[\=^&?AKX9NO%WBZZU"TT2TU#P_I+-I/A_Q#XJU6YU7Q5XATKP
MIX=TS3/#OA32M2U?6-0O_$6MZ58PV]C8W$C27B?*%#,H!Y?_ ,-+?#K_ *%S
M]H#_ ,1._:G_ /G-T '_  TM\.O^A<_: _\ $3OVI_\ YS= !_PTM\.O^A<_
M: _\1._:G_\ G-T '_#2WPZ_Z%S]H#_Q$[]J?_YS= !_PTM\.O\ H7/V@/\
MQ$[]J?\ ^<W0 ?\ #2WPZ_Z%S]H#_P 1._:G_P#G-T '_#2WPZ_Z%S]H#_Q$
M[]J?_P"<W0 ?\-+?#K_H7/V@/_$3OVI__G-T '_#2WPZ_P"A<_: _P#$3OVI
M_P#YS= !_P -+?#K_H7/V@/_ !$[]J?_ .<W0 ?\-+?#K_H7/V@/_$3OVI__
M )S= !_PTM\.O^A<_: _\1._:G_^<W0 ?\-+?#K_ *%S]H#_ ,1._:G_ /G-
MT '_  TM\.O^A<_: _\ $3OVI_\ YS= !_PTM\.O^A<_: _\1._:G_\ G-T
M'_#2WPZ_Z%S]H#_Q$[]J?_YS= !_PTM\.O\ H7/V@/\ Q$[]J?\ ^<W0 ?\
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MW2M5U73?#VM^*[O3+?Q%X\^'&CZ0FH+X=\-Z[?);RWR22QZ7/Y2NR[2 >X4
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M#G_9P'[)W_K4_P &Z /H"@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M+QJWQV\6^+? GB#X=?\ "Q/C!IWBGP]X>\4ZEX)U/7?["TSX'?!?P ]]?/X
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MIQ=>OE;49<V#P^(J4:LL&H3G5A.G&&'P^$E.K[6I.&$HXNB\)B)N-+L/#_P
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M /\ A<GQ%_Z-._: _P#"C_98_P#HEJ #_A<GQ%_Z-._: _\ "C_98_\ HEJ
M#_A<GQ%_Z-._: _\*/\ 98_^B6H /^%R?$7_ *-._: _\*/]EC_Z):@ _P"%
MR?$7_HT[]H#_ ,*/]EC_ .B6H /^%R?$7_HT[]H#_P */]EC_P"B6H /^%R?
M$7_HT[]H#_PH_P!EC_Z):@ _X7)\1?\ HT[]H#_PH_V6/_HEJ #_ (7)\1?^
MC3OV@/\ PH_V6/\ Z):@ _X7)\1?^C3OV@/_  H_V6/_ *):@ _X7)\1?^C3
MOV@/_"C_ &6/_HEJ #_A<GQ%_P"C3OV@/_"C_98_^B6H /\ A<GQ%_Z-._:
M_P#"C_98_P#HEJ #_A<GQ%_Z-._: _\ "C_98_\ HEJ #_A<GQ%_Z-._: _\
M*/\ 98_^B6H /^%R?$7_ *-._: _\*/]EC_Z):@ _P"%R?$7_HT[]H#_ ,*/
M]EC_ .B6H Y#5M6^)/Q)^)/P"EE^ 7Q0\ :)\/\ XH>(/&OB3Q)XU\0? N?2
MK72I_@7\9O =I;V]IX#^,WB;5KO4)_$7CC0HD2+3#&L;3RRRQK#\QL&Q]7T
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M59TZV%=*A3EUI^'GQSO?&&GZ#JNM?$-/"U^W@W4?%_C#1/'\&FZ>ZP67Q/\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H ^?_  Y_R=/\9/\ L@'[-/\ ZL7]K&@#Z H * "@
M#Y__ &3O^36/V:?^R ?!O_U77AR@#Z H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#Y_P##G_)T_P 9
M/^R ?LT_^K%_:QH ^@* "@ H ^?_ -D[_DUC]FG_ +(!\&__ %77AR@#Z H
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MZT:Y\-Z==>,KSP]?W6B^';O5(=8GTA=9TGPUINL>*1]MM;5DO_%NI>(]1C6
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /G_PY_P G
M3_&3_L@'[-/_ *L7]K&@#Z H * "@#Y__9._Y-8_9I_[(!\&_P#U77AR@#Z
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@#Y_\ #G_)T_QD_P"R ?LT_P#JQ?VL: /H"@ H * /G_\
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MYW.3<_=2C=^CVOC7PQ-;PO<ZWH^EW9U2V\/7FE7VN:$U_I?BJXTZ'53X1O\
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M'# 3=2%>./E2A#V,E4]E.K3S*I&-?;V4DLJQ,6G=N7*H<_+7='Z(K$D* "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@#Y_\.?\G3_&3_L@'[-/_JQ?VL:
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@#Y_\.?\ )T_QD_[(!^S3_P"K%_:QH ^@* "@ H ^?_V3
MO^36/V:?^R ?!O\ ]5UX<H ^@* "@ H * "@ H * "@ H * "@ H * "@ H
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M$III.+3BU=-;6Z--=!U(84 ?/_AS_DZ?XR?]D _9I_\ 5B_M8T ?0% !0 4
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M.QPK>?$O1?ATT5K>'5I8].TO47DOI+NZ97F7+AL/B89?.<73<*F$HU[2IR>
MP5;!Y72QE2FZ;:E_:>95\;5PU*A*%;#X189*,W.BZ%23KX2KCJ,*DXQJTL3.
MDW&FZ>/Q.#_M&&'H5(U)QI1R[!5,#A8UL14E*GF%3VCI_55]8]8L/V;O$VIZ
MIH^H>,O#_P -)],TNR\/W$G@^TGO-0\-WNJ>"?!MPWAFQO+;4/#B)=V,OQ5\
M8^./$=S=RPM-OTK0)VCGN/,%M>-G&/\ :L\M2]I-9G4RY5H1@L'6Q'U7+\O4
M?9.2A1P.2X2K2A3C"2IU\UQL*,80IPG4PPL)_5LOPN-KS<(K!4<PE!^T>*A[
M?$X_-<3!U.64<3C\;3R:-3VDJCKX?+Y1JU8JK*#\7\$?![Q+=^,=+^$FN>!M
M.\1:!X:\2?#VXUKQUK&@>)-*3PIX?^'MAIOB[5M'\'P:WX+30KG3_$WQ9AO+
MM+C0M?\ /ET_7MDUE&NDG[-T8&KA57IXW#PGA,-E-3%RPTJTN?%XE87#K)LB
MPU9R=.O2>!PL%CGR_6L,ZF'J8AU82S>,9SCDXT9T(THPQ>;8:5/$T:-ZF!H5
M<WQ^+S7/,10Y^:G[.MA,9'*83G&GBU6I48\DE@74I?1GQ<^!WBWQK\18OB%:
M:1X%\26^EW'@K1[;PIXCO;C2EU[P7I$/BO5/$.G:AKT'AK4I-.%]XOUKPW<3
M61M;^VN[+P@+:8*NH2H//P?^RU*U65"%2IB<16G)\[4(QI8&E0RJI.FX3C6G
MA,35S*OR6A*%6O@\33JRK8"C$[,1[+$X=8:5XJAA5&A.*:JQQ&(S/"ULR@Y*
MHE["OEF7X;"TN7D?-B,=2K<U&O>-[X3_ +.-OX2\73^*_&>F^"]8N-+CU&_\
M$6FG:3!)8^"_$'C+Q9K7C'QQ<^&K>[TV)=%A,T_AG2[6>V5)Y8/#/VJ;RIKZ
M6,=5"<<+AG2I3J2Q,8T,(L1*3]I4P.&PWNIIRG*A[?'8W-:E3"PJ5*-/"RP.
M&52I##1Y>?$NIC*T)5:5.CA[O$2H0E4E3^M<F&P='FC*U.K+"8#+<$X8ITZ=
M2>,Q>95(TL/3J0@>:ZE^RSXH\2WWQ,UWQ%HGPNF\1>(I?B??>%[^5'UFW'B3
MQWJ<?AW0/%^K6VH>%(_LNK>&?A7I.DV%HD;7N;K5-943(ETTLG)0HT5EV$R^
MNI.$H8'#8KDER3IX7$9EBLRXD6&K1Y7SYA4Q%*&%;ITYTJ6"PU.=5I.1UUJ_
M)F,L=AH*K"C5^M4J.(NXU:^7Y1@<%DM*LTW*EA5BH9C5QM&E>+EB*>(IJ56*
MC#4^'/[+WB'0OBG%XK\7W]O?Z5X5\5W^O>$-2MM?M;R\FTRRTJX\,^ ] &D7
M'@*#4O#]CHOA.Z-E<PKXNU"UNKBWEG6T7^T9C%W8?%32K8NO[N85UC/;6?-&
MMB,PKU)XO%3J05#FA*FX1P^'K4L1+#I4:4:ZAE^'G6\^KAJ5.GA\#@DX9=0P
M^58>*E)\U.EE>'PDHTH0E[11=7,L//%3G2E1C*%2IS0E4Q-7D]2T3P?\8O#G
MBWQ_;:3;^ AH'CKXA+XRN/B!J&M:Q>^)+;0GTW1-,?PW_P ((?#JVESJ%KIN
MBKI=I=MXBCMHX9H[M[:26%[2XY,)SQP.#P>*ERK 2Q\FX)3>+>)Q^*QM%R;Y
M/866)AAZ\G[>2I82$:.E6+PN^)N\5B<30E*H\50PE*E&I)PC@?J^#IX:?LU^
M\5:E]9A5S"%**P\:E?&XA5'!QE5Q'C%Q^S1\1/$=NL?B"W\ Z9JZ:CXMMM=\
M7Z7K&KWWB?X@:9\0]=BT[Q1J&JZA)X:L[C1+2R^&LVIZ;IOA_P"TZG ES+IR
M"YMK;18#<5@N7#1RVK4BG/#8/ 8:OAU&$J%:>"J83,\55K2E&]>IFN<9;AE6
MFX0E1P6*Q]23KUJ\:-*L5*=2KBYT:DX588S&8S+\1&:I5<)*>$Q^7Y71IPC&
M4*<,KPN8*JY+F^L8G T/=BZM6N^;3]D'Q[K7BZYO/&.JZ3=Z)XA:VU/5)],\
M2Q!/#%Q=^(-2\1^(M%T'0=3^&]W<SR-<MHEC::UIVO\ AR?[%H]@L\1.CVL=
MP81U,+3A:JGB\#4P^)P]=TT_;8K#8?#UJ<ZD>:,Z<)9Z\QS/$TW5KTJJQLXJ
MGS5JO)GCJ5+$1Q.&I14<#BJ6)PGLH1C0E##5'/+Z4Y2BJBJ55P_1RS!QNN>G
MB<)5J1K*-=R.HA_9M\9:UX=\'Z?XU\#?![5-?T?QEX;U+QKXK?6=6O\ Q'\0
MK"T\11>+O%.JW^IW?@P-:1ZGXBT'PDZ>'[@7\:VEE-:#4((H8%JH5/JU7 U\
M%2CA883#UHPPK:J4X5Z>4XK#8*I5J\L/K-99EB98NKBO8T:JFI8J7MZM>K1C
MO7DI_P!MT:56I3HX^O4G0J-\\XT*^84XRPW+/G]C3HY#+%9=3E&=1Q=2G"A'
M#QH0KR@M?V5?B+'-XBGC\4>%-(?Q#\,-*GU!;*+4KD:E\>+'Q!\3/%EEK.IE
M[6$2^!-&\2>/H=0M+<*]Q--HNG;XH8;#R;PQ#BLOKX&A*K7CA*U+^SY.?U:H
MX/+,NRW&8NM4A&LJ.8XFE@*KI58TZ\,-B,=7QMJN)I8:5+HI5\/+&9;7Q-&7
ML?K6->/IIQFY974Q6'JX'*J4N6GSX:CAZ4<)6BU1C4PN'6#Y70QF)MZ/\ _@
M-K?PGL/$_B"X@LX_&VJ>%]-\-:98S>)K37[(PZ&FH7]G/KGB'2OAYX8EU"[N
M]>U2]EENKG3=0NUBD:1[JXEN)$4S"K4EEV.PV6N-&OBY2JTU*'LJ.'E3HRH8
M.G"G3<J4(T:;O4="A1@U[.A&G*GAJ52?G8.F_K6 EF,YU*.$4XU)PFZE6M+%
M5*%3'UVZMJCE4>'I>QC5K5))JI4E.,J\H0XG1OV3M0\O0CXIB\':WJ]AXE^%
MZW7B61))M9M_"G@F[C^(_BFXT>:?1]]CKOBGXR3ZM<WL<$ELCZ?=P.]PTULD
M%=-*KAL'B\-4P4)4L-AJN*G&$DG5^KX7+)9+P_@I55)3J4<%AJ=''U'4E)+&
M5<92C3J4ZSJLG[>OA\=[5PHXG&X:K&5.G'GPL<7F^93Q7$%:C"K>5)5L#7EE
MV%G)UJL88/!U;TI*T.;UC]E7XG7?AO0HYM9\/ZOJFE_$#Q%<-H%CK;^'=(M_
MAC/K?BKQ!X=T&QU+6O _B>U>_D\3ZGX?UW6H[GP])%>/HME:HQ71;-YN##Q]
MA1R:EK.>%RG!87$3;48+'X'+\'EV$J0I<D_;8/!X:ECX4(2E3K?6\PJYA"5*
M2IX>CHXN^;*-14Z.(S+'8NA'V;E4EA\QS'$9ACH5*D:M)TL3B)5</1YOWU!8
M+"/ NGRX_&XB<VG?LG^,='\1^$VTZ+PF^D^$XA>M>ZYK5MXDTS7;B?4M:\=7
M.ER^!M7^&DD7AB[A^)NM2W=KK7A?5]!:.QLK 36DYLH[-;K5<1[/,'AG"G5C
M@98+!\T7S2>&RY8#*Z[KQ?UC"N@G*=>C*KCL/).K3IT7+%SQ%"VXU(8.E57+
M"IB95\6Z:IP<(8O$48YIA[1IPI8RGBLNPM"A&I.EA:_UJ=;%2J0M*GB'>$_V
M/;B+3/"EKXR\,?#&\ET_5OAU'KJPJ=4,GAOP+HLWBK4H;&[N/"ED&U+Q+\:;
MN>]U/%M:QS:5'"DAE>)+=>JI4P^&K.KEE/DIX=9A4PM&K&-H\N!639)@*M2\
MYRP>!P+JX^527--9G5JN-*4:TZI@_;XBGB/K4_98G&J/MY4':DL1C<VGF6>8
MRC3DG*$L7AU1RNG2E5E4CAJ-*7UF#II/ T[]CCQK+JNG6GB*Y\/S^&I],L;J
M_@T+Q%!IVG>&M6U/Q+K7CGQ[I7AGP[??#.]GA74?%FIQBUUG3-;\.SI:6]GY
M]NS:/;17&5&K/"R52G5>*KY7+ 2P%6O%*6(649?@:&60Q"A+GHQ6/PV)QF*@
MJN)HRCBJD(4VZM3DO'PCC8XJBVZ.&S%9A2JPCRJ5&GC\3B*4YJ48QC7E2R5X
M' T$Z=*<*N"G-5H^WG4?1ZS^R5XAU'387_LKX<W&O:QX7DLOB%>2S7=G+XTU
MWXE_$KPYXG^-CZAJB>&KBYN;2/PGX=&DZ%+=).RK?>6\-HEM$]:81X;!XG#4
M8<TLKP5?(XTHJG3A4=#)5BL6\35HINA/$YCF\L'B\;2TYXTL2EB5+$RM>(G4
MKX?'6G.&)Q:SRI%<_O4:N)P;RS)*,,7%1K0HY9EV*QN'O3IPO*.$J>SJ.G[O
MJ7Q=^"?BKQYXAN=+T_2O %W\/M0^&)\ :,FOM*K_  OOM0N]3@\2^*/#OA$>
M'KW3=>U6Z\/3:+9V.^ZTHV;:.Z&4V]Y*C\M**J5\7/&.?/B,3@JLL3"I+ZR\
M)AI.K5P5*2Y*F%GB:_OU,73KR;O0JRHSJ9?AXU=H5HX*EE,\!0C[?+*F,J>P
MJN2PE6M4CA(X*M7A3:=6GA/9XJ]%J,YQQ%6E3K45B:M6EZ1\(OA@?AMHWBNZ
MEL=";QAXM\3Z]KVJ7]B&"WEM'*=+\&6%_JLEDEU=-9^%--T*WGE>)LW(O9D5
MC,2]XNOB)Y?1H8;ECB84*U:496A1>98VK7Q^,:Y(_P"[QQV*K4L/)P]HL'3H
M1E%2CRKCPV'HTL2W4=18:"PN%HMS=:K#!8+"X; TFN?D4)UZ>%^N5:$&J4,3
M7JP52K;VT_*IOV?_ !'>^#OA_P"'M9M/ 7B6?PKIOC_Q]KEEXC@N]4\-^(/C
M_P"*4N;K2]6O=-N=-D%YX3L];\2^+KSS)E^T1L-,:&WWP9BG%I4W6EEDI2GE
MN5X;*\GG7C!5*<8*C2KXZI**E[#&RP^#IPC.BIJ<LPQ_.U&WM.JC.%:I?'JK
M"CF6;_7<QA2K.J_J%.566'RVG.<*;KTL.Y8*-'F6'A".586*IN,N2GYEX._9
M/\72ZIYWCW3_  2WA[5[KP39>*/#D.I:=K::OX=\+W&N>--7BOAI7PQ\+6=]
M)KGQ$;PFMQ87=O>1)IVCW1:[GEO9(FWIO#X=-TJ7/*A5JXC#PJ)2AS83 + Y
M'2J\WN1E@I8W-,?+$4:%*4,7# PITY4Z494^.I&M5B^;EHUI8>I0E5H-TW_P
MHX_#XC.5&+4I1P]?!X"A@*%%U95)4L7B9U:\9KEFEE^RQX\AU?P6SZ7\/K6R
MT74]3\2:VT>J6^K>'+P^*O&.J>.O%O@R/P#K_P -+N"TMO[6GTVST[7]$U7P
M[>0PV<$]PD_V%+*[QHRJ8=>T4O;5\)E^%PM#VG-:OB<OR^2P.+Y^9UL#5IYS
MB,7C:T:=3$498?V5%49SDIX?HQRCBWBZ-TL/B\36M-4XPE1PE6O1P<J,Z$6Z
M&*C+A_!8+"\M5<_UQXNHJT(U93JX]G^QGXI;7+"+6)/#D^@7FA^'YM>NM$UF
MST=+3Q)+J=_XJ^(C:;X?N_AMJ%R;S6_%UTDD&MV'B'0KF.TCLHYXG_L2TBN-
M*4U@IS^IN52&4U\+/*O;J-YT<JP."H911Q/L^1TG'%X:MBL=RRKTJSQ-7EI.
M5>JX98R+S"E6A77L/[4IX^.,A";J2HSS3&8N6+=/$3C&6*IT,NQ&'P6"C.E0
ME1^J-TWAXUG:]XO_ &4_B'J>CV.E:-I?PQBU3Q#X<UG4/'OC S:=::Q-\4?&
MFJWL_BSQ%=2:O\+O$-UXKTO3M,U*6WT2W%WH4JI%);SW$4$B"+&&'PBKT\%-
M2ED6$AEV#A&*5*I6P-.4'FTZE*BZ?L\?F<J-.K4K4\2HJK4J56JE6%.1TRKU
M(*>-HP4\REB\=BXPKR=2%/DIJGD>%]O:[PN!HN>&K16'4ZE.CAE"4$ZS<VJ?
MLL?$'Q NM6LFD_#GPM>#QK=ZEI?CK2O$&I:MXQO?!\'AZ3X:>$-!6XN?!%I/
MX:CT/X>W4E\]M!J%]%=:M:+$KQV]_<SKK2G&O4PE?,H1DYU,35S&A"/[O&5,
MSQ[Q>9RJSC*C[:$L#*648>G5@W&E*C7E.+P%&-?&FG@*=3#9;/FIX;!X"AEU
M7$QYW@WE&&H5L#"G04N2,:V>X99AB9.=2*PU?%4?9UJF(OA^S^$_[,GB'PU\
M3U\;>-;NTN5\,^*/%NO>%[W3=?M+Q[^+5;?5/#7A:Q?2Q\/],U#0='T;P#?P
M:9_9DWB;6[8SV430Q)'!&[:8/$3H8:I.JW+'XO"?5\5)_O/;5\1B*.,S'%RJ
M_N^9XK&4(5:-.=*<Z%*:H*LHX>GSXU\/"]/"T>5X"A/#N@G!0>'PV"I*G@L+
M3IR=?DG23DJ^(H5</'$2]M6E0YLPQ%.EJZ]\'/BMXF^)<OB;RO"7@G4-/\6Q
MZMI_Q<\%^//&>G^(O$'@W3+OS]#\$^,?A5:Z%:Z#XE?^S9KG1KJ\UG6-3CBA
M O;&%+B5(K#BP\:M#"UW3DJ&+JX?'0JTK.KAL5BZ^%JX;#8QQERK"RHM8+$2
MJ4J53$\V#6&C4=*?MEW8J6'J3IQC3=>BE@HTY5/W=?"4Z<H5<;"G6I-5*RG6
M^MSPM*<H8>/UURQ%.I["5/%^0^&_V2_B7I>F6&MZT^A:_P",+-]*TSQ+I&H^
M.C)I7Q*T2^\1:;XF^(JZ[XATOX4Z5>0V^N:SHNES1V.KVWB3=:I>V5Q<K%J,
MH7LA5I86=".#PT8X!U8.6$JVJ>QIX/ 8^AE?-5Y>3$UL)C<:L74J_5Z4ZDZ$
M:[E4K2<%RUE7KK%>UQ-\4_:3AC*=*-.4JE?$T%BH4Z4Y5JN"H5LKIU\%3I4\
M94C0E6HQI*$,!AZTN[U7X!?$R76?$L6B^%?A)H7A[QUH_@K3_$4.C>(M<TVR
MT?3M,U_5O$WCOPWHOAU?!$D6H_\ "374FF:;=ZK)=Z8);6/S_L$<MND#\T'4
MP].I3H3YIX3&O'86I+FA*K5PF!C5RBG4BI3]AA\)Q!4QV8SIJ>(?L<7.BG5=
M2;BYI59Q=2G",*V$Q&#J1BO?HK,*M/!9AB56BH2KXA9%A<NHX2-J-.&,P7/+
MEIRM4S[S]DC4OL6BV<&D?#N[!TWP+;^.+B2-M-NO'&K:K\1=/\=_'/7-9FB\
M-70O+K53X?T2TT\W*32&"YU& R6:R(]=<98;#8NFL-2E++,)BL.L)0J6O1PF
M4Y;BXY55;C\6*K9M6PN)S.+:A7AE]"<YU9SE!16EB<1A,1*2A3S#'4<Q>(2G
M4E0]MF=2EAGAZ;=JT:&6915S3"975E*2H/&P7U50I-3YI?V0?'VK^*[J\\6:
MAHEWHNO_ &?4[]M-\2Q6]MX8N;K7]2\1Z_H.A:#??#6[N6#W3:'I]KK6EZ[X
M<G6QTBQ6:%CHUK%<<^"E4P5.E)2C6Q>75<-BL/4J1?+B,5A</AZ]/VW++VU&
MG4SUYCF.*C[7$0J1QM11I.=:KR:9A3I8QXNA%>SP.-ABL+*%*$*$Z>&JRGE\
M*GNJ<*E:/#]'+<)!-*5/%82K.->,:[D>V? KX+>,? /B'QSXT\36'A:UU?Q!
M9W)T?2+75K7Q==:;K>M:I?:_XRFA^(%QX!T'7SX7U?6FTEX-)U6379;1=,#K
M=*KI:6Y-O#Y+7P&!]ZN^2-#VJC3BJ&&PSI8*CBW12IXFI2JU<14GB7059^VJ
M2G4KSJ2<7.G2K9E1Q%9R]C"57VD^9U'*56I33JX>E6<YX7EP]*--T8XJ5!KV
M5"E1P]/"QGB/,M%_9E^(F@R7&B6NF?#AM$\8:#X"T_XA:_;:UJ.E7TOD>*=<
M\=?%O3M+\-0>#)HM1'BOQ!JAL#>W6JVICTS[.AAWV$<<FL9QPK5'"IO#97B\
M/6R]S=JM>EDV48;#<.T\5R6A3>'S6C6Q^,E3515/K591C/VLN3*NJF*G6KU8
MPC6Q]#,J=6+E*J\)//,?4>9RI8EJG6Q,</E7U/#99"2P].G7P2G*-*$W"::I
M^ROXRBBT;6](T_P!+XJ71DN/'ACU"^T-_B/X@\>?$CP_XN^,FEZSXAM_#%S=
M_P!@S^'/#=OH>F27,-V7L]0N+66VMHD1J*#H8.K'#TJ?UG*Z"R[#4Z-1*E[2
MCE^#S%K&8B%/GI3Q&*SK$8'-,91<)QJO"5HRJU/K4X/>M.K6HUW2KRP>*KU\
MQQ*FH*M/#.2HX3*L-AZRE0J4XX+)ZN8Y=2JTU2^KU)X+%QIU)X6,5FZA^REX
MXU>ZLGD\._"_PW)K/BS7_%?B1O#NJPZAX5TR+7]1TO1-2\-W/@'Q)\++G2O&
M^G2?#3POX:TZ*_2/PSJ45Y)JS0W=I%>LTA@YK#ULL56I*OA\OI4U4=2,92KN
MOB\1FF.HTU&4*N$E',*_L\+B:.*5\/1PM7%4,1/"PPU2,1.JZ&/>$BL+B<16
MIRP[C)7PDL!@(8#+<1&K[-*I%\^-Q>+P52A*G[3$>QHUDW]:I^Z_$?P3XO\
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M5>?*I-S>34:%7V:Y?:8JI&BY4O:.I#>M[*CB,[J.=\%E<L'2_=7J2>(>&RS
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MKT\'B<9"E*2BG"D_986+:YI16/QBJ8*A.48KVU.7(J[4XT['QD^-OB;P!?\
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M$^H:CHWAVP\,:QIWCKPOH=WH.KGQ=K$.F&9H;BUEA,5_%)Y4PC2JE%RCE-+
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M'DK>Z^>E#PW0/VAOBE8SZQXLU#3/#_B31M>.C^([+33XKN+"S\/^$?%WC@>
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MCDA[-TN1>R=2=5PLN7VM7$4,54J..WM*F)PN&Q$Y_%*M0HU&W.G!J'3?A/\
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M^RQ_T<M\ /\ P\GPZ_\ FCH /^&L?V6/^CEO@!_X>3X=?_-'0 ?\-8_LL?\
M1RWP _\ #R?#K_YHZ #_ (:Q_98_Z.6^ '_AY/AU_P#-'0 ?\-8_LL?]'+?
M#_P\GPZ_^:.@ _X:Q_98_P"CEO@!_P"'D^'7_P T= !_PUC^RQ_T<M\ /_#R
M?#K_ .:.@ _X:Q_98_Z.6^ '_AY/AU_\T= !_P -8_LL?]'+? #_ ,/)\.O_
M )HZ #_AK']EC_HY;X ?^'D^'7_S1T '_#6/[+'_ $<M\ /_  \GPZ_^:.@
M_P"&L?V6/^CEO@!_X>3X=?\ S1T '_#6/[+'_1RWP _\/)\.O_FCH /^&L?V
M6/\ HY;X ?\ AY/AU_\ -'0 ?\-8_LL?]'+? #_P\GPZ_P#FCH /^&L?V6/^
MCEO@!_X>3X=?_-'0 ?\ #6/[+'_1RWP _P##R?#K_P":.@ _X:Q_98_Z.6^
M'_AY/AU_\T= !_PUC^RQ_P!'+? #_P /)\.O_FCH /\ AK']EC_HY;X ?^'D
M^'7_ ,T= !_PUC^RQ_T<M\ /_#R?#K_YHZ #_AK']EC_ *.6^ '_ (>3X=?_
M #1T '_#6/[+'_1RWP _\/)\.O\ YHZ #_AK']EC_HY;X ?^'D^'7_S1T '_
M  UC^RQ_T<M\ /\ P\GPZ_\ FCH /^&L?V6/^CEO@!_X>3X=?_-'0 ?\-8_L
ML?\ 1RWP _\ #R?#K_YHZ #_ (:Q_98_Z.6^ '_AY/AU_P#-'0 ?\-8_LL?]
M'+? #_P\GPZ_^:.@ _X:Q_98_P"CEO@!_P"'D^'7_P T= !_PUC^RQ_T<M\
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M.6^ '_AY/AU_\T= !_PUC^RQ_P!'+? #_P /)\.O_FCH /\ AK']EC_HY;X
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M.>8M2G:*DZ52GF-2$J4)0FI4X3C75W$Z"#X5-!\'_#OPH;7Q(V@Z/X1TIO$
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MW#1D_>7-EV;1S55'&T=*KC['DO[G\3FG_#/-_#7[*VD>&M-O]+L;SP%IT?\
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M9E6_><ZA5IKD=&$N6I#ZDK0Y0H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H \Z
M_8H_Y.R_;Y_[M9_]5KXKKXW-?]_K_P#;G_IN!])E_P#NE+_M[_TN1^GM>>=@
M4 % 'Y$?L_I\8/\ A0_P3_LS]G'XJ:YIO_"H_AO_ &?K>G>*/V?+?3]8L?\
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M -$#1_;>$_Y]U?\ P&'_ ,L#^R\1_/3^^7_R >7\;?\ HUWXP?\ A6_LT_\
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M ,!A_P#+ _LO$?ST_OE_\@'E_&W_ *-=^,'_ (5O[-/_ -$#1_;>$_Y]U?\
MP&'_ ,L#^R\1_/3^^7_R >7\;?\ HUWXP?\ A6_LT_\ T0-']MX3_GW5_P#
M8?\ RP/[+Q'\]/[Y?_(!Y?QM_P"C7?C!_P"%;^S3_P#1 T?VWA/^?=7_ ,!A
M_P#+ _LO$?ST_OE_\@'E_&W_ *-=^,'_ (5O[-/_ -$#1_;>$_Y]U?\ P&'_
M ,L#^R\1_/3^^7_R >7\;?\ HUWXP?\ A6_LT_\ T0-']MX3_GW5_P# 8?\
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M *-=^,'_ (5O[-/_ -$#1_;>$_Y]U?\ P&'_ ,L#^R\1_/3^^7_R >7\;?\
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M (5O[-/_ -$#1_;>$_Y]U?\ P&'_ ,L#^R\1_/3^^7_R >7\;?\ HUWXP?\
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M -$#1_;>$_Y]U?\ P&'_ ,L#^R\1_/3^^7_R >7\;?\ HUWXP?\ A6_LT_\
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M ,!A_P#+ _LO$?ST_OE_\@'E_&W_ *-=^,'_ (5O[-/_ -$#1_;>$_Y]U?\
MP&'_ ,L#^R\1_/3^^7_R >7\;?\ HUWXP?\ A6_LT_\ T0-']MX3_GW5_P#
M8?\ RP/[+Q'\]/[Y?_(!Y?QM_P"C7?C!_P"%;^S3_P#1 T?VWA/^?=7_ ,!A
M_P#+ _LO$?ST_OE_\@'E_&W_ *-=^,'_ (5O[-/_ -$#1_;>$_Y]U?\ P&'_
M ,L#^R\1_/3^^7_R >7\;?\ HUWXP?\ A6_LT_\ T0-']MX3_GW5_P# 8?\
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M *-=^,'_ (5O[-/_ -$#1_;>$_Y]U?\ P&'_ ,L#^R\1_/3^^7_R >7\;?\
MHUWXP?\ A6_LT_\ T0-']MX3_GW5_P# 8?\ RP/[+Q'\]/[Y?_(%3]C;PKXY
M\._M,_MDZKXZ\$:Q\/[GQOX?_9D\4Z%H.OZKX-U;5CH5IH7Q2\%?;KN7P+XH
M\0:9;^;KG@_7%CA_M%IO*@CDDCC$R@^!C:\,3B:M:FG&$N6RE9/2$8NZ3:W7
M?8];"TI4*%.E)IRC>]KVUDVMTNC['Z35RG0% !0!\_\ [)W_ ":Q^S3_ -D
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M+7R["U<76HMJ-:-*E&;2]G*TE.M4A]7P\9<JK8F<*,7SR2.^M?B3\.KWQ6?
M=CX^\%W?CA=,36CX,M?%.AW'BL:/(D<L>K'P[#?-?C3&CEB=;K[/Y161"'PP
MS<*=2HL4Z<)36!J>RQ#BFUAZM[>SKV3]E4OIR5.65]+&;G",</-S488N*G0D
MVDJT))RC*B]JD91C)J4.9-1;3LF3:S\0? 7AO7]"\*>(?&_A#0?%/B@RCPSX
M:UGQ+HVEZ_XB-N<3C0M&OKV*[U<QG&_[)#+M[XJ*2]M4JT:/[VK0A[2I"'O3
MIT]?WDXQNXPT?O22CH]=&547L:*Q%5>RH.7(JDO=I\_N^XINT>;WH^[>_O1T
MU1Y9H7[3'POU_1OC'XGM=3C@\(?!#5-4T?Q7XLEUWP3<Z-=7VAVDMSJ\>F)I
M7BR[OK+[-+%]F7^W;+13<RR(;,7,)\T<U3%4Z.2X;/9*7U3&2JQP].,;U:ZI
MU8T:4J5OW,_K52<5A::K>VG&5.I.E3IU\/.KM3H5*F<5,EC98FA##SK3DU&E
M0]O"524:O-:K#ZK",GBJOLGAZ,J=:E[:5;#8FG1W/!'Q[^&/C73/ %S_ ,)3
MX<\,Z[\3-'&O>#? _B'QK\/Y_&.M:6S2^7=:9I_A;Q=K-KK4;0PF4MI5[?K&
MI*3-'-'+%%Z=;"5:&*Q."35?$8&E2K8B%+FFZ$*D(33J>ZK07.HJLKX>JUST
M*U:C*%2?!1Q=.MAJ>+:E0PU>K5HTIU>6FJLJ51TFHIR;C)R6M&HH8FDW[/$4
M:-:,Z4;.H?M _ 72&U&/5?C;\(M+?1[C[)JZ:A\2?!MDVE70D,)MM16YUI#8
MW F!C\N;8VX;<9XKDHRCB/8?5VJ_UIQ5'V;Y_;.4:,HJERW]HY1Q.'E%0O>-
M>BUI5AS=?+)3E2Y6JE/G<H6?-%4Y8B%3FCO'V<\)BX3NERRPN(C*SH5%'H?^
M%I_# 6?BG4?^%C^ QI_@8QKXUOO^$O\ #PL_!YFMEO(1XIN?[1\OP^7M'2=1
M?M;[HW5QE2#1-JE2A7J/V="=6>'A4E[L)5Z4_9U*,9NT75IU/<G33YX3]V23
MT)IKVM2-&DO:59488B,(>]-T*D/:4ZZC&[=&I#WX5$N24/>C)K4\\\2?M._!
M3PZ?#*1>/?">OMXT\+>,O%W@^71/&G@5=,\2Z5X%M8[G6?[,\1:WXIT[13(V
M^2.*6?48;;-G>//<00V5Q+#K1HU:V,J8&%*<<11HX3$3BXM2C1QN)IX;#U%!
M)U9QFZCK1]G"3J4:<W152HZ5*IK0I+$0PU2G5@Z6)QRR^,H\U2V(]G5G).%&
M-2I)4I4H4*JIPG.GB,3A:4H<U>)Z4GQ(^'Q\3P>!W\<>#X/',^DIKJ>"9/%&
M@?\ "6_V.Z>8-4'A^/46O)-."Y_TN.)X#M)60CFH:26,E&2E3RYR6)G&_)0Y
M=6ZS:3HZ6=JJ@TFKI&$97I8.JXNG''J+PZDX_OG*]HTI1E*%9W3C^YE.+<7R
MMI7&>$OB;\-O'USJ%EX%^(/@?QI>:1!I]UJMIX2\6:#XCN=,MM5A^TZ5<:A!
MH]_</907EO\ O;>29469/FC++S5NC5C3=5TIQI1J2HN?*U!58).=)RM95()I
MRA?FBFKI%5%["N\+5_<XF*DW1G[E5*$_9S;IRM)*%1<DG;W9^Z[/0\(^+'P]
M\ _$G]I+X)Z%\1? _@_Q]HEI\#_VD=6M=&\:^&=%\4Z5:ZK;^//V6;.#4[?3
M]=LKJWAU".TO[Z!+A(UD6.\G0,%E<-F!U_\ PR=^RQ_T;3\ /_#-_#K_ .9R
M@ _X9._98_Z-I^ '_AF_AU_\SE !_P ,G?LL?]&T_ #_ ,,W\.O_ )G* #_A
MD[]EC_HVGX ?^&;^'7_S.4 '_#)W[+'_ $;3\ /_  S?PZ_^9R@ _P"&3OV6
M/^C:?@!_X9OX=?\ S.4 '_#)W[+'_1M/P _\,W\.O_F<H /^&3OV6/\ HVGX
M ?\ AF_AU_\ ,Y0!XA^T'^S)^S;HO@/0+S1_V?/@?I-W-\</V9-)FNM,^$_@
M.PN9=*U_]I+X3Z%KNF23VN@([Z?J.B:CJ&GW=NS&.YM;^XMYE>&=T8 ]O_X9
M._98_P"C:?@!_P"&;^'7_P SE !_PR=^RQ_T;3\ /_#-_#K_ .9R@ _X9._9
M8_Z-I^ '_AF_AU_\SE !_P ,G?LL?]&T_ #_ ,,W\.O_ )G* /$/V@_V9/V;
M=%\!Z!>:/^SY\#])NYOCA^S)I,UUIGPG\!V%S+I6O_M)?"?0M=TR2>UT!'?3
M]1T34=0T^[MV8QW-K?W%O,KPSNC 'M__  R=^RQ_T;3\ /\ PS?PZ_\ F<H
M/^&3OV6/^C:?@!_X9OX=?_,Y0 ?\,G?LL?\ 1M/P _\ #-_#K_YG* #_ (9.
M_98_Z-I^ '_AF_AU_P#,Y0!Y!\;?V>O@%X&\+^#?%/@KX'_!_P '^)M+^/\
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M /V:?_5B_M8T ?0% !0 4 ?/_P"R=_R:Q^S3_P!D ^#?_JNO#E 'T!0 4 %
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MV9OB5H^@>%[;PE-\.FO_  U\)?V?O!$FEWVH7NEV.IZU\)?$^MZYKC6>O2>
M-<E\-1S)J=O)IFO6^C7FH07,#L+6V8B6O;S+'/$YSFV88=36&QV<5L=2INH\
M/5IX>KE6/RZ*56DJDJ-:G+$8>4Z5%\F)PU&>#J5X4JK3XLOPLJ/#>2Y1BJJ^
MNX##8ZGB*RI+$4:M3$XK(L5;V=65+VL*SRW&TYSJQC+"U<52QE&E5KT^6/)7
MW[)_QA?P5JVA6M_X GU37;3]I?1;K^V/'?C_ %86.F_';2]#N-*U*3Q/K7A'
M4=4\1:OI>O:(MM=QW<-JEQ:W;7<,\+Q)IQY\!*E@ZF50DW*A@</A*524*4*<
MN; <3/.*/LZ*FTXU\&_9U95:\JU/%?Q*N,YIXJ?MY;F$L-CY8W$4G[V=9/FG
M)&JZK]G@^'IY/BZ7-*%&,9*O6G6PL*=*GAW0IPHQIX.#C"CZ>O[/GQ"CUZ71
MA+\/SX(N?B]I/QLE\:"_UM/B1#K6FV-C W@V/01X;:PFT]VL18KXA/B&.5='
MN)=-_L8Y^T'FJ1]IAXT[VG@*/$='"I^]'$K/XYQ%3Q#]UX5X=YOS58TXXOZS
M4PE&HI4;\L/$IX5PH3I^T:GCEPZL0X>Y]7_L)Y-?V,O>>*6(63J4%4CA/J]3
M%U9-U>3]YU?P7^!/B'X:77P9FU&?PPR?#S]GZX^%6OKHLM\6O?$MQK7A#57U
M#31/I%J+G1V?0]5D:>X-M<&6\1C;DRR-'Z^+QM"MB^)*U*$H4<VGDCPT6HIT
MJ>5T\YIU(5(QDXP7+F&'C0C3<URTZBE[-0@IZ9A2EB\UPN.I6C2H8[B;%24M
M)N.<XO 8C#6233G"&%J+$7DE&3@J<JJ;E'J/$?\ R=/\&_\ L@'[2W_JQ?V3
MJ\HW/H"@ H * "@ H * "@ H ^?_ -I;_DG7AS_LX#]D[_UJ?X-T ?0% !0
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M H * /G_ ,.?\G3_ !D_[(!^S3_ZL7]K&@#Z H * "@#Y_\ V3O^36/V:?\
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M'7_S1T '_#6/[+'_ $<M\ /_  \GPZ_^:.@ _P"&L?V6/^CEO@!_X>3X=?\
MS1T '_#6/[+'_1RWP _\/)\.O_FCH \@^-O[0GP"\<>%_!OA;P5\</@_XO\
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MX@T+4?L/[,O[..G7GV'5])N9[2[^SZA:7=K+Y4K^7-:RQ/AXV4 'T_0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'S_X<_P"3I_C)_P!D _9I_P#5
MB_M8T ?0% !0 4 ?/_[)W_)K'[-/_9 /@W_ZKKPY0!] 4 % !0 4 % !0 4
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MFA*$OB3PV)JX=\RLN63=+F<=>1OEO*W,_1*Y3<* /+_BGXW\2^"M/\,)X/\
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MI*C7HRE3E.G*5&M"=-RISG3DX\T)2BTWT]<Q84 % !0 4 % !0 4 % !0 4
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MG4JU9N4ZE6I-RG4J3DYSG*4Y-R;9LU@:!0 4 % !0 4 % !0 4 % !0 4 %
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MX;G;I4^6G&C&I*]ZE:K"C'V5.I7G4E1A.LJ/(\1B'5]KKD.H* "@ H * "@
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MSX/_ /B1GC3_ .ACH_L/%_\ /RE_X%/_ .5A_:F'_DJ?='_Y,/\ AHOX_?\
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M/_\ B1GC3_Z&.C^P\7_S\I?^!3_^5A_:F'_DJ?='_P"3#_AHOX_?]$,^#_\
MXD9XT_\ H8Z/[#Q?_/RE_P"!3_\ E8?VIA_Y*GW1_P#DP_X:+^/W_1#/@_\
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M3_Z&.C^P\7_S\I?^!3_^5A_:F'_DJ?='_P"3#_AHOX_?]$,^#_\ XD9XT_\
MH8Z/[#Q?_/RE_P"!3_\ E8?VIA_Y*GW1_P#DP_X:+^/W_1#/@_\ ^)&>-/\
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MI?\ @4__ )6']J8?^2I]T?\ Y,/^&B_C]_T0SX/_ /B1GC3_ .ACH_L/%_\
M/RE_X%/_ .5A_:F'_DJ?='_Y,/\ AHOX_?\ 1#/@_P#^)&>-/_H8Z/[#Q?\
MS\I?^!3_ /E8?VIA_P"2I]T?_DP_X:+^/W_1#/@__P")&>-/_H8Z/[#Q?_/R
ME_X%/_Y6']J8?^2I]T?_ ),/^&B_C]_T0SX/_P#B1GC3_P"ACH_L/%_\_*7_
M (%/_P"5A_:F'_DJ?='_ .3#_AHOX_?]$,^#_P#XD9XT_P#H8Z/[#Q?_ #\I
M?^!3_P#E8?VIA_Y*GW1_^3#_ (:+^/W_ $0SX/\ _B1GC3_Z&.C^P\7_ ,_*
M7_@4_P#Y6']J8?\ DJ?='_Y,/^&B_C]_T0SX/_\ B1GC3_Z&.C^P\7_S\I?^
M!3_^5A_:F'_DJ?='_P"3#_AHOX_?]$,^#_\ XD9XT_\ H8Z/[#Q?_/RE_P"!
M3_\ E8?VIA_Y*GW1_P#DP_X:+^/W_1#/@_\ ^)&>-/\ Z&.C^P\7_P _*7_@
M4_\ Y6']J8?^2I]T?_DP_P"&B_C]_P!$,^#_ /XD9XT_^ACH_L/%_P#/RE_X
M%/\ ^5A_:F'_ )*GW1_^3#_AHOX_?]$,^#__ (D9XT_^ACH_L/%_\_*7_@4_
M_E8?VIA_Y*GW1_\ DP_X:+^/W_1#/@__ .)&>-/_ *&.C^P\7_S\I?\ @4__
M )6']J8?^2I]T?\ Y,/^&B_C]_T0SX/_ /B1GC3_ .ACH_L/%_\ /RE_X%/_
M .5A_:F'_DJ?='_Y,/\ AHOX_?\ 1#/@_P#^)&>-/_H8Z/[#Q?\ S\I?^!3_
M /E8?VIA_P"2I]T?_DP_X:+^/W_1#/@__P")&>-/_H8Z/[#Q?_/RE_X%/_Y6
M']J8?^2I]T?_ ),/^&B_C]_T0SX/_P#B1GC3_P"ACH_L/%_\_*7_ (%/_P"5
MA_:F'_DJ?='_ .3#_AHOX_?]$,^#_P#XD9XT_P#H8Z/[#Q?_ #\I?^!3_P#E
M8?VIA_Y*GW1_^3#_ (:+^/W_ $0SX/\ _B1GC3_Z&.C^P\7_ ,_*7_@4_P#Y
M6']J8?\ DJ?='_Y,/^&B_C]_T0SX/_\ B1GC3_Z&.C^P\7_S\I?^!3_^5A_:
MF'_DJ?='_P"3#_AHOX_?]$,^#_\ XD9XT_\ H8Z/[#Q?_/RE_P"!3_\ E8?V
MIA_Y*GW1_P#DP_X:+^/W_1#/@_\ ^)&>-/\ Z&.C^P\7_P _*7_@4_\ Y6']
MJ8?^2I]T?_DP_P"&B_C]_P!$,^#_ /XD9XT_^ACH_L/%_P#/RE_X%/\ ^5A_
M:F'_ )*GW1_^3#_AHOX_?]$,^#__ (D9XT_^ACH_L/%_\_*7_@4__E8?VIA_
MY*GW1_\ DP_X:+^/W_1#/@__ .)&>-/_ *&.C^P\7_S\I?\ @4__ )6']J8?
M^2I]T?\ Y,/^&B_C]_T0SX/_ /B1GC3_ .ACH_L/%_\ /RE_X%/_ .5A_:F'
M_DJ?='_Y,/\ AHOX_?\ 1#/@_P#^)&>-/_H8Z/[#Q?\ S\I?^!3_ /E8?VIA
M_P"2I]T?_DP_X:+^/W_1#/@__P")&>-/_H8Z/[#Q?_/RE_X%/_Y6']J8?^2I
M]T?_ ),/^&B_C]_T0SX/_P#B1GC3_P"ACH_L/%_\_*7_ (%/_P"5A_:F'_DJ
M?='_ .3#_AHOX_?]$,^#_P#XD9XT_P#H8Z/[#Q?_ #\I?^!3_P#E8?VIA_Y*
MGW1_^3#_ (:+^/W_ $0SX/\ _B1GC3_Z&.C^P\7_ ,_*7_@4_P#Y6']J8?\
MDJ?='_Y,/^&B_C]_T0SX/_\ B1GC3_Z&.C^P\7_S\I?^!3_^5A_:F'_DJ?='
M_P"3#_AHOX_?]$,^#_\ XD9XT_\ H8Z/[#Q?_/RE_P"!3_\ E8?VIA_Y*GW1
M_P#DP_X:+^/W_1#/@_\ ^)&>-/\ Z&.C^P\7_P _*7_@4_\ Y6']J8?^2I]T
M?_DP_P"&B_C]_P!$,^#_ /XD9XT_^ACH_L/%_P#/RE_X%/\ ^5A_:F'_ )*G
MW1_^3#_AHOX_?]$,^#__ (D9XT_^ACH_L/%_\_*7_@4__E8?VIA_Y*GW1_\
MDP_X:+^/W_1#/@__ .)&>-/_ *&.C^P\7_S\I?\ @4__ )6']J8?^2I]T?\
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MV$Q57G=J>/DHQY*47.&*RFA3C.O[&2C=8J;IK$.4:E:-/#4*F&EB9RESB_M
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M)49-TURF4DI1E"24H2BHN+U3C&O+%1BT]'&.)G/$)/15Y2K+]Y)R=;5/AYX
MUR&VMM;\#^#]8M[+5[GQ!9P:IX9T74(;37KR=[F[UNVBN[*18-7GN9))9+Q
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M&,4W>T8I+1)&Y2*"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M _X9T^/W_1<_@_\ ^(Y^-/\ Z)RC^V\7_P ^Z7_@,_\ Y8']EX?^>I]\?_D
M_P"&=/C]_P!%S^#_ /XCGXT_^B<H_MO%_P#/NE_X#/\ ^6!_9>'_ )ZGWQ_^
M0#_AG3X_?]%S^#__ (CGXT_^B<H_MO%_\^Z7_@,__E@?V7A_YZGWQ_\ D _X
M9T^/W_1<_@__ .(Y^-/_ *)RC^V\7_S[I?\ @,__ )8']EX?^>I]\?\ Y /^
M&=/C]_T7/X/_ /B.?C3_ .B<H_MO%_\ /NE_X#/_ .6!_9>'_GJ??'_Y /\
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M/X/_ /B.?C3_ .B<H_MO%_\ /NE_X#/_ .6!_9>'_GJ??'_Y /\ AG3X_?\
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M/_\ B.?C3_Z)RC^V\7_S[I?^ S_^6!_9>'_GJ??'_P"0#_AG3X_?]%S^#_\
MXCGXT_\ HG*/[;Q?_/NE_P" S_\ E@?V7A_YZGWQ_P#D _X9T^/W_1<_@_\
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M3_Z)RC^V\7_S[I?^ S_^6!_9>'_GJ??'_P"0#_AG3X_?]%S^#_\ XCGXT_\
MHG*/[;Q?_/NE_P" S_\ E@?V7A_YZGWQ_P#D _X9T^/W_1<_@_\ ^(Y^-/\
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MI?\ @,__ )8']EX?^>I]\?\ Y /^&=/C]_T7/X/_ /B.?C3_ .B<H_MO%_\
M/NE_X#/_ .6!_9>'_GJ??'_Y /\ AG3X_?\ 1<_@_P#^(Y^-/_HG*/[;Q?\
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M S_^6!_9>'_GJ??'_P"0#_AG3X_?]%S^#_\ XCGXT_\ HG*/[;Q?_/NE_P"
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M2M-_9Y^/?BNTTRX\1> ]=T?5DT]?$7AO0KY[>*^2.632X/-5U7:3] _0O_\
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M?]G[P7\&O ^O?#_PA<7<6@:X]Z%,6@?#OPY?Z9;7=@-.2V@N? ?@;0!K$\$
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M /V:?_5B_M8T ?0% !0 4 ?/_P"R=_R:Q^S3_P!D ^#?_JNO#E 'T!0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M^6G!2G)Z1BWH7Z0@H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M6<ZDDU/]E#Q)<_%;P7XQO]2L?&WAW0;*RU^]M=9\4VGAR_T_XI66KZQXGO\
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MX?$8FGB:O.JF/JT\/C*E.GB*F)YLGQ5^S=XH\=7?C0^+;'X>ZOIU_<_&C6-
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MT!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M, =?_P ,G?LL?]&T_ #_ ,,W\.O_ )G* ,#]G+PGX5\#>)_VHO"W@KPUX?\
M!_AC2_C_ *+_ &9X<\+:-IWA_0M.^V_LR_LXZC>?8=(TFVM[2S\_4+N[NI?*
MB3S)KF65\O(S$ ^GBP12Q(55!8D\ !1DDGT %3.<*4)U)R4*=.+E)O11C%7;
M?9)*[&DVU%*[;227?9(^!?AI^U;:?$#7OC-I>D?$GP+XA=_!WC/QY\,-&\-:
MGX;U77_!>E>![_4O"=]8^*K+3[BYEBN;UX/#/B>V35XA,1XEOK;88-/5(^+'
M5,1#@S,\UP[?U_+\)3QTL3"*=!4LUPM;%X##J,^:#Q66O#U,-CTX\JJ3H<R;
MFSOA2HQXFRO+*L''"U\9++*M"<)TZKQ67U</'&5IS=1S]GCIXC%4L'R0HP^J
MY8L1!SGB)-._9V^(_P 8;SQM\/M(^)&H?&271_B)\)K[Q3:R?%W1/V=A9ZKX
MHTP>%+UY/A_J7[/ODR:5I(TS6M2GGL_&,!NY8S8&U6*2WO0_TN(H86CBN(\N
M5/V>(RJK2J8>%2<OKBPRQ.)PF*>(=-RP56-&H\OI_P"S/GC6KU)2E*@Z2/G,
M'BJV(ROA_,9-5%F/)"O6H.*P;JU<#+%T84:-:,<?"594,55HU*O+3A0H3I5H
M.O4@Z?WS7DGIA0 4 ?,'[1OA/PKXX\3_ ++GA;QKX:\/^+_#&J?'_6O[2\.>
M*=&T[Q!H6H_8?V9?VCM1LOMVD:M;3VEW]GU"TM+J+S8G\N:UBE3#QJP/T#]#
M?_X9._98_P"C:?@!_P"&;^'7_P SE &!^SEX3\*^!O$_[47A;P5X:\/^#_#&
ME_'_ $7^S/#GA;1M.\/Z%IWVW]F7]G'4;S[#I&DVUO:6?GZA=W=U+Y42>9-<
MRROEY&8@'T_0!\*_'GQI\:;7XO:SX8^'%W\;)]+T'X-Z-XQAT?X/Z?\ LT3P
M+XBOO$?C6P^U>,)?CQ;#4KK2YX-#L(4M?"\[7 %O<GRUEEB9^%5JM&CGN,=G
M'+JN%C2>(BY8&$986K7J*M#"6S&=W!2J>QNU235&4:K/2EAJ$\/D%.[I3S+$
MYI2K3I2MBG3P_P#8T:3H/$<V!@Z7UVN[UHKFJ5*7.ITH2Y=WP'XQ^(OQ^C:Z
M\,_%F[^'^G>'O _PPUFWN_"7A+PC<3>-?$/C7PA#XIN]3U^P\?Z#K\NE^"BU
MU;VD.EZ:-+U(26=^6U8?NUB]K'X9X7%YU.@DE@<WQV7X;#5I>TP_L<+1P5>G
M/$SH^QQ%2K56+5G0Q%&$*'))PG4J7I^+A9U8T<JP680=/'2P$,3F-2"]GB*>
M(>-S#+JN&H4:JJ4:+PU;+:\YSJPQ"JU*M.$8TH49>W^M]";4VT72CK5SIEYK
M T^T75;O18YH=(NM22%%O9],AN)YI8+)[D2-'%)-,Z(P1I'*EFPKNBZM26&A
M.GAY/FI1G)3G&G+6"E.,8J;46O?48J7Q*,;V5T%6A2A#$3C4KT[PJ2A%PBYP
M;C)\CE)P=U[T.:7)*\>9VN:U9&H4 % 'PA^S)^S)^S;KW[-O[/FNZ[^SY\#]
M9UO6?@?\)]6UC6-6^$_@/4=5U75=1\!Z!>:AJ>IZA>:!)/?:A=7<TT\UQ/(\
MDLDKN[,S$D Z#Q?\$/@O\-?BU^RMKOPY^$/PO\ :W=_'#Q1I-UK'@KP!X4\*
MZK<Z5/\ LP_M%WD^F7&H:%I-K/-I\EW86,[V[R&-I+.!RI:%"H!]GT ?#7C_
M ./_ (J^%W[3FNZ=XIUVWC^!6G?!_1;JXTY]-TY)M'^(.H0_$[Q19ZL=:2S6
M]-M?^'_AKJVFBUGNG@^U26(AB669C).']H\MX@J*D\5C_K-2GE%.+M.I5P6#
MR>=7+J=*-O;UL;/.H8BDWS5(0P-=)J#LMZV%J5<7PY2PMX4ZZ:S"3<'"%'$X
MR>#H8R?.U*$,-B88?#2]DU!K&\]6+5/VE/P_PS\6/VG?$6G_  TT+7?$'Q1N
M_%^L^)/CZ?%>F?!'1?V;K'Q+:VWA+4_!+^&M%\WXZZ5;^'AH^@VWB2ZT^::!
MDU.[D6&61I]LC):IK]S"E.IB/JF43=6O#V*H8C&X;/,9E57&5(/]]&&)CA>:
MC1PJ]G#F]^"?O/.%2E5PF:XR%)8>G6SK*8X*E6<W7P^79GPW6SF&$O2;I2Q$
M).BZU2LYV]G5A3JN\%+[I_9X\:ZWX^^$OAS7O$]S=W/B>&[\2:!XD_M+2]/T
M;5K76_"WB?6/#FH:=K5CH\CZ:NN6DVF&WO)M*(T^>YAGGL42UEB1>O%TX16!
MK4XTXPQN R_%IT75="4L3@J%:K*@L1_M$*#K3J>QIXB^(IT^6%9NI&3?+1AB
M,/5Q^$Q7M/:X+&8FE'VT:<:WU;VCJ8*55T/W$ZE7 U,-5E4H*-&;J<U.*BTC
MVRN,W"@#Y_\ VL?^36/VEO\ L@'QD_\ 5=>(Z #_ (9._98_Z-I^ '_AF_AU
M_P#,Y0!YAXO^"'P7^&OQ:_96UWX<_"'X7^ -;N_CAXHTFZUCP5X \*>%=5N=
M*G_9A_:+O)],N-0T+2;6>;3Y+NPL9WMWD,;26<#E2T*%0#[/H ^?_P!HOQ+\
M1/#/A/PD_P +M4TS2_%FL_%#P'X?@.LV-O?:5J-CJ.J'^T-#U 30R/96NHV\
M)LWO;7;<6HN//A.^,*V4*DX9KD]+V/UK#U'F4Z^'4E"=>E@\CS3'JE3J?\NJ
MWM,+"5&;?)[6,%64Z#J4YSB'3IY;F%6566'G%Y=2I5XQ53ZO/&YUEF7NNZ+M
M&M"G3Q<W.BW%U(<T:=2C5<*U/YH\?_M"_$'6M/\ B)<> -8\3Z/)9:I^S%H-
MAX?\-:=\,KKQSX8UWQW\3M;\&_$SPO8R^/K*X\.GQ:'TY]*'_"032V%K<V8E
M5X8V>5N_#X6-?ZA[.=7%T,7G>;4J5;#JG2E7RW#\(8'.<&U'%<D:=..)JSQ&
M(34<8H.MAKNK3IT8\\JU;#XS,\/B84\+5P'#N'Q<Z5;VLJ=+'RSO,,'.LI48
M^UJTJN%HT'AI17L*U&5'%0AR5G4E[Q^SIXS\=:QJ/Q/\'?$.;X@#6O!FL^'I
M]*L_BKIOPJM?'R>&O$>A)=6E_J]_\$)#X+U*SGUJQU^"T.F(D\,6FE+TM.WR
MS&,*F6T,5'V3J1Q>,P=5TE7@H3P\,+7ITZL:]^:O]7Q=&M.K0MAITZ]*%.*J
M4JTI5.HJ692PBE42E@,+C%&I[%J]7$X_#3G1E2U5!O"1BH5_W\:\:\F_8SH)
M?3]<YT!0 4 ?,'[1OA/PKXX\3_LN>%O&OAKP_P"+_#&J?'_6O[2\.>*=&T[Q
M!H6H_8?V9?VCM1LOMVD:M;3VEW]GU"TM+J+S8G\N:UBE3#QJP/T#]#?_ .&3
MOV6/^C:?@!_X9OX=?_,Y0!@?LY>$_"O@;Q/^U%X6\%>&O#_@_P ,:7\?]%_L
MSPYX6T;3O#^A:=]M_9E_9QU&\^PZ1I-M;VEGY^H7=W=2^5$GF37,LKY>1F(!
M]/T ?G'8?M"?%C3O"&HQ>)]=LUUG7?VA(]$^''B:WT;1;==1\!67[4-G\+/$
M_@.^L7LVM9-?TOPTR!;U+>.XN+#6([E'-[IEU=5Z&54*6)J\)X;$)/%8G+L)
MB\=!2:6+HXWA[$9E2QE**:G2]CC/9X;&0I-4J56.%J7A2S&&%I]%6"IXOBUJ
M*^I8/#YQ'!)<_-A,;E^7RKTZ523]VHJRA+%X7GE.53V..HU:?L\+"=;ZW^ _
MBO7_ !GX"N]:\2W_ /:6IQ?$3XNZ$ES]ELK/;I7A?XJ>,?#>A6ODV%M!$?LN
MBZ586_FE#)+Y'F3/)*[R/SU80AA,BJQ5IXS)<FQ=9W?OXC%Y9A<1B*EMH^TK
M5)SY(J,(\W+",8I17-4?+F.=8=:4L)CZ]"E'^2E!0Y8WWE:[]Z3E)]6SV6N<
M84 % 'S!^T;X3\*^./$_[+GA;QKX:\/^+_#&J?'_ %K^TO#GBG1M.\0:%J/V
M']F7]H[4;+[=I&K6T]I=_9]0M+2ZB\V)_+FM8I4P\:L#] _0W_\ AD[]EC_H
MVGX ?^&;^'7_ ,SE &!^SEX3\*^!O$_[47A;P5X:\/\ @_PQI?Q_T7^S/#GA
M;1M.\/Z%IWVW]F7]G'4;S[#I&DVUO:6?GZA=W=U+Y42>9-<RROEY&8@'T_0!
M^<5C^T'\6=.\(:C#XGUZT36=>_:#CT3X<>)[;1M$MQJ'@*R_:AL_A9XG\"7M
MC)9/:2:_I?AID"WJ6Z7%Q8:Q'<HYO=,N[JN[+,/3Q<^%<)7?+B\5EN$Q>-4)
M6^M4L;P]B,QI8VC%W=-T,9[/#XNG!.C3K0PE1\E+,886GT5(1IXSBQJ,7@L%
M0SB.#7O\V$QN7Y>Z].E5EM4C64)8O"\\I2J>QQU&I3]GA83K>R>"M(^)B_M
M^-O"FJ?M!_%3Q!X5\$^$_AMXPM- U3P]\!;:UU>X\9:K\1;+4](UF_T'X*:=
MJ9T>&'PIIGV?[!?6%VI><R7<N]1'C@J<8Y75Q=5?6*M#,L5ER]I[L94Z>595
MB85Y*C[+_:(U\PJS]UQH/V=&+H."J1J<V8ZXO!4Z'^QT\;AZF,E&E[WLW2S!
MTUAZ;K^V?L)4H>RG[1U*_+*4HUXU.6I'ZYKG&% !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 ?/_AS_DZ?XR?]D _9I_\ 5B_M8T ?0% !0 4 ?/\
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M_A.W_P"$,\7^-?A\MYX3TGS1IGA/7D\!^(M'7Q/X6M1/<B+1]8%]9(+NX"P
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M:3=>$:B<VZD,TI3?-3SGF>-CTK.<H3;:7P/FIP<73Y'%KW>6[O!X2^!GP_\
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MSPU*5"F]N6E.JZTHV5D[U&Y<TDY+9-1T.BJ "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * /G_P .?\G3_&3_ +(!^S3_ .K%_:QH ^@* "@ H ^?
M_P!D[_DUC]FG_L@'P;_]5UX<H ^@* "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^?\ PY_R=/\ &3_L
M@'[-/_JQ?VL: /H"@ H * /G_P#9._Y-8_9I_P"R ?!O_P!5UX<H ^@* "@
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M04VZ3M@)8%575Y8U?9N4<PHNG&'M4Y1J1E**493^EJD@* "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H ^?_#G_ "=/\9/^R ?LT_\ JQ?VL: /H"@
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MO>_M/K_]F=++D]C_ &=WES^V^Q[/W_0:1D% !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 ?/\ X<_Y.G^,G_9 /V:?_5B_M8T ?0% !0 4 ?/_ .R=
M_P FL?LT_P#9 /@W_P"JZ\.4 ?0% !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M+_[H']K?]0__ )/_ /:!_P +-_:G_P"A]^ '_A@_B+_]$U1_8/\ U%?^4O\
M[H']K?\ 4/\ ^3__ &@?\+-_:G_Z'WX ?^&#^(O_ -$U1_8/_45_Y2_^Z!_:
MW_4/_P"3_P#V@?\ "S?VI_\ H??@!_X8/XB__1-4?V#_ -17_E+_ .Z!_:W_
M %#_ /D__P!H'_"S?VI_^A]^ '_A@_B+_P#1-4?V#_U%?^4O_N@?VM_U#_\
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M+_[H']K?]0__ )/_ /:!_P +-_:G_P"A]^ '_A@_B+_]$U1_8/\ U%?^4O\
M[H']K?\ 4/\ ^3__ &@?\+-_:G_Z'WX ?^&#^(O_ -$U1_8/_45_Y2_^Z!_:
MW_4/_P"3_P#V@?\ "S?VI_\ H??@!_X8/XB__1-4?V#_ -17_E+_ .Z!_:W_
M %#_ /D__P!H'_"S?VI_^A]^ '_A@_B+_P#1-4?V#_U%?^4O_N@?VM_U#_\
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M+_[H']K?]0__ )/_ /:!_P +-_:G_P"A]^ '_A@_B+_]$U1_8/\ U%?^4O\
M[H']K?\ 4/\ ^3__ &@?\+-_:G_Z'WX ?^&#^(O_ -$U1_8/_45_Y2_^Z!_:
MW_4/_P"3_P#V@?\ "S?VI_\ H??@!_X8/XB__1-4?V#_ -17_E+_ .Z!_:W_
M %#_ /D__P!H'_"S?VI_^A]^ '_A@_B+_P#1-4?V#_U%?^4O_N@?VM_U#_\
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M+_[H']K?]0__ )/_ /:!_P +-_:G_P"A]^ '_A@_B+_]$U1_8/\ U%?^4O\
M[H']K?\ 4/\ ^3__ &@?\+-_:G_Z'WX ?^&#^(O_ -$U1_8/_45_Y2_^Z!_:
MW_4/_P"3_P#V@?\ "S?VI_\ H??@!_X8/XB__1-4?V#_ -17_E+_ .Z!_:W_
M %#_ /D__P!H'_"S?VI_^A]^ '_A@_B+_P#1-4?V#_U%?^4O_N@?VM_U#_\
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M$L2JSK5/8RK8:FH.7[Y_<%;G(% !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0!YU^Q1_R=E^WS_W:S_ZK7Q77QN:_[_7_
M .W/_3<#Z3+_ /=*7_;W_I<C]/:\\[ H * /RF_9Y_Y(#\#O^R/_  S_ /4+
MT2ON<)_NF%_Z]4__ $B)\KB/]XK_ /7R?_I3/8:Z3$XL?#WP?:2>)KS1/#^C
M>%]<\7VLUMK_ (F\-:-HVD^)-1,L<D:W5YJT6GF6]NXC*[QR7?G['.X#-<[P
MM!X6I@535+!UI.56C3_=0J<S_>*2I\K3K1YJ=2<'&KRRDX5(3M-;1Q%55Z.)
ME+VM;#V]G*I^\Y+<O*ES7]U<L'RN\'RQ4HN*L=-IFFV.C:;8:1IEM'9Z=I=E
M:Z?86D0(BM;.RA2WMH(P23LCAC11DDX7FNNK5G6JU*M1\U2I)SD]%[S=WHK)
M:O962V1S4X*E"-.-VHJUY-N3[N4GK*4GK*3;<FVVVV2WME9ZC9W6G:C:6U_I
M]];S6=[8WL$5U9WEI<QM#<6MU;3HT=Q;RPNZ/'(K*RL58$$BL9PA4BX5(*<'
M:\9)-:--:.ZT:379I,VIU*E"I"K1J2HU:4E*$X2<)PE%WC*,HM.,HM73333U
M1#>:5I>H:;<:-?Z;87VCW=H^GW6DWEG;W.FW-A)%Y$EE<6,T;036C0DQF%T*
M%?E*XXHKTZ>*C.&)A'$0J.\XU4JBD[\UY*::D^97N[ZZ[DT9RPLJ<L-)X>5&
MWLW3;IN%E9<CC9QLM%:UEL<M'\,?AK#IG]BQ?#WP/%HX\S_B4Q^$]!33!YNE
MKHDO^@+IX@^?142P;Y/FM4%N<Q )3E",[<\5+E3BN9)VC*K2K2BK[*5:A1JM
M+1U:-*H_?IP:J-6I"=.I&I*,Z,E*G)2:E"4?;.,H-.\91>(Q%FK->WK6_BSY
MM@^$_"S317#>&M :>"/1X8)SHVG&:&'P[<3WGA^**0VVZ./3+NYN9[-5(%K)
M<2/ $9V)OFESNI=^T=2=5RO[WM:E&6&J5.;?VD\/*5"<[\TJ,I4I-P;B9O6C
M'#/7#T[J-)_PXISI56HP^&-ZE"C4=DKSHTIOWJ<&ET?PGX6\.W>KW^@>&M T
M*_U^Z%]KU[H^C:=IEWK5ZH8+>:O<V5M')J5T [@2W#2.-QYY-9TJ=/#TEAZ$
M(T*$92FJ<(J%-3G93GR12BI2Y5S2M=V5V[(JI*56I[6K)U*JC&'/-N4^2'PP
MYG=\L?LQO9=$BE=> ? M[97>F7O@OPG=Z=?VLMC?Z?=>'-'N+*]LKC4)]6GL
M[NTELVBN;635;JYO7BD5D:XN)9B#)(S'.6&P\X*E.A3E3C'#Q4)0BXJ.#A*G
MA(J+5E'"PE*&'5K4(2E&GRIM%0JU*<N>G4E"?-7GS1DT^?$N#Q,KII\V(=.#
MKRWJN$'4<G%6B?X=_#^2VTJSD\"^#GL]"TV[T;1+5_#&B-;:/H]^D4=]I6E0
M-8E-/TVX2&%9;:!8XI!$@="%&-WK7^M/7$VI+VK_ (MJ%6%>@O:?':C7ITZU
M)7_=U:<*D+3C%J'K2E0>M"4ISE3?P.=2G4HU)N'PN52E5JTIR:O*G4J0DW&<
MD]$^%O#T<,<=GHVDZ=+;76KZAI]U9:1I23Z9JNNB\&KZO8":RDBAU.\>_O7N
M)S$YN&NYOM E$T@?*I3YZ4J49.E_L[PL914&X8=NG)T(J<9P]CS4J4O8RA*D
MY4J;<'R1M?M&ZD*E5>W<*E*K:HY.\Z%/V-*3<91FI4Z+=&$XRC.%)N$)1CH<
M%\,/@QX6^%4^NWNBW%W?ZGXA%E%J-_=:1X*\/@VNGS:A=6MK#I'P^\)>'-(C
M O-6U*XDN#IS74TEXQGN) D:QW0BL-@X8*DN6C";J6VO+DA2C:*M3IQA3IPA
M&G1A3IJSDXNI.<Y/$5JF)K*K5DVX>TY8[\KJN#JR<Y<U6I.I[.DI2JU*C2IP
MC%Q2:?5I\.?A[%-XCN(O G@V.X\8PO;>+IT\,:(DWBFWD#K);^(Y5L0VN0LL
MD@*7IF4AV!')SDL/AXX>6$5"G'"2G[65%0BJ3J7YO:.G;D<^9)\[CS75[W']
M8KJM2Q'MZBQ%!6IU>>7M*:LE:$[\T5:,5:+2LDMDB*'X9?#>VU1=<M_A]X(@
MUM%TY4UB'PGH,6J(NC1QPZ0JZ@E@)U6QBBB2V D_<+$BQ;0H M4J2J5JJIQ5
M7$3J5*L^5<]6I5IU*56I4E:\YU*5:M3J2DW*=.K4A)N,Y)Y-MTJ-%N]'#PC3
MI4W\%*G"I"K"G3C\,(1JTZ=6,8I1C4A":2E&+4+_  J^%\J:;'+\-_ 4D>C1
MZE%HZ/X/\/.FE1:Q-)<:O'IJMIQ%C'?3S327*P!!.\KM*&9B2X0A2J4ZM."I
MU:-.A2ISBE&4*6&E&>&I0DK.-/#SA"5"":C2E",J:BXIJYU*E6-6%6I*I"O.
M=6K&4G)5*E2/)4J5$VU.<X>[.<KRE'W9-K0V+7P9X/L?$-[XNL?"GAJS\5ZE
M MKJ/B>UT+2[?Q#?VR"-4M[W6H;5;RZ@588@(Y9F4") !\HP4J=/#JLJ$(T%
MB)*=50BH>UFKM3J<J7/)-NTI7:N]=29RE5]@JLG46%BX45)N7L8/>%*]_9Q?
M6,+)]AT_@[PC=>(K7Q?=>%O#EQXLL;8V5EXHGT/3)?$5G9DL3:6NM26IO+>V
M)=SY4<RI\[<<FE3I4Z-6K6I4XTJU>*A5J1BHSJ05K1J224IQ5E:,FTK+30<Y
MSJ4Z5&I.4Z-";G3A)MPIS:LYPB[QC-K1RBDVM+EE_#?AV31KOPY)H.BOX>OX
M[Z*^T%]+L6T:\BU26:XU**[TMH#;7$=W/<W$DZR1,)GN)&D#%V)*E&E5I0P]
M6E"I0IPI4X4Y14J<:=!1C1A&#3C&%&,(1I124::A%02458I5*E"JZ]&<J->4
MYU74@W";J5&Y3J.<6I.<Y2E*<[\TFVVVVR*U\)^%K&*""Q\-:!9P6NH0:M;0
MVNC:=;Q6^JVME'IMKJ<$<-LJPZA#IT,5K'<*!(D,21*P10HTE[TZ=27O3HNO
M*$GK*$L2ZLL3*+>L7B)5Z\J[5G5=:JZG,ZD[YPA"G&<*<5"%2-*,XQ2491H>
MR]A&25E*-'V%'V2=U3]C2Y+>SA:'1/!G@_PS>ZMJ7ASPIX;\/ZCKUQ]KUV_T
M30M+TJ]UJZW._P!IU:ZL+6*74;C?)(WF7#2-F1CG+',4:=/#45A\/3C0PZDY
MJE3BH4^=Z.?)%*/,TDG*UW;5FE6<ZU7VU:3JUE"--5)MRG[./PPYI7ER1M[L
M;V71$P\*>%A+>3CPWH GU"#4[6_F&CZ<);ZVUJ6*XUFWO)/LVZY@OYX89+F.
M0LL[Q(TH<J"(]A0]C4PWL8?5ZR4:E+DC[.<8SKU8QG"W+)1J8G$U$FFE/$5Y
MKWJM1R%4FJU+$*<EB*#4J=6[]I3DH4::E"?Q1:IX?#TTXM-0H48_#2@HVHM"
MT2"^M]3AT?2H=2M-,_L2TU"+3[2.^M=&,L4QTBWNTA$L.F>=!!)]E1UBW0HV
MS* C9ZSQ$WK/%\GMY/XJWL_:.G[5[U.1UJSASWY?:U.6W/*^:C&,*--14:>&
MYO8Q2M&ESJ$9^SCM#FC3IQERI75."=U&-N?M?AK\.K*QU_2[+P#X*M-,\522
MS>*-.M?"NA6]CXDFF+&:77[2*P6+6)'+,6:[28MN.2<UA]7P_P!7AA/84_JE
M.2E&CR1]E&2M:4:=N2,ERQLU%-<J[(W^L5_;_6O;5/K7+R^VYY>UY=4X^TOS
M\OO2TO;5]V#_  V^'4EAI&E2> ?!3Z7X>AN[?0--?PMH36&AV]_";>_@TBS:
MP,6FPW,#-',END:R(2KAE.*V2M6AB%I7I1IPA4_Y>0A2J4ZU*$9_%&-*M1I5
M:<4TH5*5.<4I0BUD]:56@]:%>3G5I_8J2<9PE*I#X9R<:E2+<DVXSFF[2DGN
M'PYX>::>X;0=&:XN=5M-=N)SI=B9KC6["VM[*QUB>4P;I=5MK.TM8(KMB9HX
MK:*-'5(U %%+V5DE["565+3^'*O&I"O*G_)*M"M5C5<;.I&K4C.ZG)-SE*<5
M3FW*$84Z2C)WBJ=&K[>E3L]%"E7_ 'U.'PPJ_O(I3U,BS^'G@#3GUF73_ W@
M^PD\1W4-]XADL_#.BVKZ]?6]R+RWO-9>"R4ZI=178$Z2W)E=9!O4AN:SI4:-
M"G3HT:4*-&A5CB*=.$8PA3KPDI1K0C%*,:L91C*-2*4U**:::0ZE2I6J2JU9
MRJU9TI8>4YMRG*A*#IRHRE)MNE*G)PE3;Y'!N+CRMHO7?A#PE?2M/?>%_#MY
M.^MV/B5YKO1--N)7\1Z7;V]IINOM)-;,S:W:6EI:PP7Q/GPQVT21R*L:@:12
MA*C."49X9U71DE9TG74U7=-K6#K*<U5<;.HIS4[\SNY5:DX2ISJ2E3G2C0E&
M4FXRHPFZL*,HMV=*-24JD:;7)&;<TE)MDVJ>&?#>N)?QZWX>T/6$U33/[%U-
M-4TFPU!-1T<RO.=)OUN[>07>F>?)))]EEWQ;W9MF6).4\/0J*I&I1ISC6=*5
M12A%J;H.3H.:::DZ+G-TG*[IN<G"W,[N%:K2E3E3JSIRH>T]FXR<73]LH1J\
MC33C[6-.FJG+;G5."E=1C:KI7@KP=H*VL>A^$O#.C)8B<62:5H.EZ<MF+JTM
M-/N1:K9VL8MQ-86%C;2>7MWPV4$;92%%72<8U.;VD5/FIU*4N9)WI5JOUBM2
M=[WIU:_[ZI!^[.K^\DG/4S7N_#[OOPJZ:?O*=.5*G4T^W3I3G3A/XHTYRA%J
M,FG1NOAO\.[UM$>]\!>"[M_#-I'8>&VNO"VAW#>'[&)HFBLM$:6Q8Z3:(UO
M5AM?*0&&,A?D&!QB\0\6XIXI^SO6:7M?W4U4I?O/C_=SC&=/7W)Q4HV:3+G4
MJ585*=6I*I3JSJU)QE)RC.I7C*->I*+;4IUHSG&K)IRJ1G)3;4G?M*H@* "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#
MSK]BC_D[+]OG_NUG_P!5KXKKXW-?]_K_ /;G_IN!])E_^Z4O^WO_ $N1^GM>
M>=@4 % 'YM?LW_LQ76O_ +._P%UU?V@OCAHJZU\%_A;JRZ-I-A\ GTK21J/@
M?0KP:9ICZS\"M0U!M/M1-Y$)OK^]N3'$AGN)Y=TK]T,RQM.$*<*W+""48KDI
MZ)*R5W%O1+KJ<DL#A9RE*5*\I-MOFGNW=Z*5CV?_ (9+O/\ HY7X_P#_ (+_
M -G#_P"AYJO[5Q__ #__ /)*?_R O[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
M\%_[.'_T/-']JX__ )__ /DE/_Y /[/PG_/K_P FG_\ )!_PR7>?]'*_'_\
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MITU-NO+DI3EAL-]8Q$*&*H8ITOJJKUJ&'X<_:PTK7?$\4S^$_$EK\+]3T?P
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M@ H * "@ H * "@#Y_\ #G_)T_QD_P"R ?LT_P#JQ?VL: /H"@ H * /G_\
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M>R<Z2PV!>69>W5JSJ8/!2K5:E1NK.;G5Q]2->HI8Z+H/VL<-7C13PT(R^D
MH"J H4 * ,  <  #H *Q;=_,(QC"*C%*,8I))*R26B22T22T2Z"T#"@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@#Y_P##G_)T_P 9/^R ?LT_^K%_:QH ^@*
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M_P"[E0!]_P! !0!\_P#QD_Y*+^R=_P!G >(__66/VEJ /H"@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H ^?_#G_)T_QD_[(!^S3_ZL7]K&@#Z H * "@#Y_P#V3O\
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MFV$PLTE[3$X;"\N.S50I*$:BKXUT<KIX*K&G3G#$JMB84Z$H5(TUY)XA^/\
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MRZM5Q#4Z.'PJP^(KIX;V4U@EE<Z3Q3I5HRP^SX5_:$^-GB31_"^M6D7PUO\
M39/^%.MK%U#X-\7:7>^*9?BMXUU6S@TSPYH5[\09I?!]Q;?#F;PSX@FGU&[U
MXVTTMS;FUNDG$EA3IPHUXQQ-*=)PG4PM;"PJPJ5X8O!<-4,[S/EKQA[&<,-7
MJ3H8>G"G-XM4ITW6P\HQKSBJW1ACL/4JQAC,)_:-6->4)+".C#.:V3Y-2Y.;
MVLJ^98C!8BC6E[2G3PDL3A*R56,*E"KPNH_MG^/$T[Q5XIT&7X9>(= L="\+
MW-QHVGZ6+2]^#NL^,/$MWH]A8_%'Q]XO^,'AWPIJ^J:3IN@^))]8T6:?P,UE
M?Q6>F2:E&9A=/R<KHT:/MJM-QQ6+PV&HYC2=-Y=4E_9N,S'&0H1J5J4\73@U
ME>&PN,IUJ:Q+QTIT\).O36!?7B:,J&85J%.,:L,"LQ]OA54D\94C@LQR_+J&
M(3I8>L\)2Q2Q&-QO+5PU>-/#X&3E7]BZF+I_0_B;XT>+O!GP7^'WB[Q9K7PJ
M\,>(O&FIV&CZE\0]3GDE^#GA&UU*RUK5=.\7ZLMIXR99M/O+#3;"VM],@\8-
M!+JFNVEC#KLT;I>3=&,H^RS*AE]*7U6;I.56%:-2I5EB:.'INM@<'2=/"U<3
MB*N*E.GAE.E0K/"TZN)>&G5I?5*O-EW/B\OQV.Y8UU0M.A"E.$?:4*V/I86A
M6JSA+%4Z:H8>M'$8OV=2M2O2G"-:%.?MJ?#Z5\>?C9K/]B36ND^ ;6RL+[X2
M:1XC:[\.>*$O_%6J?$'QWJ^@W"^%M.F\7P2>#K.3P*OA_P 6Q/JC:Y-8Q7[6
M<T%^SM<6>F&I4:^*PRJ*6'I8FM+#O"RFGB<-6H<-T,\Q\*U=THTY2R^I6EA>
M6.'B\7/#UZ;^I2C&<L95XPPF*7M%]9PU+'8B&)Y;X.O06;5<JR7V-.,Y5)3S
M:OA*])OV_L\-]9P>)4J\%.C4Z[XT?M!^)/A?XUOO#ECH-C?Z5IOAOX?^.M2U
M*;2=?N_[+\%W/C?6O#OQ(OKBXTZ<03ZG;V47AR'2;!/+GDN=6N+@Q7MO8S11
M<>&J4ZLJD)1G4EA\;2PM2G3:C4F\RPT*.24*"FFIXC%YJL3&HU>G#"86<9^P
MK5*%2KWUZ=*CA*-95HPK8G#9O4@JDE&E3EE-##8RM7Q$[KV>$CAJTHSE\7UF
M6'AS1A4G.GQ=O\4/C4OQ%.LW<WA6PT6UU?X4?#KQ#X(N+76[Z1-9\2KKWCOQ
M9::!Y'B>WMM-\3Z!\/=?\*W-]JUQ!JR7K>'[R"#3[.&99HM(NA@J5>6+;K0J
M3S6U6E=PE#(\AE7GB\+*=U# 5\[HX_ QINE&M64L/[;$1J8:G"KS8KZQ5H85
MX'"N$HTL/BZ?M5R3GA\YX@P^4X6ABZ<9V6(HX6A#%.7-&&$GB:T81Q5/$.5'
MGO!O[3.JZUX8\1:UIOB[X<Z;%X9^'6I_$BZ\ W5SK/C#XE>//^$H\-CQ?8ZM
MX&U+4OB?C0?!^F>(M?M/#F3I_B*S-[I%_IEJ=(BM(((3&8#'2P.)P=&=.OF,
MU@LEPTL-+V<,-F.(^J8'"XO&5^2I)T<=B*LL1@E*/MZV"GAL=+'8RI5J07:Y
M8.CFF&EB<13H9=*OC,57Q%>,J=/^S\OQ^/H5Z*PZ5)T<5A,NRWV^86M*E7JS
M]I@J4E)S]D^%WBKXDZ#X!^).D>/-<\/:OK/PAT#1].@\2VFEZ]J$AU2U^&>C
M^)=4M_%3ZIXLEN?&>L6=U?6\USJ,%QH'V\7NT6ME(K2'/B+&0IY;FV;8*$<.
MXXG-?JTE",,/6PV&G&-"M1H.7[B$:WUC!3A4Q%9>UP<Z[G&-1T*?+DU#$8C,
M,GP6.]Z688;+L1B(QE"%6EB<;BL73Q-%N%)4J2<*5'$4*<<-"-"CB:=.,*E.
M%.I/P7X<_%WXX7=WX?\ %=Q\0/A_\3](\KX->!=;;P]H-Y#I_B_7?$]AK/C[
MQA+X)L=$\?7.E:;K^D^"=>\.7$VL;]6@OQH$\,&EZ?'-YL/=C8X?+JF.A/"X
MB=-U<WC1^+VE>CD>1SKTL;1YHRC1PV.S6CBL)*A&E*52I5I+ZTEAJ%.KS^TQ
M.,PF K4*-/"U)4L+C9QDWR8>.=Y_ALI^H8FU1RE++84)SIUJLHSPL:DXU(XR
M=>K4I^P_LY?'SQO\6?"WCSQ_XNT_P7I?AG1((Y=.T/P]J?A_4_%?AC5+*ROK
M_P 1^%?&#>%OB3XOM9[ZQMAI6R:]C\(ZGYL]W#>^&[ P(\_%FO+E.15<PE5C
MBL1"&+KTZM)?[)6P]"FN1PE"=6E*2KPK1=3"XW&4*M%TJBJT:CG1CTX9+'9R
ML!A54H475C0Y,3!4\1"4ZJA1JS@YQK0]M!R=3#XC!X:IA:M*5.-3&PE[:/*>
M!_C=\3==@\$R^&)OASJ7A>ZO_@WI&O3&;Q7XMU/7O%'Q-T>3QOXXL?"_B&Y\
M=W$>G:1H'AC6])U:TN;B77U:&TN=/C@CA\FXLN_%83ZICJ^!GSQA1KYQ@,'*
M4+.I1R7)8U</CZTW[U2-;,<-7P57GBJV*E.-6IB8UU*KB^*=9O"/'87#U:=/
M$4</F?)6DJE2C#,^(Z^6PP4X1E%4ZM&#C[?D]E0P$H<F'PE6BXX7#<AXE_:X
M^*-IX,\*Z]I7A[P9H\?B+7O^%=S^+O%5MI^D>%=.^(/AIM2L_'5U]C\>?%SP
M);W7A@^([:VT'2[9/$HU&ZFMM6O+--5BLK>VU+AA_M&)RVEAXNE_;>$AF.7T
MJS7M*N'J4\ \-AZLJ?-5CBL7/&5JD%AL'BZN'PN#A7>$Q$,9*6![\1+#8:IF
M\ES5\'DV-Q6#Q$Z<[3I<M?'JE4?-2^K\N$PN"P\L5.KB,/AL1BLRIX3ZU@*^
M$G3Q-O5/VAOB;K2^(=&TSXK_  )\':UI?Q&^%7@.74M+\-_\+"\*^'=2\0Z@
M\7B33-6\<_\ "WM/T^\UN6YTK5M./AV\TCPYK%DS6T"+.^K:?J0VP\*57%95
M4BYU<!C\RS.%/W5"6)P6!P.-QV'I49)S]O/%TZ6%C+%X=VHUJM:E+"Q=#FJ8
M5)5<)@\14Q5&'UC#970JUHPK*]#$XC%Y?@J^+G"48SPM# O&5J]*EB(5J.)I
MTJ>)CBZT:6-P,+VI_'W]H3^RM8U_2+7X1Q:2/!GQ2\;Z&MYX:\7WUTNB^"_'
M*Z#X"DO&M?'MM#J-]X[TR5(+:SB>Q%A+#)J*W.I+_P 2F.<%&E7E@?:2Y?K/
M^JLITE+EFI\23JQC@8RG"RJ4J<%4GC'!QP]6#PKP6(C6CBZ715^JTL2\/.M4
MPE*A6S7#5L15HMPIQR3#8>.:YFZ<)7CA\'CW5]C@74=;'8.K2FL9@ZF'J/$0
M-^U-\6M3\=?$/P]H'AOX?V47A#Q!I7@&R\)>)-0T8^,9?%6O^--'\(>'?$MY
M%X?^*-]KMIX1OWNM0O#!K/@3PWML5M+[3M4UA)C#2P%&>-HX6I"4%]?QDJ=.
M2;E]5P^&=?%XN&(5-5:,\2\GPF*Q4(O%8;$4,936#K9?.FWBEAC>?!07MG"C
M4IY;'%RYVU3KUJV71GAX4')0G;^V\5@<IY:5/%4JG/6J3QF%JQ5!=OX4^*OQ
M6\0_%;X=^#M5\??##2;62_\ C8^MZ=9>"+VSN/B3IWPX\2Z/X5M;;PFFL?$R
MYO=$O+2XO]8EN);==94_\(Z;N6.*WO1:6]8",*\*^(J1G)4<IP=>6&32J1GC
M\;CZ6&S-2C&;6%J4,#A*JHS4H4(YI'"U*^(KU,-BZ,9@Y86I##*2P]2IF=.G
M1J->UI3P\,HP>.Q."J3?LX?6Z=;'3I04.2M6EA)8F-*C1P6-PN*Y+6?BIXA\
M$?'KQ'XV\;>/=(MOAG#XLU3X7:!H=Q#XXTJWM['PU\+U\>ZX=+TVS^(LWA_Q
M;X]U#Q7>V&EVKS^%7U)X='U&&P:-7:.3BPV*I83*\=5KWQ6*Q^$S?,\.J:O+
MV>49I1RBE@Z5.I&HZ2]W&XW$2P\J<ITJ57$XFI+#*G2P/5B:7M\7A:&%;4,)
M/*\'737LZ>'QN:4ZV,=?%XA*FZM&6">%H48S<Z$<;F.78>E&.*HXB>.WM)^/
MGQCU=O#NIPZ+X$@TE+SX0:3XFT$:/XCN_%&H^(?'V@/XS\6>'] E/B>V@T:7
MP_X)U/0-32ZNK75C<2VU];-:1"9+BR[<73AEE7%4\9SUUA:N=X>/L(J*K_V+
MDOUJIBZ;;J6HU<XPV-RZG1<7*2E13KPG2YL5S.?UFE2KY>I1PN+HX+&X:KB(
M\G^QYEQ#5RG QK4E.+A4EA/88C%57.,<-+FG"CB8U/94,?X8_%'Q!\9_$WB3
MQAJWQ2\-Z=X'\"_#OPMXP_L_P#>ZKX9\.>&-6UGQ)+XCO_#7Q$\;ZCXGU'3?
M&%YI-E\.Y-,UJYBT?0$TZWUO6M/:)99+ET*T)Y3EV:XZI4PV,J4<2L-AL1.:
MIY=B)4,LQ,ZE6C&:E+ZG6_MK+ZV'QRQ$HXN>%PV(A1H*C[.I4)?7L?EF6T(8
MC"_6X5ZM? O#WS:A&IB<-AL Z_*OW.+E[#,XRRR%W2J?QY8A?5*Z[[0OCQK<
MO[./B#XPZQXR^$7]J03:E#I.N3_8?"7PQM[F/4(-+L;"+Q'JWQ5U#2/&L!O6
MDCL]8M/%.AV6LO+:P@:/))-]FPS"^%H97]7]I&KC%0NZU"4:]6,ZT_:2HY;[
M2%6->.&A.=/!QQ>)CB'3]OA<;B,+7H5)/++XO%8^-;V<J.$G4CRX>I*=*FX4
M(2C&ICXTJJE2E7G"%7%?4*-7"*<J.(R^&+P]:@>-W?[77Q.A\2MI&E:/X*UB
MT\*_#2U^(.OQ:UI=IX!UWXAZ9>^#8?$K:UX(\):C\8M5\9>$]+T^\U"QM)UE
M\&^,K"0V.K(^O6=S9B"3I]DH5LS6(E3P>'PF-I9?*<ZZJ+ NI5H86.98Z=.E
MRQP?UBI.=7#XN.5U*&"4,3#$XJ3E2C4X2I4,MG[V)GC85:Z6&A"JZ_L,5BXU
MLNP:]NJ&)QT<%A)3P]3"XS&4\9B:V&BJ&&PM:&*?:ZC^T]JOARS-F_Q ^#7Q
M%USQ#X$BU_X<WW@'0]<BT+Q=XE\4^-;?P3X3TW1(K3X@^(W\2:#HNJ"5?$&I
M6EY;"-=3TV5TTQ9-DKPU!UL73P,J56-2.,R3#SJ-*G_LV-J8RMC\PE1E?ZOA
MXY?##3P+G7JPJXB&)IJM7E4HTH8*<HX>&9MTJN ]CGM>>'IU4J\:F48/+\13
MP$<1).,\35J5<9"<WA(2C&$9?5(K#8B4K.L_&GQXXT[5=8U?P%H?AC7?B!\3
M=+\$01Z?XKL=;FTWX/Z)X_OVUF]O;/XF:9%XMDU77?"VFR)X;M[6*&?2X;YK
MAYUN2=,\RM6EA\LJXNZ_M"'#^-S^BHI3H0H5IX.A@:-6G.\*L_[.S>CBJ]>H
MXTL/B8.I1A3G1HUUW4J-&MBJ>"ES5Z$LVRK)ZM6C5]DEC9/#U\;>KR\^'I4,
M9@,SRQ1BZDJ]>KA</652@L50QGC'_#5/Q \(^#+'5K[QA\-/B'XKGMOAAX9U
M'Q_I]SH/A[P'H'_"8>%/$/CT>*==\-^)?V@/#OA*]LIC)HN@6=]:>)?#<FJ7
MD6H?99K@VMOH\7K8G#6QU7+\#!T:DL?B\'"M7;J4L4\LP^40IQI4DUB,/B,=
M6S+$XJ6'PL<97C@:='$K XJE3A5."CB5/#QQ^)ARTJF7TL?1P=!?OZ%3'YEF
M&%Q%"O4O*'U?+895&C"IC)04<546#GB\/5Q=;$3^HOA/\7?&?C#XH:WX%\2^
M(/A3--X5\">'=2\0^'OAY'/XJN]/\47]EI#:PVK^,K?QW*OA)(M3N;^.T\-Z
MOX3BN+VQ-KJ-EK-XL5];V)*&$^JYMC*+JRPV$Q\L-1G/EIPITX.NI1E/EE#&
M5H^QE'$^S>#JX"K#V>)P:A7PM:L3JJG/*<.IJ5?%X:IB*CY$G.*J?NI1HQJU
M/JM.MAZ^"Q%*I*OBZ5=U*]*C6G['VC\5TG]JOXC^)KB_E\%7OP;\9VNH:KJ_
MAG1K+PW#K>K/X(\07?QAT/P/\/K?XC:_8>,9K8ZGK/@W6+W6;KP_!8Z9?60\
M-W5SYDL-P+>UPP-&6-PN62A4C3J9C3RBO&M*$EAU"KEV,S7.L/1BY*6*KX#!
MX.;4X580H8B=+#8F#52%>?5CYX7!5LSA*<\,\KGCZ'U:NO\ :*U3#0^IX7$2
MG3]S"T,7GLL/@L)1JPG5QV&QD*]"I3GA<53C<UOX]_$[2-=^)>CZ#JOPUU;Q
M+X#TGQKJ'C+59=,\97NDZ98_#/P3X$O[40?#:+XJ7#Z%JWB+QAXTU.VM;5=1
MLI)M/MK:YFGOGLXC>114\1A:6*P5!U,-4K**HSFO;5\QQ>>ULCP6!I8ITW&A
M3KX?)L96G+V=:EA,16HU882I.MBEB*<,+',:.%KUU@:TWAZ4Y5ZJA1I9>L%B
M\UQ6:<EH4YT,M68Y3AL3B)JA/%5(8JG*M1H0PL,#H^(_VCOB5X/M]>TWQIK/
MP@\%ZI%X@BTVU\57^@^*-4\+>&KN+X;Z9X]U'P&=%_X3?3;_ .)GCPOJ=K9V
M"6%_X6-]')<SI8))IQMKS#&58T*>(^K<U:6%CF]>C+V?-_:E#+<3@L/'ZK0C
M44L,W4Q&,IXBI.MBHT(Y;6Q4H1I5)4\-&"A5K+ U,115&.,H92IP]LH?4,3F
M4LT@YXRM*FU&C'ZCA94J3HTJE2KF6%PD:LG4IXBH6'QK^*VN^&K?4O%]W\.?
M#V@S>(_@O\--8^R67C#PS?WGC7Q_:?#_ %CQC<Z/XGM_B9:OX:T[2[7Q-J.F
MV%H'O;RYU$00M<_N##J7K5L/AL)FE*E*4ZM"MF6;K JFU4G]6X>HYA4<JZ]F
MX8J>*S')L90^K^QC0EA73C7IUXU*U,X5BJ&(RS%8BCSU(1RRC7KM?N*M"6;U
M*E#!PJQC.3PD\/@<PR;,\76I8J53#TGB7AJL*DL/B,-I_#KXV>,=5O\ P_X?
MT*ZT;Q;<_%:'5/'/@S4;^?4-130=(C^)WBNW\=V^NS6>JO!#IGA3P?)X,TRT
MTNV:TF75[HV=RZ^>SVO+A*2JTL)0J4ITI8#!Y/C<=65IPJ8;,\N^M/V-1R_?
M8C$YG3Q>'PU2,ZE"E@JV&Q%*C5PV"J0J=N82A0GC)0Y8XF6/SK*Z5"-Y4HXK
M)ZF!R_!R=G^[56@J^:9A3E[-U)T<1&C.%?$4T7_'7Q8^*FE_&#QCX5\%>,_A
MI>K:-\'/"GAWX;>(/"]U+KEGK/CK6KB[\0>-=2U72_'=OJ-WH=IX1M-8E2,:
M5!;SS:>D44L3Z;>R:CSY;_M2JTJD_?K9KC,)&M&FW#!X?+\B6:S]I",_WU7%
M3DZ-*,ZM!J=)-/DJ^[>+G1PD:,IT*JA1RMXQJ$XN>-Q&,S.>3X2G%RC:A0P>
M,6"J8NI&%64,/BZSDJE2>%CA^$U/]JGQ[HWB;5-/DUSX3:I'X-LOB)!XW\))
MX8\3:+K^C-\/)M-\/R>._$WB=_B#J5C\.?#&J>(-=T368=$O]'UBZA\,W!U(
M:K=%ALNG*E5I3Q4?W.!Q4<(J.(E5A.AEU?,,WP^!P^&QM9QI+&UL-@_KM;,%
M1A@?JN,PZPE3EA*%>J8C"XK#U*="FHXFMAZE/VT*492K8RE/(<;G2^I89-SI
M3G5P]/+L,ZD\1'$5I5*D$I0EAX>?_P##37QETS73%I'B/X8>,[KXD^.-1\,>
M!_'5Y:P>#/@Z]OX,TOPC:6?A_P /Z%XV^/6G75YJ6O\ B7Q/XC4ZWX=U7Q)?
MW-KH$%_:>&M2MFC@LNC+Z,:\\OP<XU:4YRKX_%PK04,55HK'8O+:M'"T8QJ8
MK"0PV&R3ZXZ,L-F%+#XK,%'%UL)]9=5\N*KX2"Q6,IU9JG2A@\%%T>6OA</*
M=">:RQ=2NZV'PF,;I9K@\-&3K95/&0PF(5%26 A&O]C?'CQM<0_ GQ-JO@?4
M;G5-;\3Q:=X(\+77@+6K!M3G\3>+=?L_!4,?A?7&U.PM8-8M=2OYQ%<S:AIZ
M6\]D7GN;40O)#Q3I^WQ>48>E2JXK#8[%X*LXTZJP]2OE=/ES/%U*595:7+&M
MD^'Q%6%2G6CS4Y*5&<G*#>^&JSIX;,,3*MA<-BLNPF.O*O%5L-1S.A2JX>A0
MK4Y0G[5QS7V.%EAITI3G6?U>=)S;IG@F@>)_C;\,KCQ%I>F:3K$'A;2_#WB[
MXP3^#OBSXBUSXS?%;0_".AV7@^PTGP-;>*;'XD:J&U[Q-KMA\1KBWFN?$'BF
MWTQ#9^0MU':OIYZ)8FE]4KRKU,.ZF5TL-3G.*>%I>VS3$YK]46)Q+HM1H97A
M\/AZN8XGZK4JRI<U*,ZB<,:M</AJ>)Q.582C"OA,3F]98=5J\HU<.E@.2.88
MWV,:K<)XEYAEE'!X2E7HTVJ6*Q56%"K4^KNWH_[4'CE+'3]:\WX=?%CPWK/C
M;1_!^A^)/A'I&O?V%J^O^*?!_BO4-*\%:1JMQXMUJWU2\TGQCI/A_2M2\4*T
M%AY6NS-<:=I3Z==>1H\-)SA@8-TLPQ*S&C@IXF,J%#%SP<,KQ=+,G%*I+#Y;
M+ U<XJ3IQJXJ=5Y8I83%5YUJ>&J<$*TG[?%54L/@L#A\MQN+I+]]B</3QF,Q
M6!JY?&WLE5S*%666581G3PRY<3.E4HQ<J=6/+^-OVFO%WA71_&<,'BSX9:#X
MSCO?B)9MJ>IV?BWQ1IUYX@^%FD^%=&N? _@[X=-\2K2=/%^K:M?:IJD4-OJ6
MGQVFD1VVK7EC?A[BYFY8X=YG2P^&RN=2E_:,H^QC*:>(K?VGG>8Y-A*U#$1C
M4CA,/@J6"P<LRKN&+HX''XJ-!8>%3$2C#LC4C@\74EFL84*&#CA95JJO/"X'
M"0RG!YWB'CG349XC$U7F&(HX"E3IT,1F.'P5?EJKZI0P\O0OV??B_P#$CQ7\
M1]<^%NI+X>7P]\)]'/A7Q"GB'5]%O_BOJ>L:']FTBP\<7;VOQ2U373I>OW%G
MJ%WY'B+P-X<W0W=E>66L:LEPRIW\]''4<PS948T*&)Q-;ZK1H-..#7UF:I83
M$*G&K0<Y81>UD_K.&Q.&KTY86I@)Q_VM<<X8O!/*L+7J*MBZ^&PV)Q-6453C
MB/K&!AB<56PT$J"IQH8ZO3PD:.'HXC"J$:K6(PLZ<,&L._\ VHO';ZOXTA\-
MGX::U<:;)XK\-Z;X!BL_$#^*/ /B^R\;Z5X"^'G_  M;Q'!XA:UM$\8:KJMK
M<P:&FAZ3=P6<AN;:\U."&69.++X5,93RZ:2K4\REE<UB*32HX=XJK1J8_+I)
MN<L1C<MRYXO$XNK3E36#K8&IA\1@VZV'E4Z\3RTJN.C2YXO*X8YU</44/K=>
MC@\MQV,694*?M(*G@*V*P=/#81S]I'&T<9AL0L3AJCGAH0^*OCG\0=&ORGB+
M6?"<>J?#W5OB_P",<^'H=9\/:!XW\(_#+2/">FZ]I,V@W/C"]O\ 6+O2SXY\
M2 E;F6WDO?!%MJ<ME9JJ6D=86I0<<)C.=/#2H8;#X^-6/O48X[BK^RXYI0IQ
M4_8PIX+*Z]5<\JZH_P!HT:2K5O;Q;BK2QO)C,+1HMXV6(I0P=&$$Y8FN^&<1
MG5'+XXB:49NICZN6P<Z:P5?%T(8JE"C"A3Q,WZG\2?BAXXL/@%XG^(UIK_A;
MX77FLZSHEKX%\1^)-#_M6Q\+>%/%/B?0O#.@^)/&%EJ_B/2[--0EM-2DUF1K
MFXM;73HKR"&[MKIK&<79*AB*>,R'+Y\E+,,3C,/1QE&?O04Y5:E:I@:?+.$I
M5X8>,,)4C1J2GB\;&K1P-2F\1AJU+7"2HXF.;8G#TY8O!X7 8[$81J7LW6>$
MP$ZOM[QC57U>MB:<Y85\L9?5)4*U>,9.K1CY&WQK^,?@V_\ &WC-W\/?$GPS
M/J?Q.ATWPKI6GZOI^KZG'\&?A[IVDZMKOA.:Y\7WEAX0\-7?Q3TC4[*;3IK7
M7)2/$D-U)JL9MO)GGVM&GA?>HU,)/%4*V84O;S@WA(8OB'!Y;@/KF(JRH498
M>>48FGF$5?+Z-*&&Q%>53_:*\J$NE6^M8"E*2J4<-/+<!BJ]"C*?UKV^39CG
M]6OA\-2J5'];O;!4TI59XF4*.%C1@Z,*M;Z'_9P^(GC+XI_#YO&GBV?P+>0Z
MGK-X/#-[X#O=!O;*?0H(;6)H=5;PK\2O'^BC6+76%U2T=],\6:C%-%;03R0V
M$\LME;=>*PT<)2P4).;Q,Z/M*K<)TZ<U.<Y4*E&-2$91C.@Z;G!2Q%.-53]C
MB\12<9G'A\0\14KRBE&C&2BJ;<)5*-1)^TI3G"I)54ER5*=6='!UI1J\E7!4
M)4[U/?JXSJ"@ H ^?_#G_)T_QD_[(!^S3_ZL7]K&@#Z H * "@#Y_P#V3O\
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M5J7.3C*FL.YIQ6*]O[)_S?5O8*MM\/(\312YK<W,^3FY*G+=T_4M.U:TCO\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!\_\ AS_DZ?XR?]D
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MM\.O^A<_: _\1._:G_\ G-T '_#2WPZ_Z%S]H#_Q$[]J?_YS= !_PTM\.O\
MH7/V@/\ Q$[]J?\ ^<W0 ?\ #2WPZ_Z%S]H#_P 1._:G_P#G-T '_#2WPZ_Z
M%S]H#_Q$[]J?_P"<W0 ?\-+?#K_H7/V@/_$3OVI__G-T '_#2WPZ_P"A<_:
M_P#$3OVI_P#YS= !_P -+?#K_H7/V@/_ !$[]J?_ .<W0 ?\-+?#K_H7/V@/
M_$3OVI__ )S= !_PTM\.O^A<_: _\1._:G_^<W0 ?\-+?#K_ *%S]H#_ ,1.
M_:G_ /G-T '_  TM\.O^A<_: _\ $3OVI_\ YS= !_PTM\.O^A<_: _\1._:
MG_\ G-T '_#2WPZ_Z%S]H#_Q$[]J?_YS= !_PTM\.O\ H7/V@/\ Q$[]J?\
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M4X4Z5*"O:%*C3ITJ<4HPA%*Q]0UD:A0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M_M3_ /1&_@!_XDM\1?\ Z$Z@ _X2/]J?_HC?P _\26^(O_T)U !_PD?[4_\
MT1OX ?\ B2WQ%_\ H3J #_A(_P!J?_HC?P _\26^(O\ ]"=0 ?\ "1_M3_\
M1&_@!_XDM\1?_H3J #_A(_VI_P#HC?P _P#$EOB+_P#0G4 '_"1_M3_]$;^
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M_P#HC?P _P#$EOB+_P#0G4 '_"1_M3_]$;^ '_B2WQ%_^A.H /\ A(_VI_\
MHC?P _\ $EOB+_\ 0G4 '_"1_M3_ /1&_@!_XDM\1?\ Z$Z@ _X2/]J?_HC?
MP _\26^(O_T)U !_PD?[4_\ T1OX ?\ B2WQ%_\ H3J #_A(_P!J?_HC?P _
M\26^(O\ ]"=0 ?\ "1_M3_\ 1&_@!_XDM\1?_H3J #_A(_VI_P#HC?P _P#$
MEOB+_P#0G4 '_"1_M3_]$;^ '_B2WQ%_^A.H /\ A(_VI_\ HC?P _\ $EOB
M+_\ 0G4 '_"1_M3_ /1&_@!_XDM\1?\ Z$Z@ _X2/]J?_HC?P _\26^(O_T)
MU !_PD?[4_\ T1OX ?\ B2WQ%_\ H3J #_A(_P!J?_HC?P _\26^(O\ ]"=0
M ?\ "1_M3_\ 1&_@!_XDM\1?_H3J #_A(_VI_P#HC?P _P#$EOB+_P#0G4 '
M_"1_M3_]$;^ '_B2WQ%_^A.H /\ A(_VI_\ HC?P _\ $EOB+_\ 0G4 '_"1
M_M3_ /1&_@!_XDM\1?\ Z$Z@ _X2/]J?_HC?P _\26^(O_T)U !_PD?[4_\
MT1OX ?\ B2WQ%_\ H3J #_A(_P!J?_HC?P _\26^(O\ ]"=0 ?\ "1_M3_\
M1&_@!_XDM\1?_H3J .@^!?@[Q5X%^'[Z/XUB\/V_B;5/B!\8O'6I6?A;6-1\
M0:%IW_"S?B_XZ^)%EI=CK>K>'M"N]4^PZ?XKM+26YETBP\R:UE9(0A4DV#8]
M@H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^?_  Y_R=/\9/\
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M "(?6,1_S_J?^!R_S#_AGGX _P#1#O@__P"&S\%__*2CZIA/^@6E_P""X?\
MR(?6,1_S_J?^!R_S#_AGGX _]$.^#_\ X;/P7_\ *2CZIA/^@6E_X+A_\B'U
MC$?\_P"I_P"!R_S#_AGGX _]$.^#_P#X;/P7_P#*2CZIA/\ H%I?^"X?_(A]
M8Q'_ #_J?^!R_P P_P"&>?@#_P!$.^#_ /X;/P7_ /*2CZIA/^@6E_X+A_\
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M *G_ ('+_,/^&>?@#_T0[X/_ /AL_!?_ ,I*/JF$_P"@6E_X+A_\B'UC$?\
M/^I_X'+_ ##_ (9Y^ /_ $0[X/\ _AL_!?\ \I*/JF$_Z!:7_@N'_P B'UC$
M?\_ZG_@<O\P_X9Y^ /\ T0[X/_\ AL_!?_RDH^J83_H%I?\ @N'_ ,B'UC$?
M\_ZG_@<O\P_X9Y^ /_1#O@__ .&S\%__ "DH^J83_H%I?^"X?_(A]8Q'_/\
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M_@<O\P_X9Y^ /_1#O@__ .&S\%__ "DH^J83_H%I?^"X?_(A]8Q'_/\ J?\
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MA?P)I*?VCXJU"'3M8TOQ+XR\0ZH9-1\1G5]5DTAI/$.G^5<37MW<2R6<CO!
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M*,Y1]G.;I8G%UN?V2E4A2ARXB*C!5:CBU).<DHL]GIFH4 % !0 4 % !0 4
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M]!5+_P &0_S#ZOB/^?%3_P  E_D'_#0WP!_Z+C\'_P#PYG@O_P"7='UO"?\
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M^?%3_P  E_D'_#0WP!_Z+C\'_P#PYG@O_P"7='UO"?\ 052_\&0_S#ZOB/\
MGQ4_\ E_D'_#0WP!_P"BX_!__P .9X+_ /EW1];PG_052_\ !D/\P^KXC_GQ
M4_\  )?Y!_PT-\ ?^BX_!_\ \.9X+_\ EW1];PG_ $%4O_!D/\P^KXC_ )\5
M/_ )?Y!_PT-\ ?\ HN/P?_\ #F>"_P#Y=T?6\)_T%4O_  9#_,/J^(_Y\5/_
M  "7^0?\-#? '_HN/P?_ /#F>"__ )=T?6\)_P!!5+_P9#_,/J^(_P"?%3_P
M"7^0?\-#? '_ *+C\'__  YG@O\ ^7='UO"?]!5+_P &0_S#ZOB/^?%3_P
ME_D'_#0WP!_Z+C\'_P#PYG@O_P"7='UO"?\ 052_\&0_S#ZOB/\ GQ4_\ E_
MD'_#0WP!_P"BX_!__P .9X+_ /EW1];PG_052_\ !D/\P^KXC_GQ4_\  )?Y
M!_PT-\ ?^BX_!_\ \.9X+_\ EW1];PG_ $%4O_!D/\P^KXC_ )\5/_ )?Y!_
MPT-\ ?\ HN/P?_\ #F>"_P#Y=T?6\)_T%4O_  9#_,/J^(_Y\5/_  "7^0?\
M-#? '_HN/P?_ /#F>"__ )=T?6\)_P!!5+_P9#_,/J^(_P"?%3_P"7^0?\-#
M? '_ *+C\'__  YG@O\ ^7='UO"?]!5+_P &0_S#ZOB/^?%3_P  E_D'_#0W
MP!_Z+C\'_P#PYG@O_P"7='UO"?\ 052_\&0_S#ZOB/\ GQ4_\ E_D'_#0WP!
M_P"BX_!__P .9X+_ /EW1];PG_052_\ !D/\P^KXC_GQ4_\  )?Y!_PT-\ ?
M^BX_!_\ \.9X+_\ EW1];PG_ $%4O_!D/\P^KXC_ )\5/_ )?Y!_PT-\ ?\
MHN/P?_\ #F>"_P#Y=T?6\)_T%4O_  9#_,/J^(_Y\5/_  "7^0?\-#? '_HN
M/P?_ /#F>"__ )=T?6\)_P!!5+_P9#_,/J^(_P"?%3_P"7^0?\-#? '_ *+C
M\'__  YG@O\ ^7='UO"?]!5+_P &0_S#ZOB/^?%3_P  E_D'_#0WP!_Z+C\'
M_P#PYG@O_P"7='UO"?\ 052_\&0_S#ZOB/\ GQ4_\ E_D'_#0WP!_P"BX_!_
M_P .9X+_ /EW1];PG_052_\ !D/\P^KXC_GQ4_\  )?Y!_PT-\ ?^BX_!_\
M\.9X+_\ EW1];PG_ $%4O_!D/\P^KXC_ )\5/_ )?Y!_PT-\ ?\ HN/P?_\
M#F>"_P#Y=T?6\)_T%4O_  9#_,/J^(_Y\5/_  "7^0?\-#? '_HN/P?_ /#F
M>"__ )=T?6\)_P!!5+_P9#_,/J^(_P"?%3_P"7^0?\-#? '_ *+C\'__  YG
M@O\ ^7='UO"?]!5+_P &0_S#ZOB/^?%3_P  E_D'_#0WP!_Z+C\'_P#PYG@O
M_P"7='UO"?\ 052_\&0_S#ZOB/\ GQ4_\ E_D'_#0WP!_P"BX_!__P .9X+_
M /EW1];PG_052_\ !D/\P^KXC_GQ4_\  )?Y!_PT-\ ?^BX_!_\ \.9X+_\
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M\&0_S#ZOB/\ GQ4_\ E_D'_#0WP!_P"BX_!__P .9X+_ /EW1];PG_052_\
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M\ E_D'_#0WP!_P"BX_!__P .9X+_ /EW1];PG_052_\ !D/\P^KXC_GQ4_\
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M ?\ HN/P?_\ #F>"_P#Y=T?6\)_T%4O_  9#_,/J^(_Y\5/_  "7^0?\-#?
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MU[\FM'MH?JK7"=84 % 'S_\ LG?\FL?LT_\ 9 /@W_ZKKPY0!] 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M7QMU/3]/TR'PW>65U\-?!WPS\"R>(-?G\?G1OB*E_P")].O_ !#-X>!TN8:
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M&QIRYG"ADV:PJ87$P=2I&4:U"E/%8:<?K%?#L/VK/B[K.N?$ZTL?#/P]T=_
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M,H24H22<6FFFFKIIK1IK5-:-"TAA0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MXJU6YU7Q5XATKPIX=TS3/#OA32M2U?6-0O\ Q%K>E6,-O8V-Q(TEXGRA0S*
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M^(&NZQKHT+7?$[V-CX;\ >'M:U6;RO#_ (8UZ_EF%EY,4.F2M+(GRA@#S_\
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MA</&49)QE&4:,$XRB[.+BU9II--69NUQ'H!0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!\_\ AS_DZ?XR?]D _9I_
M]6+^UC0!] 4 % !0!\__ +)W_)K'[-/_ &0#X-_^JZ\.4 ?0% ''^._ ?AGX
MD^&;KPAXNM=0N]$N]0\/ZLRZ3X@\0^%=5M=5\*^(=*\5^'=3TSQ%X4U73=7T
M?4-/\1:)I5]#<6-];R+)9I\Q4LK 'E__  S3\.O^AC_: _\ $L?VI_\ Y\E
M'0>#O@7\/_ OBJ+QKH[_ ! U3Q-;>']8\+6>I>.OC%\7_B;_ &=H7B#4?#VK
M:W8Z79?$CQUKMII7V[4/"GAR6>:T@AFD_LBW1I"BE2;!L>P4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 >7^/O@]X(^)6J^'M=\2CQA::WX5T_P 0:3H>
ML>"OB9\2_AEJMKI7BFY\.WGB#3+C4/AMXNT*?4M/O+OPGX<G>WO9+B-9-(@>
M-48,6-O(-O(X_P#X9I^'7_0Q_M ?^)8_M3__ #Y* /4/ ?@/PS\-/#-KX0\(
M6NH6FB6FH>(-65=6\0>(?%.JW&J^*O$.J^*_$6IZGXB\5ZKJ6KZOJ%_XBUO5
M;Z:XOKZXD:2\?Y@H55-@V.PH * "@ H * "@ H * "@ H * "@ H * "@ H
M\_\ B%\,?"'Q0L]!LO%L/B ?\(OX@'BGP]J'A;QMXV^'^NZ/KHT+7?##WUCX
MD\ >(=%U6#S/#_B;7K"6$7GDRPZG*LL;_*5-O*P;>5CS_P#X9I^'7_0Q_M ?
M^)8_M3__ #Y* /0/A[\,?"'PNL]>LO",/B ?\)/X@/BGQ#J'BGQMXV^(&NZQ
MKHT+0O#"7U]XD\?^(=:U6;RO#_AC0;"*$WGDQ0Z9$L4:?,6-@V/0* "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H ^?_#G_ "=/\9/^R ?LT_\ JQ?VL: /
MH"@ H * /G_]D[_DUC]FG_L@'P;_ /5=>'* /H"@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M>.6.5T=65B" 7_\ AD[]EC_HVGX ?^&;^'7_ ,SE ' :1\)_A9\+OVI_A?\
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MY^,6N^'Y/ >C^#/"N@^+O$7C/PCX@\<@^*?&4OPVT"W\,^$[3P_<:U.FH_\
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M%+=0V@U:6R;S51HS=3%T,2G@JV!OAZT:MHPHYE0RW#8_&82K6FX4%1H5,3'
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MC/GCPOP/^)_Q ^+7C[QCXKN&@T;X61> ? %WX/\ #$&MZ+J5R-5\4:2->O\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MT0QM)':PVZ32SS(\\QL&QU__  CG[4__ $63X ?^(T_$7_Z+&@ _X1S]J?\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % 'SQ\?9O&^@6_A3Q/X"\1G1]4O_$&D?#.^L]2E
MOKK0?L7Q+UO2_#5GXGCT9)3:R^)?#NL7%AJ=K))"/M$$5]I\LL45]YL!AJ"Q
M.84LOJU:E/"YM2KTZLZ3BJ^'_L_"8O-'6PDYQG[*M6PN%QF!=K4_:8K#8RM#
M$/+J%&4XFM'"X"OCE2C4Q&5SI5J,)\_L:[Q%>A@?J^+A"<'4P_M<1A\3)I^V
MIK#3I8>I16+Q$I<'J?@;Q1%\2-'^"T7Q$\='X:^)O"4WCW5M1;Q[XVB^)D-Q
MX$/AWPK>^'=*\?6NLQZQI6CZ[J&M^'M9NIK+4+6:*;2=5MXE,.NR&TUA%8V.
M;5:O[C^R*M&KA8T%&$>;./KSP].NG%NO0RRIE^.K485Y5OK#Q>#P]>^#R[ZO
MBLZM6I@YY9[*2JXC-57I8J=:G&<+8#ZO4K5\/15J.&KXZ&,H86<:%*G1PU&C
M5KX6%+&UHXBGCZ3IOQ1U#PA\0_%6J?$?6'\3?!J]O?#'@U;+5M6L- \1Q_#*
M5-9O];^(.CVC16^N:OXOM!%IFIK-!=Q6,,;3:6(;B:1VX<3F?U7*:?$;PE*=
M>N\5B\5A5SPPJHX*ICLIQ&$PD'*:HQJ5:&-S##5N1U*-:M@*-98FGEE.5;LP
M^$ABLUK9%3FZ&'I.&%PU>]6I7IU<TH8',\)7KMUHRQ*RR%? X54YU4\;&AF$
M\144<TG1H?1_PCM-93P/I6M>(]:O=;\0>,$3QEJTL]Y=7&GZ9<>(H(+Z'P_X
M=MK@A--\/:59-:V%M#%%"91:/=W"M>7ES++ZV.P\<#6>61E[;^R^?"RKN/+4
MQ-6G4FZ^)J+FFXNM7E4G3H^TG'"T'2PE*7L:%,\S XEX^A#,_9K#K,X4<1##
MQG*=/#TG1IQH4HN5E*<:48/$55&'UC%2K8CV=-5%3AZ97$=H4 <!\5[R\T_X
M6_$B_P!.N[FPO['P'XNN[&^LIY;6\LKNV\/ZA-;7=I<P.LEO<PS(DB2QLK(R
M*RD$ UY>=.HLJQWLJLZ%1TFHU*<G&<&VDI1E%IIJ]TTT>IDD*=3.<II5:<:M
M*>,PT9PG%2A*+K04HRBTU*,E=----:-'Y0>*?'_QJUSP[I7AAOB5X_\ #US\
M+?A[XZ^$'B7Q-I>NZQI>H^,?B!J'@F[\1:3X\N[VUNH6U'6M.\%6G@768;LR
MRM%?>,]14.DUNY/TM:C+%YU5Q5!0PCS>K@,-AL-[)1P^&Q&7\8<,97FM>G0Y
MI4WAL5C<?CL!2@X*^"P=2FW*CB90?R%?'O*LEP'*I8N>#CC,TK5)MOV^$QG!
M_$F:93@I5YRG7E5P;P<GB^;]W+$0P>)A*I4IP='Z9^!7Q%^(WCWX_:+-XBUO
M7K;0-"^$_C_X:ZIX9DEO;70-:^)OPK\5?#;3O'/CR+3WF$5ZTVL^([[2K2[D
MB+I#IESY3^7=,7,*Z&*R_/<VA15*GG%3)L?@*$GS2R_ UEG%%X6W*E3JRQ>'
MQ*KNG[M>C1P4W=1A;V<5A9X*GEN!]O.K4R;%U<'B*\HN%7&2Q.%KXG#5<1)2
M=.K&65T,JQ]*--RC1K9CBZ<Y*M&=.E^@M><4% %2_9DL;QT9E=;2X964E65E
MA<JRL.0P(!!%<.:3G2RS,:E.3ISIX6O*,HMQE&4:4W&46K.+BTFFK--71T82
M*EBL-&24HRJTTTU=-.:333T::T:/R,TCQ]X7'PC\&ZMX*^/GC/Q"VJ_#+PM=
M_M%Z@?VA/'?BZW\"7L_B#X=)?:MJ'BK4?&U_<_!OQ(9M1\1V;V>E:GX>+6DV
MHR-:XTI);+VLRAAZ6;2P]/V<>%UF6 A0Q:JN*=5YCAZ4<-2QZG&KBJ&)P,\1
M4Q4)UJ\*;H825Z+Q4OK9B%.-;.O9TXQSK#U.(5'"J,>>&%IY7Q!4H55EUG2@
MJ&-PN71PU98>#4YNG&<[\L?N;]GW5M#OM3^(-K\._'.J_$CX06<GAF7P?XLU
M+Q]K7Q3@/B"ZM]57QGHFB?$/Q#K&KW_B32;)K;0YCYNK:BMI=:E>VD<L:P?9
MK6%&K_9\)8NDZ.)CCL33H<U"-"=7+EA,MJX>JXQA3]K!XJMCZ=+$RBY5J=))
MU*BIJ;\Z4E',W3H24J']GX6I64:CJ1AC'BLPA..LY^RG+"4\'.I0BH1A>%3D
M4JTK_3%<QTA0!\_^'/\ DZ?XR?\ 9 /V:?\ U8O[6- 'T!0 4 % 'R!\)](_
M:G^%WPL^&GPS_P"%7_ #7/\ A77P_P#!O@7^V_\ AHCXBZ9_;'_"(^'=-T#^
MU/[-_P"&6KO^S_M7]G^?]F^U7/E>=Y?G2;-[&WR#;Y'?_P#"1_M3_P#1&_@!
M_P")+?$7_P"A.H /^$C_ &I_^B-_ #_Q);XB_P#T)U !_P )'^U/_P!$;^ '
M_B2WQ%_^A.H /^$C_:G_ .B-_ #_ ,26^(O_ -"=0 ?\)'^U/_T1OX ?^)+?
M$7_Z$Z@ _P"$C_:G_P"B-_ #_P 26^(O_P!"=0 ?\)'^U/\ ]$;^ '_B2WQ%
M_P#H3J #_A(_VI_^B-_ #_Q);XB__0G4 '_"1_M3_P#1&_@!_P")+?$7_P"A
M.H /^$C_ &I_^B-_ #_Q);XB_P#T)U !_P )'^U/_P!$;^ '_B2WQ%_^A.H
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M/_T1OX ?^)+?$7_Z$Z@ _P"$C_:G_P"B-_ #_P 26^(O_P!"=0 ?\)'^U/\
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M.H /^$C_ &I_^B-_ #_Q);XB_P#T)U !_P )'^U/_P!$;^ '_B2WQ%_^A.H
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M/_T1OX ?^)+?$7_Z$Z@ _P"$C_:G_P"B-_ #_P 26^(O_P!"=0 ?\)'^U/\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
# __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>99
<FILENAME>g20922dsp540.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922dsp540.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MI0L[FP.*C8L7-,8;J!!F@8HH * "@ H * "@ H * "@ H * "@ H * "@ H
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M0XU*NY:G;0F7R@9@ _?;TKFV9VIZ:DPZ4%!0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 (: ,C5[1GC%S;627-ZGRQ;R,)
M_M<\5479ZF5176AC0:@/#H:36]0DN+Z49\I"6"K[#@#ZUKR<^Q@JGLU[QTUC
M>QW]E%=1!@D@W ,,&L6K.QTQES1N<#JNB^(]4U.0S0NT8<^7F1=BK[<^E==.
MI"*/.JTZM1FK:VX\%Z+/=7#++=S$ *N<9[#/YDFLV_:2LC:,50@VSFI_%6LS
MRE_MC1^BH  *ZO812U.1XF4I:'H&F(^J^'(%U./S&FC^<,,;N>#^6#7!+W9N
MQZ<%STUS%6+P7HT4A<P,X)SM=R16GMY6M<S6&BG>QOQQK&@1%"JHP !@ 5@]
M3I2ML/ % PQ0 M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M\NYFJ4$]B^.*DUV%H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M.>XK"I#D9V4*W.C?K(Z!: "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * *#ZE9_;UT\S+]I=20GM3Y6M3/GB_=(K#0=.
MTV9Y;6V5)&/4\D>PST%-S;T8HTHIW1I@8[U)H+0,3% !1L 8H I:K:O>Z5=6
MR-M>2,JI/K3CI),SJ*\&CR>31]2BG,#6,_F XP$)_4=?K7IJJN4\:5"5[6/0
M?"6B/I-BTD_%Q/@LO]P#H*X:T^=GI8:GR1U.DK$ZQ: "@ H * "@ H * "@
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M=%'X#O161L+0 A[T ?-7QB_Y*)=_]<HO_017H8?2!Y]?XSVWX=C_ (M[H?\
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MO_017H4/@//K_&>W?#K_ ))[H?\ UZI_*N*I\;.RG\*.HJ#0\\^-'_)/IO\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>100
<FILENAME>g20922dsp597.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922dsp597.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MXU)J$OBH8=:TJ/\ =DU^]K+_ )^R<&W&G"WVI7AGO!0 4 % !0 4 % !0 4
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M &L__P $?_3=0Q^SD_\ B?\ Z7 \G^*/_)1/C'_VD3T'_P!'_$6NBC_"P_\
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M/K-%NDV]91C'FM?2*HS<'[-Q2]C^%D7PMOOC#H%SX:\9?%7XC>);#PE<W/\
M;WB#5['6?#^CZ=<6]Y!)I5[/>:;:ZC;R127Q,<,0\I)M10$ES*J^1F;S.GE%
M>&)P>"R[#3KQC[*E3E3JSFG%J<5&<J;34=9/WG&#Z<K/I<@CD-7B3"3P.9YK
MG6.H824O;XBM3K8>C3E&<72G*=.%:+BY^[&/N1G42;OSI?;5?&'Z@% !0!^
M5?O!_(84 % '>?![X7W_ ,:_B%:>'+<F#POX:O;;4?%6H[!)%)<VB0ZA;:4J
ML#'(+5KC2+VXAE#),][I=J\4UI=Z@UE\_GN9T\%AYP^)Z7C>W,W?EI]_>LW-
MJW+3C*S4I03^]X-R&MB\12Q7P3J>T5"5K^QA"T:N+L]+TW+V6'BT^;$24FN2
ME-K]L]+TRRT;3K'2=-MTM=/TVU@L[.W3)6&WMXUBB7<Q)9MJC+,2S$EF)))/
MY55J3JU)U:DN:I.3E)^;=WZ>FRZ'[U0H4L+1I8>A!4Z-",80BND8JR7=Z+5O
M5O5ZEZH-0H \Y^*7PYL_BCX7_P"$4U#4KG2K*35-/O[BXLX8I;IXK&1W:W@,
M[>7!))NP)624+C_5MGCT<KS">5XGZU3IJI.,)0BI-J*<E:[MJTNR:OW1XN?9
M+2S[ ?V?6KRP])U:=24H).5J;;Y8\VD6[_$U*W\K(_!GPA^'7@#6M=\3^&/"
M]A8^*?$]OI=KXC\3NK7.NZS;Z-IUCI>GP75_.S-#:1VNG6?^BVHM[<R1>;Y/
MF,6/-7Q5?$/]Y/W5*4E%:1BYR<G9>K>KN[:7/1PV$HX.G"G2C;DA"FI/63C3
MBH1N].D5>R2OK8ZJ_P#"?A75-236=3\->']1UB/3Y](CU:_T;3KO4DTJZCNX
M;G3$OKBV>==/FBO[Y)+8.(W6]G5E(F<-DISC'EC.48WO9-I75K.RTNK+7R78
MW<(-W<4VE:[2O;M?MJ]"#_A"/!8708_^$1\,!/"LCS>&$_L#2@OAR:2:&XDE
MT%?LF-'D:>WMY"UIY)+P1L3N12#VE3WOWDO?^+WG[W3WM=?F')!<ON17)\.B
M]WT[?(@F^'W@*YEN)[CP1X1GGN]677KJ:;PUHTLMSKB&4IK-Q(]D6FU93//B
M[<F8>=)A_G.6JM562J22BN5+F>D>V^BTVV%[.G_)'>_PK?OMOYEJ;P;X0N;K
M6+VX\*^&Y[WQ#:K8^(+N;0],ENM<LD2*)+/6)WM2^IVJQP0H(KEI$"PH ,(,
M)5*B44IR2@[Q7,[1?=*^C]!\D+OW%>6CT6J[/O\ ,HZS\.?A[XCTK3=!\0^!
M/!NNZ'HH0:/HVL^%]$U32M)$:)'&--TZ^L9;>P"I'&H\B-,!% X PXUJL).4
M*LXRENU)IOU:=W\Q2ITY)1E3C*,=DXII>B:T-,^$_"QGT2Z/AK0#<^&8?L_A
MRX.C:<9_#]N8DA,&B2FVW:5#Y,<<>RU,2[8U7&% "YYI27/)*7Q*[U]>_P Q
M\D?=]U>[\.BT].WR(6\%^#G_ +>W^$_#3?\ "5*$\3[M"TMO^$C5?,VKKV;7
M_B<*/.FP+OSO]:_]XY/:5%R_O)+V?P^\_=_PZ^[\K!R0][W(^]\6BU]>_P R
M'0O ?@;POI-QH'AGP9X4\.Z%=R-+=Z)H7AW2-(TFZE<*'EN--T^SBMYI&"J"
MSQL3M&3Q5.M6<XU'5FZD?AES2YEZ2O=?)D.A0=.5)T8.E+24'"/(_6-K/YHZ
M:&&&UABMK:**WM[>*.&""&-(H8(8D$<44448"Q1(BJJJH 4*   *S;<FY2;E
M*3;;;NVWJVV]V^K+C&-.,80BH0@E&,8I)125DDE9))*R2T2*UCI>F:9'-#IN
MG6.GPW$KSW$5C:6]I'//(JK)-,D$:++*RJH+L"2% )XJIU:E1IU*DIN*LG*3
M;26R5V[)=D12H4,/&4:%&G0C)N4E"$8)R>CDU%)-M))MZZ%+2_#/AO0Y[BYT
M7P_HFCW-WG[5<:7I5AI\]SE@Q^T2VEO&TWS 'YR>1FKJXG$5HQC6KU*L8?"I
MSE)1Z:*3:7R,J&!P6$E.>%P=##3J?'*E2ITY2Z^\X13EKWN)!X8\-6FJ2ZY:
M^'M#MM:F+F;6(-)L(=4E,@*R&74([<3N64D-ND.0<&G+$XF5)4)8BI*C&UJ;
MG)P5MK0;Y5;IIH$,#@J>(EBJ>#H0Q4KWK1I4U5=]'>HHJ;OUN]2:30-"EMK^
MSET729+/5)WN=4M9--LWMM1N9&#R7%_ T)2\G9E!:2578D DY%2J]>,J<U6G
M&=%*,)*<DX):)1=[Q2Z)62*>$PDH5:4L+2E3KR<JL'3@XU)/5RJ1<;3DVKMR
M3;$T_P /Z#I%C+IFDZ)I&EZ;/YGGZ?I^FV=E8S>:GER^;:6T*12;T^5MR'(X
M/%%2O7JS52K6J5*D;6E.<I25M5:3;:MTUT"C@\)AJ4J&'PM&A0E?FITZ<(0=
MU9WA&*B[K1W6JT$TCP]H'A]9DT'0]'T1+AP]PFD:99::L[KG:\RV<$8E<;FP
M6R>3ZTZN(KU^7V]>I6<=(\\Y3LNRYF[?(6'P>#P2DL)A:.$4W>2HTH4E)K9R
M4(QNUYFQ6)TA0 4 ?BU_PHOXP?\ 1._%'_@N?_&OV/\ MS*/^AA1_P# S^8_
M]5.(_P#H38K_ ,%L/^%%_&#_ *)WXH_\%S_XT?VYE'_0PH_^!A_JIQ'_ -";
M%?\ @MG,^+/AC\3?"NE+>ZEX.U326O;VST?3+C5[66WLCJNI2>19K-Y8::2"
M(>;=3K;QRRK;6=Q(J-Y9IK.,OFI1P^*IUZJ3<81EJWLNR2NU=MI+N:T>%<XC
M5IO'9?7P6#C*]:M.FTJ=./O3:6MY<J:A%)N4K))MGZH?LZ_""S^#WP]T[2#'
M(^O:A%'?:]>W2QB_FNIWGNS%>M$S)]J^U7M[=7"Q,85O-1O/L^VW\F./\PS?
M'O&XF5I<U*DVHOI*3MSU+?WFDHWU5.-.+U3;_>\ARQ9?A(RE25&O7C"]/_GS
M1IIJAAD_^G46W4:;4J\ZTT[327O=>4>X% !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 4+S2M+U"?3;F_P!.L;ZYT:\DU#2)[NT@
MN9M+OY;"\TN6]T^6:-FL[MM,U'4+1IH2CF"^N(B=DSJU1E*%U&3BI*S2;5TF
MG9VW5TG;ND^@G&+M=)\NJNMGM\M'8OU(PH * "@ H * "@ H * "@ H * "@
6 H * "@ H * "@ H * "@ H * /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>101
<FILENAME>g20922dsp86.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922dsp86.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /O3]IG3_BMX&OM:U#X3^)+OP[>^/K/2E\-S6_V(V\/CGPO
MPL_#U^M\GEG3=?TWS;1<RH1=3(Y=(X&)^EP%/!YC@*M"K3M5R_F=3?WZ,[2B
MXZZ^SG.4Y=E%[GPN/K8C).(*-11;RO-8PAS*W[O$PBX6DMTJD:=*G%[7DMM2
M#]E/XO?$?XM:XWBF77KW7?#/BU]0UG6-'U+35TVT^&@T>SCT2?P#IT802R:[
M;^-!J;S2SNWGZ8FE7*K&;B14PQ."P=#!RO[M:E*,:2L_>:<9\S[+D=O6+^?H
MTL?F%;-\/A*</]CE0G4JO2T;QK0BEUO>,/DROIG[>W@[PGX3\-W/Q/TKQ#)K
M^IZ5XI\4ZM/X1\-W^IZ-HOA/2?BYXN^&EGK.IO;"4V-O'+X?LUE9S\\MY$L8
M9YD0\#RZ=9Q=)J*DYTX-NWO<E-R7_D\;'MQQ4DY1J*SIJ-_\+<E'\8R_ [#_
M (;S^$RZ:]V/#?Q*;4T\8W'@C_A$_P#A"=87Q9_;,7A=O%]CG06@%TEO>:(!
M/&S1@JI+2A$1F$_V9B/B]I%1E[.:][HY27_MK^XMXVDU;7[ON+7AK]N_X->*
M#,=.L_&=M$H^'\^FOJOAG4=*76],^(WBNS\%:)K6D+?11-=Z0GB*\CMI;E1L
M^1F0NH)JO[-KQNK+]W*4'KLX/E?Y:>@EC:*4M7[D8R^4M4:GC7]M7X6^!KK4
M;"\TKQGJE_IGCCXA_#YK'0O#UWJM[<:Y\,-$\-^(O$TL-O9AW;38=(\36=S]
MIP$6.TNY)"B0LPB&"JR4=ES1A):]*E^7\BI8NE!N.ONMK;MN59?VZ/@B=8\+
M:98S>*-3TWQ+9?#RZNO%%CX9U6?PYX3F^*<%M/X&T_Q7J*VVW1;[4(+NVD\J
M<*T2R[I0@5MM/+Z]/HDXN7+KJ_9R=.=EY6DM>B?D1+&4>271VTNG:Z::O:]M
MC1\-?&?QTNHZ3JWBBTT23P3KOBGQAX7M3IT<\>M6%YX8CUJYAEN8'RLJ2)H[
M+\C9&YF;! !]:OE&#]A*%&4ECZ<,)5:GI!^VA3B[/R=33R/C,+Q%F=/%+%8Z
M-)99B,5F&#IJDIRJJIA/KD[N/+LXX&KKW:[G<3?M%^#+?2;'5O[+\42V]Y8W
M^L^1%H5Z]W:^'=,:T2?Q'=0+'NBT5I;I5BN/NRF*79N\LUPRR'&\[I6I23G&
ME%J6CQ$FG&%^ZO3;[75STH<990Z=*K&G7BY0=1)T9J4:,7)3J232M%\M3ST-
M+5/CEX/LM:/AR*357EG&FVB:Y!I=Q<:':ZKKVEKJNC6,]Z%$?VN>SG@E6(L,
M@X)&#A1R;%N@ZD(4XJ"G.5-S2E*,)RI5+)OI*$U\K[&]7B7 *NZ$%4511C%R
MC!\E.52FJ\'>WQ.%2G+LKI/J<QX4^/6A6^A^#[/6)]:\0ZG?Z'H%_K.OZ;H5
MU]@T_P#X2"\GL]+GU=8E;^SS<RQ$A3SL <@ \=.,R><Z^-JX6,,'0C4FH4YS
MC&4G2A&=2,4V]HSA;75RLCCR_B7#QI9?AL4ZF,Q-:E2E5G3IR<8QJ5)TZ<I-
M)=85&[+1)/J=!>_M!> M/UB^TW4&U2PMK.]U73(M;NM-N4T:_P!1T.[ALM5L
MM/O-FVXFMKB=0X'H3T(SSK(\6Z=-Q4)W2DHJ<>:$9WMS)M6;Y=MU8ZUQ=E3K
M3H3E4C[*ZA4]G-PJ.-O:J+2;]WFI;I7YE:]F=%\<M"T[7?A-X\MM3@2XCLO#
M6K:O;%E4O;WVD64NHV4\3-_JW2>W7)!&Y6=#\KD'+)*M2CF6!7.XQG5C3JK2
MU2E5?LZD):?#*$G'RW5FDSLXCH*MDN/;BI2PU*5>FWO&K1_>TII[IPG"#5M'
MRV::;1\@_L9^']=T+XN_M$RQ:;J6E^!O$FD? ;Q?892>/P]J7Q!\4?#F+7/B
M1K&EI*QA;4KW4;ZPGOY+50IDDB1L&$)%TYS)2K2M*RC*<8*UN2*G*,;=_=4=
M7OI>YCP_[6>7T*M76O+64].:45%)1;V23OM;=GRKKWP#^,=SX.\:V,/P^UR6
MYO?V6O'GA*RA L3)/XEU']KGQ'XWL=(4-=D"[F\*W5MJ2Y.TQ2+N82#:#ZU2
MISHZ^Y3JJHHK;6G13VUU<+,[/9U)-\T;VBHROUY92<6_3F9ZV?@[\3Q^T_JW
MBL>#M8'AN;X]1>(X-6'V4VSZ(O[,&J>$SJ"@W&_[./$D\>GLQ7=YTQP"F2*E
M7PZH0IJ3O3IJFGKKR2FXR>N[Y_P$L/RM>XNAY'!\!/C3::)X&U"+X<ZY<W7@
MK]F3]FQ+K2EFTZ*ZO_$?PT^/EAXT\4>$K1Y+T1C6H_#UM-<H'(C<A45]S 5L
ML;1A.LO:N2JU:E1.VW.^>WHF[+T1@\)6M->S2YZ=.&^WLTU=>;O=G?:5\*/B
MQK_CC2?B#+\.?$>BZ;XP^*?[9WCN'3M2.FC5M$T/X@_!7POX3\&+KUO;WTL5
MG?ZGJVBW4<=NDLVPN@E90"3C]9I4W2IJHY*E3PT+VW=*Z;^>YT^PJ2YINFDY
M2D[7[GD7@CX#?&[0_!1^&5W\,/$S:A\59OV.O$&GZS%+I1T+PI;?!O2/#UKX
M\L_%T\VI1S:9J%K)HI>"&*&Z-REPK1MYJ>4=EC*,JM&<JEHTWBY-<M]:\JM2
M-M/LN=D]U9>9B\/6E^ZC247+9IVMRIS;MU^&UGIJ?HIX)^#6OS:5JVN^(]2U
MS.CZM\3;_P ,>!98K"+3K74]6DURRMM562!3)<S3V]ZTL0DE*QO*-H5=RMIB
M<VPJGA:%*A'GC#!TZF(DYRE)0ITJCO&3<59QY=%HEHKGRV$X?S!TL=CJ^+G4
MI0K9M5PV!C&E"G3KSK8RA"K&<%&?/4I5:DWS2MS5I+:QF>,? 7B)4\&WEQX;
M\4ZO:S? ZQ\!7&E>&=3M]*NF\0(UO<'1]?G:8+#H=S%)+%+(JW"H]ODH<*3M
MA<SIJ.(HT\32HOZ^\53J2IMN#C[.TJ;]G*S?LM.9)6DU97TY\PR;%SK99S82
MMB*,LLIX:I&E65*4YR]OSTJ_)5I^Y'VGQ0E*3\[6.@TS3_&/A#5?$?A2T\ S
MZI;>*-5\,ZE;ZE--;7>DZ+HMMX(TK1=49;MY8Y6URPO=)6* F!?/)$GRC ;G
MKU\-BZ5'%?7_ &-;#T*L9*"G#VDOK=>HKQC%02G&H^:RVLVF[G70PF88/%8K
M TLI5>..J8>HIRE"4:>&6%PV&J.,YS]I[>DZ%;V=]W&G[_*[QX/1?#7Q#\/Z
M;\./[#\&Z_H7CC2M#\(Z3%K>F7UC/H^N:.NH%_$F@>.[&Y=8[9+&(O+;31BX
MF83_ +N2,JJKW8G%Y;5KYI5Q&(I5\*ZF(:@XSYZ3=*ERSH-137-R^^N:*E[.
M%[I'E83 9MAL'D7U;+ZN#QRIX2$JT94^6I#ZQ5]K3Q474<9<D6G"2A4:52:4
MDU8IZG\*-:U&:^\-W_@+Q7XDN--\5>-=7@GNO%L.A^%H--UG7#?:;/H:Q0W0
M-W>6MVAN8O(AVO9$EB6P%6S*A&,:L,50H4:L:=HQHQ=7GC[6_M).E?12M\<D
M][+=F%R>O"JZ5;*:]6I!U7S3K_N8J7L$_8I8AZU.1<UZ<;*G"V[1]C_%W_DE
M?Q(_[$;Q7_Z8KVOF\L_Y&.!_Z_T?_3D3]"SO_D39M_V"U_\ TVSC/@!_R(>C
M_P#8*\'?^JY\(5TYO_O$O5_^EG+D'_(MP_\ A9[B.C_7_P!E%>;_ "_UU/57
MV_43^(?0_P#H8HZ?UV8?U^(#M]3_ .AK0_T_0H5?]7^$G\Z'\7W?D6O@*QZS
M?]?$?_H$=6OL_P"%_J32_BQ_[?\ _3<R2+[K?[]Q_P"CI:PG_&7^*G_Z8,L-
M_N57_K[B?_3]4:?NK]354-I_XI"E\6$]%^HP_P"N/^Y'_P"AFIA_NTO2?_MP
MX?\ (QI?]>'_ .E5AL?W!_UU_P#:<=34_AX_TJ?^FS)?PLJ](_\ IQCFZ_@/
4Y45OX$/5?DQ1_P!XJ>C_ #1__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>102
<FILENAME>g20922dsp88.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922dsp88.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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:8FI7E4]DJ/QQA=<E.<H_&I2NK?%:R21__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>103
<FILENAME>g20922g03a10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g03a10.jpg
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M$0'_Q "C   " @(# 0$             " <) @8!! 4#"@$!  (# 0$
M          0% @,& 0<0   '  $# P(#!@0'      $" P0%!@<( !$2(1,)
M,11!(A5A<3(C%A?P4:$8@9'10E*B"A$  @$# P(% @0$!00#     0(# !$$
M(1(%,09!46$B$S(4<8$C!Y&AL4+!4C,D%?#18G)#-!;_V@ , P$  A$#$0 _
M /W\=*4=*4=*4=*4=*4=*4=*5\#J  D\3AZ^0]A$/4"_7M]!'M^/6B=W0KL
M-_\ S"_U!O\ RKU0HNS$V%<F$WB(@(]NWJ(!]/VEZS+ 1;F-M-3?I^)\/QM6
M)4G53UKY)JE4,;Q6*<0'Q$""'Y1]!["'K^8._KUI21FMD("T)TN&#*/70#^M
M9 !FW+JHZ_C79*(B4!'ZB'X?3J0C!U#*0RGQ'0_UKS\:X.8"A]>W<!_'M^(!
M]1]/J/65FO<:@>%-?[1=O*E(Y/<S<3XJ,81MH<]*2^AWE5W'Y3B.>1#N\;9K
MTTV(GWA\]SV$(O,R1R+*$*X?+$0BV)% 4<N44^Y^IW#\=G<\Y'%1--#&P^60
M:) O3?*=0$!.I)4>M:,K*APU,I.Z6U]G7_H>OY^E>5Q8N?,G1$K;?N36<YOA
MM8L"S ^28C RCZZ:O4(%$%#.)+:K\TD H[FVS95"=X>#9G;17@)#/G9Q$23.
M=3@L!$XOBY9,GEEN9,H+;$L#;8BFS;AX,9+-U M8UCCG)9@TQC"MX>7Y_P#5
MJ<P@B)""(" B4!$!^H#V^@_7U#JD!#"XZ&I)!!L=2*SZ]I1TI1TI1TI1TI1T
MI7!A\2F-V[]@$>W?MW[!W[=_PZ:^&IIKX:FNL=S[8E 4S&$_?Q*3\QS=B^1O
M$O8.X%_S^G^G6L2 DJ 0X\#I?_UO]7Y5Z; "_P!9\/*H'GN0]/$9>*SF.E]J
MM$2_>PTC7,O-%37Z3+Q[TL;)1UAL+Q^QJE>>1;LQBN4';PCA(4SE%+R#Q&XQ
M.'SLA$GF5<7%==P?(/Q KKJ@()>]C;:-;5%EFLL@A!>1-+#S_'H*B,(/FYI?
MWBTM>LEXW08J&6AV5-JR^S7TS!R@V.5O/2]R4@Z8Q?LU@43.#2/=IF,/<I^Q
M0[V#R=F\8'$YS^1R;+L,3+B0J;D$$LF0^06TV!1"5U)W;K+%Q%Y&0QY.Y4BN
M=Z6W$]+6:_X^%)=S4S_/\'S1&W;7RKYS:7I%IDV56Q_(,?VUQG%]WC6#E(O!
M9[F%"S6(AP^YEG2(&?NO$S&'CBKNW:B2")CC><%W!A\AFQ\=Q_ <"\;-9I<J
M*:8QJ/J=Y%FB51&/<[%0%T)T-)(XX9FGF<M))I&E[6/A8?X_RIW> .=<@<IX
MEX[2^4EU>7S=H^ ?/;W)R$^M;GT.M.3LK-0U&>71TDF[N[G.X!^V@U9I4ONR
MJK SDPB*G<>-[ISN-Y#G'Y+B<6+!C$0OCPD_$2J@$B]R S L/'76I''8LN)$
M4GDWNS7OTMZ==:8'4=GR_$JA*W_7KW4\TI$,!_O[5=9Z/KT(BH1(ZX-P>2"J
M*:SQ5!,QTT4_-50I#>)1[=4L,T^3-]CA1B;D"VQ5#!4:0VM&9#<+(;_003T\
MZD9$L&(GR93JB?Q_EUOZ556KS9Y)<^G"57^-*KH4;"I!NNTLWR';E3I=O4$T
MW)$@,3BOCDVC#SVV6%NF)Q)-2Q(^JMUR!^9[V$G7<Q]L8?%PGD^^5R<<QE_C
MP A7,FM8!I W_P!6,DW1G1VE 8HHVZP_NGR%_P!DK>XV#E?;ZW\K_P#?RJ"[
M]JGQU?"='O9NW3E]Y,<[MD.Z=/GKMRALG-??[)]HFX>$<.BH]\YS\5/YB;%(
ML9",6H]D$%@3\1V\=C=U_N?D?\/V?%#%AXJ*TD$<HBBQU#&SYLC!P%U&^1U4
M!@"-I.D2?+X_AV5^18G)EN"P&X#33<= H\.O4VN>E/Y\8W+*]\W>-*7)&XCF
M$='7N\W!&D5/+PN#Y.A5>MR9J\6EW:SVYG$?UAH4'+QSI.5?Q;%K$"O_ "VW
MNE(*IX_[G]I0_MUW-+VSCR2MFP(IEDEB^..=F]UX(=[,5 ]H??[B"=H%JD\1
MERYRM-(J_ #[=+?X_A5C9/4I1_8'^/QZY10 H"BRVZ>56-R=3UK+KVE'2E'2
ME'2E<"(!]1 /WCUBSHJEF("CKZ4K$RB9 [G.4H>H]Q, ?0!,/_J'?]W7MQ;=
M_;7MC43:EM5 R-G$&MTPJ25M<FG TRK0C)>?N=RG5@[DBZG58PCB6FG":?\
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MS8\9$D D^-?EDFE0'VXZ*)(XE'R)*S;WVZ5ST:?\ME??<@-F%]LS&^CW!:Q
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M?=7<?,@)R69/+&JV"[B$ M:P1;*-/2MF+@8>&NW&C51_'^9N:8CQ#U^H@/U
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+TI1TI1TI1TI7_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>104
<FILENAME>g20922g03b10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g03b10.jpg
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M$0'_Q "X  $  00# 0$             " $#!PD"! 8*!0$!  (# 0$
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M9%6<***+/'RQ">ZY<*&,JX7.=0YA,81UXG-Y#)Y/-?DLB_W@_+LZ#8+!;+X
M* %'V5 %7&,)D6TMA^7Y?&LK!Z!]0?XZZV0*JA5OM \?[]:ZU76U*:4II2FE
M*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2J&'8!$1   !$1'
MT  ]1'J'0-*5XFPY(H53DH^'M%UJ%<EI8%#Q47/6:$AI*3226(V55C6$D_;.
MY!))RH"1C(D4V4$"[;CKK'!D3 F"-W Z[03;WVK1Y88_ZKJI\+GK[J],64:'
M.@0BI%!<IF51%(14(HD7;N4!4H"GV]>G7K\-<9M^.A>52JKUOX?#K1'CD^EU
M(J-7*_E12>)6*U\I7=!S-'=2<;4,?8]KXIN;_F'*MJ=)Q5 Q3CF'5423D[3;
MI=8$B&.<$6B13N5Q(W254)UX;$S^=Y2+A^/0-GRRL@4D*/D!9Y6D)$<<2*"[
MO(5"BP)#$ ZY<RX<>Z35R; #J3Y5JQIUNSE9<UY J>+65*LWD5R!3JRERFSK
M)@[M.!/'WC&0>'G:+Q[J!")HM,C9*K[65/((5U%5N:6E3J3<RJDS,T;G]M)B
M]O\ H+'GR2Q_AOCRLWKP@+/R?(1J4#0":X,!O+_-=),?"C7TIPN3/&CUB9+/
M.$95.45L0?I7R4>.X>/MZD5*T:]BKQD<=7$1CJ"LF8LX99N:A(9O/2Q);-W+
MCD]=#%;(3U^MATA<J"HILXE)(Y4XVJUIF8B1$VS9%,WDMLW>O)#'EB>/!C5B
M[GY4Q46VI-E"2:'9( L;FZH0&"U,E,?'X^^8ELC<"#]HGX>&OP!M[3FCA[Q=
MDL&1EJR'EFV,LH<J<ZR<=<>0F6FD>+".F)UG'E80E!QW&N.]U6<.8SCO_KZ_
M&B<Q_8 [ER*KMRNH;;D^4Q)/1[>X:$8_;.$SO&I^N;(?^MDS&Y'K2M=@NB1*
M?3Q52(,#ND1(^\R$^I);4>8&G47T'PZU-PI-OZA'IMU /Y &JT);4ZR>>E_V
M5)!(%CJ:YZWI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI
M32E-*4TI7$X=Q1#;NW^ @ @/[! >FVE*PK>N/>#<DW>F9+R)A_&]WR!CPJOZ
M%N-LJ$)8+)3P5<@\.%<EI)FX<Q8'>%!4?:$NZ@%-U,&X2H.4Y; BDQ\";T\:
M;20:C=8&W0> )UN.O6N;1QRN%=59O"XO7Z^6,K8ZP=C.\96R=9HRFX^QO6I&
MTV^P2 '!I#PT8B*RZI6[=-1T\=K&$J39J@0[ATY4(BD4RARE&O@CDY#-7"Q;
MY/*R$!4%V-V^D%%U^?7;<78 L+A21U5(PA8H!&/$6'[*^:&&G.2'DMYEN;K3
M'\IC*4QFPDZU"3LQ!D<,?'5B&\1J R9X5FY%Y 6CR?<A8!=%5R1<ZS3$57%-
M!TE^9G50/]6FQN'["[<D?.09/JHJ3B*0&7+EO>3 QW0DQP0O;[[EH=LKQJD;
M[#=_/.\W)SE8F,9CZ'W^74;M/AY^6Z=H/&WQI<?ZI1*E"3A&,M9F-4HU4B0D
M;MF+.V8+S*D04D924=_B9RY7NX3T@#Z<L4DH+9FF8[EXJW:I !?!E^<[[Y[9
M,<<P;%55B4+BXV* Q0JJ_)$BJ"978[)' 8L\C7,V(8_%8GJR[F+L;Z7*N;7
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M54 $2-HYG6Z) (#MW"!46Z<5&D-MZ] Z!KR/)<YR?-Y2GD<S)GR$&W=)(T@
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M,)=ONZ\9]]_"_'>&?CX><R]C?.F2T,22#R+1(9+'J2K*?;5G'B\E],LZQK_
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MK1F/*4V./N.V)@%^O)Y*R([!!%$QV<,DZF?TI65'J+F55;)'<BF)&Z!1<.4
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M_)F,NH9!+L2+],@XSN_D.,R>#_#'$SH^TX%V9,[[(I9#8*SRLY1S$3>T8+
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BWQ^O[H>O]_\ +2E<OI^Y]W^0>O\ ;I2G_;][_'_5I2O_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>105
<FILENAME>g20922g03c10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g03c10.jpg
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M$0'_Q "K  $  00# 0$             " $"!PD#! 8%"@$!  (# 0$
M          0% 0(#!@<0   & @( ! ,&! 4$ P    $" P0%!@ '$0@A$A,)
M,5$406$B,A46<8&1%_"AL2,80G(D)30F&1$  @$# P($ P8#!@8# 0   0(#
M !$$(1(%,09!42(383(4<8&1(Q4'H;%"\,%28C,DT?%R@E,6DJ(70__:  P#
M 0 "$0,1 #\ _?QBE,4IBE,4IBE,4IBE,4IBE6F$ XY_Q\,YRND:AI/EN-?(
MUD"]0P[E=F9?K_1X>%U72FNW>S&WIA>A]<-)&EOT8;[?"-32,C,6"4+YE*YK
M'74*0\Q9Y@2&(QCT?(43.%VZ2D_AN+S.:R,AX?RL#%C#9&2?ECC)"W'FUR%5
M0;EB  :C94I2,JHW2$Z#SU'\O[>->3Z([]V[V J.\T-UUJA1MMTUV'O6B5+'
MJXUB4UQ??V&PKIYJ:JXV@32YV\%:Y-_!N5#F$%'L2J8 )R)"S.[.([?Q,/!R
M.&DR,CC\S$+R13@;XV25XMP"VTGV+D*=;HPM<68\<>?(FSLG!S$M%&RE"-+^
MXH=O_B0!4^R% I"%   "E*  'P    \,I4W;!O;>UA=O,^?W]:GEBQW-\QJ[
M-ZQ3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%
M*8I3%*8I6+=R[;H^B=<7+;NS;$PJFO->5N4MEPGI ?\ :8P\6F0Z@-TBF]9[
M)O53E;LVJ13KO':J:"13**%*,2<R">-8U:0-<,M[64CYAH2S;MJA1:X8GPK8
M%4!DDL(@I^V_@/L\ZU54F6NNO-?[ [^=@*ZO_P N.QZC#6_674DDT0<3^G*+
M>Y9VCUYZ[048X4.VC;I)*2:5CV(\0,'U+Q)Q]0/TD6B"?JU)Y)\/LGA5,, A
M$F5O<(&D5/=G$TE@L9A16$*."79"0;D53I//#$V=G*-V[TA>MB; :WU\3;I^
M-3!UHAJ;H)UDUQ5MM[6IU78PS9BWN&PK9+-*\A?=M728/*W:SHINCG66D+K?
M["Z>F2**QT"NB@;@A?-E3S&3R'=7/LW;V-DYI*1184+.KRMB8D8AQS>- N_Z
M95>>0(4W@^D%[B7CPQ0QR/+(]I&)W'K<F_X#H/\ +4XDC =),X"!@,0A@,4>
M2B E 0$H_:4?L'(Q!4E6ZBI0.X7\ZY,Q6:8I3%*8I3%*8I3%*8I3%*8I3%*8
MI3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I7 HLF!3\B/X0\0* B;P^P #X
MB(AQG(31M)[0/Y@ZCR'^(^2_'I62+6O87K2WO/9=#[/=C+8CLNXU>K]!_;@M
ME?N>\K;97Z#.F;;[?Q9&\S2];2$BJJ1K(U;K>+^/EY!BGZYI"[/8UB9,RS%1
M++_CW?!P/U3$NO.9(>+!WQM8!E:.3*C.X;QL]W'4+K^8TBL#&+P)LB)FVNRC
M&4@NUP #_2"3I]U?>8WIE/S!_<:[0QUCINMZ4Q4K?2;0$C&R"5_'^X948)ML
M">UV]22?/>S.\W*Q8FNQ'I XKE?<B@J)5GDBHGWCPX5P(.V.UL:27O+.QG7.
MR%;W",3W(IQAXY50(<>%XXI<Z63W2DD(0E54AN<+2,\DV4I_3@OY9&NZYU/Q
M)_&W\?/:0T?;NZ>PQWUVOK$44:)96Q(?79&4-,5>G.89TWDTM+UBT^0ZUFB*
M-:HUNZN<VCZ:5DMC46*"BL+&M_5LX>9;]O&EFXOVL7N.7!]I\O?9Y8<@?ZJQ
M-8P1.NF&[%OJ8&3*0Q[@E9B.9ES 2JOTP)VV(.[[O(>?]1Z:"MUA X(0/D4H
M?9\@^7AGB5!"@$DD#J>I^WXU8VMI5V;4IBE,4IBE,4IBE,4IBE,4IBE,4IBE
M,4IBE,Q?6U*IR'C]WQP#?X?;6;4 P&^'/\P$/]<!E/RD'[*$$57,UBF*4Q2F
M*4Q2F*4Q2F*501X_P(CS_+%*U4>XWWU'0E46T'UO%EM[O]NM%Q4>O6@ZBJQF
MK>SD'I2_KFT+DR.Y)'4^CZX@%%I9=_-*-&)UD$43&,"HYZ/M'L^;NKD=W*)[
M'9D4E\_,D.W'QXD(.[W;6:5M+0 ^XY(51?K$GS4A4X\<B-F,;*M]03T!UT\?
M*L)=8>DT1UVTU2ML=X+S6FE,ZZ4I:_Q.I'<H1QI;3-K2"4M6S]][<MCLQ3[^
M[%668?/'\G:I%!)BRD'*Y8I@D8Q5QN>Z^X>/EYV>/LF;(R8&3V%RG2WO0*5$
M?T\84>RK *=JLSL-3:[!JS#P\B5&BY")76]_; Z]26/4DKX]?+PT^_JC]Y]]
M=D1O8"U0ZE8UK N)*"TWJ:<E9B%N>J]:W2LS7T78ZU0Q$4E(7LWMZO.4"0#$
M#I/*+3Y$PJB$@_5!/JRX/9W&9'%\BD[\O/BDL2 D61(K!7@60C2"+<1FD,=V
M0L<=TLRE:?-RHXL&4/@H0)$OK$+&U]>I.@!Z"MN=-J->HU;@:C58Q.%KE=BF
M4-#1K<#>@QC8Y$J#9OYU/,=53R%Y.H<3**'$3G$QC"(_) L<CH3[@5K7%BR;
M(QL2(OT]J,;1 =/0HU:O0QQ>T#TN+ #R'A:O9!\ _@&7*@A0&^:VM:GK5<S6
M*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*H;X#X<_=_/!4-H>E9 OH>E?&F)V*K
MS):3G)2.A8IJD95W)2SQM'1[1,HE**CAZ\50:HDY.'YSA]W.9C'NM[<6K_C^
M'G7*6:&"WN&PK',-O?4UD>OHZK; K%O?QZ;0[QA4)-*TN6@/A<@U.Y+!?6^@
MFN9HJ!//Y>13-EE)P'/0*'RL66&%A=6<%5(\"+@:&_QJ$O*8#L1%*'<> Z_9
M60X>:"8;(NT64FV27.J0"2<>XC7*8HCP)U&CP$G!$E1_((A^(/$,KY(FA;8S
M(S6_I\/@=3K4V.0RBY4J/CX_&ON<C\A^'/V?'Y?'X_Y9I72JXI3%*8I3%*H8
M0*43#X  "(CX^''V^'CBE18[ =RNO'6&1@(_>5SE:6%ECGDC%R:>O]B6B!^G
M9O6K!4C^>I]6GXJ)<J.'1/32=*I**% QB@(%'B[X3M[FNX96@X."3)R5M^7&
M-SF]^BCU'IX5PR6DCA,GM9$F,#ZS%$\FWRW; 2M_"XUJ/QO<OU+<XTSKK7J/
MLOVK>"+HK<FH=,6:$KPJMC"EYW-\W"&LZ2BR.Z'T_,D^<&Y 3 0Q0')[=@]T
MXZSGD_T[B9XFL8L_*CQIY#Y1X[VE<VN;*N@U)%18\Y6*1KBYBJQ])>"1%^TL
MX  ^)K#FW%NV^P-<7+:W;G<T%[=?5VC1$W:+I5=%W MIWW,TEBW8O$$KIV#=
M1#*(UG*'5*HV/'4^/?2#QPN1NVD0.)!-MA1=M\;G8L>")^8YR10H@D_)P3(V
MFWVR/>FMYK-$IT.OAB:/.RM%D6'#'S>?Q]7AIY"O,>USTT@*0]M_<6RZC;ZQ
MOFZ8E"OZ>H]C;O9+8>G.MJ:PR=:B]@VFP.I&US6]=R/71;5L!\]<KO3R:S=@
M944V"898=W][Y^5Q./V0)D!P=DN9[*[(/<=28L9!\K1X$?Y"&[ G<YZJ:C8&
M%CQ93S8XV<625VG4R.--X/7UFY^RWQKP6VKQ>?<H[ .]*:A1:N.IO72]LU;C
M:)^-"4UKO_<]4F52&<R!4C E:-.Z&GHA46L8456-QNC8$W %BXT5G&W#< G;
M7;:=Z]S_ .WDR&+<;'<^Y*A%TR @*DI-$Q*V*% 1*A:P6M,O(RCE_I^$UYD_
MU1_X]VJ ]3J+V'C8GITW1ZSUW5]90"5<JT;]*V5D)&=DWJZIW,E/V&<<'?SM
MGFWRZBSF2G9Z0<'7<K'./)C<% "@ !\[S>;Y#GN5^JY0WG"%4 ^18$(6!$ Z
M[([*S+H";."S U>8V,N-CV7^K4^9/C<UDW.UM+>%;4Q2F*4Q2F*4Q2F*4Q2J
M"/ <^/\ (.1_H'CBE6 <OW_$0X$.!_H/ AX?Y9J0!ZGL/C>M2_A8_A7&*Q?S
M!X@'Q$"B/ ?/P'X  _TS191J&9#Y:@5G<I%[-?[*"J(_ IN0$ $#)J!\1X\!
M'@H@'V\<YON6WJM;[16M]PNH._POTKQ]WV)0M:P+RT[%NU2H-8CDCKO;%=;#
M$U>%9I)E QS.)*:=L6:8% 0YY/\ $0^>:)$V9+])CVER6^50"Q_^IU^ZLM+&
MD>\L%4=;UK^/[J?56U)OVO7N0VCW FV:[]-2(ZL:MM6T6Z2K-4A"H.+F1G$T
M!HDX54 I%3RH)B7DWF\O C[+&_;_ +KD17FA@PX_;!#YLR8<9\25EG(2PM8+
M8GPN35(O.\>TS18YFG<'U;8I)POPO$J[/^XZ>-ZYJ]O+W%]N+J'I_3W6O6^M
M/$5CQ=C[+;L):+GZ!T2?2.Y#4FF8F4;QCHAS"*K5Q9$S@ <>8#<\3Y.V^S.,
MC2?D^>;.D8@/C8.')N4CK;D))#CN">C) 1;P/6I'U6?,CB/']B06VNTBO&!U
M]<:@,I_RL_2NVEU8[@;$<).MU^X#>X)HDXC3-ZMU4UA1=)PBB;-XY=2*4C.W
M5+;MU?\ ZLW4(@<47C3T4TQ,GP<WF!D]Q=E8%X.'X S)MU/(Y8G9F\"!C1X@
M5?&QN;^-<(<3DLB(G+R]TA.C8X"HO_4"9";]-&'6LIP?0?K1'RK:T6>D2.V[
MDB1A]3;]U7.W[2EY)S')F3;OY!M:YJ0KAG92FX'T6")3" "(<@&5#=[=P-"^
M/@NF#@,"/;QD0;0?!6(9_L)8M\:E)P^(!^<#.WFQU/\ =_"I6UNGU:H,BQ]6
MKD#6V( 0/I8"'CH9N() ;T^48ULV3'RBH;@! >.1X^.>?R,S/SK-F322V_QL
MS-;XW.A-M; :U8+'&FD:JH M8#I;H/NKTQ0XY^/\_NR.C7TL1;^-;5=F]*8I
M3%*8I3%*H8H&*)1^ @(>'Q#[P^0ABE=<S5 Z9TCD*=-01,<ARD,0QA$3&,8H
ME$HB8P\B(^(XNPU1F5O-20?Q%/Y5PJ-D46X$*7A-+R>BD4/P$-Y@*0J9"  %
M >>. X ,Y9!E,1,<A23KN)O^):_7[>IK C5G# >H:C4Z?B?*M1]DD4/</[,O
MM;H%2DNE?3?8<&_V;(%(!H;L5V]ITDA/5_5J*JZ?TTWJOKLX(UE)TZ)E6\E;
M3-F)N0C7)3>JP8)>S\ <SEB+'Y3D<<B!'8%D0FSRD$W1PP]N,Z;MS.-% -/E
MY0S,Q<+% = -;: E]8@3XB1-SW'R[;'5A;X/;C=6PNW.WYWVUNH5OD:S))1K
M%SWE[05%RFJ3K%K674(LEI^IOTT7#=UV.W/$)N&K9L50IZU$**R+CR*F:E''
M;?$?I^&G>7=,$B<!&UH\5K>YR$PU*JP7_070S.BM=3M0JY%2)UW(>/1[L2?4
MO]%_+X^5_/6XK9#UWZY:FZQ:BJ.DM,U9*G:_I,6RBH2*36.\>"DT2*F+N6DG
M(K.9:4=*%,=9PJ8QCG$?AD#N3N3D^]N0?DN=*.FU4CB1?;AAA0 1P11W)C6)
M0%"@WN+FY)OVP>/AXY24N^0]M[L;LY TW'0&P-AI6>/*!  ?$?*''CXB/P\1
MX .1RF$7I ZN -3UT'C:W7QM;6IH).E7>;Q^S_3,EB#8 FM0&\>E?$DK##PR
MK!*7EXF+4E9!.)BTY&0:L#R<FL"AT(Z/!VLD+R16(D82()^90X%$0#@,S'OE
M<Q(K-(!N(4$[5\VMT'G6K.B.(V8!FZ7\?^-?83/Y^1 0X  _CSR(#]OAXAQA
M6W7(L4\&!!!\_LM6W30]1^%<GR^'^/EFP(.HI5<4KB.<2AX!SX\<<\>'W??F
MFX;MI]/Q(T_&@L3J0/MK@7=>@"AU/(FBDF*BBRA@*FD0H"8YU3B/E3(F4!$1
M-P4 \1$,Y3S>T+GI?P!:X\S;Y5'BQT%8N2; :>9/\JUX;9]T;JQKV>DM?4>=
MLW9K<;-,A4M.=6*E,;QMX/UA.1I'3TM3TG=&I*KA5,0,>;EH\B)/]P_X/'+_
M (+M[F>X<=,S$6*+CW:PGD=5QA8B]\@E8[V/2]Q?6HCYT(#B(%Y8QJHU)^ T
MK'['?'ND[G;&=:PZ::;ZQP#M=LV:3/;/<CVW7UNU4 3O)I74NCHB5C4P;D,!
M4FKBSH+'4*(& I1#+S&XKL[CLDIW'RIF=79?9P(O?W6!V_[EG6)+D:W1@/$U
M'67E<F)FBCC@<=#+=@?N4J:BWO78':+1:I7G9GWJNM>C'BX>FIKO6?5:@R5N
M.YDSA].PJU4L]]OVR+ Z1(F8C4X1RIU!\3I\@.6N'A]D\Y.T';G;_<7(Y4<1
M:\>9"XN/.*+!9RO4D[K >(ZU7R9+XDB)R_(XL,C+\NY(RQM<[ YN1Y?,;>=0
M.V7N[9#HJEFJW8;W1]C5*86^BB=U;VW9ICVU^NJSIHL)7[NN-)G6<=N*Y)-
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MF$#+)NF[<[EU&G18[9WRO#O"I2=A<D%LU/YT61 +PH'LN5[FX3@.'/:/[?\
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22F*4Q2F*4Q2F*4Q2F*4Q2O_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>106
<FILENAME>g20922g03d10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g03d10.jpg
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M$0'_Q "R  $  0,% 0              " $'"0(#! 4&"@$!  (# 0$
M          ,$ 0(%!@<0   & @( !0(#!@,&!P    $" P0%!@ '$0@A,1(3
M"4$442(587&!D206,B,S\*&QT1<8X4)38W,9"A$  @$# P($! ,%!@0%!0
M 0(# !$$(1(%,09!42(387$R%(%"!Y&AL2,5\,'14F)RX8(S)/&2HA8(4V,T
MI"7_V@ , P$  A$#$0 _ /OXQ2F*4Q2F*4Q2J?Q']WA_RYQ2JXI3%*T'.1,
M$Y@* ^'(_B ";_@&8) ZZ4J%W:'M1.:LD8736B:=%[F[7['C7+_7.JG4T,1
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MQ^F*57%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I6DXB!#"7@1 IA !'@.0
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MEKKISV'DP6*<PE1,B^F*%!QAT7' B0WO^DQ?'D  <ZF1^F'=6#"LV:<&'<P
M67+QT))\+,X/[JB_KF,SB/V,P@^/L2[1\2=ME'Q-O.N67Y&-JSBJB=#^,CY
MK 8J!G;9:U4S4^KV;I,4?<1#W;MM=@LW55(/'MJ)%.4_Y1#GPR/_ -D11+;D
M.9X2)[V98<R#)=?]R0NS+^(J49\K/[>-C2M?Q8%%_P#,PM5M=D_)?V'UQ'L7
M-PZ*L=/'D&CERF[[$]U^LNKXYG[2A$T$W:,-.W>Q.EUQ.  FT9+G P\<&-P
MV<7L+&Y5G@X+E%SY8C9_M\6>=@>O2,?V\JS/E96('DY*"#'A'_3=LB,+)IKM
M)*C0W'S'6H=RGS-=Y9R\RM8TK\<L%MJ'K,N,)8KS"[NLL)JHCDL<O).E&&\;
MUJRB:L78L@;G;J.TGJZ1W(>D@&Y#/:)^C''8N%]WS?.8^&Q72*:)H9R=-! [
M&5VN1=56XZFPKFMS>4^(KXD#23L2"VOM;1T*2_2Q\]IZ6/C64Z.^3+J17:#4
M)?<^\=.:SV5(U2/F;GIZ%VC5MO6VCSH,4',]6CIZK<656;-!NUA1!PW1]"Q0
M*8 #U<9\S/8?=,W+28G#XN7EX"M99!CR*K#H&NP 4?[CI5J/G>/:)(YY8$S"
M1>/W 6)O:RKU8GP U-[5Y0GRN=?+')I0VIM7]O-YR)WAF2I=6]4=Q+1S02I$
M5^[=V*Z5VG5I%@)5"_YOW8EX-SY!SE[*_3ON#! ;/? Q[_\ U<N".WSW.+?C
M4^)R^/FLZPQY%TZ[HG7]EP+U[V-[*=K;N$PE2.@^PJP@DW']#FMY[@U-0&,@
MY622! SF'ITQLJRM6B1U#>X!D"K 4G@ F$ SD/P7$0HJ97*0^X7]8A1IE'GM
MD7TN+>(\?&L?=<@[%H,3^2?I=I I(\S&?4OR-=[ -/D(G'#[^['G4G7,<H!0
MCR5EGM?9,VW Y405%RYFG-&BE5$S <2"5 2B/I 2\ /.^1%V(,H@/R65"JK8
M6C@L=;DG^9N!TM8 C6]2;.7.I>( ^ !T_$WO4EJK5+O%MSA9]DO[6Z55%054
MZ[ 5]LB4QS&!-!LQ1<*E3(F(%#E4QAXY$>1SBY,V!(=F#C''B7_[F\M\_2*N
M1I*!>1R3\A5POM__ '#_ .C[?T_Q_P#K?_)E.IJY&*4Q2F*4Q2K>[+V92]2U
M*1O%]L,=6ZU%E_J'S\ZAU73DZ:@LXF'CVI%Y&=GI18GM,X]FDL\=JF B*9SB
M!1WQ\>;)G]C#7?D,=1Y?/RK225($W/TKYA.U/8*_]P>PKNY0E%^Y<Z/VT]Z>
M_'WUYN -7$#N#N5L[79GF^M\[ZC$G"S67U7U;TM+.0E8$040:J_?-GI_NU"(
M!]@XS@<WM3BL;(P<J!>5Y7&>7)FT9^+XZ*;;).BA@1F9#H8\?</I92%</IYO
M-D3E9/8D0_TR)E;=_FG%_;4Z6L/$7N2PTL#7T'=-.L53ZDZ1KVIZRY=SDH+B
M3M^RK]+G(M9-K;:MSK]7V'L^SN.3**3%OL"JJP)"82,F@(M4O2D@0I?D_)\K
MD<[R3<CDPB!54Q0QA@Q6!7;878$JSR_]9BH55:1E55 "CM8.*F)&0 ?>E(>2
M_@U@-H'@+6('EX5*_*E7:VU#B0 X 1Y$0X !$1$"B;C@ 'S*4<4K'GV?^1G2
MW7LUHK\2N3:E]JL9*R=N@ZQ.PL;4]5Q\20 >S>[=E2KI*K:RCFZQB$*R45=V
M1^<13CXMVL44\Z/%=N<QSDV_$*P<7[JQG)D/H^Y;;[>(HTO)*&0@7_.+[=#4
M<D\,,3R3NJA1\O#SZ5C=ZV=<.TWRD?VYV5^2:86J'7%>>3O.@>BM$7GJK2;-
M6VLFF]IMT[*L)-K'66\IOFZ)72$!,%135252.\:)&#[;/JW(\SV=^E^%)P':
M\!Y+]190/O,^47BP#87Q\$"RF>]FDD8OZ=%7\P\[!%R/,)[KRJ,*_I4?G\+7
M\A^TUF#[0=G])](=#VG;^U9-I7J=2H<S>NU6%1:EL5SFBIH,JSKS7-:0%-69
MLU@DG#=@R9M4O0D94HG%-(IC!\BXWC.2[CY9,/']S+YB=_J<^KUG\]_RZW=F
MZ DD^-=P'&PX1'_T4&IOI>PN;=.OD.E6NZ#V#O!<==VS9_>&*HE"M&S[2-LU
M;H6F1QEI+0>K'3!L2NT+85P%83W38JH?U,JH5,B3)V<Z"9C$+P6YW/A=K</R
M,?']MY$N7E*MLJ=BOVPE%MR0[0+(+64LQ+W#+Z+%J^%-G2SLTPM@GZ#_ &\]
M/CH:\M:/DLUT:X6:CZ+TCV6[:2=/L;RGVJP]=-8(6+65>M\<I[$G6Y#:MLGZ
MA1'<I"._\B03CWCX&*X&35$IR'(%_!["YS,PQR;R8/&X=MZ_=YL&*9EO8,B3
M>MP;:;%U\+U)EY38PV[#-,?R+U7^PUKJ9G<'RCWLK-GK+J#U[TFWDFGW![=V
M'["O;J[KI5 7$H/M=:?J"BD@](F4G*19Q)(IQ$!4$ YRQ!V]V7B%.3Y?G%DG
M5[/AXN%.9;>:9;RC':_G[7A>QN*A.1RTT2G'A2&_^<WV_&P-;;/KG\BEX]UO
MMSY :M1H9R#8'$7U>ZSUJG314_$'R+2^[9LNTG;0PJ' $54V &](>H0Y'PLY
M/+_IUQ^8F1PG&<QE0JURO)9D#1.;W"^UC8F/,4;HRB;<0;*X.M:KB<K.A&3D
MHS'H8PH9;CJ+[A<=1N!%^H/2J./BJTO<70.][[P[B=ED_?%?]#W%V1NB-1Y$
M@%*E_9^L?^G5?.W3.'K*0R!@]0^/(>&7(_U-RH-Q[<XKB>);SAQI6/\ ^U+D
M5 W;\,R;>2GGR_A(0/W0+%_=7;1GQW?&)H$G]SR/6GK-4OT\SAZ%LV=$5^8<
MI'/PJY='L&S7DJX_(!.1$51*4"^8<91S/U*[^Y*,8XY.17;\D44<-_\ ;[*(
M_P#ZC<FD7'<1PR_<+ D4::!FD)6WE:1F(^1-_+2K2V_Y.OBYZ[N7E<UM9J+L
MJ[,Q%BTUCT[U*ON"YO5R@546C1GJ:MOH5$"E<%$QEWJ"1.>3&\\ZG$]E?J7W
M5=_8S1!MNTV4TN-"0=!:7((1C?J Q(&M3#DN/BD7VC&^_H(UUO\ $AC_  %6
MVLGR7]Z=F.(Z+ZC?$QV4E$99JDNG?.T\U6.OE0C0<G*5NJK".I&8GY!$G^H<
MI3)'] < 'CE[&_2?A^,BW=S]S\1QT:2W>*&=,V9E!]:(87D]MV%PI=2H:QVF
MUJJS<MGK,RP8N2Q((!(LH)Z'5>GGK5F)CJU\]7:7[0F\>XV@.GU3*ZDRO:=U
MQKMDM4].1K]P4&[&<L)E81R9%LU-[0&;2:)A\1.(\\CZO$Y#_P"/7:#;L/$Y
M?N3)8 E\AXL5$/6PM$KN1;Q4 ^%ZY\O'=U\D-F1DQ0XQ&J "]OG5P],_"&>B
MR!I^U]P=F!8')TU).4T[K/5-"F95?[Q:046DKWL"O[BV8X64>K>[ZTY=OZ3E
M*)0 "@&4>8_6CB,R(0<+V]B'CT-DCR99&"#RMC'%?X^MV/QM6,#M-^.D:6#)
MEBD;JT>UF?\ WB82H/\ D1!;]M2BC_ATZ/+OF4IM.C7WLA-LG:;]*8[';>V1
MM8/O4EB.4G7]N2UB0I*)DUR>HA$8M),O(E]/I'@/(9/ZM=VR91''?;X&.%^C
M'@LHOI]<YFD:PT'KW#Q-=5^W>+D833P^[/XOO9':_P#G (2WD%114\*7HG2^
MLSH#KK3VKZ(9-$6I5Z=K^JUM<C50Q15;^_#Q+10&ZGI#U$Y](\>(#GA<WG^X
M,V1OOLS)FWGQ,K$>6I8J"/,BPZUUH,/%@ ]F.-2/]-R/Q'C\:NR*7Y>#&X .
M  H^!/#RX#P !#Z<>6<\I*5&UB7\=UFO\[6JP+EO06!\:UIID+X ''D/EY"'
MCX?7QS"KN:\B^OQ.H!^0)TIX:=*W\GK%,4IBE,4IBE;2RI$2@<X\%]0%$WT
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M[([F-DVX3(T#2.O(MU>]X['=^A4X-Z/J^"^XL<HD0J)Q6>*IH1S0I1.X<)$
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M/NULY(TQT^T[?@M[6/#ZA*+:3.!K-(0=\C"VTW/I0;1G!P3C1%\QM\I^HM8
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M_46C"J0?(C2NYB\3@8:".&-=BC2XN?/J;_W5-/V0*!")D(1-,OI(0I?24A0
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82F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*5__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>107
<FILENAME>g20922g04e69.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g04e69.jpg
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MJUA@[*P9RDG"/'L!+,)EHTFH5XK'S,0Y<QSARBA*1+]$Z#EN8P*H+$,0Y2F
M0X'><!P' <!P' B0[X\S+8&Z@-_+XU-XO9# <]C!B</#R3=YND8K#23@@'26
M 3M?SP50]"^H>'J!B?XRA 5O3HME+5'JOZFNS'5*(CZMMMU0:^8-M.0XQJT7
M;#D;"-IIM?D<Y52S$2,=T_81%@L,H]D43J$*2$F+ *9P5.D' MT:L[%4#;?7
M+"NS&+GQ']$S;CJLY @1*H"BT>6=CTEY& D/0I!2F*S+ XCGR0@!D7C54@@
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M"U*C4>!C:S5:[%HF.H5E$0D0W:L&2)EE3J'\" *BIS',(G,8PA[G@. X#@.
MX#@. X#@. X#@. X#@. X'"8QD=%D<)QD>RCDW;UY)NDV+1!H1S(R*YW4A(.
M"MTTRK/7SI0RBRIO5150PF,(B(CP.;P' JH?(FK<IJQL;U9=PE3(9NCJ9LC"
M85V 7;D,=PYP)F5ZHW>N'!C^C9LPC&"MCBRJ','B[LR ^@^/T"U0U<MGK9N\
M9N$731V@DY:NFZI%F[ELNF55!P@LF)DU45DC@8IBB)3%$!#Z<"#OO&W@R%@C
M#F-M-=4I SC??L/N".O6N[&*=+IS&.:]8EF\5DW/3]1D4SN$BL>5V1,5K(>2
M0LI!P1\7S1CW0%"4S577NJ:G:VX.UKI+ES(5O"6,JCCMC,/@ )*Q.*[$-F<K
M:9;T.<#3-JERKR+PWJ/DZ=*#_;P,_P# <!P' <!P' <!P' <!P' <!P' <!P
M' <!P' TD[(-1(??#1G9K4^539_=Y>Q=.15/>/C^TTALE0WLV?%\^X6 BADF
MT'D*$C72WB'J9%(Y?T,/ B+ZF.UC'%'Z3F>;MQ[.K1KIU]-+3JIL9"394D+D
M.1,$$2KU)J#.'<+D>RM[N=,-"-RI' AEY@[KS$I$E52AC?I$P;GG>#8C*'>]
MO% R4#=,RQ4GC7K_ ,.S8K WP-JL9W()A8XI@L1 $'=\:/#M6;T6[9:1;*R<
MKZ*(3J D"TOP' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <#\]3L$_P"@
M_P#[MK-_7_\ Y+_TR_KW4?\ EQ^.?C/_  A_YB?QD[[GY_[O_P!$^T]CW?S_
M /AO]K_(>[[W^G][P/T"ZG^+_BU:_"/X3\+_ !^&_$/QG[+\;_%_XYM_ ?C_
F /&?^N_A/XKVOM/M_P#0]CP\/V^G ]!P' <!P' <!P' <!P/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>108
<FILENAME>g20922g05a19.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g05a19.jpg
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M9K:>"KI(PR/)<+R9&7W9\VW;=QN+F6UM&RWVR#^%$W&E<"][CB^1]/J<>/I
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M_',($L\@:T.?,X@ 9DDX #\ I  P"J/1XUENU\]V9L$$H4!E)5;UM3RFR&7
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MOBJ-D?+SJF=X-]?P.Q^WY3K:N-,]7=<[3L40U4U;;!V_D0*S6HJ..)QY.S
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:1,(F$3")A$PB81,(F$3")A$PB81,(F$7_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>109
<FILENAME>g20922g05b19.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g05b19.jpg
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M?L6R]LX_:F<N!D8R[I]QY4!Q\574XV"_$2Y;7Z7EB7UF/J$<9'5*VG2+$TN
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MUJM[AP(6&U)RM7M%53HWOI>E3T6]H?LGMI5_U'<6Z2#BBPXV$C?[C293K_\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>110
<FILENAME>g20922g05c19.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g05c19.jpg
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M..[,@Z0U;.(LVPUO52>=_18Z J_<7]J26$QL50#!OAA-7WQW3O??.WS9?:^
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<E,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4K__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>111
<FILENAME>g20922g05d19.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g05d19.jpg
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M&7DDB,IR5($14;AQ@.09)TOMC_&F_A=NF/$3?.X3-C;+*3Z;!;RSD"Y$(;0
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M1*]R0HS)3LWQGR$(U%00.3OO?FTX<4>Q=B[=C8NS8;DQY$P_494TE]<EW?\
M+5C;Y%6.T:V UO6K*X64G%9ECX#A<^^QM[*B/R4TGGUI3X+2Z=U1JK8VMJ/[
MZF6:1S#+;75]+D-I,CQ8U#?R;:GQK)(UXW3 DE3B3&0\WG0?]PS!$2KM7OW(
MVF3+W#*RLN+NJ<Q"+/6TDD$:L6D2,-K&9#TCJ0CI *@ $U;C-!U,9V=&(^L
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'G%*<4K__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>112
<FILENAME>g20922g05e19.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g05e19.jpg
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M*O\ :0U$47-+WA=L-X;J:9DSJ=./T"-M&X5MK=HI!"*>E[_U'CU$8JLN+W$
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M:QII$(I/S"A;SMGL_:[N/_)]RWK+?:HJ.E9%1\S6$T&H'TQO><&1G5*XU]
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M+SCA$*-('EWZY9$\;+9%[=OMR-0=2K[C2&S2.H!4ZPYK*UT,  I5U;;D:)#
M-)$9<VH^;U'U>9P]@"GC>-TUSKK4K_=]LG?INNZW7N6-I+%AZ2Z+($#;;4>+
M'!R1*ERI#@-,M )&XZ8BB<JF:S:]LO=YW&':]N9KO9Y Q@J!B>))P#0*EQ.
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M$3")A$PB81,(N=M^^XGKW7-\I^DZK<*6;W5LJM!!TN"1W-W1P)$-Z<E_>4\
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=)A$PB81,(F$3")A$PB81,(F$3")A$PB81,(O_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>113
<FILENAME>g20922g05f19.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g05f19.jpg
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M(T[6-6D3&;^]9CN;3N%C)<N-F=K'7/:E/3+::M;YFV#+3C49"?%E@DK;;0$
M9B-YNKB1FX[DUKK&W<1# UHCA#VBH#6-H-+20YQ-2<B34IQKQ5JU\")5PHM=
M CMQ84%AJ+$CM#Q;9890EMIM Y/HE*?YD^ISFY9Y;F9]S.XNGD<7.)S+B:DE
M05NY@H3")A$PB81,(F$3")A$PB81,(F$3"+&1\$4/W#?].T& ++;]AKJ.*I;
M;+*93I7,ER'B0S&@5T=#\^PDNE)"6V6UK5QZ#/4VK9-WWRX^EVF"2::F-*!H
M'$N>XAK0.)<X#M60:2*Y#MP'M*K3_+>WM\D!O1M6AZ#JJE '=>Q&)#NP3HZV
MR3(U[K^,N/(8\5\>#EK)C>0]?84/KT9VOI;9(Z[S=.OMS'_SVI#8FN!REN7
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M25+=" [)M&GKE]WVPD(4XY;O35+6/$'D\GGU^N>)-UCU1/;BU??3BW;DUKM
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MQY%MZR:]#]<LAV_H&Q:'[E?WU]+A5EK"V)O;_-<$GQ$"N9]-HU.$A/@T#O\
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M8P,BM*^::XECMHFUXE\SF @#$Z=1H, 5MC;+\M]1\3V1CBYI:!WKH8O?O?\
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2)A$PB81,(F$3")A$PB81?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>114
<FILENAME>g20922g0910042201519.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g0910042201519.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  4 '0# 2(  A$! Q$!_\0
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M%SL]?U'Q[H&E3745W<NCVNSS<1DXW_=J*#XC>&I]+NM06]=8;5PDBO&0^3T
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1*"-8XUZ*@P!1114O<I;'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>115
<FILENAME>g20922g0910042434445.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g0910042434445.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  8 ($# 2(  A$! Q$!_\0
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F/&***2J23NF)5ZB=TSH/^$,\._\ 0*@_7_&BBBESR[D^UGW9_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>116
<FILENAME>g20922g0910042554707.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g0910042554707.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  4 '0# 2(  A$! Q$!_\0
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M%SL]?U'Q[H&E3745W<NCVNSS<1DXW_=J*#XC>&I]+NM06]=8;5PDBO&0^3T
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1*"-8XUZ*@P!1114O<I;'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>117
<FILENAME>g20922g0910043129628.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g0910043129628.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  , $@# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#MO'-EJFC@
MWVD7EY'$[M(T,,Q7<Q!WI[%ER5/9E'K4.J^*-1T'0/#VI6EX;V&>*XGVRDXE
M01;HU9B-W'!)ZYS7<>(;.._LH+:4L$>X0':<'O56X\%:)=Z18:7<6\DEK80F
M" &5@0I78<D=>*UYM%<QC&TFD<@?B+K\5R;273-,\]IVMHV6:3;O6>.)B>,[
M?W@([\&GZ7\2-5N[RTM[K3;-#<KO4Q2L<+LG)SD==T'Y-ZUUC^"="DN5N6MG
M,JS-.#YK??:19">O]Y%/X5!)\/?#LD*Q_9IDVJJH\=PZNH!<\,#D?ZQP?4-B
MIO'L7:1R2?%+55LQ?2Z59&WD4QQJDS!_-$,<HSD8V_/CUXK0C\4ZI=W#":=+
M6[MI'MS;P?/'<2I+M.-PW8*G\*Z!_ ?AV6W^SM88AW,XC$C  M&(SCGCY57'
MIC-7M)\.Z=HF/L<;A\,&>21G9RS;F9BQR23WIJ45K8B<925DS(_X2B^'D9LX
M3YI=@J%F)17"<8'#=3SQQ3WUK49HK6X^R*(9;C]P(IL,^-_RL,=]H]N?:M8Z
M#IY$*^6X$&=NV1AD%MQ!P>1GG!I@\-Z6&9O(8[FW8,C87KP.>!\QX'K3YH=C
M/EJ]_P"ON,I/%%V1:J;6!Y)'.]8BY*@,BD8QE6&XYSQ\OO16M'X<TZ-E(24N
:C[RYF8LW3ACGD?*O!]!14RE#HBH1J=6?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>118
<FILENAME>g20922g0910043129893.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g0910043129893.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  %  ,# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#OHKZWCB5&
;TZ"1@,%F+9/ZT445\[[67])'UOL8/77[V?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>119
<FILENAME>g20922g0910043934869.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g0910043934869.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #R A\# 2(  A$! Q$!_\0
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MB[,TA.,US1>@4444B@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI*4VT>SA:;ITE%[A11161T!1110 4444 %%%% !1110 4444 %%%% !1110
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M#@J<'[XK[(K&M%*5S>D[H****Q- HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MDE9GR=<?\?,W^^W\Z]5_9_\ ^1OU3_KP_P#:BUY5<?\ 'S-_OM_.O5?V?_\
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M?&>W_'?_ ))XG_7]%_)J^;#T-?2?QW_Y)XG_ %_1?R:OFP]#2H_".K\1]@>
M_P#D0=!_Z\8O_017G?[0G_(%T/\ Z^G_ /0*]$\!_P#(@Z#_ ->,7_H(KSO]
MH3_D"Z'_ -?3_P#H%8P_B&DO@/ W^XWTK[2T3_D :;_UZQ?^@BOBU_N-]*^T
MM$_Y &F_]>L7_H(K2OLB*/4\4_:%_P"0MH/_ %PF_P#0DKQR'_CXA_ZZ+_,5
M['^T+_R%M!_ZX3?^A)7CD/\ Q\0_]=%_F*NE\")J?$?2WQP_Y)M/_P!?4/\
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MX+_Y$?0O^O"'_P! %?';?=/TK[$\%_\ (CZ%_P!>$/\ Z *FOLATMRK\1?\
MDG6O_P#7E)_*OD:OKGXB_P#).M?_ .O*3^5?(U%#9A5W/I?X&_\ ).(_^ON;
M^8KF=>_Y&'4?^OE_YUTWP-_Y)Q'_ -?<W\Q7,Z]_R,.H_P#7R_\ .M</_$D<
M68?PXB:-JCZ-JD=]'$LK1A@%8X!R,5TS_$G4"A"6%LK=B68UQB(\C;41G8]
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M8Z,-@W1GS-W/";O_ (_KC_KJ_P#,UV?PT_X_=0_ZYI_,UQEW_P ?UQ_UU?\
MF:[/X:?\?NH?]<T_F:ZZ_P#"9Y^$_P!X1Z-115"XUK3+2=H+B_MXI5^\CR $
M5YB3>Q[SDEN7ZX3XF?\ 'IIW_75_Y5UEOK6F7<ZP6]_;RRM]U$D!)KD_B9_Q
MZ:=_UU?^5;4$U55SEQ<E*A*QYT>AKWFR_P"/&W_ZY+_*O!CT->\V7_'C;_\
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M]*^TM$_Y &F_]>L7_H(KXM?[C?2OM+1/^0!IO_7K%_Z"*TK[(BCU/%/VA?\
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MTZXX!_G7D9Z&O<UMHKW15MIES'+ $8>Q6KQ+2<6S+ 1<E.*['D?_  D^N_\
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M5O"O_(EV7_7%OYFK/B?_ )%?4O\ KW;^55O"O_(EV7_7%OYFME_"^9S/^/\
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MQVLR3""3#LAR,D],_A^M=[6=9MJ-^QOAE%2FH[7_ $"BBBL#K"BBB@ HHHH
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?\OR04445@=84444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>120
<FILENAME>g20922g10u33.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g10u33.jpg
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M! ,!  (! P(' 0     % P0&!P$""  3"1$2%!4B%B%!,B,S)!<8$0$
M                _]H # ,!  (1 Q$ /P#OX\#P/ \#P/ \#P/ \#P17[.N
MRC*&Y]F,MZ$E\JB4%-98PABE7AN8 K3FDSE2V6<1KJIG%?$1,Y>67-BNFK$2
MU%.4':[A3]/R:)_KWU"E:N_KWO !SY?76E@5CT_873,WT *T3QB3^PZ]=YG0
M7.S,A4V933T8O=>T-Q#?HR:CHE(#[\XB\U:J%3.@']Y@=HLLH'2CX'@>!X'@
M>!X'@>!X-+7_ 'Y7G-=9&K3LER7W%CU6PL#&(J&=RFP+%F1;;=O%ZWK*%C,;
MF)M8<Q(XPU&"VFFRJZNV=MLIHZ*JIA!#FGF2RKYNT)]@_<L+3C5O!61,?R/S
M"_(A9((XOKF0C$!Y8F>*AFV@J7=.V6V^5:1&-5';:.,G6 0E7**3QX_"UCP/
M \#P/ \#P/!'6'7N2FW1ENTB&K[=Q#Z8C\3Q+;?;3V#OF36T):(!R]I4CZNF
MA-6P0IQO7DE''LD'C1$:LS?(:HJ**;;:Z!(KP:GO*\ZDYJJ><7E>D[!5K55<
M W,AF$QD3C9$>+'-L8UUT32137>DB;]QOHW9LFJ2SQZZ53002464TTV"G;ZS
M+H$_8O=LR[7MJ3&!<[AD7 N.:>)YE#3T/-<B49;6)9F#WY(D3>^!MCVGUQ6[
M% @G*QB:PX($V=1T<ZWSJ8RN%\/@>!X'@>!X'@>!X*Q_KSBS=M;?V@6-IOME
MQ9'V%2ENHCNU1TPU;5CSUSU6"*:!!!ZZT(MW#J,.'/\ I0RV6751WT^713;8
M)KWW?M1<QU5*KJO&;"8#74.:I+%#953?95V^>N$V(6.@!C?58G));)BSA%B*
M%,4G! F_72;MDE%E--,A0'(C7071/<WU]RGHRO6,>F%V69+[:YCY-LB/F3@7
MC3DBD80RF%J]"7Q&0I)N#/\ <%O$97'(,.T,K.PM5+G\X%)N2:+YR]"Q;G)E
MH=^U3[,9JFWV70BM.<"4I_*X1=900-"(]?MO&HWATHIAKEZP#7$%?K(Z:9RF
MB4;[YV_*N=?!:/X'@>!X'@>!X'@>"H[@FZ:CI[@NXNO+>F4/K.K9-TSWGT-/
MIL_/K/HZ# F.O;E9CG+IWJ4D'ZRFX06P::C1^RBF[_;5FW0V<[83V##\XU3:
M7>-MQCN[KJ'G('34,(1^7_7WR!*%"PPE7V&Z1GX^I^EHBO\ ".)]$3-H_:NH
MJ'=);8K87GX\:[&EW3E(/6B!SJ4?=Y.S)4^EJQI?ZOZV"PJ(*NFKG91[T'U%
M91*Q)@R:?G5T.53;\\1P>XV_&^%M,H_U:8_&NX;#^OP6X+23O>Z7&&[7_P!G
M[WNIFT$:Z87?B&'-H:$\>I[$"^KG?0C_ '*]Y\<'&R6$6_\ 'M2J;3;"FZ.R
MR@6,^!X'@>!X'@>!X,%*7[85&)&4>E6@-F- EW[LV_)- S$.V9CW#A<J],/T
MUF(IH/23RLHY6TW20TTSOOC.NN<>#FE^IN@IEW+R7PC*+PB[@5PWSF)_]#J*
MI+56C<]LKJOH\9)+!03Z8N N+$"0C&GHH\DSQ[#(Y^ST=FS*FILKKJFT%I*!
MT[^"G'H$M&N7_MIYYZ/E3 \A$.JN0KIY+-RI,J!3BX:Q:$(N.LJQ&F6IDT$W
M$;&:V$61\+M#1]NZ>(MV^^B.F,*>"5OUMLB^O$//DID#MT^/6W$GW0)=R1BT
M:A9G]YT5)CEYY:2&/1#\@&DC%HV#HT(*([J[.7:"BRJBBJF^^P3A\#P/ \#P
M/ \'YWWT3TW44WU333UVWWWWVQKIIIKC.VV^^VV<:ZZZZX_.<Y_PQCP<V72$
MY+?:70'45[RT7*QOU)\_5K<TTK.,U_*Y+';+^RF2U/"[0'2B0ER,$F8LK&N9
M <OC^B48CSMFJYG;Y%,@^U3'809+!<M]?^7.W!W$^SQ+*#S?D?F_=VCMH^3V
M2=;TY#=G">^A1%N3TWU6SMC.'*>CC&?^37&_YQ@)<^#GO^TGHNNNI!8;EJB$
MA$PD%7=040YM[IM\;;1FJ^6Y)&[RB\7E4'BLG,"7(R]^DY5%%Y, 4K2-*NB*
MHW!5J3V;*[-F! +_ ,.)$@! L$!&L P,*.8B0P<4T0'BQ0D:V29CAHU@U32;
M,F#%FCHDBBGKJFFGIC77&,8QCP9'P/ \#P/ \#P527:S<_9#83OG*"RP^QXN
MJ>8*,>M+2JVT HUKT#-@;+34UP\WWC*;R7;P)-G(&[FR"3 F'_J2UC.%'"BI
MM!F&XOL/B3D5]<74M>U4_#56BCS=,(#%7(V20&J0,)C2\8VB_P"T&2B<Y95_
M!!HN,JJ-V[AUE%LR3QK\>=-M4\X"8$3 0^I*VC$6%?Q,7@-:PD''1>%%6HH'
M'XE$ ;46/TV55RW9#Q@P0/TQ^<YT322T_P L8\%:*]N]'?866V#\ES$US9Q/
MAO(1T@[3&CHT1N>^2;1R["X%\?1N6B)/% %5.4E,.];2,,GN2&R.4@(W;3;0
MUH&P%:=K9O>O)')T,BX-U5G'T&2Z$68N;$BCN61V8HH'*NHZ12**.5W%M2 O
M)7B\P)N),LHFP)E&KO+]1Z[6S^@+)_ \#P/ \#P/!6;U](Y=U87F/ 7.M@-H
M;('C,8.[&MH&<ED:LWF>GI]$R)N)%*>7&CF0TM=EDN6NC8(X_D_V\<;ZK$WC
M9U\;=FY"<M,4[77/M4P"E*EC3*(US6<7%1&) 66N<X:BQ+;1#5P]=;_ER4,D
MEL;NG[YQLHZ?O5E7"^ZBRN^^P5A??E)@,+^J;I.7RJ*+3V-1,[SK*9!!$5$4
MMIL"C/3U,GS43W5651PDE(!0U9KOMKA7.-5,_P"RMC\H[AL#'*5G=LR.,67W
M4^8)4((?_P!X57P:"'OF4*(-26P@]#2W<&I0D:971:L$4;:?F+LLI0005U4V
MRF:430?:A90KO%Z_B:BGQAHE"H3'=]_B;(- \?C,7C8W.WQH-F^B#$6&"B67
MXUTTUT2003QC&,:ZXQX*ZOK%FBG4M1:?8K*H0_KZQNP 2#5")O7>CK$;HBIK
M2N9IST,QA4.-)(%"L+F*IPGA=1;'\B85U3PDEHFEH%F_@>!X'@>!X(1=N]3R
M_G>,5W"*2KE"YNJND)>5JWFZKGQ= '&5I8/AY^8G[*M4S\VI*/T?5($'L0DK
M]DBX>9PJU8M4\O'[7&0V!R/S@ES'3[*%E9B7M"T)28(V/?%QR--JA(;ANR6I
M,U9S/2#-B@V'AASA=HBQ#"FR>C4*!8LAZ&/B:ZYR'S];]7PCDFM4I<=#2&P+
M!EY+>&4;1L"8/#5G7Q:[L<]? *Y@H4<S(NL+O-66ZQ$HLC@8 %I+D2"J+1NJ
MI@*[[OXEZLOKBGMHO>,OCTT[$OBNSTBH2HQQ3>0<\<E32!165XH>)TNE)P*V
M=[#;D#6<RR?J,D21\JZ5RVT8"T&+)N%EO)/0,:ZKYCH?HV)[9U#W'5T/G.S!
M55!9Z ,EQ#;>31,OEMKH@D>A\ET=BB"6NNOPOF:J?XQG7\>"-_:<_*6\;;?7
MM1UD-(C?-V0?69V@=8,0Q]_4'):4[BD*MZ5OFS_0HC&YO9,8D!0% %7@]T@\
M/(N%_P!'[<:\51"P0&%&QL('CH9#=J( BQX44V4<NGJC<:+:(L6*&[Q\NY?.
M]T6J&NN55E%%5,X_5OMMMG.<AE/ \#P/ \&F>A;\K+EZF+!OJX3:@*OJW![&
M33AHT5)&2;IPZ;"P$6BX5O\ ]V1S.92)^T$A1;;&SHF5>MVJ.NRJNFN0B-Q'
MSE+=S1WMSJ$7(W/7E[#R&&D=G:P1ZXY,HLR\%OXIRQ7+&.%#46C;,6T!CR$R
M>CEU%Y1+?G=NEE$D6*#4-_=2=50GF"-Q;),86G-JVP?)U[S_ $Q%D7"\MN2V
MTX3+)F @H]RW9$&D1%ET8BNB\D9;5N !Z[ZKD'*"/]60UWSGR>O'; *]5]#$
M$[*ZWFK.1CD9&NZ+K1>A*OE! 81'T!2\;=F'L9C82/#@@UJ?D ]B/)S@JQW)
MD,::J-V;0)R^"O AP49A\[GTOY7ZJNSDP#:9$M*YY5,%"U3954.;-D1\S)93
M:4/AEXP2QF-8RR:%C:K@XC'LCA!=W^IZY9[OU5G2@;\YOY5JKF$1*TX0G(9+
M.K)D6\SN"Y;&-*R^W;@FBC)H-VDD]F#I)#=QAH.8(M1PMBBQ!A626C4:R:-M
M-4L!)/P/ \#P/ \%1PL<C]B'9;J7%7"!3CKZZKD)Q^#QI<,];(7-]@$!T)@I
MM.)"G(1:7\S!^1OY7 V,J#_TLEY\X).]EG"P-CEN$S.LNGAG,4(B+YM"YA:%
MH7!8@6E*(JN"BDB9V?VY*Q9PL$'OG+P@($1:$@A$=?&)&>(.VK ("'NG:JG^
MWKIN&ON9>57T7GICKGH-PA,NR+<K6"Q29/5% 9N(\^Q<>SS(#?.W.Y9O&@9I
ME4 VP3!!XL\?;+EI(ZPBZ?J[?"U0;!.;P/ \#P/ \#P/ \%?WV"WG9,$@L!H
M#G$N/'=<=?2Y[3E#$'+Z/8WK5HVCY"36OT85!G4WV3L3H&OQ[@JLW29NL/C*
MXL;MC38BFIJ'IY#.:6^N'EZK(6;E,@DN8^.BU*4Z%E,B_N"Y^E;K(C7"<:B3
M$D2WU<3&X[BDK9P\?OE_C;_NW+H@]4;M$G"R0>?Y H*TVIN5]6]7J-G'4%S;
M?O&L %R P>@_*55/@40:".<:]4<%W8 L^%.(OJ3E<D9-&G]PR=\^51UT'ZM$
MM0GUX'@>!X'@>!X'@>#'ERPL *)G3A%B'"!1[TL8+DW2+$:+%C6RKP@1(/7.
MZ;=FQ8M$=U555-M=$T]<[;9QC&<^"DBBKZBHX/??W)]*MP,=BESQ<!4'#T*:
M G0BV#7+<2E$X+TN##,+":0TF3OCN*=2+!\;'T-TT';!Q&&.JNZS=13 2AY@
MY_MRRK5_^X>V8P% WQ_#R*&\ZT2(D+N31#DNCY*18F%!S[7=^2BIOJ:>X9MD
MIY+1&?V:C4>R$"\Z,6JZQ +)O \#P/ \#P/ \#P/!5/]J<E5DU;0KFEW- M8
MT_<IQ^:[3N<G-$XAI2O$E8B7DWN0@Z(M3X0J'TNYT''ULD0SG+9JC*G2N?RJ
MDGIL'R<Z5:KVO+ZJ['OBDRU7514F!YC@#GB<."P22P(4H+>!MKZNNJD$VT7"
MVC)1*3)2(A76Y-6%!]4UO^J9<N=&H6Q^!X'@>!X'@>!X'@>!X.?"P(K6Q3O(
MO:'VF65044:9E]0P[D[F*M64HDD8;Q@38MM:T#<7<]JZUZ-3+%9M/MGJD$!2
BAX.KH!)M=T6>I.0[H.4PZ#_ \#P/ \#P/ \#P/ \#P?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>121
<FILENAME>g20922g12b66.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g12b66.jpg
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MU<Q"/PB. 7'$)DIRT+)&6YL; JS4R,DL1FBO>(!0 [WZ!#K07Y@?.P $( Q
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>122
<FILENAME>g20922g20o84.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g20o84.jpg
M_]C_X0 817AI9@  24DJ  @              /_L !%$=6-K>0 !  0   !D
M  #_X0,K:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@
M8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B \
M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!
M9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ-#4V-C$L(#(P,3(O,#(O,#8M
M,30Z-38Z,C<@(" @(" @("(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO
M+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR9&8Z
M1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B('AM;&YS.GAM<$U-/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(B!X;6QN<SIS=%)E9CTB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(@>&UL
M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(B!X;7!-33I$
M;V-U;65N=$E$/2)X;7 N9&ED.D8P,S9$141&1C,T-S$Q14%!,4$V1D1%0T%!
M-$9"1#0S(B!X;7!-33I);G-T86YC94E$/2)X;7 N:6ED.D8P,S9$141%1C,T
M-S$Q14%!,4$V1D1%0T%!-$9"1#0S(B!X;7 Z0W)E871O<E1O;VP](D%D;V)E
M(%!H;W1O<VAO<"!#4S8@5VEN9&]W<R(^(#QX;7!-33I$97)I=F5D1G)O;2!S
M=%)E9CII;G-T86YC94E$/2)U=6ED.C@T,&0R834Q+6-E860M-&4Q8RUA,# U
M+3%F,3 S,&1F,64Y92(@<W12968Z9&]C=6UE;G1)1#TB=75I9#IE.&9F9C!C
M-RUD8V9E+31B8S(M8F9F,BTX8SDT-V,Y-C@Y,3<B+SX@/"]R9&8Z1&5S8W)I
M<'1I;VX^(#PO<F1F.E)$1CX@/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0]
M(G(B/S[_[@ .061O8F4 9,     !_]L A  ! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! @(" @(" @(" @(# P,# P,# P,#
M 0$! 0$! 0(! 0(" @$" @,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P/_P  1"  V )H# 1$  A$! Q$!_\0 >P !
M  (" P$!              @)!@<$!0H# @$!                     !
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M_B\LBKPWR"-2-B=$Q:QL>F)\:5"ML=FIQ2&A-(4)S3"C2Q8$$6<9QG@9!P'
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M1()<MCS"X29ZPG6NS<PMJ5L96PL:E6K<7IW3)P9%DL@K)OQ#C2B0C,"$./\
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CL0SS>^=7,0['LB>R?II.R.J@:&*M*Q<20ZFAZN. X#@?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>123
<FILENAME>g20922g21a59.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g21a59.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /?Z /'_ (:?\EB^(?\ UW7_ -#:@#V"@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H \J_X5CXV_P"BK:C_ . I_P#CM 'G_P *_!WB
M+7;#6)-+\;7>C)!>F.1(H2_FM@?.?G&#0![!X/\ !WB+P]JTMWJ_C:[URW>
MQK;S0E K%E._.]N0 1T[T =K0 4 % !0 4 <'X0\%:EH'CWQ5KMU/:O:ZM('
M@6)F+J-Q/S J .O8F@#O* "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#@_AAX
M*U+P58ZO!J4]K*UY>&XC-NS, I &#E1S0!WE !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M%A0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M%$9GA6X6W,J"=E+K'N&XJ" 3CKCD<^] ;$E $4MU;P30PRSQQRSL5B1G ,A
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M8YHX7E199,[$+ %L=<#OBCR#8<TD:.B,ZJSG"@G!8XSQZ\4 .H * "@ H *
M"@ H * ,_4M=T?1C$-4U6RL3+GRQ<W"1;\=<;B,]10M79;CMI?H6WN8(EC:2
M:-!*P5"S ;B>@'J:.MB;Z7'R21Q &1U0$A06.,D\ 4#(Y[RUMCB>YBB/'WW"
M]3@=?4D#ZFA:NR FH * "@ H * (#>VBWRV)NH1=LAD6 N-Y4'!8+UQGO0M;
MVZ ]!8KRUGE,4-S%)(%#E4<$A22 <>F01GV-'2X;$U !0 4 % !0 4 % !0
M4 % !0 4 % ''ZW\4O!OAS6)])U76?L]];[?,C^S2OMW*&'*J0>".] &?_PN
MWX>?]##_ .2<_P#\10 ?\+M^'G_0P_\ DG/_ /$4 '_"[?AY_P!##_Y)S_\
MQ% !_P +M^'G_0P_^2<__P 10 ?\+M^'G_0P_P#DG/\ _$4 '_"[?AY_T,/_
M ))S_P#Q% !_PNWX>?\ 0P_^2<__ ,10 ?\ "[?AY_T,/_DG/_\ $4 '_"[?
MAY_T,/\ Y)S_ /Q% !_PNWX>?]##_P"2<_\ \10 ?\+M^'G_ $,/_DG/_P#$
M4 '_  NWX>?]##_Y)S__ !% !_PNWX>?]##_ .2<_P#\10 ?\+M^'G_0P_\
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M_P#Y-;YD6CG5?[(MH[Q+HW":K;^3+=><&?IYF%E^9>-_&67KM..!JN5RB_\
M%]UG;SW[Z_@1+FY9+_#]_,OEVVT_$NZHNOOXUV1?;O+,\(@\LR"V^S;3YV\C
MY=^>F?FZ;>]8Q5TT_P"]?TM[MOGVU[Z%U':SCV5O7FUO_P!N]]/F0P:/=VG@
M3PU:Q6UX9H;V&21',CO'\Q))W9( _(4YMWBUTB__ $A_KI^ 22]]?WO_ &]?
MIK^)CZ7#XH@AL97.M-*([!W$LDS#>Y=9\@GLH7(/"GG )S6M2RNH]Y?=R77_
M )-M]R["GOI_7O\ _P C^&H[2(/$\*Z?+(=9:0)I[R":29AO<LL^X$XX4+D'
MA3S@$YIS2NTN\E\N2Z_\FV?R\A5-+M?U[_\ \C]ZU+&GGQ#?2:?;7 UJ)$BM
M(;IF\V/+AY1*=W?C;EAU&#GI4.TG=;.__I'^?XFE5V3Y=[O_ -*C;\+_ "OY
MC&'BQ7TY2=4,RQ0K:']YL+B<B;S\<']UMP7Z]OFH@[M-[Z7[6Y=;>=_GMTN3
M))1:7]ZW>]_=\[?AWZ%>"37[W3$:QFUAXY'A%U(7FSN^U*/W;?W?*W;MO&,9
MYS2HI/EYMO=_])=_/>WE?8)-J4K?W_S]WY[^?X$GV?QA;W&O+%=:@Q3>J1>3
M,R^2'4(8Y6D(9_+W?<7=G.XYQ2BTX)S[J_??6UNENUE;;6Y4E9M0[:?^ ]>G
MQ=[OY%_5%U5K.!=,DUY++[)+\TZ3-*!Y\>-P4K)]S<!SYFW/4TWUYO[O_MU]
MOE>VFU]".W+Y_DN_SW\[="MIW_"6S^(=&>XDU"TM!!%LC,,TX?#MYGF.60*2
MNSF52V#P-P-7&RD^;^O=^Z_-V_\ 229? E'N_7?3Y6[^?6Q>\96>NW_B%=0T
M[35FCT1(Y8F>1T=G+!I!&H0B0E%"=1]XBHI/EGS/:]OE;7Y:W_[=+FN:/(NU
M_*_37RM]S,S6-,UV_P!,U6/;JTHO+?45,+O+M^64&$!3]W(+8QC<..0*(VBH
M\W3E?GOK^']7-;INZ_J\/\_N9#JEMJ[3SS00ZX1'%<)8O&L_F*QBM_*!)^8
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M$-S;I*5!MUSC<#B@#IO^$$\'_P#0J:-_X 1?_$T '_"">#_^A4T;_P  (O\
MXF@ _P"$$\'_ /0J:-_X 1?_ !- !_P@G@__ *%31O\ P B_^)H /^$$\'_]
M"IHW_@!%_P#$T '_  @G@_\ Z%31O_ "+_XF@ _X03P?_P!"IHW_ ( 1?_$T
M '_"">#_ /H5-&_\ (O_ (F@ _X03P?_ -"IHW_@!%_\30 ?\()X/_Z%31O_
M   B_P#B: #_ (03P?\ ]"IHW_@!%_\ $T '_"">#_\ H5-&_P# "+_XF@ _
MX03P?_T*FC?^ $7_ ,30 ?\ "">#_P#H5-&_\ (O_B: #_A!/!__ $*FC?\
M@!%_\30 ?\()X/\ ^A4T;_P B_\ B: #_A!/!_\ T*FC?^ $7_Q- !_P@G@_
M_H5-&_\  "+_ .)H /\ A!/!_P#T*FC?^ $7_P 30 ?\()X/_P"A4T;_ , (
MO_B: #_A!/!__0J:-_X 1?\ Q- !_P ()X/_ .A4T;_P B_^)H /^$$\'_\
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MY:N&E!<+OVL"8\CC."!GKG.I[M"4UUU]/=3M^/E^5JAK6C![*]_/WFOT\_\
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M/'6L67VBU6&S-S9+=2S3O$XBG6 (VU!ORK'?C)+8VG@T1U2ET[=?B<=/NO\
M-+S'&/-+E[M)>5US:_TN_D-G\9:M#;W,ME#;)M6[N66Y$CG$0C(7[_RDAR..
M!U [%Q5M^G_R;7]?Y;%)>T\KN*^^%_S_ *N0)XGUFT_M.\FFBN#%/>O A#J(
MQ'"K*I ?##ZCU(P34K1)=;/_ -+M_7W=[S3M4J)=&XK[X7_K_AK6KCQMKEO<
MS6!CL!<Q-*_GM&XB*) LNW&[(;Y\9SC"DX[45'RQ;71/YV=OZ^[K<J*OR?WN
M7Y7O?\OQ+?B/7=0'AC2+RV=(+N\MI)"XW[4;[,[Y"AAGD=&SZ]1FJKQY)SBN
MB?\ Z5%?KN1AY<\82?5K\;C-1FU?3M/\(6UOJ6#,S+<NP=S,! []6<MU'<GG
M![8)6TE4MLHR_"R_K_/4*.M.+ZMQ_%_U_P -H9VD^*=6C@T:UOFAG;R[:43>
M9(A*O;RL0Y+88YCR2>.>F1FM*UHRFUTYO31)KTWM_D*CK&WDO7XK?U]VILZ;
MXMU&?PCK6H7,<*ZAI\+2B(P-&H_=[UR-S!A_M*Q! [=!G-<J37>WX_A_6YI2
M2G447UM^-^O7;?\  R]0\>:[92K80V5M=7GG<SQJ%A\OR1+CYY5 8 X)W]!N
MQ_#0]&UVO?Y-+Y;^?ZD+6,7_ #6M\[_?MY;_ 'RW/C+7_L]Y/#!9*D=Y]F6$
M0F:15$(D9L"4>9UQA,G'(!QBE)**3>WO?@VOE?O;3MKHH-R=E_=^]I/TTUZZ
M_+4M?&T\=[!!8VEFFE++'9QPQQLK9:W\X2+R $'3;MSC)R,8IU+Q4F]_>MY<
MO?U_R[EP]Y)_X6_/F=M/3_,U?#7B+4]5M;K^T$M@XL8+Q#;JR "1&)4Y8DX*
MGD$=>G&28B*IPG;HVON2?ZD4I<TXKND_Q:*&@>+;^XU/2+*=(4L[BVB4,%>1
MC*T/F$&3>Q4\?=<9(YW'I6LHKGFNS=OE;Y=>EK=A)OV<9??\VU_3#5O'-_I.
MH:P)+:%[:UBD:V41D^8R!2<R*Q'\1RI52 ._;"'OI+JVON<N6_G\NNAI*T7Y
M?\!OY/33OO?H9K>+=3TB"[L;*STN&6S>Z>:2*U9(9BD:3$JH?@G>022>>?:F
MWHGT2V])<O\ 7;8(+FE;K)K\8MZ^:M\UV%O?B)KL%TUC;Z=;SW,<KN\F%CC\
MI8HY,$R2J%/[S!;)^Z3M/06H^\EZW_\  N73^GV\P2O%2[VMY73?SV\OPUGU
M#X@:K:_;9H[.V\I6N88875B\;PH&W2$-@JV>@ QD<G-337,TN_Y<RC;UZ_A8
MF3LF^UOQBY?\#]1-3\=Z_87#6$5A:W-U%<3"250(XC'&B/C]Y*H4XD +;CC:
M3M/0.*YG'M;7_P "Y=/Z?1>8UJG\K?-7^?X'HT;%XD8KM+ '&<X_*DU9V%%W
M28ZD,* "@#BO"W_)2/'O_7>S_P#29: .UH * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@#S__ )N%_P"Y8_\ ;J@#T"@ H * "@#C
M?$3Z9IFJR_VAI]O>V-Q ]]-%<>5@21&)%93*RHO#<DG^$=.<B:2;[-6^=_\
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M6$RF1%62*,!F4AI$9ESE>Q(.1@FCEO?R_K^O0;=DO-M?<K_JCIZD84 % !0
M4 % !0!S'BS4]!L7MDU?2EU*18Y)U7R$E,,2@>9)\Y&  P!QDG/ -$7:5UI:
MVO;73\?\RN5R5N_3NSBTO[ KJ4(T.4VMS>70EN(5B:XFC3$WRMD#;EB<-V(
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M<NT % !0 4 <5X6_Y*1X]_Z[V?\ Z3+0!VM !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 >?_P#-PO\ W+'_ +=4 >@4 % !0 4
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M0$VC.T'*@,2,DG)RW+E5WLOTU_#LM/(J+::MW7X:?TWKYEY;[1!;VNO->3+
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M[V?_ *3+0!VM !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MD-O>W9V\O=:M]^O;KN9>M>$+C3X;1;?1$>.:ZDCEMXYUB\Y/M&8H]P/ \O<
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M^'-:DT^9Q\__ ');\T5=7T7^R;_3]/>V@+M=J-.A^V!9+>,73,2B EF#(R<
M8 7YL8J:;YIQ[JUWY6V^_6_W:V,:O+R2MM9_?RK7UO==]>S9UNO^%;G4/$\F
MKP0-]HB^R+;3>;@)B1O-(7/7:W7&2"0.]1&ZBTM&^;[N6R_'\EV(GJUV27_I
M5_R,30_ =VEQ8"_MKY88;M)KCS+B! \BQO\ O (%4D%BO+DLW\0&.=%.,?>7
M1.WEK'3MT>VG7<F2DU9Z]WWW^?\ P]CK=7M+OQ%#H%U837-BJW'GO+'Y7F1*
M87'1PRGE@. >OXU"7+)Z]/U1K=*,H^?Y,YS6/!]^-<TXV5I+/':R1R+>$6V\
MEI"9C([ 29.<@1X4\@]A26M^FC7RY;+S>O?R>Y,KM;WV?S37RM965OR(_"WA
MWQ%;:]IMQJ.EK:P64$%L&%PCEA'%,A8@'C+.,#G@CW W=12<I?S7?W\G^3,Y
MQ^%+H_\ /_,LZGX<\23ZQ>:Q#Y!$ERR+:>6!*83&8A^\\S;M_CV[<^^>*Y7%
M^S<>K4OQU7Y)&[:YTUTY?PW_ /2I&?>>!K^VTV2TL]):[@9%/DM>["9S$ 9B
M^<Y5AR>O/&<552\G)+SMY+3\]?OUT;,Z:Y5%R_NW\[<WY77W::I$+_#^^&EQ
MO)9W;S22C[1!#- Y(5 (R!-NC 4[CP-W.1DBJD[RT[R?HW*]^ZT[:K[R*::@
ME+HH_<HI-=GKWTT]"]-X4U8S,J:<S7:L6EU!YHV-S%QMB)R&)4C/*@?+D<G%
M"?O7\_\ VY._R6G?HM E%\ENMO\ VUJWS?RZO4N>'-.U#0_$5]J-[IDL"7NV
M*3RUME1I3+@,HCPQ7#9W/EN#TZ%4E:')Z?D[^7W>5_*ZFL^9=+_==6\_ZTWU
MGUC1-2N_'UAJ<>GL8K:2/;<QK;@>7@APS$>;G)^ZI"X]3Q12]V3;\_RT_'OY
M6[CJZP27E]]]?P[:[F7XO\*:SJ>N74]KIGV@R;REW]J";8S;E!%L)Y^?+<\#
M=GUHIZ._]/M]RT_X=FRDDXOM;Y6=W]_Z>2*M[X!OGB$PMKQWFN[B26*&: D,
M7_<R#S@RH ,\H-X+9&3FFK)I+_AGU\]K;=K&>EM?[OW*.W;?O_D7)_"=R]T&
MN/#@O;N&]6>34'FB+7">:"H"DC<43C+!<8.W.XT+HUIO]]FK_>T^_P!R(GK%
MK?;[E:Z^=GY/=D5KX)N[JXTZ*ZTE[6WAFC-\R7"J;N14DS/E&R025'.&.<$8
M%5%I2YEHELNS_K\KO4NI:2DN]_FG):?)7].AL:[X>NM0\122?V6MQYK1^7>L
MR$0Q 8DB()W?/R, $'=ST%8<ONR7K\[JR7R>NNBW6H-ZQ:Z6^34KM_=IIKTV
M*FK>$KB3PAH5E;Z-%+<V=G)"8T\L>2[V[+D$D#[^,D'WK>I:5:36S5OQ7Z)D
M8>\%#FZ23?X_J[_\$R[_ , WT9-M:6MVVFI,7CAAF@9O,:*(>:3.& PZR98#
M?ELC-%[R3];>6OW[=OF6FE!+K97\]_EVWT^X[;48+^QU*PU.VL9M2,-L]M)#
M'(@DRQ0ALN54_<YY'7@=JF^LDEO;Y6O^&OF9J/NQN]OZ^_0Y'4O"NLW2WH&B
MP+?3QL8[JW=%2&,P[3;C)#<OD]-O.[(/%))*R[;^?;[OPMIN;QFN>,GW7R]Z
M[?JUH[;^A6U[PA+I>DZO=V6FQVX7S@KQNJD0FU (!!R 9N2!W^;WJV[M)=?_
M )-6_#;L86M%>2U_\!E?UZ>I!=^#M<ET=;>'0S!&'>:VMXY;>9[:4*@!,DN2
MJLRNV8_FRP)(YJHR2J1?:WW<S;6FNBM9;;K:Q-G*#7=:^;MO_GUV>]RQJ/AJ
M;0M.OM8,7V>[VSS^9)/NWSBY5[=!R>HR !_>(ZFLU>,5"&_NV];-2_!_=Y(N
M,>>5Y[>]?R6EG]^OJ>A^'=/?2_#]E:2\SI&&F/\ >D/+G\6)-5/EYK1V6B]%
MHB87:YI;O7[]33J"PH * "@ H * "@ H * .,\;:'JVJ7UC=:5$IGM8)?+D9
ME&V0O$5')[A6%**7,[[.R^6J?X,OF2A;SO\ <G;\;',V_@/6H-=LY/+N$M()
MI/L_D20*+;_2&?>2ZLP#(5X3!.-K8!XN+>KZV_1Z??\ +YI"G:UE_P /I%7^
M5GKNNFXW3/ >J6]FAO\ 3YKV>*_MYYEF>V*SLKMOE10H[,.9&WD<8X&2+2Y+
M:6O\O=M^>NGKN35O+G2Z_C[R=ONT[*]EH7E\':H1#,]@/M,$=KY+^8FZ-ENG
M=R#GC]VWX@D>HI0]U+OI_P"D6?XEMIII_P!_\7>/]="M\/Y,>(99(+1KB>WM
M7@O)8F3=),;CEW!(*G'.&PV%X!P,E.SIZ:)J/X)W_'?KKKK<RJ+][YWG]VEO
M\ETTT=M3U:D4% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 >:SMXR
M\/>//$U]I/@W^V+'4WMWCF_M**WQLA5#\K9/7/ITH M?\);\0_\ HF'_ )78
M/\* #_A+?B'_ -$P_P#*[!_A0 ?\);\0_P#HF'_E=@_PH /^$M^(?_1,/_*[
M!_A0 ?\ "6_$/_HF'_E=@_PH /\ A+?B'_T3#_RNP?X4 '_"6_$/_HF'_E=@
M_P * #_A+?B'_P!$P_\ *[!_A0 ?\);\0_\ HF'_ )78/\* #_A+?B'_ -$P
M_P#*[!_A0 ?\);\0_P#HF'_E=@_PH /^$M^(?_1,/_*[!_A0 ?\ "6_$/_HF
M'_E=@_PH /\ A+?B'_T3#_RNP?X4 '_"6_$/_HF'_E=@_P * #_A+?B'_P!$
MP_\ *[!_A0 ?\);\0_\ HF'_ )78/\* #_A+?B'_ -$P_P#*[!_A0 ?\);\0
M_P#HF'_E=@_PH /^$M^(?_1,/_*[!_A0 ?\ "6_$/_HF'_E=@_PH /\ A+?B
M'_T3#_RNP?X4 '_"6_$/_HF'_E=@_P * #_A+?B'_P!$P_\ *[!_A0!7\-VO
MBK4_BG)XEUSPS_8MJNC&Q4?;HKC<_G!Q]WD<$]NW7F@#TB@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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ML:_?^(H_%@M],O("OVBW2&&4.J+NBF+%R&^8?+G&!G Y&,U,&[-OO+[DHO\
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MR,T4[QY 8 _(D9(.1EL^F%*+4&_)KYJW-^.QK3Y7.RUV^YN*3_,V_">K:_\
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M37=BL&ISGR]URL*3P8=HP#EMQ^;>,)NQD] :=M6EU7WZ?UY>82O&-Y?UL_\
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M8K:YGAVVYN;>&%XT=B% 5F#E7.?N CG)P#FB<6E)+>WY*]G\N_IN.-M.U_\
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M'/3/-3HD[[:_BK/\![_UYW7XF)::-X<UW%K8ZEJ,<L%O%$DJ!H6:*,,FY&*
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MM'V4GTM^MOP;_P"'-.;PAI\T<R--< 2I<HV&7@3N'?''8@8]NN:E.R2[6_\
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MOT[%1?*K+;_@-?KOOMJ2Z9X0MM(EMVM-1OUCC WP^8@28C.TL HQC.-J[5P
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MJ7DW]SBE^8YQYV_1?>I7_P" 5DTC4+.VL+U-&>:]M[R2[DC1X@[I(TV(PQ8
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M+HF^^R*IKFC=^7XM+]3BG^*6KRZ+9S06MG!?O;(UQ'*C.(Y&FB0' <?*4EW
M9[CFMG3O4Y5W2^_FO]SB9<]E=]I/[DFOON:VH_$"^T&2:WU&*VFEL;EX[F2&
M-D65!;-,I12S;3D ');O6<??5X]G]Z<5]VIKRM.S?;[G?\K,WCJNMZ9H%[J6
MJK8S%8!+;K;*Z$N>D1#$YY*@,",Y^Z.Y-6]R/Q7MY>OE^/J13:E:3T5KOR6_
MST\D8]SXH\02>']'OK633K>ZGO%T^\BEM9)0DWF;&*D2*0 03@YR".13LG4B
MH[25U]S?Z6$VXPDY+6/^:2_!W&VOBS6YM?U:RDGMQ'I\S1!4T>Y=9-L0<DSA
M_+3DG@^WK6<G:DZB_O?@VEZ_(M)\Z@_+\?R+/A#Q7JFIOI,6KBT9]5T[[?"U
MK"T8CP5#(P9VS]\8/'?BMYT^5SC_ "V_&_\ D9J3:4NC;7W&3HGCGQ#K%\UM
M&+'S)9+N*%'L9HD1HBP3]ZS[92<<JF".3VK*.M-2W]U/MVNK?/?;;N7*T9\O
M3FM^#U_X'4Q?'?BG5=<\.:5<6%U>:1:7&MV]EOMW>"<DI()@3GH&^4#'5">1
MBMZ=.,I)7T>WIT^_?TL93DXQ?=+7U[%:V\(ZJTNJ+<>.?$FVWU"6WA\G6@Y\
MM86<;]N=K9'(.#CMWKF;:H\_6S?EH]/^"=*BG4Y>GN_C:_\ P# FM-;M;^+2
M&U_QS<W<:VYN;ZTO'DM8VDP65O[@"G[VX_2M4E*IRK:]M>O]=C&[5-3>[BWZ
M;V_+78W[/PCJLFH7,%SXY\2>6NKM9Q>3K0=O*$18%MN=KY'0XX[5G?\ =J76
MTG]VW_!-)))M+HH_BTG^>ARW@JT\0^*]-GFD\;>(8)8M26V)747*B((SL<$Y
M+87CG'M3T5.-1]FW\DMOFPE&U6=-=+6^<K:EG2X=8UVWNKBUUSQSIT2:=/=0
M/J.HE(964KY9$QVJ5(.2,#']['-.2<8-O=6T]=_ZT] BDYJ/2]KK^M'Y:FC<
M6%QIZW$5UXK\6S3VVA+JSM#KPV.W0HI",,9Z,"?QZTZEH\[7V9)?>13O)0O]
MI/\  JW$%]%<>'(4\3^)BNKPVTKR/XHC1XO-8 A8"N]\>HX_(U?L_P!\Z5]O
MT5_D+F_=>T7G^'GU,KQC+J^CZ5=:EI/B[Q/Y5AJSZ;<Q7.JLY? R'5E"XR!T
M(.*P4O@D]I7_  9M*%N:*W23^_\ X)T.G63ZDNDE/%'C",W^E2ZCA_$  38<
M;-QC YS]XXQZ5<UR<_\ =2?WF5-\W+YMK[C+\._;/$-]J-J_B[Q/8/I\2W<G
ME:^+]7@&=X#Q *'Z8'UXI.T:;J/9;_=I;Y[^0*[FH+=[??K?Y$_AG5FGL_#F
MN+KGBN0W6O0Z?Y%QK>^,C<IW,OE_,"."N?QHFG'D7=7^YV'!J3GY/\SU35O%
MVHVDNMWEI%;'3="=4NHY$8RSDJK,48, NU6'56R?3K3@K\K>TG9??:_W]/Q'
M)6NENE?\]/PW\S/U/Q_J5K9WD-O%9MJ5C]LDN%9&*B*)-T9P&R"V^+OW:E]E
M2\OQYN7_ #:*@E*7+W:MZ-7_  V]2&[\;ZW9Z1I]TUW;DW=TD+._A^\C\I3&
M[DB,R;I/NCE>!S522C*S\_PMTZ?,B%Y0<O3\7WZG066LZW?^ WU=#9P7@1Y8
MY'MW:*6-22K>7O#+N4 X+$C/.:BO>E&_5+5?I<=*U25D]&]&<Z_Q"U;3;!9=
M12"XEFT4ZE$;33YRJR'HK[6?"CNQ*CW%.M^[=2*WBTOS_P NY-#]Y[-O:5_7
M2WW[OIV+>@>,M9UK7VM'D@@@C,&4CTFXFW[X4D;,ROLCY8@;AZ=:U<$F_)R7
M;;S)4FX1?=)_?Y":QXXU>P\8WVF0+;?9;1[50KV4S;Q*1N+3AMD6.VX<]*RI
M>_OW:_!?>_(NI[JT_EO^+^Y:;]"ZOB_46=-3$=M_8TFI'35BV-YX;S#'YF[=
MC&\?=V].<]J<$Y<J>\DVO+1M7]4O*P3]WF_NVOY[7^Z_GL9=YX^UR+3=8E2V
MLXI=)N(K*9C$\PDF>1061$?=M","%SDDX[<D?>49?S.W?9:_CMY:]2FK2E'L
MF_\ +_@_@7;_ ,7ZGIVG6,MQ?6< N9) ;Z]TJXM8$*@;8V1WW(6).')QQT)H
MM>22[=]]>G;\62OA;??MMY^?X'<V[O);1.^S>R MY;;ESCL>,CWHDK-I$Q=T
MFR2D4% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % &
M-+X7TR;Q2/$3QL;[[(;,Y(V-&6SR,=>WT-)))2CTE:_R_K\!MM\OD0Z7X1LM
M*NH9DN;J=;6)H+2.9E*VL9QE4PH)Z 98L<#&:;;DFGN]WU_K\^HNNFV]NE_Z
M_P" 5I? >ERZ)8:4T]V(+**2*-@Z[B'4@Y^7&>>.*:=IJ?9)?<T_T0I+F33Z
MMO[[_P";)'\$:0;W4[R/SX;C4)(IG>-@#'+']V1..#ZYR#Z<G*5XQ271M_>K
M/^O,+)N[UT2^[;^O(7_A#+%]#U73)[N[G.JDM=W+L@E=BH7/"A1PH'"XXIWM
MRI?9=_QO^8];MOJK?(9J'@FRO;B2>*_O;*1YXKG-N8\++&"H<!T89(P#G@[1
M^*6C371O\59_+]165K/LE]SNB6Y\*+=K \^L:BUU'&T,ERIB22:)CDQL%0+C
M@<J P['DT::Z:.UUWM_PY2;7JMO+^K=1LO@K3)+IG66XBM)9(Y9K*-E$,SIC
M:S?+NXVKP& .!D&FI-.[]5Y-_P!?J39<O*M-+>J[?UK;0CC\":3'<BX$ESYH
M=7#%U[3F;'3IN;'T ^M$7RVMY?A%Q_)_>$DI)WZW_%I_I^8U? &D(VX2W6_"
M#=O7HI<CM_TT.?H/2H<5R\O]?#R_E^)5];^=_P#R;F_/\!]EX,CL]'BTF36M
M1N[&#R1#',(!Y8B967!2-2?N@')/'YUJYMRYWO>Y,5RII;6:^\J-\.-,CU-]
M1T^_OM.N6NY+L-;F(A7D0(^ Z,,$#/U)J(^ZE'I9KY-W*D^9W?E^%U^I-)\.
M?#4\+0W-@ER@MEMHO/17,"C<2R$C*L2Q).>H'I3OU6C[]K627HK: FTTWKO\
MVW=M^I=G\*65Q)J4DL]R7U"Q2QF.Y?N*&PPX^]\Y]NG%$G=-=W?\O\@@W!Q:
M^R0KX)TY+E6%Q=?9/.2X:RW+Y+S+C$A^7=GY0<!@I(SC-/F=[^MO*][V^][W
M(Y5R\OHGYVVO]PU? NDI=V=VCW27-I;2VJ2QR['*2')RR@'().",8S4+W4TN
MR7W;?D7>[5^C;^^]_EJ36GA*WM8-3#:C>SW>I1"&:\D,8E"@$+C:@7(W'D@G
MUS3=G'D>U[^O]6Z!%\LU/MM_7^94D^'7AT*%L[0:<A$0=;...(2F.174MA>3
ME<9]"?;%*34N;SOY=?\ /\B;6C;R:^^W^0ZX\#VKZF+^SU74-/F6>2=!;^45
M1I%"O@/&PP<9/N2:B/N[=K?*]_S'+WM_)_-)K\G8U+W08M1M]/BO+JXE>RD$
MJRG8&D;8RY;"@=&/0#FB24F_1K[QQDXJWI^#O^A@WOPRT2]$9$]Y!,EG#9^;
M$R;BL3JZ,<J06!4=L8[5;F^=S6[:?S5_\R%%**CV37R9=/@?3)0C7DUQ=RF9
MYYI92@:X9HC$=X50,;#@!0.GUI=+=+-?>TV_6Z+3:=[ZW7X; ?!&G36WV>_N
M;K4(BT6Y;K8X:.,DI$1M * G//)[DT-W=WYOU;5K_P"1*5ERK;\MOSM9WZ$B
M>"M(@@%M:HUI:K?1WZ00!$C21,<* O"G;DCU)Z4*33B^U_QO_F["E%--=[7^
M5O\ )!'X26#4=0NH-:U"*'4)3+<6JB$QLQ0(>3&7' '1JAQO#V;VU_&[_4N]
MI\ZWT_ /#O@^S\.B#9>7=Z]M;BUMWNO+S#$,':NQ%]!DG)X'-:RFY7;W>_RV
M_,CE2MY7_'<@TOP+9:7>P3C4;ZYAMKB6YM[:8Q^7%)(6W,-J!C]]@-S$<U,6
MXI+LK?+^D5+WFWW=_F<U\1?!NK/X1TNS\*VC7]W::R-0V32HO7S6.22HQN<#
M'7'YU4)N#BUT27W*Q,XJ?-?J<9:Z?\8K.34'C\)Z<3?7CWDFZXCX=HS&0/WW
M3!]^>]9M7I^SZ6:^]W-.9\_/Z?@16FC_ !>LT#IX1TY[XV\=M)>O/&9I(D.0
MK?OMO8#(4'CK5N3;OW:;\VC-12CR]DTO),FLK#XQ6%Y<W,7A+3F>XU Z@X:X
MCP)"A3 _??=P?K[U*TBH=%?\2VVVWWLONV_(IVGAOXJZ5!Y6C^#-.TU3=)=G
MR;M7RZ@CGS)VX(8@C^5"T2717T]58&[N4GN_T=_S)CHOQ9CTF;2K/P7I=G82
MP3PF"&=,#S<;V!:8G/''.!Z4I+FCROR_ <9.,N9;WO\ .UBO-X;^+DZRJWA6
MR DTD:0<7,7^I'\7^M^][]/:JF^?FO\ ::?W$07(HI?9O;Y@WA7XF23:1<S>
M M+EO=)BBBM;EKS#A8SE<@7 4^_R]ZKG?M'46[_X87+[GLWL5?$O@OXJ>)K0
MVLOA.SLK=[I[R6.UNHP)9F&"[;YF/3L,#VK)1M;RT7YFG,W?SM^&B+EAX>^+
M5A_9ZCPC82I8V$FGHDES'AXG.6W8F!S[C%7)\_-?[22?R(BN3EMT;?S8W2_"
M_P 4M 5ET+P3IVEB2:.67R;I7,H3.$8R3L=IR<@47=DGJM=/56"RU?7_ (-R
M30?!?Q&BU'1;*\\,6EII%MKL>J2-#<1YB^8;@!YA^4#.!@GW-3:ZBG]E6_&Y
M5]9/^;4]JU#PA8:C?3SO/<Q0W11KNUC91%=%<;2^5+=@/E(R!@Y%./N_)W7D
M^_\ 6G44O>^ZWR[?B_,CO?!&D7NH:S?/YT=QJ]F+*X:-@,( 1E>/O8(Y.>@X
MI)6BXKJ[_-%*5I1G_*K(=%X27.GF\UG4+X6$ZS0"<0*%(1DP=D:Y&&/7G@<U
M?-=\SWU_$A+ECRK;3\'<NV6@6MAH<VCPRS?9)/,559@3$KY^5>.@SQG.*SFN
M>'(^UBHOEGSKO?\ K\R@?!6FFV,'GW.TZ7_9>=RY\KU^[][WZ>U54_><]_M-
M-_*_^8J7[KDM]F]OG;_(;IG@U-&OWN+#6]1ABD,9EM\0-')L14&28RPR%&<,
M/PJW-MMONW]Y/+:*2Z)+[ANH>![/4=5O[V74;Y(M0$0NK1#'Y4PC^Z"2A<>^
M&%1#W/D[_/3_ "14O>^ZWRU_S9-_PAU@-0^T+<72VPN#=+9 IY*SG_EH!MW9
MR<XW;<\XS0M%;UMY7[??U!Z[];7\[;?DMBE/\.]*DLA;17E];DH@DEC=-\KI
M*)5D?<I!?=GG&/F/'3#3LTUI:UO*RM^6_HAWO>_6_P"/]:=B]=>%YKVS6WN/
M$>K.WSJTG[@>8C  HR"+81QP=NX9.#S4M)Z-:?G_ %Y6!-QV_P"&_KSN:NF:
M;%I5G'9VSO\ 9HD6.&)L8B55"A00,GIGDDY-7*3DVWN1&*BDD7*DH* "@ H
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MT ']IQX_U$_0G[GU]_:@ .IQC_EC,>">%ZXS[^U  =3C'_+&8\$\+UQGW]J
M ZG&/^6,QX)X7KC/O[4  U*,D 0S<G ^7KR!Z^]  NIQMMQ#-R<#Y?I[^]
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M]\QZ?+0 U-IV< YP.!U^[P/EZT ";3LX!S@<#K]W@?+UH $VG9P#G X'7[O
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % '/_P#"">#_ /H5-&_\ (O_ (F@"2#P7X5M
M;B*XM_#6DPSQ,'CDCL8U9&!R""%R"#WH W* "@ H * "@ H * "@ H * "@
MH S4UVQD\0/HD;L]Y'"9GPORH 5&"?7Y@<>G7J,D?>3:Z6_&_P#D$O=:3Z_I
M_P .2ZCJ]AI/V7[=<K!]JG6WA+ X:1LX7CIG!ZT+62BM_P#(-HN71$EI?VU\
M;@6TN\V\IAD^4C:XQD<]>HZ4+5*71_YV_-!?5KM_E<LT 5OM]L-2&G>;_I9B
M\X)M/W,XSGIUH6M[=+?C?_)@W:U^M_PM_FBS0 4 4[[4[336MEN7</<RB*)4
MB:1F8@GHH)Q@$D] !DT+5\J!Z*Y0N_%VBV.K2:9<W,B7,01I2+:4QQ!_NEY
MNQ<X[D41][;O;Y]@E[JN_7Y&C::A:WLUW#;R[WM)?)F&TC:^T-CGKPP/'K3M
MHI='^F@;.Q:I -+HKJC, S?=!/)^E #J "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * .1A^)GA:YA2:"Y
MOI8G&5=-+NF5AZ@B/F@!_P#PL;PW_P ]-1_\%-W_ /&Z -'0O%>C^(Y[N#3+
MB62:S"&>.6VEA9-^=O#J.NT]/2@#:H KW]];Z9IUS?WDGE6MK$TTKX)VHH))
MP.3P#TH YQ?B/X:90RRZ@01D$:3=<_\ D.@ _P"%C>&_^>FH_P#@IN__ (W0
M!KZ%XBTOQ+:SW.E7#S1P3&"3?"\3)( "5*N >C#MWH U* "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@#E/AG_ ,DS\.?]>4?\J .KH XKP[_R57QM_P!<-/\
M_0)* .UH Y_QW_R3SQ+_ -@NY_\ 134 :NE_\@FR_P"N"?\ H(H MT <5\//
M^/GQE_V,-Q_Z+BH [6@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H Y3X9_P#)
M,_#G_7E'_*@#JZ .*\._\E5\;?\ 7#3_ /T"2@#M: .?\=_\D\\2_P#8+N?_
M $4U &KI?_()LO\ K@G_ *"* += '%?#S_CY\9?]C#<?^BXJ .UH * "@ H
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M\T.UC7[_ $OQI;P%U_LAK4><"HS'([E4?/7&0%(_V@>U9IZ37I;ULW^-OO\
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M<9'"[B>P--*\^5?U_7_#BC=PYC)?XD:"NIWU@CO+-9K(6$;Q,S&,9<!-^\$
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MEWO?ROJOU7R1TE04% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 <0GPB\$QH$CTJ=$48"KJ%R /
M_(E #O\ A4W@S_H&7'_@QN?_ (Y0!L>'?!VA>%)+M]&LVMWN]GG,\\DI?;G;
M]]CC&X]/6@#=H KW]C;ZGIUS87D?F6MS$T,J9(W(P((R.1P3TH Y$?"7P6
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M ,S17PG8);K );C:L,<(.Y<X23>.W7/7VK-*WX?AL6W>_GS?^3;_ / *%O\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * .?5<-]T<-G[O3E>3\O2@ 1,;?DQC!Y7I]WD_+
MTH $3&WY,8P>5Z?=Y/R]* !$QM^3&,'E>GW>3\O2@! G[LC8>@.-O/W.OW>E
M "LF=WR9SD\+U^]R/EZ4 #)G=\F<Y/"]?O<CY>E  R9W?)G.3PO7[W(^7I0
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M ";/D(V'H3C;U^]S]WI0 K)G=\F<Y/"]?O<CY>E  R9W?)G.3PO7[W(^7I0
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M0 FSY<;#]T\;>?NC_9Z4 *R9W?)G.3PO7[W(^7I0 ,F=WR9SD\+U^]R/EZ4
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M]?O<CY>E %BS&+V,X RS\[>#]..* -B@ H * "@"L+"U!!$(X.>I]O\  4
MT^U7;B$?*<CD^W^ H !I]JNW$(^4Y')]O\!0 #3[5=N(1\IR.3[?X"@!/[.M
M I7R1CZGTQ0 IT^U;=F$<G)Y/O\ XF@ .GVK;LPCDY/)]_\ $T !T^U;=F$<
MG)Y/O_B:  V%J23Y(R3GJ>O/^)H /[/M?^>(' '4]L?X"@ _L^U_YX@< =3V
MQ_@* #^S[7_GB!P!U/;'^ H /[/M?^>(' '4]L?X"@ _L^T_YXCH1U/O_B:
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MMV81R<GD^_\ B:  V%J=W[D<G)Y/7_)H /[/M?\ GB!P!U/;'^ H /[/M?\
MGB!P!U/;'^ H /[/M?\ GB!P!U/;'^ H /[/M?\ GB!P!U/;'^ H /[/M/\
MGB.A'4^_^)H /[/M?^>(Z$=3WS_B: #^S[7_ )XCH1U/?/\ B: #^S[7_GB.
MA'4]\_XF@ %A:C;B$?*<CD]?\B@ &GVJ[<0CY3D<GV_P%  -/M5VXA'RG(Y/
MM_@*  :?:KMQ"/E.1R?;_ 4 )_9UIMV^2,?4_P">U "G3[5MV81R<GD^_P#B
M:  Z?:MNS".3D\GW_P 30 '3[5MV81R<GD^_^)H #I]JV[,(Y.3R??\ Q-
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MV[,(Y.3R??\ Q- #X[2"*7S$B ?GGTSUH FH * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * *>H:G!IB(\\=TX<D#[/:RSG@9Y$:DC
M\?I2OK8=B@?%>G!U7[-JV6;:/^)1=XSQU/E\#GK_ (4Q%NQUJUU#?Y,5ZFP
MGS[&:'KG&-Z#/3MT[]:I1;U)<E'<Y]M,M&\>P36"%[Z)FGO[HXRL90JD&?0G
M#!>VW/4C*I.REVV]6W?\%]RLASZ7WT^27^?XZOH0_$:XN8E\/0V_V]UN-36.
M6&QN3!),OEN=H8.G< \L.E3'6HEY,MZ4I/T_-%&\UH^%[^TN98-4@LX-+NIW
MLKN[-Q(6$D07+;W!//'S' /X5=])+?X$OFWY??\ J3;2+VU=_DB];>.[V\EL
M[*#P_*-3G\US!.TENACC"DLC21JS9W@#*J,@\@#-'+=Z;)7?WV_X/I]PD]+O
MJ[+[K_UOK]Y%<^(=0-_>+?QF&UM=8@MX3;7)5RI16(<;.1\W(!YSCC&3*:BH
MR?\ ?]-%+_+[]?(<T[-+M'[W)?UZ>HU/B6&T][MM)($ME]NLU%QDS1;PGS?+
M\C98''S#GK5<KORO>\4_^WMO^"*34;OI[W_DN_W]#=LO$X?3=:NM0M/LK:1(
MZ7"QR>:"%0/E3@$_*PXP.<CGK43:A353U_!V_,J$7*I[->7XG):QXSU+5;*'
M3H; 6=W/-92$)?.FZWF? _>(@96^7! Z9X)K6-/]XD^C:?JHM_-?G:ST=S)U
M+4W-=5=?>EKVW\^^YJ^)(9+SQYHFF-?7UO:M87,K+;7DL.74Q[6)1ANQD]<U
ME?\ B2ZI)K[WTV-6K1@N[M^'?<QM#\;7JV-A>W,,]W>SV-HA5[GRXG:2=HP^
MW:<$\$D=1@8XK6W-)J*M>WR]UR_X I+ECKT<ON32_P"&_P"";@^((CU;4+6?
M2;@6NGJXN+F%)71'2/>PW>6$V]@=VXG'RC.:R<DH.?36WG9V^_TOZC2DYQAU
M=K^5]?ZV'R>)M>ELM%N4TFVMEO[N)?GNRX,+(7X(3(;CD8QZ$]14ER5.672]
M_DNGE]VVQ$9<]-SCY6^;2_KU^13_ .%F(+*:\;2CY#V<]Y9$3Y:=(F"L'&W]
MV3D$?>XZX/%$8N5N_N_=+;_@E-6E;I=KYQW^6F_X&C-XRFLO$>GZ1?:=%;F[
M"_O6G?:68G"HQC"L>.064\\!NM$5S2<>W^5_NZ7^](ER:@IVT_X-OO\ P[-G
M6TB@H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MCKTQQBFWT]/PV_,%I_7R(W\&:#):0VSVDC+$S,'-S+YC;@ P9]VY@0 "&)!
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MH5N2+76__I37Z$)OGDGTM_Z2F=!2*"@ H * "@ H * "@ H * "@ H * "@
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M-M<P0*X?:)#(<EMH.2 N1R 1QGJ;<.2+3W4K?@OU,^=2<7'9K]3KZR+"@ H
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MO.[->D 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M+<7$J0P1*7DDD8*J*!DDD\  =Z ,/_A._!__ $->C?\ @?%_\50 ?\)WX/\
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M6GL=0G>]FBMENI)844(RNQ "<C@=L]L<DTW\7(NZ7S>G_#BYO<Y^EF_DE?\
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MDOQ=M/+_ ()/%XSM;V.,QVFHVY9H6B#)&#,KL5&,L<#((.<'N.,&D]-5KO\
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MK/3+BSGBFG=[2&6%-[+R)'#L3@#G*C&*$[+E79+_ ,!5E^8K?FW]^YLTAA0
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M\@FR_P"N"?\ H(H MT <5\//^/GQE_V,-Q_Z+BH [6@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * ,3Q-X9@\3VEI#+?W
MMB]I<"YBFLI%217"LO4J>,.>U &+_P *\G_Z'GQ5_P"!L?\ \;H CF^&S7,$
MD$WC;Q2\4BE'5KR/# C!!_=T =#X6\-V?A'PY::'82326MKOV-.P+G<Y8Y(
M'5CVH V* .=\2>$8?$=[87AU;4M-N;%9$CDL)5C8B3;N!)4_W!Z4 9G_  KR
M?_H>?%7_ (&Q_P#QN@"M?_"V+5+&6QO_ !CXGN+688DBDNXRK#.>1Y= '9:3
MIL.C:-8Z7;L[064"6\;2$%BJ*%!. !G ]* +E !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0!C^*?#=GXN\.7>AW\DT5K<[-[0, XVN
M&&"01U4=J ,!/AS)'&L:>./%2HH  %Y'P/\ OW0 [_A7D_\ T//BK_P-C_\
MC= &QX6\+6WA2SO+>WO;R]:[NFNI9KQU>1G954\A1_=':@#=H Y_Q?X0LO&>
MFVME?75W;+:W2W4<EHZJX=0P'+*?[Q[>E &5_P *\G_Z'GQ5_P"!L?\ \;H
M/^%>3_\ 0\^*O_ V/_XW0!O^&?#]KX6\/VVC6<T\T%N7(DN&#.Q9V<Y( '5C
MVH UJ "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
MX.R^&"Z=90V=GXS\406T*A(XTO(PJ@=@/+H G_X5Y/\ ]#SXJ_\  V/_ .-T
M :7AGP=;^&;[4;U-4U+4;K4!$)I;^57;$88+@JH_O'U[4 ='0!3U;38=8T:^
MTNX9T@O('MY&C(#!74J2,@C.#Z4 <HGPYDCC6-/''BI44  "\CX'_?N@!W_"
MO)_^AY\5?^!L?_QN@#8\+>%K;PI9WEO;WMY>M=W374LUXZO(SLJJ>0H_NCM0
M!NT % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% ',IXAN_P"W@CBW&F273V284^8)$C+EBV<8^5AC'&,YYP"+3CS/LW]SM_P0
M:=[+I:_SM_FD2^$?$,WB2TO[J2W6"**[:* #JT6U2K'W(;/T(JN5J$6]WO\
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MLF5HO.!%PA!CY^?K]W@\].#3?NWOT$M;6ZF'K?Q!T/1FT]SJ%A+:W:22^?\
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MCBN;8IZCXED2RT:?1[:WOVU:41P^;<F*, QL^XLJOV7' [U;A)3<.UW]UO\
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MIHF@)97]U9&YUNW@E>UG:)VC97RNY2#CI^0H VO^$"LO^@WXB_\ !S<?_%4
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M?\4OU';1VW5OQ-'3]3L-6M?M.FWUO>V^2OFV\JR+D=1D$BAIK<FZ+5(84 %
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M;\68]M\.M4BTVV61K%9[,0)'#93S6D<PC$@W,Z#<C'S<\9^[WSQK.5W=+O\
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MT :O@3_DGGAK_L%VW_HI: .@H * .:U?0+V\U>26V: 6EXL"71=B'41.6&T
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M7],M:YX;OM6T/0;>73M+O9;"59)[2[F;R) (F3 ;RVSRP/*=JTG).HYVWO\
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MY_\ 134 :NE_\@FR_P"N"?\ H(H MT <5\//^/GQE_V,-Q_Z+BH [6@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * .9\9
M:1K&J0Z1-H1LOMNGWZW06]=UC8".1",J"<_.* *'F?$__GU\*_\ @1<__$4
M5M0M_B;J.FW5C)!X61+B)XF9;BXR P(R/D]Z -;X=^&[SPCX$TW0[^2&2ZM?
M,WM Q*'=(S#!(!Z,.U '44 <GXJTGQ%<>(-&U?P[_9K2V45Q%(E_)(JD2>7@
MC8I_YYG\Z *WF?$__GU\*_\ @1<__$4 9/B;1/B3XG\.7NBW,?AB&&[0(SQS
MW&Y>0>,I[4 =OX:TV;1O"ND:7<,C3V5G#;R-&25+(@4D9 .,CTH U* "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#E_B)X;O/%W@34
MM#L)(8KJY\O8T[$(-LBL<D GHI[4 9MNOQ.MK:*!;?PJ5C0(";BXYP,?W* )
M?,^)_P#SZ^%?_ BY_P#B* +?@70M7T2UUA];:S-YJ.I27I%F[-&H9$&,L >J
MF@#JJ .,^)/A;5/%6D:7#H\EHEU8ZE%>_P"ENRHP17&,J">K#]: &^9\3_\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MMJNF)H\&CFT6ZU"_6UWW<;.B*8I'SA64Y^0=^] %?[/X_P#^@GX=_P# "?\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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MK,V"@ H * "@ H * "@ H Y3QE_R$O"'_8:7_P!)YZ .KH RO$__ "*>L_\
M7E-_Z : .4^"7_)(="_[;_\ H^2@#T"@#E-7_P"2F>%_^O*__G!0!U= '%?%
MS_DE7B#_ *X+_P"AK0!J^!/^2>>&O^P7;?\ HI: .@H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M_.^<=-O/W<Y^[0 &[N1G$C'@XPO7[W(^7IP*  W=R,XD8\'&%Z_>Y'R].!0
M&[N1G$C'@XPO7[W(^7IP* %^UW.X#>Q^8# 7[WS'I\M "+=W)V_O&.2.B]?N
M\?=Z\F@ 6[N3M_>,<D=%Z_=X^[UY-  MW<G;^\8Y(Z+U^[Q]WKR: !;NY.W]
MXQR1T7K]WC[O7DT )]LNMA/FM]=O3[W'W?84 *UW<C=^\88)ZKT^]Q]WKP*
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MG^($JW,4@M[D63PEG'EKYD#"4QD/VP"/X<^V:%J[?X;?]O7M^GZBD[?+FO\
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MR>OI@!I\L>7T7W7M^8Y:N_G?YLZFD 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 <U->WUGXTL[-]0DEAO0Y%NUL$BC15R
M-LF,M)D<C=TYVC&2Z>O,GT5_Q7X6WWUZJ]A3NDI+O;\'^NVWSW+WB?59M%\/
M75Y:(DEY@1VT<F=KRL0J XP<%B*A\VBCN_Z?X%QMJY;)7,[3_&=F/#NF7VK,
M8+NZ1E>&"&24B6//F*%4$\$'\JTGRJ7N[6O\G;?[T1'FV>][?/7\[:%L>,M
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % '(P_$SPM<PI-!<WTL3C*NFEW3*P]01'S0 _P#X6-X;_P">
MFH_^"F[_ /C= &CH7BO1_$<]W!IEQ+)-9A#/'+;2PLF_.WAU'7:>GI0!M4 5
M[^^M],TZYO[R3RK6UB::5\$[44$DX')X!Z4 <XOQ'\-,H99=0((R"-)NN?\
MR'0 ?\+&\-_\]-1_\%-W_P#&Z -?0O$6E^);6>YTJX>:."8P2;X7B9)  2I5
MP#T8=N] &I0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MT((IVLD^^OWAU:[$SND<;.[!$499B< #UJ6TE=C2;=D9^F:]IVKR21V4SLR
M-B2%X]RGHR[@-RG^\N1[U5G_ %_6A-T:5(84 % !0!5U#4;72[87%T[*A=8U
M"1M(S,QP %4$DY]!0M6H]P>B;?0M4 5;[4;33+9KB\G6*-1DDY)QD#H.3U%'
M5+O^N@-V3;V7_#_DBU0 4 % !0!&)E:=X0'W(H8DH0N#GHV,$\= <CC/44>8
M$E !0 4 % !0 4; 0VEW!?6D5U;/OAE&Y&P1D?0T!LVNQ-0!534;22^^Q).K
M7'EF3:N3\H;:>>G!XQUH6M[=+?C>WY,3=FD^M_PM_FBU0,8DJO)(@#@QD Y0
M@'(SP2,'\* ".592X4.-C;3N0KS[9'(YZCBCI<.MA] %634;2*]ALWG47$Q(
M1 "22!N.<=..>:%J[+^MO\T)NUK_ -;_ .3+5 S&U'Q3I.E:@;&ZEN!.L:RO
MY=I+(D:$D!G=5*H/E/+$=#0M1N+23[FI%<1S%A&6(7'S;2%.1D$'H1]*+6)O
M?8EH&-$B&0QAU+J 2N>0#T./P/Y4 .H :\B1(7D=41>2S' % #J *$.LV5QJ
MT^F0M,]S /WA%O)Y:' .#)MV;L$';G//2A:JX/2R9==TBC9Y&"(HR68X % $
M-G?6U_')):R>8L<KPL<$8=3AASZ$4=$^X/1V_K:Y*\JI)'&0Y,A(&$) P,\D
M# _&@-A] !0 4 % !0 4 11W,4DICC8L0,E@I*]2"-W3.0>,YH#8EH * "@
MH * "@ H * "@#E/AG_R3/PY_P!>4?\ *@#JZ .*\._\E5\;?]<-/_\ 0)*
M.UH Y_QW_P D\\2_]@NY_P#134 :NE_\@FR_ZX)_Z"* += '%?#S_CY\9?\
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MI&(TODA$XNE0(00,?O?O[?N\XZ<559Q=5OIK;]+_ /!Z[]3.BG&FUU_X.O\
MP/+;H.\*Z=?+XF;4+Z.^#-IJ1H\[O@KYTFT,"<;PFS.1D9/J:2TC)/=\M_6V
MMOGVT&]5&W>7W75OZ>O?8GTRXEM+>+1'T6XENXKF1VD:%A"JEV83"7;M+<@[
M0=V3VZUF[NFK=(V\[J-M.]_+H_D.UI._5W^]W_#S[:'.VUEK]EI=BMS>:]<W
MDEG%):L6D.VZ))=9MH "@;1^\XQN[UL^55.5=&O3EZ^5]_/:P5-I-?WOO^S;
MR_#OH54C\:_\)H+<OJG]F^?]BWGS-FU9?.$V[/0I^[W>O&:BG\.N_P#\BK?^
M3/7S05--OZYM_P#P'IV.B\"1ZZM]=-J]Y=RR&,>?'-:31HLN?X'DD96&,_ZM
M0N,=^*<;<FGEZ^?G^-NW44_XNFVOW7T\OU[]#F;[0M5SXAL8],N6M-1:ZO6(
MB)!D1Y%5?<MF$C'78:=&R4$_LM/[[)_=JWZF\FO:IKK9/Y)._P!^A?O'\4'Q
M!?2Z>FH1,T=Q%Y/EW#(I"?NW#R.8LMC(V(,$X)SUB%M>;;_[977?:^WRVTP>
MG*H[Z>GPO?YV3Z_>+/H4^N:K8KI[:W%9Q07)5]31R';,)$;>8-_EEE/#8)PV
M/EK1-QO+M:R[V;_&VW5:-ZENSI\KZO7[FG_2T+&K7NN7OB#2[JTM=2L]DEOY
MD(BN65T9P)=VUQ"NW)'S*Q(Y&!@U--+G=WH[_P#I-T]?/M9I[D3O[.RW7YI_
ME9==T]#9\'-J<][J@OYIFAL)#80AY2XEVL6,A/<D,@R><J:G>DI=7^FGXN[^
MX<OXC2V7_MVMODK6^9A_;2W@2UTT:=JOVNRN+>6:,Z9<#Y5N4+%3LP^!SA<G
M%53:3A)[)+_TFWYE[.HN_/;YWL;=S%-XC\0V%WI]YJNFVZ6DZ/*MGY+$[X_E
M(GB.,X)& #QP:2CI*^SY=._Q?/\ X?T,F[N*2VO^A+XELWTWPM::9ID5PD".
MD)D@^T.\* '#;8&61N0!PPZY/ -3-N<OZ^[_ (?0TCHI-[_\'7_/0YW29=?2
M]T$W\>L33%$C88FC1,.X9F^\C?+MR)2#CE6)ZZPLWKV_]M7RWOMK?=6,6GR^
MC?\ Z5IY[=]+=;FAXGTO6M2UJ[U*P\M4TJ&/R(I;1V>=PPE81L' &=J+G#=Q
M6<'R/G??\$K?^W,UE'GM#RWZ7>WW63^9GZWJ'BB:]EM-*LM723[1-,LQ1EB$
M;6QV+D\$[^W0,!G!(S4$EI+973_\#6W_ &[L_N(3E9M;NS5^GNK?Y[KYE%=.
MU2ZT[6(8+?73:W)F$8O/,661/LN%!/WB-_ W<]C4Z)>]YO\ \FA;;K:^WGUN
M7%VJP]5?[IW^5_QM;H:L(U(7ZBW&MB<%1 '$X@^R^2/O;OE\S=G[W[S/M15O
M:5M_>O\ CRV_#;SN335E%/;W;?AS7_'?3:Q'IUKK.E:EH45Q<Z]J+O%"7>5Y
M J%B3)N*J8V R 5DVD ?*2>*V?+[226RO]UM/QZK6_2QDN9TXR>^G]=_OTZW
MN:NM#4CXGQ'_ &GYID@^Q^09!;>5D>=YFWY,XW??Y^[MYK&FKW3\[^EM+?/M
MK\C:6GW?^37?X;;Z6OU*8T1X?AC#9/!J&Z.[25XUDF:8*+D,2,'>?EYP/J*J
M#]ZDWT4?_2>OS[[>@0_Y>>?/^MOO_'YF5;Z9XDTZTN9--EU,2W?V]O+D5BD(
M%P"A5.,,5+D'(+9Z\#$O2$8OM"_X76G9=%V[E:-RDM[NW_@+[^=M6;^E:=J=
M[X"U>Q>YN;F2X65+8W=O+ V"@&,3.\F-V>7.>>!C%5-V47;:S];._P"7_!U)
MIZ2WM^GG_6@_4=3N]3L&.FZ->V[P1JLT[P/#-&OF)YD<65RQV!CN0XRHQDXP
MG:]V]+KY[_/3[]78(:14;:V?HG;3R_K4Q;JUUJYM)VLY==2TAMKN6QW23K*6
M'E&(/N^=CN\S"ODD=01502TYM_=^[F?R^&U_QU*ARMVZ7_\ ;=?.U_\ @:%;
M6/[3L==BTYKGQ$UFTUP8Q:RR/(X\J J22=Q02,W3IDCA<BHU:M'=)V]>9VO\
MN^CZC27(F^KC?[I7M]VR^6I+=OXJ.N6TA2_BG1!%<1PQW+QN#;DF0-O\D?O.
M,*FX$ Y&:52UI\G7FMY=OO\ *W;<BEM'GW7+^:O]VN]^_HO_ !4'AW1[F]:X
MU2]>U@L[PBZE8>=(V]98QGCH5^0< X.,FM:B5^6/\SBOFDD__ G?[TM"*=W!
M.6GNW?E9WM]VGYF_K6BWTGAK0;5Y+JZOK:Z@>21)7!+C.YF*G[N3WX%9U-*B
M=/IS6_\  7;\;>OS&O>IOFZM7_\  E>WHK^EO(PX;36[^P6TM[OQ!:-*;9;V
M>0R"1)M_[TQEP0%QUV_)TQWJ_=YU;X;Z>EI;]=[;]=@DY*-W\76VWQ1M;Y7^
M6Y=^(>D7%Y+9M;QW\DGV.>!'MQ(X5R8R"RK\O0,<L,9 [XJ(ZS[7<?PEK]Q4
MK*@UOO\ /W9?K;[_ #,W5+3Q);&2QBOM5&G6]U(%N##<7,TA,<3)_JG1BNXR
M<YV C!&!P]^5];/_ -*>]]-K;[CLDG?7;\M=O/MJ=!XNCUIO#^E)!=7,?SK]
MNE@MI7DQL/\ !!(K_?QG8W'N,T3M[1VVUMZZ6_"^^G<FG?V:OOI_P?G_ $C&
ML+'Q*E^M_<7VL2O'<6T2Q%62,QM$OF.8]Q!.>N6(!![DTGI\^;\G:W3?_+8<
MME;I;_TOKU^'\-6.TJ]UBQL!-)::[.MM=Q&;<)G>;*,'Q&X##YBN0I:,<%3P
M<5+[+7G^6F^N_?5>EA)?%=]OSU\MNV_;O4MK3Q/JMYI-O=S:Y8V\VPW)21U9
M!_I)*EAP/^60)!_NX/2A)*&^J7WNT/UO^/F#?NW7\S^Z[_38AENO$$,F@27\
MNN0W#R648*$I 4+J)!-G^,G_ ($>W&ZKIV=77K?_ -)NK?._Z]!U4HJ2CLKV
M^]_I;]-3J_$[:HOB72K2PFF2'4OW4K)*1Y0C82%@.VY=RDCU%8QOS-=E?[M+
M?>X_<PF[03^7W]?DD['-V \31:7J37L^H7$[HBW"?9+M!"Y<!GC*S%GVC)Q
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % &>-28G_4XYYY/ XY^[[T
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M@ &I,<9@QTSR>!QS]WWH /[2?&?L_/4#)YZ_[/M0 '4F&<09ZXY/(YY^[[4
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MS1=.AFEEO;9EAG6WD"3@E'8D -QQZG/:B/O-)==AO1._17-R&^,LRIY8"L2
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M.QPQ!PHY/S<CY>G- "FWE#G,#' !.%'(^7@<=?\ "@!!;S+UMVX52<*.1\O
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H Q'\1PCQG
M%X<2!GE:T:ZDESPF&4!>G).2>O&/>G!<RD^UOQ_RT^\<O=2??^OT_!EO5]7B
MTB"%W@EN)9Y1##!#MWR.03@;B%' )Y('%3?6R"VC?;_AB+2?$.GZQ#;O;R%)
M9A)B&08D4QMM<$?[+'![5?+U6UD_D]B;]U;6WS-6I&44U6!]<ET@))]HBMUN
M"V!MVLS*!USG*GM0M4WV&U:WG?\ "W^97U77XM,NX;*.SN;Z]E1I1;VP3<$4
M@%SO90!DCOD]@:5]_+?R_KR$]%?[O,N:;J%MJNG07]G)YEO.NY&QC\".Q'3%
M4URNPD[D4FK0+-'%#'-<DW/V:0P)N$+;=V7/88QSZD4EK;Y_@/OY6_&W^=_0
MOT 5=3OXM*TJ[U"=7:&UB:9P@!8A1DXSCGBIE)15V5"+G)174YZ#Q]82'R[G
M3[ZSN";?;!,(RS),^Q'!1V&W/7G(]*U4&Y<O6[7HTK_DC/F7+S=+7_K[SJZ@
MH* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MO^;M^%B;>_)]';\E?\;F]0,* "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * /)M&\0_%W7=&L]5L].\+_9KN,2Q[_.#8/J-] %_[7\9O^@=X5_[ZF_\
MBJ -/P/XA\4:EKFO:/XIMM-ANM-6W9?L ?:1('/)9CG[H].] ';T 9?B74IM
M&\*ZOJENJ-/96<UQ&L@)4LB%@#@@XR/6@#A8-1^,<\$<R:=X5V2*&&3-T(S_
M 'Z )/M?QF_Z!WA7_OJ;_P"*H W/A_K^MZ]I^JCQ!!9PZAI^HR6;+9AA&=J(
M<_,23RQH ZZ@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H Y3X9_\ ),_#G_7E
M'_*@#JZ .*\._P#)5?&W_7#3_P#T"2@#M: .?\=_\D\\2_\ 8+N?_134 :NE
M_P#()LO^N"?^@B@"W0!Q7P\_X^?&7_8PW'_HN*@#M: "@ H * "@ H XJXT#
M0XOB$;XZ)8O.M@UUO%LF\RB0?/G&=WOUJ(R]G&I*/2W_ +=?[PDN><(OK?\
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MO_7J555JL5VYOP<5^GZ=+E%XO[-N#J%B;=Y[M[I8]3BR)GD"R,(YXRH+*FW
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MZ!UYOE^;_P Q]G;V4'F"TM$@VXB;;#Y>0H^4#@9 !P,<4WJKOK_PWZ"Z^?\
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M>K_?/3ODY]<TK*UOE\AW=[_UV_(IMX<T_P ZP,,0MK>RD\V.V@1$B9]NU6(
MSD#I@@?7 Q5W?F?]7W^\5DHN*6]OP_X9?<7YK*UN)%DGMH977&UG0$C!##D^
MA /U I+35?U_5W]X%/4?#^FZE82V<END22!E+Q(JL S!FP<=R 3ZT=O*WX;?
M('JFGUO^*M^1+'HVE10""/3;1(0C($6!0NUCEAC'0D#([XH>JL]O\M@6FWJ$
M6BZ5#:I:Q:9:1VZ1M$L2P*%5&^\H&,8.!D=\4[O\OPV^[H"]W8+O1M+OX)(+
MS3;2XBE<2.DL"NKL  &((Y(  S["EV?8.EB0:;8AMPLK<-YGFY\I<[]NW=TZ
M[>,^G%#UW_J^_P!X+3;^K;$,>@Z/#-:S1:39)+: K;NMN@,(/4*<?+G/:FFU
MMZ U??U^9+;:7I]G<23VMC;P32DEY(XE5F)QG) YS@?E26BLMOZ_S8FKN[W_
M *_R&)HNE1W\U^FF6B7LZ[99U@422#T9L9(^M*VCCT8[W:?5"0Z%I%O<6]Q#
MI5G%-;1^5#(D"AHD_NJ0.!["JN[M]Q6OH+;Z)I5H[/;:9:0LTAF8QP*I+D$%
MC@?>()&>N":73EZ%7;=R9["SDL#826D#V93R_(:,&/;_ '=O3'M1+WMP3Y=C
M.N/"NBW*V,3Z?;BTLMWEVJPIY/S#'*8Q^5%_>YNMK?BG^A+2:MYW_!K]2^=,
MT\W8NC8VYN0%'F^4N_"YVC.,\9./J:!^1';:)I-D,6NF6< \TS_NH%7]X1@O
MP/O8)&>O-&R2[!W\R<6-HL"0+:PB%&#K&(QM5@<@@=CGG/K0M+6Z?\-^6@K+
M7^O/\PN;*TO%*W5K#.I5DQ(@;Y6^\.>Q[BDTGN4FUL5[;0](LU"VNEV<"A2H
M$<"J " ".!T(51] /2FWS:,2TV)+73K:SDG:% HFVY0* H"J%   Z8'^>*'J
MFGU!*UK=%;\_\RH/"_A];22T&A:<+:3&^'[*FQL$D9&,'!)/U)H[+L.[O<U(
MXXX8DBB14C0!551@*!T %-MMW9*26B'4AA0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 <#?:3J=UJ]U(;G6$CEN9TVQ7,J((Q""FT*0%^<=1R3D9P<5
M%W&FVM[-_-2T_#IU0DVZENG,E\N77\>O1^96MVUU[R-I_P"V!J9"'I(+;R/(
M&[(^X'WY_P!O/M6E;12Y/[WZ\MOPV\[BHWY8<_\ =_3FO^.^FUM2G;Z=XGL]
M0T:*76-7E400.K26TTQ:1F)E61DD1%P"!^]4\?=YS6CY?:M+9/\ "WW;WV5R
M8\SI)OJOFG^?XVWN;/C"QO!XEM-5LX;]VMK"3)M6DQQ-"2NU3@DKOXQDX[X&
M,H/EYGYQ^Z[O_7^9K)<T4O\ %]_+I^)DLFL:M>->3:;J,:M+-Y:3QL61#/;%
M1WP"%8X]CZ&J@N6,4][J_P#X%/\ )6^5N@F[J=O.W_@%OS_'S.@\+/J<VO:Q
M%>33-;:8[6L):4MYI9O,W'U(1HUY]#ZU*_@WZO3_ ,!TO\W>_H$K*I9;;_?;
M3Y:V\F<VA\0MHU_#"VL1D2Q?:+B9+B1RN6\PI'E7!Z9$+E<<J0>";J/:_GV^
M_?O^*+G\4K?UJOEMMU[ZV-KPA8WEOK_VF_?4)I9=.1$FGBFC4A99.&5G<*P4
MIC>=Y!)/.ZM'\,DM]/R^[UMI^!#LU'_M[]/^#O\ HC/WZY$+B6-=::YC1GOU
M82E"XF0J( ?E(V!^(^HP#S6<7:,6]O=];_:\[?AV&U=R2W]ZW:UG;ROMY[W+
M.BK?7WBVRU6_LM5MU,MXD*S^:!&K"(H&4': 0&(SQGCJ!54URQL]VO\ VY_C
M:WRVT);NI=N96_\  ?\ /]?,K:[9>(;S5=0\BZUB"""*[FA6V9U61U6+RER.
MHSN( ZX(Y&14P]V'-U5O_2I?I;Y6\BHI.IRO9M?=RQ_6^O>_F:'C>PGOK*QG
M^SWLL_V*ZC"VXE(WO"<!E3CDC'S#&>.]3->_)1[?^W+]"J#_ (;ETDF_N?ZV
M_P"&N8U]I_B+3[+[!#?ZJUDLD+SW+13SR8,3;@JPLCA=X7(0C&>F,UI)WD_)
MNW_DMO\ V[5Z=#&G=)6[+_VZ_P"%O/KOOT.L?VHO@G3H7-W)<R&-+BX2*<2Q
M#!.XQP2>8>0 0'[Y)P#2J*\[+^G^"_1%PLHMO^M?.[T7S9C:4VN$:?\ VJ-=
M-TL$:VOD+(J&02.'\X$E<;0G^L)X^Z2W-#NXMQ^*WR^%?*_-?;7Y"AVE\-WZ
M[NWGM:W3N.MC>_V5 )1XEV;XO[6+>=OW;'W^3C]YC?LSY7RXQM[TY\E]/AUM
MW\K];>O7R*5[.]N;\-U\MMNO?6P6VG:Y=O'+=7&M1@26\: 3RI^Y9W#%@#][
M9MW$\J><@\T);<V[O?\ \ 3_ /2NWH8MR5^7;2W_ (&^_P#=[]-S/GFUQ=8M
M[%)M=:YBL@;=(W8Q^8)Y%1I^Y!0#EN"!SD[:*;YFF_[E^VJ7-\]_TU-)IJEI
MWGZZ6Y?EM^NEQVH'Q1)JVJ/9G5+<313H8XX[EA$X=/+96=RA)7<1Y:J.2#G%
M1!7BD^KC\M=5\ON>]K#J.R;2U5_G[KMMW=O/SOO;OT\0:/;2V]I=:A,?[1-A
M!)<S,69)HD_>Y/WMLF2/0;@,8Q5JTG"+TO>_RDWZ_"FK]=!-N"E+>UGZNUK>
MEVG89J=AXC=KYH+S6E6R@N9;=(WDQ-(LG[H$]6X_A[CU%*D_>4I=X_C*5_PM
MZ*WD$EJH+:SU_P"W8V_&_P [^9:T"XU5/'\=O?3:NKR1W+SQW#?Z,Q#C88A[
M(5Z<<\_-FG"W*_1??U_'_@:!*]DWWZ=K.WS[^>_09JNDZO=^)=06";5+.T:6
M>8M:,\8F*P0!!N'^T&QCK@CU%9MN-.ZW2=EY\S_3H;OE=D^O*GZ>]?\ 0KQ6
M.H0W-W?7L6LQVUW<0->_96N/,8?91]U4.X#S.#LYXP> :UERQ;BMKRMZW5OE
M:^^AA%RE"#Z\JO?_ +>O\]O/>VK)O[-\1W1%Q<7^LQ$)90^1'(5!#3#S'.T9
MW!  Q!XR<T02O[W5Z_\ @"V\G*_Z GJ[;).WWRM\[6\]KB&WUS3K:5D&KW*R
M1743B6:X?8JW"K$PVG?N$99AM(9P.I/-)V<;/^[]]G?;Y76R-;14KKI?\K_G
MUZ&<EGK8M!<2C5Y;NWM]0AM)ECND8[E1H\JS,PS\V"Y)R ,Y  JGHU?=VO\
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MJ1QFG)\SNE8I*VY<J1A0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0!#:V=M91-%:6\5O&S%RL2!06)R3@=R>2:.B78.MR:@ H * "@ H * "@ H
M* "@ H C%O"+AK@1()V4(9-HW%020,]<9)X]Z-@)* (9;2VGGAGFMXI)H"3$
M[("T9(P=I[9'I0M'= ]58FH I6ND:98W=Q=VFG6MO<W!S--%"J/(?]H@9/XT
M+1<JV!ZN[+M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M '4F&<09ZXY/(YY^[[4 !U)AG$&>N.3R.>?N^U "_P!HMG @SV')Y/''3WH
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M[3;&?(XQG.6ZX)Q]WVH #J3+G,&,9SR>#SQ]WVH #J3+G,&,9SR>#SQ]WVH
M#J3+G,&,9SR>#SQ]WVH Y/7_ (KZ'X?O(M/DBN;S5)1&5L;2)GE(<9!&0%/&
M. V:/M.*UMI]P*W(IO1-7*^G_%==0U..Q'@[Q) S3)#))-9;4@+$8+G/R@9S
M]*5U:X[:V.T&I,<9@QTSR>!QS]WWIB :DQQF#'3/)X''/W?>@ &I,<9@QTSR
M>!QS]WWH R;#QK8Z@=3$:&,:=*8YFE.U3@'+ X^[D$9]0?2C3D4^G]?\/Z,+
M>_R=24>,M'9HE34;%S.Y2$"Z!\TCLO')Z<#U%.SO85U:_0%\7Z?A/-EMX'D=
MDCCDN%W.0S+QC.<E?KVQGBDM;)?UI<&[7N07_CS1=.AFEEO;9EAG6WD"3@E'
M8D -QQZG/:B/O-)==AO1._17-R&^,LRIY8"L2 V3SCTXH N4 % !0 4 8:VT
MP9/W!&7X^4<?=Y/R]* $CMYOW?\ H[#+ #*C@_+R?EZ<4 $=O-^[_P!'898
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M9S@#^[TH =);S#S/]'8X8@X4<GYN1\O3F@ DMYAYG^CL<,0<*.3\W(^7IS0
M26\P\S_1V.&(.%')^;D?+TYH )+>8>9_H['#$'"CD_-R/EZ<T *;>4.<P,<
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ME\"T6W:7);;P?IQ2 U: "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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MKF%XBH96PQ&?F&,9!]:I*ZNMK7_&WY@]-^]OO5_R.@I % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M<O<V5Y<>(;5X]$6VAL[E[IKJ-X_](S$R  9#;CD9W #"CD]B#Y4WY-6]7?\
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M.Y\)V=YI_A/2[/4%9;N"!4D#/O(([9!.?SHG+F=PLDW;:[MZ7T_ V:@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
MIZA)J4:(=-M+6X?)W"XN6A XXP0CYY^G]*6MQZ% W7BG>H&CZ3MW?,?[4DR!
MQR!Y')Z\?Y#$6[&;6)-_V^PLH, ;?(O'ER><YS&N.WKGVJE;J2^;H:%24% !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MK)/9+_VZ7YVU[Z=C%\.:YK]G<K?W+VEU#.E@MU*482.9"54*,D C<"22<XX
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M= 1GFLZ=W*26[Y5_Z4_TVZNW8J=O=OT4G]R7^>_17[D5[XE\3O.^F69TS[1
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M6]DAN8FMP/.7[,9 "JS.%_[Z;L>.E*5E!RW]V6GFFE^OY_*]5**75QU\G?\
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M]/,A7<E'N[>6J3_7Y[Z;%ZW\3^(KV4(D6FVD=W>-;VDLJNY4(C,WF)N7)^4
M ,.Y]J$M-=U=_)-+_@@I=;:>[][5_N_708/&UY-);636]H;B]B2:)2"5:(*_
MFGK\P!CX_P!]<^\2LX2?9-M>5E;\79^C+2:DE?K;YJ5G^&J,]/'>M6<#W3:?
M8?V5;E8%BA5A(S?91-QSA5'3&#P>V.=JD;2:;U;E;Y2M=_UY^F=!<\8VTTB_
MOLK+[_T\SI?"6OZAJ]YJEI?RZ=,]BT:B2P9BIW*6YR3@CCC/\^)M[M_-K[K?
MU^'F)2;E;I9/[[_Y?J=14EA0 4 % 'E'@/XF^#-*\!Z)87NO00W5O:HDD;*^
M58#D<"@#HO\ A;G@+_H9+?\ [X?_ .)H S_ FMZ;X@^(?C34-*NUNK1XK!5D
M0$ D+*#UH ]%H Y_QW_R3SQ+_P!@NY_]%-0!@Z?\6/ L6FVL;^([=72)58;'
MX( _V: +/_"W/ 7_ $,EO_WP_P#\30!6^%E_:ZI!XKO[&836L^O3O'(N<,IC
MBP>: .^H * "@ H * "@"/R(?M'VCRD\_;L\S:-VW.<9],]J-@(+/3-/TTS-
M8V-O:F=_,E,,2IYC?WFP.3[FB]E;H@>KN]RE;:5X?U'3YI8-+L9;74/WDV;5
M0)SZN"/F/UI65DNFX[M2??;[BV^G:7#"Q>RM$B"HIS$H 5#E!TZ*>1Z=JJ[;
M^?X_YDI)+3M^'^10AC\/6^L&VATV&*_NW,SE+$J79#]]FVXX)X8GGL32CM:/
M3]=/QU^7D$K7][K^FOX:>C\RP-%T3_2;/^R+39<+NG7[(-DH)).XXPQSDXZ]
M^]*RM;L4V[W_ *Z?U_PQ)-HNGR:=+8I:Q00R0?9L11JNV/GY1Q@#D\=*J[;O
MZ/[A1]W;H1:U'H@M4EUJWM9HK;]XGGPB4IT&Y1@GN!D>M+=^;T^_3\1?#'R6
MOW:_@6H]+T^$*(K"V0*XD7;$HPP7:&''7;QGTXIMM[_U??[P2LK+^K;%25=#
M\-6SSK:6]FLK;2MM;?/*V2=H5!N<Y+' !/)J6].7\/Z\BM?B)M(;2Y[-;K2H
MHDA=0GR1>60$^4*5P"-O(VD<=*N2?7KK_P $GK?K_7^=_F.@T32;:-HX-,LX
MD9Q(52!5!8'<&P!U!Y!]:2;5K=/\K?EIZ#:NVWU&_P!@Z.([R/\ LFRV7IS<
MK]G3$Y_V^/F_&E:R2Z(.M^IG:OX.TS6([>%_]&M82Q\B"&$*^[AN2A9<C(RA
M4\GFG%N,N;^M[_G\@^SRK0UCIFGA,&QMRH+MCR@>6^^>G4Y.?7-2[6U_I MU
M;^NGY:$5M:Z5?:99F&SMWLEC!MT, "HI7'"D?+\I(Q@<$BKE>[YMP7NZ+I^:
M,R]F\.6.NVR2HL%Z)%D+Q6IV[BAC3S)%7"\,0NXC/04H-MNWG][LWZO;^K ]
M%_6R_2_];EQ++0/$%O<3G3[.\BG<Q3&6V!\QHF*X;<.=K XS^%*UDOO^];_<
M.[3:ZK3_ (!)J>@:?J\%I;W<"O;6LHD6':IC;Y67:RD$%<,>/I1]KF81?+%Q
M6FWX-/\ 0BOK#P_%<V#7NG69F9A;6K-;*Q4X+!5./E'RD]AQ33;EIO\ Y"M[
MODOUT_4F;P[HC)=HVC6!6\.;D&V3$Q]7X^;\:FRMR] OK?J03'0+GPZ%GMK:
M71P1$(7M\Q\/L V$= W'2FW=IO=V:^>PHZ)J/2_X;EM-&TN*-XX]-M$1UVLJ
MP* PW%L$8Y&XD_4DT[O^O+;[AO56_K7<H>(;K0;::Q_MFQ^US;R]JJV#W3JR
M\EE"(Q7''/%2G:6F]OP&U>.NQ+;-H6O647E6D-S;2,9P)+4[1(&Y)#+\KANQ
MPV0?2JY;?+]>W_ _45^G]:6W_"WX$L<&C0:C'916EM'=)#YB*L &U  G!Q@<
M87'I[4OBYOQ^?^=OP!NS5_E\O^'_ !?F$>AZ&;A9X]+L#/ JQ*ZP)NC"\JH.
M,@#C [4[MW??\>G_  !63T[?\/\ \$S=6DT;1]5TJ6Z^UAH(I%L[2TLGF1
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M@(ZKZ8SC(IKI/Y_\'U[?+R)T7-%>G_ _->6NS-4Z=8M.\QLH#*^[<YB&YL@
MY..X50?8#TI-75NA5V91\)V+>(8=7,CAH%58H%BB1$P"!\RH'( )PI8@9Z=*
M:;3;ZO\ K^NHG\*BME_7]6-&6+3S?1E[:*2Z+J0PAWLK!6VDD#Y>-P!..N.]
M)>7];7_3Y!_7XZ?B(^BZ5)!)!)IEH\,J>6Z- I5ER3M(QR,DG'J32LK6_K3;
M[AWM^/X[_?U([FWT;3-.9KBVM(+..(1$>4H4(#\J  =,GA?4\4W+6[WT^_I\
MQ*-U;IK_ ,'_ ()7L[K0]6CWPVHDWRLCK+9.CHY3YMZLH*97NP&00.XIN.EN
MEOUU_'IW$M[]?Z2?W:7+$7A[18(4ABT>QCBC8.B+;(%5@, @8X('&:3UW_J^
MX]OZ^?YZC+C3]#M+RWN)M/LTNI0+2*7[.I<K@_N\@9"X!XZ4;MI]=_/U!>ZE
M;:/X=-"_#9VMNY>"VBB<HL99$ .U<[5X[#)P.V33;;W$DE9+H5TT72HKFYN8
M],M$N+H;9Y5@4-*/1CC+?C2Z<O0J[O?J+<:/I=W:26ESIMK-;2,'>&2%61F&
M,$J1@G@?E1V?82]W80Z+I1N?M)TRT^T;0OF^0N[ ! &<9P 3^=#UOYAM;R&_
MV#HXN1<C2;+[0%"B7[.FX # &<9P 2!0];WZ@M+)=":+3[>"\^TQ($(A6!54
M *J@D@  >_Z<4[[ON*R2273_ ('^1G7OA+0[R&9!IUO;O/()))8(45W(=7.3
MCG)1<YZXI+2RZ+IT+YGKYJWX6%D\)Z))>64[:?;^791-%#;^2GDIEE;<%QP0
M4&"/>J4FFWUT_"_^9+U5G_5R]=:3IM[9R6=WI]K/;2-O>&6%61FSG)4C!.><
MU-MO(=VAYT^R:6*4V<!DBC,4;&,91#C*@]@<#CVH>M[]=_,2TM;H1G2; 1%(
MK."'YMZLD*95]NP,,C&0O&?3CI1*\MWW_'?[PC:.WE^&Q3\/^&[3P[#,EM))
M*\Q!=W2-,XS@!8U50.3T7N<T[Z<O]=OT0K>]S?UU_P V;-(84 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % 'EWB&3Q&?$=[+IZZE$I2XA,44=TRX\AS&
MZL7\K)<+@(F0>IYP5"_)+^K/F7?RU[?<:JWM(7V37W=;_P#!UZ[#[BSU[3XF
MM'N=?NK$212330N[7#,T39VGLOF!,J/E'<;<U4M>9+HVE_Y+:_=?%OH<\.;2
M_5*_WRO;SV\[>;-2#3=5N/ OAK3Q/J.GW!>);EX?DF1=K%MV!@<X!XQS]*<K
M*K%K9?=HMBOL3[M_/66_W'.W5OK5]=:JD\6K?8IH'>2!%O/W<B31D!79SN)7
M<1Y2JIZ<XX5/X$WW@_Q=_/3S]58=1.[4>TE^&GEK_P !FA-INI-JFJ:JAU&.
M:"TG:WDEGF1/EF#(IR<8('0CI41E[.+G+^ZWYZRO^%O2_F#CSU(QCM9KTO&"
M_._S7=""'Q'JEM92?:M5MAJ1AGD:!V_<))*Y* \A=J%0?3K5\G+4Y)=-_/W9
M7^5_T\B'/FI\\5OM]\$OPN_O\S.U:7Q!9:8AN)M=B$!:*UDA=@#BX=29V;J#
M&(\$\G/R\FJBTZD+[OEOVZ7^=]_\KCJKEIS2Z<WKMI\M_P#A[&_X]TJ>\OO,
MMHKYI9-.FA1H!(Z*WF1D9497.-Q&X<X]A6<5[S6VL/N4G?[M/QZ7"I\&U[*7
MXQT\]?ZUL9>J6GB2V,EC%?:J-.M[J0+<&&XN9I"8XF3_ %3HQ7<9.<[ 1@C
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MX/;??4U:C*6O>WRM_GU$AO-;?Q)JDMFNKW<MO<S*87D*VIA$)(12. _F;?\
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MHWU!X-)I/<:;6PZUM;>RMH[:T@CM[>(;4BB0*JCT ' JFVW=DI);$M(84 %
M!0 V...&,1Q(J(.BJ, 4 .H * "@ H CEMX9FC:6))#$V^,LH.QL$9'H<$C/
MO1MJ'2Q)0 4 % !0 4 0P6EM:M*UO;Q0F9S)(8T"[V/5CCJ?>C96#K<FH *
M"@ H * "@ H * "@ H * "@ H CB@A@W^3$D?F,7?:H&YCU)]3[T;*P=;DE
M$*6EM%=2W4=O$EQ, ))50!G Z9/4XH6BL@ZW))(TEC:.1%=&&&5AD$>A%)I-
M68TVM45M/TS3])MOLVFV-O909W>7;Q+&N?7  %4VWN39(MTAA0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MOD 7^S[G.?[8O.N<;(?4''^K]L?CZ\T (-.NAC.LWIQCJD//3_IG['_OH^V
M &G70QG6;TXQU2'GI_TS]C_WT?;  #3KH8SK-Z<8ZI#ST_Z9^Q_[Z/M@ 3^S
MKK:1_;5[G&,[(<CIS_J_8_F?;  ITZZ.<:S>C.>B0\=?^F?N/^^1[Y  Z=='
M.-9O1G/1(>.O_3/W'_?(]\@ =.NCG&LWHSGHD/'7_IG[C_OD>^0 .G71SC6;
MT9ST2'CK_P!,_<?]\CWR +_9]SN!_MB\QZ;(?7/_ #S]./I[\T (-.NAC.LW
MIQCJD//3_IG['_OH^V  &G70QG6;TXQU2'GI_P!,_8_]]'VP  TZZ&,ZS>G&
M.J0\]/\ IG['_OH^V !/[.NL8_MJ]^NR'V_Z9^Q_[Z/M@ 4Z=='.-9O1G/1(
M>.O_ $S]Q_WR/?( '3KHYQK-Z,YZ)#QU_P"F?N/^^1[Y  Z=='.-9O1G/1(>
M.O\ TS]Q_P!\CWR !TZZ.<:S>C.>B0\=?^F?N/\ OD>^0!?[/N=P/]L7F/39
M#ZY_YY^G'T]^: $&G70QG6;TXQU2'GI_TS]C_P!]'VP  TZZ&,ZS>G&.J0\]
M/^F?L?\ OH^V  &G70QG6;TXQU2'GI_TS]C_ -]'VP )_9UUC']M7OUV0^W_
M $S]C_WT?;  ITZZ.<:S>C.>B0\=?^F?N/\ OD>^0 .G71SC6;T9ST2'CK_T
MS]Q_WR/?( '3KHYQK-Z,YZ)#QU_Z9^X_[Y'OD #IUT<XUF]&<]$AXZ_],_<?
M]\CWR +_ &?<[@?[8O,>FR'US_SS]./I[\T (-.NAC.LWIQCJD//3_IG['_O
MH^V  &G70QG6;TXQU2'GI_TS]C_WT?;  #3KH8SK-Z<8ZI#ST_Z9^Q_[Z/M@
M !IUT,9UF].,=4AYZ?\ 3/V/_?1]L "?V==8Q_;5[]=D/O\ ],_<?]\CWR *
M=.NCG&LWHSGHD/'7_IG[C_OD>^0 .G71SC6;T9ST2'CK_P!,_<?]\CWR !TZ
MZ.<:S>C.>B0\=?\ IG[C_OD>^0!?[/N=Q/\ ;%YCTV0^N?\ GGZ<?3WYH 0:
M==#&=9O3C'5(>>G_ $S]C_WT?;  #3KH8SK-Z<8ZI#ST_P"F?L?^^C[8  :=
M=#&=9O3C'5(>>G_3/V/_ 'T?;  #3KH8SK-Z<8ZI#ST_Z9^Q_P"^C[8 $_LZ
MZQC^VKWZ[(??_IG[C_OD>^0!3IUT<XUF]&<]$AXZ_P#3/W'_ 'R/?( '3KHY
MQK-Z,YZ)#QU_Z9^X_P"^1[Y  Z=='.-9O1G/1(>.O_3/W'_?(]\@"_V?<[B?
M[8O,>FR'US_SS]./I[\T (-.NAC.LWIQCJD//3_IG['_ +Z/M@ !IUT,9UF]
M.,=4AYZ?],_8_P#?1]L  -.NAC.LWIQCJD//3_IG['_OH^V  &G70QG6;TXQ
MU2'GI_TS]C_WT?;  G]G76,?VU>_79#[_P#3/W'_ 'R/?( ITZZ.<:S>C.>B
M0\=?^F?N/^^1[Y  Z=='.-9O1G/1(>.O_3/W'_?(]\@ =.NCG&LWHSGHD/'7
M_IG[C_OD>^0!?[/N<Y_MB\Z@XV0^I./]7[X_#UYH 0:==#&=9O3C'5(>>G_3
M/V/_ 'T?;  #3KH8SK-Z<8ZI#ST_Z9^Q_P"^C[8  :==#&=9O3C'5(>>G_3/
MV/\ WT?;  #3KH8SK-Z<8ZI#ST_Z9^Q_[Z/M@ EM;2>WDW2:C<7(V[=LJQ@9
MS][Y5!S^GM0!;H * "@ H @EO+6"X@MYKF*.>X)$,;N TA R=HZG YXH6KL@
MV5R>@"![VTBFBADNH4EE<QQHS@%V R5 [G )QZ4+78-B>@".>>&UMY)[B5(H
M8U+/([!54#J23T% TFW9#U974,I!4C((Z&AJV@D[ZH6@"**ZMYY9HH9XY)(&
MV2JC@F-L X8#H<$'GUHZ7#9V*UOK6E7=S<VUMJ=I-/:_Z^..=6:+_> .5_&B
M_N\W3N.UGR]2U!/#<P1SV\J2PR*&21&#*P/0@CJ*;3B[,E-/5$E(8C,J*68A
M5 R23@ 4;  ((!!R#T(HV 6@!CRQQ%!)(J%VVH&.-QZX'J>#1Y!YA)+'"%,L
MBH&8*"QQDGH/K1Y!MJ/H R]2\2Z#H]PMOJFMZ?8S,N\1W-TD;%?7#$<<&E=;
M#LTKEFSU33]1.+&_MKD[%D_<RJ_R-G:W!Z'!P>^#5--$W1-%<P3O*D,T<C0O
MLD","4; .#CH<$''N*72X^MB6@ H * (6O+6.:.%[F)99'*(A< LP&2 .YP,
MX]*%KL#T)J "@ H * "@"":\M;:T>ZGN8HK:,$O*[A44#KDG@4=O/]0)QR,B
M@-PH * "@ H BEN8+=XDFFCC:9]D8=@"[8)P/4X!./:A:Z(.ER1F5%+,0J@9
M))P *-@ $$ @Y!Z$4; 1RW5O#-##+/''+.2L2,X#2$#)"COP">*%KH@VU&/J
M%E%?16,EW EY*I>.!I )'4=2%ZD"A:WMT!Z6N6* "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M_%3M);Q+?[XS*&D^PX!_TE!&02F#^Y8]/?/(.&DG:^GP_KS?I^@2=GIM9O\
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MML.Y<C.#ZBCS#I8=0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MC)K3KZ7_ ,M?^ 94TYN45\O6W^?_  =3$@\4:[*D<IU-DOKD++:Z:88P989
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M/^._^2>>)?\ L%W/_HIJ .?^"7_)(="_[;_^CY* /0* $9@JECP ,F@"'[9
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M%@X:+<48;T?:PZC*,RG\"13:M9DJ2=UV-2I*"@#BOBS_ ,DWU#_KO:_^E,=
M':T % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!S_
M ([_ .2>>)?^P7<_^BFH Y_X)?\ )(="_P"V_P#Z/DH ] H 9+_J7Y ^4]:
M*MM:PR6N'A7)+#)49')]J (AE=.N8B!A2P&1GN>.G].] $TEI"UF<1*C[,Y*
MC(.._'N: )K5BULN0002,'M@XH \Z\2YU/XZ>$-./,>G6<]\P_W@4'_CR"@#
MT:Y_X]V_#^= %&Q;R$88*Y3=@KZ #/ Z?_7H -/C\NZVXQB/H5P1POL* &6
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MY7:=]U9M^NS_ *T^_50?(U*/>R7IT_K4S[^S\+Z3HUWK-WXAGOTO;691(+B
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MO\M^O3?^K#U6C5K:?A;\FOP\[R77AWP_>Z#%:6&LVES93&+SYY;Q,"*!R[%
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M6OY6+[Z7I(>2*3Q==?;[$?OYS=Q":.-PHV,-N$4[5Y 4Y&<YYI)_:Z;/S?\
MGZ6'\*M\UY6Z^?SO^"*-\GA?14D\1R:X]Q%O:X@ACN(6#LA+,L? +G.206)]
MQ2A&TE%;O];K[O>_(37/?R_2WX^ZB"70[$>(8/LNKV\%GIFR[NPVHC>C#)#2
M0A,#@XW,V,?PY -*'N:WT6G_ )+R_)[=_E=BDO:)6W>O_DW-\];]M^MD:5[?
M:+K.CC59;FZGM]'N&C\Z,Q_OF:/RRW'RD$29XQ].U$E=:Z<]X^EY6_-?<$9V
MNEKRV?W+F-".#0;C3M+$6JQ26VE8EBD2X0@A4:++'ICD],<C\*N;<Y.3Z_\
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M^!>L?!6HV'B2VN(WM&T^"_:\WF1_.^:W\HI@@]" <ECD?3FXSMOVDOOES?\
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MS_H8?_).?_XB@ _X7;\//^AA_P#).?\ ^(H /^%V_#S_ *&'_P DY_\ XB@
M_P"%V_#S_H8?_).?_P"(H /^%V_#S_H8?_).?_XB@ _X7;\//^AA_P#).?\
M^(H /^%V_#S_ *&'_P DY_\ XB@ _P"%V_#S_H8?_).?_P"(H /^%V_#S_H8
M?_).?_XB@ _X7;\//^AA_P#).?\ ^(H /^%V_#S_ *&'_P DY_\ XB@ _P"%
MV_#S_H8?_).?_P"(H /^%V_#S_H8?_).?_XB@ _X7;\//^AA_P#).?\ ^(H
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M2+E2Y]21'R: )O\ A9_A3_G[O?\ P5W7_P ;H /^%G^%/^?N]_\ !7=?_&Z
M#_A9_A3_ )^[W_P5W7_QN@ _X6?X4_Y^[W_P5W7_ ,;H /\ A9_A3_G[O?\
MP5W7_P ;H AN?B)X*O8Q%=/<3QA@P672+E@".AP8^M $W_"S_"G_ #]WO_@K
MNO\ XW0 ?\+/\*?\_=[_ ."NZ_\ C= !_P +/\*?\_=[_P""NZ_^-T '_"S_
M  I_S]WO_@KNO_C= &EHGC+1/$-X]IIL]Q),D9D(DLYH1M! ZN@'4CC.: -Z
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M_?)]L@ -1NCC.C7HSCJ\/'3_ *:>Y_[Y/MD !J-T<9T:]&<=7AXZ?]-/<_\
M?)]L@"?VC=;2?[%O<XSC?#GMQ_K/<_D?;( IU&Z&<:->G&>CP\]?^FGL/^^A
M[X  ZC=#.-&O3C/1X>>O_33V'_?0]\  =1NAG&C7IQGH\//7_II[#_OH>^
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MT_Z:>Y_[Y/MD !J-T<9T:]&<=7AXZ?\ 33W/_?)]L@"?VC=8S_8M[]-\/O\
M]-/8?]]#WP *=1NAG&C7IQGH\//7_II[#_OH>^  .HW0SC1KTXST>'GK_P!-
M/8?]]#WP !U&Z&<:->G&>CP\]?\ II[#_OH>^ !?[0N<X_L>\Z@9WP^I&?\
M6>V?Q]>* $&HW1QG1KT9QU>'CI_TT]S_ -\GVR  U&Z.,Z->C..KP\=/^FGN
M?^^3[9  :C='&=&O1G'5X>.G_33W/_?)]L@ -1NCC.C7HSCJ\/'3_II[G_OD
M^V0"6UNYYY-LFG7%L-N[=*T9&<_=^5B<_I[T 6Z "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M:/,.MA] !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MJL$*W]_/88A6687*PNX'G;S^[V8/S1_= [>G&;U7W_\ I.GX_P!6*NE'3?\
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M]X C1 *EXT95/..\,/-?<?+/4LW;!R!AJU]?ZTEZ=>7_ #W9#NHZ;_\ [/\
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MH BE\?BTN;&*_P#"^N627MU':1S31P;!)(VU<[92<?A0!V% !0 4 % !0 4
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MBMHYPMLR8E6W +1OAOD"Q2'*8*X"-UY!ZAR>M_.WW7_!^[^.Q$-EZ)_DK?\
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MU'_L"VW_ */GH ZN@#BOB1_Q[>&?^QAL?_1E ':T % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M3_&@#D?'NM:5?IX9AL]3M+F7_A(+$[(IU=L>9UP#0!Z'0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0!QU[XVN[34Y[<:1$UO$[@RF[P2J.BN=NSK^\4@9YYY'&5!IQ4GI
MK;[VTOQ6OEWV')<J=NG_ ,CS?E^)2E\;7=SJ$=G'%' WG0%9()O-22*210"=
M\:D$KGIQSU/:Z<;R2?G?Y)/]?^ )M)M>7Z2_5'?5($%I:06-L+>V39$"S!<D
M\DDGK[DT=$NVGW:"2M?[_OU$OK&WU&U:VNE9X6(+*KLN<'.#@C(XY'0]#Q0M
M&GV'T:+!'&*'J&Q1TW2+/25E%JLNZ9M\CS3O,['&!EG). .@S@4;*P;NY>H
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M,TBST>&2*S20>8^^1Y9GF=VP!EG<ECP .3T%5>Z2#K<O4@"@ H * "@ H *
M"@ H * "@ H KVMC;V33M C!KB0RR%G9BS' ZDGC   Z #BC9) ]7<L4 5[N
MQM[Y8EN$9UBD655#LHW+R,@'D \X.1D#TH6CN'1KN6* "@#+U+PUH.L7"W&J
M:)I]].J[%DN;5)&"Y)P"P)QDGCWH I_\()X/_P"A4T;_ , (O_B: )(/!?A6
MUN(KBW\-:3#/$P>.2.QC5D8'(((7((/>@#<H * "@ H * "@ H * "@ H *
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MH1S)*_I^/]:]NIO4B@H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H S(="MH-9;5$>4SL)!M)&WY_
M+SVS_P LE[]S^#3<8\J_K5O]6'^=_P +&#9> [=;&19II;2>XFGDN%LY0RND
MK M$2ZY*X51D!3QP11%\JBELDOPU_![>6XV[RDUU>GE_P^[\W\RS9^!=.L1J
M7DWE_F_B\EBTP;RDRQ 0$8&-Q]??-2E:/*O+\-@TO?U_'?\ K_@6CD^'ND3:
M=/9W$L\XGY9Y5B8[MV_.TILZ]BN/:BRZ?UO_ /),7K_6W_R*+TGA+3I-,M[
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M31R<GU=_P:MZ:E>R\ 1R>'=/L=1N[B*ZM+B6Y62UN"2'D+9R[+EN'()P,Y/
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M:.-KV\::=4??N0)M49*C!)^<XP 6(YIII14?7[V[_@M/T[3)7ES>B^27^?\
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M7?,_+\+K]2*Q\$V5AJB:C'?WSW".K*7:/&T;\+PG(Q(PR?FZ<T1;BK+^MO\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * /@"@ H ]@_9Q_Y*'J'_8+D_\ 1L5 'T_0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0!X_P# #_D$^)/^PHW_ *"* /8* "@ H *
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M;^Y7*FDA]-\1WFCK/<3VWV:.YC-Q,TKJQ9U8;F).#@'&>.<8%4G>+\G^#7_
M8FK6?>_X6_S_  )_%33C1#';Q7DK2S11LMF66787&[# @KQGYLC'J*G>23_K
M1O\ ,=[)O^M=/PW&^&7L_LEQ!;1ZA!+#+B>#4+EYY8V(! W,[\$8(VL1^M6]
M4FMOZ_K_ (!*T>H[Q1%9_P!BS7=Z]X([53(%M+R6W9SCA<QLI.3@8/K6<K_9
MWV7JRXVZ[=?D2>&M-N-*T"UM;NYGN+D+OE>:9I2&)R5#,22!G R>@K6=KV6R
M_'S^9G&[U?7\/(UJ@H* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@#S^3Q7:I\0T3^W(-OVC^S3I_P!J7=DIN\WR
M\YSOPF<=*=+WK];W^5ORT4G]PJON^5K?._Y[Q]-3T"D,\S>[TU]0U<7MYKZ:
MA]ODAMFAGO$@#<>6@((@'/&#QZU$.9TUR?%KOZOOY#;2F^?96_)=O,]$T];I
M=.M5OF5KL1*)F0<%\?-C\<UM/EYGR[&<.917-N87B6;5H=3T3[-<1P6#7L:3
M!<F27.[Y?0+P#WSTX[Q#^(D_/\F_Z^\J>E-M;Z?^E(Z6@84 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!Y5_P *$\/_ /0P>(O_
M  ,3_P"-T >?_"OX9:7XNL-8FO-4U6V-I>F!1:3J@8 #ELJ<F@#V#P?\,M+\
M%ZM+J-EJFJW4DD!@*7DZN@!93D *.?E'YF@#M: "@ H * / /^&9?^IN_P#*
M=_\ ;: #_AF7_J;O_*=_]MH Z_X<?!__ (5]XAN-5_MW[?YUJUOY?V7RL996
MSG>W]SICO0!ZA0 4 9^M:9_:^F/9^=Y6YXWW;=WW7#=,CKC%&TD^SN/HUW37
MWJQH4",+4M'U677$U32M2M+5Q;^0Z7-FTX(W;LC;(F/UI)--^=OPO_F#L[>5
M_P ;?Y&Q;K.MM&MS)').%&]XT**Q[D*22![9/UJG:^@EYE.'25CUN_U!I ZW
M<,4)B*< )O[YYSO].U+3D<'U=_P2_0?VE)=%;\;B:%I1T33%T];@S01,P@W+
M@QQYRJ=>=HX!] *;;:5]_P _ZZ^8K6;:Z_U^8FIZ7-=7$-[8W0M;^%&1)'C\
MQ&5L95E!!(R >"#QUZU.JO;K_7^?WE:=3)\-Z9=Z3KE]%?ZA_:-S-!&_GM&4
M*J"P"#YC\H))&23R<DU:=XM=G^:_X']=9E?F3\G^#_6_]+1=34C"@ H * "@
M H * "@ H P9?#]U<7>RXU/SM,%P+E;=XB90X;>!YA;[@8 A=N>,9QQ3B^6S
MZK;\5K]_^=PEK>W7?^O/J;Q&1@]*EJZLPV.?TSPT]A=6OF7BS6-AN%C (=K1
M;ACYGR=V 2!@+P><GFJ3:U>]K?+3\=%?\@E[S^=_GK^&O_!.@I 9^GZ7]AU'
M5+OSM_VZ99=NW&S$:IC.>?NY[=::TBH^OXCD[M/RM^+_ ,R75-.BU73+BQF9
MECF3;N3AE/8CW!P:GJFNC3^X%;9[%72]*N+2[N+Z_NX[J^G58S)'#Y2A%)*@
M*68Y^8DG/)[#I57LK+U_KR)UOZ?U]_\ D6-3LY[VT"6MX]I.CK(DBC(R#T9<
MC<IZ$9'U'6IUNFAZ6LR+2=,DL/M,]U<+<7MVXDFD2/RT)"A0%7)(  [DGKS5
M:)60M6[L=K&F'5;2*W\\PJMQ%,WRYW!'#;>HZXQ1'22EV_R:_P""-WY6EU_K
M\M#0I % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 AS@X.#VI.]M 1A'PT#X2.BM=DS%2WVK9SYV[?YFW/]_P";
M&?QJF]8M?9M;Y?YK<:WE?K?\3=4$* QR<<D#&:3)6BU,;_A&[>32]5T^ZD,L
M.H322M@;2F['0YZC&0:FS4%%/5;/SNW^!2=IN7?I\DOQL:5A#/;:?;P75Q]I
MGCC"O-LV^80/O8R<9^M:2:;NE8F*Y58@U33?[2^Q?OO+^S7*7'W<[MN>.O'7
MK4K22EVO^*:_4;UBX][?@T_T+] !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0!Q_@#P+_P (-::E!_:/VW[;=&XSY/E[,C&/
1O'/UH ["@ H * "@ H __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>124
<FILENAME>g20922g23q22.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g23q22.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /W\H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MK\M::=K6:TMUOVL?T"FFE*+3BU=-/2VZ::Z>9C_\)/X:_P"AAT/_ ,&UA_\
M)%/DG_(_N8N:/\R^]!_PD_AK_H8=#_\ !M8?_)%')/\ D?W,.:/\R^]&O!/#
M<Q1SVTT4\$JAXIH)$EBD0]&CDC)5U/J"14M6TM:W0I>6Q+0!DW&O:%9S/;76
MM:3:W$1 D@N-1LX)HR5# /%),K(2I!P0."#WJE"72+MZ,7-%:<R5NET0_P#"
M3^&O^AAT/_P;6'_R11R3_D?W,7-'^9?>B]9:GINHB3^SM0L;\0;!+]BNX+H0
M[]VP2>1(WE[MCXSC.TXZ&DXN.Z<>UU8::>S3MV+U(84 % !0 4 % !0 4 %
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M?5-;%ZH-0H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MG_L3]#_](8J_&LY_Y&V8_P#815_]*9_3_"__ "3N2_\ 8'0_](1ZA7F'NA0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M\D_H]_X))_\ )LOB/_LL7BC_ -13P+7R.>_[Y#_KU'_TJ9]'E'^ZR_Z^2_\
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M_)<? ?\ U\:W_P"HSK5>'Q)_R),=Z4__ $]3/K.!O^2JRG_%7_\ 4:L>;_\
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M*^H_^@"O5R/_ )&^7_\ 7Z'YGS_%?_)-YS_V"U/R/Q:K]C/YC/=_V9?^2X^
M_P#KXUO_ -1G6J\/B3_D28[TI_\ IZF?6<#?\E5E/^*O_P"HU8\W_P""R/\
MR$_V?/\ KQ^)W_I1X"KXCA_X<5ZT_P#V\_=,YWP_I/\ ]M/Q.KZ,\0_H]_X)
M)_\ )LOB/_LL7BC_ -13P+7R.>_[Y#_KU'_TJ9]'E'^ZR_Z^2_\ 28GZA5XI
MZ@4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M_98O%'_J*>!:^1SW_?(?]>H_^E3/H\H_W67_ %\E_P"DQ/U"KQ3U H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!Y/\=/\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M[@4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M7#3MSON?JOA?CJ\<9F&6ZRPTJ'UE;VA4A4ITM.B]I&IKW]FNS/T8K\]/V<*
M"@ H * "@ H * "@ H * "@#^,;XP_\ )6_BE_V4;QO_ .I-J=?H6'_@4/\
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M37-3E.#2IN*24G963LTT?E5\9-5;6?BM\0KXR-(I\6ZU:0NVX$VNFWLNFVF
M_*J+6TA ! (  P,8'ZAD])4,KR^FERVH4Y-><XJ<MO.3/P'B6N\3Q!G%6]U]
M;K0B_P"[3FZ<-]5[L%9=$=-^SEX7TSQ;\7O"VF:Q;)>:;;'4-6N+24*T-P^E
M:?<7=G%.CY$L'VY+8O&0P=%9&&UCCFXAQ-3!Y3B:E&7)4ERTXR6ZYY*,FK;/
MEO9]'JM4=W!> H9AQ'@*&)@JE"'M*LH.UI.E3E."DGHX\ZCS1LU))IZ-G[&
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M[7/F7^XXG_ _S1M@?][H?XD?TE_M>?\ )KWQ\_[)7XQ_],]S7R& _P!]PO\
MU\A^9])C/]UK_P""7Y'\AE?>GR)^]/\ P1U_Y$CXV_\ 8U>$?_31J]?+Y_\
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M._QM_P"Q5\(_^G?5J^>S_P#AX;_%+\D>SD_QU_\ #'\V?O37S![Q_%Q\3?\
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M1_V(_C3_ -(K:O(SK_<9?XX?F>CE?^]Q_P ,OR/</^"PW_)2?@[_ -B/KO\
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MT-7^%4_PR_)GQ>'_ -XH?]?(?^E(_7[]I#_DB7C[_L'Z?_Z?-+K\EX=_Y'6
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M\T;8'_>Z'^)'])?[7G_)KWQ\_P"R5^,?_3/<U\A@/]]PO_7R'YGTF,_W6O\
MX)?D?R&5]Z?(G[T_\$=?^1(^-O\ V-7A'_TT:O7R^?\ \3#?X9?FCWLG_AU_
M\4?R9^Q&J?\ (,U'_KQN_P#TGDKP(_%'U1[#V?H?Q'5^CGQ)^DW_  2I_P"3
MJ8_^R<^,/_1VC5X^=_[C_P!Q(?J>EE7^]?\ ;DOT/Z6:^//I3^2C]MW_ ).P
M^.G_ &/%U_Z1V5?=9;_N.&_P+\V?)8W_ 'NO_B9A_LA_\G0_ /\ [*IX._\
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M](K:O(SK_<9?XX?F>CE?^]Q_PR_(]P_X+#?\E)^#O_8CZ[_Z?DKFR#^#B/\
M''_TDWSC^+1_PO\ ,_'>OH#QS^SGX/?\DC^%O_9.?!'_ *C.F5^>XC^/7_Z^
M3_\ 2F?9T?X-+_!'_P!)1U7B?_D6O$/_ & ]6_\ 2"XK.'QP]5^94OAEZ/\
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M .)F'^R'_P G0_ /_LJG@[_T\6U5C_\ <L5_U[G^0L'_ +UA_P#''\S^A/\
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M7,_)):)'[]PUP[AN',#]7I/VN)K<LL16V]I-)I**^S3A=J$=]6WJV>B^(?\
MD :Y_P!@?4__ $BGKS\/_'H?]?(?^E(]G&?[GBO^O-7_ -(D?@U7[D?R8?9_
M[$W_ "/WBO\ [$]O_3UI=?'<9_[AA?\ L(_]QS/TSPO_ .1OF'_8&_\ T]2/
MTNK\X/W \@^/W_)&_B%_V+\W_H^"O7R'_D<9?_U]7Y,^<XN_Y)K./^P=_P#I
M43\8:_83^9C[<_9'^'G@KQQIWC>7Q9X<T[79--O="CL6ODD<VR7$&IM.L>R1
M<!VAB)SG[@KXOBO,,9@JF"6$Q$Z"G&JY*-M>5PM>Z>UV?J/AWDV5YI1S2688
M*GBW0G05-S3?*I1JN25FM^57]#["_P"% _!O_HGOA_\ [\S_ /Q^ODO[>SC_
M *#ZOWK_ "/TC_5#AK_H3X?[I?\ R0?\*!^#?_1/?#__ 'YG_P#C]']O9Q_T
M'U?O7^0?ZH<-?]"?#_=+_P"2'1_ 7X/0R1RQ?#_0$DB=9(W$,X*.C!D8?O\
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M1_@TO\$?_24?%U?XE3_%+\V?5'_!.#_D\_X-?]U#_P#54^.:XLW_ .1?B/\
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MC_W',_3/"_\ Y&^8?]@;_P#3U(_2ZOS@_<#RGXY6LEY\(/B)#$"63PKJ=T<
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M4V_M>1XM#Q.QM>O1H1R>DY5IP@DJT[WG)15O<WN]#ZK^/6F3ZM\'?B#9V_\
MK$\/3ZA@ L3'H\L.KS* .2S0V,@'N17R^158T,WR^<M%[50^=1.FON<D?H'%
MM"6(X;SBE#>.'E4^5%QK-?.,&C\7Z_8C^93]%OV(-1MWT'QWI&]1=6VKZ5J)
MBSAS;WME/:JX!/S*LE@P.!\I9<_>%?GO&E.4:^!JV]V5.<$^EXR3M]TOZL?L
M_A;6@\)FV&NE4IUJ52W7EG"44_1.FT^UU?='W/7Q)^JGY$_M+Z_-<_&OQH-.
MU&Z6VM)='L"(+J9(EN;'0=+MKV-4C<!6CNXYXV']Z-LU^L<-T%#)L'[2FN:2
MJ2UBKVE5FX[KK%IKR9_.O&^+E/B?,_8UI*%-T:=HR:7-"A2C-63M[LU)/S3.
M0^#MQJU_\5OAS:C4+^0?\)GX=N)$:ZN'5H;+5+:\G5E+D%##;R9!&,9S77F\
M:5+*\PE[.,;8>JD^5+64'%=.[1YW#<\16X@R6G[:HU]=P\FN>5N6%6,Y75]K
M1=_(_2;]J/\ Y(3XY_[EG_U,?#]?G7#/_(\P/_<;_P!1ZI^V<>?\DIFO_<M_
MZF8<_(&OUH_G(_2;]B/_ )$OQE_V-%O_ .FJVK\ZXT_WS!_]>7_Z6S]M\+O^
M19F7_85'_P!-1.0\6_M@^,_#/BKQ+X=7PCX;E30-?UC1DEEFU1994TO4;BR2
M60+< !W6 ,< #+<#%=>$X1P>(PN&Q'UNM'V]*G4LE"RYX*5EITO8\W,/$?,\
M#F&.P2R[#26$Q%:BFY5;M4JDH)NTDKOEN;?PQ_:S\0^-?'GAKPIK'ASP_IFG
MZ[?/827MI-J#7$4TEK<-9+$)YV0M+>K;Q?,#Q*<<XK#,N%</@L#B<51Q%6I4
MH14E&2A:RDN:]E?2-W\CJR+Q"QF9YM@<OQ."P]"CBINFYPE4YE)QER)<TFO>
MFHQU77N?==?$'ZN?&O[9WAS0KCP'I'B>=+>#7]-UVSTJPN@B"YO;*^@OIKC2
MVDX9XHS UV@.X1F&;:!YSD_8<'8BO#'5<+%N5"=*4Y1N[1E!Q2G;9-WY'M>Z
MO\*/S3Q,P6$GE.&QTE&&,H5X4J<K+FG"<:DI4F]VH\OM([\O+*R7,S\S*_2#
M\./UD_9(FFD^"^DQREBEOK6OPVX.0%A:_:X8+G^'SYYSQQECWS7Y7Q6E'.*M
MM'*G2;]>6WY)']">'<I/AG#IO2G6Q$8^2]HY:?\ ;TI/U/S8^*=E)IWQ+^(%
ME(=S0>,_$H#%2F^-M8NY(9-I)V[XG1L9/WNIZG]&RN:J9;@)K1/#T=/-4XIK
MY-6/Q+/Z3H9YG%*6\,9B;.UM/;3<7;I=-,]._95OK:Q^-7AL7,J0B]L];L(&
MD<(IN9M)NG@B!/'F2/%Y:KD;F=5&20#YG%%.4\FQ'*F_9RIR:7932;]%>[[)
M'N< 584>)\"IR4?:0KTXMNWO.E)Q7K)JR75M):NQ^N5?E!_1)X/\>?C)+\'=
M&T*_M-+LM8O=:U.>S2PN[R6S(M;6T::YNXC%%(7$4SV<;#  ^U+SR*]S(LG6
M;5J].=65"%""DY1BG[SE:,7=JUTI-?X6?)\6<2RX:PV$JTJ$,35Q-64%3G-P
M]R$.:4U9._*W"+_Q(^8?^&X-?_Z$'1__  =7O_R%7TW^I5#_ *#ZG_@N/_R1
M\)_Q%/&?]"BC_P"#I_\ R!ZCI_[2GB^^L+&^3P!9[+RSMKM-NIW)7;<0I,NT
MFW!*X<8.!7EU.',)2J3I_7I)TY./P+[+MW\CWJ/&^8U:-*JLHA:I",U:K*UI
M137V?,_F+^,/_)6_BE_V4;QO_P"I-J=>IA_X%#_KW#_TE'K5OXU7_'+_ -*9
M[%^Q%_R=A\"_^QXM?_2.]KGS+_<<3_@?YHVP/^]T/\2/Z2_VO/\ DU[X^?\
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M$;P9>_#_ ,:^(/"EY',JZ7J$Z6$TRE3>Z3)(TFF7RG #K-9M$Q*Y"OO0_,A
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M87+5)1D]I5ZD'",4NO)"4IR:^%^S_F/L+]J/_DA/CG_N6?\ U,?#]?(\,_\
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M  B5[XCU_P .WNC0_P!O>&-=^V6MAIVHP7<OF>&=:U%+?RY9XEVSM$S;LJ"
M2/!S?%8?%3H/#U.=0C)/W9*UVK?$E^!ZV6X>MAH555AR.35M8O9/^5L_26_B
M>:QO(8EW22VEQ%&N0N7>%T1<L0!EB!DD#UKR(Z-=+-'I/9G\M?\ P[@_;/\
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MS<;_ ,^?_)Z?_P D?:7[ _['7[1WP4_:$T[QQ\3/AU_PC/A:#PKXGTV75/\
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M<J<XQ6BU<6DKNR6O?0_)/_AESXZ_]"-_Y<W@[_YH*_5O]9LC_P"@[_RCB/\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * (%NK9KB2T2X@:ZAC266U66,W$44A98Y9
M(0V](V*L%8J =IP>*KEDHJ7*U!NR=G:ZW2>UUV(4X.;I*<74BDW!-<R3V;CN
MD[:-JSL3U)84 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M+^ZIS:T3:NDG9VV.LLKRVU"SM+^RE6>SOK:"\M)T#!9K:YB2:"50P#!7B=&
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M_'K;?]>\/_HM:^$E\4O5_F?KE/\ AP_PQ_)%BI+"@ H * "@ H * "@ H *
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MNFFA]GD>4Y;@,+AZ^"P5+#5J^'H^TG"-I3]R,O>?7WG?U/#/!O\ R>3\6/\
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M &)I_P#J-(K_ +(?_)&[+_L8-=_]'Q5?%G_(XG_UZI?DR/#G_DFJ7_817_\
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M6,82YX.TH\L_=NU9Z--IIOQ3P;_R>3\6/^R?Z;_Z0_#2O9QG_)(95_V%3_\
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MDV^R9]-Q)&EG_"V9+*Z\,6G&,X2I24XR>'JPK3@G&]Y.,'%+^9I'CWP-\2?
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M ,EB>IKISF4I9EB92DY2?L[MMMZ4H):OLM#AX6A"ED6!A3@J<(^VM&*44O\
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;104 % !0 4 % !0 4 % !0 4 % !0 4 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>125
<FILENAME>g20922g24r30.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g24r30.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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=%^J8=TWA74K89UL&Y.;A74:BG7>(7M92C*,?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>126
<FILENAME>g20922g26f32.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g26f32.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  5 %T# 2(  A$! Q$!_\0
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F/!VBQW5G<IIELL]F@CMY!$NZ)1T"G' K9HHJ;M[EQC&/PJQ__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>127
<FILENAME>g20922g29h61.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g29h61.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1  (! @0$ P0'!00$  $"=P ! @,1
M! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_  !$( %(!/@,!$0 "$0$#$0'_V@ ,
M P$  A$#$0 _ /&Z],Y H * "@ H * "@ H * "@+V/:O@KX*$LSZ[?Q$HH'
MDJR\$^O]?RK&M/ECRHF"]I-]D>\UQ':% !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'PY7IG(% !0 4 % !0 4 % !
M2'Z&_P"#_#,_BG7HK&($IP7('09_3O\ D:&U%79G-O11/KC3;"'3-.M[*!<1
MPH%''ZUY\I<SN=<(*$5%%RI+"@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@#X<KTSD"@ H * "@ H * "@-Q45G<*H
M)8G  &2:$#LD?3WPI\&KX:T$7<P/VN[4,P(P0/\ ./PQ7)6GS.R'1B[NH^IZ
M%TKG.K9&7:^(])N[I;6&]1IR<!"""3Z<BM'3DE>QA'$4V^5,U >:S-]A<T +
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M?#E>F<@4 % !0 4 % !0 4 >F_"'P2=>UA]1O$86=N 5/]\Y_P#K']:SJ3Y%
MZD<OM)<JZ;GTHH"J !@#@"N [5IH.Q0,\R\:Z.VE:M'JMFK+'*^\D=$D!S^O
M7\Z[Z%3FCRL\;%T73DIQ/-_B!!/;ZA;>+='::**XEW7"*QVP7 .?R;J/Q^E1
MR*+Y6==.K[1<\=R_XENM6^)S>']2TD2I$0;6\BBSMM9,Y9V/]TKR#_LXZU$4
MH-IF[=]CT+PQKIMM0LO#NDP(VEP?NUD<,9' !)<G..3D].].5%1AS2>IRT\5
M.=7DBO=[C/BGX^U7P/\ V3_9D%I+]L\WS/M",V-NS&-K#^\:QI04MV=LY..Q
MVND:D+W1]/N;B2))[FWCE9 <<LH/ )SC-1;L7=%N.[MI9GABN(GEC^^BN"5^
MH[46L%T$=Y:RSO!'<Q/,GWHU<%E^HI6L%T.\^'S/*\U-_P#=W#/Y46"Z0EO=
MVUTI:WN(YE4X)C<-@_A1J@NA+>\MKK=]FN8IMO#>6X;'UQ0U8=T/2>*1BL<J
M,PZA6!(HLT*Z8@N(2YC$R%QU7<,BG9A=#3>6RQ/*;B(1I]YMXP/J:5F%T/BF
MBGB$L,J21GHR,"#^(HM8::>Q'-?6EM(L<]U#%(WW5>0 GZ T)-H5TBMK5[+I
MNC75Y"%:2)-RANE7"*E))F=6;IP<ET.*A\:^);BV>YATR"6!#\SI$Y QU_BK
ML>'I+>1YBQF(DN91T.D\->)XM=MG\Q1#<Q#YT!XQZCVKFJTN1Z:G;0Q*JK71
MHW#<0HFYID"YQDL,5E:6UCHYX]Q99XH%WRRI&OJ[ "A)O8;E&.K8Y)$D4,CA
ME/0J<BDTUHP4E+9C9)HH1F65$!Z%F II-[('.,=V,N3(]G+]G<"0H=C9XSC@
MT+1ZBD[Q=F<[X,MM8MH;L:K*[993&'E$A'7/()]JWK\KMRJQQX3VB3YW?YW_
M %.B-Y;"<0FXB$IZ)O&?RK'EE:]CK]I"]KD^>*DT(A=6YE\H3QF0?PAAG\J?
M+*VQ'M(;7)12+V/G#_A0?BG_ *".D?\ ?^3_ .-UU^V.;E7</^%!^*?^@CI'
M_?\ D_\ C='M@Y5W#_A0?BG_ *".D?\ ?^3_ .-T>V#E7</^%!^*?^@CI'_?
M^3_XW1[8.5=P_P"%!^*?^@CI'_?^3_XW1[8.5=P_X4'XI_Z".D?]_P"3_P"-
MT>V#E7</^%!^*?\ H(Z1_P!_Y/\ XW1[8?*NYBWOPNU:PUR+27O[&XNBH>2.
MV=W,:D@+G*#EL\#\>!S6D:B9G/W5IN?1OA+P_!X:\/6NGPIM95!D.<DMWYKD
MJ2YI>1M1ARQN]V;HK,V"@"IJ-C%J5A-:3KF.5<'V]#^!JHR<'=$3@IQ<6>1B
MW-C+>^'M9B LKU1%.#_#_=D4^QY_"O0FE4CS1Z'BTI/#U.61P_A?5-2^'/BZ
MZT'6%,-E>$078/0*<A95/H,Y]QGOTP:YE==#TWHFNY[MX/\ #AT:VEGN$!NY
M&*[@<@(#QCZXS^517J\[LMC/"X?V4;O<\W_:&_YES_MX_P#:5*CNSHJ=CEO'
ML-Q<>*?"$%K,8;B32K)(I <%&+$ @]L&KII6;L3*]T5/%6@7WPU\:6UKI.KR
MF>>V#K<!=C .61@?R)_+N,TXM2C>P-<KL3>)=$N?A3XWTN>RU-YY/+6<R,FT
MG)*NI&>0<'\_QHBU-;":<67O$&B2^(_CQ>Z-%=M:?:I=K2KU"B$%A^(!'XU,
M6E"]AM7E9&7;>&]0T[XCW?@BQU:2&&[D%O-,G&^+ ?D>N/ZCH:KF7+>P6:=C
M8\+VEUX#^-JZ#:W9FA=Q!(2,;T= XR/49'Y>]2VI1O8:NG9FK\&O^2D>(_\
MKG)_Z-%34^%!#XF4=$_Y+]J__72\_P#0&JK+D"_O&'\-O DOCF/4H)-3DL[*
MUV,R(N[?(P8*<9QP ?S]Z<Y**6@DG)FC\-]?U+PE<^*]-#*WV6RGG"=5$\1"
M@_3U]<"B:YK,(OENAGAGP+??$?2-8\3:AK$AO$D9$#KNWN$#<GLO(  Z?A0V
MHM1!+FNS;^&/B"\O_ 7B'1[J0R1V,:/ S')"L3E?H"N1]33LO:1L957^YDCT
MCX>_\BY,".//;_T%:6)TGH9X+^"SDM'54NM?5,;!93!<>FX8K>>T#EI/6I;^
MMQWACP]=:\&_THP6ENX8<;LN<=!D=@.?I15G&"VU##4YU7=O1&H]D_BOQI>V
M=W<R);VF[:J=L$+@=NO.:BZI4E)+<TY7B*[@W:PGAB2;1?&<^CI*7MW9DP3Z
M L#]<#'XT54I4E*P8=RI5I0OH5;&QF\9Z]>F\O'18@2F!G:,X  [54G&C%61
M$(RQ51W=K&EX:@U;35U/3[NWG%H(9"CLA"AAQP3ZBLZS@[.)MA_:Q<E-.UC-
M\-75Q9>%M=GM0?-4( 1SM!R"?P&3^%:5H1YXHQP\I*C)HKZ3X;76-!N;NWG=
M]0CDXA! XXZY[]><U4ZG)/EDM":=%U:;E&7O&WJE_K.E>!XH+TNEW)+Y.XL"
MVS!/4?E6,(PG5TV.BI4JT\.N;<RI_#*V/A.#78KN07("2$#@ $\8[@C(K6-5
M.?(UH82HN%%5%+4[OPKJ$^IZ!;W5P0TQW*S 8S@D9_*N*K'DG9'IX>HZE-29
MXU7J\J['@>TGW"CE78/:3[A1RKL'M)]PHY5V#VD^X4<J[![2?<*.5=@]I/N0
MWEREG:2W$A^6-2V,]?;\:5EK=%1E.4DKG=?#+0V2 ZE<0F*9]LL@*D,TK+WS
MTV*=H';YNYKAK2MHCV*,.:6O0]*QBN4[1: "@!* \CBOB%I"2V":HAQ)!A'&
M.JD\?D3^M=>&G9\K/.QM)./.MT>/_$=?M_AO2=4GRUW#,]GO_O1A0PS[@D_G
M5M<LK$T).=)29[+\*[VXO_AIHT]U*TLNQX]S==J2,J_HH%<E16DT>C%W1Y_^
MT/\ \RY_V\?^TJTH&=4P/%?_ "/O@7_KPT__ -#-73^%DRW1;^.'_)2=)_Z\
MHO\ T;)11^$=3XD'Q_\ ^1LTS_KR_P#9VI4?A"KN7K3_ ).?;_KI)_Z2FD_X
M0_MD'_-S/_;Q_P"T*%_"8OMB:M_R<Q'_ -?,'_HA:(_PV#^,G^#7_)2?$?\
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M%.P>@4K= $Q0EI8+BXI^0!BE8 '!I@> U[9\J% !0 4 ([K&C.Y"JHR2>@%
MTFW9&UX#T"/7=2.J7,$K0$$)OR%$605X]789_P!U1ZUQUIV6AZN'I;1^\]E4
M * .@K@/32LK"T#"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M"V!@9/>J0F61WI#8M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
=!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>128
<FILENAME>g20922g32c30.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g32c30.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M]_V:TC$4>\Y; ]30!>H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M2T<G(XR>>M %.TT:[BN=+,\5R)T6PV*++>4"A ZB7I&!M8L,C()'.<4 >DT
M% !0 4 % &(-7U!-6N+6XL[*&WMXTFDG-XW$;%P#@Q@9^0Y&<=.: +J:KI3^
M1,E_:-]H^2%Q*I\S! PISSR0,#N: 'QZKITK2K'?VSM"P60+,I*$G !YX)/%
M %=O$.CK/90_VE;%[TD6^)5(DP<<'///'UH MVU_97KRI:7<$[0G;((I Q0^
MAQTZ&@#/UG7'TR^TS3[:S-U>ZA(Z1*6V(BJI9F=L' ' Z')(H +/Q%9R6C27
M\D6GRI+)"\<TR@;D;:2I[KDC!X/S#(!XH ?'XET:34-0L1J,"SZ> ;A6D V
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MY0649X''3B@!L.DZC#J$=O)ITDGFZC;7BW VE(HTMXT8,2<AMR,  #]X>K8
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M9'&2 ,NM%U&/3=*@@LHW&EWD-SA)0&N/E;S#@@!6W.2.<'';I0 7=AJ\]K?
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E '/Z9_R.VO\ _7"U_E)0!T% !0 4 % !0 4 % !0 4 % '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>129
<FILENAME>g20922g37l23.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g37l23.jpg
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M  (" P$!              @)!PH$!08# @$!                     !
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M@&="OVI4.9$$FR;P<5%$V*J[(B-(,UM%4%T=]TE4]\;:[9USC/@=GX#P'@/
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M4]L?^[11/;&<9_YXSX'V\!X$.._NJ5.+^2K;Z"%Q;$\FD<91Z+557WY>&/\
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M]1W4Y:-4,2:<HA&HP; 8$EJR;/H[0]1L=5!,*!*[J_K1N=U5-MW;IVJJ$X/
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>130
<FILENAME>g20922g38v66.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g38v66.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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@R.O&RO-'?5SG"% !0 4 % !0 4 % !0 4 % !0!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>131
<FILENAME>g20922g39h15.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g39h15.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MD'<?3L>Q'8T 7* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#D;?XCZ'J
M*%M&AU/5P"5W6=A*4R#C[[ )Z]^U $<WB3QA<2!=,\#/'&PR)M0U"*+'3JB%
MSZ^E ')^.OB%XC\$IX?&KRZ='=7-]YEQ#8AG M5P&4E^<G=U '3C.#0!3T7Q
M/:^(?C5J6MW,X.F:1Y>E6&U<YFF?8&_$B3GTQ^(![50 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'E/\ :VM^
M+O&FL1Z';Q*^E7!LX;R\0F&SV\22*O\ RTE9@0.RJHY&X@@'/^-="-O#J6D7
M^K7<RPZE8ZM+=S,/,*2*;9G!4 #8P4X'0 #WH X6?XA^,?!4UJECJ"+;WB&Y
MD@DB1T:42/%*V<9 :2)VP"/O4 3?\-!^-O33O_ <_P#Q5 !_PT'XV]-._P#
M<_\ Q5 !_P -!^-O33O_  '/_P 50 ?\-!^-O33O_ <__%4 '_#0?C;TT[_P
M'/\ \50 ?\-!^-O33O\ P'/_ ,50 ?\ #0?C;TT[_P !S_\ %4 '_#0?C;TT
M[_P'/_Q5 !_PT'XV]-._\!S_ /%4 '_#0?C;TT[_ ,!S_P#%4 '_  T'XV]-
M._\  <__ !5 !_PT'XV]-._\!S_\50 ?\-!^-O33O_ <_P#Q5 !_PT'XV]-.
M_P# <_\ Q5 !_P -!^-O33O_  '/_P 50 ?\-!^-O33O_ <__%4 '_#0?C;T
MT[_P'/\ \50 ?\-!^-O33O\ P'/_ ,50 ?\ #0?C;TT[_P !S_\ %4 '_#0?
MC;TT[_P'/_Q5 !_PT'XV]-._\!S_ /%4 '_#0?C;TT[_ ,!S_P#%4 '_  T'
MXV]-._\  <__ !5 !_PT'XV]-._\!S_\50 ?\-!^-O33O_ <_P#Q5 !_PT'X
MV]-._P# <_\ Q5 !_P -!^-O33O_  '/_P 50 ?\-!^-O33O_ <__%4 '_#0
M?C;TT[_P'/\ \50 ?\-!^-O33O\ P'/_ ,50 ?\ #0?C;TT[_P !S_\ %4 ?
M55 !0 4 07E[:Z=:27=[<16UO$-SRRN%51[DT >=^+/B=J>GPH?#?A34M00L
M UW<6DD5N![$@''(^8X7W] #SJ_^,/Q-TP&]N='T\V0;'FQ0-+;YZ8\Q'(_\
M>]/6@!?^&E-8_P"A?LO^_KT '_#2FL?]"_9?]_7H /\ AI36/^A?LO\ OZ]
M!_PTIK'_ $+]E_W]>@ _X:4UC_H7[+_OZ] !_P -*:Q_T+]E_P!_7H /^&E-
M8_Z%^R_[^O0 ?\-*:Q_T+]E_W]>@ _X:4UC_ *%^R_[^O0 ?\-*:Q_T+]E_W
M]>@ _P"&E-8_Z%^R_P"_KT '_#2FL?\ 0OV7_?UZ #_AI36/^A?LO^_KT '_
M  TIK'_0OV7_ ']>@ _X:4UC_H7[+_OZ] !_PTIK'_0OV7_?UZ #_AI36/\
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M 8W_  TEX@_Z FG?F_\ C0 ?\-)>(/\ H":=^;_XT '_  TEX@_Z FG?F_\
MC0 ?\-)>(/\ H":=^;_XT '_  TEX@_Z FG?F_\ C0 ?\-)>(/\ H":=^;_X
MT '_  TEX@_Z FG?F_\ C0 ?\-)>(/\ H":=^;_XT '_  TEX@_Z FG?F_\
MC0 ?\-)>(/\ H":=^;_XT '_  TEX@_Z FG?F_\ C0 ?\-)>(/\ H":=^;_X
MT '_  TEX@_Z FG?F_\ C0 ?\-)>(/\ H":=^;_XT '_  TEX@_Z FG?F_\
MC0 ?\-)>(/\ H":=^;_XT '_  TEX@_Z FG?F_\ C0 ?\-)>(/\ H":=^;_X
MT '_  TEX@_Z FG?F_\ C0 ?\-)>(/\ H":=^;_XT '_  TEX@_Z FG?F_\
MC0 ?\-)>(/\ H":=^;_XT '_  TEX@_Z FG?F_\ C0 ?\-)>(/\ H":=^;_X
MT '_  TEX@_Z FG?F_\ C0 ?\-)>(/\ H":=^;_XT '_  TEX@_Z FG?F_\
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MBTOKNPD:2SNIK:1T,;-#(4)4\%21V/I1NFN@;-/L5Z "@ H * "@ H * "@
MH * "@ H * "@ H ^_Z .;\8>"=,\8V4<=UOM[VW.^UO8/EF@;U4^GM_7!H
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MB%/*\K-T7V[=N=P#9_'.<]\YH X^@ H * "@ H * "@ H * "@ H * "@ H
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M[_1?_&Z #_AG'P?_ -!+6?\ O]%_\;H /^&<?!__ $$M9_[_ $7_ ,;H /\
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M !N@ _X9Q\'_ /02UG_O]%_\;H /^&<?!_\ T$M9_P"_T7_QN@ _X9Q\'_\
M02UG_O\ 1?\ QN@ _P"&<?!__02UG_O]%_\ &Z #_AG'P?\ ]!+6?^_T7_QN
M@ _X9Q\'_P#02UG_ +_1?_&Z #_AG'P?_P!!+6?^_P!%_P#&Z #_ (9Q\'_]
M!+6?^_T7_P ;H /^&<?!_P#T$M9_[_1?_&Z #_AG'P?_ -!+6?\ O]%_\;H
M/^&<?!__ $$M9_[_ $7_ ,;H ](\+>&[/PCX<M-#L))I+6UW[&G8%SN<L<D
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MBG)V1%)J%K$UHKRX-XVR'Y3\YVEOP^52>?2JY7=KL2G>/,MBS2&% !0 4 %
M!0 4 % !0!S'A/P?_P (M>ZW<?VK<WO]IW1N-LW2+V'/)]^. ..*<7RTHT^W
M]?UYW%)7J.?<@MKB33Y;S29=&N+NXFOVFC)@8P.C.&#F3:54H.Q^;Y!@=#2A
MJHKM_F]?._EU94]&Y=_\DK/MMZ6^XY4IK]SXA8M;Z@;2:>-Y8'AN62%TNHB,
M-*[*?E+',:JN,]<<51MR:_U>,KKOO9:_+<)[NWFO\OO_  ZF[>Z;*_@G04GM
MKT/;3Q.\< E#KU'*IR1R,Y&/6LII^[;^5K_R1_KH5UG_ (K_ /D]_P M3GK/
M3/$NE>&K>S@NM5$3V-G)<-)%+(T/+"1(TC*,"%" JA#8&>IYWK-.HUT3W[Z/
MMY_)>A$5:%UOK^:_2_FSI)[;6Y?A_96T=]J O9+J%#<1PM%.L1F )*LSL,)_
M?)..6YS0TG4BGMU_\!?;3?MUV$G:,FOE]Z^?]=C%U"X\1Z7I%W:06VN7;M#>
M6UJ\?F.X(E_=NS$YSLR0QY.,#)/*IOFE'F_N7^3=_P!+KKZ#E'EGIMK][4;?
MC?T+UWI6K3274WVG6E=_MA"QW,RJ-A!A"@' YSC'WNAR.*QNXQNM[7^?-_ET
M*BDVE+O%?+EU_'KNF8WV?Q5#J6KOI<>KQ7TLLDB^:N+4QF'JHX!D\P+UY].,
MUI&RC;I=_P#I>EOE?;_Y$SC>]WO96]>57O\ U^IJZ-IVMW0TN)M7UA;1;XR-
M)]GFMV*+'G8WG/(Y0MQ\Q'<+QBJC923?1/\ -6_7S[BG?;NU\M)7\NVVFW4O
MZ]!JZ^(KF33UO8UDV@R6Z$YQ;SXZX4X8IP3C.VHC\$D_/_VS_@[:[V-8V]I=
M]H_^E2O^!@-;ZQ-86]S9V^LI>6[7*6CS27,GS-$,$K(%8 D'_69 / ;&*;^*
M^VGX<R_2_9NW>S)UV?=??9_K:]KJWS0\1:ZFA(&NM>N;/SWP;:VG@N ^P;.)
MI'D*;\YWD+ZC;4S3:MY.WWK?Y7WU^=AQWU[J_P"-_P ;?#_F7[ZUO(/!_@G>
M-3M)+1XC.]G:&:>#_1W4YCV/W(!RIZUO5DO;R:>FOYH<+^SDGO\ _;%2"&[L
MI]-GENM>LH2EWBYM=-,TTN^96!E0POL+<G&U>G0=*S3LFGII'3IIS=?NZ]2)
M:ROOJ]>NT?PZ;;)&]I>HI;:]J44T6J-]O$'D3OIL^'_=A<NRQA4.>H.W'H*A
MQ<H2@M'=^FRZCORRC)ZZ+\Y%>S@FNM)T/PZVFW,5QI[QBZD>!EA144@E9"-K
M[NF%).&YQS5U+59.>RL_Q35OE?TT$[Q35];K\))W?W?\ YNR\/ZT;&"273IO
M/FO1I<P=&!%HJHAD/^R?*)!_VZJ,KSC)Z<WO/_$G=?E;YA-*TXQ6BT7H[K\.
M;[D=+X[TJ^N]2L[G3_MZ3PV-TJ2VCR#RW/EA>%.">N 1SCVK."]]^?+_ .E*
M_P"!4W:B[;J__I,OUM_3*PM=7L=5:U6YUNYO(7V1S2-(T#VPBY+$ 1E]^?\
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M?/>VIT>J:9>W_AKP]'<F\GNX;NWDE=-\+\=68(QQ[Y8XI5-*B<>TO_27^O\
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MAK D-E)(WEXW"2%XB0>C .!E3@X89!QP:=FE<5UL:%(84 % !0 4 % !0 4
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MM>T?PE8:;::!>)J8=I+#4OF)*L!E1&5(D&P$#.0,Y'04 >@W6@_\)Q\*M/\
M#^A71;3-(3[0-1NH3 )I55PJ!&/"D.27R0,=#V .TU_PG)J2>$;V/Q#'I5YI
M%K( JPK.9U:)%D"Y8?PJ>0#][/&* /+M<N_#4>E?VS\-;F\M;^QF-U<3W,DO
MELJKR!YI*N^2AV\G ]J .F\"'PS-I9>VU'4K[7+FWG07]Q'-!;N[AOE 9O+!
M&=HQZ4 7O@AIOC#2I-:M-=>7^SX+AXD68Y)G7:&921N*D8P<XX- 'L- !0!G
MZIK=AHRQM?3.GF9VJD3R,0.IPH) '<]!WI75[#L[7*DGB_0HGN5>](6WC>1Y
M/)?RR%&6VOC:Q ZA22/2FM?Z\[?GI<$KM)=?^'_+4CB\:Z!-(T:W<JLH?<)+
M65,%5W$'*C!V_,!U(Y&10]$Y/9:_I^'7MU!*[277]=OO[A;>--!NIEABNI0[
M$@;[65 "%W<EE &5Y&?O#IFA^ZFWTO\ AO\ -=MQ+6UO+\=OEY[7TW$OO&WA
M[3?+^UZAY9E2-XP(9&+B0,4  4DDA&P!SQTY%-Q:;3Z77W6O^:$FG%26SU'-
MXKTF)#<-?"6"18FA2"VD>1MX+# 4$OD*3@#@ YH::NGW?X)?Y[[:@M79=OU:
M_2UMQ\GBO28WC3S+AO.B\V%UM)3'*-I;"/MVLV 3M!SQTJ97BI7Z%17,TN__
M  VO;YE2S\:Z9-ID>H3S2HLP0I;K9RM,A9 ^"H!+<<Y"@ ?G5R7+)Q]?TW[;
M]?0B,N9)K^M7_E^%]B:+QOX<GU(Z?%JD;W 7<0%;:!LWC+8VC*\CGD XZ&DU
M9-OI^FC*6MEW_K^O/3<O6.O:;J-G/=V]PPA@YD,T3Q%!C.2' .,<@]".12?N
MJ[_K_@^01]YV1FR^+;-Y;!K63;;R7#1W!N87A:-!"\FX!PIQ\@^;!!&<4TMV
M]K/[TU_GMOL->\G;?3\78L'Q=HPLS<F><+Y@C$9M)O-8D$C;'MWL, G(!& 3
MT%+^O^'[?,2UO;^O\_D4H_B#X?\ M4D,UTT">?';PRR1.$G9T#KM;;@\'U_F
M*:B_GK^&X2]W[O\ /_+]-RPWCGPY'9RW<FHF*",J"\D$BAMV=I7*_.I((#+D
M'L:3TMY_?WV&U:]^G_#?\/VZBIXNTAD:Y%_YEN8XV2)+64RY9G&-H&YB2A&T
M+D;3GV;7+O\ UHG^6M]A+577G^#M^>GF3_\ "3Z69;:))9B;I0T,AM91$Q()
M \S;L#<'Y2<^U1)M)VW2_2^G?Y K:7_K6VO;7N9/ASQK'?:?)/J[PVSK&)1L
M1@NP012.2>>AD/&<X'?!K:K%0V\_S:*<7S<J]/GK_D6=<\86>A:GI"W<JQ6-
M]%*V\Q.SEEV%0% ST8D\<8[8-9[3<'T7Z_D)+FI\Z[K\4_QT1J0:]IES/'!!
M="2221HE"JW+*NX]NFT@YZ<CGD4[/\_P=G^)',OR_%77X$%]XDTVVMY/].2&
M02/%EX'<*Z#+948. .^0.1SR*4?>:MU_SM^>@3:BFWT_RO\ EJ1_\)5I<^X6
MUZ08Y51MUK*?,!;'R<#=D@@,N1FE?3FZ?\!O]+^:V*>FG];I?K;RZF9%X]T&
M?28[S4;CR+:\1%2VEM)-Y+ACM(P=^X*< #G'?(JI1^R]?^&3_"^O_ 87<9NW
M3_-J_P"'W^I>7Q=X8L&TZPBO8H1<I&+6..)@A#\(HP,*3V7@X!., U5I2FX]
M?Z?Y?IW)TC&^R_K^O4Z*H*"@ H * "@ H * "@ H * "@ H XC5?AZFJ:A)=
MRSV$I,LC(MWIJW 1'VEL!FQO!7AL8P<%32@E%)?UNW^KN-N[O_6R7Z+_ ##4
M_AU;:A=?:/,L7?>^%N].2X1$8(/E4D!6&P8;IS@J:I.V_P#P=V_U)22O_71+
M]/*Q3@\ W][9:G:WVH>1:RSW1M8! A\KS-RA\J1D;3G;Q@D\] '"7+RM[JW_
M *4I6_!:_F5*W-IMI^$;?Y_<OGMW'A2Y75)]3T[4X[:[>0,GF6WF(B^4L;*5
M#+G[@(.1CW'6+='UO?YM/]/^ +I%=K?A?_/_ ()57X?6R:?+8B]8P22P.<Q_
M-MCC";<Y[XSGMGI3FN??^]^*M^ W)MWZZ?A+F_$M^&?"7_",QRBV;34:0HK&
MVTU+?=&N?O;6RSG/WB<>BCG-N5U;U?\ PW;\?7M"C;;^O7^D=/4%!0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!YU
MXT\!:QK^O?VCI=[:P".))(1*S@K<JV-YVCIY98?7%*$4F^;K^35I?/16^93:
M:7];7<?Q>OD4M:^%U_>:T+BQN[:*TB5$A1F8%59!%<# &.45<>^<XK6$VI\T
MN_X7YK?^!?@9VM!1CHTO_)M+/Y+0EN?AMJ4GC%M5BN[5++[4FV/<VX6Q;S9$
MQC&XRX]L9J*3Y-9:[_A\/W%5+R5H_P!77++\+6\SH-:\+W6O:G#<7D-F;=7A
MWPLY<,L<K-W4=05X]<CW,P7+-2_J_*U^;%4]Z'*OZ5XO\DS.A\"Z@E_9LUU;
M+9^;,]VB[BS#S9)(-O ^Z9.<^@Q3>L>5_P J7SY>5O[OT*;UNN]_E=/\U^+(
M=/\  NIZ?IC1QI;&[@$202-J-S(6$9/S R;A$>>%",!SU!X<VV^9;W_1K?KO
MU_X(E%+1ZK_@I[*W;?O]SLIX5UV"ZL[Q3I\\ULD+[&<Q(\B"52IVQX Q+G<%
MZK]T9X=[7LOZ:2\[;;:Z.UR4F_BZ_P#R7,O7SVUU"+P"_EWLLWV/[=)9"*VG
M"9-O+YDDAVY'"@NF,<G;T%)OEC:&Z:^=DDK_ '?B6K2TGM[U_P#M[M\NHQ/!
MFKQV1BWV,LU_;"&_D9W'E.9'D=XAM.[)<X!*_=4Y[52:C))?"FGY^[;\[?*[
MW)?-*.N_O?C_ )+^D0WW@34KJ\E=OL\L4DDZ;?[0N8 (Y)#)N(BV[SR04)P<
M [ATJ:;Y6F_+\+_G^'F5-W=U_6B7Z?.YO:QI&JW6H17=K;:;+L@EM#%=N[(8
MW*'>0%Y/RX*="/XA1%V;OUM\K-_Y^5GW$M$O+;ST7W>6_P")DR^#-4FM9;&3
M^SQ;QK<>3*I;?,9GW$.NW"@>Q;/!XHB[.,GTY5\DT[^NGXO4F<;PE%=;OYM-
M6]-?N21L6WAR:WUM;X>0$%]+<';G<5:((!TZY'Y40?*DGV:^^7-^1,HMRNNZ
M?W1Y?S.DI&@4 % !0 4 % !0 4 % !0 4 >&?&N"*Z^(W@.WGC66&6X".CC*
MLIEC!!'<8H ="OAS3=!\1ZA,NC:7->7LFG16US:YLG6WFR"8U&2Y'?/4#CB@
M#SZ_T_XH>)O$&OM#9WD%Q,R1ZC:V<_E1$F, !EWX.4QUSUH [RU.O/96=QX8
MNM.U;4]$TNUM9=(N4>1[695\N0I\P56Y8$@\A: +7C76M<\-?##15U'3[*QT
MR^ L-2L;:';+$'#EO*YVK\JG&<\D4 0P75K)XPL/$&H?VC%;Z?9"*VLYY59+
M/?"8U:9>0?.RH79W'S4 1)87>H'3? .I^%M-MI]0"ZC=_8+58Q9P-F(L,DXE
M# #< 1@T :/AC2=!L;N;0=!U>ZUCPW'%))J)NI1)_9TJ9:-HQM 0EMY) /*
M\8Y +GPINI[_ ,4:W/8:MKFJ>'H%^S17&IWGGAYE?)*=, J5(XSS0!ZU0 4
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M2:@04 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MT^^PYJT8M=]?N;M_G_PY6^)NOWWA_1[*:UU>/1K>:X\NXU!K;[085VDC$?\
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MFU2\(7R6G ),8^;=G@\[<9&,YXJ8^\KKY>:7]?KL$O=OY6OY7V_-?>;U !0
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MWOB\[^=U9_AVL2E966W3RU3_ $6]]C0T;0ET6-HDU"]N8MHCB2XD!6%!T50
M/S;+'C)-$FYIJ77J.R3TT7;^OZ70H?\ "$Z<+6U@2YNT-K;K!#*KKO3:X=7^
M[C<"!U&/4&B[3YEOI^":_)NX2M*5VN_XM/\ -*Q5U#X=Z3JD5LMY<WLDL GW
M3>8H>5I5VLS87&1U&  "!Q2M;;32WIK>_KO][*3MOKK?_@>FWW(WM)TF/1K*
M"RM[B9[:"%(424J<;<_,2 "6/?)QQP!SFI2YFW;^NWH9QCRJQH5)04 % !0
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>132
<FILENAME>g20922g46r96.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g46r96.jpg
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M P,# P,# P,# P,# P,# P,# P/_P  1"  N ,X# 1$  A$! Q$!_\0 :P
M P " P$               @)!@<#! H% 0$                     $  !
M! ,  00" 0,$ P     $ P4&!P$""  3%!4)$1(7(2(6,20E&",S&1$!
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M8;!MZQI,ZN3F[F[HC:/,_LNR9]+Y":ZRB82AU6]ZY.KLZ%EN!I&^ZBJN^V?
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7@'@'@'@'@'@'@'@'@'@'@'@'@'@?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>133
<FILENAME>g20922g50a04.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g50a04.jpg
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M;W-H;W @,RXP #A"24T$!       #QP!6@ #&R5'' (   (  @ X0DE-!"4
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6?']U7^+^?:D?@?\ E?Z[:9?]VW__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>134
<FILENAME>g20922g50a06.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g50a06.jpg
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M;W-H;W @,RXP #A"24T$!       #QP!6@ #&R5'' (   (  @ X0DE-!"4
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6?']U7^+^?:D?@?\ E?Z[:9?]VW__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>135
<FILENAME>g20922g53s83.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g53s83.jpg
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M=3AH53TR-];V7$4^;S46M@'K8C"TNGP*W)6YDJ-I,D9:C+E.;QI$9)8:VQ'
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MY1964R2-NE:_7R+IVFG-;\2==+E2][7)WFM:]*D[<42=AG(3R<0VXE.0?Z6
MU<X#@. X#@. X#@. X#@?/=_E+G\N^7+?F_RG_3&_,_W=_??X?FX'B/E_P!I
M/Y:]I_??J+Z9^L;%^Y7\N_\ .W_Y_?K;ZT:/@/WA^ _Q=^U/O7C]6?:7^'WO
MGO\ \8_R_AP/:!4WXKK/\??CZ&?B;\5_\<;?QG_U]_LW[N]'@=@<!P' <!P/
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>136
<FILENAME>g20922g54g94.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g54g94.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /0/C,2/AGJ&./WD/_HQ:TI?&C.I\+.!_9]8G6]:S_S[Q_\
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MW1(H&.A9I0.>F*;AYAS#M4\;W>B06/\ :.B&VN+N9HT22\C5,!0<F0G )S@
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# __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>137
<FILENAME>g20922g55v98.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g55v98.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1  (! @0$ P0'!00$  $"=P ! @,1
M! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_  !$( "@ BP,!$0 "$0$#$0'_V@ ,
M P$  A$#$0 _ /W\H * / ?CGXU&D:7!X8L'0ZCJOE75XQ5)/LFG6TZR1?*V
M0)9[J$!20<);RY +(:_GSQXXX6395A^%L!./]I9MR5\1*T9_5\'1JJ</=E=*
MIB*]-*#::5.E6NDY4Y'Z?X;<._7L;4SC$Q:PF!YJ=)7:]K7G!QEJK/EI4Y-R
M2:O.<-6E)'IO@+Q5%XP\,:?K"[5NBIM-2A7@0:E;*JW*@8PJ.&CG0<XCN$!.
M<U^H< <5TN,N%\NSF-HXIQ]AC:<=J6,HJ*K12V49WC7IK6U*K33?-<^/XFR6
M>09QBLO=W13]IAY/[=";;IN_5QLZ<GI><)6TL=C7V9X 4 % !0!"ES;O-);1
MSPM<0!6E@25&FA5ON-)$K;HP>Q(&>U.S2VLN@?H34@"@ H * "@ H * "@ H
M * ,K7-9LO#VD7^LZA)Y=II]N\\F,;G(PL4$8/6:65DC0=VD45Y.>YU@>',H
MS#.LQJ>SP>74959_S2:TA2@GO4JU'&G376<HK0[<MR_$9GCL+E^$CS5\5-0C
MVBMY3EVC"*<Y/I&+/S[US4-3\47^L>*=1;:);F,.WS&-)9E9;'3;8'KLM8&Q
MDC$5J[$E]JR?YX9[F.:<5X_.>*\RERJM6@I2U<(SJ)QPN"HWW]G0I2M=KEH4
M)SDY5'&%3^I<MPN#R3#9?DN$5_9TY<JT4G&#3K8BIVYJDU>R=ZE2,4E&\H^B
M_!'QA_PC_B3^Q;R79I?B$QVXWG"6^J)D6,N2<(LVYK=L#EI822%CK](\#.,O
M]7N)?[#QE;DROB)PHIR?NT<=&ZPL[MVBJUY8:5E[TYT7)J--L^3\1<@_M/*/
M[0P]/FQF5*4[+>>&>M:-K:NG958ZZ1C423<C[4K^W3^>0H S-;UG2_#>C:MX
MAUR]ATS1=!TR_P!9U?4;C<+?3]+TNUEOM0O9RBLPA@M()96VJ3MC. 3Q51C*
M<HP@N:4FHQ7=MV2^;$VH1<F^6,4VWV2U?W'Y&> )OC!_P4;\3>*_$^K^-_%W
MP?\ V5O"NOSZ%X<\+^"KH:+XG^(5U @DE.M:PGF>;Y=I+8W%YYZ7=E;O>0V=
MC;R7$5W?Q_0U5ALEITZ<:4,1CYQ4I2FKQIK^['UNE:TG9N3LU$\BG[;,)2DY
MRHX6#M&,=)2]7]U]TKV2O=GN%W_P2^_9E2TB;PVWQ(\&^(K4;[3Q?H'CJ_&O
M0W0C9?M)_M&&ZM S.=SB&V@)R0C1@\<JSS')^_[.I#K"5-<MNVEG][9N\LPR
M7N\\)+:2D[_C=?@?4'PXDTCX*>%O 'PF^)7QQL?&'CV]^W6.@ZKX]U[1-'\9
M>. =4G:T@TS2;S4#?:S-:VUU96>4DU"<F-/,F=G7'#6YL34JXBAA72HQLY*G
M&3A#36[2M&[3?1=D=5*U"%.C4KJ51W2<FE*6NEE>[MHNK\SKO!?QA^%7Q$U3
M6]#\!?$/P=XOU?PTQ&N:;X=U_3=5N]-59VMC+<0V=P[?9A<HT7GKNCWX7?N(
M!RJ8;$4(QE5HSI1G\+E%I/KUZVZ;EPK4JC<:=2,G'=)IVZ=#C9OVI/V<+;7S
MX7F^./PNBUQ;M;!K)O&>AA4O6 VVC7?VS[,EQO81F,S!A+^Z($@V5JL!C>3G
M6%J\EKWY);=[6O\ AMKL1]:PRER>W@FM+<R_SL>DZ_\ $/P'X5U'PUH_B3QE
MX9T+5_&-_;:7X2TG5-;T^SU+Q+J%W-%;V]KH=A-<+/J<CSSP1_Z/'( T\8)!
M=<X0HU9QG*%.4HTE>;46U%+K)[*UNII*I3@XQE.,7)VBFTFWTLNOR.IO+RTT
M^TNK^_NK>QL+&WGO+V]O)XK:TL[2VB::XNKJXF98[>WBA1Y'DD95149F( )J
M$FVHQ5V]$EO?9))%MI)MNR6[,WP[XD\.^+M&LO$7A/7]%\3^'M265]-UWP[J
MMCK6C7Z6]Q-:3M9:IIL\UM=+%=6\\+F*5@LD$B'#(0'.$Z4G"I"5.<=XR3BU
MU5T[-::DQE&<5*$E*+V:::[:-:&/;_$3P'=>-;_X;V_B_P .R>/]+T^#5K[P
M:-6LAXEM]+N(XI8M0_L=I1<R6?ESV[--'&R(+B'>5\U-U.C5C25;V<E1D[*=
MGRW72^U]-O+R$JE/G=)37M(J[C?6W>VYYQJ7[4?[.6CZ_)X7U/XW_#&RUZ"\
M33Y["?QAHJM;7KLL8M;J<79@M9UD8*Z2RH8VRLFT@@;QP&,E#GCA:KA:Z?)+
M;R5KLS>*PT9<CKPC):6YD>[1R1RQQRQ.DD4B+)%)&RO&\;J&1XW4D,C*00P)
M!!!%<EK:;6Z&X^@#YF^*&I:CX]\4V'PW\-MOAL9A<:U<#=]GBND&'-RZ9_T:
MQAD^8?Q3S>7M,D:9_F#Q3S+,N/\ BO >&?#,N>C@:BK9E6U]C3KQ5I.M*-_W
M.!ISO-;SQ57V*BZM.G?]@X,PF$X8R7$\6YNN6>(A[/"4].>5-ZI4T[?O,1./
MNO[-&'/?DG*WE>IZ?I^KZE-H^B2O!X)\$6T\E]J^(V:Y<LB:AJI.0EQJ.I7D
M45K:1AL,D-L $CC?9^49KE^7YSF=;)LCJRH<#<"T:L\5F%H.5:3E&.+Q[=U"
MMC,RQ$*>$P%-2:E2IX6,53HTZG)]K@L5BL!@Z>/S""J<1<15(1HX7WDJ:2;H
M89+64*&$I2E6Q,K7C.59MRJ2CS<O;^&M=U+2]5\5Z7ILL6CZ1=())8&.ZU&=
MX^SG >X%K'Y)FE7+()%D?@LR_*X;AG/\SRK-N+<JRRI1R;)Z\>>=*3O05^9>
MR>DZJPD/9/$5HWG34XUJFCG./M5<WRS!8S Y'C,9&6/QM-\L9I6J/9\ZUC!U
MGSJE3?NR<73A]F+^V/AMXM7QAX6L=0D=3J-J/L&K(, B]MU4&;:,86XB,<XP
M, RL@)*&O[@\,^+X\9<*8',:DT\RPJ^JX^*M=8JC%)U+*UHXB#A7C9<L74E3
M3;@S^=^+LB?#^=8C"0BUA*O[[#/_ *<S;M"_5TI*5-]7RJ32YD=[7Z ?,'R5
M^W:=57]D;XY?V-O%W_PB,0EV!B1I1UO25UW(3G9_8AU#<>@7)/&:]#*N7^T,
M+S:)3T]>5\O_ )-8Y,==82OR_P OX75_PN<5_P $V9-'?]CGX5+I.T213^-H
M]8&%\X:Q_P )WXC>?[05'+&U>S:/.2(&MP>F!KG2DLQK\W]SE].2-OQO?SN1
MEMOJ=*VEN:_KS/\ KT/NJO*.X_&;_@H_X6'CG]I?]CGP2][?Z9;>,-:G\*W]
M_I=P;34+72O$/C#PKI&KS6DZLI29=,O+O SAOND$,0?I,EJ>QP68U;)NE%22
M>UXPDU=>J1XV8PY\3@X7<5)\K:T=G**?X&7^W%\)OAO^S[H7P]\!_L^^#].^
M&WBW]HO7K?X8^(?$VE7VK2ZC-X(TZYTI;[0(7U#49/LEKJNL:[H+ZE+!-;/>
MPZ4EO=--#(VRLKQ%;&3K5<74=:G@H^UC%I6YVG:6BUY5&7+=/E;NK,6-HT\-
M&G3P\%2GB'R-IN_*K76KTNVK[7M9GZ$:?^Q;^S/8?#2/X7-\(_!UYHXTI=/N
M=<NM#TY_&=W>?9V@D\02>+A;?VI#K[/)+(MW#<H8?,\J$1VZK"OD/,\:Z_M_
MK$XR3NHJ3Y$OY>2_+R^5M=WKJ>@L%AHT_9>QC9*U[+F]>;>_G?\  _#'5K;Q
MW+\*/BYX%75M1UCQ-^P-\;+75_A_XBF9KG4M/\%7'BS4O!OB#2;>2/YX;+3O
M$OAGPIKD"JQ2""/4%!2&V@6/ZF+I+$8>KRJ-/-J-JD=DYJ"G%^LHRG!]W;JV
M>&U/V56G=RE@*B<'U4>9Q:^3C&2[*_9'ZK_M0_&BY^(_[,/PI\._#ZX-IXP_
M;"F\#^"?#L,2EI-*TCQ;!87OCBXNU\S L;#3II=(O#YC&,:L6!VHTL?@8##*
MACJ\ZJO3RWGG+S<+J%O-M<T?0]7%5O:86E&GI/%\L8KLI6YODEH_4Y?]@75+
MOX.^-_VA/V/O$^H2LWPE\3WGC;P)>:FR13W_ ,/-;EMO-OY0$CBMH%BO?#6I
MR;<H)O%=R =L0)TS:*Q%+!YC35O;Q4)I=*D;Z?A*/I!$8!NA/$8.3_@OF@W_
M "/K^,7ZR9^=/Q"^)GBIOAK^T7^TWHMQJFG:O^T]\;)?@]X1UF+SK'4=.^$'
MANQO-9U.UL+E"DK?VE:V'@_P_*1&A,>@Z@A*,Q1O8HT*:K8+ R2<<!1]M./1
MUI-15U_=;G-?XD>?4JS]GB,3&\7B:GLXO9JG%-NWK:,?DSZZ\->.O^"=>@_"
M>'X477PH\3:M;2Z"NE:SXJN_@7K3^,M4U1[62*Z\2#Q--I4NHV>K_:I[BXMI
M(;D"RWK%;".&-8QY\Z6<2Q'UA8B,6I7C!5X\B5](\MTFK*STUW>IUQGE\*2I
M>RDU:SE[)\U^][73[=NFA\=?#/\ ;:_:<^#_ ('T+X:>&=$\0:QX<\(1WVF:
M#J&K^&II+Z72#J=[=:=$XOM!NYH(+>TN(K>&W-Q(L$%O##'MCB55]*MEF!Q%
M65:<HQG.SDE+2]DGM)+5J[=M7J<=+&XFA"-*,7*,-$W'6UW;=/;9*^BT/Z-?
M&WB.7PYHQ;3XC=:[J<RZ7X?L457DN=4N05A8QL0/(@4--(S%4"Q[2P+C/XMQ
MQQ)6X;R5RRZD\7G^:5(X'*,+%*4JV.KIJFW!M+V5!)UJTI.,%"'+*47.-_T/
MAW*:>:Y@HXJ?L,LP47B,;6;<53PU-IR5TF^>H[4Z:2<N:5TGRL\CN- N_!7A
MV'PKHKC4?B+X_DD34M1WLTEO;,&?4[MK@@O#96Z2R(LS89Y)99U!9-B?D&(X
M?QG _#E'A3))K,O$CQ!G..-QG,W.E1=Y8[$2K-.=+#8>-2<(5I6J5*U2MBHI
MS@J4/NJ69T.(<UJ9UF$?JG"?"T8O#T+)1G45EAZ2@O=G6JN,92IKW8TXPHMJ
M,N>63>>"UNKG2_A-X;D=;#36M];\?:\(]K2WDR VL+')'FBW),%M\ZCS(&8D
MV\SUY&-X)CBL3E7A%PS5E'+\LE2S/BO->2TIXBI%.A2;NTIJDV\-A??@N>A*
M3;P^(J'=A^(70HXSCC-H+ZSBU/!Y+@N:ZC2@[5)I:/EY]*M;W9>[42256E ^
MC],T?3='TNVT6PM8H=-M+?[+';;59&B((D\X,/WSRLSM(S9+M(S-DL:_I3*\
MFRW)LJPN28#"0HY9A*/L(4>5.+A9\_M$U:I*JW*5:4KNK.4Y3NY._P"2XS'X
MO'8VMF&)K2GBZT_:2J7::DK<O+;X5!)1@E90C&*C9)'B%GI#_"?QW'+:[E\#
M^,YTL&SN9-&U0L[V,,SG[L*RR2QQ.[?ZF>4/N>WW/^&8+)Y^$G'U.KA;QX$X
MUJQPCW<<MQS<I86G4D[<M.,YSIT)SEKAZM55.:>'4Y_HU?'1XWX:E3JV?$?#
MT'66R>*PR25:44MY.,8RJ1BM*L(<O+&KRQ^@J_H<_+3&\1:!I'BKP_KGA?7[
M./4-"\1Z1J6A:SI\VX17NE:M9S6&H6DA4A@DMI/+&2I!&[(((JH3E2G&<'RR
MIM2B^S3NG\FA2BI1<)*\9)IKR:LS\:/AU-\;/^";'C#Q/X1\3>"?%?Q:_9=\
M4:U/K.B>+/!M@-4U?PQ>R+%;I>WELABAT_4YM-M[2WO].OGL[:YELHKG3;O]
MU<17/TE987.J=.I3JPPV.IQ490F[*2[)ZMI.[BU=I.TELUXU/VV6SE"4)5L+
M)W4HJ[C_ ).VC3LG:Z>Y]0?\/._V9;VUA7PQ_P +*\9:_<QJ;7PCX;\ :G<>
M()IW4;;5%NY;>S>42LD1,=Y(NYAM+#FN'^P\<G[_ +.E".\Y5$H_A=_@=7]I
MX:WN\\I=(Q@[_HOQ/GK]H37/%/Q+_:)_X)X>/=0^''B_P)=W_B>VOM;\*^(+
M"9]5\*R1_$#PU$T.L200*MNCQ6QNHFN([:0V\T;30P2;XH^S!QIX?!YQ1C6A
M548VC*+TE^[EM]]G:^NS:U.?$2E4Q&7U'3E3;EK%K6/O1W[;7Z:=$?3W_!0/
MX!>,OC+\,/#7B/X9P27OQ'^$'BA/&WA[28Y"L^M6*0J=6TW3HAM\[6A-9:5>
M6R>8C2_V;+;1;IKJ,5PY1BZ>%KSIUGRT<1'DD_Y7]EOLM6GVO?9,Z<?AYUJ4
M94OXE&7-%=UU2\]$UZ6ZG,67_!3+X)1>#D;7=%\>Z=\9K>S2TO\ X(+X+\2#
MQ0WBF.V7[1IEGJ$FFG3DTXWN_9-<W45T+<>8]D)AY!MY)BO:>Y*F\->ZK<\>
M7EOHVKWO;HDU?[5M25F5!0]Z,HUEO2Y9<W-VO:UO5WMTZ&)^QC^R_P"(A\-O
MCQXP^.NBR:1XN_:KNM=F\0^&[H,=4T'PGKJZ]-LOO-8R6&L7U[XGU2\>V<^=
M!'!IWV@QW:2PVMYECH>VPE+"RYJ> 4>62VE./+MW244K[/WK75FYP6%DJ=>=
M>/+/%7O'JHN^_9MR;MTTZZ+P7]@3X4?$V]^,J:;\4;&>#P[^QGIWCWX?>!O/
MM9K>*]\7^.O%NOMJ>J6LUR'34[*/2?[95)K=MJ12Z,4E:-5#=>;8BA'#7P[]
M_,G3J3UVA3A&R=MG?ET?7FT,,!2J^VM55HX)2A#3[4I.[\U:^W]TZO\ X*/>
M"O'7P_\ '7@[]H3X3Z9>7VK^,_!OC/X">-[+3;*\O9[B/Q5X9UFQ\.:B+>QB
M=Y+N.UO]5=)F*".Y\.Z,I$JNR#/)JM*K2J8/$248TIPKP;:5N22<EKTT6G:4
MMBLQA.G.&(I)MRC*E))/K%J+T]7\TCTWX[?L5ZKKO[#W@#X+>!K2UF^('PDL
M]"\5Z;:Q3Q0+X@\616&HOXXL+2]D9(X9-5U#7M;NK;S76-KB*S221%S*F&$S
M.-/-*N)JMJC7<H-_RPNN1M?W5&*?E?T-:^";P-.C37[RC:26UY6?,K^;;MYV
M-'X:?\%)/A-;>%;#1OV@H_%OPJ^,6C6-O8>)O"NJ> O%<[ZYK=N)+:6[\/1:
M-H]S]FBO9X-XMM033_)FN&@5I8X1.\ULEQ'M'+!\E?#2=XR52"Y8[VE=KX>Z
MO=*^C=ATLRI*"CB.:E6BK.+C+5[:63W[.UMO,^B_#'[3MMXKT.R\0Z9\$/VA
M(].U(W3V#7OPW:UFN+."\N+6VOU@?5=R6UW# EU"6P6AN8F(!; XYX%TI.#Q
M6'O&U[5-G9-K;=;/S1TPQ*E%25"JD]O<Z7LGOUW1[O;Z:)M5F\3ZF-[6EO-:
MZ';[#*--TY@&N[R-$W%M0U#RU9F50ZP)! %#>=YOQ&'RU5LVK\4YFN>6$HU*
M&64N5U/J6#:OB,1",>=RQ>8<D9SE&*J0PL:&%48S^L>U^BJXMTL#3R;!^[&M
M.%3&3NH^WKK2E2;?*E0PO,XQ3?)*LZE9MQ]ER5;73+JRDU3Q)/;+>^)=41;:
MRMW9?+TZQ1F_LW1EF4L(;:-V-Q>31[M\K3R*'6.)!R83*\5@:F:\35\,L;Q/
MFL8T</2DUR8/"QD_J>71J+F5.C3E+ZQF-:GS>TKRKU8*I"G0IK:MC*.(A@LH
MI5GA\HP+=2K-)\U>LTOK&*<';FJ22]EA:<K<M-4H2<92J2>EX;\/V_AVQ>!9
M#=WUY<2W^KZE(H6?4]3N6WW%U* 2$7=\L<0.V-%51G!)]+AKAW#\.8"="%1X
MO'XRM/%YAC9Q4:N-QM9\U:O-)M1C?W:5)/EHTHQA&]G)\F;9I5S3$QJ."H8;
M#PC0PN'B[PP^'IJU.G':[MK.;5YS;D]TET%?1'EF;K&D6&NZ;=Z1J<"W%C>P
MF&>(_*0#@I)&XYCFC<*Z..59%(Y%>9G&3Y?GV68S)\TPZQ& QU-TZL'H[;QG
M"2UA4IR2G3G'WH3C&2U1UX#'8K+,70QV"JNCB<-)2A);::.,EM*,DW&47I*+
M:>C*^@B_@L4L-4E-Q?:=BU>]VE1J-NG%IJ!& %FF@"F9!D).DRJ60*S<^0+,
M,/@(9?FM7ZSC\M_<2Q-K+&4H:8?%M62C4K4E%XB"O&GBHUX0<J<83EKF3PM3
M$O$X*'L<-BOWD:-[^PF_XE"^[A3G?V4G9RHNG*24G**VJ]L\\* (8[:W@DFE
MA@AAEN&#W$D<21R3LHVJTSJH,K < L20*=WIKML%K>1-2 * (S#%YHG\J/SU
M0Q+,47S5B9@S1B3&X(6525!QD ]J+VTV78+?@24 % !0 4 1/!!))#+)#$\M
AN6:"1XT:2!G78YA=@3$63Y25(R.#Q1>WD%OPV): /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>138
<FILENAME>g20922g66d01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g66d01.jpg
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M14[IM*IEIJ6?9[A=>GD6;JOR&X;%=W25<J,Q9F+XCJ+KT:VF[2^8@9X2,!F
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MQ!UBM5EL#*MUZ#K[,%#K T@XEA$M@55_A14$&#=NE^Q0 _U&^/D?_7P9SP/
M\#P/ \#P/ \#P/ \%5/V VBQ=(-I3ZX<QS_=U9O<)3+8#H'6HFD7JDY+G7)M
MIL"DOO#]KNTC7$L_L=LN>:U:2I;>NQ$H>?!_9DE_U)MVKI5(+1(:&B*Y#Q->
MK\7'PD# QK&&A(6):(1\7$1$6U28QL7&L&J:35E'L&:!$D44RE333(!2@
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H3:23ZTVF[C& DD#J D@DW!$H!-7P/ \#P/ \#P/ \#P/ \#P/!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>139
<FILENAME>g20922g68y41.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g68y41.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /W\H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M(IPP.,$5K'#UY)2A1J2B]FH2:^32L9NM1BW&56$7'=.44U\F]#._X7I\$?\
MHL?PK_\ #A>$O_EO5?5<3_T#U/\ P7+_ "%[>A_S^I_^!Q_S.V\.^*?#'BZP
M;5/"?B/0?$^F1W,EF^H^'=7T_6K!+N%(I);5KS3;B:);E(YX6:(N&59D) ##
M.4X3IOEG"4'O:2:=O1V+C.,U>$E)+2\6FOP-ZI*"@ H * "@ H * "@ H *
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H _,W]KOX5GPY
MXBC^(NE(!I'BJZ%OJ\")M%CXA2W+F8;5 \K4+>WDF)))\^"Y9C^]05^D<)YI
M[?#O+JK_ 'N$C>F_YJ5[6]:;:7^%Q[,_#O$7(/J6-CG.'5L-CY<M:*7\/$*-
M^;3I6C%R[^TC-OXD?&E?8'YH?=O['GQ5%E>77POUR](MK]Y-0\)&=W98;Y4>
M74M(B=B5ACN(D^U11_(OFQW(&9+E0WP_%V5\T(YG0A[U.T*]OY=H5&NKBWRR
M>KY7'I%GZQX;\0>RJ3R'%5;0K-U,)S-VC.S=2BF](J27M(1T7.IVO*:3_,?_
M (*9_LU2_"?XJGXK^'+*.'P#\5KV:ZG2W 1-#\>"-[G7-/:%(E6&UU*-#JEN
MV]BTLFI1A42U3?YV38SV]#V$W^]H*R\X;1?K'X7Y6[GZ!F>&]C5]K!6IU7]T
MNJ^>Z^?8_,BO9/,/W5_X)3_M+3:C9ZI^SEXQUB$RZ/;2Z[\+#>RI'<3Z>;B>
MX\2^%;>61E-V]K+.FIVENOF2B"35,8M[)%A^9SO!\KCBZ<;<WNU+=]HR\KVY
M6]K\O5GNY5B;IX:;MRZPOVZQ^6Z7:_1'KO[6_@#5?#OQ"E\8N\]WHGC,126]
MU+()#9:EI]I;VMUI3X ,42P1036^X &-W12QMG(^MX3Q]*OEZP:2A6P=TXI6
MYH2DY1GYN[:EYI-VYD?CWB'E&(P6<2S)N53"YG9QDW?DJTX1C*D^R45&5.^\
M6XJ_)(^7=,TV_P!8U&QTG2[66]U'4KJ"QL;.!=\UQ=7,BPP0QK_>:1E'. .I
M( KZ:I4IT:<ZM62ITZ<7*4GHHQ2NV_1'P="A5Q-:EA\/3=6M6G&%.$5=RE)I
M127FV?M1\*/A]I_PR\#Z-X8M(XA=PP)=:W>1JH?4-;N41[^ZDD !D19 (8=V
M2L%O"F3LS7XWFF/J9CC:V)FWR-\M.+^Q3CI"*73365MY.3ZG].\/Y/1R+*L-
M@:45[2,5*M-)7J5Y).I)OJD_=A?:$8QZ'H]><>T% !0 4 % !0 4 % !0 4
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M?;R%H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M[X?TG_[:?B=7T9XA_3K_ ,$O_P#DT?PK_P!C5XX_]/\ <5\9G/\ O\_\,/\
MTD^GRO\ W.'^*7YGZ%5Y1Z 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0!C^(?^0!KG_8'U/_ -(IZVP_\>A_U\A_
MZ4CFQG^YXK_KS5_](D?@U7[D?R8>[_LR_P#)<? ?_7QK?_J,ZU7A\2?\B3'>
ME/\ ]/4SZS@;_DJLI_Q5_P#U&K'F_P#P61_Y"?[/G_7C\3O_ $H\!5\1P_\
M#BO6G_[>?NF<[X?TG_[:?B=7T9XA_3K_ ,$O_P#DT?PK_P!C5XX_]/\ <5\9
MG/\ O\_\,/\ TD^GRO\ W.'^*7YGZ%5Y1Z 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 8_B'_D :Y_V!]3_](IZVP_\ 'H?]?(?^E(YL9_N>*_Z\U?\ TB1^#5?N
M1_)A[O\ LR_\EQ\!_P#7QK?_ *C.M5X?$G_(DQWI3_\ 3U,^LX&_Y*K*?\5?
M_P!1JQYO_P %D?\ D)_L^?\ 7C\3O_2CP%7Q'#_PXKUI_P#MY^Z9SOA_2?\
M[:?FW\#?V4?CA^T+>&/X>>$+DZ+$I>Z\8:_YVB>$+8+,(&1=:N+=EU&Z60G=
M::?'>7(5'8P[48CU\3CL-@U^]J6ETA'6?W+9>;LO,\VAA*^(?[N'NK[3TC]_
M7T5V?TN_LE? O5?V=/@IH/PPUO7M/\1:IIVHZWJEYJ.E6US:Z>)=9U"2^-K;
M+=GSIHX=^SSG2$OC/E)TKX_'8F.+Q$JT8N$6HI)[Z*W3;T/I<)0>&H1I.2DX
MMMM;:N_X'TK7&=(4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'YX_MQ?\A7X=_\
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MX4,VV272]$L[)+,E=N8UU"YP0?WASQ[M/((I+VN(=^T(I+[VW?[D>1/.)?\
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MI\<UQYO_ ,B_$?\ </\ ].P.K+?]]H_]O_\ IN1^O/\ P56_Y-6?_LHW@_\
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M=?\ "'C/[OL;?^#Z2_4]/@)M<5Y6NZQ*?_A)7?YH^I/VV_\ D2_!O_8T3_\
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M\=^*;6$?,2>(88QZ<< # 'P^:JV88CIK'_TB+/JLO_W.AY*7X2DC^;O]IO\
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M5Z>(@_14*E3\Z:/K#]M7_DEF@?\ 90-*_P#4=\55\KP;_P C2O\ ]@L__3M
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M@?\ D:P_Z^5/RF?3XO\ Y%TO\$/SB?R^5]H?,']+/_!*G_DU:/\ [*-XP_\
M1.C5\?G?^^_]PX?J?2Y5_NG_ &_+]#])J\<](_C4^.G_ "6[XQ?]E4^(7_J6
MZO7Z#AO]VP__ %[I_P#I*/C:_P#'K?XY_P#I3/N[_@DI_P G->(_^R.^*/\
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M4_\ 2F?5'_!+3_D[#2/^Q'\:?^D5M7#G7^XR_P </S.K*_\ >X_X9?D>Q?\
M!8+_ )*W\*/^R<WO_J3:C7/D'\"O_P!?%_Z2C;./XM'_  /_ -*9^4/AC_D9
M/#W_ &'-)_\ 2^WKW)_!+T?Y'DQ^*/JOS/[8Z_.C[8^'_P#@H_\ \F8?&7_N
MGG_JUO U>EE'_(PP_P#W$_\ 34SAS+_<JW_;G_IR)_+!7VQ\L?TZ_P#!+_\
MY-'\*_\ 8U>./_3_ '%?&9S_ +_/_##_ -)/I\K_ -SA_BE^9_/U^TW_ ,G)
M?M!_]EP^+'_J>:_7U6#_ -SPG_7FE_Z1$^?Q7^\XC_K[4_\ 2F?5'_!+3_D[
M#2/^Q'\:?^D5M7#G7^XR_P </S.K*_\ >X_X9?D?TSU\<?3'X@?\%E?^;<?^
MZO\ _O+J^DX?_P"8O_N%_P"Y#P\Y_P"8;_N)_P"V'X?U](>(?U!_M8?\H]O%
M7_9*_AM_Z<_!E?%X'_D:P_Z^5/RF?3XO_D72_P $/SB?R^5]H?,']+/_  2I
M_P"35H_^RC>,/_1.C5\?G?\ OO\ W#A^I]+E7^Z?]OR_0_2:O'/2/XU/CI_R
M6[XQ?]E4^(7_ *ENKU^@X;_=L/\ ]>Z?_I*/C:_\>M_CG_Z4S[N_X)*?\G->
M(_\ LCOBC_U*O M>9GO^YP_Z^Q_])F=^4?[S+_KW+_TJ)^E_[<7_ "%?AW_V
M#_$?_I3H]>EP5_"S#_%1_*H?GWBG_O&3?]>\3_Z51/A"ON#\G/;-/_:+^,VE
MV%EIEAXVGM['3K2VL+* :-X<<06EI"EO;PAY='9W"0QHNYV9CMR23S7BU.'L
MGJ3G4G@E*<Y.4G[2LKR;NW95$E=OHDCZBCQGQ-AZ5*A1S24*5"$:<(^QPSY8
M0BHQ5W1;=DDKMM]VSB/%WQ%\<>.S;_\ "7>)=3UM+1WEM;>ZE1+.WED 5Y8+
M*W2.WBE*C:76(-CC..*[L)E^"P/-]4PT*#E9-Q7O-+9.3;DTNU['EYCG.:YK
MR?VCCJN*5-MPC)I0BWHW&$5&"=M+J-[:;'%5V'EGZ@_LB?#6[\)>$M1\6:U8
M266K^+I8!8PW4!BNK?P]9J7M)-L@#PK>W$TL^W #Q06DG.1C\SXLS&&*Q=/"
M49J5'")\SB[Q=5Z26FCY$E&_1N:/W?PZR.IEV75LPQ5)TL3F#CR1G&TXX>&L
M'KK'VLFYVTO&-.6NAB?MM_\ (E^#?^QHG_\ 35<UOP7_ +YC/^O*_P#2T<OB
MC_R+,L_["I?^FI'YLU^BGXD?M+\"O^2/_#O_ +%?3O\ T U^.9W_ ,C?,/\
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M!E?%X'_D:P_Z^5/RF?3XO_D72_P0_.)_+Y7VA\P?TL_\$J?^35H_^RC>,/\
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M'Y _M1_\EU\<_P#<L_\ J'>'Z_6N&?\ D1X'_N-_ZD53^<N//^2KS7_N6_\
M4/#G(?!3_DKGPY_['#0__2Z*NO.?^13F/_8/5_\ 26>=PQ_R462_]AE#_P!+
M1^UM?C1_3P4 % ''_$+_ )$'QQ_V)_B7_P!,M[77E_\ O^!_["*/_IR)YN<?
M\BC-?^P/$_\ IF9^&5?MI_*I^AW[#O\ R"OB)_V$/#G_ *3:Q7Y_QK_%R_\
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M_P"_XW_K_6_].2/ZJR;_ )%&5?\ 8'AO_3,#L*Y#T@H * /BC]MO_D2_!O\
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MS7VY?:14KKR5S^A\!2J5N J=*DVJLLJJ*GRMI\_L9N%FM5[R6Q^5/_"0Z_\
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M*<7.HW%IPA&*:4NLFHJ_O-?EY_PF_C3_ *&_Q1_X/]5_^2Z_3?J6#_Z!*/\
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M:7>_VDM4_)H^<QV#EAZCG"/[B3NFMH_W7VMT[KS/SZKU3SPH [?X>_#CQO\
M%7Q1I_@WX?>&M5\4>(=1D18K#2[66X^SP&6.*2_U"9%,>FZ7 94::\N6BAA4
M[I'45E5K4Z$'4JS4(1ZM_@N[[):LNG2G5DH4XN4GT7YOLEU;T1_5Y^RS^SWI
M'[-'PBT?X<V%\FL:JUU<Z]XLUY+<6R:QXEU%(([R>"+&]+&WMK6SL;82DR>1
M8Q-)AW8#X?&XJ6,KRJM<L4E&$>T5M\W=M^;/J\)AUA:,:2?,]Y/O)[_)627D
MCY]_;B_Y"OP[_P"P?XC_ /2G1Z^UX*_A9A_BH_E4/R3Q3_WC)O\ KWB?_2J)
M\(5]P?DY^YOP]_Y$'P/_ -B?X9_],ME7XEC_ /?\;_U_K?\ IR1_563?\BC*
MO^P/#?\ IF!V%<AZ04 % 'Q1^VW_ ,B7X-_[&B?_ --5S7V?!?\ OF,_Z\K_
M -+1^8>*/_(LRS_L*E_Z:D?FS7Z*?B1^TOP*_P"2/_#O_L5]._\ 0#7XYG?_
M "-\P_Z_3_,_ISA3_DF\F_[!:?Y'K%>4?0'@_P"T!\(E^+'@]8+%E@\3>'FN
M=1\/2,(PEU(\&VZT>>1_]3!>"*##AEV36\#L2BNK>YD&;?V5B[S7-AJ_+"JM
M?=2?NU$ENX7>G6+DEK8^3XOX=7$&6J%)\N.P;E4P[TM)N-I49-[1JVCK=6G&
M#?NII_D9JVCZKH&H7.DZUIUYI6IV;^7=6%_;RVMU ^ RAX9E5@&4AE;&&5@R
MD@@G]8I5J5>G&K1J1JTY*\91:<7Z-=MGV>A_.V(PV(P=:>&Q5&>'KTG:5.I%
MPE%^:=GMJGLUJM!UAKFM:7')#IFL:IIT,Q)EBL-0N[2.4D $R1V\R*Y(51R#
M]T>E*="C4:=2C";CLY0BVO1M.PZ6*Q6'BXT,35H1ENJ=2<$_51:3VZF:[O([
M22,SN[,[N[%G=V)9F9F)+,2223R2:U244DERJ.B2TM;;3I8P;;;;;;;NV][]
M6WW/JO\ 9O\ @1J7C?7]/\6^)=.NK/P5I$L.HVS7,/EIXEOK:='M[*V689FT
MP21EKB959&6,P*VZ1FA^6XBSRG@J$\)AJD98RJG!I/\ @Q:LY.VT[/W(WNF^
M9JR2?W_!7"=?-,71S#'494LKPSC4BY1LL3.$DXPBI;TDU>I))II>S3O)N/ZH
M5^8'[X?G#^U/\#-1L-:O?B5X4L+J_P!*UAY;SQ396EOYK:-?I''YVJA(5WG3
M[LB2:=RK>5/YSNXCF41?H?"^=TYT89;BIQIU:"4:,I.WM(W=H7>G-#2,5UC9
M)73O^+<?<*UJ.*JYWE]*57#XAN>*A"-_8U$ES5;1U]G4UE-M/DGS2;Y9)1^(
M*^U/RP* +FGZ??:I>VNFZ99W-_J%Y,EO9V5G!)<W5S.YPD4$$2L\KD]E!J*E
M2G1A*I5FJ=."O*4FE%)=6WHD:T:-7$5:="A2E6K5&HPA"+E*4GLHQ5VWZ'ZS
M?LX_!T_"SPH]UK,"+XQ\1B&YUG#+(=,M8P39:(DD;M&QAWR2SO&2'FF9=TD<
M$35^5\0YO_:>*4*+_P!CPUXT^G/+[52S2:O9**>T5>R<FC^A."^&_P"P,O=3
M$P2S+&VE6U3]E!?!033:?+=RFXZ.<FKRC"+.+_;5_P"26:!_V4#2O_4=\55V
M<&_\C2O_ -@L_P#T[0/,\3_^1!A/^QA2_P#4?%'Y@U^EGX2?M+\"P#\'OAX"
M 0?"^G@@C((*$$$>F*_',[TS?,.EJTOS/Z;X4_Y)O)O^P6G^1^??[1?P,U3P
M!XCU#Q+X?TMYO NKW#WD#V$#-#X=N9R9+C3+R*,'[)9K+O:VE(6+RW2'=OC(
M;[WA[.Z6.P]/#5ZJCCJ*46I/6JEHIQ;^*5M)KXKIRV9^0<:<*U\HQM;'8.@Y
M93B).<73CIAI/65*:7P03NZ<M(\K4+\T=?EZOICX,O3ZGJ5U$EO=:A>W$$>W
MRX)[N>6)-@VKLCDD*KM7@8 P*B-*G!MPIQBWNU%)_>D:SKUIQ4)UIRA':,IR
M:5M%9-V5BK%%)-)'##&\LTKI%%%$C/))([!(XXXT!9W9B % ))( JFU%-MJ*
MBKMO1)+=M]$B(QE*2C%.4I-))*[;>B22U;;T21^H/[+'P8O? .D7WB[Q5IS6
M7BKQ!&MK9V-T@%YHNAQOYIBF4.?)N[Z98998F&^-+6W1MCF5!^9\3YQ#'588
M3"U.;"X=\TI1^&I4M:ZTUC35U%K1N4FKKE9^[< \,U<HPU7,,?1]EF&+2A"G
M)>_1H)WLU?W9U9)2E%^]&,8)\LN>)]#^/_!NG^/_  ?KOA+4MJ0:O9/##<F)
M9FL+Z/$MAJ$4;$;I+>[CAE #+N"%<@,:^?P&,J8#%T,52WHR3<;VYH[2@WVE
M%M=;;]#[+-\LHYOEN*RZM[L,1!QC*UW3FM:=1+O":4K75[6OJ?C3X]^'_B7X
M<>(+OP]XDL9();>5UM+](IO[-U6V4_N[[3+F6-!<6[H5/0/&28Y%21&5?V#
M8_#9AAX5\--24DN:+:YZ;ZQG%-\K7W/=-IIG\TYOD^.R3&5,'C:3C*#?)42?
MLZL5M.E)I<T6OG%^[)*2:7+V&IZEI4WVC2]0OM-N-NWS["[GLYMIZKYMO(C;
M?;-=4Z5.JN6K3C4BNDHJ2^YIHX*->OAY<]"M.A/;FISE!V[7BTR&ZN[N]G>Z
MO;JXN[F0YDN+J:2XG<@8!>65F9B!ZDTX0A3BH4XJ$8[1BDDO1*R1-2I4JS<Z
MM252<MY2DY2?JVVV>I?"7X/^)OBOKT%AIL$]CH<+EM8\1S6TIT_3[>/#211R
M[0ESJ4@(2*V5MQ9PS[(D>1/,S7-\-E5"4ZDE*NU^[HIKGD^C:WC!;RD]+:*\
MFD_?X>X<QW$&+A1HPE2PL7^^Q$HOV=.*W2=K2J2VA!.[;N[14I+]D](TJQT+
M2].T;3($M-.TJRMM/L;>,!5AM;2%((4  '(C1<GN<D\FOR"K5G6JU*M27-4J
MR<I-]9-W?XG]*8?#TL)0HX6A!4Z.'A&G"*VC&"48KY)'R#K'_!/?]D#7]7U3
M7=6^$7VO5=:U&^U;4[K_ (3[XGP?:=0U&YEO+VX\BV\:QPP^9<S2/Y<4:(N[
M"*J@ =L<UQ\(QA&O:,4DER4]DK+>!@\OP<FVZ-W)MOWY[O?[1TWPW_8H_9D^
M$?C31OB%\//AG_PCWC#P]_:/]D:O_P )E\0-5^Q_VKI5]H=__P 2_6_%=Y93
M^;I>I7L/[ZVDV>=O3;(B.N=;,<97IRI5:W-3E:ZY(+9IK6,4]&D]&72P6%HS
MC4ITN6<;V?--[IIZ.36S?0]?^*OPA^'?QM\*GP3\3_#W_"3>&#J5GJQTS^UM
M<T7_ (F%@)EM+C[;X>U.PN_W8N)OW?G[&W_,K8&,*%>KAI^THSY)I-7M%Z/?
M22:Z=C:K1IUX>SJQYH73M=K5;:IIGS1_P[@_8P_Z(U_YD/XK?_-S79_:^8?]
M!'_E.E_\@<O]FX+_ )\_^3U/_DCZR\">!?"OPR\(Z'X$\$:5_8GA3PU:M8Z+
MI7V[4=2^Q6KW$UTT7V[5[RZO+C,]Q,VZ>XE;Y\9P !PU:LZU256I+FG)W;LE
MY;))+;HCKITX4H1ITURPCHE=O\7=F)\5?A#\._C;X5/@GXG^'O\ A)O#!U*S
MU8Z9_:VN:+_Q,+ 3+:7'VWP]J=A=_NQ<3?N_/V-O^96P,50KU<-/VE&?)-)J
M]HO1[Z2373L*K1IUX>SJQYH73M=K5;:IIGS1_P .X/V,/^B-?^9#^*W_ ,W-
M=G]KYA_T$?\ E.E_\@<O]FX+_GS_ .3U/_DCZK^'?P\\'?"CP;HOP_\  &C_
M -@>$?#R7D6CZ1_:&J:I]C2_U&\U:[7[?K5[=WMQOU"_NY<SW$A7S=B[4557
MAJU:E>I*K5ES5)6N[);)):))+1+9'73IPHPC3IKEA'97;ZWW;;W?<SOBG\)?
MA]\:O"<W@;XF:!_PDOA:>^LM2ETO^U=;T;=>Z<[26<WVWP_J5C=KY;NQV"<(
MV?F5A54*]7#3]I1ER32:O9/1[Z237X"JT:=:'LZL>:%T[7:U6VJ:9\R_\.X/
MV,/^B-?^9#^*W_S<UV?VOF'_ $$?^4Z7_P @<O\ 9N"_Y\_^3U/_ )(^J_AW
M\//!WPH\&Z+\/_ &C_V!X1\/)>1:/I']H:IJGV-+_4;S5KM?M^M7MW>W&_4+
M^[ES/<2%?-V+M155>&K5J5ZDJM67-4E:[LELDEHDDM$MD==.G"C"-.FN6$=E
M=OK?=MO=]SYP\3_L"?LE>,?$OB'Q?XD^$_\ :/B+Q5KFK>)->U#_ (3OXEVG
MV_6M<O[C4]4O/LEAXR@MK7SKZZGD\FWAAB3?MCC1%"CLAFF.IPA3A7Y802C%
M<E/1)62NX-Z)==3FEE^$G*4Y4KRDVV^:>[=WHI6W['8_"?\ 9#_9W^!OBB3Q
MG\+?A[_PB_B672KO1'U+_A+/'&MYTR^FM;BZM?L?B+Q+?VHWRV5JWF" 2+Y6
M%<!F#9U\?B\3#V=:KSP33MRP6JO;6,4^O<NC@\/AY<]*GRRM:_-)Z>CDUT/I
M.N,Z3X[\3_L"?LE>,?$OB'Q?XD^$_P#:/B+Q5KFK>)->U#_A._B7:?;]:UR_
MN-3U2\^R6'C*"VM?.OKJ>3R;>&&)-^V.-$4*/0AFF.IPA3A7Y802C%<E/1)6
M2NX-Z)==3CEE^$G*4Y4KRDVV^:>[=WHI6W['7?"K]C[]G3X(^*AXV^&'P[_X
M1CQ.NG7FDC4_^$M\<ZUC3[\PM=V_V+Q#XFO[3YS;P_/Y&]=GRLN3G.OC\7B8
M>RK5>:%T[<L%JMM8Q3_$NE@\-AY\]*GRR2M?FD]/1R:/I:N,Z3X[\3_L"?LE
M>,?$OB'Q?XD^$_\ :/B+Q5KFK>)->U#_ (3OXEVGV_6M<O[C4]4O/LEAXR@M
MK7SKZZGD\FWAAB3?MCC1%"CT(9ICJ<(4X5^6$$HQ7)3T25DKN#>B774XY9?A
M)RE.5*\I-MOFGNW=Z*5M^QU7PL_8Z_9Q^"GBR'QQ\,OAU_PC/BF"QO=-BU3_
M (2[QWK.RRU!%CO(?L7B#Q/?6C>8B*-YMRZX^5E-9ULPQ>(I^RK5>:%T[<L%
MJMM8Q3_$NE@\-0GSTJ?+))J_-)Z/?1R:/IJN,Z3SOXD_"3X:?&#1$\._$WP7
MH7C+28)))K2'6+027&G3RQ^3+<Z5J,+1WFD731?(T]G/!(5&"V!6U&O6PTN:
MC4E2?6S[=ULUY-,SJ4:56/+5@I);76WH]U\CXLUK_@EK^R=JD\DMCH_C?PW&
MS96UT7QI>SP0CY?EC;Q%;ZI,5^4_?F<_,>>F/0CG6.BK.4)6ZN"7_I/*CBEE
M6$>RE'R4O\[G1>$?^":O[)7A2\BOIO VJ^++B!_,A7Q=XHUC4+-6Z 2Z;83V
M-E>(!GY+FWF7G)4D B9YQCIJRJ*FO[L4G][NU\FBH99A(/\ AN5OYI/\E9?>
MC[DTC1]*\/Z7I^AZ%IMCH^C:19V^GZ7I.F6D%CIVG6-I&L-M9V5G;(D5K;11
M(J)'&BJH4   5YDI2E)RDW*3=VV[N_=MG=&*@E&*48QT26B26R2Z&C2&?'?B
M?]@3]DKQCXE\0^+_ !)\)_[1\1>*M<U;Q)KVH?\ "=_$NT^WZUKE_<:GJEY]
MDL/&4%M:^=?74\GDV\,,2;]L<:(H4>A#-,=3A"G"ORP@E&*Y*>B2LE=P;T2Z
MZG'++\).4IRI7E)MM\T]V[O12MOV.J^%G['7[./P4\60^./AE\.O^$9\4P6-
M[IL6J?\ "7>.]9V66H(L=Y#]B\0>)[ZT;S$11O-N77'RLIK.MF&+Q%/V5:KS
M0NG;E@M5MK&*?XETL'AJ$^>E3Y9)-7YI/1[Z.31]-5QG2>'_ !E_9P^#'[07
M_"-_\+=\&_\ "7?\(C_;'_"/?\5%XKT#^SO[?_LO^UO^18UW3OM?G_V+IG_'
MSYWE_9OW6SS)-_3A\7B,)S_5ZGL^>W-[L7\-[?%%VM=[&%;#4<1R^UAS<E^7
M62M>U_A:[+<\/_X=P?L8?]$:_P#,A_%;_P";FNG^U\P_Z"/_ "G2_P#D##^S
M<%_SY_\ )ZG_ ,D?:6F:;9:-INGZ/IL/V;3M*L;33;"W\R67[/96-O':VL/F
MSR/++L@BC7?([NVW+,223YTFY-R>KDVWZO5G:DHI16BBDDO):(??V%CJEC>:
M9J=E::CIM_;3V5_I]_;PW=E>V=S&T-S:7=K<(\5S;2PNZ/%(K*RL58$$BA-Q
M:<6XN.J:T::VL^E@:3335T]&GM;T/A3QE_P34_9,\77,MY;^"-6\&W,[%Y3X
M-\3:II]L7)))BTS4GU"PM%Y V6UK"@"C"CG/IT\XQU-6]HII;<\4_P 59OYM
MG#/+,)+:#A_ADU^#NON1R.F_\$J_V5;&Y2>ZA^(FLQ(REK+4O&"16T@4Y*.V
MCZ18W 5AP=DZG'0@\U;SO&M67LX^:A_FVOP(6586/\\K='+_ "2/LWX5_ WX
M2?!#3;G2OA7X#T+P;;WHA&H7%A%/<ZMJ:VQE:V75=>U*>YU+54A,\QB6[NYA
M'YTFP+O;/GU\37Q+3K57-QV3T2](JR7G9([:5"CAURTJ:@NMM]-KMW;MYL]7
MK U/._''PH\ _$B73I_&F@_VS+I$=S%I[?VIK6G?9X[MH7N%VZ3J-J)=S6\1
MS('(V?*1DY]#!9IC\N52.#K^P55IR7)3G=QNE\<)6M=[6\SQLUX?RC.I499G
MA/K,L.I*F_:UJ?*IM.6E*I33ORKXKVMI;4X3_AESX$_]"-_Y<WC'_P":"N[_
M %FSS_H._P#*.'_^5'D_ZA\*?]"K_P N<9_\T'N>G6%II6GV.EV$7D6&FV=M
M864'F2R^3:6<*6]M%YLSO))LAC1=TCLQQEF)))\2I.=6I.K4?-.I)RD[)7E)
MMMV5DKM[))=CZNC1IX:C2P]&/)2H0C3A&[?+"$5&*O)MNR25VVWU;9<J#0*
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M)8LMJ"3DDG)S[F&XCS?"Q4(XKVL(Z*-6,:G_ ),USZ?XK(^3QW!'#>.G*K/
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M2NVVWNVVWJS1K,V"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H \BUSXL6^B?%SPK\*&T2:>X\4:*^LQZTM\D<-FJ+X@;R
M'L3;,TS?\2!_G$R?\?(X^0[O6H95*ME.*S15E&.%J*FZ?*[R_A:\U[+^+M9_
M#YGSN*X@AA.(LOX>^JN4\?1=95N=*,$OK'NN'*V_]W>O,OB6FFOKM>2?1!0
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MIU75C4<XQ=:C3O3<*D(Q?+4D_>C-72TM=/Z&KP#[$* "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@#XX\=_\GB?"7_L1YO\
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MT<.U./5>[2C^<)+Y'S?A\U5Q7%.+I/FP^(QL73GTDE/$3T_[=J0?S0[X*_\
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MM7BY1=^24;ROQWP@^"?@[2;X>-[V;7?%'B2%XTL-0\5:BFJOI31*Q$UBJ6L
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IBC",/9V3E=N4N8^IZ^8/O0H * "@ H * "@ H * "@ H * "@ H _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>140
<FILENAME>g20922g70b71.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g70b71.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M %O_ -_5_P : #^U-/\ ^?ZW_P"_J_XT ']J:?\ \_UO_P!_5_QH /[4T_\
MY_K?_OZO^- !_:FG_P#/];_]_5_QH /[4T__ )_K?_OZO^- !_:FG_\ /];_
M /?U?\: #^U-/_Y_K?\ [^K_ (T ']J:?_S_ %O_ -_5_P : #^U-/\ ^?ZW
M_P"_J_XT ']J:?\ \_UO_P!_5_QH /[4T_\ Y_K?_OZO^- !_:FG_P#/];_]
M_5_QH /[4T__ )_K?_OZO^- !_:FG_\ /];_ /?U?\: += !0 4 % !0!#]L
MM?/\C[3%YV<;-XW9^E $U !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 >6:%X5A\2Z]K=]XDOH;NUNM3N#;Z:K
ME=XMY#$#*/XPH5<+]T;LGEJ *WQ%M'T_6G5+=72^%O=6"$?(UW;$[H?0&2$E
M0.^"/8@'SYXH>SF31IK-]V^R.]2P9DVSRJBMCH1&L?% '/T % !0 4 % !0
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MQ_T%;W_P(?\ QH /[>UC_H*WO_@0_P#C0 ?V]K'_ $%;W_P(?_&@ _M[6/\
MH*WO_@0_^- !_;VL?]!6]_\  A_\: #^WM8_Z"M[_P"!#_XT ']O:Q_T%;W_
M ,"'_P : #^WM8_Z"M[_ .!#_P"- !_;VL?]!6]_\"'_ ,: #^WM8_Z"M[_X
M$/\ XT ']O:Q_P!!6]_\"'_QH /[>UC_ *"M[_X$/_C0 ?V]K'_05O?_  (?
M_&@ _M[6/^@K>_\ @0_^- !_;VL?]!6]_P# A_\ &@ _M[6/^@K>_P#@0_\
MC0 ?V]K'_05O?_ A_P#&@ _M[6/^@K>_^!#_ .- !_;VL?\ 05O?_ A_\: #
M^WM8_P"@K>_^!#_XT ']O:Q_T%;W_P "'_QH /[>UC_H*WO_ ($/_C0 ?V]K
M'_05O?\ P(?_ !H /[>UC_H*WO\ X$/_ (T ']O:Q_T%;W_P(?\ QH /[>UC
M_H*WO_@0_P#C0!]9_!F>:Y^$^B37$KRRMY^7=BQ/[^0=30!R?@R*P\=WGB[3
MII9K&^T[69KJRN;5_+FMQ(2IVD=02AW#H<\]J . \6^,/%]OX.T^WU34X]02
MYEFBE$ULJS65S X4@.N#N&0P;K\U 'EUY>3W]Y-=W4ADN)F+R.0 68]3Q0!!
M0 4 =W'X=\.2?#$^)1::H;X7@L1$+V/87*;M^/)SC/\ #G/^U558M."A]J_Y
M_B%.SYG+[-G_ %V,+6O!FO\ ARTBN]6TYH('<1[A*CE6QNVL%)*-@YPV#2NE
M)*7]=[ DW&Z.KU#X>:;;C5[JUFO)K1;*UFTU0RF2:6<@*K87!P0_ P>*<H2C
M>/7FY5Z;M_=846FHR>BY6WY-:6^\S[#X5>(IM56RU".+3U:":43//$ZDQCYD
MR&P&S@$$@CDG@5#:492[*_KT_I_YC5^:*[NWIU_+9=3"U/P?KVCZ8FHWUCY=
MJ^WYA,CE0P)4LJDE0<'!(&>U-^Z[/^O+U\MP6NW]=+^GGL=U9_#+1;C^SMUS
M?#[3X=?57PZ<2C&%'R_=YZ=?>JK+V?M>7[-K?.Y5)<_L[_:DU]Q@Z/\ #G5?
M[2@36M,NC:RH_P ME<VYF5Q$9%#!F^3C!PV#CI2E[L97W2;\M&E_5M2$[N-M
MFU^-_P#+T,]OAUXK2T@N1I)>.;RB@CGC=L2\1DJ&+ ,>,D 4W"2ER=;V^:U_
M(%)./.MMRKK'@S7= ELX]4M8K?[9(T<+?:8G4LI ;+*Q P3@YQW]#2@N>:@N
MOZC:<8N71'9:C\'KRUTJ[CL91?ZO;Z@ML%2XB2-XS#O. 3G?GC&<X[5,FDDU
M_>O\GT^6^]OD.*3O?LK?/^OZN<5>>$-=T_1DU:ZL#'9LJON\Q"ZJQ(5F0'<H
M)!P2 #3E[KL_ZZ_D"3=_+]-#H8O#GAV7X9?\)(MIJC7WVP6 B6]CV&0INWX\
MG.,_PYS_ +555BTX*'VK_G^/X"IV?,Y?9L_Z["Z7\,]10ZH=?MIK9;;3I[F$
MP31O^]C"G8^W=M.&!*G!YI-6@VM]+>>MGZ_(=-<TXKH_\KF<GPT\7/-'"NDC
MS'4MC[3%\F%#D/\ -\AVD'#8..U#5KWZ?YV_,E:I-==OQ_R9K6'PLU.XT+5C
M<6[QZU;R6PM8A<PB&5)2>=Y.TYQQAN3QS3DFHJV]VG\E<47>3OM:Z^^QA+\/
M_%+:=+?#2'$$6_=F1 ^$;:Y"$[B >"0,#UI)-VMUM^.WI?S*V;7;]-_4GN?A
MIXNM+F"VET@F6:;[.JQW$3XDV[MK%6.WY>?FQQS27^;^[<.E_3\=C"U;1K_0
M[Q;74(1%(R+(A619%=#T964E6!]032OJUV&TUN4*8@H * "@ H * "@ H *
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M;6R"#[8/K6KE=)=KK[T8\N_G;\'<V-,^+\FG6,%D-*E$*VTL$CP7QAE.^7S
MRN%^0CIWS[5.EK/M'_R7_,;5Y.2[R?\ X%_E;_@&%I'CQM,\3ZUK+V+W!U*V
MEMQ')=NS1A\8)=]S/@ #GK[4Z4O9PY?-/[G<J3O-273_ "L= OQAQJ=Q=G0<
MK/J)O63[7V,'DE,[/?.[]*G3DY'VDO\ P)W_  !.SNO[O_DO^8Q_B\Q72 FE
MW8&G- HC.J/Y3QQ-D#RPH7>?E!8@_=X J^=NI[1];W^:MIV77]3/D2I^S6G;
M[[Z]^Q4TKXH_V9+;O_8_F>3JEQJ./M.,^:A39]WMG.>_H*A:04.T7'[W>Y;U
ME*7=I_<6[CXQ7-Q-I%P=-G$UB\#2(=1D\B01CHL( 52>"2=W08JFTZCGWO\
MBK?(EQO#D]+?)W^?;]#SS5+F"]U2ZNK:!X(9I"ZQ/)YA3)SC=@9_(5G"/+%1
M[&DY<TG+N5*HD* "@ H * "@ H * "@#Z_\ @E_R2'0O^V__ */DH R?C%\+
MYO&=M!JNCK$-7M5*,C';Y\?4#/\ >!Z9]3STH YKX6^+(-5TZ?X<>.8G\_\
MU5LMX"&9>T>3R&7&5.<] .@H U=-T*]TJVUS7;?4[_5;C0]9W10S2$L\4<:)
M)N ^_(8F*ACS@#&-Q! .1UVQTMM+TS3+6W=H+R80:5?1Q,ZW=G,W$+<9\V)B
M& ;GY/?D \=73KYT5TLIV5AD$1$@C\J '?V7J'_/C<?]^F_PH /[+U#_ )\;
MC_OTW^% !_9>H?\ /C<?]^F_PH /[+U#_GQN/^_3?X4 ']EZA_SXW'_?IO\
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M/MK&U39;VT2Q1K_=51@#\A0!8H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * .?\2:'/J]_P"'KBW**=.U
M$7,C,<'R_+D4@>I)9: )?$?A#0/%EL(=;TR&ZVC".1MD3Z,,$?3- '$I\ ?!
M$=P)1'?X#9"?:2 /QQG]: .D7X:^&$B$2V]^L8& HU6Z QZ8\R@#H].TZTTF
MPAL;& 06T(PD8)('.>_N: +5 !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % &=J?B#1=%>--5U>QL&D!*"YN$B+ =<;B,T 4/^$[\'_\ 0UZ-_P"!
M\7_Q5 &S=7EK9(CW=S%;K(ZQH97"AG8X51GJ2>@H @DUK2HM5CTJ34[1-1D&
MY+5IU$K#!.0F<GH>W:@ AUK2KC4Y=,AU.TDU"$;I+5)U,J#CDH#D=1V[B@"6
M^U"RTNT>[U"\@M+9,;IIY!&BY.!DG@<T 55\2:$US:VRZU8&>\026\8N4W3*
M<X9!G+ X/(]#0!4?QQX2BD:.3Q1HZ.I(96OX@01V(W4 2VWBWPU>;OLOB'2Y
M]F-WEWD;8STS@T ;- '/^&_&6D^*KK5;;3&F,FF3^1-YB;03SROJ,@^AXZ4X
MKFIJHMF)OEFX/=#8=3UN]O)KBRAM6TZ"Z-L86!\Z0*VUW#[@JX.[Y2#G;U&<
M4H[)RZ_AV];_ *]1S33:6Z_'2_Z_?VW*VJ:_ID<HM[>U7[=%>0DI=64D8.Z9
M(VD0LH#$;OO*3SBG%<VJVU_)M?D-JU[]F_N)F\5?9?#>F:C=6[O-?.L06")W
M56;/) !(''>HD[)6W:O_ .2W&EJ^R=O_ ":Q!X?\>Z3JWAV&_ENU-PL,37$<
M$,C?.X^ZB@$O\P8?+NY!'4&MJD5&7N[7LOZ]-?34SBWU->Y\2Z19Z&-9N;P0
MZ?D*99$9=I+;<%2,J<\$$<'K6;]UI=_^'*6OR(H_%FB2:>U\MX?LZP/<,6A<
M%40[6)4C((/&,9]JKE=[>GX["3N[>OX6O^:(;CQMH%K/-#+=S!X2P?;:3,/E
M.&P0N#MZG'0<G YJ4[[?UT^Z^E]A_P!?A?[[=-RKIWCG2YM2U.PO+V&*>TF<
M* K!?+50P);[N[&3C.<#..*(ZPYO6_\ X$U_E]_FB;^];TM\TG_G]Q<;QGH,
M<5M)->M;_:;@6T2SV\D3F0\A2K*",CD9 S32;DHK=_H-NR;?3^OT&W/B)++7
M+BUO+F"VM8=A#/&Q+YCD=AN!PN!'G)'0$=2,*.L6WT;_ /;?\_R'9N7*NR_%
MM?H1GQQH_GVJ*UP(YC)ODDMI8Q#L0,=X905X((W8R#D4[.]GVO\ BE;U_P"&
MZ@]/OM^>OII_5F2S^,]#M]-^VS7<D,>\Q[9K:5'5L9^9"H8#'.X@#'.<5,[I
M:;_U]W_##2N[?U\N_P C(U+Q==VWA?PWJ7VW3=.;5&C$US>(6@B#0L^0/,7N
MH RW>M*D5&JX7VO^%AQ2<)273_.Q2;QQ=/#IAEUW0M+CN8[AC=W<1,5QY<@1
M6C!E3 8'=U;CN>M)K7MI%VZZW_*W;J2]-%KJ]>G3_.V_0ZC1]8FO+G4(II;>
M:.T6(K/;J0L@:,,6'S-QZ<GCN>M3)J,92:M9M?<E_F*.K23O=)_>VOT,G_A(
M->73K75C%9FSU# MX/+820%U)C+MNP^3M! "XSU.**B=.\7O9_>E=K[D]?P*
M3BW?I=+UN[77W_\ !,__ (3^^EEO&M[6!K<::D]JQ#9:Y*JQC;GIB1.!SUJ^
M6TG'^\DO2Z3?R9*;48RFM+-OO?71?^ LVO$/BI- U73+:ZD6"WEBEGNIS:R2
M*J1@9 *\+RW4YQC&.14)IR:Z)?F[(=FJ?-UO^C;_ "_JQ:MO&6@7DL26U_Y@
ME0.DBPOY9RNX#?MV[MO.W.['.*)+E3;Z?T_6WD.U[6_KH-L_&N@W]Q#!;W<I
M>9E5-UK*@.X94DLH ##[I/#8.,XJN5WMZ_AO\^MNVNQ',K7]/QV_'3UTW+UY
MKEC8:A!97)GCDG(5'^S2&+). #(%V D\8)!Z>M3'WG9%/W5=E74/%-AI>K-8
M7@FCVVXG,H@=E.7"A00IRQ)X4<GC I+6_E;\;_Y?U9CM:WG?\+?U_P .AX\4
MZ,;)[O[65ACA>=]T+AD1#ALJ1D$'@J1GVJDFW9>7X[?D3?6WK^%K_FC)USQ[
MI>FV[M;W<>Z&XBCF::)UCV&54D*N0%8KNYVDX.,^E$5=J^S_ ,FU][6G?H4T
M^5M=OZ_ TKGQ5I\/AE]>M_.N;13@".!]^=VW!3;N!!ZY'%#34HQ?5K\?Z_06
MZ;[7_P _Z^_8)O%^AV\ERDUXT8MD9Y':"0( HRP#;<,RCJH)([BE=6O_ %O;
M[K]=@\OZVO\ ?;6VY'%XV\/W%F+J"]DFB+E (K:5V. "3M"[MN"#NQMP0<X-
M-IJU_P"O7M\P]/Z]._R-Z.1)8UDC8,C@,K Y!!Z&AIIV8DTU=#J0PH * "@
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MJ_!-?K_P"?5/"G]I:H][]M\K=CY/)#XQ%+'WX/\ K<\@CC'>ICHFN]_QY?\
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MC;::EONC7/WMK99SG[Q./11SFW*ZMZO_ (;M^/KVE1MM_7K_ $CIZ@H* "@
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MY79E&7-9K9_U_6B.IK,L* "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M\FD6,=T+E8,3"5I@VYOOLNTG&?3BDM-%YK[W?\P<4W?SO]RM^1=H&% !0 4
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M]VM_Z9H[6GZ1^_F_'2WY=#I;*ZNK#PGKMU#&IUN)Y9+F-$RHG"C!51SM*A6
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M-Y>3RC'*\.IQV)([4 ?3% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M#%BC21Y%C42/@,P')QTR: 'T % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M-&B$2JIPH.-X/)+<$4 ;EC8P:=KFLBQ\=I'<SSF74;:.654BNRS>:551PI.
M,Y/R\DT >WT % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 96K?ZV/Z4 9U %B^_P"/V7Z_TH G
MOO\ CRM/]W^@H LQ_P#('/\ N&@#/;_CUMO]YOZ4 -N_^/N7_>- $D__ !_C
3_@/\A0 /_P ?4_\ OG^9H __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>141
<FILENAME>g20922g72h92.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g72h92.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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F:/(U<=9>$[2*2::^E>_N)<;I)CR .E34K-6LK&E&BHMMMOU/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>142
<FILENAME>g20922g75f04.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g75f04.jpg
M_]C_X0 817AI9@  24DJ  @              /_L !%$=6-K>0 !  0   !D
M  #_X0,K:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@
M8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B \
M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!
M9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ-#4V-C$L(#(P,3(O,#(O,#8M
M,30Z-38Z,C<@(" @(" @("(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO
M+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR9&8Z
M1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B('AM;&YS.GAM<$U-/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(B!X;6QN<SIS=%)E9CTB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(@>&UL
M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(B!X;7!-33I$
M;V-U;65N=$E$/2)X;7 N9&ED.C(R0D$T,S,W1C,T-S$Q14%".39!.4$S,3$Y
M.3(X-S9$(B!X;7!-33I);G-T86YC94E$/2)X;7 N:6ED.C(R0D$T,S,V1C,T
M-S$Q14%".39!.4$S,3$Y.3(X-S9$(B!X;7 Z0W)E871O<E1O;VP](D%D;V)E
M(%!H;W1O<VAO<"!#4S8@5VEN9&]W<R(^(#QX;7!-33I$97)I=F5D1G)O;2!S
M=%)E9CII;G-T86YC94E$/2)U=6ED.C@T,&0R834Q+6-E860M-&4Q8RUA,# U
M+3%F,3 S,&1F,64Y92(@<W12968Z9&]C=6UE;G1)1#TB=75I9#IE.&9F9C!C
M-RUD8V9E+31B8S(M8F9F,BTX8SDT-V,Y-C@Y,3<B+SX@/"]R9&8Z1&5S8W)I
M<'1I;VX^(#PO<F1F.E)$1CX@/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0]
M(G(B/S[_[@ .061O8F4 9,     !_]L A  ! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! @(" @(" @(" @(# P,# P,# P,#
M 0$! 0$! 0(! 0(" @$" @,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P/_P  1" !2 +T# 1$  A$! Q$!_\0 >@ !
M  (# 0$! 0            @)!08'"@0# 0$!                     !
M  8" @$# @,"# <      @,$!08' 0@ "1$2$Q05%B$7-R,8,4$B,C15939G
M.#D*,R1D)35F.A$!                     /_:  P# 0 "$0,1 #\ ]_'
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M(INSN=-9I5:T9/Q&R14I1T,A6M-;SAI2&&JE.45@!JA>]$*1'9 M0K4QQ91
M1>W@+>. X#@. X#@. X#@. X#@. X#@. X&GV$R.DD@<SCS)-'*N'A\BS\TM
ME@LR=I5N\(7.#8I2II6UIGY,M9#G!@--PJ)"K)-3Y,*Q[@1!\XR'F0UQUWB7
M8";+M5J)62MMZDZ?N)^ENSFP!SG+HE=G:GM\[OR^3WI')(]IFZ()7C6-\>9*
M;B6KFU(0A?E)*=L8C4[0EP60'J-9F=ICK0U1]A;43,QL3:A9V9H;$Q*)N:FE
ML2E(FYM;T:<!9"1$A1D *** ' "RPX#C&,8QP,EP' JE[=MAY_6.O4<UVUZ=
MOB;=[V3QLU9US+1&&9>(R?-LED6O=1912!P^.R415ISC(%:T[!29*>4E"(T(
MS2@C"QJJ*RB-+UE *D@36D9H96T0C\*C3:A0M[:G3-$=;$[8DSA$U)$+<0<>
M6G]PWV22P"-&(6 X\\#H' K>V1[,:IHFRK'H:(5Q;]\WS6]1(+:D44KN)F(:
MVB"&2KW)L@[5;5_2DUHJ.HU4L/95J@@+LXX5#0H3A)TRE4-(D5!*[6>U9=>5
M"U;;\ZJ]SI>46+%4DJ<*P>70YY=8B0Z&GG-*)P<%3%&%ABM4S_'4C >W(E!&
M3_:-) 8 0<!W/@. X#@. X#@.!JD@GD&B?G[IF<4C7@LHW/W!(FAF\%'CP42
M9GZBL3>"SC,^D.?X!"_#'X\#CS9N#J8]RIB@C%LYK\_3>3NI+''8<Q7%7SU*
MGMX/R>$IM:X^UR%6[+5@Q)3<>@LD6?V8O/\ -SP)&<!P' <"DZ[K"M/LZMB=
M:?ZHVM-J2U1I>2)HYN?N/5CDA;YI8,J.9"W([4O5^1JVQU;T[D4WO*17.)H1
M@XMD+R4U)0'*5*GV0N0B479X1%(S"X\0:FC\0CS+%V-,>I/6GIV=@;4S2V$'
M+%1AJI6:4B2 "(TP0C#,X]0LYSG.>!L/ <"*>XFZFO&B=1+;EV*FY<98QK26
M&'Q=K2F/UB6G-W#^0QUW5<'0Y$]S>;OZG(2TZ-*#(2\9R<H&2G+-. % $HO2
MQ:<V BW8GMY4+O+^QG8NN76D^K'JL@LM"JEM'U.[D_7)G*;RDZD3=&(E()8J
M+(76-+G%,4RPQJ28;P&G'%&%E!M.CQ.S5OV?*NTW?7>JSFO5VDH4M40^*UPX
MOFO&FTRDP%)I\QD,)@* \F?WEKQ7(O\ LD;D$U^0NL5[R8Z-R,+8%J^:'?MD
M]MMSKAJI9+X;')KJU4UMKT< U>I!H;&*/]E.Y\T/42]<8R0Y?/I!BM].*_F<
M%8RW83\]-;K,(\P%.+B>0S*DZ7(PCQKQ+8=KK<6O%$WIJ\IE&Z=HNL(L:/\
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MQ$ILWM;=+TM(PG7G7E>O2M4A:G_"5HD\4JYZF\92.X&\:!Q"C=0&K&\\163
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1[_\ AO\ &3^L_P"T/@<#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>143
<FILENAME>g20922g76p10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g76p10.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M#(Y91GE3$TT_JF;.>(IO72JY)XB%V]6JDE4711JQBMCUVOV$^%"@ H * "@
MH * "@ H * "@ H * "@ H * &NZ1HSNRHB*7=W(5$102S,Q("J "23P *F<
MX4X2G.2A""<I2DTHQBE=MMV222NV]$AQC*4E&*<I2:225VV]$DEJVWHDCX*\
M?^*+KQ]XKN;BVR--L4GMM+0G:D.F6?F337TH. KRA9)W_B"[(@6\M<_Y_P#B
M%Q3BO$'BW$XC#7_LS 1JT<#%Z1IX+#\]2KBJE[)2JJ,\14?Q*/LZ*<W3A?\
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MB0L/#%W=_9]=LX$8KIT5\ZQW2>5&O%D[,LT '"3Q)%\H,0;\LXHX;K>%7&V
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M-PG0G)1=E*,7*+[--)K7L[-=4F=]+%X>K%2C5C'O&32DO5/MWV[,Z"Q_::^
M.J?$'1/A;HWQ8\&:[XX\0IJ!TK1M U>'78Y)M+A-Q<V-SJND?:-/T[4S LKQ
M65W=0SS""011NR8J'@<7&C*O+#SC2A:\I+EWT32=FUW:32ZE+$X=U(THU8RG
M*]DG?;I=72?DW<^#/^"/W_)!/B-_V5Z^_P#4,\'5ZW$7^]T?^O*_]+F<&4?[
MO4_Z^/\ ])B<)\'M6L?V3O\ @H!\=?#GQ/N8_"/@GX\3:UXC\#>+M:"Z7X9O
M;S4O$(\6:79)J]TBVT5O;+K.NZ.\KW$:I>6<$,@+7,1&N(B\?E&%G07M*N$Y
M8SA'622CR-V6NO+&6VS;Z,BBU@\?7C5]R%>[C)Z1WYEKMI=KUTZGTU^W_P#'
M7P+X>_9W\:>!-'\3:+K_ ,0?BA8V/@[PEX1T/4+76=<U)-;U6TM-2O%TW3FN
M)X[2/2UU!8YC$%ENC;VT;":==O#E&%JRQE*K*$H4:#<YSDFHKE3:5W97O;3M
M=[(Z<?7IQP\Z<9*52JE&,4[O5V>BOTO\[(^6_B]^R[XG^&W_  3K^'3)'<6W
MQ4^!VN67QFN9;0"2^T6YUO6+F]\1:9'OA*HNC66KZ==76 5,OA%I%=D^63OP
MV.A6SBMUH8J+HI/9J,4HO_MYII>4SEJX65++J?2K0:J>:N[M?]NIIO\ PGOO
M[#&L:E\?_B)\:/VOO$.D2:2WBR#PK\+/ FFS/YJZ%H/A?1M+O_&-KI\[,6FT
MZ]\3-I\P?:@\^SNN2S,D/)FD8X*CA<NA+F]GS59OO*4FH7[-1NO1KY]&!;KU
M*V+DN7FY807912<K>3E;YIGP?^U ?&_[/OQ;_:3_ &?O MA?Q>'OVNY/ WB'
MP5'IYDB\K5=?\66\?B/1=/AAA5(;;4;V[\5Z++;P,R_8C80M$5E7R?5P'LL7
MA\%BZK7/EW/&=^T8>ZWYQ2A)-];N_?@Q//AZN)P]--1Q?*XV[N6J7J^:.G2R
M/<_^"@?[/]S\-?AG^S!XP\'^%/\ A,_"7[.D5KX;\7Z3-I\=_I=[H=NWAN^M
M]2\0V$L5RJZ1J&HZ'J<&HRSPW,!;78UG&'Q+RY1BU6KXZE4J>RJ8N\H.]FI>
M\K1>FL5).*33]W0WQ^']E2PLX0YH8;W9*VEM'=K71M.^ZU/M#P%I?[ /Q'\%
M6?C[PWX!_9@_L">RCO+TZIX%^%>E7WA]S$);BP\26-YIJ2:)?VPR)8KG:, 2
M(SPNDC^;5EF]"JZ,ZN)YXNRM.JU+LXM/WD^EOS.VFL!4@JD:=%1MK>,%;R::
MT:\R]I&@?\$^-=L(M3TGPU^R%=V$TMW##<KX=^#\:2O8WD]A<&,36",\0N;:
M8)*H*2*JR1,\;H[3*>;P?+*>+BU;3FK=KKKV?R",<O:O&.'MTTI]-.Q]+:AI
M0\4Z[:B]C$GASPW,9Q;R<PZOXB7Y49T!Q-9:9&64AAM>ZFDC8'[(X;\SS#*5
MQ7GV%6-IJIPWPU4]JJ4]:>89NO=BY13:J8;*XWBU)<E3'5*E*2?U2I&7V&%Q
MO]B996^KRY,VS:')SQTGA<#NTG:\:N,=FK>]##PC-/\ ?Q:KS:5#XD\1+KFK
MI&= \+B5-$M[HK]FNM55B=1U^='PGV>U$:6]L9,X>&XG7"M$S<];*:/$G$<<
M]SBG!\/\*J<<LI5VO8UL>FWC,VJQE:'LL*H1PV"=6]JE/$XJ%H2H3EK3QL\H
MRIY;@)-9GG'*\7.FG[2GAFK4,%!KWN>MS.KB%"UXRI497DJD4>']".H:[?>-
M]8@#7ER!9^&K>X3,FCZ#%O$,PC<9MK^^,DMQ("!)$EQY)(S(I.'LA>89]CN.
MLYPZEC<2EA\EHUH^_EV54^94ZBA)7HXO'N<\1632JT*=;ZNY1O6@S-,R6#RW
M#<.9?5Y</0?M<?.$K1Q6-E;FBW'XZ.&Y8TJ>O)4E#VJ3M3D>@5^A'RY5O;*T
MU"TN;"^@CN;.[ADM[FWE&8Y89%*NC#@C(/4$$'!!! -<N-P.$S'!XG 8[#PQ
M6#Q=.5*M2FKPJ4YIQE%K?5/1IIIV:::3-L/B*^#KT<3AJDJ%?#SC.G.+M*$H
MNZ:]&MGHUHTT<?X-M;_P\+CPC?L\]MIF^?PW?L2QO-!:0!+24\XO--DEBMW!
MV[HY;9D&"<?&\%X3'\.1Q/!^/E*OALLYJN38J6OUC*G-*.'J/6V(RV<X8:JG
MRJ5&IAITX\KER^_G];#9HZ6>X5*E5Q=H8^@M/98U1UJQ76EBXQE5A:_+.-:,
MG=*_=5]X?-#)(XY8WBE1)(I$:.2.10\;QN"KHZ,"&1E)!!!!!P:-O*P'RYXK
M_8E_92\9W\NIZY\#_!BWLTOGSRZ##J'A))IR=SRS0>$[_38I9';+2,Z$R,S,
M^YF)/?3S/'T5RPQ4[+1*5I_^EJ6WX'++!82;NZ$;^5X_^DM'IGPW^ WP:^$
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, 4 % !0 4 % '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>144
<FILENAME>g20922g78m49.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g78m49.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M<[> K>_3RZK.A%M7<_JW-&FY7NKN5.+W=F>O_P#!0C"_'K]B<GC_ (J3XF\
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M;&9+1S+'X.GA,#P]D^,E@IJ<*CJ4,3ELX1<X?%%\D*3<6KKF:=N4K7]G+;>
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;8&A3Q$7*2G&C2C*\XM2?-&"EJI-/7KK?4__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>145
<FILENAME>g20922g82f51.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g82f51.jpg
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M$0'_Q !\  $  @,! 0$!            " D&!PH% 0($ 0$! 0
M         0(0   & @$# P,!" (# 0    $" P0%!@<( !$3"2$2%106%R(Q
M05$C)!@9"I$E@3,F)Q$! 0 " P$               $1 B$Q05'_V@ , P$
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M>6-G"6"R,(-FU:RE*=.HN7833%J\%4[F)>$6 0**9E0NOX#@. X#@. X#@.
MX#@. X#@. X#@. X'-5H-OGH[K'D+RAAN#L)A#7C;1YO_GZRYIB<M79G4KG8
M<85]*/B-=%J:2UN&TM>J+%X1@V"$,VA"O$TE16(1+ON.JP1=\:>?+!Y"?]AS
M;+<NAPUF:ZS8[T8I>+L2SETK<G2Y:>Q]>+;4I;']I95F;;-9]&)R99JK<IJ,
M5>HMU%8A-!0Q$Q4(00L,\PU0G]6KWKOYCL2P-CF+-IE,+4G;"H5)P=LYRMHM
MDYVE&Y1))Q[-$5['*X:GC1]KBTUC?3-RLG"JH>U(ITPO&IUPK=_J%6OM0E6T
MW4;K6H.WUB<:"(LI>MV.+:S4+*MCF O5L_C'B2Q!'I^DX<#TTIF'7E7<$A*Q
MJTVP9M)!]#)/FQY5DP?J.$6+YW'%5%XV9O56:I4E3D*10R1P*(B4>@5$>>'*
MV0\:>-7,$!B*P+5;*>P5LQ'JQ1)]LX=,G$;+;$9+K>-'ZZ,DT 58I3[;FGP
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M78NQW;;QFFW4VC8O@H21<W2RY EXJ$J+""^D6"1":?32R$?](LU]Y#)G$>Z
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M:H5)VS?I1%DA(V<BTWT<H"T>\3CY-LZ:$=L5B@=%0">](P=2B \#(@#IZ!Z
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M KB\G_\ C1_MN>?Y2OPS_;W]PP_TWY;^O[OW9[E_B/LS[9_^\^X^UW^GPO\
M5?3=[W_R>YP(W^(__![[LD_XDO[=/N3XR-_*7X\^Y/RU]N?*.?BON;\G_P#Z
ME]H_+^[L]S_K>]VO;Z]K@6Z9/^POQID/\J_$_B_[&MOY(^>]WP?V%\!(?>'S
M7L_5\3]O?4?4]/7L^[@5C>$]MB5#1^"4UBFLKRFFSK)&5%M16>;*Q&P-Y@\.
MA>IQ(8V-D6=NLDO:L7&N2<HO4'L\UAK$6!500?-![23A8+<N X#@. X#@. X
=#@. X#@. X#@?!]O[^G_ )Z<#[P' <!P' <#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>146
<FILENAME>g20922g83a33.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g83a33.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MA@* ,^'5_&6L>/K#X9'QMK5A_8-[XRM+WQ!81:='J.N6MEHO@/7]%-ZDEHT
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M-4=&+=U-<L=9'T-\3O#ML-0\-^'%69].&I_ C07;:2PL1K?Q#T^0,5!&?L^
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MS*7Q(_HZ7\"GZ1_]L*MU_K=(_P"RGW'_ *2ZG3?3T+>T?1&WIO7P7_V+L_\
MZ3:#4B/!OB;_ ,BE\*O^N\'_ */TF@#Z*M?^1FUW_L&Z)_[EZ /"OC#_ ,DX
M\1?]COJ?\[J@#UK1?^/;X=_]BX/_ $UZ/0!I:C_R.'AG_L%^(?\ W%T >2_%
M+_CY'_8Q2?\ J.:50!R=W_R2'QM]=$_] M* /5?"W_(M_#7_ +!]E_Z'I] '
@ 6'_ "<#XB_[!$O_ *;'H X2Y_UDG_72/_T*XH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>147
<FILENAME>g20922g89x17.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g89x17.jpg
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M  (# 0$! 0            @)!08'"@0# @$!                     !
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M-H2A4_R6P[.D@$Q+H[IVLD""*0B--;<B2MC.R,;>WM[>U(4Y7C-.":H-"5G
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MREJK:M6"D=6IM'\6\7J)3:Q>TQF-%O2B+. 60DUU1,BGY!IJD/3'P' <!P'
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MO4>GG>;0QA?VY\.,?WAEPY2S+GDMK2FB*5-9)QQR?QE9,#JO8;0LYV@A6O\
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M9]CC@LD915-MCJC1]BI)!DLEJD#A>6OTKF];R9F3#-3(/NX:RK9@R*5>$XW
M]I);4^5.4A:U+A0'.>OF;(=A=X>US9)F(&OA,;NRIM)*YDBV-,C4H4@U2KY2
MIN!*R/C:G&LD\<_6ZU'D!:X]6>(W*4!/L*"E++"%PG 8QZ8QC'Y8_#'^K@.
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H_3+_ ,C]6^1X_P#O^3V_\WIP+&N X#@. X#@. X#@. X#@. X'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>148
<FILENAME>g20922g93z86.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g93z86.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /?Z /'_ (:?\EB^(?\ UW7_ -#:@#V"@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H \J_X5CXV_P"BK:C_ . I_P#CM 'G_P *_!WB
M+7;#6)-+\;7>C)!>F.1(H2_FM@?.?G&#0![!X/\ !WB+P]JTMWJ_C:[URW>
MQK;S0E K%E._.]N0 1T[T =K0 4 % !0 4 <'X0\%:EH'CWQ5KMU/:O:ZM('
M@6)F+J-Q/S J .O8F@#O* "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#@_AAX
M*U+P58ZO!J4]K*UY>&XC-NS, I &#E1S0!WE !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MOF1_9I7V[E##E5(/!'>@#/\ ^%V_#S_H8?\ R3G_ /B* #_A=OP\_P"AA_\
M).?_ .(H /\ A=OP\_Z&'_R3G_\ B* #_A=OP\_Z&'_R3G_^(H /^%V_#S_H
M8?\ R3G_ /B* #_A=OP\_P"AA_\ ).?_ .(H /\ A=OP\_Z&'_R3G_\ B* #
M_A=OP\_Z&'_R3G_^(H /^%V_#S_H8?\ R3G_ /B* #_A=OP\_P"AA_\ ).?_
M .(H /\ A=OP\_Z&'_R3G_\ B* #_A=OP\_Z&'_R3G_^(H /^%V_#S_H8?\
MR3G_ /B* #_A=OP\_P"AA_\ ).?_ .(H /\ A=OP\_Z&'_R3G_\ B* #_A=O
MP\_Z&'_R3G_^(H /^%V_#S_H8?\ R3G_ /B* #_A=OP\_P"AA_\ ).?_ .(H
M /\ A=OP\_Z&'_R3G_\ B* #_A=OP\_Z&'_R3G_^(H /^%V_#S_H8?\ R3G_
M /B* #_A=OP\_P"AA_\ ).?_ .(H /\ A=OP\_Z&'_R3G_\ B* #_A=OP\_Z
M&'_R3G_^(H V/#?Q$\*^+M1DL-#U3[7=1Q&9D\B5,(" 3EE ZL/SH ZB@ H
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M_P#H5-&_\ (O_B: #_A!/!__ $*FC?\ @!%_\30 ?\()X/\ ^A4T;_P B_\
MB: #_A!/!_\ T*FC?^ $7_Q- !_P@G@__H5-&_\  "+_ .)H /\ A!/!_P#T
M*FC?^ $7_P 30 ?\()X/_P"A4T;_ , (O_B: #_A!/!__0J:-_X 1?\ Q- !
M_P ()X/_ .A4T;_P B_^)H /^$$\'_\ 0J:-_P" $7_Q- !_P@G@_P#Z%31O
M_ "+_P")H /^$$\'_P#0J:-_X 1?_$T '_"">#_^A4T;_P  (O\ XF@ _P"$
M$\'_ /0J:-_X 1?_ !- !_P@G@__ *%31O\ P B_^)H /^$$\'_]"IHW_@!%
M_P#$T '_  @G@_\ Z%31O_ "+_XF@ _X03P?_P!"IHW_ ( 1?_$T <GINDZ;
MHWQ]:WTO3[6Q@;PUO:.VA6-2WVD#.% &< <^U 'IE !0 4 % 'F-]KOB>P\2
M:E/!<VMQ:VWVES%*KJ$B3R3@ -AFY(!XQDG!SBJHJ\5S=6E]\I+^O1+S,ZCM
M)\O2_P#Z3%_TO/?H=#X<\2ZMJ^N7,%UIZP6!\W[.^Z,-^[DV'@2LS9ZYV)MZ
M<YS2BKT^9[Z/[_Z[Z]E8MO73T^[^O^"4!J/]G:9_PD4FJ7$E\QN ]FTK/')L
M#GRU3.V,KM'S 9XP<YI1T22ZI/YNVOHK[?J6H\\VGI9V_'\;K7\=C-FUO4=$
MO]0-G9:&+Y8);N[NH+-D%P$5'"G#YW8<C)+=0<=JJ"O[JV3M\V[7_'\&@4>>
MTNKM\DU+[_A\B:Z\=ZW8ZM+I\QTDO:[GF)WQM,HV';$I8_-B0#))Y'3G 4;-
MJ^VB^^3C?TTO^'F8RG:+:\W_ .2J7^:_'R)/^$TU^749+2SMK203O&;*2>+R
ME9&=E+$+*[$#&<D)G'3G(B-Y)+K^G*W^G?[C2;46^WZIQ3_/M]Y=TOQ?JEWK
M.FZ7/;6PFO$$V]%8*(E#B4C)Z[U7'LXZXJX6GJNU_DTK?BW]PI7BM>[7S3=_
ME;;S-7Q+K-_IT\,%@UK&WV>:Z=[I692L>W*###!.[KSC'0U-[7;V5M.KOV_K
ML:1C=)=W8Y^74=5U3P)XIO1;V5@)#,L+1(Q=PN59I!D?-@ 9![9]JJ5.ZA!]
M6O2S:_/5LA3Y9.:Z13\[\M_PTL57\4ZA97D6D1QQOIR;(K>8(T1)CGBB<!A.
MSL 6/W@O3^($U3;J7D]]_D[_ -?H.%/DA;LOQY6_Z_.Y3T_Q?X@MM+5;-+:X
M>.U-Q-+>22NQ6.WA<X^;J2Y'&!SGDYS32OKM_P &QO.FG.RZNWXS_*WZ>G2:
M/XMU#4?%D>GRBP6TF2=DC5F^T1^4X3YAG&"<D' ]/>HC&][]$G]_3U_KIKS2
MT46NMORO_7_!TQXO%OB/38)XFMH+KSYIELL,7D!%UY>7WNBD?.,+N7[H&[GA
M13E&*ZVC^,6_O]W\?+5-J,GVN_S7X:_AT-WPSXAU[6-8:VO;*S@MH+8-.5D!
MD\TNZ@ (SJ!A"2-Q(/&3567*Y?=]R?Z[]0;:DH_UU)_%/B"WTYK<+>&%[6X5
M[A0&^YY4C<CC</D)P#VK)7<ER^:^=O\ @HUC&]X]=/\ TI+_ #.:'CGQ*L5Y
M');645S8I/+*)H-I=8TB<#:DSA21(1G<W8X[5K&-[?=\^:P*%]NMK?-2_P O
M(M7OC/Q%:7#645C;75S;/(T\B*L<;1J(VQ^\F79Q( 6RV,9V\\$4FUV_X+7Z
M;6>]KF7-?3[ON3_7R[F[H.NWVIW6H17C6J!-QACB5@ZJ&9<[LE9!P,E<8)P1
M64_X3?6WYJ__  SV?R*B_?2_K^NZZ:;W.:T7Q'J=KHEE?:C*RW/EV4:1S2%D
M,$C(K3$Y&YR2<DYV\>IST24?:-/35W\K)M?UU=UT033O*W2]O/77[NW;U+6E
M^.M0U3%W ;!K&.Y6)E16+SK)</$C(V[ P%!/!W<_=J(QORWZ_GRJ7W:_\$4G
M[THKI=_\#UT_%'1>+-8O=)TZ,Z:JO?2L1'&T(D#!5+-UEC P 3DM^!K&4K:]
ME=^G]-=&6DGH^KM\S)UWQ7>0>%=/O[4V5M+>6;7+O=2%8U C#%0PZ,<\'GIT
M-5B%R2E!=+^N]M/O_0FA+GC&;ZM>FS?Z&%:^+=<BTK;%96U[;1VQ>Y-Q([2.
M2%5<;FP<E@3DJ, ],U<]9R2[V7JYR7Y+OY;;947[D6][7^Z,7^OZ^NO:^)O$
M-RK6\R:=I]S;*6G:ZV[9!N"@*(Y7$9YY!9NPXW9&<W[KDNWXZ_Y;=]+Z&D=[
M/S^Y)/\ 7?MK8IZ?XMURW\/V=U/+9W'E06ZS!HF$LSRIN#@[\ #(R,'.&.5Q
MBKK/D<K=+I?]NQO^/;IW95GS6??\')QM_7H;O]LZ[_8&C-,EA;:KJ4FPMAY8
M(059QD94L=J@=1R:JI%1FXKHORWM_6Q--\T.=^7XV_K\#)T_4]6OK7Q'K'VU
M(W6P0VT:ARD+>6Q+ %]K9/.< XQS6,G:E)KO^%D[?C]^II!7K1B^FG_DS5_P
M^[\:-GXI\2:/:W,EVMM?1%I%B(W"1I J<X9L*F6/!;WW"M&]>5;N]O\ P.WE
MWTVVL8Q?7II_Z1S?IKW;V[[QUO5Y?!MU<WL8LKV*=8)70QC8A=0SX620(0K$
MX+'&,T63<//_ #M^/X7MN5%OWK]$_P KK^NOS(I[RXT.^?2-(U5)6*F8G4C+
M<>0%7<5WEP26Z@$_*,G!&!4.=DWTC?\ 33\=]>Q5KM>=E]]]?PM;0SSXT\0S
M6DE_!%I\5OY4TR12PN7"Q(KD$AP"3N*]!C&>>E:6M+E?]>]R_P#!_#T5.]6R
M6EVE]\;_ -?\#5L?Q U)[N^C8Z<%$TUM;1P@RSK(LBJF]"ZCYMZC&Y>QS@\)
M)M*V[^[>S^?4JRO?II^,>:_HMO,;9>./$=T\6;.P2.!T2[W@A]S7+P84*[*/
MNAOO-C!&3G(I1O:W6UOFK^7_  1N/*GWU_!)_K;\?(Z/PGXAO=?EOEN(H8Q8
ME;:;8I'^D#/F8R3\N-F._)YI*S@IKKMZ67ZW7R(E[L^7M_F[?AK\S+U_QAJV
ME/J$]M'92002R6T4#JWF>8L/FAV8-C;QC&W/(.>U*"<K=W_\ER_T_P &#LN;
MIR_C=7T]/T>QV.GM>-I]NVH+"EX4!E6 DH&[A2>2*)63T%%MJ[+-(84 % &8
MWA[3'U-]0:W8W#YW#S7V9QMW;,[=V.-V,XXS2LN5QZ/^OE\AWU3_ *_X/S);
M32+"QG6:V@\N18$M@0Q/[M?N@\\XR>3SS5N3;;?77YDJ*22738O5(PH "<#-
M)NRN!YU;>.M6G7[,T=I'>7-S%% Q@8QQ)(7PY(<K*OR<,K+DG!"T[727K?Y1
MO:W_  ZZ^0Y^XY/HMO\ P)+\+ZK=;>93L/&FH1QVT.FZ?IUE:@6X>);=@"TT
M\D19<, !E0XX.02.^1<8\Z7GMY>YS+[MN@I>ZF^J<K^=I)?C?S^9/8?$+6KS
M5K:U72XI(8E47<B[(P[&5X\IOE! _=DA0')SCCJ9TY>?I;_VWF^?;9=_(3NM
M.MVO+25OZ^2ZCM/\>:U?O90K#8K)?I;SQ-Y;E8$E9UV.-WS,-F<@J#R,#&:'
M%I\O5=>C]URT_KS*G:*YOZTDH_C?Y>9)8>/-:O=:T^S73(3"8H3=R!D0%I)&
M3*%Y%( V$X"N3TXZEP2GKLGM_P" \WS[;+O?H1-N"\[O\)<O]:]EUN7M4\6:
MK%XON-'MK!?L,,:+),S(C;G5B"I:0'C;T5&)P>1CG%MNG-[;I?)7_K:V]S3:
M<4M=G][M_7W6,*U^(&IZ7HRRW,27,,.FJ\1*L[SRK LAW2AB W)RK*IP,@FN
MFJO?DDNNG_@2C\UKW5GIYF5+51O\^^S?Z:=^_0V+OQ!KL_PTUR_F6.PU2UBD
M"NFP]%#9VI(^T\XP6)Z'OBHE'6"75I?^36_K[K]2Z4KMW[?I?^NX_3_%VIOX
MB@T^XCMWMVNS8$)&RR^8L'FF7EB AZ!<9Z'<>E4DI7?DVO*TK6_JQG=QBO+E
M^=U?3T_S,_QAXQU2S;5[/3KB,1BUN/*G6V*M!+&JEAN,GS\,>0H /<UE3O-I
M>:^[F47_ %=?Y;:1:_K7E<E^6VI2?Q?XGTJ^OK8&#49GOC&A\H1I$B6Z2,/G
MF4#.>[<?,?FZ5>EEI_,_NE:W_!]-.IFKZ:_RKYM-_/;R]30U'Q[K&G+>7C65
MJ]K"\L:P+DR;EMA,"7#%2,Y!P/0@^IR]+]_PGRZ_??\ K1P?,TO3\5?0LZ+J
M=V!XFU'5/*U"XTUDFA6%3M0_9E8B-6+%,Y(X/<^M34?LZ;DN\E^*_ N"]K.$
M7U2?WM_CYE:'QIKT\\5@BZ=]JDVO]H$+F(*]N\JKMWY+ J 3GD'.!G%.2Y5)
M_P O-\[<OW7OYV\S.$N;E_O6^5[K]/T\S8U#Q?/8>&M(UQ[:/R+R$-(H/*R-
M&60 ^[ +]6%54@XU72CZ+UNOTN_D%)\T%.6FU_3K^-OD9DGC?5[?49HI;>U,
M<<TEGY:QL'$J6_G&0G=]PGC;C.,'=VJ)-*$IKM)KY2MKZ[]"H7<HQ?\ =3_[
M>5]/3_/L2Q^+]5O-=T_3K7["BW+1AY&C9]H:W,IP X[C ]CWJU'WY1Z)O\''
M_-F/.^2,NK2_'F_R0W7/$>HZ)XMNWB=)K1?L,3VS[BQ\V21"8^<*>A/!SC''
M6IAM9]W^$4_NT_&YK-6U7:_EO8R;?Q1K7B>TLFN+&"T$E];S6V_8<*6? =%E
M9C@H#DA,D$8&,TDFG%WUU]/@;_7OY^0ZEDI+IM]TTOZTT\RV/&-W+<:;/Y-J
MTMP@M;LQ6Q#Q,P<J1*7Z$IG9M/7K6<FG&3CHFK_-1YOG:_D..DDGNG;Y<W+\
MMO/]2[X%EU.]U)KB]U%YX4TNSV1L7R"Z99CERK,2#SMS[]<]51).?^)K[DO\
M_P"M+80DWRK^[?[VU^G_  VM^[K$V"@ H * "@#BO"W_ "4CQ[_UWL__ $F6
M@#M: "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H \
M_P#^;A?^Y8_]NJ /0* "@ H * /.KKQ-I>E:SK=QK.A6T4+W0LA,$MEDF78I
M8N6EW2#E?E5<X X)Z.EJHQ6C;_)V7X]?RW:J.S;>T5^:NU]W3^E(GBFQTK5[
MJ\%C;QK*I>>:"R"S3;#< ACO[" 8)S]!GY2.D/+1_>D[_C_P32,.?5;W:^YQ
M2_/^MB3_ (3#PU;FZUA/#MTMZP87!6P07!B55;>W.2F'3@\\\@8.$X\JMT>_
M:^VHDG*S^[Y]ON?W:7TO->ZEH>A:A::<OA^+^S[FU,FVVLEQ&'<!R_10I^7(
MZGWQ35^=P?2R7XV_%*Q#G:"J+K=^>B6OW-W_ *O4&L:)+K,5\V@7-]>C"!XK
M:$)YIW%" SY#D(1NS@ <D<5$)67,NMORYG;Y2N_U>[DE>W:_Y\JO\XI+[[6V
MWEBT6/P]-XATO2;*.22!KU'-LJLS%=V6QSG.,\TZEZ2:73^OU?WE0C[2:4M[
MV???_@?@9NJ3Z=H]]:W]RDC?:-.>..VAACVH"\8(0D@*69USNR.!RH!S4H+W
MZ2ZV7YI+Y:_\'1"IWE&-7MK]Z;;_  _J]R2?7- GO-%T34]'.^;:;:.]$#-$
MZY _=ER^1M^\JE??%._-4;6^_P"OR^=NQ"]RFETV_3Y_*XFI^([73YM8TI].
M+JCIL5-/EDA?S "QD95*#)8YR1ZFH@^:W^)+\MO,JI[J;_NM_FONT1F/XH\+
M7E[>/I.FZ=)J*W,0ED>.%VE!E5"_R,6!! QOP> <4HOW.:.VO_I+:^^VO7O8
M)>[+E>^WXI/[D_3M=%:W\7:9-HUI-%H<%I+);G[0LNG@!HS QS&NX90F+;@D
M9"^F#71R7G9;?C\44K_*5_+UNB/:S45)[_\  DW;T?Y^=RS8ZWH<'B34-5CM
M=5EN_FBAC-K#&LK!UC98BH4N<A!ER0 >#UQE#X+KKKYV:;_1^;MUT*;5U%Z6
M^[33]=%MKW.HTA]%\2:&+R/24%K-YL30W-LJMC>0ZLIZ99<D'KWYHG'E6NUD
M_P -/N_ :TEYK]=_ZZG-'QCX8>VDL[;1YR\,\=N+>Q2WE8E-SHH,;LJ@;&X)
M!7OMSFA2;2G?N_NM?\&O7;R%I&3A\OOO_P '[[FYJ.KZ*GV'53H[7]Q<VK2(
M\<"-*EO@%R2Q!VC<,J"2<\ T2CR2E"6W7M\QP;G%2C\O4XQ=>^R:PEE:^%[&
MTT>6Y>W\U=/A8-!NB0CB<<,77)V\#;\K8.'3N_BTW_!NW?:WW]EJ/[+=/I;_
M -)<O+OI\];NQOZGXJ\+Q6,>H:GH>V-KA9;22ZB@03L5.)8W=PH.U/XBK8 X
MY&5K%J^CU]5W_/I?\P<;773_ "TM_P /IV-#0-?\-WUQJ]WI>G^0J(D]U>K:
MA$G#('!WC[Y"GG/(S1./LX/FV3>GX/04?>FDMV9USJ]KJ5WI&DP>&T1)I/L\
ML5[:Q.([8H7&U1)@*P3WQM.5R *I)N;YO._JK?YI]?S:EU+1NNK5OG?7\'O9
M_K2G\3:;IOB@Q7/A14BL7G6&>"TC=XP#&6D# _(O[QB>A/&,G(I4U[1=F[+\
M9+7[E;Y]-0J/ETW2_P#D4_P7Z:]#6T?6?"FOW3>%XX+>[&G#,:3^3*"8SM+!
M 25()_B5?;(I)<\?:?UK_G]_<J3M)I]?SW_KH NG?3([Z^TS3I?#D6XQVR6^
M7MECR$?D[3G:!M501N')YI7YK.6K:5O^WK:?.^^@/=I:)-W^3U?R:O\ COH1
MOXJT*Q$ENWANYAE$;BZMUMX=T,8V9WX?!!$B'"ELCMD8I\O-YWM][;LOOO\
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MZ?)_YF:DK)+S_P G^5ON,/6+W_A'-;:PBU73Q);!=12*^C#7.H3R&12J%64
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MPM_R4CQ[_P!=[/\ ])EH [6@ H * "@ H * "@ H * "@ H * "@ H * "@
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M_P#29: .UH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M*<GB77/#/]BVJZ,;%1]NBN-S^<''W>1P3V[=>: /2* "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@!#P#4R=DV!Y-+XG\4PV>@2IJD7^GK+
M*TMT%C1I%956%0D+%LC)V@!CSA@!BM*:3E%/M'YWW^[Y);NZ"KI&36EG)>EF
M[??^-K+5FQXBUSQ+IVGZ@UO<*K64BQR3.BH@664$2%BA $<?!.TC))(.*A-.
MU^]ON3O]^GWV*MO9=+_UZ/F\]%WUSU\1>(Y8+V1]:BC^RZ=#.K1*#%(7ED3>
M7:'(&U5.[:%!&[&W.;DDHW>FJ7:VB;W_ %]'KLH*ZC;7XOG;;U^6_0;_ ,)A
MX@FET!;:[B2"=7)ENV1?M;B;8%'EQN'^7YODVYSNR "*:5ZEFND=/7?3R];+
MK>YG)M0T\]>FEK:^?I=VMHSM?#-S&L=W8F5 T=Y<>3&7!8QA^2!UP"V/;@5$
M=:<7Y?JTOP1<M)M>GY)O\6;] !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 0VUK#9P"&W39&"6QDGDDDGGU))HZ)=@\R:@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M[W+?KRW]9?Y?YZCF[7MTYO\ R7^O^ (_CV_M+?4[ZZ2S-EI5V+>X\M&W.AW
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M\<DS&X928AD_+B,Y4YX8\\<Z4TI33Z/_ .0YM?O_  #F:C-/=7]-VOOT.O\
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M%TC,Q>XB,8$0B\P'8DLG)Z8+#KG Q@YM\J;?2]_ER_Y^?Z O>DE'K:WSYO\
M+R[>9;L/%-_JOC#2;=I;6&UE,Q^SQRL)OECZNO0J2P(/&..N>-(KWI7Z)_\
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MMNP\6ZG+H&K3SOILMW9WZV*36Q8P9;RQO;)SP7)(SQC&>]#5XP:TYK[^3?\
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M!J>K7%R)%33X'A@W2E8SY98YW2-N)/?&[W-*K+V=.;6Z;_!+_,T<4\1R=/\
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MLE5Y1(&(V '[I,1!)P/E!^[S5.]O7_A]?O;^_J4Z:BVNWZ-1_P OZ1:LM?\
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M&_X)Z?=>Y,9-^\N[_.WZ:D$_CGPQ=Z<J:3HMM<PQL%=1';RB*-(Y)(WV+)C
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M?Z?U^I!>>*?#M[.NG+H+SM#,<>;8))$I:9H6YW *S$/R3T.<'D5"NDIKHO\
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M3IUZBCPU+#=!8_*M%LXDF#DRCA]^P\*^,'')P6+8H3[/^NOG_6W4TL^3LO\
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M'1!/:+<ZSK,UW<0R0HUW#)%(B2%4^8>6OE<Q@*2%R<_>)S56;O%?UU]+^7X
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M+]-C'U#P?XC5UN=(TS[,BJ;F&T\^-?)>-V,4/!QR)'Z$J, 9Z5G9VM)W\_\
M%H_NC;U-?=?3^DDU_P"3*_S-;P]X-O=(\56MPZ71CMXE1)U>W$7E"$)Y9^4S
M'Y@3MR$_BSGBM>=-R?>_YW7W+37;9:&5I-+FU>G_  ?O?;N6M0TG6I[G4[&#
M3F6VO!.)B98S:3*RD*=C,763.W. %/S$\GCG:O3<?ZOOI_P=NAT*24U+T_X-
M_P!/D8=QX#N9;*6X72KJ$2W$?F6,+VS$Q+ JJ DFZ$;7R3WXR#P*VF]='_-]
M[EH^ZT[:J_J<\$[:]+?/37[WW["77@/5YY;Y9XKRZFDLFB2:6:V:-E\C8(F;
MRQ*QW\X^5,_-P>*.:*;;5];^OO7T^6FKTVV-(:2C?;\N_P#2.\-O%K7ABYTY
M+5[$",VZQL$_=, ,8VDKP<=#VJ*C;]^.KO=>J?\ P"*245R26FS]&O\ )G%:
MYX7U_5?#D?GZ4IU&[::YG6'[.[03E0L7SR@@*%7!9/FR!C'-4FHRC;I_G=^?
MI^)I!I7YNZ7R2M?MKO9]WHV31>#-2BDN;N*T=;J[%W]IW7 /F*9D:./[W *A
M^G +$G!-#LH\NZT^=GK^'^07O'?72WE[EO\ TJPO_"+W<E[&UKX:_L]6:(VD
MGGQM_9Z*Y,BX#?+O4XVQ[EYP3@5-FXM-ZZ_--62^3UUT738E-)WMIV\_YOR\
M]/-F;!X7\7)9F:/2TMKZUM;:QML72'>JK+'(YP>,"3>!WP.^0-9RC4>NTF[^
M2:C^.@? [K7EU7F[W_%-HMW?@2_:_P!12.&\9)$\M)4EMXXVA^4*@(7SB5 Z
M%@H(R.>*R7O?%U=W_P"!7OIY=]>BT(<>5)1Z+3_P&UM>[[:=7J=7JMD+KP;J
M>BZ79SG[-%]EBB\T!GPBD!7+>AQDD'(_&G)N3C-]T_NEK^0[6C*"[/\ %?U_
MPQD:=I.IZ=>?VK;Z-?F%)RPLKJ\2:Z8&/8S>8TC*>0N 7Z9Z=*2?+OYK[W%Z
M_<_P&US/TM^'-]VC^^_>YIZEIMY>^'(5GT:&7_2C/<:;$4 EC+,=AW$(S<@G
M)P2#2DK./6W^73R3_P RKMJ72]OS7YI?IYF)I/@V]M]3MM2N+1A<0SQ>4//!
M$$/S;E SC@%5)[@<9%5%N+W[W??W$OQDK_BS.2NGIII9=O?;_"/ZI&Y+X;:6
M_P!>OV%T)YR1;JMY(L3CR%3F,-L)R",L,\#VK.:?L7&.[3_/\/D="DN>#>RM
M^;9REWX%OK73&L[/2GNX/+4+"][L;SC'_K2Y)/RN2?7GCI55;R<K>=O2T?S2
M:_/1LQIKE47+LK_^3:?BG\M-45Y?#%_;M->ZG:C3XXK%HI;O-LD:XC7RVW+^
M\9@RC.XX!Q@=ZJ<^64IQWO=+N^9-:>:^>Z]52A[M.$NB2?DN5J6OKVTV9V_@
MXSP:-:0WT+IJ-W$;ZY/&%>1LE?4$9P..@]J=2*5X1^S9?G^MW\Q0DVE)];_A
M9+\+')R^#-;MX=/BL[9?LSQM+=P^:JE9MNT@'/21>#CH1GN:B.EDU=)+\XMK
M\&^VY=1<TG*.]Y?E*S_%>=K=BS'X5U47=F;/31I^FW-P1/:^8@-I K+(@PI*
MG+JXPI./,]C5+31OI>_FN:WW77_@/H2UH[=[6\FDI?E^-]RGI?@.]\R"+4;&
M>XB^TJUX+EK8Q7!$<H,@6-06!++S(2QS@CC-+3ETTT=O)V^[[O70V<DY2??\
MN9/UT2]%LKW*ESX%U6-=-5?#XNX!;PFZA%VL>Z?RV5G8Y^<@["<]=HZX%54U
MG+ET^*S[7Y;/[T_SW,W\7EI\TG+3[FE^&Q<E\$ZT\NJF87EQ=SVDD7VD2VZ1
MS QA53.WS20>S,%'4'M0N6_DW_[=>^G9?-;(SM))=6E_[;;KW?1:=7J=1KEG
M>6.C6.B:3I5Y=:<R&*X-O-&9$B QM!ED7ELXW9) SWP:3?-/WMOZLO3_ (8U
MA[D;IZ_U=_U^EAEO<W\>N7-]J6AWT%M:(8;,AX#&$)4$X$A8LV!U P!CJ>2+
MOJ]V_P!?Z;_X!,O=22V2O]R_39??Z6/$(U*\U6SL%TF[N-)RLDTUN\(RX;Y5
M;?(K!1@,=H)/ ]082YF[_+U[_+IYZ]"V^6.GS]/^#_6^F+;^&]3N/#U_97>E
MJLD.DBP@5W1A/(H?$B\G:#E<;L'.>!CG1OF?/U;3]+?\._E]Q<9)55?9-O[V
MG^%M?P+,OAJZE\9VEVMM>16\4B7#R?:U^SLPBV$^6/FW\*O.5P,YSQ1%VDWZ
MV^?;\W?7MN8O6G&/6R_!WU_2W?79&/XH\)ZMK'B&_N(]*#B6&6 2!;98Y(V@
M8*"V/-9O,QD,=HX('&1-.T4W)?+O:2:MTV77K?H7O.+OHFONLT[_ #?3IYG7
MZGI1O-*TH6^G+%+;3V[K&0@:!%=2P!!P,!>BGMQFKO\ O>9OOKZI_J8*+]CR
M6[:>C1EZ9HU]%J<?V[22]O8B>-&+QN)_-G2174%N-H7)W8.1QFE%^Y;9VBO_
M  %-7^?3KW-7HVEM=O[[Z?C;M]^E&/1-;AGL+G^RG<Z/^[6-9H\W8WDEDRV!
M\N#A]O/'N8A[MGY)?=%K[KO[ON%-<S=O-_?*+_3[R;6?#NHW?@VQTMK 7!:9
MY+B-$MY'CW%F&/.!3AF )P3C.*4D]$ND;)^:27K;?;78<-+ONV_DVWZ7VWTW
M,JT\"75Q:I)J>D1RW;@B4RNCD@6J*H)SR/-7/U ;T-:UG\3I]I6]>>Z_"]NQ
MG2BXN*ELFK^G*T_QMZG67\-WJW@Z_P!,BCE6^2$6Y)9,E]BDD$DCOW[@T3LY
MJ4=N9/Y*7_ %%-4G!K7EM\W$Q/%7@^\N=.\F/[5K,UPQ\V>9+0RH54B/ = B
MJ"3DJN[GBL7?[/2[^>GSV72W0WC9:OR7RU^6_?S\BNOAC4)9H?M.@^;>&XAD
MGOWN$^>(,A\LC.6V@$8(QQD9)-:.UW;;WOG=2L_Q2[K;8QM+V:76T?E:U_Q3
M>FCWW*]AX-O+#3[2&?P\EW:1Q1A[&.2- 9?+QOZ@?*V>>O.1DBAN\F_6WEI'
M_)K37Y,UG;G;CM?[U>>EOFG9Z'<ZE97$_P#8_E19^SW222#?G:H1@>3R>2/>
MC_EXGZ_D2M*;CZ?FF<9-X)N[O4KNXNM,27-RC1,SH2$-Y(\F.>,Q-SZAB/44
MZ?*DK_/_ ,!?ZFU22>W9_?:*7XIC=)\':G:>);.XF@N4AMY3]F,+VPBMX0[8
MC)*F0 KM^5" 0<'&*5-M:RWMKY^ZE\]>^G5:G/.-]%M?_P!N;O\ =VUZ;"^+
M?#&MZKXCN;RTTXL?*>*.:/[.BO$UNZ[6<_O2WF-TR$Q@]:4$E=/K_FK6MY+K
MK?8Z8RBI1OTM^>OX=O/T*>J^!-1BL[RST_2FNK1B_P!GB:]V%)6BB'G[B<Y#
M+(#W);T)-.3O_6ROM;S7_!(@THQOO97\WK^6GW::I&SXMT#5-2DTD6^G&8VD
M:,DD8M]T<@920SR LH(''EX)/4@4]'6<NEU]U]?/Y;;[[&-FJ')UL_OMIY;_
M #VL/D\/W,7@5M(AT10/M;^;;QQVSEXS(QWHLF8R<%3\_;/&<5FUS*"[)?)I
M?Y]OS-(W3F[ZMM^MW_EIZKL9=CX)O0+*YO[)_M%FEI$A>X7"(LK^:<*0O^K(
M'0<$@=Q6EXVO+K>__@"7_I7Y)ON9-2VBMMO_  .Z_#;L7?"EA?/X.U>X@\F\
MGGWVUBSX9);>(%(NO!!^8\\'=Z4IW<(J>[UE\[7WTV2^9HK*H^6UEHNW5_@W
M9VZ(YRZ\#ZT=!N;2'0Y)HBTWV2*:Y@MVMBRQGS,0X0='7"COSPQ-7&2C*+D]
MK:^2DVU\TUY:>2%!-2;Z/IYV2_!I^>O<T=-T.[U-(+NVL5N!-.6M=161"+5!
M<2-)C)W8=2!\H(;/.!4->[;;1?-<B5OOUU]=Q4_=;OK9O3L[O7\ONMU(=-\%
MZW?7M@NLZ28+6RAMX5\N[&7\F*8!CM(."[*<<\$9[@74DIJ<EN^9I>O+;\GY
M7^15K.*6R?X7?^?J6+/X>S0K96TFF"2U\F)[A9I5D#3^1*K%LDY.YHQ^ QP.
M%5=U/D_O<O\ Y);\F_74SIIIQOY7_P#)OT:7IH0WO@34R+>..RN!:"-&>"U>
MVW&Y,:@S$RA@""IRX&_)R,\T-KVC:VN[>2T^:OKM^I5.ZII2WLK^=KW\GTWT
M^XL3^ [OR+^0Z<;F>[CO!,)9E?S<RJT*X8XY 8C@ $DG!-)-))6T3B_N>OX:
M>FAI/WHM)ZVLG_VY9_C:YN^)=$N]0N[9[?2O-_T=8[9]T:_V?+NSYF">PP/D
MR>,=#2CI4;?=:^2O==]?QZF<E>FDET>GJE;RT_#H96K>''TOX=&R2SDEN[K4
M(I)H6NF4RLTRC:'R=H*@#C@4H_\ +J-KI+;_ +==_7KZ[;#>BJ2;W_\ DM/3
M\^NY#:^$M6B>V5M)VR[D:TG$Z'^S8Q*S-%DG=RA"_("#T/ %4WNKZ]7W]U*W
MWZZ^NX*U[VTZ+L^_Z_*VQD:OX7O+3PA+))X:2)K03$,'B#@M 5\TX<C[P&77
M#-U* BEO*-NNG;[4;>G565TOGHK.SOLM7UOI+[[73UL^G17OQ^$-56R*G0,1
M2"06EM]J23^SYBL8$^YB/XE=LKEOFZ9)K1-*2^6O97;M]S2[:6V"/1M:=5_-
MY_UZ[C[CP)J26T[0P3>;=><UZ4EC9YU^TJRH!)E.4W8##;R0<9-9JRBH]%RZ
M>=FGOV=ODM-D*TKWOKK^:_/7YO4FL_ <K-";S3&F1?LRH+J2%W2(22&1/D"J
M!L< JHQCY1N JVU?7SOY^XDM]_>7WJ]D*7-]G3:W_@6OX?FR'_A"]8^VV[O!
M=%HK?RX#%);".! &'EEF4R<\<(0I!Y(Q7.^9PE?XFM?/W4OS[Z=5J:Z*2MLG
M]WO-W^ZRTUZ;&CI/@Q](UG2YDTKS(+>57+O(LCHY@*O)EFSG<!DCD\8SBMTT
MIR?3WK>GNM??:7WZ[F/++EC_ -NM^JYORNODM-CT*H-0H * "@ H \CU"YU2
MU\6ZU<6&NE9[);F>2*2..1E0>050#'RJ?4Y.!P0>:JA\*OJKI??.:_!:_=TT
M,ZWQ/IHVOE&.OW_+?J6F\3>*)I]5CBU.RAF$RQ)#GS7M";A(UW)Y2[0RDG#.
MQ;JN!T4(N4(]W;7Y.ZZ;?AU-4US.ZV4OP6C_ *T\@'B;Q+!?:C#<ZI: 0/Y4
MRJP,MM&)%3SS'Y6$!0E_G=@>PP"*(\LE=NR?X>5_PVOUV&XN+MNTOOTOMZ]K
M=MS2\/SK>^*X=3O=5%W'%:O!:W$B1*LP,VU7!"CEN!\I ; P*(7]ZZLW;_V[
M]%?_ (;3.;5TKZ*_Y1_5M?T[^@4B@H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MN?QHFG'D7=7^YV'!J3GY/\SU35O%VHVDNMWEI%;'3="=4NHY$8RSDJK,48,
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MX[<D?>49?S.W?9:_CMY:]2FK2E'LF_\ +_@_@7;_ ,7ZGIVG6,MQ?6< N9)
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M <9.,N9;WO\ .UBO-X;^+DZRJWA6R DTD:0<7,7^I'\7^M^][]/:JF^?FO\
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M;GI\O7G'K0 +J<;;<0S<G ^7Z>_O0 +J<;;<0S<G ^7Z>_O0 +J<;;<0S<G
M^7Z>_O0 G]J1[=WDS8Q_=^GO[T *=3C7=F&;Y3@_+]??VH #J<:[LPS?*<'Y
M?K[^U  =3C7=F&;Y3@_+]??VH #J<:[LPS?*<'Y?K[^U !_:48./)FXQ_#TZ
M>_O0 #4X_P#GC,. >5Z9Q[^]  -3C_YXS#@'E>F<>_O0 #4X_P#GC,. >5Z9
MQ[^] !_:<>/]1/TSC9[9]:  ZG&/^6,QX)X7KC/O[4 !U.,?\L9CP3PO7&??
MVH #J<8_Y8S'@GA>N,^_M0 ?VE'D 0S<G ^7KSCU]J !=3C;;B&;DX'R_3W]
MZ !=3C;;B&;DX'R_3W]Z !=3C;;B&;DX'R_3W]Z !=3C;;B&;DX'R_3W]Z $
M_M2/:3Y,V!_L_7W]J %.IQKNS#-\IP?E^OO[4 !U.-=V89OE.#\OU]_:@ .I
MQKNS#-\IP?E^OO[4 !U*,,1Y,W'7Y>G./6@ &IQ_\\9AP#RO3./?WH !J<?_
M #QF' /*],X]_>@ &IQ_\\9AP#RO3./?WH /[3C_ .>$^<;L;/;/K0 '4XQ_
MRQF/!/"]<9]_:@ .IQC_ )8S'@GA>N,^_M0 '4XQ_P L9CP3PO7&??VH #J<
M8_Y8S'@GA>N,^_M0 #4HR0!#-R<#Y?I[^]  NIQMMQ#-R<#Y?I[^]  NIQMM
MQ#-R<#Y?I[^]  NIQMMQ#-R<#Y?I[^] "?VI'M+>3-@?[/MGUH 4ZG&N[,,W
MRG!^7Z^_M0 '4XUW9AF^4X/R_7W]J  ZG&N[,,WRG!^7Z^_M0 '4HP2##-P<
M'Y>G)'K[4  U./\ YXS#@'E>F<>_O0 #4X_^>,PX!Y7IG'O[T  U./\ YXS#
M@'E>F<>_O0 #4X_^>,PX!Y7IG'O[T ']IQX_U$_0G[GU]_:@ .IQC_EC,>">
M%ZXS[^U  =3C'_+&8\$\+UQGW]J  ZG&/^6,QX)X7KC/O[4  U*,D 0S<G ^
M7KR!Z^]  NIQMMQ#-R<#Y?I[^]  NIQMMQ#-R<#Y?I[^]  NIQMMQ#-R<#Y?
MI[^] "?VI'MSY,V,?W?8'U]Z %.IQKNS#-\IP?E^OO[4 !U.-=V89OE.#\OU
M]_:@ .IQKNS#-\IP?E^OO[4 !U.-=V89OE.#\OU]_:@ _M*,''DS<8_AZ=/?
MWH !J<?_ #QF' /*],X]_>@ &IQ_\\9AP#RO3./?WH !J<?_ #QF' /*],X]
M_>@ _M./_GA/G&[&SVSZ^U  =3C'_+&8\$\+UQGW]J  ZG&/^6,QX)X7KC/O
M[4 !U.,?\L9CP3PO7&??VH P];^(GA?P[&&U35(8&.T^4&#RX;D'RU)8#'.<
M4F[/E!:QYEMN9=C\9? ^I:A;6-IJDLES<RK#$GV60;G8@ 9*XZFF!V"ZG&VW
M$,W)P/E^GO[T "ZG&VW$,W)P/E^GO[T "ZG&VW$,W)P/E^GO[T 4[+Q1INHR
M7D=H9)7LY?)G 3[CXSM_*A:Q4ELP>CY67#J<:[LPS?*<'Y?K[^U #(]8ADC+
MK;W( 8J=\14Y!(Z'!_A_'(H 9=Z]9V$7F7(EB3S%C!*]68X4?4G^8H6KL@Z7
M+,5ZLLPB$4H//++P,4 6J "@ H * .>4+N'R]6QTZ\KP/EZT ";3LX!S@<#K
M]W@?+UH $VG9P#G X'7[O ^7K0 )M.S@'.!P.OW>!\O6@! 5\LGY>@&=O'W.
MGW>M "OM&_@#&1R.GWN#\O6@ ?:-_ &,CD=/O<'Y>M  ^T;^ ,9'(Z?>X/R]
M: '?*)!P!M?'(^[RW7Y: &KM&W@#&#R.GW>3\O2@ 7:-O &,'D=/N\GY>E
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M+TH &VG=P#G)X'7[W(^7I0 -M.[@'.3P.OWN1\O2@ ;:=W .<G@=?O<CY>E
M#OE+C@') X'7[O ^7K0 U-IV< YP.!U^[P/EZT ";3LX!S@<#K]W@?+UH $V
MG9P#G X'7[O ^7K0 @*^63\O0#.WC[G3[O6@!7VC?P!C(Y'3[W!^7K0 /M&_
M@#&1R.GWN#\O6@ ?:-_ &,CD=/O<'Y>M #CM#'@#:X'(^[\QZ_+0 U=HV\ 8
MP>1T^[R?EZ4 "[1MX Q@\CI]WD_+TH %VC;P!C!Y'3[O)^7I0 +M&W@#&#R.
MGW>3\O2@!,+L(V]03C'7[W/W>E "MM.[@'.3P.OWN1\O2@ ;:=W .<G@=?O<
MCY>E  VT[N <Y/ Z_>Y'R]* '#:6' .YR.!][YAT^6@!J;3LX!S@<#K]W@?+
MUH $VG9P#G X'7[O ^7K0 )M.S@'.!P.OW>!\O6@!,KLS\OW2,[>/NCC[O6@
M!7VC?P!C(Y'3[W!^7K0 /M&_@#&1R.GWN#\O6@ ?:-_ &,CD=/O<'Y>M  ^T
M;^ ,9'(Z?>X/R]: '?*'Z 8(/(Z?=Y/R]* &KM&W@#&#R.GW>3\O2@ 7:-O
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * .1A^)GA:YA2:"YOI8G&5=-+NF5AZ@B/F@!_P#PL;PW_P ]
M-1_\%-W_ /&Z -'0O%>C^(Y[N#3+B62:S"&>.6VEA9-^=O#J.NT]/2@#:H K
MW]];Z9IUS?WDGE6MK$TTKX)VHH))P.3P#TH YQ?B/X:90RRZ@01D$:3=<_\
MD.@ _P"%C>&_^>FH_P#@IN__ (W0!KZ%XBTOQ+:SW.E7#S1P3&"3?"\3)( "
M5*N >C#MWH U* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#E/AG_ ,DS\.?]
M>4?\J .KH XKP[_R57QM_P!<-/\ _0)* .UH Y_QW_R3SQ+_ -@NY_\ 134
M:NE_\@FR_P"N"?\ H(H MT <5\//^/GQE_V,-Q_Z+BH [6@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M^]6]$F:-))^B?_DUOR_K8L+\2= .I6-@TC1SW83Y9)(E:)G.%5E+[B<\?(&
M[D"J@N=VCK_PU_R[V^\AOE5W_5G;\T.UC7[_ $OQI;P%U_LAK4><"HS'([E4
M?/7&0%(_V@>U9IZ37I;ULW^-OO\ 4IJRBUYW]/=_*_W7&Z#XP23PUIT^H>=-
M=O%:"9U10&><A0< @8SUX^F:Z*D4IM1[M?<N;\A2?+*2[7?RYFOT)(?'=K*R
M?\2G4TC?8PE9(]H1VV!^'SC=QC&>^,<UE'WK?+\5=??_ ,/8)>[?RO\ AO\
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MECGS!U)^[6KLW*W2W^7Z7^;,HIJ*EWO?ROJOU7R1TE04% !0 4 % !0 4 %
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M "!/W9&P] <;>?N=?N]* %9,[ODSG)X7K][D?+TH &3.[Y,YR>%Z_>Y'R]*
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MH :B8V_)C&#RO3[O)^7I0 (F-OR8Q@\KT^[R?EZ4 ")C;\F,8/*]/N\GY>E
M B8V_)C&#RO3[O)^7I0 FSY"-AZ$XV]?O<_=Z4 *R9W?)G.3PO7[W(^7I0 ,
MF=WR9SD\+U^]R/EZ4 #)G=\F<Y/"]?O<CY>E %BS&+V,X RS\[>#]..* -B@
M H * "@"L+"U!!$(X.>I]O\  4  T^U7;B$?*<CD^W^ H !I]JNW$(^4Y')]
MO\!0 #3[5=N(1\IR.3[?X"@!/[.M I7R1CZGTQ0 IT^U;=F$<G)Y/O\ XF@
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MNS".3D\GW_Q-  ;"U))\D<C'4^W^ H /[/M?^>(' '4]L?X"@ _L^U_YX@<
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MW^5_NZ7^](ER:@IVT_X-OO\ P[-G6TB@H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MGI?MTN.;M>W3G^Z-O^#Z^72U:>/+JQLIVU2T\XCSVMY$D ,FVY\H(5"@+]Y
M#D\9)QW:7-&-MWR?^3+?\'?\!MVE+LN;_P EU_(9??$"XM+I'DM0C6XN(+FS
M20,K3J\*IB0J#M_>]<#KR.*(KF^'K:WWM/\ (K11;?3?TY7+^O,Z+PIJ6H:E
M%JAU':LT%_)"J(0P10%X!P,CD\D9H5N2+76__I37Z$)OGDGTM_Z2F=!2*"@
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M H * "@ H * /(?$7C#Q5=>+;'PQHFNZ78R311RR/]E>2YC7RB[L0R^41QP
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MM_Y+M]P-7O?K?\=_OM^HYO"VBM$8FL59"DD9#.Q^61][]^[ '/;MBCI;T_\
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M.@%/F;5G_73]!65[FM4C"@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MJ3M4%@#P!SGU---QCRK;3\-ONN.7O.[->D 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 4]2U;3=&MUN-4U"UL8&;8LES,L:EL$X!8@9P
M#Q[4 9?_  G?@_\ Z&O1O_ ^+_XJ@ _X3OP?_P!#7HW_ ('Q?_%4 ;%C?V>I
MV<=Y87<-W:R9V302!T;!P<,.#R"/PH L4 9^IZ[H^B>5_:NJV5AYV?+^U7"1
M;\8SC<1G&1^8H S_ /A._!__ $->C?\ @?%_\50 ?\)WX/\ ^AKT;_P/B_\
MBJ -R">&ZMXKBWE2:"50\<D;!E=2,@@C@@CO0!)0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 5[Z_L],LY+R_NX;2UCQOFGD"(N3@
M98\#D@?C0!C_ /"=^#_^AKT;_P #XO\ XJ@ _P"$[\'_ /0UZ-_X'Q?_ !5
M&IINK:;K%NUQI>H6M] K;&DMIED4-@'&5)&<$<>] %R@"GJ6K:;HUNMQJFH6
MMC S;%DN9EC4M@G +$#. >/:@#+_ .$[\'_]#7HW_@?%_P#%4 '_  G?@_\
MZ&O1O_ ^+_XJ@#8L;^SU.SCO+"[AN[63.R:"0.C8.#AAP>01^% %B@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * .?\ ^$[\'_\
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ME(R"0>,$U7*[M=DG]^PF[)/NVON_X<P[/Q!?MXI,+:GJ$@.IR6IMI+)5M5B
M.,3>6,OP.-Y)/&/2*7O15^J?X-[=]O/J^@ZGNM^7+^-KW^]]NA<NOB);;KZV
ML;"6>^LYHHWA6>W<D/*(\_+(=O)Z-M/(XZX</?LULW]VC?Z=+C:Y6XO>S?W?
MU_D6/!WBPZT@L[J&Z%VHE;SI8@B2A)"IVXZ[<J,X .>">:<5S4U+RC^*W^;3
M_P"&L1>TG%]Y?@]ONM_PYUM(H* "@ H * "@ H * "@ H * .2\;1I+?^$8Y
M$5T.M+E6&0?]'GH Z+^R]/\ ^?&W_P"_2_X4 9?B;3;!/"FL,ME;@BRF((B7
MCY#[4 <]\$O^20Z%_P!M_P#T?)0!Z!0!R.N013_$GPNDT22)]BOCM=01U@]:
M .C_ ++T_P#Y\;?_ +]+_A0!QGQ8T^RB^%NO/':0(XA7#+& 1\ZT ;W@3_DG
MGAK_ +!=M_Z*6@#H* "@#C->N[D:W>S1W5Q$-+CM7BC25EC<R2,'#*#A\J !
MG..V#3AI9]Y<ORLO\[_(4GO'M%R^>O\ E^/H6-)AN+?QC/!'J-S>*MNSWQDD
M8QK*S@Q*BDD(0N[(7'&">2*(? _*R^>O-^GDNG4<]UW=_NZ?\!];,T_$]]<Z
M=HAN+63RY?/@3=M!X:5%8<^Q(I+6<5W926DGV3?W)F9<?$#2K75=1TV6&;[3
M8Q-,R1R0R,ZKC.%60LI^8<.%S1'WU==TOO=O0F?N:OU_"_\ 707_ (3RPA\Y
MKZPOK"* 2^;)<+'M1HUW,GRN<G;@Y'';.>*.E_ZWM^#T_+345U>WG;\+_EK^
M9%9?$32M1M$FL;:YNY6E,1@MWAE8$+N)W+(4/'. Q;MC/%.VJ_K:W^:VN.Z_
M+\;_ ';/>Q+XM\2S: VD7$4<TD4\D@>!(BS28A9E!X)7D D]L4MI./D_3>.K
M?:UQ.[C%KNO79Z>M[?\ #7+*Z_'I6GL=0G>]FBMENI)844(RNQ "<C@=L]L<
MDTW\7(NZ7S>G_#BYO<Y^EF_DE?\ K]">P\2VVH:D;2.UNHT8R+#<2*HCG*'#
MA<,6X/\ > SVS26JOY7^7<IZ/\/GV-J@ H * "@ H * "@ H * "@ H * //
M_C;_ ,DAUW_MA_Z/CH ZO3-,L#I5F38VY/DI_P LE_NCVH M?V7I_P#SXV__
M 'Z7_"@#D_ARB1S>,4C4(B^()P%48 _=Q4 =O0!YI\:5#:/X85@"#X@M00>_
MRR4 >@?V7I__ #XV_P#WZ7_"@ _LO3_^?&W_ ._2_P"% '*?"4 ?#;3@!@":
MZ_\ 2F2@#MJ "@#DO%<MQ+?K:17=Q:K!I\]XKPRM'F1"@7<0>0,G*G@]P:GF
MY5*I_+;\;W_(I6<HTW]IO\+?Y_@,6:X@\4Z-<&6^$>I(3(TLV;?/EDK"L8/R
MMP6W%>0"-QX U4>6<X=K_FOR6G3T>K,4W*G&IZ?)6_5V_P"!L;&O7ES"=/LK
M.;R)[^X\D3[ QC4(SL0#QG"$#.1D]#TJ$N9V[)O^OFT:[1<O3\S"M?%Z:5&]
MO?3:AJC_ &U;6%O[/>.X^9"PWH40$?*WS(,8Q[TTU)+Y_A;?MH]?Z0FG'F\E
M?\;:=]=OZ8^S^)F@:@MU]C,ES)#M\N*%XI'GW,%&U5<E<L0,/M/?I22;5TOZ
MLW^2?W!*T9.,G;_@:?FUZ]#237I];\*W.H:);3I<@O&D5Q'LD5E;#?*>XYP#
MUHDM(N^CM]UP6C::U7YVNC.T_P 2/86T\<\U]J\@N%@BC>V6&[W,I.'4B-,?
M*<,."._&:&]%IW_!7U[/R].XEN]=DOQ=M/+_ ()/%XSM;V.,QVFHVY9H6B#)
M&#,KL5&,L<#((.<'N.,&D]-5KO\ ^DMK[TM//<).RUT_X=)_=?7RV,GP_P#$
M":]U)4U&PO(DNH[8HJQH8[<R9 W.#_$V,#)//('-:1C>\>MW_P"DIV_/_/85
M1\DW?9?_ "35_P OT/0*@H* "@ H * "@ H * "@ H * "@ H XSX;:?92?#
M;P\[V<#.;*,EFC!)XH ZC^R]/_Y\;?\ []+_ (4 <EX8AB@^*/C:.&-8T$-A
M\J# ^Y+0!W% '/\ CO\ Y)YXE_[!=S_Z*:@"WIFF6!TJS)L;<GR4_P"62_W1
M[4 6O[+T_P#Y\;?_ +]+_A0!R?PY1(YO&*1J$1?$$X"J, ?NXJ .WH * "@
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M=U=2(ID:&WD93' 7.7*X4-R?[Q..V*%HK>5OEV&]7^/S[FU0 4 % !0 4 %
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M !CXGN+688DBDNXRK#.>1Y= '9:3IL.C:-8Z7;L[064"6\;2$%BJ*%!. !G
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M/VVC6<T\T%N7(DN&#.Q9V<Y( '5CVH UJ "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H X.R^&"Z=90V=GXS\406T*A(XTO(PJ@=@
M/+H G_X5Y/\ ]#SXJ_\  V/_ .-T :7AGP=;^&;[4;U-4U+4;K4!$)I;^57;
M$88+@JH_O'U[4 ='0!3U;38=8T:^TNX9T@O('MY&C(#!74J2,@C.#Z4 <HGP
MYDCC6-/''BI44  "\CX'_?N@!W_"O)_^AY\5?^!L?_QN@#8\+>%K;PI9WEO;
MWMY>M=W374LUXZO(SLJJ>0H_NCM0!NT % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % ',IXAN_P"W@CBW&F273V284^8)$C+E
MBV<8^5AC'&,YYP"+3CS/LW]SM_P0:=[+I:_SM_FD2^$?$,WB2TO[J2W6"**[
M:* #JT6U2K'W(;/T(JN5J$6]WO\ >U_7F3?]Y**V5OR7ZD.J^)=3L]3U&WLM
M*M+BVT^W2>>6:^,+$-N.%7RV!("'JPJ$_=<GM>WGLG^I6\U!;M7_ !:_0TIO
M$.G1(T8NH/MPMC<BS:55F*@9SMZ@>^*51^SC)K7E'3]_EZ<PRQ\3Z1=Z(-5?
M4;.&!44SL;E=L#$ [6;. 1GOBM*B4)6OI>WJ9TY.<4[:VN&H^*M"TNS>YNM5
MM%C6-9,>>N2K$!6'/0DCGI2L[\OG;YEIW5UVO_7W$&LZ[?V>J6-AI=A:WDES
M!+<%Y[LP(JH4'!$;Y)WCTZ4MN9O:._X_Y%))Q4D]W;\+EC3_ !)IE];:8S7<
M%O<ZC")H+6691*P(SPN<G'M5RC:3BNA&RU]"PNN:0R7C+JEF5LN+DB=<0?[_
M #\OXUG=6YNA5GS<O41->T>1%=-6LF5HO.!%PA!CY^?K]W@\].#3?NWOT$M;
M6ZF'K?Q!T/1FT]SJ%A+:W:22^?\ :U *)C.S&0[$D #(Z'GBA?'RO3_@[?\
M#]@^SS+O;_/[OS:1U44B31)+$ZO&X#*RG((/0@TVFG9B34E=#J0PH * "@ H
M * "@ H * .1\=I+<-X;LDO;NTCN]66*9K2X>%V3R)FV[E(.,J#^% #_ /A
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M7L_%=@8(UU:ZLM-O&G>W$,ETN'D4X(C+;2_4=@>>E-6E;EZ_?V_0AW5[]/\
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M^(O_  <W'_Q5 %3X<-<+%XFM)KV[NTL]:F@A:ZG:9UC$<>%W,2<<G\Z .VH
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M>(-&U?P[_9K2V45Q%(E_)(JD2>7@C8I_YYG\Z *WF?$__GU\*_\ @1<__$4
M9/B;1/B3XG\.7NBW,?AB&&[0(SQSW&Y>0>,I[4 =OX:TV;1O"ND:7<,C3V5G
M#;R-&25+(@4D9 .,CTH U* "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@#E_B)X;O/%W@34M#L)(8KJY\O8T[$(-LBL<D GHI[4 9MN
MOQ.MK:*!;?PJ5C0(";BXYP,?W* )?,^)_P#SZ^%?_ BY_P#B* +?@70M7T2U
MUA];:S-YJ.I27I%F[-&H9$&,L >JF@#JJ .,^)/A;5/%6D:7#H\EHEU8ZE%>
M_P"ENRHP17&,J">K#]: &^9\3_\ GU\*_P#@1<__ !% !YGQ/_Y]?"O_ ($7
M/_Q% &EX#T*]\,^#;+2M1>![N)YGD-NQ*?/*[C!(!Z,.U '1T % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!YQX?TKXE>'O#]CI$
M$7A>6*SB6)7>>XW,!W.$H TO,^)__/KX5_\  BY_^(H D\(Z%XALO$>OZUXA
M.FB;4DMD1+"21E7R@X.=ZCKN'KWH [&@#+\2Z;-K'A75]+MV1)[RSFMXVD)"
MAG0J"< G&3Z4 <S;K\3K:VB@6W\*E8T" FXN.<#']R@"7S/B?_SZ^%?_  (N
M?_B* +?@70M7T2UUA];:S-YJ.I27I%F[-&H9$&,L >JF@#JJ "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M8'XT#V'T 5KF_MK.:UAGDV274GE0C:3N;:6QQTX4GGTII7=EZCMHWV+-(04
M06UW!>+(T#[Q'(T3<$893@CGWH6J3!Z.W]=R5)$D7<CJPR1E3GD'!'YT .H
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H X_Q_+/:+X<OXM/O;Y+
M/5EFECLK=II GDS+G:.V6'YT 1?\+(@_Z%/Q5_X)Y* *.M>/5O\ 0=1LX?"?
MBGS;BVDB3=I$@&64@9_.@"W\(+"\TSX6Z-9W]I-:74?G;X9XRCKF9R,J>1P0
M?QH [B@#B/%]]-H_C+PYJHTG4K^VAMKR*3[!:M.R%C#MR!TSM/Y4 ._X61!_
MT*?BK_P3R4 <WX]\6R^)/ VJZ/8>$_$_VJZC"Q^9I,BKG<#R?PH [WP7!-:^
M!?#UO<1/#/%IUNDD<BE61A&H((/((/:@#<H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MV'3JO3[O)^7IR: $6[N>,R,.!G*]/N\GY>G)H %N[GC,C#@9RO3[O)^7IR:
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MPH 3^R1C'G#&#G]V.O/^- "G2LYS,.<Y_=CKS_C0 '2LYS,.<Y_=CKS_ (T
M!TK.<S#G.?W8Z\_XT +_ &7\P)E'^U^['/.>/2@!%TK&W,PXQG$8' Q^72@
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M/Y]: %_LO#9$HXP1F,=>/\* $&E;<8F'&,?NQUX_PH !I6W&)AQC'[L=>/\
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MUI=1@O+EQ$)EA@?;LC$C!F P,GD=R>OI@!I\L>7T7W7M^8Y:N_G?YLZFD 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M.I'4%7 8'ZBAJPDTRW2&% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MMU)04 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 <I\,_P#DF?AS_KRC_E0!U= '%>'?^2J^-O\ KAI__H$E ':T
M <_X[_Y)YXE_[!=S_P"BFH U=+_Y!-E_UP3_ -!% %N@#BOAY_Q\^,O^QAN/
M_1<5 ':T % !0 4 % !0!3?5;&/5X]):X OI(C,L6#R@."<].O;Z^AH6M[=
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M%<1S%A&6(7'S;2%.1D$'H1]*+6)O?8EH&-$B&0QAU+J 2N>0#T./P/Y4 .H
M:\B1(7D=41>2S' % #J *$.LV5QJT^F0M,]S /WA%O)Y:' .#)MV;L$';G//
M2A:JX/2R9==TBC9Y&"(HR68X % $-G?6U_')):R>8L<KPL<$8=3AASZ$4=$^
MX/1V_K:Y*\JI)'&0Y,A(&$) P,\D# _&@-A] !0 4 % !0 4 11W,4DICC8L
M0,E@I*]2"-W3.0>,YH#8EH * "@ H * "@ H * "@#E/AG_R3/PY_P!>4?\
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M "@ HW KBPLQ:Q6HM(1;Q%3'%Y8VH5.5('08(!'I3N[W!ZWOU+%( H * "@
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MO0 #4F.,P8Z9Y/ XY^[[T ']I/MS]GYZXR?3/]V@ .I,,X@SUQR>1SS]WVH
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M<?=Y/R]* $CMYOW?^CL,L ,J.#\O)^7IQ0 1V\W[O_1V&6 &5'!^7D_+TXH
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M.!\W!^7K_C0 &WF/2W895B,J.!\W!^7K_C0 &WF/2W895B,J.!\W!^7K_C0
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MMY24(@8 N<94?+R.3QTH 2.WF_=_Z.PRP RHX/R\GY>G% !';S?N_P#1V&6
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M^DDMHU(VK$<$;0/NC.>.*$W[.*>ZO^;M^%B;>_)]';\E?\;F]0,* "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H Y3X9_\ ),_#G_7E'_*@#JZ .*\._P#)5?&W_7#3_P#T"2@#
MM: .?\=_\D\\2_\ 8+N?_134 :NE_P#()LO^N"?^@B@"W0!Q7P\_X^?&7_8P
MW'_HN*@#M: "@ H * "@ H XJXT#0XOB$;XZ)8O.M@UUO%LF\RB0?/G&=WOU
MJ(R]G&I*/2W_ +=?[PDN><(OK?\ ]MM]Q>\-:]J&I2JM\UG(+BS2]B^RJP\M
M6)^1LL=Q_P!H8SSP*UFN3F76/X[_ .7XH2?-RM:)WWW5K;_?\C-@\4ZS<V^F
ME9]*CEU=E^S*4<M;*58_O%WC?]W&04^8XQQ2L[\M]4K_ (?U\KOH7)*+D^B;
M7W-+]?EHNI47QOKTEX#';:?]BMA!]J;YRTA>=X3Y?. /EW G/''.<BHI.S>S
MM;YQ3_"_S\B'=775*7_DM_SM\O,L#Q7>R.5O8;*8BYB:*$0/E5\PKE7)*2$8
M&&4C!."HK)2M%2ZV;_\ )6_TM?5-7">CY?.W_DT5^M[;IVW,2#QEJ[:A+>QQ
M6%U?7-I:K EJP81"5G8!U=U&X=/OKNXZ9Q5N+C)P7>U^FB;T_K3S!R3BI/16
M;L]]7%:_UY>9U&A^(-?U35K*VFL[*& 6[27A,@,@8.Z#9L9UY*@D;CMY&2::
M2;?:RMZO]/,'=)+K=_<K?YF5K'CS5=-O]0-O;PSV*0W)MG> 1YDA7Y@3YI9A
MD$$^6@]">\PO+3J[6]')+S[_ / *FN5I?U\+?Z?CN+<>,->MXKBRNQI,%_#(
MWF32%UMP@A67;DG.[YL;NG!.WM4U+<KMV=_.S2T^_P ^W6XXWO%_S6MY7YOO
M^'RW.F\(M_Q0FBM@'_0(CCJ/N"ML7[LY_,BF^9W[O]3GO!1GO=4OM29+&)GT
MVT$"Q6Q7R T9;:#N^YG^$8[>E353A&I9Z\S_  2_S_/N#LZR3V2_]NE^=M>^
MG8Q?#FN:_9W*W]R]I=0SI8+=2E&$CF0E5"C) (W DDG.. ,\-)*\>EW]Z@G^
MGX[Z:JJG&I*W1?ASR7^?I;J;D7C34D@L[FY^PF*_6&:,*K*;='F2-E<ECN;#
M\'Y1E3QQ1&*YN63VZ^JD]/N^:?0N2LVE_>_\E_KY&=J7Q'U!-,NK[3I-(,-N
M9W#W#L%N$64QH(R#RW )]<@#&<B::YG%/KR_^3-_HOZMK4DE)Q7]646_Q?RM
MU((]:UW3M.UQ(6M(+>:;46MI K-*LB%GW'D #J /;.>U3&[C&/E^',E^-_D-
M:UH^;BOO@G^GS\C4\<I<R:?X=6Y%C=QAY)+B&YM3)%.RVTC#Y2W RIX.<'!S
MQS4K1J2DELFU]Z_S_/N9TKRIQ5]W%?(W?"ES?W3ZN;R>*2-+I5@2.(H(D\I#
MMY8YZ^W?UXJ2M%7WN_\ TIK]#.$KO3:R_),RY-8UR'Q%J-A#>68\^_6"V:X@
M8I HMQ(<@.-Q/897N>>E1'6'_@3^YI6_'?\  VFE%I]TOQ<M7]WY+S)M3\5W
M\7AO1+ZU^P07&HW*6[/=,WDIN5OF!!!/*C [YQQG(>\U%=5?SVO82TC-R^S_
M /)6,RX\>:HBZ?-!;PRQAXX[X+"-B[YC$&61I5(!P2 $?WQUIP2E)=G;[VKV
M^5UT1.RDNJO]R;7RV[O_ #L?\)=K!CN$#6(N&=?)46\C;4+$$KAL7' 'W&!Y
MQCUS3O%/[_N;VWZ;ZIZOH-Z2:]?P:6_SV=FM%U-BZU^Y_P"$3MK^T>*2^N2L
M<0CMVD5Y"?NA'>,CH?O,N._2JGI))=?\K[^G7\ BU9M]/\[?GT_$Y>V\>^(;
MJ!+A+2P2"W@$UYO#;R1.\15 KD#.S.=S ?[6<BTES+L^7_R9+\OQ\A3?+!OJ
MN;_R6S_X']6.D\2Z_J&F7,J6)M$2ULVO9?M"LQF53C8F&&T_[1SC(X.:B&LG
M?:Z7WW_R^?D5:_+%;N_RM;_/Y&+>>+_$"&ZS'I%K;&:9+>6Y=P"D0)</SA2>
M ",XP3@]*SEK!W[-_*]E;SZ_<NNCCK)6_N_>US?<4-$U_6(-)TBPT:UTU9IK
M>%6FG1C\HM5?<=I!8]@..,<UO7E:I/LN9_=R_G<FZ;7>3_-S_!6O]_<T(O'>
MHW%[I$MO;HUA=B".X!A \J62,. )#*">"IP(R,?Q#LJBY)RC_BM_VZF_T\B;
MM0C)[Z7^;M_6X6/C+Q!]FT9=0MM/6[UJ-&LT@#E1\R[]Q)[1MNP/[IY-5R>_
MR/=;^FM_R2OW>Q4_=3:VNU\]$OO=[^2-+Q1XEUG1M1E%C9VMQ9V]G]HF\QBL
MFXL54+R%QG!.2, 'GTQ3;;7HEZMC:LD_5OT23,UO%_B*"R3[5;V=K<122>>S
MQ>:2JA",Q0RR-&/GY;+[0 2,-6GNW3Z?\&V^R_I7!)M/OI^3>W7;RN1:]XDO
MKW0M4W_9#8W4=Y;1Q(K>=&8D?YV;=@@[>FT8W+R<T4U[\4_)_P#DR5O77[TT
M5%VFK=TOOC?^OO)-:\9W:6-S8V=S:0W^R] X+/&L*$JV-W7..:A7F].U_P#R
M9+\KDTE:4(]VE]\;_G;Y#D\1ZK UQ:V_]F0SVZRW$\TD+!9Q&D>0 'R&._[Q
M)P .#5R:2<[:+I_V]):?=VU;,Z7O/E>[MK_V[%Z]]_N7D6=+\6:S>>((8[BV
MM(]+N+M[2(*&,VX1&7<3G  QMQCGKQTIQC=.^^K^Z7+^/];Z+GNKK^[^*O\
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MXTV. K</&DL$C.HAP<,0X!+ XZ#'7GI2;Y=^FOXV_P"#?\ @N>UM+V7WQO\
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M;AKB,@*L21OPB2N,D2;<;SZY&"M$FHPY^EK_ '-K]/EYA&-WR];I+YIO]/\
MACO8-1230XM3D_=1M;B=N,[1MW?C3K+V3DNUS.BW5C%]['#6_C;Q!(;NUD@M
MX[E'A>.5[3),4BR-D0).[.<1] P;!SMXY=K1N^C:?R2?RWWUL4FF]-FKK[[?
MUMV.\TJ\_M#2;2\+1L9HE<F+.W)'.,@''U -$DD[(29;J1A0 4 % 'E'@/XF
M^#-*\!Z)87NO00W5O:HDD;*^58#D<"@#HO\ A;G@+_H9+?\ [X?_ .)H S_
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M!Z53;;NR4DM$5'T/0Y+R>1]+L'NIQF9C A>0$;<L<9/&1S]*4?=V_KK^:O\
M(;U=W_7]7_$GGTG3;H.+C3[68.ZR-YD*MN=<!6.1U&!@]L4!TL-MK"RL;ES
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M[\YW8(ZYYSUHV#N$6E:="4,5A;1F,80K$HVC;MP../EX^G%#UO?K_7Z!UO\
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M6UHECY]S</:JL;37*G=(< [BV &/J1QFG)\SNE8I*VY<J1A0 4 % !0 4 %
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 9XU)B?\ 4XYYY/ XY^[[
MT  U)CC,&.F>3P..?N^]  -28XS!CIGD\#CG[OO0 #4F.,P8Z9Y/ XY^[[T
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M@ .I,N<P8QG/)X//'W?:@ .I,N<P8QG/)X//'W?:@!?[1;.#!CUY/ XYZ>]
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M<*.1\O ^7K_A0 "WF7K;MPJDX4<CY>!\O7_"@ %M-G;Y!SL/.T8^Z./N]>U
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M6!-W>:<T:M'$<,\G)V\G/< #K4U+U)\_FW^"7Z&D6H\R[K_VZYZY';S?N_\
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MS\K^ERI^]S6ZW^]V?Z:]]['H-G!*E\"T6W:7);;P?IQ2 U: "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 <O<V5Y<>(;5X]$6VAL[E[IKJ-X_](S$R
M  9#;CD9W #"CD]B#Y4WY-6]7?\ X/37[P?\O>VO:WZ]/3[B3Q=ILVLZ';Q#
M2A>QB9)9K8R^7,H /,;AU"R XYW8ZC/-)JTEY7U7];=QQ?NON^_Y/^MSCG\&
M:_>:<J:C;O>21Z=>QV_VB=7DB=I$:!68GEP%^]D@$=>AK1NR;7Q>[KYIN_\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H IZA)J4:(=-M+6X?)W"XN6A XXP0CYY^G
M]*6MQZ% W7BG>H&CZ3MW?,?[4DR!QR!Y')Z\?Y#$6[&;6)-_V^PLH, ;?(O'
MER><YS&N.WKGVJE;J2^;H:%24% !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M_8I;&<'&<=<4 8,&N>-)X(YD\):?LD4,,ZR>A&?^>- #_P"U_&W_ $*6G?\
M@Y/_ ,9H L^$?$ESXCM]3-YIR6%SI]\]E)&EQYRDJJMD-M7^_CIVH Z*@ H
M* .<\5Z;?ZJVEVME=RVJFX+32(TRC:$;@F*2-NN/XL9QP:<-)W>R7ZK_ (/?
MKH*3:C9;M_H_ZZ>IBWFM^)EU"?R;&016KN%(LYBJCD#<,_O\ !_DQG.WK4IZ
M7?;]5T\M5?KOL.VJBN_Z.VOF_NZG3^&9+N7PSI\E_P"9]K:$-+YJ,C;CZJW(
M^AY%7)):+LOR$M;^K_,UJD84 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M'>6T<2*WG1F)'^=FW8(.WIM&-R\G-%->_%/R?_DR5O77[TT5%VFK=TOOC?\
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M>9KZ)J>IZGKEG/+=6_V*?3?/\B*-N&+\?,6Z@8!XZ@].E.W*YIZVY?UV]?\
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MU_7?Y>9I:SXCO=,\11VP^S+8JL>[=$[N[.6 &Y3B(\#&]<,3@$&LT])/M?\
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M7;QGTXIMM[_U??[P2LK+^K;%25=#\-6SSK:6]FLK;2MM;?/*V2=H5!N<Y+'
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M(XIKU4GB2*:98HUBX,:0LDF#(>2C=NF,U6BLE_>_]*T7W=]/P,X<SO?=6_\
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M=+!YDE $(L[87AO!;Q"Z*",S;!O*@Y"[NN,G.*%IL#U)J "@ H * "@ H *
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M  TZZ&,ZS>G&.J0\]/\ IG['_OH^V  &G70QG6;TXQU2'GI_TS]C_P!]'VP
M)_9UUM(_MJ]SC&=D.1TY_P!7['\S[8 %.G71SC6;T9ST2'CK_P!,_<?]\CWR
M !TZZ.<:S>C.>B0\=?\ IG[C_OD>^0 .G71SC6;T9ST2'CK_ -,_<?\ ?(]\
M@ =.NCG&LWHSGHD/'7_IG[C_ +Y'OD 7^S[G.?[8O.N<;(?4''^K]L?CZ\T
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M[\T (-.NAC.LWIQCJD//3_IG['_OH^V  &G70QG6;TXQU2'GI_TS]C_WT?;
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MKF*.>X)$,;N TA R=HZG YXH6KL@V5R>@"![VTBFBADNH4EE<QQHS@%V R5
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MT!Z6N6* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MJE)>MDM?QL6G=2CT:B_2\K6_ QK_ %_QCKG@O7GU&X6*SOM,DNHE:.W5H K
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M$K)R2VL_O7P_>_\ AD>BT@"@ H * "@ H * "@ H * "@ H * "@ H * "@
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MZ&A>[M_70'KN6+:UM[.$0VL$<$0)8)&@5<DY)P/4DG\:/(/,EH * "@ H *
M$(!!!&0>H-#5]&&Q7L=.LM+MOLVGV<%I!DMY<$81<GJ<#BG?H'6Y9I % #9(
MTEC:.1%>-P596&01Z$4!L#1H^W<BML.Y<C.#ZBCS#I8=0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M<WT?B>UN;I+B[9'M7CNXGMT6$1(H8%G1IADJ3M0X;=SCDUTQFO:.2TUD_O\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 <-\8(EG^&&J0
MOG9));*<>AN(Q0!A_P##/G@GUU'_ ,"!_P#$T '_  SYX)]=1_\  @?_ !-
M!_PSYX)]=1_\"!_\30 ?\,^>"?74?_ @?_$T '_#/G@GUU'_ ,"!_P#$T '_
M  SYX)]=1_\  @?_ !- !_PSYX)]=1_\"!_\30 ?\,^>"?74?_ @?_$T '_#
M/G@GUU'_ ,"!_P#$T '_  SYX)]=1_\  @?_ !- !_PSYX)]=1_\"!_\30 ?
M\,^>"?74?_ @?_$T '_#/G@GUU'_ ,"!_P#$T '_  SYX)]=1_\  @?_ !-
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M3:>FEGW]]I_^2V\MGU$\7>+M4TWQ'<V^GWXA2&)T:"1XRV[[.\BR+'Y6[;N
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M7KV\T[5)?[4_M#R;-)C+Y:#[/.58O#A0!\N%X;+#/)-37M"E*4>E[/NK;_\
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M_G0 D=Q%(Y122P&?ND<?Y- !%<12MM0G.,X*D<?C]:  W$0E,63O';:?;O\
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M-*45)68TW%W00Q)!!'#$NV.-0JC.< <"J;<G=DQ2BK(?2&% !0 4 <5\6?\
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MMYUN4!.>' [@ ^W^<4 +:1!@\TBJ6<G^'MD^U $$F^W,T"*Q$O*8'<YSV^E
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M?^MV_P!637/@^PNK62!KBZ4.96W!P6!< $Y(.<8!&<^^:E:--=/_ )+F_/\
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MS,X0Y8J/:WX1Y?R(D\(6*_:P;FZ9;@L=I9,1AI/,(7Y<_>SUSU^E2M+>5O\
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M&I<KNOZTM^7?_,6Z:?7^K'1PQM%"D;RO,RC!D< ,WN< #\@*3&/I % !0 4
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@#A_B]*D/PQU.60X1);9F/H!<1T 5_\ A=OP\_Z&'_R3G_\
MB* #_A=OP\_Z&'_R3G_^(H /^%V_#S_H8?\ R3G_ /B* #_A=OP\_P"AA_\
M).?_ .(H /\ A=OP\_Z&'_R3G_\ B* #_A=OP\_Z&'_R3G_^(H /^%V_#S_H
M8?\ R3G_ /B* #_A=OP\_P"AA_\ ).?_ .(H /\ A=OP\_Z&'_R3G_\ B* #
M_A=OP\_Z&'_R3G_^(H /^%V_#S_H8?\ R3G_ /B* #_A=OP\_P"AA_\ ).?_
M .(H /\ A=OP\_Z&'_R3G_\ B* #_A=OP\_Z&'_R3G_^(H /^%V_#S_H8?\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MMD 0:C='&=&O1G'5X>.G_33W/_?)]L@ -1NCC.C7HSCJ\/'3_II[G_OD^V0
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M #J-T,XT:].,]'AYZ_\ 33V'_?0]\ "_VA<[B/['O,>N^'UQ_P ]/3GZ>_%
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M1#+& 70,,J#TR.V<&CS#K8?0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M\SM)-''?E0P2>)X]@W@*=HDQT[ D8&*IM1DG_6\OT:O^K%O!I[VM_P"2Z_\
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MG'X4 =A0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M)9B2223R31Y ]6V6* ,>^\)^&]3O)+R_\/Z9=W4F-\T]G&[M@8&6(R> !^%
M%?\ X03P?_T*FC?^ $7_ ,30!8L?"?AO3+R.\L/#^F6EU'G9-!9QHZY&#A@,
MC@D?C0!L4 % %'6=0;2M)GO4A\YH@,1[MNXD@=<''6DV[I+JTOO=@T2;?1-_
M<KG++XZOBDB/I-I%<@/Y:/?/MD*.ZR#*Q$C&PD<<CKMH;25^R3^35_Z^6I7*
M^;E_KI_FOZU+OA3Q%-K]]=29=;;[/%+'&^TE2S29Y '95ZYZ5HX<L7?NU]Q"
MDI1C)=?\HO\ 4Z.YM(+Q8UG3>(I%E7DC#*<@\>]0M'?^MK?DP:NK/^K.Y/0,
MKFQMSJ*WY1C<+&8E8NQ"J3DX7. 20,G&3@>E"TO;J#ULAFHZ;;ZK:&UN6G$1
M.3Y%Q)"Q]MR$''MG%*R>XTVMB>""*VMXX((UCBB4(B*,!0!@ 53;D[LE)15D
M24AB,H92IS@C'!P?SI-75@6A2TS2+/1X9(K-)!YC[Y'EF>9W; &6=R6/  Y/
M055[I(.MR]2 * "@ H * "@ H * "@ H * "@"O:V-O9-.T",&N)#+(6=F+,
M<#J2>,  #H .*-DD#U=RQ0!7N[&WOEB6X1G6*1954.RC<O(R >0#S@Y&0/2A
M:.X=&NY8H * ,O4O#6@ZQ<+<:IHFGWTZKL62YM4D8+DG + G&2>/>@"G_P (
M)X/_ .A4T;_P B_^)H D@\%^%;6XBN+?PUI,,\3!XY([&-61@<@@A<@@]Z -
MR@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@"J^F6$C,SV-NS-G),2DG)!/;N54GZ#THV5
MOZ[_ )AO_7E;\M/0@A\/Z+;9\C2+&++;CLMT7G.[/ ZYY^M'2P=;EZ&&*WA2
M&"-(HHU"HB* J@=  .@IMMN[ ?2 * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * &2PQ3Q&*:-)(SU5U!!_ T!Y%.?0
M](ND"7&E6<JAMX#P*PW;MV>1UW$GZG- [M_U_79?</ATG3K<J8=/MHBF-I2%
M1C&<8P.VX_F?6G=BZ6_K^M%]Q<I % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '.C
MQ3N\41Z(MDQ8M+NE^8A514.>%(R3(!@D=.N2 2.L7)]%?\6OTOW\NHF[.WFE
M^%Q[>-?#Z+$WVYB)460%8)&VJ1G<V%^4#C). N1G&132;=E_7_#WT[]!O2]^
MG_!7Z/[B[!KVFW6\6\[2LD/V@JD3DE,LN0 ,GE6&!SQ4WTYO3\=4.WZ_AN9L
MGCWPW#Y"RW[QS3EA% ]M*LSE3@J(RN_=GMC/3U%/=V7K_7Z]NI+=M7_7]77J
M6;_Q?H.EV=I=WNH+##=Y\DF-B6QU& ,@CN#TP?0T[>\H+<:UCS+^OZM^A%+X
MRTE9EA@>>>0W"082WD(RS;=P.W#*"""1D \$BE'WFDNO^3?XVT$VDF^W^:7W
MJ^VX^\\8Z'87LUI<74BS0G;)BVE95/!/S!2. RD\\ Y.!1'WK)?UK;\]/7U0
MY>ZFWT_RO^7Z]F0W/C&PCW);K(\R2B)XKB*6!QG." R<C@\]#@X)Z4NB?];I
M?JO,4FHZ?ULW^G]=66GC[P[<*Z'4HQ<0PB::.-)&V# /!*@D_,,#&3Z4Y:7?
M3_@V_/\ 3NBFK3Y.O]?I^O82X\>:'#9Z=?I=*^GWLKPK/AAAE!X"[<DY4C%.
MUI<K[7_%?YWOV1+=E==[?@W_ ,"W=]RY+XMT:&2:.2>=6B4. ;27]Z"0 8_E
M_>\D#Y-W44MOZ]>GR?W!=::[Z_E_FAFA^+=-UY;MK24.+=FR4#-\H[GCY2>?
ME//!I7M#G>W_  7]^BOIW0UK/D_K9?=O;Y!_PF>@%H@M_O\ ,"L"D,C!0RJP
M+$+A1AEY. -PSUJFFFT^G]?\-WZ";25W_7_#=>W45?&7A]KNSM/[143WBQM
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M7//'6C[/-_7]/IWZ$W5[?U_7?L8W_"P="&KQ6,D[P>8K#-Q#)"ZN"ORF-U#
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MF62%(HY4^5_N.L>YOF8'#EAC/TJ8)15NB5ORW^5_,&[\SZO_ #3_ $]#6M_
MNF6PBBCN+O[) 5:&V+J8XB'5B1\N3DH,Y)[XQFJ4FGS=?ZT%^O\ E:_W?(CE
M\%I(+VU^VR_8KR()(72*1UQ([!0KQLI7$A'(R,#ZU*2Y5%[*WY6_1;#O:7,E
MW_%W_._WDLG@ZVO=(O-+O)95MII8BAAE(=4B";!NQURF3CUZTVVVI=;M_/\
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MA_733R,Z_P#AQ9W>I:?,E[=Q0V\!A<I*%<C! '"X((9P?8C&#S2C[KUVM_\
M(_\ R/WE-W?-UO?T^)Z>=W]Q.GPWTB.\>X2[U ;B0(S,&1$))**"IPIW-[_,
M>>F"UTT];_Y-?A?\%YWE*SNM/^'3_-?UI:?3/ 6EZ1:RPV4C1&2)XMZ6UNA
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M M]< #\A4B'T % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 ? % !0![!^SC_ ,E#U#_L%R?^C8J /I^@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MNGX;C?#+V?V2X@MH]0@EAEQ/!J%R\\L;$ @;F=^",$;6(_6K>J36W]?U_P
ME:/4I^+=3%M<:9INR_E^VM)F&P)267:OW0X*[.2#NW+TZUFM9<OE?\44](\W
MFE^#_P OZW-+PW-YVB1'[1-.4=T)N%VRIAB-C\G++T)SSC/>M)='Y+Y^?_ Z
M$+2Z_/\ K[O+ON:U24% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0!Y_)XKM4^(:)_;D&W[1_9IT_P"U+NR4W>;Y
M><YWX3..E.E[U^M[_*WY:*3^X57W?*UOG?\ />/IJ>@4AGF;W>FOJ&KB]O-?
M34/M\D-LT,]XD ;CRT!!$ YXP>/6HAS.FN3XM=_5]_(;:4WS[*WY+MYGHFGK
M=+IUJM\RM=B)1,R#@OCYL?CFMI\O,^78SAS**YMS"\2S:M#J>B?9KB."P:]C
M28+DR2YW?+Z!> >^>G'>(?Q$GY_DW_7WE3TIMK?3_P!*1TM PH * "@ H *
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MAA0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M % !0 4 % !0 4 % ''^ / O_"#6FI0?VC]M^VW1N,^3Y>S(QC[QS]: .PH
)* "@ H * /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>149
<FILENAME>g20922g96c86.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g96c86.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M]_V:TC$4>\Y; ]30!>H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@#+3Q!I[S;!(X0DJLIC;8S!2Y .
M.H4$_A0 MMKMG=ZTVEPB1I5LX[T28&QHW9E7'.<_(>W<4 2:CJ?V"6VA2RN+
MN6X+!4A* C R2=[** 'Z?J,>H+.4BDB:"4PNLF,A@ 3T)'>@"Y0 4 45U>U?
M6FTE?,-RL1E8^6=@ VY&[H3\ZG Z C/44 9D?C/2VMVN9$N(;5H!<032( ES
M&6"J8\'DDL@ ."=Z\<T :.EZO#JHNE2*6">TF\F>&8 /&VT,,X)!!5E(()&#
M0 V#6[:X32F1)0-2C\R'('RC9O\ FYXX],T 7I9&C,86%Y-S;25*_(,?>.2.
M/ID\]* )* "@"&:X\AANB<Q;69Y01MC ]><\^P/3G% $D<B2Q))&VY' 93Z@
MT 4-:UJUT'3_ +9=K(T>\+B-<MCJS?15#,?93]* -&@ H * "@ H \RL=-U:
M\2SM;ZPECN9+B;[7:F _9(HS;2*K*V-N2VP'!)^9N.N "M%X<EGN?MMOHTT(
MAT"UB@1K?R_+G$TC/A<<.,YR/[Q(.#0!WNKZ=_:&J:9O$XAC,A=H9GB*Y7 R
MRD&@#G)=,:#5-^H:?/=:4+JY+1&%IRQ*1B-BN"3T<9]3U]0".STV^AM-)35+
M*:XUH)IX^T"(R&/84\[,H&%Z/GD;@>ASR ;/A-+'1K+3M#6%XM1DL5NYU923
MGY5.YNQR< 'LI X% &K-#(WB6QG"$Q):7",V. 2\) _':?RH X";2-1OO".B
M:9#I]PMQI.GV\=P)(F1=\<UL[*A/W^('QMR.G/- '6>&+:?^VO$NIO!)%;W]
MY&UN)4*.RI!&A8J<$#<K 9P>,],4 8EU:7E[X>L-.AL;K[18:;-#,'A9%W^1
MY8520 ^6Z;<_RH FU3PP@U*UT^VL&.E>9;^:JK\K?)<+(S>K$% 2>3QF@#,@
MT/5I-,+:FMP7LI8+#+0>?Y\,0;][Y8Y8,S@D?[ ]* +^C:%)#<F]ELKJ=X+&
MX2W+J(6.Z>0JJ#.$^0@*#@JK8..10!%IVDW$EM-92:-BTC:94D,'EK<!H$PQ
MB/W3GY3@8+*2.M %B*V\FXT;3+"P:&TU*-#.@A,(@\AMSLR$ _.65.G.0?>@
M"_XBTW5=:\06MM;QPC3K:VD>7[2C&.5Y0T8 P1RJ;\_]=![4 8^EZ1KT5]I8
MOXY)6O5A749!T6:U9B)C_P!=-J#\!Q0!A7WAC4[S03;M%=RW;"&.[6.T,.YO
MM<#%R_64A4<AAG:-V<9% '2:-:W6A:_J=U-87*Z<EW<1VL<$+.%1X[9EV(O1
M2T<G(XR>>M %.TT:[BN=+,\5R)T6PV*++>4"A ZB7I&!M8L,C()'.<4 >DT
M% !0 4 % &(-7U!-6N+6XL[*&WMXTFDG-XW$;%P#@Q@9^0Y&<=.: +J:KI3^
M1,E_:-]H^2%Q*I\S! PISSR0,#N: 'QZKITK2K'?VSM"P60+,I*$G !YX)/%
M %=O$.CK/90_VE;%[TD6^)5(DP<<'///'UH MVU_97KRI:7<$[0G;((I Q0^
MAQTZ&@#/UG7'TR^TS3[:S-U>ZA(Z1*6V(BJI9F=L' ' Z')(H +/Q%9R6C27
M\D6GRI+)"\<TR@;D;:2I[KDC!X/S#(!XH ?'XET:34-0L1J,"SZ> ;A6D V
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MY0649X''3B@!L.DZC#J$=O)ITDGFZC;7BW VE(HTMXT8,2<AMR,  #]X>K8
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M9'&2 ,NM%U&/3=*@@LHW&EWD-SA)0&N/E;S#@@!6W.2.<'';I0 7=AJ\]K?
MZ6B/JEE]E*0RKMMCNEP6R1GY903MSRIXY% $FF>&9[6YT^::.$M;ZE?WC$')
M F>4H1[[7 /XT <]8:7JEOK6HZ9'9K.6T[3+>6195 A*%]Q.>2,%B,9.1C S
MD &^-'U"XNC8RVWE6BM>LUSO4AA,Q*[5SG(#G.0.1QG- &5?>&+^XFEEDT59
MY+NQM;=U6_>.-7B=]WF[67<NUE*X!.0<T ;%SI-];6%O';VSNRWUS.6M9%26
M/S'D967=A3]_Y@<]>AQ0!#/X<U.X6*:4P&[.IVMW*X. 5CB16P/]Y6P/>@"O
M_P (UJUUK4=]>*CD6]G'*TDVXO+%<+*[!<84<9&,<]A0!:;095\4-.NEN\;7
MXNA.UXXB4>2%+>7OYDW9'W<8/7- $QMM8377U#^S(7:_LK6&53,&2W>.21G!
M)P6&)3M(&25YP#P 9)\*ZA<Z<^FS6P406E_ LC.I2<SM\F,'(XSG(&#TS0!L
MR:!<MJ6KW2B/_2[RSF0YYV1&,MG_ +Y;% '2T % !0 4 % !0 4 % !0 4 %
E '/Z9_R.VO\ _7"U_E)0!T% !0 4 % !0 4 % !0 4 % '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>150
<FILENAME>g20922g96r61.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922g96r61.jpg
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M  (" P$!              @)!0<$!@H" P$!                     !
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M*0A"% I"$* %*4I2@ %*4 ]  /P 8'U@,!@,!@,#Y.0BI#IJ$*HFH4Q%$SE
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MQ\-#1[&(AXABTC(F)C&C=A&QD:P;IM&,?'L6B:35DQ9-4B)I))D*FFF4"E
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M#^32DH555R]LVN/W9ZIIOJE*PIRD5"U69YPD;69&T2TH9-HK1%%/L*B,6S(
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M*P]+C?WH5QL\DILVO^B65/D(5LL@NV;O'[A0?B(HJJ 7%X# 8# 8# 8# 8#
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MG]5VN*IZ469-=JH215L#MN5 Q5""542B!@$/7 U7XM+1K"W>.'AZ3TX\B'5
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M<:13F#1[(TLBR6C490S5 9%*.<KH.7#!-Z*?V4V2[EJDH=(# 0QTRF$!$H"
M<W 8# 8# 8# 8# 8# 8#T#_XP& P& P& P& P& P& P& P& P&!XVO*?IGEE
MUTA>]O:#[ YMBMI1'D!TO(;NY,[?U>L_\?=SZIC>0+3#JP&S-H-M8$A:K9[!
MSB[<S"SB2GW<22P,EVP&;3SDA6X6,?\ G/J'"M'Y O$#R-MW0&[]F!MRZRW4
MU\T+2=@:_KXWVP6RT3E0J<+7-K(-KV&L*#4)!.$J3PY?ULC&QYW38QSJN#F#
FT&X# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>151
<FILENAME>g20922gra001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922gra001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#^17AI9@  34T *@    @ ! $[  (
M   1   (2H=I  0    !   (7)R=  $    B   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $-H86YD<F$@
M2W5T;VQI>6$    %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,X
M-0  DI(  @    ,X-0  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M'A+>SVKKEKNT!++&<]-DAP?16Q]/7_ARFH:EK%_KEY(QCD!C .<%B03@=@
M/QJ71M%ROL:.O:I&%MST3-+7B$5[+#^UAJ*O+(8([+>8PQQQ;(>G2M)_VDO!
MRVR2)9ZLSLY4Q>1&& P#N^_C'/KG@U'LY=#?G74]=HKRJ[_:'\%VUY;0Q_;[
MF.9%=YHH!MAW=F!8'([X!_&MGQ1\8/#7A+5+*SU/[7(M[:K=Q7%O&KQ^6Q8
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MC=TZ\5A_"_3+^W^"'CN"XLKF*:6"01QO"RL_[@C@$9-%_=^XTZ_>8L]E;?\
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<H 0#%&*6B@!-M&VEHH 3%&VEHH  ,4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>152
<FILENAME>g20922gra002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922gra002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#^17AI9@  34T *@    @ ! $[  (
M   1   (2H=I  0    !   (7)R=  $    B   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $-H86YD<F$@
M2W5T;VQI>6$    %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,U
M-0  DI(  @    ,U-0  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                            ,C R,#HP.3HQ," Q,CHP-CHP,  R,#(P
M.C Y.C$P(#$R.C V.C P    0P!H &$ ;@!D '( 80 @ $L =0!T &\ ; !I
M 'D 80   /_A"R-H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O #P_>'!A
M8VME="!B96=I;CTG[[N_)R!I9#TG5S5-,$UP0V5H:4AZ<F53>DY48WIK8SED
M)S\^#0H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(CX\<F1F
M.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N=S,N;W)G+S$Y.3DO,#(O,C(M
M<F1F+7-Y;G1A>"UN<R,B/CQR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2)U
M=6ED.F9A9C5B9&0U+6)A,V0M,3%D82UA9#,Q+60S,V0W-3$X,F8Q8B(@>&UL
M;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E;&5M96YT<R\Q+C$O(B\^/')D
M9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](G5U:60Z9F%F-6)D9#4M8F$S9"TQ
M,61A+6%D,S$M9#,S9#<U,3@R9C%B(B!X;6QN<SIX;7 ](FAT=' Z+R]N<RYA
M9&]B92YC;VTO>&%P+S$N,"\B/CQX;7 Z0W)E871E1&%T93XR,#(P+3 Y+3$P
M5#$R.C V.C P+C4U,#PO>&UP.D-R96%T941A=&4^/"]R9&8Z1&5S8W)I<'1I
M;VX^/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](G5U:60Z9F%F-6)D9#4M
M8F$S9"TQ,61A+6%D,S$M9#,S9#<U,3@R9C%B(B!X;6QN<SID8STB:'1T<#HO
M+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B/CQD8SIC<F5A=&]R/CQR9&8Z
M4V5Q('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR
M9&8M<WEN=&%X+6YS(R(^/')D9CIL:3Y#:&%N9')A($MU=&]L:7EA/"]R9&8Z
M;&D^/"]R9&8Z4V5Q/@T*"0D)/"]D8SIC<F5A=&]R/CPO<F1F.D1E<V-R:7!T
M:6]N/CPO<F1F.E)$1CX\+W@Z>&UP;65T83X-"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/#]X<&%C:V5T(&5N9#TG=R<_/O_; $, !P4%!@4$!P8%!@@'!P@*
M$0L*"0D*%0\0#!$8%1H9&!48%QL>)R$;'24=%Q@B+B(E*"DK+"L:("\S+RHR
M)RHK*O_; $,!!P@("@D*% L+%"H<&!PJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*O_  !$( #0!#P,!(@ "$0$#
M$0'_Q  ?   !!0$! 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,#
M @0#!04$!    7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S
M8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H
M:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZ
MPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 #
M 0$! 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  !
M G<  0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q
M%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X
M>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(
MR<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /6?
M&6N:QX?F%U9Q":W88 +-@'@<XZ=:2R\?6L?A1M2U+SB\'^O6 ;MG)QU/H.]=
M#J^F0ZG:26=R&=90,D$?N\$'OTSBO(+(/H.J/HNIK&]M,IBN%F&[>6'!YXX#
M=Q71&*9YU1RI3NSO_"GQ0\/^,;O[+H]Q(95Y*3%0S+D#( 8Y&6'-9^I_&KPQ
MI>N3Z9.]S+<P'!6W57#')&!\W)&.17@VM6=Y\*OB9'=Z8ZB*1Q<6^S(5K?S.
M$(&,\ITZ5WVE^$-$EU]/'>Z"YTXQK.T,JA]UPP/FJ<C& 7Z?K1*F=4JBJ1NC
MW.WO8F_=&X 8 %=[@,<\U)<W4-JB37EU';KD EY JGVR:\N\&2:CJGBR2XO)
MI)DB&'1'.U<J<<'Z5%^T-=7%IX"A:UN9;<B\0[XW*DG9)\N1_*LW$5.I='K,
M%S'=*9K29)HSP&1]PS^%2*QQEOUKRKX8^)[31_A;8WOB._: 23;1)-(>?W:'
MJ:Z:Y^*7A"TC@:76K4+,2$+/UQC/\ZCD9JGJ=@2P.>HHW?4YKFM1\?>'=,T]
M;VYU>U6!SPQ;@_YQ5S2?%>CZWIK7^FWL4]I&FYY8SPIP"?T(HY&7<V6#/QDK
M[BD#$R Y !Z GK7)K\3/";0S3#68?W+%67?WSBK&F^/O#>L6,E[9:C T< R_
M.=O7_"CE:%<Z0LP+,Y 5>>#2AB<;>5/.:Y;1_B%X9U^^^R:7JEO<3L=IB#9/
M4#^HJQ<>./#]CK2:3+J,0NW.!'NZ'GC]*+"N="">0-W'<TT,3P6P,_*<]:R=
M?\4:/X>BC?6[^.S24_*S-C/3_$?G5.]\<:!IMI;W5]JMG';73 6K$_>)X'Z@
MT6'<Z4,2<'&1VSVIJLQRK;A[UR%[\3O"5BZ1W6MVBS2*#M#8.TUU%K?P7MNE
MU:3I);,,[AWHL.Z+!)VX4D^]-9\%021@9)KD;SXH>$[&^DM+G5X8I%/.7QSZ
M5KMJUMJWA^2^TN<31O'\KH?;/]134;LSJ3Y8E[^T[5E;_2X<@XXD''ZU.LZS
MD^3*K#'\+9KQ+2M/U#6=5N+>VU&XC=9&+ S-W)]/I5^QU'6O"NLQ6VHW,DJ2
M,!\SL?YGWK=TM#BIXMJ6I[ @;Y0S'/?FE+;FZL,5E7'B#3K1H%N[I89)@&52
M<$@]Z?;:]I]]>FTM+A)'4 D*:P=-G;"K&39IY*K_ !&D+<9RPK%O?%NCZ?(4
MN;U$?H4+=*OV>J6NI6XDM9E=3W!I>S81J1<K%M7XXW'ZBE))'.1]*S;_ %[3
M],7-[<I$/4G%&G:]I^J_\>%TDWL#G_/2GR.X^>+0RX\1:?:WZ64]R%F8X"EP
M#_/WK35]W*EL$9%<#KNBZ/<^,H+RZU+RKD,"(?,QDY';'M76WVKV&EPI]MNE
MA4*-N3C/^<5=2&BL9PJ1U-/<=N/F^M-!*MU8UDV/BC2=0;R[:]C=O0-6A<WL
M%C;F6ZF6.,=6)J>1EQJKEN3EN<DM]*>O)SS^-8$'B_1KFZ\B*]C9\X W5N0R
M&3#*P*$9&*3@T*%128I7)SCD5Y_\1?#INK4:C;#,B?>P,?U]J[_=QNP?RJ*:
M%)[=X)5RCJ0:*4W>X5J2J0/ M>TY/&O@I]/3']J:5";N)R.9$1"HCR< 99\Y
MR?I7.?";Q!&C7/A'6'*17LC1P@Y/ER@[GZ#_ &?4"N\U:UE\)^+%:#BW,XF1
M>Y;=P"/3 ZUY9\7=.@\/^,X]0TL>7+>0I.^/X7<%B1GW-=K?NGGX;1N#/IKP
MKX>C\/:7Y)^9F/+]SR3ZGUK@/VCT+?#N(YX-VG'_  "2O4-"N'GTFW/!PG)_
M.O+OVD '\ VTH."MY'D>HVR5RJ6IWQI\J//=6WM^SGIK1'YH[LY_[\I3;#X8
M:??_  ;;Q++-(UVI_=@LV%_>[3_%CI[4[6G(_9UL7B^7==MD'O\ NEKM] 0?
M\,RL ""2<G_MXJ[Z$MZGG_PV\!6OC3PWJ%WK=Q*S6D;%%WMC(4D<!L5=^#KS
MVGB#Q9H[.QLH;281C/I(BC]!70_L^C'@'Q,3\VW(!_[9&N>^%.&^('C,-RHM
M;AL>G[Y*=QW9E?##P59^-_%^JVVI22*EO,Q 5F&<E_0CT%9^B>$UF^)DGA<7
M,J6A(("NPR-H)Z'W]:[?]GYG3QCXGD*[B'7:!_OR5E>'X_+_ &E)Q]]U !"\
M_P#+)*-Q-E37?#D'@+XR:#9:+*^6O896^8\CS2.Y/]T5H^))&D_:&TQF_CB1
MB.V2KU8^+ '_  O30@>KR1 8_P"NS53UX;?V@M(4]1;Q_P#H#T6%S'7_ +27
M_(#T?'7+_P#H4=<5\2]X^'?@S'^L\B/=_P!]O7:_M)?\@+1_JW_H4=<9\1\C
MX>^#0G#O!&"3[N]**T'<T-8^$6FV_P )8_$?FR/>_9DO,EV/WD4X^]ZFD\*>
M)]4TOX!:Y=6LK-]C:$1%B"?GN-K<GZUZ/K[&/]GE,K\_]C0J?^_:5XUH@)_9
MX\3*&(_>6^WV_P!*YIV'S&K\/OA9IOB?P'>:O>S2-<)"SQL68YPK?[7M5[X'
M:E<VFJ>(="FD=X+>*9DW-G!#1K_(5V?P:(?X0W"8&Q8'QS[-7#_!XA?B7XJC
M;YD"3R<>GFH*<=[$U*B4-3OOA]QXFOP!E=V<^G+4_P"(Y3^W+ (/FWC/YK6!
MI&I7^F:I=MI432,\K;@HR0,G'8UJZ?I.L^(];AN=3@EC"'/SH1_0>E;.U[GE
MQDF[6%\=*[:EID:??DLUC^F6:M[2_#T?A?09M2MG9YY859MQ)P3@]R?6LOQX
MAB\7:1&A^ZL8_#>:[#6O^1)FV9W?9TQ[]*B]DBE"3G(X3P?H%CK]G>S7P=I
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:BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>153
<FILENAME>g20922gra0439.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922gra0439.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#^17AI9@  34T *@    @ ! $[  (
M   1   (2H=I  0    !   (7)R=  $    B   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $UI;F%K<VAI
M(%!H=6QA<F$    %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,X
M.0  DI(  @    ,X.0  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MH\^K7%FSZ]86EA<;OEBM+QKE=N!R6:-,'.1@ CCKS5Y@3C:VW!!/'4>E+10
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M(;LAED#;@"23N4\ CT!'0@#AM!\0:IHWAN72Y=)EN?$=P3)=7MQJ$1M)IV4
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D)C) 8$CD'@XP>^"<8/-/HHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>154
<FILENAME>g20922immu.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922immu.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M_0EXBDK)W^YBI+N/R[67?M!4CC;\KCK]]9%<$=O+8'FG\-DS1-26FR)Z!A0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 >3?
M%KX:V/Q.\':EX<NF^S71/VW1[T1Y-AJMN";69F'/DNS213 8W13D'A./3RS&
M/ 8FA5C*4*<*E.4U!\MXQDFXM*UU96L]-UU/#XBR?^V,!7PU^:I*C5C2;7,Z
M=2<&HR@V[QE%V:<;--1::Y4?C5JNF7^B:G?Z/J=O+::AIES-97MM-&R-!<VT
MABE5<H,H75MI9BS1B*7!68,?V#"8R&+IJ=-W3O:S[>GJ?S9F/M\+C)9,U*G6
MPUFZNL9RLG*S>C=T[?$]D,L+^[TJ]L]1L)I+:]L+F&\M+B([9+:ZMIX;BVE0
M@D$K)!RK+T?T-5*@L4JV'K)3AROE4US)-IQ=E+1/76QS4L76P6*HXNC4G2G&
M483E"4H2DJ4HM<THV;6E];GZH0GP[^U+\!M5\/:K=RV#^)]%&CZX^D2-#J'A
MSQ%;/#<0:C91R,=LEKJD-I>VPE(25$"2Y56"_CN)P];*,P]G)/E;NKW2MJK6
MU[6_SV?]+Y-F='.,MC4A)2E%6E%-.[T:OM>U[[:6Z6/Y>?BAX<^)7P?\>^)?
MAOXOUW6(]?\ "FHR:;>2V^I:HEG>(@$UGJ=B\SQM-8WUC)!>PR-&A\J[164%
M#7UV#G0Q.'A:$.:RUM&_WVN<&(A5IUY>]*,$]KM+[KV."'BCQ,A##Q'KJE2&
M5AJ]^I4KR"#]HX((SFM)4**A*,J4)-)K6,7LK=43.M-.').4;;VDU^1_43^P
MG^T?;?M!?!;2+C6=2LF^(W@Y$\-^-K%)@E[<264:#2O$K6DKF;R-6L"DTDP
MA^W1ZA%#\D "_$8_"NA6G*,.6$M%9:>FA])@:RJTHPYKSC=O7733UZG'?\%#
M/VG9O@%\+$\/^%;N%?B+\28[[1-%=9%,_AW04A\GQ#XH\N.02+<Q1W<%G8E@
MH^U7AE!=;.9!IE6!>+JN+VC;1J^[M_7R)QU>6&BG=J]^MME<_FE_X2;Q(/\
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M&'Q=X?FEFD=@D<<42:AN>1F( 50220!R:N> QE-<_P!5K*$>LJ4XK[VK'/\
MVWD\I4Z5#.<%4J2M91KT)M[]%5;._C/R]2>3@GG('0CV]*Y->JY6NGH>LGI&
MTHR32:<;6V\FT// ],?A2;<5HKVZ!MY6/)_$?QW^"'@_6;SPYXM^,GPL\+>(
M--, U'0O$7Q#\):)K%@;FVAO+87FEZEJ\-S:F6SN+>=!)$N^*>.1<JZD[0H8
MB:4HT)2CTM%O\4C)XBE!\KDDUYHQE_:;_9N9E1?V@?@D6)"JH^*_@0DDG
MU[DDXX%*6%KK7V=2-O[LO\A1Q%*3LI+1VW1[=')'*B2Q2))'(BR1R1LKH\;J
M&1T=20R,I!!!((((K).SY.L3;H24P"@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#EM=\8^$_#,L
M4/B/Q1H'AZ2XRULFM:UIVDM.L87S# +ZZB,P7>F=H.-PSU%;X?"XJM*7LJ$Z
MT4E;DA*;[/2*=M58XL1FF5X"5L;F>#PDW;W,1B:-*2TNO=J335UKMMJ88^+7
MPN_Z*3X"XZ?\5EX=&/\ RHU4<LS)<RC@Z]5W5HJE4O\ *T7;OMT.1\19#&U\
M[RU7V_V["].W[P/^%L_"_P#Z*5X _P#"S\.__+&J_LO-_P#H4XO_ ,%5O_E8
MO]8\@_Z'F6_^%V&_^6%JS^)?P\OY%BL?'G@Z]D8E5CM/%&B7+$J<,%6&^8G!
M]!4SP..IQUPE6#BM5*G-<K6Z;<5MU-*6=9/6=J68T*C>W)7IRCY<KC-II]&M
M&MCL4N(I462*:)XV&4>.5&1@>A5E)!'N*XHK$1DXSI.*CY/L_(].$XU%^Y:J
M6Z)I[>E^S)%;@]>,C(;(R"!UQU%6I7:C\+^X(N;?+.');KM^B)5Z#MP/PXIV
MMIV*M;3L+0 4 % !0 4 % !0 4 % !0 4 % !0 4 (> >V!],8I2ORM+1V=O
MT#;RL>6?%WXB6OPQ\%:CXFG5I[D$6.D689E%UJMRC_9(7*LI$0\N21RAW!(6
MVUZ.7X*6-Q5&C'^9-V5]+ZZ==O0\7B+-J>397B*\M)J#Y7?E:>R:=KIJ_34_
M,O4/VE/C/?ZA_:"^,;K3\NLD-CIMO8V^FVXW;S"+:>SE-Q& =H-T[NP'.,[1
M^E1X9R^&%H)TZ<:CBN9N$7*]M=6[J^]M$NA^$5>-<WGB:]:GC,2J,I/DC&O5
M4$EI9)/E6W1'W/\ LW?&F^^*FG:E8^(1&GB;01;-<O; QVVH6-W'B&\$&XK%
M<"6W=9$3:JF0$#YN/B.(<FAEU:G.C+]VU)<JT5^9VT3=]-F[M;;6/UC@SB:>
M<X>I0KQO6BXR4Y.\K*G&ZNU?5ZM)^>][_4-?.'W(4 % !0 4 % !0 4 % !0
M 4 % $;@[&Z$!6^7IG /%9R4HQER.SBG;U2T)YI4TY+[.J7IJ?GU^UU\)F4_
M\+5TK.&.G:9XELBI;#"(6MGJR.,E!Y<5K9NC87*VY!!+D_><(YM&')A*R:FU
M-Q>W9-/3=6OYI^6OY#XD</J%!9U@HN5>4Z$:D;MVB_:*3LWRI)<JTV^9\&=/
MPQUX(X'4=J_0JR;A3]D^2<7S-O5-.UDETL?D\E2OK[RE3A=)VM4Y??OZ/2R/
M?OV<OB8/AUX^MTOG@C\/^*GL]&UR2=Q%%:,LTJZ9JLUQ(=JQ6LUU(LQ<*H@N
M+B0G(&/G>),LAC<'4K4XOV]",6M=[33:MMLW;;7R/KN!LZGE.98;#UVI8:M.
M479)6YJ3C&[WTERMVZ%K_@IW^S.?B%X+C^/_ (78-XC^'.A?9/$U@D)+Z]X,
M-XMU'?6LT,;>5J&C2WU_<NYVQO8W-TTC@Z= K_!9;BOJ]?ZLWRM:6?1K?T7Z
MW>[/W''TU5P]+%4O>A649*W123>OH?SYMGGE<\\@;ESZ[3C(SV.*^LE)[<K=
MNO3U/G5%Q;N]F?2W[)OQ]O/V<_C3X?\ 'J127>@WB)X9\9Z?&7#WOA?4I8$N
MY4"9_P!(T^XBMM1AX +67ER,L4DA''CL-'$8645[LXM/[M-OG_3U.O!5YT<1
M'I&S5]/)_H?NM^WG^SII_P"TU\&[+QAX(O-/U#Q=X$TW4?%7@_4=.:'4+7Q9
MX>N["*[U+0K6YL-WVP7MM:0W.GR122KYT2JHV7;D_+Y;BY9?B)N<79V5NUI)
M]>VWJ?08ZA]:H0Y6DTK_ 'Q/YDPOWACA2R=&VRX"@F!E4F51YBG(&< G'W0_
MV<Y*-5TE[RBK\ZVTO\^A\U!<\E!^XWI9_P# /Z.?^";7[/EO\'_A))\6_%:P
M0>+/B?IL&J>9<H8'\.^!+21KC3; SW"J$2_?_B;3.,*\9L26_P!%P?DLTQ;Q
M>,6$H[4&XRTO>2>EM%:U['OX1/+L-5Q-5KV>FFSM:]U]VQY)\:?B9=?%#QG/
MK#((-)TM9]*\/VHR&CTQ+J9Q/+)U:XNF,<\N<X\N.(';'D_HW#N5TL#A9\Z:
MJ3BN6[=K\EEIVNS^>N*LY_M;,92E!SHQ=2/+&R]UU9NS:UU79KRL<)X3X\4>
M&_;7M)_2^@KNS*7M,NQ-)1Y)0B_>>VG97\SR\EA2H9O@IT:<$N9>Y)U');]>
M==C]V(.(D_W0?IP.!["OQ)R;E/2W+*45Z)V3^9_5=%WH4'RJ/[NGHKV7NKNV
M]/4>W3\5_1A2;<4K:--+[VD_P--ODG^1_*M_P42X_;&^,GM/X(_3X;^#J^VR
MAS>#I[*R[/NSY/,/:0Q,VI)*^UO(^,[/_C\M/:Y@_P#1JUVU(T_J]63B[P33
MUMJEK;L8X6I.-75WO+MYG]KOA_C1=&'II&G?I:0"OSR=-_6:E6_NN\4NN]]S
M["G_  H,VJ904 )G'^?2BWX E^ F<8&/_K4[>=K$\UFE8=2*$SCVQ^'2C]!7
MMTV ']/Z4;?($_*PM PH * "@!,T"OY"C^5&WR!?=8.GX?TH&]$_(0'VQC\.
ME.UO(F+OTY; #^&/Z4MBK6%H * "@ H * $S3L.P _I2V%:PM !0 F<?A3L.
MPA;';I19=P2\Q0?;'_UJ+6^0-<OR%I;?(04 % "9H%?R%'\J-OD"^ZP4#"@#
M\[OVW!C5O __ %Z:H?IB6S']*_0N"&U*MM9=/FNQ^-^*4*BEE<*<E&6+J5;-
MJZC[*G3CJO/G6W8^%!Q_GTK[GFY>?V:<9)JS5FUW^*ZV[I_>?E4L34K*@XM0
M5/FB[KJDG=6VW ?E_P#6H4Z]M*L_2U+_ .0(^L5$[.<8VZV&D%N&VL,@@,JO
MC;]TX<'[N!P, ]*B2A)6J)M]6^_7:R^Y)=B:?-0FZM"I^\D^9Z)J][Z)K:[V
M/2?!/Q;^('P[,8\+Z_/:V23BXDTJ[5=0TR638\;!K6=EVHRN<B-D((5@<J,>
M5CLIP.-@J<HKG^%-\UU=QM9[K;HSW\OXOXCRRI&5*K24+IM.C!W2NGU[2?H?
MJ%\%OC-I'Q7T!;I4CT[Q%9$P:UH9G22:"2-80;RV7AY-.E:0;)"HP5=6R5)/
MYGGF4U<IQ7)\=-\K4ELE)2WOVM;\3]UX7XEIY_A(*K:GB[3YELGR-:I+_$CW
M%3E5[<#ISV]:\EZ/T/JDN7W?Y=/NT%SC\/Z4MO('H&:-.XK^0F?;I[CM4IR_
MD:^:_P QZ=]AP_E_2J7I:W0%^0=/P_I1^ ;+1;;(:6P.G3MD=J=O/8E22^+W
M;=_^ ('SVQCW!Z?2GRVVU'S4^DT_O%!YQC'XCM[5"OVY; K_ ,MDNHZF,* $
M)QC_ #C%"7X!T?\ =$W>V,?ATH?NDQE=VM:PSS0.HVX[=>GTJN1]-;?+\QQ5
M1K^$XVZ7C^C'JVX9QC''Y5-FO*PU=;QY6NEU^@I'!'3@CZ<4+2WD*2]V27NZ
M-)]M/T/FO]J/P;J?BWX92G2(I+J]\/:M:Z_]B@226>\M8(+FSNH8(8E9I9EB
MO3,% R1 P')%?0<,8F&%S&#JM1C.Z3[.VE_+?\$?&\>9=5S#)JD:*NZ*YFNZ
M4DVEV9^31C:(F,J5,)$;*ZNCH58Q[3$R[]P*\J%++T8!@0/U9+#58PJO$Q[V
MU^2VZ+0_GG$QK82'U>-"7/%\KIV]Y6OJWM:7Q+7122W1][?L6>"]2MKWQ-XV
MNX)[2PGLK;0]+66*2);X/Y%[=W47F1@30QO;PHDB,1EY!7Y_Q9C<+6=.C03Y
MXMW=[JRDUM9;NUC]C\.<KQ>&A/%5UR1:BE&VOO4HM=7L?H)7Q)^K"9Q^'N.,
M5-Y)_P -V6SNO\PM9=K##(!VZ>X[5:B^W+8F]]*:YVMTM+??8/,'H:'%K97L
M.U3_ )]M?./^9)2&% !T_#^E ;>20W=CMT]P.E.UNMK G%_:V&^9@XP1CW':
MFHZ:,34T_=IMQ6SNE^#=]-A5<$XQC].E*S72UAVDMX\J7FOT8^D 4 (P^4CV
M(_3%"TMY K+?9;F-K6E66MZ5J&C:E!'=Z?J=G<V%[;2KOCFM;JWDMY8V'7#*
MY'!!YX.:TP\ZF'Q,*].;BH6:2;6J?EM=:/R.;%86CBL)B*.(A&I"K%J*DKI/
M3EW[/56/Q<^*/P_U#X8>,M2\*7TTEVD/EW>F7YB,:7NFWSO):21DC#/$5>WD
MSN.Z,LQ+,2?V+)\=]?P-.OJN5N#3:;O!)=#^8L\RFIDF9XG!S:=YRJQLI)*%
M64I124M=%IIIV. '4=.".#PIQ_"W^P>A[X)QS7J6BTXS5XRC)6?G%I?<VCR'
M[2-I4I.%2FXS35[KDDI/;;2+7_ /TY_9<^(5MXX\$7/@+Q"+>\U#PS;#36@N
MI8KA-8\,7AFMX ]O<?-<6]M'OLY4=7'E+:EB?.Y_+.(\IG@L=+'07+3K3;3C
M&22>C2;VUM=6[=#]\X#SS^TLJIX&NW*IA8<K<I1?PRY=$K-6OUUU/Y_?VT_V
M;[S]G#XOWVBVK6\_@GQ<M[XJ\"75K%<1I;:1<ZM=(_ANX>8M&;_1SBU=8W<O
M;-IMRS*]S)&OHY5F,,71III\T8Q3;MORK72V^YZF/PKPSY^DFVK7VOYGR)T'
M3TZ@'H01P?<5W2DH5)1:]V2LE^/Z'+%JI2CR^[*#YK^2TZ>I^\/_  2H_:'.
ML^'=9_9X\1W;MJ'A:.Z\4>!+F[O8P;KP_=749UKP]9P2E9)KBPU*:3455#,[
MQZO.WR):;E^5SK!^R:JT_=YF]D^UUM_6BL>WE>+]I>E-WY4DDVN]C?\ $7_!
M.JUU?]LJS^(IM= N/@;J]W?>/]<\-R6DIA3Q!97-K+=>$9;'<+>2PU;7]3;4
MP1BW:TAU.U>#?$&F*>;^RP%3F<G6DN52;5]4DG=]=_.]K[IFDLKYZL*\.6,*
M;O9)]'>UUIY:GU'^UM\47\.:'!\.]'D47_B:S:76IE?'V/1HI"GV9XHLOF_-
MO<1L/D_<+*HYF3/H<,Y*\5.OF4TG3YURIJ76*>C^%I)6]4^USXOCKB+ZA2PV
M6TG*,YTY<SC*"UBW';677I8_-\Y53MQD [?XAP./ND9'T(SVK]*J3514W17+
M&A9R2[1L^GDNI^'8.]*5>=?WG*[5^F_?S?0]F^!'@"Z\?_$;1+%6:"QTB:+7
M=4N#'(P2TTZ<3BV+(-L<T\HMX%&_</.W<[3GQ^)<;'!Y:YI<KJ\D=&E\7-UL
M_P"4^IX(R:>9YY3Q%U[*C[1V:D_@C#M9?:/V1@!$8&=V"?3@9X'  X'&0.<9
M[U^1-INZ5KZG]*6C%1A%<JA&,;?X4E^E[="1NGXK_P"A"HELO6/_ *4@[^A_
M*O\ \%$O^3Q_C)_UW\$_^JW\'5]OD_\ N=/T_P#;F?+9E_&EZ_H?&5E_Q^6G
M_7Q!_P"C5KMJ_P"ZXGUE_P"DLXL/_%CZK\S^UG0W$6AZ.Y*JJZ1IY9F*JJJM
MG"22S, H &22>@-? 3WE_B9]I2_@4QJ>*?#C#/\ PD.A+R>#J^G-C!QU6XQU
M%046K/6--U%S'IVJV%Z\8!E2SNK>YDB4\!I1"S^6I/ +*G..O0@'-^(/B3X!
M\)S+;>*/''@_PS<LJ,L'B+Q+HNC3;6)"M]GU&\MY<-C@[<'C'%:0ISDGRQ;4
M>R?Z*QG.JJ347U\R_P"'_&GA3Q4K/X7\4>'/$<<7E&230=:T[64C27!1I&TZ
MXE$:LI!4OM!R,%JSE3E!K5QMTM_P1QJ1EL=706<OXC\9>%?"*13>)_$N@>'(
M)0QCFUW6]+T>)P@^8HVHW$7F*._E[B/2KC3<MNGK_P ,9RJ*#MM;T,G0OB=\
M._%%S'8^&OB#X*U^]DW".TT/Q5H&KW3E<@E(-/OYF8<$X S\OL<#IN"O9I+U
M_4(U8R:BM_\ ([N,DCKG@?P[<=1@KDD'BH-"">ZAM(GGN98K:"(,SSSR1P0Q
M(K;=TLLK@*O<'(% &4/%'AS_ *&+0>/^HO8#&/I<4 7[74;.^0R:??6=[$I*
M/)9W$-U&CA=P5GAD(5\= : .'U?XL_#/P]=R6.N_$?P)H=[%,T4EEJ_C'PWI
MUTDB8#PFWN[U)$9<@E'0/CMQ6BHRTT?W,Q]M%?+T.KT+Q)H7B6U^V^'];TG7
M;,-M%YHVHV6IV9(R0%N;&:6,G;@\/GU"]!+@X6Z?UYFD)J5[:6-LD[2?NG;G
MGL<=^1TJ=EZ%;?(XSQ#\0_ OA*7[/XI\:>$O#,Q176/Q#XDT71F*O\J'RM1O
M89"K')!"X..&JHTY55[J;\DF]O0RE6C#RMZ#_#_CWP5XL#?\(IXQ\+^)"J[F
M7P_KVEZT8U!V^8ZZ;/.8X]P(W/QFB5.5%\DDXM=&K>FY4)JI'F6BV^X[*I+,
MZ_U.PTWRS?:A:6"ON$;7L\5O%(X'"*\S('<?W5<-[8H H?\ "4>'0O\ R,.A
M,0O0:MIX8D#H";@#)/K@4 :UI=P7D4<]K<07$$BEHIK>6*>.0*0"R30NR, 3
M@X[T 6J .?/B;P^KE&U_1$*%@ROJEB&#*=K(5-PK1NC8!!'UYZ/;RL3S6^1/
M;Z]HUY,MO9:OI5W.P++!:ZA:7$I" DD0Q2L[< \CBEL-._R)[S4[+3UCDOKV
MSL8G8(DEW=6]M&[8+81YW4,P"G*CG'2@91;Q1X< '_%1:$,'MJM@0, _>_?G
MY<X[K]1W -:*XBEA6>.:&2)@'6:-@87CQ]Z-P2&7T8%A[T+5\JW0G+ETVL>=
MW_QA^%>EW1L=2^)WP]TZ]1]K6=_XT\-6=VA4A2KVMQJ"R[MW&-BL"1E/758.
MK+51DUY1D_QV_&WF2Y\J[6.RT/Q#HOB&V^V:'JVF:Q9AS&+S2M2L=3MBR@''
MVC3YY8\D$$#<#@\@5$J;HK6^G=-?G;8<9<WR-P=!4K9%;?(* "@#A-:^)7P_
M\,2-;>)O'G@O0;J' FM]8\3:-I4RG('-O?7R219) ^8-U'K5JDWLGIZF7MHK
MRMZ#="^)_P .O$TRVWASQ]X+U^X;"I!HWBG0M4G=QG<%AL;Z20E<9(\L<4I0
M=.W0N$U+;[)WBG*J?4 \ CJ/0\C\:DH6@#\[_P!MW_D+>!_^O/5/_1UI7Z#P
M3O7_ *ZH_(?%'^/P[_U\Q7_I.'/A08R!D+D@<G:!DX'/UK[?G5/VLWM'7\&?
MC=*+E"$%IS56OO\ 9H^L_ W[*&M>-O"FB>*;?QCI5A%K%J]VEI-I5Y));@W5
MQ$(FE2["R%5B"Y"C[I]<U\AC.+(X/$3I>RDU!VOSP2V3ZI[7/T[+> )9E@:=
M=3A%R5]856])-;II=.A4\9_LF^._"VD7>KZ9J&D^)HK!&GN+.Q%Y!J1@0%9W
M@MGB*2^6BF7;YRL,;<28(.F"XQP&+J*C.GRSND_?I/79WLU;5/0Y,?X<YEE]
M*5:-:,Z<4VDJ=;1)76Z?0^5L] 4VLN=P=2KHP)!5E;@%2M?5SA1J4HU:-HN+
M;?\ VZT^C?1,^!J^VPU:-&MJI.*6EOBLNJ3W:/3/@]XTN? 7Q$\-:S!))':R
M7\&G:I%&0B3:=?SPVEPLNXX94$_FC(RIA)4@DUYN=T,/F.4U9>SC[:'*E)I-
M^XVMU_B['T?#&.Q.5<082'M)*C)2?*G9>]'M)6^R?M4C@0JW81JV>F0$SG S
M^7-?C;CR-Q_ET^[0_I:-3GIPJK13BI+7NKKRZF?_ &QIJ,5;4+)2IP0UY:*0
M1V(,HP1Z$9I<CEMI;Y_D90K*[5V[>G^9+!J-I<NRV]U;3[0"5AN+>5D&/O'R
MYF.W(/512]@UUM\F:>VBNFWFBEJ6O:3HH1M6U73M+1@-KW]]9V4;GN$:YD0,
MP/7#<54*.(J:03TZ)-_@HLPQ.-PF%DE*R_[>BMG;K)%K2-7TS6K3[=I&I66J
M6?G20K=:?=6]Y;^9%M$D0FMI'3>C'!&[([TYT:M!J%5.,FKI--:;+1VTT-Z.
M(HXF'M*-N2+Y=&GJDF]F^C1IG@'V'\JC;Y&JTM;IL9.IZMINDQ>=J6H6&GVY
M.!-?7=M:1C&./,N752?;-:0IRJ?"G\D_R1S8G%X7#+_:6HJ*UNXI?^32C;[S
MEH_B-X#,KP#QKX2\U2H\M/$&B^:A8X4,IO3\Q/L*TEE^.MS1C-0>WN3Z;ZV?
M4\Z.?9'S^SI5(<\;77/2_)3NCKK"_M-019[&ZM[N Y FMKB"XC8@9P)(&93@
M<\&N?V=>F[5'HO*WDOLH]6EB(UE[BM%>:?ILW^9I4&H4 )TQ[?IBE>UN@&5J
M6KZ?I2F34;^QL(OX6O+RWM%..I#7$JKP3BMZ<.:UD_N;_)&%;$T\,O>6WFE^
M9SR^/?!,KB*'Q?X6ED_YY)K^CLX .T@#[:.A_P#U53P..IKWH5(I?S4Y+\+,
MX5F^72ER1S&G?I^^I^G_ #].MLYX;F!9H)8YHFY26&5)8V4JI!62,E6'/\)(
M]ZP<9QTGNO*VGI9'I4Y4YQ4J595XO[2DI6?:ZE+;??J63P/3 ^F,4EI\BVM&
MMBI<O#$GF32I#&H.YY76*, \'<[$ #\1349W_=OE:Z?TB9U*48NG5BI1EHT[
M?JT>8ZGX"^$&LZA)JVJ^%? =_J4\@EN+V\L]$GN+F08 ENF<'[2Y"CYI=YP!
MFNZGCL=2IQI_6:L5'2R;2\NVWX'AU,IX:E6GB*V"PTJT[7;4+Z)):<Z6R6R1
MZ-I[V)CCBT^2V:"!$B2.TDB>&%$C"H@2'*1A5& !CC '%<,U5E4]K.3:UWON
MW>[[L]BA&A""6%IQIT8V5HI);:;76BMU-2D;&;>7UOI\;SW=U;6D"EM\UU+#
M!"F,GYY9711\H)QG. <T1A6F[0Z;*S>GR7]=S.I5CAX\U?\ AO;5+1:];+;U
M./?XE?#Z&4Q3^._!\4BG#1R>)-"B=6'4%&O0P_&NK^S\=:\:=33>U.;7_I)Y
M,L_R924(8JG0G?5^TI)OLG^]7Y(V=.\4>'M8XT?7=%U3GY1IVK:?>%P.K!;2
MXF)4$$' !RI]*RGA\52TE>-NCA)??>)WX?&8+$I.&/@[K1*K!_E5:_$ZFLCK
M"@!#P#V 'TQBC;Y"=K.^BZ^A0O;VVT^![F[N+>TMH_OS7$\-O&F3C)EG*HOX
MFM(P]K9*Z?H_R1%2KA\/2E4E9**ONE^<E^9R4GQ%\!QR&*7QIX2BERP$3^)-
M#24[>"!&U]G(Z')7IP,5JLOQB2<(U.3H_9SY>V_*[Z]KVVW/-EG.6JFKXV%&
M=VN7VM)-6;6MZJMM<Z32M8TS51YFEZCIVHPJ,F:POK:]09 (&;:1U'_?582I
MUH?Q-$NEFOS2.[#U\-7A&5+%QK-_94XRT[^[4DM#9J3H"@ H * /F7]I?X3R
M_$CPJM_HT47_  D_A6.ZOK$&,M-J.GB!YKS2(RJDK/(UO'+;DY'G0A#Y8D\U
M/H>',V65XR7-:,*RC%M]^9-/]/FCXCCG(99QEBJTHN6(RWVM:G&-KM^RD[6>
M_O0BM'=WL?DZ?EVYXW$A>V2I8'\04?\ [Y/I7ZG3494)U8O63C;Y2C^A_/DH
MRI*E.JG"OB':I%Z.-M5=;K5=3J_ WB_4/ /BS1/%>F[FGTB\2:6W$AC%]8X9
M;_3V<*VV.>V9E9@"01'@8+%>?-,$L?@U1ZV6FG1-=>USORC,7EF94JWPJ.U[
MV^R^ENQ]Y_M2?!71_P!K[X!I;^$[O2?^$GACM_%7P\UFX!<6NIVZQC4M%GF3
MY[.'4;076ESC.R"X\J>1'>V41_DU"I6RK&5*%6/(J=1PVZ0DX7T?E_D?TI"M
MA\ZRR,Z-13E*E&346M)3IJ5GYINUC^6S5-,O=%U"^T?4[26RU+2;Z[TO4;*X
M0I<:?J%A,UM?6,J$+Y4\-W'-#*FT'=:@M@D9^QHJ%6C#$Q=^;33R_P"&/!BI
MT:7U62Y?9S<OPM^IK^"_%VN^ /%GA[QKX8O9=.\0^&=5L=6TJ\MV=)8;FRN$
MD17*21^;;.K3))#(TD;1RS!HWW!&QQ-/V\>1+F2NK>5K%PJJGU2M^GH?US_
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MH4EE^90&^Z=PR,'_ .M7?+;396_,\]KW6GHW;3TL_P!#T/X;?%;XC_"#7?\
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M ^-W[.WQ)\>_$G7?$_AVQT@Z5?Q:3';O=:E':SNUEI-E92O)!(N5/FP,!Z@
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M&EAZ*]JXVI<W(X\OM/AO>-K7N?,=G=2V=S:WELVV:UG@N8'/(66!TEB8C(R
MRJ>U?43IJ=&5.;Y&DU9Z/9JUG^1^>X>I+#^SQ-*+JN/*X\MWHK233C?1V5FM
M.Q^R/P;^*6A?%#PY%J6GR1P:M:0V]OKND,TGGZ;?F,&15,^)+BU8J3%/M 9
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MD)1%9:FHVGSI;83NLI9@PAC#C(C?9]KPEG"P<_JM6Z51:65^J;3MMZ_+M?\
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M2C3I3G3C:2?NTVTO/X5U'>%?%6O^"]9M=>\.:E<:;J5FT122)@8KI(R<VM_
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M61_R\^$./^HQ>]O^X364.+,!3O:-37HY-K[N4SAX99W332Q+DGTDG+\Z@?\
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M^_U/5?FC\R\2?]QR_P#Z_P _SH'YF_X5^I/^+\C\6PVTO^PN7_J,?=7[$?\
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M_ODO2/ZGUN7_ .[1]7^A]JR?ZM_]T_RKSNL?\4/_ $I'9+X9>C_(_BJ\;_\
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M[CE__7^?YT#\S?\ "OU)_P 7Y'XMAMI?]A<O_48^ZOV(_P#D(?$+_KR\/?\
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MM:?!CMCQ%=#TZZ+J8'ZD"L<S48X.K'G3:CW7F;9>I>VA[O+:Y_6 O3Z #Z8
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MV/I:M&%:#32;CL?RE_M$_LO?%#]FWQ+=:/XPTFZNO#,FIR6'AKQ_:6<@\/\
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M#I^G6<3SN\CQP6=O#$K2.[D1@LQ.2?!DW.7,][W^9ZE.'LDHJR2MIZ:&S2-
MH 8Z;T*= <#TX!&?THU6VEM@V^1\^>,?V4_V?/B!XCU+Q?XU^%'A/Q#XFU<V
MIU'5]0@NGN[K[#9V^G60E:*YB3$-A:6MNN$&$MT!)QFMZ>+Q=&T:=5QC'9*3
M7Z&#PU*4G*I!2_KY'-I^Q%^RI&RLOP/\$*Z$,K+;7X*LIRK _;@000#D5H\?
MC'=2KS:[<S_)H3P>&3O"DHM>7_!/I672+:;3Y-+E19;&:T>PE@< A[.2%K9K
M9B%QY9@=HRVW?M/WL\UR7DJG/?;;UO<W2M!0Z1Z'S./V'_V40/\ DAG@9>2<
M+:WP )))Q_IWJ3V%=7U_&024*\HI=.9I?<EH<\\'AY_%35_0[_X;_LY_!?X1
M:U/XA^&_PZ\.>$=8NM.GT>YO])AN4G?3+FXM;R>T'FW#K''+=6%C(X51N-JA
MXQBL:V(Q-?2=1R2[MFE+#X>BOW<.5K:R_P"">UE<XZ<8]1C!!XQ[@?E6/+[E
MEH^_F:Z[=#YIUG]CG]F7Q#J^JZ_K7P9\&ZCK.N:C?:OJVH7%O>FXOM3U.ZEO
M;^\G9;P S374\LC$ #<YP!77'&XJG",(5I14;:7LM++2WIH8/"X:33G24G'R
M_P""7_"?[)O[.O@7Q!IGBKPE\)/".@^(M'F-QIFK6-O=K=6<YC>(R0F6[9=V
MQV'*GKGJ*F6+Q<])UG*/9R;_ $!8:C"7-3@HV\CZ'1-B[0 H'"J"2%50% '
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M]EI>WNJ*CU/<P.093EMOJF#IPY6W?E7,FTD_>;D[62[>AWJH455&T!0 ,94
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
D4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>155
<FILENAME>g20922ndsp10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922ndsp10.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /W\H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M_/SH_P!4N(/^A?\ ^5\-_P#+@_ULX?\ ^@__ ,H8G_Y2'_#Q3P+_ -$,^/\
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M@_Z%_P#Y7PW_ ,N#_6SA_P#Z#_\ RAB?_E(?\/%/ O\ T0SX_P#_ 'Y^!O\
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M -^?@;_\_.C_ %2X@_Z%_P#Y7PW_ ,N#_6SA_P#Z#_\ RAB?_E(?\/%/ O\
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MZ/\ 5+B#_H7_ /E?#?\ RX/];.'_ /H/_P#*&)_^4A_P\4\"_P#1#/C_ /\
M?GX&_P#S\Z/]4N(/^A?_ .5\-_\ +@_ULX?_ .@__P H8G_Y2'_#Q3P+_P!$
M,^/_ /WY^!O_ ,_.C_5+B#_H7_\ E?#?_+@_ULX?_P"@_P#\H8G_ .4A_P /
M%/ O_1#/C_\ ]^?@;_\ /SH_U2X@_P"A?_Y7PW_RX/\ 6SA__H/_ /*&)_\
ME(?\/%/ O_1#/C__ -^?@;_\_.C_ %2X@_Z%_P#Y7PW_ ,N#_6SA_P#Z#_\
MRAB?_E(?\/%/ O\ T0SX_P#_ 'Y^!O\ \_.C_5+B#_H7_P#E?#?_ "X/];.'
M_P#H/_\ *&)_^4A_P\4\"_\ 1#/C_P#]^?@;_P#/SH_U2X@_Z%__ )7PW_RX
M/];.'_\ H/\ _*&)_P#E(?\ #Q3P+_T0SX__ /?GX&__ #\Z/]4N(/\ H7_^
M5\-_\N#_ %LX?_Z#_P#RAB?_ )2'_#Q3P+_T0SX__P#?GX&__/SH_P!4N(/^
MA?\ ^5\-_P#+@_ULX?\ ^@__ ,H8G_Y2'_#Q3P+_ -$,^/\ _P!^?@;_ //S
MH_U2X@_Z%_\ Y7PW_P N#_6SA_\ Z#__ "AB?_E(?\/%/ O_ $0SX_\ _?GX
M&_\ S\Z/]4N(/^A?_P"5\-_\N#_6SA__ *#_ /RAB?\ Y2'_  \4\"_]$,^/
M_P#WY^!O_P _.C_5+B#_ *%__E?#?_+@_P!;.'_^@_\ \H8G_P"4A_P\4\"_
M]$,^/_\ WY^!O_S\Z/\ 5+B#_H7_ /E?#?\ RX/];.'_ /H/_P#*&)_^4A_P
M\4\"_P#1#/C_ /\ ?GX&_P#S\Z/]4N(/^A?_ .5\-_\ +@_ULX?_ .@__P H
M8G_Y2'_#Q3P+_P!$,^/_ /WY^!O_ ,_.C_5+B#_H7_\ E?#?_+@_ULX?_P"@
M_P#\H8G_ .4A_P /%/ O_1#/C_\ ]^?@;_\ /SH_U2X@_P"A?_Y7PW_RX/\
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M/ O_ $0SX_\ _?GX&_\ S\Z/]4N(/^A?_P"5\-_\N#_6SA__ *#_ /RAB?\
MY2'_  \4\"_]$,^/_P#WY^!O_P _.C_5+B#_ *%__E?#?_+@_P!;.'_^@_\
M\H8G_P"4A_P\4\"_]$,^/_\ WY^!O_S\Z/\ 5+B#_H7_ /E?#?\ RX/];.'_
M /H/_P#*&)_^4A_P\4\"_P#1#/C_ /\ ?GX&_P#S\Z/]4N(/^A?_ .5\-_\
M+@_ULX?_ .@__P H8G_Y2'_#Q3P+_P!$,^/_ /WY^!O_ ,_.C_5+B#_H7_\
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MG_Y2'_#Q3P+_ -$,^/\ _P!^?@;_ //SH_U2X@_Z%_\ Y7PW_P N#_6SA_\
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M ,_.C_5+B#_H7_\ E?#?_+@_ULX?_P"@_P#\H8G_ .4A_P /%/ O_1#/C_\
M]^?@;_\ /SH_U2X@_P"A?_Y7PW_RX/\ 6SA__H/_ /*&)_\ E(?\/%/ O_1#
M/C__ -^?@;_\_.C_ %2X@_Z%_P#Y7PW_ ,N#_6SA_P#Z#_\ RAB?_E(?\/%/
M O\ T0SX_P#_ 'Y^!O\ \_.C_5+B#_H7_P#E?#?_ "X/];.'_P#H/_\ *&)_
M^4A_P\4\"_\ 1#/C_P#]^?@;_P#/SH_U2X@_Z%__ )7PW_RX/];.'_\ H/\
M_*&)_P#E(?\ #Q3P+_T0SX__ /?GX&__ #\Z/]4N(/\ H7_^5\-_\N#_ %LX
M?_Z#_P#RAB?_ )2'_#Q3P+_T0SX__P#?GX&__/SH_P!4N(/^A?\ ^5\-_P#+
M@_ULX?\ ^@__ ,H8G_Y2'_#Q3P+_ -$,^/\ _P!^?@;_ //SH_U2X@_Z%_\
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M5:"='#5/95I4ZM&M[&I=1Y:RHU*CHOF:A^\45SM0OS-)\'7I'F!0 4 % !0
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MM/\ $>N:!?\ P<TG1[+XV:#;)=>+,:G<@Q>-Y)KJ'98:E'<,=/D@N;DWD2J
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M?_DP_L?-O^A7B_\ PFK?_(!_PM'X9?\ 11? G_A7>'__ )84?VQE'_0UP?\
MX4T?_DP_L?-O^A7B_P#PFK?_ " ?\+1^&7_11? G_A7>'_\ Y84?VQE'_0UP
M?_A31_\ DP_L?-O^A7B__":M_P#(!_PM'X9?]%%\"?\ A7>'_P#Y84?VQE'_
M $-<'_X4T?\ Y,/['S;_ *%>+_\ ":M_\@'_  M'X9?]%%\"?^%=X?\ _EA1
M_;&4?]#7!_\ A31_^3#^Q\V_Z%>+_P#":M_\@'_"T?AE_P!%%\"?^%=X?_\
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M?_(!_P +1^&7_11? G_A7>'_ /Y84?VQE'_0UP?_ (4T?_DP_L?-O^A7B_\
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M^%-'_P"3#^Q\V_Z%>+_\)JW_ ,@'_"T?AE_T47P)_P"%=X?_ /EA1_;&4?\
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M^36/V:?^R ?!O_U77AR@#Z H * "@ H * "@ H * "@ H * "@ H * "@ H
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MHX3$WIMXG!4,=B*."Q#E1C"C.5?"TZ55U*4(4JG/STX1C)17M5<1U!0 4 %
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M<O:4)8G$2Q$J6'G?GHT:4G&G1A&5XTZ=-2E.<7-]G:?"GX7:?K&B>(;#X;>
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MY-N3;9M[2I[2K5YY>UKTJ="K/F?/4H45:E1J2O>=*DE:G3DW""^%(U+?X?>
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M: _\)S]EC_Z&F@ _X4W\1?\ H[']H#_PG/V6/_H:: #_ (4W\1?^CL?V@/\
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M: _\)S]EC_Z&F@ _X4W\1?\ H[']H#_PG/V6/_H:: #_ (4W\1?^CL?V@/\
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M3Y?:T*6)IZJZ?-0KTJBLW932=I)I:] @H * "@ H * "@ H * "@ H * "@
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MV5/.,#CJT).,H8O#X.ABX)XA^S@ZN*53$46JF)CBJ]2.&P\JV.E/#TB_XO\
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MM:B<O:?693JUO?K8O%5W'V4)XR4*=.-/S_P]^R#:V=IX6DN/"?PS\+WGA4_
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M,:EJJ>,IX.>)J4:U.C5PG-2I356K.M['V"LS4* "@ H * "@ H * "@ H *
M"@ H * "@ H * "@#Y_\.?\ )T_QD_[(!^S3_P"K%_:QH ^@* "@ H * /G_
M /9._P"36/V:?^R ?!O_ -5UX<H ^@* "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^?_  Y_
MR=/\9/\ L@'[-/\ ZL7]K&@#Z H * "@ H ^?_V3O^36/V:?^R ?!O\ ]5UX
M<H ^@* "@#Y_^.FH>+QJWP)\)>$?'7B#X=?\+$^,&H^%O$/B'PMIO@G4]=_L
M+3/@=\:/'Z6-BGC_ ,(^)-*MO.\0>"-!,LQTN2;R898HI(O.9J/T#]#F_%/@
MCQ3X.T^+4-<_:[_:"A6[O;?2]+LK;PK^R]>ZIK.KWA86>D:-IMM^S,\^HZC,
M4<K#"C;4BDED*0Q22)/-^\HT*<75KUVXTJ4;<TG&+G-WDXPA3IPC*I6K5)0H
MT:<95*U2%.+DG91IUJTY*G0P\>>K4E?EA%R4(Z13E*<YRC3I4H1E5K59PHT8
M5*LX0EO? +5?&4]]\;_#'C'QEXF\;R> /BUI7AO0=6\9:=X!T[Q-:Z)JWP+^
M"OQ!ETG5A\-?#&@Z'=S6OB'QOKZI/!8LWE/'&T\ZPI(=)Q4)RC&:FHMI2CS<
MLDG927,HRL]US1B[;I/0B+YHI\KA=?#*UUY.S:OZ-G.?'/\ :0_X4_XOT3PG
MO^"&F_VKX6O?$W]J?&KX\_\ "E;2Z^R:G'IO]D^'%_X5OXI_X2'4/G\Z5-]G
MY2M'P_F97EI5W4Q./H1INH\!3P4U2H_O<7B'C'CDHX?"I1]HZ?U+D7[U<]6O
M2IVC?F?1*ERT\#+WE]=J8N'/*-J%'ZHL#_%K7?+*K]=O"/)\%"K*[M9=EH_[
M0W@.YTWP%+XB37_">N^./#?A[Q&^@WGA?Q5JB>$8?$I$&E1^./$&CZ%/I/@J
M*[U$36=G<^(+O28[V:WDCMM\B,B>G6POL\=B<#1J*L\/5C14Y)4H2K3A"<,+
M&4W[.6-<:D+X*G4J8B\XJ,)*<'+E4G#"SQ51T_94WB+RHU%7C.CA9U(5<914
M4JM3+U&G*M]=]C&A&BU4J2IJZ3(/VFO@I.->(\6WL$?AV+4)+J:^\&>.].MM
M3;2?$$7A/4K7PC<ZAX9AB\=ZC;>)[FSTF2R\-OJMRM[J%E;&+SKVW2;DA>IA
M:.,I4ZE2EB%A)4H0ISE7J0QU'ZQ@ZD,+&+Q4J>(HJ4Z=1473?LJT>93H5HPW
MC3DZLZ*Y4Z-3%TJLW."HT*F =58N&(Q#DJ&'E0C0K59*M4@WAX/$QYL/:JVW
MO[3'PDLM$M]9CU#Q??RW=SKEA;^&]-^%GQ5U#QS%J?ANVT^\UG3-4\ 6/@J7
MQ+H%Y:V>K:9=RQZGI-H4M;V.[/\ HN91EBJOU2DZG*JW^QU<=!TYPE2EAZ%5
MX>I.6(4GAZ,:>*7U6LZU2FJ&)_<UN2HG$6'C&O/DYO8\N*H8.2J1E"HJV)I5
M<10C"A)1KUE5PU&KB*4J-.<:M&#J4Y2BXM\UI?[67PRGT;0-=U@^(=(@\5:#
MX4UKP_H-EX$^*7B;QU-)XET'6O$4EG>^#= ^'MQ=P+;:7H5_<I<VCW\<UO:3
MW,GV: 0/==N*P_U3$8[#3J*4\!7Q5.I-*4:-.AA*.45:M?$3J*F\)*F\XPD<
M13Q$*:PRJ4U4J_6%B\/@N#!XR&-^KNG%4EB:-"5.-22A4E5Q&(S>A3I4U9TZ
MT:O]C8EX:I1JSEB9QE&G2]G/!UL;W-S^T)\([6_\-Z?_ ,)->7;>*[;PA=:-
M?Z3X3\9ZUH)B\?7UIIW@M=4\2Z1X>N=)\/7&LW5];BSM]6O;*:9/,F5/)@ED
MC(X3$2QN)RY4W'&82K6H5(2<8+V^&PTL9B*,*DW&E6K4<+!XBI3HSG.%*5.<
MHI5:7/U.I!8>.)NU3=&IB&K/VD*%*<Z4ZM6C;VU&$:M.I1YJM."E7ISH1O5A
M*"T/&OQB\(_#S5;VR\5WK6MM::/X?U"*'2-(\8^*O%-_>>(]=U#0=,T_3?"7
MA?PEJ$^K-/=6#+$FG7%[>,RSF2QA@A6XFXH5H2J5**4I58UJ%&G"G"=24I5:
M&+Q+YHQC>*A1P=:JY152G&E3JSK3H<D54Z)4I0I4:MXPI2ABYSG4G3I0C'"2
MP%-\LY22E*53,*-/DG[*4JE2A3PZQ,ZM2-!;+XU> M0\3:=X/M'\92>(+_1+
M'Q!)9M\+OBA!;Z#IFHVUW>6'_"9ZI/X.2Q\!:A/;V-RR:=XDN=*O245?L^^1
M%?6;C3692E."I91S_6:JG!T8RITJ5>=.E6C)TL36C1K4JDJ.&G6JJ$XMPLS%
M/3":24L<[4:?+)5G'VTL.JDZ#7MJ5"5:$X1Q%6$*$G";C4:A)J*Y^.OPNM-%
ML=>;Q%<SV&J>%_#GC'28M/\ #/BS5-6UC0O%UQ-:>&GT;P_IFASZIJ^JZA<V
M\T<.D6=G/J)9,&T&1FZ].>%Q6(P-6$OK>$KPP]2E"+JSC5G2Q%912I*?/&-'
M"8FM5J0YJ=&E1J5*LX07,:2@Z<>:;C3A&6+@Y3G"$%+ 5L-A\3%SE)1BXU\7
MAJ---KV]6M"&']K)V'Z;\;_AMK&H^$='TK5]7U#5?&T&J7.AZ=9^"_&\]Y;P
M:%J(T?79/$]O'X<+^!AI>LE-.OAXD&DFRO)$M;D17$BQM:P]5UJ]&*C)X:CA
M\1.I&<)8?V.+IXBKA9PQ49/#5/K,,)B'AXTZLY5O9-4U*3BGA.K"E"G*KS49
M5)SIPI3A*%=SI2PL:B6&E%8BT%C<+5E+V?+'#U?K3?U>%2K'!\1?M#_#SP5J
MFOZ7XMU"]@N=(\17F@6EEX3\)_$GQ]K$_P#9?A'PMXNU:XU+2/"W@*YDTTV6
MG>*;2XF>U?4[*.S\NYEOHY1=VNFX*=+DPK=14W7HXK$2E-QIX>E0PF83RZI6
MJ8FI*-.C2A75.G5J8GZO"%6;C&56BH8BKUU</4I.G:+DJJPL81T=6I6Q:QDZ
M-&C1A*<ZTIPP->5-4TZK]G-3HT[4W4[GQ-\3/"'A/PQI_C#4;G6;_0M5BM)]
M+E\(^$?%_CW4=0M;ZV%Y;WEGH'@;0M7U2YLOL9%Q)<QV310Q9DF>- 6JL1%X
M/$RPF*7U>M3G4A4]I[D*+HMJK+$5I6HX>G3:M.K6G3IQ=DYW:.;"3AC<-2Q>
M$E&MAZT*,Z4HM?O8U^7V*I1=IU)5.9.,(1E-J[Y;1DUQLW[1WP=AUW0_#J^*
M+Z[O?$-AX2U/2[S3/!WCC5O#@LO'C2Q^"I=2\7Z7X;N-"T-M=G@DM]/CU+4;
M22[G"V\*O,ZQMJ\/7C5QN'E1G&MEU7%4*T'%I^WP6$AC\50I77^T5Z.#J1Q#
MHX?VM1T[N$9<DN5*I#V<:G,DI4H5G%Z3A1GB*V$5:K3=JE&E3Q&'JTJ]2K&$
M,-*-\1*E&4'+L_"_Q.\#^-+FSL_#&MC4[N^\*Z?XUAMQIVKVDL/AS5+Z\TRP
MN]02^L(3I5U+J&G:C;_V?>B"]633KM7MU-M+LRJ1E2IXNI[LJ>#5#GJ1FIT7
M]9H3Q.'=*M3YZ=>-2A%5N?#NLHTJE"I*T<10]I<DZ<J4)QE%U:N.H13B_P"+
MEM:CA\;3>EHRH5J]*FU)QYY.7L^=4ZCASVA?&SP)JFB6VJW6MV5O*S>!K>\B
MTZV\3:A8V]Y\1]:/A_P;!;7E]X8TVXNXM0U8" 2O86_V?E[M;>(>8;H4IXF.
M&=!<_P!9<J<=DG6I95A\YKP3DU[M/ 8FE7A4FH>TC)0Y8XA3P\";5+%9CA'I
M4RN&)Q%6+WCA</C<?@75E:\.?VV78J$Z-*=9QG2E[.=:C*C7K<G/^U!\*8+R
M^?\ MNY3P]H^E^*KO4]7N?"7Q-MKFZOO"WB7PSX3N[#P?9'X?M:>/-OB#Q'#
MI<PT74[FZ343;6-M97LTUQ_9\T8NKA8XN,*CA766O#0C3E*M6CFE.O5PLWAW
MRXF%.M1I*K0J1HU(5*?MIU)4(T5*KM[&3=2$'&53#5L31KOGI^RHO!4L94Q2
MG74W3C5PZP->56E/D4*,56<[5</&LGQ%_:9\ ^ / UQXN>U\67NHR^$O$/BW
M1/"FH> ?B3X=UJXL] AFW2^*K/4/!#WWPXTB>^CBLUU;Q-I^GVOFW,2HTC2(
MCW0HNOF.$RR$HNKB*^64IRC.$J=&.9XJ&&H.=12]DJ\KU94L'*I#$UY4*M*$
M%.G4Y)PL:5?V<ZE1X>A4J5Z:G*G/G?U:"G7J4Z+4:M6A1C*$ZN(IQ="E3J0J
MSJ*G.,GJWG[0_P .- AW^*M9739#KWB#1R-#T7QQXJM]*M/#VK#1[W6_%EWI
MO@U$\'Z+;WCPPW>KZH(=%MYI!&FJSJ5E;.@OK$J%*C^\JUEHHIJ'//%XK!X:
ME&I)13KXNKA*M/"8>:IXC%5X5*.%HU^2,ZG,ZOLZ,J]6/LH1I4:O+?FJ\L\M
MPF95I*E#FE.GAJ.+ISJU*7M(4J$Z-7$O#5*LL/2Y[0/VI?AYJ^E-XBOO[5\-
MZ)&GBN/[-K?AGQ];>,+V^\,^/8/ $-MH7@X>"3<^(!J6JW-O';06$TVHR7-U
M'90Z=--'<FT*<7*A0JJ,I3Q>&R?$TJ-.$ZE;_A5PV88J-.K1455A*E2RZO44
MH0JTZF'I5L94E0PBPM;&*=>$<;7P7/3BL)7S6C4K3JPA0?\ 9=7+J4ZM'$)R
MPM6E.68T8.3KTW&M.CAJ2Q&(EB:>$T[_ /:F^"&F6VEW-[XFUV%=4MM7O&MU
M^&_Q.FO] L_#U_9:9X@N_&^F0>#GO/A[:Z5>ZC8QWTWB>#2$LQ=Q/<M%&X:M
M*%"IB:]/#X?EK2J_5%"<)PEAY2QU;$X?"06*4OJWM*^)P>)PT*?M?:?6*,\/
M**K)0=\Z7.K2C4INNO8N$EB&\-2PM>LH89KV]1QP^-PN(BJ=.3JX>M&O2YZ*
ME-=[X]^+'@;X:)I/_"5ZCJB3ZXM[+I>F^'?"GB[QOK5U9Z7%#-JNJ_V%X(T+
M5M0AT.PBN;5KO5);:.SM1=P?:)X_.CW\[G"%65&4O9NG'GJSG[E&A!RY%4Q-
M>5J&%IN=XJIB*E*#:DE)N,K;0A.IAOK5*+J4.:$(.'OSK5*D9SIT</2C>KB:
M\Z=.I4A0P\*E:5.G.:@XPDUQO@_XYV'C?XE>,O!^@Z.\_@_P;X.\,^*)/B"T
M?BV+3]<G\462:Q80>'I)? Z>'M8T<:%-!<F_M?%<UT\DC1)IK10RW,=3?U7
MYUC,=&6$_L;'5<%.E)+VC>&PT:^*G.$W3G3]FY1A"%.%?FARUZLL/2Q&!EC,
M5.-;%93A,&_K4LTPBQBG'^'"%3$3PV'IQG'G3J3G3J>TC7^K<KBZ=%XFK0QU
M/!-\"?%?QUXO.A^)KOX76VC?"KQ;I;ZUX;\61>-UU#Q79:.VE2:QI^J^.O U
MSX7L(/#=CJ%I&HMTTKQ#XDNUDO+5+NUM=\QM=ZM">"^MT<S_ -BQN#I>TG2C
M^_A&I&I3IU<'*K3M)XVG[6_)2I5L-/V.)5/%2<*/UA.I&K4I_4&L9AI5Y8?V
MJE&GSV=2,<503<J=3!3=-N-:I5HUG"I0G'#24Y^RG?\ :0^$D.CWFLRZKXL@
MCL=>TWPS+I$_PM^*L'BZ;6=:M+N^T2WT_P #2^"E\1:K;ZE:6%Y)8WEEI=Q:
MW@MV%M-*>#SN2BL(]9?7)XBG3C&+G.-3"4%BL32KTXISPM7#X9QQ%:GB8TIT
MZ$X5915.<).U**GC*?/&+R^E0K5G*480]CB<3]3P]6E4DU3Q%*MB[X:G4P\J
ML)UHU*:;E3FHWV^/WPL6V\'7W]M:TVG>.5MCH>J1>!/'\VD6C7>I)HMK!XMU
M:'PPUGX NY=9<:>MOXHGT>4W:O:[//C>-=E2D\2L(G!U90HSIR52FZ-:.(H_
M6,/]7Q*E]7Q$J]!JK0A0JU)UJ<H3IQE&<6Y4X_5:V+5_8X:IB*=6/++VU*6#
MG.EBW4PUOK%.GA:E.I'$U9TE2H.$O:S@HLP[']H[P)JWCX^#-%_M._T^S\)>
M.O%.K>*'T+Q9I^G)_P (-K?A/1+BU\,_;O#$=OX]M9[KQ)=1F_\ #U[?Q0W.
MCO:8EGFVPQ0Y:V7XS,DY1P^%CELZ:4)RJUH9E]>=&<:"7UB-.<,'&IAI^RE#
M&4ZRG0;A#FGT5*7LZE'#\\7BJF+J865/FBH4Y4*%2K7YJ[E[%3P\H1I8FBYQ
MGAI37M_9NT7Z5X$^(GA3XD:7>:MX4NM4DATS4YM&U2QU_P ,>*/!GB#1]5@M
M[6\:PUGPMXST;2M9TBY:QOK&ZC6\L(/-M[VWN(M\,\;OK4H5*,*%62BZ>(C*
M=*<)PJ1DH5)T9KFIRDE.E6IU*56G)JI2JTYTZD8SBTN>,XN<J?O1G!0DU*,H
MWA4CS4ZD>9)3ISCK"I#FA*TDI-QDEV]8EA0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@#Y_\.?\ )T_QD_[(!^S3_P"K%_:QH ^@* "@ H * /G_ /9._P"36/V:
M?^R ?!O_ -5UX<H ^@* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M%+TBO//1"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^?_#G_)T_QD_[
M(!^S3_ZL7]K&@#Z H * "@ H ^?_ -D[_DUC]FG_ +(!\&__ %77AR@#Z H
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@#Y_\ #G_)T_QD_P"R ?LT_P#JQ?VL: /H"@ H
M * "@#Y__9._Y-8_9I_[(!\&_P#U77AR@#Z H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M'O2=>4/:1H*,;MUI4_WD::7.X>\H\NICZ)\;/AIKGC+Q%\/XO%>AV'B_P]J
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MQ-8)X9N[J+6;9[8:D]LDBQ2DR)A/,C"_[74IPH)SISG1IJLES4?:5<=A<O\
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MC!1QGM%:,4IQP\XQA&[E.DXXA06):A2J8BAB\/1=2>$Q'LOH*I&% !0 4 %
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M#FY>:7+S<M^7FE:]N9VN:=<YTA0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!\_\ AS_D
MZ?XR?]D _9I_]6+^UC0!] 4 % !0 4 ?/_[)W_)K'[-/_9 /@W_ZKKPY0!]
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0!\_P#AS_DZ?XR?]D _9I_]6+^UC0!] 4 % !0
M4 ?/_P"R=_R:Q^S3_P!D ^#?_JNO#E 'T!0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 >->,_CW\-O /B&]\+>()_&LFK:7I&GZ_K)\,_"?XK^.-(T'1M4DU&*
MQU'Q%XC\$^"=6TCP];O_ &1J<A.HWUJ8XK*6:0)"N^IISA4]HU)4Z5&O]6G5
MJM4,/"M[.A6<)8BMR4%R4L3AZE23J<M*-6#J2C<J490=*"3J5JU/VM.C2_?8
MB=/VE2E&4,-1YZ\N>K2J4Z25/FJSA*--3DK'K]M<07EO!=VLT<]K=0Q7%M/$
MP>*:"=%EAFB=<AXWC965AP00:UJ4YT:DZ52+IU*4G"46K.,HNTHM='%IIKHT
M94JE.M3IU:4E.E5C&<)1VE"24HR3[--->1-T_#\>GM6;?*F];15]$V].R5VW
MY)-OH7^!RM[XT\/:9HVEZ]J5Q?Z;I^LZMHFAZ<NH:%KUCJ4NK>(M7MM#T>RF
MT2ZTQ-1LY)]2NX$)N;2)88V:>=H[>-Y5NG!U:V&P].SK8N$YTHW2;C3PE7'5
M.:[2A*GA:%6I4A4Y9P=.5*4567LPFU2ABJDY1A3P;G&K)R2BG"LL,N23=JOM
M:\H4\.Z+FL5*I2^K.JJM-RZJI * "@ H * ./UKQWX8\/^)?"W@[4;N^/B3Q
ME_:;Z!I>FZ#K^MR26NC+:'5-3U.?1=+NX/#VBVTE_I\,FIZM+8V8GO[6#S_.
MN(HW=&,J]2M2I)N6'I*M5DURTZ<&YJ"G5E:E&I5=.HJ%%S]MB'2JJC3J>SGR
MNHG1H1Q,URT95J>'BUK*5:HI2C&-.-ZDE&,93JSC%TZ%-<]:5.#4GV%(04 %
M '+6GC/P[?:S?:!87=U?ZGI>LMX?U9+'2-9O+31]870;3Q,++5]4MM/>RTIF
MT6_L)T>[N(8W:]MX$=KB9(FJ$95*<:L4U2E&O.$Y>Y&:PV(AA*RIRGRJI*&(
MFZ?)!RG+V6)E",H87$RI*J_J\Z=.HG&=1491C%.;4:\<1*E.:@I>SIR6%JWG
M/EA%NC&<HRQ.&57J:D90O]1M]-2VDN([^1;J^L].B%AI>IZJZ7%].MO!)<QZ
M7:7#V=BLC@S7MPL5M;H&EN)HHU9P17-4A26DI\]F_=BO9TJE:7-.5H0O"G)0
MYY1]K5=.A2YZ]6E3G,Y*G3E4=W&'(FHISE^\JPI1Y813G*TJD7-QBU2I*=:I
MR4:52I"_04% !0 4 ?,'[1OA/PKXX\3_ ++GA;QKX:\/^+_#&J?'_6O[2\.>
M*=&T[Q!H6H_8?V9?VCM1LOMVD:M;3VEW]GU"TM+J+S8G\N:UBE3#QJP/T#]#
M?_X9._98_P"C:?@!_P"&;^'7_P SE !_PR=^RQ_T;3\ /_#-_#K_ .9R@ _X
M9._98_Z-I^ '_AF_AU_\SE !_P ,G?LL?]&T_ #_ ,,W\.O_ )G* #_AD[]E
MC_HVGX ?^&;^'7_S.4 '_#)W[+'_ $;3\ /_  S?PZ_^9R@ _P"&3OV6/^C:
M?@!_X9OX=?\ S.4 '_#)W[+'_1M/P _\,W\.O_F<H /^&3OV6/\ HVGX ?\
MAF_AU_\ ,Y0 ?\,G?LL?]&T_ #_PS?PZ_P#F<H /^&3OV6/^C:?@!_X9OX=?
M_,Y0 ?\ #)W[+'_1M/P _P##-_#K_P"9R@ _X9._98_Z-I^ '_AF_AU_\SE
M!_PR=^RQ_P!&T_ #_P ,W\.O_F<H /\ AD[]EC_HVGX ?^&;^'7_ ,SE !_P
MR=^RQ_T;3\ /_#-_#K_YG* #_AD[]EC_ *-I^ '_ (9OX=?_ #.4 '_#)W[+
M'_1M/P _\,W\.O\ YG* #_AD[]EC_HVGX ?^&;^'7_S.4 '_  R=^RQ_T;3\
M /\ PS?PZ_\ F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\,G?LL?\ 1M/P _\
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MG1?"NE7.JS^//VIK.?4[C3]"LK6WFU"2TL+&![AXS(T=G A8K"@4 ^KZ "@
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MX=*,*WUK'8A<T,93Q>$Q-&A2A1]ZG-4Z'?B*\\1#,YU8T\1B,1CJE2BJM/\
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MQN)FZDI1EB%C*V83R]5:E3$XB5; X7ZO.LH15.?Z$(BQJL<:JB(H1$0!515
M5555 "J   !TQ7&VVVVVVW=M[WZMON=48QIQC"$5"$$HQC%)**2LDDK)))62
M6B1X#\9/^2B_LG?]G >(_P#UEC]I:D4?0% !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % 'S_X<_Y.G^,G_9 /V:?_ %8O[6- 'T!0 4 % !0
M4 ?/_AS_ ).G^,G_ &0#]FG_ -6+^UC0!] 4 % !0 4 ?/\ ^R=_R:Q^S3_V
M0#X-_P#JNO#E 'T!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!\_P#QD_Y*+^R=_P!G >(__66/
MVEJ /H"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#Y_\.?\
MG3_&3_L@'[-/_JQ?VL: /H"@ H * "@ H ^?_#G_ "=/\9/^R ?LT_\ JQ?V
ML: /H"@ H * "@#Y_P#V3O\ DUC]FG_L@'P;_P#5=>'* /H"@ H X_QK\0O
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M6M=&\:^&=%\4Z5:ZK;VUW9P:G;Z?KME=6\.H1VE_?0)<)&LBQWDZ!@LKAC]
M_0\O_P"&3OV6/^C:?@!_X9OX=?\ S.4 '_#)W[+'_1M/P _\,W\.O_F<H /^
M&3OV6/\ HVGX ?\ AF_AU_\ ,Y0 ?\,G?LL?]&T_ #_PS?PZ_P#F<H /^&3O
MV6/^C:?@!_X9OX=?_,Y0 ?\ #)W[+'_1M/P _P##-_#K_P"9R@ _X9._98_Z
M-I^ '_AF_AU_\SE !_PR=^RQ_P!&T_ #_P ,W\.O_F<H /\ AD[]EC_HVGX
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M (-_\E%_:Q_[. \.?^LL?LTT <_\:OC!X]^'^LZMX8\*Z9X7O]?\2^%O"?\
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M1=8C"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * /G_PY_P G3_&3_L@'[-/_ *L7]K&@#Z H * "@ H ^?\ ]D[_ )-8_9I_
M[(!\&_\ U77AR@#Z H * /'_ (M_#SQ5XXE^&NK^"O%OA_P?XF^&7Q N/'6F
M7GBGP9J/CK0M1^V_#CXA_#>\TN^T32?''A.[7.G_ !"N[N*YBU=/+FTV)7AE
M21@#;Y!M\CG_ /A'/VI_^BR? #_Q&GXB_P#T6- '0?"3X>>*O LOQ*U?QKXM
M\/\ B_Q-\3/B!;^.M2O/"W@S4? FA:=]A^''P\^&]EI=CHFK>./%EVVW3_A[
M:7<MS+J[^9-J,JI#$D:@FP;'6>(OAYX,\6>(O!'BSQ%H-MJ?B+X<:GJ6L>"M
M3EFO(IM"U'5])N=#U&XACM[F.*Z$VF7<T1BNHYXU81S*BS0121NBWAJ]7$T;
M0KU\+5P4YV3;PU:I1JU*5FFES3P])\Z2J**G",E"K5C,J?O</]4J-RPWMZ&)
M=.[2]OAO:>PJ.UF_9^UFU%OE;:<HMQC;#\/?!CX9^$X],A\.^%H-*AT?QSXG
M^)6FQ6^H:P8[;QKXRM]=M/$FM;)=1<2_:[?Q+K48M)0]I +M?L\$7V>#R7"4
MJ6'H86#Y</A<O>54H65H8!U:5=X=-ZV]K1IS]HVZONV53EE).IR=2>85)6Y\
MTKT<3BFHQC[:OAU15*K)1249+ZO2<N3E]I*+E44Y3FY85S^SI\'[NZT&ZD\+
MWL?_  CMAIFE6ME:>+_&UAH^JZ;HE]-J6BV/C#0K'Q'%IWCVUT[4+BXN+2+Q
M+:ZLMK)/(T C,C9*$GAIPG2]UT70E3C)*<*=7"T*6&P^(ITZG-3IXNE0H4*<
M<7",<4E1HOVSE2@XSB$L7'$1KI2^MRQ3K224*E2.-K5,1BZ,JD.6H\+7K5JT
MZF$YOJK]K5C[%0J3B^;^(?[,W@;QEX)\4>!='M['PUIWCRUT?0/&MS=VFK>)
M[C4?"&G>*/$'BZYTK1XM1\1PP:'K4FL>*=?FM]8,5X;5M1)^RSK;6J6JI-TY
MY+3DE+ Y-B\#C(8?EC><\LPN#PN"INK)3:I*EEV!H8F+C.6(PU*M3YZ5?$3Q
M2?/4IT<;'#U'0Q.*IYK&G66OL:N=5I5<QK^ST52=252M4H0<HTJ&(=*:A/#T
MY86KZOXN^&W@[QQH&G>&_$&FW?\ 9VC75E?:'-H>N^(/".M^'[[3K>6SL[[P
M]XF\):IINL>'[V.RGN;7S].OK:1K>ZG@9C#/(CJM>O7>*J3G]8;J-U(U)TY2
M57^+";A*+G3J_P#+VE/FIU++GA*RLL+;!8;ZG0C&.%=*G1=*48U(.G2<)4KQ
MJ1E'FI3ITZE*HESTJM.%6G*-2,9+SW7?V7O@/XFTO0-'UWX>6.HV/ACPSXV\
M(:*)M6\1+=V^A?$:V-KXXBN-2AUA+S4M0UA6EEN-3O9[B_-Q<3W*7*7-Q++(
M5;5JF(JS2B\5AL)@ZD815*E]5P&(H8K!8>%&FH4J5+"UL-1=&%*$%"$/8K]S
M.=.3H-X:.'C3;E]5QD\?"55NO/ZY5H5\/5KU:E;VDZTJM+$U8U56E4A5E[.I
M.,JE"C.GU\/P<^&UK91Z=;>&(;>P@3X>1PVD&H:Q#!#'\*+Z'4O $44<>H*(
MH])O+>%PBX6Y";+P7$9*GHGB\14Q%;%5*G/7KXO&8ZI*48OGQ688*&78RJXM
M.-JV#IPHNG;V4$N>G"%5N;YL-A</@Z?LL-3]E367PRNR<G_L-.IBJL*-Y-NZ
MJ8S$S=:_MY.J^:J^6'+EVWP'^&EIIOB70XM/\3-H'BF""WOO#MS\1OB1>^&]
M*CM+L7UD?!?AZ\\6RZ=\.YK6]2*>WE\*VVC26\EO"\+(T$93EY?]FHX7FGR8
M:I"K2J<\_K5*=))4N3&<WUN,:<8J,*:KJG"*48Q4=#M=:?UJIBWRNM75>-5.
M$'1K+$IK$^WP[C]7KO$*4_;NM2FZSJ574<G5J.70>&?A?X/\'>&]7\*>'H=?
MLM,UVZO;_5[J;QMXVU+Q+>ZEJ%I;6-[JDGC/5/$-SX@759;>SM\WJ:FMP)(_
M.$@F9G:Z[^L4*6&G^[H4%4C3A02PRIJKB:V,J*'U?V3BI8C$5JEHM64W!6IJ
M,%A0A'#8BOBJ:YJ^)G3J595?WZG*EAJ&$IWA6]I#EAAL-0I1@HJ"C33Y>9MO
MSN\_98^"6H:8NEW_ (>\37JM-KLNH:I=_%'XK7'B?Q!'XGL--TK7K#Q=XPE\
M;-KOC/1[W3-%T6UDTS7=1U&S\G1M/C6!5L;<15*I*7LUI&G2I*E&E&,84>6-
M:>)C.=""C1G7AB:M7$0Q,X2Q$*]6I6A552I.3VC5K4VI1K5%.%:A7A/VDW.G
M4PT)TZ/LIN3G2IQA5JPE1IRC1J0J5(U*<U.2?30? ?X7VOBI_&5OHFK0ZZ]S
M#?-L\:^.5T8ZI;>&[#PC9:T/"_\ PDG]BKK]IX=TRSL[751IXO;55D>WGCEN
M)I)252I+VUYN]?ZS>5[3IO&5JM?%RP\U:>%GB*E>JJT\-*E.=*7L)2=",::R
MY8JE@Z-E[' 4\-1I0^RZ.#FZN%I5H[8JG0JOVM.&)]M&-5*K;GBI*C8_L[?"
M.RCNTG\/ZQX@FO\ ^T4O]1\:>._B!X]UF_M]4T._\-W5C?:[XU\4:KJ-WIBZ
M+JFHV\%E-=/;6OVV:2UBAE<R&;VI^RA^YCR3@W2_=5&ZF(R_%2JNK3Y:CQ/M
MLJRZ4,6YO%4XX.A2IUHTH*!,J<)8N&.E'FQ%.M3KP;UA"5*CCJ%.$*3_ ',,
M.J69X]/"1@L+*6*JU)T95)<ZCM?V<?@_:Z9/I$WAO5-8M+N_N]3O7\4>-_'O
MB[4;^]OO!FI?#VYEU'6/%/B?4+_4$;P;J]_I8BN;F6-(Y4=$6:"*2)RE*5.I
M2OR0K0JPER)4Y-5ZN#KU9J=/EG&M.O@,)6=>,E6]K2=15%*I5<]\-5JX.I&K
MAZDJ<X?5N5W<E".#Q57&86$(RYHPIT,16J2A2BE34&J/+["$*<;GA;X _"WP
M;J&G:OHNC:W+J^DWUAJ5EJWB'QY\0/&&J"^TK0O$?AC39[K4?%WBC4KC4#;>
M'_%>N:?&MW+,JP3V\8&+"S^R[+%8B$:ZIRA"6)5?VC5*G[\L3'+XUYU.6,7.
M=;^RL ZE1R52<J#FY\]:O*IS0H4J:E",7&$J.&P_+S2Y8T,'B:N,PU&G%MQI
MTZ.(KUJD(4U&*]I*-G!\I+\(_A)9?"X>/K\W>G:GXD^)GCW5_B!XMU/2M"_X
M1S3;C4]0M[+3K2VL-';5-2DM;:UTK3;)&::_N7GN6N[IF5KHQQXTVJ6699E<
M5^XRZG73ORVJ5L7B:V+Q53E44H4Y5:[I4*3YY4<)2P]"=6O*DZT[J*57,<?F
M%2;E/%_5Z5.+_P"7.%P="&'PM%RO>I.,(RJ5JMH*KB*M:=.E0I.G0ITK/]G3
MX/V-[J]]#X7O7?6(;BV:TO/%_C;4-(T6TO-7M->U"S\':%?^(YM.\!V5[K%A
M97=W;^&[72HKN2TB-RDOEJ J#>&HX:A1]V&$JX*M2;]^I&675(5L!3=:?-5G
MA\)4A!X?"3G+"TE'DA14+Q*Q'^U?6?;>]'%QQ4:T(^Y3J2QM"KA<75E3ARTW
MB:U"O6A/%<OUG]]5DJJG4G*6Y\0/@S\._BA=:?>^--'U*_N=-TK6M!C?3/%G
MB_PNEYH'B)+9-<T#6X?"NO:;'XBT&]^QVC2Z;JJ7EJSVT4GE"1%89*E!2K27
M,OK$*=.K'GGR35&525";I\W)[;#3K59X:OR^WPTZDIT*E.3N:1JU(?5W"7)/
M"5EB*$XI1J4JJY.9PJI*I&%14X1KTE+V5>$8PK0J07*=%J7@+PEJ\'ANUU31
MX]0MO"274>A07EU?7$-M'>^'=0\)WD=U')=%=5CF\/ZKJ%HZWXN@PN3(1YJK
M(NV(E];J8ZKB%&K+,J%?#8F\8\M6AB:^'Q5:GR)*$5.OA</.\(QE'V?+!QA*
M<9<]"E#"4L#1P]Z5/+:N'KX:TI<U*KA:56C0FIMN<G3IUJD5SRDI.7-)2E&+
M7$^%_@!\*?!]W;W^B^']3;4+/4]+U2QO]<\9^./%5_ISZ%9ZK8:)IFF7OBGQ
M)J,VF^&=.M=<U=;30+5XM*MCJ$SPV:.VX7[:K>D^=RG1=>7M)>]5JU,10>&K
M5<35E>KBJTZ$G2]MB9U:L8V4)QLK4XQ]G.BDHT)1A!48^Y1I0IXJAC8QH48<
MM+#1>)PN'J35"%-5/8TX5.:G%0+#? SX;M<>*)38>)!9^,H[Z/7_  XOQ#^(
MJ>"IGU.\&HZE=:=X#7Q6/#F@:C=ZB'NI[W2M+LKF:>XN)9)6DN9FEBA*6&CA
MH4G=8*O@\1AW4_>RH5,OK0KX-49U>>5*C0J4Z?)AH..'=.G"C*E*C%02Q=.&
M-598A76(PV)PE90;HJM1QE">&Q'MU1=-5JM2C.4/K%7GQ$+\U.K"24EX[X>_
M9,L+/XA>+/%'BOQ?)XI\)Z['XVATOP1#9>*-"BTZ/Q[K6G:UK(O)D^(%YHMN
MT4VFQ1Q-X2\->##<F66ZU?\ M74'-X:P$U@<-AZ?+[3&8/\ L]4*]W:DLLQ5
M+&85J%1U9\RQ&'P]1T?;?V?2]G*GA,!A:%6=%F84X8_ZQ3FN7"XOVOUBE>5Z
MBKY?BLMK4U*FZ4%&>'QN)C*O.E4S&=Z'M<?4E04Y>_:W\.=$O_#WQ,T;2E_L
M6\^*5KJO_"0ZIF[U'?JVH^$['P;%JWV&YOE1?(T?2M*C^RVSVD4GV+<=LLTD
MK\6.P[QN6O*Y3Y,/&-:$%RWY%B,15Q5;K&4N>M6JSUG[O/RQY81C%>A@\9+"
M9C@,QG#VT\ \,HQOR<U+"U95:=.ZBTM9S]]QE+WO>YDDEPNF_LV?"JP\(+X0
MDT[Q)<1-=:!J,^O#XA_$FW\81ZGX:@D@T6?1_&Z>,6\2>&[&QCN+V*STW3-8
MMK2SM[^YM;>%+>XECD]#$UOK&(IUU'D]AB<3BJ<6^=NIBZ;HXB6)FTI8V5;#
M\N&KSQ?MG7H4Z=*JI4Z<(1\K X=8*@Z7N59U,+A\)5<J<?9NEAIQK4HT:$N>
MEA84\2GBZ-/#QIQH8F3KTN6LW4<EI^S1\&+&ZT6ZL_"^IVQT&VTJSM+.+QSX
M_32;RST/7-;\3:39^(=$'BG^S_%EI:^(/$6KW\<.MVVH()[B-]I-K;^1%.K.
MC*DZ=HJ@J*I1<8N%)X;!X; 8:I3IRBZ<*V'PN$P]*A7C%5J+@ZE.I&K4J3GK
M*G&>'GA9.4J-2ICJL[SG[2<LSKO$Y@JE;F]M.GC*S<L11G-T:D7[.4'2]PTK
MG]G_ .$]U;7MO_PCE]9O>IIZG4=(\6^,]#UVPDTO6?%>OV%WH?B'1O$-KJGA
MW48=3\<>*W%[I=Y9W#1:U-;-*ULL<,>5K8?"X52E"C@E25%0E*$HQI8#"Y7"
M#G!QG.F\!@L-AJE.I*5.M&GS5HSJ3J3GK&;A&K!*,H5ZF,JSC*,9QE5Q^-CF
M.*FXS4H\TL="&)IM+_9JL(/#>RY(I=7%\-?!=OH7ACPW;Z1)!I'@R]34O#<,
M&K:U#<Z=J,=GJ-C_ &@=2CU%;V]OFAU;46DN+NXGDDFNWN)&:XQ*'6_?585I
M?NYT:4Z%/V7[B-&C/#/!NE1A0]G"C".&?L:4:48*C!15'D<8M11BL/1JT(7E
M3KSC5J^T;K2JU88RGF'M*LZSG.K4EC*4,15G4E*5:?-[9SC4J1EQD7[/?PV@
MT?5=&AD^),2:[?6=_K.M1_''XW)XRU-M/AGM["ROO'R_$,>);G1+:*ZN5BTE
M]6-A']IE*VP,C%AJ,J="C*$94,/.K45)PBZ56I6A3I59XJE;V>-G.E1HT92Q
M<:[=&E2I7]G3A%5%\F(Q&+C:.)Q$:<'4LN:G"E4J5J=/#=,)3A5JU:BIX548
M<]6K)Q<JDW)-/_9S^#FE>(=(\3:9X2FT^^T%M(ETG3[/Q1XPMO"MG=Z%X<;P
M?I6IKX'AU]?#LNLP^%F_LDZE+I3W<EI''!+,\<2*FDZU2I+%3JR=9XOZU[3V
MMJBY<;&4<93IQJ<T:-+$\TIUJ-%4Z4ZMJTH.K&,U+YG&E!U*B5&%*":J5%*2
MH8Q9A1=::DIUZE+&)UX5:TJE2,I5(J?)4J1EIZ%\#_AUX<B6UTVR\3-I\&MZ
M)X@TW1M6^(OQ&\0:!H&H^&[O[;H:>%O#^O\ BN]TWPGI=G.$$>EZ-:V-CY<4
M4+6QAB2-7&M5A*A4]HZE;#2Q$X5JK]MB.;%82M@*[J8BKSUJW/A<16IVJU)J
M,JCJP4:R519XBC2Q+K>U@HPK_5^>G3_<T6\+BZ..HR5"C[.C"<<7AZ-:=2$(
MSJN+C5E.$YQEZW61J% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % 'S_P"'/^3I_C)_V0#]FG_U8O[6- 'T!0 4 % !0!\_
M_LG?\FL?LT_]D ^#?_JNO#E 'T!0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!Q_C7XA> ?AKI5O
MKOQ%\<>#_ &B7>H1:3:ZQXU\3:+X5TJYU6>VN[R#3+?4-=O;6WFU"2TL+Z=+
M=)#(T=G.X4K"Y4 \O_X:Q_98_P"CEO@!_P"'D^'7_P T= !_PUC^RQ_T<M\
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M.6^ '_AY/AU_\T= !_PUC^RQ_P!'+? #_P /)\.O_FCH /\ AK']EC_HY;X
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M]H!Z!0 4 % !0 4 ?/\ X<_Y.G^,G_9 /V:?_5B_M8T ?0% !0 4 % 'S_\
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M2P]*BHQ6%PV582D^5-QHY1F#S3#+71RGC'[2NVGS+W::I(K_  /_ &;?AQ\
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M0!] 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?/_AS_DZ?
MXR?]D _9I_\ 5B_M8T ?0% !0 4 % !0!\_^'/\ DZ?XR?\ 9 /V:?\ U8O[
M6- 'T!0 4 % !0!\_P#[)W_)K'[-/_9 /@W_ .JZ\.4 ?0% !0 4 % !0 4
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M<W0 ?\-+?#K_ *%S]H#_ ,1._:G_ /G-T '_  TM\.O^A<_: _\ $3OVI_\
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M: _\1._:G_\ G-T '_#2WPZ_Z%S]H#_Q$[]J?_YS= !_PTM\.O\ H7/V@/\
MQ$[]J?\ ^<W0 ?\ #2WPZ_Z%S]H#_P 1._:G_P#G-T '_#2WPZ_Z%S]H#_Q$
M[]J?_P"<W0 ?\-+?#K_H7/V@/_$3OVI__G-T '_#2WPZ_P"A<_: _P#$3OVI
M_P#YS= !_P -+?#K_H7/V@/_ !$[]J?_ .<W0 ?\-+?#K_H7/V@/_$3OVI__
M )S= !_PTM\.O^A<_: _\1._:G_^<W0 ?\-+?#K_ *%S]H#_ ,1._:G_ /G-
MT '_  TM\.O^A<_: _\ $3OVI_\ YS= !_PTM\.O^A<_: _\1._:G_\ G-T
M'_#2WPZ_Z%S]H#_Q$[]J?_YS= !_PTM\.O\ H7/V@/\ Q$[]J?\ ^<W0 ?\
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MZ?XR?]D _9I_]6+^UC0!] 4 % !0 4 ?/_[)W_)K'[-/_9 /@W_ZKKPY0!]
M4 % 'G_Q"^)WA#X76>@WGBV;Q /^$G\0#PMX>T_PMX)\;?$#7=8UT:%KOB=[
M&Q\-^ /#VM:K-Y7A_P ,:]?RS"R\F*'3)6ED3Y0P!Y__ ,-+?#K_ *%S]H#_
M ,1._:G_ /G-T >@?#WXG>$/BA9Z]>>$9O$ _P"$7\0'PMXAT_Q3X)\;?#_7
M='UT:%H7B=+&^\-^/_#VBZK!YGA_Q-H-_%,;+R98=3B:*1_F"@'H% !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % 'S_X<_P"3I_C)_P!D _9I_P#5B_M8T ?0% !0 4 % 'S_ /LG?\FL?LT_
M]D ^#?\ ZKKPY0!] 4 % 'S_ /&3_DHO[)W_ &<!XC_]98_:6H ^@* /G_X-
M_P#)1?VL?^S@/#G_ *RQ^S30!6^*'Q+\:>!_&%]%X8\.WWCJ*P^$>N>*K7P+
MIR>3=:QKMIXR\+:/#="^T_0M5U9(+73=3OY9H--L-3N)(HY/LNG7MX((),J=
M1J&<R<.=82MP_3IRM5:H4\=_K!];J2C0I5JM1-8'#-1C2JR4J:4?90J5IBY>
M?,,DPWMUAZ>+PW$%6HG[->VJX".1RP=)3JSITZ4I3Q>(HQE.K1H\V(4\1/DI
MQE#SZT_:GUV:?X;RW7PYL++PUXJN7TOQEXREU#XQIX>\#^)8_$K>&G\)2K=?
ML[V^H:=XAAN?LWFQ^/K'X<VWFW]O;075Q(9/)ZZ-.G5QE+#*K:CBJ%*>%J+V
M;^MU:E.JY4J$E4^J24,33^JJ#QBQLZG.E@54I^QEG4G4I9?6Q?L_]HPN(K0Q
M&':JQGAL-3IT,1#%UXNC]85*K@ZL\4JE'"UL)3H4O;5<9##U:->=GQ1^UOIG
MA;0--UN;P9>:E+J7A_X@:M#I>BZAJ.N:E'?>#OBOX4^$VF6!TW0O"]]J-S:Z
MEJWBJ*ZFN+.PN9[-+":&&RU"8J*QA&=3"X>K2CS5L3AN&J].FU4<%/B/!8G&
MQIU)TJ=6I&.%6%G352%"I+$R^&E2:Y'U8>$:L,;.I45!8#,,]P<XN5.,YT<B
MCCJE;$4U5J48.56G@Z<E1G4A3I/%4_:8E4U[26MX._:#\;^,Y? ^E6GP>N]"
M\0>)=9\3V&M6WC6^^(7@#3--TGPE'X7O-3\0^&AX[^#FC>(_%-C-8^)#'9B\
M\+Z )K[39K622"#=>Q=$*5.6(H4W5Y</++ZN.JR7LIXBBZ6-67QH/#TZTH\U
M:M*GB*3J5Z+^HSC7G"%=QPDN-U*D,/B:CHOVU/'8?!4$N94*WUC 8W'QJNO.
M$)05*."GAZ\(4*SAB6U!U*"C7J1?%[XT>-]#\3+X7\&Z)I5IIFA?$#X'>'_%
MOBO4/$EI;ZXL?Q&\=^';*73?#_@J\\,7L.M:5=>'[C4;2XU635M-FMYIG^P0
MW,UG-):8Y:XXK%)UTX86-;-<+&,7>=:O@.'L1FC]IHOJ].$YX65&476J59PD
MJU"&%DJE7KQ"6'P^*Y(^VQ,<IK9@DY*$:,'B,1@Z,X-R?M:L*V&J5*E&I&G3
M]ER<M2K6J1H/EK3]I;QI;CP1IQ\ [=*\7^#4OM(^(/C;7/%MM8:IXQO;75SI
M?AK^U/ GP)O_  E9W,FHVFG6K/K.K>%9IFOF_L[3;]X52YX:]:M_9^95::C0
MQ>$RNGC,+3EK/%-931S*M5BJCI4JBI4WBIU*>%J5J]\)7JSP>$PCA.'1*GAZ
M&8TJ-64I85YUB,#B9P2]GA:4<\J973BN6=2M&<W[)4(XF,*5JV&HRS'$8AUI
MQI:%^T5\3=6\->!Y=8\&Z+I\DVE?LY:AXT\3>'_'L:3G4OC/XITG2[73] \/
M:S\++Z&^TLVS74FI_:+C29X8;P6^F71N,:A9_08O!4Z6:9EAJ<O8TL'F&<9=
M2@[UKXC+<@AFU7VC7U=NA3EB%3P]:$HU*U3#TZU?#4Z-2IA3P\LQDL5@7*<5
M/%?V-/-I-)PA##SQ&:X:@X>]+EQ4GET)NE*%:A2]M5C*I7]A3^M6? O[2_C"
MR\)Z'/\ $#POHU_>:IX6TWQ)H>OZ1XQAN)==TX^/_#7@'6[OQ7I-MX+L+7P/
MJ%O?>*+2XMK2UFU>"[BLKE&N;6>&:*'S\-%5Z.7)_NL36EPW1K134X?\+V&G
M*CB*<[QE.I[3#8B=;#>RI4XN=..'K5J;E*EZ.-MAL;G,:=G@\)4XHE1<I1A5
M3R&>)K_571YI3=#V$:-"..4ZKC*SQ=*E4K8:.*B^)/[1_C73?$?BNP\-:)I$
M7A'P?X3_ &@9-?U:T\601>*WU?X6:#X U'3K_P .PZAX UK2+>Z6_P#%SV;V
MNI)>0HPEGF2;[$+*^O**4<;]5KUGRT<94RZ%",??7M*W%6-R&K&LKTG+#U:&
M"^L.5*I"JE4="FZ<N7&0ZL-1]MB*F&A3BZF$S?+\#5E5E-0E1QW#;SR+C3A:
M;E&4W3O[6%OJT&N>.+FL)T&I_M0:_P"'+GQ!J&O_  SL(/ VF7OQ,T/1-?L/
M'QOO$FM:[\,]/N]2NUU+PO/X+L;'0-&O[>PNTCU#^W[QX)H6\^T2VQ<GGPW-
MBH4H1C&ECL9'VF%I.7[AP?$&%X>7UC$M.6'E]9QN&Q'NT,1".%=64ZBK4E2J
M>9*M##O">T=2>'?U2&(J*'/7C+$<-UN)).CAZ*;Q+AAL/5PZC'V%2KB73C2H
M\M3W/2O!_P 8-;O]'^*-YXZ\(:1X<U3X4QQ3ZS8>#O&<GC[3]1MY/!UGXRSI
M>JWGA7PW*9Q97B0>5-819D0L&\ME9LL;B*."RS$YDN>I'"5L70G3<53?M,'"
M@Y\LYRY>24ZSBI3Y'&,.:K&G/GI4^W!T*N+S# 9>N2F\QH83$49\_,E3QF+Q
MF%I*HHQM&48X559\DJD/WG+2G4IQA6J^71_M+_$%[K2_#B_"7P=-XV\4-X&U
M#PCIMG\9GOO#%SX9\?VGBNYTC4_$OB:W^&;7>@:K;?\ ")7INK&RT/6K9HID
MDT_4;]D>->NK0JTL2\"DI8O"8C%8;&WYXT*53"X"MCV\-5<.;%*<*#I*-6CA
M*M.I.E*K2A1J0JRYX5*<\OAFD>?ZEBJ"K85<L?;S_P"%'*\O<:]/G5.A9YMA
MZJE3KXE/V>(I652FE+,?]J6^T74-*\8>,-+M?#WPZ/A'09/'L#ZQ#=VGPZU:
M?QWX[\$:GXDBU=/#<5QXCT1?$.@:/8,]Q_9$<=G>?VBT,4D4MO)SQJT(O%2Y
MZE7#XG"Y5BLNDZ<8592S#)\7F]#!U*,:LDJ^,ITHX:FJ=3$R>8+#83#QJ+%.
MK#2*J5L/0=*E;%X;'9_@\12@W.-593FN3Y95KPJ.,91I82.(Q>.DW2A?"*K.
MNX.C!+TWQ;\?;[PE\$_"GQ6O/A[K3:YXT?PQ:Z)X#BB\5:O?6NH^+Y VBVNN
M'P=X'U[7;94M'BDO%TWPOJUS!*S6\5K<NJE]<=3JX',<+E4E&IC*LYTJO(ZD
MZ-&MAL%6QF-C&I1I59584?JU>E1J^SA"MRPK5?JU!U)T8PU6AB<)C<?3JWP.
M'YIT*EE3EB</4QU/!8&M&GB98=TWBE7P]>5&;]K1A4E3C&O5A&%3RVT_:-\4
M:IJNA:KJGAWQCX(TR]L? ,6H^#-1T2[T#5+35-0^)WBGPIJ^IPIX^^'=CXAU
M#PYJ.FZ1:3VJ76C:!>W-G+!)''I5W+)Y<3G1PF(QDI5'B<-2H_6:<?W?/3A#
MAOB'-:M"O2H5:EL1&KEM*/)'%-4J\*<W.OAG5PV)G%>TCA,#[)*GB*N,EA9S
MA*:IU/:9QPA@J$J53$4(I4Z<,YQ,*\OJWO<V(HTYQJPPV-H:-E^TGXIUPZ#!
M?^#K#PJGB%/A9XG\/7OA?XAZ;XKGO/"OQ'\3:AH^EP^([;4_AU'#I5^MMI_F
MWUC82W0_?-!9:R&C-R%CJ5;"3Q^%E45/'Y9',*5907M<-]8H<.YYFL)4JC5.
M=>G3EEU-TY<N'YJLJ=6I3K82+H8R)XB"PV$QE*,Y8+'XC#QH2DG0Q7LEGO#V
M6U/;4*D*BP\ZBS:I&I2E[6<*5*I24\-C9^TP/)>$/VCOB/>^!_A,/%ECINGZ
M]X@T[X+>*;CQ'X=U>Q\52>+O"GB?5+#2/%!US0D\':7;^"O$%Y>&Z\K3M/-_
M&8Y'-E>K-:W$-KW9D\-@\VQT?9.EA\KGF<L3A:;=6'L5PYQ#FF7K#XAR56M.
M%7*8U*T7"FHRC1CSXC#XCFF9C[6@\10PLDGB<P6&PE6:<735#BS(\IQ5.K!Q
MG3C!X7-51HU'5J59Q]M4E"A7I19[!^S[^T1J'QR;499_ACXL\&:4VCZ?XE\,
M:WJGA_XEV.C:UH>J2LEI;76K>.OA;X2L/^$F6'R+B:S\.W?BG3Q#<+);ZO<J
MIQG5PM6A0K^TY8XW"5(4JE&3=.$IU(U91]@ZBABYTZ;I.&(G6P.'=&52BHQJ
M>TTJ5>E]:I4J//4H5HUY1J.#4H/#SHTYQK*#J8>FZLJS>&C'%3JU(T,0ZM*@
MZ=I>)^#_ -HSXR:'HOC/4_%OAKPOXNO]+OOB?\0=7MKGXH:5X<TOPI\*?!/C
M76/!D>E>"#!\&=.N?$.OQ3^'=286>OW'E2'R+BY\26?]J0Z;IN-"=#ZEE3K\
M\>3+LCQ&/KPA[;$2Q7$%*IB<+&AAX2I4ZM&G3A:2C'#5J=XX:C#-J]*>*K=?
ML98K-L1A,$XI8K,<RR[+Z=2]*G;)YT*->MBIWQ-6C.M/%4)-TWB:32JU52P=
M.G[.?;^)_P!JWQ+H&E-K%E\)3JUIK7Q#U+X<> H;+6/B'XAU76]3T"WU_4M>
MU+Q+X?\ AO\ !;Q;JWAG2XM)T/=;'3;#Q)/-<RS17$-E:6QOY5!2?U>G.+6(
MJPQ^(G"$9U84\'E^.673FJL8J+Q%7$M.E1JJCA_82C*IC85G]76,)4IPJ5E*
M4<-3I9;[TE3C4>(S3+L+F.'IJFZJ7L84\2Z5:M[3VL:M-*EA:RJ1+MC^TAXD
MU/5K#3M#^'VK1>)_%L'@A-'\&_$[7)OAII^@SZCH'C?Q#XA&J2W7PUN/$&CW
MD5AX2N?*MKVPU&:_DDLC';:5#]JE%**5/%RC*,Z6$JXW$59N4/:PP6%R[AK$
MNG"-*<\/+$0JYY"$L+*JO8U88V=7,9T(4:6'XEB7]9E2E&<9O#X2G1@H5?8U
M<77S3B'!PJ2E4H0Q%+"UJ>3NI'&3ARU:4\%2H8!8JM)XN#1/VIO%.MS^&[^#
MX4Z3%X.OHO@\GB;6V^)3R:SHM_\ &7Q%<^%]$MM \/P^!&MO$]OI^IQ6TEY<
MW&L:*#;77F6R7$D9@/1@\+]:JPA*I[*%>K7P]!\LG-U</P]@N(9^UIRY/8TW
M1Q?U924JM3VL(RE24)R]ETUING6S+"TX^TQ.5X>OBZL>9*F\/ALVS7*ZKA47
M,Y59+*JF(I0Y%3FINE.M3<(3K>E_$[XT:Y\.?'W@KPW)X%\_P5XC-E'K7Q+U
M2Z\;P:%H-]J&L1Z1::/&?!_PP\4V-OJ;R36S"3Q5JW@[3Y6OK6&VOYYFF2VX
M\+*-;&3PM5^P7*E0T;GB*KIU9JG24U2P[;G"G2C3^M/%5)3?L<+5Y8JIMBHO
M#Y<L;2M7G"=3VU)7_P!GH4HTJDL35Y%5K>R]DZ]252GAYT*$<+.6+KX:$H3?
MCVE?MEW.IS>)YU^#?C:#P_:7+Z;X.\27.A_$[2="U;5CXXTCX?6=CXN\2>)?
MA)I7AOPRMWK>L1W,<_A_7_&L<=AINHSW1MY[9+6>L'"IC<#@*U'V=+&YBL#.
MA0KU/J]*5+,*$L32:JU(JO*K2HQ7MJ=/!U(3G4HPP5;&^UC(NI"%'%9A2E44
ML-E?]I+$3I\M2JGE5#$UL5*G"$GAW2;PM6C2=7&4:SJRI1K4*"E5='M=2_:3
MU+PSI'C&3Q=X(\/Z;XB\#?#KXA^-]9TK1/B;IOB31I[_ ,!:EI5@-#T_7H?#
MUK<1PZ@FL64@FU/2-+O[5I%BGTD&2-I-<'3IXV5'V$Y1A5Q>0X-.4(W]IG.8
MYIEE1KV=2I2J+"5\KFX>RK3^L*JJ57ZGB:5:A#"CSO,\'EM?DH+$K,9RK*?-
M"C3P.$R?&PE.,XTIQ=7#9MSU(U525)8:=6C+%82K1Q,N)^(W[17Q+T[2/%FL
M>'/!NB:7:Z$?C-I?A:\NO':W*^(-<^&7@_Q5J]S=>*/#S_"^XDT[14ET>TFM
M$TW7TN)[GS(KH):Q!KWFP_/6A2E%)5J^'J5HT9/]W&A2XERC)9U'5BN>&*FL
M3B)4H<E;#QP\_P!XI8FI"6"VPBAB,SR#!<LG3Q^995A*C4XTI.IF7#N*SJG1
MYG#$?[*G[.C6KJ%/$PJTXUJ<)T8U,+BJNM?M6^)O!M]=^'[CX=Z]XQ\;77B3
M[$=#T-?'7BSP_I5KHWPP^%GBSQ+'HE[\*_@)KNOM"+_QVL=BFM:$XN9OM,UU
MJNEVLEM9V79BXTJ56G#"TZM?#0695JD_9M8ET,-G>-RVC&,'4^J3KR5!<L*F
M(P5&%/V<*N(K5VZU:*-*K++<#C:M2C"IBL+EG)'FY*;Q&-I9C74ZMW4KP@J6
M FZTL/2Q,DW"-'".%.O6?J'A?]H/6M<^*.B>!M<^&>K> /#_ (HT'3M2\*Z[
MXVB\?:/KWB#5;WPQ'XGN/#]KI7_"KI/"MGJUA;QZM!=:7?\ CRTUR)M"OI?[
M%-M&LSW#"7J9O1]O3J5LKJ5U&-"2J1K8?#XF&'>+4YNBI8>I[2G5IU,']=A&
M%:A'$3H59SIT^9UI_5\!BEAZE.EB(T/;.JE'ZO5K*:5"2I.M*,X58PHWQ,<)
M"K.4GAY5H>RG6=X]_:+_ .$'^*'AKP'%X8L]=T76?$>E>#-4U_3]8\2SZGX=
M\5ZWI@U?3=.U+3M-^'U_X>TR!M.FLKD_VYXPT.^FBNO,T_3[\)AO+A7N\6I0
M<53PV95\-)7Y*\\JP5;'8JE*I-4X1?)0G2BL-+&5XU;.MAZ-)5*M/JQ<)83#
MX:ORN2J5LOA5@[1G3HYGF,,KPV(I0BYSJ06)E+VDZL<-ATJ<H0Q$\1*E0J<1
MX<_:D\<:SHV@SWWPA\/:3X@\>:#\-_$/PZTO_A:UQ=Z)?6?Q(GU6VT^+QQXC
M;X;V[^#KBUETB;>MAIOB03?:K2*W,EU.+9>^OAYT,?5RJ\98_"8N>'Q$=51A
M2A@,9F#J4JJ4IUJJI8#%4G0]C"*K1@U7>&E4Q-)XJ,<)]:K3ES8&A/&TJ=2-
ME6J5L%F> RN:E1FX0I4:E7,\)6A4^L3FJ'MW4HPJ4HTZNA:?%OXJ_P##-OB3
MXCVEGX;U/XAZ=X]\<:-;Z?J^LK9>'K6PTGXTZSX/MM/76M"\*W/VZ&QT"VBM
MH+O^R%DNC;1S7&R661J*\:=.MPA"DW*AG$>&5B)R7)4E_:E/!*O-4U.<(5*M
M7$6DH5'2H*<JE'VL:4*-55[4JG$_M(_5_P"R<+CJM*%-JO&$\'E*Q7,I2=*5
M2'M(U*\85/9U)WCAZJPW-*5'$/[2WC3P"OC75/B)X,M]6\&:5X@^-,&C:]X<
M\0-J'BAYOAK%J>N#PZ/!5IX)M(WT==(TZYM+?6#K%Q?33VN;G3DCD6X;CPM3
MVV!PVDI8ZM0G6H+DDXXB#XCI9%3E75%5)X:JJF/P,E2PU#&1EAXU9N?UF*HU
M#$+V.84Z%E"E5KX##5(IIK#U:O"RSVLZ$I.+Q5.3PF,UJO"S5:M2I4Z?L5>G
MZM\+/CIJGCGP1XR\6>*?AMXJ\#W/@J"XO;FPN/#_ ,2K&RU[3XM(?6(YO"L_
MQ0^&/@'6-9F6**2VG4>'XH8[I?+AN+F-TF>\QJ4\ORVKF#;G]76(52BW3A4Y
M\/"G.4HKVLG'#5/:*-*OB(X>3E3K\]&FJ3;6!7U[,J.7T+QAB?JTJ-:49*'+
MB:U6C"%22BZ*KT_9*K6IX>OB:<*5:A+VSE4<8^/Z?\?OB5=>*=6?7= M=,T^
M73OV>[_PSX2\$>,O#OBD7,'Q,\3_ !!@DGN_$>J^ ;5FO-2TK2=#@N],C010
MM:_\2S6%6X:^E[:N'G@Z3I2I/%YE0S//L)5I0NJ;EEG"BS6&'I2?LYU:;Q49
MRH5IQPE=5IPEB*-3"T_JF(Y:^)I5,#EN,H-X7"XV.$J1KSE%5'2Q7$.2Y9&=
M6G:O"A*C2QE9UX06(A4HSE3I5Z>+2K8.QI/[2WQ*\2S?#^UB^'_A?PEKM[\7
M+;P?X]\&Z[K_ ,2K'7=%\*W7@+QAXI@O43QI\#?#$LVHS2^&KPP3:=;:AI%V
MVDF&UUF:.ZEN=/YVJ5*D\8ZBQ.#I99F^)JRHNW)C,OI86K1PZC4Y*\>:GBJ,
MZT<90P6(I4J]*M]6JQE!5.R$75CFU&$'2Q6#_LNI1C6DH2>'QN;TLME7FJ2Q
M%":<W.C#ZMB<12YE7G]84\+&CB,:Y_:+^*>MZ;X,UW3/"^D>%;_QE9?!+Q'X
M>\,S>/=.U70M1\/?$;Q?/I:V/B+6+KX4PWOA?6+J!3;W4UA)KT5O D#V41NS
M)YFKPM;#YS4RM\F(KX6OB*%>E*4J='FCD7$>-I*E7IPE5M"KE^%KU5*C)SKP
M^K4Y?5U4GBN?,W]4PM:IS^RI4<75H1Q%*/M*LXX//N&<OQ<I8>JXTE&I2S#%
MTL,_;4G"C5EB,2XU?8QP7HMK^U#MT#Q=J&K^#;#3M7\$^&+S5-7TVV\:1:AI
M=UK^E?$/7OASJ.BZ)KS>';;^TM+_ +6T026VIFR@EF^WQ6\VGVMRCQ+G15'$
MXC!4\/4G[#'XWA["TIU:?LJJAG]>=!59T>>:3PWLIU(QA5J4L93BJM#$*A*%
M:3S%U<LP^-J581G6P.#SS&2IPE+EE')\KR[-804Y4XR3Q-',:=.JY4D\'5IS
MBXU[:</=?M*>//"_B?Q):^+/#6EW0M?$GQ%\.>#-+T/QG9V^AZL+'X@_![P+
MX0F\97NL?#N"\\/W"ZA\0U:XO;'4+NVM+3[<\EEJDYM/LAEE.IC\LPLJ2A+,
M\7.E3<:LI4Z$)O,.)J$_9U8<\[*CDKIVEAJU3%3AAGAZ6&JUZU%]U6C3A4S*
M?M'' Y;4ISE.-/FQ'L8\-T\YKQ5.554I\W,IP3J4.2K4=.IB(X;#2K8CJKG]
MI#XA^9/X=TKX2>$]0\?Z%K'CK2?%NE2?%V\M?!NG?\(+X:\)>+;JYT+QC#\+
MKJ^UX76D^,-.@CAN?#>D2PWT4MO<+%$C7*<U>O0P^'ACVYRRR&6XO,J\U&'U
MB$,!FCRK$4:-!5'2K3=:%6K0E+%485*,%[1T*TG2CE2H5I55A9J$<96QV7X.
MA&-3GI-9E@L9C:%7$5+1JX=PIX-QJT?J]6:=2%2C[;#RIUJG=>.OB_J6E>&/
MA%XM\,>&_$&O3_$"2[OM/\(Z7?Z+97NK[OA'XT\>:?H5])J&A:BTWFW.BVL"
MC3KC39EN?(E^TS6\4UAJ'?C,+5P&8YSE_+'$5,KPV+;=JOL^;#YGEN"E6M1A
M.NE3CBIU6X4\0_8QJQC@\17E0E2Y\HK4<UR6CFNN&IXFGEU:*?*ZD(XRK27L
MXRG4IT.9J?LVZKC3;?\ &PR_?PJ^$OC3XB\<?!?QWXXL?#NAZ%X_\(Z=XGBN
M/!EWJ'Q!LH-%\0:5H2ZUI>G>(W^('PD\'^(M*FFL[O3KIUE\)%#!>0RVSW<$
MT<K^?GKEEN4SS#"U%6@\-5K1J\L'3_<5:E*O[-0JR=1T72FO95GA:CK0="M'
M#ZU%UY33^MYKA\!BZ4J'/5P\>2[YY4ZZC[.3DX*FH3J<]/VU">)IJ,93A*I*
M+I+C_ W[2'C#6+GPM%XB\ ^&;71KOQ!X,^''B37M*^(SWVNV_P 2/%'A32/$
MN-(\$W'@FR%_X.1-8ME.HS:O8WX GF71VM(/M#^O7PU&.8RPM-RI4\76SJ&!
M5E-N.25,PABEBFW#V-WEF*6'E36(=5/"RK1PTL5R4_#P^/<LMABI)U:F&I9/
M/%^XZ2Y<Y>!CA)X>*]I[1VS'"3Q,).G2H3^M4:.(Q4L*Y5>M\9?'K6O"GQ'U
M+PE!X'TC4O"WAN?X7P>*/$DWCQ-.\1V[?%;7K[PUH/\ PCW@?_A%[G^WS;:K
M:(;A9M9TUG@DD-F+NYA-H_#@8_6N:56]&G+'XG+:+A"=><\3A\MP69\U2$5'
MV5"5+%RISJQ=5T72]M4I_5_;UL-Z-:7LIUJ--<]:AE7]KR4O<A]6IXC,:->G
M&?O.5>$< IT8*')5G65&I4P\O8O$>8Z7^V+J^LMXLGTWX*>+VT;3998/"6N:
MAIWQ+\.Z+K5S;>.='\"26'B+Q+XH^$.F^&]$U"ZO=5DN[&+P]KWC-)K?2[P7
M4MC,BQ/GAN?%8'+<1!0IXG,ZF5*E1JS=*'L<W494*BG.*KU)X>,Z<\7"GA)4
MHPG&>$KXR#YC:NH8?$9C2<G5HY7'-55E22JU'5RC"XO$5U&,)/#QH5)X.IAZ
M=2MBZ5959TE5PU-RG&GJW'[1_P 6[;76\-'X*^!VU1_$OB'P/93#XV:N-*N?
M%WA/P/9_$'6UDNC\%_M5OX8&B/J-O;:D;%[R:^LX8I-*M[:Y-Y;DJE&.$K8Y
M2F\+0P.89H_<2J_4,JSN628Q^SYW#ZW*LZ%;"X?VKHUJ<ZJK8O"NE!U\(U8+
M&QP,[QJRS+ Y6I1]Z'UG,LGCG&#=WR/V<:?/3Q<K7H)4YT(XN4YT:61<_M#_
M !%UO7?",GP]\/:/<Z3XJO;*:\L/&WBI-)_LZTU;]GZ?XI:39:0WA_X=ZA-$
M%OT)NY;V[U!S):E8-EO>B/3EF%+$Y?\ ZU4KPJ?V!A\_E&K=\[KY7B,CH4IJ
MFH1A*BWF,DJ,I1J?O*E6>(J>QI4)U@Z]#%TN&*SC*A+.JN1*=))2C&AC\5Q!
M2Q=ZCFI?6*=/+(.E.,51K*-*C[+#2E6Q4Z?A/]KKQ?<7'PQ\.ZQ\(]?\0ZOK
M'@[X8ZW\0]9\"Z)\5?$UAHMW\1[2&>POM#ET+X.W?A^;2K6V<ZAJA\0>)O"K
MV4*7,=BFK/:_OO1QE'#TLSS[#1<L/A<IQ6+P<93U7UK!X.CC*].56K]7IRP_
M[^&&P]>G*>)KU'3J5L!A*56,CAP>(K5<MR[$U'3GB<7A98[DC*U\*\5B<-0Y
M:=/VU:.+K+"U)>PJ4XX6$FJ<<PJVG4AZ-\)OC-XW^)7Q%T<:EH6D^%? _B+X
M3W_COPOI=EXFM?$VJZC:3^*=%T[2=3\41?\ ",:;-X4\116<U[#<:-;7NL6<
M;3[?MLUS;RI:X4:#A2SF.)E&6+P+R*T:4E4P]+Z]3SVK5]AB8N/UJ-:GA<&W
M.5*$8NE?#.I1J^VK=682>&S;+\'0GS89RXBH5I2CR3JU\IQ.2X5/V<E)TJ=*
MIB<7[&U2-6K"M?%4*-2G"G#E_$O[1/C2\-@=$\.:1X9\.ZO\4?#OA/PWXF_X
M331-3\5ZK:Z!\<O"'PT\?V&O_#?6_#]K<:%!>0:GJ*6EYI-YXA:&"2.:]?1[
MJ>T258"G&O++Y8A\KQ>!J9C&C#WXSP>(R/,L?A'.M%*5#$T:U'#2K4I4O8*I
MS4%B*\H5J+[9PIPHYQ*ES3_LVGC\-.=2$Z#I9AAJ%6K&5&,DZ>(P]J-1TYRJ
M0J5HJ-:GA*F$<L1',\/?M;:I<Z_X'\)67PO\?^+X[_3?!D_B[Q)9Z%X[U_4-
M'?QO>S6NFWD5SX$^"S^#;JPL(8GO-4NM8U[P7Y%M;SM9VM_+"T1C+HQQS2E)
M86FJ="G&K-.,'B?[)P69U/;3JNE1A3E'&4J2J4*E6I+$SN\%AL+.E,QS%?4J
MV-I1<:E2A6S*I[*+N_JV$S7,,OIPH4Z7M\2ZTY8"M["E7IJ'(J4*F85JOMJD
M8/$7[3WQ6.@ZS-HOPN\'Z/?WVG^*-6^'M]J7Q,U#4(=5T[P'\5?#?PY\2OXJ
ML;;X9C_A&;BX3Q#;7NGQ6<VO"1&D2Y>SDB D6$IRKTLEK3DJ;QF(X2E7I1O-
M1PG$Z]I2A3JOV;E7I<CH5KTXPIQJ+$4IUYP>&E-:=.GALXQ,'*5#+7Q%A%4Y
M8\ZQN24<?.,U1Y[3H3C@*U17JTYNM36&<8TJBQD?9_!7QI\1:]\6O$OPQ\5^
M 8_ HTV+49O"U_J&H>.;B^\:V^D26$=_JFBO>?"O3O"-[I 6^CF7^RO&VL:C
M#%-;'4--L)9GAMUA?9XG#8FK&;C6PTDW0<>6I"@ZU2E&K5C4=.:VH<TL-#%X
M2-2NJ7UQR4'5,4JF$K8*G:-2CBJ5/FKPE*5*.)GAU7EA82C"2YX.&*@HXIX/
M$58X2K7H8:I0_>1\U\5?M8ZKX7M_$NOR?#73;[P=8ZA\7O#?A6\M_B)$OBW7
M/%OP;T7Q3J^NV?B#PDWA(V_A30+T^#M7AM-3AUK6;A1/I\MWIMLMZH2L%1K8
MR.%IJ,8XK'X?!8W"TXS4Z<L)C,RR_+(^VJVC['$PJ9E0G*C"G6HKEK4:F*IU
MZ?LY=SP?+F-+ ^UC&E#$8/"8JM+W94:V-P<<;0>'HMWQ=*-*<55?-1KJTZM'
M#U\+"6(5?Q-\?_BGI\VC6\G@'3-+\4:!\1-3TCQ%X)\/>,4\4Z?XST'_ (41
MXS^)VCZ?IWBG4_ >FW6FZM)<V&EAXHM)CVW>G_9UO)[.X>5ZHRPD%B\1B:C>
M$P.%QRQC4)OZK4P6:9'1KXN@H?O,73HY?F%6O2I2CAY5Y.5&=*G4A3J+GPU*
MKB\)4]E&G1Q&+H93B<OG5JRC#ES#,*N"A2Q;C3FL.Y5\-5HUITXXQ4:$HXBD
MZM2]&/5^'-;L/VFY/#/C_P (W_B'2O /@SXASKHGB;PY\3_B%X9MOB%HFDZ/
MIUWJ$S>&O"6H:7I&OZ9_PG,3Z'-!X@&L0&UT/53;A#J)5=:>'J8"OAL=724Z
M^%QRCAYQ]K3:^LU<'@JTZ59.C[+$X7VV:8>O3IJJT\LE"=2A5GR<L\2L1A\1
ME]*G.$D\!+$3G"-"OAJLZ'UK$X:$XJ6(]K0I5</@L31E/#JEBJV-4XPQ.6T?
M;_5E<AJ% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0!\_\ AS_DZ?XR?]D _9I_]6+^UC0!] 4 % !0 4 ?/_[)W_)K'[-/
M_9 /@W_ZKKPY0!] 4 % 'E_Q.^&$?Q)C\%RP^-/&'@#6_A_XPD\:^&O$G@J/
MP;/JMKJL_@WQAX#N[>XM/'G@_P 3:1=Z?/X=\<:[$Z2:89%D:"6*6-H?F-OD
M&WR./_X4W\1?^CL?V@/_  G/V6/_ *&F@#L/AA\,(_AI'XTEE\:>,/'^M^/O
M&$?C7Q)XD\:Q^#8-5N=5M_!O@_P':6]O:> _!_AG2+33[?P[X'T*)$BTQ9&D
M6>6661IOE-@V.J\0^"O!OBV"\M?%?A+PSXFM=0TJ?0M0MO$.@Z5K4%]HES<0
M7=SH]Y#J5K,ESI4MU;6TSVD@:%Y+>-V0M&I$.G3DIQE",E.5&<DXIJ4\,ZKP
M\Y)K66'=>NZ,GK2=:JX./M)W:;C.G43<9TH5J<)+24(8A4EB(1>\85U1HJM%
M6554J2FI>SC;F(/@K\&[2Y\*7EK\)?AE;7?@.)H/ ]U!X#\*PW/@V%I3,T/A
M2>/2@_AV(S,9"M@UN"Q+8R<UNJU6->>)C5G'$U*<:4ZJE)594H1<(TI33YI4
MXP;A&#;BHMQ22;1FZ5*5'ZO*G&6'52554G%.G[6<HSE4Y&N7VDIPC*4[<SE&
M+;;BFK=O\(_A39ZAXAU6T^&/P]M=4\6PZE;^*]2M_!?AN#4/$T&LFU.L0>(;
MR+35FUF&^-C9&Y2\>99S9P>:&\I-N*A!8267J$5@).,I8:R]@Y0E.<&Z/\-N
M,JE246XWC*<VK.4K[^UJ^WCBO:2^LP<7&KS/VL7"$J<'&I?F3A3E*$;/W82E
M%6BVB_X8^'/P]\$6>F:=X+\!^#/".GZ+_:7]C6/ACPOHF@6>D_VR\,NL?V9;
M:58P1V'VZ6WMWN?(5//:",R[BBXVG5JSDISJ2E.-*.'4I2;:H1E&<:*;=U2C
M.$9QI_ I1C)1NDUBH0BI14%%2JQK2222=:%.=&-5KK5C2J5*4:C]Y4YS@FHR
MDF:S\./AYXCU_2_%?B'P'X,UWQ3H:PIHOB36?"^AZIK^CI;7T&IVZZ7K%]8R
MW>GK%J5K;7:"":,)/;12KB2-6&=+_9YU:M#]Q4KQY*LX>Y*I#DG2Y*DHV<X^
MSJ5*?+)M<E2<+<LI)W-NI3C2J/GI0Y^6$M8Q]HN6IRQ=TN>/NSLO>6CNBA%\
M)/A3!X@TOQ9#\,OA[#XJT+3_ .R-$\31>"_#<?B#1]*"SH-,TO64TT7FGZ?L
MN;E?LT$T<>+B4;<2-E0BJ<:].FE"&*I*A6C%6C6HQA"G&C52LJE*-.G3IJG.
M\%"G"*7+&*15E*O[+VS=9T*]3$TN=\_L\35G*I5Q$.:_)7J5)RJ5*L;5)SE*
M4I.3;=W2OAK\.M!T]=(T/P#X*T;28YM*N4TO2O"NA:=IZ7&@ZG)K6ASK96EA
M'"LVG:Q-+?VCA UO<RO/"4E8N=%4J)4TIR2I7Y%=VA?"4\ ^5?9O@:5+!.UK
MX2E3PW\&$8*%"$:F(JJ$8U<7&I"O-)*=:%6K6Q%6-66]2-2OB<16J1FVIU<1
M6J23G5G*5"P^$/PFTNT\36&F?"_X=Z=8^-;9+/QE96'@KPU:6GBVSC@>VCM/
M$UO;Z8D>O6RVTDD2Q7RSJ$D9 -K$')P@\+# N*>"I352&':7L85(\BC.-+X(
MSC[.G:2BI+DA9^[&VJJU(XMX]5)1Q[33Q*DUB+.4IR3K7]I9SG.;7-9RG*3U
MDVX(O@O\';?3--T6#X3_  T@T?1FU%M'TF+P)X6CTS2FUC2?[ U=M-L$TH06
M+7VA?\2VY,")Y]I_HTNZ'Y*Z%B,0JT<0J]18B$7"-7GE[2,'BHXYP4[\RB\;
M&.,<4[/%1CB&O:I3,Z<50]HJ*5%5:U/$34%R<]>C35*C7GRVYJU*DE3IU'><
M*:4(R458TO$'PX\'^(M"U30)]&L]-AU2#Q"G]H:%;6VD:SIMYXILKK3]=UC1
M]4M(%FTW6KNWO+D37D1$DWG.)C(KLK<E6BJE/V2?LTH>S5HTY+V3Q-+&RHRI
MU85*-7#U,51I5Z^&K4JF&Q$X)UZ5173TI2C1JT:OLXS="=.I!2YERSHX:6"I
M3A.$H5*56C@YRPM"M1G3KX>@^3#U*22MR'P5^!?@_P"!?AW5?#OA6>]OXM;U
M0:KJEWJ&E^"]#$TT>GVFE6]O;>'_ (>^$_#7AS2+*&PLH$$.G:)9B5S-<7!F
MN;B::3LKUWB*%'#3IQ5&BJGN^_/G=2RG*;J3GHX1A2C3CRT:5&G3I4J<*<%$
MYZ=)4JSK1DU4Y(4XM*$7&-.I6K+WH1C*I4E6Q%>M4K5I5*]2I5DYU))14>L\
M._"SX8^$%F3PG\./ ?A=)]</B>=/#OA#P_HBS>)3!-:GQ#,NFZ=")-<^S7-Q
M#]O;-QY<\B>9M=@<E*4:>&I1DXTL%&<,/!-J%"%6+A4A1BM*4:D&X3C!14XM
MQDFFT:R2G.O4FN:>)Y/;2EK*K[.K&O3]JWK/V=>,:T.:_+5C&I&TTF8?CCX+
M^!O'/AJ\\)7.GQ^']$U;[+:>(8/"^F^'M,F\1^'8M7N==OO".J74^B7,L?AW
M4M4O;R>[CL6LKEWO;EXKJ%[F9I)H_N,3E^)AI_9M;!5Z5+:DZF612RSGC#ED
MX9=*-.>%I*<:4?90HSA4PLJE"HIQYL/B\/%ND\7#&P=6&E6F\RE%YC5I2=XQ
MKXZ*E#$UG&563G[>,H8JG0Q%+O==\->'/$^B7OAGQ-H&B^(O#>I6WV+4?#^O
M:78ZOHFH6?RC[)?:5J,$UM=VWRK^ZEB=?E''%35A"LTZT(U7&:J+G2E:<7S1
MFN:]IQEJI;IZIW'1;PT5"@W0C&#II0;BE3<>1PTM[KA[KCLXZ-6,+3OAE\.=
M&L+#3-&\!>#=%T_2+>QM-(M-&\,Z-I,&CV^EWD^HZ7%I*:?90C3%LM1N;B[M
MOLWE?9[B>2:'9*Q8NOSXCVKJ5:GM*L'3E5C4E&LHO#5L'[M5-3BXX7$5\/%J
M2<:-:K25H5)Q<QA3A&%/V5.5*G4=94Y4X3I>T=?#XF4W3DG"4I8C"86O-N+Y
MJN&H5)7E2IN/E'PF_9;^&?PCO/$%_IB7OB>[\076EW+R^*M*\#'[ VB7]_JN
MF31+X7\':(NKZW'J.HW-S+XCUP:MX@O)?+DO=6N7A0KM[7_9*>$]G348.;<H
MTX4[JIAJN$G"-*DH8;#498>OB:4L-@Z&&P\H8K$J5)JM4NJU.-;$2KSN[RE-
M1DW4]^5?"XE5*E:K[3%8BI3JX'!2HSQ5>O.@\)0=)PE#F?J.@?"GX7>%([B+
MPO\ #;P#X:BN]1TO6+J+0/!WAW1H[G5M#2.+1-4N$T[3H1-J.GQQ1):W+@RV
MZQJ(60*,3[2HE37M))498B=-<SM">*ISHXJ<%?W98FE4J4L1)6=:G4G"HY1E
M)-U80KSJU*T%6J5_9^UE-*<JGL:T<32]I*5W/V6(A"O3YF^2M"-6-IQ4E;\,
M?#CX>>"+_7-5\&> _!GA'5/$]T;[Q+J7ACPOH>@7_B&],DLQO-<O-*L8)=6N
MC-/,_FW3RONF=LY<DS!NEAX82DW3PM)\T*,?=I0ERJ+E&FK0B^6,8W44^5);
M)%5/WV(EBZO[W%RA&G*M/WJKIP^&#J2O-PC]F+ERKHD5-8^%/PN\1+HJ>(/A
MMX!UU/#>KW7B#P\FL>#O#NIKH.O7M])J=YK>BK>Z=(-+U>?4I9;N6\MO*FDG
ME>5W,C%BZ4I4*U'$T9.CB,-1AAJ-6#<*E+#TX1I0P].<;2A1A3A&G"E%J$81
MC!144DE)*=*O0FE*CB:DZM:F]85:M1R=2K4@_=G4FYR<YR3E)RES-W=[NN_#
MOX?^)]"U#PMXF\#>#O$/AG5=0DU;5/#FN^&=%U;0M2U66Z^W2ZGJ&D:A92VE
MYJ#WW^D-<31/(TO[PL7YK)TJ3C0BZ<7'"MNBG%6HN4IRDZ:M:FY2J5)-QM>4
MYMZRE?6%6K3E5G3J3A.O!4ZDHR:E4IQI0HQA-IIRA&C2ITE&5XJE3A32Y812
M\W^)7[.7PW^(_A2R\(?V?!X+T[3[O0[FU;PCX:\ 26YA\-VU]9Z)IE_X:\9>
M#?$'AK6=)L(-1NC9VNI:'>+I\S1W6G_9;N"*>.ZCG5Q,<55JSG4C4K59<TKN
M=6O3P]*I7]H[UJ.*=/"X:FL;AJE#&PI48T(8B-"4Z<\:5.A0H5</3PU*-*K1
MIX=J,>1*A2K5:\,.XP<8U,+[2OB)3P=:-7"3E7J5)T)57&I'MO"OPJ\!>#_#
M&B^$],\.:9<Z;H=AX7L()]7L;+4]2O/^$+E2Z\,7NJ7UQ;%[[4=-OT^V6MP_
MS6URQFM_*;!'15Q52I7=>%L._:3J0C1O3A3G/#4\%-TTFW&4L%2I82<VW4GA
MJ<*-24H12(ITE3=:5^>IB(U:=:HU!2JTZU?$8FI2FJ<80]C*OBL355",(T(R
MKU>2G%3DGH:U\.?A[XE\0Z'XN\1> _!FO^+/"Y8^&O$^M>%]$U7Q#X=+/YC'
M0]:OK&6\T@F0!C]EFBR>>M846\/5J5J#]A6JQY)U*?N3G"TH\DY1M*4>64ER
MMM6E)6LV:U4JU*-"LO:T(2YHTY^]",KQ?,H2O%2O"#NE>\(O>*M2A^$WPKMM
M5\3Z[;_#3X?P:WXWM9+'QGK$/@WPY%JOBZRE4)+:>)]0331/K]JZ *T5]).C
M  $$"L_9TUA9X'V<5@JDE.>'Y5["4U)R4Y4K>SE)2E*2DXM\TF[W;*YY_6*6
M+YY?6J"Y:=:[]K3CRQA:%3XXKEA&-HM+EC%;)6S[CX(?!:\TC0/#]W\(/A?=
M:#X46]7POHEQX \*3Z1X:744:+45T#39=):WT=;J)W286D</FJQ#[@36ZJU8
MXFGC(U)QQE"$*5.NI-5J=.DXRI4X54^>,*<H1E"$9*,'&+BDTK1",:5*5&DE
M3HRJ^WE3BN6#KW;]LXJT75NV_:-<]VW>[9U<O@SP?/$8)_"GAJ: SZQ=&&70
MM+DB-SXAM[BTU^Y,;VI7S]3M;NZAO),;KF.YE28NLC X2ITYTY4ITXRI2HSP
M\H.*<'0JUH8FI0<6K.C4Q%.GB)TVN2=:$*LHN<5)./[N=&K#W*F'J4:U*<=)
M4JV'P[PF'JTY*SA4H85O#49Q:E2P[=&#C3;B<O??!3X-:GX=3P?J7PD^&6H>
M$H[FPO8_"]]X"\*W?AU+S2M,L]%TN[31+C2GLUN;/1M/L+"WE$(:&VL;>",K
M%"B+O5K5JV(HXJM5G5Q6&G4J4:TY2E5I5*M256K.G4DW.$ZE6<ZE246I3J2E
M.3<I-MQ;IPG3@W"G.$:<HQ=HRA&<JL82BK)PC4G.I&+5E.<II<TFWJ6'PP^&
MNE>*3XYTOX>>!M-\;-IL>CMXPL/"6@6?BDZ1%%#!%I1\06^GI?G34@MX(UMC
M<>4J0QJ% 0 *%2I26)C3G*G'&U/:XA1;BJ]6_-[2LE;VM3FUYY\TKZWN1*$)
M1P\)14H82*C0BTFJ,4I)1I)Z4XI2DDH<J2E)+=C;_P"%WPRU3Q/_ ,)MJ?PZ
M\":CXS\FPM_^$NO_  CX?N_$_P!GTJZBOM+@_M^XT][[R;.]@@N($\_;#+"D
MD85T!&=-*C&M"DO90Q+E*M&'NQJRG0J8:;J)64W/#5:N'DY7<J%2I2=Z<Y1;
MJI5E259>U5!)4E/WE34:JKQ4%*_(HUDJR4;6JI5%[ZN37_PV^'6J:/)X=U/P
M#X*U'P_-H=CX8ET*_P#"VA7>CR^&M,D:73?#TFF7%@]L^AVDKN\%@8C;Q,Q,
M<:DDTZO[^I.K6_?5:E6G7G.?OSE7H\SI5I2E=RJTN>?LZC;G#GERM<SOHJE2
M+O&<HM>WU3:_WIP>*V?_ #$NG3=?_G\Z<'4YG&-K,?@+P+#X5N? D7@OPG%X
M(O+>^M+SP;'X<T=/"MU:ZI/-<ZE;7/AY;,6$]O=W-S<2SQO;LLSSR/(&9V)J
MM*6)=-XB3KNE[+D=1N;A]7Y70Y7*_+[%P@Z5K>SY(\G+RJTTF\/)RH/V$FK-
MT_<=O9JDU>-G;V25.W_/M*'PJQ-;^"_!UG#:VUKX3\-6MM8S:C<65O;Z%I<$
M-G<:O;2V>K3VL4=JJV\U[:3SP7+QA6GCFD24LKD&9KVJJ*K^\56E5HS4O>YZ
M-:O'$UJ4T[\U*KB80Q%6F[QG7A&K).I%241A"G['DBH?5IT:E+E27LJF&P[P
M>'J4[6Y)T,(WA:,HVE2P[="#C2?*5?!_P]\ _#S3+G1? '@?P?X&T:[NI;V[
MTGP?X9T7PSIEU>3(L<UW<V&BV5M!-=/&B*TKHSL% )( JIRE4HT\/4DYT*,9
M0A3DVZ<(2;<H1@[QC&3;<HI)-MMJ[&DE7K8I)+$UY*=6K;][4FM%.I4^*<DM
M%*3;71F7I'PA^$WA^&^MM!^%_P .]$M]3O+;4-2@TCP5X:TV'4-0LKR]U&SO
MKZ*STR-;N\@U#4=0N8II0SQS7]Q*K!YW9I>M"CA7KAL.JBI4G_#I*KAWA*JI
MT_A@JN%;PU1124\.W1E>FW$<O?G*I/WJDIQJ2E+63J0K4<1"HY/5SAB,/AZ\
M9-\T:U"C534Z4)1@TOX+_!W0]&B\.:+\)_AIH_AZ#7[/Q5!H.E^!/"^GZ-#X
MHT^1)K#Q)%I=II4=M'K]M+%&\.H+$+B)HU9)%*@BG.;6'3DVL)"M3H*[_<T\
M1"I2KPI?\^X5J56K3K1A:-2%2I":E&<DS[>+J?\ +S'V^M2^UB>6491]N]ZW
M+*$)+VG-:48M:Q5M/4/AE\-M6TN/0M5^'W@C4]$ATK3M"BT?4/">@WNEQ:)H
MTDDND:-'I]S8/ FE6,LLKVUH(Q# TC&)%+',5DL14JU<0E7JUY<]2=3WYU)^
MSJT>><I7<I>RKUZ7-)M^SK587Y:DT[4YQ<6IRBX3E5BTVG&I.M1Q,ZB[3GB,
M-AZ\IKWI5L/1JMN=*$HYMY\&?@_J$'ABUO\ X4?#6^M?!%G+I_@RVO/ OA>Y
M@\(V$R)%-8^&(9M+9- LWCCC1H;$0(RQJ"I"C&WMZZQ4L=[::QL_9*6(YY>W
ME["I&K0YJM_:/V-6$:E*\OW=2,9PM))K&5.G+"5,!*G&6!K.I*IAG%.A.552
MC5E.BU[.3J1G-5&XMS4Y*5U)WT)_A?\ #2YO?$&IW/P[\"SZCXMMKVR\5:A/
MX2T"6]\36>HV^G6FH6GB"[DT\RZS;75KH^DPS17C3)+'I=HCAEMH@F#A!X:>
M"<$\'4G[2="R]C*HISJJI*E\$IJK4J5.9Q<N>I.=^:4F^A5JT:M.O&K.->C[
M/DJ*4E.'LH3ITN2:?-'V5.I4A3LUR0J3C&T923LZ'\._A]X9TW3=&\-^!?!W
MA[1]&M=3LM'TG0_#&B:3INE6>M&,ZS::;8V%C%!8VM^8HC<Q0(B3F-?-#[1B
MJW^TJ<<1^_52@L+-5/?4L,G%K#R4K\U!.$6J+O33C'W?=5L:,8X:WU=*ARUU
MBE[-<EL2E4BL0N6UJZC5JQ5;^(E4J+FM.5[FH^#/!^KZ7I^B:MX4\-:IHNDP
MM;Z5I&HZ%I=[I>F6[Z5=:$\&GV%S:O!9PMH=]>Z<4AC13:7D]N1Y,KHSKMXF
M=>>);KSQ49QK2J>_*M&I4A6J1JN5W4C.K2I59J=U*I3A-WE"+3P_^Q4J=#"?
M[)1HJFJ=.C^ZA!46G14(0Y8Q5)QBZ:27(XIQM9$7ACP+X(\$^'QX3\&>#?"O
MA'PJINR/#/ACP]I&@>'P;YF:^(T;2K."T!N&=S+^Y_>%V+YR:,1*6+I^RQ3>
M)I*G['DJOVD?8I.*I<L[KV:3:Y+<MFU:PJ26'J.K07L*KFJCG#W)\\4E&?-&
MSYXJ,4I7NE%6>B,/1O@]\)/#>LZ5XB\/?"WX<Z#XAT+2$\/Z)KNC>"/#.EZS
MHV@Q*ZQ:)I6J6.F17.G:0BR2!;.WECA =@$^8YM5:L77E&I*,L4HJLU)IUE"
M,(P55IWJ*$:=.,5._+&$$K*,;*4(3C2A.*E"A.=2E&235.I4G.I4J4T](3J5
M*M2I.4;2E.I.4FY3DW7/P>^'LWQ(NOBQJ/AK1]9\<M9:18Z3KFLZ-HFHZAX6
MATB#4K<-X4U.?3#J&AR7D.J3K=F&\Q,(HAA0I#QAI/!T\53P_P"Z>,KU:]:I
M'W:E15L/@<-+#SG'EYL-&.7TJD*4N:U6=:;;4HQA-:FJ]6%2K*4X4J&'HQHR
M=Z$7A<3CL32Q"IR32Q*GCZT'55G[.%*,5%QE*=ZW^$_PLM-;UWQ+:_#3X?VW
MB/Q1):S>)M?M_!OAV'6_$4MA=6]]8RZ[JL>FBZU>2WO;2UN(FNY93'+;12(0
M\:D*E_L]*%&A^XHTZL:\:</<A&O"3G"M&,;1C5C.4I1J)*<92;33;9I4_?3=
M6K^]J.E4H.<_>E["K3]C5HN4KOV52BO95*=^2=/]W)..AOMX2\*O=)?/X9\/
MM?1ZE?:PEXVBZ:UTFKZGIAT74M52X-MYBZE=Z.383W(82RVQ,$C-%\E+EC[*
M5#E7L94:V&E3LN1X?$8A8O$8=P^%T:^*2Q-:DUR5<0E6G&51<Q/+'VBJ\J]K
M&M2Q*G9<ZQ&'H?5:%=2W5:CA?]FI5;\].A^YA*-/W3,?X;?#N2/3HI/ /@MX
MM'O](U72(G\+:&T>E:IX?TY=(T'4M.1K$BQO]-TE$LK.XA"26UNH@A9(@%JI
MR=2K4KU&YUJKQ+G4D[SF\;2]CC'*;O*3Q=%*EB6VW7I+V=7GCH"A"-%8:,%'
M#QA1IJDDE35/#5WBL/!07NJ&'Q4I8FC%+EI5VZT%&HW(QX?@M\'+>Z\+WT'P
MF^&<%[X'$X\%7D/@3PM'=>#Q<W4E[<CPO<)I0D\/B6]FEN'^P-!OEE>1LNQ)
MJ$YTJCK4YRIUG1IX=SBW&?U>C2]A2H.2M+V-*C^YITK\D*7[N,5#0)PA4A.E
M4@ITYUJF(E"23C+$5JBK5J\HNZ=:K52JU*K7/.HE.4G)7-GP]\./AYX2U;5M
M>\*> _!GAG7-?GNKG7=9\/>%]#T75M:N;V:&XO;C5M1TVQAN-2GGGMK>25[B
M21I'MXV<ED4B:;=&@L+2?LL+'EM1A[M)>SE6E"U.-H+DEB*\HV7NRKUFK.I/
MFJJE7KQQ59>VQ4(.G&M/WZL:<E24H*I*\U"2HT4XIV:I4DU^[C:!?A?\,TUW
M5_$Z?#OP*OB7Q!<Z3>:]XA7PCH"Z[K=WH%W;:AH5UJ^K#3_M6I7.FW]E9W-I
M+<2R-;36D,L)1XE92DWAZ?L:#="ESU*G)#W(>TJTZE&K4Y8V7/4I5:M*I*W-
M.G5J0DW&<DZJ3G5<75DZCA1EAXN;<G&A/XJ";O:C+[5)>X^L60W/PG^%E[JG
MAK6[SX:?#^[UKP7&8?!VKW/@WP[/JGA.(OYIB\-7\NFM/H,?F$OML9(!NYQF
MBDWAZDJM!NA5E2A0E.'N3=&G#V4*+E&S=*%)^SA3;Y(P]Q)1T)J_OX2IU_WU
M.56I7<:GOQ=:K456K6<973JU*J56I4:YYU$IR;EJ:%]\/? .I6$FE:EX'\'W
M^F2Z9K>BRZ;?>&=%NK"31_$MY!J/B/29+.>R:)],U74+6VNKVU*&*ZFMXI9T
MD>-6"LN2-*W[N,<)&,/LJ. 5L#%1V4<$M,(DK89:4>1%4YSH\WLI.DY5:V(?
M*W&]?$>T^L5G:UZM?VU;VU1^_5]K4YW+GE>MX>^&'PT\):YJ?B?PI\// WAG
MQ+K<$%KK/B'P]X2T#1=<U>VMEC2VM]3U;3=/ANK^")(8E2.>614$2!0 HQ:J
M5(TZE*,Y1I5JCJU(*349U92E*56<4[2J2E.<G-IR<IR;=Y.^3IT[T9>SCS8>
MFJ5)\JO2I1C&G&G3=KPIQA"$%"-HJ,(Q2M%)12_"KX73ZYK_ (GG^&_@&;Q+
MXJTN71/%'B&7P?X>DUSQ)HL\*6\VD:_JSZ<;K6-+DMXXXGM;N6:)DC52A50!
M-!O"QE##/ZO"=:GB)1I?NU+$49^TI5Y*%DZU*HE4IU7[\)KFC)2U-93G*KAJ
M\I.5?!PE3P]1MNI0A*_-"C-^]2A*[YHP<4[NZ-#6/!.@ZI%?2VUG9:'KUR9K
MJR\6Z5HOAR7Q)HFM-H5SX:M?$>E7.MZ-J%K_ &Y9Z)=SV4$UY:7<8MY&MI(I
M+61X7RJ4^>E7HQJ3H1Q*J1JNF^252%:5&6(A)V=UB/J]!5G\<O94I*4:E*E.
M%T*D:$J-Z4*]&A&C!4*G/[)TL/5G7HT7&G.G)4J5:I4JTX0E%0J3G.'+*4FT
M\ ^!] ^&O@WP]X%\,0SP:'X:T^/3[+[5-]HO+C#O-<WM_<!$%QJ%U=RSW,\H
M1 \UQ(P500!U5ZSKSC+DA1A3ITJ-*E335.C0P]*%"A1IJ3E)4Z-&G"E#FE*7
M+%<TI2NWSP@X.M.4W4K8FOB,36J24(RJXC%5ZF(Q%64:<*=.,JM:K.;C3A"$
M7+EA",4HKKZQ+"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H ^?_#G_ "=/\9/^R ?LT_\ JQ?VL: /H"@ H * "@#Y_P#V
M3O\ DUC]FG_L@'P;_P#5=>'* /H"@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /G_P .?\G3
M_&3_ +(!^S3_ .K%_:QH ^@* "@ H * /G_]D[_DUC]FG_L@'P;_ /5=>'*
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M5XAEG33=.^RQ+!9V[WFHZCJ&H7<&FZ3H^E6,7SWNK:AJEW:65K;K@R3W429
M8D9-R]IAZ%*E*OB,55A0HTH<O-4JU':,4YRA3A&*4IU*M6<*-&E"=:M4ITJ<
MYQWA#F56<I*E1PU*KB*U22FXT:%"G*K6JRC3C.I)4Z<)2Y:<)U)M*%*$ZDHP
MEQGBGXW_  \\'V.O/JNMV#^(?"GA_3_%?BKP#I^M>&;[Q[X;\-WEY9V<^MZM
MX;AUTR0Z78M=E[BY222)EMI1:O<R&*.;:%-U<12HX9K%4ZF8X3*W7I*4J%/%
M8ZO'#X6-6;C&5)59R32G!55#FFZ?+"?+SNJJ="56O&6%G' XO,(T*J2Q%2C@
ML-4Q-:-&G%S]K4Y:;IQY&Z?M90C*I%/F7K1= GF;AL";]W;8!NW9],<UA6G'
M#TZM6K[L*$92GY*";E]R3-:;510=/WE.W*UUO;EMZW5CY<^'_P"US\-?'%X8
M=1TOQ3\-=+N_">K>._#OBCXD-X,T?PMXI\&:'XDA\)ZIXCTS6=%\9:M'I5E#
MK%WIR"'Q NBW4D>IVLL5NZ.Q3HHTI5L*L1I0JQ64RGA:CY<136=T95LK32YJ
M4ZF*]G4I1HT:U6M"O!TJE.$I0YYQ,EA,34P\TY0I8C-<(Z\5^Y]ODLW',8OF
MY:L*>'C&55UZE*%"5*$IQJOE:/;+?XH_#.[UG0_#EK\1? MSXA\36MW>^&M!
MM_%WA^;6?$%E8-*E]=Z'I<>H&YU:UMG@G666UBE2,PN'*E#B*<959584HNI*
MA1I8BI&"<G3P]:,9T:\U&[A1JQG"5*K*T)QG%PDU)74JM.G"G4G4C"G6K5,/
M3E*249UZ4I0JT(-M*5:E.$X5*<;SA*,HRBG%I4KWXQ?"/38/%5SJ/Q3^'%A;
M>!+JRL?&\][XW\,VL'@V]U$D:=9^*I9]35?#UU=$$0Q7YMWEP=@:LU.#HT,0
MI)X?%5I8>A537LZV(AR\]"E/X:E:'-'FI0;G'FC>*NC50FZ]3"J+>)H4O;U*
M*3]K3H6;]M.G\<:5HM^T:4+)ZZ,TY_B1\.[35O"^@77CWP7;:[XWMFO?!6BS
M^*=#AU;Q?9I"+EKOPOITE\+C7[9;<B4RV$<Z!"&SMYK94JKKXG"JE)XG!1<\
M1247[2A!-Q<ZU.W-2BFFG*:BDTU>Z,^>'U>EB^>/U2M-4Z=:Z]E.<G%1A"I\
M$IR<X)1BVVY127O*_'Z3\>/AMXB^*LGP>\*Z]9>+O%5AX=UKQ'XDE\+:IH&N
M:7X+31=4T?2?['\8R6.L/=Z#X@OKG6%:SLIK,F6/3KUW:/R5$DX6/US#8[&4
M)1>%P#PD75O^[K3Q<L9&%.A./-&I.BL%5EB(WC[*,J6LG.R>)E'!U<'AZSY<
M5C)5E"AJJT*="E2JSKU:<K.%!^WHTX3UYJE2*2M>2R]'_:;^!&K1_$*Z_P"%
MH^!M)TSX7^+8O!/B[6M=\7^%])T:PUV>VMY88O[0NM9$<<$EU-<6$<EQY'FW
MFEW]O$':TDPJ*]OA,MQE*TZ.;5*U+!\KO*O.A4=-QIQC?FE-<M:E!7G4PU6A
MB8Q]AB*,YN?N8S%X"S>)P%&E6Q$5&2]C&K>RE=+^&UR5I).G3K<V'E/V]*M2
MI]K\1OB;X<^&7@6]^(.L+?:KHUH^B0VEKX=6QOM2UN[\1ZKI^BZ'9:)'=7]K
M;7MU>ZAJEE'"INHU?S058\9:A/Z]@,O<)1Q./QM# PC*+7LZE:IR2J5E;FA1
MPT5.OB9*,I4J%*K/DDX<K491GA,7C:4E4P^"P6*Q\Y0?,I4,)AJF)E[-QO&4
MJD*?)15U&I5G3CS)2NN/T']I/X(:_!\1[V'XD^#=-TGX4>)X_"/C;6]:\5>&
M=,T;1]7EM[62/S]1FUCRK:T:[GFT])[DVZR7NFWUO%O>U?$Q<98+ 9A&<?JF
M9U:M'"SYE:M4I5'3Y8='*JE&M1A?VE7#5:&)C#V->C.8N9XS$9>J<_KF$H4\
M17I<DN>C"<)3DIJV]!1<<1*/-2HU5.A*I[:E6IT^ON/B]\)[+4;#1[OXH?#N
MTU?5$TZ33-*N/&OAJ#4=1CU>PN-5TE["QEU-9KQ+W2[2[O+<Q(XF@M99HMT<
M;,KE%PEB*<DXSPCKJO%JTJ+PL*=7$JJGK3>&IUJ-2NI\OL85:<ZG+&<6Y52F
MXT9QJ1<*ZHNE)27+46(JSH4'3:=IJM7I5*-%QNJE6G.G#FG"271:1XM\,^(O
M#D7B[PSKFF^*O#-Q:7-]9:UX3NH_%%AJ5M:&9)VTF;P^;L:O(LL$T0BL_/D>
M6,Q(K2?+2KJ6%ASU:<XKV<*J7))RE3J052G.$4N:4:E.49TW%-3A*,HMQ:9I
M22JU71IRA[2-65":E.$%3K0FZ=2G5E)QC2E3FG"JJCC[.49*?+9V\6'[3?@*
MZ\&Z/XOT/2/&/B&3Q/XQ\3> _!_A+3]+TS3_ !9XL\1^#Y-;3Q)!I=IXEUO2
M[&QL[!/#>O237FKZCID")ICDR S0"=5N;#T\+5E!RAB<N>;MP<)JAEB4)O&U
MI1FX*BZ5;#5(1IRJ5JGUK#TJ=*>(J>Q54X*=3'4O:1I?4,51P4I3YHJIC,1[
M)4L+2BX^TE6E4JNE*$H0]BZ.)JUO9X?#U:T?6_A]XYT#XF>"/"WQ \+274OA
M[Q=HEAKVD->VS6=X+._A6:..ZM7+>3<1Y*.H9UW(=CNN&;JQ>%J8+$5,-5<9
M2I\K4H-N,H3A&I3G'F49*,X2C)*48S2=IQC).*PIS<U43IRHU*-6M0J4Y\O-
M3K8>M.A6IR<)3A)TZM.<.:G.<)<O-"<HM2?85S&@4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'S_X<_P"3I_C)
M_P!D _9I_P#5B_M8T ?0% !0 4 % 'S_ /LG?\FL?LT_]D ^#?\ ZKKPY0!]
M ?I_2D[V=M'T=KZ]-+J_I=>H;?(^,/"?[/\ XB\(_%+X6-<'_A*O"_AC6_V@
M_B[XA\;2?8=&4_$[XIZY!!H.DVWALZQ=WQBL_"WB'Q1;)<EKF$1V$9DDCEFC
MC'1E\XX6E.%_8?V=P]E^1X6*5UBI5<;#&YMBG9-47+$8"A6<)/\ YCG3A.M[
M*K,69?[8YU6N>KF&>T\QJQC[D,-A,ORFME^7X>5W>NTJF&7/"WOX)U)4J4*D
M(1ZKXH_LYZK\0_%/Q1UVT^(,/A^Q^*7P8TKX.:C82^%+K5-1T2QL?$&LZI?:
MGHNLVOB[35BCU'3/$.J6<]G+8R.)DLKI+M4MI+6ZPPT:5&%:C7HPQ5"OG.4Y
MK5@U;VU'+?9*IE]9OGC4H8B--J$E&+H?6,5SPQ*J05+IJ8JNO[.JX2H\)C,K
MPN;T,/62C/V5?,J=)4L9"#2<:V$KX?#5FG.4:T*$*<?82O6/-O&/[$L'B+5=
M4UW2/B&^A7\OQ)T[QOH6FII/C'3_  YI6B:5\+])^%NG>$;Z#X>_%+PAKFHQ
M6>DV.H7%O=VGB'2H@VL7%O<V-U:M+%<ZTZEJF%J8B*Q6N</'1J7<<9_;&94<
M=6E[)MT%.%#"X7 2CBZ6.PU:A3J2GA>:=+V'+./^S_5:4Y86G0PN4X;#NDU"
MI2CE*QLX<U5+VC57%X^OC;T)X7$4<1&A.GB;TY.I[SXX^"D/B/1_@YHOAC5=
M)\&:?\'/''A3Q;I>D0^&7U+P[?V7A?1M3T2V\/II,&O:?+IL$4&I">SF6]G%
MK/8VKRPW:(T<A4K5:F;_ -K5).O6]AFE&U:\Y\^8X2IA56<UR)SI*HU-.'+6
MHSK4HJC*<*U)4Z=.&58K*Y4XM8IX*4IQO%*>#S'"YD_<DZDG&M6PL>=.I[1-
MJ3JRM)3\-E_9&\92>![_ ,'P_%W0M)FO?BA_PLS2[[0OA_XST^S^&E^R2RSR
M_!JSG^-]U?>!]:GU6ZU/4)I+_5_$.B/)K%_!_P (\+*[EM76$G'"5.'I6G4C
MD"J0C)R3K5<._9TJ>7^UG"<7EL,'&>">&Q-+%UGAZBA3Q5&.'PT:.E5JI4SR
M:IPC#.E34Z34O9.I3G.N\97C3G2<LQEBEAL2\5@Y8"+K82G7="6*JXC$UM6Q
M_9'U$>-+KQ'K7Q4FU;2)/B1\3?B9;6%OX/CTGQ-#KOQ#\ _\*_LI[KQ;!XED
MBN[WPYI,MVFG3IH]O$(9HH7MMUM'..94G_9=;+)5)14\GS7*(5*;Y/90S7.H
MYQ6Q"C/VC=5VEA:EYVJP<:D72:G"J.4XXRCBH2NHXW(\97IU/?5?^Q,L^H4Z
M#<?9\E"MB(4<P<5%N&(5:+=6-9.EG_#?]B^P\"67PVTZ^\5:-K\'P[\<:'XH
MDNY?#'C"[UGQ5H_@WPKXBT/P%X>UG5/'/Q8\5FP_L/6O$=SKD/\ 9$6GZ5%<
MQE-.T33?,:0>LLPD\52QDZ2C7IX?,8\M.4H4XX[,(X?#3QT'/VN)E*GEU*IE
MZ6+Q.+Q$J-2FOK:IX>%&7+]7MAL?A'4=>&.GA$ZF(_>U8X?#XZ&95J-H.EAX
MO%XNAAZU65##8>FYQKSJ4*M7$.I#VOXH_![5/'WC7P-XUTOQ/HFES^"O#?Q*
M\/KH7BCP?=>,/#^JGXA:+8:4+^YM+#Q=X?GB>R;3T62+[3(MU9WU]:J;66>.
M\MO'^KP?]KJI"%:GFV70RZ49QE[E-8ZABZNL9QYH5HT53G!<LU.-"M"K%4IT
MJWI1KQC2P%/EE"> S.AF<*E.:A/GH83&X2,4Y0FHRC''5*E*I:2A->_2JII1
MY73/V=-1M?V;/$'[/FH_$:]OCK6AZ_H%GXECTB_:Q\.:1JTLIT_PWHVA:_XI
MUC4IO"&F6+)IL&GZEXEU"Z-BIMSJ*CRVA[,97K8FIE>(4_:8S+:V7XB=;%I8
MAXZO@,52Q?/CE36&]LL1*E&G7:<*M6G[U:M5KRJUZO)@(QP53&."^KT<5]9C
M3IX%RPGU*&)PSP[> E)XCZK5I2E+%4G%.A0Q4G]6PU#"QHX6ES"?LKZXTMUJ
MM]\1]$N?$5Y\=_ /QGGN(?AQ+9>'CI_P^\*:/X5T?P$N@P^.C<)IEK%I;WEC
M>#5<VMQ)"TMO>"*47>M&O"AB,GK1A*2RRIGU6MS5$ZN+J9['&T:E>5104:>)
MH83%4\*JLJ=:%2&'3]E#FC&EC4H.M@<9@JKA:OEF39=0Y*?)##1R?&T,QB^1
M2<JM'$XRG6J5:#J0E&&)J4X5TE%G9?&?]GA_C!XIMM<E\<7GAG3Q\(_BE\)[
MVQT[27FU:.#XF#0#+XCT#7EUJV31M4LF\/P1ND^GZBES!<2Q*;9SYM<"I6IY
MQ2DHU(9I3RJ*4E)*$LKQU7&*%5PG"5;"8OVKI8JA"6'JR]G2G3Q4.64)>E3Q
M=2C+*'3]U97C:^+DK_Q?;8*>#CR.UZ.(PZJ3J8?$?O8PE.:E0FW&4/+M/_8\
MUG1M \(0:%\2/#^C^+_#*>.8KWQ/_P (+XR\3V^M2>+/!R>"]'UR:W^(7QH\
M1ZZGBOP[I5O:VUA>W/BB^M(K(W6GV^G6MO-#]CUS*^/6804Y8>&999B<OK1C
MR^[/%XS"XO%8FDXQIRYL5]4ITL6Z[Q&)Q"2J2Q:J+F?/@E2PCP/M*2Q/]F9A
MEV,PSD[.-++L/CJ%/"323I*FGF&)Q%)8:EAJ-'$N%3ZO4BIPJ:FA?LDZGH$V
MH6VF?$JS\/:%<? >W^!\>G>#_!NJZ'=:I#8^&(= TCQ3XR;4?B%JVD>(-3T:
MY?5[O2S8:%H5W!%K$MG=:A?0H&-9Q)YO3XIIU?W4>),5+$QI?'A\))U(IRA2
M?+-UIX.EA\!B*E&MA:6(P]&#GAU4IX>>'C*5_9=;A>N_]KK\/<DJU:I=8C'2
M4ZE:K3G4B[1PM;%5:F-]E7ABZM'%RE.AB:5.MBZ6)](U_P"!-_KGP4\ ?"T>
M*M&LM9^'4OPWU#2==C\(7TOA&_U;X97FF7VC+K'@-_&0N;SP]//I5L9M-_X2
M59055X[U)(T=>K'XZMBL]AGU"U#$QQ&*Q')5O6AS8W"8K"5[<CH-3IQQ=6KA
M)ZO#UH492590E&IR8#!4\%DU7)/:5'AZF%CA/:4I*E6]C3KTJL5*3552]M"C
M&AC5RQCBJ-7$04:,:R4/(-2_8GM]0T?6;-OB($UC5_AY\:_#(UI_"!E_LSQG
M\?O%$7B+Q_XWTNP_X2E%M+,6\(TNPT<2F6WM6?SM4NGDD:3"+H4Z?U6-#FP$
M(<.82%*<E*J\MR+%U\9B,)5K*$54GFM6M&6(K0I4J=&5*'L\-*FHTX^G#&8V
M.,PV85*T98NCB\9F%10I\E"6.J9?A<MRVM3I2E4G3AE='#U'"G.M6EB)5W*5
M6G.'/+M?"7[*NF>$OC5J'Q47Q''KVCW<>B7=AX4\06OC.[G\,:_X>\(Z?X+T
MO4?"[P?$B#PE86\&CV,RQO<^!;W5X?[7U"*'6DM;G[.FU'%2I+,>:"E7QN*Q
MV*C6C_%C+,:[K8J%2=55FXR@UA_]D^I*="CAH8B-=T(R?#*@OJV5X6$N2EE^
M#P."J0VI5J67.<\.XPINFXM5Y1Q+A7GBJ4<0I5J5.E4J.:F\;_LW3^(_B)KO
MCS_A)H[O0M7U[X=>/-3\%G06/B74O%GP?1KGP1I6D>/;GQ1%:Z#X.?5(X;NZ
MTE]"F>2ZFN98]0MDNYT?S:53%Y;A\34PB>*Q.&JYMCLOIIQI?[;FF4/**JQ$
MY\T:\(8?3"J^'=";C[6I6HTXT5U8FEA\P=&A6E]4A7PN$RS&5E'VG^P8;-:F
M:7HPC&,J5>I5JSIXFJY5_:X:,(TJ5'$16(-;X4?"/7=/_9?L/A9XB:3P;XQ\
M4^!_$T?B^XLIK/6;C0/&GQ$_M?5O%%W!/;W4EIJ4]IKVOWSAH;AH9#"/+D$9
M5AOQ!@\-C,+_ &/A,7[; X3 8'+*%>5.253#X#"8?"1E*DW2FHUHT+SBY0G:
M<O>C+57E6+>#S:MG-3"-3KYOC,S>'G44GRUL?5Q%&BZD>:/[N@Z5)-)I*"O%
MV:/.Y/V.I-0L(+;7/'^F7%U!H/[/'@^.72? MUIEC;>#/@5XGB\67WA[3["^
M\<ZD]E%XIU6)3<2_:I/LJ10!X[TP MZ;S'FS6>:SH*52MGN)SRK%R5YU9Y6L
M#@:'M.2ZIY=BW5S"BW&7-*M.CRPDW7?F4,)/#973RFE7_P!FP^28K)J'-!/V
M?U[$3^O8V2NN>OBLO6&P-57BN:@Z\6H5?JU/NO@]^S1:?"CXA^.?'$WB5/&
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M%$2;7YQ#I_A>V^SZE%,B_O[B$B."T+^8NDJM:6'Y)U.?&1P7$-&.)DKS^O\
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M * "@ H * "@ H * "@ H * "@ H * "@#Y_\.?\G3_&3_L@'[-/_JQ?VL:
M/H"@ H * "@#Y_\ V3O^36/V:?\ L@'P;_\ 5=>'* /H"@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M_DZ?XR?]D _9I_\ 5B_M8T ?0% !0 4 % 'S_P#LG?\ )K'[-/\ V0#X-_\
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MZ'-=W<&J6$*?9&C2W87-P\_6\5-9@LRHTZ6'K59Q]K2C37U:C2HX''X7"8?
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M3P9X[\$+X;T/39)?$GQ!M-$B\2:2;3X>^#/^$@^+7B71OL^MPV=W:?V]XK\
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MX2K@<'[2GSJKBL%@/[1S+,H0C&G-T*.%HXBE+ZPJ?*6G[3GQJUF*V\/:-?\
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M"PV-I3RC"RBDZD*F88R"S/&X=.-U1I8/*GBL-)U6JGU_+I7<755"3/'GQ_\
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M_4K4)QG[.NUC*N8UE-^T2R;$J%)1GS0L^(?BM\0/$%SX>T)]2?6/[/U;7/\
MA'KVPL]0T"?Q;HOCG6;OP'X"UJ]TC1]0B:\M4\#Z9\7O%-NMM-']HM_#VBW\
M0225)!RING"6*S##SHSAA)4\;AW&6D:4\5GV8)*W/ALQAD>693@YTY17U;'\
M0RP\XQ2]@M%&5*G4I8*M"5*.(A5P.(CRU*5\/A,ORW"TJZG>5;!U.*\WII8B
M,_8U<'D]>?MJ\+SG]!_ WXJ7OC^RM?&:_$/P9?>$(O L6O:_X&T?2Y+RX^';
M:@EOJ'AG2[_QM#J4\,^N66@6NI1ZS8WP^TFX^SW$5O90$+<]&8..6X;-<5CJ
MD<9]5:E+&8=I8:=:G2G6QT<,E%1Q&$:G1^K5J;NDN:HU[>%*E&'@J];!X+!4
MJN'G*K.C2PU=26)>&IU)86C4Q-*HE6PN*JUH1E[.LH**]OA[5ZN&J5SP/0/V
MC/& \4:"O]MZ!HND^)+P>,O%%G8:?'XG\0^'[:]L+[QW=V?CWPAK'BBT\0Z'
MH$/PCB\)6UOK?A6TU*TM]6O)I+J J?L3S&'U*%:AC7&,\JPF(55>T_V58RA3
M2S"%3&4X5:F&J0S^OBJ5#ZW2^K3P5"A"E5D\11Y-)KZS4Y\$O:QS'$TZ>$G"
M?[RO0K5U@<HQ&&I5HTJ.)PU;"X>&-Q<*%6.)M6Q$N2BL)7Q-2_X2_:K\4'5=
M-?QSXR\"Z)HNH>,].TK5]9\SPK<_#K3M*LO#.O\ CC6G\%_$33/%DJZVTVEV
M&DZ1_9FM6%AK-M=:BET]NL4T<(B/L\/24\5*5L-A<PQ%6$X.GB:T\!3PF#J4
M\/"FZM"O2GF69X2KAJF&JU4J.#S#"59U,13E*CGB*D)UJM/ 3<XU:N%IX2:A
M*5/V>-QE6MAWBW-TY8+$T\HRW,JF*C6_=>WQ&7SI1A3FHUJVG?M._%[Q5K%I
MH^CGPKX?U26\\-:EHVBZS#I<.J^(]*\;7'_"6Z7%=Z!>:U'KD'AO2OAM?:9#
M=ZUI>GW*_P!IVFL2S7%M!IDD+72I2PU2G_:%J?\ 9]2%'-:<9PFL-' X;#U,
M]Q$JE)R=&=*O5Q%++J=:-*E45'!RE/$_VE24%C9VI5I9?*G7CC,/B:V6585'
M-8B4\7C,OR>$+P@JD<94P,<;B5352M'#8U4Z4*7U65:M]4_!;QMX@\:V[>(?
M$OBO0)$\86E_XK\"^!-/TR#3M5TKX=2Z]>6OAGQ!JEQ-J,]YJ\VH:2=+EDG%
MO96\4EWY"QM(AD9JC/#T(4,1%RS*A2P53'JW)]3KXRE5K+!3I)RY)T7&KAG.
M<VZU3 UJE.-.//!.K.+QE54FJ>%C7QN&P]Y1J/%_V?/#X;$8JG4B^65%UO\
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MK]%&*;<*5.*]VE1I\TN2E34:<7*<E'GG.4NB:UM79'>V@9XO-\MFAC9H_/\
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M0)$"KM;JNT8(Q1U3ZQNT^J;NFUVNFT^]WW"VCCT:2:Z63NE;LFKI='J9.O\
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M1+Y=![>6M_GK=^NKU\V*D$$>/+AB3;RNR-%VX4KQM Q\I(X[$BC_ (;Y:?\
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M)3E)OJJ=.E%16T(0I4:5*$()0A3I0A%)12-G[!8^2+?[%:>0!@0?9X?) &<
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ME2C14,-&A[]6 @H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MDN=\3_M&>)? _P 0]8O]<MM,N_A+/\4-.^#6A+9P7#:X/$6E_#?Q-XVU[4[
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M4G.4NE/P)^"W]B6_AH_"GX?'0+346U>WTAO">B&PCU1[3^SY+_[.;/:UR^G
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ML59SJ1M.4I-\\U7I8KF:Q-!)4ZM_?@HTXTERRW5J4(4KIW]E&-/X(J*M:?\
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M.K0J\BC[\*.(A@L'EF#G%4OJT_;4<%1S%T\6JBGA<1G%25*G6A@J2J^HZ;\
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M7+'+E&%6E'%5*L>BU;]EGQ?-X8:*Q@\"?\);J/P\\;Z?XIU%;R\TV7Q+X_\
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MR? #_P 1I^(O_P!%C0 ?\(Y^U/\ ]%D^ '_B-/Q%_P#HL: #_A'/VI_^BR?
M#_Q&GXB__18T '_".?M3_P#19/@!_P"(T_$7_P"BQH /^$<_:G_Z+)\ /_$:
M?B+_ /18T '_  CG[4__ $63X ?^(T_$7_Z+&@ _X1S]J?\ Z+)\ /\ Q&GX
MB_\ T6- !_PCG[4__19/@!_XC3\1?_HL: #_ (1S]J?_ *+)\ /_ !&GXB__
M $6- !_PCG[4_P#T63X ?^(T_$7_ .BQH /^$<_:G_Z+)\ /_$:?B+_]%C0
M?\(Y^U/_ -%D^ '_ (C3\1?_ *+&@ _X1S]J?_HLGP _\1I^(O\ ]%C0 ?\
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MGP _\1I^(O\ ]%C0 ?\ ".?M3_\ 19/@!_XC3\1?_HL: #_A'/VI_P#HLGP
M_P#$:?B+_P#18T '_".?M3_]%D^ '_B-/Q%_^BQH /\ A'/VI_\ HLGP _\
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M@!_XC3\1?_HL: #_ (1S]J?_ *+)\ /_ !&GXB__ $6- !_PCG[4_P#T63X
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MR? #_P 1I^(O_P!%C0 ?\(Y^U/\ ]%D^ '_B-/Q%_P#HL: #_A'/VI_^BR?
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?/_AS_DZ?XR?]D _9I_\
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M='ZC6]DIUU%4#EK0E4R^O@*>&H4:,LHS+#0IJ_*\SS?%QCC,96FH)U%# 87
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M3%UU&+;<ZN/Q5=8%KV=.6!5&I4C&5J1]05RE!0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!\_\
MAS_DZ?XR?]D _9I_]6+^UC0!] 4 % !0 4 ?/_[)W_)K'[-/_9 /@W_ZKKPY
M0!] 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0!\_P#AS_DZ?XR?]D _9I_]6+^UC0!] 4 %
M !0 4 ?/_P"R=_R:Q^S3_P!D ^#?_JNO#E 'T!0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M'S_X<_Y.G^,G_9 /V:?_ %8O[6- 'T!0 4 % !0!^-OP$\ VMY\#/@O=MXW^
M.%HUU\)_AU<M:Z3^T5\?=#TJU,_@_1Y3;Z9HNC?$JUT_1]/C+;(;*QMK>VMX
MU2*"*.*-47ZO#9;@IX>A.5&\I4X2;YZBU<4V[*22U[:'S];'8JG6JPC5Y8PG
M))<L-$I-+[/1(]8_X5Q9_P#0_P#Q_P#_ !)[]H__ .>I6W]E8#_GQ_Y/4_\
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M*GXJ @^Q K9Y3@%I[#;_ *>5'^*GJ81S'%M)JJTFDU>$4_FG!-/NFDUU0?\
M"N+/_H?_ (__ /B3W[1__P ]2E_96 _Y\?\ D]3_ .3']?Q?_/W_ ,EA_P#(
MA_PKBS_Z'_X__P#B3W[1_P#\]2C^RL!_SX_\GJ?_ "8?7\7_ ,_?_)8?_(A_
MPKBS_P"A_P#C_P#^)/?M'_\ SU*/[*P'_/C_ ,GJ?_)A]?Q?_/W_ ,EA_P#(
MA_PKBS_Z'_X__P#B3W[1_P#\]2C^RL!_SX_\GJ?_ "8?7\7_ ,_?_)8?_(F-
M+X9\.6_B"Q\+2_$OX_KKVHZ3J6NV5A_PTM^TRWG:5I%WIECJ-U]I7XG&WC\F
MZUC34\J259'^T[D1ECD*$,JP$_K"A0O]45!U??J+E6)==4=YKFYWAJZ]V_+R
M>_R\T.9RQV,A"E4E5Y85JDJ4'RPUG""J2C91NK0:=VDGLFWH;/\ PKBS_P"A
M_P#C_P#^)/?M'_\ SU*/[*P'_/C_ ,GJ?_)B^OXO_G[_ .2P_P#D0_X5Q9_]
M#_\ '_\ \2>_:/\ _GJ4?V5@/^?'_D]3_P"3#Z_B_P#G[_Y+#_Y$/^%<6?\
MT/\ \?\ _P 2>_:/_P#GJ4?V5@/^?'_D]3_Y,/K^+_Y^_P#DL/\ Y$/^%<6?
M_0__ !__ /$GOVC_ /YZE']E8#_GQ_Y/4_\ DP^OXO\ Y^_^2P_^1,FV\*^'
MKO6=4\/VWQ+^/LFKZ+::7?:G9#]IK]I56M+763?+IDC2M\4!$_G'3;W"QR.R
MB'+A0Z;U#*\OG"I4A0YH4:TL/)\]3W:T*-"O*&L[W5+$T)W7NVJ))\RDDI9A
MBH3A3E62G.FJT8\M._LO:5*2G91T3J4JD%>S;A*VB-;_ (5Q9_\ 0_\ Q_\
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MHJDY+DAHJ^'HXJEKRV?-0KTIZ-\O-RRM.,HK8_X5Q9_]#_\ '_\ \2>_:/\
M_GJ57]E8#_GQ_P"3U/\ Y,KZ_B_^?O\ Y+#_ .1*=IX(TR\EOX8?'G[1B/IM
MW]BN#=_M&?M/V$3S&VMKO?83WWQ*BCU2T\JZB7[59/<0>:LT'F>=;S1Q"RK
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MLJ>)Y:5*I"%*-#!MSPTH8>I^]I2I4:<</'EKU(W/%'A6_O/&OB&.3P5XEO\
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M7> I9:F+6WMGC"MQS7"UE1="6%SC+IUJGLY>TG@%4P$:]2.+E:*PLHSKT:^
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MZ<5"$$HQC%)1C%*R22LDDE9):)$U(H* "@ H * "@ H * "@ H * "@ H *
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MI_?+_P"0#R_C;_T:[\8/_"M_9I_^B!H_MO"?\^ZO_@,/_E@?V7B/YZ?WR_\
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MNO"I2C*,8P4;223NI2?1M6LUU/3P6'GAJ4J<W%MR<ERWM:T5U2['W37 =84
M% !0!\__ +)W_)K'[-/_ &0#X-_^JZ\.4 ?0% !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M:Z/XZ\??%2QT_P 1G4?$4'B/0/@U<7.L7M]!J%K%'\./B)JOB+]G?P_:>"]
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M/>P>$H9IBL+A,+3E>G"K5K82>$Q%2-15<35I\M6A"G3HXRI4G]_'ZO3J2]W
M8? T*M:FKO,<7B<+#%UL5*E:4J%.A+$+!2IT%3IT*V#JRQ$HRJJE3X#XE?##
M7?B#\;+_ ,:77@KX<>*O#_PH\#:1'X6TCXF?"BX\8W^N>+KVXUWQ)>R?#;Q3
MJ'BG3=.\':G'/I_@^VGU9=)UQPZ"(?9V@??Y5*K7P&&SS-L+&4LR=1X?"0IQ
ME3Q,/[/P,:^&Q$*MY3GAJV+S3$0E1HTZ,L1+!2A]8YHTW1[ZD*&-JY/E-=RI
M8-*5;&5IM5<).CF&+I86MAYX964L5A\-E=2HJE64E0IYC3E[&K3JSA/C_"&O
M?M%^+;K2-)L_%_Q1LM#\6:UX8_M?QSXH^#6A>!=;\$7%MX>\<ZO\1M&\*^&/
M%/P\MQ:>$HM0L/!6E:/J'BJPUJ>2ZU.Y>/4]8@0;O7C1PCJ04:\EA<)/,,13
ME-Q^L9E@Z=/+\-@:>*Y8TX86O5QN-KXKV-*AA,6\)E]>-3#TX_OWR/$2A2C*
MKA>7,IQPE&KAZ<9U,OPV*EB85JJI5H5YUJU..7X7'4L7B?K-;!.OB<NC@Z\,
M15G1I>B_'?6/&^B^)_#%UX6T7Q3J]QX5\"^(=5M=<T[P/KWC&.RU/6/$W@?P
MIJ^O0V'A_1)+34_%.B^!;[QCJEKX?C>*ZU0RO#865TJ31Q\-%PGBLRJSG/+Z
M<HY=A'5HP=1QP6,Q.+Q6.AAZ<U5E4G'$97E-!UG3Q2P4<3'%XFE.C"4:G0J4
M?J^ H3A#%U*<\?C*<ZTXP_V[+LIKT<!1KJFZ,:=+,)YCB>>JIX:'-A?84JD*
ME>'+R&A>)?C-=S>"M!USQ9\:=+\)>(-:\4W&A?$5/@WHTOQ,URUL[GPP/".A
M_$G1;;X2W.A?"S3-02Y\6RS7VJ^$/#\@L['3(IKK3-0\_P"T[N\6N?#TXYC@
ML*JRP4*R>!QM2&*S7VD*^.52K3C46 P^4RE1PV.P\ZV+Q^(^J-QH/#T^&<JD
M(8N$93GA:^)C1CC5!_6<'#ZC@>:6'P3I*=:-3,:N.5/$5J&(HX;#X)+$4ZJQ
M='$P\VU+Q5\?_%GASQ[>WGB+]HWPI#=^$?!EMJ^F>'OA%IVD2>"O$_BGXCVN
MA^);3X2E?A'?>,/%:^%/"6F:Q+?ZFDOB%;^/5(=2T:6VCDM9('AZ%-/ Q^MJ
MI2K9IE$:.*J1]E6G2IT,1B<PGB<)*'L\'@<77G@\-AX9A!2PM2E4IYG5JX-8
MB>(]*O#V>,Q?U>I1E3PV%XGA&DTW2J5,)3H+(ZOM95%[6OB8RJU7]6J*E6G+
MDP].%>C*C3Z'7_%'QETR;7+#0I/BYI=Y?:_XYL;+Q5X?^!>E:KXO\8^)O!=A
MX1\/?#?2/$^JW/PQ_P"$=L?"/B&SAU?6;SQ5>V-I8[+G^S;+7-'.GBUBRI.I
MB(4'2I8?"8NISXJEA)2J4LNJU:^;9K#$_7ZDY2K8>&7Y=ALJH*G3KT,=F%.<
M<5A9X]1BZW+&-'#UE1Q&(KXG +^S\//'\KJ8S!X-Y7@<2XX;#PP\GB<16S/&
MYE*=1T*^%RVK0K4,5A*=3%*K0[S4M=_:!MO$4WB6\UWQ'I7AFS\6^(-(D\*Z
M/\,#XFTN+POH'PADN-1\475MIGA*^\6>(I+CXI60_L2ST6]MGNX;UX@NHB:"
M&SFI*E]7QDJ%2<9XC"YO4P[K49MX:=/.J>7Y334*2YGB*F&E''5I5HU*3P,J
ML_JT?82Q9>'DYQP='$X=TZ^&_L:G6E1JT^7&8BKA_P"T<TG*I5<J6'P=/"5*
MN71=.U2.:X3#05:+Q%3#UNCT;Q5\4]/_ &;+CQI)#\3_ !-\0[!)=;_LS6?"
M/A^+QYKUIIGB6)KO2]"\(6O@/P?Y-OJNA6ETNF6FL>'=(U>*#4H!J(@O8WDC
MWQL/8XC)Z6%IPG&I7RRG7BZT)/V>)Q%*&(^MXF$Y8:$J%.M+ZSB<-[+#4X47
M6]G2M4BHI6?]L.I67N8?,)8><:5:G1C6AE]2>%^KT*D98N48XJ,+4*LL9.I7
MYZ-+$8[#NC4J\!/X@^/^J^'_ !O9>.M#U-]-L?%.@>$+W28/AU:^)['Q%H_Q
M(\6^$KK67L=)A\,ZI+XE\)^"? 6JZAI$NH16=Q!?W,NI27[?\2J1HG@Z,(RR
M15L2G6GCO92JI*G9Y3BLPK+'35U]2IYQ/#X##X.565"6 IWQ?M+UJ&+3GB)Q
MGFM7"PJX2%' U\;A7&SKTW7RJA2P.%@_;257&83'/&8S,\/"%:=2<,+0P/M8
M3JX&7 S:-\9M:2\U2U\6_',7WA3Q#^T1\2+.ZUOX?:9)JGAC5M!^W>!/AEX'
M^&^FZU\*;73M8M-6\-Z_/>0R26/B*UFCBO&T]B\YN;;FPOUBG@,)7P]6,L9+
M)\OH)8KW*F*Q^=YC0QF*IYBVX3HX;*\1E=;#XR5..%KT<+C:,Z>(PV >#2UC
M'!SS*K@Y.K@\%5S>E&I2@IO!T<LRK 3I5,10J46X2^M5L3@,9@,-SXF%2K@[
MUJ%?,\+F/M?0IM3^-FI:]XEL[";Q7X,U)-2\03^*?%NA?"33Y=1O?#7@3X4>
M%[?1M#\+ZUXB\"W6F^(M2U;XA^*-6U72YVC\0QHEEJ>GQ1-]FN+.WK%R4,%C
M<3@*35*%+.<11PSG&-2MF3SQ8/*XSI/WW3GDN6TUBJW+"I4P]7#2]LO]FQ%'
M+ 4JE:661QD:%+%R>0X'$8B4M\-7R_'YAF&*DU:-)87,,3+!1P_M(4,)7A'$
M5*3>)K4L5Z#\3+?QI>_"SX3?\)GIWB'Q#I\>I>$[SX^:5X*TG5[W7]5T:#PK
MJ,^K6]CX:\+0MJNKZ6?'*Z$^H:/I-M//=:?'>6J6EQ#+);2]&81RR&>UXJDZ
MV31EF$,-#V?UG#NM).G@GBZ;C5E5POLG6Y&XU(T\8\%6Q#5"G5JPC*JN+>1U
M:LW.AG%3#8.4;RITJ]-/%86>,A"I:A"&*CA/;0YX1HR?[WZM&G7="*\F\=WN
MI^%?#&C^&_V8O"'CGX->&]?\/:IK_AF#X6?LX1^'Y]1\?W.L66BI:^.= \<?
M"J?3_A[H5E9%=4OFUK1M)U+5H$5=,O5:Q>.YC#NM4S3"8?&U)2PF%KY-&$'6
MIO"K 8W&5WF<YU$VXRPM.5.:PN&K4,12JUZM;$0=.-:5%\V%PN"KXRC@U7J3
M68NO%1J4L74KX#"T:F!HT5R.3EF#A7PT,=7H8K"TXT:=."E5Q&&4^ROM=_:*
MLM;UCQ3I5QXDUO2[35?B[!H7PVO/!>C:7I=_H7@?PBVE>&KG4];/AQ=7;7/$
M'Q%T^"_TJ2#4[*UN=+UNY"6MXL<$UGA&I&.%FZT/8U<3E]?$.HHSQ"P-6KGU
M"."C3PU)QK8BMA\BQ%6IB\))U:M2IA(TH1I8ASK5^BEA7]>P&%JXF"PT,?E&
M&KUX3IKVM"ODTL3F.(J.490A2ACX+#1]DJ<<-B)WJUYTW'"0\N3Q]\>H[/Q!
M<GQ'^T;=^%]5UBTL])UY?V?- M/'UK?6?@8>)YK'P+X-F^$:MX:\+:UXAU:W
MT6+5OB%I&LC36\+W=M>7JW5_'=1SCHU*6%JTJ,'*O&&;8C!RC6ISK5X8>>78
M? X;,:L8+"495$LTQUL-3PV(Q%&6'HT'#$KZNXPL93K87$5ZE&-*O1RRGBJ/
M)55+!5<37S:GCJ]"#J?6Z\L-[#*Z,8.K6HT_K,\=557 IU$_PQK'QA\#W'PT
M\(:KK7Q2\*Z3X1D\%77C._LOAMH5UX"\0>&[GP3+\0OBGXX^)'C[7/ -Y%9:
MA=^+8/$7A^/2_#6JZ)?6-U)%=7<,B:E:;?4J_4:68XITG&>59:L?@Z>'E[50
MI83 82.6Y%0R]1<\7F&*KU'@\9&I"KB*$Z$:F!</K5";Q'-&C7Q67T9X1?5,
MQS98?,I4W&,\1#&9GQ#.>982NW"EA*:PN!K.4G+#8>HZDY8J"6'A.%#Z1^/'
MBSQ79^#?"4_P]U#XA:;J/B/Q'HHSX%^'=_X@\6W6A7-O)+<64,VO_#?Q7H/@
M"]8S6<K7OC72+&PVVL]C/>Z7-<B_L.2A2<,[P."Q%O8QJ5%73G!89*G.$'.O
MB4U3GAZ;;=2AAL7A\97I<U3 3KU*/U7$:QQ-'^R<=CJ=)UY_5XSPJM451U&U
M548X=6KN=:C3J4:<Y4I4:%>K2EB8Q@[G@FOZ_P#&#P_K7Q+NK7Q;^T?+IVN?
M$C7=*M[?1OA/I_BR_P#"NG^&O!UI-X5L?AC%>?""XT>+3O%6JI,+GQ)J">(-
M!M%M$MKF6TUB]N+P^=[6O_95&-*C*6+=#.L9"3<8U9XRAFBHX3 5G5C:C@?[
M,4<53C*G3Q&*G&<<!B:CDJ53KC&/UVU5TXT*"R;"-ZN'U3%X!UL5F,HT)1=?
M,,/FDIX6K"E.4,/"K&MBZ"P&&HPH<YX@UG]IKPU::[KMAXF^+>O^,+#X<_!3
M0=5T>^\$/'X)AN-9M)[[XC?$+PU'X._9]\3M?>-[.^:2R73M'TCQ+):S3O)J
M7A^XTV&PAM?2QDL/2Q>9TL-!_P!GU>(,5AXUE*4ZN'R_#973J8">"BZ=>4J&
M-Q[JT\16J4Z^'Y.6$L7@ZW^TTN/#5*M?#Y=6J4(T*D<L6.IX>HU)SQ.)S6I2
MQ6!S&I&>"3J8#+%AJE!0GA*]65.=3#8:K*KB\/BO</&=K\3Y_@C\,M,OOB%\
M3K7Q9K'C/P'!XG\?_#CP1Y?C&WT*[UTZA--J_AJ3X7W+Z=&NG1V-CJ-PWA'0
M[=9BTVH66G:;)>6*W5C2CQ!D]*$%'#49U%B(QG#ZG6KX?*\1*+JU'6Q$*6$Q
M694J5H/'2A&E6]BL54J*E-Y8:K6CE&;8F48U:\J;E1A4A45>CA\3F.'I5(T8
M*GAZM7%X3+:U?V<XX6%>4J/MJ5&GB%"I#R^>3]H?PA-X_P#'7@RV\1ZIJ?C*
MY^,?B6+P-K/A.)- B/A:Z\(_#[X>:UJVH67@Z?Q"_BF]T32(M8@TK3Y1#=:=
M#/';:+=W,(N)N%5:U++<%2G:=)8;!5ZLH\\:V!J9SG<\RKT<+3C2Q%2I++\M
MQ>,P^.^L8?,*V'Q>&P?[FG&4L-7[)4XU,56J4L1*<J&(^J4%6C;ZS2R[(<32
MJ*?/5H8>CA<1Q!0I5,-5HU<OI8FGCZ^(C6<*KJX?NH/'/Q2\'_LL>*?&WBKQ
MAK>H^/;^VNHO!^J:G\/=8/B?0=5\37EAX;\+:=>>#6^$/@74_%E]9^);\200
MCX=:-=7L$EM;_P!GW,O[^\Z\9[&E6R/"THRE*OB,#3Q-2C#V\JE"IC/;8FK[
M"C5Q+A/#Y4Y+$1C.%JF'JUO98-R=&CGELJE6MFF+JX:->AA*>-Q5/!RJ3PD.
M7 8&526'^M5H0G"CB<10FZ=:7MG1IUU%8C%*$:L\3PYJW[1NO:E)'8^)?B,W
MA.!O&_C?0]:\2_#;PIX,\5>*M+TC2/ <?ACP!JFDZ[X M4\(6FJ^,;SQJD$-
M_I=GXA31=.C-Q.+F2/48\<3S87 XG%TZ4:F,R[ SY,$YJLL7B<7CL?+!5:U7
M#SBJM3"9=@J?UJA@)T(>TS#"*K&A74J4JP[PU2O@L+.K6A]<KT*6)Q+HNG2P
MT*.%JT\RJX123E3INOB\NG@OK\:\JN)PF92H_6<NIQ4J.@_$']H*P\,ZKXQM
MH?BI\1[*#6?A6R>'M?\ A-I_P[\37NM:_K6IZ+\2/"OACPUJ/A#1M4L/AOHJ
M7_AN\BUK6EOKN.*PU&X_MS4+.,RUT5:5/GP%#!SC*%?'9CAZ-?$U%%SP3RF;
MR['YG[.--86,,UY93IT\/AL3["G*E/!5*DZ,<1DI5*M*O*I36$QN&P5/$8NC
M2Y98:G5P^-PM;$83*ZDZM5X[&ULMI8^@D\16P5;$U\"L+B:$Y8CZKT32_&Z3
MQH?#0U'6++Q)+J7@'PWXA^)EA\*M/.F6GA6#P=XP\=>+M0\,Z]?^$9-/U"QF
M\3W-IX;T^RN[[4_[.N+2VFNH'N;Z7^U^91I2IXRI1G5H87#5<SJS?+".-QM'
M 9=EF!RZE*FZ;I2Q57'X[%9M"I1P]2C.FL;A</\ NJ%7#X=U93A*BY6E4Q.'
MPD\)AK3Q&'P.)QF>8RKCZ-;$0]@XT:62Y?AL)4JRE0J59?4:]2$*N(HU8YGA
M_P 8?'R6VB76+WXFCQ=X<^%'_"5^%/"H^&&G67AWXM:_-H>IWJV'Q2\=?\*W
METOPEXB@U#^R+!O#^BZAX)N_M,-U.MO-:W,4%HL3*M'#YM5I4L/',,-[##NB
MI598"CSX++U5QV"<74Q>/4,?5S"4:=&OC7'#8:E">&E*7M:W5AZ-%9A@\'B<
M3;*L1CJR^O0BGBE2IYMF$(4:L/X6'H2RFEE]1XBMA*3JU<3/V6)C.$J=/L/@
MWXD^.4OP6\=>-?%4^I>,?'<EMX@U7P=X.UOPKK?A:\T[5--TB3[/X7C'B'X0
M_"[4]1T:ZUJ!6M'O/# GCBNS =8U8(EZVV91I8?!X>&%J-S=F\5[/ZQ5CAZD
MZ<?:UL+1JMU\3A8^WJ.%*CET\535&FL!AJC<JF.5P^L9K"EF$UA,*YX>E7A%
MI4J53GG+$3H57[2*H.G4HTX_[5F$*<Z52I]<J*?LZ7%^#]4_: \8ZEH>CZ=X
M]^*UAX1USQ(-1U#X@^+_ (-^&_ OB_3M+TSP?KO_  E/A[2/"WBGX:64/A[0
M6\8WWA%-%N/$FB7NIS+8:J3=:K:(MQ)T48X>G74:]/FHX.&-KT4ZT9O'T(5L
MEAE\,=4HN,:>(K>WSB6(HX2&!K+"8:E>AA*\O;+C]KBHTZMZ,)5L73RZA)1Y
MHT\MQ=6>9XK'U<-&3G+%4*6$P>"P4)U:N*H1Q>/C4=:KR*B_NE05 !)8J "S
M8!) P20H R>O  ] *XV]7IR^2O9>6MWIYMLZ8IQC&+DY.*2<G9-V5KOE48IO
M=\L4K[)+06D,* "@ H ^?_#G_)T_QD_[(!^S3_ZL7]K&@#Z H * "@ H ^?_
M -D[_DUC]FG_ +(!\&__ %77AR@#W/4=2T[2+*?4=6O[+2]/M55KF_U&Z@LK
M*W5G6)&GNKF1(H5,CH@+,,LX Y(H7Q4X+XZU2G2IQZSJU9QITJ4%O*I4J2C3
MIPC>4YRC&*<FD)M0A4J2:C3H4ZE6I)Z1ITJ4)5*M2;>D:=.G&52I-VC"$92D
MU%-EVC;RL,I:CJ$&E6-SJ%S'>R06D?FRQZ;INHZQ?,H(7%MIFD6MS>7DF2/W
M=O!*^,G;@' M9TH;.K4ITHWTBI59QIQ<Y.T:=-2DG4K5'&E1@I5:LX4H3G%2
MDH4ZM1W<:-.I4DHIRERTH2J24(13G4J.,6J=*G&56K/EITH3J2C%I8:GINJ1
MSRZ9J%EJ,5K>WFFW,EA=07<=OJ&G7$EGJ%A.]O(XAO;6[BE@F@<AXI(G1U5E
M( O@IS6L*D>:$E\,XW<>:+VE'FC)75U=-;IE23A.5.2<9PY.:+5I1]I3A6I\
MT79QYZ52G5A=+FISA-7C*+=Z@04 4;S4]-T^2PBO]0L;&75+T:;ID5Y=P6TF
MHZ@UO<7:V%@DTBF[O3:6=W,((@[^7:S/MVQL5%\7(M9\LYJ*WY*:YIRMORPC
MK-[16KLAV:A.I9JG2Y.>7V8<]2%&GS/://5J4Z4+M<U2<(*\I13R/#.H>&-?
MM)?%/AA;.>#7)I8[C5[?3WL;C59-$N+C1@]S)/;0SWD<$EG/#!+(&1HD5H&:
M%T9B"4:-&5.T:.,IT<=3Y;)3CC,-AZM*NXK:I5PWU?FYTJL8PA3J*,J?)&.9
M2J5EJZN$J5L#/F34H2P>*Q%*K03DDW"EBGB>7EO2<YU*E-R51SETM!12U'4(
M-*L;G4+F.]D@M(_-ECTW3=1UB^900N+;3-(M;F\O),D?N[>"5\9.W .!:SI0
MV=6I3I1OI%2JSC3BYR=HTZ:E).I6J.-*C!2JU9PI0G.*E)0IU:CNXT:=2I)1
M3E+EI0E4DH0BG.I4<8M4Z5.,JM6?+3I0G4E&+NT;?(?X&!XG\*>%_&VB7OAG
MQGX;T#Q=X<U$1+J/A_Q/H^G:_HE^MO-'<P"]TK5;>>UNA'<0Q2H)8FVO$CC#
M*",YTJ53D]I3C/V4E.'-%/DG&ZC.-T^644VE)6:N[/4NG5J47)TJDJ3E&4).
M$G&\)KEG!V:O&46U*+T:T::'>'8_#5EIRZ)X330K32/#;_V FD>'5T^#3M!D
MT^*(#15L--"PZ6]M!)!_H8CB,:21_(H89WG5J8BV*J595WB'-JK*3G[5TZDZ
M%1JHV^=PK4JE&;N^6I3G3E:4))<]*G1PZ>%HTX4%AN6+I0C&"I>TIPKP3IQ2
MY.>E5IUHJRYJ=2%17C.+<MRWA_7EUKPS>-H^LHMFMGXB\/W)LM14:?K-O,B6
MNM:5+Y@%G?6BW"B*YBV3QB0 ,H:HC[R]K#WHT:W(IK50Q%%4:ZCS+X:U*-6A
M6Y;J<%4HU+)3@WO"K/#UJ;IU'0Q$(PKP<9.%2,'4J0IUH6:DHNK0JPA46CJ4
M:D8OFIR2LW5_IFDI9K?7MAID=U=VNEV"W5S;V27%]='RK+3K,3.@FNYF79%;
MQY=R,(IQ3YG.I&%^:M6]HXQO><W3ISKU6E\4N2C3JUJC5^6G3G4E:,)-9I0H
M4KI1HT*"IQOI"%-3J4Z%*/2,5*K4I4::TYJDZ=.-Y2BG4T/Q#HWB6WOKK0[Y
M+^WTW6=8\/WDT<5Q''#K&@:A/I6L6:M/$GG-:ZC;7%N\D>^,O X5VVG"2;I4
M*R35/$0]I3;37-3YY04U%VDHR<&X-I*<.6I#FISA*6DXRI5JN'J1<*M#V3G%
MK95\/1Q5+79\U#$4JFC=N?EE:<91CM4$A0 4 8NK_P#".WCZ?HFO?V+=2:C=
MQ7>E:1J_V&=[^_T":'6H+G3["\W&ZN].N+.WOTDAC9[9[6.<%&C5U<&U57LG
M:O0A*LN5^_3IIPP\ZJM[T8*6)A0E4TC>O"FW>JHR'/V47>7LX5^;#/7EC4=:
MC6<\/T4_:X>G7<J6O/1IUFXN$9VVJ0''>.?'OAKX<Z&OB#Q3/JL5A)J.GZ1:
MP:%X9\3>,-;O]4U6X6UL+#2O#7@[1]4UC5;N65O]79V,[*B22.%CC=UAU(QJ
MT*'O2JXF52-*$82FY.E0JXFH[13Y8TZ%"K5G.5H1A!MR6EZ47[.K5O&%.@H2
MG*<X0C'VE:EAZ:O.44Y5*]:E2IPC><ZE2,8Q;9MZ%K5GXBT?3M<T^'5K>RU.
MVCN[:#7=!UWPOK$44F=J:CX>\3:=8:KI%R,?-;7]G;3)_%&,UO4IRHS<).+:
M47>$X5(VE%27OTY2BVDTI).\97C)*46EE3G&I'FBI)*4HVE"<'>$G!^[.,6X
MMQ;C)+EG&TX.4)1DTUW7=)\,Z1?Z[KEXEAI6F0^?>73QS3;$W+&BQP6T<DUS
M/)*\<<<,,<DDDDB1QHSNJG%RC&5*,I*+K5:5&',TDZE:I&E2BV[**E.<4Y2:
MC%-RG*,4VM$GRU))>[1IU*LW_+3HTY5:LWY0IPE.7E%GEMU^T)\)K+7="\.R
M^(-5:]\0VOAZ]T^]MO!'CR]\-6]KXMU2]T3PI+KGC&S\,RZ#X8&M:KI]S;:<
MNLZE8-?.(_LHE$\)EVH4:N(JRHTJ<E4C[MIQ=*]3ZI3QTL/!U>13Q5/"5:=:
MMA(.6)H1DE6I0EH*K^XISJST5/ZSSQC[]2$,)6EA\17G1AS5886G5A./UJ4%
MAI*G5E"K*%.<H^H:]X@T?PQIQU;7+P6&GK>Z5IHG,-Q<%K[6]4L]%TFUC@M(
M9999KG5-0L[9%1&^>=<X&2,XIRJT:,$Y5*]2-.G%)MN33?32,8QC*=2<K0I4
MXSJ5)1A"4E2C+DK32;CAJ-;$5&M>6CAJ4Z]:=EK+DI4YRY8IRE;EA&4FHNYJ
M&IZ;I%L;W5=0LM+LUGM+4W>H7<%E;"YO[N&PL;<SW,B()[B^N;>WACW;I)9X
MXT!=U!%K.G36LZLE"$5\4YN]HQ6\I.SM%7;L]!).TY)/EI0G5F^D*=*$JE2I
M)[1A3IQE.<W:,(1E*344V%GJ$%\UZD$=ZAT^]DT^?[9IFI:<KSQ103-)9/J%
MI"NI612XC"WEF9[9W62-93)#(J"UA3J;1J<_*GI)>SJU*,N>#M.G>=*3ASQC
M[2DZ=>GS4*M*I..9<]2GJI47!2=GR^_2IUH\D[<E1*%2*FZ<I*G552A4<:U*
MK3A=H*,2;Q'HUOXBT_PG+>!?$&J:/JVOV.G""Z<RZ1HEYI%AJ=X]S' ;>W6*
M[UW2XPDTL<DIN6,22+#,8JA&52.)E!7CA/J_M7=+D^M?6%A][7]I]4Q%N6]O
M92YK:7)6IQHN4HQ]O.<*<7)<TY4X*=3EA?G<:<90]I44>2$JE*$Y*=6E&=ZS
MU""^:]2".]0Z?>R:?/\ ;-,U+3E>>**"9I+)]0M(5U*R*7$86\LS/;.ZR1K*
M9(9%25K"G4VC4Y^5/22]G5J49<\':=.\Z4G#GC'VE)TZ]/FH5:52<\RYZE/5
M2HN"D[/E]^E3K1Y)VY*B4*D5-TY25.JJE"HXUJ56G!+K4]-L;C3K.]U"QL[O
M6+J2RTBUNKNWM[C5+R"SN=1FM-.@ED5[VZCT^RO+EHH5=UAM)I2 D3LKBG*4
MH03E*%.5644KN-*$Z=.51I:JG&I5I0E-^ZIU:<6U*<4Z?NQYW[L%*,.9Z1YY
MWY(WVYI<KY8[RL[)V9>Z?A_2EM\@*6G:A!J=HEY;1WL4+R7$2IJ.F:CI%V&M
M;F6TD+V&K6EM<QQM+ [1R-"J31F.:%GAEC=RWNTY;*K3IU8KJHU:<:D5./Q4
MZBC)*I1J*-6C44J5:$*L)PC*DFZB5U[*I4I.Z:7-2J2I2<6TE.FY0;IU8<U*
MM3<:M&<Z4X3E=H**5]IVGZE'##J5A9W\5M>6>H6\5]:P74=OJ&G7,=YI]]"D
MZ,(KRUNX8IX9E >*2)'1E900XMPG"I!\M2GS\DEI*/M*52A4Y9+6/M*-6K1G
M9KFI5*E.5X3DFI1C.$J4XJ5.7)S0DKQ?LZD*L+Q>CY*M.G4A=>[4A":M**:Y
M/0/$O@<>(=<\#>&S;6VM:/<WVJZ[IFFZ'>V-E;WVJ2V6LZA>W-_%IT>GS:A?
M77B".ZD=;AYKB>:]8[YK6[\AT[U:'M:;YJ&&]G1CK90BIXFA"%.,FFZ<)X/$
M4OW:<*;I.+Y>:"E5:3A6IJM*]?%0YT[\\G&A3H4TJDES<DJ=">%4*=5QFL//
M#2C'V,Z3>KXJ\7^&_!&E'6_%.JP:/I:W,%I]JG2XE'GW!;RT$5K#+(55$EED
M<(5BA@EFE9(H7=,G.,9TZ6KJ5O:>SA%.4YNE1J8B<81BG*4_94IN$(ISJ24:
M=-2JSA"50I3J7Y(W472BW=))UJU/#TKMM)<U:M2IIMI<TU=I:GGW_"_OA:GB
MN3P;+K.N6NJP:GH^AW&H7O@+X@V/@ZUU_7['2]0T;PW>?$*\\+1>%K/Q+=VV
MMZ2(M(FUE+YI=0@@^S^>XCKHHT:E:I*E2@W.,L3&"=H>W>#G5IXKZJY.*QBH
M3H5U.6%=:*]A7:;C1JN&,JD(4J5:_-3J4:>(?(G.5&A5@ZE.KBX04IX*$J:4
M[XN-"T)TI.T:M)S[KPWXW\,>+;K6[/P[J$E_-X=OI=-U<_V;JEI;VU]!>ZAI
M\MM%>7UE#!>R+<Z9=9^RRS#RS!/GR;NWDGS@N?#TL5"SH5FE"5TF[T:&(B^1
MVFHRH8FA4A-Q49*=HMN,U&Y_NJ\L+/2M"$:CBO>2C*=2FO?C>'-&I1JTJD.;
MGI5:52E5C"I3G%=/++';Q232NL4,$;RRR,=JQQQJ7=V/95522?:LJU:GAJ-6
MO6E[.C0A*I.3O:,(1<I2:5W[L4WHF]"Z<)U)PI4XN4YR48Q6[DW:*7FVTD>+
M_#[XR_"+Q]?W]UX,EU*+6-6T:+Q(S:S\-_'7@;6?&'AW3HK>"W\0>'X_&'A/
M2;OQ[HEM%?V4,=_I"ZG;H-0MHTD'VJ)9-Y4:F&PV+JNC4I4\)5Y\315.:Q%&
MO5I1BI5\'&/UFG6K4\*J4?:454JO"^PCS3P[A#/W9XFG34H3G*V&IXA2C+#3
M5.I7FJ%+')O"5(TYSQ%;DIUY1A&I4Q%E"JZDO8[.ZBOK.UO8%N4AN[:"ZA2\
ML[O3KM(KB)98UNM/U""&ZL;D(X#V]S#%-$P9)$1U905*<J-2I2DXN5*4HMPG
M"I"\6T^6I3E*G.-U[LX2E"2LXR::9%*I&M2IU8*4858QG%3A.E-*232G3JQA
M4IR2?O0J0C.+O&45)-"7U]9:797>I:E>6NG:=I]M/>W]_?7$-I96-G:Q-/<W
M=W=7#I%;6T,*/))+(RHBHS,0 36<I1@KRDHJZ5VTE=M)*[ZMM)+JVDM3>G3J
M5:D*5*$JE2I)1A"$7*4I-VC&,8IN4F]$DFV]$3Q2QS1QS0R)+#*B2Q2Q.KQR
M1NH:.2-T)5T92"&!((((JY1E3E*$XN$X-QE%IIQ:=FFG9IIJS3U3,H3A4A&I
M3DITYI2C*+3C*+5XRBU=-----:-:H?4[>5BCR'4OCO\ "O2K>^GF\2SW;6&L
M/X>^P:'X;\5>(]:U+7XIM9AET3PYH'A[0[W4O%6K1CP_J\[VFC6E_,EM:?:V
M06LL4TDQESTZ-6G&=6%=<T%3A.I+V:I86NZTH0C*<,.J.-PDWB9QC02KT[U$
MW8MP<9UJ<G&#PT82J.4X1A#VE2=&$/:2DJ;JRKTJN'5%2=5XFE5P_)[>E.G%
M$^+/PFU*P\*>+O[22?\ M35;_P />&Y[KPIXA3Q)IVMNZ6&K:'=:-=Z$NM>%
M-5%TMO875GJ-I83+<RVUG,@N)H8GVC1DL53I4G"=?%8>4J<Z-2G4A6POUK#T
MZCAB*4I4JE".)]A*LU4=.G["=>KRT\)6J4<9S4:->56,XT\!6O4A.G-2I5X8
M+$8B+]C**J>U>!^L5*3C!RJ4*DE2<HUXJ?K]9EGG'BOXK>#O!GB/0O"6KGQ7
M=^(?$,#7>G:=X4^'?Q#\=FWL$OK;36U+7+GP/X6U:W\,:6+V[AB^VZS-86YQ
M*PDVP2M&4/\ :<14PM%KVE!4'4<FJ=*G]8==4/:5ZG)0@ZOU;$.,95$[4INR
M2N*LUAZ$:]1\L)^VY(Q]^K4^K1HRK^RH0YJ]14EB*"E[.G+WJU."O*<4_1Z!
MA0!1NM3TVPN-.M+W4+&SNM7N9;+2;6ZNX+>XU2\@L[G49K33H)9%>^NH]/LK
MRY:*%7=8;2:4@)$S**[YU%.3I4Y5I1BG*4:4)4Z<JCC%.7)&=6E!RM93JTX7
MYIQ3'[L>=^[!2C#F>D>>=^2-WIS2Y7RJ]W9VO9BZ=?P:G8VVH6L=[%!=Q"6*
M/4=-U'2+Y$)( N=,U:UMKRREXYCN((G'&5Y%.UE%])1A-=[3BII-;QDDTI0E
M:<)7A.,9QE%#7+*I#K2G.F[:KFISE"3C)7C.#E%N%2#E3JPY:E.<Z<HR=J22
M."-Y972**%&DDDD94CCC12SN[L0$15!))(  )-9SG"C"=6I-4Z=*+E*4FE&,
M8J\I2;LDHI7;>B2*C&4Y1A"+E.348Q2;;;=DDEJVWHDM6SR/PQ\>/A;XOU*?
M3-#\0WS21Z7>:Y9:AJOA3QCX=\/>(]$TY4?4-:\%^*O$6@6.C>.](M8I89)K
MWP[?ZI!%'<0R22*DR,]5'[##8G%5[X>G@H2JUX5DZ6(H4HM)UJN%J<N*IT6V
MHQK3HJG.3482E)I#<)*O1PT5[2I7K?5J;IVJ4Y8E*4GAU5I\U+ZQ%0J<U%S5
M6/LJJ<4Z5119X:^/'PY\7ZEI^D^'9?&M_>:C:6E_%GX4?%>SM+2QO[]]/TR]
MUC4;_P %06F@6E\\4ES9S:G/:)=V*'4K9I=/'VFMUAZO-5@XJG*A)0J*I*-+
MV=7ZL\7+#S]HX\F*I4.1U\+*V(H5*V'P]:E3Q&)P]*KSSKT:<83]I&K&IR<G
ML7[?GISJJA"O35#VCGA)U>:,<9!2PLO98B2K..&Q$J?L58FH4 ><>)?BW\//
M"%UKUCX@\11V-WX7\.WOBO7K>+3M8U"33M TZS>_O+Z4:;I]QYC16JQ,;>+?
M<$WMBBQ&2_M5N(C-3A4G2C.LJ-:&&:IPG4G]8J3PE.E0A3IQE.I6K3QV&C1I
M4XRG6<JGLHS^KXCV6BI3YZ%-\L'7LX.<HTX*#CBY^UJ5)N-.C1C' 8MSKU90
MHT_8RYYQ;AS86E?'WX6:Q86U_:ZYK%L;GQ%_PB?]DZUX'\>>'?$]GXA-M9WD
M.F:MX0\0>&;+7-$DGMM2TN2WDU#3[:*X&K6'D/(;ZW$W2J%1U,-2BHRGBZ<Z
ME+DG":<*6)IX2M>49.,)8>O4C'$0J.,\/"-6M6C"C1K5(82J1A3JU9*<:=&,
M9MNG-<U.6'Q&)A4I+EO7A.CA,2Z<Z*J1G*A4I0<JL7 ]DK$L\L\=_&CX=_#3
M5]*T3QAJNK6%[JUH^HI)I_@[QKXCTO2M*CO[72WUCQ5KOAKP]J&F^"]$6^O8
M(?[1U^[TVUSYA\[;#*8WAE];Q3P5"TL1&6&ARR:IP]IC)5X82BJM1QI.OBIX
M>M##T%/VU:<.2G"4I14E7E'"X?ZU5?+1Y<1-6]^I[/!PI5,555*'-5=+#4ZU
M*=>JH.G2C4BYR5SU,$8&.G48Z8[8I6MIM;H"::3BTTU=-;6Z--= H&% %*PU
M/3=4CGETS4++48K6]O--N9;"[@NX[?4=.N)+/4+"=[>1Q#>VMW%+!- Q#Q21
M,CJK*0!:PIS6L*L>:$E\,XW<>:+VE'FC)75U=-;ICDG"<J<DXU*?)S1>DH^T
MIPJT^:+UCSTJE.K"Z7-3G":O&46[M @H * "@ H * "@ H HW^F:;JL4,&J:
M?8ZE#;7MCJ5O#?VEO>16^HZ9=17VFW\,=Q&ZQ7MI>P0W$$Z@/%+"DD;*Z AQ
M;A.%6#<:E+GY)K24/:4JE"IRR6L?:4:M6C.S7-2J5*<KPG)-2C&<)TII2ISY
M>:$E>,N2<:D.:+T?+4A"I&Z]V<(R5I135ZD,* "@ H * "@ H * "@ H * /
MG_PY_P G3_&3_L@'[-/_ *L7]K&@#Z H * "@ H ^?\ ]D[_ )-8_9I_[(!\
M&_\ U77AR@#8^/7PWF^*G@*+PE%X=\%>+(3XO\#:YJ/AWQ^PB\.:MI'ASQ7I
M.MZK83SGPMXA\F>>PL9X4SI4PD\YH7>%)FFC*,:<<PRK$5J<:F'PE>K.K=*5
M2FJF!Q>&IUJ$793JX>M7I5U2E4HQK0ISHRK4XU&QSG6A@LRI8:?L\3B<,Z5+
MFO[-MU:4IPJ-.]-3I0J0I8B,*T\)7='%PH59T(P?R]H_[('B:&]^+TNN7/A_
M4+OQ]<OX8TWQ,GB.UL[MOA+XB\;Z?JWB;P?=Z)X<^#^A7VGQ:3X.LDT?0K35
M/%WC2*T, CTZXT&TN)8EVP<XTL)EU+%2E*O''8#&YE/EC5ECZV5WQ-#$5)MT
M:<JV+QZ;Q,IX9XF&&Q%2%7'YA[&E&48B"K5\;R1A1PO]G8W"9?3I4X45E[Q&
M JX##T**4:E2&&HTZD)5O98B%#$5\/3Q?]GT\34E.'HEW^S%9V6J:SKWAWPG
M\-X-0G^)WPWO] M=C:)!X=^$W@F[\&ZI>^&=)O+/PG>G2K^]\0^'[_6KBRM;
M58-1G>VAN[Z/"W-FL)4>&_L_:/[W-*N8M+G59UL!C\MRJ%.#<(RH8#"K*%##
MMT:.'EAZ[H1E:+K374I4<;1PW^S1CA*&&PG+)OVDIXF>+S2KBN924*^8+,<Y
MP-3$PC7K/#8F-63=2M6IQ\KE_8^U^;0K'P]'X#^!.GP:@/&[ZQ>65_JD47A'
MQCXB\23ZC8_&WPEH=A\,[&UU[XEQZ&UG8V@OI=(G\/KIT$.GZW=VYF6X66U)
MX.KDWM*DHT\KPF0TX.DE[3#5,K4_[1PN#;Y%3H9U/V=3%XN/L9U)1:Q&!Q,5
M%+HQ%63K9CB:5L54Q..S:JZ6,YIT,?AL=5IUL!'-(PES5H93+V].G@G[:&(C
M7G4AC,'6DYK>U?X*ZIHOB7PE;>&=-FA^-?BCXC^-O%_C7XLZ7X7U>XL-(^&?
MB6#QWH36%Q\1K[1+>Q;5M)T'7=(32O#WG2S'5K>.^.GFR>\O:6#C2<:>!]FL
M/E=/*W0S>FI3H_6L1C*N&S+%QP<E*%2M/%YMAITEB:=IX#+*DY2EAJRPF&J9
MUFXT*V*JTX8G&T<5AGDL:DZE98>IE]/"99#%8J"3C2]IDT:E7&TJOLZ.-Q4Y
MX:A5KRI0JT_H?_A7%POPB\9^#O OA[2OA-K^NZ/K.@Z5<:=>I]L;^S]._P"$
M3\+>(-=U_0+=+O\ M:?PWI6C!KF.:]O+&(0Q1W$LMFN)QE6MBX8.=6$*Z]KA
ML77P,I.AAK3Q-/&8[+5*E"<:-.M%U<+7JT*,J:G.I.E&M349U+PTG0JRMB*S
MGAX5</0QM>,,7B%)1K.GC94L1.<,0H8VM5QU*AB:B^LJ7/BX8>MB<10I?/&G
M_LKZS:W?AK6?^%9?L_6!TOQ;X@\8V7@2SNKV]\)_#_Q W@2U\/>'/$GAC5]1
M^%IG\2>(YO$EF-8U2[?1_#+RW$MG>;[B\TA7U#.K&I"GB88/$RI5JF5YIA</
MB.2%.6!Q&88C 588?!TJ;MA\OH4L+7II4ZT?WF,QE2&&A3Q;H48I1IS^KK%T
MY>R6,RR6.I1JRK1S/#819M3Q.(QE2I&$ZN-K4\QH<L:JK.4<#1P]3&\C]HJF
MM_L<:YI_@CQ%X:^'FI:#HMQK7A3X-^'M;"7MCITOQ'D^'\WB.Z\52^.]7UWX
M:>,+&8:V^LV%F3J7ACQ3!)IVCII\UDMJZPP=&-JPJU(PPV&IPRVAG&*Q=+!2
MY?81P,\JH8#"0E&I2KQ>)HUX3Q59N+G6J4<-66,ABTJ]&J%;%2A"KCJZEFSP
ME1U<QHJ<,2\PQ69T\PQD:<J53#2I8%1HRIX.%.I"&&EF.87PLZ3E2Q.XW[(_
MV+P[KL^A:-X!M?&^B^"? WA_X,-XAN;_ ,2:%X!U;PMJ6M>++N>.YM?#.COI
M5C/XI\2ZM:#^P-,TS&D0PVMM#86\@LK72IB*CK*=+$2I3>;X*M/$J#>)>3X*
MED^&AAI.I6JU*U;V67XFM.G7Q-2&)Q-6C+%8BK*/MH\M.E)X587$Q57"K+\T
M7U7F@J4<XS9X_P"M8N,X4*<(PE">70I3AAH?5%1Q'U;"P4VJUJS_ &:/'.E&
M_GEU;PUXODM/B3X3\1>'(-=UG6=)\SP__P )5X9^(/Q)U+5;Z+PUJWV/Q1KG
MCC1EN4LK:SN+06FAZ?;)=VGVRX:VC#5(8*.6K#T^581YE3G&4FW'!_5\[I9)
MAZ=36=2IAJN9TJ^,Q,E2G6J0C-PKSP=&5?6N\1B7F,JF)=&>/I8>;=*,E'ZU
M5I9=@LTI^SG4E"."GEN#Q&!RZ-IU\)1S#&0<W"NHTN$US]DOX@^(/!D.AS:3
M\+M'M]2^*FK>-?&7@31];T2ZTOQEH^I:?%:VR>//B#XI_9PU<?$;6-.O9-3N
M[:?5? =OJ"+-IZ+KB7VE1ZM/A1HT*,LBP[<ZF R_!UL-5@DJ/L*M7$8:<<;A
M:=*49+&0PV']A/%X?%99B:]2I.NZU-U*\*_3B<15G4S3%89NAC\54H5*=5S<
MY58TJ6-A/"U)235' 3GBJ-2&!KT\UPE#V$Z5.A]7J8>C@OH;XE_!O4?$S_!/
M0M#\->!M8\+?#;6M(OKRZ^(NL77B)],L=$BT^RA6Q\':MX&UFW\8:[)IL%R+
M;6[CQ!X9U#2KR.WO(+FZ26[L[GIC7]KGU3.<5[L_9XIQG2C&-7VV);FW2BO9
MK!2A5A1G'$4:E23I.OAI4)4IOFY*="EA\BJ911C)PG"E25*4VJ7)1IN%-5IR
M53ZW0]^2K8*MAU3K1C3G"KAL13H8C#?/'B/]D3Q;J?AOQ!H%AX"_9ZV>*]6^
M,MYKD.JO>3Z%-K/C?Q,-:\$_%"_\/6WPL2U\3>-]%T=[G2+>PU/<FC^:MW9:
MM>,KV\W/@Z>'C2R;"XRFXX7 X7):52-!OFPL\)5=/.UEWO4E1GG.&5*HL=#Z
MOB,++#PP,:4\/.6(CT5:^)CC,PS"C[*M7GB<35I4JU/DI8ZG&A%933S.<'*L
MJ.75_;?6<)"6(I9I4Q5?,:E3#8M4H4[7Q"_9 \1Z]-XUD\*Z#\+M(37?B'X:
MUBX%M>:!I5Y\1?AYHOP\L/"$/@GX@W'B/X >-K"'3M,UFR&L0Z?<Z1XK@OIP
MDXFTF[CAGMKC*-:6%6.IJ=&>)S:MCJ,+>RJ5L9F<L9A<RBK4YRQE#"5:^"Y*
M-3 UJ$ZDL7A\SYJM6D^>G"KAJ,Z&&G"FZ&79;@<)B/9KZQ1HX:C&.+PG,Y2C
M&G7Q%*A6^LS]O&MA*5+*\1ESPU&,Y>_>,_@5I^L:=^S_ .';/P=X&\4^%/A!
MXDTZ^N-&^(-[+JLMCIFE^#-8\-Z5>:'?ZCX1UN35]8TZ_O=/NXXKA=(\]M/B
MD-Y;M"B-K6Q5>IG&+S?F7UJ>"S"%#$I>SKT<=6K8.OAJZ46VH3^K5*.(DJSG
M2==8F*Q-6C&$X5&V42RV-.G&GB,1A98C#\D'AIX93K2Q5&DHPITZ/+*I'V,8
M86-*>&C6R_DPN'Q4ITO"M;_9!\7R>%+X>&-7\-^'O'NN^#8;7QMK^EZG]DN_
M'OB;6_B=;?$?QMHFLZ]K?P\\01IX-8V]WI>G-?\ A[7;>*T\1ZI!+H/V:>6"
M[YY1A2IK T4L1E=%Y-2C0K0HP5>EE.5YEE[Q.*A*EBJ,L37J8O"8FK!TZGM(
MY?2H+$T4J-3#]E1J6.JYA3JSI8J53/\ V5247.6'HYGBL!4P5*BZ=7#S@\/A
M,/B</STYTOJ]>O#'4UB*ZJ<_LK? _5M$_9YT7X4>#=-\.V-[876C:GJWA'4/
M%%[:>#->C'B>'Q-XN\%2^)/#7@+3O[(\)ZP7U&Q*:5X)L;&*TNS:Q:%%9,;,
M;YA5AB<;@ZBHPQV PB5'ZOB5*,:F'A@:V$PRJ*K+'RJRP=2>'Q5.&(JU_;RP
ME.E4JQ4N>'-@H5</A\6HUW@<=B5)K$8>G1;IU'4I>TG"%*E@J5*IBJ%.I2JU
MZ%.C6H5L34QM)SQ<%4GPUI^S5KD/Q"T36[+P=\'?".@>'K[POKO@_5O#5UJ#
M>(_A9;:+HUG%J_PH^'7A^#P'I6F:7X(UGQ&FJ7^I:U:ZAI<VI6^M7-I=Z&2D
M$\&<I3A#'NAB:BQ4J>8T(5IIN684<5@*V P$,=>K)X;#Y3&>'J8; TI8S#>W
MPE+$TWAZ\ZLINM2P]?#9?0>%CAXP^IRKTJ4[4J.(HYQ+,\9B\,_9Q]KBLPI*
M&$K5YTL-55/F4YUJ:C3*&A_LW?$W5=+\/:'\1+[P'%HVAZ'\*O";6/A37/%-
MU=W&C>#_ !E<>-/'NH/K-]X?TV;^T/%FK:+X,D>UBAMUMHX[VV^US-;175[M
MS8-8F->.%Y:-3$0G/"2?/AZ.$P&28O!Y-@8)V^L1P.88_$SJU:T*<<5A(4?:
M8=.4\,G6EBI.O.E4IT\3*&:I8E0Y:E2IGN:82KFU7V=YPPJJY7AZE'#TZ;KR
MH8NK*<:_(X3I4]4_9,U..UT2RT+PM\'E_L3PG\?])\,ZC<P+82_"_6OBIXL3
M6?"UWX"L+?X>W:Q66D:*);#9;W6B&V::>2&.Z^T/CG@J5>'L,?&4J=?+N'<O
MQ56G.?UBKA\'.K#/L(I\U.?U?%X;$UH8&7M$Z<*-+"NCAZ->=2CM/$5:6(IX
MO#8;#U?89GB\RAA:RDJ-2O0PU&GE&)JU;59JO5Q.%IXK.(QI2=;%UWCHXBM6
MP5&G7U?#7P>L[7XE>(M,^&G@H>'/A=X1T#P@=2T/6-!UKX>Z)\0?B]X#U/Q7
MJ/AW;J5WX?EN=>\/FZUK3]5U?Q19Z=J<5Y>Z9I1@GU1H]1MUZJ6,KU:6)QU5
M0L\=7Q&6T&Y4I4:F)PU#+\?7G02_V>E0P^$A2RVA4I0]I5KU\9"G25'!8JI@
M\)AZ/]F8)SG[>6$AA,VQL'.K5GEM)X>O@,-"3J4Z->K*57&PQ,(XG]WA)5,L
MQ7)&LJ='WSXH_"^X^*ES\.;'6+[4-*\-^&_$%YXH\21^%O&_C3P9XCFU*+PS
MJVCZ)::)XE\%76D:I%:17^M7%Q/*FH:<TB6<2-'(D\D2\D(4X9A+$OFG2H83
M$T\,^:=.2Q-;$8-1JU:4)NG*G]1AC:,Z4Y5H^TQ$/<DH^TCI[7$+!?5X*E3J
M8JMAOK<91C6C]5HQJXB5.A4G!2C568TLNG"K[.#=&E6LZ<W!/PC5_P!G3Q[<
M^//$OB_3(_ 4&MV?_"6S^"OB7J7B3Q5JWQ&UC3]9\!:GX2\-?#;Q1+J'AB=_
M#O@#1=1O[?5)A9ZUKPU.[TR'4)=/@U":>:;.G!U<OS'!8N2H/-*6+PF*>&I4
MXJO3QV:PQ<L=4451B\3@L I8+ X3D=*C:FJ6+P^'3H'51JTL/C,NDE/$8#"5
MLMKJ%>52I5P2P%"A"K2P+J59_O<QQ%!UL9CJDX5)T<3BL/5P^(G.GBJ?U)\-
MOAWX5^%7@[1?!7@_1]/T?2M)LK2"1;"VCMWU&^@L[:SN-6U&55\R_P!4NA:Q
MM-=W#232E1O=L#'?C<4\9B:M;E5*E*I5E2I12C3HPJUJE=PIPC:,$ZE6I4DH
MI<U2<ZDKSG*3\C+\&L%A*-&3YZZIT57JW;G6JTJ-.A[2<Y>]-J%*%.#E\%*%
M.G%1A",8^'ZQ\!O$VL?%;4_B7-KUOB_\8:<&T"?Q%XKN_#3> O#_ ($CM_"T
M\_@R4C0)/'ND?%2,>(+:_:Q:5+8M NH*&,5<-*,L/@,7AZ%25'%XZCFLY5KJ
M;PF9XF5/"X'&8-R7/3C#)\/#!8N%.5#VD\16G+V_U;"L]*M*C7K4)SH\M/!P
MRZC&,)*/U[#TL3BL1C\-CFHI^PJ/'UWAX*59*I@\-)^RCBL7!>5?"_\ 9:^(
M'@+P]$EW=>&=0\;:C\1?!NL>-_%-YXN@OI/&?A_P7'JMYI7BF^CT'X(>%XI/
M','B:_M=5\K6+;7]0NX].AL;[Q?<1QPS6_1B)WP^$P^7_P#"73HTLXJ*%*,9
M+"X['Y5B<MH5*3BJ-*M!0JTXXAT,-E<7*/UQX>OB(2A7P:=6MF5?'*./K5Y8
M+V4[1PRJTJ6;X#'XG#U5"-6M1PSH86M2PM">)Q\,/[>>&H?5\-.5L'3OV/-=
MO&;4/&OPX_9ZU^]O+[X00^);"YGOM9D\<V_@;6O$>H^,/%WC/Q;KOPMFO=>\
M6:U)?:)=):WFGW$:PV=QHK:A';NU_<;4:F%P^*P=?"T/J-&GF&*Q?L*2YJ>!
MHSR6K@L#3PB;A[?$X/'XO%XBIC)?5*^,MAL55DJ\/8PRK+%U*6(ISQ/UC$QP
M?LX8YIT,1CL35S; 8W%1Q4*;J4L'E]7"Y;0H8?"8?ZS#!3JUXT8NBJ,:?1>(
MOV8/'OB;1]*\/ZMH_P *M2LF;XE[KK4_$/B*[3X<^(?&7CW6/$]A\6O 6A+X
M!BM-5^($6DZA;V]M'<S:)+H4UKML-9O(9;@W>.!JSH8O*\37J-U,%@^'83KP
M2>(A7RFG+^T\/AYR:<:&<56I8C%\\)SC%+$8&O%1A'JJ5)06*=!0KQEBLP]G
MA<1&V"Q6"K4\)1RJCCZ-*24Z62X;"QPM+!*-2&(I2<H8O!U;375']FK6;6^U
M;Q7_ &?X3U[QMK6G_'"+6M2G\5Z_X6U764^(6JV5GX/\+Q>-[#P?JFH^'?#&
MG^$(9#<_9-/N!'JUK;7D5G=3%[I>9P5/ SPM""BJ^!P="O2]SV%7%U<>LTS3
M%58U*5:&(6'QGMHY71Q%&I3EA,5B<+6AAJ56I&I5&:IXG#XIN2K8#,:&*PTI
M.59*AE^3U<HPT9PG.*5;'0CA,1F+IRC"%:DY4_K'LJ"CS>D_LD:A)HNB6GB#
M1?A/:7/AK1?AWI'A;2_#&E6^E^'/"%SIWQ-O?''Q \3Z-IVE>"M)T\>-+G36
MTJ"TUBTT?23<7UC=7:VVBQZE-;KZ;Q%../IXZG.K'$0QN J2K+FC+ZGE66QA
MA<)AZ<ZU:6%PV)S'$9E1Q.$CB*L893BH4)8C%NG[%\'LIU,)B,'6IP]G/!9U
M1BU5G*I4KYO*-"G+%U'"*Q']GX3!9;6I8B5/VM;&PJMTZ/)1Q#X^?]GCXD^-
M?&6I^&O%7@CX>MH.EV6K%OB%J'B;Q5=W.BZUX^^*WBKXDZQXJ^'OAVX^&UK8
M:]XRBL8/!R1WDNK:6?#MZ'%M>:IY;^;SY34CAE@,94FZ.)RN?#M%J,$YUI\.
MX##5*T:7,Z<J."S/$YCF-"OC8RG+$TOK.&G@8*-1U-LWBL:L9AU*K7J8RCG?
M+5J.,*$,)G#H9?E]&JH>T]IBLFPF4TG'"SBX.*R_$?6(3J)T_HSXY_!;5_B?
MXF\$:QI>E^ )9?"OA;XEV&E>*/%$"S>*O /C/Q'I>CQ>#/&O@Q3X5U(W5WIN
MHZ9.TL2ZGH3Q-<6][#/-/8QP/QPAR5LQKJ+C4KX*GAJ<J56I0E4@\5&>,P=6
MI14:M"EC,)SX98RC4J5L+3J8BE3PU2.+J3I^A0JX6&'R_#XJE+%T,+FN"QE6
MA5M*C5H8>ABJ4U*,W*%2K&I6HUX4ZE)PJU*$'*K2=.+:?!;X.Z[\-]"\>31>
M'_A]\/\ 6_%]K9+:>$OA]JFK:WX/L-9TG2[ZR7Q9JOB#5/"VA7WB+Q7K=Y=Q
M7.JZG/HL5Q*ME:1RR7LMNUU<:9MSXK)\9EN"J*,ZTL;5PZG"-"A@EB\-AJ%/
M X:G2=2-/!X:IAYUX^RITHRJXFO4CA:3DX/S\OHPP^:8;&8MSKTJ5#!8?$2<
MG.MC)8?$XJO7QE=S:;Q%>.)]BHSJU7&G1IQ=>2LH>()^S/\ $(V-Y%<?#KX*
M7-S'\%/"WPJM7N?B-J=[K%[-I]MH=IJ4EAXQU#]G2>\\#^'DBM]9-SHPL?$V
ME^)&-FU]I>EF6^^U]&8/#8JMG=2C#V4,VS2CBXQE3A*%/#X>7/2AB*;E*&.H
MQ>'P:CEE>V'I.->=+%KVDH3Z,-6KTXY9/%XBIB\;@88J57$.4J;K8G&+$?6:
M].%.4)83&5ZF*K5/[3PE:CB:49>PE3Q"IX2M@^QA_9_^)<-YH^C6R?"31?"$
MVD? O3?$\OABVU?PZT.F?"K6]4\2ZSX1\)^!=-T"/2-*T+4-?U![F*Y.I(#;
MW5U92:?&ICG1U*\JF*Q,_:3^KPS'&X_".=ZU92GD=#+\L=1U)/D>69AA*&+I
M0YZ_-"2Y:L)X=1Q/+*-2GA51PZC'GP6(P<J-10=*C''9E.>9U5*G2I1Q&)S'
M**\L+5K_ %?"*GC,)1Q%.E;$26$XOP!^QWKUDEU#\2V\->*[KQ#\1/#VL_$;
MQ#/K]E?W?Q)\)>$EUC7=%77-&T/X.^$5FU-_&;Z,SVGB+4_&%S#IGVJR;Q%=
MVT45G+&&6%H8?+*'L>2A@*6)E+"R2Q%*IBZF!JY92JS<W2H2<\-C<76Q=>E@
M,+4Q.(HX26*ABJE\11Z<QY,7B\WKTI5*7UN5-X2<9.C4P]*>;8',:V'<HRJ5
ME3H4,!2PF$2Q4Z=*,I_5J. A.I3G]UC[7I-YX=T+0_#=I'X;CLKJ"ZO;>[L]
M+L/#EGI=M;0:/IFG:-! TEX\[.L44,*6UM;V]C.SS*ZV]O=)U*E>MB*N)J2E
M*474]I-NI4K8B=6-U)O6W(ZM6K6G/F]I[*$*=7VM6IA\(4J>&P]"EA:<*<*4
MX48T8)4X4</&E4]^"C'D2ISA1HPHQ4?=J.?-&-+EGT-9[?(T/D?3?A5\7M:'
MB#PGXQMOAUH/@K6/BY<_$O4_$GAOQ=XB\4^,/%.GV/C:W\3^'?#LWA_5?AYH
M%AX0=-.T7PUIMS>IK7B)A;V%Q%;)&\D5Q;/ \M"ED<J\?WF1P=2%"+=2G5QM
M5XO$U:[Q#=&<*5/,L94QE.@L/+VJ4*%6I&"J.L\4U]8SEX.G&-/.:/U:I5G[
MDZ5#^SL)E-2U"*J1J5J^ P\Z?M7B(1P]::K1I5HQ5)?4&OZ9>ZQHVH:7IWB'
M6/"E[>6[0VWB/0(- N=9TB0E2+O3X/%.AZQI,MPH! 6^TN]BPQS$3@C.I"4U
M%1JRHN,H2;@H7:C)2<'SPFN6:3A)I*:BWR3A.TE4)*#;=.-1<LE:7,DG*+BI
M+DE!\T&U.*;<7**4XSAS0?E6I?#[XA6/PR^(GAK3/BCXE^(OC#Q'X=UJP\+Z
MO\3T\!>'[?1=2OM(N+"SC-W\*/A;H8@TY;F9)Y)I=)U6Y1E_=Y4>68QM*&+P
M<<'+#PE3G4C'$?O*E.=;"SJ4EB*//:K"$OJZK1HRC0_B5/WKG%1Y-LNJK!9C
M1QLYSE"@Z<X4N6$H*K1<YP=E[.HU4FZ<:R=:RIP3I1A/G<_)->^#/Q6\;>$[
MN'7+'X<^%=5T+X4^)OA=X%\#^'/&'B'7_#1MO%,6@Z?J^H^(O']_\-](O;<2
MZ'X?M["WMK+PA*EE]LNIY/M[&&.V]&6(Y\REFE7]_B<;F&5XC%*4'&-/!X3-
MH9CC</37M)K$U,8H4WSU%04'2C0CRQJ5:\N# 1K8#+\)EF%J?4(973J3PF)I
M?O*RQU+*\1@,MQ/LY1I4Z$,%4Q5>I*E&5=UFZ53GI^R]C/B_B1^R9XD\6Z%J
M>H:;%X+3QKXG^*6J^*/'%E+J&DPZ3XO\ K:7>@>%? 6I^(?&'P:\=6TNAZ;H
MUKX:U"72;CP5=V<VI:69(FM[E(-3BY(4Z,9Y;0K7Q6 IT\0\:IQA"57&XK'U
M,P>,Y8WJ5IX-XO'X7!2AB\%B:-/%.O1Q>&DZM&KKRJG''SPG^R8BK1P%##3_
M (LL/A\-E^ PN*PU&<G&.'AB\3@:->O/V.(IXBE1AAL5A:U*HU2LZW^RG>7>
MB_$+PT?A[\(/&=M>>%M#\._#3Q1\0?$>KZUXJ\.^'+#1O"^AWGPR:36/AEK;
M>&O#+6^C:I=+K>EWUU)/=ZJ+F?1/.C:5]:M5XBK2Q.(ITYXN.;4,7BZG)&^:
M82GG#S)K%MKFC4HX>.'P5+"REBJ-5475>)H3JS9G&G**]DJGL,/_ &?BZ.&A
M2C3IK*<9B,NKX5SP-.G"E2JPJXG$UL14K<F$J4L/4C@(49X3#X>E"7_AF3QA
M9>*-6U[PSX?^$?A&]T>U\3GP!XIT?4M93Q"FE:M\/]2\)>&/A%<:=!X&MK7P
M7\*/#FHZA!?+:Z1=ZC!?S:3;7IT>RO9)F?)J5?!YG@\9BJLWFE+%X/$UU%2K
M8RCC,TAB?[0Q4ISO/&8/+HO!8/"SE6A2:@J>/I4$Z3[<-5IT,7EU25&+PE"O
ME^+G1UE]0GA*-'ZU1RW6,%+,L72G7Q>.E'#SJ4<5BJ%7"5ISAB*?TY\*/ ^F
M?#/0?^$"\-^#=-\+>%O#5OHUGI>HV=S9M=>+KY='M(]8U_4+.UA,J7#3106[
M7FH74M[=RV]P\D<<,<$MWV8O%/&U*N(DE0YL1B72PT$O9T,/.JZT>51484W5
MKU<34E2IJ2LXUZE1U\16I4?)P.#^H4,/0NJT_JV'>(Q%Y<]7%0@\/*,W)<]3
MV>'H890JRDDH2CAX0C3P\;X_Q(\(^.9_%W@OXC?#VT\*:[X@\(:/XM\._P#"
M*^-_$.K^$]!O['QA/X:GN=5@\1Z)X4\2W.E:S8MX:B2,?V)=I<07]U;L]OY@
MF3BHRG0K8KEA3E2Q]"C0J5&G[;#K#UIUH.DEI5I593_VC#2G1]I.CA:JKQ>'
MY*GJ3E"I@J>&E>,Z&-I8R#44U-PPV+PLJ<VY)P?)BI2I54I\C4X.G)57*'2?
M#3P;J/A#2=9DUV^L-0\3^+?$^K>,?$UQI5O-:Z2FJ:JMK;0V&EQ7+M,UC8:3
MI^F6*3S;9+C[$UQ)'&\[1IJ_9TL-@L%0E.5# 4ZL(SJ*,9U)XC%XG'XFJX1;
MC3C4Q>+KRITE*I[&DZ=)U:K@ZL^*G3E]9QV,JPA3K8^I1G*%.4I0A##8/#8"
MA!3G9SDL-A*+JS4*<:E9U:D*-&$E3C5UCP!XKU+Q9%XBLOC?\4/#VCQW6GW#
M> M'TGX+3^$YHK(0"YL9+S7_ (0ZGXF%K?\ E2&X:/Q'',OVF3[)-:@1^5&&
M?U><I55]<BY3:A6NHQ4HM1BGAW0GRTW[T.:;DY)>TE.-XOHK-5:<:=.*PLHT
MW!U*=W.4N:3]JU6=6G[1*2BE&$:7+"-Z;DYRGY?XA^&GQ$O/C^?B9::/HNJ>
M'+7PMH6AZ+/_ ,+]^+'P_N;";1_^$GU&XAUWX8^$_!%UX;\>6=[K&MVT9;7=
M5N%MH+<RPVGFH8[G/")T*6;J<(>WQE2HZ<I7Q%*I1^IX?#T*%;#UN6E0E2J_
M7JOUBC&I7MB(*,DX1<*Q+5=991YY+"X3WIQC%4JL*]7%QJ8FK#$4Y>UK4YX;
M#8"*PLW2HSG0J0K<U.MS1\+\5_LA^/=<\-6>@S:CX/UZSC\=-JNLZ)<ZI9Z5
MHGB/P)+I:-I/@BZM_&'PA^(EAIOAKPAK>I^)%T71(-%DWQM9:DNJ:;K)FN1I
M"%*-7*:=24ZV$PF&K8;$2D[5IU57PU/"YK&49*N\PCEF$I824J.,P5:A)U/8
M8[V52K3JU7Q%>HL?B:$OJN-Q-6.)HQC*;A1E5CC9X_ SJSE*-?#XS'8F.85\
M1B,'6I5Y)82>50PV%P7L.XO?V</$<-C\1[73O"'PKUC7+VUT32? 7Q#\5>*?
M$5[XWO/ EC>^'C>_"7Q#J5S\/[^^\'^%3HFCW.G"_P!)U?6Q<S7SZE<:2+J2
M83:TL374\-BJLE'&0SB.88MT4J4<?&GFM7,Z&(K2A&+]OA)O"TZ&#G"M05/"
MQI0Q-&G)1I\JPN%5"I@&JD\MGE.(P5"C.<IK+J];)%E+^JQG.49TZU5U<7B*
M\'A*K=>=)TJEO:2H:O\ LW>/M?U^#QGXBT'X*>)/&4^I?&;Q$-7U-=0=_!/B
M;Q%H?A?P_P#"/5O"<^I>!M3N[R31='\(:7:7^)]#*S2G4;;SY+2*U?DJ45'
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MIRI9C#GE*=-4*N"P^7TZ4X4Z>)IU5B7&I']U)>-:_P#LG:E-I6E?9?"/P?\
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M_P G3_&3_L@'[-/_ *L7]K&@#Z H * "@ H ^?\ ]D[_ )-8_9I_[(!\&_\
MU77AR@"CXL_:F^%O@[Q?XE\#WUC\4M8UWP?>Z=IOB$^#/@M\5_'.DZ=J.J>'
M=%\5VFGR:]X1\'ZAISWIT#Q%HMV\"7+21IJ$0D52V* ,'_AL;X4_]"O^T!_X
MC-\?O_G=T '_  V-\*?^A7_: _\ $9OC]_\ .[H /^&QOA3_ -"O^T!_XC-\
M?O\ YW= !_PV-\*?^A7_ &@/_$9OC]_\[N@ _P"&QOA3_P!"O^T!_P"(S?'[
M_P"=W0 ?\-C?"G_H5_V@/_$9OC]_\[N@ _X;&^%/_0K_ +0'_B,WQ^_^=W0
M?\-C?"G_ *%?]H#_ ,1F^/W_ ,[N@ _X;&^%/_0K_M ?^(S?'[_YW= !_P -
MC?"G_H5_V@/_ !&;X_?_ #NZ #_AL;X4_P#0K_M ?^(S?'[_ .=W0 ?\-C?"
MG_H5_P!H#_Q&;X_?_.[H /\ AL;X4_\ 0K_M ?\ B,WQ^_\ G=T '_#8WPI_
MZ%?]H#_Q&;X_?_.[H /^&QOA3_T*_P"T!_XC-\?O_G=T '_#8WPI_P"A7_:
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M .=W0 ?\-C?"G_H5_P!H#_Q&;X_?_.[H /\ AL;X4_\ 0K_M ?\ B,WQ^_\
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MZ%?]H#_Q&;X_?_.[H /^&QOA3_T*_P"T!_XC-\?O_G=T '_#8WPI_P"A7_:
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M !0 4 % !0!XKKO_ "<5\+/^R+?'S_U.?V;: /:J "@ H * "@ H * "@ H
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M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'BOP#_Y$;7?^RU?M)?\
MK17Q3H ]JH * "@ H * "@ H * "@ H * /%?V;?^3=?@'_V1;X6?^H-H5 '
MM5 !0 4 % !0 4 % !0 4 >*Z[_R<5\+/^R+?'S_ -3G]FV@#VJ@ H * "@
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M#Q[J>I^%K?P5<6]Y+X+_ +-\'7.NRZ7IK+?PV#1RV&GQW\2W$D5PZV^8X^3
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M7_K17Q3H ]JH * "@ H * "@ H * "@ H * "@ H * .P_9._P"36/V:?^R
M?!O_ -5UX<H /#G_ "=/\9/^R ?LT_\ JQ?VL: /H"@ H * "@#Y_P#V3O\
MDUC]FG_L@'P;_P#5=>'* /$=$_Y+%^U-_P!EJ\*_^LR?L\4 =]0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 >*_ /_D1M=_[+5^TE_ZT5\4Z
M /:J "@ H * "@ H * "@ H * "@#Q7]FW_DW7X!_P#9%OA9_P"H-H5 'M5
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M--4*]"M).JH8JC4P\95''G,GQ!^T7;:3JL4MOX2\2R>"],?XA#6O%DVGZ/\
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M 4 % !0 4 % 'BNN_P#)Q7PL_P"R+?'S_P!3G]FV@#VJ@ H * "@ H * "@
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M_D1M=_[+5^TE_P"M%?%.@#VJ@ H * "@ H * "@ H * "@ H \5_9M_Y-U^
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M$H5\14Y%%S]EAZ4ZTU",ITXRJ2C!QI1E4A&=24(N<$^9<W;?%[P+<3^*K?\
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M?2K5J%2A*,G&M2E3I1G"K2<Z=6,VZ4IJC7]GHZT%'!RC>2Q<\;34>649TJF
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M0 4 % !0 4 % !0 4 % 'BOP#_Y$;7?^RU?M)?\ K17Q3H ]JH * "@ H *
M"@ H * "@ H * /%?V;?^3=?@'_V1;X6?^H-H5 'M5 !0 4 % !0 4 % !0
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M0GU29-.,EGI%Z-,U?4='AU:PF\1:5I.H&>#['JE[X?CU.TMYA/ 4FN8R)8R
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M >U4 % !0 4 % !0 4 % !0!XKKO_)Q7PL_[(M\?/_4Y_9MH ]JH * "@ H
M* "@ H * "@ H * "@#Y&^$GC[Q7HGA[Q3IFF?!'XG^+K*U^-/[17D>(O#NK
M?!BUT?4?._: ^)EQ)]C@\6?%W1-53R)99+:3[5IEMF6VD,7FP&.:4V#8]/\
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M * "@ H * "@ H * /%?V;?^3=?@'_V1;X6?^H-H5 'M5 !0 4 % !0 4 %
M!0 4 >*Z[_R<5\+/^R+?'S_U.?V;: /:J "@ H * "@ H * "@ H * "@ H
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M >*Z[_R<5\+/^R+?'S_U.?V;: /:J "@ H * "@ H * "@ H * "@ H \5^
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MI149X"O1Q.&DY3Y(5J%&KAX*K#F]I5I>SK3TC6HUU))QQ"3J1J6?A7\*=/\
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MH /^&8M<_P"CG?V@/_!3^S3_ /0Z4 '_  S%KG_1SO[0'_@I_9I_^ATH /\
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M0!\__LG?\FL?LT_]D ^#?_JNO#E !\&_^2B_M8_]G >'/_66/V:: /H"@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^?_P!FG_DG7B/_ +.
M_:Q_]:G^,E 'T!0 4 % !0 4 % !0 4 % !0 4 ?/_[)W_)K'[-/_9 /@W_Z
MKKPY0!] 4 % !0 4 % !0 4 % !0!\_^(_\ DZ?X-_\ 9 /VEO\ U8O[)U '
MT!0 4 % !0 4 % !0 4 % !0 4 % 'S_ /LT_P#).O$?_9P'[6/_ *U/\9*
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M0% !0 4 % !0 4 % !0 4 % !0!\_P#[)W_)K'[-/_9 /@W_ .JZ\.4 ?0%
M!0 4 % !0 4 % !0 4 ?/_B/_DZ?X-_]D _:6_\ 5B_LG4 ?0% !0 4 % !0
M 4 % !0 4 % !0 4 ?/_ .S3_P DZ\1_]G ?M8_^M3_&2@#Z H * "@ H *
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M_ I__*P_M3#_ ,E3[H__ "8?9/'/_1+]?_\ %GO[;?\ \P]']AXO_GY2_P#
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M_)4^Z/\ \F'V3QS_ -$OU_\ \6>_MM__ ##T?V'B_P#GY2_\"G_\K#^U,/\
MR5/NC_\ )A]D\<_]$OU__P 6>_MM_P#S#T?V'B_^?E+_ ,"G_P#*P_M3#_R5
M/NC_ /)A]D\<_P#1+]?_ /%GO[;?_P P]']AXO\ Y^4O_ I__*P_M3#_ ,E3
M[H__ "8?9/'/_1+]?_\ %GO[;?\ \P]']AXO_GY2_P# I_\ RL/[4P_\E3[H
M_P#R8?9/'/\ T2_7_P#Q9[^VW_\ ,/1_8>+_ .?E+_P*?_RL/[4P_P#)4^Z/
M_P F'V3QS_T2_7__ !9[^VW_ /,/1_8>+_Y^4O\ P*?_ ,K#^U,/_)4^Z/\
M\F9^F>'O$FB6TEGHWP<O](M)M0U;5I;73/\ @IA^VE86TNJZ_JM[KNNZG)!:
M^ XT?4-1UO4=0U"[N"IDN;J_N+B9GFG=V/[#Q:_Y>4E_V]/_ .5A_:F'7V*B
M^4?_ ),T/LGCG_HE^O\ _BSW]MO_ .8>C^P\7_S\I?\ @4__ )6']J8?^2I]
MT?\ Y,/LGCG_ *)?K_\ XL]_;;_^8>C^P\7_ ,_*7_@4_P#Y6']J8?\ DJ?=
M'_Y,/LGCG_HE^O\ _BSW]MO_ .8>C^P\7_S\I?\ @4__ )6']J8?^2I]T?\
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MK_\ XL]_;;_^8>C^P\7_ ,_*7_@4_P#Y6']J8?\ DJ?='_Y,/LGCG_HE^O\
M_BSW]MO_ .8>C^P\7_S\I?\ @4__ )6']J8?^2I]T?\ Y,S])\/>)- TK3-"
MT+X.7^BZ)HNGV6DZ-HVD_P#!3#]M+3M*TG2M.MH[/3],TS3[/P'';V&GVMI#
M#!#;P1I'%'$B(JJH /[#Q:_Y>4E;^]/_ .5A_:F'7V*BMY1_^3-#[)XY_P"B
M7Z__ .+/?VV__F'H_L/%_P#/RE_X%/\ ^5A_:F'_ )*GW1_^3#[)XY_Z)?K_
M /XL]_;;_P#F'H_L/%_\_*7_ (%/_P"5A_:F'_DJ?='_ .3#[)XY_P"B7Z__
M .+/?VV__F'H_L/%_P#/RE_X%/\ ^5A_:F'_ )*GW1_^3#[)XY_Z)?K_ /XL
M]_;;_P#F'H_L/%_\_*7_ (%/_P"5A_:F'_DJ?='_ .3#[)XY_P"B7Z__ .+/
M?VV__F'H_L/%_P#/RE_X%/\ ^5A_:F'_ )*GW1_^3#[)XY_Z)?K_ /XL]_;;
M_P#F'H_L/%_\_*7_ (%/_P"5A_:F'_DJ?='_ .3#[)XY_P"B7Z__ .+/?VV_
M_F'H_L/%_P#/RE_X%/\ ^5A_:F'_ )*GW1_^3#[)XY_Z)?K_ /XL]_;;_P#F
M'H_L/%_\_*7_ (%/_P"5A_:F'_DJ?='_ .3#[)XY_P"B7Z__ .+/?VV__F'H
M_L/%_P#/RE_X%/\ ^5A_:F'_ )*GW1_^3,^3P]XDFU6RUV7X.7\NMZ;I^IZ3
MIVL2?\%,/VTGU6PTK6KG2;S6-,LM0;P&9[73[Z[T#0I[FWBD6.>31;!Y5=K.
M$QG]AXM?\O*2_P"WI_\ RL/[4PZ^Q47RC_\ )FA]D\<_]$OU_P#\6>_MM_\
MS#T?V'B_^?E+_P "G_\ *P_M3#_R5/NC_P#)A]D\<_\ 1+]?_P#%GO[;?_S#
MT?V'B_\ GY2_\"G_ /*P_M3#_P E3[H__)A]D\<_]$OU_P#\6>_MM_\ S#T?
MV'B_^?E+_P "G_\ *P_M3#_R5/NC_P#)A]D\<_\ 1+]?_P#%GO[;?_S#T?V'
MB_\ GY2_\"G_ /*P_M3#_P E3[H__)A]D\<_]$OU_P#\6>_MM_\ S#T?V'B_
M^?E+_P "G_\ *P_M3#_R5/NC_P#)A]D\<_\ 1+]?_P#%GO[;?_S#T?V'B_\
MGY2_\"G_ /*P_M3#_P E3[H__)A]D\<_]$OU_P#\6>_MM_\ S#T?V'B_^?E+
M_P "G_\ *P_M3#_R5/NC_P#)A]D\<_\ 1+]?_P#%GO[;?_S#T?V'B_\ GY2_
M\"G_ /*P_M3#_P E3[H__)A]D\<_]$OU_P#\6>_MM_\ S#T?V'B_^?E+_P "
MG_\ *P_M3#_R5/NC_P#)A]D\<_\ 1+]?_P#%GO[;?_S#T?V'B_\ GY2_\"G_
M /*P_M3#_P E3[H__)A]D\<_]$OU_P#\6>_MM_\ S#T?V'B_^?E+_P "G_\
M*P_M3#_R5/NC_P#)A]D\<_\ 1+]?_P#%GO[;?_S#T?V'B_\ GY2_\"G_ /*P
M_M3#_P E3[H__)F?IGA[Q)HEM)9Z-\'+_2+2;4-6U:6UTS_@IA^VE86TNJZ_
MJM[KNNZG)!:^ XT?4-1UO4=0U"[N"IDN;J_N+B9GFG=V/[#Q:_Y>4E_V]/\
M^5A_:F'7V*B^4?\ Y,T/LGCG_HE^O_\ BSW]MO\ ^8>C^P\7_P _*7_@4_\
MY6']J8?^2I]T?_DP^R>.?^B7Z_\ ^+/?VV__ )AZ/[#Q?_/RE_X%/_Y6']J8
M?^2I]T?_ ),/LGCG_HE^O_\ BSW]MO\ ^8>C^P\7_P _*7_@4_\ Y6']J8?^
M2I]T?_DP^R>.?^B7Z_\ ^+/?VV__ )AZ/[#Q?_/RE_X%/_Y6']J8?^2I]T?_
M ),/LGCG_HE^O_\ BSW]MO\ ^8>C^P\7_P _*7_@4_\ Y6']J8?^2I]T?_DP
M^R>.?^B7Z_\ ^+/?VV__ )AZ/[#Q?_/RE_X%/_Y6']J8?^2I]T?_ ),/LGCG
M_HE^O_\ BSW]MO\ ^8>C^P\7_P _*7_@4_\ Y6']J8?^2I]T?_DP^R>.?^B7
MZ_\ ^+/?VV__ )AZ/[#Q?_/RE_X%/_Y6']J8?^2I]T?_ ),/LGCG_HE^O_\
MBSW]MO\ ^8>C^P\7_P _*7_@4_\ Y6']J8?^2I]T?_DP^R>.?^B7Z_\ ^+/?
MVV__ )AZ/[#Q?_/RE_X%/_Y6']J8?^2I]T?_ ),/LGCG_HE^O_\ BSW]MO\
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M_ I__*P_M3#_ ,E3[H__ "8?9/'/_1+]?_\ %GO[;?\ \P]']AXO_GY2_P#
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M_ I__*P_M3#_ ,E3[H__ "8?9/'/_1+]?_\ %GO[;?\ \P]']AXO_GY2_P#
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0!M_LZ?\E^^.?_ &1_]G/_ -33]IROEL[_ -[I_P#7J/\ Z74/
M>RO_ '>?_7Q_^DP/MVO&/2"@ H * /A#]F3]F3]FW7OV;?V?-=UW]GSX'ZSK
M>L_ _P"$^K:QK&K?"?P'J.JZKJNH^ ] O-0U/4]0O- DGOM0NKN::>:XGD>2
M625W=F9B2 >W_P##)W[+'_1M/P _\,W\.O\ YG* #_AD[]EC_HVGX ?^&;^'
M7_S.4 '_  R=^RQ_T;3\ /\ PS?PZ_\ F<H /^&3OV6/^C:?@!_X9OX=?_,Y
M0 ?\,G?LL?\ 1M/P _\ #-_#K_YG* #_ (9._98_Z-I^ '_AF_AU_P#,Y0 ?
M\,G?LL?]&T_ #_PS?PZ_^9R@ _X9._98_P"C:?@!_P"&;^'7_P SE !_PR=^
MRQ_T;3\ /_#-_#K_ .9R@ _X9._98_Z-I^ '_AF_AU_\SE !_P ,G?LL?]&T
M_ #_ ,,W\.O_ )G* #_AD[]EC_HVGX ?^&;^'7_S.4 '_#)W[+'_ $;3\ /_
M  S?PZ_^9R@ _P"&3OV6/^C:?@!_X9OX=?\ S.4 '_#)W[+'_1M/P _\,W\.
MO_F<H /^&3OV6/\ HVGX ?\ AF_AU_\ ,Y0 ?\,G?LL?]&T_ #_PS?PZ_P#F
M<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\ #)W[+'_1M/P _P##-_#K_P"9R@ _
MX9._98_Z-I^ '_AF_AU_\SE !_PR=^RQ_P!&T_ #_P ,W\.O_F<H /\ AD[]
MEC_HVGX ?^&;^'7_ ,SE !_PR=^RQ_T;3\ /_#-_#K_YG* #_AD[]EC_ *-I
M^ '_ (9OX=?_ #.4 '_#)W[+'_1M/P _\,W\.O\ YG* #_AD[]EC_HVGX ?^
M&;^'7_S.4 '_  R=^RQ_T;3\ /\ PS?PZ_\ F<H /^&3OV6/^C:?@!_X9OX=
M?_,Y0 ?\,G?LL?\ 1M/P _\ #-_#K_YG* #_ (9._98_Z-I^ '_AF_AU_P#,
MY0 ?\,G?LL?]&T_ #_PS?PZ_^9R@ _X9._98_P"C:?@!_P"&;^'7_P SE !_
MPR=^RQ_T;3\ /_#-_#K_ .9R@ _X9._98_Z-I^ '_AF_AU_\SE !_P ,G?LL
M?]&T_ #_ ,,W\.O_ )G* #_AD[]EC_HVGX ?^&;^'7_S.4 '_#)W[+'_ $;3
M\ /_  S?PZ_^9R@ _P"&3OV6/^C:?@!_X9OX=?\ S.4 '_#)W[+'_1M/P _\
M,W\.O_F<H /^&3OV6/\ HVGX ?\ AF_AU_\ ,Y0 ?\,G?LL?]&T_ #_PS?PZ
M_P#F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\ #)W[+'_1M/P _P##-_#K_P"9
MR@ _X9._98_Z-I^ '_AF_AU_\SE !_PR=^RQ_P!&T_ #_P ,W\.O_F<H /\
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MLFU3S/"*GC<NPT)8YPA76%G4PV-KXZMAY867U2EEN)7UC%49+%4^FO\ X_\
MCN+XF>$OAIIWC3X17.KCQ)X/\/ZY9+X(\37>K^/=+UOPA)X[UGXA>#K*Q^*;
MKX \#0:%9ZI:Z?>:G)XLCU#4M-O+1;B(VA,PHWECJSI3I8;!TLVE6I74Z^7/
M+L')4IXZ<HT8RJXK,I8=0RZ-*C6>7UJ>)CB)<U3ZN5X5*>#P]7#U:&(J5Z6
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MS<JGLHJ$I64G*JU3BHMMU'R+WM#N:0&7?ZYHFE7%E::GK&EZ;=:BXCTZVO\
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M_#[1;/2O'7Q%U;0?#ND_#_4VUZQ\2^*-?A\.Z#X?U+4-.O\ PL+^^OKZ_M;
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M:M)N,X3BX3A):.,HR2<6GHTTF@ZR76,I0DNTH2<)Q:Z2C).,D]8R332:9=J
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MT,;C)T,!0Q-"%.=.<\#ET:V:5<?A<=6PCP\Z5*CEDL)"K1ABW6]%L?!GQ/\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@#Y_P##G_)T_P 9/^R ?LT_^K%_
M:QH ^@* "@ H * /G_\ 9._Y-8_9I_[(!\&__5=>'* /H"@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M?^&L\#?_ "BH /\ AFW]G7_H@?P6_P##6>!O_E%0 ?\ #-O[.O\ T0/X+?\
MAK/ W_RBH /^&;?V=?\ H@?P6_\ #6>!O_E%0 ?\,V_LZ_\ 1 _@M_X:SP-_
M\HJ #_AFW]G7_H@?P6_\-9X&_P#E%0 ?\,V_LZ_]$#^"W_AK/ W_ ,HJ #_A
MFW]G7_H@?P6_\-9X&_\ E%0 ?\,V_LZ_]$#^"W_AK/ W_P HJ #_ (9M_9U_
MZ('\%O\ PUG@;_Y14 '_  S;^SK_ -$#^"W_ (:SP-_\HJ #_AFW]G7_ *('
M\%O_  UG@;_Y14 '_#-O[.O_ $0/X+?^&L\#?_**@ _X9M_9U_Z('\%O_#6>
M!O\ Y14 '_#-O[.O_1 _@M_X:SP-_P#**@ _X9M_9U_Z('\%O_#6>!O_ )14
M '_#-O[.O_1 _@M_X:SP-_\ **@ _P"&;?V=?^B!_!;_ ,-9X&_^45 'D?[/
M_P"S_P# ;6?@-\$M8UCX)?"/5=6U7X1_#;4M4U34OAMX-OM1U+4;[P;HUU>W
M]_>W6C/->7MQ<RRS2SS.\DDDC.[%F)(!ZY_PS;^SK_T0/X+?^&L\#?\ RBH
M/^&;?V=?^B!_!;_PUG@;_P"45 !_PS;^SK_T0/X+?^&L\#?_ "BH /\ AFW]
MG7_H@?P6_P##6>!O_E%0 ?\ #-O[.O\ T0/X+?\ AK/ W_RBH /^&;?V=?\
MH@?P6_\ #6>!O_E%0 ?\,V_LZ_\ 1 _@M_X:SP-_\HJ #_AFW]G7_H@?P6_\
M-9X&_P#E%0 ?\,V_LZ_]$#^"W_AK/ W_ ,HJ /(_V@/V?_@-HOP&^-FL:/\
M!+X1Z3JVD_"/XD:EI>J:;\-O!MAJ.F:C8>#=9NK&_P!/O;71DFL[VWN8HIHI
MX722.2-71@R@@ ]<_P"&;?V=?^B!_!;_ ,-9X&_^45 !_P ,V_LZ_P#1 _@M
M_P"&L\#?_**@ _X9M_9U_P"B!_!;_P -9X&_^45 !_PS;^SK_P!$#^"W_AK/
M W_RBH /^&;?V=?^B!_!;_PUG@;_ .45 !_PS;^SK_T0/X+?^&L\#?\ RBH
M/^&;?V=?^B!_!;_PUG@;_P"45 !_PS;^SK_T0/X+?^&L\#?_ "BH /\ AFW]
MG7_H@?P6_P##6>!O_E%0 ?\ #-O[.O\ T0/X+?\ AK/ W_RBH /^&;?V=?\
MH@?P6_\ #6>!O_E%0!Y'^S_^S_\  ;6?@-\$M8UCX)?"/5=6U7X1_#;4M4U3
M4OAMX-OM1U+4;[P;HUU>W]_>W6C/->7MQ<RRS2SS.\DDDC.[%F)(!ZY_PS;^
MSK_T0/X+?^&L\#?_ "BH /\ AFW]G7_H@?P6_P##6>!O_E%0 ?\ #-O[.O\
MT0/X+?\ AK/ W_RBH /^&;?V=?\ H@?P6_\ #6>!O_E%0 ?\,V_LZ_\ 1 _@
MM_X:SP-_\HJ #_AFW]G7_H@?P6_\-9X&_P#E%0 ?\,V_LZ_]$#^"W_AK/ W_
M ,HJ #_AFW]G7_H@?P6_\-9X&_\ E%0 ?\,V_LZ_]$#^"W_AK/ W_P HJ #_
M (9M_9U_Z('\%O\ PUG@;_Y14 >1_#;]G_X#7OC+]H"UO?@E\([NVT7XN:+I
MNCV]U\-O!MQ!I.G2_ ;X):Q+I^FPRZ,R6%D^K:KJEZT$ 2,W.I74Y7S;B1G
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M@;_Y14 '_#-O[.O_ $0/X+?^&L\#?_**@ _X9M_9U_Z('\%O_#6>!O\ Y14
M'_#-O[.O_1 _@M_X:SP-_P#**@ _X9M_9U_Z('\%O_#6>!O_ )14 '_#-O[.
MO_1 _@M_X:SP-_\ **@ _P"&;?V=?^B!_!;_ ,-9X&_^45 !_P ,V_LZ_P#1
M _@M_P"&L\#?_**@ _X9M_9U_P"B!_!;_P -9X&_^45 !_PS;^SK_P!$#^"W
M_AK/ W_RBH /^&;?V=?^B!_!;_PUG@;_ .45 !_PS;^SK_T0/X+?^&L\#?\
MRBH /^&;?V=?^B!_!;_PUG@;_P"45 !_PS;^SK_T0/X+?^&L\#?_ "BH /\
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M@#Y__9._Y-8_9I_[(!\&_P#U77AR@#Q'1/\ DL7[4W_9:O"O_K,G[/% '?4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'BO[-O\ R;K\ _\
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M.SA.G)PJ0DMXSA.,H3B[.,HN+2::+= !0!XK\+/^1Y_:2_[+5H7_ *SK\ Z
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M5)J[G2$O8)M3M;*"/5; 6VH7%I%)#!>2O<QV[R+*]K<JGE.Z35/%Y?B)7E#
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M=SX1A\)ZEI]_X=O=0NO%_B.:QBL$NX$L/[8L_&VB^*[.%+6]EBAFTGQ7I-S
MD4-LLS6'G65Q=>5>OBJ&+G5YJU%2C*4TW*HG2]DY5)1E!UJDK*59XGV]/%R<
MWC*6(E-R5X7V.%HXS#QH+V6+3:BN50I3^L0Q,73I3A4HPIQG#EITJ=."PT&G
M@WA:M*A4I,T/]GWP!9>!)_ _B+3_ /A*H=6\.Z9X=\3W]W<:K8OK=MI.MZUX
MDL9(H;;56DT>2VUWQ#JMU!/:W NXS-%ONY6MXW7:K5C-86E3I\M#!3PM2C"?
M)-JI@\)A,#2G4M3A"?/A\%0IUZ2IQPU6/M(2PZIU:D)989UL-&7[YNI.692E
M*//&W]JUZF(QD(N<ZE7DE.HU!U*M6M"*B_:N=YON+GX;>$[C7]-\31P:YIFJ
MZ7;V=I%_8'C#QAX:TN_MM/1HM/M_$&@>']>LM+\40VL3O'"FL6=\(D=DC"JQ
M!R4FIXJHWS/%RG.LI^_"52I"-.I5]G/FIQK3IPA&5:$8U6J=*\_W5/EE4:<:
M-"A&"A#"TX4J3A>%2-*G)SA2]K&U5TH3<I1IRFX)U*KY?WM3FOZ+X'\+^'9M
M*N-'TO['-HFA3>&=,?[;J-Q]ET2XO;?49K+;=7<BS;KRU@D\Z423#R]HD"LR
MDC)PC4A'W8U88.G-=X8"G7I81:[>QIXFM&ZLY\]ZKFXP<:J0C5KQQ-1<U:-3
M&U5+;W\PJT:^,E96C^^JX>E*UK4^3EI*$923P=3^$'P[U?2Y-&U#P^TNGR-X
MM<Q1ZSKUK*DOCG5QKWB:>"\M-4CN+:YN=85;J.:&5)+-T3[$UN$4")14G0=W
M&6%HX7#TI1E*$Z=+!5*%7"J$X.,HRHU,-0E&HG[1NG[TY*4N;=UJDI593Y9^
MWJ*K4C.$)PJ36$K8#WZ<HN$H2PE>M0G2E%TIQFW.$I)24>C_  =^'NA;FL=(
MU"2>2_OM5GO-5\4^+=>U&[U+4O#-OX.O[^^U+7==O+J^NY_#EK!:/+<32LQC
M$Y/V@F4U6MB*%3#58Q]A4PV)P<H1C&G'ZMC,53QN)I)4U'E]KBJ4*[E&TU/G
MY9152HI8I*-;#8C7VV#K4*]*;;;C5PU/%4:$G>_/[*CC,12A&?-%4Y0I\O)0
MH*FDWP;^'<NG1Z8NB7EG#;Z3X8T2RNM+\2^*='UC3-/\&VVI6?AO^R-?TK6[
M?4]'O;.TUC5(/MUE=P74T=]*D\TJMBM<16JXJK5K5JDO;5\77QM2<&Z4I8C$
MTJ-"O)NER>Y5I8>C3G07[AJ'\.\I.66%P]'!4J=##TU&C1PM/!QA+]Y%8:E6
MEB:4&JG/S.G7DZU.K*]6%10E&:<(./>Z/I5KH>F6.D64NI3VNGVZ6T$NL:SJ
M_B'4WCC&%:]UO7[Z\U'4K@_Q3WEU/*W5G)I5*DJLW4DHQ<K74(0IQT5M(4XQ
MA';I%7>KU;-(05-63=KM^]*4G=MMZR;:2;TBG:*LHI))'D_[-O\ R;K\ _\
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M_P#H;: #^W?VBO\ HEGP6_\ #^>.?_H;: #^W?VBO^B6?!;_ ,/YXY_^AMH
M/[=_:*_Z)9\%O_#^>.?_ *&V@ _MW]HK_HEGP6_\/YXY_P#H;: #^W?VBO\
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M=?CY_P!D6^*?_J#:[0![50 4 % !0 4 % !0 4 % !0 4 >*_LV_\FZ_ /\
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M_P!5UX<H \1T3_DL7[4W_9:O"O\ ZS)^SQ0!WU !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0!XK^S;_R;K\ _^R+?"S_U!M"H ]JH * "@ H
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ME&$J5&E2E-U)4X1BYO>3C%)R>KUDU=ZO5[DE2:!0 4 % '8?LG?\FL?LT_\
M9 /@W_ZKKPY0 >'/^3I_C)_V0#]FG_U8O[6- 'T!0 4 % !0!\__ +)W_)K'
M[-/_ &0#X-_^JZ\.4 >(Z)_R6+]J;_LM7A7_ -9D_9XH [Z@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H \5_9M_Y-U^ ?_9%OA9_Z@VA4 >U
M4 % !0 4 % !0 4 % !0!XK^TE_R;K\?/^R+?%/_ -0;7: /:J "@ H * "@
M H * "@ H * "@#Q7]FW_DW7X!_]D6^%G_J#:%0![50 4 % !0 4 % !0 4
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M6634H-2A@Z<IUVDU%RI2K1RZBE)IJ6%6-S.I6Y*:I36(P5JE6>&4:'T/4@%
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M^RQ_T;3\ /\ PS?PZ_\ F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\,G?LL?\
M1M/P _\ #-_#K_YG* #_ (9._98_Z-I^ '_AF_AU_P#,Y0 ?\,G?LL?]&T_
M#_PS?PZ_^9R@ _X9._98_P"C:?@!_P"&;^'7_P SE !_PR=^RQ_T;3\ /_#-
M_#K_ .9R@ _X9._98_Z-I^ '_AF_AU_\SE !_P ,G?LL?]&T_ #_ ,,W\.O_
M )G* #_AD[]EC_HVGX ?^&;^'7_S.4 '_#)W[+'_ $;3\ /_  S?PZ_^9R@
M_P"&3OV6/^C:?@!_X9OX=?\ S.4 '_#)W[+'_1M/P _\,W\.O_F<H /^&3OV
M6/\ HVGX ?\ AF_AU_\ ,Y0 ?\,G?LL?]&T_ #_PS?PZ_P#F<H /^&3OV6/^
MC:?@!_X9OX=?_,Y0 ?\ #)W[+'_1M/P _P##-_#K_P"9R@ _X9._98_Z-I^
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MPR=^RQ_T;3\ /_#-_#K_ .9R@#Q#]F3]F3]FW7OV;?V?-=UW]GSX'ZSK>L_
M_P"$^K:QK&K?"?P'J.JZKJNH^ ] O-0U/4]0O- DGOM0NKN::>:XGD>2625W
M=F9B2 >W_P##)W[+'_1M/P _\,W\.O\ YG* #_AD[]EC_HVGX ?^&;^'7_S.
M4 '_  R=^RQ_T;3\ /\ PS?PZ_\ F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\
M,G?LL?\ 1M/P _\ #-_#K_YG* #_ (9._98_Z-I^ '_AF_AU_P#,Y0 ?\,G?
MLL?]&T_ #_PS?PZ_^9R@ _X9._98_P"C:?@!_P"&;^'7_P SE !_PR=^RQ_T
M;3\ /_#-_#K_ .9R@#Q#]F3]F3]FW7OV;?V?-=UW]GSX'ZSK>L_ _P"$^K:Q
MK&K?"?P'J.JZKJNH^ ] O-0U/4]0O- DGOM0NKN::>:XGD>2625W=F9B2 >W
M_P##)W[+'_1M/P _\,W\.O\ YG* #_AD[]EC_HVGX ?^&;^'7_S.4 '_  R=
M^RQ_T;3\ /\ PS?PZ_\ F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\,G?LL?\
M1M/P _\ #-_#K_YG* #_ (9._98_Z-I^ '_AF_AU_P#,Y0 ?\,G?LL?]&T_
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M@ H * "@ H * "@ H ^?_P!K'_DUC]I;_L@'QD_]5UXCH ^@* "@ H * "@
MH * "@ H * "@#Y__9._Y-8_9I_[(!\&_P#U77AR@#Z H * "@ H * "@ H
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MV\@V\CT__AK']EC_ *.6^ '_ (>3X=?_ #1T '_#6/[+'_1RWP _\/)\.O\
MYHZ #_AK']EC_HY;X ?^'D^'7_S1T '_  UC^RQ_T<M\ /\ P\GPZ_\ FCH
M/^&L?V6/^CEO@!_X>3X=?_-'0 ?\-8_LL?\ 1RWP _\ #R?#K_YHZ #_ (:Q
M_98_Z.6^ '_AY/AU_P#-'0 ?\-8_LL?]'+? #_P\GPZ_^:.@ _X:Q_98_P"C
MEO@!_P"'D^'7_P T= !_PUC^RQ_T<M\ /_#R?#K_ .:.@ _X:Q_98_Z.6^ '
M_AY/AU_\T= !_P -8_LL?]'+? #_ ,/)\.O_ )HZ #_AK']EC_HY;X ?^'D^
M'7_S1T '_#6/[+'_ $<M\ /_  \GPZ_^:.@ _P"&L?V6/^CEO@!_X>3X=?\
MS1T '_#6/[+'_1RWP _\/)\.O_FCH /^&L?V6/\ HY;X ?\ AY/AU_\ -'0
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M /\ P\GPZ_\ FCH /^&L?V6/^CEO@!_X>3X=?_-'0 ?\-8_LL?\ 1RWP _\
M#R?#K_YHZ #_ (:Q_98_Z.6^ '_AY/AU_P#-'0 ?\-8_LL?]'+? #_P\GPZ_
M^:.@#Q#]F3]IO]FW0/V;?V?-"UW]H/X'Z+K>B_ _X3Z3K&C:M\6/ >G:KI.J
MZ=X#T"SU#3-3T^\U^.>PU"UNX9H)K>>-)(I(G1U5E(!MY6#;RL>W_P##6/[+
M'_1RWP _\/)\.O\ YHZ #_AK']EC_HY;X ?^'D^'7_S1T '_  UC^RQ_T<M\
M /\ P\GPZ_\ FCH /^&L?V6/^CEO@!_X>3X=?_-'0 ?\-8_LL?\ 1RWP _\
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MFIZ?>:_'/8:A:W<,T$UO/&DD4D3HZJRD V\K!MY6/;_^&L?V6/\ HY;X ?\
MAY/AU_\ -'0 ?\-8_LL?]'+? #_P\GPZ_P#FCH /^&L?V6/^CEO@!_X>3X=?
M_-'0 ?\ #6/[+'_1RWP _P##R?#K_P":.@ _X:Q_98_Z.6^ '_AY/AU_\T=
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M1T '_#6/[+'_ $<M\ /_  \GPZ_^:.@ _P"&L?V6/^CEO@!_X>3X=?\ S1T
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M0JUOJ].;;FDH5,0O80EM.LO91;G[I:O]4^+VE6DU_J?[5_Q5TVPM@K7%[?\
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MWCSTJE.I&]N:G.$U>,DW;\SXV_\ 1T7Q@_\ "2_9I_\ H?J?]AX3_GY5_P#
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MXJ>,<$'TK6FK9=D*VMDV4?\ JNPPL4T\SS=IW3QDVFMK>RI6:L>STC,* "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M_P +&L_^A ^/_P#XC#^T?_\ .KH_M7 ?\_\ _P DJ?\ R ?V?B_^?7_DT/\
MY(/^%C6?_0@?'_\ \1A_:/\ _G5T?VK@/^?_ /Y)4_\ D _L_%_\^O\ R:'_
M ,D'_"QK/_H0/C__ .(P_M'_ /SJZ/[5P'_/_P#\DJ?_ " ?V?B_^?7_ )-#
M_P"2#_A8UG_T('Q__P#$8?VC_P#YU=']JX#_ )__ /DE3_Y /[/Q?_/K_P F
MA_\ )!_PL:S_ .A ^/\ _P"(P_M'_P#SJZ/[5P'_ #__ /)*G_R ?V?B_P#G
MU_Y-#_Y(/^%C6?\ T('Q_P#_ !&']H__ .=71_:N _Y__P#DE3_Y /[/Q?\
MSZ_\FA_\D'_"QK/_ *$#X_\ _B,/[1__ ,ZNC^U<!_S_ /\ R2I_\@']GXO_
M )]?^30_^2#_ (6-9_\ 0@?'_P#\1A_:/_\ G5T?VK@/^?\ _P"25/\ Y /[
M/Q?_ #Z_\FA_\D'_  L:S_Z$#X__ /B,/[1__P ZNC^U<!_S_P#_ "2I_P#(
M!_9^+_Y]?^30_P#D@_X6-9_]"!\?_P#Q&']H_P#^=71_:N _Y_\ _DE3_P"0
M#^S\7_SZ_P#)H?\ R0?\+&L_^A ^/_\ XC#^T?\ _.KH_M7 ?\__ /R2I_\
M(!_9^+_Y]?\ DT/_ )(/^%C6?_0@?'__ ,1A_:/_ /G5T?VK@/\ G_\ ^25/
M_D _L_%_\^O_ ":'_P D'_"QK/\ Z$#X_P#_ (C#^T?_ /.KH_M7 ?\ /_\
M\DJ?_(!_9^+_ .?7_DT/_D@_X6-9_P#0@?'_ /\ $8?VC_\ YU=']JX#_G__
M .25/_D _L_%_P#/K_R:'_R0?\+&L_\ H0/C_P#^(P_M'_\ SJZ/[5P'_/\
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M_:N _P"?_P#Y)4_^0#^S\7_SZ_\ )H?_ "0?\+&L_P#H0/C_ /\ B,/[1_\
M\ZNC^U<!_P __P#R2I_\@']GXO\ Y]?^30_^2#_A8UG_ -"!\?\ _P 1A_:/
M_P#G5T?VK@/^?_\ Y)4_^0#^S\7_ ,^O_)H?_)!_PL:S_P"A ^/_ /XC#^T?
M_P#.KH_M7 ?\_P#_ ,DJ?_(!_9^+_P"?7_DT/_D@_P"%C6?_ $('Q_\ _$8?
MVC__ )U=']JX#_G_ /\ DE3_ .0#^S\7_P ^O_)H?_)!_P +&L_^A ^/_P#X
MC#^T?_\ .KH_M7 ?\_\ _P DJ?\ R ?V?B_^?7_DT/\ Y(/^%C6?_0@?'_\
M\1A_:/\ _G5T?VK@/^?_ /Y)4_\ D _L_%_\^O\ R:'_ ,D'_"QK/_H0/C__
M .(P_M'_ /SJZ/[5P'_/_P#\DJ?_ " ?V?B_^?7_ )-#_P"2#_A8UG_T('Q_
M_P#$8?VC_P#YU=']JX#_ )__ /DE3_Y /[/Q?_/K_P FA_\ )!_PL:S_ .A
M^/\ _P"(P_M'_P#SJZ/[5P'_ #__ /)*G_R ?V?B_P#GU_Y-#_Y(/^%C6?\
MT('Q_P#_ !&']H__ .=71_:N _Y__P#DE3_Y /[/Q?\ SZ_\FA_\D'_"QK/_
M *$#X_\ _B,/[1__ ,ZNC^U<!_S_ /\ R2I_\@']GXO_ )]?^30_^2#_ (6-
M9_\ 0@?'_P#\1A_:/_\ G5T?VK@/^?\ _P"25/\ Y /[/Q?_ #Z_\FA_\D'_
M  L:S_Z$#X__ /B,/[1__P ZNC^U<!_S_P#_ "2I_P#(!_9^+_Y]?^30_P#D
M@_X6-9_]"!\?_P#Q&']H_P#^=71_:N _Y_\ _DE3_P"0#^S\7_SZ_P#)H?\
MR0?\+&L_^A ^/_\ XC#^T?\ _.KH_M7 ?\__ /R2I_\ (!_9^+_Y]?\ DT/_
M )(/^%C6?_0@?'__ ,1A_:/_ /G5T?VK@/\ G_\ ^25/_D _L_%_\^O_ ":'
M_P D'_"QK/\ Z$#X_P#_ (C#^T?_ /.KH_M7 ?\ /_\ \DJ?_(!_9^+_ .?7
M_DT/_D@_X6-9_P#0@?'_ /\ $8?VC_\ YU=']JX#_G__ .25/_D _L_%_P#/
MK_R:'_R0?\+&L_\ H0/C_P#^(P_M'_\ SJZ/[5P'_/\ _P#)*G_R ?V?B_\
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M2I_\@']GXO\ Y]?^30_^2#_A8UG_ -"!\?\ _P 1A_:/_P#G5T?VK@/^?_\
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M&']H_P#^=71_:N _Y_\ _DE3_P"0#^S\7_SZ_P#)H?\ R0?\+&L_^A ^/_\
MXC#^T?\ _.KH_M7 ?\__ /R2I_\ (!_9^+_Y]?\ DT/_ )(/^%C6?_0@?'__
M ,1A_:/_ /G5T?VK@/\ G_\ ^25/_D _L_%_\^O_ ":'_P D'_"QK/\ Z$#X
M_P#_ (C#^T?_ /.KH_M7 ?\ /_\ \DJ?_(!_9^+_ .?7_DT/_D@_X6-9_P#0
M@?'_ /\ $8?VC_\ YU=']JX#_G__ .25/_D _L_%_P#/K_R:'_R0?\+&L_\
MH0/C_P#^(P_M'_\ SJZ/[5P'_/\ _P#)*G_R ?V?B_\ GU_Y-#_Y(/\ A8UG
M_P!"!\?_ /Q&']H__P"=71_:N _Y_P#_ ))4_P#D _L_%_\ /K_R:'_R0?\
M"QK/_H0/C_\ ^(P_M'__ #JZ/[5P'_/_ /\ )*G_ ,@']GXO_GU_Y-#_ .2#
M_A8UG_T('Q__ /$8?VC_ /YU=']JX#_G_P#^25/_ ) /[/Q?_/K_ ,FA_P#)
M!_PL:S_Z$#X__P#B,/[1_P#\ZNC^U<!_S_\ _)*G_P @']GXO_GU_P"30_\
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MV?B_^?7_ )-#_P"2#_A8UG_T('Q__P#$8?VC_P#YU=']JX#_ )__ /DE3_Y
M/[/Q?_/K_P FA_\ )!_PL:S_ .A ^/\ _P"(P_M'_P#SJZ/[5P'_ #__ /)*
MG_R ?V?B_P#GU_Y-#_Y(/^%C6?\ T('Q_P#_ !&']H__ .=71_:N _Y__P#D
ME3_Y /[/Q?\ SZ_\FA_\D'_"QK/_ *$#X_\ _B,/[1__ ,ZNC^U<!_S_ /\
MR2I_\@']GXO_ )]?^30_^2#_ (6-9_\ 0@?'_P#\1A_:/_\ G5T?VK@/^?\
M_P"25/\ Y /[/Q?_ #Z_\FA_\D'_  L:S_Z$#X__ /B,/[1__P ZNC^U<!_S
M_P#_ "2I_P#(!_9^+_Y]?^30_P#DCT7]EC6H]=^.?QWNXM'\8:(L7PG_ &=K
M8VOC7P)XV^'NJN4\8?M+RFXM]%\>>']'U"YT]A,$2]AMGMGDBGB25I;:9(O
MS3$4<3B(3HSYH1IJ+=I+52F[6DD]FO(]; 4:E"C*%6/+)S;2NGIRQ71M=&?>
MM>:=P4 % !0!\_\ [)W_ ":Q^S3_ -D ^#?_ *KKPY0!] 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M&.6!H9-4QM#$5*3I+#X>GFF98C!X%5<3@HQRZ-&O#%SA5IXB<<JE>LJ<,7'
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M5N:G2I8S,:-/%X"='V5.K3K8B5ZZFG3GUG6OC=<_%_QK8^&- UOPA<:W\=_
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MTY87!U_K55)T<1)4ZKE4>#A@8X6Y>>/OVR[W2/A+H5N?$?A7_A*M9^(C:O\
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MI)BFXTJ-?$5)*G0PL%4JSDTE"+G"E'?>4ZM2G2IPC>=2K.%.$93E&+WZ0PH
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MN58[*\55A[U.ZP'LZDGA:,ZN)]C2CBZ<<1AL#/$U(0IPCA7BDOWZ\W!X>-'
M9YA*ZM+,\'F^$H3B_:SI+'87$83"2Q%9QH2Q-6A0J4Z=7$\D*DG!5.24H\L^
M)N?V9O$6C>/9?C7K%AX9U;5;#XG?&/XJ^)-.T.36O$/B#5_#NH?"Z;X>> /
M7AVUE\,V[Z@D^DV>G3:II?[B&:\MH$C^W^5"R>)6K5,#D>-PZH/'3_U=SK!2
MA"ESRQ&99MGM+-6YP;E[3#4*$9X>DY7DJC514*?/4FO0C1>-S#"TXXA82E+-
M.&Y4Y5)J$,'@<IRRIAJTJ52R]CB)YC5G455<M\%4J1G5BXJC+RS1OV*->OO@
MG\(?#&@^'?A_H"7OPGU2U\:Z'XFL[GPS-X$^+'CM-!U.Y^,^BZ!HOA*ZC\1_
M$WPS%:W.DZ?#J4^AW%E'%"MKJ]GY,B3?08SV&$SRK0I8F=?+LKGE%# 8VC45
M3%8>CD]:O+%QPDG:$7Q Y4YXW&TZT9\\9U:E#&QKSI'#@L9.IA_K]+ 1I/'X
MS,\;B<LQ=-0HXFACYREE^#QLN6=18?)X5)JCESHRH3YH0;P\\-1JP]CU[]D;
M5?$J>.9=;E\+ZCK'C[XV?#CQ!JWB*\U+5KC78?@W\.XO 48\/6NH2: 9(/$6
MLMX%BDOK2W-O:R-J1,E_,;.$GBPU:E2K9'5J82E"&#QN=9GCJ5-7IUL9C*F9
MU,LIP4E'VF&PCJY2JE.I[.$5@ZSIT9RE>H36+6%S+#4\3[7FR?+LFP,ZJDG3
MHPHPHYI7JJ,Y<F*K1QV>_5JL'4FUB*$:DJ<:E54^1TO]C/Q]X?SJ'A+Q'X'\
M%>(X='_:G.E:SX>36(6\/ZU\:?$-O/\ #[2]%B@TFT&G^$]!T19[FYMK8VT<
M>K%;JVL[B0M=5S07LLNCA?WE>4<ER/+*M*5:I3ABYX7'QQ^;*KB(<U:E3DJ?
M]GY56C"I4PN"KU5"EAHQ6'J>G[>A4S2&.JX:/)3S[^TX1_B>SP]#)ZN58=>R
MERPJ5\54G3Q^9TW.,,16HPC4KXAVJQQIOV'M7OO#WCBWNO 7P$L+GQ;\4/@)
MXMN/"5A>:Q<^&M7\+?"V/3KOQ3I_B/7KWX<?:+SQ3K6L7?BYY]7ET.[DU2WU
M3R[]HOM4PA[Z5;#4,7D[Y/:X' YSG685*,J-*%/#X?,,NEEN!A@</%NE'ZC"
M&%Q+P?-1H2Q%.I[.O!34X^3*GB5A,?&E6E''U\@PF61KRJSG*OC:>95,?C,1
MB*C2G'ZU%TZ,,0E7K4/949JG4="*J=)XJ_9-^(>KZCXTS8_"CQ5X5\2?%#Q=
MXFB\">*=;URR\(7OA_6?A[X6\#^!M2UK0K?X>ZG;OK/@*/P\S:;H %SI]TTL
M5VFH:7=00?9?,MBJN"PF&KXN4<9'"9O0ECHIU,1@L9F&>U<UAF^"<ITY5,<\
M-4^IS<JN&JX=1O1QE2$ZL*GH1G3H8F5:E!QPV'GD<J&$C+V5*KA,LRROA,3D
MU;DO"C@*^.K/,8U(T<1&<DJ-7 Z*J22?L:>*;C7-&UC5/$6A^(=2\-Z_^S%I
MND^+-;U36KCQ.? 7P'A.JZ_J*[]$D_LWQOK_ (FOM:B*PWDR/IUZR2ZBIGF@
M?V:>8J.;O,_J\*$<1G.?YI6I4XKW*>/R)Y/EN%IR]U3ITYQIXG&IQHPDW)*%
M?V=._E3P=3^R%ED<1[1TLDPF6PYX<M&.)EGJS',:\:=ZCA"&#A1HY<W*I4I5
ML/3_ (*;JKUWXZ_L^:Q\5OBG\-O'.GQ>"$B\%>!OBKX?L];UVU6;Q5X-\8>+
M;/0V\%^//"44OAO4;?4[[0]3TB=UMY[S2&MWOOMEO</-#Y,GA*C4@N(9T:CP
MV*S3+*&#PN(IRE&I2G#$U9XBE4Y'"<*6+PU:>'EB:55UJ--UZ,:,X8JI.G[<
M:V&=+**6(PL<91P&<4<?7P]5)TL1AH4*E*5+F?,DXU72K^RE2E2KU:&&G.=.
M6&I-S?LU? ?7/@_-XQU?6+3PEX<NO%6F>#=-F\(^!-7U;7/#DVJ^$K#4;35/
MB'K.M:QX;T*ZUGQYXKN=02XU2\N-,:?&G6D4U[J#Q?:#ZV+Q?M<#6PV'IQH.
MKCL9C:%%0C'#Y;3Q%#"4:66810LOJ>'GAIXCFA2PT:E7$U9+"TI*4JOCT<-4
MIXG#5*V)GBOJF!HX*IB9\SQ.85*>(Q%>>/QBE.?+5E&M&E2H>VQ'L(0G;$SA
M4C3H_.5A^QA\7?[%\8WEOXN\(_#WXA:EX:^(OAR+Q/X'UW5]1OOB$_Q$^*=G
M\2=7U3QIK6J> [%_"T26T.I:+I^EVVF>*(M)7Q#?W:3WWF-:S<"O3RO"X-0C
M54:7#-'$85J$</4AD%*O3KRE6J4L2J]3,I5^:K*M@?9PH4_J=2EB*%3]WZM6
MO]8S+$8FM*3IRQ.>8C#XE\SQ6%_M+#1P>7TJ5.E5P[ITLKHT</4DJ6,IU,7B
M</0KPJX.K152?H/BOX/>)?A9^Q?XW^%'@3PBTGC?QQ;77AIM \*7[>(M)M=8
M^)>LV7AK6-5L[OPK\,/"-AH&@6VG:C<:G=S:=X(T33K 17=RUD561Y]L>_[0
MQ'#V 4%7P=/%9?3K+$5*E&G#"8?$O,<;3JXJ=3%U(4G&%?#4)R<FH3H8;#8:
M"6'PD<<HG4RRMFV;2GR8VC1QN,HN*5>=3%8? _5\N5.@HX55*\YTL(ITXM3J
M5%4K8C%5)RK8IT/!_P"QUJEOK?ABZ\4Z7\.M.\&O\43\2_%WPO\ #NIZSK'A
M:RFT+X3S_#;PS8V,]_X3TE?&]_J=_=3:WKVI:IIVBK=2B.)[.[_>2R]-/$4H
M5U4JQ>)]EALYE0E*$81P^.SG'X&M.GA\/S3IT<#A,%1QM*C:<YRQ>*J8J-'#
MNIRT>)1Q4,)3H4)K"SC'(\%5G&<Y5:^ R2>-Q<,14Q"C3J?7JV-EET%!1Y*.
M!P<,/]8J>PA[6Q9_LD^+[WQGXXUGQ'>>"?)U32?C9HEMXML+W5;CQA\1-"^*
M<4MIX4\'?$"P;PS8P>'O!O@32VAM-/TRPU77X)Y(([V&'3)/,BN/'KX>=3(<
MPP5*;I9AC<MA@YQ<Y3P];,*>*IXQY]B:S_>SS"K4INE&+H3>"P]:M0HXBK0]
MG1AZ\*V&HYUE.84*4J>'RW,L#CJ5N2-3"83"9?+!3RC"4TN18*M5G]<J-5**
MK5J%"5:A.LY8A-\+_LL?%+1V^#_B75?$W@W4/B%H&J:WK'Q%U:&^\01:;;7M
MO\*-4^&'PV_X0N";1'.K:=X5L;Z1Q8W<.@I=SZKJ>H"2VGG:";U,QQ$ZU;._
M[/JRPL,TRO.:4*THQ5:.<9QCLOQM;&3C!V]G&G@HY;1FJLJV&P-'"QMB)1FG
MY. H?5<'EF&K_O8Y=BLBI.E%QC3K9-DT,7?"3J*G%NIB,;B%FTU*E.#Q3EAW
M45*G0K0\\TO]BSXM6OA[XA2V>I_#;P-X^\5?#/X2^!Y?$O@W7-8O]8\<WOA'
MQ/J.O?$[4_B!XM\1_#:2:?4O&\+:;:R:K?:-XH>WAW6UQ9:A;6VS4%B98.I2
MJT\/@HX?"8G.J>85,M@Z<,%' T,N5#"X&*G0K4JGU;'XC&8BM*>"4<Q@J;Q"
MI3KS5#IHRK>VP]7%UEB,9AL!FV&CF?LW'&2Q688JC*&)]G3JTE1I0PF%P]*A
MAJ&)A_9LYUE@JKC"DR;QC^Q%XQUKX?:1\.],T;X57OA<?#W4=%;PWXR\3ZIJ
M>E?#[X@>(O&2:SXJ\<^!K;0?A'I.B7&IW7A^XO;/3KFP\,>#5T*2(1Z;91VM
M]-'#4:U-9MA\54O5PF$Q?#TJ,W&<L32R[*\15K8[+Z<JU>O5BL6JD(2K2QLY
M8FA1I86O&G3A3E3S7M:."K+!M87&UJ>>>TIQY%@Z^)QF#PM'*<57HTZ5*E4^
MHU\(ZLZ,\-4M5Q=?&JK7Q,9K$_2W[0OP5\6?$O2_!6A>%['X>Z]X3\/:7XML
M]5\ _$JYU>+PCJFJ7?A<Z7X#UO4++3] UF#Q%#X?U>,3+I6H6:1$W:WL5PEU
MIL"3>5F%+$8VMFM>52+K8W+\30P]62O/"8VOB\-6EC*:Y6HUG0I5J%/$0E&K
MA?:R=.-2-6I%=>6/#X##99AE[6G# XW SJQI2:6)R_#X;%X>O@:C4H.5*I.O
MA\1*E-2I8EX6-&JJ:DJL/ - _8J\66/B+P-;7K^ [3PWX+T']G.RT?Q=I^NZ
M[>^-_"[? Q[O5=5T+PMH-UX,MK2!/$VOZMKJW/B1O$$-P-.U2>S;2665B/HG
MF2><9CF:3A"6;9ICL-!0BY5<)C,EIY+A,%B).:5"EA*=-8BK3@L5'%3C&$I0
M<858>3&AB_[&PN6UJL*M266+"XE6MAZ6/Q&;2S3,,QP\(PC[2K4Y,-2PBE'#
M_5*E%8B/,DZ$X]8_8[^+.I6OQ8N;7Q%X%TOQ?XJ\"?&/P;;>-4U?Q#<ZW\5V
M^*'B.UU31KKXLS#PE!)X?L?"7AZVET'2K"PF\4Q6L=\]Q9&RCC^PR^/AU"CE
MN&PL\+3J^]PY'%X/F<<+B5D^(A6S+'2K*G[2689VE.-2<L/S8:G*5!XC%0E"
M5'VUC*RS2.+]IRK"XG'8O!8I4X?6<'&O@Z^&P&6T:#_<QP.7U:E'$S?MK8W$
M4(8BKAJ==U)U-*^_8]\6^)O$NE>)?&N@?!SQ#;0?'CP'XVOO!^H7VK:QHEO\
M+_!/PA7X>:5X>L+_ %GP!,]UK6GZW<7FJ?9)K&&TU);>$276GM,PM_1PV(H8
M;,,'CKU)5XU.)<77Q*485HYCF^)HRP6*H0C.S5#"8+!4YP=:E+#8F/UJA4KR
MPU&-3R70<LIK9<Z-*"AE?#^6X>"YI4W3RK%5\9C:=6;2<8XJKC,92C6C2J.6
M#JRPM6@HUJK?T3XZ^$6O>+/C=X)\:ZGHW@3QW\.-"\/)8P>&/&M]>03_  ]\
M96>LOJMM\2O!>@MX2UK2_$GBB2W6RL(Y+VXT&XTV.Q,EG?-]LGA;SL)[3#U,
MWJ^UE0Q6+IT5@\;22EB<&Z='%TZN'IQER>SI8J>(A4KUZ=93FJ<:56A6A"G;
MLQ')+!8##T$XQH3Q,,5A6Y0PN-P^(>!]FZ_))J3P,<-7^KX>I0J4IRQ4VJF'
MDN=_,#?L8_$F^T7X@65_JW@>RUOQMX.U+X;^*?$NF>(?$#ZQ\7=)\4?$#2M=
M\0?$+XDWK>"K:2S\7:9X-M]3T?0]$C.N6ME_:,L$&JVEE((H-L!4CAZ&5X>M
M"-/#4,;PUB:^%I)RHTO]7_:U<37P\I2IRK8O/<0Z,L=5J1H580I)U:^-J1C)
M&+E.>-QF*PM:<*BI<1RP=::O5A5SFC[++L#.+E4C2R[)=%34)55B.2G4AA<(
MXRA4Z%?V,;R+QQX>U^;P]\*==\+Z/^TAXH^+*^$=6:\%E9>%M0^&>G^!M >P
M6?P9?PR^*8=:TRV\0WUF\,,-Y?I%=/JAN;9)6>$Q5?#1P-5PIK'X3*<_PT*T
M%RO#YAF6>RS? U<-:,7'#T:$8X-N/L981UZ];#TJW*J=;EQ6']K0QV#I3_V/
M%5>'(.G4BI.O@LJRWZGC8XIW?-7JU:M5TI2598C"4:6$KRH0K2]A#?\ ['7B
M(?#WP/HL>B?"GQ1KLM[\0-8^+_A[Q5J6LKX+\7^*/'E[K>KZ=XIGU%O ^IWO
MBW_A#-:\0ZQ>Z/HFJ:;86C3:@\\4NF7444Z<M:G/DPF!PV*G0P>$R3"Y7A\2
MH)8G+\;0H9=1J9QA*,:D8RQU:&!E157ZU0Q%*C.$:>)C3C*A/T8UHK$8_&U%
M.K7K9Y5S.--RY8XK+E4QT:&38FHKJCA?8U\#4K<E#$TIU\"O:8>LZGMH^W_!
MKX+>*_A1XV\5^(O$6N6WC32V^$GP?^'V@>([B_U>]\;7"?#32=;BUM=6T>;2
M9(@-3UC5KC4DGMM7NY9I)Q%+;*\*S3]V89GS8;B/$1POLZN.SG&YO2HT(<_-
MAYX#!8?#X9\JC-U<//"UE"$*<XU'BIS@Z<I2IOR\)@:L)</X?ZRIT\ORQX*:
MF_94J>+JYA6Q%:M14I3C'#U:$\)1_>3A*A# TH-UH-3I_(?PR_9:^,OC7PGK
M7Q#NI=*^!?Q"\9^&OC9<Z;K-A=^('^).IWOQN\71^)K:V^(,6I>$]*G\!6?A
MW3+:.TM-$MY/$4MK=:A-?F:&YADM;CGEAOJ.6X;+XNG*M2P.083%86A5I3P6
M(_L^O3S#,:E7$NEB(5\5CJU3$X-3E@ZU#!X:KB*'_"A0K6CZ=;%RQ.;8VO92
MPU'-<PQ.#Q-2E)U:<:67XC(LNC1PDIP4<)&A#!YA5?UJG/'U,-A'*E@W33/9
MOA;^Q_-X7U/X7R^)?#_@IO#_ (,A^)WB;7?# \2IXFT[4/B;XNA\+:!H>K6.
MFZ-\(/ /AJ'1X?#&CZN]S';>%M*5=0U/[3]DN[MYM0DZY8BG2>(JX>/[_#99
MAL#EJLZ2PTGF$\UQS=3GKU*/+C*& >!JT$EAX1J1P^'P5*C0H/S7A_K&&6'Q
MJ]O+$YE#%8ZM*7/*OA\/EV+P%&$J?LX>WJ5ECZZQ7UFI4J5Z=&E]9Q6,G6JN
M'/6/[*'Q-M?#OB 7&B?!S4IO$/QGE^(?B+X<ZQXAOM2T;XB^%+G1==MV\'_%
M/XOP_!FRUOQU8V/BG76UK3[?7/"&K&&WT^#2+F[NX"ES;\%*E1IX#)\OJ15:
ME@,-CZ&L%"EAZ^(CAZ.$S.&%A)4,=F6$H4)1J8F:P,\75JT\74E#'898NMWU
M)0J8S/,5>I0GF'U'V5:$^:NXX;%*OBL.I3_>8' 8VFHTE@J>(Q=/"-5849/
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MA\-AW6UA:GB<)3K.-)7E@85<MH3E/#X>O4H5LT]EB9PA?$2K?8E0,* "@ H
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MPZ_Z&/\ : _\2Q_:G_\ GR4 '_#-/PZ_Z&/]H#_Q+']J?_Y\E !_PS3\.O\
MH8_V@/\ Q+']J?\ ^?)0 ?\ #-/PZ_Z&/]H#_P 2Q_:G_P#GR4 '_#-/PZ_Z
M&/\ : _\2Q_:G_\ GR4 '_#-/PZ_Z&/]H#_Q+']J?_Y\E !_PS3\.O\ H8_V
M@/\ Q+']J?\ ^?)0 ?\ #-/PZ_Z&/]H#_P 2Q_:G_P#GR4 '_#-/PZ_Z&/\
M: _\2Q_:G_\ GR4 '_#-/PZ_Z&/]H#_Q+']J?_Y\E !_PS3\.O\ H8_V@/\
MQ+']J?\ ^?)0 ?\ #-/PZ_Z&/]H#_P 2Q_:G_P#GR4 '_#-/PZ_Z&/\ : _\
M2Q_:G_\ GR4 '_#-/PZ_Z&/]H#_Q+']J?_Y\E !_PS3\.O\ H8_V@/\ Q+']
MJ?\ ^?)0 ?\ #-/PZ_Z&/]H#_P 2Q_:G_P#GR4 '_#-/PZ_Z&/\ : _\2Q_:
MG_\ GR4 '_#-/PZ_Z&/]H#_Q+']J?_Y\E !_PS3\.O\ H8_V@/\ Q+']J?\
M^?)0 ?\ #-/PZ_Z&/]H#_P 2Q_:G_P#GR4 '_#-/PZ_Z&/\ : _\2Q_:G_\
MGR4 '_#-/PZ_Z&/]H#_Q+']J?_Y\E !_PS3\.O\ H8_V@/\ Q+']J?\ ^?)0
M ?\ #-/PZ_Z&/]H#_P 2Q_:G_P#GR4 '_#-/PZ_Z&/\ : _\2Q_:G_\ GR4
M'_#-/PZ_Z&/]H#_Q+']J?_Y\E !_PS3\.O\ H8_V@/\ Q+']J?\ ^?)0 ?\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
: H * "@ H * "@ H * "@ H * "@ H __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>156
<FILENAME>g20922ndsp11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922ndsp11.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /W\H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H \_P#B
MQXZ_X5=\+/B7\2_[+_MS_A77P_\ &7CK^Q/MW]F?VQ_PB/AW4M?_ ++_ +2^
MR7?]G_:O[/\ (^T_9;GRO.\SR9-FQ@#\\O\ AX3\3?\ HWGP)_XD!X@_^A\K
M[7_43-_^@G!_^#*W_P SGQG^O.4_] ^+_P#!='_YH#_AX3\3?^C>? G_ (D!
MX@_^A\H_U$S?_H)P?_@RM_\ ,X?Z\Y3_ - ^+_\ !='_ .: _P"'A/Q-_P"C
M>? G_B0'B#_Z'RC_ %$S?_H)P?\ X,K?_,X?Z\Y3_P! ^+_\%T?_ )H#_AX3
M\3?^C>? G_B0'B#_ .A\H_U$S?\ Z"<'_P"#*W_S.'^O.4_] ^+_ /!='_YH
M#_AX3\3?^C>? G_B0'B#_P"A\H_U$S?_ *"<'_X,K?\ S.'^O.4_] ^+_P#!
M='_YH#_AX3\3?^C>? G_ (D!X@_^A\H_U$S?_H)P?_@RM_\ ,X?Z\Y3_ - ^
M+_\ !='_ .: _P"'A/Q-_P"C>? G_B0'B#_Z'RC_ %$S?_H)P?\ X,K?_,X?
MZ\Y3_P! ^+_\%T?_ )H#_AX3\3?^C>? G_B0'B#_ .A\H_U$S?\ Z"<'_P"#
M*W_S.'^O.4_] ^+_ /!='_YH#_AX3\3?^C>? G_B0'B#_P"A\H_U$S?_ *"<
M'_X,K?\ S.'^O.4_] ^+_P#!='_YH#_AX3\3?^C>? G_ (D!X@_^A\H_U$S?
M_H)P?_@RM_\ ,X?Z\Y3_ - ^+_\ !='_ .: _P"'A/Q-_P"C>? G_B0'B#_Z
M'RC_ %$S?_H)P?\ X,K?_,X?Z\Y3_P! ^+_\%T?_ )H#_AX3\3?^C>? G_B0
M'B#_ .A\H_U$S?\ Z"<'_P"#*W_S.'^O.4_] ^+_ /!='_YH#_AX3\3?^C>?
M G_B0'B#_P"A\H_U$S?_ *"<'_X,K?\ S.'^O.4_] ^+_P#!='_YH#_AX3\3
M?^C>? G_ (D!X@_^A\H_U$S?_H)P?_@RM_\ ,X?Z\Y3_ - ^+_\ !='_ .:
M_P"'A/Q-_P"C>? G_B0'B#_Z'RC_ %$S?_H)P?\ X,K?_,X?Z\Y3_P! ^+_\
M%T?_ )H#_AX3\3?^C>? G_B0'B#_ .A\H_U$S?\ Z"<'_P"#*W_S.'^O.4_]
M ^+_ /!='_YH#_AX3\3?^C>? G_B0'B#_P"A\H_U$S?_ *"<'_X,K?\ S.'^
MO.4_] ^+_P#!='_YH#_AX3\3?^C>? G_ (D!X@_^A\H_U$S?_H)P?_@RM_\
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M?^C>? G_ (D!X@_^A\H_U$S?_H)P?_@RM_\ ,X?Z\Y3_ - ^+_\ !='_ .:
M_P"'A/Q-_P"C>? G_B0'B#_Z'RC_ %$S?_H)P?\ X,K?_,X?Z\Y3_P! ^+_\
M%T?_ )H#_AX3\3?^C>? G_B0'B#_ .A\H_U$S?\ Z"<'_P"#*W_S.'^O.4_]
M ^+_ /!='_YH#_AX3\3?^C>? G_B0'B#_P"A\H_U$S?_ *"<'_X,K?\ S.'^
MO.4_] ^+_P#!='_YH#_AX3\3?^C>? G_ (D!X@_^A\H_U$S?_H)P?_@RM_\
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M?^C>? G_ (D!X@_^A\H_U$S?_H)P?_@RM_\ ,X?Z\Y3_ - ^+_\ !='_ .:
M_P"'A/Q-_P"C>? G_B0'B#_Z'RC_ %$S?_H)P?\ X,K?_,X?Z\Y3_P! ^+_\
M%T?_ )H#_AX3\3?^C>? G_B0'B#_ .A\H_U$S?\ Z"<'_P"#*W_S.'^O.4_]
M ^+_ /!='_YH#_AX3\3?^C>? G_B0'B#_P"A\H_U$S?_ *"<'_X,K?\ S.'^
MO.4_] ^+_P#!='_YH#_AX3\3?^C>? G_ (D!X@_^A\H_U$S?_H)P?_@RM_\
M,X?Z\Y3_ - ^+_\ !='_ .: _P"'A/Q-_P"C>? G_B0'B#_Z'RC_ %$S?_H)
MP?\ X,K?_,X?Z\Y3_P! ^+_\%T?_ )H#_AX3\3?^C>? G_B0'B#_ .A\H_U$
MS?\ Z"<'_P"#*W_S.'^O.4_] ^+_ /!='_YH#_AX3\3?^C>? G_B0'B#_P"A
M\H_U$S?_ *"<'_X,K?\ S.'^O.4_] ^+_P#!='_YH#_AX3\3?^C>? G_ (D!
MX@_^A\H_U$S?_H)P?_@RM_\ ,X?Z\Y3_ - ^+_\ !='_ .: _P"'A/Q-_P"C
M>? G_B0'B#_Z'RC_ %$S?_H)P?\ X,K?_,X?Z\Y3_P! ^+_\%T?_ )H#_AX3
M\3?^C>? G_B0'B#_ .A\H_U$S?\ Z"<'_P"#*W_S.'^O.4_] ^+_ /!='_YH
M#_AX3\3?^C>? G_B0'B#_P"A\H_U$S?_ *"<'_X,K?\ S.'^O.4_] ^+_P#!
M='_YH#_AX3\3?^C>? G_ (D!X@_^A\H_U$S?_H)P?_@RM_\ ,X?Z\Y3_ - ^
M+_\ !='_ .: _P"'A/Q-_P"C>? G_B0'B#_Z'RC_ %$S?_H)P?\ X,K?_,X?
MZ\Y3_P! ^+_\%T?_ )H#_AX3\3?^C>? G_B0'B#_ .A\H_U$S?\ Z"<'_P"#
M*W_S.'^O.4_] ^+_ /!='_YH#_AX3\3?^C>? G_B0'B#_P"A\H_U$S?_ *"<
M'_X,K?\ S.'^O.4_] ^+_P#!='_YH#_AX3\3?^C>? G_ (D!X@_^A\H_U$S?
M_H)P?_@RM_\ ,X?Z\Y3_ - ^+_\ !='_ .: _P"'A/Q-_P"C>? G_B0'B#_Z
M'RC_ %$S?_H)P?\ X,K?_,X?Z\Y3_P! ^+_\%T?_ )H#_AX3\3?^C>? G_B0
M'B#_ .A\H_U$S?\ Z"<'_P"#*W_S.'^O.4_] ^+_ /!='_YH#_AX3\3?^C>?
M G_B0'B#_P"A\H_U$S?_ *"<'_X,K?\ S.'^O.4_] ^+_P#!='_YH#_AX3\3
M?^C>? G_ (D!X@_^A\H_U$S?_H)P?_@RM_\ ,X?Z\Y3_ - ^+_\ !='_ .:
M_P"'A/Q-_P"C>? G_B0'B#_Z'RC_ %$S?_H)P?\ X,K?_,X?Z\Y3_P! ^+_\
M%T?_ )H#_AX3\3?^C>? G_B0'B#_ .A\H_U$S?\ Z"<'_P"#*W_S.'^O.4_]
M ^+_ /!='_YH#_AX3\3?^C>? G_B0'B#_P"A\H_U$S?_ *"<'_X,K?\ S.'^
MO.4_] ^+_P#!='_YH#_AX3\3?^C>? G_ (D!X@_^A\H_U$S?_H)P?_@RM_\
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M0A-QY.90G*E5C"37+*5.HDVX22BT_P"&_P 1-5-X-*\!>--2.G7DFGZ@-/\
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M5:M3H5)T<-R^UJ1A)PI<TE&/M)).,.:348\S5Y-):M'2V?PM^)VH6EM?Z?\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@#]'/\ @G7_ ,B+\<_^R_S?^J-^!E?BO%O_ "4&8?\
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MVXBJ2M2S+),)G^"DK6^LX%PJK"U-]:F%]E]7J/64HRIN3A%4H'YSU^IGY2%
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M_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\
M_P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_
M *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^
M7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H
M_P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\
M5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$
M_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_
M *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [
MZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1
MW^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]
M\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8
MOCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*
M^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_
M /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#R
MD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'
M_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6
MWA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7
M_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\
M_P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_
M *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^
M7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H
M_P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\
M5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$
M_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_
M *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [
MZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1
MW^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]
M\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8
MOCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*
M^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_
M /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#R
MD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'
M_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6
MWA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7
M_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\
M_P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_
M *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^
M7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H
M_P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\
M5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$
M_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_
M *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [
MZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1
MW^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]
M\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8
MOCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*
M^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_
M /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#R
MD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'
M_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6
MWA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7
M_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\
M_P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_
M *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^
M7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H
M_P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\
M5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$
M_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_
M *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [
MZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1
MW^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]
M\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8
MOCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*
M^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_
M /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#R
MD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'
M_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6
MWA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7
M_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\
M_P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_
M *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^
M7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H
M_P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\
M5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$
M_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_
M *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [
MZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1
MW^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]
M\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8
MOCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*
M^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_
M /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#R
MD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'
M_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6
MWA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\ _P 1W^.7
M_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_ *(]\?\
M_P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^7!_8OCK_
M *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H _P#*^&_^
M7!_8OCK_ *(]\?\ _P 1W^.7_P [ZC_6WA[_ *&'_E#$_P#RD/\ 5//_ /H
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M1*49/UV[\>:MX>^$/P9N?&7C_P (^+=7\=>(OA_HNH_$/0C=>#?#.O0:AO\
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MS]S+:.:9?0ISH3<L5B88G$4ZM&E*A254<5AN>C7P\9XN$</C<S]E!0G6GEV
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M:3I.FZ#I>G:)HUC:Z7I&D65MINF:;90I;V=A864*6]I:6T$8"Q0101HBJH
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M,()R3G4FXTZ4.:I4E"G&4EI"#G)0BXIO;FE&$=-=93<8KYM=MRGH_B#2=?\
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M]B.>BXUYX%YLY5G"5&=:K3UK4%//<RS'-J6 DG1]C+,L+F$.3%P]A6P4\-'
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M\0Z*A4E2:A5CR=E^R_-?:_I^D^+]+\$ZO\+O#WB+1=7T?1)KJ\U5]2TSPO\
M!C3OACX9T'6_"][X8@T]M-L=3NO%.HM!-J6I13?:[=FC5G>&#OK8NK4Q6.S&
M#^KYEB99U7IUHKGE2S',,RP%?!YC"3<?9U\+EV"IX1*$6Z56E2K4JKDU*EY>
M'H2PF78#+*$HQP]+!9/@,6E'EEB<'@99GC,5A9S;G*4:V:8C!XA55[)U\.JV
M&K4H1A*6,\P\+?LB^/\ P]HNN7&MV?@'XB^*M:\9:7<>-K7Q;XQBL/#7QO\
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MQ4ZD(4JN(>)RQYCZ2?VC/@^LOB& >)=1>7PTEB\Z0^"_'<YUY=2O;K3+#_A
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M7%8?%8S#Q;4XN<,-BJV'A5E"I"$Z3K0I1JNE./-2<_9MR<7)]Q7.:!0 4 %
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MK&T=9UZU6L^:5ZNUN<N_V9_#.K^(_AQXR\3^+O$WC#QC\-(IK/3?%'BKPO\
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M6,88VI4M%1E[2G2M)4U4IU/*F_92\)3Z?8:/>^._B/=Z-I?@#Q#\/=-TWS?
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MI&M*MDO^S%X4CG\./8^+_'EA8>'[+X>Q7&@Q7OAQM$\5ZG\+]<D\1>$=;\7
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M#A,+@J%_8X2E3HPYFG+EI04(N322<FHWDTE=W=D:U<YTA0 4 % !0 4 ?/\
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M?SVEDS64$OV,QW-[9"6*67/"_OL1RU4Z&"^NX/ *O%>TG*OB83J5N6BN6]/
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M(1C*%;"6JSJX>M)88S]"_:@\1ZLEM%/\+;"PU3Q-X>\#ZY\/])7XA)<3W_\
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MXE_X6)_PKC_BG_%UUHED-2T&;4EDO;;4I]*L?,M LLT%M\XCJK2?MLGI8/\
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M^#5%5L.^?S;5_P!H7XD:'XS\,?#>Y^"L&K^.=733=?US3_"/BCQWXF\/^'/
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M  H * /G_P"#?_)1?VL?^S@/#G_K+'[-- 'T!0 4 % 'S_\ M8_\FL?M+?\
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MC#X?$5)I*4ZU"C5DW.E"48KGX8?#2]U;Q#KUY\// UWKOB[2#X?\5ZU<^$M
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M4_VH_'%CX6A\2^.O%7A6?Q/XOU&Z\67%O\,OL=WX#T30/"NL+JN@:!J'Q+^
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ML;A(4<2\1B,/SX:GA<8\50CA\/6Q4:?V]7";A0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M5,OQF%P-)TXPAA5B,++!+"*WM*U/#RPM25.M4IXAT)XF%+,995/$<\'P&O\
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MO&/_  K>U\%VGAKX27IUO3?';>+-!\9>(U\0^#-'\<:_#H-CH?Q-T3P[X8^
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M"\3AJV)<\1B,)@*V'P^(PM'+)2S6EAU+"XBGB85:.)6,RP,JN#IY-2I^SHK
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M>UJ3?+0C7JU:M3F24:WM\?C</2G&\OJ:I:P=6K1A\]Z#^RIXREL=7MO$MO\
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MQ_[. \.?^LL?LTT ?0% !0 4 ?/_ .UC_P FL?M+?]D ^,G_ *KKQ'0!] 4
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M:4W:-&M&<H2I55#FM5_:-\#:9XOTSP>KW-Q/!_PDD_C?Q'_9GBFT\"^#M/\
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M2;HT\1%TIQJTIT*LZM.%6E6IN5&K!U*-6G)TJD^2=.4)\LE8]%K(T"@ H *
M/G_X-_\ )1?VL?\ LX#PY_ZRQ^S30!] 4 % !0!\_P#[6/\ R:Q^TM_V0#XR
M?^JZ\1T ?0% 'GWC3X?IXOU/PGK=KXJ\3^#M<\':A=W6GZKX7'AB:>[L-3AA
MM]8T'4K3Q;X9URRETJ_AMK999(;6WO8O(5K2\MF+,Q1_<8J&*7OJ-&I0J49?
MPJU&K5P]9PJ./+5CRU<+0J1E1JTIW@XN4J<IPDZEJF%GA6E&]6%>E45U4H5Z
M=+$4(5J>OLY25'%8BGR5Z=:DU4YG3]I"G.'D^G?LJ?#?2=>^(.N:?<:G:?\
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M*56AA\%B,#"E=4(1AB_;+$UX?5%AY4L36A4I0E4HRI*"PF%=*%.<*DZN!+\
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MB405ABJ='%X>6%J4(1P_L<THPA'G_=?VMBJV(Q%6$IRG-UH4J]3 49U)5/\
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MHOZW.IEF3XS'XC"T*RC[18C'8K#83ZC%TW+&X>MB<71P]7 UJ.&P76Z;\?\
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M/LN"$YRIU^?#SA1EB\%A:E&$>?,J%:&'S+.*N#PE.4\/*MC<1#*L)@J$*]'
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 ?/_P;_P"2B_M8_P#9P'AS_P!98_9IH ^@* "@ H ^?_VL?^36/VEO^R ?
M&3_U77B.@#Z H HWVIZ;I<<$NIZA8Z=%=7MGIMK)?7<%I'<:CJ%PEII]A ]Q
M(@FO;FZDCAA@0EY9)%1%9F +BG*<*45S5*G/R06LI>RI5*]3EBM9>SHTJM:=
MD^2E3J5)6A"32E*-.$JDY*%.GR*4I-*,?:5(4:?-)V4>>K4ITH7:YJDX0C>4
MHI\!HMA\+?%&G?$CP[X:U/0]>M-8UW7=+^)EMX>\52:A?6WB75-*M-/UK2]9
MO=*U9[WP[K2Z.+&(6J364UK$+<PI" AJ%2C5R_!0Y/;98_;O#.2]I0JQECJ^
M*Q"C.7-&O!XVMB'5@W.%Y3H27LU[-;4JE3!9E4Q5.U#,X2PE>?-&/.G1P]'#
MX2I.C-.*C]7PM&,+PY*JIN;4Y2G*7<Z3/HY@DT[1;FPE@T&5-$GM;"YAN!I-
MQ:6ELZ:7=)%(QM+F*RGLW\B7:XCGB8C;(I.U2I4KOZU4DZGUJ56:J=*DHUJE
M*M*,E[LN7$4ZM*?+\-6G4INTH22Y*-.CAX+!T4H1P4:5+V2=Y4H^QIU*,))M
MRCS4*E*I#FUE2J4ZBO&<9.W>7EGIUG=:AJ%U;6%A86TUY>WMY/%:V=G:6T;3
M7%U=7,[+';VT4*.[R2,JHJ%F( )K&<X4HN=2<:<([RDU&*Z:MV2.FG3J59PI
M4H2J5*DE&$()RE*3=HQC%)N4FVDDDVWHB6&:*XBBGMY8YX)XTF@FA=9(IHI%
M#QRQ2(2LD;(RLK*2"""#@UI.$J<I4YQ<)P;C*,DU*,D[.+3LTTU9IZIZ&4)P
MJ0A4IR4Z<TI1E%IQE%J\91:NFFFFFM&M49%UXE\.6-]_9=]K^B6>I!M(3^SK
MK5;&WO@_B"[N[#05^R33K+NU*^T^_M[0;,W,ME/'#O>%PJA&4W%4XN3E.I3B
MHJ]ZE'#O%UH)+>=+"IXFI%:PPZ=:25-<Q51JC356J_949-)3G[L&W5HX=)2=
MHMNOB,/123UJUZ-->_5A&5Z\U+3M/>QCO[^RL7U*]33=-2\NH+9[_4)(9[B.
MPL5FD4W5ZUO;7,JP1!G*6\C!=L;$)-.<:2UJ24W&"^)JG!U)M1W:A",IS:5H
MPBY.R38VFH3J6M3I<G/+[,/:5(4:?,]H\]6I3I0O;FJ5(05Y2BGCZI9^%_$E
M_;:+J4ECJ&I>&[S0_%R:0NHE;W3IXKJ^'A[6+S3[:Y20VC7VG7YMFNHV@DGT
MR5D#26A,3A%QG2Q=--2PLZ]*%17Y85*^$GAZ]-_9<Y8/&2BXRO*-.O&:46X2
M%5IJ=!T:L+T,6X22DM*CP>)PV*BX-Z_N<32PU23@]'R0G[E1QETM("E8:EIV
MJP/<Z7?V6I6T5W?:?)<6%U!>01W^EWL^G:G9/+;R.J7=IJ%K<VL\)(>&:VEB
MD57C90W%I4Y6:C5A"I!VTG3J14Z=2+VE"<&I0DKQE%J46TTQRBX3E3DG&=/E
MYHM6E'FA&I'FB]8\T)PG&Z5X2C):23=VD(* *>H:CI^D6%[JNJWUGI>EZ;:S
MWVHZEJ%S!96%A96L33W-Y>WERZ16MK#"CR22RNJ(J,S$ $T)7E""5Y5)PIPB
MMY3J24*<(K>4YSE&$(J[E*2C%-M(N%.=2<:=*$ISD[1C%-R;Z)15VWY)%*\T
M+1]3U/0]<N[5;G4/#S7T^AW1GN EE)JEDVGWD\<$<P@FEDL9)85DECD9$GE$
M942ON(ITJM2I&\*LZ$\+/?\ @SKX?$3IN+T5Z^$P\V[<R=))-1<D\7[.O2H)
M\M2E3K0Q5)JS2JQH8C#PJQDM6O88NO!*[A)5.9IRC"4;5IJFF7\^I6MAJ-A>
MW.C7B:=J]O:7=O<SZ5J#V5IJ26&I0PR,]C>-IU_870AF".8+VWE"^7,C,^67
M)3JV?LZO/R3M[L_9U)TJG++:7)5ISI3LWRU(3@[2BTM))PDH23C)PC446K/D
MFY*$TGKR2<)*,MFXR2;Y7:_2$% !0!Y6?!GPUD\9:G\3[G4+G4=>\,M=6]Y<
MZM\0O%&L^%O!-W;Z/#%J,]AX/U3Q+<>&? ^L#0KA/M-Y8Z7IUVUO?RM/*R7D
MAEFG5A@</7KQJ1HX?%QJ<^(J23O2IXB4*U.&)JN4J>'CBL.X5J-*I"@J^'Y)
MPYZ"4'*+QM>CADG5K825."P]*\?WDX1K4'6P]+E5:NZ=>%2A4KPJ5E3K0E2D
MH3BWL:1\4_ACK^EIKF@_$;P'K6BR&Y6/5](\7^']1TMS9:,OB*\":A9ZA) Q
M@\/NFIR@2'R[-Q=-B AZUJPGAUS5H2H15*5>\TX+V%.M3P\ZUY67LH8BK2H2
MJ?!&M4ITFU.<8N8-5)T:=-\]3$5(T:,8ZRJUI^WY*5.*NYU)?5<3RPBG)_5Z
M]D_95.7N(9HKB**>WECG@GC2:":%UDBFBD4/'+%(A*R1LC*RLI((((.#2G"5
M.4J<XN$X-QE&2:E&2=G%IV:::LT]4]!0G"I"%2G)3IS2E&46G&46KQE%JZ::
M:::T:U1)4E%,ZCIZ:A'I+7UFNJRV<VHQ:8;J!=0DT^WF@MI[Z.R+^<]G%<7-
MM$\P0HKW$2,P:102*YO:\OO*A[+VEM?9^V]K['GM\/M?85_9<UN?V-7EO[.=
MDY1A*G"4E&595'3BVDYJC[)57!/62I>WHJHXWY/;4N:WM(7N4#"@ H * *UY
M>6>G6=UJ&H75M86%A;37E[>WD\5K9V=I;1M-<75U<SLL=O;10H[O)(RJBH68
M@ FIG.%*+G4G&G".\I-1BNFK=DBZ=.I5G"E2A*I4J2480@G*4I-VC&,4FY2;
M:223;>B)89HKB**>WECG@GC2:":%UDBFBD4/'+%(A*R1LC*RLI((((.#6DX2
MIRE3G%PG!N,HR34HR3LXM.S335FGJGH90G"I"%2G)3IS2E&46G&46KQE%JZ:
M::::T:U1D:KXE\.:"XCUS7]$T9_L%[JH35=5L=.?^R]-FL;;4=2"W<\9^P6M
MQJ>FQ37'^KB?4+9796GC#J$93DH4TY2=2A248J[]KBJCI86E9:^TQ-6,J5"'
MQ5JD7"FI2314VJ5&IB*G[O#T5.4ZLO=IPC2I5*]1RF[1BJ="C5K3;:4*5*I4
ME:$)-<W<_%CX666N2>&+OXE^ +3Q+!KFE^&9O#USXR\.P:Y#XDURVDO-%\/R
M:3+J*W4>N:A9PRSVMBT0GN(XG>*-U4D%&,L3R?5HNO[1XF,/9KGYI8*$9XQ1
MY;\SPD)1GB4KNA"495>1-,*S6&4I5_W$84Z-:3J>XHT<15=##U9.5DJ=:LG1
MHS?NU*J=.#E-6._I % !0!@:/XK\+^(+[7=,T#Q)H&MZEX6U!-)\3:=H^L:=
MJ5]X<U22!+J/3==M+*XDETC4&MG246]VD4A1U<+M(-$%ST:>)IKFP]652$*L
M=:<YT6HU81FO=E*E)J-2*;<&TI)-BDU3K2P\WR5X0IU94GI4C2K)NC4<':2A
M549.G-KEFHMQ;29OT#"@"G+J%A;WEGIT]]9P:A?I=2V%A+<PQWE[%8B)KV2S
MM7<27*6ZSP&5HU81B:/?C>,B:<I0B[SC!U'%;JFIPIN;2U4%.<(.3]U3G"-[
MR28URQ4W[L)35-2>B=24*E2--/9SE3I59J*]YPI5))<L)-7* *5OJ6G7=U?V
M-I?V5S>Z3+!!JEG;W4$UUIDUS;1WEM#?V\4ADLY9;.:&=$F5"\<J.H*L"2+4
MHN<?>A&<J;DM4JD%&4X76BG&,X.4?BBIQ;24E=R3A*,9+EE*"JQ3T;IRG4IQ
MJ)/5PE4HU::FO=<Z52*?-"21>ZCI^F)!)J-_9Z?'=7EIIUJ][=06B7&H7\RV
MUC8P-.Z":\N+ATBBA0EY'=512Q I77-&%_?DJCC'JU2I5*]5I;M4J%*K6J-?
M!2I5*DK0A)J92C3A*I-J%.#@I2D[1BZM6%&DFW9)U*U2G2@G\=6I"G&\IQ32
MPU33-4T^#5=,U&QU'2[J'[1:ZE87=O=Z?<6XS^_@O+>1X9H?E;YT<K\IYXI3
ME&E3]K4DJ=)4U5YY-1C[*4%4C4YG9>SE3:FIWY7!J2?*[E*,O:2I*+]I"I.E
M*%O>C5IS=*I2E'=5(5(RIS@US1G%P:4DT5(O$?AZ;3-*UJ'7M&ET;73IBZ'J
MT6J6+Z9K#:T8ET==*OTG,&H&^:>$6PMWD\\S((M^\9VG2JTJ_P!5J4Y4\3>I
M'V,HN-6]&E4K55[-I2O2HTJM6HK7A2I5*DK1A)J)2C3C4G.2A"C-4YRDTE";
MK1PT83;LHS>(G"@HNS=:<:27/)1>S6913.HZ>FH1Z2U]9KJLMG-J,6F&Z@74
M)-/MYH+:>^CLB_G/9Q7%S;1/,$**]Q$C,&D4$BN;VO+[RH>R]I;7V?MO:^QY
M[?#[7V%?V7-;G]C5Y;^SG9.482IPE)1E651TXMI.:H^R55P3UDJ7MZ*J.-^3
MVU+FM[2%[E PH Y+4/'W@32;BSM-4\:^$M,NM1\21^#M.MM0\1Z/97%_XNE@
MCNHO"MG#<7B/=>)'MI8I5TR(-=-'*CB(JP)=).M.C3HIU9XBGB*M*,%S2JTL
M).I3Q52G&-W.GA9T:L,1.*<:,Z52-1Q<))3*4:<,34G)0IX*5&.(E)I1H2Q$
M:4\/&LW94I5XUZ$J*GRNK&M2<.95(7Z"XU/3;.[T^PNM0LK6^U62XATJRN+N
M""[U*6TMI+RZBT^WDD62\DALX99Y%A5RD<3NP"J2%%<TI0A[TX4Y5I16KC2C
M4I4I56EJJ<:M>C3E-^ZJE:E!OFJ03)2C34'.2@JE14H.324JKIU:L:4;VYJC
MI4*U105Y.G1JS2Y:<VKM!04 4K#4M.U6![G2[^RU*VBN[[3Y+BPNH+R"._TN
M]GT[4[)Y;>1U2[M-0M;FUGA)#PS6TL4BJ\;*&XM*G*S4:L(5(.VDZ=2*G3J1
M>TH3@U*$E>,HM2BVFF.47"<J<DXSI\O-%JTH\T(U(\T7K'FA.$XW2O"49+22
M;NTA!0 4 % !0 4 % %&#4]-N;G4+.VU"QGN]'DABU:U@N[>6YTN6XMH[VWB
MU"".0O922V<T4Z+,J%HI4D4%&!,N<(TIUG)1HTY3C*=TH1E3C&52,I?#&5.,
MX2FFTXQE%RLI*[<6I0IV:G.$:D(V]Z5.4ZE*,XK=PE4I5:<9+W7.E4@GS0DD
M[3M1T_5["RU72;ZSU32]1M8+[3M2TZZ@O;"_LKJ)9K:\LKRV=XKJUFA=)(Y8
MG9'5PRD@@UK4IU*,Y4JL)4JE-N,H2BXRBUNI1:3BUU32:$URRE%^[*G*4)+9
MQG"3A.$EO&4)Q<91=G&2<6DTT)?ZEIVDP)=:I?V6F6TEW8V$=Q?W4%E ]]JE
M[!INF622W$B(UW=ZC=6MK!""7FFN(HHU9Y%4S&+E.%*"<JD^;E@E>4N2$JD^
M6*U?+3A.I*R]V$)2=HQ;347:<DGRTH2J3=M(4X1<ISD]HPA%.4I.RC%-MI(N
MTA!0 4 % !0 4 4[_4+#2K9KW4[ZSTVSC>")[N_N8;.V22ZGBM;:-I[AT17F
MNIH88U+ O)*B+EF )=<U.%_>JSA3A'K.I.2C"$5O*<Y-1A%7E*322;86M&<M
MHTH3J3?2%.E"52I4D]HPITXRG.3M&$(RE)J*;+E !0 4 % !0!3@U"PNKF^L
MK6^L[B\TMX(M2M(+F&6YTZ2Y@2ZMH[Z"-R]H\MK)',BRJA>-U=<JP)(M2BY1
M?-",Y4VUJE4A&$I0;6BG&-2G*4?B49P;24HW&N648/W92@JD8O1NG*=2G&HE
MNX2J4JL%)>ZYTJD4[PDE<H Q+GQ+X<LK]]*N]?T2TU2(Z.)--N=5L(+^,^(;
MN[T_0 ]G+.LJ'4K^POK:SR@^TS64\4.]X75:A&4^7V<7+FG5I1Y4W>I0P_UN
MM35MYT<+_M-6"]ZGA_WTDJ?O"J-481JU7[*G*W+.?NQ=ZU+#JTG9.]>O0H*S
MUK5J5->_4A%Z\LL5O%)//)'!!!&\LTTKK'%#%&I>2221R%CC5%)+,0  23@5
MG.<*4)U*DXTZ=-.4I2:C&,4KN4I.RBDE=MM)+<N,93E&$(N4Y-1C&*;;;=DD
MEJVWHDM6S'\-^)O#?C'1K+Q'X0\0Z'XJ\/:BLK:=KWAO5K#7-&OUMYY;6=K+
M5-,N)[:Z6.Y@FA<Q2MM>%T.&4@:SI5*3BJM.5-SA"I%2BX\U.K"-2E4BFE>%
M2G*,X27NSA*,HMQ:9FI1<JL(R3E0J3I5(IJ].K2DX5*4TM8U*<TXSA*TH23C
M))JQN5!13M-1T^^>]CL;ZSO'TV\?3M12TNH+A[#4(X8+E[&]6%V-K>+;W5M*
M890KA+B)BNV121*\*=1:TZO/R27PS]G5J4*G++:7LZU*K1G9OEJTZE.5IPDD
MN://4I<R]I0<%4A=<U-SI4ZT%..\7.C5I58)I<U*I3J*\9Q;N4#"@ H * "@
M H ^?_@W_P E%_:Q_P"S@/#G_K+'[-- 'T!0 4 % 'S_ /M8_P#)K'[2W_9
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MIPJ58TX5O9^WE"+IP56K4<,-AHM48>W5R'4% !0 4 % 'S_\&_\ DHO[6/\
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M)7M))M)WU9-4&@4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 ?/_P &_P#DHO[6/_9P'AS_ -98_9IH ^@* "@
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MPH4J6&R_!TX>SP^5^T6&A%M>RC4I4:-2#DGSU*<H8>A>G5E."G2IU%%5(J9
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M27UK*ZDZ^!G*_LZ.(JO#JK*M"FZ=3$T90P]/_9Y5J=-5J=&OJZ3A/G/^&:/
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M/#8OFJ<SG5PW)0JKF=ZLJ*YY\\Y5!]U\"_AA>^)-4\5W.@7LFKZQ!=Q7:?\
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M4J<TG*M4PM2:<I.$W@J4*.&A*G?V<J-)0A4^KN+H3Q,5BZE.6*7MC1\*>#=
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MT\7"K.<*6YIOQQ^-MR_AN6XTOX?&*PN/@UX?\<:3:^'_ !,->UCQIXV\-?\
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M(8BK+!TZ>/IN%*BU0KNGR5'AJE>?N=8%A0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % 'S_P#!O_DHO[6/_9P'AS_UEC]FF@#Z H * "@#Y_\ VL?^36/VEO\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^?\
MX-_\E%_:Q_[. \.?^LL?LTT ?0% !0 4 ?/_ .UC_P FL?M+?]D ^,G_ *KK
MQ'0 ?\,T_#K_ *&/]H#_ ,2Q_:G_ /GR4 '_  S3\.O^AC_: _\ $L?VI_\
MY\E !_PS3\.O^AC_ &@/_$L?VI__ )\E !_PS3\.O^AC_: _\2Q_:G_^?)0
M?\,T_#K_ *&/]H#_ ,2Q_:G_ /GR4 '_  S3\.O^AC_: _\ $L?VI_\ Y\E
M!_PS3\.O^AC_ &@/_$L?VI__ )\E !_PS3\.O^AC_: _\2Q_:G_^?)0 ?\,T
M_#K_ *&/]H#_ ,2Q_:G_ /GR4 '_  S3\.O^AC_: _\ $L?VI_\ Y\E !_PS
M3\.O^AC_ &@/_$L?VI__ )\E !_PS3\.O^AC_: _\2Q_:G_^?)0 ?\,T_#K_
M *&/]H#_ ,2Q_:G_ /GR4 '_  S3\.O^AC_: _\ $L?VI_\ Y\E !_PS3\.O
M^AC_ &@/_$L?VI__ )\E !_PS3\.O^AC_: _\2Q_:G_^?)0 ?\,T_#K_ *&/
M]H#_ ,2Q_:G_ /GR4 '_  S3\.O^AC_: _\ $L?VI_\ Y\E !_PS3\.O^AC_
M &@/_$L?VI__ )\E !_PS3\.O^AC_: _\2Q_:G_^?)0 ?\,T_#K_ *&/]H#_
M ,2Q_:G_ /GR4 '_  S3\.O^AC_: _\ $L?VI_\ Y\E !_PS3\.O^AC_ &@/
M_$L?VI__ )\E !_PS3\.O^AC_: _\2Q_:G_^?)0 ?\,T_#K_ *&/]H#_ ,2Q
M_:G_ /GR4 '_  S3\.O^AC_: _\ $L?VI_\ Y\E !_PS3\.O^AC_ &@/_$L?
MVI__ )\E !_PS3\.O^AC_: _\2Q_:G_^?)0 ?\,T_#K_ *&/]H#_ ,2Q_:G_
M /GR4 '_  S3\.O^AC_: _\ $L?VI_\ Y\E !_PS3\.O^AC_ &@/_$L?VI__
M )\E !_PS3\.O^AC_: _\2Q_:G_^?)0 ?\,T_#K_ *&/]H#_ ,2Q_:G_ /GR
M4 '_  S3\.O^AC_: _\ $L?VI_\ Y\E !_PS3\.O^AC_ &@/_$L?VI__ )\E
M !_PS3\.O^AC_: _\2Q_:G_^?)0 ?\,T_#K_ *&/]H#_ ,2Q_:G_ /GR4 '_
M  S3\.O^AC_: _\ $L?VI_\ Y\E !_PS3\.O^AC_ &@/_$L?VI__ )\E !_P
MS3\.O^AC_: _\2Q_:G_^?)0 ?\,T_#K_ *&/]H#_ ,2Q_:G_ /GR4 '_  S3
M\.O^AC_: _\ $L?VI_\ Y\E !_PS3\.O^AC_ &@/_$L?VI__ )\E !_PS3\.
MO^AC_: _\2Q_:G_^?)0 ?\,T_#K_ *&/]H#_ ,2Q_:G_ /GR4 '_  S3\.O^
MAC_: _\ $L?VI_\ Y\E !_PS3\.O^AC_ &@/_$L?VI__ )\E !_PS3\.O^AC
M_: _\2Q_:G_^?)0 ?\,T_#K_ *&/]H#_ ,2Q_:G_ /GR4 '_  S3\.O^AC_:
M _\ $L?VI_\ Y\E !_PS3\.O^AC_ &@/_$L?VI__ )\E !_PS3\.O^AC_: _
M\2Q_:G_^?)0 ?\,T_#K_ *&/]H#_ ,2Q_:G_ /GR4 '_  S3\.O^AC_: _\
M$L?VI_\ Y\E !_PS3\.O^AC_ &@/_$L?VI__ )\E !_PS3\.O^AC_: _\2Q_
M:G_^?)0 ?\,T_#K_ *&/]H#_ ,2Q_:G_ /GR4 '_  S3\.O^AC_: _\ $L?V
MI_\ Y\E !_PS3\.O^AC_ &@/_$L?VI__ )\E !_PS3\.O^AC_: _\2Q_:G_^
M?)0 ?\,T_#K_ *&/]H#_ ,2Q_:G_ /GR4 '_  S3\.O^AC_: _\ $L?VI_\
MY\E !_PS3\.O^AC_ &@/_$L?VI__ )\E !_PS3\.O^AC_: _\2Q_:G_^?)0
M?\,T_#K_ *&/]H#_ ,2Q_:G_ /GR4 '_  S3\.O^AC_: _\ $L?VI_\ Y\E
M!_PS3\.O^AC_ &@/_$L?VI__ )\E !_PS3\.O^AC_: _\2Q_:G_^?)0 ?\,T
M_#K_ *&/]H#_ ,2Q_:G_ /GR4 '_  S3\.O^AC_: _\ $L?VI_\ Y\E !_PS
M3\.O^AC_ &@/_$L?VI__ )\E !_PS3\.O^AC_: _\2Q_:G_^?)0 ?\,T_#K_
M *&/]H#_ ,2Q_:G_ /GR4 '_  S3\.O^AC_: _\ $L?VI_\ Y\E !_PS3\.O
M^AC_ &@/_$L?VI__ )\E !_PS3\.O^AC_: _\2Q_:G_^?)0 ?\,T_#K_ *&/
M]H#_ ,2Q_:G_ /GR4 '_  S3\.O^AC_: _\ $L?VI_\ Y\E !_PS3\.O^AC_
M &@/_$L?VI__ )\E !_PS3\.O^AC_: _\2Q_:G_^?)0 ?\,T_#K_ *&/]H#_
M ,2Q_:G_ /GR4 '_  S3\.O^AC_: _\ $L?VI_\ Y\E !_PS3\.O^AC_ &@/
M_$L?VI__ )\E !_PS3\.O^AC_: _\2Q_:G_^?)0 ?\,T_#K_ *&/]H#_ ,2Q
M_:G_ /GR4 '_  S3\.O^AC_: _\ $L?VI_\ Y\E !_PS3\.O^AC_ &@/_$L?
MVI__ )\E !_PS3\.O^AC_: _\2Q_:G_^?)0!@?LY>&M.\'^)_P!J+PYI-SX@
MN]/T[X_Z+]GN/%/BSQ5XYUU_M?[,O[.-]+]N\4^-=9U76M4VSW,BQ?;;^X\B
M%8K>'R[>WBBC /I^@ H * /G_P#:Q_Y-8_:6_P"R ?&3_P!5UXCH ^@* /.?
MBO\ $2U^%7@;4_&EWILNJQV%YH6G1VBW46G6JW/B'7=-\/V=WJVK7$<D6BZ#
M:W6IPW%]J,L<B6EI!<3E'\L(T>_*OA,+1]DJ^.K1P])UJOL:*JRA.4(U*O)4
M<?:.'LJ484ZE2K7J4J%*G.I4A%[4J<)0Q=6K4]E1P.%Q.+JM14I^RPE&=>HJ
M<'*"G4<(/E3G"*UE.<(1E./":=\;[OP_I^MW'QH\+6OP_ETE/#TVF:EX0U;Q
M%\4O"/C<>*&U--(TOX?ZO:> ]$U?Q?XL#Z7*L^@6/AQ[U/M-F\"7,5W%(VTE
M2C"BHRJ?6JF)K83ZK*D_K$IT*%+$RK4:5*56=7">QJ3<J[C#V4L-BE6A3C1<
MGSQ]IS.4E2CA/81KK$^WIJC33K+#NEB)3=..'K>VG2C2C)RAB/;TEAZE2JZE
M*G<U']I3X,Z5H&C^)+KQ5?OI^MPZU<VMGI_@SQUJ_B2PM/#-TMCXIOO$7@_2
M?#-SKWA*PT*^9+;5KK6]-T^'2YG6+4'MI&"E5(^QJQI3G!1<*%1UU4A+"0I8
MERCAJU7&QD\'1HUY0J1HUJM>%.I*G4C&3=.:CI&%1JI:E4C4IS=)47"<<34J
MQA"HZ.'PLHK$XFM[*I3K1I8>E5J2H5(5HQ=*<9OJ9OC%\-8+;6+S_A*;:6TT
M'Q!X.\*ZE<V=EJM];Q>(/'\?A^;PCIEM-96$J:A+J$'BGP_*'M#/'#'JD4EP
M\2!V2I4JM-PC4I3I.=;&T(J<90;J9=3K5<;I))J&&AA\0ZM5VI*5"O#G<Z52
M,9C:5*->+3HRP$,RC/F7)+!5)UJ=*M&5[2=6IAZD*5)7K59>S5.G)UZ/M/(=
M>_:]^%%CX3D\;^';^^\3>&[/0?%WBBZN(_"WQ(TZZU/0/!^FQRZG?^#(Y/A_
M/:^*TM]:U#1-.O)5O+*TL1J$TL]WYEE);/S2G45*-2EAJM>5>AAJF&IPA+VM
M6KCZ^"HY?"4)1C*E1QBQEZ-=J4IU*?LZ5"JHXFIA>J&$G+$RPKE"E*AC9X/$
MSE*]'#SH1S.>+C*I2513Q&&CE6*G]6@G*=.,)*4?K&!CB]K3/VG/ #:/)K7B
M"6^T<?:=&TFV\-Z;X6^)_B#XA/XBNO">C>+M>T23X=6_PWM_$$DVCZ;KVF2W
M$MA8Z@L,$S2WXTZ2&6"/MQ-".%KNC[:%2,JN-=&K"4'1E@L%B%@JF-KU%)PP
M=.&-A7P]=XAQP]"4*2^M3G5=.EP8>I*O3HU.6-'GH824H3J04XXG%_6:E+"P
M2;C6G4P]".(PZIR=;$TI5*U/#_58T<3B>DU;]HKX.:)+X;CO/&!FA\4Z)I7B
M73=3TCP[XJU_0;+PYKEV-/T;7_$_B+0M#O-+\$Z)?7^^VMK[Q#>:7!--#-%'
M(SP2*D1HU7C9Y?R<N*IU:6'<9-1@\1B$Y8?#PK2:HSQ&(2OAZ$*DJM?FA[&$
M_:4^:ZDE0P3Q]52IX:+Q'-S1DJL5@N7Z[.>'M]8A3P/-'Z]5E25/!7_VF5+4
MUO'_ ,6-$^'GB#PCI&MMI]IIFNV'C+7]>\0:GK$6E6'A/PKX*T>&^U+7[H2V
MLJWD)U/4=#L/+:6U53JHD\UFC6&?"E.,J^*HS4XQPV$5=2C"51SQ%7'X+ X7
M!1A'WG6Q3Q->=",>><WA)TJ=*<IWAI.G65##5Z-)UU7QM+!Z-1C3C/!9ACIX
MB<WHJ=*GE\E+2R=6,ISA",I&-#^T7\(Y] N/$*Z_K44-MJ]IH/\ 85UX!^(5
MEXZN]8U"SEU+3;#2OAM=^%8_%FLS7NEP7%_:_8-%N1<VEM-=P&2WA>5+:<50
MT<O;RJ02C[\J4J"IO$1Q,8WEA'AHU:4\5]:5'ZM"K2G7]G"I!R44I2Q$8RC;
M"4Z=:<^>*HNC6J2I4*M*NVJ.(I8BM"='#U*$ZD,16A*C1<ZD7%9R_M+?":Z@
MM-7TGQ?HE_X672_&VLZSK)3Q1%/96'@74=&T'6&TRP@\*7$>L7$/B37M.TN2
MU>\LK@W$KQ6<5]/;W$%N<LXP=9P<J$H83V+I)UJE>MF.,K83+H4:--.=:GCI
M83&RPM7#^VE7]C0G1I5,-BZ>)C+:5X.4:%6E7G2K0Q$EAO80H9>\QQ<ZKK<K
MIRP=&>&>+5:-*EA55J1Q5>AB:,<-6I/^TY\.)[WPZFEWQ_LJ[D\<2>-+WQ39
M^(/ .K_#K3? >@V.KZK=>)?"'B_P]9:U8W;W&N^%H([._L]-9X?$-M=Q/*CP
MI=4H.,Y>T3]A]2^M4:M%+$QK5YYGA<KH8&"H.=\36KU<5%4H\U>-; UL,Z#J
M\RIJ3FJ<)4Z<I2^NT,+4C43H1HTJV7YAF7UR<ZJBOJT:& DU52=&2J*?M8PA
M.2S]<_:P^&>GVF@/HUKXXUW5-=^('A;X?GPV_P ,OBGHGB?2KOQ+'/J,>J:K
MX7U3P*FM6.F+X=L-5U6WN)M-C@OX=-F%K.RJ\D10INMB\#A4U&.,EC8NJY1]
MGAY8##JM7IXEW2P]6+JX6$Z5=TIT:>*IXRLJ>"A5Q$(KUH8;"YGB+2JO+*.'
MK.G2BZCK4\5B?JF'K4'&ZQ&&G652FL3AO;PJ5J4L)AU7Q\Z&$JZTO[3GPIT>
MSM;KQ/XCM;$7TVKW<$OAS1_'GB[3]+\)V/B74O#6G^+_ !G?V/@:!? 6@W5U
MILZOJ>NI9Z0DT%REKJM];P?:Y%AH_6Y8&E0]ZKC*&!JQO:%%5,QH4\3@L/'$
M3<:7M\51JTI8;#571QE9S4%A54]TVJKV2Q,U&<J6'KXO#I>SE[>=7+G[+,N3
M#0YZM2G@L3&K2J5J'MJ*IQI5I5*?ME3CU=M\=?A;>>,W\ VGB.YN/$D/B*;P
MC.L/AGQ8^AVOBB'0[3Q(OA^[\7+H?]@VFKSZ'>PW=K:S:FDEVJ3K:K,]K.L)
M1A*O&,J2]V<,5.GS?NW46"Q%;"XM4E4Y75J8:M0J^VI4U*I3I0>(E!8=JJ\I
MU:=+FO+F4/JKFX7J*G#&PISPE6HZ?,J='$*M2A2KSY:,J]2&'4_;R5-V/&GQ
MK^&?P\\06'A?Q?XCDTK6[_0KWQ1':QZ%XCU2&T\,Z7?6NG:IXCUC4-'TBZL]
M T"QN;VW^U:CJ=Q:6UM&7GGEC@BDD3.$XU)8J,9)?48T95Y2]R%+ZS'%2PZE
M.5H<U=X.O3HP4G.K75+#0C*OB<-3JZRC.'U1>SG*6.J5*6'A3A*I.M4HO#JI
M"G"FI3E*"Q5&<DHZ4O:UOX5"O.GD6/[0_P (K[0==\1Q>)-0@L/#L^DVVH6>
MI>#?'&C^(YY/$$KP>&CH?A#5O#=MKOB>'7)HY(](FT;3K^/57B==.>Y9"!I.
M%2G##S=*HWB:M7#PIQA.==8BA25>OAZN&A&5>A7HX=K$5J-:G3JTL.U7J1C1
M:F12J4JM6I2C5IQ]C3C5E4G4A2P[HSJ>QC7ABJDH8:I0E67L%7IU94G7_<\_
MM?<+O@[X\_"GQ]<6-IX3\42:E=W^M:YX<ALY?#WBC2[N#7?#&C6.N^)-*U&U
MU?1;672+S2K'4K*.]CODMS:WDITZ;9J$<EJCG3=."J.=.5*6#K9A&I"K2J4I
MX+#XR&7U<13J4YRISIK%SC3@X2DZL>:M24Z,)U(S.I&E+V<U*%15Z.%E3<)J
MI3Q&(PV)Q="C6IN//1G4PN$K8B*K1A^Y]E4=HXC#NKS-U^TS\*+(Q:C-XGL3
MX6GT[P;/::I;:9XVO=8O-4^(&OZUH'@RPLO#MGX+E^V6^K7'A_53;S07LEP?
M(C=[-+6YM[J>81J24'[*;>)G&GA80A.=6M4AE7]M8FG.BHJK2JT<NJ86O&ER
M5)S=:=":HXJE&A6UQ">&E4C5<:7U1XN.+522@\/]5S&AE/.U=WHO'SKT)UY^
MRHQ]A[6C/$4/K%7"[WA_]H'X3>)]>B\-Z1XDO3J<\=^86U/PGXST'29+[2+2
M2^UOP\GB#7O#UGI1\8:3:07,NI>&_MO]KZ<+2X^W65N;>41DDH4<9B'.'L,!
M3G7JU%4@Z;PU.I&E/%X><9..*P4*LH4Y8W"NMA54G"#K<TX)QS<M7"T'3J0K
M8N5*%.G*E5A.-6O!U*%&O&4%+#8BO33J4,/B52K5J:<Z=.44V:?P[^-'PW^*
MLM_;^!]<O=0GT^RL-5:#4_#/BOPK+?Z%JKW$>D^)=!C\6:'IC>)/"=\]I<K:
M:[I(O=-N3 X@NI-IK66'K4Z<JLZ;I*E-4JL)^Y6H57!5%2Q.'E:OA:LH>_&G
MB*=*<HJ346HRL2G&-2-*]W+VO)*/O4JOU>HJ5?V-:-Z-;V-24(U?93G[-SI\
MUE4AS8\?[1'P@DU?5]%_X2FYBFT6T\2WD^I7/A7QC:>&-1B\&03W/BV/PSXR
MNO#\>@^,+W1H;6Z-]::%J6HW%JUK,DT2/$ZKQRKTH8.OCYRY,+AL-#&3<E*,
M_J<Y0A#%TZ,DJU;"SG5HQAB*-.=&4JU!*;]M2Y]E1G];PF!BE+$XS$+"4HQE
M&<5BVIM8.K4BW2P^+<:562PN(G2K\E*K/V?+2J./2> OBUX"^)<NI6_@W5[R
M_FTJRT74[F'4/#GB;PW)-I'B*">XT+7-,3Q-HVGG6M!ODM+U(-3T\75H\MA=
M0";SK6:./NJ87$483G5I."I8BMA9IM<U/$8=0=2E4A?GIRY*E.I#GC%5:-2G
M6I.=*<9OEIUZ554)4I<U/%48XBC-*7LZM*5ES4ZEN2;IMJ-:G&3J4)RC"M&G
M-I/@]0_:7^%WAZ]U.U\3^((+*&TUWQ!IEO=Z#HOCWQ5;V&E^%=0M?#_B'Q!X
MXN],\#+9^ -(L/%37^F3ZGJ-V^CI]C23^UB[RP6F.$7UWZG3H7E7Q<:<DI+V
M=%?6<5BL/E\(UZKA#VN81PLI86C45&MB*JJ4\)3Q5*-/$5M\1&IA*E>%6'+[
M%1<8*\\1-+ X3'XB4,-34ZDZ>&H8W#SJU*/MHTJ=:D\3]7JS="/21?'CX52^
M,;KP(OB:9-?M)]1LFEF\.>*K;PS<:IH^E?V[JV@Z;XXN-$3PWJWB2RT4/?W&
MC6.K7%_#;0RS26RQPNR9*<7A,9CK\N&P%*O7JRDG"7L,+7>%Q.(I4Y)5*^'P
M^)3PU>OAX5:5+$6HU)QJM1:2O5P]&#52>)GAJ</9M5(QJ8RE&MA*=:<'*&'J
M8JC*%7#PKRIRK4ZE.=-2C4@Y,U#X_?"32=)T/6]0\6K::?XE\(67CG06DT/Q
M(;O5?#NJ7NDZ;I$EGIB:.;R75]1U'7-+M;'1?L_]J7LUR8[6SF>&41]%>A6P
MN*QN!JTI/&Y?5HT*^'IQ=:M&MB(XV=*G"E1]I.M+DR['5)JC&I[&GAJDZW)#
ME;SHUJ->&&JTJ])T,7'$SI5G5IQP\J6#EAX8BN\1*2HPP\)8O"I8B=2-"H\1
M1]E4GSQO3F_:*^$=OIOA?4G\0:PQ\8ZSK'ASP]HL'@3X@7/BZZ\0^'K*?4=;
MT&Z\#VWA:3Q#I&M6-E;RRS6.H:9:SH H,>74,J=*57$4,+1<*U3$4'BJ<J=2
MG.B\-'%4,#4KO$1DZ$*5'%8BG1Q$YU(QP[5:5=TX8?$2I*I6IT:->O5YJ=/"
MUX8:JI4ZBG"O5P]3%T:7LG'VKEB,/3=3#\L&L0IT50=26(H1J;/Q ^-GPU^%
MUS967C/7;RPN[RQFU=K72_#'BSQ3<:5H-M(L-WXF\20^%-#U)_"GA2WF81SZ
M[K(L-.A?*RW2$$#*G*-2O/#PG%3I.DJDI2C"C2E7E*&'A5Q$W'#T9XB4)K#P
MJ58SK\D_9*?)*VZA-TZ,XPE)XASC1IQC)UZSI0C.JJ.'2=>LZ49TW55.G)TG
M5I1J<LJM-2M>'/B_\/\ Q=XOU_P+X8UB]UKQ!X5:*/Q#]@\-^*)=!TB:?2M$
MURTMKOQ=_8HT%+NZTGQ#I=U;6XU(RW*/<>0DAL;L6V\:%65"IB>3EHTJM6@W
M-JF_;8>O5PU>E"$W&<YT*U&<*T81DZ2]G.:C3JTI3SE*$/JRYXR>+HT<124)
M1J/V&(A.I0K25-R=*G5A3DX2J\BD^6*?-."D^\^+GP\L(9KB[\1)#!;^,[SX
M?/(=,UEU;Q=IVG7&K:AI,!CTYOM0M=/L[V:>[A\RUB%E<K).KV\JIQ2Q%&&'
MHXJ4[8>O0QV)A-)M?5\L>*CC*LDDW"-*6"Q$8\ZBZTHTXT%5>(PZJ[0I5:E;
M$T(4Y2JX.>!IUHJ+]R>9/ QP2O;EDJSS+!+F@Y1I>VO6=-4ZOL^3TC]I3X+:
MUH>J>)++QC+#H>DZ'X>\22:AJWA?QCH$6IZ'XK98?#FH^&4UWP_9R>,(-0OF
M%A -"346:_\ ^)?M%\#;UUXBC5PLJE.K2DJ]'%+!2H0BZF)^LM.4*2PU)3Q$
MO;0C.>'G&FZ>(ITZE2A*I"G4E''#SCB?9NC)2IU:%;$1JR]RA['#<OUJ4L1/
MEH0>%YH/%PG4C/"JI2>(C356FY<3H_[7WPLU/5?&D$CZ[;:3X6U70_#FG^3X
M/^(>H^._$'BB\T1O$'B/0H?A):>"#XML;GP]IEQI,M_NTV9H%U!WNX[1+<M)
M%-*>'A6E*,75Q.,A3Y9PJ47@\%3P*JYA4Q,).CA\-'&8JM@JLZ\H4J-;"M3K
M<]54X$O:1Q2P_L^6G]4PE9SJ2]E/ZQC,1F5.C@H4:BC.K6J8;+UC:*I\T\1A
MZ\:E&G*E!U9=EKO[37P1\.SZ+;W_ (T>X;7_  [H/B_39-!\+^,?%%J/"GB7
M5&T71O$NH7OAGP]?V^BZ%-JB_9WOM1EM8+=W3[2\*R(6J-.;QT\N4'];I8G"
M8.46K0CB<?SK!476=J*EBG!J@_:<M1\JBVYPYBK..'P<L=6_<X:%+,*SYTXU
M5#*E1EF/^SM*OSX*->G+$4_9>TIQ55N%J%=T]J?X]?"2UN?$=G+XQMA<^$O&
M1^'WB"*/3=<G:P\7IX8_X3.;1P8=,<7A@\,++?SW-L9K:!+:X6::.2WE2/GG
M6IT\'2S"4O\ 8ZU/,:L:J3DO9Y4ZL,?.2BG*$:$Z,Z:<U'VU25*G0]K.O0C4
MZ%AZSQ$\+&FY5Z4<OG*"U<8YIB*6%P#;5TO;UJ]**5[TXR]I6]G2C*:\A\3?
MMD_#72]"7Q/X8@USQEHTVF>$;JQAT_P9\5[37]5N?B%X@L-!\"3Z/HK?#"<:
MKX8U2235L:O;7,C?:=*%A:V=[=W&R#MCA:ZQ]++JM&I3KU<=0P-HQY_8RMC*
MN.GB%>/LOJF$PCQE.*YUB<-+V[GA\/+#5L5R0JQK82>-H-2P]+"X[%.=3FHP
MFL'3P?+2H3G'EJ5)XC'8?"UU)TU@ZE3]\W['%K"^K6_[07PCN==OO#L7BJ07
M^FPZT]Q=2^'/%=OX?>Z\,V=QJ'B31++Q7<:&FB:EXITFQL[N:_T"SU"?5+-+
M.<W-G%Y+[>2=2G2PF-QTI)83 49XBK46J>%IU(TIXK#Q5Y8O"1JRA2>*PBK8
M?VM2G3]ISU(1ELHS>)P>#]G*.)Q\Z%.E3E&4'&KB8>UP]"NY)+"UZU/]Y2H8
MIT:TZ:E.,'&,FJU[^T%\/(O@YXD^.>ER^(]8\!^'?#]QXC2]A\%^--/N=:T^
M+3+;5+:ZT*PU7P];W>J:9<07EL!J=K;3649\\RSH+*Y\B\QIXK+>2E4PLYXR
MM6CAJ6&CK5EB)XEX.G2G&"G*DZM=)4I5(I5:<Z5:E[2C6HSJ&5NCFE6-.A64
M:*CSSK3C.-.%*-)UZLTY17M)4:49>TI4N>M&K">&<%B(NDN/\-_M3>"]4\6?
M\(IKMAJOA69])^%KPSZAHGC1I+/Q-\3K2_NK+PWXJM+GP9:?\("L<D>DV=I>
M^)I=).I7NKBSBMXKB)([GK6%C.KCZ&'K*M4P>88_!0:452K4\!@,%CZE:%?G
M=+VTJ6*JWP49SQ$(8.M4M)1J1I<D<2_982M*C*$*^74LPJ;2E1A5QN,P5E"'
M-4J4*4\%.=;&J$<)"%2A-594ZBFMZ_\ VGO@[96OBRXBU[6;S_A$?#7B3Q9*
MT'@?QXMAXBT;PC&&\17?@76Y/#"Z=\0(=.E>**\D\-76K+:-,HN3%7F5J[IY
M?5S"E2E7A3IT*D:2M"M.&*E&GA*OLJG+4AAL54G"-+&3A'".,XU/;>S?,>G1
MPM2KCJ&7_#5JXF6$O&+J1CB:<9SJ89RI*47BX0IU7]3BWBIRI5*5.E*K"4%O
MVGQM\'VWPN\&_%/QB=2\$:5XPA\+PV^F:WH?B:/6;37O%<MO9Z;X>;1I] M]
M6EOGU*X6VC)TR(2C;,@\F17/H8W#_4LP_LU3^LUY2K1HJE"<YUO886MC:BA2
MBI58U(X:A5FZ$XQQ$9P>'G2CB?W)YF#Q4,9@99BH2P^%A:4Y5N6'LJ<\3#"T
MZE27,Z7LY5*M*]>G4JX7DG[>GB*N$2Q#P-$_:D^!>OSB"R\:7%H%M?$MQ<W7
MB#PAXY\*:;I<_@V*ZN/%>B:YJOBCPUI]EH'BS2;2QO+J[\.ZC/:ZM!;6TER]
MD(%,E8J-Z-2O!QG1IT*6)4H2C-5:%6K2P\:N&Y&_K48XFO0PM;ZM[5X?%5J6
M&KJG7J1IOJLU6H8=PE'$XC%+!PHRA*-98F5">*I4ZE*252C[?#4YXC"SJQA3
MQ5"+K8:=6FN8@U+]I7P$_AC7]:\)C5=<UG0=7\#Z*_A7Q%X?\8?#C5Y[CXA^
M);'PQX5U%;3QKX6L[Z3PY?7=W-);ZS::?>65RFG77V>64POLN%"LYY<N3EHX
MS&?5:LY2C&6#5"G]:Q\L32DU4H5L%@(SQL\+B%0J2IJFY.G3JQJJ;\U/'.DX
MU*F$R[&9A15_W6+CAJ-65*.'Q$5.E6IXG$0AA8UJ#KQC4JQM&<K0E?U#]IOX
M):9:6=]-XQN+BRO9-2:"[TGPEXVURV32M&O7T[4_%MW-HGARZ33_ (?6U]%+
M"_C"Z,.@!HG_ .)D0I(SH1>(G1ITO=E6IT*L74:HQA#%N2P?MIU>2&'GC.1O
M!4Z\J=3%QY9X:%6$HR>CA*,JE-+GJTZE6BJ=/][4J5L/&#Q-+#TZ?-/$U,+[
M2$,5##QJRPU62I5U3J^X;]S\<OA?9^-[?X>3>([@>)+BZTK3U>+PYXIN/#$&
MKZ[8C4]#T"]\=V^B/X9T[Q)J.G-%=6FCW6KPW]S#/#)#;ND\9=T82Q%2K2I1
M?M*,L1#EFO9N<\'#VN+IT%4Y?K%3"T[U,1"A[2="G"I.HHQIU''.M.&&P^&Q
M562CA\7"C4ISBU-*EB*SPV'K55#F="AB,0GA\/7KJG1KXBU&E.=5J(_QW\;O
MAG\--1CTKQAK]Y87@L8-6OQIOACQ9XEMO#FB7-S-9P>(?&-_X8T/4+7P1X;>
MYMKJ,:QK\VFV.ZTN/](_<2;%AXO%8B.%H+FJ2J4Z*;]RE]8J\OL<-[>?+06*
MK<T%0PSJ>WK.<%2IS<XIZSISI48UY0?))590C%.=6<*$8RKSIT8<U:I3H1E%
MUZD(2A1YH>TE'FC?;\=?$SP7\-],T[5/%>J74$>L7J:=H>GZ+H7B#Q=XAUZ^
M:WEO&M= \*^$=*U/6==FBL;>XNYEL+"X\BVMIKB;9!"\BRVHUEAW[M51G.2:
M:C2I4G&-6O7F_<P^'HRG"-7$5Y4Z%*4X*I4BYQ35&/MJ7MZ4H.C[G+-SA",I
M5?X5.FYRBJE6M9JC1I\U6LTU2A)IH\.\'_M9^ _%&AR^,)IM.TGP7&?'EW;Z
MFMSXHU?6M5T#PM\0+?X<>&]<T3P]I7@>4ZF?$GB W<-MI:7BZB91:0V-KJ;7
M$S6.OLITZ-!UXN.*KX?*ZRP]%/$5%/.'C:N7T;4_>J.M@L&\5S485?9WE3K1
MI0C3K5G*,/KE;!4I\TZ-3$+GJ+V%)4LNR_!8K-ZE6I5<8X:66XG'4<)5AB/9
MPG"-7$*M%TY4"S?_ +7?PFM?$'AO1K:;Q//9:IH7Q!\2^)-8N? 7Q&TQ/ .D
M?#>SMY_$/_"8Z;>>#%O/#FIPW%Y912V&KQZ9-;K>6K2@/J.G0ZCCSPC3QV(J
MR5/ X# TL8\4G&=";KXN6%HT*=2#<)U92P^.3A3E.K&O@JV%=+V\9QIE*E4K
MRPE+#P=3%XO,89;##-.G756>&6)51TYJ,HTN2M@YPJ34:=7#XR&,ISEA*5:K
M"MXM_:R\#Z'IEEKGAZ&3Q'I5TW@5?*O-.^('AC7YH?B%X_TOP3X<U;1]"U'X
M=2/KV@7,#^(M0@N[*>26].@I#8VUS%>F[L^F%"HL8L'7IU*,WB/J[4:<ZM2$
MZ6#S3'8JG.A!>U6(IT,N3HX>$9SK+$0G5>%I2PM3%Y1G2G@WCH58_5?JN,Q,
M*LGR4JKP]'+Y4(4ZS_=N-7$9I@\-B*LY0C@Y5)IJM6P^+H8?V'PU\8?AUXMB
M\,2:#KTUS)XON_$FGZ+976A>(M)U5=0\'B7_ (2G3];T?5])M;[PM?Z7)"T-
MS;:W;Z?+%,\4#)YTT<;XS2IN5YP<8X%YESPJ4YTG@E6H8=UX582E3FE6Q-*F
MX0G*HI>T7)^XK^S4IJG\<*E-K%PP+C.E4A..*J8:MC*5.4)14XJIA</5Q%.I
M**I3I*$XS:JT>?Q^Q_:V\ >(/$NN^'?"=OJM_;Z5IWP]FT[Q7KGAOXC>'?!V
MO:Q\1_%"^&M!T+3M?'P]OHI)93-9W,-S&LT-TEX7@+6MAJ5WIEX.C4QE*-:'
M+2A+&4\-&%27LJ[I++?[8QE>-*LJ=IX7+O\ :/J\Y0E\"Q4\%#$8.IB=,<OJ
M%2I0JRA]8H8;,*]>',K8>I@\54R^A2KSCS\L<5F%#$X15(J<_:4'##4<96E&
M@^U3]ICX),_B8'QG)#;>$M!\1^)]1U6Z\+^,;30-1T#PAQXJU/P?XCNO#T>E
M_$"WTA\1WG_",7FKM;R,L4JK(RJ<H-3PT<5'2C+ZLTI>Y4=/&U(TL)7]A*U;
MZMB:DX1H8KV?U>KSP<*KC.+>L,/6J8RE@:<.;$U<1/"147%TUBJ<)3J86I63
M]C2Q-*%.HZE"K4A5I^QK<\(NC5Y.Y\#_ !.\%_$0ZPGA/4;Z[ET&:RCU*WU3
MP[XE\,W20ZG;&[TK4K2T\3Z1I\VJ:%?VR2O::M9)<6-T()OL]Q(89 FTJ-2G
M2]K*/+!5JV'DFTITJ^'Y'5HUJ=_:4:L(U:53V=:,)NC6HUHITJU.<N.%>C.I
M&E"HI3E0H8J-M5+#XAU(TJL)+W91<Z-6E+E;=*M2JT:JA5ISA'SS5/VH/@OI
M<GB>%O$FKWDGA6P\2W]U+IG@;Q]J.EZQ_P (<COXJLO!^OV7AB72O'&J:.8I
MAJ-EX>O=3N+#[-<F\CA%K.8N&MB/9X&MCJ=.56%*A3Q$(6=.=6A7J0H8?$0C
M449/!5:U2C36/Y7@H>VHSG7C"I"4NV.'D\;A<!*485\55>'BK\ZAB%3G6>%J
M.GS^SQKHTZE2G@)\N-K1A+V-"HU8?X.^.D%W\&]*^,7Q.\/S?#6PUE[-K'P]
M':^//$7B,1ZS?P:;X=TM_#E]\.="\0W?BV_OKB&VCT?3-"U$3S2P_P!FW>I0
M7$,\OI8S#/!8C#X&4OK&-J^[*GAX3K1]JH5*THT>6/MY0I8:FZ]=XC#X2MA5
M"O'%8>A]7J2.#!XA8VGB\52C[+ T'.=.K6E&DWAJ:@O;U;MT*?/.3C2]AB<5
M1K1=&5'$5)5E3BMU^T]\$++3-+U:;QA=M;ZF-1D>UM_!OCJ\UGP[;:+?RZ7K
MFH>.O#UIX9EU3X=:3I6I0S6NH7_BFST>UL)HGCO)H74@90I.I7AAZ<J<W.%"
MI&I&K2>&Y<3*<,-?%J;PL98F=.I3P\'64ZU6G4I4HRJ0E%=*C/WH^SFJT9SI
M*@Z<UB:DZ5.E6J1HX5Q6)KN%'$8>L_8TII4L10J7Y*U*4^BU7XZ?"O1?%MCX
M)O\ Q05UR]O=+TOS;70_$FH^'=.U;7+6.]T#1O$'C/3M'G\/>&-:U6TFMY-/
MT_5]4L;F^6Y@^R13&:/?G#WGB8I.+PD<2Y\Z=-2>#I2K8RG1<^58BMA*-.=;
M$T,.ZM:A2A.I5IPA&4E%6<:-##XB;2HXF%&I3E'W_P!SB*ZPN'KR4.:5/#UL
M2_84J]11HU*MZ<9N2:5'5?VA_@YH?AK2O&&J>,XK3PWK7@G5OB-IFIG1?$DL
M=SX)T2ZT.SU#Q!Y$&CO/#:K<^)-#2*.6))KG^T(S;1RA7*:2HU:=66'G2E"M
M"IEU&4)1<90K9M5=#+Z,T[.%6O5C.'LY6G1]G5=>-*-*HXZU*4Z,:[G'E^JU
ML=AZD4TY>URVGB:N.4(1;G5CAZ>$K.52E&=.3]E&$Y2Q&'57@M4_:M\%V7B/
MP[H6G:5XAUJ/Q/X[T#X>Z?\ 9/!WQ4M];T[6;_1K_P 3ZW<>)- O/AG&=%TV
MR\+0Z=JMK<"[N%OK74);N3[#I]E+?%4(.K4A2FI4$Z>88B=624:-'#8#"X:<
MIUZE1T_8UOKV*IX"O1J**PM24/:57B%7PE#&I+DPM7%P7-1I4\)**M-5*\L7
MC\1@Z?U6"A+ZS1=/!XK$4JU.35=T'1HPDZ^#GB>ET_\ :5^%C0^'5U?Q+8P7
MGB:WM]6L3X=T[QMXHT33O#>M:O=Z;X0U_P 6^((_!=G!X$L=:C@A\B;Q(FE6
MLETT]M9W5\L N)G3I3J5*&'A"4:]2&%C*,X^RIQQF(PU#$?4:=6HXPGBFJ\/
M8867L\=6A.E*6"HU*GL8WB%+!K&SQ"5*G@JV,A)<UZOL<#7JX?$8F="*=14,
M/4H5%B<135;!X=P;>+E"U1]7HGQM^&?B+QK>?#[2=?NY_$UG>:QIJI/X9\5Z
M?H.IZIX<VCQ%I/AWQAJ.AP>'_%&KZ221?V.CZI?7%D8I1<Q1&&0)GAU]:HRK
MT/>IPI^WL_<G+#^V^K?6:=.?+4JX55W&B\33C*@JDZ<'44JM-2,4OJ56C0Q/
M[NI7<(Q7Q*-2K0>*I4:LX<T*.(JX5/$TL/6E"O5P\95Z=.5*,I+8U?XH>!=!
MD\41:IKHM7\&3^%[7Q&%TW5[@:?>>,[B&T\,V*-:V$BW]_?7%S:HMM9FXF3[
M7;F5(UGC+JDU7]C[+W_;X[^S::6\L9R8:HZ5GJHQIXNA.=>5L/",JCG5C["O
M[,G>G*M"49)T,!4S2:49.V!H_7/:5TXIJ7+_ &?C/W4;UG['2F_:4N?D;/\
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M^L4ZF']MB(4Z2K4JM)S4Z52,:NF?M*_!+5)]3BA\;)80:1I?B;6KC5=?\/\
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M/<_X9Q^)NB:UX)L?"E_\/K+P_P"%CX BTCQQ!J?C/1/B%\/M#\/W>F:CX_\
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MXZAB\ZEAIKFE4PN9SCC&\+6E2AAECZK4ZSH4$4KK]E;XI_$KX4?#[PCX^O\
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M.*Y?98;*LGH5J<(X:/-7K..$I8#"XUQP^(G[5'Q;U;PWXWU'28/AAILWP=\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MJ'N7HTW'//[-7P=;1)-"ET'Q!<;]4TC65\1W?Q'^)=W\0;74?#ZWD6A3Z?\
M$^Z\7R>+],33K;4=2MK6&TUR&*"VU*\MHD6WNYHY+=6?-AI7Y7A:E:K'E2CS
MU,13C1Q,L0HI+%O$TJ=.EB/K2K*O3ITH55.-."C4+4WB.6,%'$TH4)TW"#I1
MH4ZJKTJ-&C).EAJ=&O%5Z,,/"E&C72K4E"K[QTVF?!?X::-\.-:^$FF>&A:?
M#[Q#'XIBUK0%U?7G:_3QI?:AJ/BCS=7EU1M35[Z\U6_D=X[U&C%P4A,:(BK4
MJ]64LODVKY4L"L*E&"C1CETJ4\'%045"4:,J--N-2,HU>5JLJBE-2JA.IA<3
M7Q=&I.&*Q%2=:I6YY.HZM2"IRJ\\FY1J.*5IQ:E&24XM37,0>*O@?\,?&NM6
MFO\ B/P[/=W]MIEKHEU#9^(O%&BZ/X@T6PFEN-/T7QIX=T36K32O'FCV<]Q<
MR6UCXCLM4M[=[J=H8T,\A>*56I0Q$L52FU6E6AB?>]^"Q5/E]GBX4I\U*&+I
M\D%#%0A'$05.FHU%[.'+DXQ^ITL!;EPU"G*C34?=J0HSBH5*$:\;5UAZT4E7
MP_M/8UE_%A.[.1\$_LV^!?#.K:AXGUT7GB_Q5J/C+QGXTGO-0U+Q%!X974O%
M6LZE=6=S'\/I?$-WX<_MS2/#EW9^'[;7'T]]1%CIRQ)<0PR&!(A&E3P6&P,:
M473I8*.$J.I^]<Y58U)9C5I.KSRPL<RQ&(Q-;%4:$HQJQK.E7E745)ZUINMB
M:]?EAAXRK8:I3IT(^P4(8##X7#8&%64&I8F6&A@J%6$JK<(8I2Q.'I8>32CH
M:3^S1\%-$AOK:Q\'SF&]BTRS2._\5^--771]'T;7=/\ $NF^&/"_]K>(KD^#
M_!L.MZ5I]R/#FA_V=I+?9$C>R:',9UC6JP=*7M)3J4L1A\7[6H_:UJN)P?.L
M)6Q%:IS5<5/"^TJ/#_69U51E.4J:C*3;SJ1A4G4E*G!*KA\9A7",(0HPHYA2
M=#'*E0A&-&A/%4I6KUJ,*=:HU&<JCG"$H^C:-X#\,>'_ !3XM\9Z19WMIK_C
MEM(E\42G7->N--U&XT+3TTK3;V/P_=:G)I.FZ@NFPV]M+=V-E;3W$5I;I<R2
MBVB$>=-NCAGA*>F'=>KB5%I2:K5U%57&<KSA"?)&3I0DJ7/>HH*<I2=U92KU
M*%6J^:>&H+"TVO=M056I7C"2C93Y*M6K*$JBE.'M*D8249R3\XNOV9_@G>WO
MB&^NO!LDY\36WB:UO;"3Q1XQ;0M.'C2UNK/QA=>$_#G_  D']E>!=4UNWOKT
M:CJ'ANSTJ[O&O)WN)I'F=F,/)X6%.G1=HT5AX0<OWDH4<+B*.*P^%C.ISS6"
MI5\/0J1P*E]3_<TXN@X0C%6ZU3ZS0QEU'$8:K]8A*,8QOB5"5)8NI&*4*V,C
M3G.$,76C/$PC*2A52;/2_%/@;PMXT\,S>#_$FE"_\/S+8A+6&\O],NK*;2YX
M+K2K[2M6TJZMM0T;5;&[M;:XM-0L+JVNK6:WBF@FCEC5PJKE5K1Q$ISCB(5'
M5C5A.=*K&I)2C*4:E.4)QYX3G3FHM*=.<Z<TX3E%Y86V"IQHT(QC0C2]@Z4X
M1JTI4>50]E4IU5.%6'*DG&I&2=DWJDSSP?LX_!IK-;&[\'OK$']G^)=/N&\0
M^)?%OB6ZU(^+]/M-(\1ZOK5]K^O7ESKOBF\TBRMM//B'49;K5HK16M8+V."2
M2-[E.7*XQ?L+4J5&#H)8>5"G2Q3QT8X6=!4Y81RQK6,K3PSI3Q&*IT<17E4J
MT*,X%*]&K2K1;E5H8B.*C*;]JW6A0EA:;J>TY_;0HX:<Z%"C5YZ-"C.I3HTX
M0G-/2O?@3\+M0\167BB]\/WUSJED-$9XI/%?C$Z%K%WX92"/P[JWBKPL-?&B
M^,=?TP6EJ;35]=T_4;^W:UA>*X1XD95&<H5L56A:-3%U*U65DE&G6KQY*U;"
MTTE3P=>K!<DZV$C0JRA[CGRZ&:I16'PN%3E&C@Z"PM-*<U.6%2FEA:]52]KB
ML-^\J-X?$SJT7*I4DX.4YMZ-E\'OASIPT,67AWR/^$:\)^)O!&B,-6UUI+#P
MWXQNM,OO$UFDLFIL\MU?W>CZ?+)J$K27JM WEW"":4295:<*N#QF G'_ &3'
M87"8&M3C[G-A,!2JT,)0C*'+.E"E2K3A^ZE!S]QU'.5*DX=4:]:G6A7A/EJ4
M\PKYI&R2A]?Q$ZM2KB94[>SE)SKUG&,HNG356I&E"$9R3L>$?A1X#\!:K<ZQ
MX2T>YT6[N_#/ACPA/!!KWB*?2&T'P9:-I_AJW7P_=ZM+I<5[96+&W&HQV:WL
ML6(YKB1% '54Q-:M+'SJSYYYEC:F88AM1;EC*M.G1JUHZ?N?:4Z5*-2G1]G2
MG[*DY0;IP<>"C@\-AHX&%&G[..782.!H6E*ZPL*M2O"E4;;==PK5JU2G4KNI
M5A*M7Y)I5JJGPD_[+WP/N=6U'69O!]Z]WJ4GC&5[?_A-/'BZ/ILOQ!TV^TGQ
MO+X<\/IXG&E^$Y=:M-2OFO'T6ST]I;BY>[)^U8F'/2C&C0^K05Z*PT<':?[Q
M_4X8G"XNGA.:IS3^JTJ^#P[HX?F]C1A"5&E"%"K6IU.SVD_KM#'\S6*P^*H8
MZ$EI#Z[AZ-7#TL5.BK4:F(5*M4C4JU*<YUGR3K.I4I4I0UA^SQ\($\4?\)<G
MA.6+5?.@O'LXO$OBV+PM-J]KHZ^'[;Q'<>!X]>7PY<^+8=$2.Q3Q!+I3ZHD$
M4<:W86-0KJ+VM/%4JO[R&+6,C-3][V<<P=26/6&;N\&L8ZU9XE81T?;.M6Y[
M^UJ<V5.,:,<+&DE36#6$C#ET<HY?*G+ QKM6>*CA)4J4L/'$NM&E*E2E!*5.
M#BW1OV=_A#H&@7GAC3O#%Z=%O_"GAKP-=6VI>+O&NMSR>$/!^J:OJ_AKP\-1
MUKQ%=WD6FV%[KNIB.*.X3,$Z6CE[6W@AAZJN,Q-:I2JU:KE5HX_#YI&;4>>6
M/PD,'"ABJDDE*M5BL#AI3]JYQK583K5E4JUZ\ZLRI4YTJN'DO]GJT<PP[I7:
MI1HYKS+'TZ5--0HJNIN-Z48.E&-.%%TXTJ2A;L/@+\*]-\87'CFU\.WIU^ZU
MK4/$TZ7?BOQCJ'AYO$^IB1+KQ2/!FH:_-X>C\4"VD:TAUA-+6^MK-4LK>>*T
MC2%>2E&-'#/"0BO8*G6I1C-*I*E2Q$JL\33H5*G-4P\<5.O6EBE1E36)=2;K
M^TYF:UG[>7-445)RPTIN$8T_:O!TJ%'">V]FH>W6&AAJ#H1K<\:52FJT%&M>
MH^7@_92^!-O97^GKX1U62UO_  WJ?@\+=?$#XD7LVD^%M6U;2]=NO#_ABZO/
M%TL_A#2H]6T;3+BUM]#DT]+$VBK9"W1F5KC.I"G&E&I*/)5RVMS\S]LZV3U*
MU7+:L\1?V]2IA9UZG)*I4DY1]G"HYPHT8PBM&.(Q%;$UU[:==YBZD)^]0D\V
MI*CF/^S.^'7UJFFJEJ2LZE:<.6=>M*?1ZM\ ?A7K6F-IEYHFLQ%O$%YXI76]
M+\<^/="\80Z]J6GVVDZGJ%MXZT3Q/:>([1K[2[.VL[J*'5(XKF"+RIXY$9E:
M+1YJ+Y(I4(8JE&FHQ5*5'&XRIF&*P]6BDJ5?"UL95GB)86M"IAU-4U&FHT:4
M8*G"-%5>5<SJRPE24IMU:GM<#A*6!PE>-2HYSAB*.$HPH+$0E&M*,JKG4E*O
M7E4M6OP)^$UAH>M>&=/\&66GZ#XATKPYH>KZ7I][JUA:W.C^$I)9=!TR-;34
M(S9V4$MQ=R20VQA6Y>]NGNA,UU,9-?:U.:A/G:>%Q]',Z2O:-/&X>&!IT*L8
M+W8PHT\MP,*>'2^KPAAH1C22YE+-X:A+ZSS4U*6+P6(R^O*3<IU<+BZF.JXF
M%2<FYRJ5JN98ZI4Q#E]8E4KN;J\T*;AZ/IFCVFD-J+6DNIR'5-2GU6Y&I:WK
M.LI#=7$4$+Q:;'K%_<KHVF*EO&8].T\6UG$S2/% CS2,^:]VG2I+6-%346]9
MOVE6I6ESU'>I5:G4DH.I*;ITE3H4W&A2I4X:J*52I45XNI[.Z3:@O94H48\E
M._LZ5X4XN?LXP]K5<Z]7GK5*E2>I04% !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'S_P#!O_DHO[6/_9P'AS_U
MEC]FF@#Z H * "@#Y_\ VL?^36/VEO\ L@'QD_\ 5=>(Z /H"@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M,**C-U%1A#$X+,</7I5*U2E3I+GI8R6%KJ-*4%E^U5H]YK][;:-H>K>/=/\
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MA4C@?:5'1E5]RM_VB/#4WBE?#\GA'QY9Z*OBB'P!=?$&ZL/#@\#V/Q&E2/\
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M<L_KO#^)S>:ES3INDKX:6)AB'%JE@ZN&P]7#RQ53%3P'07?[5GA72K9XM?\
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MU4IYMA(*E"$J4LPPN(KX7"*E3A#"MO%5<5]:BJU:GB*\5C<94<*^*I8+#X7
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MW+\O^L^SYWR_5?J'MO8\\O;>U]G[6ER<\XM2_9JU.^U&_P!%C^(5O:?"._\
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M5JUH^TY8^JUS%A0 4 % !0 4 ?/_ ,&_^2B_M8_]G >'/_66/V:: /H"@ H
M* /G_P#:Q_Y-8_:6_P"R ?&3_P!5UXCH ^@* /GKXXZOXUB\0_!#PAX.\:ZG
MX#3X@?$36?#_ (BUO1-*\*:KK*Z+IWPS\=>*4ATM?&/A[6].M+PZIH&G,)I=
M.N %5U*,KD5K@::JX_$JK>5# Y3B\?[)62K5</F.38>G"<DN=4Y0QE:%14Y0
MFZ<Y<DZ=54JM-UY*CEU2O&*=;Z[@,/%MOE4,3]8A5O%-7:C%3INZY:L*;EST
MO:4JGQ/=?M-?M%Z#HVN?$B'0O%&O:7_:OQIT-- \27'[.FC^ +.'X>V'C9]
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ME+V?)FF3\/9A..'G=XGZS4K9QB88&52O4I1CA::KT<0U7-\)26(S"KD57$O
MT:4\WOG%;D<J<<MSS.<KYJL7&C@G1P6%RW#8W-N6%.<Z>,A["KE\>2<^AO\
MQ)\2_%OB+2-:U?X@ZM9:?<?M&:S\.-"\)Q^#_A;=V?@W3T^#OB;7(=>TC4M?
M^'E_K5OXVL]2GGBBOVU'R?LP-O-9RK-<_:./$THT\OFO;2KUL5EG&$WB$XPG
M".69EG&!P\:#I**C2JX;!T8XA3]K[6UU*+;;O*L5+%?VK5G0C1I99_JE-X:]
M3V>(EF,^#\7B(8I2FY3ITZN/KRH1INC.C5E[3F<Z6&=#E_AC\1?B%\,_@/\
M!?PQ#XZU;7]7^,_P:^'NC?!S4=;T?PG-=^'/B5?ZC8:5K-K')IGA^QM]<M-.
M\/\ BK3=<AM=5AOK@V7@+6)KF:ZVW,C?49E2CB>(L3E48PA/#X[ 8B5134)U
MLEIX5U,U<::BZ4)86CEU1QJTZ<82Q6=82A&%.$:$48WEP%?.,SD_;X?#X[B#
M#U*==Q5&IFD<?B%DU)QP\:>*4LXQ4JU'$^QE["BL-&5/ZDI^_P#5OQ3\0>,I
M_B/\/OA5HGC_ %'X9:?X@\#^//%^H^/]-TKP;J&M7NI>"[OPC:6GAZQB\::#
MJVBV\<]MK^HZG?9TMIC;:8ZVLEKB2:'Y[FC)YWC/;4\/#)L/A<32PL[NE76)
MJXV%6I7ESK$/!X%8:A3K*A5HUG4QV'<L3!)1JKDE0P>60=.>+K8[&+!U*ZM%
MTO9X9U8J$(KV:Q6.FI*ASTZE*$</72HSDX<GE_[/'Q*^)_QB\:6FHZ_X\FL/
M#N@_"?X<>*9O#GA;0?"UMX>\;:SXFU_XL>'KS7KJ]USP]J.MVOA_4+'PEHFK
MV5KI>K6+1M)%_I,]L\D=QZD:%.G@*^85<-.C5Q&)HT8X.O*5\O\ ;\/\/YK5
MH3<8T:D\3@\5F&(PZ=;2WM57H2FJ7L.:O*5/%4\#!RBJ57-Z<JSY74K0RO/\
M;EV'J6Y?916*PU",L1R0Y6_9RPSH^_*IS'Q)^*?QET"X^-FOZ%XS\1W-KH/Q
MU\ _!;PGX0T;0?A.+;0]'\8Z!\+-2U/Q)!?^-K+2X[SQA#=>)-7@TM]>\4VN
MBI/JD"W]I=K'"@X</2<\/PU2E&M7J\0U\[56I1]BJU"GE6(XA^KPPRJVPZE6
M66T*%>5>GB9RI)?5:+Q;E[?JQ4XX:MFDZ=.$H93E^6XN-.JZWLZM7&_5Z%9X
MAT(3K_5,,JSQTH47AY<U*JJV-P^#;GAJ/@_XJ?'+Q+XX3X1>*?%?B7X70:.O
MQ#UV+X@>(#^SIKOQ&URU\'Z7\.-1T_PCXXTOP#>>*?!?AS54_P"$RUF]U"*T
ML=(O;G1],T^ZM$TYKF:>.:_)_8^-S6.)I4L3E6 =5X:$*OU;%3>.S+"O%RG5
M;J2HX2G@\-1QE+"UXJ&9XOEE4I4E3PLR5*5"K@L*J>(Q$,UQ5"DJLXTJ=;"*
MIAJU;V%!4VXU9XJ=*4\OQ.(PKA]7I8BA*CBJU%XN7*^&OVD_BI_PIGXL>+_$
M'Q L)-9T+]D_X2?$KPGJPT;PG;1_\)MXK3XE6.I>(+2PBTKR[N*_U?1- BCL
MKF.XM$>*-(85^T2>=[3PF&5?+J/L)4IU^+\GRN=*<Y.HL#C<)PK5J8:=N7EE
M4GC<T?M4H55>IR3A"A35)5(.EFE>'/&MEU+!<2U(U::?LJE7*LTS6C3JTWS3
MFXT<)3P/N>TFI1E3E4]I4JRE.U'X]\0Z'X4\;Z=X7^(_C/PGK=AXV_:@\?7&
MB?#[P9\.M6US5(-$^)=_;VNI:UXJ^+45QX5\-^$K>\NWCN;:6"QN[EYXY(M5
MLH;.5+GYNOB)8/)<-BJ*5991E>#E[.J^3"4Y8C'9O[-8MQ:Q5>.(C@ZD:5/!
M5:5>"H5E&.)KXC#4H]D>3%9I1HXA?OLW631YX\SQ%14N%N&Y5UA(1MAZ-6$L
M31YZN+A5P]J\/<HPIU:T,#X;?$CXEZI<2>+7^(FKZ1JWQWU;]FG1M=U=-(\"
MRZ)\,U\:_!>3Q7>:MX6L=1\,R&.]N=7MDT334UV?6[-)]:@:>VNY@1/[5;+Z
M6$S7-.'Z-2<<-0XDXGY*C:EBJRR[*\NQ%'!TY.#HJ=6$J?M9.@Y_4\OM2=/$
M3JUZOAT,2ZV!IYQ6G26(PG#V3VIS35&H\3Q9F&4RJU%"=.I^YIO$8N*A5A'Z
MUBJO/&>#IX?#X7UOPCX_^+7BSXK:-\)S\6=7BT;POXQ^+^AZIXZT3PW\/1KO
MQ"T[P!I?P?UK2UU+^T?!-YHEAJ5KJ/C37= U670=,L(I6L+PP1V-TL1L>? >
MSQ-+#9E.-*4'EM7%2PU-U%AYUJ'$6.RB$^9U9XE8?$83#1Q#A'$1G[:494JR
MHWC4[\93>'H9EA:4Y*K',\HPT,1))U\+2Q_#^99G7H*/)'#2K4L1AZ$J<ZM"
MIRX>4(5(2FYRG]<?%KQ.O@[X>>)->_X26/PC-;6]I:67B%_#LGBQ[#4=6U&S
MTC31;>'(KRU_M6_GO[ZWMK>%YTB\^YB:4-$KHW!5YI5,%AZ<JD:F+Q>%P\8T
MHQ=:I[6M",J5%U(SITJDX<T8UZM.K2H?QJE&K&#A+2DK1Q-3DC*.$PN+Q,G4
M<O9TX8;"U:\JU6--QJ3I4(TW6JTJ<Z=2M"$J5.I3G.,X_ </Q<^/M[K7C[X=
M>'?&GCO79?!GQ!\.::TM^W[,7AS]HO5]#U;P#>^);VQ\)Z3J>D1?#O4[BTOX
M+6^FTW5='TC6$T@W._R;H0NU4*KK8*.-J04886MG=*2PR]MI@'DDL/B,?3G5
M3GAJ2S'%T,5/+:])K$/+J4G2K?6Z3YIJ5#,)8+VL(^WP>3XFF\6I4:<IXNKG
MM*OAL'4I0YH5JW]E8>6%6-HUHV_M"I&53"_5,1#ZIE^*C77[.GASQZOCZ[T?
M4]?M?"FAQ^,S\.H[K6+CQ+K/B+3_  I+#8?#^/6;NRMM>OM9FFLK96O]2TVU
MN;F*Z8WUA"4GZ\=2C4QV"H8+FC2S)T*U"&%?/.KAJV#_ +03H5,52?L4\(I8
MCFQ6'G4HTHRIU:4JZ*R^HI4,PK5:;MEBS*-58N4:;P]7!5:^'Y<5]7E".(>'
MQ%.-*HL).C'&SC_LU2C&M"4/DGPG\9_C%XI^*MK\&KCXS^+O".FP?%OQYX)?
MQ=XC\,? QOBAJ6F:-\)O"GC[3K"ZCT;PS?>#K'6X]6U+4!"JZ##<II[&#4]/
MCU*)_LF>&BL70IXJ4X4%2RC.,7*-%WHRJY=GN6X"G4K2J.KS*&&Q-=8SZK7C
M0G[.4J%2BTJD-<QY<OGAZ=&G+$O$8C(Z<Y5=%0698'B.=6,(4O9U(QJ5,OP+
MPOUJ$:JQ-2$O]IP56%/$II?QV^,'B^Z\833?'*R\!6GPZ^ =W\2+*2U\+> 9
MM'\?ZOX4^)?Q9\(#Q5JA\0:!>W<?@7Q!I'A'P[=WEIHEUI\RC5+0Z9J%EO8W
M9.LL/EF)SF&#6/KTO]7JL<KINJO>SG),'CZN!BXREB?:5,55J8?+).3J0JR:
MQ,<8E&C'KPV%IU\7D^4N<E'&9IQ+@*F-BU]8E1RO'8##8:K%3A'"*KA:>(K/
M&26&="K.C4E!0I<LX4$^+GBSP<GC;XAZ1H&F#Q#!H_[4_P 04TC4M#L+^\L-
M>TGP5\#]6MK(:E+:'5;#3[>ZO9OMMI87=L+Q+2,3I*]M;^5=+#0P]*GEE+&1
MP^'B\1@EC6H\M&CB?$K.,!4Q=36,:E.A0J2Q"A5<J,90Y^5.[//R%O,XU\7B
M<-4E6QF;\+U)X6G+EG4E/PW6+>&HQFW3AB*U6C##T:S7M*:J3IQFJ=6M"I[O
MJ_BKQ5H5MI/@;_AJ?Q'XN\6Z[')XJ@@\"?#OX-7WQ9@T2#PK9ZK-:&]U'3H_
M!/A_PR]_<V]Y;ZAKWA6*9["_2W-\SH^J1<N-DZ$\PI48SD\DIY@ZD[TX1YJ5
M?"0H_P!I5:K]@JV'CB'&M2PTL![;VV&KJ%"G0K+&3@IRQ-#!XNI*G16:O+G&
MERU9JF\33S*I..!IT^;$NC76!J*A/$+'2I3P..I\^(JXBC3P?@_@KXI^./&>
MGZK\6YOBKI7@/Q?:_LB^'_&UUJ3Z-X/O$UZ7P?\ $SXKK!-J]M,=1TH>&;A+
M*WMM8&@M#)(^N1-I.I6.(6DWK57@,)FF.HX2.-DY\,8N664OK$56K9CD<:TL
M+%U(_78_6JU>I1RI/EKTZ]#_ &N&*7-0EWX"D\<^'LKQ-2I'_A9XURQ5W[%8
MJ%'!9EDN#A7_ ';G@G7IT:$*N*?LZF&E:HZ4:4&IPGTOXL?%E]='A7P5I/Q
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M2BU4E.&&JO"T5.I*"5'"UJT*]58J6+Q/''[1OQ2T_P"$>I^/=+^*7B6;Q?\
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M"QPV3YGBZ6=.$ZW-[2M6RVIA:E:$*E98?%8#&JC[!/V48C"E@Y3QF(E5J8#
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M[)594\/BJU"E.M&C*=.G7G3IPG7I1:]C6E.DX0E!PC\/Z#XJ\:_"YM0\;?\
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MM+ZU*M4P>,K4JJQ6)E6I82&5XQ^-7QU_M"VT?P9K_B?Q,GA_X'^'?B])XO\
M!>G?L\Z+X5\1Z]XDU?Q6US:^-A\;/%GAR?2_A7I,6BV=BZ^&7BUN"*??J6KP
MW:(;\K<F$K9G7A!5\/E.+PF!ITL16HTZ&)HO!X>K+&XC$8:I*O'$YDZLI82M
MAZ5/+(5:=5T*..IIX>AK1IQKTLHIU8U\+7S>KF52O2I4Y3QF!=#$4Z4,NP\:
MU*-&I6R[GG#%PQ=+ZW4<:',L.YU)+HIOB;\8KO0/$GBN?XF:AX9'B'X[^#_@
MOIFG6VC?#34_#GPQT/Q-=>#FOO$MGJ)\+WLVO^*H;C5[_2K"[O\ 5-5T5FU"
MQEFTZZ"--)>'P\)5LBP'M*U;^UL5Q$YXGD5*NJ628GBJ.$PU"E.E&%+ZY#*<
M'2Q'UC#U<0K25&5"M)\_D1S"N\+G&.>%I1GD^$R.2P\9RJ49U<WP'#4\57KU
M:52I*I0R^6:XK&T_JM:E"4:=3VM6K0]FJ4'C?Q=\3]#\16^@^#/BKX0^(7BZ
MU\$WNB2^.+>R^#_A+QOJLL7QCTW1;[PIHNMZUIU[X8A^*L.ENVFQZ9?6]EH5
MUK5MYT^BV+,L5KRX:?UK$8QTJ$Z>'JKAZ4XX)P<\7_PG\7U*E?"1Q$IJMA_K
M.!I5ZL*E;$U,)@8YC]3Q%*=2K-]N,4<-BL!3G6A0E&EGCC+'QE*&#<J_!RIQ
MQ-3#TZ=6DITL?4="5*E3^L5*N5K%TL:J-*4^:N/CM\:-;NO!G@+PSJ/Q@N]8
ML-%^*6H>+M2TSPI^S'H7Q,7Q#X'\2:+IMAX=\5Q_$/QS;?#Z_P!*TS3=9B?7
M+[P0YEO6:VFL_P"Q(GF2(G55:CC,RPJIQP^#P&6XFC*\Z>75JE?$9OA<7+&Q
MKS68T*-/$92Z/LZ%91ISE5J/&SI2PD:^L9*%2.!J4:T:V(Q]?"5>:2GBL+&G
M@<MQM&G@JE'#O 5JV,IYA]9PU3%1E*.%I.@\#B,13Q5?#87B#XF?$KXL?#;4
M?$_C3QIIO@IO#7Q,_9A\-7'POT)O ?B#PKXFG\2ZO\'/&%YXAC\5646IW^I3
M7>KZ[J,>D7'A_P 1G2S:Z))OCU!R\T/L0PF&PV?9!4HSGBZ>+SO'4H4*D94J
MN C@)XVE2HN+C2JO$QHTJ>-Q;Q,'&>%Q%/V-&A'EQ%2G*I3PN?85S5%X/AK,
MZLL4X1C]<>(PF986;JTO:UZ5"G/V:P=.A1K.KA\Q<XU<36Y'AE]=?&[Q'X]L
M?B!\.?#OA'QAK7A72[OP5\6_&6O6OA_1_"6IZIXAN/ ,?@F\T71HIO%7AG6E
MLK>YEU6\M9S:01SO!?2B*2*X6WN+;YNOBJF#I<08[V:Q$<FRE8ZCAY*2A5Q'
MUGV2C6=-PK.BZ;ES1I5*53GC3<:D8JI&IWTL)3Q.#P=+G^K5<?G> RZ6)5O:
M8?#XC 9O7JSI1GS4/:JKA*$HRKTJL(J,DX-2:/F/X??'_P"-!\/V7B'QYX@\
M0^&M#\>?"4^,[;Q1XPTO]GC7+?P_XMO]=\'Z1HT/P?\  /PD^(UUXH\4^#;J
MX\52:<!XOBN+FRO?[(-]?YO)K-?=Q6"I8>MF&61JU_;X?,<KPV&?)"IF%>&+
MQ%>E7HUI4(5<LP\J\*,:F7XGV<J-)1Q4I_VA"E%GDT*U3$4:69J@J$'2S%U\
M,U5^I86&#P.)Q?M95*[PV8U,1@?J\EF&$]G3J8N/,Z-+*94I0G6A^+GQ]O=:
M\??#KP[XT\=Z[+X,^(/AS36EOV_9B\.?M%ZOH>K> ;WQ+>V/A/2=3TB+X=ZG
M<6E_!:WTVFZKH^D:PFD&YW^3="%V\RA5=;!1QM2"C#"UL[I26&7MM, \DEA\
M1CZ<ZJ<\-268XNABIY;7I-8AY=2DZ5;ZW2=34J&82P7M81]O@\GQ--XM2HTY
M3Q=7/:5?#8.I2AS0K5O[*P\L*L;1K1M_:%2,JF%^J8B&Y>_'KXA^(?!GC_QQ
MH7Q:?PTGP;^#7A7QY9:;?>!O".E0_%CQ!>VOB3^UW\9:/JD>O:AI.A3Z[X=;
M0;:T\):Q82)?M<21:C?0O:Q'K]Q5*>/I4'B,/B<[P>7T,%3G-TJV"QV"R3&8
M>K0G*G2Q<<7BX9M4E@_;RY*2H0IXG"U:D,0EI@XQQF)P^45*E3*H5,/C*U;,
ML2J?M,'6P>9YI@,30K*\,!4HY3' 4JV:U*5OK%+$PJ86O@*<Z<YV? ?Q=^,4
MT7A/XC^*OB;-_P (_P"(?VA?B_\ "_4_ ]_X1\(Q>'M \&^'(OB7>Z-?->:9
MX?M/$5SXCTB?P?9PF8ZO'!<62O%<64EZQO3%94,!A<.L1B%4^M</8[,)8R46
MXT,1@_:5J6(IT:4H*=.I0@XXFC*4U4GRSPTL,KQEV>P>+GF/L,.Z$\!4X;E2
MH4Y-2K+-J7#M'%8:K4Q'M>7]_FM:MAYQC3E2G[M5U:2C2AXY\0?B_P".]0E'
M@_5/B=X@\1^%/%G@'X8_%FW\4?$7P1\.?!^B:-J%M^T#\(;+3M8\'^'O"4ME
MXDTWP&VG:_<S26GC2>_NF2SMEM=9N9(-0>/MPF$2S#ZO5B\)BLDXAR'#TU5J
M1JXR^/I9S&OAJ[HQC@G6G4P-*E@G"A1J1KU)SKT:N%J8657B6+A*A+%X64)X
M3-,BXO3]G"I#"2IX;(:M2C.E[:4L7SI5)/$3]M*C.,TJ2I585*='T[XC_$?Q
MGX;^(%K9W6O2?%*X^#?Q6\9:SX8U672]'M=4NKB^_93^*GC$>!-8@\*:?I]C
M>:CI=X88XGMK.VN&L-7TU+HS7:2W5UYM+%5*.59UF5&@J&*PN2Y[@H5)-^SQ
M4<)G'"')F#51PA'EJ8FMAL7R3AAOK. Q,H+#0;HT>V.%AB<9EN6592I83,\9
MPOB9R;BHT98S,,ZPE2G1E9R5%4L%2Q-+VSJU4L3K5JPY&>M?LU_$?XQ>)/$]
MKIOC]?%=_H7BCX:6GC^TU+QQ>_LXV5Y:ZQ+J.FVSV_@'0_@GXZU?5+SX;W-O
MJ4IM[KQ':3WEI+IT<5SJUU+>B.'TZV%HT%G.&UA4RG%82C253FGBYT\1''>T
M_M!T8_4:=2+PE*6&=!4%7C/%*%.K'#>U/ HXRKB(Y)B8^R=/-,/BIUE2DX89
M3HK!3I2P,<0WBZD(+$5*>+56=25)RP4G&BZTX'VQ7FGIA0!\_P#P;_Y*+^UC
M_P!G >'/_66/V:: /H"@ H * /G_ /:Q_P"36/VEO^R ?&3_ -5UXCH ^@*
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MR/#YS5IU)S;2HY+AJ&,Q4,)-3A6E&K#$0]E]6<81J)+%RPJK8:5?&^'?@/\
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ME> DZ4<KI4%/#J/+]3Q,<WC@\1"%KNE6J4EAZ2A&G'W'5FE[7GBX^QZ3XU^
MT]_X-NKJ\^%GAGQI\1K35-6\*:'JFM_#7_A,O$0\11V,7B"31GT/6[]/$TE_
M'I6F1WMQHU[J4-R--MA)-*+>/9RQPZE[; 48*LH852K4*<)-0PN(G/'256ER
MJU"=>M6Q,G*/L:E:=7$1E/G=6717YL'/$2K2=&,,=*$JLKTXU,9EZEEE.K>:
MA)5Z-!+"TE5C#%8>A..%J4Z$N:A'/\0>!_V5/!EGX<\%>*O"'[/GA33]1\31
MZYX1\)>(/#_PXT*SO_&,UU:Z=%K'AS0=1M(([KQ,][J%E:K=V4#732WT,0<O
M,BL4.:=?"TL->6)P%-PPT*=W5P]*HJM:4:$8^_1ISCAJ]5JFHQDJ%6;35*;C
M%5\E/'5JSY:./YIXV<](8GV7LU*>*E+W:WL_:4E*55RY.>FFUS1O#%)^R7>0
M:K)"_P"SM=6W@'6M)L-;>)OAK/!X*\1'Q)=W^A66JLA9/#FM'Q?K5_<6D,YM
MY_[2U:XDA7[5=.75&M)0PV.H56J<?W6'Q%.7NKZK@Y4?94:L79?5\!&5+DA+
M]S@U*G:-%-%2H3G+$Y9.BY3Y*V+KX24&Y>SQ,J=>OBJU!J_)B)8>E6K5IPM5
ME1IU)RDZ<6K&O:A^ROXS^'&H>*_$]]^S]XK^$=YKTFK:KXDUZY^'.N_#BZ\3
MK-%93:GJ&L:@\^C3Z\+B""W:XFF:XWPI&6W( )J1C@I9=*K%82=%NI@'->R<
M'B*E2NYX1RY7%UZU6M6<J-O:U*E2I>4IR;=%3JU,=##J52I+E>,C3O*36'HT
MH0^LJ-V_88>E1A'VO\*C2I17+"$$LWQ!\2OV;?@Y=ZS\2]9^)/PV\,S^(_ ?
MA>.SM6\8>"=)_M[PKX37Q9>^%D\)V,E]:-K)N?MVO06?E33QS&T$-ML$#BC%
M8NK@J&/P]:-:M5ABJV.K4$G/%/$SPN#P\U[)N+YY4L-AW[Z523FO:5'35&--
M87"PQG]EUJ#HTL)*,L'A<3[D,*H2K*M5_P!HC%ITZ<JL)SBIRIT(R=2%.$Z]
M:=;HM+U+X-_V/H'QK\,^%_!-V_Q$U7PG>6OC'2(/AYI^KZIJ'C0Z;X2L-4NO
M%-]JME#JNH1V5_#82);:G>W]Q% UAI\-].T-I/URP53 XUY0N6BY/'0_=J?L
MIP=)YEB9QA"'M*M+&?V?0Q$I0HR51TL/B\1R4,//$4.*E7H8["?VM*GSNA1H
MU7[91]O2>&]KA:=&<Y-PH5<&L;B\/RU*M.&'=;%4(SC*M*%2EI7A?]EOXG:G
MJ46A^'?@%\0M9\%Q:IX3U>/2M(^'?BS4_"<&K3WS:UX:U)+2WNI]!BO;JYU,
MW6G3" 323W1EC9GDSRX9>SHT\9@UR8>I'#T(5Z.E.4,%&B\)1A5A:,HX2%/#
MO#TU)K#QIT?9J"A"W94<J&)6&JMT<9AJM3&JE/W*U*MBY3G5Q:@[3A5Q4YU)
MU,0DIUI2G*4Y.4F\/PS\;?V7++7_ (H:CIWBSX0^"]=T+Q?9?#[Q_KM]K7@#
MPS?:[K7A_2K*/2K6_P!334X[C5K:PCU&?2;5;]E>&>PO[2&)1 =SIOZU@,"Z
M<U6PN=5<;7I4%+G]M76)C@\55E25XSK8GEPE5S7/.OA<5E]6;MB**,JCA0QF
M(PE6#I5\DPV'A)RBX+#X2>'GCJ=.G*2BX8>C"&(<U'EHTJN&Q<?BP];D]6L;
MCX3:AX7T+PYILWP[OO!>N6EU:>&M!L9/#5SX7UBQT'?<7MKH6EV[-8ZA::=]
MCDEECM8I$M_LK,X3RR5)2?M*56<G[3#4</F%*<G[U*A0EA983'4Y/6%&C*K@
MY8?$Q:A3E4PKIS3G2NY3IUU7YIQK+'XC%8.M=J:Q&*Q'UKZ[A:M[^VQ%94\;
M]:H3YJE3V>*]K&7+6MST&F_L]_'*UUJ>VL/@U\8+*UUNQM_$4T%KX(^(%K;^
M(_#D<L>FP:U)''?QPZWI<-U.L"7)$]JMS((P@D.2G2=*&#QM*G[.$JD\7A:\
M(\L75G"E1J8G#U8I)U)4\/0I3K4Y<SA0I0E)QIP47-P=3%86HTZOL887$T96
MYOJ\:E:K3P]>F]?8QK5<14A2J+D52I6G&/-.;><NO_LRZ;JEUX.36O@38:U\
M,KS5?B)>^%5U+X?VNJ?#W4%CNKW7/'5UH8F6?PG>"'6+Z>[UJ2"U<+JD\DT^
M+ER[I59U(1QM&HYT\'!8&->$FXT*==K#K!JK%M4H5FE16'4HQJ-*FH.UC>=&
MM*I3P4Z4Y5<U=&<*$HR<\9+#\DL/.%)J^(=#ZO3E1DHS=+V$'!Q]G'E?I>J?
MLTWVM^*OB_HNH_ R\\2>$K672O&_Q1TN\\ W&M^&;**%9Y]-\5>-K21KK1K5
M(%61[>_O845%#%0HS4QE]2PM2I&7U3!8ZJU4DG[*CB*].:IM3DN6G5JPFU3:
M;E.,[1T>A')/&5\/AN5XK$TZ=.I0I6=2K&E.+G2J4H>]*-.<).=.4$HRC)RB
MVFV:WPY\<_#'XK7GCW7?!$&BZVNF:IIG@77/&%A%X?U+3_&-E;^&M+\7:3_9
MOB#2+N['B'PQ!8>.I%@^T2*B3W>HB*$)*9;C>MA*U+ X=8BDZ6&S">,JO#58
MRB_:X?%5<JKU*U&24?:5/[.BHR]Z4\-##J;CRJG#-UHK&>RC44Z^#HT)0J0D
MFJ<,0G75.G-/FBX33=6"45&K=KF=V<+HVL_LP>&/$_Q$_9YT;0OA-X3?3O!E
MMXZ^(G@RTT?P'H'AF^\/>)7U"PU";Q#H5N88[UDL[:WEU(W]AY4=IKNEO-(R
M:A&#SJ4,1EE>O*I"669'B:>$DISBZ.%J\L,53M%MPH04VN23]G?$0FH)SI3<
M>IT<1A,7@<7!2AF&>O$5J=6G=8JM+#.--U)S5JM253FJQHR3FYK#8I77L9'>
M6=Y\"O%W@K5?&.F3_"CQ9\/9?"LV@ZSXETV3PAK_ (0N/!7AL7L\VA:AK%JT
M^G3>&=-$NHN;*:8VML9;@E$W.3&:26&P^+Q&:4Y>QKJ.,K>WC?ZQ)1;IUY*K
M95JDE*U*I)MRYK1E[QGEO/.M@<'E<K5<)4>'PM+#.SP]2M[&$J5&%+6C*:HX
M>,H4U%R5*DFFJ<+>$?#_ .-_['6K:+\.]'T*'X3^"_",FD>%OB3\-8=7M_AE
MX7\*Z=X@\0ZQXGT#3M-\*VT6I_9]/^)=CJ>B:Y!<VFG0K<V[S/$LS2M/''Z5
M3#XQ8]TI2E4S+ QI8:@HRE4KSH8W!.HOJ;CS3GA)81NC4=)^RG"7)%3I2N\Z
MF&IX7"XCEA3> KXK,(8ITDGA_:Y1BLOJ2Q&):2IN%6OBL'B\%5J7E/EAB'[.
M<:3E[9?VG[/.K75Y\"]4MO@SJ=[JOVSQ9?\ P<OX?!%[=:E_:&H3:QJ'B6\^
M'MPKR7GVG59KB]FU&2P?S;B62=Y&D9F/ J4<732C36)I9.J5))1]I#!1I)0H
MTTDFL,J<7&%*"Y%!-1@DK(MUJF'G]8=65">:<W[UR<)8OGAR3]^Z=?FIPY9:
MSYH1Y7=1LJ7CO0/V:=)C\#>'/B;HOP,TR&&5_#WPTT'QWIW@&RCBFOK?^SY-
M#\#:7X@A14EN+606S66E1 R1R>44*MM.D93Q>8-PE+$YM6I2;:;J8N=&#4IM
MM7K2I1<5*3U@FDW:QG'EP.#BX6P>7X6K"I%K]UAZ->F^>E-6Y:5.K!IRA)6G
M%KFBUN;'C_7_ ((V7A:\O?B-?_#.?PIX$UFVDEB\57'A2?2?#GBKPU9+KNF6
M\4.M2_9=*\46-DL5Y:Q#R;J%#'+%L4AJY<7BH8>,,RJ\U:LXXJIAYQ]_$5Y0
M5>ABHX63:E5JR<,1AJL:<FW-5:-1W4XK7"X9UO:Y90C&G1Y*%'$4O@HTJ%9T
M)4%B8)<M/#RY\/4A[2/(U*C.*=X-\5H7CK]E_P 7>#?A;<F]^#EIH7Q%\*3:
M7\,_#'B"?X?VT^I:#XAALH]<\&>']#>ZEANU:6UM;'4]'TO[1%Y^G+!,CM;J
M%]2OA\1@\VJX&-3VV9894:D70E*<YT,)*&)PF)HR252>&I>SI8K!UXI0A&-*
MO2<;1DN3#YC'%Y?+,U5J0P5?%3E6J5N:FECZSQ%&JL3SM*&.J/$8JE5C5:Q#
M=?$4ZBO4JQ>A8:_^RWH?CSQ)XBTC5_@)IOQ2;2M=N/%NL:5?_#RT^(<VC>$W
M>S\2/K]_:3)K$NG:1-I4EO>F[D,5H^G&.?RV@(3S?K,,'E^.Q%&3CE].G'&8
MGV/\*49RFZ5:HHM4Y.M4E-4:DW^\J2DH2<I,[98.M5Q678:KAY?6HRA@L#"K
M!^T@ZE.E4AA<,I+FCS4:M&HJ-)*]*I3FHN$HMZ'A/XB?!'XB?#!/C+:WG@B/
MP#\0]&TPZYK_ (AD\+6]G?VK2-HMIH7C+4'NIK*6]M+V[ETIM/O+N;R+F:6S
MVB1F0].8X)8%2P&.A2C1KR6(<)<KH5IUJ%%^WBI+V=9U,/0HIUH\RG2P].TY
M4Z4&HH*I/&8AX1NMB\ ZV%E5H-SG&E@JN(J-PJ4[S6%7M*^,I/W8*EB)XCEC
M[:;?E]]X%_8W\7O\'?!VGW_P,CT*WU'Q!XT^'7PK\,77PL3P?\18]>\-:[X:
MU6Z@\#P6<UOXNT?['J]_=&73(0/M-K'+)*ZQO&^L5B)8O%*K2EB\3ALL^JU*
M5:,JLL'@ZV)R_'4L0J;]_#VE@,/]7JNU)4JE3EBW.$X<M25%X2'+5C0H5\=2
MJ*M3E&'ML3@UB,(\.ZB]VI9XBI1K4M:G-&-.\;2B^Y\1ZA^R?=ZKI_ACQ;??
ML\7.N?";;<:5X>\1W/PVFU7X:?V=I-QKBSZ?I.IN;CP;]ET+1KK4 \,5GY5I
MI4MQE8;9G3.C.M6KSS;#SG5Q*YZ4\93<I5=:M+#U*<L1&\M:V)H49P<_XN(I
M4Y+GJPC+H^J2IT</E?U9PP^)=-T,)[-JG5<N:-%TL/91FY6E&FX0=[24>IT_
MC"X^$$&G:SH&N:'X \0VOCK4O",_BSPO=-\/@GB6/QEJNF>#M!\2>)=-\4ZG
M8VOB"SF?3K.UADF-Y=7JZ&EEID%[=06]HTQIRE5H86?N+ 5JTH*:DXX+$4*6
M+S:;Y(J52C6<Z&(Q-Z=/GA5E4QE;V=&&)Q-(C4=.A/,:4WR5<-)0JP=OK&'I
M1H8>=.G6NJ<J5.EC*-.2G4C1A2KTZ;DO;TH5.6\4^,_V3/%FBV&L>-?%?[.W
MB;P[X#UW2XM,U7Q3KOPUUG1?!GB6ZM89]%CL+[5KJ:V\.Z[-9-;R6JQ/;W#Q
M&-HLH5-"YY8G#8F/-+&8^5?#T*JNZV)D[?6:%&:]^M)\T?;TH.3?,O:1U0I4
M_J]/%Y;*'L*6 C3>)PKCR1P\8NK1I.O0:2HQBXUJ5-U(Q2<:M..TD5?B-XI_
M9I^"?A'6YO$FG?"S2K/7/ U_(O@>PL_ -CKGQ(\'^&+/4]4?0- \-7]Q8IXP
MT^W@U359(K$&2UC.K7+'RUNI&?7#+$5L;@\KP[FL3''9<H4HN5\'B:N(P.6X
M3&5(1O+#K#2HX*FL0H>THTL)1A2N\/2IJJ5)3IRS"'+&C*GB4L5M":JQKXVO
M1C72Y92Q<JE>JZ?-:O5KSG.[J3F_5X_AI\,Y?$J>/E^'?@<>-)?L5R/&#>$M
M 'BO?:6<]G82-X@%@;[S;>QO;NWB;[03'%=31H0DC!LHJ6$E7A2?L.>=1U?9
MOD4YS7)5G/EMS.I%<LY2UE'25UH84ZD,5A\-.S=%T*4:4)I?NZ*G3Q%*DHW<
M8PIU:=*K&$?<C5IPG'WH1DN-U+Q'^SAXFN/%_B?5]>^"7B&Z\!Z1J7@_Q[XA
MU+5/ FK7'@S0=0E,NK^%O%^K7,\K^'=(N9K0O<Z;J,MO#(UMF6)C'QS?[/+!
MU,1^[EE^:3IT)U/=>'Q<Z$N:E1G/^'7G1E4YJ=-N;IRJ7BDYZ]:^L0Q5+"+V
MD<;@4\52HKF5?#JM3Y7B:=/^)256E'E=:*CSTXV<G%$>D^-/V:OAAX#T1M"\
M6? WX>?##6+6]O\ PXVDZ]X!\)> ]4LGN+6+4;W1#9W5KI-[:M=ZG9)/-:[T
M,FH0B1MTZ!^O$QK5ZL<OQD9UJ\Z=.C'#5E*=25&I^ZI4E1G>3ISO[.G!1Y97
MY(I[&.%IV53%8&G:-.L_:5J$=(UX0J57SU*:M&M&G0JU'=J:A1J3TC3DU*_B
M3]G"TM-9TJ37O@E;6'A/0M,^'OB#37U3P)#:>&O#/B"*)=&\#ZS9M.(]&T+4
MH! +;1KE(;>Y3RQ% XQ45YRJ_6<5B9NHL97E'$5JK<O;XK+8XBO.-:I*_M:^
M A+%UI*;E4PL98BH_9IU&31G&A6PE3#R5'$86$<3A94VH5*-/'UL/&&(H.-I
M4X8W$0PD8U:=HXFM'#I2G.-.W&^"]7^#]I\3X/&/AKQG+\0]0^+_ (0UH>'?
M&&F:OX)UCP!X6\ _">ZT][CPCX>U+PM%906FD0ZIXPEN@\HU:ZEE^T+>7ZQV
M5I%'I"56A0S##5DZ,HJ&<8S$XA.%7%JO46%PU2=25HRA0I2Y*"C"E25*52O*
M57$UZ]6JW"G7I8+%X>4)8; UX9+AL-AVG##U\1AZ^+K\M.-W&=994EB;SE.,
MZ>%HTJ5.A!1I/\7_ !A_98L=$7Q_JGB+X/>*-(\=^+?!WPKU#Q/INI_#[7K;
M6M8BUEVT+1==UN34/(OK3P_<WU_JKVT]S,^G1+>W44 ;=NG#4IXC$97E]&+O
MFM:MC<%&S]G5Q.%PW,L7223Y\1)X3#X'#UZ495)8N6!PL9*4J?+&,JPP^&S3
M$8K6GD]%X7&1DG*>'H8RI&E6PM:#_A49QKSK8JE5Y*7U:.(KU5[.%1GI/AS4
M/@GJ&N2^"/"5]\++[Q)\.5NVF\(>'+GPE<ZYX$37DE2_:70-,=KKPNNHQW4R
MS%H+87 N7#[Q(<YP@JV'=>E#VN%C167.I%<U)8>G[%1P#FKP5&'U2@EA;\D?
MJU&T%[&'+4U&E5IQJI4ZU6M/,*:E:,YXBI[:4\=!.TI5IK%XASQ,;SE]:K-S
M?MI\U[3?A!\)=%T#7?"FC_"[X=:3X6\47$EUXF\-:;X)\-6&@>(KJ4H9;G7=
M&M=,2TU>X<QQEI+N&5F*+DG:,4ISC#!TU)QIY=.G4PL4VHX6I2J*M2GAX[49
MTZL8U:<J:BX5(J<6I),K_E[7K_\ +_%1G"M4_P"7E:%2,H5(U9_%4C.$YPG&
M;:E&4HM-2:>])X)\&3-JSR^$?#$KZ_>:-J.NM)H&E.VM:AX<^Q_\(]?ZLS6A
M.I7FE_V?8?8YKCS'M?L-OY#)Y*;5%N'L^1N/L:\\3"SMR8FI95,1&WPUZBC%
M3JJU27*N:3L@7NJR]U?5G@K+1?4VJR>$M_T#-8C$)T/X5J]9<G[V?-2TWX;_
M  [T7Q'K?C#1_ 7@O2?%OB:,1>)/%.F^%M#L/$?B")5""+6];M;%+S58PBJN
MVZFE&% Q@5,8QIX>I@X)0PE5MSH15J,V[W<Z:M"3?-*[<6W=]V.;=2M2Q%1N
M=>@N6G4D[U*<=%RPF[R@O=CI%I>ZNR//_$/[.OPMU+PCX@\'>%O#'A?X967B
MJ.*U\07?@7X;_"-Y=8T]+^XU.;2]5TCQK\/?$.@ZOI]Q>WEY-)'?Z/<GS+N:
M6-HY9&D,5*?M*>'H.;CAL-.G.-"T'2O1C*-'W)PER>QYKTI4O9R@]%+E;B](
M5G"=:JUSUJRK)U)2J*HI8A4HUYJ49Q<I5H4*5.M[3GC5A""G&7LZ;BOAK]G'
MX0:#\/+;X9:KX+\.>//"\6J2Z[=VGCSPMX0UNUU'7IVC:36)M!M_#UIH.G7"
MK#!'#;Z5I&G6EI%;Q0VEM!#$D:]5:M[6KA*R@J4\!SO#24JLZE"56M5Q%6<*
M]>I5Q#J5:]>M5J59UI5)3J2;E:R7+0I1POUM4O<6,E3E6C",*5.:H4*&&H0]
ME1A3I*%&AAJ%.$5#:FI-RFY2?H>D>!?#F@^)]9\5Z58Q6.IZYX?\+^&;N*U@
ML[6RCTCPA+KLVB6]O!:VL;*(3XAU!/WDDBJ@B2)8U0AI5:HJ-:BYRE&OBZF-
MFY-N3KU</A<+.3UL[T\'2O)IU).ZG.4(TH4Z=.GS89QA&"PE"6'I*,8QY:<Z
MLJTHW2YK<[O&'-[*F^:5.G"I5KSJW&\&^$&BB@;PIX;:"#6]0\2P0MH6EF*'
MQ'JJWZ:IK\49M=L>MWB:IJ:W%\H$\PU&Z$DC"XDWXN$'"%)Q3ITZ-3#Q@TN6
M.'JIJK0C':-&HI252DDH34FI1=V;^VJ\U6?M9\]?V'M)<SO4^K.@\-SN]Y?5
MWA<,Z'-?V3P]#V?+[*GRX'AKX1_"CP6C1^#_ (8_#SPG&UAJ.ENGAKP7X;T)
M&TS5[B&ZU;3F72]-@!L+VZM[>:XMR/+GD@C>569%(NHW5P]7"U7[3"UX4Z=2
MC+WJ52G2594J<Z;O"4*2Q%=4XR3C!5ZW*E[2?-G_ ,Q,<9_S%TZDZT:__+Z-
M6HJ:J58U/CC4FJ-%3FI*4E2I\S?)&UX_#7X<MIVF:.W@#P4VDZ)HH\-Z-I9\
M*Z$=.TCPZ+K3+X:!IED;#R;#11>Z+HUQ]A@2.#S=)LI/+WVL1CTG7KU*TL14
MK3GB)U<-7E5E.3J2KX.<ZF$K2FVY.KA9U*D\-4;YZ$ZDY4G%SDW'LJ?L7A_9
MQ^KR6(BZ7*O9N.+IRI8N+A;E:Q5*<Z>(5K5J<I0J<T9-/G/B=\'_  Y\3O#V
MN>'KN=?#J^)Y-+_X234]+\(?"_Q)>>(+71O,_L_3M<L?B?X \5Z1JUE")'$0
MNM+EDAR?(DBR<\DJ$9.CKRTZ.(EBO9J-/DEB94Z=+ZP^:#E&O&%"A%5J<J=5
MQHTH2G*%.,5O3J>RE4G&*5:I0CAO:WFJD</&I5J*@I1E%.CSUZ[]E-3IIUZT
MHQ4ZDI/6^'/PQ\+?"_P5:^!/#MO)-HL,NK75XVI)8R3ZK?Z]?W6IZU>W]O8V
M-I81F[O;VY<VME96EG"CK!;6T%O%'#'V8NK]<4(5:4%0ITH4(4O>G"-*"LHM
MUI5*E5RNY5*E:I4JU:DIU*LYSG*3YZ$)4&YJI*5:3IN53EITW>E2IT*7+"A"
ME1I*E1HTJ5.%&G3A"%.*45:[D\-?"KX7^"XK:#P?\-_ /A.&RU6XUZSA\->#
M_#VA16FN7=G/IUWK-M'I>G0+!JLVGW5U:R7:!9GAN98F<I(RF(U*D(4Z<)RC
M3H4IX>G%-J-.A4G"K.C"*=HTIU*=.I.G%*$ITX3<7*$6JE&,ZE>K.*E5Q52%
M:M.23G6JT[JG5JR>M2I!-J$YMRC=V:NQFK_"3X5>(%TA->^&7P^UM/#VKW7B
M#04U?P9X<U)=#UZ^OI-3O=;TA;S39!INKW&I337<MY;^7-)/*\KN9&+&:4I4
M*U'$46Z-?#48X:C4@^2I2P\(JG&A3G&TH48PBH1I1:@HI144DD7-NI"M2J/G
MIXB;J582UC5J-<KJ5(NZG-Q]URDG)K2]C;OO!7@W4M(UWP_J7A+PS?Z#XHFN
MKCQ-HE]H.E76D>(I[V.&*\GUW39[1K?5YIXK>!)7NXY6D6",.2$4#.5.G.E2
MHSIQE1H2E*G3<4X4Y2K3Q,I0BURPE+$5:N(DXI-UJDZK]^<I,I-T*LZU%NC6
MJ**G4@^2<E"A#"P4I1M*2CAJ5/#Q3;Y:%.%)6IPC%8I^$_PL;0E\+M\-/A^W
MAE=!;PJOAT^#?#IT)?##W27K^'%T@Z;]E&@M>1QSG3Q%]G,L:R&/>H(TK-XB
M52>(?MYU98>4Y5/?E.6$51864W*[E+"JM66';NZ*JU/9\O/*\TXQHN,J452E
M36(47!*+BL7[/ZTHN-G%8GV-'ZPE;VWLJ?M.;V<;5[[X-_"'4_#.C>"M3^%7
MPWU#P=X;GCNO#WA*^\#>&+OPSH-S$7,5QHV@W&EO8Z7.A=RLEM!$R[VP1DTY
M3G/$T<9.<I8O#<OL:\FW6I<J2C[.H_?ARJ*4>62LDDMD*,8TZ&(PL(J&&Q=U
M7I125.LI2YI>UIJT:G-+WGSJ5Y:O4N:O\+/ACK^L:=XBUWX<^ ]:\0:/:VMC
MI&N:OX0\/ZCK&E65C=P:A96>G:G>:?)<V-K;W]K:W,44,B)'-;12( \:L"G*
M5&M4Q-*3I8BM*,ZE6#<:DY0OR2G.-I2E"[Y7)MQN[-7&TG1IX=J^'HQJ0A2?
M\.$*U-T:L(0^&,:M*4J52*24Z<G"2<6T=9-I&E7.I6.L7&F:?/J^EV]]::9J
MLUE;2ZEIUIJAM&U*UL;YXC-9V]V;"Q,\<3HLQLX/,#>2FV5[KJ<ONNM!4ZEM
M.>G&7/&$[?%",_>47=*7O)7U*<I."I-MTXU(U5!OW55A"I2C54=E4C3K5J<9
MVYE"K4@FHSDGQ=I\(/A-I\?BR*P^%WP[L8O'JSIXZCM/!/AJVC\:)<^9]H3Q
M8D.F*/$:R^=+O&H"X#>:^[.XYCV=-86&!Y(K!4Y^UCA^5>PC53BU4C2M[.,T
MXQ?.HJ5XQ=[I%*I46+6/522QZA&FL3S/V_LX*T:?MK^TY(K2,>;E2T21F2_
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M1+W*:]V.B2T2T270<TJE:>)J+GQ$THRJRUJ2BFVE*;O)I-MI-V3;?4[&D 4
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MP_+"&&S#-J\%"DIUIK'U,-6>(I4ZLX8:HL2Z+I8FCBG1G>$9.52%:K&/U?\
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M$[-<T(NZ2HSE4I4YSHSP\Y13=*HZ;G3;6L9.E.I3<H[/DJ3C?:36I<K,T"@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#Y_\
M@W_R47]K'_LX#PY_ZRQ^S30!] 4 % !0!\__ +6/_)K'[2W_ &0#XR?^JZ\1
MT ?0% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M -%D^ '_ (C3\1?_ *+&@ _X1S]J?_HLGP _\1I^(O\ ]%C0 ?\ ".?M3_\
M19/@!_XC3\1?_HL: #_A'/VI_P#HLGP _P#$:?B+_P#18T '_".?M3_]%D^
M'_B-/Q%_^BQH /\ A'/VI_\ HLGP _\ $:?B+_\ 18T '_".?M3_ /19/@!_
MXC3\1?\ Z+&@ _X1S]J?_HLGP _\1I^(O_T6- !_PCG[4_\ T63X ?\ B-/Q
M%_\ HL: #_A'/VI_^BR? #_Q&GXB_P#T6- !_P (Y^U/_P!%D^ '_B-/Q%_^
MBQH /^$<_:G_ .BR? #_ ,1I^(O_ -%C0 ?\(Y^U/_T63X ?^(T_$7_Z+&@
M_P"$<_:G_P"BR? #_P 1I^(O_P!%C0 ?\(Y^U/\ ]%D^ '_B-/Q%_P#HL: #
M_A'/VI_^BR? #_Q&GXB__18T '_".?M3_P#19/@!_P"(T_$7_P"BQH /^$<_
M:G_Z+)\ /_$:?B+_ /18T '_  CG[4__ $63X ?^(T_$7_Z+&@ _X1S]J?\
MZ+)\ /\ Q&GXB_\ T6- !_PCG[4__19/@!_XC3\1?_HL: #_ (1S]J?_ *+)
M\ /_ !&GXB__ $6- !_PCG[4_P#T63X ?^(T_$7_ .BQH /^$<_:G_Z+)\ /
M_$:?B+_]%C0 ?\(Y^U/_ -%D^ '_ (C3\1?_ *+&@ _X1S]J?_HLGP _\1I^
M(O\ ]%C0 ?\ ".?M3_\ 19/@!_XC3\1?_HL: #_A'/VI_P#HLGP _P#$:?B+
M_P#18T '_".?M3_]%D^ '_B-/Q%_^BQH /\ A'/VI_\ HLGP _\ $:?B+_\
M18T '_".?M3_ /19/@!_XC3\1?\ Z+&@ _X1S]J?_HLGP _\1I^(O_T6- !_
MPCG[4_\ T63X ?\ B-/Q%_\ HL: #_A'/VI_^BR? #_Q&GXB_P#T6- !_P (
MY^U/_P!%D^ '_B-/Q%_^BQH /^$<_:G_ .BR? #_ ,1I^(O_ -%C0 ?\(Y^U
M/_T63X ?^(T_$7_Z+&@ _P"$<_:G_P"BR? #_P 1I^(O_P!%C0 ?\(Y^U/\
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M*+^UC_V<!X<_]98_9IK(H^@* "@ H * "@ H * "@ H * "@ H * "@ H *
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M]A\0JKJ2GS<E;-*N+PSI\G+42A6]OA^6C'SKPU>ZI!I7P@T*Y\8V$'V3PO\
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M[;U-VG'-.(XNI[5PS;&1<FHJ3Y'"/O**C'G5K3Y8QCSI\L8JT5]/5PFH4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % 'S_^R=_R:Q^S3_V0#X-_^JZ\.4 ?0% 'S_\
M!O\ Y*+^UC_V<!X<_P#66/V:: /H"@ H * /G_\ :Q_Y-8_:6_[(!\9/_5=>
M(Z /H"@ H * "@#.U>"6ZTG4[6!=\]QIU[!"FY5WRRVTL<:[G(5<NP&6( SR
M0*X,UH5<3E>98:A'GK5\+B*=.-TN:<Z4XPC>345>32NVDMVTCKP%6%#'8*M5
MERTZ->C.;LW:,*D92=DFW9)NR3;Z)GYK_#+]FOXE:!\)O&FBZWX$M;3Q?JWB
MK]DO4-/4ZOX5N+JXL/A-X:^"EIXED_M*UUB2&%='U/PSXN$<<DZ-,UM(]FLZ
MW<+3_6X[&X:6;9?BL+5M1I<39UF5:48SC_LN-KUH4Z[BXJ4G6PDXTY02=54W
M[.<(V<3GAR*EBHR2YJG"F/RR*:_YC*M3B*K0H7Z7J8S U%4THQE.+E43I5.2
M]XR_9G^,'BO5OCMX=2'3=+\!V-OJ%W\";F#4])DN-5F^)OC;PY\1_BII5U8:
MK%JEII$B:CX<O-&MI=7TFYLVA\22 VT]F)X7^<PGM,/E^7U:LJDLQRW,<KH1
MA2C0]M_8V28W$8O!RH5:RE0YYTL5@</'#UN5.?#^&E6E!5*=97B91JXW$TX>
MSJ9?F>7YG5KPJ4W2HPSC&Y,LCHNM+#OZS-4FL?F->O0C&4_[:K6=7$TGRS+\
M%/B-<66L>.[_ ,+?M$W_ (OG\8>#M8TN6X^(W[+'A[XN^'[KP]X5\5^%I?%/
MAKPWX&\(:;\+-2E&G^(4TN6T\2Z_>/?Z85F<6MQI-I8W?2YO#T*=/#R4*M:O
MF=6=2E!5I2CC:651E1QT,7*-%T,5/+E*O3PD*LZ%2$:U.M7J8W$/"X4H*I4Q
M<:UE06 P.%C"I*4*,_J>-Q.+IK"O#P=>E/".NZF$KU515>I4GA<11I8:A2JU
M<P? WXV7VFWVD^)_AYI^JCQ=X%^"&CWLND2?#30](TQ/AO\ M#>(_&>IZ3XL
M\/Z9K%AI\?B"Z\ ^);2]NV\,Z?=Z//?Z?K,5N\0DLHKSOI5<)3KY=2C&%&GE
MF<91F3E#VT\+^XR?!8*M' *JI8J%# XS!7PM/$PIU(X26&]FYU(5*=/=8CGR
MZI3DJCJ5L%QOAU"LJ7UGFSO!P>!J8N5"V&G6Q5>-2&(J49SY:U15*\G!U<2>
MF^*/@+XQU2\^*,ND>&['3;WQ;^T]X,^(&D:W'<:$DZ>%=+^&G@_PS=>*#LOE
MGC>RU2VU^/[(WEWK@3-% \=RKR^'BL/*OE>0X&C-8>KA\/QG#$2U4:57.</Q
M/2P<I<J;G]8^N98IRI\[IJ4/;<GL*GL\J\U'&8S$4Z7MJ<H\(1C"/+%U891G
M648W%TO>Y4E0H8;$3BIVC/EY*7/*4(R\!MOV7?BY??#V3PIJGAWXDZEJ/A3X
M3:?\*[*P\7>)_P!FRT\":U:?\)EX"U/4;'P5IOPU\$:3K.N>&3:>&;^]BO?'
MFJZ1?VVYHETZ\N=5NIHO;GC*>(S.EF7*X4\7Q#PYC*\,1"#Q5/"95F,\14JU
M8X:4<#".%P]:I3HPPJKU*].=2G'#86-.C"IPU*.(P^5XW+J59XC%T<LS]8?%
M4KQC5QN99-CL+#EQ&+G5S&%?%XNKAJF+A6J+#^WA2Q%;,,4\-&H_H_Q;\*/'
M=G\=-.^(7AWP3+JGAG3_ (J?"_Q!/;Z1JOA:PN[C2;'X2?$OX;ZWJUM9:OKE
MA%MTBZ\4>'Y+B&22&XFL[.3[!#>2PI!)RY+6^JRQU/%-Q688K/DJC]^-*&.P
M7"\Z&(J\O--TZV+RK'4I1IQJ5XUI1JSHJC4=8[*K4:&84J47R?V'D&&H4XV2
ME7RWB7,LQKX:";482C@JU"5.<^2A)R5+VRE"48V?VD?@MXY^*7B?7CX;TV"3
M3M5_9A^,7PZMM3NM4T^RMH_&GB?Q%X!U/PWI5Q%)*]Y'!=1:#J#/=QV<L$*V
MY$DB/)&LBR_$?4)9ABG3=6=+-.#,PH48N*EB(9%F.;XW&4X2DU3A-0KX>$/;
M3IQG*LN634*KAI.%+$5,EHU*CI4(_P!NT,54C'F>'I9GEN'P5*MR73J6DJDN
M6GS22IZI<T>;S>\^%_Q=^)'Q_P#!'Q-\1?!Z]\)^$](\4?!B_GT[Q+XE^'6K
M:K86_@3PA^T'::KJ=]:^&_%VK6SRVGB7QMX7-JME/=R/'?6UP%22"\BL.W 5
M,/A)XFK.M%SGB>(*]&48U.:G',,GX=P>%3O#W:TY8/'4:J@Y0IN$E[6=&=*M
M6YVI/*5E\HJ3HY9EF$:WC5KX;B/"X_$<C;5Z"PE'VM-U8TISY90E3524*3T;
M#X2?$GP/K^N^(8?A)_PG^G:_<?M&^%K/PS8Z_P"![2;0K+XG_$^3Q;H7BBY'
MB3Q#9V \*ZKI2B/5(K*:?5X +91I5V3)%;_/5:-:MP]C<H;_ -HQ^299A(3F
M_P!UAZN5RSVV&JR3E.U2&88.6&E1A4I*IAHQK3H1C&K#V*U6E//\'FT,5*.&
MR_%T,1.BHSOBY5<FX>PM7$4EI#ZS@\3EN/HVQ'LE.EC<14HU6I<F(]+L?A-X
MLD^ O[+_ ($U7PU;S:U\.]5^ MYXST6>^T:X@T<>!+33FUN7[0;UK34CI]]:
M*R?8I;EI&A5K<2<&OI<XQ='$<;+.,+5<\#'%9[5C7M*+4<7DN;X3"SY))54Z
MF)Q6'@K0YJ;GSSY(0G./RU+#5X<.8W+O9JGB,1/ Q]C&2Y71AQ#EV+Q,.:ZA
M[/ZA1Q$I1DU[2"=)1=2<:<O+]?\ @-\1;70K1_"WPV\':EKL'Q[_ &F?B#)I
M/B9_#<OAK5=(^(/@OXL:-X3N?$MLE]_Q,M+UBXUSPM9W5B-]P(;E5O(H8H)7
M@\C!RCAL#@:%2#<</PY5RZ=.,83E"M4XCRG,)T:$:DHT766%P^)Q.'E4J0PJ
MQ%.G&K6@Y13^FQ-3#U<RQ>)A4E!5LRX<Q<:T'.E4_P"$_),+A,36]I&,JM-T
ML5"K3G.,)5G%U*M"G6YES\%;_ WXV^,?C#H7CKQ;\.M8@\,MJ_[/LTNF^*[O
MX)V4GAVQ^%OB'Q]=:M:Q^'OAYKU]:1:9:KK>CWMBG]J^(KJ02R8FMA%%IECV
M82I##9A&O*M*3_M#,L<\0Y3G4DL9POF&7T'4DXP?UFGCIT:-3DI<L%5HU5B<
M2HUZ]+Q<P=;$9)A,MHT(TG0P=/"SI4N2G0L^(^&<;B*=)-N;H3R_!8U^_4C"
M<:$\/'"4*DZ<L?Z?KGP\^,_A[7O$+^$_AU%<Z9XF^(?QBO;?Q-X=B^$M[X\\
M,V?CJS\%Q:9JNEWGQ(UE-.T'PEJ,UEXAEU=;>PUS4C<6.G.VA7L.^.3Q:>'E
M4R2GE<_W%99;F.&6JC1FZG$&=XZEA<;5A&K6=&6$KY?/"PP]*I"+J5HUJN$K
M4J<H>C3J^RS''XV5Z].6:91BH0DY2O2PG#.7Y?4K8>CSTHO$T\92Q.'<JV(P
MLE2<W1E4I8B<U\CV^D:O\(?AQ<?L^^,=#\,^)_BS\2O#7P)M=+\.1?$'X6WW
MBOPC=^!X?#VA3:1+X.B\1KXEU6PCO-%U/Q'I%]X>T34[/=JM_+J,ND);335]
M!#$4LSSC*5@XN,,KXFRS-L16C&4^3#\V3RQ'M_9RKO#XG!4</4P>)E7E3PGU
M*G2E0QF)J58T:GGYS[;^S\^Q<\/[-YCD'$N74ES4HSK5L1C.)L1AZJE*&$HU
MJ.,>9X6-..'C]9^MQ=*6 P\8P5+WP?LY_%F+Q#K^B7J?$_6+"+XD?%GXHZ'J
M]KKW[.VD_"Z27QM'XO&EVB32^"+GXK77B233O$-OHMWIU]J%II;01R%-;BM8
M+>R7YO$4*U7AZ>$I0Y<9@LBQN4QI5)1BL34Q&$JTI2P\<*J%"I0Q&*E'&U'F
M$Z-6AC.7$5(X^M15>K[,L1!YQ]:]JZ>%QF8Y)BINC!)TZ675\OJ.&(=957%X
M:G@G2A+!4ZDL30:I+ZJ\17E3]9N/A-\1$\-VUM:^ /"^J3^ ?V6=%^&_@OPO
MXK_X1W5_#&N>,_$0LSX]T34=*?46MI[2UL_!OA6U0WDEK973ZA,GVAK?S98?
MH\VQBJ9GQ'F.'G*O',\^RZ=-4X16(AE>7XJIBY8O"2KNG3AB:DL?4EA:=:=)
MT\3E>&J58TX^RG+Y_(\/6PN2\+9?6G/#8C 9=C9XN$I_[)+,JV"P^%P<,2\/
M[2M45*4,?'%5*,*D5A<QJJA.K5G4A#YSUS0/B'\/?BI>?M'_ !;T]_#W@[3-
M=^$VJVOA_P"(_CC]G;P-?Z[)H'A+XP^#I_#FG/8>,K+PIIVNZ+?>,=$UG3K?
M5_$]ZEQ&C[=:$\<5CI>&&QF%R[#RP];DQ.*Q^,SGD:G>M3_M/ \/<N-C[:-)
M3J4EE6,R[&TZ$8U883%3G36/?M:V+ZJV$K8VC1]DWA:6$P>$I3A[.U%+ 9K/
M$K"R]DJSCAL7&O#$X6<I.^-PL85Z>!I2I0IP^#/A=\2/%&F^'_BQX0\/^/-,
M\/:SJG[2.F6_AGX57'[/LFMV^B_$OXKR:_IFJQ/\>?#VH^&-2\$ZMI%@%N;W
M0IXKJ2,VLUDNJ6-U7+4P57"X&GD^+<Y_7LDR3!U*<U[+#T)8.>;5:E#&<U-Y
MC0IQAF&&]E&C0E6I^Q:Q6"AB*=*-#LQ&-IXS'U,TP551A@L<L93]G-U)XJ<\
MFR3"+$X:=&O_ &=5QM*O@\9&JZU1TN?%8E8;,E'VJQGI7@W]F7QSX8\ _$[P
M^_A.2XUC5/B%^S!J/AJ]U/Q3X8\0:SJ'AWX4Z3\'+?5I[GQ-!9:$EVVC7/AS
MQ2D;SZ3HLER;226UL1]LB67UIXV,L9DN)511E0X@S7,,5.%.5*]'%SJTEB90
M]I6;EB<-)*I!5*M11DX3C'6*<W0:Q:IP4(5N$\=EM.FH4Z:ABZT^(:U#!PIT
M80HT80JXW \D:4?JE"\(1K2A0E47UC\ _#?B?P?H'C?P[XH\/W6CRQ_%WXK^
M(-(U![_0[[3_ !'H'C;QYKWC/1]5TL:7JMS=6D:66NQ6D]OJMKIMREU9W 2&
M2W\JXG\]U(U,NR*'\.O@LNPN"K4I?%"I@J:P[GS1YJ<J=?D]K1<9N:IR2K0I
M5$X)YA5C7S?,L32O+#XE8&=.>RO3RS!X6K3<7::G2K8::D^7V<HRA*G4G>2C
MB_"_2=+UOQM^USI6M:;8:OI=W\??#27>FZI9V]_872)^RY^S-*BW%G=QR13*
MLL<;@.C ,BD<@$8)6G2J+2="I3K4I?:IUJ,XU:-6#WA4I5(1J4YQM*$XQG%J
M44US2BIPJTII2IUZ=2C4@U>-2E5A*E5I3B])4ZM.<J=2$DXSA*4))Q;3]O'A
M/PJLT=P/#7A]9X=>E\513C1M.$T7BB:SETZ;Q)'(+;<FO/I\TUJVH BX:&5X
MC(48J2'[I4E2_=JA&M"FH^[[.&(J5*N(A!*W)&O5JU:M:,;*K4J5)S4I3DV]
MOK'3ZW['V_\ T^^KJ@L/[7_GY[!87#*CS\WLEAJ"AR^QI\N</AW\/UM]7M%\
M"^#EM?$%C>Z7KUL/#.BBWUO3=2U+4]:U'3M7A%CLU*QNM8UO6;Z:"X$D<MSJ
M][/(K2W4KR5"<Z?L53FX+#RPLJ2BVO92P,80P4J=K<DL'&G3CA7&SP\805'D
M48VISFY.3G)R;KR;;=^;%1IPQ3OO?$PHTHUWO6C2IQJ<RA%*/Q%\-?AUXNM=
M2L?%G@'P5XGLM9DTJ76+/Q%X5T+6K759="W_ -B2ZE;ZE831WTFG>9)]E:=7
M-OO;R2FXYF*]G.G4A[E2C7EBJ<HZ2ABITZ5*>)A)6<:\J5&C3E6351TZ5*#D
MXTXI1%*FI*"4%+#QPDE'1/"PG4JPPS2M?#PJU:M2-%_NXSJU)J*E.3<VF_#[
MP%HJR)H_@CPAI*2Z=J&CRIIOAK1K!9-(U?4;G6-6TJ1;6R0/IU[J]Y>7UQ;'
M,4US=33R*TLK,RJQC7IUJ-9*M1Q%.A1JTYKGA5HX6E.CAJ52,KQG3PU&K5I4
M(23C1I5)TZ:C&<DW!*E5HUJ2]G6P\ZE2E4C[LZ4ZSH.M.G)6E"=5X;#.I*+3
MF\/0YF_94^6FGPN^&<7B/2_&$7P[\"Q>+M"TJ#0=$\51^$?#Z>)-&T2UB,%M
MH^E:XNGB]T[2H86:..T@FCA1255 #BJFYSECI^TG&KF2FL54C)JIB'4MSRK3
MWJRDU%MU.:[C%N]D0J5-4,'A?9Q^JY=9X6CRKV6&M'E7U>G;DHVC[O[M1]W3
M8XWP!^SM\'_AUX?O] TCP-X9U)M;TZ\T?Q3KNN^&?"]YXB\9:3>WU[?/I?B_
M4[;1+;_A(=.C:^EACMKN.2)851"IP2SHSEAL/@L+AW["C@(9>J:I^Y^^RS#X
M?#X;&24;1^N16&I57B(J,U73J4_9^[&-RYI8C$XJ<Y3K8C$9AB.:3NZ*S/%X
MC&8G#T6_>IX;VF)JPC2N_P!U:-1U)<TI=UXB^''P\\7:EH.L>+/ ?@SQ/J_A
M6?[3X8U7Q%X7T/6M2\.7 9'%QH-]J5C--H\^^*)M]H\+9C4YRHPJ;='$/%TG
M[+%N,H.M#W:O))-2A[2-I\LDVI1YK--W6I,HQGA?J,XJ6"YH2^KR2=#FIZ4Y
M>R?[OFI_8?+>/V;$%U\+_AI?:_JWBN^^'?@6\\4:_HL_AO7?$EUX2T"XU_6O
M#MS%]GN= U;6)M/:[U+198/W;V-Q-) Z?*T9'%3"*I4J]"FE3HXJI"K6IQ7+
M"M5IM.%2K!6C4J0:3A.:<HM)IIHU52HJV%Q*G)8C M/#5;OVF':O9T)WYJ35
MW;V;C:[[L<GPR^&T7BN'QY%\/O!$?CFWTU-'M_&:>$]!3Q7!I$<7V>/2H?$2
MV U"+35@)C6V6X$03Y0N.*N,I0^M<LG'Z\Y2Q-FU]8E)IR=>W\5R<8N3J<S;
MBK[(R<(..&@X)PP2BL/%I<M!0YE!45M24>:7*H<JCS2M:[)_"OP[^'_@2;6+
MCP1X%\'>#;CQ#>OJ6OS^%?#&B>'IM<U&1F>34-8ETBQMVU*]9W<M/<F20EB2
MV2:49.%"GA8MQPU'X**=J4-$O<IKW(Z)+1+1)%32J5IXFHN?$32C*K+6I**;
M:4IN\FDVVDW9-M]34F\+^&;C0+OPI/X=T*?PO?VM]8W_ (;FTC3Y- O;+4VF
M;4K.[T=[<VES:W;7-P9XI(624SR&0-O;*2LJ"6BPJH*BNE%8506&5)?\NUAU
M2I*@H6]BJ<%3Y>2-JI3G0J2K49RHUI5*E64X-PFZM:<JE:HY1M)U*M2<YU)M
M\TYSE*3;DVZ=KX&\%6-M9V5EX/\ "UG9Z=K5[XET^TM?#^DV]M8>(]3%^-1U
M^S@BM%2UUJZ&J:GY]]&JSR_VC=>9(WVB3>YMU%%5'SJ%&>'BI:\N'J)QJ4%>
M]J-2+<9TE[DDVI1:;!2E'VBC)Q5;V"J)-KG6&]@\,IV^+ZO]6PWL+W]E]7H>
MSY?94^7%T_X1?"?2+$:9I7PP^'FEZ:HLPNGZ?X*\-V5B!IU[JNI:>!:6VF)$
M!:ZCKNN74/R?NI]9OI4VR7<S2%1NK3ITJK=2E14E"$_>C!2P<,NDH1=U%2R^
MG# R22O@X0PS_<Q4%+UJ2JO6K*:J2F_C=18F&,51RW<UC*5/%J3?,L33A73]
MK",DS4/@]\)-6\/Z!X2U7X6_#G4_"OA6XAN_"_AG4/!'AF]\/^&[JW#B"YT#
M1;G3'L]'N(A(X22TAA9=[;2,FJE4G/$TL9.<I8R@DJ=>3;K4U'EY5"J_?BH\
MD+*,E;EC;X59))4<3ADK8?&7^L4O^7=?F;E+VT/AJ\TFY/G4KMMO5EOQ!\+?
MAEXKU+3-9\4_#KP)XEU?1+.33]&U7Q!X1\/ZSJ6D6$K(\MCIE]J.GS36%F[Q
MQEH8'C0F-25RHQ-.4J->>)I-TL3.5*<JL'RU)3H58UZ$I35I.5&M"-:E)N].
MK&-2#4TFIJTJ=>A'"UJ<:V%@JD8T9Q4Z48UJ3H58JG)."56C*5&HDK3I2=.5
MX-HAUGX2_"KQ'9:;IOB'X9_#[7=.T;6KSQ)I%AK/@SPYJEEI7B+4;VXU+4->
MTVUOM-EBL=:NM1N[NZFO852>6>ZEE>1I)&8D6Z=7#UX-PK82E3H4*D7:=&A2
MC&%*C2FK2ITJ4(0A3IP<80C",8I**2TDW.&(I3?-3Q<G.O"6L:TVK.=:+TJ2
M:T<IJ3:TO8N#X;?#I?%\?Q!7P#X*7Q[#8+I<7C<>%M#'B^+3$C,2:='XE%A_
M:*6"Q$H+<7(C"D@+CBBG*5#ZQ[&3H_6WS5^1N'MI7BVZO+;VCO&+O.[O&/9$
MSC&JJ$:L54CA;*BI)25%+FLJ2=_9VYYVY+6YI6^)WR/&WP5^#?Q*U"UU;XC?
M"7X9^/\ 5;"S&GV6I^-O ?A;Q5J%G8":6X%C:WNNZ5=36]F+B::7R8W5-\KM
MMW,2<HTJ4*E2K"G&-6KRJ<U%*4U!-04I)7ERIM1NWRINUKFKJU72A0=2;HTI
M3G"FY/DA.HH*I*,+\L935.FIR23DH03;48V+KX*_!N^L-7TJ^^$OPSO-+\00
M:!:Z]IMUX#\+7%AK=MX3MUM/"UOJ]G-I31:E!HUJJPZ?'<)(MG&H2V$:C%;R
MJU)3C4E4E*I'%5,=&3DW)8VMRJMC%)NZQ550@JF(3]M/ECS3?*K9T4L-&G##
MKV$*.&^ITXT_<4,)=R^JP4;*.&YI-^P5J5VWRW;.BT3P+X)\,RVL_ASP=X5\
M/SV-GJ.GV4VB>'M)TJ6SL-7U0ZYJUC:R6%I$UO9WNM$ZA<0QE4FNC]HD5I?G
MH=6H^>]23]I##4YWD_>IX.%2GA(2U]Z&%IUJM/#1=XT(5:D:2C&<D\_8TN:$
M_90YZ3JRA+E5X2KJDJ\HNUXNLL/055JSJ*C24[^SA;JJ@T"@ H * "@ H *
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M-3M]/UW5K6>;3Y+NPOH$N$C,;26<Z!BT+A3;R#;R/3_^&L?V6/\ HY;X ?\
MAY/AU_\ -'0 ?\-8_LL?]'+? #_P\GPZ_P#FCH /^&L?V6/^CEO@!_X>3X=?
M_-'0 ?\ #6/[+'_1RWP _P##R?#K_P":.@ _X:Q_98_Z.6^ '_AY/AU_\T=
M!_PUC^RQ_P!'+? #_P /)\.O_FCH /\ AK']EC_HY;X ?^'D^'7_ ,T= !_P
MUC^RQ_T<M\ /_#R?#K_YHZ #_AK']EC_ *.6^ '_ (>3X=?_ #1T '_#6/[+
M'_1RWP _\/)\.O\ YHZ #_AK']EC_HY;X ?^'D^'7_S1T '_  UC^RQ_T<M\
M /\ P\GPZ_\ FCH /^&L?V6/^CEO@!_X>3X=?_-'0 ?\-8_LL?\ 1RWP _\
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ML?V6/^CEO@!_X>3X=?\ S1T '_#6/[+'_1RWP _\/)\.O_FCH /^&L?V6/\
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MK'[-/_9 /@W_ .JZ\.4 ?0% 'S_\&_\ DHO[6/\ V<!X<_\ 66/V:: /H"@
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M69T:>,E[:I/ZG0_LRA-TI8R;_<86OCG7J8C%4,3"6 K>RRR=;#RC.C/QR_\
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M[Q.$PT?JE-QK5:3?-37L9PCAJ.'C"$*LITZ:]5\._M!_&+5KT^)[[2/ NG>
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M /9I_P"2=>(_^S@/VL?_ %J?XR4 ?0% !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % 'S_P#LG?\ )K'[-/\ V0#X-_\ JNO#E 'T!0!\_P#P;_Y*
M+^UC_P!G >'/_66/V:: /H"@ H * /G_ /:Q_P"36/VEO^R ?&3_ -5UXCH
M^@* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * .$\<?#CPY\0[>Q
MM?$5WXTM[>PDEDCB\(_$KXC?#Q+KSD$<L&K#X?\ BO1?[<LV08^RZC]JAP6_
M=_,<Y^RI^T52<%4M'D=.I^\H2BVFXU,-4YL/43M:7M*4N:#<'>$I1=.<O9NE
M&3IIOF4X/V=:+2:3IUX<M:FU>Z]G4C:24U:<8R74:-HVE>'-(TS0-"T^TTC1
M=%L+32])TNPA2VLM.TZP@2VL[.U@C 6&"&"-$50, **Z:U:KB*U2O7J.K6JR
M<ISD[N4F[MO^O30RA"-*/)!62;;NVVY-N4I2E)N4IRDW*<Y-RE)N4FY-LTZR
M+"@ H * "@#Y0\+>!/"_Q*US]L/P7XQL;K4/#VJ_M!>#)+RUL=9UOP]>B;2O
MV:OV7M7TZXM-:\-ZC8:EIMS;ZE86=Q'-9WD$BM OS8)!SE2C*>'J7E&IA*U/
M$49PG.G.G6I.].<94Y1E>+Z7L^J9K2K3H^V4.7EKT*^&J1G"%2,Z&)HSP]>G
M*%2,HN-2C4G3>ETI7BU))KMD_9I^$7]GZK876E^,-8GU>71YI_$7B/XL?%KQ
M-XYL'\/7IU'1/^$?^(7B'QQ>^)_"J6.H-)=0IHVKV"I--+*%WRNS:/:ER?N)
M4*KK1G17L*LJCHU<,W5JT>2K63PU>OA^2M.</85JU'E]G5G&6+2DW[1*M%TI
M4?9U5[6E&G*K2KR4*57GI4Y.OA\/6]I"$:GM</0J<W/0I2A)I_[-GP;TI8?[
M.\-:K:30>-O^%BB^A\=?$!=5G\92>'HO"E]K5[JY\4F]U%M2T"(6FIVUU<36
MVJB2:34H;J:>622IR<Z4*#C&.'AA<?@HT80A3HK!YG5>(QF&]C3C&FZ,\0UB
M*5-Q<<+B(4Z^%5"K2I3@TK/F?OU4\')59_O*WM, Y_5*WMY\U;ZQ1C4G1^L\
M_MYX>4L-4J3P[]F=OH'PP\#>%Y_!USH6A_8)_A_X*G^'?A%_[3UBY_LGP=<O
MH$D^C[;S4)5O]S^%]"/VN]%Q=#[#Q.!--YO16QN*Q%?,L15J\U;-ZE"KBY<L
M%[6>&EBI4)6C%1I\DL;B7:DH*7M;34E"GR9JC3C2P]%1M3PE6M6I1N_<JXA*
M-:5[WESI)<LFXQ^RHG?5RF@4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!^8
M7[(OPQ\%_%#3OVPM-\9:;>W::+_P43_:*UK1-1T;Q#XD\(>(="U5+;PM8F_T
M/Q3X/U?2]9T:XDL+R\M)FLK^#SK>\GMYM\,SHT<D54C5LU.-.I1>KY:E&MR^
MVH5H7Y*^'J\D'4H5HSHS<(2E!N$6M(U9PIU*2:=.HZ<G&48R7/1FJE*I'F3Y
M*M*:YJ56'+4IN_))<SO]HZM^SM\']8LO#^FS>%+C3;#PSH=MX7T^T\,^*?&'
M@^"[\+6KO)%X5\1Q^$_$&G#QAX7,DDSR:/KW]I64SW$[2P.T\A?:4W/$U<7-
M1J5*ZIJI"<(3P]3V,>2@YX247A92P\/<PTG1<L/'W:#IQ5B(RG3I4Z4:DX^R
MJ5JT*G//ZQ"MB7S8FK#%7^LQJ8B24Z\XU5*M449U'*<8R706_P 'OAO9V+Z9
M:^&HK?3V\<I\2/LD.I:S'"GC*-H6CU:)4U$>1$GD0A;"/;9*$"BW XK&5.,X
M8:G.\HX.&84Z7-*3E&&:1S"./3DWS3>(6:8^\JCE*FZ]Z4J;IT73Q5"E%8A1
MIJ,<3++I5(QTBWE*RY9?:*LH+#K*L E&"C&HL/\ OE4]K6]ID2_ #X23>'?"
MOA.3PEN\/^"/#%]X-\,6']O>)E_LSPWJ,VB3WNF_:EUD7-YYDOAS1F^T7<T]
MPOV/"2J)91+TRKU9XQ8^4KXN,\#-5+)>]EN)HXO!/D2Y/W.(P]*I;EM4Y.2J
MJD)2B]L0WBL-C\'7]_#YI6QF(Q,/A]K5Q]#,,-BY\T;2A[6AFF.ARTY0C#V_
M-3C"=*C*G)J_P(^%^LV=Y9W.A:G8O>^+]5\>-JWA_P 8^-O"OB:S\5ZY%%!K
M.JZ-XL\,>(K#6M ^VVT*03VVF7]I;2P[H7A,3NC<M.E"A#"4J2=.&!I8BA2C
M&4DO88O%U,=B*%77]_1JXNK.O*E7]I3YU3M%*E24$[.IBJLH1G/%U,-5J.<(
MS7M<'@Z67X:K3C-.-&K1P=&&'C5HJ%3D]HW)RK5I3Z'P?\+O ?@"\NK_ ,(>
M'H=$NKW1-$\.W<D%YJ4ZW&D^'K[7]3TN*6&\O9HVNEU'Q1K]S->[/M5W+J4D
MEW-.RH4ZY8BK*B\/S*-#VJK*G&$(0A-83"8&*IQC%*E3IX3 X2A3H4U&C2A1
MBJ=.+<G+)4:<94YV;G2C6BIRE*4W]8Q$\77G4G)N56K6Q-2=:I6JN=6<Y2<I
MNYWU8&H4 % !0 4 % !0 4 % !0 4 % !0 4 ?/_ .S3_P DZ\1_]G ?M8_^
MM3_&2@#Z H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^?_ -D[
M_DUC]FG_ +(!\&__ %77AR@#Z H ^?\ X-_\E%_:Q_[. \.?^LL?LTT ?0%
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M.@ _X:Q_98_Z.6^ '_AY/AU_\T= !_PUC^RQ_P!'+? #_P /)\.O_FCH /\
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MN2G5@_:8>I4Y9S5.GB:?-AYU'"G.HJ<*CFX0G-1<82:];K,T"@ H * "@ H
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M<'F.%Q]6K/$4I2PSBJ>$GA*4:%2I6E+$Q?LXT%6G'ZTK$L* "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /G_P#9
M._Y-8_9I_P"R ?!O_P!5UX<H ^@* /G_ .#?_)1?VL?^S@/#G_K+'[-- 'T!
M0 4 % 'S_P#M8_\ )K'[2W_9 /C)_P"JZ\1T ?0% !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!\@>'/B/I/PN^*/[2=EXM
M\+?& ?\ "3_&#PWXI\/:AX6^ GQQ^(&A:QH0_9V^ WAA[ZQ\2> /AYK6E3>5
MX@\,:]82PB\\Z*;3)5EC3Y2QL&QW_P#PTM\.O^A<_: _\1._:G_^<W0 ?\-+
M?#K_ *%S]H#_ ,1._:G_ /G-T '_  TM\.O^A<_: _\ $3OVI_\ YS= !_PT
MM\.O^A<_: _\1._:G_\ G-T '_#2WPZ_Z%S]H#_Q$[]J?_YS= !_PTM\.O\
MH7/V@/\ Q$[]J?\ ^<W0 ?\ #2WPZ_Z%S]H#_P 1._:G_P#G-T '_#2WPZ_Z
M%S]H#_Q$[]J?_P"<W0 ?\-+?#K_H7/V@/_$3OVI__G-T '_#2WPZ_P"A<_:
M_P#$3OVI_P#YS= !_P -+?#K_H7/V@/_ !$[]J?_ .<W0 ?\-+?#K_H7/V@/
M_$3OVI__ )S= !_PTM\.O^A<_: _\1._:G_^<W0 ?\-+?#K_ *%S]H#_ ,1.
M_:G_ /G-T '_  TM\.O^A<_: _\ $3OVI_\ YS= !_PTM\.O^A<_: _\1._:
MG_\ G-T '_#2WPZ_Z%S]H#_Q$[]J?_YS= !_PTM\.O\ H7/V@/\ Q$[]J?\
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MGC22*2)T=592 ;>5@V\K'N% 'S_\&_\ DHO[6/\ V<!X<_\ 66/V:: /H"@
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MIH /^%-_$7_H[']H#_PG/V6/_H:: #_A3?Q%_P"CL?V@/_"<_98_^AIH /\
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M+I'B%;+S+NVBCO/^)/KVE7'G6K3P_P"E>7YGFQ2)'3A)8;#XNUL/BE7=*?\
M,L-B:^#K^[\4>3$X:M3]Z*YN3GAS4Y0E(E[E>>&E[M:%.C5E'M#$0]I2E=>[
M[T-;)WCM)1>@_P ,>)]#\8Z):^(O#=]_:.C7LE]#:WGV:\L_,DTV_NM+O5^S
MW]O!.GEWUE<Q9>)0WE;D+(RLTI7I8:LOX>+P^&Q=%_S8?%X>GBL/4MO'VE"K
M3GRR49PYN6<8S4HJ(SC*>(IQ=Y83$8G"559^YB,'B*F%Q%.[TE[.O1J4^:-X
M3Y>:$I0<9/?H+"@ H ^,/@AX0^+7Q*^"_P (?B+KO[5/QPM-;\?_  O\ >-=
M8M=)\+_LPV^E6NJ^*O"FDZ[J%OID%Y^SI=3PZ?'=W\R0I/<W$BQJ@>61@78
M]/\ ^%-_$7_H[']H#_PG/V6/_H:: #_A3?Q%_P"CL?V@/_"<_98_^AIH /\
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MI/&U#]H_X[^'-+\ 6FLVWPEO_$_Q?\/?#+Q3X.GTCP_XL@T/PE:^,/B+\//
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MM/'QS.51O'1GBJBJZ+W\9AL1A,2W%6@_:8?%XBGK%J'M.>FHSC"4>&.$P]/
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MBZMXUZV(GBJDJ3=!5*TXRC*52%%TX5(M2_ASC*DG&FU!.E3<?;Z@84 % !0
M4 % !0 4 % !0!\_^(_^3I_@W_V0#]I;_P!6+^R=0!] 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 ?"/[/7P6T_Q]\'?V:O%?C6]TW6_"EM^Q]\+_ NF
M>"UT2ZL[B*37_#?PX\1ZOKFH^)TU^1[FZBO?"&@-IHT^PTF;3Y(;B<W5S+)
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M+^UC_P!G >'/_66/V:: /H"@ H * /G_ /:Q_P"36/VEO^R ?&3_ -5UXCH
M^@* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M4?\ ;K_^=E0 ?\*,^,7_ $3[_P ZC_MU_P#SLJ #_A1GQB_Z)]_YU'_;K_\
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M$/[8?@X:M:6=YX6\9V6G3_$KXA_#9KO_ (0WXC7>LW%[X#T:75X[SP[X2L_
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MG_K+'[-- 'T!0 4 % 'S_P#M8_\ )K'[2W_9 /C)_P"JZ\1T ?0% !0 4 %
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M[.:C&*;IWNG52U?&:S^R+XWOWM=7&L:-/JGAN[^#VK:%I.E?$3XD?#<:U>^
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MK'_LX#PY_P"LL?LTT ?0% !0 4 ?/_[6/_)K'[2W_9 /C)_ZKKQ'0!] 4 %
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MZ@ _X2/]J?\ Z(W\ /\ Q);XB_\ T)U !_PD?[4__1&_@!_XDM\1?_H3J .
M\9:1^U/XM\1?"?7_ /A5_P  -/\ ^%7?$#4O'7V3_AHCXBW7]N?VA\+/B7\,
M_P"R_/\ ^&6H?[,\O_A8G]I?:?+N]W]C_9O)7[7]HMC8-CO_ /A(_P!J?_HC
M?P _\26^(O\ ]"=0 ?\ "1_M3_\ 1&_@!_XDM\1?_H3J #_A(_VI_P#HC?P
M_P#$EOB+_P#0G4 '_"1_M3_]$;^ '_B2WQ%_^A.H X#XL:1^U/\ %#X6?$OX
M9_\ "K_@!H7_  L3X?\ C+P+_;?_  T1\1=3_L?_ (2WP[J6@?VI_9O_  RU
M:?VA]D_M#S_LWVJV\WR?+\Z/=O4 [_\ X2/]J?\ Z(W\ /\ Q);XB_\ T)U
M!_PD?[4__1&_@!_XDM\1?_H3J #_ (2/]J?_ *(W\ /_ !);XB__ $)U !_P
MD?[4_P#T1OX ?^)+?$7_ .A.H /^$C_:G_Z(W\ /_$EOB+_]"=0!T'P+\'>*
MO OP_?1_&L7A^W\3:I\0/C%XZU*S\+:QJ/B#0M._X6;\7_'7Q(LM+L=;U;P]
MH5WJGV'3_%=I:2W,ND6'F36LK)"$*DFP;'L% !0 4 % !0 4 % !0!\__!O_
M )*+^UC_ -G >'/_ %EC]FF@#Z H * "@#Y__:Q_Y-8_:6_[(!\9/_5=>(Z
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MINI>'? UUK=U-X<TN71[\_:=!M5M6:6TTBX2"33K.XM+%[>U-K]F@FL\3['
MPQU>.*S&E0Y<35C4C6<I*O6>'C4KP<HXBO1P3PN'Q.(4ZOM\12JU77KN;K5.
M*'L7B<;5PE-4<#6GAYT(*C/#17^P8..*<</.%*=%5,PCC*O(Z5._/SJ"C)'M
MM<YL% !0 4 % !0 4 % !0 4 ?/_ ,&_^2B_M8_]G >'/_66/V:: /H"@ H
M* /G_P#:Q_Y-8_:6_P"R ?&3_P!5UXCH ^@* "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M/G_X-_\ )1?VL?\ LX#PY_ZRQ^S30!] 4 % !0!\_P#[6/\ R:Q^TM_V0#XR
M?^JZ\1T ?0% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MC_Z&F@ _X4W\1?\ H[']H#_PG/V6/_H:: #_ (4W\1?^CL?V@/\ PG/V6/\
MZ&F@ _X4W\1?^CL?V@/_  G/V6/_ *&F@ _X4W\1?^CL?V@/_"<_98_^AIH
M/^%-_$7_ *.Q_: _\)S]EC_Z&F@ _P"%-_$7_H[']H#_ ,)S]EC_ .AIH /^
M%-_$7_H[']H#_P )S]EC_P"AIH /^%-_$7_H[']H#_PG/V6/_H:: #_A3?Q%
M_P"CL?V@/_"<_98_^AIH /\ A3?Q%_Z.Q_: _P#"<_98_P#H:: #_A3?Q%_Z
M.Q_: _\ "<_98_\ H:: #_A3?Q%_Z.Q_: _\)S]EC_Z&F@ _X4W\1?\ H[']
MH#_PG/V6/_H:: #_ (4W\1?^CL?V@/\ PG/V6/\ Z&F@ _X4W\1?^CL?V@/_
M  G/V6/_ *&F@ _X4W\1?^CL?V@/_"<_98_^AIH /^%-_$7_ *.Q_: _\)S]
MEC_Z&F@ _P"%-_$7_H[']H#_ ,)S]EC_ .AIH /^%-_$7_H[']H#_P )S]EC
M_P"AIH /^%-_$7_H[']H#_PG/V6/_H:: #_A3?Q%_P"CL?V@/_"<_98_^AIH
M /\ A3?Q%_Z.Q_: _P#"<_98_P#H:: #_A3?Q%_Z.Q_: _\ "<_98_\ H::
M#_A3?Q%_Z.Q_: _\)S]EC_Z&F@ _X4W\1?\ H[']H#_PG/V6/_H:: #_ (4W
M\1?^CL?V@/\ PG/V6/\ Z&F@ _X4W\1?^CL?V@/_  G/V6/_ *&F@ _X4W\1
M?^CL?V@/_"<_98_^AIH /^%-_$7_ *.Q_: _\)S]EC_Z&F@ _P"%-_$7_H['
M]H#_ ,)S]EC_ .AIH /^%-_$7_H[']H#_P )S]EC_P"AIH /^%-_$7_H[']H
M#_PG/V6/_H:: #_A3?Q%_P"CL?V@/_"<_98_^AIH /\ A3?Q%_Z.Q_: _P#"
M<_98_P#H:: #_A3?Q%_Z.Q_: _\ "<_98_\ H:: #_A3?Q%_Z.Q_: _\)S]E
MC_Z&F@ _X4W\1?\ H[']H#_PG/V6/_H:: #_ (4W\1?^CL?V@/\ PG/V6/\
MZ&F@ _X4W\1?^CL?V@/_  G/V6/_ *&F@ _X4W\1?^CL?V@/_"<_98_^AIH
M/^%-_$7_ *.Q_: _\)S]EC_Z&F@ _P"%-_$7_H[']H#_ ,)S]EC_ .AIH /^
M%-_$7_H[']H#_P )S]EC_P"AIH /^%-_$7_H[']H#_PG/V6/_H:: #_A3?Q%
M_P"CL?V@/_"<_98_^AIH /\ A3?Q%_Z.Q_: _P#"<_98_P#H:: #_A3?Q%_Z
M.Q_: _\ "<_98_\ H:: #_A3?Q%_Z.Q_: _\)S]EC_Z&F@ _X4W\1?\ H[']
MH#_PG/V6/_H:: #_ (4W\1?^CL?V@/\ PG/V6/\ Z&F@ _X4W\1?^CL?V@/_
M  G/V6/_ *&F@ _X4W\1?^CL?V@/_"<_98_^AIH /^%-_$7_ *.Q_: _\)S]
MEC_Z&F@ _P"%-_$7_H[']H#_ ,)S]EC_ .AIH /^%-_$7_H[']H#_P )S]EC
M_P"AIH /^%-_$7_H[']H#_PG/V6/_H:: #_A3?Q%_P"CL?V@/_"<_98_^AIH
M /\ A3?Q%_Z.Q_: _P#"<_98_P#H:: #_A3?Q%_Z.Q_: _\ "<_98_\ H::
M#_A3?Q%_Z.Q_: _\)S]EC_Z&F@ _X4W\1?\ H[']H#_PG/V6/_H:: #_ (4W
M\1?^CL?V@/\ PG/V6/\ Z&F@ _X4W\1?^CL?V@/_  G/V6/_ *&F@ _X4W\1
M?^CL?V@/_"<_98_^AIH /^%-_$7_ *.Q_: _\)S]EC_Z&F@ _P"%-_$7_H['
M]H#_ ,)S]EC_ .AIH /^%-_$7_H[']H#_P )S]EC_P"AIH /^%-_$7_H[']H
M#_PG/V6/_H:: #_A3?Q%_P"CL?V@/_"<_98_^AIH /\ A3?Q%_Z.Q_: _P#"
M<_98_P#H:: #_A3?Q%_Z.Q_: _\ "<_98_\ H:: #_A3?Q%_Z.Q_: _\)S]E
MC_Z&F@ _X4W\1?\ H[']H#_PG/V6/_H:: #_ (4W\1?^CL?V@/\ PG/V6/\
MZ&F@ _X4W\1?^CL?V@/_  G/V6/_ *&F@ _X4W\1?^CL?V@/_"<_98_^AIH
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M7[3_ /T<?X[_ /"%_9^_^<O1_J)E'_03C/\ P91_^9P_UYS;_H'PG_@NM_\
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M-!?M/_\ 1Q_CO_PA?V?O_G+T?ZB91_T$XS_P91_^9P_UYS;_ *!\)_X+K?\
MS0'_  T%^T__ -''^.__  A?V?O_ )R]'^HF4?\ 03C/_!E'_P"9P_UYS;_H
M'PG_ (+K?_- ?\-!?M/_ /1Q_CO_ ,(7]G[_ .<O1_J)E'_03C/_  91_P#F
M</\ 7G-O^@?"?^"ZW_S0'_#07[3_ /T<?X[_ /"%_9^_^<O1_J)E'_03C/\
MP91_^9P_UYS;_H'PG_@NM_\ - ?\-!?M/_\ 1Q_CO_PA?V?O_G+T?ZB91_T$
MXS_P91_^9P_UYS;_ *!\)_X+K?\ S0'_  T%^T__ -''^.__  A?V?O_ )R]
M'^HF4?\ 03C/_!E'_P"9P_UYS;_H'PG_ (+K?_- ?\-!?M/_ /1Q_CO_ ,(7
M]G[_ .<O1_J)E'_03C/_  91_P#F</\ 7G-O^@?"?^"ZW_S0'_#07[3_ /T<
M?X[_ /"%_9^_^<O1_J)E'_03C/\ P91_^9P_UYS;_H'PG_@NM_\ - ?\-!?M
M/_\ 1Q_CO_PA?V?O_G+T?ZB91_T$XS_P91_^9P_UYS;_ *!\)_X+K?\ S0'_
M  T%^T__ -''^.__  A?V?O_ )R]'^HF4?\ 03C/_!E'_P"9P_UYS;_H'PG_
M (+K?_- ?\-!?M/_ /1Q_CO_ ,(7]G[_ .<O1_J)E'_03C/_  91_P#F</\
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M /"%_9^_^<O1_J)E'_03C/\ P91_^9P_UYS;_H'PG_@NM_\ - ?\-!?M/_\
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M9P_UYS;_ *!\)_X+K?\ S0'_  T%^T__ -''^.__  A?V?O_ )R]'^HF4?\
M03C/_!E'_P"9P_UYS;_H'PG_ (+K?_- ?\-!?M/_ /1Q_CO_ ,(7]G[_ .<O
M1_J)E'_03C/_  91_P#F</\ 7G-O^@?"?^"ZW_S0'_#07[3_ /T<?X[_ /"%
M_9^_^<O1_J)E'_03C/\ P91_^9P_UYS;_H'PG_@NM_\ - ?\-!?M/_\ 1Q_C
MO_PA?V?O_G+T?ZB91_T$XS_P91_^9P_UYS;_ *!\)_X+K?\ S0'_  T%^T__
M -''^.__  A?V?O_ )R]'^HF4?\ 03C/_!E'_P"9P_UYS;_H'PG_ (+K?_-
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M7[3_ /T<?X[_ /"%_9^_^<O1_J)E'_03C/\ P91_^9P_UYS;_H'PG_@NM_\
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M-!?M/_\ 1Q_CO_PA?V?O_G+T?ZB91_T$XS_P91_^9P_UYS;_ *!\)_X+K?\
MS0'_  T%^T__ -''^.__  A?V?O_ )R]'^HF4?\ 03C/_!E'_P"9P_UYS;_H
M'PG_ (+K?_- ?\-!?M/_ /1Q_CO_ ,(7]G[_ .<O1_J)E'_03C/_  91_P#F
M</\ 7G-O^@?"?^"ZW_S0'_#07[3_ /T<?X[_ /"%_9^_^<O1_J)E'_03C/\
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M (+K?_- ?\-!?M/_ /1Q_CO_ ,(7]G[_ .<O1_J)E'_03C/_  91_P#F</\
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M /"%_9^_^<O1_J)E'_03C/\ P91_^9P_UYS;_H'PG_@NM_\ - ?\-!?M/_\
M1Q_CO_PA?V?O_G+T?ZB91_T$XS_P91_^9P_UYS;_ *!\)_X+K?\ S0'_  T%
M^T__ -''^.__  A?V?O_ )R]'^HF4?\ 03C/_!E'_P"9P_UYS;_H'PG_ (+K
M?_-!^@7[#OQ)^(OQ)\#?%"X^)7C*_P#'.J^%?C!<^%M(UG4]'\):+?1Z$?A?
M\+?%,=C/;^#/#NB:?-Y6K^*-9=9FLO.*7"1O(ZQ)M_/<\P%'+,TQ6!P\IRI4
M/9\KJ.+G[]&G4=W&,%HY-*T5I;=ZGZ!D>.K9EE>%QM>,(5:WM.94U)07)5J4
MU92E)K2*O>3UOLM#[5KR3U0H * /G_\ :Q_Y-8_:6_[(!\9/_5=>(Z /S1T7
MX7>'-2^"DOQ%N]>GT36$^($?A,W&HO/)X9M=-;3(+TW5W9Z1H-_JKW/FR% U
MOYHPRYAP&8?MV.S3$X3/<ORRE1C6H8O!5<3))?OW4IU*T(PIRE4ITHIJG'^)
MU;]]*UOQ3+,KP^,R7.LQJU94:V6U\/2IN_[E1JSP<93JQ5.I4ERK$3?[NS]V
M-H2::E%>? K4K/5?!NA)XZ\"7>K>/8-"O?#-E:_\)RK7FE^(9S!8:G+/>>!X
M+>SMAMD>2*>5+E5C.(&8JK72SR%1YBO[/Q4(Y0\1'%2E]5M1GAJ#KSA:.*E*
M;<4HP=.,X.<HWE&*E*.=?)I8>CE]5X_"R6:3HPPL8K%<U;VV*IX1/WL+&,(P
MG4YY^UE!^SA-P4Y\D)N\._ ;5_%GC*Z\"^&O&W@75M=TZVUBXU0(WC2RL],;
M1+RUL;JVN+G5/!5KYT[W%R1&;1;B,BWE+R(#'YN=7B"C0RS^UJN Q<,')4)4
MG_LKG66(C*5/DA'%-Q:C%.2J^SMSQ2N^91VCP_6EF/\ 9,,?A98V%6M1J07U
MI*C+#J7M.><L*H.*<)13I2J7:O;E:D9/@KX)>-?'&H>-=-T]=-TR;P!;7D_B
M&36)[R""&>RFN(7TZ"2RL+HRW[M9W9166-"MLY,B\;M,?Q!E^7Y=@\SJ.=7#
MX[D]@J48NI.,Z:J<ZC.4$HPBX*?O7C*I!6U=IP7#N88W.,3DE+V=/%824XU9
MU)25&,H58T4N:,)2?M)-RI-0M*$)RTM9\=X(T+1?$?B.PTC7O$2>&=/NI8HC
M?_V;?:K<332W$-O%965I9(0;J5ILJ]S+;P(L;EY00J2>KB*E:C1E/#X=XJLF
ME&DIPIWOO*4YZ1A%*\FE.>W+"6MO&HQHRJ)5\0L)0BIRG5<)U.50A*2Y:=-.
M4Y2DE%*\(^]>4XI7/IG3/V>?A_>?&7Q?\.+GQGK=M;>'H99=,TF.U6?Q#J<,
M'ARQU>>]NM:.DII5C:+=7;QJBP33N(2ABC&V=_C*G$^91X8_MNG@:4ZR6(<I
M<SCAZ7LL74PU*+INHZ]6<HQBY*,H05W+G7\,^UCPQEO^M5'(:F.JTZ-1X-07
M+S5ZSK8/ZU7Y9JFJ-&-.SY7-3DTXPY)-.9\=$8)'H2/RK[E;+H?#R7+*26T6
MTOD>H?"WX<IX^OM<N=3U1M"\)^#]#NO$GBO68K87ES;:=:@[+33[0R()]1NG
M5HX@S!5VNY#[!')YF;YDLKPD*L:3Q&)Q%:EAL-14E'VM>L^6"E)IJ,([RE;^
M6/N\W-'T<HRV6:8U8555AZ-*E5Q.(K23<:.&H1YJM2R^)J\4H+WFFY)24&B:
M/0O!?C.]L_#/PT\/^/E\6:CK,%II,6O:]X=U;3]0TPPW+W5S=I8^']*?1;J$
M1PS-^_OH$A6X+RCRPS0JN8X2+Q69XC!1P-"C4J8ATZ=:G*BX\O(XU)U:BJP^
M*+O2I3E)P4(MRY325/*Z[GALOH8Z>+J2I0PKG.A)5IRDHSC4I1IP=&Z=X2C7
MK)-6G:-YQ?J7PAU6VTKQ!JVB>)_!WC%/"+Q#Q19^%K_5Y[W18)9!!]ODCU;0
M]/BU+38[@B*2ZTR6^BC;)9@@+!4,YHU:V I5<)B<%3S.:I8:MB(0A2J5)?!3
MER59U*,JBUIJM3IN>T;R:B]:N18BG]?A3Q6%Q.)RNG*KB,/2J3E5A3I_QI1<
MJ4:514/^7WLJL_9]3H=5_9S\?Z+X_P##'P\O9] 74?%UM-<Z)K,5WJ+^'9OL
MMK<7=W!)>?V2+F.Z@2WVR1"S8JT\)Y20/7+0XFRZO@,TQ\(UE#*$Y5Z4HP59
MPNE&=./M'"49OF46YQUA-.SC9W7X=S##5<JI3=)QS?DC1J1E/DA.?*_9U;P4
MH3C"I3J.T91<*D7"4FI*.-IOP@.H^&-6\7+\1/ 5II'AZXTRRU\W4/Q"-SH^
MH:L[Q6=C/!:^ 9_M<QFBEC:2Q:[A4H3YNTJS;U\ZCAZ^$P_]G8J<\>ZJPK@\
M)RUO8TU5FX\^*@X)4VI+VRIMWLES71,<BF_[43S#"1>2N"QB?UO]RJF(GA:;
MTPK513K0DE[)S:5I3444=#^$'BGQ#X#\4?$33+C1Y-!\*W%S!<0R7%[%JFIQ
MV*V<E_>Z/9MI^V>SM8+^VEF>>6V9%<C87&VKQ>=87 XO+L%B(585\QY.1)0<
M:/M)NG35:2J6CSU8RI1]G[1.:WY?>,\%DF)Q]',\1A:U&=#*U4YIMU(JM[*E
M4KR5!2I*3DJ%/VW)5C2ER2BVDVTJVC_##4;WP[I_BK6O$7A?P5H.LWLUAH-[
MXIN=81];GM91!>OI]EH&B:I=?8K:9ECEO)X(+=&.TRY!QMB,SI4<6\!1H5L9
MC(4XU:E*@J=Z-.:;IRJSK5*-*#J)-TX.ISR2YE'ELS##995KX2>/J5J6#P4)
M^RC6K.:52JK<U.E"E"K5J.":<W&FXQU3DFI);MM\&A<Z!KWB:/XF?#@Z-X8O
MK'3-=NXSX_NH["^U&:6WLH8WL? ,Z:G'++#(%N-/:[MR '\W8RL>2IGBI5,#
M1EE>-53,54^K0:PL)5/94E6J)QJ8J$J,H0DFXUU2=[QMS)HZJ>2^UCF4J>:8
M*4,H]F\3*+Q4HPA5KRP]&I"4<*U5A5J0?(Z3FU%J4U!,N?#OP!X/UKP%\4_&
MWB8^(-0'P_;PY]@L?#FL6&AQ:FFLW]S8S/-=ZMX9U22)5\N*6/\ T5&QN5T!
M;,:S;,L7@Z^08;#0ITIYQ6KTJCKP=1T?94:56-HTJU.,I)RE&251Q>CC*R][
M3)LKPF-GGOUBK.I2R?"?6*<L/+V:K<OUB^M:C*4835&+@Y4HSCS-SA?W5UVN
M_L]V=WINB^*O!_B:WTGPMJG@"X\?WB>.VOFU/0M/L+NRLKV&63PMH%T^J@R7
M\3PRPZ=;^8D<A"$@;N*'$53"XC'8+,*"K8C"8S"82G+"12C6GC8UI4%R5ZJ5
M*4?82C54JTE&4H[)2:ZGD%'%X;+L7EM:5"GC,+F6*J0Q<KNC#*I8>.)DJE&D
MI5(R^L*5**H)N%-N[E.,#SO2OA&^K:5?Z_!\0/ =OX>L?$>F^%(M;O!XY@L[
M_6-4L1?6T=K O@=KR"W5/-C>>]M;2-7@<[O+*2/ZE3-G2K83"O+<5+&8N%>I
M3H1>$<U"A.,)-R^M>RO+GBX1C4E)J23BI)Q7F4\I52AC\5#,<+]3RV%"=>NU
MBE"*KRE"*47A55;C*-IOV?*KIJ4HW:NW/P*\3Z0-?F\5:YX3\'Z=X>\31>$9
MM5UV^U:6RO\ 79;6&_CMM-30=$U*ZEB^P7$%RT\UM!%''(3(ZLDBIA2X@P>)
MC@/JE&OBJV/I5:].C"-.-2-*A4E1J3J.K5ITH*-:$J7\5\TU[O,I1;Z*W#V,
MPM3,(XFMAZ%#*WAXU:\ISE2E/%4X5J,*:ITYUISE1J0J./LDXPE>5K2MCV7P
MHU*72]0\0:IXF\(>'/#-GKMSX<L?$>KWVK7&F>(M3M)3%./#<6@:)J5[JEFB
M;93=K9I L;@M("&5=Y9O24\'AZ>%Q%7&XR@L0L*H0A6HTFE[V)]K4ITJ+4G[
M-QG5OSJR3NF^:.45>7'UGBL/' Y=6^KRQ?/.="K5U<88;V=.=:NY07M8J%%O
MV?OM)*5NHT[]G#XBZIJ?B72;'^P9[KP]X?L/%%LT6I336OBG1]5$YTNY\*W5
MO8R17YNC;R+&MPUI\^$;:^57CK<3Y=AL+#%5H5Z<5B982M3=-*KA:U-<U18B
M#G[JIP]^3INH^36"D=M#AC,,1BZ>$HU<//V^%^N8>LJK^KXBCSQIQ]E4Y+J4
MJDE!*K&DD]9N$'&3\YO_  'K.F^"-'\>7,U@NDZSKNI^'K>R$ET-6M[[28EE
MN6N[>2S6&* A@%*W#ON!#(N*]2.8X>68K+(J4JSPJQ:FN5TG2=3V22DI<SDY
M:Z1Y>77FOH>8\MQ,<OKYC-*G2PN-6 J4I\T:T:[H.N[P<;*,8Q<97DIJ>G);
M4XJN\X H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M^'M2MM2UJXL[G0X=>EM_AWHK:A?3&-0+NXGU 1203-+/'YN^?R_[,QW]B8+
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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ME\ /_#M_$7_YP%'^O_\ U*?_ "Z_^]P_U!_ZFW_EK_\ ? ?\,4_M3_\ /E\
M/_#M_$7_ .<!1_K_ /\ 4I_\NO\ [W#_ %!_ZFW_ ):__? ?\,4_M3_\^7P
M_P##M_$7_P"<!1_K_P#]2G_RZ_\ O</]0?\ J;?^6O\ ]\!_PQ3^U/\ \^7P
M _\ #M_$7_YP%'^O_P#U*?\ RZ_^]P_U!_ZFW_EK_P#? ?\ #%/[4_\ SY?
M#_P[?Q%_^<!1_K__ -2G_P NO_O</]0?^IM_Y:__ 'P'_#%/[4__ #Y? #_P
M[?Q%_P#G 4?Z_P#_ %*?_+K_ .]P_P!0?^IM_P"6O_WP'_#%/[4__/E\ /\
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M 4?Z_P#_ %*?_+K_ .]P_P!0?^IM_P"6O_WP'_#%/[4__/E\ /\ P[?Q%_\
MG 4?Z_\ _4I_\NO_ +W#_4'_ *FW_EK_ /? ?\,4_M3_ //E\ /_  [?Q%_^
M<!1_K_\ ]2G_ ,NO_O</]0?^IM_Y:_\ WP'_  Q3^U/_ ,^7P _\.W\1?_G
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M %*?_+K_ .]P_P!0?^IM_P"6O_WP'_#%/[4__/E\ /\ P[?Q%_\ G 4?Z_\
M_4I_\NO_ +W#_4'_ *FW_EK_ /? ?\,4_M3_ //E\ /_  [?Q%_^<!1_K_\
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MZ_\ O</]0?\ J;?^6O\ ]\!_PQ3^U/\ \^7P _\ #M_$7_YP%'^O_P#U*?\
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M /? ?\,4_M3_ //E\ /_  [?Q%_^<!1_K_\ ]2G_ ,NO_O</]0?^IM_Y:_\
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MPQ3^U/\ \^7P _\ #M_$7_YP%'^O_P#U*?\ RZ_^]P_U!_ZFW_EK_P#? ?\
M#%/[4_\ SY? #_P[?Q%_^<!1_K__ -2G_P NO_O</]0?^IM_Y:__ 'P?5W[#
M7@GQ5\.M'_:#\'>-4\/Q>)M'^/\ %_:2>%M7U'7="']H?L__  #U2R^PZKJW
MA_1+NZ_XE]]:&7S=+M?+F,L:>:D:S2_%YMF']J9AB,=['V'M_9_N^;GY>2E"
MG\7+"]^2_P *M>VMKO[/*<!_9>7X? ^U]O[#G]_EY+\]2=3X>:=K<]OB=[7T
MO9?<E>:>B% !0!\__M8_\FL?M+?]D ^,G_JNO$= 'T!0!SGBOQCX1\!:)<^)
MO''BGPYX,\-V3V\5YX@\5ZWIGAW1+22[GCM;2.YU75[JWM8'FN98HHU>52[R
M*BY9@#$JE.FZ<9U(PE5ER4U*23G-1E/E@FUS24(2ERJ[Y8RE:T6U<*=2:FZ<
M)25*/--QBWR134>:5E[L4Y15W97:6[1HZ/K&D>(=*T_7- U73=<T35K2"_TK
M6-'OK74]*U.QN4$MM>Z?J%E+)!>6DL;*Z30R.C*058@UO5HU</4E1K4IT*M-
MVE"<7"<7VE&23B_)I&-.I3JP4Z52-2#;2E"2E&\6XR2<6U>,DXOLTT]4:59E
MF;#K.CW+:M';:KIL[Z!<_8]=2&^M96T6[%A:ZK]EU98Y2=-N?[+OK&\\JX\M
MO(O()L>7*C-,Y1HT%BJLE2PW+4DJLFHTN6C.=.K+VCM#EI5*=2G4=[0G3G&5
MI1DE:IU'4A14).M44)0IJ+YY1J-QIN,;<TE.491@TFI.+4;M,LV=Y::A:6M_
MI]U;7UA?6\%Y97MG/%<VEY:7,2S6UU:W,#-'<6\L+I(DD;,K*ZLI((-:U*=2
MA4J4:M.5&K1E*$X3BX3A.+<91E&23C*+34HM)IIIJYC2JTZU.G6HU(U:-6,9
MTYPDI0G"24HRA*+<91DFG&2;3333L,N]0L+!K-+Z^L[)[^[CT^P2[N8;9KV_
MDCEFBL;-9G4W-VT,$[K#'N<K#(P7"$B$USQII_O)\[C'[4E3A*I-QCN^2G"5
M2=E[L(RD[13:MKEA.H_=IT^3FEM&//4A1AS/://5J4Z4+VYJDX05Y2BG<H P
M+CQ7X7L_$6G^#[KQ)H%KXMU;3[S5M)\+7&L:=!XBU/2]/=([_4M/T22X6\O-
M/MGDC6:XAA>.(R*'92PR4U[5UU27M'A(PG64/>=&%27)3G52O[.,Y^Y"4[*4
MO=BV]!3:I*C*H_9QQ$Y4J+E[JJU*</:3ITV[*<X4_P!Y*$;RC#WFE'4GU#Q#
MH&D3BUU77-'TNY:V%XMOJ&IV5E.;1KZTTQ;H17,Z,;8ZEJ%A:"4#;Y][;Q9\
MR9%8C[S<8^]*,Z%-I:M5,3*I'#4VEM/$2HUHT(_%5E2J*FI.$K$I1A;F:C>G
M7JJ[M^ZPD83Q557_ .7>&A4ISKS^&C&I"51Q4HM[% RAJ.J:9H\$=UJVHV&E
MVTMY8:=%<:C=V]C!)J&JWL&FZ781RW,B(]Y>:C=6MK;P@EYIKB**-6DD52XQ
ME.<*4$Y5)\W)"*O*7LZ<ZL^6*U?)2IU*DK+W:<)S=HQDT[/EJ2L^2C"52;MI
M"$%>4Y/:,(K64G9):MHOTA%/4-1T_2+"]U75;ZSTO2]-M9[[4=2U"Y@LK"PL
MK6)I[F\O;RY=(K6UAA1Y))975$5&9B ":$KRA!*\JDX4X16\IU)*%.$5O*<Y
MRC"$5=RE)1BFVD7"G.I.-.E"4YR=HQBFY-]$HJ[;\DBVI# ,I#*P!5E((((R
M""."".XIM.+::Y7'1K:UO+I8SC*,XQE"2E"23BTTTTU=--:--:IK1HIZCJ6G
M:-8W.IZOJ%EI6FV4?G7FH:C=06-C:1 A3+<W=S(D4$89E&YW49(YYI+6=*FM
M9UJE.C3BOBG5K3C2HTH1WE4JU)PITX13E.<HPBG*23)2C3IU:LY*%*A3J5:D
MY-*-.E2A*I5J3D[*%.E3A*I4G)J,(1E*344VKM&WE884 % !0 4 % !0!0CU
M33)M2NM&BU&PEU>PL[+4+W2H[NW?4K.PU*6]@TZ^NK%9#-;V=U/INHQP32(J
M2OI]RL;,8) K49.#J13=.-1TG)+W55C"%25-R6BJ1IU:4W"_,H5(2:Y9Q;<D
MX>SYDXJJI.%U;G5-Q4W"_P 2@Y14FK\KE%.S:,Z^\6>%M,U[1?"FI>)?#^G^
M*/$<5_/X=\-WVLZ=::]KT&E1"?5)M%T>>Y2[U2*S@99+A[:&40HP:0J#FBFG
M5E6ITE[2>&IQK5HP]Z5*C*HJ4:M11NX4Y56J<9RM%U&H)\S2%/\ =4Z=6I^[
MI5:JH0G+W83K.$JBHPD[*55PA*:IIN;A&4K6BVN@I % !0!2L]3TW4&O8]/U
M"ROGTR]DTW44L[N"Y;3]1BB@N)=/O5@D8VEZD%S;2-!+MD5+B-BH#J2)7A3J
MK6G5Y^2:^&?LZM2A4Y);2]G7I5:,[-\M6E4IRM.$DIYH\]2ES+VE!P52%US4
MW4I4Z]-3CO%SHU:5:"DES4JE.HKPG%N[04<^GBSPM)XFF\%1^)?#[^,;;28]
M?N/"2:SIS>)K?0I;G['%K4V@K<F^BTE[O]PMXT A,GR!]W%.FG5A7J4E[2GA
M)TZ5:4?>C1J58RG2IU6KJG.I",ITX3M*<8RE%-)L)_NG053]V\4JCH*7N^V5
M%Q55TKV]HJ3G!5'"_(Y1YK<ROT%("E=:EIUC/IUK>W]E9W.KW;Z?I-O=74%O
M/J=_'97>HO9:=%+(K7MVNGV%]=&&$.XALIY2NR%V5QBY.48)RE"$JDDE=QIQ
ME"$JC2VA&=2G&4G[JE.$6[RBF^5J$ZEFJ=/EYI6]V//.-.',]H\TY1A&]N:<
MHQ5VTB[2$4H=3TVXOKW3+?4+*?4M,CM)M1TZ&[@DOM/AU 3M82WMHDAEM([E
M;:Y,+2HHD%O)L+>6V"*YH.I'WJ<:DJ+DM8JK"%*K.DVM%4C2KT*DH/WHPK4I
MM*-2#<N48U/9.2C5]G&KR72E[*<ZM*%7EW]G*I0K4XSMRRG1JP3<J<TEO]0L
M-*MFO=3OK/3;.-X(GN[^YAL[9)+F>*UMHVGN'1%>6ZFAAC4L"\DJ(N68 JZ4
MJ<+VE4G&G"/652<E&$(K>4YR:C&*NY2:23;*M:,Y;1I0G4F^D*=*$JE2I)[1
MA3IQE.<G:,(1E*344V-T_4]-U:T2_P!)U"QU.Q>2YA2]T^[@O;1Y;*YFL[N)
M+BVD>-I(+NWG@D4-F.2"1& 9" VU&$*C?+3J4J=:$GI&5&K3C6I58RVE2J4I
MPJTZB;C.G*,XMQDFU&49.<8R4G2J5*,TFFX5:-25*M2DE\-2E5A.E4@[2A4A
M*$DI1:5-?$GAUM*L]<77]%;1-0FT^VT_6%U2Q.E7UQJM[#IFEV]GJ G\BYFO
M-1N;>TMTCD9IIYXXHPTCJIJ,92E2A"+E.O%3IQ2;=2'LG74H):RC[",JRE&Z
M]DG4OR)LKEDG77*T\+[95E;^"\.Y1KJJO^7?L)0G&MS6]DX24^5Q=MJI$4I-
M2TZ'4+72);^RBU6]M+R_LM+DNH$U"[L=.ELH-0O;6R:033VEK/J6G1S31HR1
M/?VRNRF= SC%R51Q3DJ/)SM*ZA[3G5/GM\/M/9U%"]N;V<^6_)*S<7&"FTXP
ME-4U*UHN;C*:@GLYN$)S45KRPE*UHMHNM2TZQGTZUO;^RL[G5[M]/TFWNKJ"
MWGU._CLKO47LM.BED5KV[73["^NC#"'<0V4\I79"[*1BY.48)RE"$JDDE=QI
MQE"$JC2VA&=2G&4G[JE.$6[RBF<K4)U+-4Z?+S2M[L>><:<.9[1YIRC"-[<T
MY1BKMI%VD(* *5KJ6G7L^H6MC?V5W<Z/=I8:M;VMU!<3Z7?265IJ,=EJ$,,C
M-97;:=?V-TL,P1S#>P2A=DR,SY7R0J6?LZG-R2M[LO9SE2GRRVER5(3IRLWR
MSC*#M*+2<HN#C&2<92A&I%-6;IRE*,9I/>$I0G&,EHY0DD[Q=KM(04 % %+4
M=2T[1K&YU/5]0LM*TVRC\Z\U#4;J"QL;2($*9;F[N9$B@C#,HW.ZC)'/-"UG
M2IK6=:I3HTXKXIU:TXTJ-*$=Y5*M2<*=.$4Y3G*,(IRDDU*4:=.K5G)0I4*=
M2K4G)I1ITJ4)5*M2<G90ITJ<)5*DY-1A",I2:BFT7&IZ;9W>GV%UJ%E:WVJR
M7$.E65Q=P07>I2VEM)>746GV\DBR7DD-G#+/(L*N4CB=V 52017-*4(^].%.
M5:45JXTHU*5*55I:JG&K7HTY3?NJI6I0;YJD$U*4::IN<E!5*BI0;:2E5=.K
M5C2BW;FJ.E0K5%!7DZ=&K-+EIS:NT%!0 4 1RRQ6\4DTTD<$,$;RRRRNL<4,
M4:EY)))'(6.-44DL2  "2<"HJ5*=&G.K5G&E2I1<ISDU&,(Q5Y2E)V48Q2;;
M;225WH5"$YSC3IQ<IR:C&,4W)R;LHQ2U;;T26K>B(K.\M-0M+6_T^ZMKZPOK
M>"\LKVSGBN;2\M+F)9K:ZM;F!FCN+>6%TD22-F5E=64D$&MJE.I0J5*-6G*C
M5HRE"<)Q<)PG%N,HRC))QE%IJ46DTTTU<RI5:=:G3K4:D:M&K&,Z<X24H3A)
M*490E%N,HR33C)-IIIIV+-06% !0 4 4H]2TZ74+G2(K^RDU:RM+._O-+CNH
M'U"TL-0EO;?3[VYLED,T%I<SZ;J,<,SHJ2O87"HS&!PK46X.HDW3C-TW)+W5
M44(5'3;V4U"I3FX_$H3A*UI1;;BX*FY)Q57GY&U93]GR*?+?XN1S@IVOR\\+
MVYE>[2$4K?4M.N[J_L;2_LKF]TF6"#5+.WNH)KK3)KFVCO+:&_MXI#)9RRV<
MT,Z),J%XY4=058$D6I1<X^]",Y4W):I5(*,IPNM%.,9P<H_%%3BVDI*[DG"4
M8R7+*4%5BGHW3E.I3C42>KA*I1JTU->ZYTJD4^:$DKM @H * "@ Z>V/PQBD
MVHIMOE4=6WHDE^5@*=AJ%AJEG;ZAI=]9ZCI]VGFVM]87,-W9W,>2OF6]S;N\
M<R;E8;D8C(([4^D)?9G&$XOI*%2*G3G%]8SA*,X26DHR4DVFF#TE.&TJ4YTY
MQZPJ4IRIU*<EO&=.I&4)Q=I0G&49)231<H * "@ H * "@ H * "@ H SH-8
MTFZ74GM=4TZX31KJ>RU=X+VVE72KRV@ANKBTU)HY2+&ZBM;B"9XIMCI'-&[
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M 8.$ISJX7-,9FN.:4W&-'$T*T\HP?UFHG+%?4X2P&)Q56.$O5JRJ8"A6H8K
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M/8I59RC5A3P].$\1F"]I"OB<;[>K7P^*52G(]?\ ACX ^*&E>/=,\8>+=?\
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M*KC\1.G.$*TO;YHYTL=*51Q@W3C@<1CL%@:<(TWAX8J-6O4QM7"X9T^DUO\
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M-6-@Z;IT\2^)94U&7O4JG$5-0=5M*,)U,%[_ +.4:=)U(U:L(^PC4E?<\._
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MTT ?0% !0 4 ?/\ ^UC_ ,FL?M+?]D ^,G_JNO$= 'T!0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0!\__  ;_ .2B_M8_]G >'/\ UEC]FF@#Z H * "@#Y__ &L?^36/
MVEO^R ?&3_U77B.@#Z H ^4-)TGXD_$GXD_'V&'X^_%#P!HGP_\ BAX?\%>&
MO#7@KP_\"Y]*M=*G^!?P9\>7=Q<7?CSX,^)M6N]0G\1>.-=D=Y-3,:QM!%%%
M&L/S '7_ /"F_B+_ -'8_M ?^$Y^RQ_]#30!T'[/7BG7?''P"^!_C7Q3??VI
MXF\7_!_X:>*?$>I_9;.Q_M'7?$'@O1=6U>^^Q:=;V]I9^?J%W<2^3:P0PQ^9
MLBC1%50 >=_'RS\6ZQXG\&:5H5QKGB;0+70?%.K>*OA-\.OBU+\(/BQXC9+W
MPY;Z!XI\/^(+'Q3X;NKO0M(G;4;2[LG\0Z):2S:]9FXGF,:6[Y4[*MC*E2C6
MKT\/2PBIU,/._P!2KUJU=.6*PSE"G7CBL/3JO#>UE4498&NJ6%K3FZF'VG4A
M'"4*$)TJ&*Q&)G/FKI_[1AL-AJDJE##34*DH5(XFK@I5I0@G[.I#GKT*?-#$
M^'2_M >-/"_PL%]X6^(GAW4M1\(V'Q)U/6=%^*OPX\<>,/C-++X0\4:K8P?#
MK6/!_P -?$Z+976D6UN-)NO'IU36[>\DTIK\:;/#--=(\RQL<-2^O)4,?AZ&
M!RVK)X)^QIXV515J>)Q<ZM2G"EE"JRPE22P]7"SITZWUOVOU*CA%2J.A@)2Q
M?]G157+ZF(Q=2G!8NI'%RP<9X7 XFA2HQHS]IFL6L?2K0Y<3'$PPU; X9SQN
M,Q#JK:N?VC?C7?7-]XB\/Z5\,(/!^G^,?@'X/7P]J^G>*9_$FH7'QR\-^ [A
MKL>*K3Q'#9:9%X>UKQO!<;3X?O#JEK UH#ILR"\F]6.73695<LG65ZF:\099
M0K*+M1IY+@Z^,AC:M)R_VB5186M2E@H5<-=NG4CC()NFO/I8N%7(LNS>%!QJ
M5^'<NSZK3=5<LI8K,L;@ZN"IR5&]).CAZ3I8N2K>RJN;GAJT)*-/%U;]J;XN
M:9X@?X:O8^&Y?&GA_4OB(FO^+?#/P-^.OQ1T#6K/P;J/ARTT*TT_X=?#'4=8
MUKP9-K">(PL^J:IK^IVFGOIC^7%J+W<<,/D4:ZQ6#^OX>A/_ &?#4JE3!MR<
ML17>:9]EDZ=+,/91P^#C)Y#5KTG7H5ZC^M0I*G4CAJ^(-W*%'%8C 5:EJDL5
M[&AB$J:C0H?V3DN:SK5<)*O]8QDZ+SNAA>3#SP]*K[*>)JU\)*I0PE3Z6UCX
MH^)9/@UX,\=01>'/A7XI\96OA43:9\7=/\2C_A$]2UVV2;4-*F\(Z>FFZQXE
M\16+"X2+1/M.AR7/V:0RW=FJ,P[,RI4\'FD<#AL73KX>56LH581]O4JT:6'J
MXB/L:-*HHRG)0BJ\O;<N%I^VK<N(E2C0JK#2J3PF)JU:2=;#+D?+.=+#N:Q=
M/">U]K7H1JQP]1RY\+SX>-7$RGAZ#C0==U*7S2O[4/QJO?!D&MV/A_1XK30?
M&OQ(\)>,OB-!\$/C'XET)9O!4^C+H'VSX1:-XBC\<_#ZPUZVU.^FFUFY?Q-!
MI":(SRVMVE]"T?/"I"6'RO&5.7!T\?@_;1HUZJ5*=>EF.88#$4:F9QIRHY:H
MK 1K*6,PDO9RQ?U:LX5<)4]KI2CSU,YPD9O$XG+\=A<-"="G[T<-B\LP>8QQ
M4,'.HI9C[*6,AA?983&4_K,8+&T*GU>JHP^@?B=\3;K3_#7P1\5Z!-H^JP^,
M?%=E*MYI>M^(WT&ZL[GX6^.O%$%UI\^C:II \0Z3+<:7:^5%J]O<VDL4BSO9
M)=Q6TUI.;NKE6,S2G&G*,\NR[/*T88B%IJI@<+*I2C6I*<J:;E%*IRN4Z;O]
M7K4Y?O'TY+3AF.7U*E62C*;R:$_8O12Q6?93@JZIU*E*->')'$54K1HSDX^Q
MQ,)T)U\-4^>M)_:D^->G^'?A7J7BW2_A??ZG\=/AAX'\6>";?P_H_B?1M/\
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MVZOU-7&8A0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % 'S_ /!O_DHO[6/_ &<!X<_]98_9IH ^@* "@ H
M^?\ ]K'_ )-8_:6_[(!\9/\ U77B.@#Z H ^0/#GQ'TGX7?%']I.R\6^%OC
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MA%*+0OV>_A/X=EAN;'0-6NKNTU?0M:L;WQ!XX\>^*[_3+CPO<37?A[3]*O\
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M*%6K)RGA:'U:F[VM056=:,)*-E4Y*E6HZ<JBE.FJDX0E&$I1?7U)(4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0!\__!O_ )*+^UC_ -G >'/_ %EC]FF@#Z H * "@#Y__:Q_Y-8_:6_[
M(!\9/_5=>(Z /H"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M^SO):0V]Q/%, >O_ /#-/PZ_Z&/]H#_Q+']J?_Y\E !_PS3\.O\ H8_V@/\
MQ+']J?\ ^?)0 ?\ #-/PZ_Z&/]H#_P 2Q_:G_P#GR4 '_#-/PZ_Z&/\ : _\
M2Q_:G_\ GR4 '_#-/PZ_Z&/]H#_Q+']J?_Y\E !_PS3\.O\ H8_V@/\ Q+']
MJ?\ ^?)0 ?\ #-/PZ_Z&/]H#_P 2Q_:G_P#GR4 '_#-/PZ_Z&/\ : _\2Q_:
MG_\ GR4 '_#-/PZ_Z&/]H#_Q+']J?_Y\E !_PS3\.O\ H8_V@/\ Q+']J?\
M^?)0 ?\ #-/PZ_Z&/]H#_P 2Q_:G_P#GR4 '_#-/PZ_Z&/\ : _\2Q_:G_\
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M]'&8G!4Z-&52O1Y,%B?8-<T+7O#7_!/GXZZ1X@O-7NYX/@=^T3-IBZUX.N_
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MC&<U&E+FPJI0H4986HI8AXCC]/\ BQ\5O#?C7XH>)+3Q)X0\3_"R#]H[X8^
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M-3=2-2-15<1/#4\3B>5P2C3CAY5XX*5*3G4AB<+B93FN>-*EZG6904 % !0
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M,(Q\PU+]G+X/ZG9:)IT_AG4K2ST#37T.UBT7QKX[\.MJ/A^2]N=1E\->*)M
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M * "@ H * "@ H * "@ H * /G_Q'_R=/\&_^R ?M+?^K%_9.H ^@* "@ H
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M4 ?0% 'S_P#!O_DHO[6/_9P'AS_UEC]FF@#Z H * "@#Y_\ VL?^36/VEO\
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MH4Z]:K2E0PM"REB)\BHZQ<W[_,^7EC%N7M%#1-QYHILT_P#A%?V5/[6.@_\
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MQ_M ?^)8_M3_ /SY*DL/^&:?AU_T,?[0'_B6/[4__P ^2@ _X9I^'7_0Q_M
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M(>$+74+31+34/$&K*NK>(/$/BG5;C5?%7B'5?%?B+4]3\1>*]5U+5]7U"_\
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MHRCHO=68_6I.6C6&]ZZQ/.[>9]1GRU8RQ#DZN'XFH<SB[I\0X?!X:G/6>O\
M9]+"*$(W_?4YJFI8>,/>\V^)'[*&IZO8:7X?TG5=;U%O$WQ$T&ZU_P 1Z/\
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MACJU:HZ%6O4ABH8JEB,/C(._06/['#::]AJVGZ=\/;#Q99W/@/7%\1VZW_\
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M^XJX#<* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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MWP _\/)\.O\ YHZ #_AK']EC_HY;X ?^'D^'7_S1T '_  UC^RQ_T<M\ /\
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MO@!_X>3X=?\ S1T '_#6/[+'_1RWP _\/)\.O_FCH /^&L?V6/\ HY;X ?\
MAY/AU_\ -'0 ?\-8_LL?]'+? #_P\GPZ_P#FCH /^&L?V6/^CEO@!_X>3X=?
M_-'0 ?\ #6/[+'_1RWP _P##R?#K_P":.@ _X:Q_98_Z.6^ '_AY/AU_\T=
M!_PUC^RQ_P!'+? #_P /)\.O_FCH /\ AK']EC_HY;X ?^'D^'7_ ,T= !_P
MUC^RQ_T<M\ /_#R?#K_YHZ #_AK']EC_ *.6^ '_ (>3X=?_ #1T =AX*^-W
MP7^).JW&A?#GXO?"_P ?:W::?+JUUHW@KQ_X4\4ZK:Z5;W-I9SZG<:?H6K74
M\.GQW=_8P/</&L:R7D"%@TJ!@#U"@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /G_X-_\ )1?VL?\
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M /G_ ,1_\G3_  ;_ .R ?M+?^K%_9.H ^@* "@ H * "@ H * "@ H * "@
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M:$95H<.<4X:OB/9UG'FG4JU\'1K5L/1IX6OB*E*K&IB,5BZM2?U]+X7\3?\
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M0 4 % !0 4 % !0 4 % 'S_XC_Y.G^#?_9 /VEO_ %8O[)U 'T!0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % 'S_\ !O\ Y*+^UC_V<!X<_P#66/V:: /H"@ H * /G_\ :Q_Y-8_:
M6_[(!\9/_5=>(Z /H"@ H * "@ H * "@ H * "@ H * "@ H * /G_]IE+S
M_A5UG>66D>(-<_L+XP?LX^*=0T_PMX<UWQ;KO]A>$?VB?A9XG\1WUCX;\,:=
M?ZKJ_P!@\/Z1J=_+#865S-Y-C*RQML(H /\ AI;X=?\ 0N?M ?\ B)W[4_\
M\YN@ _X:6^'7_0N?M ?^(G?M3_\ SFZ #_AI;X=?]"Y^T!_XB=^U/_\ .;H
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M /\ AI;X=?\ 0N?M ?\ B)W[4_\ \YN@ _X:6^'7_0N?M ?^(G?M3_\ SFZ
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MI;R^3=030R>7LEC=&92 <_\ \*;^(O\ T=C^T!_X3G[+'_T-- !_PIOXB_\
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M /\ A3?Q%_Z.Q_: _P#"<_98_P#H:: #_A3?Q%_Z.Q_: _\ "<_98_\ H::
M#_A3?Q%_Z.Q_: _\)S]EC_Z&F@ _X4W\1?\ H[']H#_PG/V6/_H:: #_ (4W
M\1?^CL?V@/\ PG/V6/\ Z&F@ _X4W\1?^CL?V@/_  G/V6/_ *&F@ _X4W\1
M?^CL?V@/_"<_98_^AIH /^%-_$7_ *.Q_: _\)S]EC_Z&F@ _P"%-_$7_H['
M]H#_ ,)S]EC_ .AIH /^%-_$7_H[']H#_P )S]EC_P"AIH /^%-_$7_H[']H
M#_PG/V6/_H:: #_A3?Q%_P"CL?V@/_"<_98_^AIH /\ A3?Q%_Z.Q_: _P#"
M<_98_P#H:: #_A3?Q%_Z.Q_: _\ "<_98_\ H:: #_A3?Q%_Z.Q_: _\)S]E
MC_Z&F@ _X4W\1?\ H[']H#_PG/V6/_H:: #_ (4W\1?^CL?V@/\ PG/V6/\
MZ&F@ _X4W\1?^CL?V@/_  G/V6/_ *&F@ _X4W\1?^CL?V@/_"<_98_^AIH
M/^%-_$7_ *.Q_: _\)S]EC_Z&F@ _P"%-_$7_H[']H#_ ,)S]EC_ .AIH /^
M%-_$7_H[']H#_P )S]EC_P"AIH /^%-_$7_H[']H#_PG/V6/_H:: #_A3?Q%
M_P"CL?V@/_"<_98_^AIH /\ A3?Q%_Z.Q_: _P#"<_98_P#H:: #_A3?Q%_Z
M.Q_: _\ "<_98_\ H:: #_A3?Q%_Z.Q_: _\)S]EC_Z&F@ _X4W\1?\ H[']
MH#_PG/V6/_H:: #_ (4W\1?^CL?V@/\ PG/V6/\ Z&F@#0_9XUSQ-KWPVGE\
M7>)-0\7ZWHOQ0^/'@IO$FK6/A[3M5U72OAY\=/B/X#\.W&IVGA31-'TA-07P
M[X;TJ*9['3+*.62)Y?*5I&R >X4 ?/\ \&_^2B_M8_\ 9P'AS_UEC]FF@#Z
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M6*P]&O2@J6(H4:=>FYPJ*<O::Y2PH * "@ H * "@ H * "@ H * "@ H *
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M2^(_$GC?2;[PHWQ-T[4_ _B72]+\!_\ "1:7K8^(,?P_DU[1;"SOS);3Q?\
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M4CMS/"XO#XZA[RM)>SQ6%H5?=:YO9\D^:G*<)=)3*"@ H * "@ H * "@ H
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M -FG_DG7B/\ [. _:Q_]:G^,E 'T!0!\_P#P;_Y*+^UC_P!G >'/_66/V::
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MIH /^%-_$7_H[']H#_PG/V6/_H:: #_A3?Q%_P"CL?V@/_"<_98_^AIH /\
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M^AIH /\ A3?Q%_Z.Q_: _P#"<_98_P#H:: #_A3?Q%_Z.Q_: _\ "<_98_\
MH:: #_A3?Q%_Z.Q_: _\)S]EC_Z&F@ _X4W\1?\ H[']H#_PG/V6/_H:: #_
M (4W\1?^CL?V@/\ PG/V6/\ Z&F@ _X4W\1?^CL?V@/_  G/V6/_ *&F@ _X
M4W\1?^CL?V@/_"<_98_^AIH /^%-_$7_ *.Q_: _\)S]EC_Z&F@ _P"%-_$7
M_H[']H#_ ,)S]EC_ .AIH /^%-_$7_H[']H#_P )S]EC_P"AIH /^%-_$7_H
M[']H#_PG/V6/_H:: #_A3?Q%_P"CL?V@/_"<_98_^AIH /\ A3?Q%_Z.Q_:
M_P#"<_98_P#H:: #_A3?Q%_Z.Q_: _\ "<_98_\ H:: #_A3?Q%_Z.Q_: _\
M)S]EC_Z&F@ _X4W\1?\ H[']H#_PG/V6/_H:: #_ (4W\1?^CL?V@/\ PG/V
M6/\ Z&F@ _X4W\1?^CL?V@/_  G/V6/_ *&F@ _X4W\1?^CL?V@/_"<_98_^
MAIH /^%-_$7_ *.Q_: _\)S]EC_Z&F@ _P"%-_$7_H[']H#_ ,)S]EC_ .AI
MH /^%-_$7_H[']H#_P )S]EC_P"AIH /^%-_$7_H[']H#_PG/V6/_H:: #_A
M3?Q%_P"CL?V@/_"<_98_^AIH /\ A3?Q%_Z.Q_: _P#"<_98_P#H:: #_A3?
MQ%_Z.Q_: _\ "<_98_\ H:: #_A3?Q%_Z.Q_: _\)S]EC_Z&F@ _X4W\1?\
MH[']H#_PG/V6/_H:: /0/AA\/;/X7>$(?"5EKWB#Q1CQ!XV\4ZAXA\4G0O[=
MUC7?B!XV\0^/_$=]?)X8T+1=*@\SQ!XFU,Q0V&EV4,4/E1+'^[+,;!L>@4 ?
M/_P;_P"2B_M8_P#9P'AS_P!98_9IH ^@* "@ H ^?_VL?^36/VEO^R ?&3_U
M77B.@#Z H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M !_PIOXB_P#1V/[0'_A.?LL?_0TT '_"F_B+_P!'8_M ?^$Y^RQ_]#30 ?\
M"F_B+_T=C^T!_P"$Y^RQ_P#0TT '_"F_B+_T=C^T!_X3G[+'_P!#30 ?\*;^
M(O\ T=C^T!_X3G[+'_T-- !_PIOXB_\ 1V/[0'_A.?LL?_0TT '_  IOXB_]
M'8_M ?\ A.?LL?\ T-- !_PIOXB_]'8_M ?^$Y^RQ_\ 0TT '_"F_B+_ -'8
M_M ?^$Y^RQ_]#30 ?\*;^(O_ $=C^T!_X3G[+'_T-- !_P *;^(O_1V/[0'_
M (3G[+'_ -#30 ?\*;^(O_1V/[0'_A.?LL?_ $-- !_PIOXB_P#1V/[0'_A.
M?LL?_0TT '_"F_B+_P!'8_M ?^$Y^RQ_]#30 ?\ "F_B+_T=C^T!_P"$Y^RQ
M_P#0TT '_"F_B+_T=C^T!_X3G[+'_P!#30 ?\*;^(O\ T=C^T!_X3G[+'_T-
M- !_PIOXB_\ 1V/[0'_A.?LL?_0TT '_  IOXB_]'8_M ?\ A.?LL?\ T--
M!_PIOXB_]'8_M ?^$Y^RQ_\ 0TT '_"F_B+_ -'8_M ?^$Y^RQ_]#30 ?\*;
M^(O_ $=C^T!_X3G[+'_T-- !_P *;^(O_1V/[0'_ (3G[+'_ -#30 ?\*;^(
MO_1V/[0'_A.?LL?_ $-- !_PIOXB_P#1V/[0'_A.?LL?_0TT '_"F_B+_P!'
M8_M ?^$Y^RQ_]#30 ?\ "F_B+_T=C^T!_P"$Y^RQ_P#0TT '_"F_B+_T=C^T
M!_X3G[+'_P!#30 ?\*;^(O\ T=C^T!_X3G[+'_T-- !_PIOXB_\ 1V/[0'_A
M.?LL?_0TT '_  IOXB_]'8_M ?\ A.?LL?\ T-- !_PIOXB_]'8_M ?^$Y^R
MQ_\ 0TT '_"F_B+_ -'8_M ?^$Y^RQ_]#30 ?\*;^(O_ $=C^T!_X3G[+'_T
M-- !_P *;^(O_1V/[0'_ (3G[+'_ -#30 ?\*;^(O_1V/[0'_A.?LL?_ $--
M !_PIOXB_P#1V/[0'_A.?LL?_0TT '_"F_B+_P!'8_M ?^$Y^RQ_]#30 ?\
M"F_B+_T=C^T!_P"$Y^RQ_P#0TT '_"F_B+_T=C^T!_X3G[+'_P!#30 ?\*;^
M(O\ T=C^T!_X3G[+'_T-- !_PIOXB_\ 1V/[0'_A.?LL?_0TT '_  IOXB_]
M'8_M ?\ A.?LL?\ T-- !_PIOXB_]'8_M ?^$Y^RQ_\ 0TT '_"F_B+_ -'8
M_M ?^$Y^RQ_]#30 ?\*;^(O_ $=C^T!_X3G[+'_T-- !_P *;^(O_1V/[0'_
M (3G[+'_ -#30 ?\*;^(O_1V/[0'_A.?LL?_ $-- !_PIOXB_P#1V/[0'_A.
M?LL?_0TT '_"F_B+_P!'8_M ?^$Y^RQ_]#30 ?\ "F_B+_T=C^T!_P"$Y^RQ
M_P#0TT '_"F_B+_T=C^T!_X3G[+'_P!#30 ?\*;^(O\ T=C^T!_X3G[+'_T-
M- !_PIOXB_\ 1V/[0'_A.?LL?_0TT '_  IOXB_]'8_M ?\ A.?LL?\ T--
M!_PIOXB_]'8_M ?^$Y^RQ_\ 0TT '_"F_B+_ -'8_M ?^$Y^RQ_]#30 ?\*;
M^(O_ $=C^T!_X3G[+'_T-- !_P *;^(O_1V/[0'_ (3G[+'_ -#30 ?\*;^(
MO_1V/[0'_A.?LL?_ $-- !_PIOXB_P#1V/[0'_A.?LL?_0TT '_"F_B+_P!'
M8_M ?^$Y^RQ_]#30 ?\ "F_B+_T=C^T!_P"$Y^RQ_P#0TT '_"F_B+_T=C^T
M!_X3G[+'_P!#30 ?\*;^(O\ T=C^T!_X3G[+'_T-- !_PIOXB_\ 1V/[0'_A
M.?LL?_0TT '_  IOXB_]'8_M ?\ A.?LL?\ T-- !_PIOXB_]'8_M ?^$Y^R
MQ_\ 0TT '_"F_B+_ -'8_M ?^$Y^RQ_]#30 ?\*;^(O_ $=C^T!_X3G[+'_T
M-- !_P *;^(O_1V/[0'_ (3G[+'_ -#30 ?\*;^(O_1V/[0'_A.?LL?_ $--
M !_PIOXB_P#1V/[0'_A.?LL?_0TT '_"F_B+_P!'8_M ?^$Y^RQ_]#30 ?\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
.. 4 % !0 4 % !0!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>157
<FILENAME>g20922ndsp12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922ndsp12.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /W\H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\
MROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T
M+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JE
MP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#
M1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_
M .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$
M?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__
M .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18
M?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'
M7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#
M^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_
M ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y
M0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!
M_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9_
M_P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?
MZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?
M_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\
MROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T
M+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JE
MP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#
M1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_
M .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$
M?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__
M .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18
M?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'
M7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#
M^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_
M ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y
M0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!
M_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9_
M_P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?
MZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?
M_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\
MROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T
M+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JE
MP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#
M1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_
M .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$
M?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__
M .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18
M?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'
M7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#
M^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_
M ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y
M0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!
M_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9_
M_P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?
MZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?
M_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\
MROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T
M+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JE
MP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#
M1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_
M .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$
M?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__
M .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18
M?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'
M7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#
M^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_
M ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y
M0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!
M_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9_
M_P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?
MZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?
M_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\
MROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T
M+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JE
MP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#
M1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_
M .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$
M?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__
M .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18
M?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'
M7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#
M^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_
M ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y
M0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!
M_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9_
M_P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?_EP?
MZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\ ROB?
M_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T+_\
MROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JEP]_T
M+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#1_JE
MP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_ .>#
M1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$?'+_
M .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I#^VO'7_18?C__ .)$
M?'+_ .>#1_JEP]_T+_\ ROB?_EP?ZV9__P!!_P#Y0PW_ ,I.#^*>K^,Y/AA\
M1HKKXJ_'#4+5_ ?B]+C3]6^._P 9-7TJ^@;P]J*S6>IZ3JGCFXL]4T^:,M'-
M:7<$T$\;O%-&\;LIXLRX7R/#9=CZ]' \E6AAJ]2$O;8A\LX4I2B[2JM.S2=F
MFGU31VY;Q-GF(S' 4*N-YJ5?$4*<X^QPZO"=6,9*\:2:NFU=--=&F?TKU^1G
MZR% !0 4 % 'Y9?\%"?^2F_L\_\ 8B?M ?\ J0?L^5]KP)_R-\3_ -@=3_T]
MASXSCG_D4X?_ +"Z?_IG$'Q/7ZP?E04 % !0 4 % !0 4 % !0 4 % !0 4
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MLR*[#SPH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H X3XH_\ ),OB+_V(GB[_ -1_4*\W./\ D49K_P!@>)_],S/1R?\ Y&V5
M_P#87AO_ $] _I@K\$/W<* "@ H * /RR_X*$_\ )3?V>?\ L1/V@/\ U(/V
M?*^UX$_Y&^)_[ ZG_I[#GQG'/_(IP_\ V%T__3.(/B>OU@_*@H * "@ H *
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M_&E[;Z7:7OB_Q1=VNA2P3Z):W6OZM<6^CSVJA+:;2X9;MDT^6%%58W@6,H
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MR;E*4I2;<I2;;E)MMMMMW(JL@* "@ H * "@ H * "@ H * "@ H * "@ H
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M3OV6/^C:?@!_X9OX=?\ S.4 '_#)W[+'_1M/P _\,W\.O_F<H /^&3OV6/\
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M^RQ_T;3\ /\ PS?PZ_\ F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\,G?LL?\
M1M/P _\ #-_#K_YG* #_ (9._98_Z-I^ '_AF_AU_P#,Y0 ?\,G?LL?]&T_
M#_PS?PZ_^9R@ _X9._98_P"C:?@!_P"&;^'7_P SE !_PR=^RQ_T;3\ /_#-
M_#K_ .9R@ _X9._98_Z-I^ '_AF_AU_\SE !_P ,G?LL?]&T_ #_ ,,W\.O_
M )G* #_AD[]EC_HVGX ?^&;^'7_S.4 '_#)W[+'_ $;3\ /_  S?PZ_^9R@
M_P"&3OV6/^C:?@!_X9OX=?\ S.4 '_#)W[+'_1M/P _\,W\.O_F<H /^&3OV
M6/\ HVGX ?\ AF_AU_\ ,Y0 ?\,G?LL?]&T_ #_PS?PZ_P#F<H /^&3OV6/^
MC:?@!_X9OX=?_,Y0 ?\ #)W[+'_1M/P _P##-_#K_P"9R@ _X9._98_Z-I^
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M&T_ #_PS?PZ_^9R@ _X9._98_P"C:?@!_P"&;^'7_P SE !_PR=^RQ_T;3\
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M-I^ '_AF_AU_\SE !_PR=^RQ_P!&T_ #_P ,W\.O_F<H /\ AD[]EC_HVGX
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MJ?UE8[AO#_[9/Q,UGX>ZMXKU6^^#'@LVWC/PYH,>K:W?_#K5[FPEU;3-8O\
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MH:EIVD6<NH:K?V6EV%OY8GO=0NH+*S@\V5((O-N;F1(XM\TD<:[F&YI%49+
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MSI1E+GE&A135+#PE*TIPHPIQDXQ<D^2-O1*S * "@ H * "@ H * "@ H *
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M*-'!8)T?KILZC\&_&>K_ +(^I?#S79O'>O\ Q,UKP;9ZAKEOJ'Q4\0OXAO\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0!\_\ [6/_ ":Q^TM_V0#XR?\ JNO$= 'T!0 4 % !
M0 4 ?/\ XC_Y.G^#?_9 /VEO_5B_LG4 ?0% !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M*T7[2K+#4J$>9,T/]K2SO?!^F>*-9^#OQ1TB8>%O^$[\7Z58R_#S7O\ A!/
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M$/#/AS]G^QTKP5;W7Q(T!$OOB5\;9_#&L:O?7?A7XI:7I6LW:6FC/@:EX>O
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MN%%XBG5Q%3$RHPY*E:E*51JK@L7+V,*</A/X\?$CQ<?"6E>'?$/PB\61:O\
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M0 4 % !0 4 % !0 4 % !0 4 ?/_ .UC_P FL?M+?]D ^,G_ *KKQ'0!] 4
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MM:M9*I7<'4DDES.E1I8>G=*R]RA1I4U9*T8170UZ "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#Y_P#VL?\ DUC]I;_L
M@'QD_P#5=>(Z /H"@ H * "@ H ^?_$?_)T_P;_[(!^TM_ZL7]DZ@#Z H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M0J6:H5\/@ZRE)2A5C4QF98S+*5*6&:]O&#KX:C%8B4(TG4Q=*E[LN5U+UO\
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MG.])0J4Z251.G.<ZM#$8FBJ,)J,ZZK4<)B)4948U(UI4I4Z;E4M!X6F?M4_
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M&%4I1598?DFI-2H3PV6X/*X5:<+^QJ3EAL%1<XXFEB*?M7.=.G!-1CZGX/\
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M(RO#"QHXW X]JE*:G5FZM7+L)3JSQ-2O5="DH0G!I26Y\0_@YHWQ%U%]0O\
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MM:L?%-KXUM]3T/QI9?#*/Q'X@8>)[&SO6L_&FK^*[&3[+%#):M;J(:QPDJN
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MO=-U3X*:3J;WMQ<F*Z>*Y\0ZS'Y[OAUMD%K)SY+)8JKPYAL2N>OCL1"KBK_
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MI=#T#1-&EN+:VL[B72M*L=.DGM+*>^NK.UF>S@C,MM!<ZGJ4L43$K&^H7+J
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MJ==[U82J5*E1PJ<T7.<YM<TI-ZLWPP^&EPVB//\ #SP-._AG3;C1O#;3>$M
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MSXK^(?VFM!\/>*M?\)ZIXQN8KKXO7'AV+3K#PC9QWO@OX:Z9I5]-8:]X4M]
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M[/:46T^6<;QG&TH.46F[M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M 4 % !0 4 % 'S_^UC_R:Q^TM_V0#XR?^JZ\1T ?0% !0 4 % !0!\_^(_\
MDZ?X-_\ 9 /VEO\ U8O[)U 'T!0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M4LNI7E)9;1PM&+FU4=2."PJPF'E)5%*%*<*,*5Y82.&YITU.2<IUO:[/BO\
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MI3K>UPW.U5IT*=2,9+WCPG\//#W@R#Q1::0DXLO%>K1ZO?6$BV-O8V31>&-
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MT4W14)R]G&6']E5EA^:A6JU:56O&KK>)_@IH?BGQ/K'B2[\2>+;&+7X?A_\
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MQIJ*4JO]E8O)W7O)2DJDL'BYMI2]BJU.%54DY5U6T_!W[,_PU\"_%GQ%\8-
MLH(?$?B9]8NKV&;PC\,9)H-5U^>.XUG5;7QLG@%/'9ENG656L;CQ=<::B7,D
M<5C&BQ+#&#M@<)7P5"*C2K.R:_=RA2=9XB5&U'V4*U.59QJ.6+AB*RE3I\M6
M/)$SQ45C*V#KU_>JX*%&$'*U2[P^$6 HS7M54]C.&%BJ7^R_5XR7.YQE*K6=
M3UQ_"6FR>-+7QT9KT:O:>%[_ ,)Q6PD@&G'3M0U73M7FF>$VQF-ZMSIENJN+
MA8Q&\@,;,59"D_8+'J&JQ[P+J7^S_9ZS!4>2UK<W]I5_:\W-?DI<G)RS]I%6
ME&K6P-:3:EE\,;"FE:S6/>7NMSIIMN+RZA[+E<>7FJ\RGS0Y/-M0^ ^@ZAXV
MN_%C^+/'$&DZGXGT/QQK'P[M[[P__P (1JWC?PW:Z9::+XIN6N/#4OB*VO+>
M/1-%<V-CX@M-+FETJ":>PEE,K2Q3BZ=)47)U(4:>84\-S6O@UFD,53QKHN"C
MSNK''8UQ6*^LPHRQ52=&-.4:3IWBH0Q<>64(T74^JK$2IKEEBX8*K2K86&(O
MS)*C/#T%[2@J-:K2HTZ%>K5H)TGK7'P@TO\ X4_:?!G2O%'B_P /:-8>'=)\
M,V?B32+CP^_BR'3M):T"[Y=7\.7VCW3W5O:?9KJ*XT::WG@NKB(P!9.+QTIX
MZM3KU)>RE3K4*SC",7";P[@XTZD*L:D9TIN$?:TY*TU>+]UM'6L3)8K'XMPB
MZN/J9A6G:52'LJN8SQ%2I4H3I5(5:4Z%3$2GA9JHYTIPI2<IRBV[MM\,8+CX
M<ZS\-/&/B[Q7\0=*UW3-3T2_U?Q#%X.T#7!H^IVIL_[.M/\ A6OA'PMIEC%:
MP$BWDM]-CG0X+2R%5VNO.59T*D9.AB<-4I5X8B$I.K]9H8E8JAB6ZKJP=6E5
MC3:7(J4E2A[2E.4JDJG)A8K"2FDHUJ$DX+#U*=)T(T)450J894X0AS4*D.?G
MC4<Y_O9QC.--4X4^?\-? [2]#O$UC6/&WCSQWXG&M>'-7F\4^+;CPG'JMS!X
M1L]:LO#VARVGA/PAH>E1:3:)XAU>0F#38;R>6\:6YNYGYJE/E^K\D(P=#$8W
M%2M?]]B<?@5EM>K45W&-L)"C3ITJ"HT(.A"2I.4JSJYNA3;Q/Q1A6H8/"PAS
M-K#X; YA#,Z%&E*7-.2>*C*52KB9XC$5(5)0=:T*/LKWCWX,Z)\0-4U74K_Q
M'XKT>+Q!X"U/X=>(=*T.;PZFG:UH=]/<75G<71U?PYJ%W::IIEU>WTMK-87=
MG&QO)%O(;N-8DBC"/ZEBI8J"YY/$Y7C%"=^2&)RC&+%X:I'EY)^^^;#UX2G*
MG.A.7)"G7C3KPUQ*>*PU+#2DZ<*-/,J7-"W-*CFF$AA,52ES*<>6U&A7I2C&
M-2%:A#WY4)UJ-7SOXG_LB_"SXL:G?ZWXE-Z^L7OB0>)8KR]\/?#'QI::;._A
M7POX/O;&P\._$_X>^*-"^R7>E^$-'=YKG2[B^BF6=K2\MHYFCJ:484JN%J^S
MA/ZL\0I1G&+5:GB<2L74HSG95:<%57NRPM3#U>2\)U9ILZ9XFK/"4L$VXT:%
M#"T(<LIQ:>#J9E4HUI)2Y*E1+-<7!QJPG0<72DJ*K4HU3VZ^\ Z%>W?@"ZQ/
M8I\-KVXO/#UCIJ6%CIQ^T>%=6\'_ &2ZLH; 1QV$6E:Q<&*"R%FL<D,&W]TA
MB?6I5E5KX_$5;UIYEA,3@Z_/*<^:EBL7@L95ES2DZCJNK@:45.<Y-PG5YE*<
MHSAYT<+2IX3!8*FO9T<!7P]>DH1A3M+#4,1AZ<>2$(TXT^3$S;A3IP2<8*')
M"+B_EZ/]B[P;X/TO5[3X4WL7A6^UWQK\/-=?4HO"WPLT36/#FC>$?'.G^+-0
MMM'\5>'?A9#KOBB_9;9Y(!XWO_%"O<06XFE2-IF=8.<L(LLH0JSHT,!+%2E4
MI*G"K)3R7,<KPD/8*$<!.-&>,CS2EAE5=&IB92J5:D^6>V9+Z_5S+&5:<*V,
MQZ5U5YI4^>KFF!S#%R]JW+%TO;?59.-.C7C1C45&-.G2ITJ3I>A7/[,FARVD
M26?Q*^*NDZS>6WB&P\:^*-/U+P8-;^(^F^++Y=1\0:?XIBOO USI>FQW-R@\
MJ?PMIOARZL4)BTZXLXR4.7LL-RU,/]5I_P!G5Z-&C5P+=1X>K&A6QN(A*=1U
M'C.9U\QQU2JXXJ,:WUJ<:T9PC2C3UC.K"O3QJJ-9A0K2K4<3RP52C*6'P6%Y
M84E!86<(T,MR^,56P]5IX2$[N<Z\JO3ZI\!O"=]H?B_0K'5_$_AY?%GB+P/X
MJBU'1[K1GU#POKGPZT_P=8>$[KPZ-9T/4+1DM?\ A!M#G>#5[35HII?M F1X
M91"G4\7B'6PF(]I:OA,7C,6I\L;U)X^5?ZW3JQ<7'V5:GB:]!JG&G4A3J-TJ
MD*T858NE*-"A1PL*4?JU#*?[&C3?/;ZHI8R<6Y*2G[:,L;4<9J2C^[I7@[3]
MIM>/?A!X6^)-SX.NO%4^KW1\'3ZA+'#;W%E;VWB"'4].%G<6'B2W73RE[IXO
M[?2]72"W%H%U#0]/F'[N PR<=2E3J5,752=)XK"8K!J,)S4:,<7'V<JU).3?
MUFC1E7H8:K5=7V5/%8CW95)J<72JU:6'H8?VCFJ&+P.-YY*//.OE\Y5*7/R*
M,.2<I/VT(0@IKW8\D;I\=IW[-?@73?!TW@J'5O%LMA=?#C4?AK?:C<ZCI4VL
MZAI^L:Q=:]J_B&]NSH@BF\57NKWMW<S77D"W9[AR+49X[7B9_7_KZA&,XU\A
MKPII2]E3?#E2K4P%**<G/V4O:N&(3G*=2,8\E2E/FE+CEAJ3I.A%.--T\ZI)
M*3DU#/(8>GB8J4W.36'IX:E3P?,Y>RA'EJ>VBHJ.IIGP&T#2_&MKXLC\5^-[
MC2=,\4Z[XZT7X>75[X?/@G1?''B:TU:SUSQ39-!X:B\137=S%K^NO]AO?$%W
MI<4NKSS06$4HB>'+"U)X2E*FG[:2H3PM&I5UGAL)4K1KSPU)QY8R@YPA&-2O
M&MB*5&*H4JU.BY4WTUI3K)Q]I*G&K#!PQ$8/3%?V?3P]+".MS*3C[&.$PLN3
M#NA3J3P].I6A4GS.53QK^SYX>\:S>(9)O%OC+0HO%?C+2/&FOV^B1>!96NKW
M1?#&A>%;.RT[4?$?@?5=2\,1+8^'[*X34M O=+UFWNI)9K35+?\ =+"86H\)
M6RVM%*HLKJ8JM1A/2+JXJLJTY5)4W3K.,7S4O8QJQH5Z%2I0Q=+$TYN)IB:S
MQ5%4JD(+EPM'")\BJ+V5#$XW%TVZ595</.HJ^.G-2J49\DJ&'E25.4:DJGH>
MO_#W0/$OB#2?$.JM?S3:1X5\8^#DL$N(TT^\T?QPWAXZS]N'D&Y>Z5?#5DD,
MD-S"%$]QO61F1H>>M1IXC#YIA:L5*CF]"&'KQV_=TY59+V?+;E;=:2;U5E'E
M46FW6'Q-7"T<+2HRY?J>,PV.IS=YS]OA:&*P]+FE-M2CR8NI*:DG*4XP?,DI
M1G\[:%^Q7\-?"W@[5/ _A?7-7\,Z/K&OZ3K.H3^'_A_^SOHNL7-EH,-S%HV@
M7&K:;\#X;BZAL9;I[JVUZX:;Q/;7*BXM]>BE>1I.MXFK)X'VDW)8&I7K<L93
MP\:M;$*C"=5QPLJ$<-/DHJF_J"P<9TIRIU8U(1HQI<]&,<-4Q%3#Q5.=:E&C
M%R2KNC24JDI4[XGV[Q-.KSQC5I8]XNE.-.%X7E5=7N]8_9Q\.ZA<-?:3XX^(
M_A'4Y[GQ>-2U3P]JOAR2]U;0_'7]BMXD\+WS^(_"NK1KI<\_A_29X[ZVCMM8
MMY+9F@U2,32B3CE2C+"XC S][!XNE7I5Z-HQA5]KC<RQ]*H^2,90GA*^;8V.
M'C1E3I2HU%2Q-+$P5G=!_5JM*O3BOK.&K82M0K27/4HRPF7X++;0E._/#$8?
M 8:6)C6553KP5:'LY1I\G.)^QY\)(/'ES\0X()DUR^\.+X>OGN/"OPJU._GE
MC\'Q^!HM>M?&>L?#F[\8Z'JR>'X+>,0:/XDT[3"\+.^G-]HN1<:XJ^+HYWAY
MOV5//?KOM51_<RH_VA7>(Q7LYT^6=53J3J)1QLL7"$*CA&*4*/LYPJ^J1R.-
M/WWD7U.-)U?WGMH8!16%A6A.]*"IN$)\^$IX6K*<8RE4=CM=8^ /AO4X9OLO
MB7QEH&I_8/A99:?KFCW'AN34='E^$.HZGJ7A?4;"#6_#&H:?->S2ZM=QWJ7]
MC>VTT941V\#+N/7+&57C5C>6/M/[5QN;2A9^SJ5,QRZEE6,PLE?F6%K8*FZ7
MN3AB:<JM2I2Q,*BI2I<5++\-3PM+!RBZM&AEV$RV"G)IJ&!QKS#"8B]/D_VF
MCC%3K)_P)^RA"K0G2=6%3?\ '/P@\-_$#6-&US6K_7;>\T.SL;*U73;G3H()
MH[#QUX)^($3W*7&EW#-*VM> ](A<QO&IMKF\15662*:WQPM:6#KU<12BN:K4
MPE5QE=Q4L%2S2C22LT^5QS;$.I>3;E"@XN*C453LL^6G&4G)TL)FF#YG:[IY
MMA*6#Q,Y<J4?:1ITHRHN,8PC4<G.%2%H*;4OA1HE_P"$/'_@Z/6?$FF6GQ$U
M/7=7U35-.N]-CU?3+W7_ "/M1T=[G29[06\9MH]EO?V=_%(K217*7$,C1MQ2
MPT)8+!X&[]C@:DJD+QISYW/,J^:2A6A4A.C6HRKXBI2G1G2=.IAK4JD9MSE+
M:E4]EC,5C.7FGBXTX5(\]2FDJ>78?+(NE4HSI5Z-3V&&A4C5I5H5:>(;JT9T
MVH*'E\_P!;P1\"/%/P6^$,.AF#QE'K^E7UWXF;1O!^G:'9^,["33/$>OZ7H/
MPU^']KI,MY;+))?6^A6>EZ':7-Q))&;VQC<.G?*M[>OE%.NG# X"O"<W"=2K
M7A0IXZKF,:-'ZQ.?/^\G]4I.I6BL-AN2?+B)4/8UC*ZBRG&ULTI+V^-C5H8J
ME3FH4J-7$X:AA<-3C5E1A%TJ4J>&C5K5(4JU6I5Y](NK[2GKI^S?X<&OSZQ)
MXT^(#Z8Y\5W%EX-%WX4C\*Z/JGCCP[<^'/%>KZ<$\(C6)KV^BNYKL)J&L7\%
MM<LQM88()IH)N.M0IU\+F.#FI.&883'8%S<OWE#"9AF%#,ZM&BTE3]S%4$Z5
M2K3JU%3J3I3G.$:$:.%"+H5,EK1LJV38C+\6FD^7$XG+<MJY3AJE=2E.48K!
M5?9RIX>="$I4Z=22=3VDZECQ7^SOX=\46SV\7BWQ?X>,_A+P/X)NYM-LOAUK
M)NM \ W7B*]TF-K;QSX U^TMK^>Y\27,D]]:V]O<QO8V;V,MF\<C3].*J2QF
M(Q%>LM,5F$LQJTX.5-.O*G&DE3K4Y1Q6'C!14J=3#8BCB83]Z-=625X5_4\K
MP.5TDG2RW#8C"T*LTIU%#$K+X595*<KX6NW#+J5-TL1AZN&E"K752A/FINE+
MI?[/NA:/XHTS7[+QQ\1QI.D^((_%MIX(NM9T.^\+GQ5_PBUWX0O->N[N\\-R
M^([ZYO=,O'FGM[C7Y;/[8@NXK:*>25YHD^:&*ISC&4<1#,*=-<D(+"TLSQ%;
M%XNGAHTXPBE+$XBM4IRJQK5*,9NA2G'"_N#&G2C1HNC2E.,9TL!2KRE.52>(
M>6/ _5*M:=5U)*K"EE^&H5'2=*%:$74K0GB;5XQ^#?V>-!\ RV\'ACQMX_L?
M#DGAS3_#OB7P?+<>#KS0/&?]D^%H?!^FZWKL]WX,DUC3M;AT2TT^,OX>U70[
M>9M-MVN+:4*RR+%VQV&S/!XI>UPV94ZL%3;DEA)5XTX5ZN%E%J:E5C3UIUY5
M\/&52K4IT(5)N9WUL97K8^EF:DJ.,HXBKB%."NI1JYAB\S^KRA4YX>QIXK&X
MEPE&,<1R34)UYJ$+9-I^S'X?LM,TZ"#XA_$P>(M"L?!=CX;\<_:? B^)_#H\
M 1>,+#PW<V-O'X"70;V>/0O&^LZ1.NJ:)J,-U:+ 9XI+H2W-QTXC%XC$59U_
M:.CB:V*Q.,KU::C?$5L9@<#@<;[6G-3HJ&*CE]'$2A2I4E1Q4IU,+]7A&A3H
M^=AL+A\'3GAZ%/EP3P5#+Z>&YI^SH87"8Z68X2%.?,L0WA<2X.G.M7JRG"E"
M&(=9.I[35M_V</!<'A[7= EUOQA>'Q/X1\2^$_$.LWFH:0^L:JWB_P 2:AXM
M\1^))WBT*.T@\07FNZG>SXMK.#3X5E$-OI\,,:(D0JJCB:.(HTH48X>MD56C
M1CSNE27#U:O7P-).<Y5IPG*O-8J56K4KUE:2K0J.4Y77A/%*3Q-:=>K.AF>'
MG4ER*<J>:83 X&I[L(0IQ^KX7+\-2PD:=.$*<8/VD*M].G^(7PDM/'FHZ+K5
MKXT\;^ ==T72]9\/?VSX(N?#276I^&/$+Z;+K?AW4K;Q;X7UZQ-G<W&CZ9,+
MNUM+74;9[0-9WUOYDHDY94H5/KE.JG4PF8PI4\9AFW&EB84'7=*,YPY<12<%
MBL3!3PU>A-PQ%2,I/W'':E-T*6'A3C&-? R]IA,3RQ=?"U7&$)3I\R=&:FJ=
M+VE+$4J^'E*E3FZ//3A)='X,^'_A[P$EU;^'5O(+*>P\-Z9%8W%P+F"PL?"N
MA6GAW2;>T=XO/(&G64'F/<33N[@MN&<5U5J]6O5QM:M+FJX_&XC'U962_?XF
MGAJ51144HQIVPT'&*5U*4_><7&,>:AAJ6&IX.E13C3P."HX&FG)R_<T*^+Q$
M)3E)N4JKGC*JG-RM*,8>ZI*4I]O6)N% 'S_^UC_R:Q^TM_V0#XR?^JZ\1T ?
M0% !0 4 % !0!\_^(_\ DZ?X-_\ 9 /VEO\ U8O[)U 'T!0!\U^#]3\7?$CX
MB>/[P_%/6_"6C_"WXAOX2/PQ\,:3X >'5=.L='T758[[X@:CXI\(ZWK>W6AJ
M$MU:'P_J/AY4T^:W&^2Y$DD=8;EHX##9I7_?PQ?]I1E"H^3#4/J>/Q^7PY'3
M]G6]M&GAZ6,J.M6E3<YTDJ+P]_;SC%.6*J9?2C+!_5J>!JQK1]ZKBUB<-AL9
M.I!5J;HQPT:E2MEK5*G4E[7#8J7UF-:U/#<#IO[5VO:YK7B3PUX?^&VC:QJM
MIXA\%Z9X*U-?%_CG1O!7C#1/'=_XJL=%\0#Q3XG^"VF%H(O^$7DFN9?#-AXO
MTSR[Q5L]6O9H7BJ:,*U;#Y;-4U2Q.+Q&,P]:C5E*FZ#PF45LW]I&,H?694ZU
M.C*C2=?"X3G;C5I\]*[71C:<,!5Q"Q$I>PH6C>$.:M[6.:9;E=>C4CS+#1JT
M:F94W*G#&5:E.I1JT,5#"RY)RN:E^U;<Z9#\,I'\"6=U<>*O$=OX6\=Z-IFN
M^,]:UCP#?W'Q#G^&$6J6\N@_"F^T2]\+/XGT_61#JOBG6_ J74.ENMI'/>,U
MG%TX>C3Q6/PN&I5)1PF/P.%QN'Q$X*FT\7ECS2CAL3&53ZO2KN@Z4/8T,7BJ
M\ISFZ5"I2@JD^9^UC@,PQ4Z:A6RW$YI0G3YI2A5CE$W'$U,-.G"=>HN11G>>
M%I4:'ML.L77PZJN4(K?]HOQ7>^)+/59]$\)>&OA_/X/^,&M>'/M_CT7NH^);
MOP'XA\+^&+&3QCIVG> [J]\#%M:O;R"*+1)?%DC+?!;FW%^D-B>*E*3R^6+E
M'FQ5? Y/BL/A8QJSBUG,Z4\#!5:5&=6>+JTJBI/"QPTXSK24,)5Q/+4J4^EQ
MI\U6+E[+"8+.*N Q.*DX*<(Y?A,XEF,E1J5(8=86G4P4*\,15Q=&I[*DI5H8
M:G5:GZ[\%/BMKWQ;\-P>(KSP9#X22UU/Q1X?\0V%Y?\ C&WU+3M>T#4;*VL8
MM/T7QK\-O"FLS:5>V4UW<23ZUI7AZ\MG@MXUTZYCNC<6_9*E26'P^(C4<H8N
MC&I22]C/WH8C%X7$PJ2HUZL(>RJX9>QY9SJ5(U)+$4L'7I2HOCIU92J8NA*'
M+6P=>G3DO?Y'2JX.AC:52+J4Z4W-PQ-&$J?LE2O[2='$5J2ISJ^W5SFP4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% 'S_P#M8_\ )K'[2W_9 /C)_P"JZ\1T ?0% !0 4 % !0!\_P#B/_DZ?X-_
M]D _:6_]6+^R=0!] 4 <+K7PN^&?B3Q/H_C7Q%\._ NO>,O#S0OH'BW6O".@
M:IXGT-[>3SK=]'UZ^T^6^TQHIOG0VT\95OF7!YI4DL/4JUJ"]A6KPE3J3I^Y
M.I3G3E2E"<HVE*$J4YTY1DVG3G*#3C)IJLEB*,,/B$J]"E)3A2J+GIPG&<*D
M9QA*\8RC4IPFI))J<(23YHIIFA_"OX8>&99Y_#?PX\!>'I[G4TUNYFT/P?X>
MTF6XUF*YN[R/5IY+#3HFEU-+R_OYUNF)E$E[<2!]TSEJ@W2AAZ5-^SIX12C0
MA'W8T8RI5*$E2BK*FI4:U6C)023I5:E-^Y.2942JRK3JKVD\1/VE64O>=6IS
MX>K[2HW=SG[7"86IS2O+GPV'G?FHTW%+KX4_"Z]U/2=:O?AMX!N]8T&6\FT/
M5KKP=X=N-3T6;4=6_M[4)=)OY=.:?3I;K72=1F:W>,RW?^DN6F^>BE)T)JI1
M;HU(T:.'4H/DDJ&&BH8>AS1LU1H0C&%&G?DI1BHPC%)()QC4BX5(J<'4KUG&
M237M<5"5/%56G=>TQ,)2A7G\5:$I1J.2;1 WP?\ A*]WXEOW^%WPZ:_\9PWU
MOXPO6\$^&FN_%=OJD<$6I0>);DZ9YFNPW<5K;).EZTZS+;Q"0,(U S5*G'#_
M %.-.,<)S\_L%%*ES\ZJ\_LTN3G]K&-3FY;\\5._,DS55:L<1'%*I*.*C[/E
MK*355>RIU*5*U2_.O94JU6G3L_<IU:D(VC.2>SX?\!>!?":Z>GA7P7X3\,II
M-I>:?I:>'_#FCZ,NF6&H-IS7]CIZZ=9PBSM+EM'T@S0P[$E.EV9=6^S1;.B5
M>M+VG-6G+VK3G><GSN-2O6BYW?O.-;$XFJKWM4Q%>:]ZK4<L(TZ=./)"$80Y
MU5Y8I)>UC25"-2R27/&A&-%3^)4DJ:?(DCK*R+*EU?V-B;5;V\M+,WMU'8V2
MW5Q#;F[O94DDBL[42NOGW3QPRLL4>YR(G(&%.!:RC36LY<SC%?$U"$JD[+=\
ME.,IRM\,(RD[)-@_=A*;]V%/DYI/2,>>I"E#F>T>>K4ITX7MS5)P@KRE%.W0
M!3U#4-/TBPO=5U6^L]+TO3+2XO\ 4=2U"YALK#3[&TB>XN[V]O+ETBM+2&".
M222:5U1$1F8@ D%TN5;.4HQBN\IR4817>4I-1BEJY-)7;1=*E4K5(4:-.56K
M4DHPA"+E.4F[1C&,4W*3>B23;>B+*.DB))$ZO&ZJ\;HP9'1@&1T920RE2""#
M@@\4Y1E"3A*+C*+:<6K--:--/5-/1I[&4)PG",Z<E*$DI1E%IQ<6KIQ:T::U
M36C6P^D44;/4]-OY=0@L-0L;V;2;W^S=4AL[NWN9=,U$6MK??8-0CAD9K.]^
MQ7ME<>1,$?RKN&3;LE0LTGR4ZJ3]G5Y^2?V9^SJSH5.26TO9UJ56C.S?+5IS
MIRM.$DES14YTKI5*7)SPO[T/:0C4I\T=X\].<*D+I<T)1DKQDF[U(84 % !0
M!RNO>.O!/A6VUF]\3^,?"OANS\.VFGW_ (@N]>\0Z1H]MH5CJT]Q:Z5>ZS/J
M%W"FF6EY<VEU%;S7+1),]M*D;,T; .*<W2C!<SKXA8.DHZNIBY1I3CA::7Q8
MB4*]&2H1O5<:U*2C:I!MJ+<W3BFZD:+Q#BE[RH1E.+K.*U5&,J=2+J6Y%*G-
M.5X2MLZ5J^DZY9)J.B:GIVL:<\UU;QW^E7MMJ%D\]A=36-[ EU:2R1--;WMM
M<6\J!LQRP21N Z, Y0G3Y.>+ASPA4A=-<U.K"-2E4C>UX5*<HSA)>[.$HRBW
M%IF<*E.HI.E.,U&4H-QDG:<&XRB[-VE&2<91>L6FFDT2MJ%A'?P:6][:)J=S
M:75_;:<US"M_<6-C+:6]Y>069<2RVEO/?V,<LR(4C>\@5R#*@913DJCBN94?
M9\[6O)[7VGLN>WP^T]C5]G>W/[*IRWY)6M^[RW]U2;4;Z7<4G)1[N*:;2U2:
M;T8EEJ6G:C]J_LZ_LK_[!>SZ;>_8KJ"Z^QZA:[1<V%UY$C?9[V'>GF02;73>
M-RC(J8M2A"K%\U.IS\DUK&7LZDZ,^62TER5J52E.S?+4IS@[2A)(>DYTWI4I
M<G/'[4/:4X5J?-'>//1JTZL+I<U.I":O&<6[M,"BFJ:9)J5QHL>HV+ZQ:65I
MJ5UI*7=NVI6VG7T]Y:V.H7%@LAGALKBYT^_BBG=!'(]C<(C%H7"M)N,IQ5X0
MG[.4EM&?*IJ#:T4^1J7*]>5J5K-,<HRA&G*47&-;VBIMJRFZ7L_:J#>DO9>V
MI>TY;\GM:?-;GC>]2$4=/U33-6BFGTK4;'4X+:]O],N)M/N[>]BM]1TJ[FT_
M4]/FDMI'6*]L[^WN+:>!B)(9H)(Y%5T90[-1ISM:%6$9PETG"7PS@]I0E]F2
MNGT8Y1E3G*E.+A4AR.4)*THJI3A6IWB[-<]*I3JPNO>ISA.-XRBW>I""@"G>
M:AI^G"W;4+ZSL%N[RVT^T:\N8;475_>2>59V-N9W437D\N$CA3<[MPJD\4+6
M<*4=:E3GY(+XI>SISK5.6*UE[.C3J59V3Y:=.<Y6C"32DU"$JDFHTX."E)Z1
MBZE2%&FFWHG.K4ITH7^*I4A"-Y2BG<H&5+Z_L=+M)K[4KVTTZQME#7%Y?7$-
MI:6ZLRQJTUQ<.D<2EV5068<L!U-"^*G!?%5G3I0CUG4JSC3I4X+>4ZE24:=.
M"O*<Y1C%.32$VHPJ3;Y8483J3D](PITH2J5*DWM&%.G&4YR=HPA&4I-139;H
M&% %*\U+3M.^R?VA?V5A]OO8--L?MEU!:_;-0N=_V:PM//D7[1>R^6^R"/<[
M[&VJ<'"33G"DG>I4Y^2"^*7LZ<ZU3ECO+V=&G4JSLGRTZ<YRM&,FA^["51^[
M3I\G-)Z1C[2I"C3YGM'GK5*=*%[<U2I"$;RG%.[3 * ,/Q'XF\-^#M&O?$7B
M[Q#H?A7P]IJ(^HZ[XCU:PT/1K!))$AC>]U34[B"VM4::2.-3+*H+.JCD@$6M
M2A1CK5Q-2%&C!?'5K5'RTZ5.*UG4G+W84XIRD](ILJ,)SYN2$I>SC*<N5-\L
M(+FE.5OAC%*\I.RBE=M(O7NJ:9INFW6LZCJ-C8:/864VI7NK7MW;VNFV>G6T
M#7-QJ%U?3R+!;V45LCRO/(ZQJBEV8*":<DX2Y)KEGSJGRO1\[DH1A9Z\[FU!
M1W<FHI7=A4(RQ3HQPL7B)5^54E27M'4<[<BIJ%W/FNN7EOS75KW+:.DB))$Z
MO&ZJ\;HP9'1@&1T920RE2""#@@\42C*$G"47&46TXM6::T::>J:>C3V(A.$X
M1G3DI0DE*,HM.+BU=.+6C36J:T:V'TBBI8ZA8:E ;K3;VTO[9;B\LVN+&YAN
MH%N].NYK"_M3+;NRBXM;ZVN+::,G=%+;R1N%=&4.S4:<K6C4A"I!])4ZD%4I
MU(O:4*D)1G"2O&4)*46TTPVE*.TJ;<9+K&2WC);Q:ZIV:,_3O$OAS5[@VFDZ
M_HFJ72QWDQMM.U6QO;@0Z=J4^BZA*8;:=W$=KK%K<V$S8Q%<VTL#E98V0*/O
M+FC[T53P]6ZU7LL73G5PE2ZT]GBJ5.=3#S^&M3A.=)RC%M2Y14N3F2GSUZ?+
M=7]IA94X8FG;?GP\ZM*%>/Q495*<:BBYQ3VZ"@H * "@"BVIZ;'J4&C/J%BF
MKW-E<ZE;:4UW;KJ5QIUE/:VUY?P6)D$TME!<WUC%+.B%(WO($9@TJ!G%.2JN
M"<E0]G[1K54_;>U]CSV^#VOL*WL^:W/[&KRW]G.RE*,'3C)J+K<_LTW9S]DH
M.IR)_%[-5*;GRWY%4AS6YHWO4AA0 4 % %"UU33+VXU*SLM1L+N[T6YBL]8M
M;6\MY[C2;R>RMM2@M=2@BD9["YDTZ]L[I(IU1F@NX90#'*C,FU"E[>3Y:'O_
M +QZ0_=-QJ>^_=_=R34]?<::E9HJ490E",HN,JD(U()IIRIRG4IQJ13UE"52
ME5IQDKQ<Z=2*?-"22Z9J>FZSI]EJVCZA8ZKI6HVT5YIVIZ9=P7VGW]G.@D@N
MK*]M9'ANK:2-E9)8G96!!!(-7.$Z4G"I"5.<;7C).+5U=:.S5TTUY.XI1<)U
M*<DXSHSG2G%JTH5*4Y4ZE.<7K&=.<90G!I2A.,HR2::+U2(* "@"E/J6G6MY
M8Z=<W]E;ZAJ?VG^S;&>Z@BO-0^Q1+->?8;:2027?D0LLDOE*WEJP9L YI)IS
ME3B[SC3=5Q7Q*E&=.E*HXK54XU*U*FYM<JG5IP;YIQ3'[D8RE[L935*+>B=1
MPJ58TTWHYNG1K5%!>\X4JDTN6$FKM, H * "@!DDD<,;RRND442-)))(RI''
M&BEG=W8@(BJ"220  2:F<X483JU9QI4Z47*<Y-1C",5>4I2=E&,4FVVTDE=Z
M%0A*<HTZ<7*<FHQC%-R<F[))+5MO1):MZ(KV%_8:K8V>IZ7>VFI:9J-K;WVG
MZC87,-Y8W]E=1)/:WEG=V[O%=6LT#I)'+&[(Z.K*2"#6M6E4H5*E&M3E1JT9
M.$X3BX3A*+M*,HR2<91::<6DTU9HRIU*=6$:M*I&I3FKQG"2E&2Z.,HMIKS3
ML27-S;65M/>7EQ!:6EI#+<W5U<RQV]M;6\"-+-///*RI##'$K.SNP554DD 5
MC4J4Z-.=6K4C2I4HN4YSDHPA&*NY2E)I1C%*[;:26YK"$ZDX4J4)3J3DHPA%
M-RE)NT8QBKMR;:225V]$+;7%O>6\%W:3PW5I=0Q7%K<VTJ3V]Q;SHLL,\$T3
M,DT,D;*ZNA*LK @D&MIPG2G.E4A*G4IR<90DG&491=I1E%V<91::::335F94
MZE.K3A5I3C4I5(J4)P:E&49).,HR5U*,DTTTVFFFM":H+"@ H * *>H:AI^D
M6%[JNJWUGI>EZ9:7%_J.I:A<PV5AI]C:1/<7=[>WERZ16EI#!')))-*ZHB(S
M,0 2"Z7*MG*48Q7>4Y*,(KO*4FHQ2U<FDKMHNE2J5JD*-&G*K5J2480A%RG*
M3=HQC&*;E)O1))MO1%E'21$DB=7C=5>-T8,CHP#(Z,I(92I!!!P0>*<HRA)P
ME%QE%M.+5FFM&FGJFGHT]C*$X3A&=.2E"24HRBTXN+5TXM:--:IK1K8?2*"@
M#!\0^*?#'A&SM]1\5^(]!\,:?=:C8:1:WWB'5]/T6SN-6U2X6TTS2[>YU*XA
MCFU&[NG2&"V1C)-(P2-68@403G6HX:FN;$8F3A1I1UJ59J+DXTX+WIR48RDX
MQ3:BF[63"7N4J]>7NT,+!U*U1Z0HTTU%U*DW[M."E**<I-13:5[M&CJ&I:=I
M%G+J&JW]EI=A;^6)[W4+J"RLX/-E2"+S;FYD2.+?-)'&NYAN:15&2P!5US4X
M7]^M4ITJ<>LZM6<:=*G!;RJ5*DHTZ<(WE.<HQBG)I _=C4F_=A1A4JSD](PI
M4H2J5:DWM&%.G&52I-VC"$92DU%-EVF!1NM3TVRN=.LKS4+&TO-7N);/2;2Z
MN[>WN=3N[>SN-0GM=.@ED5[VXBL+2[N7CA5V6&UEE("1LRN*<I2A!.4J=.56
M45JXTH3I4I59):QIQJ5J-.4W:*G5I0;4JD$U*4:<8RFU",IQI1;=DZDHSG&F
MF[)SE"G4E&"]YQIS:5HR:S_$GBGPQX-TJ37?%_B/0?"NB0SVEK+K'B35]/T/
M2HKF^N([2QMI-0U.X@@2>XNYHH8HS(&DDE1$!9@"HKGK8?#P]ZOBZD:-"E'6
MI6JSOR4J4%[U2I*SY803D[.R=AM<M.O5?NT<+2G6K3>D*-&E'FJ5:DOAITJ<
M4Y3J2:C"*O)I&\",#'3J,=,=L46MIM;H)--)Q:::NFMK=&FN@4#"@"BVIZ;'
MJ4&C/J%BFKW-E<ZE;:4UW;KJ5QIUE/:VUY?P6)D$TME!<WUC%+.B%(WO($9@
MTJ!G%.2JN"<E0]G[1K54_;>U]CSV^#VOL*WL^:W/[&KRW]G.RE*,'3C)J+K<
M_LTW9S]DH.IR)_%[-5*;GRWY%4AS6YHWO4AA0 4 % !0 4 ?/_[6/_)K'[2W
M_9 /C)_ZKKQ'0!] 4 % !0 4 % 'S_XC_P"3I_@W_P!D _:6_P#5B_LG4 ?0
M% !0 4 % !0 4 '3\/Z4G=)V5VME_P $#\\(_#_QHMM>^*6J>-M(\0:+H7C'
MQ+X3M/A[X9U7Q9J?B^SM_'EA\3+"]T77?#3ZA\9?&QL]*?3E&J$:9X=^'MO8
MVNEW"7&B*+)+EGE/-2HY-0JRY<=]?RO%.+DO:4,-&&.J\185UI*I5J0C@*3I
M*53'UZ6,HU81P^'P=6MBL,YS3VDZV:U<*XK#1RC.L*ZD;QHU:M3#X3"Y%-TK
M481Q-7$U)1E[/!0J4\9.U7&8]+#8D_0^@H\W^,6@:MXJ^$GQ0\+Z#:F^USQ%
M\/O&.AZ-9">VM3=ZIJOA[4+&PMA<WDT5O;F6ZGB3S9Y8XTW;G=5!(RJP=3V$
M4W%1Q.%G*47:4(4\32J5)Q?1PA&4E:[NO=3=D_4R3$T<%G&5XK$3]G0PV*H5
M:DK2ERPIU(RD^6*<I62;M%-O9)L^4_&_PO\ C5HG@_Q5X)\ P_$77=,U[Q/X
M,N]'UF]^+WC"_P#$?A&-_"KKXIU'2[Y/CQX!UZY\/Q>*+.R5]!3QII]G;QZE
M=3Z?IE_;VZ:9-6*GB*\IJE)49X3&YI/!5N6,N;#_ %? SP$,6YN2KQGB*V:1
MC7QV&S.K"5'#0Q.$G1E3Q%'R,LA#"4Z#K4N=2RO+H8FASV3QL,5CEBWATHSI
MT94\-3RR]'"3R_#UZ<JJIXNE6==5>Y^&'ASXP67Q+\,ZIXVTSXBWT,?PQ\,Z
M=XHU[7_'UC!X%L/$T'A728M9MO#'@WPG\4KNR\1:G<>(H[Q[J]U[P):W$,LU
MY+8^(KBR%G95Z=:>$>.XEEAHQH8&OBJLL"IQE.K.F\3"5*%*$E5IX?"PPZER
MS@\!B8RIQHUL+BUB:M;#\L(XNGE_"^&JM8C$X2C*.-J0;I^\EBH^VQ$VU5KX
MJ;="*H<V-P?L)0KJMA<9AJD<7R]S\._C!:_%_P ;:MX4T7QMH#:[\1;SQ)I_
MCB7XCZ<GPKG\(R?##PWX?ET[5?AI:^+9YM2\3S^*=*B-O=7?A*1X(K"24:G;
MQLMM?>1;%?V0L-AJJPV)H83/*<HUE[7VE;%X_.<3E;P;M5AA71K8K"XO$U$\
M.Y4N>C-XF4G1H=\HT/[0J8BK!UJ-6ODDH>Q_=RC#"PRRGF?UE\])UH5<'0Q>
M$H0?MTJTJ<X4J"BL5+Q.V^%O[9D?PUU.SN?$'CN?5W\;Z!<^(/#WV_48M<UO
M3;31-?AU[5O GB:']N9=4BTK4/$EWX;N_P"SD\>_"RV@M]"E%OX?1+N?3;OM
MQ$Z#A@/84Y1I4WCW"-E[?#>T6!^HPQ,)57&O&A[/'2<\3CL\E*IBE3JTJE*E
M0J4HPJJPJ8UUJM/V\J-&+J22GAJTHUJ\L1["/U?]S5J4G3A#V67Y;%1]G*->
MA451KW7_ (5C\<WN=#UZZ\4_$/4?$'AC0?V=H-->+QL_A31-8U&P\7ZC'\:Y
MO$OP_P!-\?ZIH.H7<G@N[C6Z34;K7(Y)(XWTN\NKVVBG7MA4P=+,*M;E@Z5;
M-<=&HGS5:/\ 9E3)<#1HU*,)4:"I*6:0Q->C&GAZ&(P\TVJ=*A5J*MSTHSJT
MZM*K&>'HK)\5.A%2<:M+-8XC,\1E^'G5C7Q%2K[.#P&%JU*N(K4<11;^M5:C
MCS4>Z^-O@#XD^*M;U36/!VJ^-[!_#_PWGN_!%KX:^(>I>$-)O?B?::]]LTR/
M7-'LO$-A9Z_:MIZ>3+;Z[!<Z7-#.\=PCLL?E>9EO[C-)8C$:X=X[AV-JG[VE
M]06+Q\<^M0ESP4G@ZM"\U36);5.6#E[>BI0VQW/5P*PV'?).6"SY3G!1A56+
MGALN>3\M5I2BXXJEB90<9<D+3AB&J%><*WFUG\-_C1KOBWQ/IOB&W^)ME;ZS
M+\5+'Q;XNN_C"X^''BOP7X@L]?M_AOHGPZ\&^'_&9U'P#XCT@7OAQ;O4[7PU
MX7N5.D7Y;5-6:Z667CQ&'5;(\SPL(-5ZV31HJE7E[6I6SV%3!MXRG5;JPIY=
M4A2Q\9X6=6A0J4\7AZ-;+JBA4J4NF-:I1S;)\5&472H8^C6E*C#V5.AE:P]>
M-?!XBE)WKX_ZS/#U*>*BL1-.C4K4<=A(.."ESOAGX#^/=:\%>$?"7B;0_BOX
M>\/^'(OV=7MM"U+XYZ\VL:=K'@KQ9XL;XDZA!XA\*?%:^NGLCIMUI=_:1#53
MBW31X[6W@NM&@M=,^GKXS#U,ZHYK&2?+FN<8JESP;J4L#B>%L/A\OH8N+C*&
M)JQS6-3#8Q3EBHXBK4QU6O5Q.#Q^)Q&*^<H8/'8/*WE<53JN.6Y1@ZTJ:I_5
MJV)PO$%.OC*^"IU(P>%IO+J:JX=PHX.I2IPI4J-.E7I4Z4*]W\.OVKI/B7X"
MOCXC\7VO@^R\0ZM.\MAJI\1+HEL?BUXPU>=_&%K)^T9X,LM7T35?AY=^%M/M
M$N_"_P 2YM.@@E6UT[2[NV47/D8*2A[+VW*JZRO 4YRG%>Q=:GD&%HXJA-VQ
M*6*EG$,55EBJ6 C.I.I3J?VE*C)^Q]C$1E'"8VE03DI8[,/91YG*O&G5QM1X
M#%4I-T9?5\-A94Y/"U<?"$^3V=7 5KM/T?X'^!/B?I7Q(LO$7C[0?B!!?6/@
MCQIH7BWQ5XN^)>F>,/#?B?Q;J?B;P9?6VK?#GPQ;>+M4D\%^$[O3M'NWBL8]
M*\-+$+58[G34F5;B\TP<Z-++<;2C%T/K$,E]G0K/V^+57"T\V6/E7Q45*-12
MK8FC.E^^E!PJ7HT,&E4P\=,R7M,TA4P_O86&*S.I!TW[.A#"5IT?[-H^P<*;
M>(H8>,J6(JJG%NHI.=?'J<*]+GAX"\?Z1\2O%6KWT/C[P!X,G\9?$GQ+XP^(
MT_Q?T_2OAF_PMU?PAJ=M%#IW@^R\;R/H?C>U\1_V7K"Z_<^&].ELK72YW.MA
M6%@WG83V>%R+$T<5B5ESI83,X<U5J<HXROGN,QF7XG#5&ZE+#T:6%KN6)A[2
M@J\JL*-7#8J3<\/V^]/,93PN%68XC$8K)Y8.G3I[2PV7Y1AL93QE/EC/&0Q*
MPN(P>'H<N)7M7&M&.&C%5<1Z)\*K+Q9\4OA'XQU;Q;J^J7,OQ T*Y\*Z VG>
M)=9TRPN-!T+1)_#%MXQ\/WVD7EO/I'_"5ZP-6\11:G82PW$EAJVD?O3]EC(V
MX@PM6OE&*P]/"_5<PS*E7S"6$J:/!8C&TJ4L-E4G4A3DJ.#H4L-#$X6O#V:Q
ME3,(5J?)5J4SDR>OAL-FM"O1Q,L7EN5SI8&EBN?VCQU#"8BO*IF,DHQI_6JK
MKSH?6*%XU8X/#XC#5G3E1<?%/"OP(^)-EI/A[6--T?XI^"?$7@[X1?!S0-!T
M^]^,US>7MYXP\(?$#QG>^+M/\276G?$G5K3Q?X7DT35$FM-.UV\OM.CT_6H;
M6WM;6ZLUM=-]G&XR%3-*^.PTU*CCLZP%65*K#G5/**M'#4,;]9ISC*G5Q]##
MNK"OBT\1C)XN@\1A<5B)5/;U^*AAIX?AC+LHJ.-3'97@^((\]!RI4IYA+ 97
M#*ZV#E%4)T,'7QN#G*EA5'#8>%."AC<)2HN,'Z7\ ?!GQ_T'XI_$75OBKKOB
M&[T"[&KI81W.^]\):[-<^(?M7AW4O#4UW^T#XI?07TOPZC6,]G8?#7X=6]R]
MZTLZ7TUK%,_FY>XTLBI8?%)2S"*P7.Y:5(UZ>'JQS"M&=L1*K0QF(E"<(SQT
M(48TJ?U?+\(JM:E3Z,:I3S:57#MQP?/BW#E_A_5IRI?5*%2'^SJ%>A!6=2.&
MKSE*-=5L;7YJ=6K0O/"7QK7Q9X-N+C2OBCKL%I\3OB7J=TUI\3;30O!FD^#M
M2^(FKW_AC4-8;2OBUI6J:S?6_A"6Q_LSP_J'ACQEHQCAATV]L]',DEY9Y4(I
M+]Y.I2G'(8T)5%&G4G''_5\9&:PM*I[3#5\75J3HQJUL;3HQI-8?%83,J<Z%
M?#XGMS/V-:L_JK@L.L1@)QI0C.E&JJ66Y1"JJ]2FZ&(P]"..HXR51X6K4]NI
M8UXC 8WV^$J1YWPIH7[0?A/0;748/!/Q>UVX:_\ B#I=QHWB3XNZ'?>--3E\
M3:%HL/AKQKXBMM>^./B7POX<T[2]6TR[1[+PIXA,<(OI+_2O#>GM=2Z;#EF2
MKU\'6PV%5/#5*^48S#4/8SJ<F#Q?MZ%?#U*E>K'Z[*K4A'$TJ5257,*M"]"E
M4QTJ52K4P[P[P\,9"K4<IT</F.7XFJZL8<V)PU.EF5+%X;#TJ$88:5-U,3@\
M0HU:&70J*E.G.G*6#PU3$U[+P!^U*OQ5\$:EJ7B#Q6GA2S\&^$K>>2PO_P"U
M=-LKJP\ V]EXOT+Q>9?VB=!L;K6=3\81WLT6MI\-/'5W$UQ!+#K-I&&2VZ<R
MM4Q'&4\&THXF6</+HP3H4ZM&O2E#*J6%<E6>#K82O*&)O"AE;:I>PJXJK3J2
M@>9ET*M/*N#*6*<HXO!T,JCF<IR]O56*HXUU,QJU^65*.*I8C <F$?M,3CX*
M7M:]'!1KPIU:_=>'OAK\0[SPEX4\'ZG>^,4\1^"?A#<:Q>>)O%OBC6M?U"]^
M.OC3PK>>'([RR\67.I7>_P#X1V/_ (2&1QIDQM+:7Q)8R6FQH*O.W"=3B.OD
MUH4XNK@,JC!NC.5&=98_$UFZD8U8^U7U'"X7$RFDH2S'!VC2HJG3WR6;P_\
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MKU\'A9TX_5\37<J]>E2FY_5<77S*IBJBI\SH^TP5#"5*.$I4I8RK25&A45/
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MKX.O"4:D(24J.)PU>C+W7";I^TI3J49TZDN>G6YZN*H2I3HUL'4IPJ1FH_\
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MIQK4Y*K0EAHXIU87]G"E+$5\,G*327*JN'E'VL>:@Y/V4:LJU.O2I=):^/\
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M4% !0 4 % !0!\__ +6/_)K'[2W_ &0#XR?^JZ\1T ?0% !0 4 % !0!\_\
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M8UL)A\-A935WAWA<QI9E1=6G2]AAZU)UZ%-5*5"A@Y2C*OR5J;J1=+T7XN?
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M[6PB_P"$AT;1(+]W,VFSWEJK7 XJ2>(P<<9A5]:A6K8*C0A2:;K_ -I5XX;
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MJ-TY9;F68-1H4H2K2G*& O35*-:M.:CAJ6$JU,1&IA^?\6?&+4;#X-Z5\5-
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M0<8U(QE4CB:M&^)H5L31]G4H+#TL3"MB,1E_TQ69T'S_ /M8_P#)K'[2W_9
M/C)_ZKKQ'0!] 4 % !0 4 % 'S_XC_Y.G^#?_9 /VEO_ %8O[)U 'T!0 4 %
M !0 4 % !0 4 % $<T,<\,MO,@>&:-X98V^Z\<BE'0X[%21^-9UJ-.O2JT*L
M%.C6A*G.+VE"<7&47:SLXMK0NG.=&I"K3DX5*4HRC);QE%IQ:\TTF>&V7[-G
MPAT[0;GPW8Z+XEMM/G7P]'#<1_$SXH?V_I$7A.YU2Y\,P>&_%3>,CK?A2WTP
MZSJ<%K#HVH6*0VMVUFBBT585Z*E6I5="56;J3P^(J8I3D^:I4Q%;#4\'7J8F
MH[U,4\1A:4*&)CBI5HXBFI*M&ISSYLX1A3E6E"G"*KT_8RI^SA[&--5_K48T
MJ#C[&C[/$I8BBZ-.#HUXQK4G"I&,E<3]GCX1Q:?9Z3#X;U"WTRS\*Z[X)%A;
M>,O'%M:7OACQ'?W6J:II>LP6_B1$U\?VC>WMQ;7&IB[N+&2\G:QEMC*^XI5)
M4*U.O2M"I1CE48>['DA_8<Z4\KE"FTZ<:F$]C3A&JH*I5I<]&O.K1JU83RE0
MIRHO#RYI4Y5LSKRO4J.<ZF<QJ1S-SJN7M)PQ?M'.I2G-THU8T:U.$*M"A.G<
M\3_ GX8^+;S4-3U;1M7MM7U/5AK=WKGAOQKXY\&>(/MW]@:3X7F6VU_P?XDT
MS4;#3KK0="TBTNM.M;F&SNUL(VNH)I,NV*C%>S]U2A25>+IR2E2JPQ-98BO2
MQ%*5Z>*H5*T8U'0Q,*M%22<8*R.MUJKI4J+E[F'IT*5+1*5&.&J8NK0E2FDI
MTJU*6.Q:CB(2C7Y,14I>T=-\BU8?A!\-[73)M&M/"UK9:3/)X'D;3;&[U*QL
MXS\-KG3[OP2EK;VE[&EG!ID^E:>5AMQ%',+<)<K,CNK;JO66(EBO:.6(EC*V
M/<Y>\WBZ^&I82K5?-=>]AZ%*GR6]G'DYH0C-RD\::]E[3DNG5P57+IMMRE/"
M5GC95:<I2;E*=2688R4Z[;Q$I5W)U>:--QX>^_9]\/3>+_#6KV-Q#8>$M$\=
MZK\5K_PG,GB+69]1^)%_'=B#5-,U/6?%MQIWA'PVM]?W>KW6A:-H-LEYJZ6^
MH-<Q.+J._6#J/"3ISUF\%@ZV"P+NU+#TL4TL5&K4ESU<535&%*A@J$YPHX&$
M9>SA/EPRPMXN3Q=.M&=G4Q<\-+$SE=\\,%"$,/[&$7"%&O*$98?%XEQJU,7@
MJE3"U$E.4Y=SX]^$O@7XER:5<>+-.U62\T1+^WT_4O#_ (M\7^"M633]5%NN
MK:-=:MX*U[2;S4?#U^+2S-WI%W//871LX#<6\AAC*8*G!3G)Q4E5C&%6G/WZ
M%>%.3G"&)P\^:AB80E*;A"O3J1C[2HHI*I-2I5JD:+H1FXQ4U4A*/NU:-51<
M56P]>-JV%K*+<?;8>I2J\KY>>VAO^&O!7A;P<VK-X8T>WT9=;GTRXU&"T>X6
MU>31?#^D^%M+6VLY)F@TZWMM T+2K1(+2."+;:!RAD=W?HK5ZU>,HUJDJG-4
MQ%:3D[R=7$U95J\Y3?O2=2I*4W=NS=HV6AC&$*=/"TJ<(TZ>!PU+!T(0BH1I
M8:C5KUJ=*,8I*T*F)K24FG+W^5R<8P4>1U+X)?#K4K+PS8_V=KVD+X.>^;P]
M>^%?'?CWP9K=E!JEXFH:GILWB'PCXFTW5-2T2\O8H)KC2[V\N+*9[6W,L#?9
MXO+RH?[-/#3HMQ^J4,)AH0;YJ4J& IQI8.G7H3YJ.*C0IQY8?6857[U5MMUJ
MKG4_WE+%TII..-KXG$U)62J1Q&+JU*V)K4*JM5PM2K4JS<I8:=%J+4(VIQC%
M>:7/[-PO_C?#\5+[Q)IT'ANRU:?Q);>!M&TKQK9G4O$ESX/O/!=QJWBB75/B
MCJ?A/4+B73=3O_,N](\"Z!J=P(["&[U*XAM'6Z,'&GAL-F&&K4UB88VCBL-"
MF_X%'#XW$+$8F$*<_:S@ZLTY3CAZV'PLZU;$8BKA9UITYTKK3DW1>&;PTDL)
M[>I=NM6E@:U&MAI<]/V,7*G+#8:G"IBJ>+Q%+#TOJ]'$4J4G%=KX=_9U^$/A
M662;2/#>I&:27PY()-7\:>.O$;P1>$'UQO"^GV9\1>);[[#H^EKXDUF*UTRW
M\JSAANE@2 06\$<-5I2Q%&-"NW7A&IBZLG4?/4JU<?E_]EXRK7K2O5Q%7$8"
MU"I5KSJ5-%44E62J+-1C%QY(QI*'LE3C3BJ<*4:.-P^8TJ=&G3484:5/&X6C
M7A2I1A34HS2AR5:T:D-C^S?\(=-\/W?ABRT3Q%#I=W_PBX5V^)'Q,FUG3(_!
M.IWFK^$8?#_B6?Q@^L>&;;1[V_NOL<.D7UE'!#(+6-1:QI"FOUFO[3"UI5'*
MM@\5/&0J3M.I/$U<+#!5ZN)G-.6,^L82G'#XJ&+=:&)I.<,1&HJM3GAT:/[]
M>QI\F(I>QE3Y(^QC3]M]9C&C1M[+#NEB4L10E0A3G0Q$8UZ,J=6$9*Q;_L[_
M  BM;CQ+/'X:OY$\5Z3XCT/4=.N_&/C>_P!$T_2_& 8>*[;PGX?OO$<NF> S
MK#.TE]+X:M-)ENI/WLSO( XQI/V%&G0II1A16'C!M*52%+"5(5<-AXU9)U8X
M3#SI4G1PBG]5IJE3C&DHTX)=%&K4PV*P^-HR=/$87$+%PDOA^MJ,H_6ZE-WI
M5L5)3J<^)K0J5JCK5W.<G7JN?<^+O 'A?QOX?@\,>(+746TRTN-/O+"71O$/
MB/PMK>EWNED&PO=(\3>%M6T[6=(O8EW1_:+*_@D:.66-V:.61751>UQ%+%5/
M>KT:DZL9;+FJ0G3JQE%6A4I5:=6I2K49QE1JTYRIU*<H-Q,L.HX7#O"THQ6'
M=*%%TYQC4CR4Y4YTM*BG[]*I2I5:53^)2K4Z=6G.-2$9+F+/X&_"VP\/S^%K
M7PP8]"N/"NH^"9[)M<\1RM)X8U;5KK7-0TUKR;5WN<S:I>W4YNA,+E?-V),L
M:JBW"<J56E6IVA4H/)W3:C%*#R"ZRFT;<EL(I-*/+:LO]X5:R,OJ]+DJ4VI2
MC5>;.;E.<Y2>>3A/-7*<I.;EBIPC)R<KTFOW#I7=Z$7[/?PBAUC6=:/A:XGF
MUT>(EO\ 3+[Q1XOU#PM$/%\4T7BS^R?!=_K\V@: =9:>:?4#I>F69O+F0W5P
M9+G][6<5[.BJ,7*,8TE1A/FE[:E1AB,-BJ5*CB+^WHT\/7PF'J82%*I".#=-
M+"JC&4U+>4I2JT:TG^\H3IU8](RJTL+5P4:E6FK4Z]1X2O5H3G7C4E5IRM5<
M^6-N@\/_  G\&>&X?#L-G'XHU(^$M:U#7_#MUXM^(/Q \=:EIFIZIHU[X>O&
MBU;QKXGU6]ELCH^H7MO'837$EI!Y[2001R@.-E7J1ESII3>&J8.4^6///#U<
M30QE2-2?+S59RQ&&H3]M4<JRC2C2C45*\'C.A2G=.-H?6*>*C3BW"E3K4:-6
MA3=&E%JG1A&E6JQ5&E"%%N;FZ;FE).\6_"?P)XXU*;5O$NE7]W>77A;5/!=^
M+3Q+XHT6RU3PSJ[F2[TO6-,T36K2SUA(Y7EDM9KVWGGL9+B>2REMWGD9\\._
MJF(EB:'NUI5,#6;:4X^VRW$K%X*JH3YH1JT*ZNJD8J<Z4IX>HYX>I4I2TKQ6
M(HT\/5O*E26+C%)N#Y,?AOJF+IN4'&4J=>BH*5.4G352E1KQC&O0HU(9GB'X
M(?#CQ-?W^K7VF:Y8:WJ6KQZY=:_X6\<^//!'B(:@FB:-X<<6OB'P9XFTO4;#
M3Y]%\/:+;7.GVMU#9W7]FPR7,$LH+DIR=&="=-\KPTJLHQWIR]M66(J1KTG>
MGB:4JZ514<1&K2C))PA$UG4G4H4\/-J5&C1HT*:<8WIPH3Q<Z3IRMS4ZL'C\
M8E7A*-?V>(J4G4=)\BV/&_PN\&?$.'0X?%5GK%S_ ,([<7%QI4^D^+O%_A>^
MC^V6,FFW]K>:CX6UW3KK5=,O+"5X;K3[Z:YM;I2/M$,A4$95*-*K4JU:E.,I
M5\/7PM2-E[.>'Q+IRK4I4E^ZE!SHTJD+PO2JTJ=6BX5*<))4ISH4Z=*G)I4*
MM&M3D_?JTJV'4XTJU.M/FK4ZT85*M-U83C.=.K5IU)2IU:D9<^OP$^%:>*=*
M\8IX>OTUO1)-*N-.1/%OC--!BO\ 1?#\GA33=8G\)+XA&A7WB"+PS*=+.K76
MG37TEHD4$MP\<,:IO.I.I/&5*C]I+'/%NKSI25L=&2QD*49)QH4\2YRG6I4%
M3IU*MJTHNK&,UC&"IX;"82#E##X"AA\-1A&<XVHX3$PQ>%A.2DI5OJ^(@JE&
M5:525-RJ1C)0JU8S=IWP'^%NE>'[GPK:^'[YM!N_"U]X(>POO%GC'5?)\(ZA
M?RZE+X=L;K5/$%Q<:;I4-Q*R6L%I-"ME D5K9B"UACA2HUJL:T,3SN6)A4RR
MM[6?OU)ULGJU:^7UJTY\TJ]6C5KU9SJ5G4GB7+_:I5E&*55XK$3KSJKF>(_M
M%32]V-LVA0IY@H0ARPIK$QP])M4XQ5.:E4HJG4J593;)\!/A5+XDU'Q5+X<O
M9-3U-M8GN+.3Q7XQ?PQ!J/B'3KG2-=U[2_!3>(#X>T3Q3?Z9>WMM<:[IVEVN
MI2QWURKW9^T2^9S*C36#Q>7\O^R8VE5P]2#;<EAZ]3VU;#T:C;JX;#U:R5:I
M0PTZ5*=6,:DH.<8M:QJU(5L-B(S<:N$EAIP:T4IX.,(82=>"M#%3PT*=.%"6
M)C6E2C3IQ@TJ<%&[KGP5^&_B*!H-2T.^5CH_@W0H;S2_%'BW0-5LM.^'VJWN
MM^#AIFLZ%KMG?Z5>Z;J>HWLR7UG<P7<HG:.>>6(!!UO$UWBOKOM/]J^NRS#G
MLK/%3H3PU24Z:2A.E6P]2I0KX647AJ]&I4I5:,X3DGC"%.G@,-E:IQE@,)1J
M4*-&<8U%"G5>#E*TIJ4G4C/+\'5HUG)UL/6P].O0G3K)S;?AS\,V\%:OX^\4
MZMJ>G:WXL^(?B"#5=8U+2="F\.Z?;Z7I-A%I/AS1;33KK7-8N#]EL8I)[FZF
MU"5KR_U&_NECMHIX[2VSIR5++\+@(1Y8T9U\16=_<JXS%S53%5:=/:A1E*,5
M2PZ<_90C>=6M6G5K5'42GBI8A+EC"E2P]&-Y2G&A1NH.O5E)O$8J47&G5Q/+
M2]I1H86E[*,</ \A\-?LKZ;9>._&OB;Q3KUCK'ACQ-H'C_PII?@#P]9^/_#^
MAZ3X?^)6IV-_XIBG'B#XK^)[>SO[E-,ME9_!]AX)LWGN;^\>P:XN8VM#!26#
MRYX)IU:S> 2JMOEI4LME*>$HT(S]I7C2I3E%4Z-7%5Z%&C2I4,-1H0]K[;IE
MB:M/,*&-P36$]ABH8]*T9SECH4JM/ZQ4LJ>%E*;Q%>K6DL&J^)JSA/%8BNZ:
MOZ[+\$?AM-XM;QO)HVI_V^\EE</L\7^,XM#DOM.\/7/A*SU63PE%X@70I-;3
MPU=RZ:=3;33>/;K%&\["WA\O.<5.EC:$_>I9@L2JT9-O3&1Y<5&DWKAXUU9U
M8X=THRFE4:]HE)8TY2HQP<*<I0A@*.'P]"*;M&CA,9''X:$U>U7V.+C[:FZW
MM)1<JD$_9U:L)QWWP+^%VH:,V@S^'+F/3SX6\%^#(C8^)?%>EZC9Z!\.M3N-
M:\$Q:9K.FZY!J.E:GI&K74UW;ZM9W4&H"78[W3&*/9TU<5B*V)J8R=62Q-7&
MO,)U(_NV\6Z;HRJ-0Y5R5*+E1JT+?5ZM*=2E4I3IU)QE.'_V3"8? T$HX3"4
M<7AZ5*24XJCCZ="EBH2]HI.:JPPU!7J.4J;IJ5)PDY2;8/@7\-+=?%MN-*UV
M?2_'%E>V/B3PY?>._'VH^$+A=3F^U:E>Z?X,O_$\VAZ!K5W>[[N?5=)T^ROI
MKF::YDN&GGDD?F:O06'NXPA5H5J3BW"KAIX6;J8;ZG6BU6P4,//EE0I82I1I
M473H^SA'V%'D/^7E.JTI3A2G0DI)3AB*=6"I5?KM.2<,=.K37LZM3&QKU*E-
MSA.<HSFI:WA?X3>!O!VB>)/#^BZ?JSV'B]Y)/%$^O>+O&'BW6M=EDT6T\.O/
MJ7B3Q7KVHZO<W!T6PL[3SFOMX2V0A@PW48J,<;@WE^(BI8-QJP=**5-<M=MU
MM:2A+FJR<ISG?GE4E.HY<\Y2=8><\)B,/BJ,Y1KX14XTIRDZGLXT:U;$4H15
M1RCR4JM>JZ<+<L(.-**5*%.$9++X5> =/8/9Z#Y++X@\.^* ?[4UF3&N^$_#
MVG>%?#]]B746'^BZ#I.GVOD_ZF7[/YLT<DSO(^U2O5JUZ6)J2YJU"KCJ\)62
MY:N90Q%+&RLDHOVT,57CRM.-/VEZ2IN,'')4X+"4,#RVPN&PN$P5.%W[N&P&
M-_M#"4N:_._98S]]SRDZD_X=2<Z7N%3Q)\'?A]XP\1?\)/XJTK5/$-ZNE7NC
MQ:7K'BWQA?\ @ZUM=1TV]T:_N;+P!<:\WABPUF?2-2U"RDU>WTB+4&M[Z>$W
M/ERNK8TU[&.*C3<HO%\G/-2E[:"ISH581P]=OVV%BJV&P]?DPLZ,77HTZ[3J
MQ4S9U)_N5S<L:#4HPC:,)N+G*/MX1M#$\KJ2LL1&JDN6/PP@HX\_P#^'-UX<
MTWPO=#Q]=6>BZO-KFB:Q=?&+XP7'C?0]0N+;[%<?V)\1IO';>*]'L);(O;/8
M6>LP6C0RRPM 8Y75M/:35;#XA/EKX6G.E&:23J4JE6->I3Q5DOKD)U84ZDH8
MOVT7*C1NOW%+DRY()5H\D73KU*=9TW&+I4JM*#ITYX:DTZ>$<(2G"/U6-&T*
ME6*]VK44G_\ "@OA9_PDM[XM?0]7FUJ_BU>*;[3XV\=W.D1/XAT9_#_B"[L/
M#=QXE?1]+U/5=+<I?7]G8075Y*D=S<S2W,23+A*C2EAL9@W3C]7Q]'$X>M!1
M2_V?&8JEC<1AZ4E:6'H3Q="&(5'#RI4Z=3VDJ48>VK<]J4E6R^OS/VV5UL/B
M*$[OF^L83"U<%AJ]=_\ ,76HX2M4P\:N+]M/V+C!R<:=-1T-8^"WPWURSNK*
M^T2^C2[L?!.GM=:7XH\6Z%JMM;_#F\N]0\%OIFM:'KMIJ&CWNF7=]=NEY8W-
MO<RB=EN)9D 4=;Q-=XF.+Y_]HCF%?,U*T;/&XG#4L%B)SA;DG2KX2E##5L+.
M,L)5HNI3G0E&K54^:GA</1HPP\*,70IX*EE\837M%'"4*TL10@O:<UJE#$2]
MO1Q'^\TJT:=6G5C.E3E"N/@=\.(;_1-4L-.\0:+J&@7]_J%I=^'/'WQ \,S7
MSZGXBU#Q9>V7B1O#_BBS_P"$OT-_$.JZG>#2-=_M'3XVOYTCMDCE9#E2G*A4
MISIV7L<-A\'&#2E1]AA,,L'AE*A).C.K0PR5*EB)TY8B"]Z-53;D:RIQE1J4
M'=PJ5\1B7+FE[55L7.-3%3A7O[>G[>=.G*M"G4C";ITN:+]G#EWO"7PT\)>"
M=0\1ZOH<&N3ZOXLF@EUS5O$OC'QCXUU2XAM)+Z:QTRTU#QGK^JW&D:#9RZGJ
M3VND:?):V%JU_<-;VT9G<M#2> AECUP<.?W/MU)5*=.C.I6K?QZ]:5*E2INO
M6J5*W)3A'GM"*6DVZF(^LR=ZJ344M*=-2FZDHTJ,;4:,93?-*-*$%+EBFFH1
M2P-,^!OPVT/4/#6IZ%I>NZ'/X4T6P\/:;:Z-X[\?:5H^H:-I-K+9Z58>+O#^
MG^)X=,\>Q6=M/-' ?$MIJSPB5_+92Q)JI.=3Z\Y<E3Z_&2K0JPC5H2E.A##2
MJ?5Y_NHU94*5*E.M2C3K3A2I1=7]W3<:KSEB:WUBK)_6'7J8AUH/V5;VE7%S
MQU1>UI<E14I8JK5K+#\WU>,JM51I*%6I&7D_PS_95TKP?J/B*\\6ZY9^*+'4
M?^$<M?#OAK0H/B%X?\->$M*\)>*X/&?A^RTNU\7_ !8\:7ME%9Z]9:<\6GZ/
MJ&BZ'##8K!;Z)#'-.)]</6GAZ--N<ZV8<^'J5<5.7/.<\-0Q>'I-.<95YODQ
MV)YYXS$XVLU*G&-6$:,$+$2=7&U<32_<4)T<TP_L5K>EG'LH8U3Y>3#QG4I4
M(1<\+A<+)SE5K.]24'3](E_9W^$MU)J\VJ:!K'B&YUW4)]1U*\\5>._B!XMO
MIFGT3Q/X=&G0WWB;Q1?7%CX=AT?QIXJ@MM#M9(=,M3KES+;6D4S"1<8WAA*>
M"@W&A2A5@N6355^V6'C4JU,0FJ]7$..$PT5BJM2>)C&A34*L5%(WIXO$T<1+
M%4JKIU9.BU9)0I^PQE',*2HTK>RH16,P]&M*-&%.,_9QIU%*DN0FL/@!\+]-
ML-.L+73/$K'2O%.D>-+'5;OXC?$G4?$T7B30]%C\-Z??R>+M0\6SZW=1?\([
M'_9<]G/J$EK=V4DMK=P3P3R1OM]8JJK2K*24Z*Q$5:,>6<<5R_6(UZ:7)B56
MG"%6:Q$:J>(IPQ'\>$:BXXP4,/5PBYEAZU"GAG#FE[M"AB:F,H0I2;YJ'L,1
M5G.C*BZ<Z,6J5.4:48P4,G[.WPADU+2-4_X1F^AFT862QV5IXP\;66AZL-,U
M2XUK2?\ A+O#=IXCCTGQQ_9VJW4]U9?\)%9:I]BDDS:^5@8QPO\ L7LEA[1C
M0CAXTHR2J0HRPN%HX+#UJ4*G/&EBJ>%PV'H_7*:CBI1H4N>M*5.+3K1C7]O[
M1>]B7BO;3C[E2I'&XBMBL51G4ARU)8:M7Q.(J2PKE]67MZT(THPJU(RZ"X^$
MG@QXK5=/@U;0;JQ\0>(_$MIJ6B:]J]GJ5OJGC+6_[=\8/%<R7<OEPZQ<O=0S
M(%'D07DJ6)M"(VB*?[JKA*L='@\/3PD(OX7A:6(PV*CAZD?^7E)U\)AYU%*\
MJL:;HU)3H5:U.IIB)O%JO]8]^5?EDY?!*%6EE=;)\/7IN'+R5L-@:TX49+W5
M54,1*,ZT%,TO%7PW\'^--4T;6?$.GWL^IZ!8^(-*TZZL-?\ $6A$Z3XILX;+
M7](U*+0=6LX];TB\BM;.1K+4DN[=;BPM+J.-+FUAEBSG1IU*>-HSCS4<PP[P
MN(IMRY*M%N32E"_*JE/GJ>QKQ2KT%5JJC4IJK44M(8BM25!4YN/U;%4<92:2
MO#$X?F5*I&5N9*TY1J4[^SK0;A6A4A[ISVM_ SX9>(#;/?Z)J<%S91^$8K'4
M=%\8>-/#6KV">!;?7+/PP+'6?#GB&QOK(VUEXDUZUE:"XC-[;ZK<6]\;F%]@
MZ*M6I6JU*U23E.OBL5C*G2-6OC:&'PV*]K35H5*5:AA,/">&G&6&_=*2I*;E
M)\=*A2P^'^JT4Z=!8*AERBI2NL)AL3]<P].,^;GC.CBK5J=>,EB(S46JONQ2
MU?"WPG\">"=6MM:\+Z7?Z1>VGA'2? R11>)O%,^ES>'-"FEFT:"^T*[UJ73=
M2U.R,]Q'#J]W:3:E'#<S0+=B&9XV?MJBCBH<UXXRM3KU$U%KVU*A#"QJ4TT_
M82G0I4:5;V'LUB(T,/[=5'0HN&M2,:M6-><4Z\)5Y>T2Y:DOK%>KB:D:LXVE
M5IK$5Z]:E2JN=+#U*]:5"%-U:G-#I7P?^'VB:E=:IINC7L-U=ZUXI\0^7-XE
M\4WNGV>J^-H?*\5SZ1I%]K4UAH<&I,9;B:UTZVM;<W5S<WBQ+=7,TTO+.C3G
MAOJ=2/-0^I5LMM)R<_J->M0KSPWM6_:^SC/#4%07/?#4J4:&'=*A>F]9U:D\
M33Q<I-XBE7PN)C+1+ZQ@L-6P>'K."M"52.&Q%6E.4HMUDXRK>TG2I2A@ZA^S
MU\*-1TJ#0IM%UVWT2&TT#3KC2-*^('Q$T/3-8TKPQHZ^']&T7Q/8Z+XKM8?%
MFA1Z.HMIM,UI+^TNU+-=PSNS,>Q8FLL?/,N?FQD\96S"4I*,J?UVNL(IXKV$
MDZ"K1^HX65":I)X:=+VF']E.=24^>C1IX:A3P^'3H0I8:EA(2A*4*L,-1GC*
ME.E"O%JM%*>/Q4I.-12J>TBJDI*E15/LO%/PX\%^,[FPN_$NBC49]+TS4=&L
M7&H:I8BWTW5M0T#5-0MA'IU] CB6^\+Z%)O=6=/L.R-E2:99<8MPJ^VB[556
MP=?FW_>X#$_6\).SNOW6(_>6MRU/AJJ</=-'_N-3+;)8*JIQE2225JF#Q>7R
M2DK3BG@\=BJ*Y9*WM>>-JD*<X)_PK;P3_:5WJSZ%%+?7^OZAXGO'GO-1GAN=
M;U7PK#X)U"ZFLYKQK=XIO"\$5BUJ8OLX"F41"=FE,.,7AGA)14L,\+B\$Z<D
MI1>%QV/CFF*I.]VU5QT8UW)MSA;V5.4:+=-RX1^L0Q>L<33Q&&Q4:D92C*.(
MPF#J8##5%RM).EA*DZ227+)OVDE*JHS7(>'_ -GSX3>&8WCTOP]J;C^T?#6H
MVSZSXT\<^)9M+_X0W6(]>\+:3H4_B/Q+?2^'O"^F:O&MQ;^'],>TTF,[E%EL
M=E;IAB*].=.JJC=>G*K-UIVG7JSK83$8"I4Q->:E5Q53ZIB\31A4Q,ZLZ:K3
MG3<*CYC.IAZ%2G*A*FHX=QY(T8?NJ%*'UC#XMQH4:?)2PZE7PF&G-4(4_:*A
M2ISYJ<(P77Q_#;P7#J']J1Z+MOQJ?B76//\ [1U8_P#$R\7V<-AXBN?*:^,?
M^EVEO#'Y>SRX=FZ!8F))X7A:#P\\*X?N)X3%X&4+R_W7'8U9CBJ7-?F7M<8E
M6YT_:0_ATYPI>X="G)5XXE.U:.*PN-4M-,3@L"\MPU2WP_NL$W1Y+>SG_$J0
ME5_>''Z;^SU\)-(U?3]:T_PWJ$%SI=GH]E9V1\8^-YO#X70/"TW@C2KRX\*W
M'B-]%O=8B\)3-I3:I<V$U[-;)%'-<2""+R^K$5)XO^T?K+]O_:LL5+$J:34G
MC5;%JFK6P\<1\56&'5*$II5''G2DHHKZM3P=*A*5*G@*-##T(QG)<E'#8U9A
MAX2=[U/8XQ.M2E5<Y0<JD(R5.K4A*LO[.'PA71[71!H.O"WL-*T+1=+U$_$+
MXCGQ/HNG^&-1U_5/#L>@^,3XM.O:#<:;/XGUR*UNM/U*VN(;2]^PQRK900V\
M3KU:N(FJM6I-UE459U8R<*TZJPT<'.I5JP<:E:5?#QY,4ZLIO&.4ZF*]M5J5
M)RNG+V6'6$IPIPP<?K')AU3I_5Z:Q-3"5:D*5#E]E2IQJ8#!U,/2IPC3PD\/
M3EA8T9)M[5O\#_A=::+_ ,(_#X8(TP^$?%O@>=)-;\13W=[X=\=WMMJ7C&+4
MM4GU=[W5-6U?4K6*[NM9N[B;4Y+AI9C>>;/*TE3KU).I\,54_L^\(0A3IQ65
M.N\OA2I4XQIT:>%^L5E"E2C"FXR49PE&$%%8>4\+B\'CJ4Y?7,!6JXBC6J2E
M5J*M7^K^TG.55S=9M87#Q2K>T4(4HP@HPO%]'XD^'OA;Q5!I\.K0:O"^D6&I
M:;I-_H/BGQ3X3UC2[75K.*PO_P"SM<\*ZUIVHV5S):011K=0W23Q;=T4B,Q8
M\]6*JUZN)FY*O6@Z4YPG.FY4Y8K#8R4&J<HKEEB,)AYS5K2C!TI7HU*M.<4H
M0H4,/A:<(JAA)QJ4H22FH3IX7$X*$KS4FY0P^+Q$(MM\LIJJK5J=*I#';X/?
M#Q_A_'\+WT6[;P9'=VVH&Q?Q'XH;59]4M?$,7BQ=8O/%3:R==OM:E\2PKJ5Q
MJ-SJ4MU=7+227,LK32;]:]2>(JX>M-\E3"*E&@Z*6'5"-"C["C&C&@J<:,:-
M'W*4::C&FDN5)Q36M"<\/+$R@^:6,AB*==U?W[K0Q5&>'KQJ>W]IS*=&<J5G
M\$+1ARJ,;8*_L]?"R*RT>TM=.\5Z?<Z'J-_JMMXATKXG?%#2?&]]>:JUDVJM
MXB\?Z9XR@\2^++>^.F:7]JMM;U;4(+@:79":-Q9P")PJSI5,/4I<M-8:$*<*
M481CAW"G6JXB*JX516&K_P"T5\17DZ]*HYUL1B:DW*>(K2J8*E!4L52:<EBY
M<]2<G*==3]E"@I4L1)O$8>4</3IX>F\/4I.GAZ5*A#EI4X0CTLGPE^'TFLZM
MXADT MK&N0^);?5;PZMK8-U#XOTKPOHGB)3 -2\F$W>F>#/#4.Z*.,Q?V;O@
M,4EQ<//A4A"K@:V6U%?!5Z-2A4I;7I5<7BL=4AS1M./-BL;BJMXR4E[7DBU3
MA3A#HHUJF'JJM2DXU8XG"8M2=I/ZQ@,)/ X6H^:Z;I86<Z7*[PJ7]I5C.HE-
M>/W'[,]L_P 7] ^(-CXAL="\)^'KG0-4A\%Z)8^.X+W6-=\-: OAW2=2\1WM
M]\5+OPGJ<\-A';0_VA'X"M=<:VT^SLY-:>VB=)NFA7JPQ&*Q>)F\17JU<;5H
MI*,*5&>84JU'%R4)JK*#J_6,15E#!SP6'J8BHJ]>A5J03?-7H4IX'!9?0BZ%
M'"4L%0;<I3G*CE^,AC,-2C*+IN5.G*E1A%8OZ[*$56]E*FZL?9>PZ]\*? _B
M3Q98^-M3T_54\1V-@FDRW6D>*_%WAVRUS2(I+J6#1O&&B>'M=LM,\<Z/!)?W
M[0V'B&SU2WA-_=&*)#<2[^94X*&*I2BIT,9&<:U&I^\H5/:47AISEAZG-1]L
MZ#5-5U35>,84N6HG2I.'1*I4E##PYY1>$JQK4*D&Z=:C.%2G6Y:>(I\M>%*=
M2E3E5H*HJ%;EM6IS3:?.>'_V?/A-X9C>+2_#VIR ZCX:U&W;6?&GCGQ+-I?_
M  ANKQZ]X6TG0I_$?B6^E\/>%],U>-;BW\/Z8]II,9W*++8[*W3'$5H2A4]H
MY5H2K2=6=IUZLZ^#Q& J5,37FI5<54>$Q>)HPJ8F=6=-5ISIRA4?.<U3#T:E
M-T'34</R\D:,/W5"E'ZQA\6XT*-/EI8=2KX3#3FJ$*?M%0I4Y\U.$8+1TWX)
M?#K1=<T7Q#HFG:_H>HZ%";>!-$\>>/M&TG4X!/>W$47BOP_IGB>#2_&Z6\NH
MWQMQXAL]4^S"Y=;?RUP!A0C'#4G0I17L'0I8?V4TJM)4Z&$HX&FU2JJ=.-98
M3#8>A+$QBL34A0I>TJRE3BUK5BJTG.HOWDJU:NZD?<JNI7Q=3'U8NK#EJ>QE
MBZU:M]6YOJ\76K1C2C"K4C+-@_9]^%UI97.F6FG>*;33)?$&E>*++3;3XF?$
MZVT[PUK.BW-W=6,W@BQ@\8K!X M"]_>)<6/AN/2K2\AN9+>[@G@8QTZ=J4<!
M!)2662G*@ZJ56:C/#_594*LZJG/$83ZLO8+!8B57"1I-PC02D[NO_M+Q[JMW
MS.#AB>1NDJC=>&)=9*DX*GB_K-.&(^NTU#%JO%5E652\B6/X!?#"+1?$7AI=
M+\1MX=\33:?<7&A2_$3XC3:1H-SI-]_:FE77@'3IO%C6_P ,;JRU(1W=O-X0
MCT-X9[>WEB99+>)HR/-"CAJ,9SC]3J*I1JJ<_K--JG[%16+YOK7LE1O05!UG
M1]C*='V?LZDXRT=2;Q&(Q+LZF+A6IUXN,?8UEB&Y5Y5L/;V%6I6FY5*E6=.5
M6=24JDINI)R?4^'?AKX.\*^%]3\':/IUZN@ZT^IRZQ%J?B#Q'K^I:I<:U +;
M5KO4-?U[5KS5;R^NXQF6YEO6F>1GE+^:[.TXF$,7AOJ=:G#ZJH5J:I4X1HPC
M"O6K8BK"$:*@H1E6Q%624;*"ER0Y81A&,8:4L'B7C*$Y1Q3JT:SJ3E*K)U,/
M1HT*,G[5SOR4</1@HOW6H)M-N3?.GX$_"[_A++;QH/#]ZFLVLNE78MH_%7C"
M+PQ=:IH5C!IFB^(-4\#QZ^OAS6/%-CI]K:6]OKE_I5SJ4,=E;+'=*+>+R])3
ME*6)E*3D\3];YN;WE3>.52.->&3NL'+%1JUHUY81475C6KQFVJU53RE1IRPV
M$PDH+V&!A0ITX[-T\).-7"TJ\U:>*I8:K"%6A2Q,JM.C6C&K3C&I%2750_#[
MP=!X"'PP318F\"KX:?P?_8$UU?W,3>')+!M,?3)+RXNGO)5:Q9HC,]PTW.[S
M-_S4L3*>,DYUIR]IS4Y*=.4J-2$Z3C*E.G4HN$Z52G*$)4ZE.49PG%3C)25S
MLIXJO1QD\?3GRXJIB*N+E/EBTZ]>M.O5FX-.G:=6I.3I\OL[2<%!0M$Q-*^#
MOP]T:V2UM='U"Z5==T'Q+)<:WXI\6>(]2N]=\,Z!8>%]&U+4=6\0ZY>WNIW$
M.A:996S_ &NXG6X\DRW*S32/([KS^LRI2K1A+V+QKA%4Z<()YA0KX;&7IPC&
M$E7HXFO"2E%J+J.<%&:C)<R5J5.@FXTJ-+#T()2:<*6$S"6:X:$))\T51QTG
M6A9IJ/+0O]7C&DM'P-\-?"GPW@U"S\))XAM-/OY8I%TG5?&WC7Q/HVCQVZR+
M!8>%M%\4^(=1L?!NCQ)(433-!M].LT1(D6 +#&$)SJ3H*A.I*IRN;]I5?M:\
MG.,(-U,14YL1524(\L:M62B^:45&52;D2C&5>>(Y5"<XJ+C32I4='*7-'#T^
M6A&<I2;J5(TU4J/6I*5E;S'PC^S%\-/#VAZCIFL6NI^*=1UC2M6T74]6U#Q)
MXS5+73=7UK^W;RW\'Z9<>*KJ#X<F;4(--NII?"YTJ2>\TFTO97-S;Q/%E3A[
M++L%ET92C3PE'*H.I&<X5YULIP]*CAJRQ$9+$4XTJM.=?#8>-9TL)*M4C12Y
MIRGI*I.6+Q.*GRR]OB<RKJC*G"5#DS+$8FI5IU<.XO#XF?U?$RP=7$5J4JM>
M@G3G:E-TEV6@_!+X>^%;..W\/:7J-M=6]SXDU&VU75_$_BWQ3JIUCQ9I-KHV
MNZMJ.I>)M?OKS6KZ[L[&T\V2_N9W9XFE#+-+)(^>.HO&8/$X2#AAE6P&-RZ#
MITH1A2P^.QG]H5XQHTU3A:6.MB-.62M[*$X46X"POL\-BX8MPE6G''83,)J5
M2;<\1@L%_9U"7-)R<5# -X:,$O9*-INFZD8R7&^#OV8/A?X9\!Q^"M2L-2\3
M27/AOPGX?UK7M3\3>-9-3E_X0^.VFTB?PK<WOBJ\O/AQ:VNLVYU:RL?#-]IT
M6GWLGVFU*7(\X^ECL2L7BJ]>C">$C4Q=3&0Y*L_K$*DO:Q@IXR/)B:WLJ-:I
MAX.I-J.'J5*$8QHU)TWS8"G4P5'#TYU(XF=##SPS4Z4/J\Z=90^L)X.7/ADL
M2Z5*6(_=MUY4J<JSG*G!KHH?V??A=!;:'9#3O%4MGH.L2^(5M+OXF_$Z]MO$
M.O2W.GW@UGQ_!>>,94^)NIQ76DZ;)!<^+EUN2W-E#Y#1A *YU/EG1FH4TL-2
M]E1ING3=&C'GK57.E0<71I5YUL16K5,3"G'$5*U25:I5E4?,6J453Q-).2^N
M2E*O/GG[:LI4889TJE?F]O+#_5J<,,L,ZGU=8:*PZI*C[A)'\!/AW;:3KN@V
M#_$/1]%\07%I<7.E:#\9_C+X?L-,%C-//#9^$[71/'MK'X&TEWN)1/IOAU=+
ML[E"L=Q!+'&BKERQ]CAL-->VHX2;E"-;]]S+V7L%1KRK<\L5AHTK0AA,2ZN%
M@E%PHQ<4UT.K-XFMB[\N(K\SG**4+SG5C7G648)1CB9U8^TJ8F$8XB<I5>>K
M+VM7GV]?^$7P_P#$GA3P[X*OM%N;'0?"!TT^$AX9\0>)?!FL^%GTFPDTJPD\
M-^*/"&L:9K6A2II4UQ9-)8ZA TMM<SV\I>&>1'UQ%2IBL54QM:K.6*J^U]I4
MC.4)5(UVG6IU/9N*J4JDHPE.C-2I2E"G)PO3@XQ0?U:C4P]-*5&K;GC5BJRE
M)3]I&HW651NM&I^\C7O[:-2]2,U-N1K^%_A]X/\ !:V2^&=&CTL:=HJ>'[;9
M=ZA<L-+74;K5W2X:\NYC>7LVJ7UY=SWUP9;NXFNI9)YY&<DDIR<ZT[1C[>&%
MIRC"$:=.-+ TZM'"4J5*"C3HTL/2K5*5*E1C"G&FXPY>6G34<84:=.-&"3?L
M)XNI&4I2G-U<=.C5QE6K4G*52M5Q%3#TJE6I6E.<IQE/FYJE1S[.H-3Y_P#V
ML?\ DUC]I;_L@'QD_P#5=>(Z /H"@ H * "@ H ^?_$?_)T_P;_[(!^TM_ZL
M7]DZ@#Z H * "@ H * "@ H * "@"O=+<M:W*V4L,%XT$RVD]S;O=V\-R8V$
M$L]K%<V[W,*2[6:)+B!G4%1(A.Y<,4ZT<-B'AY*->-.;IN4'42FHOE;@I0<T
MI6]U2C?:Z+I>S52G[6+E24H\\8R4).-US*,G&:BVKI2<))/5QE:S_-+PS\:O
MCB=!A\=?\+,^&OC34O!GPIUGQ!\1M*C\(:[9:9<77AGQPUCK?A(:#H_Q,>W\
M)?$BWM8KFUGUBZ2Z6W988I-#"NQ7KRM4L1BL+>,IX+-/]2J*FIIMSSJMFV%J
MXG"U7"5.G&C4Y%C*,:<UB\3@I4U4P2C"EA^7,I3PL\RI0E"6*RRIQHZ,(ITZ
M<(953R?$82GBZ?-4JUHU:<G4P4G4IU*&"Q\:G/C).=?&>U_#G]H;QWXR_:*\
M8?"C4?#>@:7X>\/2^)X$L9M2\"V?C.PT_0;J"VT?Q?-I_P#PN2\\5ZSH&O&6
M,PA_AEH5I;"[MY$UB_C96DSRQ2QF7XO%UERN@G\&JH5EBW0C@L1&E]84:M6A
M&IBXUJ];!2C&BZ7U.?MH58Z9C+ZIB\MHX?WZ6+AAI2<M.>%?+5C:E>C.HZ',
ML+B6LOJ4</3QO//VE:6(H/#UL/'E/'7[5GBOPU\6OB+X,\,VWACQ5HG@_P +
M:Y<S6;Z/;:=K7A7Q-HVDZ;J8'B&?3OBKJWB/6-$DLY[_ %'S#\./#EK)9VS?
M8-6U"6"7//@ZKQ.&KU:E6GAJ,L33ITL943CA\/1CG.!RC&U<33YG#EP7UWZU
M5EB,=EU3V5*G46&^J8F.,I;8Y/"5<#3I4*M>K.E4<\+&_ML94>59EFF%A@JC
MA%WQ'U*E@8JAALQIK%5JD)8B&)H/ SK^$_C+\3=9&H1>$OB3\)/'VJ>+OC9H
MW@72?'FE^'?%6J_"V#2&^!#^-9;[POX7M_B9-+L75]'V2Q6?BV[MIY);Q_/B
MGG=;3MG!T<)1J*C4I1IT,XQU6-9KVM6&!GAXTH4IJ,72HXB,N:DZE*I[&-7V
ME-8JE&$\3I3C2J4L3B)UH57A<KRN<%A[0A&MB^)<1EM7VZ<JOM:V'HU^2HTZ
M%2<L/1I5(X?DE2A8L/CM\3]7\*:)JOBNU\%B'QGHWP+\=^'+3PHOC?P_=:!8
M^+_BUX5\(ZSH>MZO;^,5N/$<JP:C'>0W%LND6L@EET[4-.O[196U#HIT:<,T
ME@7S.M@<5A.>?NNG.CF&7YMB:--4I1DG4PL\NG2J5:G/3Q*J0KPP^$J14(DZ
M%3"XC,L-4J0FJ&"XNI>[3L_K'#="%*5>,Y2DX4\;4Q"J4Z5.,<3@%3_=8ZM6
M<*]*=OCA\49=#N[CQ2/!%W8>)_!^I^+_  K!X6T_QKX5U+0$\+_%#PSX*O=.
MUW6K?Q[/<:XU]:^(;2\CGT[^P1 UM/;317D,N\\."_?X7)ZM73$U,3P/5JRB
MW"BZ?$KE4JTXT7SM?5)8::3K5,10Q5.M&GB,+[.G4CB.#,:_U:>:4Z$+4*&'
MXUHQ4Y7J^UX>A4C0J<\%3Y(XB$K3]E[.O0J4E7PV)ISJ06&PKS]HGXA:KJ#/
MIOQ>^"/A_2?#GQR\.>#?%NHV?@U?%OA#1_#>N6_BBTM-!U?XB6/QM?3KCQ#<
M:QIVEVLR36OA'5+"\N[**XTD07]HVIUEL)U_]5J]=>VI9S]=ISA2_=K$XBG@
M88FC0P,FJWM8RDJM/"8NA4Q-/&5*E#GP]&OAL7ED]<Q<\+3XEC"4,++*Z.'J
MT)5?WLJ-*.9T,+B,7C(*I0E1A&C557$X?$4</]7I8?'PHXJO'V6:89/B3^U)
M\2_ /PV7QC)>?#H^)-9\>?%+3O!WA+_A$F6'6_#'PQ\0^(-#N-(N/$?BWXZ^
M$;./Q;?0Z;8WH?3O[4O1']N&G>&=7^RRM \*HSQ/#>'JOG>98#+,PQO):G[&
MCF.&R^M*=%?[17G#".O7=5TL+BWRSH>VCAJ=*>(Q'50HQQ%3-E&JL/A\)FG]
MD8:I-1E-XGZQBZ47.FZE&E+VWL8PI*IBL'2<Z33Q'ML=0PM#0C^,_P 1[3XH
M^)-"USQ)X5\4C3OC#I<'A/X=:-I.N^%?&&C^#M5_9\\0^.M+FN[C2O'<@\8:
M1J&NV%UIEO+J^A7-I)J.FZM<1*98+"T\/5.^$RO%8B-/Z_CLOPO$3JRI)QA[
M; 8V4<+A:U!_6%3Q%3"NA7IRA[.M]5J4I4XRE.IB*^V'IT<93P]13C@,-C\J
MR#%)3<:C]IC,\R_ 8RM"NU3G&%!U*KJ1I.FE&=##UG[+ZQ'&L\._M,_$7Q)I
M=PGA_P 2?!?QCJ=_J?PHLTUCPOX>\5R:#\-=8^(?CJR\*:O\.?'M@WCR>XU7
MQMHEC=-=-B^\,W+-$1=Z)8(T9FZ%@_:8N&"HUE*E[?$TJ69**GA,QI4,GS?,
MGB,#3A4MRT:F6T(UE'%XJG*GC:457I5+\OC5,9['!PQM7#3H598?VM7+YRMB
ML#468Y1@HTL54E"$E[=9AB(TW+!T'"K@:LHK$14H1]D3XSZUI'P$\9_$/QEJ
M/AG1O$G@G6/'7A'4=>L?#UY<>#VUKPGXWU/P-8^(6\-ZMXXTV33=!NKNTM+R
MXMM1\8V5O813S&[UR*VMI+Y>''U*=+#Y7B,+>E_:E# U84ZTZ4N6IB(P=6A[
M:=3!T=9*I3H5JDJ*O*E>G.H_8S]BC@ZD,PQV!KSC6C@J?MW4IJ=+_9YY91S2
M$G34<54=2C0KQC4I4HU9UZE*4:$4ZD(Q\+T[]IOXTZ[\/M,\5:99?#73=1TG
MX>_&_P"('BF#5M O=4MO$%M\'?&>E:';6'AX^#OBUJVF^'#KVCW<TWVN+Q#X
MSM;*6:%X9=3AC(G])X:C3Q$9U.=82FN&E6HQYUB(U,ZJ9E0Q<%4K4:/*\)4P
M*E34\)'G:G0D[5(XFGR86G+&9CEV4X>M#VV;8C$4,/B7&$J$5]3RC%X6K*G1
MQ%;VM-_VG[.?)B8RJ4XQKJ-":EA7UTOQO\3^(OCCX2\&?\)=X(T"QM/BC'HL
MWPNM+?Q!%\4;WP^/AEXEUZU\::YJ2^(ELKGP1J5^T,=M:/X;2U:73XY%UB>[
MA-E%SY?156I6E5;KSH4\XC.-+E5/!SP>+K8*A1QD92FY5\31I1S##ZX>K"E5
MINGA\10Y\7'G>(<\%B)J,<,I87)*])U$Y5,4L9B\FK8BK@I_NN2EA98FMEN)
M<(XE3G"O"K4P\IJA+6\0_M#^/-,_:=T[X+VGAOP_!X<FETN%/[8U+P-I?B'Q
M+I]_X?.LZGXJ\+OKWQET?7]0L=%N!+:7&GZ)\.O%"3&QN2VJV4B/%#Y^$JU*
M]'.:LHI?V;2QLN5:RPZPV&57#XBO"DZ]6I0QM=PPL/:4\OITG4]LL37C3G3?
M3F<?J5'*JE!^TEC?JTIWTA*5;,*N#JX:$ZCH4J=;"X:FL>^2KBZU6,Z>'^IT
M76HUY^5:W\3_ (\?$+X9Z7IMSXJ\!^%+_P")7A[X)>*](UOPAX9^(.CWWA[1
MO'/Q-\/^#/$7ARZO-,^+MCJMQ=21ZK;7$>LZ/J^@7$=O+>6<217 @U1/2I82
M,LVIX"K)MY7BL)5Q+3E&GB:.*RS-L=2HP491G2E0KY5.-2525>CBH5*?/AX0
M56A4[,1"&"Q^<4::YZ-.CQ=1PRJ1C.I1GP_.E15><VE3JSQ%'$\U*,:%)8/$
MTHUG+%0_<&S-^T]XZT63QO86NH_#+6=4\':+\7X9OAG%I_BV7XB_#M/A;H/B
M.\\,^-OB9J.H>-+FXU'PQXLET'3'@272M%=D\461M=8U5@]Q)A3E+&TIXFDZ
M<Y8K#8/&1J02AAL)BL9C\OPL\EQ"I0<?KE&.-Q+YH?591>6XGDRUT??I8X3!
MJGG'#^35?:QI8K,<+EL^>3>(QF%G0JU)YQ@YSG6Y<)&=&G1_>RQOO8JE]9QM
M+%WP<^YU?XZ?$#PUXD?PWKWB3X30>(M'^'LWC&P\!MX<U[3O%WQTU2XT/7]<
MCT#X0C4OB(@L5T<Z=86-[,EEXON+F6269[/28Y8$:,5.-"GGU3#4:F+J9/4G
MAHX>+@J\51PV"J2S:NKOEP%:MB,1&G0<:<*2PE6E+-*LXSG#DRKFQLL@I8RK
M3P-+.%A*TL;)2^JT8XO'5,/]07-93QF'H0HU*E=UX>T>+P\XX"$&H3X7X=_M
M+?&3XD>%="DTF/X7:?KGB/XKQ> ;+Q'/;>&O%.A:?;R?#KQ;XRO[+4_"7PK_
M &C?%TMIK^CW^@6-K+'J/BK2+BZBO"S:7IK,/+VK471H4JZDIPAA<SQ;E&[A
MC*&7_572KX:I&,\/2ABIUJ^&<:=?,8T)8?ZQ[:M&I'#E827M5G4JU&='ZAA\
MKJ0IW4*F'KX_-J&7UL-B(5%'$57AJ-58A3J87+G5J5%0]E3="K.5/5_VIOC)
MX=^'<7C75-#\ 7S^*O 7@/Q]H#:+I<UI8_#_ $KQ+K9T/6[CQK=>-_BCX=TC
MQ)I^G*]MJ'VZ;Q#X$M46>2UN)T%NM[=8XMQPV,J9??DJ8;%8.-7$2=/V*H8_
M 9IC,/14*E6@HUXULK>!]LZ[^LSQ5&K0P<:R6!J[5J%3"5\52FUB)89YQAU2
MIPJ*=2ODN8Y9E]?$1E".(FJ-:.83QOU;ZO)X6CA)TZN-J0G/%4.@/[1'QEO?
M!.B^,K&S^&6GPZ7\*;_XJ^*[2XM8O%L?BO2])\6W>BI;^$-=^'WQ;U?0?#BZ
MSH-M'J4%PNL>,XM/EN5M9'U#8\R]D</#^VOJ,U.&&=?A7"NE[\:]&OQ'/%4*
MW-6K4**K0R^M2A*%L'1CC:<9\M2A&K3JT_-J8F<,OJ5::C4Q*H\2UJ56\50E
M'(J>!K4E*E3J5I0E7^LU</7C]8YJ%2*J6E[)T*WIGPY^)GCUO"_[0&H>(O$/
MA;XD^*OAGXK\?1Z-X'\)^&I?#'B/2M.TF+4-4\)^'=>ME\3ZW/=7&KZ8FGR:
M?=&QLI9K>=9,7ID$M>2ZTZ7#N Q[2J8I_6J6(Q%IK#JMA\9/#U8SI4X5)TY8
M:*^L5J<)2J+"U</%TW4B\3BO5PM*EB^(WESKPP>!KK*)TH2UJT:&/P>'JRQ$
MJDIQ52DZDZM'GY(P>+PN-<)PIN.#P7ANK_%_XD_%CP!XS\.^%?BA\,K]O[=^
M!MF/B=\*]&\=6>CZ,/B/\1(/#7B7X8WLVB?%JWU6S\;Z)9K8S7NH:;XGT6_^
MRZZL9TW1+J6"Y3V*> A4K93)U'.A',<72E43M1S3#X/+JF.IXO!NE5_=X>5>
M/L)Q]KF&%G.DXNMB(NOAH9X.JO9XN<X1AB)Y1FF)>#FKXG*JV&PSG&&+4X)3
MJUH.LL*YT,)4HXC#2KSP]:E",*O:?M,^.?B-X O['0-'^)?A[PEX5U3]GKXX
M3QVFH:+J7_"4^(?B!X/\/Z/<Z,OA/QU<>.(+[3_%"6%W?:E:Q+'JEPL&BZQ/
M<)?2/#=Z+RTI?6L5G&D)58U<HK8/#Q2IU(4ZV/KT\95DJ2C"KA*/^RT\9"&&
MIPC"OAX0EA5*2K^ID>%HTY<+1J1C4?\ ;>!P6+J5N:M2JT:M/]W2E3K3G*+K
M3HU:<95JU:I5JU*2<Y^SJ4\3SOQ#_:/^,?PG\):M;ZS%X!UC6M+\7^#=(;QU
M:Z)::'X2\-^%_%?@F[\36EYXLT[XE?';PIIDVI1ZKIS:)]ONOB#H$%U-JMG<
M0VHN&73)XKUJ<L3.G&*H/#XS-,)6<I4J=+$5\%#+<12IX93G!X7ZS0S16I+^
MTJU)X*O*%*O2DY4/"RN$IX2E*;J8KGRK+<=3IQ51UZ4,77S#"59UZD:=?ZS'
M#/+O;U:SI8*$UB%"<Z'L_:U/8/B#\:_%7A?X#^!_B5/J'PR^'OB#Q-'X6?6)
M?&VM^'-?\/:8VLZ7-?W=MX7BL_B;X=TKQ[JDLD*+9V-AXVMQ/;R37-I<:A);
M1VE_>91IX+-J>!A*I*G*M.G[)4:M3&2<(INA3PSC1Q-2I3DY1JNCA:U?W/W6
M JRJ*,=LN=/%8'&XN;]K##49U*56$Z5'#2@L3"C3Q->OSXFAA*-6E)58JKB'
M1C6G2PU;&T8REBH>+S_M<_$V#XE>-?#%CX&T;6M+\*^#-=\0V?AZ0^&?#7CK
M6;32?!,?B;3?&=GX>OOC#>^.KG0-4UB2'2?[)M_A7*+0SO+_ &_=R6DMNSHT
MXSHYI.O4A@7A,74PWM)36(HY?R9W#*XO'2PT9J=+ZG*>:RQ56>5P]A3C"E0J
MT\11Q3QI3=2ID\*?-6ACJ.$JZ4_J]3&?6,NEC:BP<,94P\*5:G67U2.&=;&?
MO*=55J]"=.I3I]5J/[4W_")>%]+\2:M\5?@7X\T/6O OQ;U32_&_@JROM)\)
MW_Q&\(Q^$[OPC\-M.C;XE>(WU'Q%/9:EXB:YTR.^74;W^R]UM:V1MIXWSQ*=
M'#8RG2BY9A3H8.K@DVN3,(SQ684,=BJ%.+?^S854<'&I*GB*U/#N5:K6Q$J4
MDJ/=EU*EBJE"6)J+"T99QA<#BZ+DH5<MHXG".K&CBIU5!K%NLE&$ZN'PRDJU
M&C]456<'4Z"W^*?Q*\0ZC=RW$G@^RT>S^,7@3P!X?MK'3_&5OJ:3ZQX!\/\
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M+B<TX;C&_-[6EA<PR7&XBK5G5E/FK8:==.$N:')/&X'%3C*,53PF"]<_9?\
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M_P G3_!O_L@'[2W_ *L7]DZ@#Z H * "@ H * "@ H * "@!"0 22  ,DG@
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MXSA*,HMQ:872E4CM*E.I2FNL*E*<J56G);QG2J0E3J0=I0G&4))2BTKM !0
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M[I0DTIW5*A7:479Z4<3AJSTTI8BA4^"K3<MN@HY_7/%GA;PO)H\/B7Q+X?\
M#LWB'5(=#\/Q:YK.G:1)KFM7$<DL&CZ/'?W,3:GJDD44KI:6PDE98G*H0IPD
MTZGLHM.K[.M6Y$_?]CAX.I7J\JU]G0IIU*T[<M*"<IN,5<))PI3K27+1IRI0
ME4>D(SKU(T:,92?NQE6JSA2I1;3J5)1A!.32=3PGX\\#^/+:ZO? WC/PIXSL
M["X:SO;OPGXBTCQ%;6=W')-"]K=3Z/>7"6]PLMO.ACD96#02*1E"!?)-4Z=7
ME:I5$G"=GR24J=*M%QEM)2HUJ-56;O3JTIKW:D&U)J%:IAY-1KT+>TI/2I3O
M*<%SP?O1O.G4@KI>]3G'>$DMVSU/3;^74(+#4+&]FTF]_LW5(;.[M[F73-1%
MK:WWV#4(X9&:SO?L5[97'D3!'\J[ADV[)4+))\E.JD_9U>?DG]F?LZLZ%3DE
MM+V=:E5HSLWRU:<Z<K3A)(YHJ<Z5TJE+DYX7]Z'M(1J4^:.\>>G.%2%TN:$H
MR5XR3=.7Q)X=@M==OIM>T6&R\+-<IXFO)=4L8[7PX]G80:K=KKMPTXCTAH-+
MNK:\D%TT12WN(IFQ'(K%6]RE4_Y=UVXTI?9J2C6GAI1IO:;CB*<\.U&[5:$Z
M3]^+BKIPG6K_ %6C%U<3>G'V,$Y5>:K",Z4?9QO.]2$X3IJUYPG&4;J2;UT=
M)$22)U>-U5XW1@R.C ,CHRDAE*D$$'!!XIRC*$G"47&46TXM6::T::>J:>C3
MV,X3A.$9TY*4))2C*+3BXM73BUHTUJFM&MBI?ZGINDQ0S:IJ%CID-Q>V.FV\
MM_=V]E%/J.IW45CIMA#)<2(LM[=7L\-O! I+RRS)'&K.X!(IRG"E!.52IS\D
M%K*7LJ52O4Y8K67LZ-*K6G9/DI4ZE25H0DTY2C3A.I-J%.GR\TI.T8\\XTH<
MTG91YJDX4XW:O.<8*\I).]2&>6ZW\/OAUKGQ"T/Q!KUSJ=_XPTRU36=!\-WW
MQ#\8OX>B70;B*!/$]G\*V\3#PU-J.GWFJVJ?VY_83W4$UY:_Z2LAAP\,GAZF
M)KX=-U(KEJ5'^]EAUC*53#I4Y3YWA%BJ-#$4DJ+H^VA'%Q]Y3Q/-&)5.O##X
M?$65.3O3IW]G&N\+5AB/WD8.*Q7U>M.A6M6554IK"SM%T\.X>I4BREJ&I:=I
M%G+J&JW]EI=A;^6)[W4+J"RLX/-E2"+S;FYD2.+?-)'&NYAN:15&2P!5US4X
M7]^M4ITJ<>LZM6<:=*G!;RJ5*DHTZ<(WE.<HQBG)I _=C4F_=A1A4JSD](PI
M4H2J5:DWM&%.G&52I-VC"$92DU%-B-J>FQZE!HSZA8IJ]S97.I6VE-=VZZE<
M:=93VMM>7\%B9!-+907-]8Q2SHA2-[R!&8-*@:HIR55P3DJ'L_:-:JG[;VOL
M>>WP>U]A6]GS6Y_8U>6_LYV4I1@Z<9-1=;G]FF[.?LE!U.1/XO9JI3<^6_(J
MD.:W-&]N22.&-Y972**)&DDDD94CCC12SN[L0$15!))(  )-1.<*,)U:LXTJ
M=*+E.<FHQA&*O*4I.RC&*3;;:22N]"X0E.4:=.+E.348QBFY.3=DDEJVWHDM
M6]$5["_L-5L;/4]+O;34M,U&UM[[3]1L+F&\L;^RNHDGM;RSN[=WBNK6:!TD
MCEC=D='5E)!!K6K2J4*E2C6IRHU:,G"<)Q<)PE%VE&49).,HM-.+2::LT94Z
ME.K"-6E4C4IS5XSA)2C)='&46TUYIV*+>(_#R:BFCMKNC+JTE]_9<6EMJEBN
MHOJ8TIM=.G)9&?SFOAH:-J/V<(9/LBFXV^2"]3!.IS>S3GR1G.7+KRPI3HTJ
MDW:]HTZF(H4YR>D)UJ,)-2J04JJ-4?9^U?LO:\G)S>[S^T==4^2]N;G>&Q*A
M:_,\/74;^RJ<NM))'#&\LKI%%$C2222,J1QQHI9W=V("(J@DDD  $FHG.%&$
MZM6<:5.E%RG.348PC%7E*4G91C%)MMM))7>A<(2G*-.G%RG)J,8Q3<G)NR22
MU;;T26K>B*]A?V&JV-GJ>EWMIJ6F:C:V]]I^HV%S#>6-_97423VMY9W=N[Q7
M5K- Z21RQNR.CJRD@@UK5I5*%2I1K4Y4:M&3A.$XN$X2B[2C*,DG&46FG%I-
M-6:,J=2G5A&K2J1J4YJ\9PDI1DNCC*+::\T[%NH+"@ _3],?C2:NG'5)JVC:
M?;1JS3\TTUT#;Y')>$/ WAOP):ZG:>'+6^A_MK6;OQ!K-[JVNZ]XFUC5=8O8
M[>WEO-2UWQ/J>H:E>M'9VEE9P1S73QVMI8VMI;)%;6T44>G/+V&%PU[4,#2]
ME1C9+E@YSJ2<FES5*E2K4J5:U:HYUJ]6<ZM:I.I*4FYMU*];$S=ZU=IR>T4H
MJT:=*"M"C1@K^SH48TZ-/FDX0BY2OUM0(* "@"C:ZIIE[<ZE96.HV-W>:-<Q
M66KVEK=V]Q<Z5>3V5MJ4%IJ4$,C/8W,FG7MG=)%,J.T-W#* 4E1F:3Y(U$OW
M<G.,9?9;IRY)I2V;A).,TG>,E9V8Y1E3<(SBX.<%5BFK.5)SJ4XU(IVO!U*5
M6FIKW7.E4BGS0DE>I".9DUCP;]GO/%\NJ>&?LOAZ/6]*O_%$E]I7V?0X;"^2
M'Q)IMYK32[--CMM2TF-+ZWDFC$<^F*LZK);@)4%)>RC337]H/#1IJ-_]IE.<
MJ>#4$OXSE4Q$Z>&4>9N=>4:5Y5&I.I%TW-58\CPD)59J:LZ-.5"&(E4DI6]G
M"6&]G7E-VBZ')5;]GRR.F!&!CIU&.F.V*FUM-K="4TTG%IIJZ:VMT::Z&#H?
MBKPOXFDUB+PUXDT'Q#)X=U:?0/$$>AZQI^K2:%KMK%#/<Z+K"6%Q*=,U:&&X
MMY)+.Y$4R+/&S( ZDN,7*A0Q,4Y8;$J4J-5*].K&G.5*;I37NS4*D)TY.#:C
M.,H.THM*IITZLZ$UR5J<82E3EI.,:BYJ<I0=I1C.*;@VDI)7C=&]2$% !0!1
M35-,DU*XT6/4;%]8M+*TU*ZTE+NW;4K;3KZ>\M;'4+BP60SPV5Q<Z??Q13N@
MCD>QN$1BT+A6DW&4XJ\(3]G*2VC/E4U!M:*?(U+E>O*U*UFF.490C3E*+C&M
M[14VU93=+V?M5!O27LO;4O:<M^3VM/FMSQO>I""@"J]C92WEMJ$MG:R:A9P7
M5M9WSV\+WEK;7S6SWMO;7+(9((+A[*S:6-&59#:0EP3$NT7N\UO=<DHRMI=)
MW2?=)ZI/1/5:C;;BH-WA&:J*/13C&<(SMLIQA4J04MU&I.*=I23M4""@ H *
M "@ H * "@"CIVIZ;J]M]LTG4+'5+,7%Y9_:M.N[>]MA=Z=>3Z?J%KY]M(Z?
M:+6_M;FVFCW;HIK>6)PKQLH=FHTY6:C6ITZM-])TJL(U:56#VE3JTYQJ4YQO
M&<)1G%N+3:4HN52*:<J,YTII/6%2G)PJ4Y+>,X23C.#M*,DXM)JQ>I#"@"BV
MIZ;'J4&C/J%BFKW-E<ZE;:4UW;KJ5QIUE/:VUY?P6)D$TME!<WUC%+.B%(WO
M($9@TJ!G%.2JN"<E0]G[1K54_;>U]CSV^#VOL*WL^:W/[&KRW]G.RE*,'3C)
MJ+K<_LTW9S]DH.IR)_%[-5*;GRWY%4AS6YHWO4AA0 R22.&-Y972**)&DDDD
M94CCC12SN[L0$15!))(  )-3.<*,)U:LXTJ=*+E.<FHQA&*O*4I.RC&*3;;:
M22N]"H0E.4:=.+E.348QBFY.3=DDEJVWHDM6]$5["_L-5L;/4]+O;34M,U&U
MM[[3]1L+F&\L;^RNHDGM;RSN[=WBNK6:!TDCEC=D='5E)!!K6K2J4*E2C6IR
MHU:,G"<)Q<)PE%VE&49).,HM-.+2::LT94ZE.K"-6E4C4IS5XSA)2C)='&46
MTUYIV+=06% 'S_\ M8_\FL?M+?\ 9 /C)_ZKKQ'0!] 4 % !0 4 % 'S_P"(
M_P#DZ?X-_P#9 /VEO_5B_LG4 ?0% !0 4 % !0 4 % !0 4 ,D!:.10,ED8
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M%X"5>V+P4(P6(IX)/"3</J-6G1C=?4I2J8;%RPU3&2C5C+$JA7Y:^(=7FJO
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MD+KPCI6D:++\2O ]QX@OO%WASQ!JGBGXL2^(O%VAZ)+_ ,(]XCT3Q_=V]_\
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M/UNZH_6%BG2S-T>;Z[%+%X7ECAO9/V'FGB#X:_'GQ]X'T_0?&G@WXHRGX?\
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M -K'_DUC]I;_ +(!\9/_ %77B.@#Z H * "@ H * /G_ ,1_\G3_  ;_ .R
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M)*%=87#5,74IX>?P5:LJ5-\D(RU<HW<8OF7J-04% !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?/_P"UC_R:Q^TM_P!D
M ^,G_JNO$= 'T!0 4 % !0 4 ?/_ (C_ .3I_@W_ -D _:6_]6+^R=0!] 4
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M_:Q_Y-8_:6_[(!\9/_5=>(Z /H"@ H * "@ H ^?_$?_ "=/\&_^R ?M+?\
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M!]U>:!XVEO;OP3J_B#X0^&/%J:9X?TZ?X=:7)XXT"37KC4/-U74K[1[R(ZM
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MQTZ#<O84N,)U.>T/9RR*MCJ=)82RJ*T52P_L?K/MW'VG^T_6OJTO[0Z'PO\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H ^?_P!K'_DUC]I;_L@'QD_]5UXCH ^@* "@
M H * "@#Y_\ $?\ R=/\&_\ L@'[2W_JQ?V3J /H"@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M#_PH_P!EC_Z):@ _X7)\1?\ HT[]H#_PH_V6/_HEJ #_ (7)\1?^C3OV@/\
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M^B6H /\ A<GQ%_Z-._: _P#"C_98_P#HEJ #_A<GQ%_Z-._: _\ "C_98_\
MHEJ #_A<GQ%_Z-._: _\*/\ 98_^B6H /^%R?$7_ *-._: _\*/]EC_Z):@
M_P"%R?$7_HT[]H#_ ,*/]EC_ .B6H /^%R?$7_HT[]H#_P */]EC_P"B6H /
M^%R?$7_HT[]H#_PH_P!EC_Z):@ _X7)\1?\ HT[]H#_PH_V6/_HEJ #_ (7)
M\1?^C3OV@/\ PH_V6/\ Z):@ _X7)\1?^C3OV@/_  H_V6/_ *):@ _X7)\1
M?^C3OV@/_"C_ &6/_HEJ #_A<GQ%_P"C3OV@/_"C_98_^B6H /\ A<GQ%_Z-
M._: _P#"C_98_P#HEJ #_A<GQ%_Z-._: _\ "C_98_\ HEJ #_A<GQ%_Z-._
M: _\*/\ 98_^B6H /^%R?$7_ *-._: _\*/]EC_Z):@ _P"%R?$7_HT[]H#_
M ,*/]EC_ .B6H /^%R?$7_HT[]H#_P */]EC_P"B6H /^%R?$7_HT[]H#_PH
M_P!EC_Z):@ _X7)\1?\ HT[]H#_PH_V6/_HEJ #_ (7)\1?^C3OV@/\ PH_V
M6/\ Z):@#S#XW>+_ (M?$GX+_%WX<Z%^RM\<+36_'WPO\?>"M&NM6\4?LPV^
ME6NJ^*?"FK:%I]QJ<]G^T7=3PZ?'=W\+S/!;7$BQJY2*1@$8 ^SZ "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
="@ H * "@ H * "@ H * "@ H * "@ H * /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>158
<FILENAME>g20922ndsp3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922ndsp3.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /W\H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^?_V:?^2=>(_^S@/VL?\
MUJ?XR4 ?0% 'SA^U9I.E:]\)=.T+7=,T_6=$UGXX?LMZ3K&C:M96VHZ5JNE:
MC^T]\'[/4-,U/3[R.2WOM/NK2::":WGC>.6.5T=65B" 7_\ AD[]EC_HVGX
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MY/6J>]3SO%5L)AW!IM3H86IBW5J)M6HSITIPISCSN56,H\J4927L](T"@ H
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M]F3]F3]FW7OV;?V?-=UW]GSX'ZSK>L_ _P"$^K:QK&K?"?P'J.JZKJNH^ ]
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M&J-2J8S#3Q,>1W5*,)45[*L].2O*EB,/B(TUS?[/7I3E*+FHGL]22% !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'S
M_P"(_P#DZ?X-_P#9 /VEO_5B_LG4 ?0% !0 4 % !0!\_P#[-/\ R3KQ'_V<
M!^UC_P"M3_&2@#Z H \?^.G@[Q5XX^'Z:/X*B\/W'B;2_B!\'?'6F6?BG6-1
M\/Z%J/\ PK'XO^!?B1>:7?:WI/A[7;O2OMVG^%+NTBN8M(O_ "YKF)GA*!B
M#G_^$C_:G_Z(W\ /_$EOB+_]"=0!0\-^&_C1KWQH\*_$7XC>%?A?X/T3P?\
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M(_\ LX#]K'_UJ?XR4 ?0% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?/_B/_DZ?X-_]D _:
M6_\ 5B_LG4 ?0% !0 4 % !0!\__ +-/_).O$?\ V<!^UC_ZU/\ &2@#Z H
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * /G_ ,1_\G3_  ;_ .R ?M+?^K%_9.H ^@*
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MXGLO"-[?Z</&^H:1HNF?!>\OO%.GZ6R17<_A_3?"?A_Q5:W.H1)<6T/]F:A
M\RN6B'U=2M0Q&<Y=5PLXUZ.7XSCB>,E27-'#4L3BN+)QEB7&_LEBL)C<NA0E
M44?;+$82G2<I<G+\CE%*K@LDS..>TZDJ>.R#(J.70J2YW4K0RS*\+@J>'CS7
M4\'Q#0KXBM!-.C.CB,95IJ#G4J\'X,T*_C\#ZC\$;33;Y_!_[2^N?$?XB:[=
MVRS-96-M\,O'WC9?BW97\S-LM;?7M&T7X9Z4L4>&E;7M0< $,Q^0Q"B^%<#A
M:B_=\*\+99GE+G=HRI8WAK!2P.'HN-I2JX7B>53-:D*CY71K2CK%<A]-@7-9
MWFF80FI5\XXCS;A^470YU&I#B#%1=:I.,E:I5X<JYEA\/.JN6E/*,*HNHY*F
MOHS7-/\ #\_[%O[)&J>*-6U+0M!\/77[*FJZMK-EXP\0^"K/2M.-QX3L+S4-
M9UC0-9TWR-.@@O&?SKR?RK:40W2&*>WBEC^USUNGXE^TA9UGF6?T:,9/W*F)
MJY1F_P!3H>SE>%2>)QL,-A84G";Q*K3P#A5HXRM0K?+82G6K\#YCAZ-)U7*E
MA)SC"'-4C0HY[@IXJK%I.I36'P:Q&)E5IN,L/[%8N,J=7#4JM-_PY\=:G??$
MCX;16GQ'\7ZS\9]4^*?C[2/CM\+I_%>M:SHGA'X=V-CXYET6ZNOAW=WPTOX?
MZ-:RV7@C^R/$-EIFGSZTNHHTESJ7VQV7P,IA&=*A9*OA*G#]#$9A5G)S>'SM
MT, ZE-59.<L-B_K\L;A9973E3I+#PK5'A_\ 9HUX_08YPBL:Z\WA,51S%4\D
MIT=(8W*GC_9PJRC'VD<9AZF3MX^OF564JF'Q\:6$CBJ/M?J,]3XW_%NX^'^O
M_M'^'=4\?ZKH6O:WI/P=U#X3:#%KVIVFJRVES,FB>)K[P38K/&XMK?4D,FKS
M:4"MM'-'-?,@F0MQY7S5IY7A;^VQ*XVP,*\+\TXY57GPSR1KQ;<HY?6E]?P\
M%42PU7$3Q&'CS5*LXRY<YE/#TLVKJ3PU#_4O,98>I?V<'FF&AQ56FZ$DTGF%
M&B\NJWA_M,:5/#U5:G0C*'FF@ZQ\4-%\*^"/B%X7\=?$?Q-\0/&/Q,_:S\&1
M:'K_ (S\2^(_#>HV?A>T^/&L> M"LO!NJ:L^C6T^G:WX,\/I:WL%I%?>0#8M
M=FR$=O%TS@Z.4TJ4')^UX%RK-*U5057$K&/_ %857&4I.,YQK1PV8XR,J=)<
MF)FXUL12Q&*7M7Z>'AA\1G&*>+J/#X/!<8T,%RQE[.E' 5JV(H8BA-+25)I1
MJQ<^:6'E"*H2I4N:#\Y\4>,H;+6FU;X*_%7Q5XVGE^%'@.'XI^(/$'Q4\7SG
MP?#J?Q8T%/B2M]X\.D^)]4^$LZV@GAU>UT?35_X16%A<6VFZ5L\Q6U0IYCG-
M&,:,>')8_*84Z[Q<\/0JX6EEG&E7!_\ "I!RK8FA+'0PL:>*GB)O$5ZD\%/&
MTX7]AY%"6*G'(JO+*KQ)'+L]E4PTL/&M6I8N>*X,AB;91.=*A1KT<+/%5:6$
MC049>QIU5@<;*U'$^S?#6[\4^/M8^&GAC5?B7>ZC\.]2^)_Q#71)?A3\?/C#
MXRAU#PSHOPRTK6K7P_=_':]T'P9K?Q&L+/Q?]MNX]1M+K4T5'.DW.HW#V=W#
M71AX\F+P52O3G+%83(,PQ:56C"C2JU*7$F2X? XFI@TU"LX8+$U,,IXG#*EC
M:-L2XXB.)E5J5C*L:=*E2P51*AC\UP.%K.-=8J=-U,FXDJ8VC2K\CGA%4J83
M#57AXXB>(P6)4ITGA(1P=*CN_MF:GX1\,>-?!FO:EJNG>'_$LNE:/HVFK\1_
M#6G>(_A7X^TD>*6OK_P8$_M2TU>X\5H8<RZ;9W$(O+76H)#;ZE]A>"W\2E+D
MS#%^RP:S"I52G7P#BW6Q<*&2\1TZ'U*,(U%+VE3%U,#-SHUX8;&8C+ZCH6J1
MCB/4KT;X# -XJ>#^KUU&ABH-\N"G/-^&:M6OC:D^7EC"GA(8RCRXFA4JX; 9
MK&5>DK5J?7>)M$TS4/BK^Q%\2+GPKJ'A'Q3KNH:O83^&;^^OFA\$Z=+\ ?'>
MI3^$=.T,SC3M#-M?>5%=&RL[:2X?3;9;@NMG D'TJHQP>?<98:EBECXRR3-I
MRQ;?//$NGGO#-*%3VLG*;IN*E4C34W256M7K13J5ZM2?A^UEB.&LDK/#O *.
M8Y)".%AS4Z-%>QS6?NT&J:4O>4%.=*%94*=&C-05)4X_,7PQ\;WNHZ9\&O"F
MG_%CX(>.KCPS^TKJVH'X#>'=&NK?XWZ+:R?%+QK87NO:MX@L_BKJCV]EH5IK
M$WB&Z,G@O1H)[&T%G/<I%<L;S@R.-/$2X0JU)+$JAPMAJ:Q6'TH8'_C$84?]
MJC^_C/5+*ZD9UZ*>.Q$*U.DJ].C0ATYARX>CQI0Y)825?/\ &5*>'Q$I.KC*
ME+BFGC80PO(J$H^W='ZS2:I8A4L+"<JDI4(U<3']B:YSN"@ H * /G_]D[_D
MUC]FG_L@'P;_ /5=>'* #XR?\E%_9._[. \1_P#K+'[2U 'R5^V1JO@[PG\4
M/#_B&];38/%5_H>AZ4/#GQ+\+Z?XF^&OQ9T*PTWXKRIX(\/6D6H0ZK?>+9+S
M6)]+N=.@#QR/XP\.SM8:I]G-LV6 K5*.-Q$,+0>/K.M]8E@(1Y,=.I2P48T<
M5@JJ@UR72IPJUO;4\%B<+5FZ>$6(6)J^I>4\OP\*N+67TJ2G&CCDU&EAIU\W
MR&>(CBY.5-P]E2P<,9%0G2=;!TL;&-63I25#V;Q+X=TD_M$?LR^/&T2_T?Q-
MXC\*?$RWO;#4M0O;IO#MC%\/-&F'AG3]/DN7LM%M[>Z!,\6GP6ZS7"-++O8*
M56)IK"9AQOA:.)^M4I\/YC4G7NY_69T\\R.E3K<\G*7)[-R=*FI>SA[6I.,5
M4K59U/G'4EB<FX0KU<-]3G3SK+HPP]E!895>'^)JM6E[.-H>T4E"G4J./M)0
MH4*4I.G0HPA\C_ +QI<:_H_[)'A^U^+7P.^),_@_QO%<GX/>"M%N[3XP>!K:
MXT7QCX?OO$/BO7+3XK:]BRT*SUF:6^2X\*^';>Y\Z*%Y$D>*"X]/ 2E/%Y?7
MUQ5.?#OU>>-P[<,+A4\GP=:FJ\?WT:CKU<'3RV%.>(C;%UXXB%*52A"-#TN(
M)U<-6XLHTO\ 9_:\3XB4L+7Y76QD'Q35F_82?LI4_9\_]J1G"C4E]3PT\/.K
M["M6JU/HS]HSQA%I'C[QM8>-_B7XP^&5CIGPGT76?@%%X3\7ZYX6N/&?Q4DO
M?&*:U8V.D:-=6\?Q1\26TUKX+@@\':A#K%M/#J9=M-F\]GA\J$L0L/F%3+(_
M7>)Z.,C#!X"I%5*-3 ?5,+.G4>&GRTITL1C)8ZAC\9+W\OH4*56.(P/-[:IV
M0IT'B,CIXQ4Z.0UW6_M#%.JZ#A75>$52JXJ+A/"PIX/]_AE&I3^M5IUHM5W0
M5./?_LX0^)_$7BSXO>+_ !WKGC"X\5:/XK\/>%X_#EUXN\3IX0\-1WGP<^$O
MB+7=/L? T>LG0(KG_A)M2U287;V$UU ;FXC@N$CN)5E]W'4L+A,##^S>6O2Q
MF*SSDJU'[64Z.#XCSG"X&,*E12E2A'#TJ<'*ER2J04(5>>%&C&G\_A*F*K/
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MU>_C:2S>1)2L@538-CK_ /A(_P!J?_HC?P _\26^(O\ ]"=0 ?\ "1_M3_\
M1&_@!_XDM\1?_H3J #_A(_VI_P#HC?P _P#$EOB+_P#0G4 '_"1_M3_]$;^
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M_P#HC?P _P#$EOB+_P#0G4 '_"1_M3_]$;^ '_B2WQ%_^A.H /\ A(_VI_\
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M_M3_ /1&_@!_XDM\1?\ Z$Z@ _X2/]J?_HC?P _\26^(O_T)U !_PD?[4_\
MT1OX ?\ B2WQ%_\ H3J #_A(_P!J?_HC?P _\26^(O\ ]"=0 ?\ "1_M3_\
M1&_@!_XDM\1?_H3J #_A(_VI_P#HC?P _P#$EOB+_P#0G4 '_"1_M3_]$;^
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M_P#HC?P _P#$EOB+_P#0G4 '_"1_M3_]$;^ '_B2WQ%_^A.H /\ A(_VI_\
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M_M3_ /1&_@!_XDM\1?\ Z$Z@ _X2/]J?_HC?P _\26^(O_T)U !_PD?[4_\
MT1OX ?\ B2WQ%_\ H3J #_A(_P!J?_HC?P _\26^(O\ ]"=0 ?\ "1_M3_\
M1&_@!_XDM\1?_H3J #_A(_VI_P#HC?P _P#$EOB+_P#0G4 '_"1_M3_]$;^
M'_B2WQ%_^A.H /\ A(_VI_\ HC?P _\ $EOB+_\ 0G4 '_"1_M3_ /1&_@!_
MXDM\1?\ Z$Z@ _X2/]J?_HC?P _\26^(O_T)U %#PWX;^-&O?&CPK\1?B-X5
M^%_@_1/!_P +_BAX*M;7P5\4/%?Q"U75M5^(7BOX.:[!<7$&N_!SP7;Z7I]C
M:?#*^1W2YO9)9-4@ B18W<FP;'T?0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
;4 % !0 4 % !0 4 % !0 4 % !0 4 % '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>159
<FILENAME>g20922ndsp5_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922ndsp5_2.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /W\H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M?_Y0PW_RD/[:\=?]%A^/_P#XD1\<O_G@T?ZI</?]"_\ \KXG_P"7!_K9G_\
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M!_K9G_\ T'_^4,-_\I#^VO'7_18?C_\ ^)$?'+_YX-'^J7#W_0O_ /*^)_\
MEP?ZV9__ -!__E##?_*0_MKQU_T6'X__ /B1'QR_^>#1_JEP]_T+_P#ROB?_
M )<'^MF?_P#0?_Y0PW_RD/[:\=?]%A^/_P#XD1\<O_G@T?ZI</?]"_\ \KXG
M_P"7!_K9G_\ T'_^4,-_\I#^VO'7_18?C_\ ^)$?'+_YX-'^J7#W_0O_ /*^
M)_\ EP?ZV9__ -!__E##?_*0_MKQU_T6'X__ /B1'QR_^>#1_JEP]_T+_P#R
MOB?_ )<'^MF?_P#0?_Y0PW_RD/[:\=?]%A^/_P#XD1\<O_G@T?ZI</?]"_\
M\KXG_P"7!_K9G_\ T'_^4,-_\I#^VO'7_18?C_\ ^)$?'+_YX-'^J7#W_0O_
M /*^)_\ EP?ZV9__ -!__E##?_*0_MKQU_T6'X__ /B1'QR_^>#1_JEP]_T+
M_P#ROB?_ )<'^MF?_P#0?_Y0PW_RD/[:\=?]%A^/_P#XD1\<O_G@T?ZI</?]
M"_\ \KXG_P"7!_K9G_\ T'_^4,-_\I#^VO'7_18?C_\ ^)$?'+_YX-'^J7#W
M_0O_ /*^)_\ EP?ZV9__ -!__E##?_*0_MKQU_T6'X__ /B1'QR_^>#1_JEP
M]_T+_P#ROB?_ )<'^MF?_P#0?_Y0PW_RD/[:\=?]%A^/_P#XD1\<O_G@T?ZI
M</?]"_\ \KXG_P"7!_K9G_\ T'_^4,-_\I#^VO'7_18?C_\ ^)$?'+_YX-'^
MJ7#W_0O_ /*^)_\ EP?ZV9__ -!__E##?_*0_MKQU_T6'X__ /B1'QR_^>#1
M_JEP]_T+_P#ROB?_ )<'^MF?_P#0?_Y0PW_RD/[:\=?]%A^/_P#XD1\<O_G@
MT?ZI</?]"_\ \KXG_P"7!_K9G_\ T'_^4,-_\I#^VO'7_18?C_\ ^)$?'+_Y
MX-'^J7#W_0O_ /*^)_\ EP?ZV9__ -!__E##?_*0_MKQU_T6'X__ /B1'QR_
M^>#1_JEP]_T+_P#ROB?_ )<'^MF?_P#0?_Y0PW_RD/[:\=?]%A^/_P#XD1\<
MO_G@T?ZI</?]"_\ \KXG_P"7!_K9G_\ T'_^4,-_\I#^VO'7_18?C_\ ^)$?
M'+_YX-'^J7#W_0O_ /*^)_\ EP?ZV9__ -!__E##?_*0_MKQU_T6'X__ /B1
M'QR_^>#1_JEP]_T+_P#ROB?_ )<'^MF?_P#0?_Y0PW_RD/[:\=?]%A^/_P#X
MD1\<O_G@T?ZI</?]"_\ \KXG_P"7!_K9G_\ T'_^4,-_\I#^VO'7_18?C_\
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M?_Y0PW_RD/[:\=?]%A^/_P#XD1\<O_G@T?ZI</?]"_\ \KXG_P"7!_K9G_\
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M!_K9G_\ T'_^4,-_\I#^VO'7_18?C_\ ^)$?'+_YX-'^J7#W_0O_ /*^)_\
MEP?ZV9__ -!__E##?_*0_MKQU_T6'X__ /B1'QR_^>#1_JEP]_T+_P#ROB?_
M )<'^MF?_P#0?_Y0PW_RD/[:\=?]%A^/_P#XD1\<O_G@T?ZI</?]"_\ \KXG
M_P"7!_K9G_\ T'_^4,-_\I#^VO'7_18?C_\ ^)$?'+_YX-'^J7#W_0O_ /*^
M)_\ EP?ZV9__ -!__E##?_*0_MKQU_T6'X__ /B1'QR_^>#1_JEP]_T+_P#R
MOB?_ )<'^MF?_P#0?_Y0PW_RD/[:\=?]%A^/_P#XD1\<O_G@T?ZI</?]"_\
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MD1\<O_G@T?ZI</?]"_\ \KXG_P"7!_K9G_\ T'_^4,-_\I#^VO'7_18?C_\
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M%;F]G_N_MZ<*?+;VB]KR\E[WI\U[65KO/^V?=X>7U;_D0<O_ "\_C\N(5?\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % 'A/[2__ "1+QK_W+G_J6Z#7S?%O_)/9A_W
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M)_\ EP?\.Z_ O_1<_C__ -_O@;_\XRC_ %MX@_Z&'_E##?\ RD/]4^'_ /H
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M;>(/^AA_Y0PW_P I#_5/A_\ Z /_ "OB?_EP?\.Z_ O_ $7/X_\ _?[X&_\
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M)_\ EP?\.Z_ O_1<_C__ -_O@;_\XRC_ %MX@_Z&'_E##?\ RD/]4^'_ /H
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M;>(/^AA_Y0PW_P I#_5/A_\ Z /_ "OB?_EP?\.Z_ O_ $7/X_\ _?[X&_\
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M)_\ EP?\.Z_ O_1<_C__ -_O@;_\XRC_ %MX@_Z&'_E##?\ RD/]4^'_ /H
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M;>(/^AA_Y0PW_P I#_5/A_\ Z /_ "OB?_EP?\.Z_ O_ $7/X_\ _?[X&_\
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M)_\ EP?\.Z_ O_1<_C__ -_O@;_\XRC_ %MX@_Z&'_E##?\ RD/]4^'_ /H
M_P#*^)_^7!_P[K\"_P#1<_C_ /\ ?[X&_P#SC*/];>(/^AA_Y0PW_P I#_5/
MA_\ Z /_ "OB?_EP?\.Z_ O_ $7/X_\ _?[X&_\ SC*/];>(/^AA_P"4,-_\
MI#_5/A__ * /_*^)_P#EP?\ #NOP+_T7/X__ /?[X&__ #C*/];>(/\ H8?^
M4,-_\I#_ %3X?_Z /_*^)_\ EP?\.Z_ O_1<_C__ -_O@;_\XRC_ %MX@_Z&
M'_E##?\ RD/]4^'_ /H _P#*^)_^7!_P[K\"_P#1<_C_ /\ ?[X&_P#SC*/]
M;>(/^AA_Y0PW_P I#_5/A_\ Z /_ "OB?_EP?\.Z_ O_ $7/X_\ _?[X&_\
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M)_\ EP?\.Z_ O_1<_C__ -_O@;_\XRC_ %MX@_Z&'_E##?\ RD/]4^'_ /H
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M;>(/^AA_Y0PW_P I#_5/A_\ Z /_ "OB?_EP?\.Z_ O_ $7/X_\ _?[X&_\
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M)_\ EP?\.Z_ O_1<_C__ -_O@;_\XRC_ %MX@_Z&'_E##?\ RD/]4^'_ /H
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M;>(/^AA_Y0PW_P I#_5/A_\ Z /_ "OB?_EP?\.Z_ O_ $7/X_\ _?[X&_\
MSC*/];>(/^AA_P"4,-_\I#_5/A__ * /_*^)_P#EP?\ #NOP+_T7/X__ /?[
MX&__ #C*/];>(/\ H8?^4,-_\I#_ %3X?_Z /_*^)_\ EP?\.Z_ O_1<_C__
M -_O@;_\XRC_ %MX@_Z&'_E##?\ RD/]4^'_ /H _P#*^)_^7!_P[K\"_P#1
M<_C_ /\ ?[X&_P#SC*/];>(/^AA_Y0PW_P I#_5/A_\ Z /_ "OB?_EP?\.Z
M_ O_ $7/X_\ _?[X&_\ SC*/];>(/^AA_P"4,-_\I#_5/A__ * /_*^)_P#E
MP?\ #NOP+_T7/X__ /?[X&__ #C*/];>(/\ H8?^4,-_\I#_ %3X?_Z /_*^
M)_\ EP?\.Z_ O_1<_C__ -_O@;_\XRC_ %MX@_Z&'_E##?\ RD/]4^'_ /H
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M;>(/^AA_Y0PW_P I#_5/A_\ Z /_ "OB?_EP?\.Z_ O_ $7/X_\ _?[X&_\
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M4KN;K5L7@</C9XN#;4H474Q%;"1@XRC;"149.K3KU<1]"5D;!0 4 % !0 4
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M()J4HTU!SDH*I45*#;24JKA4JJG&]N:HZ5&M44%>3A2J32Y82:N4#"@ H *
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M/%]C\/M<^*/PZT7Q[J;V,6F^"-6\;>&M.\7ZA)J;;--CL?#5YJ<>HW;W;C;
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MYX=\*>)OB_XS\6^(/"=MXZU70_#_ (/T;QMK-MXZU2T\9WRV_A[XBSO]OO\
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M^"['3(;CQ!X@\:ZMX9M[6WT+2_'-SX6T70_$TT>IVVK^)_'%WX#MM-\)WZ^
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M*S+/G_\ :Q_Y-8_:6_[(!\9/_5=>(Z /H"@ H ^?_$?_ "=/\&_^R ?M+?\
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MZ>*A'&Q53$2IJNK^RI8S&5<=C\-!PY+TL=6Q&)A7JU.?%QP^)KX;#XFA1J.
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M596BE%*56K-I))).RV.DK(#Y_P#VL?\ DUC]I;_L@'QD_P#5=>(Z /H"@ H
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M<M\ /_#R?#K_ .:.@#'\0_M)?LA>*="U?PSKW[1?P O]$UW3KO2=6L?^%V>
M[47FG7T+V]Y:M/9^*89XDE@D>-C'(C;7(SS3BW"I0JQ]VIA:U#$4W_+5PU:%
M>C)I^[)1JTX2<)J4)I.%2,H2E%U&4Z?-[.<J4G&<%.$I0G%3BX.5.I!QG3J)
M2;A5IRC4I3M4ISC.,9+77]J_]E=%5$_:5_9_55 55'QD^'0 51A0!_PD?0
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M]'+? #_P\GPZ_P#FCH /^&L?V6/^CEO@!_X>3X=?_-'0 ?\ #6/[+'_1RWP
M_P##R?#K_P":.@ _X:Q_98_Z.6^ '_AY/AU_\T= !_PUC^RQ_P!'+? #_P /
M)\.O_FCH /\ AK']EC_HY;X ?^'D^'7_ ,T= !_PUC^RQ_T<M\ /_#R?#K_Y
MHZ #_AK']EC_ *.6^ '_ (>3X=?_ #1T '_#6/[+'_1RWP _\/)\.O\ YHZ
M#_AK']EC_HY;X ?^'D^'7_S1T '_  UC^RQ_T<M\ /\ P\GPZ_\ FCH /^&L
M?V6/^CEO@!_X>3X=?_-'0 ?\-8_LL?\ 1RWP _\ #R?#K_YHZ #_ (:Q_98_
MZ.6^ '_AY/AU_P#-'0 ?\-8_LL?]'+? #_P\GPZ_^:.@#Q#]IO\ :;_9MU[]
MFW]H/0M"_:#^!^LZWK/P/^+&DZ-HVD_%CP'J.JZKJNH^ ]?L]/TS3-/L]?DG
MOM0NKN:&"&W@C>2625$169@" ?=] !0!\1?M%_\ )?O@9_V1_P#:,_\ 4T_9
MCKV<C_WNI_UZE_Z73/-S3_=X?]?%_P"DS,2OJ3P3D/%WCKPWX'@LYM?GU,/J
M$DT5A8:'X<\1^+-9O#:Q>?=O:Z%X4TG4M1G@MX,23S):M'"GSRNB\USU<50H
M3C3J3<9.$ZKM&<E3I4W",ZU648N-&C"52G&5:JX4HRG"+ES2BGK3H5*D7*"2
MBIPIIRG"%ZDU-PIPYY1YZDHTYRC3AS3<83E;EA)JGI7C_1M7UW1-+L);>[T[
MQ5X1_P"$Q\)ZW:W0FMM<TZVN+.'4UCA,*& V\.KZ%.C;Y/.34)/EC-LV_IY*
MD*V.PU6#I5\ Z+G%N+4J5?VL8SBT]>2K0J0J*SA&,\-.-2?MG&E$HN-*C6Y9
M>SG5JX>?-"4'1Q%-<RHU(R2E&<XQK.,9)3C+#5X3C%PCS=W2)/+_ !/XY\16
M_B.3P;X#\+:7XJ\26.BVGB+6E\0>*+GP?H6E:5J-U?6.E1MJMEX8U^YNM6OK
MG2]2\FVBT[RECL)7N+F#="L_.JE:4JTJ-!3P^$G"G6FY\LW4G3]JZ6'AR.-6
MK3I.G.HJM3#TTJU%*K*4I*'0J-.G3P\Z]25/ZVZRHJ$(S5L.Z*J3JWJ0E3I_
MOXQA*$:LISC.*@E&4E/%\4O#5KIVIW'B3[=X5U/P[X9TWQ7XJT/4K&\NKSP_
MI6J7FJZ=:S2S:7;W$&HA[W0]41!923R%+=)&C19H]W1%PFJ4J3<HUL3A<'%2
M7)-8K&+#NAAYQNU"I?%485)*4J-.;DG6<82DL:E*K0H^VK14::CCIJ<9*<)T
M\NC&>*JTVDING&G.%2'-"%2I&:4:?M%*$<G4/CO\,],O[G3+C5-?FO+379_"
MS)IO@'X@ZS%<>);6WOKN?P_IMUI'A:Y@U;6DM--NYS964EQ-Y:QOLVW$)EY\
M/B:6)]E[!RE[>56-/]W4CS^PK/#UYPYHKFI4*L91KUE>E14)SJSA"$I+5X6M
M&-234%&A2HUJC]K2M2IXA8=X=U/?_=RK+%4/90GRSFZEHQ;C-1GO/C?\,M.E
MUB*^UZ]M(M"L]:O+[49_"_BZ/1)!X:M+B^\066E:^VA#3=>UG3;6SO7NM+TR
MZO+Z V-RDENKV\JHXXBBXU)*?+&ER.\HRBITYUJ>'C6HN27M\-[:M2IO$T/:
M8>+JT^:JE.+=0P>)J5L)AH4FZ^-E3A3A>*<:E6'M*5*O=KZK5J4_?ITL3[*I
M.'O1BXZDD/QJ^&\VDZQK UK4(;;0KS3+"]M+KPIXOLM<FNM;(704T?PU=Z#%
MJ_B&/56R-/ETJQO8[XHXM'F*-MJ=:%*G3G)3_>5JN&5.-.I.M&O0I^VK49X>
M,77I5*-!K$58U*<73P[6(E:BU,YXQ3DX*<$HT(8ES=2G&E["I.5*%55I25)Q
ME5C*BFIN]9>Q_BM0+MI\6_AY>Z9>ZQ:^(EEL-.T[1-5NW_LS64GCL_$5]=:5
MH^RRDTY;F>ZFU6QO+%K2*%[B&ZMI+:>*.=#&+4H/V7+*,HU\3A\)2E%J4*E;
M%4\-5PWLYQ;A.C6I8O#U(8F,GAG3G*?M>6E5<%:24W[.<52HXJM-.$XN,,"Z
MJQBE%Q357#.C/VV':]O3_=\U->VH\_H_Z?IC\*K;Y"7]?\,% PH * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M#X^_;W_Y--^*_P#W(O\ ZLKP=7G9K_N%?_MS_P!.0.S+_P#>Z7_;W_I$C]N:
M^./I H ^./CE\/)/B7^T1\#]"B\<>,/ #6GP7_:.U;^V/!4/@F?5;D6_CC]E
MZS_LRX3QYX-\2Z>-/D-^)W,-A%<^99P!+A(C-%/M0Q%;#3<Z,^237*W:+TNG
M:TDUNEYF56C3K14*L>:,7=*[6J371I[-EG_ADN\_Z.5^/_\ X+_V</\ Z'FN
MK^U<?_S_ /\ R2G_ /(&']GX3_GU_P"33_\ D@_X9+O/^CE?C_\ ^"_]G#_Z
M'FC^U<?_ ,__ /R2G_\ (!_9^$_Y]?\ DT__ )(/^&2[S_HY7X__ /@O_9P_
M^AYH_M7'_P#/_P#\DI__ " ?V?A/^?7_ )-/_P"2#_ADN\_Z.5^/_P#X+_V<
M/_H>:/[5Q_\ S_\ _)*?_P @']GX3_GU_P"33_\ D@_X9+O/^CE?C_\ ^"_]
MG#_Z'FC^U<?_ ,__ /R2G_\ (!_9^$_Y]?\ DT__ )(/^&2[S_HY7X__ /@O
M_9P_^AYH_M7'_P#/_P#\DI__ " ?V?A/^?7_ )-/_P"2#_ADN\_Z.5^/_P#X
M+_V</_H>:/[5Q_\ S_\ _)*?_P @']GX3_GU_P"33_\ D@_X9+O/^CE?C_\
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M#_ADN\_Z.5^/_P#X+_V</_H>:/[5Q_\ S_\ _)*?_P @']GX3_GU_P"33_\
MD@_X9+O/^CE?C_\ ^"_]G#_Z'FC^U<?_ ,__ /R2G_\ (!_9^$_Y]?\ DT__
M )(/^&2[S_HY7X__ /@O_9P_^AYH_M7'_P#/_P#\DI__ " ?V?A/^?7_ )-/
M_P"2#_ADN\_Z.5^/_P#X+_V</_H>:/[5Q_\ S_\ _)*?_P @']GX3_GU_P"3
M3_\ D@_X9+O/^CE?C_\ ^"_]G#_Z'FC^U<?_ ,__ /R2G_\ (!_9^$_Y]?\
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M']GX3_GU_P"33_\ D@_X9+O/^CE?C_\ ^"_]G#_Z'FC^U<?_ ,__ /R2G_\
M(!_9^$_Y]?\ DT__ )(/^&2[S_HY7X__ /@O_9P_^AYH_M7'_P#/_P#\DI__
M " ?V?A/^?7_ )-/_P"2#_ADN\_Z.5^/_P#X+_V</_H>:/[5Q_\ S_\ _)*?
M_P @']GX3_GU_P"33_\ D@_X9+O/^CE?C_\ ^"_]G#_Z'FC^U<?_ ,__ /R2
MG_\ (!_9^$_Y]?\ DT__ )(/^&2[S_HY7X__ /@O_9P_^AYH_M7'_P#/_P#\
MDI__ " ?V?A/^?7_ )-/_P"2#_ADN\_Z.5^/_P#X+_V</_H>:/[5Q_\ S_\
M_)*?_P @']GX3_GU_P"33_\ D@_X9+O/^CE?C_\ ^"_]G#_Z'FC^U<?_ ,__
M /R2G_\ (!_9^$_Y]?\ DT__ )(/^&2[S_HY7X__ /@O_9P_^AYH_M7'_P#/
M_P#\DI__ " ?V?A/^?7_ )-/_P"2#_ADN\_Z.5^/_P#X+_V</_H>:/[5Q_\
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M+_V</_H>:/[5Q_\ S_\ _)*?_P @']GX3_GU_P"33_\ D@_X9+O/^CE?C_\
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M#_ADN\_Z.5^/_P#X+_V</_H>:/[5Q_\ S_\ _)*?_P @']GX3_GU_P"33_\
MD@_X9+O/^CE?C_\ ^"_]G#_Z'FC^U<?_ ,__ /R2G_\ (!_9^$_Y]?\ DT__
M )(/^&2[S_HY7X__ /@O_9P_^AYH_M7'_P#/_P#\DI__ " ?V?A/^?7_ )-/
M_P"2#_ADN\_Z.5^/_P#X+_V</_H>:/[5Q_\ S_\ _)*?_P @']GX3_GU_P"3
M3_\ D@_X9+O/^CE?C_\ ^"_]G#_Z'FC^U<?_ ,__ /R2G_\ (!_9^$_Y]?\
MDT__ )(/^&2[S_HY7X__ /@O_9P_^AYH_M7'_P#/_P#\DI__ " ?V?A/^?7_
M )-/_P"2#_ADN\_Z.5^/_P#X+_V</_H>:/[5Q_\ S_\ _)*?_P @']GX3_GU
M_P"33_\ D@_X9+O/^CE?C_\ ^"_]G#_Z'FC^U<?_ ,__ /R2G_\ (!_9^$_Y
M]?\ DT__ )(/^&2[S_HY7X__ /@O_9P_^AYH_M7'_P#/_P#\DI__ " ?V?A/
M^?7_ )-/_P"2#_ADN\_Z.5^/_P#X+_V</_H>:/[5Q_\ S_\ _)*?_P @']GX
M3_GU_P"33_\ D@_X9+O/^CE?C_\ ^"_]G#_Z'FC^U<?_ ,__ /R2G_\ (!_9
M^$_Y]?\ DT__ )(/^&2[S_HY7X__ /@O_9P_^AYH_M7'_P#/_P#\DI__ " ?
MV?A/^?7_ )-/_P"2#_ADN\_Z.5^/_P#X+_V</_H>:/[5Q_\ S_\ _)*?_P @
M']GX3_GU_P"33_\ D@_X9+O/^CE?C_\ ^"_]G#_Z'FC^U<?_ ,__ /R2G_\
M(!_9^$_Y]?\ DT__ )(/^&2[S_HY7X__ /@O_9P_^AYH_M7'_P#/_P#\DI__
M " ?V?A/^?7_ )-/_P"2#_ADN\_Z.5^/_P#X+_V</_H>:/[5Q_\ S_\ _)*?
M_P @']GX3_GU_P"33_\ D@_X9+O/^CE?C_\ ^"_]G#_Z'FC^U<?_ ,__ /R2
MG_\ (!_9^$_Y]?\ DT__ )(/^&2[S_HY7X__ /@O_9P_^AYH_M7'_P#/_P#\
MDI__ " ?V?A/^?7_ )-/_P"2#_ADN\_Z.5^/_P#X+_V</_H>:/[5Q_\ S_\
M_)*?_P @']GX3_GU_P"33_\ D@_X9+O/^CE?C_\ ^"_]G#_Z'FC^U<?_ ,__
M /R2G_\ (!_9^$_Y]?\ DT__ )(/^&2[S_HY7X__ /@O_9P_^AYH_M7'_P#/
M_P#\DI__ " ?V?A/^?7_ )-/_P"2/ /VK/V0[.7]FKXYWFN?'?XX>)K'PW\+
M_&'C6+0=6@^!=II6IZKX#T:Z\::#;ZG-X;^"&EZG_9_]N:!ISS)9ZC9R21QO
M&)5#DUG5S#%UZ<J56KS4Y6NN6"V::U44]&EU+IX/#T9JI3I\LXWL^:3W33T<
MFMF?I[7&=(4 ?/\ XC_Y.G^#?_9 /VEO_5B_LG4 ?0% 'SUI_P <KA=7^(%U
MXGT+P]X9\ ^ ];N_"S7R^*M>\0?%/4?$<6H6]AI%H/A%HGP^FD%IKZ2M=:*+
M#7]4U#4H+BP:#3-]Z4MYH3C/!4<34YU6QE24,-1H4YXB3]C[:6)IU^6,)T<3
MAJ='V]:C3I8B%+#\]>K7ITH<TM<12]CBUA:=2FXTZ.&K5ZU>I##481Q5*E.E
M*C4JR]G5H^VK1P4JU6>'7UZG7PT%4G3C[2Q#^T;\/KDIJ5G<:A=>%#X6LM?_
M +5@T#Q;+XDFU75?$.M>'=*\(V'PY@\,OXEO_$\MUX7\4B;2X[ :C;R:*\+6
M+,SF"YIT55=9<L6\&L+*DUB(8N.)P57,:U2G*@YKV6%P/U+%U*RYZ7U?&>UG
M.E"A-RP3<E1G3Y?9<V94\1*I+V#PM7+L1@<)[.I"JHOFKXG%SP])2<'*M0C2
MHQKSKQ4:>H_M3?!^S\.ZCXFTR^\9>+-.TKPM)XMO?^$-^&/Q(\2&QLDT^/4H
M=*UFZT_PLUEX6\4SVD]NZ:)K]WI5\JSK)-!%$&D15%.E)15.5;FJ8>E2E1M5
MI8B>*JT:%%82O!NAC.:=>E?ZI4K<JES.R-:<4YT859K">U>(YG7C.FZ$,(\3
M'$U<53Y'6P]*E+!XJGSU:454K4)T*/M*]J;ZS7?C5X5\.P?#">^T7XB.?BOJ
MEMI7AZTL_AIXWN=3T>6?29]8>?QII*:)]M\&VUK;0$7/]J06\EO^]EEC6VL[
MR>TTJT_8X[$8!U*;GA<-B<74K1J1>%C0PO(IS^M7]BN>=6E3IIR3=2K3IRY9
M3BGC3FIX"6/:=.$9TJ2HR7^TSJU937LJ5&/-*K*%.E7K2E3YJ<J5&3HSJSJ8
M>%;B_!G[4OPO\4^&+OQ#<7>K:7<6-MINH/HL'A7QQK.H:GIWB*_UJU\)S^#X
M;+PFLWQ"N=3M]#O6^S>%H-8>"YM+RR<M/92U$DZ>%P6)G&47B84(SI<K=6CB
M9Y?1S#$494HWJNCAJ56<OKKIQPU;#TIXJ,XT5/DVJ4JU#$8W#UX1I?4\1F%)
M5>>+H3A@,PEESE[?2C"O.H\-S8)U'B:53&86BX2E7H2J^AW/QC^'EIX(T'XA
MG6;ZY\->*5M1X:73/#'BO5_$FO7-W!<7,6F:1X'TK1+CQ)J&MK;V=[)+I<&D
MO>P+871G@C%K-Y;KQEAZT*$E[2I.$:D%0_VF,J,H0J1Q$9X?VL'AO9U*<_K*
MDZ"A4A)U%&<6YHIUZ>(J03A#"2J0K.JO8>QJ4J[PLZ515O9N%58E?5XTI)5)
MUFJ4(RG)1;9?C-\.+>R6_NM>N;&V.K:GH;B_\.^)["ZM]5T3PA<>.]8L[RQO
M-&BN;)['PO:7-S<-<0QI#+ ]G(RWH^S5%>4,-1K8FI4A[##X?&XJ=2G.-6'U
M?+\>\LQ=6,J3FIQIXY?5X<G,Z[E"=!5:=2$Y3A7]<J*C04E6=;!8=4ZL94*C
MKYC0H8G!T53KJG-U:F'Q%.M*FHN=&DJLZZIQH5W3Y.R_:;^#-\TR6^O^(D-M
MI.G:Y,;SX:_$[3D33-:O+S3_  [.9-0\'0*9-=OK&:WT: $S:S(]NFEQW;7=
MN)MJE&M1]M&5*;GAZLJ$Z<(NI46(A##U9X6-*FI5)XJ%+%4:T\+",L1&A[6O
M*FJ6'Q$Z4TZM.K.A3I5(R>(H+$PDI+V:POLZ]5XJI5O[.CA:<<-7A5Q%:<*-
M&M#ZO5G"O.%.26?[3OP4OI='M[7Q3JK76LSV%O%92> _B';W^DRZEXIU7P1;
M?\);87'A1+CP/&OB[1=0TB:3Q%%I:6UVD,-RT375N)R%&=2I3I4^63J0I3A-
M5(>Q:KX7ZY0BJ_-[#VE;#WE1I>T]K4G&5&$)5HRIJZBG0H5,15IU*4*+Q"E&
M5.<:UL''#SQ,UAW%5Y4J-+%4,1.M&FZ2PLWB^=X:%2K'H],^./PSU?5CH]EK
M6J*YOK[3K/5[[P=XUTKPCK%UI>E:KK6I#PYXYU3P[;^'?$T%IIFAZK+/<:3J
ME[#";)XY)%E*HV"G!X.>.YE##4L+5QTI3:IS6#HSPE.6*]E/EJNA*6.PKHU5
M!PQ$*OM*#J4Z=24"I^YQ-+!RC)XBKB88*,81E42Q<X5ZD<-.=-3A3KI8:M&=
M.I*,Z=6'L9J-:482L>(/C-\._"_ACP]XNU75=5;2/%=M'>^'+?1_!_C/Q'XB
MUBR>S749+VR\'>'?#]]K\EG;:<ZW=U.=,$=G ?.NFAC^:KK+ZKBI8+$-4,12
MC.=55&H0P].G*$*E7%59-4L+1I5*E.G5K8F=*E2JSA2G.-22BRE:M2=>A*-:
MC[2-&$Z<HS5:K-S5.GAN5OZU.LJ52=".&]JZ]*$JU'GHQ<RUX8^+?@#QGXAU
M7PQX6UFYUO4="L;#4=6NK'P_XD?P[8V^J:1H>OZ9'+XO;2%T+[==Z)XBTB^@
MLEU)KF6">61(66TN3!K4H5:%+%5J\?J]+!UJF'JNJXTK5:%2M2KQ@JCBZJP]
M2A4AB)TE.%!^S]K*'MJ//"J0E'+I0?M(YIAH8O#<B<^?#5)U:=*K-0YG1C5G
M1JQI*NJ<JCA+D4K%'P_\:_AQXFN[:TT;5M6F6_O+VSTC4KOP;XUTGP_X@_L[
M2;O6[R_\,>)=6\.VVD^)]#BTVRGE.KZ3>WE@6\J);DS3Q1R<\I*G0K5ZMZ$,
M-AL1BZL*J=&M2PV&J82E5K3P]50KQ@IX["JFW33K*<I454A1K2IW4O1Q4<%*
M,G7EB:>#BH1E4@\75ABYQPWM::E2]O&.!Q7MJ7/SX>5+DKJG.=.,^;N?VF?@
MO:6[7<GB?56LX](\):W/>VO@/XA7ME:V7CR;1[?P9#=WEGX5EAL]6UF77M+%
MGI<SQWTPFD9;;9:W#0[2HU8UL3AO93=?"8N> G347*;QE*C#$5<-2C%-UZM*
MC.,ZL:"J>S3M/EDFE<*;J*].=*4/J];%\\:U)T_JF'>-57%>T4^3ZM%Y?BE'
M$<WL:CA35.<WB,-[98_VF?@L7U%)O%.HZ:NDZ'<^(;V?6O!'C[0;--/T[4=-
MT?68(;[6O"]K;7FMZ1K&L:;8:KHUO++J6DW5R+?4K2UF5T52A*//M)4\1A,*
MG"4:BJU<?6EA\%+#NFY+$X?$UH2IT<9A_:X2<EI7LTWG-NE%2J4ZE**HUJ\G
M.G."I0P^%EC:D:W-%>PK?4X2Q=/#UN2O6PR]M1I5*=I&E:_'_P"%]['H_P!A
MU'Q1>WFN:WJ&@6>AV7PU^)EUXHMKW2;NWL=3NM;\)V_A!]9\-Z!:SWECYNN:
MM86.F)'J%I,;SR;J&24A"4W24;.-6BJ_/S15*E3=2O17UFLVJ6$J>VPN*H.C
MB9T:RKX;$4'356A5A!3G3I_6N:<5+!R<904DZE1JCA\1_LM.+=3&+ZOBL-6Y
ML)&O'V5>C4OR5(MY?_#1WPPTY-$7Q)XAM],F\0R3S:;<Z5I/C?7?#]IH]UJF
MIV?A;4/%'B0>#+2R\%3:W:Z<SVL&NM81W-REQ;:9<:FD"W,^2G3=*-1-Q4<)
M#$U'.+IQ4EE\,SKT*4I6]M6H8.:Q,L,E''+#.-6M@Z#E[..M6'LJE:G?^#BE
MA.1N*K^U>,_LWFGAXRE.-#^THU,''%+GPDIQ36(3ERQZP_%30+WX>W?Q"T./
M45TX 6^D1^,_#7CWP VHZG=7D&EZ/#-I^M^"VUZVTR_U2[LH8=0MM!OTECN5
MGMH[F/&[:5*=*O@:%5.G/&U\-14-'5@Z^(C0<:E*ZE1K4_>E*CBGA^3E3Q%3
M#TG*M"*4Z,_K4_:.6'P5*O6JU:,56@Z.'P[Q56MAYQDJ>*I*A%SC4P]2I"I9
MPI2G47(,\.?&;X=>*_%MWX&T+7+F^\26!\117,*^'?%-OHYN_"&L1Z#XHTZT
M\47VAP:-J&J:9J<UNEQ8VU])=)%=6]R81;7$4KS1C]8H2Q5#WL/&%.I&4K0E
M.E5E.%.M3IR:G4I<].5.=2DITZ55*E4G&<HQDZ\*N#G2HXJ'LJTW3A*,'[2-
M.I5PL,;3IU)P5J4JN&G[:A&M[*=:%.LZ<&\/7C2KW'QT^%-I=2V,WBV%;V"R
M\3:@]DFE:[+=BV\(>+HO 6N!+:'2VEDN4\7S)I=M;(K3ZA,'_L^.Z2-W5TJ<
MZWL_9)2]K_9G(N:*O_:ZD\OT;5O;*$I3O;ZM&TL5["+3=5Z<\*INO%TE3==2
M;Z?5<&LPKO3>-/!RC7<U>+A**BW*2B^'T7]IGP5K]IXQAL@UEXA\-7WBVSTO
M3]9L_%]IH7B"/PWX[E^'%K=6WBVP\%WUG-]J\4MIUO<V>D1:W?:8NL6;75KN
MG1'*$'6PV78GX:>,GE:FE\5*.;RG/!3BI^S]K&KA:=2JJW[O!QK4J^'JXNG'
M#U:\9K2HX7&XC"U:DN3#4L36E.G3E.7)@,#A\7F473?+R5L%*M*E*A*:K5H0
MAB*$)PKTT[_B/]H_P-I&D3ZII$&O>(([3QGX/\&RW$7A/QS8:'J=SXFUM=+N
M[CP5XCG\(O8_$B33K.#5;@VWA5]7>:?3TL28;B[CJ*4J<WETN:4</F7UQT9*
MG*5=PPF68G,U5C@XWQ,J->EAXQHUU3]A4555:56I"$B9WH1QL:R4:^ A3]K"
M,X.E"O5Q>&P$*%7$SE3H47#%XJE#$*K.-;#PC5E*@ZE-TGT'B+XZ>!O#OPYT
M/XI+!XS\0^%_$>H^'],T:#PKX \9:YXGN+GQ'JD6D6:3>$+;11K.G20W4CBX
M@O+*WN(W@:V$+7LD-M-HZ<EC<!@$XRJYBX^QJ0G"KA_9RPTL8L0\32E.@L,L
M+%XCVRFX>Q3J)N$9-.FXU*..K*2IPR]5U5C5?LI^VH5WA)8:,*G+)UY8NV%A
M!I)5)*525.C&=6'+>%?VG_ACX@C\2F_O;_P]+X=U#Q3"D=[H/BN2'6=,\->.
M)?A\MUH=_P#\(Y%::[K=UXB^PVW_  CNDS:CJEO/K.G6TUL+B]AC>8PF\'0Q
M:@Y^UIX2;IT8RK5/]OI8C$X+V-.G%U<5"MA</4J^VP]*I0C.CB:2JS^K5)CF
MHPQT\#&:;C"I-3E>E&*PN%PM?,%B'54(X26!J8ETJT<1*G)TX1Q22HU8M=[:
M?&3X=7G@$_$R+7+N+PBMW<Z:9KWPYXHT[7EUFSUB7P]/X>;P9J&BP>(E\3C7
MH)-.713I0U"2Z"P1VS2.JLJ\98?ZJI1=1XRG3JX>-!/$RK4ZM%XB$J4</[65
M3]PI5)J";IQA4=10]G/E*2=6=>G;V$L+)QK?6/\ 9E1MRM2JRQ/LHTZ<HSIS
MIU9N-*I"I3G3G*%2$I>:^'_VGO!VLVFHZ]<V.JZ/X8L+K6[6%;SPU\2F^(%^
MUAXM@\"Z*MK\,4^'(UC[?JOBJR\56":0Y758WT.W,=A<B]G_ +,I1Y:5!U%+
MZS7AAZD*-&*Q/N8K^T\10;J4)33C+*\!3S*I*G&HL-1K58XWZM&A3JXI5+T:
ME>%1>QA1J*,:E;]Q"=.&$RNK6E>LH<M6&,S;"8*C2>F,<XU<+4J.7L5H2_M1
M_"JSU_5/#NH0_$K3+W3M3T'0[9KWX-_%=4U[7_$'A>Y\96OAWP[;P>#I;S5?
M$%OX=MFN[G3DM5N81(BF,L2%O#T*F)FZ5)1]JL3B,,HNI32DL+.E2K8I5%)T
M?J,*U1TI8QU%0A[.5:I.&%J8>O7F\HTW6]E4CAXX&ACY5)4YTU&EB,5]3I4Y
M1J*%58F5>5.$</[/VLYSE2IJ=?"XZEA:=S^TYX,TOQ9H'A[5XY8]+U^T\27D
M7B/1[#QGKMKI<6F^/;'X?^'F\065MX(CF\/6.JZL^L++J^I&UTBS?2%6/4;V
M*\BN!GA%'%/V2G&&(E2RFI1CS+V-;^V:6.Q.#A#$R<*4*E3"X7#SIT:WL\16
MKXRGA:5&56*]I->M3H4I5TJDJ-.IF,:DG3<'2CD]/"QS1SIMNI*>%Q6)]GR4
M(5E]5H8C&UZF'C2G273>+OVA?AKX/\,R^)Y;GQ)XAA&D>(=:T_1_"'@SQ5XC
M\0:Q:>%_$NF^#]5&F:58:27+#Q)K&FV44ERUM#,+G[3'*;.&:XBB#YUA7&\J
M>+_LAQG&,IJ-/.XRGEU2:@I32KTH5*BIJ,J_[MT51>)E3HSVA&,EB6ZM.BL)
M4S&E4]K4A2?M,JC5>/45-Q<XX9T91J5H)T(RE2YJJ56FY4+W]I+X9:(;N7Q!
MJM[IEFEX+>UA@\(_$G4/$-G:6FB:%K&O:MXR\,Q>!$N_ ^B:/_PD&G0W^JWY
M;3;!ITBU&]LKP2V=OO3H5*E6GAX.G4JU:U2E"5*K3J8:T<;7RVDYXM25"E/$
M8_"8W#8>%248XEX?GPE3$1G[F-*HJR;I0J*5.E2E*C4IRIXMUJE&&+="AA&G
M6Q4J>"Q&"Q$UAXSK4_K+C5HTXPA4K==I/QF^'.N^,Y? &D:[<WOB:"XU>SDB
MB\.^)UT9=1T"*UN=6TD>*I-&70WUJWM+RWN?[.74C=/;LUQ'"\,;R)EAT\32
MJ5J*O3I1J3?-^[DX4,9/+ZTZ<*G+.K"AC(?5ZTJ49QHU)T?:.*Q%!U"I5I4G
M2C*I&]6I1I146I^_B,"LRP\9<G-R>VP+>(I.?+&I&%6,&YTJL8&K?&CX8:#J
M$VE:QXMLM.U"VN/%-M/;7-IJ:/#)X+T*U\3>)F=OL)46]CHE[9W)GW>5)]IC
MCA>29A'40DJE/VE*,JD50GB$H0G.;I4\S>3OEIQBYRJ3S)2PM&A&+K8B493H
M4ZE*,IK1:UUAE_&>*H8.VR6(Q& 69TH2F_<A!X%QKSK2DJ-'FA2JU(5IQIOD
M9_VGO@Q;7M[8/X@\1M+9:==:DL]O\-/BA=Z;J:V.L:-X<O=-\.:Q:>#9+#Q5
MXC@\1>(-&TF30M&N;_4TO[]+)K070:)=8TJDHU90IRFJ,Z,+1BY3J?6%6G0J
MT(13GB</4IX>O5CBL/&KAG1HU*WM?90E-5"$JD*52"_=U(2FY-J,:*IX>KBI
MQQ3DTL)5AAZ-2K*CBO8UE&*O"\HJ7>ZY\4?!?AGPQH/B[7[W5M'TCQ+<Z58:
M)!J'A/Q;;>(KS4]:@DN-+T<^#I-#&OVFN3K%(@TVXTR&[65?(>%9B(S&):PF
M)C@ZC4\1+V_)"@UB5/ZMAZN*KNG+#>UA.-/#T*M1RA*46H6BW)QBYI_O*56N
MK4Z-!TU4G5?L(T_:XJE@J;DZW)RQEB*]*FINT+351R5*\UPNF_M.?!75K&[U
M#3?%.J7=O::=INI1I%X$^(0O-575;RXTRUTWPUIS^%1=^*_$D>JVMSIUUH.B
MPW^J65[ ]G>6<%TIBJI1<+6M5;G3A"-%JO*I&MAZN+HUZ,:+G*M@ZV%H5\12
MQU)3P52CA\14A7E&A5<)4H\W*Y*DXK$<[JM4E2EA,11PN(I5Y57"-#$4<1B<
M-1EAJSIU^?$4$J;]M3YL?Q-^U+\-=(\'VOB30!XG\5:IK%E<3>&_"UMX#^(]
MCK%Q>C6[OPM81>+K67P7+>?#32KGQ593Z7_:WB>QTZV6:&4*9638U0IN>,R_
M!\T$L=/+/WZJ4WAJ5#,W0G0K2Q"E]7YWA:ZQ=/#.JL17IQ<:=-ST25:C#"XK
M&U?:QP^"_M%5(PHREB)3RF%26.IT,--TIU98>5/V52:<:%*I*"K5Z47SKTKP
M?\6_ ?CO7M:\,^&=6N[[6/#]K;WUZLOA[Q-IFEWEA<W5S8+J7AGQ!K&C6FE^
M,M)34+*ZM)+_ $&[U&WBG@:&62.7"5-)*MAOK=%J6'4J:NVH5%&M!U</4E0D
MU6A2Q-*,JN&K2@J.)IQG.A4J1C)HE*5&K##5X^SQ,E5O"+=2"J8:5*&*HJK%
M>S=7"U*]*GB*5XUJ,YQC6ITY/E6+XS^+D7A/X@>!? MMH$^L)XDU&VM/%&O)
MJ5O8V/@2VUJ/4;7PA+?PRP22:G?Z]XAT^33[2SB,.$M[RX>4>1%#=F$2Q.)J
MX?6G&-.LJ=3E<HUL90PU3'SPD;65Z>78?$8O$5.9_5T\'"<']>ISC6*E#"8/
MZU.I'VGM<-%47=2]A7QF'P$L2Y6<8QCBL7AJ-*$K2Q,I5O8W6%Q+IN\&?%:7
MQEXE&A6WAM[.Q6U\=WLNK2ZIYC1V?A7QT?!&@W'V$::@9/$$EAXAOX?]('V>
M'2$!\\W1-N4%&IA98B<U3E'"Y5BHQ5Y1=/-J6-Q-!<[Y4I4L)AL/5KKE]V>+
MC25U3]K4=>4*%>-"FW7YJ^*H*I&-J:EE]' K,(S<FI*KA\?C5@H0C&4*WU?$
M5_:P4:=.IQ]_^U)\,K+Q;+X=BGUNZTO3=&UO5=9\6)X3\;KH3W.FZWX?\-Z;
MH7@F[3PI);_%/7=3U[7?L$5EX2N=5F2YL)+9D-S)% \8>^)HU,134G1C'">Q
MC&%26(Q$\;'%5L.Z.%4/;RPTL'@,;BWBU'V/L:*J0<Z+JUJ+K*&'J4L-.M3C
MB95:L)PG4A"E1I8:*CBZE?%2?U:A4PV+KX#!U,-6JTZRK8ZFFE./).WJ'[0V
MA2V]A?>#=)N/%.GW^B&[66\.K^$[^S\1WOC_ $3X;Z!X3U;0=;\/+J>BZG=>
M(KW7(;M+^TMKG3G\-7$<UH[N1!O3HN6(6'FU&]7*%&<)0JPGA<RCC<17Q=.I
M"?LJE/ 8# U,9.,:C]K&<*?-2;YB*SE2H590I5'B:=#-JRI5(2H*^4X.CB94
MJDJB52%3%5,7@J6%M1G&I3K3Q$92C"E3Q%N\_:;^"^G7>L6EWXDUJ%=$2V>?
M4A\/OB/+X?U(77B;2/!D*^%O$T/A)M(\9R_\)5KFEZ8\>@7NI/%<7#)*J>1,
M8L:">)HQK4(2J1G+#1A!0E[:I]<HXK$X2=/#M>WJ4L3A\%BJU"M"G*E5ITG*
M$VI0YM)1<,2\))QC6A1QU>:YX<E*GED(3S#VM6_LJ,\&JE-5Z56<*L)SC3</
M:243J?%WQF\ >!?#^D>)/$UYXBLK/6]-DUC3M+M/ /C_ %KQ>VEVMM;WFH7U
MWX"T/PQ>>)=-MM.M[NV?4&O-)M_[.\Y5OOL[<4L0XX3$5<-5G!3H<SJ3A.-6
MA2A&7)[6IB:3GAZ=&4_<A7E55&I)J,)RDTF8>$\32A5HTY.-2I"C3C*,J=2I
M6FIN%&G2J*%6I6E&G4G&E"$ING"=11]G%R7(W_[4/P1TV_FTJ?Q5JTNH0336
M9L]/\ _$75IIM6M_#FF^+F\.6:Z5X3N/M_BQO#.JVNI1:!;>;J<UO'=R16CC
M3[O[-I4ISHJM*:Y8X98F4Y77*H8/&U,NQE523<9T,'BZ4H8NO!RHX6FZ>(KS
MIX:K2JSQH588A471;DJZPSA=2C;ZYA8XO!J:DHND\71G&.%C44)8C$7P=%3Q
M:=!;,?[0?PBFU32](M_%<EQ-JVFV6J6U]:^&_%=SX?MXM2T#_A*M,L=7\4V^
MA/HV@:]>^&RNI6VBZG?V>I7%LZRPVKJZDSB4\%+,88I>P>5K%.OS:*^!3>,C
MAY?#C*F%C&4L13PCKU*4(RG.,8QDU=!_6*67U:"<Z>:*@\/:,KN&)K?5L-5J
MQ:4L-1KXE?5J-;$QHTJF(3H1FZJY"YJ?QT^%NCVT%S?^))XDNM-\&ZK:PP^'
M/%-W>W5M\0/[7'@V&VTZST26ZN-4U,Z%JBQ:;'"UZK6ZK+;QF>$2WB*53"5J
MF&JTY>WI8O%8%TZ:=:?UK!8/Z_BJ,(T>=S='"-5I2AS0<91C&4IRC%YT*U'$
M87#XRE6IK#8FA1Q,)SG&E;#U\30P="O4C5<)4:57$XBG1ISK1A&4E5:;CA\0
MZ7%S?M5?".WU*RL,_$.XMK_PIIGBVUU>P^$/Q2U'36AUO6;G0-&\/LEAX1FO
MH_&=[JMCJ%M#X?:R%^9].N;4P+=Q&"I4).6(@ES.A+#*#IM5HXI8G"RQRG@Y
M474CBJ-'!>SQ=>M2<J4,-4]O&<Z6'QD\-4YQIPH5)>[2K3QM*4Y6IQH5<#B*
M>#JT<0ZC@Z566*J+#TZ<ES.M[*E)0GC,!'%^D^*_BOX(\$:-X;USQ->ZSI]M
MXNN%LO#>G1>#O&6I>)M5U%M!U+Q*-*@\':5H%SKR:P-&TC493I\NFI<K):FW
M:(7++"RK+ZO6KX>;4JF&IUJU3V4E6A&CAYTZ=:LJE%U*<J-*56FY58SE35.3
MJ\WLHRFM,-&6*PSQ=*+C0BJ/,ZR>'E%XBK"C0A*GB/95(U*E6I"G&DXJIS.S
MBK.W'G]I7X,&*2>#Q5?WMM%H&@>(VN=,\%^.]4M38^*X+"X\*V,=SIWAF>*;
MQ-K2:E9KIWAV-VU>^D=XK6QEE@E2.ITJE.IB:+IRE5PF*E@IP@G4E/$TZ-/$
M5*6'5/F>*]EAJD,16GA?;4Z6'YJ]2<:4)SB):4N=K#\\/:-8AK#2HP]OB<*Y
M8F-=TY811Q6$KX6;Q2H\F)C3P\^6M7H0J;&E_'?X6:Q8_;['Q)<")8M$=[>]
M\-^*]*U2";Q#XHU;P7INF7.C:IH=OJ%KKH\4Z%JVG7.DRVR7UC+8R?;;>W0J
MS%:#H1C.;BX2:Y90G"I&47@O[1]K&5)S4J"P*GB9XB+=&%*E6E.I'V%90))T
MX>TJQE0BG75JD73GS8>6%C.')449^TG+&X.&&I\O/C)XK#QPD:\JU-2XC5?V
MG?!6EZ9X1,$-WKWB#QI=^$?[)TWPYI'CG4= T_1_'&NVECX?UKQ;XQF\#6]C
MX$BFT&[_ +76W\1QZ5-,+2YM[,71C661JFXXM8.JXX:>'YUCJE62IT,)4PF7
M2S+,J4*TK0Q%7"8:E5G"C%PKU*?L:F(HX.-67LIJ_P"S4\7.LXJ5&>)IX>G2
M;KU,3..-J9=@(J%&,YQCC\=&C@UB(1K8.GB*DXT<3BH4E4J:;?M1?!466IWD
M/B'Q!>/I=Q;0_P!E:?\ #;XFZAXBUB"]M+F_LM8\*^&++P=+JWC+PO/86=W=
M1^(-"LM1TI[>UFG%[Y,3NO/B)RPN'G7J4IQ]FL2YTY1=.I0>#A0GB(XRG/EG
M@/91Q6%YY8V.'C'ZS0N_WD+W34:E>.'IU:4ISCAYTY0JTYTZT<5*O"A]6JPE
M*GBIU)8;$15+#2JU4Z%5."<))=+I?Q7MK[P5\+_%E[IT&@7'Q.31[C3]$U>\
MU7S[&TU#P[?^,+Y)+G3?#EW_ ,3*R\+Z7J-V8KN'3[5Y;4VSWL+21M)UXZ@\
MLQ>,PN,G&/\ 9=#%5\=.FW.-".#I*->5/2*K4X8VI0PW.W2G*E4=>G2G5C'"
M5,L+-8_#2Q66M8JA.M1AA)R;HK%4<1CZ>%PU91G'VL)8C#U%BJ=%4IRB[4ZT
MJ5"-;&4;G@3XS?#OXEVNJWO@G6=0UBVT?2]'URX=O"WBW2C=Z+K]E<WVBZOH
M<>LZ%:/XETR\ALKV.*ZTA;Z)KBQN;7?]JMY84SQ=*K@</B,5BJ<J=+"5<10J
MKE<JD*N%A3J5:;HPYJM_95J56E[EJ]*K3JT'4ISC)E&<*]>EAZ4TZE:$9P;?
M+3<95)4G^^E:BG3JPE3KQ<U+#SBXUU3EH>3Z7^US\-]4NO!<W]F>-M'\/^,?
M#^IZY%J7B'P'X[TK5],CB\5:#X5\/W-_X77PM/>6OAC6)]8N+E?$MT]KI=K#
M:0>?< W?^CW1HN=6>'G.-'$QAE+A3E*%E5S6.8.&&KU7)4<-B:53 .A&E4J?
M[57K4HX-UHU*,ZTUZT,-"M*I"I%X:MFD*O-!P4:.3QH2QE>$9-5JRBL50FJ=
M*C*I2I+%/%K"UL)6H+V'PE\6_ /CG7]=\,^&-8N[_5?#UM!?7GG>'?$VE:9?
M:=<75U8)JGAK7]7T>UTOQCI2W]E=6LE]H-YJ5O#/"T,LJ2X4X4VJF$>.@U]6
MC[/F;:C.,:M.5:A4G1DU6C1Q%*,JN&KRIJCB:<)SH3J1C)K6J_88A86I[M9^
MV22]Z//AI4J>)I>TC>G[;#3KTJ>(H<_MJ$ZD8580D['$S?M/_!6#3H=7?Q+K
M;:7/?W5C#?P_#OXE7%J\-A/;6FHZ_P"=;^$'4>"[&]O+:TN_%)(T2TN91;7.
MH13@QB\-"6*> 5!7_M&.%G0YK4],?;ZA[5U.18:6.;M@H8GV4\6XSCAXU'3F
MHF(M@UC?;RC#^SEBG7BI1G)?49U(8V-.$'*5>>#=*4\53H*I.A2E2KU8PHUZ
M-2I<M/VD?@Q>?VT8?%\JPZ#:7EY=75UX7\86-C?QZ?XF_P"$,O8/#.H7OA^*
MV\8ZC#XK:WTEK'09=2NOM>H6,(A+ZA:BXF'-/#0Q5.G.I2J+!.G&%.<Z]2.8
MX>>+P,J>&C%XBI#$T*5:=.<*4HWH8BFVJF'K0@HRA+$/"QG#VD?K_,W.*I4_
M[+FH8_VM9M4:2PO-&=5U*D4J,H8A7H2C4>3K?[4WP:T#0X-<N=3\8W?GZ1XF
MUM-"TGX5?%/4_%UK8>#;RVT[Q*^N>$;3P:VK^%&T^^O+2&X_MZTTQ8?/625D
MA5I$BK-TX2E2IRQ?+3P]1?5^6K!_6WBH8:/MHR^KPG6JX+%8=1JUJ?L\32>&
MK.G6<8.Z$?;UZ.%O[&M7K3H0A5C4A4E.G'"SGR4'#V]5*EC<+7@Z5*HZV'K0
MKT%4IOF.OO\ XU^ ]%\'^#O&OB*3Q/X<L/'<D-IX<T35O WC-/&EUJTVB:GX
M@&@/X(L]"N-<CUT:;HNIL+,6+/*]L(H/->X@$^^+@L%B:V%G4A5G0IU:[E1O
M4BZ%!4W5K+ECS1A2C4A.JIQA4H1Y_;PINE54(P'/F&$>-HTW1HP5'VCKRIT?
M9NOB*>$I1E*<U3ESXBK3IPG2G4I58R5:E4G0:JO-\,?M$?!_Q@Z)X<\57%^)
MI/!\=G,WA;QA8VNICQY<W=CX8FT>\U'0((-9M)[_ $_4;2>YL9+B&PN=,O;?
M4'M9K.=(K^K5N:G3Y5S5*V(H07/#WIX7!3S*I*+YK2HRP-.>*PV)3>'QE))X
M2K7YX*45:L</3]K6C4I0BH\SE2JIPF\9A\OE0J1<.:GBJ.,Q6&HXG!U%'%81
MUZ4L31I4YQFR^_:$^%UE/=VL6H^*-9N+"P\4ZG?Q^&/AQ\2/%4>G67@[4/$.
MDZQ/JMWX=\)WMMHZ2:KX4\0V>GM?36PU:?2IH]+-XVT-R59^QP=;'.+>&H86
MABW/W81G1Q-*C7H*G.K*G3G5G0Q%&NZ*G[6EAZD<17C2H7J+MIX2K4KT,-%P
M52OB98."52$OW]/V*JP?(Y/_ &>6(I4\1))QH5I.A5<:\)TXYNM_M!>'=*^%
M_@CXI1>'?%Z6'CK7/!^C:9X9USPOXDT+QK;GQ-J<5M?"3P@-$N]9O=4T[2H]
M4OTT_3["\?45TY18R20W45T>K%4HX',Z&6XFJG*JL7)U*$9U^6.%R[%9@VZ4
M(^VBVL/&A4IU(4ZN&JU;8F%.=.<%PX:M#%X'%8ZBI.EAU34>91IQG*OC,/@<
M/+VM6=.C'#5*^*HS>*]I*FL,Y5J?M6HTY:^F?M _";6-4\(:/IGB2^N[SQQ'
M:-H+Q>$?&@T^&XO[*YU#3]*\2:N_AU;#P3X@NK2SNVM]'\17.E7\QM94BMGD
MC91,*4JE:K0I2IU)T8.:E"K2E2K1CAZ>+E]5KQFZ.,E'"5:6+G#"5*TX86<,
M3**HR4QSJQI4E5J*5.*J.E*,H352E)8R677KT7'VM"#Q\9X.-2M"G3EB83HQ
MFZD)15GQ+\9_!O@S6-5L/$NH1VEI87VA^'[,:5IOB_Q'XCU'Q?J^B:UXH/AN
MU\,Z%X1N7O+H^&]+M[RU73+O4[BZ>[>V>TMI5M1J.$:M*5.4DY.I&MB::C&G
M*2=/"4,)7KU;I<_[GZTO:N-.5&$(\_UB4XXBEANOZO/3EM%0P]+$U9590I4Z
M='$XV67X6:J3FH257%4ZM*2E*G.DXQE*#I5%52Z_\7]%L_"'@SQ/X2LKGQG<
M?$J^TG2_AWH]NS:#+X@O=8T^[UF.2]FUNWBDT&PLM#T[4]2OGNK4W%O;Z9<(
MMI-=B.UEVJT,33Q:P%.G3EB53K57)U;X:G1H4E4E7J8BA'$+V$G*C2I5*,*R
MJUL1AX04E44EE1Y)X?%8JI[2A0P34:T949QQ$:KQ4,%'#_5ZWL9QQ'UJ:I2I
MUG15+EJ3K2IPI3E' U'XWV_PZTBVD^.5AI?A'Q)<M<W:Z%\+F^)7QQMK/P_!
M)#;KXBUB\T+X1Z1J&A:4+N4P37NH:+;:?#(8H_MSR2A%=*-/$XG#8+"SE4Q5
M:>'HSC*"I4J>(QF(GA\'1>(E-THO%2BE1]O*A.I45:%.$XT95'A4G/#8?$XS
M%*%#"4(5JL9>TYJDZ.%H1KXNI[!14Y+"PES5O8^WC3ING4J2A[2,%IQ?M"_"
M"75=<T?_ (2UX;GPY!XEGU:ZN_#GBNRT.!_!^L1:!XFL+?Q)>:'%I.HZUIVJ
MW%I#-I=G>W%[B^M95MVANH9)<H24\/\ 6::<Z4OJ_LU&+=2M]:JRH8=X:BDZ
MV*52O'ZNGAZ=5*NXT9-59PA+IJ4JE"I"E5C[.4DI2<FE"BG@HYC'ZS4;]GA>
M; N6*BL3*DW2I8B2O]6Q'LN4UO\ :O\ @]HWA+5_%1N_&\YT<^(8IO#3?";X
MMV'C))_#&F6.JZM)?>#K[P-%KFCZ';6^J:3Y^NW^G6^E6_\ :4!FO$WBBI'$
M\F'6#H+%U\9%?5H0J0C3E4GB\1@*-*OB+NE@I5L=A:^%A];E2E*K2J*$9N-F
M\'"GB\5+"^U]G["M1HU7RN4KU:5'$+ZO35IXV2PN(HXEPPBK2]C.%1VA)2+N
MH?M(^!/"NFZAJ'CN>XT5]+&V_P!*\+^'_B)\1-:TQ],\.:%KGBZYU32?"_P_
MDNK;0=#FUZTMKC7(8KG34\V'[3=6=U(]E!TRHQEBHX;"U/K2KXNKA\/5C&U*
MI"./KY9AZE:HWR82>)QN$Q="E2Q$XQG*C>A6Q$97CR8"=7&T:$U1]G7EA\).
MK0YTZD<3BL/3QBPN'C:,L8X8/$X.NY48^U2K3]KAZ,:2G4[&Q^-GPUU'QL/A
MY8Z]=S^*_P"T+C2'LQX9\5IIMOK-KX=M/%LFB7?B.30UT:RUQO#5[%J,>G3W
M\=U-!%<M#$_V.Y$$4J%6M&K.E'FA0A7J2E=*+AAL:\NQ$J3;2K*AC$J-7V/.
MZ?/2J2M2K4IS<J].$:$FVE7^KN'NR;2Q5#ZQAI5(I7HPKTKNE.LH1G.,Z,6Z
MT)4US/CG]HKX?^"?%.F>#9;F[O=9GUN/3-=O?[(\2V_@[PA9VV@:AXNUV[\2
M_$&+P_<^&]'U33_".E7NJC1;S5+:^FA$+^7'!+]H3'#OZQ.7*I1PM"EBJM6N
MU:*CAHSI16'C/D>-G/,987+IT\(ZM2C6Q-YQ<J?LI]4\/B%2O0I>WQ,JF#A3
MP\'S57];QN%PL95(TU4GAX>RQ$\11G7A3IXGV+I4Y\T^:*']H?P1>VVEW?AJ
M/5]4AG\0:EH^MQ:SH'BGP-J/AW3](\%:UXYN_$%UHWC#P[8ZA<:5+I.DV_V.
MYCMEMKW^U;>2VN7BRU9UYSP^'Q&)]GS0PF"QV,J0YK5HO!3PU!X65&SJ4L7+
M%8W!TI8>O&E6I4JZKNG*/LX55AXT\15AAZ=:*KUZ^!P^&5I.GBI8VO*$)X>O
M%2I5J$<-A\?B8XBC*I0J/ 5L/&HJM^6*T_:2^'5L?#NF>*[G5/#GBC5=$@U#
M6-,L_"_CCQ-X<\+:NO@V?QWJOAC6?B!H_A(^'['7K'PW9WM\;&^O+&\DM[=9
MDM L\0?KQL*."JYORU_:X3)HXJI4Q+A*G3J4<%B%A<15P_-_O*IUW&E.&&=:
MI"K)4Y153W3/!JIC:."K8>C.V82P_L*<N3ZQ&.-J4Z>">*HTYU'A7B'6HI.K
M)4>>4HPKU(4Y5#IO"?QP^'GC?5],T+PS<>+;^_U;3#K-LTWPS^)FEZ;;:2QO
M!9:AJ^M:OX0M=.T"UU)=/O)-,DU.ZLQJL<)ETW[5&RLS>&KPEBH2A[.6"]VL
MIRC!0J+V7-ATY-*6+IQKT:E;"0<L50HU:=:M2A2DIO!XF@OJW+453ZW&$Z2I
M7JWIU(2G"M)4U)T\/)TZE)8BIR4?K-*KA?:?6:52E'UNL#<* "@ H * "@ H
M * /G_\ :Q_Y-8_:6_[(!\9/_5=>(Z /H"@ H ^?_$?_ "=/\&_^R ?M+?\
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MU/+J<XT?9ZR4YW@ZW-5]HXR]BU1E1AR82JJ=&M7PU7%8?#XBEZ_4EA0 4 %
M!0 4 % !0!\__M8_\FL?M+?]D ^,G_JNO$= 'T!0 4 ?/_B/_DZ?X-_]D _:
M6_\ 5B_LG4 >@?$+XG>$/A=9Z#>>+9O$ _X2?Q /"WA[3_"W@GQM\0-=UC71
MH6N^)WL;'PWX \/:UJLWE>'_  QKU_+,++R8H=,E:61/E# 'G_\ PTM\.O\
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MBQH /^$<_:G_ .BR? #_ ,1I^(O_ -%C0 ?\(Y^U/_T63X ?^(T_$7_Z+&@
M_P"$<_:G_P"BR? #_P 1I^(O_P!%C0 ?\(Y^U/\ ]%D^ '_B-/Q%_P#HL: #
M_A'/VI_^BR? #_Q&GXB__18T '_".?M3_P#19/@!_P"(T_$7_P"BQH /^$<_
M:G_Z+)\ /_$:?B+_ /18T '_  CG[4__ $63X ?^(T_$7_Z+&@ _X1S]J?\
MZ+)\ /\ Q&GXB_\ T6- !_PCG[4__19/@!_XC3\1?_HL: #_ (1S]J?_ *+)
M\ /_ !&GXB__ $6- !_PCG[4_P#T63X ?^(T_$7_ .BQH /^$<_:G_Z+)\ /
M_$:?B+_]%C0 ?\(Y^U/_ -%D^ '_ (C3\1?_ *+&@ _X1S]J?_HLGP _\1I^
M(O\ ]%C0 ?\ ".?M3_\ 19/@!_XC3\1?_HL: #_A'/VI_P#HLGP _P#$:?B+
M_P#18T '_".?M3_]%D^ '_B-/Q%_^BQH /\ A'/VI_\ HLGP _\ $:?B+_\
M18T <AXUUO\ :2^&MCX;\2Z[\0_@?XIT2[^*'P:\%:QHFD_ GQYX5U6YTKXF
M?%SP1\-M0N-,\07G[1^NV^FZA9VGBR:]A>?2+^-I+-(WB*R%E-OD&WR/J^@
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M\0ZUJLWE>'_#&@V$4)O/)BATR)8HT^8L;!L>@4 % !0 4 % !0 4 % !0 4
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M "47]D[_ +. \1_^LL?M+4 ?0% !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M/[4P_P#)4^Z/_P F'_#1?Q^_Z(9\'_\ Q(SQI_\ 0QT?V'B_^?E+_P "G_\
M*P_M3#_R5/NC_P#)A_PT7\?O^B&?!_\ \2,\:?\ T,=']AXO_GY2_P# I_\
MRL/[4P_\E3[H_P#R8?\ #1?Q^_Z(9\'_ /Q(SQI_]#'1_8>+_P"?E+_P*?\
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MG_\ *P_M3#_R5/NC_P#)A_PT7\?O^B&?!_\ \2,\:?\ T,=']AXO_GY2_P#
MI_\ RL/[4P_\E3[H_P#R8?\ #1?Q^_Z(9\'_ /Q(SQI_]#'1_8>+_P"?E+_P
M*?\ \K#^U,/_ "5/NC_\F'_#1?Q^_P"B&?!__P 2,\:?_0QT?V'B_P#GY2_\
M"G_\K#^U,/\ R5/NC_\ )A_PT7\?O^B&?!__ ,2,\:?_ $,=']AXO_GY2_\
M I__ "L/[4P_\E3[H_\ R8?\-%_'[_HAGP?_ /$C/&G_ -#'1_8>+_Y^4O\
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M4O\ P*?_ ,K#^U,/_)4^Z/\ \F'_  T7\?O^B&?!_P#\2,\:?_0QT?V'B_\
MGY2_\"G_ /*P_M3#_P E3[H__)A_PT7\?O\ HAGP?_\ $C/&G_T,=']AXO\
MY^4O_ I__*P_M3#_ ,E3[H__ "8?\-%_'[_HAGP?_P#$C/&G_P!#'1_8>+_Y
M^4O_  *?_P K#^U,/_)4^Z/_ ,F'_#1?Q^_Z(9\'_P#Q(SQI_P#0QT?V'B_^
M?E+_ ,"G_P#*P_M3#_R5/NC_ /)A_P -%_'[_HAGP?\ _$C/&G_T,=']AXO_
M )^4O_ I_P#RL/[4P_\ )4^Z/_R8?\-%_'[_ *(9\'__ !(SQI_]#'1_8>+_
M .?E+_P*?_RL/[4P_P#)4^Z/_P F'_#1?Q^_Z(9\'_\ Q(SQI_\ 0QT?V'B_
M^?E+_P "G_\ *P_M3#_R5/NC_P#)A_PT7\?O^B&?!_\ \2,\:?\ T,=']AXO
M_GY2_P# I_\ RL/[4P_\E3[H_P#R8?\ #1?Q^_Z(9\'_ /Q(SQI_]#'1_8>+
M_P"?E+_P*?\ \K#^U,/_ "5/NC_\F'_#1?Q^_P"B&?!__P 2,\:?_0QT?V'B
M_P#GY2_\"G_\K#^U,/\ R5/NC_\ )A_PT7\?O^B&?!__ ,2,\:?_ $,=']AX
MO_GY2_\  I__ "L/[4P_\E3[H_\ R8?\-%_'[_HAGP?_ /$C/&G_ -#'1_8>
M+_Y^4O\ P*?_ ,K#^U,/_)4^Z/\ \F'_  T7\?O^B&?!_P#\2,\:?_0QT?V'
MB_\ GY2_\"G_ /*P_M3#_P E3[H__)A_PT7\?O\ HAGP?_\ $C/&G_T,=']A
MXO\ Y^4O_ I__*P_M3#_ ,E3[H__ "8?\-%_'[_HAGP?_P#$C/&G_P!#'1_8
M>+_Y^4O_  *?_P K#^U,/_)4^Z/_ ,F<!\0O'OQ/^*%GH-EXM^ WP^'_  B_
MB >*?#VH>%OVPOC5\/\ 7='UT:%KOAA[ZQ\2> /@)HNJP>9X?\3:]82PB\\F
M6'4Y5EC?Y2I_8>+7_+RDK?WI_P#RL/[4PZ^Q45O*/_R9Y_\ 9/'/_1+]?_\
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M_P P]']AXO\ Y^4O_ I__*P_M3#_ ,E3[H__ "8?9/'/_1+]?_\ %GO[;?\
M\P]']AXO_GY2_P# I_\ RL/[4P_\E3[H_P#R8?9/'/\ T2_7_P#Q9[^VW_\
M,/1_8>+_ .?E+_P*?_RL/[4P_P#)4^Z/_P F'V3QS_T2_7__ !9[^VW_ /,/
M1_8>+_Y^4O\ P*?_ ,K#^U,/_)4^Z/\ \F'V3QS_ -$OU_\ \6>_MM__ ##T
M?V'B_P#GY2_\"G_\K#^U,/\ R5/NC_\ )A]D\<_]$OU__P 6>_MM_P#S#T?V
M'B_^?E+_ ,"G_P#*P_M3#_R5/NC_ /)A]D\<_P#1+]?_ /%GO[;?_P P]']A
MXO\ Y^4O_ I__*P_M3#_ ,E3[H__ "8?9/'/_1+]?_\ %GO[;?\ \P]']AXO
M_GY2_P# I_\ RL/[4P_\E3[H_P#R8?9/'/\ T2_7_P#Q9[^VW_\ ,/1_8>+_
M .?E+_P*?_RL/[4P_P#)4^Z/_P F'V3QS_T2_7__ !9[^VW_ /,/1_8>+_Y^
M4O\ P*?_ ,K#^U,/_)4^Z/\ \F'V3QS_ -$OU_\ \6>_MM__ ##T?V'B_P#G
MY2_\"G_\K#^U,/\ R5/NC_\ )A]D\<_]$OU__P 6>_MM_P#S#T?V'B_^?E+_
M ,"G_P#*P_M3#_R5/NC_ /)A]D\<_P#1+]?_ /%GO[;?_P P]']AXO\ Y^4O
M_ I__*P_M3#_ ,E3[H__ "8?9/'/_1+]?_\ %GO[;?\ \P]']AXO_GY2_P#
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M:YX6&JNMAZ%9KE=6G";2V3E%2:^5[%RLC<* "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H ^/OV]_\ DTWXK_\ <B_^K*\'5YV:_P"X5_\ MS_TY [,O_WNE_V]
M_P"D2/VYKXX^D"@#\_OVL_&7A#P-\;O@-JWC7Q5X;\'Z5/\ "O\ :(TZWU+Q
M1KFE^']/FU"7Q=^S7<Q6,-YJUU;PR7CVUI=2K"KEREK*X7;&Q'JY/4ITL3.5
M2I&G'V4DG*2BK\\':[:5[)Z>1Y^90G.A"-.#DU-.T4V[<LE>RZ'D_P#PT-\
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M+_(/^&AO@#_T7'X/_P#AS/!?_P NZ/K>$_Z"J7_@R'^8?5\1_P ^*G_@$O\
M(/\ AH;X _\ 1<?@_P#^',\%_P#R[H^MX3_H*I?^#(?YA]7Q'_/BI_X!+_(/
M^&AO@#_T7'X/_P#AS/!?_P NZ/K>$_Z"J7_@R'^8?5\1_P ^*G_@$O\ (/\
MAH;X _\ 1<?@_P#^',\%_P#R[H^MX3_H*I?^#(?YA]7Q'_/BI_X!+_(/^&AO
M@#_T7'X/_P#AS/!?_P NZ/K>$_Z"J7_@R'^8?5\1_P ^*G_@$O\ (/\ AH;X
M _\ 1<?@_P#^',\%_P#R[H^MX3_H*I?^#(?YA]7Q'_/BI_X!+_(/^&AO@#_T
M7'X/_P#AS/!?_P NZ/K>$_Z"J7_@R'^8?5\1_P ^*G_@$O\ (/\ AH;X _\
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M+_(/^&AO@#_T7'X/_P#AS/!?_P NZ/K>$_Z"J7_@R'^8?5\1_P ^*G_@$O\
M(/\ AH;X _\ 1<?@_P#^',\%_P#R[H^MX3_H*I?^#(?YA]7Q'_/BI_X!+_(/
M^&AO@#_T7'X/_P#AS/!?_P NZ/K>$_Z"J7_@R'^8?5\1_P ^*G_@$O\ (/\
MAH;X _\ 1<?@_P#^',\%_P#R[H^MX3_H*I?^#(?YA]7Q'_/BI_X!+_(/^&AO
M@#_T7'X/_P#AS/!?_P NZ/K>$_Z"J7_@R'^8?5\1_P ^*G_@$O\ (/\ AH;X
M _\ 1<?@_P#^',\%_P#R[H^MX3_H*I?^#(?YA]7Q'_/BI_X!+_(/^&AO@#_T
M7'X/_P#AS/!?_P NZ/K>$_Z"J7_@R'^8?5\1_P ^*G_@$O\ (/\ AH;X _\
M1<?@_P#^',\%_P#R[H^MX3_H*I?^#(?YA]7Q'_/BI_X!+_(/^&AO@#_T7'X/
M_P#AS/!?_P NZ/K>$_Z"J7_@R'^8?5\1_P ^*G_@$O\ (/\ AH;X _\ 1<?@
M_P#^',\%_P#R[H^MX3_H*I?^#(?YA]7Q'_/BI_X!+_(/^&AO@#_T7'X/_P#A
MS/!?_P NZ/K>$_Z"J7_@R'^8?5\1_P ^*G_@$O\ (/\ AH;X _\ 1<?@_P#^
M',\%_P#R[H^MX3_H*I?^#(?YA]7Q'_/BI_X!+_(/^&AO@#_T7'X/_P#AS/!?
M_P NZ/K>$_Z"J7_@R'^8?5\1_P ^*G_@$O\ (/\ AH;X _\ 1<?@_P#^',\%
M_P#R[H^MX3_H*I?^#(?YA]7Q'_/BI_X!+_(/^&AO@#_T7'X/_P#AS/!?_P N
MZ/K>$_Z"J7_@R'^8?5\1_P ^*G_@$O\ (/\ AH;X _\ 1<?@_P#^',\%_P#R
M[H^MX3_H*I?^#(?YA]7Q'_/BI_X!+_(/^&AO@#_T7'X/_P#AS/!?_P NZ/K>
M$_Z"J7_@R'^8?5\1_P ^*G_@$O\ (/\ AH;X _\ 1<?@_P#^',\%_P#R[H^M
MX3_H*I?^#(?YA]7Q'_/BI_X!+_(/^&AO@#_T7'X/_P#AS/!?_P NZ/K>$_Z"
MJ7_@R'^8?5\1_P ^*G_@$O\ (/\ AH;X _\ 1<?@_P#^',\%_P#R[H^MX3_H
M*I?^#(?YA]7Q'_/BI_X!+_(/^&AO@#_T7'X/_P#AS/!?_P NZ/K>$_Z"J7_@
MR'^8?5\1_P ^*G_@$O\ (/\ AH;X _\ 1<?@_P#^',\%_P#R[H^MX3_H*I?^
M#(?YA]7Q'_/BI_X!+_(/^&AO@#_T7'X/_P#AS/!?_P NZ/K>$_Z"J7_@R'^8
M?5\1_P ^*G_@$O\ (^5_VV/C)\(/%7[,?Q,T#PM\5?AOXDUV_P#^$,^PZ)H'
MCGPQK&K7GV7X@^%+VY^R:;IVJ37%QY-G;7$\GEQMLB@DD;"(Q'#F6(P\\%6A
M3KTY2?):,9Q;TJ1;LD[Z)7]#JP-&M#%4I2I3C&/-=N,DE[DDM6K+L?T U\H?
M0!0!\_\ B/\ Y.G^#?\ V0#]I;_U8O[)U 'T!0!YS<?%?P1:^,[CP$UYK<^O
MV%N;C6+BP\&^,]2\*^'%&EMK2P^+/'NG>'Y_#'A*\?21'=I::SK%C/)%<VSI
M&PNH/-F$X2I8NOSQI8?!1G*K6K25"C:FX*HJ56LZ=.O.DYQ]K3H2J3I+F=2,
M5";CI.C5I?5(NG*53&\OL*=-.K5G&=2=&$_8T^>K"E.K3J4X5IPC2G.E5C&;
M=*HH]]:W=K>VMO?65S;W=E=V\5W:7EK-'<6MS:SQK-!<V]Q$S1S6\D3(Z2(Q
M5E8,"00:TJQEAY585XNA.@Y*I&HG!TW!M34U*SBXM-24K.+3O:QA2J4ZU.G5
MHSC5I58QE3G!J49QDDXRA*+:E&2:<6FTTTUH1:;J6G:Q86FJ:1?V6J:9?P)<
MV.HZ;=07UA>6T@S'<6EW:R/%<0,.5>-V4CH:3C*%E*+C=1DDU;W9)2BU?I*+
M4HO9IIK1FC3C*I3:Y9T9SISB])0J4IRIU*<EO&=.I&4)Q=I0G&49)--&-KWC
M/PMX8M]4GUO6[&R_L73K75]3M5D:[U.TTR^O)=/L+UM(L5FO9(+J_@GMH&CM
MW\Z:&2*/<Z,H4+3J4:4&G.OB<-@X:Z?6<95A1PU*4OA@ZM2<4G-QBHWJ2E&G
M&4E-5^PH5,143C1HT,7B7+E;_<X"BL1BYP23E4^KTG&=2--2FN>G%1<JD%+I
MJ-OD/\#&\0>(-(\*Z/>Z]KMX+#2M/6)KJY\BYNF4SSQ6MO'%:V4,MQ=3RW,\
M,4<,$4DDCRHB*S, 16=7#44TJF+KT,-23=N:MB:L*%&%W914JE2*<Y.,()N=
M2481E)*;5.EB*TD_9X2A7Q-5I.3C1PU&=>M/EBG*7)2ISGRP4IRY>6$92:3E
MM=9L+FPN=3W7-C8V<VIPW4VLZ?J&@F :1=7-G?7+Q:U:VL@TX/:32Q7NS[-<
MV_EW5M++;313235G##TE7JU(4J/LHUG.4XI0IR@JEZK;_=2C%_O:=7DJ49*4
M*L83C**TC3G*M["G%U*O-&"C#W^:4U%QC3<+JHWS)>XY6G>F[3C**)M9TZ'2
MX-9BEFO]-N4L);6XT6SO=>^U0:E+!%9W5I#HEO=2W5F_VF&5KB)'BCA+7$CI
M!&\B:3A.C66'JPE2K*JJ+C.+BZ=3FY&JO,DJ*C+2I*IR0IV;J2BDV8TJE.M1
M]O1J1JT72E7C.$HRC.G&FZMZ3BW[5R@OW4*?-.M)QA2C.<XQ=?P]XDT3Q5IS
MZMX?OEU'3DU/6M'-TD%S!&=0\.ZQ?:!J\,8NH8FEC@U;3;V 3(K12B'S(7DB
M='8<91AAZEK0Q5"AB:3NO>H8FC"O0J);I5*-2%2*=I*,E=)Z%MJ-2M2YHN>&
MJ2I5%&2DH586YZ;E%N//3D^2K%-RI58SI5%&K3G",M_KVD:9,UI=7T0U%=*U
M'6XM'MA)?Z[>:5I#6R:C>:;H-BDVH:I'!+>V,+"SMIV\V^MH@IEN(D>&^6%:
MHHRE##^S]IR0E4=/VOM%2YHP4I+VGL:OLU;W_95.6_LYVN,'*=&%XP=>?LZ;
MG.-.$II)R7/4<8+E4E*;<DH1?-)J.IIPRK-%%,@D5)8TE19H9;>4*ZAU$L%P
MB2P2 $;HY$1U.59000+G%TY2@[-P;B^649QNG9VE%N,EII*+<6M4VG<RA-3A
M"<4U&24DI1E"5FKKFA-1G%]XRBI1>C2::)*DHI?VEIPU$:/]OLAJS63:DNE_
M:H!J)TY)TM7OQ9>9YQLEN72(SA-@=U0MN(%$?>]KR^][#V?M+:^S]M[7V//;
MX?:^PK>SYK<_L:O+?V<[)M0=.,FHNLJCIIZ.:H^R]JX)_$J7MZ/M.6_)[:ES
M6]I"\]Q<06<$UU=30VMK;123W%Q<2)!!;P0H9)9III&5(HDC5F9V("A220!4
M5*E.C3G5JSC2I4HN4YSDHPA&*O*4I-I1C%*[;:22NRX0G4G"G3@YU)M1C&*;
ME*3=HQC%7;;;222NWHA+6ZM;VUMKVQN8+NRNX(;JSN[6:.XM;JUN(UEM[FVG
MA9DF@DB='21&965@RD@@UM4IU*-2=*K"5*I2DX3A).,H2B[2C*+2<91::::3
M35FKF5.I3K4Z=6C4C5I58QG"<)*4)PDDXRC*+:E&2:<9)M---.Q/4%F,?$&D
M#Q"OA7[8#KS:,_B#[ L%RQCTA+V/3A=S7*PFW@WWC^7'%)*LLODSM$CK;RM&
M0M4^L\C3^IO#JKK;D>*6)=#1VYN=82NWR<W)R1]IR>TI<ZFU3EAXR3B\6L0Z
M6CM)83ZLJ_O).,7#ZYA]).+G[3W%+DJ<FS0,Q=?\0Z-X6T[^UM>ODT_3_MVD
MZ8L[17$Y?4-<U2ST32+.*"UBEEFGNM5U"SMHU1&)>=<X&2"*<JM"A!.57$35
M.G%)MN33D]OAC&$95*DY6A2IPG5J2C3A*2:C+DKU$FX86C6Q%1K7EHX>E*M5
MG9:OEIPDU&*<I-*,(RFXQ:^(/$&D>%='O=>UV\%AI6GK$UU<^1<W3*9YXK6W
MCBM;*&6XNIY;F>&*.&"*221Y41%9F (K.KAJ*:53%UZ&&I)NW-6Q-6%"C"[L
MHJ52I%.<G&$$W.I*,(RDIFU3I8BM)/V>$H5\35:3DXT<-1G7K3Y8IRER4J<Y
M\L%*<N7EA&4FD[FH:EIVD64^HZM?V6EZ?:JK7-_J-U!96=NK.L:-/=7+I'"I
MD=$!=AEG ZD4+XJ=-?'6J4Z5./6=6K.-*E2@MY5*M24:=.$;RG.48Q3DT@;4
M85*DGRTZ-.I5J2>D:=*E"52K4FWI&%*G&52I.5HPA&4I-13:NT;>5AF7K>LZ
M7X;T;5O$.MWD>G:-H6FWVL:M?S"1HK'3=,MI;R^NY%B1W,<-M#+(0BLQ"$ $
MX!SJU848.I.ZC&RM&,IR;;48QC""E.4I2:C&,8N4I-**;:1MA\/6Q5>CA</!
MU*^(G&G3@FDY3G)1C&[:2NVE=M)=6D<WH7Q&\(^)=;UOP_HM]J%W?>'+'3;_
M %NX;P[XDM-#T]-6L;?4[.QE\37ND0Z.^MC3;RSNYM)COGO[6"\MYKFVACGC
M9]ZD)4*6)KUN6A1PE:K0J3G*,(\]"52%>5-R:5:C1J4JE*KB*/M,/3JPE2G5
MC43B<M.K"J\'&ES5)8ZA#$T8QA)OV-1Q5)U$E>C.KS*5*C6]G6JPO4ITY0BY
M+1T;QGX6\0ZE<:3H6M6>L75KH/A_Q.[Z:SW=@^@^*GU5/#VIVNK0(UC>P7W]
MB:D\8M[B5O+A25E6.>%I:E0K4XU93I2I_5\14PE133A*&)I4J%>I1E"5IJ4*
M6)H3E>-E[1*_,FE7/!.E%5(2E6A.I",91E+V<*CHN;C%MQ@ZL9TX2FHJI.E6
MC3<G1JJ'3UD4% !0!2U+4M.T;3[S5=7O[+2M+TZVFO-0U+4KJ"QT^PL[=#)/
M=7EY=2)#:VT4:LSRR.JJJDD@"A)N5.G%7G5G3I0BOBG4JSC3I4X):RG4J2C3
MIP5Y3G*,8IR:0TF[\J;Y5*3LMHQ3E)NVRC%.4GLDFWHAMUJ5M9SZ9;RI?2/J
MUV]G:/9Z7J>H6T<J6-WJ!DU&\L+2:#1[,V]E,JW=_);6[S/;VRRFYNH(IJC%
MN4X?"Z<)5'S-07+"=.#2<FE*IS5(M4HMU9152<8.%*K*"5G3=6+4J<>2S33;
M522C%QBFY3C=IRE%-0C><W&"<E3\0^(]$\*:8=8\07\>FZ<+[2=,%Q)'/-OU
M#7-4L]$TBSCAMHI)99[K5=0LK:-41B7N%S@9(F*<ZM"A!.57$U(TJ4$FW*;3
M?3X8QC&4ZDY6A3IQG4J2C"$I*E&7)7J)-PPM"MB*K6O)1PU*=:M.RU?)3A*7
M+%.4FN6$92:B]OI^']*-OD24M.U"#4[1+RVCO8H7DN(E34=,U'2+L-:W,MI(
M7L-6M+:YCC:6!VCD:%4FC,<T+/#+&[EO=IRV56G3JQ751JTXU(J<?BIU%&25
M2C44:M&HI4JT(583A&5)-U$KKV52I2=TTN:E4E2DXMI*=-R@W3JPYJ5:FXU:
M,YTIPG*[04>50?&GX>W!\2-#?^(&LO"=UJ=CK&MGP'X^3PS]NT;4;/2-1L-)
M\52>&%T?Q'?1:M?1V(M](OKZ62YM[R")'ET^[2VJE%UJ6$JPM&&.K82AAU4:
MI3K3QM54,)*%.JX5'1K3E%QQ/+]75*=.O*JJ%2%22KM8;ZW[73ZA2J5L0H)U
M'2ITL-5QE7F5+G?/2P]&<JE)7JTY\E&<%6JTJ<_5:G;Y#_ \^U#XI>!M,\'W
MWCNYU>XD\,6&JWNA/=V&A>(=5O[S6K#Q'-X1DTK1M!TO2KC5=?OYO$<$EC:P
M:997;WLAC-F)TEC9QIKZBE&4GF-.A5PT81E4E5I8G#K%TJBC!2E&#PK^L3E-
M15&A&=6LZ<(3E&E&\L7!3A_L'M%7E[2FH4I45^]A*HY>S4Z4_P!S.GS<\<0G
MAG%8B+I+NK6YCO+6VNXEG2*Z@AN(DNK6ZL+I(YXUE1;FRO88KBSG"L \%Q%%
M+&P*2(KJ5%U(.E4G2DXN5.3BW"<9QO%V?+.#E"<=-)0E*,EK%M-,RIU(U:=.
MK%2C&I&,DIPG3FDTFE*G4C&<))/WH3C&<7=2BFFB>H+"@ H Q+GQ'HUEJ)TR
M^NVTZXSI,<$VHVMYI^F7UUK=Q?6VFZ;I>LWEO%I^K:Q)-I]P&TZRN9[N$/;O
M-#&EY;M.XKGY5%ISE.I3A"Z]I.5'#_6JKA2;]I.G##J5656,724:5?W[T*RI
MD[4H*K-J--VO*ZY87JTL/!5&FU2=2M7I4J,:G*ZU2<8TE-W+FG:C;ZG;O<VL
M=_%''>7]BRZCI>IZ1<&;3;VXT^X=+35K2VGDM&GMI&M[M(VM[J!HKFUEFMIX
MI9!Q<8TY:6J4X5(JZ;4:D5.*G%.].HDTITJBC5I2O"I"$XRBG)<DYTW:]-I-
MIIQUC&2Y9QO":M))N$I)2YH-J<915^D(Y?3O&7A_5=8U/0=-N;V\U#1M3NM&
MU4P:+K;Z=I^J66E:+K4]C=:U_9W]G0S_ -G>(-+D0-=8E>6:&(O/9W,=NXIR
MITJL?X5:%:=.6T9QP^+J8&JHMVO*&)I5:;IKWVJ=2I&+I0E-$[4Y.FY1]I%T
M5*$91G.FZ]&=>E[2$'*5+FHT_:7J**C"KAG+E^MX7VVU%J>FS:A=Z1#J%C+J
MMA:V5[?:7%=V[ZA966HR7D6GW=W9+(9K:UNI=/OTAED14E:QN A8PN%$FX.I
M%-TXU'2<DO=56,*=25-M:*I&G5I5'#XE"K3DURSBV/W7"+]USBYQ3T<H*7(Y
M176*DG%R6BDK7OH8B^,_#I\0VOA1[NZM_$%\-;>PTV\TC6+&2_MO#B:.VLW]
MC->6$4-YI=N=?TB/[=#(]M)+=^3%*\L<B1E-.K&4J:<E3INK/1ITX+$SPD?:
M)V=.52M3FZ-.:C4KT8O%48U,-:L$KPC*;C*-.->EAN?EER.O6PD\;3A"=N6:
M^KTZCG.#E"E5ISPU64,3&5);]]?66EV5WJ6I7EKIVG:?;3WM_?WUQ#:65C9V
ML33W-W=W5PZ16UM#"CR22R,J(J,S$ $U,I1@KRDHJZ5VTE=M)*[ZMM)+JVDM
M2Z=.I5J0I4H2J5*DE&$(1<I2DW:,8QBFY2;T22;;T1/%+'-''-#(DL,J)+%+
M$ZO')&ZAHY(W0E71E((8$@@@BKE&5.4H3BX3@W&46FG%IV::=FFFK-/5,RA.
M%2$:E.2G3FE*,HM.,HM7C*+5TTTTTUHUJC)LO$&D:AK&M:!97@GU7PZNF-K-
MLL%RJ6!U>":ZT^-[IX1;RW$EM TK0Q2O)&DD+RJBW$1DF%ITIUH-2ITZ]3#2
M=]JU*EAZ\X6>K4:6*H/G2Y&Y."DYTZL8.34*L:$DXU)4*>)BK.SHU:V)P\)J
M5N5WJX3$0<;\\?9\THJ,Z;ELT#"@!"0H))P%&23V ZFIG.-*$JDY*,*:<I-[
M*,5=M^22N"6J2WZ(R/#^OZ1XHT32_$>@7@O]%UFSAU#2[Y8;BW2\L;A=]O=1
M17<,4HAEC*NC,B[E967*L"=)PG2:C4@Z<G&$N62<914X1G%3@[2A-1DN>G-1
MG3E>$XQG&44Y1=.I7HR7+4PU:MAZD7]FKAZLZ%6%]GR5:<X\T6XRMS0E*+4G
ML5(@H 0D(I8D*J@DD\ !1DDGT %3.<*4)U*DE"G3BY2D]%&,5=M]DDKL:3;4
M4KMNR2[[)'->%_&&@>,K&WU3PY<WE_I=WIVFZO8:F^CZS8:;J.G:M'-+87.F
M7^I:?;V^I*\4#.RVLDK1+)"TRQBXA,FLJ=2FG[2$J3C)0<)ITZL9>QHU_>I3
MY:D5R8BFG*4%%5HUL.VJ^&Q%*E,G[.O6PLDU5P\JD*BY6X1G2Q&(PM2'M$G3
M<X5L-54H1FY*G[*O;V&(P]2KKV.JZ9JEJ]]I>H6>J6<5Q?6;W.F7,.H0K>:7
M=SZ?J5GYEF\@-W:W]K<VLT(S)'-;R1.HD1E&<W[*G&K*,O9RI0KP<8RFYTJE
M-5:=2G&*<JD:E.49TG34O:1E%PYE)7I+]Y*EI&I3G[.46U%PFK7C/F:Y'&ZY
ME*W+N[(Q] \8^'_$US>V.D7-VU]I=CH>H:G87^CZSHM_ID'B*TEO])AU&QUK
M3[2>PU&2TA:26PGCCN[8-&+J&%I4#Z.#BJS4H2CA\35PDY0J0J1^L4:6&KU(
M1E"4HSC&EB\/)5(.5*7.XQG*<*D81*2IU_JTKQJJE&NE9V=&>(Q6%C4C.W)*
M,J^"Q,8\LG>--5%^ZJ4ISVKW4M.TT6IU&_LK 7M[;:;9&]NH+47>HW;%+2PM
M3/(OGWL[@K'!'N=R,*I-0M9PI+6I4Y^2"^*7LJ4Z]3EBM9>SHTJE6=D^6E3G
M4E:,)-.34(2J2:C3@X*4GI&+J584::E)Z+VE:I3I0N_>JU(4XWE.*9IVH0:G
M:)>6T=[%"\EQ$J:CIFHZ1=AK6YEM)"]AJUI;7,<;2P.T<C0JDT9CFA9X98W<
MM[M.6RJTZ=6*ZJ-6G&I%3C\5.HHR2J4:BC5HU%*E6A"K"<(I23=1*Z]E4J4G
M=-+FI5)4I.+:2G3<H-TZL.:E6IN-6C.=*<)RNT%&)+XBT:#Q%8>$Y+S;X@U+
M1]3U^ST];>Z<OI&C7FE:?J%Y)<QP-;VRI>:UIT:)-+'),9G,*2+;S&*H1=2.
M)<-5A/J_M=4N3ZU]86'T=F_:?5,1;EO;V4G*RM<DU35'FE&/MY3A2BY+GFZ4
M8SJN,+\[A24Z:JU%'V=.5:C"<HSK4HSNOJ>FQ:C;Z/)J%C'J]W9W>HVFE/=V
MZ:C<Z?836EO?7UO8M()IK.WN+^PBEF1"D;WMNKL&F0,HIR51Q3DJ'L_:-*ZI
M^U]I[+GM\/M?8UO9\UN?V53EOR2L/W%!R]U5'*,&].:4$I2C&_Q.,6G)*[2:
M;LF7J0!0 4 4)-1MXM2M=*:._-U=V=Y?12QZ7J<NFI!8364$\=UK,5HVGV5X
MSW\!AM+BYBN+E([F2WBECL[EH'&+DJC5DJ/L^:[47^\]HH\BDTZEO92]I[-2
M]E>G[7D]K2YVURQC/2TI\B2:<K\KG=Q5Y1A:+7M))0YK0YN>48NKH_B#2-?.
MK#1[P7@T/6;OP_J3+!<Q1V^KZ>D#WMI'+/"B7?DFXCC>6W:6)95EA+^;!*D:
MA:=&AB(-2HXA573DGNJ&(K82II\4>6OAZT%S)<ZBJD.:E.$Y2VHUJ^':<:N%
M=)5(M-<OM\-0Q=*S:Y9*6'Q%&I>#DES\DFJD9QC2\1^,_"WA&QU>_P#$.MV.
MFPZ%H%]XHU2%I&N-0MO#^F\7NJII-FLM]=6L<F(LV]O*6E=(D#2.J,Z:=6K"
MC2]^K*OA,,HQU:K8^K*A@Z<ND'B:L)PHN?*ING4:=J<W&DO>A%RA3YXUZD74
MG"G'V>&C">)J<]248*GAX5:<J]1R4*,:D)5'%3BWTBL&567.UE#+D%3@C(RK
M $''8@&AIQ;CLXNWW:;K3[B(3C4A"<-83BI1NFG9JZT:36CV:36S29D>(O$.
MC^$]!U?Q-X@O!I^B:%I]UJFJ7IAN;DVUE91--/(EM9PRW%U($4A8;>*661BJ
M1H[LJDBG*IAZ,=:F)KT,-2C_ #UL36AAZ%-=$ZE:I"";LDY)MI7:TC&_-[T8
M1IPG4G.<X4Z=.G3A*I4J5*E1QA3ITZ<93J5)RC"$(RE)J*;+%IJEI>K?/$+R
M"/3;J2TN9-0TW4M*C+PP0W+S6LFIVENM_8B*=,7EJ9K8LDL:RF2"58YG*-*E
M[>I.-.DE5DY2E&/)&C5J4IRJ)M.G%2I3E%U%%5*+IXBGS4*M*I/.E+VT_9TH
MSE).DDN2:YG5I4ZT%!N*51\E6$9*'-[.LJF'J<M>E5IPKMX@TC^P#XGM+IM8
MT,Z5_;5K>^';:[\3-J6F-;?;(;G1;3P_!>W.N^?;%7@CT^&YDN-Z"!)&=0VL
MZ52E66'JTY4:RJQHN%1.FX5)35-*ISV5*,9->TG4<84HJ4ZLH0C*2NDE6:5*
M4)7;2;G",;QNFG.4E%6::U:U5M]!F@>)=$\46MY>Z#?IJ%K8:QJ^@7<\<-Q$
MD6KZ!J$^E:Q9#[1#&9'M=2M;FV=HPR>9!(H8E#B%%^SHU;-4\1#VE)[<]/FE
M",TGKR3<'*G*W+4IN%6FY4IPG)-.%2=*490J451<X2C*,H^WP]'%4KJ233E0
MKTIN.\')PFHU(SA&U=ZQI=A<P6-U?VT6H75IJ%_9:6)!)JM_::4+<ZC/IVEP
M[KO45MOM=H)!;0RE6NX%(W3(&SE.,(5IVE)8>G[6I&G"=2<:=^52]G3C*H^:
M7N148MSFU"*<FD7&G*7L[6C&I5A1C.<HTZ?M9QG.%-U)N,(R<*56I:4E^[I5
M)OW(3:LV=U%?6=K>P+<I#=VT%U"EY9W>G7:17$2RQK=:?J$$-U8W(1P'M[F&
M*:)@R2(CJRC:I3E1J5*4G%RI2E%N$X5(7BVGRU*<I4YQNO=G"4H25G&333,*
M52-:E3JP4HPJQC.*G"=*:4DFE.G5C"I3DD_>A4A&<7>,HJ2:+-0:&);>(M&N
M]?U7PO;7GFZYH6G:/JVJV2V]T%L['7YM5@TF1[MH!;/+/)HFI'R(YFFC6!'E
MC1)X6EJ,7.C*O'6E3KSPTI76E>G1P^(G3MO>-'%8>;:7+:K%7O=(DU"5.FY1
M52K3=6,.9.?LE-TE4E!-RA"52-2%.4U&-65*M&FYNA5Y+L6IZ;-J%WI$.H6,
MNJV%K97M]I<5W;OJ%E9:C)>1:?=W=DLAFMK6ZET^_2&61%25K&X"%C"X5)-P
M=2*;IQJ.DY)>ZJL84ZDJ;:T52-.K2J.'Q*%6G)KEG%L?NN$7[KG%SBGHY04N
M1RBNL5).+DM%)6O?0O4@"@#Y_P#VL?\ DUC]I;_L@'QD_P#5=>(Z /H"@ H
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M5=&E5#VJQ^!Q..F\PIX+#4J$YU6OK&+J+%5IXFM5GRN=.&)PM/ 0IX15JU'
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MPT/]G;3_ (8:/H_PUTOQ!!K-EJ>K>%] NY_!O@?Q'I,?BN'5]4\+ZUXG\*>
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MJG"G2I4X0484Z5.$8PCT5<QN?/\ ^UC_ ,FL?M+?]D ^,G_JNO$= 'T!0 4
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MTRX_L/18]/M_,DN;H+Y:,\[H+6TO)[1XARPN)QF$K0=*M@,+C,77YVH4J5/
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M=W5U+>:9I]F[^$_&5II^J7>K:Y-X:MH]$U:]\/16.NK#KEO+:7DFGW-RFGN
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M6+>!P]6.*YOJTX5<7&5&+A5E[T)MVC"<E!KW[2_P[L8O!\/AEM:\9ZOXYN_
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M"/)F:XDU37T>'RIC!&;>ZDR4"")NN5:FLPR>K3I)X+)Z,:%.$DE/_9,HKX'
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M*-2E.#5H.49T*?-"K"I0JPYZ5>C4HU)TWY=XD_97^&?BOPG%X.UN36KW3(-
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M+^,/PV^'FH>(-;@\/^(EUOP]X7^(&E-JAAM;SX<6OQ?\>>+KO29/'WB/QO\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^?_P!K'_DUC]I;_L@'
MQD_]5UXCH ^@* "@#Y_\1_\ )T_P;_[(!^TM_P"K%_9.H ^@* "@ H * "@
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MA-=_#[Q&[I96UU'%'% 9)5:=4 !G_P#"Y/B+_P!&G?M ?^%'^RQ_]$M0 ?\
M"Y/B+_T:=^T!_P"%'^RQ_P#1+4 '_"Y/B+_T:=^T!_X4?[+'_P!$M0 ?\+D^
M(O\ T:=^T!_X4?[+'_T2U !_PN3XB_\ 1IW[0'_A1_LL?_1+4 8'B7]HWQ1X
M/TZVU;Q%^RY^T!IVGW?B#PGX6M[C^VOV9;O?KOCGQ5HW@KPM8^58_M'32)]M
M\3>(-(LO.9%A@^U^=<20V\4LL8!O_P#"Y/B+_P!&G?M ?^%'^RQ_]$M0 ?\
M"Y/B+_T:=^T!_P"%'^RQ_P#1+4 '_"Y/B+_T:=^T!_X4?[+'_P!$M0 ?\+D^
M(O\ T:=^T!_X4?[+'_T2U &!XE_:-\4>#].MM6\1?LN?M :=I]WX@\)^%K>X
M_MK]F6[WZ[XY\5:-X*\+6/E6/[1TTB?;?$WB#2++SF188/M?G7$D-O%++& ;
M_P#PN3XB_P#1IW[0'_A1_LL?_1+4 '_"Y/B+_P!&G?M ?^%'^RQ_]$M0 ?\
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MQ]6>7X*:AC*6/RO!JO6C>E6IX^EF>)K5HX6$N>E5P>&RJM5GAOKE=3]OA_\
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M&4E*TI)R48)J$?&OVL?^36/VEO\ L@'QD_\ 5=>(ZQ-3Z H * "@ H * "@
MH * "@ H * "@ H * /G_P#:Q_Y-8_:6_P"R ?&3_P!5UXCH ^@* "@#Y_\
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MIQH1G+V.L#4^?_V3O^36/V:?^R ?!O\ ]5UX<H ^@* "@ H * "@ H * "@
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MW[-_PK*_@GMI[6R_Y"=O)',_ENE&P;!_PD?[4_\ T1OX ?\ B2WQ%_\ H3J
M#_A(_P!J?_HC?P _\26^(O\ ]"=0 ?\ "1_M3_\ 1&_@!_XDM\1?_H3J #_A
M(_VI_P#HC?P _P#$EOB+_P#0G4 '_"1_M3_]$;^ '_B2WQ%_^A.H X#XL:1^
MU/\ %#X6?$OX9_\ "K_@!H7_  L3X?\ C+P+_;?_  T1\1=3_L?_ (2WP[J6
M@?VI_9O_  RU:?VA]D_M#S_LWVJV\WR?+\Z/=O4 /A/I'[4_PN^%GPT^&?\
MPJ_X :Y_PKKX?^#? O\ ;?\ PT1\1=,_MC_A$?#NFZ!_:G]F_P##+5W_ &?]
MJ_L_S_LWVJY\KSO+\Z39O8V^0;?([_\ X2/]J?\ Z(W\ /\ Q);XB_\ T)U
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MSZ5<ZKX5\*:3H6H7&F3WEI:SS:?)=V$SPO/;6\C1LA>*-B44V^0;?(]0H *
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M'_\ A5_P T?^S_B!\)_'7VO_ (:(^(NH>=_PJ[XI^#?B7_9?D?\ #+5MY?\
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M /G_ ,1_\G3_  ;_ .R ?M+?^K%_9.H ^@* "@ H * "@ H * "@ H * "@
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M_9 /C)_ZKKQ'0!] 4 % 'S_XC_Y.G^#?_9 /VEO_ %8O[)U 'T!0 4 % !0
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M#^F6.BZ%I>G:)HVEVT5GINDZ396VFZ9IUG H2&TL;"SBC@M+:- %6*)$50,
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M_E)2^J83_H%I?^"X?_(C^L8C_G_4_P# Y?YA_P ,\_ '_HAWP?\ _#9^"_\
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M_P#!</\ Y$/K&(_Y_P!3_P #E_F'_#//P!_Z(=\'_P#PV?@O_P"4E'U3"?\
M0+2_\%P_^1#ZQB/^?]3_ ,#E_F'_  SS\ ?^B'?!_P#\-GX+_P#E)1]4PG_0
M+2_\%P_^1#ZQB/\ G_4_\#E_F'_#//P!_P"B'?!__P -GX+_ /E)1]4PG_0+
M2_\ !</_ )$/K&(_Y_U/_ Y?YA_PSS\ ?^B'?!__ ,-GX+_^4E'U3"?] M+_
M ,%P_P#D0^L8C_G_ %/_  .7^8?\,\_ '_HAWP?_ /#9^"__ )24?5,)_P!
MM+_P7#_Y$/K&(_Y_U/\ P.7^8?\ #//P!_Z(=\'_ /PV?@O_ .4E'U3"?] M
M+_P7#_Y$/K&(_P"?]3_P.7^8?\,\_ '_ *(=\'__  V?@O\ ^4E'U3"?] M+
M_P %P_\ D0^L8C_G_4_\#E_F'_#//P!_Z(=\'_\ PV?@O_Y24?5,)_T"TO\
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M%P_^1#ZQB/\ G_4_\#E_F'_#//P!_P"B'?!__P -GX+_ /E)1]4PG_0+2_\
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M_P"1#ZQB/^?]3_P.7^8?\,\_ '_HAWP?_P##9^"__E)1]4PG_0+2_P#!</\
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M/K&(_P"?]3_P.7^8?\,\_ '_ *(=\'__  V?@O\ ^4E'U3"?] M+_P %P_\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M3_Z)RC^V\7_S[I?^ S_^6!_9>'_GJ??'_P"0#_AG3X_?]%S^#_\ XCGXT_\
MHG*/[;Q?_/NE_P" S_\ E@?V7A_YZGWQ_P#D _X9T^/W_1<_@_\ ^(Y^-/\
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MI?\ @,__ )8']EX?^>I]\?\ Y /^&=/C]_T7/X/_ /B.?C3_ .B<H_MO%_\
M/NE_X#/_ .6!_9>'_GJ??'_Y /\ AG3X_?\ 1<_@_P#^(Y^-/_HG*/[;Q?\
MS[I?^ S_ /E@?V7A_P">I]\?_D _X9T^/W_1<_@__P"(Y^-/_HG*/[;Q?_/N
ME_X#/_Y8']EX?^>I]\?_ ) /^&=/C]_T7/X/_P#B.?C3_P"B<H_MO%_\^Z7_
M (#/_P"6!_9>'_GJ??'_ .0#_AG3X_?]%S^#_P#XCGXT_P#HG*/[;Q?_ #[I
M?^ S_P#E@?V7A_YZGWQ_^0#_ (9T^/W_ $7/X/\ _B.?C3_Z)RC^V\7_ ,^Z
M7_@,_P#Y8']EX?\ GJ??'_Y /^&=/C]_T7/X/_\ B.?C3_Z)RC^V\7_S[I?^
M S_^6!_9>'_GJ??'_P"0#_AG3X_?]%S^#_\ XCGXT_\ HG*/[;Q?_/NE_P"
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MGWQ_^0#_ (9T^/W_ $7/X/\ _B.?C3_Z)RC^V\7_ ,^Z7_@,_P#Y8']EX?\
MGJ??'_Y /^&=/C]_T7/X/_\ B.?C3_Z)RC^V\7_S[I?^ S_^6!_9>'_GJ??'
M_P"0#_AG3X_?]%S^#_\ XCGXT_\ HG*/[;Q?_/NE_P" S_\ E@?V7A_YZGWQ
M_P#D _X9T^/W_1<_@_\ ^(Y^-/\ Z)RC^V\7_P ^Z7_@,_\ Y8']EX?^>I]\
M?_D _P"&=/C]_P!%S^#_ /XCGXT_^B<H_MO%_P#/NE_X#/\ ^6!_9>'_ )ZG
MWQ_^0#_AG3X_?]%S^#__ (CGXT_^B<H_MO%_\^Z7_@,__E@?V7A_YZGWQ_\
MD _X9T^/W_1<_@__ .(Y^-/_ *)RC^V\7_S[I?\ @,__ )8']EX?^>I]\?\
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M (9T^/W_ $7/X/\ _B.?C3_Z)RC^V\7_ ,^Z7_@,_P#Y8']EX?\ GJ??'_Y
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MRRS!I7C3P^(>#QV7PP\8\ZK*%66(E3KQJ7]2MAIRS:I1P56-3!RSC"Y"E/\
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M&\XPV16E^[5#%4,FJXO,\1SRYI5J5#&8''QQ/,Z4:,(T?8*KS<I]/_ CXO\
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MWFH)?^(]0\.P^$+2*P\)ZMI]B);>_35[ATNI4M#!)'+!>7'F8JM4HY-B\;_
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MIXFLJK45[:<_:UE4JPA./L-04% !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M&B_C]_T0SX/_ /B1GC3_ .ACH_L/%_\ /RE_X%/_ .5A_:F'_DJ?='_Y,/\
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MSX/_ /B1GC3_ .ACH_L/%_\ /RE_X%/_ .5A_:F'_DJ?='_Y,/\ AHOX_?\
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M/_\ B1GC3_Z&.C^P\7_S\I?^!3_^5A_:F'_DJ?='_P"3#_AHOX_?]$,^#_\
MXD9XT_\ H8Z/[#Q?_/RE_P"!3_\ E8?VIA_Y*GW1_P#DP_X:+^/W_1#/@_\
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M3_Z&.C^P\7_S\I?^!3_^5A_:F'_DJ?='_P"3#_AHOX_?]$,^#_\ XD9XT_\
MH8Z/[#Q?_/RE_P"!3_\ E8?VIA_Y*GW1_P#DP_X:+^/W_1#/@_\ ^)&>-/\
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MI?\ @4__ )6']J8?^2I]T?\ Y,/^&B_C]_T0SX/_ /B1GC3_ .ACH_L/%_\
M/RE_X%/_ .5A_:F'_DJ?='_Y,/\ AHOX_?\ 1#/@_P#^)&>-/_H8Z/[#Q?\
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MNQ^LM>:=P4 ?$7[1?_)?O@9_V1_]HS_U-/V8Z]G(_P#>ZG_7J7_I=,\W-/\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H ^/OV]_\ DTWXK_\ <B_^K*\'5YV:_P"X5_\ MS_TY [,
MO_WNE_V]_P"D2/VYKXX^D"@#\_OVL_&7A#P-\;O@-JWC7Q5X;\'Z5/\ "O\
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M+_(/^&AO@#_T7'X/_P#AS/!?_P NZ/K>$_Z"J7_@R'^8?5\1_P ^*G_@$O\
M(/\ AH;X _\ 1<?@_P#^',\%_P#R[H^MX3_H*I?^#(?YA]7Q'_/BI_X!+_(/
M^&AO@#_T7'X/_P#AS/!?_P NZ/K>$_Z"J7_@R'^8?5\1_P ^*G_@$O\ (/\
MAH;X _\ 1<?@_P#^',\%_P#R[H^MX3_H*I?^#(?YA]7Q'_/BI_X!+_(/^&AO
M@#_T7'X/_P#AS/!?_P NZ/K>$_Z"J7_@R'^8?5\1_P ^*G_@$O\ (/\ AH;X
M _\ 1<?@_P#^',\%_P#R[H^MX3_H*I?^#(?YA]7Q'_/BI_X!+_(/^&AO@#_T
M7'X/_P#AS/!?_P NZ/K>$_Z"J7_@R'^8?5\1_P ^*G_@$O\ (/\ AH;X _\
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M+_(/^&AO@#_T7'X/_P#AS/!?_P NZ/K>$_Z"J7_@R'^8?5\1_P ^*G_@$O\
M(/\ AH;X _\ 1<?@_P#^',\%_P#R[H^MX3_H*I?^#(?YA]7Q'_/BI_X!+_(/
M^&AO@#_T7'X/_P#AS/!?_P NZ/K>$_Z"J7_@R'^8?5\1_P ^*G_@$O\ (/\
MAH;X _\ 1<?@_P#^',\%_P#R[H^MX3_H*I?^#(?YA]7Q'_/BI_X!+_(/^&AO
M@#_T7'X/_P#AS/!?_P NZ/K>$_Z"J7_@R'^8?5\1_P ^*G_@$O\ (/\ AH;X
M _\ 1<?@_P#^',\%_P#R[H^MX3_H*I?^#(?YA]7Q'_/BI_X!+_(/^&AO@#_T
M7'X/_P#AS/!?_P NZ/K>$_Z"J7_@R'^8?5\1_P ^*G_@$O\ (/\ AH;X _\
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M$U*FXU:>M+V5"O5Q&%;P6)J9IC\;2Q"HTZ]7 TYT,YCE#PZJR5*:RRMFLYK
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M*RC&4E2>04:+=U.EA,LCDGUQ8>:FOJM:O7R>EBXNFJBK2ITJ-:=-\F)PW _
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MPM3'<M\#"O.#QD?]V]JXS47B7#!SS&-6I!QRM5G5G"2G&:PM-3QOU91O/%/
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MS"Y55UE"5:A@L-5PF&J3J4G3JTZE.C5DG3P]2AA*CC3=7"SY$;XG_:8UX/\
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MZ?X-_P#9 /VEO_5B_LG4 ?0% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M_P#HI'P _P#$?/B+_P#10T '_"6?M3_]%(^ '_B/GQ%_^BAH /\ A+/VI_\
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MJ /H"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M55\\Z4E1I5(TY5HSG2Q,I2K5I>U3JU94U3K5,16I8C#\OV?7";A0 4 % !0
M4 % !0 4 % !0!P.M?\ )8OV6?\ LM7BK_UF3]H>@#[NH ^?_P!K'_DUC]I;
M_L@'QD_]5UXCH ^@* "@#Y_\1_\ )T_P;_[(!^TM_P"K%_9.H U?V@_'?BKX
M<?#&Z\2>"CX?C\37'C7X3>#],G\4Z3J.N:%9?\+%^+/@CX>7FHWVCZ3K^B7>
MI?8]/\47=U%!%JMCOFMH@\H3<& /$O\ A+/VI_\ HI'P _\ $?/B+_\ 10T
M'_"6?M3_ /12/@!_XCY\1?\ Z*&@ _X2S]J?_HI'P _\1\^(O_T4- !_PEG[
M4_\ T4CX ?\ B/GQ%_\ HH: #_A+/VI_^BD? #_Q'SXB_P#T4- '%_$GXN?M
M3_#WX=>/O'W_  F_P U?_A!_!7BGQA_9/_"A_B+I_P#:?_",Z%?ZU_9WV_\
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M/_T4CX ?^(^?$7_Z*&@ _P"$L_:G_P"BD? #_P 1\^(O_P!%#0 ?\)9^U/\
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M/_T4CX ?^(^?$7_Z*&@ _P"$L_:G_P"BD? #_P 1\^(O_P!%#0 ?\)9^U/\
M]%(^ '_B/GQ%_P#HH: #_A+/VI_^BD? #_Q'SXB__10T '_"6?M3_P#12/@!
M_P"(^?$7_P"BAH /^$L_:G_Z*1\ /_$?/B+_ /10T '_  EG[4__ $4CX ?^
M(^?$7_Z*&@ _X2S]J?\ Z*1\ /\ Q'SXB_\ T4- !_PEG[4__12/@!_XCY\1
M?_HH: /$_P!H+7OVCM3^'VFV&N_$#X)7&GW/Q<_9ZC5-(^!OCO2KR/41\?\
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MJ_9M_P#6BOA90![50 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M7)BZR6'=%.A5][^&_P !9/!UG\0+N\GL!XT\6Z#I'AK2_'?G6^M>,M,T?3O
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M3FX*G5J5,KYH?6IX>-.G/DK*%>7LZ;9?VS_@Z)/%\-C)J>KS>$4EEE@TS5/
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M6KQ5_P"LR?M#T ?=U 'S_P#M8_\ )K'[2W_9 /C)_P"JZ\1T ?0% !0!\_\
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M/_5=>(Z /H"@ H ^?_$?_)T_P;_[(!^TM_ZL7]DZ@#)_:T_Y([;?]EJ_9?\
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MAS=^53DHW^'FE:UW<>O)?7V?/R7^S[3DY^7^7G]G3Y[6YO9PO?EC;QWX^?\
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M;UJRI\T%.5*G-0E.$)-2G!/M=5^"5IH?AB7QGJ?[7'QPM?"T-A;ZG_;8T_\
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M /0Z4 '_  S%KG_1SO[0'_@I_9I_^ATH /\ AF+7/^CG?V@/_!3^S3_]#I0
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M25HX65&TJ<IV^_Z^?/</G_\ :6_Y)UX<_P"S@/V3O_6I_@W0!] 4 % !0 4
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MB+_T:=^T!_X4?[+'_P!$M0 ?\+D^(O\ T:=^T!_X4?[+'_T2U !_PN3XB_\
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MSU*=26LZ5)4(/I&FJM2M917NINI5FY3MSS2IPG)PI4HPV?\ A<GQ%_Z-._:
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MW_[*P'_/C_R>I_\ )GD_7\7_ ,_?_)8?_(A_PKBS_P"A_P#C_P#^)/?M'_\
MSU*/[*P'_/C_ ,GJ?_)A]?Q?_/W_ ,EA_P#(F:GA#0GU:?0E^)'Q^&K6UA;Z
MI)9O^TU^TK&QL+J>XM8KF&23XH+'<QBXMI8Y!"[F(F/S0GG1>8H99ET_:\E%
M-T)0C47M*EX.I%SIMQY[J-11FJ<[<DY4JT(R<Z-6,'+'8R"I7J\JK*;A[L/>
M]DX*HE[N\/:4^9;I5(-JTXMZ7_"N+/\ Z'_X_P#_ (D]^T?_ //4I_V5@/\
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M*-[22::53QN-I5*U&=1QJ8>K5HU(N$+PJT*DJ56#]W>%2$HMJZ=KIM69I_\
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MUZ?MO?PU:K0J+DA[M6A4E2JPORV?+.,H\T6XNUXMIIFQ_P *XL_^A_\ C_\
M^)/?M'__ #U*/[*P'_/C_P GJ?\ R97U_%_\_?\ R6'_ ,B'_"N+/_H?_C__
M .)/?M'_ /SU*/[*P'_/C_R>I_\ )A]?Q?\ S]_\EA_\B'_"N+/_ *'_ ./_
M /XD]^T?_P#/4H_LK ?\^/\ R>I_\F'U_%_\_?\ R6'_ ,B'_"N;,?\ ,_\
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M>I_\F'U_%_\ /W_R6'_R(?\ "N+/_H?_ (__ /B3W[1__P ]2C^RL!_SX_\
M)ZG_ ,F'U_%_\_?_ "6'_P B'_"N+/\ Z'_X_P#_ (D]^T?_ //4H_LK ?\
M/C_R>I_\F'U_%_\ /W_R6'_R(?\ "N+/_H?_ (__ /B3W[1__P ]2C^RL!_S
MX_\ )ZG_ ,F'U_%_\_?_ "6'_P B'_"N+/\ Z'_X_P#_ (D]^T?_ //4H_LK
M ?\ /C_R>I_\F'U_%_\ /W_R6'_R(?\ "N+/_H?_ (__ /B3W[1__P ]2C^R
ML!_SX_\ )ZG_ ,F'U_%_\_?_ "6'_P B'_"N+/\ Z'_X_P#_ (D]^T?_ //4
MH_LK ?\ /C_R>I_\F'U_%_\ /W_R6'_R(?\ "N+/_H?_ (__ /B3W[1__P ]
M2C^RL!_SX_\ )ZG_ ,F'U_%_\_?_ "6'_P B'_"N+/\ Z'_X_P#_ (D]^T?_
M //4H_LK ?\ /C_R>I_\F'U_%_\ /W_R6'_R(?\ "N+/_H?_ (__ /B3W[1_
M_P ]2C^RL!_SX_\ )ZG_ ,F'U_%_\_?_ "6'_P B'_"N+/\ Z'_X_P#_ (D]
M^T?_ //4H_LK ?\ /C_R>I_\F'U_%_\ /W_R6'_R(?\ "N+/_H?_ (__ /B3
MW[1__P ]2C^RL!_SX_\ )ZG_ ,F'U_%_\_?_ "6'_P B'_"N+/\ Z'_X_P#_
M (D]^T?_ //4H_LK ?\ /C_R>I_\F'U_%_\ /W_R6'_R(?\ "N+/_H?_ (__
M /B3W[1__P ]2C^RL!_SX_\ )ZG_ ,F'U_%_\_?_ "6'_P B'_"N+/\ Z'_X
M_P#_ (D]^T?_ //4H_LK ?\ /C_R>I_\F'U_%_\ /W_R6'_R(?\ "N+/_H?_
M (__ /B3W[1__P ]2C^RL!_SX_\ )ZG_ ,F'U_%_\_?_ "6'_P B'_"N+/\
MZ'_X_P#_ (D]^T?_ //4H_LK ?\ /C_R>I_\F'U_%_\ /W_R6'_R(?\ "N+/
M_H?_ (__ /B3W[1__P ]2C^RL!_SX_\ )ZG_ ,F'U_%_\_?_ "6'_P B'_"N
M+/\ Z'_X_P#_ (D]^T?_ //4H_LK ?\ /C_R>I_\F'U_%_\ /W_R6'_R(?\
M"N+/_H?_ (__ /B3W[1__P ]2C^RL!_SX_\ )ZG_ ,F'U_%_\_?_ "6'_P B
M'_"N+/\ Z'_X_P#_ (D]^T?_ //4H_LK ?\ /C_R>I_\F'U_%_\ /W_R6'_R
M(?\ "N+/_H?_ (__ /B3W[1__P ]2C^RL!_SX_\ )ZG_ ,F'U_%_\_?_ "6'
M_P B'_"N+/\ Z'_X_P#_ (D]^T?_ //4H_LK ?\ /C_R>I_\F'U_%_\ /W_R
M6'_R(?\ "N+/_H?_ (__ /B3W[1__P ]2C^RL!_SX_\ )ZG_ ,F'U_%_\_?_
M "6'_P B'_"N+/\ Z'_X_P#_ (D]^T?_ //4H_LK ?\ /C_R>I_\F'U_%_\
M/W_R6'_R(?\ "N+/_H?_ (__ /B3W[1__P ]2C^RL!_SX_\ )ZG_ ,F'U_%_
M\_?_ "6'_P B'_"N+/\ Z'_X_P#_ (D]^T?_ //4H_LK ?\ /C_R>I_\F'U_
M%_\ /W_R6'_R(?\ "N+/_H?_ (__ /B3W[1__P ]2C^RL!_SX_\ )ZG_ ,F'
MU_%_\_?_ "6'_P B'_"N+/\ Z'_X_P#_ (D]^T?_ //4H_LK ?\ /C_R>I_\
MF'U_%_\ /W_R6'_R(?\ "N+/_H?_ (__ /B3W[1__P ]2C^RL!_SX_\ )ZG_
M ,F'U_%_\_?_ "6'_P B'_"N+/\ Z'_X_P#_ (D]^T?_ //4H_LK ?\ /C_R
M>I_\F'U_%_\ /W_R6'_R(?\ "N+/_H?_ (__ /B3W[1__P ]2C^RL!_SX_\
M)ZG_ ,F'U_%_\_?_ "6'_P B'_"N+/\ Z'_X_P#_ (D]^T?_ //4H_LK ?\
M/C_R>I_\F'U_%_\ /W_R6'_R(?\ "N+/_H?_ (__ /B3W[1__P ]2C^RL!_S
MX_\ )ZG_ ,F'U_%_\_?_ "6'_P B'_"N+/\ Z'_X_P#_ (D]^T?_ //4H_LK
M ?\ /C_R>I_\F'U_%_\ /W_R6'_R(?\ "N+/_H?_ (__ /B3W[1__P ]2C^R
ML!_SX_\ )ZG_ ,F'U_%_\_?_ "6'_P B'_"N+/\ Z'_X_P#_ (D]^T?_ //4
MH_LK ?\ /C_R>I_\F'U_%_\ /W_R6'_R(?\ "N+/_H?_ (__ /B3W[1__P ]
M2C^RL!_SX_\ )ZG_ ,F'U_%_\_?_ "6'_P B'_"N+/\ Z'_X_P#_ (D]^T?_
M //4H_LK ?\ /C_R>I_\F'U_%_\ /W_R6'_R(?\ "N+/_H?_ (__ /B3W[1_
M_P ]2C^RL!_SX_\ )ZG_ ,F'U_%_\_?_ "6'_P B'_"N+/\ Z'_X_P#_ (D]
M^T?_ //4H_LK ?\ /C_R>I_\F'U_%_\ /W_R6'_R(?\ "N+/_H?_ (__ /B3
MW[1__P ]2C^RL!_SX_\ )ZG_ ,F'U_%_\_?_ "6'_P B'_"N+/\ Z'_X_P#_
M (D]^T?_ //4H_LK ?\ /C_R>I_\F'U_%_\ /W_R6'_R)\O_ +9^@7G@[]F3
MXJ:YH7Q"^."WRZ?H&DR1:M^T'\=/$FE7FE>(_%_A[PWKVF:GH/B/XB7^F:KI
M]]H>K:C9S6]Y:3QO'=N"N<$<>89?A,/A*M6E1Y9QY;/FF[7G%/1R:V;6QTX/
M&8BKB*=.I4YH2YKKEBMHR:U44]T?NU7S1[84 ?$7[1?_ "7[X&?]D?\ VC/_
M %-/V8Z]G(_][J?]>I?^ETSS<T_W>'_7Q?\ I,S$KZD\$^9OVBOAQK_C_P#X
M1 VNG^(/$GAG2&UW^WO"/AN'X47NH:C?WT-@NA:H=-^-.EWOAB]M]/>WOU8R
MB&\@-^L]F[/&T4ODXK"5*N.A5M4E%8>=*A*$Z,5AL2ZM.7MYNI3G6H\U.+@L
M5@KXJ@UR1I5(5IN'I87$4Z6#J44X4J\L3AZCG)UUS8>G3Q,:E**HM*;=6I0J
M^RK_ +B:I-R<:D*3-+P?X>U32?%OPGT:9]2GO? _PFUVQ\576IZY'K]_;G7+
MWPI!H>G:GK%GH^EV^L7<L_A_5I%N5L+0,-'D=8E$GS>PI\^.S>LI\U%8? X:
M34)1C6Q49U*OM$Y-WJ4**J2JZJ?_  H4IRA35:,5Q3<(X"C24'&I7S*MBJ,>
M2G#V6%A2Q<*D>6E>%"$IXO"1IT*;E22P\H0J55A>=_0]29'@WB%_&?AGXLZI
MXIT?X:^)_'&D:Q\._#GAZ"Z\.ZO\/]/BL=7TGQ#XJOYX=4C\7^--%NH[8V^K
MV3":RM;[@R (738W#2=>E/-J,<*Y?7*N#G2JSE35#]W0K4IJKRRG7BHRG%RY
M</-N%^13DN4[JLJ%3 Y7'VZC/!5<SE4I*,W4Y<3'*_9.G>,:,G+ZI6C:5:%I
M*/,XQES+YQ\0_L\^/;F\\._VA:^*-:\KPY:QZ-_PA>L?"2UT_P"'?BN]\4>(
M/$.O3)K7Q-\(:IK?ANPB36M.M[76?!5L^I/%H:QS6F(K8J8/"K!X[+TG.?\
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MG2;KQI+%*=2RY<ORY5N"\/\ P5N]0M?AWHFK?!.S\-:#HOC;2M0\?6FI^)]
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M0O@!_P"'[^(O_P!#+1_;W_4+_P"5?_N8?V3_ -1'_DG_ -N'_"LOVI_^A"^
M'_A^_B+_ /0RT?V]_P!0O_E7_P"YA_9/_41_Y)_]N'_"LOVI_P#H0O@!_P"'
M[^(O_P!#+1_;W_4+_P"5?_N8?V3_ -1'_DG_ -N'_"LOVI_^A"^ '_A^_B+_
M /0RT?V]_P!0O_E7_P"YA_9/_41_Y)_]N'_"LOVI_P#H0O@!_P"'[^(O_P!#
M+1_;W_4+_P"5?_N8?V3_ -1'_DG_ -N'_"LOVI_^A"^ '_A^_B+_ /0RT?V]
M_P!0O_E7_P"YA_9/_41_Y)_]N'_"LOVI_P#H0O@!_P"'[^(O_P!#+1_;W_4+
M_P"5?_N8?V3_ -1'_DG_ -N'_"LOVI_^A"^ '_A^_B+_ /0RT?V]_P!0O_E7
M_P"YA_9/_41_Y)_]N'_"LOVI_P#H0O@!_P"'[^(O_P!#+1_;W_4+_P"5?_N8
M?V3_ -1'_DG_ -N'_"LOVI_^A"^ '_A^_B+_ /0RT?V]_P!0O_E7_P"YA_9/
M_41_Y)_]N'_"LOVI_P#H0O@!_P"'[^(O_P!#+1_;W_4+_P"5?_N8?V3_ -1'
M_DG_ -N'_"LOVI_^A"^ '_A^_B+_ /0RT?V]_P!0O_E7_P"YA_9/_41_Y)_]
MN'_"LOVI_P#H0O@!_P"'[^(O_P!#+1_;W_4+_P"5?_N8?V3_ -1'_DG_ -N'
M_"LOVI_^A"^ '_A^_B+_ /0RT?V]_P!0O_E7_P"YA_9/_41_Y)_]N'_"LOVI
M_P#H0O@!_P"'[^(O_P!#+1_;W_4+_P"5?_N8?V3_ -1'_DG_ -N'_"LOVI_^
MA"^ '_A^_B+_ /0RT?V]_P!0O_E7_P"YA_9/_41_Y)_]N'_"LOVI_P#H0O@!
M_P"'[^(O_P!#+1_;W_4+_P"5?_N8?V3_ -1'_DG_ -N'_"LOVI_^A"^ '_A^
M_B+_ /0RT?V]_P!0O_E7_P"YA_9/_41_Y)_]N'_"LOVI_P#H0O@!_P"'[^(O
M_P!#+1_;W_4+_P"5?_N8?V3_ -1'_DG_ -N'_"LOVI_^A"^ '_A^_B+_ /0R
MT?V]_P!0O_E7_P"YA_9/_41_Y)_]N'_"LOVI_P#H0O@!_P"'[^(O_P!#+1_;
MW_4+_P"5?_N8?V3_ -1'_DG_ -N'_"LOVI_^A"^ '_A^_B+_ /0RT?V]_P!0
MO_E7_P"YA_9/_41_Y)_]N'_"LOVI_P#H0O@!_P"'[^(O_P!#+1_;W_4+_P"5
M?_N8?V3_ -1'_DG_ -N'_"LOVI_^A"^ '_A^_B+_ /0RT?V]_P!0O_E7_P"Y
MA_9/_41_Y)_]N'_"LOVI_P#H0O@!_P"'[^(O_P!#+1_;W_4+_P"5?_N8?V3_
M -1'_DG_ -N'_"LOVI_^A"^ '_A^_B+_ /0RT?V]_P!0O_E7_P"YA_9/_41_
MY)_]N'_"LOVI_P#H0O@!_P"'[^(O_P!#+1_;W_4+_P"5?_N8?V3_ -1'_DG_
M -N'_"LOVI_^A"^ '_A^_B+_ /0RT?V]_P!0O_E7_P"YA_9/_41_Y)_]N'_"
MLOVI_P#H0O@!_P"'[^(O_P!#+1_;W_4+_P"5?_N8?V3_ -1'_DG_ -N'_"LO
MVI_^A"^ '_A^_B+_ /0RT?V]_P!0O_E7_P"YA_9/_41_Y)_]N'_"LOVI_P#H
M0O@!_P"'[^(O_P!#+1_;W_4+_P"5?_N8?V3_ -1'_DG_ -N'_"LOVI_^A"^
M'_A^_B+_ /0RT?V]_P!0O_E7_P"YA_9/_41_Y)_]N'_"LOVI_P#H0O@!_P"'
M[^(O_P!#+1_;W_4+_P"5?_N8?V3_ -1'_DG_ -N'_"LOVI_^A"^ '_A^_B+_
M /0RT?V]_P!0O_E7_P"YA_9/_41_Y)_]N'_"LOVI_P#H0O@!_P"'[^(O_P!#
M+1_;W_4+_P"5?_N8?V3_ -1'_DG_ -N'_"LOVI_^A"^ '_A^_B+_ /0RT?V]
M_P!0O_E7_P"YA_9/_41_Y)_]N'_"LOVI_P#H0O@!_P"'[^(O_P!#+1_;W_4+
M_P"5?_N8?V3_ -1'_DG_ -N'_"LOVI_^A"^ '_A^_B+_ /0RT?V]_P!0O_E7
M_P"YA_9/_41_Y)_]N'_"LOVI_P#H0O@!_P"'[^(O_P!#+1_;W_4+_P"5?_N8
M?V3_ -1'_DG_ -N'_"LOVI_^A"^ '_A^_B+_ /0RT?V]_P!0O_E7_P"YA_9/
M_41_Y)_]N'_"LOVI_P#H0O@!_P"'[^(O_P!#+1_;W_4+_P"5?_N8?V3_ -1'
M_DG_ -N'_"LOVI_^A"^ '_A^_B+_ /0RT?V]_P!0O_E7_P"YA_9/_41_Y)_]
MN'_"LOVI_P#H0O@!_P"'[^(O_P!#+1_;W_4+_P"5?_N8?V3_ -1'_DG_ -N'
M_"LOVI_^A"^ '_A^_B+_ /0RT?V]_P!0O_E7_P"YA_9/_41_Y)_]N'_"LOVI
M_P#H0O@!_P"'[^(O_P!#+1_;W_4+_P"5?_N8?V3_ -1'_DG_ -N'_"LOVI_^
MA"^ '_A^_B+_ /0RT?V]_P!0O_E7_P"YA_9/_41_Y)_]N'_"LOVI_P#H0O@!
M_P"'[^(O_P!#+1_;W_4+_P"5?_N8?V3_ -1'_DG_ -N'_"LOVI_^A"^ '_A^
M_B+_ /0RT?V]_P!0O_E7_P"YA_9/_41_Y)_]N'_"LOVI_P#H0O@!_P"'[^(O
M_P!#+1_;W_4+_P"5?_N8?V3_ -1'_DG_ -N'_"LOVI_^A"^ '_A^_B+_ /0R
MT?V]_P!0O_E7_P"YA_9/_41_Y)_]N'_"LOVI_P#H0O@!_P"'[^(O_P!#+1_;
MW_4+_P"5?_N8?V3_ -1'_DG_ -N'_"LOVI_^A"^ '_A^_B+_ /0RT?V]_P!0
MO_E7_P"YA_9/_41_Y)_]N'_"LOVI_P#H0O@!_P"'[^(O_P!#+1_;W_4+_P"5
M?_N8?V3_ -1'_DG_ -N'_"LOVI_^A"^ '_A^_B+_ /0RT?V]_P!0O_E7_P"Y
MA_9/_41_Y)_]N'_"LOVI_P#H0O@!_P"'[^(O_P!#+1_;W_4+_P"5?_N8?V3_
M -1'_DG_ -N'_"LOVI_^A"^ '_A^_B+_ /0RT?V]_P!0O_E7_P"YA_9/_41_
MY)_]N'_"LOVI_P#H0O@!_P"'[^(O_P!#+1_;W_4+_P"5?_N8?V3_ -1'_DG_
M -N'_"LOVI_^A"^ '_A^_B+_ /0RT?V]_P!0O_E7_P"YA_9/_41_Y)_]N'_"
MLOVI_P#H0O@!_P"'[^(O_P!#+1_;W_4+_P"5?_N8?V3_ -1'_DG_ -N'_"LO
MVI_^A"^ '_A^_B+_ /0RT?V]_P!0O_E7_P"YA_9/_41_Y)_]N'_"LOVI_P#H
M0O@!_P"'[^(O_P!#+1_;W_4+_P"5?_N8?V3_ -1'_DG_ -N'_"LOVI_^A"^
M'_A^_B+_ /0RT?V]_P!0O_E7_P"YA_9/_41_Y)_]N?-_[7WP0_:2\3?LS_&.
MTUWPS\#]"T31_!]QXUUC4M)^,7CSQ#JL6E?#J[M/'VH6^F:+>? '1K>_U"ZM
M/#4UI"D^J6,8DND9Y55#GGQ6;?6</4H?5^3GY?>Y[VM)2VY%VMN;8?+OJ]:%
M7VW-RWTY+;Q<=^9[7['[&5XQZ04 ?/\ XC_Y.G^#?_9 /VEO_5B_LG4 ?0%
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MWL/BWI_PWT*\74?!&K'X@1V?A.\\9^+7\,V%KXWM'T.^LM-TZ:!+CQ%-IMA
MU]:37EQ&T=[:6/FT*O/A\'C)P<:,Z><XFO1BXNM2P65^WP4<9[2[PT8/-HT:
M%2G.I[65/FIT(SK5\,WWUZ<(/%4:6*I1J8993%U*JJ*DL5F&*P-26"5.,7B*
MU991BIXRG*C3DE.E6G.'U;#^TQ-SP)^U[\+?B/XX\-> /"5IXCU+6M>T;3-7
MU'RF\(R/X+;5_"D/C+3['QAH=MXNEU^R232+FVC.LV6CZAH27EU#8OJRW<JP
MGOC@ZDJN90A*$J.6^T3KIMT:TZ5:-"I2@^7VE&LIN;A2QM/"SK0HUG0C5=*2
M6.*Y\$Z-+%4_88N<Y0GA74H.O14,14PLIM1JRIUXQKT[3^I5,5*E2G2Q56,,
M)5A7EHW?[4WP^C^(WB_X9:+I?B7Q=KW@33-8O/$TOA67P9J,6E:EHNB/X@G\
M/WVCS^,;?Q!IMY/IR[;;4[W1;70Y[IA81ZL;X&W7AP]2E6P6*S%U(T,OP?,Y
MXB=W25.CC88'$S;I*HX/"U)3JSP]54\76PM"OB<'A\52@I2VJ4W3Q>!P'Q8W
M'U*=*%!*49Q=;#/%8><G4C"$J-:'LZ?MZ$JM'#UJU&EC)X:4],9_VQ_A/)XM
M\(^#-+MO$FN:KXU.CWNAKIO_  B45Q<^$_$&I2:3HWC^ST#5?%MEK^O>#;B\
MM;]S<Z)I&J7-O96+ZM=6D&D3VM_==,</65?$X:K#ZM/ 0K3Q?M&E]3E1HRQ,
M:6+C!SJ8>=;#^QG"56$:-*IB:&%Q=7#8UU,-2Y95H1P='&1:E3Q$I1P\>:$)
MXCV48/$>P524(U)8><IT72C+V^*JT,0LOI8R-*4CI/#O[1EAXL_L(>&?A;\4
M]7/B+&I:8$A^'5BA\$"YAL3\1[J;5?B+:Q67A)KV1XH(9I$UB^%K//I^DW=K
M'YYRBK04\0_J2I8?#XG%JO>,LOCBZ52MAJ6+A!3G[>I"C7YJ.&CB)X>5&<<5
M[!NGS]&(C]6J5Z%_:UZ-7&X>E3IQG?%5\NQ*PV,I4)2C"FG1E/#S]I7G0H5(
M8FBJ56=55Z5'FIOVL/!GAS28M9\66NKQ^'Y/",GQ%N/&1@\%^%O#NE>$M:UR
M\T_P5;W-CK_Q,FU35;^]!TJQ?4=(MK[3TN;ZWN-2?1(;U+>VB<U2IS]K3EAJ
M^'674)TJLZ<*E3,,=0PU1850<DL(TZU1N>-G2P4/JV,HT\QQ53!UY%U*4XXV
M>$ITIR<:N8QDHQE/V-#*98BEC<3*<8Q6)A&>$J5(T,'3JX^-'$8-U<%!5Z<Z
MG;Z-^T'X5U?X1Q_&)?#WBZTT.;4[/1[31%B\,ZYKVIWNI^(K+PSI!T"Y\)>*
M-7T#Q/9:C?ZC8R6=[HVNW]M<PW"F*9I T:]&(H5</6P&&5.=;$8^=.G"DJ=2
ME4ISG.<*BQ%/$PH3H1PZI5:M>I4BJ:P]-XFG.IAY0JSPP\EB%F#@N6.64<17
MJRYH3C*GAL']>G[*5*52,I.E^Z4&XSAB5+#5HTJL*D8\Q??M2^';"TC,_P /
M/B9!JL-I\1-0\1:*UKX"DNO!&E_"_4M'T[Q3K'BB_7XA+HQL(QK=I=6XTO5M
M1FNHH;B*&,WD?V8\Z4JV&G7PDU4@L-2JJ:A*:C7Q%;'8/#X/V5Z=6KBJF/R_
M$8.%.E>E4J156&(^IN6+CU4Z$IXA856EB98ZA@:-!24*N*]OA*./6)HJ:M'"
MT\)B<-4KU:_LIX>6)H4:M%8BHJ([5?VFO#G@GP[JFO\ C;1_$,7ASPE8Z3I_
MBSXF+:^#/"?@,^/K]](L?^$+L;/Q)\2I-4L]4?5=7M8'N'^VZ%I[&:*^\1*;
M&YECUQ,J-.=1TFHTZN)KX? PG7I.6->&K8BA6="K-8>G&-*6$Q+]IC(X%5HT
M92H0J<])3Y\)_M<8SI7BE16*Q$)0GSX##5<)3Q^'>)Y8RC6J3PU?#Q4,"\55
MG7JPA[&FYJ$>RTCXZ>'M8^&.B_$VV\.>+TA\1ZA_8WA[P@;70+SQ7KFMR:I=
M:38Z=HTND^([OP]JD%[+:275MK%KK\NCR6&-1.I+8J]PCQ=&KA*^%POLW6Q6
M+IJI"C']U4C;"SQE6G6CBOJ_L*F&HTJOMX5_9N,Z;A'G<J?/&&J4\1"O5=6%
M##8645.NYQKT>2I4HTJ-2G/!O$^VC6J8BA"G&BJE7VE149TX5HU*<.#MOVK_
M  U/9V=P_P -OBI;79$\^O:4]I\/[JZ\'Z=;?$'4?AI)JNOWVF?$.ZTJ>UD\
M1Z3J)MH=&U'5KN_M[262PMKIXGB1TZ<9UL+3C6@J&+CE/)B9<\</SYW1G6P%
M%MP5652451]M[.E.GAXXO#5JTX8:52M3*\GA:.)JU*<I?58YK)QI\M5R_L6A
MA,1F$8RIRE2C4H0Q?+*G4J4YJOA\3AI1CB(0I5.BT'XXW7C'XI:!X)\,>#=?
M@\)W>D>--?N/B#KD&APZ%XCT[PG>Z5X>9/!MK:>*WUR)&\1ZU; :CK&@6EG>
M6UE.VG/=1R+<PS@H2Q-#%XNI:AAZ&$P5:E"4E[>I+,YJKE];EA[2G##5<%A<
MPG*G6G1Q:J+#R=.,%44ZQG^S2PM*G5A.O+&U<-6BO^7<<)0Q2QM-*;ISG6PV
M+^H4JM6A#$86E[:5"K4CB*E**YB+]L7X37/B'QUHVGQ:]JFE?#:2\A\8^,]*
MF\':AX9\/R:-XFT_PMXC&NQ6WB]M<\,KI-U?2WCOKFBZ8M_8Z5J%WHIU2.T;
M,X5?6L)1QL$XX;$UL-1PTN657ZS+&1J?55AUAU6]I4K5HT<-]6TQE*MC,)*O
MAZ6'JRKPTQ-.6%Q-3!OEGB:%"I7K4HU*:G15.@\5*-2%2=.=E0A5DZT(RPL:
MM&IA)XB.-Y<-+H9OVD_#MKK5II-WX#^)EE:->^#K'5O$%[H_ARRT7PU+X_EO
MH_"@UU+GQ6FHQSW0MK*2:RL]/O+W3X]<L)-2MK-3<&T3M".)=64*/U1X^G-2
MG"?^T99E%+.L9AHRI2G"<Z>$G5BJT)/!SKX6O3ABFI8:>(YI5X)0=.,ZT:D,
M'5I.$':KA\=FE7*,-7ASJ+4)XJG&2IS4<0Z-6G.-&4HUH4LS1_VEM,GM]+-S
MX-\>ZQ;3Z9\.M:USQ1I/A_PSI/AWPM9?%K5EM?!UGKMIJ/Q%N[[^TK2PO-.G
MU1-+_M800R"]*Q0SI#'TO"RIXF>"KU*>&J87%2RNK5J32HSS/#8+!XBO2I)*
M52$*U7%*EAU.,H4ZW^RU,34FJ=:NU4A>LZ-6&+I1PV-S.E4HIJG+*\/6S14J
M\:E1QC5<Z66S5.2]G4Q3G3K0PM"$ZM+#>@WGQG\/6_A6W\4Z?HOBC75UCQ+?
M^$_!>AZ19:6-<^(&JV+ZB%D\)IJFL65B^E7,&D:K=PZEJE]IEH;*PEOY9HK(
MI</R?O.7!<E&<JF,H?6E33@I4<-RNJJ^)E*<:5"#H.E6M.HIIXC#X:4%CJGU
M5=/L^668JI)4Z>5U(TJ]5QG*'M74HX=TH*G"=6<X8RNL%-*G:.(IUG=T(>W?
MD6@_M4/+X=T[6-9^&7C:[U#4]=C2[T3PR? ;R^!_#7B7X@ZKX$^'=SXNU/6?
MB-:Z7JFKZO<:<DAMO"U_KLC^<9+:WEM?*N)]J5/VKRR%*:KK&TL&Y8F$9QPR
MQ.-P5',XX6$)+ZS?"X#%8>IBZCHNG0BGB,3+"PJTZ4<*E3E>:2ITJE\O6.E]
M5DH?7'1RF,Z&88B48U'0C1EC\+CJ6!E4JTGBJ=+DHQJU*&)E#,;]M+PII0T6
MS\6?#WQGX>\1^*?$WBG3/"/A.+Q!\*M6\0>)?"OA?7V\/W'CG1K&'XAPMK%H
MUVI4Z%I/]I:[(UO=/I^FZC9P?;)# 4_K\\KH4:D5B,?A<OQ=:#;E]1IYHI3P
M$L0X*4I4JU&/MJN(H0JT<%3O+'SPL>64ZQLZ6"CF55S]IA<!4Q5"G54916,Q
M&7\L,?AJ'.HPIUZ.(;HT:>)G0EC.:BL,IXF=7"T.K^+/QT\4> OBCX1\'Z5X
M0U.]\+-HL/B#Q?K]KHNC>([O4)]<UN/PKX+\#>&-,'Q*T'4=)\0ZQXA=X1JM
MWI.JV4 6,RP"T74=0T3+!/ZQB<PHN$IRPD*-.A0@X1J8O$XBCB\0G"O.;HTJ
M6%PV!Q.*KJO&G&5'#UW4Q.#?U/Z]6*4:&#P-:-6%*6+JUIU*M535+"X3!?55
MB'4@XPG5KUZN.P>%PE'#SJ8B6(Q%.%'"8RI*5&'3^&?C]IGBGQ#H/A/3_A[\
M1H/$FHCQ WB/2[NW\$C_ (5VGAG7;7P[J3^,]2M/'%QIS!K^ZW6PT"\UUKN.
MVN6MQ(;=U72A&&)52I0K0GAJ5&A5E7]Z,$\0\RIPH\DHQKNM'$Y5B<+-*BX1
MJ.E5]H\).6)ASUZTL-*G2JX>I'$5*LZ<:*Y)2<:=/+,1*MSQFZ,:7U3-L)BU
MS555]FYT?9K%J.&GS^I?M9_"O3?B)XJ^'"_VWJE_X(M[O_A*]7T+_A'=9LM"
MUBUT^/48O#NH>'[#Q')XMMM0O(Y[>WL[U_#8TF[OKB/3;?4GU _91GA6\9AZ
MF)PZYZ:JJA0UC_M5=X^GEBH4IJ3I4J_UNIRQHXNIA:E2A"KBZ4:F$I3KKHQ'
M+A*M"C5FHU:B<ZD6IQ>&P\<%/,'BZKG&*GA8X6'/4K89XB-"<Z=+$>RJSC!V
M=&_:0AUS4KSPW9_!WXN+XVL->O='N_!,O_"J3K%OI^EZ?X5U+5/%4^KP?%27
MPY;:#:P>,]!C>*;7(]3>>>:W@TZ6:TG2+>E1=6GA:\:D(X>LKXBJY?N\"OK>
M,P,7B7%2=3FQ&7XZ,%@5C&XX6M.W+&[SKSAAW7CSQJU81C*A2A**K8MRI>WY
M*5&HZ=2C.-"6'K5/KT<'"E3QN!]K*$L9AXU+?PB^.S_$;7M1\.ZAX4UO1Y)I
MO'^K>$O$!M=.B\,^)?"/@_Q[/X+BN;&0^(+C57U$H^DWDD]QI5A87*:H&TV>
MZ2"8QSAZ3KY=1QG/&-2.&RO$UJ;T?)G-#$XO!3IQBYI05'#5*-159QK.M1E6
M]C"A6HMF+JTL/F4L#!RG"53%4*<[+W:^64\%2S*C4?-:3I8W$SC2E24J:I<E
M*K..*IUJ:HO^TCH$LK77]B>*O#?AC3O$?CC3;OQ9X@T+1+[1_$&E_#1?%-MX
MRO?#EMI/CD:U#9P:GH-C#!J4^BW"W+ZU806MG</<7$FEYTEST\'5O[^+P4<=
M1PBC*6*KT<35RW"Y?[+V:J4XU,7B<UPWL*$FZE:G1KM^PC/#5JVN)4<-6JX;
MGA4]GB*&$J8J-2FL'A<0\-6S'%0Q52JZ2C'!X/!8REBZBE&E@\5!J<ZKP]:A
M+FM8_:DOX[[3]+TCX0_$2#7(/'-SX>UOPKK,?@"3Q'>:'8_#C4_B'<ZIH0TC
MXESZ7I,QLSX91O\ A*-3T/[)_P )! MY#%-+'&T\\*<)8BO-4L-AL)F.+Q,5
M:4Z,,OJX'"5)^T4O85:5/$X^/-4PE3&>V^J8K#8>,\1R6I0NO9Q4XUL6\NCE
M\Y0<:6*GCL7BH*"A+EQ,)/"Y9F,XJK1I.E/ZO6KJ.%5>=/TKX:_&B7XF^*M<
MTK2OA]XGTSPCI?A;P7X@L/'NJ:GX/.GZK?>,-$M/$B>'I/#^G>(KG6M)U"UT
M35-)FWW5DL<C/=JQA2.SEU7MJ82>'690Q$XTL1EN98C+O9^])5OJL:?M*]&I
M%./)&I/DE&?(U&5+E<ZRQ>'P?%3Q4*T,IJX>,ZE'-,OAF'-90]A"K6KT*-.H
MI-<\IRPU;WJ#JPBZ;N^25*I4\X^*GQO^)6@>-+[P-\.O"5AK][?^)?AYX#T'
M4FL=-U4:+XGUW1O%'C;QEJ7B#1]5^)/@\ZUI&E^ ]*TB\@LM.U&TN&EN;@RW
M!0QQCFR^/UVMAZ<KT:2QV.CB*SB_9T\NR_!Y9.=1<O-4C5K8_,'@U65.K2H1
MI3E['$8A4<+B>O%WPF'K58X:==T,OP^+Y55A3=:ICLSQ&6X:E2YH.*]B\'6J
M55.:=>>(PL%+"X>GC,;0]%\2_'32?"_BO3_"'_"*>,/%4BZ_X?\ "?B;Q3X:
M@\)V_A?PAXA\16EOJ&GV>M+XD\9Z=J=U(=)G75)X-!L=>EL;%DGO!$LD1FS5
M6DW5J2OA,*HYA*E5K/W:O]F8*OC\5"FX1YYNG1P]2BJ[HT\-/%J6&C556G6A
M2BM"MA</1E.$L3B)0P<W2H4Y*?)C<?#*Z%9*;]G&%3&RY%3]O.M"$74E%T^6
MI+G?"W[47@SQ,^G,_A3Q]X9T[5[7P'J>E:QXGL/#-AI]WH7Q$&NP^'M?D2S\
M5W=WI>E'4O#U]8.VI6MG-)+);S6D-S8S"[&U:E+#<T<5_LM2E4Q=*K"HI*5"
M6#RRIF]7VS2<(R^IT:K=)2=:C4A[/%4L/*=/GJLE1O*G..+P[J.C1KT'[2EB
M:L<UP64.GAG[LJJ]OF&#K0JJ"H5L-6YJ%6K6IU:%/M;[XR:3;>$O"OB?3O"O
MC37[SQY>S67@?P;I=CHEMXK\4>7:ZEJD-W:QZ_X@TW2=(T^?0-+N-66YUO5M
M+2.VD@2X,%W,MJ9JTJ]*M'"^PG+%1PZQ->C>$)X2DOJ\:_UGVLZ<8SPM;%4<
M-7IPE4G]9G[*BJKLVH2HRIUZWUFE'#TJTL/3J\ZG3Q53GJ0I+!NESO$1KJE4
MK49TTX2PM.IBY2AA:<ZT>)U+]J'PCHIU6YUCP;\0M-T#2--\822>*9;/PE/H
M=YXF\ :/?ZUXQ\!Z8+'QC/J%]XETR'2=5MGNX[#^PYKS3+BUM=8GF3:7&'M%
M/V3=64E"IA81IU?:8[#5,PPN5T\5A:3IJI[*KB\;A(T:>(CA\5B*6(I8C#X>
MK0DJ@XJ2Q&!PN(C]2J8JIAZ-9UY0A3P%7$8"KF<(8RK&4J45' T*F(K5<//$
M4*$8\M6K"I>"MVW[2_@Y%U8Z_P"&/'?@^31=1UK3+JV\0Z=H#7CW&D^$-*\<
M64=O9Z#XEU.9[W6/#VL6<MAI;(FIF;=;7EE9W&V-U*G-.G"G'VU>K3K2A2A*
M+E*K0S3"90\-"I*4</.K/&8[#1IU(5I81QE/FQ,)TJL(3%Q;P?/*.'HXUX9T
MJU9JE2]CB,)F6,EB:CFU*CA\+#*,=#$RK0IS@Z2JPA4PM2&(EQ]C^VA\+M3U
M#QAI^E:)XSUA_!*"TUB311X)UMD\4KXHTCP9-X%ET[2/&]SJ6B^+!XDUB"TM
MH=;LM*M-4%K=SZ->:C;V[2TZ=.=:C3KX6/UJEB,5A<+A94FG#&1Q3GRXFA4;
MC35"A2IO$XN%>='%X7"RA7KX:%.5PES4YNE5C[&M0P=;&XBE)P5;"0H8*>.=
M*O14G5YY4:4Z:J485L+'%Q>#JXFGBOW1<MOVE=2N_$NJ>']6^%WC+X<VVC^(
M[/19M<\5W/PW\2V]S/8> ;WXG>+M+NM/\#_%*\GT*XL?"MM:JFHJVK0K<:K;
MAK:4J\0QJ3]C@,9F$I0<,%A\SQBHKGYL1A<![/ JK2JJ$E&4<XKT\/4I.G4Y
MZ=/DIU8SKU*F!UE1J/%T,#2G!3Q;R^%"K)Z2KXS'RIK#K#R=.JY5<OHXC&47
M4E1J4Z5*OB*U#DH8:CF6%X<_:HN[WPSX6G\8>%+SX<>*'C\+:]XUM_%EE:QZ
M18>"=4\%>*?B#K7B/1(M*\47UZEO;Z+X-UVQ6/5ELK^"[ABEN=,$$\*S]6-I
M4\!/$3K5HRPF5?VE3S!JRK4ZV7X7 QO2A%U:;A7S#-\H=.$*M=K#8B="I4AB
MX2<.>C4CCJT\-EL_:5<=4P4\H=2+@L9A<?G%;"T(<LW3J+%++<'C\1.,HTH*
M>&EB*:J8:,HOK_"?[3OASXD>!M4\5_#[0=5O;N7Q##X1\$P:E?\ A74-'\9Z
MUJ%H;O3]1TSQ#X%\3^(=//AZVMTN[K5/,NHM2TJ#1]174-/MKFW$#YXC#UZ%
M/"J<HX2KB/:NHZL)-8*CAX1JXC%UK.%+$8:E0G&I1K83$U,-CJLJ>#PV+>)J
M<L:HUL/*KB.95*N&PE*C6E*E'WZRKU9T,/AZ<)+VM#%5Z\8TE2Q=&A4P\:U+
M%8FG3PC=4YWPE^V9\+_$5AK%_"NM:MH/AC4- T+5_B%X=M_"^J^#+_5]:N)]
M(B.GV'A_QOK>NZ)/+XBBL["+0-:L;37&;7]+DAL;FTG:\1QBL13PN(PM"M&G
MF<Y+ T*BYJU:,L/7Q>&C"K&,<+5J5J6'JTVJ=5/#8F*H8^&"JU:5.=^QQ&'K
M5L#BG3>,P%.;Q<H*4*5&6&Q.%PN-E.-5^UH8?"RQ$L1/$UU'"SP6%QF)P^(K
MT\--F]XS_:+N]*\*>-M7\._#CQF+CPSI2V,.NZ_;>%7\+6WQ*U";3-,TCX=W
M>GZ5XY;Q#KVO+K.M:;:W T#3KVP,WG6<6JB\C:-%2BIUL!&,E5HXS,<-@Z3I
M/GGBJ+S%8+'UL*MH1PD:6,J.KC/JU)QPTZ\74PUJDA2A&.)FZ=2N\#A<5C,1
M1BIT:E&E0RV6:4/:SJTG&'UO#^QY%2AB:U#ZQ36)P].:G3BW5OVIM"T;PYJF
ML/\ #/XI:EK/AO\ X2F?Q7X-TRW^'9\0>&M*\'WPTW5==U.]OOB/;^'6L)[I
MHULK2SU^\U*\+2106+SV=W%:K#J.+JX&&%G&5+'5,)1]HW:.'KX['8G+L/AZ
MR:52I5>,PF(HMX2EB:;5/VT)RP]2E5J*,7#V]+$U:="MAD]9\U*G6C3P.#S"
MOB*<JGNT,-1P>/PU>K4QL\,J,9^SJN-9<CUG_:;\%6VL:CI]]X;\=Z?I.F3^
M+]-?Q9/I.CW&@WFO^")+.#6_#FDVVG>(+G6]7U47=ZEG#)9Z/-9R7L3V!NUO
MC';R13:JP3AK5K1Y\+1>E7&0>:1RB$Z"=H1C5Q57#2HRQ,\.JN&Q5+$T^:E3
MQ,L/,FZ?)[6$J*3H*LYQ<(X55\EEGT)UY-<JA' 4Z[JNDZKIU:$X224Z,ZO"
M:Y^VO\/_  JS:;XJ\#?$3PUXQ/B/4?#UC\/M6O/A*GB_6CH^D>&-;U/4/#T-
MK\59M-UXPV7B_0T31;#4Y_$%S<33VMGH]Q<6D\<6^'HO%5<NHT)PG/'*3FHR
MYWA(1QN)R^57$1IJ4ZE*&)P>*52K@HXRG2I8>K7JRA1CSFE9*A3Q%652FJ=!
MT(4Y2J4Z,:U7$4Y5J-%/$2HK"U94%2K<N8_4E&&*P?-)3Q=",]?QQ^U1IV@V
M/BC_ (1KP#XVUF6R\*>/M5\(^);BT\.Q^$O%/B/P+=6NA7?AVSTV/Q8OB^9O
M^$NU32-(^U+X:CLYI[U8[>]<G<.>$:M=4X4K4*F(J9;&@ZD7.-6EFF-P^#PF
M(A[*7(H557EBJ%/$5L+/$86C5Q%/]RE5=T'AE*E7Q4I_V=1J3ACJM&-Y8/ZO
M@,7F6)I5(S2<J]##8'$4ZL*,:_L,6OJM90KPJTX0:A^U7H6A0B_\6Z;=> K'
MPC#XPD^*5KXPCT2WU+29/#<?@RPTJ+2;C2/&%_I,$>M:U\0?#,EK<76I3QQV
M[SP7OV*YAG-II6E1IJ6*IR53 UZ=.&&BJE.-?Z_B<VQ.78;"UIU/9X=*/]E9
MS&O552.'YZ%+$4\2\,IN7)A?;XA0PS<:>88>K"6*I^SJN,L%3R2>;8S%X:E#
MGQ$HX?V^6*4'3GB(+$^PEAG7JTFN\TS]H7PSJ?P:NOC9%X9\6P:!:O*BZ,TO
M@F[U2\"ZK#I-M>V'B#2?&EWX-O/#]R]Q!=)X@C\5'18[-WN[G4;>"WG>"\51
MJ86I@J+@YUL;*G"%-J6'J4ZDYSI^RK0QBPTJ52,Z<H1C)7Q$G2^J?6/K&']K
MMA&L7/%PC)4U@HU9SG)J<)1I86.+DZ3H.LZDO9RY/9P3JPKQGAZM.G5IU(1X
MB[_;(^%VG^,'\#7VE^*HO$6F:7:WOBW3[&7P-XAO_ VI7_AV#Q)I_A_Q'HGA
M;QQJ6KW-U=6UW8V4.KZ)IVL>'WU'4+73QK/VN=(F4:3JSQ<<,UB88:LL-2J0
MO&GBL6\93P"PM)UE2EAZ\L1-QA#,8X%5(4:]2G*=.C.2FK*.'I8>K6E&DJU"
M>,E%SIN=+ P52;QKA&4I5Z*I4_;2IX)8K%4J$Z5>MAZ5*I"3[X?'?3;*QUF7
MQ-X"\?>#M6T+0M"UV]\,ZX/ M[K7E^*?$M_X5\*Z9#-X5\=:QI;ZSJ^IZ=.;
M:U.I*1&R?:&@E+1(0I\]2A3A.,O;XW!8!22DX1Q.,:<X.2C[T<!2G2Q./J4O
M:0I8>M3J4I5KR476YJ-*M6]G*I2HX;,\7%P2YJF'RO#T<15J1IS<*D/K"K2I
M86->%&52M0KPJ1I*$93Y6_\ VD[)[>_O]'\%^-4TS1]7^(=LNH:EIW@N.R\9
MV7PKM/%H\8'PM<7?Q,TZ72;2/4O#MG!#K>L6L=G(VM6*+$ZRW4^D\M2HZ6#A
MC4E)RRV6:0PK;5>IA:DLNHX2JIPC5A#VU7,Z-6%'EJ8FMA\/B>2E&4\)+$=4
M</S9A1RR,U.I7QV#RU8BE^]H4,;7HU,95P]6*Y9U*E##X7%86M[-JGA\?RPE
M4J.C6I/C[O\ ;$T#PMH,.O\ Q$\-:MX0UB_F\+>&K'X676I?#6#Q1_PG>I^'
M6\8ZOI-EXXU?XJ6/A;68E\-:EX?N+>VN)=#NBUQ'"@N]0U.+3;'MQ-.E0Q,L
M'2<\76]OC.1PA:;PN"6"HXB<<+'VE7$SH8W$U,+-8&>*JUJU*O##8:K0PLL9
M7X\//V^'PV*J0>!PU:A3KQK5G>C5ABZV.A@GSPC_ +&JE/+<36G+&JE1IPJ4
M'6KX>?-3?NG@3XO:=\0/$>L^'])\)^,--BT'1]"U2^UGQ#%X9TBW2?Q#IMCJ
MUCHS^')/$[^*K2_%C?!FN;OP];:<TEG=P07\T]K)&KEAY4XXR3J4[83&5L$G
M":J*M4P]2I3K3IRI<\80A*G&2AB98?$5:-?#8FC0J86O"L\*>+C4E@XQI58O
M%86GBVIP]DZ,*L82IQG&HX2J2ES2@ZF%6)P].M1KX>K7A7I2IKUNN<ZCY_\
MVL?^36/VEO\ L@'QD_\ 5=>(Z /H"@ H ^?_ !'_ ,G3_!O_ +(!^TM_ZL7]
MDZ@#Z H \PMOA;HNG^/M/\;Z;*UFMK%XWN[S22+NZ.I>)_'$WA1;SQ'-?WFH
M2- ]OI?A<6$-G% L*17[",Q+$L;5AW'#4Z]-1YE*E&A0>M\/1J8_&9GC::O=
MS6,QV(HUW=Q=)X?ECS0G&-)55[3[,(NIBJ.,KRY??JUL)EJRG!V:<8TXT<$Z
ME.HN23KR]C-RA*G5>(HW_P "?A=J?BV^\;WWA^^G\17[W\TTQ\5^,(]+@N]5
M\-3^#M5U+3?#D6OKH^CZO?>&KAK&YU"PL+:ZN$AMGFF>6T@>')4X1PF*P/+?
M"XRCB<-5@VVWAL7B:.-Q.'A-MU*5"KBZ$,3*E2E"FJ\JU2,5+$8AU;<F\1A,
M5:,:^ Q&'Q5*48QC?$X6E4H8:O6C%*.)JT*%65"E/$JJX453I*U.E2C#GO'/
MP"T+QDVEZ/'+I>D^")!X.A\::%_9&IZCK7B?3/AOJ,&J^ _#^G>(;CQ.EMX8
MT&SO!>B^ACT:]N+^*^=%NK1C))/U4\1568?7Z\W7E3Q=?,J<-(?\*F(PT<'4
MQ59VE[2DL/3H\F$IJC2]M24JCJT:E?#UN>-"GA\%'!X-/"N.%IY<IWYU3RVG
M*K4="A"6E+$RJ5';'2E4K4X6=-1Q%'!XG"^Q7GAO1+[5M#UR[L1+J?AJ+4X=
M$G\^ZCCL$U>WAM-0,=G%.MO)+):P)"LLL3O$CRK$R+/*).9PC*6(F[N>*P\\
M+5=W>5"I5HUZE.]_=4JN'HSE*-I-TX^]96->6/LJ-'EBJ6'K4\12BHI<E:E0
MQ&&IRBTKI1HXJO3Y;\C52[BY1@X_,K_LH:#_ ,+$\%^(;;68K#P#X#32)M&\
M$6[_ !'O-7O]2\/W>I:EX>;Q/XCU_P"+&I:)KNF:/JFK7MQI:-X.AU'34\FT
MLM5@L8VMI=,/)TGB95G*M.=*=&CRR]G"E"KEBR>K5J7]I5GC*N 7L*N,HUL+
M5Q"C2GC%BJM"E4B8V,,9"<7!*>*Q"Q.+J37/4K369/-G3BX^SC'"2QBC5^I5
MHXG#4I3Q4L-2H2Q,G#UF^^!7PPO]!M/#4V@ZC!I5AH'AGPSIPTWQ=XSTC4M-
MTGP=K<'B3PZNFZYI/B"VU/3M1MM<M+2\?4[:[BOKF2T@-U<3"% M.K4^M/&*
M7L\0ZU"NY02IQYL-2KT*$'3@HT_J\*&)Q%'ZIR?594J]6G.C*,Y)ZNK-NI*5
MI2JK,E-RC&3DLX=-YC=R3=\0Z5.7-\5*4>:@Z<FV]_PE\,_"7@F7Q%<Z'#KL
MU_XJFCEUW5?$OC+QEXWUB[2W%T+.QCUCQKK^K7MCH]I]NO3:Z9:SP65J;R<V
M]O&9GW85X>VRZ65M\N%E&LFHJ*G*=>E"C4K5:EO:5Z\J5*C3=:M*I4]G1I4^
M?DIPBL81C3Q2QL4WB8QIP4I2E)1ITJE2K"G"+;C3@JE6I4<(1C%SG*4DY-LX
MSP_\!/"6E67A<WU_XIG\0>&?!=EX#DU_PUXU\>?#Y=>T+2]/NM*TL^(-$\&>
M+;'3]8U&RLKRY-I>7L-S/8W%Q-<Z>]G(XV==;$5*U;&8B7NU,QE&MB8IR=&6
M*<*$:^)HTIN<<-.LZ%.+E3?MOJ\*6&JUZU.FKTE&-:%6%.$5AL15JX:/(I.E
M0EBJN)H8.I.?-+%8>A[3E=+$.I1K2=6I.BG7JQ?%VW[,]I=_%S7/B;XE\3/=
M6,]KJEOX;\.^%9OB/X3NM)O-8T.W\+W_ (EU+7)_BOJ\+^-6\.VR6(\0>%M)
M\&WLJ.SWDEW)' UM&!JRP5*L])8JM.I[T5&.&IT*F8T<TG0I8:4:CC2K8W#T
MJN)PSKRR^LW7_P!AA]:Q'M(Q-*G6>#C"FHTL)*E4?/\ O*U:M1P-7+Z52O5]
MV->5*CB*JH5J]*KC*,8X:$,8HX:/-[AXH^'?@OQI?^%=3\5:!:ZU?>"-1OM7
M\+3WDMV?[(U/4=%O_#UW?11QW")/<-I&IWL*M<+-Y;3":/9-&DB<\J<)/%-Q
M5\9@\3E]5K1O"8N5&>)HQ<;.G[5X>E&4Z?)45-3I1FJ=6K"=QO"GAZ2E+DPN
M)PV+IIRD_P#:,'S_ %:I-R;=7V3J2FHU>>#J<M2495*<)1X.Z_9P^#5WIOA'
M1I/"=S#I'@C1[/0-!TJR\5^,].TY])T_4+;5["T\0V5AXAAA\8_9M7M(K^&7
MQ FIRQW3SW*.)KF=Y>F5>I+'RS)M?7)3P=12Y(*$)Y?-SP4Z5%15&C/#<TJ=
M*5*G!QH3GAT_83E3>3H4OJ<\OY%'"3>-YH1O&368PE#'P=2+57V6*4E*M2Y_
M92J4Z-5P]K0HSI]KIOPR\#Z1<:;=6&A+%-I%KXRL[#S;_5;N..'X@:U;>(/&
M!E@O+Z6*[N-2U:TAF>XN$EFC!DB@>*&:6.3GG&,\-4P<XJ6'JX/"9?*,DFW@
M\%1=##T.9^^HQIV51J2EB)1A4Q$JM2G"<>B$YTVY0G*,GC9YCS7?-]<G[9>V
M4KW7)'$5H4:::I4*<O9T:=.G&$8\GX5_9\^$O@N^L]3\/^&[^+4=/OM)U"SO
MM4\8>-O$5W#-X?TOQ)HF@P"?Q%XCOG?3=,TCQ;KUI9:>Y:TM8;F%((8Q8VGV
M;H>(K.$H.HY<[Q$IRE9U)U,71PF'Q5>I5:=6IB*]' X:%7$SG*O/EJ2E4<Z^
M(E5P5*E&59PIPIQK4</AG3A%4Z4,/A<8\PP]"A1@HTL-1I8Q^VC2P\*4+V@X
MNG%03[KX!?#2X,C6]KXRT.2;PSI_@^>;PG\5/BKX,N)]!TO7+OQ'8PSW'A+Q
MIITLU_'J^HZG(=3=VOGCU6^MI+EK:]N(9L(I1HO#6YL-?#/V,O?H_P"R818&
MC!4I7IJG]4C3HU:2BJ>(C1H/$0JRP]&5/IE6J2:;Y5*-;'8A-0@FJV8UHU\9
M--133JUH1J17PT9)N@J=W?I-$^&/A+0O"6J^!(K6[O\ P?JUG-I+^'=6O9[[
M2K#P])I%OH,?AG2K-V6/3="BTFUCA$$(5I'DGN9Y)KNYFGEO$SGC(*.)G*=1
M2G-U4_95G.=>>(C/VE'V<H2H2E&&&=+V?U>G1HPI<GLTQ4*M7"XI8RA4E"O&
M<*D9.3FU4C:4ZLG4<Y5:M>LZF(Q%6M*I4K5JM3FE[-4Z=/R:Y_94^',^K^&Y
MX[SQK;Z!H-KXC>\TM/B7\5F\0^)];US^P+2VO_%7Q!;Q]_PD'B/1[#0M'O-+
MCT#5;N^T][;53&T0AMHX2TX.I7JUJ-.O.=*G2A&5.'L%%U'5QKQ.&Y70QU3'
M3HY?*K5Q5.=1/ Q<Y5743I9NZI4Z5*U#EJTJKJ1YE6IK#4,30P=+!U8SB\!2
MPZQN,GRX91;G6BZ<J*C55?MKCX ?"BYNKRY;PY?01WVK>'=;FTRR\6^,].\/
MQZAX6\-/X-TE[/PS8>(8=)TVU;PH_P#9%Y:6EE#;:E9QQ6^I17<<,:I-64J\
M9PQ$GB%4ECY3]LW5<GF<)0QL92J.4G3JN<ZT:3?LZ&*E+&8>%+%-UBH2E1IT
M*5!_5Z>%P^%PM*-']S[.A@L;#,,+&+I<C4J.+IQJ0JW]KRIT7-T)2INQX7^!
M?PQ\'RZ9=:+H>I-?Z/?-J.G:MKGC#QIXJUJ&X&B:IX<MHY-;\4^(=1O[JPLM
M#UO5;*RL9[B6UL(KZ064,!((J=2I.E6HRFW#$4<10K.]IUH8NI@ZN)J5:BM4
MJ8FM/ 8/VF,G*6+E&A"'MN3FB\/8TE.,U3C#V<Z$X0BN2E36&6(6'HTZ,;4J
M>%HO%8B=/!PA'"QJU'65'VJC..!J?[._@:6&"+0Y?$&A^5H-CX-59O%WCCQ!
M8:7X)CM+33-7T7PEH&M^*I]&\(:IJVCV45C>:[8:<M_.DL\LTDUS+YZ)2?UF
M5>I&-6->K"KB(3A"7MH4I0K4L(I3C)4<O>)H8:IB,!1C#"XBE05%TX-PJ4^B
MI4J3M44W#$T77J4:L7*#I8G$SKNKCY1IN'M\PIQQ>+^J8RNYU<-4K1:<\/&>
M%J^C^)?AWX*\82^#Y?$OAZRU8^ /$-MXJ\().UPEOHOB"RTO4=&L]1AMK>:.
M&XDM]/U6]2*.X2:.-WCG1%GMX9(IE[U:KB)>]7K4,5AI5'K/V.-BH8J*D]8N
MM"/).I&U3D<X*:C.:E$$J6#G@(1C'!U/JW-2Y5R_['6IXC#6NKQ]E6HTY+E:
MOR\LN:#E%\II/P'^&'A\>#5\.Z)JWAI? 4#V?AY?#?C3QSX>5[&6_EU273O$
M:Z+XDMAXVTV34[BXNWL_$8U6!Y[B69HS)(S-7//VTJ[DY5)X>CA9*7O4Y4</
M1GA\.I4G>E*IAZ-2<:%=P=>BYSG3J1G)R97_ -I57VN]7$U\6YQ7LZD:^)J0
MJXATZE/EJ4J5:=*DJF'I2AAY4Z-&DZ7LJ-*$;EY\%_A[>6OA&T73=;TO_A!9
MKN7PS>>'/&WCGPKK%FFHW<-_JMC>Z[X:\1V&HZYI.H7UM;7%]IVJ75Y:7LMM
M#)=03-$A4HREAZE"K2?*\/A\/A80=I47A\)3C1PU*K0E>A6CAZ<5&C[:G4=.
M\G%J4YN53DYT<90=E3Q^(K8NJDE&7UJO4KU:M>E.*4\/5G/$U_?P\J34*LZ<
M6J;Y27QO\'/AY\1=3TW5_&&BWNIWFE6\=I"EOXF\5:+I][:V^I6NL6=MKVD:
M%K=G8>)H+35;."[M8]7MKY;6;S)+<1--*9(HI8?$_6Z24<0IX6JI-*2C5P56
M5;"U8PES0C5HSJ5%&K&*J>SJ5*,I.C4G"45E[?"O!5?>P\H8FFXIN,G2QE!8
M;%4G4C:JZ6(I1@JM)S]G.=*A5<?:T*,X9"_ +X8KX@E\2-I_BB>[FUG6?$)T
MJ[^)7Q,O?!T.O:_)=RZIK-KX N_%\GAFRU.2:_O94N;?2(I()+N5[=HG<DY+
M#T5AY85PYZ,L/6PB51RJ3IX?$*K"O3HU*CE5H.I3KUJ+G1G3J?5ZDL.I*B_9
MFLZM2I7CB)3:JQJX6M>/N*=3!4\+3PGM80Y85H4%@L+.%*K&=)5Z$,0X.NG4
M<]E\"?AE8>%]5\'6^CZTVBZUX9T3P=J#W7CCQY?ZZ_ASPU)J,WA_3K?Q7?>)
MIM<L#I\FJWS6]Q:ZC#<1>:NV4>5%Y?95Q%:M.%6K-RJ4\?1S-2LE)X^A'!1I
MXF;23J5/^$["2J>TYHUJE.=6M&I4Q&(G5Y*&&H8:+ITJ:C2^JUL"J4KSHPPE
M>6)E5P].A-RI4Z4EBZU-1IPBHT?8T(<M'#8:G1SHOV<_A%%!XGMV\/:Q=Q^+
M;+5-/U/^TO'?Q U66PL];U&/6-9@\)3ZGXIGE\!+?:S#!J-P?#+Z0TUY;07<
MA:XACD3';#T\+%N%.A5PE6FX2<*L)8"49X",:\'&O&E@7"/U.@JGL,+%<M"G
M3BVGO!*%252RDJD:L:E*HE4P]5UZ=6CB*E;"U%+#5J^)IUZT,5B*M*=?$QK5
M?;U*GM)W=;?LZ_!^S,!A\+78$2^,TNTE\6^-+B+74^(5EIVG^-$\6PW'B)T\
M9IJL.D:9),NO+J(%Q8PW<82Z0352DXTY48?NJ,J7L53II4Z=*"QM;,82H0I\
ML,/6HXS$5ZN'Q%!4Z^&5:I2H5*=&3IE49SP[YZ52<:OUK"XQU7.4ZSQ."PD<
M#AZDJTW*K+EPD(T9PE-TZZ7-7C4FW)U]7_9O^$OB#P[IWA77],\7Z[I&EVWB
M#3[?^V_BM\6-6U6?2/%,$%OKWA_5/$.H>-YM6UOPS=1VEDQT74;VZT^.33[.
M6&VCELX'BM5JD<12Q-U[:BJ*3<8N,Y8>M]8H5:U-Q=/$8BC6O4I8FO&IB*;E
M-0J)5)J54:M3#:8>3H16(I8J,:?N0I5J-.=&'L(1M"A25*I4I2P]&-.A4ISG
M"I2E&33UO%_PBM?%7P]N_AP?$_B:TTK5/$&EZGJVHOJVJG7'T:T\66/B._\
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MG#X>K2HXC!5UA_9-5L74>,EAL54C1JX++GEDZ.)PTJN)^M1YB.\^/W@F:_\
M%EA/XX31?B!J/CGQ5XKT*R^&#^)KCP%I^K?%/PGH/A/7=)T73O!]QXF\2>/+
M3X9-JLTVC//>0+'I5DPT4_99GO\ EP4::P. RW$5:M*V'RV<J\8Q]KAL5F=+
M.\WQV%H<RGAXTXYG*A@,5B<7'$0P-;%4\75EA\*W0CUXKD6(S'$X3!J6,^N5
MJ5.DZT8X?%X;*\)@<FECL76<H^]-4*&:Y=AL)4PTL?A88S!4ZE?$.C7I7H=5
M_:>O_!$QTWQ3\5["^TWPQ\7_ !';ZAXE^&_P^7Q[KVHVGC:VT7X.^%[RTLOA
MG;Z!8W%SI6D:A?ZBEMH(G_L_7D(*R&WU"UZ*,8^UP*K.E&<8<-QJ0BI_5Y5L
MVQ.(JX]XF?MI5%3RG"?5\+F"PU6@HU4ZZJX51E"I,*V%A.O%PQ53!3Q./DZ[
MA&.)H8/*\OP]*O'!X;E2JULSQ]>MB\EEBX5)5(86-*=&LJDZ$<7Q1\6_VA6\
M>^*=)\*7/C-_&?A7PY\2M6F^%UW\/=/L?AE<Z)H%]9>&/ VOV?B6Y\!WOBKQ
MGJ^LS:S!XE+^%-7O[-(])N-&_LUK^":.?EA)/"XS%4KU\-'ZA3Q#EST\3E]?
M,,T@I0PN'I4*U:4<#E6"S.$\1B<-C*>+KRH8W"4JN'G'#0=:E*E/+<,\33CB
M9)5*:A"\,>J&0SQ6*5:K5K4L-22SW$8#!<E/$8*I2H2E"M4IR;Q91C\8_M/3
M:#H.D7'BSXPC5==B\/ZMX7\0^&?@K:W>H3W?B'QE'X:UO0?B7JGCK]GOPSIW
MA_PYX1T[9K,CW'@?P-J^J66J(UHSKH]Y<7?HX>E0>/R^G-P<</7P7UJ%22HX
M6M@'*KC,3B)U85JTGC*V&4<LIX;"8BE/#XVC]9Q.%HT\=2I83GJNK/ 9A6HU
M84*^(IYR\/!4JTZF%Q."P.'^H4:,:D8<]#%XSZS74\33KQE34<)0QE:K&%3$
M1WTOQ8>\^.$EG!\6Y-)\9:S\0[+QWX;/PJUBRT?1['5]4\+?#3P)KO@C5W\%
M?\)'X]\1)X#TY]9NG\*W^LZ1;VEI-";:WOEA>XX<NC&MA,APV+5/$X&=; *K
M'$QE2J4L1B\\>:9CA'1=G#+Z6%Q.*R[%8O,%*A.K#!UL+BX8)8KDZ\15JX7&
M8W%8#$2IYAEM*=7".I%5Z52EE_#V)5"47'VF$<J^?8:AB\)@<-*GBI_7\2L;
MA76JJG1]P^!>N?'#7OB=\0E\>2WGA?P7X6FUK0- ^'[^$M>@T9]-AUPP>"=?
MT'Q5JOPC\/6]S>'PQI[-J$&E^./']K-+JT+"+09+8V<FM"HIY1+'XV4J^8XR
M5&K55_?PF(5*53&T84TJ->M1=6JJ47+"55[3#N>&S+&4ZR2Y*L*5#&4,#@*4
M\/@,%3C3HRDU)8FA"E&FJE5*%2%*M*HH5J*6*P]2EAYSPV*RY8BE+$+R'Q3\
M1?VD)=,U*;PC??%'^SM=^*=[HTGBO4?A5KF@3^#_  C#:3S:(? G@9_V6O$O
MBL))>7-I::E>>+/#7B339O[*N'LO$6FPW\=Q8\F#56K#):%5^PGB*&)G/$5.
M64JF,53 TZ$:].+H4L/ETX3QE>&'Q4LFQU*4)T:V85X4L/7Q_3B']5Q.<55&
M.*A@JE"G'#PNJ*P[ACY5Y4*T)U*N)QU&=/!TGB<%+-L#6C7I5Z.70;Q>&P7:
M6OC?XT6,.I:GXE\0?%N3Q%X;\=>$?"?B/PIX;^!%S<^!3X-C\9V,5SX_\*W2
M_#74-7\9:EXA\,:=</>IH?B?4[;0HO%++/IUE<Z7]I3NA5PRJX*K##.MA<QQ
M&,]K3J3<*N!JPP&8U,+@(+GI-858SZAAIYEB?:4,14BZ\,90PU6=*&%2G6HT
MJ])5X8FOA,NPDZ56,'".*E5IX&..Q52/OKZU@GB,;B*&6T51K5G@H4%A,1*H
MXU2;Q;^T5K>C^*/%6WQ]X5MO#G@#XA^-[#P/'\.]"N]4\2:OJ?BWQ-:?#3P)
M/]I\)ZQ<WMSIGA3PQ;S:E8:+YVHW$GBFT/G 26RS<;H1>!BL36YOK=+)L+*7
M)&K[&MF-"K5SC$5<+&GSU*65K,L%1HQY52G5RNK"O&NXXZE5[J2IU<SP/LN;
M#X&..QRJQYZ<:T\/E4LJHT?95JLZ=&A#.:]#-*]"=:<91PV+2IU:/L\/B*''
M6WB#XG_#OQJ]UX<\0?$:_P!)O_'7AGX4>$/@UXC\#:-X/^'<^C7?P6-_X9\0
M>#4;X7Z+?65CI_C>UNIM730=4NX]-TRTNUU*S6:QCB@[DI8JIB,/[5RQ6;U<
M^G[>M+ZS4RNMA,SH1IXJ<E5C+$9?#)L.Y8>4Y3PN.Q6,P]+#UWF&(Q%>KYD'
M>C#'XB6(I?V5@\EQ&*5.EIG$\;*=/$T8J4.3"XZKC<QC.JZGLL92Q&!J_6H4
M\LGA*='[R\'SW<GA^QMM1U+4]:U;2E?1M9UK5?#MUX7FUC6-)<V.J:I;:5<:
M;8QC3KF]AFEMKBRB>SFA>.2UFGA9)7RK2HSG[7#TW1PU:\J4)2YJD:?,XQ55
M.THU?=O.,X4W=\T:<(2@C>$:U.]/$NG+$1Y95/8W]@I580KJ%"3E4YJ5.-6-
M-*56K5IN#HXBH\33K)=/6)84 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MOV@/_!M^S3_]$72&'_#3FN?]&Q?M ?\ @V_9I_\ HBZ #_AIS7/^C8OV@/\
MP;?LT_\ T1= !_PTYKG_ $;%^T!_X-OV:?\ Z(N@ _X:<US_ *-B_: _\&W[
M-/\ ]$70 ?\ #3FN?]&Q?M ?^#;]FG_Z(N@ _P"&G-<_Z-B_: _\&W[-/_T1
M= &+!^U])<^(M5\)P?LW?M /X@T31= \1:GI_P!N_9S7[+H_BB^\2Z;H5Y]J
M?]H06TWVF]\(>(H_*BFDEB_L[=,D:3P-, ;7_#3FN?\ 1L7[0'_@V_9I_P#H
MBZ #_AIS7/\ HV+]H#_P;?LT_P#T1= !_P -.:Y_T;%^T!_X-OV:?_HBZ #_
M (:<US_HV+]H#_P;?LT__1%T '_#3FN?]&Q?M ?^#;]FG_Z(N@ _X:<US_HV
M+]H#_P &W[-/_P!$70 ?\-.:Y_T;%^T!_P"#;]FG_P"B+H /^&G-<_Z-B_:
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MY_T;%^T!_P"#;]FG_P"B+H /^&G-<_Z-B_: _P#!M^S3_P#1%T '_#3FN?\
M1L7[0'_@V_9I_P#HBZ #_AIS7/\ HV+]H#_P;?LT_P#T1= !_P -.:Y_T;%^
MT!_X-OV:?_HBZ -'P[^TNFK^-O _@C7/@K\8/ <_Q UK5/#N@:]XIN/@S>Z$
M-8TKP9XJ\=R6=\/ _P 8?$.IV_G:%X-UORI5TR2+SHXHY'C$H8 'TW0!\_\
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MO?J2;UE*<[SE)ZN3;>K/*]=_Y.*^%G_9%OCY_P"IS^S;6!L>U4 % !0 4 %
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!P.M?\ )8OV6?\
MLM7BK_UF3]H>@#[NH ^?_P!K'_DUC]I;_L@'QD_]5UXCH ^@* "@#Y_\1_\
M)T_P;_[(!^TM_P"K%_9.H R?VM/^2.VW_9:OV7__ %IOX0T >$_''5O'^B?#
MG5M0^&MI-=>)8KO2(R;2&:YU"RT:;4[:+7-2TNUMO"7BF:YU*UTMKF:&*+PS
MXA=G0;=,O#B%\*CE&M@XWE"A*K)5YP3<HQ5"M*E;EHXAI3Q,:%*;]DTJ<YWJ
M8>-\31UII<E=QC&=:--.E";2A*7M::GS.5?#)<M!UJD/WT;U(02C6;5"K\\Z
M)XY_:2>&S$FGZUJCMX'UN[@G/@C4;6SO/'UMIOB6Y\&Z!?W7B;P'X*U*WL-1
MTJ+3+K6;Z?PSH5K;ZS9VFGVDUI%JDEI:]U6-&^-]YT5"-!P=.,9<K<<!',I4
M(_6*_M886-2I7RJC4J3K8RI/&4J\Y_4:5&M.&C3=?+XU9MX:>)4,7*4FJE+"
M>VE[&HK8>DO;UJT:F%Q+I0Q$</@(X;%+#4Y5IXTR[.3XP7VOWWB_0_$7Q=OT
M\.^&=.BT^^\3?!W0?"6M>,MWBO1IM5\):GI>H>%H&ETRV\_6PES8:)X9OG@B
MMY(;RZ@M7U'5,8.&&JUZL:/M:6(Q&1T'34W>OA7B<XHU<9./NRHXG#X:O3JR
M3J4*5*JXU<9@:%&K##KFQ+J3IT8\L:6*H9?GE:3BI3AA,>L/EE6EA</-.<*U
M&O6PT8036.=6/MJ>&QM6OS+"QZ#XL_:(\6>-9-#M=1^+?A/P5K>NZ%)%XAU_
MX?>'!XE\+VTFC_$&?Q+HBOJWP2T;1;.UM-5TWPM;0W4L7BR&0S6T\.M7D=^8
M!-*#>!KRE6YJV%IXBM1DHM2Q<?JT'AHSC4C3G&;Q,*G/16$PE=)SI\K53#UH
M>AB%AZ<\7[*TI1C*ER7?LJ=6GFV5T74PO*Y.K"KEV)Q=:%66*Q-.4:<I.C1G
M@\1[3DM7^,O[0D$&D6FFZCKS_$R3_A&='A\ 3^!=(M_"NIO=_"2X\6:G=Z_K
MTGAN2Y\/^/F\2QW3G0$U&&:.QL[2:/0S:W1O)>BK&E/$R^JIRPLZF+EB>5RM
M@Z%&<(Q^HSC2Q$\5&E0J1J5I.ECI4L6XT*B510P>+O%X:E@UB*<*DJRPU.7U
M2M+DE]=J?VY4P%&6+Y?84*5"M1I4H4:T*F!H5_;8JI1KOV4IX#2U;XD_M)6O
MPVM+FQ@^(]_XV6]U_4O#D^E^!];NH-;L-(CT9V\._$2WU[]D_0;NSU*2:?69
M+%;#P[X*M;^VLX;:+7FOF,S[T88>69Y/3G:.'<L'''1DTJ$L/7QU6E5Q%*:K
M.<<1A\+"E+$TZN(PLHRK/$T,!6I4Y48\"C.5'%Q^&<E.-*?-",Z.)5"\*?O1
ME!X6I4DG2JPI8V,)TYTL7BZ$)4ZDH-)3XSV]UI^F:-I/CS5[?3OB%XZ\47'A
M_P 4^ 6\.^'/#&JCQ[XEOO \WAG7QX=LKCQ#IFM65_>W6H2W6KZE%:H+.0OI
MPGCM[CSINK2PF6U<.E6Q& RRE2H3J-1JQQ*X5S##5L+.DE"'L*,_JE*C6E3Y
MIXJI[!5L34G4I8281I5'B85U*@L;FF&J5X4XRG3GA)Y]EN)KXKVDKSAB*<HU
M7&A!<OU55JTJ:IX>GB<5](_LZ>(/BMX@T3Q!-\41<"YM]2M8].34],\1Z9J]
MM<-;,^LV+KK7P7^'-K>:-;W1A2QN-.LM;0H9EEUB^95E;MJ0P\<+AW2ESSE4
MK<L]I3PR]FJ,Z\9.%2.)<_;<ZE@\#!TE0Y</&?M92PI2Q+Q5:-6*A35*DW!;
M4\0Y555A1E'VE.5#D5'EMC,9453VKE6=.=)1Z'7?^3BOA9_V1;X^?^IS^S;7
M*=9[50!\G_$.'58-3^+/@]/#?BV_OOBK-X2_X1/4-&\*Z]K'A_RX-)TC0M7D
MUSQ)8V#Z1X6.GM8373IK5_IYGA*"T\^5C&(P"G&6#@DH3P&?8?,:CFU3A]4H
MU<KQ+JPG.T*LG]4KTE0I.>(]I!7I<E2$Y1FD?;87%QB_=Q/#V,RZ#BN>7UNJ
M\ZC"DZ<+U(J7U_#-59QC1M*;E4C[*IR\N^M?'O2;*.ZU?Q'\2KK3->@M-0UZ
M^T?X8^'=2\0?#RR3Q;K.G30^"] TSP%<SZU?-HZZ*\UMJEAXEN?*>:]M[=8S
MY:YX6<W# 4:\7=4,IJU*S5IUL5B\IQE;$X6NERTJ6'IYEA\+0K2ITZ-3!QQ,
MH8C$T8RA7H:5;JKBI4(0ERULWI4:+=J2H83-LNH82NISJ1G*I/+*^/Q%"]9T
M\7+#T_8T:KC.%;S-_%/[4'ARQL])\,:9KMA:0>"]<O\ 1(;[P?XBFEUC4I[;
MQ!J-_=:II6E_ [Q':Z=XMAU,VQTZPU+QGX5M99'CA?3M0BE#-IAH5JM.&'JR
MCA'1PF68:T.6I]6I0RS+:4:F'E5=.E4JTL6Z]/$QJ5L9*.'HU4\+0J1AB):4
M(4/KV#L^?#8G-\54K3KN5%585N(,9[58EPBZM&A4RQTJ]*K##8.,:M:-7ZU.
ME&I0I]/J$OQO^&NH:_\ V)K/B3Q-J?Q ^(&B>!H]8\2Z'X,TV\N-=\4_##P%
M#I/Q#@@L_#.E:??6'A:]T7Q!!-8V%J89(TF6[BGFLWD3N@Z,\3EV6*,*6%K5
M\PESJ4G4HTL#CI8S$2=^=-YAE<,5&G-T_9_6X8/V$:,*T^;.I5J0RW!YC.*Q
M.*P668.I5I34XPE/$8S.*%++W&C&,Z:CF>-RJ4^>I3KTL'5KU)UY/V2=[5-:
M^/WA70==\2:5J>LV=KX3VP6/A+4/ _@_0_".J07.G>+KS5O$>OZBWABRNK*W
MM;RWTBY:XL]4TFSA=Y&O#)'=XC\VA6M1R_ZS&5*GBG1PU;EBW/+\-3X>RO$*
M>$I*UZ\,P>*P="C65>E.K;+Z.'56G3A&\+0=7'2PKYIJ.)A)3IP?/C*F(XJQ
MV$JJ7+&:DIY7['%3G1@JW+...E4E&<Y5?9_@!XQUOQ6OCZ'4_$_BOQ78:!KV
M@V&C:EXV\':?X'\1I%>^#M!UJ_@U#1+'PWH31D:AJ4[Q-<:7:NT$D#(LD+1W
M%SZ$Z7)A:=1TU"<L5C*46I-N=&@Z5.E*<7I"KS>T5:*491K>TA.G0G"6%H<J
ME+VM#6WML#A\14BE^ZA7JXO,(5%AZEG[7#QA1HQH58U*\*E.,:D,1B.=UZOT
M17,;'BNA?\G%?%/_ +(M\ __ %.?VDJ /:J "@ H * "@#G/&'ABQ\:>%/$G
M@_4KB]M-.\3Z'J>@7MUIKV\>H6UKJMG-93SV,EY:W,"7:1S,T;36\\895WQN
MN5,M24J,Z=25&IAZU"O3G%1;C4P]:%>F[3C.#2G3C=2BTU=-:F^%KRPE>E7A
M",W2=U&?-RRT::ER2A*S3M[LHOLT?*'BG2+*_CA\.ZKXR_:%^-&HZ?K^IW7A
MGP_H\7P0T*]M=7\!BSM[SQGIM]IGAKP3ITT/AS7M5M(HH]?U"6.35;!!#I]X
MT";]:%=JMAL=3I-3H1G7EB.6HUAZ-7$2H<U6FF^=8VGA<50I4L/1K8C$Y=B<
M9RTW1FYT\7AX4:-3 U'%8::PV&GAIW2K^TPZQ=.@JG*JT%3HRP^*J8BG7HPH
MU(X:$L3&M)T9U])^&O[,]IXX;Q6_C#0O"_C379=/^+4OA;Q':_"3PQX]TO[+
MJT'CC5-9U*;4O!MOX]M=,GNM/GEU"WU#69K*" 7$=LEK##%Y%X67]G2K4\+.
ME5I9=[6#=*7[FC1KX:M@E3J>Q=-2@HX^,H3Q:GB/;_5W4J.7-"<XR%;,OJ]/
M%QJQQ&,]CAH1DHNKB:^$JT8TW1TJ0E67U+V/^P<M"M3=:<(3=3VIT=O9? BW
M>PU6']HFS;P_=^*]>M_!6C2_$GX;77A'2O%6KKJJ:]HWAVWN=-D7Q%JC7GB.
M>?[%K5QKD]HTL=M;+;V4TMI<8PHSJ4<+@(1=:M6P<:&&DZ<*E:> HTI8*E"C
M3<)4JE*A"+H^UC1E.M*G%8NKB)4H<C5:G2EC,3'DI48UE5Q48SG"E'%2Q6'S
M.=6M.,U.E5K5<.JTH>TA2C"K6J4*5*=3VB\Q3X'_ +-&D^*]&\-6VNV7B;Q/
MX8U.YU#6]^E_LY:GI^C^?XA\)6,OA_6_#.K>"(-!^'KR7>NZ9=I;^%=%\/:G
M=@7DR37.H7*B\Z,'6:JQS"@H4Z. ITJ*JN51P<J2S;%TYPQ,9RQ2GA)X?%\U
M.A7IT,-S4%*C##8=RPV>-I^VA6H8F4I5<:YU73M'G<:M##4ISG0E'ZO5CB:<
M:/[_ !5*K.K9I5;3Y9][X@D^#7BSQEKOQ&UK]H#P/:_#B]M_ OAUM+TCXD>
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MDJ4J=*,W6HJG%0<(_258F@4 % !0 4 % 'BO[-O_ ";K\ _^R+?"S_U!M"H
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M<>$=2\=_"^R_X2%/$_AG3_"&K?$&%M=N8=,7PIJVK>!]#T_4;SQ#IMIY6M1
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M@ H * "@ H * "@ H * "@ H * "@#@=:_Y+%^RS_P!EJ\5?^LR?M#T ?=U
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M6G4L[2A5YU&,VDZ2K1]GS5(4*V(I1A.E)5Y.;C&AKO\ R<5\+/\ LBWQ\_\
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MI3BI4*=*KAZ]=9;&GF53+W2J.CA<TQ6$H4*E2*A5]EB*685)U:N'<U*G.@\
MU.G&52GRU5SXBG7I5L/#!\0_'OXF36-YJ?AWP7X;T\+X@\1>'_#$>H>/9Y[7
M7E\-?$+PIX+U:_\ $=I'\,9;CP_(6U2Z^Q"PU#4% DE>ZBE*PJG/&G4C5R^G
M-1]KBZF&<J5_<CAZ^,]A2<:J2<:U:R]HG3G"A2GS1=2JG%$HQCA<75^&%#"T
M:ZJ+^(JU?AS%9W[/V;?)*A0C&"YG*G5Q%:E&/^S493E/I=$^.'AWQ0GC+Q+K
MWP^LX=:^ _AC6M4\5W"S0:UJ'A+Q=%+X@L]:\'^&M2U#0K":22YT;PZM\=07
M^SA/9:SI32VZI<_NA17U6.9822E3Q[PF"PTI2A1G6EB(86MBL/B9*4XT*6"Q
M5?"8?$?O*U/ZS3Q%^66#]]T:%3$9CALDJ\L<1*M.M4IOGJ4Z,(U/8Y;CH<L'
M&H\=AZF,JT8QY<30I1=.4+XBQ4\0?M!^(-(M-3L=:^&_A.XO]"\-^(O&'C?3
M;;XJZ7JFEP>!-%L= O;B;09QX4^TZ[XCN;#Q+:!=$UC3/#L#-%*?[0:TN+*Z
MORK2H<F(6)YIX3#/#8;&*-"=::Q.,Q.+PE.C1H6MBJ//@ZDJDN>GB8PJ48?4
MI8F<L-"*$JE6MEL,'+EQ&:J5?+Y5).A#V-*%.<JF)K+F^JU5.I!0]DL50DHU
MJBQ2CAZ[I^;Z!\>;/P-I.FW?@GX3^'_#?@7Q)HMKJ/P^\"^"[:]#:C>>(_$L
MVGVNK^*_#O@+X8W^L^$]5QIVHK=Z=I.D>)V1BF3+/'.EHIU,1&H\'7;KXR,,
MM5.$9RJX?#T:N#SC,*BHUZ4:GME4P^&H-)TJ="%6-X55AIRQ4\$Z,^7%T'R8
M:V9NO.4:<*U?$87&9)ET.>,ZBA%4ZV-FHR]NZU2C)\U%U84:#^S? WB:;QAX
M3T7Q)<Z%J_AFYU2U,MQH>NZ=JVE:GIUQ%-+;3136.NZ7INH1PM)"TD+W>GV4
MLD$D,KV\)D,::UZ4:,U&%3GA*G2J1=X<T55I0JJG45*I5IPK4N?V=:G"K4C3
MJQG!3FH\SG#U9582<Z;I3IU*M)JT^5NE4E3]I3=2G2G*C5Y?:49RIP<Z4HR<
M(MN*X'0O^3BOBG_V1;X!_P#J<_M)5B;GM5 !0 4 % !0 4 ?/5G\+?%]A+_:
M'A;Q#IWA7Q-H&O?$6WTG5O$'AX^-- U[PG\0_$MOXTNH[W1-/\4Z%?Q7UGJ/
MD6T,_P#:EHRS:9.[PW-M<H&=.52-'#4^?DIRP>#P6*I12YW'*_;8;!5Z-9IQ
MIUY8><JDG.G7I7Q56%2C.=.G4C5949UZT_9N7^T+%T*CFW*$Z^'I0QM":E&[
MH5*]/FA3IRC[.E1P:I5HJ-:@<3XZ_9G\6>/[FT77OC/JNH:7IMKJ(TVUU+0=
M2FN8-1UKP/JG@W6)[N#3/&VG:#J5E))JD^I6R3^'C?6<LMQ;PZE]EG\I"E[.
ME7=5THU(I2I1C*\V\/*5.:A5=3GBZRE2A&5>A##QJTW.-:C4G)5(]6&QM3#5
M,+.,8J-*MA,35A"]-5*V$S*./C[-IN=.A*G'ZM["M+$Q@X8?$1?M*+527X@?
MLS:]XQ@\8Z1I/Q1?POX8\<111ZUH%KX<U=41[+PCX2\,:7<6MYX>\=Z&TS0M
MX69Y;348]0TZYM-4FLI;'<@NFZ*.)<,9A<55BZZP>/CF-.#D[JM',*F.<6Y<
M].4*OM%3J.I1G4C4I4<1AZE"<)1GRQ<(83 86,7%X/+HY;.46HJM14\5)STA
M[6C4BL3RT?95E"*52.(ABJ=2-.E>3]G+6H[@"/XC6UK9:7)J+>%7LO \$&NZ
M.FJ?$3P]\2+A]4U>;Q'-;Z]>0ZMHLT%O+_9UDBPW<33PW,T$LEYC&I4IT'"G
M-T\0L/A<+"K'2,:6!RS-<LPK=-W<JOLLR53$352,:E2A+V,,/[=NGS4</2HS
MI>[[2A"IB:TZ<]7.KC:N%K8I*I\4*,JF&_<TE>5*G45.=6LJ5)QJ>'/V9]5L
M==UOQ/XI^(D7BK7->L-1M[VX?PYKJP0WM_X4U#PB;[3D\3?$'Q#<:;"ME>"4
MV-O=I;!S<I;I;0W(CAYL1AZ53!9C@J">'CCZ.84V[\[IO,)9+4F[OEJ5849Y
M1:E&M4G4]E6ITI5FL+&576BIT\QR_'U)^V^H5,MFH-*+J++5G*AS.-J4*E;^
MU^>I*C1IT_:T'55'GQ$W#I/BM\#]>^(/AKP#X2T[QAI6EZ/X9?3H-;&J>$K7
M6;BXCT_3A:6WB+PM<?;H+CP[XPLIHUEL;E[B[MK>69;A[>::SA)]#ZS?/X9S
M.G>$,1/$QIQERU:<VZ\G2C62M*AB%5C1Q<)T^:=*$?8SHWJQK9X6D\'E$<MI
MRC4J4\/1P]ZD%/#UHTYX9WKT&V[05&4H1A42FJE7#UN:-6%;#^G^"/#NH:1J
M7C[6=21K>7Q9XO\ [3M;-I8II+?3='\/:#X2T^::6">6-IKZ#P]_:&%*LB:A
M'%(BRQ.HQ4_]CPE%I1J0>)JU%'X8RQ.+K5XTXW2_AT9TH32YH>V57V<ITW&<
MMIW]I2CS<U'!87#82C-WYZD*?M<14J5+V]_ZSB\136BO2I4Y/632] K, H *
M "@ H * /%?V;?\ DW7X!_\ 9%OA9_Z@VA4 >U4 ?/GCCQOXLTQ_B1XDT*\D
M&E?"!]"OM6\+_8],4>*M,MO#[>*/%\*ZA?VK30W3Z#K%E_9SV]S9Q+?Z(J7$
MC03W""*,W&G3Q$Z:KPQ&-K8-4^=1Y(>SP]"A6323C5ACJTJE6-5SA4P48JG3
MA4J1K'5#!U<3B<+EU"=.CB,;A*%>A4DI2_?U<PQ-%4:J4K1I3IX!T(U%'GHR
MQE2O)5O8TJ:YNYU7XV:1=^%M.NO$EO>WOQEEDL[.467AM;+X.ZG!:7GB.\BT
M%(]$@F\5:?%X.M-1BADUDZE++K&F6LDBQZ?J$D%CV4L/&.*JY=4K.HLN@L95
MQ7)RSQ-'#U:.'QN'5--0I1K8O$8.G@6J;J8?"5\74Q-;$U\/05;SIXJ'L*69
MT*?-3Q=58;#X2K>,%]8A.I@,16E"4ZGM*="C7JYE3AB/95ZJI4<%]5@YU1=3
M@^*_BW7?%GPMC\2VEBG@ZWB\5IXLU#0_"&L_\)G:>(;B_N/ ?AC7= OO#TME
M9Z=97^CZQ#J]Q8V=C>2PZ7I4NGW<%Q=W+VW-3YEAJ>:2I1J5,KQ"P_U6[IPQ
M6,PGU?&/$^WO.KAK8.M@I4I4G&4,RKXBK&$,+@Z-'$[-TH8A9=4E.=#,</[:
MI6]WVV%PE;VN$K4*=/D5"O4JXBGB.5UZ=6DL#&-"O3K5Z[Q%+L?A]\1-8U>P
MT[Q/XOM=<LH?'VJKI7A+PKH?A36?%-CX8ATK?I]Y<^)?$GA?0[V'37U#5$O+
MAK[6+RRT^*V2RAC\N>.Z>?2,:%6GAJ-/][+&T)9@IU5[.FL)B*-.OA<,Y3Y:
M"JQPDJ4ZE*4YUJN-K8FEAY5Z$,.EDYU(.O4JKDC@*JR^K&DW5=7&T,16H8G$
MTJ:A]8^KO$0G1IRY.2GAJ%+$XGV%3$3IP^:O&GQ7\<?#?4/CK\/O!DF@^'U-
MS!IOP)M--\.:%86/AC4],\&^&O%GQ&E:RM]*%KJ9M;'Q+-XBCCO8[EI6M[U&
MS$ JX0G/^SL'*I>57"UZN(J-:K^Q,'B<5A8X:,%I2C1EEBR^-6*C&G+-<!&_
M.HGJSH4X9E@G[*4J&8X:E"K;>6<YAC*M+#UZM1SC.3Q3K_6*ZNW['+,55BIU
M)RC4S-4_:!^+EEHWC30(]=MCXNO/&:ZUX'U<Z)HQ&G?#'PY=/#XWM9K/^S_L
MUY<6MUH,EC]IF@FDC?Q_I.7RJ,G;AJ<*^)R>DURQP^;.GF44YN5;+\1G?]GY
M?R6B^6I6J5_JG+3<:DJ.78FNI>V;E+PL77G@\KS/&\ZE.ID-.K@4U=K-J>08
M?,\:W&$4HTZ="K_:%-UFZ$JW/AK<BAAY?0FO^)]=\=>-;;3?"?Q%\>?"_0]'
M\%>*];OVN?A_I6@&_P!8T37-#L8Y]4LOB_\ #J:_N?#<5O>3G[3H[Z?#<JTA
MBOB4#Q><YRHX3-LRYH2A@Z&5UJ%&KI"V)>=.JL33A*EBJ4YO+Z,/93J4*L(-
MSC%>TC-]<IWQ^6Y9&G/FQ$LRA6J4D_:.6&>31HK"U91JX6JDL?6?M(4\13=3
MEBVU"4'YIX5^(OQ-U_0M4^*5[\0-5TL:7XH^%VD6_P ,&T/P/_PB.K0>+/!W
MPTU'4],AN)O"Z^*DUF\U'Q?J<EE(GB,K%)]D5[:>&-X9?9KX6G@\5@*"IU,1
M',L;C,-.$W^]PE.&98S!QJ4W2C"+>7T:$<1B76A6C4IT,3S>RYHU:-XF*5+$
MQH5H5_[/RJMC(XK#+]UCZF&>/E"ORU)UXQP^/CA:2I0HU(N,:T'3JSE[U3ZJ
M^'^N:EK.F:Q%J\BW&H>'_%?B7PW+>I$D OX-*U.5=.O'BBABCCN'TR6R$XB1
M8_/2;RP%P!YE*2J8/ 8A+E=>BU43_P"?V&KUL%B)K^6-:OA:E:G'[%.I&&O+
M=D_<Q>.H)WC0JTY0TMRPQ6%PV/ITEK)R6'ABXX=3;<JOLO:RM*;BNZI@>*_%
M/_D>?V;?^RU:[_ZSK\?* /:J "@ H \&\??%GQ/X7\97/A;0O"GA'4K/3_"^
M@ZY>:SXI\>Z]X8DFU3Q3K.O:#X>\.Z-HOA[X9^*KO6+ZZO\ 0V7,?ER8N0(H
M)I%"29PE4E'%3]G:%"K&C2C#GJ5:TXX:>-Q'+2A3E*,</A:<ZK:<W+E^&,5.
M<-ZM&-+#8.NZB7UJ>*C+G<*=*C'#3R^E&4ZTYI7K5<PITX1<8KFC9SYIQB>$
MZ-^U?X@U9[GQ7?\ A1=*\#Z7X;M]7N]-TW6+D^(QK&ES?&BSURPFLO$_@33Y
M[C1[B3X:,T'V@>'-0@:*U:YAB-Q=VEOW2PSI4J<TXU)XRI16#YJE.-.5/%Y5
MEF-IK$SA*<*,J5;,(1=:E6Q-%PYYM.-**KE'#U<35IX:G&-*2J5J%><O:\\:
ME/-\LP4'1I2I1DXNCBW*<:D%4;E.C3A&:I8A?4/PW\=ZMXP_X2#3O$7A_2_#
MOB'PS<Z7%J-GH/B@^,-$DM];TBVUO2Y;/7)-#T::2?[%=1B>";38/+<9B>X@
MDBGERE3@J<IPE)NCB*^$JJ4'"U?#*C*I[-MMU*-J]/DJ25.?,JE.I2ISIRB<
M<:JG.ERI^RQ&%H8VA)Z2>'Q%3$TJ?M8J\855/"U'*%.I6IJ+IRC6GS-1].K(
MU"@ H \5_9M_Y-U^ ?\ V1;X6?\ J#:%0![50!R7C[4[[1? OC/6-,G^RZEI
M/A3Q#J6GW/E0S?9[VQTF[N;6?R;B.2*7RYXHVV2(Z-MPRLI(/%F%2I1P6(J4
M9NE4C'W9)1;B[I72FI1;5].:+7=,[LLHT\1F. H5H\U&MB*,)QNU>$JD8R5X
MM25TVKIIKHTSY>UCXL>+_@Q-I5EJVO\ B?XTS>+?#&C:GIMKJ^AZ;!J_A_Q'
MJ%_9V5M97?\ PIGX8RWTGA[48;B]E@$'A+6+^.31+G:;B)V%IZ6(E"&,Q^74
MJ*E4PF+I4J53][S3I3H9KB*\:W*JL?:T:>6PE3=.E1@_K"^L2ITTJR\?#U)S
MPF68ZI)QABL%6KUH+V:BIPK930HRH^T=/EC*KF3A54ZU25J<?80G44J<[O\
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MI1>Z:35FBH3G2ES4YRIR2:O%N+LTXR5U9V<6TUU3:>C.57X6?#%$\-1)\.?
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M **G\%O_  P?CG_Z)*@ _L+]HK_HJ?P6_P##!^.?_HDJ ,&:\^,5M8_VG/\
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MK+WW=6ZD_:4*JG*-3#0A"#C*2LJ56K6I.U[1G2J5Z[A.*C/]XU*4E&FH&O\
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M_9.H R?VM/\ DCMM_P!EJ_9?_P#6F_A#0!BT % !0 4 % !0 4 % 'BNN_\
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MZ_'R@#VJ@ H * "@ H * "@ H * /%?V;?\ DW7X!_\ 9%OA9_Z@VA4 >U4
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M5I3G4IPJ1E.@TJD8R3E3;BI14XIWBW%J232O%IK1F;J7@S]HK3_BGX-^&?\
MPMOX+2_\);\/_B7XZ_MO_AG[QS'_ &?_ ,*[\1?"?0/[+_LW_AI=OM?]H?\
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M !_PI+]HK_HM_P %O_$</'/_ -%%0 ?\*2_:*_Z+?\%O_$</'/\ ]%%0 ?\
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MO_$</'/_ -%%0 ?\*2_:*_Z+?\%O_$</'/\ ]%%0 ?\ "DOVBO\ HM_P6_\
M$</'/_T45 !_PI+]HK_HM_P6_P#$</'/_P!%%0 ?\*2_:*_Z+?\ !;_Q'#QS
M_P#114 '_"DOVBO^BW_!;_Q'#QS_ /114 '_  I+]HK_ *+?\%O_ !'#QS_]
M%%0 ?\*2_:*_Z+?\%O\ Q'#QS_\ 114 '_"DOVBO^BW_  6_\1P\<_\ T45
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MC]FG_L@'P;_]5UX<H ^@* "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M-I\EW83/"\]M;R-&R%XHV)13;Y!M\CT__A<GQ%_Z-._: _\ "C_98_\ HEJ
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M /\ A<GQ%_Z-._: _P#"C_98_P#HEJ #_A<GQ%_Z-._: _\ "C_98_\ HEJ
M#_A<GQ%_Z-._: _\*/\ 98_^B6H /^%R?$7_ *-._: _\*/]EC_Z):@ _P"%
MR?$7_HT[]H#_ ,*/]EC_ .B6H /^%R?$7_HT[]H#_P */]EC_P"B6H /^%R?
M$7_HT[]H#_PH_P!EC_Z):@ _X7)\1?\ HT[]H#_PH_V6/_HEJ #_ (7)\1?^
MC3OV@/\ PH_V6/\ Z):@ _X7)\1?^C3OV@/_  H_V6/_ *):@ _X7)\1?^C3
MOV@/_"C_ &6/_HEJ #_A<GQ%_P"C3OV@/_"C_98_^B6H /\ A<GQ%_Z-._:
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M /D__P!H'_"S?VI_^A]^ '_A@_B+_P#1-4?V#_U%?^4O_N@?VM_U#_\ D_\
M]H'_  LW]J?_ *'WX ?^&#^(O_T35']@_P#45_Y2_P#N@?VM_P!0_P#Y/_\
M:!_PLW]J?_H??@!_X8/XB_\ T35']@_]17_E+_[H']K?]0__ )/_ /:!_P +
M-_:G_P"A]^ '_A@_B+_]$U1_8/\ U%?^4O\ [H']K?\ 4/\ ^3__ &@?\+-_
M:G_Z'WX ?^&#^(O_ -$U1_8/_45_Y2_^Z!_:W_4/_P"3_P#V@?\ "S?VI_\
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M /D__P!H'_"S?VI_^A]^ '_A@_B+_P#1-4?V#_U%?^4O_N@?VM_U#_\ D_\
M]H'_  LW]J?_ *'WX ?^&#^(O_T35']@_P#45_Y2_P#N@?VM_P!0_P#Y/_\
M:!_PLW]J?_H??@!_X8/XB_\ T35']@_]17_E+_[H']K?]0__ )/_ /:!_P +
M-_:G_P"A]^ '_A@_B+_]$U1_8/\ U%?^4O\ [H']K?\ 4/\ ^3__ &@?\+-_
M:G_Z'WX ?^&#^(O_ -$U1_8/_45_Y2_^Z!_:W_4/_P"3_P#V@?\ "S?VI_\
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M /D__P!H'_"S?VI_^A]^ '_A@_B+_P#1-4?V#_U%?^4O_N@?VM_U#_\ D_\
M]H'_  LW]J?_ *'WX ?^&#^(O_T35']@_P#45_Y2_P#N@?VM_P!0_P#Y/_\
M:!_PLW]J?_H??@!_X8/XB_\ T35']@_]17_E+_[H']K?]0__ )/_ /:!_P +
M-_:G_P"A]^ '_A@_B+_]$U1_8/\ U%?^4O\ [H']K?\ 4/\ ^3__ &@?\+-_
M:G_Z'WX ?^&#^(O_ -$U1_8/_45_Y2_^Z!_:W_4/_P"3_P#V@?\ "S?VI_\
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M /D__P!H'_"S?VI_^A]^ '_A@_B+_P#1-4?V#_U%?^4O_N@?VM_U#_\ D_\
M]H'_  LW]J?_ *'WX ?^&#^(O_T35']@_P#45_Y2_P#N@?VM_P!0_P#Y/_\
M:!_PLW]J?_H??@!_X8/XB_\ T35']@_]17_E+_[H']K?]0__ )/_ /:!_P +
M-_:G_P"A]^ '_A@_B+_]$U1_8/\ U%?^4O\ [H']K?\ 4/\ ^3__ &@?\+-_
M:G_Z'WX ?^&#^(O_ -$U1_8/_45_Y2_^Z!_:W_4/_P"3_P#V@?\ "S?VI_\
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M /D__P!H'_"S?VI_^A]^ '_A@_B+_P#1-4?V#_U%?^4O_N@?VM_U#_\ D_\
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M.;I\T(NC"C%N!] US""@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M_P !A_\ + _LO$?ST_OE_P#(!Y?QM_Z-=^,'_A6_LT__ $0-']MX3_GW5_\
M 8?_ "P/[+Q'\]/[Y?\ R >7\;?^C7?C!_X5O[-/_P!$#1_;>$_Y]U?_  &'
M_P L#^R\1_/3^^7_ ,@'E_&W_HUWXP?^%;^S3_\ 1 T?VWA/^?=7_P !A_\
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M_P!$#1_;>$_Y]U?_  &'_P L#^R\1_/3^^7_ ,@'E_&W_HUWXP?^%;^S3_\
M1 T?VWA/^?=7_P !A_\ + _LO$?ST_OE_P#(!Y?QM_Z-=^,'_A6_LT__ $0-
M']MX3_GW5_\  8?_ "P/[+Q'\]/[Y?\ R >7\;?^C7?C!_X5O[-/_P!$#1_;
M>$_Y]U?_  &'_P L#^R\1_/3^^7_ ,@'E_&W_HUWXP?^%;^S3_\ 1 T?VWA/
M^?=7_P !A_\ + _LO$?ST_OE_P#(!Y?QM_Z-=^,'_A6_LT__ $0-']MX3_GW
M5_\  8?_ "P/[+Q'\]/[Y?\ R >7\;?^C7?C!_X5O[-/_P!$#1_;>$_Y]U?_
M  &'_P L#^R\1_/3^^7_ ,@'E_&W_HUWXP?^%;^S3_\ 1 T?VWA/^?=7_P !
MA_\ + _LO$?ST_OE_P#(!Y?QM_Z-=^,'_A6_LT__ $0-']MX3_GW5_\  8?_
M "P/[+Q'\]/[Y?\ R >7\;?^C7?C!_X5O[-/_P!$#1_;>$_Y]U?_  &'_P L
M#^R\1_/3^^7_ ,@'E_&W_HUWXP?^%;^S3_\ 1 T?VWA/^?=7_P !A_\ + _L
MO$?ST_OE_P#(!Y?QM_Z-=^,'_A6_LT__ $0-']MX3_GW5_\  8?_ "P/[+Q'
M\]/[Y?\ R >7\;?^C7?C!_X5O[-/_P!$#1_;>$_Y]U?_  &'_P L#^R\1_/3
M^^7_ ,@'E_&W_HUWXP?^%;^S3_\ 1 T?VWA/^?=7_P !A_\ + _LO$?ST_OE
M_P#(!Y?QM_Z-=^,'_A6_LT__ $0-']MX3_GW5_\  8?_ "P/[+Q'\]/[Y?\
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MU')PAB71:JNE"J\;3_V9?%UE:Z7>2_$SPK)XIT+4OAZ^AR6_PG>S\":9X?\
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M3QD7EF)RV<9SE4;^M_6J>(Q4)8OZY:O5PE3!86I*M&NIPRW#\UZ:A1I=Y<?
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M3AA9XCG4YRHX]8'$>UA2HRK3P]&5/&5(XK+\/CG4IX.2JX;"UZU/#D4G4A#
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M57#_ .RQPU2=93I_NU2K8NK&G4J\T>7DJ8JO6C"<[J5:K5C&3E.:3=IWPO\
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M.3G.3[RE.3E*3UE)MMMMLO5 !0 4 % !0!\__M8_\FL?M+?]D ^,G_JNO$=
M'T!0 4 ?/_B/_DZ?X-_]D _:6_\ 5B_LG4 ?0% 'PIXS\ ?&?Q)\5+WQ-_PC
M?CF[_P"$,U7QWX@\&ZC+\4K+3?AQJ<,/P^U72?AIX?T+X;Z=XTCMI=7/B+6&
MN]1U_P 3Z';7EK?6&VSO6TV6,P<L(U:> S&<82ACZ^7YGAJ<[JIB88G$9G2I
M8?$8/VDUA\(H9%4Q%*G*C5PU6M5]M#%N%Z<Z_9ST98W+L+4Y)95+'914Q#]F
MTJ.#H4HXO'>VY>2MBJ_]KX.A:E4ABL+#!5J<L-#ZS[:6'X[5?A=\5_&&B>)[
M#Q%X&^/MYI-_-\&M(ET[7?CE::/XDOM"T+7O#?\ PGD6@:=X+_:+G\,2P3:7
MI-Y>S:SJ%SH.O3RZG>P.VJ*;?9ZT98:IF-&M4A"AAY9[B,9%PYU*A35',:N7
MUJD.62H8? XZI@(4Z67RDZN'IPQ$\NI9A@88K%^#3ABJ. =.498O$QR'ZK4I
MU90]G5Q-:.#H8JG!Q<5B<15H_7*TO[0C[".)C]5CF,\KS"MAL'UGB3X;?'.Q
M\/2ZAX?;XE:QXK\1^(OBTUSI<OQ3.H:/X8\.)X:\?Z%\(]+GTCQ1\08-(N-/
M)U/0+^\EMEU&]N-26S;42;>U$VF>?.G3KX18'%QG5PV.RERQ\X1HK$?VAC\?
MEE?,,/A>:*I4Y83 5\WP670C[+ 0^KT/WL+PK3]O#8CZMB8XC#4HQI8/,,%3
MH4,1.?-4P. P\8.O+$TXUJL'C\PR[ 8G$5:GUC&4L#CL?"-"IB*^*P]6OX/\
M%?&WX=Z1X8F\(^"OB?<>';#Q)+-I/PS\4_%_P]J>OZ+8:5\*+OPIHX\9:E=>
M.M1T2P\(7WBZ3[?+X=\+:GK5IIQM-,N['3Q(;BWL^G,,5C*KQ\HNEBL5CL)G
M%6C5:ER83%8O%Y;B,)AZE6LEB<55HT:&9<F*JQJ>SKXV."6(C@:-/%1\_ 8:
ME0H8*@I3PU"A_9&$Q47"FJM:CA*F/6*Q6"A2G.A0=3GRE5N:="MB,)A<;*I3
MJ8NNZ6)S?"'PH^,OASQ'/XAO-%^)E_XTO]4^">D^(?&4GQ>DU#P_K?A?0O"$
M>K^(YH_#VH?%18H+:P^*0U"WU*TCT*R>32=7N1I,>I#4+^"6J[CAX8K#9/54
M,-];SZI1CBX>V3E#)JV79+6J3FJ]1T\0_J^(G4=\2\QITEC*%/"8/!XJCM6<
M<;'#8O'4Y4,3+!8*<\/@I*G'"5ZW$ZQV:8"C+FI1DJ653]A0J3E4I?5Z,H4J
MT:]:5*IH>$?AU^T!J8TZVUFY^+O@ZVUW5O ,'Q(U+6_B[I>MZW=:GX=EUWQ#
MXV\6>"[31?%NJZ;X&\$ZY<6.@>'+;2/#ZZ5-):ZW-<7.B:<]DTTCY,'&I^ZY
M_P"RXSQ=>A@ZSJ/&0IO+\3@Z6&QF-A4=2IB<3BL50QKC2Q-7"8)Y<Y83$T*F
M+5.C$GB*E+$5)NG1S6,/9SJ48?[!5E/,LKJ4Y9?AZLG[.G@<#3S2$:F.H4\3
MB?;4:>,68.#<_8;;PS\4-"^#W@7P];CQGJ_B.W^(/AF\UY!XTAU'Q?IG@9/B
M0-?GTN]\7^(_%\4OB%+#PLEGI5_+-K=_=WMG'=A?[0FE$-S'MYO%9)5G2I2]
MA@8QQJC&-.C/'4^'J]+G=.$$I0J9VJ,O<I.+NJDXJ"G4B<DZ-'/HT)QE.IB,
M9' \_M*G^QULR5).E*K*4Z>(_LF=:OAI5)TUA\7[/D]@J<*<(O@[X!^)VA>*
M-/\ $_C77?&L\FL>!M8N_%>D^(/'$_B'0K'Q=XD\9MKVF>&]$T"'6[G2])C\
M)Z+]LTM=0TZSB-[;ZA;1RWMXME$MH4W'#83%X).GB)TJ&24Z.)<9N5?$X3!8
MNAFF*O43JTJ>*K/!3]C>$7*$ZLJ<JTJE:H\7!RQ\:U&HOJ\<9GGN04J<8X.6
M*PO]DQ]G=0EST'B:LI5%4KT9Q]E&6'H.&'.%\$0^-?!/CGQ!\5_C;J7BWP#X
M4T'PMXFLO$VO>.OC+:R_#;7M?U?QGIR:#?>&O -CXXO/#OA#P_IV@V,%GI=U
M/I6DZQ=MKTD>HQ->_/<X86O#!Y56A6I\V,Q=+)8TJ+4L1BZF.C0QL<SA2;]I
M:KB\9]56&PF!FZ4Z3IJE3]I*K1H]&*IUL5F%.CA(1J87#5LSK>VIQ]C&&!I*
ME++X3M*FZD*>$K8NKF6(QM*4J6)P:G3KPP=.E.OB&U_:,UG0;2;0])\;7J_$
M?P+>O!KDOCNP\,I\/)_B+\3KK6-9EU+2=4UJ#5;;Q'X9^&]_HT>A?V9IT_D/
MI.HVC36+R0K<]="E+!XG#X7'<D7@I\-?7&FJ\*SRRA6JYS3P\X-RE+,,?4J8
M?$N<J5&>%^JU*<ZJPZH+&K5A5C5S#!5U.M&7$T<%"%&*PTH2I8.CPU7JT:R5
M.K3Y,&ZL_:0FW7Q-6=:DHXNO6CJGP%\9-!L--U4M\:O$&M>)Q\8-:\5P>'/B
M=H=]?>$;S5EUY/AEX<T+0?'7Q)TKPM#:Z9IWB6[CA:R::)M0T72)+^4P65M<
M6/&YU%A:>%]FO=R;"0J2Y5)U<VKU\FGF$G656CB81HK"XJG25"K0A'!5,:\+
M6I8W$?[9M[BQ<,7)1DL'G%*-&A%U(4*V38+!YGAJ$JRU]I4QLX9=BL7*K&5>
MKC,0W4@J%.<*/ 7_ ,)OC;XETCP1X-\1>$OB4^@-!X!FOL_'S6[C1M"1OB!>
MW?Q.;XB2ZG\7-4\2?$#6KWP@^GBS\.7>H^,_#=E&UW:07EPUE;-J'HJ=&&:4
ML:I1C/+:]&O1<8QEAW#!Y52Q6#H8>D\/25>M_K!AY8?$YECL)A\8\+4P>+H2
MI5OK;H^;65>>68[#3H^WACL/C<+[-3]CBYU<76J8#ZUB:D7*AA\)1RNI2QE/
M X"K*-;%QQV'Q%-TZN%G#MM)\(_&G5FMH_'?AGXQ32)X%UO4/#R:%\9K/POH
M>@_$6?5/&]]JUCXUF\'_ !;T_5O$6GZ@M]X9M- 0#7=-T^PM8?.M]%N8I OC
MXRC*>3XVE1<IYK3RW#4*-2;M"M'^QLOPM2E[)5/8K-5F*S'$8S$UTJ<FZ4L+
MF575R].DZ5+-J$)6>2_VQBJTI1C:O&BLWQ%?"U97>F5T\MC@Z-#!44JLIRQ=
M/'X*K2=%4^*TGX9?&'PGH7A;PKHG@KX\GX=:9X5^&VF:YX4TGXVZ#8>-;QX=
M)^(%UXFL].\7W_QM>Z\.7L/C75_#4NIRZ+K]AC2=-L;31;^\@MY--B]?'5*.
M*Q./@E!4/K6*AETH2J4H4:,<'DL,JJ8J=.G'$3PF%4,YI5X*&(KUL9]5J5L)
MB\-^]?!1GCJ>%PTJGLZF+E2]MCYRIJI7K8NMB\1_:;P[G-T/;8N%#+:V!==Q
MI4:&(S><JV#S/$0J'HGASX6_'22_\,:EXJ\5^.4O_#6N_"+2K>#3_B1>OX:E
M\/\ AW3)M<\?^(=:L;?6+5O&<^IW&K7OA&4:[9W,MR=)L]6^P)(L5["J-6G1
MQ5&K4]GBU5K9F\1-T52C[%Y)# 854\+'FH4'B<WPT<VA&@O]BAB94*=2A^_C
M5K%T.;#UJ6#J2HTU1H3P].<JCKTZD^(L15E2K8EU)5*U3!9#.C3YI5I4<34A
M..(GCFJ48=+\6O#GQ:UKXF6$VB1^.;?PO8VG@N]\-^)O#OQ$LO"'@;P?=Z9X
MBO;WXBWOQ$\-6GB6QU;Q[<W_ (:6QM-.TR?1O$.DDH_FC2YF>\;S:-6EA?K>
M,QLG1C@JTZ]2<[U*-?*J>#HN6"P]&,G&GC:V)6,57&5H49X2C/#8C!XIUJ,L
M//HQ,:E>C3P>'I^T^LX>O2IJBG#%4\TJ>UCA,37JRG3OE^&:PLX8?#3G.O5>
M,IXW"XFA/#^RY'PC\)+[4OV7;BT\*IK.J:I\4M>M/BSKF@>+_&7B768_$ND>
M(_&UCXTU?P*]_P"+=6U+^QK+6/!8.A3(OE6\KWDT][&TEU=2R=U:%3*Y\.8+
M$815UPS' 4\3AZ;@JDL7A\.GBZL:DW%5ZF'S:4\PHT<165&K.C'#.K2I5'..
ME*O'$8SB/&1Q<)3S1YOA\%BZ+E&A"C;%8+*<12]AS\D%@XX91KX>+E"ER3P\
M5"AAJ-/2^+$GQF\<^$M%MO"?P<^*_A73HM(\:64_@73?BCX ^&/B>/Q18Z9I
M;?#F^U/QI\,?B](^F_#T7"ZS%/;Z#KC:@]RNFI<V!TXW)'+6H/$5:G-CI4JN
M)HQ5'$7J2IX.K/%<F*Q&*HI*>*Q4,,HUL%17M\%44L1'%2IXAX>=+3+YX2E"
MC2K4'0A1QV$C6C&%&4:N7^PQ#KQP[U=&,<0\,JM1*ABHTZ<WA8U%S4ZN._PJ
M_:!TX1Z[H7BWQM=>*-'U+6['P]9^(?B/J-]X57P[H?P3?PIH,VO:'_PD;67B
M34/$GQ+L=,UN>[U:UO[BT::>9192SW4MUU8C$4JD\;6C0G16-IYM4JTZ"P_/
M3]MGU-8'"X"%9?5L+5HY)SXG#54H1CB8O#8K$?5YK"G+E<8TZ>583,XNI1P;
MR.A*M&<U5E[.BL;FV/QE2+]KBG+$U<5D\L.FX2HRPN*I4:CPU+$4^*3X?_'N
M*S\07,7A+X^R:%XCUBTC?P9??M*(/&]S)I_@87=CK^H^+H/BR\'PW\.WOCW5
M=4@U;2OA[K,#JFAZ1]AL9=/:XA?DQM.3PM7"X=TI<T,VKX2WMU'!UI3RZCEV
M'Q-><OK>/A'"X7&8BG"NZ]#ZYCI4<5+V45B5>%2A6PN*Q%>;J2HY;0QT?9T;
M5%[?-EF53!X>,/JE&K)5<JE&LHT:BP-&K+#J&/\ ]G=K3OAQ\8O!5[\.-,O-
M!^+.I>&?AD/ %PFM>#/BK=V&BS>&/#O@%=3\6Z/J'@/1?'5O?_%#QWKWQ.T^
M>PNSXCTG4+ :?KEG-9WJN-0:/U9U\)_:V*Q5&"A0C6S"A1H3I4W1K8>I166Y
M)A\)0]S"8#"82A6IXRMBJ\<-6P^+PE53?U'ZO*AS.C+$Y91IU:KP>-Q-#"XS
M%>S<[4,QJ9W+'9QS8B];'5X2P$I4:%&G4Q?MJ?M$G+'2BL1]&_'>'XLW^D^%
M?^%6Z/XAGU%3XON;Z/2_$&A:$;#4KGX=>*-+\*)XC:^\5:8E_HL/BC5=/N)8
MK&34V6ZTZRE$/EQFZMO+]@JV+KX.KB7A\%B<'4PWURGS7P]2MF>54YXJC#D=
M1UJ.6?VG6P\G2352,8WA5E"$^S#XI8>A0Q3PGMY0Q.$K5L'-4_;UL+0A7Q4\
M-2JR;H4:M;&4,#A:TY5.1X6MBH?O:<IQ?DEY\+_BIHFH2Z'+<_&_QS\.=0\8
MZ+!K::#\9Y=)\?ZC;VW@?1H'\76WBC5/B/X?O_"GA)_%\NIOJ.A>&=7T>9FT
M>"2STN:VOKJ*]Z:=2%7&4O:TZ=##2J9G6PZ2G[/ RJ8K K!T\8X-U\;1C0H9
MC6HQE'&PIO,*.'J484\/2AA.2-.MA\+1G2Q+KXNC@LNI8J,X4Y?6I4HYO'%Q
MPL:E-T:6*J>VR=2Q$GA926%KS6*=:3GB,J]\-_M$:8?%*^$_!'BJUU/Q-;?&
M?3+34T\?^$['2-.U;Q!XOT'2?!/CK71+XTO+_5KRQ^&6@:9)I-P+:YODNHK^
M"^ATT78D?+#-5:6#P6+O2PM=9)/$33Y*F%5;-<UQG$U'#+#I>RJ2J9A&KA7A
MVJ;P=.*C66)I1PDNBI.&"Q-7%X+#4\7'#5:E6.'JN4Y8^K@<ARW"Y1&M7K<D
M_J5>MAL70S*G4DJJQE6A4C#$8>F\>N9\9?"S]HG7O%6I:UI.G>,[7Q3X-B^)
MTW@GQKK/Q,M=6\#RO+;1^%OAK'X1^%:>/X;"37AX'\1^(9[O7O$ECHNIMK=C
M/#)J4>F74$[1&<X4,1BJ:]G6Q=+#T,7AG!3KUO;YQA,7FCPE2G7P]'!8:G@\
M$\)@*.%Q6$JU<+BHO$2H8ZC*M*IT:2A0PE/%U94L.\(Z<Y/DI3]ED6)C%XV7
ML:U7%N'$2PN,K?6<-BX1]E1E0IXBBJE&'L?AKPC\7_"W[.UYIVGW/Q'U7XBZ
MAJ-IJ=UI'B+Q#I5QXXTK2;K6M)B\5:!X0USQ5\7O'5I9:F_A^WUJXT<ZU\1=
M:@M;W4H5?4+>VB2&TZ,:\/.>54.64\'0]G'$RP\U3Q%2G*=6NH5:OL\(VJ-2
MI2PN(J4E]:> HS=#$8G&\F)JXX#G]IFN(Q,W2KUX8N6&C.G!T*6)A@W1PDX4
M82Q$(TJM>G3Q$Z3C&A[:I-O"8>C*5"/C>C?#/XS>%-*\6'3/!GQLLE\767Q/
MOOL.A?&/0_&WBVTUG5/$O@/PSX*E\0^*OB%\<=%OM7U./X>^#TO(I[?Q$9=.
MAU76+/3]3TZZ2R2?.KSRR^G@)5*52IAX97*G.FJN'H<]3,<\S+-,/*=)0Q2I
MP6(RW 5<9",,7B*,%5A&I+VT(;PER8_ZQ&K*>%J2DW'$1A/$T8TLGP-#"PP\
M9PQ&$ITEF&)SO%SP;C6P;QWU>I.G4P\82EMVOP3^)-_XEDO9-*^*O@K5]6T+
MX$^&-2\6Z7\??%?B'3-,\)Z!J,GBCXD:397>O?%"\UK4-=;4+:71VU*ZT5IV
M@UAIK2_G?4-4D&]-T(8G%TW:> KYOBZU6Z=.>(P='(8T,K5-T8QE1IK-%-5O
M9_5*\XU93J4HQ49QYYU,13H4?8\M:I0RZK2PT:U-?N,7CLXK4<?7J4Y5:T'B
M/['K4,;A*<JV,PV'Q& H4/;5?JN#IRPO$_PF^-VNOHVF1Z'\8(+G1_\ A=&C
M>"O%-M\8]-MD\(ZAK_BW3K7X>>,?%GBF3XI3^,]7\-6'@?0],E33[1=8NM2N
M+S48-<TR-+B3[1G@)Q^N8/%XF,:->6&RB5>I*$>2'_"CB<QX@P<L+0@\/B)5
MJL<'1R^C4A/ 1PE&A3E5PTJ:5#>O["A&O2I4%C<OIXUUGA76KJOBO8Y-AL!@
MI8?'5>6IE]"I4Q&:3S&K2]GCJ&)J*I@HXNDG+$]+XH\*?M(>*/#WC?PQ>^'/
M&:6EOHWQ]GM=2LOBCI.E7WC77O$>HKI?PPTKPVFB>-;&;2_#MOX/U2\N(H]9
MO]#6WU32]LL5O$EO=77-['"5\+0>+HU)494,IPV(P-XSJS6(S:GC,_K2JSFJ
M,I8:EA7A\NBZT_;99C_JM51M7PL%"=7#8FDZ+A4K8?$?6(5Y5*M'#3C@\BG@
ML)1FJ<)8FF\PQU2&*Q\J-*/U7&47BL-.M-TJT"^\!_%O3K.3POI/@WXW2?#2
MRUW0M-TCPSX?^-NF:%XR_P"$5LOAGH-OH,<GCZZ^,"ZWIFDZ9X\;Q"=>.GZW
M;ZE<FUTY;*/6M-22.YVQ<Z^(K5*CK0J8RO+-I1KR<XX>CCOK>#HY=C*L8TU5
MK8&>68>=2-&I0Q$Y9A7Q5;'8!5:JKO#!4Z.#PN"A0IO#PPV%RV-:E*-.K4K4
MG+-ZN88:A2DY87#XZ%?$X"E&5*M2PU/ 8:E3P68TW".&H[6D_#?X^6<V@Z_X
MH\1?$+7=<\-:UX5T]K+PQ\0+:PTG4_#?AKX0D>)M9_X1V]\3:9HWB+6?%'Q$
M:ZTV*/Q%%LMV:RU$Q6!CEOJO&RH^TQU?!^TBL=_;E65-0I.I2C6_X3LKPN$I
MU9_5L-*$*6&SZ%2,U[";Q.#=>/MJF&JZ48QJ\M*2^H0HK*(THU*L\12YX9O_
M &AC)5L1"DL;6H4,MQ-7)J\IP=;'?5(XCV%3FP\J6FGP]^(5_P#LL>-?!FL>
M'?B->^,_$T.KV\^C:I\4[V^^(6JV&H:C;6TTW_"0WOQ<U'2?"^KW.BI-,V@Z
M5XVC\/)*7@B:VM+R6UBRQD:57^P*<J,)4,/B<MEC*6'G64(4(9A&MBX>WK.E
MC,3'ZMS\SQ-3%8FDI?5J>(QZPU'$5HR^6)PU7-J]+$3H8J5/'?4<1B5"4EB?
M[/E3P=5T,/SX;#..,4%&6#I86#Y8XWZM@:U6="@?";P#\4]&^)%G/JMG\3]#
M\/\ AFX\3:?)J'BKXM2>+_!7B7P!)!/9_#?PMX<\'?\ "?:Y.OB;2;3^RKG6
M?%'B#3;/5I[ZQO(8M4U:QO5:#KI5KPQ=7%5(5JV*H5(UU*G'VM3-/KN'J_7L
M.X48TL+ERPL,5A\/AZ4L/5JPK4:F/P?UNG/$2RQ5""EE\,O52AAZ%3"3C3O&
M*HX5974AB\)749_OL1/-:JJQ:^L4*%&A&GA<13H1IX=>:WUC\<?B/XC^*'B[
MX=?\+5L%TWQ9\5++PIJFI_$O3-*^'.MZ9HG@;4OA?8>$O!/@S3O&TQ_M%_B/
MHL/B!M:\3:%HZ64]K/)IMZR7TSW/'A$HY9A:N-H5$L=A>:K3IU(RQU?#8_.J
M..PN(P<Y36'POL>'Y2]A4^L4,3.O5IX>K%X65Z'IU*U.&9^P4,-B(8"> C2G
M%SIX:A6PV&ABL;#,?9*=;'5JV.JULKQ.'5*KAZ&&7M;0Q^ C3K^A?\(/\<?B
M!K,3^(E\?_#KPJWB*.>+2;3XKO9:P_A/PU\+9-,T+3O$6I^ ?%336.K:U\0/
M%6J76J-H=]<$_P#"'VCMJ#K'933:5I5**QE?#SH5\?*EG&,P\?9OZG1S*IC<
MNP^58=4ZE./ML#2P&!K8_P!AB**PT:^.JT*M*:G6I3\_#?NZ>&H2A-494LGR
M_%U*LU/%/#T7F&.S/'8=J3A1QE7$/ Y6Z_/+$U,'S5(>S>N'Y:#X0_$?Q5H?
M@S_A)=$^->F:WH=MXS\7>.;G6?C3#+JGB7XDZ9X(E\(>'+?X?WOASXI7L'PZ
M\-ZU<>+O$U[:GPZ/"#6Z:- +^+3Y)56><9:$,QJY._J\'@,32RVA7<WBZ.*Q
MN,PLXU,;B$ZL:JP='+HRK8?ZQB<'/Z\Z>'IU*3Q6&.C \S=.EF%2%.5?,,OI
M8^5!57@:F68:.*Q%3ZI1FW5C!8MX*,*M>@\SFJ$:U6<\31H8R,<_@7]H4>)/
M#C:U:?&#6SX-CM&E\5^$OB[H^A:/KF@V'P@ELUT?3/ 5Q\2-*TWQ9XXU#XI1
M-/>7_CK3OL<7GVIM;XVLD[6.V,>'KULZQ.']IA'B5G$*4(*$[SQ&8QP^5O"T
M9OV&%PN%RC$RQ;J0EAL=_:&"K0?-3>#C5XL#'$T<'E.&QD:>)G!91S2]I5IN
MA]74,9F=3,*T5*OC*N)Q6'GEM.C1E6PLLOQ="M.5/$4\:ZN/I7PT_:2N]:^#
M^GZG/\3O#/@;3X&U7Q#_ &7\1=5\3>+K#Q7:^)]6OCJ'CKQ!KO[3 8:=J6@0
M>'H6\-0P?%_0;9K[5;2WMK=+>UU"1PG##XS$XCW*_P!4P>'^J4(Q_P!CE.G1
ME4Q.#E4KTZE;%RQ-><Z"Q.,PE'%4J5/#5*.;T)QJSETXJ$*N J4Z%2K&OB<7
MBHUJE10IXCV=:EA*.%Q5*GAG'#X=8*2Q=5T\)B,/0KU/9UZF45/:O!X?N--^
M&OQ7M-0^#-UJ<?QFUS5M1\1W?C/XJF?XT:CI_@3PU-J>IG58=!NET3XM:?J,
MB>'89WL+#0]&\/\ B3PWJT,4EMK,)+VNIZ<\%['!XN&'<X5<-@,LIT?K=2$Z
MOUK'1P4,/5KT:595?:RQ5>A"=6&.H8>&&C7^NX&O2QD<70QLXU/V.:/#IUJF
M-S2K["*E[)T<LCCL2Z-.Z<(X>+PF,]JJN&E/&RK82AAJZ>&A1C2U_CI\/OCE
MXDU'Q]XI^'FO>+]+OM+TSX>Z)X"\/Z3XLN[72-4LX-1U6]^)FL0^%;+XD>$-
M/U/Q#?Z%KKZ+:G7-?T$Q2Z5#=VE]875K8:E;^?2<J=*:JTG/ZUF->%=7<YQR
MR.7X7ZLJ#6(P_P!7G/-H3J5ZU"M#%PPD9Q@JD:U;"8KKG43]C2A"BH87!5*U
M*;YJ<I9GB,54ISCB9JC6]M2P6!P]"M@L/.C4P53%XJI'%\U-S=#@&^'WQZT>
MTTB'0K/XX>(=3T+X/>-#8WWB_P"*MEI&EV'CW7K/Q%?:)I=M9Z7^T'K-QXT\
M0V-]JUEHZQ^/W\26-I:Z5IU[9>,%O+*XDU?T*SP\YYK2=XX:2R[!0K4;/%5L
M-"K@J6,KX92I8?#4:KPGUFO+&QHY7F'UZE*"IXK#XN,L-C@I^SEDWMJ%.2CC
M:N*Q=.3JPHJ"A>%*M4=3'8J-*6)PM.4,-1GCL-]7S&O&=.DJ$,-"IXT^&7[0
MOBKQ+)JFD:9X]TOQ!X13Q5J?@;Q/XE^)VFW?@*&1/AO>Z'\.M.M_AEI/CVYL
M=<\36WB#69]0U37/$VF&X75-+V6FI3Z5<))%S*4J=3&8ETZ?MJL<;3FZ495)
MOVV>X>+GEU.I/#TL%2EPU/&8;#>RJY=B*E2=2GBY8:7LZE6,/)T\/EN#J4UB
M*$5E<IQQ$I4^7ZOE_P!:KQQ^(H.I7Q%:7$&"PBKV688:G@*RJX.,\6JLJ+-&
M^#/[0%_X*O;?4/%/QJTS47\&>.]5M-'U#XE7?AV^7XF:Y=^&M/\ "UFNH:/\
M>O'FJ67AG21X;N]?%E)X^U*U9O$UW9Q_9[&671EZXO#TZ^&C%)4L-4R2G2J7
M]KR4:N88NOG%;$4ZM&"Q53 X>6'H4:>*CB_;4.:E.>8U*=.K":%:K32>)PT<
M1&I/&UL9"'[FIB/JF$5/!8;#5%6G#!?VJ\7B*=:MA(X&&'Q& PN*IX? 2;JU
M?<?!'@+Q;X2B_:/\26.@^,O^%@>+-:UFZ\-3:]X_EUC0?%BZ7X3M-.\'WOAK
M3;KQWJ-CX466[M_*G-SI_AR:-W%OY1TVPLG3R\4ZTN'%@L+!X;$U:N:5)TZ;
M4L31J8G,,3[&K3Q%6:34<OEA50IK&1CSX?FK1H59-G5@%!9W@9YG7^L8+"4<
MHH>VY&J?U>EA<*\;2G0@E*I../6.KSDZ$E/ZU*=*=6=;$.7/^&?AW\7[GQ+X
M1\2:UJOQ*TR#2/%O@BP@T34OB.9+*P\"Z!\*8U\2:KXMT71/&%]IOB_7M>\=
MO=:;<K>2:UY+K!J%J$:,ZA+[$Y8>&88K$TYTY4L77SW$58>SDZ,*56H\#E>!
MP=.=."P\(TZ.&SFG6C2I5:3>)PLZE)UJN%J>30A6EE='#5?;T,5A,%DM%3E.
ME*IB,;1Q\<;F.*G4A*4HPEA,17RVI3E4DJ[H4ZBISIK#SHYGQ(^"_BGQO\5?
M'&HV^C^.=-L_%!^#7AO_ (3"V^(+#PHG@'P[K\OBOQK;V/@NX\>/':^(&O+%
M+ 2MX458QJWVFSFF>]U0CS<NC&E[N)@XTGG5;'55SR=6I2P>44Y90Z%5.<\/
M&&<PE[1T:F&KQA4DX\D:=&O#T<=4JRI*%%TZZCD]7"4:<Z:5.CB,QQ];!9K*
MK'W%B)RR7$4L30515:,ZN I4ZSE*EAZ#XG6OA?\ M RV&E^#Q%\7-0T0ZC<3
M>&]:TCX]ZIX>U'P/;ZI\8M=>_O/B!XIC^)$/BKX@7.E?":]\/OI&G23>(;":
M6QU*'4D%PMEOZ\#.E+$Y/7Q5J%7"0R6>)E.G&>&G3PV#IU\?@UA:/[NOB\5C
MH3P&,Q.(@Z?U9T,5A*\ZKQ:K&/C1JX7,Z>$]IAGBUGD(1A).HL1]2P]#*\72
MK5+2PF'K8NGB\?3PV'E!8>>*I86MAJ>&I1^K]-8VEU\+OAIXZ\+R7'BKP9\8
MOC=\3_'>G^$M-U[XDW/BOQ%K<_B#Q:^FZ=XP\ 6DOCWQ#/8:-H?@?4]+U&Z:
MT&EW%G!HC7.H6EH8XVK+!J-2GPGE=**:PE+ 8K,</S?O<-0IUZ>)S]UZ\4W[
M&O4ABUAZBK5*=6OC:$?:+'XRM!Q/GP^(XDSA4H05)U*6"JU%*KA,5B:6!G2R
M2#HS^.OBJE&E"O0J4:<K4JN'@IY7@L/4BFK>'OVFM<MO$/ARUTWQ?X9@A_X7
M2NG^+U^).BFZU#4_%_B*U\/_  XN]!MK'Q)+<P>'= \ ZWJ6K1KJOV.Y@U7P
M]F.Q\Y+*6^6&C3G# 5<3*=&]/*,/B:&CJ+V^;4\=Q!B74@I0C+#T\&\-E?L9
M5)O+LQ6'<:3A7P].IS>$KN>$HPQ<\%6GB\/[:4WA:ZR_(:F$R["8BE+EJU5F
M682I5\SIR]G0CBJ4ZWM:L:JKP/%7P_\ BQ9^*&\+:!H_QSU[PA!XI\#2Z9KZ
M_&Z6RT#4?#]G87MWXHE\4^)&^-^D?$'2+IO$/B#59C'H^E:C;2)H.C63V%WI
M426EH\+7J3Q="K6I4J$:&-Q4XQJ0C[&EAEA<KH8-PC2]O]=E2^I5IQH9C1JT
M<76QF.^N>QKUZ>:PY,7A?9X.I##XBOB*U;+L-3FHRY)SQJQ>;/$)RFZ7U:G6
MH5< ZN(P%7#U\,H4)8-8B-'$9?7Y4_#?X\W_ (QD\<W_ (9^)Z^(-,":+>7D
M_P 7=)NM/UB'7?BUX0E\1W_PT\&0_$F+0?!&A:?\+M!OX;2Y>'0]:OHM5N$U
M*&>^C5;M94X488;ZQ!4IXA9-[>4[U:L*F'PV/Q&8K$U+5>7 XG.:&4NO@L$Z
MF'J8!)QP\ZBJT*/7F+]I]<PU*,:V'H0SJ>%E!RH.\L,\)DL:+3C*>,IX7,<?
M.IBL;3C5CF6&A"GCL-@I0Q%7;U3X4>.?&4'AYO'/@SXY:AK3?&W1+_Q]<V?Q
MYN=%\-77AO1#XCU'P_XK^'?AKPU\;]-T[0/"6F:S_P (KYMI_96D:])':&[?
M3=1U&UCG:<OE+"_V'B8OV.)PF"Q-6HJR]M+^UEERP\_K4I>VB\)C:]3%.A1P
MWML.H^SPV)PN$P6(Q45>,Y:M#B+#<_M*=91A@O8PA24\#4S>A76%34*,UC*.
M6TW2K8FOR3]JYNACZTE3DVVWA#]HO5;[P>FKZ7\5-.O(8]!U.SU6#XM:)IWA
M7P9KJ_$#7]8^(3^.]+T3Q_-??$.TOO#,^F6'A[2)K+Q%I4=G';PW$&A7*RO%
M6':I?5JLGSXC!4<!SNI!2IXS"T,GP%*O@5A[RHQS7%9E#'K&XZJE&A[6EBL#
MF->5)PK<^*A_R,<+0YI8.O7SE86I%RCB:=>KC,9+*L75JRJ0G'*L)A7@)4<)
M1?MZDUC*688&O3E0]EZ[\'? /Q.T+Q1I_B?QKKOC6>36/ VL7?BO2?$'CB?Q
M#H5CXN\2>,VU[3/#>B:!#K=SI>DQ^$]%^V:6NH:=9Q&]M]0MHY;V\6RB6TJF
MXX;"8O!)T\1.E0R2G1Q+C-RKXG"8+%T,TQ5ZB=6E3Q59X*?L;PBY0G5E3E6E
M4K5'BX.6/C6HU%]7CC,\]R"E3C'!RQ6%_LF/L[J$N>@\35E*HJE>C./LHRP]
M!PPY\X^,OAY\5O$5EKFD^/5^*&DV?Q#U>Q^'/BU-0^+MX^A^,[[Q3\4/"O\
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M.,EB:V$2E*M0==-*,US+"3=+%5*<91C.=+#5XU*%6LH^R52E-QG*GR5)[_\
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M48K1-RG4J2A1HTXJ52M7J4Z-*,JE2$7PT7QD\.,;8O8WJ6]QJOA_2'NK;6_
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MS:MA\#5S&4YU5/$8:I6IPA&NJ-'2O.K*==X6M/!*4L36HRIM?6,/BIY14RC
MU:5=*+C#*J=:I+!0IQIU%!PI5:]25*G6CTGB3X#^+-3\>OXGT'Q]X9\-:(?$
M'A'6[.TC^'VMW'C3PY;>%= B\/'1?"WB^P^)VG:78:9>V3ZJDMMJ'A35K<Q:
M[>PRP3JT;11A74HUI5:]657VF)QN(JN#=.>(6,IX&%2AB95'7A5I2_L_#>TM
M2A.]##UL/+"XW#T\888JA1JX:E0PU&&&E0P.%P=*3CSJB\)B<SK4\50472E2
MQ%.&93I4&JCA&,:L,1#%87%5L(^6@_9=\2Q%/.^)VBSQ:/>VC>%K9/AQ<6L-
MK8'XL:!\4?$$GBJ2W\?BZ\5^)M?D\-Z98:CJL=SI4,IMDN18+NGM[F\!.6#A
M@85&Z_U:GE=&HM(1=+*L!F> H_5HM3^K5&\PAC8U)O$<F.PT:KC.G*G1H;XM
MRKU,QE2E+#T\:LYDH7YU[?-XT(.I7O:%>GA*<<9@\-",*%6EEV-GAJ6(I5HR
MQ=7L='^"7C?1M+\):'!\0_"K:7X*^*3>.M+0?#;58+S5] NHO$8U#1/%US#\
M3%CUOQ7)>^(GU"/Q)!!80+>:?;3W&BW7SJ^=!>SIY9&K[]3+LMJY<IP]Q*/U
M&& PN(P\'[18>M2HPG'$*;Q%/$4\1B84H824X5*3J^SDL\C2I*$,XKQQ<5.T
MW1Q3S6EFM9R<53]K0E5I1I4*25*K1I*"GB:_*^?D=+_9>\064VG0WWQ(T.^T
MFYT?PIH_C98_AQ+!XA\0P>"?&NM>-M%30_$%WX[O%\*V^H:EK#-K<3V&JM>S
MI)<Z?)I#RJL-TFJ-*C1C%1A@W@L1A5%R7LL?@,KP.6X>I4;;E6P6&> IXK!X
M)RA4I5:E:GB,;BZ-6M"I&)3K5L;5@_9T\=+.:4Z+YITJ>#SO%8S$XJ-""E!4
ML?..+^KUL<^:GB*6&P?-@HRPU-KU+X:?!.P^'=[X>U!=4MM2O=#\&ZOX?N)[
M?1%T@ZMXB\6>)8?%?CKQA=A-2N1]KUK5[+3I3;MYC0_9GS<S"0"+2-14J>(P
M]%2AA94,HPE"E*?/[##9-A\9A\/3YG%.<IK&3G5G:/-.$9.+DY2:Q$(5\5]:
M2E3E+&YQC91YG)2EFE?"U*<97LV\#2P\L-1F[_N:KA"-&$>27FNA_LI1:5XM
MLO%MYX^N]8N+37/B%JKV%WX:L(K.?3_$/BN'QC\/?#96"_#)HO@K7HGU.(9:
M?4=1F>[DFM49K=N:G&>'RZ6"P]1TZW]EX;!0Q#NYQQF%P5;*Z68\L903=/*J
M\\!2PR<:<*:AB)3J8R/UE[U?JM3$5:GU=PH5<:L2Z*J:+#UJCQF9X2,W#F?]
MIYJ_KE>M/GY:#>7>SGA525+G_$_[&\6K^'O!^CZ'\0+CP_>^!-$\%6.AWL%C
MXRTR&\UKP]<>*;WQ+XA\0W'P^^)WA'Q#>W.OZIXECU)ET_Q+I4UO?:3#--<W
MT<\\$O3.=!9E+'X?"PH056G"EAVY2HX?+L-@YX+!X*E33A2;PU#$8VBJE:E6
MP]7#XJ=&I@FHJ;FE4;PM2CC84\17Q*QM7$5X4H4I5<=C\PR[,L1B(PG&O"C1
M>)RS#\M"-ZL(N:ABXR5*5/I?$G[*>E:YX.\<^&K+Q!9^'K_Q5??#BZTG4=#T
MCQ'HUIH%C\,UT;4=%T"0^'O'VF>(KS1I?%EIK>L2&Q\4Z/>J_B"01WJ7,)O;
MC.<G#ZG]5<J"PF.Q&-Y93DH2=7!_V90IQCAGA/9QP>6T\)0PZ@U15;#1JRH/
M#SE@R(*,?:3FOWU?+7E]:K&SJ5'4QV,S#%UG+$K%7^O5L;5IXJ,_:5*M"4XN
MO[6:KP['4/@A?CP)\//#7AOQ'X?\/:]X#\56GC.;5)O"6M^(O#7B'Q ]MK46
MN:GJGAW7/B!-J][J-U?Z]>ZU;WNJ>*=5NH-7MK+4+N;47@D2XO%575QD<1A_
M]FIT\-7PE*'+2=3"T:U%44\'*E2HT,-6I03I0E#"NE]5K8G#>PY:[G%4$Z>"
MQN%Q"6+JXQ8?FJU76FY2PF*PN(H^V=6M5KUH<F$HT*B>(C.4(IPJ4N2,5R_B
M_P"#7CD?"SX1_"GPMJWAS7+O0_%_AS6?&OC?QQX376]"NIO#"ZIXRE\2ZQX%
MTWQGH%SJESJOQ"M-&F^Q6.LIY,U\9Y6D@MY%D;J)YI@,5A;9;A,GPM2.%I^]
M7DE3P$<FPF%IU)2YH5*6$Q-7$4L54C.-.>"CS)U9TE)R5%83.Z;A4E4SC%5:
MG+1E&DH1QF:K,\7[:6BGAI4HU<'7I07/B8XE4W3A1G6G2RT_9:UBWU"1K3XI
M>3HVNW/A?5/'MC)X(M9M4\3ZKHOQ3U_XIZ[;Z?JP\0I;^'?#&OZGXHU>TNM,
M73;V>.**P\N_*V\\=]5&M3H2PT514\-EM7#UL'3D_?C/!Y7# 8.6*JQ4?K#P
MN*H8?-:'LX86$,8\6N1TL33CAIQ<L3C*5?VU=/$XO#8S"UI^SC[*-'&+#T*B
MPU!W]E+^SL-2RQSK5,3.>&HT*DF\73GB:O8:7\!M4\,7?PYU7PIXMT"TU?PC
MJWC[4O$TNO>!KK6].\62_$[7[7Q#XOU6QL+'QII4WASQ:UU;-;V>KS7NL);V
MM]>036=VLX\O+#S=!4*32G0H93@LJV4:ZC@:,(PJ4JUG&E#$XB"Q..H.E46)
MJ1I/GIU*2JO3$2=>EF$;MU\7FLLSIU:K=7V5HXNAA\+4C[LJU'"8/$T\+A^6
M=#V<,-2Y5&'[I<IJW[*PNM.T#^R_&&E6?B#P]<>(=?74-5\%SZSHNO>-/%?Q
M,\,?$O7];\5:##XPL)M:TNYO/"UC8C3/[4@DCAVE;[$$: PE2I@W@?9N+A@,
M-E6%IQ<5I3P&!S'!XBK&WNQQ6*K9@LRI5^27U7,L/3Q,Z>+<IQ%B6\5#,*%6
MK66'S+&8K%UE&HE5?-*%/+L-[9PE_LF!R_V^4U\.H*&-R[$3P_\ LJBF7;3]
MG3Q9#/H7VCXJVY6U7XD2^*->TWP9J.D^._$UW\2=:UK5M3LTUV'Q[)HVG>&(
M!?Z.D>F7'AG4YHY?#EI<6E_9L%2'EQ&'IXC"XG ZT,'7RFAECITVDJE2EAZD
M)XW%74E6K2Q>(Q>/INA'"5J5;%8BE+$5</B,52Q%0JU8XG#XZ?LZF.H9FL<J
MCIJ,:6&I?5*>'P.&A!QG2@L)@L/@L5.O5Q4,91I4JTZ$,;0H8NFSX0_LMV?P
MSU#P1J.IZ]H_B2X\!V>N6>ESIHOC5]1N1<65CH_A2XN]:^(?Q4\;:C%)X?T*
M3Q5906]I=6UBJ^++C[#9Z;#&T%SZCQLYSQ->2<<5BZ$Z524)<M)SQ&(H5L95
MY6IUJD\1# Y70]IB<3B*\:6"Y:E>M&I"-#AC@</"C3H*"E##XK#5Z$II.I3H
MX3"XZA2P[4.2A%>VS#$8M_5L/AJ*K/FCAXS<ZDNF^)O[/=G\2(/BI)/XDETG
M6/B+I'@30K'5K2SU2VN/#^C^ =5D\0V&CSWFA>)=)U6^TN^\07>I37BZ9JV@
M7+07QBM[JWN(DO!YL85(4*=*,_>IYM_:R;]K&+JPPN#PV'IR5&K1JOZK]4^L
M4)JLN7$593<'#FIU/4IUHQQ$:E6$JV&CEF)RUT'*#C'Z[+&+%XFBJM*K2IUL
M11KX:C4YZ-52C@:'/SQ484^!_P"&7?$Z6.HV&G_$;PUX;76/ACX@\#:_?>'/
M _CMM:\6:YX@L=5MW\0^--:\7_''Q#>>*K"TO]5N-2MH;V4Z]'<O< >)_)O[
MN*Y['5A?%15&#PU2O@ZU'"RA36#I?5\5A\5B.?#T:=&$JN+E3Q%"I/#_ %2G
M+#8N4,50Q=:AAZ]/'#U*U"OEM?VTU4P&(JXB52+O6E*5!X:E"E.O]8A3ITJ5
M'+WR5:6)A[3+J'LHT*+=!)X@_90U/Q7_ ,)/IFN_$BQB\+>(?^$QODTOP]X'
MN-$UN/Q#XS\"-X#N-4U/Q3)XVO+C4[32=*NM4M-)LX(-/>TTZ_%C+<W,EM%>
M+A><8S4:DY2@\0J/M)RY(PK\087/[UU0>'JU:TZF&^J8JM1K865;#R7L(X2<
M9NKGAW4PLL(Z-66'=&.7JM*C[DIRP&55LMIQH>T]M3HT(U98;-,/0KT\8J.9
MX=XB<L1SPC0MZ'^SEXT\(P>"+[PWXR\$0>)?",^LZIK.M1>%_B='X@\=WUU;
M:?966BZGXT\9?&_QGJ=MX6N=,T+P[INI6^N0^,I7@T:SETQM+N-/L6LNJ6+J
M>WJ5(>[1EA/JZHRY?9?6*CK2JXO$4Z<*2Q+IUJSQM"$7AL8\5&HJ^9U:6+Q4
M:F5*@HX6E@JE>I&E#%8>ISQ<IU*.&PT^:G0PL:M24*$E"KC:&E\)&AC)PIX&
MFX*4O9O&_ACQ)KEW\)+M8[34;GPMXR;5O$<]CMTZVM_M7P_\9>&CKFGZ?J%_
M*TL-IK>NV5PED]U<3+$697EE@&_DJPIU*^/A1<\/1Q>79C@Z%:7+5J82I7EA
MZE&K/E]FY2E2P]7".5*,;SQ*YE3H.K.'1AZE2G@)PQ'+6KN>73JTJ<>6GB50
MQV&JUJ2E.4G1IPY?K:DY2F_JJHI2G52/%_!_[/\ XN\*R>'/"FJZ_HWB[PPM
M[\,=:US78?#EQX;N+,_!O3[+^P=(MH;SQSKMQJ%QK'BNRTO6F+6\<5JL6N^;
M=SS7]E';=M+$PCBIXB-)87V%?'8NE"F_W<ZV8Y71R:-"%+E?LZ&"PE*M)3=6
M#2668>%&NZ>.Q4LL6JE9XBK&;=;'TOJM>:M"I['^VLPSFO6JSBHTZDL5#'2R
MVK0I4:4)JIB<7&6&@J6"EO?$;]FBW^(7Q4?XB77BEH=-U'PAI_A36_#-['XW
MN4!T"YUO4_#.LZ#%H_Q*T?PW!J>FZ[K/]IQR^(_"?BIXKK3[::P?3Y@TK^;&
MBXX7.<*JCB\S52=*K'6IAJ]3"4<$YQ51U*?LU1I226'IX3%26)Q-.>,E1J*E
M#J>(J*KE-6+:CEDI*5%R:HUZ-2JJF(IU%2]E5D\5!1H5U6JU\-.G1PU\(YT>
M:>!H_P"S/XRT>[\.>(E^)?@RX\8>$[WP<F@;_A#<P> =,\.>$/"_B?PK:Z':
M>"[7XF1WL-SY'B_7=0M]0'B,M:W]]))Y,ML1:+Z2QM18NMB97FL=7QU7%Q<O
M?<,?#)E5IX2=K85TGD\:>'E4ABE#"8K$4*L*U2<L1/SI8:7U:.%AB*L:.%I4
M(8:+G)P]IA\1C:_ML="ZCC)8GZSA9XWD6%=?&99@<7"5'V%*C3]-L/@?96OC
M&+QI=:Q#=ZH_Q1U7XGZJZ:.UO/J5X_@.^^'7A;1S=/JTS06&B>'KU]N5E6:8
M-(D5MYK@\V#J2P=*E1C:4*6$S*ALHN5?,LUI9A4Q4FOBG3P]/^STFG*5!47[
M2*HQIOJKRJUGB?WKC'%?V;3G%^_&&$RZC":PE%/^%3K9M3CFS<=8U)UZ,E4=
M:59<#JG[+\M[\3O'_CZ+QE9-9>/9([V33-;T7QCXBU#PUJ\OAJP\$ZAJ?AF"
M^^**^";&Z;P=;W^GVUW)X FU&#^UIQ/?WEGFQ?*A"%/+ZV6UN:I1K5*_-.G-
MTZTL-BL35Q6)PSJS]M4I*K4G2IRE@I8.+H8>CS4YXJ$,7'6K7KO&8;&TJLJ=
M3"T:%.%.3;HQGA&JF%FJ5/V,:D:.*BL:J>+^M-8J=>=*=&%5TXX,'[(266N^
M =3M_&]O>:;X-\*/X.OM#UO2O'<NGZ]IMGX@UKQ%HNJ7>F^'OBWHNCZOXG.H
M:I:76JW_ (LTCQ;'J-]I$&HP6VFW3NYTK3J5GF563A'%9AA,)!584XKZOC<%
MA%0P^)PU"7-AL-0P]?VF)PF&PU&CB,)[6I0HX]4FK91A0AA*&"]BG0P^,S"J
MES-.I@<RJT7B<#7J*U>KS8:A#".JZRHU:3E]9PE=6C'H;']EC1-&T>PL;+5K
M:>72/ WP[\$V\Q\-VPO9K'PKXRE\;^.YXKJ36%>#4_'>I&!+V9IL0/;13R?;
M'7B\5B8PGB<5@L$H<F,P^,PV%A44(QHY1A%#(,N4FHP5++<8I8A3<8PJPJ.@
MX4+>W)5.6)I^RQTZ$ZN(HYQ"OB/82A?%\0\M/-L;[.$YN,'1C!8;#PO*A)3<
MJV)A-48<+X2_9B^(5[X*T^Z\5^,O!_ASQYY-UJNG6&B_#R[;1/#^H^,_B'X7
M^*/Q#L/'"VOQ-DG^(VJZGJ_ANWTBYU+3=7\.6K6AF-O9KY@-;TI4\!++Z%.M
M_:%/+'E%"55QE1IXC"Y)1K4L,\+1:Y\)6J5JSQ[K8B6*_P!LIT*LL/RJO1KZ
M3K/$SS?GA5A@<TGF]58>M*G4Q,:N8X?%8'"U,177M8267Y?B987#X6AR4Z=&
M4J+KUE2PE7#]GK?[-GBK5-6U75;?XEZ!:3:[=_%"PU2>Z^&DFK:A;^#?BE<:
M#-JFGZ#<W?CP6^D^,+.WT&WTZ#7IK.^LWT]8+>?0Y)+<W$W#0I4(858"O3=?
M U:%.CBJ:G*G4K>QS'-,QA&G67-+#T<14S.7]H4TISQ%6C2KX6M@'"E"DW6K
MT\92S##RA1Q6&Q&$Q5*#C.6%>(P^5Y?EDZV(PZJP=:K&. E/ S56D\%#&8NA
M/ZU"O4<NY\'_  #TGPGK>C:VFIV]W/I?C/QGXUN'71OLEYJFH:YHS^$/"D5Y
M??VG,\J^'/ DAT1'E64W0C2=1:8:%^J&)JPES.;ES8+&8::O[LJ^8YM0SC'X
MI*WNNMBZ+4*:_A49^R]I.,(6Y9X7#\E.E1C.E"C5RN4$ZCF_895D\\JI8>;M
M'FA.I)8^R480Q"DU2E.;JKDOB)^S(/&VC^($T_QI)X>\5:[\7+?XL/X@M[;Q
MAIL,UUIF@KX5T'0]6/P_^(_A'Q'=6>F>'XK18)M.\5Z0WVNRBG9/L[2V4W)0
M4J']BIN-590\Q;4U+EJO,\5BL1B*GLU-4_:*CB7@E]8ABJ,L+%TZM"HI14._
MVT92S;VT95J>98? 8>G&4H2>%IY>L'5IPHNI3J1C1GCL-6QLX0A3FJF,KNG5
MA6_?O*O/V5[NYCU/2[7QUI>B^&]1U#6+J/2]#\':Q9W^C6NM_!E_A/<PZ#JT
M_P 0K@65];7$U[K-G=S6ER(_[5OX+B&ZNK@:G'=:-*MAZV%E3_<U,)C\&H*T
M(.CB<RRW'X6-948TG*.%P^6TLKJ1H2PWML J-*@\%[%^UG#UZF'Q678M-3K8
M"OEV)DI<SC6JX2KFE?%>UYI2J5(8S$YG/'+ZQ4KU:./I_6*E;%0=.A1P[/\
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MU/JO+%.IB51IU986=:O'%T<&I0EAJOU7FQ6+P,ZT:48;3]IC7Y[B*77/!?\
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M&V+_ .8F*2A55HRBXI)=W7.4% !0 4 ?/_[6/_)K'[2W_9 /C)_ZKKQ'0!]
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M]C3G*G&O%1>D*\8JM34U"JH3BJU*C54Z4-&D6% !0 4 % !0 4 % !0 4 %
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MQ>CLRVG!QC)<LI0C4BGHW3E*<(S2>KA*5.I&,E[KE":3O&5KM @H * "@ H
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MK++QNA&.58K+J+=*M7RG!9='$/5PQ6'P6)P&+S-P7*Y8C%X7$?4X0C4IQP^
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M\<__ $+M !_PNW]HK_HB'P6_\2/\<_\ T+M !_PNW]HK_HB'P6_\2/\ '/\
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MZCX!\::_X%UB:-+?]F:=#93:MX<OIK9RZR/;2P/+'#*SPQ '3_\ "[?VBO\
MHB'P6_\ $C_'/_T+M !_PNW]HK_HB'P6_P#$C_'/_P!"[0 ?\+M_:*_Z(A\%
MO_$C_'/_ -"[0 ?\+M_:*_Z(A\%O_$C_ !S_ /0NT '_  NW]HK_ *(A\%O_
M !(_QS_]"[0 ?\+M_:*_Z(A\%O\ Q(_QS_\ 0NT '_"[?VBO^B(?!;_Q(_QS
M_P#0NT '_"[?VBO^B(?!;_Q(_P <_P#T+M !_P +M_:*_P"B(?!;_P 2/\<_
M_0NT '_"[?VBO^B(?!;_ ,2/\<__ $+M !_PNW]HK_HB'P6_\2/\<_\ T+M
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M ,2/\<__ $+M !_PNW]HK_HB'P6_\2/\<_\ T+M !_PNW]HK_HB'P6_\2/\
M'/\ ]"[0 ?\ "[?VBO\ HB'P6_\ $C_'/_T+M !_PNW]HK_HB'P6_P#$C_'/
M_P!"[0 ?\+M_:*_Z(A\%O_$C_'/_ -"[0 ?\+M_:*_Z(A\%O_$C_ !S_ /0N
MT '_  NW]HK_ *(A\%O_ !(_QS_]"[0 ?\+M_:*_Z(A\%O\ Q(_QS_\ 0NT
M'_"[?VBO^B(?!;_Q(_QS_P#0NT <QK_[3/QY\-ZKX(T>]^!7PCEN?'OBB[\)
MZ.]K^T5XR>"VU&R\%^+O'4LVI-+^S-$\-D=(\%ZI"KP)<2?:9[5#&(GDF@ .
MG_X7;^T5_P!$0^"W_B1_CG_Z%V@ _P"%V_M%?]$0^"W_ (D?XY_^A=H /^%V
M_M%?]$0^"W_B1_CG_P"A=H /^%V_M%?]$0^"W_B1_CG_ .A=H /^%V_M%?\
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M_0NT '_"[?VBO^B(?!;_ ,2/\<__ $+M !_PNW]HK_HB'P6_\2/\<_\ T+M
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M ,2/\<__ $+M !_PNW]HK_HB'P6_\2/\<_\ T+M !_PNW]HK_HB'P6_\2/\
M'/\ ]"[0 ?\ "[?VBO\ HB'P6_\ $C_'/_T+M !_PNW]HK_HB'P6_P#$C_'/
M_P!"[0 ?\+M_:*_Z(A\%O_$C_'/_ -"[0!T/PY^.'Q%\0_%/3/AGX^^&?@KP
ME_;GP_\ &WCK2=;\'_%77?'F?^$&\1?#C0+_ $O4=-UKX1>$/L?VC_A8UG/#
M<PW5W_R#9HWA7S$< '0_M8_\FL?M+?\ 9 /C)_ZKKQ'0!] 4 % 'S_XC_P"3
MI_@W_P!D _:6_P#5B_LG4 9/[6G_ "1VV_[+5^R__P"M-_"&@#%H * "@ H
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MA85/:4SZWKF.@* "@ H * "@#Q7X!_\ (C:[_P!EJ_:2_P#6BOBG0![50 4
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M.W,5AXX_&K"P]GAHUZJI1YX5.6FIRY(\].=2G.T;+FIU)PEO&<DTWPY=*O+
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M_P!6+^R]0!ZQ^UC_ ,FL?M+?]D ^,G_JNO$= 'T!0 4 ?/\ XC_Y.G^#?_9
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M% !0 4 % !0 4 >*_ /_ )$;7?\ LM7[27_K17Q3H ]JH * "@ H * "@ H
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MQQL[L%4D 'A'_#27[.O_ $7SX+?^'3\#?_+V@ _X:2_9U_Z+Y\%O_#I^!O\
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MM? U5S.-)2I3GAIUJ7[I.,*D(>TK*/MJGTI7.:!0 4 % !0 4 % 'S_\9/\
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M6*A&I&$?8_VL?^36/VEO^R ?&3_U77B.LRSZ H * /G_ ,1_\G3_  ;_ .R
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M%Q."RZI'DIRI0=54ZU*KSQG&G+ZS%4J<<1*I1P]:I:G6G0IQJ4T_MNO.-@H
M* "@ H * /ASX7?#O5O&%O\ #/Q/8SZ4FE_#;]K#]MC7_$-KJ$MRMU?:?KGQ
M@_:1\'V\&E0PV4T5S<#4=?M))4N9;5!;QS,KNZK%)IA'2I5\SEB(>UH8_)<7
MEO)9.]3$9CD^+3G&5E['V.7UX3:<I<\Z45!QE.4(Q2G5P="A1E[.M0S/ 8U2
MNXI0PE/&1FHN-Y*IS8BFX*R7NR;G%I<WFQ_8E\=:+XA^*D'A?Q;X<F^'OB#Q
M3^SIJ?POT#6[W58KWP)X5^%7Q5O_ (E>*O!I:T\/3K_9,5QJ^K)H*"XNMD=S
M#8S-9VMG$X[,JQT\)1R...E/$XC*<ZQ.-J5U9U*^"_L&.3X*,V^3GQE&-.E2
MK3E_&I45B)UZF(J3@;YFX8Q9A]7BZ']H9/F6%G3?\..99CBZ.)K5X6YG'#UY
MTI8BK%:T\16J1I4?9VM]?_%GX-W'Q,U#PUK>G_$KQY\/]8\'6GB6+13X3M_A
MS?:?<7?B73H]+N+W4K/X@_#OQ5''>Q6"W-G#>6$=G<0VVK:C$KE;IQ7AXG#U
M9T<S5&:E4S# 5, Z=5M472G-5I0E*FE7A"M6IX=U_9U$Y1P]+E2E"[VHUJ<7
M@X5::]GA,;1QJJ02=:-2A"I2@XJ;=*7LX5JSIQG!Q]I-2E=QAR^._#;X-_&/
MX0_#OX2>&=+T_P"#_P 3?$?A/X86GPY\2:_XUU"\\(^(='M\VDEQ9>$/&OAC
MX7:@VN^!K4VT<,&@:GX>TNZNOLEM=7VLR7"OYGKY[7IYOC,\4.:A@\YIT:<\
M1RKZS/V4<33=7&X6,EA\75BL3*>'5*O@Z.'?MZ<:4EBI5*/!0A+#.CB$_;XC
M"8W'XJE2F[4U'$U*52"H8B,74P=2HZ2>-E['%>UE.'LO94L+3I5/3O@]^SWX
M?^$^C^"(E\2_$+7=?\)>%=+\-RSW?Q0^)Q\&7K6.DQ:7+<6_PME\8R>#[",H
MA,*1:(&A(256^T RFL3BE4Q&+JT8R5/$J,/W\OK-;EA[*T_;5N><*TO91E4J
M4G3;<JL%:E4G"55%+$256NH4JBQ.)Q2AAD\-2C/%8C$XB5)QH\GMZ5)XJ=.F
ML3[5\D*/-K1I<GG^K? /QO\ \(YXCET>[\'7'C*R_:5G^/W@2#5[W5[?P_<1
M)>6GE:#XBU*VT&XO-$NKO2&U>TDN["PU,6KW44JI=HCPOYN!C+!4^%I<D:U?
M(J>=4*\>=TX5*6<5\]4O95/9U)*5'#YM1JI3I*,J]"5)VIN-86(I1Q-3B>,J
MDJ-#//[%G1E%*<Z=7)\)P\Z?MJ;E",J<\?D;4HQJ<WU6K&:<:MZ<<"Q_9\^)
M%KXPE^.UUIWPPU3XQO\ $37O&,7@J\\1>(3X$T_1=:^'OACX<1Z#IGQ$/@1]
M5M=8MK/PGIFJ?VV?!C^9)-=V/V&..9+N#II2C@:>%I82/MV\#F&$Q52;^KMS
MS'-J.:RJTHQ6)O##1H4\$J+G36*IN=><Z$Y>R-L14J9BG#'-8>CA*F73P5.B
MO;JV68?,Z4%B>?V',\15SC'5^:%G@I_5E'ZU&A)5O6O!_P /_B5\./@YXLT?
MPA<>![GXJZYK'Q \::-;:U<ZW'\-]#\4^.O$>J>)(='-U8:6=5N_#.E3ZGY7
MGQZ?:SWIMWE^SV9NO+M\L9[2."RW Y=4<EEN&PF"5?$)0J3HTI)5JJIQ]O"G
M.-.52.$H.56G1C"A2J5*L82E+6C5IU\PQ>/S&A[..,G"K/#X>ISJ,J&!P^$I
MP]M.G2<O;3PT*N(K>QA+GK5IQIN22E@_!WPO\=/ ^DZ\/%7@;X4W_B[7)K36
MM>\96_QL\6:UJ?C?Q,]S8V5]-K$<O[.^B0^&M'L="6X&F65@E]# MC:6"PQ)
M/-?Q]"^K0HX?"X>,\/A:%>%J>E6?LJTI2QN,JU6Z;Q.82:IR4)0HTJ^E&-7
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M8-8F@4 % !0 4 % !0!\_P#QD_Y*+^R=_P!G >(__66/VEJ /H"@ H * "@
MH * "@ H * "@#YE^+?@'XP?%"+6_AU=6WPO7X9:]K'AW4+?QI'K'BK3?B%X
M3L-%U+2=8FM++P<?#FHZ9KWB(7^ESFS\01^*?#ZVAOX)/[*EDTT_VC6#Y*>+
MRS%XKFA5R?&TL=3=%J:Q4L-B/;8>A*,U!X2E.GRX?&24\8\12]O&$*,<2HX=
MXI)X/'X;#2D_[4R_%X"I&;]G[#ZYA*N%J8B-6'M/K'*ZOMJ6'='#>SG3A&6(
MJ?Q%M?!O_DHO[6/_ &<!X<_]98_9IJ1'T!0 4 % !0 4 % !0 4 % !0 4 (
M1P1TX(],<8K.M!U*-6G&R<X2BK[7<6E>U]->PUHUY'SSX-^$GB/PY^SC>?""
M]O=$E\2W'A+QWH*7MK<W[Z&+SQ/<^(9M/D:YETV*Z%M&NK6PF86192DFQ) %
M+\F<86IC\BHY71<8UZ>399ESE-M4_;X++,+@JLDXJ4O92JT)RIRY%-TW%RA"
M3<%TY17A@,[K9E63E0GGV8YHHPLZGU?%YQB<PI0:DXQ]M&C6C&<5+D552C&I
M*"4WYQ??!/XM^&+O3=8^'*_#;4]7USX ^$O@CXW_ .$M\1>)-"MM'N?"*:H=
M*\7>&WTCP3K#^)4AD\1:VKZ3?IHGVA8[,B^M<2*?4SJ2S>MQ;A.>6&RGB;'2
MQL:J@IXK"RJ0K8:NGA^:-*LZN%EA^1_6:?L*U&5_;PJ+V?GY'&IE.6<'4JL:
M=?'\*X>=%PC>-+%*<,OFH_6G%U:4*6)P,G'_ &6IST\54ERTIPM.SKGPI\5Z
ME\.M*^!_A?1]/LU^!5A\ /$'PT\<>);_ %2#0O&?B?X>:G;ZI/H>K6]OX?EG
MT>S2#PM8V]QJ&G3:TR+XG!$/FV<EM-V8K,JN,SJ?%$*4(8NEG.9KZG4E**G@
ML;E7U>M6C74&X2E3S?%T*+5&I36(P/,YS4JE*EC@,#2P>5QX?Q56I7H8W*5'
M$8JE!<]+%K%RJ4FJ+E&G47UG!TL54H^VI3]A/V3C1C4H8B?/77P'^,=YXPC^
M.DUO\,%^+UG\3M,\6V'@9?%_BE_ 47A"P^&FJ_#"7PU)\1?^%=IJS:K/:ZWJ
M&M?VB/!HC2X\FR:VEBB%U7'A)0RN/)@X_65CJ>:QQ\JUJ+Y\SJ915B\,H>W]
MW"O(LNIVJ2C]9B\3.V'E4A&'9B(4,<I+$PEAI8?#Y73PTZ3=;FK99C,TQBJ5
MX3=%1A76<XW#\E.4I4%'#U^>NXSHRCT+X"_&?P)XETGXN>&8_A;XB^)^L2?&
M >//#>N>*O%7AKP=;VWQ2\1^'?$VG0^&O%FG^ -9U'43X=E\*Z78YO/#^GC4
MXI[JX(T^5Q&<Z<883 U\DPDV\OQ6!PF'J8JI32Q,,5AL;F^-EBHX6,W3G2J5
M<]S"V%EBX.$88:*Q+49WNM'#8S$3QU:E+#XFECJ6(HTJ<_:TYT(Y1E^35:-6
MK-4W"K5I97@\3&M"C.-.I[:C[&<9QJPZN?X ^,3\ M,^"*77A2>\\*Z;X'\3
M:#XSN=0U5(]6^*'AGQO%X^O8M6\+IX??^Q/"4FN:=9B.[M=7U"Z>'4KF/[%;
MFSC>\VJUEA\7E6,RZFX_ZO5LOI8*A6EI6R_!8"GETHU\1"+='$UL+[:E[E"O
M"$G"NY3O*@*DXVSF%6*I0XCCG\L6H1]JL)6SG$8K$0^KQJ2A]:AAJN*]JI5)
M863E0A%17/[2GS.K? 3XN>)/%TOQPU2U^&-A\7=+\9?#S7?#/@RT\7^*=2\!
MKH/@3P]XY\-3Z1J?CR?X>V6JQ7^JVOQ'\37/VR#PE(MG)'8QF&\2)VDG#5JF
M7*DL*_K$:^)S:KBX5$J%J.:9?EN 5&A.'MW*6%EE&#Q/M)P@L1)UJ+IT$X58
MY55+%+%4Z[C1A]0R["X=QBJW+7P.;SS>>(E"3HNG]9<W@N2-6HZ%%.LIU)3G
M2:_#OP)XD\&?M+>$=4\9/H:^+?B3X!_:M^(>OZ?X9O;_ %30-%N;[Q;^Q=X<
ML-%TO5M4TO3+K5X;71/#&EH][-IFG&>8S2?980P6A.%+ Y9@:=2599?2Q,75
ME!4G4GB\RQ^:5;4XU*JA"G5Q\Z-/]Y*4J=*,Y<LI.,1NK4Q6.Q-5*$<1/#JE
M3C+G]E2PV P>!BG/DIN4JCPKQ$_<M"59THRG&G&<O9/VL?\ DUC]I;_L@'QD
M_P#5=>(ZR+/H"@ H ^?_ !'_ ,G3_!O_ +(!^TM_ZL7]DZ@"A^U9>7.F_"73
MM0L])U#7KNP^.'[+=Y:Z%I,FE0:KK5S:_M/?!^>#2=,FUW4].TV'4+N6-;>%
M]0U"PM5DF0W%S!"'E0 O_P#"Y/B+_P!&G?M ?^%'^RQ_]$M0 ?\ "Y/B+_T:
M=^T!_P"%'^RQ_P#1+4 '_"Y/B+_T:=^T!_X4?[+'_P!$M0 ?\+D^(O\ T:=^
MT!_X4?[+'_T2U !_PN3XB_\ 1IW[0'_A1_LL?_1+4 '_  N3XB_]&G?M ?\
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M#_PH_P!EC_Z):@ _X7)\1?\ HT[]H#_PH_V6/_HEJ #_ (7)\1?^C3OV@/\
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M'_T2U !_PN3XB_\ 1IW[0'_A1_LL?_1+4 '_  N3XB_]&G?M ?\ A1_LL?\
MT2U !_PN3XB_]&G?M ?^%'^RQ_\ 1+4 '_"Y/B+_ -&G?M ?^%'^RQ_]$M0
M?\+D^(O_ $:=^T!_X4?[+'_T2U !_P +D^(O_1IW[0'_ (4?[+'_ -$M0 ?\
M+D^(O_1IW[0'_A1_LL?_ $2U !_PN3XB_P#1IW[0'_A1_LL?_1+4 '_"Y/B+
M_P!&G?M ?^%'^RQ_]$M0!XA\)_BQX\M?'G[3<T'[,GQPU&34/CAH%Y>6=GK_
M .S;'<Z!<Q_LV_L^:<FDZLVH?M!VMO-J$EI86NIJ^F3ZC:BUUJS1[E+Y+RSL
M#8-CV_\ X7)\1?\ HT[]H#_PH_V6/_HEJ #_ (7)\1?^C3OV@/\ PH_V6/\
MZ):@ _X7)\1?^C3OV@/_  H_V6/_ *):@ _X7)\1?^C3OV@/_"C_ &6/_HEJ
M #_A<GQ%_P"C3OV@/_"C_98_^B6H /\ A<GQ%_Z-._: _P#"C_98_P#HEJ #
M_A<GQ%_Z-._: _\ "C_98_\ HEJ #_A<GQ%_Z-._: _\*/\ 98_^B6H /^%R
M?$7_ *-._: _\*/]EC_Z):@ _P"%R?$7_HT[]H#_ ,*/]EC_ .B6H /^%R?$
M7_HT[]H#_P */]EC_P"B6H /^%R?$7_HT[]H#_PH_P!EC_Z):@ _X7)\1?\
MHT[]H#_PH_V6/_HEJ #_ (7)\1?^C3OV@/\ PH_V6/\ Z):@ _X7)\1?^C3O
MV@/_  H_V6/_ *):@ _X7)\1?^C3OV@/_"C_ &6/_HEJ #_A<GQ%_P"C3OV@
M/_"C_98_^B6H /\ A<GQ%_Z-._: _P#"C_98_P#HEJ #_A<GQ%_Z-._: _\
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MFN64)8JIAJ')"E6M#TSX-_\ )1?VL?\ LX#PY_ZRQ^S34#/H"@ H * "@ H
M* "@ H * "@#YP^+?CGXC>%_B;\"=%T1M%TSP/XS^)5MX6\07,BC4M?U]9_
MGQ$\03Z;!!/;+!X>T^SN?#6CRF[CENKF\:\>)!91VCMJ.N70C7S&K0KMJG#
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M%J*4H5:RE./2?"#QOK?Q ^*?P U_Q)/%=^(+3X+_ +9'A76M0@M(=/AU/4O
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M[=KGPR^-NA7UEI(U*RT[1_%_Q>^(_P#PGJV&A6[:43_PA^FK++9_:I&BNI#
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MOK>3[ 6M?W]57A\3"OE^(PRED%6OA:\,!3DX2I+"X+!Y<L.L3+VCEAJV"R[
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M4 '_  D?[4__ $1OX ?^)+?$7_Z$Z@ _X2/]J?\ Z(W\ /\ Q);XB_\ T)U
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M/_T1OX ?^)+?$7_Z$Z@ _P"$C_:G_P"B-_ #_P 26^(O_P!"=0 ?\)'^U/\
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M/_T1OX ?^)+?$7_Z$Z@ _P"$C_:G_P"B-_ #_P 26^(O_P!"=0 ?\)'^U/\
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M.H /^$C_ &I_^B-_ #_Q);XB_P#T)U !_P )'^U/_P!$;^ '_B2WQ%_^A.H
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MB6OWU.O2SFRQ<,)2CA:U.,IX>NIPHU.L^!7AN/PS^T]^TO;26GA>#6M1\#_
M'6?%=_X0\,+X0T?Q!XKU"+XEOK?B(:(VJ:G/;W-]<IYCF\U34[DX437<[+O.
MV#=%</8VEA:<Z&#H<49E&A1E.,_8PEDG#564(N%.E!*56I4JM0I4TYU)R<7*
M4I/?'NK+.,HJ5YJK7GD7O5+-.4:>;8VC04G*<Y2='#4J-"+<K*%*$81A3C&G
M'[4KD-@H * "@ H * "@#Y_^,G_)1?V3O^S@/$?_ *RQ^TM0!] 4 % !0 4
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MN,S3'X+'4HS7MJ=#ZM#/J%?#U4O92Q%+&8;/:^'J.$L+4IQIN=*:J3C*CX&
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M=N6?)+E;Y7;:_P"%-_$7_H[']H#_ ,)S]EC_ .AII '_  IOXB_]'8_M ?\
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M_P"$Y^RQ_P#0TT '_"F_B+_T=C^T!_X3G[+'_P!#30!Q]YX>FT_Q;I_@"_\
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MC_Y.G^#?_9 /VEO_ %8O[)U !^TM_P DZ\.?]G ?LG?^M3_!N@#Z H * "@
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M8+ XYQE/ZP\9]=RS!YI]3I4L+"57!XB%+&*C1E759XG$0BJE#"8:M#%Q]O\
M@A\1OB_\5WC\?W-O\-K/X3:OKGC_ $33O#T%KXFM?B+X?C\'^)M3\+:5J=_K
MLFIWND^)9M5NM&O)[K3/[(\-OI27$4?VG498I%::-/DP>!JXI\U3,LKRW,Z,
MJ2Y84I9A0H8R.$J0GS.K&GA<0KXVG5A?$4G36#]G5]K1VQ,U]=QF&P:<895F
M&)R_$>V^*M]5]I2J8JC**C[%?68*%+"SIUE6P\_K2QL.6%"M].UD6% !0 4
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M<EBYRJ-9%4?-+E3L\[S%J/N1BK1348Z7Y4N9RE>3^OJY#H"@ H * "@ H *
M/G_XR?\ )1?V3O\ LX#Q'_ZRQ^TM0!] 4 % !0 4 % !0 4 % !0 4 ?F9\=
M= \=>&=)_:%M_ .K_"[Q/%X\^,?PJ\127TWBK49?B=X*\?W5U\+-&T#P,?!E
MAH,]M)-]GT73=6T[4KGQ%IT]I;:EO&DW$4*SS[97*?M^",)4C..&P.?3E&OA
MVY?6\-4S;%8_-/;2?)&C]3PU;%87'.#Q7M<#A_J]2-#GDX7F<9/#<18FC*I'
M%U^%<;1="O-4X48T<JQ^'P57"R=W4AC<394*,HT(_P!HSJ5:>(K3G[%?6?P;
M_P"2B_M8_P#9P'AS_P!98_9IK$@^@* "@ H * "@ H * "@ H * "@#SWQS:
M:)>S:-:1:AX TKXE21:[_P *MU/QKHEEXEN].U@Z5)%J]]H6@G6]'U/4UBTB
M607T&E:I82-:NRS3I$QSA4IU*JQ-+"SC3Q,L+*-=J'//^SY8C#K$1FDTU0G6
M^KQYJBGAXXGZM*I2JRC"G*N:E"-*6*ASX:.(ING&4N2'UU4<0\,XMIKV\8+$
M2@H<M:5!8E4YTTYSC^>'[.*:?IWC6+PSXHBTU- \(_ [XX>$[&_U&Z6XTGQ'
MJ&@?'+6+7XE^)?#L=Q#%;V7AF^A?2)AIULC)I]LZV)DF@M8II8QLX5N&>)\0
MJ<Z&&JY!P>J-&JU.K1P-#*\_PN'C5JJ,/;N<Z%*M'$JG26)C5PM?V-&=2-*!
M&C5P_$F0THU5B,7'.^)JM6O0C[/#SQ^.?"N8TX4Z7/46'KT?K&/PU3#RJUIT
MJV&QL95:LHUJDJGP:O/B9X#^%0^.>C>+OA=?1^#/V5?@JNL_#_6K#7O$?CNX
MT'P?X;\7^*H-'N5TGQ'HZ_#F]UM-;B%AJ%UI_B@W26Z.U@I@(F^ESBM4P^89
MK3Q5%XN6-XCA#$K"J/MGBZV"R3 NA]8;E2>*PN+J8K$3P/L8QDL72Y<516(Y
MJ<X:AA\?CL'EV4XK#X#*Z']JRRZI45\/3PF(SS'M8M4^:G.I@*F P. HTL5]
M8@J+PF(O1K<FOU;\8+^;4/B'^QWJ5];'3]"U#XH:U>:A9:G\AL]=O?@OX^F\
M-6=V&/DB_BOY9XHE;Y_M*QB+YJXL'2CAL^S?#.K3J^QR+-Z>'G'_ )>5J>:Y
M&IRHWW;P,<9-V][ZM[=OW%,Y9UZV*X:IXJG3G06(QV25<53_ .?>%J.M)PKN
MR_=QQTL!%W2C[=4+KFY#YN^";V(_:5NENCIB^ O-_;(3P8)A"ND->CXJ?#5_
M%HT[S ('(F_X2$R%,MY:WW_+NHQYN":_U.S18ZWM/[#RAP53X_[+6;\91IM)
MZ_5E@WDJO'W?9O!<WO2A?NS;^T%G=+E]HJ:SG#*?):WUO_4WAUX7GY-?K/MO
M[6]GS_O/:+%V]Y5#S'X-OI7_  K#X]CQD=.'A_\ X8O\''PDNI +$?AY'>_'
M5+)K!)@&-@%.B8, R2U@7/GE<WF[S'_5+%?Q/]9HYCE+J))_6UF3X6X4>$YT
M_>5=YM''^Q5N7ZU'$J"NIGH9;]9_UYRGFTP/]J\2^R^#ZO=<88]8KEY?W5EE
MO]G^W>WU7V'/^[<3Z[^($FM+H'[$[Z\P2U;XG?#X>-3J&(XO[2D^$OC%=)6_
M Q )&\9MI2Q+( /MAM1&/,V"O9Q:PRXXQZA;V:H\2_44O^@A0O#V5_MK+UCV
MK>_[)5&O=YCYC)G-< IXGD5?ZIPU[?VMD_9/-,K5:UM.;V_L%)/W/9^T3UY3
MQGX;R2C]KBZ2=K)?A]_PLG]IJ/PN'$*:4_BK_A#_ (!RZLM@<"&74!>CXB%O
MO2ADU?'R+)CR\J6!_L!\W)[19#C73OTP"XWSQ8JW-HL/[-Y8I<ON>R="_N.F
M>GF+:Q>)4+*7]NY![?FYO:?7/]3*OL%"^\N1+VB6U;V7+^]]J=)^S2TC>,OV
M?,!1IZ_"K]NA?#WE+&EM_P (HG[2_P  %\*_8A$ IT__ (1\:=]G8=8?+.3G
M-:U5%8'AS?VG^KW#GM>:_-[7^P\![3GYM>?F^.^O->^MSFI6_M#B3D_@K/<Y
M]GO;_D85_;<M]X_6?;6M[O\ )^[Y3Z5_:Q_Y-8_:6_[(!\9/_5=>(ZYCI/H"
M@ H ^?\ Q'_R=/\ !O\ [(!^TM_ZL7]DZ@ _:6_Y)UX<_P"S@/V3O_6I_@W0
M!] 4 % !0 4 % !0!YMX_P#A'X"^)ALI?%FE:@VHZ;;7MCI^O>&_$_BOP+XJ
MLM.U-K=M4TJU\6^!M;TC68-)OC:6WVJQ2_6VN1;QB>*0(,92HPDZE^9*O&,*
ML5.<85H0Y^2&(IQDH5X4W4G*G"M&<:<Y.<%&3N:JM4C35)2O3A4C6@FHOV=6
M*<55I-INE546X>TIN,W"4H.3A)I^:Z%^R1\"O#/AFV\':!X:U_1_#NE^(QXM
M\/6NE?$/XB:5J7A/Q!)IITG4=1\)^*-,\4V^O>'GU.S>X748[/5(H[]KV[:[
M24W<_F];KU7+"R;7-@J=>A2M&$8_5<15C6J8&I3C&-*M@55A&<,'7A4P]/EI
MQA34*5&-/G]G&^+;O)XZ=&K7<Y2J.>(P_,J6+YJCE*&,C%\CQ5.4*SA%)S;<
MW+3'[+OP1AT31M TWPMJ_AZR\/W7BFYTFZ\)_$#XC>$-?MD\:ZQ/K_BO37\4
M^%_%MAK5WH.IZQ.UU/H]Q?RZ>SQPXM@MO"(HG.4W2Y[2IT<+A,#[*48O#U,)
M@8.GA*&(P[7L,53H0E*--8FG5:4ZEV_:5.;7GDG7E>]2O7>)E4DDZL<3*$*<
M\11JRO5P]:<*<(U*M"=.=11]^4KN\5_^RI\ ]0O?MDO@);1'T;PSX;O-)T?Q
M-XQT#PSJ_AKP>MROASPUK_A+0_$-IHGB+PW:?;+AO[*U/3[NSF>3S+B&5U5E
MNGB*]+$RQ4:DG7EC'F#<_P!Y'Z[['#4(8J-.IS4XUZ%+"8>.%J1@I81T^?#.
ME.<Y2QJ4HU81A.4_<H3PRFJE2%7V-6M6Q&(@Z\9*M+ZU6Q%:>,E*;EC.91Q4
MJT(0C'HM0^ /PGU3Q9_PF5YX:NVU1M6TS7[K3+?Q3XPLO!6J>(=%\C^R/$>N
M?#BQU^+PGK_B*R:TL7M]5U+1;J\B?3K-TF5[.!HHPU2I@Y*5"3C*+KRIN3]I
M[">)<Y8B>%53G6%J5Y5:SJU,-[*<W6K.4FZU7GN<8SINER1I0E"-*I[**HRK
M480A2A0Q$Z*A/$X>%&G"C&AB)5*,:,524%3]TET/X#_"KPUXSE\?:/X8EM?$
M;:AK6K6HE\0^*+WP]HNL>)%=?$>L^&?!E_K4WA[PIK.K"68W]_HVEV-S>FXG
M:YEE:>0NL/*6$I2H4).,)48X9<SYYPPL*L:T<)3J3YJE+"1JPIU%A:<H8=2I
M4G[/]U3Y7BO]MJTZV)_>5*4X5/Y8SK4Z3H4\16A#EA7Q-*@W1I8FO&I7ITI2
MIPJ1A*47Z]4@% !0 4 % !0!\V?L[:)HVI>![S4M1TC3+_4?#_[17[7%]H-_
M>V%K=7NB7MU^TS\;=,NKS2+J>)I=-NIM-O+RTDEMVC=X+J:)B8Y65G"4J4IS
MIMTYU*4J$Y1?*Y49U*56=&35G*E*K0H5)4W>#J4:4VG*G!I22G!4YI2IQG"J
MHR5XJK34E3J*+T4X*<U"=N:*G))KF=_8K[X>> -3U#4]6U/P-X/U#5-:E\.S
MZSJ5]X9T6[U#5IO"%Y_:/A.;4[RXLGFOY=%U#_2=.>=W-E-^]MC$_P U.E.>
M'Y/82=#V5>>*AR-PY,34HK#U,1'EMRUYX=*A.LK5)44J4I."Y2IMU(\M1\\?
M83PUI:KZM4G[2IA[.Z]A.I^\G2_ARG[THN6IUTD<<L;Q2HDD4B-')%(JO&\;
MJ5='1@0R,I(*D$$$@UG.G"K"=*K"-2G4BXSA)*491DK2C*+NI1DFTTTTT[/0
M<)2IRC.G)PG!J491;4HR3NFFK---736J>QY[K/P?^$GB/2?#F@>(?A;\.M=T
M+P:+8>$=$UGP1X9U32?"HLHEM[,>'--OM,EM]#$$")'%]BC@\M$"K@ "M95*
MD\7]?G4E+'K7ZS*3>(OS*?\ &;]I\48R^+XHI[I$2C&5"IA914L-6E.52DU>
MG.53F]I*=-^[*4^>?.Y)N7-*]^9W]"CCCAC2*)$BBB18XHHU5(XXT4*B(B@!
M$50 %     J6W)N4FY2DVVV[MMZMMO=OJPC%02C%*,8I))*R26B22T22T26Q
MR]]X$\#ZGHVO>'-2\&^%-0\/>*;J\OO$^@WWA[2+O1O$=[J!C-_>:]I=Q9O;
M:O=7)AB,TMW%*\GE)O+;1C-TJ3I4*#IQ=#"MRHTW%<E&3K3Q#=*%N6FW7JU*
M[<4FZU2=3XYRD[C*5.K6K0DX5JZC&K4BVIU%&A##1522M*:CAJ5+#Q4FTJ%.
M%)?NX1BLH_";X5GP7_PK8_#/X?GX=C&/ )\&^'#X+&+G[8/^*6_LW^S.+O\
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M0,* "@ H * "@ H ^?\ XR?\E%_9._[. \1_^LL?M+4 ?0% !0 4 % !0 4
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MPU&W)1DDZ4.5QE'EIN\(\LH0:LE9QBUK%6QKCX+?#34O^$_B\2>$= \8:?\
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MRTZ<YNT82:;34*M2UJ="#J5)?9ITXV4ISEM"$;I.4FHJZN]0G^ GPAM=6L-
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M&:?AU_T,?[0'_B6/[4__ ,^2D ?\,T_#K_H8_P!H#_Q+']J?_P"?)0!FZ7\
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M@/\ Q+']J?\ ^?)0 ?\ #-/PZ_Z&/]H#_P 2Q_:G_P#GR4 '_#-/PZ_Z&/\
M: _\2Q_:G_\ GR4 '_#-/PZ_Z&/]H#_Q+']J?_Y\E !_PS3\.O\ H8_V@/\
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MEPM1TGVGCGXL_&;X:^+'\ 3?$V778O&FD_ >_3QQKOA3P3:3_"^?XF_$;4_
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M!U,3HIX;ZCPQPVZ.#2IP5#^TL1[6K3YZE.5/_A.Q;A@N:7[C%M_VB/C]XO\
M"/Q/^(5G\2?^$7M_A/\ L]>'OBI9:+X?\'^";KP[\0-=T_QK\8M'FU.ZN/$.
MC:QJ5IX*\5Z#X"TN[^S:;JEO<PI?VTMC?P!)A>^I1PJ=++L9.E[.>9YSP_@G
M@ZZJ-8*GG.5</8G&8>KR2P]:=;!8C-JOU>3G2E&<)1Q2KQ<:=(C0E7Q<<IIU
M/8NW$]&.-4>:I.649A7PF"Q"A)1H-\M.*Q,525*M*,_8<D90JGV=\(_%/CU?
MC)\3?AWXM\9W7C;2[#P!\+/B1HEUJ.A^&]%N]!N_'E]X[T_6?#=A_P (UI5@
MMUX:MI/"=K+8_P!IC4-2B6ZECNM1O2%D$?5Z4<MQDDFZN6YUBLMC5D_WE?#T
M\!EV,ISQ"BH4?K$9XNK"4\/1P]*=-4_W$9QE*?&ZLZBR+%I1HT\XRN>)J4(*
M7LZ->A7A2<J,JDIU>2K"K%RA5J5.6<'*$HQG[./U!7GFX4 % 'YLV'P\C^(^
MG_!_0M6\+W?B;P;)^UE^WG9^-XUTRYOM+L-!UKQ[^U-H8EUJXAA>+3+6>^U"
MUM(IYVB!N;J!(V\UT!O!THU,5FZG5EA?:</8RG0KPFZ52GBUG?#>(P[P]5-.
M.*IK#5,30Y'[1?5YU8JU*31B*U6A@\'4PZ4ZU#.LKK.GR\Z=&G1S&-5U*>O-
M0M4C3K<RY.6HH3TFD_&-5^''Q\3Q-\6/#7B_PCXK\5_\(?K7[%?A+P;\0=/T
M/6-23XE^"_!'QUUCQ0_BB>6UT[R3KNB^&-8MXO$(@DF2WETJ?4)C!!=HJ>OE
M.-CB)9%CL7&G@L=4XJQV)Q])-0HTY+A6&!EC:2DH^SP6.Q%-5:-_W=&K7>"C
M4G4HL,QH4L-@L;@,#+VV!CPUG%/!1YI3JTOK6.PU2CEM1R<YU,1AE"I1HMRE
M6Q.'I4\1*/-.3/OO]H+PG\5?%A\(1>"/#O@+Q9X4T*XU;Q#XH\,>,?'/B+P3
M+K6NZ=:1GP2(7T3X8>,4U?3].U)[G538S16#/J&F:.ZS%()$D^4QL:BHYG4=
M.4U'+,71PKI<TZU+$XFE4HUJ\*"Y(UJL<)*IA\-!U4N;%5I\L:U/#U:?=A)P
MC]5IPJNC5GC<,Z[DXPI5,'3ESSPTZOO2I0KUU1>)E&#YL-1J8>7/1Q-:#^5/
MAWX+M])^%W[-]]\9_!?[1/A;Q=X>^ MAX"TN#X.R?%VYT_2I9+CP]>1:?XQ/
MPH\/:7XX\*^+9_[!TN:]LM9MH_#-N();.ZO;Z:".1_I>(L1.>=<3U<LJJ689
MA]0JT[SC/ SQ.$CF4:*PU:;_ +/KT:53'2]O+-84HU/:49T<.J=+%2CY%.FG
M3H/&1:P6&Q^=2DJ3DZRI8NMAYU*DZ<$L6N949QP%;+.:NZ<:SJ5*3Q=&@_K7
MX/:-^T,?#O@B7XN^+OA[?6LG@[2X/%WA(?#?5CXS;7)-&BBO5U#Q]#\3VT*\
ME_M O)<K!X*ABD!DAC*\7#8XOZM'%XSEY*L4XNA+#*5"C"M%TI3G&%5UZDZ*
ME&LJ*4Z,_>I5+Q5-TIZR=W3>"]IAZ$<1B6EBG[:O/">WQ/U2-X.C["LL,\(J
MKJ/%/VE.MS.4JJE2^>M8\(>+=-\/:[XID\*>-+B'P1^V[<_%6YT71O#VL7VN
MZ]X&BN(-,N]8T'P]:64E[XJLH;75)=1BATV&XEN1I3BT2>9$BD\K*VL+3X&K
MXARIPP>'XGPV(7)4G/#RS/$<4T<+.K2IQG5@I3Q>$ESN'NX?$JN_W+<U.,I3
MQ$^-\/0C"4L8^%ZV'<G&$*RRK"\'8S$PH5).--U$LLQ>&BN9+ZS3EAY.-1-+
M@[WX?ZIXE^*FL?M Z]H'QKT;X7:I\4O%C_V?X2\/_$OPQ\47\-:A\&/A[X%L
M/%4GA#PS86?Q'T:RF\2^$M3LPFD6%MK44%[#<O''I\]S)'T8>%/ X?"T\5.2
MGB\OS9<E&52HJ.(Q7$6$Q^#H5IX-S2]M@L+]9JJI-8:G4]EAL:E4CR'=CL2\
MTC1I82E&*RB>3QE4Q$*=*5>&"PG$D<9+"+%12_=5<]HT5*T:E>.'Q-7 2J3>
M'=3ZR^'/BGQGX$^!.O>+O&N@?$CQ;/X>O_'FJ^$O#,>C:MXB^+>M^ K?Q#J;
M?#W2;S1KE3JU_P"+[CPY_9<;1ZH1J"[T.JLEVET4K,:U3#X;+Y5:4*^9RP^$
MIXR.$C!T/KM22A.2>&C*A"G34H2Q=3#1>%ISC7GAU*BJ:EEA*.&KXW$4L)6E
MA\K<H2PU3%NNIQI0P5">)YEB;XN5\9'%K#0KIXBI!T86O**.,^"WCK2=;UGQ
M?\6?&GAWXJZ?\1M?T70=/O-%N_@'\?-(T_P1X*M-7>+0O!'A^^\0_"[3#XMU
M*+5]>NM0U>\T^*9GDGGN3'%I6E)-#K2HK"X7ZI2K4\1/%XVB\5B%RTE6Q=6$
MJ.'4(5.6K2RW!4H2I0Q&(4*=*56MB\9+"2QRH4^6KB)5Z\)U:52A0P.&QD\'
M0Y'.5*A"-&MC:M6I24Z<\PQSH4''"49SG5CA\-@L##%UJ%2MB*OQNEE\>>+_
M  EIOACP7\7K#XM_#WXB^%+[PC?:KX9\9R_""X\/+XBTD>*O%M_J]L;[X;WB
M'PC+X@BM6U2X@\5V<FY=/M[.:=#/CE5O[4P..7+2I+ZS1S".(3C.C@E2Q=*I
M##>TVQ.*YJ+HU<KG-UHUJ-+'3>&I8VA1TQ_)]1QV"JQJ5'*BJF >']Z-7,'3
MI5L&\0J;2>'PF+IQ^LTLSC&C3]C6JX2$\14P=6M)\;-?U;PM^T+X(\1:!H>H
M^)M>T?\ 9G_:)OM#\/:3:37VHZUK,'B7X,G2M,M;:!2[O<7WV>,MPJ*[.Y5$
M9@\-'$U,OXPP^"E&EB\7'A?#4:E2ZI4*F)QF>T(8BO))\F'P[J*O7J-<M.C3
MG.32BST)K"K#\/2QTW3P5'-\95Q#C&4ZGL*64U*E54J=-2J5:TJ<)1HTJ<95
M*M5PITXRG**?D^F?!?\ : ^#^H?"SQ&OB7PMXPU"[\+>+OA-XE/@'X5^+O#^
MM:?J/Q%MM0\76'CSQIJ0^)OB>V\06^F_%6V@:XU&#1=#BM8_%>IWCO!;%XX\
ML?&]#B#*<M<H1Q^31PF75HOV5*E7R##SCE2E*K*I4P\Z^72QV'A5GBGSXN>$
MI35:K.DX\>%J*:R[-,?1IT983.%FN,PO+4KU9TLYQ5.EFV$P[IM*K3HU*F$Q
M#A/#U']4RSW)4HPFJG Z5\/(Q\"_[ \"?!+XN^&/B=!X;^%4?[16J3^&_%7A
M=?B.OA[QUX=OOBWH)O-0N[!/B_XZUO2(O%,J^)=&T[78]1L+F6P&L?Z;%92>
MGC*N4SS2.)HX=+@U9M0J_P!G^PE;ZN\'C:6&E3RKDG6I4,!7G@9YI1]A1^OJ
MG#ECCYT'*ACAH9A1CBJ6*Q,:_%3R[-*-',85%[)5JDJ;H3>.E.-*V(A&<<IA
M*M5J9+*3<X9<IR=;T72O@_\ "OQQ\3_@[;^&/V?/%?A_X,Z+=_&S5)M \?\
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M5T>'ZU',J-6M)WJ1EGKE6Q.5JM2Q6(K3>,E0KT:LEB>PT3X<7FF:?X9?XS^
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M+/%'QD$MGK-Z;9;F'X::G:3^'[Q()V72II;ZTO8U,]RDTGS,:%"5'AS+&U'
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M'%45*,H3>'J8JI]7G*$XQG"5:C&%9TYQC.G[3V<USQ9[Y^UC_P FL?M+?]D
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M<.;V=2FY4YQE"<XR[O\ X:Q_98_Z.6^ '_AY/AU_\T=2 ?\ #6/[+'_1RWP
M_P##R?#K_P":.@ _X:Q_98_Z.6^ '_AY/AU_\T= !_PUC^RQ_P!'+? #_P /
M)\.O_FCH /\ AK']EC_HY;X ?^'D^'7_ ,T= !_PUC^RQ_T<M\ /_#R?#K_Y
MHZ #_AK']EC_ *.6^ '_ (>3X=?_ #1T '_#6/[+'_1RWP _\/)\.O\ YHZ
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M'+? #_P\GPZ_^:.@ _X:Q_98_P"CEO@!_P"'D^'7_P T= !_PUC^RQ_T<M\
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M'7_S1T '_#6/[+'_ $<M\ /_  \GPZ_^:.@ _P"&L?V6/^CEO@!_X>3X=?\
MS1T '_#6/[+'_1RWP _\/)\.O_FCH /^&L?V6/\ HY;X ?\ AY/AU_\ -'0
M?\-8_LL?]'+? #_P\GPZ_P#FCH /^&L?V6/^CEO@!_X>3X=?_-'0 ?\ #6/[
M+'_1RWP _P##R?#K_P":.@ _X:Q_98_Z.6^ '_AY/AU_\T= !_PUC^RQ_P!'
M+? #_P /)\.O_FCH /\ AK']EC_HY;X ?^'D^'7_ ,T= !_PUC^RQ_T<M\ /
M_#R?#K_YHZ *=K^U!^R18RWTUC^T/^SG9S:I=_VAJ<MK\6OAG;RZC?BUMK(7
MM])#X@5KN[%E9V=OYTI=_*M(8]VR)0K3:A"DG:G2Y^2'V8>TJ3K5.6.T>>K4
MJ59V2YJDYS=Y2DV-+FE.WOR44Y?::A%0@F]VH02C%/X8I15DK%S_ (:Q_98_
MZ.6^ '_AY/AU_P#-'2 /^&L?V6/^CEO@!_X>3X=?_-'0 ?\ #6/[+'_1RWP
M_P##R?#K_P":.@ _X:Q_98_Z.6^ '_AY/AU_\T= ' :1\6/A9\4/VI_A?_PK
M/XE_#_XB?V%\ /VB/[;_ .$%\9>'?%O]C_VG\1?V6O[-_M3^P-2N_P"S_M7]
MGW_D>?Y?F_8;CR]WDOM ._\ VL?^36/VEO\ L@'QD_\ 5=>(Z /H"@ H ^?_
M !'_ ,G3_!O_ +(!^TM_ZL7]DZ@ _:6_Y)UX<_[. _9._P#6I_@W0!] 4 %
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M484YYA*G+G4.26)4\Q5+DSB-.A3A3CRO#U,?:*I>N:-X$\5^*OC9\,_B??\
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M?97$&DQR:B-3G.K7H72;551;C3+JL<)F\\RJXB52&/Q5?%)24O:X.=+ASB;
M4\3B$G*'UW'8O-,!1E]5GBH4Z>&HU:N)M"U#BS3#8FKDN%RK"OEJ9=AY8>7L
MY.-#$TL3F_#=6MA\,YRIR^JQP>6X[$5?K6'PU23E"E2@Y5*L:GOGPY_Y.V_:
M8_[)]^SW_P"B_B=6.7_\D]F'_94YC_ZH.%SOQ_\ R-LE_P"Q#+_U<Y@?5=8&
MH4 % !0 4 % !0!\_P#QD_Y*+^R=_P!G >(__66/VEJ /H"@ H * "@ H *
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M #FZ #_AI;X=?]"Y^T!_XB=^U/\ _.;H /\ AI;X=?\ 0N?M ?\ B)W[4_\
M\YN@#R#XE_&WPOX@\:?L]:MH_@W]H"[T_P #?&#6O%/BFX_X98_::M_[+T*[
M^ 7QP\%6]]Y5U\(XY+W=XF\8>'++R;1+B8?VCYS1BWMYY838-CU__AI;X=?]
M"Y^T!_XB=^U/_P#.;H /^&EOAU_T+G[0'_B)W[4__P YN@ _X:6^'7_0N?M
M?^(G?M3_ /SFZ #_ (:6^'7_ $+G[0'_ (B=^U/_ /.;H /^&EOAU_T+G[0'
M_B)W[4__ ,YN@ _X:6^'7_0N?M ?^(G?M3__ #FZ #_AI;X=?]"Y^T!_XB=^
MU/\ _.;H /\ AI;X=?\ 0N?M ?\ B)W[4_\ \YN@ _X:6^'7_0N?M ?^(G?M
M3_\ SFZ #_AI;X=?]"Y^T!_XB=^U/_\ .;H /^&EOAU_T+G[0'_B)W[4_P#\
MYN@#R#X:?&WPOX>\:?M"ZMJ_@W]H"TT_QQ\8-%\4^%KC_AEC]IJX_M/0K3X!
M? _P5<7WE6OPCDDLMGB;P?XCLO)NTMYC_9WG+&;>X@EF-@V/7_\ AI;X=?\
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M #FZ #_AI;X=?]"Y^T!_XB=^U/\ _.;H /\ AI;X=?\ 0N?M ?\ B)W[4_\
M\YN@ _X:6^'7_0N?M ?^(G?M3_\ SFZ #_AI;X=?]"Y^T!_XB=^U/_\ .;H
M/^&EOAU_T+G[0'_B)W[4_P#\YN@ _P"&EOAU_P!"Y^T!_P"(G?M3_P#SFZ #
M_AI;X=?]"Y^T!_XB=^U/_P#.;H /^&EOAU_T+G[0'_B)W[4__P YN@#D-$\:
MV/Q*_:2^'FN^&O#?Q0M-$\*_ _X[:3K>L>-?@U\7/AEI5KJOBGQY^SA>>'],
MM]0^)/@G0K?4M0O+3PGXCG2WLI+B18](G>144*6-O(-O(Z_]K'_DUC]I;_L@
M'QD_]5UXCH ^@* "@#Y_\1_\G3_!O_L@'[2W_JQ?V3J /H"@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* /G_P#:Q_Y-8_:6_P"R ?&3_P!5UXCH ^@* "@#Y_\ $?\ R=/\&_\ L@'[
M2W_JQ?V3J /H"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * /G_]K'_DUC]I;_L@'QD_]5UXCH ^@* "
M@#Y_\1_\G3_!O_L@'[2W_JQ?V3J /H"@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /G_P#:Q_Y-8_:6
M_P"R ?&3_P!5UXCH ^@* "@#Y_\ $?\ R=/\&_\ L@'[2W_JQ?V3J /H"@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * /G_]K'_DUC]I;_L@'QD_]5UXCH ^@* "@#Y_\1_\G3_!O_L@
M'[2W_JQ?V3J /H"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * /G_P#:Q_Y-8_:6_P"R ?&3_P!5UXCH
M ^@* "@#Y_\ $?\ R=/\&_\ L@'[2W_JQ?V3J /H"@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /G_]
MK'_DUC]I;_L@'QD_]5UXCH ^@* "@#Y_\1_\G3_!O_L@'[2W_JQ?V3J /H"@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * /G_P#:Q_Y-8_:6_P"R ?&3_P!5UXCH ^@* "@#Y_\ $?\
MR=/\&_\ L@'[2W_JQ?V3J /H"@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * /G_]K'_DUC]I;_L@'QD_
M]5UXCH ^@* "@#Y_\1_\G3_!O_L@'[2W_JQ?V3J /H"@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /G
M_P#:Q_Y-8_:6_P"R ?&3_P!5UXCH ^@* "@#/DTG2IM5LM=ETS3Y=;TW3]3T
MG3M8DLK9]5L-*UJYTF\UC3++4&C,]KI]]=Z!H4]S;Q2+'/)HM@\JNUG"8S;R
M#;R-"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * ,_5M)TK7M*U/0M=TS3]9T36=/O-)UC1M6LK;4=*U
M72M1MI+/4-,U/3[R.2WOM/NK2::":WGC>.6.5T=65B" :% !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
, % !0 4 % !0!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>160
<FILENAME>g20922ndsp6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922ndsp6.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1  (! @0$ P0'!00$  $"=P ! @,1
M! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_  !$( B@"XP,!$0 "$0$#$0'_V@ ,
M P$  A$#$0 _ /W\H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M=.$GHIU(QYY0BWI*<8+G<5>2C[S5M33_ .%-_$7_ *.Q_: _\)S]EC_Z&FI
M/^%-_$7_ *.Q_: _\)S]EC_Z&F@ _P"%-_$7_H[']H#_ ,)S]EC_ .AIH /^
M%-_$7_H[']H#_P )S]EC_P"AIH /^%-_$7_H[']H#_PG/V6/_H:: /,/ 'A#
MXM>*?%?QNT+4/VJ?CA!:?#7XH:3X*T*2R\+_ +,,=S=:5?\ P7^$/Q&FN-6>
M?]G25)]076_'^L0*]O':QBUMK)#$9HY9[@ ]/_X4W\1?^CL?V@/_  G/V6/_
M *&F@ _X4W\1?^CL?V@/_"<_98_^AIH /^%-_$7_ *.Q_: _\)S]EC_Z&F@
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M/[0'_A.?LL?_ $-- !_PIOXB_P#1V/[0'_A.?LL?_0TT '_"F_B+_P!'8_M
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MVYV24H]T347L:-+$5?W6'KZ4ZL_=IU&FHM0F[1E9RBO=;U:6[1W7P+U#Q?\
MVM\=O"7BWQUX@^(G_"NOC!IWA;P]XA\4Z;X)TS7?["U/X'?!?Q^]C?)X \(^
M&]*N?)\0>-M>,4PTN.;R9HHI9)/)5J0'0?$OQ3KOA[QI^SUI.CWWV33_ !Q\
M8-:\+>*;?[+9W']IZ%:? +XX>-;>Q\VZMY)++9XF\'^'+SSK1[>8_P!G>2TA
MM[B>*8 ]@H * "@ H ^?_@W_ ,E%_:Q_[. \.?\ K+'[-- !XC_Y.G^#?_9
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MHS5I*G6JP3Y:DT_$?@W_ ,E%_:Q_[. \.?\ K+'[-- SZ H * "@ H * "@
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MGP\\#:EX]T>*.#2/&]_X2T"\\7Z5!$LR10Z=XEN-/?4;&)$N;A52&Y0*)Y
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MBL5&=:E',J#I1A2JQHSI2M+_ '7V'+0RF.:<45*E&K'GI1P>+Q&"ED7MLO\
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M(PHXRO1I*E4GF-*G#VT*U/#SYIX5\OZZUY1TA0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % 'S_\&_\ DHO[6/\ V<!X<_\ 66/V
M:: /H"@ H * "@ H * "@ H * "@ H ^?_@W_P E%_:Q_P"S@/#G_K+'[--
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M0 ?\+M_:*_Z(A\%O_$C_ !S_ /0NT '_  NW]HK_ *(A\%O_ !(_QS_]"[0
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M_0NT '_"[?VBO^B(?!;_ ,2/\<__ $+M !_PNW]HK_HB'P6_\2/\<_\ T+M
M!_PNW]HK_HB'P6_\2/\ '/\ ]"[0 ?\ "[?VBO\ HB'P6_\ $C_'/_T+M !_
MPNW]HK_HB'P6_P#$C_'/_P!"[0 ?\+M_:*_Z(A\%O_$C_'/_ -"[0 ?\+M_:
M*_Z(A\%O_$C_ !S_ /0NT '_  NW]HK_ *(A\%O_ !(_QS_]"[0 ?\+M_:*_
MZ(A\%O\ Q(_QS_\ 0NT '_"[?VBO^B(?!;_Q(_QS_P#0NT '_"[?VBO^B(?!
M;_Q(_P <_P#T+M !_P +M_:*_P"B(?!;_P 2/\<__0NT '_"[?VBO^B(?!;_
M ,2/\<__ $+M !_PNW]HK_HB'P6_\2/\<_\ T+M !_PNW]HK_HB'P6_\2/\
M'/\ ]"[0 ?\ "[?VBO\ HB'P6_\ $C_'/_T+M !_PNW]HK_HB'P6_P#$C_'/
M_P!"[0 ?\+M_:*_Z(A\%O_$C_'/_ -"[0 ?\+M_:*_Z(A\%O_$C_ !S_ /0N
MT '_  NW]HK_ *(A\%O_ !(_QS_]"[0 ?\+M_:*_Z(A\%O\ Q(_QS_\ 0NT
M'_"[?VBO^B(?!;_Q(_QS_P#0NT '_"[?VBO^B(?!;_Q(_P <_P#T+M ' >#?
M&?[17A+Q%\6-?_X5)\%K_P#X6A\0--\=?9/^&@?'-I_8?]G_  L^&GPS_LOS
M_P#AFB;^T_,_X5W_ &E]I\NTV_VQ]F\EOLGVBY-@V.__ .%V_M%?]$0^"W_B
M1_CG_P"A=H /^%V_M%?]$0^"W_B1_CG_ .A=H /^%V_M%?\ 1$/@M_XD?XY_
M^A=H /\ A=O[17_1$/@M_P")'^.?_H7: #_A=O[17_1$/@M_XD?XY_\ H7:
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M /0G4 '_  D?[4__ $1OX ?^)+?$7_Z$Z@ _X2/]J?\ Z(W\ /\ Q);XB_\
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M_J<_LNT :5 !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MC!N?M:=>G-TSSZX_9,D%MXE^Q^,M&?5M:U/X<ZMH^KZGX7\86U[X2O?A_P"
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M(C5;A3AR9;4R=8RE.+J3G_L$X2^K2C32Q-'F^L.G5<*7N/P:X^(O[6/M\?\
MPY^G[+'[--<!V+3Y!\9/^2B_LG?]G >(_P#UEC]I:@#Z H * "@ H ^?_@W_
M ,E%_:Q_[. \.?\ K+'[-- 'BW[3-IXTO/CS\"HO NO^%_#FK+\(_P!HJ2XO
M?%GA#5?&FG2Z<OC+]F99;6'2]'\;^%IK>]:Y:SD6Z;4)HTC@FC-L[3K+;@''
M?V%^T5_T5/X+?^&#\<__ $25 !_87[17_14_@M_X8/QS_P#1)4 ']A?M%?\
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M@ _X4E^T5_T6_P""W_B.'CG_ .BBH /^%)?M%?\ 1;_@M_XCAXY_^BBH /\
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M\ !VOQD_Y*+^R=_V<!XC_P#66/VEJ /H"@ H * "@#Y_^#?_ "47]K'_ +.
M\.?^LL?LTT >>_&W_DXKX(?]D6_:/_\ 4Y_9=H TJ "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#QCXJ_&1/A//X
M=2^^'/C_ ,5V7B;6M%\,Z9JOA*7X>?8AXF\0WTFGZ1H5Q#XK^(&AWL-U/,BM
M]I%HUE&LJ&2Z0AU2:+G7QE/ TZ4O;5HU94;N"C56'PU;%U^5\_N^QH4*DY>T
M5/FLHTO:2:B74C&E@ZV-E4C[+"KFK)*?/2INK0HPJ27):4:E6O"G%4I3FFI2
MJ0A!*4NPC^(G@Z'4]'\-ZUXAT'PSXUUC2H]7@\ Z[XD\,1>,H;<P-/<*VD6&
MM78O/LOE7"2SV$UY:YMI3'<21KO-S]E">,C2KT\13R^,IUJE+GY*=*.OMIJ<
M(5*5-IJ2E6A3:35TF[&:YU##2JTIT/K=3V5&-3E3JU4[>SIN,I1J5'H^2G*4
MM5=)Z'%>&?VC?@AXIT2P\06/Q.\$6.G:KXAU?PMI)UKQ5X>TFXU/6M&U!M/F
ML["VN]35[B:?-K=6\2CS9;74;*<1A+F/=I&C5;P,(P<JN/PU/%4*44W5E1J+
M_GVKRYJ<E*E6@DW1KPJ4:G+5ISC$G*-.>-A)VCE]5T:U3:G&:CS_ !NRY;*7
M+/2,U"4Z;G3M-]1X:^)WAKQ-J7Q)TZW^V:6/A7X@7P]XGU'6?L%EI9G/AW2_
M$\E_97::A+_Q*HM-U:#S)[M;0J\,V4\M!(^3<89?1S.I4C1PM:>+IIU)*#@\
M%B)X6K*HW[D8NI3;@^9WA9R4)7BJY9/&O 4XNK7]CA*T533DIQQD'.C&"7O2
MG96E%1MS-*+E>Y8TWXI_#'6+:>]T?XC> ]4L[34M)T:YN]-\7^'[ZVMM8UV2
M&'0])GGM=0=(=2U&:XMX[2U=A+<-/&L*.74'2-&M*5*,:4Y2K3K4J:49-SJ8
M>$ZF(IP25Y3H4Z<YUH1O*E"$Y345%M9JK2Y9R52/)3I0KR?,K1H3:4*TG>T:
M4W**A4=H2;23=T5=5^,/PDT%=VM_%+X<Z,HOM3TS=JOC?PSIRC4M$NK:PUG3
M\W>IQC[=87UY:6]U!_K+>6ZACE5'D4-G2_?.BJ/[UXB,)TE#WO:PJ5*E*G*F
MHWYXSJTJM.#C=2J4JD$W*$DM90G3]JIQ</8-1J*2:]G)T88E1G>W(WAZM.NE
M*S]C4A5^"<9/$\2_'GX6^&=(M=??Q;H>M:(_C?3/ &J:MX?U[P[J.F^&-=U%
MI W_  E%^=8B@T6ULDC,EWYLGG01D-Y+#HE**JX*G.2H4\?#%SHUJC4*$E@\
M-7Q-3]X]&Y+#SHT^123KN%.3BFY1B;<*6*J1A*K/"1PDIT::YJ[CC<5AL)0<
M::U:E+%4ZMWRIT8SG#G:C&742_$[X:V]EX;U*?XA>!H-.\8SI:^$+^7Q9H$=
MEXIN9"JQ6_ANZ?4!%KD[,RA8[)IF)8 #FM?955B5@_9R6+<'45#E?MO9I*3F
MJ5N?D46FY<O*DT[V)YX*C4Q//%8:C+DG5NO9PGK[DI_#&7NR]UM/W7IHR_I7
MCOP1KFOZQX4T3QEX5UCQ1X>!.O\ AO2O$.D:AK^A@2+$3K&CVEY)=Z8!*Z)_
MI$,?S.HZD"LZ7[ZC+$4?WM"$_9RJ0]ZG&=YI0<XWBIWI5%RMWO3FK>Y*U5&J
M-6%"J_95ZD/:0IS]V<J=H2]I&#M*4.6K2?,DXVJ0=[3C?DO$WQP^%'A71?'F
MLWWCOPM>CX::=+J7C/2='\0:+J>O:&J92"SOM(M]0\^SU&[N=EM;6]R(6FGE
MCB3YF%85:\:6%AC(IUL/4K1P].=/E<*E><U"-&-24HTN?F?O*4XJ$5*4W&,9
M-=-'#5*V*C@M*->4)U7&I>+C1I4_:U*LHV<_9TZ?ORDHNT;-)W5]CPG\2?#'
MBGPIX,\6_:[70+/Q\EL/#-CK>M^%I+W4KJ[M[F\M=.LKCP_K^J:;JFI26-G<
MW(M]-U"]81P2EL-#*L??B<//"XF6$FU*O"FZLHQYM(0IQJU9:QCS0HQDO:58
M<U&W[R%2=*4*DN##5UBL-+%PA.%"$^24II+E;K_5J?/9R]E*I6<:<:=7DK*I
M.-&I3A7O245U\7_A-9)827GQ0^'=I'JC2)I;W7C;PU;IJ+Q:I)HDJV#2ZFHO
M&3689;!A$7*W43VYQ*I084XNK4I4:2=2K6C0G3A%<TYPQ-.5;#2A%7<HXBE"
M56A**:JTXRG3<HQ;6U1JBJOM7[)4)5H5.;W?9RPSIQQ$9WMR2H.K25:,K.DZ
MM-347.-XI?BSX%TX^*7\1^(_#WA&P\)^([/PM>ZMXD\7^"++3I]5O],L=4M(
M%DMO$UQ+I5S+#?Q)'8ZU#I=](5\V.T>VE@GG2<?986KS*+Q=3$4J5-_%*>&J
MRI5%%J].H[P<G&E4J3I+W:\:-52IQ<O<G7C]C#4*.(J5-H0I5XWA*?-:<(K1
M>TG"-*;:=&I5C=K13XF_#9[";58_B#X';2[;2+?Q!<:DGBS06L+?0;N^GTNT
MUN:\6_\ *BTB;4K6YM([QG$+SVTL*N9(V44H3;A&,6W4J8>C!).\JN+C&>$I
M12^*IBH3A/#P5Y5HRC*FI*2;%JKK5?[5JMO]A?+C=?\ J#DU'%?] [=JO(S2
ML_&G@[4/$6H>$-/\6>&;[Q9I-M%>:IX7L]>TNY\1:9:3K&\%UJ&B0737EG;2
M)-$R230HK"5""0PS-->UA5J4OWE/#S]G5E'WHTJFJ]G4:NH3O&2Y96E[KTT8
MI2C!T%)J+Q,/:T4W9U:2T=2DG\<%=>_"\==RA+\2?AU;^*(_!$_C[P5!XTFG
M^RP^$)?%.A1^*);G['%J(MX] >_%\\_]GSPW7EK 6\F9)<;&#%TDZRJ2HKVL
M:$9RJ.'O*G&D^6I*;C=1C3E[LV[*#TE9EU8RP\:<ZT70A5Y/9RFG",_:2=.G
MR.5E+GG&4(6OS2BXQNTT)-\2_AQ;6J7UQ\0/!,%C)I>L:Y'>3>*]"BM7T3P]
M=)8Z_K"7#WXC;2],O9([>\NPQBMI76.9T=@#+:C!S;Y81AAJKD](JGC;+!U&
M]E#%W2PT_AKW7LG,E+WG!?%&K7H./55L*I/$T;;JKAE"3KT_CHJ,G444G:I8
M?%KX5ZK/X>M=*^)GP_U.Y\7+=/X3MM/\9^'+VX\3K82RV]ZWAV&VU)WUI;>>
M">*4V8F$;PNKX9"!<J=6#K1]C-SP]".)J047SPH3CSPK2CO&E./O0J2M"2::
MDUJ3SP4%4<XQI^T=)3;2C[5.*=/FVYTYP3A\2YHZ>\K\_P##?X\_"WXI:5?:
MCX:\6:+'=Z.-6D\0>'-1USP_'XF\,6VC:I>:5<WGB/2+'5[I]&LGELGFCFN&
M1&AEB<E2^U9?*L'0S#GB\'6P^%Q#K*2]G26*P\,1"E6J?!"O3C)PJT^9\M6G
M4BG)1YG34XXS$9?*G*.+H8G$X94W&TZTL+6=&52A#XJE&;2G2FHIN$X.48R?
M*M4_&KX-KX>3Q:?BU\,U\*2:B=(C\3'QYX6'AY]6$;2G2TUHZK]C;41$K/\
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MAY585,-.O4E1:K5*-"G&I*'TO^S%_P AS]IW_LX#2?\ UFG]G2LC0^K* "@
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M6=77ZPX1Y>:K#X9-W;]Y/XGJVVWVO[,7_(<_:=_[. TG_P!9I_9TK W/JR@
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M9B_Y#G[3O_9P&D_^LT_LZ4 =9\9/^2B_LG?]G >(_P#UEC]I:@#Z H * "@
MH ^?_@W_ ,E%_:Q_[. \.?\ K+'[-- %?XQ?!SQIX]\:> ?'7@7Q]X7\%ZMX
M+\+_ !#\)W%OXL^'FJ^/].U?3O'^J_#?6)9H8='^)'A";3+VRN?AQ9JKM<7L
M<L>IS QHT2LQL&QPO_"DOVBO^BW_  6_\1P\<_\ T45 !_PI+]HK_HM_P6_\
M1P\<_P#T45 !_P *2_:*_P"BW_!;_P 1P\<__114 '_"DOVBO^BW_!;_ ,1P
M\<__ $45 !_PI+]HK_HM_P %O_$</'/_ -%%0 ?\*2_:*_Z+?\%O_$</'/\
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MQS_]%%0 ?\*2_:*_Z+?\%O\ Q'#QS_\ 114 '_"DOVBO^BW_  6_\1P\<_\
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M\<__ $45 !_PI+]HK_HM_P %O_$</'/_ -%%0 ?\*2_:*_Z+?\%O_$</'/\
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M_P#HLGP _P#$:?B+_P#18T '_".?M3_]%D^ '_B-/Q%_^BQH /\ A'/VI_\
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MQS_]%%0 ?\*2_:*_Z+?\%O\ Q'#QS_\ 114 '_"DOVBO^BW_  6_\1P\<_\
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MA:LFHT<:VL--NT*[C%SDJ$G[M5Q@G)JFY6BG)Z*Y5O/B7\.=.US5O#%_X_\
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MK7C7Q5X?@3P/<Q-H?BWQ3X(\+>!]*U^6>[\9W@OI]"TS1M;AM4MXM.+6VOI
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MI*-!.,,-&=?R2S^ /CO3?!W@#PY8?$CP5_:GPI\4S:QX&UC4/A-J%_8G2Y=
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MIIII-&5*K2KTJ=:A4C6HUHQG3J0DIPG"24HSA*+<91E%IQE%M---.Q9J#0*
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M4YR:C"*O*4FDDVPM:,Y;1I0G4F^D*=*$JE2I)[1A3IQE.<G:,(1E*344V7*
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MFHK7EA*5K1;5VD(* "@#Y_\ C)_R47]D[_LX#Q'_ .LL?M+4 ?0% !0 4 %
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MX3V2PT(\OU><:.$C@7)RJJ> DZ3C[5U*]74^./@KXD>+O$&G2^"X]1T^/3?
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M^+]EKDGPVU#QKXLT2?P\WC?Q!XF\676I>*/$'A_PO:W,VG7.G-XABM;NXO\
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M/.OJN,Q&6PHXFE[.I7PE&M>E&.$QU'QK[1XK?XK_  T^" \<?$WQ#XFT&]\
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MM6N5NX]??9=)P9?3H+ Y72QKFJE2O0KYE[\U457 8/$8GEHN#K2IX/,\Q5+
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M9>U2%':K4KRPL(?;EBHPC5EAHQWE7C2G"I*BDZBA.,W'EDF^<U?]HGX"Z%I
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M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?/_P 9/^2B_LG?]G >(_\
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M\*]%^&.K^)CK$</BW3?%GB[6;G1(8F\97$7C]?B'K]K=Z7#?B"QBUG5?-AG
M>XC6&XE7R75@HSA4C#$Y)6]FI4\DH8:E3IRUYJF"RN6!PF(YG?EJ4<6J&8IM
M3E[:BH\RE+V\:?M_9YNO;7KYO+%QE4G%S]EAL;7:JX:$92ORT\LG/+,,^9+#
MTU1J1@XT50EYIK'[*4E_X@^+^MVWC2P_XN9'JM[HXU[1_'WB&X\&^(=:TNWT
M#4KVWL9/B_:^&GTN;PY%+H[Q:+X9\-:I)8SFWGUJ94%9Y=*I@*.#I*HZDL#F
M%#%PG]JIAH9S'.\3@JLJGMI\F*Q-.DG[&=##)TJ=6M@\16BYMXJG3Q.)E747
M04\)*@U3?LYTL3#*_P"RL)C<-.FH1IU\)2YJM*=>GBJ\*M2HJ&(P]*2IQC\9
M?LK:KXO\41>*+KXA6*R1>/-;\42:2=#^(FFZ3J&A>)?#?@SPWJ_A[6HO!7QJ
M\.3ZW<K8^#UM+:6]GFTC^S]4GL]0T#4F!N9'AE0HRPRK4?K=*E0Q^%JPJN,_
M:X?&9MB\U4%"I">&YHSQ,*5:6(PV*55X3#5J$<)*FHFG/..'Q-*E+V-:<\LK
MX>K"\7A,5EV73R]2HM2]M3P]3VE7%0HX>OAZ]'$5:LGBZL:DHOMO OP$U+P9
MX]A\1MXTTV^\(:1JOQ"UOPYX.L_!4>E7]MJGCVXTYH[_ %[Q4WB.\.NW.A:5
M#JNA:9]GTW2XX=(O[:S:-VL//N=:%=TZ-3VR=?%RPJP4:RDZ<%1EC5CL3.5'
MWO:8K'XBGAJ^.Q$ZC]MB:,J].G1=>K!YXBG0K.DJ6&I8:G1KX"O&,(ZQE@,G
MJY/"G!W2A1]C5]I2@H\U)NI"4ZT94W2R]7_9UUO5->\5Z@GQ!TVPTO4]>\7>
M-?"T5IX%*^)M%\=>+? VI^ SK/B7Q2WBTKXOTG2-)U:Y73=-@TS0Y(8XK:">
M]N8[:+9QT:,8Y?4R[$RE7I3H8S!>[)TE]1S#-(YGCH-+GD\76:EAHXJ,X4X4
MI<[PLZ\8U5VT\2J.8TL;3IVI2K9;7QE%N+>(EE5*A2PM*G4<+X;#N>%H8FK!
M1JUI8F,^3$4\-6K8:IZ9X(^$VE?#^37F\-S6>GPWWA;P?X.\/V=II0M;/PWH
M7@K2;^TTFU6"*^VWW_$TUC5[]V3[)G[8L1RT9GDWS&KB<?A<VHRKNG6S3&8W
M&^UMS>QJ8O"8+!PC""<+PP]/ TW"//%-RDH^SC9+SL#AZ."J99*2E7A@,'A\
M).$IM>WE2Q>+Q5?$.3YN6KB_K,85I-5)RE0C4G.HWRQ\LTS]E;0=)TS2]-MM
M:M#_ &7X*^''@:*[?PU";LZ;X6\:2>-O'UXEQ_:OFQ:CXXU!H1>S>8WD/:Q3
M.+V1:Z95Z"Q;KT<*L/0CC\)BJ5"$W&-+#93AHT\CP":BDZ668I3Q*ER)5H3=
M#V5%_OFY1JUZ%2&+=&OB*^'SJ-:LJ/L_:8WB%*&:XOD51J$9TH0CA</&5\/+
MGE.OB*<U1AEZC^S%XJU-/$]O=?%FT>QO[+XO6WAC3F^'[):Z5=_%SQ38^)-1
MU;Q/+;^-8KOQ7J%I:IJVB;K.Y\/I+INIK&B6T\,MQ>88.:PD<NDX1GBL LCI
M*JER0>&R?'PQV(HPI>]R2S:>'P4\=4G.LGBL/+$1I^SK?5J>^*E+$U<2_:3H
MT:]3$UER22Q-*O5RFIE.$G2Q*BG3CEE*M5>"4*<9QC*$*M6K*E3JJ'XC? KX
MH7>A>*[WPKXS\.:EXANO$OCSQ1X>T^3P5>VDJ7?CCX=77PZM(KK5+SXF);&Z
MT&.^^T6]]]F2+^SK1K#^SI;MDOZYE2C*CA\#6YJN%KT<5EF)<W>,<#FG$F$S
M?$UYPBX5*CPM"&)I5J=*K3J8N-2V&G@VE3DZ%183$?7J=)2J82IEN84\-&<J
M5/$XK)\HJ8*&"<O?5/#9A6IX:K34E*."Q45B*L\3%>[<T_\ 9BUB*PT+[?X^
MT*VU>PN=*LM4;P=X O\ PEX:_P"$-\.^!O&G@?PSX;\*^'F\?ZC<^'KW3$\:
MWVJ1ZGJ&K:^IO80_V-8E@CL^C,)+'PS*E5=24,UIYI+$2G*,ZJQV:8?+\+/%
M4)QIPC1ITL/EU/#1P[A4G+#5\52^LQG55:.&6TXY;]6=&$%+!T\HP]&/+>G]
M5RO,99FZ5>,FY5:F)Q-2=2=>E/#<M2&'DZ<Z=.M1Q'8_"'X 0?##X<ZWX$N-
M=@U*_P!8TF3PW_PEVDP^-[?7(?#EMI]UIWA^QEOOB!\2?&^HO/I,5]>M;+;Z
MG9Z= URPLM,LHB8S.;N6<9?B,#6DZ$L9'$2Q$Z?PSQ&)C&E4KI2O6E)T*6'H
MREB<3BL1.%"$98EQC",'E=.&58ZCBZ48UHX26'6'C47O1H8>7M(T)N')1495
MI5:LHX7#82ASUJDE04Y2E+S+1?V0&T[P!I_@2Z\:Z1,FEZAI5_'JT/ACQGJE
M]K$?A)MO@C0_$]W\1?BYXNU+4O"EA;76M6]YH=CJ>E6-[!J\UI;PZ=827-G>
M]BQU1X[+\?5BI5L%B?K<H1LJ=3%59PIXO$+GC4KO$5,!3IX3#8C$U\77PE6G
M2QCJ8BMAL(L-S1P<*6$S'!TI.-/&X;ZG";_BT<-"$JF'I_NW2HI4LP<<=.&&
MH86A5DJE+V%/V]:I.V?V1+2YU3XFR:KXMM=;T/XB^)6US[%K.E^.-9U/1].U
MOQ18ZYX[\-VXUGXK7GA>STW7-%M9/#_F:#X0\.S+9?9?[1?5VM/WW)@/9X*A
MEE%T^>65XF%>$XOEG5C1Q#S"C3K5*L:]>2>:T\-F&(IPK0PE:K1J*&#HSK>U
MI^AC)QQ=3$5%35%8G 5,)*$&X0AB'E+R:EC*,:7LE&=#!3JQI^U5;$1E5G&G
MBZ=%ND]'QS^SUJD&@>,]6\#7>F3>.=8O_B;XBT_R="L]+\_Q/XV\+-\._!]S
M=WDNNPH=/\)>"+F6S,4CN;P0"2 6>%M7PE"4\/A\OJ3E5PN(HRR[%.K><?J^
M:\08/-LZQE2$)TJE1N-&<84:56%?V$525>K5Y)JH3P]#%T\QAA7.IEM? 8_#
M8;VO)"I+)LCQ6 PF6QG[-QHT<5BZOMU/D]EAJE:HY4Y*4ZJO^'?V=O$>A+X1
MU'_A.?"4?B+P_P")?!%UJ*:'\--0T+P/>>"/ .@^)O#_ (?\%:)X17XCW-YH
MDMM%XHO=1BU2\U_6@NHPPS/926T<=G'WUL2ZN(J5VYR^L3S3$UI5)QE66/S/
M X7 2Q.'G&$*="%&AA*5&%"I1Q#>'J8FE[95:L,12\[#X2CA\'6PL:<$U@<N
MP&&:3Y:-++LS6:QE5BVW7JUL2ZOM9PEAKITVDO9S57(TO]E[Q!93:=#??$C0
M[[2;G1_"FC^-EC^'$L'B'Q#!X)\:ZUXVT5-#\07?CN\7PK;ZAJ6L,VMQ/8:J
MU[.DESI\FD/*JP\])JC2HT8Q488-X+$851<E[+'X#*\#EN'J5&VY5L%AG@*>
M*P>"<H5*56I6IXC&XNC5K0J=6)3K5L;5@_9T\=+.:4Z+YITJ>#SO%8S$XJ-"
M"E!4L?..+^KUL<^:GB*6&P?-@HRPU-K5;]F>:R\*PZ-HGB3PLNMQ^";[PS+J
MVO\ @36;_2[W7O%'C"Q\9^/_ !K=Z5X9^(WAS45UK6-4TS3Y[9[77K6XTZZM
M([D7=UL6)9GI'ZOAY3H82"R2E1BIN5;"T,AHXRG@EAZ[24<0JF+5>5>=.<)3
MI+GH3E.4UM*5&6+JXMTFW5Q&>8B=.4E.E5><U,-:EB*=2$U7I87"T:N"C"5E
M4PU=TX^QIQ]G/T#Q)X%\37VC?!SPC<ZE>>++7P]XL\-:GX\\4ZD]A97VH0>#
M-"U35--UBYLXY4\Z^N_'-AX9D,5LDVPL\DF4C9CK6=/$YE6Q4+Y?1AA<R=&-
M*SM7QF%EED*2:2Y7'#9AB\5&:A&E&>&48JG*5&#YE%0R_$X:2E5JXFKA(Q4'
M-0ITZ68X?'U5.5:M.M/#>PPCP+A.MB,166(IJNZT'B:T?+-$_96NH=(TO0O%
M/CK2]?TWP\GAO0-$M]-\!GP^MQX%T/QSH?CS5M)\7>;XNU/_ (2CQ5XAU3P_
M8)JFN_Z#:S W#QZ/$]W<&;2CB(TJ^'Q+H4_:PE@ZE6G"*IX53RO YEA,I6!H
M6D\%2P%?,%C*=.57$OGPU&G2G0A&#IUCE]9KXVM14<-]:_M91O'VDH+/L3AJ
MF:\\KPC4=3"8>6#PTE"F\/[7V]3ZQ*')+W/Q;X2\5>.OAKXW\%ZGK.A^'M8\
M5:;XGT+3]4TG3=3U/3M&TG4VN[/2#>V4NKZ;<ZQ=+I4D'VP6]WI2R223);M
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M!?VM_P!0_P#Y/_\ :!_9'[=G_1]W_FL'P=_^.T?V#_U%?^4O_N@?VM_U#_\
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M3^S#\'0 !U)/F\ "E+(XPBY2QBC&*;;=.R26K;;J622U;>PEFKNDL/KT7/\
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MM_U#_P#D_P#]H']D?MV?]'W?^:P?!W_X[1_8/_45_P"4O_N@?VM_U#_^3_\
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M=H\\XTX<SY+1YJDXPC>UYRC%7;2::?!^VYJME:ZEI7[?=GJ6G7L*7%E?Z?\
MLU?!>\LKNWD&8Y[6ZMKAXIX6'(>-F4]C5?V U;_:K*2C)?NMXRBI1DOWFJE%
MJ46M'%IK1A+-)4YU*<\,X5*,YTYQ<[2A4IR<)PE%P3C.$XRA.+2<91<6DTT7
M/[(_;L_Z/N_\U@^#O_QVC^P?^HK_ ,I?_=!?VM_U#_\ D_\ ]H']D?MV?]'W
M?^:P?!W_ ..T?V#_ -17_E+_ .Z!_:W_ %#_ /D__P!H']D?MV?]'W?^:P?!
MW_X[1_8/_45_Y2_^Z!_:W_4/_P"3_P#V@?V1^W9_T?=_YK!\'?\ X[1_8/\
MU%?^4O\ [H']K?\ 4/\ ^3__ &@?V1^W9_T?=_YK!\'?_CM']@_]17_E+_[H
M']K?]0__ )/_ /:!_9'[=G_1]W_FL'P=_P#CM']@_P#45_Y2_P#N@?VM_P!0
M_P#Y/_\ :!_9'[=G_1]W_FL'P=_^.T?V#_U%?^4O_N@?VM_U#_\ D_\ ]H']
MD?MV?]'W?^:P?!W_ ..T?V#_ -17_E+_ .Z!_:W_ %#_ /D__P!H']D?MV?]
M'W?^:P?!W_X[1_8/_45_Y2_^Z!_:W_4/_P"3_P#V@?V1^W9_T?=_YK!\'?\
MX[1_8/\ U%?^4O\ [H']K?\ 4/\ ^3__ &@?V1^W9_T?=_YK!\'?_CM']@_]
M17_E+_[H']K?]0__ )/_ /:!_9'[=G_1]W_FL'P=_P#CM']@_P#45_Y2_P#N
M@?VM_P!0_P#Y/_\ :!_9'[=G_1]W_FL'P=_^.T?V#_U%?^4O_N@?VM_U#_\
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MW_4/_P"3_P#V@?V1^W9_T?=_YK!\'?\ X[1_8/\ U%?^4O\ [H']K?\ 4/\
M^3__ &@?V1^W9_T?=_YK!\'?_CM']@_]17_E+_[H']K?]0__ )/_ /:!_9'[
M=G_1]W_FL'P=_P#CM']@_P#45_Y2_P#N@?VM_P!0_P#Y/_\ :!_9'[=G_1]W
M_FL'P=_^.T?V#_U%?^4O_N@?VM_U#_\ D_\ ]H']D?MV?]'W?^:P?!W_ ..T
M?V#_ -17_E+_ .Z!_:W_ %#_ /D__P!H']D?MV?]'W?^:P?!W_X[1_8/_45_
MY2_^Z!_:W_4/_P"3_P#V@?V1^W9_T?=_YK!\'?\ X[1_8/\ U%?^4O\ [H']
MK?\ 4/\ ^3__ &@?V1^W9_T?=_YK!\'?_CM']@_]17_E+_[H']K?]0__ )/_
M /:!_9'[=G_1]W_FL'P=_P#CM']@_P#45_Y2_P#N@?VM_P!0_P#Y/_\ :!_9
M'[=G_1]W_FL'P=_^.T?V#_U%?^4O_N@?VM_U#_\ D_\ ]H']D?MV?]'W?^:P
M?!W_ ..T?V#_ -17_E+_ .Z!_:W_ %#_ /D__P!H']D?MV?]'W?^:P?!W_X[
M1_8/_45_Y2_^Z!_:W_4/_P"3_P#V@?V1^W9_T?=_YK!\'?\ X[1_8/\ U%?^
M4O\ [H']K?\ 4/\ ^3__ &@?V1^W9_T?=_YK!\'?_CM']@_]17_E+_[H']K?
M]0__ )/_ /:!_9'[=G_1]W_FL'P=_P#CM']@_P#45_Y2_P#N@?VM_P!0_P#Y
M/_\ :!_9'[=G_1]W_FL'P=_^.T?V#_U%?^4O_N@?VM_U#_\ D_\ ]H']D?MV
M?]'W?^:P?!W_ ..T?V#_ -17_E+_ .Z!_:W_ %#_ /D__P!H']D?MV?]'W?^
M:P?!W_X[1_8/_45_Y2_^Z!_:W_4/_P"3_P#VA?\  EC^TG:_M!_LRR?&+]I3
M_A<?A@_%#QDEAX8_X4YX"^'OV#73^SE\=FM=>_MKPLYN[KR=/75+3[%(/)?^
MU/-;Y[:.N+'99]2I1J^V]IS34+<G+NI.]^:7\MK6ZG3A<=]9J.G[+DY8N5^:
M^S2M;E7<_6RO+.\* "@ H _.23_DMO[47_98/"7_ *S3^S]7U.1_[I4_Z^R_
M](IG@YI_O$/^O:_]*F='7LGFGPW\:?%4FG:]\2$UWQ[XG\'>)=*N/!,?PDT+
M0_%VMZ%%K_A^]_L-O$6HP>'M.NH;;Q5(VL3ZO97]S<6]Z^EVUM#(DED)O-F\
MO"SOB\ E5G+'3XCR_#XC#MMPCEL\;EL*:=!MPCAJT*E5SQ7)!UL1*I@9U:D(
M_5WU9A&G3P%:4+1H1R#,JZJO]W;,Z='-W:%=<LI5J-*E@JE/#^TDHQ<<3&DI
MR<X_0/@YI8?BY\7[.T'_ !)FL_AYJ=QMYC3Q;>:7J]IJZ9#G;.?#^F>$9'3:
MO$L3G)DR>_ \GU'&)2<E1S?%PIIO2%.6!RO$5(0[0^MU\14:6GMJM;[7-;#%
MW]OESUYI9;%S7+9<L,=C88>?-9<TY)5J;;E)JG0I1M&*CS>QUJ0?#.M:?JOA
MOXL?'CXN^&+:]O\ 4_">K>#=-\6Z!9^=*WB?X>W/P\T"?5H(+)&(FUO1I2VK
MV#)&TLAM[NS7C4"5^<YOJ63YW6ES/!8_'YKA\9%)/V4HX3!K"8Z-[-?5JE65
M/$6=I8.O6G*,IT*'+[M6'UROD.#34<5A\KPU?!2;45*K+-\YC6PDY-?P\93I
M0C&[2IXJEA:EU!58S\5\)^+?'<&@^ K2T\2:1X;GM/AQ\)G^%5KKGQ6\<^#_
M .UX[CPSI-SK<^E_"[PG\/\ 7+?XN^=J,MS97=O=S3W%G% A@AL-ZWDWT%;V
MT^(,90KR7M5G%*A4I1K5)UO[-]E@8SA#".$:5&G4C+%2CFD:L'0JN4JF*H0P
MLH+ES.>&J1S#%8:4OJV(AF^(]J\/&,*6-EFN;>QD\3S1JRK4Z4,'-9>M*RE&
M$:5:>)LOI3X8+9^'?@I\;;;0]8U1=<T/Q9\=I=02X\4Z[K&L:!J*:YXEN]';
MS-7U2YO-%N)=).EZC&5-NUP;P:@WF37LD\WD9Q6=#@O#U<%6E%87)U"%:,VZ
MD*]&#C7INMS.I[6A53IRIN;=!KV<5"*43LC%8CC"DL1"$OK-;)Y3I\J]E.G5
MP>"<G&G90=*51UJ<;045"FL/%1IT(4Z?B]EXHN]3TCP7:>!OB?X\\0Z3XAL/
MA##\4-9;QQXEU'4-!\:ZW\1O VF7&DP:I-J)F\':OJ>A:EXFBO=!T]K!((;6
MVF%I TPDG]M8?#5LYQ6#I5*D\H6.E'"RA5J<M;EROB.MC*,,7&2JU84Y8;+Y
MU8*L_J5=QA2]A-\D? I5*\,JH8K$4H0S..6XJK4@Z<.6$:;RWZI7=-OD]VI.
MK'#UI4Y_VC1E5J5ZF)A#FEWFI:W<Z%XGU+1[3QQXRA^*>A_$_P '^'O _P /
MKGQGXFUA=6^%4E]X:MKS4KOPOJ^JR)XMTV?0I_$-Y?\ BS4H[^\M;JVE0ZE&
MUL(3P9?5G7Q&73YHU<=7KYC#,Z'-^ZH86E7Q\</.5%?N\"H82& K8>O2IT98
MJM4A3E*M[>5)]N)IQITL:J\?JV AA(U<NKP7[ROCY82G4=-5$IRQ$Y9E*KA*
MN#FW2PV"BJ\*.'45BCEKWQGJ\7A3Q/?:+\1/&EU\:6UG4K/X@>!Y?$^OG0_"
M/AJ/XFZ?I]YJ=U81:%K2?"Z"P\%LPT[5M-L+*6]L[JYU(6FJS6X>VY:-6']G
M91^^Y\-7HY74S6M4Q-6C##XJ6$J3Q=*>.A"K4P,JF8/ZKB,-3E!8>A&,XQP<
M(RQD>I4Y?6\R5?#1I2H5,QCE<:=*FYUZ,*53ZC*&'E4C3QT'AXT\9[6I&;J8
MOEPKKIUEAJF?<>,O&D7AK3_LWC+PS=_"^?XB/;WFO67[17Q,G\/:9I2^#Y[A
M=%U3]I2?X;1ZU#IDOBI(I5N;1[KR[A_[(N-4MU9;6JG4JVPL,=*G2H>QS!TJ
MLL15R^$Y0JY8L#%5HPC+&U8TZV/]DW"G0QE*G"4JF+KT*L:N$(-2Q'U2BY5E
M3P/M(JC#%UH1G+'_ %NNL+.I[/"IPI8&G4C%5:F&C.KB8X;"PJPQ-+,\1^*-
M4O?A[XUM?BI\1;VQMD^$OB2;X3S^&_&/BZ#3/&]_)J7CZTN[;[;J.C^'9OBQ
MJ-IX>M/"MLYOM'N+:ZMIY-7MX9$NA>*\;R.@_;SF\Z4LKC+#3C[&G/#.E@Y5
M<2L&E&$%B,4\3]<G.E"KE_LZ<%'!*4?:^AE<:5/-,G>$2CE;QDY5*\:D<14H
MUHSPTJ-)8N/,[4^:I+!4HU*CQ4F\/7GC:U&I&/J>@>)K[3/C1H&FS^,+CQ%+
M?WVD6-OX7TCQ]XGT;Q!X>T6Y\*0J+?6?@QJ^FS:#XA\$6]T#?GQMI4MC>"9U
M@-Q,D$D,WHT*KEFN84&WB'4K9O[2LIRJQINCB<16HK%8>HE/+'"E"G@\).C)
M4\9-T*LJ52.,54^=LJ>3X"K&#@HT,KC&G*FJ<OWD<-3G4PF)IR4<<YRE5J8N
MA6C-X:C[=0G&IA8PIM^*T[^&?C'X]U;3=;UO1M3UCP!\&UOYK?Q+KD<MOX'C
M^(^O:=\2=<T#0GOWLP^C>''LYI;RTLB^E_VE-=QM!-J,[W?+AWA:<,=0Q.*G
MA\)4S>E4Q\O;5(RHX:>56PDW4<G+!8;$YC3IX2KB:,J"5/GBZT%2C*G[M7GJ
M9;E#HTH5\70HYU'"TW&/+/%1^HU*<'!*U:O[&IB:U*C44WB9T*$)QJQH48P]
M3^$UW9^(;7XJZ1X=\5>(/&?PRBN;.P\&>);CQ5KGB&XF:_\ #JGQ-8^'?B'-
MJD^K:[96FI.GE:@NIW,MK<W%S;072_8UCMLL9"O7X>S!8BG*,W+'T\*XITZM
M; PPV&EAJLE3:E*^)EBZ-*LTI8K#TJ523K*?MJOG4YK#YM@)4O9J,,-@ZU9-
MQJPCC/KF-C4C4IU.>G3E]6IX.I4PSA&G#GNZ<.>45\H^!]'L9? $VK^'_%WB
MZPOO ?[*'AW5K:70/'OB2">P\:Z)JGQ"N+FTUJ>#5VFO4TG6;.[M&\.ZB\VG
M0#?:26 2WAC@Z,?65*MG6:82M[:E"OD4L++G=3#UJ#P]1.<U=QQ:KTW[.=:L
MZL[)RISA5<IGT"HTZ^;9;EM>"E0Q>?\ $F'KQDOWOLYXO)80Y*K_ 'M&<J4H
M5E5I3A4K2DJU253VDW4[[PUXR^(E_P#%.U34?$NC:?XED^(%K:IX;U/XJ^.%
MU2\^&DC0Q(UC\"=)^'MUHDVG76F,]]%XL?4T,-TX%UJ=M#%)9(\NY_KBI56G
M:KG$<92C5GB*D/93S!8.-2G5IPAEJH>SP;IRA4A'%THI1EBZN+@G\SBFEET)
MTI2:EA<GGAJLJ"I0=>KA\OJ8R-.K3E[7'>TK5,71K1<:GU5N<U3I4\(ZAV_Q
MRUKQ)%\0!H6E^*O$V@6-X_[/=JRZ%K5_IA@3Q!\8=<TG6WMEMYE2*:^TN*.T
MG<)F6&)(Y-R(JB<!#ZSFJPU6<W0>.Y904Y1O3APYG>)=*\6I1A.K0I3DX.,H
MSA"K"4*M.G./9BN7#Y#'$PIP5>-'-FIN,6^:GB>'(4I.Z]YT5B*W(I7BE5JQ
MMRU*BES/B'QKXF^$5CXQ\16&I>,O%.A?#KXKZMX$MM$U+7]=\3WT^E>./A]X
M5U#PW;WEYK>I75WK-Q:?$74])@M[O4)[J>VM=7NHDD6%BM93EBGA<HH49-XO
M/:6:930J-14*6.I9QBJ>6XJJTDU[+"X2IAJM6/OUN>%2O*I4BI%PH89XG&*O
M5]AA<)#*\VKVAS/ZNJ,J.94J?(N>%+V-:>8.E"\%5PJC"G&+CR<U-JWQ/\.^
M.D\,:KXVM8/$NA:K\/=,\&'Q5\7?'>D:OXHTDZ)X9F\67=I\)M!\!ZY8_%&+
M4=6N/$<-SJ%U>2RZ9MRC:9%8BXEVP\XRS)QPS3C',*U&M1E5K8FK#*X5O88>
M^%G2IPP_-A(T\3#,W6?M<7.4L7C)157"4^?$W>71Q$J*A.MEM3%7C"-##PS.
MK+$U9*%>,Y55'#5I4:$,MY)IX:G"%&A4=>,WSGC;5I]0LOC#X:U7QGJ_C.67
MPYXYO]4N/"_Q0\=6\^A1:)JMMJFGQ^/_ (3:G;V[_"[[':6[6-I/H=_:V6LP
M&66[L[B*X5X># 5:,J.6_6:S6&PN)X?Q-?&_6:CH7CFF"H8NK4Q$I4JV6XR<
M*]7%3P,YNG@8T:M2E'"U\!"2UQJK1>)IX3#\^(Q=/-,/0PTL/3]M&4LMQL\/
M0I4DIT<QP<I0H4EB_9>VK5:F'I\U:EC*OM?3(ENM5UK5-9T/XD>/)M+7XZ^
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M0T<5&7(HN<:OUNO*4*CE"-63J4XPJ2G*7W/6YY84 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 <Y'_P EM_9=_P"RP>+?_6:?V@:\
M;._]TI_]?8_^D5#TLK_WB?\ U[?_ *5 _1NOECW@H * "@#\Y)/^2V_M1?\
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M]&T_ #_PS?PZ_P#F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\ #)W[+'_1M/P
M_P##-_#K_P"9R@ _X9._98_Z-I^ '_AF_AU_\SE !_PR=^RQ_P!&T_ #_P ,
MW\.O_F<H /\ AD[]EC_HVGX ?^&;^'7_ ,SE !_PR=^RQ_T;3\ /_#-_#K_Y
MG* #_AD[]EC_ *-I^ '_ (9OX=?_ #.4 '_#)W[+'_1M/P _\,W\.O\ YG*
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M.4 '_#)W[+'_ $;3\ /_  S?PZ_^9R@ _P"&3OV6/^C:?@!_X9OX=?\ S.4
M'_#)W[+'_1M/P _\,W\.O_F<H /^&3OV6/\ HVGX ?\ AF_AU_\ ,Y0 ?\,G
M?LL?]&T_ #_PS?PZ_P#F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\ #)W[+'_1
MM/P _P##-_#K_P"9R@ _X9._98_Z-I^ '_AF_AU_\SE !_PR=^RQ_P!&T_ #
M_P ,W\.O_F<H /\ AD[]EC_HVGX ?^&;^'7_ ,SE !_PR=^RQ_T;3\ /_#-_
M#K_YG* #_AD[]EC_ *-I^ '_ (9OX=?_ #.4 '_#)W[+'_1M/P _\,W\.O\
MYG* #_AD[]EC_HVGX ?^&;^'7_S.4 '_  R=^RQ_T;3\ /\ PS?PZ_\ F<H
M/^&3OV6/^C:?@!_X9OX=?_,Y0 ?\,G?LL?\ 1M/P _\ #-_#K_YG* #_ (9.
M_98_Z-I^ '_AF_AU_P#,Y0 ?\,G?LL?]&T_ #_PS?PZ_^9R@ _X9._98_P"C
M:?@!_P"&;^'7_P SE !_PR=^RQ_T;3\ /_#-_#K_ .9R@ _X9._98_Z-I^ '
M_AF_AU_\SE !_P ,G?LL?]&T_ #_ ,,W\.O_ )G* #_AD[]EC_HVGX ?^&;^
M'7_S.4 '_#)W[+'_ $;3\ /_  S?PZ_^9R@ _P"&3OV6/^C:?@!_X9OX=?\
MS.4 '_#)W[+'_1M/P _\,W\.O_F<H /^&3OV6/\ HVGX ?\ AF_AU_\ ,Y0
M?\,G?LL?]&T_ #_PS?PZ_P#F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\ #)W[
M+'_1M/P _P##-_#K_P"9R@ _X9._98_Z-I^ '_AF_AU_\SE !_PR=^RQ_P!&
MT_ #_P ,W\.O_F<H /\ AD[]EC_HVGX ?^&;^'7_ ,SE !_PR=^RQ_T;3\ /
M_#-_#K_YG* #_AD[]EC_ *-I^ '_ (9OX=?_ #.4 '_#)W[+'_1M/P _\,W\
M.O\ YG* #_AD[]EC_HVGX ?^&;^'7_S.4 '_  R=^RQ_T;3\ /\ PS?PZ_\
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M=?\ S.4 '_#)W[+'_1M/P _\,W\.O_F<H /^&3OV6/\ HVGX ?\ AF_AU_\
M,Y0 ?\,G?LL?]&T_ #_PS?PZ_P#F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\
M#)W[+'_1M/P _P##-_#K_P"9R@ _X9._98_Z-I^ '_AF_AU_\SE !_PR=^RQ
M_P!&T_ #_P ,W\.O_F<H /\ AD[]EC_HVGX ?^&;^'7_ ,SE !_PR=^RQ_T;
M3\ /_#-_#K_YG* /,/%_P0^"_P -?BU^RMKOPY^$/PO\ :W=_'#Q1I-UK'@K
MP!X4\*ZK<Z5/^S#^T7>3Z9<:AH6DVL\VGR7=A8SO;O(8VDLX'*EH4*@'V?0
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MJUY\9?$UEXGMK;3/#5MJ7AO7OBQ?_#M?$/BCQ9+H7AK05\/IH>CW2Z;+X?\
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M)\MC.4H/V6*H5*>(G.E2=2E/VU15:].-+#3K>J? GXXZU\9].UOQ+=_#37/
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M3DTY4Z<G=PA)I-QBU%M)M:&+_P *A^$W_"0Q>+O^%7_#O_A*X+_5=4@\3_\
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MTIOWJ;U@TS;VM12Y_:24[XA\W,^:^,Y?K;O>]\5RQ^L/>ORQ]KS61E77P?\
MA+>V>BZ=>?"[X=7>G^&I]4NO#MC=>"?#4]GH%SK9E.M7&BVTNF-'I4]^9YOM
M4ELL37'G/YI?<<ZJM6CB(8M59QQ=.%.G&LI256-.E4IUJ4(U+\\84JM*E5IQ
M4E&%2G3G%*4(M92A"6'JX245+"5E%5*+2=*:A1^KP4Z;]R2AA_W$>:+Y:/[I
M6A[IKZ9\/_ >B^(M3\7Z/X)\(Z3XLUIIVUGQ1IGAO1K#Q%JS726$=TVIZU:V
M27E^TT>EZ8LAGF?>-.M0V1;Q[,Z<I4*,L-1;HX>4G-TH/DIN;G.HY.$;1<G4
MJ3FY-7<YSDW>3;J?OR4Y^].*II2EJTJ-.=*BDWJE2I5)TZ:^Q3G.$;1DTX)_
MAK\.;KQ!J'BRY\ >"KCQ5JMJMCJGB:?PKH4OB#4K)-/NM)6SU#69+ WEY:KI
M5]>V0BFF=!;WD\./+E=6B,8PHU\-&*CA\5S^VI))4ZWM71E4]K!>[4]I+#X>
M4^=/G="BY7=*'+4IRE4PE64G*K@&I8:;;<\/*/M'&5"3UHN+JU;.FXM>TJ6^
M.5Y-8^'?P_\ $5G)IWB#P+X.UW3Y9-%FEL-8\,:)J=G)-X:8OX=EDM;VQDC>
M32G9FLF*DVI),!C)JI>_4]K/WJJK5,2IO6?UBM2C0JXCF>OMJM"$*-2K?GG2
MA&G*3A%)91ITZ=.5*$(PI2P\,(X124'A:=256GAG%))X>G5G.I"BU[.-2<IQ
MBI2;;-5\ ^&M3T?PUX=2RCTC0/"FM>&M:TC1-$M['3M*A?PC>0:AH&G"QCLS
M%!I-K>VEE,EO;+;[390JK*@9'T]K6^NT,?*K.>)H?66I3DY<[Q6"Q. J.HY7
ME)QHXJI*#YDXU5"3NH\K=2*J4,5AY7C'%RIRJ2BW&;<,91QL]4_>]O4H\F(4
ME)5J56M"6M3F45K\,/AI8ZCK>L6/P\\#6>K>)=4TW7/$>J6OA+0+?4=?UK1K
MV#4M'UC6[V'3UFU75+'4;:VNK:[NGEE@FMXY8G5T5A-&4L+3IT<-)X>C0G5J
M4X4VZ<*=2O3G2K5(1C:,9UJ52I3JRBE*I3G.$VXR:=3_ 'E6I7J>_7K45AJE
M26LYX=+E5"<W>4J*CHJ3;@EIRV)+KX;?#J]\0:IXKO? /@J[\4ZWH<OAC6?$
MMUX5T*X\0:OX:G3RY_#VJ:S+8-=W^AR)\KV$\TENPX,9%9>SI^PQ.%Y(_5<;
M*,\11LO95YPTC*M3MR5916D934FNC1:G-5L+B%.2KX%WPU2[]IAW=N]"?Q4G
M>4G>FXZR;ZL\LT7]F+X8:3\0-:^(5UI]MKEWJGAM_!MAX>O_  C\,M,\->'_
M  @]A'I+>&+.W\)^ M'O]?T9='A33X8/%.H^(/LMH9+>T,$4\RR]%&M5HPQ5
MZDJV*QM=XBOBJDI.O5J.O2Q*E)1<:'M%7P^'J/$*BL7.6'H.KB*GLXVB22EE
MKH16$IY1RO"4Z*4(X><:52CSTIOFK4E:OB)>RIU88=5,15G&BG[/V?JGB7P5
M;:WHNMZ3H^KZIX#O/$+67]J^)/!=IX9MO$-Q%:1VUHT+W.O>'M5M6,VDVJ::
M;A[1KF"V(%E/:S10S0\M:C3Q$/8UTZF%G4G.O0YI0AB55CR5H594W"M%5ER^
MTJ4*M&N^2%JR2:=TIO#\DJ*C"K0I1HX>IRQD\-&G.52BZ,)J5%JC4J5)TZ-6
MG5P_-4J.5&7/*]'3_A-\,=+N=%O[7X?^#O[6\/:'HWAO1M<G\.:1=:_8:%X>
MC,>BZ9#KMS:/?"TLPTC0QFXPCRR.H#2,3TUZLL37QN(JJ+JYC4J5<2U&,56G
M5I5:$W4C%)2YJ%:KAVFFO85)T?X<I1?/2I1I8?"8:\JE+ Q4:/M92J2A:K1K
MN2E-RESRQ&'H8B<[\T\11IUI-U(1DC7/A)\*?$VFZ9H_B7X9?#WQ#I&B:1+X
M?T;2M<\%^&]6TW2-!F-@9M$TRQO]-EAL-(<Z5I9:S@2.%O[-M<H?L\>S.K^_
MJU:]?]]6KN#JU*GOSJ.E4]K3=2<KRFZ=5^UAS-\E3WXVEJ=,:U6&D*LXI5*M
M6RDU^]KTJM&O4T?\2M1KUZ56?Q5*5:K3FW&I-.=OA;\,FU+0M9;X=>!&UCPM
MI]II'AG5F\(^'SJ7AS2M/NX;^PTS0KXZ?Y^D:?;7UO;W$-M:/%''+!'(BJZ*
M1HJU6-;$8A59QQ&+UKU5*2J5G[*K0O5G?FJ?N:]>C[[?[JM5I_!4FGSNC2>&
MHX)TH/!X:2E2H<J]C2DI4YJ5.E;DA)3I4IIQBGS4Z<MX1:KQ?"/X46]_I.J0
M?#'X>0:GH$VO7.A:C%X+\-QW^BW'BFXN+OQ//I-XFFB739M7NKNZFOWMWC:\
MDN97N#(TC$Y))4YTDK4JF$A@)P^S+ TERT\%*.TL)3C[L,.TZ,%I&"1M*4I2
MYY2<IK$?7.9MM_6UR6Q5WK]87LX?O_XON0][W5:BWP/^"KZ3+H#_  @^%S:%
M/HUEX<FT5OA_X3;29O#VFZG/K6G:#+IQTG[/)HUKK%U<W\-DT9@BN;B6>-%E
MD9S4VZG\1N=JE"JN;7][A:/U?#5-;_O,/AU["A/XJ-']U3<8>Z*FW1M[)^RY
M5B4N3W;+&SC4QB7+:RQ=2,:F)2_CSC&57GDDSJX_!?@Z&/R8O"?AF*(6.BZ7
MY4>@Z6D8TSPW>S:CX=T[8MJ!]ATO4+BXNK*#'EVLT\DL"QN[,;E5JSESSJ2E
M/VRQ',Y-R^L*,8*O=N_ME"$(*K\:C",>:T4E,8JG2AAX)0H4Z=:C"G%6IQI8
MF*AB*48*T8TZ\(QA6@DHU8Q49J221?U'P_H.L3VUUJ^B:1JES96^HV=G<:CI
MME?3VEIK%NMIJ]K;37,+O!;WUHJPW,:%5GC4)*&48KGG1I5%6C4I0G'$498>
MJI1357#SG"I*A4334Z,JE.G.5*5X.=.$G%N$6KC.<'2<9N+H5H8BFTVG3KTX
M5*=.M!KX*T*=:M"%2-IQA5J14E&<DZ1\&^$#;"S/A7PV;0:/8>'A:G0],-L-
M TJ4SZ9H8@-KL_L>SF9I(++;Y,+,6C12<UO*I.=:>)G.4L14KTL3.K)MU)8F
MA-U*&(E-^]*O1J2=2E5;=2G-N4)*3;,8T:4,/3PD*4(X6E2K4(45%*E"AB*<
M*6(HQII<D:5>E3ITZU-)0JTZ<(34HQBEE)\,/AK%KFL>)X_AYX&C\2>(;G2+
MW7_$*>$M 37-<O/#]Y;:AH-WK&K+IXNM2N=-O[.TN;.6YED>VFM8982CQ*RJ
MC*6%@J>&D\/3C4G54:;=.*JU*=2C4JJ,;)5*E*M5I3G;FE3JU(2;C.2>U24J
MKC*K)U)1HRPT7-N36'G;GPZ;O:C*RYJ2]R5E>+L7XO G@B#Q;<>/X?!OA6'Q
MW=Z:NC77C6+P]I$?BVYT='61-)N/$:68U";35=$86KW!B!12$R!2I-T*=>E1
M;HTL5.-2M"'N1K5(*T9U8QLJDXK2,IIR2V:(J)594955[26&3C1<_>=)/FNJ
M;=W!/FE=1LGS2ONR-/A_X#B\53^.HO!/A&/QO<I!'<^,D\-Z,GBJXCM;.XTZ
MU2?Q"MD+^5(=/N[NUC5K@A(;J6)<)(RDI2>'A5I4&Z%.NYNI"#Y(U'4E1E4<
MXQLI.<L/AY3<DW*5"BY7=*'*54J[P[KKVSPG\!U/?]C_ !%^ZYK^STK55[EO
MXM3^>5^NI#"@ H * /G_ .,G_)1?V3O^S@/$?_K+'[2U 'T!0 4 % !0!\__
M  ;_ .2B_M8_]G >'/\ UEC]FF@#UWQAXAMO"/A'Q3XKO6V6?ACPYK?B&[8*
M6V6VBZ9=:E.VP EL16SG '.,5RXUXJ."Q;P-.57&QHU?J].$'.<ZRA+V4(4T
MI.<I3Y5&"C)R;22=['9E^'CB\?@<+)\L<3B*-)N]K*I4C!N[LE9/?H?#W@/X
MC_'JWT;P_P")-?U'XL>+_#>J:A\(+#7KZZ^!%SX<U_3M<^Q^)KGXEV_ASX>K
M\/\ 2_$T7@.]N[+PAIAUC5M.N/L\^OWU_:W]OIEJ6LO9Q4<+AL3[.E2=:BL7
MG$J$937M<1A*>5<N AB)1FJ."E+,Y3K86&(>'K<N&^K8V=55Z,ZWEQJ?7L)6
MQ5%O+<2J&&Q$Z*_?86BJV<8%_5\'4E"5?'5Z&4SQT<;6IJM0JP^K5L#3CBXX
MFE#I(_$_[2>LZ&WB:U/C+P_>:'\,?$?Q$/@J]\!^'OM'B#Q/XJ\6:]=>!/AS
MJ<EQH<LLTOA;PEH\-IJ>G:)>VNIW4FI69DOHI[B*:;DE"&&BI8FJITZ:R#!U
M:E#FK\M6IA6N(LRIX>%/ZQ7AAI8NC7P-.$%3GB,$Z'L:RCBL-5ZJL*DZ\/8Q
M@H?6\\Y:,*L:,JM#+JV"IY/0>)Q'MJ.%_MA4L2J^*JPG&G#%5JM"-*G3PTZ'
M.Z]8?%[7;O2_%/@GQ]\9-3N?"/P]O]1T'Q#XQ^$&E>&-?USQ=\2?&VB:79^%
M9O"6J_"718=*\-Z19>"[HZD;G07UFTTOQ*EPVK6HE2^DWPD(8;&TYUZ-.6'J
MXO(\ W[:G.I6P$L35Q>;XC%3IN/L5'"8C \KPWU*$L9@8TYTW6P]?#U>6O+$
M5LIJ1HS2Q$X9SC^1T_9_5<;EN5JAEM#"1JQE-QQ6(Q6/5)8BKC/;QE.,/;\^
M%JX>?Q-\0/CG)XV\336VK?%_PI8:#!\4[:XT;3_@3=^+/AQ96NC2V>@?#2_T
MS4-,^%NL^+?'OB?7)M>T[Q(\GAG4=1TVVMM.O;.YTWS=,O@_GTVXX"MB)2=6
M5;#X=<LE*CB*>.K9E1=3#8.G&A6]G2PN7X?&86KC\=A\7A9XC$8;,*,:F&DL
M/2]"OAW]8H4L/B**5"MAW.2CS0K8:>18O%5ZM=U,11A-T\UC2HQPN%KX3$RA
M3^IRE#$8FA7J10^,?VE+CQK\)= 2[\?:%X2D\)Z!XJUOQ!XF\#'7_$?BS54U
M+6=1\8^$O&L/@K]GD>&]# \/VFFV.G!M7^%.HQW&HQ3M;ZK.LVFP]<Y4Z-7.
M<3.CSQRO#3='!4FG]9BLMH.%15%5J0ECOK]6JIPP&/S&BZN$J4Z>7RP=?#XE
M^?3YZF#R^C"4UB,?B*\:F,J.,%AI/%SI8:,*,L-&K'!1IQA6JO'X'"5JF$Q-
M-2Q^$QF%Q2?KMI+\<-/^ 4FL7GB/Q'JGQA\;VOAMM.MY_!_AV1/AEJOC.^TC
M2DM8/#^D^&;5KG2_#,6I/?:A+KQOGW:;?2SS6]J!!;77PT</C,KRNGB(8B.&
MQ6%HXW,%*$5BJ.'E3J9E7BTWAJ4,12P^)C@HTHI\]>C2A.K5=)O:%6.*IYMC
M:%-X>B\+FE;+\/6A.G4C:&-JY5"K3J-U_K4N?!T:U)M:TTI4HS]O.IYK;^(_
MVB=-^+WBW0]:\5>*K7P#\/\ 0-4U#3=2E^%FN>,F^).E-X226/5KJW\"? 2V
MTR;Q7:^,K]VM=,\,^.H[Z:QT+[%+X1N9[G^U9..$N?*\TQ+O2QJA+"4*+4I^
MPK_6?883&I<E*I5E6H4HXG&^QI9A@4\;*2>5K#/#0T<5#&97A;3JT9.%>OB/
M:T:2JWE+$8G"VY:T*.&I492P6$6(J8'&QKX>G7G7S..(C&>!9^.?C'!HGA_6
M-1T[XKW^LV7@PW,_BSQ)\$U\0^)M,B\4_$_3_#WB76_#>D>$_@]X>ODN=*\'
M:.NIZ?X4O-$T[6KJTUVTGU?1[Z32IQ;=4J5-8BK1YOJE.JLKPSKTITZF+IQJ
M8/-\;6IU*OOX&L\3CZ64X#$8FE">7Y=.G#&8BA@XS?M<JCJP5*=)PQ_[[,ZJ
MPUJF&PKJT(910PE9*ORXBA3PN'QN<UX4:F(EBL?4I8K+\#F&*A.A7?*:-/\
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MOB'4JPQ2Q$EB/[-G3K--03XN+XDNHO%/B'XL>)/-T3]G3PAX@\*W'PNLM?\
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M*K[6E1JYEC,Y2Q.'Q%*O4:Q+RS+<"\6Z->=/VV)J4*:I82KBL)7X<2ZDJ/\
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M+S[0/&_[2/B&XUZ^L;SXJZ9J6IZ)X&TQM"\4_"'2-'\"^!/&WB_XBP:'KO\
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M\JM;$SE1DTZ="GI6?C_XP:;+=^%?!?@CQXUOX(O/BG?65EJWP_ET+PQ>>%/
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M;A\;CI3K82EAI1H8' 1DZF&Q;M0QU#%YAE^)G5PN=I=Q\7-&;7/%MMIOQ/\
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M:IHNJ6T]^OBNVTQM7CFG\)V^E6EU?S:I"LL/V>W9HC*[(CIQE#$XK"SA*%7
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M9T<-2J>W5>A#,J4(/VD)T$JE*.+@X\T'R4ZLKS3YZ=#%4JDN6CC*,JNA:?M
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M_9.2M4=5\JDYG3>&?'/@GQHVLQ^#O&/A;Q8_AS4Y=$\0IX9\0:3KK:#K-O\
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M'FN8YC%5;U82IYAB\/B98:2]R7-0IX:EA:-93451CRO#V48QT_A#\ (/A?\
M#G6_ D^NV^I7^L:3)X;'B[28?&UOKD/ARVT^ZT[P_8RWWQ!^)/C?49)])BOK
MUK=;?4[/3H&N76RTRRB)C.^;RGF^ KX.K+V$\7'$2Q$X).$\3B(QIU*_)*]:
M;=&EAZ,GBL3BJ]2G0A&>)<5",./*Z<,JQU'%THJM'"2PZH0J+WXT,/+VD:$W
M#DHJ,JTJM64<+AL)1YZU22H*<I2ESGAG]FBYLKCPM>^+?%GAW79O#E]\/X7T
MSP[\/!X1\+W7A;X5V7BY_ FA6F@3^+M::PO[7Q+XHBUNYU&2\O$FFTB&*UL[
M&,IY';]=E+$O&U%*6*E7Q^-E-3<8K'8_!4<ME4I1LY0PU# QQ%*C0E.I653$
M>TGBYQHPIF2PU-8"65:RP%&CA\/A85%"4Z=.EF&$S&O4Q%2,8?6<3BYX'#TJ
MTU&AAXP@Y4\+&I5Q$ZW:?%WX+WWQ5O9D;Q>FA:!J7PQ^(?PUUC3HM&U"YU5X
M?'G]AN=8T76[/Q3IR:/<6[Z%;QSQRZ??/<V\KQ0SV+DS-YJA)+'*ZE]8EE56
MDO?C[*ME>,K8I*I*G4IU9X7%1K>RQ-&C4PM9NE0J4\7!TW"7="O5HSR^="K.
M@\'6Q-6?+R>_[?"O#4JM/GIR5+&8%RJ5,'7J+$48>WQ$:F$JN<)TN0\$_LUO
MX4CT>^N/$^CW?BG1O"?CK1H==L]!\9W!N/$WC"#P]I5GXUO;GXA?%3QCXAU'
M4M)\,^&M/T:*.]\27,AM6EA@N;2V*6T>V8-8W"9IA87H/,L%0P2J)4W.A#VF
M*K9@Z?LZ=)2_M'$5<+B*KG>I[;!0J8BKBZD^>&&"YL)4RQ5>7$X3+L9'%.C)
M3YJBP\7#!4(U*DZJH4<+'$YERTJ5)4+XV+I4:"P[5>?4_P!G.ZCT$>&/"'BW
M1O#FB6GP;T+X3Z187W@R\U:*P?1=<AU6YU:4:=XST?[3I>L6D7V/4]*06\\^
MR&6+5+<QND^]?%5*^98S,M*=3$9KD^90A&_+2IY/B*^(IX-J]I4[UN7#S@J2
MPZ]HJE+%0G3IT<:>'BL%@\)B9SQ56CA,\PV)Q4I/ZSBJF=X;"4:V+]HW)TZ\
M*^&EBYRE[9UJE7XJ4HNI/%\1_LQ:UXIN/%L.I?$72K;1O$&K>*/%6G1:3X!E
ML?$ECXO\8>![_P"'^K:EK7B>3QK.?$&DV7A_5M2@TG3XK'2Y;*,VD5S>WZ64
M8//A52H4Z5"M3^MX6A.K2C1JM.$\OQ.=TLYQF&Q$>5JKB,5[.6"GB4H4%0J2
MG+ SJI2.I5\51J2Q&#JPPV+K4\'.M/V4:D'C,MP=+#Y?4I4Y-2HX2CB</AL?
M4POM)UZM>E.G''4L/7K4IVA\+/$NJ?$_6_%>E^%K;PCX=\%^$?#GA?P%X=\3
M7FD2:!XN\8>#)?%'_"(^-KC3_!VI7\VG^$-%L?$]W%9V=ZUK?SW$B3O8Z>^D
M64\^M'$5W#%XRM67US,,;.M"$X>TJ8!8BG2P>:8R4E)0JXS'8/#T:.'ITJZC
M#"1JT:V)IRS"O3PN,Z&&IT<KRZE14\)E]&2Q%2*C3EC*:>%Q6 P"K3C.I"E@
M\;2K5Z]2>%:ABYJKAHXFE[55_5/B=\._$7C>+P-J&@>*-!\/>*? GB(^(]/O
MM?\ !EQXR\-SWEQX?U?PY>2OX:B\6:+/%>Q6FM7DUA=+JY-I.$:1+J/S(I<.
M51Q=2K3;A0KX;$X*I'W76CAL35PU6<J%9Q]G1Q26%C1]M/#UZ4J%;$TI8=JK
M[K?M)8+ZM4G:M[3#U[P<H4*E;#\[A#$4%)SKX/VLUB/J_MJ<XXG#X2O#$1J8
M>+?F.F_LR+9"'0[OQ?::QX&2X^$]U<:%J7A61]:U%_A;<WFL)9ZAK4'B:/3)
M-'U+Q//#JS6,/AZ!()&O8=T\-S$MEM0J_5ZU"I3@HPP&-Q&*PE--N-"-3(Z&
M28:FY575J5*F!AAL/B:&(YX3]M1A)Q56]=K$1EB/KD^=T:^98:=#%SIMQ525
M?.\1F^+=.*?[JCC*.,QN6UZ+E4E/#5:=ZSC2E2JY6I?LG6M_XG\(^(I_%EO?
MPZ5>^/)/%N@ZOI_C@:#XJT[XA>.;_P =:Y8QZ-X6^*F@Z>&>\N[>U:/Q-9^,
M-/>+3+1_[-66(/48*=3!5J56,^94L!E.%2MK'%Y/1K+"XZDINI1IR^N5ZF-Y
M70GB*-3ECAL90ES5)O,$\PI58U6E5EB,3*$N5**P6(I8+!K!5%3]G6FJ679?
MAL%S0Q%*C7BZ\\5A:\:D:5/9U/\ 9?TS5/#W@KPW+XI>UL-&U[Q[KWCI+'P_
M9Q)\27^(,VHZOK>GZD)[V:32M/E\43Z5?SB.:YEN;?1QI\DHM[J4GFJ4%4I4
MJ3DW]5R&&38=O:E7I1R]4,QE%<O/5HU<%4Q<*2<%]=KQQ#JN5&U7>-:I3JUJ
ML)-NOG"S*;F^>?U50QV&CET)/2-..78N&6PK<C]E@Z*C1HTYNE.ABG]F'Q!8
M^'](TO2/'_A:\U2#P#JWA3Q'K/C3X=^(-<_M[Q#KOB'PMKFJ>,+:+PK\5_"M
MWH4XB\,6=I:6T.HS3V*Z?HS6U^BZ48K[OQ598BOCI4U/#8?%5LLK4HPFE6PU
M3+ZV:8J5>G64%'ZUBL9F<L;4JJC&FL3"<W0J1JJ%+EPE"GA882+O5>%CC*4H
MR4/85\/7PF#R_#4,10<)0K1P>7X*."4JCE.OAZV(]JW5KU:L]K2?V:[BS^*6
MA?$C7?',OC8V?ACPAI&OV7BFT\82W.L:[X'MY!H'B>RM-(^)&G^$+*\BU66;
M4P^J>"]>O8;JYG>SU&U\TX*%:.&Q&:U:5-4J>/Q%;%4(1?O82KB,)0P%?EE-
M3@H3P=&5!_5:6"JRA6J4ZE6>'4*$9Q-!8FG@83Y4\+!4:L;3=.KAZ>,Q..H4
MO>J/$2]CB,1!P>-Q6.A;#8>HZ?UI5,34V/&7P3\8>*]:^*U]!\1=(\/:5\0_
M 5WX*LM'TKP7K?[FYN;*VLX/$/C:>?XCM;^+=0L8DOK:V;1;'P=<&RU-[2[N
MKO[+9RVG-AT\-1E&,83K_P!IX+,%SQ;PR^IXBE5E2>'YE-RQE"A1PN,FL1&G
M5A2A-8>$TK=TJW[S"U*7/AYX7#UJ,:].26+@ZE*NJ;I57!T8T\-BJ\L=AX5L
M-B)T<1']U6A3K8J.(SX/@%XJ_P"$Y_X2F[^)&E#26\2Q^-[G0M*\ S:??7GB
MU/AG/\.X)+OQ#=^-K]Y?#6F2/%JNDZ2+-7LI!+%/>WS-#<6I5C">$Q^%AS1E
M6P^<8?!U9.,JF%EFV,CB7BZKC"'UG'4:$L1EWMXO#0J8"I1HJC2]@Y5N2C&=
M'ZG>490B\J6-IN-Z5;#Y4HRIX+!QJ.I+ 8.MBZ5#'U:?/BJOUQ8FHJW)C*U,
MY?PW^RE<Z5XP^''BO7O&FC^)X_!W@7P;X)U_0YM ^(6F:'KJ_#V\U/4?"&L:
M1H%M\:7T*PU"VU2_AU"5_$^C^-7%[9)=:?+ILCDCT(XU0QN:XN%+V7]H5?K,
M(PE_NN*GA,/A*GL/:1J4Z6&C3HU(X>%"E0QE*EB:U"KC\32=C.=/$U,-A*%7
M&U*T\,\7&I.5X_6J6,KSK8EXE494IU<3BH3C3QLYU)8+$2HT*D<OH^S4#T;Q
MS\$;[QWXK\1:CJ7BK3QX/\46/PNL-7\*S>&+RZU">T^&_C._\6W&EG7?^$LB
MLSH.NIJ-Q97=D^AN^UW9[B>)OLZ\>#DL+.G.K".(^KYG+,J*LH\M199'!X>,
MV^?G^IXZCALTPLE[/V=6%:FX2E6A7H;8EUJL/9T:JHPEE^)P%2$X*K#EQF(C
M]<K48IT_9UL5E[J8"K*;K6Y,'B*7LWAJE+%>?^*OV4(O$WB#PUXAG\86\SZ;
MXC^(U_XDT;4M-\<1>'/$WAKXD>(=.U35/#DNC^#/BKX9CE>+1M&TC1B=?;Q)
MI%U#:O)=:%*TB+ 9?*. JT)*+JT:>%H4IQ<KR>)I8C'8^6*I^T57#P]KF.85
M\7R5<-B*U"5/#+#8JC.E*K5O%3J58U?JU26 J/$T,32=%RA&$L-E^$RR@YRI
M.EB)5*6&PBC&=#$X:#6)QD)TITJT84_:]9^'VM7'Q)\->/- \0:%I=GI?AJ\
M\(:WH>K^$KG7+FXT.XO8M14^#]:L_%6E#P=JCW,$"7,\]AKD-S#9VD9M8VMD
MDK&,)-YQ&K5J2I9Q0H0FX2]G6A6PRQJHU56?/&5-/'5)U*,J7-*I&$H5J7O*
M4RA25'+H4J4:=7*ZE9T6TI4?8XE8*-:G*BE&3FH8&E"A4C6A&E&I64Z593BH
M>&6'[+?B2R\.6NDR?$S09M5\+6WAS2/A_J*?#.:WTNPT'P]X[T'Q_+'X^T9?
M'[3^/?$&M:SX=T\ZKJ=MJ?AV.<^;+;V5I+<3M/UTL0Z57#XB-.G"KSX+ZQ"$
M%##>RR_!9C@,+2P&'LW@5AJ69UJV&<ZN,C0Q-+#34)4**P[>+C3Q6)QM91="
M&)CG/(H27M85,\KX>MC'4J.+A6IRCAH8;V:HTI2PLZT)5?:SC6I["?LO?:=.
MUJ/Q!X[D\0Z]J_AKXK:$OB2[\,6UM?6%[\7O$W]J^)=:LX+35DC@NH_#MKHV
M@6RQ>4T=OI0<2[)W@&5!TL-&A2IT8_5Z4<BA4IO5UJ65XO$X[,83FU=+.\9B
MJF(Q22]G2JJG+V=?V<4J=;%K$_7:==4<3"OB\7348+ZO3Q;P.#P&45G0;?M/
M[&HX24**JSG.O#$58SJTYRE4GT,WP4O[3Q/?>*K[6;?Q-H6F?$:'XK:#X&T[
MPREIK5QJ6B_##_A M%\.3:_KGC<:5??9;BWLM1T^9['1H8+BWA6=\J;Q"&)J
M8:G"O4HO'8W"TLWA2G#V=.?/FN80Q?ME[22C]8HX6>-RV51UH1K83$4TE1]A
M..)Q6'<[8*GB88;+Z]/*<-.->$JJHX;+KU'1ISI1YH4*V/AALQFE0KUHU8XR
M'-6CBZ2PL/P6^%_BGPR=2\8:PEKH&M^)O%WB?5$\+ZU;V_B*^\&?#O7_ !%X
M@\5)X%L-2T#Q!%IEAXBF\2:V=4U#4;5]9M/DCTU/MT.GV5_%I%1PF%P>!]M#
M%NAAZ-+$UZ494U6EA*+PV6TJ4JD(U/JF6X6U"G&K1C.O4GB\3&.%EBYPC5:4
M<5C,7B_J_P!6B_9_5*;C3BZ56<<$LTQ5>%*555*^9U,-4J2<*\>5_5:U3GJ0
MQ%*O]+5@4% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M\'?^?;XU?^(O_M-__.AH /\ AK3X._\ /M\:O_$7_P!IO_YT- !_PUI\'?\
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MH /^&M/@[_S[?&K_ ,1?_:;_ /G0T '_  UI\'?^?;XU?^(O_M-__.AH /\
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M_66/V:: /H"@ H * "@ H * "@ H * "@ H * "@#YI_:T_Y([;?]EJ_9?\
M_6F_A#0!BT % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MK^TE_P FZ_'S_LBWQ3_]0;7: /T:H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@#Y_^,G_)1?V3O^S@/$?_ *RQ^TM0!] 4 % !0 4 ?/\
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M0C47O1BE%-))&OMJUY/VL[R==R?-*[>*<98IMWU>)E"#KMZUG&+J<SBK30>
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MTM0!] 4 % !0 4 ?/_P;_P"2B_M8_P#9P'AS_P!98_9IH ^@* "@ H * "@
MH * "@ H * "@ H * /F+]K][R+X)^9IVE7NNZA'\8OV97L-$TV73+?4=8O$
M_:6^$;6NE:?/K>HZ?IT-[=SA+>)[^_LK59)E-Q<01!Y4 /+O[:^,7_1K/QJ_
M\*K]F3_Z(>@ _MKXQ?\ 1K/QJ_\ "J_9D_\ HAZ #^VOC%_T:S\:O_"J_9D_
M^B'H /[:^,7_ $:S\:O_  JOV9/_ *(>@ _MKXQ?]&L_&K_PJOV9/_HAZ #^
MVOC%_P!&L_&K_P *K]F3_P"B'H /[:^,7_1K/QJ_\*K]F3_Z(>@ _MKXQ?\
M1K/QJ_\ "J_9D_\ HAZ #^VOC%_T:S\:O_"J_9D_^B'H /[:^,7_ $:S\:O_
M  JOV9/_ *(>@ _MKXQ?]&L_&K_PJOV9/_HAZ #^VOC%_P!&L_&K_P *K]F3
M_P"B'H /[:^,7_1K/QJ_\*K]F3_Z(>@ _MKXQ?\ 1K/QJ_\ "J_9D_\ HAZ
M#^VOC%_T:S\:O_"J_9D_^B'H /[:^,7_ $:S\:O_  JOV9/_ *(>@ _MKXQ?
M]&L_&K_PJOV9/_HAZ #^VOC%_P!&L_&K_P *K]F3_P"B'H /[:^,7_1K/QJ_
M\*K]F3_Z(>@ _MKXQ?\ 1K/QJ_\ "J_9D_\ HAZ #^VOC%_T:S\:O_"J_9D_
M^B'H /[:^,7_ $:S\:O_  JOV9/_ *(>@ _MKXQ?]&L_&K_PJOV9/_HAZ #^
MVOC%_P!&L_&K_P *K]F3_P"B'H /[:^,7_1K/QJ_\*K]F3_Z(>@ _MKXQ?\
M1K/QJ_\ "J_9D_\ HAZ #^VOC%_T:S\:O_"J_9D_^B'H /[:^,7_ $:S\:O_
M  JOV9/_ *(>@ _MKXQ?]&L_&K_PJOV9/_HAZ #^VOC%_P!&L_&K_P *K]F3
M_P"B'H /[:^,7_1K/QJ_\*K]F3_Z(>@ _MKXQ?\ 1K/QJ_\ "J_9D_\ HAZ
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MC]I;_L@'QD_]5UXCH ^@* "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H ^?_ (R?\E%_9._[. \1_P#K+'[2U 'T!0 4 % !0!\__!O_ )*+
M^UC_ -G >'/_ %EC]FF@#Z H * "@ H * "@ H * "@ H * "@ H ^?_ -I;
M_DG7AS_LX#]D[_UJ?X-T ?0% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M?XY_^A=H /\ A=O[17_1$/@M_P")'^.?_H7: #_A=O[17_1$/@M_XD?XY_\
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M_P#0G4 '_"1_M3_]$;^ '_B2WQ%_^A.H /\ A(_VI_\ HC?P _\ $EOB+_\
M0G4 '_"1_M3_ /1&_@!_XDM\1?\ Z$Z@ _X2/]J?_HC?P _\26^(O_T)U !_
MPD?[4_\ T1OX ?\ B2WQ%_\ H3J #_A(_P!J?_HC?P _\26^(O\ ]"=0 ?\
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M\#G=M\W+>[;O=EJ<U7IXI3DL315H5;OVL%91M"I\45RQC&R:5HI;)%"3X/\
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M/VI_^BN_ #_PQ7Q%_P#HA* #_A3'[4__ $5WX ?^&*^(O_T0E !_PIC]J?\
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M/_T5WX ?^&*^(O\ ]$)0 ?\ "F/VI_\ HKOP _\ #%?$7_Z(2@ _X4Q^U/\
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MBQH /^$<_:G_ .BR? #_ ,1I^(O_ -%C0 ?\(Y^U/_T63X ?^(T_$7_Z+&@
M_P"$<_:G_P"BR? #_P 1I^(O_P!%C0 ?\(Y^U/\ ]%D^ '_B-/Q%_P#HL: #
M_A'/VI_^BR? #_Q&GXB__18T '_".?M3_P#19/@!_P"(T_$7_P"BQH /^$<_
M:G_Z+)\ /_$:?B+_ /18T '_  CG[4__ $63X ?^(T_$7_Z+&@ _X1S]J?\
MZ+)\ /\ Q&GXB_\ T6- !_PCG[4__19/@!_XC3\1?_HL: .0^(7PF_:2^)/@
M'QQ\.==^-GP/M-$\?>#_ !+X*UBZTG]F[QY;ZK:Z5XIT6]T+4+C3)[S]J:ZM
MX=0CM+^9X7GMKB-9%0O%(H*, ?5] !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 ?/\ \9/^2B_LG?\ 9P'B/_UEC]I:@#Z H * "@ H ^?_
M (-_\E%_:Q_[. \.?^LL?LTT ?0%&WE8#YFUW]I*UTKQ/XH\-:7\/_%_B_\
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MC64,5+V5USQJ8;%PRZ%*K'>E+%9E-Y?AI37)/$TJ\;KV3OK#X]_!KR-0NO\
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M&S+G%TI5(5/<]DG*3DTH14:U/#3O-M0_=UZU*C57->C4J0A44'**<?AWXY^
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M3P<(1M1C]?5;#0>*IN[Q$<+E6(GE5&$9T7&AA\%44U+#Q@B$(0G*4W4JK%K
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M<8ITZ<,?3BH-0EA?J\/:8KG7:?#?XI:Y\>OB/\,[BP\<Z3)X=L-)USXJ>+/
M7AD6QG\'Q1F7PU\.O#/C358+][TZ]?2:OJ>JWFF7EO;)'<^%?+$""U+7-82A
M['Z[C*LX8JGA,%AJ<*T)7P_U_-8>UG'#3IN5#%4L#@*.)H3K.<W*>+P^+A&D
MJU*G0O&NK0OELU"ABJF98C#5(14JDIX/):Z6(Q*J24'0>(S*&7NA%17-@JV)
MPS=9TJM>?(1?&3QQJ?B_XC^-/ACXZ\/^*H[CQ1\0--N_A^ME;ZL?!7@3X1^"
M/%&CV?B/6KJ'6S)H=QJWQ+TF.:RBDM;47]OX@ *SI$)K3R98B6#X=Q&/TJ0G
MEV.SMU[\]*C5Q%3"TLKPL)P3C.I++J%*M7PKG%TG''R4(5J-1U?4CAL+5SVC
M@*K="I0Q&3Y1"G";<L5)UXXO-J]2G)15&&%IX_%X1UZ<9+ZQA,NA.M4CB:=%
M>Y6'QE\5-\"/&OQTUV.#1-#A^'Z:YX'L+G338ZC=2VGA]I3XDU6'49(OL<&M
M>(;A!8V$_E"&PM[2>X=9+V6*U]+/,+4PLJV7X6K'#YACLP6$PKK-1AA(XS%4
ML%EU+$2U?M8\\<3C*C47AW6>%=+GPDYUO(R.O3QGU#$XV:> P^#IUL?4I0G)
MU)T*,L5F=2A&"E.5'#TX3H8>-*$Y8BI1JUJ,ZU&MAFOG"T\??%?X>^7XX?Q]
M>?$2'0KK1/A>^DOHKZS/\0+?X9^$_$7Q'^,WBK3[RRU)TLKEYYM6T.UEM[-F
M-YX6TV.25X9O(IUZU'#^WJ4,,I8;%+-,9&%6JL//#8#+*7]A975Q-6NTH>WS
MM4,3B*KY8?5<TJ5ZKFH1JTKH4<7F'U'#^WP^#QSGE<).4+4'C^(\?@\QQ6%P
MJ]HY5\/@^'Y1J86"E-TUAL0J<H\E9U/H#X!_%WQ[X]N_$OB#Q7J_@V\\%:7X
M4T[5=1N/#=UHNI:=X<\3W'FZE=:)IGB'P[K.I6FJZ9:Z!LDN/MMPM_%(L$TD
M-O%?1PI.,5++,!F6*Q4Y3I8*I:C7<'3>(AAJ5?\ M";I7E!4HU8X985T:E9*
M4L5AZM>M5PSD8X:I6Q^+RZEA:2@\72J3J4.?GE1=>KAUEM-R<82]M.F\7]9]
MI"BI<F'JTJ%*G4:?B>K_ +0_QJM9M(M9=<\-:/>>./ R?$?PO87>@:)I5_:6
MGB;Q#J]E\._!6DZ;X@\3+>>-]?:P&G'76TN"XN8&-C#:V$$FI"<2\-C*53$9
M=RTZF;Y;]1P]:FYITZN8U\/[3&0G&DW6HY;@ZE&M3^MJ+C6O7KO$4*>!JTI]
M<ZF#<</F$*L?[&Q>(S*-.K"?-/\ L_+Y86$,9"=2$*<J^81Q-/$82E-05.#=
M#V6+G4IU865_:E^(/V'4O'%CKO@SQ99>%-;\>_\ "9?#/PGID=U>>'O!_P .
M?"&LV&LZ_KOB)=8N+O1SJ7Q.T2--)DN;&V233=81VAN%ADN(-(_5YQHU:%6+
MPF8T95</BJ]14\+AWF&:T<+D4:]:G&5-5/J6(I8K,H2E%T:5''-1ISPC]HJ%
M.:YL+C5*AF.$6 I3HX6$\36Q.*IX6AC,\]CAG"%5T\-3EB\)AH4XSE/'T<#2
M]M-YA"BNJT_XR?%K7?&MAX,\*>/O 7B?2_$JZ%=CXC:1X6BU/PSX<ET2P\2Z
MU\5M.T%+'Q/Y7B;3-,M8/!&F17,MX\EI?^,(Q<RW#1/:PQ)4:5''SK5:E"AE
M<<?BI5ITW"KBL#AZ&%P]*I&FX.E3E/,L9>C-.<*M' 9A2Y9SP[JSCG53#X*K
M1I.6,Q\L-0^JQO5HX7%8JK'$8:C5KQY).I++,)FM2O&2IR<HY=5A"A#&PB>M
M?LM>+;_Q;\/EUKQ!\2[/XA^(_%-Q-X\6.%]-@N-!\'^([Z_L?!5NVCZ=<2#1
MX+C2]!>5X<(BWRZI&@W0N!TU\/+#8; T94)4ZV&HTH8N;DJG^WXBC2S+$X?V
ML;PJ+"_7X4<.U*5\$L)--PG"3QYK9AF475CR?6:]*A3C)-.AE]:>6?68)*-H
MXJIA)5YI)J-:I4@Y2FIM_3-<9N% !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '
MS_\ &3_DHO[)W_9P'B/_ -98_:6H ^@* "@ H * /G_X-_\ )1?VL?\ LX#P
MY_ZRQ^S30!] $#&,<=,'ICTQ1;IT[ M-M+;$#VUM)Y/F6\#_ &9UDM]\4;?9
MY%4HKP[E/E.%) *X(!(Z4;/FVE9J_6SW5][/KWZA;3E^SIITTU6FVG3L*MO;
MI+),L$*S2[?-E6)%EDV+L7S) NY]J?*,DX''2BUDX[)WNNFMKZ>=E?O9=D';
MO&UO*U[6[6YI6]7W8D5K;6\:106\$$418QQQ0QQQQE]V\HB* A;<V< 9W'/6
MCRZ)<MO[NGN^FBTVT78-K]&WS/\ Q=_75Z[F#K?@_P .^(KSP[?:QIJ7DWA7
M5'UG1$:6>.VMM1?2-4T(3SV<,J0WRQZ;K.I1QQW4<T<;7'FHJRHCJX/V=65:
M*7M)4:M"[2E:G6E2E4Y5)-1G+V,(>TC:HJ;J4E)4ZM2,FY2]E*AS.-*<Z4Y1
M3<>9T*BK4U)JS<8UH4ZO)?E=2E2G).5.#70>1!\G[F+]TH2+]VG[M%*LJIQ\
MBAD0@# !1?047=V[ZO=]>N[^;^]]R4DDHI6C'9=%I;1=--/30:MM;HTKK;PJ
M\[I+,RQ1JTTD841R2L%S(ZA$ 9LD;1CH*2T22T46VEV;W:71OJ^H_P [<OR5
M[+T5WIMJP>UM9&C>2V@=X9?/B9X8V:*?&WSHV924EV\;Q@XXS0O=::]UQ32:
MTLGNO)/JNO4'LUT=KKTM:Z\K*W:RL/>**3'F11OMSMWHK;=PVMC<#C*\'':C
M;R:_1IK[FD_5)] Z6Z=ODU^3:]&QLEM;RE3+;PR%94F4R11N5FC7:DJEE.)5
M7@,.0. :+6\K7M\U9_>M'W6C#HUT=DUY)W2^3U79Z[CUBC0[DC16VJFY453L
M3.Q,@?=7)P.@R<4=_-W?KM?U#M_=T7DNWD1"TM5CFB6VMUBN&D>XC$,8CG:4
M8E:9 N)6<<,6!)[TK+E4;>['9=%K?1;+77UU&FU+F3M+37KHK+7?1:+LA1:V
MP:!A;0!K12EJPAC#6R,H1D@.W,*E%52$P, #H*J[NY7]Z2LWU:O>S?57U]2;
M))1M:,7=+HFM$TMDU=Z^8):VT>?+MX$W2&5MD4:YE9][2G:HS(7^8L><\YS2
M6EDM%'1+LM=%V^*7_@3[L;Z^>_X+\HQ7_;J[();:VGB>&:W@FA=MSQ2Q1R1.
MP8,&>-U*LVX Y(Z@'M1MR].5WCY-.Z:[-/6ZZAM?I=6?I:UGY6TMVT%-O;M(
MDS00M-&GEI*8D,B1[E?8CE=RIO1&V@@94'J!0M&[:-VO\KVOZ<TK=KONPZ)=
M([+HMKV739;=EV"2WMY7CDE@ADDAWB)Y(D=X@X <1LRDIN"J#@C.!GI0M'=:
M/:_DFFE\FD_5)[H.ENF]NE[-;>C:]&UU$%K;*TCBW@5Y6WRL(HPTC@(NZ1@N
M7;;%&,G)Q&O]T8%HDEHHNZ79WO?R=]?77<'^EODDTEZ)-JW9M=23RHPQ?RT#
MDDEMBAB2JH26QG)55'T4#H*+:6Z:JWD]6OF]6';RV^5[?==_>^YYG;?!_P "
MVOC:7Q_]AU2YUYKY]5MX;_Q%K]_H&F:O)I<&BR:MI'AF\U*32]+U$Z7!]G6>
MVM(VC6XNC%Y;7MRT[H2>%A*G2TYE5BI2]Z<85ZTZ]:$*DKSC"I5G.4DG\+]D
MFJ*5-%7]];GT7[KFC'W(U'AU&-%U8QLJGL^2G**DG%U*5&M)2K4:52'I;11,
MP=HHV=0 KLBEE"L' #$9 # 'CN >HI+3;3_AFOR;7HWW#RZ+I]W^2^Y=ACVM
MM(8S);P.8)3/"7BC8PSG<#-&64^7+AF^=<'YCSS0M&FM'%-)]4GNO)/JMF#V
M:Z.UUZ;77E96[6T%EMX)_+\Z&*;RF+Q>;&DGEN4:,O'O4[&\MW7(P<.1T)HV
M=]FDU?K9VNO1V5UY+L'2W2Z=O-.Z?JGJNS$DM;679YMM!)Y<JSIYD,;[)T&$
MF3<IVRJ  '&",<&A:--:.-[/JKWO;M>[OWN[A;1QZ.UUTTM:Z\K*W:R'>1"&
M9O)B#-N#MY:!F#!58,<9.51 <]0@]!1LK;+MT[[>KN&SOLU:S]-%]U].P@MK
M=91.((5F5619A$@E5&"!D$@7<%(BC! .#Y:_W1@VOTYM_.S;5^]FV_5ON'9=
M([+MTT[:::#5M+6-61+:W1&8NZ+#&JLYD:8LRA0"QE9GR>=S%NIS0M%%+11M
MRKM;16[66BML'?SO?YI)W]4DGY)#C;6^^&3[/#YEN'$#F*/? )!B00MMS$&
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M"/,I/V556J4I-W7/3E&:4IJ,ES-G4"&%8A;B*,0+&(E@"*(A$JA5C$>-H0*
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MN@?U^+?YMOU;)* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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ME%N";4:L*U"=TK5J%6*O%1E+H?\ A@C]DW_HE'_E]?$K_P";&J_LK ?\^/\
MR>I_\F3]?Q?_ #]_\EA_\B>8Z_\ LK?LBZ3KEYX;T+]GGQEX\U?1X+*[\1P>
M#_&/BKR?#EMJ$<LUDVI7OBCXJ:+;7-[+;PM,NFZ;-?ZAY312FT$<\+2\RP>7
M?O)0P=2>'H571JUX2E*%*K&-*I.GR*J\15E"E6IU)K#T:W*I*+_>-0>\L1C8
M4Z4I8FG&I7BYTJ+Y%4G!2G3536'LZ5.56G.E"I7J4H3G"HHR:I57#RCQ?X)_
MX)S>#GTR.?X>S:F^H^'Y_$3PVOQ,UO1;[3((KN338-,U/2?&?Q;T/4(]>GU6
M">S_ +/AM)YK5[:>74!9VL$MQ'E4IY-3KU:$:<:KI1P3C.&(BZ55X_EEAE3J
M.O&/*Z$HXJM7GR8;#8:=.IB*]+VM*,]82S!P<IUU2<*F*IS@Z4YRA]2?+B9/
MV-"K&7)-.G2IPE*MBZD9PP5+$RA-1]J\/?LI?L,>(I++3[7P9X>M_$=UH%IX
MEG\(O\8O$&H>)=,TF[MXKE+N]L] ^)NHPO:+',F;VTN;JS?(:&YDC97;NJY7
ME=&>.C:$HY;)PQ,U4K1CAY1NVJ_M'"5!JSNJT:<E9W6AQ0Q^-G'#RC-\N+?^
MSODIM5U=J,J+BFJBDES1Y+NVZ4DTL^T_9I_8 OKR\M[#0_!=[9:=:VT^HZS9
M_&_6+C3-.N+Z_LM.L-.OEA^*+7EK>W5QJ%D(3):+!(;J&-9S--'$^4<!EDO:
MOV48PI2I4U)U9<LZE1XI.G%QJ-J=)X.JIQJ*FY-25'VOL<3[#1XO'J=*FI2E
M.I2KU^54X\T*.'C1G.M).";I.%92]I34X4XPE*LZ2G1=73_X96_8#_L!?%?]
ME>!_^$6:_P#[*7Q)_P +F\5_V =3,WV<:<NL?\+!^R&_\_\ =?9Q-YF_Y=N[
MBG_9^5I85\D4L;;ZL_:S_?WOR^P]_P#>WL[>SYKV=M@EB\PA+$0DY1G@TW7B
MZ<4Z"5KNLG"])*ZOS\MKHW!^Q=^Q1_8A\2CP3H?_  CBQM,VOCXH>._[$6&.
M8VSRG5?^$Y^RB-;A6B+>;@.I4G<,4YY=EE.%*I.G&%.O['V<I59J-18CD^K\
MC<TI>W]I3]CRW]KSPY.;FC>(X_%R]IR5>;V/M>>T8/D]AS^WY[1]WV/LY^UO
M;V?)/GMRNV+8?LI_L#:I-I-OIFD>"=1GUZ]U#3M"@L/C+XLNYM:U#20#JEAI
M,5O\0';4;VS!!N(+<2/#G]XJTZ>6Y95=.-*G&HZE!XF"A5G)RPRDX/$149OF
MH*:<755Z:DG'FNK%SQ>/I*M*I*5..'J0HU7*G&*I5II.%*HW!*%2::<*<K2D
MFK)W.<\2_L]?\$]/"^D>+=6N]&\)7O\ P@T"R^)=+TKXP^*+S6=+DDN$L[:S
MN[ _$:-K.]N+QTMXHKIH"\KA =QQ6*PN3.%"K%TY4*^*H815E7;I0JUZBIKV
ME15.6,:2YZU9WO3H4JM1Q:IR-'6S.,ITY*I&I"C5K\CH^_*G1I^UDX05-SFY
M+EC!1B^:<Z<5K.-^M@_9%_84N=6TSP_;^&_"DVO:UIL6LZ/H<7Q<\92:QJND
M31>?#JFFZ8GCTW%]ISP_O%N8(WB9?F#$<UO_ &7ERKXG"^Q7UG!INO2]I4]I
M12?*W5I\_-32;2O-1LVEN<\<PQ;P^'Q?M7'#8I\M&JX05.I*W,X4Y\O).26K
MC%MI>1EV?[+7[!^IZ^?#FC>%/"^M7]M9:G?ZLND_&;7KR308=+%FTHU?34^)
MPU* .EX&$L5C-#$('-S+!YD/GXTL'E%:G5KTU3EAJ-*-65>-=RH\LG!+WXU9
M<ONU(5%.:C3<)1M-RE&+WG7S&ERQG*4*TZL:,:,J7+4DVL0KQ3IJ+49X6K2<
M%+VKJ*2C3E&E7E2K)^S'^P9>V.F:GX<\'Z+XST[4O%6E>#A>^#?BIXO\16EA
MK.K,5MX]1N;'XAM%:QQJ \J[FE564K$V:I8#+74P,%0O#,/K7L:JJ3]BUA,'
MBL;5;J>TLTJ6$JP3CS?O7",N6+E..5;&XW#QQ7M9N%3!?5U5I.$55B\3C*&"
MIKV;BFOWV(BY<W+[D:CCS2BH2Z7P]^QS^P]XN_M'_A$_"7AOQ/\ V/>/I^K?
M\(]\5O&VM?V7?QY#V.H_V;X[F^Q7B[6S#-L<8.5XK2GEF75:-/$4J*J4*M^2
MI"I4E3G:U^6<9N,K75[-VNNX5,;C:-1T:LW2K15W3E",9I7:NXN*DE=-;;IK
M='02_L%_LGQ12.GPCDG:.-W6"+QW\15EF95)6*,S>-8XQ(Q 4&21%R1N91DB
M:F68&G3G..$E5E"+:A"I)2FTKJ,7.K""E+9<\XQN_>E%7:(8[%.48O$*FFTG
M*4(\L4W9R:C"4K+=\L92MLF]#PVQ_9U_9;N=5U[2KO\ 9#^*FCMX5M+>_P#$
MMYJ'Q'TB6ST6RNK"[U&UGF&D_M%WMQ>B6VLIL)86]VZMM#JF<UQ5*>5T,'C\
M=5P-6&&RUXF-:7/=JKAL)1QDZ,8QKN4IRHXC#JG)+V3G6BIU8*%65/>-?&SQ
M.%P=+%0J8C%_5Y4X*-OW>(Q57"0JN4J48J$*M"NYQYO:J%*3A3FY4HU.ITC]
MF;]A#Q!H]IJ_A[P1HNM>;>>%M/O]+L/B_KIU30+SQ;<6-OIUGKT%Q\48HK#4
M$:^CW6(FDNYFC:*R@N[AHH9?4>3Y?]8^KTH0KI5\3AO:T:M2I2]KA:5:M5C%
MQDY3:C1E[L(2G!-5*L:=&-6K3XZ69XNIAUB'*="^%IXQ4JM.,*JHU5%PE*/*
MXP3YU[\Y1I732J-N*?4Z/^QU^P[XAU+5]&\/^$_#>N:OX>E6#7M*T?XK^-M3
MU+0YV9T6'5[&R\=R3:;*7CD4)<)&2488R#C&CEN65Z7MZ%.-:@ING[2G5G.G
MSQWASQFX\\>L;W75&U3&8ZA4C2JS=&K*//&$Z<82<-+24913<?>C[R5M5KJA
M(?V._P!ARX\177@^W\)^&I_%MC:_;KSPM#\5_&TGB*SLL(1>76B)X[-Y;VN)
M(SYKPJG[Q>?F&53R_*ZL:\J4(U(X1\M9PJSDJ,ND:KC-JF]'I.ST">,QU+V/
MM)2I^W_A<U.,?:;_ ,.\%S_"_AOL^S*MA^R3^P?JEEKNIZ9H'A#4=-\+RSP>
M)=0L/B_XPN[+P[-:JS7,.NW=OX^>+2)851S(MTT10*2P !J7@LIAAHXV2IQP
M<M(UW6DJ+LTG:JZG([.45I+=I=47]8S+ZPL):I]:E:U'V2]J[W2M3Y.=WLTK
M1UL^QPVL? ?_ ()\Z3>Z-IT'A;P]K=SXA\*^(O&&@MI/QCUD6.K:5X:>!+L6
MFKZK\5+'3_.G+WA@>2ZCMV71M3>2>)+&5ENCEN75\3/"TJ"E6I1P524?:3YE
M2Q]>.'H5%!5'4G!N49OV<)2E"5-48U:M6C2J7&MF#PRQ?M5&A]8GA;\B=JU.
MC4JU$U&G*RI\D*51_P#+NK7H1FHJIS+T'_ACW]AQ?$ \(MX3\-)XL-C_ &G_
M ,(LWQ8\:#Q$-.QN-]_8H\>F[^Q@ _OQ$8^#\V*2R_*W]9Y8PDL'=UVJL[44
MM6ZOO_NDEK[_ "V6Y@L;C_98>JW*$,5;V3=.%JC>T8247&;Z>Y*5[.S9#H'[
M(W["7BN[N-/\+>'?"7B6_M+2UO[JRT#XN^,M9N[:PO5#V5[<6VG>/II(;2="
M#%,ZA) 048BJAEF75(U)4J*G"C)0FXU*C4)N*G&$FIM1DX-2479N+4DK:E5L
M7F&&G&G7<J$Y.:C&I3C"3=*<J=1)2@FW3J1E3FE\$XRC*TDT.NOV0_V%;#Q'
M;>#K[PWX4LO%UY#]HL_"UU\7/&=MXCNK?9+()[;0YO'JWL\/EP3-O2%EVPN<
MX4XSC@,JDZ\81A*6$A*I62K2;HPBDY3JI5+TX133E*=DDU=ZCEBLPITZ56;G
M"E6ER4YNG%0G.ZBH0DX)2ES-1Y8MN[2M=E#3_P!EC]@'58]6FTK3/ NI0Z#8
MV^IZY+I_QH\57D>BZ;=QB:TU#5GMOB"ZZ=8S0LKQSW!CC=2&5B#FK66Y;R.H
MJ2]G&M'#N7M)\JKSDH0H7Y[*M*<HQC3^-RDHJ+;2"KBLQP\W2K.="I&-63A.
ME&$E&A?VTG&4$U&CROVKM:G9\UK,H2_LP_L).FBRZ)X'TSQ9;:UXJE\&I=^$
M_BCXNUJST[7;?1]7UN>VU>[A^(JQ6'E6NC7*.K.TB22Q!XU1F>/&6#RM1I5(
MT.>E7P^*Q-.K&JU2G3P=*56KRU9UHT]5%QC)S5-2_B3IQ3DM*5?'5/K:5=0G
M@?JWM:;@O:1^M8O#8.DO9QIRG?VF)IS<;*3IJ;@IR482T;3]D_\ 86F'A."\
M\'^'-'U?QOIUKJ?AKP]J7QA\1G6=7AN;>.Y":3#IWQ*NX-=,:2J&FTFXO[=O
MO1321LKMUSRC+X8NM@8TXU,3A^9SIQG652,(WO-TIN%6$59N\Z<6DG=*S.?Z
M]CE1>(<I1H1G*G[1PA[/GC+DY>=1<5)NWNMJ2NE**E>*T],_8Z_8=UK6=6\.
M:-X3\-:MXAT H-<T'3/BOXVO]9T4N0$&K:7:^.WN=-+$@#[1%'G/%94LMRVO
M3E5H4HUJ4)<DITZLYPC-73@Y1FTI+E:Y6[Z/31E5,9CJ,H0JS=*4US0C.G&+
ME&R?-%.*;5I1=UI9I[-"WO['/[#VF:]IWA;4?"7AO3_$^KQO+I/AR]^*WC:T
MU[4XH@6DDT[2)_':7=[&BJQ9H8G "G/2E'+\KG4JT84XRJX>'M*L(U9N=*G_
M ,_*D5.\(?WI)1\PEC,=3IQJSFX492Y8SE3BH.6BY5)Q47*[2LG?5'-WO[,G
M[ ]MIOB2_P!/\,>'/$<_A7PYJ?BK5-$\,_%KQ;J^NC1]*AN9;BXBTV#XB!@K
M/:3PH\S0Q&5"C2*02,)8;*(X>IBJ5)8BC1]ASRHU95%%8E0E0;:J<J56$XU*
M;;7/3:G#F35^G#SS'$8["9=[54,1C*SP]-5H*"]I&K["HFO9N7[FK>%51C*5
M.2<9+F5CI[/]C/\ 8IO=-M=6B\!Z4EC=7MMI22R_$SQVJ)K-U/'9Q:'+(OCI
MHUUG[=+':_8PYE\]A$%+D ]LLHP$:L:,:4:DISJPIN%2I)570]K[7V34O?5-
M4*TI\J]V-*HY)>SG;AAF6+E2]LYRI1C3I59J<(1=*%>%*I2=1<MH*<*U&46W
M:2J4W%M3BW0U']D/]B71-4U'3->\ :1X?73;;19WO]9^+/B;3[6:377U=+*T
M2WF^)0O[>X(T6\96N[*VAG"L+26Y:VNEM>>6!RFG3E4JJ%!1K5:*4ZTHW='#
M4\74:?M.5*G0J.I.$I1JPIPE6G3C0E2JU-_K68?NE"4I^TASKEIKW4Z\,-%.
M\%?GK5(4XN'/!U)PI.2JR4':B_8Z_8AN?"]QXUL/!6C:IX2M=.O=7D\1:/\
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M_/C_ ,GJ?_)A]?Q?_/W_ ,EA_P#(A_PP1^R;_P!$H_\ +Z^)7_S8T?V5@/\
MGQ_Y/4_^3#Z_B_\ G[_Y+#_Y$/\ A@C]DW_HE'_E]?$K_P";&C^RL!_SX_\
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M,#1]LU*4/K.+JTXJK[.K6H4Z=+#RE6NZG)Q99B\-2P&$PS48O"8?!06(2?\
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MCG.BJD:4JS<\-2IRISC#V=-U:D74:45R.O?#'XM^.]+TRQE\):EX('AGX<>
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MCQ]Q\!OB7IJ3!H?%MW8>+/ USX2O/#GP_P!3^#L=CX:BU+QCXS\2/X?UR_\
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MHC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\
M)/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[<
M/^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^
M%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_
M /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\
M0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_
M ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_
M?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_
M *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH
M_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO
M^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?
M_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J_
M_<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#
M^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J
M(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R
M3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\
M[</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9
M?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M
M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A
M? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A?
M#_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W
M\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_
M^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6
MC^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_
M *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_
M ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_
M -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_
MLG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^
MHC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\
M)/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[<
M/^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^
M%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_
M /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\
M0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_
M ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_
M?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_
M *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH
M_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO
M^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?
M_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J_
M_<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#
M^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J
M(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R
M3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\
M[</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9
M?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M
M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A
M? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A?
M#_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W
M\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_
M^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6
MC^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_
M *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_
M ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_
M -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_
MLG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^
MHC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\
M)/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[<
M/^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^
M%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_
M /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\
M0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_
M ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_
M?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_
M *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH
M_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO
M^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?
M_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J_
M_<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#
M^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J
M(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R
M3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\
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MDKJ\79KL+?:A!IRVSSQWKBZO;33XA8Z9J6ILD][*L$,ERFFVD[6=DKL#+>7
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M\!6K8?$^SPF88J,\/3A?#UO0I2I0Q%.M'#4L.L-F$:^$A&+JT,)AL'DU;)<
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MDN6G1A&$%VC!*,5\DDB6I- H * "@ H ^?\ XR?\E%_9._[. \1_^LL?M+4
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M6;5&A*C3:K2C6J0;H-5XJ5'WSEM-_:H^&DNG:CK>O#Q-X8T9?%6I^'M#;4_
MGQ'7Q!>:;H<&B6^N>*_$_@^7P3%K/P[\-6'B35;C2I]2\0VEI8PFU@FN+R$7
MT<2[4*+Q']FTZ,HSQ.8Z*G&<)4Z4ZF8XS+\%2JXF,WAZ=;'3P<I8:A5G3JSF
MY8>$)UJ-6,<:M:G2^ORES0HY;252K*I'V<ZG+@Z&88B6%H-NOBJ.%PF*PU2M
M6HTWR\\Y."PZI5Z_I^@?%CP/XHA\97/AZ]UG5+3P#=ZOI_B.\MO!_C(6*ZCX
M?O=6TW6M,T.^ET!+?Q;J5E?:)?PS6FA2:E,C"WRF+VU-QRXBI'"Y:LUJIQP4
MJ<JL';]Y.E&G"I[6-!VK.C*,UR5G!492C5A&HY4:RI]2H5'CX999?7)+#OEY
MH^SC]9ITJU"-2O?V%*<J5>E4=.I4C4A"<93C%'D6A?M:_#?6]2\&V[Z?XST#
M3?&GAGP_KME<>)? WC?2]8TRY\7>*I/"7A*SU_05\,SMH.DZGJ5I>+%XAU&Z
MM=*=VT](+J==4MY&[8X2M]:QF!FE#$X7ZHHQYH<KJ5L+C<7B</5J.488;%82
MCA:=\-5:K5YUJD*4'+#R4^:I)PHTL52C[?!2_M-RK04FW2RV67?[3AZ2BZV)
MPM6ECWB)UZ<$L'0H3GBE3M66']=\(_%KP#XZU_7/#'A?6+N_U;P];07UYYWA
MWQ-I6F7VGW%U=6":GX:U[5]'M=+\8Z4M_975K)?:#>:E;PSPM#+*DN%/-27M
M\+]<I-.@G33NU&I%5J;JX>I*C)JM"CB:495,+7E35'$TXSG0G4C&3557]7Q"
MPM3W:S]LDE[T>?#2I0Q-+VD;T_;8:=:E3Q-#G]M0G4C"K"$G8Y&+]I3X+RQ>
M()U\6W26OAFROM0U*]G\(^-K;3YK32_$P\&ZH^A:A<>'$MO%$EEXH:'3KF'1
M9;^6WEN[7SD1+N!I5%\^&H8J$92HXF>60HI0DZE1YQ3]IECA02]LX8R*DJ55
M4_9\]*M3E.-2A6A!.<(5ZN&<E&K0CF4JBNK0_L=O^THRG\$9X56G.FY>TE3E
M"K2C.G4A*5NT_:%^$UWK,.@?V_JUCJ,MC+>R?VSX'\>Z!I^GS6^A2^*+C0=9
MUG6_#%II^@^,H?#<$VJ2>&-1NK76H[.-KE[!81OJIKV='&8B3BJ& IU*U2:E
M%Q=*A4C1KSH.+:Q4</7G&AB'A?;?5Z]Z-;DJQE!:JG.4Z5*$?:5*M:%!1IVJ
M2C4JR4*#JJ',Z-/%2<?J=>MR4<9&I2GA:E6-6FY4+K]I?X/Z?9Z3?:EK/BG2
MXM9L+S5[&#5?A=\5-+U%=!T[5=.T:]\2ZAI-_P""H;[1_"T-[JNGEM;O[>VT
M\07'VO[3]D1YDUIX>M5Q,,'"'^TRG@Z;IR:@Z57,*F*HX.CB.=Q6&KXBM@Z]
M&%'$.G5]LJ=&4%4Q&'C5YJN(H4*52M.K%T:<,7452#]I"K2P-+#U\55PTJ?-
M'%4J-#%4:KJ89U82INI.$I1H5W3T;W]H7X0:?K6MZ!>>+)(+_0;2_N[J0^&_
M%;:3?MI6LZ?X<U/3/#7B"/0FTOQCX@L_$.K:7I5QHN@WFI:C#?:A;VDEJMQ*
ML;84[U:-2O2IU*D*<J,5&-*I*M46(59T*E"@HNOB*-18>LXU\/3J46J4_P!Y
MH=<J-2%2G2E'EYX2J.;:5&E&.'^MOZQ7;]CA9?5/]J4,14I3EAD\1&+HIS6;
M8_M(?#B]\07WA^2R^).CG3?#WAKQ%=:OXF^$/Q/\*:-#'XLUY_#FAZ1-<>(_
M"=E-9^(;C4Q$J:?=6\$LBS,81*;2\6SUI4I5E-PY5RXO#X&"<XWJXG$T:5>,
M*5FU-4J=>B\4TTL*JL98CV<%*4<)3C"%.>LN:ACL5.*A/GHX;+U6=6M5@XJ4
M:=18;%O#R2E[=8:7)?V^$^L]9-\8O $/B6T\'Q:AK6H^(;O7+_P\MAH?@OQM
MX@2TO]*&E_VG<:M?:'X=N[31-"M)=9TV"?6]0GM=,BN+D6[W:SH\:1AE];47
MA[2A*G5J^T;4*48T:^-PK52K/EITJM2OEV.IX:C4E&MBWAJCPM.M'E;BO6IX
M5SA5;C4IU*5)TXQE.K*56AA,3%TZ4%*I5IPH8_!U*]6G&=+"QQ%/ZS.DVTG^
M)?B_\/O"/BG1O!FNZS>0>(-<GT^VM+>Q\-^*-:L;*YUB::UT.W\0:YHFC7>F
M>%)M6N[>XM].36KS3VU":"2&R$\J,@FF_:NM&DG)X>->4K1E9O#85XW$4J3M
M:MB:6#7UJ>%HNIB5AW&K[+DE&3UJ\M"DJM6<*<'*BK2G!3C'$8A82C5E3YO:
M0PTL2U0^M3C'#1JWA.K&2:7,ZC^T?\'=,T1_$,OB?4+S3(X+6X?^PO!?CKQ)
MJ*QW&F1ZU.#HGA[PU>ZCYVFZ1/;WNK1?9/,T:"Z@EU9;))XR]2Y:<X1G4IQC
M4E44:KJ4_J_LZ4J5.IBGB>;ZNL#&K6IT/[0=58%XARP\<0Z].I3C483<YTHP
ME[:E.-*5+EE[7V\YUJ<,*J5O:2QDGAZTXX.,7BI4:;Q"I.A:HZ>I_M/?!'2=
M3N='G\6W]UJ%K<W%@8-%\$^/?$*76K6WA[3O%C:!I=SH'A>\@UCQ+)X9U2UU
M2#1K"2YO[FU2ZFM[:5+&Z-NY0G3C5G.+IQP\<1.;DG'EA@\;4R[&5-;7I8+%
MTI4\955Z>$@Z=?$2IX>K2JSRHU(5U2]C)35;ZMR-;?[9AHXO!\S=E#ZY1E%8
M13Y?K.(?U2ASXM.BM8_M!_"0:QH>A1>)[JYU#Q#:>$;[338^%?&-_IR6OCV&
M[F\%RZIK-CX?ET_0/[9^Q3PV:ZI=6;37!BM5'VFXABETGAZU.OC,+*E)5\OJ
MXW#UH)7:Q&7X2GCL70IN-U6KTL'4CB%1H.I4JTHU948U/85O9XQQ>&E0P^)5
M:*HXFEA:].3O']QC,7/ X>M*,DI4Z4L73="<ZBA&A-P]NZ:J4W+F]!_:;^'F
MOZ7#XB U_P ,^'EM_$]U>OX\\(>._!WB%K;0?$6D^%M,N] \.ZCX18^(;;6]
M8UBRAL(X;N&\N9+J&UM;.YOH[VUTW)1?LJ5=6K0KX;+Z].%"]?$\^9K$3PE"
M6&I*55RG2P6-J<U%5DXT(5H*>#Q%#%SZ798JM@5_O&&KXVE.4O<PWLLKIQEF
M.(6*D_9*&#J5L-3K.HZ=.'M*WM*M.IAW1J:NH?M*?!S2M#TS7[_Q%K5M:ZM#
MXEN+73F^'_Q%;Q1!%X,N["S\6_VKX,C\)MK^A2:-)J5G)?1ZEIEH]K;M)=3*
MEM!-+$XQYJM*E"<)>VA1JQG&I3E1C2KUGAZ=2IB%)T*,%B(RP]6=6I"-"O&5
M&NZ=2+BKITZE6G5J0I5/W%>.%<'"<*TL14P]3%T:-*A)*M7J8C#4I5L-&C3J
M/$PE2>']I[>C[3N?%OQ,\&>!T\,MX@U*]1_&6H_V5X7M='\/>(_$]_K-\NFW
M6L/'::;X8TG4+KRH]+LKJZDG>%(8XX6:211C*Y7'$RP<ER5Z<)U:BE[D*-*E
M7P^&JUJU65J5&C1K8JA&K5JSA3I1FZDY1I4ZDX<SKTHX...YN;#3<(TY14IR
MJSJ4:V(I4Z5**=6M5JTL/5=*E3A*I5E%4X1E4G"$N!3]HCP#K,W]G^"+FX\4
M:NGB/P5H[V=QI?B3PQ97.C^,=3NX$\7Z!K.N>'H[3Q;X9AT?1O$NH1:GH;ZA
M879T":W2\C9C)&1LE1JU^;"X64L="K4J0E">'E@,KKYI)5L/-1KT_:TJ=&%)
MU(053ZQ"=)U$FGT5XSPOUF%2E4=;#Q@HPA#GC4K5,=ALM5*-5-47*AC,51IX
MZ,)SK8*+;JT'4Y*52;3/VB/AI.WA2TU37HK&_P#&%G%J6ES6&C^-M1\,6MAJ
M-A>:[X?_ .$@\7W?@[3].\(:GJ?AJU_M&#3?$+:3<R@3):I=)$)I742H2Q-*
MM*-"ME])RQ4:DH0A3K4,-3Q..H4:DY1CBIX.$W4J0I?[3'"J.)Q&%PRE*$%*
M%6G-PE!2;Q4\/25)^WE*#S">6X6M*-)2Y(8G$QC0A53GA)8ISH8;%XI056=W
MP#\;_#'Q)\2^+=(\,6>N#0/!^A:!JU[XLU_P]XH\(V&H3:_<Z^L$>AV_BSP_
MIIUS1$T[0OMJZ_82W.G7$=_#]FFE"R.A*#HX'$8_%..$H8?$3PSC5?)5A.AA
MJ.*Q3Q-&:C4PGL:>*PMHUHJI/GJ2E"G"G"5:.>E/$X7!X:HL7B:]*5:4:-ZD
M(TI58T,'.E6IJ='$K%U:>-A'V-23IRP<E*[J+EJVG[2/P:O=*U;6HO%=W#IF
MCWWAJPFN+[PAXVTQM1/C+4WT;PCJ/AJWU+PY!-XN\/ZUJD4MMI^M:''J.G7;
MP2^1=2")RM.C6A&@W0JQG7J5Z,*/LY_657PV%ECJU"IA>7ZS1KQPD'6C1JTH
M5*D>7V<9RG%.GRQYW[2#I0I*LZ\:D)85TO:TZ$JD,5&3PTXT:M6E#$.%67U9
MSB\1[-.YJ:Q\;_ ^E?"F^^,5M%XNU[PG8Q3D6&@^!_%EUXRN+ZVU=_#\NBKX
M)N=(M]:L=9CUR-[&:UU&SLC:RQR&\-O'%(Z36B\/6P%&K_S,9X*%"=/]_3<<
M>J<L/5YZ'M%*G*G5A-<G/.=U2I0J8B=.C-T$JZQ?+)45@(8J=?VW[ATU@X3G
M735;D:<8TY2B[<LH6J)^R]\FT#XW?#CQ-XHM?!NDZKK'_"07=M)-#;ZAX,\;
M:+IXO+>PCU.^\.RZ_K'AVUTF#QI8Z?*+B]\,27RZS91I(UW8PB*0I<*,I_6O
M92A5C@W4YI0J4Y0G"CB%A*M?#24FL7AJ6*<<-4Q6%=;#TZ\HT9U8U)*+YWB*
M<(X7VJG0EB_9*%.I"4*D)UJ$\52I5X-7PU:KAJ<Z]*E7]G.K1C[6G&=-QD\!
M?VA? 5O\3O$WPQUBZET>\\/W-CIL&N7%EK<WAZ\UIO!\WCO5](O_ !#!HK:'
MX;U"R\+""^CM=2UB&ZO(EO9(+;R[!W?"A*-7!XS&.]"G@ZF,<G47)">$P2P5
M.MBJ52?+&MR8O$U<-6HT54J4/J_M:EHU+4^NK0Q-'$86C["56.+P^#JP=-.I
M.%3&8S&X.C2K4H1E*A"<L+1]CB*W)2KU<73P]-^UY54ZOPK\7_ ?C72O%.L>
M&[[6[NU\&/(FO6]WX+\:Z-J\2KIJ:Q;W.FZ#K?AZTU+7]/O=,DCN+"\TJTO;
M?4$=38RW&:6+G]2P,\?7C*-"DJRG%*]:E4PZBZU&O07[[#UZ2G"52AB*=*K"
M%2%2<(TYQDXPZ6*Q=/!4)1G6JJC*F^:*HU*=>I5HTJU+$-K#U:$ZM&M!5Z=6
M5+FI37.N5V\3^'G[4-QX]T&R\1+X(MM'M=:UOP;:Z%I=_JWCC2=?7PYXRUK4
MHK/Q%XBLO%_PHT"UTIH?"6AZWX@-OIM_KD$D-C&([XVM[;7\W5.A]4>'AF%2
M&$F_K4,4U.%2G@Z^"RBKG&)H5I.5.I&5*C+ T9.I1HI5\7.#L\/:KE.K#V^.
MI855,7#"QIRHN%.2J8F.)S"CE."JPIZPC1Q&82Q$9/VLJU'#X?VLL/+$2J8.
MAW\7[3'P:GL=3OK;Q%KEU_9E_I^G+IMI\//B1=>(=<DU:TO=0TF\\&^%[?PB
M^L>/-%O=.TS4KNVU;PW8ZK83VVG75Q%<M#;RNG/5YZ%%5JE*I%*6(A.#IS56
MA+"QP\\0L71:57!>PAB\+*K+%PH1IQQ%&4VHU(MZPY)UG1A6HR<:-&O&<:U)
MT:E*O*M3HNAB%-T,1*K4P]:E"G0J5*LJM.5)0]HN4Z3PE\6M \0> O OC[5E
M?PQIWQ#6&;PY;WZ:@\C6NH6FI:QHDFH-)IEN^DS77AW3_MTJ7L-NEL\AMFE>
M14:;3&P_LZHL/C'&AB:>&]MB*?-&<:%6C@UB\=156G*5.JL'RUX>TA+]_&BZ
MD(+FY$J,:M9XSEI2Y<)C*N%6DU.:69_V9A:GLIPA5A/$UIX=^Q<'.BZW+-N-
M.=0Q7_: ^'5Y:Z!=>&M;BU\:_%I.I6<<&D^-&EGT+4=+\3:^US90:5X0U*>X
MUK^P/!OB2\@TF:*TEG-C%$\ENU]:M/G6;PT,16K0E'#X&C6KXF48\U2G3I8/
M#XJ+C3]U3=\=EL:T7.$J%+&1J-3JQCAZMPISK7IX:5&I7=:%&$95Z<(.7]IT
M\KJ-U+RM!5OK"P]11E2Q,\+6Y:D,+1Q>+PO%:%^UK\-]<U/P;;MI_C/0--\:
M>&O#^NV5QXE\#>-]+UC3+GQ=XJD\)>$K/7]!3PS.V@Z3JFI6EXD7B'4;JUTI
MW;3T@NIUU2WD;KA@Z[Q>+P+BHXK#?5(QBI1Y95:V%QN+Q&&JS<HQPV+PE+"T
M_P#9:K5:O.M.%&#EAY*>-23A1I8JDO;X*7]IN5:"D[TLMEEU\3AZ2BZN)PM6
MECWB)UZ<$L'0H3GBE3M66']:\;_%WX?_  ZO],TSQ9K-W97NJ(L\<&G>'?$W
MB,:;IINH[(Z]XDE\-:-?Q^$O#"7DL<$FN:V^GZ;'(P22Z5N*YL.OK6*6"H6E
M7;HPLVH053$2E3PM&56?+2C7Q52$Z>$H2FJV*J0E##PJ2BTG7E'"X:6+K/DH
M0C6DWO)PPU-5L3.%.-ZDZ>&I2C4Q%2$)0H0G"564%.%[FB?$[P5XBU'QAIND
MZI=S/X"N;BS\5ZC<Z#XBT[P[IE[9&;[?9)XJU+2;?1M2O;-8&>Z@L;^YDMHW
MBDG6..>)I,O:TE@/[3=2-/ IUDJLVJ=UAZM6C6G&$^6I*E"K0JTW6C!TG.#2
MFVU?;V4_K,,%&//BIJGRTX6J2_?4<-7HJ7)S*#K4<50G2C)Q=12FH*3HUE3\
MJL?VI?AM?:IXEBBC\5IX>\.6'AMX-;E\ _$>/4_%FM>)7\3SVFD> O!K>"QK
M?CVV71/"]WJJZIX>M=3M)[5VFMWEAMKB6'62E1PM7%5XNA&&(J8=4W&;KP>'
MP^'Q.,JXN@H*K@:6&AC<'S3Q,8)>VE*K[&$:<JT1Y*E6%##588B<:$L36<))
MT:5&IB*>$P,X8A-X?$/'8E8NA1A0JRG[;"^RC&=2M&,=JQ^/7AW6M5T^+P\M
MCJ/AW68_!+^'O$DMUKT*:Z_BCP[XE\;ZI:66EV/A2^N+6\TOP+H$&K*M^UG'
M</J:6<LME,J&XNK3^JQQ[Q;=!Y75S&.*C%>UE3P^7X' XB6*IN#<*U.>*S'#
M8.U.;?*JM:B\1.,,-4252K[.&&I2E6E2PM1QKKZK&+Q6;3RJ%!JK^_6)A4PV
M-E5HRP\71E2HQK.G1GB<1@KFM?M%?"#0-,35KSQ-?W-K)HFC>(XXM"\'>./$
M^I-HFN:;)K-GJ T;PUX;O]0\J'1HQJ-\OV;?IEG/;W6I+:074,DJK0>&Q-?"
M5I0HUL)B*V%KN52FJ5"KA_J_MG7KN7L:-"D\7AH2Q56I'"JI7IT_;>TDHBH/
MZS1PU:C&4H8N%.="/+)5:JJSK4Z,*="25:5:K/#XE4L.J?MZGU7%.%-K#5W3
M;=_M%_"*SFUN >(-8OY?#]W::;>)H7@/X@^(OM>K7VCVOB&VT/P^V@>%KP>*
M_$#:!>1:FVE:(=0O8[-)[J2!8+6=X8JIT*<ZM6$X0I3KPDW"=U]5Q&)PF*J<
MMN;V&$Q&$K4L5B$OJ^&E[)UZE..(P[JSAZD,5)1P\E4_<4<0VG[D*6(IX2IA
M?:3=H4ZF*CCL-]4HU)1K8J=25/#TZE2E6C3R=?\ VEOAU8Q>#HO"\NK>-]5\
M>7/@1?#UKH'ASQ=<Z5!8>/\ 5=,L=&U/Q5XFLO#5WIG@:)]/OYM0AM_$$^G7
M%VEA-#;123#:O1#"UI9D\KY8PK4*U:C7G*452I/"X2IF&*C3JJ]+$UZ>"I.M
M##T*DISC.C*3IT:BK*:M>C0P57&5IN@H4IRITIPJ1KRK>VE@L/1J8;D^LX=5
M\R4<O=:M1C3HXASC/WZ4X'0>*/CQ\/\ P7XSU#P3XD/BG3;O2?"ECXNU#7O^
M$)\5W?A"WL]5U:31-%TD>)['29K*X\3:IJ4$]O8:3 \MS>3PFUMTDNV2W?EI
M2]M'&.$9OZG5H4%#DFZF(K5X.?L\'2C&57%3HP]G.M&C"34*O/!5(T,8\-T3
MI5(2P2Y+PQD,9451./LJ-/ PA4KU,55;4,/3C3E*<JE64:=*,(O$2H_6<%]9
MMWOQK\#6GPO\0?%RW_X2C4_"WAFSU:YU.PL_!7BR'QE#<Z),]M?Z/-X&U31[
M/7=/UF*Z3RGM=0L;-H0?-N##;JTRE=NA'"/E=?Z_.A3P_P!7MB/:SQ%98>E&
M+HN<>;V[=&<6U*G6C.C-1K1=-&%C'$U:M'VD<+]6YW7EB5.A&C"G16)G5FJD
M5-T_JSCB*;IPFZ]&5.>'555*?-RGA[]I/P%KGC>7P3/'KV@W4R:##I,^O>%?
M&6E.^KZMX-F\?7>A>)H]0\,06W@+6+3PP(;E++7[VRN[LQ7ZPV^=-FSM[-1I
MYC.56FEEE;&J<XU*;P\\+@:>!]MBJ6(YE3J\E?%U*56A3YJU"G06(J)4ZJY,
MK5_]DE]6J>RQ>&PE:-HN5:%3%X_'Y?"E5H4U.<*3K8.G"GC&_JM:MBZ-"G4<
MI477[7PE\9?ASXWMO%%YX=UVYDM/!L$%[KUQJOAWQ/X:AATFZM;J]L/$&FOX
MET:P&O\ A>]M+&\FM-;TK[;IUVEK*UM=2B-L9UT\)@YX[$QE0PU&=:E4]I%P
MJT:N'ITJM:C7P\DL10K0IUZ-1T:U*%1PJTY*+4DW5*U;&4\#AYPKXFM3HU:2
MHSC5A6IXBI4I4IT:U-RHUHRJT:E-NG4ER5(2A/EDK'/7W[1GPFTK0M%\1:IJ
MOBC2],UZ2Y-@NI?#'XH:?JL6G6=S;6EUXDU;0+OP;'JGA_P7%<7EDK>)]4L[
M/1@+VW;[=LGC9]H4*L\50P486Q-=T(J$FH>RJ8JK.AA:&)E)QCA,3B*U*I2H
M8;%2HXBM4ISA3I2E%I9RJTH4,5B?:P=#"0K5'.,HS5:EAZ4*]>K@^1R^O4:-
M&I"K5K8+ZQ2IPDI2DE>V[I_QI^'6J:W)H%AJNKSW2^((O"EOJ/\ PAOC6+PO
MJOB*2/4Y9=)\/^-)O#R>'_$EU:KHVJ+>#2]3O!8O8RQWA@D7;6-).M"A4IJT
M<1&=2DI?NY5*5.A+$O$0A4Y9RPTJ$>>EB5'ZO6YJ<*-2<ZM*,])VI*I*ZE&@
MHNJZ<E5C1<\70P,:=9TG-4:ZQ6(HTI8>HXUX<TISIQITZDX8VK_M"_"O2(03
MKU[<S2^'?$?BJ 6OA+QWJ%G#H/A>XU>QU36]7O=%\*WXT/0UU#1+ZVCOKM%C
MN7$"V8NGO+5+F*;J8E.."C&O6EA\NKTHSFZ5.:S>G[3*X.JX24:F,7P45&>)
MAKST%*+B;4:/M*U*E)^SY\9BL$_@4O;8#$T<+CE&-2=)26%JUZ?M:KG&A&GS
M5Y5HX>G5K0R=._:'\+W^L:CX:EL-5T/7/#WBG2_">OW7B?P_X[\/>#)M0D\)
M7/C?Q&_A+QIJ/@A+3Q'!I'AW3M5N&ENHM(BD%G \\EG!J-E-=;N-+V4\9&IR
M9=2>92E4K*%'$+#Y=.6&EBGAG4DO8SQSHX24E7<82E6]E*O5HQH5N:G'$5*5
M&,*=.KC*E#+:SIT:DJE*%3,*^&IPPWM?91J2Q*H8B&)I45AO:5(SIJK'#QAC
MJF T=/\ VCOA-JKQ6^F:GXLOKZ?Q#%X:ATBU^%OQ4EUV2]GLK74H=230$\%G
M46\(OIU[:7:^*!:_V(8+A)AJ'EL&I0ISJ5,/1BN6K7]M[LFH.@\/*C"M#&\[
MC_9]2E/$8>,J>.^KU$Z]'W?WM/F)5*=.G7J\ZE3H0I5.:#YU6A6>)5%X-PYO
MKWM?J6+<%@OK#E'"UY).-*;CUGB[XL^ / >M:9X>\4ZW-IFJ:KI&K>(+>./1
M/$&I6MGX?T&2SAUK7];U/2M*N;+PWH5B]_:"?4-6N+*VC$VYI0JL5SA)5)5X
M03D\+&C*KH[0^L+$O#QYK<KJ8AX.O3P]*+=6O7C##TH3KUZ%.IHTXRPE-1<J
MF.JNCAZ<$ZE2M4A/#4YJG3@I5)*F\70E5DH\E*E*5:I*-&E6J4^'G_:=^#%M
MHM_KDFO>)/*TO4]0TJ_T6+X9?%&?QI;3Z5ING:SJ-VWP_@\&/XG.B6^C:OI6
MH2:PND-IZVFI6MS]J\B='8F_8TZ%6I>%.O"I44FFHT84:T\-5>*=K8)TZ].5
M&4<9["2J)0:YI13JG3G5E*%.+DU*A"FU\.(EB5-X?ZG/X<:JRI572EA'7C-4
M:W*W[&KR=K%\7?A[,@:/7R,Z_9>%E272=<MI#K^H>#X/'UMIHBN=-1O,'A&X
MCU&:3'E6R++'</%-!+%&\8IX&G5J5J;_ '-/,:C47&2Y,JG7I8V3G%RA&%*M
MAJM%5)24*M50IT95)5*2G.&3Q=.E5PZ<Z=6C@:Z:3NJ68XBEA,%*<&E.G*M6
MK4E[.<8U*<*D*U6$*,E4.)T3]HWP%>Q>"[/6$\0:7XG\8Z;HUXN@Z3X0\=>,
MK30;[7=#'B73- \1^*?#/A.YT?0=?GT-ENH[#4[JQN)DRT$<J;7>\3#ZI6QF
M&J23JY='$>W<5+V;JX*A*OCZ.%J2C%8R>%5.KS4Z"E7<8QDZ$)5(TR5*#A"M
M2J1J83$5(_5JR=E6PN(QSP& QTX.T\-AL;4=/DJUU"C"4IPE5?L:DE5\._M2
M_"'Q#IGA?4A=^,M$/BTV\FG:?XA^&OQ!TS4;#3K_ %:31-$\0>)XCX;DC\(>
M%M8OX_+TW7-:EL-.O68Q07+S12Q15&A4=7#X>R5:O3HRY7**5*M7I^TA@:M6
M_L88_1PA@_:.MB&HSPL<11JT*M6:DG0IXNK5I5*5/!XC%T).5.?-+ZC**Q5>
ME3475GA</"=.IB:ZARX*,U#'_5:\*M*GU&F_'OX4ZIJNL:/:>)+M)M!E\6V^
MI:C?^%O%^D^&DN? =S>VGC&VM?%VJ:#;Z'J5SH\NGW9NH;+4;AXDC$I7RI$=
M^?VD%A?K;?+0>&>,C=-5)X53P])5Z=%I5JM*57%X>E"5.G)3JU/9PYIPG&/3
M/#UJ6-HY?*F_KE>KAL/"G'W_ -_C,+/&X:A*<.:G"M4PL)5_93E&<8)<\8MQ
M3V/%'Q;\"^#?#FC>*-<OM973O$-M'=Z'8Z1X.\9^)?%.IV[V2ZE)+:>"/#7A
M^_\ $4HM=/;[3=@:7FRB5Y+L0K&Q6L5)8*O7PV):IU<+&M.M;WX4:6'E&G6K
M5:E/FITZ%.<X4Y5YSC1YZE."FY3@GCAO]KHTJ^':E1KRIPI2;4/:SJJ4J-.E
M&;C*K5JQA.=.E34JDX0G.,7&,FJNE_&GX;:S86>HZ9K]S=6]_J^EZ!8(OAWQ
M1'?7>LZSX+MOB%I^FV^F3:*EY+=/X.NH=1=%@/DCS(9_+N89(4UQE&K@)5(8
MFG*,J*S"4E!>VM'*ZE>CCG^YYURT:V'JT5):5JRC2H.I4J4HSG"SAC*%/$X:
M2G0J4<%B%-ODC&CF&)IX3!U*G/R^R5:M5I653E<*52&(J*&'DJK\ITO]KGX;
MZI=>"Y?[,\;:/X?\8^']3UR+4O$/@/QWI6KZ9'%XJT#PIX>N;_PNOA:>\MO#
M&L3ZQ<7*^);I[72[6&T@\^X!N_\ 1[HT'5JSPKE&EBE#*7"E*4/XN:QS#V>%
MKU>94<-B:=3 .A&E4J7Q=>M2A@W7C4HSK17K0PT*TJD:D/JU;-(5>:#@HT<G
MC0EC*\(R:K5E%8JA4]G2HRJ4J2Q3Q:PM;!UJ"[V?]HKX/6L_B^&X\63P1^!M
M)US6]=U&7POXOCT.73/#%W#I_B:?PUX@;0!IGC9]'U&YM[+4(/#EWJLUE=3Q
MVUS'%.ZQG&DG6P]+$THN5*O5P5&G[K4ZDLQJ>QP$X4FE5E0QE3W<-BHP>&JK
MWH57%7-JL70<E4:2I0Q$JDE)3A1>$I5*^(I5JD'*%'$T:-*K5GA:LH8GDISD
MJ347;%U3]I'P7I%[IRR:5XTU/3M9UWPSX5TQ-!^'/Q1U/Q5;>(=?L-7URXC\
M2>$'\!6]QX?T:T\-Z?:ZH+UKBYFEM[F=VLX(X(9+Y1<7*-.3=.3EBG*;C:A1
MI83!83%SE7JMITJO/BZ6%E0=-^RKR4:M2$J.80P,3DHX:6)I1G4A1ITZLXJ#
M4I4Z^85,MH5<.GI7HSKX?%2]JG",X4J/U;ZS+'8&.(]/\+_$?P5XS^PCPQKD
M>J?VAX3T;QQ;^79:E;[/#'B%KA-$U&]^V6<7]FO>-9WGEVEWY%T?L5P3"!!(
M4TKTIX5XSVZ5*. J1I5YN4?90J.DZW+&JFZ=3EH\M6HZ4YJE3JT)U'".(H.I
M<XRI5HX><91KRGBJ:IN+YE/!5XX;$1E&UX\E>7LHN5E5G"JJ+G[&KR>?K^TO
M\&&LM3U!/%.HO9:7=Z!:)<1^"/'LB:\?%&K'0O#UWX)">&"?B!I-_K -G#J7
MAD:M9M,"GG@BLX\TXTN6G4<ZTYTXT?9U/K*E#"5\=[^%Y?K-.-3"8;$5Z$ZE
M*,,1"C4]A*HXM"KVPM6M2Q#C0>&O[2<Y1C1C*&)H8.K3]NW[!U</BL3AZ&*H
MJHZN%J5J:Q,*7,CM/$GQ3\%>$3X3BU^^U:RNO&[,OAO3H?"?B[4-6NA#!:W-
MY+?:/IFA7%[H=M8VMY#-?3ZI;V<=A$)9+QX$MY6C)N%+%5L'.I3C5PU&MB*L
MO:4_J]+#X>I3I5:\\4I?58T8U*M*,:CK*$W-.G*2U%2O6PM/%TX3]C5E3IPC
M*G.%:56K0KXBE0CAIQCB'B)TL-6Y,.J7MG4A[%0]M*%.7%0_M+_!NXL=4OK;
MQ%K=U_9=]IVGKIMK\/?B/=>(=<DU>UO+[2;SP9X6M_"3ZQX^T:]T_3=2O+;5
M?#5CJUA/;:;=W$5RT%M+)&55*A2C6JTZD(\]>$XNG/VN'EA8X>>)^MT.7VV"
M5"&*PTZTL73HQIQQ%%R:56%W'DG5E1A6I2<:-*O&<:U)T:E*O*M3HNAB%-T,
M1*K4P]:E"G0J5*DJM.5)0]HN4Z+2OC;\,]:TBRUS3?$,\NFW\'P^GM)9O#OB
MBRGD3XI7D=CX$1K"^T6&ZAN-2N)8MT$D*2VD<BS7R6T)#UT3PM>EB)X648JO
M2Q.)P<HJI3DEB,'@*>9XJGS1DXVHX&I"O*HI>SMS04W4A.$<W5IQE7A-NC+"
MT'B:JJQE2<*2Q>)P"O[11_>2QF$KX:G15ZU6M&$*5.;JT?:<G:?M(^ ((-!7
MQ(VKZ1J?B;6AI^DZ=HGAGQKXYBM].U?QG?>#O >M>)M4\)^%+NT\&6GB>:VM
M9;-M<DL8&DNY((KFX^RR2UEAX?6OJ<,.I3J8K!X?$R3A*$*56KEM+-*N#=:=
MJ4L3AL-4YIT5)5Y1CSQHJ,HWVJQ='Z_)QE&E@*V,HROR^VG' 5:N'Q>(CAH2
MJ5GA85\/7C&O&,H>SC3E4=*I4]C"E:?M6?!^73)]5U&X\<^'H(/$'BC0A!KO
MPL^)-K?O;>#]1&F:]XP-A;^%IY[3X>VERT2W'BB[2WTNR>86^H7-G=));QO#
MTIXF.7.BE?,Z.&KTXRE&#I0QDG#!+%.34,+/&VO@HUYP>+B[X;VKC-1JK3E2
MKXO#JU:I@YRI-4G[7V]6E&+Q%+!QA>IC:N%FW2Q-/"PJSI2C[2SP]6A6J^K>
M'_B1X0\4^)/$_A30+^^U'5_!L\=GXC>/P]XCBT33KZ6ST[4$TX>*+C28]%O-
M3^P:MI]P;.TU">=8[C>T85'*0DWAI8NSCAXRJ04Y^YS2HU\3AJWLXSY95%1K
MX.O3K2IQE&E*-/VCBJ]!U.;V]+V\<-&:E5E3A5M"\U&G4HX?$4G.<$X4_;4<
M51J48U)1E6BZCI*7L*_L^ @_:*^&MO-HMAK6N):ZKXBDT^YTBVT+1/'?B.S_
M .$?\2^*M7\+>#/$&L:E#X*M8_#=AJE[I:PR7.J):V-K=W45L+ZXBN+.ZOZP
M\/K4L/3P]Y5*M+#3DII4H0K8G!1QT*'/4<8^TG2DWAZ=7V.)K\OL_JU/$*>'
MATXFG+"PQ-:I&2P^'JXZC?EO5<LKG2HYB_80<YN&#JU+U:E/VM%8:,L6ZBH0
MJRI>\5!F% !0!\__ !D_Y*+^R=_V<!XC_P#66/VEJ /H"@ H * "@#Y_^#?_
M "47]K'_ +. \.?^LL?LTT >W:SIB:SI&JZ/)<W=E'JNFWVF/>6#0I?6B7UK
M+:M<V;W,$T27<2REXVEAE0.BED=<J<,3AZ>+PV(PE6_L<32J4II.SY*D7"5G
MT?*W9]&;X6O+"8G#XFG&,IX:I3JQC--Q<J<E-*2BXMQ;5FE*+M>S3U/*8?@/
MX&MUMX8/[4@M;1/A5:P64<VGK:QZ5\'+UM4\&:*L?]F$IID>JN][<*K+++*V
M%ECB C'H5,7B*N+K8RI/FJ5\?F&8S3^%XC,<LCE55:>\J=*A%5</%2YJ>(7M
M'.<6Z;\ZCA(8?"TL)1J5(4Z.7T<M4E-\WU>GBYXJLW>\75QRJ2PN.GRKV^%M
M#EA42JKCX_V7_#,=AX@L#X^^)4R:MH$WA;0WN+SP5./ GA^3Q3!XO33/"=E)
MX&-C,B:I:VB/-K]IKL]W;VD,.H2W:Q*5Y*$7AJ.%I4YRY\)5R2JJK:=2I+A]
MU?[.C-6]G&,(573J*C3I<W+&K%PQ,JM:IU5U3Q.)Q&(K482AB*>=4Y4+-4O^
M%^%&.923O[9RJSI.M!RJR5*=6I"FEAU2H4A/V5?AVGB'XB>(A>ZK]I^*4-M'
MXQ1- ^&,%YJ4R75C<ZC/)XKMOAY'XIN(M2CLGMI]/N]>N=.A@OKE-/LK(F-H
M;PK6"ITJ.'C[.CALRH9G1IQ<HQI5L/CI9C"DU&477I?6I*;GBG7Q7)"%*.)C
M3CRO/$4_K3E+$3E4J3RZOEM2;Y>>=.O@(Y:ZR?+;#UH8:$>6.$6'PTJJ]M5P
M]2<I.6_XH^ 6D>)?$FJ>*H/'?Q!\,:OJ6N:5KL4WANY\'0G1Y;#PA=^!M0LM
M(FU?P9J%Q;V6K>'+MX;GS9II[:5!=:3/IMR\LLN*HQ5#$X:\G3Q<<PIUW?EE
M5HYBL!*I1E*'*U&C7RS!XBA4BXXCGI^PK5JV"MA5O*49U<%5E2IN674\+'#K
ME]RG4P=;,:M'$<K]VI44,UQN&E3JJIA94:B?U=5X0KKF;W]E?PQ/H@\,Z?X^
M^(FA>'7\._#OPK?:381_#6]^WZ1\-+'4+'10=6\1?#?4]6TK49_MZW4VHZ3J
M&G7=M>64%WI,^FW!GDN/0GC)U<=4QU2G"4IYK6S=4ESPI4\55H8'#J-+V<X5
M*="E3P%%4Z<:G,U*K3JSJT9*G'##P^K0ARSE6Q*P?U&IB:]L16Q%-XG%XN<\
M5&NJE#$U*U;'8EU_;4)4JRJ6JTI63/5/&OPSL_&MYX9O7\3>*?#T_ABU\1V5
MNVA2>'I3J-IXGT-]!OHM1?Q)X=U:1)HH&2>"ZL7LKE98MKS26\T\$_FU\/3Q
M,L<ZMW#,,#B<OK0C:$/8XFMAZ\W#D490G&IA:3@E+V5E:=.=H<N^'G]5A@80
MBI/+L;@\=1G4O.?M<'3Q%&,9MOWH5J.*K4J]U[1QGS4ZE*HE-<3J7[.7@^ZE
MT6[T?7O%WA'5/#-GX'TSPSJ_AN?PTEYX?TGP'HOBKP]I^EZ=%K/AC4;/[)>:
M-XU\36]TUQ:SS*=2\ZRELKBWMY8.[$8G$8JMCZU6K)/-,3CL1BE%\GM5CZ&#
MH5J',K5*=&#P&'KT94IPQ%.LJG[]TJDJ3PPM/ZG@:67TIR>&P^$H86E&?+/D
ME0QD,=];M).$L56JT</'$2J1G1K4\-1C.@VI2GN_#_X*Z)\-]5T?4="\3>,+
MJ#2/AOH/PU;2=:NM U*SU6R\.:EJ>J:?XDU2^;PZFK/XI>YUK5C<S6VI6UG=
M?;2\]B\T,,L+EB'+ZZE1I4Z>+J8:I"G3@J<,*L-AHX2G1PT8<MJ'L84XJE6]
MM&CR7PWL/:U_:[5I.M[&_NRH8K,\4Y1WJ5,UK4L1B8U.;F7)&K2A*FX*%32U
M6I5227'WO[,'A'4+[Q+->^,?B)/I/B&Q^)6GP>%CJGAR/P]X<A^+>I66K>.)
M=$AA\*I=S7EY?V]\T5SJ][JLUM'KE_;V[QVS00VN>%J/"QPRY8UZF$>71A4J
MQ3G]6RO&4\;AL$^7D@L-*=&C2Q/)"-?$TJ%'VU>=:G&LM<1B<16G4JPJO"UI
M3IUH5**C&='$T<KK932Q5.4HS:K4\/6]I34^>C#$4X5(48QE7IUNF/P"\#I\
M8K?XVVJM:>*X]$MM"N8/^$=^']_!>6EC:M9:>8_$&L>"[SQ7H2V\!3%IH7B/
M2K*5HUDN;6=RS-&%E+!RS-TY.7]J3=6JF^5JM*-"$ZBG2]G4J<T,/"/LL1.O
M0A><J5*%2<IODK4H5J66TK<D,JA&E12]Y>RA*O.%-PJ^TIPY9XBK+VU"%'$2
M3C"I6G2IPA&'Q_\ L]^!?B1H?Q#T+Q/)J5W;_$?7O#7B+4Y;BU\+:NNEWWA"
MQT2T\/P:=H_B7PUJ>C:AI5M-HD=X;#7M,UJVFGO[WSXY8)5ABQ]C!4\'3A&,
M'@L3B<7&?)"HZE?%4YX>K.K&M&I2;6$E'"4Y1IPG1I4:-2G*.*IK$'5*LY2F
MVN53P5+ 24)5*3]A1Q5?&TWSTIPJ\RQ.(G4E[_LZD;4:E.5"4Z<^&\5_LQP7
MJ^!T\+>,M?T2VT(_"_0O%VD6T7@WP[H'C?P9\-_&+>+;.VU72?"W@&UCL+]9
MKK5X4LO#I\-:9.FL3)=VTL4%ND/H0QD_[4CC:].-?#2Q%;&2H3E4J*CC5EF(
MPN$Q5"56<JLZM/%++ZLEBJ]:G26%5;#TXXE7J<<X3AD\LLPSA2E"EB</2G[*
ME%?5LQK8.GF-&4:=.-.*> H5:>'E2I1J*LX1J5'2G59J)^RYX4%GXCM)_''Q
M)O3KOAGQ)X0TZ>]U+PI<GPAH/B?Q3'XOU"T\-V+^#O[/EE&K0P*;G6K/6)[F
MWMXH-0DO$B3;R81RP5+!TJ4I2>#J</U(SF[SG_JU*H\MA.W+&,%":I5XTHTG
M5C3A43AB95:]33$4Z6)JXB=2FE1Q*SGGP\7)4>;/:<(9A4LI>U=24E6JT)2J
MR^KSQ6(ITE'#.E0I3>-OV6_A]X]\*V/AC7[[5[J33?B#KGQ,M->U'1OAQXHO
MQXG\07.J2WTD^A^./ .M^%[RVCLM5FL+87'AZ6:U@MK9[>:.[@6YJJ+CA\3E
MF)H4X47E=&5"E"*;4J=2O3Q==N<G*O2JU\736)J5\+6P]=3E4A3J4Z-6I2E5
M7]_2QM&K[T,?]5=5*\$Y8/!4\OHMPI\M*K'ZM349T:\*M"<I.HZ7/"DZ>_8?
M /PYI_CZQ\=1>)_&;1Z9XAD\7:=X*-QX:MO!5GXIN/!$O@"]UQ+&P\+V^HS7
M,^@/&!!/JDMK:RP!K"WM$FN([C7#UYX:-:,4JG/2QN'INHY2="AC\QI9K7IT
MGS*_^V0JSC5K>UQ'L\37HRJSI>PA1PGAXRA"$)2H*4\'4Q/LFH?79X##+"X9
MXF*7)R0IPP\G0P\</AY5L)AL1*DZU.4YRZG\"= U7XA?\+ NO%?CI3_PD^A>
M-#X/@U72(?!S>*/#OABX\)Z?JL]HN@_VG=@:9)9R_8KC59;*.[TFUO(+:&X-
MP]US48JA3J0AK-_7U2J22]IA_P"TL/'#8ET;)1YW24HTZM2-2M2C4JT8U%0F
MZ1UXBH\53A1J1BJ<:&$P\E&*3J0P.9RS;#\\G>5XXJ4U+D<(SIR2G&4Z=&I3
MRKO]F_PC/H>@:3:>(_&6DWWA30=!T;PWXFL9_"\^OZ/>:%XHM?&)\2Q+JWA2
M]TR\\0:CKUC93WYOM-NK*X^RIBRC8LSZQFZ6)6(PZ6&Y?J<(TJ=U2CAL%@,?
ME=+"1BW*4*#P&9XS#MQDL1"-6,Z%>C5I4IPRQ$*&+E5>(PU.HJM?,L3*/OP7
MMLSQ^"S.I-<DXM>PQN7X:MAXWY?=G3Q*Q%*I.#PH/V3/AO;:Y\/_ !*-0UV^
M\0?#[4/$>H6>L^(=*^'7B_5-:?Q3XHU/QAK":EJ/C#P#JMSH\TVLZM>,=0\,
M2^']1:)DADO'2-0"C-X?$+$4$J+CE^#RWEA>'[G 86>%PU3VL6L0JL8U)U:J
M594,17ESXBA52C%17A+%8>I0Q-:I7E4QE;&>TJ.,Y1G7GAW*C&E*+POL*=/"
M8;#X:+P\IX3#T84\+4HWFY>R:3\.]%T7P#=?#NRN]572KW3_ !!976I-/:+K
M<TWB>?4;S6-5-S#8QVPU2:^U2\N?,6T$8DD!\K:-M<F,P\,;@(Y;4E*%"G@<
M/E\7&W/'#X7"T\'2UG&<7+V-*/,Y1E&4N9N-GRG5A*SP6/GF%&$?:RQ]?,'&
M7,Z?MJ^+GC)QMS*?LHU*CA"//S1I1C'G;7,<1IOP \*V=BEIJ.M^)O$,[2_#
M!KW4]6'A6VO=2M?A'-%>^$=,NH?#WA73+&'35U1'OYH;.SM=T]Q+Y)@B81+W
M5Z\Z]:M5FK?6,7F..JP3GRSQ&9Y5'*,1-\TI37+AX0JTN6<73Q,5.\H?NSAH
MX:&&HTZ%"4J*HX&CEM.46E*&#H8ZOC?8K3EM5AB)X'$-Q;K8%1A.]=/$.+X3
M? /PQ\!_#7BK0OAHR*NMSW6HZ;;ZEH7@+0X["]^QM!86MWJ_@?P)I&I>(84=
M8!)JGB27Q%J\BINFO9VR&Y<?/%U\G>78><(UJ&'K4L/4=Z4(RG!QIMT:"CAJ
M,:<O>MA<+2NY2<E.337H<]&OG$\SQD6UBJT:F(A#WFU*M*K7E"=63K<U5SDU
M3E7]C3]V-&%&"L<GX!_9?TKP_P"%_"VE^-?'/C+Q_KGA^#P2$U+6)/"=M:Z=
M%X0UW1_%Y\.Z-:>'_!ND1-X<N_%VC6=]<W&H07>LWHM8!=ZG)Y2;/2EB*-#&
M*OE]+V5*C-J#FESU:5'!8_+L J].FUAZ3P&%S"N\-3P5/#485^6<H5%%QEY\
MEB<7"K5QLX4<7BXXIUUA(\E&G4S/%4,9FT<.ZBG5]ECYT%AJOMYU)K!RE3HN
MA.3J+K;CX!Z3+XAUGQ!!XZ\?6?VW5-?\2>'M%B;P1=:%X$\9>)]&O-"UKQEX
M:M-5\#W<NHZU-9:CJ&R#Q-<>(=-MVO9_L]A$DK(?-HT_J^$J82G)N,J=;#QG
M-0G.GA,1CEF.)PD(RBZ+I5\0G[2I4I5,4J4I488B%-\J[*E3VE>-=QY4WAYU
MZ<)U80Q57"8>GA<)5Q'+451O#4J-!TZ-*=+#2KX>AB:M"IB:4:J\W\/_ +*,
M>F>()H[_ .(WC6[^'EKX:T#PS%X-2;P5':^,;2TU_P 3>+-:C\8BT^'=G+H&
ME3:[XAB2#1/!-YX<TS['ID%I+:FS2.SA[*&(]G*=:=&#KT\7A*N&2=1PHT\L
MPN"AEE9U'-8FOBL-BH8VLHXNMBL-'VM.<*2J2J6QQ:GBX/#R<%0JT,9&M45.
MG"O4JYG-4LRI>['V$</B,%A<O@ZE.E3Q<\0\;7JUI5JOMY[FF_LE_#W03X\D
M\-ZSK_AFZ\;^+-/\<IJ>@Z#\*+'7/#'BK3/$<GBN#5M,\0?\*T?4_%#G7)6F
M\CQO=^+;=$VV\,45NHB'/0=3"8/+<'AZLJ*RF4O85(J"?LIX&>6SHSI<OU6:
MG@:M2A4Q#P_UVISNM/%2Q"C62KTJ.)Q.,Q.(HQK?7X1C6A)S:<X8FGC*56-5
MR^LTW1Q5*%>C0IUXX2F[TXX94'[(ZS6_@-9ZZWB.>[^(_P 18;_Q(WPYOI]1
MM1\/(KO3O$7PROK34="\4:<K?#YX#J-Q>65O)=V%Y!>:.Q$AMM+M3/*9+I26
M'J^TH05'ES"OF$81<W&#Q6 CEF*PJYI2F\-6P<53<Y2EC*4DIT,72G"FX#AS
M04*LG5D\N_LVI-VA.M2CBJV,I5:CI*FE6HUL16Y525.A4ISE3Q%"M!V*N@?L
M[^'_  [J_@W4K7QKX_N[7P5K7BKQ-9Z3JESX1OAJOB7QCK.M:SK.M:SXED\'
M#Q3*\CZW+:FPM/$%GILUK96<=U97#0EY"E/V-6G4A"-J&7TLMHP2Y(4J%.E&
ME.35-P=>I7E'ZQ6>+>(I_7&L92ITL3"E4INO%XFG4A5G*4Z^-6.K5-'.I4IQ
MI0H4TFG3P]'#0HJE16#IX:HL-.K@YU9X.I/#NSK/[/7@_4_BM=?&6TU'4M"\
M:WGA[_A'KG4-/\/?#/4+P116<EE8WUAXB\4_#_5_$>A7-I&ZNEMI.MV&GRRQ
M))=V5R^XOCAJ:PD,QI4I2C3S2?/6C&3I/G<</3J-5:#I5I*I2PT*3A5J5(4H
MRJ5,-&A7E[5:5Y?6)9?.K&,GENE-27/&4%/$580E3J<]./+5Q-6?M:,*5>=X
MTZM6I1A&FN.U7]C_ .%FI+X.03ZS O@/Q=KGB_PNNH:7\/?&L>FW7B>\TK5O
M$EC%!\2/ GB.)1J.O:4NJR:NB+KT-W?WS6FKVT5RT0ZJ%>6'Q6$Q<(Q53"89
MX.*4>2^$C6K5,/AHU*?)7H4<)2K?4Z%/"5</%X.C0HUU6]DI$R<IX7,L).<I
M0S2M1Q-63M=8JCA?JDL2HV]E5J5X.I5KQQ-.O1GB*M2M&E"7+R^A)\#?"T)>
M6'5?$D-TUU\4-12]2?1%N8=8^*DH&J:S%G0C'_:&DZ:&TS2B\;10V;F.ZBO'
M"RKQU*%&IA)X*4+49Y>\ME:4E)X:KBHXW&:\UO:9ABXQQ&+J))^TN\.L.I23
MZ(5U3Q5+%*A2=2CCL!F$5RM0]MEV72RK#0:C*/[I8224U?G<XQDJD4G%\3X1
M_9S&D^+=:U_7?&/B"Z\.+XBT#4/"/PUL)/#B>#-*M/!/A7P]X7\%ZIJ%PO@Z
MU\17FNV*:++>K9/KLVCPW-TL\=D]S&+@],ZL\11KSQ7O9CC*N;UZM>+<?85<
MUJXVA5EA5#DC*53*:U#"5*F,IXFK3<9TZ%2%&-,X/J].%+"X&G3A#+LOPV68
M.A#D7M:]#+I0QT(XR4N>[CF\\37@\.Z"G1CAXU4_WE-K;_LN:#:Z/HNE0_$G
MXG+-X;\,>&_#6@:R6^&YU72CX-\72^,/".NPK_PK?[#<:UI=W*;/_2K*XL[Z
MU1#JMGJ%XBW8)5:GMY8JFU0Q,GAFZM.$$_\ 9\OQF654H.+I*&+PF/Q,*U)4
MU2P\I\V6PP#YN;IQ;CC756(IQG1K8G,<5*E[RC[3,<7@,?-*:DJ_+AL;EV&Q
M.&_>\[FIPQ,\32DJ:Z&/]G7P5_9FJZ==ZKXKU2;7?"/BCPAK>L:E?Z5<:OJ=
MOXXUM-?\9ZM/.NB)%#JVLW<-K%.+:""SBMK&UM[2SMHK:)4=.K["I%X>G##T
M(5\HKPP\.;V,?[&Q.*Q>&I6G*=2<*]?&XF>-G5J5*^)E5E4E6C5E*I+-JJYT
ML0\34^NT88R,<5'V=.LJF+PF!P4<1%4H0H0KX.AE^&C@I4Z,(TFI\\*JFT>D
M:QX$T37/$.A>(K][YI/#N@>)_#VGZ9%+!%I?V?Q8NCPZA>RQBV^TC48;/1Q:
MV\D5U$D<.HW@:.1I(WAYJU&GB*>94JT?:?VIAOJE:;;4XX=U'5JTZ<DUR^WJ
M*C.JY*3;PU#D<+5/:;4:CPU/!4J$8TXX#%T<91:BFXU</0Q&&HK6ZY(4\56]
MU)7;7,VDD>&>$/V2/A]X%\.:)X6\,ZYXATC2O#WBO4/%6EII'A_X2>'IU.H^
M$=:\%2:/?R^&?AAIO]LVR:-KU\5U;41=:^\^R6;693O$FV+G/&X>IAJ\WR5L
MOQV757"U-3I8^I2JU:D:--1P^&JTZM&G.C'!T</A])0JT*M*I4A+/"VP56M5
MP\>5U<3@<3[TIU'SX"O"O3A4JU)2KXFG4=.%.JL95Q,^6%.I1G1Q%*E7A5TW
M]CGX7:?J^K:S+?:UJ5YXA^&T7PQ\1W%_H'PJ75=8TB#PK8^#$U+_ (2K3_AM
M:^(M"OO[#TRQ0Z?H6L:5H?G6_P!H_LCSI97DWK8NM4GF=2FUA*F9XQ8]RHKD
M='&+$+%>WAS<RQ$E73G&.8+&PA&3I4XPHJ-.-X2;P2R%44K<.QA3PJFN=>PI
M5*U2C0G&5XQC2=>:56@J.*J+E]OB*KC<]2\'_!O2/"VC^.-*U+Q1XR\=3_$0
MQCQ3K?C&^T4ZK=01>%]/\))9V,?A;0-$T_1[$:;8>:+>QL+>-+B]NI8U3S=J
M\N.A2QN!J9?.C&A0K2Q4ZDJ7,JE2KBY*56M.<Y3<JB4:=.FW[M.C2HT8Q5.G
M&*6$G/!8G XJC*U7+J.&P]"\8\L*6$Q&(Q%"+BHQ4N2>)J1E)WE424JCE5=2
MI4PO#G[/?AW1+O0]3U/Q=XY\9ZWH6J^'=0@UKQ3<^%?M=W8>#M+\2Z9X1\-W
MEGX<\):1IRZ%H[^*M1OX!:V-M=R7T<%U=W=S(C^;T/$5)2=5I.O*6-K3JV?/
M/%YAAZ>$Q.,:OR0K/"4WAH4Z4*>%I4JU=0PT9592,51IQP]3!QCRX/V>&H4*
M#E*5+!T<)C</CZ=/#J<I2YIU\)AU7KUY5\56ITJ5.I7<:%#V70:I\'=$O_AI
M#\,K37O$VAV-MJ>F:Y!XCTMO#LGB1=;TOQ=;>.%U25=9\.7^C7<]SXAMO.N8
MKG1YK>99YD,(#C;E3DZ57*:L-LFC@Z=&G+WH2HX+"1P5*E4YKSY7AXJ+J4YT
MJ\)VK4*M&M&$X[TY1I2S1QI0MFSS1UH^]:+S:6(EB73M)-<KQ-14E-S2BHQJ
M*K'F4J?A7X(:%X6\73^*H_$_C#6H(M8\3>(?#GA36[GPZ_ACP;KWC6ZO+WQ=
MJ^@)I?ANQU2YO=4NM2U)F;6M4U<6J:C<P:<MG;S-":HU'0HJE%*4X898*%63
ME[2& C5H5J>"2C*-+V5.>&P[525*6*FJ--5L15Y2,5?&5*-6N^:5*="M*RBE
M5Q.&P/\ 9U+$U/=NJBPKG#DI.G0YJDZBHJ;36%JW[-W@[Q%JWB^\\3^(/&/B
M'0O%MSXDU ^"K^Z\.6OAK0=9\6^%KCP5K^MZ1/HWABQUR\U.?PS=W5A$VMZU
MK$5G%<,MC%; ($YH4HPP4\"W[2+A6I0J5%&I.C0KYC_:M6C"G.+PTH3Q]JTW
M6P]6I.*="<Y8>=6E/HIXFI0QU''X;_9JU.KA*]6-)R4,56P-"EA\+4Q*<G*2
MHTJ%&U&$Z>'=6E2Q,J+Q5*G6A/H/P1B^''P2\3?"CX:ZC:P7=_H?B>QT'5-1
M\/>!/!UM8ZEKUG=06]S=:=\)_ ?AS2EBM9[@2F:'13=2E"T\LTK&2M\>UFE/
M#X7'7>%?U?#XGDE/GG@_;06*5.,Y2IPJRPKJ4Z-*FJ&'4E3BHTH\TEGE\Z>6
MXWZ]2HJI*C4CB*="4K0<Z$4Z%"==QJ5W2E4A&-2O6EBJ\(RG/]ZU&FZMY^S9
MX0O;^*ZD\0^+K>PBO-$NQX<M&\*)HB1:-\-=6^%,FFP-/X3EU*VTV^\*ZO,)
MEBU))H+F%)M/FLO-NENS%-8Q9I'$+VL<W>:_6.;1R6;/!2K*\.6[H5,!0J8>
MH[U-9T,1/$83DP\,<#[3+\/E='#R5!Y5A<KPM)TTHIQRG'5\?0<X/FC/GJXB
MI3J4YJ5)4U2J4J=+%TJ>)CSFC?LD>"O#/A#2/!WA?QAXS\(VNBW?B-K35?!N
MB_"#P9JSZ+XJTU=+UGPY.OA7X5:?I[6DL$5O(-62P37Q-;K*=8+/*98Q<?KL
M>3%-U(RP6(P%:*;A"O1Q%>EB9.5.'+2HN%:A1E"GA(8;#.,/9U:%6E.I"=85
M+!2<L/%1<<9A,;1<E[25"M@Z57#T^6I4YJM=2P]>O1J2QL\55Y:TITZE.M"C
M5I>I^*O@UX1\7^!/#'PZU&76[3PUX4O/"5Q8Q:1J0TR[N[3P@UNEOHVHW4%O
MF;1M1L()-/U&VB6#[59WMU;[HUF-=5;$SQ&;TLZK0A4Q5'$XG%QA)-T76Q-#
M$T&Y0;;E&E]9E6I0E)Q]M3I.HJE-3ISYL-A8X+*GE&%JU*%#ZOA\,JL9)8B$
M,-6P]>$Z=11]RLY8:"=6,5.%Y3HNE54*D.0M_P!FKP78V%I8:9KWC'3E@\2?
M$#Q+<W$%WX=GN]1G^(6B:MX<O-.N9K_PS<?8]-TG1=3BM-)_LY;&XM8=)M(I
M;BXC>[6]X:M&%7!1P#;CAXY+/([7;D\/.K@JT\1.4N;VF+E5P%&3E/FP_*Y4
MOJ_L8T:=+LIS5+%QQD*<55I9I0S6E&S]G0K4%BOW%&G?EIX2J\=C*E6BE=UL
M36Q$)PQ%255ZNE_ /PO86D5O?:YXF\072S_"Z6[U35E\*6]YJ-O\()XK[PAI
MMU!X?\*Z98PZ:FJQO?S06=G:AI[B7R3!$PB7O>,K?6Y8Q6C4ECL=F,HIR<)8
MK,,LAE5>;4Y2DE&A3A5I*,ER8B*FW*'[HXZ6$IT,/'#4I2I0IX"CED'%I2A@
MJ6-KXSV*LK6K0Q%3 XAN+=; \L)MUT\0[GC7X):%XX\5CQ/?>)/%^EV]_HNE
M>'?%_A71KG0(O#?C[0] U/4]7T32_%']H^';S5H+2TO]9U1BNAZKHWVN.]DM
M[\W=OMB7##3>%J<Z_>QCB:&.I4YWY*&.PWLO8XRG[-PG*K#V%"U.M.KAN:C"
M?U?VB<WUXF3Q6"6!J)1IJGC*#G%+VCP^84Z-+&4'S<T%"M3HQCSJ"K03G[.K
M#F9MP?"GPO#\/O$WPUD;4KKP_P"+AXY_MZ>:Y@35;N3XA:GK.J^(9A=VEK#'
M%,;G7+P0LL \M$A4ARA+9U.>=# 48594)9;0P-'#U8*'M(2R^%&.'KM5(3I2
MK.I0CB*O-3=&I6E-NC[.7LS7"XFM@\?+,8R]IB)8EXG]XKP5FE2H)1Y6L/AZ
M$*6%HQO[2.'I4U*I.HG4EXQX@_8_\!^+=&EL/%WBWQMXNUJ3QCI'CA?%OB_3
M?A1XLU*#6-&\*6W@VVBM_#/B/X87O@R+3CHT$S+;CPM_H]S?W-W9-:SLCQ;P
MK*EB<%BJ-&G1J8.>*J-QB^:M/&5\/B*\ZM64I5X5'/"86%.OAJN'KTL/0IX:
ME5AA^:G+EE3C+"O!3O*@L-A\)&-^51HX2IC9T(RA#EIUE%9AB*<H8B%:E53C
M5K4ZF)C[<]$L?@7H6G>,X_&EKXG\5QW$?BIO%O\ 8@A\$KH)O)/AW9?#2XL!
M$G@Q;V'3)-#TZRG"PWT5Q#<0LEM<06,TUE+GS7I5J,U[6%;"YG@VIRFVJ&:9
MAA\SJQNI)RE1Q6'B\/.ISR]G.=/$/$1C1]D5::JQPL6W%X-X"5*2LN2> IXZ
MC&<8V=.G]8I9AB(XBG3A"ASM5\/2P^(E5K5?.I?V,_A&VD_#C3(7U@7'PRUS
M4=<T/6M8TSX?^.-4O9=4N=*FN+;4X_B+X%\0:?$L-MH.@V%E>Z78Z;J6F6.B
MVEGIE]9VZ,CZT<15H8O!XSFYZN$PE/!MRTG6A#FE4JU:\.3%1Q&*KU:^*QM6
MA7HO&8C$5:F(4TXQAO7J2Q%'.*-3;.,;/'U6K_NJ\O;Q@J4&W1E1HTL1.C1H
M8BG7I1@HSE&59>U?1>.?V7?AWX_\,6?AK6[C4V_L_P"(FO?$VQU>[T;X>>*;
MJW\2>(;O5);P-H?CWP+KWAJ\LH+'5I=.M!=Z#<3VMO:VKP7"7D NCC0:PV(R
MO$4HJ,\JH2P]-6O[2%2O3Q=><YO]]2KXC%TUB:M?"5,-652=6%*=*A5G1E%?
MEQ%/'TJD$J>/>&=2$>:$$\'@J>7T%R1DH581PM-0E1Q$:]&<G[25-SA2E3W/
M^%!>'5\>67CF+Q3XUMX;/Q'I'C ^";2[\.6G@J\\5Z+X*D\ VNMWUE:^&(]2
MF?\ X1]=. L1JB:?#<:-9W-K9V\OGM<ZT:\J,IS<8UI)8U4'5O-X2.83]IBE
MAW=-RJ2E6M6KNOB(T\3B*,:JH5/9HJ.57#4L+)I4Z>&PF%DXPA&52&"Q_P#:
M.'E/EBHQE'$.2E&C&E2G"7O4W.G2J4Y_&7P.TKQCK_B#Q&_C3QOX>U#7;#P/
M!"-!/@PPZ!K'PZU^^\1>%O$^C'7?!FIROJUO>ZC>(]IJ<NHZ3-',WF:89293
MA1]IAXM4:TH3CC:N.ISM!RHSQ&6+*,92@I0<'1Q>!2IU55A4JTI+VF$JX:<I
M2E%>G3Q+A[:FITXX586=)RFJ=2-/&QS##U9)24H5\-BXQJ0G0E1C6484\9#$
MTZ5*$+\_P:T27X9ZO\,T\0^*X(M=N+O4M6\8?:="O?&%_K]_K*:]?>(+E]4\
M/W6BSWL^IH&:UDT5M.6'%I'8I:(D"75<95,NE1IQPE/*J^$KX:E13]G3E@\3
M'%TXOVKJ5)^TKQ=6O4G.6(JU*E2M*M[>7M!P6F-^LOZ[+,,/6PV)E5C&+JTZ
MV!_LYWCAXT*<'#"*%*G[.$(Q]G!N,O>YJLOP(\&WGF?VI=:YJS7?BCQ3XPU2
M2\GTJ"36-=\6>#KOP%=W-^^F:/:%19^%;V:RLQ:_9C$HC+M*8U(QJTH5<)5P
M+3CA*F!S# >S3;4*.99FLVQ$HN3E+VJQ"E3A*3E%8>I.G.$Y-35T*E7#8A8J
ME5E'$/$9;B*D_=_?2RO!TL+AJ=6*BH.BYT*..J4H1A'Z]2C5I^SIWHN/X;?
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M+!+<:JTJIHVDR2A;B'P]H^FO!I.G1R$2):V$3O\ OI)6:<5A\-6RVAD\5*6
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MDIMS]A/,\5F5:GSSYIR^L/%U<%B:E5U*N(P7+&K.>)YL3+WVN4T"@ H ^?\
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M#UL%4QT)SPD\5].5B(* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % 'S_\ &3_DHO[)W_9P'B/_ -98_:6H ^@* "@
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M??M*?#SPN/!7A+5O%=_H5M\2[;PCIWCV/P*TGB3PQX%T[P#X6-JGASP_X+^
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M.(\ZL?%O[1>J:A\+O#]]K'Q=T+5C)\++K4KC3_A)X=;1?$?AW5K]]2\>:O\
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MX)\=:KI>H3_!SQ1J=WHTWB_Q%X&\#2:?KFBR_ CPA#K&J:'X:U'QO>QVFI>
M=!NM2TR^94TF_6TNKJ7T(4<*\;2I2I0:;R#!8B=2<%0Q> S#-Z^.S*,XJO6A
M2G'#Y;E.%Q52-2$<+5F\76CED)N-+CE5Q,L/7K4N6A5IU<WQ^!E!5E4P&/RK
M(<10R^G2C*G"M4ACL7CL77PLI\_OT*>#IXG'2JPE/M_%_C3]I;2/#GQ.E\(>
M'M46+X>>*;OPUX>:\\*-%+XMT'Q%XHTC4K?Q'X7TSPQX#\1ZE=Z)X)^'-\VF
MVCZ9X7UNXO\ 5X;DSZ9J:Z2T.I\+G4JX;+\3BYRIU\?4J8>OR2E.O0^IU,PA
M4S"K_L^+<:N:XBA@HX:,Z+P]&A7KXFM&%&OA\5A>V/U6GB:]#!X>^&P6$P]:
ME3<%3IU*E3+<!"GA*<YU\+%TL/B:F88S,*,'3KOV.#P."Q%.K]8PKIQ:O^U-
M!X0U/6K'Q+XB\0ZIX-^%^G^(=)L;_P"'UMH:_$/QAXLUOQ6]MI7B.._^$>E:
MY+_PB?A2+0GOK?P[X5\,ZA?7JP'^R;1Y9-,NM\<H87ZS5A^\C'&9=EKA#7V5
M&E1PD\TSFBJ#S&<I8A8W_9H1EC\+AZ^!Q$51Q24\/#'"RC75&DN:%:=#,,7+
MVJO&-1>S66Y>J]6.6T9<^+P6-IUO:0PM6.7X["SJ8BG4GA\Q.&U[Q#^TGJ/P
MSL?#MUXM^+\NK^,_#?B&^T+7O"/P;DN/$SZOJ=_9:#:^#_'.K>*O@'X6L/"'
MA_1H;B_U6;4;_P !^"M5U.RGACTR476F33ZBYX;"8O&X7+\52<L'?**6*_>0
MI8;%8/'X[$QS&O7G"M5G"IA,!+"49X?"XO#UO;.KBZN'H8=U*.%=#&UL%#$9
MK"C&K*G5Q]6CAX*JJ]"KEV#PU;!X;"JI2;E',\53QGL\5BL-CL-AXJ&&]KBJ
MU7#5*ON_QEM?'GAG5_A'I7PSO?B99VG@_P '?$+5M.\/^#-#M[WP9XQ\0^#O
M"VEVO@SP+\0]1;P5JL>C:5JD5SJBVYN-4T&&22R*VLW]J+ITMK-7%5\1F.>8
M^K4C>K@Y2Y*M&=:G&IC,?35?&4:<'2GB,3@*2>(6$HU_KF(?LH4(/"O,85M,
MMR_"4<JR;+:E=82E2S+*\+5KTK+$4\%3PN*4W%2]I"G0E6I8:G5JRH3I4X5)
MNK.#]C*/5? 76/B#K=CXNO\ Q/KWC[Q#X?E;29/"^K?$3X<6OPM\6+JKV5V?
M%EAIO@V3PAX>OK/PC9WXL(M+?7=-N;^0_:S+?:C;BWN97CU"AEM;V49?6:57
M%_5Y4ZE.OB*^!6'PL\'7KJ"E0CCIXB6,@Z4<-ATJ<,/[7!4ZCFI\>&EB98Z'
MME"-*6%PLJU+EG"A1QTJ^+^LX>C-R=2IAZ>'6#O4^L5_?E4]GB):J'ROX>T;
MX\:GH/AOQ1IOC7XY/XG\,> =;UV&\^('P\L$\1R_$#XJ_$/3+4^ 38:U\+-,
MMO\ A%/#\7A"^2_N(]&DN+72?$4<^F:EIVER6,R=6&C2PV)P/MH4*^'<N&<M
MG4IRY)8K!J3Q.>8K$J4EB,/#V%?".FW+#8B>*P4(8YUL=A\93K].:0J^SSFC
MA*D9/ZWQ+C:$8\CC0J99A*E#(H8-N,X2^NQQ6(LG4Q-&M)U8T:+<Z$L-[]\$
M_$?QW\4?%?XDS?$:YO/#WA7P_>:]HVD^!9?"FNQ:-<6G_"0-'X.\2:'XMU;X
M2>'[:ZO7\.6,DFHQ:7XY\?VLTNKPN(]">V-G)RX)4_['AB:]YXW%O#N4)24)
M8.M&DYXJA&#5"K4H\]2-&,JF$G!3PSJ4,SQ=*M91BY-9BL/0A*EA\/&RJ*2G
M#%P4%"56:C"M"G4G6Y:]!1Q="=/#U)8;$Y=[>E+$+RW7?!4?B+6_%EEK?PT\
M5ZK^TA=_$35+_P $_%6?P/X@FT;P#X(3Q<D7A+5_"'Q=N]._L#PUH^G^!X+)
MK[PMINL07^I78U&.[TNY_M&:6=99)4O[$JX>^&>$J8:IG<ZEJ-;%*CB7B<PP
MM3E2J9CAL9!3P>74J:Q%"A0K87VWU:=&O*EIG3]I#.*%-NI0Q& ^KY5",8U8
M4<17RNG1AB.2_)A:V'S-U,7B\36=*LU2O0G6C'!T7L>(-5_:0;P]XVUX^(/B
M'!%K'PU^-^KZ+X=T#X?Z,FH>#;RT\7VEI\(K?1HXO -_KFJ^.Y/#=U?2W-K*
MU_YL%C$+?2S> WESSQA1JY?2HXNM6I3Q$.%WB*].$U7H2S.K.6;0H0H7E[++
ML/%TL=RQJ8NG65.K1K8+VBI'3[:E#'*=+"N4<)BLRA3PZG1=/&8?*\&Z+JU:
M^)?L*=?,LPA0Q64*3AA)4L3B88B.,HT(JG7L_%'QJTKQCX8T&SU_X]ZWH?A"
M[1+QM3^$^E+I?C;P!I_PKNO%%MX@\;>+-1^%$%WJ'CS6?%]NNB1Z3X9NM"N[
M"1!%JMB;VXB:\Z,7.JZ><XZ-*E'$T<+G$EA(<BHQQN'Q,<!EU' *C->WJ8F%
M>AG,\3"6(RR=*-?"8:C2CAJZAYN"IKV.58*=6M26)JY33HXI^_4G"O4ABLQK
M9A]92E@,)A,/3Q.54Z>+A',G7CA\96KUUC(U*+=0U/X\>$['P_-XCU3QKXN\
M7P?#7PSK.N>+K3X*:9XFD\'WWC3Q3X7T;XAQ>!+'P7\/Q-=:KX;\/Z1>WL/A
MR6YU.^OYM<^U2V.J6>F1V=CMB8X.GC\RPM*<J6!P^(PN"CCZ,93Q=:@J6=8N
M=6,7"K0J4<;CJ.48-SIX>M0RVG3I8C%QA.3Q6)M5J]>A@\PAA5!XW^T\7#)Z
ME6U'!U8?V;3R^%>O/DJ\^!P6/S2<N>MAZ^:3H8C!X6K0E6Y:?KUC/K^J?L]>
M+8OB?JWQ1:/6(/%NBV'B"U\ :C<?&"7PEJNH76D>&=<U'X?_  P\()=0>)GT
M^XM[J6ST[PY9200LK7EE9RQW20<N/@H4<OIUJ5#ZW%X:5>E2A4QN"E7I8CVT
M*.(C&I4C6P]6C3HT\RC&O]4G4GBJ5"M'#RI,Z,ODUBL34P]6=7"QO.A4K-8*
MNJ;P5*6(]FZE/#3I5:&*EBH8!NDL3:EAI*->L^>I\[^%[WXQZ3JOP?\  OPR
M^'>G_L_?#W6&FUS5;[P;\(=<\/Z-XDU:U\5:M8W;>)O R?!/Q''X#T_7?".C
M:+J,ECXF\2?#G5[27Q/%'_;5]/I5Q:'OAS2S"K]:G&6'P6$PTZ67NM&K2@JM
M*6)Q^%IXR$L-AI3HXBM.E@ZF$Q,^6O3J5JV58N&(BH\U>A2P^659X*HJN,KX
MG%4:F+]E*%><X4<)1R_%5:-15*]5<TJT<9*>%J4ZT,'%4L=@J4J=6KZ98?$?
MXIV4^E^)]5F^-6I27?Q-N= \;_#RT^"5PN@>#-'L-&\7W&D:?X+O%^'$.K^*
MM+U;5;;PK9W?C#_A)-;T>*2[>X6ZTFU:1(/-H3Y,%@ZLJ<L14JY9B,6XS7LZ
MM3,J>%PZJ9;*'[I8*A1K5\57PDL3!3Q<LOIX>GB\6\1&%;KKP7ML?1YH4/J^
M)I4*$Z3]I2>!GFD73S&J^;$/$5YY?0=+$8;".-3#?7G5G@:-3#\U+*&N?M%Z
MMX)\8^,-8O\ QQHATCX1Z1>:?\/X?AIX?U:]U7Q]XTL?%6J:G:WVF#P-JFJ>
M(;3PII?B#PC8G2]#C:2XO?"LL5U]K>2^M;SLEA\)2<<!C'3S*-3-<MR?$5(K
M_9IX*$,CHYIFU.+M>GBZ]7-90E6O@Z.&59JDHQHU,-G2Q-15:=;"X6<5AH9I
MF])5:RH5<0EB\P>49)4E&3CA)T</@*"K583^N5)9C0FJT7",JN%--\4-!UCQ
M-+X>MOB=XRMX/B1X@/A#X<^+OA=%#\/O#]E\._A#J=Y\.-/\(WT/PIT^+PUH
MVK^,(-$FCUFWU46EM)IEO8B]@UBXO(]0YU7Q4L'.LXJ>:/#\08M8O$U)SKT\
M;/.J.6PIRE3?MJM+^P\5B<33I4Z=2MF$7BEA_K=&<X!AJ&$]M@L!7ITJ.4QE
MPU@6J%/V=*G@GAZ.95L<\,X.#Q5#,\-/ U(2BEERKT:]6GAXX3 ?5F^#?&G[
M0EYHWP[E\3>+/BG/J?C/XD!]2T7PY\&];M-4T'PW:_V?8:II>H>+O'_[+/A?
M1M#\(6]_-)J.SQ)H'A[4[FP-U!I/BG5;NQC>_P"ZG1H+,,!1C4C5PM'#8BO4
MJ591IQJJ2C+"K&2C5BZM6,J.)HU*>!66XI^WP=>>6TX0G&OA)UOJF:5*G+A\
M0E1I4X03JN%>"K3Q*P2A]84?:*KA*>&JXB6;8"-3#XB%;&1CB'7P'L'QNT[P
MY>^/_#O_  M[P'XF^(OP</A.\MK+P_I'PW\4_%WPT/'\FM6T[77C;P#X/T#7
M+J^":-;VQTN_O](N-/LY4U$O-;W4UJ9?-PE.G/%XZ->$)8FHL!# 3JQ;I4X-
MXU8[DJS7U?#5I3>"]I6KRI3]A%1H5%!XN,NJLZRPV#^KU90H4YXR>/A"=.$Y
MVC@HY?[MXXBO3C?,5.AA_:0E.=.IB:,O9T*E+@]>\6?%;PKXOU?2?A_H'CG2
MO"_@&&Y@\+_"_P +_!N&S^&%[\,]-^&[:G8ZK#XK?P:\MWXUE\8B/1]-\,>&
M]8M9;5888;W098?,O14WF&,H8RK]85;,\0L?0JSQ=116%QCQ-7"Y14PLY+_:
MXU4L+CL?C*TL5E]'!U<5"<L-B*%-5'AJ>">*R_"QIK 8-SRZK3G%/EQ=.KB,
M/4S;ZXO9\N70PV&JXNG1PT_JN-JXO#0Q,:V(I8I8:E=T.#]IW3==TJ+7OB-X
MHUZVT[Q3\)-,U:WC^&7A*PTG7+B]\.1ZK\6F74++P@9K7X?6^GX&GSV\\=Y%
MKYFM9-;GA*:1!VU*N"I8JO..&G4P4<5GZHQYVYO 4,KG6RZM.,+3^LRSB*PF
M$IKE]I@M:U#&SJ1QB\Q0S&>6X:2E"GC:F7Y1B*GO0]S%5LZ^IXK#QC)+E=/+
MN;%8]3C*;_=8C#0RZA"I3K<\;S]JV_TN76XO&_C/2[G4O!,'BVW\.1_"GPL@
MTGQ#XF^(=U%X!\$Q2ZAX+N+N(6/A1_LWC#[;]KNX+>UM+J!] E::ZO)PD(8>
MO@:&.C'$>PQ7#>'Q,XUH.G6G4I<G$U12I.*6!P\5'$82K2=-RQ<Y*GB:E"'U
M"/7CZ=>-/,G@I0NO]:_JUI1;C3R_DJ9(XQFFY8G&RE[.A*HI4:N&C4H?5L1B
MW''0V]2\7_$./X@VR6*_%#P]#J/QA\3P^*;+PE\#[T3ZKX/\+6F@:/X?O]3\
M?:S\'=8T'6/";66FW][)&NL:=K=_;:XEMH&LM=:.FCW/+@9QCA:=2K%14<OS
M/&5(RA5]E'%SQF91P[KX6FJ.*Q&*^J8? X2E2P,_;RJT<-B,1A<9@<9]<I7B
ME*F\723^L5W6R;#86I3E'W,-5P&$JXVG2JU.:A25+,L?BL5.KB^;"453QE!.
ME74HOC['QQ\;9=$TG5KK2_B-XPUNR@^*_BC1]<\8? ZXB@T[5]+C\*>'-"N_
M"/A6#X3^%_$GA:Q7P[XE\;WUEH?B(P>(M3?3;_2;?5-=M+B&YN]YJ%&%&7M)
MX5+!Y=1Q3I2CB,7[#'YS&.85W4H1EA\37P>%P5*K3PN'PL;T<9AL5C<ICB<'
M5IT-)SC6GCUA:<E"6/JK"T*DE2PM:&&RK'8W!X>NZ\XUJ<*N8SP.'JXZI..%
MAB,%4]AC<.L12C7ZK3=:_: U32H=,L/%_P 5H=!?4?'_ (DL?B'X@^$GAG2?
MB;JW@7P_X%T--,T:Z\)W7PXL=*\-^*K_ .(FO7SZ/:ZCX2AOY].\,NMSI]TY
MF>7'&>TI8.I6IT(K%83*\3-8>G6A4=?,)YI&.5PG)2J0ESY;AZTLQCAIPA26
M)I*V#KS3PUT(TL1B**ISY*6(S'+\-6E63HTZ%.IA<?4S"MA82DJSP5"I#!4:
M-;&3;CBY59NMB\&J*Q7L'B63Q/J7A'X%^#?&D]O_ &E\0-8T#1/B8PB6RCU)
M],\ >(/&6OZ+%;Q*D<4&JZUX92QN;4(J26-U?0!0' '=BZ6&GGF/C@+/!9?3
MS#&X2#O.%66'Q&'PV"4I.3E*%&>,ACE=R<G@XJISTW44N#+YXK^PI8FO[:CC
MYT<%3E-*/M,-]:Q-"GB'5DJ<(TYO#RJX-5J=.E*GB\11G05"K[)P^>=#\%VU
M[JGAO_BV7C"R_:,T?XAZ7K?C_P",%_\ #_7[*+2O!^E>+VUS7-)\/?%*[TI-
M.\5>!]2\)P/H6F>$/#6HZFL2:K;"[TRUEMKF6#ERZK3PT,!BO?I8/"Y;-YI%
MJHL1C,=6R:O1K0JX=1=?,<3+-JBQ"K1A6H4(T8SP=:"IX*C+?&454EF>'G"-
M>IB*]6&31<X0I87"4\RA3RZM3K4$Z&7_ %++^2M5H8B6&KX_DKX?&1JK%XNI
M*GI/ANRA\.>.-3\*_#+Q>WAN\^)'A:^\?^/+3X0^-OAQ\<?BA\/+G4M4UOQ'
MH6MZ1XA\/Z5XV\;RZ'?2Z=;375G;NVIZ/=7%II=M)=12PS84*4,/@\@PN,C"
M.6X>IB:-?#0O6HXGZKE+I9;F>,PF'52<:F)S":6-IUH5)5\7AZF.Q$%E^,E2
MB3G6K8[.I824WCZM*C4PV(JNG3EAJF,S2G+,LNPN+Q7)05"EE=*H\'6I3IPP
MM.MAL+2K+&X*&(?J&A/\%_!OB/X:ZE\+/!6G?"WPS8V?C77O$^D6'P?U[X7:
MO)8:ZVC>#-+@U'P/>>$='UL:IK?BZ'0ULDN-*,^H_P#".%K99UM@Z=E%XEXR
MM1J5?:T'E]'"4:4*\)TZ>,Q^8X7%8->SA.4*7L\-A,VJ5W)06!IU:E3%.A3K
M2E+#$)?5:%2DI0E3S&>+KRE2J<];"99D^9QQ=13E%2K*A4S# )-.I*K.M&%%
M5*G,H[W[2_B[XI:#;V>E_#L?$G3I+[PGXNU/3=7^&'P_L?'.MZAXWTK^RO\
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M1H4I4/J&LAA0 4 ?/_QD_P"2B_LG?]G >(__ %EC]I:@#Z H * "@ H ^?\
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ML3AJ-#$T:F7UL0[SAAZTJU&M.3H8B$WA84JF%E"=Z?S=<?LK^%O$'BG1-/\
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M % 'S_\ &3_DHO[)W_9P'B/_ -98_:6H ^@* "@ H * /G_X-_\ )1?VL?\
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M]'+? #_P\GPZ_P#FCH /^&L?V6/^CEO@!_X>3X=?_-'0 ?\ #6/[+'_1RWP
M_P##R?#K_P":.@ _X:Q_98_Z.6^ '_AY/AU_\T= !_PUC^RQ_P!'+? #_P /
M)\.O_FCH /\ AK']EC_HY;X ?^'D^'7_ ,T= !_PUC^RQ_T<M\ /_#R?#K_Y
MHZ #_AK']EC_ *.6^ '_ (>3X=?_ #1T '_#6/[+'_1RWP _\/)\.O\ YHZ
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M1T '_#6/[+'_ $<M\ /_  \GPZ_^:.@ _P"&L?V6/^CEO@!_X>3X=?\ S1T
M'_#6/[+'_1RWP _\/)\.O_FCH /^&L?V6/\ HY;X ?\ AY/AU_\ -'0 ?\-8
M_LL?]'+? #_P\GPZ_P#FCH /^&L?V6/^CEO@!_X>3X=?_-'0 ?\ #6/[+'_1
MRWP _P##R?#K_P":.@ _X:Q_98_Z.6^ '_AY/AU_\T= !_PUC^RQ_P!'+? #
M_P /)\.O_FCH /\ AK']EC_HY;X ?^'D^'7_ ,T= !_PUC^RQ_T<M\ /_#R?
M#K_YHZ #_AK']EC_ *.6^ '_ (>3X=?_ #1T '_#6/[+'_1RWP _\/)\.O\
MYHZ #_AK']EC_HY;X ?^'D^'7_S1T '_  UC^RQ_T<M\ /\ P\GPZ_\ FCH
M/^&L?V6/^CEO@!_X>3X=?_-'0 ?\-8_LL?\ 1RWP _\ #R?#K_YHZ #_ (:Q
M_98_Z.6^ '_AY/AU_P#-'0 ?\-8_LL?]'+? #_P\GPZ_^:.@ _X:Q_98_P"C
MEO@!_P"'D^'7_P T= !_PUC^RQ_T<M\ /_#R?#K_ .:.@ _X:Q_98_Z.6^ '
M_AY/AU_\T= 'H'@7XL?"SXH?VI_PK/XE_#_XB?V%]A_MO_A!?&7AWQ;_ &/_
M &G]K_LW^U/[ U*[_L_[5_9]_P"1Y_E^;]AN/+W>2^T ] H * "@ H * "@
MH * "@ H ^?_ (R?\E%_9._[. \1_P#K+'[2U 'T!0 4 % !0!\__!O_ )*+
M^UC_ -G >'/_ %EC]FF@#Z H * "@ H * "@ H * "@ H * "@#Y_P#VL?\
MDUC]I;_L@'QD_P#5=>(Z ./H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H \5^ ?_ "(VN_\ 9:OVDO\ UHKXIT >U4 % !0 4 % !0 4
M % !0 4 % 'BO[27_)NOQ\_[(M\4_P#U!M=H ]JH * "@ H * "@ H * "@
MH * /%?A9_R//[27_9:M"_\ 6=?@'0![50 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0!F_!+_DXKXW_P#9%OV</_4Y_:BH ^PJ "@ H * "@ H * "@ H
M* /G_P",G_)1?V3O^S@/$?\ ZRQ^TM0!] 4 % !0 4 ?/_P;_P"2B_M8_P#9
MP'AS_P!98_9IH ^@* "@ H * "@ H * "@ H * "@ H ^?\ ]K'_ )-8_:6_
M[(!\9/\ U77B.@#CZ "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M@ H * "@ H ^?_VL?^36/VEO^R ?&3_U77B.@#CZ "@ H * "@ H * "@ H
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MC90Q?Z,+>[L[>WBFMKQ\YUL?CZ\+RH2G4I1Y%RU:N 5?A6<:,)1J8>HIU*>
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M % !0 4 % !0 4 ?/_QD_P"2B_LG?]G >(__ %EC]I:@#Z H * "@ H ^?\
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MZ_$.)R2%7#P4G[.G4HTH8NG/VV)@VW"$JM.<*R^P:S.P* "@ H * "@ H *
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MR-*6(YX0>(]FT_XH?$B;PO\ '#QKJ-MX.L+'X?Z-=/X7\+QZ;?WNIV^LZ?\
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MU)5:LVH1A"/-.<FH4X0IP5H4X1@E%><_"S_D>?VDO^RU:%_ZSK\ ZS-3VJ@
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M_P"S@/$?_K+'[2U 'T!0 4 % !0!\_\ P;_Y*+^UC_V<!X<_]98_9IH ^@*
M"@ H * "@ H * "@ H * "@ H ^?_P!K'_DUC]I;_L@'QD_]5UXCH X^@ H
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MXR?^JZ\1T <?0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M14 '_"DOVBO^BW_!;_Q'#QS_ /114 '_  I+]HK_ *+?\%O_ !'#QS_]%%0
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M?]%O^"W_ (CAXY_^BBH /^%)?M%?]%O^"W_B.'CG_P"BBH /^%)?M%?]%O\
M@M_XCAXY_P#HHJ #_A27[17_ $6_X+?^(X>.?_HHJ #_ (4E^T5_T6_X+?\
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MXX_:AMX;&;2-8\>^+9KF]2YMKN5KQ=2@C>.YAB%JC6[2W(!]D4 % !0 4 %
M!0 4 % !0 4 ?/\ \9/^2B_LG?\ 9P'B/_UEC]I:@#Z H * "@ H ^?_ (-_
M\E%_:Q_[. \.?^LL?LTT ?0% !0 4 % !0 4 % !0 4 % !0 4 ?/_[6/_)K
M'[2W_9 /C)_ZKKQ'0!] 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 ?/_[-/_).O$?_ &<!^UC_ .M3_&2@#Z H * "@ H * "@ H *
M "@ H * /G_]K'_DUC]I;_L@'QD_]5UXCH ^@* "@ H * "@ H * "@ H *
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M:Q_[. \.?^LL?LTT ?0% !0 4 % !0 4 % !0 4 % !0 4 >/_M">%M=\<?
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MU !_PN3XB_\ 1IW[0'_A1_LL?_1+4 '_  N3XB_]&G?M ?\ A1_LL?\ T2U
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M0:)XJT^"[18VCCNH;A(99X42>8V#8]/_ .%R?$7_ *-._: _\*/]EC_Z):@
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M7_HT[]H#_P */]EC_P"B6H /^%R?$7_HT[]H#_PH_P!EC_Z):@ _X7)\1?\
MHT[]H#_PH_V6/_HEJ #_ (7)\1?^C3OV@/\ PH_V6/\ Z):@ _X7)\1?^C3O
MV@/_  H_V6/_ *):@ _X7)\1?^C3OV@/_"C_ &6/_HEJ /,/ 'B_XM>%?%?Q
MNUW4/V5OCA-:?$GXH:3XUT*.R\4?LPR7-II5A\%_A#\.9K?5DG_:+A2#4#K?
M@#6)U2WDNHS:W-DYE6:26"W-@V/3_P#A<GQ%_P"C3OV@/_"C_98_^B6H /\
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MC_98_P#HEJ #_A<GQ%_Z-._: _\ "C_98_\ HEJ #_A<GQ%_Z-._: _\*/\
M98_^B6H H?"]/&^O?&CXI_$7Q+\+O&'PQT36?A?\%/!6AVOC75_AIJ.JZMJO
M@OQ7\>M=\07%O!\-OB!XKM[73X;3X@^'$1[VYM9)9)9Q'$RP,Y-@V/H^@ H
M* "@ H * "@ H * "@#Y_P#C)_R47]D[_LX#Q'_ZRQ^TM0!] 4 % !0 4 ?,
M%MH'Q]\#?$#XSZOX*\$?!_Q?X8^)GQ T3QUIEYXI^,?C3P)KNG?8?A!\+/AO
M>:7?:)I/P&\66C;=0^'MW=Q7,6KOYD.HQ*\,3QL";!L;_P#PD?[4_P#T1OX
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MW\ /_$EOB+_]"=0 ?\)'^U/_ -$;^ '_ (DM\1?_ *$Z@ _X2/\ :G_Z(W\
M/_$EOB+_ /0G4 '_  D?[4__ $1OX ?^)+?$7_Z$Z@ _X2/]J?\ Z(W\ /\
MQ);XB_\ T)U !_PD?[4__1&_@!_XDM\1?_H3J #_ (2/]J?_ *(W\ /_ !);
MXB__ $)U !_PD?[4_P#T1OX ?^)+?$7_ .A.H /^$C_:G_Z(W\ /_$EOB+_]
M"=0 ?\)'^U/_ -$;^ '_ (DM\1?_ *$Z@ _X2/\ :G_Z(W\ /_$EOB+_ /0G
M4 '_  D?[4__ $1OX ?^)+?$7_Z$Z@ _X2/]J?\ Z(W\ /\ Q);XB_\ T)U
M!_PD?[4__1&_@!_XDM\1?_H3J #_ (2/]J?_ *(W\ /_ !);XB__ $)U !_P
MD?[4_P#T1OX ?^)+?$7_ .A.H /^$C_:G_Z(W\ /_$EOB+_]"=0 ?\)'^U/_
M -$;^ '_ (DM\1?_ *$Z@ _X2/\ :G_Z(W\ /_$EOB+_ /0G4 '_  D?[4__
M $1OX ?^)+?$7_Z$Z@ _X2/]J?\ Z(W\ /\ Q);XB_\ T)U !_PD?[4__1&_
M@!_XDM\1?_H3J #_ (2/]J?_ *(W\ /_ !);XB__ $)U !_PD?[4_P#T1OX
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MW\ /_$EOB+_]"=0 ?\)'^U/_ -$;^ '_ (DM\1?_ *$Z@ _X2/\ :G_Z(W\
M/_$EOB+_ /0G4 '_  D?[4__ $1OX ?^)+?$7_Z$Z@ _X2/]J?\ Z(W\ /\
MQ);XB_\ T)U !_PD?[4__1&_@!_XDM\1?_H3J #_ (2/]J?_ *(W\ /_ !);
MXB__ $)U !_PD?[4_P#T1OX ?^)+?$7_ .A.H /^$C_:G_Z(W\ /_$EOB+_]
M"=0 ?\)'^U/_ -$;^ '_ (DM\1?_ *$Z@ _X2/\ :G_Z(W\ /_$EOB+_ /0G
M4 '_  D?[4__ $1OX ?^)+?$7_Z$Z@ _X2/]J?\ Z(W\ /\ Q);XB_\ T)U
M!_PD?[4__1&_@!_XDM\1?_H3J #_ (2/]J?_ *(W\ /_ !);XB__ $)U !_P
MD?[4_P#T1OX ?^)+?$7_ .A.H /^$C_:G_Z(W\ /_$EOB+_]"=0 ?\)'^U/_
M -$;^ '_ (DM\1?_ *$Z@ _X2/\ :G_Z(W\ /_$EOB+_ /0G4 '_  D?[4__
M $1OX ?^)+?$7_Z$Z@ _X2/]J?\ Z(W\ /\ Q);XB_\ T)U !_PD?[4__1&_
M@!_XDM\1?_H3J #_ (2/]J?_ *(W\ /_ !);XB__ $)U !_PD?[4_P#T1OX
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
: H * "@ H * "@ H * "@ H * "@ H __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>161
<FILENAME>g20922ndsp7_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922ndsp7_2.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /W\H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M/_!=;_YH#_AH+]I__HX_QW_X0O[/W_SEZ/\ 43*/^@G&?^#*/_S.'^O.;?\
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MZ"<9_P"#*/\ \SA_KSFW_0/A/_!=;_YH#_AH+]I__HX_QW_X0O[/W_SEZ/\
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M$_\ !=;_ .: _P"&@OVG_P#HX_QW_P"$+^S]_P#.7H_U$RC_ *"<9_X,H_\
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M _X:"_:?_P"CC_'?_A"_L_?_ #EZ/]1,H_Z"<9_X,H__ #.'^O.;?] ^$_\
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M_P#.7H_U$RC_ *"<9_X,H_\ S.'^O.;?] ^$_P#!=;_YH#_AH+]I_P#Z./\
M'?\ X0O[/W_SEZ/]1,H_Z"<9_P"#*/\ \SA_KSFW_0/A/_!=;_YH#_AH+]I_
M_HX_QW_X0O[/W_SEZ/\ 43*/^@G&?^#*/_S.'^O.;?\ 0/A/_!=;_P": _X:
M"_:?_P"CC_'?_A"_L_?_ #EZ/]1,H_Z"<9_X,H__ #.'^O.;?] ^$_\ !=;_
M .: _P"&@OVG_P#HX_QW_P"$+^S]_P#.7H_U$RC_ *"<9_X,H_\ S.'^O.;?
M] ^$_P#!=;_YH#_AH+]I_P#Z./\ '?\ X0O[/W_SEZ/]1,H_Z"<9_P"#*/\
M\SA_KSFW_0/A/_!=;_YH#_AH+]I__HX_QW_X0O[/W_SEZ/\ 43*/^@G&?^#*
M/_S.'^O.;?\ 0/A/_!=;_P": _X:"_:?_P"CC_'?_A"_L_?_ #EZ/]1,H_Z"
M<9_X,H__ #.'^O.;?] ^$_\ !=;_ .: _P"&@OVG_P#HX_QW_P"$+^S]_P#.
M7H_U$RC_ *"<9_X,H_\ S.'^O.;?] ^$_P#!=;_YH#_AH+]I_P#Z./\ '?\
MX0O[/W_SEZ/]1,H_Z"<9_P"#*/\ \SA_KSFW_0/A/_!=;_YH#_AH+]I__HX_
MQW_X0O[/W_SEZ/\ 43*/^@G&?^#*/_S.'^O.;?\ 0/A/_!=;_P": _X:"_:?
M_P"CC_'?_A"_L_?_ #EZ/]1,H_Z"<9_X,H__ #.'^O.;?] ^$_\ !=;_ .:
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M/_!=;_YH#_AH+]I__HX_QW_X0O[/W_SEZ/\ 43*/^@G&?^#*/_S.'^O.;?\
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MZ"<9_P"#*/\ \SA_KSFW_0/A/_!=;_YH#_AH+]I__HX_QW_X0O[/W_SEZ/\
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M=E]*=:OA*=2;K1A23E6Y7*E&A4G02?MJ=.M.<)>YR\[47MZK^SGX_P!%\?\
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M&RIR6'YI)=EJ?Q6\"7_Q%\3ZF_Q+\/ZI\+?$FNVUSXA\!>*/ _BO4EU&TL=
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M8SP].52&)P>(=:I0IXBK2=6FFH4USX:?LO?FUSN=52S=$\2_#CP!XI\=^/\
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MR&:5J6)S/,<11ES4:^*Q%2G*S5X3JSE%VDE)7BT[-)K9I,JUL< 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 >L?L,_\
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M^)O_ $<-X$_\1_\ $'_T0='^O>;_ /0-@_\ P76_^: _U&RG_H(Q?_@RC_\
M,X?\.]OB;_T<-X$_\1_\0?\ T0='^O>;_P#0-@__  76_P#F@/\ 4;*?^@C%
M_P#@RC_\SA_P[V^)O_1PW@3_ ,1_\0?_ $0='^O>;_\ 0-@__!=;_P": _U&
MRG_H(Q?_ (,H_P#S.'_#O;XF_P#1PW@3_P 1_P#$'_T0='^O>;_] V#_ /!=
M;_YH#_4;*?\ H(Q?_@RC_P#,X?\ #O;XF_\ 1PW@3_Q'_P 0?_1!T?Z]YO\
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MPW@3_P 1_P#$'_T0='^O>;_] V#_ /!=;_YH#_4;*?\ H(Q?_@RC_P#,X?\
M#O;XF_\ 1PW@3_Q'_P 0?_1!T?Z]YO\ ] V#_P#!=;_YH#_4;*?^@C%_^#*/
M_P SA_P[V^)O_1PW@3_Q'_Q!_P#1!T?Z]YO_ - V#_\ !=;_ .: _P!1LI_Z
M",7_ .#*/_S.'_#O;XF_]'#>!/\ Q'_Q!_\ 1!T?Z]YO_P! V#_\%UO_ )H#
M_4;*?^@C%_\ @RC_ /,X?\.]OB;_ -'#>!/_ !'_ ,0?_1!T?Z]YO_T#8/\
M\%UO_F@/]1LI_P"@C%_^#*/_ ,SA_P .]OB;_P!'#>!/_$?_ !!_]$'1_KWF
M_P#T#8/_ ,%UO_F@/]1LI_Z",7_X,H__ #.'_#O;XF_]'#>!/_$?_$'_ -$'
M1_KWF_\ T#8/_P %UO\ YH#_ %&RG_H(Q?\ X,H__,X?\.]OB;_T<-X$_P#$
M?_$'_P!$'1_KWF__ $#8/_P76_\ F@/]1LI_Z",7_P"#*/\ \SA_P[V^)O\
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M!T?Z]YO_ - V#_\ !=;_ .: _P!1LI_Z",7_ .#*/_S.'_#O;XF_]'#>!/\
MQ'_Q!_\ 1!T?Z]YO_P! V#_\%UO_ )H#_4;*?^@C%_\ @RC_ /,X?\.]OB;_
M -'#>!/_ !'_ ,0?_1!T?Z]YO_T#8/\ \%UO_F@/]1LI_P"@C%_^#*/_ ,SA
M_P .]OB;_P!'#>!/_$?_ !!_]$'1_KWF_P#T#8/_ ,%UO_F@/]1LI_Z",7_X
M,H__ #.'_#O;XF_]'#>!/_$?_$'_ -$'1_KWF_\ T#8/_P %UO\ YH#_ %&R
MG_H(Q?\ X,H__,X?\.]OB;_T<-X$_P#$?_$'_P!$'1_KWF__ $#8/_P76_\
MF@/]1LI_Z",7_P"#*/\ \SA_P[V^)O\ T<-X$_\ $?\ Q!_]$'1_KWF__0-@
M_P#P76_^: _U&RG_ *",7_X,H_\ S.'_  [V^)O_ $<-X$_\1_\ $'_T0='^
MO>;_ /0-@_\ P76_^: _U&RG_H(Q?_@RC_\ ,X?\.]OB;_T<-X$_\1_\0?\
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M)O\ T<-X$_\ $?\ Q!_]$'1_KWF__0-@_P#P76_^: _U&RG_ *",7_X,H_\
MS.'_  [V^)O_ $<-X$_\1_\ $'_T0='^O>;_ /0-@_\ P76_^: _U&RG_H(Q
M?_@RC_\ ,X?\.]OB;_T<-X$_\1_\0?\ T0='^O>;_P#0-@__  76_P#F@/\
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M@C%_^#*/_P SA_P[V^)O_1PW@3_Q'_Q!_P#1!T?Z]YO_ - V#_\ !=;_ .:
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MKVG3A.?/"-.A4J5:481<JV'P\<116+Q%*,Z&#G)TL54HU(5(1BF_:6^&8O\
MPO8Z9;?$;Q#%XN\5Q^$M&UG0/A'\3M0\,W5P^F7NJG7+3Q/_ ,(HFEZQX1CM
M;*0R:YI-WJ%E&K-,THMK:ZGM<::<Y\CC+#\N&Q6*F\0GAO94<(J/M)UHUU3G
M14Y8BA3H2JQA"M4JPC3D[FU9?5OK:J/]Y@ZE&C*G"]2<Z]6I5@\/1]FI1JXB
M@L/B:F)H0DZM"-"=.I!5YT*-;8\"?'+P9XUTC2+XW0TK5-8\06GANTT%H=6N
M[QM2U?P_'XUT"&-FTBW-Q]J\!W>G:Y-/#&]I9QW$\4MT6LY6&_U:M%8.+IRC
M6Q&&G6J4]+X>IAH1CF-&K)-J"P6+<L'[6K[)8BJ\/[*/-B\/3F5X5,)/%QQ$
M53CAJ]2G"<9<\:U%YEB<LPF(IN*][ZU4PM2?LX<[H1C5E4DZ5"I63]4^/_PF
MT3Q3JG@W4_$]Q:ZYHEU?V&K_ /%,^+9=&TS4M,\'Q>/KG2[WQ1;Z"^BV^K-X
M/D;5(+%]0%Q=0VUT+:.62SN$AY74A'"8C'-N.$PE#$8B=1II>RP>(6%Q+I)K
MFK2H5W&%6G152K!2C4</9RC-[O"8A5<+05)RJXSZM[.,;3:6,K3P^%G6Y6UA
MJ5>O3E0I5<1[*G*JX4U/GJ4U//M/VD?@_>W/AZTAU_75E\3MIXTUKKX>_$>Q
MMK:+6M1?2/#MYX@O+WPE%;^$M-U[4HVM]%O=<ETZVUE\?V5+>!E)Z9T*U*I7
MHSIN-3"QJNI'3W9T*$L36P][V>-I8:+KSP,6\9&BX5704)PE+EC.$J"Q%.<9
MTG"%5.#4Y.A-1:Q*A%N;PD&W"OBU'ZMAZL*M&O5IU:-:$-"3XY_#^X;PM%HN
MOZ=>2^*H="U:T_M&'Q+I%O#X;UK2_$'B!=3NKH>&+J/2[U?#OA/Q'?1V.KG2
M]PTMDN)[3S8V?.<'1GBO;-4\/E\*]3%5>:+A1C1PU*M>$KJC6M/%Y>JRA6O1
MHXVE62J3G0H8C6I1K0E5H4X1EC*56-'V'.E/G69T\LJ+EASU+^V>(AAG&E.&
M*JX6O&$XT,/C,5A.(@_:O^%\VJ>)(MGBZ/P]X=TWP_<1:V?AW\37U/Q-J6OO
MXDG2T\%>#(O!#:WXTT>VT/PU<:O)KVAVNH::;.;STG:"WGFB7*Z="KB*_P#L
M\:=>I1Y*EXU:*PU#"UL96QU.2B\NH898_ 4Y5<9[*//B4JGLKT77A.G4KX?"
MX>M3KUJU.55J,X^SY9S=/!1P]>_L,;5QT\/F*HT<+4J5KY?5Y83YGR>J^$?B
MOX&\>:K=Z1X1U'5-;>QTS3M6GU:V\*>+8_"GV?5;*PU&QMH/&MSH<7A^[UEM
M.U33[I])M]3EOXH+N.6:V2,[AM/#5Z7UGVM-TOJF(J8::G:#=6C5KT*OL8R:
M>(IT:^&KT*M?#JK0I5Z<J,ZD:EHOFI8O#UOJ_L:GM?K-&->#@I34*<Z=*M3]
MNXIK#5*E*M2JTZ&)=*M4I352%.4+R4>L?%[X?:#XRT[P!J6M74?B74IK"U2*
MU\.^)M2T?3;W5@_]BZ?XC\4Z9H]QH?A34=4,;+I]IK6HV$]^V%LXYV8 X4+8
MF5>-%J7U;VO.VU"+E0H?6J]*E*?+&O7H87_:J^'HNI6HX;]_4IQI>^;XB<<)
M3I5:[5.%7V;CUDH5<0L)2JSA&\Z=&IBI+#4Z]2,:,ZZE2C-SC**AT3XR_#OQ
M#H$GBG2M8U!_#B>)=)\(PZU>>%?%VE:??Z[K>L6/A_38='N=5T*V76[&36]1
MM;%M2T\W-C%.98YKB-K>8152A*K3P%6GI',J+Q&'4FJ<I45A)8[VDZ<W&=&,
ML)"5:FZT:?M(JU/FDU%Z3A*G4QM%J]3+E7>)4;35+ZM5JT<1&4H<T7.C.A4]
MI3BW.,%&JXJE4ISGD#X\?#O4K;3F\*>(-/UZ\UC5(]*TN%K;Q/;65Q*OCA?
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M!G4C4E#E<O95LOH5:<G>I.\Z&)GB,)R8>'13J>P>7^PIPH+*X8*&&48+EI/
M5LQJ49J,KJ4I4LUQN%G&2=-4*D9TJ=+%4X8F,OA+]FCX=>"/B8OQ2\/+/;:Y
M_P (OI'A6XM;C0/A[?"XM-#T/2O#FG7*^*;OP1)XPTUDTG1=-C;3M-\366DO
M);M.^FF>:623T/KE7GS:7NK^U\35Q=513IJ-:M5E6J23I.#K7E.:C]<>*=*$
MG3HNG%14>54(1P>2X%7]GD6'IX6A*7ORE0I>U=.-134J<91G6J3=7#TZ%6<F
ME4G.$8P6P/@5X?\ ^$C\0^)G\2^+Y+O7;CQO>06C2^&$LM OO'FA>&?#VJWV
MBM#X72[>]M=/\,Q+93:G=:DT U6_A8R6KV]O:>?*A2EEU3+)PYJ=7#8K!RJN
M4O;?5<9F=?-<304DU",*N*KKF<::DX4,/>7M*;J3[*=94L93QL:-/VE/&Y?C
M^5Q;B\3EN75,KHR>O.HSPE3EK1C.*<XQE#V?-44^1LOV<X%34'B\6^(O!.IV
M?C>UUWP9KG@2XT*75=!\.:5\.](^&.GZ"Z>,/"6K:8\=QX<T^]\]!ICM;RZG
M))97$4Z+/794KU*[A7KV6)Q']J_VC&#<:6-CF>;/'RA.<>7$0M1PV5TO:T:M
M#$P>"5.G7]CI/@CA84Z5+!Q47A,NHY;0RV3BO;87ZAA*L/;2WHU:SQ>89LTJ
MU.M0G0Q,/:4/:17)T^E_L]> M'T>YT"TEUYM*NO%'P^\42VUU?6EZS2_#2/P
MZ?#FDRW-UISSW6DM?^&[?4;O[3+-=W%WJ%_*;M1<!(W"NZ-7!U:5*G1>!K8N
MO3A""A3]IB\)5P$7[.-HP6#PLJ%'!1HJE&C' X/F51TZGM>BMSUEB;U)0JXO
M#?5*]6'+&I5I3Q^)S#%\SY7&^.JXW&4L7:*BZ&*JTZ$:#]G*&?KW[-W@W7K&
MWM7U[QAIUU8:OXM\3:9J]A=^'Y-1TWQ;XM\>Z-\17\50)JGAN]LKC5=,UW0K
M&"QAO+2ZL5LO-M;JSNUD)K&C*6&EA)X=JC6P6&PF$I5(QCSQH8>-2.(C:47"
M^9.HZF82Y.:550JX5X6<5(WE7J3^MJK:K''3JSJQE%)-3RZME-&FG!0E&&#P
M%:=##N,E4DE&>)GB:BYWD7_[+?AF^T=-'D^('Q.7SM/^+VFZWJ<E_P""]0U3
MQ+#\:+B"\\32:Q-K'@>\BBFL;JSL&TTZ;!IZP16$5I.MU9/+;37"I[!TOJ].
M&'AAJ.!I4:<(IQIRR_'+,:5?FGSU*E:KB?:2Q:K3J4<6ZTZE>C.O&C6I7#%5
M8RE4=I5I8O"XR517I3]KA,MEE4%%T'25*,L+)ZT53JT:EI86IAXI1)]3_9A\
M*:W_ &];:UXT^(6IZ)K8UZZ@\.37?A"UT;0=?\6>';OPOXJ\4Z.--\&6UX^L
MZGI.HZJCQ:E>:C86AU6Z_LZQLDD"(8>:PLXRA3C)4Z_M*<:G-.-/#O-J><U,
M"E*3Y\+6QE)*K.LZF-EAY3PZQ:IR:.2'M:,:7U?$U<+5ITL/"=6C)4ZE:O@\
M%# X+&5%&/LU7P=*CAZM"E2A2P2Q>&P^+J82I7HPFN[U_P"&\T7ACXLVW@N^
M%GXI^(^E7-O:7FKSB/3=$OHO!UGX0T6*T_LW3C-:Z19PV$=V(MES+Y]S=,'"
MRJD6%>E3Q>'C@<2G+"8G%2JXZ47^^K4L7B:;Q\[OW95W@H_5J%U"+C1P\*DD
MU.L^G!5HX'%8#%TZ$:CRO#T*&'HW]G3E'!U,1B</1G-1G*$)XG$5/:U>6K*G
M"I)TZ4E"-)\;/^S5X4FU"[FB\5>.-/T&]@T:>?P/IMUX8A\)KXH\.^%]-\(:
M!XTA$_A2;6!KFG:-H^D"VLWU>31UGTRVNFTI[F/S3MC)/'+'1Q+E4>+GF$J<
MW)J>%6:QQ$,PA0<.6,EBH8O$QE+$QQ%2DJ]18>=%-)<V#7U/#9-AE"FX9/0R
M[#J/):%>EE>+^O82G65[QA3Q251J@Z,IJ,(5)3C&QU7CSX'>!OB#\*K?X/:S
M;RP^$K"S\-VFFI'8^'=5>Q/A*6QGT&9M*\5:%J^A:N()M.M6:TU;1]0LIPA2
M>UDC8K1CYSS#'?VC7:6*6)JXI-0ISBJE>G6I55R5H586E2Q%6$7;VE)N-6C4
MIUJ=.K&<!2AE^!CE]#F^KQP\,,[U*D*CA3=.4).I1E2GS>TI0G.S4*MI0JPG
M2G4IRX]OV8_"377AR1?%?C6TTS0K3X>07_AK2(O /AWPUXJNOA?KDFO^$=1U
M[2O#O@.P6S:WO9[E9-/T%]%TJ1)PQT\36]M+;ZSQ$JF(Q=:I%5%BJV+Q"I3G
M6G"C6QV5/)\54IRG5E6G*IA(T'%XBK7]C7PU&K0]DY5U6RCA84L/&A0D\+-4
M(825>BH4JL\'3QDL;'".,(JA"CSU<12J.C1I5:^&Q-?#UZM6G*"AN>&/@+HW
MAFS\*Z>?&?CC7;#P"-=B\ 6NN'P45\&V6LZ!_P (S:V&E3Z/X*T^XODTC19+
MVWL;K5YM3O=NHW/VVZO=R>7SXIU,93Q7MZLWB<=EU?+<1B8VA6K4<17PN(J5
M91BEAXU^?!X=*5*A"ERQ=Z3E*4GVSFJF*>)G3C*+S.&:^Q=_8K$QCCE.-K^T
ME1JSQ]6K.G.I)QJ0HNC*E&#C+)\5_ W4-5M_@QX7\)>-==^'_A'X36UZ\&J>
M'?\ A%KGQA->6?A=?!OAZUMXO%O@;7M(^RR:)JOB3[;>I;V=Y%(]L;)D,SR6
M^]:O/%9IC\RQ+M'&8:O0EAJ7-"E4^M8S"8BM"4XSCB*%*G3PD:5+ZM6A7:JR
M7MJ<(R5;%0<,M^J1Q%:>*EBZ%>KB*K4ZE6-.EC9U*M7:C7Q$\?5PN+=/$8>K
MA95*4JSIJK2H6YZT_8]^%.E>(/$/B+P_-K&@7?B;P%-X U-[32_A]J6KBRF\
M/6WAG^V+/QSXD\":GXRLM673;.U<P1>)%TN:ZC:\N--FN9YY9LXN"H8S".A2
ME@L95I5)X:,%0H\E*I"7U;DPWL/:X>=.#PW)7=:5'#3E1PL\.HTW#K^MUOK.
M68R;53%975G6A4J+G]K4GB,1BW.K3E>E"7UO%5L0Y8:GAYRG)0J2G1C&FNP\
M7_L]>%_&VK)?:SXD\71:3:>!M1\!:3X6TK_A$-*TG1],U33_ .SKN[M=6L_"
M">)+V8Q+;RKI^IZ]?Z.MS96MT-+^T6L,D;5:NJ^/Q:K26.QN(PN)6(M!SP]7
M!XNACL/*E3<7AZCIXNA&M">+H8JK!5,10IU(8;$UZ-3SXX:A'"8#+W3YL#@*
M52BZ#E)1Q%.KA:^!JQKRC*-6,:F%Q$J-2.%J8:,^2C4DG5I0J)=*_9]T&QO9
M=:U+QGX^\3>*KO3/%5AJ/BW7KOPJ-8O[KQ3H^B>'CK)M-%\):=I&FZCI6AZ%
M#9Z='IFF6-E$FH:B\]I<S7TLIQKTJ%?"XS!_5X4*..P\\-6]GSJ<H5JL*V+D
MYRE*;J8R='"JNY-J-/!X2CAHT*6'IP77AZLZ%3 U96Q-3+L5AL30=6,+P6#A
MF$,/AOW4:5Z$/[3QDFW?$5)U7*IB)N]]OQ+\*[35(/AQHFG162>%O"%KK7AS
M4M.NII[>X/A35O >K^$%&CS6ELP35H6N+! 7\A/L\MYAP^Q7O&_\*6*SBOCI
M2_X6,OQN$JNDU&4:N+Q^6X[VB4E)<L7@9QL[VE.$K34'&7-@J,<NPV3TL&U&
M>18W XO#>TBIJ7U3"XS!<E1IQY7[+&RK<\8RYZE%4G&$:SJTO/C^RUHLVFRZ
M=?\ Q2^*NJ-?:CX1N];U'46^&,NIZQ8^!K9[;PQHD5Q%\,8U\)V5B7>XBO/"
MD?A_5(KJ22ZAU".XEDD?>GB:E/&4,;93G0QN(S%PES<M3'8FC@Z%7$5'&4:M
MI0P4(RPT*D,'4I5J^%K8:I@YPPU/*6$H^PQ&&I7H4Z^!IY9#DM>A@*57'5:>
M'I<ZFI<KQTDJ]=5L4GA\-65=8F$ZU3N/B/\ !#1/B7JL.I:CXI\:Z!#)HL7A
MS7](\,WN@VNG>+M#MM8@URSTS7Y=5\.:A?QVL-_'.&32K[3/M,-_<6][]IA9
M$CYL,EA<9]=A[TXXC+L4J<F_9K$Y5B*F(PE7EARR;BZM2$H2E*DXR4U3C7IT
MJU/HQ$%B<"\#/W8.CF&&]I'6K]7S/"T\+C*7-/GA[\:.'J1J<GMH5*$>6HJ5
M2O2K><2_LJ>%M'\0>*/$'@ZYCL9/B%\1/"?C3QK:7VB>!;5S;Z'XUMO'>L06
M?B?1? <'B[7FU+5;0P_8?$?B74[*V@OIHK-+6"*."M,!4>!CEF%4(SP.75L1
M7C%KDE&H\!C*.$<:=)4\/4G1QM7"8F6(K4Y8M_5E-XB=1+FUQ]2IC?K5:\88
MRO@H8#F<>>$J$_JN#Q3?M'.5&<LHIXC#T5AW3H>VG"I4HN3G4780_LY>#EM?
M%-G>:YXLU.'Q5I?Q!T.?[;+X:232M'^)WBZ?QGXNT[29+#PQ;,([K4IE@,UZ
M;VX:VMH$EFEEB$U&'J3PT,)",G+ZI_86L]?:KAZKB*F!C5BN6#4UB9T\5[.-
M-UH*,DX5G4JS5>=2MBI8V-2=#$+Z\Z4Z<I<V'J8["8'!RJT)3<Y1J86. I5<
M$YRG'#3J5:<(O"^QPU+F(?V1_AWIVK>/-<\.ZQKWA75/'7B73/&3:EH'A_X3
M0:SX<\4Z5XB'BF#6-+\27WPRNM:U[.L&5Q8>+M1\3:?;Q3M;VEG;0)''$L-.
M>$H8+#TIN,,!7JU:;7N7AB,-B,'B:%2%)4Z4XXC"XJM2JXET_P"T'>-6.,C7
MC&JEBE2QLT\10A."PV'PSIOGY7]3>$>$JI\_M*4\-+ X64*="=+"U'2?UC#U
MHU*JGZ#%\$M MOA?/\++;Q'XOAL+C6[KQ)-XGDO=%O\ Q;-K=YXW?Q_=7]S<
MZKH-UIM\TNNR.LD=UI<\4ENQAD1LEC<JO-5R>JH1BLE67*A32]R4<LITJ5&-
M6[<VZBI*=:I3G3K>VE*M1J4:O).$04TLT]K5GB*F;T\?2K5*KBY1AC\/5PLH
MTDHQA"&%P]14<'3Y'2HTZ-&FZ<Z<.1ZGAKX2>&_"VIZ+JUE>:S=W>AW'Q&OH
M/[0GT^2.ZU/XH>);?Q1XBU6^%MID#2W\=U UI:NC1K%:7,T4B3.RR)-.?LH0
MIQA%>RP."RZ$K/FCA\&HMV::7/BZL*6)QDFFJN(I0J4XTESQE4W4JJI[:K*M
M*IC%CI2GR\WM*>&K8+#TTU%*-#"X.M+#8>G%)QHQIQG*HX19SWB#]GWP3XFT
MVQT_5+[Q*TEA\4IOBPNJ6VHV=KJ=UK5SK#ZE<Z'?RQ:8(;OPI-8M%H[V+P>8
M;"SM1]H%W;QW:SA^7"5<LJTH)/*J-:C2C*[C/VU6>+E5JIN\JL<R<,T@X.$(
MXZA1DH>P4\/-XFV)IYK2E",%F\*$*KC&/-3]A@J&6J=!S4W3J5,#1GA*M3WI
M2H8K%4TXQK6CT"?!CX<7?@:'X=>*?"VB?$'PM%JNI:[-IWQ!T/0/%5O?:WJN
MLZEK]WJ][8:AI1L9=0.IZK?2I*MHA3S2%QR3E4I0JTL#2G%-Y;A,+@\/4<8N
MK3AA,'3P-.I&4DTJTJ-->UG%)3E*;Y5&3B$)3I5,=.%2<?[0Q&(Q%://+EE]
M8Q,L4Z.KNZ%&;A##TY.7LJ5&C!-NG&1P%G^S!X+T?PGX?^'?AOQ#XH\)_#/2
MK*>RU[X<^&=.^&^D^%O'HNK]M1O+KQ6(?A\=2M+VYN&(FE\.:CX?\V/$;AD4
M*.FG6J0Q.#Q-2<L1_9L<#]4IU9SE##5<N?M,-B(-2C5E5]LHXBJJU6K1K5X^
MTJ4I.=3GSK4J52ECZ5.G'"?VE4Q\\1*BDI3I9@E3K8:T^>"H4\/?"X9J/M\/
MAFJ=.LG"G*'H%]\%_AK-H?Q"T/1O".@>#/\ A:=M?V_CW5_!6A:%X<U[Q+)J
M<5W#>7^L:G9Z7OU74Y([^^'VJ^6YDS>3-G=(Q,4I.A' TJ;Y<-EV+H8REAUI
MA_:T*]"NXNDK14*SPU*EB%!0G4HKD4XM1E'7GJ*O+%PJ2ACWA_J]/%JSQ-&$
M*4J6'E2JS4FI83F53"J?/3I5(0?LY13B\'5O@)X4UKQAJ'B?4-9\52:/J]QI
MNJZO\.TN]&B\#:GXGT718/#ND>*[V./0AKDNK6>C6=A!#;#75TQ9-.M+LZ>;
MZVCN5RE3C4P^+PU:]>&)6,4)3E)3PJS&A/#X]89P<$GBJ52K&<JT:TJ?MJWU
M>5%5:BE7M&J>7TZ<8TEET,)2A:*E[2C@,;+,<'2J*ISQ4,/C9.O%TE2G4:C"
MO.K2C&FN:\/_ +/,?AO5_#X'BS7_ !5HVGW'ANYU/4?&EUH][XCDTOX<&[F^
M%_@/3(?#WA?1[&#PSHNKZK>ZP^I7/VG5KFYL;>.\N+T7,DT'='&5G6GB*\E.
MO&6+Q/M(I1GB<PS##?4,7C<3R\M&GR9>I8>CA<+0I89U,1+$QAAZM"3QG$\)
M2AA8X*AS0PD50H4L.YU'1P6"H5Z6,]AA$Y.I*IB,1A\-#$5\74Q%2>#H_5IR
MJP>'>$ZKQU\#]'\>:]K/B"[\7>,]$N=8\->%= ^RZ%)X3%GIE_X&\7S>./"'
MBW3#K?A+4KF/Q#INO3RN(9[BXTFZC*I?Z7=^5&4Y*,JF&]HZ-1TZLL52Q<*G
M+!SHSAAJF$J0A>#C.EB,/4E3J0Q$:WLKRGA'AJE2K.IZ+Q$G3H473@Z="EF-
M"4?>7MJ.:4:-#$TZC4E*/+&A3E2G1=&HIQ]^=2"4%-/\$O#]W\,_%/PUO?$?
MC.Y'C4WEWXG\=+JNGZ?X_P!2UV^^R>;XFCU72-'M+#2M;B^P6 MFT[2[.VLU
ML;=+2VAC@C5'55&K_9]/ZO"GA<LQ%'$4<-&55TKTL>\RE2G*I5G7G3Q&*G5E
MB+UO:SC6J*-2#<7'EIJ5.>855/FKYE2JTJU24*5^6I@5ET>6"IJC^YPL:<*4
M94Y0O3BZL:MY\^3H_P"SA\.=!O+RZT]=92&[\8^#?&"Z;-=V4^G6;^ =/@MO
M#'A^QAETTO;^';75(6UPQ>:US)J<\L[W9B*P+K"O4IRPDX/EGA*V:XB,EHYU
M<WAC:6(E-*T5&C1QU>EA:5-4Z-&-I>SE4E5J5,ZE"%6GB:=5SG'%4<#1J<TY
MR;>"K8*M[=N4GS8G&/+\+3S"M/FGBZ5*$)_PZ3IY<7[,OA"VU>34;;Q7X]MM
M/U._BU?Q=X9AOO#*:%XYU>S\8ZYX[TO4?$TG_"*'5%:S\1>(=1E%KI.IZ59W
M41C@U&VO8DVG&ES4L/2PO,YTL-3H+#J:B_JV)H9?A,MCF%*T4I8R5# X:I^^
M57#4\536+P^&HU[36M9>WKU\5-OV^*A7P^(G\3K8"M/$-9;-3YE#"4*>)JX>
MA*BJ6,AAFJ,L5.,4:]O^SSX)MM#@\/\ ]H>(YK&#P1H?@!FGN-&:>YT/2_$,
MGB76);EET)8WU#Q+?.J:Q*L:I-%$GV2.REW2MJJD:=>%>C2AA_98G*L13ITW
M-4Z:R--95AH)SDUA\&Y2E3CS>TDY.-6K.FHPB\1&GBHXF%:E!_6EGZJ-)Q=^
M(U#^T)))J*E%P4L/96A)R]HJJ=C9^(GP:T7XDZC]NU;Q%XITJWG\"^+_ (=Z
MGI.B-X:33]8\.>-'TN358[N36/#.H7UI=(^CVABDTZ]L0PW+<I<($6.,._JU
M:M5LJT:]7*J\J517I>TRC&5<9AG:/+)QJ>WKX?$PE.5.KAZTK1A7A1KTR;JI
M81X>O4P5? O%NA7H-*I3EB\-'#N:C-5*/M,.Z=+$86K[+VM&M3LIRP]7$4*W
M&>/_ -EKX<_$344UC69M0CU:V\6Z?XNTV[ET/X<^)[?1Y],\.Z-X8M])TW1/
MB!X#\0Z1!IJZ?HL,D<[:?)J-M<7=W+9W]L9L*J#^KXS#8Z&N(H3Q4ZDG\6)>
M,Q%'$576J1M5IR_V;"T(U<)4PU;ZMAZ=*527-5E456,:F#E@.50PZP^&PU.,
M=%1IX18Y4K1=X5K/,<9*5/%PQ%!RJIJDO8T/9]M\1?A';>/Y- N(?&?BSP1=
M^'M*\0:);S^%M.^'>I07FE^)K?3;74[/4-(^(?@+Q/I4T9@TN"-#%80E4FN(
MB6BG9#A5HQK5<34J2<HXNA]7JTY1A.,Z?UBEB6FZD)5%S3I04K5.622E).I3
MI5*>M*JZ-"A0@E'ZMB:6*IS5X5(5:.%QF$IN+IN"BE#&U)VC%?O(4[-4U.G4
M\_F_9;\-7-LUE<?$#XE26=OX!7X>Z)"LO@"VF\/Z:/L4LE_9ZE:?#^+4-7NF
MOK&*\33]>N]8T6UE9ELM*MK?; F\I3=>OBHU)PQ-7$9?B(U>:4YTI997HXG"
M)JJZD<3.%6A%RQ6/CB\=-3Q$98MK%8GVO/&C1]AA<+4I1K86A2Q]*I1:]G#$
M+,J>)H8OF]A[*6%A*AB948X;+I8'!PC2PLEAO:X3#5*6?K'[(/PXUZ\T'6-8
MUKQ/K/B;0O&^J^/1XG\3:;\-/&FI:CK&MP^&X-3BN+#QM\.]8T;3(&B\)Z$E
MO<:+I>E7^G1V?DZ9>V4$CQ-IA:OU*O@ZV'IQIQP5'$8>$/?NZ6(QN+Q\X2Q#
ME]=C:MC:T7*EBJ<JU+V<<5*NX*1<G4GA<PPM6K.LLPGA*DYRY4Z=3!X%8"E*
MG2A&&&Y71]I4G1J4*F'^L5ZM:%&$G#D]AC^%/AA?!/C7P#<2:I>:-X_N?&]S
MXCGGN+:+4ICX\N=0FU2*WN+*SMXX(K6VOQ96?[EFBM[&U61IGC:23":?U?!T
M*4WAOJ$:7L*D.5SA6I5WBOK+555*<JU3&.>*JJ=.5&=:<U[%4G[-=6'Q,\+F
M"S*E"$:ZGAI\G+:G_LF%PV#I0Y8M/E]AA:49>]S-\S4DVK>57G[+6@:EI=[9
MZI\3?BOJ.KZGX@E\0ZEXKO+WP$^O7<TOPTO?A4^GQ0)\/DT?2-+7PYJ-]/'%
MI>DV+PWUU+/!)&LKQ-NYTY<L98:D\/*.+CB*#4^3&+&XK"8K$/%2Y_;R<I8+
M#T(NG5I..$@L*OW*4%GA:T\']7=*W-A(9?2HMZ<E/+,97QN%@X0Y:=6*JXB:
MFJT*G/RTZ[_VN"Q)T&J_LV?#K4_B;H/Q3\E[37M"\*VW@P6JZ!X U.WO= L+
M74;33;6/6O$/@O4?$GA@VT6JWASX6U[0!<$Q_;!<K$BKE/\ >QSV%7]Y'B%5
MOK:NZ<N?$4Z-&K.-6BZ=:7-3H4DJ->I6PL)1=6G0C5J5)SY:=*-&GDU*E>/]
MA>Q6%;M448T)RJ03I55/#QES3J*5:E1IXB4)NG*LX0I1INT_X VECI?@O2)/
MB9\2=0M? <.OZ9H!O1\.!.GAG7?#Z>&D\+7,UC\.K9GT_3M.BA^QZA'Y6L[X
MS]JU2ZCFGCFG'J68O'5,9)U<1F>7XS+\75TISKK&UZ.)J8J4::C2IXB-7#TG
M"-&E2PEH+VF%J%X.%/ 1PM+"4XTJ& QV#QV$I:SAA98*E7H0P]*51RJ2P]2C
MB:].K[>I6K\L[TJ]*48RCD?!GX(ZGX&\0:AXL\67=I=ZI:>'M"\!^$[&SU2+
M6;>P\,^%[*+2(?$VHW5OX.\+68\;:_IMCHZZBFFZ'8V=I#I%I8VIG2.6YN^V
M>*=2./KSIPCC\ZQD\?C7!3]G2J5:.%ISP>&G4JU*D\,JN&>)J59*B\36G"4\
M/26'HI81PL*,L%AJ#DLORC#0PF$A*7O3C3KXVK2K5H)*$*E"EC:N&P\5*M4I
M4ZF)<\37EBI\F);?LQ)XC7QO/\3O''B;6_\ A,/$_P 0-;M/#.D3>&+7PMX4
MC\6PZKX5M;_1KB+P/9ZSJ>OGX;W5MI$\OB"_UJ"V:>\73HX$$3CGP4E@*&60
MIMUZ^"AAYSG6]Y>T_M*EGF.PE.$>2G]1KYI"2<W3CC9X1>S]O156I ZJ\ZD\
M7CL1A9SRQ8ATU'ZO.TY3PN7T<NP>,JRG!WQ-%4(8VEA_?P5'&0H5)TL54PM*
MN_2-6^!_A[5_&?\ PE<_B'Q9!ID]WX4U75/ %K<:!'X*UK7_  -+;S>$]>U)
M9/#KZZ+K3GL[ I9VNNVNFRMI]O)<6,TL>\SAF\+5KU4W6G6K8G$0]IJJ&(QF
M#C@,56IJ/+S3K8:"A:O[:-&5ZN'C2JOG(J0C+#T,/3OAHT<-3P4I4I2A.M@J
M5:KB*>$J-N25%5:]?VGL52J8BC6J8;$U*V%DZ)QZ_LJ?#N/P[#X8BU;QDFF'
M5_B%JNJO)J6C7E_KT?Q%T+6?#.H:1J-_J'A^>:TTG2M!U=+#2$TMM.GL+72;
M*U6=[87$5T4G*A3P5.A)T?[/RREEE"4;<T51Q&78R&-GS*4:N.^M97AJTYU8
MSP]1\].IAI453I4]X5JD,:\P;]IBEFL,VA*>JHUH/&_[-2CI&&$E',,6I4K.
MISUZF(558N<Z\L/6/V/? ?B-+:Z\4>+O&OB[Q+:>+=/\8Q>+?&&E?"7Q;J*:
MAIWAW1_#$=I;>'_$?PMO?"FFV+:?HMO(IL/#MK<VMQ=7<]A<6C7#5<*D:.+P
MF,HT:=&KA)8J4N52OB'C*]#$5W6JN3Q$9REAL/3C5PU;#U88>C##0J1H+V9S
MS@IX*6 DW[%8?#X:G:R]G3PCS#ZO[B2HUG3AF>*@XXJE7I5+PK5:=3$P]N_3
MM$^$5QX>\=ZIXZT_X@>)9Y]?O+,:WI-]HO@.#3V\.Z5:ZC%I'A;3O^$;\):.
MXM+6ZO;=UU/6#K>KBWL$LX=0A@ED#1AF\/3K4I-UX5ZE6O4<VU*IB9J,*=62
MC:E%4J3J*7L*5&MBJD<)+&XC$4\'3HR=>*JSHU(I4)8>A1PU-17NPHTY4ZE;
MEO><IXBI23Y:M2KA<+&MC?J&%PE3%2JPKZE\"M!U/QMJOC"7Q5XT@L]9U73?
M$VH>"+>Z\.+X/F\:Z+HUAH.C>-6$OAF36VUFQT[2M*$-F^MMI GTVWNVTQKI
M/..3IWPE7".<FG#'0P]2]JF"CF-&O0QJPW*E3DZ\,5B/>Q5/$RI>VFJ#I0?*
M=%:LZ[POM:<)1PT<)"47'W<13P..EF.&I5KMM0IXJ7._8.C*HHQA4E.*L:>L
M?!?PEK'PCT_X+O=^(=-\*:7I'A;1K*^T;51I7B6W@\(W>E7VE7=OK-K;*;/4
MC<Z/:R/=6T4,@9I'A,,FQX^K&UGC<PAF%:$(SCBXXIT8IK#SBI/GPE2G)R<\
M%6HRGA:U!R_>X6<Z,I6DV8X65;!T:].&)J5*^)P^+H5,34<)8B4\;1K4J^*;
M4(T_K3E7GB(R]E[-5[2]DX+V9S=G^SCX&TEF;0M2\3:$Y^(5G\0D;3[G1)5M
MY+#3]2TZW\(VD&IZ!=PV?@U(]:UF=+2&-+J&ZU:YN[>]AN7$J<\XNK1IT*M2
M56,8YLI2DUSU9YQ3KT:]><TE*-:A0JTZ&&E1]E&-'"T*-:->F\1'$**5.6)E
M%)?6*.58>*<8R5&CD]7!5L+"DI)WYZN!A+$2K>VG4=:LHR@E05!_A;X)R?#3
MPWXCM/ OBK7=6UR[^&N@^!= 7QD_ABVTRUN/!>E:U8>%=0NKOPIX(LKNW<G5
M8X[LQQW-N$M5GM[!+F6Y>\>:2K9E@LTPCE&A/-L35Q-6M%2YJ57$X+!9?B)T
MJ?.J=G2P5.O&E:*5?FA3G0P[A3I;X)8:EFV"S#%*<X4)<M9*U2=6@\RQ68\L
MG5ES5)TIXW$TX3G54ZM.47BZE>LO;F+\/_V9M \'6_@676/&GC?QMK?@1?#4
M6EZAX@D\(VMM'IWA30M<TC0_#<&D^%O!VBV$&@65UXAOM222.TCU*XN[6PDO
M]0NTLTBKOKXN$\;B<93H0]KB)8F4JLU^^G*O%T8U9N#C3C.CA)U\)1I484L)
M2I8O%RAAE6KRJG#0A7^I+"XRK]8E*--R;]_V=7ZU@L?B94ZM1/$57BL;E^&K
M5JV,J8C$3]FDJL%*2<MQ^S'X1O;'QAI5_P",/B)>Z3XFT?QWHFAZ:^J^'K:#
MX;VOQ(OI-4\57/@6;3O"]O<_VK-J;BY@U#Q#<>(+FS*^3:RPVSO!)Y\(*&&P
MV';<JF$CEU*GB;N&)6%RJIAZF!PD:E+V:IT:+PF'YIT8T\37=&E4Q&(JUJ-&
MI3ZZ<H4\54K.A1K8:OB*V+K8&K3C5P=?%8JGBJ.+K5H3O5FL53QN+A5H.M]5
M4<155*A34K*S??LV^%I+FTN]"\6^.?"%SIFB^!='T>?09?!]S-I,W@#4?$=_
MINN03>*/!NKR7NM7R^+?$,&H/J+7MO<#4I+E+>'4 MXNTZCG5=3EC3BL74Q4
M*5)>QI485<M64U<%1C2Y/8X.6"C3I4Z=-QJX7V4'@ZV&3FIXPAR82G@W*=6,
M*%:G*=6<JM2K6JXW"YE]>K.HY1GC8X["4L1*IRJGBI7ACZ6+I1I0I\O:_LB^
M"-"\1>'_ !MX3U_5M+\<^&?#-YX<L/$VO^&OAMXYU&[DN+O7M1@UO4=5\4^"
M+G7;/5(=5\2:I>N?#VM^'XKZ:1/[2CO$C"%8>I+"QJTZ+]E1KT<%AIQ@E3FJ
M.#PV P-J=2"4W.>"R^A2C#$?6<%1JIXB&"YY5%4FI1IU73G5A[:='$XO%Q51
MRE3=7%XO$XZ<94KJ$:?UC%UE*>'6'QLL/+V'UR*A1G2]:^(OPGM/B-;Z$EQX
MQ\:^%=1T*WUBP&N^#[KP[8ZQJ.E^(=+&E:[IEW-JWAK4H+.*]BCMYC=:7!IU
M[;RVL;6EU;J9$DY<1AJ.(J8F4X.-+%X6O@ZM&,I>SE0KU:-;E;;=7]U5P]*<
M/WEIJ+IXA5Z4YTY=6'K5<-2P\%)5*N$Q.&Q=.M.,>>.(PT*U)5.5)47[6CB<
M11J1E2<5&LYT52K4Z-6GR,OP.T_PIHHE\!6HUG7]*\3Z/XPT;1O%GB-- \/:
MAJV@_#^S^&6BZ=K6L:1X+U>\MM"T[P[:0WD$5OIT\IO[6-C(L3E4Z\;7K8V;
ME4C2<ZSS.,ZDHR?LO[9Q=;$8[%0IQE'VV(IT<15P5"G*K1A/!-8>I6C-+$QY
ML%0I83#+!.K5EAJ6%P&%I1]R4H4LJE2Q.$P].325*%;'T5B\354:DXUZ^(K4
MZ<HR^K.[X ^!'A_PG\&;GX1ZO/)K$'B'P_?:/XSU6W::RN-5?5=(71+I+*5I
M)+BTL+'1X[32M-CEEFDMK#2K&%I)&A+O6-J?6%0IT:U:G'!>R="M.4)XGVU*
MJL0\;5E*$J4\77Q:EC*[=-T95ZDHJG[%1IKJPN*Q-#,JV<2Y?KE?&5<8X?%2
MI<]:=6&%IVC3;H4%/V<6HTY5'SUY1C6JS9G:G^SO9Z[!ID'B+XI?%'7?*\.W
M?@WQ7+<O\.-/D^(O@^YOI+^+PUXN&@_#C3X[2PMWFFA6;PTGAZ\FAGDBO+JZ
M5VRH553QTL=&E!3E+ UITGS>QGB\NG6JX7%RCS<WM85*]2<J*FL%4NHU,)*$
M8Q7-"#HX:EAJ%6IAWA'B(X6M2FX5\)1Q5/#4J]##U%\*E'"8=PQ$U/'4)TU4
MPV*HU&Y/2_X9[\%)ITVG0:CXEM1+H?Q7T07EM=Z3'=PM\9->@\0>+]9B/]B&
M$:VMQ MO9SM"T<%LSQF&1FWUG>,J,</5IQKTHX;*L'.-17]KALJ;DZ51QY6X
MYE-JIF?+R^VJ1C.A]6=[[T:U?#UZ=>E5:E1QLL?!.--QA7C1>%P-DX-^RRO"
M2EA<#2OR>P:CBUBY1A./G6G?LHZ3KFG>,+'XI>)=:\3Z7XGUWQW?Z?X'LW\-
MV_@KPG:^);34_"&E7VDO;>"]/UG5]>A^'$UAI<K>(M0UNTMW-TEE!'!LR.[P
ME"E*I*MBU2C*IB*JIU94\16S&&=XVG0I3A+"SPLLX3J0>(PM2M6P\(T:[]E6
MKT)8TXPP]>K]5@\)@FL/1="E5J0^LT<'EU#*\/4Q56FZ5>-1T*"K>QP]6G1P
M^(=*K3=3$X3#XN/7^'_V9?!'AWPU8^&+35M;%OIO@;QYX L;O3M$^&?@]K/2
MOB)=:5<Z[J%GHOP^^'N@:#8:VD>BV%O!<VNCPIY2.;B*XE<RUM7K+$*M&M2C
M5IXB&6TJM.;JSC.CEE2O4C0]^I*4:&+=?EQE*G*$)0HT%AXX;V=V\%SX"IA:
MF&J."PF+J8Z$.6FH2Q4Z<:=*M5481=:IADZ[H3J.4KXS%>V=95(J!>?LWZ-=
MZKK.NQ_$+XAZ=K=_J?AO4-#U+2H?AII[^#8?"C72:-INB6<'PW%EK5O#IU]>
M:<MWXKM?$FHQVDYCAOHF2.2/GBI1DJLZDZE>6+Q&+K5)2<95YXK#5\'7A.-+
MV=*BJN'Q$Z=2MA*>&Q=3DH2J8F<L-AY4I]E35.-"%.,,/1P%# 4J:U5*.&K8
M7%4:ZE/FJ5*L,7@Z.*A2KSK8*G5=>-+"4Z.*Q5*M3C_9>\+VMC+IVG^._B18
M6L_A70O#%T!=^"]2GO)_#OC[4/B-8>*+N\UWP/?7%SXBDU_5M56[$DK:?>P7
M\BW>GS3)#/#I3FJ:P\'3A.GA*V4U:4)1M&"RC"4L%0I7AR3=*K0H4O:7DZE"
MK%ULOJ8*K.I.=RUH5:&B]N\_=2=DY3?$::QUU)."]E)J>&Y8+E<(1K_6*<?9
MEJS_ &9?",$,EKJ'BSQYK]C T5IX=L-8O/"WV3PCX:/C#0_&NI>#M$33/"5D
MUUH.J:IX=TRWO9]:;5M3FLXC;+J,:A2AA)_4Z>#A&*JRP<LOE&I4NYS_ +)I
M5:65QFHN$(K NI[:DZ,*4ZN(I4:V*EB)TTQUG[>6-Y_X./IYC&K0N_8NOFU*
MM1Q^,Y&WS8FK'$5W2=1SH87V]>&$H4*-:K2GW>L?"30=7\'_ ! \'G5=>L(?
MB/JFKZQKFM63:(^M6]]JWV2,/8C4M#N].DAM+/3["S@AO].OHVM[...Y6XRY
MDSI7HPRF$)22R;%4L70UU=6EFL\X_>=XU,94FYJ'(_9RY:;@U&2F<*4ZF93G
M1A)9KAWAL1#WE%TY972RA\K4E.,GA:497YM*SE-)1:@F^%?A#X<\)W^A:E::
MAKFH7F@2_$.[BEU2;2W^WZK\3?$EMXF\2:SJ*6&D6BR:DMU;O;6S0B".*UNI
MXFCD9E=-8U%"*C"E"/)@L'E\&N:\,/@TFU%N3?-BZL*6(QDI<WM:]&%2"I^^
MIDN><91K595Y2QD<:YS4.;VE/#5<%AZ:Y(1C&CA<'6EAL/3A&/+2C3C-SY(M
M<[JWP&L-2_X2Z&#XA?$/1[#Q-XHTWQSINFZ8? 3VO@?QOINJV>MCQ1X5FU;P
M'>WEQ=W&J644TUCXANM>TSYG2*PBC;8,*$)86C@Z5&I*,\OK8JIAZUH.I2I8
MV.-ABL*DXNE.A6AF.,BY5:4\5355>QQ%-TZ3A6(5/$SKNK1C*&+I8>GB*=ZB
MA7GA%@UA,1)J?/3K898#">S5"=&A-T4Z]&LYU7.&R_9T\%VEIKEM<:QXMU:;
MQ-HMKHOB'4=7O](NK_5U/BW4?&7B"^N9%T..**[\0ZEJ)M]1CMXH;465C8VN
MGVU@EI%MWA.%&5!X:A3PL,+B\OQE*%/G48SRNI*O@Z3<IRJ3IT\54Q&+G*I.
M=>MB<5BJM:M-UI(BK'ZQ1G3Q3^LU*F&S+"5*THPA5J4\SP.#RZLVJ,*=*,J6
M$P&%IX=4Z5.G#V2<Z=1MD&O_ +-'P[\3>'KGPQK<NN7^E7<'Q(6YANI-$N5N
M+[XH>*K/Q?KVK7=O=:%):WU];ZA9I;VL=U;S6ALYI[:\MKQ)6KFJ485*.'I-
M)2PF&RS#4:G)3G*G#*ZE.M"7)4A.A.6+Q-&CB<<JM*=*O7I1E&G3BYQET1KU
M%*O*<G46(Q%7$33E*#M4P.)RRGAX5*4J=6C0PN7XJIA,+[&I"M2I1I/VTJE*
M$TWPA^SIH/@6XT6;PQXS\6Z/%I_A%/!6MZ;H^A_"3P[HOC'1+.XUV[T1=9T7
MPS\+]-L="N=)N?$>JR6TGA*#PT)#,HO5NUC51OBY/&X;,<'7<I8;,:"I2ASU
M&Z-7ZO#"RQ="<Y2J1KSHTX1=.<ZF#BXIT\+!F6'E+"K ^S:4LOQ=?%TI<E--
M_6*N'JUL/4C"$:<Z,Y8:DG-P^M64O]IYI2D\JW_9@T6RLM)ALOB9\3;/5/#_
M (8\ ^&=!\1P1_"Y=7TD?#>]\17'AG6+:W?X8MI4NII8>*-6TV>"YTR?3IK:
M1)#8"^4WC:XG$5L5B*F*G+DKU<94QTY0TO6Q&7++,;&SNHT\;07/5C%)X>LY
M2P$L'!NF9T:4*&%HX)\U?"T*5:E&%6I4EI4QV%S"C.4E.,Y5<)B,'AW3K.7M
M,5"G&.9RQ_+%QZ'3/V=? NEP:I##?>)IVUO_ (1 ZS=7M_I]S=ZF_A/QWK/Q
M'FDN[A])W.VO>*O$&K7&K*NU9DNS':K9JB[2-?V?U6,*5.-+!8FEB:%.TG&G
M+#9?ALOP5.[DZDJ>"CA:>*P[J3E6^NRJUZU6LJLX-OVLU6]MB:N(=?"XS"S=
M5QEIF"E#&58Q45"%6MAO88-1A&-"AA,'@Z&&H48X>#+GQ,^ G@_XJ:P-=\0:
MIXLL-0A\%:_X+LCH.L0V%MIRZ]+#(OBBUL[BPN87\7Z6BWL6FW]PDZ6B:QJ
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MFL54A4=)4XU\33R/$X#,(U:=58=4Z5:I0P=&GBJWLNX^"?[0'CSQO\)OB/\
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ME2LX1G.G)TJL82I^^Z6(PV%J4:T:E"+Q,(QQ,_)]"_;&^(UX?$$]WK_P,O\
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MMQCJ5GBZM6GSTY5YJM4Q"\"GB,1B<DP^.5.G0K5L%Q1Q'4PZE>MA5E^#7U'
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MM].*Y[6TVL4FFDULU=?H+0,* "@ H * "@ H * "@ H * "@ H * "@ H *
M"@#Y_P#$?_)T_P &_P#L@'[2W_JQ?V3J /H"@ H ^(/@E^T)\ O WA?QCX6\
M:_'#X/\ @_Q-I?Q__:G_ +2\.>*?B7X+\/Z[IWVW]IKXN:C9?;M(U;6K>[L_
M/T^[M+J+S8D\R&YBE3*2*Q-O(-O(]?\ ^&L?V6/^CEO@!_X>3X=?_-'0 ?\
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MWP _\/)\.O\ YHZ #_AK']EC_HY;X ?^'D^'7_S1T '_  UC^RQ_T<M\ /\
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M^S[_ ,CS_+\W[#<>7N\E]H!]?T % 'S_ /LT_P#).O$?_9P'[6/_ *U/\9*
M/H"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * /G_P 1_P#)T_P;_P"R ?M+?^K%_9.H ^@* "@#Y_\
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M7O,,PS+#XG^T*\I2Y<!E<<HAAU6KPJ3AC*U/"3K4'BL5BSU#PY\=?C)XEO\
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M<D;$USUZN)G[U:JHQ;Z1A"52<*5*"]RC1A.K5G"C2C"E&=2I*,%*<F^MI %
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MF^\I2<I2?>4I-RDWJY-MZLM5(!0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % 'S_ .(_^3I_@W_V0#]I;_U8O[)U 'T!0 4 ?/\ ^S3_
M ,DZ\1_]G ?M8_\ K4_QDH ^@* "@ H ^4/!6M_M)?$JQ\2>)="^(?P/\*Z)
M:?%#XR^"M&T35O@3X\\4ZK:Z5\,OBYXV^&VGW&I^(+/]H_0K?4M0O+3PG#>S
M/!I%A&LEX\:1!8PS !XUUO\ :2^&MCX;\2Z[\0_@?XIT2[^*'P:\%:QHFD_
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M[LN=QM+1V99U+XM?"K1M>M_"FK_$SX?:5XHNX)+FU\-ZEXS\.6.O7-M!IO\
M;$UQ;Z/=:DEW-!'I'^G,Z0E5MOWY(B^:LU*+6*:DFL IRQ+35L/&ER.HZ_\
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MQ"\(VEU\,M#\/^)/&-Y?>)O#UII>CZ'XCM'OK#5+F]EU0"VT]+0VDLMU<+#
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M:'J,]R+G3_#]]=PZS;V4FOA=&M;AIQE.&)I+#*24)9=F&%=2-)4(TZN-S/\
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M#U?_ (;!^"/K\8/_ !&;]I;_ .='5?5,7_T"U?\ P7/_ .1%]8P__/\ I_\
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M_B,W[2W_ ,Z.CZIB_P#H%J_^"Y__ "(?6,/_ ,_Z?_@<?\P_X;!^"/K\8/\
MQ&;]I;_YT='U3%_] M7_ ,%S_P#D0^L8?_G_ $__  ./^8?\-@_!'U^,'_B,
MW[2W_P Z.CZIB_\ H%J_^"Y__(A]8P__ #_I_P#@<?\ ,/\ AL'X(^OQ@_\
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M^@6K_P""Y_\ R(?6,/\ \_Z?_@<?\P_X;!^"/K\8/_$9OVEO_G1T?5,7_P!
MM7_P7/\ ^1#ZQA_^?]/_ ,#C_F'_  V#\$?7XP?^(S?M+?\ SHZ/JF+_ .@6
MK_X+G_\ (A]8P_\ S_I_^!Q_S#_AL'X(^OQ@_P#$9OVEO_G1T?5,7_T"U?\
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M_I_^!Q_S#_AL'X(^OQ@_\1F_:6_^='1]4Q?_ $"U?_!<_P#Y$/K&'_Y_T_\
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M^!Q_S#_AN3QS_P!$<T#_ +X_;;_^EYT?5,7_ - M7_P7/_Y$/K&'_P"?]/\
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M_P#@<?\ ,/\ AL'X(^OQ@_\ $9OVEO\ YT='U3%_] M7_P %S_\ D0^L8?\
MY_T__ X_YA_PV#\$?7XP?^(S?M+?_.CH^J8O_H%J_P#@N?\ \B'UC#_\_P"G
M_P"!Q_S#_AL'X(^OQ@_\1F_:6_\ G1T?5,7_ - M7_P7/_Y$/K&'_P"?]/\
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MNI.EA+QEB*].,J-&$HU*E2,)*3]7K;;RL0% !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M]G2C3G3J8>I&U7EE%57&.7J7PS\>V/CK3?#GA#3[VU^&TOC7P'XYUW4+_1?
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 1_L^?\ )T_Q;_[(!\&/_5B_
M'&OGLY^U_P!R_P#[MGL99]G_ +C?^ZY]^5\\>P% 'P3\'/V;OA;X^\/^-?%G
MB,?$C^V=5^/_ .U+]L_L#XY?'#P=I/\ H'[2_P 6M,M_LGASP?\ $72](T[_
M $2S@\S[)8P>=+YD\V^>:623:&(Q%.*A3KU(0CM&,Y)+6[LDTEKKZF4J-&3<
MI4H2D]VXQ;TT6K71:'J__#'WP1]/C!_XDQ^TM_\ /<JOK>+_ .@JK_X,G_\
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M?_@$?\@_X8^^"/I\8/\ Q)C]I;_Y[E'UO%_]!57_ ,&3_P#D@^KX?_GQ3_\
M (_Y!_PQ]\$?3XP?^),?M+?_ #W*/K>+_P"@JK_X,G_\D'U?#_\ /BG_ . 1
M_P @_P"&/O@CZ?&#_P 28_:6_P#GN4?6\7_T%5?_  9/_P"2#ZOA_P#GQ3_\
M C_D'_#'WP1]/C!_XDQ^TM_\]RCZWB_^@JK_ .#)_P#R0?5\/_SXI_\ @$?\
M@_X8^^"/I\8/_$F/VEO_ )[E'UO%_P#055_\&3_^2#ZOA_\ GQ3_ / (_P"0
M?\,??!'T^,'_ (DQ^TM_\]RCZWB_^@JK_P"#)_\ R0?5\/\ \^*?_@$?\@_X
M8^^"/I\8/_$F/VEO_GN4?6\7_P!!57_P9/\ ^2#ZOA_^?%/_ , C_D'_  Q]
M\$?3XP?^),?M+?\ SW*/K>+_ .@JK_X,G_\ )!]7P_\ SXI_^ 1_R#_AC[X(
M^GQ@_P#$F/VEO_GN4?6\7_T%5?\ P9/_ .2#ZOA_^?%/_P  C_D'_#'WP1]/
MC!_XDQ^TM_\ /<H^MXO_ *"JO_@R?_R0?5\/_P ^*?\ X!'_ "#_ (8^^"/I
M\8/_ !)C]I;_ .>Y1];Q?_055_\ !D__ )(/J^'_ .?%/_P"/^0?\,??!'T^
M,'_B3'[2W_SW*/K>+_Z"JO\ X,G_ /)!]7P__/BG_P" 1_R#_AC[X(^GQ@_\
M28_:6_\ GN4?6\7_ -!57_P9/_Y(/J^'_P"?%/\ \ C_ )!_PQ]\$?3XP?\
MB3'[2W_SW*/K>+_Z"JO_ (,G_P#)!]7P_P#SXI_^ 1_R#_AC[X(^GQ@_\28_
M:6_^>Y1];Q?_ $%5?_!D_P#Y(/J^'_Y\4_\ P"/^0?\ #'WP1]/C!_XDQ^TM
M_P#/<H^MXO\ Z"JO_@R?_P D'U?#_P#/BG_X!'_(/^&/O@CZ?&#_ ,28_:6_
M^>Y1];Q?_055_P#!D_\ Y(/J^'_Y\4__  "/^0?\,??!'T^,'_B3'[2W_P ]
MRCZWB_\ H*J_^#)__)!]7P__ #XI_P#@$?\ (/\ AC[X(^GQ@_\ $F/VEO\
MY[E'UO%_]!57_P &3_\ D@^KX?\ Y\4__ (_Y!_PQ]\$?3XP?^),?M+?_/<H
M^MXO_H*J_P#@R?\ \D'U?#_\^*?_ (!'_(/^&/O@CZ?&#_Q)C]I;_P">Y1];
MQ?\ T%5?_!D__D@^KX?_ )\4_P#P"/\ D'_#'WP1]/C!_P"),?M+?_/<H^MX
MO_H*J_\ @R?_ ,D'U?#_ //BG_X!'_(/^&/O@CZ?&#_Q)C]I;_Y[E'UO%_\
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M2#ZOA_\ GQ3_ / (_P"0?\,??!'T^,'_ (DQ^TM_\]RCZWB_^@JK_P"#)_\
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M_P" 1_R#_AC[X(^GQ@_\28_:6_\ GN4?6\7_ -!57_P9/_Y(/J^'_P"?%/\
M\ C_ )!_PQ]\$?3XP?\ B3'[2W_SW*/K>+_Z"JO_ (,G_P#)!]7P_P#SXI_^
M 1_R#_AC[X(^GQ@_\28_:6_^>Y1];Q?_ $%5?_!D_P#Y(/J^'_Y\4_\ P"/^
M0?\ #'WP1]/C!_XDQ^TM_P#/<H^MXO\ Z"JO_@R?_P D'U?#_P#/BG_X!'_(
M/^&/O@CZ?&#_ ,28_:6_^>Y1];Q?_055_P#!D_\ Y(/J^'_Y\4__  "/^0?\
M,??!'T^,'_B3'[2W_P ]RCZWB_\ H*J_^#)__)!]7P__ #XI_P#@$?\ (/\
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M_B3'[2W_ ,]RCZWB_P#H*J_^#)__ "0?5\/_ ,^*?_@$?\@_X8^^"/I\8/\
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M_P D'U?#_P#/BG_X!'_(/^&/O@CZ?&#_ ,28_:6_^>Y1];Q?_055_P#!D_\
MY(/J^'_Y\4__  "/^0?\,??!'T^,'_B3'[2W_P ]RCZWB_\ H*J_^#)__)!]
M7P__ #XI_P#@$?\ (/\ AC[X(^GQ@_\ $F/VEO\ Y[E'UO%_]!57_P &3_\
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M?_@$?\@_X8^^"/I\8/\ Q)C]I;_Y[E'UO%_]!57_ ,&3_P#D@^KX?_GQ3_\
M (_Y!_PQ]\$?3XP?^),?M+?_ #W*/K>+_P"@JK_X,G_\D'U?#_\ /BG_ . 1
M_P @_P"&/O@CZ?&#_P 28_:6_P#GN4?6\7_T%5?_  9/_P"2#ZOA_P#GQ3_\
M C_D'_#'WP1]/C!_XDQ^TM_\]RCZWB_^@JK_ .#)_P#R0?5\/_SXI_\ @$?\
M@_X8^^"/I\8/_$F/VEO_ )[E'UO%_P#055_\&3_^2#ZOA_\ GQ3_ / (_P"0
M?\,??!'T^,'_ (DQ^TM_\]RCZWB_^@JK_P"#)_\ R0?5\/\ \^*?_@$?\CF_
M@W\+?!_PP_:7^-&F>$X_$GV:3X&?L\WQD\4>._'?C_4$FU/Q]^TS;WJ0ZMX^
M\2:S?06;QZ#IA6TBN$MXWBEEBB22[N'GB=>M43C4J2FFXM\S<G[G,HZN[27/
M+1.VNQ4:5.FTX0C#E32Y59:\M]%9:\L=;7T/L.LC0* /G_\ 9I_Y)UXC_P"S
M@/VL?_6I_C)0!ZGX]\4P^!_ _C#QE.BR1>%?#.N>(&B8.RS?V1IMS?+ 5B^=
MO,>!4PGS'?@<FN?%/%*BX8&G&MCZ\J=#"TYNT*F*Q%2-##4Y.\;1G7J4XR?-
M&R;U6YUX"A3Q.,PM"M4]C0G4BJM2ZC[.BG>K4<I7C%4Z:E-RDK)1N]$>&VO[
M36@:3.FD^-?#WBG3Y]'&I:-XL\:V.CZ>G@&'QEX:\!6GCOQ'H^B1R^);C7]1
MA6Q;488)+73+Z*.ZTV2QNKF.ZDMUN_1JPH5:N)EE[G4PS>*G@82:GB<73P^>
M+(%"G"DM:\L=5PT(*<:,*WUB'L7*<:U*EY&%KU5AL#]>E1HXFI'!+%R4XTL/
MA*F,RS^U5*K4KSBH4H86%6K52G4JX>C3>(KPAAG&O+ _X:<NH-8\1R>)?">M
M_#?PSH.NZ+H20^*-&T+7_%$TECX*\2?$[QEJ%[9>#?B1>QZ9I\O@JS\.1Z=
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MG5#%UZ=+XIX=826!7+.NN6.(518Y14XT,/RU,/7AR2M=?1U<9TA0 4 % !0
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MIQ<XPFXM/3FA"5K7C%W2T:P.@* "@ H * "@ H * "@ H * "@ H * "@ H
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M&2>+Q6%IX*M6Y6G&[P]*G&$+>SHS@J]&%.O^\.*G1ITH>RI\T8?4W@+<\_\
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M*4*,8PBYSG5G:*44YU*LIU*DK+WIU)RG)WE*3DVRS4&@4 % !0 4 % !0 4
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MJBA5 55 554!555&  !P  ,8%0VVVV[M[L:2BE&*45%626B26B22V2%I#"@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#Y_\
M#G_)T_QD_P"R ?LT_P#JQ?VL: /H"@ H ^?_ -FG_DG7B/\ [. _:Q_]:G^,
ME 'T!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % 'S_X<_Y.G^,G_9 /V:?_ %8O[6- 'T!0 4 ?/_[-
M/_).O$?_ &<!^UC_ .M3_&2@#N/C!/KUO\+?'P\+65[?^);KPMJVFZ!:Z=:7
M5]='6=5M7TO395MK-6F,4-W=PS2NH CBADD8JD;,,,1A:6-C0R_$2E#"9CB<
M'@\3.+LZ6$Q>*HX;%UN;505'#5*M64VK0C!S>D6=.#Q4<!7682HRQ"RR%7&*
MA!I3Q$L'2GB88:GS63JXF=*-"E'[52I&*U:/E7P+\/+GPOX;_:/^*?AK5/%6
MN^*(-)\5?#;X8?V;X=\#7_BKPSX<^$^A_P#"-6'ASP->6W@"74[M)?&FB:DT
M.F7S:U:2RVEG,UE-?RW<]]OF&(KULEE-3JX7&\18NOF>,Q"C5=5K%9CB:6!J
MU*>%CS5*%'*GA\1#V=%XJE3KU_JE6FZD6HRC!4Z&=9+EN-IT(8#A[#Y7@*4)
MS_<*%?+LOQF,Q$I591=&K4KXBI"J_:QC4]E".(E*C2P]#"Y/A;P_\9],UW1?
M%&@>,/BQXACT>#X+_#FVD\>>";6QUOXA:#::=K'COQSJWC>?7_A_IUYH>G+8
M^*ETB.^M[+0;\:QX<@M]5O[J[6>UEZ\;5>&K9G4IX&A-XO$9U.-&C4H^S]CE
MV25*&4U*DZ$U&.(KYW1J3I4:-6&#E0QU6KA\+["M1EA_/IT\36P&64YXGDJX
M;#X3$5*LHKVE'$YKG^&PV:8:$)P4I8?"Y9A:-=PE[>O&C"%2%:CR5JF([;X&
M_$'XR1?#[XH_$_XZ:G>6']A:/<:G)X*O?"&OZ%#X.U+P[I6I:IXC3P_J7B+X
M1^!+O6O#DR-8PP(#XTACETV=[?Q5J<=R%@X\UY,%D<I9?*>/Q]7V\L+54>:O
M4E-0H87#O#*%*JYRQ*YZ*JY=@,0XUU1J8>LX1K2]# 4IYCGU+">PE@L/4KTZ
M+H.I&I!0J5HJG-5HQG2]M3I^TABIT<=C,/5DJ=>C#!1;HR\2E^)'[647@G3=
M9T74_B%XDTO7H?AWIGB/Q3KGP<UKP/XI\):^="\5/X\N_A_X!TS]G;Q5XFE\
M/OK,'@J&.^\0_#_Q);-+>ZH\-Q:Z>\=SI?=BL/0>,6"I57A:-7&8WZMB6X3J
MRH0674\+'%4[/#T*=2K4S"K"CB:N6XB-'#.EB,?"I4PM3$<M+%TZV%GCJ>"E
M]:E14YX-5%]2PRQ%>56C&AB9..*QE;#8:,L/B:^'CBZ$ZE? XJCA*BHYCAH^
MB^*M8_:*TG0]9U2]^('Q0^V:5K'@WP+H.C_#OX+Z;>7GCRXA\(>'M5\9^,K1
M[_X.^,/^$0FU#7IM6L]/O]=@L_#-K):7%O?RV_VN"YTC+DI5<;A%3_=4\SS#
M&SE1<HQCE^ P^(E@:-)XB<O9OFJT)9A+ZQ7]OBLNQ,:>"JJ<:>)EM0=-TJD5
M.RPF#P_-7Q,*K=3&5Y8C$I2IT(4JU>G2P&(P>'KU,%@;T,SPTI2P<HTL5EN(
M-4\<?M&R:OXU'AU_B4=:T>U\=:!'X5UGX5:?;> ]*MUAN-'^%7C31/&2^"(W
M\?>,-3U9]'UK58M%UK4M%L+&;4K:ZTK3YK*-I\Z$8U8TN><(0Q]7#4YU^647
ME^*K9Q@:-:A0PM6K"M/+<'E53'5*V,Q?M5B:N'HU\/CJ,*TL/"*LE@ZN"JJ$
M\=0P<*6(J8?FC&KF&&HY%7QN*IUZ]*+I4,?7S:-#+\/2PZP\H\S2PM:WM7[+
MI=_\:?#/@;XXW5W?:Q\0?$OAS4M3;X:2:UX7TG3+C5Q#X*\/W\L>G:+X9TG1
MQJOA^'Q;=:U;V$)>ZOKB"Q$$FIW4S"837G0^I99./M,.JV*J4\34C"=?%8?
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MQKX;#9&L72Q,YQ:488C,4L/E;A*$8U?:X?%U,R<Z7L<)8F.*H3Q'U2KE;Q6
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MN8Z H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H ^?_  Y_R=/\9/\ L@'[-/\
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M'+? #_P\GPZ_^:.@ _X:Q_98_P"CEO@!_P"'D^'7_P T= !_PUC^RQ_T<M\
M/_#R?#K_ .:.@ _X:Q_98_Z.6^ '_AY/AU_\T= !_P -8_LL?]'+? #_ ,/)
M\.O_ )HZ #_AK']EC_HY;X ?^'D^'7_S1T 4[C]J#]DB\N;"\N_VA_V<[J[T
MF>6ZTNZN/BU\,Y[G3+FXM)[">XL)Y?$#/9SR6-U<V[R0LC-%<2QDE)&!<6X2
ME*#Y92IRI2:T;I2G2JRI-K5TY5*%&I*#]USHTIM<U.#2E&,U&,XJ2IS56*:N
MHU(PJ4XU(I_#.,*M6"FK24*E2*=IR3N?\-8_LL?]'+? #_P\GPZ_^:.D,/\
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M1F47'D<OWEH4$U*2E2O5I5:4*L?<Z[Q'_P G3_!O_L@'[2W_ *L7]DZN$#Z
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^?\ ]K'_ )-8_:6_
M[(!\9/\ U77B.@ _9._Y-8_9I_[(!\&__5=>'* /H"@ H * "@ H * "@ H
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ML;__  TM\.O^A<_: _\ $3OVI_\ YS= !_PTM\.O^A<_: _\1._:G_\ G-T
M'_#2WPZ_Z%S]H#_Q$[]J?_YS= !_PTM\.O\ H7/V@/\ Q$[]J?\ ^<W0 ?\
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M$=Q:7?V?4+2XB\ZUGFAD\O?%(Z,K$V^0;?(]?_X:6^'7_0N?M ?^(G?M3_\
MSFZ #_AI;X=?]"Y^T!_XB=^U/_\ .;H /^&EOAU_T+G[0'_B)W[4_P#\YN@
M_P"&EOAU_P!"Y^T!_P"(G?M3_P#SFZ #_AI;X=?]"Y^T!_XB=^U/_P#.;H /
M^&EOAU_T+G[0'_B)W[4__P YN@ _X:6^'7_0N?M ?^(G?M3_ /SFZ #_ (:6
M^'7_ $+G[0'_ (B=^U/_ /.;H /^&EOAU_T+G[0'_B)W[4__ ,YN@ _X:6^'
M7_0N?M ?^(G?M3__ #FZ #_AI;X=?]"Y^T!_XB=^U/\ _.;H /\ AI;X=?\
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M<W0 ?\-+?#K_ *%S]H#_ ,1._:G_ /G-T '_  TM\.O^A<_: _\ $3OVI_\
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MXU&YQYZ=.E2IS:E=<U.E0HTH2WC3HTH1:C3@EWE22% !0 4 % !0 4 % !0
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ML.G&?,FJ%%-6I0Y:VN?!3P%JVB:3X7T_2K;PAX5T_P 8>'_&NH^&O!FD^&]
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MJPG3J0=I0J0E"24HM*[044-.U33-7MWNM)U&PU2UBO+_ $^2YTZ[M[VWCO\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H ^?_#G_ "=/\9/^R ?LT_\ JQ?VL: /H"@ H ^?_P!FG_DG
M7B/_ +. _:Q_]:G^,E '>?%O3/$>M?#+QSH7A&!I_$FN^&M4T'2 EQ9VIM[G
M6K=M+-_YU_-% JV45W)=D,X+"U*H&D94;*I0H8J6%PV*A[3 5\7@J>-C=J^
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ME"M5II/$X:.(C4GC:V,A#]S4Q'U3"*G@L-AJBK3A@O[5>+Q%.M6PD<###XC
M87%4\/@)-U:O4ZIX6^.4VN>.;N'PO\8[SP[K'C70--U!%^,.F>'/%^N>";?3
M=>M-17X?:?I?QDG\->!-"&NP^%KQ]>T\^#/%<^EWVJP/82:G96\]_P --0^I
MT^>$O:5ZV88B-!U)1=.K.#GE\<?B(N=6EAJ#JUJ#P^65J]"K.A@*M>A*F\7&
MIO:-*#7MI5<3A,!A:$*L*5)TIU(8G QQDZ$*J@L1B,5A:>+J*>94(3PM:<HX
M?'>SKTJ6"\S?X+_M":=H]WK>AZ?\3+/XF0_"7X?Z38ZUJ/QBUCX@6=J=1\>:
MWXA^+'@*TM_$'QYT*37O%4.@WVE:7I^L7]YHL?E:3%<6OBBSU )/#O5]G36(
MI4Y^WA4Q> P^,J0H^QGF."P61T:.'QE"%.O0E@Y_VU'%5L:H8C#5Z=+%U98:
MEC%B<91K9<D:6*7)35>&&6>5L#5JUIOZO5QN:35"C7C.E552G2RJ.&JX&G*A
MB:-?%4J=/-%0A@L'*/1:G\'/C1K.G>"? NN6OQ>\5>&'A^']Y<ZGK'Q9BT"R
M\,PWOCZ\U7XHZ/\ $*RT[XO:QKOQ'O+;PK=6>EZ3IFJZOX\TLV5C(;K4[R_C
M5]0ZZ,L-#.*&)E.,(Y7BZ4Z-=+VE.MA\!EM.O@)0PZPU&E+&ULZPW)F&*K8+
M"U*=.MAJ^"E":Q52GQUXUI95C*'L%46883%4)X:G.I2KPQ>-E+!5ZT\16Q&*
M=/+J&"JK'8;"4,75G5K_ %S"8BE##SP4*'L7QPTOXOZKK'B^R\)^'OB9J.AW
MO@[P)IWAF?P#XS\-^%K0Z['XH\2:CXOCUBXN_BYX,US1[:72[?PS97&IZ%+!
MJ45I>S'3;B>9);=?)A!MMRA*5268T&XU:U2EAG@J."FH2=3#NIB*%\7B<1*L
MZ="OSU<-ETJ^"Q^%IU:#]2I[*-##JG/V3I83'N<J4(5*_MJN(RV-&C&AB(0P
MM6<:.'JRHNIB*2]C6S"G#&99BI86O6ZGXD^"?'7B.P\ ^'M&G\:Z7H&A>%?%
M>I>)U\*_$K5M(UO6]=LO"L&A^%/!%WXTEUZQ\1WJ7NH:OJ%^=;^VV\XG\-V\
M]S?6\TZM)IF/M:M?.\1A9QE-X.O3P$73CAX3QM?&8>M1Q3H4.6A1A@Z6%FI8
M=Q]E.&,=",*M%5Z,\LLITZ>#RFAB9^PFL=@5C.:57%3IX&.%QBQBCB*O/4JM
MUY8:GSR53$2C>K34*T(5J7BD?P^_:'?6HK;4W^).J:EH.BVMM;^,(_BU%H/P
M_P!<\-V_PJCTF]\+)X1T'QG:W]]\1-5^(QN;R;Q'K.CP26$<R76F^((_(2SI
MYNJ>*I9_5P--T)XA9S"-!V_VGV^(Q*R=8!>TA1R^C@\*\'5KSYL%B*N)HU\)
M4IU\'B?:4L\J=2D\DI9ARQ5#^R:BJ4U*:PTZ5?"U<W_M)UIU*N.E6I_7<)A:
M2CC\*\-]4JSA2QT*]>KV\7P_\:>$/@!\)O G@KPS\3EM[*;0[/XB>%H?B;:V
MWQ4BT.?1]3.KV>F?$/4OB3<0Z+M\5R:3)<OH?BTR6>DB]AT%Q/%:P5UYQ4I8
MC-)RH153 4J5>.$C2E+#THSA24<NAC9QC2Q4Z%"%X594XU:U7%4\-[98C!_6
M%.,M]K3R[&5<;.7]L5E2J3J.-.O[7$2QF'>85:-.K*=!3Q6'6*JT?;.DN>JZ
ME65'%R<X\7X2^$'QU.E>%+C7?$'Q+T;4=";X."VT.3XS:_KUK8W \;:KXN^*
ME[XAUB7Q?+=^/8+'P[KK^%(;?7)]1AO(M&MIFMKSR;6:VTI5*%'&X>522Q2H
M5I8>I7]C3ITJV#P?#>'H4\1]3473IU<USF%=UY.,Z^'E.GB*4L,U.O,KQ<*6
M886C!U,-)9E5P\E5DL3]8S#.:T,)!XB352&'R;+J& QU&E!TUB(3Q>#JNJZU
M7#/UKXF>'OB]XF\=WVD^')O%OA_P=?Z?\*+2+Q9X?\2Z1ID&EQ6'CW6M>^)+
MPV$GB%+\:Y<>'M/\/:9',-&EC:WU6=5GF GMUX,)"E[5O%*I[-XV3J0]HTIX
M/#Y/BY82-)T[SIJOF]=4,<HRHU948X6I"7[I5L/TXBHZ6'H_5*=.KBEA<=3O
M.[C&KC<7E>%<ZE.2A"53 X".,Q^7U%.JEB(UJ<U1E*G#&?/_ (N^#OQPUW0X
M?AUJ>F?$[Q+X.U&>_M=+GM_CC?:8OAK2M<^+.O6^LGXFZ[=?$-?$WQ*6R^$-
M_H;Z9I%U)XBTVYDMM5M]3B606*-U8"=/ZWDV*Q-J.(P']B5ZTZE.$\,U@\/2
MQF*PL,+17LZV,J9A3> Q&+Q$)16&6'QN%Q%3$?6Y5S%2BJ&8?4*M?!UJ_P#;
M<:3I32K0Q*P6'H95C*.(?+/!T*V,IXO'T\/AI4_JT\32PM7#TL-2BL/Z7I7A
M+]H"[U/PO8S+XJT'P]K3?$Q_B%>WWCNQ>_T&#3/B>WB;P-I'@^UTKQ)J0AM_
M$7AN[FT.&^MI;.XTO1K4+*NGWL=M;1<JE5CAYUY\M7%4<GR2O3HMR<JV=X;!
M8V&-PU6;Y81ISS#$4,9BZCJ5,/BX8.E@I+$4,14GA\ZE*+<J=*=.E1CC<PR^
M$:=.=.$,HQ-+"4,)F5+DE&;Q6!P>7NE3ISC"LLUS*MF24H4:T,7YU/\ #;X]
M>-5^&^D^-_#7Q-D731\*M8U2]F^+NEZ/X1TF?1-3'B+XAV/B_P /^%_B/<W/
MQ#US4=?TZ"RM[?4K;7=&MM'O+22SF@O[>X@:VHX7%5JV#4:WU!XE8*>)<INI
M3I</QAD[]E)2HQQM+.X*MC\;4@L0L5RU,-B*^'E*O2K$2YZ6+H0@H8?,I8FG
M4I0O)T8XO.\11Q<EB&Z%=X2'#^*3RS#4Y1ISE1G3S'!4I*CA:F[9Z/\ M-WW
MAW3/[>\+_$>QMM&\)?#_ ,,ZYHVB_%/PBGC[QG>7NO:K<_%;6-(U=/&T&DZ)
M<J=.\.QZ=J<VN6FIQ:+JFH?89++5'^RV]UJ>%]K^Z<ZF#Q.)HT8T*DYTJN'P
M6#R?$1P5?%8FBU55?$9GC8K.%@IUY5I9=3JP>,I2C[293J>TJ5:<(4,3AUF6
M(C)6JX:I6QF;8*K'"X;#5H.-2GA<LPV*AE;Q].E1I5L9&C6IX>E"I4?6?!'P
MW\1_ OBG08?'WA'Q]J'V[PE/I6C:YJ/C/_A9Q\)WGB/QSXZ\7^(_#WB'QGXE
M\:W^NW%AI>@6'P_T^"^N8ITN?LEO%#//.6@@UI5(3H5:;:I8N>'RF.(DJ<*5
M"LLMRN"G5BJ<;/$2S;,LSI2@_P![4INA7@JF&I8G$T<:\(NIA\0J5HT,3F\:
M4(SJ3G"EB<7E^'PB<*CDJ:J9?ET,PJU(U715:>,HN&%K3P6%Q>-XP3XF^/\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M%.C:<*6'PJ7UB4HQC+CO@-\,?BS9:;\._%FL>$? /AF7X;>"?B1I/@_1&O\
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M: _\)S]EC_Z&F@ _X4W\1?\ H[']H#_PG/V6/_H:: #_ (4W\1?^CL?V@/\
MPG/V6/\ Z&F@ _X4W\1?^CL?V@/_  G/V6/_ *&F@ _X4W\1?^CL?V@/_"<_
M98_^AIH /^%-_$7_ *.Q_: _\)S]EC_Z&F@ _P"%-_$7_H[']H#_ ,)S]EC_
M .AIH /^%-_$7_H[']H#_P )S]EC_P"AIH /^%-_$7_H[']H#_PG/V6/_H::
M #_A3?Q%_P"CL?V@/_"<_98_^AIH /\ A3?Q%_Z.Q_: _P#"<_98_P#H:: #
M_A3?Q%_Z.Q_: _\ "<_98_\ H:: #_A3?Q%_Z.Q_: _\)S]EC_Z&F@ _X4W\
M1?\ H[']H#_PG/V6/_H:: #_ (4W\1?^CL?V@/\ PG/V6/\ Z&F@ _X4W\1?
M^CL?V@/_  G/V6/_ *&F@ _X4W\1?^CL?V@/_"<_98_^AIH /^%-_$7_ *.Q
M_: _\)S]EC_Z&F@ _P"%-_$7_H[']H#_ ,)S]EC_ .AIH /^%-_$7_H[']H#
M_P )S]EC_P"AIH /^%-_$7_H[']H#_PG/V6/_H:: #_A3?Q%_P"CL?V@/_"<
M_98_^AIH /\ A3?Q%_Z.Q_: _P#"<_98_P#H:: #_A3?Q%_Z.Q_: _\ "<_9
M8_\ H:: #_A3?Q%_Z.Q_: _\)S]EC_Z&F@ _X4W\1?\ H[']H#_PG/V6/_H:
M: #_ (4W\1?^CL?V@/\ PG/V6/\ Z&F@ _X4W\1?^CL?V@/_  G/V6/_ *&F
M@ _X4W\1?^CL?V@/_"<_98_^AIH /^%-_$7_ *.Q_: _\)S]EC_Z&F@ _P"%
M-_$7_H[']H#_ ,)S]EC_ .AIH /^%-_$7_H[']H#_P )S]EC_P"AIH /^%-_
M$7_H[']H#_PG/V6/_H:: #_A3?Q%_P"CL?V@/_"<_98_^AIH /\ A3?Q%_Z.
MQ_: _P#"<_98_P#H:: #_A3?Q%_Z.Q_: _\ "<_98_\ H:: #_A3?Q%_Z.Q_
M: _\)S]EC_Z&F@ _X4W\1?\ H[']H#_PG/V6/_H:: #_ (4W\1?^CL?V@/\
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MN@"WNM0L+37]=@MKB2-I((]:OTB9%O)A( >W_P##)W[+'_1M/P _\,W\.O\
MYG* #_AD[]EC_HVGX ?^&;^'7_S.4 '_  R=^RQ_T;3\ /\ PS?PZ_\ F<H
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MOB:/@ROA'QJV@1^)%B8ZHOP\&B?\(&UJMV!I?VO^SV@'VLJ:TX?NL%AEA?\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MEE;74<4<4!DE5IU0 &?_ ,+D^(O_ $:=^T!_X4?[+'_T2U 'J'P]\:Z5\2O
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MQ:=TT]4TUHTUJFA:0PH ^?\ PY_R=/\ &3_L@'[-/_JQ?VL: /H"@ H ^?\
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M,:N)HP^NRPV/SJ>!QF'QL%!8;#3I9#.,J\8T*%>-:M4Q%%^QIRC1VO NK_M
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MM--FD\0ZS;:;XR\1:<EM/-%?:%X>EL)L=F'3Q,:%7$QH4*^,S&BL52HRY*6
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M::EIZ)(&BU.SM[5YK>'5+DOY5:$X</<18?V<Y1S;,<UHUZ,8RG4]E4R/(J6
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MG^,M&^+=A?77A^S\0_%#2OAYHWBSQG;:1J4>B?&GXE>)+F5]+\&7WA:&74?
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MAH#>-O\ CRDUVYM[O[2N+606IM ;A2K585EBI.+AE^9RPWLJDZ<K+&Y(LO\
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M^R\/_/4^^/\ \@'_  SI\?O^BY_!_P#\1S\:?_1.4?VWB_\ GW2_\!G_ /+
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M/[+P_P#/4^^/_P @'_#.GQ^_Z+G\'_\ Q'/QI_\ 1.4?VWB_^?=+_P !G_\
M+ _LO#_SU/OC_P#(!_PSI\?O^BY_!_\ \1S\:?\ T3E']MXO_GW2_P# 9_\
MRP/[+P_\]3[X_P#R ?\ #.GQ^_Z+G\'_ /Q'/QI_]$Y1_;>+_P"?=+_P&?\
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MG_\ + _LO#_SU/OC_P#(!_PSI\?O^BY_!_\ \1S\:?\ T3E']MXO_GW2_P#
M9_\ RP/[+P_\]3[X_P#R ?\ #.GQ^_Z+G\'_ /Q'/QI_]$Y1_;>+_P"?=+_P
M&?\ \L#^R\/_ #U/OC_\@'_#.GQ^_P"BY_!__P 1S\:?_1.4?VWB_P#GW2_\
M!G_\L#^R\/\ SU/OC_\ (!_PSI\?O^BY_!__ ,1S\:?_ $3E']MXO_GW2_\
M 9__ "P/[+P_\]3[X_\ R ?\,Z?'[_HN?P?_ /$<_&G_ -$Y1_;>+_Y]TO\
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MTO\ P&?_ ,L#^R\/_/4^^/\ \@'_  SI\?O^BY_!_P#\1S\:?_1.4?VWB_\
MGW2_\!G_ /+ _LO#_P ]3[X__(!_PSI\?O\ HN?P?_\ $<_&G_T3E']MXO\
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M$Y1_;>+_ .?=+_P&?_RP/[+P_P#/4^^/_P @'_#.GQ^_Z+G\'_\ Q'/QI_\
M1.4?VWB_^?=+_P !G_\ + _LO#_SU/OC_P#(!_PSI\?O^BY_!_\ \1S\:?\
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MM)4X<[<7":J^RIU)4IXE4'%5W@HSA-/'*F\&E%R]OR+F-KP3\8OAW\0]6O\
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ME4]NX*SI2<O6:R*"@ H * "@ H * "@ H * "@ H * "@ H ^?\ PY_R=/\
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M^+Y+O7;CQO>06C2^&$LM OO'FA>&?#VJWVBM#X72[>]M=/\ #,2V4VIW6I-
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M,GCXPBIN<<13^L5&W/'+%XE4U&G'$1A%(I0BZE&IB%];<,#/+ZT:J26)P]3
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M%_:QH ^@* "@#Y__ &:?^2=>(_\ LX#]K'_UJ?XR4 ?0% !0 4 % !0 4 %
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M$C_:G_Z(W\ /_$EOB+_]"=0 ?\)'^U/_ -$;^ '_ (DM\1?_ *$Z@ _X2/\
M:G_Z(W\ /_$EOB+_ /0G4 '_  D?[4__ $1OX ?^)+?$7_Z$Z@ _X2/]J?\
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M $)U !_PD?[4_P#T1OX ?^)+?$7_ .A.H /^$C_:G_Z(W\ /_$EOB+_]"=0
M?\)'^U/_ -$;^ '_ (DM\1?_ *$Z@ _X2/\ :G_Z(W\ /_$EOB+_ /0G4 '_
M  D?[4__ $1OX ?^)+?$7_Z$Z@ _X2/]J?\ Z(W\ /\ Q);XB_\ T)U !_PD
M?[4__1&_@!_XDM\1?_H3J #_ (2/]J?_ *(W\ /_ !);XB__ $)U !_PD?[4
M_P#T1OX ?^)+?$7_ .A.H /^$C_:G_Z(W\ /_$EOB+_]"=0 ?\)'^U/_ -$;
M^ '_ (DM\1?_ *$Z@ _X2/\ :G_Z(W\ /_$EOB+_ /0G4 '_  D?[4__ $1O
MX ?^)+?$7_Z$Z@ _X2/]J?\ Z(W\ /\ Q);XB_\ T)U !_PD?[4__1&_@!_X
MDM\1?_H3J #_ (2/]J?_ *(W\ /_ !);XB__ $)U !_PD?[4_P#T1OX ?^)+
M?$7_ .A.H /^$C_:G_Z(W\ /_$EOB+_]"=0 ?\)'^U/_ -$;^ '_ (DM\1?_
M *$Z@ _X2/\ :G_Z(W\ /_$EOB+_ /0G4 '_  D?[4__ $1OX ?^)+?$7_Z$
MZ@ _X2/]J?\ Z(W\ /\ Q);XB_\ T)U !_PD?[4__1&_@!_XDM\1?_H3J #_
M (2/]J?_ *(W\ /_ !);XB__ $)U !_PD?[4_P#T1OX ?^)+?$7_ .A.H /^
M$C_:G_Z(W\ /_$EOB+_]"=0 ?\)'^U/_ -$;^ '_ (DM\1?_ *$Z@ _X2/\
M:G_Z(W\ /_$EOB+_ /0G4 '_  D?[4__ $1OX ?^)+?$7_Z$Z@ _X2/]J?\
MZ(W\ /\ Q);XB_\ T)U !_PD?[4__1&_@!_XDM\1?_H3J #_ (2/]J?_ *(W
M\ /_ !);XB__ $)U !_PD?[4_P#T1OX ?^)+?$7_ .A.H /^$C_:G_Z(W\ /
M_$EOB+_]"=0 ?\)'^U/_ -$;^ '_ (DM\1?_ *$Z@ _X2/\ :G_Z(W\ /_$E
MOB+_ /0G4 '_  D?[4__ $1OX ?^)+?$7_Z$Z@ _X2/]J?\ Z(W\ /\ Q);X
MB_\ T)U !_PD?[4__1&_@!_XDM\1?_H3J #_ (2/]J?_ *(W\ /_ !);XB__
M $)U !_PD?[4_P#T1OX ?^)+?$7_ .A.H ] ^$_CK_A:'PL^&GQ+_LO^PO\
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MP'AS_P!98_9IH ^@* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /G_ /9._P"36/V:
M?^R ?!O_ -5UX<H ^@* /G_PY_R=/\9/^R ?LT_^K%_:QH ^@* "@#Y__9I_
MY)UXC_[. _:Q_P#6I_C)0!] 4 % !0 4 % !0 C*K*490RL"K*P!4J1@J5/!
M!'&#2E&,HN,DI1DFFFKIIZ--/1IK1H:;BTXMQ<7=-:--;--;-'GWAOX1_"GP
M;-X@N?"'PQ^'OA6X\5K*OBF?PWX+\-Z'-XE6=IGG7Q!+I>FP-K"R/<W#.+LS
M;C<2$Y+MDE%2P?\ 9\DI8#7_ &9J^'U@J;_<O]WK",8/W?@2CLD@3<<3'&)N
M.,@[QKK2M%\W/=5?C3Y_>NI7YO>WU)K/X5_##3O#6J>"]/\ AQX#L/!^N00V
MVM^$[/P?X>M?#6L6UOI]GI-O;ZIH4&G+9:A!%I6GV%DB3P2*MO8V\*@1PHJW
MB)SQ<:<,5)XF%*7/"-5NHH3Y_:.45.ZC+VC]IS*SY_>OS:CISG1E&=*3I3A!
MTHR@W%QIRE5G*FG&S4)3KUIN"]URK59-7J3;J7WP<^$6I^&-&\$ZE\*_AQJ'
M@SP[<17?A_PC?>!_#%WX8T*Z@\SR;G1M N-+>QTRXC\V7;);01,OF-@C<<DI
MSGB:&,G.4L7A;>QKR;=:CRJ*C[*H_?I\JC%+DDK*,4MD9QA&G0Q&%A%0PV+N
MJ]**2IUE*7-)5::M&IS2]Y\ZE>6KU.HM_"GA>SUZ3Q3:^&] M?$\NCVWAV7Q
M';Z/IT&O2>'[*X>ZL]"DU>.V6[?1X+J22:.R,I@CD=G5 S$E*4HK$*,G%8NI
M"K72=O;5:<90IU:MOXE2$)RA"<[RC&4HQ:3:8XQ:PR<4U@X5*>'32M0A5=-U
M845_RZA4=*DZD8<JFZ=-R3Y(VYFP^#_PETK5M2U_3/A=\.M-UW6+K4;[5]:L
M/!/AJSU;5;W6+::RU>\U+4;?3$N+ZZOK.XN(+F6:1WGBGDCE+*[ YQI4Z>'E
MA(4XPPLJ<Z4J,8I4G2J3HU*E-TTE!TZE3#T*DX./+*=&C*2<J<'&YRE4Q$,7
M4;GBJ4J4X5I.]6$\/"K3H3C4=YQE1IUJU.E)-.G"K5C!QC4DG6M_@E\&;/PS
MJ'@JU^$?PQM?!NK26LNJ^$K?P%X5@\,ZG+8L&LI-0T&/25L;R2W95,330.8R
MH*$8K23<G0<FY/"U8UJ+;NZ-:$*=.-6E?^'5C3I4H1J0M)0ITXII0BDJ7[B=
M6I1_<U*\)4ZDH>Y*I3G.K4G3G*-G*$ZE>M.49-QE.M5DTY5)M]+H_@?P5X=C
M6+P_X/\ "VA1)IT^D)%H_A_2=,C32;F_NM4N=+5+*TC"Z=+J=[>WCVP'E//=
MSS,IDE=F53][&K"K^\A7A0I5(S]Y5*6&I2HX:G-.ZE##T9SI4(2O&E2E*G34
M8R:<4J=.A[/V,(T?8SKU8<B4.2KB9TZF)J1Y4N6>(J4J4Z\U:56=*G*HY2A%
MKF[?X)_!JS\+:GX%M?A)\,K7P3K=[_:6L^#K?P%X5@\+:OJ(>.07^I^'H]*6
MPO[WS(86\^>WD?=$AW9484XQJT\+1JQ52C@?]WIR2E##V;:]C%WC2LVW^[4=
M6WU9K"<Z=?$XFG)PQ.,O]8JQ;52OS1Y9>VFK2J\T?=?.Y7CH]"[-\)OA7<7G
MA/4;CX:?#^?4/ 4"6O@6^F\&^')+SP7:QA!';>$[E]-,GAR!1&@$>GM;J-BX
M' K55JJQ-;&*K-8S$1Y*M?FE[:K"SCRU*M^><;2DN64FK2:M9LQ5*E'"PP*I
MQC@J4N>&'44J$)W3YHTK>SC*\8OF44[Q3OHCT"LS0^?_ (-_\E%_:Q_[. \.
M?^LL?LTT ?0% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MP=_^E<4 '_"OOV[/^BF_^9S^#O\ ]*XH /\ A7W[=G_13?\ S.?P=_\ I7%
M!_PK[]NS_HIO_F<_@[_]*XH /^%??MV?]%-_\SG\'?\ Z5Q0 ?\ "OOV[/\
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M'_T-- !_PIOXB_\ 1V/[0'_A.?LL?_0TT '_  IOXB_]'8_M ?\ A.?LL?\
MT-- !_PIOXB_]'8_M ?^$Y^RQ_\ 0TT '_"F_B+_ -'8_M ?^$Y^RQ_]#30
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M9S^#O_TKB@ _X5]^W9_T4W_S.?P=_P#I7% !_P *^_;L_P"BF_\ F<_@[_\
M2N* #_A7W[=G_13?_,Y_!W_Z5Q0 ?\*^_;L_Z*;_ .9S^#O_ -*XH /^%??M
MV?\ 13?_ #.?P=_^E<4 '_"OOV[/^BF_^9S^#O\ ]*XH /\ A7W[=G_13?\
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MR=_R:Q^S3_V0#X-_^JZ\.4 ?0% !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M>,Q:HRH4:V*G/FE.6'IU*OLN1TU*=15*ZK5*&%E0]@J1GS_\&_\ DHO[6/\
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MFH12JI*56$Z55NI3G1^K2A-\T98?G=7ZO*+NG1]JW4]DUR<[<^7F=R9_A/\
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M_P#SS: #_A>?QB_Z*#_YRX_;K_\ GFT '_"\_C%_T4'_ ,Y<?MU__/-H /\
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M8X' '  XQCIQ7$"2222LELCY_P#@W_R47]K'_LX#PY_ZRQ^S30!] 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?/\ XC_Y.G^#?_9
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MZ?#%X,U5;F_OK2RM89+BPA\YIKR-*-@V/N^@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H _+#X(?MP?#+X:_!?X0_#G7=,T^[UOP!\
M+_ '@K6+K2?VC/V')]*N=5\*^%-)T+4+C3)[S]JZUGFT^2[L)GA>>VMY&C9"
M\4;$HIM\@V^1ZA_P\5^#O_0$_P#-A_V$_P#Z+F@ _P"'BOP=_P"@)_YL/^PG
M_P#1<T '_#Q7X._] 3_S8?\ 83_^BYH /^'BOP=_Z G_ )L/^PG_ /1<T '_
M  \5^#O_ $!/_-A_V$__ *+F@ _X>*_!W_H"?^;#_L)__1<T '_#Q7X._P#0
M$_\ -A_V$_\ Z+F@ _X>*_!W_H"?^;#_ +"?_P!%S0 ?\/%?@[_T!/\ S8?]
MA/\ ^BYH /\ AXK\'?\ H"?^;#_L)_\ T7- !_P\5^#O_0$_\V'_ &$__HN:
M #_AXK\'?^@)_P";#_L)_P#T7- !_P /%?@[_P! 3_S8?]A/_P"BYH /^'BO
MP=_Z G_FP_["?_T7- !_P\5^#O\ T!/_ #8?]A/_ .BYH /^'BOP=_Z G_FP
M_P"PG_\ 1<T '_#Q7X._] 3_ ,V'_83_ /HN: /H_P#9DTRYT7]FW]GS1KR3
M3YKO2?@?\)],NI=)U;2M?TJ6YL/ >@6L\FF:[H5[>:;K6GM+$QAO]/N[JUN8
MRDUO-+#(CL;?(-OD>X4 ?/\ X<_Y.G^,G_9 /V:?_5B_M8T ?0% !0!\_P#[
M-/\ R3KQ'_V<!^UC_P"M3_&2@#Z H * "@ H * "@ H \%U+XX:G'XU\6^"O
M"OP1^+7Q!E\$7^CZ7X@U_P +W_P6TW0;:_UK0=,\1V]M"OCWXP^'-4NC%I>K
M6;2O'I;1ARZ(\A6C"+ZTHU)?[)AI8JKA57K:PYJ$J<:U7EH>VK>RI^T3?[KV
MLDI<E*;LGKBJ3PBPZ<E5JXG"1QD:=._.J4\1B\+",G-4Z:J3JX*M9*;BH\CG
M*/-9=CJ'QE^$.D:MJ?A_5_BG\.-(U_0[*_U+7-!U/QSX7L=9T73]*M8+[5;W
M5M-GU59]/M+*SNK:>XGF1(X8IXY)&5)%8RITW3JUHU(RH4+<]6+_ '<$\1+"
M1<I:**EBH2PT>:U\1&5'^*G%904YU*-#V<HXBO*,(46DZKJ.A'%*E&$7+FJ?
M5Y1K\L.:]&2JJ]-J3GU#XM_"G2#X375?B;\/=+;QX+8^!EU#QIX;LCXR%X85
MLSX3%SJ2?\)$)VN;<1_V?]HWF>,+G>N=E1J_7)9>J4_K]-2E+#<K^L1C!-RE
M*C;VD5%)N3<4DDV[6(56F\'_ &@JD7@$U'ZRI+ZO=IM+VU_9W:BVES7:3[,H
MZ-\6/#VM>.Y/AY:VFH+K46G^+=3^U+=^&M1TH6W@W7M$\.ZE'-<:'XAOI;*_
MDO=>LWCL;NWM[J..*87D-K*J121A8O%X7$8NG:-/"+".:;NW]<KYMAZ7LY0Y
MZ53EGDV)=5PJ-4^>E3;]NL12P\8FM#"8S"X&HFZN+5=P<4DH_5L+E>+G[2,G
M&K3YJ>;894^:FO:\E2K"^&EAJ^(W8_B-\/9?&,OP[B\>>#)/'\%DVI3>!H_%
M&B/XQATY%#-?R^&5OCJ,=DJLI,[6PC (.[FE2_?4\15H_O:6#=J\X>]"@]%:
MM*-U2=Y15IN.Z[HVJ?N'1C5_<O$?P5/W'5TDU[-2MSZ0F_=OI&3^R[<7IO[0
M?P@U?7O$^BZ5X\\*ZA9>"_#4WB?Q9XLL?%'AB[\'>&[:TU:[T?4=/UW7K;6G
M31]7L;BSEDNH+Q(%@B*L\@8E5SA5A+#U\4Y*EA:#P2C6FU&E7^O_ %KV$L/4
MOR58\V$J0DTU[\J<8<[E+EIPFL5A\#"+JXVO+&P>'IIRKT9X!8%U85Z2_>4Y
M26/HNG'E;:A5<E!1CSUO#W[1WP7\0VFI:G%\0O"&EZ+9^+3X-TK7M9\6>%++
M0_%^I_V9X:U.*X\&ZHNN20:_I\R>*]&MXI(661[B?RQ%AXFFZEAZW^P0=.4<
M5F*Q+HX649+%6PF88K+:EZ%N?WJ^$G*GR\UZ52DWRSDZ<>58FDYYI%.U')WA
MXXG$77U>#Q& I9C%.K?EC[.A4DJOM.3DG1KI<T*;F^MM?B[\*+V/Q=+8_$[X
M>7<7P_$Q\>26OC3PW<1^"1;>;]H/BYX=28>&Q%Y$^_\ M V^SR9-V-AQS>TI
M_588[GC]2J3]E#$<R]A*I>*5.-6_LY3O**Y%)RO**MJCK5*I];6 5.7U[DC4
M6&Y7[?V<E>-3V-O:<DEK&7+RM:ID$_QG^#UKHWAGQ%<_%?X:V_A[QI>C3?!N
MNS^.O"\6C>+-1,AA6P\,ZI)J@MM>O3*I006,L\FX%=N1BMU1JO$TL$J4WC*]
M-5:5!1?MJE)J,HU*=*W/*FU.#4XQ<6I1:=I*^*JTW0K8I5(O"X:;IU:RDO94
MIQY^:%2I?DA./LZEXR::Y)W7NRMZ56>WE8M/MMT/G_X-_P#)1?VL?^S@/#G_
M *RQ^S30!] 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 ?/_B/_ ).G^#?_ &0#]I;_ -6+^R=0!] 4 % !0 4 % !0 4 % !0!A>)=
M6O\ 0M$O]5TOPOKOC._LTC>W\,^&KCPU:ZWJC/-'$T5A/XP\0Z%H\;QQNTS&
M]U6S79"X1FD*1R9U)RI\G+2E5YI1BU!P7(F[.<N></=CO)1YIV^&$GH:4X1G
M)QE5A0483DI34VFX0<HTU[.$WSU&E3@VE!3E%U)TZ?-./CGP]_:#TKQMX?\
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M6<F#HU,-A,+0JSC.K0HTJ<YPA&E"4X0C&4H4XVC3BVFXPC:,%:*T1XC\&_\
MDHO[6/\ V<!X<_\ 66/V::P.D^@* "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * /G_P 1_P#)T_P;_P"R ?M+?^K%_9.H ^@* "@ H *
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M3+?4/B3X)T*WU+4+RT\)^(YTM[*2XD6/2)WD5%"EC;R#;R/J^@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^(/V>OC;X7\#? +X'^
M"O%/@W]H#2_$W@_X/_#3PMXCTS_AEC]IJ]_L[7?#_@O1=)U>Q^VZ=\([BTN_
ML^H6EQ%YUK/-#)Y>^*1T96)M\@V^1Z__ ,-+?#K_ *%S]H#_ ,1._:G_ /G-
MT '_  TM\.O^A<_: _\ $3OVI_\ YS= !_PTM\.O^A<_: _\1._:G_\ G-T
M'_#2WPZ_Z%S]H#_Q$[]J?_YS= !_PTM\.O\ H7/V@/\ Q$[]J?\ ^<W0 ?\
M#2WPZ_Z%S]H#_P 1._:G_P#G-T '_#2WPZ_Z%S]H#_Q$[]J?_P"<W0 ?\-+?
M#K_H7/V@/_$3OVI__G-T '_#2WPZ_P"A<_: _P#$3OVI_P#YS= !_P -+?#K
M_H7/V@/_ !$[]J?_ .<W0 ?\-+?#K_H7/V@/_$3OVI__ )S= !_PTM\.O^A<
M_: _\1._:G_^<W0 ?\-+?#K_ *%S]H#_ ,1._:G_ /G-T '_  TM\.O^A<_:
M _\ $3OVI_\ YS= !_PTM\.O^A<_: _\1._:G_\ G-T '_#2WPZ_Z%S]H#_Q
M$[]J?_YS= !_PTM\.O\ H7/V@/\ Q$[]J?\ ^<W0!H?LR:3JN@?LV_L^:%KN
MF:AHNMZ+\#_A/I.L:-JUE<Z=JNDZKIW@/0+/4-,U/3[R..>PU"UNX9H)K>>-
M)(I(G1U5E(!MY6#;RL>X4 ?/_AS_ ).G^,G_ &0#]FG_ -6+^UC0!] 4 % '
MY6> W^*2Q_$,>'/CS\2/!>C#X_\ [3GV+PSH'AWX'WVDZ9_QD7\4OM'V2Z\8
M?![7-7E^T77GW4GVO5+K;+=2+#Y4"Q0P^_@LJP^(PM*M.=2,I<UU%Q2TG**L
MG!O9=]SR,5CZU"O.E",'&/+:ZE?6*?2277L=QYGQM_Z.B^,'_A)?LT__ $/U
M=7]AX3_GY5_\"A_\K,/[4Q'\E/[I?_)D-S>?&6RMY[N[_:I^+5I:6D,EQ<W5
MSX7_ &9H+>VMX$,DT\\TOP 5(88XU9F=V"JJDD@"IEDV"@G*5:I&*W;G!+LM
M7"V^A4,QQ=2<:=.E"<Y-1C&,9N3;T224FVV]$EJR5)OC6ZJ\?[4GQ?9&4,CI
MX3_9H965@"K*R_L_8*D$$$<8JWD6%BW%SK1<79IN"::T::]GHUV(CFU:45*,
M:4HR2::4FFGJFFIV::V:(Y[OXSVD$US<_M4?%NVMK:*2>XN)_"W[,T,%O!"A
MDEFFED_9_"Q1)&K,SL0%"DD@"LZN48"A3G5K8B=&E2BY3G.=.$(1BKRE*4H)
M1C%*[;:22NRX9CBZDXTZ=&$ZDVHQC&,W*4F[1C&*DVVWHDE=O1'$>&/BOK_C
M:^ETSP7^W1XE\7:E! ;J;3_##?LDZ_?0VJLJ-<RVFE? Z>6. .R*9&0*"P&<
MD4Z638*M&<Z-:I5A2Y>>4)TY*'-?EYG&#4>;E?+>U[.VS%4S/$T90A5IPI2J
M7Y(RC.+ERV<N5.2<N5--VO:ZN=A>ZK\7=-2"34?VL/BI81W-Y:Z?;/>^&_V8
M[5+B_OIEM[&Q@:?X J);RXN'2**%"7D=U5%+$"J6281SA252JZE3F4(*4.:7
MLZ<ZT^6/L[RY*5.I5E9/EITYS=HQDU+S6O"$JDHTXTZ?+S2:DHQYIQIQYFYV
MCS5)PIQO:\YQBO>DDY;J^^,EC;3WE[^U5\6;.SM(GGN;JZ\,?LRV]M;01*7D
MFGGE^ "I#$B LSNP  ))P*3R7!QM>K5C=J*O*"U;48KX-VVDENVTEJRXYEBI
MR4(4H2D]HQC-OY)2N0V>K?%S4&O$T_\ :Q^*=\^G7;6%^EGX<_9BN6L+Y(8+
MEK*\6#X L;6[6WN;:4PR;7"7$3;=LBDM9'A'&,U4JN$G-1DI0Y6Z52=&HD_9
MV;IUJ=2E-+X*E.<)6E&26:S:LVXI4G**@VES72J0C5IMKGT4Z<X5(/:4)1G&
M\9)N[YGQM_Z.B^,'_A)?LT__ $/U']AX3_GY5_\  H?_ "LK^U,1_)3^Z7_R
M94OM4^+VEVKWNI_M7_%73K*)H4DN[[PW^S':6L;W$T=M;H\]Q\ 41&EN)8HD
M!8%GE15RS &7DV"BZ<76J1E5G"E!.<$YU*DE"G3@N3WISFU&$%>4I-1BFVD-
M9GB;3:IPM3A.I)\LK1ITX.I4G)\_NPIPC*<Y.T8PBY2:2;$N-5^+MG<V%E=?
MM8?%2UO-4EF@TRTN/#?[,<%SJ,]M;2WEQ#802? %7NY8K2":=TB5RL<+NP"J
M2*6281R=.-2JYQA*JXJ4.94X3ITY5&E3NH1J5:4)3^%3JTXMISBG,LUKPBI2
MC3C&4XTTVI).I*,YQ@FYV<Y1IU)1BO><83:5HRM<\SXVC_FZ+XP#'_4I?LTC
M&/\ NWZC^Q,(O^7E56_O0_\ E8_[4Q'\E/[I?_)E>UO_ (QWL(N;+]JOXL7=
MNSS1K/:^&/V9;B$R6\TEO/&)8O@ REXIXI8G4'*O&RG#*0!9)A'&$E4JN,XQ
MG%J4+2A.*G"<7[.SC.$E*,EI*+33::8?VIB$W'DIIQ;BU:5U*+:E%KGT<6FF
MGJFFGJ176K?%RPFT^VOOVL?BG97&JW;6&E077AS]F*VFU*^2UN;YK+3XIO@"
MK7EVMC9WEP880[B*TFDV[(F*D<CPDI<D:E:4U"4^52@WR0<5.=E3OR1<X*4M
MHN44VN97I9EBN2I45*'LZ/+SRY9\L.><:<.:7-:/-4E&$;M<TY1BKR:1=\SX
MV_\ 1T7Q@_\ "2_9I_\ H?J/[#PG_/RK_P"!0_\ E9/]J8C^2G]TO_DP\SXV
M_P#1T7Q@_P#"2_9I_P#H?J/[#PG_ #\J_P#@4/\ Y6']J8C^2G]TO_DP\SXV
M_P#1T7Q@_P#"2_9I_P#H?J/[#PG_ #\J_P#@4/\ Y6']J8C^2G]TO_DP\SXV
M_P#1T7Q@_P#"2_9I_P#H?J/[#PG_ #\J_P#@4/\ Y6']J8C^2G]TO_DP\SXV
M_P#1T7Q@_P#"2_9I_P#H?J/[#PG_ #\J_P#@4/\ Y6']J8C^2G]TO_DRH-4^
M+QOVTH?M7_%4ZHEHFH/IH\-_LQF_2PDF>WCO6LQ\ ?-6T:XCDB$Q387C90VY
M2!,<FP4G4C"M4E*AR>T2G!NG[3G=/G2A[OM%3J<E[<WLY\M^25F\SQ,5!NG"
M*J<Z@W&24O9>S]IR^_[WL_:TN>U^3VE/FMSQO;\SXV_]'1?&#_PDOV:?_H?J
MK^P\)_S\J_\ @4/_ )6+^U,1_)3^Z7_R8>9\;?\ HZ+XP?\ A)?LT_\ T/U'
M]AX3_GY5_P# H?\ RL/[4Q'\E/[I?_)E>YO_ (QV4:RWG[5?Q8M(GGM[9)+G
MPQ^S+;QO<W<\=M:6ZO+\ %#3S7$L44<8.YWD5%!9@"?V)A+QC[2KS2=HKFA=
MM)RLE[/5J,6[+HF]DP69XFTFJ=.U.+G)\LK1C%7E*3Y_=C%:MNR2W98\SXV_
M]'1?&#_PDOV:?_H?J/[#PG_/RK_X%#_Y6']J8C^2G]TO_DP\SXV_]'1?&#_P
MDOV:?_H?J/[#PG_/RK_X%#_Y6']J8C^2G]TO_DR"ZOOC)8VT]Y>_M5?%FSL[
M2)Y[FZNO#'[,MO;6T$2EY)IYY?@ J0Q(@+,[L  "2<"D\EP<;7JU8W:BKR@M
M6U&*^#=MI);MM):LJ.98J<E"%*$I/:,8S;^24KF;KGB;XF^&=/\ [6\2?M?_
M !'\/:5Y]M:C4M<T7]ES2=/^TWLJP6=O]LO_ ("Q0^?/,Z1Q1[]TC.%4$D"A
MY+@XU*-%UJL:V(J*E2IN4%.K5E?EI4X\G-.I*SM"*<G9V6A,<TQ$J=2K"%.5
M&C3=:<U&3A"E%)RJSDI\L:<4TW-M12:NS9$GQM[?M1?&#';'A+]FG\/^;?J?
M]AX1?\O*RM_>A_\ *Q+-:[2:C3:>S2E\OMAYGQM'_-T7Q@&/^I2_9I&,?]V_
M4GDN#BFW5JQ45=MR@DDMVWR:)#_M3$?R4_NE_P#)E2PU/XO:I9P:AI?[5_Q5
MU&PN5+VU[8>&_P!F.[L[A%9D+P7-O\ 7CE4.K+E&(RI'44+),&XPG&K5<*D(
M5(24H<LJ=2*G3G%JG:4)PE&<)*ZE&2E%M-,'F>)C*<'3IQG2G.G.+C).$Z<G
M"I"2Y[QG"<90G%V<91<6DTT6_,^-O_1T7Q@_\)+]FG_Z'ZG_ &'A/^?E7_P*
M'_RL/[4Q'\E/[I?_ "8>9\;?^CHOC!_X27[-/_T/U']AX3_GY5_\"A_\K#^U
M,1_)3^Z7_P F'F?&W_HZ+XP?^$E^S3_]#]1_8>$_Y^5?_ H?_*P_M3$?R4_N
ME_\ )AYGQM_Z.B^,'_A)?LT__0_4?V'A/^?E7_P*'_RL/[4Q'\E/[I?_ "8>
M9\;?^CHOC!_X27[-/_T/U']AX3_GY5_\"A_\K#^U,1_)3^Z7_P F'F?&W_HZ
M+XP?^$E^S3_]#]1_8>$_Y^5?_ H?_*P_M3$?R4_NE_\ )AYGQM_Z.B^,'_A)
M?LT__0_4?V'A/^?E7_P*'_RL/[4Q'\E/[I?_ "8>9\;?^CHOC!_X27[-/_T/
MU']AX3_GY5_\"A_\K#^U,1_)3^Z7_P F'F?&W_HZ+XP?^$E^S3_]#]1_8>$_
MY^5?_ H?_*P_M3$?R4_NE_\ )AYGQM_Z.B^,'_A)?LT__0_4?V'A/^?E7_P*
M'_RL/[4Q'\E/[I?_ "8>9\;?^CHOC!_X27[-/_T/U']AX3_GY5_\"A_\K#^U
M,1_)3^Z7_P F'F?&W_HZ+XP?^$E^S3_]#]1_8>$_Y^5?_ H?_*P_M3$?R4_N
ME_\ )AYGQM_Z.B^,'_A)?LT__0_4?V'A/^?E7_P*'_RL/[4Q'\E/[I?_ "8>
M9\;?^CHOC!_X27[-/_T/U']AX3_GY5_\"A_\K#^U,1_)3^Z7_P F'F?&W_HZ
M+XP?^$E^S3_]#]1_8>$_Y^5?_ H?_*P_M3$?R4_NE_\ )AYGQM_Z.B^,'_A)
M?LT__0_4?V'A/^?E7_P*'_RL/[4Q'\E/[I?_ "8>9\;?^CHOC!_X27[-/_T/
MU']AX3_GY5_\"A_\K#^U,1_)3^Z7_P F'F?&W_HZ+XP?^$E^S3_]#]1_8>$_
MY^5?_ H?_*P_M3$?R4_NE_\ )AYGQM_Z.B^,'_A)?LT__0_4?V'A/^?E7_P*
M'_RL/[4Q'\E/[I?_ "8>9\;?^CHOC!_X27[-/_T/U']AX3_GY5_\"A_\K#^U
M,1_)3^Z7_P F'F?&W_HZ+XP?^$E^S3_]#]1_8>$_Y^5?_ H?_*P_M3$?R4_N
ME_\ )AYGQM_Z.B^,'_A)?LT__0_4?V'A/^?E7_P*'_RL/[4Q'\E/[I?_ "8>
M9\;?^CHOC!_X27[-/_T/U']AX3_GY5_\"A_\K#^U,1_)3^Z7_P F'F?&W_HZ
M+XP?^$E^S3_]#]1_8>$_Y^5?_ H?_*P_M3$?R4_NE_\ )AYGQM_Z.B^,'_A)
M?LT__0_4?V'A/^?E7_P*'_RL/[4Q'\E/[I?_ "8>9\;?^CHOC!_X27[-/_T/
MU']AX3_GY5_\"A_\K#^U,1_)3^Z7_P F'F?&W_HZ+XP?^$E^S3_]#]1_8>$_
MY^5?_ H?_*P_M3$?R4_NE_\ )AYGQM_Z.B^,'_A)?LT__0_4?V'A/^?E7_P*
M'_RL/[4Q'\E/[I?_ "8>9\;?^CHOC!_X27[-/_T/U']AX3_GY5_\"A_\K#^U
M,1_)3^Z7_P F'F?&W_HZ+XP?^$E^S3_]#]1_8>$_Y^5?_ H?_*P_M3$?R4_N
ME_\ )AYGQM_Z.B^,'_A)?LT__0_4?V'A/^?E7_P*'_RL/[4Q'\E/[I?_ "8>
M9\;?^CHOC!_X27[-/_T/U']AX3_GY5_\"A_\K#^U,1_)3^Z7_P F'F?&W_HZ
M+XP?^$E^S3_]#]1_8>$_Y^5?_ H?_*P_M3$?R4_NE_\ )AYGQM_Z.B^,'_A)
M?LT__0_4?V'A/^?E7_P*'_RL/[4Q'\E/[I?_ "8>9\;?^CHOC!_X27[-/_T/
MU']AX3_GY5_\"A_\K#^U,1_)3^Z7_P F'F?&W_HZ+XP?^$E^S3_]#]1_8>$_
MY^5?_ H?_*P_M3$?R4_NE_\ )AYGQM_Z.B^,'_A)?LT__0_4?V'A/^?E7_P*
M'_RL/[4Q'\E/[I?_ "8>9\;?^CHOC!_X27[-/_T/U']AX3_GY5_\"A_\K#^U
M,1_)3^Z7_P F'F?&W_HZ+XP?^$E^S3_]#]1_8>$_Y^5?_ H?_*P_M3$?R4_N
ME_\ )AYGQM_Z.B^,'_A)?LT__0_4?V'A/^?E7_P*'_RL/[4Q'\E/[I?_ "8>
M9\;?^CHOC!_X27[-/_T/U']AX3_GY5_\"A_\K#^U,1_)3^Z7_P F'F?&W_HZ
M+XP?^$E^S3_]#]1_8>$_Y^5?_ H?_*P_M3$?R4_NE_\ )AYGQM_Z.B^,'_A)
M?LT__0_4?V'A/^?E7_P*'_RL/[4Q'\E/[I?_ "8>9\;?^CHOC!_X27[-/_T/
MU']AX3_GY5_\"A_\K#^U,1_)3^Z7_P F'F?&W_HZ+XP?^$E^S3_]#]1_8>$_
MY^5?_ H?_*P_M3$?R4_NE_\ )AYGQM_Z.B^,'_A)?LT__0_4?V'A/^?E7_P*
M'_RL/[4Q'\E/[I?_ "8>9\;?^CHOC!_X27[-/_T/U']AX3_GY5_\"A_\K#^U
M,1_)3^Z7_P F'F?&W_HZ+XP?^$E^S3_]#]1_8>$_Y^5?_ H?_*P_M3$?R4_N
ME_\ )AYGQM_Z.B^,'_A)?LT__0_4?V'A/^?E7_P*'_RL/[4Q'\E/[I?_ "8>
M9\;?^CHOC!_X27[-/_T/U']AX3_GY5_\"A_\K#^U,1_)3^Z7_P F'F?&W_HZ
M+XP?^$E^S3_]#]1_8>$_Y^5?_ H?_*P_M3$?R4_NE_\ )AYGQM_Z.B^,'_A)
M?LT__0_4?V'A/^?E7_P*'_RL/[4Q'\E/[I?_ "8>9\;?^CHOC!_X27[-/_T/
MU']AX3_GY5_\"A_\K#^U,1_)3^Z7_P F'F?&W_HZ+XP?^$E^S3_]#]1_8>$_
MY^5?_ H?_*P_M3$?R4_NE_\ )FU^S9=^,%_:7^,=EXK^('B3XA7,_P #/@A<
MC5O%&F>!-,U"W@L_'WQYBLM.AC\ ^#?#=B;."2^U.96ELY+AGU*42SR1Q6\=
MMY>/P5'!J2I\TFG1LY--KG^L<RT459^SCNFU;1ZG=@\54KN//RQ5JFD5I[OL
M;/5MZ<\MG;RT/T!KRCT H _,7X<?\>?C_P#[+_\ M/?^M'_%2OL<J_W"A_V_
M_P"G)GS>/_WNK_V[_P"D1/0J]$XSYI\.2:RGQ:\4IXI7XM-=2:OX@6SVIJ)^
M#,?PY71=/;19+Q]0QX?341?K>+C2S_;QN9)?MRG2PI3S,,H?V;COKKDFJ&8?
M7UB+^QO_ &E5^J?5O:>]S?V7[+_=/]B]G]8^O?[<J#6V(558J@Z'P*I@E@UA
MW'VNN!7UOVZAT68*J[XC]^FL(L$_82K1EZ-\%_M7_"KO!GVKS=O]E'^SO/QY
MW]A?:[G_ (1WS/\ :_L'^SNO/KSFO47UCV&!^N<WU_ZE@/KG/_$^N_4Z'USV
MG_3SZU[7VG]_F,)6^LYCR>S]C_:&8^Q]ER^R^K_7L1]7]ER^[[+V/)[/E]WD
MY>7W;'5^,H)[KPAXJM;6&6XN;CPWK<%O;P1O+///+IEU'%##%&"TLKNRJJ*"
M6)  )->-Q!2J5LBSBC1IRJU:F#Q,(0A%RG*3HS48QC%-RDVTDDFV]$CT,JG"
MEF>75*DE3IT\50E*4FHQC&-6#<I-V45%*[;LDMSY#B\#_%7PU#\/KPZ]XW\=
M3Q_"_5;3P#::SH/A:S'PQ^*A\$7,%FVOKX5\%:1++H%W827.F12ZW.T=E=V\
M<=TT\U_%+:^AFRQ4,9Q.L-7J8C%UZ%=8/'*-&3EA_KE&>,PZC3>'P\L77<,/
MB\))<D:RHU:--T'&^(Y<ECA)X'AOZW0^J8.AB,$\PP:E)6A[)0H58*M*IBN3
M"RE6HXBE&<ZBC7IUZG-3HU7#$\(Z%\1[FUM_[1U7XB>*K.'X@_!S4+NQ\0_#
MOXF^'$TO6+#Q8MWXGO;"Y^)WQ%\4ZM=VL%FL!O)=(@L?#,*0PRZ>Y)N@KP_[
MJM@*E.]:C0Q&:2PTW&I1J*C+A[-Z,(S6)E5Q<8U<34HTJ4LRJ*NJTU3A&<)P
M9CF*E/ 5X.,88J='#JM3IN-5RG'.,JJ1][#QIX-NG3IXF:6#IMNDISQ'LX4Z
M"?(:SIWQ1\7V?Q TQM,^,,NG>*OA+\2X=;\/:O#\6%-OX]TK4M#O/#FG66L:
MQ<6&AR-+8RZC:VT7@K1]-TS48H9XY9]4\_RK3BP,8+!4_KCQ,J5"KPYC5)?7
M(XE.ACJ;S7E:?UV5>,&JLJ5*%"G>"J8#"Q5)2A]#)X>CC%[&I0598['86,TZ
M'L)8.O@\=3PT^6-J%*BYTZ#A5K.OB:+J06)Q%"HW+%=XI\7_ -JW']N+\?T^
M%HU#Q$/#*^'E^*Z>+UUA?#'PZ'@I=76U_P"*M&B!1XJ!_M+_ (E7]H_:O[<_
M>XK;%O$?5ZW,ZCS9QQCR]T+>R^L_VYGC?UCD_P!BY?JG]D_5?[0_V+ZG?V?N
M\IX.!CR>TA:C'"1G@5C%6YU46'658%55@U\?(L;]:6)_L_\ VWVOLO8?NO;F
MI::/\8VM(_$OB"]^)"^-='UK]GVV&G:7JWB)/#4L>HCPG8_%&4^&]*F&B:[:
M?9[K6C?RRVUW;63V\MS";:2-ICV4(4XYMB*D7)X>IG.94DIRJ.BL!_8^'E0]
ME"L^2%#Z]&3PU=J,U5YJ<:J<JL)=:^KSHUZ*O'#QR7$UL.ZOL88KZY1QF<SP
M*KU**5\8Z$<%&OAX2<*ZE3A.G4A[&W(7>E?$O4_^%A:#/#\6]=CU20R:C=ZM
M8^.-,M]*NH/B7X>N="31]%U\ZYH%]>QZ$^IM'J'P^UB'34M=-$NJ:9%</$;?
MR<#1J5,%E%.O[5^QS'AZI4JS]K"O[6EC;YA.2J/ZUA>6E[*IBIPK8C+85*<Y
M9;5H4E>K6,<(5<PJTI4US83/:5.C#V;A*C5RJLL*N:E'V-:*KQ5'#PK4\/F-
M18B$<1&O5C6<-'XCI\2?!NC?$BUTC5/BE;^&/#.K_$>YT76;G7/&&HW=MH#_
M +/PU:VNO^$LU2[GO+^PM_'UQ>_8[B[OIX[:_B2WMGC:VCBB[(MQHX*-3VL>
M6ABJ#47^]<EQ3DU+"1O-_O,5/+GB849U>:M7PSK.<ZE.563[:5&C6S?AU4(T
MZSQ>*RRIBH6C*ESNGGM/$QJ4H+DI4'[/+Y5L/"$*,9RHS]G&52%_<O@RFKRZ
MKXN-L_Q);P!<:-X7_LQ_B;/XM'B ^,F_MQ?&;:2_C&0:M#HAMSX?,;6Y72_/
M\]M(/V?)KKE3A+ XVBU*,98S$PPJ;J4ZZP3H4(I3E)QQ<+8GZQ[%XIQQL5S.
M35'ZLSP*<XI9=5BY2Q2P_-C':G/"NJI0EAW22O2E4=/VGUCV">$E#ZLM<1]:
M/ M"T7Q!X;\,Z+H5Y9_'ZPT/2[#Q_:Z3;>%9/BK/JX^*H\77[Z3+J]U;RRWM
M[X8FT9[&:PN=1EE\(3/+>27SL[@GPZ7UY99AHT%4CF%+(\EI9;"47"G3QE+#
M8BGFE/%0JI8:#IXN.'A3AF"5.&"C&.6)8=02]2$:4<QQ+J^Q>$JYQFE;'RO!
M\V"K5\/5RZ>&=-NL^?"SQ,L1_9W^T_6W?&_[4ZA]#>+1\2/['^"81O$"^(/[
M4(\>MX6C:6))_P#A5/C/[0U_$LT-A)IX\6_V88$U"6*S-X+$%U8QL/;S51>*
MSF. E4AAGE^:K"RIQC.<:OM<*L)*E&M.G"6(C#VCH1G.$W::4E[[.?([+*Y_
MVBJ4L8EE7,JKY6W_ &C@_K24H1E4BGA_:K$.C&35'VKY7"Z/FW3(_B</!FK:
M=<7OQP.G6^M^"+K6-?ETCXUMJ5_<JFM1^*=+B\-S:]#\0]$L':+1);J]\!^(
M_$NDK<SP#3K8Z>FI)-Y]?7#8/6K"A#%8CDC2^NMU*,\#3C"]116:484\9[:>
M&CFF'Q,N:26*JRH.G[#>C'DJ8J7-2GB*N#E'EJ?5(^QJPQT)1J**3RNK6JX2
M4Z=582MA_P!U2J3P]&&*>$]KTMEK_P 6++1M1TS4=&^,(U;7?#GPM7PM,EMX
MIUWR1HGC35;3Q3>ZCKMGH]A'X<U&Z\/'2[VZMM6M],U*XM;A(IXKFZM[@+T1
ME6E4P%"JI0Q2SG*L5BG9>QA@JF$R2&*I.O1C'"5:<,91S"&)HX;EH*52KB(X
M:C@ZLI0X)0A!X[$4IIX.669QA\-"]1U?K4'FM7!S]A5YL33G*E7P<<+6KN=7
MFH0I2Q$Z\*;J5(;/XV?\)=XXNKOQ+\05U=8_BGYF@Z=X#^)*^'CH0TW7D\ C
M1_&%_P#$MO!7VK#>'I;5O"'A<:\;I/)U!%S=W!\EK&1R3-.2=>>->6/G2A7I
M5(9GST+O"NM/$5*LHVKJFLO5+ 5*#<ZWLZZP]$]EO!O-LJ3A2IX2..P?LFIT
MZE-X)<OUCZW&-.E&*E[RKK'REB(5O]T=3"+7WC7-$\7:!\$8K+PI=^-+WQ-+
M;^&+[7+B\UO6==\;/:7FIZ/-X[_LBYU^\N+BTUH:(VM?8[*U\A+:?9%900LL
M:#WLV5"&*ITH>U64T,9R57A'4G7^I*K4=XU*;EBJL>9T_:U*4YXMX;GCAY>T
MC22\C)FYT75Q5EC:V!K2IJLH0I+'_4G'#*=.:C0IQ6(C3YHRC&BZEYXA-2JR
MEYGX3T3Q1KWC?1+*"[^-MI\(X=<\0WVB'Q-K?Q+\/Z]/%9>'/"\T=OXBU'6[
MNU\5?V&WBI=4:SM_$DZ3W!CO(4672Y(XI>7!K$K&PJ8NW+0PF+J89)OD<5CL
MKC@_K<(OV-7%JC+'\M*LIU)83DEBX/$QK..V+E26%C3PW*IUJF!IXII/G4WA
M\]>*=&<DY4J?*LK52KA'"C'$./L9QFTSK/C);?$"\\23VGAJ;QW:Z3<Z;\*;
M=KCPM-KMM% \OQATZ/Q3+;7&F_NX+M/";7#7D@^9; .9_P#1P:,'2E6S6O3Q
M,JD<%*OE]GSSIP]FL#GKQ$8S37+"598*-:5.49*H\-[T:OL)+IHRHT\-&5J3
MK0P'$;2G&$G[=83+O[/O&2:E4]K[?ZI&2;<_;*DF_:(XW4;3XN>$4U6U\)1?
M$37;*3Q_XA^&>CQ:QJOB3Q!<Z+X9\8Z+X:N]$^(<FJ>(+NYO=8T_PYXE75 =
M3N+FZ>.VO;JW\[9;(D*HQK5X97A*[G"GFD,50Q5=-TJN$C@,XQSHU/:1M[">
M)R.-:E3J\GM<9C/[)J3J2E)5)<BJ0I5\SQ7LZ=3^S)X+%X>C/G]GC%5RS#QQ
M.#A&FG":EF<Z%2I%QY,)1I8Z-+V*E5A*O#I/Q9MOC'+'+XJ\?PVUAXAAMM(T
MRV\$_$/7?#U_\/;71H8XY+[QE?\ Q0LOAXM[/<+.9YK[0+CQ*MX05\^V*/7/
M0EC)K&5:DIQQ%2.;RK4Z5'V<:;D\9_9OL'BJKH2<(/!3H0RZG2YJD51QSIT_
MK==W5A3I4,-1@XRIT_[-C2JRFJE2<HO"_7W6A0A#$Q4IK%QJO&U:D(T)>UPG
M/6^JT8^:V_A_QYJWA2_L/$EO\;O$>GZ/XK^$OB/6=0O/^%O:'K8U31OB$K>*
MCI7A6ZNK_5);Z+PU+'>3GP-XAUGPX)M/CGT6TM)X(I).W NG'$9/5J0G"E@\
M<_95%+%.,OK&3XS#OGAB.7'0PM/'_5U56:QKP5+%SC+$SPL<9%;XJ2_X5:-#
MV4:N+P681<&L/R14,3A:^&IJK3D\%.I."Q$:#PL,+6<*7)B:<IUL/"/=:;X/
M^(EW]FDN]9^-<:Z[X4^.FIZRC^*OB%:&WUK0/'-BWPMM+)!?1MX;E.E7-T]K
M:V(LWU6UA\N[6^M8S&."O#$X;(\76H2JRS'"Y'DN*H1;E5G/-_J<WBTX2<_;
M2C4BJ>)P+C/#RG)3KX>5>U1U@7A*M2]94X4Y9_6P:C+W/^$:K]=YI^^U.,;T
ML/*GC6U6P[FH8>O1ISC!17\/QLU#Q[X9O=0\1>.M#=H?AM/H&FZ+\/?B+K6E
MW-G)I.C2^.D\2ZCI?Q'T'P/HLYU3^W(KN'QEHUY>PP%'T@RW7DP1]TX3IYQF
M_LZCG2CC<:HT^2:H?V<J=L+[#$2JU,-+F=^66$H?VDJ]U*,\-[.3X*,XRR++
M>>'+B995%UI3:]M',W.M?]S3A'%<\8_57&-:K' R]Z-;V:6)<L;Q#X'^(^H?
M#ZYTV5OBWK=UXT^"'Q3E\5:;J>O>.+T'Q;I&M>&Y?!6GVUG<WHC\.ZE+8W.K
MP1V-BMD^JV\<J7<=Z$8USX6E3IX'"?6_K$H8:GPAC*K4\3+%*O3JTI9M*$J<
MOK3JPIPYZ^'HN].M&-2%*&(:D_;IU*'UC$U82H4ZL<XS7"4%:C"E_9^(I9M&
MC)Q:5*5%5(X14<743]C&<(TZT*,H17OOQ#\)Q^*?#_P5&DVWCI[72/&OA;4(
MBNK?$#1M=L=-B\/ZJB7GBEY+^UU<312?9$N)-=+3I+,Z7!$D\HDO-Z6(EF^'
MKT?XU.&<)3HRBJ$*E3*L;[!KV36'CSXA4:5.224E-X=-TZ]2G/PLOE&GE&+H
M55R\T<O4H2C[[<,UP"KQA=<[4*+KU4J;Y8*G#$T^5X>C5I^)VVI?%C6O"OAO
M1XH/C+IVLZ%\*=-\.>*]0N-,\9Z5<W'CNU\>> K35;VQU&]MU'B#4!HT>MSI
MK-M]K@GL[BZ:*XFC%TL6U><<;BIUZ,*M# XO'\*NG!J6'G##?6LQ_M6,J:<:
MF'A&#H0QUU!.$:4Y2E1]C5ET9AR4L=C/8>SE",>+ITU#EG2M.A&>3*+C>G)W
M3^I4XMSI3O3C"G5O ZC4-+\7:'JFN:%JLWQIN_A9I/Q.F6*XT#5/B/KGC.72
M+WX<^&[_ $C['X@TJZN/%VM>%$\=WFLK.UG=W4,$L:6UR4TVVN(HN:<9/#X*
M%55?=PN;4J2A[1S^MPS*E'+OK5GRU(O+_K*IU,?S8:J_9SQ4YR]E,Z,9&DHP
MGA71]I7H8&MC%>"BH<^9PQBH05E0KMTLLE*A@XTZ\:4JDL-3BZLN;;M-$\86
M_P"S7X!T+3(?'>B^(#K'PZLM1CL$U31_&MAH]Q\1]&7Q!)?#30MSI[KX?DOI
M+UQB)(#<-(?)#&NRE152?#6'K/V5"&&P-/%*E.=*G%4LD<94I23C.G!8B$*6
MKA4A/E490K*+48>=&.)XEK>Y+F_UBJX5UE&?/4G5QM3!S@JJ?M*DY2ISHNTI
M3DXN*E=7PH]'^)'A6:RO]'D^+6NO8^-OBYX<M]+O_$?BK51+X&M/"/BK5O""
MR3>)9-0M;BYE\366CQ6'B;5X;^Z+WD-I]JFMG6V;SJ<\6LKK5*BJO%5<HS'G
MLE&K'$X;.:6&R^5*#IS5+$++'4J6I4O:XZ">(K1Q-11J*X4\-+&*E[2G1P]+
M,,FE"4KRA[+$X+#/,G4<91J5</'$5*SJ4O:*GA9P]G16'Y'$X7PS!\4]1N]5
MTN"\^,\'A;6-9^"-_#=7MM\8M'U>S,_B_5K+XDVXUGQ]=-J]K$=-M[&2^2PM
M=!TN&VF1[.PCB!O;OT</2IU)8;#593^K4LQQ]I*>(I<V!GP_C)86,JE2K+%N
M"Q].$(RQ.(>*AB94K>QJ5*"?'CZGLL!3K4(1_M"6'Y*T?W55QKPS/*N62C0C
M#"\\<-7Q3MAZ#H5*5.M[2IB*=.K0PVUXPM?B+9Z/%X3A_P"%QBRM-?\ BI:>
M&=<M+SXN:U=!K/4M+C\"6VO7W@J[M/$VMVSVESJ,EEJ>N>*;'2'2TD349[AF
MMWMO%J5,?/+Z55>UCFF&P5>5&/LYI5:M#,,QIPYH15/"?6%@L/@],?&O'%+$
MPKTL+B:JJJMZ5&.$I5\1']U+"UL7EZFY.,G3HU<KP];$N$INI5]B\?4JJI'!
MQC6HSI/#JOAJ-X/.U;Q#X[MK?PIJOC*\^+^C^*]4U7]GRU\.-IL?C+1/";:3
MJ^H>"+;QUI_C"TL(X- M?$-QX@G\0P7=KK$<>I&WDMXK)/LQN%KZ!1I+B&K1
MP[DW4S3,$HU)-X.6 A@:]7 K#7;HRC'D<Y*C?%+$0J/%?[(J)Y^$A)9/'ZPE
M*>&R/%NK)>R=>.:4WCH3J.4?WG(J/U-TZE7_ &9IN>%?UUIE-K/XZ(OQ0NI/
M$OQ)E\4_\(C\4OM6A:9X"^)UKID=^;34%\#CPKXLU;XE7GA>XOD/]G/8-\/_
M  U!=RD,FJ)#.6:O(RVGB7A<-"O5JN52EE<<3)QG1E2QLL;@/KLHO$SKUY\E
M-8U2^KJGE,J#E5]U1PU!^I2^J/.\N52-&G@HYE+EYI4:E.66J&(4%7]E&A2I
MQDGAG-XSVF.A6BH+G@\36/NKPIHL7A_0-.TR*YUN[,</GSW'B'6]9\0:K)=7
M1-S=-<:CKM[=76/M$LFRW$BPVZ;88(HH8TC3VZ_)&I*G22C1HMTZ=G?]W!M0
MO-N4ZLN6UZM2<ZD_BG.3=SYS#.I*A2J5K^VJ0IRJ77+:?LXJ7N)1C3U6L(1C
M%2N^5-MOHJR-PH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M3^^7_P @'E_&W_HUWXP?^%;^S3_]$#1_;>$_Y]U?_ 8?_+ _LO$?ST_OE_\
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M3^^7_P @'E_&W_HUWXP?^%;^S3_]$#1_;>$_Y]U?_ 8?_+ _LO$?ST_OE_\
M(!Y?QM_Z-=^,'_A6_LT__1 T?VWA/^?=7_P&'_RP/[+Q'\]/[Y?_ " >7\;?
M^C7?C!_X5O[-/_T0-']MX3_GW5_\!A_\L#^R\1_/3^^7_P @'E_&W_HUWXP?
M^%;^S3_]$#1_;>$_Y]U?_ 8?_+ _LO$?ST_OE_\ (!Y?QM_Z-=^,'_A6_LT_
M_1 T?VWA/^?=7_P&'_RP/[+Q'\]/[Y?_ " >7\;?^C7?C!_X5O[-/_T0-']M
MX3_GW5_\!A_\L#^R\1_/3^^7_P @'E_&W_HUWXP?^%;^S3_]$#1_;>$_Y]U?
M_ 8?_+ _LO$?ST_OE_\ (!Y?QM_Z-=^,'_A6_LT__1 T?VWA/^?=7_P&'_RP
M/[+Q'\]/[Y?_ " >7\;?^C7?C!_X5O[-/_T0-']MX3_GW5_\!A_\L#^R\1_/
M3^^7_P @'E_&W_HUWXP?^%;^S3_]$#1_;>$_Y]U?_ 8?_+ _LO$?ST_OE_\
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M'_RP/[+Q'\]/[Y?_ "!M?LV6GC _M+_&.\\5_#_Q)\.[FW^!GP0M1I/BC4_
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M6>B:W</<6?B".&;2[VYLHM.-UI=DT-Q%)+<7T%M%:HQ>Z>%58CJKX>MA<7/
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MKNO4YE%1J2CB/J]*CSSA1HT*<(5>1\E/S0?LN_%6\T+QDOB7Q+X,\1Z]XD\
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MMR>Q^HX'*:^6X.K5C*GB(SQ[E7A5Q4G%SJO+\#.&-A7ITZN&[Z=6I4MBJ_\
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M4:--2Q/UN&33I0E/"S>'QN!EE4\!7<8U95*V#PN*P=7%9A[52]MB*-'-,;'
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MG*GC:&2ULMRCVE&\Z<HX:M6E4QM><JL\;R0KNC"K*I2G'XX_9,\02V?BO1_
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MA>+Q)>>*+Z2Q:ZU"">VO8%> (TMDNV93ABGF56A24J]>EG?L'B)2JWQF-Q>
MC@,?B92<^:O2RG!QPF(<H5I0Q-.GBJ=2K5DJE"J%2I3EAO9JGEM.K_9T,7#
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MJFE%QHX;$2C4<?8RG35.52G[2$FF@?&'X>>)?#WBOQ5IFN7$6@>"&NQXGO\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@#Y_?]IGX7?;-7LK*S^,&N?V%X@\1^%M0U#PM^SC^T3XMT+^
MW?".NZCX8\26-CXD\,?"R_TK5_L'B#2-3L)9K"\N8?.L9561MA- %#5OVK/A
M+H&E:GKNNZ?\<-%T31=/O-6UC6-6_9;_ &GM.TK2=*TZVDO-0U/4]0O/@_';
MV&GVMI#-/-<3R)'%'$[NRJI( /H^@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^?_  Y_R=/\
M9/\ L@'[-/\ ZL7]K&@#Z H * /G_P#9I_Y)UXC_ .S@/VL?_6I_C)0!] 4
M% !0!\__ +)W_)K'[-/_ &0#X-_^JZ\.4 'QD_Y*+^R=_P!G >(__66/VEJ
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MD)J$<'B<'04J<FHT\)6=3$TJN(Q4UB73Q#E3C1QG)A<RHUZ%**IRRFIC*_\
M9]+*K5KPRG,JL(SEB<)B:D:<U%^UQ,?JE&I3HX*DZ7M*,%B76P\JV)P&*P\Z
MW+-9C2P=-XBKTNO_ !8_:4FT^_TGP9X5\;7'BSPYX9^*2^(Y?$?PYU?PYX>E
MU>U^+'@JQ\)WGAWQ*?A]J5IXDU"U^%E_XFO[!/#UCXA@O7M\36.I7ML]H."#
M4\JI8F4I4G]7X8A7DE*.*AB)X3&1XAG2PKH5ZLG''4J"G+ZG6H0A4A4P4)49
M:^MAX0A4Q5#$I2Q']H9W/"V=.=!X)4LPK9'0K58XBA3C"J_J-*;>(I5X2ISI
MXW$8:=15)]!\&=<_:*\8ZM\.X?&OB/Q/HOAI+7XB:QJVH6W@J]LM6\01^'M8
M^&]MX4T#Q[>_$W]G+X<RZ/?7PU+QP"NB>#/#9O;&TBEL;CS;26Y'J1I8:G3J
M5ZO+*O1PF"M04X+#U:V)JYS"=6')B:V(E/#X6GEM6O3=6C[/'6E+#T\)56$J
M\#53ZK7A&K)5)9C2A3J67MZ.%^INO6CRRH0H2IO%TU2I5U"KR8>L\/.<\9&.
M*5KQ7XQ^.=I\5M?T[1KKXE9MO$45IH'@VT^%%C??"2\^&K>&(;J\\:W'Q1;P
MG/(OCR'7FOXXM(/BR&1WM+:W'AR:*<WLG@RGB(Y7BZM).>,CAL[E74X\L\)7
MH4\>\DCE].T/KOUJ5/+/;1Y,PUQ>+4OJOL$J?9)6QF&A*%.&&>*R>-"4*CE]
M:HUL1@HYP\>[R^IK"T:F9.B_]B3CA<).-;$O$.$^Y:T^)EO\(_A1<ZW?:]XY
M\<7_ (M^&.N^*9=>\$>%GO\ 0CJ%[IU]K]M!H&D^$[6#P_9:+(]PD-W-;-J5
MBL(>?47GC,U>IG2I83-ZE+*_>PV!CQ#3H8B$O:SJ>SR//%@:KK1]SGKXAX7#
M15"-*EBXU(825.K'%585_%P53%8O(:.(QU)PQF,?#U2KA94[1HWS?)/KM/V-
M1.?[FC'%8NK*MSSPM6-3%4GAEAJ"PWE'AO7OVG/#/A#3?%6OZS\1/B!?6OP[
M^%GQ/\3>%KSX;>$=,U:;4+C4-1M?B?\ #+PQ8^'O!FE7!U:/0#'J%KI5S)<Z
MNNHV%M#]J2VOFMB8YT<%CLPH4*;QN%P.-C0HU(2BYXJGC<'C*-*JYJ4:3P^7
MYC#!XFI4HI.&#J5X8B6)E[*1[M3#QQ.(J0PU>&$>+J9O"BJCC*AAHY;C\#6P
M'OSE"47FN"GBL Z^(JSHW:QF&I0E0G&7/7?C3]L*P^(/PZTR[\RUTO5M-\+:
MO>_:/#'BG4_#=Q)K]]<:IXVT#Q1_P@/[-7BE-,O?#6G7$>C:1)>^/OA\)I;"
MWNK[^UO-N<32IQIXG-<)5K0K?48SPL,1&,G"O##990C'-<-!RH4I5L7FBQ-:
M>%6+Q,?8)86C@*#>'Q%?CJ583HT,51I5Z=#%^VQ%.C45.EB*,JN/Q"PF Q2B
M\9.%/#X#ZBL3-8:,O:U<3*&85/9RCAL+PUX@_:!U^[\'3>,=;^.%U!X.^.VB
MRZCXHTKX<W6G:/XAT35/"/CS2QID?@?6?V8O!GB33/",&O'P]'?7$MOXIL+*
M#Q)'<+XPGET^6[TE1Y886ABZ$>7%5,JSNC2H5Y0J2J8GZGAJV%KXBI!4(4IJ
M<,1'"QK83*Y5<33=!X;$0KX>%;KE""6<X>I6CRVP%6$J,.14U2SO"JO1HJHL
M5SN6#E4KOZMC<95E3PBYG3I5:M+%]+X7U;]K"WAT'4=9\6?$?5YX/"7[.?C#
M4M'O_A=X*TRPU+Q!\0/%]UX:^+'@:_\ [.^'D%]9:5X=\.VL&M2PVMU;ZMIE
MQ>/<WU\VG&*QC]"O0PE#$XJ%"5/$PH9ECL%14ZJC3JX7^RXXK#XV52$E94\>
MWAL/5C)8?V2=#$1Q6(7MS7$4,--5YTJ[PRG3XAJPC3<*DJ,LJGS931@JBESK
M,Z<_9U(U+U<6Z<98">&;FGSW@[QE^V3XHU#4M#\17VN>"I[SQ-X0T_7KK2_!
M6M:S?^"5U/Q?86>L#P%>>+?V6_#G@[4?#$'A@:L9[V7Q3\37M9Q9W7V\VWF)
M+Y^ I4:U#+_;UZD8U*E9SJVI4JUZ619MB:E+$QK1I2I4Y9I2RVC@I4\NIJ4I
M5</+%XMUZ#/.SFI4P6,QTLNI0Q%&G6ITZ%*2J5*<\/+.\MP]'$P>'G4DZCRR
MMBJV.IU,7!NG>M2P^73PM:G'V;X1K\5?^%M:1>?$3Q#\3[^$>!OB-X2ACU+P
M3IVF>$];G\'_ !>UO3]!\4>(KW0_ =G::)XHU7P7'HM_#LOM(LM2CN))M,L6
M@#)%5#V;AF<E2A3GB\OX8Q?*YS2H8B>#QJS*AA54J/WJ&*G3]KAYNMB*:Q$O
M;\].A0>&TS"G['%9?2HU76PV&Q.:4_:QY93G&OALHQ.&C75-<KI)_7*,,0J=
M.$9X&E1]K"O7Q$<9XGI__"V?@A!\:-4T;3?BOK^N_$VY_:&UCP]=V'P;TOQ+
MJ;_$71O&\^G_  QNM3U#P?\ #6*Z.ES>#8!-IUSXLN+K3);=4MK*40BRLQ64
MJE]6R+)ZS484I<-U93FW1A[/%X[&KB:>(G'V>%IUW2> J5VXT\;*/-4H\\H5
M'#LQM.E_K+#,?=JY9*C[#%1IRIN3=/*,CJY71I6:KNE0KSSC!J4*GL*-6-\P
MJ+$3K8FIZIJ^J_M-Z7<>(/$FBZWXPU]]2U?XR:'HO@+4O 'A6/PYX?T[P[I.
MIWW@'Q!87=EX6L-;O=1O+ZPA@MWU37Y=/U%;^"W2%)F%R_'AFE0ITL7*<8UL
M//$U\3"%\3A?9\38+!3I86C&,J52I_8.(Q6+IX>KA\1B*U3"0Q%-NC[6C/S:
MDL1[3!/#TZ<JGM<!15&HY4\/6E6X3Q&.JSQE9<U2A27$%.AA,17HRHT\*JU3
M#N"J^SY-#X43>.[;PI^T;XGL+_XH^(=;OHK?4/ OB/XC_"UO ?C;7]0TSX6Z
M7;6CCP7)X)\.P7DUOXAMI;2)(O#EJLI@CB:&=LS7,8]5L/D5>."A"AC/KF.J
MTU2E]8E*,Z> A0Q$J<G-J52G"\Z=HKVD*G[K#OFP]'OR[V&(SS*(XV<I8183
M 4,2ZJ5"G2:S;.*F)P\:D5#]U1A7BXU/:59*E4IS6)KPE#$5,[2[S]H_P]KD
MEYJ?B[XE>--+T+Q'X-@.B3_#CP%:6WBG2/%O@A]7\4^9/I/@?2[A8_#WB6-;
M/3Y+/5-/6V,AMM;N-1E(ECUQ-:.&GC%3P\L12IXK/L)3Y;SJ?5L#E<L?EF.I
MN,H0GB,7C&LOYW%X/$PC&EA\+#%\U6?!AXUJ]#+Y5*GU>M6PF18NLG'EA#$X
MS.GEN98.491J3A0PV70693IZXS#U)RQ%3$?4N3#1X3P'XS_:=\;ZIJ>@S:Q\
M7/"OAK6O%OP]N=&\<:U\+M*L/%VA^'M;T[XAGQSHXT[Q?^S]X7TK14TK4]!\
M-6\0U'1?%!MSJ-M<G7M6MM3A1>GZO#V.70GB(QJ4<5FM.M.E*,OK6$HY53Q&
M68BJZD8N$L1CI5*<XQPF7U$X?4W0C4Y<35VK3G!8NI3H)2EAJ')2E)36'Q;S
MC+J.)I4XT:D_:*CEV*KRC66,QV'K0I2Q%.<7AL33INO?B?\ M,V7B#X7Z7:Z
M=\4[Z^TCQ%X<TGQTM]\-!8>$O&'@^^^(%YX7UCQAJ&HZ3\%]4MDUVU\/Q6>H
MS65GXO\ A\MLMP^J0Z;J6FQ^0^>#JPKU/K-:C2PM"OED:E6C5J2I4\'CY\-T
MLQ@J$JM2$U0EG%2>7U95\5CJF%="6'Q.%I2E];CE.-6&#QD8RE.O0Q6:+#5(
M^S=3$4,)F^,H8>-2,5).3RS#4<324,+AJ>8QQ4?J>->(<,.N2L_CC\?];T76
MF\!>)_%WC/Q5=_#NR\5ZSHNJ^ M,T/2?!]Y=_$#P[HWB"Z^$&LZ#\']9NOB/
MX;TSPQ-KLFD:E;:5\1H[^2W:2-=8N$.FP2H05&LE.I+"8:KDJ^M5(2HYA[+&
M8/B&M5>(P4*&)^KNMB\)EU&,7@E&&%?M*==TI2S.IUXM2H9[3PL:4(77$=.&
M%E)/"5)Y;C<DH8)5<5.M1<<1'#8K&3Q=+Z]AY0Q35&OA\'.,<-3]^^ NJ_'[
MQ=K6@W7Q'\2^(]+\/:1X7?4UM8/!\^EQ^,KV?Q#XCTNTL_&VH?$/X!^ -9L]
M;MM)CL+JYM="\->$DDDM[&YA1;2XFAO-X*$'C9UJ=.53V."C2I1;6'A.O]=G
M6K4.7$UJTZE.E2P49PKUG&A7JXF-3#)5,.J/$Y3G'#PI7A3EBLPYIM2>(]GA
MJ62^QIU%.A1HPI5L36S5494Z,Y5L-"GR8N=6A5J/[,KF.@* "@ H * "@ H
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M0IPKU::IU/J57(,6ZUDHPLI5\#ET:[C2@IUL/1YZ5!VA3^ZJX#4* "@ H *
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MN(EBJO[S%3A&G*M/WJLH0OR0E4=YN$+OEBW:-W9(Z^@ H * "@ H * "@ H
M* "@ H * "@#YPT_]G[7_#\FMP^$/VC/CAX/T36?&'CGQJOAK2=*_9YU'2M(
MU7XA>,M=\>>(K?3+OQ7\!-8U9M/;Q%XCU62%+[4[V2*.5(O-98UP;!L9_BS]
MG+Q1XX\*^)?!7BG]J+]H#5/#'B_P_K/A;Q'IG]B_LRV/]HZ%X@TZYTG5['[;
MIW[.-O=V?GZ?=W$7G6L\,T?F;XI$=58 'T_0 4 % !0 4 % !0 4 % !0 4
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ML7]K&@#Z H * /G_ /9I_P"2=>(_^S@/VL?_ %J?XR4 ?0% !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M\N[US]M?X2>$_$WAKP;XSL?$G@?Q1K:63:OH'C2]^'OAC6_!YU/7KWPUI?\
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M$&JCH4*688[+,15G.DYT:D<-B<OQ+J+#U:TZM*/M,+'$)34,C7_C_P#$B;X
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M"\.Z;XG\2KK6FZ;J^F^+K_3GO7\+Z5%-/X0\=Z!\.I]+N-2UOQ/9:9I=W?\
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M&O*JU*<52]I2G"/T37,:!0 4 % !0!\_^'/^3I_C)_V0#]FG_P!6+^UC0!]
M4 % 'S_^S3_R3KQ'_P!G ?M8_P#K4_QDH ^@* "@ H ^0/A/I'[4_P +OA9\
M-/AG_P *O^ &N?\ "NOA_P"#? O]M_\ #1'Q%TS^V/\ A$?#NFZ!_:G]F_\
M#+5W_9_VK^S_ #_LWVJY\KSO+\Z39O8V^0;?(Z"YT#X^^./B!\&-7\:^"/@_
MX/\ #'PR^(&M^.M2O/"WQC\:>.M=U'[;\(/BG\-[+2['1-6^ WA.T7.H?$*T
MNY;F75T\N'3952&5Y% -@V/H?Q#H&D^*M UOPOKUJ;[0O$6DZCH6LV0N+JT-
MWI>JVDUA?VHNK&>&XMC+:SRIYMO-%*F[=&ZL PSJTH5H>SGS15XR3A.=.<90
MDIPE"I3E&<)1E&,HRA)232:9OA<36P6)H8O#3]GB,+4A5IRY8RY9TY*47RS4
MH2LTGRRBXO9IK0\QT3X ?"_0K2^LXM,\2ZQ_: TF.>_\9_$?XD^/]<BM-#U2
MQUO2]-L/$/CGQ=J^J:5H\.KZ;97?]G65Y;VDDL&Z6%]S;NAU9WIR]U3IXBCB
M^=0@ISQ&'E.6'JUIJ*GB'1=2I[)5Y5(P52I&*49R3Y%1IQ3@HVA]5Q."C"[Y
M*>&QE+V&*I4H7Y*/MJ2C"<Z483:A3?,G2IN-S4_@A\.=3L=#L/[/\0Z.OANZ
MUFZT:_\ "/C_ .(/@?7;4>(M4;6]=L9/$G@WQ3I>K7NC7VK%+J?2[J]FLI)+
M:V)M_P#18?*BDW0EAI4VXK"8?!X6$+MTI8?+Z,:&"IUJ,KTL2L-2CR4Y8B%6
M24ZK<G*M6<ZY(JEBZ/*N3&XC%8JH[?O%B,;6J8C%5J%7^+AIUJM6;D\-.E:+
M5./+3C&"SM3_ &>/A+J][KU]J'A_5YI?$5M?V^H0)XY\?6VG6T^JF-]5UG0-
M)M?%$=CX4\4WTL,<MUX@T2WT_5;B0>;->/(2QBG&-%)4UR<M6E5A)7YZ+H8N
MGCJ5/#S^/#X>.,HTL2\+0E3PTJU*G.=&3A&U3_>RIRJI573I2HM5$IPJP>#G
ME[>(A.\,55C@*E3!PKXF-6M3PTYT(5(TY.+J3_LU?!FZO-:O+OPOJ5Y_;]EK
M]G?V%[XW\?7FAQOXJT^?2O%&K:3X=NO%$FEZ!XGUBQNKR._U_2[.SU2\-_=R
M7%Y))=3/+O0K5,)/GH-4YQJ4:D&HQ?L50Q=+'4J%"Z:P^#ABZ%&O]1H>SP;G
M1I<U!QIP2I3FJN$K\\I5L$J?LY2DY.<Z-#ZM1K8CF;^MXBCA_P!Q2Q.+]MB*
M=+W(58QT.[\<?#7PA\1-,T[2O%%EJ;1Z/?1ZEHVHZ!XF\4>#/$6BWT=M-8FY
MT;Q7X-UG2M:TF26QN;FUF^R7\(GM[F:"8212NC82BI5O;MM5>6I3DU*45.E5
M<)5:-6,6H5:-25.G.=&K&=*4Z=.;AS4X.,TE&A0CAJ<(^PA[/EA.,:G)*BFJ
M52#J*3A5IIRC"M!QJQC.<5-*<U*7PA\.?!?@$3KX0T*'1%N=-T;2)T@N;^:.
M2P\/B_&EQM'=W4J^=&VJ:@\EP )KB2Z>2YDFD(8;2J2E3G1:C&C.LZ[IQA"%
M.,WA<'@K0A&*C3I1PF PE"G0IJ-"E3HQ5.G'FFY80P]*G6>(C%NNZ2HRJ2G.
M<YP6*QF-;J2G*3J5)8K'XNO4K3<JU6=:3J5)*,%'B+/]G3X/V-[J]]#X7O7?
M6(;BV:TO/%_C;4-(T6TO-7M->U"S\':%?^(YM.\!V5[K%A97=W;^&[72HKN2
MTB-RDOEJ!%!O#4<-0H^[#"5<%6I-^_4C++JD*V INM/FJSP^$J0@\/A)SEA:
M2CR0HJ%XF^(_VKZS[;WHXN.*C6A'W*=26-H5<+BZLJ<.6F\36H5ZT)XKE^L_
MOJLE54ZDY2TK[X%_"W48=1ANO#,G_$T;7Y+B>WU_Q-97T%UXE\71>.]5U#2]
M1LM9BNM$U7_A+X(-4MK_ $Z:UNK":"/[!+;)&JA1O"$:=.4Z2A'!PC*G.=.I
M&.7PQM+"J-2#C4CR4LQQM*?+).O3Q$Z>(]K#EC&ZE25;%PQM90K5Z=.I17M(
M0G3=*K0R[#5(5*$HNA4C*CE.7QM4IRM+#*I&U2I5G4HZ=^S]\,-&O-#U#1K'
MQ;HVH:$=RW^C_%'XI:5?>(7&I7>K[_']YI_C.&;XFR?VGJ&HW);Q<^MDR:E>
M$G_2YO-UC6G3J<\.6,(QY514(+"Q_=*CSQP?+]5A5=.,8NM&BJKY*;<W*G!Q
MRJQ]M2E2JRE)RFINJYS^L^ZH*,(XKF^LQHJ-.$5AXU50Y(1A[/EBDNS?X<^"
MI/!M[\/I="AF\'Z@-3^UZ-/=7\R2-J^IW.M7TJ7DMVUW!.=5NY[J*6*X1[>3
M8UNT7E1[.>I3C4I82C+FC# 4L%2PSA.=.I0AEU.C2P3I5:<HU85,/##T?9UE
M-5N:"J.HZC<G5&V&GB:E**3Q=7&5JZE%5(59YA5K5L9STZBE"5/$3Q%;VE%Q
M]ER5'34%3M!8?A'X,?#KP//8WN@:/J9U2PU#5=437-?\6^,?%_B.]U'6=.M-
M'O[O6O$GB[7]3U3Q#,=)L+&RA.J7=Y]FM[."&V\F.)%7=U9<T9)1AR8>KA4H
M0A3C[&MB*&+K)PA&,'4K8G"T*U6NXNO4G#WZDE.:E$J<9*"FY25*I1JPYISE
M[.6'H8K#T8T^:3Y*5.EC<6HT(VHJ5>I5]G[5J:M?\*E\!#QO>?$3^R+W_A*[
MZ:.YN;K_ (23Q.=,:\C\/3>$_P"T(_#/]L_V+;ZG)X<F&GRWD.GI<30VUH)I
M'-E;&#%1C'#8K!VOA\73Q-&K%ZOV.,JX.OB:4)RO4I4ZM; 8:LX4I0C&K"=2
M"C.OB'5TKMXBIEU6LW*>52A/"N_*J<J2QJIMJ-E5]FLQQR@JRJ*/UB=DK1Y<
MS1?@=\.?#6J>'=6\.6'B7P]-X7TS2='T^QT/XA_$72- OK'0M*AT/2%\4>%]
M/\5PZ/XVNK32+:VM([OQ%8ZI<"*U@7S?W,>SI>)K2Q&-Q4Y\]7'RJ5*RG&,Z
M?M*O+[2K2HR3HX>K/ECSU</"E4ERJ\G8*S==155W<93DIQ]RI[^(J8J4'4AR
MU'2^L5JU6-%R=&#K5E"$8U9J717'PV\%W?BU?'5QHN_Q4J11KJG]HZLF$@TG
M5M#B'V%+X6?RZ7KFJ0Y^SY/VK><R1QO'RJG"-'&89*U''PQ-.O&[_>0QBRQ8
ME7OS1]HLGRW6#BX?5OW;C[:O[7*=*G4Q&%Q4XWKX)X>5&5VN1X3^TUAWRIJ,
MO9_VQF/Q*2E]8]_F]C0]ESUG\"?A+8WVAZC!X*TYKSP[\.I/A+I4MU<ZG?JG
MP\E2&-O#5[#?7TT6K6XBA,:W%^ES=(EU>(DZI?7(GWKU:F)GFE2LU*><NG+&
M2Y8Q=65*4IPE%Q4?8OF<93=#V;J.EAG4YOJN&]ET>UJ^TP=7VDHSR_%XC'8=
MJ37L<7BK>WK12:7-.VB:<:=Y>SC#FE>J/@1X$3PY=^%$U+XKQZ->:C'J<BQ?
M'WX[QZG!)%!]G2QT_7X_B0-4TK01#\O]C65[;Z<< FUR 1%1^V6'59*NL-SV
M55*I[;VGQ_7.=2^O*6MUC?K&C:6DG>*3]A*;HJ-#F4(J-.,80I*G+FA]7A%*
M&%Y7HGAXTGR*,&^2,8IVE_ 'X3:)JJ:QI'A:73KF+3K32H+.T\1>*H="M;2Q
M\)R>!8&L_#*:V-'L[W_A$732Y+V"QCN9H+2T$TSM96S0/$3EBZ684<3)UH9I
M#%T\3S:RG3Q]7"5\73A/XZ-.M6P.&J^SH2IPA4A.=-0E7KNHM54RNKS2=7)J
MD*V$DY2;A5IO'2A4J-M_6)QEF6/ES8GVK<L54D[MIIEY^S_\*;S3[/3AH&JZ
M:NF:/X2T#2=1\/\ C7QUX9\1:/I?@:RU?3/#4.B^*O#OB6RUG1Y[;3-?UJSE
MNK*_@N+RWU*>"]EN(G*5KB,3B,57Q.(JUI^VQ>*Q.,KRA)TO:U\73PE/$N:I
M<BE2JQP.#<L,U]64\/3JQI*I'G,,'A</@:-##X:C&-#"X6E@J4)I5HT\/0J5
MJU&,56]I:I2J5ZTJ>(_WB#F^6JDDEN_\*E\!M%)'<:5J%^\\W@2YN;O5?$_B
MK5]2O+KX::JNM^"[J^U75-;GO+ZZL-41;AYKB>1[PY6^:Y0E2HUZE.I[6GR4
MI?6<3BTH4Z<(+$8S 4\LQ,XTXQ5.*J8&E3H>SC%4X<OM:<(UI2J.J=&%'VG+
MSR=7!++IRG4J5)RP:JXJNJ+G4E*3:JXW$R]K?VW[SE]IRTZ<836'PK\#Z;X>
MM/"MMI=ZV@:?XJM_&EA87OB+Q-J8L/$-IXB3Q79SV5SJ.L3W%GIUOKL:7$.E
M12II\2K]GCM5MB8:SHR>'_L_V5HO*L.\+AG9-TZ#P=;+^23:;K6P6(JX>,ZS
MJ3C3<.62=*DX56IPK_7U5CS+,ZWM\1%7C&=7ZQ2Q3G&,>6-)RQ-&%>HJ*A&I
M5=2I44I5JSGR%K^SA\';+6+_ %R+PSJ37]^^H,R77C;QY?:9IZZKXIT3QMJ5
MOH.AWOB:73?#5E<^*_#VDZG+:Z3:64#3P2L8\75P)S#SEA*%'#47RTL// 3I
M\W[R<7E?MEET/:U.:K*E@XUZL,/0E-T:=.7LHT_9QC&-U;5I5W4C'_:%BU44
M8J$9/'X>IA<;/E@HQ57%T:LUB*R2JUIN-:<Y5H0J1E\5_L[_  B\:3:I<:_X
M<U)YM=GUF;77TKQIXZ\-?VXGB"RL-/U>PUM?#?B6P&KZ+/!I>GM_9=V)K*.:
MTCN8K=+@>;2PLG@JF%J8;]V\'*$Z47[\%4IYAB<TI5)4JG-3JU:./QF*KT*E
M6$YT/;U:5&4*,G3!>[5J5E[M:K4C5E46DU.&#PN ]R:]ZG">#P6%H5J5-QIX
MB-"$J\*D[R>_X\^#WP_^)+Z3+XLTK4Y[C1;:\L+.[T3Q9XO\'WLND:B+<:EH
M&JWO@_7M+GUWPS>FTM3=:-J4EWI]R;:)I[:0QJ1/+'VM6K*,9NNH1K4ZD54H
M5XTYSG26(PTU+#UU2E4J.E[:E/V?M:JARJI-2*?[FA1P]*]*&&_@2BW&MAWR
M*FY8?$*U?#SE",(SG1J0E/DI\[DZ<''H-'\"^$_#^FZWHVC:-#IVE^(KFXN]
M6L;:>[6WGFN=+LM%E$"&X/\ 9\/]EZ=96ZPV?D11K #&BL69EBXK&X6>"Q;=
M?#SCBXRC*4N:2QN*Q.,Q7-4351NMB<9B:KDY\T74Y8.,(PC&,'3AE]=8C!06
M'JQEA9)Q2Y8O!87#8+#<M-WIQ5+#8/#4E%149*GS34IRG*6'H_PB^'F@1V<6
MD^'OLB6'B#1O%-HO]K:Y/Y.O>'_"%CX#TB^S<ZE(7\CPGIME8^0^Z&3R?/EC
M>Y=YFZ:^)K8JO3Q%>?/6I2Q\HR<8I*69U,36QWNI*+]O4Q>(E9IJG[3EI*G&
M$%&:-&GA\)3P%*/)A:.%P6"A"[=L-EU>GBL'2YFW-^QKTH3YW)U*G+RU9S@W
M%\^/V>OA+!H#^&M,\.ZEX<TYO%.M>-(KGP?XS\<^#/$%GXC\12O)K5[IGBSP
MGXET[7-)M[N-_LSV-EJ,%F+1([-8%M(DA3G@O9PR^E3;IT\KPOU+#1C)QC#"
M>T59X>:32KTG6C"M*%?VJE6A3JRO4IPE':;56MC<14A"=;,*\,57DZ<&Y8FG
M16'AB(^[:E75%.FZM)0G*-2LI2?MZWM-'4?@G\/]8UJPUW6[?Q9KMUI>G+IM
MC8:[\2OB5K?ANW1=-NM(_M$>$-5\6SZ$_B(Z=?7D+:X^G-J;"ZE9KLO(S&:M
M.G6CCHU:<)+'PK4ZONQ3C3Q$/95Z>':2>$A4IWIRAA'1BX2G&UIR3=*<Z'U5
M4JDX?4Y49PM.7O2P]:.)HNO=_P"U.E7A3K1^L^VM4I49[T:3A%H'P)^%_AE-
M#72M U#?X<\36_C#2;K5/%OC+7[^'Q):^!S\-K?4[G4=?\07MUJ31^"<:8(;
MR:XAVJLWE_:5$PZZV*KUU-59\WM,-C,)/W8IRH8_$K&8R,G&*;G7Q*]M.J_W
MW.WRU$I234&Z5">%IVAAY4\-2=-)*,:6#Q3QF%I05OW=.AB'S4X4^6,8*-"W
ML(QIIFC_  (^&GAW4-#U'P]IWB7P^_A_3;'2+2PT/XB?$;1] U&RTO34T;3A
MXH\,Z=XLATCQK=6VE10VL=WX@L=3N%BMH%$N((]F%1NJL;&K^]AF$)TZT)I3
MIVJ0C2J2I4Y7AAZLX0BIUL/&E6ERINHY*YI7KU<15]O5G>NJU2O[2*4*GM*N
M*JXZ:<X*,G2^M5Z]:.';="#K5HPIQA5G&4LGP,^&#V?AVQ30+VTA\)Z5X/T3
MP[+IOBKQ?I5]I6E^ KZ74/"MK;ZGINO07C"UN)[@2/).\EY%<2V]ZUQ;R/$V
MLJ]6>85,TG)2QU6NL3.HXQM*JL/BL+>5*WLI0EA\;BJ4Z3@Z4XU7SPDXP<<J
MW[^A5P]7WJ-5XIR6SYL9B,)B\1.,HVG3J/$X'"5Z52G*,\/4H1EAY4FY7UO%
MOPG\!>.'UV7Q+HL]W<>(](\.Z'JEY9ZYXAT6_%CX1UN_\2>&9-,U#0]5L[G0
M=4TS7M2N[ZVU/3);.^CF:-A<?N(?*PC>$5&G.=+EQ$<4I4YSIS5>-'ZOSJ<)
M1FE*A>C.FI*G4IRG"I"49S4MOK%7V=.BY*5*E3QE*,)1A*/L\?"A3Q<)1E%J
M:K0PU!>_S<CIJ5/DDY-X&D? #X3Z%I.MZ+I_AFZ%AXCT^ZTS7OMWBGQ?JU]J
MMK>ZY?\ B6]:^U;5M?N;Z:]N-=U34+R6\:Y^TR273[Y67"C2%25.5"=-1IO"
M5\#B**A"$(4JN6XBIBL"X4XQ4(PP]:I.4:2C[*46J<X2I1C!<M:E'$4:U#$.
M=>%>AB\-4=2I4G.=''8+"Y=BHRJ2DZC=7!X+"T74<_:0]E[2G.%6=2<]'0?@
MO\.O#/C&Y\=Z+H^I6OB*XDUV9&E\6^,;[0].E\3W%M=^(WT/PEJ&OSZ#X>;4
M[VT@NKO^S--M/M%P'N)=TTCN\T&\-1]A2?+3]E'#KF]^:P\)PJ4Z$:D^:I&A
M1E3A["C&2IT(IPI1A"4HO2M^_J*I5NY1J0K63<(NM3HUL/&M*$.6$JSHUZE.
MI6E%U*J<75E.5.FX79?A+\/I[C[5+H&Z?S_&]QO_ +5UM?WWQ'"KXS?:NI!?
M^)B$7C&+?'^B""N:6$P\\/4PLJ=Z%7!ULOG#FEKA*^*CC:M'F3YES8J*J^T3
M56-N2,U3O V6(JQKT\2IVKT<5A,;"5HZ8G X*6786KRVY7[+!SE1Y&G3G?VE
M2$ZJ4UQ0_9D^"PU";4O^$8U8R32W=P+%_'OQ$?0;6[U#PG?^!M3OM-\-/XK.
MDZ5J%]X6U*\LKNZLK*":[\Q9[AY;F&.:/JE.4Z>+I3]Z&-6+A5NE=T\;BXX_
M%4H2MS4J-7&PCBG1I.%*-=>TA",KLRP[^J?5/JZC1^HK ^QM&.DLM5&.!J5+
MI^VK8:G0I4*=>M[2M]6B\-*<L/.=.6SXB^ ?PL\4:G9:UJNA:M%J^G+I,-KJ
M>B>-?'7A>_6TT73KW2;/3IKKPSXET^2ZTE]-U&\MKK3YVDM;^.4"^AN/+39$
MTJE3%5*D5-XZ>+GB(R2=.N\=3P5/%*K2?[NI3J1R[!-4I0=*G/#PJTH0JN<Y
M94:5/#PI4Z,>14*&$P]&2O[2C3P$\;4PCH5'>I1K499AC5'$TI0Q#AB*E.=6
M5.T%XZO[(VE67Q(\+>)-!\5MHWP[\*GP7-9_#B.S\5SN9O .D0Z-X>MY-5/Q
M"CT+5;)+:SL=U[KWA#7/$"I%)9P:_!ITB6<&U.M4EB<;BL<UCJF+ECY^]&*3
MGF.!JY?B75C-586E0Q%=R^IPP,\14=&>-GBW17/>.C#%87"X6C!83V,\/*K.
MG=.?U;-O[9H^R]FZ4J26+48JC4GB,%1I*7U/!X7$5*F(E[3H7P/^'7AR);73
M;+Q,VGP:WHGB#3=&U;XB_$;Q!H&@:CX;N_MNAIX6\/Z_XKO=-\)Z79SA!'I>
MC6MC8^7%%"UL88DC4C6JPE0J>T=2MAI8B<*U5^VQ'-BL)6P%=U,15YZU;GPN
M(K4[5:DU&51U8*-9*HL\11I8EUO:P485_J_/3I_N:+>%Q=''49*A1]G1A..+
MP]&M.I"$9U7%QJRG"<XR];K(U"@ H ^4/!6B?M)?#2Q\2>&M"^'GP/\ %.B7
M?Q0^,OC71M;U;X[>//"NJW.E?$SXN>-OB3I]OJ?A^S_9PUVWTW4+.T\60V4R
M0:O?QM)9O(DI60*IL&P>-=$_:2^)5CX;\-:[\//@?X5T2T^*'P:\:ZQK>D_'
M;QYXIU6UTKX9?%SP1\2=0M],\/WG[.&A6^I:A>6GA.:RA2?5["-9+Q)'E"QE
M6 /J^@#Q*W_9[^&UGKNH^(+-OB/9SZMK&M:_J6C6GQN^-=KX+N]4\17-W>:Y
M-+\/;?X@IX7\B]O+Z[GEM1I MVDG9_*#8(Q]A2^J2P,XNMA98>KA73K2E6M0
MK0J4YTXRJN<H*,*DE1<)1EAWRRH.G*G3<=JM>M6Q-/%RJ..)HSPDXU*=J,N;
M QH4\,Y>R4%-0IX:C3G&:E&O3@Z==583G&6]#\&OAO;,KP>'/+>.#X=VZ-_:
M^O-MB^$]W+?> %P^J$'^RKN:23)YNMVV]-RH '97Q.)KSQ%9U;5\3BLPQTY\
ML?\ ?,SR]97C:W*DH_OL#&-'V:2I4[>TI0IUFZAYE++L%1H4L-3H\M"A@L)E
MT(<]33!X#%RQV%H\SDY/V6*E*K[1MU9WY*DYTTH'!^ /V8OAGX*T72K&^LK[
MQ5J^GR:==/K&LZ]XNN[=+O3-4&MQ+H.A:KXGU"S\):--JR17ESHVDBVT^[GC
M$MU;SOS6$(PIX;#86,$Z=##4\-+G2J2JQAE5?)Y*K*:E.I2^IXO&TL/0JRJ4
ML'#%55AE3D^<Z\53AB\9C<943C/%8VMC(1A*5-4)5,UI9O3]FJ;A&-6&*PV#
ME7Q%.-.KC'A*3Q+G#]VLGQ5^RIX U#X>^.? '@]6\,0_$+0XO!NMZEXBO/%W
MQ*;2? DMUOU'POX(T_Q;XR>#P39):RW/]F6FF>5I.FW9M[H:3<K;+;O3Y:T\
M+'%IXO"T\9A<9B8S=\1C9X*3J8:.(QDU.O4Y:B2E.LZTUAZF*I4)4*N(>(IZ
MT:GU6K+%8:G3I8JGA\31PJ]G'ZIAGBU&-=QP4/9T.2JHQ=6E35%5Y4Z'MI5*
M=)4GZ:/@OX CU?P_K=I9:_I%[X<TK2]$M(/#GCCQSX5T74M+T2U^Q:39>*?#
M'AGQ'8:+XSM[2T+PP1Z]I^HK%'(Z1A4=E-U:LJ]?,,162K2S2I6JXF%1*K1J
M5<1!4JU7V%7GHQJU*<:=.=6,%5E"E13F_8T^7DH8:EAL+@<)1O3AEU*C0H5(
M/V5>%*A+GI4_;TN2JZ<*CG4C3Y_9QG5K2C!>VJ\^GX(^&'A'X=KJ$/A5?$MO
M8Z@(D_L?5_'GCOQ3X?TFVM]ZV^G^%_#OBKQ)J.F>#M*BC?RH[#0K33K5(HXH
MEA$<,:I,YRJT'AZ[^L0DY2G*M^^K5'.*A+VN(J\]>JFEK&I4E&[E*W-*3>\D
MGB'B4O95'%1Y:7[FBK/FYHX>ER4(U')MRJQIJI-MN4F<AI/[.'P<T22Y>P\+
M7NV:727M+>^\7^-]6L?#]OH?B73?&&F:3X.T_5O$=S;>!_#L?B31M*O6T7P_
M#IFG3-IUNDUK)%$J"Z%:MAHTU2J2YJ52G5]I-NK6G.C1K8>C[:O5YZU>%"CB
M*]/#TZTZE.@JU1T8P<Y-W5E*MB*^*J.]7$T<90J62C!PS"G*ECIQI1M2AB,9
M"3^LXJ$(XFM*U2I5E42DNM\8?"OP-X\U?0]<\4:5>WVI>'H;BVTR6U\1>)=%
M@-K<ZEHVLR6NI6&AZQ9VNN6HU;P_HUXD.I07<<4VGQ21JC9+94O]GKRQ%)N-
M23PTG=N4.?!5I5\+4]G*]/VM"I4J^SJ\GM%3K5Z/-[&O5A.*L56HJA45Z<5B
M8JWNS4,9A9X/%4_:1Y:GLJ^'J.-6ES>SE.%&LX^VP]"I3R-<^!_PYU^\DU*Y
MT_Q#I>K2ZYJ'B&76_"/C_P"(/@779=0U:WTFUU2&37/!7BG2K]]&NXM!T4SZ
M.UP=.EDTRVF>U:6)7#HMX98>-%N$,*IJ%.[=*2GC,5CVJU*5Z>)4<7C<75IK
M$0JJDL15ITN2E-P%*$9+&<T4WCY4YU96_>*=+"8? 0G0J?'A9K"87#T93PTJ
M,IQIIS<IN4I=3XA\!^&_$[6<NK0ZNMYIND:SH>G:II/B?Q/X=UJPT_Q!%8PZ
ML+/6_#VL65_:WLR:;98OH[E;J)H=\,T;N[/G.G&52K5UA4KTU2FZ<I4KTU7I
MXA02IN*C'VM&G)J*2<8^S=Z<I0>M*I*C"C2C:5.A6A7A&K&-9>VIT,1AH3DJ
MJG[1QHXJO&U3F3=3GDG4A"4?/C^SE\*3I^GZ3+8^-+C3+'4;K5KNPN_BW\6[
MNU\4ZC>RVDMS=_$*&Z\<R+\3)6^P6<?_ !5HUH+#;1P*! HCK>%65*MA:]-0
MC+ J'U>'LZ?L:$H5JF)C6I8=Q]A#$K%59XMXJ--8AXN7UJ55UTJBYIX>E/#X
MW"SBY4\PDY8F3E+VU9.A'"NE/$<WUAX9X6$<,\+[58;ZM%4/9>R7(5_^&9?@
MO]OU74_^$8U;[9JT6LQ;SX]^(?EZ&-?\0:5XLU.3P9;?\)7Y'@&X;Q1HFF:O
M%/X:CTF6VOK;[5:O#/+(\D4G/#X:.$HU)TJ45A8QE&<U7C#!4L30PE)8GF^L
MJC0P^+Q.&IT55]E'#5IX;D]@_9G0Y7JNJZ=.3=2I5E!TJ3HRJUH\M>I/#N#H
M3G7TGB)3IRE7JQA6JN=6G"<>_P##7PW\*^$[G3;[3$\07>I:3HE]X=L]7\3^
M-/&GC;6AH^HZE;:O=V=WK7C/Q!JE]J.Z_L[619;NXGEC6$11.D64-^UDO;V4
M8?6HX2-50IPASK +%1PKDHQ7O4UC<5S3^.LZO-6E4E"FX\RP])3H5'SRGAGB
MW2<ZE2?)]=EA98F,5.;2A-X+"\L/@I*E:C&FIU%/E=>_9^^$WB;Q'JGBC6_#
M=[=ZCK2RMJUDOBSQG:>&+^_ETEM!;7[GP59>(8?#S^+%T9A9Q^(/[+_M6**.
M)8KQ!%'LYXTJ<:-3#\MZ4U748R;E[%8ER>)6&E)N6$6)<ZCQ"PSH^V]K6]KS
M>VJ\_6JLU6H5TU&MAZF&JQE&,8NI/!U(5<(\19)8I8:I3I3H1Q/MHTG2H\D8
M^RI\O<Z[X&\+>)M$T_PYK>E_;=&TJYTJ\L+/[;J-M]GN-$9&TN3[1:7<4\OD
MF-/EDE=7Q^\#Y-5BHK&U*M7%+VE2M'&1F_ANL?A,3@<6K0Y4O:X7%XBEHDX>
MTYZ?)4A"<<*%.&&H4<-17)1P\L'*G&[?*\!BL-C<([R;D_8XG"8>I9MJ?L^2
MKSTYSC+C]9^!/PH\0Z!K/AC6?"4-_H6O^$/"?@/5;&;5=>'G^%_ MSJ%YX2L
M8;F+5%N+&ZTR\U2]GAU&UEAOO-D21[EV@B,?37Q%;$UI5Z[56I+,7FLG*$+2
MQTHT83JRAR\CA4AAZ5.IAW'ZM4I*=*I1E3JU8SK!K^S\+@\'@W+#X? 82M@:
M$8RE>GA<12C1K4N=MSES4X1CSSE*I%KFA.,M32?X1^"!XHL_&%I;^(]&UFS@
MM;=H?#?CWQ[X7\/:FECIZZ58OXB\(>'?$UEH/BBYMM,C@M8;C6--OI88K6W2
M-U6WB$>2G-2QD^9R>/=2593;FN>M;VM6E&?-'#UZCBG.OAU2K-I-U+I,2A"-
M#!X:,5&E@*=.E0Y5:4*-*;J4Z+J*U2I1A.4Y1HU)3I7JUO<M6J\_*G]F_P"$
MLGVJ2[TOQ;J=_=ZUI>O2ZYK7Q4^*VN>*$N]%AUBVTVRMO%>L>-;G6;+P[#:^
M(?$$']@V]]%I3Q:[J,4EF\=].LLM)X:&$:7U:-/%4I0LK5HXS#QPN)^LNW-B
MISH0IP53$NK4INC0G2E"I0HRAT+$5HU*E6-2495(PC9.T*:IXJEC8>PIK]WA
MVL50HUKT(TVY4J=VXPBETD?P8^&D6-GAE<"W^'EIM?5M=D0V_P *;J6]\!1,
MDFILKKIES/*YW F[#[;[[2H"C>KB*U>K7JUI*I/$XO'XZKS0@XSQ.9Y>LKQU
M1PY>2U? 16'=)15*"_>4H0JMU'YM'+\)AZ-&A1I.G3PV#P>7TTIU+PPF Q<L
M?A*2ES\UZ.+DZJJN3K3OR5*DZ:4%4T+X'_#KPY$MKIMEXF;3X-;T3Q!INC:M
M\1?B-X@T#0-1\-W?VW0T\+>']?\ %=[IOA/2[.<((]+T:UL;'RXHH6MC#$D:
MS&M5A*A4]HZE;#2Q$X5JK]MB.;%82M@*[J8BKSUJW/A<16IVJU)J,JCJP4:R
M51;XBC2Q+K>U@HPK_5^>G3_<T6\+BZ..HR5"C[.C"<<7AZ-:=2$(SJN+C5E.
M$YQEKZ+\*? OAS7K3Q+H>E7NFZO9IXLC22W\1^)A97">-O$EQXN\1C4=(?6&
ML-6,WB.[NKV WMK<&P:YE2P-M%(R&(3E2C.,+*,\+@<&TTG_ +/EL)T\#%<R
M?+.A3J5(*M&U:<*DXU:DXSDGMB)/%5(5:WO5:=6I6C)6A+GJT*&&J)N'+>G.
MEA<,I47>DYT*59P]M3C47)>)?V</@]XML+;3-;\,ZDUA;1>+[9K?3/&OCSP^
MM_8^/-7FU_Q7I>M-X?\ $UDVOZ-?:U.][_9VI-=VL$R1/;0PM!%Y;P]2>$KX
M3$4)<M3 TLLI44_?IQCDRBLKE*E/FI5*N!Y?]GKU(3KP<JC]HW5J\Z22]H^6
M/-5Q&*Q,I<JY_:XYWQG+.W/"EBK16(H0E&A6C&$*E.4(0C'>N/@K\,;K3%T>
MY\+QS::O_"<;;635=<8(?B-JYU[QBZR'4_,66^UC%TCA]UFZK]A-LJ*!G57M
M73E*4HSH8;"X2G.$I4ZE*C@JF'JX14ZE-QG3J4*N$P]2G7A*-=3I*7M&W*]Q
MFXQ<+1E"52%64)QC.$Y4\#6RV*G":E&<'@<16P\Z4U*E5A4;J0G.TDW2/@K\
M.=$\(^,/ ]KI.K7?A[Q_]L/C)-=\8^-?$^L>(7U#0;#PQ>3:AXG\2>(;[6GN
M)=#TNPM3,FH)(/LXD#"5FD;H>)JOZ@KQBLKJQKX90ITX1I588R68*?+",5-_
M7)2KR]HI*<I.,U*#Y14)SPU>.)HR<:].$*<9-N?+3I\_LX)3YHJ,%4G&"M:,
M6H*T8046ZQ\#_A;KYUW^V/"D.H+XEU]_$^N13ZIKA@U'6Y/ 3_#"2[EMUU,1
MI&W@9WTPVT:);D-]H,7VO]_6,Y2G1A0<G&G2CBH0Y6X2@L9B5C,0XSARSC.6
M)2K1FI*=&22HRIQ21O0Q>(POL?8573>'H8+#4VE%\M#+\8L?A(:IW]CBTJO,
M[SJ?PZLITO<*/A;X _"SP=J&G:OHVBZW+J^E7UAJ5GJWB'QY\0/%^J"]TO0O
M$?AC3I[K4?%WBC4KC4#;>'O%FN:?&MW),JP3V\8&+"S^R[/$5>3$T[QC'%K$
M*MRTZ<75^MQR^.)E.48J4JE997@74JM^TE.BYN7/6KRJ\,*%.FI1A%QC*CAL
M/R\TN6-#!XFKC,+1A%MQITZ.)KUJD(4U&*]I*-G!\ICW/[,?P8N+JUN_^$:U
M:W>RM_#,-O:6WCGQ[!H;S>"]3CUCPIJ.H>&%\3_V+K6L:7J$,;0:AJ6GW=SY
M0:U>5[5W@?EC!T:-6EAY>Q<X3C&3A"LJ3GERRF4Z=.O&I3C*>7QAA:UH?[12
MBEB/:[G7.M*K4E4K1C4=66(=5V]G*M'%8JMC:U.I4I<E25/ZWB*^)H04U'"8
MBHZV$5"K&,X^;_"_]D72_!\/B>V\;^,;[QU;ZQIGA[0M#&E2^._!5YX7TOPO
MJ6JZKI%WH^L?\+,UG4?#?B"*[U5S')X.N_".D6*VZ)H^B:8C2+)TSJQG0BI0
ME'&.O'$5,1"M64N>&&J850A4G.IC)4Y4:^)I5GC<9CJU>C6>'K5IX>,:2YYQ
MYJUTHRPT5BE&E4A3FG]:KX2O)SIQC3P<72J8'#5:/U3!810Q,)8NSQ$HSA](
M^&OA_P"&?"=S!?:5%K4^I0:!:>&!JWB'Q9XL\7ZS/HMC?WVIVMK?:QXMUO4K
MW4I4O=1O)/M5W/-<,)0C2F.-%2'-\U>248/$^P=50A""D\-"I3HOEA&,4XQJ
MU%)Q2=1R<JCG))H44HT87E)8:6)E3YIRER/%O#O$6<FWRS^J8?E@VXTE3M24
M%*:EVE04% !0 4 % 'S_ .'/^3I_C)_V0#]FG_U8O[6- 'T!0 4 ?/\ ^S3_
M ,DZ\1_]G ?M8_\ K4_QDH ^@* "@ H * "@ H * "@ H * "@ H * "@ H
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /G_P .?\G3_&3_
M +(!^S3_ .K%_:QH ^@* "@#Y_\ V:?^2=>(_P#LX#]K'_UJ?XR4 ?0% !0
M4 ?DEX&\+?"?5O"?[+.K_$'0OVF_#OBCX4_!#X:^ OB1X$TW]E_]IB?0?'-W
MX/T+PQ>:9X>\:3Z?\([BUUG3?#GC/2KN[A%I-+!=.[(TTMHY2:L _J&,Q.+I
MQC4==4:D(35X4<=AHUZ6'S"FMEB:%#$UZ=*334)NC7BE6PU&43&6QN7T\!43
MA[*I42JPE*-3ZIB53^NX&\6DZ&-EA\*JZ=[TJ=6E:V(FU]6^(OB/I'Q/^*/[
M-EEX1\+?%\?\(M\7_$GBCQ#?^*?@)\<?A_H.CZ"/V=OCQX82^OO$?C_X>:+I
M4'F>(/$V@V$4!O/.EFU.)8HW^;;()):)62V1]*^,_!^F>.=$30-6GOK:S37/
M"VOK)ITMO#<_;/"/B;2/%>FQ%[FUN$^S2:CHMK'.OE[VADE6-XG99$JE)T,3
MA<5"SJ82<JD$_A;E2J46I)6;7+5DU9Q?,D[V33TA5E3ABZ<4K8O"XO!SONJ6
M,PU7"U91LU:<:=63IMJ45-1<HRBG%^-ZG^S#X&G\3^*?&OA[7_&W@;Q9XF\1
MZ!XO@UKPMJ6AO_PC'B70M+\3:--JOAO1_$WAW6-(B_M?3O&'B)=3L]0T_4;*
MYFU.>[6VBO)9+B2:#JX7"0P6&K3H4:=?&U=.23=+'T\##$8-\\9Q^JJ678:M
M12BJV'JQ_<UH4XTJ=-5)^VQ-?%5XJO+$8'!X&<9747' 8JIB\)B+TW"I]9I5
M)PIN?/[.I0H4:%:E4I^U56UI/[-7@32-,UO3(]5\77@\2V7A2VUZ]U#4=+N;
M[4[WPMX^\2_$MM:N'&B)$NIZOXJ\6:S-J CACM3%+'#96UDL8K6O4C7H87"N
MC"&$P6*PV)HT8\[A!83!8' 4<,Y3G.I.A'#Y?0C)SG+$3E*K.>(E*:<4JE;E
MG[6O.O7J8?,\/.O-Q562S2DJ%>I:$84J<Z-.,(X6-*G3H4(PA!490BHJM\&O
MV7/A?\"O$.N^(? >GV=I)K%E_9EM:CP1\)=(N-$TQKM;V73K;Q;X3^'.C^+=
M>MI9XK9I/^$G\0Z^[FTA<OYB;R4:U2A@/[/YG*FY4Y2G=TW45"$J=&-2E1=+
M"R]E&<^6H\/[:\YN563J3<EBW]<Q\\PJI>WG.O5E]M>UQ$N>M4C*K[2K3YI.
M35.G4A1C&3IPIQI0I0IP3_LO^$KNZN1?>,_B-?>'XM0UK5?"_@ZYU/PS_P (
M]X&U'Q'JW]LZ_=^&Y8?"4>KW;7ET]V@CU_5=;CM(=0N(;!+1&4)EAE]6^H27
M[VMED<NHT*L_CCA,KQ>!QF%P3C#DI2HJIEN!A4J.G]<G2PT(/%7<Y2QQ5"EB
MHXJDX*A2QDL?6K0IZ1EB\RP6.P.*QB<^>4*\J698ZI&%.4<*J^(G4EAI6BH]
MK\4/@QH7Q5NM%N]6U_Q3H3Z/I/B;0)8_#DOA^.+6-#\6#1WU33-4&N^'=4:.
M);WP_HMY%-I[V-PDNGJAF>WFG@GO"S>#Q<,7!*;A4P%94YW]G[;+,PHYCA*C
MY'"I>%6E*G**J*G.C6JJ4'45&K1TQ:^N93CLGFW3P^/553G"RJP5; 8_+:GL
MW)2IKFPV8XA>_3G:?)-6<=?.?B=^R%\*?BMJ&IZSXC%TVN7_ (HNO%46IWOA
MGX6^-4TJXU#POX0\):EIVF:#\4?AUXIT);"ZT[P/H4K2W&E7-]%.D[6UY!'.
MT59P4:;P5HQE'!0KTW&48OV]+$8^OF,J=6=O:04,1B:BA+#3P]3V3]G.<[R<
MNNIBZM6BZ$_X7)A8QBI3BHRPBQ<:56T9J,YN&-KPG&HIT7>G-4HU:5.I'LOB
M'^S_ .$?B)X1\)>!KS4M7T#POX2ACT]-!\/Z5X!;P[KFA+I0T:3P[KOA#Q%X
M)U;P[)H[62H(EL=(L9[%D5M-GLB*6-BL?C*^,Q;E7GB:=:%2,YSFFZU6C75:
M-6<I8FGB:-6A3G1Q5.O#$1]^,JDXU)QES81_4L*L+02AR2A.%11C"<)PA6IN
M].FH8>I3JPKU56P]:A5PM1RC*5#GITY0Y'1?V4/!6B0:+I$?C#XAWW@_2;3P
M-;7G@74+[PD_AKQ'/\-]"TC0O!NH:Y+:^#8-8%W8)H>GWA33M6TZVN+J!7N8
M)HXXHHNC%5I8VOFF(Q:5>>:5<PKS3YHJC6S3!K 8VK1]G*#O5PO/3C&LZU.C
M*K.K1A"LJ=2$QC[&.&CA&\"L+"%%>Q;7/AJ>88K,H86?M'4_<+$8N<)J/+4K
M8:,<-7J5:4\1&LV7]E#PC>^'-5\-ZSX_^*NN1S:!I/A;PEK%[KWARQU_X:>'
MM!U:RUO1-/\ !&HZ#X1T_P#?6>HZ9IK_ -HZ_'KNH7"6,45Y=W,6Y'FK4>(J
M5*V*2Q&)Q6(HXC&UIWC+'^RI8S#RH8F%)TZ,:&(PV8YCAL3#"TL,ZM+'XCWU
M4]E4I10HT,++#K#4*=##8'#XC#83#<JJ4<)'$2PM1U*/MO:575HUL#@*^%E6
MJU5A:V"P\Z$8.,N>1_V1/@\OQ/T'XJ66C:?8:WH2^'2+%_ WPDUZWOI_"6DV
M6B>&[L>(?%OPXU;Q9X<N-/T_3-,6'_A&?$>A('L(YBAE:5Y=*&*K8?%YAC(R
MYJV8U,56FTW3=.MC;K%5(5*#I5I>V4IJ=.O5K4.6I4BJ2C.:<SH4YY?EV625
M\/E>&HX2ES6G?#4*LJU.E.G44Z&DZE2]2%&%62FDZC5*A[+Z@KG-@H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H ^?_  Y_R=/\9/\ L@'[-/\ ZL7]K&@#
MZ H * /G_P#9I_Y)UXC_ .S@/VL?_6I_C)0!] 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!\_^'/^
M3I_C)_V0#]FG_P!6+^UC0!] 4 % 'Y6> W^*2Q_$,>'/CS\2/!>C#X__ +3G
MV+PSH'AWX'WVDZ9_QD7\4OM'V2Z\8?![7-7E^T77GW4GVO5+K;+=2+#Y4"Q0
MP^_@LJP^(PM*M.=2,I<UU%Q2TG**LG!O9=]SR,5CZU"O.E",'&/+:ZE?6*?2
M277L=QYGQM_Z.B^,'_A)?LT__0_5U?V'A/\ GY5_\"A_\K,/[4Q'\E/[I?\
MR91O-8^+6G26,.H?M9_%*PFU.Y>RTV*\\._LPVLFH7D=I<W\EI8QS_ )6N[E
M;&RO+DQ1!G$-I-(1LB=EEY-@H\UZU2/LZ<ZLKSIKEI4^7VE27N>[3I\T>>;M
M&/-'F:NBHYAC)1E.%&,H4^12DH3:BZDXTZ:DU*T>>I.-.%[<TY1BKR:3GM;[
MXR7MM;WEE^U5\6;NSNX8KFUNK7PO^S+<6US;SHLD,]O/%\ &2:&2-E971BK*
MP()!JY9#AH2<)RK1E%V<6XIIK=-.G=-=F0LUK](T]+K:6ZT:^/HU9]B?S/C;
M_P!'1?&#_P )+]FG_P"A^I?V'A/^?E7_ ,"A_P#*Q_VIB/Y*?W2_^3.6M_'O
MC>\\2W/@RT_;2\;W7C"RA:XO/"EO9?LIS^);2W18V:>YT*+X$M>P0JLL1+O
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M)1DKQDF[GF?&W_HZ+XP?^$E^S3_]#]1_8>$_Y^5?_ H?_*Q_VIB/Y*?W2_\
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M *.B^,'_ (27[-/_ -#]1_8>$_Y^5?\ P*'_ ,K#^U,1_)3^Z7_R8>9\;?\
MHZ+XP?\ A)?LT_\ T/U']AX3_GY5_P# H?\ RL/[4Q'\E/[I?_)AYGQM_P"C
MHOC!_P"$E^S3_P#0_4?V'A/^?E7_ ,"A_P#*P_M3$?R4_NE_\F'F?&W_ *.B
M^,'_ (27[-/_ -#]1_8>$_Y^5?\ P*'_ ,K#^U,1_)3^Z7_R8>9\;?\ HZ+X
MP?\ A)?LT_\ T/U']AX3_GY5_P# H?\ RL/[4Q'\E/[I?_)AYGQM_P"CHOC!
M_P"$E^S3_P#0_4?V'A/^?E7_ ,"A_P#*P_M3$?R4_NE_\F'F?&W_ *.B^,'_
M (27[-/_ -#]1_8>$_Y^5?\ P*'_ ,K#^U,1_)3^Z7_R8>9\;?\ HZ+XP?\
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M -#]1_8>$_Y^5?\ P*'_ ,K#^U,1_)3^Z7_R8>9\;?\ HZ+XP?\ A)?LT_\
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M ,"A_P#*P_M3$?R4_NE_\F'F?&W_ *.B^,'_ (27[-/_ -#]1_8>$_Y^5?\
MP*'_ ,K#^U,1_)3^Z7_R8>9\;?\ HZ+XP?\ A)?LT_\ T/U']AX3_GY5_P#
MH?\ RL/[4Q'\E/[I?_)AYGQM_P"CHOC!_P"$E^S3_P#0_4?V'A/^?E7_ ,"A
M_P#*P_M3$?R4_NE_\F'F?&W_ *.B^,'_ (27[-/_ -#]1_8>$_Y^5?\ P*'_
M ,K#^U,1_)3^Z7_R8>9\;?\ HZ+XP?\ A)?LT_\ T/U']AX3_GY5_P# H?\
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M *.B^,'_ (27[-/_ -#]1_8>$_Y^5?\ P*'_ ,K#^U,1_)3^Z7_R8>9\;?\
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M (27[-/_ -#]1_8>$_Y^5?\ P*'_ ,K#^U,1_)3^Z7_R8>9\;?\ HZ+XP?\
MA)?LT_\ T/U']AX3_GY5_P# H?\ RL/[4Q'\E/[I?_)AYGQM_P"CHOC!_P"$
ME^S3_P#0_4?V'A/^?E7_ ,"A_P#*P_M3$?R4_NE_\F'F?&W_ *.B^,'_ (27
M[-/_ -#]1_8>$_Y^5?\ P*'_ ,K#^U,1_)3^Z7_R8>9\;?\ HZ+XP?\ A)?L
MT_\ T/U']AX3_GY5_P# H?\ RL/[4Q'\E/[I?_)AYGQM_P"CHOC!_P"$E^S3
M_P#0_4?V'A/^?E7_ ,"A_P#*P_M3$?R4_NE_\F'F?&W_ *.B^,'_ (27[-/_
M -#]1_8>$_Y^5?\ P*'_ ,K#^U,1_)3^Z7_R8>9\;?\ HZ+XP?\ A)?LT_\
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MVJ"@H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M_P#(!Y?QM_Z-=^,'_A6_LT__ $0-']MX3_GW5_\  8?_ "P/[+Q'\]/[Y?\
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M_P !A_\ + _LO$?ST_OE_P#(!Y?QM_Z-=^,'_A6_LT__ $0-']MX3_GW5_\
M 8?_ "P/[+Q'\]/[Y?\ R >7\;?^C7?C!_X5O[-/_P!$#1_;>$_Y]U?_  &'
M_P L#^R\1_/3^^7_ ,@'E_&W_HUWXP?^%;^S3_\ 1 T?VWA/^?=7_P !A_\
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M_P!$#1_;>$_Y]U?_  &'_P L#^R\1_/3^^7_ ,@'E_&W_HUWXP?^%;^S3_\
M1 T?VWA/^?=7_P !A_\ + _LO$?ST_OE_P#(!Y?QM_Z-=^,'_A6_LT__ $0-
M']MX3_GW5_\  8?_ "P/[+Q'\]/[Y?\ R >7\;?^C7?C!_X5O[-/_P!$#1_;
M>$_Y]U?_  &'_P L#^R\1_/3^^7_ ,@'E_&W_HUWXP?^%;^S3_\ 1 T?VWA/
M^?=7_P !A_\ + _LO$?ST_OE_P#(!Y?QM_Z-=^,'_A6_LT__ $0-']MX3_GW
M5_\  8?_ "P/[+Q'\]/[Y?\ R >7\;?^C7?C!_X5O[-/_P!$#1_;>$_Y]U?_
M  &'_P L#^R\1_/3^^7_ ,@'E_&W_HUWXP?^%;^S3_\ 1 T?VWA/^?=7_P !
MA_\ + _LO$?ST_OE_P#(!Y?QM_Z-=^,'_A6_LT__ $0-']MX3_GW5_\  8?_
M "P/[+Q'\]/[Y?\ R >7\;?^C7?C!_X5O[-/_P!$#1_;>$_Y]U?_  &'_P L
M#^R\1_/3^^7_ ,@'E_&W_HUWXP?^%;^S3_\ 1 T?VWA/^?=7_P !A_\ + _L
MO$?ST_OE_P#(!Y?QM_Z-=^,'_A6_LT__ $0-']MX3_GW5_\  8?_ "P/[+Q'
M\]/[Y?\ R >7\;?^C7?C!_X5O[-/_P!$#1_;>$_Y]U?_  &'_P L#^R\1_/3
M^^7_ ,@'E_&W_HUWXP?^%;^S3_\ 1 T?VWA/^?=7_P !A_\ + _LO$?ST_OE
M_P#(!Y?QM_Z-=^,'_A6_LT__ $0-']MX3_GW5_\  8?_ "P/[+Q'\]/[Y?\
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M_P !A_\ + _LO$?ST_OE_P#(!Y?QM_Z-=^,'_A6_LT__ $0-']MX3_GW5_\
M 8?_ "P/[+Q'\]/[Y?\ R >7\;?^C7?C!_X5O[-/_P!$#1_;>$_Y]U?_  &'
M_P L#^R\1_/3^^7_ ,@'E_&W_HUWXP?^%;^S3_\ 1 T?VWA/^?=7_P !A_\
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M\1?M,^"O"GBC5] USP]XXL]'T'Q#J7A/5/'ITK1W\'0>(],^'R?$M]*MBGB
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M4\)4CBZF(IY=&E4E&-2ASO+,U>(JXZEA\/3C##.5:DIIU.XF_:K\*K]M>T\
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M]5HU9U72HP5:JI]QX,^&GA#P!IFI:)X8MM9@T34Y6=]%U?Q=XN\4:/IL#1&
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M[!PM34$Y)]E68@H * /G_P .?\G3_&3_ +(!^S3_ .K%_:QH ^@* "@#Y_\
MV:?^2=>(_P#LX#]K'_UJ?XR4 4/V@?$]EH,O@'3O%WC:[^&7PLUW5-<@\?\
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M2>!PMJ^+C1<98NO@:>1XG.<7B\%"7)"$:$J-/+Z;J*O2K8BHG*K1D_81]?\
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MH4Z4*E3"8B4L/.2ITVW%-TX.7*=.$PV(JX[^SIN$JT\;B,/0G!-1KX>&8XK
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M."P=.$DZ<'[*KF=:O];M.K#%X>-7'RFL)5HNCC:565)K 8K!X7,9<=9_L_\
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MVA>!M-U'0O[?\+0MH-Q);:1JDFDVMRD%M)J$5E'YO+.3GA>'L/6IK'4<JPV
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M/\9/^R ?LT_^K%_:QH ^@* "@#Y__9I_Y)UXC_[. _:Q_P#6I_C)0!] 4 %
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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MYP4HI)MNR%+W%BG+W8X!VQ+>BP[TTKM_P7[T=*G+NNZ)=8\9:UX<M+6_U_\
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MG"4IP])T^_\ '6K-:+I7[97Q+U-K^SOM1L%T_3/V5+UKS3]+O(]/U.^M!;?
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M_P#LT_\ ).O$?_9P'[6/_K4_QDH ^@* "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * /G_P#:6_Y)UX<_[. _9._]:G^#= 'T!0 4 % !0 4 % !0
M!5:QLGO8-2>SM6U&UMKFRMK]K>%KVWL[V2UFO+2"Z*>;#;3S6-E)+$C!9&LX
M&8$Q(5:;CSJ+Y54Y.=+3F]GS^SYK?%[/VE3DO?E]I/EMSRN/513U46Y171-K
ME;2Z-K1M:VTV+5( H * "@#Y_P##G_)T_P 9/^R ?LT_^K%_:QH ^@* "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@#\^_!7_)5OVK/^S@+/\
M]4#\": ,7XG?"G6_B%J-H8_%'AVPT-(8$>UUGX?6?B'Q)X>OK=[D?\)#\-_&
M%MKVE77@WQ.T%TZ"]O(->CB:""2WMX3YZW3PML/BZ6*J151T*T*U-P_=5K04
M4\-*JN:,L'5<9*O2=+VM6E7Q-%UU3J05)UGSX:=&%DYP]G*-1*KAI)SY_:3H
M/DFZ\)1IRHS5>-*G.C1J>PE4AS2\MM/V4SINKZWK%AXZE>Z76W\1>")=;A^(
M7B)/#FHS^,[+QW>6>M:#JOQ:D\+ZQH<^N:?:;[?0_#GA.Z$=O&RWPN5-P]82
MK5P6'PE*DX>VP<:-%3E%SA4P]# 8O+:<)J<I5XU(8;&UI4Y4<32H0K-2CA52
M2H+*O1I8CV]*I[3ZOB9RKU8J<85/K$J]+$^TA.G3A2<)5:256G7H8B5:C*5.
MK5E)NJ5];_98US7K/5=*N_B/H$.D>(-7N?%6N6-C\+K73UF\6:AX(UWP/J%Q
MIJ6'BZ&UL?#LEEJUO.NG36E[>&2Q=KK5;N6\EFK;!5H8*O@91IRJ8?*ZM"6$
MIRFE*%&EB,OQ,Z56<::A-RG@6J;I4:%*A'$2A"@Z=*C3AO4K5YX;'48U%1K8
M_!5,)4J4X\O*Y9C7S&G6IKF]ISQJ8BHJTJM6K5K3C3J^VIM5(U.A^)WP0U/4
M?^$P\3:#=W&L:EJVE>*K2R\,V%AIMC?B[U[1_AU9:%=:3K^K>([.RT>^T7Q'
M\.M&UC[;<072M UQ!%9M/'#))QU9XE83ZKAIJG7E4P\Z6(;M]6Q5'-\;F-#%
MU/C<\-1AF.(I8G#PISK8A1ISIRBN?#U;H>P4:5#$1O@X*,<13BI*6(PD<LQ6
M7XG"4N2I2]G6Q=.LHT*KJTZ="?NU)QC/ZQ0ZF'X,ZC9?#OX;>&M'\3VUEXL^
M'E_#XDA\0^(-"_X2K2];\57NE:W8>)M2\1Z%;ZKHTNIC4+CQ-KEYNM]1T^2.
MZFAF$A6-HI>K&3I3QDI8.G&C@(8:674J,X^TY,N]G1H4Z4)3DW"M"AAZ4%5F
MJL6O:PK4JU.K.#YL!*K2P>)IXWW\5F$XXG$SI2]G_MGUR&8.4+*2]BL3!15)
MJZHQC&G.E4A3JPX!/V6+D:?#H3^/=/70=(U'4O$_AN"P^'6BZ1J-AXQU:RAM
MKNYU6;2M4@TS4O""2P[H/#]GHVE%(1%;RW\Z6\1CQA*=*5*K2E^_P5J>%E5Y
MJD51_M:CF\EBH\T9XBM+$8>$'5HU,)"-.524*$:SA5@J]-8JI6E7TACISJXN
M-)1A*5:65XC*4\-.2J.C!8;$U)OZPL;7G749U,1.$JU.K"G[*U[<>,H?&^L^
M/H-1U+4M5M=3\8Z9I^F_$3PEX<U<Z?KLWB/3UT?0_!_QETR"TF@U:ZN) WB3
M_A+XB%@/D"43RWE8)T\!*A"C"4L-AZE6O"-22J5(XB=;$5:<USP>%4::KQ@X
MK!^TER.U6$9QA3TQ4JN+P]:C.483J-P4H1<%]6J8'+\!7HS<)QKRE4I9?!QG
M3Q%*G%U9J5&HHT^7Z8U;PS_:GBCPEXD^W>1_PBHU\?8OLWF?;_[<L(K'_CX^
MT)]E\GRM_P#JI=^[;\F,G*E'V>)JXB]_:X.IA.7:WM,7@<5[2^M^7ZG[/DLK
M^TYN9<G+)55[2E0I?#[#%T\5?>_L\)CL+[.VEK_7>?FN[>RY>5\_-#@/VDO^
M3=?CY_V1;XI_^H-KM4,]JH ^:_&/P!O_ !WKFL7/B+QCI)T;4]/\4:9#>Z/X
M#LM#^)\&F>)]*U#29/#EY\1=/UQ+?4_"%I%?I+%ITGAR.XDETK3I;J^GEM2\
MV=.'LZ-6#;5:2II2IN=*G5E2J^VI5<92A*]>M2GS.E.A5PBI.=25.$9SE(ZX
M8MT<3A<11I0_V:I0JQC57M?8RHRHRG]4G*TL.L2Z$5B.=UW*%2M2BXTI4H4>
M6T;]E_5=#MHY[7QYI-QXAN+;Q#H6N:EX@\,^-_'^E:QX6\2V7A_3;VV;1?BE
M\8/%$MKXAAL?#6G0P7@U&72_+\V*XT*Y@<1+U1K-6A**5*LX5,2H1A&I*M3Q
M#Q$*F&K2A.I0;GR^T]N\9*3A3J0E3K4Z=2'-2D\/!QIMOZO4P\\&Y3FO91PU
M'%T:=*O&C.C"K32QN)E_LD<!*,IVA*,.>$]KP[^SKJND>*/!>MZIX]L-8TOX
M?ZE=R^&M)A\$+I=T-)E_X2Q[2RU34E\3W$%WJ5O-XI.+ZUTZQB9-,A5;..1W
ME.&'2HQK2E%3KULMPN7.:<E&,<'AJ^$I581FZDU*5"K:LI59.<_:M2A3J*E3
MCEC&E7P\-*-6>)JI24.:-7%YIE.:UOX<*5/V<:V6.G0IQI0=*G7CS3J2H7J\
M5XT_9JUJ\L-"\-:9K%]J-AJ>O^"H=7UC2[2PT"Z\/^'])\-7/A+X@+J5Y>>)
MI9=3T?Q-X-QI4&FV&ESW%K>W0N9;EH0KV.^ E3H8["5*D/W.'J8C$57+E=.O
M3CA\NEAL!*ER3E)SS;+,#C)S<J5+ZI1K4)OG48XN\QK5:]/'5\-^ZQ=>\<.X
MRY:V#K5\US#&+,*%?W?8U,%A,TQV'3BI5:TITO9QI1G5E3]L^(/PBN?&.J17
M>F>(=,T+3[WPW%X-\1Z=J7@[3O%AN/#D&IKJ\'_",MJ5_%:>'M=CNU7%Y>6&
MMVVV*!C8&:VAFBX:F'5>6/5><I4<P^KSJ\MH5E6PBQ7L)PKM2Y(-XNHZJ4/;
M;2PV(PM1RJ2*<OJ]/ K"QC2JY<L3"BY+GI>QQD,+3KPJ4DX2G:&$IJDG55+W
MJD<11Q-*7LSR2']EG7X+^PUY/B5H@\1:/X'B^%.ER_\ "M OAX?#6.QO[#[-
MJ?AU/&R_VAXY\F_<KKZ7MK9QF,QQZ*MM/<03]6,D\:LU]M[L\^C6^ON%U'VL
M_8.G/ QDYO!PA/#TW4A.>)E7A[DZJ='!SPJPO+@HY52I)NAD-=8C *;4JO-[
MT91QM;E4L5%PE:/LXX64:JE6O*=6M[3L/A_^SK%X#\?+XP'BJYUFP@BN[JQT
MF\N?B%'+IVNZGI=MI.J7]I9CXH2>$(;">V@D"P#P5]L7S5+ZE*T8<[0KJG]?
MM"TL7/$JG)M3E2P^*Q\LRJ4)NK&HY6Q#@U+#O"1:I1YZ<I2J2GQ_5%[/+8.=
M_J%/!QG9."J5<%ERRVE6C&E*G9O#J7-'$/%6=2HHRC'V:I]YX+\%>/M#\8>)
MO$GB[QMX5\6VFM"XATR&R^'^J>'/$&AZ:E\;C2-$76Y?B'JMA<Z196\MPCI#
MH5E/=W$HNI[@L@C.&&Y:."="HG4Q4IPG4KQ:A&K.,9QDZE)JH[13A##0A5A3
MP\%5?)5K8BM6EU5TZN*C6IOV="FI0IT97G[*$E#F5.:<$IU9PC4Q%6<)SK.-
M.FG3H4,/2HT/CY_R(VA?]EJ_9M_]:*^%E(9WWC70M8\1Z!/IFAZUI^AW[RPR
MI/K'ANS\6Z'=QPL6?3M<T"ZNK-]0TJ?@2I::AIMS\BF&[A.2<JE+VCIW4)4X
MN7/2J0YZ=6$H2@XR2E"491<E4IRC-)5(152%6DYTIZ0GR*I9SA.44H5*<N2=
M*2E&7-%N,HM2473G&47>G.?(X5.2I#YB@_9)BBUS1=;?QE#%%"FF6_B#POHE
ME\0_!O@G[#H>M7.NZ-IW@;PKX*^+^D6OAG3[._NY9(K37O\ A,;:-PKQ01EI
M?/WBTG*$IU:U&7/-RK5?:XGZQ*-2,:GM:D98?EHQG&G1B\&ZL*%*G1^L.,$U
MG5E.KAY4O<IS=2LUR0Y*7L<31PE#$TIPA*-9RQ$,)&I5J1Q-.%3$5L16J49\
M\(T]2/\ 9N\4V5MI$.F?$GPW:3>&]!F\#:'=O\*+.2[?P#/I&KZ0]AXAOK?Q
M?;7NN>*$&J_:(M42[L=.CFMVD70M]Y=M<Y8J+QM/&1Q#2GF>$Q&%Q7LHNE2M
M5^I.G/#45)QHR@\!1C4]H\1ST7*C0^JP5+V73/$7Q=#%1BX_5,QEFE",INH_
MK5:>(EB(5IR5YX>:Q57V<*/U>LI^SJ8G$8MTU?<D_9WDCT/^S=/\7VMKJ$,^
MKW]KJ$_A9KBV.IWMYX%OM/GU"P@\16TE[;6TW@:UCEA2\MY)X;PQI/;&!7;I
M=7_:L/B+.U#%2Q')?>,\]Q.<SIIV]UN.)EAE/E:4XK$.$DW0.#"T(X;!8C!/
MWUB*6'I2FDH2Y:'#=3AYM+WM9*I];5[J%O86DG[43X=_!NZL]<^.&L:['K6C
M67C_ %#5/#WA?29M0TJ9M!\+7L=W?>(-5T2+2KJ]ATD:_P"-=;\1:TD,US/<
MK"VG"Z2&6(VUORU*%.KD,<K<G&IB_:NK*24ZU'#Q=2EEV!J3:Y*T,!AI24(Q
M3HQ^L5:4'.*<Y=\L1.&<X3,$XUGE]+#V:@H4JV,Y</\ 7,1"+_?QA6IX3 49
MJK-R=7"U:L5:JISP+_\ 9J\2ZE]KEN_B)X52ZUCP?>_#/7GL?A#IEE%<_#R[
MMM*LEAT[9XK:[L_&Z6VDVR#6KZ]U734PJP:!!'$D:]E/$6Q%>O5CS?7L7A<P
MQ4:<I4N;&8*M4K8=X9KF]A0<JLO;QJK%8RK:+CCJ7LJ/LN+#PE@WETL-)*>2
MTYT,![6/M81H5(I5(XNFG".)GS1@X>R^J4(1]M%X>?UG$RJT=:_92U#5A:0)
M\2?L=GX8GUZY\"?8_#_B#1=8TR77?%%GXKD'BCQ/X0^(FAZMXA6&^BO(5?2;
MOPQ,T-Q#OF:6*:6\YTY6HS;7UFC3P.'YH\\*4L/@,'F&7TXNE"I&3JU,-CVZ
MDW6=%UJ?-]7]E5J4',</1IQE1@I?5I2Q-5QG[.I45?%8C!XNK)5*E.25)8C!
M0=.FJ?/"E-TU6YJ="K1]5NOA%J$7PNT/X;Z+K7AB."P1HM;MO%_@[6/B-X.\
M4V]V]U<ZE;:KH/B[QY<Z])&VHW1O[9Y/%\\T%Q;P^=+=P*T$EXIPQ->BU%T\
M+0IT:-.G'DA6H1PT:$,+5PM>C3HQHXO"QP\84*[H5814ISE1G75*M2K#0EA:
M=:TY>WK5:]:512FXU)8F=:6(IUX5I5I5*&(5>?MJ<:E*4I6Y:D*+J4*GJGA;
M0_\ A&?#>@^'?[1O]7_L+1].TG^U-4F\_4M0_L^UBM?ME],?]9=2^5O=O5CU
MK3%5_K.(K5^14O;3E+ECLKN]NEWW=E=W=E>PZ</9QM:,;RE+EIQY*4.>3E[.
ME!RDZ=&G?DHTW*7LZ480YI<MWZ=^R=_R:Q^S3_V0#X-_^JZ\.5@6?0% 'S_X
M<_Y.G^,G_9 /V:?_ %8O[6- 'T!0 4 ?/_[-/_).O$?_ &<!^UC_ .M3_&2@
M#Z H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H \/_:*U+2M-^%5
M_'K'PY\'_%FTU[QA\*?!4/@'Q_/;6O@W6M5\?_%?P3X'T*X\0W%UX5\2I!I^
MEZWXAT_5RZZ%J4BMI*F&(3!'0 ^</^&<?^K!?V /_"R__(KH /\ AG'_ *L%
M_8 _\++_ /(KH /^&<?^K!?V /\ PLO_ ,BN@ _X9Q_ZL%_8 _\ "R__ "*Z
M #_AG'_JP7]@#_PLO_R*Z #_ (9Q_P"K!?V /_"R_P#R*Z #_AG'_JP7]@#_
M ,++_P#(KH /^&<?^K!?V /_  LO_P BN@ _X9Q_ZL%_8 _\++_\BN@ _P"&
M<?\ JP7]@#_PLO\ \BN@ _X9Q_ZL%_8 _P#"R_\ R*Z #_AG'_JP7]@#_P +
M+_\ (KH ]0_9^TW2O!OC[XG?#F']GKX'_ O6]+\'_"SQKJ%U\$-4MM5TKQ=I
M7B_6OBSH6C6^N3K\(/ ,\>H:/=^ M=>-)+;48_+\0DQ2Q,TR. ?5] !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!\6^#?@;\$_B+\6/VJM;^(
M/P>^%OCO6;7XY>&M-MM7\9?#[PEXGU.WTY?V9?V=M173X+_6](N9X;(:AJ6H
MW0@201B:_N9=N^=V8 ]2_P"&3OV6/^C:?@!_X9OX=?\ S.4 '_#)W[+'_1M/
MP _\,W\.O_F<H \0T#]F3]FV;]I+XKZ%+^SY\#Y=$TWX'_L^:MIVC2?"?P&^
ME6&JZUX\_:;L]8U.RT]M -O:ZA?6F@:%!<W$4:R3QZ+8)*SK9PB, ]O_ .&3
MOV6/^C:?@!_X9OX=?_,Y0 ?\,G?LL?\ 1M/P _\ #-_#K_YG* /$/BO^S)^S
M;IOCS]F2ST[]GSX'V%IKWQPU_2==M;+X3^ [6VUK2H/V;?V@]=ATS5H(- 5-
M1T^/6]%T;4%M[A9(UNM)LK@*)K6)T /;_P#AD[]EC_HVGX ?^&;^'7_S.4 '
M_#)W[+'_ $;3\ /_  S?PZ_^9R@#Q#]IO]F3]FW0/V;?V@]=T+]GSX'Z+K>B
M_ _XL:MHVL:3\)_ >G:KI.JZ=X#U^\T_4],U"ST".>PU"UNX89X;B"1)(I(D
M=&5E! ![?_PR=^RQ_P!&T_ #_P ,W\.O_F<H /\ AD[]EC_HVGX ?^&;^'7_
M ,SE !_PR=^RQ_T;3\ /_#-_#K_YG* /$/A/^S)^S;J/CS]INSU#]GSX'W]I
MH'QPT#2="M;SX3^ [JVT72IOV;?V?-=FTS28)] 9--T]];UK6-0:WMUCC:ZU
M:\N"IFNI7< ]O_X9._98_P"C:?@!_P"&;^'7_P SE !_PR=^RQ_T;3\ /_#-
M_#K_ .9R@#Q#7_V9/V;8/VDOA/H4/[/GP/AT34?@?^T'JVH:-%\)_ <>E7^J
MZ+X\_9DL]&U.\T]= %O=:A86FOZ[!;7$D;201ZU?I$R+>3"0 ]O_ .&3OV6/
M^C:?@!_X9OX=?_,Y0 ?\,G?LL?\ 1M/P _\ #-_#K_YG* /$/V@_V9/V;=%\
M!Z!>:/\ L^? _2;N;XX?LR:3-=:9\)_ =A<RZ5K_ .TE\)]"UW3))[70$=]/
MU'1-1U#3[NW9C'<VM_<6\RO#.Z, >W_\,G?LL?\ 1M/P _\ #-_#K_YG* #_
M (9._98_Z-I^ '_AF_AU_P#,Y0!XA^TW^S)^S;H'[-O[0>NZ%^SY\#]%UO1?
M@?\ %C5M&UC2?A/X#T[5=)U73O >OWFGZGIFH6>@1SV&H6MW##/#<02))%)$
MCHRLH( /;_\ AD[]EC_HVGX ?^&;^'7_ ,SE !_PR=^RQ_T;3\ /_#-_#K_Y
MG* #_AD[]EC_ *-I^ '_ (9OX=?_ #.4 >(?LR?LR?LVZ]^S;^SYKNN_L^?
M_6=;UGX'_"?5M8UC5OA/X#U'5=5U74? >@7FH:GJ>H7F@23WVH75W--/-<3R
M/)+)*[NS,Q) /;_^&3OV6/\ HVGX ?\ AF_AU_\ ,Y0 ?\,G?LL?]&T_ #_P
MS?PZ_P#F<H /V3O^36/V:?\ L@'P;_\ 5=>'* /H"@#Y_P##G_)T_P 9/^R
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MM7$5IX:4IT*'+"C6Q,\?BJ]/$T8:9C&&$Q.*BI2Y(X[-(\Z@Y1G.AG>/P-/
MP4WAL+1KRIX>E4_=XB4*'UNA"&7T<.J$:OOO[+WQR\1_&&+QW9^*[_P=J.M^
M$-8M;2>7X=VF@WO@ZTBN_MR)I]IXR\,_&3Q_:>)-0ADL)6E2^3PAJL,,UK+>
M^'K)+ZW,G7["F\KP&.I.<HXB4X.=2/LO:N%.C/GI4%[:G[+]YR^UH8['47-2
MI>VC5I5(G-5=2CF%;"34(J,92C3A/VLJ?+6G3:K3DJ%:,FE%1C6P.%<G&K*G
M[2,9*GUW[2W_ "3KPY_V<!^R=_ZU/\&ZY30^@* "@ H * "@ H * "@ H *
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M#LW:4))QE%ZQ:::31N5!84 % !0!\_\ P;_Y*+^UC_V<!X<_]98_9IH ^@*
M"@#Y_P##G_)T_P 9/^R ?LT_^K%_:QH ^@* "@#Y_P#C)_R47]D[_LX#Q'_Z
MRQ^TM0!] 4 % 'S_ /M8_P#)K'[2W_9 /C)_ZKKQ'0!] 4 % !0!\_\ P;_Y
M*+^UC_V<!X<_]98_9IH ^@* "@#Y_P#$?_)T_P &_P#L@'[2W_JQ?V3J /H"
M@ H ^?\ ]I;_ ))UX<_[. _9._\ 6I_@W0!] 4 % 'S_ /M8_P#)K'[2W_9
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M "@ H * "@ H * "@ H * "@ H ^?_#G_)T_QD_[(!^S3_ZL7]K&@#Z H *
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MLB(K, #U_P#X:6^'7_0N?M ?^(G?M3__ #FZ #_AI;X=?]"Y^T!_XB=^U/\
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MBR? #_Q&GXB__18T '_".?M3_P#19/@!_P"(T_$7_P"BQH /^$<_:G_Z+)\
M/_$:?B+_ /18T '_  CG[4__ $63X ?^(T_$7_Z+&@ _X1S]J?\ Z+)\ /\
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M'%'I< $3M([@V#8]PH * "@ H * "@ H X_XA>-=*^&O@'QQ\1==M]0N]$\
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M#_PH_P!EC_Z):@ _X7)\1?\ HT[]H#_PH_V6/_HEJ #_ (7)\1?^C3OV@/\
MPH_V6/\ Z):@ _X7)\1?^C3OV@/_  H_V6/_ *):@ _X7)\1?^C3OV@/_"C_
M &6/_HEJ #_A<GQ%_P"C3OV@/_"C_98_^B6H /\ A<GQ%_Z-._: _P#"C_98
M_P#HEJ #_A<GQ%_Z-._: _\ "C_98_\ HEJ #_A<GQ%_Z-._: _\*/\ 98_^
MB6H /^%R?$7_ *-._: _\*/]EC_Z):@ _P"%R?$7_HT[]H#_ ,*/]EC_ .B6
MH /^%R?$7_HT[]H#_P */]EC_P"B6H /^%R?$7_HT[]H#_PH_P!EC_Z):@ _
MX7)\1?\ HT[]H#_PH_V6/_HEJ #_ (7)\1?^C3OV@/\ PH_V6/\ Z):@ _X7
M)\1?^C3OV@/_  H_V6/_ *):@ _X7)\1?^C3OV@/_"C_ &6/_HEJ #_A<GQ%
M_P"C3OV@/_"C_98_^B6H /\ A<GQ%_Z-._: _P#"C_98_P#HEJ #_A<GQ%_Z
M-._: _\ "C_98_\ HEJ #_A<GQ%_Z-._: _\*/\ 98_^B6H /^%R?$7_ *-.
M_: _\*/]EC_Z):@ _P"%R?$7_HT[]H#_ ,*/]EC_ .B6H /^%R?$7_HT[]H#
M_P */]EC_P"B6H /^%R?$7_HT[]H#_PH_P!EC_Z):@ _X7)\1?\ HT[]H#_P
MH_V6/_HEJ #_ (7)\1?^C3OV@/\ PH_V6/\ Z):@#U#X>^-=*^)7@'P/\1="
MM]0M-$\?^#_#/C71K75HK:WU6UTKQ5HMEKNGV^IP6=W=6\.H1VE_"DR07-Q&
MLBN$ED4!V .PH ^?_#G_ "=/\9/^R ?LT_\ JQ?VL: /H"@ H ^?_P!FG_DG
M7B/_ +. _:Q_]:G^,E 'T!0 4 % !0 4 % !0 4 % !0 4 (>!]!_*IFW&$V
MM'%-KY($?"FB^/OB)X,T7X;_ !,\1?%CQ5X\L/'?B;Q3IVN_#;6/#/PY6WLM
M#TVP\9ZN]Y\/W\#^ M$UT7ND6_ART:0:UJFM136AN$D(NI89AS4\9#!9?@ZF
M*HSQJJ\.T<VKUX^[7H5H91A\PG5E&GR8?ZKB<35^H\DJ490KXK!NG5BH585M
MEAIXS%9FJ$_JL\)G=3+,-23C]7J0GQ$LHA&HZJG7=6CA.?%J5*LM,/7G4I3I
MW=*OIO[8GC[6O"-YXETC]G'QM.8KKPY=V=U>:'\>K#PR?"GB.WU6XAU:[O6_
M9MD\2:EJ]C_9UHE[9^$O"/BW3H?[<L)UUJ6T^T7-IZ5>A]4=&.*K4\/[.KB*
M.,E4<H1HSP\*<U*DIPC5=*ISS2K9A2RNG3EAZ\:TJ<O8*OS8>I'%053#)UX5
MX1GAHP=.52474A!NLU4^K1;C.,Z=/!8G,*U7WE"ER1E47=7_ .U%<_9]9\0>
M&O!WASQ)X%\,Z7I+ZUXD;XDP^'KZ\UOQ#\/[?X@Z#%X/T/Q!X3MD\5>&;FPO
M;&U.HKJ%EJ)FEF%IH=XUI.D?-C_:9<L9*O1DE2J9A1PT%*DZ]6MEL95*\,31
MA4E]64J<*DJ3I2QCY5#$5XT,#/ZXNG#4)8BKE.'YHTZV.6!GB$^90PU+'YI4
MR>"A*I&FZF(HXNE/VM#$1P5XJ-&E4JXZ<<&^-OOCM\:)/'_AC0].\*^%[36=
M4^P7LW@?4_B;:)X.O-)U7P+X[\2:8LGC4?!A=9T35HX=!L[J\AALM9A-U$MK
M;S+9QSW5UT.G#"U<WC5E]8I93#-HXEVY)4JN7SX-=2IA'S0CB*5.EF^,AAZ>
M)6%=25:K6Q5:E".&I8+Q5C7B*N3N#J86GF*RBK!*,:KG2S"AQ>HTJ\+-T*LL
M3E6$=:K1KUHJG1HT\-1=6>(6,V/#'[81\8>-O#/AOP]\)/'6H:%JD7@>'7O$
M%EX;^).KGP_J/CO1=*UVQE6_\._"_4?!D_AG3K/6+5[_ %;4?'.BR)''+/:6
M-Y (Y)=*&&=;%XJ@Y^QH4IXJG1K58RH<T\)AOK,EB*>)5!X=UERT*-*G+$XG
MZU4I4:^'H1FZL?2S!5LOI4>>G&OB5>5>E0FJO+".98K*YO#NFI5*[A6P=>N_
M:TL+3EA(N5*K5Q"EA5/\4OVD/&WPK^(WC+P_-X%L_%6AK:_"_3?A_;:)-X_U
M76[OQ+XR@\?WVHOXETKP'\*?%6K6&C+:>"K\+)I.FZ_.CVEJ?LS+J$YTKAP\
MJE3#SO23Q,LTQF'I6=1T_JF"RO+<=6=1PHR<*T98V#I)ITZOM:L:M7"T\&JV
M)UJ04:ZY*B6&P^4T<9B5+V<*GUG$YS4RO#0H<]:,:M.?N2K-NE4H^SM1I8NK
M6A3BC?M2^,[JSN+[2?@G=VZ:/X5\$:_XAT[QQXE\1?#OQ%:W_CKQUXH\ :3I
M6E^&_$/PR&H3V[:GX9:^2\UF'P^TFG:E;3FVCF)MJ[*F'E%T'3E"5+%X[!9?
M0?M(.:KXS#97B[8J-&5>G0^J4\QE3QD:5;$SAB,/[*C&NJDJE+*/.L)'$5(.
M%2%'.<15@E/E]ADM&=6I4P\ZD*3KK%_NOJ?/3H7A.I+$/#SI*E5LV?[27Q(;
M^UH+KX)Z9<ZC8'XBZ#8:7X5^)6H>([[6/'GPV:%]5TBUMYOAGILO_"+W5I<1
M2VVKQQS:B[QSQ'0 RPFY\]8B%3"PQ%",YSKX7Z[2@X2LL-1S:CDN.G7]BJ]6
M$L-BZKK4J>'H8N6)P<'5_<XAK"&C@Z6+CAJSC"$,52PM6<91YE4Q63U<\P*H
MJJZ-*;K8.FJ-?V]?"T\/CJD:4:M?#*6,CVVB_'_[9\%-8^*NI^'+2UUG0;V;
M1]6\&V6H^+=/_LSQ VJ66F66DZQ>?$_X=>"-:T%B=4TRXNI=4\+V0MK>Y-Q&
MMU (Y)^S&4W1>5PPDHXIYO5PN'P\Y3A"@Z^)Q7U*2=6C/%-4Z&*C4HU;0>)C
M4I5*,L+'$1=$QPE6-:69*NG0654L17KPC&4ZT:.'P']H_P .HJ,75JX9QG1B
MJCHU(U*4XXAPGS1\STSXQ_&3QE\=_ OPSDT?PSX#MO#%SXXN_BQ:>&/B#9>,
M++6%T31/ .J:#8:/JVM_!U+J_P!-:U\?Z?)=VGV?P;J*W"/LOA:VD8US7 TJ
M-9X_&N<YX+#865*%.=/D?U]XFIAZDW&,TYT:/LHO#UZ>*Y>>=6.*P<JE&5"&
M^,I5:.7X>45&&(Q.+RV<:D:E[8+$TLUJ>R<94I052K+*\2JKY9\M*GAUAJU\
M=+$8'*\=?MP67@/X@:O\.+WX=/=Z]HNI>(O#MVL7C&UMT'BR\@CO_@GX?$4^
M@B9I/B+IOVI[>X2-TTZXL)[;%^RASAE<7FDJ%.DG2G7="C#F7-'ZXLUG@,QP
MS<.9K^S<%%9W5GR\TLKG"O.E0C*X\=&&7WJU8UY8*C"6)K5844Y0RVGEM#%3
MQU*G*I%5D\RK?V)2I*I%5,=3DG5IZPCL:_\ M=WVA^,M5\)0_#S3=;5].O;K
MP?JND>+O$K:=K]YHGC7PYX"\0Z=J6MWWPMMO#FGSV6OZ^T1BT7Q#XFNHOL!_
MM&TTTW$0:<.IXJ,50C:K5K9<J*J/V=.>%S3$*CA,4Y23K2A*$Z>(<L/A\3AG
M3<XTL55K0C3G-6*P]!8BK?DH4<<\3"FHU*E'&8#*\9F=;"149>RNHX*KAV\3
M6P>(5649+"2I*I.&U?\ [1/Q&TK3/%D^I?"_P);ZMX;\2-X+TW2+;XJ>-==G
M\4>*=*\.6OB[Q3#H6G>&?@-J7B#4M)L-!GGDMI+#P_?:C=RV$ZR:59VX6Z::
MM2E#"T,93<ZE&O''8A+V;52E@<OS+%957Q%:,'4A2D\70HJ*E/ZK"GB8RQ&-
MH.*C.:#C4Q>+PDW[)X.>'H2FW!0GBL;@<%F&#H4G4G2YW.ABJCK6M5@Z"6&H
MXQSJ*AEZ)^UAX@\3)X6UW0?A9I\G@76-.^"]SK&N:GX_NM,\0:5>_&W69O#W
MA^TTOPI_P@4ZZQ!I^JK;-?37NJ:+(MK=>;#;RW$3V@[G@:OM\5AU.,91Q&.P
MN%;:?M*V#R#"Y^GB/9NI3H4JE'%+#N="IC.6M'FA&K2ESQQC63GBJ#B_K&7X
M26-Q,4I1A&A0S3,\MQ*I.K&E5G5C_9=:O0IUJ&']K&7LJ\L).,>>IX(_:6^)
M8E^%=A\2/AOH.CZ=XY>2UU3XB6.O_$+4?"5KJU[XNU7PUHF@Z9>Z-\$[K2;?
M6YI(-(B\GQ9K/@V&>?5[>'3KB_F\Q(\<!3IXU82$)RA4KY7@,73C*"A5Q-6O
ME%+,JTJ4)U(T/9)2J.5.EBJ^+H^SKKZK.A2I8C$7BG/#K,:E.'MJ6#S#,Z$F
MG[M##X+,:F#O54/:5^:G&$W[9X>.&G3A2JU*]"I6K8?"_27Q1\>7_@'1M'FT
M;0['Q#XA\3>)](\'^'-+U?Q!_P (IH<FM:R+E[9]<\1KI.JRZ3IJQ6<^9+;2
MM2N'D,4,%K-+,JUR<U26*P>#HPC*KBWB&G.3A&-/"X6OC*S]V%24I^QP\U3I
MQA[TVN>=*DJE6&S4*>%QF*JR<:6"A1E)1C%RE*OB\-@J44I3IQ4?;8JFZDW)
M<E)3FHSDE"7SG+^UEXC2/49(OA?X?D'@K0M<UWXE_P#%U8C_ &5#X5\;ZUX&
M\16_@$6_@>9O'\ZZAH_G62W2^&S<K<+;W(L+XQVMQT86,,9B*,</*2PF+J9/
M1P]2I#DK.MG=7%8?"*K0C*<:=&&(PK56M3KU^?#R6(P<,6E[-SC*=7!1G2DJ
M<L=!9A/V;JQI8?V.7X'*\RG.6*KJFJ4I87-*::K4J=*AB*4X8BO2H<V)AB^'
M_P!I7XD1?\(O:^(/">@W_C/QCJOQ!\.>&="L_'<>D^ YK[1OBQ=>#M#G\1Z_
M?_#'^V='FCL+&ZB:XL[>_67RHPFE3WFH1I8*A&=2.#H4XQEC<5EO#V,J<\VJ
M5.6.R?.\UQ<J$Z<'*3G0RV,W1G2JI5ITZ%*KA\/A<3C<;PU<5"&+QD^:<<NP
MV)SVG1:A&%:I2P69</9;A5B*-235.I&OF[BY4\3%0H0K5ZT<14JT,-@]U_VJ
MO&#17D]E\)M!N8/!NGWU]\4)O^%J,(]#.B>/M9\ ZW!X&DM/A_<IXZ=+O1+J
M]M#?MX6$T*M%=?8+I/(:\(J.+Q6$C"=2& Q];)L/AZTJ25=UL[KU\+AO:8;V
MGLX4:->BO;5J>*K*5"K#$86.)C[KZ<SE4RO"XRI5@JF)P-#-<5.G"35+V&59
M9EN;2Y:LH1J>VK8;,J<(TI8>,:>(IU*=2JH6J'J/P^^-6M>*_B=XT^'/B?P.
M/ 4^@C5+KPLNJW?C=M;\9:'I&I6^G77B*RCU3X8Z5X5N])VW^E3%O#?C/Q3+
M;#5K2+4([*XD,2YX=>URJ>82O&K0]DZ^'BKRP\:JK.G&M[3V-95&Z%2"=/#U
M,)4G"JJ&,K1@I3TQ*EA\52I1BY8:JY0IUW;EJ5(TX5.6G[)UJ:3BZDE"M6H8
ME0I\TL-%N<:?F<W[5OB"VMK;4I/AAHTNE>+-/U'4OAE]B^)T%SK6N0:-XV\-
M^"=1B\;Z0W@V-/ US]K\3V4\0L;SQ/&/)FMKR6QN0L3Q0YZ]+ PC%1Q^-CE%
M:-.\GAH8;.94XX:I+%1@W[6G[6$J]%8=QE&-66#K8Q4IVVKTXX?^TJKDY83*
MJV:X6K*,5[:6)RG!9AC*D:5)S5.5&JLLQ%.G5GB*=2+GAYU*$8UO<]/\=?%G
MQQX1F\$>&;#P'X/U;X@^)O"_B?Q;K&E:C\3KOP[X+T73/!,6A?\ "30Z7XRN
M/A[<W^OWXN/$-BME'+X:TN.>**YN+R73HX?F,15HT)9C7A*<\LR>A2Q.)JRC
M"&*]C5G4A#V&%]K*G4FG1J<_M,70HP_=1=?VE>$!T<-5J8:E4?+'$XO&0P&&
MIISE3E7JT\17INO54.>E3]CAI.7LJ&)K>TDH4Z%6G"I5A\[:/^TE\:_&7BRP
MN?!?@[PE=^&=6\2Z?_PBN@:SXRF\/7.I^'=6_9[TOXI&W\9:K'\.]:D\/W5E
M?:I:S12Z,FK&>>X-E(([2V-Y==>)P\LK_M%8VU:IEF%X@J5U3;Y53RO/LFP-
M'$4.:%.53$O#8G%4OJE94:'-54YXE3C!TN/$2O+ASV,OJ\,UJ8",FI4\0ZE6
MO0XKIU:5X/V,<-]:RFC/ZS1K59NAA8UJ*F\9/!T^O\/_ +8S^*/%?AG1=!^$
M/CK4-#U72_ -SKNMV7AWXE:J_AZ_^(7AG1O%.G;K_0/A9J'@X^'M-L-<M/[2
MU+5?&NAW$ BGD@TZZCC4R1BJ+P=?.Z4Y15+*9YI2I59OV,*U7*\/4KU%5=;V
M<*,<1[-4,-[">-K2Q%6C&I0ITJBJK:O"MA8X&-2FI8JOR2KT:4U5=*$LRQ.6
M2='V:=2M.E6PM:O.-6EA(2PL&Z56IB8RPL?0[/XY^+YO@AX;^+EU\.-&@U'Q
MMJ/PXMO"7@^W^(%Q=)+8?$W6_"^A:)=^(?$4G@>W71KNWN?$9ENK6SL-618K
M(&*XEDF,<.^*P%;#9EA\HIRA4QLYXNG5<G*%"C/"X;&XOW:BC4J5(NAA(^T:
MHQ<*M2I"G&O"E"K7TITTZF<^TFHX7*(XR2J13G4KK .<*W+2?(J;J5*=18=2
MJM3@Z<ZSP[E.%+SO5/VF_&7AG1?%]Q_P@6C>(-9\"V/Q)\6>-K'5_B?!I%EI
MFB>#->O-#&F^"-3M/A/!)XL+:G;-#"E_IFF206ODR7M]+=W,$-URY>J6-JX"
MG3G..$KU\OPCKSA'ZQ[7-<XQ^7X64L/"?L7&G#!SJ591K4[+V5&E#$U5B*T6
MJ%7ZW3PE14Z6*Q+7)3A/FP\(8?)\GS#$R]K44*JD_P"TZ?)&5.4:E58B;GA,
M/&G2I\UXN_:/^,WA3PW\1KJT\(>%-52+7/C'I_P^\3ZMXQDL)XKWP#)>:O'I
M>M>%-,^'\T46B6WAZSO8[?4!JUW>7EY8+!<VMM#<"_6,NA5Q:R;#.,7C,35P
M\YIR<(5\)+BO#9#5YZD82^JXAK'X14HTZ&(IJA[3$3FL13^K5N/%8K#X?V^(
M:J4\-+#T5&,81J2P^*J<%U.(:;A%U8?6:,J^#Q#K.I4P\X3K1ITH2HI.'NOA
M?XU>*+_XO7/PM\7^ +7P7 VFR3>'=>N=4\>WO_"8ZA9:79:CJD?AJZF^$=CX
M1O\ 3X%?4V5$\:MK/D:9]IN-#M4D<6^N'C3Q-/,IPE*%3!5:O)0G&,:SPE/%
M?5HXJM"=2+C"?M,+*^#^OX>E+%T:%?%4Z[]FXE5G1AE/M5%O'TJ"J5(R;HQQ
M53"5,5+#4)PC)SE35&M'_:X8&I-4*U2E1J4H1G4M_M8_\FL?M+?]D ^,G_JN
MO$=9'2?0% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!\_\ [)W_ ":Q^S3_
M -D ^#?_ *KKPY0!] 4 ?/\ X<_Y.G^,G_9 /V:?_5B_M8T ?0% !0!\_P#[
M-/\ R3KQ'_V<!^UC_P"M3_&2@#Z H * "@ H * "@ H * "@ H * "AKIT[!
MMY6/.O#'P?\ A+X)UO5/$W@SX7?#KPCXCUO[0=9\0>&/!/AK0-;U?[7.UU=_
MVIJNE:9!=7_G7+O+)Y\LF]W9VRQ)I4TJ&&>#HKV.#<80="'N4>2FG&G'V4;0
MY:<6XPCRVBFU%),51*KB%BJJ]IBHN;5:?O54ZC3J-5'>:<W%.;O>32<KM(Q9
M?V>_@'/IVJ:1/\#_ (03:3K>KKX@UK2Y?AIX,DT[5]>0RE-;U2R?13#?ZNIG
MFQ>3I),/.?#_ #'+A^Z6$5/]VL W+"J/NK#2:C%RH)6]BW&$4W3Y6U&*V2M;
ME)SKU7)NIBDHUIMOFK14W44:LMZB51N:4VTIMRW=SIK[X7_#34]6LM?U/X>>
M!M0UW3-%G\-Z=K5]X2T"[U;3_#MU ]K=:!9:C<:>]Q::+-:R20R6,4BP/&[(
MT95B"FDYXN;5YX]*.)D_BQ$4U)1KO>LE)*253F5TGND3']W'!QA[D<OFJN%4
M=%AJB5E4PZ5E1FEHIT^6274B\2?"CX6^,8'M?%WPV\ ^*K:2.RBDM_$G@[P[
MKD#Q:=!/:Z?&\6IZ=.K1VMM<W,4*D$1)<2(@578&KM5?;WM7565?VGV_;S>&
M<ZW/\7M9O!X-RJ7YY/"X9MMT*7+,(1I<GLHJG[*G"C#E2CR4:<<3"%*-K<M.
M$,;C(0@K1C'%XF*25>JIS7GPQ^&U_P"(]!\87_P]\#WOBWPK;)9^&/%-YX3T
M&Y\1^'+..-XH[30=;FL&O='MEBDD016DT*A9& &&(-0J3I5L3B*4Y4Z^,3CB
M*D6XU*\7O&M-6E53ZJ;D@<(.A1PKBGA<-;V-%I>RI6<6O9T_@A9P@URI6<8V
M^%6/$GPQ^&WC&?4+KQ=\/? _BJZU71HO#FJ7'B3PGH.N3ZEX>@OAJ<&A:A-J
M=A.]YHT>I 7:64Q>!9QYH02?-6/LJ?+4C[./+6JT:U1<JM.MAXSA0JS5K2JT
M(5*D:-1WE2C4G&#BI23TYYWI2YWS4(5J=)W=Z=/$^S^L0@]X0K^RI>VC&RJ^
MSI\ZER1M/IWP[^'^D6$>DZ3X%\':7I<6GZ+I,6FZ=X8T2RL(]*\-7MQJ7AW3
M([.VL4A33]*U&[NKJRMP@CM9KF66!8WD9CT5*]:K-5*M:=2I&M'$J4YRE)8B
M,*=..(3;;5:,*-&$:OQJ%*G%2M"*41C&$/91BHT^2O3Y$K1]GBDUBH<JTY,2
MFU7C;EK)M5%(74?A[X!U>SO=/U;P/X/U2PU*769M1L=1\,Z+>V=_-XB01>()
M;VVN;)X[J74XU5+QI58W2J!.7 KF=&CR0I^RA[.G"5*$>6/+&G/$1Q<J<8VM
M&$L7&.*E!)1>(C&LTZB4C6-6I"JJ\*DHUE4IU544FI^UI89X.E4YT^;VE+"2
MEA:<[\T,,W0BU2;B2Z-X$\#^'/#'_"$>'O!OA30O!@M[JS_X1'1O#VD:7X8%
MI?&0WMK_ &!8V<5C]GN#+*98_(VR>8V\'<<Z8C_:X>SQ7^TTU"-/EJ_O(^S@
MDH4^6=UR022C&W+%)))6,J$8X23GA4L--SE4<J2]G+VDG>51N%GSR>LI?$WN
MRMX7^&_P[\#VVFV7@KP%X+\(6>C1ZI#H]IX7\+:'X?MM*AUR>TNM:BTV#2;&
M!+&/4+FPL9KI8%07$EE \H=H4*ZRKUI_'6G+]W3I>].3_=4G)TJ6K_ATG*3I
MP^&#E)Q2;8*,8QE",5&$ZL:THI64JT*<Z,*LDM'5C2J5*4:C]^-.<X)J,I)S
M7WP_\!:GJTFO:EX(\(ZAKDM]H.J2ZS?>&]&N]6DU/PM]K/AC49-1N+)[A[[2
M#?WWV"X,ADL_MD_V=H_.?=G2DZ#BZ+=%PJ5ZL7!\CC5Q.'CA,357+:U3$86$
M,-7FO>JX>$:-1RIQ445(JM%PJI582I1HN,US)T88A8N%)J5TZ4,5&.)C3^".
M(2K)*HE(R(/A!\);35=2UVU^%WP[MM<UC4#JVKZS!X)\-0ZKJNJF6&<ZGJ6H
M1Z8+B^U S6UO)]HFD>3=!&V[**1-&,<-"E3P\50A0DY4XTUR1IR=2E6<H*-E
M&3JT*-5N-FZE&E/XJ<&G5_?3G5K?O:E2'LYSG[TI4U1K890E*5W*"P^)Q&'Y
M6VO8UZU*W)5G&6AK_P -?AUXJLI=-\4> ?!7B33I]<B\33V&O^%="UBRF\20
M1Q0P^();74;":*37(X8(8UOF4SJL**) $ !&,82PLXQ49X%U'AY))/#NK5G7
MJNBUK2=2M5JUJCI\KG5J3J2O.<FTTG'%P:3ACU".)BUIB(TZ=.C"-=;5E"C1
MI4H*IS*-.E3@K1A%*S:^ O UC;?8K+P9X3L[,2Z+,+2U\.Z/;VPF\.7[:IX>
ME\B*S5/-TO4V:\LFVYM9V,T!CD.ZKA.=+V?LY.G[%N4.5N/)*6%IX&3C:W*Y
M8*E2P;:LWA:=/#O]U",$E"$95IJ*C.O3G2JR22E4I5*M>O4IU'O.G.OB<36G
M"5XRJXBO4:<ZM1RYRU^"7P8L=>L?%5C\(_AC9>*-+OM1U/3?$EIX!\*VVOZ=
MJ6L3SW.KZA8ZQ#I*W=I?7MS<W,MS/%,DD[W$CRLS.Q,4TJ-.=&C^XI3PZPDH
M4_W<7A5>V&:A9>P7-*U+^&KNT5=EU6Z[DZ[]LY5?;R]I[]ZUJ:]L^:]ZMJ5)
M>T?OVI4U?W(VVA\-_ 1\$P_#>Z\(>']4\ P:=%I*^$-<TRVU[0)-,@(:&QN=
M-UI+J*\MT8*0DZR ;1Z#!5C&O[+V\56]@J*I\Z4W'ZO"-.BTY)OGIQA%*?QW
M7,Y.3;=^UJJKB:RJ2C5Q=7$5JTE)IU*F+JSK8ARLUI5J5)RE!6A[W*HJ*27)
M)\ OA"GB;P[XG_X0'PDTW@W0=*\/^"=(?PKX8;0O!$&C:AJ6HV5_X.L/[&W>
M&M45]4N(3/82P 1)&B(I#,^D*M6GBL9CO:SEC<;[%5,1*3==0HTZU)4XU;JH
MJ=2%>2JP<I*?+!:)-/&K3IU<-AL'*E#ZKA:F)K*BHKV<ZN*EA)RJ5:;O"52G
M/!TY49\JE"52M)N3FG'?N?A%\*+RUUVQN_AA\/+JQ\3R:E-XEL[GP5X;GM?$
M,NLW=K?ZO+KMO+IK1ZM)?7UC97-RUTLIGELX))2SQ(RX^SIJA3PWLXK#4/9>
MSI<J]G3]A4Q%:AR0MRQ]C5Q>+JTN5+V=3%8B<+2K5'*K_P"T3Q?_ #%3C.$J
MW_+V4*E+#T*D95/C<9T<)A:,XMVE2PV'IR3A1IJ.G9_#SP!IVEIH>G^!_!]A
MHL6BVWAN+1[/PSHMKI<?AVRGEN;/0$T^"R6!-%@N9YY8K$1B"-YG=8PSDG>=
M6K4K/$5*LYXB57#UW5E)NHZV$ES86LYMN3JX:7O8>I?GHRUIN+,W2I.D\.Z<
M70E'$P=/E7LW#&1C#&0<+<KCBH0A'$Q:M7C&,:JDHI)F@?#CX>>$]<U[Q-X6
M\!^#/#/B3Q3(LOB?Q!H'A?0]&USQ'*DCRI)KVK:=8PW6KR++)(X:[EE(9V(.
M6),4FZ&'6#HMT<)&;J*A#W**J/1S5.-H*;6CDHW?<TJ?OJJKU?WM>,>15)^]
M44+17*IRO)1M""Y4[6C%6]U6JV?PJ^%^G:IX@UO3_AOX"L-:\6W%G=^*M7L_
M!_AZUU3Q-=:==QW^GW/B"_@TY9]9N+6^BBN89+R29HI8UD0JZA@J3]A1I8:C
M^YP]"LL13I0]RG3Q"?,J\(1M&%9/558I33UYKA4;JU)5:O[RK*E4H2G/WI.A
M5I^RJT7)W;I5*2]G4IM\DZ?N23CH:'C#P!X$^(-C:Z9X^\%>$O&^FV%[%J5C
MIWC#PWH_B6QL]1@5EAO[6TUJSN8K>]C5W"SQHLBAB PR:48QA7HXF*4<3AGS
M4:J5JM*6FM.:]Z#T6L6GHNPW*3HU\.VWA\3'DK4F_P!W5A>_)4A\,XW5^62:
MOK8(O '@2#Q#)XNA\%>$H?%<UK:V4OB>+PWHT?B&6SL;*ZTZRM)-:2R%X]K;
MZ??7MK%$9BD<-Y/$@"2NK5=^SQ%&_P"ZQ;JNO#[%9U_8.LZT=JCK/"X5U7-2
M]I]6H<]_8T^6'&,OJG-%2^H6^JW2?U;E551]A?\ @\JKUDO9\ME6JI:5)WRW
M^$GPIDU?PYX@D^&7P^?7_!NGQ:1X1UM_!GAQM7\*Z5;P-;0:9X<U)M--QH>G
MQVSO$EM9201JCL@4*2*;G)U,96<FZV8PE3Q<VWSXJG)6E#$2^*M"2TE&HY)K
M1HN<G4C"%1N<*=25:$9.ZC6E45656*=U&I*JE4E-6DZB4V^97.E'AGPVND:;
MX>7P_H:Z!HS:0VD:&-)L!I&E-X?N+6[T%M-TT6_V>Q;3;JQLIK,PQI]FDLX7
MAV-$A6I5JTJ_UJ56<L3><O:N4G5YJD)TJDO:-\]ZE*I4IS=[RA.<)7C*29=I
M55>RKJHJJZ5%5;=55%]M5')NHI7YVVY7;9X=\6_V7OAK\8KO1;C7_P"T-(M]
M)GUB>ZTS0=,\$26&M'Q#<)<:[-<CQ+X/UBXT'6+_ !/%<:_X9N-!UN2&\N(F
MU/9)M6,#_P )^84,PH+]YA50]E3>E.F\-B*F+I.FZ?)6IP^LU)5J^'IU8X7&
M3C#Z[0Q,:<$G7G.OAYX=SE3G)RE[:$G[6[P]+"QDU+FHSJ4:%"C#"UJM*I7P
M2@OJ=3#\T^;V*\\!^!]0LI=-U#P;X5O]/G?699[*^\/Z3=VD\OB*VN++Q#+/
M;W%HZ32ZI:7=U!>NZLUU'<RI.9%D8-G.G3G!TYTXRIRIRHN#BN3V4\1#%SI<
MMN7V4L52I8F5.W(\13IUFO:0C)32O1E0G2;A4PTZ-2E-2?/3J8?#/!T*L9WY
MXU*.$E+"TZB?/##RE1C)4VXO+\/_  G^%OA+79_%'A7X:^ /#/B:YTZVT>Y\
M1>'_  ;X=T77;C2;*"WM;/2Y]7T[3H;N73H+:SM(8[9I3%'':PHJA8U"[^VJ
MI8A>UFEBZCK5US.U:LY2FZM97_>5'.<Y.<^:3E.4KWDV\_8T4L)'V4$L!2]C
MAERQMAJ-K>RH*W[FE96]G3Y8VZ'GW[6/_)K'[2W_ &0#XR?^JZ\1UF:'T!0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M?L ?^)]?_DXT '_#:G_4Y?L ?^)]?_DXT '_  VI_P!3E^P!_P")]?\ Y.-
M!_PVI_U.7[ '_B?7_P"3C0 ?\-J?]3E^P!_XGU_^3C0 ?\-J?]3E^P!_XGU_
M^3C0 ?\ #:G_ %.7[ '_ (GU_P#DXT '_#:G_4Y?L ?^)]?_ ).- !_PVI_U
M.7[ '_B?7_Y.- !_PVI_U.7[ '_B?7_Y.- !_P -J?\ 4Y?L ?\ B?7_ .3C
M0 ?\-J?]3E^P!_XGU_\ DXT '_#:G_4Y?L ?^)]?_DXT '_#:G_4Y?L ?^)]
M?_DXT '_  VI_P!3E^P!_P")]?\ Y.- !_PVI_U.7[ '_B?7_P"3C0 ?\-J?
M]3E^P!_XGU_^3C0 ?\-J?]3E^P!_XGU_^3C0 ?\ #:G_ %.7[ '_ (GU_P#D
MXT '_#:G_4Y?L ?^)]?_ ).- !_PVI_U.7[ '_B?7_Y.- !_PVI_U.7[ '_B
M?7_Y.- !_P -J?\ 4Y?L ?\ B?7_ .3C0 ?\-J?]3E^P!_XGU_\ DXT '_#:
MG_4Y?L ?^)]?_DXT '_#:G_4Y?L ?^)]?_DXT '_  VI_P!3E^P!_P")]?\
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M*.(=*G4JK#U90KNG3G45/DA)KB/VL?\ DUC]I;_L@'QD_P#5=>(Z0CZ H *
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MC_Z):@ _X7)\1?\ HT[]H#_PH_V6/_HEJ #_ (7)\1?^C3OV@/\ PH_V6/\
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M<TS[59V/]HZ[X@\%ZUI.D6/VW4;BWM+/S]0N[>+SKJ>&&/S-\LB(K, #G_\
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MC_98_P#HEJ #_A<GQ%_Z-._: _\ "C_98_\ HEJ #_A<GQ%_Z-._: _\*/\
M98_^B6H /^%R?$7_ *-._: _\*/]EC_Z):@ _P"%R?$7_HT[]H#_ ,*/]EC_
M .B6H /^%R?$7_HT[]H#_P */]EC_P"B6H /^%R?$7_HT[]H#_PH_P!EC_Z)
M:@ _X7)\1?\ HT[]H#_PH_V6/_HEJ #_ (7)\1?^C3OV@/\ PH_V6/\ Z):@
M _X7)\1?^C3OV@/_  H_V6/_ *):@ _X7)\1?^C3OV@/_"C_ &6/_HEJ #_A
M<GQ%_P"C3OV@/_"C_98_^B6H /\ A<GQ%_Z-._: _P#"C_98_P#HEJ #_A<G
MQ%_Z-._: _\ "C_98_\ HEJ #_A<GQ%_Z-._: _\*/\ 98_^B6H /^%R?$7_
M *-._: _\*/]EC_Z):@ _P"%R?$7_HT[]H#_ ,*/]EC_ .B6H /^%R?$7_HT
M[]H#_P */]EC_P"B6H /^%R?$7_HT[]H#_PH_P!EC_Z):@ _X7)\1?\ HT[]
MH#_PH_V6/_HEJ #_ (7)\1?^C3OV@/\ PH_V6/\ Z):@ _X7)\1?^C3OV@/_
M  H_V6/_ *):@ _X7)\1?^C3OV@/_"C_ &6/_HEJ #_A<GQ%_P"C3OV@/_"C
M_98_^B6H /\ A<GQ%_Z-._: _P#"C_98_P#HEJ #_A<GQ%_Z-._: _\ "C_9
M8_\ HEJ #_A<GQ%_Z-._: _\*/\ 98_^B6H /^%R?$7_ *-._: _\*/]EC_Z
M):@ _P"%R?$7_HT[]H#_ ,*/]EC_ .B6H Z#]GKPMKO@;X!? _P5XIL?[+\3
M>#_@_P##3PMXCTS[59WO]G:[X?\ !>BZ3J]C]MTZXN+2[^SZA:7$7G6L\T,G
ME[XI'1E8FWR#;Y'L% 'S_P"'/^3I_C)_V0#]FG_U8O[6- 'T!0 4 ?/_ .S3
M_P DZ\1_]G ?M8_^M3_&2@#Z H * "@ H \-U;]HOX7Z'\1K/X3ZC)\0D\>:
M@TITW2;7X*_&C4;+4;2VN-/M;W6-.\1Z;\/Y]%OO#ME<:KIT=YK,&H2:?9M=
M(+JYAYQ6#C+'.K'#*[P]O:^T_<*BG.K3IRJNO[-4H5IT*L</4J.,,1R-T)5$
MTV8EK!PA.M[L*E_9N'[SVDHTHUY4Z2I<[J5H4I*52C34JM/6,X1DFEZEXI\5
M>'?!.A7WB;Q5JUIH>A:;]G%YJ5ZS+#"]W=06%G"%C5GFN+B^N;:WAAC1Y)99
MXXXU9W ,Q:=;"X=->VQF(HX6A#9U,1B*D:5&E&_VIU))7=E%7E)J*;0_=IXB
ML]*6$H5\36ETIT,-1G7KU96VA1HTYU)OI&+?0/%?BC0O!'ACQ!XR\3WW]E^&
M_"NBZEXAU[4?LMY>_8-'TBSEO]0N_L>GV\]U=>3:02OY5O!-*^W:B,Q ..(Q
M%'"TG6KSY*<7"+=I/6<XTX*T4WK.45M97N[)-G1A,+7QN(H83"T_:XC$24*<
M.:,>:3V7--QBO632\R]H^KZ?K^D:5KND7'VO2M:TZQU;3+KRI[?[3I^HVT5Y
M97'D7,<<T/F6TT;[)8T==V'56! [,3AZV#Q%?"8B'LZ^%J3I5(7C+EJ4Y.$X
M\T7*,N646KQ;B[73:U.#"XFAC<+A\9A9^TPV+I4ZU*?+*/-3J14X2Y9J,H\T
M6G:45)7LTGH:58FX4 % !0 4 <_XI\5>'?!.A7WB;Q5JUIH>A:;]G%YJ5ZS+
M#"]W=06%G"%C5GFN+B^N;:WAAC1Y)99XXXU9W )%IUL+ATU[;&8BCA:$-G4Q
M&(J1I4:4;_:G4DE=V45>4FHIM#]VGB*STI82A7Q-:72G0PU&=>O5E;:%&C3G
M4F^D8M]"QI.N66LOJT5G!K$#:+JL^C7AU;P]K^@1S7=M#;SR3:3+KNF6::]I
M12YC$>J:8UY8RNLL<5P\D$JQM*]*C66D*ZFXIM*HO9U9T9>TI.U6BW.G)P56
M$'4I.G7IJ5&K2J3&^6I*E]J$:<FUK"U6"J1Y:D;TY249)5(QE*5&=Z550J1E
M!;%( H S]5U*WT73-0U>[CU":UTNRN;^XBTG2=4UW4Y(+2%YY8]/T30[.[U'
M5KUD0B*SL;6YN)G*QPQ22.JF*DXTHN<E)I-*T(3G+5J*]V$92:3>K2M%7E)J
M*;6E*E*M4A2@X1E-J*=2I"E!/^]4JRA3@N\IRC%=6<YK?Q!\)^&8/!T^O:C<
MZ4OC[Q!I'A7PK#>:-KD5W?\ B'7+*[U#3-*NK Z;]IT6Y>UL;LO_ &G%9K T
M#1W#12X0ZN+CCH9;>,L746*E",)QJ0E'!4*F)Q,HUH.5&4:="C4J1DJC5512
MHNI*44\(U(RP53,+2AA:,<+*<IPG3G!8W%X; X93HU(QK1E/%8O#T90=-3I.
MHY58TX0J2AY'^T!82:]K_P"SEX0EUOQAHNB>+_CAJND^)%\%>.?&7P]U75=*
MTW]GGX]^*[33+CQ%X#UW1]633U\1>&]"OGMXKY(Y9-+@\U75=IG]"_T+_P#P
MS3\.O^AC_: _\2Q_:G_^?)0 ?\,T_#K_ *&/]H#_ ,2Q_:G_ /GR4 '_  S3
M\.O^AC_: _\ $L?VI_\ Y\E !_PS3\.O^AC_ &@/_$L?VI__ )\E !_PS3\.
MO^AC_: _\2Q_:G_^?)0 C?LU_#B-6=_$OQ^5$4LS-^UE^U,JJJC+,S'XRX"@
M DDU,YPI0E4J24*=-.4I2:48QBKMMO1))7;>B0XQ<FHQ3E*3222NVWHDDMV^
MB/$+F#]EB#PIH'C6S^)7[2'B'P]XJU;Q!HWAN?P7\??VX?'>HZY>>%;K4K/Q
M#+IF@>#/'^J:K>:583:3?&74X[)K$1QI,+@PSPO+4_W-3"TJO[F6+P=+,8.?
MN0A@:L,/4IXK$5)6IX2@XXK#\T\5.BH2JPA/EG>*OV4^;%T_=Y\#B5@JL>>'
M-];?-;"TUS7K8BT)OV5%5)I4ZK<4J53E[+6/AS\ -"\ P?$Z\\?_ +0$_@B[
ML=%U#3]8T;]I[]K[Q%+JMOXCN+&TT!=&T?P_\5+W4]9N]0N]2L(;:TL;.XN)
MI+J-$B+'%7B:=7!8E8.O2J1Q3K+#JC"G.K4=77W5&E&;:BHRE*:7)"G&524E
M3BY*,.GBH5*E'X*%*O6J.?[KV5/"PG4Q#J*KR.FZ,:<^>$^6<91<.7G]TX_5
M[#]FO0-&\/ZWK'BG]KS38O$[:U_8^CW7Q._X*$1^,'M?#FS^W=6O_ ?_  E'
M_"2:)H%BLUN\^KZEI5I8(EW;N;G9<Q-),^6E45*=2G'EHQQ$ZCJ4_84*,YJG
M&IBL1S>PPB<W:V*J49*TFTE";BXPG*E4K0I5)0I5H89)4YN=7$5*4ZT*.&I*
M/M<54E2I5)1AAH56_9SC;FC)*S=Z3^S#9>)-&\*R?$G]HN?4-=A\,366H:?^
MT-^VOJOA*W'C0[?!\.L^.]+^(EQX:\.7FM,8ET^UU;5K*:[:YMU@C=KF$2:T
ML/6JXK%X*%.4<5@JM;#U:<_W;^L8:BL1B,/2=3EC7Q%##M5ZM"@ZE6G2_>3@
MH)LQ56D\'A\="I&IA<306*IRIM5']5<_9+%3IPYJE+#.HI0^L5(0H\T*BY_W
M53EU?B%X._9X^%MSI=GXR\<?M*VEUJ]IJ.I6UMHG[0/[;/C":VT?1C:KJ^OZ
MS'X-^(FJMX>\-V)O;07.L:H+.P@\]/-N$S7/"<9U9T5)1=&-*52<W[.A15:<
MJ='VV(J<N'HNM.%2-)5:L'4]G4Y%)4YN._LYJ%.2BY.M.5.E3A[]>M.$.><*
M&'AS5Z\H1<7-4:<^5SIJ5I5*:E1ET#]FB#QI;> 3\0_VC9=?N;C1;);BU_:&
M_;7O?"=OJ?B.Q34O#^C:AX_M/B+)X7TK7M2T^6WN+32[S6(+RXCN[9HH&%S#
MYFU*C4K5:U&$'&K0GB:;C->R<ZF#@ZF+IT/:\GUF>%IJ<Z\,/[65&%*M*:BJ
M-7DPK5J>'P^%Q52:6'QE.A6I3C[Z]CB:\L+AJU3DYG1HU\3%T*-6LJ=.I6Y:
M<).<HI^G_L_6$F@:_P#M&>$(=;\8:UHG@_XX:5I/AI?&OCGQE\0M5TC2M1_9
MY^ GBN[TRW\1>/-=UC5FT]O$7B/7;Y+>6^>.*35)_*5%;:,S0^CZ "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^?_#G_ "=/
M\9/^R ?LT_\ JQ?VL: /H"@ H ^?_P!FG_DG7B/_ +. _:Q_]:G^,E 'T!0
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MN'H93B,'C</S5.?FC/'5OK6'A3K82@Z?NXFC4KTJ-:'0:'^QO\2])^(OP_\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 ?/_AS_DZ?XR?]D _9I_\ 5B_M8T ?0% !0!\_
M_LT_\DZ\1_\ 9P'[6/\ ZU/\9* /H"@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@#Y@_:-\6>%? WB?]ESQ3XU\2^'_  ?X8TOX_P"M?VEXC\4Z
MSIWA_0M.^V_LR_M':=9?;M7U:YM[2S\_4+NTM8O-E3S)KF*),O(JDV\@V\C?
M_P"&L?V6/^CEO@!_X>3X=?\ S1T '_#6/[+'_1RWP _\/)\.O_FCH /^&L?V
M6/\ HY;X ?\ AY/AU_\ -'0 ?\-8_LL?]'+? #_P\GPZ_P#FCH /^&L?V6/^
MCEO@!_X>3X=?_-'0 ?\ #6/[+'_1RWP _P##R?#K_P":.@ _X:Q_98_Z.6^
M'_AY/AU_\T= !_PUC^RQ_P!'+? #_P /)\.O_FCH /\ AK']EC_HY;X ?^'D
M^'7_ ,T= !_PUC^RQ_T<M\ /_#R?#K_YHZ #_AK']EC_ *.6^ '_ (>3X=?_
M #1T '_#6/[+'_1RWP _\/)\.O\ YHZ ,#]G+Q9X5\<>)_VHO%/@KQ+X?\7^
M&-4^/^B_V9XC\+:SIWB#0M1^P_LR_LXZ=>?8=7TFYGM+O[/J%I=VLOE2OY<U
MK+$^'C90 ?3] !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * /G_ ,.?\G3_ !D_[(!^S3_Z
ML7]K&@#Z H * /G_ /9I_P"2=>(_^S@/VL?_ %J?XR4 ?0% !0 4 % 'S_\
M!O\ Y*+^UC_V<!X<_P#66/V:: #]K'_DUC]I;_L@'QD_]5UXCH ]_.0IVXR
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MPY\8/%<GQ)L/"'B_4_!'Q-T?X96?PRO[6;P%86/Q. TBVNKGQOK.B7-\=?\
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MRI4HMTZ-+V=&FU"FHQ]>J38* "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H ^?\ PY_R=/\ &3_L@'[-/_JQ?VL: /H"@ H ^?\ ]FG_ ))U
MXC_[. _:Q_\ 6I_C)0!] 4 % !0 4 ?/^H? O5AXO\=>+?"/QV^,'PZ_X6)X
M@TWQ3XA\/>%M.^!VIZ%_;NF>"?"/@!+ZQ?Q_\%_$FJVWG>'_  1H(EA.J20^
M=#++%'%YS+1L&Q@>+/V<O%'CCPKXE\%>*?VHOV@-4\,>+_#^L^%O$>F?V+^S
M+8_VCH7B#3KG2=7L?MNG?LXV]W9^?I]W<1>=:SPS1^9OBD1U5@ ?3] !0 4
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M'+? #_P\GPZ_^:.@ _X:Q_98_P"CEO@!_P"'D^'7_P T= !_PUC^RQ_T<M\
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M.6^ '_AY/AU_\T= !_PUC^RQ_P!'+? #_P /)\.O_FCH /\ AK']EC_HY;X
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * /G_P#9._Y-8_9I_P"R ?!O_P!5UX<H ^@* /G_ ,.?\G3_
M !D_[(!^S3_ZL7]K&@#Z H * /G_ /9I_P"2=>(_^S@/VL?_ %J?XR4 ?0%
M!0 4 % !0 4 ?/\ \&_^2B_M8_\ 9P'AS_UEC]FF@#Z H * "@ H * "@ H
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MPZ_Z&/\ : _\2Q_:G_\ GR4 '_#-/PZ_Z&/]H#_Q+']J?_Y\E !_PS3\.O\
MH8_V@/\ Q+']J?\ ^?)0 ?\ #-/PZ_Z&/]H#_P 2Q_:G_P#GR4 '_#-/PZ_Z
M&/\ : _\2Q_:G_\ GR4 '_#-/PZ_Z&/]H#_Q+']J?_Y\E !_PS3\.O\ H8_V
M@/\ Q+']J?\ ^?)0 ?\ #-/PZ_Z&/]H#_P 2Q_:G_P#GR4 '_#-/PZ_Z&/\
M: _\2Q_:G_\ GR4 '_#-/PZ_Z&/]H#_Q+']J?_Y\E !_PS3\.O\ H8_V@/\
MQ+']J?\ ^?)0 ?\ #-/PZ_Z&/]H#_P 2Q_:G_P#GR4 '_#-/PZ_Z&/\ : _\
M2Q_:G_\ GR4 '_#-/PZ_Z&/]H#_Q+']J?_Y\E !_PS3\.O\ H8_V@/\ Q+']
MJ?\ ^?)0 ?\ #-/PZ_Z&/]H#_P 2Q_:G_P#GR4 '_#-/PZ_Z&/\ : _\2Q_:
MG_\ GR4 '_#-/PZ_Z&/]H#_Q+']J?_Y\E !_PS3\.O\ H8_V@/\ Q+']J?\
M^?)0 ?\ #-/PZ_Z&/]H#_P 2Q_:G_P#GR4 '_#-/PZ_Z&/\ : _\2Q_:G_\
MGR4 '_#-/PZ_Z&/]H#_Q+']J?_Y\E !_PS3\.O\ H8_V@/\ Q+']J?\ ^?)0
M ?\ #-/PZ_Z&/]H#_P 2Q_:G_P#GR4 '_#-/PZ_Z&/\ : _\2Q_:G_\ GR4
M'_#-/PZ_Z&/]H#_Q+']J?_Y\E !_PS3\.O\ H8_V@/\ Q+']J?\ ^?)0 ?\
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MED=V9B;?(-OD=!0!\_\ AS_DZ?XR?]D _9I_]6+^UC0!] 4 % 'S_P#LT_\
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M#@88N,J-7%1CQ6KXE5L15K?4L?0H225*,98=U,7F&7O%4J#<9.5/ X##XN&
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M2Q^:SM&-%5Z^'>+EBZ<HTN6E"V9*I'#8>C/%4</@</EM",Z=*688B-/UVT^
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M9/#WQ$T[6?$O@35]:OO"OPW\(:MI<WC#X@0->W\/@2Q\4>+?LTES,7N?$U[
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M0 4 % !0 4 ?/_AS_DZ?XR?]D _9I_\ 5B_M8T ?0% !0!\__LT_\DZ\1_\
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M6?@W6M5\#Z1I7@[78-<^(-Q*+>TO[_PCH)O19^*M7\(74_AS4-7UVUMOB!+
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MXUYX>$85(U->L/[36G^'M'T^^\0^&O$VJ:;+I'BR.U\8Z98Z+96/B_Q)\/\
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MGCE]8<ISG.E4DFHTK=3HOP3^$_@N]T+4(K:\_MG3B-/T'6/$WC+Q)KFMHO\
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MA%*C.K.@Y4U6E!U::J573G"5:JYZ]E^PWIEBMMY?[1O[1EW+:7TNI)=ZO<?
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MJZ]XE?5-*%GJDMWI,U@-)M4D$T6G11W>U">&PU?!^P52%#*,3E$\)4DU*O+
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M*_O-%,E_::*=8@C>R35IOLS2B%)+F/2K2='^TK3A567XBIA4Z<XR]KB(8_\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'S
M_P"'/^3I_C)_V0#]FG_U8O[6- 'T!0 4 ?/_ .S3_P DZ\1_]G ?M8_^M3_&
M2@#Z H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@#Y_\.?\ )T_QD_[(!^S3_P"K%_:QH ^@* "@#P_5
MOV9/V;=>U74]=UW]GSX'ZSK>LZA>:MK&L:M\)_ >HZKJNJZC<R7FH:GJ>H7F
M@23WVH75W--/-<3R/)+)*[NS,Q) ,_\ X9._98_Z-I^ '_AF_AU_\SE !_PR
M=^RQ_P!&T_ #_P ,W\.O_F<H /\ AD[]EC_HVGX ?^&;^'7_ ,SE !_PR=^R
MQ_T;3\ /_#-_#K_YG* #_AD[]EC_ *-I^ '_ (9OX=?_ #.4 '_#)W[+'_1M
M/P _\,W\.O\ YG* #_AD[]EC_HVGX ?^&;^'7_S.4 '_  R=^RQ_T;3\ /\
MPS?PZ_\ F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\,G?LL?\ 1M/P _\ #-_#
MK_YG* #_ (9._98_Z-I^ '_AF_AU_P#,Y0 ?\,G?LL?]&T_ #_PS?PZ_^9R@
M _X9._98_P"C:?@!_P"&;^'7_P SE !_PR=^RQ_T;3\ /_#-_#K_ .9R@ _X
M9._98_Z-I^ '_AF_AU_\SE !_P ,G?LL?]&T_ #_ ,,W\.O_ )G* #_AD[]E
MC_HVGX ?^&;^'7_S.4 '_#)W[+'_ $;3\ /_  S?PZ_^9R@ _P"&3OV6/^C:
M?@!_X9OX=?\ S.4 '_#)W[+'_1M/P _\,W\.O_F<H /^&3OV6/\ HVGX ?\
MAF_AU_\ ,Y0 ?\,G?LL?]&T_ #_PS?PZ_P#F<H /^&3OV6/^C:?@!_X9OX=?
M_,Y0 ?\ #)W[+'_1M/P _P##-_#K_P"9R@ _X9._98_Z-I^ '_AF_AU_\SE
M!_PR=^RQ_P!&T_ #_P ,W\.O_F<H /\ AD[]EC_HVGX ?^&;^'7_ ,SE !_P
MR=^RQ_T;3\ /_#-_#K_YG* #_AD[]EC_ *-I^ '_ (9OX=?_ #.4 '_#)W[+
M'_1M/P _\,W\.O\ YG* #_AD[]EC_HVGX ?^&;^'7_S.4 '_  R=^RQ_T;3\
M /\ PS?PZ_\ F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\,G?LL?\ 1M/P _\
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M3OV6/^C:?@!_X9OX=?\ S.4 '_#)W[+'_1M/P _\,W\.O_F<H /^&3OV6/\
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M^RQ_T;3\ /\ PS?PZ_\ F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\,G?LL?\
M1M/P _\ #-_#K_YG* #_ (9._98_Z-I^ '_AF_AU_P#,Y0 ?\,G?LL?]&T_
M#_PS?PZ_^9R@#T#P+\)_A9\+O[4_X5G\-/A_\.O[<^P_VW_P@O@WP[X1_MC^
IS/M?]F_VI_8&FVG]H?9/[0O_ "//\SROMMQY>WSGW&WD&WD>@4 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>162
<FILENAME>g20922ndsp8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922ndsp8.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /W\H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M]/\ ^3#Z_A/^?O\ Y+/_ .1#_AK.\_Z-J^/_ /X,/V</_HAJ/[*Q_P#SX_\
M)Z?_ ,F'U_"?\_?_ "6?_P B'_#6=Y_T;5\?_P#P8?LX?_1#4?V5C_\ GQ_Y
M/3_^3#Z_A/\ G[_Y+/\ ^1#_ (:SO/\ HVKX_P#_ (,/V</_ *(:C^RL?_SX
M_P#)Z?\ \F'U_"?\_?\ R6?_ ,B'_#6=Y_T;5\?_ /P8?LX?_1#4?V5C_P#G
MQ_Y/3_\ DP^OX3_G[_Y+/_Y$/^&L[S_HVKX__P#@P_9P_P#HAJ/[*Q__ #X_
M\GI__)A]?PG_ #]_\EG_ /(A_P -9WG_ $;5\?\ _P &'[.'_P!$-1_96/\
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M .?'_D]/_P"3#Z_A/^?O_DL__D0_X:SO/^C:OC__ .##]G#_ .B&H_LK'_\
M/C_R>G_\F'U_"?\ /W_R6?\ \B'_  UG>?\ 1M7Q_P#_  8?LX?_ $0U']E8
M_P#Y\?\ D]/_ .3#Z_A/^?O_ )+/_P"1#_AK.\_Z-J^/_P#X,/V</_HAJ/[*
MQ_\ SX_\GI__ "8?7\)_S]_\EG_\B'_#6=Y_T;5\?_\ P8?LX?\ T0U']E8_
M_GQ_Y/3_ /DP^OX3_G[_ .2S_P#D0_X:SO/^C:OC_P#^##]G#_Z(:C^RL?\
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M_96/_P"?'_D]/_Y,/K^$_P"?O_DL_P#Y$/\ AK.\_P"C:OC_ /\ @P_9P_\
MHAJ/[*Q__/C_ ,GI_P#R8?7\)_S]_P#)9_\ R(?\-9WG_1M7Q_\ _!A^SA_]
M$-1_96/_ .?'_D]/_P"3#Z_A/^?O_DL__D0_X:SO/^C:OC__ .##]G#_ .B&
MH_LK'_\ /C_R>G_\F'U_"?\ /W_R6?\ \B'_  UG>?\ 1M7Q_P#_  8?LX?_
M $0U']E8_P#Y\?\ D]/_ .3#Z_A/^?O_ )+/_P"1#_AK.\_Z-J^/_P#X,/V<
M/_HAJ/[*Q_\ SX_\GI__ "8?7\)_S]_\EG_\B'_#6=Y_T;5\?_\ P8?LX?\
MT0U']E8__GQ_Y/3_ /DP^OX3_G[_ .2S_P#D0_X:SO/^C:OC_P#^##]G#_Z(
M:C^RL?\ \^/_ ">G_P#)A]?PG_/W_P EG_\ (A_PUG>?]&U?'_\ \&'[.'_T
M0U']E8__ )\?^3T__DP^OX3_ )^_^2S_ /D0_P"&L[S_ *-J^/\ _P"##]G#
M_P"B&H_LK'_\^/\ R>G_ /)A]?PG_/W_ ,EG_P#(A_PUG>?]&U?'_P#\&'[.
M'_T0U']E8_\ Y\?^3T__ ),/K^$_Y^_^2S_^1#_AK.\_Z-J^/_\ X,/V</\
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M'[.'_P!$-1_96/\ ^?'_ )/3_P#DP^OX3_G[_P"2S_\ D0_X:SO/^C:OC_\
M^##]G#_Z(:C^RL?_ ,^/_)Z?_P F'U_"?\_?_)9__(A_PUG>?]&U?'__ ,&'
M[.'_ -$-1_96/_Y\?^3T_P#Y,/K^$_Y^_P#DL_\ Y$/^&L[S_HVKX_\ _@P_
M9P_^B&H_LK'_ //C_P GI_\ R8?7\)_S]_\ )9__ "(?\-9WG_1M7Q__ /!A
M^SA_]$-1_96/_P"?'_D]/_Y,/K^$_P"?O_DL_P#Y$/\ AK.\_P"C:OC_ /\
M@P_9P_\ HAJ/[*Q__/C_ ,GI_P#R8?7\)_S]_P#)9_\ R(?\-9WG_1M7Q_\
M_!A^SA_]$-1_96/_ .?'_D]/_P"3#Z_A/^?O_DL__D0_X:SO/^C:OC__ .##
M]G#_ .B&H_LK'_\ /C_R>G_\F'U_"?\ /W_R6?\ \B'_  UG>?\ 1M7Q_P#_
M  8?LX?_ $0U']E8_P#Y\?\ D]/_ .3#Z_A/^?O_ )+/_P"1#_AK.\_Z-J^/
M_P#X,/V</_HAJ/[*Q_\ SX_\GI__ "8?7\)_S]_\EG_\B'_#6=Y_T;5\?_\
MP8?LX?\ T0U']E8__GQ_Y/3_ /DP^OX3_G[_ .2S_P#D0_X:SO/^C:OC_P#^
M##]G#_Z(:C^RL?\ \^/_ ">G_P#)A]?PG_/W_P EG_\ (A_PUG>?]&U?'_\
M\&'[.'_T0U']E8__ )\?^3T__DP^OX3_ )^_^2S_ /D0_P"&L[S_ *-J^/\
M_P"##]G#_P"B&H_LK'_\^/\ R>G_ /)A]?PG_/W_ ,EG_P#(A_PUG>?]&U?'
M_P#\&'[.'_T0U']E8_\ Y\?^3T__ ),/K^$_Y^_^2S_^1#_AK.\_Z-J^/_\
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M'++7/@1\</#%CXC\8>"_!46O:M/\"[O2M,U7QYXLT7P5H-QJ<'AOXWZIJ?\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0!Y[\1O\ CS\ ?]E__9A_]:/^%=>=FO\ N%?_ +<_
M].0.S+_][I?]O?\ I$C].J^./I H * /@/XF_P#)T_CW_L@'P#_]6+^TU7T.
M0_\ ,5_W"_\ <AX^;?\ ,/\ ]O\ _MA)7T)XYY#X\^#6A^/]9.M7NO\ BG0Y
M[CPS>>$-6@\/W&A11:OH-X]U(;62YU;0-0OM&N(Y+VZ*WFA7>DW+B79/+-''
M&D?G5\MH8E8^%24U3S&E3I5X1<$G[&-6-*2ER.HN55IITG-X:JG:M0J)R4NV
MACZN&6#]G3INI@*\L10J2BW*$IO#NI%Q<O9SC-X6BTYPE4I.'-0J4I2E)WO#
M'P];0?$UIJ]Q>"\LO#/@31_A]X1\YXY=373('M[K7-3U>2"PM($U"_N=/T6(
MQ6L?E*FCK*-IN3#;^HZM2IB,WQ=6T:^:XBE4G&#?LH4<-&M*A&*E[RFZ^-QL
MZEY27(Z$4[TY.7G0HTJ&%RO!4>;V&64ZR3F_>=2K[*GJD^24:.'PU*-*;BJG
M-7Q*DN7EE+U"H-#B;OP#H%_XHUGQ3?I<7T^O>#;;P+J>E71M9=%N-#M]0U34
M"K6C6OFM<32:M=12EYVC:((HB5@S/RRP="=+,Z-6/M*6:^P]M&73ZM3K4H>S
M:LXW5>3DVY24HPE!PL[]"Q5:']G^SE[*>5U,35HSCI+GQ7U-S<FVT^1X&C[.
MRC;FJ<W/>/)XQIW[*?@71M)M=#T?Q1\0--TZ#2/$WA^]2/5/#]W>:IH?B?6M
M7UVXT^XU;5/#%U?Z:UK>:W?I!>Z/=:9?20F..\NKORU(SQ.!IXNC4H5ZE25.
MO@L)@JJ]Q2JQP=*I1HUIS4.?VKC5G*K34HX2M*4O:8:492B]XYC5AB(8F%*E
M&M1Q;Q=%J#Y:$I0PE.5&G3<G3]AR8'#*FIQG4H>S_P!GJ46VSO=#^"OAC0=/
MM].M]3\17*6WB_POXU$]Y<Z4;B75O"7AW0O#.GQ2_9='@B^PRV/A^SDGC2)'
M::6=HY(D9(X_1K3=;$X/%22C4P5?,\134;\KGFO]H_65--MN,/[3Q'L4I1<>
M2CSNIRS]IY:HQCAGA$VJ3PV7X5/3F5++:^'Q&'L[6YG+#4XU&T^:#ERJ,FIJ
M"7X)Z/#='4_#_BWQKX1UUM4\6W\^O:!=>''O[BS\::ZWB+6M!GM]=\,ZEI\F
ME+J91[:3[$+ZU$8\F\5I)6EX:>$C1ITJ-*K4IT8T:5"K&+C%XFE0JXJM156H
MHJK3E3EC,2H5<+/#U5&HUS]3OKXN6(G.K5HTI5?W7LIN+;P\J6#PF!YJ2<G&
M7M:."H.M2KJM0J5(*;I)PIJ'5>(/A[I?B'PWH_AZ35?$5A/X<GTV^\/>*+;4
MUOO%>D:MI5O):VFLIJGB"VU*/4M1:WFN8YVU.WOH[E+N=;B.596!WQ$'7Q%+
M%0F\+B*$JDH2HQII1C5ISHU:7LYPG2=*I2G*$HR@[>[.+C4A"<<*51TZ>(HR
M7M:6*BHU8R<HJ?+6IXF#_=2IN'L\12I581IN$(N$8*/LKTWS_AGX,>&O#'B+
M2_%L.J>(M4\26$7BPZCJ^KW6F2W'B74/&1\-C5M7UU+'2+6'[:D/A32+>VBT
MZ+3[2W@A,26VQ8Q%5",,+&=.A'DI2H+#J#E.:C'ZY6QTYJ4Y2FZE7$XBM4J2
MG.2?/:,8I*UU:]2M2G2J6ESXFABG*R4E+#82M@J-**C:$:,*%:245'G<TIRF
MY.IS\MJ'P-D\1?$'X@>(]?\ $VLV_A/QD/!T-SX1T34+2/3O$MEX;TUH)K'Q
M;#?:!+<VUN;XY7^Q=3LWN8'>&\>2$^17)@<*\,Z\JTW5OFT\RHTKKV,)PP^6
MPPU:5HPJNO2KX*<W2<YX625"52G5E&T#$UO;*G3A3C!1RWZA.K9JO:IBLQJ8
MF$7=T_95*&+I0C.4/;TIJM[&5'F<ZO367P;TO3WOK6T\7^.X/"UU_P ) ]GX
M&AU;2K?POI%QXFBOX]5GL_LVAQZK?0&34[Z>#3]6U34M.MII4DM[.,V\'DS4
MP%.ME^)RRM6J5,/7P?U"GS.'-AL*J<:4:=&U-0E*%.$(4ZV(A7KTX1Y(5%"=
M2,](8J5'$T<51HTJ%2G6AB*BA"T:]>%1554J7;=-RG&]6.%EAX5VYRK1G*<Y
M.+Q#\%=(\1:7IGA^X\7>.;3PQ:>'=)\+:QX7M=1T2?0_%.CZ,%6TCU:VU;P]
M>R:7>N@=9[[P[-H=U.KJLLS+!;B#T*LI5\QEF-63E)XN&.5%V]E#%4YJI2J0
ME;ZQ&,*D835%5_83E&]2E/GJ^TY,-_L>7T<!AU[/ZO1>'AB%I7]C.FJ4X2M:
MC-R@K*<Z,JE)N3H3I7,W4?V??">IRWMO<Z]XP'ABXO\ 7M;LO \5_HT?A?1?
M$OB.WU&'4_$>FJ- _M22^\W5]2NXK6^U.]TZ&ZNVN(K)9%1D\VMEM'$82K@Z
M]2I5@\/6PM"<G!U,'AZ].5&I3PTN2R_<SE0ISKQKU*.'D\/1G3HRE3?;2QM2
MA6I5J5*E"4:F#J55RMK$3P-6A6P[K7DW'EJ8:A.;H.BZTJ4957.;E*7H&B^
MM'T'5-%U:SN=2DN="\$VO@.S2YFM7@DTBSN+2YBN;E8K.-GU(O9Q!I$>.+#-
MB$$@KZ=2;J8S-,<[*KF\\-.M%?!%X66.G3]DM7%-YA6Y^:4[J-+E<>6;GY='
M#PH8?+<+!R=/*Z=>E2;MS2CB(X*$W4:23:6!H\O*H).52ZE>/)R&I_ _PWJV
MK^)+JZU[QE'X=\7SWM]XE\ V>L6MCX0UC5]1T0>'KW5;U;73$UB22;34B#V/
M]L#36G@BNFL3=1K,..&$C"C[#VM7V5.5:>'2GR?4ZE?$/&3JX=TU!NHL5*>(
MI3KNL\/5G*>']D[6]*.+G"K"O2ITZ>(2H1J55!.=:&&484H55/FBHJE"%"HZ
M4:<JV'@J%:52DY1E6M_@3H33"^USQ9XX\5ZS%?>#I[/6_$%]H#:A8:9X%\1V
MWBG1/#UI%I'ANPLAI;:M:J]W/):2:A=JW[^^=XH7AZ<.OJ]:&)5IXI59UJU:
M48J>(J/!XS P]JJ<80C"C1QV(=&EAX4*4*LY5.1RJ5?:<\Y*5&6&C"-+#*A7
MP]*E%.U"GB)X>=;V<YN564IO"8>-ZU2MRPI1C%)(?XP^"VDZ_P"'M?T^QO\
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MWQIXJU[PW=>(+N#4_$>HZ5*;V7Q%I=GI%VDVG:7HEAIVFVD-G80&&UT:STN
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M_(/^&/O@CZ?&#_Q)C]I;_P">Y1];Q?\ T%5?_!D__D@^KX?_ )\4_P#P"/\
MD'_#'WP1]/C!_P"),?M+?_/<H^MXO_H*J_\ @R?_ ,D'U?#_ //BG_X!'_(/
M^&/O@CZ?&#_Q)C]I;_Y[E'UO%_\ 055_\&3_ /D@^KX?_GQ3_P# (_Y!_P ,
M??!'T^,'_B3'[2W_ ,]RCZWB_P#H*J_^#)__ "0?5\/_ ,^*?_@$?\@_X8^^
M"/I\8/\ Q)C]I;_Y[E'UO%_]!57_ ,&3_P#D@^KX?_GQ3_\  (_Y!_PQ]\$?
M3XP?^),?M+?_ #W*/K>+_P"@JK_X,G_\D'U?#_\ /BG_ . 1_P @_P"&/O@C
MZ?&#_P 28_:6_P#GN4?6\7_T%5?_  9/_P"2#ZOA_P#GQ3_\ C_D'_#'WP1]
M/C!_XDQ^TM_\]RCZWB_^@JK_ .#)_P#R0?5\/_SXI_\ @$?\@_X8^^"/I\8/
M_$F/VEO_ )[E'UO%_P#055_\&3_^2#ZOA_\ GQ3_ / (_P"0?\,??!'T^,'_
M (DQ^TM_\]RCZWB_^@JK_P"#)_\ R0?5\/\ \^*?_@$?\@_X8^^"/I\8/_$F
M/VEO_GN4?6\7_P!!57_P9/\ ^2#ZOA_^?%/_ , C_D'_  Q]\$?3XP?^),?M
M+?\ SW*/K>+_ .@JK_X,G_\ )!]7P_\ SXI_^ 1_R#_AC[X(^GQ@_P#$F/VE
MO_GN4?6\7_T%5?\ P9/_ .2#ZOA_^?%/_P  C_D'_#'WP1]/C!_XDQ^TM_\
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M28_:6_\ GN4?6\7_ -!57_P9/_Y(/J^'_P"?%/\ \ C_ )!_PQ]\$?3XP?\
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MW_SW*/K>+_Z"JO\ X,G_ /)!]7P__/BG_P" 1_R#_AC[X(^GQ@_\28_:6_\
MGN4?6\7_ -!57_P9/_Y(/J^'_P"?%/\ \ C_ )!_PQ]\$?3XP?\ B3'[2W_S
MW*/K>+_Z"JO_ (,G_P#)!]7P_P#SXI_^ 1_R#_AC[X(^GQ@_\28_:6_^>Y1]
M;Q?_ $%5?_!D_P#Y(/J^'_Y\4_\ P"/^0?\ #'WP1]/C!_XDQ^TM_P#/<H^M
MXO\ Z"JO_@R?_P D'U?#_P#/BG_X!'_(/^&/O@CZ?&#_ ,28_:6_^>Y1];Q?
M_055_P#!D_\ Y(/J^'_Y\4__  "/^0?\,??!'T^,'_B3'[2W_P ]RCZWB_\
MH*J_^#)__)!]7P__ #XI_P#@$?\ (/\ AC[X(^GQ@_\ $F/VEO\ Y[E'UO%_
M]!57_P &3_\ D@^KX?\ Y\4__ (_Y!_PQ]\$?3XP?^),?M+?_/<H^MXO_H*J
M_P#@R?\ \D'U?#_\^*?_ (!'_(/^&/O@CZ?&#_Q)C]I;_P">Y1];Q?\ T%5?
M_!D__D@^KX?_ )\4_P#P"/\ D'_#'WP1]/C!_P"),?M+?_/<H^MXO_H*J_\
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M/_SXI_\ @$?\@_X8^^"/I\8/_$F/VEO_ )[E'UO%_P#055_\&3_^2#ZOA_\
MGQ3_ / (_P"0?\,??!'T^,'_ (DQ^TM_\]RCZWB_^@JK_P"#)_\ R0?5\/\
M\^*?_@$?\@_X8^^"/I\8/_$F/VEO_GN4?6\7_P!!57_P9/\ ^2#ZOA_^?%/_
M , C_D'_  Q]\$?3XP?^),?M+?\ SW*/K>+_ .@JK_X,G_\ )!]7P_\ SXI_
M^ 1_R#_AC[X(^GQ@_P#$F/VEO_GN4?6\7_T%5?\ P9/_ .2#ZOA_^?%/_P
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M)%M/!_\ :U_IEK>W$F@P:;(;OSKM76YNIY9JI2G0H+#4ISA3C/"34E*7M8O
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MD81NWRPC]F*LET2,8TZ<'.4(1C*H^:;22<I)**<FE[S44E=W=DELD=+6984
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'S
M_P#M+?\ ).O#G_9P'[)W_K4_P;H ^@* "@ H ^?_  Y_R=/\9/\ L@'[-/\
MZL7]K&@#Z H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@#Y__ &EO^2=>'/\ LX#]D[_UJ?X-
MT ?0% !0 4 ?/_AS_DZ?XR?]D _9I_\ 5B_M8T ?0% 'P'X>^'&H>/\ XJ>
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M/$VH^"]&^&%O:_#'6Y/!7PZO=1\':A!XPU#P=/?^,/%NN>/;S3[VSLO#^O\
MV&R&GFPO-/\ [0MEDGJM.G&GG&.PM.<:L,'G<<#[92G]3Q57,/[(PL:.&IP]
MOB4\BQE?$UJE>GBZ6(4I_58<U.M"CSX.G[:&299F,:;6.Q'#ZQE>,N1>S]G0
MS;&XC%3?/1P\,/F>7O 0P]-X/$T93IXFO5E0K4*=;H8/$?QQT+0O%FC>'=$\
M2-H/@OX6Z1X^T34H_AC9Z.OB2^O_ (9?V?:?#+PUX/M?"-O=?VQ_PL#3]6\0
M:M9+HJWMBE[I^EPP#[>+>R[,QHX>J\THMQPF$H9E6RC#QIM8R^$Q%7!+#X_D
M7UB-;+\IR_$UL/!4^:GBJV&IWG5IX;%TZTY36=6?#OUE3EB<7A<+CLTJ3B\.
M_K$,9F-;,8>UK5,-"AF&8SC@J<%5;A"A/%XBH\/B*V%Q3Y#5I_BKJ/B70]+T
M;3?B?#X?^%K:UK.D?#O2OA#I_A3X8W^F^!?AK=W?PUG77=5\!VUQJOB[6/&=
MUH]W:Z3H6K66FZ4--;3+W2H;ZR5I,*]:M*6<9E)SCF$<-G2P]2<WB?J6-JYB
MLII?5J=-SK8Y+),9B,54K5I8ZEC%*3P;E*%54JP<*6(639=CN65',<5D,L7B
M9*5.52E.-'.<?C,=S4^3#^RS3 2P3PT(8'&4:E2&)Q$W2K4:5;J+SXH_&G4;
M);J&U^,^A>$IO^$$\'R^)-.^"32_$2XU)/ NN>(_$/C?P]X'U?P5?2Z/_;?B
MF_\ #'AY[CQ)H+:3HTFE7KW-G:QN]PFF8*$99@Z%/V-\1G&)P-&A4A5<L/A(
MY;#+L!5KU%4HT8XKFS3&>VJ3=>M2H4,'3JTL;7A3CA@EB5A\KI5O8UZRP> 6
M.Q%5RI>RQ&)Q&,IXZNZ,'!XCZC'!X6E1PV#A?FS2>/FL7@<-",NQ^"_B#Q(?
M&?AM?BQ_PEY\>W_P<^'VFZ;=>(/!M[8RW^L:ROB;QCX]2?4?#WA#3?#EG>V'
MV3PYIVHQ6XLEM[C2[)9[>VDU.R2[ZZE&A2J9[0PM2E.K2QM.C5E2J-4<1A,I
MP6"ITL?AX5:M2;H8C,,XS'V;C.JKR]E"<O8RC#'G]K'*\1*A5AAE''U<-5Q,
M80Q</[5Q\O99=BJ5&/)2Q.%R_*,'6G&_/4C4KU6I0P]6J9FM?$KXE:W\<_$G
MASP5K?CP:-X$\6>"=-OO#EA\*GN? 6HZ%:Z!;>(OB1=ZW\4-3\'3VUSJDEAX
MBTZSTW0="U^UU=-2TJ&1[::PGG5O+PTY0P.(S*K1>*HQEG;C#6G)4</@)X7+
MX8:E:G6QF(>?X*M%SPZQ6'AAJ]:GB4JL*:P_9CJ,U5H87"8JC"O6H93=)JHZ
M.*KYI4J8M8N5Y4\+1_L&I0Q#5?V4I<V&EAZD)U)*MQVL:[^TUIOAWPC%<>+/
MBB/&/B[P9+XSTRS\/_"+POK6EV_Q%NQ:?V5\)?%FK1?#NYL?A_X"TZT<2ZIJ
M/B"?3]4OIIKG^S]=L39BP?OHT:6'S:&65:D,;#+9Y71J8J4E3PN84I5:M+.L
M?4JTW&G%4(T85<!A<%5IUN7$-^SS%*,:;=?#U*+QZHUJ.78NIF-J=.F_[2PN
M'C5C6RB%#"UZC?UW%4:U2AB)XRE4P>'E@Z,,3]2G4JXFKV7B_P 3?'"[B^,.
ME7&C^(H_#?A'4WT.SO8OA]:>*&\>V7C^W\)1VK>&= B\.ZG-XD\*^#=+UKQ(
M^H[-+NYKZZLH;9WGCL;Z"XY<+2I5:>5?7(1JPQ>9T\%4HUFDGA:>>UJE?%8I
M05L/3K93'!X#"UI3HTHRJYAC,3&E&GA,<34^N4%B?85HT,73RR>9X;$8>IS1
MHXFAD56E3P,8N+J3QE;/J%?'.FI.I2HK+J-%U5CZE##>/>-O$/Q^OO$EWXF\
M-^'_ (C7M_\ #*#XA7FA^"-2^&T_A_X7>%[^V\1:7\/?"]_X6U*S^&6H^)OB
M%XA7X7^*/$VOM-H\WB73YO)-KINB3W<,UG'%"==8:ICJF)?MLPPV6T,34J\_
MUFC+,<2L9FM/"484L1.*P-;*8X!XC%X/&2JU,91QZJQR^LXU-84Z$JM#+H1E
MA*5&IBJN'I4W#ZIBJ&6Y?B(Y=_:-?VV%I4WF..Q.!Q=#+X5L(L(L/5P^*]EC
M,%3Q#]VN+CXM-^RAKU[JWC#X@W_Q"U;0[V:Q\1^&O!=_:_$K0[36-2BB@CB\
M-#X.^'-1U'6=(L+B97FM_AOH&HSPVOF6^F6U[LEK?,J5*.)RG#0E*E2^N9;2
MQ=;#<OOX>IC:2Q%:RK8^-%K!S_?VQ$J<*T*E27U>BY4*667U:T'F.(C"E7JT
M:..JX.CBU:G]8P^ G["E-SIX:-6-;'TG.C&I3G3=.K2H3EC(1=2MQ^AZ3\</
M#_C>Z\8:'K7COQ'9W_B6\\,'1?%/A30M/G\9^"_A]\'-132?$/C757\$Z=<:
M)J^I_%!/] &D_P#"/6<BZW>-);W:31BRRJUZE' 9M.EAJ:QF*P^>YG#"1YOJ
M^'S"&88#*\#2P[A5G*=2O@,'1Q3I2K3IU,)S.A0A.E+$3JA2P53$8.%25:A"
MC'(LOCC/CK5Z-2>*S?&5,3&K!^RPF$PV98O \SI_6X9GA,/#$8ERK5,//K?@
M=XM^-\GPJ^(?CSXFW&O:_P")(+'4=0T;P(O@;Q%I.JZ+K>D:3>W%_H7AJ'6O
M@Y\/M4\0Z->7QL8M.ADT;7Y$>*6-?$>MK*LL=YG!0RN-+*9^VQU=UEAL35E%
M2Y:KI4,)];@XP4'1KQJUZM:K@<N_V:I#VF!@J3JU3*U/%YS1IX]4\#A$\)1Q
M%)<T:,)\TI8FM3KRJ5H\DJ4X4Y1I8['THU*,ITL3%5/8T^<N-9_:*\):9=Z?
MXE\5>/?$4.H7GPRT76_&OA;X3Z/J^O>#[_4_".O:AXUU'X=^$]"\#W4>KZ1)
MKT/A#3(KO6[+Q+;Z5>:WJ=W?R?8+![2STQ<L(YXFEAXUJ=.AF&;?5I1Y95L9
MAJ&$P%7+Z$ZE1/#86G5Q57'QAB:L(*=#!QPKQ$L5B*6,6&#>(=#ZUB/9PJO*
MLOQ#H3YYTJ>)KYI5PV*I\E+DQ4\1A<O@L35I1FY5:DZ56C@Z-)2P]7#T[5OV
MJM5\,>'9;3Q)X]TC4K;PU\+KMW\3?#3P:^N:UXH^('Q)U$:C8^-K2R\'6%A;
M:5X1^'8L$U^'08M%F\P[X[S39D9I]8T(K&THU:V'4%7P6"K0HRF\*E@LD6+S
MK'TJM1NM*..Q6(]CE$I36'AC\)&A*GB(2K8.;JVHT\=1C7J5*M".?UJ=5T;\
MR>/^J\-8>FZ2=.4V\+4>/?)-PP.,CC*LJ-.5#%4*^L^(OVIXM>\%>#M-\0^*
M['0]2\9>.;=OB;JWP[>]UR[ATKQC)I?AG3/%&@>$O@)KFAV7A*;2;2\N?M5[
M)\.VN[*]TV>#Q0)HIS><^62C5QF!6.I1ITZ6#P>(G2C-J&*A*OCJN(AB*DW2
MA0QW]G4\OIRA3Q>&>'S&MB.3+,5!+"8>LR53#X?,?JLX5I5JLJ-.I&$V\'.6
M7Y7[.>&A&56I6H0S*MF:;JX;'4JF&PL85,=AN:GBJWKG[0'B?XMZ=K6DZ%\.
M[KQSH\EQX9U+4O#=UX+^'-OXTL/%GQ!@NXH-*\(^._$.J^&=:TGX?>!EM3]I
MO;R[?0KF[2X*Z?K-M-9/#=QE[53-?95X_N*=7+>6%5^SPT\+5KUXYK7K5TH3
M=7"4(4'AZ%"M3KRG5E)8?&*U.GT3]E1PE&I54ITI_6XXJ>'2GCJ,J=/#2P4<
M#AYU/9RJ8N<\5"57%4JV#H^QIQQ%7"QJ*N^-T'PMK45K^U-\=+#5_%'B'QYJ
MZ>.?!_@*72O#G@>_\3>'-+^'6FRZ.GA_P'>0> )M4NHIO'FEZNT&F7[ZU:RR
M6MG,UE-?R7<]]SUE*APW1PN'G6PU;.*T\;B,1RU)5W3JX^OA\OJU:>$CS5:-
M'*/J^(C[*B\53A7Q'U2K3=2+73@H.OQ'EM+-:>'IT,IIY=AE!S_V9?6\!@,?
MCJ_-5E%T9SQ.)JTZC]LHU%1IQQ$I4:6'H87G/!GASXQ6/B;P[XDTCQK\6-9M
M-+_X4C\-EN_'G@>VM=;\>>&[:QU;QSX]UOQM)KWP_P!/O=%TZ+3O%8TJ.]MK
M+0=0&L>&X+?5;^ZNUGM9?6Q%2-'%XZ7U.A*.-Q><3]E1JT?9_5\OR6=#*ZLZ
ME"7+'$5\ZHU9T:5*I'!NACJM6AA'AZU&6'\1QQD\KP$56_VG"87#8ESE%>TI
MXO-,]P^'S/"0A."E+#X;+<+1K.$O;UXT8PJ0K4>2M4Q'I'[-OB;XZ>*9/'WB
M;XNRZGI?E3)967PVN?"NMZ=;>&M3M'NIYO\ A&=>USX/^"I=;TZ6U>"UD%MJ
M_P 0[)[BT^T6?B(PW MD\^L_JF0QKP?U_'.DZJE",H575IT9.O0]A)TZKI5*
MSIO!QK9?@Z]*/M*52KCW:M#TL127]NU<+1JQI8&E4K4X3NI4JE"=>$,%7]I'
MVL(U8T*=2IBE'%SYI5X7PF7NE[*?!^$]0^/FIZ7X6U30Y/$O@C3HW^#EYK'A
M2+X4:3X;_P"$@\7^//&VJZY\9KGQ#;^(/ 4%[IV@:?H.LXN[BQ@TJ\EU&P^T
MOJ$4DMR=2[:4*-#%4:-6O]=P^&K3P%)R_=TIX'+^&Z&(IXOW)1E1EC<;S8?!
M4>:C0PF*A]4GAZL;8.CCC*\)K,53HUJ51QQ^(AB+QJXAU:^;5<ORC \MZE&I
M' 4<'1ECL1?$.ME.+^LT:W+3H8TX[6=3^+_BS7O$/BO6K;XLW</AWPIXNTL^
M#M1^#$+>"?"GB+Q?XTT3P+%_P@^F7/P[GUWXHS:1\/G\27VHW\EUXETO4H-1
M,FF6Z6\LULG'E<:,J>%EBJ2JSS.?#6&K2Q+Y/]EQF*^N\081T8JG'"X6G7RW
M"855L9!5Z#<,3/&4\-*GB)WF,IQJ5J&$:H5LK>?8[!UZ,I32Q&5Y9BJ.1UG4
MM4]MC,P_M-UZ5/"5J5.$J$\#4PM7%QJ^R]+US6_C'>:9X_T+4?#VN-X,\-^.
MK;X?06\_PWT_7T\>>$_'/COPXQU33?#%CX5U$ZAX%\(?##5[C2I)ETUEO+N+
M46OB8M)DN+C;".=:62XK%SY,7B<7&,X\_O4ZF5XC&U9XS%59.^%GG-?!X.EA
M*WM:$,%3Q%3&J4?:X.OAYJ3IX>684\L4\-1R_+'7HSITW":KU,DPM/#4,&I2
M@JLL+CZF+QF-PT*-6JW2PF"PJG*.+P$_.+_Q!\:M5\2ZMX^G3XQK)X&\.>)5
M@\+K\'(XO#'@GQ%KWCG0/"$<_P -=.D\!'Q%\4=5T/X=1^)M0N;R.^\166J+
M?(=%@19WMESRN<*<,/BL2IRJXY\.T:]2LY*I]6Q>(ECL_P )["DH2P^&6)RW
M!8/VV(IRQ6'YXXMXF.'E3K5#,*$:LJN686-+#_4%GV(P=6FXNBJV7Y9B<-D=
M24ZBG2J8C'K-/;4Z="M1PU+V$\#B,-4Q$*SH[_C_ .)W[0%[I?B6\T+3/C1X
M1M=;OOB1<_#NV\+?"72M<\8I<^$(/#6A^#?#VKC7/ WB/2_"?ASQ#>VWBKQ+
M)J7B2P^T3VMY!8V%Q;7*0VTCP]"I7_L[#U*\,)C9+".HY.$\+%9AG&.H59XN
MM>-/ER;+EELJ^&PM>G7Q$Z];$4Z]7#8:M-W.M1H5JM2=!U\JPZA[2K0YWC)T
MZ.68;'26%PE1QJ5<9F&+Q&*P5*<J<<)@UEU.ABJ%+$XSV\/H+X37EZOC;XG0
M>)+/Q5_PDUUK>FZ;!J^J>"?$VEZ/J?A[P7X/\(6*7MIXF;PY:>'KE;WQ!KNO
M7\%O87T@=KZ_CMT)TR]CLMTJ,\![7"T_JU.OCLQQ56A.K[]*=7'8C+\,H4ZD
M_;3B\LRG 3<E&5HSI5:DK8FC.KPPC6A6POUJ*EB*&79=@WB(6E]9<*-7,J]6
MHJ453H2IXS,L7A'3?+%2PRLHN:@OH&N4ZPH * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M1=2<ZLVE9RJ5)NI4J2?VIU)RE.<W>4IR<I-MMEVD,* "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M9%CO)T#!97#9B.O_ .&3OV6/^C:?@!_X9OX=?_,Y0 ?\,G?LL?\ 1M/P _\
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M-I^ '_AF_AU_\SE !_PR=^RQ_P!&T_ #_P ,W\.O_F<H /\ AD[]EC_HVGX
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M[E@MM"\%^(#HUU$MU-J-_ [6XZ(XJ.$Q<<91I<U;,'6IXF@X74*53"XJBO\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#Y_\ $?\ R=/\&_\
ML@'[2W_JQ?V3J /H"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H ^ /V^O^;*_P#L_P#_ &<?_=RH ^_Z "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@#Y__:Q_Y-8_:6_[(!\9/_5=>(Z /H"@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * /G_X-_P#)1?VL?^S@/#G_ *RQ
M^S30 ?M+?\DZ\.?]G ?LG?\ K4_P;H ^@* "@ H ^?\ PY_R=/\ &3_L@'[-
M/_JQ?VL: /H"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@#S_P =?"?X6?%#^R_^%E_#3X?_ !$_L+[=_8G_  G7@WP[XM_L?^T_L?\
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M*S*#_AD[]EC_ *-I^ '_ (9OX=?_ #.4 '_#)W[+'_1M/P _\,W\.O\ YG*
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M-I^ '_AF_AU_\SE !_PR=^RQ_P!&T_ #_P ,W\.O_F<H /\ AD[]EC_HVGX
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M$T_:T8R]UU:6G[VDG9SIZKWX7CJM=3K?^&3OV6/^C:?@!_X9OX=?_,Y2 /\
MAD[]EC_HVGX ?^&;^'7_ ,SE !_PR=^RQ_T;3\ /_#-_#K_YG* #_AD[]EC_
M *-I^ '_ (9OX=?_ #.4 >H>"OA[X!^&NE7&A?#GP/X/\ :)=ZA+JUUHW@KP
MSHOA72KG59[:TLY]3N-/T*RM;>;4)+2PL8'N'C,C1V<"%BL*!3;R#;R/+_VE
MO^2=>'/^S@/V3O\ UJ?X-T ?0% !0 4 ?/\ X<_Y.G^,G_9 /V:?_5B_M8T
M?0% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0!#<0_:+>>#=L\^&6'=C=L\Q&3=MR,XW9QD=.M<^+H?6L)BL+S>S
M^L4JE+FM?E]I!PYN6ZORWO:ZO:UUN:4:GL:U*K;F]E.,[7M?EDG:]G:]K7L[
M=CY0TW]E;2_!/PLT'P!\(]5\+?"W7X[3P[8?$#QKX6\ 'P_??%&VTC0;_1+^
M3Q+/X#\5^&/$5OJEQ-J5QJ=MJ5KXI6ZL[U4=I;N)[B&Z[<SJ+,*M2E&/U3**
MD\3)8"G*2I4?K$:<>?#*#IT:=:G&E3IIU,/6P]2DG3K86HE3=.E6<:^88[V<
M*N9XJK4JT<36BJTJ+GC?K:IU(S3=>BXN5"I#GI2<9<]*I1DD,^'O[*5AX"T[
MP;8-XLAUM_"-[\.KA;VZ\+K'=ZE;_#OPAXE\*6=M<3SZ]=2*]Q_PD<MYYSR3
M>2\<JA)#<M(F6)<L5*M*7+!UYYA4DH148*689!@,BFHPC:,8P6"^L**TE&HL
M-[JI^VGA)7J8ZI>7-BX4()RE*<X>PXHQ7$O,ZDY2J592>(CA'*4N9RI+%RE*
M4O8Q\O\ $7[(^N^%OAQK5GX4UW4/&GBZW\$P^&O!D6EZ9HGA:ZTCQ=!%\';;
MPIXX_M37_%$MK96?AW6_A3I^MSP*EW.]O/+!;074]M'!J/5B,34Q3A0C4G@9
M8G%X"53&1FW+"T:&.S_$XRI*,5[2LL3A<]Q&#E3A[TW&TG&GB)SPW8YX:OG%
M?,\134<%+^VYU,#%*3KTLTC2_P!CI3:C3A4A[%1H5:L84HU'"K+V2I)2^E+#
MX'Z9I_A3X(>%+;59&L_@WK.FZX)M2LUU:[\37UCX-\3>&;BYOKF2XA\C4[G4
MO$LNL2WQ2=FG@8>6&G\V&,?.EBL9C:]&A#"4*V"QF PU&G%1A@\/B*5/#484
MDOAIX;"TEAXTUR\U)N'/&-T^+ RKT,MQF%Q4O;XS,I8>OB:_NQYL7#-L+G&)
MK<D(1A^_Q-":2BH*FZJFD_9J$OG77_V*?%'B/1O"GA;4OCE<S>%O!'AIM#\-
M:0?"&NQ16%Q=?##4_AKJDTNG67Q/M]!U+3Y1J4VKVR7NA7.J6=Q<7EO%K+6E
MV88QUE4Q]7'5Z4:TZG/3<9+FYL/-TING/VGM(JI&=&$(U</##QGAKTL12Q%3
M]^O76:.GF$L90H1H4:F8T\RJT8R:E*M2SYYS"*K14)<DJ4OJE2G5C6I.K3H8
MVE3HSI>QEZ'XN_9,TCQ=9>)M,N/%D^E6'B;Q'JFM3C1=$_LV^L[/4?@?8?!M
M-*L]0M=91X1"VGPZRMQ&L9^[:)'&R+>!U<1.;IU(^[6H1QCA)SJ?Q\3Q/@N)
M:=6;I3I56J=3!0PE14ZU*K5C)UZ>(P\XQB>(Z%-X;+L+)+V>"P^#PLVHP;J4
ML+@,VR^?(JD*E.G*K1S6;I^TIUZ=)TE&=.O"I**]2^!OPDF^$'A?4M'O]=3Q
M-K>N:[/K^N:]'=_$RY&I7C6&GZ3;2R#XK?%CXAZQ%-'I>E6%NP37_L["V5H[
M:')!JOB%5HX2A"'LZ>$A425J=N>M7JXBK).%*G-J=6K.=JTZ]12E+]ZTTD0I
M.%6I4<N;FC2IPOS7C2HQ:A!^][.\>:5G2I48V:CR6C&WM-<IL% !0 4 % !0
M 4 % !0 4 % !0 4 ?.5[^S1X!U#Q!\7O&E]HG@^[\?_ !-;4HM)\?7?@;1;
MGQAX(TW4OAOHWP\DTK3O$4TC:C=6(CTV^O3%#=Z?&XUB>W* %YIA?NLOA@<-
M_LKDZ_UFI3]QXM5LRJ9A&->,>7G5.]&BO:2J7^KTJB4>6$(=T<9_PHY5CJU/
MV]/*8X-4J,Y7C&>$KUJWM*;E&2I2J.M:\8-Q<>:\N:RXC7OV5]1O-$\/6'AK
MX@V7A3Q!HGCSQ_XP7Q[I_AWQ?8>,[*Q\?^))?$&H:-X>U'PE\5O#T$.U?L,$
M\7B.V\5:-J#:3927NA3) L ZJ&)5#'Y=BO9_[+@Z%*A6PT96CC%1Q$L2H5U-
M5*$J$ZDZO/3GAIUH.M5J8;$X>O/VJXYR<L%BL)9/V]++X1<]8T:F R7#Y/'$
MT^3V=>GB)1H.K"K1Q-&4*=2>%FZU-RE+3\;_  G\<>'?A#KNA^"I(?&_B;3O
MB[+\5O!MDFDZ583P-J'Q+_X6!/INJ6/B#QEINE^+[FQO-1U=DB?7/!D5]%%:
MVPO-,F0W[<SKU:57ARK&GS5,GH/!5)0BI1E0_LS&Y33G&A4K4G&2P>(I4ZL_
MK-25/$*IF%*C6C&&5SFO2CC5G,<35]S,*>#G"/-*G/V^ CEM2*G7A2KQ<:V*
MR]57#ZJH2I5/J-24%*6.AY#HW['WB?Q9\,OL_BOQ;_PK_P =Z[JE]K=R=+\.
MZ7>S>&+?Q!XN^,FH>)]%$&E^*)M.%WJO@CXQZSHCBRO[VWTVZA6YM[K5%BC9
M^V<\-AY9-AZ=L7@<NIX*CC*7-)TL?A:.49'@J^ <YT:-14)8S),-BHXCZO1G
M.,(06%PZ]U.GC,;*IF>,4883&XJI*KA*DJ=*;PN*H8RGB,'F'LKU(.HO9<TZ
M$JU64J>(JT:V+KRE5J5.QU#]B_2[SQ7XJU:+QE*?#6OW%[J6E^'-4;XG:J/#
MFK:JVF1:O]ETEOC)#X$N=(N-,T^2S$!\ 17P6X$DNIS-$-W'@YSPKHU)R=:O
MA\?0Q<*NG,Z-//:6?U\--U57<'6QE&"A5PDL+&DH0G.A7G[1U>3%X2GB:'U>
MG>A2> E@^6[2C4CD-;A_#XF*HNASRHX6LY3ABOK/M'*K3A.C"=/V/MFJ_!6W
MU3PGXI\*2:Y"MMXF^*ND_$R61]#2:"WCTSQIX9\7R:!)9-J2K=I<?\(ZUHUV
M7C ^W&4V[^5Y4LX*V#_L.Z]L\EK8NM%O3VDL1C,RQD&OB]E*A+,(J,ESMRPZ
MJ+D<TJ?;&2C5SNIR+ESC U,%R=*,9Y#0R/FVM425#ZQ[.T$U+V',E'VK\>\6
M?LH>)_$LL6G1?&2YTWP6/B'=?$N?PI%X9UV!/^$@?XLZK\3[;R[C0OB/I-GJ
M-FZ:G%I5Y;>(-,U^WF.E65_90Z;=1'>J2</[/Y[5'EF'HT*#:;:5/#RPM52A
M.4Z/)*G*52@X4H8G#UY.7UJK1MAUT8_%O%+'JC3CA99EAIX7$2NY2E!Y3@LM
MIRC.+I5(3IU,&Z\TI^QKT,16P=:E*_U@UM,_9.L-/T72]&_X2^/9IWACX'^&
MI+JT\+Q6-S,OP>\6>)/$][?0LNMR?9)]?'B.>W9<R_8VB:9FO?.,2]&*J4\5
M3JT)4G2HU:N8S<822<:>.X8_U;C2@^2T5AH?[33?*XM?[,H07[TC'8AXNK5K
M4X1H5)8W%XV/,O:*,L3Q!@\^4&E[-R5.IA/8.2<7.53V]H./LY=3^SQ^SRGP
M'MM<@E\43^+I[^RT#0=.U.[OOBC<ZA;>%O"L=_'H&E:C'\0/B]XSL!=6W]IW
MS%_#EAX6L2;EQ'ID48CCBVK8ZIB,/[*I%1JU<15Q=>4?AJ8BK3HTI3BZOM<6
MOW="G!K$8W$MJ$=5)-R\^&&IT*E)47)8;"TG1H0GR\\(2FIS3]C&AAGS.,7:
MGA*5FI-.TFCZ4KB.@* "@ H * "@ H * "@ H \T^*?@K7O'?AQ=%T'7?#&D
MN;ECJ.G>.?A_8?$SP1XDTR:UN+.ZT;Q/X5N-7T:[O+)EN/.C;3]<TN19K>+S
MGGMC-;3XU**J2CSPI5J/).$J5:GSQO)P<:L'&<'&M3490BY>THN%:JIT9S]E
M.EM1J^QUC*K1JQE&<*E"JJ4XRA=QC)RIU$Z3GR3FHQIUN:G#V5>E[W-\Q?\
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MGA\/0I8V-&-:%?Z3KG.@* "@ H * /G_ /:6_P"2=>'/^S@/V3O_ %J?X-T
M?0% !0 4 ?/_ (<_Y.G^,G_9 /V:?_5B_M8T ?0% !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MSON^KAJF'Q6)HTHQQ<?;4<'AKOV3K3S'-J.7Y1B+2E!4Y8^&'S#%4&ZM;"K
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* /G_P#:6_Y)UX<_[. _9._]:G^#= 'T!0 4 % 'S_X<_P"3I_C)_P!D _9I
M_P#5B_M8T ?0% '%Z3X"\.Z'XC;Q)I-JNGR)X9M?"ECI%C;Z?9:%I.FP:OJ.
MMW3Z98V=C$]M<WU]?QM=$S/&XTVT*11NLKSE*U"G6ITU95_JD9.[]VE@*-2A
M@Z$(IJ$*.&A6K*E%1O'VLH\WLXTX0*O+5>'E*$54PT\?44TO?J5,RJ82KBIU
M6V^:<ZN#IU'+24JDZLZCG*:<9;7X>^ ;+4=6UBR\#^$+35]=N-0N]<U2U\-:
M+;ZCK-UJMI:6&J7.K7T5DLVHW%Y8V%C;7$EP\C30V4$<A9(458]E3^KO">SC
M]5E"M3='E7LG#$556KP=.W(X5JR56M%JU2JE4FI229?M*GM8U^>7MX2H2C4N
M_:1EA:=2EAI*?Q*6'I5JU.@T[T:=6I"GRQG)-H^'?P_7Q!HWBP>!O!R^*O#F
MEG0_#WB8>&=%'B#0=%,1@.CZ-K(LOMFEZ7Y),?V2VFBBVG;LQQ6RJ3C6Q>(4
MY1KX]6Q-1-JIB%S*=J\_BK+G2E^\<O>2ENDS#V5+V.%PWLX_5\ [X:ERKV>'
M?+R7H0MRT7R>Y>FH^[[NVAS_ (>^#/PW\-^-?$_Q)M?"FA7?Q#\6:A<WFJ>.
MM0T/0IO%ZV=Q8Z;IB>'[3Q%%I<5_#X<@L=)L8XK SNG[MG<N[LQBA?#8+ZA2
M?+AY.M*LE:/UF5?%XC&.6)45&-:5.>)E2I.<6X8>G1IZ\G,]*MZV(^L592J2
MA['V,9R<X894,-3PR6%C)OV"G[.=>HH-*6(Q&(J:*KRK:\/?#+X;^$7:7PI\
M/O!'AB1]7U#7WD\/>$]!T5WU[5K9K+5=;9]-L(2VKWEF[P7%X3YTT3M'([(2
M*=VJ,,/>V'I4)X6%+_EW##5*E.M4PT8?#&A.K1HU9T4E3E4I4YN+E"+4SA"I
M5E7J0C.O*K&NZDDG-UH0K4H5G-WDZL:>(Q%.-1OGC"O6@FHU9J6,/@C\%U\.
M2>#A\(?A>OA&;61XBE\+#P!X4'AR7Q K^:NNR:&-)^Q/K(D^<7IA,X;G?FE'
M]W]1Y/<_LS_<^73ZIO\ [M:WL-W_  N7=]RZC=66.G5_>3S1MXR4_>>+;LV\
M4W=UV^6-_:\][+LCLH?"OA>WF^T0>&]!@N/[3MM:\^'1]/CF_MBRTF/0;/5O
M-2W#?VG!H<,6G1W6?-CM(DME<0J$%<\[P?,[T_;<CN[Q^L.4J_*_L^VE.<JU
MK>T<Y.?,Y.Z^PJ7_ "[C3I45#[*I4*OMZ-+EV5.C7_?4H6Y:=7]Y!*>I5OO
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MUDY/64E3BWU:I4J="DF]VJ5&E2HTUM"E3ITXVA"*6C2 * "@ H * "@ H *
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M /0G4 '_  D?[4__ $1OX ?^)+?$7_Z$Z@ _X2/]J?\ Z(W\ /\ Q);XB_\
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M@ _X2/\ :G_Z(W\ /_$EOB+_ /0G4 '_  D?[4__ $1OX ?^)+?$7_Z$Z@#
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M&FS^*-4UU=2FNX-,;PGJ'PZ\27'PW/Q(75M2\'>'?"E[XY\0:KX=BD^'8O\
M2=&LM2US^TXK62PM[N*SO%D@@[,SE1>*R"6/I2Q>&PCRI9HE46-J8B-"G3C6
MJ8ETH2CBZBFJ=7,:=#ZU'&^SQ,85,2Z]Y]6 5**SOZG!87ZSA<S661I1JX&G
MA\76RVI#"N@L5.G4PD5F$O:4G46$I8.I)>QI4<)0I(\,NO@UX=\7^*-#N?!_
MP*U#3/@3!\:/@7?>&_!/BCX2:EX9LM'U+3K;QS'\4O%=C\-?%/AFTOO!?ANZ
M@NO"%M>WESIVGVU]=:;-=E9%E%U=U@I5,/F&25\14MBL-CN):M"O[6,WALOG
MPS2_LZFJL)OZK!YYAIXC X23IU*&)^KSA2I59481X,TBL1@<RHX>E*4*^!R*
MGBJ;C*V)Q*XHPGM[TW'_ &JK2R2MB:6/Q,75C4P-6K1JU*E*G7M[M\;/@[IW
MQ'^,?B6_\1^ [CQ5HMA^S%K^G^'KBZT2[U+1K?QJ?%DU]I:Z8QMY+3_A,K3R
M+>[L&CS?6K8GM?+9MY^>Q'UFAEO&^*PD:D,TC')*N75:<9?6?;8?#\02G/!2
MBO:>TIU)X>%25#WTJT*4VHU^6?LT?93S+@W"UXTYY9&MG2QU.I&+P_LJM3AJ
MG2I8M27L_J]:G#%.-&M^ZJO#RJ<LI852I^$7?@GQ;>PWH\4?#KX@Z[^T!JM_
M\&]2^"7Q'B\'^))5\">'+/PE\.H?$UI>?$@V#Z=\.8[+7].\<S:_HNJ7^G7&
MM)?-#]CU$W<<"_4XUT%FM=96X86='.LRJ9M5NE0QV42S7$U:5*E+WH8_#5<E
MEA\#A,%0]I+#X^+Q2HX>WUT^>PJQDN',*L7+FG4X5IX?!4JE.4ZV%SS^S:U.
M4JU)QE4P^-_M25'%?7ZL*<88=0I2K_N)T5U_P:^"_B#P99? 3Q!X1\(MX'^(
M^J6OQMTSQQXK\0^"=<U,P0ZA<:_JWA6#XC6$&IZ'J&I:!!JRV4NFZ;<ZQIJ)
MY^RPE@^T$MYN#=2C'"X:C*.&P\N#\E5:$H/V4LRPKX7ISC.$9TT\RIX:6:4%
M*;E7HTXUX2A*EAYTEV8QRJXG$XFK3E6K?ZY9TX3@DIQRVLN*G2G3GR2Y<NKU
MHY7B*G(HT,56EAZSG[>O"LX?B/\ "GXC>*?BY:V_Q!T<>/+.[\4_LN-K_B#P
M9\/O%/A3P5J6F>'O$WQVO-9B&G7GBCQ.]M8Z;8:KH<6JB;7KJ+;J<1N%@AU"
M.&NG"+".IEL94%&C#-N(ZM6&)E3JP?M>!<'A:56494J<%A\3CH2P]"%2,XSK
M1>%]I6J1DGKFL\1'!3^KU&ZLL!@*,'14E5IWXQRBM5BI1E*4:]+"1KXOVE/V
M=2C1@\1%05%U2O\ \*RLO#/B5=(\8_"7Q-K_ , /#OC?XU6/A3P#H7P]UWQ1
MHV@^(=:F^'>H_#G6]%\$:%HURUCX?ME3QU;Z7K=K:IIVC7-Z9!<6(Q<1>9&4
MJN2*.)C7KY[++,3A\OKRE+VU!X?/>(J<Z+Q$Y)X/$U\L>2_5,16E2Y\!AW1I
M5XPK0I8C;E]GBLQC05*AET<UR^OBJ2IQ]C7PT^&LK]I.-"$&L;0AFTL;/'86
MC"M*KC:CJU*%6I1J2H\#X#\%_%#P#\)(/B%I'PK\<7?CKX2>&OV=?%?AWP;=
MZ)K=OXEUY-&\+^)/"WQ"\)6%N]F\^JZ\OA+Q'J]O)9QB9Q>?9?,&_9GU,56K
M4:M:>&G&K5QN;8[!5'3Y(4Y8?,>%^%\'A\3*,U%0P.&SO"87%5:EH1IQRW$1
M;BZ%6"F5"AC,ZSNE)RPF#JX-XC#5:L57<*^!XPXKS2G1C5<IIXG$X"I'"^TI
MU)U)4,TA-.=+$Q=3H=3^$7BW0-1\&CQ7X&\1>*?!R^ ?A'K'Q]TO1?#&L>)K
M;QE=:IXQ^,?BKXD:.NAZ=IMQ/XU$'C?Q3H^K7_AVS@N[JXL%\LV=RDJV]P2C
M@,-F.+POO8C)<OQ%#!8&56#K\T,#D%?+LLQE6E"$_:J-2G3YL1&G*&'QM:EB
MJGLO9NM2W>(K8W(:.)=.>&S?,JF=8V5&.(<:N$6-SCA+%U<&Z]2I2E",<JP^
M.P-&G*4?;X?"U,'0C*WLR]\,]"G^'?CWP_\ $33_ (5?%'0OA[!XT_:.\/:#
MX=LOAEXRN=9TRR\>)\*K[P1=/X5LM+FU/P[X4OO^$2U.VMY[FQMK'2U-M;7K
MZ>D#)!P1GBJ625\OQ*G7S''Y)C:46ZL:K^M8?BC/<7'#XC%*<Z2KUL)C*=>%
M>M65/$J+G3K5Y5Z+JY4OJU1YFL-".&P=+/\ (L8FJ$L/'ZG3X,H9=B*U#"RA
M2JU(T,;*-&=##T9UXR=1>PBJ%;D\5U3PGXQNOA=X)L#^SWXJT[XK>$?!'P9O
MM \4:A\+?B?XX\9Z=9Z??:7?^*H/ WB*T^R:'\']7TW??6E_86UZNL:C_9TD
MK:)J27%JR>I0C&'$.55:%:%.AA\[RBGC*D9>R=; 0PV5X6I5KXJM_$P%6'MZ
M=; 4EB*&'@L1]8C@Y8C&8FDN(?\ :\)Q34C%U99CA>*JN!A)^T]CCJN8Y[BL
M)3IX:BY*.-5L'B<+F;G256>(PBP^)Q/U*EA*GZ=? +2=5T?PYXYAU?3-1TJ:
M\^-/QEU:TAU.QNK":YTO5?B%KE]IFI017<4;RV-W9313P3J#'+%*CQLRL">*
ME[F59#2?NU*& C"I#[5.:Q.)ER36\9<LHNSL[23V:.C'3C4S7,*U-\U*K3RC
MDEK:7L^'\HHU$F^M.M3J4:BWA5IU*<DIPE%?%?B;P[_PE7@+X-:!_P ()X#^
M)?V_]N_]K5?^$(^)MY]@\$:WY'Q*_:XN?+UR[_X0WQ7Y*6_D_:H?^)!?YN+2
M!<19\^%X&E[3,ZK^K4:_L<HS*=ZKLZ-L3E<?;4?W52]9<W(E>E[E2H_:JW)/
MKI3]GD?$'[V=&_\ 94;TUJ^;.,"N27OPM"=^6;N[1;]R?POU_4-.\2_"O2/A
M=\/?"?@3X3?LMS_%[XQ3>&]>U?X#+X>\2Z?IVFVG@#Q'XDM=1M9/%'P9\-:2
M/&.KW_AFUT9#J?A;588[<C9-)/)"EOI&/UVM1P7]I5J%/!97F68*G*%/D>(P
M^(PM..%HNI4J*5&5'$RS#%2A##UI4\+7IP<%'ZP_-2CAL)F6/>!IUZD:F78:
M,U.5Z=/$XGV,\3B%%4I\M!S=##152K!8K%T9U8.E[2E/S6?6_B%H6M_&SXD^
M&?CE9^(F\$>'_@;+J5]X8\+^!Y?#'Q1O;>?6](UH:^)K?69-,MGM/.MS%X9U
M32)+>_CGE,IA46,>>73@_J,O8<N%SCC##8.6'O+ZO['-<LX.P\\9AIM_6?>C
MBH8K \^)KTE2C"%7ZXINL_,S&?U>IF_)5E+%Y-PIB\5[9NG[=5,KS+C#$8?!
M8B"@L.I4IX6IALS<</1JU9MNA'+Y0<"C?_&KXX^([[QG?W6F^+(/!=YXZ^,7
MPIO-&U6X_9XT?X;6OA[PW;>,M*TV_P##\EQXY@^*U[\1\:+9:G-:7&FW%I<V
MEQ=K::4L*P:B_B9DHU.%<5]9M-YOP_C\<YS:56A7A@JV(C2P=+".O"IAJ4H?
M4L9'%WQ%*MSXFM6P7L:F"/J*26&XAHPPJG)99F>1T8J"C&%2.*Q&70KU<9/$
M\BBIQQ56O@)82<(U5#"T(PQ-2M)EO0OBS\2--^'5_P"+-,\>KX8M?@S)\"_!
M&B_"J?1/"UWI7Q'T[Q5X*^&5W)<ZU>WFD7'B1=8U>Z\5ZE8Z(^A:IIL$4^D*
M;FVU#$\*_89UIG56N_\ ;9Y[Q#FN7U*$?=>6PHYOB\'[6FZ=Y/$X?"THYUB7
MBO:X>67U%%4:"MBSXS)^:EPM@:=&C4@\JX.P^;TZD6F\97IY55Q48-34XK"*
MMAXY;*-*,,0\3[5JO=TZ2]%^!OC_ .+^IWOP,U[QE\2;OQ;I_P 6Q\6-/U?P
MU<>&/!FD:5HA\(7FLWOAK4=$N=!\/6>J?VE]@TX6=]]MU&[M9P8Y(+6UD5VE
M\K!*,E0P]5>VG7X5RK.W6D[3CBZD>'Z>(A",.2FL/7_M>I5<)PG4A6IKV56G
M0?L(^GC:[AB*\Z*=&E2XKS3)(4;J4?JE!\12IRJ2E%U)5Z,\GI4Z4H3IQ>'J
M2C7A7Q"^LO+^/>B6.I?$+7?V?KF22TTW]J_4O FI3Q61N;:XO]/\&VUW#\9$
M-S:- \$<O@7PAX,L))ENHY<ZZHC&[EN;#4:F-A5R^FYRGD-?&YS&7-R1PU"O
M@7_94J5FG-T>+*<<54IVDF\4G57LG)'JU\14P4*.;J5.I+$8.GDD*52&GM?[
M0C&K+VB=YUZN3YOCYT*<E'V4<FE.,IQO"GX_8_%?XAOX?T3Q/X?&N7WB[PW>
M_#S]D?6=4T"R\&2^*-#\7:=>^([_ .+.J: ?B7K.F>#8=:U*XT/P19VCZW<O
M9K=36XDBO7\JTN.^6)_M#%X?'4</7PU#C;$3S+V5&I1<E@\OR2ICL/AZ3KIQ
M;H9OC\XPF*<*4JLJ6!Q'L*:G%3I^>\+0R^CB\#^[C+@JA6IT*N-E5;JPS3B#
M+\JPOMJ=#DDI/)L%@LSPT_:I55F5&=9T\.JCJ]Q>?&3XN3^%]=T/6/'OQ%\&
M^,O =O\ $G54TWP]X>_9H\2_$KQ'H/A:W\./I&L_$_7X-?\ $/PP\!+97NM7
M-AJ>E6ZZ+=7;16U]%/H]OOMI^#&XF-#+99M0]C6JX7!TJM>E#VT,LHUIYAF^
M&I>UJ56\7BHXNAEEY4LOQ3J8;$T<=AH2Q->6&H0ZL&E/,WE=:$HT\7BZ=/#R
ME.,\?*E]1R_$XBG2I4E"CAZM&KC82I5\=1G1JX'%8*K*,$J^)CP^DZYXG^)^
MM_#?QO?>+-4\)ZSXN\0_L@^)?$(\*VGAR.QU&_U[X6>-=7NK5K?Q-H6L^39"
M]+B**%XW43'YV=(GBZ\UP='*\XSG!8=2GA<%G_'-&G2J.Z<:/!64R3E*')4<
MG2ISH2:FOW5:K**C65*M2\+#XBIC<#7JUI*->>0<+)U8I*2?^OV:X:,E%ITU
M*,YT\2OW?*\10I1E&6%E7PU;US]EC4?'_ABS_9R\/ZCX]OO$OA+XC?!OQ?K"
M^%+[0/"UCI_@^Y\&77@Q=#_X1K4](T:UUB=9].\174=^NMZCK FGCCFM/L,8
M-NW7I)XS"UU[:OA,JR7%QQ%^27/4I4</7H^SC:G]7?-"5!.+KTO9M5*]?VGN
M?39O37UK.,=3M0<>+<XP$Z<+N%6G7Q/$&+5:;J.<XXB%3 1C>G.%"5.JU[!2
M@IRS_&GPDNOB3\=/CXUC\#?V??B%>QQ?#W3+3Q_\5M:N].\8>!+FY\"VY@N?
M"-M8?"#Q)<W"V<DBZA$;?Q+X=E^U1@1R0-BZ7P,#AZE3+<S5*O+*ZE?.<PIQ
MQ^&YGC*367Y/:48QGAG>AS<U#_:DG*<[J"3]I&)KPI8_*O:4OK].AD^$J2P5
M?E6%J)YQG]XR<HUXVQ')[/$)X625.G3_ (U^2GG^)?B9\1?AAK'P]TC1_C#X
MU\>0>'OBU\(/@)XELKKP)\.](\ 74FH6?AC2/%4_B37?$3R>,_$WCZ8ZI/JJ
M7?A;5%M+>2:VBNM*>VL=0O9O:>*I9EF-;%4Z"H87.J?%.*H7E&,:/]FX;.,1
MAXX"E2C&<?JV)RY87$3QD:^&K*EB)Q>&EB,!1?C2I5,MR2MA_:^TQN0X;*W5
ME%5)SE/$U,$W]<J5Y5(.A5PV)A+#TZ#AC8*M2=6OB94\35I<M%JGQ8O-(^!/
MQAUSXY>.-3\1ZM\'OC9XX@T,^'OA#9>%-.U32? =I=V<%C96?PQBU&:&0F&:
MX%YJEV_F0/\ 9GM;>22!_%S6M4RJ&?5<-:6*H<)K$JK-7<:M?&9'.:C!<M-4
MJ=>LJE)2A*:=&A"M4JP]M&M])+"4,3G&'P,XJE@H\=_V="C!M)8;#_ZRT(+G
MFYU74EA<*\/4E[2SAB*\X1A7CAZV'TO$WQG^/GP]T#P="_CO5_B!JWQ1^'/P
M>\0-=Q^%OA7I6H^#-;\7^,/#OA?Q))X)BU&/PUX?\JYLM:W6$?C/5+Z"'4WA
M,US):R"R/NXO#TUQ%G.04:5?V& S6%&G6H.D\6Z%7+^*,7[!O$7PMH5\AH4Z
M,O83Q'L,15@UC,4J+E\GEV85)Y/DF<U(PK5,?D^+Q<Z%7VBPT9X;$<-T:5>I
M]5I/$M0HYY7Q&/4*E'#S^J1E3EE>'=:K3[;PKX[^/'B?Q'X1^&^L^,?%_P /
MV_X69XVT"_U_4$_9RU[XJ:GX9T+X;:1XTTZS\7V/@-?&/@SPMXE36KV:WE6W
MT^Q>XTJ2VN5LK66\CEBYZ7LY2P^(<J4GA\DS/&U:,56A@JV)P'$&5Y=0E4K3
MO6]E+"XJK3QU/"XJ+IXN.(5.I0Y:<*7=C95,%&E1I^TD\?C\!0A5KPIQK8>G
MC,IS_$UE1A3FH5HPK9;1KX+$5\/%-2C0JPQ<:&(J8GLO@/\ $GXDW_Q);PW\
M3?%&LZI)XK\->(O$/A9+.U^$WB'X4Z]:^'];TRTN=8^%'C;X>2VOB'3])L[?
M5;>UO=)\>:?>7<D]Q#)9ZD5MYDN3!1C5RRISP;QN'HY?B:WM;PK0CBJ=2-2<
M94D\'B<#B*RISR^5-4<73H1<L0L1[7FH=&.IU:&-<Z;Y<!''8W 1Y>5KGI>T
MJ8:EB(5.3$X?,*5##5UC[*IA'B55I4H8=1HJI]KUB,* "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H ^?_P!I;_DG7AS_ +. _9._]:G^#= 'T!0 4 ?/_P"TM_R3KPY_V<!^
MR=_ZU/\ !N@#Z H * "@#Y_\.?\ )T_QD_[(!^S3_P"K%_:QH ^@* "@ H *
M "@ H * "@ H * "@ H X3Q#\+?ACXNU_1_%?BOX<^!/$_BCPZ4/A_Q)XA\(
M>']:U_0C',+B,Z/K&I:?-=Z85G D7[--%AP&'S<T4?\ 9JTL3A_W&(FN656G
M[E245&4$I3C:32A.4;-VY92CLVFJT8XBC'#8A*OAXOFC2J+GII\T974)7BGS
M0C*Z5^:,7NE;N^GMC\,8H'MY6"@ H * "@ H * "@ H * "@ H * "@ H *
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M7_0N?M ?^(G?M3__ #FZ #_AI;X=?]"Y^T!_XB=^U/\ _.;H /\ AI;X=?\
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M #FZ #_AI;X=?]"Y^T!_XB=^U/\ _.;H /\ AI;X=?\ 0N?M ?\ B)W[4_\
M\YN@ _X:6^'7_0N?M ?^(G?M3_\ SFZ #_AI;X=?]"Y^T!_XB=^U/_\ .;H
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MN;>-I&0/+&I+J ?5] !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MM4A5PS=!U5.,6OK$(652%6,.ZK(84 % !0 4 % !0 4 % !0 4 % !0 4 %
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M X;+:-XX+!U<-6HTKMJG5P:MAYJ4FYMP5DTY-5+1]JI\L;*?A#\//^$/\&^
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M&K4=:C&G649KO])^%?@+0Y=!FTO0?LLOAG6O&GB'0V_M369_L.L?$*\U._\
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MQ598BDJM']\J.%;;I4:%*;P_)/$\E)8ZO*I.?)S4Z%J*JTL4\<U4ITJ&%O\
M5Z<:56=*I^[^LXRG>:E6J1]K_LU";B\-1C!I5::Q=95*RP\,+]34A'S_ /&3
M_DHO[)W_ &<!XC_]98_:6H ^@* /$OBYX-\;ZQJWPU\:_#J#PQJ/BKX<>)-6
MU!=!\8^(=:\*Z#K^B^(O#&K>&]6L9O$&A>&?$-SIMW"U]97T#G1;^-WT\PNL
M?G":*:+GAL96Q$*<*BQ678G+I\TG%THUL7EV.IUH)0DJDH5LMITY4VZ?-2K5
M)*K&4(J4UZ-'$X:G1J3J4JF$QN&Q]!P47&56C1Q>#G2JIM25.>$S#$VE!\T:
MT:+E&=/VD7J_!3P)K'P\\!6^B>(KG3KKQ+J7B'QGXR\2-HTUS<:+;Z_X[\7:
MUXQU6PT:XO+*TN+G2K.[UJ2T@GN+6VEFCM5EDAB:0HO7B*E)T\OPU"4IT<MP
M&!P,*DX*G.JL'A:5"5:=.,ZD:;K3A.K[.-2HJ:FJ:G/EYFY5<3B<5CL;B^2-
M;&XB510IMN%*A3A##82BI.,'.5+!T,/3JU7"/M:L:E3EBI**]8KF&?/_ .R=
M_P FL?LT_P#9 /@W_P"JZ\.4 ?0% !0 4 ? '_.4W_NP#_WXJ@#[_H * "@#
MY_\ VL?^36/VEO\ L@'QD_\ 5=>(Z /H#'&/PJ914HRA)7C)-->35F"T^1X7
MHWP4L([/3H-<U"\:?0?[,TK1VTFZB2W?P]X6^(-MX\\*K>0WVFR21:BLFGZ?
M97@CF>)XHI3 8FE5H-,-)X9T:R][$K#X"E6<GS1E4R_!8[+XU8M<LOW]+'5L
M15C*[A6<(1E.-*4Z]592J5L7-N\*\LY<.DE#/?J]3&1DM5S4*E)T\+).SIQ5
M2K!RJ>RI7OBQ\#_"WQB?1_\ A*-1UJ"WT:VU2WAL+&#PO?6,S:H+7-_]G\4>
M&=7&FZU:-:1FTU72S87T DGC6X\FXECD6&?U3'4L?3]ZM0GAJD%)*T982NZ]
M/EG'EK0C.3Y<13IU84\134(UH3]G2<%5?M<)4P;]VE5YU-J_O1J4W2E"<&W2
MJ147>G[6G.5&=YT94Y2DWR+? :]O+CQEJ&J^*=3NWO\ Q%XX\1>#_"ZWEBGA
M#2M5\3>';SPW9:[J!B\-1ZR^JQZ=J-_#);'4KO3XQ<M-%:M< 2#AJX>J\EKX
M"FX2QE;"9GA54G?DHPQ^8XK&.%)Q2]V4*E!5)U:=2K":K4Z,E2E[_1A:L:&8
MPKOFA@XU\JJU(4[>TKPRW"9?2BJW,^6\<3@W5IQI2I1J*&'=9OE<(['A3X#Z
M;I$&AWOB'Q3XJ\2^)=+3P1_Q,K^\T0PV=OX'M]2&D>'=.BT[PUIT;Z!#>:WJ
M\OG7-O)J=Q]H4W-](8U">ICYT\5B,14IJ2A6Q&85W.2BJM:6/P5?+I3K*-Z<
M9T\)7?LX4(TZ,:R]HX3YJGM/,PU&I3R_"8*LU&.&P^%I1ITF_8T9T,5@L;4=
M%S7M&JV(P&'C-UG.7L*<:=-4K+EFT+X!Z+X7M+C2_#OC;X@Z-HNH^&K;PWKN
MCV>H>&Q;ZX;'PR/"=AK]Q?S>%9-3TCQ#;Z5#8[;C0[_28FETRU>6"0(ZR8UV
M\12Q5"J^:EB&Y0CI;#U)>Q]I.C=/F53V*YZ.(]OAFZE9JBG49Z<L3-XVEC^6
M"Q%*O4K.ZO"<:F.Q.8.A.G)R@Z,:^+Q"BTHU_9SY)5I<L''G]"_9A\+>%K:!
M/"OC/QOX8U*WU?4=:&M>'[+X9:3=/>:MX?T[PUJ/F:39?#A-#Q/INF0L[II"
M2M<2RW)E,[*Z%2U11A*-J"PV(PDJ,7*-.6'Q6(PV)K4U9J=&+JX6FX+#3H*E
M&4XTE"+BH<J27(Y_O:E.="K&I4]ZI[3#1S"-*I4EO6FH9C6A.5?VLJL:=%57
M.U3VLWB']EKX8^(M.L-,N%U2&#2--\&Z7HJSV_A;Q+!ID/@BR\1:;IDPTKQO
MX9US3-5N)['Q1JD5RVK6.H*289H$M[B%9:JK4E5K5*SY8U*F(Q.(=H4VE]9P
M^7X:I1A&49*G2C#+,+*FZ:C7A*,U[9TYRICC=-NI.5:4J:A.4YR4IU%B\3C'
MB)NFX.5:5?%UW-?P)1GRNCHCT/P5\/U\(ZUJ-Y$;"'2[?POX2\%>&['3K2QT
MY(=%\-+JE[->WFG:/I6FZ9IU_=ZKKEX#:Z99Q6L4-C;M$L?G-#!<JSG'$N:M
M6Q6*E6E:524:=&%&E0PU",JLZE22I1A5GS3E?]\J7OJBJM2%3Y(X.E!WHX2E
M6LW&$)RQ.+K1GBZDO9J%-QG&AA.5*$7[2-><K^U2CZ;6)84 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 ?/_[2W_).O#G_ &<!^R=_ZU/\&Z /H"@ H *
M/G_PY_R=/\9/^R ?LT_^K%_:QH ^@* "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^4/!6B?M)?#2Q\2>&M"^'
MGP/\4Z)=_%#XR^-=&UO5OCMX\\*ZK<Z5\3/BYXV^).GV^I^'[/\ 9PUVWTW4
M+.T\60V4R0:O?QM)9O(DI60*IL&QU_\ PD?[4_\ T1OX ?\ B2WQ%_\ H3J
M#_A(_P!J?_HC?P _\26^(O\ ]"=0 ?\ "1_M3_\ 1&_@!_XDM\1?_H3J . U
M+2/VI[_XI^#?B7_PJ_X 0_\ "(_#_P")?@7^Q/\ AHCXBR?VA_PL3Q%\)]?_
M +4_M+_AEI?LG]G_ /"K_(^S?99OM']N>9YT'V+9=FP;'?\ _"1_M3_]$;^
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M&?\ 9?G_ /#+4/\ 9GE_\+$_M+[3Y=WN_L?[-Y*_:_M%L;!L=_\ \)'^U/\
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MB27(Z,7I[>A#$TWNIT*E7$4(5(R5XM2JX6O%*_,N3F:49P<MND(* "@ H *
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M<?J.%RO*ZSQ,9TL1#'T,#2Q:KXFC[*4<5CJN)P[4HPC&_;_LC?;=45->\"_
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M-ZLH75&DL-C,1E5/ Q7LZ34J^$RW!5:<YRIJ56NHJ56;Q5?$TOK>N8Z H *
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MLT_^K%_:QH ^@* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H ^?\ ]I;_ ))UX<_[. _9._\
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M -$.^#__ (;/P7_\I*?U3"?] M+_ ,%P_P#D0^L8C_G_ %/_  .7^8?\,\_
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M_HAWP?\ _#9^"_\ Y24?5,)_T"TO_!</_D0^L8C_ )_U/_ Y?YA_PSS\ ?\
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M  V?@O\ ^4E'U3"?] M+_P %P_\ D0^L8C_G_4_\#E_F'_#//P!_Z(=\'_\
MPV?@O_Y24?5,)_T"TO\ P7#_ .1#ZQB/^?\ 4_\  Y?YA_PSS\ ?^B'?!_\
M\-GX+_\ E)1]4PG_ $"TO_!</_D0^L8C_G_4_P# Y?YA_P ,\_ '_HAWP?\
M_#9^"_\ Y24?5,)_T"TO_!</_D0^L8C_ )_U/_ Y?YA_PSS\ ?\ HAWP?_\
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M .4E'U3"?] M+_P7#_Y$/K&(_P"?]3_P.7^8?\,\_ '_ *(=\'__  V?@O\
M^4E'U3"?] M+_P %P_\ D0^L8C_G_4_\#E_F'_#//P!_Z(=\'_\ PV?@O_Y2
M4?5,)_T"TO\ P7#_ .1#ZQB/^?\ 4_\  Y?YA_PSS\ ?^B'?!_\ \-GX+_\
ME)1]4PG_ $"TO_!</_D0^L8C_G_4_P# Y?YA_P ,\_ '_HAWP?\ _#9^"_\
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M:]K[-=D=!_PR7>?]'*_'_P#\%_[.'_T/-=']JX__ )__ /DE/_Y Q_L_"?\
M/K_R:?\ \D'_  R7>?\ 1ROQ_P#_  7_ +.'_P!#S1_:N/\ ^?\ _P"24_\
MY /[/PG_ #Z_\FG_ /)!_P ,EWG_ $<K\?\ _P %_P"SA_\ 0\T?VKC_ /G_
M /\ DE/_ .0#^S\)_P ^O_)I_P#R0?\ #)=Y_P!'*_'_ /\ !?\ LX?_ $/-
M']JX_P#Y_P#_ ))3_P#D _L_"?\ /K_R:?\ \D'_  R7>?\ 1ROQ_P#_  7_
M +.'_P!#S1_:N/\ ^?\ _P"24_\ Y /[/PG_ #Z_\FG_ /)!_P ,EWG_ $<K
M\?\ _P %_P"SA_\ 0\T?VKC_ /G_ /\ DE/_ .0#^S\)_P ^O_)I_P#R0?\
M#)=Y_P!'*_'_ /\ !?\ LX?_ $/-']JX_P#Y_P#_ ))3_P#D _L_"?\ /K_R
M:?\ \D'_  R7>?\ 1ROQ_P#_  7_ +.'_P!#S1_:N/\ ^?\ _P"24_\ Y /[
M/PG_ #Z_\FG_ /)!_P ,EWG_ $<K\?\ _P %_P"SA_\ 0\T?VKC_ /G_ /\
MDE/_ .0#^S\)_P ^O_)I_P#R0?\ #)=Y_P!'*_'_ /\ !?\ LX?_ $/-']JX
M_P#Y_P#_ ))3_P#D _L_"?\ /K_R:?\ \D'_  R7>?\ 1ROQ_P#_  7_ +.'
M_P!#S1_:N/\ ^?\ _P"24_\ Y /[/PG_ #Z_\FG_ /)!_P ,EWG_ $<K\?\
M_P %_P"SA_\ 0\T?VKC_ /G_ /\ DE/_ .0#^S\)_P ^O_)I_P#R0?\ #)=Y
M_P!'*_'_ /\ !?\ LX?_ $/-']JX_P#Y_P#_ ))3_P#D _L_"?\ /K_R:?\
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M_P#D _L_"?\ /K_R:?\ \D'_  R7>?\ 1ROQ_P#_  7_ +.'_P!#S1_:N/\
M^?\ _P"24_\ Y /[/PG_ #Z_\FG_ /)!_P ,EWG_ $<K\?\ _P %_P"SA_\
M0\T?VKC_ /G_ /\ DE/_ .0#^S\)_P ^O_)I_P#R0?\ #)=Y_P!'*_'_ /\
M!?\ LX?_ $/-']JX_P#Y_P#_ ))3_P#D _L_"?\ /K_R:?\ \D'_  R7>?\
M1ROQ_P#_  7_ +.'_P!#S1_:N/\ ^?\ _P"24_\ Y /[/PG_ #Z_\FG_ /)!
M_P ,EWG_ $<K\?\ _P %_P"SA_\ 0\T?VKC_ /G_ /\ DE/_ .0#^S\)_P ^
MO_)I_P#R0?\ #)=Y_P!'*_'_ /\ !?\ LX?_ $/-']JX_P#Y_P#_ ))3_P#D
M _L_"?\ /K_R:?\ \D'_  R7>?\ 1ROQ_P#_  7_ +.'_P!#S1_:N/\ ^?\
M_P"24_\ Y /[/PG_ #Z_\FG_ /)!_P ,EWG_ $<K\?\ _P %_P"SA_\ 0\T?
MVKC_ /G_ /\ DE/_ .0#^S\)_P ^O_)I_P#R0?\ #)=Y_P!'*_'_ /\ !?\
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M0?\ #)=Y_P!'*_'_ /\ !?\ LX?_ $/-']JX_P#Y_P#_ ))3_P#D _L_"?\
M/K_R:?\ \D'_  R7>?\ 1ROQ_P#_  7_ +.'_P!#S1_:N/\ ^?\ _P"24_\
MY /[/PG_ #Z_\FG_ /)!_P ,EWG_ $<K\?\ _P %_P"SA_\ 0\T?VKC_ /G_
M /\ DE/_ .0#^S\)_P ^O_)I_P#R0?\ #)=Y_P!'*_'_ /\ !?\ LX?_ $/-
M']JX_P#Y_P#_ ))3_P#D _L_"?\ /K_R:?\ \D'_  R7>?\ 1ROQ_P#_  7_
M +.'_P!#S1_:N/\ ^?\ _P"24_\ Y /[/PG_ #Z_\FG_ /)!_P ,EWG_ $<K
M\?\ _P %_P"SA_\ 0\T?VKC_ /G_ /\ DE/_ .0#^S\)_P ^O_)I_P#R0?\
M#)=Y_P!'*_'_ /\ !?\ LX?_ $/-']JX_P#Y_P#_ ))3_P#D _L_"?\ /K_R
M:?\ \D'_  R7>?\ 1ROQ_P#_  7_ +.'_P!#S1_:N/\ ^?\ _P"24_\ Y /[
M/PG_ #Z_\FG_ /)!_P ,EWG_ $<K\?\ _P %_P"SA_\ 0\T?VKC_ /G_ /\
MDE/_ .0#^S\)_P ^O_)I_P#R0?\ #)=Y_P!'*_'_ /\ !?\ LX?_ $/-']JX
M_P#Y_P#_ ))3_P#D _L_"?\ /K_R:?\ \D'_  R7>?\ 1ROQ_P#_  7_ +.'
M_P!#S1_:N/\ ^?\ _P"24_\ Y /[/PG_ #Z_\FG_ /)!_P ,EWG_ $<K\?\
M_P %_P"SA_\ 0\T?VKC_ /G_ /\ DE/_ .0#^S\)_P ^O_)I_P#R0?\ #)=Y
M_P!'*_'_ /\ !?\ LX?_ $/-']JX_P#Y_P#_ ))3_P#D _L_"?\ /K_R:?\
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M_P#D _L_"?\ /K_R:?\ \D'_  R7>?\ 1ROQ_P#_  7_ +.'_P!#S1_:N/\
M^?\ _P"24_\ Y /[/PG_ #Z_\FG_ /)!_P ,EWG_ $<K\?\ _P %_P"SA_\
M0\T?VKC_ /G_ /\ DE/_ .0#^S\)_P ^O_)I_P#R0?\ #)=Y_P!'*_'_ /\
M!?\ LX?_ $/-']JX_P#Y_P#_ ))3_P#D _L_"?\ /K_R:?\ \D'_  R7>?\
M1ROQ_P#_  7_ +.'_P!#S1_:N/\ ^?\ _P"24_\ Y /[/PG_ #Z_\FG_ /)!
M_P ,EWG_ $<K\?\ _P %_P"SA_\ 0\T?VKC_ /G_ /\ DE/_ .0#^S\)_P ^
MO_)I_P#R0?\ #)=Y_P!'*_'_ /\ !?\ LX?_ $/-']JX_P#Y_P#_ ))3_P#D
M _L_"?\ /K_R:?\ \D'_  R7>?\ 1ROQ_P#_  7_ +.'_P!#S1_:N/\ ^?\
M_P"24_\ Y /[/PG_ #Z_\FG_ /)!_P ,EWG_ $<K\?\ _P %_P"SA_\ 0\T?
MVKC_ /G_ /\ DE/_ .0#^S\)_P ^O_)I_P#R0?\ #)=Y_P!'*_'_ /\ !?\
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MB3Q\NE_8/">KW:Z9<Z0TVDG7O$#:]>K:W T^WT/2(+^2ZF\AP9K>&V4>;=Q
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M=>ISRG:M5J*G[.@J5&EM5F;A0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?/\
M^TM_R3KPY_V<!^R=_P"M3_!N@#Z H * "@#Y_P##G_)T_P 9/^R ?LT_^K%_
M:QH ^@* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^4/!6M_M)?$J
MQ\2>)="^(?P/\*Z):?%#XR^"M&T35O@3X\\4ZK:Z5\,OBYXV^&VGW&I^(+/]
MH_0K?4M0O+3PG#>S/!I%A&LEX\:1!8PS '7_ /".?M3_ /19/@!_XC3\1?\
MZ+&@ _X1S]J?_HLGP _\1I^(O_T6- !_PCG[4_\ T63X ?\ B-/Q%_\ HL:
M#_A'/VI_^BR? #_Q&GXB_P#T6- !_P (Y^U/_P!%D^ '_B-/Q%_^BQH /^$<
M_:G_ .BR? #_ ,1I^(O_ -%C0 ?\(Y^U/_T63X ?^(T_$7_Z+&@ _P"$<_:G
M_P"BR? #_P 1I^(O_P!%C0 ?\(Y^U/\ ]%D^ '_B-/Q%_P#HL: #_A'/VI_^
MBR? #_Q&GXB__18T '_".?M3_P#19/@!_P"(T_$7_P"BQH /^$<_:G_Z+)\
M/_$:?B+_ /18T '_  CG[4__ $63X ?^(T_$7_Z+&@ _X1S]J?\ Z+)\ /\
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M?M3_ /19/@!_XC3\1?\ Z+&@ _X1S]J?_HLGP _\1I^(O_T6- !_PCG[4_\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@#Y_^#?_ "47]K'_ +. \.?^LL?LTT ?0% '
MS_\ M+?\DZ\.?]G ?LG?^M3_  ;H ^@* "@ H ^?_#G_ "=/\9/^R ?LT_\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M#_'EI<6]WX#_ &X?$VD7>GS^'?'&A2(\6IF19&GBEBC:'Y@#T_\ X1S]J?\
MZ+)\ /\ Q&GXB_\ T6- !_PCG[4__19/@!_XC3\1?_HL: #_ (1S]J?_ *+)
M\ /_ !&GXB__ $6- !_PCG[4_P#T63X ?^(T_$7_ .BQH /^$<_:G_Z+)\ /
M_$:?B+_]%C0 ?\(Y^U/_ -%D^ '_ (C3\1?_ *+&@ _X1S]J?_HLGP _\1I^
M(O\ ]%C0 ?\ ".?M3_\ 19/@!_XC3\1?_HL: #_A'/VI_P#HLGP _P#$:?B+
M_P#18T '_".?M3_]%D^ '_B-/Q%_^BQH /\ A'/VI_\ HLGP _\ $:?B+_\
M18T '_".?M3_ /19/@!_XC3\1?\ Z+&@ _X1S]J?_HLGP _\1I^(O_T6- !_
MPCG[4_\ T63X ?\ B-/Q%_\ HL: #_A'/VI_^BR? #_Q&GXB_P#T6- !_P (
MY^U/_P!%D^ '_B-/Q%_^BQH /^$<_:G_ .BR? #_ ,1I^(O_ -%C0 ?\(Y^U
M/_T63X ?^(T_$7_Z+&@ _P"$<_:G_P"BR? #_P 1I^(O_P!%C0 ?\(Y^U/\
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M-6]3Z>K(9\__ +-/_).O$?\ V<!^UC_ZU/\ &2@#Z H * "@ H * "@ H *
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M534M:4%/FG5JUJU:I[=6)H?/_P"S3_R3KQ'_ -G ?M8_^M3_ !DH ^@* "@
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M^#= 'T!0 4 % 'S_ .'/^3I_C)_V0#]FG_U8O[6- 'T!0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % 'YP:!^T!_PI:?QO\/?^%@?L07_V#XP?''7]
M_BS]LW_A!/%5E_PG?QD\=^/?[$\2^#_^%'ZS_P (]X@TG_A)O[+O+/\ M2\V
M7.FS?.,[$-@V.@_X;4_ZG+]@#_Q/K_\ )QH /^&U/^IR_8 _\3Z__)QH /\
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M<: #_AM3_J<OV /_ !/K_P#)QH /^&U/^IR_8 _\3Z__ "<: #_AM3_J<OV
M/_$^O_R<: #_ (;4_P"IR_8 _P#$^O\ \G&@ _X;4_ZG+]@#_P 3Z_\ R<:
M#_AM3_J<OV /_$^O_P G&@ _X;4_ZG+]@#_Q/K_\G&@ _P"&U/\ J<OV /\
MQ/K_ /)QH ]@_9BU;_A*X/C1\0O^$G^#_B7_ (6'\8(-?V?!3XH?\+>\*^'_
M .QO@U\'_ 7]B7_C#_A%?#N_Q W_  AO]J2V?]EQ>1;:Y8_/)OWDV#8^GZ "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#Y@_:=U;_A
M$X/@O\0O^$G^#_AG_A7?Q@GU_9\:_BA_PJ'PKK_]L?!KXP> O[$T_P 8?\(K
MXB\OQ O_  F7]J16?]ER^?;:'??/'LW@V#8\?_X;4_ZG+]@#_P 3Z_\ R<:
M#_AM3_J<OV /_$^O_P G&@ _X;4_ZG+]@#_Q/K_\G&@ _P"&U/\ J<OV /\
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MXE_X6'\8(-?V?!3XH?\ "WO"OA_^QO@U\'_ 7]B7_C#_ (17P[O\0-_PAO\
M:DMG_9<7D6VN6/SR;]Y-@V/I^@#Y_P#VEO\ DG7AS_LX#]D[_P!:G^#= 'T!
M0 4 % 'S_P"'/^3I_C)_V0#]FG_U8O[6- 'T!0 4 % !0 4 % !0 4 % !0
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MNH6D?A0SVVMGQE9:=X9N[SX;V5AJT']FW]]XHM-+@T^Z)M[LQSKY5<N8U:F
MP^,JPIQQ,\)A(XN/+6I_5JL*L*DL(HXV+GA;XUT:D,':I*6)E":P\*LH2BNK
M"TE7Q.%PU5U,-+$8J&$Y)4:GUF,W[&51K!M1Q,XT*6(H5ZTHT^2E1K4:M2<*
M=:G.5_2?VC_AC=R>#],U;6)M(\1>*M(\'7UQ80Z-XGUG0?#&I^-]-LK_ ,/Z
M!XG\<Z?X?.@>&]5U![V&#3[?6K[2[C47DB%K [3(A]:O@G3S3,LLPL_K,LMQ
M6*PBGR^RC7JX/FE6IT.>7+6Q%.C'V];"X>=:O1I/GJ14%S'DX'&O$Y3EF:U:
M+PT<RP5#'^R3=65&A627MJO)%3AAH5.>G];JTZ5!RIS]Y<DU'G/$?QP\=6VC
M>/O%WA/P7\,;GP-\.?$GBW0]<\3_ ! ^+_B7P-#+:>#;+2_[7U:QMO#WP5\7
MB=(=>?Q%I4EN9T=9- 0QM+)>-!9^7*JZ>!P..=.4HX^$Y4J-.,YXB<_[1Q6!
MPM.E14.:K+'0H8?$810O*JL73A"+2C4J>O&@YXZOEU-3CB,,\,INK&%*C;$8
M##YA*:J.J^6E0HXFFJM6I&G&,H5G+EA34I9WAS]J32K+0K/4OC3HMC\)M:NM
M&\":@_A&PO?&_P 0/$-IJ'Q%U+QG:^%-'FM-.^&&FF:[U*T\([[6"T%S?-=W
M,]A=6-G-%:-JOH8FA3P\J=*G.KB,3+$U<'[*G1]HUBL+E.#S3&X>+H5*WM*N
M$AB:L92HJIAJU.E"K0Q%2I5GA\/PT*LJU-5[0IX.5&>)C7J5/90EA/[0AEU#
M%_OHTG2H5ZM6E-_6?85:$*BE7I0IPJ5(>\>%OB+X-\8^%[CQCH6L%O#]@^IP
MZK<:OIVJ^&K[0KG1"ZZQ9>(M$\2V-AJ?AS4+$Q/]HM-3L[2>$#,D:@C/)B94
M\'AUBZ]6G'".DZ\:T:D*E%THN<93C4IRG"2A.G4IS49-PJTYTI)5(2BMZ"EB
M,1+"4J<Y8J%6%%T7"<*JJ5(TZE./).,9?O:=6E5I.W+5I5:=6FY4YQD_.]/_
M &F_@MJ>BZCKMCXIU26VTR^TG3SIK>!?B#;^*=5N-?M;F]\//X7\%7'A:/Q!
MXQL]7L[*^GTZ\T+3-1M]0BL+J2SEF2VE,=U*=2C&@YTJD95ZM6A&FH3E7IUL
M/3IU<12Q&'BG7PM7#T:M*MB*>)ITI4*%2G6JJ%*<9O.G4I5)5HTZM.4:%"&)
ME4YX*A+#U*TL-3K4L0VJ%>E4Q$)8>G.C4J1G77LH-U&HNAXB_:D^#NA^$X_%
M5KXANM;2[T?Q+J]EINF>&/&E[J%I'X4,]MK9\966G>&;N\^&]E8:M!_9M_?>
M*+32X-/NB;>[,<Z^57+F-6I@,/C*L*<<3/"82.+CRUJ?U:K"K"I+"*.-BYX6
M^-=&I#!VJ2EB90FL/"K*$HKJPM)5\3A<-5=3#2Q&*AA.25&I]9C-^QE4:P;4
M<3.-"EB*%>M*-/DI4:U&K4G"G6ISE?TG]H_X8W<G@_3-6UB;2/$7BK2/!U]<
M6$.C>)]9T'PQJ?C?3;*_\/Z!XG\<Z?X?.@>&]5U![V&#3[?6K[2[C47DB%K
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MB)XBC@*>*DX5'0YZLJ>+B\/3=:CAL-1C*.'J8FA4Y3XK_#?X^:EXOT'XF?\
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M6G[7#25&<FZCIXF@L0U2_1*O,/1/G_XR?\E%_9._[. \1_\ K+'[2U 'T!0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'S_\ !O\ Y*+^UC_V<!X<
M_P#66/V:: /H"@#Y_P#VEO\ DG7AS_LX#]D[_P!:G^#= 'T!0 4 % 'S_P"'
M/^3I_C)_V0#]FG_U8O[6- 'T!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % 'Q!\$OVA/@%X&\+^,?"WC7XX?!_P '^)M+^/\ ^U/_ &EX<\4_$OP7
MX?UW3OMO[37Q<U&R^W:1JVM6]W9^?I]W:747FQ)YD-S%*F4D5B;>0;>1Z_\
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M<UK+$^'C90 ?3] !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M.@ _X:Q_98_Z.6^ '_AY/AU_\T= !_PUC^RQ_P!'+? #_P /)\.O_FCH /\
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MQ%_Z.Q_: _\ "<_98_\ H:: #_A3?Q%_Z.Q_: _\)S]EC_Z&F@ _X4W\1?\
MH[']H#_PG/V6/_H:: #_ (4W\1?^CL?V@/\ PG/V6/\ Z&F@ _X4W\1?^CL?
MV@/_  G/V6/_ *&F@ _X4W\1?^CL?V@/_"<_98_^AIH /^%-_$7_ *.Q_: _
M\)S]EC_Z&F@ _P"%-_$7_H[']H#_ ,)S]EC_ .AIH /^%-_$7_H[']H#_P )
MS]EC_P"AIH /^%-_$7_H[']H#_PG/V6/_H:: #_A3?Q%_P"CL?V@/_"<_98_
M^AIH /\ A3?Q%_Z.Q_: _P#"<_98_P#H:: #_A3?Q%_Z.Q_: _\ "<_98_\
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M *&F@ _X4W\1?^CL?V@/_"<_98_^AIH /^%-_$7_ *.Q_: _\)S]EC_Z&F@
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M.?\ 9P'[)W_K4_P;H ^@* "@ H ^?_#G_)T_QD_[(!^S3_ZL7]K&@#Z H *
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M]3:\LZ3Y_P#V:?\ DG7B/_LX#]K'_P!:G^,E 'T!0 4 % !0 4 % !0 4 %
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M\_\ AS_DZ?XR?]D _9I_]6+^UC0!] 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0!\_\ [-/_ "3KQ'_V<!^UC_ZU/\9* /H"@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H ^?_ (-_\E%_:Q_[. \.?^LL
M?LTT ?0% !0 4 % !0 4 % !0 4 % !0 4 <QXN\&^&_'>CKH'BK3O[4TE=6
MT#7%M/ME_8XU3POK>G^(]#NO/TVZMYO]&UG2["X\LR>7+Y'ES))$[QO5*4J.
M(PN*IOEKX.HZM&6_)4=.I2<N5WC+]W4G&TE*/O7MS)-7&I.%/%4HNU/&8>OA
M:RLO?H8BG*C6IWWCSTY2CS1<9QO>$HR29T]20% !0 4 % !0 4 % !0 4 ?/
M_P 9/^2B_LG?]G >(_\ UEC]I:@#Z H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@#Y_\ @W_R47]K'_LX#PY_ZRQ^S30!] 4 ?/\ ^TM_R3KPY_V<
M!^R=_P"M3_!N@#Z H * "@#XA\9?%J;X6_M3_$;ROAI\0/B'_;GP _9]W?\
M""W'PXM_['_LOXB_M08_M3_A8/Q#\+;OM7]H'R/L'V['V*X^T>1F'[1T8?"8
MC$\WL*?/R6YO>BK7O;XFNSV,:N(HX?E]K/EYKVTD]K7V3VNCH/\ AK.\_P"C
M:OC_ /\ @P_9P_\ HAJZ/[*Q_P#SX_\ )Z?_ ,F8_7\)_P _?_)9_P#R(?\
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M_(A_PUG>?]&U?'__ ,&'[.'_ -$-1_96/_Y\?^3T_P#Y,/K^$_Y^_P#DL_\
MY$/^&L[S_HVKX_\ _@P_9P_^B&H_LK'_ //C_P GI_\ R8?7\)_S]_\ )9__
M "(?\-9WG_1M7Q__ /!A^SA_]$-1_96/_P"?'_D]/_Y,/K^$_P"?O_DL_P#Y
M$/\ AK.\_P"C:OC_ /\ @P_9P_\ HAJ/[*Q__/C_ ,GI_P#R8?7\)_S]_P#)
M9_\ R(?\-9WG_1M7Q_\ _!A^SA_]$-1_96/_ .?'_D]/_P"3#Z_A/^?O_DL_
M_D0_X:SO/^C:OC__ .##]G#_ .B&H_LK'_\ /C_R>G_\F'U_"?\ /W_R6?\
M\B'_  UG>?\ 1M7Q_P#_  8?LX?_ $0U']E8_P#Y\?\ D]/_ .3#Z_A/^?O_
M )+/_P"1/ 'UKX="\U>\LOV=OVW]"_MSQ!XC\4ZAI_A;]I^'PCH7]N^+==U'
MQ/XDOK'PWX8_;9L-*TC[?X@U;4[^6&PL[:'SKV5EC7<11_96/7_+BW_;]/\
M^3#Z_A%_R]M_V[/_ .1#^WO W_1#?V__ /Q,'6/_ *.JC^RL?_SX_P#)Z?\
M\F'U_"?\_?\ R6?_ ,B']O>!O^B&_M__ /B8.L?_ $=5']E8_P#Y\?\ D]/_
M .3#Z_A/^?O_ )+/_P"1#^WO W_1#?V__P#Q,'6/_HZJ/[*Q_P#SX_\ )Z?_
M ,F'U_"?\_?_ "6?_P B']O>!O\ HAO[?_\ XF#K'_T=5']E8_\ Y\?^3T__
M ),/K^$_Y^_^2S_^1#^WO W_ $0W]O\ _P#$P=8_^CJH_LK'_P#/C_R>G_\
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M9_\ R(?V]X&_Z(;^W_\ ^)@ZQ_\ 1U4?V5C_ /GQ_P"3T_\ Y,/K^$_Y^_\
MDL__ )$/[>\#?]$-_;__ /$P=8_^CJH_LK'_ //C_P GI_\ R8?7\)_S]_\
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MG_\ )A]?PG_/W_R6?_R(?\-9WG_1M7Q__P#!A^SA_P#1#4?V5C_^?'_D]/\
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M .CJH_LK'_\ /C_R>G_\F'U_"?\ /W_R6?\ \B']O>!O^B&_M_\ _B8.L?\
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M'>IBI5*DZTZ5.59U:M6$W#F=)UE352$8R<J<Z3=*$U3KPK1C/FE&W/-2V_\
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M_(/^&/O@CZ?&#_Q)C]I;_P">Y1];Q?\ T%5?_!D__D@^KX?_ )\4_P#P"/\
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MO_GN4?6\7_T%5?\ P9/_ .2#ZOA_^?%/_P  C_D'_#'WP1]/C!_XDQ^TM_\
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M $%5?_!D_P#Y(/J^'_Y\4_\ P"/^0?\ #'WP1]/C!_XDQ^TM_P#/<H^MXO\
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M?_GQ3_\  (_Y!_PQ]\$?3XP?^),?M+?_ #W*/K>+_P"@JK_X,G_\D'U?#_\
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M'[2W_P ]RCZWB_\ H*J_^#)__)!]7P__ #XI_P#@$?\ (/\ AC[X(^GQ@_\
M$F/VEO\ Y[E'UO%_]!57_P &3_\ D@^KX?\ Y\4__ (_Y!_PQ]\$?3XP?^),
M?M+?_/<H^MXO_H*J_P#@R?\ \D'U?#_\^*?_ (!'_(/^&/O@CZ?&#_Q)C]I;
M_P">Y1];Q?\ T%5?_!D__D@^KX?_ )\4_P#P"/\ D'_#'WP1]/C!_P"),?M+
M?_/<H^MXO_H*J_\ @R?_ ,D'U?#_ //BG_X!'_(/^&/O@CZ?&#_Q)C]I;_Y[
ME'UO%_\ 055_\&3_ /D@^KX?_GQ3_P# (_Y!_P ,??!'T^,'_B3'[2W_ ,]R
MCZWB_P#H*J_^#)__ "0?5\/_ ,^*?_@$?\@_X8^^"/I\8/\ Q)C]I;_Y[E'U
MO%_]!57_ ,&3_P#D@^KX?_GQ3_\  (_Y!_PQ]\$?3XP?^),?M+?_ #W*/K>+
M_P"@JK_X,G_\D'U?#_\ /BG_ . 1_P @_P"&/O@CZ?&#_P 28_:6_P#GN4?6
M\7_T%5?_  9/_P"2#ZOA_P#GQ3_\ C_D'_#'WP1]/C!_XDQ^TM_\]RCZWB_^
M@JK_ .#)_P#R0?5\/_SXI_\ @$?\@_X8^^"/I\8/_$F/VEO_ )[E'UO%_P#0
M55_\&3_^2#ZOA_\ GQ3_ / (_P"0?\,??!'T^,'_ (DQ^TM_\]RCZWB_^@JK
M_P"#)_\ R0?5\/\ \^*?_@$?\@_X8^^"/I\8/_$F/VEO_GN4?6\7_P!!57_P
M9/\ ^2#ZOA_^?%/_ , C_D'_  Q]\$?3XP?^),?M+?\ SW*/K>+_ .@JK_X,
MG_\ )!]7P_\ SXI_^ 1_R#_AC[X(^GQ@_P#$F/VEO_GN4?6\7_T%5?\ P9/_
M .2#ZOA_^?%/_P  C_D'_#'WP1]/C!_XDQ^TM_\ /<H^MXO_ *"JO_@R?_R0
M?5\/_P ^*?\ X!'_ "#_ (8^^"/I\8/_ !)C]I;_ .>Y1];Q?_055_\ !D__
M )(/J^'_ .?%/_P"/^0?\,??!'T^,'_B3'[2W_SW*/K>+_Z"JO\ X,G_ /)!
M]7P__/BG_P" 1_R#_AC[X(^GQ@_\28_:6_\ GN4?6\7_ -!57_P9/_Y(/J^'
M_P"?%/\ \ C_ )!_PQ]\$?3XP?\ B3'[2W_SW*/K>+_Z"JO_ (,G_P#)!]7P
M_P#SXI_^ 1_R#_AC[X(^GQ@_\28_:6_^>Y1];Q?_ $%5?_!D_P#Y(/J^'_Y\
M4_\ P"/^0?\ #'WP1]/C!_XDQ^TM_P#/<H^MXO\ Z"JO_@R?_P D'U?#_P#/
MBG_X!'_(/^&/O@CZ?&#_ ,28_:6_^>Y1];Q?_055_P#!D_\ Y(/J^'_Y\4__
M  "/^0?\,??!'T^,'_B3'[2W_P ]RCZWB_\ H*J_^#)__)!]7P__ #XI_P#@
M$?\ (/\ AC[X(^GQ@_\ $F/VEO\ Y[E'UO%_]!57_P &3_\ D@^KX?\ Y\4_
M_ (_Y!_PQ]\$?3XP?^),?M+?_/<H^MXO_H*J_P#@R?\ \D'U?#_\^*?_ (!'
M_(/^&/O@CZ?&#_Q)C]I;_P">Y1];Q?\ T%5?_!D__D@^KX?_ )\4_P#P"/\
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M;H ^@* "@ H ^?\ PY_R=/\ &3_L@'[-/_JQ?VL: /H"@ H * "@ H * "@
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MX*,(1BK]]H&DZCJNB:U>V@GU+PY)?RZ+<--<JMA-J=FVG7LR6Z3+#+,]C)+
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MITW/WG%RU.^J!A0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M^GU2CB*\(66JO2PM>?,UR+V?*Y*4H*6U3$% !0 4 % !0 4 % !0 4 % !0
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M &<!^R=_ZU/\&Z /H"@ H * /G_PY_R=/\9/^R ?LT_^K%_:QH ^@* "@ H
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MWE8T* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /#]6_9D_9MU[5=3U
MW7?V?/@?K.MZSJ%YJVL:QJWPG\!ZCJNJZKJ-S)>:AJ>IZA>:!)/?:A=7<TT\
MUQ/(\DLDKN[,S$D S_\ AD[]EC_HVGX ?^&;^'7_ ,SE 'T!0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % 'S_\ M+?\DZ\.?]G ?LG?^M3_  ;H ^@* "@ H ^?_#G_ "=/
M\9/^R ?LT_\ JQ?VL: /H"@ H * /'_%/[0GP"\#:[?>%O&OQP^#_@_Q-I?V
M7^TO#GBGXE^"_#^NZ=]ML[?4;+[=I&K:U;W=GY^GW=I=1>;$GF0W,4J9216(
M!S__  UC^RQ_T<M\ /\ P\GPZ_\ FCH ]PTG5M*U[2M,UW0M3T_6=$UG3[+5
MM&UC2;RVU'2M5TK4;:.\T_4],U"SDDM[[3[JTFAGAN()'CECE1T9E8$@&A0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!X?JW[3?[-N@:KJ>A:[^T'\
M#]%UO1=0O-)UC1M6^+'@/3M5TG5=.N9+/4-,U/3[S7XY[#4+6[AF@FMYXTDB
MDB='564@ !I/[3?[-NO:KIFA:%^T'\#]9UO6=0LM)T;1M)^+'@/4=5U75=1N
M8[/3],TS3[/7Y)[[4+J[FA@AMX(WDEDE1$5F8 @'N% !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MY_\ VEO^2=>'/^S@/V3O_6I_@W0!] 4 % !0!\_^'/\ DZ?XR?\ 9 /V:?\
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M^UC0!] 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M*DHQ8_==9;>PE1A_U]E7C*=!89[8OV\(5)T?JOME5A2K2AS1I5''JO$'Q8\
M^&?"FB>-;_7)+SP_XF;38_"\OAK1=?\ &6J>)YM6M)+_ $ZW\,^'/".EZEK'
MB&ZFT^&>[$&G6%S(MO:SSNJQ02.BQ$9X3$/"5J<XXF+FG3C3G4E%4E>I4FJ<
M9<E*FK.I6E:E!.+E-*4;U1A*M2K5H+DIX=7JRJM4/9/VD:"IU%6=-PK.O*.'
MC0DE6EB)*A&#JM0///"O[0VB>/?BM8?#[P3I%YK/A]OAZOCS5/&]SI_C?2K:
MR:ZUS5O#]EX>MK6X\!MIW]L1:CH6K0W]IJ^NZ'>VD]I):Q65Y<VE_%INE.C/
MV6:UZJ5.CEWU6-*4&JOUJ6)H4\7&=!Q:A6PSPE:E5HU\'/%NLYV5*%->V>=6
M:A2RNI3O*6/KXZC4A.%6E/"_453C456,J?-#$>VJ*G4P]>-"6'@H5*TXO$X.
MGB>0T_\ ;%^'$MSILNL:5XQ\-^'[^R\>W$FL:GX'^(+76F2> ?'-OX*U*ZU?
M1+3P9)<Z/X6W7 O9_$>H-::=8 ?9[V6*991"8.C/&J@J:Y:F+P^08C#Q:<5)
MY]3S"5*C5J3Y*>&JPJ8&%&A&M*/U]XFG4PG/2E1G7SKU)4,96P<:;J_5<1G6
M'K2A*,WSY/++5+ZK"FZCQRK0Q\ZC6%]I+#K"U8U8\\:T:'MNE_%WX?ZSXON/
M NFZS>3Z_;SWMFCOX<\3VWAV_P!2TN.2;5=&T7QG=Z-'X>U[7]/BAG>\TK3=
M4NKVT6WF:Y@B$3E<Z">(IU:E)-QH1<Y*2Y).E"M'#RKTH3Y9UL-"O.%">)HQ
MG0A6J4Z4JBG4A&5U:D*$\/"I)1>*5/V;7O1YJM#ZU1ISG#FA1K5L+_M-&C5<
M*M;#IUZ<)4DYHU;XL^"M%\7VO@.^N]8@\27\1.G>9X2\8+X9N[W[#=ZE%HJ^
M/%T!O#,7B"2QL;JX327U87S0PM*ML4&3S5*_+AL?7HQ]I+ 4<16=.4O9.JL-
M3]I55%U$G65.+7M94(U?8J\JB2C*W3[%Q>&]H^6GB*E*GS1_>>R]M5C0IRKQ
MIMRH0J591IT9U_90K5)1ITY2E))^9^"_VJOA?XF\"Z9XPU2?7/#E_=:#X2U>
M]\*R^#O'^H:S+=>+K5)-/T_P59IX.@OOB?$U\+JRBO/"UAJ44\UE.BA9(WCC
M]#'4883%5</2J2Q2CB9X:"C3FJ\I0A5K*=3"+GQ%"G+#T*V)C5JPC2>'I5:\
M:DJ-.<UE.+I5L71J6IK"2Q2=24HQHRAA<7'!RE&NVJ,JGMJN'ISH1J2JTJV)
MH4)1]I4IJ?8Z;^T#\)-5T^YU.R\4S&WL[31;NZBNO#7BS3]1MVU_Q3>>"=.T
MV71]0T*"_3Q OBVPN-)NM&-M_:-C=".*^M;=IXO,GV%3GI4X<E5UJ]##TW2J
M4ZL9SQ-+V]"I&=*4X/#3HJI4^N<WU2,*&*<J\?JF)]DIJ5*-1U*<Z?L:.-Q$
MXRA.-2%++J5*OBY.FXJHI4Z->A5C3Y?:5J=>A.A&K&M2<]OPO\7? 'C'Q'J/
MA3P]K%[<ZQIJ7\H%WX;\4:-I6L6^DWD.G:Q=>$O$.M:+::3XVL]-U&YMK2]N
M/#][J<5G/<PPW+Q22HK9T82KX58VDN;#M4I)OW9^SKQ<\/6=*5JRP^)A&4\-
MB'!4,1&+E0J5$FPJ?N:KH334XSE2DTG*G&M!-SP\JL>:E'$TU&?M,,YJO#V=
M3GIQ]G4Y?2JD H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#Y__:6_
MY)UX<_[. _9._P#6I_@W0!] 4 % !0!\_P#AS_DZ?XR?]D _9I_]6+^UC0!]
M 4 % !0!^?OQ1\ >,]=E_:9\#WWP2^+OB/2/B=\4?"/Q%^'WQ)^&VO\ P)@/
MA[4O#OP9^"/AG1M?L;3Q]\:/"^JVNOZ+XY^'>I2^3-IR03101%9I(KIL8U*4
MG5P=>E6J86O@<12KTZM*7)42B^6M34M4HXC#SK8>I=2CR597C*R1K3J1A3Q5
M"I35;#XW#U\+7IRT4Z5>FX/5:QE!N-2G):QJ0A):H]&^&?B#Q1\*O!6C>"?#
MW[*'[14]II<<TMYJFI>*?V6+G6?$&M:A<2W^N>)-=O?^&E ;[7-4U6XNKVZN
M& WS7+X 4*J]V)KJO.'LZ,,-AZ%.G0P]"G?V>'P]&*IT:%/F<I<M."2YI-SG
M+FG.4IRE)\M*%2/M*E>O/%XK$3E5KUZG+SUJLK)R:BHPA&,5&G2I0C&G1HPI
MT:48TJ<(KUS]GKPMKO@;X!? _P %>*;'^R_$W@_X/_#3PMXCTS[59WO]G:[X
M?\%Z+I.KV/VW3KBXM+O[/J%I<1>=:SS0R>7OBD=&5CS[?(UV^1E>+_V>/ /C
M>PU^QUR77]^N_$?1_BBNHV.H6UEJ>B^)=&T[P]HZ1:+=Q:?^YTB[TKP[%9WE
MI<K=?:8-3OXG?RYD6&J$WAYY+4I:3R*K6JT;JZJJOF5?-:E'$Q?NU*/UNNIP
MBE!TWA\+6A*.)H0KF=6E"M#.:52[IYYAH8:O';DC3P,,!3JT&O>IUH4::DIM
MRBY2JPG&6'JU*$N>NOV7O"5^^J6VH>,_B-?>')V\43>'/!]QJ?AG^P/ EWXS
MNIKSQ+>^&)HO"2:M=3W4MU?*B>(-4UV&SCOYXK&*VC8*I@Y/!2R^I#][7RM9
M;2H5:GQQPF4XS 8["8*48<E.5!5<KP$*E1T_KDZ6&A!XI-RE++'X2ACJ.,PT
MX>PH8]YA4K0I:*6*S/!8_ 8K&IU/:2A7E2S/'5(P@XX15\1.I+#2M%1B^)G[
M)_PP^*O]LR^)?MCZCJWC8>.X=0O/#_PV\8IHNK/X/\.^![NVTSP_\2_ /B;P
M_+I]UHGAG3RXU'2+^XCG>6:VN(&\H0YJ$8O -1C? 4L90BW&$G4HX['RS*M3
MG*46X6Q,H^SJ4'1JQI0]DZDH5*ZJ^A5KSK0]G/2"IX6"C&52"3P?UM4:C4)Q
M527)C<1"4*JJ47S1FJ2JTZ=2/=ZW\&/#^H^#O!/A+1M8UOP))\-[G3[WP/XC
M\"V7@W1-3\-7MAH]_P"'S-I^A2^$KGPH+:XT35=4LY=/D\-R:>([]_)M(6CA
M:'?$5Z]?&3QJKU*%:K"I1J<LG453#U73<\/-XGV\Y4W*A1E&3G[:G*C3E3JP
ME&YAA5'"X2M@N2->A747-3BH-U(5XXF%=?5_8*-6.(@JKY4H5&YPK0J4ZE2$
MY?AU\&?#'PSU"ZU31-1\1:AJ&H:!::'JEWKM]97DNISQ>*O&'C2_U^\-KIML
M!K>I>(O'.O7-T8!#: /#':VEM'%M:Y8ANB\-"G"CAXO#*G3CSM4:>$P=' 4*
M4)3G.<H0P]"FG*K.K6G/FG4JRE)@Y5)PP\:]:=>K0JXVLZT^7VE6IC_J2J\Z
MA&%*,:<<!AZ>'IT:=&G1IJ4(PY5!0Y-?V;?")TWQCI-SXE\:WECXQ\/_ !+\
M+R13W7AB,Z#H?Q3\0_\ "4>(+/0Y+/PK Y-MK$EU)93:FVI2QK>21SO<HD0A
MSPM66#IX.$+5)8/^P%&<U[TX\-U,5/+(U%#DA:-+%?5J[A"$JM'#T)7CB77Q
M%=4TJ.:T\VIKEJT:N8UH4=Z"JYJLO>-E9WK/VE;+X8B,76<:=2OB(P4:'L*-
M"GX1_96^%?@?XL:C\7_#^G6=MX@U*ZUO4Y;63P1\)))+?6_$1E;6M;M?''_"
MN%\?17=T;F]#6S>,'L52]FA2T6 I$A@ZDL%AL3A*/NTJ\?9JS=-TZ/MO;N@E
M0=*-:E[11E_M<<1-<E.TU[.'+.(@L2\)*LW*>$AAH*4K5'4^J8:&%H2DJJFJ
M<XT:=--X94$YP=1KGJ5I5)=:_9D\%^(/BO8_%[5O$'BZ\U_1]<7Q#H&G7*^"
M[O3_  YJ$GAT^%]2@T/6+SP9-XFT_0]1TG;]JT5/$!TTW$:W<-I#=#S3S4J2
MH4<70C*36,H8W"U)^[&H\-CE7]K1G*$8>VC2JUW7PTL3[:KAY4J5&E4CA%/#
MSVK5)5O9J_)3I2PD_9KWJ?M<%B</B:-:,:G.J%67U=4:[POL%7I5:TJL95YJ
MM'*TK]E3PUI.D:3I\?Q'^*EUJ?A+3/#>C_#KQ5=W_@8Z_P##;3?#$1CLK7PP
MEMX!ATJ_CN&9VO/^$CTO7C=*5AE)MH(8(>JO6JU\34QO.Z6.KUW6KXB*3G7C
M[#%X:%"K"HIT/8TZ&.Q=.')2A6YJ\J\ZTL3&%:$U5"M5KSJTXRI5_K+5'6,*
M4\7C<)F->I2G%QQ"E+%X#!55&=>=."PT*<::I2JPJ;]E^S9X'M;_ .'FKW6M
M>--7UKX?Z_XB\32:MJ>L6)G\<ZSXHOUUS4[CQU9V.D6UA?PQ^)X-/UNTMM-L
M]*@L;W2;3[''!:H]M*Z=2&'K.IA\/3H4E@W@H4(^T=&G!QQ--5H\]2=6>)C1
MQ^9T?;5JM5RIYGC744ZDZ<Z66)A]<HU:6*:K3K8K#8F55TZ2JKZJL-&GAX2A
M3C&GA91P.7JK2IQC[9X#"3J2E4I<\JWPM_9=^%_P?\<^(O'?@W3[.TO]?744
M2T/@CX36$VCQZM?C4]3BLO&>@_#G3O&NJP7-X [Q:_XIUF,!8U156&(19X23
MP67QRVD[4(PH4D[NF_8X:/)0ISA1=.A5Y(J/[RK1G7G*/M9U959U:E2\2OK>
M,>-JMNK*K6KR3?M$Z]>[JU5*M[6K3;<ZG+"C4ITH1JRI0IQHJ%.'T;4C"@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * /G_ /:6_P"2=>'/^S@/V3O_
M %J?X-T ?0% !0 4 ?/_ (<_Y.G^,G_9 /V:?_5B_M8T ?0% !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M_P "A_\ *P_M3$?R4_NE_P#)AYGQM_Z.B^,'_A)?LT__ $/U']AX3_GY5_\
M H?_ "L/[4Q'\E/[I?\ R8>9\;?^CHOC!_X27[-/_P!#]1_8>$_Y^5?_  *'
M_P K#^U,1_)3^Z7_ ,F'F?&W_HZ+XP?^$E^S3_\ 0_4?V'A/^?E7_P "A_\
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M_P!#]1_8>$_Y^5?_  *'_P K#^U,1_)3^Z7_ ,F'F?&W_HZ+XP?^$E^S3_\
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M_P#)AYGQM_Z.B^,'_A)?LT__ $/U']AX3_GY5_\  H?_ "L/[4Q'\E/[I?\
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M_P "A_\ *P_M3$?R4_NE_P#)AYGQM_Z.B^,'_A)?LT__ $/U']AX3_GY5_\
M H?_ "L/[4Q'\E/[I?\ R8>9\;?^CHOC!_X27[-/_P!#]1_8>$_Y^5?_  *'
M_P K#^U,1_)3^Z7_ ,F'F?&W_HZ+XP?^$E^S3_\ 0_4?V'A/^?E7_P "A_\
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MW-\+CZU:O3I2C",97O923TBVMY-=.Q^J=> >N% !0!\!_$W_ ).G\>_]D ^
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M6/$PYK1>,52O4QU/$PJ2K1P\85+>S]@I+M?@3)KEAJGP<-WXN\8^(?\ A/\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!Y[\1O^//P!_V7_\
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MZNC^U<!_S_\ _)*G_P @']GXO_GU_P"30_\ D@_X6-9_]"!\?_\ Q&']H_\
M^=71_:N _P"?_P#Y)4_^0#^S\7_SZ_\ )H?_ "1A2^(?#$WB6R\7R?#/X_MX
MBT_1=0\/6>H_\,U?M-+Y.CZI>Z=J-_9_9%^&0MI/-O-*L)/->%I5^S[4=5=U
M<IYK@*3Q+IU^5XM8=5?<J/F6%>(=#>#Y?9O%8CX>7F]I[_-RPY2> QDXT(2I
M7CAIU*E-<T%RSJPA3J/22;YHTX*TKI6O%)MM[O\ PL:S_P"A ^/_ /XC#^T?
M_P#.KH_M7 ?\_P#_ ,DJ?_(!_9^+_P"?7_DT/_D@_P"%C6?_ $('Q_\ _$8?
MVC__ )U=']JX#_G_ /\ DE3_ .0#^S\7_P ^O_)H?_)!_P +&L_^A ^/_P#X
MC#^T?_\ .KH_M7 ?\_\ _P DJ?\ R ?V?B_^?7_DT/\ Y(/^%C6?_0@?'_\
M\1A_:/\ _G5T?VK@/^?_ /Y)4_\ D _L_%_\^O\ R:'_ ,D'_"QK/_H0/C__
M .(P_M'_ /SJZ/[5P'_/_P#\DJ?_ " ?V?B_^?7_ )-#_P"2#_A8UG_T('Q_
M_P#$8?VC_P#YU=']JX#_ )__ /DE3_Y /[/Q?_/K_P FA_\ )!_PL:S_ .A
M^/\ _P"(P_M'_P#SJZ/[5P'_ #__ /)*G_R ?V?B_P#GU_Y-#_Y(/^%C6?\
MT('Q_P#_ !&']H__ .=71_:N _Y__P#DE3_Y /[/Q?\ SZ_\FA_\D'_"QK/_
M *$#X_\ _B,/[1__ ,ZNC^U<!_S_ /\ R2I_\@']GXO_ )]?^30_^2#_ (6-
M9_\ 0@?'_P#\1A_:/_\ G5T?VK@/^?\ _P"25/\ Y /[/Q?_ #Z_\FA_\D'_
M  L:S_Z$#X__ /B,/[1__P ZNC^U<!_S_P#_ "2I_P#(!_9^+_Y]?^30_P#D
M@_X6-9_]"!\?_P#Q&']H_P#^=71_:N _Y_\ _DE3_P"0#^S\7_SZ_P#)H?\
MR0?\+&L_^A ^/_\ XC#^T?\ _.KH_M7 ?\__ /R2I_\ (!_9^+_Y]?\ DT/_
M )(/^%C6?_0@?'__ ,1A_:/_ /G5T?VK@/\ G_\ ^25/_D _L_%_\^O_ ":'
M_P D'_"QK/\ Z$#X_P#_ (C#^T?_ /.KH_M7 ?\ /_\ \DJ?_(!_9^+_ .?7
M_DT/_D@_X6-9_P#0@?'_ /\ $8?VC_\ YU=']JX#_G__ .25/_D _L_%_P#/
MK_R:'_R0?\+&L_\ H0/C_P#^(P_M'_\ SJZ/[5P'_/\ _P#)*G_R ?V?B_\
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M2I_\@']GXO\ Y]?^30_^2#_A8UG_ -"!\?\ _P 1A_:/_P#G5T?VK@/^?_\
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M&']H_P#^=71_:N _Y_\ _DE3_P"0#^S\7_SZ_P#)H?\ R0?\+&L_^A ^/_\
MXC#^T?\ _.KH_M7 ?\__ /R2I_\ (!_9^+_Y]?\ DT/_ )(/^%C6?_0@?'__
M ,1A_:/_ /G5T?VK@/\ G_\ ^25/_D _L_%_\^O_ ":'_P D'_"QK/\ Z$#X
M_P#_ (C#^T?_ /.KH_M7 ?\ /_\ \DJ?_(!_9^+_ .?7_DT/_D@_X6-9_P#0
M@?'_ /\ $8?VC_\ YU=']JX#_G__ .25/_D _L_%_P#/K_R:'_R0?\+&L_\
MH0/C_P#^(P_M'_\ SJZ/[5P'_/\ _P#)*G_R ?V?B_\ GU_Y-#_Y(/\ A8UG
M_P!"!\?_ /Q&']H__P"=71_:N _Y_P#_ ))4_P#D _L_%_\ /K_R:'_R0?\
M"QK/_H0/C_\ ^(P_M'__ #JZ/[5P'_/_ /\ )*G_ ,@']GXO_GU_Y-#_ .2#
M_A8UG_T('Q__ /$8?VC_ /YU=']JX#_G_P#^25/_ ) /[/Q?_/K_ ,FA_P#)
M!_PL:S_Z$#X__P#B,/[1_P#\ZNC^U<!_S_\ _)*G_P @']GXO_GU_P"30_\
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MV?B_^?7_ )-#_P"2#_A8UG_T('Q__P#$8?VC_P#YU=']JX#_ )__ /DE3_Y
M/[/Q?_/K_P FA_\ )!_PL:S_ .A ^/\ _P"(P_M'_P#SJZ/[5P'_ #__ /)*
MG_R ?V?B_P#GU_Y-#_Y(/^%C6?\ T('Q_P#_ !&']H__ .=71_:N _Y__P#D
ME3_Y /[/Q?\ SZ_\FA_\D'_"QK/_ *$#X_\ _B,/[1__ ,ZNC^U<!_S_ /\
MR2I_\@']GXO_ )]?^30_^2#_ (6-9_\ 0@?'_P#\1A_:/_\ G5T?VK@/^?\
M_P"25/\ Y /[/Q?_ #Z_\FA_\D'_  L:S_Z$#X__ /B,/[1__P ZNC^U<!_S
M_P#_ "2I_P#(!_9^+_Y]?^30_P#D@_X6-9_]"!\?_P#Q&']H_P#^=71_:N _
MY_\ _DE3_P"0#^S\7_SZ_P#)H?\ R0?\+&L_^A ^/_\ XC#^T?\ _.KH_M7
M?\__ /R2I_\ (!_9^+_Y]?\ DT/_ )(/^%C6?_0@?'__ ,1A_:/_ /G5T?VK
M@/\ G_\ ^25/_D _L_%_\^O_ ":'_P D'_"QK/\ Z$#X_P#_ (C#^T?_ /.K
MH_M7 ?\ /_\ \DJ?_(!_9^+_ .?7_DT/_D@_X6-9_P#0@?'_ /\ $8?VC_\
MYU=']JX#_G__ .25/_D _L_%_P#/K_R:'_R0?\+&L_\ H0/C_P#^(P_M'_\
MSJZ/[5P'_/\ _P#)*G_R ?V?B_\ GU_Y-#_Y(/\ A8UG_P!"!\?_ /Q&']H_
M_P"=71_:N _Y_P#_ ))4_P#D _L_%_\ /K_R:'_R0?\ "QK/_H0/C_\ ^(P_
MM'__ #JZ/[5P'_/_ /\ )*G_ ,@']GXO_GU_Y-#_ .2#_A8UG_T('Q__ /$8
M?VC_ /YU=']JX#_G_P#^25/_ ) /[/Q?_/K_ ,FA_P#)!_PL:S_Z$#X__P#B
M,/[1_P#\ZNC^U<!_S_\ _)*G_P @']GXO_GU_P"30_\ D@_X6-9_]"!\?_\
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M#_A8UG_T('Q__P#$8?VC_P#YU=']JX#_ )__ /DE3_Y /[/Q?_/K_P FA_\
M)!_PL:S_ .A ^/\ _P"(P_M'_P#SJZ/[5P'_ #__ /)*G_R ?V?B_P#GU_Y-
M#_Y(X[QCXUMM6?X<:?'X0^,&EO/\?_V9MM_XI^!'QK\&:%;^5^T1\+YS]N\2
M>+O &FZ3IN\1&.+[7>P^=-)%;Q;YYXHY./,,PPE?"5:5*KS3ERV7+-;3BWJX
MI:)/J=.#P>(HXBG4J4^6$>:[YHO>,DM%)O=GZUU\T>V% !0!\_\ AS_DZ?XR
M?]D _9I_]6+^UC0!ZKXY\8:9\/\ P=XF\;:S#?7.E^%=%O\ 6[RTTR*"?4[R
M*PMWG^Q:=#=7-O#-?W#*L,*2W$"-)*@>1%)81*4U+#TJ5*5>OBL1AL+1I0<%
M*I7Q>(IX6A34JLZ=.//6JPCS3G"$4W*4DDV7",'SRJUH86A0IU:U:M5Y_9T:
M&'I3K5ZU3V<*E3DI4J<ZDE"$YM1:C"4K)^?^&?CUX(U:WO4\7>?\(-?T[Q3;
M^#+OPE\4]9\$Z-K?_"0W^GZ+JVE6&GW6A>+=8T;79;[3O$.BS0)I6K7SDZA'
M#(L=P&A7I]BI?5%0JPQ%3&1Q$J=.ES.K?"5GA\3%TI1C4?L:G*I3A&=)JI3E
M"I)33,VJD(NI5HSH450IXF-6:BJ<L/4CB91K<T924$OJ6,4X5?9U8?5:\ITX
MTX<[[31?B9\-_$DM]!X=^(/@C7I]+U__ (134H=%\5Z#JDNG>*=DT@\-7T=C
M?RM::_Y=O<-_9\H2XQ!(?+PC8Q@N>GAJM/WJ.+55T)QUA65"#JUG1DO=J*C2
MC*I5<'+V<(N<K13955.A4K4:R=&KAHTI5837).E&O4C2H2J1E9PC6JSA2I.2
M2J5)QA"\I).G>?%;X?Z8NM7NI^+O"VF>'?#NE6FK:WXNO_%WA&T\-Z5%=ZEJ
MNE1P:E=3:\MQIL@N]%U!//N[6"T=K::**YDGMKB*WCGA&BJ\Y*E0G.C3HU)-
M*%>=>A3Q,(T9IN,I>PKX6LHMQG.EB\-5HQJ4ZG.A*]3V-/\ >5H1Q$JM.-W4
MH1P]7V$Y58M)QBZT,11O'F5.KA,33K^RG&"J8_A?XZ?"OQ5:>$KBS\;>&=/F
M^(%YKUO\/M,UCQ)X<LM6\>6F@:M?:5+K'@W3TU>67Q'I%VEB;ZUGLA*SV=W;
MS2)$9"B=/L*OM*=%0D\3+!X;'5*"C+V^'P^)P\,3!XBE;GHRITYI5N9<M.<9
MP<KQ9G[2G[.M7A44L)0Q4L$\2KK#SQ5.I[&=&G5DHQG*-=3H1MI5G!RH.K2E
M3J3N^/?C%\.OAM>Z#HWBCQ3HMIXH\5:II&C^%/!BZQHT?C#Q/>:SK6GZ%"=
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M80J5)3D^6$847256;D[14*3K454DW:#JTN9KVD;X>H_&+X7:=JGB7PW_ ,+
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M2L-2%R@M]83HQQ%*52B\5A8X?$X>O#$2C6JU_K>-J9AB9R<Z;P;]MB)PNJV
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MZ&'K)13^IU,1E]?-*<:\YRIX?7!8>=1SIUYT*4W&%>M1]Z4+=G\?[E4F.I^
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MP?\ &"[\*>(M.^%X\GP;H/BJ33+6UO?B^/\ A86KZE>>(+?2=(N[+Q'X=@U
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M9BUN3-YPP689GA,%5^M4L!A\=BJ#5-U*F.A@\1AZ,:-&,:D%&52E7EB:E?\
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ML]"^*_C.3XH6_A'Q3_P@'B/P'\/K'PV^E^)_"OA"+XC27MS#JFN>(7TJ$?\
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M)Z&D).4(2<'2<DFX2Y>:#:NXR<)2A>.SY92C=>[)JS)*DH* "@ H * "@ H
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^?_VEO^2=>'/^S@/V3O\
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MI_\ HBZ #_AIS7/^C8OV@/\ P;?LT_\ T1= !_PTYKG_ $;%^T!_X-OV:?\
MZ(N@#%@_:^DN?$6J^$X/V;OV@'\0:)HN@>(M3T_[=^SFOV71_%%]XETW0KS[
M4_[0@MIOM-[X0\11^5%-)+%_9VZ9(TG@:8 VO^&G-<_Z-B_: _\ !M^S3_\
M1%T '_#3FN?]&Q?M ?\ @V_9I_\ HBZ #_AIS7/^C8OV@/\ P;?LT_\ T1=
M!_PTYKG_ $;%^T!_X-OV:?\ Z(N@ _X:<US_ *-B_: _\&W[-/\ ]$70 ?\
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M1?\ Z$Z@ _X2/]J?_HC?P _\26^(O_T)U !_PD?[4_\ T1OX ?\ B2WQ%_\
MH3J .0\:Z)^TE\2K'PWX:UWX>? _PKHEI\4/@UXUUC6])^.WCSQ3JMKI7PR^
M+G@CXDZA;Z9X?O/V<-"M]2U"\M/"<UE"D^KV$:R7B2/*%C*L ?5] !0 4 %
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M=_9]0M+2ZB\V)_+FM8I4P\:L#] _0W_^&3OV6/\ HVGX ?\ AF_AU_\ ,Y0
M?\,G?LL?]&T_ #_PS?PZ_P#F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\ #)W[
M+'_1M/P _P##-_#K_P"9R@ _X9._98_Z-I^ '_AF_AU_\SE !_PR=^RQ_P!&
MT_ #_P ,W\.O_F<H /\ AD[]EC_HVGX ?^&;^'7_ ,SE !_PR=^RQ_T;3\ /
M_#-_#K_YG* #_AD[]EC_ *-I^ '_ (9OX=?_ #.4 '_#)W[+'_1M/P _\,W\
M.O\ YG* #_AD[]EC_HVGX ?^&;^'7_S.4 '_  R=^RQ_T;3\ /\ PS?PZ_\
MF<H \@^-O[/7P"\#>%_!OBGP5\#_ (/^#_$VE_'_ /98_LSQ'X6^&G@OP_KN
MG?;?VFOA'IUY]AU?2=%M[NS\_3[N[M9?*E3S(;F6)\I(RDV\K!MY6/M^@ H
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M=HQ245LDDE9(QA3ITDU2IQIJ4I2:C%13E)WE)I)7E)ZR;U;U9M5F6% !0 4
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MQ%_^BQH /^$<_:G_ .BR? #_ ,1I^(O_ -%C0!R'@?X3?M)> -%O="T;XV?
M^YM+[QA\0O&LLFI_LW>/)KE-5^)7C[Q-\1M=MXWM?VIK=%T^#6_%6H06B&-I
M([6&W2:6>9'GF-@V.O\ ^$<_:G_Z+)\ /_$:?B+_ /18T '_  CG[4__ $63
MX ?^(T_$7_Z+&@#L/@]X!U7X:>"!X:UWQ#I_BG6[OQA\3/&NL:WI/A^Y\*Z5
M<ZK\3/B7XN^).H6^F>'[SQ%KL^FZ?9W?BR:RA2?5[^1H[-)'E+2%5-@V/4*
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M6A"4:-2$(0G3<812Z#QU\(? 7Q'FT&X\6:7J=S<>&HM2M=*N-(\5^+O"D_\
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MV)K3KUIV6D>>K4G/EBE&-^6$8Q22\9^,G_)1?V3O^S@/$?\ ZRQ^TM2$?0%
M!0 4 % !0 4 % !0 4 % !0 4 ?/_P"TM_R3KPY_V<!^R=_ZU/\ !N@#Z H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M /G_ /:6_P"2=>'/^S@/V3O_ %J?X-T ?0% !0 4 ?/_ (<_Y.G^,G_9 /V:
M?_5B_M8T ?0% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!Q_
MC7X>^ ?B3I5OH7Q%\#^#_'VB6FH1:M:Z-XU\,Z+XITJUU6WMKNS@U.WT_7;*
MZMX=0CM+^^@2X2-9%CO)T#!97#'Z!^AY?_PR=^RQ_P!&T_ #_P ,W\.O_F<H
M /\ AD[]EC_HVGX ?^&;^'7_ ,SE !_PR=^RQ_T;3\ /_#-_#K_YG* #_AD[
M]EC_ *-I^ '_ (9OX=?_ #.4 '_#)W[+'_1M/P _\,W\.O\ YG* #_AD[]EC
M_HVGX ?^&;^'7_S.4 '_  R=^RQ_T;3\ /\ PS?PZ_\ F<H /^&3OV6/^C:?
M@!_X9OX=?_,Y0 ?\,G?LL?\ 1M/P _\ #-_#K_YG* #_ (9._98_Z-I^ '_A
MF_AU_P#,Y0 ?\,G?LL?]&T_ #_PS?PZ_^9R@ _X9._98_P"C:?@!_P"&;^'7
M_P SE &AI/[,G[-N@:KIFNZ%^SY\#]%UO1=0LM6T;6-)^$_@/3M5TG5=.N8[
MS3]3TS4+/0(Y[#4+6[AAGAN()$DBDB1T964$&WE8-O*Q[A0 4 % !0 4 % !
M0 4 >'_&?Q;X^T"^^#_AKX<ZCX/T76_B;\4+SP5=:WXU\*:UXTTK2=*T[X1_
M%;XDSW%OX?T+QOX4GNM0FN_A]8V2.^KI'%'?SR&*5E10?H'Z&?\ \(Y^U/\
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MT '_  CG[4__ $63X ?^(T_$7_Z+&@ _X1S]J?\ Z+)\ /\ Q&GXB_\ T6-
M!_PCG[4__19/@!_XC3\1?_HL: #_ (1S]J?_ *+)\ /_ !&GXB__ $6- !_P
MCG[4_P#T63X ?^(T_$7_ .BQH /^$<_:G_Z+)\ /_$:?B+_]%C0 ?\(Y^U/_
M -%D^ '_ (C3\1?_ *+&@ _X1S]J?_HLGP _\1I^(O\ ]%C0 ?\ ".?M3_\
M19/@!_XC3\1?_HL: #_A'/VI_P#HLGP _P#$:?B+_P#18T '_".?M3_]%D^
M'_B-/Q%_^BQH /\ A'/VI_\ HLGP _\ $:?B+_\ 18T '_".?M3_ /19/@!_
MXC3\1?\ Z+&@ _X1S]J?_HLGP _\1I^(O_T6- '0? OQCXJ\<?#]]7\:R^'[
MCQ-I?Q ^,7@74KSPMH^H^']"U'_A6/Q?\=?#>RU2QT35O$.NW>E?;M/\*6EW
M+;2ZO?\ ES74JI,4"@ 'L% 'S_\ M+?\DZ\.?]G ?LG?^M3_  ;H ^@* "@
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MAEV(RJ&)J5HQKX>C2@Z.,JJGSXC"U(X>5*6#KNO6C.J\?Q5KGQ]\*VWQ(O-
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M%*NL+3;P.#Q&(Q6$G/I?C+]J#5[6&PLM;^+=OK>J?\(3;?$.?7?@EH6BZ?\
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MS_\ M+?\DZ\.?]G ?LG?^M3_  ;H ^@* "@ H ^?_#G_ "=/\9/^R ?LT_\
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M=DCKZ "@#Y_^,G_)1?V3O^S@/$?_ *RQ^TM0!] 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MVIZ%_;NF>"?%WC][&^3P!\:/$FJVWG>'_!&O&*8:7)#YT,44LD?G*U 'T!0
M4 % !0 4 % !0 4 ?,'[3OD>1\%_L?\ PN#_ (3;_A<$_P#PK;_A2G_"FO\
MA*O^$J_X4U\8/[6^W_\ "^/^*2_X1_\ X5W_ ,)UYOVG_2?M/V'[+^]H \?_
M .,BO^K_ /\ \Y94 '_&17_5_P#_ .<LJ #_ (R*_P"K_P#_ ,Y94 '_ !D5
M_P!7_P#_ )RRH /^,BO^K_\ _P Y94 '_&17_5__ /YRRH /^,BO^K__ /SE
ME0 ?\9%?]7__ /G+*@ _XR*_ZO\ _P#SEE0 ?\9%?]7_ /\ YRRH /\ C(K_
M *O_ /\ SEE0 ?\ &17_ %?_ /\ G+*@ _XR*_ZO_P#_ #EE0 ?\9%?]7_\
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M@ _XR*_ZO_\ _.65 !_QD5_U?_\ ^<LJ #_C(K_J_P#_ /.65 !_QD5_U?\
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M0#]I;_U8O[)U24?0% !0 4 % !0 4 % !0 4 % !0 4 ?/\ \9/^2B_LG?\
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MG0?0% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M*O6='#T/:.$<)*O.C*G^[JTI8A4%6<*]/EK1Y_JU!Z5+1E3C*'+*[>A/\(O
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * /G_ .#?_)1?VL?^S@/#G_K+'[-- 'T!0!\_
M_M+?\DZ\.?\ 9P'[)W_K4_P;H ^@* "@ H ^?_#G_)T_QD_[(!^S3_ZL7]K&
M@#Z H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /G#XH)XWT#
MXT?"SXB^&OA=XP^)NB:+\+_C7X*UNU\%:O\ #33M5TG5?&GBOX"Z[X?N+B#X
MD_$#PI;W6GS6GP^\1H[V5S=21210"2)5G5P;!L7_ /A<GQ%_Z-._: _\*/\
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MU !_PN3XB_\ 1IW[0'_A1_LL?_1+4 '_  N3XB_]&G?M ?\ A1_LL?\ T2U
M!_PN3XB_]&G?M ?^%'^RQ_\ 1+4 '_"Y/B+_ -&G?M ?^%'^RQ_]$M0 ?\+D
M^(O_ $:=^T!_X4?[+'_T2U !_P +D^(O_1IW[0'_ (4?[+'_ -$M0 ?\+D^(
MO_1IW[0'_A1_LL?_ $2U !_PN3XB_P#1IW[0'_A1_LL?_1+4 '_"Y/B+_P!&
MG?M ?^%'^RQ_]$M0 ?\ "Y/B+_T:=^T!_P"%'^RQ_P#1+4 '_"Y/B+_T:=^T
M!_X4?[+'_P!$M0 ?\+D^(O\ T:=^T!_X4?[+'_T2U !_PN3XB_\ 1IW[0'_A
M1_LL?_1+4 '_  N3XB_]&G?M ?\ A1_LL?\ T2U !_PN3XB_]&G?M ?^%'^R
MQ_\ 1+4 '_"Y/B+_ -&G?M ?^%'^RQ_]$M0 ?\+D^(O_ $:=^T!_X4?[+'_T
M2U !_P +D^(O_1IW[0'_ (4?[+'_ -$M0 ?\+D^(O_1IW[0'_A1_LL?_ $2U
M !_PN3XB_P#1IW[0'_A1_LL?_1+4 '_"Y/B+_P!&G?M ?^%'^RQ_]$M0 ?\
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M*491P].I*O5C3]&D\(?%U_B-!^T(WP?\3&[@^)IN$^$@\0_"EO'Z^"#\(I?
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MR/NBH&% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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ML>-?$VB^%=*N=5GMKN\@TRWU#7;VUMYM0DM+"^G2W20R-'9SN%*PN5 /+_\
MAK']EC_HY;X ?^'D^'7_ ,T= 'J'@KXA> ?B3I5QKOPY\<>#_'VB6FH2Z3=:
MQX*\3:+XITJUU6WMK2\GTRXU#0KVZMX=0CM+^QG>W>19%CO('*A94+ '84 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M5>%&'URG@*57$U:4%*G6K8>E/EE4IMJ=:G3IP4JM>=+!8ZK0II2J8:,6F^K
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'S_\ M+?\DZ\.?]G
M?LG?^M3_  ;H ^@* "@ H ^?_#G_ "=/\9/^R ?LT_\ JQ?VL: /H"@ H *
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M]&T_ #_PS?PZ_P#F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\ #)W[+'_1M/P
M_P##-_#K_P"9R@ _X9._98_Z-I^ '_AF_AU_\SE !_PR=^RQ_P!&T_ #_P ,
MW\.O_F<H /\ AD[]EC_HVGX ?^&;^'7_ ,SE !_PR=^RQ_T;3\ /_#-_#K_Y
MG* #_AD[]EC_ *-I^ '_ (9OX=?_ #.4 '_#)W[+'_1M/P _\,W\.O\ YG*
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M.4 '_#)W[+'_ $;3\ /_  S?PZ_^9R@ _P"&3OV6/^C:?@!_X9OX=?\ S.4
M'_#)W[+'_1M/P _\,W\.O_F<H /^&3OV6/\ HVGX ?\ AF_AU_\ ,Y0 ?\,G
M?LL?]&T_ #_PS?PZ_P#F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\ #)W[+'_1
MM/P _P##-_#K_P"9R@ _X9._98_Z-I^ '_AF_AU_\SE !_PR=^RQ_P!&T_ #
M_P ,W\.O_F<H /\ AD[]EC_HVGX ?^&;^'7_ ,SE !_PR=^RQ_T;3\ /_#-_
M#K_YG* #_AD[]EC_ *-I^ '_ (9OX=?_ #.4 '_#)W[+'_1M/P _\,W\.O\
MYG* #_AD[]EC_HVGX ?^&;^'7_S.4 '_  R=^RQ_T;3\ /\ PS?PZ_\ F<H
M/^&3OV6/^C:?@!_X9OX=?_,Y0 ?\,G?LL?\ 1M/P _\ #-_#K_YG* #_ (9.
M_98_Z-I^ '_AF_AU_P#,Y0 ?\,G?LL?]&T_ #_PS?PZ_^9R@ _X9._98_P"C
M:?@!_P"&;^'7_P SE !_PR=^RQ_T;3\ /_#-_#K_ .9R@ _X9._98_Z-I^ '
M_AF_AU_\SE !_P ,G?LL?]&T_ #_ ,,W\.O_ )G* #_AD[]EC_HVGX ?^&;^
M'7_S.4 '_#)W[+'_ $;3\ /_  S?PZ_^9R@ _P"&3OV6/^C:?@!_X9OX=?\
MS.4 '_#)W[+'_1M/P _\,W\.O_F<H /^&3OV6/\ HVGX ?\ AF_AU_\ ,Y0
M?\,G?LL?]&T_ #_PS?PZ_P#F<H /^&3OV6/^C:?@!_X9OX=?_,Y0!0_93TG2
MM ^$NH:%H6F:?HNB:+\</VI-)T;1M)LK;3M*TG2M._:>^,%GI^F:9I]G'';V
M&GVMI##!#;P1I'%'$B(JJH  /H^@#Y__ &EO^2=>'/\ LX#]D[_UJ?X-T ?0
M% !0 4 ?/_AS_DZ?XR?]D _9I_\ 5B_M8T ?0% !0 4 % !0 4 ?/_QD_P"2
MB_LG?]G >(__ %EC]I:@#Z H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@#Y__ &:?^2=>(_\ LX#]K'_UJ?XR4 ?0% 'S
M_P#M+?\ ).O#G_9P'[)W_K4_P;H ^@* "@ H ^?_  Y_R=/\9/\ L@'[-/\
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MGP _\1I^(O\ ]%C0 ?\ ".?M3_\ 19/@!_XC3\1?_HL: #_A'/VI_P#HLGP
M_P#$:?B+_P#18T '_".?M3_]%D^ '_B-/Q%_^BQH /\ A'/VI_\ HLGP _\
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M@!_XC3\1?_HL: #_ (1S]J?_ *+)\ /_ !&GXB__ $6- !_PCG[4_P#T63X
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MR? #_P 1I^(O_P!%C0 ?\(Y^U/\ ]%D^ '_B-/Q%_P#HL: #_A'/VI_^BR?
M#_Q&GXB__18T '_".?M3_P#19/@!_P"(T_$7_P"BQH /^$<_:G_Z+)\ /_$:
M?B+_ /18T '_  CG[4__ $63X ?^(T_$7_Z+&@ _X1S]J?\ Z+)\ /\ Q&GX
MB_\ T6- !_PCG[4__19/@!_XC3\1?_HL: #_ (1S]J?_ *+)\ /_ !&GXB__
M $6- !_PCG[4_P#T63X ?^(T_$7_ .BQH /^$<_:G_Z+)\ /_$:?B+_]%C0
M?\(Y^U/_ -%D^ '_ (C3\1?_ *+&@ _X1S]J?_HLGP _\1I^(O\ ]%C0 ?\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MPW^U%\56@\97MIX4M_&=^FN+JMNL/]KV_A :7J.IGPGX"\'>$M5ATYH["_\
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M5A@YY_4D\.ZU&2A4J5,!E5+,,QQ7NPI86OE\Z<U5IM5%O5E1PM3$^TIRKX?
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MJPV_B"_T^33;?^QY9<SK,L<>."@L55RB,_W%/,J.#J)2<;U9XOVE>-*A6O\
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MK1XV\/\ A?P9I\_C[P?>ZQ\,KW^T]9U6^L)O$WQ$\.^!/A+J7B?3I](MX?\
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M-92C"4<+2E%2CA*498>#2:I4*<9\DJ4=HTZ<:E3DE%<L(U)\K2G*^;XD\-_
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MYG6P:DXNK-8'%87!X)R]@XK X3VS=+!TZ-:U??LP>-M*TW39/#-G\/I]=A\
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M4G6P&(PV=9AC<;%TL36IPP\<+AU&JX.<,L51>)PV+@XI5<<I\RYKJC*I3PV
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M_9J^,GB?5M3\1>+M-^'VI7L^F>,HK_3;/QOJ6D1^)=6\<W]CH.LWFGZAX?\
MAEI=YX02T^'#:_9:=+>7GB6>2XU*V&H,\=J6?APD8X;"*G*,O:SH8&A)1G&T
M$L1_:F/J7E3]A4]IG.%RZLJ$L*Z53"1Q5.I*52L=>+=.OC'4I+DA0Q>(Q6&K
M/G4X>QP=?+<MI2A":JJ7U'%U5B,5#%1JX?%4:53!TXPLH^PZ9\$_B#HGP#\2
M>!].U#PT?B!XFUM-5U>Y1K'1(M8T$:[I:S^$]:\6^$?!FBM?ZI)\/=-7PS_P
MDP\.0S[1#*]L_D MT8JJJSR6%6E'&8; 5*$\71=Z5'%R56=?$-49_6*<85:\
MHU<1AW&-''<E:$X86.+E&CCA%&C+,G>IA_:X7$X;+Y1J.=7 MX.I1P<HUHJ%
M6V'QE2>+HVE.KA/:*$*V(G156MSFI_ OQ_=^(+;7;'X?_ _3(=9\+Z]HEYH%
MO?ZL/#_@?7+]]/T?2?&?]EGP>;7XAZ[8^"[1M/0FW\,&/,]G#+';:A/<Q\\J
M$:]+-,%B<3/V.:4J"GB:<%[:BYO%RS2GA85)2Y'C;Y;'ZQ*JU4GE\,35P\>2
M&%E5&J\//+:]*A'ERNK/EPKDHQQ%&C&A++E6Q$:<I1CA:T\UJ>PA3G"$<QBE
M*M5PZKO$T7]DJ_T6S\.^9I/@'Q#J7A:^\5^(+&Y\0M-J$U_JOA?P;'\-/@)H
MNI7EUX>FDDT/2_"P?4]0X86VK+YMI;W'F-*.C'5ZV,6.KQE##8['8/&IU(TH
M_NLSSO'QQ>8XU-2C*<L!A8_V7@9R_>XG!\D:LL-[-1<8&AA\-'#86K6K5<!3
MQ.5T:L>2E>>49=AY5*N'A%*,:$L9G-LTE1I.,*3G5H^VG3?)+A_!?[-OC7Q'
MHOB#0YM \,>&=,M-3\(>'O"?Q&UI+Q_B#;Z%\#KBT&BV=CX8N_"UN=,TO7OB
M9I&N>)FU*/6QYVG>(\PVGF31R1&*J5*F&^L8!_V9B:T\;C\-2C-SY7B<%++\
MEHUJD7&>%_LW*X8'VN':Q,HXJC5IS5\3B8TM:-65+%<F*4<:GAHX/'2BN3#R
MJX^K5Q_$5?"4&G1E/%5<?B<!1G3C1A%8>A7YZL<%AXU^@\'?LC>)&D\'?\)S
M9>&I+'39=&TGQA97/BFX\87/BGP]I][#XUU^;5+O_A!/#\.N3:_\1_#_ (2F
MFMM6M[V46<.J237\TNHO:KT*O0I5ZE:A1C3H7]O0POLZ?LZ-3!X;%8/)J#>L
M4L#',L9BUB*-*G*GB<-@E"%2SJT^.I3KU*$H5:\JN-:J4YXR/+2E5>-Q&&EF
MM54XQDZ-/%X/"RP?U9590Y,9)0=".%A[=^I_LM_$2_FT&TCM?A]:0_VIXFUW
M6=1&H+J&AP1^/O'%SXA\=^"]1^&VO> =2T;Q7X;NO#5EX9T6SNK63PYJ$/V6
M[E>Z4,J3<6%G5PBPCI<JJX'"8.E[_-4AB*V'H5,5*:E>.)PE1Y]BL;C(5Z&(
M484)87FP]:6$A1EVUY1E/%5*4I495L57J4?87P\L,J5*AEV6XE>_5I5JE/*L
M+06)HUZ-12Q/UF.'K8>GC)U:68G[,7QFUBR\3ZEXDB^'\'B;5?A[XC\++;Z;
MXH=-*U/7_B/KVF?\+$U:)M,^$^ER>&+&+PO8WUII"RCQ%=,VJ*U_.TEOYK:4
MXX6ERQ5%UZ$\7D\:E.O:I/\ LW!XSZ_F-*K.+A1K5\PQ%/#>UA##T*,?83E3
MG'V\HQ4ZE2&*C5PM;ZI'"?VG7PLX4H-TL9# 3R_A^<:51S7L<#1K58UXU*E3
MG3IQ]G*%)0ET,'[,_P 18+[7X)=,^&&H:7XYT+Q3ILQO+R_>S^%VI^)-9U#3
MYM;\.^')?"LMKXPO+?X:6G@;0[4S2Z$T;>%94:46^HRD9N%/%866!QTZKA6I
M815\5&:>(E&<\1C\VPF&347A8XK-L7B*E/$QJR2H?4Y5,-*IEE"E6FE-8.I@
ML9@\-"-? 8BM*EAIU:LL-.%##9;@<HJUFDG.5##X/%5\32C"+>(S'&0H5J:Q
M=6O#>'P \1^$6T3Q?I_AWPOXF\4:!X\U?QBT(O[B/6M:M?#GA>?X=?!/P;_P
MDT_A^>YLM(L]$FT[4M4N&"PVUY:7;I'/%=325U4L2WCL'6K1C&5>&*EB:M.*
MIJ&8YWF-*IFF-E"+C&O1P&55\PP6$C4?M<12HX&FHTJD::AR/#0HX"O@J,I5
M:&&I9;AL-"M[\UE^2X18JE0H2YHJAB,?GF$PV)G=58PAC<9&4YM0;Z#]J.7X
MQ:K#X7\._#3X.^+O'D&FW#>-+W6M(U_X3Z7H(\3:3IFO+X(T.YA\<?$G0-4D
M.G>-8_#FOW<\.F20?9[&U2WFGN'GAM//G153$-NK.A16&Q="G5I->VI5,=&&
M7UJZ@[0DZ64XG-'1BZD5]=EA+N--3JT^^A5A"C&G7PZK*M6P<L13YY*+P^&K
MQQM6C":5V\3B,+A<)4YX.F\%7Q<I0G.,*-7Y9NOA]\8/#]_I3^!OV/\ Q_+X
M<T2U^&/ANX\'ZIXP_9J\.6GCGPKX-MO%.L>(6\7:OI/QJU-VU?5O'VM:)JDZ
M36&K17L/AKR[F2-M2G"=KQ"6+Q.)CA*48UL9B:]&A&3AA\+2HY?#"9)"G1]G
M*F_[-JU<PG"G"-'V,J^$KTJTJF I0ES1IN>"CA\56G6Q?U/EJ8O7ZQ6QV.S7
M"8G/*E:HIQ<Z&.P& P^'BDH-RKXVE5INA73C&GA_]I/2_%L'CW1_V,M<75%\
M7Z=XAG\(:?\ $+X!^%O"1AT;PEXBDTIUNH?B_K$S7B?$SQEKNL7$:V,*72Z;
MI5SYL$\9MH<*;G@Z,J.$J>TG&CFGL:U6'(\-B\7]2P>'J4J<95.;#PRVGFC=
M"=5NAB,XQ5*G4KP7UB=8B^+Y%62A2;P2K4ERU.>EA\15Q=7DJ2A3]GB9U,'P
MYAGB/9R]KA\G;]E0]LJ,<E_ 7[1<^G2^&-7_ &2/&/BK2/$&F^"+#Q)XAUOQ
MY^SLFJZ1$^OWGC'XT0^%_#3_ !>O;5KKQ?XEU"_)U,ZOILIM[BT$\);2+=9=
MHU(X>M2^J\T:&5XVC7R^<VOK%3#9/EF"H</83%S2]VG0S#"2Q.-4'6C.&*Q<
MJ<95,1*,8JNMB(XJ=5*-3,L+C:=:E"I-TL-BLWQF-6/Q.'JN*K5OJN65\'AL
MNA5]ERRRZA!/#TIU&Y7^'?QBD\,^(YO&/[)_Q(U77-5L_#=G>ZA!J_[./B";
M2M#U#QA=_$3XX7/AF$?'+^T5UW7]3U74=+L+>S17DL]#T)G>*:(6T.4Z\,!2
MPU3#U*L?[,Q&&Q"Q$:3^LU*629?2>2QJ4J7M?:RJ9W2K9EF-.FO>68XQ4Y5Z
MD8.=UZ"QTL7AY4H5*..PN8X:C0J5(4H4*F<5IX"I?$N*C['+\@I99A<"Y4Z2
M57 RIU/8T:\ZZ]'_ &//^%D>/_&?A_Q7\1?@#XK^&T'@#P3XHMXO'_BP^%TU
M+XA_$GQIJN@77B?7=1L1J1U_3YSHZ-%90I!J5A;1S:M83:A#-8VUO/U0C2PE
M"O*G25">)PN"P-"E"K"M&CA<)*=3&NI5@Z;Q%;'X^GA\1+$5,-2>(>'>,4I/
M&3,\4Z6(Q4J>'@UA(9EC<Q?MH5%6ASJKA\IPU-SYE3IX'+L3B<-4HQJ/DMA:
M2484(IZ7Q1^"/Q>O="U'S-#\+ZAXPN/B;XKU#PYXST+5=7N_$_B6[^)$OB'P
M3H5QXEO?^$.\SX>^$?!WPV\4RB7RKK6U\SP[9QQ)Y: 7G#A(4X_V/A:M"#A+
M"1P>.P\IU%A\3"'LLQSO$5\2DFYYM#+\1@\)0J4I1IULSHTO:1^J8=/OJ8JK
M1EFN)HUE:4Z%?"U)8=59X9X:5".3X.A@W5<9QP^9_5,3C\0J]&-7#4,=B)TH
M?7\5]7Z76_V:/'4T=GK'A7PO\)_#%[)>:&1X%MM2NX_"7AO3?ASX)\::5\+T
MCOK;P.H\1:A:^-?%C:Y>R?V7I6([.SLX9)ELC-=]%:3Q,ZE*OBJDHXJ6:8F>
M*A%1K83&YM2RO+*T\+1YE&5.ADN&QM.E[2K%RQN(C7Y*<%3A1X,/2H4(8:$L
M+"I1PU/+,).A.7-]8P> Q];-JSE64(N%?%8Z&!I-5*>(IQPE&N[*MB)6DF_9
MD\=06NM^$[.R\!WVB:?>_#S4_ OC35M8U*3Q3IVE_"S1_#%[X7\!1:4WA6<:
M#9W?C[0M1U+4=9MM6N':'Q!>RI9275QBV,17JUI3Q6'C#+\;#$9G6@Z?,XU)
MXN.*PN7R=G3="AE67U\-1AA(^TI59X#V?[NGC:\X[86]-TJ>-KRQM'%X2EA,
M7*4%S4UB)2J9YB(1<W#$XS,JE7$5*>(:PKHNM0YE+^S,/&O2U_\ 9.\0VEKI
M=CX:T;P9J-EIW@[P?X9NIX?$-[X&\3ZQKMOK-_XV\:>.KW6[+P?K%E?:S?>/
MM,\#WIM]8TK5[>Y@LM5\^+S+E(V*TXJMC?J,7@:$\126!IQ<)4L#A,MP53"9
M1'V-2G4A4Y(9EF]/$0LY)QR[$4:JJTYVRIP]K'#UL=&-3,/98ZIC*L.>$<5B
M<XQ>%K9G1A&E.A4H4(T\!0^K3C6?/&O7P=:E##KFJ?4'P3\/>)?!?A=?!6OZ
M7HT9\-PZ?'+XHT6RT[1+?QKXEU6W;6?&.O\ _".:1H6EV>FB37K^;=<P0(+Z
M=[JX,-N6\NM<37AB;U(1="-*;P]"C>3C'"X:C0ITJD8SJ598>-2LL3&GA'4J
MJA0IT7&M5A4BU,(U:=62J2]JZL%6G4E-3G&I.MB(T\+.HJ5%8AX7 4\#&6+5
M.G[:<I0=&E.C.)\@VO['WQ3'B.'Q%J'BWPC=AK3XYP:AH<TNM-HEUI_BWXD6
M'Q'^'7A/[)#91(NCW7B.UFO_ !5?>6;B]AG;2%CN;01RP\M&KB,)EBHTI*IC
MZ&5\/TZ<IJ*@\UR;!U\%1J<TE-PPF7TJJKX&FH.57-(PS"JJ,8SPM3KDJ.(K
MUEBE)87$9UC:TW!*56.3X^->&.I+FLI8[&4:E'!.;M#"X&C&G0G]82Q)J^%_
MV4?&]]XCL-0^(%IX+/AV=_!^G^(M#CUFWU^35-#T;4M4\=>*$N8-.^&OA?37
M_M[X@6'@1)M,:UFMQ8:/>N]S-+>-$W5AY87#.7)!RITZSK4:4DJD$L#@)X')
M*<W-V4\'+,LTQLJU.G#V>)P^7QHTW&+G3XJT*M>"DXQI8OV%>E*O1DZ>N9XW
M!ULWC"FXS<*%7!Y?'!TE*K4KU*>88EU:L'1BJFGXB_9N^(4$%O=^%/#GPIDU
MS6==^(7BOQ5=&[M/#%W%K-S);Z5\*=)M-=E^%_B.=_"6@^"X5TZ:UL[/3;DS
MV=F]O<1PF<2>>X5)82CA/:RI3IY?3A[:_M%',<9.K7SC%5*=J<\1^_KRAEZE
M7HQ^J*5#$12='V7HJ>'E6Q%6K3DXU,=0C&DFW%95@Z2IX>E3<Y.-"K7JT*..
MQ<8TYTXXNM7G1O)NI/0TS]D_4[31+'2;Y?"&IW6ER_!WPKINM7:R3:C9?#GX
M;M8^+O$<=C+)HI;3-:\3_$,ZU]JBLS#&+&[M9?.,UG'"O=B*\88E8G+Z$:/)
MC<9C:<)7C[-8/ 2P'#.$=6+E4K8? 3P^"QE957*U6MCZ<858U7*IY].G5GA9
MT<9452I7P%3#UO=3HO%YQCJE7B3&4:*=-4JE;!8JIA\&W*=JN#P<YJ$'.$>=
MT?\ 9>^(LEU\.HM;TCX;Z=_9:P7?C[5]/UC_ (272O$<GB'Q5=>+/BKHVH^!
M?%7PXFL]937]2,'V'5+.\\.WMBDD0EFN4TJ""[K!SP^#QM*K"57ZG@*& P^'
MI2<7.5/*LMC1RNISPY)87&X/,:F(Q=7$T)JGB%&E)X;VE2?LZQ\7C*68PY;S
MQ^(S*K&4IN4J2Q^-GSTZKG&=/%83^RH87"0PE6DW2Y:]&G7I4JOM%ZM\4/@E
MXQ^(_C3QG:ZC8^#=0\#^-/#7ACPO:>(]5U2_?Q+\/_#]C/>77C'3/"WA=O#T
M]K_;6NW+VQ76HM9T]HMEI)-#.=$MH;SEP$IX2?MZEO;X3-J&:TIP2YL1' PP
M-3+\!5FTI4</2QN'Q56M)>VO3QE;V4%5KRE0UQ2]I2C1I/\ <SRW%8'V4HP5
M.AB,8\72KX])PFL1+ZI6PE.E0J145/!<O-"G7J.6I!\%/$FE?!WQ]I>A-X;T
M[XS?$7_A(]7\2^*K6>ZT\ZAJGB'5Y;V31CXOL]*&K0V%GH+0:#8Z@;266SAL
MK6=+9C (BJJ4</DV$ITXU\%@)Y9/&T)+DIX_V->EB,WYX7G&^95IXZ;C/FBX
MXF5&3C!MQJDE3Q>98F%3V-:I'&4<OK^RA.>#IPPSP633=.;E&<L'1H8"KB(.
M4HUJ]&K-\[G=^6>(_P!G#X@ZA)'XA\.^&OA3X<U.^U32+F7P/;ZI?+X2\/67
MP^\%>,]*^&!2^@\$#_A(M2MO&7BH:W?2?V7I>V.PLK*&69+'SKNYKVG-0JXF
MHX8AYGB)XN$5&MA,=FM'*\KK5,+2YE&=.ADV&QT*3JU8.>.Q"Q#ITXJ$*.=.
M-&,J,ZF%C.G2CEF%J4*DN?ZQ@L!F&(S>KS5N5.-?$8Y8&BU5ABJ<<)2KV?ML
M1-J'Q+^R=KUE!%:> HO#5GH.EV/PL\+MX<M-27PM<^,_"W@U/$>M^))O$>N+
MX1U:%=8U7QSK6D:E<K>:9K$5]!X9,,[1MJDQCJ=;FQ=;$QPT*4*N85\12H4Y
M*&'PU"AE\,)DL(472J4^7+JM7,*D:=*%*5)U\+7I595,#2IR*<9?4E0Q51U\
M7]0E"IBFI*O6Q^/S/"XC.ZE6I&<7*EC,!@,/0IJT$JE?&4ZL'0K7CZ1\'OV<
M$\&^+KCQ=XRL/"NJWEIIOG>&8H$_M?\ X1[Q1XDUFZUWQYJ^G37VC626$URU
MGX0L8[BQM+(SCP[)=&WM&O6MX]*,Z>$PU:AAW-5'.%"%76#>!I1JXA147.I.
MDZ^9YEF]:I0]K6A'#RP-'VM14%RXU(3K582J14:+=3$5*?M)34L5*GAL#1YH
M<L*,E@\MRW!0HUU2A4=;%9A[D(SYJOUI7.= 4 % !0!\_P#[2W_).O#G_9P'
M[)W_ *U/\&Z /H"@ H * /G_ ,.?\G3_ !D_[(!^S3_ZL7]K&@#Z H ^"OB?
M\9?&D=EXK\017UG??#UO'/B;PKH?A+2=!OVUW6?"OPGT2XU[XK>(KCQ'8:O'
M=(7O/"?BO0]/CL[:!4N+JPDFEN4F$(QHU'2I9?BJRC.K5H8G-U&K5AA:6&PM
M+$PPV33JU)\\9T\5CJV48JO5J\M&.78^KST6J#J/K^JO$XNKEE"I'"U)5<NR
ME5)RY_;XW-*:GBU24-:;P.78G$5'2O&O];RBO%5:+FD<C??%?XB_%75E^'7A
MCXI>#]3LO%Q\!Z;J.O\ @W2K?4-'\':W=#4?'_C[1+'6M)\1I-J=AH_P^\+P
MV$TLUU;S-=^.K%VDBWK;P]L:$*&(J5:U?FP>38RMB_K,H^QEB,+D=.C/$5_8
M2YZ<L-B<XS#)\)2@I5HPI4\PIUWBO93<_-^L1G@J4HT52Q.:8"=%8+GJ.=&I
MG%3ZGET88F$8SEC,+@J.>9A6C&%%S>78:I3^IQKQ3Q$_:#^)MW+:ZZWQ*\'V
M5SH'A)Y]'TS77T[PGX<\;#XG>/?%"?#W7=:EN+X6MAJEK\)O!9U6V%Y/8:7-
MJ6N6MN]S#]K819.U&G.M4A*G5JPRK!U\.Y16(P>*I97A\YSV-.G7=*C'$J.)
MPN&H1K3YH<F8\D*L<.Z=3MJPI+$5,#"3IPP=7-,0YSISE.4<+6CD.61G*BVI
M9=B<ZECY5O8JKB8X6CEM:M[&<N>7O5Q\<O%_A_\ 9T\/?$NX,.H>(O&.O:5H
MVAWGC#3] \&V.@VOB37VTRQU3Q;-8^*KCP_<6MA9+-/%?V>M66GZP3IZV\UN
MNHI)3QD%A\9E. <E0EC(<U:KRRI^SA# U\RE%T,3R3P^,EAZ4<)+#5G*5''R
MFW3E&'U9<V#G&M2S;%<LZU+ SJ1I4Z:4_:3AB:.7J4*M-VJX%XN<L6\5"-X9
M7>I:<Z;J3\PLOVC?BH)/!EA!K?@S5X_%/Q#F\+3>(9]*:>P\.>#?%UK9:/\
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M-KPFFZLJ>'P>(I4(JJ_W-2.*C""UJ5?&? 7C;XPZ%-H7C>^^(S>.6N];\/\
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MMMMVV7W(?0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 ?/_ .TM_P DZ\.?]G ?LG?^M3_!N@#Z H * "@#Y_\ #G_)T_QD_P"R
M ?LT_P#JQ?VL: /H"@#Y-^-/P[NM \%7>G?#WP#X]^(1\??$CPMJ/Q-L[#QE
M;>(_%5YX/T[5#KNLZ?97WQD^(-C;0:#/'8#18=$M=5M+.RMM?N?L5I$@=3.'
MJRPV,R*E[!SP.5UZN-O%Q4_KE##?\)]:O5<HUL36CCJ67U:E>M*M5E0P,:,Y
M.$:<$ZE"G6P^>U>>G''9A@_J45555P>'Q-9T,72H4Z?[K#JE@<7F-7#TX*E0
MCC*JJ.#<ZE^'\9^$OBMXF^(&@_%+6/AMXL_X1C5--@\'ZQ\+O"_B;P9#XWM_
M#.E6FKZ_IT/BS6(_%UAI7V35O&M_8KJ%GHWB*_ABM_#>G))+<VNI:C'#5"E#
M#5L?2J>RQ<\RIRJ^TYJL<)3Q>%G1P^6PK*48U:D*&$Q>=XJ=9X:26)Q-&$*4
MZN"PM6O-6;JT<"Z$%A/[-J3I*4H7Q<L-CE"IF,L/[.K*C2O5RW)L/1@VJOU=
MYA.4X.K3A0]!3X7^/+?X3?#CX5W-YJ\XU/QI%>_$+5])\5ZA!<>%?!B:WK'C
MJ;POI'B%[ZTUBXTZ-X-&\&VTUHZW(LKCS?W*1DQ[U73J8W+75?UG#Y1@:;JS
M:E3EF6-P.7T\'0G*$97Y\3CY1S2K&O)TIT\-5H8F5257EJ9TU*CA<YE07L*V
M88BLL+1E&,UA,+C<=>M'WIRITYX?*Y5Z<94I35+&U*<\-#V<8^S\%C^$7QFO
M;+Q-X*U3PMXMATSQ3I6OWGPUO[+QU;1>&_A%XA\7^,O&%U>ZMXEFA\:1ZQ=Z
MOX<\,CP1)IJ:?;ZO']K^W_9)+?[7<R09X)15+*_;5)T\;@9Y7*M7FX2C'"4Z
M6&QN.H811IR4L3+'5LQRV'MZ2I?4L-ED)5?J_M^;KJ5HX?&XC$4L+2Q6 E5Q
M3^J.I.;QE>A&C@,'/%2J4Z?LL#BZ&%AF=94ZDJJKX_'JI0J8K#X)U?6=)^'/
MC^T\#?&V\L= US1_B=\6/B!<^')=8GU[29+^Q\"07VG>!-%\9:=?V^MSQ6\5
MGX&AO/$BVR_9[P:A>7<2VHD9 U1]E/#Y!A9QA1PM7%3S'-*4(RARRKXVOF&+
MP<W!N4IRPU/#Y)AZU*<H^R6&JR=*$:BI80Y\)B\?BH5GBZ^6Y?A\)EE6M2A.
M-:KALLH1HRG3DX\]&6<5,1BZZQ+4W3=6/OKDC/S[Q9\)OC9M@\9^$[#Q79>/
M3K7Q.\5L\/CF*==*T.TT@_#GX=> =)TG5_$C:+_:5UX2OH?$A!@2QDUCPXAU
M"Z226-ZFA5=/ZN\1#VE'$X3"K,XQ7+B*E;-<YP68YM##RA;D64X&GC<NH2IU
M:37-AZV"]I-U;VX\M'$TL,Z3EAJU/#9?'%P<X1H97EF*6&Q-25+V;4<TSFCA
M:N(E4]KB7E^/Q6&K\D:<52K>)/A1\0;W^V]>\%?#CQ_X3M;#P?J2:'I&K_$+
M2M?\5ZCXK\1S6W@>Y\9V$5WXMO++0?'&G?#^[\;WK,VK.;Z36-*,UX+Q);>R
M=.2HSDZL%.AB,5E]*>'P_NQHY=B,?0Q><X>$OW-J52EE>4THPIS4</4KYE*@
MJRE*K7B*DW0JTYKZS0I8K$*MB>><:N/R_+\1_8RQ&%BW0J4Z^89GB'4G/5QR
M["*I3I4H4;6/$.A?'/4=>US7K_X3>/M:\):YI?B>T\/?#2V\;>#+*ZTZ^\):
M1X;T#X9P^-[R+XBP6(T>]GN/'VO3C3]0U+=+>Z<MW$]S86J'*=*5?"XNC*O&
MEFF/D\13Q+YGA,#B<=BZ]#$56H4XUG++LOPF3SH4Z5.I3]MB,UGA[SE&I'2C
M[+#U<!RQ?]G8&.%PE=<\IXO&87#X>>+;ITYQ5&$L5C<9B,)BJDZU&JZ>6Y=&
M;GA\1B(PSOAI\!/BSHOBWPQX;UVY\7VFA^ ?$/ABZTCQ;:ZGI<&A#PMX8T_3
M-0NK;3;NW\9S:CJ6L>+_ !,^N'7H;_PM&\ZZOJ"S:DT%MIPF]&AB:/UF>-]C
M"@J/]I4HT))\LJ$OK.793A*<(\T'A,%E?U'$05\/&EC*'M%3GB'4//K4:T\(
MZ$U"%3%K"UY/#*4%2Q=>K3S'-<3-RFG3K_VA+&8>AR/$1G@OJE)I0GB:B[;X
MS> ?B9\3O&'BKPIJ/@/7M6\-ZCXA\"Z?X2\3+XGT:Q\!^'_A]:6-CK/CVXU3
M2HO%%KJUWXHUS4H==\.R(-$U!4LKJP82+;/<*_DX7VM+DQ=+]UF."Q6,QBE5
M:Y9RP6'57(\'AU'VT7AZN80H5\;*K##RES8JG5E..'P+/6Q#HQA"G2J5)T*^
M70P\X4VZ4Z.+QF.Q&&QV,]HE&;JX'+)X?$X%*I)+$4%[%4IU\4SRO2O@1\:?
M&^E0P^/++Q=!?>);32/"'Q.&K:QI.FZ;KEEX@\4:%KGCZ\CT[1/B!K4=_P"'
M=&T;0=2TC0GCCTF2)?$:QQ:<;4SLG=26$I5L/&"G5P$<1A\1!8CE^L2EEF'Q
M.+P];&12J1CB,QS!87"8Q4JM92HU<4^6A2HX24N2I6Q-.EBU0IPH8RG#$QP\
M\+4E3CAEBN;+:%' XCV=*I[# 83$RS1>TPV'J5*N6X.]1XROB?9SVWP=^/\
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MQ6/4\2Z%# >TJ>-/AGXI^%5KJ_CC2=,\5K9^'O'MG>>&8+SXB:YJ<\VC>"O
MD/A_P7:FWU'Q9<)>^)/'_P 5+G3K:ZGFCDGFTR=;>^9 JI6$ZV(JJDJ$70S'
M-/[85.G&%%TZ>-S;%1R; 8*"TC3PN&RZM+B"I)2C3IXW#SG5JQFERS3PV&47
M2Q3K5,%@*&4K$8BG4J>TJ8;*^?B#-LRE3C%5)5%"C/(:>&BY3<91J4&J%2HB
MA-\)OC?96'A34O#.A_$O1="DTSPOX6^)NAW_ (GTCQ%\1_&]QIUKKFLZUXHO
M+:7XJ6^DVVFW?BL^']-"6GB:TN!ILVJQ>0NGM%&W16CAHXO%QI0<LLKRY\!@
MX^]3PWU.D\/@8XVI6<:CEBJ.)Q%;$R3Q'-7R_*98N52=3%4Z&5*6)J4*56NU
M3S:G&M];Q"E[.E4>8XK"XC&+ T*=*JE'!?5ITL(I/#^SHYAC7A.2MA\//$]#
M=? #XIWW@_6/#]^/%LKVGA1-#\$P0>/KJSB\/^(/BOXYNM3\9ZU''8>)8H;C
M3_A]X=_L%=)ANI+UH&TV\BTPW&8I)=:=54<1@Z]XUZV%QN4T93G=QE@,FIPQ
MN(K0FZ?-*KFU>MB,LC4J8>G6Y,)A:F)A2HUJ]]E6G^\G3H4Z,5ALQQD:%6G"
M5"MCJF&6"RS"5J5.<IJ,7A9X[,*4,2L'4J9O5Y)U*F'C.GD/X(_: 77/%/B*
M/P1XXNX?$4XTF\N-8\2:<?'/ARUUW6'EUJQT"7PU\9M$T?QYX,L-(T^PLM/;
M4+?PK>V!ODN4>])OQ7%1TH4*=2GRQKU:<Y\J2G-0A6QU2&-H5*DZ"J/'K#8.
MGB:5:<)866*P\L'3P7L56JNHPKRC0ES0P%"=.E*4IJ,YTXX7*\/7PLU!UX2J
MX&>.S;%X:I&SQT,-*GB%B[3H9;_ SXS:CHO@W2K_ ,)>(X+B75?B7XEL[I?$
MN@1+\+=:\:>(O#O@3PY<I#;^-KI+.[T+X6/XG\0F'1GU: ZM>S+!+O<^=V89
M4%B<!&M4M'"8#+L/6JOFY*]'%X[$YQGN$3A"-?VM.-#"Y!@ZKC3BL+BIOF]E
M37)A*<Z,<PJX6G4OB<;5Q=*E4E&<%6RO*:>"RKVN&YW1JX/'9M/^V*U.5>4J
M;P=)UZ=2O4O'KM<^'7QWUX7-WI?A[Q=X;^('A_Q7XWAB\97'C+3&T+4?!VKQ
M>(/ OP_\/^$M+L_%\GF^']+\/:OH'BG5#JNFZ=+)=^&Y66.YU2Z_<X4%3KK"
M_6N>E1S/#4</FT>91Q$L3B\5A:V:XB#IPG"G0P5"&.HY4Z,X5HN> Y81B\;,
MZ8S^I?6*=*C2QGU!TZN6*<I^QC1RVA&OA:56;A3K2QN;8FC3PN/YH3I0I8O'
MQEB7AZ& ]I[_ /!_P)K'PZ\:>.;%-!\61^$]8DT72O#FHZGXM'B6RCTWP1X:
MT:V/B'6'UOQ+=ZM_PD'B36M=UJ$/'!<%K;PE ]Z]NQMUGZ(U_;X.HJJA1K5<
M;CL=[-4U!485ZM+!T<%2E#F4HJC@%FC<G"$99C.%Y8A58K@CA50KT*D*U6O[
M# X# 5'.3_?UH?7\;7QT8MM*G#ZS0RZ7,XUO;45[*B\)&-9?25<IU!0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 ?/_P"TM_R3KPY_V<!^R=_ZU/\ !N@#Z H * "@#Y_\
M.?\ )T_QD_[(!^S3_P"K%_:QH ^@* "@ H * "@ H * "@ H * "@ H * "@
M H * "@!K*K##*K %6PP! *D,IP>X8 @]B :-O*VWY .H * "@ H * "@ H
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MM=*^&7Q<\$?$G4+?3/#]Y^SAH5OJ6H7EIX3FLH4GU>PC62\21Y0L95@#ZOH
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
EH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>163
<FILENAME>g20922ndsp9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922ndsp9.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /W\H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * /RH\6?"OX8>./C[^TYJWC7X<>
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M1#JU<31J*E*O4O*E2K0DISY9TZJDE*+;3:C5A6H3NE:M0JQ5XJ,I=!_PSS\
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M_@N'_P B'UC$?\_ZG_@<O\P_X9Y^ /\ T0[X/_\ AL_!?_RDH^J83_H%I?\
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M "(?6,1_S_J?^!R_S#_AGGX _P#1#O@__P"&S\%__*2CZIA/^@6E_P""X?\
MR(?6,1_S_J?^!R_S#_AGGX _]$.^#_\ X;/P7_\ *2CZIA/^@6E_X+A_\B'U
MC$?\_P"I_P"!R_S#_AGGX _]$.^#_P#X;/P7_P#*2CZIA/\ H%I?^"X?_(A]
M8Q'_ #_J?^!R_P P_P"&>?@#_P!$.^#_ /X;/P7_ /*2CZIA/^@6E_X+A_\
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M *G_ ('+_,/^&>?@#_T0[X/_ /AL_!?_ ,I*/JF$_P"@6E_X+A_\B'UC$?\
M/^I_X'+_ ##_ (9Y^ /_ $0[X/\ _AL_!?\ \I*/JF$_Z!:7_@N'_P B'UC$
M?\_ZG_@<O\P_X9Y^ /\ T0[X/_\ AL_!?_RDH^J83_H%I?\ @N'_ ,B'UC$?
M\_ZG_@<O\P_X9Y^ /_1#O@__ .&S\%__ "DH^J83_H%I?^"X?_(A]8Q'_/\
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M7,[Q$Z;7O4H8VMETZ'.TW!U*RH5JM14I2C"IS)NS@Y^8Z=X3\5^.;CXE^%-
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M3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\
M[</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9
M?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M
M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A
M? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A?
M#_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W
M\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_
M^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6
MC^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_
M *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_
M ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_
M -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_
MLG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^
MHC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\
M)/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[<
M/^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^
M%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_
M /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\
M0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_
M ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_
M?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_
M *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH
M_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO
M^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?
M_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J_
M_<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#
M^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J
M(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R
M3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\
M[</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9
M?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M
M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A
M? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A?
M#_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W
M\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_
M^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6
MC^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_
M *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_
M ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_
M -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_
MLG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^
MHC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\
M)/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[<
M/^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^
M%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_
M /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\
M0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_
M ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_
M?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_
M *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH
M_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO
M^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?
M_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J_
M_<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#
M^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J
M(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R
M3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\
M[</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9
M?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M
M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A
M? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A?
M#_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W
M\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_
M^AEH_M[_ *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6
MC^WO^H7_ ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_
M *A?_*O_ -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_
M ,J__<P_LG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_
M -S#^R?^HC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_
MLG_J(_\ )/\ [</^%9?M3_\ 0A? #_P_?Q%_^AEH_M[_ *A?_*O_ -S#^R?^
MHC_R3_[</^%9?M3_ /0A? #_ ,/W\1?_ *&6C^WO^H7_ ,J__<P_LG_J(_\
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MI:JG&I5I0E-^ZIU:<6U*<4T_=CSOW8*48<STCSSOR1OMS2Y7RQWE9V3LR]2
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M3?!.F:[_ &%J?P.^"_C][&^3P!X1\-Z5<^3X@\;:\8IAI<<WDS112R2>2K4
M9_[2WQ=\;_!WP]X!UCP'X2L_&^I>(OB;HGA?5/#<WGKJ6H>')=%\1Z[KB>&9
M([ZVB3Q1]CT%A9"Z\^"24B%XB95>/&%>G3S3+Z&*;IY;4I8^MC*L(RG5H4<)
MA)UW7A"*DZD:#2JUZ482J5:$*E.CRU90DNJGA76R_-JM*<88S"4\']4C5?+0
MJ8C%YKE^7TZ5:6CIPJ_6W!5N:,:%24*U3GI4YTY\V?VI=#_X2Z\@TRU;Q?X2
MUCX=_"7Q+\-;+PC9)/XT\:^*/B3K'Q)M/^$?M#K&MV.EP[-.\$138OY-+CL3
M;ZE)J%XD41^S>C+"5*4*]%TW6Q\,SK8.G"C.FZ,L+0RK"YE/%>UG*--TE3K3
MJ1KJJJ=6DZ$*,*E6I!5,I1I_V=EN8_O,-2K0Q[QBKTZJGAJN&QV5Y?1H2HTZ
M<ZU.O]<S#ZK7IRA-PK<JE[*%.K(]S^'/Q'TCXD:5J=]I^G:UH&I^'M<N_#'B
MKPKXE@L+?Q#X6\1V-O9WESHVKII.I:CI\TPLM0L+J.YT_4+ZTN(+V">VN)8I
M5<XRI)4,+B:=15L+C(5)T:L8U(1FJ.(K82LN6K"G5C*EB</6HSC.G%J=-V3B
MXR?,IVKXG"S@Z6(PCI\\).#]VM1A7HU(RIRG"5.K1J0G"49.UW"2C4A.$?0:
MR- H * "@ H \?\ VA/%.N^!O@%\</&OA:^_LOQ-X/\ @_\ $OQ3X<U/[+9W
MO]G:[X?\%ZUJVD7WV+4;>XM+O[/J%I;R^3=030R>7LEC=&92 <=K'PS\8>'M
M*U'7-=_;"^.>CZ-H]E<ZCJFJ:CHG[*=G8:=86<33W5W>74_[-:QV]O%"CNSN
MP "DDUG4J0HP<YNT8V223E)RDU&,(1BG*<YR:A"$4YSFU&*<FD]*-&K7JPHT
M8.I5J-1C&*NV_P"MWLEJ[)'F6@:G\3]'\8_L_P"MO\8/C!XC\%_$_P"*.O>$
M7\-?$[P]\#=-DUSPI'\"/C+X^TS7IK#P-\$_#&M^%[Q_$'@?0;NU@EU<3FT=
MTU"S@EG>V@Z:E&IA[4ZZ5/$Q;]I24E/V.UH3G%N#K1U56%-SA3:455G+F4,5
M.G.<O83C7P\4E&M%^Y6EKSRH_P ]!>ZJ=?W57?/.G!T/8UZ_V#XG'B4^'=;'
M@V718/%8TR\/AV3Q':7M]H(UA8':P75[73K^RNI=/:X"++]GNH9 K%E)*X/)
M7G5I4G4H457J4W&7L7/V;K0C*,JE*-5QFJ52K34J=*K*%2%*I*-2=*K"+IRZ
M*"HNK".(E*G1D^64X)2E"Z:53D=N=4VU.5/F@ZD8N"J4W)3C\JZ+^U4NNM<Z
MD^AGPSX=^%?A/5]=_:/EU;3M3U34? WBFR2XL+/X8>'HM,FC&J>*I-1M+S4F
MF2.]0Z7'IC1VY;Q#:30=O)1FJN,PKJ8K+,7/"83*'!0CB<?F&-K8=0H>SE)Q
MIO!1K0P>.A-QY<SQ$<-&M'ZEC$N5*O3=# XF5'#YI2E7JXZ4I\F!PN782G6<
M\>Z]5TI1H8YP6)RZI-)/ 4<3B:T8VHQJ=7>?M2^%M(LKR+Q%X$^(GACQG!J7
MA;3;#X:^(%^'^G^+-:/C9=9?PG>:=JA^(#^$[>PU$>'=>19-2\3:>UO-I,]K
M=I;W9C@EQY*C^JPHTW7K8C$8G".C3<.>C7P>%CC<3"<I2C2J<F$G#$0GA:F(
MA7C+EPTJU6%2G#1-*G6Q%1NA@J="&(I8JI"I&CB:53%4,#!T5R.M&?UO$X>C
M5H8BE0KX95Z-;$TJ.&JTZTO>/"/B/_A+/#VG:^=!\2>%Y+Y9Q/X?\6Z:ND^(
M=)N;2ZFL[FTU"TAN;FW=DGMY/+N;*ZO+.YB,=S9W-Q;3Q32:5J2I2BH5H5X2
MITZD)T^=)PJTXU(\T*D*=6E4C&2C4HUJ=.M1J*5*K3A4C**SI5'44[TY4I4J
ME2FXRY7K3DX<T)TY3IU:<K<U.K2G.G.#4HR?3I*R- H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /G_P",G_)1?V3O^S@/
M$?\ ZRQ^TM0!] 4 % !0 4 ?/_P;_P"2B_M8_P#9P'AS_P!98_9IH ]PU5=0
M?2]232/LPU5M/O%TS[;)+#9C4&MY!9?:Y8(9I(K;[28O,>.*5E3<51B IY<=
M2K5\%C*&&FJ>(K4*M.E*5U&-2=.482DXIM*,FF[)NRT39OA94:>)P\\3&4L/
M"K3=6,4G)TU).:BFXIR<4TDVE?=I:GQNG[*4]POA>75IO#NH:GX,TWX Z'X9
MU:ZEO+RXT*U^%VM2^)/&7B#2HKK22EGXMUK4-1UBRBOXRL_V*\=6N;?[3<12
M^K4Q$(X_&8K TU@HU<?F%7#R@K5*&7O(UE^4X.*348TZ.+CSXRA!QHU\++V<
MWB%3IT8\;J8VO@O88^5'%SKX.L\32Y7##3S;-,QE7S?&Q27,XT\/'"ULKYTW
MA\?A:<U"DV\0<?H'[+?Q$L;K6O$&HZ+\&U\8:AIWPZT/5O$FFZKKI\2?$J'1
M?BA8>+?B+K_Q!\6W?P_-W]KU[0-!T.&QT@6NJV^EL;G3(+P68CNZG"SPV&6&
MA3I2PF&>-P&)J82E+GH8..6X'&1P56A*7)4QV-HYGC'C:^)Q/U:>.CAZ"KRA
M54ZDMLQC1Q=;'5X4^>K+#\28?#RKN4[T<Y^JPP^'E%2MA:.&PM*OA(*F\1'"
M\ZKTJ5>$YX2/3R_L[^,9- U&"Z\"_!75_$NJ>/TU#QYJ^J>(=<DE^/W@<1^(
M!;6?Q5U0_#*34+./3K[5M+O8?"9D\2:3-%H":4+RUL;HFWX:4.3 Y9AO9TT\
M/A94ZM%Q]IA:>80PE/#T\X]G^[688JI-5ZM2.*A1J4JF*^L0Q57$X:C4>]2J
MO;9M4C*K4E7;> K.K*EB,+0JYG2QM7+*<DZKPF#CA:?U&%2A.<:D%S3P4(3G
M2.#L?V./%6D>%]:T_0=)^$'A7QA=_"#P5X0TKQSX-AM?#^K:3KMGXPU[Q3\2
M/"VA)>?"S54\-^!O$<&OW6G17Y_M86]LEO!-X<N8+?RING%.$Z5;#TG6J48X
MW+G:M.FZF8Y;E^5Y=@J-#,YRHUJ4ZE/$Y?'$U:<L/BJ6/C5=*K+#JG%O*A&A
M1QZJ>RA'!)9]4HN,)*M@,9FN+QU3#XG#.%:G.?L,-BJ4*4(8G!RP-2E7^K5:
MOUR<Z7MEA\!-=\-_LZ:;\+_ L?A7PAXST_6O#/BZR%Q=KK/@O2_%>C>.-&\9
M7DT,/A7P1X+M#I$MUILTGV#1O"WABT9[EXXK2S65I%VQ==U,=EE6A5G'#8*2
MHRE+G>(IX'$4<1AL9'#RKU\7*5>CAL9B(X#ZQ6J4J;AAZ<HQPU-4(XX*,<-3
MS;VM"%6IC\/C8*FI*-*=:>#>&P<JCIT:7LX\]+#5,1.G3E6YU5KN6(Q$I5*O
M+:5^RKJT6D7OAS7=>L=8T:;XA:=<6LLFH:LNII\,H/')^*GB"SNKEK(M)XM\
M3>.A"NJ&"2W@>QL;()<F6V*S8TJD(_V7[;#TY0PLJKKT7S3I.C@<'C\#P[A(
M*;_>T,OA7H8FJZR3JUIXJC4CB:,:3DZT\54GF=6&(]G7Q6'I4J551@I.MC*>
M78?B#$RBHI8>6,PN'Q6'P=.E[6.#7LJM!X>5>K&CQ\?['>NKXP^&K79\*W?P
MP\(ZSXCUQ/ &EZII'A[2/ >K:A\1_%'CC2M5\"V-S\&=:O3=6]CJN@:8AT'7
M_AU/;1:#+";R^L[Y[9'@ZLJ-6&(Q#E5QE#*\MPM*M*4JGLZV#P,*-:@H)T*C
MP>(Q+K*LJN(JX?%8*5&ABLLG]7II:9C[/&X3%4:=&%"6*QN-G6IP7)#$8;$4
M\+A:>(K2?M(+,(T,-4Q52I]6J5EF.-Q6(PV/P]24JU5$_8S_ +2\)ZIH6K>#
M?@_HER_A;XH6=E9^'0\VA:EX_P#B-XJM+X?$G6[1/A_I2'6M*T+1-#;3D>VU
M!].N8(X+>X9=/MKXK U'A(Y1S7YLNI<+T(<C<?JE+*ZLJF<RP<DXQC7S"4:-
M6G75/#U)U8U%4="%:KSZ5<166+QE>GRXNE7Q^<XZ=+%Q4UCG6A-9+A<P=I2E
M@\-'&YGA,;AN:M3J4*T*UJ]1NE2O>(/V3/%OB/QY\7/$NKZKI>L'QGH.H^&/
M!OBF]\36UIKOAGPOXETVU\+Z]X3.FZ7\(8-:31;?PU)JD]O;W7Q!UK39=4,5
M[%H^F74LEY%.!DZ%%PQ,(2G7S*A6QCBKK&X".=0S:K2J*/L(QK0I4:&!PSJP
MQ5:E04Z=''8?#2>%?.W7P]7 5<#B)TWE.$<\ YZK!YM0RCZAA,3&G4]O&=.I
MBW/&8M4WA:51U/W^#QM:E&M+VSXD_ 7P[KOASX5^#?#/PW^%6I^"O!'Q(T_Q
M3JO@SQ;I]G9:&=+73O$<=]?Z1%'X/UV*7Q*-<UJWU5Q+:VIU%X[N.YU"!KV2
M8MU\1+,\-F4IN.(P6%Q4,+5B^6>$Q'U:-+ ^RA%)+#T.2-.%*G4HK"<N'Q5"
M-2>"I4)NE1P]'*<SRV*E;'0PL6FVXU_98W"5Z_UJ3ES5'7H4*M*I.<*SJ^TE
M3J1Y:DIQ\7NOV3/%EMX4UH>%M8\.^%OB)XC^'4^D>*?%>C:A+;ZAXK\6^)?B
M1;?$'QI8:AKFI^"M4^S^%A%!J&DZ1<76CZO'90>)]1/]A&+?;7N=6,8X>6 H
MMU\NI3X?C"C45*G]8I9)A,9AIU<6I4L51E6QSKX:6*IRHUX5Z.$CA9U51E#V
M/1%8=YFL?-U(/FXEC!Q3Y\+3S5X597]7]E5P\E_9L*-1^SI5<-RU^6O3JRKS
MJ5EN:Y\'?$'@K]G/P?\ !OP5X(TF]UGQ!XV\+_V_X=M/%%YI7@JUCC\1)XW\
M7FY\7>!_A'I5KX/\-WUOH-W:_:-)\ :+:1W.LQP6NG02W48;HQ=2.*S/)TJ*
MQ6!RYSK<N)G4C&$<+AL36PD)2K5L94KJCF4\+&AA:E:HJN'I1P]J.$A*-#EP
MM*6'P>>U4X4L3BZ,J-H*$W*&-GA<HJSITX?5$JT<NJU*\ZD%.5*K3J8VM]<G
M&LZ_'7_['?B#4;WX:6M\G@T^ ]%UOQ1X@\0_#'P[JFG^&/!_@W5?$WB;^WX]
M1^'L6I?!_P 1WESJ.D6ZPV=IJ&CW7PWU(2B^O(=0LTU6>QC6#J/ YA0KPK5,
M7#+\+A:>"Q-=+ZQ1K8.KC<2HQI0DI4L)6JXFAAOJ\<=.A3R[!X?!8G#YE2HT
MXQC&QGC,'C81A]5K9I5J?7:$*TYTL12K8/+<%4=7$2@HUJR^I8G%^TJY?*M+
M&8^K7H8C!UHRKUNKE_9;NH9_ -W#X*^$FL^(&^)6K_$GXH^+_%-Q)K,MQ?:C
MXKU/Q%%9:?X8U7X<:@OC)K&UU[5K?1[ZXUOPG<:!<[+RQ:6.ZOK.[G!3^K5<
MIO*5"CE&5T\/"5!+GGF$L%0HXK&4XWI_5J]7%86C56.A4J5YX92P52BZ"C!=
M&,?UJEG/M9/%ULPKSITE4M3C3RZ@Y4<LPM9I58U\/1P:HT\7@*E*5'$UJ;Q*
MQ$,;[+&TL>W_ &5O&E_J.M7>L+X!T2[URZ_L;QEXI\-Z_P");KQA\7_#.H?$
MGPOXMU;6_'6JW'A;3Y])UNR\+Z!>Z'HVBP7>L6^EIKETEEJMI;".&)9=[*AA
M<OPV,I*5*A/+*U;#TOX/UO*,'C'2QG,^1XFOF.;3P6)QTJM.E/ZM2K4JM3'2
ME"QCZE2M+,%04:T:ZS*&'JXASC7P^'S13PSP%'DG-8?!Y=@L5B)4:=.4X8S&
MX;+ZKHX&,*ZJ^U67P8U?PW\'/B!\/O!?_".>&-1\2>(_&FLZ%IVAW%_X?\,:
M?IVM^(Y;VRT*.[TC2TNM 2_T&.*WU"]T^QEE@O-4U"\A6ZEP]QA7]I4PF2T&
MHXS^S?J;KTJ[Y:6(I4\:\;B,#=0JJ."C&I/ 8:#HN"P-.C1EAXTKT8U&-%8W
M-J\:E7#+,J<HPK0O5Q%#$/**&7QQZ4JE-RQ,<51_M!_OHSE6;;Q'M&ZIY)XA
M_9@U;6YO"6GZ9\-_@;X,\*VWA[3+>/1-"U/4FM?@=XR@\0ZCK6O^//A!IMG\
M,]+LO$OC+6+>YTZV&OWJ>$;ZP?2A,INTN[BVE[\/6CA\QAB_;59/"5\!6H5^
M6U:6%PDHU*N2JC[5T\'E^)J>W6(GAZM18JA7='$8.4:-#V?-C(+%Y57PCIJ.
M*Q4<UA7;J2G"M5QN'H87"9C7J2CSU\9@:=*=2C&K3E*%6I^ZQ<'SSFW7_P!D
M-O$DNNZUKNG^!?$'B37M,^.]SJ4NN2ZG>6>JZ_\ $+7;&7X=Z/JS/HK?;/ O
MAW1+*.:339K:: :M;VVH0V4EW"MX."A0I4<%#!TY5,(W@\KH3JT'[\,6\76Q
M^<YE3<N5O'8?%UJKR+$-PJT*5?$4HSP,:DE+NAB$\?3Q5:ASTZ68QQ*@JTU?
M!8++EE6%P;BXM*.:8>%&MG"3]DJU"G3]GCZ7*Z?+>'/V=O'WBO7O%GB[^S=#
M^&VL6GB+X@Q>!OB9<ZGK^J?%:ZCM/A[>_ _PW'/H.I>$].@\%>$9;72-)\4,
MMEK>L_VQ)9Z7<RP6Y6,Q=%:I5KY?B93<:&*S;"8QU*.&E[.\,XSA9UR8K$RA
M*=&O@\+)9?'#?5:T<%B95,0I>UI5*-?'!RA@L5EN%JJ.:Y?D[R:@GB*;2HPR
MG#4'B89?!J*F\5F+QGM,QG-/$8*MB,+&-;"U\/7HZ/@O]CR\T[PII&A^*=!\
M#W_ER?$#Q/XIT2\\16GB#P_XP^(&J>&8?!_@W5?$%EX;^"O@+0]4TZ31K_Q
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M X:GC>>GC-9U)SGB,6J\Z>(KXZ6*C1I4*V-C&EAY4?J[Q;\,_$,/A?X/^&O
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M_P"S@/#G_K+'[-- 'T!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M;QAK/AO6$M/%]E]E\2V/@?PYJ][=M;3W\>F+=V%T\-^DBVES$Y4Z#E7J253
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H ^?\ XR?\E%_9._[. \1_^LL?M+4 ?0%
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M7JAOETS4K#43I=_-I6I+87EO=G3M4MDBDN--OA;R/]DOXHYX&>WEV2()D+*
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M1?\ Z+&@ _X1S]J?_HLGP _\1I^(O_T6- !_PCG[4_\ T63X ?\ B-/Q%_\
MHL: #_A'/VI_^BR? #_Q&GXB_P#T6- !_P (Y^U/_P!%D^ '_B-/Q%_^BQH
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M@!_XC3\1?_HL: #_ (1S]J?_ *+)\ /_ !&GXB__ $6- !_PCG[4_P#T63X
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M?\DZ\.?]G ?LG?\ K4_P;H ^@* "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H ^?_P!FG_DG7B/_ +. _:Q_]:G^,E !\9/^2B_LG?\ 9P'B
M/_UEC]I:@#Z H * "@ H ^?_ (-_\E%_:Q_[. \.?^LL?LTT ?0% !0 4 %
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M\_\ AS_DZ?XR?]D _9I_]6+^UC0!] 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % 'P!^T/\ \GV?\$ZO^[N?_5.Z)0!]_P! !0 4 % !0 4
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M/@!_XC3\1?\ Z+&@ _X1S]J?_HLGP _\1I^(O_T6- !_PCG[4_\ T63X ?\
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MT '_  CG[4__ $63X ?^(T_$7_Z+&@ _X1S]J?\ Z+)\ /\ Q&GXB_\ T6-
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M?M3_ /19/@!_XC3\1?\ Z+&@ _X1S]J?_HLGP _\1I^(O_T6- !_PCG[4_\
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M?R-'9I(\I:0JIL&QQ_QD_P"2B_LG?]G >(__ %EC]I:@#Z H * "@ H ^?\
MX-_\E%_:Q_[. \.?^LL?LTT ?0% !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0!X[^T-I&HZ]\!OC)H>CZ=<ZMJNK
M_#+QMINFZ79V$^J76HWU[X=U"WMK*WTRU!FU":::1(UMXAOE+A%Y85#I*M7R
MZDU2Y)9CEG.\13]MAXTUF&%E4GB*7/353#PIJ4Z\74IQ=*,^:I!7DO4R6M##
M9I@JU2;I0HSYG)35)QM&5G&HTU"5_AE9VE9V>Q\?_$#PK\3/V>OAC'H_P:\+
M:+H_Q#\0/K>O6EY^S%^SMIGP[\"ZS?Z%I6FIHWA?XF:')X0^,M\;ZZ^TZI+;
M:CY_A>WNC8MI[ZQI,DL4UQO5Q/\ MF$H4_:/#82:K5Z-24IX2O&IBHK%5<+3
MI4Z'LJM/"4J,)4)9A2K8A6GAGB)PC0H^5E6$PTL/&OC91H3Q?U+".K&-LQH)
MT<1*FZ]::JQE0CB)N-2O+ 8B&#G6=:K05*55RZ+Q!JG[4ES%XHU[2O%OQ$TL
M_P!F?%#5-#\+:=\+O!UQ9VMSX)T7PSK/@G2+<ZMX"O=4O#XEU6\UO39A-=RS
M75M$(-+-I?VLE[(8=0H8FE&JOK5&-:O4GSR45.%/BC$9=3P_-15/EI3R2=+&
MJ47[:3HT<:JSPLJ]*OIEL%CIX&EBZG]G1Q&*R?"5:D4H.C1QW#U'&8_&OZQS
MPC/!9M2EATYQ6'HO$8G"XFG.K]5EA//]9\4?'/X7R>./BCH/A&\CO;K5?"_A
ME_"=UX9TKPK9>,I_%OQ'^/'A;PC#IUS>Z3:Q)?6/BGQ7\/-8NY[4FXN[.]GN
M;H74NH(\^].BZF'R[)L/B%3GFV)>$A5TJ?V=7GPSPI/^U7AUK4P^"679GAIX
M6/+AJ=JT%"'U*U+EPZC5QM;,L;3K*&5Y50QU:-.,4\31PN8YE6Q^7N51Q2KU
M<+7=:A+VM/$/$TL)3]HZ=><*GT/\9A\?-,TCPGI_@7QGXPAU70OA!\2?$?B3
M6_#/@7PAK\GC/XA>$-,\&OX3T6_@U/P;J=IIHUW4[C7_ /B7:1;V%S=1&ZBL
M6AD@CEM9E+#SS;&XFE2]GEM*O@7A\')RY)TJ^8NG7C.JY>WE&C@DW4Y*L9PD
MX5Y5(QC.-7T<GPL*^797A<SQ4:&.Q>8X#"XO%PE3A4P^&JX+,9XO$483YL-"
M-/%4\(E5KT:U*"Y*<DW6N_$?$GQ(_:AO_B=J6E>"[;XP:/X4OYK/1M0DU_X:
M:7?V7@[6(/B5X T>;4O!T@^"-A9W_AN^\#WWBC54OKOQIXW A>9;F/1[K2V5
MIP%&C7JU*-?$NGAIUH3I5I*,:\:4)XF.)P]252%&E"<5+#QI5/JE:C5<85\/
MB\52CB*<\8NG'#4:LDI8ZEE^(E4HI5%A9UY\.XS&X2K%7E6G6CFE"EAJM!8K
M"RI5Y?5:N#G]<PTJ5OQ!XE_:Z\,>&M7FT?4_'?C.^N;;QG8-/K/@3P_I5YX;
MTSP3\9-/\(Z=XJT,^#O@QK$]]XHU_P"&EW>Z^+8^%/%<%Y)8+=Z+X>:UW6<D
M2=-T</SI4%4AD>)K3INI[2E4Q^59M5QV#IP]GBW['#9EA,LHU(RH5,3AEC*T
M<5C*%.I2KX2<5"5#'>RPC6*IPCC(053D=.JX_P!C5Z52K55;"0C.G3Q>:4J7
M+7HTZSPE*'L<1B:-6GBOL/X':IXZUCX7>%M2^)#0R>+;FWO&O9TL?$.F7-Q9
MKJ-VFCSZKI_BGX>>!-0L]=?2%LC?1OX0\/Q?:_M#6]C;V[11KTX^%"G6@J$8
MQO1H.K&#C*E&NZ,'75%QQ.+?L?:\SI*I7G5C!J%5\\9'+AW-^V4G*4(U9QIN
MHK5.16MS_N:$&XRYHQE3I\DJ:A+FE)RD_6:XCH"@ H * "@ H * "@ H * "
M@ H * /SJ\$? S7/#47CCXEO\/\ X2-XDU7XQ>+YM(EB_9UAB^-B:;J?[1#S
M/K&M_$C5_$6I'Q)H<OA(7%Y;-%X7TXPV3Z?=0WFW3TGG(R>"RS)Z.'2AB7@<
MJ4WA$J%.GRX&-6O2Q-!*K.>*CB8T'6K>VHM8JE4G.BIU(QH]>9^SQN:9Q6;5
M6G0P>+]@ZS]NY5UP]]7I+"3O",(2J2J89X?DK*M&I5PDN:-2I"4&BZY^T_I&
MK_!!?$'C3XM^,HO'_ANUN?&OA>#X8Z%X7N_!^NZ^TL-Y<:QXCL?V;[[PY;Z%
MH%O/!/'H^K>+_!&LQMI=U(USXADOK;3(7B,/"5/.\LIU/:3HY345#'.?(OK*
MP-:K[107L(5<57Q:CAZ7U.IB(4%4H0K99^[Q&.F\=]7PV)Q&)PW\*AGF,C3P
M\;5:=;+J.94:.%A1G'VU:%-X2$ZDZF)C*.,C6G5HYAA(TH1.B'C#Q]X _9[_
M &<[#4_&7Q/T#6;^UM="\=>()O -CK_Q935]#\(:WJ3Z-'X,U;P/</?Z;_;N
MC_9+[5H_#MRZ:-:2:I)J,,+RZY'KQ!B*3S+,Z^!<5A:64XO'X3E@HTJU:E_9
M\</+,$U!8"C*CB:];%1F\NIX?,%A\#-X252."J<="E*,L33<I8A3SZKA:M6I
M:%2G@ZN+S!^TR^-*G"&+K2G2PM/"0HT<6JV#JU\30H8F-%5(<1X0\??M.7>@
M_#S6])T[6[\_%_\ X0G2=;US3OAQX?M5T77==\#_  ,UN]^*NM7-EX:%O_9$
M.C1?%*P:]OOM=DE]!I.G*I%O!!%ZN.PV&PN<U,JC#V&&PV(QV(@ISE["A0RO
M/,\J8G+9<THSA6SK#5,MIX>7NUI\E;%4Y4ZU>I7GR2J0K8#%YA1Q%2I5C&KA
MJ"HTZ-1UY8W"UZ&6XR+YZJ=+*L;2PU2LHU:U!83$UI5O;0I4T]+PKXJ_:]\4
MZ_KGA_7=3\0>!X+OQSH>E7^H:3X,O=5U+PAI5QK6H17,O@VZ\6_LTZ/X/N_#
MTGAZWCDFO7\5?$YK2\EMI'O$@=[5OG\%&=7!91+$U)PJ5?:RKRBH1J*K3R+,
M<36P^(5:-.5.A'-J> H8*5+ P55.MA_[0QDJM"J=&8SJ8;'9BL%"%?#TFH4(
MSYY1E2EG668;#XFDJ#FIUI995QU?&PJXR#BE"M# X/ZOB*<?<KR?XW:U\-O@
MGIEOXF\9^%O%NN^,'T3XC>+],\%>%9_$MIX=T_PUX[E.LW^C^(/!]_H7A^>_
MU32/#;&Z;18;5;C488X8%BN4MWJM*=?V&)IQ6#YLE6/J8:FI.$<QE@,'66!B
MZ\JM:*IXRK6I.A*I+$N%*I0<U67MJ?3AHTZ6&S^-5^WJX3&5*&!G5=IU,/'B
M*A@XUX1H^RA6E+*'4K*I&#H\E\5[-TXGS+XE^+7[6BQ>#I/#>C?&.+Q"GPX=
M/'>EW_PMLI/"S^(+KX1:OK>E>*?#=I:_!"X>36S\0%L=.NM-NO'ULUI=V7V=
M_"\EGJ$4Z=DX4:N99A3HSC0P5>4X47)2G]3K*IAYPC"4G153#2H1KN%9U,P3
MC-T*]?"XQ4U'OI87 8?'X/!UL4\52P^9TJ;K<T8T\9EJSZ>75JF,K4X.G"M'
M .GBVL/#+:<J,XX^A4J8:A7IU/1-6U;]K/PP/$UQH6N>,_B'J&GZIXJ\.>'M
M&\2> O!^C:)J<$WP8L?'^C^*+C4O#G@2RN8VLOB'->>%[26*X:RDCBCL;NVU
M#5HWN)U7C0A3DH/EA.C7E.HIMUL/'!\483+HSI*%*NIXC%9%6Q683A]3Q7MI
M4*>)P."C1C4P]?Q$ZRHY34BE.O6AA*M:DXKD]OB<MS653"U5*K1]CAZ.883+
M[N>(P]2@L74IXG&J%6C4H>\_LR:_\4?$7P]N;[XJS7-UJB^(+Z'1;K5M)\4Z
M)XEFT1+:R('B6Q\4? KX1M]OCU5M32&:P\%V5J]FMGB:ZF6:XEVQ<,/"C@72
M2C6E1DZR@TZ;:K5%2DOW]:I&I*@J3KQJ1P_[_GE3P]*E*$(S2E5]OB(RNH1]
MG927P5'&]6%.4:<:<J,7RNFXU<3)-SC.O/EBSZ*KA.@* "@ H * "@ H * "
M@ H ^0OVH_#?A[7;GP7=>(O"6M^*HM+M/$2:/;W7P2\1_'SX>P:Y?S:$8)]<
M\&^!;I/$>@^+DM+&[31O%5N+6TTL7>HF>\5[B*WN>=*<<17E0I*6+=+#JCS2
MGAJKY:U2<H8#-(RC#*J\FH1KXG$3A!1GAJM.-;ZO55/J]I; 5*$W&.%E5=6N
MTH5;1IT*U*E#%8&=YYG@Y5<0JTL#AZ=6=6>%2FZ"E3J/Q$>/OVQ;+Q?K6EZ5
MX-NM"TO2_AZDOASP9J4'BSQ;8);P_#RQN;:XL/%@^"=QI>O?$.T\;O<6;PZ]
M\:+8W]MI\JMH"7%Q#?3>K)X:I/-)XO%3G!YA*-7$X>C"-:AAGG<*7UC!87V=
M&C4IRR1U,7*CA\/F\_K3I>S5&,*N CYD(U*%#!T\+AXWI8>"PE*O6FJ>*K1P
M;E[',*TJF)Q.'A+&+V,:M7^S72I\OMJE9/ZU4W;[Q_\ 'N.+2AX:U[X[ZU9+
M;:@W@+4?$'[.^FZ#J?Q)\4QZG81GP[\8;)O ]O)\/?"4%I+=K!KDFD_#'[2(
MY9%GG6T@DUK"C&^886G7A3A"3RY2IQJ?[.\!4QF.IYCC:E;GE[+,</E]/!XB
MC@_K?-.O.ZRV<ZT\LP.>)E7IY?BY495)5HK'24E1BZU+&0P."J9;@J-/F:Q&
M"Q&83QM'$8GZO.%&A3ITY9I3Y'F.(L-X@_:6T73H;S7O%7Q8N]*\36UAJ?B;
M4-"^$/A75_$WPML$\;:]I5Q;^ /#>D_#6[N=?U!]#3P^]Q::QIGBV\\E[C4+
M6U2(^4G#A)SE#+</B(/W<-DM:KB)1:J5\9C<EQ]?%8/$1CR4:.%I9MAL'AZ\
MJ5*A5P,<7*GBL90C*GB</VU'4]IBZE*E3YU6SNC2P_-:A&A@\YRO#X/$1J3J
MQG.K/*<1F6)PSE7=+&RPM)T*%:49TZ_GP\;_ +1?ABV^&FB>"=&^-4$]I;2-
MXOTK5?AE#_PBFH:;XANO$\Y\20K#\$]2G@\26NK76G"XTN;Q_H+6A2.X&B7V
MGM(\F<Y8Q8.I&E35/ZMD4,-"#:J3PN/P7"E'$8/ZHKP5:%3'T?J;E4EF+]O3
MG@ZM"A7Q%"I!KV-.46N:K]9X@G7=1QG%U\!C>+ZM#%_6DHWHNGE<I8Z+A0P$
M'A\3'%0Q$UAYX=^O^"M<_:&T+XJ_#'X5^(/&GB#QOI?BOPCI?Q8\4^-/$V@?
M#K1M:\/:;H.DW.D^,_A[+HOA3P;HD%E!J'C36?!,EC-+937\5M_;D+7S/:(R
M^\J6#EC>(*4'?"\/UJOL:D9QFL=3S%+#913J3C+XZ$\'G6.JU:$*%.HJ& IN
M-2G5K1EYD*N*66Y'7JNV/SVE1IU,/RJB\OK8&=+&YEBHPJ*I.K1Q&'Q&%RKZ
MO4;GA:U:6(]M&<J45PWQ=^*GQ0E^)/BKP-H6O^)=3-SX@\:>$8OAS:?#+PUX
MI\!7OAZR^ ?B+QEHTG_"27?A"_EU/QO=^*OL#WOAV36+F1;5-/671[:TOUGU
M;'(:=/$2PM3$^]:4\35G-NC]6E@^,,JRZG4P<H^S]KAJ66U*E3$8N/MUA<?.
MO&6*PN(PD,/3]'%U%AWBHMQH.'U"EA>22G+$1Q>"=?$_6HRG>AB/;1Q%+#4.
M6G*M@*,<1##8FE5J8VC0\;_$+]LBR?Q;I^C:5XI@TKP/XK'AC4O%%GX-^SWW
MB+0]=USQKX@TGQAX*CT?X)_$:[UL:3X6A^&V@W3Z3X%\0P+<ZOK:SV:36QU'
M2^"E+FPN#Q-9RI3K*GAI4I*<JD<9EF'C1Q6)JPI4:TE@L\Q=6>(IMO"PA1PL
M%A\5@E*4:_33I8:$\11IU)UIT<-+&4E.-&GAY4\PJ99*C@XU/:T;XK):4,XI
MJ"E[2:^ISQ%#'5JD</+UKPMJO[2%[XG\(:YXC\0:_#I<%[\+=(UWP;H?@6U3
MP9K-OXC\-:K+XU\176K^*OAMI/C"U-AJ2:7( I\/)87'FPWUF4F2W@ZJ?LZ>
M/KTJE-3HU\=F6'7,TJ>$H8;A["8[#5<-*C6J*4*V<+$X.E6Q&(Q<*].?U>/^
MU0C./EU*E:6$4J/-%TL+E]>$N63K5YXCB7$X*M2Q$:E&BE5HY(J&)Q-*CA<-
M*E-+$I0P[:J)XL\1_'GP[XV\9^)8K_XH:YX)M?%_BSPYIG@+PK\/O"5T+;PE
MIWP7M/%.F^*O#FIW/@BZU75=>?X@176G6L]W?W^G3R7#Z<--NKM8E'/15-8!
M+$5:D:V+PF.J2K*-ZF"KTN*J&7810HTZ-5RB\FK5<;5I2PV*Q%?"T5B<-3O"
M<JW37G5>-A#"T(NEA\5@(<DI+DQ=*MDF(Q.*3JU*M&%*,<?"A0A4]OAZ=#$S
ME3Q.)C2J1IT/&-&\;?M?:OX;\3&+5/BE82>%H?C'KOA;5+_X4Z3/K_CZS\/>
M'OA5KWPQT?7;?7/@5X/$<NK:EKGC'3Y++3?"'A[4'2SOK"*1[_2_[37TJ.'H
MR643Q,Z5"K4C@Z.,HPJ1=*%2OQ!BL#7K^T5:I)QH91&CB^93I4W)T<94HX>@
MZV#GV8:E0JSQ%&=5TZ-?&X"-*O*48UJ.%J97FL\7:,H1I0Y,QPN$C-UJ>)5+
MVL:4*]6GB:%66YXF\9?M?>&_'=CX6TJZ\0ZWX8T_QG)8Z9XV\0^#=1@3Q8+V
M#PQJB:7XMM_A?^S5XQAC\(V<6L:M91:I;#X?1[]+VW/B.:XMKE3R8%1JXS!Q
MQ"C1HJG*$XMMJK2H9IFV%Q&)GS3P].GCY9?ALOQ.&IRQV%P]6MB%6I9?B<+6
M5*AX^*JXKZCC*M&/L\1)1JT[0=J%6IE.68BCAXQ?MZ]3"+,:N/I8GEPN+Q,*
M5+ZO+%X7$0A4K>]?L[^*/BMJWB+XIZ)\2)_%^O6NCZ]YGAWQ9K/A+4/ _AJ:
MUN-1U>$Z!X9T#7_@SX&U18["TM[%GN_[6^(-G<)<02P>(7=Y;>.,(E/)<#5J
MI1QL6H593?[W$?N*3E7]FG2E0A[55+8>K@<-4HN:IJMC>256'?C+PS6O"ERQ
MPLHR<*5-RE##\DXJ,9U7&K3KSJ1FTJU#&U%5="K4G@LOA.A"M]45 !0 4 %
M!0!\_P#QD_Y*+^R=_P!G >(__66/VEJ /H"@ H * "@#Y_\ @W_R47]K'_LX
M#PY_ZRQ^S30!] 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % &/JGA[0-<FTBYUK0]'UBX\/:FFM:#/JF
MF66H3:'K,=M<6<>K:1+=P2-INIK:7EW MU;F.41W4R!]LC!G!NE4]K3;IU5"
MI24X^[/V=5)5:?,K/DJ*,54A?EFHI23LAMMTJE!N]&JX.=-_!-TIJI3<H?#)
MTZD8U(-I\DXJ4;229L4A!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MHFAU%[:5"57][+"IQHN?O.C%\UXTG*[II\\KJ%D^:5]W?K*0!0 4 % !0 4
M% !0 4 % !0!\_\ QD_Y*+^R=_V<!XC_ /66/VEJ /H"@ H * "@#Y_^#?\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M^?\ XR?\E%_9._[. \1_^LL?M+4 ?0% !0 4 % 'S_\ !O\ Y*+^UC_V<!X<
M_P#66/V:: /H"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * /G#2?VK/A+KVE:9KNA:?\ '#6=$UG3[+5M&UC2
M?V6_VGM1TK5=*U&VCO-/U/3-0L_@_);WVGW5I-#/#<02/'+'*CHS*P) +_\
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M: _\1._:G_\ G-T '_#2WPZ_Z%S]H#_Q$[]J?_YS= !_PTM\.O\ H7/V@/\
MQ$[]J?\ ^<W0 ?\ #2WPZ_Z%S]H#_P 1._:G_P#G-T '_#2WPZ_Z%S]H#_Q$
M[]J?_P"<W0 ?\-+?#K_H7/V@/_$3OVI__G-T '_#2WPZ_P"A<_: _P#$3OVI
M_P#YS= !_P -+?#K_H7/V@/_ !$[]J?_ .<W0 ?\-+?#K_H7/V@/_$3OVI__
M )S= !_PTM\.O^A<_: _\1._:G_^<W0 ?\-+?#K_ *%S]H#_ ,1._:G_ /G-
MT '_  TM\.O^A<_: _\ $3OVI_\ YS= !_PTM\.O^A<_: _\1._:G_\ G-T
M'_#2WPZ_Z%S]H#_Q$[]J?_YS= !_PTM\.O\ H7/V@/\ Q$[]J?\ ^<W0 ?\
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M .<W0 ?\-+?#K_H7/V@/_$3OVI__ )S= !_PTM\.O^A<_: _\1._:G_^<W0
M?\-+?#K_ *%S]H#_ ,1._:G_ /G-T '_  TM\.O^A<_: _\ $3OVI_\ YS=
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MA^;$?6J<JF&A.K1C"#C2G5BX_/5UXW^+?Q&^-OPC^'VL^+M&\/1> _BM\0-
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MNGE-75KFR^H\<YX?W6N7F_M+&_O8VK+VVE1>SH^SY6__ &=/@[J>OZIXDO\
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M_66/VEJ /H"@ H ^?_C)_P E%_9._P"S@/$?_K+'[2U 'T!0 4 % !0!\_\
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MV$_^CN?_ #HK\8O_ *(>@ _MO]A/_H[G_P Z*_&+_P"B'H /[;_83_Z.Y_\
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M"QK^S>)G)4:"J5OW9>^)?Q_T;P?\"+WX[>"M'F^)NCB#P]<:%HVF74^AWOB
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MG3_!O_L@'[2W_JQ?V3J /H"@ H * /G_ /:Q_P"36/VEO^R ?&3_ -5UXCH
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M  ;_ .2B_M8_]G >'/\ UEC]FF@#Z H * "@ H * "@ H * "@ H * "@ H
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M'B/_ -98_:6H ^@* "@ H * /G_X-_\ )1?VL?\ LX#PY_ZRQ^S30!] 4 %
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M=?\ S1T '_#6/[+'_1RWP _\/)\.O_FCH /^&L?V6/\ HY;X ?\ AY/AU_\
M-'0!XA^SY^TW^S;HG@/7[/6/V@_@?I%W-\</VF]6AM=3^+'@.PN9=*U_]I+X
ML:[H6IQP76OQN^GZCHFHZ?J%I<*ICN;6_M[B%GAG1V-O(-O(]O\ ^&L?V6/^
MCEO@!_X>3X=?_-'0 ?\ #6/[+'_1RWP _P##R?#K_P":.@ _X:Q_98_Z.6^
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M >W_ /#6/[+'_1RWP _\/)\.O_FCH /^&L?V6/\ HY;X ?\ AY/AU_\ -'0
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M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /G_XR?\
M)1?V3O\ LX#Q'_ZRQ^TM0!] 4 % !0 4 ?/_ ,&_^2B_M8_]G >'/_66/V::
M /H"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M-TT[2BFNJ1:K,U"@#Y_^,G_)1?V3O^S@/$?_ *RQ^TM0!] 4 % !0 4 ?/\
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M:A%X>EEU>> IRQ32YL5@W*AF%:+_ '4,1&.,I3CA,NC.ABL3A)0K4Z\L4Z>
MKX]O^U%\0]3U'6D\-K\,?$QN[K^P-*\*:;:Z\=8^%WC*Z^)/A?P'X<\+_%SQ
M$GB2:"XUS5['6]4UF?3+;1M"NM*AT&X 758FCN95EU.6/PN7RISC[3'3RRJJ
M]FL-["M@\9F6;X6C&\I5\5E."P-:,ZL:L8O%.G1Q&%PLJD(R,>Z."EF$)S^K
M5< LRIJA5YW4KO#J=#+<=SQIQCAL+F>83P&&PM"I"I+%4L;'$8;%SIX?$NE[
M59?%GQ?HWP<^('C[Q5%X6UC5O!GB/QIHMKJ&B6.J^%O"M_9^&O$<OAT:UJ-K
MJ&M:]=:/I.GW<%[_ &C=?;KH&WT>YO4C@646\&%>K"GA,EJ\RP4LS^IPJU<0
MXNCAX8O&O#4\?)*5)1PU3!RHYE&A*LG3A66'GBY*+Q+J-&M]=S;#JBZ_U&G*
MMAZ%!N=?$..44,Q^I1DH2Y\4\34J9?&4*%Y58QE]64[T3R3Q#^T5XYT.;PEH
M6E?$+X$>,M=UKP]IGC#0;_1/#FNQZ=\<X=9\0ZCI<'@CX,:5:?%C5'74]-L-
M.^TZIXE.J>([:R34+&XFT>*UGD>V[\/053,886K1JTZ="O@,-B:.JQ=.EBY1
M=?.:L72<<)EF%HU85(1J0KK%3I8F@\;AI0I3K<V,E*CE5?,<-.E/FCFLZ-Y\
M].C4R[#T)4<NJ27)]9QF.Q5:5"G*#PLH*#<<+6ESJ#=?^/GQL,NNZGH"?"S2
M/"\6F?'?6M(N?$'ASQ9K-]I_AGX-Z[8Z%:>*=5DTSQMIUOJIUK599["#1H?[
M-+13QZFNI9MGTNXX*"Q+P4*\J*Q6)J8/*\93HT)<GM)YQBZW]DY;!SYW[?,L
MN5.K];LX8+$T:T/JF.A6A[#NA2HU,?3PM.O2C2>8QR^<Y54G%4LN53-L59PB
ME2R3-(5,)BE\%55J%.=?"2C[:O27]JCQY)XM\3V>E0?#CQ=!X'OO$UOXI^%W
M@]-4UGXK:=IWAGX2CQ1>:YK-Y;>)Y+7PG"WQ+LKWPS9VNH:%*VIIJ5H]O/%)
M:N;W:K*A'!YCC<+)XNA0IYE["KS1HX>G6PV>/+,##$XFI^YYL7A%+&5:2E1E
M0P\)XWGE0C5IT<<#!8NKD^#Q$_[+QN+CDOM(UH.:Q%3,</2QF,>$IPDIT<)@
M<)B:<_K==U(3Q5"K@)1A5Q.$J3J>"_VD?C+XT\*:1JUE=_!6VF\1R?$#Q';:
MW&EGXHTOPKX!\ ^&89=;?6=.^'/QM\3:9KNO:?XRU;P_8YMO&>F_;+2]DDN;
M'1+F-H$>/B\!AL35Y9UU@,MJXV=2G"?)BYRQ6$IY?1HQE&*H3QU-9G3<:=7,
M:-*I@XUZ.+Q<6\-)82G6Q=>E3C0=+ZQF. RU4922J87$8JAF.(KQKN2C5FL-
M2PV%E'VF$P=:K5K3P]3#8>#ABUJZG^U-XGT74;Z'5-4^%MK/H/PP\"^(O%/A
M>W674;CP=XF\77/A?3]5U/XD>+;/QZ6^%OA709_$\&I2V6M^%I'O](L[J]LM
M89K2[AL^BMAH1QF<4*.)IQP>'S=9;A<74:]A"FI33J5*B<88W%REA\1A:> I
MRP-3ZW+!QE4Y,2Y4<L&YXC+\IQ<Z;C6Q&78G,*U!M4\17]C@\1C*-"AAGSU,
M/"M3IT9_75+,:,)SJX:I3IU%A:F-Y=?VC/BO*GA#5(_B%\,-8M%U?X]:S#IG
MAKX6:UHMS\;/#/P9TW3["7POX+LO$GQ=U.\TOQ!>:Y<ZY/;7-A+K!GM]'MM1
M\C[#;W=I?\LW4PU&IB)X*<JM+)'C*F#J5Z="I2KXO-9X;+L9.;2>&PD<''#X
MC'?68NG@O;U,-B9QKXG"UL'UT<'4Q%26&6)P^&IU<[R; 4L;=UJ-/#X[*?[1
MK<R3C3Q$W6;PE&=.I257W*U).TX3RX?VO_B)_P *VB\6ZUX@^"GA5/$J^.=9
M\*>+'M;+QKH]M8^!-*TN\U'P ?#GPV^.OB"S\9?$JYN[V\6RCTSQO8R36.E7
M^H76CV,MA+IS5C<)74%A,'+V^82PW/1A!2C4S)XFM##8.I@XU(*GA:5.K*:S
M#$>VS/"8)K"S6(Q%+%SGA5@*;Q-9>UA'#TI8W X"=.K44)X&OB:>-KU?K+E&
M-2K&G3H8:G1IU*&6XG$8C$SI*C2=.D\1[%\3;?XH6OP2^"_@#2_'EUIOCSQG
M?^$= \8>));/Q7J/B#5[?3/"FI^-/'2Z3J?AGQSX9UC0;^\M_#>HPK>VFK17
M$<=S]FM9+6::&ZM;S9X7#9W7EAL-4KY)DM/,,94P\*LH5ZN#RRC[+"IUU+FG
M4K8J>"HS<X5O:U\1'$8F&(H4\1A<5RY74Q&,R:OC:OU?"YGF:POLG*RPF$Q&
M<8^A3JQI4:JJ.5+ X?%8BIAZ2G&5.AA+0G3E&-6EYEX;_:K\57&CZUJB>,?@
MROA*UT+X7P6WB>^L?%$GAKX2:QX[O_$&GSVGQ/\ B'JOQ)FB\>3>'[;PW)#J
M1CC\)R'5K^#3KF\MYVGN(;KT9QJ1A6Q%#FQF:5L'1QU&$8X/$.AEDLTJ?5,*
MG2C5I8IU\OPN5XBEB84L5]8G5IX:/+2PT\Z#C%4H4</B9RPF">(KY96]K',Z
M-%YA@\NPU3%UIQQ/U:LJ;S+&8_#5:>*KX2G@9>UQ$Z<EBZF[X@^.,]AX@NX-
M8\=>';O4/#'BC3++6KWPEK&L^&]+\56'@7X(:Q\:)SI/@^[^(NM1Z;;:WJFK
M6$,=M:RS76I:;I5TMW<ZA:6,3VO'7E.CAL9B:5-TYX7#\08NEAZ[4HJKA)9?
MPY]7QU9PHRI.AB\;6S.4.:A2PD(X/%*-&NZF)Q'=2H0Q57+,!.M[6.9U,CI4
MZ^&C[%T9YCFV+QL:KJ.35;#5LNRBG@*=9.K&IC,5B,+!\E6OA:.9H_Q]\8:
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M]"%+/#SHXN^+526(IU</F.88/$7CEN K83$YF\'EM-*K%4Z+H8++95IO'O\
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M4R[C]JWQOJUQX&T_0+_X;^&=8\:ZAX2U3PSX?\4^%O%.K^)_'W@[X@?$;6=
MT)O#OAN#QKH5WH(T3P18V.K:[X@NO[3M[>ZO1;G2X \0D6%P[GB\'0Q#C%TH
MX>.8X>,XJIAYQR.AG>88AXB/M:-'#PA+%8++XSIUOKV+P>(@J]-4I7>/JQPU
M'-)0A/#?5GCZ>%Q%:,JF'K8C#8VKE.#PD(TXPGB,5C<PI0KUJ5.5%Y=@,;@:
ME1XA3JUZ7I7P7\??$S6_B#)#K-WHE_X&\?Q_%GQQH-HT&KW'B7P[H?AKQQH/
MA/P1<'6)O$4NG1:#KN@SR74&DVNC0F*6SN+LWT[7LL%ME@(1EE,/K%3GQ>&P
M64XQRBN5Q>?5,SS&.&Q"DG.M4P]&,:,*EZ2P\,.L'R5HTZ==Z8SV-+'8AX>5
M2ES9C7P+H5DW[191@,)@,QQ.&47&.&HTLTH+FIR566,_M*&*_P!GFJD*AX5^
M/'BCQC\>8?A_I6L^ (="LM2^)>G^)/ I\/:]?_$?0;#X>SVND0>(];\5V_C&
M+2O#SZWK&L:#=V&A77AF::?1[^+4([YA<!(7EU-XC"8C%U5[6BL%'$0J4)*-
M+#XJMCJ="A@*LI\[Q.(CA:>-J8V-)4'@<716%J*<>2M7>9TZN#JT*5!T_=Q>
M"H57.7/*K1Q>48C,W7HTXJFZ,(5:<,)3G4E6A7:K5(N,J<Z,//\ 6?BIXA\$
M?'KQ'XV\;>/=(MOAG#XLU3X7:!H=Q#XXTJWM['PU\+U\>ZX=+TVS^(LWA_Q;
MX]U#Q7>V&EVKS^%7U)X='U&&P:-7:.3CPV*I83*\=5KWQ6*Q^$S?,\.J:O+V
M>49I1RBE@Z5.I&HZ2]W&XW$2P\J<ITJ57$XFI+#*G2P.F)I>WQ>%H85M0PD\
MKP==->SIX?&YI3K8QU\7B$J;JT98)X6A1C-SH1QN8Y=AZ48XJCB)X[I(OCK\
M9]07PQ>V&C>!+*S&G_ 27Q7IMWHWB*^UB]\0_%[79TU?PCH&SQ79)HTVC>$K
MS1]4?4[R+4MCQ3H;"=;H-IWHSH0PF.Q6%Q%58B."QV/RV4:%X5*U;*LBCFN/
MQ-)R52,:4:G,L-A^6K.O&,Z$Z]"<%B*G*\5A*^#>(P=2=)5\)7S+#5L33<:7
MU/$YE+ Y!1J4HM5'B\?.A5PV*:J4Z>%K5\/B%&<(SPT_*4_:)\2^.=7U'Q%/
MXZ\'0>#;;PKX8TB?P?X=D\5>&)/ VN?&;XGZ#\/M-L/B-\0['X@VJ:EXVT'3
M](\5O<6^EP>&;C0;^62VS<W'DSAX##-3H.K.GB)XO&Y5A\/BJ4KX&O&GA\7G
M.:4\!2ES_6Y2HX; X7!XRI&=''3KO#_5(PJ8O"3ZLP]K@ZF*A15*E1RN/$5>
MI*I'V];V^2T883 _6(QC&%' XRKF'UO$X>K!NA0H8?%2Q2I0CB(^HG]HCXEZ
M2FJ^*M6TOP)-X$;PI\4_$V@6<4.M:9J.F:+X-^(>D^$?"'BOQGXRN]?O+.TT
M+5=(U<ZC>Q0Z$&L[;1KR_P#MCAC8VW%2G&6"I5:]:E1KXFGPU4=5^YA\&^(I
M57!5Z<N656-"A3E6JR57"QIU*4\*O:1J1Q<"=*DL1/#X-5ZBPE?,\,L-*,JN
M,QW]BX)O'RPMOAE#,Z4<%AXU%7J8N&882K:E.E4C7WO"'QY\2GX(_&KXM^(_
M$WPT\7:7X N_&*^#/%?@_0-9\'^#/$EGX6\.V,DD\W]O>._$'VNQ'C)M6TL:
MI;ZK;6US!IZW$:0B7Y:QJE0RW*)TDL)F.925'_;[X>A"I7S6KEN#JUJ;2JX6
MC5A&EBZD9U*LH4:R?/H&">&Q&:UJ-2<UEF$C0JUYT%]9G"F\'#,L2\-4HJ?U
MZ-'!5J2A.GA:4ZN)A7IPP\HJFY\!_P -/^-5T)+JY\=_ 2QTO7O%?]D>%_C4
MVD>)+OX12):^$+'7]0\-:);)\0H7^)_B5]>GET.PN])\1Z/!?RP7QAM/M>E2
MZ==&(O1FJ4:%95E3S'$X>C*#^LYMA\-B,%2P<<)AHWJX6KBXXJO+WECI>QP$
ML;2HU<+BZ?L,,++VE.G7FJ=2BZ>7T\2Z5>'L\LQ5=9FL9/&8GEG25'"2P&&<
MJ=18;DGF>'PM;$PG%5ZR>,/CK\;KWP#XK\46.O?#3X+V7AK0_A#H6O:GXN\'
MZGXFU#PY\1_B7:^'[G75N;C4O'_A_2-!T;P[:>,O#-RTFK6U]L+70NXBL0#]
ME7"^SS*AAZ56,J.*SZIE^#C+E:Q.$PLL*JL_:PJ15>=3$4\TP$*6%5.IBZU*
MG2PM:A7E&<KHJI)5'"G]:ITLDQF:JI:KAW6]E_;,<-RX:I"5;"JO3P.#Q?+B
M'.>'A6=.M3J*3E2AU#]J/QI9:[XELI/%'PPN[/P+X4^,5]XT\,:=X2UZW\9Z
M<?A/I*6B^+[_ %Z;XCSZ5X*L_$7B+4M!O],\.ZEIE_+_ &'J4-]_;,RR[HN*
MI1>-P683HR>#I8S#TH86O[:*I9;CLQS2CE^"P>,Q$H1^LU\-0EBJV93HTL*\
M!BL,Z%2FX\E2OT8?#5*6-R?#3JTL9".-RZGBZD(SJ/%X3$9/7S:KB<+A:#E4
MIQO16$HI3Q*Q4O:RHVG!T(>D_$KXLZK\(?!WPF\-Z;XY\%Z=?Z_X1F:#XF_%
M,:OXQT?Q'J7AG2- %GX>TNSTKQ5HM[XS\?>+KC4VET^&#6O.ECL]0NHH-0>
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M )/_ /:!_P +-_:G_P"A]^ '_A@_B+_]$U1_8/\ U%?^4O\ [H']K?\ 4/\
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MIIIKHTUNBU_PLW]J?_H??@!_X8/XB_\ T353_8/_ %%?^4O_ +H/^UO^H?\
M\G_^T#_A9O[4_P#T/OP _P##!_$7_P"B:H_L'_J*_P#*7_W0/[6_ZA__ "?_
M .T#_A9O[4__ $/OP _\,'\1?_HFJ/[!_P"HK_RE_P#= _M;_J'_ /)__M _
MX6;^U/\ ]#[\ /\ PP?Q%_\ HFJ/[!_ZBO\ RE_]T#^UO^H?_P G_P#M _X6
M;^U/_P!#[\ /_#!_$7_Z)JC^P?\ J*_\I?\ W0/[6_ZA_P#R?_[0/^%F_M3_
M /0^_ #_ ,,'\1?_ *)JC^P?^HK_ ,I?_= _M;_J'_\ )_\ [0/^%F_M3_\
M0^_ #_PP?Q%_^B:H_L'_ *BO_*7_ -T#^UO^H?\ \G_^T#_A9O[4_P#T/OP
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M'_\ )_\ [0/^%F_M3_\ 0^_ #_PP?Q%_^B:H_L'_ *BO_*7_ -T#^UO^H?\
M\G_^T#_A9O[4_P#T/OP _P##!_$7_P"B:H_L'_J*_P#*7_W0/[6_ZA__ "?_
M .T#_A9O[4__ $/OP _\,'\1?_HFJ/[!_P"HK_RE_P#= _M;_J'_ /)__M _
MX6;^U/\ ]#[\ /\ PP?Q%_\ HFJ/[!_ZBO\ RE_]T#^UO^H?_P G_P#M _X6
M;^U/_P!#[\ /_#!_$7_Z)JC^P?\ J*_\I?\ W0/[6_ZA_P#R?_[0/^%F_M3_
M /0^_ #_ ,,'\1?_ *)JC^P?^HK_ ,I?_= _M;_J'_\ )_\ [0/^%F_M3_\
M0^_ #_PP?Q%_^B:H_L'_ *BO_*7_ -T#^UO^H?\ \G_^T#_A9O[4_P#T/OP
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M'_\ )_\ [0/^%F_M3_\ 0^_ #_PP?Q%_^B:H_L'_ *BO_*7_ -T#^UO^H?\
M\G_^T#_A9O[4_P#T/OP _P##!_$7_P"B:H_L'_J*_P#*7_W0/[6_ZA__ "?_
M .T#_A9O[4__ $/OP _\,'\1?_HFJ/[!_P"HK_RE_P#= _M;_J'_ /)__M _
MX6;^U/\ ]#[\ /\ PP?Q%_\ HFJ/[!_ZBO\ RE_]T#^UO^H?_P G_P#M _X6
M;^U/_P!#[\ /_#!_$7_Z)JC^P?\ J*_\I?\ W0/[6_ZA_P#R?_[0/^%F_M3_
M /0^_ #_ ,,'\1?_ *)JC^P?^HK_ ,I?_= _M;_J'_\ )_\ [0/^%F_M3_\
M0^_ #_PP?Q%_^B:H_L'_ *BO_*7_ -T#^UO^H?\ \G_^T#_A9O[4_P#T/OP
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M'_\ )_\ [0/^%F_M3_\ 0^_ #_PP?Q%_^B:H_L'_ *BO_*7_ -T#^UO^H?\
M\G_^T#_A9O[4_P#T/OP _P##!_$7_P"B:H_L'_J*_P#*7_W0/[6_ZA__ "?_
M .T#_A9O[4__ $/OP _\,'\1?_HFJ/[!_P"HK_RE_P#= _M;_J'_ /)__M _
MX6;^U/\ ]#[\ /\ PP?Q%_\ HFJ/[!_ZBO\ RE_]T#^UO^H?_P G_P#M _X6
M;^U/_P!#[\ /_#!_$7_Z)JC^P?\ J*_\I?\ W0/[6_ZA_P#R?_[0/^%F_M3_
M /0^_ #_ ,,'\1?_ *)JC^P?^HK_ ,I?_= _M;_J'_\ )_\ [0/^%F_M3_\
M0^_ #_PP?Q%_^B:H_L'_ *BO_*7_ -T#^UO^H?\ \G_^T#_A9O[4_P#T/OP
M_P##!_$7_P"B:H_L'_J*_P#*7_W0/[6_ZA__ "?_ .T#_A9O[4__ $/OP _\
M,'\1?_HFJ/[!_P"HK_RE_P#= _M;_J'_ /)__M _X6;^U/\ ]#[\ /\ PP?Q
M%_\ HFJ/[!_ZBO\ RE_]T#^UO^H?_P G_P#M _X6;^U/_P!#[\ /_#!_$7_Z
M)JC^P?\ J*_\I?\ W0/[6_ZA_P#R?_[0YZ+QA\:/$'QN_9=LOB+XF^%^LZ)%
M\8/%MU:VO@KX9>*_!>JQZJG[-/[0,4$]QJFN_&'Q7;SZ>MI-?(]JFG0R-)+!
M(+I%@>*YXL=EGU*E&K[;VG--0MR<NZD[WYI?RVM;J=.%QWUFHZ?LN3EBY7YK
M[-*UN5=S]':\L[PH * "@#\Y)/\ DMO[47_98/"7_K-/[/U?4Y'_ +I4_P"O
MLO\ TBF>#FG^\0_Z]K_TJ9T=>R>:?$WQ+U:'2/'/Q?N=+\4^(=*\?QV_PP?X
M=^']+O[ZPMO$OBA=.UC[%I0L+-HT\8+=1BXBOM,NQ>06EDAOS# R"ZC\W+&O
M;N%.<I5)<40C5I)N:^HSP/#E/'U)T=8*C#"RJ3JXMQYL+*%.4*E*4E[7IQ$;
M*<JD%"A'A^3E6C&+J0K0QN=SPO+)R4H55B%!8:C%TEC93JT)_681E"C[KX+:
M>+XM?%VTME"Z0UC\.]4N@F#%'XOO=*U>TUF,$2';,= TSPE(Z;5XDB<Y,F3W
M8/V?U+'1A-RC0SC&4Z2>T:4L#E=><8+I#ZU7Q%1I:>VJUOM<UN?$.I[3*W43
MC6J97!U8\MH^YCL;"C)2LN:3M6I-N4FJ="C'W8J/-[)6@C\[_B9XC%KXP_:=
M\)GXI_"3PD/$EOX=M/\ A"O&^CRZGXN\7_:_AIH]H+7PLUO\0=*FCDNB?L4(
MA\/:W(+EPT:R.%AKYRE6J+ XZG2<,?4P^=XBO#+J'-#&UI4EEM94X585*DZ;
MKNERTJD</&5)QG-5%;GI_1)2I8O(,1#GPDHY522QM3EEA:+6:9W:<Z<XPA-8
M?G]I6A.OR5(2A"<%%M5-AOB5J>DV^N>%-3\3:SX<\;:A\</@Q-H?A&;6M3NM
M?T?P-KEM\+5O;:TLY95N9O"0O?[?T^Y:)/L<UV]U;2[I[EXW^BJ5(U:V#P]'
M%JO7H8KBF&*K0I^U<7&GQ)B<!4KTHJ3DO8+!5L%3DFIQI4HX=-45R?/T:4J.
M"JXJIAE2P];)<LGAZ?.HI5HK#X?$QIU&URUH58U77DFJL(/VM6W.K\UX>\<Z
MW:6&O:5:^.]4\6:HMS\.;G5/%WASXE^+==L([Y_BMX4TC5;3Q5X+\4V4.H_!
M?Q=J-IJ5W"_A:QO?L#VD%]$;*#[-A^/ R4Y8+V;4:,<URVFU#$/&X:K&K3Q7
M/'#8V7[VLI*G3EC<+7E6CAV\-*G)>VJ<_IXJG&.,S#FIJ$_[,X@G"C*E&A6H
M*AEU6KA:D\/!.BX4)QM@\PI*E4Q,KU9>U<:<Z,TNK_$;1?!.B>-?"GBSQSKO
MCGQ'XN_:*\-P:9J?B77-<TBXMM M_BQJ/A33['PQ?7D^FPW.G:AX:TK[-<PV
M7VPQI]D,KVPC@3*,:E++\OC&M4:Q?#&6XW$U92E*HJLJV01KXN$_98B=&=+"
MX[%J3HT:GM-*]:AB<1%2DZ<,/5S+'^WA&%# 9[2HTZ<>6E!TI^UIRP\W>"=.
MK-0:]I)*C)+V<J5/F3-*\3>);OPKXT>R^*WAG3_#EO:>#I]7OH_C5\6OB1:6
M&OG6)5UZP\1_$P> =$OO@_!JVG^7;WT.GWX.@M#'=I8V,,S"95)\M.%ZE%8"
M.-BL+;%5X4*U*>#QW-1><Z3Q$*>(AA<1AYR=?VE:$L#7K26+P^&.6G&7-14Z
M56.)GA:[Q$EAJ3Q$)1Q&"4*D<IO*E!PA+&4JBC[&].I[>G?ZE4Q%/-U3X@7\
M.@>&-8;QQJL=CIL.L6^C>')/C=XML-5\3W=EXAN9(-8^$_Q'@\-C3?C[*\$E
MIIMAX?\ %6G7DMU%:1O<L[W)N;JL/7F\?@:TXU:E6M2P/+A)1]GBZ:AB,10K
MN>7VCA<?0QD*<:M7%TE0J8?"^QQ$)X:IB$XZJ@J]/$X9*CAH1Q&)IU,3=RP=
MY8+!5*<GB^:6(RUX64ZTI4Y.5*6*GBJ*C5I8!4X_4GQRUQK+3OALVL:]J_@K
MP!K'C*"W^(WB&SUV]\(7FC:(_A?7KS2X-2\4Z5>V=SX7L;CQ1!HEK<7L%]:D
M-(EN90ERP.N,6%ACE1QV,>&PD</C72J4ZTZ,*N.IRH1PU/VL6G).C+%UJ-*4
MN7$5J-*E*%3F]G+# >VGEV)K87#*OC5#"-4ZE.-2I3P\ZT%BZD:+A*,ZM.FU
M&HU&]"C.MB(N$J*G'Y_USQF(;?Q*UA\3_'D_BS2=,\-_\,YZ=?>(-<TS4/B5
M:/I=D9=0N_"0@TFW^),EYXA_M"QO;C4=-O1;6%O!?));B?[=.82<YXK">UE4
M_M&IFV"I8K#RAR.GE51Y?SU:F#Y5#"PJ86>*Q.)Q*P^'GA<7[;#)T/JT<-"Z
MD<-&@U3E;+O[.QE2=>/OJGF%/%9G&-/#XQ\U3$.C&G@(86C]8KPQ5*5*H_K#
MQ$JDG10>(-0T:'6KSQG\0KR]\3?''XV?#S4=,'C?Q6NEGPE'#\35LM"T[2;3
M5DM["6TNM$T^2TU"UCCU"W$0MX+I+8+ /+Q<''(\-!2J8EYCP]F5:JZDISE.
MMAJ=?$X::3=HN'LU1G&,5'$T92IXJ-=/3V*:C',,<ZE*EAWEL^'*M-0A3IJE
M/%+A_#XM-Q2YHU(XRO-JHY1IU7[>ER57*H_-_$/Q#T70OA%X<3P9XW\61^)_
M"OP=\%ZOX:5OC'K.D:.M_ MS)XBNM%\.:9)?7_Q,NM-O+&YM-3L->BU#2M-6
MQCL2=)@CN77Z#%8BC4XEOAZOM:"SK+J,I3K2K<^5XB> C&O&C[U*M@L5A\4F
MLVQ#]M5KRQ-:.,JUJ5"E4^=RG"UH97A\#B<,Z6(JX7&<U)452FL?&.(2PWM?
M=JT,51G3<J>6X3D@J<L.GAN2KST_6KW4]+\3I\6-+\4?$#QS'\3+M/BMI=E\
M.-#\4^)5TRX\#V^AWTWA&^;PMI.^#1M'FTR&QO8O$MO'I4EW?7;Z>^H7"S_8
M9OG,?%3X<S9QG4KXNGA<;4Q].HY-87$X?,I^SC*+;^KNG1A3I4,*I0I9A@9U
M,36PN)]ZK2]3+VEF^2RYE3PDJN2^PJJ,*<JRQ.78=XOD:2==?6ZN*E5K14ZF
M!JT*?LJV'5).7J]SK%O9_"7X(W'@WQ%>7.E7>O\ PXT]-4L?$FH:N^I:?+"\
M5[:7.MRZA<7&IP-+&\4J7%Q,,P^6X_=[5]KB*K.&9P]E5<:52.=SA*$GRU:5
M/AW.,1A*O,G^^]ZG0Q5*NW*4ZD:>)4Y5+5#P,M5LH?/'EK4GE4)Q<>65&K+/
M,KH8JCR67L>7GKX:I0C&$:4'/#<D::=-?+^IPZS+\"]"N]3\:^/]=?XA_LO_
M !1U_P 5IK7CCQ3?PWVK^'-+\+ZCH=Y:P2ZKY>DO -0N[:=;!+9=1@F=-3%Y
MO8MSYC0A3GB<"W.5.&'R'%J3J5%46(>-P5"K-3C).,:\:KE.A'EH*I&-2%*$
M^:3^WRZ,/[;52-.%*6'XIQ6705.$::C@ZW]MOV2C!17-2>%I.A7_ -XH62HU
M:<8P4>ZL=<N=$N8-)M?''C*#XIZ1X\\ Z)X)^'T_C+Q+JT>J_"RZE\+1W^HS
M^%-5U22+Q/I$VB7/B*[O/%%]%>W-E<6SPKJ$(M$@KKA-SS*A[_M,7+&9K2S.
MDZDIQH82AB<QIX>I4@W)85PP=/ 5Z&)C&G5QN(J1C5J5Y8B<'\G2A%9;)XB"
MPV"674:^75Z4%&5?,*F!HUI4HR@I.LY9G*M@ZF!?[G"8&*K4Z&&A".)70>&]
M"O\ 7HOA,-0\<_$XGQSKGQ2F\4M:_$OQS8M?VV@0>(H=$TZS-IK\8\/VEHJ6
MC#^R!8/*]E&\[RL7+^114OJ> 7M:MUP?3S-R=:JYRQ]2/#+>(G.4W*;BZ]5Q
MI2;H?O:J=)QKUHU-*^(E&MBZBITDX\28C+X+V4%"&$I2X@E[)4XI0ES+#0BZ
MDXRJQBH>SG!T,.Z7'6GB_5/#/ASP'X@\2^//B9=VOCCX,-J_C*^M_%BVYBU&
MP\;_  ZT33];AGU8-I7@*PM]+\1:A!JNKZ9;Z:YLVGOIY6OX8[M/3FZ2ABJ=
M>HXPK+AVNY2K_5J<:^-PV9U,8I8A2A/"X?%2PM)1P^&J4:4*RI4<'"@ZTE+O
MQ&']AB*\,-&+_LW'\0X.E%TW7F\-@_:_5H^R49/&8JA[.,J57$QKRD^9XIU:
M"E!<UX9UZSU7QOHE[JWBS6E\/^%OC!KFF> [J;XO^-O%&GQV7B/X,_VOH-M'
MXQU74+63Q:NI^(5F6U^UR:I!(\]UIFGW5[9.?M7#SU*>!QM=U)4\SCDW$^&I
MKFG"?M,)B\LK4J2IM4Y5*M' U:^*4JM&.(G1HT,?.+>#PM>CGC:5.5?+:%"D
MIX2.)R+%8QJ*?(IRSC#UJTVE)8:FZM+"X:HJ55THRE.C4]E4Q.+PQJV?CG7Y
M/!=M?:WX_P#%EA\4K?X>_#&_^"/AZ#Q9K43_ ! N]1\%Z!>:I>W/AE;Z.W^)
M%W>^*IM5L]3;4H=2-A;0K<!K,N;E_9Q/)#/,32I2DL5'B&&'KX:*O3HY0Z^#
MC*4</K3I85X66*K3Q\:<)TJ\:E)5U["-,PY:2PWO-QP3R_'5:E;D2E#'T\9F
MD(0IU[*;K4X4\O5+!JI*%2,X7HR]LT>A?"ZZ\1PWWPE\37GC'QIJ>H>,?BO\
M:?"6OV&L>*]=U30I- T>Y^)]]HVG6WA^]U"73;.33[GPWIX@O8;9;L0J;8W#
M6RI"D9=2C"&74^>5:.)X6PF.J2JR<Y3Q2_L1QKJ4KNG+V>,KTYJGR1K\RJUX
MU*Z]J<^+<YPS6<H1H5,!F]&C"%.,81C3J*I3K46H_'!RM.*DY>RE"*I.$+Q?
MV_5$!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M4(J,%&TFT[IR?2+TU-7R_C;_ -&N_&#_ ,*W]FG_ .B!KO\ [;PG_/NK_P"
MP_\ EAR?V7B/YZ?WR_\ D \OXV_]&N_&#_PK?V:?_H@:/[;PG_/NK_X##_Y8
M']EXC^>G]\O_ ) R],T'XM:,VI/IW[*GQ@@DU?4Y]8U.5O&?[.%Q->:C<1PP
MO<3S7/[0TCG;;VUM!'&&$<,-M##$J11(BJ&=8.G2IT(4ZRIT?:<D;1=O:U:E
M>H[NHVW*K5G-MMN\NR23GEF)G4=64Z;G*-.+=Y+W:5.-.$4E!**C&*T25Y.5
M25ZDYREJ>7\;?^C7?C!_X5O[-/\ ]$#3_MO"?\^ZO_@,/_E@O[+Q'\]/[Y?_
M " >7\;?^C7?C!_X5O[-/_T0-']MX3_GW5_\!A_\L#^R\1_/3^^7_P @'E_&
MW_HUWXP?^%;^S3_]$#1_;>$_Y]U?_ 8?_+ _LO$?ST_OE_\ (!Y?QM_Z-=^,
M'_A6_LT__1 T?VWA/^?=7_P&'_RP/[+Q'\]/[Y?_ " >7\;?^C7?C!_X5O[-
M/_T0-']MX3_GW5_\!A_\L#^R\1_/3^^7_P @'E_&W_HUWXP?^%;^S3_]$#1_
M;>$_Y]U?_ 8?_+ _LO$?ST_OE_\ (!Y?QM_Z-=^,'_A6_LT__1 T?VWA/^?=
M7_P&'_RP/[+Q'\]/[Y?_ " >7\;?^C7?C!_X5O[-/_T0-']MX3_GW5_\!A_\
ML#^R\1_/3^^7_P @'E_&W_HUWXP?^%;^S3_]$#1_;>$_Y]U?_ 8?_+ _LO$?
MST_OE_\ (!Y?QM_Z-=^,'_A6_LT__1 T?VWA/^?=7_P&'_RP/[+Q'\]/[Y?_
M " >7\;?^C7?C!_X5O[-/_T0-']MX3_GW5_\!A_\L#^R\1_/3^^7_P @'E_&
MW_HUWXP?^%;^S3_]$#1_;>$_Y]U?_ 8?_+ _LO$?ST_OE_\ (!Y?QM_Z-=^,
M'_A6_LT__1 T?VWA/^?=7_P&'_RP/[+Q'\]/[Y?_ " >7\;?^C7?C!_X5O[-
M/_T0-']MX3_GW5_\!A_\L#^R\1_/3^^7_P @'E_&W_HUWXP?^%;^S3_]$#1_
M;>$_Y]U?_ 8?_+ _LO$?ST_OE_\ (!Y?QM_Z-=^,'_A6_LT__1 T?VWA/^?=
M7_P&'_RP/[+Q'\]/[Y?_ " >7\;?^C7?C!_X5O[-/_T0-']MX3_GW5_\!A_\
ML#^R\1_/3^^7_P @'E_&W_HUWXP?^%;^S3_]$#1_;>$_Y]U?_ 8?_+ _LO$?
MST_OE_\ (!Y?QM_Z-=^,'_A6_LT__1 T?VWA/^?=7_P&'_RP/[+Q'\]/[Y?_
M " >7\;?^C7?C!_X5O[-/_T0-']MX3_GW5_\!A_\L#^R\1_/3^^7_P @'E_&
MW_HUWXP?^%;^S3_]$#1_;>$_Y]U?_ 8?_+ _LO$?ST_OE_\ (!Y?QM_Z-=^,
M'_A6_LT__1 T?VWA/^?=7_P&'_RP/[+Q'\]/[Y?_ " >7\;?^C7?C!_X5O[-
M/_T0-']MX3_GW5_\!A_\L#^R\1_/3^^7_P @'E_&W_HUWXP?^%;^S3_]$#1_
M;>$_Y]U?_ 8?_+ _LO$?ST_OE_\ (!Y?QM_Z-=^,'_A6_LT__1 T?VWA/^?=
M7_P&'_RP/[+Q'\]/[Y?_ " >7\;?^C7?C!_X5O[-/_T0-']MX3_GW5_\!A_\
ML#^R\1_/3^^7_P @'E_&W_HUWXP?^%;^S3_]$#1_;>$_Y]U?_ 8?_+ _LO$?
MST_OE_\ (!Y?QM_Z-=^,'_A6_LT__1 T?VWA/^?=7_P&'_RP/[+Q'\]/[Y?_
M " >7\;?^C7?C!_X5O[-/_T0-']MX3_GW5_\!A_\L#^R\1_/3^^7_P @'E_&
MW_HUWXP?^%;^S3_]$#1_;>$_Y]U?_ 8?_+ _LO$?ST_OE_\ (!Y?QM_Z-=^,
M'_A6_LT__1 T?VWA/^?=7_P&'_RP/[+Q'\]/[Y?_ " >7\;?^C7?C!_X5O[-
M/_T0-']MX3_GW5_\!A_\L#^R\1_/3^^7_P @'E_&W_HUWXP?^%;^S3_]$#1_
M;>$_Y]U?_ 8?_+ _LO$?ST_OE_\ (!Y?QM_Z-=^,'_A6_LT__1 T?VWA/^?=
M7_P&'_RP/[+Q'\]/[Y?_ " >7\;?^C7?C!_X5O[-/_T0-']MX3_GW5_\!A_\
ML#^R\1_/3^^7_P @'E_&W_HUWXP?^%;^S3_]$#1_;>$_Y]U?_ 8?_+ _LO$?
MST_OE_\ (!Y?QM_Z-=^,'_A6_LT__1 T?VWA/^?=7_P&'_RP/[+Q'\]/[Y?_
M " >7\;?^C7?C!_X5O[-/_T0-']MX3_GW5_\!A_\L#^R\1_/3^^7_P @'E_&
MW_HUWXP?^%;^S3_]$#1_;>$_Y]U?_ 8?_+ _LO$?ST_OE_\ (!Y?QM_Z-=^,
M'_A6_LT__1 T?VWA/^?=7_P&'_RP/[+Q'\]/[Y?_ " >7\;?^C7?C!_X5O[-
M/_T0-']MX3_GW5_\!A_\L#^R\1_/3^^7_P @'E_&W_HUWXP?^%;^S3_]$#1_
M;>$_Y]U?_ 8?_+ _LO$?ST_OE_\ (!Y?QM_Z-=^,'_A6_LT__1 T?VWA/^?=
M7_P&'_RP/[+Q'\]/[Y?_ " >7\;?^C7?C!_X5O[-/_T0-']MX3_GW5_\!A_\
ML#^R\1_/3^^7_P @'E_&W_HUWXP?^%;^S3_]$#1_;>$_Y]U?_ 8?_+ _LO$?
MST_OE_\ (!Y?QM_Z-=^,'_A6_LT__1 T?VWA/^?=7_P&'_RP/[+Q'\]/[Y?_
M " >7\;?^C7?C!_X5O[-/_T0-']MX3_GW5_\!A_\L#^R\1_/3^^7_P @'E_&
MW_HUWXP?^%;^S3_]$#1_;>$_Y]U?_ 8?_+ _LO$?ST_OE_\ (!Y?QM_Z-=^,
M'_A6_LT__1 T?VWA/^?=7_P&'_RP/[+Q'\]/[Y?_ " >7\;?^C7?C!_X5O[-
M/_T0-']MX3_GW5_\!A_\L#^R\1_/3^^7_P @'E_&W_HUWXP?^%;^S3_]$#1_
M;>$_Y]U?_ 8?_+ _LO$?ST_OE_\ (!Y?QM_Z-=^,'_A6_LT__1 T?VWA/^?=
M7_P&'_RP/[+Q'\]/[Y?_ " >7\;?^C7?C!_X5O[-/_T0-']MX3_GW5_\!A_\
ML#^R\1_/3^^7_P @'E_&W_HUWXP?^%;^S3_]$#1_;>$_Y]U?_ 8?_+ _LO$?
MST_OE_\ (!Y?QM_Z-=^,'_A6_LT__1 T?VWA/^?=7_P&'_RP/[+Q'\]/[Y?_
M " >7\;?^C7?C!_X5O[-/_T0-']MX3_GW5_\!A_\L#^R\1_/3^^7_P @'E_&
MW_HUWXP?^%;^S3_]$#1_;>$_Y]U?_ 8?_+ _LO$?ST_OE_\ (!Y?QM_Z-=^,
M'_A6_LT__1 T?VWA/^?=7_P&'_RP/[+Q'\]/[Y?_ " >7\;?^C7?C!_X5O[-
M/_T0-']MX3_GW5_\!A_\L#^R\1_/3^^7_P @'E_&W_HUWXP?^%;^S3_]$#1_
M;>$_Y]U?_ 8?_+ _LO$?ST_OE_\ (!Y?QM_Z-=^,'_A6_LT__1 T?VWA/^?=
M7_P&'_RP/[+Q'\]/[Y?_ " >7\;?^C7?C!_X5O[-/_T0-']MX3_GW5_\!A_\
ML#^R\1_/3^^7_P @'E_&W_HUWXP?^%;^S3_]$#1_;>$_Y]U?_ 8?_+ _LO$?
MST_OE_\ (!Y?QM_Z-=^,'_A6_LT__1 T?VWA/^?=7_P&'_RP/[+Q'\]/[Y?_
M " >7\;?^C7?C!_X5O[-/_T0-']MX3_GW5_\!A_\L#^R\1_/3^^7_P @'E_&
MW_HUWXP?^%;^S3_]$#1_;>$_Y]U?_ 8?_+ _LO$?ST_OE_\ (!Y?QM_Z-=^,
M'_A6_LT__1 T?VWA/^?=7_P&'_RP/[+Q'\]/[Y?_ " >7\;?^C7?C!_X5O[-
M/_T0-']MX3_GW5_\!A_\L#^R\1_/3^^7_P @'E_&W_HUWXP?^%;^S3_]$#1_
M;>$_Y]U?_ 8?_+ _LO$?ST_OE_\ (!Y?QM_Z-=^,'_A6_LT__1 T?VWA/^?=
M7_P&'_RP/[+Q'\]/[Y?_ " >7\;?^C7?C!_X5O[-/_T0-']MX3_GW5_\!A_\
ML#^R\1_/3^^7_P @'E_&W_HUWXP?^%;^S3_]$#1_;>$_Y]U?_ 8?_+ _LO$?
MST_OE_\ (!Y?QM_Z-=^,'_A6_LT__1 T?VWA/^?=7_P&'_RP/[+Q'\]/[Y?_
M " >7\;?^C7?C!_X5O[-/_T0-']MX3_GW5_\!A_\L#^R\1_/3^^7_P @'E_&
MW_HUWXP?^%;^S3_]$#1_;>$_Y]U?_ 8?_+ _LO$?ST_OE_\ (!Y?QM_Z-=^,
M'_A6_LT__1 T?VWA/^?=7_P&'_RP/[+Q'\]/[Y?_ " >7\;?^C7?C!_X5O[-
M/_T0-']MX3_GW5_\!A_\L#^R\1_/3^^7_P @'E_&W_HUWXP?^%;^S3_]$#1_
M;>$_Y]U?_ 8?_+ _LO$?ST_OE_\ (!Y?QM_Z-=^,'_A6_LT__1 T?VWA/^?=
M7_P&'_RP/[+Q'\]/[Y?_ " >7\;?^C7?C!_X5O[-/_T0-']MX3_GW5_\!A_\
ML#^R\1_/3^^7_P @'E_&W_HUWXP?^%;^S3_]$#1_;>$_Y]U?_ 8?_+ _LO$?
MST_OE_\ (!Y?QM_Z-=^,'_A6_LT__1 T?VWA/^?=7_P&'_RP/[+Q'\]/[Y?_
M " >7\;?^C7?C!_X5O[-/_T0-']MX3_GW5_\!A_\L#^R\1_/3^^7_P @'E_&
MW_HUWXP?^%;^S3_]$#1_;>$_Y]U?_ 8?_+ _LO$?ST_OE_\ (&5IJ_$1?CG^
MR_\ \)=\&O'GP[TW_A;GB\0:WXHUSX0ZGI]U??\ #-GQ^\K2X8/ 'Q1\2:@E
MY)!]IG62:QBM@EE*KW"2O#'/P9CF-#%T(4J49QE&:E[RBE91DNDGKJNAUX+!
M5<-5E.<H-.#BE%N][Q?6*TT/TPKQ3TPH * "@#Y_^#?_ "47]K'_ +. \.?^
MLL?LTT ?0'3VQ^&,4-I+LD!YM8?%OP%JFI^&-'TK5-1U2^\7_P!O/HB:9X7\
M5ZA;FU\-7USI>K:EJ]]9Z));>&M&34K66U@U+6)K"TO)FBCLYYWGB$CH+ZQ_
M!:E%8+!YAS-J,%A<?25;!2<Y.,%5Q-+FJ4L+?ZU*-.L_8_N*W),YPIJ;D^5P
MQ>)P3A_R\>(P=?ZMBXPIK]Y.GAJSC"O7A&5"ESTY3JJ-2G*7I-(HX*V^)?A.
M]\9:AX#L9=?OO$&D7%M::M)8>"_&E[X;TJ]NM*DUN&PU/QM:^'Y/#FGZA_9:
MQ3O:W&JQS1B_L$D1'U&T6YJC"5>E4KTU:C3=1*4VJ2J.E45*I[#VKA]8]G5;
MIR=#VBC4IUH/WJ%90=1>QE&$])RIPJJ,6I25.I45.#G&',X.;?-&,U&3HIUU
M'V$95%WM2(Y_Q7XIT#P-X8\0>,?%6HQZ/X:\*Z/J.OZ]JDT5Q/'IVD:3:RWM
M_=O!:0RSS"*VAD?RX8I)'V[41F(4XUZ]+#4_:UI\E-2A"]F_>J3C3IQ2BFVY
M3G&*LMVC?#X>MBZ]/#8>/-5J.T4Y1@M$VW*<W&$(Q2;E*4HQC%.4FDFSDK[X
MQ_#73M%MO$5SXH@.B7?P_P!2^*=KJ-KI^KW\$_@/28]+EO=>B^PZ?,S*$UG3
M?*LPOVRX-P5M[>5HI!'UXFA6P=;&X:M1FL1EU?"86O2A&56JL1CJV(P^#HTZ
M=)3G6J8BMA:].G&A&HW*"V4Z;ER82M1QM/ 5<-6INEF4:T\/*<XT8RIX>G3J
MXBI4=9TU0IX>G6IRKU*_LX4>=*I*+NCEF_:1^$R:'!KHO_&LBW'B=O!L?AZ#
MX1?%ZX\?IXE30Y/$S:9<?#*W\"OXNM&_X1R)M4\Z?1(X#9M'<B3R98W>)PG2
M=!<KFJ]*M7C*DO;0C2PU:&'Q$ZLZ7/"@J.(J4Z%15Y4W"M4ITFE4G&+TC9QJ
M3NJ<:<:$DZK5+VD<2Y1P[P_M7#ZS[5TZO)]7]K=4:\OAH5G#U7PKXK\/>-M#
ML_$?A?4X=6T:]:YCANHH[BWDCN;&ZFL;^QO;*\BBN=.U*SOK:XM;FRNX8;BV
MGMY89XHY8V1;JT:E"48S2M.$*D)1E&I3J4ZD5.G5I5*;E3J4ZD)*5.I3E*$X
MM.,FF1":E?W9TY0=ITZE.=*K3E92Y:E*K&%2E/EE&7)4A&7+*+M9HZ&LBPH
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MM*G.9R5.$JCNXP=--13G+]Y5IT8VA%.<DIU(NHXQ:I4E4KU7"C2JU(7:"@H
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M5<3[/!0IXBO.G0E6Q4J,:6&P\IXF"J3?#@Z/U;+,=A5_LN*Q4Z<H3H."</\
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M5M-U'PU\)M&\/WFD?$K5-$^$>AR:C>_"WPIXZ\5^&_!GACP['#:3>#["'7=
MM(] U[5[VYFT.R,^J^(Y+M=+,\:S)O55.K1C3G7K/$T,/1P=#&QBJ=;"T*^;
M8C,<?/"TU4FL/6PD(972RF4*MZ<\-6E&>"A4A"-4,1*.,PE:MAJ:P]/&4<3B
M8PJ576Q:P>$Q&%I+$U966*J9A_:&.685*L/=PU'+\.UC'3Q%:K[-\8/@_KGC
M'PU\//#.F:)X%^('A_PJ#9:_X*^*NKZQ9>$_$$::&NDZ1X@U>'3_  SKZ^*;
MW1;I&OH='U*RCMKJXF6?[;975G;W$>6.=3&YIB\9>&'AC*.,A"I&'/4R_$8C
M$X>M#&X2E>$95Z5.E6P].4:^&J48UYRI5DG.G/FRV']G95@\'&K4]M@7@^;D
MFZ:QE'#X:OAZN"KUM9TZ&(G5HUZDG1Q,9O#0IU<-.,W*&5\"_@OIG@WQGXP\
M3ZMX>M+OQ9X>\-?#KX0Z1\0M4\/6]KXB\3^'_!_@G1KK5=8M]7N;=KVXT_4-
M>U:>TE<74R2_\(Q:PNS_ -GQE>[$8CVV&S.I1C"@L_S/,,?4H:*2I1]CE^&I
M8Q1C%5)<V!KXV+E"TXXYUX+EKHB5-O$8&,YQG'+\#2@J5*E*GA,)B\1C,RQE
M>G@(S<W&A#"XS"4*<85:L</&$\-SJO'%*7CZ?L9_VEX3U30M6\&_!_1+E_"W
MQ0L[*S\.AYM"U+Q_\1O%5I?#XDZW:)\/]*0ZUI6A:)H;:<CVVH/IUS!'!;W#
M+I]M?'FP-1X2.4<U^;+J7"]"'(W'ZI2RNK*IG,L').,8U\PE&C5IUU3P]2=6
M-15'0A6J\_95Q%98O&5Z?+BZ5?'YSCITL7%36.=:$UDN%S!VE*6#PT<;F>$Q
MN&YJU.I0K0K6KU&Z5+T_X3?L]>(/!WQN\??%/QG?67B:[U%]6M?!7BD:YI3>
M(+7PUJ]\L\?A'4]'LOA/I&IQ:-IEC;Z=;V\.J>/O&%IYUBUY8V.DR7<L=/!U
M5A<MKT&G'%XFI.6)E%N<,5S5I8CV]11="DJT*EH8?FPE;$X?#2EA(9A/#)4I
M<V+HTJE?+O8I_5L#0PT81GI*C6P^!A@9*FY.M*5*O?$8JLJ=3"T9XBJJM7"5
ML1".)7E.F_L__$KX@WWQ#\=3Z;X=^$GBKQ!J?QEF\'^/;#6?$5U\4KZV\76F
MH^!O#%GKMEJG@W3U^'GA^Q\-:?H6I+I]A?\ B 75_;6.I-%:SVWE2\V'A*AE
M&#IQE:KBL!AEB<(N50J+%YMA.(\5#$XF=&;^L4YRQ>5PP]7 5X8"&*Q4>?%7
MJ0J[UI499Q+$T(3C2P681JTZM>,:B5;+LHJ9#"I0PL:BIUL)BJ\(YES_ %JB
M\9AZ.%HU$HS52ET/P]_9*;P[IOAG_A(O"?@74SX>LO'OB>X\'W'B>UU#PYJW
MQ:UMO"ECX9\2&[\-_!/P9HVC1VVD>&9)9=0TSP-;7$&I:DVI"TO]1C-]/TXJ
M=/V.(6%I<M:EE]' 8!QE/"_5*>(KXG%9O"E5A/$3P_M*ZP+PL\/&,:<(XFE1
MP^"HR5*ICA/:PJ4*>)G^[JXU8C&XA*-:O7IX?#U,+A85*+CAX8USI8_'QQ?U
MVO4K5J=# T:^*Q,)3=#F#^R+XQN?"N@>%+KPI\$8=/;3O%%O+''?ZBW_  K+
MQ-K6IPS67Q6\-#3/ACI-I\4/BW;Z1!;6B^*-4L/!NI0RV272W<DES>_;-,+7
ME0Q^"Q%2I[F"CE;A5HT84)T%@L7B\3B\%@<-&;HX##9DL12ABIX6I3H2G2G-
M9:L/4I8+#Q3BZ%+$SI4J<JE:OC)5,+B9U,3A\?"OA\%1PT\VQ$N3$9@L#/"U
MIT\/B85JM2ABE0EF*Q&'^OU_=/#/[/TFF_$[3?BCJR:#/XHC\<?$3Q)J>OPW
M5]>:W)H6K:%#X*\%>%[&YO-,C:UTG_A&;/3+[5[*&6WMWU;2K>8+>E$N(HPE
M66$INE&RA5RW%8>NHP4?:8S&9U2SB4VU9RH8/_:<+@N>\HTZSDJ=*=2LYK%8
M>G5=)4ZM2<</BLLG2=91<HT,'D<\!B4FK^SKXG'^SQ%2I#]Y6PZ]E6K>SA3H
M+EO$G[/'B_Q-\9/$7C^2+P)I,C:S;Z]X1^)<>HZQJ_Q)T&#3_A[-X/TWP9I6
M@7'ABUL?"VA?VU>7VLW]]:>(K]M26=K.;3XP8Y[;SX4)PR['T:-66!Q]>&:P
M52A-VQD\RA]7IU<74:C.G2P6#I8.%'!TX5J?UW!X?,(5J52FZ,^Z=6E/%8-U
M</#%8.E'*XRA+]VZ2RS,GF4N6G^]ABJN*J5L;AWB7+".A@L5+"^QK+VM2MY]
MX%_96^(_@/PSI7]DQ>"6\<IKOBK6_$&M:GXW%Q;:YKK?#;Q?X/\ !WC>^_X1
M/X">%+;4/$O]I^*;A]3:[T=]2GA>.>\\1:Q<6$4<_H8F5/%8>M@4OJ& Q>79
MAA94J%.,G@Z^88W*?:O">]1H*DLNR^M3C&AA\#AXXFM)QP"]O7K/GP//A\;2
MQ6*Q-;%N&,RGV\W)N>.RW+I8C$.A65656I"I''U*&*HJMB<=4MAJ="6,A1C"
M,.>^)WP._P"%0Z+#9^"_ %AX]TC7[CP1H,WPN7PU\2?$N@_$G_A$? FNZ#%J
M_P 5M1\(_#WQ!:2:B?$6O6%RS>,I;72=0MO#.F07NL6$=HAL<\77K9AB,9A(
M4*3>,Q&<8S!QG&$,-EM7&0R>.'Q$/;.G@YUJ,L%C9SIU*U*M[3,JN.H/$XS#
MQC5C!87ZO2PE>OCITGA\)EV&Q\X13KXSV-?,ZV*H*=*,\93PU:G5P7LJF&P]
M6-!8266K"TL)CIJ?T1=?!77[+]G;X=_"C0=*\&ZI/X6T_P &0>)_!6NWMUX/
M\">-K/3(4D\3^%M3NO#GA_7#I.@7VH2S3M:PZ-J5K,EN+*:V>TN9,;YK*AB,
MZH5Z,/K65X2M4IPI8J4JLI86&#K8+!59NM"I]8KX2^'Q4(U[>TK4(R=6E54:
ML8RQUJ> KNK_ ,)68X[_ &IO Q=..$Q5;,*>8XFAA^6M"=*A5_?X#GA6E.G0
MKRGRUK.E4X>']F[Q38^/AXDT+PO\(/#5MH$ZZKX"U[2;_5T\1^%-.M_A_P#\
M(S8_!GP[I%OX(M-/\'_#*/Q&9-4NKO2[QUU!99/.\/QW;BY3BQ$:M7"9E".(
MJ+'5Z&9X58AOWLQCC9UXX6MF<FY3C'*\)4H4L)@8RQ5.-?!X;%4\30M5I5=Z
M7LW6P<<50A+ QGE]5T8*"_LV>&Q6'Q6.^I15."Q5;,ZD,6L1C:LL'B?8XVIA
M*GM\/2HQAEZ5^QEH7AH:/<V-AX<DG\.1_ ,VNI-_:-SK+WOPFU9M:\5^,V!T
MR3[9X\UBTQX?M+X@W,.D@V4=W;VDK65=];,HX/%XO,<-A'&C2Q^:XNC1I<TJ
MD,%5R)8+"82E!)OVM?'0]IF?)+FQ])4IUYXJO1I065L=C:3IX^M1Q>,QV!=#
M%5:T5"G5S#'YE5Q&.Q-26D?J^!I5?K>2TY05/ 9C[6I2IX=59UWP/AO]F?XI
M>+?!6N^+4T_PU\'?B!XR\,>*"+C2_$6JWOC/Q3'\2/B-HWQ.U?2_B3K/B+X:
M%?!?V.TMM3T&VT(:+XTM-);Q'J<^V]#2VEWSU<.\)@:.63E1Q3PZR.ABJ-"5
M-X+$/)</6HU:SKU*.(CC7C:]6-2;JX.,'A:+P7-/#XB,\/W1QD,1F6*Q,W*M
MAI5LUEA,;4HU*6/P]*O0K8#+(8:A&IA9X/#X3"^PK3I*O3Q&*Q.'P>*J/"8K
M#3E7[2S_ &-XY?"-CX;O]%\&64&D^ UT?0-)CU==5TCPUXV\4^-HO$7Q \5Z
M39Z-\-/"F@V=U:VNC^'KS09M)\)Z%'::E'=O;6.EAEN'ZUBO88^CC*$YR>'Q
MV1U*7.IN=' 916Q&*J8>G5K8C$XB-3$RQV,P+OB)*&7QH482A0<\+'S)X>-3
M!5J'\.K7HYXJL5&E*A4Q&,P&"P65U*E-4J4*E.@\&JV*IU*<HSKS^L5(XS%+
MVYI7'[.?CJ>7Q[?CP;\%V3QO\4+#Q)XB\*:GX@U35D^(O@^"R\26\^D?$?XA
MQ?":PU?7-(AU76=,UBR\(ZGI>OVENNCW&B?VR=)U"*/2>"G[N6Y;@YTZ<IX=
M8Z<J;C?"87%8BC2AA\4L.N2EF>*PTHUX2Q-:E@*E6%;#XB:>/P$,5B>ZI5D\
M1F-52G:6#P&%P=53E2Q*6$Q6'=>/M(\SP-+&8'#4J%:G1EBE[9UJK4X5YTSC
M)OV./%=MX;L]-T+1_@YX>\3Z?\%]#\):5XU\+VUKX?UKPWXO?QUK/BKXAZ#X
M2^V_"S6DT+P'XETO7M0TF&]87?\ 9MO)-"WAW4+>\FBK7$NG-XN-*>(G2E4R
M6BE6JTW/,,MRG!4\-##YC*5"K2<G7H4,1B8NCBZ69QA2H5EA5AJ<Y726"IRH
M+V+C3AB^)\1!)3M@ZF<SC/ 8K"0A6IR^L8#WXP4*V%GA^>3P^*?-9/NOV.->
MG\.^#_!@\*_"*_\ "5KIOAYM2T;Q5JKZW8_#SQ$WCJ;7/B+KWPST#0?A%X<\
M.2ZUXA\-7DEI:ZE9:'X*31KC3E%CIZPZI<F'KI8FE3S7"XR]2,<NQ&"KX:O%
MSEBU1P2EB*66J6)KXF>'PL<?RRJU8XFO/%8&:P4Z5&EA,&J7#4HTZN68O!2I
M\M3'TLXI5XQJ<E"I/&8##X++\5.%*E2C.KA8X=R<724J=:M4QBQ%?$RK/$?H
M7I3ZF]C"VL66GZ=J ,RRV>EZE<:M8PQI/*EJ8;^ZTK39)F>T6"1U:SB$<DCQ
M*95C$LO#>\:;;_>2ITY5%NHUG3BZT(2WJ4X57.%.K*-.56G&-65&C*;I0N"Y
M.:"C&-.$ZD:2B]Z,9RC0E*-DJ<YT5"=2E%U(49N5*%:M&"JST*184 % !0 4
M % !0 4 % !0 4 % !0 4 % 'S_\9/\ DHO[)W_9P'B/_P!98_:6H ^@* "@
M H * /G_ .#?_)1?VL?^S@/#G_K+'[-- 'T!0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % 'SAI/[5GPEU[2M,UW0M/^.&LZ)K.GV6K:-K&D_LM_M/
M:CI6JZ5J-M'>:?J>F:A9_!^2WOM/NK2:&>&X@D>.6.5'1F5@2 7_ /AI;X=?
M]"Y^T!_XB=^U/_\ .;H /^&EOAU_T+G[0'_B)W[4_P#\YN@ _P"&EOAU_P!"
MY^T!_P"(G?M3_P#SFZ #_AI;X=?]"Y^T!_XB=^U/_P#.;H /^&EOAU_T+G[0
M'_B)W[4__P YN@ _X:6^'7_0N?M ?^(G?M3_ /SFZ #_ (:6^'7_ $+G[0'_
M (B=^U/_ /.;H /^&EOAU_T+G[0'_B)W[4__ ,YN@ _X:6^'7_0N?M ?^(G?
MM3__ #FZ #_AI;X=?]"Y^T!_XB=^U/\ _.;H /\ AI;X=?\ 0N?M ?\ B)W[
M4_\ \YN@ _X:6^'7_0N?M ?^(G?M3_\ SFZ #_AI;X=?]"Y^T!_XB=^U/_\
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M[4__ ,YN@ _X:6^'7_0N?M ?^(G?M3__ #FZ #_AI;X=?]"Y^T!_XB=^U/\
M_.;H /\ AI;X=?\ 0N?M ?\ B)W[4_\ \YN@ _X:6^'7_0N?M ?^(G?M3_\
MSFZ #_AI;X=?]"Y^T!_XB=^U/_\ .;H /^&EOAU_T+G[0'_B)W[4_P#\YN@
M_P"&EOAU_P!"Y^T!_P"(G?M3_P#SFZ #_AI;X=?]"Y^T!_XB=^U/_P#.;H /
M^&EOAU_T+G[0'_B)W[4__P YN@ _X:6^'7_0N?M ?^(G?M3_ /SFZ #_ (:6
M^'7_ $+G[0'_ (B=^U/_ /.;H /^&EOAU_T+G[0'_B)W[4__ ,YN@ _X:6^'
M7_0N?M ?^(G?M3__ #FZ #_AI;X=?]"Y^T!_XB=^U/\ _.;H /\ AI;X=?\
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M #FZ #_AI;X=?]"Y^T!_XB=^U/\ _.;H /\ AI;X=?\ 0N?M ?\ B)W[4_\
M\YN@ _X:6^'7_0N?M ?^(G?M3_\ SFZ #_AI;X=?]"Y^T!_XB=^U/_\ .;H
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MM\.O^A<_: _\1._:G_\ G-T '_#2WPZ_Z%S]H#_Q$[]J?_YS= !_PTM\.O\
MH7/V@/\ Q$[]J?\ ^<W0 ?\ #2WPZ_Z%S]H#_P 1._:G_P#G-T '_#2WPZ_Z
M%S]H#_Q$[]J?_P"<W0 ?\-+?#K_H7/V@/_$3OVI__G-T '_#2WPZ_P"A<_:
M_P#$3OVI_P#YS= !_P -+?#K_H7/V@/_ !$[]J?_ .<W0 ?\-+?#K_H7/V@/
M_$3OVI__ )S= !_PTM\.O^A<_: _\1._:G_^<W0 ?\-+?#K_ *%S]H#_ ,1.
M_:G_ /G-T '_  TM\.O^A<_: _\ $3OVI_\ YS= !_PTM\.O^A<_: _\1._:
MG_\ G-T '_#2WPZ_Z%S]H#_Q$[]J?_YS= !_PTM\.O\ H7/V@/\ Q$[]J?\
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M /G-T '_  TM\.O^A<_: _\ $3OVI_\ YS= !_PTM\.O^A<_: _\1._:G_\
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M&T_ #_PS?PZ_^9R@ _X9._98_P"C:?@!_P"&;^'7_P SE !_PR=^RQ_T;3\
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M-I^ '_AF_AU_\SE !_PR=^RQ_P!&T_ #_P ,W\.O_F<H /\ AD[]EC_HVGX
M?^&;^'7_ ,SE !_PR=^RQ_T;3\ /_#-_#K_YG* *'[*>DZ5H'PEU#0M"TS3]
M%T31?CA^U)I.C:-I-E;:=I6DZ5IW[3WQ@L]/TS3-/LXX[>PT^UM(88(;>"-(
MXHXD1%55  !]'T % !0 4 % !0 4 % !0 4 % !0!X5X_P#B5\1-'^(OAWX;
M_#CP#X+\6ZGK'@SQ!XUOK_QM\2]<^'MAIUCH6M>']$^R6G]A?"OQG+J-W//K
M\4G[R.R2-+=OF<L %152K_:<U&$:&5K+N>3F^><LQ_M/D48<G*HTHY94<Y.H
MFW5@E&RDS.O6I8>>6T9.<JV9O'\B45R0C@%@'-RDY\W--X^"A%4VDJ<FY*Z1
MS'A3]JSX;:MI>COXF?4?"WB.^N/&5MJ&BV&B^*?&>E:5'X \6:EX,\5>(YO%
MOASPU)I]KX"MM:TR4CQ)JW]D6J07-M)>"S>7RDUFJ"C&K1JN6&E@,#F3J5H?
M5_8X?,</7Q&$AB'*4J-/$5HX7$0I485ZKQ%2FHX65?VU!U='3Q%&M+!XBE!8
MR.)J82-+#U/K+K5J2P4JD<-&$(UZWLXYCA76B\/3J4.:M[>G36&Q#I=CH7[0
M_P (O$4A@L/$U]:W0U?PWHJV.O\ A#QMX5U&2?QA=S:?X3U"#3O$_AW3[FX\
M-:S?P2VUAX@BB?2;N9/*@O7D(4U##UIO#QC2ESXB>(IQA:U2G5PN$JX^O0Q%
M-VGA,1#!T*N(]ABHT:TJ<4X0DYP4LZE:G1IU*TY6H4XQFJJO*C4A+%4,'[2A
M5BG3Q-.&)Q6'IU:F'E4A156,ZTH4[S65XA_:4^%7A75=>AU[Q1IMAH7A:,VN
MO:L]EXQGN['71XOT3P2+"*RM/!TME?Z:FO:_864VH6VK2F"Y:2*2W$5M=7%K
MS8:<<4DZ7O\ MZF#HX503E*M4Q=7.*,8.#490E.KDN)CA5%5?K*C.3=&,L$\
M==13IXEX7EY:E#"X_&8A3O#V6'P&#RK,*E2$FG3JQC@\UH5JWOTYT^:E3HPQ
M-26)C@]#_AHWX0CPW>^)VU_6H[73_%$7@JYT27P!\0X?'8\67%E'J=KX?@^&
MDOA1?%MYJD^D2QZE#!;Z)*TU@WVZ+?: S"JK]C3PE62<H8V%:=)PBZGN89S6
M*E45-2=!81PFL7[=4_JKBUB/9O0V5&HYXFG91^ITZ=6I*4HPI>RK35*A4IUI
M-4JU/$56J.&G1G4CB*S5*@ZE1\I$O[2WP3DNO#UK;^-#>#Q)8Z-J-I?Z?X;\
M6ZCHNDV?B&X:RT"3QEX@L=!ETSX?/J-\DMI:Q>)[O2))[B&6WC1IHG1=H4*E
M2O+#T^64XSA2C)3A[&M6J4:>(I4<-B.;V&*KU</5HUZ5'#5*M6K1K4:E.$H5
M:;ERNM3A0E7DW"-.%:I4IRC*.(HTL/6J8?$5:^%:6)H4L/7HUJ->K6I0IT:E
M"M"K*$J-11XSQA^TE<Z/X]O_ (;>&/"GAW4_$'_"2#PGH6J^,_'MQX#\&ZCK
MNG>$-*\;^)M-U#Q#;^"]>ET_4+/0]=TG[):65AJUQ?RF^#16D.G33UAA57Q:
M7LJ/*VL;6BI2M[7!X+%8/+G6H*,92J59YGB,1A'1Y8TZ4<'.K/$<U6G1-\2H
M8-*=:I%TN3 Q;A*$IT<3CUFM:G2Q$'."H4HX/+(8EUG)SE]>PD(T&JD:D[+_
M +3%CH.L^"/#OQ$\"^*OA_JGB/\ X6./$-WJ6D^)-0\*^%H?AK"D^H:XOC&R
M\+C2]0\(7]NPO+36+R;1T%FZ374-M*QMD:JX:=:M&E6<:%'+/[1YJ\/85HM8
MVE@OJE6A*4E'$*<JK_<U:\9R6$A0=99C@IU4Z6*C&A#V,:^(K9CA<NC#"RJ5
MZ=26*P%3&PJT)^RIU*J@U1P\X2H4I1G]>F[4\KQKA3\5_M@?"O0?#E]KFCP>
M-?$5[I?B7X=Z#?\ AH_#7XIZ'XCBT_XB^);;P_I'BBUT'5/ :ZIJGAJ1#J$U
MGJ5C87%GJ=Q8IIME<R7MY;Q2=.&PM7$8S+<(H.G]?Q57!RE)-/"UZ6$J8N5+
M%T[*>$J^S@G[/%K#M0E*M-QHTJLX:4Z:J4<;5C4BXX7+\5F%*2:E2Q=/"I)_
M5J\6Z5>G[2=*-6M0E5AAJ518FM:@G,]2T[XY?##5?&@\ 6/B*XE\1M>WNDPF
M3PWXJMO#UUKVF6KWNI^%[+QI=:)'X=OO%]E90SSW.@6^JRZG;Q6TTDUHBPR%
M,L/"6*IU:N'M4IT8SG=-+VE*E5]A5KX=-IXK#4JUJ-7$X95</3JM0G4C)I&%
M67L.158R@Y*BY)PE>B\3!5,/'$I*^$J5X2A*C3Q/LJE3GAR1;G%/UFH*/E#X
ML?#WP#\2?VDO@GH7Q%\#^#_'VB6GP/\ VD=6M=&\:^&=%\4Z5:ZK;^//V6;.
M#4[?3]=LKJWAU".TO[Z!+A(UD6.\G0,%E<, =?\ \,G?LL?]&T_ #_PS?PZ_
M^9R@ _X9._98_P"C:?@!_P"&;^'7_P SE !_PR=^RQ_T;3\ /_#-_#K_ .9R
M@ _X9._98_Z-I^ '_AF_AU_\SE !_P ,G?LL?]&T_ #_ ,,W\.O_ )G* #_A
MD[]EC_HVGX ?^&;^'7_S.4 '_#)W[+'_ $;3\ /_  S?PZ_^9R@ _P"&3OV6
M/^C:?@!_X9OX=?\ S.4 '_#)W[+'_1M/P _\,W\.O_F<H /^&3OV6/\ HVGX
M ?\ AF_AU_\ ,Y0 ?\,G?LL?]&T_ #_PS?PZ_P#F<H /^&3OV6/^C:?@!_X9
MOX=?_,Y0 ?\ #)W[+'_1M/P _P##-_#K_P"9R@ _X9._98_Z-I^ '_AF_AU_
M\SE !_PR=^RQ_P!&T_ #_P ,W\.O_F<H /\ AD[]EC_HVGX ?^&;^'7_ ,SE
M !_PR=^RQ_T;3\ /_#-_#K_YG* #_AD[]EC_ *-I^ '_ (9OX=?_ #.4 4/V
M4])TK0/A+J&A:%IFGZ+HFB_'#]J32=&T;2;*VT[2M)TK3OVGOC!9Z?IFF:?9
MQQV]AI]K:0PP0V\$:1Q1Q(B*JJ  #Z/H ^?_ (R?\E%_9._[. \1_P#K+'[2
MU 'T!0 4 % !0!\__!O_ )*+^UC_ -G >'/_ %EC]FF@#Z H * "@ H * "@
M H * "@#X0;]E+Q?/XMT/6Y?$F@V>D3_ !K^(WC#Q_I=I/J4A\4_#?7?'%G\
M3O!>A'?I,0_MNQ\:>'M ^U0R,ML++4M:BCN)_.59IRV*P6'P5&I&-3ZKE=2D
MX\D9)YM0Q&;/*\3&<K2C1PN'SO&UI2Y54^NT<&XP<:7M%KFLUC7F,Z%Z-;%5
M<OITJK^*&7/)<HRK/<)*/OP_X4?[*IP@^64E0491J4*DYQ7#?\,H_&[0? GC
MOP9X5O\ X5W,OQ3^$$7PX\3ZKK/B'Q;8GPUJ&C^)_B1K&F:AHMI:^";Y?$=G
MJ.E>/197 N'T5]/EL3<QKJ0;R3VY9B(X2EP_A,0FL-DN/X9S*<Z:YZE6KE.
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MA!NKC\9FDU7K4ZD9'U]60'S_ /LG?\FL?LT_]D ^#?\ ZKKPY0!] 4 % !0
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M5D,^?_$?_)T_P;_[(!^TM_ZL7]DZ@#Z H * "@ H * "@ H * "@ H * "@
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MZGIFH6<DEO?:?=6DT,\-Q!(\<L<J.C,K D ^CZ "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@#Y0^+'Q"\ _#7]I+X)Z[\1?''@_P
M:)=_ _\ :1TFUUCQKXFT7PKI5SJL_CS]EF\@TRWU#7;VUMYM0DM+"^G2W20R
M-'9SN%*PN5-O(-O(Z_\ X:Q_98_Z.6^ '_AY/AU_\T= !_PUC^RQ_P!'+? #
M_P /)\.O_FCH /\ AK']EC_HY;X ?^'D^'7_ ,T= !_PUC^RQ_T<M\ /_#R?
M#K_YHZ #_AK']EC_ *.6^ '_ (>3X=?_ #1T '_#6/[+'_1RWP _\/)\.O\
MYHZ #_AK']EC_HY;X ?^'D^'7_S1T '_  UC^RQ_T<M\ /\ P\GPZ_\ FCH
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M'1F5@2 ?1] 'S_\ &3_DHO[)W_9P'B/_ -98_:6H ^@* "@ H * /G_X-_\
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MP[<:G:>%-$T?2$U!?#OAO2HIGL=,LHY9(GE\I6D;(![A0 4 % !0 4 % !0
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M0 4 ?/\ ^S3_ ,DZ\1_]G ?M8_\ K4_QDH ^@* "@ H * "@ H * "@ H *
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M^,BO^K__ /SEE0 ?\9%?]7__ /G+*@ _XR*_ZO\ _P#SEE0 ?\9%?]7_ /\
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MO_\ _.65 !_QD5_U?_\ ^<LJ #_C(K_J_P#_ /.65 !_QD5_U?\ _P#G+*@
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ML16C2BX5L.\/4]KB(8=U\+2Q,W3I^S<-"+]IGX\W6M^#_ MAH.A1ZSXP\?\
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M_P#)T_P;_P"R ?M+?^K%_9.H ^@* "@ H * "@ H * "@ H * "@ H * "@
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M[6)R'N%YA#CFI6&P3E2A&A0<ZU:>&IQ4*=YXBFKU*$$E>5:FFG.E&\XIWE%
MZN+C[1.K5BZ%/VU1.4U[.ES<OM9Z^[3YO=YY6CS:7N:LWPX_9&M?$)\(W'@+
M]G*W\5K:-?GPQ-X7^&47B$6$<3S/>G17L1>"T6&.20S>3L"HS%L*2,U#+?\
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M@6E_X+A_\B'UC$?\_P"I_P"!R_S#_AGGX _]$.^#_P#X;/P7_P#*2CZIA/\
MH%I?^"X?_(A]8Q'_ #_J?^!R_P P_P"&>?@#_P!$.^#_ /X;/P7_ /*2CZIA
M/^@6E_X+A_\ (A]8Q'_/^I_X'+_,/^&>?@#_ -$.^#__ (;/P7_\I*/JF$_Z
M!:7_ (+A_P#(A]8Q'_/^I_X'+_,/^&>?@#_T0[X/_P#AL_!?_P I*/JF$_Z!
M:7_@N'_R(?6,1_S_ *G_ ('+_,/^&>?@#_T0[X/_ /AL_!?_ ,I*/JF$_P"@
M6E_X+A_\B'UC$?\ /^I_X'+_ ##_ (9Y^ /_ $0[X/\ _AL_!?\ \I*/JF$_
MZ!:7_@N'_P B'UC$?\_ZG_@<O\P_X9Y^ /\ T0[X/_\ AL_!?_RDH^J83_H%
MI?\ @N'_ ,B'UC$?\_ZG_@<O\P_X9Y^ /_1#O@__ .&S\%__ "DH^J83_H%I
M?^"X?_(A]8Q'_/\ J?\ @<O\P_X9Y^ /_1#O@_\ ^&S\%_\ RDH^J83_ *!:
M7_@N'_R(?6,1_P _ZG_@<O\ ,/\ AGGX _\ 1#O@_P#^&S\%_P#RDH^J83_H
M%I?^"X?_ "(?6,1_S_J?^!R_S#_AGGX _P#1#O@__P"&S\%__*2CZIA/^@6E
M_P""X?\ R(?6,1_S_J?^!R_S#_AGGX _]$.^#_\ X;/P7_\ *2CZIA/^@6E_
MX+A_\B'UC$?\_P"I_P"!R_S#_AGGX _]$.^#_P#X;/P7_P#*2CZIA/\ H%I?
M^"X?_(A]8Q'_ #_J?^!R_P P_P"&>?@#_P!$.^#_ /X;/P7_ /*2CZIA/^@6
ME_X+A_\ (A]8Q'_/^I_X'+_,/^&>?@#_ -$.^#__ (;/P7_\I*/JF$_Z!:7_
M (+A_P#(A]8Q'_/^I_X'+_,/^&>?@#_T0[X/_P#AL_!?_P I*/JF$_Z!:7_@
MN'_R(?6,1_S_ *G_ ('+_,/^&>?@#_T0[X/_ /AL_!?_ ,I*/JF$_P"@6E_X
M+A_\B'UC$?\ /^I_X'+_ ##_ (9Y^ /_ $0[X/\ _AL_!?\ \I*/JF$_Z!:7
M_@N'_P B'UC$?\_ZG_@<O\P_X9Y^ /\ T0[X/_\ AL_!?_RDH^J83_H%I?\
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M "(?6,1_S_J?^!R_S#_AGGX _P#1#O@__P"&S\%__*2CZIA/^@6E_P""X?\
MR(?6,1_S_J?^!R_S#_AGGX _]$.^#_\ X;/P7_\ *2CZIA/^@6E_X+A_\B'U
MC$?\_P"I_P"!R_S#_AGGX _]$.^#_P#X;/P7_P#*2CZIA/\ H%I?^"X?_(A]
M8Q'_ #_J?^!R_P P_P"&>?@#_P!$.^#_ /X;/P7_ /*2CZIA/^@6E_X+A_\
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M>UBKQA&+MR3=KI+31:>1WY;5JSKR4ZDY)4VTI2;5^:.MFS]5Z^;/;"@ H *
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MIK$QPRI2E5C2I3GB)-^S?$31O$EKX[\(^/='\(WGQ L-&\,>,/"]WX5TZ_\
M#5AJ%M=^);GP]<6NO6A\6:MIFGRP+!HUW870-ZLZP:CF&*8>9&^$X3C4S&G]
M4CB(YIA:&&C5E*"CA_8U,1.I3K)WJ?5<4J]*59T(UJBG@Z*]A434J:C*$\+A
MZ?UEX:>$QBQ+BE)^VC[&5*+BXK2OAI-SHJ<J=-JK5O5A)1YN7^!7PO\ $OP_
MUB_F\0:;86R-\-OA]X>M;C3KR&[LK>\TK7/B#JNI>'M/WNMW_9^E6^OZ/;12
MRV\$4J(GDC]VR1>AAU]7P%3"SK2KUXXC#*5>::GBHX7),HP#Q4[RFU*MB<-B
MY\LYNJG*4IWYU*6&+J?6,12K1YO9RJ9M6Y)6YJ/U_-:N,I4FDW'FC0G3C+V;
ME33ARIV2,^R^&'B=OC7'XNU#P_#+X>MOB-XV\26NH37>D3^1::K\*/ GA;2]
M0BM/MC7,<LFK:3K%J%$(EC$+2.J0RQO)PX:C*#I^TC91RG.\*]G^]QO$M+'4
M:>C>E; *I4<E[D8WI5)1J2]F[Q]3VL:4*,FTL3D\YI7BN3!Y=FU*HW>U_98J
MOA++5N3C4@I1IRE'BV^#7Q&A@^%&E:9I-C9:)?27OA?XO6TM[IK26?@O1O'D
MOCKPT8?*U KJ$,T$6HZ,;:V$[QQ>+)"ZJD4GESEM"I1J91#$QMA\/E62UJS<
MY.5/.,ERSV%"G&,6U*4L;6IUJE9?NY+*Z:E.<9TE)XBJJF$SBS<L55S+.EAH
MSUI3R_/,74CC*KB[<M2&$IT:E",I1G&522<.922HZ#\#_&\.J)H?B"P\;:QI
M.C:[\3M<BDF\3?"/P]\.M8B\<V?BJ V]E>>'_!-S\1)KS48O$$4%[;ZM+!#;
MR!KJ.]O?[/M(9N6AA*G]F?5L33J5ZF&R6&5.%:=&G[>2CA.=86>%@N2C*MAO
MK$*V*E"O"K&G[2C7G4K5UVRQ<*6.E7HU8QCBLQH8Z-2%&=:>&]AB(SIJJL75
MDHU</13PU..#<Z57#)X>,\'0JNC3O:!X%^*MC=Z=J4OA'Q3>:/X>\8?#V]LM
M+\6ZC\([CXBOI^B0^)-.U*VLO$WA74;.RU[P=I-MK=I)IP\17R:P574,Q[WB
MCG[8K$3Q.7XFLW-RQF.G4G*-*E7C'&917P'UK'TZ$OJLJWMI4%-X+VM18:"T
MK2A"G'@JQP]/ XC#89*-2.$I4XPA*I/#OZKFN7XZEA\'.O%8B/-2P^*O]9]E
M0=6>';E3<J\UU?A;X1:SIT_PRFOO"EA$_ASPW\<[;5)&ET25[+5?'6OZ==Z7
MAHKIS/)J-F+]I)(?,5 [K<-&SA6X)8.L\JJX;V2]O+A'+\I4;Q_WNCA\(JV&
MO?EM&M3J-S;]C*2<HS:DF^RCB::GB)U:CYI<52S*#:DW]34LXC3K7L[<M*O@
MHJGI54>1<B]E)0\C\)_ ;XFZ/;:9H>KV_CO['KB?"/4;R/PUK7P3M/#'AV[\
M">%O!^FS6?B75/$OAC6O%L-[IVJ^'[R>T;PH]]:S_:%"M8M/<7+^S6O/-ZE6
M,I^QH9OB<RA5;IPH5HU\0ZB<52I0QLJSP[6$KT,3.%.MAX>R^N0HS]A2Y:U2
M,L)4C2Y:4IY=B< H0C)5HJI5QC23G)X54JGUE5XUN25:A4<F\/5G1I<W;I\%
M_&0\#^$M'M_#EK::U:^._C]K&KM_:&CIY-AX^TGXJ66@7]S<6]XXNA>R:YX7
M5TA,\T2R1^?'&+:3R?+Q6$G/)Z6$HTTJU/A"&6<ETDL?_P (M2IAT_AO*MA<
M7)U;^Q<XN3J_O(N77A\31AF>+Q567-3EQ!@L?3E9MO#8>K)2JI6O%PH2<5!\
MM1QDXJ+NT>I^,/#'BSQ5\%_".AVOAJ]L/$EIJ_PEN]1\/ZAJ'A\7FGP^%?&G
MA;4=;:6^L=9N=-G\C3M*O+E1;7TQD5%2,-,PBKV\5.-;.\OQT+K#QS#ZW4;T
ME2IU*-=N,XZWG3E5C3FJ3J1YU)TY5*:51^=E%L%E^-PM=J-3^R<PP,&KN-6M
M+!U<-1<&E>-.M/EE3E55-QA.+K1I24XQ\:OOAM\4GTO2? ]KX#NCI_ACQ?\
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M4W!<RU3=VSW*N8T"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MG_VX?\*R_:G_ .A"^ '_ (?OXB__ $,M']O?]0O_ )5_^YA_9/\ U$?^2?\
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MXB__ $,M']O?]0O_ )5_^YA_9/\ U$?^2?\ VX?\*R_:G_Z$+X ?^'[^(O\
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M]D_]1'_DG_VX?\*R_:G_ .A"^ '_ (?OXB__ $,M']O?]0O_ )5_^YA_9/\
MU$?^2?\ VX?\*R_:G_Z$+X ?^'[^(O\ ]#+1_;W_ %"_^5?_ +F']D_]1'_D
MG_VX?\*R_:G_ .A"^ '_ (?OXB__ $,M']O?]0O_ )5_^YA_9/\ U$?^2?\
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MXB__ $,M']O?]0O_ )5_^YA_9/\ U$?^2?\ VX?\*R_:G_Z$+X ?^'[^(O\
M]#+1_;W_ %"_^5?_ +F']D_]1'_DG_VX?\*R_:G_ .A"^ '_ (?OXB__ $,M
M']O?]0O_ )5_^YA_9/\ U$?^2?\ VX?\*R_:G_Z$+X ?^'[^(O\ ]#+1_;W_
M %"_^5?_ +F']D_]1'_DG_VX?\*R_:G_ .A"^ '_ (?OXB__ $,M']O?]0O_
M )5_^YA_9/\ U$?^2?\ VX?\*R_:G_Z$+X ?^'[^(O\ ]#+1_;W_ %"_^5?_
M +F']D_]1'_DG_VX?\*R_:G_ .A"^ '_ (?OXB__ $,M']O?]0O_ )5_^YA_
M9/\ U$?^2?\ VX?\*R_:G_Z$+X ?^'[^(O\ ]#+1_;W_ %"_^5?_ +F']D_]
M1'_DG_VX?\*R_:G_ .A"^ '_ (?OXB__ $,M']O?]0O_ )5_^YA_9/\ U$?^
M2?\ VX?\*R_:G_Z$+X ?^'[^(O\ ]#+1_;W_ %"_^5?_ +F']D_]1'_DG_VX
M?\*R_:G_ .A"^ '_ (?OXB__ $,M']O?]0O_ )5_^YA_9/\ U$?^2?\ VX?\
M*R_:G_Z$+X ?^'[^(O\ ]#+1_;W_ %"_^5?_ +F']D_]1'_DG_VX?\*R_:G_
M .A"^ '_ (?OXB__ $,M']O?]0O_ )5_^YA_9/\ U$?^2?\ VX?\*R_:G_Z$
M+X ?^'[^(O\ ]#+1_;W_ %"_^5?_ +F']D_]1'_DG_VX?\*R_:G_ .A"^ '_
M (?OXB__ $,M']O?]0O_ )5_^YA_9/\ U$?^2?\ VX?\*R_:G_Z$+X ?^'[^
M(O\ ]#+1_;W_ %"_^5?_ +F']D_]1'_DG_VX?\*R_:G_ .A"^ '_ (?OXB__
M $,M']O?]0O_ )5_^YA_9/\ U$?^2?\ VX?\*R_:G_Z$+X ?^'[^(O\ ]#+1
M_;W_ %"_^5?_ +F']D_]1'_DG_VX?\*R_:G_ .A"^ '_ (?OXB__ $,M']O?
M]0O_ )5_^YA_9/\ U$?^2?\ VX?\*R_:G_Z$+X ?^'[^(O\ ]#+1_;W_ %"_
M^5?_ +F']D_]1'_DG_VX?\*R_:G_ .A"^ '_ (?OXB__ $,M']O?]0O_ )5_
M^YA_9/\ U$?^2?\ VX?\*R_:G_Z$+X ?^'[^(O\ ]#+1_;W_ %"_^5?_ +F'
M]D_]1'_DG_VX?\*R_:G_ .A"^ '_ (?OXB__ $,M']O?]0O_ )5_^YA_9/\
MU$?^2?\ VX?\*R_:G_Z$+X ?^'[^(O\ ]#+1_;W_ %"_^5?_ +F']D_]1'_D
MG_VX?\*R_:G_ .A"^ '_ (?OXB__ $,M']O?]0O_ )5_^YA_9/\ U$?^2?\
MVX?\*R_:G_Z$+X ?^'[^(O\ ]#+1_;W_ %"_^5?_ +F']D_]1'_DG_VX?\*R
M_:G_ .A"^ '_ (?OXB__ $,M']O?]0O_ )5_^YA_9/\ U$?^2?\ VX?\*R_:
MG_Z$+X ?^'[^(O\ ]#+1_;W_ %"_^5?_ +F']D_]1'_DG_VX?\*R_:G_ .A"
M^ '_ (?OXB__ $,M']O?]0O_ )5_^YA_9/\ U$?^2?\ VX?\*R_:G_Z$+X ?
M^'[^(O\ ]#+1_;W_ %"_^5?_ +F']D_]1'_DG_VX?\*R_:G_ .A"^ '_ (?O
MXB__ $,M']O?]0O_ )5_^YA_9/\ U$?^2?\ VX?\*R_:G_Z$+X ?^'[^(O\
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MU*>RI3Y*<[*-.I6CAXRE*,(^VE1KUXP<I-*-Z6&K2YI-03C&#DIU*<9].I!
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MJ1B27(Z,7I[>A#$TWNIT*E7$4(5(R5XM2JX6O%*_,N3F:49P<MND(* "@ H
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MRG*348Q;:1MA\/6Q5>CA</#VE>O.%.G!-+FG.2C&-Y-15VTKMI+JTCE/A_\
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M$G&\)I.%2#C4IRE3E&3V:S-#Y_\ C)_R47]D[_LX#Q'_ .LL?M+4 ?0% !0
M4 % 'S_\&_\ DHO[6/\ V<!X<_\ 66/V:: /<-574'TO4DTC[,-5;3[Q=,^V
MR2PV8U!K>067VN6"&:2*V^TF+S'CBE94W%48@*>7'4JU?!8RAAIJGB*U"K3I
M2E=1C4G3E&$I.*;2C)INR;LM$V;X65&GB<//$QE+#PJTW5C%)R=-23FHIN*<
MG%-)-I7W:6I\;I^RE/<+X7EU:;P[J&I^#--^ .A^&=6NI;R\N-"M?A=K4OB3
MQEX@TJ*ZTDI9^+=:U#4=8LHK^,K/]BO'5KFW^TW$4OJU,1"./QF*P--8*-7'
MYA5P\H*U2AE[R-9?E.#BDU&-.CBX\^,H0<:-?"R]G-XA4Z=&/&ZF-KX+V&/E
M1Q<Z^#K/$TN5PPT\VS3,95\WQL4ES.-/#QPM;*^=-X?'X6G-0I-O$''Z!^RW
M\1+&ZUKQ!J.B_!M?&&H:=\.M#U;Q)INJZZ?$GQ*AT7XH6'BWXBZ_\0?%MW\/
MS=_:]>T#0=#AL=(%KJMOI;&YTR"\%F([NIPL\-AEAH4Z4L)AGC<!B:F$I2YZ
M&#CEN!QD<%5H2ER5,=C:.9XQXVOB<3]6GCHX>@J\H55.I+;,8T<76QU>%/GJ
MRP_$F'P\J[E.]'.?JL,/AY14K86CAL+2KX2"IO$1PO.J]*E7A.>$CT\O[._C
M&30-1@NO OP5U?Q+JGC]-0\>:OJGB'7))?C]X'$?B 6UG\5=4/PRDU"SCTZ^
MU;2[V'PF9/$FDS1: FE"\M;&Z)M^&E#DP.68;V=-/#X65.K1<?:86GF$,)3P
M]/./9_NUF&*J35>K4CBH4:E*IBOK$,55Q.&HU'O4JKVV;5(RJU)5VW@*SJRI
M8C"T*N9TL;5RRG).J\)@XX6G]1A4H3G&I!<T\%"$YTC@[']CCQ5I'A?6M/T'
M2?A!X5\87?P@\%>$-*\<^#8;7P_JVDZ[9^,->\4_$CPMH27GPLU5/#?@;Q'!
MK]UIT5^?[6%O;);P3>'+F"W\J;IQ3A.E6P])UJE&.-RYVK3INIF.6Y?E>78*
MC0S.<J-:E.I3Q.7QQ-6G+#XJECXU72JRPZIQ;RH1H4<>JGLH1P26?5*+C"2K
M8#&9KB\=4P^)PSA6ISG[##8JE"E"&)P<L#4I5_JU6K]<G.EZ[+^SG)9_LR0_
M!?2O!WP\N[V?4O#^L:UX.\2ZG87?P]O[B'QGI/B7Q3IUO>Z+\(M,TW2+6^M;
M34!;OI/P[TNUM;F\$L&EP8)&N+G0Q.89/.I%U\!EN(H2<:G.ZL*-/VDU&'MZ
MV+J5E0J5.6&'JXJ,*^#A]1]MA</-1I9X!?5:><<TI4*V987'T5*A))*K6P,L
M%AJC]G'#*%E"A4JRC&515E+$3>*KN<ZN,/V5]0MKZ]\1^'G\(>"/&US=_%R;
M3/%7AR.=KSPCIVO^#E^'7PO\->&8O["M%LO#.E>&+/0KZ^T^V-C;KJ7A^S>*
M&[*+<1<E9XB>#Q.&^M5:T\9EM?#XJK*7LZ^*Q>-SRAG6*J5,1:M)1HVQ>#P=
M><*]2G3Q,JWL(3E6A5UHPP5/'9;B9X9?5<MS'*L13PBC#V-/"8+)JV!Q-"G&
M*A&+Q&.J1Q$DHQ]M17LZM51I4J4<[P]\$_%?P?\ V9_BAX7TCP_:W/Q.\?P7
M^FW47AW7;;6[+5M?\4);>#[#Q+?7_@_X*^![73[A;6]AO-5U6+P3).D=C+?:
ME=:G+#+<OMF+HXZEE664\-&6 GBL-&OAI5)X;#T</4Q%&684J=:,ZJPV&>$H
MU'".&HX6A"O4G]5P-.K6Y*JRWVF!QV+S/VJK8K!8:K6P]6K'GGBJN7X?$XO"
M^WHRJPJ5\17Q<G3<*N.Q&)KQE2P_UYJ-)4N-\0?L?^,=9\*VVF66F?#GPUIN
MK^.K+Q)XT^#_ (?\0VLO@#5].L/"UAX7MY=8\4^./@5XI7QOXB>2UN-7NK^]
M\"Z5=W5Y/9O%?V5YI46I3DN2>-PDJU2>(P2>.J58N*H+!U\?B,'6E++*-&2G
M0AAH8:K&C]6QN KO$8W&8J%?#QQ5;"O"E[6AA)_5F\+CZ&'P6%I555G5EBJ.
M CF<(K%U90A&U>..PT*E&OA<QPT*&78?#2HUXJE.AUWBS]DU[OP]XHBT?P;\
M,_%'B[Q1XPT=8=8^(>MWVJ6F@?#OPOH/AOP_X;TC4(=:^'/B7_A/;(P>#]#N
MM3\+WL>E6NHW+-<?VS;WMC9W\5QKSK5\LGBU"*ACL;F.83I4XVQ&(KYACZ]'
M_9TZ<9NA@L=*AAJSK49Y?7A]8PL7*<W+2A&&'A.ES59X?"8#!Y=EU&-3V53"
MX:GAZ4\5"GB^6I*C.KF+Q=2566'Q4<5A:T<+BZ$\*GA!?$O[,_C[6/%?BO7]
M,A^&>B:P8/%D?A'XDV^H:Z?&UQHOB#P%J7@S1?AI>Z2WA0VW@OX<^'KC4DU.
M*PTW5]9MKZ[TFTNGTZTNGGFDPH1A4P^*PN8.=2AF,JV'QZA*]7'87%YW2QU?
M%XG$/V<YXZAED:F7X.G*,U3FX3IXRA13HFE*O4P<L%/#4J%=8%8&OAZ-:,Z>
M'P.)R_!TH+#X&G3G-4*&88[#QJXW$P]G46"Q.+PGU7$5'1Q-/V/P7\%(OAIH
MWQ<T_P &:%X<B@\7Q:?#X<T.#7=5\,P:F-,\#:9X?;4/%WBBPT#4+^Q\2ZEJ
MZ:D;O78;+6KS[/%I\I,\L AB,PE/'9=7P<_>>+Q>.KSIJ7L:.'IXVI2A*CA.
M2$^2G&C1^MNG[*,9X_$8KF;566(GE@*5+!8K+J\9SO@,OP&$E4FE7G6JX&MC
M:T*DX5)Q4H\N(HX9*51M4*$$DH1A1CS>B_ 35[?]G_1?@W=:=\/_  ]]J\2Z
M+=>,;#P;;1Z5H4WA:#QO9:_KNG176B^$M"37?$E]X=LQIUWK T+P^-0NKB>\
M:WLC+Y:=.)EA<1C<GE5@\1@<M]G4G2E"-.FZ^%PU:KA50PJG4I4<+'-OJU>6
M$51T8T%6C&,DUAY3%U*-/.70IJ.(S&%>C"56M.M44<93IX/$UJ^*=.-:OB*>
M$EB)X:=6-2LZD,+0Q.)K.-7&R\P_X9,\3:7XT^+/BCP^OA&WGU'P9XE\/?!2
M_BU?2?#T'@2UUGPTWAS3O!']@:#\%%U+2/ ]C [3+!)XS\2Z:MV!J%MX;MKQ
MF<\F'E467XK"XY+&5L;7A3QCG.7_  H9=/,XXVO2K5(QA[.M3PE.E@<+.I1Q
MM>A1@Z5#&8;"R>&.KVD%F^68Q2FL)@*D<9"F^>?L,PIX14'7C2E5O76*Q$L1
MB\;[/$Y='$SKOZQ2Q&(A'%E3Q7^RCXP\8:[J^J:MX5^"-W=6>C>.X/"7B77+
MG5/%'B4?\)%\,;SP/X4\#W2ZI\/D@\-_#K0)]5U 365A)?Q:H8X-5ET^WO'G
MMI7/F<,S<[5ZN84\;1K-6PU3&+$9_ALRAB<1B(JM4IUXY?3JX*A!0Q,<OJ*$
MZ%6O&:]A.6U'@JF04VY0P&75LHJU:,6JBH4L#@'1Q6&P<)*FG[?,:&%QT\7&
M6#K8FG*KA*T*=&FEB-C5?V;/&$5G#8>&_A_\%(/"=MH/PMTJX^$LOBK6M'\
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M.=90DJD:E2K"\%?!X7"TJ4EA94\;A,16I4Z5*>'J4:#Q&(EAE3Y:%.-*&/\
MJ6)HTJ=&E24<)&E&%&GRP7CFA?LT>,M-MOA#8KX+^!&E?\*]MO%VH/JEDMM?
MVNBZ]KUS>RZ;/H?@R+X/:1I]_P"+K7R- FF^(5A>^#]0GN(]19M%,%XUN^6/
M52N\R^JU?J\J^2RRVA44/9M59X?$4Y+#PISOE.#=;$U76PN'JXS#8K#R=&KA
M(3AA*V"%##MX9U:,J\%F]+'5Z-:K*NI4:4L'*4L14J1?]IXJ:P\X8>>+I4L5
ME[CAJD<SQ;^NQQW,>(OV6_C3XF\#0:-<:KX TBXTSP]\*?!-GX*T/Q%)=^&=
M5\#^ ],\3PZYX?UWQ'X_^#/BNPO(=7\0:[8:K,M[\/=4@N(="M;">!61=03J
MQ52CB\PJ8VO056.+S3$8VO2?+&G&A/!X>A@:#7)*5?\ LRI/,W0Y9X.;J8FG
MC:%?!UXJE3K"SJTZ$\+B:[K2I8*K3I8Q1DL55S#%9E3Q698RKR5:3I1S/#8'
M TZE!5:]/#2J8RDXXRC*7UCZ'^&G[/?AWP5XO@\5WNAZ%-+X6\$>"? GPUC>
MYE\07?@O2/#UCXA;5VTR]U#1[%=-N[J^\6:Q8K-86]N6TV&& +;02M90Z?6Z
MD8YE:I*5;'XR<IUWS*M5P%/"9;A\-A\14G4JU:DO;8&IB\0JE6M[6O4IU:U7
M$5J:JKE]E.5/+Z%3E6$P=.K76&4:?LJ>:8S&XC$8W$TE"E2AR2HK 4<,HTJ,
M<-&C6IX>A0IS?M/'KS]F#QSK.H?$:YU!?A[IFI>+=*^(WA>Z\?:9K7B.[\>?
M$+PY\1_$%O(L'C6ZN/"]LWAW3_"GA%KW3](T*SOM?M1<+;2VUSI,(DB;BP4*
M=##X"G5I\JC/)H8[#4W_ +-BUEV+PN)QV859-0G7S',?J]6G#VD(?4J.+Q.'
M6)Q-*5/V/;4Q&*CC*N,PU51QF$GB<5E>,G3I^TP51X#&X? 9?##<DJ4<#A<1
M6P>(KU54;QU7 T\7B,%+%3J3G[MXQ^%5_9:+\-?#_P (]%\%^']$\$>+KWQ%
M/H5U-/X=TH^9X7\7VUC>VT>D>&]3^W:BGC+7=.UBX65+1[J2&XN)+SSR1<1C
MGB,;/$U)37MGEF/PF$J-O_9,17P\,)AI4Z<4HK#TL&\5@O9P<8T*->+I4YJD
MJ3G!4\'A,,\+*ESTZN)RV=9-<TZU'"YAA<9B)2JN:E]:E]5IU(U9QJ^VE!T:
MDJ/MOK-'Q>U_92UGPCX8UFU^'%WX/T3Q<?#?P'@T;7-5BU"]AU7QK\*/$MUK
M^K^+?&[VVGQ7FMRWD4\&GVZF=Y%L[&*TC>Q@"+#Z%;$P^LKZG!X3!QSG$UJ=
M.#UP^4XO*Z>4UE0C)RIK,_JU;'S=6HJD*]=8.IBZN(49QC@G5Q--RS>G2Q^,
MJY?B_;U?>@Z^;8C$O,*2DXJ/LLMPF8X?!XK"TZ<4Z$J^8<F'3DO;5K_]E+6X
M?BOH7C".33O&GAGPIX<AF\+VWB'QC9^%M9T;QY:KJ.I:CK,=YI_P7UW7;>?Q
M7XGO[B[US5-&\8Z%%/%>-%>:'K$5I!">&#E2IYS&G1C'ZQ2J8; J-6I'V.!J
M9?A\KCETZJC[>-##X:&(JTJE>>8Q>+J1Q4,-0QO/C):S4J[RN-?$U'!5Z%?,
M>6"Y:F(HXZMCECJ5"51T)58REAL/1P].. E2PN%CA/KTL')86GS-M^R+XEAT
M;P_;Q>!?@)IFMZ7X%^,.AV&M6:P2:QX*\6>/YM"CT'Q98Z];?!W3Y?''B2WT
MS2KBWO?$4]GX8O9GN3-+!>S2S2/LXT*\:V&Q5_JV*PN4X.M/#06$E]3I8_&S
MSG!8?#T:BI82AB\!CI*DL/4A0>+IUE3P> PV.E#"XT)5L'4HXFCAJ%>>'S&O
MF2H8JI4K>UKT,'065U,1CIPEB:WL\;A[XB-6G4Q"PTL).>-QF*RNG/%^A:5^
MR7I7ASQ;;^(O#FG^$]'.F_$/2/$&@ZC&+ZXUC0/#^B?"L^%&O+);BP:.7QMK
MOBT)/K>H&:*;4=-A@BO+Z[:UA@15ZM>K2KRI8B6#Q=>EGS<J*2IPK9I.I1PV
M%IQ7(X9;0HS69SP\>6"SJ+Q$:-2<Y8L=&CAZ5*AAZE&6(HX:AD>'7/6G>N\K
MQ\,?6Q=9--+$RI*64T-:DHX",;5Z5.4L&N(^&'['NN:#IFGV/C]M!UZZO?'&
MFZW\2]3?Q3#JTOQ2T?PKX:\46_AJX\06>A?!_P %03:M=^*]?BNM2765\2:A
M/8VBV=]XBUB&-(:NL\++#T:5'!TJ5/"X?,JN'PDHQGAZ.:8VG0P,)SM&%"KA
M_P"S'BX5I4<!@XSQ7L*\L%4JNI73G+%5*V,JU:RJU\96PD7BX+ZM6IX6CC*>
M8U%0C2YJT)0Q6#PM/"8>MCL32PF&KXRGA:N&BJ=.IZG\*/V>7\!^.?!/B36/
M"/PMOAX/^#&B^"-(\3:=;HOBOPGXEAUOQ!?Z_I?A6";P7&T7@BXT[78[*S>/
M6=.>SM]--HFEF&^D:#2->-+^UY1K8B5;%K+J"Q$Y<U;&X7 8.&';Q]I)K$U*
MU&&)KS4\7]<J.C[25*6!HRJUB:="K' 0I4E&EA<QSW&*A-WI8:.9XJCB<*L,
MK.+GAHQJT%:G0]E"M4=*<HU)4UY78_L^^/P-=\=_##PS\,? OC#XAR?M KXA
MU'Q%IFI^%=:T^\\=>)XH/ GBF>PT+PS-/XCOK7PKHXA>TU*ZTXPR^)KR_62:
M5IK6[XL-A\+_ &;@LJQ*G'*\7EN4K$QI2M7I+%XA9CG^!A2_=TZ4ZL*]+!TJ
M[E[3"?V1A,(Z4Z7[S#]-7%?\*E?,Z=!5,7@LSYJ7UE\ZK?V5ET\HP-=8B+E4
MCA*F(CB<?]6IKV>*HYA*I[6C67-/O]0_9AO)]?7Q%83^&=/US1_%&A_\(1XA
M(N[K5/ W@?PE\)I?"&@6'AV*;3-FG:M<^,':ZU);>:);K39WMYKF=8X[5;Q<
MZU>&/Q%"K+#9EF2S^OB:L9-*OB\T;P>%I3J*U18*CET,)7G"*_=YIA:5:G1J
M2C'$1Y,#1P^'HX'!XB@JN"RW#Y!A:-.,Y)3AE68T\TQ->K"3<%7JU*F-P-'E
MWP=6//4@ZE>G+HOV>?@;J7PLU3QOXIUKPK\-/#'B'Q=H_@S1YH? %]JNMR:F
M_A:WUF6^U[QCXOUOPOHNI>*_$^JZUKE[=3ZE>6;SF(6T,CRFU$LW1B,0UE^*
MP>!A"@JF/Q>-H4(PC1PN&C7P>!HT,-"%.Z4:%6AB'.JJ495O:NNZ<)5'0I9Q
MA7GBL-5Q>(EBEA,)##.O-*6)KU?K->6(Q-1M<T8UL-#+U2P?MZM#!.C.C0ER
M7K5O*3^QA!>Z7*^KV'@R[\4:EX)@LM:UF2^U>Z-Y\0?$?Q#NO&OB[Q7+)<Z)
M_IY\-?:9I/!\US"9;"XO[L6T6CB9YIGA*L<OKX'ZI4D\-EN)X;=!RI0C46&R
M"E[*O6:C-J..S:CRX3%RC)-82G&@\16H/ZO'3'T*6-IYE%3G!X__ %KT<8M)
M9QR3RJC)JS>&P=93K5Z"C[%XE4\:J6(Q<(U8NOOV6O'6M^)/&VNZK:_"VVU;
M7/"WQ7\'6GQ"M+S6+_XE>(=/^)'B726L[S7M9N_!L$WAZST'P(=;TBP\/V-]
MJEE;SB&>.8)=LFG\^"A1H82C2K4^6=6600QM.C*<*6)I8'&?6<[K5:D94YU\
M7FCPV#JT)U(0E@N:M@Z594*5.K5TJU<52Q-*OA*D*E7!5,=C,#B,123JX/$Q
MP%;"Y)A:-!.=&.#P,\34^O5&Y3S"5&CC*E!8BKB85-;Q/^R[K%OI_B'1O!7A
MGX3ZIX4\0>/-9\1S_#GQM<:K;> YH[KX>Z%X6T;Q+XETFR\):HGCCQ#:^(]*
MO];N],U6'RM1NM8%Y/JBWMA!+7/BHUL7A:6'FZ<)0P>;4H2Y(SA@L5B\T^MX
M.M@:+C&G15+!PCATZ:H_4Z^(Q->A3K\TXU]<-.EAJL9QC.*HRRJE)PG*%;,,
M%A,/B*>+I8[$)\ZG.IBU&#BJL:^"RW X*I["E4D\/X[!\"]>O_B?X-^&FF^$
M-)O-+^%MAX1;1OBUKG@/QU;7'POM_!GPQM],TKPW\-=1\4^!=,\-7%K>_$NT
MT[7KC4_"'B34[J\2ZN;'5+&VCTZ*1_0Q5:69UN(\SPU6KE>)KQSN.'Q"GRXC
M%5<PC++<)0KJHUBZ6'P.78G%^SIT*=;!.MA:&/IXF.)Q4H5>;EAA\)D6"QV&
MAF,Y?V94QU&FU'!JOA\TGG.8XZ%*C3^J*6.Y,/@'2DL-7ITJCH+#SPU&4:7I
MOPT_8^GT;PWX?\/>/=.\+ZM;7/Q!B\5_%2"?7=/\3VGQ*M= \+^(],\.76M6
M&C_!WP'IFHZQ>Z]K=M>:LVI:5>WE[#IL4>IZSK3 $7[?#NI@JBPT:-+ 4<?7
MPN'A%>SP>9XQX3"QG12]G1^KT\LABE!8?"X*C2QM2-:C@859U,2LHK&4GC)?
M6)U\5B_[.PTL9.M6A7^HX"L\>II7J5HXEXZG1I05?&8NI#!U:T?KMJ-##OV;
MXF>"=;\1^)/$VE:3X8M]8@U#X*3^$_"L&H:[JO@OPQ:2:GXF6'QAITOBS1_"
M/B3_ (1N]FTB/PQ+;QKHE\;I-'>(P-!#,T/EU(5\13SE-J=3$8G)JDI8B4)0
MG"A+,JW-&E6I5Z>+=.NY2QN&K4Y8>O"KA:>);A4L^ZF\/A_[&IQ]I0I4*><J
M4,.IQC"4L/E='!)NC6PTL/+E>+I8;%4JD,1@X2Q53"M5/<GX?H_[)GC&R\=>
M!?$FH)\/VTKP1X*TVV\*:3X8DT'P;H7PX\;Z5!J%T;OP=X9TOX)R7RZ=JVNW
M@FU:?1?%O@NTU&%GBO\ P_>0I%;Q]%>>(<.(70K7QN.PU:C@L344_=A5RO#Y
M9]4G3=2I4HX"BH8BMA:%?%9M2PTJM*5&C'%4GC:G'1H4E2RG#5J?+@:6)IUL
M?A:4[*JZ69XC,(XKVD:=.E7Q\HU,-0K8BEA,LK5G0J3GB%A\0\'3S=/_ &2/
MB7+XGL->UG7= MKOP_\ "?3_  U\/=7TWQ5:WEW\)_&ME\/X/"4K>&UE^"-C
MXBU;1;K6CJ>JW5W#XW\.VE[_ &DBWGAB:>RBN#TXBI0]MG];#4Y7S'$U)TE*
M<Z'ML!5E"#RNL\-.,L-A:>$C]7H\SS3V%>*S#"1PF)G*W70J)OA^68KZY+!U
M*=7,DU%+$XFGF%?,*F8TU)2IK$XRK.BL12I4L&_94WA*N+Q6$:I'J/AK]G.T
MLO$WP7\0WWP/_9]\/1^"IO'6K^*++0+HZ]>Z=XUUE/#:Z#\0/#?B#4_A'I=Y
MXI\33#P_)_:$^HC0[I9;R"Z^WW\NG1B;2%>G1QF)Q%&=2A#^S5A,&J48THX3
MVF)E5Q6"I4:<HTX82<*DX4Z]*4'&$L31^HJ&/K2I\;I>TROZEB?]KQ/]HX7$
MU:E64IK&4L/A<71=;$N?/)XCV^(IXB%&:KP4Z-.2Q4)4XMP?$7]G_P :^-_B
M[!XTGTSX5:QIFC^*M"\4^$O%?BI]4U#QYX-M= \'W-O:>$?".F-X5GL_#5C)
M\1;32M=O=6L]9\_4K:^N;.ZM NG6QN?+A3J4L+CW0E]5S*6&SBE2K4Y:XJKF
M.#G@<,\94E'GHX7!87$5J<<'1C6IO$4Z6/BX5JN)IS]#$/!8J.$P^(HSJ8.$
M,L]K2<VH1JX/.X9AB:M.DGRSJXO!QCAG6E*G.,::PTE.A-5*/H_P2^&OC#P)
M;ZM!XML_"2^;X*^&7A;26T+7M2U[RX?"'A233M6TO4/[1\&Z()K)?$EYK5];
MWP#/=QZTXFLK%K?;<=^:SIXO#YQ2PJY5CLQS#%4:56$?8PH8C!X#"X6G**E/
ME5*G@XT9T.6K!0IJK&M/V\J%#@PZQ$,3@<5B:LJV)IX*G3Q>(4N6I6QRS/,\
M;B,53IQA&%-XF.,HU)N,HN%:+I*,J=*G6G\[Z)^QE(_@RQT'7?!GP>T&^TKP
M);>'M.L_"#SMH$/C?7/&MMJOCSXGK;I\/M&BC\4-HGASP?=:/,=/EN+&^LGM
M([J&&UBU"XUHXB.$Q. Q&'J58K!XKA^5.G4M4>$P63.>(K8?#UG)2J5<=B,9
MCZ.*K<F'^LT9_6*L(RQ6)PJUS*E1QJS>$.:$<QEQ/4<I)-UJF:TH4\IEB8MR
M;CEZBX^SE5KPHQ]FZ2JSH47";7_V4O&GB;4_B/J^M^'_ (+ZIK6M^!OC)X2T
M;Q7JDVHZKXM\93_$'6]/NO#)\<:QJ7P_GD\,^'M%\-QWVCP:+8'Q#:V3;+RW
M2<S_ &>SX,+&EA\%3A/#0J8B3R!8F@I.&'Q*R_&K%9Q7KU>5SJXK,YX;!U\/
M5GAW/ 2=3"4JGL*-.K5N<ZJQ=&5.K&=/#U<=B*&(KT54JX24\!6P65X*CA55
MC0E@<+#%UX9@I5H2S7V=+$5J=.O7Q2G[A\1O@]JFL_#SX>^"?!G@KX5P>'?#
M=W"-?^$VN75[IOPKO-+D\.ZKIJZ:UOHO@N=/$6CZ1K>H6^IQ:/=Z'I]KJK:>
MBW!L'99(3,5/%XS$U?:?682PN*HX:KB8)SP^)OA_J.,6&<ZM.4Z%&A4PL*3K
MVP<<5]9P\ZE7"4J=3++H?5,#0P[<L)-5:%3$PPTE+ZS23J3Q>%>+E"C4I?6:
M\X8FKBXT)5,0Z$L/7H.AC<1;YF\+?LX>*K?6;.WU/P%X/M-$^#NE_!71],\;
M6TGB"/Q&^I?".SB^(>NCX._#Z'P-#86VG>(/$WBKQ#H3>(;76[6X%L]_IT>E
MRH&23KQ.8?4XYCF^%IU)J%?-J^74'S8C,*N$IY5'A_ X+'5)2]I23^I?79PC
M]:_M"G4H.;2G1KTW"E5Q,<)EE6>$BL70E]<IJDZ>59?CLWS/$8['XK!J:3Q%
M7#X>>"6#G4J0AE>(HTZJJ2K4L7AJEKP3\!/B!H7A72/B1XF\&^!_"OB"WB\(
M:WXYT'PSJOCKQ=XE\<Z7:_$'2OBWXKU'Q/+8_"U]:O?%MCJEI<6^C>#=/T;6
MDMO/OM/MM6"ZEYEM=\-D]6CA%4>)R["/#8:I3H4OK$(++<ES7),'B<-.'LWC
MJ^(JXW!8C$XNI1P-J.!H-J4*$4L9TY9I4Q.*P*JX"KCEFU7#K&5*=&K[//,R
MP>-Q& QBJ.5+!4:> HXK!-0J5TJ^.K5XTX58WGW/A/X8^*+[P*++6=#UE=2\
M;ZO?>"?!EE=65_IG_"M_@7%XXN_% N?$"3HW]@>)]0T&.V\VVD9+J2>#0+!X
MHVTVX:WPH0G@UD.&<HRQF IY+C\PJJI&I1EB.'L/AE@,#"K'FA64L53A"LZ+
MK-5L?FF+IRQ.#PU%HQ7L\;3SV:=:6$Q_]LX?!PJ4W2Q$JO$4J_U_&2CR*K1I
M48UIO#K$^RM@\OPU)QPN99G5HU/HOXE^!/$'Q3\!:/X1U<VGAXZEXC\':AXW
MB\/>+_$MI-;:+H&O6.OZG8>%O%VCZ9HVK?;YYM,M;>&]CBT69$GEE22"2- W
M/*E3EC,!4E*;P^%E5K3Y93I55B%@,3#"2ING-7CA\QJ8:M+FG&-2C1ES4WSN
MB=;J5*-',:>%</:5XSPU&5:E"I"6$K8FG1Q3JTI<\85:^4RQ48P7MX4<55A'
MVE6G!UG\R:_^R9XM\1ZA\*[?Q'J6D>*?"WA6^UU_%VG7GBB.TO\ 5=0F\1>=
MHGQ-DU7Q%\)?%FK:S\2T\+Z?H=L]_I^L^#=3M+B"Z6V\126]PZR=.!KRPF8X
M;'55%/#X++G!TJ4(1PN98:.(Q.8/"X>BJ')A,RS3$3KUJ<,11H5:*]GB\!C(
M\E*GR8JA[3 8[!T)R2Q>*QT:D9U*M\3EF)^K4,'A\56JSQ/M*N68##_5:,ZU
M'$UI2<<10Q6!K*4I<;J/[(%WX^O-)\51>%_#.BZ1XM^(WQ-\1_%/P;/#H/@*
M^U^RUOQNQ\'>*KV:_P#@YXPO-0\5Z1X2T_=8F!_"FK6EUXBO[RR\1:=-=W/V
ME92Z> _L.[D\/A,!@,71BDN;+\TK1JYAC/9T8>PG"HL1B<-@9.GB\/['"Y71
MP6(H8[#J-&ET9A4GB9YK*A!1K5,6L/-XB,,1]<PF78:CEE*$ZU98FD\!B)X;
M$X]8:IA,71Q+S"&*_<XFC"I+ZJ\)?!*#PSX1^)WF:9X2O/B/\39_'TVM^(+N
MT.IV^I6FN:EKS^$/#^M:A?Z8;O4/#VE:/?V%J]G);R0[_MTBPR/=2O<>?F%"
M6(R!9/A8PI.6#7MHM\M&IF>(A*MCL2[0G=2QU?$RP]25)SIT'2A&E3C!48].
M KQP^<4,PK*<:&$Q-!4(TZDYU*6"PE/"82CR2G*+AB:^%P&&JXI1FHO%77M:
MD:=.J_"[#]E+6K27X<:9:>"O@WX>\/>%_#OP[@MYM+U75[F_^$GB/PIK]UKO
MC+5_A3I,'P]TJPU37_&+3QQ7OBF:3PO?KL8W5KJ4)^S5[D\73J9OB<P;J0C#
M&?6<-4@E&O\ 4UAJ%*GD,HN4HX7*J5:&(E5C1J5H8S#XFIAYX6A*-*M3\>&'
MK1RNE@*LH8GFPF(PU>$U&,'C*D:E*&>N:I2GB<?"DL(Z&'K0A' 5<*IX/&1=
M:O[3TOXW_ /4/BEXSDUVV\/_  ZG,GPI\0?#W3/&6N.8?'/@N\\4ZM!!KE_X
M;*>"M2:3SO"D^JP07":SILEK--/$L,D6J7$UOY6$IQHXC'NJE'#X^OD3K*E>
M-2O@LOQF)K9A@ZLX.E.$,71JTX)QJ34Y4J?-&E[*%1^K.O7IPRZ>$JN.)RW^
MU:M&-6,9X>ECJ^&PCRK&*E+GC4G@\=@XRJ0E"*]E4=1.K.G&C+R#Q[^QIJNL
M7#:3X8B\(VWPSU/XE:CXF\1_"Y=1T?1-!U72+OPKX$\.6VN7\WB#X,^.8;_Q
M;%/X9U_4I?)T[3-0DOO$QO[;Q/8WML9Y^K#U>;$9;5QW,U@Z6/C%T9RIK!U,
M3FN*QE.K@84?JU6E..&EA80EAL7E[PM2.*IP]OA\34C*7*%/!XFCAZ488BG#
M+*=&K-<\\93P.$Q$)PS*51U*=7FQ&*4$Z^'S"E/!Y?E].>'C*G3^K_0/QB^"
M4GQ,A\*:2UGX>U?PQX.\*>/%L= \6WNHW=AJWC35?"\7A+P=_P )%:MIM]'K
M'ARWTW4?$CWIO?M3F:2SD%G=."T/-B8U,55S;$NO[#%8["2PE&I3IP_V:6)Q
MV&QF)QM.*</9XG"O X:6 5-QM4E4DJF&E2I5&\!'"82CD^%G&K]7P&88+$58
MQ?-*>#PF$QN&GA^:4E*HZSQ4/:1E*$:M*$Z=64Z=6I3EX/XN_8^\21^#M>\-
M?#O4]"TZ#5[OX70ZYIE]JUE$GQ.TKP/X6UC2=9F^(>L^,?A9\0+.]U?5-8UJ
M":=]6\+^+4O++PKIEI,T&]&T[JQ-:.+Q<)UJ$)8&.;YGF$<(N6%&C3QN&P.'
MI)14'[6=*>%Q&+DJ<L)5>-Q;QD,9'%4O;5.;+Z$,)1E[6K-XRIDF!R^5>"<7
M'$X3,<3BJOLU3JT.7"U<)4HX"E!-4\/AE/#1P<\)%4*FG!^RMKMGXT\"W$?A
MSX5ZCX1^'^L^#=8\(ZOXFU/6/$'CGP-I/A/P;);P^ ? \<W@J&T\/Z0?B'9Z
M=J\^L6-]92:A97DUC+IEO%IEG'(I5ZL:F.Q=&K.&9*CFE.AB.:3JXV>+P3R[
M!3S&K5G6KPHX7"5:D)X:-3&>UQ<(9E*O+%5\7[1SH87$8+#X*O1E&A*&"G7I
M0FO8TL52S[^U<96PU&%.C1<L3AY?5X25+#1I4Z<,&J/U5P="YI'[+6O^&8]
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MT'7+/POJ$5AX"^(.K1'Q1J&EP:U9>%].N])\+7-OK/B6;2[B&=-*T^6ZO")
M/)W@J.?GCR4YI2E&M+$QI<L)R=7ZD\;'%NC&,7*K##/+\4JU2FI0I\E/FDOK
M&']JH2A.<Z<9*+I4\/6JN34(4*>+E@88:6(G/EAA_;O,<)[.-:5.4E.I)+EP
MV)=%$_:)^$$EQX3MHO%%W*_C*UT:\TJ6+PGXSDM-.@\17KZ7X?'C*_C\/&V^
M'=QJ>K1S:?9V_BJ71I;F\@FM(4>YA>)-U2E[2M2BX25"#J.I&I3GAYQ6$6/M
M0Q,9/#XBH\#*.,C2P]6K5EA9PKQ@Z4X2;YOW4JMI+V4JL9TW&2Q%/V%>IAJ]
M2IA6EB84:&(I5:-?$3I1H4:E.I&K4@X2M0NOVFO@W9>'1XJNM=\20:#)-J M
M;Q_AG\4!)J.EZ3#8W.J>+=(L!X--WK'P]M+?4]/EG\8V,%QX?B2[B9]2"L#3
M5"JZN#H<CA6QCI1A"?[N5&5:L\/0CC5/E>7RK5E[.C''_5G5E_#4DTS:="M3
MEBH>RE.>"J.C.-.+JN5=>VYL/AU2YWBL3%8>LYX?"^VKP5*;E32BV>B>'OB)
MX5\4ZWXAT#0KC5[VZ\*ND.KZ@WA;Q59>&%N&QYEGIGC._P!%AT#7K^W) N;7
M2]2O)K0_+<QQ'BL4U]6J8MM4\/1J5*4I5&J3O1E4IU91A4Y9SHTZE&K3G7A&
M5"-2G*FZBFN4QYHJ="E%J<Z]*%>"I_O$J=2%*I2]HX<RHU*M*O1K4J-9PK5:
M-2-:%.5)\YY!XH_:I^&6C^#?&'BGPXWB/QG<>%K?26LM)TGP1\0P/%,WB/5/
M[!\-77A:_M_!ET/%/AB^UUDLO^$@\/0:U81OE1))*4BDB3K..%5"BY5L7BJ&
M$A3JJI1E1GB$ZD*F*I^RGB<-0EAX5:]*I/#OZU"C.&#CB*MJ;W=-4J^*H8CF
MIO!4,7B*O(HSO' )+%TJ4Y5*>'J8C#3E"GBJ+KP>"<XSQSPU%3JQ]"G^*NC^
M'K'P/!XVM[S3/%_C.RLYX_"O@_0?'_Q N+"65+1;^ZGCTKP+;:OIWAFQNKVW
MAN-=U[0M MK9IXEOA9R/Y0ZJT*,,;B<)0K>TAA-:E:I[*E1I0O449U\1&M5P
M="-5T:WL93Q7)75*HZ,I\D^7DI5)2PD,74C[)3C*=.D^;V]2,>1N-+#3A3Q5
M:M"%2BZ]"E0G4H2J1C-6<92P8?VD?@Q+I^M:L/%\T.E:#-X>BN-3N_"WC&QT
M[4H?%6NP^&?#VI^%;Z\\/Q0>-=!O=?GBLH]7\//J=@)20]RH5BN4(RG&DX4Y
M\]:JJ,*+A-8GVLZ-3$4HRPK2Q,/;T:52IAG.E&.)5.?U=U'%I=3HU(8C$864
M>6IA*.+KU6VE2A3R^/-CDZ[?L'5P6D<50C4=?#SG3IU:<*E2G&52P_:?^"6H
M6^L74/BS4;:V\/>&?%?BW7)M6\#?$#0X]*TGP+=QV7C*WOFUKPM:_9_$>BW$
M]J+[P\V-7MTO;222Q6*[@>6HPE.DJ\.65&3P2A.,HN-3^T)NEA72:?[V$JZE
MAZDZ7/##8F$\-B94:\)TXU##5YXFE@X49/$5:\L-&-FE&LJ;KPC4F[0HJOAX
MRQ.#J590IXW"QGBL).OAX2J*=OVA? -W'IUUHEW-<Z>/%VJ^&/%%[K^GZ]X'
M'@^TT+P3J7CW5?$6JVOBS1+*Y?15T"TT^>VO%B6TO(=;L[BVNGMW$A?LJD94
MW4C[.E+#8K$MN[JVPN+HY<Z"P\4ZOUJ68XG#X9X::IUX\[FH3:ITZN-.U6*C
M1O.O7G@H8.FH3MC'C9N4'AJJBZ=6FL)0QV)5:FYT92P-?#.<*RDH9J_M1?"J
MXU/P_I.G+\0=2N-=\1ZOX8N&M_A-\3;9?"MYHF@VGB*[O_&D.J>%+2X\,Z$^
MF:GHTT&I74 M[B'5X+R%WT^*YN[7*3Y*=2K4<:%.EE^+S%SK-TX*C@:_U;$4
MIMIRI8FG54X2P]6$:L9QA1<%B,5@J.*'%J,7%.I*IB<)A:4*:YY5YXU598>K
MAE'3$X:4:%:7UG#RJ4+4:[4VJ%?V>QI7[07PXN;WPWH6IZT+/Q+XAL_#UU]B
MT[1/'&IZ)IG_  E6DRZWX=75_$UUX.T^U\/)J.FP2-;'7DT9Y9E-JL7VD"(Z
MSINE6QF'J.-*KED\31Q7/.$*=/$X#"TL9CZ%.M*2I5Y8:A5]O:E*4YX:%3$*
MG&-&NJ.$<11G1HXFE/GPV+CAZV&:3]I5PN-QM7 8#$.BDZE-8G$4U1DK2IT:
M\X4G5G&I0J5NA\"?&/X?_$G5=<T;P=J6L:C=^'K+3-3O)KSP=XTT#2KS2=:N
M-4M='UGPYKOB+P]8Z;XOT2]FT75%@U'0KO4;646;LDI4J6/958X66,E2G2HP
MJRH2C4A*G7A5A3IUI4YX6:CB82]E5IS7-17-&I#EOS*^\U[*I3I-J3K1J2IS
MA)5*,O9.G&JHUZ;E1<Z4JM.-2FJG/3DW&<5*,DO(KG]K_P"&=K_9MY<:7X\T
MO1)]9^(^FZK?Z]\.OB'I>H66G?#-[>TUWQ-I/AR+PE=:CXC\.+J-_8)+?VL*
M06,#7L^H26SZ9=P0SA8O$SP45^[CC\!1QM%R<5*+Q>,PF%P5+%1E**P<,53Q
M%3$4L3B)0H<M.E#F;Q,)1TK8>O3G5I4*:Q<\-CZ> J*C+G4JD\#F&+G'"N*D
M\;B*-; 2P3PF'4ZU2M)SHJI3]A+$>EO\;/!MKXB_X1RYN+V[O+[Q)_PC.@6_
MA?PSX_\ %^HW=U;:;X=OM8O]:L]"\%2Q>'-!TZ;Q1HT-QKDMW<:1;_;[<7FH
MVMPTEK!="C5KN,(Q49R^M23<HPHQI87$8C!R=6O4=.G1K3Q>"QU"G0JN,J[P
M_-A98A37+S^TINE5Q%.7-A\/'"JI*SY_;XS#2QU&C2IQYIU^?+Y4,4G2YJB5
M2I"I1I^R4ZO1:S\3O!GA_P 56O@O4[_4H]=GT>;Q#<?9/#'BG4]$T+0X8]2D
M75O%WBK2]%N-$\%6$_\ 8^JI;3:_J.FK=R:?<16IFDB91@I1]EC:[E&E0R^'
M/7JU&J5*-E"3IPJ5'&%:NH3A4>'HRJ5U3E&HZ:IOF.CV%51PK5.4GC*KHT(0
M7/4JU(RI1DH4H<U1QA*O24ZG+[.#G'FFCB(/VDOA%=6=U=V>K^*;R:TUE-"_
ML*Q^%_Q3O?%]]=R6-OJ<5YHW@BU\%R>(->\/OI=W;WJ:YINF7>EM;2BX6\,.
M7&L*<YU,-2BK5,1*K'D;494)4)4H5HXV,FGE[HRKT(U5C_JS@Z]#FM[:GS8.
M<$JLN>+IT8T9J:DG3K0KRQ$*$L+43<,8JLL)BO9_595N=8:NXW5*HXTM,_:1
M\!:Q+?R0#5_#VEZ!X@\::3XBU3XA^&?&W@"W72_ -C,WB7Q%X:EUGPD;7Q#I
M]GK1L=.E,UWIB(TUQ^]:YB@L[^*;C*A0Q$N:,<3AIXBE2C%U,2W]>PV!PU.6
M'B^>^,EB:<\+&G[6O6=2G2IX>=6&-C@KDG"IB*$H3A4H5<+24YP<,.WB<'5S
M!N5>5E2C1P>&Q56<JD8P7L%.<X8;$X3$U] _M(?"%-#M]>DUSQ!!#=:]>^%[
M?1;GX<_$JU\:2^(=/\/R^*YM'7X?7'A!/$_VY_#4)U.WC.D W5M+!+:^<MQ"
M9*J0E04'/2,\/6Q5TU)0P^&Q-+!XFI5<6U16%Q%6%/%1K.$L,N>=>-.G3J3@
MU%\TH[<LZ--2NE"I+$1JRP[H5'[F(AB/8U88>I0E4IUZL'1I3G5M!^OZ'K6E
M^)-%TGQ#H=VE_HVNZ;8ZOI-]$DL<=YINHVT5Y9721S(DD:RVTT;A9$1ANPR@
M@@:8C#UL)7K87$0]G7P\Y4ZD;I\LX-QDKQ;B[--7BVGNFUJ84:U.O2A6I-NG
M-7C>,H2[6E":C.$HM6E&<8RBTXR2::-2L34* "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@#Y_^,G_ "47]D[_ +. \1_^LL?M+4 ?0% !0 4
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MDD>4^/\ ]D[X8?$*V@AU9M0MY=/U#PI?:'.VB_#SQ/;Z!#X-\.W?AG1],L-
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M=6RG4O+DY[^SA3C[ITE<QT!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 ?/_ ,9/^2B_LG?]G >(_P#UEC]I:@#Z H * "@ H ^?_@W_ ,E%
M_:Q_[. \.?\ K+'[-- 'T!0 4 % 'A^K?M-_LVZ!JNIZ%KO[0?P/T76]%U"\
MTG6-&U;XL> ].U72=5TZYDL]0TS4]/O-?CGL-0M;N&:":WGC22*2)T=592
M9_\ PUC^RQ_T<M\ /_#R?#K_ .:.@#Z H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * /G_P#X:Q_98_Z.6^ '_AY/AU_\T= &AI/[3?[-NO:KIFA:
M%^T'\#]9UO6=0LM)T;1M)^+'@/4=5U75=1N8[/3],TS3[/7Y)[[4+J[FA@AM
MX(WDEDE1$5F8 @'N% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?/\ \9/^2B_LG?\ 9P'B
M/_UEC]I:@#Z H * "@ H ^?_ (-_\E%_:Q_[. \.?^LL?LTT ?0% !0 4 ?/
M_P"S3_R3KQ'_ -G ?M8_^M3_ !DH /VL?^36/VEO^R ?&3_U77B.@#Z H ^%
M?$7BWPC#\2/&T7Q+^+_C_P &_$K1_'%E;_";P!X<\8:[H4VM^$&TWP]-I[^#
M_A79WJZ5\98M2N9-734+[5=&\0_V?.;V$-8QZ<KH\LO*GE\J"6*S*KB:\,PH
M/]^J=)9KB:.&A7H34HY?@YY:L+5EF%.-"IR5:E?ZZIP4:*S!3C]>C72P>6PP
M498+$0]QSF\#3J8BNJT)RGB,=1S)UZ%++YZ3A0PE/ZC4ABW5Q>#J7[5GC^R?
MXER6-Y\*M8U7PSX<^,6J?\*RM=)\3Q^.?A1-\.;359?"^I?%F\_X2N1;_1O$
M[6%H\*1:-X6.S5[?^S[G4XE>Y#R^G/&TLOC"493QU+**CQ4$_JF'Q.8YCEN#
MK914C[[>.PL,=B)2DZ].ISY;B7/ PA)<O11A">;8'!UJ5;"T:^95L#*E/D>*
MJX2EA<;7CF]!^[!82M+"T%3BJ=>G;,,+&6+56,H3["X^*G[08\00_#BWU?X-
MQ^,/^$QN],N/%LWP^\;2^&DT ?"D?$>VBA\')\58KV76(KTC3'NF\1QPS1'[
M6MK Z_96QE5A&CF%>*DX9-@\WKUXNR>*J99C<CH4_925UA(5Z&<>_&<<9*E5
MH\T9U82Y#BA5<7DGM8\W]OSRQ4HP]WZK''8?B*52-23YOK,J-7(U4A.,,,JM
M.LZ$H4I+ZPO.M%_;&^)NL?$#X<>'4\ >';>Q\8>&?A[K":#=:_\ #G2-=\61
M^+_".D^)=>U[P->>+?CCH>OW^FZ#-?WUI_9VE_#KQ0UY)I$\9U*TF+1P]V)H
M?5\=Q+AX1G7ADTLT5.E%<V)IQP-"=7"5:\*"Q,ZD<PK1IX>-Z&"I48UOK"KU
MO95*!OBZ-3"4LOC[:E*K4J*G7K-2IX>4XYKB,MKT:<JKIPH5*-&A'&I/$8J<
MW6I8:=&C"K2QE2Q9?M$_$+Q59>$M43XJ?!+1[-?B3\*$\9P:-X=\4F[\ VGB
M^ZUO3]8^#WQ#N=1\;C2K/QI9ZA#I5FU\=2T^\>YN?+G\+6226DM_5/#TH9IE
M%!57F>%KXG,\+'$8:T,+FCADV+Q.%JX/F562M7HN$:5.6,O6GA9SK4IPJ8&M
MCC*DZ>79A5^K5<MQ5/#X:N\-BG"6*RZ%/-LMH5JV*=)J,J$\/B9UJLI0PM-8
M6CBHX;$8J,Y8[!=1^TA^U-XY^!'CZQT"+PQH.I>%SIVB_$35-8N=/\0S7-I\
M)?#\^HZ=\8YX&TV\:*;Q7HUY<^#9[!7B2*6'Q$T;6\[P-(/.PDW5JXJG4C.3
MP=1QE"E3?/4_M&GA<%P]3I.3<75Q.>3Q=+&=(8+#J48TZDU4?97P\XX?#SP\
MX^TQ\*M+#\ZDX4L9EZK9EF$L5RJ/+A:N34E2P/LW*JLS;E6YL.N0X;QE\9/B
MW;R^$+_5_$?A?X7SZE>_"V3QQ#<Q^);C3TC\=_#7XM:K:>$K5M3\?V]AX<U7
M^VM,T'3+>\L8(YKO5Y;&26.[\J&QEK,<.\+AN(,,L0\34P4.)L)#ZNY4ZE?'
MY?P]P]BEB,%4;J5J<*=:OCL32PR52-/"4Y5(JGB)8O&5L\IK4L;C*U:E!0P[
MP609AAI8F$KPP&,XPS'!16)P\:T:"K/+H8>6,K.[<?K5";]BL%_9_OO[.?C?
MXEZS:_\ "(?$'4_"^LZA8?"/X/\ CO1M>T72M?LKO[/X[T_Q+9OIGB=];\4:
MI)XEU>UN_";7$NLP/I"WO]I,#86K1%Y?:S[#*G//IT.2AB<)G6:9>N2DH8:U
M&CA,51G2PT9*5&$/KGL71^L3YHT8SC4I<_LZ?D9'.3RCA7%5)U*^'S/*Z-9J
MK4Y\5SX>.&A6G5Q#BXSEB57C43=&]&?/"4L2K5'\Z>$OC!\;;;39O%L7Q&\
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M:C:I*,I7EK&+@K<SY59RF[QC92=[2DG)1BFHK3K,H* "@ H * "@ H * "@
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MAQ-1RO#QC.G*G.%7%0XCG7Q4Z<ZDFY4:F6X>4\/'E_<5*.$E5A5_V^I4UO\
M:N^+_ASP#+XDOM#\#WUWJ^D?!_Q=9:WIFDVFE>'?AUX5^*VA>+]5;_A-5^(?
MQH\+:5KQTF\\)Q6']K2^,/!=M=R^(+;%M;20K#>].:X59=BJN!]NE/!9SFN5
M5L3-0C1K2P&$R_&4/94IUJ;H5<5]?^KQ@Z^*DY8>5:G"I*K'"PY,GQ:S7"0Q
MJI.$:^1X#-*6'4IRK>TQ&8U<OQ"<Z="HI4J-.F\<TJ,/9TXSI5:RI0GC8='_
M ,-$?&G5/#6E>+]+L?A?HVFZ1\,M*^)/BK3+Z"/QS-XHL[OQQK?AN.#PCXI^
M'?Q8OO#V@V^I:%I46J072WWB]+*6[6UD^W;7FC<</&&<+!5HRC0GC.&L Z*]
MI"OA\1GSE2K^TJUZ%+VT<MKN*CRX.BL?3A.49X53A)9XC$U</DM;&Q4)XG#X
M?B?$JI>+H5J?#^&PF)H)4*=2I.C/&*O*%:,L54>$G'E2Q'(Y5+EWXY^)FH?L
MV_M-7L?Q,\/R_$'P;XP^->AZ;J^D:'?6E_X(TS2/$&H?V)I.H:?:>-VO+;6Q
MX9>WN].O1>:<\-KJFDW/V>Y$/GZARK#/%X+@FG"7*\VJY-AL777M52Q%2OFU
M+!8Q4_8UJ-:DX.4L/B8T\4ZL9TZT(U</4<71]G$U*> S3/ZGLXSH8#+OKV&H
M+DO!_P"KM/'493=:&(I5H_64_:.6']C6KT\1:E"G/ZO1SI_VC-7^&]LOPM&M
M>#-=^(7@S7/%/AN\TO4IO%]_X@O/"GA3X!Z[\0]&\9ZA:>)/'FM>(?L^J^*M
M%2W&I:KK.I?:;;[5;K=SWL4EVEXO$_7,'F>:8.E&$\-@,XQ4Z2]G[+#8K!\1
M4\LP6&K_ %>E0A3=7+:M'%SI*G1JUG-8JC&&'ER'-DV%D\2L%F$YQC7QN14L
M'42FI8K#YI2RZ>-K0=1U5)8;$XC'8:-2#CAZ%6A2P\X*?+3GI:E\>_BUX4TN
M]L/&OB'X,:%?#5_AP]U\4;[PMXGTCX:_#_PWX_\ #'B;6UG\7:%J/Q,-SJ<M
MMK'AJ'0X=1_X2;0+6XG\26,TL-F(6@N=:U*C"O+#1J^R>$S/,\MDY[YA5P&&
MRO%T*&$C&/\ LN*QL,S<*=.I+&<CP=25)8JM6HX0Y<NKSQ<*M6="51RR3*\V
MI4*+?/3>89EC,OK*I-QG[6A@:6$EC:LX4:4I4^>$U0I0J8RGN? KQKXHU&Y^
M#4^H^)+OQ'_PL#PE\9I=?4ZEJ.H:<9/!WQ#MVT#Q#I4>K7TDUG8Q6^N7.E@B
M,R207FE13/ML(%548<M.-"5"<5'A[AG'.I4:<Z.*GE^#I5Z56:A%RKYA]8GB
M:CERJ57+Z]:,/:5L1)S1E*6%Q&*5;VSH\4Y[E\94[*A4PM3%YW6I-1O4:AA5
ME="C@XPK2A1H8FI2]^/LI4_LZN<ZPH * "@ H ^?_C)_R47]D[_LX#Q'_P"L
ML?M+4 ?0% !0 4 % 'S_ /!O_DHO[6/_ &<!X<_]98_9IH ^@* "@ H ^8/#
MOPK^/O@6+Q!I'@KXO_!^V\,:I\0/B?XZTRS\4_ 'QIX@UW3O^%F_$?Q5\2+S
M2[[6])_:0T*TU3[#J'BN[M(KF+2+#S(;6)GA#EB38-C/^(7PF_:2^)/@'QQ\
M.==^-GP/M-$\?>#_ !+X*UBZTG]F[QY;ZK:Z5XIT6]T+4+C3)[S]J:ZMX=0C
MM+^9X7GMKB-9%0O%(H*, ?5] !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M%JE%TE)23IU8*O&<\/*I0GRUJ=/$0I598:I4IQIXB-*JZ,IJG/E[JTHX;%O
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M@>$=3@T;4-8/PR^)XTW5=6N=9?P];:;X)O#X-$?Q&O)=;3[&D7A1M:9I7C4
M^:F[.G)5</@<32C*<,RE&.%A&$W7K*=%XB%2&&4?K/L)8=2KK$.DJ'L8RJ^T
MY(2DKJ1]C7Q6'J2A&>!A.>(DZD/8T?92C"=.KB.;V$*\:DHTGAY5%7]L_8^S
M]JG!=$WQ>\!0:;=:I>ZCJ^D06'A6R\:W]KKW@_QEX?UC3O#>H:A=Z5:7NH>'
M];T"UU.PN&O[&ZB-A<6<=XGEAY+=4=6;54Y/$+"Q<)UGB<!@TH3A./UG,ZGL
ML#252$I4[UJGN.7-R46G[>5*S,*E:%##2QE7FI8>%',<0Y2A-/V.4TJ=;'U%
M!QYW&C2JTYQM%NO&2^KJKK;"N_VA?A%I]QXI@OO$]Y9Q>#;75[O6=3NO"7C.
M#0)XO#TZVOB)/#GB23P\-*\9W.D73B#4+;P_>:G-82AH[N.%U91G3?M:=&I2
MC*7UB>&A1IJ,O;UOK=>EA<+4I8>WMZN'Q&(KT*5+%0IRPTY5J2C5?/&^]:/U
M;F]JXP4(59SES1<*7L,/6Q=6G6J1;A1KQPV'KU_JU64,0Z5*I.-)J+-K7?C#
MX%\,^%]!\6ZU-XHM-/\ $]Q':>'](3X>?$.\\<:K=O!<W1M+3X;6/A6;Q:UW
M%96=U=30G1 ]O;6TEQ.L<"&0547L:T<-+6JZ3K-0_>1IT8JFYU:TZ?-"A3I.
MM2A6G6E"-&K4A1JN%62@33M4ISJQE&-.G4=%2E*,(SJ<\Z<847-Q5=U73G*A
M[#VGUBE%UZ'M*/[PCT'XT_#?Q1K^C>&?#>N7NNZMKOAZR\5V:Z5X8\5WVG6V
M@:C)K,%CJ&MZY;Z&VF>&A/=^'M:M$AU>[L9FNM/DM1']H*Q-K&A4E]8<4G#"
M<O/44H^Q?/2PU>FJ-;F]EB'5H8S#UZ*P\ZKJX>4J]-2I4JTZ<2FH4L-6E&<8
M8JK7H4TZ<_:>UPLW2Q,*E+E]K1>%JKV6)=:%-4*LJ=*JX5*M.,^2UC]I3X7>
M$[J:P\7:U<6%XFI^+;<)X?\ "OQ&\7VECI'@W78- UG7O$M_H_@7R/"VF6-Y
M=V:7U]?LFF6C7 (U*>#%PV6"C+'?5H8:/-5K^PC_ "454Q>+QN#P=-5ZOLX<
M^)K8&O3I0J>RJ2K0=.$)IT:E;6O%X>K5I2UE"//""M*O44,#E^.K^SH4W.=2
M5*EF-":A1]M.5"2JRC3G'$4,/TM]\=?A5IMNMS?>*?LZ-=>+;%86T3Q&UZ;O
MP/JUIH7B*W&G1Z0UUYL6LZAIEE;#R?\ B8S:MIZ:=]K:_MA/'-[M.4(RJJK0
MI8B"I0G5E*%>NL-2A&-.,I/$RK\]+ZFE];C.ABE*C'ZIBO8M4Y/G^%0IU(4I
MS<HJE!SR^IFL9SJMJE"A_9U*>+>)E-8>-+EYJJE4IQEFS?M#_"N&T\/W U'Q
M9<W7B;5-1T;3/#FG_"[XIZGXWAU'1X;*YU:'7/ &G>#)_$GA>.QMM2TR:YGU
MK2K"&WCU2R>61$NX3+M"E.=:A0IVF\12]M"<91E05+V[PKG5Q,6\/14<3&>'
MFJU6FZ=:E6I349T*T88^TBL/B\3:4:6!K0P]52A*-55JM">)HTH4)15:K.MA
MJ<L105&G/VU"U:ESTY1E+G/^&J/A59)KS^(&\9^'CH7C#Q=X/\J[^&GQ+N[C
M49/!$>GS^(-;L;;3O!\TLOAZTM-2AN9]25&M(+>.:XEG6&"5X^:E6I5,/@:_
MM(4EC*.(Q%IRC!4*&'S">6RJXFI)JGAJ;KJE%RKRI*G.LJ-3EK4ZL(;3IU(5
M\505.526$JX.@E37M)UJ^-P']H4:&'I0YJM>O*C"ORT*4)UIJE&K"$J6(PTZ
MW0I^T5\)9-&N];@UGQ%<P6FMVOAY-+M/AS\2KOQ5JFI7NGOJ]@?#G@JV\(OX
M@\4Z;=:-%-J5OJ6CZ9?6,]C;3WD5P]K!)*F[A.'LDXN,IRK1E!I\^'EAG26(
MCC(?'@70]O0=98V-#V2Q&'E/E5>BYYTI0K.HJ=2#C2I4JRJ.<(T:M*NZD:$\
M/6DU2Q2K3HUJ=+ZM.JZE6C6HPO5I5(10_M'?!T>(-$\,Q>*+^YU'7X/#-Q87
M%CX-\<W_ (?MT\9W-S8^$X];\667AN70_#5UJVHV=S96EOJ^HV,TUW"UJJ&X
M_=&J5&I6G6A2@ZCH2JQO&SA5E0P-+,JD<-47N8N2P%:EC(QPLJSJ4)>TIJ<5
M*TSJ0I0E*;<'3A[2=-QDJU*FL57P4YUJ#7MJ,*.*PU>AB)5:<%AIPMB'34H.
M7-:E^TIH</P,\5?&S1_"7C&_MO#NK>(/#UIX8O\ PKXVTO6-3UO1O%D_@ZV5
MK&W\'W^KP:3<ZFD,DM];:+?_ &6)YE>%[BTF@3GK2G3HY%4IP4I9_'*Y4(OG
M7LEF?LG'VRA3J58.DJDG"*I.6,M2^I1KK%X1UMJ2IO$YW0JS<(</SS"&(G!T
M9J:RZG.I4EAYSK4L/64U"RE]8C2HOG^LU:'U?$.EUH^/'P_TWP=:^+/%FLQ>
M'XTM?$W]MP1:5XQNX=)U/P+HEYKGCG3T74/".FZI-'I-KINI$27>CZ?-<"TV
MI:K.XMQT551C7E3PU1XBE*-2K1GRPO5H0S.AE"J<M*I7IWEC\5AZ"C3K54_:
M>UIRJ8>,JRQPBKXF6"H2H>RQN-K87#0H?O$_K.,RZ>;8>C>M2H3C*> ISKOV
MU*C[-Q="JJ>(M2>=_P -*_"-M'DUB'5_$KLFLR>'TT-_AK\3[?Q:^IQZ5#KA
M8^"IO!J^((]&&BW-OJ+:R=+_ +.2RF6\:Z%M^\KEQ526%H2JJ"E-4,764'-0
M5-8)QAB%BYN\<![*K4HTJCQGL7"=>A%J]:DIZ4.2O*-I.-.4L,HRY9/VRQ?M
M/J\L)&R>.]LJ&(]DL)[;G>'Q$8ZT*JA>T_XY^$XOA/\ #OXK>*H]0T"Q^(NC
M>%[_ $S1M'TCQ)XZU0ZKXIT+^W;/0--L/"?A^YU+6[PPQW$<1M],5IVA54B6
M25(SWYM0AE.:U\JG4E4K4:N)I1:IR3FL)3J5J\W&/.J<:=&E4JU'*7+"$)2<
MK1;%1M7IXJO2G!X;"5)0=652$(.'UV.!HU$YRBOW]:I1C""<FI54M4G(-"_:
M&^$_B;3];U/0M;UW4+/0=%L_$-P8_A_\1([C4]'OY'MK>[\*V,_A2.Y\;'[=
M')8R0^'H=4EAO8WL9HX[M3".>:=.FZOQQC5I4N6E^]G?$1E/#5(TJ7/4EA\5
M3A.KA<5&#PV)HTZE:A6J4J<YQ5-J=>&&_A590K2_??N(0>&G&GBJ56I6]G3H
MXC"5)TZ>+PU6<,1A9U*<,12IRJ04LS4OVGO@QI&F:'JM]X@\1);Z_;>)KRSM
M;?X:_$^^UJPM?!5]I^F^,)_$OAVQ\&S:KX/BT2\U2Q34#KUGIOV,2L\_EQQ2
M-'2A^\C34H.,H8:I[55*;PT:>+J5:.'G/%*3PU.$ZU&I1<JE6,858.G4<)M1
M>BI572J551JVHUXX5T_95/K$L1.@\53HTL-R_6*TZN&B\11C1I3]M1M4I<\)
M1;Z:_P#C?\,]*\1CPOJ>O7NG7S:9=ZM#JE]X6\76G@ZYM]/T:X\17UM9_$"?
M0E\,7NKV^@6EWJ,NE0:O)?):VDT[6PBB=EEIQIX^I)."RQ3=>,DX5(QIU:="
MI.G1E:K7A3KU:5"=3#PJPA6J4Z4I*I.,7-.,JWU/V*==8]T%1=->T3>*YEAE
M-PYE1==Q?L56=-U+QY;\\.;%L_VCOA+>Z1J6L6^K>*%32[K1[*?2+CX8_%&R
M\77=YX@AU"ZT.UT7P->>#8O$7B*>^L=*O[RW32M+O&EM;9KI0;8K*Q.,J4*<
MG&3]I6JX=0A%SJ0K8?#X?%8BG5I04JM!X>ABJ$\0ZT*:P_.X5G"=.I&$0E"=
M6O1A4@WAL-1Q<I\\?8/#8C$UL'AZU+$W^KUX8C%4*E"@Z-6I[:JH0IJ3J4N?
M?T'XT_#GQ/XATOPKX>UG4M8UO5=$A\116]CX3\836NG:1<7.N6,,_B351H/V
M'PE.VI>&==L/LFMW.GW(O-,FLS$+H")M8T*K5=Q494\,H2E54X.C)5*6%KTO
M85U+V.)=;#XS#XBBL/.JZN'G*O34J5*M.G+JQC1PU9J<88NK6H4TZ=15/:X:
M;IXF%2BXJK1>&J)4L1[:%-4*LZ=.JX3JTXS]3K$T"@ H * "@#Y_^,G_ "47
M]D[_ +. \1_^LL?M+4 ?0% !0 4 % 'S_P#!O_DHO[6/_9P'AS_UEC]FF@#Z
M H * "@#XP^$GQ:T#X::!XM\(>+O"7QPM-;M/CA^TCJS+I/[-W[0OBG2KC2O
M%7[0OQ/\5^'=3TSQ%X4^%^I:1J^GW_AW6]*OH;BQOKB-H[Q/F#!E4V#8S_VA
M/C;X7\<? +XX>"O"W@W]H#5/$WB_X/\ Q+\+>'-,_P"&6/VFK'^T==\0>"]:
MTG2+'[;J/PCM[2S\_4+NWB\ZZGAAC\S?+(B*S  ^WZ /GW4_V>].U;Q+XIU2
M^^(_Q'D\(^-?$ECXJ\4_"I3\/8O FLZI8:5H>DQI=7L?P^'B_P#LV6+PYI4D
M]@GBI;>=HI(Y8VMIY8'O"S>%C@XM+$?V;6J8C!.K=/"UZF/K9E&K35)TE4E1
MQ=>K5H?6%64&X2LYTJ4H1B:<,1]<]U4'F&'CA<7R>]]8H+"1P,X25;VJI^UP
MD51J2H*C*UW%PE*39/\ LT?#>]TCQKH.JC6=9T?Q[I?B'2==T[59M)NK3[/X
MB\?>)OB/<O;P?V,J&2W\0^*KU8%N5N8OL]I:1SQ3LLLEQA5I1JT*=!V7L(Y-
M&G-QA-PED=)T<%4Y*L*E&<FGS8B%6E4HUI+E=)4I2IR[)XF=3$+$M*+4<="4
M82J4E*GF&$P&"Q-/GISC6@GA\NI*$Z56G5IRJ5IQJ*3I>RYOPU^R;X*\%>&=
M,T3P5XG\0>"-<T?6M4UJQ\>>!O!OP)\#^)4?6["#2M7LKC1_"/P<TWPC?VUU
MIEK;6S3W7AB:]1;6"2*[CFMX98NB=1SGAW[T:='#5<)4IQJ5E"OAZ]>CB:M.
M;]IST'*OAZ%15<#/"5HNFN2I'GJ\_'&G&"JW2FY5J&(IRE&'-1K8:EB*-*<&
MHKVJC2Q>+@Z>*^L4FL35O3^'EU)OV:M+AOKS5]!^*7Q;\+ZY/J,.IV.NZ;JW
M@S5]7TB>3PGH?@W7UBN_&?@77/[:77=*\-Z'+?R:^NL3+=Z='=6$MC*TADF<
MN=I3C'V?^WTYTH15*G/"9ACEF57 \M%4W2H4L=[2OAZM!T<=2]M4H_6Y8?DI
M0(TXP<F[SE+ZE4DYMR<L5@*%?"4<8[NSK2P=>6%JT;?494HPE'"0K<U6?I'P
MX^%/A?X66NHV/A>35FM-1A\/PRPZK?C4&B7P[X?L/#EHT=R\"W$LTUII\<UQ
M)<2SO)/+*ZE%81J3DITJM#V<(4:E:K65.$>2%-5*.&PZHTXJRC1I4<+2A3CK
M)+FYIRNK7+FJ5HXBK4E4KJDZ<ZDN5.K*>.Q^85*TU%1BJM7$YCB)3]G&%)1]
MG&%*"B^;S-/V7_"9BU&POO&OQ'U706T+6_#?A3PW?ZIX9_LGX>:-XCU"QU+6
MK3PJ]GX2M[^^:>;3;&-)O$U]XAEM8+<06;V\3NCF$E]36!<4JV(R^KE<Z>(J
M*]:5')\3AL5@L)/EY*?L%4PE!5YPIPQ6)C3BZ^)G4C&<8Q\/K]',L-5;I8?-
M/[1G7IT[6>(S/"8S!XG%1E452<:JIYAC)TJ?/]5IU:\Y+#N*A&/J'Q#^'$'C
M^'098?%7BOP-X@\*ZI+JWAWQ;X,E\/C6]*N+O3KO2-0A%IXM\/:[HNH6EWI=
M]=6\L.H:1=JN]98?*GBBECR47"LZ\)RA*5"KA:L5R\M7#5JF'K5*,[Q<HKVV
M%PU6-2C*E6A.C'DJQBYQEHU3E3C2JT858TJM/$4G+F3HXBE3K4H5H.$H^\J.
M(Q%%QGSTITZU2,Z<O=<>)TO]G/P-HT$4%GJ/BDJEQ\-[R62XU.QN9[J_^&7B
M_6?'&FWUU/-I3/+=:IX@U[49=3(*K*LH6U6SVY/3&M[.-"E2IPI4<+/$RHTX
M\SC2AB.'Z/#2H1<I2FZ6'RW#TO8.<IU?K$?:5JM:+=,XIX*G56)]I.<IXN"C
M6G[D95)O.:N>U*S481A&I6QU:HZBA"-)49>SI4J;2DJND?LX^&O#]UI1T+QI
M\1-'T:WLM%LO$OAG3]5\/6VD?$!?#J21:++XOND\+_VN#!;R?9IH-$U31;:_
MMT6VU*"\MP8CS0I4HX:O@ZM*.(P=>BZ7L:J;IPG/+J&55<0E!P<ZM7"8:BG&
MLZN'IUX+%4*%'$I55WUJE2KBI8V$WA\9*O6JNM2TGR5<RQ.:_5X\_/&%*EB\
M9B72G3C'$JG6G2EB)QM;E/AS^QM\(_A;([>%(I;**/7_  KKFG+9>#O@]X<O
MM/B\'ZJNKZ1H<WB/P9\,-%U[Q/I)N(X!/)XEU76[Z7R1(;T7#R3R==+%5J4L
M/-M2JT*F)J2E94HUI8G+<;E;]IAZ'L<*O8T,?B9T'2H4G3JSWE1<J,N+&8/#
MXR55N'L85(X:,80M-TOJV8X+,_W56NJV(BJ^(R_#QKTW6E2=*/+3ITY1ISI^
MJ?$;X067Q"U'3M8B\:>.? FK6>CZMX9O=0\$7GAV";7?">N2V=QJWAO58O%'
MAG6X(;2:XL+61+[3H=/U2V9&^R7\ DD#\7L*4OKE*K'V^$S"G0IXO#3;5+$1
MPSQ#H<\J;AB*;IK%XJ%Z%>CSPKSC5YTH<G:JCA+"U::5/%X"=6>$Q*2=7#2K
MJC[;DC/FHU(U'AL-.4,11K04\/2E&,6I<VUX2^&/AGP5%XIMM#_M".R\5R:.
M;NRN+F.:#3H-#\&:!X$L+32W%NLT=NNB>'+!F-S+=2-.\S^8$98X]\QE/,\+
MBL+BY.4<7/'U*LXVC4E/,:M2MB'HN16G4E[-*"459/FM<G".."_LE86"I0R7
M!X7 X:.K2HX/$8G$T>?F;<IJ>*G&3NDX1IKE4E*4_/=#_9O\(Z+X>@\.3>)?
M&FMP6Y^$R+?:O<>%TOVM?@QKZZ_X-LI!H_A6PM&M\QP6-VWV42W%K;KB2.Z:
M2YDZ*F+J5JU2O7A"M4KXK'8VNY)I5\1F.34,EQDZD8N,8JK0H?6.2DJ5.&*J
M5'3C##>SPU/FPN%IX*6(>&<J<*^7O*X0O>.'P:Q>88NE"C)KVCG0EF-6E3J5
MIUINE2H>U=6JJM6K6^#7[+GPO^!7B'7?$/@/3[.TDUBR_LRVM1X(^$ND7&B:
M8UVM[+I]MXM\)_#G1_%NO6TL\5LTG_"3^(=?=S:0N7\Q-YRHUJE# ?4%)RIN
M5.4IW=-S5"$J=&,Z5%TL++V49SY:CP_MKSFY59.I-RZ<7_MF/GF%5+V\YUZL
MOMKVN(ESUJD95?:5:?-)R?LZ=2%&,9.G"G&E"E"GII^SMX*CL?&&GC5/%/D^
M-=/U[3=58WND^;;P>(OB!XF^(]ZVGL-$"PRIKGBK4((C,LX6TAMT=7F1YYIH
MS=">!G!)O+ZF05::>SEPYR?45.UKJKR+ZTH\KGK[%T.BS'_A2ABZ=?W%C,-F
MF%G[/1JGFV7X++L2X<W-:<*&!HRH-J48U95)5(U(.,(4?$/[+_PN\4/\5_[>
M@U;5+3XO#06US2=3N-/U;0]#N?#UZFKVUSX8T35]+NK&S^U>((H=7OK:]@U"
MTOKN(&YMY(7DADY8T(4\%3P5.T%0QL\=2J^SHSJPG*4ZD*-ZE.=.IAZ%2OC*
ME"E6IU%3ECL6DW"<(T]X8BI#%_6TWS/!U<%."E.$*E.OAZ>#Q%1RIRA5A6K8
M/#X+"RG1JT^6G@<+.E&GB%6K5N$G_8G^%MQX)\.^ #J-U::%H'B.\\4RMHOP
MS_9M\-7NK:M>+;PF]:3PW\"K"'PKJT-E:PVL.N>$(/#>M1QQQL-2\Z&*6+T8
M8JI3Q^78^*]_*J4:5"GSUO9QY:SQ#ES*HJ\54K-U*V'IUJ>#K-S57#3C4J1G
MS1CR4<91CR_[=).I*5.E/2-)THP=.<)4*T8J3E%XBC6G"3M"<8>X=KK'[,G@
M[7;KQ]+J'BCQR]I\0/#7Q&\*W6EI>>&$L_#^G?%*U\*P>*Y?#\__  BAOFO7
MF\(Z?=02:M>:JL,MU=C8T+Q0V^6$JO!8>&'I1C)4\9A<8I27O<^#S3'9O1I6
M@X0]C];S#$J24%4=*48*JG",CLPF+G@L5A<70A%3PE;"8B,9<\XSK8/+EE=.
M=1RFZC<\)"E&JHSC%SHPJ14)2K.KF?$;]DCX6_$Z/46\1&^DO[WQ-8>*;74;
M[0/AKXR71[^R\&:#X$EAT_P_\2? 'B7P_-:W>A>';$RG4-'OIX[AI)K6:V;R
MQ#E.TZU&ORQ52B\;?W(RYX8_%0QE:DW-2E",:]*FZ<Z,J5:,(NDZLJ=6M&IA
M&;C@\)@;MT,#A<)A:2YZD7;!5,PJ4:M14YPC5J6S/%4Y1J1E0<94YJA&M2A5
M786_[/W@:SL/[,LI=3TZQ67X1RQ6>D6WAC0].M?^%,Z['X@\+PZ?I&B>&[33
MM,M+F]B"7MM9VD$)A)CLH[+"E>J.+JQQ#Q'Q3>-QV.M.52I^\Q^44,EJT^>I
M4E4E2IX3#TY45*I*I&M>4ZE2G:DN6CAX4'B'%MRQ.6?V54?+3A>C]9S#%RK*
M-.$(+$3K9EB'.:C[.25-^RYE.534M?@UH=OX!@^'-QX@\4:CH=EXLTWQ9IUQ
M>2^'X]4L'T;QS9>/M+T."?3O#MK!-HMOJEA#:@W-M/?/:,ZRWLEP1<KAAY_5
M?[&=.*<LDH4,/2E*]ZL,-A)8&E*NDU%SCAW&#=)48MTX3<>9U'/JC-PJ9Q4B
ME%9PLR56&O+2_M6G6AC'1NW-.4\17KT_:RJJ%6HXI>PC"C'@KK]EKPG>ZAKE
MQ=^./B3/H^JGQ\VG^%&U'PFGA_PO)\3=;LO$GC"70C%X-34[B6ZURR^U1-K.
MI:M]E^UW$-MY5NXA0PLY826 J*U>MESRV-&I52YU0RC'83'X'#/DY(^RISP=
M&C.2C&O6H>[6K3J0HU:669)YG2S"A6FZ=',Z<X5H4E%>_4R?%Y).O%RC.2J/
M!XRI+EYG0C7A"I&C%.M"KU&N_ ;0]5UC6/$>E^+_ !QX1\2ZQXLF\5S:]X;N
M?"YOK4WWA#PUX(UCP_:P>(?"FJV1\/ZCHOA32FGCN+6XNH[E#<VEW;2QP&WP
MG3C4P]+"RO["&&Q^#J06GM\/F&.GF-6G5E\473Q4E*A4H.C5A""IN<H3KJKT
MU*\ZGLFTE/#K".C)7O2JX)8R-"LDVX3G[/'XFG.-6-2A.$U>DI14E9O/@?H<
MO@#X=> ])\4>,_#,WPHBT-? OC71;KP])XOTBYT+P]=>%([^5=<\-ZCH.J3W
M>@:AJ-I=0WVA7-K(M_*Z6\<BQ/#V8W%8C&YCB<S]H\+B,7[>-945'V<Z.(G"
MI5H.%55;4Y3I4IQ::K4YTJ<Z=6$HW,Z4_94<90G%5Z6-FZM15'*ZJ_6OKD*D
M9PE"<94L0E*/O.,XITJT:M*=2$[WPV^#/ACX77VI:GH>H^(M1U#6=%TW2=8N
M]?OK*]FU.YL?$OC7Q?>:_<FUTVU"ZUJ?B#Q]X@N;OR1%:#=;QVEI:QQ;'J>*
ME+#1P<*4*.&I5*<Z5.'._8PI8# Y=2HQE4G.<J=/#9?0M*K*I6G4=2=2M-ST
MSE[2I[&5>M/$5Z+Q,I5:G+SU98J=&4W-0C"G%05"G3HTZ-.E2I4HJG&FHJ/+
MAZC^SSX+U*+QM#/J?BA%\>>'OB+X:U<PWNDJUM8_$W68M<UZ732^B,(;NWNX
M52T:87"1QDB:.X;YQS8%_4(4:='WE0KY7B(\^KY\HQ^99CAD^7E]V=?-,1"N
ME9RI0HQIRI3C.=37VDO[5PN;V2Q.#A6A"/\ RZ:KX/)\#/FC?G;5+),+*-IQ
MM4J8AM.,Z<*576_V9_AEXDU/XGZAKD&KZI!\6/#NG^'?$6B7]Y:WN@6$=G%9
M1W>IZ!I=UI\D=AJ6IG1O#DFH"4W-M=2>&M/=K8$3_:<YPC+"5,'91C+'4LPA
M-QC4E2JX>O5Q>'I0A5C4H2PU'&XG'8N-&K1JQG6Q^+59U*-2%*GC2A"C6P5:
M,4I8+ 5\N]V]*5:CB:5/#UZE>K0]E6EB9X2AA\&L13JTZM/#8;#TZ3@Z,)+S
MM_V)OA<W@"R^'":C-::%;^)9O%-_+I?PI_9AT2[UC4)+2.QC:XM]%^ -IINC
MWUO:1K';ZUH.GZ/KD.U#'J@:*,Q[SJ<]?+ZTDW_9D9*C"-2M#EG*HJLJL*M.
MK#$8>I)I1E]4K8>$HZR@Y^^.FG2IXRG%I_753C4<Z=*I%TJ2ER4:E*K3G0Q-
M'GDZKIXREB8\[:25.4X2]%D_9S\)2ZWXKUB3Q)XU:'Q7I?B+2YM%>]\/R:;I
M/_"5>#_#G@C7+_2[F7PTVJRW]QI'A319-VI:EJ,27$$DB1*LSQMS8FBL7A,7
MA*\G*&+IXVBY14(2I4<=F2S:K2I*$8TU&&-=:I2<Z<YQCB*E*4YTX8>-&\'+
MZCB<#BL.K2P-;+<2H2<IQK5\JP>)P&&JUG.3J.4L)B51K*G4IPG]7HU(QA5>
M(J5\#Q]^R3\+?B-I TOQ$=1N)+:X\)W>EW^H:/\ #WQ9_9%WX0\,W7A"RN;?
M0/'_ (&U_P .Z@]UH=[=QW"ZKHNH()95N+5+6>&&2'6LW5Q>*QONPKXS&8W&
M5&H4Y+FS"GE]/$4:?M85'3I7RO"3A*FXXF,E4C]8=*I*F\L)2A@\-A\)%.K0
MPN P> A&<IQ]S 5<=6P]>3HRI.5>,LPQ$9)_[/.')&5!VES=+IO[.G@/2=+N
M-'L)M3L+*Y\-?#?PN]MI%AX.\.6$-E\,?%6L>,-%N+#0_#'A/3M)TJYO-7UR
M^^W1V.GV]JT>Q;6VM'#._35Q4ZDZ,N516&S*CF=./-5FHU:&'P6%I4%*K4J5
M'AH4<!0C&FYN<5S1C54.2,"E35+!QP2LX+"YKA)34*=.<XYQ&4<96DJ4*=+V
M[<I5(3C3C%U)2G5A5<G?>M/@YH=KX'\1?#^77_$]]H'B'Q1K7BA3=2Z E]H<
MFN>*#XPNM'TBXLO#UNKZ1'K<MU)$=1CU"\"7DD;W;JD7D\RNH9'!OFED+RWV
M,WI*JLIJT:F"C74>6#5.GAZ&&E[*%&52C24IR>)E4Q$U.E&4LYM>$,[ACH5J
M<?AI/,<-4PV+G0<N:<9U95:N)2JSJPIUZC5.$,-&GAX<'X@_9=\+>)M2\37&
MI^.OB2=$\1MX\GC\'P7_ (/B\.>'[_XE:!>^'_%^IZ(Y\%-JTEW=17]Q=QKJ
MNJZG!:W#-]EAAMY9;>6LOE_9KPTJ455J8.T:,ZKDW"BLYP6>JA:#A&4%CL#3
M7-*+K.A4J4G5=J$J/34JNIC,'C5&-.K@\3A\6XQORU\1A<KQ&34)U5-RE%1P
M.(<'##RH4Y5*=.K*+G[1U.M\1? W1-<U2\\0Z=XL\:^$?$]QXBTKQ)9^)/#5
MQX9;4M'N],\)IX)GL["V\1^%M6TZ;3=0\/"6"[AO[&^/F3&>V>WFA@>#*$/9
MNKRR:AB9XQUX:6K4L<\#+$8:;24XTO:9=A*M.5&5+$4ZE*\:Z3:.=TX.AAJ$
MH*7U'#8;#X:<DG.A/!U<PJ4,5"_N?68K,\91GSPEAZE"HZ53#RC*?/L:?\(O
M#NG^"? G@./4=?GTKX?:KX8UC2+VYN["35KV[\)Z@FI6']KW":8D-Q'-<1@7
M'D6]LSJ3Y;1$[AO[1K%8+%1C&,\!1J4*4$K4_9U,JQ&3OFC>]XX7$SG'EE%*
MM&$FG33I2BO16)H8ZA5G*2S#%QQE6=US^VCFU'.?==K*+Q5",))QD_8.45)5
M&JJX>[_9G\(2Z(FC6/BKQ_H;V^F>-=,LM8T?5="AU:S'CGXBZ9\3=4N5^U>&
MKBSNVAU_2;:WBM;VSNK&:PDGM-0M+Y)W8Q=JA2PR:5.CA\APMI0A44Z7#V$Q
M."PBJ4ZL9TJGMZ.*JO%J=-QE45.IAXX>4$.E1A2KUL1;FG6KYYB&FVE&IG\H
MSQ;IRARU*;H2A%X.<)QJT6N:=2K))K+\&?LF?#?P)INHZ5HNI>)5M=4T'XD:
M!<Q10>"M%M(XOBI%X07Q9?6.D>%O!FE:9IEV]WX-L[RWBM+&"T@FU*_ M6A>
MWAM*KRC6RVKE*IJA@ZE*C1C&,JDI4J6'QN:8ZC3ISK5*KY:=3-L11BI\]L/2
MP\%:5.<ZG3A*U7!XWZ^I^WQ,LQP^:3E4C&U3%X? TLOC*:IQIW52C1A.LU:I
M4K\U5U.:<KYVH_LA^!;_ ,8KX\NO$7BG6-;TZ'6XO#MCXC@\&ZAI>C0^(/ ^
MI>!M8T5=7M/"%IXMN/"=]8Z@+J;17\3_ &:&YM(9+!;(!D;&NZTL)G=*@J?U
MG.L-CL/4J5/:*\,9C5F,85'1G3G46%QD5+"U:KJ8FA1<J$:SI/D#">RPTLIB
MXR5'*9Y=4I\LO?53+EAZ=.O3]HJE.C6JX?#QHXB-&G3PU=RE7JX>6)Y:\?+O
M#G['6M^-M*\2VG[1FMZ=XFNYK?X?Z=X.FM9_"/Q*?P_%\/8O&L6GZJ8/'?P5
MTOP_>>;;^.=3M(]*USPKXE>"*%9KO5]5OG%W#V8BI2Q%"C.THY@\?C,?6JN%
M&;;Q>$P.$J492=-4:LIQP2J5,1A\'EL8RG%8;"X>5-U:F.'GB,+'ZC3E'^RZ
M.$^J4Z476IWOBJ.*4HP5:=6C3I3PN%]E1JXS'3E:K3Q&(K8>2H+ZB^%_P3\(
M?"5V?PL98M_A+PUX/EMH=&\%>&=)-GX8U;Q;K<&HV_AWP%X4T#1]-U2]U'QG
MK$MY]@L+2UD81-%:POYK3W7QM6O3J4I)1IRQ'UA+GK5'3:P>#P,:4)5JM6:H
MTZ&!HJG!RDX-S49*GR4X)0488>&G^S/%--1A!R>+J4JE1U.2,5*471A&$K*3
MC?VDJDGS'L%<984 % 'Q!^SU\;?"_@;X!? _P5XI\&_M :7XF\'_  ?^&GA;
MQ'IG_#+'[35[_9VN^'_!>BZ3J]C]MT[X1W%I=_9]0M+B+SK6>:&3R]\4CHRL
M3;Y!M\CH/$7Q'TGXH?%']FRR\(^%OC /^$7^,'B3Q3XAU#Q3\!/CC\/]"T?0
MA^SM\>/#"7U]XD\?_#S1=*@\SQ!XFT&PBA-YYTLVIQ+%&_S%3;R#;R/K^@#Y
MSL?V>KFPM_$&B1?&[XO-X'\1S^.I;WX?2V?P5/AZ&+X@76N7^L6EIJJ?!Q?$
M\=O!J&OWEQ:M)XAEE1HH4FEGA5XY,Y4HU,#3P&)OB:=#!8? TYS]RI3HX2C2
MP^'DG15*#J4Z-&$+SA*,M95(2D[FU&L\+CUF.%A'#UOKOU^48\TJ<J[Q"Q-5
M-595)*G6J<RG&,XN,9R5&5)J+CTDGP.\+B]OM3AU#7_MMWK?@KQ#LDN].^RK
MJ/@'PVWAG1(MJZ3O%E-9$272[R[R_-"\*?NZSQU*IB:>,=-QCB,1B,YQD>:Z
MIK$9SE3RFO%V3DJ-.BU.DE><:OO3E5A^[.?#TJ5&GA*#<G0PF$RK IJW.Z&4
MYM+.*$ME%UIXB3IU790E1M&$*<[U3S/X<?LLV6@^ O!V@>/?&GBOQ=XA\.Z)
M\,=.2ZDU#0I-,\.0_#K7/#_BV/PQX2DMO!VF3S^%+KQ-X?M6FGUF&]U:>UCB
MB:^B$$ MO7QF)HU<=C,12A*K'%U*SJU*^E;%4YX+,<OHQQ*I3C2C+#X;-,9[
M-X>-)RK575KRKS<G+6<Y3Q6,Q"4::K_VM"C",4E0IYMB85L1.FVG-5:JP^%<
MHSG4H4I45"A3A3NI4O$O[+,=MX#\4^'O"GB77_%>IW/@#4?AC\.-.^)'B6UT
MSPY\*_"FMW^DSSQ^&M0\$^"8=:O9]+DT;1+^SGUFXU;4I)?#.GVJZO81R274
M?G8KV^-H3P]?$S]MCL7@*^+S&R>-_P"$Z=6IAJM*G'V6&=>A.M5E'EAAW6J5
M75Q56NZ<('31KT5F#QN*I>VPD7C*\LM2C]2Q6(QL*D<5&NJBJ3C2QL:E3#U>
M;ZQ1P="O66#P48SE2DNK_L3_  ;UR'X9G4;"VDU'X;>%?#_@]+Z_\$?"?QJ?
M$NBZ!<2WZVVKI\5?AYXM?3I+K5+S5+NYOM#ETC49I-3F,EZ[+$T7<\5&EG.)
MS?"T(855JE.=/#4TJ5*A]7C[+!QH5,.J.(HK!T(TJ-"%"M2HQC1I7I/V<;>;
M2A7_ +(P^68O$SQ52D\35J8B;<JE7$X]PGCZ\X3<J%2>*KP5>3K4:DHS<U!Q
MC5K1J=?\/?V6/A9\,?B7KWQ.\*:=9VFK:[/KEW]B/@CX2POIE[XEO7U#7+JP
M\;:?\.;;QW<"ZNY[IC;:EXNO[6..Y,$5O';PP16_-A9O!X.6"I?PW2I4(R_A
MRCAZ#BZ=!JA[*G6C>G2<IXFG6K3G1IU9U95N:I*L32IXK$8;$RA&$\-*53E4
M8RC*M*G*DZ_[U5)4*GLYS@EA)8:ERU*D?9M3DG?U/]G7PWJOB#4=4NO&/Q '
MA^_U7Q!XE3X>Q:EX=3P=IWC#Q-H^H:)JWBVR<^%SK[:B]IJVI2)87>NW6CQW
M%X]RFF"<*Z<;PE)Y?B,NFG.G4P^,PM&K*WM<'A\?.K/%4\,TE!NI*O64:F)I
MXBM2IU)4:-2G1?LSMCBJM/%0Q=.T)^TR^K6BDW#$RRQX9X/VJDW*$:;P6#YE
MAI8?VOU:FZG,W4<^W\2?"_3/$7A/PMX237?$6A1>#K_PQJ.BZSH[Z$^L)-X6
M1(+9+@:WH.HZ?/%=6:S6]R#IX8I=2-;M;S+%+%TX^V88V>.Q"M4J3QLYPA=4
MY+,,+B\'B:;3;FH.AC*R@XS52$N22G>+OPX.C#!9?#+:5Y4:='"483F[U(/!
M5\-BL-53CRP=2G7PE&HU*$J4^649TI0DXGFNN_LJ?##Q+X*M? >N'6-4T6P^
M'_@;X>V7]JQ>%]9,%E\.M4?6O#.MS:;K7AB[TG5-:BU%EDGAU'3;S3+E8Q#/
MIKPO)'+>,J2QN.QN8S488K&XJEBVXTZ<XTJM.AC,-:E"O&M!1G0QV(A+VBJ3
MBW"I1G2JPC-=BKNZ4X*=-3S*<Z?-4A&I_:=?!XFO&4J4Z=6,:=; T)4'3J4Y
MQM)3E4NK=+X8^ 7@KPI\+H/A/I;26N@1:O8:Y->:-X:^''@J\N]2T_7]/\11
M7$^C_#KP-X?\.0R27>EVD,SVN@V[RPH0SF4B456JRK5<MJVY/[*J8>I0BI5)
M0YL/5==7C5G4Y8U*TIU*L*3IP<YS<(PYF<5"A'#PS*$?>>:4L91K2<*<)\F,
MPDL#-ITH4^:=+#R4*-2JJLTJ=-5'4C!1.*'[)O@C[7\4]1;Q'K;:G\6[1M/\
M1W9\$? 5;=-.:_%^;6XT&/X-+HOC2086W2^\;Z9XJOH[??'%=)Y\QFY84HT\
MNIY9%VP\,32Q3O&#YJE%5%'EHR@\+AW-U9SK5,)A\/7KR5+VU6:P^'5+JG4<
M\R69V<:T<-5PT(QG52A&LJ,9S=13^LU96H4_9PQ%>M0H^^J-&"K5E4JK^R)X
M+M?#NA^%='\=?$KP]HNF>&IO"6LV6AW/@2SMO%VB/XBNO%5O9:O9OX!DM= L
M[/6[Z]DM;+PC!X9LX+>Y.GI;?V='%:1]WUF7]H0S"4%-TJN3UX49RJSIJMD=
M15,#5E4G4>*K3M>G7=?$5?;QESSO7C3JPY<10AB,OQ> G:"Q=/-*4JU.-.G4
MITLXPU+"8ZG2IP@L)%5*5"BXS>&E4A5I^U4^>K7=6O9_L6_!S3O$?CKQ%IML
MVFS>/(]?%]%8>#?@]:ZEI%SXHU'^U=>O=)\>1?# >-YI+N]>Y8V^K>*-4M$C
MNF@BMD@BMXK?# S>7T\'2H)<N KY;6HZ>SM#*L7A\9A<-4AA_8TZU!U<+AU6
M=:%3$5%2C4]NJ]ZS,SP]/-/K'UA<OUO#8_#UG&TW*>88/$8&OBHRKJLZ&)C0
MQ-94WAW1HISEST:D)SA+W'XA_#B#Q_#H,L/BKQ7X&\0>%=4EU;P[XM\&2^'Q
MK>E7%WIUWI&H0BT\6^'M=T74+2[TN^NK>6'4-(NU7>LL/E3Q12QY*+A6=>$Y
M0E*A5PM6*Y>6KAJU3#UJE&=XN45[;"X:K&I1E2K0G1CR58Q<XRW:IRIQI5:,
M*L:56GB*3ES)T<12IUJ4*T'"4?>5'$8BBXSYZ4Z=:I&=.7NN-'X??"#PO\-;
MZZU#0+K7)Y[SPOX=\+7?]KWT%]]HA\/:SXO\0+JTTBV44KZU?ZMXVUNXO)3)
MY+DPB""W",).MUVL,L'3IPHX:G5ISI4X\UJ,*. P.64*$'.4I.E1PF78>$/:
M.=5R4Y5*LW)6S4/=HJ4G*=&ICZTIM14JM;,L4L;BZM10C&FI3Q"E.,:4*=."
MG*,8*/*H\WJ/[//@O4HO&T,^I^*$7QYX>^(OAK5S#>Z2K6UC\3=9BUS7I=-+
MZ(PAN[>[A5+1IA<)'&2)H[AOG&&!?U"%&G1]Y4*^5XB//J^?*,?F68X9/EY?
M=G7S3$0KI6<J4*,:<J4XSG4W]I+^U<+F]DL3@X5H0C_RZ:KX/)\#/FC?G;5+
M),+*-IQM4J8AM.,Z<*63XH_9:^%?C&_^)-[XBM]6U2+XG:7H&GZQI&H3Z9JF
M@:3=>'[C2[N/6M T35](NK.WU*_O/#WA>;48;R*^L+YO#%AY]DRFY6[B4?\
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M$U*^9XF52IR\D[4Y2INI[2=3?M/@YH=KX'\1?#^77_$]]H'B'Q1K7BA3=2Z
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'S
M_P#&3_DHO[)W_9P'B/\ ]98_:6H ^@* "@ H * /G_X-_P#)1?VL?^S@/#G_
M *RQ^S30!] 4 % !0!\X:?\ M :_KTFMR^$/V<OCAXOT31?&'CGP4OB32=5_
M9YT[2M5U7X>>,M=\!^(KC3+3Q7\>]'U9-/7Q%X;U6*%[[3+*26.))?*59%R
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M/'U72J1]G3HUYT\(\'*=2-!4JM>IB:T4J^)QCGX]\//@/\5/#VE^$]<L=/\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % 'S_ /&3_DHO[)W_ &<!XC_]98_:6H ^@* "@ H * /G_P"#?_)1?VL?
M^S@/#G_K+'[-- 'T!0 4 % 'A^K?LR?LVZ]JNIZ[KO[/GP/UG6]9U"\U;6-8
MU;X3^ ]1U75=5U&YDO-0U/4]0O- DGOM0NKN::>:XGD>2625W=F9B2 9_P#P
MR=^RQ_T;3\ /_#-_#K_YG* /H"@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@#Y_^,G_)1?V3O^S@/$?_ *RQ
M^TM0!] 4 % !0 4 ?!.E?'"?X9_&3]J70HOA%\4/'RW?QH\*:L=8\%77PF@T
MJV,_[,O[/-F=,N$\>?%3PUJ!U",6 G<PV$MMY=Y $N'E$T4'50P6)Q$'.C2Y
MX1?*WS06J2=K2DGLUY'/5Q5##R4*L^635TN63TNUT371G<?\-9WG_1M7Q_\
M_!A^SA_]$-6W]E8__GQ_Y/3_ /DS/Z_A/^?O_DL__D0_X:SO/^C:OC__ .##
M]G#_ .B&H_LK'_\ /C_R>G_\F'U_"?\ /W_R6?\ \B'_  UG>?\ 1M7Q_P#_
M  8?LX?_ $0U']E8_P#Y\?\ D]/_ .3#Z_A/^?O_ )+/_P"1#_AK.\_Z-J^/
M_P#X,/V</_HAJ/[*Q_\ SX_\GI__ "8?7\)_S]_\EG_\B'_#6=Y_T;5\?_\
MP8?LX?\ T0U']E8__GQ_Y/3_ /DP^OX3_G[_ .2S_P#D0_X:SO/^C:OC_P#^
M##]G#_Z(:C^RL?\ \^/_ ">G_P#)A]?PG_/W_P EG_\ (A_PUG>?]&U?'_\
M\&'[.'_T0U']E8__ )\?^3T__DP^OX3_ )^_^2S_ /D0_P"&L[S_ *-J^/\
M_P"##]G#_P"B&H_LK'_\^/\ R>G_ /)A]?PG_/W_ ,EG_P#(A_PUG>?]&U?'
M_P#\&'[.'_T0U']E8_\ Y\?^3T__ ),/K^$_Y^_^2S_^1#_AK.\_Z-J^/_\
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MOC__ .##]G#_ .B&H_LK'_\ /C_R>G_\F'U_"?\ /W_R6?\ \B'_  UG>?\
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M9WG_ $;5\?\ _P &'[.'_P!$-1_96/\ ^?'_ )/3_P#DP^OX3_G[_P"2S_\
MD0_X:SO/^C:OC_\ ^##]G#_Z(:C^RL?_ ,^/_)Z?_P F'U_"?\_?_)9__(A_
MPUG>?]&U?'__ ,&'[.'_ -$-1_96/_Y\?^3T_P#Y,/K^$_Y^_P#DL_\ Y$/^
M&L[S_HVKX_\ _@P_9P_^B&H_LK'_ //C_P GI_\ R8?7\)_S]_\ )9__ "(?
M\-9WG_1M7Q__ /!A^SA_]$-1_96/_P"?'_D]/_Y,/K^$_P"?O_DL_P#Y$/\
MAK.\_P"C:OC_ /\ @P_9P_\ HAJ/[*Q__/C_ ,GI_P#R8?7\)_S]_P#)9_\
MR(?\-9WG_1M7Q_\ _!A^SA_]$-1_96/_ .?'_D]/_P"3#Z_A/^?O_DL__D0_
MX:SO/^C:OC__ .##]G#_ .B&H_LK'_\ /C_R>G_\F'U_"?\ /W_R6?\ \B'_
M  UG>?\ 1M7Q_P#_  8?LX?_ $0U']E8_P#Y\?\ D]/_ .3#Z_A/^?O_ )+/
M_P"1#_AK.\_Z-J^/_P#X,/V</_HAJ/[*Q_\ SX_\GI__ "8?7\)_S]_\EG_\
MB'_#6=Y_T;5\?_\ P8?LX?\ T0U']E8__GQ_Y/3_ /DP^OX3_G[_ .2S_P#D
M0_X:SO/^C:OC_P#^##]G#_Z(:C^RL?\ \^/_ ">G_P#)A]?PG_/W_P EG_\
M(A_PUG>?]&U?'_\ \&'[.'_T0U']E8__ )\?^3T__DP^OX3_ )^_^2S_ /D0
M_P"&L[S_ *-J^/\ _P"##]G#_P"B&H_LK'_\^/\ R>G_ /)A]?PG_/W_ ,EG
M_P#(A_PUG>?]&U?'_P#\&'[.'_T0U']E8_\ Y\?^3T__ ),/K^$_Y^_^2S_^
M1#_AK.\_Z-J^/_\ X,/V</\ Z(:C^RL?_P ^/_)Z?_R8?7\)_P _?_)9_P#R
M(?\ #6=Y_P!&U?'_ /\ !A^SA_\ 1#4?V5C_ /GQ_P"3T_\ Y,/K^$_Y^_\
MDL__ )$/^&L[S_HVKX__ /@P_9P_^B&H_LK'_P#/C_R>G_\ )A]?PG_/W_R6
M?_R(?\-9WG_1M7Q__P#!A^SA_P#1#4?V5C_^?'_D]/\ ^3#Z_A/^?O\ Y+/_
M .1#_AK.\_Z-J^/_ /X,/V</_HAJ/[*Q_P#SX_\ )Z?_ ,F'U_"?\_?_ "6?
M_P B'_#6=Y_T;5\?_P#P8?LX?_1#4?V5C_\ GQ_Y/3_^3#Z_A/\ G[_Y+/\
M^1#_ (:SO/\ HVKX_P#_ (,/V</_ *(:C^RL?_SX_P#)Z?\ \F'U_"?\_?\
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ML_\ Y$/^&L[S_HVKX_\ _@P_9P_^B&H_LK'_ //C_P GI_\ R8?7\)_S]_\
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M\_?_ "6?_P B'_#6=Y_T;5\?_P#P8?LX?_1#4?V5C_\ GQ_Y/3_^3#Z_A/\
MG[_Y+/\ ^1.'U7XX3_$OXR?LM:%+\(OBAX 6T^-'BO5AK'C6Z^$T^E7!M_V9
M?VAK,:9;IX#^*GB74!J$@OS.AFL(;;R[.</<)*88I\:^"Q.&@IUJ7)!OE3YH
M/6S:5HR;V3\C2EBJ%:3A2GS2BKM<LEHFEU275'WM7*= 4 % !0!^<DG_ "6W
M]J+_ ++!X2_]9I_9^KZG(_\ =*G_ %]E_P"D4SP<T_WB'_7M?^E3.CKV3S3Y
MK^*_Q8\8Z1;>.;/P)X?MY(/ S^'+'Q'XJNM9M[:_TK5/$$FDWL$6B>&KSP_>
M6NOVUOH^I6\UY-<W^G^4MVHM8[N:-TCX:>(J5<1E_N^RP=;/,NRUSNI3J\V.
MP,,7&5-QC[*A4IXF6&A7A4E759MQI4X1CB#7%47AL'B9I_[1_8^8YC3OI"$:
M.'S&&'FI+G<ZT<3@9U/8SIQHNG&//5ES^R/3?"OB/4I_&WQ!\&:M<"[E\//X
M?\0:-<_9XH)/^$;\66U\MI97!MX8XI9[/6-#UV!'"[VMEM#*TDWF22=6%YZF
M#J3J+]YA,;B,'.5U^]4:6&QE&IRI)1M0QU/#R25G/#RJ:>TLIQ"5.MAN2+C3
MQ>$IUXKI&K3JU<-7A%\SDTW2I8AN=K2Q,Z</<II1]'K0@\(>Z\;>/_&?C_2-
M#\<:A\/])^'FHZ+H=G%HNB^%M4O=?UN]\.:=XFNKS7IO%.C:HH\."#6].M8[
M33(],NV>RNW_ +07S$6'CA'%5<-4QM.O&-1XC%4,/0:C.ARX;V=/FQ:C&.(]
MI4K^T:C1KTE'#.E*TIU+P[J\*&%> H3I<ZQ6$ABZM6,VJJC5Q.+P\:5!-.E!
MTXX5S=2K3KJ=2HH\D(T9>VR]5^,OB;PS#KQOO"ND^([#X86&BK\7O$6E:]<:
M2VGZE?:/8ZQ?-X,\,7&C7KZ];VNFWT%_/%>ZII3QPSK';M>3JT8Z(5XXC$0=
M*A*C@,3F-/+:$W-3J?6*E7#T.:4.6G'ZK3Q&)A0G74W5YH5)+#<D.9XO"5:5
M*G3E/VN,E@ZF.A%05.%3#PJ8N$8\WM)RAB:BP59QI.#I7=.]=*?NYVF?'7QM
MK5[I]KI?PMTR2W\1ZS\1?#OA*\NOB$UJMUJGPYU?5+&]N/$<*^"Y7T'1+ZRT
MF:6WNK/^VKE;AA;3620XO&Y?K5:-"$YX=0K3RJEG,:?M+KZI?"0KPE-0TQ,9
M8W#O#4U%TJ].?-6Q&$E&5.*J4\/2JRC]9<J,,72P3FJ;YY5J^%JXJE*G3YK.
ME&G1J_6)3J4ZE)P?L:6);2>9;_M*:UJ5IJ.LZ+\,OM?A_P -_#GPC\3?%EU>
M>,([+5=/T3Q)#KLUYI^B:3;>'+R+7=:L(O#][*L4M]IT%S&I(N(9-D4O3[11
ME4JSM'+:>.H8+ZPW[]L3A,OQ5+$.BTE&E2CF$/K:=7GHPCST%BI2E3IZ2P.)
MCBZ>60C&IFE7ZU"%%22IRKX/&XG U**KR44O;5:"6%G*"C.4[5_JT(^TE#8?
MM:>$-1\4MHUD?!\^FSZ[X@\+:9%%\1M';X@3:YH$.IL;G4_AN-.^UZ5X7O+G
M2KBWM]2%_<W!::VEDT^.WG68<$LRC3PN)K2A"5:&$QF,H4:5:-9RA@J-7$3I
MXJ=.,E@ZU2A1G5IQM7@HKV=:=+$N.'E;P+C4H0=1TX2J9?3J3J0<%?,)X:G3
M^K7;6(=&IBJ4*T6Z+4HUO9^TC2E(2#]IC78/#>D^(M=^&*:7'XJ^'NE?$+PK
M#9>+[K6XQIMYJGAG1]2/C*>U\&1OX9T_39_%6G7L][90:[C3HKBY>&*:$VE>
MCC7/ U<?AZWLZ-;+Z^%I5)U:CIX:%/%QQLJ=2M7C"HZ4X2P%:E6A[*=*%:I0
MC#$5*<Y5:>&$HQQ7U:=-SE0K_78>Y",JTJV"C&?LJ%&52"K/$0;>'O4ISE*$
MHRA!N'-U@^-NM77@/3_&>D>'_AS>03G77O\ 6Y_C9H%O\-K6ST$*S7-EXXM/
M#]Y>W[7<9E,,4GANS:!K.X74?L&V,S\N+Q<\%1I5ZE%0I?5WB*BJ581F^6HZ
M:IX50]K3Q,JB4:M&;JT:,Z-2FI5(8B4L/&\)AXXFI5HQG*56.(I4*<:5*=1O
MVM/VO/5C+V<J/LOX-6GRSK>V_@TZV&OB5YSH?Q^\6^)KVX\0KIT.E^!-4@_9
M[N_#T5CK^G/K]H/B7XE;3M135(;[P-=VLEI-&UQ'<K#?O((--A^Q7%K/J#W&
MG=E).C4JQQC48T\RQU&$E>WU;#\-PS91K4[4Y1E3YJ=6/)4<OK%>I2G.>&P<
M5CN>O'DJXBA1<:DL)EM:M5<?>3Q%+-<3@.?#55*4:D)O#SC!SI1@J48573G.
MNX8;>\1?M-W_ (:\)KX]N_AXD_@_Q#HWB#5?AS>VOB[S-3\1R:#H]_KT=IXC
MTT^&A%X1&I:3IE[<V4T%[K8*0A;I;65UB//3J8EU,+AJN$E3QF+A@:T*49Q:
MC1QF.R[!<DYR]GRXNB\SP\YT%%T96G".*]UR.NKA(TZF*A[6T,!B,3A,1*4+
M<E?#0Q7O04)3Y\-.MA)T55;A47/3G[!QD[>P^!_'VM>(=?\ %/A?Q/X6M?"^
ML^&[#P[KD<>G^(7\26=YH/B@:N-+FENI-#TIK/5XIM#U"*ZLDANH8F1##>W*
M/N&_,H83$XFJU%X'$U\+74;RAST,/AL5[2C-J,ZE*5'%4[.=*C452-2#IV49
MSX+^]@^2+=+'8:.)HRE92_B2I5*=2"<E&4)1BTXSG&4)Q=XR4H1\8U7]H#Q!
M97'A3QIJ'AY-"^%-_H7Q$\50WMKK%IJ^M>(M!\*^&Y]3LCJVCW>A6A\,7T[P
M_:[6&SU/4%DBXO);>3-O7FK&U:%24L525-RR?Z[2PZJ4U#VN)S#)*&%]IB:G
MLHTJM.GCYTL3&?\ LM)UE.-:O[/GI^A/ 5)8JC@*$XQJQSJ.65JD[JWL<)G#
MQ5H1]I&5!5\%"<*RE&M*-*WLJ<9M3YZ;]IW6_%']F:1X%B^&5WXB/B_X;&]7
MP[\6=.\:Z0?"/BSQ&-(GL;W5-'\&W1TGQ,MQ'':7MD;)H[:+4%NK'4+QX]E=
MN$J/$YA@</&5.I2AB,11QKI3E4I6659CC*%3"5_9P5>"6"KU4I+"U77PM/#5
MJ=/#XM8J/#C'#"X#$XB\X5:M"-3"0JT^2M&4,=E^&J+$T7/]RI?7J,8RC+$1
M4:E:IRRJX;V%7T+7OCOJFA>+8_"&M^&-%TC^WK;QTGAIM-^(NB:OXY23P;H>
MIZR^IZYX/C\/W%GH>DW=OIDIM[J/5-::*2YL8[ZQAEGD@A\_$8Z<<NSFK_#Q
M.7956S-1HU(5)0A2J4J+I5:DZ,Z='%*I7CR)4<7AINEB.6K45*T_0IX2"KY<
ME+GI8C'83!S=2G.$92Q%VIT%&I&I6H1]U5'*6$K)5(N,%S1D^$LOVC-;T#2]
M5O\ 6(M)OX;OQ9I^FZ1JGCKQ+9>!?"GA_3Y/AC\._$ATW7O&ND>"KJUAU>^U
M?Q'?&T:[TVS@N)9)H_/LX888E]3'5E@Z^'POLH2J2JYSS2Y_8^VC@<\QF!HX
M?!QK2E3J8KV%.G[.A5Q-'GI49U*F(G-3G+BP=)8K#8?$\TXQJ8+*)\BA[><:
MF-PE:O4Q%=THPE&A%TN6K4I49*-6K1A3P\54]WZ_T74#JVCZ5JC6_P!C;4M.
ML[YK3[78W_V5KJWCG-O]NTRXGM+SRR^SS[6>:&3;NC=D8,=ZU/V-:K24N94I
M2BI<LH7L[)\DU&<;V^&236S5SGHS=6E";2BY*[2DII/K:4=)+LU:ZW2>BTZS
M-0H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M)5:DVHJ,4Y5)RE:,8Q5[1C&*26[4#"@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@#G(_P#DMO[+O_98/%O_ *S3^T#7C9W_ +I3_P"OL?\ TBH>EE?^\3_Z
M]O\ ]*@?HW7RQ[P4 % !0!\8>$/@A\%_B3\6OVJ==^(OPA^%_C[6[3XX>%])
MM=8\:^ /"GBG5;72K?\ 9A_9TO(-,M]0UW2;J>'3X[N_OITMTD6-9+R=PH:5
MRP!Z?_PR=^RQ_P!&T_ #_P ,W\.O_F<H /\ AD[]EC_HVGX ?^&;^'7_ ,SE
M !_PR=^RQ_T;3\ /_#-_#K_YG* #_AD[]EC_ *-I^ '_ (9OX=?_ #.4 '_#
M)W[+'_1M/P _\,W\.O\ YG* #_AD[]EC_HVGX ?^&;^'7_S.4 '_  R=^RQ_
MT;3\ /\ PS?PZ_\ F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\,G?LL?\ 1M/P
M _\ #-_#K_YG* #_ (9._98_Z-I^ '_AF_AU_P#,Y0 ?\,G?LL?]&T_ #_PS
M?PZ_^9R@ _X9._98_P"C:?@!_P"&;^'7_P SE !_PR=^RQ_T;3\ /_#-_#K_
M .9R@ _X9._98_Z-I^ '_AF_AU_\SE !_P ,G?LL?]&T_ #_ ,,W\.O_ )G*
M #_AD[]EC_HVGX ?^&;^'7_S.4 '_#)W[+'_ $;3\ /_  S?PZ_^9R@ _P"&
M3OV6/^C:?@!_X9OX=?\ S.4 '_#)W[+'_1M/P _\,W\.O_F<H /^&3OV6/\
MHVGX ?\ AF_AU_\ ,Y0 ?\,G?LL?]&T_ #_PS?PZ_P#F<H /^&3OV6/^C:?@
M!_X9OX=?_,Y0 ?\ #)W[+'_1M/P _P##-_#K_P"9R@ _X9._98_Z-I^ '_AF
M_AU_\SE !_PR=^RQ_P!&T_ #_P ,W\.O_F<H /\ AD[]EC_HVGX ?^&;^'7_
M ,SE !_PR=^RQ_T;3\ /_#-_#K_YG* #_AD[]EC_ *-I^ '_ (9OX=?_ #.4
M '_#)W[+'_1M/P _\,W\.O\ YG* #_AD[]EC_HVGX ?^&;^'7_S.4 '_  R=
M^RQ_T;3\ /\ PS?PZ_\ F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\,G?LL?\
M1M/P _\ #-_#K_YG* #_ (9._98_Z-I^ '_AF_AU_P#,Y0 ?\,G?LL?]&T_
M#_PS?PZ_^9R@ _X9._98_P"C:?@!_P"&;^'7_P SE !_PR=^RQ_T;3\ /_#-
M_#K_ .9R@ _X9._98_Z-I^ '_AF_AU_\SE !_P ,G?LL?]&T_ #_ ,,W\.O_
M )G* #_AD[]EC_HVGX ?^&;^'7_S.4 '_#)W[+'_ $;3\ /_  S?PZ_^9R@
M_P"&3OV6/^C:?@!_X9OX=?\ S.4 '_#)W[+'_1M/P _\,W\.O_F<H /^&3OV
M6/\ HVGX ?\ AF_AU_\ ,Y0 ?\,G?LL?]&T_ #_PS?PZ_P#F<H /^&3OV6/^
MC:?@!_X9OX=?_,Y0 ?\ #)W[+'_1M/P _P##-_#K_P"9R@ _X9._98_Z-I^
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M&T_ #_PS?PZ_^9R@ _X9._98_P"C:?@!_P"&;^'7_P SE !_PR=^RQ_T;3\
M/_#-_#K_ .9R@ _X9._98_Z-I^ '_AF_AU_\SE !_P ,G?LL?]&T_ #_ ,,W
M\.O_ )G* #_AD[]EC_HVGX ?^&;^'7_S.4 '_#)W[+'_ $;3\ /_  S?PZ_^
M9R@ _P"&3OV6/^C:?@!_X9OX=?\ S.4 '_#)W[+'_1M/P _\,W\.O_F<H /^
M&3OV6/\ HVGX ?\ AF_AU_\ ,Y0 ?\,G?LL?]&T_ #_PS?PZ_P#F<H /^&3O
MV6/^C:?@!_X9OX=?_,Y0 ?\ #)W[+'_1M/P _P##-_#K_P"9R@ _X9._98_Z
M-I^ '_AF_AU_\SE !_PR=^RQ_P!&T_ #_P ,W\.O_F<H /\ AD[]EC_HVGX
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M3PKJMSI4_P"S#^T7>3Z9<:AH6DVL\VGR7=A8SO;O(8VDLX'*EH4*@'V?0 4
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M,?A\#D6)GCJ5.K)S<88O.\+3AEM>FH2JT\8G35:$J=.CS_Q!\0_M1>%M+O\
M1-&UWQ9K%M??%=M%;XC)X%#^)-!\+#P7X<OC-X<\.^!_@'X[AN= D\<WVL6E
MM=:KX2U-!8:5-#>^(+>>:+4X*@XXBME5&G?"0KT\R?M)IS?MZ6:_5<!3S!2]
ME1C&>#C7Q524:V34JU#ZK.GB:<N;ZYES+#4<37<?K=7"TLOC7HV<*7/4P>*K
M8RKE\H3>(GRO^S:=U3S.=+'U<=#ZC*A2]GA#QOJGQFU/PU\2M/U7X@_'CP]X
MET ^$_"?V#X4?!IK?1+KP[JNM>%]*U;XH>%?$<_PC\3ZGXC\2R6%UK^IS:7X
M8UV:;2K5?L[:9!>6@OFUI>RQ-? U:2E@Z>)SEPJTZTHM8*C1Q^*GAL/%2A%5
ML-B,%0PL:V.Q7UG+W7Q%\36I87V^'58>-:A3JT*TJ%>K0RC$5\/7Y9+ZYB5D
MT)R6(BJW)0JT\UG5I8?"QC@\3.-%2ITZW-3DY-=\3_%;28M2LM/F^,&C'5O&
MWC71[SQYX4^!FFZ]\0]7O_!>D>$] ^&UA?QO\*I]!;0?%2)JVK7/C+4-&DTB
MTC1]+BU+2-L2:?AS5JM"C4P]"A0QE2ACL91P*E*E@L1C:F:XR$:6-K5JT982
MEA,NHX*A*FZ^&Q>8P5'%8;%UXT[XQT*-"DZ\:V.J8BA0JY-AU7J0;Q-'+*F4
M+&XNIAU"G%XC$PS6K7IRIJCB(86KB*\*N$A4<I4^^\(WW[1>H>-/">I^*-7U
M73=%E\;OX>USP;9>$-&@\-+X>TGX2Q3>(O$.H:]>>'9=7,5U\5+25-%DL]6L
M8'@OW\PZA$\,5GWP6!^L8ITY3GAJU'.:U%5HNG*C##YW' Y72ARN#>*K8-K&
MS]OSJI@Y5.3#1G2^M'#"IB'@,+3Q%)T,?0IY/2G4I6J+%8ROA_[0S&K53YJ=
M'!4</5J8"7L4I0S3!X>/MH*O5P]6'XF^//V@-"\?ZYIW@?PGXBUOPQHFL> ]
M2MYT\,V5QIGB"S\7V4GA1?"&EZFELUP+;3?$RS^(]?U=U)TFPAM 9_(NWCM_
M.P5+$8F7)5K4\,JN.Q^!ISJ67LX2RBEC,-F56-XWPF!Q*G144XSS#$5?JU)U
M*N'E2GW8JI0HQC[.E4JNG@L%BZRI+FE:CG.(AF&'H<\HTY9CB\N]A#"T&W2I
MTZ52M5^KRK4<1+C?$"_$Y_'&EV-]K_Q:T>YTGXG^"/#>O^.? 'PHMX[KQKX5
M\+_"2]\60'5]7M_A/J]O>^#=3^)NK:G9.L=U_9NG&:YM9;FUN+O9)K&M3I>T
MQM&G5J4J5/B+'T<NJ75*IB,*\#E^%PF(C'V;J5\1EU.OCL-B/<EB:LU0P3GB
ML)@H83/%1J5,/2PE2?+7KT\II.OAY)T\#6QN88[$8O$85SE7J1PM&-' 8'$4
M)J=:G[+#XG,H/+:N,JX[T#]F_1?BAX>NGM/&%_X@.DZWX(T_X@:CH&J^'=-T
MS2/#'C[XB>,?%_B?6]"T35H]!M=3U/4K2"YVZO%J6I7_ ),\MH\%OIT5P+<]
M4Z2PM"M@*F(IXW^R%EF6X?%Q:4\1]0RV&'QM6$(-4G@JE2.%JX.MR5*DZL\;
M"IBJ[ARTLYU/K&(I8Z@ZD:.95LXQ$J56%2-6GAI8O"O)E7C5<YT,13P<L1AI
M852IQHT</0A]7I\D9U?#KC1_C1KBWNK6_B[XZ'4/"OB+]HGXDVMYKOP_TV75
M?#6L:%]N\"?#/P3\.-/UKX56NG:Q:ZOX<\03WL,LMCXBMIHXKQM/8O.;FVX<
M(L12R_"5<+4A+%/)LOP\5B?<J8K'9WF&'QF*IYBVX3HX7*\1E=;#8R5..%KT
M<)C*,Z6(PV >"2ZW]5JYI7PM65;#82OG%-5H1YY86GEN5X&=*KB:-6DW";Q5
M?%8#&X##^TQ,*M7"7KT*^9X7,75]?^&GB#]H;7?CIK>F>.;ZZ\-^#/"VGI!'
MX>B\)ZS+X<\863Z-:0Q:_!XHNOA#9:;9>(V\1R3W7E:9\3-846(^R7'AFRGC
M:^/7AWAJE'-:[A)-XC$TJ-&<N5X9+,:BP52DY>QG6IRRRBOK"5/'PE7Q,*JQ
MN$</J;\R4L7&&38=\L:CH86OB*Z@VZTGEU)XVA6C"56E1E#,:LU0;_L^K&&&
ME#ZMC*52.(7'?$#6/BUXB^*$VVV^*LFB_#GQ#XP\3P^!=-^&D$?PXU>P\%^!
M-2U'X?W@\:ZCX-GU#QKXRUKQG>:3>6MKX?U_[#:?V<UC>:?_ &A;K)/Y5*=2
M.!QV.<)+'PR[-XX=U(MK"8^KC8Y115#"TH>VQ$99+C,1BJTZU/%TJZG/ZI"]
M*K"C[$Z6'K8O 955C3^I8W'Y)&K64]/JJ5+-L3B,55EST:,,-F&7_P!GPHTW
MA,32E.GBJ]6="M0A6Y+6]8^*MQX<\7>']!\1_'_0?#^F> ?A?H]E-\.?@9/X
M&C\.76MZKX-TWQKJNDZ)K7[/Y\0:YXLBM+SQ'J^_P3=7]E967VRSETC1M4TZ
MUN[[W)TJ$\8X4IQPV'CQ#0P]"4ZD:L(9?AJF(]E0HQ]Y4\'&&'H82KB,PC7R
M^JZN$Q%/'5,NGCL)0\[ UZL\+A'5I*>8U<CS+&8N=:,H>TS>6&K5X2K<TJ</
M:8K$8BG[/#T90QBKT,1[:$ZM2G*7I-Q<?%V$Z5J/B*]\>>./#]_\7;_0])\*
M:S\+/#EZUAX9^&^A:S>^'O%VMQZ7\.(KVSUGQ%\0/!NG7UMKDSZ/IMJOB.RD
ML1:,+.6O,KU:U/#O$4J4:.9O+<XS&G3HRDZ=.O4^NTLORVA4C-SHU%E^8T)U
MH5:U3$UZF7/!)N=?%T<5T8?#1A4Q-"6/JO!1EDN#A-JGSU:6,_L:69U\7&4%
M*M3I6S'"35"CR4/K-6MB8.G0A7P7G_PE\0_&;P/X4\.O--\6_$/@N;6_AG::
MT]]\$M3TGQ'I'B+4)_&.M_%BVT#P3=^!K'Q=+X&OM8'AC3FUW7K6^EAN/$-_
MJ,.IQ:?;-)9]]587#?4\/14L7A<(\;A\&YSC[?$Y=@,AI83*88F4'"A@JDL;
M#VN'C7^K56L*\/C746(HRK83BZ\,SKPBLIQ\YRQV*H0M7PE'$8[B'"XG$T,%
M5Y9U<=7I8"OF7URK1]MA:E-X:IEU.&(A7HTS4];^-NM2R^(O$-W\<=+EO_A%
M/J$7PXB^%MAXA\$B+XE_$_5M*NM)\3:/I_PMUF/5O%_@CP+)X:DFTJ359]0N
M8K:=X[2YM9M7%]GAJ%*-2.%Q/U?'0K8KA7"8Q5>;V*M2HU\XQ.&J2C12P^*K
M2Q6#=6'[K!)RJYB\.H9;6PW1C765*5?!5EE]?"3XLJ82>&YW5<\MPT89$ZMY
MU9OZW*G+%TTHP6(Q4H4L%+E;H2Z;6?&O[0?]N^.HO!\/CZSO-$A\>^'=.\$W
M/PG@LOAGX?TV..YT7X1>*_"WBZ[\%B[\=^)+[4'T75M0@TS7=5TG3]-DO[:]
MTNPN+)'GRPW/7IT98FLY3S&IA85\547[W!8ZOG&!I8BE##.I"=3 X7*ZN/JX
MC&XA5:>*KX>EB,+C:-.L\/":ZH8"OA)8:BL7@<!&G6^J4KTGC<%0R*OC*]&=
M11:PV+K9I'#Y=A*%)8>K3B^5X6M).J_H7X5WOCO3=6\9^'/B#KOBCQ5(?%EX
M/!NNZIX*AT>UFT.P\+^$+O656^\,^%]/TFPT9/%&L:O;:2FISSW]U!83 7NI
M-:3RQ:)T*N$PTJ4'3K1^N2J*;:J^QAF6)PN&]MS<E.>)E2I1K6P]*BI86I0K
M^P47*O5RY:D*EY3YXQI8&E545%4OKM3#5<16>%2<JTL)[!4%6K593IT<Q^L8
M;VE'FP^%C\[ZW\+O&?BOXS^/_BW??#GPG96G@OQCX?O/!7Q$F_MV7XTS>'?A
MKX<T^ZO?!G@OPY%X&#+X6\3^(;OQ+:S7MOXI=+^VOIHET><R1SMY^&K5LMRO
M$YAAHSCF&(_MVL\-3BYSQ<Z^'Q&2X&AC(R5+V-&@L)@\TP]"<,9"53V6)C/#
MNJ_9].+H4<RQ>%RQ3E2HTJ>386IB*\XQP^'G''QSG$XS!-2G%U)4,9'+*]5O
M"RIU,/6A5=6G0]G.*]U7]IK0H_!GAW4?&GQ,U3QCJOA#PIXGM+W1/A)X4U#P
MEKGQ!OYOLOBGP#XU\0:?\.IM,^''PZT2RL;>]DDO[[2=;OY=?NO[.UI_L,6F
MI[:A@XYQ4P])QKX+ 8W#X>;J2=.&(RR5=O'9HZ_M*<:V+C2G.EE^"P4H.@L-
M2J8O#9@L3*M'BQ%2K7R>IF5"G]0Q684LSKTL$KUJN7UXT*4\GR^*E&52<*E6
MM*GC\5B:<XR^KR<*F!]Z,^EU_7_C7JUSXDT36M%\0-X0T/XNZ9X+FDNOAU8>
M(X_'WAGQ3X]T+75U&VTBV\+ZD6\">'_ $_\ PCDNLFSC#7U[?7E[<Q)HC7LO
MGX-M1R?%5:2EB9_6^2A[14G2Q.3T,VJX;'8BK)Q^JU<QS'!97+ VJ4(T(SG5
MIQD\5@G2WQ\H/^UJ&'HQJ4(8/#JJI1G.G4CF&"RW!8FCA[RD\6L)+%YMF&-P
MKHU_;.A@\#&;I?7\)+QK4/%/[1FH3^(/BAI>E_%&_P#%?AKP)IEC!X7\5_#:
M\\,^#? VL^//'>FV'CRT^&EII'PGU;Q7XYU#POX4\(7).JS:;X]CO9-6M+W2
MK&YT^\-C=J,(8?#U.6NJ]/'UL#AECN5T\>L-2P>-QN*J1PBPV)^HX7%YA/*\
M-2HXG"RK49T)_7ZO)0AC(=6*C&.*=.G*%;"X&MG%2GA::C[*M7PD\-@LGQ%7
M$U:U*52^!QV8XNM#"XJE2Q45*AA8PQ4/90^G1X@^+'AG]GO1-:U+6/$7BKQK
M=W6C-J_B.Q^'&L:CXPT7POK_ (GA6\U,?#G3_ .@ZCK_ (GT'PK>%&@3P1HS
MW%S8?:9M @7S+*M\?3I+'X'!4YRP]"3C0Q&(H>SJ7JT\%5E&K3O5QV'PZQV-
MI4:$JE2MB,+@?K4J]6?L*,E'@P<JSPV+Q"HJO7BI3P^&Q%7V2BW4I4ZD9U94
M<!*M3PL98C%TZ4:5#$8RC0IX.E5EB:T,3/Y\U:Z^*6M>$K*#QI8_&;Q+<R>&
M/C/%I6IZY\-I!XOL+#Q/\0=!^&6B7FJV?PL^'.FZ79^(K#X;7GB#7([.#3K>
M_N;75IVM(;M;2:6(H4:,\1@XUZ5'GJTN%Z&+7.UAJN&S/,9YIF^%JJI4J0<L
M+#+\KR_&S36'H5.:OB%A:%2<EHZ\Z/MZV!<Y?4L5FN.R^MB*454HX[),AJX?
M!*&&5/GJX;,\PQF/KX*5>*G6IT:&'M.KB(45[/\ M#>(?BKHQTSPG\+;CXC^
M&/.\(S2^%]6^''PVT[QJU_XM74K'2-.T;Q1JOB7P7XBT'P;X3TO3IQJ=V+ZW
ML+W48MT6F7D<MA-%<986<\3G*^N.3I+&Y3[3FE&%"KA<7C:U/-:]:JTISEAJ
M2HNG2PU>G5BZKKU%/#QG.B16'R_*:,Z.'^L4Z6'QR5)2G#$J6"P=&OE^&H0B
MI.G/,)1Q%!XG$8:O0H2I1I.G]9Q%",^=U>Y_:/U'6]3OK/QQXY\.>&YM8^+J
M0:7I?PL\,7]]IG@KP)HVG:+H=]ITNL>"[V>Y\>:]XTM)M3T7[1'>65WI6KW@
MCT?45BMKFPYZDZT,OK5HX?FQCRS$8NG3C4C98ZMFTJF48%1?O*']E5/99LI\
MU6C]7A!U<!BI3Q-;IHX62Q>'P\\12G1CC\HP<ZKG"$70Q&2^US3&5/A7LZ&8
M0E"@Z<H4J&+G&5>IB<*XX!+8^+_V@Y_'/A31M2E\<VFJZ/;^ &U70--^&EI_
MPK#QEX?NO">DW_Q)\4^)OB3?^$I8-+\2V_B*?6M-TGPYH?B#1KR*?3;>:ZTV
M]L+PR6_=C'AZ6(SRO@H?6<)1JYS&G1D_9O#4J&&Q+R7ZES3C5Q];&8N&%=>N
MGBL-3PV(GAZE'#XB@\15\VE#%2RK(O:5HTL?B<-E=2O-PO/ZU6S)4\RHXJ$8
MN&'HX7+(2K+]UAISQ$[TZM2+AAX4=#^(G[0WC/2_#UEI6F>//"FIMH?PJTO6
M_$'BOX6?V1:'Q;XF\97%W\2;]-'UC0[>X_L_POX4\,ZII23F.TL;F3Q)9744
MDR7%E>,?5Z$<3&'USFP%7$0H4JT8J.(>&R_),7C:^-G":Y<-+.L97P&&HTJ]
M/VF"Q="M1^K1<:N&GT5JRINO5I86I.I3AFLOJSE'V=.>-S3"8'**7UB%_K+R
MBA/$X[$2PSG3Q6$A&=2M4;E*EG:A?_&RSO/!<^N_$+XWZ8^@^'OV@-3@U+3?
MA&WBS3_%-YI/BJ/1/ABOQ+\-?#WX.S^?>/X6FN-4BTW38M FO3%;_P!GPRW*
MRN_*IP5+$8F*<<3+)LC2H<M14O;9C*<\?.DY0KNEF&#G# TL0Y0K_5)U:]9X
M.GEL<?AI[R^K_6L+2<*U3!K.:\Y5(2ITIK#X#"1]OA6KN4L#B\1+&K+*T[PK
M86E3]KBJV9U,LQ$/4(]3\;WGP'\ _P!OVWCWQ!KGBKQAX)TSQ:?&O@/1O$'B
M.+PWJ?CNS&O2:YX1\-?"[1;:UT.7P]%/;QSW_@W1KK3[*_M[O5X=/O+6ZEMO
M0K1H4LZRBE"G".'A>M.4*B?LL1A<IQ..PKJXB.(K4:6*AFE#"TIUL)B5A_K:
M2P53EE1YN"$ZD\LSJI5H^WFZ6(P\:,XRIPJTJ]>GEM:K0H2BJ]:C'"5J^84\
M'B(5:N(IP>'KPJTIR@[OPRN_C;?>/M-U3QAK.OMX1\0:1\4=4E\*7_A'1=$T
MCPI:6OC_ $ZU^%]B=03PY;ZQ-XLF\*76HO>)>:JT+064)%@)UDO;KDP:I_4)
M^W?/BOJ.25W*:Y)QQ>-HXJMC:%*,)*'L\%[.&'Q<9QJU8XAT:BGAH57AY=F,
MG!XA1P]*6'C2Q^,P\(0?M:=7!X"E#"U,57JRYG&6-QBI8W+8TG3IRPM?&0D\
M2J%*5'Z@K,04 % 'S_\ &3_DHO[)W_9P'B/_ -98_:6H ^@* "@ H * /G_X
M-_\ )1?VL?\ LX#PY_ZRQ^S30!Z]XI\6>'?!&BW/B'Q3JMOH^D6DEK;O=7 E
MD:6[OKF*RT^PL[6VCDN-0U*[O9X+:VL[6*:>XFFCBAC>1U4Q*:@X149SJ5&U
M"G2ISJU:CC"524:=*E&=2I*-.$ZCC",FH0G-KEBVKITY5.;ELHTHN<Y2E&$*
M<(_%.I4FXPIPCUG.48JZN]2MX-\9Z/XZTC^V]$L_%=C9+=36?D^,? ?CCX=:
MOYL"QL[CP_\ $#P[HNJ&U(D79<BS\B0AA'(Q1@N\Z<J<:4FXVJQ<HJ,X2DDI
MR@U.,9.5.5X-J%11DX.-1)PG"4L(58SE4A%2O2:3;A.,7>*FG"<HJ-16DKRI
MN45*\&U.,HKJZS- HV\K <OX>\9>'_%7G'0+F]OX()=3@:^_L76[72WGT;7=
M4\-:E;VVK7NG0V=W<0:QH]_$8H)Y':*.*Y0-:W,$TS46Z=.K:T*M'"XBFWIS
MT<906(PU2"=G*,Z+C-\MW24X*JH2G!2)6A.5+FC*=.I6I34)1J*%7#^R5:G4
M<')0G3E55.49N+]M3Q%%)U<+B84NHI 9>N:UI7AK1=6\0ZY>Q:;HNA:;>ZOJ
MU_.',-CINFVTEW>W4JQ(SE(K:&1R$5F(7"@D@&9S5-)M2=Y1C&,8RG.4YR4(
M0A""E.<YSE&$(0BY2DU&*;:1K0H5<36I8:A#GK5Y1A"-TKRD[)7DU&*ONY-)
M+5M)7))M4L+;2I=;N)_L^EP:>^J3W4\<T(@L([8W<D\T,D:RP[+=2[(R!UP0
M5##%+%SA@88FIBI*G#!JI*JU[ZBJ5^=KV?-SVY7;DYN;[-[J^6#3QOU581.J
M\7[/V*MR.?M;>STGRN+ES+2?+:_O6LS(\-^,?#GBT7W_  C^H-??V6-)^WJU
MCJ-B]F^MZ)IWB/38)X]0M(&2YDT35M-NF@(\R%;R-9DCD.P=-6A5P\JL*L.5
MT*]?#2U37M<-)4ZRA)-QJ0A4;I^UIN5*52-2$9RE3J*.=*K"M2PE:G?V>-PM
M'&T&XRASX:O.M3I5+2491<IX>LG3FHU(\EYPBI0<MN_T^PU2UDL=3L;/4;*8
MQ-+9W]M#=VLK02QW$+26]PCQN8YXHI%)4[7C5A@J",++FIRM[U&<*L'UA4I3
M52G4@]XSISC&<)JTH3BI1::3-'\-2'V*L)TIQZ3IU82IU*<EM*%2G*4)P=XS
MA*49)Q;0Z^O;33+*\U&^G2UL=/M;B]O+B3(CM[6UB>>XF?:"=B0QNQP"<+TK
M+$8BCA,/6Q5>?LZ&'A*I4E9OEA"+E)VBG)V2;M%-O9)O0THT:F(K4L/1CSUJ
M\XTX1NES3FU&*NVDKMI7;275H@T?5K#7M)TO7-*F>XTO6-.LM5TVX>WN;1Y[
M#4+:.[LYFM;R&*XMF>WFC8Q3Q1R)NVNBL"!V8C#U<)B*^%KQY*^&J3I5(\T9
M<LZ<G"<>:#E&7+)-7C)Q>Z;1RX;$4<7AZ&*P\^>AB*<*M.7+*/-3G%2A+EFH
MR7-%IVDD^Z1!?:_I.FZKHFB7ET8M4\0R7\>CVBV]U,UT=+LVO[]WD@A>.TAA
MME!,MP\,9>6*)6,LT:/C"TZE2C!IU*5">)E&]K4:=;#X>4[NR;5;%4(\B;FU
M-S47"G4E#2<E2A2G.\85:\<-!I-KVTZ.(Q$8/E3Y;T<)B)\TK0_=\KDISIQE
MIS316T,MQ/(D,$$4DTTLA"QQ11(7DD=CPJ*BDDGH!6=:M2PU&K7K35.C0A*I
M.3O:,(1<I2=KNT8IO1-Z&M.G.K.%*G%RJ5)*,8K=RDTHI+NVTD8&E7/AGQII
MGA;QA8V]IJ]E/:6WB3PGJM[I;Q7EI!K6E21PZEI\>J6D=YI%S<Z/J,T+YCMY
MO)O)89%"R.AZZU"O@L3B*%6+H8FDJF&K)-<RBJM.=2A*46U*'MJ%*<X7<74H
MTY-<U.+6$9T<13@X3AB*$:BJ4Y1<:E)SIJI3A6I3BY0FN6=14J]-RC.E4E*E
M.5.I>725@:!0!B>'_$>C>*-/DU30;P7^GQ:IK>C-<""ZMU_M'P[K%]H&L0(M
MW!$\B0:MIM[ )D5HI?)\R%Y(G1VIQE&&'J6M#%4*&)I.Z]ZAB:4*]"I;=*I1
MJ0FE*TDI*Z3T!VC4K4N:+GAINE449*2A4BESTW*+<>>FWR5(IMTJL9TJBC4A
M.$=NI * *7]FZ<-1_M?[!9#5OL7]F_VI]E@&H_V<)_M(L/MOE^=]B^T_O?(W
M[-_S[=W-**4/:\JY?;>S]I;3G]C[3V7/;XO9>VK>SYK\GM:G+;GE<:YO9\WO
M>Q]I[.^O)[7V7M>2_P /M?84?:6MS^QI<U_9PL7E_!8O8I-'>N;^]2P@-GIN
MHZ@D<[PSSJ][)86LRZ99!+>0->7A@MU=HXVE$DT:R-:SC36CDIM-Z1M"#F[S
M=H1;46H*4DZD[4Z:E.48MM6A.?V:?)=;R]^I"E'E@O>G:52+GR*7LZ:G6GRT
MJ=2<;O3\/QZ>U)OE3>MHJ^B;>G9*[;\DFWT%^!2TZ_@U.QMM0M8[V*"[B$L4
M>HZ;J.D7R(20!<Z9JUK;7EE+QS'<01..,KR*JUE%])1A-=[3BII-;QDDTI0E
M:<)7A.,9QE%#7+*I#K2G.F[:KFISE"3C)7C.#E%N%2#E3JPY:E.<Z<HR=VD
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MXNE'V]*E4:E7IQGU     P!P .  .@ J0244HQ2BHJR2T22T226R04#"@ H
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MAJ6&HO%1IXB*J_5YULQ^MU93=#%QQ6%K1PN,I5,*GA#Z/\8^%?%7BOX2>*/
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M.-J8*;Q&&HT%'!U;]D#4=+\+W?AWP?X<^&>M?VQX;^$.@:V_C/5;E-.U?5_
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MG@R*Z\ :;!:>#?$&OV&H7^J:_#?:=<ZA;:Y<V=UH3F*WGA[\9B4\3G.,R_\
MV:OBIYJZ2<6HXVGC\'7PV"H8YJI)X?#93[6A/#X6DL90G6PE/&PCAL35K<V-
M2D\7A,OH8ZM4KUX_5'C*W,D_K-+.9YGC<RH0MR2QF9TN2A6NJ#HPE*C[;$4(
M03]*^#_P(U7X2Z_I6N6>G^$;W4-1\!^%/#/C_7(=5U*SUO7?$,5]XFUWQ=XF
MNIF\,2MXB2+5KO1K71K&\N+%+:SOM4$;V20QVM[*EA<.L9@L$JE#*G4PT,)1
M?*_8X?+L$\+@YS@I6EC,6INGF%?GE)TL)@Y<^(<%3I544L2Z..Q$53S*-3-:
M]2$)SGA^?-\PP6+J8:E.H_:0PN"C2Q=3#7@W.K6]FZ5'VU;$K6\4^$?C7)\3
MO&6N^#['X:1Z#XN\#>&_!=CXK\2>+O%$FN^#UT>7Q3?7E];_  WL? +6/B1I
MM1\1JVQO&NC"1+&#S,>3MD\^-"&(P69Y=C7["AC\7*I.MAU&IB*F$>#PN%AA
M_P!ZH0HU*4HXZI1JM8JG2EB^9T*GOPEU_6'2Q&58BG!5XY;3J.-"?[B/UFMB
M54KU'7@JTYTZE##9?!4_9TY*5"JE->UC4AYYX,_9BUCPG\1_"NHBW\'7?AOP
M#<^'CX4^(=[JFL:A\6K?PIX>^'MGX+M_A;::7-X>BT_PUX3GU*VEUF^N;'7I
MHM1EN95FTB.X<7J>FL8ZV+QV85Z?U?&8JIF4JJP[O#'K'XFO5H/'3FHU/999
MAZM&AA,):O'V^$P^-C7H2]K1J^=4HU94*>&JUOKT5'!RC5JPIT98+$X>O1Q.
M,K8:E2A*G4JYI6CBGB,1S86K2P^-G@$J^$P^'A#L_B+^S]+\0O'UYXWU+^P)
MKRTU7X.+X.NKU[FYN_"NC_#[Q7>^+/$>IZ7;RZ9)#I_BW4I-4U'3(KRWD\Q;
M*=XQ=6ZW$\4O!A'4PDI58-4<3/%X^LZ\.;VD</4R-8' T(MN/N1S'GKXVBG"
MGB,-4Y*KK^SIT8]>*J3K4'A+1KX..!E0CAZJM3^MXO&KZ]BIN-W.5' 4,#5R
MYRO[#,L)&I&%*[KGB2_LF^,[WPMXMMM=\*?!35?$>MV'A;1=?2\U;6-3L?CB
M=&\?>'_%>L^./BWK>K?#6XGTWQ3=:5I-]8:99QZ5XH30_P"U9X[74)K<Q):]
M%%X6"P%)X94\!#&Y9B9X&+YZ. 6 HXVE4GA:E3WL=7QD\31JX^I7IX*IF-/"
MQPV+KR=6>)5XAPJ9CF&+I5:U%5\)Q#AZ56,G&L_[7C3C@:$XQFO8X;*XT80P
M\:=:I&ESRJ4:--15&?TOXL^"NE^*_%'P[FNM'\)P>"?AMX4\06_AGPP=-@N-
M.T?QI=2^&8?">K6&@-IJ:<MAX=T[1KXV0RA@N+BVDA@C>VCEBYZ[KU*F=XV&
M*J1SC%X6.&P./E*3KX=UJF(K8^O*3DY1KU:M/+'"I"4ZCC3Q,'4IQE:MEAW3
MHX;+<#]4I0R^GB/K&,H4Y.$)PI8>>%I8.G&$(1GAJU/&X]8E3C35H8:*I5(U
M*JI?%NC?LN?$7PA%X5\-WO@KPC\3?$WB'QA/XE^(FL^*O'E[:^"O'.@^"?"^
MLZ/HVH?$'4?"/[.FEPS>);_7O'3WC:1K>G>)-1U:VTJ2TOO%-_:6#&'=_5J_
ML<+#!TL)@<-A,?5<)PA5IX3'YA/"8&-3#44\/0QU2.61Q:JPI8?*J/M%#%U(
MPQ3IU:I4GC(QQ^->(C7QF+Q>#HQJ4U'#5WAX5*V:M1E3=3$8+#TL;EN"IT)S
MK9K# PQ53"86G1A7AR^KP?LK>+;#5O ]O&GP\UBR\"Z;\.V\+>/;^]UVQ\7?
M#R?P3?)JFL^$?AMX37P]?V/AOPUXFNHC9W>IV_B"WN4TJY_LVYL=2@L[8QS[
M;$0J9C7I59RQ,H8F%#$5Y^UQ6-A4R2GE6&H9GB>2,U3HXFG+,\0X1Q,,5B:U
M6HJ%"O-UVW&DX*BJ<883%RK>WP2BWA<%+$9IC,=4QF"IQE"-;&4,+BX8' 3G
M3PKPCP6&KJI4I<^".I\ _LKZ'X(\:_!SQ1)X"^%&LZCX/\$>(;?QIXVN;"V7
MQQ/\3M:?PQ<MXST>[G\%W%QKCM)I.JV<4UUK&C2Z?::B$MXI8S]GBZ85<-A*
M^:4LOIRP>7+"X'"97&&E6CA\*\50JX?$1C))+%82KAI5JZJUZDZN'G3J0G'$
MSK1Y\3+%8VEA)XR-&I7JX_%8[&TFY5*5.=><L5AXX*M4BY^QP>+JXAQP[HT(
MU7/#XQU*=?"1I5.;7X,>//B%\6O''Q$NO#_A;P8MA\0-6N_ OQ#U.[UZ]^)E
MO;^&? K?#K3M,T3PMJ'A"QL_"GA2_P!<CO-9GU6UU_4SK=F+>)K/R)K:XMO*
MI4*E/**DJ,G@<SQE#-VXTJC_ '\\QJ5L-AWF%5?O*-/#X"A@*M/ 0IU?9XVE
M0QKG0Q%&I1GZ->K%YA2P^(HPQ>782.21NI648X.OA\[JNE!.K3Q->I7QF/RZ
MKB'/"2P]"=;".E5M5E4X6#X'>,O %P+C0O O@GP]\8?&GB'X3RZ!J'P]T7QA
MXM\,V$/P]O+Z+QKXW^+/Q.U'P9H<6I>(M0L/&/B6Z,VM/%J.I@P65LE[):2S
M5Z,)TZV(H8.BW@,%#'9MCZRI1AAZ&#P.8Y)_9D<-@H_PJV+P^(566'C"E)U<
M1.CC,51P^'E6^K^?55=8>K5QE:>/Y,)@\)1=XRQ>-Q^&S:&9>UQ32]KAL!BJ
M> RVGB$ZT\/EU"EB:&!J5<3*A'&>GW/[(.CWWB&*_P!2M](U.RL_&'@"6PU"
M_P!6UF7Q'!X*\&Z%J^I:S*MU%81?9_%_BKX@^(_$BZW);W$2W^CZY=Q7-W-'
M-)ISQ3G&E[-QI4^2-3,ZDL,Z<9X=TJ^5T,ER_++U.>53+L/A,'@L56A6C453
M%X>$*E'$*%/$1TK4_:0JR^L5?KE3"8*#KJ-.FWCX9[6S7&XZ,:7+'#UI4,15
MHX*K02J8*;_V-8.,I-<?I?[(7BBR\;?#'4[Z7PQJ/@GP)IJ7FD>$;+7['0M(
M^''BRQ\6^)_&=C-X#L6^#.I:J=+:]UG2-+=M$\4^ "=+T**RO;;5+(I9133K
M8FC3Q=;VOMLWAEF'PF#QM5<\W5I9+@\JJ0KI.-6-"M5HXO%575KXZC5EBTW@
M(XBA'$25:C2DEA*?NY55S+,<36P\:5*+E0QN95L33J)S5:E]9PV$GAZ>&C3I
M4*N#Q.'G5PV8Q6*JVT+O]D2]@\%ZMI%OX?\ A?XGUO7O _PLT?Q=!XJENAIO
MQ"\2Z!\0F\9_$&Y\5:M<>"M8F%C+:+]CT"X?2]1?3A>7"PV=G$JAM.7 4<10
MH8>C/^Q<+F675*&&GRWHX'*\%4PF'K\OO1JYA6]K&.80E.$<?AL)0PM7&QA-
MNCM"I.K[;%8ARPV88K"<30J2P]6JZ=.OGSI5J5"A*<H5%@\%B85*E*3:E"5:
M56-!U.?VOLWP>^$E[\.O%_Q2\4W7@CX9^$].\1-I=OX=L_!!7Q%XB.BZ'#=6
MT%I?^(#\//"UY9:%]ABTM;#PCC7K?2)(;F.QU)K2>"TL^>M7=#)<3"I[;%XR
MI6Q>-KPM*HJTZJE4M5E=U,?B'5J5XPQ%6C3KJC4AAG[6,(.,>QIU,9@?84J>
M'I8?#PPD&Y1A3I13HQC&A2<5# TE[/FQ"IUO88FJH8EX?#XA8BKBOFOPY^R3
MJ%]HWA"[L/ 'PPT"Q\5Z-:>*_$!UFSNO#OB_X0?$;7/$VJ^+]>\:>"_"^E^#
MY[+5?B ^F:IHWAV#4;[5-!O-#@\)VL4$UW;-+9MWX?\ X2\5@</[>,UP^LHI
M4<1AI>TC7I971P]/&8"G'FA3PV!S;$TL1B,;B*$ZGU^&+E3Q6%JQHX><(S%T
MLSPN:\DJM6KFF(X@:GB(RI.I0S&HX93B:T)055U\JPSG/#4*]&-2G6JSJ>VH
MXBIB)S^I_"7P@?P?X9^)FI1Z'X7UCXH_$74?'.I:SJXU:_\ #QUJWUC6=<N?
M"7AJ]\<6?AR]U?1](TS1KZRM%EMM+NQ:3?:[JWM9I9G:?RJ]&,LEPN3T(<E'
MZM2CBH*I*G&IC:Z=3,\4IJ%1SE+$U\7+#2J03='V-&2H4_<I]5&L_P"U)YA6
M?*J-9?5ER^W]GA\-1PV%PR=.K*G!5,31P&$JXZ$7R.OS)2KQI4Y2^;&_8^\5
M:A;?!C1];LOAY'X.\&-K$GBCP%X2O?#_ (5T+3]5U'Q#_:EGXTTBZ7X"7DGB
M3Q_:Z9#8VK^(=%M_A;J4MS%>7<5[:)J4UH/2HXCZOF\<?"7/'"X3 QPDG!4U
MA,5@OK-6<<-A:<_]FP6,Q-:FZV&I8WZJZ-+V6(P6,H^SH4N'%TW7P&+PM)2H
MO'5\5]9A*O.K+&8;%4L%1?UO%3@WB*V'AA\0\//$X3$XJ"KTN3,*>)H3QN)[
M]OV7-4M+/PM=^'[GPIX>\9Z[XW\;ZI\</&5FNHMXD\0>"_B"_B^_U[0/#'B&
M*Q@OC?VU]KMA;:9+=M:0Z?%]LNH(UN-L4W-AE2IO+</B(J>6X3**6#Q.&C"/
ML\9C:?\ 9%>I5JTY/V<J.,Q>6.&-E-3JU<OJ2P<%3YJ=3#=5>=2K5QN.C7DL
MUHYA#$977E3I3CA\+AXXK+L'1JPFI+_8\GQ/M*5.//2J9KAZ-;%?6*4\2J[U
M_9Y\1R>*[*;7?!?PB\9^ X_&WC+4F\)>(-;U0Z3IFG:A+X2M_ ?CBQ\,W'PX
MO]+U+QMX;\->&(M#M])NS'#;IF[L]=@:YEMD*-2O[*FZ]>4<QA0K3I8]6JXC
M+\?/,LZS&K5PCDJ3E''U<QPM2M74\-6PGU3V$88R%ZL^6OAZ45B*&"I1CEU9
MX*%7!5+*GC</0RC+,ME2Q-11J3A2PL\)C*E'#<M>AC7BXUL2J%?#T7#R?2_V
M/O']CX/\9:?K.E?#CQYX\\9^*=$DUSQ?XS\8:=<:-XET30[B\U*QU[QGX+TO
M]FNUM/&UU%J=PRCPUXIN?$5U]DN6MX?&UL;&SE@K#K#4J>0X?V3H87+ZT,1B
M*;;Q*]K1I/#JI3C*6'H5,3B:-:NZ^-HT,MQ"Q-/"XNJ\9B*:J0]#$5:4\QS7
M&4_:*EB88BGAX4Y_5JL*.*Q$*\\,J_\ M-2C2PJPV%H8:,WC<(Z"KT%E]#"8
MC$86O^D%E:QV5G:64,-M;Q6EM;VL4%E MK9P1V\21)#:6R$K;6R*@6.)3A%5
M5' HK5'5JU:KE.3J3E)RJ2YYMR;;<YO64W>\I?:=WU.##TO88>A1Y80]C3A#
MEI1]G3CR14;4X+X(*UH1^S&RZ%JLS8^?_C)_R47]D[_LX#Q'_P"LL?M+4 ?0
M% !0 4 % 'S_ /!O_DHO[6/_ &<!X<_]98_9IH ]7\5>)8O#,.BC_06O-=\1
MZ1X>T^WU"YU*TBN)+V5Y[_R9M+T35'^UV^B6>JWD4<T$%O*]BL5Q>644C74$
M^TI0JTZ=6;IPE#$U)24>9QIX7"5\5.5FXPLE149<]2GI)^S]K7]EAZU<MJ.(
MJV;5"-.UE=>TKXBCA,/&5GS1A4Q.(HTY3C"HZ:G[24'",W'S72OVDO@UK6E:
MQK>F>*;ZYTS1=.T'57G_ .$-\<POK%EXGGN+/P^WA"VN/#23^.[B]U&TNK"*
MV\.1:K/]NMY+$QB[4PC1QG&G3G[.<G4JJC"G&,IUW-T/K46L/!2K^SEA5+$0
MK>S]C.A3K5HU'3HU90JK2E0Q-3"UG"A4HRK0G.I4IPP].>&Q,<'7ISQ4I+#0
MJT<3.E2G2E652+Q&&?+RXK#NI:N_CMX(T[S[S4)]4LM+BTCPU>P64W@_XD)\
M0+K5/%)UN?2M MOAF_@1=;NM7ETW0KRZ&FVL=SJT8AE^TZ7;1+%-<S->R]KS
MVGR8AX:"H26)O4I87#XS$\_L>?DAAZ&,P=2=9<]",:TU6JT9T*D#*,HS=H7B
MZ="6)K.JG0C3H2Q4L#AIJ53E4OK.*H8NC",O9SG*E1>'CB8XF+AA>"?VEOA[
MXL7PE;W;ZMH.K^-[W48?#VFW'AKQG<V\-F+S6&\+_P#"5:V?"L&G>!=?U[P[
MI2ZM;:#X@N-.OBL[00I<O 7>FH**:JTY2IX&CC*UITW"$I9?0S'$X>A64W2Q
MM7!8>O&IB(X256<:*^LNG&A)3)G44'6;A5A3IXF>&C[2G*%5NGCGE?MJF'7-
M5P^'K9C"IA<-6KJ$:THQB_9U_:8>E3O/VL/@Y%H5QX@T>[\;^+;2"Y\%PQ6_
MA+X6_$C6;_4[?QYJ<FD:!J>@6J>%T_X2/2OMMO?0SW6EM=I!<6$U@W_$Q:*S
MFJE2J5*V"HQ@XRQN(>'@Y>ZJ;6%>-]K73M*CAGA(RQ$,14BJ56E"K.E*<:55
MPZ*U*6%GC*5=QHSP$,3*:<X\LJF$Q$<'5PM*HFZ4\6L74H4'04^>F\3AZU;V
M6%JQKO3UC]I/X;61\6V&CSZ]K^O^%_"GBSQ3%81>#O&^G:'KJ^#I+2RUG2=%
M\=ZAX83PWJ.JVNMZCINEW5I9ZE=7%G=W@AN($EBD1)ITJ^(IJ6%IQFY8C+\-
M3]I-483GFE=8; U(2DG*KA<14NX8K#PK494XRJ0E.*U(QI0E1EC*WU3"2YG6
MK.$JBPD*5"KBJ_UFG"\Z%:CA</6KRPU=4L1RT[<B<HI]5XR^+WAOX?:MX"T/
MQ5I_BB*_\>2ZA%%=:%X5\0^(_#WAJ/1]+_M+5M3\7>(M+TQK3PYH5LS00-?W
MS0*OV@7$J16=O=W%G,IX=8G&T%B(TZ>"PF(QLJU>U"D\/AZE.FWSR;IQJ251
M.,'.W-R4>?ZQB,)2Q.%-5W@<+BYT)*IB:^%PD</2_?8CZSB83G&E3I07M:B@
MJ=1RE&G\%.<U'EA4Y+O@KXL^!OB#::Y>>%-0U>\C\.B%]2M[_P (^,/#VHM:
M75O+=Z=JFE:3XCT&PO=>T/4;>WG>PU32[>\LM0$$GV*><HP#Q"EA,)+&UX2I
MT:;K1G'EDZU*IAX0J5J%;#13Q%'$TZ=6E4EAJU*%=0JTI^SY:D')4JE*MB5A
M*56$ZLHTYQ:G'V4Z56I5HTZU/$7]A4H2J4:T/;TZDJ2E3FG-<K/'M+_:Y^&^
MJ77@N7^S/&VC^'_&/A_4]<BU+Q#X#\=Z5J^F1Q>*M \*>'KF_P#"Z^%I[RV\
M,:Q/K%Q<KXENGM=+M8;2#S[@&[_T?:C0=6K/"N4:6*4,I<*4I0_BYK',/9X6
MO5YE1PV)IU, Z$:52I?%UZU*&#=>-2C.M->M##0K2J1J0^K5LTA5YH."C1R>
M-"6,KPC)JM645BJ%3V=*C*I2I+%/%K"UL'6H+V#PW\7/ 'BWQ9K'@GP]K-U?
M>(-#MKJ\N4?P]XEL-(OK73]132-4G\.^)M1T>#1?%D>G:NZ6%\=$U#4/L-TP
MM[OR9CLK*C&5?"RQ=)7P\/J]V_<ER8N%6IA*JISY:CP^*IT*L\-B5!T,1"G*
M5&I-*Y=:4,/7HX:I.*K5E7Y8QE&=I86=.GB:4Y0<HTL1AY5J2K8:HX5Z?.G.
MFEJ>=:]^TQX'L/$]WX5T-;[6KC1]$\;:YKVO7&A>.=-\&:=!X*%CI][;:=XO
MM?!.HZ=XMU!?%&KZ/I%U9>'IM4N[&2YF,MNUQ"EI<3A85L9&4\/37LY+!4\/
M.K+V*Q&+S/&X?"9;1IQJ)5'0QD:F)JT\?"%3"Q6%Y93Y:CJ4],2E@H4ZN)?+
M1A6G'%.G:K+"8:A@<?CL56J*+Y(UZ%/!)?4:U3#UZD:RJ1]V%IWM;_:3^'N@
M1S"33OB-KUS9>,M&\ 7P\&?"7XI>*-+'B?4[Z[TZ_M]&\06G@V/3O$UEHUSI
MNJC4I])N+M[-].>VEA6_F@LY]:--8BO@*5&?+3S2I7AAJE?EP_-"AAYXE5JD
M)R<J5"K2BG2Q+OA91<ZRKO"T,3B*,58U<+AL36Q4%3J8'#4,17I0E[22^L/#
M1I4H)1C*5:H\50]E0E"G7FJD/W2G.,'%JO[2?P\M]+U76M$OSJFF>&XO'UYX
M@N]3TGQIX8M?L'PWTW5I?%$OAK5-4\&G2O$L]CKEA9Z;<;-1M;6(WS.+MYT@
ML[[CJUI4\'+%4J,Z[G@HXO"THJU3$NO/+X8*,8SY91I8QYC1C1K1C4G.HI4Z
M-"M['&2PG3@J,<;C:> C.4*TL=1R^4O9RE2HUYSQGMJ=6HO=IU</1R_&5ITW
MK%4J2K.A#%8:I4WO GQV\!>.-/TAX;V]TG7;^ZGTB_\ #NJ:!XLTJ^TGQ!IW
MA6U\8:O83KK_ (<TR9M-AT*[AN[;6);:WL=0M[BVFLY91=PJ_=CJ5/!2Q4E6
M53"86AC<6JTH^S?U3 8VG@,16J47*4Z-2GB*U&$\+/\ VF'M.;V;IQE->;A*
M]2O1R^5:A*AB,>\'"G2CS582K8W#8C$T84*\8*GB:4H83%QCBJ5Z#J8:K2<X
MUHNFN?D_:5\!7FIR:)X?M_$U]>3^%O 7BC1=<U;P3\0M$\!:K%\3-9M]$\&Z
M8?&,7@V_6SU2^NKRT86[V3NJ32DJ3I^HC3JAA*\L17P\Z?L)X+'K 5XU)1A4
MYZ=!8S&O#QG*,:\L%@E*O4C[2G33=*-2M1IU?;1Z:KC"@JM&K1Q#GA,=BJ?L
MZL9TE#!JM&G.M5I>TC"ABZ]"M2P]:DJ\JJI.5"C7G6P5+&:Y_:/^#2?V^TOB
MZ:VMO#CV*WFI77A?QC::-J*:AX@L_"<%SX4UNY\/QV'C>PC\2ZA9:;<7?AVY
MU2"TN;J.*ZDA9L5RTG[:A0Q%).=/$3H4Z48Q;K3>)I5:V$E'#V]O[/&4J%:I
M@ZOL_98N-*;PTZO*RW%QQ-7!NT:]"CC*U1<T>2$,NA&ICU*K?V2JX.,X?6:#
MG[>C*485*<9M1/1?!?C7P[X_T&'Q)X7N;^?2Y;O4=/9=5T+7O#&JVE_I%_<:
M9J5AJ6@>)],T_5-)O;>^M9XG@O;."0%,[=K*6TG3E3C1D^5PKTH5J<HSA.,J
M<U>+YH2DDUK&<&U.E4C*G4C&I"45GS+VE:E9QGAY^SFG%K7DC4C*+:2J4ZE*
M=.K1K4W*E7HU*=:C.=*<9/G-)^,7@#6KR2QL-1U@LOBP>"+6\O/!OC33-'UC
MQ,L>KR36'AO7M3\/6^F^*(;8:#K"7-[I%W>VEK)8217,\4F$,4OWM/"58:1Q
MT*M6BI?NYRHT</'%RKNG/EJ0P]3#SA5P^(J1C1Q2E%86I6E))DI*$\93UE_9
M_LEB)03J4Z4ZN+A@(TG5@I4G7ABYPH5Z$9RK8:3OB(4HIR52W^-_PVO=4TS1
M],U;5]6O=4M]1O$;1_!GC?5M/TNQTRZU.QEU#Q/K&F^'9]/\&Z;<76C:FEE>
M:]=:;!J'V-VL)+E,,<9UHQP=?'1][#8?!PQSJ-J%-T:F#I9A3@JL^6F\3+"5
MZ%?ZHI/%PA6I\]"+DD](Q<JOL%;VZQ4L'[%.];VU/%U<#-J@KU98>&+HUJ$L
M7&#PJG2G^^Y8MJA\'?CCX1^,?AN/6]'%YI5];Z#X>\0ZUI&J:=KEC'IFG>*+
M"?4M&O+/6-7T;3[/Q)I<UM;7:_VII#WECY]C=P"X,EK(%[L7AYX&E4K8EQIT
ML-4J4*\F^54<3AZ-"MBJ4HS4*L84HXBG.G5J4Z<<1AYTL33C[.I$RC5I3QM;
M!4)^WG&=1T)04FL1AOK6(PN'KPTLG6>'EST+NKAJO-AZR52#OEP?M-?!ZZCU
MF2SU?Q9>#1!H#-'9?"KXL7D^O0>*;C5;;PY=^![:V\$/+\1;#4'T/5V@N_"R
M:Q \6FSSB3R8S)6/)44*$Y4IP=?$U,)&G.$X5XUZ5!8FK&KAYI5Z$:6&:KU*
MM:G3HPI-5)5%'4WE3E&33E#DC3G5]JJE-T'&G4H491CB%)T)557Q.'H*A&HZ
M[KU84(TW5?(=_P"+?B7X2\$:?I&H:]-KH;7G2/1M&T/P;XR\5^+-18Q1SS?9
M?!7A30-1U^1;6"6.2[;^S=MDIW79A ) H-XV&7Q<98F3EI&<72C&$X4I5:F(
M3>'I8=5*E.'UFK5AA^:I37M;SC?*,D\+]<LX4%[.SG%TY\U6,I4Z4:511JRK
MRC"<EAXP=?EIU9.FE3FX\%J/[1'@/PU/K@\837F@V5AXKO\ PYI%S8Z/XH\4
MW&HZ=HUIH,>N>+-:T_PWX<NI?!OAC3O$>KW&CW.JZL8M.MY+*-[F]@:[2&-X
M:'UO^SZ=!\V)QTYTU3T4*51YGC<MP=.>(DU0C/,*F"G/!PG.#Q'-R8?VTH29
M-:I"@L7.?-3HX##TZ]1U$J=2<7@</F5=X?#N3Q%>&$P>+PT\3*%+VE&<JBJT
MH4X0JU;7_#0/PXNKZ>TTO78GM](\1>(= \1ZQK>D>-/#OAS3F\'6GB>X\7OI
MWBF\\(2:)K5SHS^%;];M$U*WMH%,337L;W=C%J,PC*=*CB+6PU7#U,5'6U>=
M"$\'0IU:.&ERU:U.MBLPP6'IRBKU)U:BP\<14PU>E#:K3G1Q$,"X2ECJU3!T
M:-*$74C*MC:/URE2G5I<\:5667PK8N--WG[D(5HT8U?:P@UC]I/X2^'_  [%
MXHUB_P#&MAIDR:O<1V\OPB^+S>(3I.@);OK'B8^$8O K:ZO@RU2[M"_B1M-&
MD8NH=MZ?,7=4*=2=?#8:,'[;%.C&,&N5T9XBM4P^'IXMRLL#5K5J52G2I8UT
M*E1Q?)%IIM48O$.HJ%JG)-4X.+36(GR0J6P4KVQZ4*D).6">(C&/,Y-<D^7T
M+P;XP_X2]_%4L.FM9Z;H/BFY\.:7?//([ZY'8:9I,^H:@;.6S@?3/(UJ\U/3
M#;NT[%M(:5G4R^5"<B6&PM:]IUWBE*GH_9_5L?B\"O?3:FJRPOUB#BN7V=6%
MG)>\\8U:<ZLZ=+FE"E3PDW.4>12>+P=#'05.+;DX1P^*P]YS5.7MG6I^R2I1
MJ5.)N_VB?@_8:AXGTR\\57-M)X-T_P 8:EXAO)?"OC%=#LHOA^BR^,;2'Q'_
M ,(__96I:SI<#)/-I5C>W-\876:.V>)@YQHU85Z'UBD^:DU!PNG&=2,\:\N5
M2C3DE4K4XXY+"U*M&$Z=*K4HQJ2A[>CS]D<+7EC,-@(POB\77HX:G34H_P ;
M$8../H4ZDK\E%UL'+V])UI4XSA3K<K<L/75.N?V@_AY$L^HW6HWMCX?CB\.P
M6\U]X4^(UAXFN];\4:AK]EHFE6O@Z_\  L%Y=IJ$7A^YFL9+26YGNTE@D2T6
MVO+&YU#2I&="7LZL7[6=:>'I4J7[^K*MA\NAFN+I5*5)2J4:V&P56A4E2<92
M4I5:%3V6*H3H/BA7H55&5*JN2-&GB*M2I^ZHPP^)QM/+L%7A6G:G4I8G&>WI
M.IS0A!4H58RJT:DZE#&F_:;^'UU<G3/#L'BC4;VY\#V7C32]4U;P)\1] \%'
M^V=:F\->'M!\0>)O^$)O9O#.NWVOVUS9FPGTN:]@DLKJ)[0W5N;8Z4J4JE:5
M*\8QAB<LH*:G3G#$+,_93ISP,XS='%J&'KT,0YQJPP\H5X3^L1H4L;7P=NI3
MI*C4JJJJ$EFKJ2IT95)8?^QE)XZ-:DW"<)TO9UER/WE*E&$E&>*P$,7U-I\?
MOA+>:QKFA#Q8MO>>&;3Q5=ZY>WNA^)M.\-V2^!M371O&%NOB_4M%M]$O+_2+
M]X1<V5O?R74<5S;W)A^SW,4LF,)1J89XNE>6'2H2@^5JI6AB:DJ-"5"AK5Q"
MJ5X^P7U>%5+$.&';5:I"$MJE&OAZM+#UZ?L\1/DC*,7[2%*<\)#'0C5JQ2A1
MY\))XBE[?V+J4J5>48_[-B%2Z/X??$_PA\3[76KOPC-X@=/#VKKH>L0>)/!/
MC;P+J%GJ3Z9I^LQ1?V5XZ\/:/>SP2Z5JNFW45S#;R0217D31RL&K:5&I"AA\
M1*/+2Q2J.G=QY_W-6="K&=._M*4Z=6G.G*%6$)J4)+ET9E)J%5T=Y1A"JG'W
MJ<Z4Y5(0J4JT;TJU.4J511G1G.#Y;IV:;XC7OVA/ ?@V\\81^,YKW0].\+:]
M+HMO>6&D>)/%M[JMOIGASPWK_B;Q%)H?A30+^\TGPMH;^)[&SO\ 6+E/L-HZ
ME[NXMDDCWYX>+Q$<%R6]ICZU2E2BK\D(PQM3+:4\37DHT<*\1CL/B:%&-:<8
M3]G!PJ2G4E3IZSI3C*HJ4776'I8=U53C*56.*Q%.MB88*E1BI5,37^H0H8Z,
M,-&K4E2KM>S7L*DGI2_M ?"6#Q#J'AN7Q/<I<Z5IVN:I?ZR?"_B__A"+>V\,
M11R^(H3\11H/_"*R:GIBRQ"[TZ/66O('D6.2!9&"U,'SQK2BG^X47RN,HU*J
MEB*6#B\-2DE4Q:EBJU+#Q>%C64JTO9Q;DFEF_=>&CO\ 6G34''WHQ=7"U<;2
M5:4;QPW/@Z-3$Q^L.E>A%5%[LH.531?CSX2\6W^@Z?X,LO$>J7&H^.Y_ VKP
M>(_"/C;X=W_AV>S\%7GCJZU&XTGQUX6TR]O;0:,FE&%X+?R)SKMH4N-I)K>G
MAZLW1E:,*-7"8O&<TI+VBIX/$T<#.+H_Q(5?K^(HX>=.LJ,J:]K4M)TO9S*S
MAAX5>>:552PL:$5>5/%/$UJD4Z%>"E1J0CA<+C\6JE.4Z<XX.5-3BZL)&[=?
M&KX:V7C.;P!<>()T\1VWVF*X*^'O$TOAZWU"ST:7Q%<Z!/XSAT9O#T/BJ/P]
M!+JAT!]475/L2&Z%H8/WE<RJ0^JXS&WY<+@*5:O5J-.*='#5%1Q-6BFE+%0P
MU9JCB)895E1JWI5>6:<5K[&I[2A2C'FJ5ZE&DH1<9RISQ'*L-]8C%MX6.(<X
M+#SQ*I0KN<%2E-RC>?2?C!\/M9\!#XFV>L7L'@=X[:6UUK5O#7BG0&U&*^-H
MNFRZ/I>N:+::AK,5_+?V<-D]A:7"WLUPD-J9I3LK;%4JF"G&EB:4X5Y3E3C1
MC"53$.I&K4H^R6'IJ=;VCE3DX4_9\]2ER5Z<94:E.I+FPE6EC8U)X6:G1I0=
M255OV=!4HT(XB=7V]3DHNE2I2O6JJ;IT9PJTJLH5:-6$.?T_]H;X7:G:Z+<6
M-YXRFGU[6M2T&QT0_"CXL0^*[>\T6\@T[6+K6_!L_@E-=\-:#87MS;0W6M:O
MIUCIEN\\8FNTWC*C'F=/EG3<)T?;NK[6G]7HTO:XBBI8G$<WL,*Y5<+B:<(8
MFI2G.5"JH1ER2M3G&*Q'->$\,U%TY1E&M4?L,/B;8:@TJV,:H8O#57]4A6Y8
M5Z;E;F0V7]HGX40Z1/KBZKXGNM+75(='TN?3OAI\3M4?Q=>36MS?*_PZM--\
M'3W'Q-TZ.PL[N[FU#PG%K5G!;VTL\T\<4;.(?NQIRG&5'G563A4C*E4HTJ'L
M?:XC$TJBC5PF$C[>BOK>)A1PS=2,8U6W8U=.4<17PLN6-7#.,)MRBJ?MI2JP
M6%A6;5&KC%*A5A+!4ISQ<94Y1E14M#I--^+_ ,.-8MK:\TKQ-!J%I>:EX2TB
MTN+.PU:XBN=1\<Z;9:QX8MH'BL")?M>E:A:7;NN4M89?,NV@5'*ZSI5*5?ZK
M4C[.LJ^,PZC)I)U<OPD\=BU&3?+*-+#4YS512=.I*+I4ISK+V9C.HJ-)U:D9
MTX1I4*TE*G44X0Q.83RJCSTW%5(3>80GAITI156C.+E6A3I^^>?:M^U1\'].
MT?7-8L+SQCXHCT(:67LO"?PU^(.M7NL'5_$J^#[9/# B\-I;^)VC\2,MA<_V
M9<7(LYY(H[HPO<0K-E1?UB&!J48RE3Q]7!4Z<N62<*>/P\L7AL55IM*M#"3P
MM.O7C7=-QJ_5\10H*KBZ4L.:5%[*>*I.TJV$I9E4E3C.#DY9345''48RYE35
M:C5G2C.,YPC3IU:>*JRIX)RQ,=#4_P!HSX;>&XKR[\3ZM-IUFU[XBCT.'2_#
M/Q$\0:]?Z;X-@T!/&%]JOAJQ\"+?:++HNJ:VT-[&D=]!;6UH]W/=Q>3?0:9<
M%&;H4H3C*K4YN=J4/J].']H8C+Z55XGG]E&A4JT+?6*WL:'-).G4JX>=#$U[
MC2J5(.I2I5'"'U6FXSIRIUWB<9@99E0PU+#27MJU6I@N2I2I4XRKSJREA94(
M8F*I3Z63XV_#:+QQI'P[CUG4[OQ-K=VNG60TOPCXRU;P]%JC:%=>)TT;5/&N
ME^'[CPYH6N-X=LKC4ETW4M5M+MK4),(2DT9>Z-&K7GBJ=.#3P<*TZCG^[BXX
M>M'#XCV4ZG)#$.AB)QH5HX>525*J_9S49II9.48X:EBDU*A55&2</?E&&)E3
MAAZE6G#FJ4:=>56"HU*T(4ZEVX2:C)JSJ'QA^'^E:[XF\/7VJZG!>>#-.BU+
MQ-?CPGXOE\,:/Y\6G3VNDW/C.#07T ^*+BWU;2YH/#T>IOJTT6H6\D5DZ2JQ
MQ3OAYXE)^RC6AAX+EE[2O7G4=&-/"4;>VQLO;1=&7U2G64*W[J;C4:B]I4:E
M.5"$TH/$4IXB+<HJ,,/359SQ%>5^7#4(K#UVZV(=*E:E-\UD<<?VGO@PME9W
MS:]XE7[78^*]2?3G^&/Q237]*L/ UW;V/BR[\2>&F\%C5O"D.FW5U;+,VLV5
MAQ<1NF]'5CI&FY2C&G*$XRAAI^TC4IRH1CBYXNEA^?$1DZ%-SK8'%T'&I4C*
MGB*,L/54*SC"6--^TKT<+",OK.(KK#4J+C*-6I6<<%-*%.24Y1]EF&#K^U2=
M)8>LL0Y^PA4J0Z75OC+X)TS4Q8KKVC+#IL^K-XJO=1FUO3[?0],T3PQ:^)-0
MN[2[B\.W5AJ5W;1ZSX96>UGO]/6)-;_U[7D4=C=PFHNHJBFE&%;D4*<JDZM:
MCC\/EOLJ4%9U>?&5IX6'L'6JU<51GAZ%"LZ>*GA5"=*=&-6%1-2^K<K;2IPC
MB<-B<=%XFHW_ +);+\)B,;^_C!1H*C5K.C1Q6'JU,@_M%_">)O#T=YJOBG29
MO$U[I]C86NN_#'XH>'[VP?6-8?P_H=YXIL=;\&VMQX(T?5M;CDLM-U3Q%'I=
MEJ,R,EE<3D&K5.7M51T4_9U*C?-%0C[*A4Q-2C.I?V=/%QP]*=;ZE.4<8Z:4
ME0:E&]S4J=*I7<92HTIS@Y4XRJ*:I*E*K6H^S4G7PM!5Z3KXRBJF%H*:=6M#
M6W=^!?B#X8^(^E3ZYX2EUJZT>&\>S@U'5?"?BSPM::J%AAGCU'P]+XJT33AX
MF\/SPSQ/;ZSI/VW3KD$_9[J78VVIT:M*G1G4A[+V\7)4YVA6@E)QM6H2:KX>
M=U=4\13IU'&TU%QE%LJ)T<17PL]*V%DZ=1+WH1G"<Z<X*I&].4Z<X2A4C"<G
M3DK346U?D-4^+]MI_P 6_#?PPM]#FO+35TOK+5O%PU"&WT_0?%8T"]\5:'X1
M%DUN[ZEJU]X9T?6=3F"30_8K>/3WD60:I#LC"1EB7F+M[*C@<-.O"H[-5Y4,
M3@L/BZ<(IJ48X99AAI.LTZ=2<JM&G>IAL1[)8J^%HX*?).I/%5H1G&,)<N'P
MU6&+C0Q=6I\*A7QF$E@J4$M:K]^5-RH1KZW@GXQ?#OXAZM?Z+X/UN[U2]TVR
M.HRO)X<\4:5IMW91ZE<Z/<SZ-K6L:+::=KZVNJVDUI=#3+J[:TE\M+D1--&)
M%13KX6.,I:X>4<+--^Y/V>-H/$X2K[*?+55'$T8SE1JN"ISE2KTHR=6A6A":
MLHT,1]5G)*OSXRGRIJ5JF7UX8;&4W*-XQJ8>M4IQG!R4^6K2JQ3I5(3EC0?'
M3P.FIRZ7?WMR)7U/Q9;V<^A^&_'WB&PM-)\%7]YHNNZUXPU6U\%1:?X'LH=>
MTG7+);G4[L:=<-IH:RU&Z,I2++VM.%#VU27LU2P<<?6E+2C3PU9UZF#E&K+E
M4JF*PE*.(IX=QAB93=6E1HUX4HUZVTJ%>%=T'34I3Q%##4(4YJI7K5:N'P52
M:]A3YI)4*N-ITJ\Z;JTL/&=&6,J86M4GAJ-JT^.?PUN]%NM?;5->TO3;+PMK
M?C6X_P"$B\!^/_"]^GA7P]<V]IJ&M#1O$GABQU"6T::Y@^R;+5GU!',E@MS&
MK,O2J%5U/8J-JRJY?0=)M*K"OFE?$8; T*E)M5*5:M7PE>FZ52,:E%PBZ\:4
M:E)SPC4IRJTZ4:L&JRQ4J=7GBL-.G@J>%K8JO'%MK#2PU&EC,/-XE5GAW&<G
M"K+V5;V=+6_VA_A#X;U37M(UKQ1=6$_AG0]9\0:O>/X4\92Z##9>'([:77[.
MT\36_AZ32-5\0Z;%>6KW>@V-]<ZK;K.AELU!K*DU63=)J?+6HT(Q37/5G7QD
M,NIRH0?OXBC]?J0P<\30C4P]+$25*K5A/0<YQI0A.;Y83INK=IVIP6"JYBE7
MT_V>I+ 4*N+IT:_LZM7#P=6G"47%OH-5^*'A[3]$\*:\)FL[#Q9JK6=A_P )
M3IGBWPG=K96.EZSK^MWDVF7_ (5DO]/FM/#OA[6+^./5;33+>=;6-3>0BYA>
M0J-8>4O;M4J5#"5<;7DK2G1P].C"49.":7.L17PF'KT9SIUZ#K5%[*IB:/U2
MI5"-3%T9U,'#VTHUJ%"$97IJK.KCJ6#M3;BYU5)3G5P\J-.K3Q$80J*<,'.>
M-HR6_P 5_!$WP_U+XHW%]K.B^"-'L-1U74=5\4^#_&7A"ZMM+TM&ENM2_L#Q
M3H&GZO+IYA4RPW$=B\=U&5DMFF1U8W5ISH2PU.K'DJ8JI0HTZ;M[15L17CAJ
M-&K3^.A6E7E&G*E7C3J4VTZD81=Q4FJ[K*@U65!3DYT_?ISA3H^WE4H58WIX
MBE[+WHU</.I3G9QA*4HN*Y:?]HOX26NARZ\^MZ^]O!KU_P"&VTJU^'GQ'O?%
MKZII=C:ZK?\ V;P+9^$I?$=YID&C7UEJ;:I!I4EA_9]Y!?BY-G,D[1+]U]5]
MHU26*HU<1&4VH0HT*%=X6O5Q<YM1P-/#XF+P^(EC7AU0KN-*KR3E&+(-5/:J
MG[WL9T*:Y=?;3Q--U<-#"V_WQUZ2E4HK">V]K"G5E#F5*HX;G@GXP^$/B!XF
M\5^&/#$/B>Y;PC;:!=7GB&[\(^(M.\&ZK'XBTFTURQ7PWXLOM.BTW7I5TK4-
M-N9([6X=A%J,$D8DC9G31TJE.AB:U:#PRPF+Q&#J4ZW[NK[3#>[5J1I2M.5&
M-6-:C[1+2I1DY*-*KA:F(RC7IRG@XTFZM/'8*ECJ%6"<J,J-6<X07M%I&I[B
MERRLGS3IPE*OAL;2PW*3?M/_  5@TZ'5W\2ZVVESW]S8PW\/P[^)5Q:O#83V
MUIJ.O^=;^$'4>"[&]O+:TN_%)(T2TN91;7.H13@QB<-"6+> CAUS/,HX2=!2
M_=Z8^WU!5?:<GU:6.;M@H8GV4\9*,XX>-1TYJ.V(M@UC?;RC#^SEBG7BIQG)
M?49U(8V-.$'*5>>#=*4\53H*I.A1E2KU8PHUZ-2IHR?M%?"*'7-:\/MXBU5K
MOP_INMZM?W\7@?Q[/X9FM/#.I:;H_B!-&\90^&&T#Q'?Z=J^L:;8W-AI.I7M
MU#<W2P/")595>&ISQ4(5*,?<J5\!AZ?/^Z=2IFE;ZOE[I1J\DJE'%5;QIXFF
MI8?EC*<JL:<922Q#6$I3KUFE1HTZ]2I.'[U4EAL-7QE:-;V7/[&K#"X:M6]A
M4Y:TH17)3DYTU+9U7XN^$M.UFXT>+5-/:30;[7X?&+7B>(;1]"L/#/@^Q\8:
MQ>6)MO#5W:ZS-:V>O>%_.B:\L8536) EU)?6O]GW&$ZU"AAZN,Q$W3P=+!XK
M%^TC%S]W"8^GEU6\59\JQ'MJ7N\]:=2BU1P]:DJU:AO"A.I4HX:DN?%XFO@\
M-2I1<6O;8VG7KT:=:2DWAZD\+A:U>G&K&-X^Q=1TH8G#U*F#:_M(?!^[N?#5
MK'X@UN!_%DMG%I$M_P" /B)IEE"-4N9[/0KC7]1U+PI!:^$[#6KBUN%T>\UR
M;3K?6!$6TN6[3#'IG0J4JM:C52I5,-"O*JIRC",'A</+&8FC*<I*"Q6'PD'B
MJ^#YOK5+#<M>=&-*<)/E]M2]A'$1J1E2D\-R\C4Y2CC*E.CAZL:<.:I+#SKU
M8X9XB,70IXI3PU2I#$4JM.$_@;XY^%/B/XRUSPSX-M=;U'2O#GA?3_$>H^*;
MWPYXMT#3+P:UJ>H6&A+X5.O>&K.#QIH][#HFMW":UHEW>V3?8HXX'G,S&"%3
MJ0P>,QU>E4P]'"U:5&$9PDJ]2I[*K7Q4)85I8JC+#4_J4H*=!O$K&+V7\+]Y
MI5C*GB,#0AR55BXXMNI&I%TJ;PTL#&$57CS8>HYRQ56-5*LI866&<:T4ZBY.
M<TC]JKX0ZGI&FZQ=3>.O#T.J:GJMA;6?B/X6_$?3=2M]/TK5SHQ\7ZS9+X7E
M?PYX!N+DP&+Q-JWV'2T-Q]GN;FWO8+FUMKHTGB)X"E0E"I4Q^'P=>G%5()0>
M/36#P]:;:ITL5B9PG3PE"4U/'.//@/K5&=.K//$5883^T'6;C3RRMBJ-2:3E
M&;P,>?&3H<J<J]+!Q_WNI2C*.$?NXGV4FD_0/B1\8?A_\)K.*\\;:KJEHDME
MJ&J"UT#PEXP\;ZK#H^D)$^K:[=Z+X'T'5]0LO#]B+BW%UJMQ;16=N;F%9IT:
M5 V5).MB:>$I1<JU2=&FO=:A">)J.EAXU:K2I4/;U8RIT?;3IJK.,HP<G&27
M33HU*D5*FE+F?+3BI1YZLM&X4*;?/7G&,E*4*,9RC!\\DH>\<YXD^/G@O1M)
M\97VF#5=4N?!=SHNG:@^H>'O%OAGPJ^KZ]J^GZ)9Z9%X]U;PT-"N[JVOM2MQ
M?PV%U?SZ< _VR"(H5"C*-\-.4HPP];'0P<ZLI1CR0A6J0QN*IQG*+Q%#!4L/
MBZLZM)O#SGAI4%7A.2:Q2G.G5^K0]OB(Y=B,PHT8W;J*G@_KF'P]1QC-X:OC
M(SPZHT:T5B)4\1"M3P]6%KK\3?CCHO@#X7'XEZ9HOB#Q;'?ZAI.A^%M(T_PU
MXW:XU[6]?U6+1=$26#1O!^KZO9:)<WDT;KJ<.B7RS0O$UC#>RW=I!=N<,0L7
ME^ IT+8S,*D80A5YZ4:,?92Q%:6*E[.<L*\-AZ=6K6I5X0J4G2G"K&DX5'#7
M"^PKT\7B)5U'"8"E5JU*M-TZG.J;4(+#<U2E3Q/MZLJ=.C4IU?82515G6CAX
MSJQH67[2OPK2TU3^WO$*Z3J7AK2#J'B3[+H'CV^\,BXL=1TW0O$%IX-\67_@
MK3;?XA+I'B75++2KS^QH);JTN;F&&_L[*XD,":58TTO:X:52OA:F)PN'P\G3
MY:U?Z_4E2R^I##TYUIRHXUQ?U?$495L)52<J6)J07.\*2K>RC*O3C2J1HUZM
M90FZE.@\)0J8G$T:U64*7L<31H4JM6>$Q$*&,4:<_P#9_<E;N->^*_@KPQX7
MT;Q=K=QXAL].\0F!-#TI? WCF[\:ZI<7%M+>K86?PYL?#DWBN;4X[*WN+B:R
M&C?:+>&VFEGBCCA=EQQ,EA)RI5/>J0IRJR5+]\H4H*'/5G.ESPIT:;J4XU:U
M24:5&4XQJSA)V-J4'54Y0<8PIS=-SE.%.$IJ4H1C3G.48U957"7U=4G-XE6E
MA_:QE%OSKP]^T]\-M4TCP=?:K+K>CZCXVT@:]I.DV?A+QUXC6UT^^T^_U[PY
M::YJFC^$GM/#_B?6/#%DNH6>@:D]IJ%RTCVUC#>.BM+>*7U)8J%?W<1EN&57
M&4HRA/V6(I8.EB\?@Z%2,G3QM7 1J2==8:4YQP\%C*E.C0E>,PC4E5=)P]GS
M8VKA*7->#E!9G4RK"XFM"I&$\)1Q>(A&G">)C3I0Q$I8;VTZE*;%T;]J;X2:
MMI'@O5))/'NCR>.1H!TS1]4^%/Q+&L:/_P )5K*^'_#$GC"VT[PK=Q>#;#5]
M786^G:EK$]G8:A@RV-U<0@R#I^I8CZZL HIXFSYES1C3IU88;ZW5PM6M-QHT
ML90H)U*V$G..(IQ7,Z?*XRE'/#V&(Q,)>TP^']M)3@G)UL/0YG+&8>DE[>M@
MW"//]8A2<(75*M[*NIT8W+C]H'PYIMV)=3M6/AM;+Q%=OK?A^U\7^)=1>>Q\
M=6W@/PMH^G>$-/\ !0UK7=;U[5(M>$=KIEK>!7T/%G)J4-W'<KR491J4E)\W
MMJE'+*U"G2A.O[>GF>&S''TYTW3CSQA0R[ PQF)E4IP>'A7?MXTH4)5).K*%
M.32E:$:^-H3J5'"C3I3RV6"PN,A4G4FH^V69XZE@L)2I.JL79U(U*=9PPLO0
M/$WQ-\(>#O#VE>)=?N-<M;/7?LRZ-I=IX.\8ZOXPU.XN;*34EL;'P#HV@77B
M:XU.'3X;BXN;%-(-S:16EP]U%"MO*8S$..$K5*%5J4Z"J2FZ3]O"%.C*,*M>
M56A[2DL-3E."EB>?ZNN>%ZEIQN\-_M5&->DG"E)1:=9/#2O--PIN&(]E-5YV
M:IX=Q5><DX0IN2L>7>'OVHOAGXC\:6WABSN=2BTG6/#_ ((UGPWXKN/#WB^W
MTK4;SQKI.O>([31M;DN?#$5MX%O%\-Z7I]];Q^([W3;B].K&&"V\RV/G;2I*
MBLPAB*D,/B,LQ.-P]6$YTU!PP&!P..Q-2GB.?V-:=*GBY^TP]&=2M2IX3$5Y
MQ5*G-P55NE.A3]E5<JD:;FG2DI4YU\RQ&4X>G[+6NW/'82M0J5)484*52>$I
MJK4J8J$8]=X=^/OPI\5&4:)XCO9C'JWAS1[<7OA/QEHW]J2^+[RYL/"^J: -
M9\/VO_"1^%M4N;*^6U\1:5]LTB9;&YD2^,=O(Z..'K/ZO%TI4YXBIB:4:=1>
MRJPJX3!SS#$4J]&IRU<-4A@Z<JZIXB%*<X<JIJ<IPC*:U6GAX2J3FI48QI25
M6F_;49JMBJ&"A[&M1YZ5=QQ6)P]&K&C.<J$JL/;JG%W#2OCGX&UWQ_IOP[T.
M#QEJVIZEIWBG4!KUEX#\7MX)L&\(^(KSPKJEAJ?C"31TTRRO7UG2]8AMRTY@
MF_LMMLP:]T]=0C#TWB*>)J0<8QPV'P&+_>-4_:X?,J<JN%G1YK>T<J48U.32
MI*$I2I0J+#8SZM6):PCP\*DHSGB,1B,,HTI1K2IU<+"C.NJRI.?LXT77I4JL
MI:4:\E0K>SJ6B]CQ_P#%WX?_  O;3X_&>M75A+J45W=PV^F^'O$WB>YM=*TX
MP+JGB'6+;PMH^HRZ!X4L&N;87FO:FEIIEF;F(7-W%YB[IH1>(Q,<)17-6DZ,
M7?W:<)8B<J6&C5K2Y:-&6)J0G3PT:M2$L1.$X45.4)):>SG[/VBCS?%R0C[U
M:LZ:C*I'#4(WK8F=.,HRJ0P].K.$91E.*C)-Z'AKXD^#_%^J^*-'\.ZA?:A<
M^#;Q].\0W?\ PCWB2TT*TU&%I$N-.M?$U]I$.D:OJ%OY>Z>VT^^NI8$EADF1
M$N(FDSYX1P+S&3Y,'%UX\\O<D_JU2M1KRC2E:K.G3JX>M3=6,'3<X.,9MM7B
MW[VGAXM3JU(4IQC!J?NUJ&&Q-%R<')0]M0Q="I24W%U%*?(I.C65/SJU_:@^
M"M[IVA:O:^)-=FTOQ)=:?;Z1J"_#GXEK:36NJRV%MIOB"ZG;P>%TOP;<7VI6
MEDGB:^-MHQO#+9_;_M5M-#%TK#U?K%'"-*&(K*#C"<X4W&56=6&'I57.450Q
M&*E0J/!8:LZ>(QL(JIA:5:G*$I&)_P!B^N^W]W^SIXJG6Y5[1*6!3>.=-T^=
M5X8%+_;*M#VM/"WC]8G3YX7O6O[2'P9NSK?E>+YDBT"UO;N[NKKPOXQL;&_3
M3O$W_"&7MOX:O[WP_%;>,-1A\5M;Z2UAH,NI77VN_L81"7U"U%QA"]3"T\72
MA.I2JK!2IQA3G.M4CF.'GB\#.GAHQ>(J0Q-"G6G3G"E*-Z&(IMJIAZT("<?K
M,L)S1C6IO'J?-*,:=)Y7-4\P]K6DU1H_5'*,ZOM*D+491KJ]"4:C2;]H[X2P
M6>@70U7Q3<3^)D\1MI.@V'PP^*.H^+Q_PB%]INF^*$U7P38>#9=?\/2Z7>:Q
MIRW4>K:;9-"MR)7 B1W159*C2JU=*E&AA5C)U*<HU*4<._;*,Y5XR=&#=3#U
MZ#C.I&4<13EAYJ-9>S+ITYU*<JJA*,88NE@G&<94ZCQ->C+$4:<*,U&K4]IA
MH/$PG3A*G+#N%=3=*I"<K^C_ !T\!ZG\+]#^+5TGB[P]X:\0QVO]E:7XA\"^
M+K'QM?7=](T=AIFF^!8='GUS7=2NRA>T@TFROS>Q%9[(W$#K(V^,HSP.(HX2
MNO\ ::Z7+2IWJU5)4I5JM.I3IJ4Z<\-3A4EBHSC'ZM&E5G5Y:<',RI3A6CBJ
ME*I&6'PDI<U=OV="5-5(TZ=:G4J\D94L1*I26'VG4G5IT'".);HQJ7?[1GP?
MLK;P]=3>)[XIXFL(=4TV*W\'^-[R]MM-EUL>&IK_ ,0:?9^');KPE:66O'[!
M?RZY#IRZ;,KI?FV*-M4*4IXQ8&FX3KOZCRN-2G*A+^TX59Y<X8I2>&FL=&C-
M81QK-8B;I4Z3G4KT(U,Y5Z4,-4Q4Y>SHT5F#FI*4*D?[*=..8IT))5N;!^UA
M*O#V?/""J5.5TZ564/2/&/B2+PEX:U37I/L3/9Q0Q64.HSZC:V-UJM_=0:=H
M]A<W6D:-J][:Q76JW=G;&:VTN_DC\_<MO+MVG.+7ML)1=T\5B</AU97E>O6A
M2O%:1<HJ3DO:3I4O=_?5Z%+GK0Z8*'+6J5'*-'#4:^(JRA'GE"CAJ-2O6FH<
MT7/DI4Y2Y8OGE:T(RFXQ?DFN?M._"/0H/&#'4_$>LWG@?2O%FIZQI_AOP'XY
MUAKF7P/JL>A^*-'T/48O#J:;K>N:?JT]K%/8VUZTL$-Y!>W"PV$@NJB,_:4:
M>(H0J5Z=:>$A24(/VE7Z[7>&PTZ5)^_4I2KKV,JM-3ITJSC1J3C5G3A+3ZM5
MI5J>&Q<J6#FX\U6<YWH8?_85F3]M5A%^S<L%S8BC3G&-?$TZ598>C4J4:U.&
ME:_M%?">XU"WTJ?6==TG49M!N_$$UOKO@3Q[HD.F1:;H'_"4ZIH>L:EJ7AJ&
MPTGQI8^'LZA<^%[JZBUF&V'G/8B,ACIB5#"4\QK5*L)8?*Z=6M6K4Y*I3G0H
M8B&$K5\,XW>+I4<54AAJT\*JRHXB2P]7DK)P7/0<J\L!2C!PKYCB*6$I49.*
MJQQ-:E*M1HUXJ3^KNM2A.KAYUG"EB:2]KAJE6E*,Y5X?VEO@Y//HEJOB#7H[
MCQ"FA3Z9#<_#OXDV<@T[Q-K=[X;\/:[J*W?A&,Z)X9U'6["6UMM;U+[)ITIF
MM'2Z,=_:O<;?5JRQ,L&XJ.(IR]G.,I0BJ57V4ZRH59RDH4L3.G3FZ>&J2C7J
MN/)3IRG:(G*,<'''I\V$E"K4A.'[SVE.A3PM;$5*4(<TZM/#4L71J8F=.,HX
M>/MG6<%A<3[&OJO[1W@"./Q=8^%FUGQ1XD\,Z'?:O8:<?"_C70O#7BB>UU6Q
M\.0V7AWXAZEX5_X1S75;Q/JFG:7--H]]JIMIKAP\1:"1%RPL?K2PE2G[N'Q&
M,RG"RG+W)4X9Q7E3PN*]C/EJU,-.C2Q&*IUH0]C5HT)2C5491DW6J4<)6J4<
M3*49T,/F6)G"C%5Y\F4T56Q])*,XTHXF@I4Z<L/6JT9QK5:=.IR-NWOR[MJ[
M@%; W*#N"MCD!L#(!XS@?2D[)NSNEL[6TZ::V]+L4')PBYQ49M+FBGS).VJ4
MK+F2>B=E?>RV/ /C)_R47]D[_LX#Q'_ZRQ^TM2*/H"@ H * "@#Y_P#@W_R4
M7]K'_LX#PY_ZRQ^S30!WOC_X<V'Q _X1EKS7?$.@3>%=9O\ 6M/N/#SZ(DTT
M^H^%_$'A*Y@NO[;T/4T2(:9XDOW26U2VN8YDA=)U4.DN-6A&K'%TY2DJ>,P.
M+R^K%-*]#%NA*<DTN:-6G/#TY4Y1DEI*%2-2E.=.711Q$\.HJ"7NXC!XE-\V
MLL'B(8F%.<5)0J4JDH*-6%2,M+5*3I8BG1KT^(U#]GKPG/:6L>BZ]XK\(ZII
M.E?#O2/#7B#PZ_A=M3\+6GPRCUN'PX-(M/$'A;5-)F#1>(]:6YBU+3-0@D^V
MDQQ1-'&8^W$8FOB<9/'3J.->IF.,S*=DN653'8&GE^(P[4E+_9I8:G)02:KT
MIUJLZ=>,G#DXL-0IX;!T<![U?"8?!TL)"G5G.R=+%T\<L7>G*G)XN>)H82=:
M?-[*LL'AX5:,H>UC5AU_]GW3=>UR]\2?\+&^).CZ[>:MHVL?VIHL_@6WN[2Z
MT[P;<^ ]42QDNO ES]EAUOP_=2+>!1OMIQ]IT9]*F>1Y.65*FZ6+H1A[.CC5
MF,*T(.4>:AF/U"53#\]_:<E"MEN#KX>KS_6N:DJ%?$5\'_LRVO>>!J55&O5R
MZGA8T)3C'2M@ZV8U:6*G",8TZE9QS7&X>=.<)825&JFL-&O"%9<YX6_9(^&?
M@KQ/)XK\-W>LZ?J<WP_T_P"'EQ</H_PXOM6DL=*\,:;X1L=8B\9:CX G\6:;
MJD>DZ1I[&SL-?M-&DN8#<R:4\TTKR[XVH\=1S[#U$J%'B"I7JUX4%[!4I8B4
MI5%2]GR^TC:<X4UC/K3H4I>SHNG&,%&J-2I2>23J5)XNOD;C*%;$RE7J8EQK
MUL3?%.;<74GB,16K5:V'CAZ]6<_WE6<5&*ZZX_9_\);]$ETG6?$WAVX\/1?#
M&STF?2/^$7D^RZ3\*/[:_P"$>T86NL^%[^U.GW \0:J;O-OYP>9);*:RF@BD
MCTJXJK7QT\=6M4G5S#'YA4INZIU*F8Y='*\11DXN-6-".&4G24*D*T*E6JW6
ME3G[-<=/"PI9?#+%.<L/1P=#"4G)J4J4J&.HY@L;'F3@\;5Q&&POMZE2$Z56
M&%HQE1NI2GSD/[+WAF&VU6V;Q[\2IUN].MM&T W%[X,E3P/H=IXUL?'EOI'A
MBS/@<6DUM_;.G644TVN6^M75Y:VT4-[<7/E1NG/A/]CC@XP_>/"5,GJ.535U
MUD<,12P-.JERQC"-'$SIS>'C0J)QAB*4Z6+]IB)].(4<37Q5>48Q^M4L[I.$
M4N2F^(*=*&8U8<W--U)5*3Q%+VLZE.E4J3IJF\*J6'I^@?$+X0:%\2=0TR]U
MS6_$EG:V?A3QWX*U'1])ET2+3?$/A_X@Z?IUAK5MJKW^A7=]9W$+:387%K=:
M/>:5/')$R2R36TTMO(H)TYXJI3DX3Q%/#QC)*-\/5PF*6+PV(HMQ;]K2JK6G
M6=7"U5RNOAJLZ5&=/JP^+K82&$5)KGP>-P^.A4DDY2JX>EB*"A-:4W2J4\35
MC4Y81J*]Z-2EK>?P3\++/P=IVOPW7BOQ=XSU[Q/;V]EK?C/Q9+X<3Q)=6&GV
MEQ8Z/811^%/#>B:/I]GIUM=W(MX[/2+<&2XFGG\ZXGEEE,=&&-P6*P$H_5Z.
M,>(G6=*4N>>(Q5"CAZ^)O5E44:LZ6'H1481C0IJE"-*C""Y7R82,<%B\/BZ4
M5*>$IX:A1A))PIX?"5:M:C05N6<H*I7K3E*I.=:;J/FJNT>7C]#_ &<_">C:
M-!H]QXB\7ZZ8=!^&'A9]3U9O"4&H7/AOX3>(;OQ'X;T2:/0/".FV*6-S<WDM
MO?B"RA>X@ "O#+NF;KK8N>(KRQ%:G"=2ICY9G4T:53&/!4,'"I)*2Y51J8=8
M^A"GR0HXVI4<$L*XX6&-*@Z&'>%5>K/#QP>+P-.%1QJ>QHX^I5>+E&4HN<Z]
M>A.GA*M>O*M5G0PN'G*3Q<:F)JZWPB^ W@KX*3^+I/!ID2V\7:O+K-S9S>'O
MA_ICV-Q/+//<1C6_"O@O2-;\2&2:<LUUXIU37[T>6BK=*J[3RT5['+,+E2][
M#8.*ITV_<?LX4H4:<'3I>SPZY*=-+VL:,:]64I3KU:LWS+:LO;9AB<RE[M?%
MN4JB^)<\ZM2M4FIU.>NE.I4DU1]M]7I*T,/1HP2B<E#^R]X9AMM6MCX]^)4Z
MW>G6^C: UQ>^"Y4\#Z':>-;+QY;Z1X8LSX'%G-;?VSIUE%--KEMK5S>6MM%#
M>W%SY2.AA?\ 8X82$'SO"5,GFY5/>E6_L.&(I8&%5*T(QC2Q,J<GAXT)\T(8
MBE.EB_:8B;Q"CB:^*KSC&/UJEG=)TXI<E-\04Z4,QJPYN:;J2J4GB*7M9U*=
M*I4J4U3>%5+#T]&V_9VTRWUEO$;_ !'^(MQX@?XC:=\2)=3,'PRLDFO=,T76
M_#D6AW&C:3\-K31[C3)=$U^]M)]2DTYO$$R06+/K1DTZT>W=)^QPV'PL/@H4
M<?1DVO>JO,:=*%>K=66'J1G1A7IPP2PN']NZ\ZM"JL9C8XAR;G+'RDW+Z]1P
M=!I[4:>!QD<;0]FOMR56$8.6)^L2]C&%*#BJ5+D-5_9M\)ZEH'ACP[%XH\::
M79^%OA]XA^'=O/92>#[B[U/3O$MWX=U'4=9U?^V?!U]!/KIU3PQ879\B"WL;
MAYKF*]L;JUF\A*E4DJM2K0?U1<V4RHPHZ0PDLDKNOESPZJ>TE:C?V3A6E6IS
MI*#E%U:=.K&ZDXUHUZ=>C"M1Q>*S+%8BG)SC3KO-:.,HXNE4C3G"U-QQM9TI
MT_9XF@W:EB(TZE>%;/U;]F'P[K-CY=S\1?BK;Z[?Q>+X/%OC'3M8\*Z=XG\;
MQ^-=!T7PYJ_]N2VG@U-/TEXM-\->'4LW\,Z?H#68T>.. I!<74-W,U2G%494
M(/!K#O#O#/GG2G%XW^T)SJ2J3E7J2JXJ525:$ZTJ%6E4>'J4I4*="G2O#XFO
MAI4ZBJ>UJT<7A<72G446Z+P5#$X>A0HP48TJ6'5+%XCFA"FINM5GB_:+&3GB
M);]Y\ /#]QJ,U[:^+/&6E6;WWPRU"#0[%?!<NE64_P *S&FB+;-JG@R\OFM[
MVTB2WO(9[V:- #<::NG7K&Z-2G[2OB*]=>WGB<=F..J*4IQ3J9IE4\HQE+]U
M*G+V4\--2B^;V\*L(6K>Q3HR\^.%HT\)A\'3C[.GA<OPF70DE%S]GE^8K-,%
M6ES*477P^*YN7W50G3J3A6H5/=<<KPW^S-X/\/G01=^*/'/BF#PC>>'O^$/M
M/$MWX7DM?"WAWPKJ,&L:#X,TR+1O">G?:- MM6LM*O&NM1-]K%Q+HFGFZU68
M6J*-(XFM"O3Q;FY8WWG7KMM3Q<_J&89=3G7A'EHQ='#YIC?91PU+#T_:U75J
M0J2O??'0ACIXF5:"C'$3JU.2"M&E/$9C@LTQ3IM\TVL5B,!AX5HU9U8K#J=&
ME&E&5UZ=X+\"MX(?4+2PUZ]NO#]W-J>I0:1=6.F+/%XA\0^)=?\ %/B77KS5
M8+9)KZYO;[6UBC@5+>"WAL5'ERRRM*,$Y?5:6&E-N6&H87"T:BY4Z6'P>#HX
M6G[O*XRKU9TYXC$59IPG4E"-*A1C"I[>IN4\14KN3;K5*U6IS-MSG5G'V5/F
M;]W#X/#TZ6$P=**4X4HR]O6Q#]C[#RY/V;-)6'S7^)GQ/_MUO'5UX^F\46<O
MP\T35)M1OO#NI>$]0L/[.\._#O3]"M;6Z\/ZM?6TU]:Z/!K#O(EW_:8O88KB
M/.-*,,)#!1<HT%A,;@ZJ4FG6I8^>'K5FVFOJ[CB,+0Q-.&"6%H*O&K*5&:Q>
M-CB=)U'/%8K%<L8SQ%7"5812O"@\#.<L/"*GS/$PC&I*E)YA+&U)T8T:4IN.
M$PBH3Z3^S?X>\.Z3J'AWP]XY^(FC>&M8^&]E\-]9T&WN_!]W!JD6G>'3X6L/
M%UQJFK^#+S6(/&$.DD RVNI6^GS2J)KC3II"6/1B)4\9/,5BL-1K8;,<7'%R
MPO*X8>C*V%IU:%&%)PDL-B,/@Z.%J4:DZBA04EAW0J2=0,+4G@\1E^+I2<L9
ME\F_;U92JU,0OK.*QL5B>=N,G#&8W$XCVE.-*M.=3EK5*M*,::]$L_A?X7LH
M_&$")>-:^--"TGPOJ%J9+:&'3_#FB:%-H&GZ+I#6EI#+;6<=O=ZA<#S9+B19
M]2N&1UC\N*+#&Q>/PN883$3G*.9XG%XRO-/]X\1C*.&H5)IN\5RTL)0C!<C7
MN7GSN4F\L!&&6U\LQ&$IQIU,IPN$P=&ZNO98+$8K$T7-=9>TQ=2,^7EBX1II
M1BXN4O)9?V7-'N?#VJ^'[[XI?%34#XAN/"H\0ZU?_P#"K[G6=5T?P98W%CH'
MAV!I/AA]C\+Z?:FX^UQ7GANRT75;>]C%[:ZC;W3RRR]2Q$UB*.)E%3E1Q];,
MY1DY)5<?7I8*E/$3G"4:L7; TVJ=&I1HJ-6M1]F\,Z5"E-"E#"N?U>$:?^Q4
MLNI)QC4A1P5&MC:U/#*E6C4I8BG_ +;4I5/KL,4ZU*G2]NZE3VM2KZOXH^&\
M'B+Q%X+\5V7BKQ5X3UWP2FHV-O>>'V\-W7]M^']9FT:XUKPSKT/BWPWK<<NF
M7T_A_1Y)+JQ6PU*,V?\ HU_ )91)%&K*CB:]>RG3Q<(PK8>2M1J>SE4G0F_9
M\E6G+#RK594U1JTX/G<:L*L%&,::?]GK+E*484ZM*M3JWYJU.K2HUL.IJ4^:
M$W*E7J1FJU.HFVI)*:4CRD_LH_#Y_%WA?QM-JNM7VO\ A+Q+XN\1:9<ZQX>^
M%'B%EB\9>*=0\8ZIH4-QX@^&E]=:)81ZSJE\8M1T2XTO6VAF$-SJURD:;(PK
ME@YTJE*34Z>7X;+I2^"=2E@Z5>CA:LZE/DJ1JT:=>2<:,Z6&Q$H0J8K#UZBE
M.3QS>/C6A6;4:F)^LQ5W.-*3I8*E4IPA6=6G.G-8"@X^WA6JX5<U/ U,+0<:
M4=_5_P!G/P=J^@Z!X;FUOQ;;:9H>C_$#1IEM+K0%GUY?B0XNO$&HZQ-/X<E,
M>K+JJKJ%O<Z;_9Q6;?'*LUI/-;3334J,\-4HU)4JN!P668/"S2@Y8=916P%?
M UZ?/&2E6IU,NP_M(5E5PM?WG6PTY1HRI$U3J4\90J482H8_,,7F&(IOFM4E
MC:69T,5A7+FYXX:I1S;$TE[.<<33A&C[/$P<).</B/\ 9YLO%L6E)XD^*'Q0
MU*>#0$\,^)[U9?AYI=S\0=$M]<CU^RL?%JZ+\/+."W@M[Q98RGAZ#04NK>[G
M@OUNXV 72E*-#'1QU*E&,XULKQ*IWJ>R^M936G6PN):<^=S<ZM7VM-S^K_O.
M:E1I5*=&=+&I1]K@)9?4J2E"5/,J"JVA[6&&S7#PPV*PT7R<G)R4</*G4=.6
M)A/#PO7E"IB(5NY\ ?#RY^'\VOV]IXNUC6?#VJZMKNOZ=H.K:?X=A;1M8\4>
M)M<\4Z_*NKZ1I%G<ZC;27VLB&VCNQ))!!:XFFNY9#*D<]2."HX;2K6P="CAJ
M%2;Y/W&%P\:-"-103BZLFFZ]:,$IQC1Y:,*L<16Q>]5^UQ=7$_PXUWSU(+FF
MN?V="C%0E4E*4:-*EAXJA1YOW<JM>/M'AE@\-@O&_"'[,$*^'+JU^)/C;Q3X
MJU?61XEN+S38+GPQ%X6\+3>.O%2>,/'.E>$ET[P-I%UJEAJM^@LI=1\2+JFI
M_8FFBMKBR%S*IUHRCA895&E)UJ^50R>,<55BH5ZJR=X6M0I2C"3I4L/+&82G
MB:M.BHU<1*%)XJOB)4J<HK%KZU6SB,JDY8+,:N9<E)[TZ>+H8[+\/6]I)SKQ
MQ.'RO&/#4J?UBI@\-RJ&'H*E",3U*;X,Z!<>/9/']QK?B6:\_P"$CTWQ9:Z%
M))H!\/Z?KNE^!=5^'UO=VBCP\-2*?V)JTTWD7&I3Q1W<23P)");A+G&E'V%#
M%T(-IXN&/@ZNGM:7]H/+_;2IM)0]I".70I4JE2%2HJ.(Q%&I*I2^KPP[K.55
MX=<WLJ5"CA*$Z5-*,,11P6+QN.H4Z^CG*"Q6,]M*-.=-<^%PDHJ,J=1U>/7]
MFCPQ;Q1VUCXT\>Z?:1:/\+=+^RPGP+<H]U\)/%;^,/#NNS3:IX%NIYM5N]5F
MO!?QO,;&5;Z:2"RMKHI<Q]%+$2H5(SI0C3ITL8\71HQ35*@I95#)IX6DE+G6
M&E@:5"*4YSKT:E"G4PU>C)U?:373KU,55<Y0J8W#8_#5I0?+S?VAC*^.JUE'
M6$*T*^)KI*$8T,11FL/CJ.+HTZ4(4_&G[/\ 9'P3-IO@R*?5/$UAX>\2:)X>
M;7_%EGX2ABOO&/C?1_'6O^)Y_$-G\-?%*V_B'^W]&LKY'E\-ZI9SO:+!<V3Q
M7$KUQR>)ITL-2PT^5X99!3A4E)*=&GP["I#!3@I4JL*DI\\7B:=2*IUG"#A*
MARM2VI^Q=3%?6>:6'Q=3.,16PZ4G2Q%7-X5*=6%7EK4:L(4:-;$87"5*=55<
M+A\362]M+D<.A^"7PO\ &GP\TA#XO\=S>)M;UBZ\1^(O&:BVL;I-8\7>(]4M
MKB*_GUXZ3ITMS;Z-H%AI^BV<=AI6@6TD4,L[V$8:VM=.[JD\/3I4L)AH-X7"
M4:-+#N2G"4)NMB\7CJW+*OB)-X[%XN5;DJUZ[H1@H1J5)2G4?%3A4=2KB:JC
M#$XJK&I7Y9*IS1HX+!X#"TU.-'#4TJ=+".=65/#455JU(\D*%.G*%;F=:_91
M^'^O>*M#\9ZCJVN7FN>&_&_B?QKI$NK:!\*?$T5D?%VJZ;K>L^';-?%OPUU5
M]-TIM3TN"2'4K%[;Q!;1N]M!K26HCACY\#)Y<Z$\-",IT,++"MRO3E6C[?'X
MBG*=:A[.M2E"68XF,OJTZ-/$Q<)XZEBZT?:/;'16/5>-=N,:T\/448V=.E/#
MX+!8%3C1FIT:LITLOPU1RQ-.O*E6A*6%>'A4G"7#>$/V9/$]]K/CV^^(VOSZ
M/HFH6/B+1/AMX>\*^,K7Q@W@&U\4>-+7Q]K6OZ3JFK?"7PM!#J,_B73-'N8M
M/UO2?%AA^P&&?5;ZR=+. P]Z&686A[::Q]&62M55&#>'AD"JK+Z$*DTZ>(A"
M-2,*E1X/"NK3H477IUL1SXF5UE3>,J>QI)994_M65?#2G5A2QE?-X.CBL16I
M4Y^TH5'1GB^10QM:%"688F.#6$II1G[5X5^!FC^$]<T/Q'#XQ\<ZSK6E:QXT
MUW4K_7[KPQ>R^+-0\<V.CV&J/KZV_A6W2W2UBT#2OL*Z(NC_ &5+;[*NZR=K
M5JI3C02A2I1C1AA*^#ITVYR5*G7S2>;3G&I*<JTJGUFI.+=6K4A4IM2K0JXB
MG2KPQE2<XU>>I*56OC,%CJE7EI*<JN!RN>44X6A3C2A2GA9N52-.G"7MO>I3
MI0<J;RM7_9S\-:WJ7B>[OO&'CXZ9XAG\5:GIWAF*]\,1:'X-\2>-/#VH>&?$
M?BOPRZ^$_P"TY=<N-,U;4Q&-;U'6K.T>^F:SM+<.5K'#TJ>'PSPDH+$47&I1
MM5N_]CK9A',\1@;0=-.AB<3&U6HT\7["4Z%/%4Z4N4[8XFI3QM#'4OW52E4P
MM>I"+DJ>)KX&A2P^#JXF+DW)8>G0H.-"$J>%E6H4<35H5,32A67H7C'X<Z7X
MN\(67@^+5=:\*Q:/=^'-1\/ZUX9_L8:QX?U'PG?66H:'>:?%XAT;5M*G:">P
M@!AO],O;=TW*\)R"N]2K5JXZEF$JDEB:5:O5;5K5/K-#$87%4YZ-J%?#8K$4
M92IRA6@JGM*%6E6A"I'AH8;#T,"LN]BJV$C2H45";DK?5JE&OAIWIRIOGHU\
M/0K15_9SE34*M.I1E.E+@?#_ .SUH/A>ZT6ZT/QO\0;4V-OXIL?$:7%[X4U0
M_$&P\7>)=7\7:E:>,+K5O"%S=1F/7==U*>&ZT"XT*["S".:XF1 HQJTZ5>CB
M<+5IJ6#Q66X++)T+RC#V>7X2K@\-B%*,E66)C2KUI3E[5T:M6K*I5H3:CR]$
M)UH5*>(]O.>-H8VOC:>)FU*K3>(GA95<-&#7U=87DP.#H4J3H.6'P^&ITL/4
MI+GYX4_9\A@\.^$= MOBS\5K2;P*][9^&?$5M)\-HM?T_P ):AIMMH\_@;S5
M^&WV*?0AIME:0IJ$MB^O1FW25=9$Y:5KQ3>-Q,L5C']8KXG#U\-CFVZ?]H0Q
M&(I8JJ\0J/LO8S=:C2:> ^I)*'+R\LZBEEAJ5/!8?ZKA8*CAZ%:CB,'3^..7
MU,/1K8>D\/[7G=:,:.)KPY,?]=@U5;E%RA2<*VC?LQ^"?#WB#2]8T?Q'X\L=
M*T#5+37- \%PZQI2^$]'UFR^'/\ PJZ'4HH?[!_M+4)U\,16+(FIZG?107>G
MQW%M' T]TMW>(K5<52QT*\^:IC:&9X95>6$:F&HYKBXXW$QPJC%4J<HU_;*A
M4E3G5IT,37PSG+#JA2HTERRI/FG)1G@JE>-2I4J?7)X"I*K2EBYU)3JU/:59
M*MB8QJ4X8BO"&)JQEB>:M*Y/^SEX1_L?0M(TSQ#XOT+_ (1G0_A?H&AZAITG
MA6XO-/M/A1XAE\3:-,L&M^%+^PGN]2U22-M3>>RE686ENULEI+$):WEBYO,G
MF<:=.G6EC)XN=."<:4Z<L!B,NC@7%2YXX*EA<7BXT(TYPQ%&>(J3IXB+5/DS
MJTY5\#+!5Z]2M*5/%*6)E)?695\;BL'C,3BYS45"I7JXC X>=2%2G+"U8JI3
MK8:I3K5836']G+P<MIXILKS7?%FJ0^*M+^(.ASF]E\,I)I6C_$[Q=/XS\7Z?
MI,EAX7MB([O4IE@,UY]MG:VMH$EFDEB$U<^'J3PT<)",G)83^POBU]JN'JN(
MJ8&-6*M!QFL3.EBN2,'6A&,DX5G4JU-JTJE7%/&1JSH8F/UUTITY/FP]3&X3
M X.5:C*?/*-3#1P%*K@G)SCAIU*M.$?JOL<-2Y/P1\$_&^G_ !MU;X@>(M3M
M--\!Z5?^+M4\"^!-,\6GQ19#Q#XO2QL-1\7W$+_#'PM<^'+U])M+Y/[,N]7\
M:)%)XAO%LK^TMHUAF67-83 XB-:\\=7A4PT/><X8?!U\P>:8FE&K>FJWML:J
M,TY82E5I1H\D\1B(RA&AEC:5.MB,+&A3C#"8:>#Q#E\$ZN(P>65,IHWH_O53
M5/!U%2<XXJ5.K[&C4CA,/6=>K7Z'QO\ LT>#_B+>?$.Z\9^(_%6MP_$'2='T
M672[BQ^'B:1X?L= UBQ\0:1%9:?#X"2/Q:MKK&GP3QQ^.O\ A+HD2:\M%C%E
MJ-Y;76,*4887ZMI*7UV&.=6I3I5)>VIPK4J:5&I"6$BH4:TJ+JQPRQ-6%/#2
MKUZM7"86I1ZH5YT\71Q4;Q5'"8G!*BIU(4Y4<93A3Q/-.$XXE2J<CG%1Q$84
M:E2K/#PI.I*_1>%?@5X1\*:=/IEO=ZA>P3_#BP^%^QM+\$^'[*V\.V5SKMS-
M+IVA>"/"&AZ-I5]>/KK+<)9:;!9E=+L!#:0^5(9],QMF.'S/#UDZ?]K.'MZL
M*E65:U+#O#THPJ5ZE9I474Q%>GS<SC7Q5=W=/V5*G&$F\%6RVM2474RNOB:]
M%N$(WGBZN$JU/:>SC3YDOJ6'IQMRRY(-SE.I)U'RS?LO>!T\.^$O#5GXC\<V
M-KX1\%Z_X.M[]-1T"_UK6)?$6J>&_$%YXPU_5=:\-7L]_P",E\2>%=+U7[8C
M06]Q<><M]:7=M(+==\5B:N)Q.*Q46L).O/+JM*-&,53PE7*L34Q6$GAX5%47
MNSJU8588CV]*O&;G5A*O&-:..'IQP^#I8&?-BJ$98CVWMISOBJ6)P%;+:E"O
M[*5)*E'"5G2P\L.J%;!TX0HX2M0P[J49V'_9L\,W'Q$\-_%C4/%/B+5OB)X?
M\,1>%Y_%FK^%O@QJ.M:Y!:)JHT[4;C4+GX4-/X9U&UEUB[F">$9/#=I<N(A?
MVEW'&(ZRC+V*S586*P:S6#4U2NG2J.CAZ$JT)S<ZE5N&%HOZOBYXG!1FI3IX
M6$JDW(J4U6^H_66\3_9]3GIJKK%T_;5*WL737+3@OWM6FZ]"%+&RI3Y)8J7)
M3<.U^&OPJB^&5G]AL/&OB_7K:>\\0:IJL&NVW@6UM=7UOQ!=Z?=3:S)I_A'P
M3H=GHMQ;?89ECM="M])L9GU?4+N^M+S4+G[8FDJR>'HX:-&%.GAJ-&A0LZCE
M1A2GB*DN24ZDG+VKQ"BX5?:4L/1P^&P^!IX3#TW2G*I-5J^(=6<JV)K.M5DW
M'WW["E0C!Q45%1BJ2J.<8QKU:TIU,15K.6G(P_LP_".WUW3O&L7A^W7XEV'B
M?4O%<OQ8;2_#;_$[5+[58=6M+NQU/Q?)H)NYM#&FZQ+80Z=%Y,%O:6=E;P)'
M':H!R*ER8983#U9X2C+!5L#65!JE]:A7PL\/5K8I15J^)G6DLQ=6:L\PA3K.
M/LX^Q?34JRK5*M3$*.(=2OAZT%4BI1H1PF+P^)H8?#QLE1H0AAH8-J/[V>%E
M6]I5GB:U3$2[GP/\*O#7P_DTQ]#FU.4:/X!\*_#G3HK^:RDCMM"\)RZG/;W"
M"UL+<_VI?3ZFTE],6\N9K.V,<4/EMYG=B,2\15Q]5TJ=&>8XB->I[.+BHJG2
M]EA\/33D^7#86,JKP\'S2@Z]6\Y1<(PP49\F%C5K3Q%3"O&3=:JXNM6K8^I0
MJXS$5YJ,>:K7J8:E*;BH0YDW&"<I-^;V_P"S986=]H]]:_%/XFP'PW;^-E\,
MQ167PA4Z'?>.KW7;W5-3COO^%3_;]8:$ZZZ)INM7FJ:1<MI>G76IZ=J%]:_:
MWY8)4\/]624K9=@<KYYJ,Y?4\!2PM&%.4))T:CJPPL%4E4I3=-U*SPGU9S7+
MNYKGJN-*$*=?'5\QG3CS<OUJO6J8B4X3<G6H.-:K-QE0JTJDJ4IX:K4J86=2
MA/-A_9.\'PV6D:9_PG?Q/_LNPTS2=*U?2X=6\*Z?IWBNWT3QS<?$#3X]8L]*
M\&VL6DV":Q?:E:G2/#2Z!I+:=J#6)T\P6UFMGTPQ'L\52Q,:--_5ZF K4:<^
M><*5;+J,J&&J\TYRK5IQC)3_ -IJUHPK4Z=:BJ56/,XK.6(P]?#56I+$PS2G
M5FJ=*$Y4\WPV'PV,C:%.-.+E'"T:BJ0A&M.M[6KB*E>6)Q/M;NG?LJ?#?2=>
M^(.N:?<:G:?\+*\3:3XJ\26-KH?PVM9IM1TSQ=;>-+NVD\5VO@"/Q9K.E:EJ
ML$L5Q9:YXAU:*"TO9K;31IZ"+R<L'/ZEAL!A:<(RHY;B8XJA%WA&-6G":HN5
M.@Z5*I*C5=/$QKU*<L3.OAZ,J]>K!5(5-,95>-K5J]:,74Q& K9?4=N:]&MA
M(X"4X^T<W2J+"1]E&-%TZ&LJDJ$JKYSU+QY\.H_'-SX;OX_%GB?PAJ?A6;7I
M]+U#PU;^#KR3S=?\/:AX<N'N;/QKX2\06,C6]MJ#W$#+:(?-A5)C-:2W%M<X
MJ"52O4N_]HP=7 U(M1<'0JXK XN=XR33DYX"E#WKP]G.JG!S=.=.+Q<*,)TX
MR^K8JEC*<FYJ4*U&ABL/&SA*/NNEC*R:W3Y)1E&44S#TOX*>'-,^&.G_  I.
ML>)+_0++4M/U.>]NY="AU+4FLO%5OXMFTZXM-,T"TT;3M"N[VW-G)I6D:1IM
ME!83O:6$%G&L7E=52O[3$Y?B?90B\L>&E0A>I**G@X*.&G.52<ZU2I1J1IXB
M$YU7+VU*E)MPCR.$O=S*-2U;^U*.,HUW*%.*Y<;AIX6O*$*4*=-5'3G*3FX2
ME5K2GB*_MJU2K.>+XA_9\\/ZWJ)UFQ\9>/?">M7&K^+[[5]7\,WGA>&_US2?
M'/\ 8*>(O"M_)K'A/44M-%EM/"WARUAN]-2PUBVBT>$6^J1N\SS<M.G"&'6"
MJ1^L9?*A4H5L-4<O98B-3&8S'\U65-TZT90Q./Q<DJ-6C3G"LZ5:G5IJ,5NJ
M\X3KU:2C0KUL3@\7&I&*<J.(P.71RNC4IJ?/3;>&C><:T*L/:MU(1@U%1ZWP
M7\*]'\ KXRM?#^L:[#I7BZ[L+N'195\/+8^$WT_POI7A*&+PS-:>'X+XP'2]
M$TL[-8O-7\M[11 8H283>.E4S# UL%BJTYNM/,9RQ%TJZ69XFOC*T$TO8\M/
M$8K$5*,G1=1>UY*DZM.G2A3Y,'0I8#$4:V&@HTZ%' T8X>3E.ARX"C##TI6D
MW5BZE*G3C6A"K&C*495H4J=>M7J5> N_V7OAM<:Q\(M=B%U!J'P9T#3O"_AJ
M6YT'X=^(Y+S0M,2%8K2\N/&/@;6+G1+J5XC)-J/A:?P[?RF5U-UY02--Y8B4
MLUS'-N6,*V:0Y*U*'-3IJ,5B%25.<)1Q-.%!8FHH4HXCV,TJ?UBG6]G&RG2E
M5R^C@*]:I7="M4Q#KU7&=:K6KSH5<35K0<?JM2IB:F'IU)U)8;GI2YWA98?V
MD^;D[/\ 99V:UXQM[SXB>-9?"-]X4\-:)\/FCU#PT?$7PYNM/\?:CX^U*'0(
M?^$&CTJ32DU.R\&"!M<M_$5U>)I$L.JRW,*QJ^.$MA,)1I1E)XO#8K+91K/E
ME[3"9/@WALOI5HM>S4HO$XV$U1HTER.E7C46+E.K'JQ$X5L5]95&%J]'/85Z
M;O[/GS]8>.-=%+]ZG/V-2O[2I7FZ=:NZ="%+#TJ=,Z9_V7_!\MI>VD_B[XA7
M(U?2OBGI'B&YO=4\.7]]XAM_B[J6C:EXGDU"^OO"LLUM+ =!TZUL1IKV$<%I
M"MM)'-''$(M:%7ZJL/3I4H1P^%>6.G0:;IWRO,J^:4I3;E[6H\17Q6)AC74J
M2>)A6E.5L3&GB(3.I7;J5:>(GA\54J^W^L4N6%2-:.41R>E5A347AXU*%&G3
MQ&'DJ%Z.)A:G;"U:^%JZ>M?LV?#K7/B7>_%&XBE@UO5?"<O@W5[2/0? -TE_
MH[:7-H\*P>)=5\%WGBWPZ8+*8A;?0?$FDV<CQK)<6L\FYFXO81^KYUAG*?L\
M]]HZ]GR3C5J0HTYU8SIJ,ZDG"A32IXIXC#P?/*G0C.<I-PFZ53):M)*G+(72
M^K*W/'DH5*U:E3E3J\]."C4KU9.K0C1Q,TXTZE>=.$(1ZCX:_"2P^&XUR9?%
MOC+QGJWB&TT'3[_7/&-SX>DU"/3O#&GS:9HFGV%OX8\-Z)IVG6=M;7$["*WL
M8PTT\T[[IIY7DZ<5-XO#8O"U'RK&XC$XNM.+?M)XG%X?"X;$5;R<HQ<HX2E*
M,8Q5.E)RA2A"BJ=*GRT</2PU>C6I1Y5AL-0P=&EHZ=+"X;$8O$4*,;KVDE3>
M,J4^>K.I5J4X4W5J5*JG5J>>:=^RWX9T^U\/::WQ ^)=]I&D^&-(\%:_I%U<
M> XK/X@^$_#>K:MK'A?0O&3Z=X!M;G[)I<VM:A")-#N-$GU""9H]9FU/>[/O
M'%3C7C7<(2=.K@\53A9PIT\?@J="G2S"$*3I\M:V&H2>'_Y%T)4H.A@J7*DN
MK&SEC:6+HU;1AC*N:3ERI7A2SF4)9AAH.?/^YK.%E.?/BH*<U'$KFT[3XD?!
M#0_B7JT.IZCXI\:>'X)-%B\.:_I'AB\T"TTWQ=H=MK$&NV>EZ])JGAS4+^*T
MAOXYPR:5?:9]IAOKBWO?M,#)'%RX9+"8SZ["\IQQ&78I0FW[-8G*\14Q&$K6
MBXRDXNK4A*$YRI.,E-4XUZ=*M#+$QCBL$\#)*$'1S##>T@E[18?,\+#"XRE'
MFYJ<5.-'#U(S5-5:=2A%0J*E4KTJW,ZK^S)X*\37'C"7QIX@\6^,K;QMXFT+
MQ)K&E:LO@S3-)QX7?4)?#>DQV7A+P;HRW,.G7%[;RQ:M?&\UYSH>DI/K$T6G
MPQJJ<71HX&G2G*G6R^OB<52Q$7R5UC,1A)81XM.-J=&O2C-UJ/U>E1IK%*.(
MG3J5$F;5JGMG54Z=/V%2C2PSH."E2^K4\7A\9+#3Y^>IB,-6EA_85<-BJE>A
M]6KXNE2IT_K5>4^\\1>!-4U=?A7IHUA]3TOP3XKTW7_$=]K\L;ZWX@B\/^'-
M;MM&D==.TR&SGU-O%-QHFHSOY5E&/L$CQ*'V)6[G3J9A/&U*2I*.'QRHTZ-X
M0AB<936#E[K;:H+ 8G,(:3<HU)T8J+@YRASNG".7UL"J?M57J8)*56;;HTL'
MCJ&81E%M3E6JJK@\/0BJC3=.I4KU*\JM)1K<'8?LR>#K:XL)=1\4>.O$-KH.
MJV%[X2TO6[SPR=.\(:38>,=%\=_\(KHR:7X4LIKK1+CQ%X=T.6>XU>;5-5DB
MTR"#^TA$NTK U9X".$5)\]3"4Z5+VM36=6EALNQF68.%11Y*<5A*&.JU*3HP
MHRJ8F%&MBI8B5-)Z8ISQ3QEJL\+2QLZ]6K2HR:I^VQE>-?'U;3]HY3QL?;X:
MI[24X8?"XS&T<!'"+$39WGQ+^%=E\2ET=I?%GC'P9>Z/'K=I'JO@J[T.SU*Z
MTCQ'IW]F:WHTT^N^']66TMKF%+9Q=Z>EEJ$$EG$UM>PAI5EXJN$I5I5_:\TJ
M>*PE;!5J=[0J4*U2A6M*UIITZV'I5(\LXPGRNG7A6HSG2EO2Q$Z,:2@HJ>'Q
M6'QE&;5Y4J^'C6IQE%-N$E.AB<10FJD)VA5<Z7LZ\*5:GYOI_P"RC\,](\8Z
MMXUTB74=-U+6_ <'P_U!8=$^'-Q>'3;3PQ8>$+/4+'Q=J'@.X\6Z1=PZ+I>G
MJMC8>(K71VFMOM$FEO-+*\O5C)2QN'S[#59<E/B&K7KXCV25-PJXFI*I6E'E
M25?FE.:BL<L8J=.3IT^2"C%981_4H<.TZ45)<,PP]+#>T]_GI8:=2I1A6C)\
MD>6I5G.53#1P]:HW:I5E",8K0L?V<-#L]7\-ZG/X^^(VHV_AY_!-[<:'<3^!
MK'0_$NO?#ZQ;3?#?B+Q#;:%X%T^9[Z&R%HALM/N-/TKS--M+B/3H[J(SOI4J
MNIBL9C&N6KBZ^.Q.DIVHULRRUY7CJE*\V^:O0:J7JNJZ59/V'LJ,ZM&IR?5*
M7U'#9>ERT,+0PN&5E'FEAL#F:S7!4)MQ:4,+B.>G%TU"I5H59QQ4Z]2%&I2Q
M7_96T+^QKK0;?XF_$NUT_4/#'AWP=JJM8_"#4Y-3\/\ AC7/%.N:9:7+ZY\)
MKX07 E\5WD+WMH+:[Q96=U'/'J*SWMSD]:>&HO\ @8:MA,1&$&Z/[W!X#"9?
M"4:E!TJV'<H8*A6OA*N'>'Q$9/!/"TI.B=U2M.=3%5=(U,1+-)+W5.G2EFN-
MCC<3RX>K[3#5(J2GAU#$T:].OA:KI8Z&+=+#3H>D^/OA!IWCRP\.6?\ PEWC
MCPC<>&K+5-)M]9\*:EHZZY?:)K>DKHVL:5?ZCXDT'6&5;NWAM96U"S6TU*.:
MT22"^AWRB;+%T:>-KXRM66F/PV)PM>E!*G2G2Q%6C7:Y8*+@J=:A2G3C"4:;
M472K0JT)3I2G"3>"P^$P]'7ZA7PN)H5*C=2I3K82G6HPG>;<:CJ4,1B*-7VL
M9OEJRJTW3Q$*5:GQEC^S'X)L[^Y,WB'QKJ'AB>*U>+P%=7GARW\+6NKV?@:T
M^'%OXA6?2?#%GKU[J<?A*SAM8H-0UN\T^VD47-K8P7,<<L?1C)RQ\,?#%_OI
MXUY@X5&DJF$CF=>OB<;'"M6BG5J8FK%5J\:^)A0D\+"M'#2G2EC@HO+XY=#"
M5)0IY=1P%%0DU4C6CEE2C6P3J>T4W35*O0AB)4L(\-0K8AU*]:E4JU:DY,@_
M9JT:&TT]YOB3\4KSQ3I>J>&+RQ\>7%[X'B\3V^E>$++Q!I>A^%H[:Q\!V^@)
MX?BTOQ5XAMVVZ&M\[ZF]X;W^T8H;R%U:LZSYJCO*I/&U<3)-QEBJV/PU/"XF
MK5E%J5&;I4J7LE@GA84'!^QA"-6O&K5**H4:N%I+DPOL*&'P]!WJ4L%2PV+P
M^.I+#1JN?--U\+0]M5Q3Q-7$TJ5*CB)U:5&C"GI>%O@';> M0\.WO@GQ_P",
M])AT?PGX8\$:G8:K'X7\2Q^(=#\->(M5\2M?7VH:KX=;4[?Q3J5YK>K07NHP
MWP@F@U.X?[$+Z.TO;'2.(<9U$Z5*6&J2H/V$8>RC2CA,N>78:E1=)P<:-.,<
M/5=*I[51EA^3#_5X8C$^VJL_:TN5)4JT<3F6*A4CK^]S?%T,5C'.,KJ23HM8
M>W)*$Y0G7>)IT_8SW?B%\%]%^(NL1:IJ/B7Q?HEM<^'[CPCXJT+P]=:#;Z1X
MY\*7%TUZWA[Q))JGAZ_U&TL1<2W.9=!U#1+F6.[FAGN)8&$8YL,EA,7+%Q]_
MFJ8.LZ4]:7UC+ZE:K@Z[4>6<I49UZC]E*<L-532KT*JBK54G.5&E2ISEAJV'
M^LJCB:,I4\11CC(T(8F-*:;C!U5A<.XUE#ZSAYTHU,)7H5'*4NCT/X<Z+X<\
M&:OX(TF\U6VL=9G\87EUJ8EL/[92_P#&VK:OK6K7T$JZ>+5+B*^UFY-ONLW2
M-(8%=) AWYXVDL=@:>7XB4G0A@:& ;B[3E1H8>&&<Y2LU[6M&+J5YQC%2K5*
MDX1@FHQ>$JRP6,6.A:I5CB5B8QJ+]W%4Y1]AAXQAR-8?#4:='"T(<W/'#T:<
M9U)U%*I+RS7/V9? USXL\#_$+0XTL/%WPS\&6G@WPI'>Z'X!U?3KC3-$M-0B
M\/V=UJ?BCP%KFM>%D@GU&Z,UYX1OM!NKA)MMTUU'!!%%KC:^-JSXAQ>%G"&8
M9]3Q'/)\U**Q%6#C"I[6BEB7"G+DE&A.K5PR<%/ZNYN<I1A*6&HY?D^3UXSE
MEN55:<HM6G5]E?#JO%PF_J]2=:.&IWJ3I*M&7-[&M1YY-X'A+]E>STKP/HVA
M>)OB9\0=?\8Z/I/A:TT;QQO\"P:CX'NO#FI:;XC6+P786WP_MM'GL7\4:;%>
MR2^)-'UZ\OO*A74KBZ$2*G3B*M*&(]IEO/@XTJD5"K:G[:KAZ.$QN78:C7I\
MLL)3A2R[,,7A53P>'P]."KSJ4E&M&G5ASN$\:I5<THT*M;$?6*M:C14Z>%I8
MO&XS#YEBZV&:E'$^]C\)A:U/VU:I98:G3<?93K4ZGHNC? CPIHL6HE=8\5:A
MJ6K^$O$WA34==U/4--GUFY;QGJTVM^*O$9N(-'ACA\0:CJ+6C-Y,,=A!'I5C
M!:6-O!;B,\.*HTL3@\QR^$%A,'F-'"T)4J/PT:6$6.]G&E[7VKE*=3,L76KU
M,0Z]3$5ZLJE:<Y.7-U4*DZ&-R[,9R^LXW+:M2M&K5C&/MIU*>6T5[:G0C1I)
M4J&586C25&%'EI^T3YG.\;&M?!NVUCP5X%\*)X[\<:/JWPZN--O/"_Q T>/P
M)!XOM;[3M#U'PT;N:PN_ UQX4F:YT#5M2LI8?^$96!5NC);16\\44L7;B,34
MQ&85,Q?[JI75:%>G!R5.O3Q#A.O3FY2E6@JM6E3K.="M1K0J17L:M.%X/+ P
MA@,!/+:45/"N%&G&,TKTXX;$4L3AE#DY$_83H4H15134Z<;5U5<I2EG6G[/?
M@:QMKRUM;GQ L=_9>!-/NS/?6=U)<6W@/QCJGCR)+B>XTYYISK?B36M3N-89
MY2UV+MQ$ULQWUFJLJ<:$:4*<(X3$4\3AX.,I0HRPV78;+<!2MSQG*AEU/"4<
M1A(RJ>TCB>>=2K4C.4!1@^6M"=2=2&(H9C1J1?(DY9O5K5<TQ*BH*$<3C555
M*K-1]G&E0PZI4H2I*3ZO7OAY<>+O!>F>%?%'B[6;C4;+7/#/B6?Q-H^G^'=+
MN[C5_"WBC3_%FGK!I-_I&IZ=!I0O]-M;;[--;W<PM8P&NGNQ]L*A)4<5@<51
M3C+ ;*4E+VSE@ZN"K2KN,8>]7A6JU)O#K#^SK24L,J"A",;;E[+,:*DXPQ\,
M5233:E0HXB<G"%*2MS>PIN-)>W56%>$7'%4Z\*E6$N)U/]G/P=J&@1:%'K?B
MO37MM \3Z%9ZS92^&I=5M9?&'C+2?'?B'7?+U3PQ>:=>:S>>(-%L7E^V6%S:
M2Q"6.6TD$KDQ3<Z,<+&G4DE@UP_&DW9M1X;4U@8W:>E7F4L5:SG.G2G1="4+
MLDHS^MQJ1YZ&.J9Q5KT6Y>RJ3SJG5HUI22DI7PE"OB*& ?/>A2KU83=9./+D
M+^RO\/4UKXIZXE_J\=U\8=%O-&\9O#H/PQMM3N6U.WCM=6U&+Q=;?#R/Q1+/
M=VZRQFRO=<O-+MUNI19:?:C8(ZPCC@J4,/0IQCAJ.8T,QIT?>5.,Z&/EF/U>
M48RC[>A5KR<:DL4Z^+]C:E3Q5.*5E-UI8BCC%B:E/'4,)+"QQ,?9NK&7U2G@
MZ6*IN<)PP^(H4Z5*=..&A1PLJ\/:UL-5E*?-Z%JWP=\):UJ>KZI?/J;2:SJG
MPZU&\MTEL%ME@^%VH_VQX6T: '3C+'HR:NTM[+"96=IKB4QRQ*Y6ICS14HRG
M*I&>*S#%S4G\57,<JAD]:[5FE##0A4H\K4H8B*J2E.-Z9/LXPC&-%O#\F!H9
M=%TW9QPM#&5L9*"YN9)XE5ZF$Q6EJN#:IJ,9Q54\WTG]EGPMI%BUC'X^^)EZ
MMM;?#K3- DU&^\&70\*:%\+?&4GC7PIH.A6/_"#K8&Q6]-K9W<^H6E_?7EMI
MUHUQ>/>Q?;&ZJ6+JTZU'%2Y:V+CB5BJ]><4JF,FL#6R_DQ#I\D8TO88C$2A3
MPD<-&C7K5:^']E4FV]\54EBOKG/^[^MQS6*]G[GL?[8J8>MBY4VKN3]KAX2C
M'$.O"4)3P]>%?"N-"/T[T_#^E<IGM\CY_P#C)_R47]D[_LX#Q'_ZRQ^TM0!]
M 4 % !0 4 ?/_P &_P#DHO[6/_9P'AS_ -98_9IH N?';XIS_"[1?#;VVL^$
M_"LWBK7YM C\8^.[6]U'PIX<EBT+5]9@:ZT73=:T>Z\2:O?W&F1:;IVC6VK:
M;->W5_''%/Y@6*;EK5I4YU(1E&+H8/%8UQY)5:M>.#EAU/"X6E&<'/$3A7E7
M;NU0PF&Q>)E3J1H.#VIT[T^94:E:4Z]##QY'&%*@Z[G_ +5C*TE*-#"4E3=-
MU'&T\56PF&<Z*Q#KTOF"+XX>(O$I\%2>(_&-MH'B'7?#G[/OVO1_#5Y<^$89
MKOXB:_X@\?ZK]G\,ZAXKU"[TZXU;PEX(L?#EDT]Y>2O>:Q?Z?:7,TDTBUZ6)
MI?V;B\P3P]3%U,OQN,HU\+&:K6Q'#W#-7-:E+#U(TJ;K4\5F68PC6IQI+ZQ@
ML!">(HRHT)R7'3J4\5AJ=6C7INE/"XN=#&S53"X:ME^=\08+A_ XWV=2HJL,
M5EV&I5,?&4[?5JV,H.+A[:=,T-&_:O\ %=]X;U?Q+<>(_@NNAW</@=%\910Z
MY#X"^"&N^+[_ %.UU#PK\6?$EWXO6V\5:WX?M[&!KV.UE\&21WE[:Z?>0:=]
MMANSG4H.E4P^%EB:4EB,9/#X?,H)2P680IX+%8J7U"A[93J*5?#T<%AL2L7.
MEC*F-@Z4(U\+6PD]85%4E4KT,+6J0H4ZDZV63:IYGA%3QN78:$L<X0KK"SJ8
M;&U\=6P\L++ZI2RW$KZQBJ,EBJ?37_Q_\=Q?$SPE\--.\:?"*YU<>)/!_A_7
M+)?!'B:[U?Q[I>M^$)/'>L_$+P=96/Q3=? '@:#0K/5+73[S4Y/%D>H:EIMY
M:+<1&T)F%&\L=6=*=+#8.EFTJU*ZG7RYY=@Y*E/'3E&C&57%9E+#J&71I4:S
MR^M3Q,<1+FJ?5RO"I3P>'JX>K0Q%2O2P&*IU%.U*M1QN=K+94:--.<I3PN&_
M?U<4JTJ7MITX2H4HU(<_FGAG]I?Q9;>$_#_B;Q%\2?A7XNU.^\(2>,8/$:IJ
M/@3PEX4T?Q_\4-.\&VEUXRT?2_B3JMAJ>A^ [:UUE-8N+H)<6DL6GV,]_IMU
M->W^H4Z:@X4)RA@JT</DV'K8V=18C!NMB\NS3,Z]>-/FI0D\:\OP6$RNK2K4
M*>/Q6(K_ %6I'#5EA,/>,C4PF,Q<73EB,+1S#/H4L'07^VWR>OE^!P]+VC_>
M>QE#-*N89@YT*OU7!TEB'A<35PE*4^Q'[0WQEU'0[F;PVWPMU:?PYX<U+Q#J
M/B9_"WBVUT;QY#??$,^#OAH?!'AM_'1N-'L/&$6D>)4@O;K7-8B@,5C?VW]I
MVLZ07.F'H\V(P2QN&K8"G6QF1X&K0DXNO"MF&(Q5+&J53DC[!X7!O+<TE3J8
M:57#T\5+!8B#JQJ5Z'/7<Z6&KU</5IXV"P^<8JCB:"C.A*CEF5Y=F+Y(1KR^
MLSC7QE;+WR8BE2K5,+4KJKA^58:?I/[2OQVUKX1VMC8:%JW@GPSK-_X2\6^*
M=.U#QSHNK>*;?Q!J'A;^RA!X%\*>%=%\5^&KO7O$VI?VE+,TD>K1BPM+">]E
MM[B&.3R>.A"OC,<\%A.25:-3+J5.C+F53$2S/%U,%3FIQYEAL+A*L*?U[%RI
M5XT98K"4O9<V(C./3%T*.'H5\>YX;#R]O+$XM)RPN HX2A'$8B=9J+G6KU82
M:P&#AR5,6J&,E"ISX>-&OB77Q7^.EWJEQ9Z++\*;6+4?BAHWPC\)PZCX7\5Z
MA-?ZO8>&M(\1?$?Q5>W-IX\M%_LO1QI7Q#MK728;?S9I+"Q\_4(/LT_VSIIP
MHXAX?ZM*?L\9+.,1&HXJ?U/+LMK9I@L/4KP3A[>KC,;1RV"E">'I0AB-%4EB
M:;PW-SUHX.=7V#^LY9@\FECH3_=0K8[-*N75)4\(_P!Y*CA\/@<QI5.:HL15
ME7IXA<JIT4ZO"O\ M1?$)M:\6VNEZG\+M<E\+>#OBC+>>![#PMXC3Q)H_C7P
M3XAT?P5X2M?%/B3_ (6)+9Z'-XH\1:WI]ZGA=]&:\L]-NH7;5K@3PW$V>&@\
M70AB:*BJ.83R*&$E*H_9X>MGV-]C1PE>I&E+ZY/ T*&-AF=>A##?5<=0>'^J
MSY)WUE.C@Z]"EF%2I3^ISQL\;3C0E'$XO+\HR^MBLRS+ T'4G'"T*M987^RX
MXBMB5C<)B:=>-5-U88?9\6_M&?$#P#I/B:U\<>(OA!X1O[#QSK/AZP^(6J^'
MO$G_  @UC::)\/M!\<WN@P>%W\>P:CX[\9F\U6[T6S@M-=\/G46TJ^O$L[=K
M(V-SS8BK%4,-+!<]>O4PV:8FG35-U*N8/+\U_LNG0PV'A.,L/6KS]I.HG5QB
MPU/#3KR]I3JN.'WPU&4ZL85>67-+*L/6A&?LXY=BLQP^(K7Q>)E"<*E&,*>#
MJT^2E1]I4S3"8!5/:KZQ5YCPS^U7\6;KQ7?Z+XKT3X=^'K?X>_#*/QO\2-.O
M9M*TOQ#K,2_#6S\5WWB/P1HD_P 6[KQ1INB6OBO4(-$%IJ7@R^L)XK6[F7Q3
M'=Q?8*[\=0]G3XBJY?&6+>"KXG 9?AXVJU7F$,?+ X&&)G1O"5+,)4IU*=.J
MLMQ$:=?"5*$,92J.H8X&5+&XGA_"TY5(?VP\-7=6M2C0C+"XF?M73C&I6_=U
M\+@9PJUZV'EF5!8RCB\'5AAE16(EUNF_&;]HBTU2RMO$VG_">1;/Q%\*=%\0
M:-X>T'Q:VLSZMXT\,KXB\8^"M#GO?&9A_M7PYHN-?76I8)ENK:Y73VT6 P_V
MK/.*>#PM3&."KXG#X?$<0T:+A%1EB:.595/,,-BX.TU&E+%P_LB<5&?UC$<U
M:-7!SC]3ERT7C:V"P5:-&-"KB\%DV,DZB:I48YCG:R><)M3]YR3EBI/FC' *
MFJ3EF*K>VH\W\,/VF_C+\3M,T^^T_2_A5ID_C+QQIOA/P_IL]YINN:AX DLO
M#7BCQ5X\L?'L'@7XL^(4U&]T;2='TOR!=S>"]3FN[Z6SO_#^E!5NBJV&=##T
M9/%4I<F'S+,*^*A!SPSR["4Z&&HU,/&%65&K4_M7%8>C.6'S#%X>K@ZGMHUJ
M%52I1WG7H^VQGL8U(QHUL)A:&%Q"]ABJV(KXRFE%IJ=:E.KEE/,<3*AB,#AY
M8.M@I04\P@U)U]0_:.^(]D=+U[4OBC\#?"$-C^S]IOQ#U'PEXQT:T\+V'BS6
M/%_BF_T'P[XHT?7?$_Q=TZ32--B32]/=-(GNVMUE\2P:9>:SY^I6>HZ9G54Z
M,<T_V>4:D*V28:&'<E7Q678K$8;ZWF-&I2I>P>-J4X.O2P\.7"RQU3"OZK[!
MX+&0Q?7]6FG@(2<5'Z]Q%2J5XN2HXJAE5:E0P7+)4Z_U6&)5:G6JXF*QGU>"
MG4^KUX3IPC[_ .(OC+K/A'X2_#'XAW,=OXIG\6:GX.TW45TSP7XB\.7&L2^-
M;2XMM!MM#\(W.OZS?>&[^\\1W?A^S$>H:EJD5LEU.]Q.(E-Q!KC</7IYQ0R?
M"44Z^)>+H052KS0CB,-EV*Q:J5:RITU3PRGA9SQ#E24Z.'YD[U:;<N/#U:*R
M_'8[&5XTZ>#=&4JD%&<(TI9MA<'5Y%2JUXXJ<,-6J>PEA:TX8S$1I3P_/2JP
MIR\9B_:'\;ZWHWA:]U]?!WA59M?\5:!<72'Q5:I?^-OA-X0\>>(/&O\ PCUM
M;^-=&F\2:#;^*-"T'3(]'FFG-_%I/B1;@- L<MMQ8JHJ.7U\PH2G&M'A_$Y[
M@XSII_N'0RK!QEB:,WR1YZV:8VM2512AA\/A\'C:=5U9TJU/JH4XUL7'+Z^'
MJQ4LYPN55G3K<CH5:N9U\1AH2KJE'W7EF7TE.O0E*GBL7FM#!U*,*='&X+$8
M'@[XJ?'.\N/ _B)?'_P]^(5I::#\#O#OB34M)T.^@\.>--;^+_C(7&MP>&-,
M\/\ Q!GTRR\0:%X*DT6];Q"\VI6[)#=+;Z3#!J;FQ]J.%PU+-L;@Y2DL-5QU
M3+H*6E5O)<BQ6:5\QH2G"U"AC'BZ<YX>,:SQ*P\:?MZ/U:E.IYOUF&(P-#&^
M]@L3' 8[,N2TI8:C_:&/PN!RW*ZT(U/:8G$PQ^78W+859U*<L \73J57BZDL
M1&KZA^T%\4/'OA'QK)HGA#QQX2TB"T^#'C3Q*G@34M!BN/%OC?Q7?ZE8^%O!
MB^&==?Q?8S:>+37KVT,TEOI%]' )PET)7U*S?3_"ITIXYYQ@%5E&I5EDF7X:
M5*4J,L)5SK&8G"SQU6M"-::IX6-"%_W45^^YH/VE%J7KQK8?!?V1BL30E+#1
MK9EC<74LJOM<)DF$P^-Q& HX>3IQG7Q6'K8BK"]1MRPL7>%&&(A7\U\5?M"?
M&+X5>%QX9U ^ M4UVS^)=M\,-,^).K)9:?X/T^TL/ /A;7GD\5GXC?&[PLOB
MCQ&VOZS-H3W-OXKTR[OY;.[O[71I9X&TN7T*U:&/QN7K!QITZF;+-J\(<JI4
M:]3"9S/+J&%PM&E[6MA?;)5)>SHTLUJX>.&DXX>M2G*>'\[#TH9=@&\35JXJ
M&6X7*X8J/.YXG!U<1@<1B*U3$XJI#V&*4*5#"8GVE9Y;1G_:E##3Q<*T(U,3
MZY\=_CIXE^$_A+PD+W5OA_X'\4:[X/\ $?B/5?$/B73=:\8>$X-6\'Z-I6I:
MIX/\(>'M,\0^'-1\8^)M4EO[IM,M$U2SD^Q:/J%\\<XLG@DYL=3E5QF8X/*)
M2J>S@_J=&:C''8R5?$?5<+&FK^RH1HMQGC\9.-6E@W4PRG1=.O*I1[LIP]3$
M8/+JN-=*-?%8O!8.JX5>7#T98BCB*LJ]Y1E*I3YL.J-&@IPG7J5HPA7YU&-7
MSWP;\1OB@NJZ+\-_#NO^&=4^(]C=>$?!/C36?&<_BSQ=]@L-"^#4?Q$\4^,+
MGP59>/M/2/4;KQCXPTG3;=X_['>[@(AN+B:.TL6L_0Q#PD,1CI48.63X2><X
MJG3I?O,34PN4XW*\FHX+ZS451QQ^*E[;$2E/VM-4ZE/&O"U*U2N\7P4Z]2>!
MP=?%04,QS/#X"K3I4H.EAL+CL[Q&:9A5Y^=\]3*\+EN7RIX)1E.4,3!X.&(I
MQ5>-#"\(_M;?$'Q'X5\:>-M7/PF\#^&;;Q/X?\&Z?>^*M2T(_P#"I-8U2\NH
M;Z]^,'_"+_&#6]VG6UDMH_V/65^&FIIJ$PTNYLK=)%U)>*,/]FR55:U.E7SB
MI)0Q$'[?"KV>"Q&*J82'+*-"MB?K%&C@L-5P^85HXIXJ-66'PM6DL%7[,11J
MX7,,RPL:,L9'*(R]K1IWHUZ\/K^%P5+&47*G5JT\-4H5,7F5;VF"G3P^%PT?
M98O&4Y5,32MZM^T%\0_"GBGQS#K?QM^ TNB:5J/PW\#-JNI>"+KPSX0^'VI>
M)O!%QXZ;XJ^))V^,M]?77@_6HW.C:;IUUJ>GPW^H_P!GVEIJ]N]M>3:EI3@Z
ME)TW3^KU:V8YA2I2J.52K&.7T:%.>5+#TXT_;9GB,3)U*.';I8FCA57QKIXR
MG5P>#IDZ,K8>M0G"M364T,=[.$DOK3QF<5<OA7IU&IJEA\#0C3KXFI&-:G5C
M+D<L*^:M'IE^/OQ6FT+4-<N+SX0^#=.\$_#*Q\7>+];\>V>K>&M"US7?$>N^
M+]#\$V^F7VM^/-.@\!:5J]IH&E:T4URZU*:WCURST]I&DN3>VN6*E'#T,1C9
M_P"S495,MPE'#2E"IBZ&/K8#!X_-</5<Y86EBJN71S##4*&&C]3EC<1"M"=;
M!KEDLL)_M$J>%I\N*Q?-F]9RI.<:3R_!8R6'R[&N-.EBZE+#9C#"9C*=>/UA
M8>G1>*A3Q,*+H5_HOX7>/3XM^'.E^);O7-'\5:XNB0ZKK*^&M F\,$27MHVJ
M:?;#PE=>+_$]QH\TVFR6K0K)KNHQW2NEW:W$EM<Q&GFTHY?1Q5>C0J58X2BY
M.%Y.=2M2PU.M4I\LZ%"K1JR<XMX2M1CB<)[2-#$1=:$F\LL<\:Z%.K6I0EB:
MDN22Y53C0>*K8:G54X5J].O14J%6"QM"I+#8KV,ZV':IM17Q?>?&[XM_&;PI
M)X;\%^._AII=SX\U7X;:3;>(/!&B>-+U_AS<^*-3U6Y\:?#+6O$VE_$W2;C5
M/B!HOA/0[^]O;_1[CPM?6'E2VIT_3[J[LM0A=7!VKX:C6Q49X2EB,34^O4.=
M83,L-@<MQF/J3PBI5U6C@X8K#87!O&1Q-2CC5CHQA[">'Q-$UCC(T:>+QF'P
MDY2IT)TU@L1&C]=RW$5LPRO+<)6S*C452C"K5AF=3$K!5*+6%J8&;]IFE&T:
MN!\-OB/XR^&=CK?BCQKX^TWQEJUYX/D\9Z5-K'BCXL:5X>T3P5K7Q*T[X9^#
MO$FH>'/%_P :O%=@O@[1/#]C=^(==UA;07L4%]:-J&IRWSW.I:II&K"MA8P3
MA@L1562RQ.)Q/LO8X?$9[A\9FF+IUJ,(4?82P\</A,ORVA2J8/#5\3'$8?#_
M %>G6KJD/"5(8Z,'"7U?"_ZPX>GAHSJ+$8BIPK3H4%"E)U*\JM3,:N)Q5>I4
MKQQ=97H5)1:H87#8;TQ_VE?B-9?$CPUX&77O@UXFT6U\)6WCWQ!XZT^'1?#6
MB_$?PG<0:AK&IZC\+-(OOCYJOB&VAT3P_;VTAOK/1?'6FZC<BXBGOM!5%8\]
M6K&C3X@K5<-7P[R&C7C/"S7-B_;4LOHUJ&*<(4^:.'Q68XBGA(X>O1PL84E.
M=',<7B(O#I1A4J?V1A\/4HUZ^=5\-##UHR:PT7/'5<-B,')RLJN)HT,/4Q"J
M8>M5JQE4H0K9;3HS^LOK/!OQF^*D_C;X->"_'GBCX-Z?XA^(7AA?&6O>"/#/
MAC6-1\8:/97.B+?VVD3V%S\6QJ>@::DUEJQ_X3.XT#4M+EN%329;6QNDM[K5
MO2EA(0S'.,#"3Q-/(Z,HU:M.2C3GBE6G"3<^6HL-&E"IA'1PM52JYA!UL12Q
M&'?+AHY2KPK8"AF>%C+#83,<3&6#ABN58A8"=2*H.5-.G'%XFM"36)^JS7]F
MU(J4L/C<,L1B,-K>*OC[X@TSXTR?#[2K_P !VUMH&M^'M/UCP'JMEJEY\3?%
M'AC5]&L]:USXG:#=6OB.SM?"_@/P[!>20RWU[HFLP7]YI%_8BZT^X$(G\NA5
M@L-C<;B??PN'AF;J.C?_ (3OJ&"KXFA4S"<HRBI9EB*$<-A<):A)T<1A\73Q
M-?FJ8:EU8ZA7H0P$<+&-3$8R. E34Y:8B>,S7^SZF%P\%ROVN$P\*F.KU5.K
MRQM"="G!>VG//\9OB3X6_9QU+XX^+-%\.:QJM_I6B>)/#GA7P[I\GAV#P_H7
MB6XTNVT]O%NM>+/&WV"Y.GVNI#5=2U":\\-V%M;PSQ2RPQ6SZBVN9TJV62P>
M7594XYE&M1PN.K\T(X2CB&HK%RI0K5</>GAZD:U.A&KBX3Q<_8TTZ,ZEB\!&
MAF6(Q=3!3]OE\:>/K8+E<Y5<=1PSQ=7!RIRIT:DD\?AX854XT\-6E"4YU8QK
M*<,/3\QD_:#^/$O@31]:TF+X/:KJQ^&?C#XEZGJUC8W.M:+J=I'XDT/2OAAH
M.DZ9X,^+6OV%KK/B02>(=.G>R\9^)K.WN;%;NUNKY(&L+KIG1C#&O"VY*E"O
MD&$G2G.K!5L3G.-Q6&M3Q%;"49T*"PU"EBY5:F"J3PSK1H^RQ=-K$G+2K8=8
M:=6O.I&-2>9U:=>E3A4IX; Y/EM.OF-6M0IUIO$8BACL30IT,-3Q&'EBL-3K
M.I+!5I*%)OBG]IKXB>$-6N/!_B;Q9\"/"/B2X\8>,=*T;5]<TSQ&^E7]AX?\
M!>#-<A\.>'/#9\?6>H^/O&T/CCQOIWAX16-[IDFJ)87EQ;:992QFVCY&_:4(
MRP$9YC7A@<?7C1I07M\=7PN=3R_#0P^&A.K4PU/%8?!9DZLF\;'!5:-.O4J5
M*4E0J=$:4K4*M24,/AWB,LHXQU)\L,L^N9=F&-KJMB)J$*[H0HY;C(R5/#P=
M',(X.5JJ6+<>J?M$>)]+UG6)K_Q7X%^&GB*]E\">"=:'Q*NM1UOP/\/_ !#8
M_#:U^(^I:=:^#=,\6:)=ZKXP\1ZKXU_L33[5M4TFYOD\,O)&UZ=,AM+O;%>S
MP]3%X?!36/P\L9GF)P,J<'5Q.-IY;7RW*:654'3^'$3J4\5F3]G3Q#I8:O&O
M]4G"OST^;"NO4P^5XC&TG0G++\LEBJ*MAJ>!JYG+-J]7,<55JTY.6#I4L%@<
M*E5J1P]/%5)8:.+H5WBN;M'_ &B?B9;6]S83_#VVD\8:?\,/"/QDU3PS;6.L
M&YTSPA<>&-5OO%&CMYEX&N?%=QXOT.?0M,MP(6B.K1W%Q!<C2[E+B<>E@Y9Y
M.CRUZ&38_%X1MUJ<%-3PF"EE:=9M48^TQ6*Q-3%8IOZJL#E>+FG1J5*#ET8*
ME];Q&58957&EG$:%/#8N5&5.E4J1S+%4L=B98>K*.(H4*.5QR^NL/4YL3#&Y
MGA,/4DX3JSP_BW_#87QDF\&>#M5MK3X/B\^)_BW5](\&^+&UCX<7'@SP^NDQ
M:/ /"7BV2U_:A;1=7\3W.LZE-;P2:!XYN=6FM+&YO$\(&YM)M,7=86?U_ Y?
M3Y:M26'GB7)RG3CF$/:0C0CA(1HUJ]"<DL0J\\+1SW#X>=+#OV]6EBW4PV4'
M_LN88ZK%T*."JX6C6I6YJ^!E5IXRMB)XA3]C&=.A3HX2G#ZY_8LJE?%2A/V/
MLJ2Q7U=\(OBSK7C_ ,<?%/0[WQ!\/]7L? =QIFFKI7@"UDU_^R]2DCN8]1MM
M8^(-IXVO[.\UR*_L+^WN/#=SX:\-ZEIABA><75M>6US<<S<8Y36S2$9XBE+$
MXI8:4$H1JX:AS3H>RC^\6*E6H2P\WB*-6%.G6=;"RH*4(U)J4:U/$8'"UO9T
M*TL)3GB(<_/..*<:'M^:#]G4PE*E5G4ITHUJ5:.+I*&(HXKGABL+A_G&\_:'
M^*7Q&\%>-X_!7BSX<:?>:_I'AW1M#NO#?AWQ!K.M?!?QOXT\<:%X(L/A]\0=
M0C\>00ZK\1?L6N7%]*EM;>'9= GTI_M5A?0M!+<W# U,3# X9U54EB,9EJ>*
MP\JD<%CL%5HXW&9M]0J1G2JSIY7A\"W4Q='$QGC*=94J=++,4TZ717J/+LRQ
M\/80JT\NPN?U%2JU(*<:V5>QIY;5K\].<%2S>O.:P^&G0DO=BHU<73YN;O\
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MKEV'J48TZM>G1K8FFFWA\ZH5*T<7[*/U%8N4:<85<(?8%<)T!0 4 % !0 4
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M"$J=./,^2$9S]I4<87Y%.I)1]I4Y?:3C3HPG*4*-*,-RI * "@ H * .1N?
MOAF]\8:?X[O;2]O/$FD:?)IND2W>N:]=:1H\<PN8[B\TGPO/J;:)IFMSV]Y<
M6TVKVNGQ:A-;2?99;E[=5B5T6\.\2Z7NRQ<8PJR?O3=.,J<_90G*\J5&4Z5*
MI4HTG"E5JTJ56K"=2G"255*O'#0J)2AA)RJ4XI**]I*+A[2:C95:D(2G"C.K
MSRH0JUHT73C6JJ?74AA0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 ?/_P 9/^2B_LG?]G >(_\ UEC]I:@#Z H
M* "@ H ^?_@W_P E%_:Q_P"S@/#G_K+'[-- 'T!0 4 % !0 4 075U;V5M<7
MEW-';6EI!+<W-Q,P2*WM[>-I9II7/"1I&C,2>@4FLJ]>EA:%;$5YJE0P\)5*
MDG>T80BY2D[7>B3>B;[(NE2J5JE.C2BYU*DHPA%;N4FHQBO-MI(\?\$?&BS\
M;:A8QP^ /B1X>\.:[I4NN>$/'/B31]#M_"WBS28+>&[>]M4TKQ)?ZSX7C:SG
MBGB7Q=H_AQ[A''V99FRHZ9TIX=8F&,2P.*P<93K8>NTJE.G"I"E*4JD.?"\T
M)S@IX=8CZU33E*I0C&E7=/'VE.3H/#36-P]>K["GB,._:49U/9U*L>1Z3J4:
MD:-7V6*IPEA*KC!0KR]OA_:Z;_'7X(Q^&[SQB_QC^%:>$-.U?_A'[_Q2_P 0
MO"*^&[#7NG]B7FN'5Q96NKY_Y<Y)EF_V*SZ8-],PO]5?3$VO?ZO_ ,_K6=_9
M\UK/L:)-SQ5**O4P%EB8+XL.Y-**KQ6M'F<HI>T4;MI+=#=.^-GPQU#QO=?#
ML>,/#MCXN633UT31M0\0>'[:_P#&4&H>'K'Q,E_X+T_^UFO?$-A#I=_ TTUO
M;;4(8C=&!(U485*_UM4Z<O:X"M6HXBCROVU#ZNJ#G4JTU=TJ3=>,(SJ<OOQG
M%J+2O-64*,,'5E./U?'4*->A64E[&HJ^(Q6&ITH5':,JSGA)RY(.7[NI1DFW
M)QCU>L>._ _AW7= \+:_XR\*:%XF\5//'X7\.:QXATC3-=\226H#7*:!I%[>
M1W>L/"I!<6D4Q0$;L9J:?[VI5I4OWE2A3=:I"'O2IT8W;JSBKN%.*C)N<DHK
ME=WHRIQ=*BL143IX?VD:2JR7+3]K.RA2YW:/M)-I1A?FE=63,&T^,OP@OK'Q
M!JEC\5?AM>:9X2U*'1O%.HVGCGPQ<6/AG6+B[6PM]*\07<.J-%HVI2WSI;I:
MW;PRM*ZQJA<@4N:*H4<5=+"U^?V5:_[JI[.FZT_9U/@GR4HRJSY6^6FG-VBF
MRO95/K%7">SE]:H0=2I1Y7[6G!73G.G;GA!--.4DDK/71C=,^,_P>UF.^FT?
MXL?#358=+T*V\4:E+IGCOPO?1Z=X9O&V6?B*^>UU5UM-"G88BOY2ENYX60U<
MX3I1J2J1=.-"M2PU1R3BJ>(KJ+H4)MV4:U93@Z5)VG44H\D7=7Q=2FN7WXKF
MIUJT?>6M+#<WUBJM=:>'Y)^VFO=I<DN=QY7:I:?''X0:M%<?\(U\3OAWXLOX
M?#VL^*;?1_#?C_P5?ZEJ&AZ ]Q;ZIJ-FK^((K<:?;WMK-:S7]Q<6]G;S(RW-
MQ"$=DSJ.5.A7Q"IRG2PM.A5J./*E"GB4I8><YSE"G"%>+YJ,YSC&K'6FY'13
MHRGB*&%D_8U,1B982"E&=_K%.WM:*A"$ZLZU%-2J4:=.=:,?^7;;2=VU^,?P
MGNKS7M,7XE_#Z/6?"6CKK_C#0V\;^%)-6\'Z.;:&[DU'Q19VNL2G1=/C@GA=
MKNX*6^V1765D=6:JO)1IXFNZD7A<)6>'JU]8T:=7VDZ2ISG-0]G.52G."IU%
M"IS0E!P4XRBL:+E6E@Z4*<EB,?2C6P]#W95:M.4(34J4:<IJM%1G!\]%U*;4
MHRC.491;AL_C+\,M2M;#6-(\<>#=8\(W_A[Q+XF7QUIGC?P3=^$;?2_"5]I.
MGZU/+J,?B/SIK>WN-7B$U[:VUS8V9MWCO[JTFGM(KRZL'AJ5>KBO]DIX>.$F
MY5E*$90QCKJA-2:Y8QG["7)*K*FJW,OJSK.%?V5TH/$*"PW^T3EB'AE3I)SF
MJRI2K.%DK.:A&[I1E*LDU/V7LU*<89_CM\$+32-"\07/QD^%5MH'B=YX_#.M
MS_$/PC#I'B&2TNK:PNH]"U*36!;ZL\-]>6EO(MK)*4ENH8VP\BAG[*JJ]+"^
MSDL375)TJ/*_:U%7YG0=.G;GFJRA/V3BFJG)+DORNV2J4WAZ^+4XO"X6<J=:
MLFO949TTW.%6I?DIS@HMRC)IQ2;:23.BLOB-\/=1\77W@#3O'?@R_P#'FEV:
MZCJ7@FR\4:)=>+M.T]TMY$O[[PW!?-J%G9M'=VK":6W1"+F(AL2+F*2=:G7J
MT4ZM+"3]E6G!<T:-6[2IU91NJ<[QDN2;4KQ:M=,JHU1>'55^R>+CST%+W?;0
MLWSTD[>TC:,GS0NK1>NC$M_B1\.[OQ7<> [3Q[X+N?'-I!/=77@RW\4Z'-XK
MM;6U$+75S<>'8KXZA#!"MQ;F21[=503Q[B-ZY5/][2K5Z7[RAAOXM2'O4Z7[
MRI1_>3C>,/WM&K2]YK]Y2J0^*$DG/]TX1J?NY5)JG!2]URJ.E3Q"IQ3MS3="
MK2K**O+V52G4MR3BWE:;\7?AQX@,?_")>-/"'C.-?%/_  ANIS>%O&7@[5(]
M!U];*^OIM/U<CQ!&T>H10V$V_3K=;G4 #Y@M##%-) *_+A:MG'#8NG7JT:[_
M (52GAZ4JU2=.2NZD5&#3G24X4_CK2ITE*I%R3@\33?NU\)[%5*.JJQ=?%4L
M)!2BTE3?M:J2]JX<\HNC2]IB)4J-2'P7\8?A]\0_$WB;PQX&\1:7XK?PEI>A
MZEJVM^'-7T37?#R2:YJ?B?24TB/4M(U.Y*ZU97GA/41>6LT4)@$]L SL\BPZ
MPHSG@HYA%6PU2O+#TY.]JO)A\+B?:TFER3H2ABZ<8U(R=YQJ*R48RD54J$Z-
M*4E[6HJ_-33]^B\/*C"<*T'9TYOVT'&+3;BFWRZ7\?\ BQ\/? /Q)_:2^">A
M?$7P/X/\?:):? _]I'5K71O&OAG1?%.E6NJV_CS]EFS@U.WT_7;*ZMX=0CM+
M^^@2X2-9%CO)T#!97#9".O\ ^&3OV6/^C:?@!_X9OX=?_,Y0 ?\ #)W[+'_1
MM/P _P##-_#K_P"9R@ _X9._98_Z-I^ '_AF_AU_\SE !_PR=^RQ_P!&T_ #
M_P ,W\.O_F<H /\ AD[]EC_HVGX ?^&;^'7_ ,SE !_PR=^RQ_T;3\ /_#-_
M#K_YG* ,O6_V:OV0/#.D:CK_ (@_9\_9QT71-'M)K_5-5U/X2?#6SL+"SMT+
MS7-U<S^'E2&)%')8CL!R0*B<XTDG*_O2A",8QE.<ZE2<:=.G3A%.=2K5J2C3
MI4X1E.I4E&$(RE))M+XMHQA&4Y2DU&,(4XN=2I.4FHPITX1E.I.34(0C*<FH
MIM<3\-/A#^QO\6/ 4/Q$\&?LN_!NYT6[O/%%CIUGJ/P-^&FCZS?S^%=?U;PY
M<B.QU'1XELC=7^CSFW2_ELW6.:+[6EK)YD<.V*I5L)0PU9TG5EB\#A,=3I4Y
M0]HZ>,PM+%T:=YSA25;V=6$9)U?91J77M7%<XJ<J53%8K"JM!?4\5/"5:OO.
MDJE)QC4E%PC*<J<&VN:--N7*W3C-.+EX]<6_[*&DZCXSTGQ1_P $^]%\*:AX
M&\$0>.=7M]0^$G[)NLE[/4=2;2/#VBP2>"_B)KB6OB+7-1ANXM.M=1:QCF%C
M<2//%%$7,TU[6FYTO?FL?@,LIT[.+K8W,*M*E2HTJDU"@Y456HUL5S5H_5J%
M6C4J)>WHJHJLEAE3E7_=4I8;'XR4[.2IX3+<//$8K$3A34ZWLTH.E2<*4G6K
M<U.FI>RKNEV.H^ /V:-%T?1;G6O^"?WAK2_%?B?Q/+X6\)?#>3X2_LL7WC#Q
M+/;:+<^(+W5;*]T?QS>>%]-T:UTNPU*26;5_$FFRJ;!T6%GGMA<TX>_3I4&L
M34^K5\76A3NGA</AZU*A.I6=54XRYJN(PT*<<-+$3E+$4H\JE[2,!2A&G.K5
MG'#THSH4J<JCM]8Q&(]HZ>'H0CS5)553I5:TU*$(0HTJM64U"G-QW+7X=?L4
MW/PHN?B^?V8/@];:!8Q:E%>Z+<? KX:#Q3::YH^MW'AC4/"LFF0Z1)!)XAB\
M36DVE"*&\E@DN57RKAX765EBX/"RP,*?^V/,_P"SW@O8NWUI9HJ$L"Z?UCV'
MLU6CB*4G]8]C[%.7M_9<D^6</-55C?;1E@7EGUWZY&O%WPRR^%6IBY35#VWM
M(TZ=&=2$L/[:-:GRSH.I&<'+C3H7[(,-E<VM]^P]X/TWX@0^*M&\'6OPDN_@
MK^SP?'6J:OK^BW_B327TV^M/$$_A&;3I?#VD:QJ#WDGBF**"/2+N.X:*XB\D
MI1=14OJD7C>:IBZ5544U]5E@:>'K8IXAUO91C&E2Q>#E&=-U(UGB\/##NK4J
M*!I!7>+]K_LT,)A<+C'*:;4Z&-Q4\#A'"-%5:BE6QM.IA5"I"G*G.G.=94Z$
M75)](\(? +_A,_V4?B'\)?@CX)^$VN7'[07Q"\&:_%IGPW\$^"O&6D7>A?L[
M_M+:?XD\(Z[=^$K=XKB.WU_0HC(EIJ-]87#V%M<V\T\8AF.M6DJ4</4IUJ>(
MH8JC3Q%"K2YN2I2JJ\6E4A3J0E%J4*E.K3A4IU(SISA&46A252E6KX:M2E0K
MX648U(2<&U[2C2Q%*:E3E.$H5</6HUJ<HR=X5(WY9<T5^A-8@% !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'S_P#&3_DH
MO[)W_9P'B/\ ]98_:6H ^@* "@ H * /G_X-_P#)1?VL?^S@/#G_ *RQ^S30
M!] 4 % !0 4 % %+4M/M=5TZ_P!*OH_.LM2LKK3[R$G'FVMW ]O<1Y'3=%(X
MS[USXO#4\9A<3@ZUU1Q5*=*?*[2Y:D7!\KL[22>CL[.VAMAZ]3"UZ&)I-1JX
M>I"I!M:<U.2E&ZZJZ6A\_P"B_"+XJV&D#PM?_'$3^%]#\*ZGX8\&#2OAY9Z9
MXHB^TZ++H>D:M\0=;U+Q/JVG>.+[28&AGACL-!\,6T]Q#YMY#."%3JQ=6MC5
MC<1B90>8XU2YIP@X82,YUZ5>I66%4W55:I[.5*3AC(4X4Z]?ZO2H3=*='+"0
MPV J8"EA</RY9@:]*HL-.I.=65"C&488)8IM3CAH\RM*4*F*DJ5!5<34M6]O
MX^O['_BPZ5XH>[^*^C7_ (R\3:UX3U]/%%QX?^-=K_PBVI>&--US17G\$W&B
M_M.6'BCPHEUI6K)"+*P\7Q:=;C[?#%8FRU 6=JTXTXT:>&=3#0CC,=BJDXU.
M:O.&/PV64:V'56<)1JTXULMC6A_:%+,4X_5Z-6-182%2>-*G;$5,1B>3%-X'
M 8*%.5*$:=\NQ./KTL1*"7+"M*&/JTY2P:P;Y^>O%JI7K<_L&G_L_O:,ESJ'
MC6ZU[5SXN^$?BR]\0:OH=M+K>J3_  LT;2=):/4;R"_B$UUJTEA>7+7*QQK;
M-JLRK!-EFETA5IT\='%TJ$*%../SG&QH4_<A'^U\FJ91[*.]OJ\90K<_+^]5
M.-%0I*TXY8K#2Q6$6&E4Y9K"Y9AG4]Z>F6\0SSY-<\Y5'"IS_4X1J5:DZ<8J
MO.M7G>#E^(7P+O\ QIXOU+7;'Q9HNEZ%XMTKPCHOCS0]<\!6/C34+VS\#:SJ
M>N>'IO!>JZQK4>G^#M2%YJUWY]S=Z%X@PT=M<V*6%];K=UQ^QC/#8S!5I2>%
MQ-:OBHND_98BGB<1@*673?UBTW[!4*%-QI4X4:T9RK\F)C"O.!Z,*[HU:.*H
M)QQM"A+"1<YSGAGAIU:E::GA8R@I5G.K).HZGLJM.-.EBL/B:=*G&/!Z5^RO
MJ@L]&L?%/C_0=:@\)6GPQ\.>$H]'^&D/AN*+P7\,_B#X<\>6>G>*H&\7ZBGB
M/Q'>OX;MK)M4M1H]C;_:)Y[?1E:62.7U:6/E',:V;UJ<9X_&8B.*Q7(_9T'5
MI9?FV!P[PM-JI4PRISS>M7ESUL3*7L</1INC&FI'!1PM+"T(8+#2J1P6&RW-
M,NP\:DW4K*&:K"1Q%3$U4H0Q+C' T5%*C1E/FKRK5*DJUXV+W]E"TO='U#2'
M\86XBU#_ (7\+AF\)1R1O'\=/B)HWCR2*: Z\!,FCQZ0--8,V+Y9A,1:"/R'
MQP^(^K/*+0YEE4.&H63LJO\ J[C88V^SY/KCC*%O?^KN;G>OK%]^;5GF6%SW
M#07U26<MR51/F="3X;Q?#SDDE!SE?%+&M\U-MTE0^U[>.UK7[-,&JW'BF>+Q
M7#8'Q-X[\=^-<1^&4<V0\:_!R7X2_P!E[EUN/[2+(2#5?M&(O.V"T\F+_CY'
M'*+EERP%]8Y;FF7NIW>9\24^('7<>]'V:PCAS?O=,1[2%O8G+AH+#9K3S->]
M&CF>2YA&C:RC')\I_LM8>,M5%5O>KJ:A:CS.DJ=2[J/G[/\ 9=UBRU+QV\7C
MK0%\,^+O#NH:7%X&C\-?$L>#Y];U%-/>3Q5XN\-S_':;2;[6%OK*6\-UX/T_
MP%>S3WLLEU?3R!'6J[=>CBX.ZJ5\3#$4&Y5'#!>SQCQ=-X-J:Q>&K4VU&G*A
MC*6'C/FK_5'4]FZ58=*C++/:-U88'"T\)6?NQJXRC3P'U!T:]X3PM:C.GRIK
M%83%5X4:-#"T\3##QK0KT#^R;KM[H'A^QU_XO7^NZYX:L==72M3U71?$?B73
M[74KSQY\,_'_ (?C\GX@_$;Q-K^I>%M-U3X:VT,^E:QXHU6ZNX=:NHX=4L(X
M;>.'L6-J4'&MA80CBX?4&JM:$)J=3!_VQ"<ZU/#QPJFYT<WE1H5*;I8BA]5H
M5ZN(Q6+=3$3K"_NL-C,'7YJN%QE7$.5.G*5/V.'Q&5U,LG1P[JO$>SFU4EB9
M2G[7#NM*I".$AAIJA#:LOV7[J?4?%7B3Q3XVT?6/%?C;PS\6-&\0W>D^ 1H7
MA^+5/B?I'PZT#^U/#^A77BS5+G2K/3](^'5BLMG=:MJ4]_/J5U-)?PC$9Y:W
M)+*,1E%",J-.M1PU.-64E.I"5+,<US2M+W(4HN%7%9HW2IQ4/80PU)SGB*KE
M5.K"8RM0QF#QE90K3PF883&*%./L8SIX+!U<%1I3NZLY5G2JRY\54E-\K]C2
MHTL/&G2I])X+^!&N>#_BI/X\MO'D-KX;FTW[+<>"/#VG>.](M->U$Z39:8VL
M^++35OBOK7A.]U(26@N5OM&\%^']29D@BN-0N((Y([G>G74%FBG3YHX^M7K4
MJ=TZ6$>(QCQ<Y4E452M"HY2J1DJ%?#X6K+$8FO6PE2O.C4P_DO"<M/)X4JKI
MRRZAAZ->I9*IC/JV$EA*<9N'LX>P4'3DH5J>)Q%/ZOAZ=+%4Z4)TZG*Z/\"/
M&^H?$+QWXBUOQ)I/A[PO+\4_$'CWP?ING^#]+N?%LVLW_P -;+P%9>(+KQD?
M$5S!+H$=M=:HW]AW/A^"\>:SC6>_;3I/L4O'2C..2T<+[5T<?'"YUA:4H74,
M+#,L[S'%N5>FW*GC9RP\\+7HVG2I4>>*JTIXO#4:F'ZX3]GF>9550YL+B\1D
MM2KSS<OK-/+,OR>48T'#DG@^7'8.MAZSG[9U*<:DL/&C'$3JU>>\.?L@:Q;:
MEJVK^,_BQ+XGO]?3PA#K)T_0/%>F6YA\(Z%\1_#L:Z)%XF^*7BA_"ZWEAX_$
MSVFERV^G6]UI<T]I80#4'CM[Q<:.)P,\"J;HTZE?-<1)\WM&IYKE=++:D%*J
MIU9T:'L85:,,35Q,U3OA95'15/V>U&M+#UJ-:$I3EAHX6G3]HXV<,'F^6YM3
MG4ITH4J'MZD\#4HXFKAZ.'A6]M3K.C&I1J?6?8OA%\'_ !!\//$'B#Q%XC\8
M>'_%%WJW@[P%X&L8?#O@$^!;:QT3X>W'BPZ/+>Q?\)9K2ZCJ<UGXF2*>2$6$
M >P+6]M!#,EM;=U7&RK8?$0J4[8C&9CB,RQ$XR:I.OB,+@<-.-*E+GG3IKZE
M&<?:5Z]2T^2527(I/BAAX489?0I:4,KP]7"T.91=9T9U:=6"K58J"G*G*,]8
MTZ<).I*:IPFZDJD?B/\ Y.G^#?\ V0#]I;_U8O[)U<)N?0% !0 4 % !0 4
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MJV/S'%QISHT\3/"JG&HX.?)@\LP&6JI+V<I0C[9X)UXP4I.$*L83?/&1]T5
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M-_\ )1?VL?\ LX#PY_ZRQ^S30!] 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M.O\ YHZ #_AK']EC_HY;X ?^'D^'7_S1T '_  UC^RQ_T<M\ /\ P\GPZ_\
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M .#?_)1?VL?^S@/#G_K+'[-- 'T!0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MLG?^M3_!N@#Z H * "@#Y_\ V:?^2=>(_P#LX#]K'_UJ?XR4 ?0% !0!\_\
MB/\ Y.G^#?\ V0#]I;_U8O[)U 'T!0 4 ?/_ .TM_P DZ\.?]G ?LG?^M3_!
MN@#Z H * "@#Y_\ V3O^36/V:?\ L@'P;_\ 5=>'* /H"@ H ^?_ -D[_DUC
M]FG_ +(!\&__ %77AR@#Z H ^?\ XR?\E%_9._[. \1_^LL?M+4 ?0% !0 4
M % 'S_\ !O\ Y*+^UC_V<!X<_P#66/V:: /H"@ H * "@ H * "@-OD?&FF^
M(_$L?Q$C^!EQKOBJ>X\&>.M?^*NN:Y/JVJ/JVH?!WR3XD\'Z=-J=G<+>W=E-
MXZUZ/PREHPG%YI_P_P!6M9DECWK(L/6A# ?VE55X\,Y?B,)BDH-QK9BHU,'E
MWMZ<E.>*J5\CY\XKUX1E_P *M.G4O&JXP+Q=!JK/#4HJ/^LN)PM7!<M:<98:
MA&<*^;2A*<5&FJ68X5X)8:%:%/#9?G6"=.I"G!T(^+Z9^U-XO^)2^)],T[6-
M#NM+TOQI^S[K7A7Q3X&MT\/&]T;Q7\:=#T#7/!FJ1Z9\4_%5[>7]G9QKIVKP
M:K;>#[W?J,]K=^'X()HI+GHPM.<*5/$N,*^*PDLQBX1<:N'Q:_U<SO%8:O3A
M2=6C/#/%8*7U:I1QV+C5J46[X>OAY06K>']OC*-.7+0JY;FTN6I[N(P=? K!
M1E[1U8T*U*ORXV%7DJX+#N@O9RIU<5&ISPZ6X_;,UV\^'6H^)/"5EX/\6>(=
M ^%OPQU[QG::&UK)9> ?'/BWQ3=^&_&MMXG&O^/-#T_3=.\*1VLUY>Z1JWB/
M0Y[1;5QJ6JV,,GVF&<;"E2Q>+^J5XO*/KV&H8/'RE1G1J8:K@\PQ3K<\JV&I
M5E5GA</A*%2G5A#V]>5.$<17A]7*]C"&)>&Y95\51JYY">#IR?UF7]G8K+*&
M$IQC3HUZE.I5HXVMB:E\/5=6E3A4HTX0DG/UOPG\>/&6M_LW:K\7[C1?#-SK
M^GF_BLKG1]5\-Z_X3U.QMM6@TU?&4D?PQ^(?CZTL-'MK2:?4+W2K/Q9K-Q;Q
MZ7=1&\R5D$9DEA(Y9[T< L?/"1K3Q//4I8&GB<7[!XFK4E3P4:U&.'Y,8IIT
M:$8U53J8F,:=2NN++Y_6ZN9147BX8&.*E1C1=.-3%U,-@/K/U6G&%3%NE6EB
MU/+XJ<75G."K+#1]K"B>5>&/B'\1/C%\1?A38V_Q1\!Z]X*\-?$/Q7+?^,?A
M)I_C_0?!GQ<M] \&:)KMG%I-SHWQ>EB^QZ3J&KZEI=]8W6K>,M'NKW3UDNK<
MO!)I]OMA8>RS!8BMAZU"*R;,ZD,-7<&I3AC\MP%/,(1G3Y)4J\<:IX7VV';H
M1I8OZM6JSKX/,L+GCY-8*AAL/7IRGB\=E:JU::]ZA&IALYQ=7 3E":K4ZRCE
M=.M.=*MAJDH8S!JO1^KT\3A,?V'C#]I?6-)_:'T?X2:-=^&-3T.[U?\ X1+Q
M+I*Z7!:>,?"VHW?@^\\3:;XDNM5O/B9;:BVB7LJVEA9M9_#Z^TV:X6XB;Q#!
M=I':2>4I/%9?G4O:<GL\%FL\/5I3Y)4J^ HUY>PFH>VG]9G'#5\1"%;^SY?5
M8K%X9XNE"4GZ%94\*\$](UU6R^52E5LU7H8W'87"*=%35&/LZ+Q5-5:E">/?
MMFL-7HX64I3@_P#9R\:^,+WX6^+==OM>D\0:UI7PY^%FKZ9-XX\27PTD:M<_
M!#PMK5Q+JVL7\LS:;8WFM32W5_><L6N;BYDW2%F/KY_)8-\03H1I4?JV=YI2
MI\ZC"G2I4Z>7N$$G.E%4Z7/.5.E[6C3YI.*G2YY35JE2J9[AL+452.%J4G[2
M-"'/4M_K'Q%0E*E36DJJP]"C2AHWR4:-/X*<(KQB;]M+XAP_"31_%L*^!-4U
M2X\<WOACQ#X]M=,^&%G\*?#L-KHEOJUG!:ZO??MCKX2\127]S*=/BOD^*=A/
M%/NBFT87L7V";GJM0KY;"%&I&EBL-BZW+7<</5Q-;#XG#TH86BIJU%U:.(=5
M5L*LY@UAJ[I1JQIXEX/AI\ULP4ITZD\/7PE."P_/6A1H8BGB7/$U)PBYRC3J
MX7V:I8RED]2V+PDYJ$:^%^M^K:5^TI\0=4\1:/IFHQ_##P1JMUHOA^XB^$^L
MSW_BSQ[XV.M^!;;Q+?>+_AYXF\!^)M1TS5?!^D:]=2:1(\>CWUE.=,NI)]>T
MS?"),\RO@H9X\)+Z]4P%+-)4Z$:5:GB,$\#AYU\-4S&G4A#FIXV4%2A&^"C^
M\IK#5\7C+8"6M-4I/).:O"-#'SPG-B&X^RQ*Q&:ULOJ4,,H3J^QQ-'"4X9E-
M1GF#I4ZT88BG0PD*F91IZ+^U'XH^(M_X?T+X8ZW\+;N]UC2O@S;:EKDNE:WX
MITGPUXN\=Z7\5;OQGIE]IVD>--->YN-&NO FFPKI#:C:7-O++>6U[<"5E:T]
M/$82C#&M8:HZV62S;-\/1KJ49_6<NR[*<+F5"MAZL4J<Y8J5:='ZW!3PZBU4
MA1J2HSIU.3"UJBR3"8K'4)4<X^HT*N,PK4J2PN+JYKE&6SI3A.,YTW16.Q%2
M6&J2]LW3P[E.G3JQG4X33OC-\0;?Q3;66K>*O#TNE:C;?"LZ-X%2?QO8:Y?Z
MC=?M6Z]\/O%7B+1]?N?BA+JVH6-MI:Z4EYILWVW3T&K:+8W*#30]EJV65QA6
MPN&JJC/$U987+<3"$'&4\/0Q' E;,X4:RG"<,0\3C:-2%#%8B"JU*E*M6E.M
MCX_6J73&#^IXFK*I3I.CBN.<-5DXSM6JY5F-*GAW'FJ3>&C[&4ITJ&&4)8:,
M,4L+*%!T*6#K:%^V1\7=>T#XJ:@^@?"WPM?^#='MM7-OXR\7_"+1I?AY=2>(
M[#2V\+^-M&7]IV;4=3UF;29=3N;6X\2I\)+=[O34L9_LWVD3Q<$''^R\+CIX
MB%JN+P='VU.,9TZRQ%#$5<11H0]M'#QQ&$JT\-1DI9E.M5AB:M58*%3!RPM?
M;%494,YQ>7TH>UHT(9@J:DYTY?['4A"AC)3]C.K/"8JE*5=^RP,H44J$8XNO
M0Q2QE#[A^"7CZ7XG?"_PEXWN)H[BYUJRG:ZNK?1+?P_8W=U9WMS87%WI>GV/
MC3Q?9/I$TMJTEK=Z=XI\065W \5U9ZC=6T\<K>AC\,L)B%2C&5.,J5"JH3<O
M:156C"IRU(U*&&JTJBYO?HU:%.I1?[N:<HN3X,/4E/VT9RC*5"M4IN4.1P?)
M+W>6=.M7IU.6+492C4_B1G&4*4XRI0Y3Q'_R=/\ !O\ [(!^TM_ZL7]DZN(Z
M#Z H * "@ H * "@ H * "@ H * "@#Y_P#C)_R47]D[_LX#Q'_ZRQ^TM0!]
M 4 % !0 4 % !0 4 <KXV\8:3X \*:WXPUQ;Q]*T"S-Y=1:?;BYO9@9(X(8+
M:)Y(X_-EGEBC#S2PPQ[]\TL42/(F56K[+V,8TY5:N(KT,-1IQ<$ZE?$UH8>A
M3YJDZ=*'/5J0CSU:D*<;WG.,4V7""DJLI3C2IX>C7Q%2<E)J%'#49UZT^6G&
M=27)2ISDH4X3J3:Y80E)J+Y#2?B]HH\,ZSXI^(6BZU\$=.\//;?VM+\6[_P7
MHNF6UK>HKV.H1>+_  ]XNUOPK?6<P95)M->GDA<K%<QP2NJ-M6=+#PI3J8BG
M%U*LJ'))RI5(UXJ+]ER5HTW-R4X^SJ4O:4:CYZ=.I*I1K0IY474K5)TZ5"I)
M1HQQ"G%*<)47[1.:E3<U%P=*?M*=7V=6G#V=64%1K4*E3HIOB;\-[:^\*:7<
M?$'P1!J7CR$W'@?3IO%F@Q7WC*W6))C/X4M'OQ+XBA$+I)OT]+A=KJV<$&J=
M.I&OB,*Z<HXG"4Y5:]%Q:JT:4;N52K3MS4Z<5&7-.:C%<KN]&$9PEA88Z,XR
MP52<*<,0FG0E4G90IQJK]W*<VTH14G*5U9,DO_B-\/=*TZ/5]3\=^#--TF73
MEU>+5+_Q1HEGITFDO?6VEIJD=[<7R0OIS:E>6EH+D.8C/=0PAO,E56RE.$(R
ME*<8PA&C.3;2488BE6KT)-O11K4,-B*U&3TJ4J%:I!RA2FXZ*$G56'46Z[EB
M(*FD_:<V$J4Z.*CR?%S8:K6I4L0K7HU*M.%11E.*?!:?^T;\&;[Q!I?A@_$#
MPA::IKNG:OK.@"7QCX-N[/6M%TG7;'P\FJ:=?Z1XAO+=X;_4=0MULX))([J4
M).KV\4MO+''I2A.K*M2C!QQ.%]@JN'EI7A+$XC%86E#V:OSR=;"N$O9N:ISK
M8>E4<:]54EC4JTJ4*%7VBGAL4ZRHUXZT)_5LOP^9XC]YHH^PPF(5:?/RWI4J
MV)I\^$C'$3]77Q%X>:+6YTUW1F@\,SS6OB.9=3LC%X?NK:QM]3N+;6Y!/MTJ
M>+3;NTNWCNC$RP74,K 1R*S9SG"E0CBJDE3PTE4<:LFHTFJ56="JU4=H-4Z]
M*I1J-/W*M.=.5IPDEM",JE9X:G%SQ$?9WI13=1>UA&I2]Q7DO:0E&=/3WX2C
M*-TTSAW^.'P6BT'0?%4GQ?\ A='X7\4ZB^C^&/$;^/\ PFF@^(]7CE>&32]!
MUAM6%IJ^HK-')&UM:32RAD92N5(&SHU5B*&$]E-8K$P56C1Y7[6K3E;EJ4Z=
MN><)<T;3C%Q?,K/5&:G!T<1B(R3H827)7J)KV=&5G+EJS7NTY<J<K3<79-VL
M-UCXT?#C1O''ASX;MXHT:_\ &OB'4GL&\.:7K6A76L^'X%\+^(?%D6L^)=(.
MJI?Z5H<^G>&KZ*&[^RR!YY8%"^6SR130C]8^O.G**I9;0K5\14;_ '='V%;"
MT9T9S5U3KWQ=.:ISY?W<:DFURQ4M)0<**JR:CS>P=*&U2M'$5X8>$Z$7_$A&
MI.//*+LEMS2M%S'XU_!I?"U_XY/Q;^&2^"=*U,Z+J?C ^//"H\+:;K F6W.D
MW_B ZK]@L]3%PZ1?99;A)=[A=FX@5G*480PM24E&GCDWAI-I1Q"2DVZ$GI52
M4)MNFY649?RNRC&4ZF*HPBY5L#_O%.*O/#_#_&BO>I?%'XU'XH]T>@Z=J.GZ
MM86>J:3?6>IZ7J-K!>Z=J.G7,%[87]E<QK-;7=G>6SO%=6LL+HZ2Q.R.K!E)
M!!K6K2J4*DZ-:G*C5I-QG"<7"<)+1QE&23BT]&FDT9TJM.M3A5HU(U:4U>$X
M24H271QE%M->:=BY4%A0 4 % 'S_ /!O_DHO[6/_ &<!X<_]98_9IH ^@* "
M@#Y_^,G_ "47]D[_ +. \1_^LL?M+4 ?0% !0!\__M8_\FL?M+?]D ^,G_JN
MO$= 'T!0 4 % 'S_ /!O_DHO[6/_ &<!X<_]98_9IH ^@* "@#Y__:6_Y)UX
M<_[. _9._P#6I_@W0!] 4 % !0!\_P#[-/\ R3KQ'_V<!^UC_P"M3_&2@#Z
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M[.,J-">#E&C1]DIRI5N2K7G*#G4U/%WP"O88_%>MVUW/XQL]7\/_ !RT[6/
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M_:]/\#>*9?.A@DAA_LO9/)$]S;K<&P;'K_\ PTM\.O\ H7/V@/\ Q$[]J?\
M^<W0 ?\ #2WPZ_Z%S]H#_P 1._:G_P#G-T >0?'#XV^%_&'@O1=)\.>#?V@-
M0U"T^,'[/7BFXM_^&6/VFK3R]"\#?'WX:>-?%-]YM]\(X8V^Q>&/#^KWGDJ[
M33_9/)MXYKB6**0 ]?\ ^&EOAU_T+G[0'_B)W[4__P YN@ _X:6^'7_0N?M
M?^(G?M3_ /SFZ #_ (:6^'7_ $+G[0'_ (B=^U/_ /.;H \@_9Z^-OA?P-\
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MI2CA,)3RJ6;/%4\)-M3B\2\?2JTVZ4)^T]K[>I5JQ>)Q,YA?%YG7Q<9.<*N
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0!\_\ QD_Y*+^R=_V<!XC_ /66/VEJ /H"@ H * "@#Y_^#?\
MR47]K'_LX#PY_P"LL?LTT ?0% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0!X?\1_AQX^U[Q]X%^(OPY\=>#_  ?K?@_P?\1O!5U:^-?ASK7Q
M"TK5M*^(6M?#'79[BW@T+XG>"Y]+U"QN_AE8HCO<WL<L>J3@Q(T:.38-C/\
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M4_\ \YN@ _X:6^'7_0N?M ?^(G?M3_\ SFZ #_AI;X=?]"Y^T!_XB=^U/_\
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M[4__ ,YN@ _X:6^'7_0N?M ?^(G?M3__ #FZ #_AI;X=?]"Y^T!_XB=^U/\
M_.;H /\ AI;X=?\ 0N?M ?\ B)W[4_\ \YN@ _X:6^'7_0N?M ?^(G?M3_\
MSFZ #_AI;X=?]"Y^T!_XB=^U/_\ .;H /^&EOAU_T+G[0'_B)W[4_P#\YN@
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MXE\)ZWX^\:>-/">DP:EXF^$.C:5;+X6\<7G@ZWN9=6\2_%+3K?6-0N7MR_\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@#Y_P#V3O\ DUC]FG_L@'P;_P#5=>'* /H"@#Y_^,G_ "47]D[_ +.
M\1_^LL?M+4 ?0% !0 4 % 'S_P#!O_DHO[6/_9P'AS_UEC]FF@#Z H * "@
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 ?.'Q03QOH'QH^%GQ%\-?"[QA\3=$T7X7_ !K\
M%:W:^"M7^&FG:KI.J^-/%?P%UWP_<7$'Q)^('A2WNM/FM/A]XC1WLKFZDBDB
M@$D2K.K@V#8O_P#"Y/B+_P!&G?M ?^%'^RQ_]$M0 ?\ "Y/B+_T:=^T!_P"%
M'^RQ_P#1+4 '_"Y/B+_T:=^T!_X4?[+'_P!$M0 ?\+D^(O\ T:=^T!_X4?[+
M'_T2U !_PN3XB_\ 1IW[0'_A1_LL?_1+4 '_  N3XB_]&G?M ?\ A1_LL?\
MT2U !_PN3XB_]&G?M ?^%'^RQ_\ 1+4 '_"Y/B+_ -&G?M ?^%'^RQ_]$M0
M?\+D^(O_ $:=^T!_X4?[+'_T2U !_P +D^(O_1IW[0'_ (4?[+'_ -$M0 ?\
M+D^(O_1IW[0'_A1_LL?_ $2U !_PN3XB_P#1IW[0'_A1_LL?_1+4 '_"Y/B+
M_P!&G?M ?^%'^RQ_]$M0 ?\ "Y/B+_T:=^T!_P"%'^RQ_P#1+4 '_"Y/B+_T
M:=^T!_X4?[+'_P!$M0 ?\+D^(O\ T:=^T!_X4?[+'_T2U !_PN3XB_\ 1IW[
M0'_A1_LL?_1+4 '_  N3XB_]&G?M ?\ A1_LL?\ T2U !_PN3XB_]&G?M ?^
M%'^RQ_\ 1+4 '_"Y/B+_ -&G?M ?^%'^RQ_]$M0 ?\+D^(O_ $:=^T!_X4?[
M+'_T2U !_P +D^(O_1IW[0'_ (4?[+'_ -$M0 ?\+D^(O_1IW[0'_A1_LL?_
M $2U !_PN3XB_P#1IW[0'_A1_LL?_1+4 '_"Y/B+_P!&G?M ?^%'^RQ_]$M0
M ?\ "Y/B+_T:=^T!_P"%'^RQ_P#1+4 '_"Y/B+_T:=^T!_X4?[+'_P!$M0 ?
M\+D^(O\ T:=^T!_X4?[+'_T2U !_PN3XB_\ 1IW[0'_A1_LL?_1+4 '_  N3
MXB_]&G?M ?\ A1_LL?\ T2U !_PN3XB_]&G?M ?^%'^RQ_\ 1+4 '_"Y/B+_
M -&G?M ?^%'^RQ_]$M0 ?\+D^(O_ $:=^T!_X4?[+'_T2U !_P +D^(O_1IW
M[0'_ (4?[+'_ -$M0 ?\+D^(O_1IW[0'_A1_LL?_ $2U !_PN3XB_P#1IW[0
M'_A1_LL?_1+4 '_"Y/B+_P!&G?M ?^%'^RQ_]$M0 ?\ "Y/B+_T:=^T!_P"%
M'^RQ_P#1+4 '_"Y/B+_T:=^T!_X4?[+'_P!$M0 ?\+D^(O\ T:=^T!_X4?[+
M'_T2U !_PN3XB_\ 1IW[0'_A1_LL?_1+4 '_  N3XB_]&G?M ?\ A1_LL?\
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MTZ5:IAZB]G7H\KG2E[M2"E?EYX.TH\W*^6Z5[.VS/F35OA/\+/BA^U/\4/\
MA9?PT^'_ ,1/["^ '[._]B?\)UX-\.^+?['_ +3^(O[4O]I?V7_;^FW?]G_:
MO[/L//\ (\OS?L-OYF[R4VS^@OT._P#^&3OV6/\ HVGX ?\ AF_AU_\ ,Y0
M?\,G?LL?]&T_ #_PS?PZ_P#F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\ #)W[
M+'_1M/P _P##-_#K_P"9R@ _X9._98_Z-I^ '_AF_AU_\SE !_PR=^RQ_P!&
MT_ #_P ,W\.O_F<H /\ AD[]EC_HVGX ?^&;^'7_ ,SE !_PR=^RQ_T;3\ /
M_#-_#K_YG* #_AD[]EC_ *-I^ '_ (9OX=?_ #.4 '_#)W[+'_1M/P _\,W\
M.O\ YG* #_AD[]EC_HVGX ?^&;^'7_S.4 '_  R=^RQ_T;3\ /\ PS?PZ_\
MF<H X#2/A/\ "SX7?M3_  O_ .%9_#3X?_#K^W/@!^T1_;?_  @O@WP[X1_M
MC^S/B+^RU_9O]J?V!IMI_:'V3^T+_P CS_,\K[;<>7M\Y]P!]?T % 'C&N?M
M ?"[PUXJU3P?K.I^)K/4="O=,T[7]77X;_$JZ\#>'[W5]/L=4TZV\0?$NS\(
MR^$="DEL-3TZ8_;]<MQ&+Z 2%&D52\*GC)0A03YJM:6'I>T7L56KQDH>QP[K
M>S6(JRJ-4J<*#J2J5OW5-2J>Z/%Q>!HQKXGW*4L,\9>-JCAA8U*]*6(JQI\\
MJ-&$\-B'.=6,(PIT9U9-4H\Y[./;IVQ^E+;RL)-65MN@4 <_XD\4:/X2L&U3
M79+^VTZ&'4;BYO+31=:U:WL+72M)U#6[Z[U*31]/NAIEHEAIEUMGN_)CDG,%
MI$SW5W;PSQ4JTZ,*M2I)4Z="G*K.4M$H1G3IM)_:J<U6/+2AS59152I&#A2J
MRAM0P]7$U*=*A%3JU:E*E"'-%2E.M4C2IJ*DTVN>2YI+W:<;SJ.$$Y+8M+NW
MOK2UOK23S;6\MX;NVEV/'YEO<1K-#)LD573=&ZG:RJPS@@$8K>K2J8>K4H58
M\M2A.4)QNG:4&XR5TVG9IJZ;3Z-HY:-:GB*-*O1ES4:\(U(2LU>$XJ47:235
MXM.S2:ZI,L5F:'RA\6/A[X!^)/[27P3T+XB^!_!_C[1+3X'_ +2.K6NC>-?#
M.B^*=*M=5M_'G[+-G!J=OI^NV5U;PZA':7]] EPD:R+'>3H&"RN& .O_ .&3
MOV6/^C:?@!_X9OX=?_,Y0 ?\,G?LL?\ 1M/P _\ #-_#K_YG* #_ (9._98_
MZ-I^ '_AF_AU_P#,Y0 ?\,G?LL?]&T_ #_PS?PZ_^9R@ _X9._98_P"C:?@!
M_P"&;^'7_P SE !_PR=^RQ_T;3\ /_#-_#K_ .9R@ _X9._98_Z-I^ '_AF_
MAU_\SE !_P ,G?LL?]&T_ #_ ,,W\.O_ )G* #_AD[]EC_HVGX ?^&;^'7_S
M.4 '_#)W[+'_ $;3\ /_  S?PZ_^9R@ _P"&3OV6/^C:?@!_X9OX=?\ S.4
M'_#)W[+'_1M/P _\,W\.O_F<H /^&3OV6/\ HVGX ?\ AF_AU_\ ,Y0 ?\,G
M?LL?]&T_ #_PS?PZ_P#F<H /^&3OV6/^C:?@!_X9OX=?_,Y0 ?\ #)W[+'_1
MM/P _P##-_#K_P"9R@ _X9._98_Z-I^ '_AF_AU_\SE !_PR=^RQ_P!&T_ #
M_P ,W\.O_F<H /\ AD[]EC_HVGX ?^&;^'7_ ,SE !_PR=^RQ_T;3\ /_#-_
M#K_YG* #_AD[]EC_ *-I^ '_ (9OX=?_ #.4 '_#)W[+'_1M/P _\,W\.O\
MYG* #_AD[]EC_HVGX ?^&;^'7_S.4 '_  R=^RQ_T;3\ /\ PS?PZ_\ F<H
M/^&3OV6/^C:?@!_X9OX=?_,Y0 ?\,G?LL?\ 1M/P _\ #-_#K_YG* #_ (9.
M_98_Z-I^ '_AF_AU_P#,Y0 ?\,G?LL?]&T_ #_PS?PZ_^9R@ _X9._98_P"C
M:?@!_P"&;^'7_P SE !_PR=^RQ_T;3\ /_#-_#K_ .9R@ _X9._98_Z-I^ '
M_AF_AU_\SE !_P ,G?LL?]&T_ #_ ,,W\.O_ )G* #_AD[]EC_HVGX ?^&;^
M'7_S.4 '_#)W[+'_ $;3\ /_  S?PZ_^9R@ _P"&3OV6/^C:?@!_X9OX=?\
MS.4 '_#)W[+'_1M/P _\,W\.O_F<H /^&3OV6/\ HVGX ?\ AF_AU_\ ,Y0
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M\+:A9Q>'O&-C?>#=+DT?0;;6_A[=:E9^,="\1V_P:U32M:UJV\77$&F7$O\
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M5Y4J>+R&KA:<)SJK"X?+J&31QE&G[>5XNK5RVHX.+2KQCAI5O8\JIT.;U?\
M9%\?:KX!U_P_I<'PV^'B7^N^"M0G^&W@?4M.O?A[XZ'A32O$FGZQK7C*\\>_
M [Q!IL&N>)[S7=,OK^&Z\ ^)H@_A'3O.FOKF0WUN\=..(>%E&FJM.ECLQQ4<
M-4Y%1P5+&4<-1H8?".5.NI1P=2A5Q=/DHX.*KXRO[&.&J1>)J\^70>#IXJE4
M48UJN6X/!O&P=;ZSB:V&Q5/$5*V)BJ]*,?:48/+TU.M5>'G+ZS4Q6&5'+J'V
M5\&/!6J?#OX9>$O!NM7UWJ&IZ)8S17<MWK>G>(OL\ES>W5Z--LM7TGP+X,L[
MG2;%;E;.R6W\+Z)'#:6MO"EI&L0SOCJ\,17C.FY2C"CAZ*J34U5K.A0IT76K
MNIB,3.>(K.'M*]65:<JU64ZLK2FTL,'A_JM.I324(2K5JD:<7'V=*-2I*:IT
M8QI48TJ4;_NZ$8<E"+5&FW3A"W'^(_\ DZ?X-_\ 9 /VEO\ U8O[)U<9UGT!
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M^R=0!] 4 % !0 4 % !0 4 % 'S_ .(_^3I_@W_V0#]I;_U8O[)U 'T!0 4
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M#G_^&*_^I-_8 _\ $!?_ ,HZ@ _X8K_ZDW]@#_Q 7_\ *.H /^&*_P#J3?V
M/_$!?_RCJ #_ (8K_P"I-_8 _P#$!?\ \HZ@ _X8K_ZDW]@#_P 0%_\ RCJ
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M )G* #_AD[]EC_HVGX ?^&;^'7_S.4 '_#)W[+'_ $;3\ /_  S?PZ_^9R@
M_P"&3OV6/^C:?@!_X9OX=?\ S.4 '_#)W[+'_1M/P _\,W\.O_F<H /^&3OV
M6/\ HVGX ?\ AF_AU_\ ,Y0 ?\,G?LL?]&T_ #_PS?PZ_P#F<H /^&3OV6/^
MC:?@!_X9OX=?_,Y0 ?\ #)W[+'_1M/P _P##-_#K_P"9R@ _X9._98_Z-I^
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M&T_ #_PS?PZ_^9R@ _X9._98_P"C:?@!_P"&;^'7_P SE !_PR=^RQ_T;3\
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M-I^ '_AF_AU_\SE !_PR=^RQ_P!&T_ #_P ,W\.O_F<H /\ AD[]EC_HVGX
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M@ H * "@ H * "@ H * "@#Y_P#C)_R47]D[_LX#Q'_ZRQ^TM0!] 4 % !0
M4 ?/_P &_P#DHO[6/_9P'AS_ -98_9IH ^@* "@ H * "@ H * "@ H * ,G
M4]!T/69M)N-8T72=5N- U--:T*?4].L[Z;1=8CMKFRCU;29;J%VTW4UL[V\@
M6ZMS'*(KN:,/LE<,X-TZBJTWR58PJ4U..DU3JI1JTU)6:A4BE&I&_+-)*2:0
MVVZ=2BVW1JNFYT[^Y-TJD*U)SC\,G2K4X5:;:?)4A"<;2BFM:D(* "@ H *
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M[']H#_PG/V6/_H:: #_A3?Q%_P"CL?V@/_"<_98_^AIH /\ A3?Q%_Z.Q_:
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M=):1V]E9^ OB'>ZGXH6^FN[>TNOAYI5IX4DO/B?I\DUA>J+WPC!K=N#9S9E
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M%UFU16)I5<11HU,+S_6(5JL*4J2J/E*^H?M0?!#2[#1-3OO%NH0V>NV6IZC
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M?AOQ7>>$B;S1E\1V6EMXYM=#D\.IXDN= >/48-";5!J<UK+'/':-'(C,5_\
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ML/B/9U[4SU2H$% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M5<5*GB*=*HI0Y(+G_M#,IXE>R7-.>']FX1A4C/W&N8W"@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@#Y_P#C)_R47]D[_LX#Q'_ZRQ^T
MM0!] 4 % !0 4 ?/_P &_P#DHO[6/_9P'AS_ -98_9IH ^@* "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M #_A'/VI_P#HLGP _P#$:?B+_P#18T '_".?M3_]%D^ '_B-/Q%_^BQH /\
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M /18T '_  CG[4__ $63X ?^(T_$7_Z+&@ _X1S]J?\ Z+)\ /\ Q&GXB_\
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M/@!_XC3\1?\ Z+&@ _X1S]J?_HLGP _\1I^(O_T6- !_PCG[4_\ T63X ?\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M"Y^T!_XB=^U/_P#.;H /^&EOAU_T+G[0'_B)W[4__P YN@ _X:6^'7_0N?M
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M4_\ \YN@ _X:6^'7_0N?M ?^(G?M3_\ SFZ #_AI;X=?]"Y^T!_XB=^U/_\
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M[4__ ,YN@ _X:6^'7_0N?M ?^(G?M3__ #FZ #_AI;X=?]"Y^T!_XB=^U/\
M_.;H /\ AI;X=?\ 0N?M ?\ B)W[4_\ \YN@ _X:6^'7_0N?M ?^(G?M3_\
MSFZ #_AI;X=?]"Y^T!_XB=^U/_\ .;H /^&EOAU_T+G[0'_B)W[4_P#\YN@
M_P"&EOAU_P!"Y^T!_P"(G?M3_P#SFZ #_AI;X=?]"Y^T!_XB=^U/_P#.;H /
M^&EOAU_T+G[0'_B)W[4__P YN@ _X:6^'7_0N?M ?^(G?M3_ /SFZ #_ (:6
M^'7_ $+G[0'_ (B=^U/_ /.;H /^&EOAU_T+G[0'_B)W[4__ ,YN@ _X:6^'
M7_0N?M ?^(G?M3__ #FZ #_AI;X=?]"Y^T!_XB=^U/\ _.;H /\ AI;X=?\
M0N?M ?\ B)W[4_\ \YN@ _X:6^'7_0N?M ?^(G?M3_\ SFZ #_AI;X=?]"Y^
MT!_XB=^U/_\ .;H /^&EOAU_T+G[0'_B)W[4_P#\YN@#0_9DTG5= _9M_9\T
M+7=,U#1=;T7X'_"?2=8T;5K*YT[5=)U73O >@6>H:9J>GWD<<]AJ%K=PS036
M\\:2121.CJK*0#;RL&WE8]PH ^?_ (R?\E%_9._[. \1_P#K+'[2U 'T!0 4
M % !0!\__!O_ )*+^UC_ -G >'/_ %EC]FF@#Z H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M&M9_NJG*.T,0\+*48XB/UKF@Y13A]1=-8SGN[0^K>UI^VYFN15(2=HR39/\
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MA-QY9Q;I6YZU/FC?#TZ56H^:/+&E6KK"TZKG?D]G+$OV"FI.*JW@VI)I7/\
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MI\]-*MF,,WS:MCJ,IS<I8NI!Y;B98?$OV\,=FU:&'AAI4(5=9>RI8O%4<!?
M8:2IRE4HRC&52&4973P&5TL)5J4JOLJM7$X3!YI1>(P\HX;$X;#4\3*:5:_O
M_P ,?@OXXU?Q3IGQ3^*EUI6EZS::N]UI/A'2- CTI=*T3P_X6O/"7P^LITA\
M6:];V,NFIXC\>:J]K'?:DC7/B6U82P-8F&MI-PH8F*KSEB\QHYA/$5.=3]CC
M,SJX*-2M1DZ<6IT<MRW!X.T;PC5K9BXUL32KQJS\^$'[.CAHP='!X#^S\/1@
MG)1KX3 +%8BI&K2YI<OUG,Z]#$QE%TYRH97ERK4H5%*G1\A\2_LM>+_!?A7P
MXND2GXB:KX=\6Z'=Z,='T"26Y2*U\3KXRUOQ)XUTSQ?\5;6WUZ^U^ZTNTTO4
M8O#MYX<CSKMY=R6UQ"3#;94,1+"8C+:M+"P]MA*"H1LKX:E2PV >&PV&HQJU
M'B*2^LK#X^C5JXFM"AB<NR^+C'V<\14[,72I8YYU*=18>ECJV+Q,:<$E5]KF
M&*E&K:7L:M+V=#!8K%X2I&-"G7KX&OC(4ZT*U2C&'3R_LO?%?QIH=_>^+/B3
MHN@^(?'UIXDO_'-C9>'O$CPZ3K_B:\AM!?>'UT'XE6%JVIZ?X$T_P[H$!U9_
M$5M92Z"+FU-P+F8SD:&&H2PN%JOZ_E^$C@HSA*4G[;_:\1F&<4H5)TX)8;,<
M9BJRIU)82&(AA(4:3C3Y>6"AB\2Y3QM*G'"XSVU:I151>TA3IT<+AL'E*K4H
MU9.^%CAZN)Q&&HXI8:MBLPQ;;GRPG+I==_9/U>\\4'Q'H_CC0[1;37M0NM T
MG4?#/B5K'0=#G\#>%/ VCV\#>'?B%HUQ/J^A:=X:NDLIDGMK1H?$VK1SV3R7
M/GAQJ5)2J5,1+FKXO^T/K=>G^[K5'CLT682J04G4H^U=&GA<%5EB*6(C*& P
M%2$(1H5*.(RA3IT<+1P=*G!X? QRJ.$A.$?W5/+<%C\.Z$YP4)SI5L5F.)Q]
MXN%:%2I4H^UE3=)T?6/&GP(LO$/PI\,_"WPWXCO?!4/AC7_!.N6/B'3;"TGU
M2*?PKXDL?$%_<VT!,5M;ZMJ4D%Z?M1CD2"XOC<>1+Y8C9SE3JYA@<5*ERX7!
M>VI?5:<Y4XO!U<KQ>4K!0J1_>4:4<+B514Z;C5C2A:C.E5<*M/*.'2R_&X.3
M4ZN,<:KK2BG_ +9',:&:?6ITW>-5O&4/;2IS;A4E)JK[2#G&?F6O_LLZQJWB
M6&6T\=:38> ](UGP;J'AGPG)X=\37%SH>D^!]-LY=&\+PS6_Q"M=$FTY_&%B
M-:O;VY\/7&H7R:A=64UR(Q%(F?/6_>UN:,,=_P *$J56%.*C&MB</6PN"J.E
M+FC3IY52J4OJF&POU:FJV$PV(O&I[13ZJD:,Z-/#6J^PE1H4<3S5I3JUU]=^
MLYE.=5KGG6S6BZF'Q->M*M-1K5))-M-0Z;^RIKVG21:,OQ'TZ3P9<_\ "L7\
M0P/X.NCXRUK_ (5K#+J=O91^)1XL6RLM.O\ Q]->>)KI)=&O9)9=7OK9I/+D
M#FJO)46)I4XO#86%?'5L!2I/3!^WRC#Y-@+NHI^T>4X;#4)87D5#]]AZ%9M3
MC/GE.:M6GRRQE?#^QQM3E4:5>6(SC%9IFLJ>'7NT(YI2QM? 5XJ4I1P_):<G
M&#AVGP+_ &=E^$SZ;=:QK6E>(]0\.>&_^$2\-7=AI6O6,MKI]Q):S:UJ]_)X
MB\7:^[:_K-Q86$UX=-.F6A> G[,[,'7:=?GI8E0IQPM3%JC"4:"4*%"AAX<M
M'"X6$E.I&A2D[PC6K5E&-.A"$8>RG.MG*$W57-6G5HQKU\4_:\OM:V*KSJRE
MB<0Z2I4)5HPKUH1E1P]&\L1B9RNJM.E0Y&?]EC6]:\.P>$_%/Q TK4="T?5_
M%%YH::?X.N=/U"[@\?:_?7'CO4O%MY-XJNAK'BG4?"&M>(= AO+*+2[:W/B"
M_O7M+EI(+>SSP-3ZH\HJSYJE?*\-EF"ERRY:53"Y5+ 8BG35.2J6>,Q^5X'$
MXV5253FI4ZN&I>S=:K7J:UVZL\R]G.I16-Q..QM*I&K46(P^,Q6'QN'PLH5H
MRC^YRJ&.G]2I*,9QEAL%)5:?U:*?>_&WX,^,?B?-ID/AOQ_I_A'1K'PSK^B?
MV7>Z%XCU.&UU;5A:06?B:R3PYX[\-K<W]E80W5M#;:H-0LXS=><+=G4JW*Z$
M*]?%RQKG7H8N.'IR4).%:%*-:K/&PI3E[2E&IC83HKV\Z%2KAY86'LFHU:J=
MT9_588&.&A&*P,YS]E)7HUFJ=.&%551Y*WLL*XUKT*=:G#$1Q,O:^_0H2C4^
M'W[.5AX#\2>']8378;[3O#=_XAU+3M'31VM5AO)_#'AWX>^"G2Y?4I_*3P]\
M.]$O=+"+%BYGU^\N_P!QN\IO2>-J3GBJ]7WL3BJ6)IRG&T(\V/S6IFN.FX)>
M\YSIY=A,.V^:AA, J3E453]WQ_5TJ.&P_M*E2&&G@9*56<IS<<!E]7#1IN5U
MS1KX_&9AFU=U54E+&8B$E+FI>TGY[XN_9-U_QGJGC_5-1^(UCIS^+S?>;9Z!
MX?\ $.C:3XIBF\1:)JNGP_%#0;7QV-*\226OA_0;3PTVH:38:#JEQ87%TTFH
M;IA''P852PM'"QTK3PM?"8CV<N=8?VV&Q$\54Q-*"G[;#8G$8F;Q4OJ]:GAH
MXCWZN&Q,>6,.ZM.G5K5YQI*$*^'Q=!S:3Q$88G+:F70I.HE"&(H895/;4HXJ
MG6JIT</3I5:"IU)5MZQ_9N\5Z%K/AWQCX;\>>&M/\:V,OBC^V;O4?!.L:]H+
MQ^(--TS2-+N]$L=3\=OJD.K^']+L+RVLI]5UK58G7Q'JZO D-S'!;[TY*C*I
M2IWCA\3AW2Q$TH+$RJ5,3AL1B*M*7*\/#ZS#"87#RC6P^(E&E@L!*52K*A6^
MM<SA"5)\]"E*O2Q.%KT&U/V<*6#PV98>CA9I3525)5,SQ&*E[*I0_>SJ1IJD
MIQE2JM^S/XU:ZUI1\3]"@TV?Q'X\\:Z$]I\/I+37H/&OBGPG+X,\.Z_KU]:>
M+8M-U.+PUH5W<PVEC9:/IJ226UE.TB-!L.$*=.6$A@\5%SI0PN*P,8TY.FJ>
M$Q^;/'X_V4JGMJL,37PLZV7TJRJ*.'HUZMJ52#C3CTQK2I8I8J%Y2E6RO$8A
M56I+$RRO TZ5.C-14.3#5<SP^'S:M3I<KE7A*"E'GE4EN:E^S;=#7-!U3PYX
MLTO2;'PS=_#JST?1+_PO/JEC;^$?AEX9\16GAO03Y/B*S/VN+QMXA;Q+]M50
MIDTK3X)+>3R/-;>O7Q&(JYEB95.7&8^IG&(5:*Y94,3F6 I9;AYTU%KFI8'"
MK&0C1J<T9O,,5*FZ$N1QYJ-&A3P6#P%6,L1A\+A\OHRC5FY*I+#YM2S/'5^D
ME7S)87 4*M24YN/U.,W[3GE%<3I/['+:3J,J_P#";V>H:'?Z9X/AU=M4\/:K
M>>(+R_\ "6C1VP@#?\)='H$V@ZAXE6[\0W%OJ&@:C<_:M;U9([I#=QS6JG**
MCB(82E#!TZ->KB,N@DZL,+-4,-ALN=:-9SC5_LJEA,-##N@L*ZBPN$]H_P!U
M6^LNI'ZPJ+Q=.G6J5Z%2AF#A#V,<4L5F&/S#,73C!WHK'RS"O0G"<JU.C1;Y
M8R;C[/U7X.? _5_AE!XQ>_\ %\%Q=>*[.QM8M+\*Z?KFA^#O#]W:0Z@+WQ!H
M/A?7?%6O0:+K>K7NH&ZO8M*;3=.8V5FJ6(DBEN+K/%PIULGK93A5+"1G[=4J
MG,ZLL)2J8>EAJ&%P\Y_O?JN#A24J-.K5FU.=1P=*,E!51<H9A1Q]?EQ$Z5O:
MIQ]G]<J.O*O5Q&*A!JC[>M*34YTJ4)-2FZDZMX*GYSX?_99\411>!;3QA\1=
M UG3_A_HW@KPWHMGH?@6_P!%,NC^$]9B\4:G-J-QJ/C75C>ZQXA\5Z!X&U"_
MGV1PF/P[-;?9Y/MK3IUU,3)XG%8VA%83$XJ?/&%.,7A<-[#+L;@<KI8;#RB^
M6EEM3,L5BJ:<VZE2E@5^Z6&7-#I_NGAI5:M:C?%N4ZD_]HQ,LPQV$KYA4Q<Z
M<:=*=3%X'#XC 2E1H473CF..J4Y*-7V2;HG[+'BG3IOMEU\1-#,ESXQ\$^*=
M;T#2_"GB2S\"ZY<>$==U#Q3>ZR?!]S\1+FRT#Q9K?BBXT[4[NZT-=.L6DT>%
M)M/NBS25A3G/#1PRPK]@L(L4Z$'^\CA/:Y1B,JPU+"SJ\]>.&PJQ'MXT:E6I
M#FI450CAIPE5JW6C"L\=?FC];IRIRJ4Y>RJUE4S'"XRN\9[)0I8AU,-AZV G
M)4J56K2QN+>(K5J=6%"E:U[]EK7+_P />%]+TWX@:5#J'AK0[2SENM7\'W6H
M:=KVN:K\0=,^(OQ,U;5M.L_%5C(8/%NI:%IEE+!%=+):VEQJ*">?[6!'<*JP
MV,HU\-37U?"/*J>&HUFZDJ.$R7"8FC@::K1]G)UHXJKA<?4K-<E3$Y=A'.@[
M2NZMJ^'QM&K=/,)YS5KJ.M)U<WY:*DJ=3GDXX' 5<QP.%C*J^6ECGRN#HPO<
MUS]G3Q[=:TWB_P /_%'0=)\;:U9>.CXKUG4? 5_JVG#7_%^A^$_#&G:[X0T>
M'QS9/H,N@^%_"JZ38Q7M[JH$>JW<\S2S2R";#V6'="M@*D9RR_$X=8:JXR5/
M&3HU\?4QV91C7C'V</K\Y8>',Z%2>&I9?@J<'/V<JCW6)FY87$5*=.>*P&*P
M^(PT9*^&I0PF%QF'PM!T_P"+*-.ICL7B:SC6I?6*^+Q4FJ4'1I4<.^_9(OXG
MLWT'QEH4$6A>+[76_#6GZOX:\3/8:9HFG?#'3?AGH>FW#>&_B%HMY=:AHUE8
MW-S:7-O>6,#'6=12>U>2Z^TQ;U*]6MB'BJLN6O76;K$3I)0<I9IF=#'JO3B^
M:*Q%##86AE?-556G/"4J25."IN$^*E3=*@L/.K4K4Z-/*X4U*24JBR^EB_;4
ML54LYXBEBL?CL1FS<VZ]/'.G+VU2%.$8Z.@_LKZEX;U2YT[3_'&CM\/-8\7^
M!/&GB?1;GP9,?%6M7G@F.UU/^Q8_$EIXHM[*RT'4?'%I)XDNHY-%O)99]<U:
M%I-MT9*O#XCV-3#.=-2HY;6Q=;!THNRC.M@:> P<Z[G[2,YY;0I48X;V$,-%
M?5,%)1A*C+VM8B"JTZKI*-#%XS!0P6+K13;JTWF.*QF,Y%-RG%8W#XRO@)NI
M5K3A0EI.<VI0Z#XD_L]^(_B5X[FUK5_'UF/!4^J>"+L^%YM%\1RW]MHWA6]M
M]4U3PS8W-IXZL]#6TUO4;9WN[Z^\.ZC=M;W]Q9!Q"D+1\F 4L%B%B9R56M1Q
M57%49<MG":PGL\!S<[J1ME^,4<;"-.--UJD5[26]],:UB<(\)2C&G"K@JF#J
MJ:YXR6)K5%C*JC'V<O:XC U(X2'M)U*>'E1IUZ=-RE-/=^$?P0UCX=^+O$_B
M_6/%MEJ5QXAM;B"YTCPQI.M>%_#>HZI>:Q<:QJ'C35_#-WXKU71X/&=Y+.R3
MW>AZ?HL<OFW#7*7+2Q&UTHR]CETL#KS2^K\KO>&&5"C.G*&#53VE6C3Q%2HZ
MU6BZTZ$72P\*-&FZ=6IB%C'+%9A'&<SA3I>WC&&GM*E.HZ$</#$U%RJO]0PV
M'AA<+4E!5>259U*DE.,*?$']G+X@#P]I7A]OB3X1NK/PCX^C\?\ A:VOOAI)
M/!J^L?\ ":WOC*YO_B%<'QA]LUC5))KP(LNBW&@PBXA-U-!<(Z6MM.'E4PW]
MBUE/FQ63X2G@8RU5+V%/)ZV4N<()JHJ]1U8XV;J5JE/V]*$80C/FQ$C$QCB'
MF]/FJ0H9K7JXF:YVZJE/'4,;3P[J2O%X.C2HRRV-*,(S> JNBY\D?9.S+^RY
M-?3>.[_6?&T&HZQ\2-)M=*\4WZ^&3:120ZWX@T^\^)L6FVJZ[(UC9Z]X3T'P
MOX9LH7GN)-.M/#=I+//J4S2M)OAJE/"1PE&DJKPV$Q^"Q:A.JIRJ0R_$8K,L
M/2J-T^1NKG&88[&8N4:<85:%>&#I4J,:-.HBHY5:M3%<SH8N6%QU&G4H3JTW
M1KXK X7+L/B*-ZDG!Y?AL'2J4.5JI];JXRNJM-8ETX9+_ [XH+\8]7\3:%XF
MT+1-*:+Q'J[>(M4\+MJ[76J>.AI_A>"T\,:9:^,;5](UCP=\// _A[3;?4-1
MBN;.XE\4:A*MF0TL*\U"FIX'%X7&5&XUZ4\%.5/W,94IXC&5<VS'$0K.,Z-.
MGC,1B,+@Z<9TJU>E#*,/)RY*<%7TQ#I1G@'A:49+"U*&(ITZR]IA\,L!EZR[
M!851BZ525.57%9QF->%*5*+EC53]JYS]I1H6G[',.C:AK5OH'BS3X/"]T/#U
MYHEIK&BZ_K6N:=J/@[PIHV@>$+.^G;QI;Z)J>A:9K&A66NA3H,=])=2SA;V%
MG,YNM*IB*6(C-QP]2=3'3ISPT%3Y)8Z<U[5J?M+5L%A9K!X.5'V*A1PN 53V
MD,/4IXAQJ6Q5'$5YU,7[2-&GC?:RASXBDJM:MC:<9TJ=.T<TJXC$5,9[>.(B
MI8S&^RC&-:BL+M>)OV6+C4+31-/T;Q-X=.D^'?!O@?P)I.B>*_">HZO9P:/X
M5.K:A?:C'JFA^+=%UC3?$E]XGF\,ZTNIZ9J-C/%-X0M(][>?)(NF)J?6,3F&
M)C%826/Q4JJE0E4I3PE&EA5A<OHX9TYP4/J-/$9M32TIUJ&9SHU*:5"FWST8
MN-#"4\4UC*V%I5G.M4A"<\7B\;BZ&*S*MBHU8U:4Z>+E@\%.-.-*,\/B*4\1
M&I4514H9MW^RCXHU.X\/Z9KOQ;NO$WA'18_AW;7$'B33_%FI^)]0TSP7<VNH
MZQI#:I_PL./2YD\0:K;22WFHZKHNLZ@]M?SV<ES(J1S*Z=:4,?/'N,'5AB9X
MFA:$(N$Z>"C0R^510C&C?!8R$<P:PU'"QKU[MJG&T5-:G[3 RP4%&$:^%Q&&
MK1DIU*7+C<57EBW2C.I*M:6 K0R_#+$8C$K"PPU"JO:U'4<G)^RKXECM]#O9
M/B%X>O\ Q+X8O]/U?2IKWP+?'P]?ZO)\3=6^)OBZ\\0:2GC,W=XVO:O)X8E<
M6VHVHM[GPE:3()(7-JL8>I4PCP$Z$Y*KA*."PT^=N5.=# Y#B\FH<L(\CC6A
M6S''Y@ZCG+VE6K2A/WZ2KO;&*GC'CHOVD*.*K8ZM"U6;JP^MX_+\3"A.;?)4
MP]#!9;2RB$%2A;+Z^)HQM3FJ9T!_9BNKAOB1J.H^.ENO$?Q-\+W/A_7-;MO#
MIL#9S^*-1MS\0KW1[=-;D>RAU+PSH_A30M/@:XFDT^W\*64D]SJ$S2O(X.C1
MP]'!0I2JX*ECL#7J4:\U56(PF"Q>(S"6$JIQC!RQF.S#-*F*J1A&FZ.+IX>G
M0A##0;'4K+%1Q].:P^/HT,8J%6FI.-#%U<%A<#@<3"E6E5IM9=3P.&JTZ<HR
M=7$5,=4<X1Q;IPZ7XF>$_C%XG^"'BOP%X8TWP#_PDWBJ/Q3X3M$O?%GB'X>Z
M3X6\!:G%K6G^'[F/4M%\(^,[G4_$EGI/]APW5I#;Z=;SM<WTEO>VGV>%)\<7
M'ZY##2K\M?$.6$Q.,C6BZE#$5Z=>GB<10J4XSISEA:SC+#58^U4YTG-JHG-6
MTP4J>75TL'&='"X2,:.%<90]O1C##0H*M"<Z52FJL*ZGB,*YT)QIQ]A&M2J2
MA4Y_D/4OV:_VI-<\(>*?!^I^#_V;K*R\9Z-'X<\02^'/C-\5+:5O#VC65P/"
M.@:9<>+/@-XDO=-T?3]<O+G5;F 7TINI?+AM7TV$3"YK$.I6Y91J7JT\3_:$
M'6A"O3EF-.K3GA:^)I\L/K-#"PI^[AIS4JM:=2=;$3P\EA%G@FL']7I\O-0H
M4HX54X2G2Y<%5@H9A2I2C-^PQ&81A2H3Q-.*5#"TH0HT5BHQQL>EM/A-^W'I
M]OXYL-/L/V8;&Q\<16UQ=/!\0O'S:GINKZ?\/=%\$Z.NGW-Q\ I;.S\,:9J&
MCC6[/2[73K6Y@GD2%=3*K-)=:8OV&-IUL-B*4OJE7$XZJXPJN%:=/,,?+$5_
M;XGE<ZN*A@JDLMHXN*I<M&GAIU*%54/95(R]3R^> JIQKUL'A<OPTE."5!QP
M$)^Y1HP<?94,5B)/$8BC5GB9.5?&*E5I.O1GA>2U#]FS]KRYL-;\,:?I/[.N
MA>";_49]8TO3M,^+OQ+7Q+I6H:?\,+?X:>!DF\23_ .2TO=,\,):6>KVMM#H
MED\EY96[/.C(TDDXFI/&<\\7&G7Q%\TG!RA*-)ULUS&KB,34Q%*G4A.LGEE>
MMDCC&M1;P52\90E"FHWE[^H5<&[?6Z&'EE$:E/$?O)2H90Z&*C1I5'_!EB<W
MH2S6M6J0Q$W6KXBD^:-1R-F3X&?MF7[K>:MH?[,']H6:^"K'1(]"^)WQ0TC0
M='T#X;Z-X@;P/I$&C7OP0U*1C9^/M:M?$]Q.+V,71T*QL5B@6,7"UBIO%/'5
M7.I3Q6/JYGB*M>,XJHJV8X..61<7R)^SP>7U,PAAZ=1SMC,?4QG,E#V$XP=.
MEA:. P<X>WP& H8'#PH7Y$Z>'Q]#'8V3E'_EYF2P6!PE=RC*E'"89T_95'5E
M)<MX]^%7[87A>_\ A?K'@CX.?"+Q%)\/M/\ !/AWPOHUA\9]>\1:3IUIX*TW
MQ-+<S>*;;Q!\)/!]QJ#Z[X@U;0=3%S::A&+6_P#!NER7.Z,-+5_6ISS;&8FE
M2IX2>8U,1+VKC+V&%P[PD<NP6&I0IU$X3R^EC,UJ4ZGL9TZN#QF*PRI1KPPK
MFE2C++50QO+CZM&FN>K)6Q=?&8C,\%FV/QLY2YJ<H8JIE."HRH1Y*E*K4J5E
M4JTJE2-#Z#\)?"/]H'4_AE%\._'UA\)?"M^/$-E\2=4\:^'/'?C#XA)XM\>Q
M?$;3OB!J>D^(O &I_#3P>+'PAJ<W]HV\@M?%]Y-:Q6ME:HEW"SR1S*<:&)R:
M>#A"-#(H4J5&G57M%45+!5<)]8E*,:'^U>WK2S2%94XVS",:TJ>Z&N:O3S?Z
MU.HJF<QKQG*G[.$Z%*IR4Z6%BFJU-T*.!I4LKJ13YJN"C4C&K3JS5:+[7X _
M%2?XL>*O%9\8:'I:ZUX8GT[7_%TGA6:YO=9UOQK#I.G^*;WX>Z4GC1D\&+HG
MA7P1X,T?3FUI-=_>2WES*MSB5;S*C2P\LOQ^ Q,9RP.*JK#RHWC#$U<-!U,;
M7JRQ5.-HT\RQF95\-5I1I1K4<-E."C"IS1IUS>KBL3]:RS$4Y<U;+U[>"EK@
MJ<X.I0P.'>'O&O4JX&*QF,G6=>%&M5SO%1C"*E[/"MO?V.WN-#UCPY:^-M,L
M-&:X\6W7AFSB\(W,BZ?)J?AOPIX%\)6^OM+XI)UNRT7X>^']2\-RQVO]EM>6
M>OSNKVLZF27H^MXJ53#8RK5]OF&'K1K2F_=H5G4XC?$>-A4HQUMBJU+ X:+]
MI+V%'#2C:I3J^RASJA1ITI86C*O2PTJ5&E&?UBI+%4'0R3$953G0K7C&+CB\
M9B<Z2=-O^T91K<WM%*K+T&T^ 6OR^-Q\3=<\:Z/=^-UT'6K*V;3/",VG>'M'
MU@:++X=\$76D:;<>([NYCTSP]I.K^,2UM/?337MUXPOYA<6D*P6L/-5B_J6;
M83#UJU*IFE&M3E7E/GE&KC)81X^OR6C'FJ0RO*J.&BFOJ\,)5=26(J8JK,NF
MJ7MLKGB,/"='+:V%?L:;G"$\-@UC94L/9RE!.I6S#$5J]1TVI.C@%"G#ZHI3
MX>']F3Q=X3U71?$/@KQCHJWW@7PWIND^#H_[&U_1M4UQ]&\)S:'I.@_$S4-)
M\<6NF>-?!L?B>^U/Q),M_HT^I++?R1V=Y \:O-UK$VQ>*K4Z4*%'&5JD70II
M?5J6'K5:%*G/V$N:"Q&79;1I8/"5,,L/4G'"X9U92IJK1JS&G"I'"K'3GB:L
M73K8O$)0IXJM7CB*N-QCPU2$8*C',\35JNM0K>WPE+ZQB.2C%U*=7#^Y_%WX
M4W'Q;\->&/#EWXHO/#L>D^+?#_B/7+O1('BNM8L=+@O(-4T2RF%XLFCKJ$=Y
M)&+M'FEMUYC_ 'H61.*=&A+,L%BY4U5PN"GBY?5JJ4X5HXC!8G!QI5W91G22
MQ'^T4W#EQ%)5*#Y(U7*-4JF(A@,3A^:,<9B*6$2KPB[4*^&QV#QOUBC"3?OQ
MGA?W'.VJ=1TZDU54'3GX%IG[(>K>%?#6F:#X/^(>G6CQ:_XKU75AJWAC7!HT
M^FW]QJ3^ O#NG:7X/\=>';FT\.^#K75+^&TTF34IK*[FU.]O;J$W$@(*OMZN
M'P>'E7;6%RRGA)597E5JYA'#X+"U,S;<O9NM/#8*&%IQJ0JK#X>%&,74G"52
MHJ%/#X>6,=.@H1KX^5>E"%H*C@)8K'8V67\]G5DIXW&O&5<1&I"K.K3]C%T\
M(Z="CU?@_P#99MO"VB6&@S^+!JUG%X@^%UYJTLVBO#=:QX=^%UG'JMAH%Q,=
M7D/FZE\27U3Q/>W<GFB0ZU=6A@;=]HKT)8N"Q6&K4*/L*&$Q..Q5.AS*4(5*
MN CE.71A>/N4\KRVA@HTDES2Q>$6*C*ESNFL?92E2QBG)0Q&-PBPU2I1BZ<+
MXC-*V9YO-4G*:C',OK>+P4X0<7#!SHPE4JRH*4N<\1?LJ^,O%WB#6=8\0_%B
MUG%UJ?Q U+1[FW\-^)5UG3I?%]A?^'="\Q[KXB3Z+#%X:\):M?6%I%IF@Z=Y
MUU:V6ISR-<)*DW!A:=&E2HTL31CB8^PHX;$P>D,12ECL-B<SG)S]I6C6S+#T
M*V#O"K&EA,/C<51I4ITG3A'NQ.(J2K^WP3^J.E6H8BA&5JD(5,)@YQPE.=-*
MG&K0HYG]7S.<9WJ8BIAH4YU(*4I'9:[^SIJ=[XP@\5Z#XSTS0FTV_P!'70["
M;PB=4M](\/\ A/X<^(/"'@K2(XW\0007CZ/XF\6>(O$:-<026\LEY! UJ#:I
M<-I.I7J+'2JSC7K8_P#M>M5E5@IKZYF?]GT/;PCIRTX9;@'@*M.[G5AC<=.%
M6C[91CSTJ="A2RS"THSC@\OIY7AY4>>\:N&R_&8C'5J<79?5ZN*Q$L!/V]%1
MJ1_LO"1J.M34H&Q\*O@1?_#KPMXXT%O%BP/XQLULM/L?"=KKNF>$_ RQ:/-I
M2W/@OP[XE\4Z_P#V%----]MFMK&XL].\V" 06,)262YRS*'U_*:^5QJ5*<J_
MUJU>I+VU6E'$4X4Z>'C4ERUIX?#1IMTU6K5*O/6Q#A5I4YTJ-#3"5:M#-J6:
MXEQQ4X.@ZE/E5*&)JTJ]7$5\37C#W/K.+G5Y:\Z<()TZ5%2C.<95)\KH/[,^
MIK??"Z_\9>+] U;_ (5=!X=T32='\.>#;GP_H3^%_"T*:A86*V^H>*-6N(M5
MO/&>E^$]<O+QKB6)E\):?:06L1\^ZN?3>.OF.-S/DE'$X]U:M2,:EJ4*SHXO
M"8:-*"BDL/A,'F>:TXP=ZE2OBJ==U(0PM&@N'ZJO[/HY=.I*M3PUHPK5)5'7
MJJ>*P6*Q=;$R511K8G%/+\/2G-Q451K8^,HU7BVX>A_$/X5^*_%7C6P\5^&_
M&VF^&HF\#:W\/]4BU#PO-KNIZ=I7B#5-.U#4]7\%WR:_86^B^(9X-/BMFFO[
M/5K<&VL93;L+62"\\F%"G)9KAL7S5L!F\,%"O2A)TJCA@OKZ=&-5<W+1Q/UY
M^V<8*JO91]G4C-TZE#T?;3I2RVM02CB<KK8FM253FGAYU*\<+&%2M1C*#G4P
MOU62H-5(^YB\5!M*H^;A/"'[-%UX,U'[3I?BS2HK+1KSQKJ?@JRC\+7*/HFI
MZMX.\._#WP'>:G/+XDE&K/X4\$Z->:3&(([ 7<>IF0B"1&:;HQ=;%8W!XZG6
MQ,EF&.PF.PDL3&T8Q_M/.,1F^.JQHK_EY4J/!4J+=1^QIX1P7-3JJ%/"A2PN
M'JX&*I5*N PE?+*TJ-6M.I4G#+,NE@_J_M':"HXC$U\7F56,J4_]MK>VUJ*4
MY\1I/[&KZ#-J=IIOC73YM%N(?#=[9-K&@:]J>N0Z]X0\)Z-H7AO[<Q\;Q:)?
M:'9^(-#M_$7E'0UOGNKFX5;Z)W-PQB9*O#$TZ4(X&,JF/EAEAHJ'L8XV<XPD
M^937ML!@YQP.#G15!1HX7 >TC.&'J4J]T9U(U\/7Q=66.J3A0IX]S5.G]9@J
MM:OCX4E1ITXTJ>:5L1B:F*A66)C!XS&JE%1K45A?H+4/@]8S?"_P?\)]-U-M
M/\-^')? MMJ>^T^TSZ]H'@_4-,U&\TB<FY3R3K,FEQPW<[F?=%>72E':7<.C
M$8E8C-\/F;HPA2PN)GBJ>'BK0ISIT:T<O5-JRA'+\2\+B:45%I_5(4[14N:/
M+2I5:>78O"5:[Q&*Q^'JT,1B:L5*566-G;,JTX/1U<90JXR"E?\ <U<0JR4O
M9*$OE?QI\%_C+!\1O$D?@G=+/\1=-\3:7XA^(^H:'H\FC:/I/Q"\2V[:Y/H;
MI\0+35/#WB'0O 7AGPSHD4DFC:['J$FG:1+%';)'>&#CP%*E*B\MQ]Y95?+X
MXRE.4N;%T<)5Q^8XY4IPYN6GFV.S?&T'AY1C/"TJ-/FKSIJC4CVXFM.CB:69
MX*RQF'5>KA*;4ZM"EBEA<!@,O^LT9U*<91P4<O\ KDJL)J$_[1S*-*C[2;P^
M(]HO?V;YVTJ?3](\80:/)+XXU'QK'+'X=-Q;P2Z3X%F\#?"K2TM'UA<6'A**
MU\.:EM21/M=YH(D46@G;8L7[;&T91JU;XF6%SB#KV:E]>SO$U)8O&M0E'F:R
M[%8W+*4).4HT*M"?M'+#QC+/"0P^#EAZ7L%7R^A+(Z2P]6SY,OR5X?%+"49*
M*C3EB<UPRQ\ZLJ=105?%4?9R=6-6GE^$/V:-7\-^-? WB.;QEH\&G> ]'\-:
M/96_A+P]XA\)ZMK.D>'/"G]@6GA+Q)<0>.;G2_$GA&+5[C4];@BUG2-2O[>>
M^6.&^C$'FS>C+&<V.S3&N#7]H5,94=&Z=%RQ,X*E5J4I1=.-?!X:E1PM"KA8
M8:I*GAZ#J3E"-2E5Y7AV\)A,/*HZM:A&@JF)JN4\3*5*O/$5YPK\T:S^OU)S
MEC(8B=>C*5;%SA2C4K4YX>SXP_9MU'Q/\1_%WC3_ (2K1)-,\6R>&KRXTK7?
M#^OZK=V[^$M*BL])\.;K/QMI^D7?@UM5@_M.:VNM%GO/,U+5$@O8&NXI[/SL
M*IX2G*,))5:6,K8ZA4LY<N+J1P\:.(K0J2G&53 _5Z<L,Z'U:\J&#]JY*A66
M*[,9['&>PA5HI45@8Y=B(QLI5<+]9QE?$1C.WNRQ5/&3PU7VJK4XTU)QIMSB
MJ?,WO[)%_P#9O$?V+Q]9WU]XC^*'A3XN:I+K_A>>.'6_%>C>'9]$U>/7I/"/
MB+0[R31I=1-EKFF6EA=V/]F7^GHQ>[220-=)+#4\NH8:*A1RNKFGU92<^:%+
M,Z*A*I-TI456QT:U3&2J8B<52K8;%/!QP]"%"A.G,I.M+,*F)C"=7,\%E^&K
M.,7:,\NS!8NG[%5)552PSPM+"X"-#WJD(T'B9UZ^(K5G4TC^RD\6@^,K.U\:
M6JZ]XHTOPE:+J,WAJ672OM.B>+V\:^*(]6TV;Q!)>:KH_BB]6RTJ^@;5%NO[
M*TJS@DOKB>)KF32%18;ZK]5I0BL'F.%QL%5NU*E@J?-AJ53V/L(^VI8_$9GF
MT:].%.G]?Q\IO#.E3=*I$81E/$/$PA-8K 9GA)<L+2A6S3#K!5<1&<Y3G*-'
M X7*\+0HU)2<88&3]KS5TZ6KXO\ V??&7C:9M9\1^-_!>M:Z=!FT-K&_^&SK
MX1FM-6\1Z;JWB"QETVU\5IJ7V>32?#_AS3[*\_M5M2LI+"XN4O&%TMO;X*G"
M'.H7DJM3"3J2F[5.;"1QM2%6E.C[*="JL=B<-BXNE*-X99@:-:56<:N)J:<\
MW3A3<G3C2>)Y:<%%T>6K3PV'I4ZE.K&?M8QPG]JX>JJC<)?VUBYTJ=!0I4EP
MEQ^R'XNO[*P\.:W\89O$7A);31;+4;#Q#IOC?5=2CTR/Q3>Z_P"*M T*^N?B
MB8QI>J:=<V^C6]SXD@\4W]E8:=!!]IN"#)770K0I8S#8J4'4E@L1@Z]*5XQK
M5?[/PM"&$6(DH.C)_P!H4:F/Q<Z-"C4QCQ5:A5J)1IS7/4A4=/%0H5/JWUJA
MBZ2A!U%3PU7&2J1GB,.XU(XA5(8>5&GAX3KNAA:^&AB,/2IQJU:!N7_[+7B;
MQ+HFK>'/&'Q'T>^TJY\:>+_&=@VB>#+_ $;4'O?'=QJ>G:U_;UW/XRO4U&73
M_ >N:OX;TDVD.GI:K):WDT=P]I%"N.$:PZRB56,:U3+*6'H5(\J]C7A'&TLQ
MQTW3J*K*-;-,92D\5)U)05#%8ZE"%L3%T>J=6<*F9RP,G@(8^TH.DHJK0GA,
M%3P>4I324)4\NGAL%C6G353$8K!X9^TI1IU%7Z3X;_LT1>"/&,GB#5-=TS7M
M,TWQ9XN\9>&[0:1K<&K1ZYXKOM3E2_UJ[U'Q9J&EO<:3I.KW>DV;:/HNCM]G
M6/S'*KY-5A:L\/AZ4)VEB:.$C@U4@N2+BY<V)Q$E+GJ/%8Z:=7%.-6-&5:MB
MI^QDZU/V&%:FIU*BHMTL+6J4:DZ;M?DPU.A3PF%3IJE3>%PCP]!T%4IU*Z6&
MPD95FZ-6>);J7P#\=CXFZE\3M!^(_AZVU:]\1^(=2L[37O M_K=II6EZYX1\
M)^$K,0)!XUL?-U_1;3PU?"QNQY-L8_%6K)-9N]PTIPPT?8866$D^58FEC*.)
MK44J6(E'%9E''<U&4O:4X570I83!59UJ5=2AE^7U(0A&A4HXC;$3^L.\J=.?
MU>IEU7"QJ1O&DL#@\QP\J%1TW3G5H5L5FF*Q^DH5H3JU*/MG!T98?H/%/P,U
M6;P-\/? 7@/QC%X>T;P7=F?4XO$%AKNJIXL']GWR1W6M3>$O%OA:^>\77KS^
MV)8XK^*VNIPR31>60%>(3K8F-6G&%##T,%/"8:A%3=/"<D,-0PDZ2E-JHL+@
MZ%3!TZ>(5:/)7=9IUJ5.1G23IT:L95)2KXG&/&8FK%4Z;Q$JM;$8K%P:C3_<
M+$8RM#$N>']G*+H+#K]Q6JQ?%_#W]F;Q-\.7DL=&^(NC-HFN^'O#FF>,YKGP
M&MWXFU/4-'E\0ZEK!T34M1\2W5CI&BZUXC\2:EJDUO=Z9JEU ]Y=I#>;YXI[
M*\2EB,'CLOC.K3PDG-X*\U*M0ME. RK">WJJ$/;/!1P%/%TY48X:53$SE*3C
M'VJKD.:&)HXR5IU_WBK0?M'0Y:N98G'U50I3J3=/VM#$0RV2J3K16#P>#CRS
M]C",>#T/]FCXJ7*6VA^(/%GA%+?X6Z1\*O"_PTU@^"[XZ/X@TSPQKVE>-_&=
MWX@T*+XASZA<W&M:YH'A1+J8ZEIIDGT*8"W>W?S;KJ6+D\14S.%*&$Q5?,)2
MGAHI2PM+!83*<5@LKCA::Y?8?4\7FN-Q%"+J5';!X%R5-QC&GC6HR4/J4,15
MJ866%Q525=S2Q-7%YEF2GCX8NU.%"<ZV78)8>I6HT*:5/.<<J/*^:F=XO[+>
MH7]S87OBGQ];ZW=OJ=YJWB:2V\+R:9#KUUXA^(VE^./&$,5M)XAO/L&GZAI'
MA;P;X7@ADDO'M=+TBYB::X^V_N<<'.G@JF"]E2YJ.!C@N2$G>7M<%2S'$^W5
M1)-3KY_F"SNM%+V;JX3"T5!*'M#3%*IBJ.-A*4*=3'O%*MR4TJ,J5;"X'*:"
M=*3E)UL+D5#'9?3K2JR;K9C5Q?*I05.6YX5_9O.B?$?5O&.M>(M/U_2;CQ[K
MWQ&L+&32-:37)O$.KN3I7]MWUUXKN=&FMO#]LR6FGOIWA_3KKR=.TU9;DBUE
M6\SP+6"PN'I./-7P=&O0H3BVHQ^M5<1/%8EJHZM18G$T\36I5?9U:=!_6,7+
MV-JU*&&K,(QQN(J5%3A1HUW@)5::CO\ V=AL)1H4XM.,?9JO@Z6,O4C4J*K&
M$8RCR.=3ZDI#"@ H * "@ H ^?\ XR?\E%_9._[. \1_^LL?M+4 ?0% !0 4
M % 'S_\ !O\ Y*+^UC_V<!X<_P#66/V:: /?)I8[>*6:4[8H(WED;!;;'&I=
MSM4$G"J3@ GTK*M6IX:C5Q%5\M*A"52;LW:$(N4G97;LD]%KV+IPE4G"E!7G
M.2C%72]YM)*[LEJ]WH?F[#^V%XDOM;U;Q)X=U3PSK?@*+PM)K:V\Y\.QVOAJ
M'Q5XT\.^#?A?J'BF[T'Q+J>H>&4N7UFZU34EUMK*5+'1=0=[+39("B]&'PU=
M1G1Q=:CA:LZ^78/V\W%T:&+QLZU:I&$XSCA<2L'@<+74\/3Q4YU\;5R^E2Q*
MCBXHK%15+$RI4*4YRPD<VQ$Z-^25?#9)@*D\7%3G"4Z57$9C+"TL)4^K\JH5
M*\G0K^P=1Y"_M!7VE>/?&VMZK\;?#/\ PBTOA_Q#9^&?B-/9:-%X;U'2_A;%
MHUUXGT_X?Z&NMMIWB#Q-JOCKQZND).)K^46G@5X3%/++'<5G&-=99BZF&P\I
MX^M.GB<-A7SSQN.C7KXK+<FPT:3C!0I5*N7YEBL15P\8>TAF&7-.G&JI4FXQ
MGC,OP]2I%4Z=L-B*T83I83 XC$4:6/S&K6Q,G*,XTL"LI6#HUJBY*L\UES55
MA,11ER^C_$SQYX;B\/2Z[XQFTS7-+G\5^*_%0@N;R?4?'!^'6C1>-?B)X4T:
M"[U9X5M[CXR?$32_"4%C:PF5+#PM=0%GA@18NN='EJ5*66..+5##O"X&$G&,
M,37J8NEPED-7&N24VL9BH9UG4\134:3G6P%2;4_9N?*I1Q-.-?%5)8##XS$X
M2=:O64:%3+:&)P^(XDQ;A&FG3K4\'P]@LBP=2$8^Y.IC>6I4<ZWM/0[+]H7Q
MKX8\/Q7-KK7AN[U?P/XC\1Z'XY^%EEIUUJ?B%K/PO8:K+XT\::Y=7^M3:KX8
MBU3QO']G\/02I]GGBUC1X5:Z_M)#:X5(NM+#QRGEQ6'QM*KA\'*<X*&$E*I4
MRKAW#UJ\7RU<=BL9#!_7Z57EJPI5,>G253+L1B:E03IRJK,9TLNK1EE^,K-S
ME-2IXR.#S?.9Q7(^3"Y5E.+Q2C.$>15\#!NI&.+P^"COZE\>_B9X!N=?\.^.
M_''@F?6%C^'?AR#6DT'0_">BZ'\0+GP[JWC;XEZ8+KQ/XWM=.2PT_P %'PS/
M;/J&I33_ &O5B8[6[3%FAB)X-0K1P\ZBC2QF:2A7GRP=;*\NHY?0>(IP<7S2
MEF^,>%C"C3Q-5*EB82BU0GB:;A*:C@*M;"5*%3&86C5>'UJ0IXC,,3BU@L,J
MD5"<IT,+EV/JXJK7^J4*D88-T7"KB%0J;GP,^)WBOX@S?\+)\?ZPD6@?#;X:
MZSK%U=6$4MIIFH_\)WK-]XC\/ZAK&F:4UQ'<:SIOPF\.^%[Z0VT+)N\<3/;0
M()%0:8ODR_ YCC:E-8?$RIY?@I4L1SP6&Q>'P-'&YM&7,G[.E+'8_!X.<GSS
MH5,MQ5-SY5--PC/&8W 99A.:I3GB<5B8R2I3E7IQKU,GR^5+$0E&E5HUL1A\
M\K0A&T9T)Y;5JR]I%,\[L?VJOB5'IEW=ZAJ7A!I=7\7Z)X0CUR"?P1)\+_##
MW>@Z[XRU'6/#GQ(_X3JWL=;B7P_I46FQ:1XE71]3BU.\M)YXOL]PEI)C[-QI
M8:G5J.BVL7.K.JH4<0_[.AAJ>*IX:ES5</BHU\7C*+PM3#5:WL<-ALT57ZS7
MP<U3<ZE"6(Q<L)S8FA2C2>'C"%649PS#%SI9?/%N,%5P=;#X;#UZV-I55"G7
MJU\OI4*F&6*ISGU7A#X]?$GQ),_A37?'_@3P+XJTZ/3+_P .+?\ AN76-?\
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ME"C%\LFW4Q=+*L%7P52+5#'X2684<PQ-:TJ5?^S(4YP<?9U,54+G]L3Q%?\
MAKPQK'@_4? >NS:EI<&J>*+DW^F0:+X$E^)WC.+3?A/I7BK49]:@L](OM.\(
MQ:[>:C;WVH6#W-_I-G:&6S_M)&4="=*O1P^(E[&*A@\)4Q$.2="IF5/+L3F>
M=?5:[E&C5CA8X)8/#1CSQE/,\+6E[5T94JG16<*,L8E3G5J4,5F$Z5&&L_J&
M#Q5/*L+.O3:C7IK&XO&8;'5:OLE]7P>#S))-TXL[/X>?&/XH^*]5N8-:\=>"
MO#W@;PK8:IX\\1>/+K2-+GDO? 5U?Z?I?A*&6^@UE- TQ[W4M#^)$G]LVCZA
M:2Z9I6F3PH[7?GUO1HQ<:-6M3J1G!X3"?5^24'BLPQN*Q%2A2A*?[V%2GEKR
MGV^&5)5*F*S:'L94HQA"7+6=6,IT:3C+V[Q-2G64H2CA</@<'1CC)3A"<E./
MU[$R>'K2FH4H9=C:&)YZE*=O6OVF/&L/AKP7H^F"_N;"+Q%KD=[K-[I\LD5S
M:^!O!%E=>/O&\T<T#K)"MYH/AV314EC.X3^([95^9UKSG*M''8>-&@\36P$*
MN/6'4K2KU\/*EALKPRC_ ,O/K&>XW*:-2B[1JT)5XRO'F1VT:<,1A*\%6ITO
M[2]EEU&K.4E"#S'FIXG$1G!KDE@LJAF694ZLIPA"6"C*4TK)^*GX[?%;P=J=
MIHWQ!\3^";&;6;#X8Z/JWB'4-!3P_P"$/AEXW\;67B_Q7K%C?7T^O,NI1Z3X
M+\.VZA;^\LQ=ZCJ^D!#!'?- G7*GAXUL7A?K]-T<+C,3AHXSW83Q$<JRZEB<
MPE0P\VX7Q5?%8&&#A&5>IAX3S"K5CB88'DESPE.MA:>/PV&E'GP3QWU&IS<U
M'#YAF^%RW)W5KQC:K.CS9C+'0H\JG' TX*6%>(A7EY9X:^-GB6W\3+XEU#QI
MI-]I?BOQ8$TOXC^*DFTKP;X:TSQ*=;\,_#_79[:RUJUT6&PG^'OPU\6:\EG<
M211WNI?$70BLMN;D*3#0]GAZ-+$\F75JE*<J\Y3_ 'OM9X6.>X_"*AB/>6,H
MX&KPQ@:=.*;PKCFE?V5>%#$4ZMXM.=3%3PLJ>,AER@H4ES4GR4,;1R6E5DJ:
M<J]">=9EQ!4]MS+ZS@\HPU*+IN5#%4^T\5?M)^.;&ZTWPAX-^(?A7Q7XFEUG
MPSIVCWLGAO0]"N?%4_C_ %NT/A**3PWJ_B:#5]2TRT\,7<>H:C?Z!HD5J]L6
MNH+Z/R9( L"E6Q^%IXJG["C0KQHXVG>4)4Z.#HRS#-JTH/GKX>I2RR5+V4,1
M['DQ\*M*5.JIQHTLL<_89?C*^'KT^>IA,3B<'4FTZ;J+FP. HQJ1Y:-=8K.<
M-BZ--476G5PT\*U*FI+%5^8@_:.^)(N-7_L+QGI-V?'UUXK\=^$;W4Y?#ERD
M.E+XKU#X=_#GP%X'T/4=:M7UR6X7PLNJZY:Z9%J6HVUQKT,"V\5QJ ECQP\,
M36P> H4(0JX^&$R^M&-1-2Q6)SFE/-$L2H2E7HX'+\/..$>(ITU2E[/$5%7I
M4\OJQJ]>+C1PN,Q%7$2E0P<,7C,!5A>$)X2&10PN'QU6G%WA+$8[&XJI6P?U
MBISRPU.BG0J2Q%.-#W#X\_$_QGX6O?AGI5MXBM]!\4Z;X*\2_$GQ3X<T=X!#
MXRUO2[/1/"'AOP+8/>SK<RZ=J?C_ ,8VH58TD;R],5I2"%$E5:$<7F>;87+:
M_P"XC"AE^#]KS<]+$Y[C:F!P&/KPIKWJ.!PN'QN*Q$M(TJL:$E:Z<>?"5/8Y
M7EE3-5&EB*]18C&NC3JSE# Y-@Y9KG*PEN5*M*4,'AH4YR]I6PV(Q,80:C4G
M3\>B^,WQ/^#LD7PEU/QGH6NVFAOI_AJ?XH^(+71_#0L]8\*^"=(\1?$"TLKC
MQ;XGCT[Q%K]Y>>*_# LX;K4)[@,GB*3R+E=/6"/6K6I8QU)X:B\-1C4QTL'&
MGR5:N*P.&K8/*<#2HX:+=:4H9C3S.E7G3IUZKAAL)1DO;8V&*(C3Q=*^(Q%3
M#3J5U@'B:2GR1P>89G4SG,L5[5Q?)2HT\NP^#G1I3EAZ<%C:-925"'U>?N_C
MGXQ>// ?P-\#:[XBU'P;HOQ+\3+;-=KJUU8>&+6YT^UBN-7U<Z&OB^^L='M?
M&#>&X(Y8M-UG4[&V6ZDN%W2+;"&3#'R^KXVAA80E)TL/[;&TL,XUJT9TL/2I
M8B.!C4:^LTXYM7H4813EB*F#DY4X3JWE'3+T\1AJ]>35JF)G1P4ZO/&G*%7%
M5981XN5*-Z,Y991J5IS48T/K<(TG*%.I&_C>A?M*_%[Q)K.DZ%I$VE0ZII>H
M^"XKC0_$7AS2-"\9>+=)U;3-'\:^*M1UKP'!XLO]<\/0Z=X'UI;*&ZTNTFLY
M-9TBYF>Y6TGCLX>BLJ>"J8JOB5'$8; +,%B:>$G*JH4\KI5,/B,0I\CG0K8K
M,*,JN#PN*LEA*^"I.IB*V*A46=)NI2A14W"OBJ<9X:K4C&$98C&UJJR["QES
M>PQ>&I4XTECL=@YU%-?6ZM*&&6!JJ6O9_M1:E>I\-/%G_"VOAA9:!\0M6T"W
M\2>'[K3H1IWPOL]3MKSQPNG:GX]_ME;!?%$?@3PQXCTZ]L-0=;C^T]1TZX@M
M+6 "*ZT5&G@L35PV,JPQ='#4L16JXNA4C&C5GA,))5:6!3B_KM">/QF5QHSH
M\U;ZM[>K-IU%"CI4YZ^%Q=?!T:E"O1JPI4</7C.-;V5;'T\!#$8NBX*KA:\5
M[;%*E65&BG1J8)NI5I2KMR?'WXK^+=#\5^+/#6K>'-.\/Z;9Z9_PC%@WAU[^
M[\5^(/BGXKN].^#GAHZF=5B;2D;PG+X/U?4Y5M9IW7QO%Y+VPM [80P-6=/!
MX7&\]/%8[$83+:U'DE3J86M+!QQV=UZB4DY0R?#XZ-+EIS@Y8C)<<YS7.Z:N
M=?#T\36JT(RJ8/ 4<=F$Y7IM8C!9?56#P\<+5DW0E/-\?E>;+#2DJBIT,7E\
M7"=2:,[P9\5OB)X9O=!_X1[5G^(&D_$OQQ\3_ /@#PQ+'-=VF@S?"^RL_"7A
MI+K5HKR\N-(TFXO-%U[Q%J]Y?/+<?922VZ[DCAE5*57&O!X:+A2J9KE%?/(8
MOEYZ="CB\RR_ZNY1C[*$J>!R?$TX/"P=-5LS<L+3G&I4YGC4=/#O$5Z]12AE
M>8X'*<12HJ<*F(Q*RS-,7F*C&KS26*Q&>Q^J4J_(J%+ 4Z.(DGA*<L0O;/B%
M\5-=T#Q3I/PJ_P"%B>&/!/B>/P%I/B&7Q5K7ATZE<>-?%&M:M<^'-&T'P9X1
M6[634HCJNFW=UJ<-A]ONK6WO-.A01-=?:HY36)Q.8/!*T<)6P]'#X.3]K6JN
MM"MB)U<3[-QJ4\+0P]&SKQA3IU:LL14]O0IX"M"IHXO!X++L1CW"4,7]=EB:
MU*7LXT(8*.#YX4(34^:O7J8Z$<+&K*I.U#V?L,35Q5.5/Q+4_P!JKQS:66D^
M,-+UOP-K=JVKZWHGC/P1;V+I9_#+3%UJ7P'X6\4>/O$::C)=^&-0N_',FFW=
MUIVI16BP:4^K1(C2Z)/?OIAU2Q#PG+4]AA,XPF"JT<95=/V.#Q>85,%B:&"O
MSTX8NMA\JK8SVU*-2$\1C\+1A"6$CC*%&<U*>(IQQ--057%Y/6QL*V'3C2JX
MZAE6"S"KCL33BW5GAZ%?%X.E3P%:%/$*-'%X:5:G5=2;I<[=_'GQ;H_C#6-?
MM/B-H/B?0?$FIW_@;PU\19I?"V@>";/0?AKI5KKWC>\\*0:KXD@T+6O$VH^,
MO%Z:):"6_N)WL_!-[*(;TV#^?G14OJZIJG*C5QL:^8133J8ROAJ6(CE.58>G
MAFHS?M:\<=CZU3"8>I[6EB<#34(2QF'G1UK1?N34Z-3^SY83!U8+FI4J..S*
MA6S+&5)U7*3J8?#Y=@,OIT55JTX8?%XG%<U>?LJU&?H'@'X\_%?Q-\2?A_X$
MUC6?"\5Y=I:VOB2R\+Z/IVK7UM?Z9I=SX@\2)\0/#6K>(M-\1^!HKG0IM&BL
M-4TZPU#3+?4;Z**ZEF^V06HZL'25:KC)U8Q]GA:%6<U3J<V&YZ-.A@*]*AB$
MI5(XBCGKQGLZ6*@HXK+,+>C)U)/$+@KU*D,-2=&24JF)A&$JD?W_ +&OBJN(
MPDI4&Z5.O2JY(L+.M4PDW/#XRO6G.FJ&&E3E4^)WQ#OXOVA(;J]\?Z'X0\&>
M&KW_ (0#1M:\6+':^%/#'BF#P<WCWQWKJF\U.SL->\6'1;OPMH^E0W;D0-J&
MMRB.9;":WN.++FN7&U:DIQK8ZGC:N%<81J5*F"RS$8++%0P4$I3]MC,VQV.A
MBDH5)U*&54X0IJ4Z-2/=CERQP-&G352%!X3ZQ&-1<BQ>8/'8F@\>DXRH4L%@
M,LIXBC[_ +];-<(I1A3K.H_3?@YX[^,?Q%URWM-:U32M"T?P9I%G=^+F/A!X
M-:\4WWB'7];U#PG8O#>:H!X-OA\-;+PSJFJ6AL[B59_&,:0BT^S[3UM4J6'J
MX[$Q]FJ<,-AYX:,KJCCZ64T,1G#]JN?VN'P^.QU/#8>-.4G[7 8FG.M45^;E
MJ.HJL,+1GS<]7&XB&(<%RU<M68RP>65*;C+V<IXJ.!S&4JBO'ZO+"UE3A*LH
MP\=O/VLO%&J>+-9O/!6J:'KOA2V\+^.=<M= BB\-R:BD-E-8^$?AY;78TOQ+
MJ&J:)XB\0_$#6=(BMX-:AT]IK47J'3+>:V+5Q8:A7Q^ KP56-&MCZ.7X?#5T
M_=P^-SO&TXX"3]GSPE2PV5QQF+QT54J5*4\/&HYT82=%=V*5+!8^A"K)1H9?
MC,4\PI*,IUZF7Y1@,57SFK1IWA4FZ.,H4</0J1A3I35>G"#Q'.JYUG@;Q)KW
MPV^"?C?QU)XMT^[UB^UJQ^'WP_U;XBZU=VOAVZE\')#X$@U74]1NIO(M1KWC
M*S\7:TEU<36<%Q_:UC%-<PQ%)(^G'5Z*H95'!TE0CF]>681I>T@ZD,NKQ5;"
MTL/.JU3]M2X8P6$K4Z5::C+'RKN;G5JRC/EPT:M3%8^MC7"53+\/'#UY454]
MA+,G4J5\9STJ:DZ-*GG^9U<JJO#PG[#!X*FTY1HWCP#?M1?$V[TG1-+T[5+.
MPU77= U?Q3I.L>*-%\%Z7K>L22^)+WPAX5\*>&](M/&MUI7Q#AFUO1M2O9=7
M\)OJ#W.F:KH'V6T2345NY"=#$3FJ.%A"6,I4,!R4)\RE7Q&/A6QD'C*"_P!J
MP-'"X)4:&,:A*F\3'&UXXBA1P=2@ZBXT(^VQE2*PE7%XVE.=.=-_5L/EM' Q
MQ#H55*5#$5<3B<6Y83VKISI1IO"5<-B,1+VD.DNOVEO&D_A+7_&<7CKX<Z+X
MA\*R>*-$UOX42Z1<:BVDW>DZK-\.=/UOQ5XB34TG\'BZ^),NGZA"-5CLX#H;
M3Q^5//#+>P.V%<\).E7Y\#G%3 1HXB\%'+X9IC*3POM)OEI5\3ALN]N\?AG*
M-18V$Z5.,(T?WSP_M80J4\;AIK%Y71J5:]&G>%3'RR[+_KV9K#TZT54AAJG+
M.AEV)473ES87%3JU(8REAUJ:K^T5XKU_6?$@\$^,_"MOX"\*:;XHUW4O'=KH
M$'BJUU'PU\-/"MA'XOU30Y+?6H;1[K4_B%XFM-*L'9KF%!X*U?$-QYGRXR59
MX;%8REAI2OSU,)@TW'$5I8['K+LAP,E.*DI8VIEN<XEUE%\^'JX!04'4]H70
MIWQ& R^=>D\776"P]>I+FA2H5E0JYAFN,Z1JX;!X+$Y)2E'VE&-&OCZLIU:G
ML)4UX]J_Q=\>>'-4U:&_U3^WIO!WA;2[_P"('POTB\U&)HO$=IX8F^._Q,UA
MICK+7UK:_;K_ ,!^%[&XE;[+;CQ!?Q^6;6!X*Z)0IX>IB?JU6G7H87%RH8/$
M8B<:>%A2RJ6#R/!5YU5S1H?6,^S2OC<?]:E*4\NREU)<W+"L\HJ6+A@)U(U<
M&\RPU.M.,*;Q.(J0SBOC*CPM3#4(QMB,)PYDF)6$>&_B9ABJ4,/3C.K[W;/^
MTK\5+#P]KVL7?BKX6W%I=R^&[+1=175O"-C9KKMK!JVM_$;0_!OB-_%$_A+6
M;BS\-PZ2VG0:YK]O,MU-=?:Y'\M+:L*_)0A3IJ->JXUL54O3A%8NO@</1IT/
M:T<-44:=6:S6OAJ/+AIU7.A/$4J7M*^&G4C="4<1[.<(PHU*E.$94ISE/#4,
M1B:E.I@Z=6O37MH2E@:68U:LJU*E!U*. GRT*6-C%^U:Y\;=3\,?#WX.7'B?
MQ=HW@W4?B;:WVIZEX]\>:#9^#X?"^@V&@77BIX[_ ,,7>O3V2^.'L#INFK8?
MVFT)N3?7T<$D%I]B:\R5+!9CC,#.K&']EY?6Q5:6'O66*K86I@<'.E@U42E%
M5\5BWB(PE&M4I8:E+#MRK3AB(XX&52K@:>*=-UYXO'PPF'@_9QC2C7^NXBG4
MQ-2G5<)TZ.$P52FL11E&EB,1/#U$J=&I)1^8].^-'CCP[HZ^([OQ+H3^(;^W
MA\5RZIXNU.V\,//>_$:2Y\4MX>T"S\1:]9>%[#Q-HOP4\/>$7@TK6KNUMOM7
MB62:.3*S0W2JQG@HK"SI3C6P47@\51H.-?%JMAZ4,?G<L.JEH8NFN(<XR_+L
M.J4I8B&$P6(H4U4Y(^RTBHUZSJTJT*U+&5IU\+5E&JL'4P\*KR?(ZWMX:TH8
MS+\KSW,:ZC3CAIXRMA93=/VT&^T\-_&+XK^+O&-A!HGQ%MH-4N[?P!X*71/$
M/@A-,_X1^YUG0;CXR^.?%WC+P1:^*W:UU;3_ (;IX>T2)UU&.V_M74KSRBL1
M^SKT5*,,(\P]O4@J%&KCJF(KTZD:E&E@N'\'0P6(JX+G7/3ECN(LQ=&I2K\]
M6C@Z6&G-5E2C.ICSS=/!/E3KRP\)X:E[2*J8K$9SF>)H8*A5C1]K"M_9^599
M6S&%6E.%+&P]K[+ZLJUSBV^+7C75M0LM1T7XDZ/8?$&R\#>(?B7X>\+M8"\U
M3XK>(/B#=W/A/X+:98^$;GQ#$L>_P5X274-3@L+9H+,>+EN@MJZ_:Q.'I3IU
M;>QY:U+^S,NKX24KO"XG'U:&<YZ\6XJI6HTLLI5,'AEBI*ZA0QWLY0I4ZF'E
MV5?JBJT88ZJZ>!^NXVM+&4IKVBP.31J9516%IP3H8EYIC<5F&)P-)SJ3JU,/
M@:4Z=>M4A5CW7B#]K+Q%=>#]9F\/^)/!,'B>R?XJ:GJMM;R6=VO@_1/#U^?A
MI\/]/U]Y-0*Z'JNO?$K4]#U!7U(1LFGI?(8A]G,B\\:$<=#!4L-B94Z&9T,K
MIPQ<+?N\7Q'F-&>64^6R;G@LCEBZF,C3:E'&8-/W55C3>>&J+#U:KQE%UZF"
MKU/:X2$>7$2PV1Y94Q'$%>C1E)^WA_:>$J8+!SG.C2J4L;AJBG+E;?/_ /#2
MGQ.\$VVIVD.JZ;XNM/@\VOZ/XETS6+C1KCQCXN\._#C19X/%?CKQ1]GU676O
M"EUJ.LP1SZ==W6EV^FR6MS9SR3W)U./RME5^O5:>+I4J.$P^9U)0C"<N3#Y<
M\5BI9;E2K5J;J1C4>-]C5S&C7E3JT<-+'4H4%5R^I7GG&C5P_L\'5K>WQ4(X
M&M*I0BZ]3%.O0H9MF$,+AZ4$ZL*&6UZU#!4\+"?M,;1PZ=6-/$PP\/;/AGXY
MOO$'C3XC_$WQ#\3=&\;^ OA-X$BTN2_\%6RIX4M/%>J6D?C'XAVUA%I6I7Z:
M^FBZ)I?A2&UGFDN;N)M5U& R%Y'5<ZU6CEF49GCJL:LHU\4Z.'JUJ<82JX'+
MH2_VFE'2,%B\?C,1AJCC)4W_ &923D_9NK.J$:V9X_)L!AXJC5JT8XFK0C4I
MSA3Q.85/J^"P]2M9595,+AZ%>K452-.$HYA2KQI1YH0H^+)^UE\0;R[\37&E
M^*?AR=-.D^&FTYM:U/P5I^FZ;KOB75-0UB/P[IWB73?%^HZ#;>*;7X;^&_$M
MXVG^)-=AC:]DTDR3V\=RUJZ]G/#X2K]:;E4H8F-*4J#INK46#P<JF;?5H57"
MA7A3Q>+R>G15.I4G"C6QLE/%RP]TW)5L10J8-PEAJF'Q-3V=15DZ:K8G"T,F
MKXI4X3Q-"&(C]?<^>C3=:KAHTO9X-3YU]!2_&G7O#_P6^%OBKQ#K5AI.L_%#
M7],T>W\6^.?#]GX1TSP;I>NPZSKUKJ?C33K3Q'=Z9%J5EX=TO[$A@UBWL=3U
M2:S\@P0WR1+MCJ=*CF6&R_VT,)%8>=;$5;M.3PN#5>M##4<3&E5AB:]3EIK"
MU8U*V"B\16J4Z\<'4IR6&YZV"S/'4J?MU@Y0A2I.I3GSRJX_#Y:IJMAN:&(P
MM.M7EBX5:'+'$8.%.G&K"=58D\OU;X^^/XT\0^'?#OQ*\$ZOXGT/3-#U?P#'
M<>$WLM?^,DWC*]U&Y\-VL7AFZU"WFL_">GZ)I^[4_$&E6[0R(]U>QR6-OI,Q
MNL\.X*5&KC*4Z$<'F%'"9C02<'A\%1IX+&9EF5?G?M<+[+ 8^'LJ-50<,;A*
M].<:LL10PE.:S7)7AAINI[? XC%X6LO9SC.O#ZS@\-@,*U.-/&5JV98&O;E:
M4\)BLO5*I.56>*,[5/CG\;[W3[WQ-HGBKPM8Z9?_  ]\1^/]'T%?!:7=_:6G
MBCQE;>%_V>=%BU"[UY//UOQ9)'?RW%Q<6QA2)#!%9K,!=55+#5X.&%KMPQWM
MLBPDE5I2A"GF.:3JU\;AJG)*5J.2X3V:S+EDZS]S%0J8:G*5-[\U*+52K2J1
MPM.KF\ZDZ')73R_A_"TXYGB:+4E[2KBL5)5\IC%>R="=2&(E5E"!1UG]JCX@
MV=GK7C/PQK_@GQW9^&/%OC72]<^'>BZ?:V\NA^$?!.A:EX>N_%OC'Q0=<N9_
M"]KJ/Q/TRVELI[NUMX5TG5C(Z7"6TEU;YPE2J0P=6D[8?-J2G1Q$Y)X?"/,L
MUHX;)85*D.6G4KK XB&)QU&=:DTJ.,@O83PSE,C3]E]9P^-YXXW+*>%C.CAH
MJMB,;B</@Z6/SM4J$N1QA1IO%X/#J#G'Z_2P476J+'0HK;\,_'3XP:]K']C_
M /"8^!(]%G%_XCO_ !Q::-I>NVFB^&O N@7UU\3_ .RU\/\ B>YT?4M/AUW5
M_ 6GZ?=MJU[+;3:AJT=Z+F33S#2Q+I8? 8W&2]M3I990QN+;=->TQ%"?U7#9
M51?,HQAB<1BEFU>,Z5&=&OALM5.G'GJ2K+.E#$5L1A:-*G3JULPJX'!TZ4:B
M<*&,JSQ&)KRNINK5H1P-"E1G3E[.M2Q&.PM:3A1K4XG/3?M5^/='D\$-XJ\0
M:!IMO8>$M UWXB0:%H&E:]XETJ_@\.77Q \6P^-_ MWXETS6]$T1O K:-#::
MSX:BU6TM-5U)_MK-#&+4],Z4:&-QU"HHU9X;VN'A"E47U2>*H0HX"M!8N;4L
M+4>>5*M/#/'QHX6K@Z="^(]IBHU(.C#ZU3PJP<G.GCJLI8:M43HUZN%Q>,JK
M*J\,-4IQC6I+ 0IXC'TJ,WC5?$\M##K"5)/-O?VB?B+XHT+QSIP^(7ASP]I^
MJZC\+O VF^,=)N/!Q3PGXK\=:IJ&H>++/2M;\.>*=8L$O]%^'.G7.H+;W&IW
MUU'>75B$G+3B).=*GA88.KBZW[NEC\3-RC"I?%87(\KJ9KF*47&G&>'Q5:.&
MP&'G1VJ2Q=&K*I[/G357GJ8B>$P]2?+EU3$1IN,'[&>9YA0RK(JE1U))*5.O
M4KULP55)1H4Z5>-"',J-39\*?'GQ]J%C?V^CZ[X>T3QR^N>#=9L_ NKZ9<W_
M (H\?1?$#^RO$$5]<:9J6M_:M \&Z'\,[_2%O]4TR+R([_2=;G+PI8M;7&[A
M]5GA8XI0C3P&)EA\TH4ZD9PR^EA8T\5G^+JUXWE!T\7B<9#*Z-91C.G2P$$\
M3',<-3H\U9.%+$2PM:&(6+P%;$99B>>=1XZI"IC<LR*A2IJ"YI8[^RZ.*QCA
M&4_9X^4VL/\ 5,1BJOK'@#XS>--7\;>"K[Q/XH\+6/@;Q]HGBOQ78:1-H\.C
M/HWAK5_&&C>&?@G!+K]WJ[RZEXI\3"^EEC@%O;QS;)X(H#-;+),L+AJJ>(P>
M*3EF&&P67RK4K.%:GF>-IXK'U<'"BN?FAEV P6/IXV3G*:J8:EB4J5*K4A'3
M&U*=+][1E[+#QS'%X>,G^\IU<%EE*.#QN->(C^YA&KFE?+IX**DG+#X[D_>R
MAS0Z#]H_XE:SX5NO"GASPO!9W>O3PW_B:*"]_M#[.^JQ7VE>#_ASILITZ^MF
MQJ'Q,\7>&I'BF\Z*:ST35%:,[=\?-A*=7%YA]7H35*5*.'H1J\JJ>PQ&9U:E
M)UYT'**K4,)DN%S_ !U6/-!QEA*,HSA/EDMZKHX?!.M7BZM.4ZM:I1C45*K5
MP65T)9ABE1FURQJU<5#*\NIN4HIU,SIQ<:J;I2\WD^/'C3P]XCU;P3XR^(OA
M#1;";Q7XAT>Q^*^J>&;?1-*@B\!>$/"=[XSTKP_H]QK,]KJNO3^,/$IT[3;*
M>[NKD)HVM,T-ZUBBO5)PQ=&-2C/V7-''8FA2C^_Q6*HQS/\ LK T8T(Q4Y5'
MBJ6,JUZF'I54\,LOI1A"MCXUX1*E6P\5*;IU94O[*PN*4G*A1PF+Q>#Q^:5Z
MSJ3Y5+#K+*. <92J4Z4,3C*DY57#"U,*^(T7]HO5O"/BW7_%/COQCX?N[2Y\
M->+X[/?'=^'X/&5O\(H['PKINE^"O"FL7XGMO%'B'XH^)O%8GM[:.>X,/ANS
M@<*CQ>6X1KU,#B</A*499KC%AJ^&PLG%R>.SK$_V?E*IU4Y<V5K"9+7Q]Y2?
M(LZHU)5'RRE-3^K?7L#[;%2PV7T*GLJV)JQC&C3P%&A+-,RQ->24(T<91AFV
M1X"<*L7.=7+<>J6'I:PC7\>?'KQ7JFBR^%/$/Q"\.>'M=T7Q!:>'/'_@_P .
MVL*^*]0T#P/X5M/'?Q?\6W&-3&H^$M$N(+34=$T?R8/G^UV4QN;EM4B2TJ3I
M3Q-'&972JYCAZ%7,,51P]XQE?+<QK99DM"LUI6KYIGE++U7P[4(2P>.E05%.
MC5JSBDJN)H5L)5]GE>,Q=+ X92JU''EJYWAZ&(Q/U::<9.&39-C:V*^LM4IK
M%Y;7J5'2IQC&=Z+XV_%KP5X6A\57-QI"Z=IGBZ33M5\&:?X=U+6M0\1ZAX<\
M':M\3/CS>6NOW>N75S96.G7<>N:#IUO%:A8-0\/PHSM!=+:Q56]EA94HTZD,
M;AHT,TE2J3J0PE.G@<OMDF7XS$5*E[+&9\L+B*E:4I0AEN8*I4=1P=>-T*53
M,JRIX3ERVOC*V2PC#%*\HU\WQE#%QP=-1E"-66$X6K4ZM148)2Q&%Q,H<D:4
ME/W3X,_%7Q1XY\4>,;N7QKX4\;^#?"_@GPYJ6KGP/IUG=Z=I7C_Q E]JU[X/
MT;6]/U.\DUA-&\/66GM*)AY\LWB"%SY8*V\,XQ1RW+<WQE7GQ=/ 8FK0PM50
ME2GBX8##^UQU>-'WH*E5JU\/1PO)4J>SG0Q5&I4K3A[5Y8:<L=B,FI4U'"5L
M?AWB<1AYMS6%IXFO"CEL)XB2@G5_=8_ZW^[@FJ6'K0I8>%94Y>#ZC^U9XSFT
MWPKXHT+QY\-5TCXAZ-I5I=?;;73YO#OP9\6^-/$GA>W\$Z/XA\0KXCMUU77[
M/PE>^+M4UC2KN>R=SX8+1+I\<\2S[0PT*.,_LW%8NE*U;#)8VFW]6Q#H4,9C
MLVI8&7+[.O06&PD:&%Q'.YQQ.-P$JBDL4J-/6K5I?5,7BZ-#$0J8;ZWRX.5&
M?MXX=.6 P>*Q]-QC5P4ZF:UL#[2E4A&%+"_VE&7/++JM=U?&7QQ^*376B:7I
MOCW3II'\1^--?\ 7UII5MHJ?%O0($\&_#WP#IT]E#J)DNM!U+XI>.-2EBN],
M+)=:1X;MK[S"KI/<9X;"_7*V$PU2G.C7EA(8?&8:?-[7#RS7-,?1P^85*4>2
M45@^&\OQ>9XB$G3=#%/#KDI5)>SI*=:&$CBYSE"OAX5Z=:$Z?*G5H95EE/-,
MUPV#KN<\/&K5S.> RBDJ\IU)_6<;05*LJ4JBV+K]HCQ=H.EVLW@75_#FLQ^%
M==\9^!]1^%@M'U'Q#H^C^#[?Q!X+\-^(/%VMW.MRZGHWB#Q)\3M,\.6NGVE[
M&HGMO$B1%+F>&:\C(.>83H2HSIQ>>X6A4PU51;PV Q698G"4\MPLW2@HUJV&
MPV(J5LSH/V<J4<'CW!4HX1NKI"-#"?688]UH3RJHI8A0IS=;'0PM)8[/,52H
MS49PP=/"QQ4L!6I\U.M5_L^7M9T\QHT:<7C/]H7XL> )_%7A_5?&G@W7=0\/
MZCH]C>76GZ)H?A3Q)?W&D>#;+5_B!9?#/1?%_B2/0_%&HVVN>*O 5O;Z;>ZT
MUZYOM5A@2YFBB6WE.EB.1X95(4JV-QL,/**CB*U3"_6,/E^ JU<+3<:TJ*S'
M#YY2Q/U2-3$J&#PL%3O75:>-*GBX.'UAX;F>!P$JL9572HX7'5)8[%8JC6Q'
M[RG1J?V9#+Z]!8J5"ARXJ6+G4C2A[&7VUX?\4O<?#^;5KC7-+U_7_#VARP^)
M[S2[!=,AA\4:7H\5WJMI=:!_:NH/H5['.ZM+I<U]<26YE$32MC<>;/Z\<%@\
MUQV!451H4L;4PTE46(I2^JRKT6X55&FJU.&(H5*3DHQ]ZG*,K2C(VR>,<;BL
M#AZG/'V]7"J=.HE3Q%*GBU1KT(5X+2%9X7$49R:C&,N=580C3G&*^ /#/[8?
MQ8U2R-_K6D:7H6C1_"?X/_$IM<FT">,)I6OW/B/1?$6I7\%_J=K8Z7<>*/&F
MG:/IFA:?=:E!';Z5>S:W=7:Q6TT<'JYCAJ6%K9C3IN5"6&SBM@:4*SC9+%8;
M"+),)4G.5%?693Q%7,<SE>*P="A]0J^QQ5>A4J<V#J?6L'E6*BWRX_"8VO/E
MA*;IK+JM+$YEB$H*4GA\)@75P>%E"G4EC<S4:E&E6P?,X]EX$^/?Q;\=:]?^
M&=.\9>#H;%==U":X\;#0]#\0V6E>&/!'@^WU?XC7FF?\(SXHETG4K6'Q'XK\
M#:/:3-J-V;6X.L+<2WWV3;7'/V-#+ZN8UW4I8/ T<QQM2:5YUL)"M1P.74G*
M<*<:5>OBJ&=XB-6-!TZV%RV*A2BZOM2XJN\73H4HTL15Q;RS"4Z,)I?5\PKR
MQN+Q:J)5)SE2AEN'P4?9*I*I2KYIA:E2K",E37->*?VF/BGX=\/6DL_C7P^G
MC'Q)X+L?'V@>$7\,>%= U&TL/&6M:I9?"GPU$/$OC)+OQ7XDU>.!;?48-(TJ
MX,<MFH TSST>ZU>$Q7UVEED8TUF%+$X++\1%R=2C#,\13PTL92Y*//B/J&7*
MK*=7%/D4Z3E6C7E[&K0IZJ>%AAO[1G4E+*)?7ZM*O27/*OEN61:GCH2E&G3^
ML8Y*GB,)0Y7RJJ\.Z-;W*YWWB?X^_$K0/.\87.O^&[?P=IWB;QQI4ND6?AAI
MY+CPS\(OA]JUU\3_ !A+K5SK!D2VC^(NERZ5IT$-LJJSVBSRSK>?N>.NVZ=1
MX1WJ8[!9ACL'3K.-*5*A7QU'+.'8\[?LZE7&U\5E^-G4JRI4G@<76M3C+#*H
M],%0JUJF%PF)2H8FE7R3 XB2O.G6Q^)A',LVBG#F6&H83*HXZG)5)>TAC<OE
M'GO45&>7\*_BW\3F\<_#7X7WOQ$T7QE//;6+^*-6T:TT+Q1?OKC:1/XT\;VG
MC#39O$MAKGA?PXEKJ5CIOA[7M*LM2TM2VG+=33&^AM1ZE.A0EC,RI4XSE@<I
MAB:-&I-\OUBA@/9933JUJBBYT<VJ9I"MB,30Q%*-/$X>C6]A:<G7CY+KUIX'
M"XNGRT:^95</B)4FU4EA99C4ECXX:C!NE#%8&CELJ5.%;#3]K0JU)2J4U1PL
MZ<NT\6?M!Z]%XSUZV\/^)O"UC#X$^(MMX;UOX>W%C'J/B2Z\">'[#3];^)7Q
M'\3S"^CN_"FB66BW=VVDS?94MIIK73S)<77]N6]O!Y.&KP^J4LRJPJ8C"RHY
MQ4KPI1L\&L$LQPF7TG)7<\9C\TP6'A"BU>>'QBA"@I4*V)7J5Z%:=:IEV#CR
M8^,LJIX=U.6V,Q&83P-6<:,.=.6%PV"Q<I5ZL+U:=;"XN5G"C&G5Z6?XF_$;
MP5\(- \=^/\ 7?"]AXA^(NL^#M.TR/5='3P]X2^%D'C6^+0R>*;V36'?57TC
M2[N..>6>^TV*_OK&"VA^QF^#+V8JC3P6/P.2U<3'V_M*]+%8Z-O92G@<NJXK
M%+#4Y6C%5ZN"KT\'[2522EBJ<ZD:E.BZ3YJ%>&)P^89MAZ52M@(157!8?DY*
MTZ&(Q\,-@JF(;DY1M2Q>&KXU1BG0H4:[C&517?SYXW^-WQ2N?[%T72OB'9^?
M-KGCG6OA]K-AI=GHTOQ;T"-/"/P\^'MO-91WA%SI.H?$_P =7TT=WI<9@N]*
M\,6U_P#ZN5)+C*&"J8]TL'[^#QE7!1PN*HM2=7!U<VS+,,/ALRE0YH22P7#N
M7XO-<12J3INABG0C:E.2IT=OK%/!/$U:GL\7A:6)I8BG*-DZV&RK+*6:YKA,
M-7YY8?VM7,YX')Z?M9.I4CB<905*M[*=8U#\:_B'\)[2+X9W7BG1=4TW2?$-
MYX+TOXI>((=$\.HFG?#CP+X3F\91VDGBSQ0EAKWB:X\6:V;&TBO=2N+MAI.N
MSO%>FP"M=7$_VC-XJE".'^M?VCBZ5*@HSJU:$,R_LO X>EA8J,W+ZS2Q<ZCP
MM&LOJL<NI*$*V.C7C-/"U,'1M4K1Q5:A_9>&Q+JN5.-+'8[#8[-<57G4:C&=
M%Y=3P512<Z-"&*QE3]XJ>&EA#WGX%>,?C%\1=0N]1\6ZMH.DZ%X.AT;P[K6D
M:;X6F@OO$_C"71)-<U>[.J:AJ1.C6-K8>(/"T,UA#8F2+4M-U.#[0L:F.ME2
MA3P_UBK&+J8F=2G2ITJBE2I/"*A@\94C/WIU8+-\/FV'PRDXOZK2H59NI*HK
M<ZJN<XX>C)6I)UZE5ZU'2Q&)KU<OH3I\D*=*L\G67XO$3BZD9RS"U.-%4DY?
M5-<ITA0 4 % 'S_\9/\ DHO[)W_9P'B/_P!98_:6H ^@* "@ H * /G_ .#?
M_)1?VL?^S@/#G_K+'[-- 'T!0!\VZG^T)\.[222PLH9;32X_%.N^&M2UW7?#
M6LZ=X3O(_"3:U<>._P"QM0CTYTUV2Q31M2@$L*-9R7UQ!:FX-Q<+$\T'[:.%
MFH25*MA_K5.EROZS5H.I2PF"GA<-;VE3ZQCL7EU+#Q45.O1Q4*N%C55BL0GA
M95X2G"->E5ITI3E4C&C3K5*=/%UHUZ[:A3E1P$<7B:]Y6H?4L0L5*C&E.2R/
M$'[2?AFTO]*T/1? OC/4O$2^-=*\-W^@7O@S4[?5-+T_4/#>I^+M2UBVLXX)
M&"Q>%[&*5C*UM' ^N:='?/;^>RH*I%3]K.2CAZ%/,YXJI&47/#PRZAAYU+V?
M)*+QN-RZ@YQFZ<G4J>QE5JTE3:<;4G&#4:E2.73PD*BG3CBEC<;4PE-4DX<\
MJD,/A,TQ'L?9JK&G@:GM(TJ4E4&VO[5OPUOM0MQ;:-K\^@:AX?\  NJ>&]=.
MD&*3Q'XA^(VGWWB+1_!NDZ7=K%*NNKX:L#JUR;B6".*)B9"-FX]$\/5HU\;A
MI0OBL'C:N!C2I_O)5'A,-3Q>+K+ELHT,-"OA8J3;=2K7C2A%5N6$W./LU'FO
M%4Z-6OBN92Y<)!9A_9&'52<5*$Y8K&T\9AX^RE)0CAG5F_858U%ZQJWQ1\$^
M'_"NB^,=8M]4TM?%]Q8V.CZ'?^'KVP\8ZQK$\,TUOHW_  CMW!%>?VE!;VEW
M-*)U6.WM[*>YEE2UA:8937LZM/#T_P!_4J1=>$:6J]FJ<:LZTN;E5)0A*"J.
MK[.4*LH8>26(E"DU3BZE.O6:=*GA'*E5G-:0:KO#1BG'F52-6L^6BZ7/"LI*
MI3<J<N<XW3_VCOA'KDOAVTMI]2GU7Q/;W^I>'-&G\/78U74[SP_XDN_!_B.V
ML[9XR&U'0=6LK@:E*'$-E:(+V2X%F?/JE3]^<5**C1PV"QDJC?)3IX#,L-5Q
M5#&SG-15+"RHTYJK.IRN%9T\-.'UBO0I5<76C!6FI1E*MC,+[-Q;G+$X">&A
M4PT8QO[2M.6)HRPT(<WMX<]:FW2H5ITZ7_#4_P &XVN$AO=<G@DT^#4]#N-/
M\+:M?Q>-+&7Q)HO@R*;P=#I]M-/KX?7=?T*V@6*$&ZBU&"XLQ<6I\T$*5:K'
MW:%1U/:X6DZ+A)5H_7J6*KT)U*;5Z<'1P6+K5W4Y986GAZD\7&BDKZU;8:I*
MG4DH>QAC'*=TJ<)Y>HRQ-!U-(^VA*I&G3@FU6K2]E0E4J)Q2ZQ^T+\-]'T:Y
MEGT#Q3!I5E_:=M-=3^!M6D\.Z7XITK3+G6V\+ZK<Z=9W26FNJ;8PLD44RQ7Q
M73WD74F6U,1A6KNE#"2I2Q%;V4,$ZE10IUZU3%4<OA"C4VDH8NO&A.4/=:A7
MG1=6G1J2C=J=)U98F3I4*%ZF,>BEA\/RNLZ]:$W%QC4PZ6)C&7[Q8>I1KUH4
MZ56,WI^'_CUX)UA-2NC8Z[>S>&M,U>/6/$FA>$=>U;PS)JWAO4K71/$_A_1-
M8M[&2:2\M]?F-O#:W45K)>+!--;+/%:SR0W-4_92Q6'YOJM>>&6']IRTZF)H
M8N4UA*\5S<DJ4XVG.?/RT*=2%6LZ=&I&H\:?.^2E5Y(UJ"E[>,)<ZPM:%!UZ
MU*<;*JIPITYPERTW^^IO"NV*<:#XJ]_:C\&P7'AR+POX4\2:Q$VL>.(O&%E9
M^'+E]7\)Z+X#\/0:MK>M+::>LMK<PC4?$?AJV$XO%@/]L7""5KN(VS9N=.C3
MGBL1/V.6TLNJXV6)46Z=)T\P_LV%"JU9TW*6%S*I%*,YU*66U)4(5*=JBN/-
M5G4PU"+GC_[0PN 5%VBYU,3@WF/M(MM.<5AY8>+:TI5\9AXXB5&\C4A_:8\!
MG4-<=[::]TFUN+.V\&C1=/GO_$/B@P>%]'\8>+=5MM*DCA%AHFD0>(_#]K+=
MSRPJ+^9[5B+EX(I;K1E@Z5>>*7L9X6MCE5Y&JD*."P&(>72Q%:<+\KEF&'S*
MA3HP4ZE6CA75H0J1]K[.,/..-6%JX22K8;%8? 5(R=XR>,S&%?%T,'R2BDJK
MRY8/'.3E:,,4O:NGR)RZ?Q-\;/!.@:!\-?$6FZ;+KVA_&+4-.?3K^WMET^S@
M\-W?AVY\5:KXO\0O?6Z&STS3O"EC=7LWVM(VQ$(7:-F&+Q-">"S'$95C4L/]
M0HX[$8N;<94\-3P;A3<K1;]HZV.KX/"05/FDYXE5$I*#35"LL5@8YAA$ZU2O
M5PF&P]'6&(Q%?$5?9JA3C*TO:4:%/$UY0LVH8><;)7E'I/!/Q5\'^-]3U7PS
MI%EKVFW>D:!HWB-;+Q!X:U#08]1\)^()=3L]'UO2XKZ!/-TVXFT?48A#*D%P
MGV<>;;HDD9DFI3G'#XC$5H\JPU5T,33GK5HU52590JTUS.\J;NK<VL9TY6J0
ME!:*T)87V34J6+566&K4FG1K?5Y48UO8U(Z25-XC#OG5H5(5J=2C*I3?,N5T
M[]HCX7376L:;&-=TZYT"QT:>ULKGPQJ%M=ZQ;^(=3ET70[/P]I<4+7D]]?:I
M;-!#ILEM;73;!)Y A4R+G"4JT%4IQE4JSJTJ/LEK5<ZE&OB875^3EAA\/B*U
M>3GRX2E2J3Q3H15PK1CA9^SJRC2I1CB9NJW^Y2PE7#T*Z4E\4O:XO#4Z"A&7
MUNI6IT\)[><E$J77[2/PYLK>]O)]'\;I>Z1?6VF^*--'@G4VU?PG>:AJW_"/
MZ/#XAC5-D+:GJ0CAL1;S71NHY%GB#6P:5*HQ6(GA*=&2E3QM>GA:5354GBJT
MXP^K2E))QK4VXSQ$7'EH4I4:U:4*5?#SJJK+V"Q/M$XSP>'JXR=-+GJ?4\/0
M>)GBH1AS-T51=1PEI*I4I8G#THSQ&&Q-*EJ:[\=?AIH6DR:\;AY'AE^(&DZ;
M*NCWDC33?#B2XLO$RP-:6LMP=+BUNWATQ)8(Y!/=W5M# LCSQAH2K5OJ]+"J
M+Q698?#5\/&HW3C5CC,;AL!@/:2M>*Q6(QN'J44_>EAISQ*7LX3<=&J=&4WB
MVZ6'P>(C1KS5I*A)Y=6S2NW)/D@Z&!PN)EB'*453JT)X>;55*#YEOVEOAP(I
M--U;3M>U'5XY-8L+JUTOPEJ=SIFN:MX,N&L/&;>&+C58;8:UHVBZI UO+J9"
MVR2RVUMYWVRXCMVJI4H1ISQ=-SC@J<%BXSJPY:D,%*<XT<;4IQYI0A6A!5*'
M*G/$TFJN%C7I1G.$TJ6(?LZ52"CB).EAYQ@VX+%5J%+$1P7.U%>V4*LN>G+E
M]C*C7CB51E"S]*O_ (H>"++P;X=^)=K'?:OHWBO3-*N_#EUI&B7$^I:CIVL:
M<=9L"RSQ0'3+5K!3,SZC+9PQD!)'65T1KQU.IEN+KX'%0<,31J5858IIQ3P]
MU4<II\C4=H^\Y3;4::DW8SP=2GC<+'%47:A&,7'G4HRCSU(TE!4[.HI*;2G%
M1]Q1E.?+3A*2\F\1_M+^ 8? 8USP1H&J^,I]8L?#T6EZ7#X>N[;1[;7_ !Q?
MQZ9X)T3Q=?-;&+1I=3UJ^M=T:I=2Q07<=Z\:VUQ#-,Z=&57%X+"QE&-.OB,-
M35>6E&G3=&CC,15CS<C<L#EDGC:M-J#IQI>QFZ=:U,TNJ5+&8BM&HG@Z6/K5
MJ,.1XEQP53$X>K:+FH-5L7AJN$H5)3Y,154W2=2$*DHQ>+?VF] TG4-!TGP]
MHEQJD6L6>O7S^)-0TO5;+PGJ&E>'UBT&*?PU>6]E//X@CN?B#KO@_1+?R;<Q
MSQZ\US9M=)$-\T(3Q=2<:*=.,H865#VJ:G4KYCBL/0RQ3BM:<,11>+QLJLDO
M9X?+ZLZBIPE"H$X_5,/[3%0E)X>=2EB5AE&I&A'!87%8[-%K)2G+"8?"5J7L
MJ:D_K=6EAY\LU5C";1OVF?#^K3P1ZGHT^CQ1ZSXOTI4NK#5[_4?$UKX7UC3O
M!2W?@[3K+3)&NIM5^(%\^F65E.ZRW,.EW5Q%YBQ2>0Z25:%"M1C.7UK"X?$T
ML.N1XJ*Q]7$XC*W4BI<BIU\HP&*S2O44E'!TXQ==PIPG66-2;P\JU&O.E%X6
MNZ-6JJE\.WAL+2_M+V;2<W/"8_%8;+%3<>>KB*\*,(O$5:>'EHZO^U!\*-.T
M[4;K4M-\9O-HEIXKU?Q3HR>!=7OM1\*VOP_N=-BU^\\31V\$EMIJVWV^TFMI
M'N6%VL;BQ,\D10+#P6*GAEAI1J0KSPD854U&G&ICL=BLLH0<I<KC5>-P6+P\
MH).:]A4J)2HKVAT0ISG6EA(I/%>TEAXT'*"J56L'A\P;C%RLZ/U7&X.I.K)Q
MI4I8NA3K2IU*G*=!J_QZ^&.EZ_<>%-535+<I8:Y?M?7WAVYM]!F3PGH,WB;5
MD^T74:-LM=)LYI1=O;K:&2 P1W#3@1GGJU94\/F.(A3<ZF5T*V*]E=>TJ1P^
M*I8"7LHJ[<WBZU"C3C95*JJ0JT8U*/[PFC:O6RJC3;D\YKX?"46HR:]KC,-4
MQE&$[+13P\*E2;7-&FU*G6<*MX$+_&K1/#WAGX>:SXV\/W]GX\^(/AL:[9^!
MO#.F2^(O$J6MC96>IZK;P01I'->#28]6L8IE3YWN+M8K:*2254;MQ5%83'XK
M+HS=>>!BI8JK2A.=*#A*.'J5?=BYRIRK>TC02C*M4HPE/V?+3JN$8:2Q>$IX
M^DG' U\1['"3K)4I5(U_;5\'&:F^2A5K87#^VJ1J3C2HU%R3J*7)S0ZE^T9\
M&=(UZTTO4M3DL8X+_4=);Q)=Z'=6WAW1=>L_#UYXHU30K_5KB!#INJ0Z+I]]
M)=*8UC@FM9+.YEBO5^SUC37.ZWLFI.G"M[-TVJGUJ.&KQPU6.$]ESO$\M=^S
MIQI<WMYQDL,JK@[:PIU*L*;A2E)R^J5*E-Q<:F'^NNG'"RQ,)\KHRJ/$4+QF
ME4I0KTJM:-.C451[VD?&KP5K>MZ;H4VE^+=&UC5+M;?2+?Q-X.U?17O+)M"U
M/Q.NLPRWULJP:4NGZ)<M*T[0S6T_V6"ZA@FNH%D&O9PQ4ZDH47@:6*K8F,IP
M4Z%/!2P4*TII2:E%2S+"*G.DZE.;J3C";E1KJG@ZL.:G"+=2-=X:.'E&,G#$
M2Q;Q,:4*#LN>?+@\34G"RG&A2]LX^RG3E/A[W]I;X>:K;6D?A6PU?7+W4)O!
M_P#9&H7GA+71X6M]6\<[)?"::CK4&GRK;7UUITUOJ'D0"2YAL[VVNIT@MIO.
M4Y9TJD/:P>&]C4K1J*I:E4C'"8.GF694Z49N+EB,-@)5Y3AI36)P];#5*D:D
M7%Z5_P!PL1"=I2C"HUROFIRDL;B<KPLI3CS1=&OF>&6&I3CSRJ*I3G0A44D9
M.A_M3>"_$=IH>HZMI$VCV6K6(U;2= U&SN]1\5ZTNM>(-7L/AK>^'].M[+[+
M,-=T+PQXCUUDDN(Y+"TLQ-,1;137*:^QJ4[<U.?UF-+#-THQM.AB)X3ZYCJ%
M:4^10>!H5<+&M/1>TQ5&F^6I6H4ZUU:<J<L12DN2GA\3BZ%2I.RA*G@ZU'!R
MJ1A!SG:MF%98?#*2_?>PK.-Y4ZD:75Z#^TE\*O$VJ:3;>&H?$FN:QJBV=OJ4
M&D>$=2OM3\+PW/BC5?!\/_"4PVT+7%E9Q>)M%UBVFEA6ZAMDL)KR9X['%RSI
M8>I4FHTN7V-6G1JQKM\E"?M\!2S&A%SER\M6>"KT*D8U5!Q=:E1DXUJD:;PE
M5A!34_=KT)8F+H-Q]O&.%JNE7G&G?WH<\9*G[-R>)Y)_5HUG"274^-/BS\/O
M -[+I6KVVH7/]FOI.I^(9=#\.W&K6'A&'7]1-CI.L>)9[2$QZ:+J^\PQX\VY
M9(I;CRO(C>5>>A:O6HX>G[O-B:. I3DN6E]<Q')&C@X3>GMJGMZ,90C[M)8F
M@\1*E'$4G.J\XX:C7KU9)*GAJ^-J03O4^J82,IU\3*&_LJ<:-1PE*SK2P]:&
M'56I0JQAP]E\=F.C_&CQ]>^%9[+X:?">[UW2=.G6RN)/$/C+5_!J_9?$%YI<
M((@CL;?7+2_T:&$)+.TVF^;O"R+$L<U;^S<#C(4)5L;G%:E# 82+]G4DL57^
MJ81595+*,L=5J4:E*<?W<*-6\G-WMTNC&.9U,OG4CAJ& P\:N-Q-6RHT[T%C
MI.F^9+V6&P;56K*HX-U)62A&'//@? WQS^']WX_\1^*/&GAGQ)X$O0-0\-:5
MXA\3R:Y=^$])_P"$3\$:=XR^)6FV%[=A-&\//8ZE!JUEJ-QIL""\N?"#B^F\
M^.VMTZXPI8?#8SZOB(UH3>+Q::C+VN(P&$S*CE&&E2B^:M.-7%5Z53#X2DG3
MDL92G0C5JRK./&ZM6O6RFA/#U(UJRP5!4>5VI9EF&$QF91A-Q2A.:RVG!K%U
M;3IPE4H_NZ+3J^[^#?C)X \?3^(VT[^T;&[\$Z7INNZE_P )'HESHUS:^'M?
MM]2FTS6[<WD>^*QNHM%U0&-S#<1&P=;F"(E ^&)O@L!B<RKVHX?"U,1AZ[NG
M*E5PM&AB:M*7(Y*7+1Q%"HG3<Z<N=14G4A.,=*+6)Q>'P-#]]5Q<*=;#M)^S
MK0J59X>$Z<FDKJK"4/>Y9).,TO9SC*7!>'?VDOAMJ=C>2:E%=1VD.GW>L^,-
M;TSPQK=SX3\,6DGA=_'%G%XQOKC3H[C2;QO [V%Q<2WUG';)<W"V)G%U)%!)
MI6HSPM*M]8C[/Z@I0J+1PJ8S#UX87&T,&XW]O.EF+J4*,(VK5W2G*G"4J=10
MK#)XS$4J>"E'%5,7.G["-*<957AL14=/ 5JBNFE7HNE6]SF5*A5A7FXX64:S
MZW0/C9\/?$LNE6G]GZ]I3WXU74](7Q#X7NM.M9]*T+1X-=O?$]C>2QO:OH\-
MI>VD;7<4Q:&YO(K6=8;A_+K+$26$AC*V(?L7EF'Q&)Q*E\="G0J8>C44NDG-
MXF#HNFYPQ$(5W2G/ZO75.*-JZPT<-%UZ6.K87#T)0C)TZM3$T\95H0O9<DE#
M+Z[E"LJ<Z7+1YH15>@ZF+'^TK\'Q>Z(\-YJ.[Q&W@VSN=53P_=K;Z)>>.H;.
M?P;I7BFZ,8DTS4;V'5--<6CK)):1ZI:2WBVT5S&[[SH5,/7Q.%JQ]C+"RQJF
MVU[-ULMPU7%8ZG":;C.>&H8>O[2:O2]I1J8>-65>#I"E4@L/3Q47[:E*%.=-
MTTZCEAJV*^J4<3!13YL-7KZTI1NZE/\ ?J+I)S7H_@'QUX=^*.@1>)-!TG6T
MT"YEM[O2;_Q%X=N]#CUJ*2%+BVUG1[;58H[BZL&1D:&]\E$E!#P/(A#E3HU:
M"I.K!T*N_L9KDKT;QC)JK3?O49_O)0G3GRU(SC4C.$6M6Y1]K7H1DJBHRE3G
M.#4Z,Y4JM2C)0J*\*L8RHJ2G!RIN$J4HR=[+T *JEBJJI8[F( !8@!06(ZD*
MJC)[ #M66VFR70K]"%+6UB#"*V@C#2-*P2&- TK2>:TC!5&9#+\Y8\EOFZ\T
M+1)+112279*Z22Z)7=DMKON'5]W>_P TD[^J23\DET'26UO-"UM+!#+;L-K6
M\D2/"RYSM:)E*D9YP11;;^[:WE;:W:UM+;= 3M>VE[W^>_WW=^X-;6[/#*UO
M"TEL&%O(T49>W#J$<0N5S$&4 ':1D#!HO9M[.2LWU:O>S?57UMW"R24;6C&S
M2Z)K1-+966B[#39VA%PIM;<B[_X^E,$1%SA!'_I *_OOW8"_/G@ =!1:R2V4
M7S)=%*][I='=7OO?7<+V=]G:U^ME>ROV5WIYL>((0"HAB *E2HC0 J26*D8^
M[N)./4YH_P" _FM4_D]NP62TM9)6MY62MZ625NR2Z!Y,.]I/*BWL"KOY:[V4
MA5*LV,D;548/91Z4K*SC;W7NNGG=!M;HXVMY6O:W:UW;U?<A^P6(@BMOL=H+
M:!T>"W^SPB"%XVW1O%%LVQNK<@J 0>157?,I7]Z.SZK2VCW6FFG338+*TE;2
M7Q+H];NZZZZZ]=2:6""<()H8IA$XEC$L:2".100LB!P=C@,P##!&3ZTK6?9I
M-?)JS7HUH^ZT#;39::>C37W-)KLTGT&26EK,H26VMY562.95DAC=1-$ (I0K
M*0)$"J%;JNT8(Q1LT]G&[3ZIO>SZ7N[]PMHX_9:LUTLM4K=D];;$GDPAS)Y4
M8=OO/L4.?E"\MC)^4 <]ABBVENFNGK:^GG97]$&UNG+:WE:]O2UW;M=]Q@MK
M82)*+> 2Q*4BE$48DC0JJ%4?;E%*JH(! PH'04;-]'+?SU3U[ZI/U2[!;1+I
M'9=K72MVLI-?-]V(MI:H)%6VMU65F>55AC42.[;W:0!<.S/\Q)R2>3S0M$DM
M%&UEVLVU;M9MM=FV^H=6^KW?R47^"2]$ELD*+6V5YI!;P+)<JJW#B*,/<*BE
M$69@N955"5 8G .!Q2LN5PM[K;;CTN]&VMKM:/N--IIK1Q22?5).Z2?1)ZJW
M4=%!#!&(H88H8E4*L44:1QA54(JA$  4(JJ!CHH'04Y>]?F]Z][WUWWO?O=W
M]1)<MN7W;;6TVVV[$/\ 9]AY"VOV*T^S(8REO]FA\A#$=T16+9M4HP!7 ^4C
MC%.[NI7]Z+NGU3M:Z?1V25^RML&UULI)IKNFVVGW3;;:ZMM]2::"&XC,,\,4
M\3%2T4T:21DHP924<$$JR@CC@@'M2V:>SBTT^S6S79KHPV36R:LUY;->EM+"
M&W@,HG,$)G6-H5F,:&586(9HA(5W",D E0<$@<4;<W3FLI>=KVOWM=VOM=]P
MVY>G+\/ELG;MLMNR[#9;6"6*2%HU5)(A"WE_NG"*"(PCQX:-D))1E(*'E2",
MUG6I0KTJM&I=PK1E&5I.,K3BX2M*+4HR<7;F34ET:L5"3I2A**5Z;32:3CH[
MV<6G%Q[Q:::T::,7PQX3\/>#?#^E^%O#NF0Z?HFCZ99Z1968:2Y86-A;):6T
M=U=73R3WTH@0!IKF2620EF=V9B3T5ZL\1.<ZJB^=W<8PC"FE9148TX*,(0C&
M,8QA&*C&,8Q2221$4XRE/FE*I.<ZDIRE*5252I4G6J3E.3<I2G5J3J2;=W.4
MGU-M+:VBC6**W@CBCB\E(DBC2-(3C,2HJ@+%P/E  XZ5#;=[N[=KW\MONOIV
M&DHVLN7EO:VEKZNW:]M1/LEKYCS?9K?SI(A!)+Y,?F/ N=L+OMW-$,G"$D<G
MBDTK2C;W9:R71NUKM==-->F@+1QMHX?#_=Z^[VV6W8%M+5(EA2VMUA39LB6&
M-8D\M0B;8PNU=J@ 8'   Z4-MO75Z[^>C^]:,$N71>ZET6FSNON>OKJ.%O;B
M7SA!")O*$'FB)!+Y .X0^9MW>4&YV9QGM1_-_>^+SM=*_>UWOW8;<O3D^'^[
MM>W;9;=D4[W1]+U$V/VZQM[D:;>6NH62RIF."\L=YLK@1C".]N\ADBWJPCE5
M)4"R1HRN+<*D:L?=J14U&76/M(2I5+/HYTISI2DO>=.I4IWY*DU)-)TY4FDZ
M<N2\;:?NZD*L-/[M6E3FO[T(OHCS'Q3^SU\ O'&NWWBGQK\#_@_XO\3:I]E_
MM+Q'XI^&G@OQ!KNH_8;.WTZR^W:OJVBSW=W]GT^TM+6+S97\N&UBB3"1JH0S
MG_\ AD[]EC_HVGX ?^&;^'7_ ,SE !_PR=^RQ_T;3\ /_#-_#K_YG* #_AD[
M]EC_ *-I^ '_ (9OX=?_ #.4 9.N_L:_LG^(='O]%N_V<O@M96VH0&WENM!^
M&OA#P[K%N"RL);#6M#TBUOM/G5E4B2WN(V(RIRC,K1*"ER:RBZ<X5%RR:]ZG
M-3BI):3@W%*=.:E3J0;A4C*$FG49<E]$U*,X-22>DXN$K7UC)*3<)Q<9TY6G
M3E&<8R7>?"7X$_"'X%:5>Z1\)_A_X9\$P:H\$FM76C:7:VVJZ[):SW]Q9-KF
MK+']KU5+235-1%K%<2O%:)>RQ6J0Q-LK:<W/D]V,5"$8)1BH^[!**<FE><VE
M[U2;E4F[RG*4G<RA!4^:SD^:3D^:3>KZ13=HQ5M(Q2BM[7;;[+4_!GAG6-1T
M#5-1TFWN;KPO>ZGJ6BJQD2TM=0UC3;K1]0OI+&-UM[NZDTV_OH!)<12LBWDV
MPJ9&)FFW1J2JTVXSEAY81ZZ>PG7PV)E!1?NQ_?83#R4HI32@XJ2C.:E4U[2"
MI2NX1KT\19-J]6E3K4J;FTTYQC&O-J$[PYU3J<OM*5*4.C,,)*,8HRT0 C8Q
MJ3& 5("$CY "JGC'*CTI=6^KW?7K_F_O?<=DDHVLH[+HOETV7W#5MK=&E=;>
M%7G=)9F6*-6FDC"B.25@N9'4(@#-DC:,=!0M$DM%%MI=F]VET;ZOJ'YVY?DK
MV7HKO3;5@]K:R-&\EM [PR^?$SPQLT4^-OG1LRDI+MXWC!QQFA>ZTU[KBFDU
MI9/=>2?5=>H/9KH[77I:UUY65NUE8K:?I6G:3!-;:=:0VD,]W>7]PL8)-Q>Z
MA<275[=3NY+33S3R.S.Y8G('0  24:=.DE:G1BH0CTC&[;5N\I.4YMZSG*4Y
MN4Y2DQ_Q*E5_Q*DE*4NK<8QA'7M"G"%.G%>[3IPA3@HPA&*M/;V[QO$\$+12
M1"&2)XD:-X0"HB="N&B"LPVD$88\<T/7?77F^:M9^JLM=]%V!>[:WN\NBMI9
M=EV%6"!!A88E&TIA8T4;#@%, ?=.U<CIP/2A]?/?[V]?FV_5ONP2Y;6]WEVM
MI:R25NUDDO1+LAIMK9I$E:W@:6-/*CE,49D2/<K^6CE<JF]$;:"!E0>H%&S;
MV<K7?>U[7[VN[=KON%M$ND;V71723LNETDGW22'F&$C:8HRN'7:8U(VR',BX
MQT8_>'?O1;IT22MY+9>BLK=K!MY6=_GKKZZO7S8Q+:VBE>:*W@CFD1(Y)4BC
M25XX@1$CR*H9D0$A5)(':C:ZV3?,U_>VN_/SW"VW]U67DM[+LKZV6@OV:WWR
MR^1#YDZ+'/)Y2;YHT!")*^W,B*&8!6) R<=:%HK+17YK?WM%?ULDK[Z+L'5/
MK%63[*][+LKMNW?466&&>)H)XHYH7&UX98UDB=1@A6C<%6&0.".U';^ZTUY-
M.Z?DT]4^C!::+16:MY-6:]&M&NV@IAA)1C%&6B&(V,:DQ@%2 A(R@!53QCE1
MZ4;.^S[]>O\ F_O?<+626R6RZ?=\E]PR2UMI0@EMX)!%,+B,20QN(YP21.@9
M3LF!).\8;D\\T+1IK1QND^J3T=NUUH[!T:Z2M==[6M==;65NUEV)554SM55R
M2QV@+ECU8X[GUHVTV2V7XA_7W:+[DK#J "@ H * /G_XR?\ )1?V3O\ LX#Q
M'_ZRQ^TM0!] 4 % !0 4 ?/_ ,&_^2B_M8_]G >'/_66/V:: /?)4:2*2-9'
MA9XW198PA>)F4J)$#JR[U)R-RL,@9!'%9UJ?M:-6BJDJ7M(2@IPMSPYHN/-&
MZ:YHWO&Z:NE=,J$E"<).*FHR3<97M))WY79IV>SLT[;-,^1?B3^S6UYX*\&Z
M/X'NK_4M5\$:9I.@Z4VM>([3191!'XP\-^-=:\6_;E\):K:WWC"]U[PGHL]P
ME_ILUA=0F_MW@C%XS5JZU:ECZ6*PE.EAX1>"A"$5'EPF'RS#8RE@L-AHU:=;
M_9Y2KT*==3<JT(8;#8C#SCB<+3<KA)>PQM*K-R^MO-*M6')%4\1B,X;HXRM5
M5/DY*E'"XG,E@G2484ZN,J0JPG2F^35\%?LW36>E:OJOCGQMX@U3XD^+=#\?
MZ?XB\3:9/HT;:=>?$5]&M[Z^T62/PS96\NJZ5X=\,^%]#M+]M+M(6@T,2C3K
M<W4D*W7AA7A)993@ZV E0PF'JJHI1E7A1Q6-QV-3M4G4I4LTQ>/KSQ5*-><H
M4J>%I4JT7AXS<8>OB:>.HYA4:]IA\5]:I4')SHQE1PU#!X)25H<WU.C2K2IJ
M"IP=;,,?4G"HZ]T[5OV4?">I:9KV@0^+O%5CX9\3:G+=ZQX8?3/A_K?A^XTU
M_"GAOP;;Z*=*\2>"M0@DM[#1O"VG)I]S<)/=6)DN!!,J3%!->4L6Z?UV3Q48
MU,;5ES-PG*IC<RJYG.I&K2]G5H585J]6C"OAYT:ZPTHT_:\]*C4IYX2+P$(0
MP<Y4'0I9?0H._.J-++\)/"PI1A/FIRH5G4>+Q&&J1EAZF-7UCV2<ZL:G:^.O
M@+X9\9Z/X TB#5-5\.I\-HI+3PU/:V7ACQ+Y>GS:%_PCLMM=V'CS0-=L+NX&
MG+$8KZ2T:ZAEBW++LFGCG,1.6*S+$YG7?-7QE+$4:ZC:"G3Q.)P^+J*#@E*C
M+VV%I6G1E"2ASP3UBXSA:-'!Y?ALMI4TZ&#GAZM!S<I2A4PU"OAJ;E[R56+H
M8JO"<*G-%N49V4Z<&L*']F/P3#JNC:Q_;WC1KO0M+UWPS8YU>T2*/P5XA\.3
MZ#J7@^.*+346UTR:[E@UR:[MA#J-SJMA:7%S>RQ6T4$>>(C'$X?,\+5C^[S?
M"5L'B;.2<H5*V'JX>:NVHRP%+#QPN"A;V-.A6Q4JE.K7Q>)K5=J,YT*F"JPF
MU++\9AL=06BA'$T(UXU9RI04:4_KCQ59XGF@[)TJ6']A1PV&ITH/!?[+_@[P
M?/X6NCKNNZS/X1U31M0TY9],\$Z%9S6_AS1]3TK0=.O]/\(^$])M[J*VN-2_
MM5[ET-Y/?Z?8R2W#06<-O'V/%S>(J8J4(RQ-7ZU*<_>25;%P5&I6IP4E"DXX
M:6)PM*$(JG&EC<2Y1G5E"I#E6&HQPRP4(*.%A'#TZ<+*<H4<-B:.+ITW5J*5
M6;=?"X24JE2<JG+AHQA*'M<1[::V_9LT:**72KGX@_$6]\)KXSN?&UAX.?4-
M M-$L]2OO')^(U[!<R:=X>M[_7H7\4B.1)-7O+Z:&"+R(9$\V=[CDI\].E@8
M>TE*IEV%AA*%5V4Z=&AE]?+L+*"BE3A7PU.M"O#$Q@JTL5AL/6G.5JD:G55D
MYU,;.G^X685)5<1&+<_:RJRI?682G5=2HL/B:,*N&J86,XT(X?%5J=*G!0PG
MU;ES^R#X3E&H7MYXV\6W_B75+SPG+JGBB[T?X;R7VNV'@R74Y]'T_P 6Z</
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M"4L-AZ"=/#X3#4<-"FK<O[F52U5NW-[24)TZ4DFJ7)0IN-.-1U9U.@K(W"@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M6%Q52E3PE%T\)0QJ2K4UGF9RITJ=;-,?AL/@,/'V];#T)XE4W5A2@E3A15/
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M /\ P\GPZ_\ FCH /^&L?V6/^CEO@!_X>3X=?_-'0 ?\-8_LL?\ 1RWP _\
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ML?V6/^CEO@!_X>3X=?\ S1T '_#6/[+'_1RWP _\/)\.O_FCH /^&L?V6/\
MHY;X ?\ AY/AU_\ -'0 ?\-8_LL?]'+? #_P\GPZ_P#FCH /^&L?V6/^CEO@
M!_X>3X=?_-'0 ?\ #6/[+'_1RWP _P##R?#K_P":.@ _X:Q_98_Z.6^ '_AY
M/AU_\T= !_PUC^RQ_P!'+? #_P /)\.O_FCH /\ AK']EC_HY;X ?^'D^'7_
M ,T= !_PUC^RQ_T<M\ /_#R?#K_YHZ #_AK']EC_ *.6^ '_ (>3X=?_ #1T
M '_#6/[+'_1RWP _\/)\.O\ YHZ #_AK']EC_HY;X ?^'D^'7_S1T '_  UC
M^RQ_T<M\ /\ P\GPZ_\ FCH /^&L?V6/^CEO@!_X>3X=?_-'0 ?\-8_LL?\
M1RWP _\ #R?#K_YHZ #_ (:Q_98_Z.6^ '_AY/AU_P#-'0 ?\-8_LL?]'+?
M#_P\GPZ_^:.@ _X:Q_98_P"CEO@!_P"'D^'7_P T= !_PUC^RQ_T<M\ /_#R
M?#K_ .:.@ _X:Q_98_Z.6^ '_AY/AU_\T= !_P -8_LL?]'+? #_ ,/)\.O_
M )HZ #_AK']EC_HY;X ?^'D^'7_S1T '_#6/[+'_ $<M\ /_  \GPZ_^:.@
M_P"&L?V6/^CEO@!_X>3X=?\ S1T '_#6/[+'_1RWP _\/)\.O_FCH /^&L?V
M6/\ HY;X ?\ AY/AU_\ -'0 ?\-8_LL?]'+? #_P\GPZ_P#FCH /^&L?V6/^
MCEO@!_X>3X=?_-'0 ?\ #6/[+'_1RWP _P##R?#K_P":.@ _X:Q_98_Z.6^
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M'+? #_P\GPZ_^:.@ _X:Q_98_P"CEO@!_P"'D^'7_P T= !_PUC^RQ_T<M\
M/_#R?#K_ .:.@ _X:Q_98_Z.6^ '_AY/AU_\T= !_P -8_LL?]'+? #_ ,/)
M\.O_ )HZ /,/%_QN^"_Q)^+7[*VA?#GXO?"_Q]K=I\</%&K76C>"O'_A3Q3J
MMKI5O^S#^T79SZG<:?H6K74\.GQW=_8P/</&L:R7D"%@TJ!@#[/H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
EH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>164
<FILENAME>g20922pre.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922pre.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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3/3!QM&/NK#T[+1:*\-ELO(__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>165
<FILENAME>g20922snap0001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922snap0001.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
MR6&.>%X94#QN-K*PR"*:;3NA-)JS/&/$6D/HNLS6N#Y1.^(^J'I^73\*]6E/
MGC<^=Q%)TIN/0S(Y'BD62-BCJ<JRG!!]:T:OH8IM.Z/5K*\D\6>#9X;>]>UU
M Q&,RQL5:.0#Y6X[$X/YBO+J0]G/R/H,/5]M3OU/G75?%?CG1=5N=-OM?U&.
MZMW*.OVACS[>H[UNHQ:ND)RDM+B:7\2O%5AJMK=S:U>W,44@9X99BRR+GE2#
MZBATXM; IM'U'HFL6>OZ-:ZK8.7MKA-R$C!'8@^X((/TKC::=F=*=U<\5^+?
MQ(O8]>CTCP]J<MNEED7,MN^W=)_=R/[N/S)]*Z*=-6NS&<];(\[_ .$_\7?]
M#'J/_@0U:<D>Q'-+N>Y?"&/Q!/H<^N>(=3NYTN<"VCN)20L8ZO@^O8^@]ZPJ
M6O9&T+VNSO\ ^UM-_P"@A:_]_E_QJ.278/:T_P"9?>6D=)$5T8,C#(93D$5&
MQ::>J'4#"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MKL=.FZDE&)[=:6T=E9PVL6?+A0(N>N ,5Y#=W=GTD8J$5%=":D4% !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 5=2T^#5-/FLK@$QRC!(Z@]B*J$G!W1%2FJD7%GBFI6$NF:C/9S##Q-C/
MJ.Q_$5Z\)*4;H^<J0=.3B^@FGWTVFW\-Y <21-N'OZC\1Q1**DK,5.;IR4ET
M.Y\;Z!:?$/P*;BSB#7T*&6U/\2N/O1_CC'UP:\Q7I3LSZ&,E6@I1/EZ2-XI&
MCD1D="596&"".Q%=1B=9\.O&,W@[Q-%.7Q87#+'=J1GY,_>'NN<_F.]1./,B
MH2Y6?0GCJQGU+08KFSD\R& ^:RJ<AU(^\/7'\B:SPTE&5F9XZG*=.\>AY=7I
M'AGI_@/03I]BVHW"XGN5&P?W8^OZ]?RKSL14YGRKH>U@J')'G>[_ ".PKE/0
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H XWQ[H2W=A_:<$?^D6X_>8_B3_ZW\LUU8:IROE>QY^-
MH<T>=;K\CS*O1/%.O\":^;"_&FSL!;7#?*3_  OV_/I^5<N(I\RYENCT,%7Y
M)<CV9P_QN\('2]<3Q!:0D6E^<3D#A)O7VW#GZ@UA2E=6/3J1L[GD];&1] _!
M/QD-4TJ7PUJ4X>XM5_T82'EXL<K[[?Y'VKFJQL^9&U-W7*S87P,1XL^SD/\
MV8!YV_V_N9]<_I71]8_=WZGG?4OWW+]G?_@'HP 50JC '  [5P'K["T % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M@RZU8&0FV41S!/1SD$_B /R%<]9;,VI'N5<YL% !0 4 % !0 4 % !0 4 %
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@#SGXE_P#'[I__ %S;^8KO
MPFS/(S'XHG#5V'F'IFK?\D=OO^P3)_Z+->5+^+\SZ*C_  %Z'RE749GLW[/G
M_(6UO_KC'_Z$:PK;(UI=3WJN8W"@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H \Y^)?_'[I
M_P#US;^8KOPFS/(S'XHG#5V'F'IVHQ23?"*\BB1GD?2G5549))C. !7E2_BO
MU/HJ/\!>AY%X:^!^O:JD=QJ\R:7 V#L8;Y2/]T<#\3GVK255+8%3;W/;/"G@
MG1?!MHT.EP-YL@ EGD;=))CU/0?0 5SRFY;FT8J.QT524% !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0!Y]\0[>:ZU/38;>)I961@%09)Y%=V&:46V>5CXN4XI$&E_#JZF"
MR:E<"W7_ )YQ_,WY]!^M.>*2^$BE@)/6;L>AVMM%96L5M NV*)0JC.< 5PMM
MN[/6C%12BNA+2*"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ P,YQS0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % %>XOK2S*BYNH8"W($D@7/YT[!>Q#_;6E?]!.T_[_ *_XT68K
MHO4AA0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MCJ#[&H::T92:>Q'K7B+2/#EJ+C5]0AM(V^[O/S-]%')_ 4*+>P-I;G+)\8_
M[RA/[6< G&XVTF/_ $&K]E(GVD3L=,U2QUBQ2]TV[BNK9_NR1MD9'4?6H::T
M92=]B6[NX+"RGO+F01V]O&TLCD9VJHR3^0I)7T'L<I_PM7P1_P!!^'_OW)_\
M35^SEV(YXFNGBW0)-!&N#5(5TPDJ)W)4$@XP >2<CI2Y7>Q7,K7.=_X7)X'\
MW9_:SXSC=]FDQ_Z#FJ]E(GVD3KM)UG3=<LA=Z7>PW<!.-T39P?0CL?8U#36C
M*33V(-<\2:/X:MDN-8U"*TC<D)OR6;'7"C)/X"A1<M@;2W.9C^,?@>24)_:S
MH/[S6T@'_H-7[*1/M(G9:?J-GJMC%>V%S'<VTHRDD;9!J&FM&4G?8CU;5K#0
MM.DU#4K@6]I%@/(P) R0!TYZD4)-NR!NVYS?_"U?!'_0?A_[]R?_ !-5[.78
MGGB=-IFI6>L:=#?Z?.)[68$QR $!@#CO[BI::=F4G?8EN[N"PLI[RYD$=O;Q
MM+(Y&=JJ,D_D*25]!['*?\+5\$?]!^'_ +]R?_$U?LY=B.>)OZ)KVE^(K)KS
M2;M;JW5S&752,, "1R!ZBI:<=&4FGL8UW\2O!]A>SV=SK<4=Q;R-%(AC<[64
MX(^[ZBJ5.3Z"YXHT="\6Z%XF>=-'U!+MH #(%5AM!SCJ!Z&DXN.XU)/8R=3^
M*7@W2;EK>XUE'F0E66&-I,$=>5!'ZTU3D^A+G%$NC?$GPEKUVEI8ZNGVESA(
MY4:,L?0;@ 3["ATY+<:FF=74%!0!2U35M/T2R:\U.\BM+=3C?*V 3Z#U/L*:
M3>B$VEN<A+\8_ \4A0:L\F.Z6TF/_0:OV4B?:1-71OB'X4UZY2VT_687N)#M
M2*0-&S'T 8#)^E)PDMT-23V.GJ"C+\2?\BUJ7_7!_P"5:4OC1AB/X4O0\4KU
MSYPZ_P )>%;'7M/GGNI;A'CEV 1,H&, ]P?6N6M6E3=D>AA<-"M%N39I:A\-
MT$9;3KQMX_@GQS^(''Y5G'%?S(VJ9>K>X_O.!FADMYY(95*21L593V(ZBNU-
M-71Y33B[,ZWX>:@T&M2618^7<(2!_M+S_+-<V)C>-^QWX"?+4Y>YZ+?ZC::7
M;B>]F$,1;:&()Y_#Z5P1BY.R/7G4C35Y.QF_\)AH'_023_OAO\*T]A4[&/UN
MC_,7[W5]/TZ!)KNZCB1QE=QY;Z#J:B,)2=DC6=6$%>3*VF^)=+U>[:VLIVDD
M52_*,HP,#N/>JG2G!7D13Q%.K+EBS6K(W,S4?$.E:5)Y=Y>)'(!G8 68?@.E
M:1I3GLC&I7ITW:3,T>.] +8-S(!ZF)O\*T^KU.QC]=H]S8T_5]/U56-C=)-M
MZ@<$?4'FLI0E#XD=%.K"I\#N7:@T"@""[O;:P@\Z[G2&/.-SMCGTJHQ<G9$R
MG&"O)V,1_''A]&*B\9L=UB;'\JU^KU.QS/&45U+EAXFT?4I5BMKY&E;HC J3
M],CFIE2G'5HTAB*4W:+-:LC<BN;F&SMI+BX<)%&,LQ["FDV[(F4E%7>Q@MXC
M\+/,)GN+9I1_&826_/%;>RJI6L<SQ&';O=?<;=E?6VHVPN+242PDD!@".GUK
M*47%V9T0G&:YHO0L5)9AW?C#0K-RCWRNX[1*7_4<5M&A4?0YI8NC'1LK)X\T
M%C@SR)[M$?Z57U:HB%C:+ZFU8:I8ZG&7LKJ.8+UVGD?4=16,H2ANCHA4A45X
MNY;J30* *.H:SIVE &]NXX2>0IY8_@.:N-.4_A1E4JPI_$[&0?'>@!L?:9"/
M7RF_PK7ZO4[&'UVCW-+3_$&E:JXCL[U)),9V'*M^1K.5*<-T;4Z].II%FG69
ML% '@O[0?_(6T3_KC)_Z$*Z:.S,*O0\9K<R/L[Q!_P BUJO_ %Z2_P#H!K@C
MNCK>Q\8UWG(7;C5[^YTRTTV6Y=K*TW>3#GY5)))./7)/-*R3N%^A2I@;OA/Q
M5?\ A#7(=2L7)4'$T.<+*G=3_0]C4RBI*S'&3B[E77=?U+Q)JDFHZI<--._3
MLJ#LJCL*:2BK(&V]69E,1VGPT\777ACQ99I]H<:==2B*YAS\I#<!L>H.#GK@
M8K.I'F1<)69](>-/^1%\0_\ 8.N/_1;5RQ^)&\MF?'==QREN?4KRYT^UL)9V
M:UM-WE19^52Q))QZDGK]*5DM0OT*E,#H/"'B_4O!NLI?6+[HVP)X&/R2KZ'W
M]#V_,5,HJ2LQQDXLH:UKFH^(-2EO]3NGGGD).6/"CT4=A["FDDK(&V]S.IB.
M]^%/BZX\.>+K2UEN6&F7K^3-&6^4,W"MCL0<<^F:SJ1NBX2LSVCXQ_\ )+]4
M_P!Z'_T:M<]+XC:I\)\M5V',?5_PJ_Y)EHG_ %S?_P!&-7%4^)G3#X4:OC3_
M )$7Q#_V#KC_ -%M2C\2'+9GQW7<<I](? ;_ )$*Y_Z_Y/\ T!*Y:WQ'12V/
M"_&G_(]>(?\ L(W'_HQJZ(_"C"6[*FGZYJ6E6-Y:6-T]O'>;1,8SM9E7/RY'
M;YN?6FTGN";1G4Q"].E 'T-\%?&]QK=C-H&HRO+>62>9#*YR7BR!@^ZDCGT(
M]*Y:L+:HWIROHSOO%GB6U\)>';G5[I3((L*D8.#(YX"Y_P \ UG&/,[&DGRJ
MY\H^(?$NJ^)]2DOM4NGE=B2J9.R,>BCL*[(Q459'*VWN9%4(4$J002".A':@
M#W'X._$>>XN1X:UNZ>9Y/^/*:0ECG'*$_P L_3TKGJPZHVISZ,]:\2?\BUJ7
M_7!_Y5G2^-"Q'\*7H>*5ZY\X>E_#?_D#7?\ UW_]E%>?BOB1[.7_ ,-^IVE<
MAZ)Y%XX@6#Q5<E!@2*KD>Y'/\J]/#N]-'@XR*59V*_A)S'XJT\C_ )Z$?F"*
MJM_#9&%=JT3M_B+_ ,BY%_U\K_Z"U<F%^,]+'_PEZGEU>B>(6+Z^N-0N3/<2
M%VQ@9Z*!T ]JF,5%61<YRF[R.F^'7_(QR_\ 7LW_ *$M<^*^ [,!_%?H=!XV
M\3/ID8TZR<I=2KN>0?P+[>YK##TN;WGL=>,Q#IKDCN>9.[2.7=BS$Y))R37H
M;'C-WW%,;J@<HP4]"1P:+A9[C[>XFM)UFMY6BE4Y#*<$4-)JS'&3B[H]<\*:
M_P#V[I9>4 74)"R@=#Z-^/\ 0UY=:G[.6FQ[V%K^VAKNB_K.K0:+ILEY/DA>
M%4=68]!44X.<K(UJU52AS,\;U+5;S5KDSWD[2-GA<_*OL!VKU80C!61\]4JR
MJ.\F4ZLS#ITH [_P1XHGEN5TJ^E,@8?N';D@C^$GZ=*X<1127-$]7!XEM^SG
M\CJ/%7_(KZA_UR/\ZYZ/\1';B?X,CQBO6/G3UGP%_P BK#_UT?\ G7F8G^(>
M]@OX*.>\=>(IVOFTJUF:.&,8FVG&]CV^@%;X>DK<S.3&XA\WLXO3J</78>8%
M $]I>7-A<+/:SO#*O1D.*F45)6949R@[Q=CV+P[K*:YI$=R,"5?DE7T<=?P[
MUY=6G[.5CZ'#UE5@I=2KXM\0'0=-4PX-U.2L0(R!CJWX?UJJ-+VDM=B,57]C
M#3=GDD]Q-=3O-/(TDKG+,QR37II)*R/!E)R=V-$;F,N$;8."V.!1<5G:XB.T
M;AT8JRG((."* 3MJCU#P3XD;5+5K&\E+7D(R&/5T]?J/\]Z\_$4N1\RV/:P>
M(]HN26Z.NKE.\\%_:#_Y"VB?]<9/_0A731V9A5Z'C-;F1]G>(/\ D6M5_P"O
M27_T UP1W1UO8^,:[SD/=/@CX-TJ\T:XU[4+2*ZN&F,,*S(&6-0!D@'N2>OM
M[FN>K)IV1M3BK7-/XS>$='7P=+K-K86]M>6LJ9DA0(75FVD''7J#^%32D[V'
M4BK7/GBNHP/HWX/>$-&7P3::O<Z?;W-[>,[&26,.44,5"C/3[N>/6N6K)\UC
M>G%6N<U\<O".GZ9#I^N:=:16HED-O.D2A59B"RG XSA6SZ\5=&3>C)J12U1X
MP"5((.".01VK<R/KWQ1*9_AOK,QZR:5,Q_&(FN&.DD=3^$^0:[CE/=?@?X3T
MF]T*[UJ_L8+JX-R88O.0.(U50<@'@$ENOM7/5DT[(VIQ5KECXV^$])@\,1:S
M96,%K=PW"H[0QA/,1@>H'4YQS]:5*3O9CJ15KG@5=)@?2WPI\%:-9^#;'4Y[
M"&YO[Y/->69 ^T$G"KGH,8^IKDJ3?-8Z(125SBOCCX3TO1Y-.U;3;6.U:Z=X
MYHXE"HQ !# #@'KGUXK2E)O1D5(I:H\?!*D$'!'0BMS(^FOBE,US\';J=CEI
M$MW/U+H:Y*>DSHG\)\R5UG.?5_PJ_P"29:)_US?_ -&-7%4^)G3#X4:OC3_D
M1?$/_8.N/_1;4H_$ARV9\=UW'*?2'P&_Y$*Y_P"O^3_T!*Y:WQ'12V/"_&G_
M "/7B'_L(W'_ *,:NB/PHPENS<^%/A6S\5^,1;:@ADL[:%IY(\D;\$ +Q[MG
M\*FI+ECH5"-V?1TOA#PW-:?99-!T\P8P%%L@Q],#CZUR\TNYT<J['RQXUT./
MPWXRU328<^3!+^[R<D(P#*"?HPKL@[QN<LE9V.A^"]RT'Q,L8U; GBEC(]1L
M+?\ LHJ*OPE4_B.V_:"U(K::+I:N<.\D[K] %7_T)JBBMV75>R/%-,L6U/5K
M.P1@K7,R0@GL68#^M;MV5S%*[L?6NC^"/#FB:>EE:Z1;,BC#/+$KN_NS$<UQ
M.<FSJ44CQGXV>#;#0KJPU;2K2.UM[K=%-%$NU XY! Z#(ST_NUT4I-Z,RJ12
MU1YAI=])IFK6=_$2)+:9)5(]5(/]*U:NK&2T9]@>(B#X9U$@Y!MVQ^5<E+XT
M:XC^%+T/%:]<^</2_AO_ ,@:[_Z[_P#LHKS\5\2/9R_^&_4[2N0]$\H\?_\
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M[_D9A_UQ;^E1B?@-,#_%^1?^)?\ Q^Z?_P!<V_F*C";,US'XHG(:;_R%;/\
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MQU/B9TP^$Y_X^_\ (BV/_813_P!%R55'XB:NQ\YUU&!]=>(/^27ZK_V!Y?\
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M *+DJJ/Q$U=CYSKJ,#ZZ\0?\DOU7_L#R_P#HDUQ1^)'4_A/D6NTY3Z3^!/\
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M/5G]E&U.%M6>K^)/^1:U+_K@_P#*LZ7QH6(_A2]#Q2O7/G#TOX;_ /(&N_\
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MNKE.\H:AH>D:LZ/J6E6=ZT8(0W$"R%1[;@<4TVMA-)[E+_A"_"O_ $+.D_\
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M[G/]3H]C6L=)L-,0+9VD4/&,JOS'ZGJ:SE.4MV;PI0I_"K%RH- H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MKF1P8C$4YTGR/4Z+0&9_#VG,Q)8VZ$DGD_**YZFDV=E#6E'T1HU!J% !0 4
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M*4?1&C69L% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
..0 4 % !0 4 % !0!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>166
<FILENAME>g20922sp1659.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922sp1659.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MF!"# ]N<$\@&F_Q LHM=_LI[&=9C/) O[Z#<2JL=Q3S-RJ=AP2!VZ4 5A\1
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MK:P_LS2=W8_VA)@?^0:  7'BD9)TO26] -0D'Z^2:  7?BCOHVE=NFJ2>O\
MUPH <+KQ/QG1]*'K_P 3.3_XQ0 Z"Y\1M-&+C2M,CB+ .T>HR.RKW(!@&3[9
M'UH V* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * ,:?Q;X=MKU[.?6[&.=&VNK3J-C=,,<X!]CS0!LT % !0 4 1?:
M8!="U\^/[1LW^5N&[;G&<=<9[T /=TC0N[!$49+,< 4 1VUU;WMNL]I<13PM
MG;)$X93CC@B@!TT\-N$,TJ1!V"*78#+$X &>Y]* )* $9EC1G=@JJ,DDX %
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M"\Y%Y,I)*!F(7:HQGT ],"@#.M_&=T="L]0N;*WA>\OXK>!?..V6%F4-*I8
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MUV@IHNKN"<?\>A&/S(H !XE=AQH&K_C;J/YM0 C>))@Q \.:PP]1%'S^;T
M\27!QCPWK'_?N+_XY0 Y?$-RW3PWJWXK"/\ VI0 -K]ZN0/"^K,1V!M_ZRT
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MA>2>7:VL332O@G:JC).!R>!0!5T+6X-?TXWEO!/ %D>)HYU"NK*<$$ GO[T
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>167
<FILENAME>g20922sp331.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922sp331.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M7Q'IR21L593<+D$=1UJO9S["YEW.@5@RAE.01D&H*%H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H \I\?Z!_9VH_VE
M /\ 1[ICN 'W'[_GU_.O7PE;GCR/='RV:87V53VL=I?F<_XLT=O'G@;[5$ ^
MNZ(I9B1\T\')Q[D=?P/]ZLZD?8U--F>C@,1]8I<LOBC^1SWP;\8OIVHS^&+R
M\>"PU,,L,H;!@F(P"#VST^H7WK*M"ZYET/0IRMH/\$_#B>S\;:C<^(8\:=H$
MF^4NO%PW)3&>H/#?D.].4^9*,-V1)JDG.>R/1O#WBK6-5\6P0O<M]EED8F$*
M,*N"0,XSQ6U;#TX4FTM3Q<)C:];$I-Z-O0].KRCZ4* "@ H * "@ H * "@
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M^!'UD_B9]767_'A;_P#7-?Y5Y[W.HGI % !0 4 % !0 4 % !0 4 % !0 4
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M^&_Q8\1>+/&=OI.HQV2VTD<C$Q1,K9"DCDL:Z*M&,(W1E";;LSVVN4V"@ H
M* "@ H * "@ H * "@ H * "@ H \[\1^-]5TK7[JRMTMS%$0%W(2>5!]?>O
M3HX6G.FI,^>Q>95J-:5.-K(SX/B5JR2J9K>VDCSRH4J?P.:T>"IVT;,(YQ73
M]Y)H]#T36K77=/6[MB0,[71NJ-Z&O-JTI4I<K/H,-B(8B'/ T:R.@* "@ H
M* "@#F_&Z:F_A\C2Q*7\P>8(L[BF#TQSUQ75A>15/?/.S)570_==];=AG@9-
M5CT1AJ@E'S_N1-]X+CWYQFGBG!S]PG+%65'][?RN=/7(>F% !0 4 % &%XV_
MY$+Q%_V#;C_T4U73^-$RV9\[?!#_ )*=9?\ 7&7_ - -=M?X#"G\1L:U\6/&
M6E^/]3L+:[%S;6]]+##:&W0[@&*JN0NX]N^34QHP<$QN<E*Q3F^)WQ'\,:['
M)KGFJ)/WAL[JV$:NF?X> 1]0?KFG[*G)>Z'/)/4M>(/B9\0M5@?7=+MKG3-
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M8[Q6,^.KD'IYL?\ Z"M>CA_X"/E<=_ODO5?H>@^*](L)O#=ZYM8EDBB,B.J
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M_&>@_M#@?\(OI)QR+P\_\ -88;XF:5=CAM:_Y-U\-_\ 84D_]K5M'^,_0A_
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M_P#135RT_C1ZTMF?.WP0_P"2G67_ %QE_P#0#7;7^ PI_$.M/^3A6_[#K_\
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M_).X_P#K^C_]!>N?#_&:U?A/,HT9OV=)2 2%UG)]AM _K6__ "^^1E]@])^
M#J? %TH8%EOWR,\CY$K#$?&:4OA/-+8B?]H?,1#C^V6.5YX#G/\ *MWI1^1G
M]L[KQBAD\:7L8(!9T S_ +HKMPSM11\OCU?%R7I^2->+X8ZB7 FOK9$[E-S'
M\L"L'CH=$SKCDU6^LD=QI^C6NA:'):6PS\C%W/5VQU-<$ZLJL^9GMTL/##T7
M"!P7PT_Y&*X_Z]6_]"6O1QW\->IX63_QWZ?JCH/B8#_PC]L0.!<C_P!!:N;
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M_@*BI-3=T;4*3I1:;O=W+]9FX4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
K4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>168
<FILENAME>g20922sp333.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922sp333.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MWH D_P"$RTO_ )]=9_\ !)>?_&J #_A,M+_Y]=9_\$EY_P#&J #_ (3+2_\
MGUUG_P $EY_\:H /^$RTO_GUUG_P27G_ ,:H /\ A,M+_P"?76?_  27G_QJ
M@ _X3+2_^?76?_!)>?\ QJ@ _P"$RTO_ )]=9_\ !)>?_&J #_A,M+_Y]=9_
M\$EY_P#&J #_ (3+2_\ GUUG_P $EY_\:H /^$RTO_GUUG_P27G_ ,:H CG\
M<Z+:V\MQ<1:M#!$I>2231KQ510,DDF+  '>@#I* "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M0<^F*-AV=[$H(8 @@@]"*-A+78P/'?\ R3SQ+_V"[G_T4U '04 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0!S_ ($_Y)YX:_[!=M_Z*6@#:NT>2SGC
MB.)&1@I]#CBLZJ;@TNQ<&E)-GG5OX-U>XOK;4K41V*_98PA>XE$D3"W,>WRM
MNT')'[P'< ,#K6TOBGK\3?W.WW;?YD4]%!25[6O\FV_6]^OJ;+>$[^+4+2>&
M\FE2W+"/SM2N"R*T2@DYSO.\$X;C!Z]JB5WS6TNFORM_7SU".BBGTLW^-_S7
MY;$2^$]8N[J3^T+QQ;F6)PT>I3F3Y8V4E>%$>21PO)YRQX%5+6[6]W;Y[?\
M#;>H1NDD^R7W-7_)Z[^A>O-#U9FT2\C:TO+VRMGMYTNI&$;EU4,X(4DD;>A
MR"1D4Y-.<FEH_P -;_TO0(Z04>SO^:_7<S8_"GB,ZO)-/JD;6GG"0+]ID97
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 <_P"!/^2>>&O^P7;?^BEH Z"@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * *>J:I::-8->WKNL"LB?NXFD8L[!% 50
M6)+,!@#O0!E_\)EI?_/KK/\ X)+S_P"-4 '_  F6E_\ /KK/_@DO/_C5 !_P
MF6E_\^NL_P#@DO/_ (U0 ?\ "9:7_P ^NL_^"2\_^-4 '_"9:7_SZZS_ ."2
M\_\ C5 !_P )EI?_ #ZZS_X)+S_XU0 ?\)EI?_/KK/\ X)+S_P"-4 '_  F6
ME_\ /KK/_@DO/_C5 !_PF6E_\^NL_P#@DO/_ (U0 ?\ "9:7_P ^NL_^"2\_
M^-4 '_"9:7_SZZS_ ."2\_\ C5 !_P )EI?_ #ZZS_X)+S_XU0 ?\)EI?_/K
MK/\ X)+S_P"-4 '_  F6E_\ /KK/_@DO/_C5 !_PF6E_\^NL_P#@DO/_ (U0
M!')XYT6%X4EBU9'F;9&K:-> NVTM@?NN3A6.!V!/:@"3_A,M+_Y]=9_\$EY_
M\:H /^$RTO\ Y]=9_P#!)>?_ !J@ _X3+2_^?76?_!)>?_&J #_A,M+_ .?7
M6?\ P27G_P :H /^$RTO_GUUG_P27G_QJ@ _X3+2_P#GUUG_ ,$EY_\ &J #
M_A,M+_Y]=9_\$EY_\:H /^$RTO\ Y]=9_P#!)>?_ !J@ _X3+2_^?76?_!)>
M?_&J #_A,M+_ .?76?\ P27G_P :H /^$RTO_GUUG_P27G_QJ@ _X3+2_P#G
MUUG_ ,$EY_\ &J ,?PGXDM-,\&Z'87ECK,5U:V$$,J?V+=G:ZQJ",B+!Y!Z4
M ;'_  F6E_\ /KK/_@DO/_C5 !_PF6E_\^NL_P#@DO/_ (U0!')XYT6%X4EB
MU9'F;9&K:-> NVTM@?NN3A6.!V!/:@"3_A,M+_Y]=9_\$EY_\:H /^$RTO\
MY]=9_P#!)>?_ !J@ _X3+2_^?76?_!)>?_&J #_A,M+_ .?76?\ P27G_P :
MH /^$RTO_GUUG_P27G_QJ@ _X3+2_P#GUUG_ ,$EY_\ &J #_A,M+_Y]=9_\
M$EY_\:H /^$RTO\ Y]=9_P#!)>?_ !J@ _X3+2_^?76?_!)>?_&J #_A,M+_
M .?76?\ P27G_P :H /^$RTO_GUUG_P27G_QJ@ _X3+2_P#GUUG_ ,$EY_\
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M/_L*/_Z1W- '04 % !0 4 % !0 4 % !0 4 % !0 4 % !0!S_B'_D.>$_\
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MD4#WK3?Z1+Y,206\D[N^UFP%C5C]U&/3M0!G_P#"9:7_ ,^NL_\ @DO/_C5
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ME&! (."..X((_"@-M"2@ H Y^\_Y*'HW_8+OO_1MK0!T% !0 4 % !0 4 %
M'/\ B'_D.>$_^PH__I'<T ;D,\5PA>&5)$#%248$ @X(X[@@C\* VT)* "@
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M?\@.V_["FG_^ED- '04 % ''7_A35+JZNI(-2DMEDFDFC$%U)%\Q\K&[;C.
MC\'(Y'X$=$D^GY<TF_P:^?WB=[R:Z_\ R*2_%?=]PV7PEJTOE(VL7:Q0N%39
MJ$ZL8O.8L&(.6;RB%R23D=> ::M>[[?H_P!;,J6UH?U\/_!^\F31_$L,UK"M
M[%):JB^9*]Y)Y@*HZX"[3N!+*22P.1T-2[RB[[_JTE\M;OY[ K1=UM^G-?[[
M:?J9E]X0\3?9XX;#6YMHR<RZC.&1RB#S-P!+A6#D1G"G=VQBM$USWMI^E^W6
MZTUV%&R@DU=Z7\]_NZ;=B>Q\!W-O;W3S:I.UY<7+'=#.81' UQYK*K(%8%AU
MR3R< @4DTK+TO\D[?)-_YCD[R<O*R^Y)O\"K'X1\50'4\ZU<7:W%RLD:2ZM+
M&K1!C\@*Q[H>"HRK-G'.,U"^&*?S^[OZZVVZ"^TVOE]Z_2ZOOU+5WX;\43.1
M;ZE]F_T>9$E_M":3RV8MLPFT!B,K\[$XQPH/--ZI_P!=?PT[?D/3W?+_ "2^
M>NNMO,W_  IIE_I'AZ"RU*ZFN;E"VZ2:[-RQ!/'[PHA/XK^=7)IVL1%-7N;5
M04<_XA_Y#GA/_L*/_P"D=S0!T% !0 4 <_XR_P"0';?]A33_ /TLAH Z"@ H
M XV[\)ZI/*[1:G+;K]I>55@NY8@0TP9MP7&3Y>X<YP3^(4$E92_KXK_FON')
MWDW_ %>T4OQ3!O"6J32P";6+L10[8P(]0G0F,-)NR0068JT8W'G*GGN6[O7K
MU_\  5_[=KZ?<3K9KS_]N_\ D=/ZN-DT/Q8T"6HU&+88/GN1>2+()/(,> H3
MIOP^[(.>V:N\7)M[7_5/Y:)KYE.R:Y?ZU=O7=?<177A7Q"MY;BQUB46D4A*&
M74)]\0WALD8/G9&Y=KG SP:B%U).7]:O3YJVNZL3)-Q:7]:+7Y.[ML[BZ?X#
MFM5$DNI7!N)+EFE,-PT06'?(ZQJ4"M]YP3DGN,XP*%I&*71+[U&R\K+_ (<-
M^:_5NWSDF_.[2_R*-CX0\6VEB8KG69]0<W?G2K+K$T8E3:P^5TB#0C)4[ 6'
M&,U46ERW6W_ U\^NC[A/64G'1/\ X.GETU78NZAX;\4W,ET+;5/(\RWFC287
M\V5+2,R@)MVJ=I WG<1C@<<PU[MO3\+7UZ7UZ7\^A2=FGZ_D_OZ;Z?F='X9T
M^]TKP_:V6H7$UQ<Q AI)KG[0YY.,R%$+<8ZJ/QZUI-IO0B*:W-:H*.?O/^2A
MZ-_V"[[_ -&VM '04 % !0 4 % !0 4 <_XA_P"0YX3_ .PH_P#Z1W- &2W@
M_5'./[3E@C%PT@2VO)8@5>X=WR%QDF-P,]CT(P#35M+]DONC;\[?+[BJCO=Q
M_KX?\G]XZ7PEJ]P]J9M9NPL:K&XCU"=-R!'!^Z1EBQC.[KP>?6=;-]?ULOU3
M^_Y"5D_+I_X$_P#VW3U^\?)HOBF7?;MJ$8@:/)G2\D60.8U0J%"8 W!F!W=3
MTJWRN5^E_P .9/\ +3]3-*2@EUM^-FOS:97D\*^)$U2T:VUF3['#(-OF7TQ:
M-!*6(*D$3%D(3YS\N,@FE%_S?UI:WZWW-)6Y;1_K;7Y.^FVHFF^ ;BRM[8MJ
MMS]JW@W#Q7#1@(HD\M%V!2RAGSALY[D\"DKJ"BNB_&R5_N0-IR;?5O[FV_O?
M_#%;2_"7BNRLK:*\U6;4&2Z,LPFUF9/,!4 %72)64 Y/E'*\_>JDU>/9?YK_
M ,"Z[V(:=I:ZOY=__ >FW8FU+POXJNQ=K;:NULTEMY23+J,V[/F!L*NW;&2N
M1OP[#C &,'.*?+9^7X+77IKKY]6:)I/_ ,"_&]O6VG73HNI;O?"VKZAX1TW1
M)+Z$O$<W4E\S7AD !P"0(BYR5.3MZ=ZJI[TN9::?C:W^?SZ=IIMP3OO?];_\
M"W;J07/A#6[_ $^6.\U5C/+;FW<1W<RQ%?(V9V#@$R8;/7&>>H--IMM+?7\4
MUK]XZ=H./E_F_P!+?,AO?"?B.<V\EO=I#+&"J'^T[@F %8>0VW,H!C?Y7P&W
M GO5*24[]+_JW:VVSMY="&G[-Q6]OT_#77\!D_A3Q<]U<R#5]\+R[FC_ +2G
MC^TKYFX#(7_1\+\N(\[N]9+2*3_K1Z^=W9VV5AM.[L_ZTTM]ZOOK<;<>#?%+
M0:5%;ZW+!#:.ADAMK]X=V$0?>,;[@"K?(0 V[)(-:1:4U)[?UT_X*L.?O0:C
MHW_G)[_-:Z[%G4M/U*QTFY;4) RSZY820C[7).0OVR'^\%"?[JC ]3UJ%I!+
MK_77K_6@G\3?3^OZ_4[N@84 % !0 4 % !0 4 % !0 4 % !0 4 % '/^._^
M2>>)?^P7<_\ HIJ ,$ZGXFA\2:M<PZ9J!MIE>*U\]-T"M'@*0BMO&[]X22%S
M\N">*(:PL]VT_DW9_A9V[W\PJ:.ZZ)[==+_GI]VI.]_XG-S+#=J'C^SR*$M[
M&9!)(LI&X2!R4RN" 3SV-$;-_P#@/YZ^O^7E>ZJ72T[/_P!)NO\ *_==VK9R
M^)/%MDLUNEC)+#'+@W4NEW+M""S\; VZ?HG*8 W<]*46W!7[+YNVWEKU>A=E
MS/U?_I7?TZ;Z#H]<\5ZE)(+W2I[-H[9V%K%;SC<3"""9E8*?F) 5<,".M:)1
M4]_^![R^_36^UOF0VTU;O]^C^[6VC'#Q5XP6;45GTN&!8KI8K=(].NYY#'EA
MDD!48D $,'"C/S5-/WE'FZO7^GM;OJNP.ZYK=%I_7Z;_ (FEXLGU,WLD-G)=
MK''!"\B6I/F-&TP$Q4#DL$48QR-QQR:4;<SYMKK\I6V[NU_0K7E7+OKOY<OZ
M-VZ7W*<WB+5]-O[#3])TS5+JREMI9!)>6$KLA <KOF+Y!)50%9-Q!Y.33U;E
M?=+_ "[;_*PTHZ>;_P ON_'[B74?$?BC2X;17TU[NX>]$+FTTR1T,956W$^9
M^[ W$;OF&5Z#I327/&/K^=M_36WXF=VJ;EUT_+;[_P#AC-N/%'BJVMM2U'^S
MKR2>/9'':PZ1/(%.]\@ R+YAQM)D4XP1P:A/W8^=OR_#73J:M*[7:_YJS\^K
MMT->^O=4G\.>)C;BZ%S&JM"D.XR1LT*,44#YL@D\#UJ](N/92^]<W_#KT1D[
MRAV;C^-FOELB'4/$>OQWTTVGQRM82QP&$2Z+<LT(+$2,0"&8C ^3 .&!Z YF
MSV??\+77WO2_3KT!/JNWXWU^Y:^?0D6:>5? RW8G%VE]^^\^-E8L;&X/\77]
M<=*J5KZ%=7ZO\V=M4@% !0!S_C+_ ) =M_V%-/\ _2R&@#?)V@GT]*3=E<$>
M?:1J/BSSKX'3[R![Z9)H)-0B\V.%6<JP"H^5 38=K%3G=QUII-02ZK?[K_\
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ME<!6<*-Q S@$^V3^9H\@'T 1)]GN/*NH_+E^4^7*N#P>N#Z' _*C8/(EH *
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MWEEMKR.Y474C11R1^0\>T.J-R&).,=_>B&B?G=??RZ_A;Y%MJUO)?A)LS8/
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M$NHF8A5!)PJD\#M0 ?\ "9:7_P ^NL_^"2\_^-4 '_"9:7_SZZS_ ."2\_\
MC5 !_P )EI?_ #ZZS_X)+S_XU0 ?\)EI?_/KK/\ X)+S_P"-4 '_  F6E_\
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M .?76?\ P27G_P :H /^$RTO_GUUG_P27G_QJ@ _X3+2_P#GUUG_ ,$EY_\
M&J #_A,M+_Y]=9_\$EY_\:H /^$RTO\ Y]=9_P#!)>?_ !J@ _X3+2_^?76?
M_!)>?_&J #_A,M+_ .?76?\ P27G_P :H /^$RTO_GUUG_P27G_QJ@ _X3+2
M_P#GUUG_ ,$EY_\ &J #_A,M+_Y]=9_\$EY_\:H IVVI1ZSXZTZXM+74$@M]
M.NTDDN=/GMU#/);E0#(B@DA&X'I0!UE !0 4 % !0 4 % '-^*Y3:WGAR]:W
MNIH+746>;[-;23LBFUG0':@+8W,HSCO0!)_PF6E_\^NL_P#@DO/_ (U0 ?\
M"9:7_P ^NL_^"2\_^-4 '_"9:7_SZZS_ ."2\_\ C5 !_P )EI?_ #ZZS_X)
M+S_XU0 ?\)EI?_/KK/\ X)+S_P"-4 '_  F6E_\ /KK/_@DO/_C5 $<?CG19
MGF2*+5G>%MDBKHUX2C;0V#^ZX.&4X]"#WH D_P"$RTO_ )]=9_\ !)>?_&J
M#_A,M+_Y]=9_\$EY_P#&J #_ (3+2_\ GUUG_P $EY_\:H /^$RTO_GUUG_P
M27G_ ,:H /\ A,M+_P"?76?_  27G_QJ@#+U[7K;6+.TLK*RU9IVU&R?]YI-
MU&H5+J)V)9HPH 52<D]J .TH * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H Y_Q#_R'/"?_
M &%'_P#2.YH Z"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * .?\/?\ (<\6?]A1/_2.VH Z
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H R]5\0:?HUQ;V]U]J:>X5WCCMK.:X8JA4,<1JQ
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M?_!)>?\ QJ@##T+Q9IT6L>)W:VU8B744==NCW;$#[);CD"/*G(/!P<8/0@D
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MF@#H* "@ H * "@ H * "@ H * "@ H Y_P]_P ASQ9_V%$_]([:@#H* "@
MH * "@ H * "@ H * "@ H * "@ H Y_P]_R'/%G_843_P!([:@#H* "@ H
M* "@ H * "@ H * "@ H * .?L_^2AZS_P!@NQ_]&W5 '04 % !0 4 % !0
M4 % !0 4 % !0 4 % !0!GZGKNCZ)Y7]JZK96'G9\O[5<)%OQC.-Q&<9'YB@
M#/\ ^$[\'_\ 0UZ-_P"!\7_Q5 !_PG?@_P#Z&O1O_ ^+_P"*H /^$[\'_P#0
MUZ-_X'Q?_%4 '_"=^#_^AKT;_P #XO\ XJ@ _P"$[\'_ /0UZ-_X'Q?_ !5
M&'=>-/"K>.M)N%\2Z28(].O$:07T>U6:2V*@G=@$A6P/]D^E &Y_PG?@_P#Z
M&O1O_ ^+_P"*H /^$[\'_P#0UZ-_X'Q?_%4 '_"=^#_^AKT;_P #XO\ XJ@
M_P"$[\'_ /0UZ-_X'Q?_ !5 !_PG?@__ *&O1O\ P/B_^*H T-,UW1];\W^R
M=5LK_P G'F?9;A)=F<XSM)QG!_(T :% !0 4 5[Z_L],LY+R_NX;2UCQOFGD
M"(N3@98\#D@?C0!C_P#"=^#_ /H:]&_\#XO_ (J@ _X3OP?_ -#7HW_@?%_\
M50 ?\)WX/_Z&O1O_  /B_P#BJ #_ (3OP?\ ]#7HW_@?%_\ %4 '_"=^#_\
MH:]&_P# ^+_XJ@##UWQIX5FUCPP\7B7272'47>1EOHR$7[)<+D_-P,LHSZD#
MO0!N?\)WX/\ ^AKT;_P/B_\ BJ #_A._!_\ T->C?^!\7_Q5 !_PG?@__H:]
M&_\  ^+_ .*H /\ A._!_P#T->C?^!\7_P 50 ?\)WX/_P"AKT;_ ,#XO_BJ
M +%CXL\-ZG>1V=AX@TR[NI,[(8+R-W; R<*#D\ G\* )-2\2Z#HUPMOJFMZ?
M8SLN]8[FZ2-BN2,@,0<9!Y]J *?_  G?@_\ Z&O1O_ ^+_XJ@ _X3OP?_P!#
M7HW_ ('Q?_%4 '_"=^#_ /H:]&_\#XO_ (J@ _X3OP?_ -#7HW_@?%_\50 ?
M\)WX/_Z&O1O_  /B_P#BJ ,/0O&GA6'6/$[R^)=)1)M11XV:^C =?LENN1\W
M(RK#([@CM0!N?\)WX/\ ^AKT;_P/B_\ BJ #_A._!_\ T->C?^!\7_Q5 !_P
MG?@__H:]&_\  ^+_ .*H /\ A._!_P#T->C?^!\7_P 50 ?\)WX/_P"AKT;_
M ,#XO_BJ -BQO[/4[..\L+N&[M9,[)H) Z-@X.&'!Y!'X4 6* "@ H Q[[Q9
MX;TR\DL[_P 0:9:74>-\,]Y&CKD9&5)R."#^- %?_A._!_\ T->C?^!\7_Q5
M !_PG?@__H:]&_\  ^+_ .*H /\ A._!_P#T->C?^!\7_P 50 ?\)WX/_P"A
MKT;_ ,#XO_BJ #_A._!__0UZ-_X'Q?\ Q5 &'H7C3PK#K'B=Y?$NDHDVHH\;
M-?1@.OV2W7(^;D95AD=P1VH W/\ A._!_P#T->C?^!\7_P 50 ?\)WX/_P"A
MKT;_ ,#XO_BJ #_A._!__0UZ-_X'Q?\ Q5 !_P )WX/_ .AKT;_P/B_^*H /
M^$[\'_\ 0UZ-_P"!\7_Q5 &Q8W]GJ=G'>6%W#=VLF=DT$@=&P<'##@\@C\*
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M*DC."./>@"Y0 4 % !0 4 % !0 4 % '/WG_ "4/1O\ L%WW_HVUH Z"@ H
M* "@ H * "@ H * "@ H Y^S_P"2AZS_ -@NQ_\ 1MU0!T% !0 4 <_XR_Y
M=M_V%-/_ /2R&@#H* "@ H * "@ H * "@ H * "@#G_ !#_ ,ASPG_V%'_]
M([F@ L_^2AZS_P!@NQ_]&W5 '04 % !0 4 % !0 4 % !0 4 % '/^#?^0'<
M_P#84U#_ -+)J .@H * "@#G_#W_ "'/%G_843_TCMJ .@H * "@ H * "@
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ME;^NI7,]>S;_ !=_T7D:DG@JTD>4#4+R."2(Q^1&(E16,8CWKA,@[5'&=O\
MLU3D[WZ_EKS?FNMR.5<JB]E^.C7Y/I8?+X/A?4/[0CU6^ANV4K+(HA;S5*H"
M&5HRN#Y:G@#OVXI/9KH^GS;_  N_UN.VSZKK_7H2/X5C?P_!I)U2_!@F6=+K
M,9E5E?<, IL !XQMQCM3;?,I+I_DU^HN56<7L_\ -/IZ%<>"XP),ZUJ1<W'V
MJ)_W ,$V"&=<1]P2"&R.>@I+W;6Z7^Y]/3\?,KO?K:_RM9_@.UF'[-J?@^'S
M9)=FI.-\C99O]#N>2:;$E8R/$6J3:3XCUV2UDDCNY].T^"%HH#,ZLTUT-PC
M);:,MC!Z5#O=)?U;7_@%QLKM]/\ AE^)+9>-=0NK2T,.FQ3,8$$\DLS0LLS%
MUV^7L)QOC.<X(ST[551V3E';6W_@/-^7XDQ25E)];/IUM?YWOZ%"7QY>1Z59
M:HTE@N_RS,C7H6V.8I&($ACW*<J.#GD8]<U*T9-+5:^OV=N^^G??LE-.\]]'
MI^;6O;;7M^:R_%3RS+_Q)U7:@.R2[VR0YV?-.NS]U'\_W\G@$XI6U:\_EO;7
ML^J0XOFBGY7\]KZ=UT;[D%Q\1KS2M.%X]HFHO-($7_38H+9 9)@#YK*HQB,
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MYOS&GP;IYCDCW.%DX8#C_EEY7_H Q^M7>5[W_JZ?YI"YJ:27)MYOS_S9'?\
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MN5WWOOYZ)?DK?F:5A8+IT$5O#-*T$421)&^"!MS\V<9)/?)[=N<VW=W_ *]
M2LC*\/?\ASQ9_P!A1/\ TCMJD9T% !0 4 % !0 4 % !0 4 <_>?\E#T;_L%
MWW_HVUH Z"@ H * "@ H * (;:T@M!(((]@DD,C $X+'J?;-&R2#K?\ KL34
M 0V]M#:1LD*;59V<\DY9CDGGW-'2P=;DU !0!S]G_P E#UG_ +!=C_Z-NJ .
M@H * "@#G_&7_(#MO^PII_\ Z60T =!0!%<RFWM)I@NXQH6 ]<"HJ2<8.2Z%
M07-)(\['B;7X9YK=KQ9FO+>&&S=;<$0W!B#LYP.5VEFP?^>>.]745E.*W3>O
MDK7^?;S8J;4N2;V:5UYMNWRTL_EYDL7Q*6U>#3[D6<UZ-*2]=I+DP_,44_.3
M&$123U#$_P"S5U;*<^7:+M^/WWU\_O,Z=W"'-U7Z/_+R^XFG^)<-O:W=PZZ:
MJ6UG%<DF^D;[^WJ%A9E'S<$@%O[N.:B?NW\G;^O/R^^QI%7:\TW]WZ>?W7&1
M_$*;5K=AIL%I!+Y5O,D<UWB:3S#&?EC*<QX?;OSP<_+5R@XRMV=O^'[?B+1+
M7LW]U]N^WD:(\>0Q/';WL%O;7K\+"UV!O(>1'V%@-P7R\YP.&&<5#:M=>ORY
M>97_ ""S6_>WXI?K<SU^)@^RPS"RLYV>UFN#%:W_ )KML+<(/+&X?+RYPOH6
MIR5KVZ)>6]M^RUZZ^5@[>K7W*^G=^2^\9;_$:\EL[2^FL=)M8)[6:7;)K$;9
MDC8#"R*"A&#D\Y'/'&"2]V]_+\6T_EZ>7?24[M>K_!)KY[Z/UOH=)H&MRZK=
MR[MIB>TM[I-A)5?,W J&*J2/DSD@'FJE#E3\FU^"?ZA>]FNJ_)O^OD;]04<_
MXA_Y#GA/_L*/_P"D=S0 6?\ R4/6?^P78_\ HVZH Z"@ H * "@!" 001D'J
M*32:LPV(K2UAL;2*UMTV00J$1<D[0.@YJFVW=@34@(1:PK=M=!/W[((RV3RH
M)(&.G4FC8-[>7]?H$MK#--!+(FYX&+1G)^4D$9Q]"1^-"T=PZ6)J "@#G_!O
M_(#N?^PIJ'_I9-0!T% !0 4 <_X>_P"0YXL_["B?^D=M0!T% !0!Y[J7B;6K
M6XBO(K@-9QK?2W%NL(8^7%*L:D'&<KDL>N>1Z83T@WY+[Y7:_P OQ-5%-V7\
MR^ZVJ^>Z^1"GQ'U%SJ5M%I=HLFGP1R&>[U!(]_W-[-$H+HN&)#8(X[5;2;;6
MBYK?BU\OGZF$;\JOJW&_SM?Y_+KH6[CQSJ&E:=J-U<Z9'>)%YKVS0W0 <+*J
M88E0$4;Q\Y)X!)Q4[1\]/+>_W;;>AHE>6FUK_P#DJ>G>Y-:^,-3U2R@N8["V
MM(";8R2)>K<',DH4HNQ2K+MS\P;//3TJR3\M?_2>;Y;KN9J7,K+^M6OT*NG?
M$QM5L)KJPTZUN1;R2B9H[MP@6-49BI:)2QP_0J!D=<<T1C?E?1_YV_K8N2Y7
M)=5_D]_N\Q'^(CK)J=T4L(X+(,GD37ZH0PEV9E)3]V2,D*-Q((QR:B.J3[V_
M&_WO35=&+[5EY_\ MOX:Z/J=7HNHS7UQJ"2$,L4B&,@8PK1JV.@/!)ZC.,5;
M5EZ-K^OR^0D[V?=)_FOT->I&% '/^#?^0'<_]A34/_2R:@#H* .?L_\ DH>L
M_P#8+L?_ $;=4 =!0 4 <3K^LZW#K21:9, L=ZD1MS&I\Y! \K+D\@MP >Q7
MZY(-:RELK_=[J_"[?GL6XZ-+>RMZN37W:?F9EG\2+ZXNHK"VTN.>26S>YCN+
MF[C@+G#LH$/WV&% )4'!ZBIU4)/^5+\E?\].C)BO>2?5M?BU]Y>3QMJ$*F]D
ML8+VR>V23_0[GS"',3OMC^0;P=F,DC''!YJY^YS+LW;[H_AKN*FG4:]%?YR:
M^_;3IW(+?Q[JNK^'1>6NEVEM*]O<2NZ:E'<"$1[<%2BLKDEQ\IVXP<U:A[R[
M>[^+M^FXHR33_KI?Y>A8M_B&U]JNI:7I]E:75Y97*P8%U(B9(<_.3$-I'EGA
M0PYZUDG>FJG37\%?^MBK6=GV7XM+]?\ @$*?$-[F_;9#:V\-O 9GBFO%21_W
M(<%@5PB9; ?=R0>*J2Y7+RO^$DM>S\M=";_"OZV;T[^NFIO^']>EUBZ#DQF"
M>RBN4$3%T4EG!PQ52P.T8)'K3<;77:WXK^OO"]TGZ_@U_G^!T-2,* .?\/?\
MASQ9_P!A1/\ TCMJ .@H * "@ H * "@ H * "@#G[S_ )*'HW_8+OO_ $;:
MT =!0!C>*,C1><^5]H@\['_//S5W9]L9S[9IQ^.-^_XVT_&P/X9>C_+7\#BX
M_".NQP)8BVQ8I?KJ0_T@;O--QEEQG[H3+]>IQBG2?+R-_927WQU^YW7H_(35
M^?\ O<WZ\OW^[VM;7<NQ3>.VN;Q9+._B@%^GD$3V;L\.6W9;:-B?=XVL_OSD
M*GM'FWUO^'_!VMZH*ETY*.UM/77_ (&]_06YE\=I'";6TOYI#J!W&2>SC"P<
M<E0K97J  V_N2.!2AO#F[:_UW]-%YCJ;2Y?E^/\ P-_P'&P\6WL0EEFOK:_M
MY9G5R+4Q_=;:L8 )V$[0=_S>XZTH:6;[:^MX_AH[6U[C:3G9[7^Y>]KZZJ_3
ML6-1N/&12ZAMK.]5HU<I-!]E/F$R*4";VXPFX$L/?#<4_P#-?K^&WGY"73T_
M1?K?R_(I:NOQ DBO5TN2[MV,L6QVCM)65-IW^4A*ACG;DR,O!.%&.3_-_=TZ
MZ+[V.-K:[V7WZ7^>_1(G>#QA;WDQCEU2<37$#_+]D6)4\L"11N)9!N!)P'[;
M>235KENETN_NOI\K;;/NTB'?D7>WXZ_+MW_(Z/PWN_LV;_GE]KG\K_<\UL8]
MO3VQ4+X(^B_X'X6+E\<K?T[*_P"-S8H$<_9_\E#UG_L%V/\ Z-NJ .@H * "
M@#G_ !E_R [;_L*:?_Z60T =!0 A (((R#U%)I-68;$5I:PV-I%:VZ;((5"(
MN2=H'0<U3;;NP)J0!0 4 % !0 4 11VT,5Q-.B8EFQO;).<# ^G_ .NC96#K
M?^OZU): .?\ $/\ R'/"?_84?_TCN: "S_Y*'K/_ &"['_T;=4 =!0 4 >?W
M^C7VI:[<7EDI^VV%U-(C-)M&XQ1B-3ZJR[EZ$#)/6HM)0NNTE_Y-^=K6^16C
MERR[Q:\ERO7_ ,"O^)2_LWQ^%>SCNKBTL(],2."*UCMSB41C.96?<'W CA2N
M,<@\C:;3G*6^M_E=;?+O;_//5QBDK-IW]6GV[::HTKG3O%]LFI76DW,RS7()
M2*X6!L-Y,8$AQCY]RL,;MF>V.:B5TN5>?R][I?R;>OX%1Z-_CZ/>WG;8=;Z;
MXLO=-M%U.]N9'B2(R1O#;Q><XGR2X0OC"!3\K@']*IV4KKR_X(E?EM_B_+1?
MF0V:^/;NWO%G-UI[)/(T#/):3/(@0[!E4"A2V."-P&?F[B8_#%O>WZK?\=K%
M.W/;I=:^6M[?AO<;>V_C%]5O;H17Q:-)$M6@^R%%5C'CRP[ [L!LF3@=@>A2
MT7G_ ,'\K6\QK6R?E_Z2_P ;O3I8Z'P[]J^W:C]H!#;8/-!8,1-Y8WY*@ G&
MSH /:K=K.VUW;TT_6YDN:ZOV7WW?Z6.@J2PH Y_P;_R [G_L*:A_Z634 =!0
M 4 % '/^'O\ D.>+/^PHG_I';4 =!0 4 0VUI!:"001[!)(9& )P6/4^V:-D
MD'6_]=B:@ H * "@ H AAM8;=YFB3:TS^9(<D[FP!G\@!^%'2P=;DU !0!S_
M (-_Y =S_P!A34/_ $LFH Z"@#G[/_DH>L_]@NQ_]&W5 '04 % $*6D$=W-=
M(F)IE57;)^8+G''3N>:%HK?U_6@=;DU !0 4 % !0!"EK#'=2W*IB:555VR3
MD+G ]NI_.C96 FH * .?\/?\ASQ9_P!A1/\ TCMJ .@H * "@ H * "@ H *
M "@#E]<NQIGC+1[^>VO9+5;"[A9[6SEN-KM);E01&K$9"-U]#0!8_P"$RTO_
M )]=9_\ !)>?_&J #_A,M+_Y]=9_\$EY_P#&J #_ (3+2_\ GUUG_P $EY_\
M:H /^$RTO_GUUG_P27G_ ,:H /\ A,M+_P"?76?_  27G_QJ@ _X3+2_^?76
M?_!)>?\ QJ@ _P"$RTO_ )]=9_\ !)>?_&J #_A,M+_Y]=9_\$EY_P#&J #_
M (3+2_\ GUUG_P $EY_\:H /^$RTO_GUUG_P27G_ ,:H /\ A,M+_P"?76?_
M  27G_QJ@"OH=V-3\9:Q?P6U[%:M86D*O=6<MON=9+@L )%4G =>GJ* .HH
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
9H * "@ H * "@ H * "@ H * "@ H __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>169
<FILENAME>g20922sp365p.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g20922sp365p.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#L17AI9@  34T *@    @ ! $[  (
M   +   (2H=I  0    !   (5IR=  $    6   0SNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 %!I;FMY($%R
M>6$    %D ,  @   !0  !"DD 0  @   !0  !"XDI$  @    ,S,   DI(
M @    ,S,   ZAP !P  " P   B8     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*BHJ*O_  !$( "8 X ,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
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M9M3D>QNXDETZS\[(%R5*-&R^D14GIS\OO7J5OK.KI\+]0UF[95OH[*>X@;8
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(8O9M">Q__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
